PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Chan, AH; Yi, SW; Terwilliger, AL; Maresso, AW; Jung, ME; Clubb, RT				Chan, Albert H.; Yi, Sung Wook; Terwilliger, Austen L.; Maresso, Anthony W.; Jung, Michael E.; Clubb, Robert T.			Structure of the Bacillus anthracis Sortase A Enzyme Bound to Its Sorting Signal A FLEXIBLE AMINO-TERMINAL APPENDAGE MODULATES SUBSTRATE ACCESS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNETIC-RESONANCE RELAXATION; NMR STRUCTURE DETERMINATION; MODEL-FREE APPROACH; STAPHYLOCOCCUS-AUREUS; SURFACE PROTEIN; ACTIVE-SITE; CELL-WALL; KINETIC MECHANISM; DIPOLAR COUPLINGS; MACROMOLECULES	The endospore forming bacterium Bacillus anthracis causes lethal anthrax disease in humans and animals. The ability of this pathogen to replicate within macrophages is dependent upon the display of bacterial surface proteins attached to the cell wall by the B. anthracis Sortase A ((Ba)SrtA) enzyme. Previously, we discovered that the class A (Ba)SrtA sortase contains a unique N-terminal appendage that wraps around the body of the protein to contact the active site of the enzyme. To gain insight into its function, we determined the NMR structure of (Ba)SrtA bound to a LPXTG sorting signal analog. The structure, combined with dynamics, kinetics, and whole cell protein display data suggest that the N terminus modulates substrate access to the enzyme. We propose that it may increase the efficiency of protein display by reducing the unproductive hydrolytic cleavage of enzyme-protein covalent intermediates that form during the cell wall anchoring reaction. Notably, a key active site loop (beta 7/beta 8 loop) undergoes a disordered to ordered transition upon binding the sorting signal, potentially facilitating recognition of lipid II.	[Chan, Albert H.; Yi, Sung Wook; Jung, Michael E.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Chan, Albert H.; Clubb, Robert T.] Univ Calif Los Angeles, DOE Inst Genom & Prote, Los Angeles, CA 90095 USA; [Chan, Albert H.; Clubb, Robert T.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Terwilliger, Austen L.; Maresso, Anthony W.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	University of California System; University of California Los Angeles; United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Baylor College of Medicine	Clubb, RT (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 602 Boyer Hall, Los Angeles, CA 90095 USA.	rclubb@mbi.ucla.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [AI52217, AI097167, AI109465, T32 GM008496]; Department of Energy [DE-FC-03-87ER60615]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI109465, R01AI052217, R01AI097167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008496] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016336] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants AI52217 (to R. T. C. and M. E. J.), AI097167 and AI109465 (to A. W. M.), and T32 GM008496 (to A. H. C.) and Department of Energy Grant DE-FC-03-87ER60615. The authors declare that they have no conflicts of interest with the contents of this article.	Aucher W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027411; Bax A, 2001, METHOD ENZYMOL, V339, P127, DOI 10.1016/S0076-6879(01)39313-8; Berjanskii MV, 2008, J BIOMOL NMR, V40, P31, DOI 10.1007/s10858-007-9208-0; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Brenke R, 2009, BIOINFORMATICS, V25, P621, DOI 10.1093/bioinformatics/btp036; BRUSCHWEILER R, 1995, SCIENCE, V268, P886, DOI 10.1126/science.7754375; Cascioferro S, 2014, MICROB PATHOGENESIS, V77, P105, DOI 10.1016/j.micpath.2014.10.007; Case DA, 2012, AMBER 12; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Clancy KW, 2010, BIOPOLYMERS, V94, P385, DOI 10.1002/bip.21472; Cole R, 2003, J BIOMOL NMR, V26, P203, DOI 10.1023/A:1023808801134; Comfort D, 2004, INFECT IMMUN, V72, P2710, DOI 10.1128/IAI.72.5.2710-2722.2004; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W., 2006, PYMOL MOL GRAPHICS S; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Frankel BA, 2005, BIOCHEMISTRY-US, V44, P11188, DOI 10.1021/bi050141j; GAGNE SM, 1994, PROTEIN SCI, V3, P1961, DOI 10.1002/pro.5560031108; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Gaspar AH, 2005, J BACTERIOL, V187, P4646, DOI 10.1128/JB.187.13.4646-4655.2005; Goddard T. D., 2006, SPARKY 3; Grishaev A, 2004, J AM CHEM SOC, V126, P7281, DOI 10.1021/ja0319994; Hendrickx APA, 2011, NAT REV MICROBIOL, V9, P166, DOI 10.1038/nrmicro2520; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Holty JEC, 2006, ANN INTERN MED, V144, P270, DOI 10.7326/0003-4819-144-4-200602210-00009; Huang XY, 2003, BIOCHEMISTRY-US, V42, P11307, DOI 10.1021/bi034391g; Iwahara J, 2001, J BIOMOL NMR, V19, P231, DOI 10.1023/A:1011296112710; Jacobitz AW, 2014, J BIOL CHEM, V289, P8891, DOI 10.1074/jbc.M113.509273; Jung ME, 2005, BIOORG MED CHEM LETT, V15, P5076, DOI 10.1016/j.bmcl.2005.07.073; Jung ME, 2012, TETRAHEDRON LETT, V53, P4216, DOI 10.1016/j.tetlet.2012.05.153; Keller R., 2004, COMPUTER AIDED RESON, V1; Kleckner IR, 2011, BBA-PROTEINS PROTEOM, V1814, P942, DOI 10.1016/j.bbapap.2010.10.012; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lee LK, 1997, J BIOMOL NMR, V9, P287, DOI 10.1023/A:1018631009583; Liew CK, 2004, FEBS LETT, V571, P221, DOI 10.1016/j.febslet.2004.06.070; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Loria JP, 2008, ACCOUNTS CHEM RES, V41, P214, DOI 10.1021/ar700132n; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Manzano C, 2008, STRUCTURE, V16, P1838, DOI 10.1016/j.str.2008.10.007; Maresso AW, 2008, PHARMACOL REV, V60, P128, DOI 10.1124/pr.107.07110; Maresso AW, 2006, J BACTERIOL, V188, P8145, DOI 10.1128/JB.01011-06; Marraffini LA, 2007, J BACTERIOL, V189, P6425, DOI 10.1128/JB.00702-07; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Naik MT, 2006, J BIOL CHEM, V281, P1817, DOI 10.1074/jbc.M506123200; Ngan CH, 2012, BIOINFORMATICS, V28, P286, DOI 10.1093/bioinformatics/btr651; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; POWERS R, 1993, BIOCHEMISTRY-US, V32, P6744, DOI 10.1021/bi00077a030; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Schneewind O, 2014, BBA-MOL CELL RES, V1843, P1687, DOI 10.1016/j.bbamcr.2013.11.009; Schneewind O, 2012, PHILOS T R SOC B, V367, P1123, DOI 10.1098/rstb.2011.0210; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Scott JR, 2006, MOL MICROBIOL, V62, P320, DOI 10.1111/j.1365-2958.2006.05279.x; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Spirig T, 2011, MOL MICROBIOL, V82, P1044, DOI 10.1111/j.1365-2958.2011.07887.x; Suree N, 2007, MINI-REV MED CHEM, V7, P991, DOI 10.2174/138955707782110097; Suree N, 2009, BIOORGAN MED CHEM, V17, P7174, DOI 10.1016/j.bmc.2009.08.067; Suree N, 2009, J BIOL CHEM, V284, P24465, DOI 10.1074/jbc.M109.022624; Teng Q., 2005, STRUCTURAL BIOL PRAC; Tollinger M, 2001, J AM CHEM SOC, V123, P11341, DOI 10.1021/ja011300z; Ton-That H, 2004, TRENDS MICROBIOL, V12, P228, DOI 10.1016/j.tim.2004.03.004; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Weiner EM, 2010, J BIOL CHEM, V285, P23431, DOI 10.1074/jbc.M110.135434; Zink SD, 2005, INFECT IMMUN, V73, P5222, DOI 10.1128/IAI.73.8.5222-5228.2005; Zong YN, 2004, STRUCTURE, V12, P105, DOI 10.1016/j.str.2003.11.021; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	72	15	16	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25461	25474		10.1074/jbc.M115.670984	http://dx.doi.org/10.1074/jbc.M115.670984			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26324714	Green Published, hybrid			2022-12-26	WOS:000362962800022
J	Henault, CM; Juranka, PF; Baenziger, JE				Henault, Camille M.; Juranka, Peter F.; Baenziger, John E.			The M4 Transmembrane alpha-Helix Contributes Differently to Both the Maturation and Function of Two Prokaryotic Pentameric Ligand-gated Ion Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; TRYPTOPHAN SCANNING MUTAGENESIS; X-RAY STRUCTURES; TORPEDO-CALIFORNICA; ALLOSTERIC MODULATION; STRUCTURAL BASIS; GATING KINETICS; MOLECULAR-DYNAMICS; LIPID-COMPOSITION; DOMAIN INTERFACE	The role of the outermost transmembrane alpha-helix in both the maturation and function of the prokaryotic pentameric ligand-gated ion channels, GLIC and ELIC, was examined by Ala scanning mutagenesis, deletion mutations, and mutant cycle analyses. Ala mutations at the M4-M1/M3 interface lead to loss-of-function phenotypes in GLIC, with the largest negative effects occurring near the M4 C terminus. In particular, two aromatic residues at the M4 C terminus form a network of pi-pi and/or cation-pi interactions with residues on M3 and the beta 6-beta 7 loop that is essential for both maturation and function. M4-M1/M3 interactions appear to be optimized in GLIC with even subtle structural changes at this interface leading to detrimental effects. In contrast, mutations along the M4-M1/M3 interface of ELIC typically lead to gain-of-function phenotypes, suggesting that these interactions in ELIC are not optimized for channel function. In addition, no cluster of interacting residues involving the M4 C terminus, M3, and the beta 6-beta 7 loop was found, suggesting that the M4 C terminus plays little role in ELIC maturation or function. This study shows that M4 makes distinct contributions to the maturation and gating of these two closely related homologs, suggesting that GLIC and ELIC exhibit divergent features of channel function.	[Henault, Camille M.; Juranka, Peter F.; Baenziger, John E.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada	University of Ottawa	Baenziger, JE (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	John.Baenziger@uottawa.ca		Baenziger, John/0000-0002-2888-5328	Canadian Institutes of Health Research [111243]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant 111243 (to J. E B.). The authors declare that they have no conflicts of interest with the contents of this article.	Antollini SS, 2005, MOL MEMBR BIOL, V22, P471, DOI 10.1080/09687860500367915; Baenziger JE, 2000, J BIOL CHEM, V275, P777, DOI 10.1074/jbc.275.2.777; Baenziger JE, 2008, MOL PHARMACOL, V73, P880, DOI 10.1124/mol.107.039008; Baenziger JE, 2015, BBA-BIOMEMBRANES, V1848, P1806, DOI 10.1016/j.bbamem.2015.03.010; Baenziger JE, 2011, NEUROPHARMACOLOGY, V60, P116, DOI 10.1016/j.neuropharm.2010.08.007; Barrantes FJ, 2015, BBA-BIOMEMBRANES, V1848, P1796, DOI 10.1016/j.bbamem.2015.03.028; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bouzat C, 2000, J GEN PHYSIOL, V115, P663, DOI 10.1085/jgp.115.5.663; Bouzat C, 1998, MOL PHARMACOL, V54, P146, DOI 10.1124/mol.54.1.146; Bouzat C, 2002, BIOPHYS J, V82, P1920, DOI 10.1016/S0006-3495(02)75541-0; BOUZAT C, 1994, NEURON, V13, P1395, DOI 10.1016/0896-6273(94)90424-3; Butler AS, 2009, NEUROPHARMACOLOGY, V56, P292, DOI 10.1016/j.neuropharm.2008.08.017; Caballero-Rivera D, 2012, CHANNELS, V6, P111, DOI 10.4161/chan.19540; Carswell CL, 2015, STRUCTURE, V23, P1655, DOI 10.1016/j.str.2015.06.020; Carswell CL, 2015, J BIOL CHEM, V290, P2496, DOI 10.1074/jbc.M114.624395; CRIADO M, 1982, BIOCHEMISTRY-US, V21, P3622, DOI 10.1021/bi00258a015; CRIADO M, 1984, J BIOL CHEM, V259, P9188; daCosta CJB, 2002, J BIOL CHEM, V277, P201, DOI 10.1074/jbc.M108341200; Dacosta CJB, 2013, NAT CHEM BIOL, V9, P701, DOI [10.1038/NCHEMBIO.1338, 10.1038/nchembio.1338]; Dacosta CJB, 2013, STRUCTURE, V21, P1271, DOI 10.1016/j.str.2013.06.019; daCosta CJB, 2009, J BIOL CHEM, V284, P17819, DOI 10.1074/jbc.M900030200; Dellisanti CD, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001714; Duret G, 2011, P NATL ACAD SCI USA, V108, P12143, DOI 10.1073/pnas.1104494108; FONG TM, 1986, BIOCHEMISTRY-US, V25, P830, DOI 10.1021/bi00352a015; Forman SA, 2015, NEUROPHARMACOLOGY, V96, P169, DOI 10.1016/j.neuropharm.2014.10.002; Gonzalez-Gutierrez G, 2015, J GEN PHYSIOL, V146, P15, DOI 10.1085/jgp.201411333; Gonzalez-Gutierrez G, 2012, P NATL ACAD SCI USA, V109, P6331, DOI 10.1073/pnas.1119268109; Grutter T, 2005, P NATL ACAD SCI USA, V102, P18207, DOI 10.1073/pnas.0509024102; Haeger S, 2010, NAT STRUCT MOL BIOL, V17, P90, DOI 10.1038/nsmb.1721; Hamouda AK, 2006, BIOCHEMISTRY-US, V45, P4327, DOI 10.1021/bi052281z; Henault CM, 2015, NEUROPHARMACOLOGY, V96, P157, DOI 10.1016/j.neuropharm.2014.11.011; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Jha A, 2007, J GEN PHYSIOL, V130, P547, DOI 10.1085/jgp.200709856; Kinde MN, 2015, STRUCTURE, V23, P995, DOI 10.1016/j.str.2015.03.017; Labriola JM, 2013, J BIOL CHEM, V288, P11294, DOI 10.1074/jbc.M113.458133; Lasalde JA, 1996, BIOCHEMISTRY-US, V35, P14139, DOI 10.1021/bi961583l; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; LEE YH, 1994, BIOPHYS J, V66, P646, DOI 10.1016/S0006-3495(94)80838-0; Leon RDD, 2008, CHANNELS, V2, P439, DOI 10.4161/chan.2.6.7130; LI L, 1990, BIOCHEMISTRY-US, V29, P5428, DOI 10.1021/bi00475a003; Mitra A, 2004, STRUCTURE, V12, P1909, DOI 10.1016/j.str.2004.08.004; Nury H, 2011, M S-MED SCI, V27, P1056, DOI 10.1051/medsci/20112712006; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Ortiz-Acevedo A, 2004, J BIOL CHEM, V279, P42250, DOI 10.1074/jbc.M405132200; OrtizMiranda SI, 1997, J MEMBRANE BIOL, V158, P17, DOI 10.1007/s002329900240; Pan JJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1703; Pons S, 2004, EUR J NEUROSCI, V20, P2022, DOI 10.1111/j.1460-9568.2004.03673.x; Prevost MS, 2012, NAT STRUCT MOL BIOL, V19, P642, DOI 10.1038/nsmb.2307; Rienzo M, 2014, CHEM BIOL, V21, P1700, DOI 10.1016/j.chembiol.2014.10.019; Sauguet L, 2014, P NATL ACAD SCI USA, V111, P966, DOI 10.1073/pnas.1314997111; Sauguet L, 2013, EMBO J, V32, P728, DOI 10.1038/emboj.2013.17; Shen XM, 2006, ANN NEUROL, V60, P128, DOI 10.1002/ana.20861; Tamamizu S, 2000, BIOCHEMISTRY-US, V39, P4666, DOI 10.1021/bi992835w; Tamamizu S, 1999, J MEMBRANE BIOL, V170, P157, DOI 10.1007/s002329900545; Tillman TS, 2014, J BIOL CHEM, V289, P13851, DOI 10.1074/jbc.M113.524611; TOBIMATSU T, 1987, FEBS LETT, V222, P56, DOI 10.1016/0014-5793(87)80191-6; Velisetty P, 2014, J BIOL CHEM, V289, P3013, DOI 10.1074/jbc.M113.523050; Velisetty P, 2012, J BIOL CHEM, V287, P18467, DOI 10.1074/jbc.M112.348045; Wang HL, 2012, J BIOL CHEM, V287, P6482, DOI 10.1074/jbc.M111.305839; Wang JM, 2002, NAT NEUROSCI, V5, P963, DOI 10.1038/nn918; Williamson PTF, 2005, MOL MEMBR BIOL, V22, P485, DOI 10.1080/09687860500370653; Xu YC, 2005, J AM CHEM SOC, V127, P1291, DOI 10.1021/ja044577i; Zimmermann I, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001429; Zimmermann I, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001101	67	22	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					25118	25128		10.1074/jbc.M115.676833	http://dx.doi.org/10.1074/jbc.M115.676833			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26318456	hybrid, Green Published			2022-12-26	WOS:000362598300039
J	Gao, W; Kim, H; Ho, M				Gao, Wei; Kim, Heungnam; Ho, Mitchell			Human Monoclonal Antibody Targeting the Heparan Sulfate Chains of Glypican-3 Inhibits HGF-Mediated Migration and Motility of Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; LIVER-REGENERATION; POOR-PROGNOSIS; TUMOR-GROWTH; EXPRESSION; MET; CANCER; ANGIOGENESIS; METASTASIS; PI-88	Heparan sulfate proteoglycans (HSPGs) participate in many processes related to tumor development, including tumorigenesis and metastasis. HSPGs contain one or more heparan sulfate (HS) chains that are covalently linked to a core protein. Glypican-3 (GPC3) is a cell surface-associated HSPG that is highly expressed in hepatocellular carcinoma (HCC). GPC3 is involved in Wnt3a-dependent HCC cell proliferation. Our previous study reported that HS20, a human monoclonal antibody targeting the HS chains on GPC3, inhibited Wnt3a/beta-catenin activation. In the current study, we showed that the HS chains of GPC3 could mediate HCC cells' migration and motility. Knocking down GPC3 or targeting the HS chains by HS20 inhibited HCC cell migration and motility. However, HS20 had no effect on GPC3 knockdown cells or GPC3 negative cells. In addition, an antibody that recognizes the core protein of GPC3 did not change the rate of cell motility. HCC cell migration and motility did not respond to either canonical or non-canonical Wnt induction, but did increase under hepatocyte growth factor (HGF) treatment. HS20-treated HCC cells exhibited less ability for HGF-mediated migration and motility. Furthermore, HS20 inhibited in vitro HCC spheroid formation and liver tumor growth in mice. GPC3 interacted with HGF; however, a mutant GPC3 lacking the HS chain showed less interaction with HGF. Blocking the HS chains on GPC3 with HS20 reduced c-Met activation in HGF-treated HCC cells and 3D-cultured spheroids. Taken together, our study suggests that GPC3 is involved in HCC cell migration and motility through HS chain-mediated cooperation with the HGF/Met pathway, showing how HS targeting has potential therapeutic implications for liver cancer.	[Gao, Wei; Kim, Heungnam; Ho, Mitchell] NCI, Antibody Therapy Sect, Mol Biol Lab, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ho, M (corresponding author), NCI, Antibody Therapy Sect, Mol Biol Lab, Ctr Canc Res,NIH, Bethesda, MD 20892 USA.	homi@mail.nih.gov		Ho, Mitchell/0000-0002-9152-5405	NATIONAL CANCER INSTITUTE [ZIABC010891] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aikawa T, 2008, J CLIN INVEST, V118, P89, DOI 10.1172/JCI32412; Akutsu N, 2010, WORLD J GASTROENTERO, V16, P3521, DOI 10.3748/wjg.v16.i28.3521; Amicone L, 1997, EMBO J, V16, P495, DOI 10.1093/emboj/16.3.495; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Borowiak M, 2004, P NATL ACAD SCI USA, V101, P10608, DOI 10.1073/pnas.0403412101; Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627; Capurro MI, 2005, CANCER RES, V65, P6245, DOI 10.1158/0008-5472.CAN-04-4244; Cecchi F, 2012, CANCER CELL, V22, P250, DOI 10.1016/j.ccr.2012.06.029; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; Derksen PWB, 2002, BLOOD, V99, P1405, DOI 10.1182/blood.V99.4.1405; Feng MQ, 2013, P NATL ACAD SCI USA, V110, pE1083, DOI 10.1073/pnas.1217868110; Ferro V, 2007, SEMIN THROMB HEMOST, V33, P557, DOI 10.1055/s-2007-982088; Ferro V, 2012, J MED CHEM, V55, P3804, DOI 10.1021/jm201708h; Filmus J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-224; Gao W, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7536; Gao W, 2014, HEPATOLOGY, V60, P576, DOI 10.1002/hep.26996; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Gerotziafas GT, 2007, PATHOPHYSIOL HAEMO T, V36, P204, DOI 10.1159/000175158; Giordano S, 2014, J HEPATOL, V60, P442, DOI 10.1016/j.jhep.2013.09.009; Gutierrez J, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-5; Ho M, 2005, J BIOL CHEM, V280, P607, DOI 10.1074/jbc.M409783200; Hsu HC, 1997, CANCER RES, V57, P5179; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Kaposi-Novak P, 2006, J CLIN INVEST, V116, P1582, DOI 10.1172/JCI27236; Karihaloo A, 2004, MOL CELL BIOL, V24, P8745, DOI 10.1128/MCB.24.19.8745-8752.2004; Kayed H, 2006, INT J ONCOL, V29, P1139; Kudchadkar R, 2008, EXPERT OPIN INV DRUG, V17, P1769, DOI 10.1517/13543784.17.11.1769 ; Li FC, 2011, J CELL BIOL, V192, P691, DOI 10.1083/jcb.201008087; Liu CJ, 2009, J HEPATOL, V50, P958, DOI 10.1016/j.jhep.2008.12.023; Llovet JM, 2014, CLIN CANCER RES, V20, P2072, DOI 10.1158/1078-0432.CCR-13-0547; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Orentas RJ, 2012, FRONT ONCOL, V2, DOI [10.3389/fonc.2012.00194, 10.3389/fonc.2012.00003]; Parish CR, 1999, CANCER RES, V59, P3433; Perini MV, 2015, WORLD J HEPATOL, V7, P93, DOI 10.4254/wjh.v7.i1.93; Phung Y, 2012, MABS-AUSTIN, V4, P592, DOI 10.4161/mabs.20933; Sanderson RD, 2001, SEMIN CELL DEV BIOL, V12, P89, DOI 10.1006/scdb.2000.0241; Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Shirakawa H, 2009, CANCER SCI, V100, P1403, DOI 10.1111/j.1349-7006.2009.01206.x; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; Ueki T, 1997, HEPATOLOGY, V25, P862, DOI 10.1002/hep.510250413; Venero Galanternik M, 2015, CELL REP; Weiswald LB, 2015, NEOPLASIA, V17, P1, DOI 10.1016/j.neo.2014.12.004; Williamson D, 2007, CANCER RES, V67, P57, DOI 10.1158/0008-5472.CAN-06-1650	46	42	49	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137664	10.1371/journal.pone.0137664	http://dx.doi.org/10.1371/journal.pone.0137664			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332121	gold, Green Published, Green Submitted			2022-12-26	WOS:000360613800137
J	Humphries, GRW				Humphries, Grant Richard Woodrow			Estimating Regions of Oceanographic Importance for Seabirds Using A-Spatial Data	PLOS ONE			English	Article							PELAGIC SEABIRD; SHEARWATER; HARVEST; TRENDS; OCEAN; CHICK; AVAILABILITY; BEHAVIOR; RAKIURA; COLONY	Advances in GPS tracking technologies have allowed for rapid assessment of important oceanographic regions for seabirds. This allows us to understand seabird distributions, and the characteristics which determine the success of populations. In many cases, quality GPS tracking data may not be available; however, long term population monitoring data may exist. In this study, a method to infer important oceanographic regions for seabirds will be presented using breeding sooty shearwaters as a case study. This method combines a popular machine learning algorithm (generalized boosted regression modeling), geographic information systems, long-term ecological data and open access oceanographic datasets. Time series of chick size and harvest index data derived from a long term dataset of Maori 'muttonbirder' diaries were obtained and used as response variables in a gridded spatial model. It was found that areas of the sub-Antarctic water region best capture the variation in the chick size data. Oceanographic features including wind speed and charnock (a derived variable representing ocean surface roughness) came out as top predictor variables in these models. Previously collected GPS data demonstrates that these regions are used as "flyways" by sooty shearwaters during the breeding season. It is therefore likely that wind speeds in these flyways affect the ability of sooty shearwaters to provision for their chicks due to changes in flight dynamics. This approach was designed to utilize machine learning methodology but can also be implemented with other statistical algorithms. Furthermore, these methods can be applied to any long term time series of population data to identify important regions for a species of interest.	[Humphries, Grant Richard Woodrow] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Humphries, Grant Richard Woodrow] Univ Otago, Dept Zool, Ctr Sustainabil Agr Food Energy & Environm, Dunedin, New Zealand	University of California System; University of California Davis; University of Otago	Humphries, GRW (corresponding author), Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA.	grwhumphries@humphriesresearch.com		Humphries, Grant/0000-0001-5783-9892	National Geographic [WGS249-12]	National Geographic(National Geographic Society)	This project was funded by National Geographic, grant# WGS249-12 on behalf of the Waitt Foundation and the Department of Zoology at the University of Otago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2010, MAR BIOL, V157, P915, DOI 10.1007/s00227-009-1367-y; Becker BH, 2007, MAR ECOL PROG SER, V329, P267, DOI 10.3354/meps329267; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Brooke M., 2004, ALBATROSSES PETRELS; Catry T, 2009, MAR ECOL PROG SER, V391, P231, DOI 10.3354/meps07717; Clucas R, 2012, NEW ZEAL J ZOOL, V39, P155, DOI 10.1080/03014223.2011.621438; Clucas R, 2011, ECOL APPL, V21, P1308, DOI 10.1890/09-0813.1; Croxall JP, 1999, MAR ECOL PROG SER, V177, P115, DOI 10.3354/meps177115; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; ESRI, 2014, ARCGIS DESKT; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Furness RW, 1996, ECOLOGY, V77, P1181, DOI 10.2307/2265587; Grecian WJ, 2012, BIOL CONSERV, V156, P43, DOI 10.1016/j.biocon.2011.12.010; Hebblewhite M, 2010, PHILOS T R SOC B, V365, P2303, DOI 10.1098/rstb.2010.0087; Huettmann F, 2001, ECOL MODEL, V141, P261, DOI 10.1016/S0304-3800(01)00278-2; Huettmann Falk, 2011, Marine Biodiversity, V41, P141, DOI 10.1007/s12526-011-0083-2; Humphries G, 2014, USING LONG TERM HARV; Humphries GRW, 2014, ECOL APPL, V24, P2107, DOI 10.1890/13-2023.1; HUTCHISON LV, 1980, CONDOR, V82, P314, DOI 10.2307/1367400; Hyrenbach K, 2005, FISH OCEANOGR, V14, P1, DOI [10.1016/j.theriogenology.2008.06.024, DOI 10.1016/J.THERIOGENOLOGY.2008.06.024]; Igual JM, 2005, MAR BIOL, V146, P619, DOI 10.1007/s00227-004-1461-0; KLEIN SA, 1995, J CLIMATE, V8, P1140, DOI 10.1175/1520-0442(1995)008<1140:OTRALC>2.0.CO;2; Lyver PO, 1999, MAR ECOL PROG SER, V188, P237, DOI 10.3354/meps188237; Meskhidze N, 2010, ADV METEOROL, V2010, DOI 10.1155/2010/239808; Michener WK, 2011, ECOL INFORM, V6, P13, DOI 10.1016/j.ecoinf.2010.11.005; Moller H, 2009, NEW ZEAL J ZOOL, V36, P211, DOI 10.1080/03014220909510152; Navarro J, 2007, OECOLOGIA, V151, P150, DOI 10.1007/s00442-006-0559-0; Nevitt G, 1999, MAR ECOL PROG SER, V177, P235, DOI 10.3354/meps177235; Nevitt GA, 2008, J EXP BIOL, V211, P1706, DOI 10.1242/jeb.015412; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Phillips RA, 2003, AUK, V120, P1082, DOI 10.1642/0004-8038(2003)120[1082:EOSTOA]2.0.CO;2; Pinet P, 2011, MAR ECOL PROG SER, V423, P291, DOI 10.3354/meps08971; R Core Team, 2021, R LANGUAGE ENV STAT; Raymond B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010960; Richdale L, 1944, JSTOR, V46, P93; Ropert-Coudert Y, 2005, FRONT ECOL ENVIRON, V3, P437, DOI 10.2307/3868660; Sala JE, 2012, MAR ECOL PROG SER, V464, P273, DOI 10.3354/meps09887; Salford Predictive Modeler, 2019, INTR TREENET GRAD BO; Salihoglu B, 2001, POLAR BIOL, V24, P328, DOI 10.1007/s003000000215; Schneider DC, 2001, BIOSCIENCE, V51, P545, DOI 10.1641/0006-3568(2001)051[0545:TROTCO]2.0.CO;2; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Shaffer SA, 2009, MAR ECOL PROG SER, V391, P209, DOI 10.3354/meps07932; Sorensen MC, 2009, J ANIM ECOL, V78, P460, DOI 10.1111/j.1365-2656.2008.01492.x; Stevens MJ, 2006, J PAC HIST, V41, P273, DOI 10.1080/00223340600984737; Team N, 2013, NCAR COMM LANG VERS; Thornhill DJ, 2008, MOL ECOL, V17, P5104, DOI 10.1111/j.1365-294X.2008.03970.x; WARHAM J, 1982, Notornis, V29, P269; Weimerskirch H, 2006, OECOLOGIA, V146, P681, DOI 10.1007/s00442-005-0226-x; Weimerskirch H, 1998, J ANIM ECOL, V67, P99, DOI 10.1046/j.1365-2656.1998.00180.x; Weimerskirch H, 2002, SCIENCE, V295, P1259, DOI 10.1126/science.1068034; Weimerskirch H, 2012, SCIENCE, V335, P211, DOI 10.1126/science.1210270; Wood AG, 2000, J AVIAN BIOL, V31, P278, DOI 10.1034/j.1600-048X.2000.310302.x; Zador S, 2013, MAR ECOL PROG SER, V485, P245, DOI 10.3354/meps10336	53	3	4	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137241	10.1371/journal.pone.0137241	http://dx.doi.org/10.1371/journal.pone.0137241			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331957	gold, Green Submitted, Green Published			2022-12-26	WOS:000360613800115
J	Meyer, WM; Eble, JA; Franklin, K; McManus, RB; Brantley, SL; Henkel, J; Marek, PE; Hall, WE; Olson, CA; McInroy, R; Loaiza, EMB; Brusca, RC; Moore, W				Meyer, Wallace M., III; Eble, Jeffrey A.; Franklin, Kimberly; McManus, Reilly B.; Brantley, Sandra L.; Henkel, Jeff; Marek, Paul E.; Hall, W. Eugene; Olson, Carl A.; McInroy, Ryan; Bernal Loaiza, Emmanuel M.; Brusca, Richard C.; Moore, Wendy			Ground-Dwelling Arthropod Communities of a Sky Island Mountain Range in Southeastern Arizona, USA: Obtaining a Baseline for Assessing the Effects of Climate Change	PLOS ONE			English	Article							SPECIES RICHNESS; RESPONSES; INSECTS; DECOMPOSITION; BIODIVERSITY; GRADIENTS; ECOLOGY; DRIVEN; TAXON; FAUNA	The few studies that have addressed past effects of climate change on species distributions have mostly focused on plants due to the rarity of historical faunal baselines. However, hyperdiverse groups like Arthropoda are vital to monitor in order to understand climate change impacts on biodiversity. This is the first investigation of ground-dwelling arthropod (GDA) assemblages along the full elevation gradient of a mountain range in the Madrean Sky Island Region, establishing a baseline for monitoring future changes in GDA biodiversity. To determine how GDA assemblages relate to elevation, season, abiotic variables, and corresponding biomes, GDA were collected for two weeks in both spring (May) and summer (September) 2011 in the Santa Catalina Mountains, Arizona, using pitfall traps at 66 sites in six distinct upland (non-riparian/non-wet canyon) biomes. Four arthropod taxa: (1) beetles (Coleoptera), (2) spiders (Araneae), (3) grasshoppers and crickets (Orthoptera), and (4) millipedes and centipedes (Myriapoda) were assessed together and separately to determine if there are similar patterns across taxonomic groups. We collected 335 species of GDA: 192/3793 (species/specimens) Coleoptera, 102/1329 Araneae, 25/523 Orthoptera, and 16/697 Myriapoda. GDA assemblages differed among all biomes and between seasons. Fifty-three percent (178 species) and 76% (254 species) of all GDA species were found in only one biome and during only one season, respectively. While composition of arthropod assemblages is tied to biome and season, individual groups do not show fully concordant patterns. Seventeen percent of the GDA species occurred only in the two highest- elevation biomes (Pine and Mixed Conifer Forests). Because these high elevation biomes are most threatened by climate change and they harbor a large percentage of unique arthropod species (11-25% depending on taxon), significant loss in arthropod diversity is likely in the Santa Catalina Mountains and other isolated mountain ranges in the Southwestern US.	[Meyer, Wallace M., III; Eble, Jeffrey A.; Franklin, Kimberly; McManus, Reilly B.; Marek, Paul E.; Hall, W. Eugene; Olson, Carl A.; McInroy, Ryan; Moore, Wendy] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Brantley, Sandra L.] Univ New Mexico, Museum Southwestern Biol, Albuquerque, NM 87131 USA; [Henkel, Jeff; Brusca, Richard C.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Bernal Loaiza, Emmanuel M.] Univ Sonora, Hermosillo 83000, Sonora, Mexico; [Brusca, Richard C.] Arizona Sonora Desert Museum, Tucson, AZ USA	University of Arizona; University of New Mexico; University of Arizona; Universidad de Sonora	Meyer, WM (corresponding author), Pomona Coll, Dept Biol, Claremont, CA 91711 USA.	Wallace_meyer@pomona.edu	Brusca, Richard/S-1673-2019	Marek, Paul/0000-0002-7048-2514; Eble, Jeff/0000-0001-6308-3104; Moore, Wendy/0000-0003-4441-6203	National Institute of Health [5K12GM000708]; National Geographic Society [8964-11]; National Science Foundation [DBI-1203398, EF-1206382]; Div Of Biological Infrastructure [1206382, 1203398] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000708] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Geographic Society(National Geographic Society); National Science Foundation(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by 5K12GM000708, National Institute of Health, W.M.M. -(http://www.nigms.nih.gov/training/careerdev/Pages/TWDInstRes.aspx) 8964-11, National Geographic Society, W.M.M. -(http://www.nationalgeographic.com/explorers/grants-programs/cre) DBI-1203398, National Science Foundation, W.M. EF-1206382, National Science Foundation, W.M. (http://www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CD, 1998, P NATL ACAD SCI USA, V95, P14839, DOI 10.1073/pnas.95.25.14839; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Bardgett RD, 2008, ISME J, V2, P805, DOI 10.1038/ismej.2008.58; Behan-Pelletier V, 1999, BIOSCIENCE, V49, P149, DOI 10.2307/1313540; Boggs CL, 1997, GLOBAL ECOL BIOGEOGR, V6, P39, DOI 10.2307/2997525; Brown D.E, 1994, BIOTIC COMMUNITIES S; Brusca R. C., 2013, NATURAL HIST SANTA C; Brusca RC, 2002, INVERTEBRATES; Brusca RC, 2013, ECOL EVOL, V3, P3307, DOI 10.1002/ece3.720; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Clarke K.R., 2006, PRIMER V6 USER MANUA; Coe SJ, 2010, RMRSGTR273 USDA FOR; Coope GR, 1995, INSECTS CHANGING ENV, P30; Crimmins TM, 2011, NEW PHYTOL, V191, P468, DOI 10.1111/j.1469-8137.2011.03705.x; Crimmins TM, 2009, GLOBAL CHANGE BIOL, V15, P1141, DOI 10.1111/j.1365-2486.2008.01831.x; Daily GC, 1996, P NATL ACAD SCI USA, V93, P11709, DOI 10.1073/pnas.93.21.11709; Derkarabetian S, 2011, MOL PHYLOGENET EVOL, V61, P844, DOI 10.1016/j.ympev.2011.08.004; Diaz HF, 2003, CLIMATIC CHANGE, V59, P1, DOI 10.1023/A:1024416227887; Dieker P, 2011, BIOL CONSERV, V144, P2810, DOI 10.1016/j.biocon.2011.07.018; Dominguez F, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050762; Dornelas M, 2014, SCIENCE, V344, P296, DOI 10.1126/science.1248484; DOUGLAS MW, 1993, J CLIMATE, V6, P1665, DOI 10.1175/1520-0442(1993)006<1665:TMM>2.0.CO;2; Driscoll DA, 2010, AUSTRAL ECOL, V35, P13, DOI 10.1111/j.1442-9993.2009.02007.x; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; Garfin G, 2013, NCA REGION INPUT REP, P1, DOI 10.5822/978-1-61091-484-0; Goehring DM, 2002, J INSECT CONSERV, V6, P83, DOI 10.1023/A:1020905307244; GRAHAM RW, 1990, TRENDS ECOL EVOL, V5, P289, DOI 10.1016/0169-5347(90)90083-P; Guevara J, 2009, INSECT CONSERV DIVER, V2, P142, DOI 10.1111/j.1752-4598.2008.00043.x; Gutzler DS, 2011, CLIM DYNAM, V37, P835, DOI 10.1007/s00382-010-0838-7; Haslett JR, 1997, GLOBAL ECOL BIOGEOGR, V6, P3, DOI 10.2307/2997522; Higgins JW, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00270.1; Hodkinson ID, 2005, BIOL REV, V80, P489, DOI 10.1017/S1464793105006767; IPCC, 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Jablonski D, 1996, ECOLOGY, V77, P1367, DOI 10.2307/2265534; Kimball S, 2010, GLOBAL CHANGE BIOL, V16, P1555, DOI 10.1111/j.1365-2486.2009.02106.x; Koprowski JL, 2013, MERGING SCI MANAGEME, V67, P140; Korner C, 2000, TRENDS ECOL EVOL, V15, P513, DOI 10.1016/S0169-5347(00)02004-8; Kupfer JA, 2005, USDA FOREST SERVICE, P485; Lenoir L, 2007, BIOL FERT SOILS, V43, P281, DOI 10.1007/s00374-006-0103-8; Lensing JR, 2006, P NATL ACAD SCI USA, V103, P15502, DOI 10.1073/pnas.0607064103; Loarie SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002502; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; Masta SE, 2000, EVOLUTION, V54, P1699; McCord RD, 1995, USDA ROCKY, V264, P317; MCCOY ED, 1990, OIKOS, V58, P313, DOI 10.2307/3545222; Meyer WM, 2011, SOIL BIOL BIOCHEM, V43, P206, DOI 10.1016/j.soilbio.2010.10.005; Mitchell SG, 2013, QUATERNARY RES, V79, P274, DOI 10.1016/j.yqres.2012.11.001; Moore W, 2013, MERGING SCI MANAGEME, P140; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Niering WA, 1985, PLANT COMMUNITY ECOL, P159; Overpeck J, 2010, SCIENCE, V328, P1642, DOI 10.1126/science.1186591; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; PICKETT S T A, 1989, P110; Powers JS, 2009, J ECOL, V97, P801, DOI 10.1111/j.1365-2745.2009.01515.x; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Rasmann S, 2014, FUNCT ECOL, V28, P46, DOI 10.1111/1365-2435.12135; Richman DB, 2012, ZOOL STUD, V51, P793; Ricketts TH, 2002, BIOL CONSERV, V103, P361, DOI 10.1016/S0006-3207(01)00147-1; Robles M. D., 2010, MANAGING CHANGING LA; Sauer J, 2011, BIODIVERS CONSERV, V20, P3133, DOI 10.1007/s10531-011-0140-y; Schimel DS, 1996, CLIMATE CHANGE 1995, P76; Strange EE, 2010, CLIMATE CHANGE IMPAC; Stromberg JC, 2013, ECOSYSTEMS, V16, P411, DOI 10.1007/s10021-012-9606-3; Toranza Carolina, 2010, BMC Ecology, V10, P18, DOI 10.1186/1472-6785-10-18; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000; Voigt W, 2003, ECOLOGY, V84, P2444, DOI 10.1890/02-0266; Wall DH, 2010, GLOBAL CHANGE BIOL, V14, P2661; Watling JI, 2006, CONSERV BIOL, V20, P1016, DOI 10.1111/j.1523-1739.2006.00482.x; WHITTAKER RH, 1952, ECOL MONOGR, V22, P1, DOI 10.2307/1948527; Whittaker RH., 1964, J ARIZONA ACAD SCI, V3, P9, DOI DOI 10.2307/40021924; Yang XD, 2009, SOIL BIOL BIOCHEM, V41, P910, DOI 10.1016/j.soilbio.2008.12.028	71	15	15	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135210	10.1371/journal.pone.0135210	http://dx.doi.org/10.1371/journal.pone.0135210			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332685	Green Published, gold, Green Submitted			2022-12-26	WOS:000360613800023
J	Silva, F; Stevens, CJ; Weisskopf, A; Castillo, C; Qin, L; Bevan, A; Fuller, DQ				Silva, Fabio; Stevens, Chris J.; Weisskopf, Alison; Castillo, Cristina; Qin, Ling; Bevan, Andrew; Fuller, Dorian Q.			Modelling the Geographical Origin of Rice Cultivation in Asia Using the Rice Archaeological Database	PLOS ONE			English	Article							PLANT DOMESTICATION; RADIOCARBON-DATES; WILD-RICE; AGRICULTURE; SPREAD; EAST; DISPERSAL; REVEALS; CHINA; BASES	We have compiled an extensive database of archaeological evidence for rice across Asia, including 400 sites from mainland East Asia, Southeast Asia and South Asia. This dataset is used to compare several models for the geographical origins of rice cultivation and infer the most likely region(s) for its origins and subsequent outward diffusion. The approach is based on regression modelling wherein goodness of fit is obtained from power law quantile regressions of the archaeologically inferred age versus a least-cost distance from the putative origin(s). The Fast Marching method is used to estimate the least-cost distances based on simple geographical features. The origin region that best fits the archaeobotanical data is also compared to other hypothetical geographical origins derived from the literature, including from genetics, archaeology and historical linguistics. The model that best fits all available archaeological evidence is a dual origin model with two centres for the cultivation and dispersal of rice focused on the Middle Yangtze and the Lower Yangtze valleys.	[Silva, Fabio; Stevens, Chris J.; Weisskopf, Alison; Castillo, Cristina; Bevan, Andrew; Fuller, Dorian Q.] UCL, Inst Archaeol, London, England; [Qin, Ling] Peking Univ, Sch Archaeol & Museol, Beijing 100871, Peoples R China	University of London; University College London; Peking University	Silva, F (corresponding author), UCL, Inst Archaeol, London, England.	fabio.silva@ucl.ac.uk	Fuller, Dorian/AAF-7400-2019; Fuller, Dorian Q/C-1908-2008	Fuller, Dorian/0000-0002-4859-080X; Fuller, Dorian Q/0000-0002-4859-080X; Bevan, Andrew/0000-0001-7967-3117; Silva, Fabio/0000-0003-1368-6331; Stevens, Chris/0000-0002-2669-5715	Natural Environment Research Council (UK) [NE/G005540/1]; European Research Council [323842]; Natural Environment Research Council [NE/K003402/1, NE/G005540/1, NRCF010002] Funding Source: researchfish; NERC [NE/G005540/1, NRCF010002, NE/K003402/1] Funding Source: UKRI	Natural Environment Research Council (UK)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Research Council(European Research Council (ERC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research is part of the Natural Environment Research Council (UK, www.nerc.ac.uk/) funded project "The impact of evolving rice systems from China to Southeast Asia" (NE/G005540/1). Some work on the database by CJS was carried out as part of the European Research Council (erc.europa.eu/) project "Comparative Pathways to Agriculture" (Advanced Grant no. 323842). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2010, ARCHAEOL ANTHROP SCI, V2, P89, DOI 10.1007/s12520-010-0029-9; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; AMMERMAN AJ, 1971, MAN, V6, P674, DOI 10.2307/2799190; Anderson D. R., 2008, MODEL BASED INFERENC; [Anonymous], ORIGINS CULTIVATED R; [Anonymous], 2014, R LANG ENV STAT COMP; Bellwood Peter, 1997, PREHISTORY INDOMALAY; Bellwood Peter, 2005, 1 FARMERS; Bengtsson H., MATLAB READ WRITE MA; Auban JB, 2015, ECOL MODEL, V307, P22, DOI 10.1016/j.ecolmodel.2015.03.015; Blench R., 2005, PERSPECTIVES PHYLOGE, P31; Bonhomme R, 2000, EUR J AGRON, V13, P1, DOI 10.1016/S1161-0301(00)00058-7; Bray F., 1986, RICE EC TECHNOLOGY D, DOI 10.1525/9780520914933; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chang T. T., 1989, Foraging and farming: the evolution of plant exploitation., P408; Chi Z, 2010, ANTIQUITY, V84, P11, DOI 10.1017/S0003598X00099737; Connolly J, 2006, GEOGRAPHIC INFORM SY; Crawford GW, 2012, HOLOCENE, V22, P613, DOI 10.1177/0959683611424177; Crawford GW, 2011, CURR ANTHROPOL, V52, pS331, DOI 10.1086/658369; Crawford GW, 1998, ANTIQUITY, V72, P858, DOI 10.1017/S0003598X00087494; De Smith M.J., 2007, GEOSPATIAL ANAL COMP; Douglas D. H., 1994, CARTOGRAPHICA, V31, P37, DOI [10.3138/D327-0323-2JUT-016M, DOI 10.3138/D327-0323-2JUT-016M]; Edwards AWF, 1992, LIKELIHOOD; Fishman G. S., 1995, MONTE CARLO CONCEPTS; Fort J, 2012, AM ANTIQUITY, V77, P203, DOI 10.7183/0002-7316.77.2.203; Fuller DQ, 2007, ANTIQUITY, V81, P316, DOI 10.1017/S0003598X0009520X; Fuller DQ, 2014, P NATL ACAD SCI USA, V111, P6147, DOI 10.1073/pnas.1308937110; Fuller DQ, 2011, RICE, V4, P78, DOI 10.1007/s12284-011-9078-7; Fuller DQ, 2011, CURR ANTHROPOL, V52, pS347, DOI 10.1086/658900; Fuller DQ, 2011, HOLOCENE, V21, P743, DOI 10.1177/0959683611398052; Fuller DQ, 2010, ARCHAEOL ANTHROP SCI, V2, P115, DOI 10.1007/s12520-010-0035-y; Fuller DQ, 2009, WORLD ARCHAEOL, V41, P88, DOI 10.1080/00438240802668321; Fuller DQ, 2009, SCIENCE, V323, P1607, DOI 10.1126/science.1166605; GRASS Development Team, 2012, GEOGRAPHIC RESOURCES; Gross BL, 2014, P NATL ACAD SCI USA, V111, P6190, DOI 10.1073/pnas.1308942110; Guedes JAD, 2015, P NATL ACAD SCI USA, V112, P5625, DOI 10.1073/pnas.1423708112; Guedes JD, 2014, QUATERN INT, V349, P29, DOI 10.1016/j.quaint.2014.08.003; Gurou P, 1984, RIZ ET CIVILISATION; Harris DavidR., 2014, ENCY GLOBAL ARCHAEOL, P104, DOI DOI 10.1007/978-1-4419-0465-2_64; Hazarika M, 2006, ANC ASIA, V1, P25, DOI 10.5334/aa.06104; Henn BM, 2011, P NATL ACAD SCI USA, V108, P5154, DOI 10.1073/pnas.1017511108; Higham C., 2005, HUMAN WORLD PREHISTO, P234; HIGHAM C, 2003, EXAMINING FARMING LA, P223; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Jiang LP, 2006, ANTIQUITY, V80, P355, DOI 10.1017/S0003598X00093674; Koenker R, 1999, J AM STAT ASSOC, V94, P1296, DOI 10.2307/2669943; Koenker R., 2010, ECONOMETRIC SOC MONO, V2005, P295; KOENKER R., 2013, QUANTREG QUANTILE RE; Krige D.G, 1951, J S AFR I MIN METALL, V52, P201, DOI DOI 10.2307/3006914; Londo JP, 2006, P NATL ACAD SCI USA, V103, P9578, DOI 10.1073/pnas.0603152103; Lu H, 2006, BOREAS INT J QUATERN, V31, P378, DOI [10.1111/j.1502-3885.2002.tb01081.x, DOI 10.1111/J.1502-3885.2002.TB01081.X]; Makibayashi K, 2014, J WORLD PREHIST, V27, P295, DOI 10.1007/s10963-014-9082-0; McQuarrie ADR, 1998, REGRESSION TIMES SER; Mcrae BH, 2007, P NATL ACAD SCI USA, V104, P19885, DOI 10.1073/pnas.0706568104; Nash JC, 2001, J STAT SOFTW, V43, P1; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pei AP, 1998, ANTIQUITY, V72, P878, DOI 10.1017/S0003598X00087512; Pinhasi R, 2005, PLOS BIOL, V3, P2220, DOI 10.1371/journal.pbio.0030410; Ribeiro P.J, 2001, R NEWS, V1, P14, DOI DOI 10.1159/000323281; Royall R. M., 2000, STAT EVIDENCE LIKELI; Russell T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087854; Saerens M, 2009, NEURAL COMPUT, V21, P2363, DOI 10.1162/neco.2009.11-07-643; Sagart L, 2011, RICE, V4, P121, DOI 10.1007/s12284-011-9077-8; Sagart L, 2008, ROUTLEDGE STUD EARLY, V5, P133; Scott James, 2009, J SOUTHWEST; Sethian JA, 1996, P NATL ACAD SCI USA, V93, P1591, DOI 10.1073/pnas.93.4.1591; Shelach-Lavi G., 2015, ARCHAEOLOGY EARLY CH; Silva F, 2014, J ARCHAEOL SCI, V52, P609, DOI 10.1016/j.jas.2014.04.021; Silva F, 2014, RADIOCARBON, V56, P723, DOI 10.2458/56.16937; Silva F, 2012, ADV COMPLEX SYST, V15, DOI 10.1142/S0219525911003293; Steele J, 2010, J ARCHAEOL SCI, V37, P2017, DOI 10.1016/j.jas.2010.03.007; Toyama S, 2002, ORIGINS POTTERY AGR, P263; VAN DRIEM G., 1998, ARCHAEOLOGY LANGUAGE, P67; van Driem G, 2012, CR PALEVOL, V11, P117, DOI 10.1016/j.crpv.2011.07.004; van Etten J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012060; Vaughan DA, 2008, RICE, V1, P16, DOI 10.1007/s12284-008-9000-0; Weisskopf A, 2015, ANTIQUITY, V89, P1051, DOI 10.15184/aqy.2015.94; Yasuda Y., 2002, ORIGINS POTTERY AGR, P119; Zhao ZJ, 1998, ANTIQUITY, V72, P885, DOI 10.1017/S0003598X00087524	80	72	79	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137024	10.1371/journal.pone.0137024	http://dx.doi.org/10.1371/journal.pone.0137024			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CQ2NK	26327225	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000360437700083
J	Xie, QQ; Li, ZJ; Yang, LM; Lv, J; Jobe, TO; Wang, QQ				Xie, Qingqing; Li, Zhenji; Yang, Limin; Lv, Jing; Jobe, Timothy O.; Wang, Qiuquan			A Newly Identified Passive Hyperaccumulator Eucalyptus grandis x E. urophylla under Manganese Stress	PLOS ONE			English	Article							PHOTOSYSTEM-II; METAL ACCUMULATION; TOXICITY; PROTEIN; DETOXIFICATION; NEUROTOXICITY; PHOSPHORUS; COEXPOSURE; TOLERANCE; EXPOSURE	Manganese (Mn) is an essential micronutrient needed for plant growth and development, but can be toxic to plants in excess amounts. However, some plant species have detoxification mechanisms that allow them to accumulate Mn to levels that are normally toxic, a phenomenon known as hyperaccumulation. These species are excellent candidates for developing a cost-effective remediation strategy for Mn-polluted soils. In this study, we identified a new passive Mn-hyperaccumulator Eucalyptus grandis x E. urophylla during a field survey in southern China in July 2010. This hybrid can accumulate as much as 13,549 mg/ kg DW Mn in its leaves. Our results from Scanning Electron Microscope (SEM) X-ray microanalysis indicate that Mn is distributed in the entire leaf and stem cross-section, especially in photosynthetic palisade, spongy mesophyll tissue, and stem xylem vessels. Results from size-exclusion chromatography coupled with ICP-MS (Inductively coupled plasma mass spectrometry) lead us to speculate that Mn associates with relatively high molecular weight proteins and low molecular weight organic acids, including tartaric acid, to avoid Mn toxicity. Our results provide experimental evidence that both proteins and organic acids play important roles in Mn detoxification in Eucalyptus grandis x E. urophylla. The key characteristics of Eucalyptus grandis x E. urophylla are an increased Mn translocation facilitated by transpiration through the xylem to the leaves and further distribution throughout the leaf tissues. Moreover, the Mn-speciation profile obtained for the first time in different cellular organelles of Eucalyptus grandis x E. urophylla suggested that different organelles have differential accumulating abilities and unique mechanisms for Mn-detoxification.	[Xie, Qingqing; Yang, Limin; Wang, Qiuquan] Xiamen Univ, Dept Chem, Coll Chem & Chem Engn, MOE Key Lab Spectrochem Anal & Instrumentat, Xiamen 361005, Peoples R China; [Li, Zhenji; Lv, Jing] Xiamen Univ, Coll Environm & Ecol, Xiamen 361102, Peoples R China; [Jobe, Timothy O.] Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Wang, Qiuquan] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen 361005, Peoples R China	Xiamen University; Xiamen University; Cornell University; Boyce Thompson Institute for Plant Research; Xiamen University	Wang, QQ (corresponding author), Xiamen Univ, Dept Chem, Coll Chem & Chem Engn, MOE Key Lab Spectrochem Anal & Instrumentat, Xiamen 361005, Peoples R China.	qqwang@xmu.edu.cn	Jobe, Timothy O/A-7087-2012; Wang, QQ/G-3413-2010	Jobe, Timothy O/0000-0002-5729-4981; 	National Basic Research 973 program of China [2014CB932004]; National Natural Science Foundation of China [21275120, 21475108]	National Basic Research 973 program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by The National Basic Research 973 program of China (No. 2014CB932004) and The National Natural Science Foundation of China (No. 21275120 and No. 21475108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali H, 2013, CHEMOSPHERE, V91, P869, DOI 10.1016/j.chemosphere.2013.01.075; Allen JF, 2011, TRENDS PLANT SCI, V16, P645, DOI 10.1016/j.tplants.2011.10.004; Allen MD, 2007, PLANT PHYSIOL, V143, P263, DOI 10.1104/pp.106.088609; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Bhatia NP, 2005, J EXP BOT, V56, P1343, DOI 10.1093/jxb/eri135; Bidwell SD, 2002, FUNCT PLANT BIOL, V29, P899, DOI 10.1071/PP01192; BLAMEY FPC, 1986, PLANT SOIL, V91, P171, DOI 10.1007/BF02181785; Boksha IS, 2002, BIOCHEMISTRY-MOSCOW+, V67, P1012, DOI 10.1023/A:1020574003027; Bouchard M, 2008, NEUROTOXICOLOGY, V29, P577, DOI 10.1016/j.neuro.2008.04.013; Broadhurst CL, 2004, ENVIRON SCI TECHNOL, V38, P5797, DOI 10.1021/es0493796; Clemens S, 2006, BIOCHIMIE, V88, P1707, DOI 10.1016/j.biochi.2006.07.003; Deng H, 2010, AGR SCI TECHNOLOGY, V11; Divol F, 2013, PLANT CELL, V25, P1040, DOI 10.1105/tpc.112.107672; Doncheva S, 2009, ENVIRON EXP BOT, V65, P189, DOI 10.1016/j.envexpbot.2008.11.006; Dou CM, 2009, PLANT BIOLOGY, V11, P664, DOI 10.1111/j.1438-8677.2008.00163.x; Erikson KM, 2007, PHARMACOL THERAPEUT, V113, P369, DOI 10.1016/j.pharmthera.2006.09.002; Fecht-Christoffers MM, 2003, PLANT PHYSIOL, V133, P1935, DOI 10.1104/pp.103.029215; Fernando DR, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00319; Fernando DR, 2013, AM J BOT, V100, P690, DOI 10.3732/ajb.1200545; Fernando DR, 2012, PLANTA, V236, P1459, DOI 10.1007/s00425-012-1699-6; Fernando DR, 2009, ANN BOT-LONDON, V103, P931, DOI 10.1093/aob/mcp013; FOULDS W, 1993, NEW PHYTOL, V125, P529, DOI 10.1111/j.1469-8137.1993.tb03901.x; FOY CD, 1978, ANNU REV PLANT PHYS, V29, P511, DOI 10.1146/annurev.pp.29.060178.002455; Francides G., 2007, MIXTURES EUCALYPTUS; Fu XP, 2011, J HAZARD MATER, V186, P103, DOI 10.1016/j.jhazmat.2010.10.122; Gao L, 2013, INT J PHYTOREMEDIAT, V15, P307, DOI 10.1080/15226514.2012.702800; Gonzalez A, 1999, AUST J PLANT PHYSIOL, V26, P811, DOI 10.1071/PP99030; Henn BC, 2012, ENVIRON HEALTH PERSP, V120, P126, DOI 10.1289/ehp.1003300; Horst M, 2011, MINERAL NUTR HIGHER; Huang DY, 1998, BIOCHEM MOL BIOL INT, V46, P107; Inagaki N, 1996, PLANT MOL BIOL, V30, P39, DOI 10.1007/BF00017801; Jaquinod M, 2007, MOL CELL PROTEOMICS, V6, P394, DOI 10.1074/mcp.M600250-MCP200; Karki P, 2013, ANN OCCUP ENVIRON ME, V25, DOI 10.1186/2052-4374-25-4; Kim Y, 2009, NEUROTOXICOLOGY, V30, P564, DOI 10.1016/j.neuro.2009.03.012; Krzeslowska M, 2011, ACTA PHYSIOL PLANT, V33, P35, DOI 10.1007/s11738-010-0581-z; Kukavica BM, 2012, J EXP BOT, V63, P4631, DOI 10.1093/jxb/ers139; Lai Y, 2006, TALANTA, V70, P26, DOI 10.1016/j.talanta.2005.12.062; Lianshui Zhang YsC, 2004, HUADONG FOREST MANAG, V2004; LICHTENTHALER HK, 1963, NATURE, V198, P1070, DOI 10.1038/1981070a0; Liu JB, 2014, LIVEST SCI, V167, P269, DOI 10.1016/j.livsci.2014.06.009; Lucchini RG, 2014, NEUROTOXICOLOGY, V45, P309, DOI 10.1016/j.neuro.2014.05.006; Marschner H., 2002, MINERAL NUTR HIGHER; MEMON AR, 1984, J PLANT NUTR, V7, P961, DOI 10.1080/01904168409363257; Mizuno T, 2008, J PLANT NUTR, V31, P1811, DOI 10.1080/01904160802325396; Nickelsen J, 2013, ANNU REV PLANT BIOL, V64, P609, DOI 10.1146/annurev-arplant-050312-120124; Pelloux J, 2007, TRENDS PLANT SCI, V12, P267, DOI 10.1016/j.tplants.2007.04.001; Portier C.J., 2012, TOXICOLOGICAL PROFIL; Reeves RD, 2000, PHYTOREMEDIATION OF TOXIC METALS, P193; Reeves Roger D., 2004, Turkish Journal of Botany, V28, P147; Ren LM, 2007, J SOIL WATER CONSERV, V3; Socha AL, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00106; Sugaya S, 2000, PLANT CELL PHYSIOL, V41, P503, DOI 10.1093/pcp/41.4.503; U.S. Geological Survey, 2013, MIN COMM SUMM 2013, P198, DOI DOI 10.3133/MINERAL2013; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Un S, 2013, INORG CHEM, V52, P3803, DOI 10.1021/ic302415s; [王华 WANG Hua], 2007, [生态环境, Ecology and Environment], V16, P830; Wang X, 2008, THESIS FUJIAN AGR FO; Xu M, 2010, ANAL CHEM, V82, P1616, DOI 10.1021/ac902902y; Xu XG, 2006, PLANT SOIL, V285, P323, DOI 10.1007/s11104-006-9018-2; Xue SG, 2004, ENVIRON POLLUT, V131, P393, DOI 10.1016/j.envpol.2004.03.011; Yang SX, 2008, PLANT SOIL ENVIRON, V54, P441, DOI 10.17221/401-PSE; Yao YN, 2012, CHEMOSPHERE, V89, P150, DOI 10.1016/j.chemosphere.2012.05.030	62	9	10	6	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136606	10.1371/journal.pone.0136606	http://dx.doi.org/10.1371/journal.pone.0136606			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327118	Green Published, gold, Green Submitted			2022-12-26	WOS:000360437700049
J	Aichelburg, MC; Weseslindtner, L; Mandorfer, M; Strassl, R; Rieger, A; Reiberger, T; Puchhammer-Stockl, E; Grabmeier-Pfistershammer, K				Aichelburg, Maximilian C.; Weseslindtner, Lukas; Mandorfer, Mattias; Strassl, Robert; Rieger, Armin; Reiberger, Thomas; Puchhammer-Stoeckl, Elisabeth; Grabmeier-Pfistershammer, Katharina			Association of CMV-Specific T Cell-Mediated Immunity with CMV DNAemia and Development of CMV Disease in HIV-1-Infected Individuals	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HIV-INFECTED INDIVIDUALS; GAMMA RELEASE ASSAY; HUMAN CYTOMEGALOVIRUS; TRANSPLANT RECIPIENTS; NATURAL-HISTORY; ANTIVIRAL PROPHYLAXIS; ERA; RESPONSES; RISK	Background Among HIV-1-infected individuals, cytomegalovirus (CMV) reactivation and disease occur in the setting of advanced immunosuppression. The value of a standardized assessment of CMV-specific T-cell mediated immunity by the CMV QuantiFERON assay (CMV-QFT) has not yet been thoroughly investigated in HIV-1-infected subjects. Methods Prospective, longitudinal study in 153 HIV-1-infected subjects with a CD4(+) T cell count < 350/mu L who simultaneously underwent CMV-QFT, CMV serology testing and CMV-DNA quantification. Factors associated with CMV-QFT were evaluated. Clinical screening for CMV manifestations was then performed every 3 months. Results Among the 141 CMV IgG-seropositive individuals the CMV-QFT assay yielded reactive results in 84% (118/141), negative results in 15% (21/141) and indeterminate (negative mitogen IFN-gamma response) results in 1% (2/141) of subjects. The mean actual CD4(+) T cell count was significantly higher in CMV-QFT reactive subjects, when compared to CMV-QFT non-reactive individuals (183 +/- 102 vs. 126 +/- 104 cells/mu L, P = 0.015). A significantly lower proportion of CMV-QFT reactive vs. non-reactive patients displayed CMV DNAemia > 100 copies/mL (23% (27/118) vs. 48% (11/23), P = 0.02). Furthermore, a statistically significant inverse association between mitogen IFN-gamma response and CMV-DNAemia > 1000 copies/mL was observed (P < 0.001). During the observational period, 5 CMV end-organ manifestations were observed. In three of the CMV cases the CMV-QFT yielded indeterminate results. Conclusions While CMV-QFT reactivity indicates CMV-specific immunity, indeterminate results due to negative mitogen IFN-gamma response might reflect HIV-1-induced immunodeficiency. Thus, dependency upon CD4(+) T cell count should be considered when interpreting CMV-QFT results.	[Aichelburg, Maximilian C.; Rieger, Armin; Grabmeier-Pfistershammer, Katharina] Med Univ Vienna, Div Immunol Allergy & Infect Dis DIAID, Dept Dermatol, Vienna, Austria; [Weseslindtner, Lukas; Puchhammer-Stoeckl, Elisabeth] Med Univ Vienna, Dept Virol, Vienna, Austria; [Mandorfer, Mattias; Reiberger, Thomas] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, HIV & Liver Study Grp, Vienna, Austria; [Strassl, Robert] Med Univ Vienna, Div Clin Virol, Dept Lab Med, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Aichelburg, MC (corresponding author), Med Univ Vienna, Div Immunol Allergy & Infect Dis DIAID, Dept Dermatol, Vienna, Austria.	maximilian.aichelburg@meduniwien.ac.at	Reiberger, Thomas/H-7613-2019; Mandorfer, Mattias/H-7603-2019	Reiberger, Thomas/0000-0002-4590-3583; Mandorfer, Mattias/0000-0003-2330-0017; Weseslindtner, Lukas/0000-0001-8950-937X; Grabmeier-Pfistershammer, Katharina/0000-0003-0665-5414				Abate D, 2013, J CLIN MICROBIOL, V51, P2501, DOI 10.1128/JCM.00563-13; Aichelburg MC, 2012, J CLIN MICROBIOL, V50, P2767, DOI 10.1128/JCM.01054-12; Aichelburg MC, 2009, CLIN INFECT DIS, V48, P954, DOI 10.1086/597351; Clari MA, 2012, CLIN VACCINE IMMUNOL, V19, P791, DOI 10.1128/CVI.05633-11; [Anonymous], 1992, MMWR RECOMM REP, V41, P1; Boeckh M, 2004, BLOOD, V103, P2003, DOI 10.1182/blood-2003-10-3616; Bowen EF, 1996, AIDS, V10, pS37; Deayton J, 1999, AIDS, V13, P1203, DOI 10.1097/00002030-199907090-00008; Fleming T, 2010, J MED VIROL, V82, P433, DOI 10.1002/jmv.21727; GALLANT JE, 1992, J INFECT DIS, V166, P1223, DOI 10.1093/infdis/166.6.1223; Gandhi MK, 2004, LANCET INFECT DIS, V4, P725, DOI 10.1016/S1473-3099(04)01202-2; HOOVER DR, 1993, NEW ENGL J MED, V329, P1922, DOI 10.1056/NEJM199312233292604; Hsu DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077479; Hunt PW, 2011, J INFECT DIS, V203, P1474, DOI 10.1093/infdis/jir060; Jacobson MA, 2004, J INFECT DIS, V189, P1362, DOI 10.1086/382964; Jacobson MA, 2000, CLIN INFECT DIS, V30, P231, DOI 10.1086/313612; Jacobson MA, 2001, J INFECT DIS, V183, P1399, DOI 10.1086/319854; Johnson SC, 2001, CLIN INFECT DIS, V32, P815, DOI 10.1086/319219; Kumar D, 2009, AM J TRANSPLANT, V9, P1214, DOI 10.1111/j.1600-6143.2009.02618.x; Lisboa LF, 2011, TRANSPLANTATION, V92, P1063, DOI 10.1097/TP.0b013e31822fa4b7; Lochmanova A, 2010, TRANSPL P, V42, P3574, DOI 10.1016/j.transproceed.2010.07.101; Manuel O, 2013, CLIN INFECT DIS, V56, P817, DOI 10.1093/cid/cis993; O'Sullivan CE, 1999, J INFECT DIS, V180, P847, DOI 10.1086/314943; Rangaka MX, 2007, AM J RESP CRIT CARE, V175, P514, DOI 10.1164/rccm.200610-1439OC; Shepp DH, 1996, J ACQ IMMUN DEF SYND, V11, P460, DOI 10.1097/00042560-199604150-00006; Singh KP, 2007, CLIN IMMUNOL, V124, P200, DOI 10.1016/j.clim.2007.04.018; Solano C, 2011, TRANSPLANTATION, V92, pE17, DOI 10.1097/TP.0b013e318224f263; Steininger C, 2006, J CLIN VIROL, V37, P1, DOI 10.1016/j.jcv.2006.03.005; Tey SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074744; Walker S, 2007, TRANSPL INFECT DIS, V9, P165, DOI 10.1111/j.1399-3062.2006.00199.x; Weinberg A, 2006, J INFECT DIS, V193, P488, DOI 10.1086/499826; Weinberg A, 2003, AIDS, V17, P2445, DOI 10.1097/00002030-200311210-00006; Weseslindtner L, 2012, AM J TRANSPLANT, V12, P2172, DOI 10.1111/j.1600-6143.2012.04076.x; Wittkop L, 2013, J INFECT DIS, V207, P622, DOI 10.1093/infdis/jis732	34	5	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0137096	10.1371/journal.pone.0137096	http://dx.doi.org/10.1371/journal.pone.0137096			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322514	Green Published, Green Submitted, gold			2022-12-26	WOS:000360435500065
J	Hwang, SH; Kim, DE; Sung, H; Park, BM; Cho, MJ; Yoon, OJ; Lee, DH				Hwang, Sang-Hyun; Kim, Dong-Eun; Sung, Heungsup; Park, Byeong-Min; Cho, Mi-Jeong; Yoon, Ok-Jin; Lee, Do-Hoon			Simple Detection of the IS6110 Sequence of Mycobacterium tuberculosis Complex in Sputum, Based on PCR with Graphene Oxide	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; PEPTIDE NUCLEIC-ACID; RESISTANCE; PLATFORM	Graphene oxide (GO) has proven to be a satisfactory DNA-sensor platform for applications in enzyme-free signal amplification, fluorescence-based amplification, and nanoparticle-based platforms because of its excellent electrical, thermal, and optical properties. In this study, we designed a novel platform for the fluorescence detection of biomolecules, using a fluorescent dye-labeled primer and GO. We applied this system for the detection of the IS6110 insertion sequence of the Mycobacterium tuberculosis complex (MTB) and evaluated its feasibility for use inmolecular diagnostics. Fifty-four sputum specimens were collected at our institution from October 2010 to March 2012. To detect MTB in the samples, we performed PCR amplification of the IS6110 DNA sequence using FAM-labeled primers, after which the PCR amplicon was incubated with GO and the fluorescence was measured. The results were compared with those obtained by conventional real-time quantitative PCR (RQ-PCR). The fluorescence intensity observed increased in a concentration-dependent manner with the FAM-labeled IS6110 amplicon. The results of the PCR-GO system for detecting IS6110 DNA were in good agreement with those obtained with conventional RQ-PCR (kappa statistic = 0.925). The PCR-GO system detected MTB DNA in 23 of 25 RQ-PCR-positive sputum samples (92.0%; 95% CI, 75.0-98.0%), but not in 29 of 29 RQ-PCR-negative sputum samples (100%; 95% CI, 88.1-100.0%). These results indicate the utility of the PCR-GO system in molecular diagnostics.	[Hwang, Sang-Hyun; Park, Byeong-Min; Cho, Mi-Jeong; Yoon, Ok-Jin; Lee, Do-Hoon] Natl Canc Ctr, Res Inst & Hosp, Ctr Diagnost Oncol, Dept Lab Med, Goyang Si 410769, Gyeinggi Do, South Korea; [Hwang, Sang-Hyun] Natl Canc Ctr, Res Inst & Hosp, Hematol Malignancy Branch, Goyang Si 410769, Gyeinggi Do, South Korea; [Kim, Dong-Eun] Konkuk Univ, Dept Biosci & Biotechnol, Seoul 143701, South Korea; [Sung, Heungsup] Univ Ulsan, Coll Med, Dept Lab Med, Seoul 138736, South Korea; [Sung, Heungsup] Asan Med Ctr, Seoul 138736, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); Konkuk University; University of Ulsan	Hwang, SH (corresponding author), Natl Canc Ctr, Res Inst & Hosp, Ctr Diagnost Oncol, Dept Lab Med, Goyang Si 410769, Gyeinggi Do, South Korea.	mindcatch@ncc.re.kr	Hwang, Sanghyun/L-5314-2019; Kim, Dong-Eun/D-8304-2011	Hwang, Sanghyun/0000-0003-3201-5728; Kim, Dong-Eun/0000-0001-6545-8387	National Cancer Center [NCC-1510100]	National Cancer Center	This research was supported by the National Cancer Center, Grant NCC-1510100. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Cristobal P, 2015, ACS APPL MAT INTERFA; Antonenka U, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-280; Artiles MS, 2011, ADV DRUG DELIVER REV, V63, P1352, DOI 10.1016/j.addr.2011.07.005; Chang HX, 2010, ANAL CHEM, V82, P2341, DOI 10.1021/ac9025384; Dong HF, 2010, ANAL CHEM, V82, P5511, DOI 10.1021/ac100852z; Huang PJJ, 2012, ANAL CHEM, V84, P4192, DOI 10.1021/ac300778s; Hwang SH, 2014, BIOSENS BIOELECTRON, V53, P112, DOI 10.1016/j.bios.2013.09.011; Kang T, 2014, J PHYS CHEM B, V118, P6297, DOI 10.1021/jp501820j; Kim YJ, 2008, KOREAN J LAB MED, V28, P34, DOI 10.3343/kjlm.2008.28.1.34; Lee J, 2014, BIOSENS BIOELECTRON, V62, P140, DOI 10.1016/j.bios.2014.06.028; Lim J, 2014, J MICROBIOL BIOTECHN, V24, P1004, DOI 10.4014/jmb.1403.03071; Liu F, 2010, BIOSENS BIOELECTRON, V25, P2361, DOI 10.1016/j.bios.2010.02.022; Liu YH, 2013, EURASIP J BIOINFORM, DOI 10.1186/1687-4153-2013-8; Loh KP, 2010, NAT CHEM, V2, P1015, DOI 10.1038/NCHEM.907; Lok KH, 2002, EMERG INFECT DIS, V8, P1310, DOI 10.3201/eid0811.020291; Park JS, 2014, LANGMUIR, V30, P12587, DOI 10.1021/la503401d; Rozen S, 2000, Methods Mol Biol, V132, P365; Veigas B, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-38; Wallis RS, 2013, LANCET INFECT DIS, V13, P362, DOI 10.1016/S1473-3099(13)70034-3; WHO, 2014, GLOB TUB REP 2014; Wu M, 2011, LANGMUIR, V27, P2731, DOI 10.1021/la1037926; Zhang CL, 2011, ANGEW CHEM INT EDIT, V50, P6851, DOI 10.1002/anie.201100769; Zhang M, 2013, ACS APPL MATER INTER, V5, P8278, DOI 10.1021/am402429n; Zhu DB, 2015, BIOSENS BIOELECTRON, V65, P152, DOI 10.1016/j.bios.2014.10.019; Zignol M, 2012, B WORLD HEALTH ORGAN, V90, P111, DOI 10.2471/BLT.11.092585	25	11	11	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136954	10.1371/journal.pone.0136954	http://dx.doi.org/10.1371/journal.pone.0136954			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322510	Green Published, Green Submitted, gold			2022-12-26	WOS:000360435500053
J	Ding, L; Gao, R; Xiong, XQ; Gao, XY; Chen, Q; Li, YH; Kang, YM; Zhu, GQ				Ding, Lei; Gao, Run; Xiong, Xiao-Qing; Gao, Xing-Ya; Chen, Qi; Li, Yue-Hua; Kang, Yu-Ming; Zhu, Guo-Qing			GABA in Paraventricular Nucleus Regulates Adipose Afferent Reflex in Rats	PLOS ONE			English	Article							SYMPATHETIC VASOMOTOR TONE; HYPERTENSIVE-RATS; OBESITY HYPERTENSION; SUPEROXIDE ANIONS; ACTIVATION; TISSUE; RECEPTORS; HYPOTHALAMUS; INNERVATION; GLUTAMATE	Background Chemical stimulation of white adipose tissue (WAT) induces adipose afferent reflex (AAR), and thereby causes a general sympathetic activation. Paraventricular nucleus (PVN) is important in control of sympathetic outflow. This study was designed to investigate the role of gamma-aminobutyric acid (GABA) in PVN in regulating the AAR. Methodology/Principal Findings Experiments were carried out in anesthetized rats. Renal sympathetic nerve activity (RSNA) and mean arterial pressure (MAP) were continuously recorded. AAR was evaluated by the RSNA and MAP responses to electrical stimulation of the right epididymal WAT (eWAT) afferent nerve. Electrical stimulation of eWAT afferent nerve increase RSNA. Bilateral microinjection of the GABA(A) receptor agonist isoguvacine or the GABA(B) receptor agonist baclofen attenuated the AAR. The effect of isoguvacine on the AAR was greater than that of baclofen. The GABA(A) receptor antagonist gabazine enhanced the AAR, while the GABA(B) receptor antagonist CGP-35348 had no significant effect on the AAR. Bilateral PVN microinjection of vigabatrin, a selective GABA-transaminase inhibitor, to increase endogenous GABA levels in the PVN abolished the AAR. The inhibitory effect of vigabatrin on the AAR was attenuated by the pretreatment with gabazine or CGP-35348. Pretreatment with combined gabazine and CGP-35348 abolished the effects of vigabatrin. Conclusions Activation of GABAA or GABAB receptors in the PVN inhibits the AAR. Blockade of GABAA receptors in the PVN enhances the AAR. Endogenous GABA in the PVN plays an important role in regulating the AAR.	[Ding, Lei; Gao, Run; Xiong, Xiao-Qing; Gao, Xing-Ya; Zhu, Guo-Qing] Nanjing Med Univ, Dept Physiol, Key Lab Cardiovasc Dis & Mol Intervent, Nanjing 210029, Jiangsu, Peoples R China; [Chen, Qi; Li, Yue-Hua] Nanjing Med Univ, Dept Pathophysiol, Nanjing 210029, Jiangsu, Peoples R China; [Kang, Yu-Ming] Xi An Jiao Tong Univ, Sch Med, Cardiovasc Res Ctr, Dept Physiol & Pathophysiol, Xian 710061, Peoples R China	Nanjing Medical University; Nanjing Medical University; Xi'an Jiaotong University	Zhu, GQ (corresponding author), Nanjing Med Univ, Dept Physiol, Key Lab Cardiovasc Dis & Mol Intervent, Nanjing 210029, Jiangsu, Peoples R China.	gqzhucn@njmu.edu.cn	LI, Yue/GRS-8071-2022	Zhu, Guo-Qing/0000-0002-3132-9592	Chinese National Natural Science Fund [31171095, 31271213, 91439120]	Chinese National Natural Science Fund(National Natural Science Foundation of China (NSFC))	This work was supported by Chinese National Natural Science Fund (31171095, 31271213 & 91439120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartness TJ, 2007, PHYSIOL BEHAV, V91, P343, DOI 10.1016/j.physbeh.2007.04.002; Bartness TJ, 2007, J LIPID RES, V48, P1655, DOI 10.1194/jlr.R700006-JLR200; Bartness TJ, 2014, FRONT NEUROENDOCRIN, V35, P473, DOI 10.1016/j.yfrne.2014.04.001; Bartness TJ, 2005, P NUTR SOC, V64, P53, DOI 10.1079/PNS2004409; Benturquia N, 2004, J CHROMATOGR B, V806, P237, DOI 10.1016/j.jchromb.2004.03.061; Brown JT, 2007, EUR J NEUROSCI, V25, P2982, DOI 10.1111/j.1460-9568.2007.05544.x; Chen WW, 2015, ACTA PHYSIOL, V213, P778, DOI 10.1111/apha.12447; Coote JH, 2005, EXP PHYSIOL, V90, P169, DOI 10.1113/expphysiol.2004.029041; Cui BP, 2013, ACTA PHYSIOL, V209, P45, DOI 10.1111/apha.12125; Ding L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083771; Gan XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094234; Jia LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085481; Li DP, 2007, HYPERTENSION, V49, P916, DOI 10.1161/01.HYP.0000259666.99449.74; Li DP, 2007, J PHARMACOL EXP THER, V320, P615, DOI 10.1124/jpet.106.109538; Li DP, 2006, AM J PHYSIOL-HEART C, V290, pH1110, DOI 10.1152/ajpheart.00788.2005; Li P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080295; Li YF, 2006, AM J PHYSIOL-HEART C, V291, pH2847, DOI 10.1152/ajpheart.00625.2005; Mussalo H, 2002, CLIN AUTON RES, V12, P465, DOI 10.1007/s10286-002-0069-z; Serafini R, 1998, EUR J NEUROSCI, V10, P1771, DOI 10.1046/j.1460-9568.1998.00187.x; Shi Z, 2012, J APPL PHYSIOL, V112, P1008, DOI 10.1152/japplphysiol.01164.2011; Song CK, 2009, AM J PHYSIOL-REG I, V296, pR501, DOI 10.1152/ajpregu.90786.2008; Stratford TR, 1997, J NEUROSCI, V17, P4434; Sun HJ, 2014, ACTA PHYSIOL, V212, P267, DOI 10.1111/apha.12405; Sun HJ, 2014, ACTA PHYSIOL, V210, P534, DOI 10.1111/apha.12188; Xi ZX, 2000, J PHARMACOL EXP THER, V294, P613; Xiong XQ, 2014, ACTA PHYSIOL, V210, P468, DOI 10.1111/apha.12182; Xiong XQ, 2012, HYPERTENSION, V60, P1280, DOI 10.1161/HYPERTENSIONAHA.112.198002; Yin M, 1996, HYPERTENSION, V27, P1291, DOI 10.1161/01.HYP.27.6.1291; Zhang F, 2014, ACTA PHYSIOL, V212, P17, DOI 10.1111/apha.12342	29	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136983	10.1371/journal.pone.0136983	http://dx.doi.org/10.1371/journal.pone.0136983			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317425	gold, Green Published, Green Submitted			2022-12-26	WOS:000360299100188
J	Grant, MP; Cavanaugh, A; Breitwieser, GE				Grant, Michael P.; Cavanaugh, Alice; Breitwieser, Gerda E.			14-3-3 Proteins Buffer Intracellular Calcium Sensing Receptors to Constrain Signaling	PLOS ONE			English	Article							HUMAN CA2+ RECEPTOR; CELL-SURFACE; COUPLED RECEPTORS; BETA-ARRESTINS; EXPRESSION; MUTATIONS; DESENSITIZATION; DEGRADATION; MATURATION; HYPOCALCEMIA	Calcium sensing receptors (CaSR) interact with 14-3-3 binding proteins at a carboxyl terminal arginine-rich motif. Mutations identified in patients with familial hypocalciuric hypercalcemia, autosomal dominant hypocalcemia, pancreatitis or idiopathic epilepsy support the functional importance of this motif. We combined total internal reflection fluorescence microscopy and biochemical approaches to determine the mechanism of 14-3-3 protein regulation of CaSR signaling. Loss of 14-3-3 binding caused increased basal CaSR signaling and plasma membrane levels, and a significantly larger signaling-evoked increase in plasma membrane receptors. Block of core glycosylation with tunicamycin demonstrated that changes in plasma membrane CaSR levels were due to differences in exocytic rate. Western blotting to quantify time-dependent changes in maturation of expressed wt CaSR and a 14-3-3 protein binding-defective mutant demonstrated that signaling increases synthesis to maintain constant levels of the immaturely and maturely glycosylated forms. CaSR thus operates by a feed-forward mechanism, whereby signaling not only induces anterograde trafficking of nascent receptors but also increases biosynthesis to maintain steady state levels of net cellular CaSR. Overall, these studies suggest that 14-3-3 binding at the carboxyl terminus provides an important buffering mechanism to increase the intracellular pool of CaSR available for signaling-evoked trafficking, but attenuates trafficking to control the dynamic range of responses to extracellular calcium.	[Grant, Michael P.; Cavanaugh, Alice; Breitwieser, Gerda E.] Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA		Breitwieser, GE (corresponding author), Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA.	gebreitwieser@geisinger.edu		Grant, Michael/0000-0003-3758-5009; Breitwieser, Gerda/0000-0001-9081-0362	Geisinger Clinic; American Heart Association, Great Rivers Affiliate	Geisinger Clinic; American Heart Association, Great Rivers Affiliate(American Heart Association)	This work was funded by Geisinger Clinic to GEB and the American Heart Association, Great Rivers Affiliate, to MPG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ruiz MA, 2011, EUR J PHARMACOL, V670, P365, DOI 10.1016/j.ejphar.2011.09.027; Arulpragasam A, 2012, BIOCHEM J, V441, P885; Breitwieser GE, 2001, AM J PHYSIOL-CELL PH, V280, pC1412, DOI 10.1152/ajpcell.2001.280.6.C1412; Breitwieser GE, 2013, BEST PRACT RES CL EN, V27, P303, DOI 10.1016/j.beem.2013.03.003; Breitwieser GE, 2012, MOL ENDOCRINOL, V26, P1955, DOI 10.1210/me.2012-1306; Brennan SC, 2015, ENDOCRINOLOGY, V156, P1330, DOI 10.1210/en.2014-1771; Brown EM, 2013, BEST PRACT RES CL EN, V27, P333, DOI 10.1016/j.beem.2013.02.006; Carvajal K, 2014, CELL CALCIUM, V56, P408, DOI 10.1016/j.ceca.2014.08.003; Cavanaugh A, 2010, J BIOL CHEM, V285, P19854, DOI 10.1074/jbc.M110.124792; Chakravarti B, 2012, ADV EXP MED BIOL, V740, P103, DOI 10.1007/978-94-007-2888-2_5; Conigrave AD, 2013, BEST PRACT RES CL EN, V27, P315, DOI 10.1016/j.beem.2013.05.010; Cottingham C, 2011, J BIOL CHEM, V286, P36063, DOI 10.1074/jbc.M111.261578; Cross BM, 2014, AM J PHYSIOL-CELL PH, V306, pC515, DOI 10.1152/ajpcell.00330.2013; Deshpande LS, 2011, EXP NEUROL, V229, P264, DOI 10.1016/j.expneurol.2011.02.007; Dong G, 2015, AM J PHYSIOL-RENAL, V308, pF267, DOI 10.1152/ajprenal.00629.2014; Fan GF, 1997, ENDOCRINOLOGY, V138, P1916, DOI 10.1210/en.138.5.1916; Felderbauer P, 2006, SCAND J GASTROENTERO, V41, P343, DOI 10.1080/00365520510024214; Gardino AK, 2011, SEMIN CELL DEV BIOL, V22, P688, DOI 10.1016/j.semcdb.2011.09.008; Gilon P, 2014, CELL CALCIUM, V56, P340, DOI 10.1016/j.ceca.2014.09.001; Goldsmith PK, 1997, J BONE MINER RES, V12, P1780, DOI 10.1359/jbmr.1997.12.11.1780; Grant MP, 2012, MOL ENDOCRINOL, V26, P2081, DOI 10.1210/me.2012-1232; Grant MP, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002208; Iizuka R, 2011, ANAL BIOCHEM, V414, P173, DOI 10.1016/j.ab.2011.03.036; Kapoor A, 2008, ANN NEUROL, V64, P158, DOI 10.1002/ana.21428; Lienhardt A, 2000, J CLIN ENDOCR METAB, V85, P1695, DOI 10.1210/jc.85.4.1695; Lienhardt A, 2001, J CLIN ENDOCR METAB, V86, P5313, DOI 10.1210/jc.86.11.5313; Lorenz S, 2007, ENDOCRINOLOGY, V148, P2398, DOI 10.1210/en.2006-1035; Luttrell LM, 2002, J CELL SCI, V115, P455; Magno AL, 2011, ENDOCR REV, V32, P3, DOI 10.1210/er.2009-0043; Mahon Matthew J, 2011, Adv Biosci Biotechnol, V2, P132; May LT, 2005, J PHARMACOL EXP THER, V312, P382, DOI 10.1124/jpet.104.073767; Miedlich S, 2002, J BIOL CHEM, V277, P49691, DOI 10.1074/jbc.M205578200; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Obsilova V, 2014, PHYSIOL RES, V63, pS155, DOI 10.33549/physiolres.932659; Pakhomov AA, 2008, CHEM BIOL, V15, P755, DOI 10.1016/j.chembiol.2008.07.009; Pi M, 2005, MOL ENDOCRINOL, V19, P1078, DOI 10.1210/me.2004-0450; Rivero-Rios P, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00053; Saidak Z, 2009, MOL PHARMACOL, V76, P1131, DOI 10.1124/mol.109.058784; Smith AJ, 2011, PHYSIOLOGY, V26, P181, DOI 10.1152/physiol.00042.2010; Stepanchick A, 2010, CELL PHYSIOL BIOCHEM, V26, P363, DOI 10.1159/000320560; Tfelt-Hansen J, 2005, CRIT REV CL LAB SCI, V42, P35, DOI 10.1080/10408360590886606; Thomas RL, 2009, J PHARMACOL EXP THER, V331, P1086, DOI 10.1124/jpet.109.160242; Tsao P, 2001, TRENDS PHARMACOL SCI, V22, P91, DOI 10.1016/S0165-6147(00)01620-5; Uhart M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00010; von Zastrow M, 2001, BIOCHEM SOC T, V29, P500, DOI 10.1042/BST0290500; Wang HP, 2015, TOXICOL APPL PHARM, V283, P157, DOI 10.1016/j.taap.2014.12.019; Zhang ML, 2005, J BIOL CHEM, V280, P11140, DOI 10.1074/jbc.M412242200; Zhuang XL, 2012, J BIOL CHEM, V287, P4165, DOI 10.1074/jbc.M111.271528	48	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136702	10.1371/journal.pone.0136702	http://dx.doi.org/10.1371/journal.pone.0136702			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317416	Green Submitted, gold, Green Published			2022-12-26	WOS:000360299100124
J	Hadjipanayi, E; Kuhn, PH; Moog, P; Bauer, AT; Kuekrek, H; Mirzoyan, L; Hummel, A; Kirchhoff, K; Salgin, B; Isenburg, S; Dornseifer, U; Ninkovic, M; Machens, HG; Schilling, AF				Hadjipanayi, Ektoras; Kuhn, Peer-Hendrik; Moog, Philipp; Bauer, Anna-Theresa; Kuekrek, Haydar; Mirzoyan, Lilit; Hummel, Anja; Kirchhoff, Katharina; Salgin, Burak; Isenburg, Sarah; Dornseifer, Ulf; Ninkovic, Milomir; Machens, Hans-Guenther; Schilling, Arndt F.			The Fibrin Matrix Regulates Angiogenic Responses within the Hemostatic Microenvironment through Biochemical Control	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PLATELET FACTOR-IV; CARDIOVASCULAR-DISEASE; ENERGY-METABOLISM; VENOUS THROMBUS; CELLS; EXPRESSION; HYPOXIA; BINDING; SYSTEM	Conceptually, premature initiation of post-wound angiogenesis could interfere with hemostasis, as it relies on fibrinolysis. The mechanisms facilitating orchestration of these events remain poorly understood, however, likely due to limitations in discerning the individual contribution of cells and extracellular matrix. Here, we designed an in vitro Hemostatic-Components- Model (HCM) to investigate the role of the fibrin matrix as protein factor-carrier, independent of its cell-scaffold function. After characterizing the proteomic profile of HCM-harvested matrix releasates, we demonstrate that the key pro-/anti-angiogenic factors, VEGF and PF4, are differentially bound by the matrix. Changing matrix fibrin mass consequently alters the balance of releasate factor concentrations, with differential effects on basic endothelial cell (EC) behaviors. While increasing mass, and releasate VEGF levels, promoted EC chemotactic migration, it progressively inhibited tube formation, a response that was dependent on PF4. These results indicate that the clot's matrix component initially serves as biochemical anti-angiogenic barrier, suggesting that post-hemostatic angiogenesis follows fibrinolysis-mediated angiogenic disinhibition. Beyond their significance towards understanding the spatiotemporal regulation of wound healing, our findings could inform the study of other pathophysiological processes in which coagulation and angiogenesis are prominent features, such as cardiovascular and malignant disease.	[Hadjipanayi, Ektoras; Moog, Philipp; Bauer, Anna-Theresa; Kuekrek, Haydar; Mirzoyan, Lilit; Hummel, Anja; Kirchhoff, Katharina; Dornseifer, Ulf; Machens, Hans-Guenther; Schilling, Arndt F.] Tech Univ Munich, Klinikum Rechts Isar, Dept Expt Plast Surg, Clin Plast & Hand Surg, D-81675 Munich, Germany; [Hadjipanayi, Ektoras; Isenburg, Sarah; Dornseifer, Ulf; Ninkovic, Milomir] Bogenhausen Hosp, Dept Plast Reconstruct Hand & Burn Surg, D-81925 Munich, Germany; [Kuhn, Peer-Hendrik] German Ctr Neurodegenerat Dis DZNE, Munich, Germany; [Kuhn, Peer-Hendrik] Tech Univ Munich, Klinikum Rechts Isar, Neuroprote, D-81675 Munich, Germany; [Salgin, Burak] Univ Childrens Hosp Dusseldorf, Dept Gen Paediat Neonatol & Paediat Cardiol, D-40225 Dusseldorf, Germany; [Salgin, Burak] Univ Cambridge, Dept Paediat, Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England; [Schilling, Arndt F.] Ctr Appl New Technol Engn Regenerat Med Canter, Munich, Germany	Technical University of Munich; Munchen Klinik; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technical University of Munich; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of Cambridge	Schilling, AF (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Expt Plast Surg, Clin Plast & Hand Surg, D-81675 Munich, Germany.	a.schilling@tum.de		Kuhn, Peer-Hendrik/0000-0001-7891-5102; Kirchhoff, Katharina/0000-0001-5547-5140				Aidoudi S, 2010, THROMB HAEMOSTASIS, V104, P941, DOI 10.1160/TH10-03-0193; Aidoudi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002657; AKAHORI M, 1995, HAEMATOLOGIA, V26, P191; Amelot AA, 2007, J BIOL CHEM, V282, P710, DOI 10.1074/jbc.M606650200; Barkefors I, 2008, J BIOL CHEM, V283, P13905, DOI 10.1074/jbc.M704917200; Battinelli EM, 2011, BLOOD, V118, P1359, DOI 10.1182/blood-2011-02-334524; Bootle-Wilbraham C. A., 2001, Angiogenesis, V4, P269; Brill A, 2004, CARDIOVASC RES, V63, P226, DOI 10.1016/j.cardiores.2004.04.012; Browder T, 2000, J BIOL CHEM, V275, P1521, DOI 10.1074/jbc.275.3.1521; BURCZAK K, 1994, BIOMATERIALS, V15, P231, DOI 10.1016/0142-9612(94)90072-8; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Collen A, 1998, Angiogenesis, V2, P153, DOI 10.1023/A:1009240522808; Daly ME, 2003, JNCI-J NATL CANCER I, V95, P1660, DOI 10.1093/jnci/djg101; Dziurla R, 2010, IMMUNOL LETT, V131, P97, DOI 10.1016/j.imlet.2010.02.008; Evans CE, 2010, ARTERIOSCL THROM VAS, V30, P2443, DOI 10.1161/ATVBAHA.110.215038; Feng Xiaodong, 2013, Int J Cell Biol, V2013, P231279, DOI 10.1155/2013/231279; GENGRINOVITCH S, 1995, J BIOL CHEM, V270, P15059, DOI 10.1074/jbc.270.25.15059; Hadjipanayi E, 2013, J CONTROL RELEASE, V169, P91, DOI 10.1016/j.jconrel.2013.04.008; Hang TC, 2013, MOL CELL PROTEOMICS, V12, P3704, DOI 10.1074/mcp.M113.030528; Harrison S, 2011, AM J SPORT MED, V39, P729, DOI 10.1177/0363546511401576; Hiraoka N, 1998, CELL, V95, P365, DOI 10.1016/S0092-8674(00)81768-7; Hu CJ, 2006, J CEREBR BLOOD F MET, V26, P1519, DOI 10.1038/sj.jcbfm.9600304; Jamison J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093968; Klein-Soyer C, 1997, CR ACAD SCI III-VIE, V320, P857, DOI 10.1016/S0764-4469(97)80870-0; Koenig W, 2003, THROMB HAEMOSTASIS, V89, P601; Laderoute KR, 2000, CLIN CANCER RES, V6, P2941; Laurens N, 2006, J THROMB HAEMOST, V4, P932, DOI 10.1111/j.1538-7836.2006.01861.x; LEITZEL K, 1991, CANCER RES, V51, P4149; Levy AP, 1999, CORONARY ARTERY DIS, V10, P427, DOI 10.1097/00019501-199909000-00013; Loeffen R, 2012, J THROMB HAEMOST, V10, P1207, DOI 10.1111/j.1538-7836.2012.04782.x; MAIONE TE, 1990, SCIENCE, V247, P77, DOI 10.1126/science.1688470; Martino MM, 2013, P NATL ACAD SCI USA, V110, P4563, DOI 10.1073/pnas.1221602110; Modarai B, 2005, THROMB HAEMOSTASIS, V93, P801, DOI 10.1160/TH04-09-0596; Mollet NR, 2002, CIRCULATION, V106, P2873, DOI 10.1161/01.CIR.0000044389.51236.91; Monroe DM, 2012, HAEMOPHILIA, V18, P11, DOI 10.1111/j.1365-2516.2012.02889.x; Nicosia RF, 2011, INT J DEV BIOL, V55, P447, DOI 10.1387/ijdb.103222rn; PAULY RR, 1992, CIRCULATION, V86, P68; Reinke JM, 2012, EUR SURG RES, V49, P35, DOI 10.1159/000339613; Rhee JS, 2004, THROMB HAEMOSTASIS, V92, P394, DOI 10.1160/TH03-04-0213; Sahni A, 2000, BLOOD, V96, P3772, DOI 10.1182/blood.V96.12.3772.h8003772_3772_3778; Sahni A, 1998, J BIOL CHEM, V273, P7554, DOI 10.1074/jbc.273.13.7554; SATO Y, 1990, BIOCHEM BIOPH RES CO, V172, P595, DOI 10.1016/0006-291X(90)90715-Y; Street J, 2000, CLIN ORTHOP RELAT R, P224, DOI 10.1097/00003086-200009000-00033; Tang JY, 2011, ACTA NEUROCHIR SUPPL, V111, P25, DOI 10.1007/978-3-7091-0693-8_5; Tayebjee MH, 2004, QJM-INT J MED, V97, P259, DOI 10.1093/qjmed/hch053; Tenan M, 2000, J EXP MED, V191, P1789, DOI 10.1084/jem.191.10.1789; THOMPSON WD, 1991, J PATHOL, V165, P311, DOI 10.1002/path.1711650406; Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x; Weijers EM, 2010, J THROMB HAEMOST, V8, P2800, DOI 10.1111/j.1538-7836.2010.04096.x; Wojtukiewicz MZ, 2001, NEOPLASIA, V3, P371, DOI 10.1038/sj.neo.7900184; Yunoki K, 2013, J ATHEROSCLER THROMB, V20, P524, DOI 10.5551/jat.17608; Zamolodchikov D, 2012, BLOOD, V119, P3342, DOI 10.1182/blood-2011-11-389668; Zhang W, 2013, J BLOOD MED, V4, P141, DOI 10.2147/JBM.S45071	53	29	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135618	10.1371/journal.pone.0135618	http://dx.doi.org/10.1371/journal.pone.0135618			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317771	Green Published, gold, Green Submitted			2022-12-26	WOS:000360299100039
J	Hamamoto, Y; Ito, H; Furu, M; Hashimoto, M; Fujii, T; Ishikawa, M; Yamakawa, N; Terao, C; Azukizawa, M; Iwata, T; Mimori, T; Matsuda, S				Hamamoto, Yosuke; Ito, Hiromu; Furu, Moritoshi; Hashimoto, Motomu; Fujii, Takao; Ishikawa, Masahiro; Yamakawa, Noriyuki; Terao, Chikashi; Azukizawa, Masayuki; Iwata, Takahiro; Mimori, Tsuneyo; Matsuda, Shuichi			Serological and Progression Differences of Joint Destruction in the Wrist and the Feet in Rheumatoid Arthritis - A Cross-Sectional Cohort Study	PLOS ONE			English	Article							RHEUMATOLOGY/EUROPEAN LEAGUE; RADIOGRAPHIC PROGRESSION; AMERICAN-COLLEGE; PREDICTOR; REMISSION; DAMAGE; DISABILITY; BIOMARKERS; FOOT; LIFE	Objective To investigate clinical and radiological differences between joint destruction in the wrist and the feet in patients with RA. Methods A cross-sectional clinical study was conducted in an RA cohort at a single institution. Clinical data included age, sex and duration of disease. Laboratory data included sero-positivity for anti-cyclic citrullinated peptide (CCP) antibody and RF. Radiological measurements included Larsen grades and the modified Sharp/van der Heijde method (SHS) for the hands/wrists and the feet. Statistical analyses were performed using the Kruskal-Wallis H-test, a dummy variable linear regression model and multivariate logistic regression analysis with 95% confidence interval and odds ratios. Results A total of 405 patients were enrolled, and 314 patients were analysed in this study. The duration of disease in the foot-dominant group was significantly less than that in the wrist-dominant group. When patients were subdivided by duration of disease, the Larsen grade of the feet was significantly higher than that of the wrist in the first quadrant subgroup, but this was reversed with increasing duration of disease. Anti-CCP status was a significant predictive factor for joint destruction in the wrist but not in the feet, while RF status was not predictive in either the wrist or the feet. Conclusions Joint destruction in the feet started earlier than in the wrist, but the latter progresses faster with increasing duration of disease. Anti-CCP status predicts joint destruction in the wrist better than in the feet.	[Hamamoto, Yosuke; Ito, Hiromu; Furu, Moritoshi; Ishikawa, Masahiro; Azukizawa, Masayuki; Iwata, Takahiro; Matsuda, Shuichi] Kyoto Univ, Dept Orthoped Surg, Grad Sch Med, Kyoto, Japan; [Furu, Moritoshi; Hashimoto, Motomu; Fujii, Takao; Ishikawa, Masahiro] Kyoto Univ, Dept Control Rheumat Dis, Grad Sch Med, Kyoto, Japan; [Yamakawa, Noriyuki; Mimori, Tsuneyo] Kyoto Univ, Dept Rheumatol & Clin Immunol, Grad Sch Med, Kyoto, Japan; [Terao, Chikashi] Kyoto Univ, Ctr Genom Med, Grad Sch Med, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University	Ito, H (corresponding author), Kyoto Univ, Dept Orthoped Surg, Grad Sch Med, Kyoto, Japan.	hiromu@kuhp.kyoto-u.ac.jp		Matsuda, Shuichi/0000-0003-0802-1255	Mitsubishi-Tanabe; Chugai; Bristol-Myers; Eisai; Daiichi-Sankyo; Abbvie; Astellas; Pfizer Japan	Mitsubishi-Tanabe(Mitsubishi Tanabe Pharma Corporation); Chugai; Bristol-Myers(Bristol-Myers Squibb); Eisai(Eisai Co Ltd); Daiichi-Sankyo(Daiichi Sankyo Company Limited); Abbvie(AbbVie); Astellas(Astellas Pharmaceuticals); Pfizer Japan(Pfizer)	M.F., M.H., M.I., and T.F. belong to the department that is financially supported by 4 pharmaceutical companies (Mitsubishi-Tanabe, Chugai, Bristol-Myers, and Eisai). H. I. has received research grants and/or speaker fees from Chugai, Mitsubishi-Tanabe, Daiichi-Sankyo, Eisai, Bristol-Myers, Abbvie, and Astellas. M.F. and M.I. have received grant and research support from Astellas and Pfizer Japan. T.F. has received grant and research support from Bristol-Myers and Pfizer Japan. Y.H., N.Y., C.T., M.A., T.I, T.M., and S.M. declared no conflict of interest exists. The sponsors were not involved in the study design; in the collection, analysis, interpretation of data; in the writing of this manuscript; or in the decision to submit the article for publication. The authors, their immediate families, and any research foundations with which they are affiliated have not received any financial payments or other benefits from any commercial entity related to the subject of this article. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Bakker MF, 2012, ANN RHEUM DIS, V71, P1692, DOI 10.1136/annrheumdis-2011-200963; Bosello S, 2011, ANN RHEUM DIS, V70, P1292, DOI 10.1136/ard.2010.142729; Felson DT, 2011, ANN RHEUM DIS, V70, P404, DOI 10.1002/art.30129; Forslind K, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4058; Furst DE, 2011, ARTHRIT CARE RES, V63, P856, DOI 10.1002/acr.20452; Furu M, 2014, SCAND J RHEUMATOL, V43, P291, DOI 10.3109/03009742.2013.869831; Gremese E, 2013, ANN RHEUM DIS, V72, P858, DOI 10.1136/annrheumdis-2012-201456; Grondal L, 2008, ACTA ORTHOP, V79, P257, DOI 10.1080/17453670710015067; Hashimoto M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098202; Katchamart W, 2010, ARTHRIT CARE RES, V62, P1128, DOI 10.1002/acr.20188; Krabben A, 2013, J RHEUMATOL, V40, P1303, DOI 10.3899/jrheum.121392; LARSEN A, 1977, ACTA RADIOL DIAGN, V18, P481, DOI 10.1177/028418517701800415; Matsumoto T, 2014, ARTHRIT CARE RES, V66, P499, DOI 10.1002/acr.22174; Momohara S, 2014, J RHEUMATOL, V41, P862, DOI 10.3899/jrheum.131018; Nell VPK, 2004, RHEUMATOLOGY, V43, P906, DOI 10.1093/rheumatology/keh199; Renner N, 2014, ARTHRITIS RHEUMATOL, V66, P3283, DOI 10.1002/art.38862; Rojas-Villarraga A, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-67; Shidara K, 2012, J RHEUMATOL, V39, P476, DOI 10.3899/jrheum.110770; Syversen SW, 2008, ANN RHEUM DIS, V67, P212, DOI 10.1136/ard.2006.068247; Syversen SW, 2010, ANN RHEUM DIS, V69, P845, DOI 10.1136/ard.2009.122325; Terao C, 2015, ARTHRITIS RHEUMATOL, V67; Terao C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085376; Terao C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059341; Tobon G, 2013, ARTHRIT CARE RES, V65, P1907, DOI 10.1002/acr.22078; van der Heijde D, 2000, J RHEUMATOL, V27, P261; van der Leeden M, 2008, ARTHRIT RHEUM-ARTHR, V59, P1596, DOI 10.1002/art.24188; van Nies JAB, 2014, ANN RHEUM DIS, V73, P861, DOI 10.1136/annrheumdis-2012-203130; Vander Cruyssen B, 2007, ANN RHEUM DIS, V66, P364, DOI 10.1136/ard.2006.053470; VanderHeijde DMFM, 1996, BAILLIERE CLIN RHEUM, V10, P435, DOI 10.1016/S1521-6942(96)80007-6; Verstappen SMM, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1882; Vittecoq O, 2003, RHEUMATOLOGY, V42, P939, DOI 10.1093/rheumatology/keg257; Wevers-de Boer KVC, 2015, ANN RHEUM DIS, V74, P341, DOI 10.1136/annrheumdis-2013-203749; Yamanaka H, 2000, ARTHRITIS RHEUM, V43, P852, DOI 10.1002/1529-0131(200004)43:4<852::AID-ANR16>3.0.CO;2-7	34	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136611	10.1371/journal.pone.0136611	http://dx.doi.org/10.1371/journal.pone.0136611			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317770	gold, Green Submitted, Green Published			2022-12-26	WOS:000360299100111
J	Liu, MY; Zhang, LL; Li, J; Li, Y; Li, N; Chen, MQ				Liu, Ming-Yang; Zhang, Ling-Lei; Li, Jia; Li, Yong; Li, Nan; Chen, Ming-Qian			Characteristics of the Cross-Sectional Vorticity of the Natural Spawning Grounds of Schizothorax prenanti and a Vague-Set Similarity Model for Ecological Restoration	PLOS ONE			English	Article							INCOMPRESSIBLE 2-PHASE FLOWS; COUPLED LEVEL SET; YANGTZE-RIVER; CHINESE STURGEON; ATLANTIC SALMON; REGULATED RIVER; CHINOOK SALMON; FLUID METHOD; BROWN TROUT; CHUM SALMON	Schizothorax prenanti is an endemic fish in the mountain rivers of southwestern China with unique protection value. To further explore the vortex motion of hydraulic habitats, which is closely related to the fish breeding process, the cross-sectional vorticity was used to evaluate the hydraulic conditions of the natural spawning habitat of S. prenanti. A coupled levelset and volume-of-fluid (CLSVOF) three-dimensional (3D) model was applied to simulate the hydraulic habitat of the Weimen reach, a typical natural spawning ground for S. prenanti in the upper Yangtze River. The model was used in conjunction with the Wilcoxon rank sum test to distinguish the distributions of vertical vorticity in spawning and non-spawning reaches. Statistical analysis revealed that the cross-sectional vorticity in spawning reaches was significantly greater than in non-spawning reaches, with likely biological significance in the spawning process. The range of cross-sectional mean values of vorticity was 0.17 s(-1) - 0.35 s(-1) in areas with concentrated fish sperm and eggs; the minimum value was 0.17 s(-1), and the majority of values were greater than 0.26 s(-1). Based on this study, a vague-set similarity model was used to assess the effectiveness of ecological restoration by evaluating the similarity of the cross-sectional vorticity of the natural spawning reach and rehabilitated spawning reach after implementing ecological restoration measures. The outcome might provide a theoretical basis for the recovery of damaged S. prenanti spawning grounds and act as an important complement for the assessment of recovery effectiveness and as a useful reference for the coordination of ecological water use with the demands of hydraulic and hydropower engineering.	[Liu, Ming-Yang; Zhang, Ling-Lei; Li, Jia; Li, Yong; Li, Nan; Chen, Ming-Qian] Sichuan Univ, Inst Ecol & Environm, Coll Water Resource Hydropower, State Key Lab Hydraul & Mt River Engn, Chengdu 610065, Sichuan, Peoples R China; [Liu, Ming-Yang] Sichuan Univ, Sch Econ, Chengdu 610065, Sichuan, Peoples R China; [Liu, Ming-Yang] Water Bur Dazhou City, Dazhou 635000, Sichuan, Peoples R China; [Chen, Ming-Qian] Sichuan Environm & Engn Appraisal Ctr, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University	Zhang, LL (corresponding author), Sichuan Univ, Inst Ecol & Environm, Coll Water Resource Hydropower, State Key Lab Hydraul & Mt River Engn, Chengdu 610065, Sichuan, Peoples R China.	zhanglinglei@hotmail.com			National Natural Science Foundation of China [51309170, 51379136, 51479127]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (Nos. 51309170, 51379136 and 51479127). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong JD, 2003, FISH RES, V62, P143, DOI 10.1016/S0165-7836(02)00160-1; Bandyopadhyay PR, 2000, J FLUID ENG-T ASME, V122, P219, DOI 10.1115/1.483274; Capitani LD, 2011, STAT PROBABIL LETT, V81, P937; [陈明千 Chen Mingqian], 2013, [水利学报, Journal of Hydraulic Engineering], V44, P1303; Chen MQ, 2012, THESIS SICHUAN U; Chen Y., 2000, FAUNA SINICA OSTEICH, P273; Clark MJ, 2002, AQUAT CONSERV, V12, P471, DOI 10.1002/aqc.530; Crimaldi JP, 2012, J EXP BIOL, V215, P1031, DOI 10.1242/jeb.060145; Crimaldi JP, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2963139; Crimaldi JP, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016307; Crimaldi JP, 2004, J MARINE SYST, V49, P3, DOI 10.1016/j.jmarsys.2003.06.005; Crowder DW, 2000, CAN J FISH AQUAT SCI, V57, P1497, DOI 10.1139/cjfas-57-7-1497; Crowder DW, 2006, RIVER RES APPL, V22, P79, DOI 10.1002/rra.893; Crowder DW, 2002, CAN J FISH AQUAT SCI, V59, P633, DOI 10.1139/F02-037; de Rooij F, 1999, J FLUID MECH, V383, P249, DOI 10.1017/S0022112098003966; Downs PW, 2011, ENVIRON MANAGE, V48, P847, DOI 10.1007/s00267-011-9736-y; Falke JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079232; Feng GC, 2014, QUAL QUANT, V48, P2355, DOI 10.1007/s11135-014-0034-7; Fu CZ, 2003, BIODIVERS CONSERV, V12, P1649, DOI 10.1023/A:1023697714517; Fu Jing jing, 2013, Journal of Sichuan University (Engineering Science Edition), V45, P12; Fu XL, 2007, J HYDRODYN, V19, P78, DOI 10.1016/S1001-6058(07)60031-6; [付小莉 FU Xiaoli], 2006, [水科学进展, Advances in Water Science], V17, P700; Gao X, 2009, ENVIRON BIOL FISH, V86, P325, DOI 10.1007/s10641-009-9521-4; Geist DR, 2002, N AM J FISH MANAGE, V22, P1077, DOI 10.1577/1548-8675(2002)022<1077:PCOTHZ>2.0.CO;2; Gostner W, 2013, HYDROBIOLOGIA, V712, P43, DOI 10.1007/s10750-012-1288-5; Habersack H, 2014, HYDROBIOLOGIA, V729, P33, DOI 10.1007/s10750-012-1429-x; Hanke W, 2000, J EXP BIOL, V203, P1193; Hou BD, 2010, YANGTZE RIVER, V41, P32; Jafarzadegan K, 2014, STOCH ENV RES RISK A, V28, P1343, DOI 10.1007/s00477-013-0841-8; Jemison M, 2013, J SCI COMPUT, V54, P454, DOI 10.1007/s10915-012-9614-7; JOWETT IG, 1993, NEW ZEAL J MAR FRESH, V27, P241, DOI 10.1080/00288330.1993.9516563; Lamouroux N, 1999, FRESHWATER BIOL, V42, P275, DOI 10.1046/j.1365-2427.1999.444498.x; Li DF, 2002, PATTERN RECOGN LETT, V23, P221, DOI 10.1016/S0167-8655(01)00110-6; Liu Jun, 2004, China Environmental Science, V24, P395; Liu Mingyang, 2014, Journal of Sichuan University (Engineering Science Edition), V46, P37; Liu MY, 2014, THESIS SICHUAN U; Louhi P, 2008, RIVER RES APPL, V24, P330, DOI 10.1002/rra.1072; Luo X, 1993, FISH SCI TECHNOL INF, V20, P173; Mao Xi, 2012, Journal of Sichuan University, V44, P13; Menard T, 2007, INT J MULTIPHAS FLOW, V33, P510, DOI 10.1016/j.ijmultiphaseflow.2006.11.001; Merz J.E., 2004, INT J RIVER BASIN MA, V2, P21, DOI [10.1080/15715124.2004.9635219, DOI 10.1080/15715124.2004.9635219]; Merz JE, 2006, GEOMORPHOLOGY, V76, P207, DOI 10.1016/j.geomorph.2005.11.004; Moir H. J., 1998, Fisheries Management and Ecology, V5, P241, DOI 10.1046/j.1365-2400.1998.00105.x; Moir HJ, 2008, GEOMORPHOLOGY, V100, P527, DOI 10.1016/j.geomorph.2008.02.001; Moore GI, 2014, MAR BIOL, V161, P1543, DOI 10.1007/s00227-014-2439-1; Noakes DL, 2009, CHINESE FISHES, V28; Olsson E, 2007, J COMPUT PHYS, V225, P785, DOI 10.1016/j.jcp.2006.12.027; Qiang JH, 2006, P INT C HYDR, P2412; Rosenfeld JS, 2011, GEOMORPHOLOGY, V130, P127, DOI 10.1016/j.geomorph.2011.03.007; SEMPESKI P, 1995, J FISH BIOL, V47, P256, DOI 10.1006/jfbi.1995.0131; Shen Y, 2008, J HYDROL, V348, P195, DOI 10.1016/j.jhydrol.2007.09.060; Sussman M, 2000, J COMPUT PHYS, V162, P301, DOI 10.1006/jcph.2000.6537; Taheri SM, 2013, STAT PAP, V54, P457, DOI 10.1007/s00362-012-0443-4; Tsuda Y, 2006, ECOL FRESHW FISH, V15, P264, DOI 10.1111/j.1600-0633.2006.00147.x; Vehanen T, 2005, HYDROBIOLOGIA, V545, P257, DOI 10.1007/s10750-005-3318-z; Versteeg HK, INTRO COMPUTATIONAL; Wang YK, 2012, HYDROL PROCESS, V26, P3489, DOI 10.1002/hyp.8407; Wang YK, 2011, AQUAT ECOL, V45, P255, DOI 10.1007/s10452-011-9351-2; [王远坤 WANG YuanKun], 2009, [生态学报, Acta Ecologica Sinica], V29, P538; Wang YK, 2009, ECOL MODEL, V220, P1443, DOI 10.1016/j.ecolmodel.2009.03.003; Xie JY, 2010, J ANHUI AGR SCI, V38, P13726; Xie JY, 2010, J ANHUI AGR SCI, V38, P13721; Yang Y, 2008, J HYDRODYN, V20, P225, DOI 10.1016/S1001-6058(08)60050-5; Yang Y, 2009, ADVANCES IN WATER RESOURCES AND HYDRAULIC ENGINEERING, VOLS 1-6, P635, DOI 10.1007/978-3-540-89465-0_110; [杨宇 YANG Yu], 2007, [水科学进展, Advances in Water Science], V18, P701; Zhao QH, 2012, STOCH ENV RES RISK A, V26, P993, DOI 10.1007/s00477-012-0583-z; [周波 Zhou Bo], 2013, [西南农业学报, Southwest China Journal of Agricultural Sciences], V26, P811; Zhu ZW, 2013, J APPL ICHTHYOL, V29, P1463, DOI 10.1111/jai.12372	68	2	3	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136724	10.1371/journal.pone.0136724	http://dx.doi.org/10.1371/journal.pone.0136724			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317847	gold, Green Published, Green Submitted			2022-12-26	WOS:000360299100128
J	Liu, Y; Gracewski, SM; Nam, JH				Liu, Yanju; Gracewski, Sheryl M.; Nam, Jong-Hoon			Consequences of Location-Dependent Organ of Corti Micro-Mechanics	PLOS ONE			English	Article							OUTER HAIR-CELLS; BASILAR-MEMBRANE VIBRATION; AUDITORY-NERVE FIBERS; GUINEA-PIG COCHLEA; TECTORIAL MEMBRANE; TRAVELING-WAVES; MAMMALIAN COCHLEA; FORCE GENERATION; MECHANOELECTRICAL TRANSDUCTION; SUBTECTORIAL SPACE	The cochlea performs frequency analysis and amplification of sounds. The graded stiffness of the basilar membrane along the cochlear length underlies the frequency-location relationship of the mammalian cochlea. The somatic motility of outer hair cell is central for cochlear amplification. Despite two to three orders of magnitude change in the basilar membrane stiffness, the force capacity of the outer hair cell's somatic motility, is nearly invariant over the cochlear length. It is puzzling how actuators with a constant force capacity can operate under such a wide stiffness range. We hypothesize that the organ of Corti sets the mechanical conditions so that the outer hair cell's somatic motility effectively interacts with the media of traveling waves-the basilar membrane and the tectorial membrane. To test this hypothesis, a computational model of the gerbil cochlea was developed that incorporates organ of Corti structural mechanics, cochlear fluid dynamics, and hair cell electro-physiology. The model simulations showed that the micro-mechanical responses of the organ of Corti are different along the cochlear length. For example, the top surface of the organ of Corti vibrated more than the bottom surface at the basal (high frequency) location, but the amplitude ratio was reversed at the apical (low frequency) location. Unlike the basilar membrane stiffness varying by a factor of 1700 along the cochlear length, the stiffness of the organ of Corti complex felt by the outer hair cell remained between 1.5 and 0.4 times the outer hair cell stiffness. The Y-shaped structure in the organ of Corti formed by outer hair cell, Deiters cell and its phalange was the primary determinant of the elastic reactance imposed on the outer hair cells. The stiffness and geometry of the Deiters cell and its phalange affected cochlear amplification differently depending on the location.	[Liu, Yanju; Gracewski, Sheryl M.; Nam, Jong-Hoon] Univ Rochester, Dept Mech Engn, Rochester, NY 14627 USA; [Gracewski, Sheryl M.; Nam, Jong-Hoon] Univ Rochester, Dept Biomed Engn, Rochester, NY 14627 USA	University of Rochester; University of Rochester	Nam, JH (corresponding author), Univ Rochester, Dept Mech Engn, Rochester, NY 14627 USA.	jong-hoon.nam@rochester.edu		Nam, Jong-Hoon/0000-0002-7477-5453	NSF CMMI [1233595]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC014685] Funding Source: NIH RePORTER; Directorate For Engineering [1233595] Funding Source: National Science Foundation	NSF CMMI(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by NSF CMMI 1233595 (http://www.nsf.gov/awardsearch/showAward?AWD_ID=1233595&HistoricalAwards=false). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHMORE JF, 1987, J PHYSIOL-LONDON, V388, P323, DOI 10.1113/jphysiol.1987.sp016617; Ashmore J, 2008, PHYSIOL REV, V88, P173, DOI 10.1152/physrev.00044.2006; Beurg M, 2008, BIOPHYS J, V94, P2639, DOI 10.1529/biophysj.107.123257; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; Chan DK, 2005, NAT NEUROSCI, V8, P149, DOI 10.1038/nn1385; Chen FY, 2011, NAT NEUROSCI, V14, P770, DOI 10.1038/nn.2827; COOPER NP, 1995, HEARING RES, V82, P225, DOI 10.1016/0378-5955(94)00180-X; Cooper NP, 2000, RADIAL VARIATION VIB; Cormack J, 2015, J ACOUSTICAL SOC AM; DIEPENDAAL RJ, 1987, J ACOUST SOC AM, V82, P1655, DOI 10.1121/1.395157; Dong W, 2013, BIOPHYS J, V105, P1067, DOI 10.1016/j.bpj.2013.06.049; Dong XX, 2002, BIOPHYS J, V82, P1254, DOI 10.1016/S0006-3495(02)75481-7; Edge RM, 1998, HEARING RES, V124, P1, DOI 10.1016/S0378-5955(98)00090-2; Emadi G, 2004, J NEUROPHYSIOL, V91, P474, DOI 10.1152/jn.00446.2003; GEISLER CD, 1995, HEARING RES, V86, P132, DOI 10.1016/0378-5955(95)00064-B; GEISLER CD, 1993, HEARING RES, V68, P253, DOI 10.1016/0378-5955(93)90129-O; Ghaffari R, 2007, P NATL ACAD SCI USA, V104, P16510, DOI 10.1073/pnas.0703665104; Ghaffari R, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1094; Gu JWW, 2008, BIOPHYS J, V95, P2529, DOI 10.1529/biophysj.107.124727; Gueta R, 2006, P NATL ACAD SCI USA, V103, P14790, DOI 10.1073/pnas.0603429103; Guinan JJ, 2012, HEARING RES, V292, P35, DOI 10.1016/j.heares.2012.08.005; Hallworth R, 1995, J NEUROPHYSIOL, V74, P2319, DOI 10.1152/jn.1995.74.6.2319; HE DZZ, 1994, HEARING RES, V78, P77, DOI 10.1016/0378-5955(94)90046-9; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; Iwasa K, 1997, BIOPHYSICAL J; Iwasa KH, 1997, BIOPHYS J, V73, P546, DOI 10.1016/S0006-3495(97)78092-5; Johnson SL, 2011, NEURON IN PRESS; Johnson SL, 2011, NEURON, V70, P1143, DOI 10.1016/j.neuron.2011.04.024; Kennedy HJ, 2005, NATURE, V433, P880, DOI 10.1038/nature03367; Kennedy HJ, 2003, NAT NEUROSCI, V6, P832, DOI 10.1038/nn1089; Kolston PJ, 1996, J ACOUST SOC AM, V99, P455, DOI 10.1121/1.414557; Lamb JS, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.088101; Lee HY, 2015, P NATL ACAD SCI USA, V112, P3128, DOI 10.1073/pnas.1500038112; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; LIGHTHILL J, 1981, J FLUID MECH, V106, P149, DOI 10.1017/S0022112081001560; LIM DJ, 1986, HEARING RES, V22, P117, DOI 10.1016/0378-5955(86)90089-4; Lim KM, 2002, HEARING RES, V170, P190, DOI 10.1016/S0378-5955(02)00491-4; Liu YW, 2010, J ACOUST SOC AM, V127, P2420, DOI 10.1121/1.3337233; Lu TK, 2006, HEARING RES, V214, P45, DOI 10.1016/j.heares.2006.01.018; Mahendrasingam S, 2010, EUR J NEUROSCI, V31, P1595, DOI 10.1111/j.1460-9568.2010.07182.x; MAMMANO F, 1993, NATURE, V365, P838, DOI 10.1038/365838a0; MAMMANO F, 1993, J ACOUST SOC AM, V93, P3320, DOI 10.1121/1.405716; Maoileidigh DO, 2013, P NATL ACAD SCI USA, V110, P5474, DOI 10.1073/pnas.1302911110; Meaud J, 2012, BIOPHYS J, V102, P1237, DOI 10.1016/j.bpj.2012.02.026; Meaud J, 2011, BIOPHYS J, V100, P2576, DOI 10.1016/j.bpj.2011.04.049; Muller M, 1996, HEARING RES, V94, P148, DOI 10.1016/0378-5955(95)00230-8; Naidu RC, 1998, HEARING RES, V124, P124, DOI 10.1016/S0378-5955(98)00133-6; Naidu RC, 2001, JARO, V2, P257; Nakajima HH, 2009, JARO-J ASSOC RES OTO, V10, P23, DOI 10.1007/s10162-008-0150-y; Nam JH, 2008, BIOPHYS J, V95, P4948, DOI 10.1529/biophysj.108.138560; Nam JH, 2014, BIOPHYS J, V106, P2426, DOI 10.1016/j.bpj.2014.04.018; Nam JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050572; Nam JH, 2010, BIOPHYS J, V98, P2813, DOI 10.1016/j.bpj.2010.03.052; Narayan SS, 1998, SCIENCE, V282, P1882, DOI 10.1126/science.282.5395.1882; NEELY ST, 1986, J ACOUST SOC AM, V79, P1472, DOI 10.1121/1.393674; Nobili R, 1996, J ACOUST SOC AM, V99, P2244, DOI 10.1121/1.415412; Nowotny M, 2006, P NATL ACAD SCI USA, V103, P2120, DOI 10.1073/pnas.0511125103; Nowotny M, 2011, J ACOUST SOC AM, V130, P3852, DOI 10.1121/1.3651822; Olson ES, 2012, HEARING RES, V293, P31, DOI 10.1016/j.heares.2012.04.017; Ospeck M, 2012, BIOPHYS J, V102, P1767, DOI 10.1016/j.bpj.2012.02.049; Plassmann W, 1987, COCHLEA GERBILLINE R; Prodanovic S, 2015, BIOPHYS J, V108, P479, DOI 10.1016/j.bpj.2014.12.027; Rabbitt RD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000444; Ramamoorthy S, 2007, J ACOUST SOC AM, V121, P2758, DOI 10.1121/1.2713725; Ramamoorthy S, 2012, BIOPHYS J, V102, P388, DOI 10.1016/j.bpj.2011.12.040; Ren TY, 2002, P NATL ACAD SCI USA, V99, P17101, DOI 10.1073/pnas.262663699; Ren TY, 2001, HEARING RES, V151, P48, DOI 10.1016/S0378-5955(00)00211-2; Richter CP, 2007, BIOPHYS J, V93, P2265, DOI 10.1529/biophysj.106.094474; ROTH B, 1992, ANAT EMBRYOL, V185, P571, DOI 10.1007/BF00185616; SANTOS-SACCHI J, 1988, HEARING RES, V35, P143, DOI 10.1016/0378-5955(88)90113-X; Schweitzer L, 1996, HEARING RES, V97, P84, DOI 10.1016/0378-5955(96)00063-9; Soons JA, 2014, J ASS RES OTOLARYNGO; Steele CR, 2009, J MECH MATER STRUCT, V4, P755, DOI 10.2140/jomms.2009.4.755; STRELIOFF D, 1984, HEARING RES, V15, P19, DOI 10.1016/0378-5955(84)90221-1; Temchin AN, 2010, JARO-J ASSOC RES OTO, V11, P297, DOI 10.1007/s10162-009-0197-4; Teudt IU, 2014, J ASS RES OTOLARYNGO; van der Heijden M, 2014, P NATL ACAD SCI US; Wangemann P, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-30; Yoon YJ, 2007, J ACOUST SOC AM, V122, P952, DOI 10.1121/1.2747162; Yoon YJ, 2011, BIOPHYS J, V100, P1, DOI 10.1016/j.bpj.2010.11.039; Zetes DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049338; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	82	17	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0133284	10.1371/journal.pone.0133284	http://dx.doi.org/10.1371/journal.pone.0133284			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317521	Green Published, Green Submitted, gold			2022-12-26	WOS:000360299100005
J	Mertens, L; Van Cauwenberg, J; Ghekiere, A; Van Holle, V; De Bourdeaudhuij, I; Deforche, B; Nasar, J; Van de Weghe, N; Van Dyck, D				Mertens, Lieze; Van Cauwenberg, Jelle; Ghekiere, Ariane; Van Holle, Veerle; De Bourdeaudhuij, Ilse; Deforche, Benedicte; Nasar, Jack; Van de Weghe, Nico; Van Dyck, Delfien			Does the Effect of Micro-Environmental Factors on a Street's Appeal for Adults' Bicycle Transport Vary across Different Macro-Environments? An Experimental Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; BUILT ENVIRONMENT; ACTIVE-TRANSPORT; HEALTH-BENEFITS; ATTRIBUTES; INVITINGNESS; RECREATION; WALKING; WEIGHT; PEOPLE	Background Characteristics of the physical environment can be classified into two broad categories: macro-("raw" urban planning features influenced on a regional level) and micro-(features specifically within a streetscape influenced on a neighborhood level) environmental factors. In urban planning applications, it is more feasible to modify conditions at the neighborhood level than at the regional level. Yet for the promotion of bicycle transport we need to know whether relationships between micro-environmental factors and bicycle transport depend on different types of macro-environments. This study aimed to identify whether the effect of three micro-environmental factors (i.e., evenness of the cycle path surface, speed limits and type of separation between cycle path and motorized traffic) on the street's appeal for adults' bicycle transport varied across three different macro-environments (i.e., low, medium and high residential density street). Methods In total, 389 middle-aged adults completed a web-based questionnaire consisting of socio-demographic characteristics and a series of choice tasks with manipulated photographs, depicting two possible routes to cycle along. Conjoint analysis was used to analyze the data. Results Although themagnitude of the overall effects differed, in each macro-environment (i.e., low, medium and high residential density), middle-aged adults preferred a speed limit of 30 km/h, an even cycle path surface and a hedge as separation between motorized traffic and the cycle path compared to a speed limit of 50 or 70 km/h, a slightly uneven or uneven cycle path surface and a curb as separation or no separation between motorized traffic and the cycle path. Conclusions Our results suggest that irrespective of the macro-environment, the same micro-environmental factors are preferred in middle-aged adults concerning the street's appeal for bicycle transport. The controlled environment simulations in the experimental choice task have the potential to inform real life environmental interventions and suggest that micro-environmental changes can have similar results in different macro-environments.	[Mertens, Lieze; Van Holle, Veerle; De Bourdeaudhuij, Ilse; Van Dyck, Delfien] Univ Ghent, Dept Movement & Sport Sci, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [Van Cauwenberg, Jelle; Ghekiere, Ariane; Deforche, Benedicte] Univ Ghent, Dept Publ Hlth, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [Van Cauwenberg, Jelle; Ghekiere, Ariane; Deforche, Benedicte] Vrije Univ Brussel, Fac Phys Educ & Phys Therapy, Dept Human Biometry & Biomech, B-1050 Brussels, Belgium; [Van Cauwenberg, Jelle; Ghekiere, Ariane; Van Holle, Veerle; Van Dyck, Delfien] Res Fdn Flanders FWO, B-1000 Brussels, Belgium; [Nasar, Jack] Ohio State Univ, City & Reg Planning, Columbus, OH 43210 USA; [Van de Weghe, Nico] Univ Ghent, Dept Geog, Fac Sci, B-9000 Ghent, Belgium	Ghent University; Ghent University; Vrije Universiteit Brussel; University System of Ohio; Ohio State University; Ghent University	De Bourdeaudhuij, I (corresponding author), Univ Ghent, Dept Movement & Sport Sci, Fac Med & Hlth Sci, Watersportlaan 2, B-9000 Ghent, Belgium.	Ilse.Debourdeaudhuij@Ugent.be	Van Dyck, Delfien/AAO-8981-2020; Van de Weghe, Nico/B-7680-2011; Van de Weghe, Nico/N-4214-2019; De+Bourdeaudhuij, Ilse/AAC-5528-2019; Mertens, Lieze/AAG-3340-2020	Van de Weghe, Nico/0000-0002-5327-4000; Van de Weghe, Nico/0000-0002-5327-4000; De+Bourdeaudhuij, Ilse/0000-0001-9969-7597; Van Cauwenberg, Jelle/0000-0003-1292-6241; Van Dyck, Delfien/0000-0003-1783-9075; Mertens, Lieze/0000-0001-7144-2656	Fund for Scientific Research Flanders (FWO) [11N0313N, GA11111N, 11O3115N, FWO12/PDO/158]	Fund for Scientific Research Flanders (FWO)(FWO)	AG, JVC, VVH and DVD are supported by a grant from the Fund for Scientific Research Flanders (FWO) (grant numbers: JVC: 11N0313N AG: GA11111N VVH: 11O3115N DVD: FWO12/PDO/158; www.fwo.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adobe Systems Incorporated, 2013, ADOBE PHOTOSHOP CC; Allenby GM, 2014, ON THE OF DEMAND HET, V35, P384; Alves S, 2008, FACILITIES, V26, P433, DOI 10.1108/02632770810895705; Badland H, 2013, PREV MED, V57, P396, DOI 10.1016/j.ypmed.2013.06.015; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Belgian Federal Government, 2013, STATISTICS BELGIUM; Bidordinova A, 2010, MOTIVATORS BARRIERS, P1; Buehler R, 2012, TR NEWS 280, P280; Cain KL, 2014, SOC SCI MED, V116, P82, DOI 10.1016/j.socscimed.2014.06.042; Carpiano RM, 2009, HEALTH PLACE, V15, P263, DOI 10.1016/j.healthplace.2008.05.003; Commission of the European Communities, 2007, GREEN PAPER TOWARDS; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Cubukcu E, 2005, ENVIRON PLANN B, V32, P777, DOI 10.1068/b31191; Danner UN, 2008, BRIT J SOC PSYCHOL, V47, P245, DOI 10.1348/014466607X230876; Davison KK, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-19; de Hartog JJ, 2010, ENVIRON HEALTH PERSP, V118, P1109, DOI 10.1289/ehp.0901747; Departement of Health-Physical activity-Health improvement and prevention, 2004, AT LEAST FIVE A WEEK; Ferdinand AO, 2012, AM J PUBLIC HEALTH, V102, pE7, DOI 10.2105/AJPH.2012.300740; Foster CE, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-61; Fraser SDS, 2011, EUR J PUBLIC HEALTH, V21, P738, DOI 10.1093/eurpub/ckq145; Gaffron P, 2003, TRANSPORT POLICY, V10, P235, DOI DOI 10.1016/S0967-070X(03)00024-6; Ghekiere A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106696; Grasser G, 2013, INT J PUBLIC HEALTH, V58, P615, DOI 10.1007/s00038-012-0435-0; Janssens D, 2014, ONDERZOEK VERPLAATSI, P116; Jongeneel-Grimen B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062525; Krenn PJ, 2013, AM J PREV MED, V41, P1; Lenders S, 2006, AFBAKENING VAN HET V; Massiani J, 2008, EUR TRANSP, P59; McCormack G, 2004, J Sci Med Sport, V7, P81, DOI 10.1016/S1440-2440(04)80282-2; McCormack GR, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-125; Mertens L, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0088-x; Moudon AV, 2005, TRANSPORT RES D-TR E, V10, P245, DOI 10.1016/j.trd.2005.04.001; Multon K.D., 2010, ENCY RES DESIGN, P627; Nasar JL, 2008, AM J PREV MED, V34, P357, DOI 10.1016/j.amepre.2008.01.013; Nordh H, 2011, URBAN FOR URBAN GREE, V10, P95, DOI 10.1016/j.ufug.2010.12.003; Ogilvie D, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-703; Oja P, 2011, SCAND J MED SCI SPOR, V21, P496, DOI 10.1111/j.1600-0838.2011.01299.x; Orme BK, 2009, GETTING STARTED WITH; Owen N, 2010, J URBAN HEALTH, V87, P189, DOI 10.1007/s11524-009-9424-x; Portney L., 2009, FDN CLIN RES APPL PR; Pucher J, 2008, TRANSPORT REV, V28, P495, DOI 10.1080/01441640701806612; Pucher J, 2010, AM J PUBLIC HEALTH, V100, P1986, DOI 10.2105/AJPH.2009.189324; Pucher J, 2010, PREV MED, V50, pS106, DOI 10.1016/j.ypmed.2009.07.028; Rabl A, 2012, TRANSPORT POLICY, V19, P121, DOI 10.1016/j.tranpol.2011.09.008; Rissel Chris E, 2009, N S W Public Health Bull, V20, P10, DOI 10.1071/NB08043; Rojas-Rueda D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4521; Rudinger G, 2006, SOCIETAL TRENDS MOBI; Sallis JF, 2013, PREV MED, V57, P456, DOI 10.1016/j.ypmed.2013.06.014; Sallis JF, 2009, AM J PREV MED, V36, P484, DOI 10.1016/j.amepre.2009.01.031; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Sawtooth Software Inc, 2013, THE CBC SYSTEM FOR C, P1; Scheepers E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073105; Spittaels H, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-39; Swinburn B, 1999, PREV MED, V29, P563, DOI 10.1006/pmed.1999.0585; Titze S, 2010, J PHYS ACT HEALTH, V7, P423, DOI 10.1123/jpah.7.4.423; Van Cauwenberg J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112107; Van Dyck D, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-70; Van Holle V, 2014, TRANSPORT RES A-POL, V69, P432, DOI 10.1016/j.tra.2014.09.009; Van Holle V, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-807; Vandenbulcke G, 2009, TRANSPORT POLICY, V16, P77, DOI 10.1016/j.tranpol.2009.03.004; Wanner M, 2012, AM J PREV MED, V42, P493, DOI 10.1016/j.amepre.2012.01.030; Wells NM, 2007, ENVIRON BEHAV, V39, P6, DOI 10.1177/0013916506295570; Winters M, 2011, TRANSPORTATION, V38, P153, DOI 10.1007/s11116-010-9284-y; Woodcock J, 2007, LANCET, V370, P1078, DOI 10.1016/S0140-6736(07)61254-9; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1; World Health Organization, 2008, INSUFFICIENT PHYSICA; World Health Organization, 2010, GLOBAL RECOMMENDATIO; World Health Organization, 2009, INT DIET PHYS ACT WH	68	9	9	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136715	10.1371/journal.pone.0136715	http://dx.doi.org/10.1371/journal.pone.0136715			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ0PO	26317754	Green Published, Green Submitted, gold			2022-12-26	WOS:000360299100127
J	Lehnen, N; Heuser, F; Saglam, M; Schulz, CM; Wagner, KJ; Taki, M; Kochs, EF; Jahn, K; Brandt, T; Glasauer, S; Schneider, E				Lehnen, Nadine; Heuser, Fabian; Saglam, Murat; Schulz, Christian M.; Wagner, Klaus J.; Taki, Masakatsu; Kochs, Eberhard F.; Jahn, Klaus; Brandt, Thomas; Glasauer, Stefan; Schneider, Erich			Opioid-Induced Nausea Involves a Vestibular Problem Preventable by Head-Rest	PLOS ONE			English	Article							CHRONIC NONCANCER PAIN; MOTION SICKNESS; POSTOPERATIVE NAUSEA; SUSCEPTIBILITY; PERCEPTION; MECHANISMS; MANAGEMENT; RECEPTORS; VELOCITY; ETIOLOGY	Background and Aims Opioids are indispensable for pain treatment but may cause serious nausea and vomiting. The mechanism leading to these complications is not clear. We investigated whether an opioid effect on the vestibular system resulting in corrupt head motion sensation is causative and, consequently, whether head-rest prevents nausea. Methods Thirty-six healthy men (26.6 +/- 4.3 years) received an opioid remifentanil infusion (45 min, 0.15 mu g/kg/min). Outcome measures were the vestibulo-ocular reflex (VOR) gain determined by video-head-impulse-testing, and nausea. The first experiment (n = 10) assessed outcome measures at rest and after a series of five 1-Hz forward and backward head-trunk movements during one-time remifentanil administration. The second experiment (n = 10) determined outcome measures on two days in a controlled crossover design: (1) without movement and (2) with a series of five 1-Hz forward and backward head-trunk bends 30 min after remifentanil start. Nausea was psychophysically quantified (scale from 0 to 10). The third controlled crossover experiment (n = 16) assessed nausea (1) without movement and (2) with head movement; isolated head movements consisting of the three axes of rotation (pitch, roll, yaw) were imposed 20 times at a frequency of 1 Hz in a random, unpredictable order of each of the three axes. All movements were applied manually, passively with amplitudes of about +/- 45 degrees. Results The VOR gain decreased during remifentanil administration (p<0.001), averaging 0.92 +/- 0.05 (mean +/- standard deviation) before, 0.60 +/- 0.12 with, and 0.91 +/- 0.05 after infusion. The average half-life of VOR recovery was 5.3 +/- 2.4 min. 32/36 subjects had no nausea at rest (nausea scale 0.00/0.00 median/interquartile range). Head-trunk and isolated head movement triggered nausea in 64% (p<0.01) with no difference between head-trunk and isolated head movements (nausea scale 4.00/7.25 and 1.00/4.5, respectively). Conclusions Remifentanil reversibly decreases VOR gain at a half-life reflecting the drug's pharmacokinetics. We suggest that the decrease in VOR gain leads to a perceptual mismatch of multisensory input with the applied head movement, which results in nausea, and that, consequently, vigorous head movements should be avoided to prevent opioid-induced nausea.	[Lehnen, Nadine; Glasauer, Stefan] Munich Univ Hosp, Ctr Sensorimotor Res, Munich, Germany; [Lehnen, Nadine; Jahn, Klaus; Brandt, Thomas; Glasauer, Stefan; Schneider, Erich] Munich Univ Hosp, German Ctr Vertigo & Balance Disorders, Munich, Germany; [Lehnen, Nadine; Glasauer, Stefan] Munich Univ Hosp, Dept Neurol, Munich, Germany; [Heuser, Fabian; Schulz, Christian M.; Wagner, Klaus J.; Kochs, Eberhard F.] Tech Univ Munich, Klinikum Rechts Isar, Dept Anaesthesiol, D-80290 Munich, Germany; [Saglam, Murat] Gediz Univ, Fac Engn & Architecture, Dept Biomed Engn, Izmir, Turkey; [Taki, Masakatsu] Kyoto Prefectural Univ Med, Dept Otolaryngol HNS, Kyoto, Japan; [Jahn, Klaus] Schon Klin Bad Aibling, Bad Aibling, Germany; [Brandt, Thomas; Schneider, Erich] Munich Univ Hosp, Inst Clin Neurosci, Munich, Germany; [Schneider, Erich] Brandenburg Inst Technol, Inst Med Technol, Cottbus, Germany	University of Munich; University of Munich; University of Munich; Technical University of Munich; Gediz University; Kyoto Prefectural University of Medicine; University of Munich	Heuser, F (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Anaesthesiol, D-80290 Munich, Germany.	F.Heuser@lrz.tu-muenchen.de	Glasauer, Stefan/A-5898-2008; Jahn, Klaus/AAC-4969-2021; Jahn, Klaus/F-9902-2010; Saglam, Murat/L-3123-2014	Glasauer, Stefan/0000-0002-4313-6210; Jahn, Klaus/0000-0002-1669-3652; Saglam, Murat/0000-0001-8766-3883	German Federal Ministry of Education [01 EO 0901]; Faculty of Medicine of the University of Munich	German Federal Ministry of Education(Federal Ministry of Education & Research (BMBF)); Faculty of Medicine of the University of Munich	The German Federal Ministry of Education (Grant 01 EO 0901) and the Faculty of Medicine of the University of Munich funded this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apfel CC, 1999, ANESTHESIOLOGY, V91, P693, DOI 10.1097/00000542-199909000-00022; Apfel CC, 2004, NEW ENGL J MED, V350, P2441, DOI 10.1056/NEJMoa032196; Bartl K, 2009, ANN NY ACAD SCI, V1164, P331, DOI 10.1111/j.1749-6632.2009.03850.x; Bertolini G, 2011, J NEUROPHYSIOL, V105, P209, DOI 10.1152/jn.00154.2010; Bertolini G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036763; Bles W, 2000, CURR OPIN NEUROL, V13, P19, DOI 10.1097/00019052-200002000-00005; Brandt T, 1976, Fortschr Med, V94, P1177; Brandt T, 1999, VERTIGO ITS MULTISEN, P485; CARPENTER DO, 1992, ANN NY ACAD SCI, V656, P668, DOI 10.1111/j.1749-6632.1992.tb25244.x; CHINN HI, 1953, J PHARMACOL EXP THER, V108, P69; Chou R, 2003, J PAIN SYMPTOM MANAG, V26, P1026, DOI 10.1016/j.jpainsymman.2003.03.003; COHEN MM, 1994, ANESTH ANALG, V78, P7; COHEN MM, 1990, ANESTH ANALG, V70, P160; Furlan AD, 2006, CAN MED ASSOC J, V174, P1589, DOI 10.1503/cmaj.051528; Gan TJ, 2001, ANESTH ANALG, V92, P393, DOI 10.1213/00000539-200102000-00022; Gan TJ, 2002, JAMA-J AM MED ASSOC, V287, P1233, DOI 10.1001/jama.287.10.1233; GOLD BS, 1989, JAMA-J AM MED ASSOC, V262, P3008, DOI 10.1001/jama.262.21.3008; Golding JF, 1998, BRAIN RES BULL, V47, P507, DOI 10.1016/S0361-9230(98)00091-4; Golding JF, 2005, CURR OPIN NEUROL, V18, P29, DOI 10.1097/00019052-200502000-00007; Golding JF, 2015, CURR OPIN NEUROL, V28, P83, DOI 10.1097/WCO.0000000000000163; Golding JF, 2011, AUTON NEUROSCI-BASIC, V160, P53, DOI 10.1016/j.autneu.2010.09.009; GUTNER LB, 1952, J CLIN INVEST, V31, P259, DOI 10.1172/JCI102601; HALMAGYI GM, 1988, ARCH NEUROL-CHICAGO, V45, P737, DOI 10.1001/archneur.1988.00520310043015; Institute for Healthcare Informatics, 2014, US MED UN STAT REV 2; Ishiyama A, 2001, ADDICTION, V96, P1363; Macario A, 1999, ANESTH ANALG, V89, P652, DOI 10.1097/00000539-199909000-00022; National Center for Health Statistics, 2014, NUMB INP SURG PER YE; Okada T, 1999, BRAIN, V122, P1293, DOI 10.1093/brain/122.7.1293; Oman CM, 2014, EXP BRAIN RES, V232, P2483, DOI 10.1007/s00221-014-3973-2; Paillard AC, 2013, J VESTIBUL RES-EQUIL, V23, P203, DOI 10.3233/VES-130501; Platzer S, 2000, NEUROSCI LETT, V283, P213, DOI 10.1016/S0304-3940(00)00943-5; Popper P, 2004, NEUROSCIENCE, V129, P225, DOI 10.1016/j.neuroscience.2004.08.008; Porreca F, 2009, PAIN MED, V10, P654, DOI 10.1111/j.1526-4637.2009.00583.x; Ramaioli C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110322; REASON JT, 1978, J ROY SOC MED, V71, P819, DOI 10.1177/014107687807101109; Rottach KG, 2002, J NEUROL, V249, P1200, DOI 10.1007/s00415-002-0806-1; RUBIN A, 1950, J CLIN INVEST, V29, P1261, DOI 10.1172/JCI102363; Sharma Krishan, 1997, Acta Geneticae Medicae et Gemellologiae, V46, P105; Watcha MF, 2000, ANESTHESIOLOGY, V92, P931, DOI 10.1097/00000542-200004000-00007; WATCHA MF, 1992, ANESTHESIOLOGY, V77, P162, DOI 10.1097/00000542-199207000-00023; WESTMORELAND CL, 1993, ANESTHESIOLOGY, V79, P893, DOI 10.1097/00000542-199311000-00005	41	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0135263	10.1371/journal.pone.0135263	http://dx.doi.org/10.1371/journal.pone.0135263			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313751	Green Published, gold, Green Submitted			2022-12-26	WOS:000360144000015
J	Bu, YF; Wang, N; Wang, SL; Sheng, T; Tian, T; Chen, LL; Pan, WW; Zhu, MS; Luo, JH; Lu, W				Bu, Yunfei; Wang, Ning; Wang, Shaoli; Sheng, Tao; Tian, Tian; Chen, Linlin; Pan, Weiwei; Zhu, Minsheng; Luo, Jianhong; Lu, Wei			Myosin IIb-dependent Regulation of Actin Dynamics Is Required for N-Methyl-D-aspartate Receptor Trafficking during Synaptic Plasticity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; LIGHT-CHAIN KINASE; SMOOTH-MUSCLE CONTRACTION; DENDRITIC SPINES; NERVOUS-SYSTEM; IN-VITRO; AREA CA1; F-ACTIN; NMDA; LTP	N-Methyl-D-aspartate receptor (NMDAR) synaptic incorporation changes the number of NMDARs at synapses and is thus critical to various NMDAR-dependent brain functions. To date, the molecules involved in NMDAR trafficking and the underlying mechanisms are poorly understood. Here, we report that myosin IIb is an essential molecule in NMDAR synaptic incorporation during PKC- or theta burst stimulation-induced synaptic plasticity. Moreover, we demonstrate that myosin light chain kinase (MLCK)-dependent actin reorganization contributes to NMDAR trafficking. The findings from additional mutual occlusion experiments demonstrate that PKC and MLCK share a common signaling pathway in NMDAR-mediated synaptic regulation. Because myosin IIb is the primary substrate of MLCK and can regulate actin dynamics during synaptic plasticity, we propose that the MLCK-and myosin IIb-dependent regulation of actin dynamics is required for NMDAR trafficking during synaptic plasticity. This study provides important insights into a mechanical framework for understanding NMDAR trafficking associated with synaptic plasticity.	[Bu, Yunfei; Wang, Ning; Wang, Shaoli; Sheng, Tao; Tian, Tian; Chen, Linlin; Pan, Weiwei; Lu, Wei] Nanjing Med Univ, Dept Neurobiol, Nanjing 210029, Jiangsu, Peoples R China; [Wang, Ning; Wang, Shaoli; Sheng, Tao; Lu, Wei] Southeast Univ, Inst Life Sci, Key Lab Dev Genes & Human Dis, Minist Educ China, Nanjing 210096, Jiangsu, Peoples R China; [Lu, Wei] Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China; [Zhu, Minsheng] Nanjing Univ, Model Anim Res Ctr, Minist Educ China, Key Lab Model Anim Dis Study, Nanjing 210063, Jiangsu, Peoples R China; [Luo, Jianhong] Zhejiang Univ, Sch Med, Dept Neurobiol, Key Lab Med Neurobiol,Minist Hlth China,Zhejiang, Hangzhou 310058, Zhejiang, Peoples R China	Nanjing Medical University; Ministry of Education, China; Southeast University - China; Nantong University; Ministry of Education, China; Nanjing University; Zhejiang University	Lu, W (corresponding author), Nanjing Med Univ, Dept Neurobiol, Nanjing 210029, Jiangsu, Peoples R China.	luwei@seu.edu.cn	Wang, Shaoli/AAJ-5287-2020; Luo, jian/HGE-7331-2022	Sheng, Tao/0000-0001-5570-0424	National Natural Science Foundation of China [31471032]; Major State Basic Research Program of China [2013CB733801]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Program of China(National Basic Research Program of China); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by National Natural Science Foundation of China Grant 31471032, Major State Basic Research Program of China Grant 2013CB733801, and a grant from the Priority Academic Program Development of Jiangsu Higher Education Institutions (to W. L.). The authors declare that they have no conflicts of interest with the contents of this article.	ALLEN BG, 1994, TRENDS BIOCHEM SCI, V19, P362, DOI 10.1016/0968-0004(94)90112-0; ANIKSZTEJN L, 1991, NATURE, V349, P67, DOI 10.1038/349067a0; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024; Caputi A, 1999, EUR J NEUROSCI, V11, P141, DOI 10.1046/j.1460-9568.1999.00414.x; Chen LY, 2007, J NEUROSCI, V27, P5363, DOI 10.1523/JNEUROSCI.0164-07.2007; Cichon J, 2012, J BIOL CHEM, V287, P3919, DOI 10.1074/jbc.M111.301911; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; Fan XL, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00160; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Gardoni F, 2001, J BIOL CHEM, V276, P7609, DOI 10.1074/jbc.M009922200; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; Gu JP, 2010, NAT NEUROSCI, V13, P1208, DOI 10.1038/nn.2634; Guillaud L, 2008, NAT CELL BIOL, V10, P19, DOI 10.1038/ncb1665; He WQ, 2008, GASTROENTEROLOGY, V135, P610, DOI 10.1053/j.gastro.2008.05.032; Hodges JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024149; Honkura N, 2008, NEURON, V57, P719, DOI 10.1016/j.neuron.2008.01.013; HUANG YY, 1993, J NEUROSCI, V13, P568; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kelly MT, 2007, NEUROPHARMACOLOGY, V52, P41, DOI 10.1016/j.neuropharm.2006.07.002; Kneussel M, 2013, NAT REV NEUROSCI, V14, P233, DOI 10.1038/nrn3445; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Lan JY, 2001, NAT NEUROSCI, V4, P382, DOI 10.1038/86028; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lau CG, 2010, J NEUROSCI, V30, P242, DOI 10.1523/JNEUROSCI.4933-08.2010; Ledeboer R C, 1971, Ned Tijdschr Geneeskd, V115, P259; Lei SB, 2001, J NEUROSCI, V21, P8464, DOI 10.1523/JNEUROSCI.21-21-08464.2001; Limouze J, 2004, J MUSCLE RES CELL M, V25, P337, DOI 10.1007/s10974-004-6060-7; Lin B, 2005, J NEUROSCI, V25, P2062, DOI 10.1523/JNEUROSCI.4283-04.2005; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; MALINOW R, 1988, NATURE, V335, P820, DOI 10.1038/335820a0; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Mizui T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085367; NISHIKAWA M, 1984, J BIOL CHEM, V259, P8808; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; POTIER MC, 1995, GENOMICS, V29, P562, DOI 10.1006/geno.1995.9965; Ramachandran B, 2009, J NEUROSCI, V29, P12167, DOI 10.1523/JNEUROSCI.2045-09.2009; Rex CS, 2010, NEURON, V67, P603, DOI 10.1016/j.neuron.2010.07.016; Ryan TA, 1999, J NEUROSCI, V19, P1317; Ryu JB, 2006, NEURON, V49, P175, DOI 10.1016/j.neuron.2005.12.017; Sanhueza M, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-10; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Sheng M, 2000, NAT NEUROSCI, V3, P633, DOI 10.1038/76576; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; Wylie SR, 2001, NAT CELL BIOL, V3, P88, DOI 10.1038/35050613; Yagi H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06353; Yan JZ, 2011, J BIOL CHEM, V286, P25187, DOI 10.1074/jbc.M110.192708; Zheng X, 1999, P NATL ACAD SCI USA, V96, P15262, DOI 10.1073/pnas.96.26.15262; Zoghbi HY, 2000, CURR OPIN NEUROBIOL, V10, P655, DOI 10.1016/S0959-4388(00)00135-5	56	12	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25395	25410		10.1074/jbc.M115.644229	http://dx.doi.org/10.1074/jbc.M115.644229			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26330558	hybrid, Green Published			2022-12-26	WOS:000362962800017
J	Minges, JT; Grossman, G; Zhang, P; Kafri, T; Wilson, EM				Minges, John T.; Grossman, Gail; Zhang, Ping; Kafri, Tal; Wilson, Elizabeth M.			Post-translational Down-regulation of Melanoma Antigen-A11 (MAGE-A11) by Human p14-ARF Tumor Suppressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ANDROGEN RECEPTOR; PROSTATE-CANCER CELLS; HUMAN PROGESTERONE-RECEPTOR; TRANSCRIPTIONAL ACTIVITY; NUCLEOLAR LOCALIZATION; COREGULATOR MAGE-11; DNA METHYLATION; GENE-EXPRESSION; STABILIZES P53; CYCLE ARREST	X-linked primate-specific melanoma antigen-All (MAGE-A11) is a human androgen receptor (AR) coactivator and protooncogene expressed at low levels in normal human reproductive tract tissues and at higher levels in castration-resistant prostate cancer where it is required for androgen-dependent cell growth. In this report, we show that MACE-All is targeted for degradation by human p14-ARF, a tumor suppressor expressed from an alternative reading frame of the p16 cyclin-dependent kinase inhibitor INK4a/ARF gene. MACE-All degradation by the proteasome was mediated by an interaction with p14-ARE and was independent of lysine ubiquitination. A dose-dependent inverse relationship between MACE-All and p14-ARF correlated with p14-ARE inhibition of the MACE-All-induced increase in androgen-dependent AR transcriptional activity and constitutive activity of a splice variant-like AR. Reciprocal stabilization between MACE-A11 and AR did not protect against degradation promoted by p14-ARE. p14-ARE prevented MACE-All interaction with the E2F1 oncoprotein and inhibited the MACE-All-induced increase in E2E1 transcriptional activity. Post-translational down-regulation of MACE-All promoted by p14-ARF was independent of HDM2, the human homologue of mouse double minute 2, an E3 ubiquitin ligase inhibited by p14-ARF. However, MACE-All had a stabilizing effect on HDM2 in the absence or presence of p14-ARE and cooperated with HDM2 to increase E2E1 transcriptional activity in the absence of p14-ARF. We conclude that degradation of MACE-All promoted by the human p14-ARE tumor suppressor contributes to low levels of MACE-All in nontransformed cells and that higher levels of MAGE-All associated with low p14-ARE increase AR and E2F1 transcriptional activity and promote the development of castration-resistant prostate cancer.	[Minges, John T.; Grossman, Gail; Wilson, Elizabeth M.] Univ N Carolina, Labs Reprod Biol, Dept Pediat, Chapel Hill, NC 27599 USA; [Zhang, Ping; Kafri, Tal] Univ N Carolina, Lentivirus Core Facil, Chapel Hill, NC 27599 USA; [Kafri, Tal; Wilson, Elizabeth M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Kafri, Tal] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC 27599 USA; [Kafri, Tal] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Wilson, Elizabeth M.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Wilson, EM (corresponding author), Univ N Carolina, Labs Reprod Biol, CB7500, Chapel Hill, NC 27599 USA.	emw@med.unc.edu			United States Public Health Service NCI from the National Institutes of Health [P01-CA77739]; NATIONAL CANCER INSTITUTE [P01CA077739] Funding Source: NIH RePORTER	United States Public Health Service NCI from the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by United States Public Health Service NCI Grant P01-CA77739 from the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Amir S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061064; Askew EB, 2007, J BIOL CHEM, V282, P25801, DOI 10.1074/jbc.M703268200; Askew EB, 2010, J BIOL CHEM, V285, P21824, DOI 10.1074/jbc.M110.120600; Askew EB, 2009, J BIOL CHEM, V284, P34793, DOI 10.1074/jbc.M109.065979; Bai S, 2008, MOL HUM REPROD, V14, P107, DOI 10.1093/molehr/gam080; Bai S, 2008, MOL CELL BIOL, V28, P1947, DOI 10.1128/MCB.01672-07; Bai SX, 2005, MOL CELL BIOL, V25, P1238, DOI 10.1128/MCB.25.4.1238-1257.2005; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Bonvini P, 2007, LEUKEMIA, V21, P838, DOI 10.1038/sj.leu.2404528; Burchardt T, 1999, J UROLOGY, V162, P1800, DOI 10.1016/S0022-5347(05)68241-9; Carnero A, 2000, NAT CELL BIOL, V2, P148, DOI 10.1038/35004020; Chomez P, 2001, CANCER RES, V61, P5544; Clark PA, 2002, ONCOGENE, V21, P4498, DOI 10.1038/sj.onc.1205558; Datta A, 2002, MOL CELL BIOL, V22, P8398, DOI 10.1128/MCB.22.24.8398-8408.2002; de Bie P, 2011, CELL DEATH DIFFER, V18, P1393, DOI 10.1038/cdd.2011.16; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Delbridge Margaret L, 2007, Soc Reprod Fertil Suppl, V65, P1; Deng XY, 2002, BIOCHEM BIOPH RES CO, V296, P792, DOI 10.1016/S0006-291X(02)00948-8; DEPLAEN E, 1994, IMMUNOGENETICS, V40, P360, DOI 10.1007/BF01246677; Eymin B, 2001, ONCOGENE, V20, P1033, DOI 10.1038/sj.onc.1204220; Fan C, 2008, BBA-MOL BASIS DIS, V1782, P642, DOI 10.1016/j.bbadis.2008.08.009; Ferreon JC, 2009, P NATL ACAD SCI USA, V106, P6591, DOI 10.1073/pnas.0811023106; Gregory CW, 2001, CANCER RES, V61, P2892; Haber DA, 1997, CELL, V91, P555, DOI 10.1016/S0092-8674(00)80441-9; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; He B, 2003, MOL CELL BIOL, V23, P2135, DOI 10.1128/MCB.23.6.2135-2150.2003; He B, 2002, J BIOL CHEM, V277, P10226, DOI 10.1074/jbc.M111975200; Henderson DJP, 2014, BRIT J CANCER, V110, P1278, DOI 10.1038/bjc.2014.22; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Huang WB, 1999, J BIOL CHEM, V274, P25756, DOI 10.1074/jbc.274.36.25756; James SR, 2013, EPIGENETICS-US, V8, P849, DOI 10.4161/epi.25500; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Karpf AR, 2009, MOL CANCER RES, V7, P523, DOI 10.1158/1541-7786.MCR-08-0400; Kobayashi T, 2013, MOL CANCER RES, V11, P828, DOI 10.1158/1541-7786.MCR-13-0207; Komori H, 2005, EMBO J, V24, P3724, DOI 10.1038/sj.emboj.7600836; Konishi N, 2002, JPN J CANCER RES, V93, P767, DOI 10.1111/j.1349-7006.2002.tb01318.x; LANGLEY E, 1995, J BIOL CHEM, V270, P29983; Li YX, 2006, BBA-MOL CELL RES, V1763, P787, DOI 10.1016/j.bbamcr.2006.04.011; Lin HK, 2002, J BIOL CHEM, V277, P36570, DOI 10.1074/jbc.M204751200; Liu Q, 2011, J BIOL CHEM, V286, P29951, DOI 10.1074/jbc.M111.244715; Liu X, 2007, GENE DEV, V21, P2711, DOI 10.1101/gad.1590607; Loughran O, 2000, MOL CELL BIOL, V20, P2186, DOI 10.1128/MCB.20.6.2186-2197.2000; Lu WF, 2013, MOL ENDOCRINOL, V27, P635, DOI 10.1210/me.2012-1294; LUBAHN DB, 1988, MOL ENDOCRINOL, V2, P1265, DOI 10.1210/mend-2-12-1265; Manfredi JJ, 2010, GENE DEV, V24, P1580, DOI 10.1101/gad.1941710; Martelli F, 2001, P NATL ACAD SCI USA, V98, P4455, DOI 10.1073/pnas.081061398; MARTIN K, 1995, NATURE, V375, P691, DOI 10.1038/375691a0; Merkle D, 2011, CELL SIGNAL, V23, P507, DOI 10.1016/j.cellsig.2010.08.017; Midgley CA, 2000, ONCOGENE, V19, P2312, DOI 10.1038/sj.onc.1203593; Minges JT, 2013, J BIOL CHEM, V288, P1939, DOI 10.1074/jbc.M112.428409; Mohler JL, 2004, CLIN CANCER RES, V10, P440, DOI 10.1158/1078-0432.CCR-1146-03; Polager S, 2009, NAT REV CANCER, V9, P738, DOI 10.1038/nrc2718; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; QUARMBY VE, 1990, MOL ENDOCRINOL, V4, P1399, DOI 10.1210/mend-4-9-1399; QUELLE DE, 1995, CELL, V83, P993; Rizos H, 2000, ONCOGENE, V19, P2978, DOI 10.1038/sj.onc.1203629; Rizos H, 2007, CELL CYCLE, V6, P1741, DOI 10.4161/cc.6.14.4428; Robertson KD, 1998, MOL CELL BIOL, V18, P6457, DOI 10.1128/MCB.18.11.6457; ROGNER UC, 1995, GENOMICS, V29, P725, DOI 10.1006/geno.1995.9945; Saha A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002573; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Sharpless NE, 1999, CURR OPIN GENET DEV, V9, P22, DOI 10.1016/S0959-437X(99)80004-5; Shen M, 2013, EXPERT OPIN THER TAR, V17, P1091, DOI 10.1517/14728222.2013.815728; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Su SF, 2013, J BIOL CHEM, V288, P24809, DOI 10.1074/jbc.M113.468579; Su SF, 2012, J BIOL CHEM, V287, P34809, DOI 10.1074/jbc.M112.372797; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Tago K, 2005, P NATL ACAD SCI USA, V102, P7689, DOI 10.1073/pnas.0502978102; Tao WK, 1999, P NATL ACAD SCI USA, V96, P6937, DOI 10.1073/pnas.96.12.6937; Vonlanthen S, 1998, ONCOGENE, V17, P2779, DOI 10.1038/sj.onc.1202501; Wagner BL, 1998, MOL CELL BIOL, V18, P1369, DOI 10.1128/MCB.18.3.1369; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Wilson EM, 2010, THER ADV UROL, V2, P105, DOI 10.1177/1756287210372380; Xu KL, 2001, MOL THER, V3, P97, DOI 10.1006/mthe.2000.0238; Yegnasubramanian S, 2004, CANCER RES, V64, P1975, DOI 10.1158/0008-5472.CAN-03-3972; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhang YP, 1999, MOL CELL, V3, P579, DOI 10.1016/S1097-2765(00)80351-2; Zhang Z, 2005, ONCOGENE, V24, P7238, DOI 10.1038/sj.onc.1208814; Zhang ZH, 2006, MODERN PATHOL, V19, P1339, DOI 10.1038/modpathol.3800655	85	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					25174	25187		10.1074/jbc.M115.663641	http://dx.doi.org/10.1074/jbc.M115.663641			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26330556	Green Published, hybrid			2022-12-26	WOS:000362598300044
J	Ebranati, E; Pariani, E; Piralla, A; Gozalo-Marguello, M; Veo, C; Bubba, L; Amendola, A; Ciccozzi, M; Galli, M; Zanetti, AR; Baldanti, F; Zehender, G				Ebranati, Erika; Pariani, Elena; Piralla, Antonio; Gozalo-Margueello, Monica; Veo, Carla; Bubba, Laura; Amendola, Antonella; Ciccozzi, Massimo; Galli, Massimo; Zanetti, Alessandro Remo; Baldanti, Fausto; Zehender, Gianguglielmo			Reconstruction of the Evolutionary Dynamics of A(H3N2) Influenza Viruses Circulating in Italy from 2004 to 2012	PLOS ONE			English	Article							A H3N2 VIRUSES; EPIDEMIOLOGIC DYNAMICS; GENETIC EVOLUTION; HEMAGGLUTININ; REVEALS; CHINA; MODEL; PIGS	Background Influenza A viruses are characterised by their rapid evolution, and the appearance of point mutations in the viral hemagglutinin (HA) domain causes seasonal epidemics. The A (H3N2) virus has higher mutation rate than the A(H1N1) virus. The aim of this study was to reconstruct the evolutionary dynamics of the A(H3N2) viruses circulating in Italy between 2004 and 2012 in the light of the forces driving viral evolution. Methods Phylodinamic analyses were made using a Bayesian method, and codon-specific positive selection acting on the HA coding sequence was evaluated. Results Global and local phylogenetic analyses showed that the Italian strains collected between 2004 and 2012 grouped into five significant Italian clades that included viral sequences circulating in different epidemic seasons. The time of the most recent common ancestor (tMRCA) of the tree root was between May and December 2003. The tMRCA estimates of the major clades suggest that the origin of a new viral strain precedes the effective circulation of the strain in the Italian population by 6-31 months, thus supporting a central role of global migration in seeding the epidemics in Italy. The study of selection pressure showed that four codons were under positive selection, three of which were located in antigenic sites. Analysis of population dynamics showed the alternation of periods of exponential growth followed by a decrease in the effective number of infections corresponding to epidemic and inter-epidemic seasons. Conclusions Our analyses suggest that a complex interaction between the immune status of the population, migrations, and a few selective sweeps drive the influenza A(H3N2) virus evolution. Our findings suggest the possibility of the year-round survival of local strains even in temperate zones, a hypothesis that warrants further investigation.	[Ebranati, Erika; Veo, Carla; Galli, Massimo; Zehender, Gianguglielmo] Univ Milan, Dipartimento Sci Biomed & Clin Luigi Sacco, Sez Malattie Infett, Milan, Italy; [Pariani, Elena; Bubba, Laura; Amendola, Antonella; Zanetti, Alessandro Remo] Univ Milan, Dipartimento Sci Biomed Salute, Milan, Italy; [Piralla, Antonio; Gozalo-Margueello, Monica; Baldanti, Fausto] Fdn IRCCS Policlin San Matteo, SS Virol Mol, SC Virol & Microbiol, Pavia, Italy; [Gozalo-Margueello, Monica] Marques de Valdecilla Univ Hosp, Santander, Spain; [Ciccozzi, Massimo] Ist Super Sanita, Dipartimento Malattie Infett Parassitarie & Immun, I-00161 Rome, Italy	University of Milan; Luigi Sacco Hospital; University of Milan; IRCCS Fondazione San Matteo; Hospital Universitario Marques de Valdecilla (HUMV); Istituto Superiore di Sanita (ISS)	Zehender, G (corresponding author), Univ Milan, Dipartimento Sci Biomed & Clin Luigi Sacco, Sez Malattie Infett, Milan, Italy.	gianguglielmo.zehender@unimi.it	Piralla, Antonio/K-4756-2018; Pariani, Elena/M-3491-2016; Amendola, Antonella/M-8980-2016; Baldanti, Fausto/J-4924-2018; Ciccozzi, Massimo/AAC-3271-2022; CICCOZZI, MASSIMO/C-6484-2016; GALLI, MASSIMO/L-7282-2017	Piralla, Antonio/0000-0002-6062-2579; Pariani, Elena/0000-0001-5681-3455; Amendola, Antonella/0000-0002-0499-8977; Baldanti, Fausto/0000-0002-3358-8969; Ciccozzi, Massimo/0000-0003-3866-9239; CICCOZZI, MASSIMO/0000-0003-3866-9239; GALLI, MASSIMO/0000-0001-8887-6215; Bubba, Laura/0000-0003-4561-7971	Fondazione Cariplo [2011-0517]; Marques de Valdecilla University Hospital [WLA 03/1]; national flagship project NANOMAX of the Italian Ministero dell' Universita e della Ricerca	Fondazione Cariplo(Fondazione Cariplo); Marques de Valdecilla University Hospital; national flagship project NANOMAX of the Italian Ministero dell' Universita e della Ricerca	This work was supported by Fondazione Cariplo (grant No. 2011-0517, post-doc fellowships of LB and CV), the Marques de Valdecilla University Hospital (grant No. WLA 03/1, pre-doctoral fellowship of MG), and partially supported by the national flagship project NANOMAX of the Italian Ministero dell' Universita e della Ricerca.	Bedford T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000918; Brown IH, 2000, VET MICROBIOL, V74, P29, DOI 10.1016/S0378-1135(00)00164-4; Chen RB, 2008, J MOL EVOL, V66, P655, DOI 10.1007/s00239-008-9119-z; Cheng XW, 2013, J INFECT DIS, V207, P106, DOI 10.1093/infdis/jis526; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; ELLIS JS, 1995, ARCH VIROL, V140, P1889, DOI 10.1007/BF01322680; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; ITO T, 1995, ARCH VIROL, V140, P1163, DOI 10.1007/BF01322743; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kobayashi Y, 2012, J VIROL, V86, P3446, DOI 10.1128/JVI.06147-11; Lin YP, 2012, P NATL ACAD SCI USA, V109, P21474, DOI 10.1073/pnas.1218841110; Nelson MI, 2006, PLOS PATHOG, V2, P1144, DOI 10.1371/journal.ppat.0020125; Okazaki K, 2000, ARCH VIROL, V145, P885, DOI 10.1007/s007050050681; Pariani E, 2013, INFECT GENET EVOL, V13, P252, DOI 10.1016/j.meegid.2012.10.019; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Schmidt R, 2002, ST HEAL T, V90, P420; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Stohr K, 2002, LANCET INFECT DIS, V2, P517, DOI 10.1016/S1473-3099(02)00366-3; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Westgeest KB, 2012, J GEN VIROL, V93, P1996, DOI 10.1099/vir.0.043059-0; Yu H, 2007, BIOCHEM BIOPH RES CO, V356, P91, DOI 10.1016/j.bbrc.2007.02.096; Zehender G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047517	28	2	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137099	10.1371/journal.pone.0137099	http://dx.doi.org/10.1371/journal.pone.0137099			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331945	gold, Green Published, Green Submitted			2022-12-26	WOS:000360613800095
J	Rong, EG; Zhang, ZW; Qiao, SP; Yang, H; Yan, XH; Li, H; Wang, N				Rong, Enguang; Zhang, Zhiwei; Qiao, Shupei; Yang, Hua; Yan, Xiaohong; Li, Hui; Wang, Ning			Functional Characterization of a Single Nucleotide Polymorphism in the 3 ' Untranslated Region of Sheep DLX3 Gene	PLOS ONE			English	Article							HAIR FOLLICLE; DIFFERENTIATION; MICRORNAS; SITE; SKIN; IDENTIFICATION; MUTATION	The Distal-less 3 (homeobox protein DLX-3), a transcription factor, is critical for the development of hair follicle and hair formation and regeneration. We previously identified and found that four SNPs (c.*118T>C, c.*228T>C, c.*688A>G and c.*1,038_1,039 insC) in 30 untranslated region (UTR) of sheep DLX3 were in high linkage disequilibrium with each other and significantly associated with wool crimp (P<0.05), however, the underlying mechanisms by which these SNPs affect the wool crimp remains unknown. In the present study, we performed association analysis between these four identified SNPs and DLX3 gene expression in sheep skin using quantitative real-time RT-PCR. The results showed that these SNPs were significantly associated with sheep skin DLX3 mRNA expression levels. Then, we constructed DLX3 3'UTR luciferase reporters and validated the association. The reporter assays showed that the three major haplotypes, derived from the four SNPs, had significantly different effects on luciferase reporter activity and the four SNPs also had significantly different allelic effects on the luciferase reporter activity (p<0.05). Bioinformatics analysis showed that the SNP (c.*1,038_1,039 insC) was located within a potential miR-188 binding site of the 3'UTR of sheep DLX3 mRNA. This SNP may affect miR-188-mediated DLX3 gene expression and result in phenotypic variation. To test the hypothesis, we investigated the effects of miR-188 mimic and inhibitor on the activity of the DLX3 3'UTR luciferase reporter with different SNP alleles. The results showed that in both sheep fetal fibroblasts (SFFs) and human HaCaT cells, miR-188 mimic could significantly decrease the allele D (deletion) luciferase reporter activity (p<0.05), but miR-188 inhibitor could increased the reporter activitiy. However, neither miR-188 mimc nor inhibitor could influence the allele I (insertion) reporter activity. In addition, transfection of miR-188 mimic dramatically decreased the endogenous expression of DLX3 in SFFs (p<0.05). Taken together, we demonstrated that DLX3 is a target gene of miR-188 and the SNP (c.*1,038_1,039 insC) is a functional SNP, and affects miR-188-mediated gene regulation of sheep DLX3. Our finding may in part explain allelic difference in gene expression and wool crimp in our tested sheep population.	[Rong, Enguang; Zhang, Zhiwei; Qiao, Shupei; Yan, Xiaohong; Li, Hui; Wang, Ning] Educ Dept Heilongjiang Prov, Key Lab Anim Genet Breeding & Reprod, Minist Agr, Key Lab Chicken Genet & Breeding, Harbin 150030, Peoples R China; [Rong, Enguang; Zhang, Zhiwei; Qiao, Shupei; Li, Hui; Wang, Ning] Northeast Agr Univ, Coll Anim Sci & Technol, Harbin 150030, Peoples R China; [Yang, Hua] Xinjiang Acad Agr & Reclamat Sci, Inst Anim Husb & Vet Inst, Shihezi 832000, Peoples R China; [Rong, Enguang] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China	Ministry of Agriculture & Rural Affairs; Northeast Agricultural University - China; China Agricultural University	Wang, N (corresponding author), Educ Dept Heilongjiang Prov, Key Lab Anim Genet Breeding & Reprod, Minist Agr, Key Lab Chicken Genet & Breeding, Harbin 150030, Peoples R China.	wangning@neau.edu.cn			Domain-Specific projects [2013ZX08009-002, 2014ZX08009-002]	Domain-Specific projects	The authors appreciate the financial support provided by the Domain-Specific projects for transgenic biological breeding (2013ZX08009-002, 2014ZX08009-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beanan MJ, 2000, DEV DYNAM, V218, P545, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1026>3.0.CO;2-B; Bostjancic E, 2008, ACTA DERMATOVEN ALP, V17, P95; Chin LJ, 2008, CANCER RES, V68, P8535, DOI 10.1158/0008-5472.CAN-08-2129; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; COHEN SM, 1989, NATURE, V338, P432, DOI 10.1038/338432a0; Denning C, 2001, Cloning Stem Cells, V3, P221, DOI 10.1089/15362300152725945; Drouilhet L, 2009, ANIM GENET, V40, P804, DOI 10.1111/j.1365-2052.2009.01919.x; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Georges M, 2007, CURR OPIN GENET DEV, V17, P166, DOI 10.1016/j.gde.2007.04.005; Hassan MQ, 2004, MOL CELL BIOL, V24, P9248, DOI 10.1128/MCB.24.20.9248-9261.2004; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Hwang J, 2008, DEVELOPMENT, V135, P3149, DOI 10.1242/dev.022202; Kim BK, 2012, J BIOL CHEM, V287, P16681, DOI 10.1074/jbc.M111.320770; Kim VN, 2005, MOL CELLS, V19, P1; Krause K, 2006, SEMIN CUTAN MED SURG, V25, P2, DOI 10.1016/j.sder.2006.01.002; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Mardaryev AN, 2010, FASEB J, V24, P3869, DOI 10.1096/fj.10-160663; Mazumder B, 2003, TRENDS BIOCHEM SCI, V28, P91, DOI 10.1016/S0968-0004(03)00002-1; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Mishra PJ, 2007, P NATL ACAD SCI USA, V104, P13513, DOI 10.1073/pnas.0706217104; Morasso MI, 1996, J CELL BIOL, V135, P1879, DOI 10.1083/jcb.135.6.1879; Morasso MI, 1999, P NATL ACAD SCI USA, V96, P162, DOI 10.1073/pnas.96.1.162; Nieminen P, 2011, CELLS TISSUES ORGANS, V194, P49, DOI 10.1159/000322561; Pesole G, 1997, GENE, V205, P95, DOI 10.1016/S0378-1119(97)00407-1; Price JA, 1998, HUM MOL GENET, V7, P563, DOI 10.1093/hmg/7.3.563; Rong EG, 2012, CHINESE J ANIMAL VET, V43, P358; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; Sand M, 2009, J DERMATOL SCI, V53, P169, DOI 10.1016/j.jdermsci.2008.10.004; Sun KL, 2013, NAT REV GENET, V14, P535, DOI 10.1038/nrg3471; Zhang WG, 2007, OMICS, V11, P385, DOI 10.1089/omi.2006.0031	32	4	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137135	10.1371/journal.pone.0137135	http://dx.doi.org/10.1371/journal.pone.0137135			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332462	Green Published, Green Submitted, gold			2022-12-26	WOS:000360613800101
J	Delestre, L; Bakey, Z; Prado, C; Hoffmann, S; Bihoreau, MT; Lelongt, B; Gauguier, D				Delestre, Laure; Bakey, Zeineb; Prado, Cecilia; Hoffmann, Sigrid; Bihoreau, Marie-Therese; Lelongt, Brigitte; Gauguier, Dominique			ANKS3 Co-Localises with ANKS6 in Mouse Renal Cilia and Is Associated with Vasopressin Signaling and Apoptosis In Vivo in Mice	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; STERILE ALPHA-MOTIF; SYSTEMS BIOLOGY; ANKYRIN REPEAT; SAM DOMAIN; BICAUDAL-C; PROTEIN; PROGRESSION; BICC1; CAMP	Mutations in Ankyrin repeat and sterile alpha motif domain containing 6 (ANKS6) play a causative role in renal cyst formation in the PKD/Mhm(cy/+) rat model of polycystic kidney disease and in nephronophthisis in humans. A network of protein partners of ANKS6 is emerging and their functional characterization provides important clues to understand the role of ANKS6 in renal biology and in mechanisms involved in the formation of renal cysts. Following experimental confirmation of interaction between ANKS6and ANKS3 using a Yeast two hybrid system, we demonstrated that binding between the two proteins occurs through their sterile alpha motif (SAM) and that the amino acid 823 in rat ANSK6 is key for this interaction. We further showed their interaction by co-immunoprecipitation and showed in vivo in mice that ANKS3 is present in renal cilia. Downregulated expression of Anks3 in vivo in mice by Locked Nucleic Acid (LNA) modified antisense oligonucleotides was associated with increased transcription of vasopressin-induced genes, suggesting changes in renal water permeability, and altered transcription of genes encoding proteins involved in cilium structure, apoptosis and cell proliferation. These data provide experimental evidence of ANKS3-ANKS6 direct interaction through their SAM domain and co-localisation in mouse renal cilia, and shed light on molecular mechanisms indirectly mediated by ANKS6 in the mouse kidney, that may be affected by altered ANKS3-ANKS6 interaction. Our results contribute to improved knowledge of the structure and function of the network of proteins interacting with ANKS6, which may represent therapeutic targets in cystic diseases.	[Delestre, Laure; Prado, Cecilia; Gauguier, Dominique] Univ Paris 05, Univ Paris 06, Sorbonne Univ, INSERM,UMR S1138,Cordeliers Res Ctr,Sorbonne Pari, Paris, France; [Bakey, Zeineb; Lelongt, Brigitte] Univ Paris 06, Sorbonne Univ, UMR S1155, Paris, France; [Bakey, Zeineb; Lelongt, Brigitte] Hop Tenon, INSERM, UMR S1155, F-75970 Paris, France; [Hoffmann, Sigrid] Heidelberg Univ, Med Fac Mannheim, Med Res Ctr, Mannheim, Germany; [Bihoreau, Marie-Therese] Natl Genotyping Ctr, Evry, France; [Gauguier, Dominique] Univ Paris 06, Pitie Salpetriere Hosp, Inst Cardiometab & Nutr, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Ruprecht Karls University Heidelberg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Gauguier, D (corresponding author), Univ Paris 05, Univ Paris 06, Sorbonne Univ, INSERM,UMR S1138,Cordeliers Res Ctr,Sorbonne Pari, Paris, France.	dominique.gauguier@crc.jussieu.fr	Gauguier, Dominique/G-2190-2016; lelongt, brigitte/N-3746-2017	Gauguier, Dominique/0000-0001-6156-9530; lelongt, brigitte/0000-0002-9308-8798	Agence Nationale de la Recherche (RenalCyst) [ANR-10-BLAN-1124-02]; European Community Seventh Framework Programme (FP7) [HEALTH-F4-2010-241504 (EURATRANS)]; NIH [5RO1DK100482]; Institute of Cardiometabolism and Nutrition (ICAN) [ANR-10-IAHU-05]; Wellcome Senior Fellowship in Basic Biomedical Science [057733]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100482] Funding Source: NIH RePORTER	Agence Nationale de la Recherche (RenalCyst)(French National Research Agency (ANR)); European Community Seventh Framework Programme (FP7); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute of Cardiometabolism and Nutrition (ICAN); Wellcome Senior Fellowship in Basic Biomedical Science; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Agence Nationale de la Recherche (RenalCyst, ANR-10-BLAN-1124-02) to DG and BL, the European Community Seventh Framework Programme (FP7/2007-2013) under grant agreement No. HEALTH-F4-2010-241504 (EURATRANS) to DG, the NIH (5RO1DK100482) to SH, the Institute of Cardiometabolism and Nutrition (ICAN, ANR-10-IAHU-05) to DG and a Wellcome Senior Fellowship in Basic Biomedical Science (057733) to DG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiari G, 2013, AM J NEPHROL, V37, P175, DOI 10.1159/000346812; Bakey Z, 2015, KIDNEY INT, V88, P299, DOI 10.1038/ki.2015.122; Bouvrette DJ, 2008, NEPHRON EXP NEPHROL, V108, pE27, DOI 10.1159/000112913; Brown JH, 2005, J AM SOC NEPHROL, V16, P3517, DOI 10.1681/ASN.2005060601; Chen Wen-Cheng, 2008, BMC Res Notes, V1, P131, DOI 10.1186/1756-0500-1-131; Cui XQ, 2009, AM J NEPHROL, V30, P413, DOI 10.1159/000235993; Czarnecki PG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7023; Czarnecki PG, 2012, TRENDS CELL BIOL, V22, P201, DOI 10.1016/j.tcb.2012.02.001; Devuyst O, 2013, CURR OPIN NEPHROL HY, V22, P459, DOI 10.1097/MNH.0b013e3283621510; Dweep H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053780; Fluiter Kees, 2009, V487, P189, DOI 10.1007/978-1-60327-547-7_9; Fu YL, 2010, EUR J CELL BIOL, V89, P428, DOI 10.1016/j.ejcb.2010.01.002; Gattone VH, 2003, NAT MED, V9, P1323, DOI 10.1038/nm935; Guron G, 2000, J HYPERTENS, V18, P123, DOI 10.1097/00004872-200018020-00001; Harris PC, 2010, NAT REV NEPHROL, V6, P197, DOI 10.1038/nrneph.2010.18; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Hoff S, 2013, NAT GENET, V45, P951, DOI 10.1038/ng.2681; Johnston AM, 2004, GENES CELLS, V9, P967, DOI 10.1111/j.1365-2443.2004.00776.x; Kerroch M, 2012, FASEB J, V26, P4079, DOI 10.1096/fj.11-194902; Kim J, 2010, MOL CELL BIOL, V30, P1582, DOI 10.1128/MCB.01605-09; Knight MJ, 2011, PROTEIN SCI, V20, P1697, DOI 10.1002/pro.703; Leettola CN, 2014, BMC STRUCT BIOL, V14, DOI 10.1186/1472-6807-14-17; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Maisonneuve C, 2009, DEVELOPMENT, V136, P3019, DOI 10.1242/dev.038174; MANGOOKARIM R, 1989, P NATL ACAD SCI USA, V86, P6007, DOI 10.1073/pnas.86.15.6007; MANGOOKARIM R, 1989, FASEB J, V3, P2629, DOI 10.1096/fasebj.3.14.2480260; Mrug M, 2008, KIDNEY INT, V73, P63, DOI 10.1038/sj.ki.5002627; Neudecker S, 2010, AM J PATHOL, V177, P3000, DOI 10.2353/ajpath.2010.100569; Pandey P, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-56; Piazzon N, 2012, J MOL CELL BIOL, V4, P398, DOI 10.1093/jmcb/mjs027; Riera M, 2006, KIDNEY INT, V69, P1558, DOI 10.1038/sj.ki.5000309; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Semple JI, 2005, BIOTECHNIQUES, V38, P927, DOI 10.2144/05386RR03; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Song XW, 2009, HUM MOL GENET, V18, P2328, DOI 10.1093/hmg/ddp165; Stagner EE, 2009, BIOCHEM BIOPH RES CO, V383, P16, DOI 10.1016/j.bbrc.2009.03.113; Stapleton D, 1999, NAT STRUCT BIOL, V6, P44; Taskiran EZ, 2014, J AM SOC NEPHROL, V25, P1653, DOI 10.1681/ASN.2013060646; Toye AA, 2007, DIABETOLOGIA, V50, P1867, DOI 10.1007/s00125-007-0738-5; Woo DDL, 1997, J CLIN INVEST, V100, P1934, DOI 10.1172/JCI119724; Yakulov TA, 2015, KIDNEY INT, V87, P1191, DOI 10.1038/ki.2015.17	41	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136781	10.1371/journal.pone.0136781	http://dx.doi.org/10.1371/journal.pone.0136781			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327442	Green Submitted, Green Published, gold			2022-12-26	WOS:000360437700063
J	Levick, B; Laudisoit, A; Wilschut, L; Addink, E; Ageyev, V; Yeszhanov, A; Sapozhnikov, V; Belayev, A; Davydova, T; Eagle, S; Begon, M				Levick, Bethany; Laudisoit, Anne; Wilschut, Liesbeth; Addink, Elisabeth; Ageyev, Vladimir; Yeszhanov, Aidyn; Sapozhnikov, Valerij; Belayev, Alexander; Davydova, Tania; Eagle, Sally; Begon, Mike			The Perfect Burrow, but for What? Identifying Local Habitat Conditions Promoting the Presence of the Host and Vector Species in the Kazakh Plague System	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASES; POCKET GOPHERS; SOIL TEXTURE; TEMPERATURE; FLEA; THRESHOLDS; RODENTIA; WILDLIFE; ECOLOGY; DESERT	Introduction The wildlife plague system in the Pre-Balkhash desert of Kazakhstan has been a subject of study for many years. Much progress has been made in generating a method of predicting outbreaks of the disease (infection by the gram negative bacterium Yersinia pestis) but existing methods are not yet accurate enough to inform public health planning. The present study aimed to identify characteristics of individual mammalian host (Rhombomys opimus) burrows related to and potentially predictive of the presence of R. opimus and the dominant flea vectors (Xenopsylla spp.). Methods Over four seasons, burrow characteristics, their current occupancy status, and flea and tick burden of the occupants were recorded in the field. A second data set was generated of long term occupancy trends by recording the occupancy status of specific burrows over multiple occasions. Generalised linear mixed models were constructed to identify potential burrow properties predictive of either occupancy or flea burden. Results At the burrow level, it was identified that a burrow being occupied by Rhombomys, and remaining occupied, were both related to the characteristics of the sediment in which the burrow was constructed. The flea burden of Rhombomys in a burrow was found to be related to the tick burden. Further larger scale properties were also identified as being related to both Rhombomys and flea presence, including latitudinal position and the season. Conclusions Therefore, in advancing our current predictions of plague in Kazakhstan, we must consider the landscape at this local level to increase our accuracy in predicting the dynamics of gerbil and flea populations. Furthermore this demonstrates that in other zoonotic systems, it may be useful to consider the distribution and location of suitable habitat for both host and vector species at this fine scale to accurately predict future epizootics.	[Levick, Bethany; Laudisoit, Anne; Begon, Mike] Univ Liverpool, Inst Integrat Biol, Ecol Evolut & Genom Infect Dis Res Grp, Liverpool L69 3BX, Merseyside, England; [Wilschut, Liesbeth; Addink, Elisabeth] Univ Utrecht, Dept Phys Geog, Utrecht, Netherlands; [Ageyev, Vladimir; Yeszhanov, Aidyn; Sapozhnikov, Valerij; Belayev, Alexander] M Akimbayevs Kazakh Sci Ctr Quarantine & Zoonot D, Alma Ata, Kazakhstan; [Belayev, Alexander; Davydova, Tania] Taldykorgan Antiplague Stn, Taldykorgan, Kazakhstan; [Eagle, Sally] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England	University of Liverpool; Utrecht University; Aikimbayev's Kazakh Scientific Centre for Quarantine & Zoonotic Diseases; University of Liverpool	Levick, B (corresponding author), Univ Liverpool, Inst Integrat Biol, Ecol Evolut & Genom Infect Dis Res Grp, Liverpool L69 3BX, Merseyside, England.	b.a.levick@liverpool.ac.uk	LAUDISOIT, Anne/O-5773-2019; Levick, Bethany/AAN-5877-2020; Yeszhanov, Aidyn/E-7440-2015; Laudisoit, Anne M/F-2646-2017; Addink, Elisabeth/E-3340-2012	LAUDISOIT, Anne/0000-0001-7626-9426; Levick, Bethany/0000-0002-6371-8744; Yeszhanov, Aidyn/0000-0001-6572-5668; Laudisoit, Anne M/0000-0001-7626-9426; Addink, Elisabeth/0000-0002-0919-6498; Begon, Mike/0000-0003-1715-5327	Wellcome Trust [090213/z/09/z]; Natural Ecological Research Council grant [NE/L501670/1]; Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate (US Department of Homeland Security); Fogarty International Center (National Institutes of Health); NERC [NE/E007899/1] Funding Source: UKRI; Natural Environment Research Council [1370745, NE/E007899/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Natural Ecological Research Council grant; Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate (US Department of Homeland Security); Fogarty International Center (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding by Wellcome Trust grant 090213/z/09/z http://www.wellcome.ac.uk/ and Natural Ecological Research Council grant NE/L501670/1 http://www.nerc.ac.uk/ MB is supported by the Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate (US Department of Homeland Security) and the Fogarty International Center (National Institutes of Health).	Addink EA, 2010, REMOTE SENS ENVIRON, V114, P674, DOI 10.1016/j.rse.2009.11.015; [Anonymous], 2014, R LANG ENV STAT COMP; BEST TL, 1973, ECOLOGY, V54, P1311, DOI 10.2307/1934193; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brewer SW, 1999, J VEG SCI, V10, P165, DOI 10.2307/3237138; Buhnerkempe MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022498; Burdelov LA, 1998, GUIDE EMERGENCY FIEL; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Bykov LT, 1966, P TEZ DOLK AK SOV, V3, P47; CAVANAUGH DC, 1971, AM J TROP MED HYG, V20, P264, DOI 10.4269/ajtmh.1971.20.264; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Davis S, 2007, EPIDEMIOL INFECT, V135, P740, DOI 10.1017/S095026880600759X; Davis S, 2004, SCIENCE, V304, P736, DOI 10.1126/science.1095854; Deom J, 2012, INT WORKSH ALM, P49; FEDOROV V N, 1960, Bull World Health Organ, V23, P275; GA Korneyev, 2005, CAPTURE COUNT FORECA; Gage KL, 2008, AM J PREV MED, V35, P436, DOI 10.1016/j.amepre.2008.08.030; Gvozdetskii NA, 1963, PHYS GEOGRAPHY USSR, P566; Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1; Hoffman JD, 2007, SOUTHWEST NAT, V52, P296, DOI 10.1894/0038-4909(2007)52[296:EOLUAS]2.0.CO;2; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kausrud KL, 2007, P ROY SOC B-BIOL SCI, V274, P1963, DOI 10.1098/rspb.2007.0568; Khokhlova IS, 2002, J ZOOL, V258, P349, DOI 10.1017/S0952836902001498; Krasnov BR, 2001, MED VET ENTOMOL, V15, P249, DOI 10.1046/j.0269-283x.2001.00295.x; Laundre JW, 1987, GREAT BASIN NAT, V53, P358; Levick B, 2015, DATA PERFECT BURROW; MORSE SS, 1995, EMERG INFECT DIS, V1, P7, DOI 10.3201/eid0101.950102; Naumov NP., 1975, RODENTS DESERT ENV, P465; Onishchenko GG, 2004, NATURAL PLAGUE FOCI; Pogrebinsky MA., 1963, SOILS OF KAZAKHSTAN, V4, P306; Randall Ja, 2005, BEHAV ECOLOGY, V16, P961; Rapoport LP., 2010, ENTOMOL REV, V90, P1003; Reichman O. J., 1990, CURRENT MAMMALOGY, P369; Reijniers J, 2012, ECOL LETT, V15, P554, DOI 10.1111/j.1461-0248.2012.01767.x; RHODES DH, 1985, AM MIDL NAT, V113, P102, DOI 10.2307/2425352; Rivkus JZ, 1992, EPIDEMIOLOGY PROPHYL; Roberts HR, 2014, SW NATURALIST, V42, P323; Ryan Easterday W, 2015, P NATL ACAD SCI USA, P1, DOI [10.1073/pnas.1412887112/-/dcsupplemental:1-10, DOI 10.1073/PNAS.1412887112/-/DCSUPPLEMENTAL:110]; Semachko LL, 1981, ZOD ZH, V40, P1070; Shenbrot G, 2002, J ARID ENVIRON, V51, P265, DOI 10.1006/jare.2001.0945; Stenseth NC, 2008, PLOS MED, V5, P9, DOI 10.1371/journal.pmed.0050003; Stenseth NC, 2006, P NATL ACAD SCI USA, V103, P13110, DOI 10.1073/pnas.0602447103; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; Venables WN., 2002, MODERN APPL STAT S 4; Wentworth CK, 1922, J GEOL, V30, P377, DOI 10.1086/622910; Whitford WG, 1999, J ARID ENVIRON, V41, P203, DOI 10.1006/jare.1998.0482; Wikel SK, 1999, BIOSCIENCE, V49, P311, DOI 10.2307/1313614; Wilkins KT, 2007, SOUTHWEST NAT, V52, P83, DOI 10.1894/0038-4909(2007)52[83:CAOBSO]2.0.CO;2; Wilschut LI, 2013, INT J APPL EARTH OBS, V23, P81, DOI 10.1016/j.jag.2012.11.007; Wilschut LI, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-49; Xu WX, 2012, ECOL RES, V27, P775, DOI 10.1007/s11284-012-0952-6	51	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136962	10.1371/journal.pone.0136962	http://dx.doi.org/10.1371/journal.pone.0136962			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325073	Green Published, Green Submitted, gold			2022-12-26	WOS:000360437700077
J	Li, YF; Rao, XY; Mattox, WW; Amos, CI; Liu, B				Li, Yafang; Rao, Xiayu; Mattox, William W.; Amos, Christopher I.; Liu, Bin			RNA-Seq Analysis of Differential Splice Junction Usage and Intron Retentions by DEXSeq	PLOS ONE			English	Article							HUMAN TRANSCRIPTOME; EXPRESSION ANALYSIS; GENE; MECHANISMS; HOMOLOG; CELLS	Alternative splicing is an important biological process in the generation of multiple functional transcripts from the same genomic sequences. Differential analysis of splice junctions (SJs) and intron retentions (IRs) is helpful in the detection of alternative splicing events. In this study, we conducted differential analysis of SJs and IRs by use of DEXSeq, a Bioconductor package originally designed for differential exon usage analysis in RNA-seq data analysis. We set up an analysis pipeline including mapping of RNA-seq reads, the preparation of count tables of SJs and IRs as the input files, and the differential analysis in DEXSeq. We analyzed the public RNA-seq datasets generated from RNAi experiments on Drosophila melanogaster S2-DRSC cells to deplete RNA-binding proteins (GSE18508). The analysis confirmed previous findings on the alternative splicing of the trol and Ant2 (sesB) genes in the CG8144 (ps)-depletion experiment and identified some new alternative splicing events in other RNAi experiments. We also identified IRs that were confirmed in our SJ analysis. The proposed method used in our study can output the genomic coordinates of differentially used SJs and thus enable sequence motif search. Sequence motif search and gene function annotation analysis helped us infer the underlying mechanism in alternative splicing events. To further evaluate this method, we also applied the method to public RNA-seq data from human breast cancer (GSE45419) and the plant Arabidopsis (SRP008262). In conclusion, our study showed that DEXSeq can be adapted to differential analysis of SJs and IRs, which will facilitate the identification of alternative splicing events and provide insights into the molecular mechanisms of transcription processes and disease development.	[Li, Yafang; Amos, Christopher I.] Dartmouth Coll, Geisel Sch Med, Dept Biomed Data Sci, Hanover, NH 03755 USA; [Rao, Xiayu; Mattox, William W.; Liu, Bin] Univ Texas MD Anderson Canc Ctr, Ctr Genet & Genom, Dept Genet, Houston, TX 77030 USA	Dartmouth College; University of Texas System; UTMD Anderson Cancer Center	Liu, B (corresponding author), Univ Texas MD Anderson Canc Ctr, Ctr Genet & Genom, Dept Genet, Houston, TX 77030 USA.	bliu1@mdanderson.org		Mattox, William/0000-0001-8084-9677; Liu, Bin/0000-0002-9113-9694	NCI NIH HHS [P30 CA023108] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016672, P30CA023108] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Aschoff M, 2013, BIOINFORMATICS, V29, P1141, DOI 10.1093/bioinformatics/btt101; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Brooks AN, 2011, GENOME RES, V21, P193, DOI 10.1101/gr.108662.110; Bryant Douglas W Jr, 2012, Methods Mol Biol, V883, P97, DOI 10.1007/978-1-61779-839-9_7; D'haeseleer P, 2006, NAT BIOTECHNOL, V24, P423, DOI 10.1038/nbt0406-423; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Fox-Walsh KL, 2005, P NATL ACAD SCI USA, V102, P16176, DOI 10.1073/pnas.0508489102; Galante PAF, 2004, RNA, V10, P757, DOI 10.1261/rna.5123504; Garg K, 2007, GENOME RES, V17, P1015, DOI 10.1101/gr.6347907; Ge Y, 2014, BIOESSAYS, V36, P236, DOI 10.1002/bies.201300156; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Griffith M, 2010, NAT METHODS, V7, P843, DOI [10.1038/NMETH.1503, 10.1038/nmeth.1503]; Jarosch A, 2011, P NATL ACAD SCI USA, V108, P15282, DOI 10.1073/pnas.1109343108; Kalari KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079298; Kalifa Y, 2006, DEV CELL, V10, P291, DOI 10.1016/j.devcel.2006.01.001; Kalifa Y, 2009, DEV BIOL, V326, P68, DOI 10.1016/j.ydbio.2008.10.032; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kim E, 2008, BIOESSAYS, V30, P38, DOI 10.1002/bies.20692; Kim E, 2007, NUCLEIC ACIDS RES, V35, P125, DOI 10.1093/nar/gkl924; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Puig T, 2008, BREAST CANCER RES TR, V109, P471, DOI 10.1007/s10549-007-9678-5; Sammeth M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000147; Santhekadur PK, 2012, AM J CANCER RES, V2, P269; Seshaiah P, 2001, DEV BIOL, V239, P309, DOI 10.1006/dbio.2001.0429; Sette Claudio, 2013, Int J Cell Biol, V2013, P421606, DOI 10.1155/2013/421606; Shen SH, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1291; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Turano M, 2013, BIOCHEM CELL BIOL, V91, P506, DOI 10.1139/bcb-2013-0047; Vazquez-Martin A, 2008, CELL PROLIFERAT, V41, P59, DOI 10.1111/j.1365-2184.2007.00498.x; Wang BB, 2006, P NATL ACAD SCI USA, V103, P7175, DOI 10.1073/pnas.0602039103; Wang XX, 2012, PLANT CELL, V24, P3278, DOI 10.1105/tpc.112.100081; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109	38	20	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136653	10.1371/journal.pone.0136653	http://dx.doi.org/10.1371/journal.pone.0136653			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327458	Green Published, Green Submitted, gold			2022-12-26	WOS:000360437700052
J	Peng, J; Lu, YJ; Liu, WY; Zhu, YW; Yan, XL; Xu, JX; Wang, X; Wang, Y; Liu, W; Sun, ZY				Peng, Jing; Lu, Yanjun; Liu, Weiyong; Zhu, Yaowu; Yan, Xiaoling; Xu, Jingxin; Wang, Xiong; Wang, Yue; Liu, Wei; Sun, Ziyong			Genotype Distribution and Molecular Epidemiology of Hepatitis C Virus in Hubei, Central China	PLOS ONE			English	Article							INJECTION-DRUG USERS; GENETIC HISTORY; SOUTHERN CHINA; BLOOD-DONORS; 6 VARIANTS; INFECTION; COINFECTION; SUBTYPES; DIVERSITY; DISEASE	Background Little is known about the molecular epidemiology of hepatitis C virus (HCV) infection in Central China. Methodology/Principal Findings A total of 570 patients from Hubei Province in central China were enrolled. These patients were tested positive for HCV antibody prior to blood transfusion. Among them, 177 were characterized by partial NS5B and/or Core-E1 sequences and classified into five subtypes: 1b, 83.0%(147/177); 2a, 13.0% (23/177); 3b, 2.3% (4/177); 6a, 1.1% (2/177); 3a, 0.6% (1/177). Analysis of genotype-associated risk factors revealed that paid blood donation and transfusion before 1997 were strongly associated with subtypes 1b and 2a, while some subtype 2a cases were also found in individuals with high risk sexual behaviors; subtypes 3b, 6a, and 3a were detected only in intravenous drug users. Phylogeographic analyses based on the coalescent datasets demonstrated that 1b, 2a, 3b, and 6a were locally epidemic in Hubei Province. Among them, subtype 1b Hubei strains may have served as the origins of this subtype in China, and 2a and 3b Hubei strains may have descended from the northwest and southwest of China, respectively, while 6a Hubei strains may have been imported from the central south and southwest. Conclusion/Significance The results suggest that the migration patterns of HCV in Hubei are complex and variable among different subtypes. Implementation of mandatory HCV screening before donation has significantly decreased the incidence of transfusion-associated HCV infection since 1997. More attention should be paid to intravenous drug use and unsafe sexual contact, which may have become new risk factors for HCV infection in Hubei Province.	[Peng, Jing; Lu, Yanjun; Liu, Weiyong; Zhu, Yaowu; Yan, Xiaoling; Xu, Jingxin; Wang, Xiong; Wang, Yue; Sun, Ziyong] Huazhong Univ Sci & Technol, Dept Clin Lab, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Liu, Wei] Huazhong Univ Sci & Technol, Dept Publ Hlth, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Sun, ZY (corresponding author), Huazhong Univ Sci & Technol, Dept Clin Lab, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China.	zysun@tjh.tjmu.edu.cn	Wang, Xiong/ABF-2904-2021		Infectious Diseases Control Project from Ministry of Health of China [2012zx10004-207]	Infectious Diseases Control Project from Ministry of Health of China	This work was supported by the Infectious Diseases Control Project from Ministry of Health of China (2012zx10004-207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansaldi F, 2014, WORLD J GASTROENTERO, V20, P9633, DOI 10.3748/wjg.v20.i29.9633; Avo AP, 2013, J MED VIROL, V85, P815, DOI 10.1002/jmv.23545; Brown M S, 1984, Nurse Pract, V9, P42; Brown MS, 1984, NURSE PRACT, V9, P42; Brown MS, 1984, NURSE PRACT, V9, P6; Cantaloube JF, 2005, J CLIN MICROBIOL, V43, P3624, DOI 10.1128/JCM.43.8.3624-3629.2005; Chen Yuan-Ding, 2002, Hepatobiliary Pancreat Dis Int, V1, P194; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fu YSH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047324, 10.1371/journal.pone.0028006]; Garten RJ, 2005, CLIN INFECT DIS, V41, pS18, DOI 10.1086/429491; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Gu L, 2013, J CLIN VIROL, V57, P311, DOI 10.1016/j.jcv.2013.04.013; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hesketh T, 1997, BRIT MED J, V314, P1543, DOI 10.1136/bmj.314.7093.1543; Hsu E, 1996, SOC SCI MED, V42, P421, DOI 10.1016/0277-9536(95)00106-9; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Liu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023347; Lu L, 2005, J MED VIROL, V75, P538, DOI 10.1002/jmv.20307; Lu L, 2014, J VIROL, V88, P7120, DOI 10.1128/JVI.00414-14; Nakano T, 2006, J GEN VIROL, V87, P73, DOI 10.1099/vir.0.81360-0; Peng JS, 2008, VIRUS RES, V135, P191, DOI 10.1016/j.virusres.2008.01.017; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583; Pybus OG, 2009, J VIROL, V83, P1071, DOI 10.1128/JVI.01501-08; Rao HY, 2014, J GASTROEN HEPATOL, V29, P545, DOI 10.1111/jgh.12398; Shang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010631; Sievert W, 2011, LIVER INT, V31, P61, DOI 10.1111/j.1478-3231.2011.02540.x; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Sullivan SG, 2007, INT J DRUG POLICY, V18, P118, DOI 10.1016/j.drugpo.2006.11.014; Tan Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003608; Wu SJ, 2011, J MED VIROL, V83, P1930, DOI 10.1002/jmv.22168; Xia X, 2008, PUBLIC HEALTH, V122, P990, DOI 10.1016/j.puhe.2008.01.014; Xia XS, 2008, J MED VIROL, V80, P1142, DOI 10.1002/jmv.21204; Xu R, 2013, INFECT GENET EVOL, V20, P225, DOI 10.1016/j.meegid.2013.08.014; Yuan MQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064698; ZHANG YY, 1995, J CLIN MICROBIOL, V33, P2931, DOI 10.1128/JCM.33.11.2931-2934.1995; Zhang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082598; Zhao R, 2013, J MED VIROL, V85, P1712, DOI 10.1002/jmv.23650	38	17	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137059	10.1371/journal.pone.0137059	http://dx.doi.org/10.1371/journal.pone.0137059			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325070	gold, Green Published, Green Submitted			2022-12-26	WOS:000360437700088
J	Noor, AM; Kibuchi, E; Mitto, B; Coulibaly, D; Doumbo, OK; Snow, RW				Noor, Abdisalan Mohamed; Kibuchi, Eliud; Mitto, Bernard; Coulibaly, Drissa; Doumbo, Ogobara K.; Snow, Robert W.			Sub-National Targeting of Seasonal Malaria Chemoprevention in the Sahelian Countries of the Nouakchott Initiative	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; VIVAX MALARIA; TRANSMISSION; INFECTION	Background Seasonal malaria chemoprevention (SMC) has been shown to be highly efficacious against clinical malaria in areas where transmission is acutely seasonal. SMC targeting depends on a complex interplay of climate, malaria transmission and population distribution. In this study a spatial decision support framework was developed to identify health districts suitable for the targeting of SMC across seven Sahelian countries and northern states of Nigeria that are members of the Nouakchott Initiative. Methods A spatially explicit decision support framework that links information on seasonality, age-structured population, urbanization, malaria endemicity and the length of transmission season was developed to inform SMC targeting in health districts. Thresholds of seasonality, population and receptive risks were defined to delineate SMC suitable health districts and define the age range of children for targeting. Numbers of children were then computed for the period 2015-2020 in SMC districts. For 2015, this was combined with maps of length of malaria transmission seasons and WHO recommended treatment regimen to quantify the number of tablets required across the SMC health districts. Results A total of 597 Sahelian health districts were mapped, out of which 478 (80.1%) were considered suitable for SMC based on seasonality and endemicity thresholds. These districts had an estimated 119.8 million (85%) of the total population in 2015. In the six years from 20152020, it is estimated that a total of 158 million children 3m to <5 years, 121 million of whom were in rural areas, will need SMC to achieve universal coverage in the Sahel. If the upper age limit of SMC targeted children was increased to <10 years in low transmission districts, a total 177 million overall, of whom 135 million were rural children, will require chemoprevention in 2015-2020. In 2015 alone, an estimated 49-72 million SP tablets and 148-217 million AQ tablets will be needed to cover all or rural children respectively under the different scenarios of upper age limits. Conclusions Our proposed framework provides a standardised approach to support targeting and scale up of SMC by the countries of the Nouakchott Initiative. Our analysis suggests that the vast majority of the population in this region are likely to benefit from SMC and substantial resources will be required to reach universal coverage each year.	[Noor, Abdisalan Mohamed; Kibuchi, Eliud; Mitto, Bernard; Snow, Robert W.] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Spatial Hlth Metr Grp, INFORM Informat Malaria, Nairobi, Kenya; [Noor, Abdisalan Mohamed; Snow, Robert W.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England; [Coulibaly, Drissa; Doumbo, Ogobara K.] Univ Sci Tech & Technol, Malaria Res & Training Ctr, Bamako, Mali	Kenya Medical Research Institute; University of Oxford; University of Science & Technology of Bamako	Noor, AM (corresponding author), Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Spatial Hlth Metr Grp, INFORM Informat Malaria, Nairobi, Kenya.	anoor@kemri-wellcome.org	Snow, Robert William/AFR-1436-2022	Snow, Robert William/0000-0003-3725-6088	Wellcome Trust [095127, 079080, 103602]; UK's Department for International Development; Clinton Health Access Initiative	Wellcome Trust(Wellcome TrustEuropean Commission); UK's Department for International Development; Clinton Health Access Initiative	AMN is supported by the Wellcome Trust as an Intermediate Fellow (#095127), RWS is supported by the Wellcome Trust as Principal Research Fellow (# 079080 and # 103602) that also supported BM and EK. This work received support from the UK's Department for International Development through a grant to the Roll Back Malaria Partnership and the Clinton Health Access Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernabeu M, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-405; Cairns M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1879; FOLLAND C, 1991, J FORECASTING, V10, P21, DOI 10.1002/for.3980100104; Global Administrative Unit Layers, BORD COUNTR ADM COUN; Gneme A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-67; Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324; Grover-Kopec EK, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-38; Hadley Centre, 2010, SAH CLIM CURR PRED; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Koita OA, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/367160; Lekweiry KM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-92; Linard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031743; Lodoun T, 2013, THEOR APPL CLIMATOL; Meremikwu MM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003756.pub4; Noor AM, 2014, LANCET, V383, P1739, DOI 10.1016/S0140-6736(13)62566-0; Pindolia DK, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-397; RAMSDALE CD, 1983, J TROP MED HYG, V86, P51; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Robert V, 2003, AM J TROP MED HYG, V68, P169, DOI 10.4269/ajtmh.2003.68.169; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-74; Snow RW, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0254-7; Snow RW, 2002, ADV PARASIT, V52, P235, DOI 10.1016/S0065-308X(02)52013-3; Tanser FC, 2003, LANCET, V362, P1792, DOI 10.1016/S0140-6736(03)14898-2; The NOAA Climate Prediction Center, 2002, AFR RAINF EST ALG VE; United Nations Population Division, WORLD URB PROSP 2012; von Seidlein L, 2003, TRENDS PARASITOL, V19, P452, DOI 10.1016/j.pt.2003.08.003; White MT, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-337; WHO, 2013, SEAS MAL CHEM SULPH; Wilson AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016976; World Health Organization, GLOB TECHN STRART MA; Wurtz N, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-336	32	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136919	10.1371/journal.pone.0136919	http://dx.doi.org/10.1371/journal.pone.0136919			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322634	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000360435500048
J	da Cruz, VAR; Schenkel, FS; Savegnago, RP; Grupioni, NV; Stafuzza, NB; Sargolzaei, M; Ibelli, AMG; Peixoto, JD; Ledur, MC; Munari, DP				Rocha da Cruz, Valdecy Aparecida; Schenkel, Flavio Schramm; Savegnago, Rodrigo Pelicioni; Grupioni, Natalia Vinhal; Stafuzza, Nedenia Bonvino; Sargolzaei, Mehdi; Guaratini Ibelli, Adriana Mercia; Peixoto, Jane de Oliveira; Ledur, Monica Correa; Munari, Danisio Prado			Association of Apolipoprotein B and Adiponectin Receptor 1 Genes with Carcass, Bone Integrity and Performance Traits in a Paternal Broiler Line	PLOS ONE			English	Article							ADIPOSE-TISSUE; CHICKEN; GROWTH; POLYMORPHISM; WEIGHT; RESTRICTION; LIPOPROTEIN; EXPRESSION; DENSITY; PROFILE	Apolipoprotein B (APOB) and Adiponectin Receptor 1 (ADIPOR1) are related to the regulation of feed intake, fat metabolism and protein deposition and are candidate genes for genomic studies in birds. In this study, associations of two single nucleotide polymorphisms (SNPs) g.102A>T (APOB) and g.729C>T (ADIPOR1) with carcass, bone integrity and performance traits in broilers were investigated. Genotyping was performed on a paternal line of 1,454 broilers. The SNP detection was carried out by PCR-RFLP technique using the restriction enzymes HhaI for the SNP g.729C>T and Msll for the SNP g.102A>T. The association analyses of the two SNPs with 85 traits were performed using the restricted maximum likelihood (REML) and Generalized Quasi-Likelihood Score (GQLS) methods. For REML the model included the random additive genetic effect of animal and fixed effects of sex, hatch and SNP genotypes. In the GQLS method, a logistic regression was used to associate the genotypes with phenotypes adjusted for fixed effects of sex and hatch. The SNP g.729C>T in the ADIPOR1 gene was associated with thickness of the femur and breast skin yield. Thus, the ADIPOR1 gene seems implicated in the metabolism and/or fat deposition and bone integrity in broilers.	[Rocha da Cruz, Valdecy Aparecida; Savegnago, Rodrigo Pelicioni; Grupioni, Natalia Vinhal; Stafuzza, Nedenia Bonvino; Munari, Danisio Prado] Univ Estadual Paulista UNESP, Dept Ciencias Exatas, Fac Ciencias Agr & Vet FCAV, Sao Paulo, Brazil; [Schenkel, Flavio Schramm] Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada; [Sargolzaei, Mehdi] Semex Alliance, Guelph, ON, Canada; [Guaratini Ibelli, Adriana Mercia; Peixoto, Jane de Oliveira; Ledur, Monica Correa] Embrapa Suinos & Aves, Concordia, SC, Brazil	Universidade Estadual Paulista; University of Guelph; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Munari, DP (corresponding author), Univ Estadual Paulista UNESP, Dept Ciencias Exatas, Fac Ciencias Agr & Vet FCAV, Sao Paulo, Brazil.	danisio@fcav.unesp.br	Stafuzza, Nedenia Bonvino/M-9224-2019; Ibelli, Adriana/B-4510-2010; Cruz, Valdecy A R/F-3067-2014; Stafuzza, Nedenia B./C-4419-2013; Savegnago, Rodrigo Pelicioni/H-7396-2012; Ibelli, Adriana/AAC-5017-2020; Ledur, Monica/A-5667-2013; Schenkel, Flavio/ABG-1842-2021; Munari, Danisio P/C-6384-2012	Stafuzza, Nedenia Bonvino/0000-0001-6432-2330; Ibelli, Adriana/0000-0003-0626-8879; Cruz, Valdecy A R/0000-0003-2853-3514; Stafuzza, Nedenia B./0000-0001-6432-2330; Savegnago, Rodrigo Pelicioni/0000-0002-6551-2168; Ibelli, Adriana/0000-0003-0626-8879; Ledur, Monica/0000-0002-2645-4735; Munari, Danisio P/0000-0001-6915-038X; Schenkel, Flavio/0000-0001-8700-0633	"Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior" (CAPES) [12280-12-7]; "Fundacao de Amparo a Pesquisa do Estado de Sao Paulo" (FAPESP); CAPES; "Brazilian Agricultural Research Corporation Swine and Poultry' (EMBRAPA); National Counsel of Technological and Scientific Development (CNPq); CNPq	"Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior" (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); "Fundacao de Amparo a Pesquisa do Estado de Sao Paulo" (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); "Brazilian Agricultural Research Corporation Swine and Poultry' (EMBRAPA)(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	VARC would like to thank the "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior" (CAPES) (grantee n. 12280-12-7). RPS was supported by a fellowship from "Fundacao de Amparo a Pesquisa do Estado de Sao Paulo" (FAPESP). NVG was supported by fellowship from CAPES and "Brazilian Agricultural Research Corporation Swine and Poultry' (EMBRAPA). NBS was supported by postdoctoral fellowship from National Counsel of Technological and Scientific Development (CNPq). DPM was supported by productivity research fellowship from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBATO GF, 1994, J NUTR, V124, pS1341, DOI 10.1093/jn/124.suppl_8.1341S; Cao JJ, 2011, J ORTHOP SURG RES, V6, DOI 10.1186/1749-799X-6-30; Chen X, 2003, PHARMACOGENOMICS J, V3, P77, DOI 10.1038/sj.tpj.6500167; Chung ER, 2005, ASIAN AUSTRAL J ANIM, V18, P1061, DOI 10.5713/ajas.2005.1061; Crespo N, 2001, POULTRY SCI, V80, P71, DOI 10.1093/ps/80.1.71; Crooijmans RPMA, 2000, MAMM GENOME, V11, P360, DOI 10.1007/s003350010068; Dalanezi JA, 2005, ARQ BRAS MED VET ZOO, V57, P250, DOI 10.1590/S0102-09352005000200018; Dransfield E, 1999, POULTRY SCI, V78, P743, DOI 10.1093/ps/78.5.743; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Feng Z, 2011, ANN APPL STAT, V5, P2109, DOI 10.1214/11-AOAS465; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Gilmour AR, 2009, ASREML USER GUIDE RE; Gonnelli S, 2008, CALCIFIED TISSUE INT, V83, P55, DOI 10.1007/s00223-008-9149-y; Gonzales E, 1998, POULTRY SCI, V77, P1646, DOI 10.1093/ps/77.11.1646; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hendricks GL, 2009, ENDOCRINOLOGY, V150, P3092, DOI 10.1210/en.2008-1558; HERMIER D, 1985, BIOCHIM BIOPHYS ACTA, V836, P105, DOI 10.1016/0005-2760(85)90226-7; HOOD RL, 1982, POULTRY SCI, V61, P117, DOI 10.3382/ps.0610117; Jiang YL, 2002, ASIAN AUSTRAL J ANIM, V15, P1543, DOI 10.5713/ajas.2002.1543; Jin ZN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100339; Johnson RC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-724; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Li H, 2003, POULTRY SCI, V82, P347, DOI 10.1093/ps/82.3.347; Libby P, 2005, CIRCULATION, V111, P3489, DOI 10.1161/CIRCULATIONAHA.104.529651; Luo NL, 2012, DIABETES, V61, pA415; Maddineni S, 2005, ENDOCRINOLOGY, V146, P4250, DOI 10.1210/en.2005-0254; McLeod RS, 1996, J BIOL CHEM, V271, P18445, DOI 10.1074/jbc.271.31.18445; Meng H, 2005, ASIAN AUSTRAL J ANIM, V18, P1221, DOI 10.5713/ajas.2005.1221; Mignon-Grasteau S, 2000, J ANIM SCI, V78, P2515; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Ninov K, 2008, SCI AGR, V65, P214, DOI 10.1590/S0103-90162008000200016; Pisto P, 2012, SCAND J CLIN LAB INV, V72, P395, DOI 10.3109/00365513.2012.687759; SAS, 2001, SAS US GUID STAT; Sawai H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010639; SINSIGALLI NA, 1987, J NUTR, V117, P941, DOI 10.1093/jn/117.5.941; Tahmoorespur M, 2010, POULTRY SCI, V89, P2092, DOI 10.3382/ps.2010-00772; Vieira SL, 1998, J APPL POULTRY RES, V7, P339, DOI 10.1093/japr/7.4.339; Vincze T, 2003, NUCLEIC ACIDS RES, V31, P3688, DOI 10.1093/nar/gkg526; Wallis JW, 2004, NATURE, V432, P761, DOI 10.1038/nature03030; Wang HB, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-193; Wong GKS, 2004, NATURE, V432, P717, DOI 10.1038/nature03156; Xu DQ, 2005, ASIAN AUSTRAL J ANIM, V18, P1519, DOI 10.5713/ajas.2005.1519; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Zhang BZ, 2005, ASIAN AUSTRAL J ANIM, V18, P458, DOI 10.5713/ajas.2005.458; Zhang S, 2006, POULTRY SCI, V85, P178, DOI 10.1093/ps/85.2.178	45	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136824	10.1371/journal.pone.0136824	http://dx.doi.org/10.1371/journal.pone.0136824			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322976	Green Published, gold			2022-12-26	WOS:000360435500039
J	Chen, SR; Gendelman, HK; Roche, JP; Alsharif, P; Graf, ER				Chen, Shirui; Gendelman, Hannah K.; Roche, John P.; Alsharif, Peter; Graf, Ethan R.			Mutational Analysis of Rab3 Function for Controlling Active Zone Protein Composition at the Drosophila Neuromuscular Junction	PLOS ONE			English	Article							TERM SYNAPTIC PLASTICITY; PUTATIVE TARGET PROTEIN; ACTIVATING PROTEIN; STRUCTURAL BASIS; BINDING PROTEIN; NEUROTRANSMITTER RELEASE; GLUTAMATE RECEPTORS; PANCREATIC ACINI; VESICLE RELEASE; EFFECTOR DOMAIN	At synapses, the release of neurotransmitter is regulated by molecular machinery that aggregates at specialized presynaptic release sites termed active zones. The complement of active zone proteins at each site is a determinant of release efficacy and can be remodeled to alter synapse function. The small GTPase Rab3 was previously identified as playing a novel role that controls the distribution of active zone proteins to individual release sites at the Drosophila neuromuscular junction. Rab3 has been extensively studied for its role in the synaptic vesicle cycle; however, the mechanism by which Rab3 controls active zone development remains unknown. To explore this mechanism, we conducted a mutational analysis to determine the molecular and structural requirements of Rab3 function at Drosophila synapses. We find that GTP-binding is required for Rab3 to traffick to synapses and distribute active zone components across release sites. Conversely, the hydrolytic activity of Rab3 is unnecessary for this function. Through a structure-function analysis we identify specific residues within the effector-binding switch regions that are required for Rab3 function and determine that membrane attachment is essential. Our findings suggest that Rab3 controls the distribution of active zone components via a vesicle docking mechanism that is consistent with standard Rab protein function.	[Chen, Shirui; Gendelman, Hannah K.; Roche, John P.; Alsharif, Peter; Graf, Ethan R.] Amherst Coll, Dept Biol, Amherst, MA 01002 USA	Amherst College	Graf, ER (corresponding author), Amherst Coll, Dept Biol, Amherst, MA 01002 USA.	egraf@amherst.edu			National Institute of Neurological Disorders and Stroke [R15 NS087601]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS087601] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Neurological Disorders and Stroke R15 NS087601 to ERG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; Bhuin T, 2014, EXP CELL RES, V328, P1, DOI 10.1016/j.yexcr.2014.07.027; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BRONDYK WH, 1993, J BIOL CHEM, V268, P9410; Bruckner JJ, 2012, J NEUROSCI, V32, P17048, DOI 10.1523/JNEUROSCI.3267-12.2012; BURSTEIN ES, 1992, J BIOL CHEM, V267, P22715; Chen XQ, 2002, J BIOL CHEM, V277, P18002, DOI 10.1074/jbc.M201248200; Chen XQ, 2003, J BIOL CHEM, V278, P50053, DOI 10.1074/jbc.M309910200; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Chung SH, 1999, J BIOL CHEM, V274, P18113, DOI 10.1074/jbc.274.25.18113; Daniels RW, 2008, J COMP NEUROL, V508, P131, DOI 10.1002/cne.21670; Deak F, 2006, EMBO J, V25, P2856, DOI 10.1038/sj.emboj.7601165; Dumas JJ, 1999, STRUCTURE, V7, P413, DOI 10.1016/S0969-2126(99)80054-9; Eathiraj S, 2005, NATURE, V436, P415, DOI 10.1038/nature03798; Ehmann N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5650; Fukuda M, 2003, J BIOL CHEM, V278, P15373, DOI 10.1074/jbc.M212341200; Fukui K, 1997, J BIOL CHEM, V272, P4655, DOI 10.1074/jbc.272.8.4655; Graf ER, 2012, J NEUROSCI, V32, P16586, DOI 10.1523/JNEUROSCI.0965-12.2012; Graf ER, 2011, J NEUROSCI, V31, P15026, DOI 10.1523/JNEUROSCI.2024-11.2011; Graf ER, 2009, NEURON, V64, P663, DOI 10.1016/j.neuron.2009.11.002; Gundelfinger ED, 2012, CURR OPIN NEUROBIOL, V22, P423, DOI 10.1016/j.conb.2011.10.005; HOLZ RW, 1994, J BIOL CHEM, V269, P10229; Hurd DD, 1996, GENETICS, V144, P1075; JOHN J, 1993, J BIOL CHEM, V268, P923; JOHNSTON PA, 1991, NEURON, V7, P101, DOI 10.1016/0896-6273(91)90078-E; Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8; KHOSRAVIFAR R, 1991, P NATL ACAD SCI USA, V88, P6264, DOI 10.1073/pnas.88.14.6264; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Lardong JA, 2015, ACTA CRYSTALLOGR F, V71, P34, DOI 10.1107/S2053230X1402617X; Liu KSY, 2011, SCIENCE, V334, P1565, DOI 10.1126/science.1212991; Marrus SB, 2004, J NEUROSCI, V24, P1406, DOI 10.1523/JNEUROSCI.1575-03.2004; Marrus SB, 2004, CURR BIOL, V14, P924, DOI 10.1016/j.cub.2004.05.047; MCKIERNAN CJ, 1993, J BIOL CHEM, V268, P24449; Michel K, 2015, EXP CELL RES; Muller M, 2011, NEURON, V69, P749, DOI 10.1016/j.neuron.2011.01.025; Niwa S, 2008, NAT CELL BIOL, V10, P1269, DOI 10.1038/ncb1785; Nonet ML, 1997, J NEUROSCI, V17, P8061; Ostermeier C, 1999, CELL, V96, P363, DOI 10.1016/S0092-8674(00)80549-8; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Paul MM, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00029; Peled ES, 2011, NAT NEUROSCI, V14, P519, DOI 10.1038/nn.2767; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Pfeffer SR, 2005, J BIOL CHEM, V280, P15485, DOI 10.1074/jbc.R500003200; Sakane A, 2006, P NATL ACAD SCI USA, V103, P10029, DOI 10.1073/pnas.0600304103; Schluter OM, 2006, J NEUROSCI, V26, P1239, DOI 10.1523/JNEUROSCI.3553-05.2006; Schluter OM, 2002, J BIOL CHEM, V277, P40919, DOI 10.1074/jbc.M203704200; Shapira M, 2003, NEURON, V38, P237, DOI 10.1016/S0896-6273(03)00207-1; SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061; Sigrist SJ, 2011, CURR OPIN NEUROBIOL, V21, P144, DOI 10.1016/j.conb.2010.08.012; Sprang SR, 1997, CURR OPIN STRUC BIOL, V7, P849, DOI 10.1016/S0959-440X(97)80157-1; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Zhang J, 2007, GENETICS, V176, P1307, DOI 10.1534/genetics.106.066761; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	57	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136938	10.1371/journal.pone.0136938	http://dx.doi.org/10.1371/journal.pone.0136938			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317909	Green Submitted, gold, Green Published			2022-12-26	WOS:000360299100176
J	Crinelli, R; Bianchi, M; Radici, L; Carloni, E; Giacomini, E; Magnani, M				Crinelli, Rita; Bianchi, Marzia; Radici, Lucia; Carloni, Elisa; Giacomini, Elisa; Magnani, Mauro			Molecular Dissection of the Human Ubiquitin C Promoter Reveals Heat Shock Element Architectures with Activating and Repressive Functions	PLOS ONE			English	Article							POLYUBIQUITIN GENE UBC; TRANSCRIPTION FACTOR; PROTEIN-DEGRADATION; KEY FEATURES; REAL-TIME; EXPRESSION; STRESS; QUANTIFICATION; RECOGNITION; BINDING	The promoter of the polyubiquitin C gene (UBC) contains putative heat shock elements (HSEs) which are thought to mediate UBC induction upon stress. However, the mapping and the functional characterization of the cis-acting determinants for its up-regulation have not yet been addressed. In this study, the sequence encompassing 916 nucleotides upstream of the transcription start site of the human UBC gene has been dissected by in silico, in vitro and in vivo approaches. The information derived from this analysis was used to study the functional role and the interplay of the identified HSEs in mediating the transcriptional activation of the UBC gene under conditions of proteotoxic stress, induced by the proteasome inhibitor MG132. Here we demonstrate that at least three HSEs, with different configurations, exist in the UBC promoter: two distal, residing within nucleotides -841/-817 and -715/-691, and one proximal to the transcription start site (nt -100/-65). All of them are bound by transcription factors belonging to the heat shock factor (HSF) family, as determined by bandshift, supershift and ChIP analyses. Site-directed mutagenesis of reporter constructs demonstrated that while the distal elements are involved in the up-regulation of UBC in response to proteasome inhibition, the proximal one appears rather to function as negative regulator of the stress-induced transcriptional activity. This is the first evidence that an HSE may exert a negative role on the transcription driven by other HSE motifs on the same gene promoter, highlighting a new level of complexity in the regulation of HSFs and in the control of ubiquitin levels.	[Crinelli, Rita; Bianchi, Marzia; Radici, Lucia; Carloni, Elisa; Giacomini, Elisa; Magnani, Mauro] Univ Urbino Carlo Bo, Sect Biochem & Mol Biol, Dept Biomol Sci, Urbino, Italy	University of Urbino	Crinelli, R (corresponding author), Univ Urbino Carlo Bo, Sect Biochem & Mol Biol, Dept Biomol Sci, Urbino, Italy.	rita.crinelli@uniurb.it	Magnani, Mauro/A-1919-2008; Giacomini, Elisa/K-3208-2016	Giacomini, Elisa/0000-0003-3289-3221; Carloni, Elisa/0000-0003-1178-9353; Crinelli, Rita/0000-0002-1235-8910; Magnani, Mauro/0000-0001-6456-6626; Bianchi, Marzia/0000-0001-9352-7319	Ministero dell'Istruzione, dell'Universita e della Ricerca PRIN [2008BP25KN_001]	Ministero dell'Istruzione, dell'Universita e della Ricerca PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by the Ministero dell'Istruzione, dell'Universita e della Ricerca http://hubmiur.pubblica.istruzione.it/web/ricerca/home. PRIN 2008 n. 2008BP25KN_001, granted to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIN J, 1988, MOL CELL BIOL, V8, P3761, DOI 10.1128/MCB.8.9.3761; Bianchi M, 2015, GENE, V573, P100, DOI 10.1016/j.gene.2015.07.030; Bianchi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065932; Bianchi M, 2009, GENE, V448, P88, DOI 10.1016/j.gene.2009.08.013; BOND U, 1985, MOL CELL BIOL, V5, P949, DOI 10.1128/MCB.5.5.949; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Ciechanover A, 1998, P NATL ACAD SCI USA, V95, P2727, DOI 10.1073/pnas.95.6.2727; Cooper AR, 2015, NUCLEIC ACIDS RES, V43, P682, DOI 10.1093/nar/gku1312; Crinelli R, 2008, MOL CELL BIOCHEM, V318, P129, DOI 10.1007/s11010-008-9864-8; Crinelli R, 2010, ACS NANO, V4, P2791, DOI 10.1021/nn100057c; Deroo BJ, 2002, J BIOL CHEM, V277, P20120, DOI 10.1074/jbc.C200173200; Deshaies RJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0094-0; Flick K, 2012, SEMIN CELL DEV BIOL, V23, P515, DOI 10.1016/j.semcdb.2012.01.019; FORNACE AJ, 1989, NUCLEIC ACIDS RES, V17, P1215, DOI 10.1093/nar/17.3.1215; Frejtag W, 2001, J BIOL CHEM, V276, P14685, DOI 10.1074/jbc.M009224200; Fujimuro M, 2005, BIOL PHARM BULL, V28, P2315, DOI 10.1248/bpb.28.2315; Haring M, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-11; Hashikawa N, 2007, J BIOL CHEM, V282, P10333, DOI 10.1074/jbc.M609708200; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Kaiser SE, 2011, NAT METHODS, V8, P691, DOI [10.1038/NMETH.1649, 10.1038/nmeth.1649]; Kawazoe Y, 1998, EUR J BIOCHEM, V255, P356, DOI 10.1046/j.1432-1327.1998.2550356.x; Kimura Y, 2010, J BIOCHEM, V147, P793, DOI 10.1093/jb/mvq044; Lecomte S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056085; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mathew A, 1998, MOL CELL BIOL, V18, P5091, DOI 10.1128/MCB.18.9.5091; Nenoi M, 1996, GENE, V175, P179, DOI 10.1016/0378-1119(96)00145-X; Oh C, 2013, ANAL BIOCHEM, V443, P153, DOI 10.1016/j.ab.2013.09.011; Ostling P, 2007, J BIOL CHEM, V282, P7077, DOI 10.1074/jbc.M607556200; Park CW, 2014, BMB REP, V47, P475, DOI 10.5483/BMBRep.2014.47.9.128; PERISIC O, 1989, CELL, V59, P797, DOI 10.1016/0092-8674(89)90603-X; Pitulescu ME, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-16; Radici L., 2013, ADV BIOSCI BIOTECHNO, V04, P1057, DOI [DOI 10.4236/ABB.2013.412141, 10.4236/abb.2013.412141]; Ryu HW, 2011, BIOCHEM BIOPH RES CO, V404, P470, DOI 10.1016/j.bbrc.2010.12.004; Ryu KY, 2007, EMBO J, V26, P2693, DOI 10.1038/sj.emboj.7601722; Ryu KY, 2006, ANAL BIOCHEM, V353, P153, DOI 10.1016/j.ab.2006.03.038; Sakurai H, 2010, FEBS J, V277, P4140, DOI 10.1111/j.1742-4658.2010.07829.x; Sandqvist A, 2009, MOL BIOL CELL, V20, P1340, DOI 10.1091/mbc.E08-08-0864; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Schorpp M, 1996, NUCLEIC ACIDS RES, V24, P1787, DOI 10.1093/nar/24.9.1787; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Tachibana T, 2002, J BIOL CHEM, V277, P22140, DOI 10.1074/jbc.M201267200; Tsirigotis M, 2001, J BIOL CHEM, V276, P46073, DOI 10.1074/jbc.M109023200; Vihervaara A, 2013, P NATL ACAD SCI USA, V110, pE3388, DOI 10.1073/pnas.1305275110; XIAO H, 1988, SCIENCE, V239, P1139, DOI 10.1126/science.3125608; XIAO H, 1991, CELL, V64, P585, DOI 10.1016/0092-8674(91)90242-Q; Yamamoto N, 2009, FEBS J, V276, P1962, DOI 10.1111/j.1742-4658.2009.06923.x	46	15	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136882	10.1371/journal.pone.0136882	http://dx.doi.org/10.1371/journal.pone.0136882			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317694	Green Published, gold, Green Submitted			2022-12-26	WOS:000360299100159
J	Dansithong, W; Paul, S; Scoles, DR; Pulst, SM; Huynh, DP				Dansithong, Warunee; Paul, Sharan; Scoles, Daniel R.; Pulst, Stefan M.; Huynh, Duong P.			Generation of SNCA Cell Models Using Zinc Finger Nuclease (ZFN) Technology for Efficient High-Throughput Drug Screening	PLOS ONE			English	Article							ALPHA-SYNUCLEIN GENE; FAMILIAL PARKINSONS-DISEASE; MESSENGER-RNA; RAT MODEL; IN-VIVO; DEGRADATION PATHWAYS; LOCUS TRIPLICATION; LYSOSOMAL PATHWAY; ALLELIC VARIATION; SUBSTANTIA-NIGRA	Parkinson's disease (PD) is a progressive neurodegenerative disorder caused by loss of dopaminergic neurons of the substantia nigra. The hallmark of PD is the appearance of neuronal protein aggregations known as Lewy bodies and Lewy neurites, of which alpha-synuclein forms a major component. Familial PD is rare and is associated with missense mutations of the SNCA gene or increases in gene copy number resulting in SNCA overexpression. This suggests that lowering SNCA expression could be therapeutic for PD. Supporting this hypothesis, SNCA reduction was neuroprotective in cell line and rodent PD models. We developed novel cell lines expressing SNCA fused to the reporter genes luciferase (luc) or GFP with the objective to enable high-throughput compound screening (HTS) for small molecules that can lower SNCA expression. Because SNCA expression is likely regulated by far-upstream elements (including the NACP-REP1 located at 8852 bp upstream of the transcription site), we employed zinc finger nuclease (ZFN) genome editing to insert reporter genes in-frame downstream of the SNCA gene in order to retain native SNCA expression control. This ensured full retention of known and unknown up- and downstream genetic elements controlling SNCA expression. Treatment of cells with the histone deacetylase inhibitor valproic acid (VPA) resulted in significantly increased SNCA-luc and SNCA-GFP expression supporting the use of our cell lines for identifying small molecules altering complex modes of expression control. Cells expressing SNCA-luc treated with a luciferase inhibitor or SNCA siRNA resulted in Z'-scores >= 0.75, suggesting the suitability of these cell lines for use in HTS. This study presents a novel use of genome editing for the creation of cell lines expressing alpha-synuclein fusion constructs entirely under native expression control. These cell lines are well suited for HTS for compounds that lower SNCA expression directly or by acting at long-range sites to the SNCA promoter and 5'-UTR.	[Dansithong, Warunee; Paul, Sharan; Scoles, Daniel R.; Pulst, Stefan M.; Huynh, Duong P.] Univ Utah, Dept Neurol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Huynh, DP (corresponding author), Univ Utah, Dept Neurol, 175 North Med Ctr Dr East,5th Floor, Salt Lake City, UT 84112 USA.	dhuynh@genetics.utah.edu		Lewis, Patrick/0000-0003-4537-0489	Rapid Response Innovation Awards Program from the Michael J. Fox Foundation; National Institutes of Health [R37NS033123, RC4NS073009]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC4NS073009, R37NS033123] Funding Source: NIH RePORTER	Rapid Response Innovation Awards Program from the Michael J. Fox Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Rapid Response Innovation Awards Program (2011-2013) from the Michael J. Fox Foundation to DPH, by grants R37NS033123 to SMP, and RC4NS073009 to DRS and SMP from National Institutes of Health.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Alvarez-Castelao B, 2014, BBA-MOL CELL RES, V1843, P352, DOI 10.1016/j.bbamcr.2013.11.018; Alvarez-Erviti L, 2011, NEUROBIOL DIS, V42, P360, DOI 10.1016/j.nbd.2011.01.029; Appel-Cresswell S, 2013, MOVEMENT DISORD, V28, P811, DOI 10.1002/mds.25421; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen PS, 2006, MOL PSYCHIATR, V11, P1116, DOI 10.1038/sj.mp.4001893; Chiba-Falek O, 2003, HUM GENET, V113, P426, DOI 10.1007/s00439-003-1002-9; Chiba-Falek O, 2001, HUM MOL GENET, V10, P3101, DOI 10.1093/hmg/10.26.3101; Chiba-Falek O, 2006, MOVEMENT DISORD, V21, P1703, DOI 10.1002/mds.21007; Choi JY, 2014, BIOCHEM BIOPH RES CO, V450, P372, DOI 10.1016/j.bbrc.2014.05.132; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cullen V, 2011, ANN NEUROL, V69, P940, DOI 10.1002/ana.22400; Davies SE, 2014, NEUROBIOL DIS, V64, P79, DOI 10.1016/j.nbd.2013.12.011; Dekker J, 2008, SCIENCE, V319, P1793, DOI 10.1126/science.1152850; Deng H, 2014, AGEING RES REV, V15, P161, DOI 10.1016/j.arr.2014.04.002; Ebrahimi-Fakhari D, 2012, AUTOPHAGY, V8, P281, DOI 10.4161/auto.8.2.18938; Ebrahimi-Fakhari D, 2011, J NEUROSCI, V31, P14508, DOI 10.1523/JNEUROSCI.1560-11.2011; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Grundemann J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn084; Grundemann J, 2011, METHODS MOL BIOL, V755, P363, DOI 10.1007/978-1-61779-163-5_30; Hayashita-Kinoh H, 2006, BIOCHEM BIOPH RES CO, V341, P1088, DOI 10.1016/j.bbrc.2006.01.057; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Hofer A, 2005, J NEURAL TRANSM, V112, P1249, DOI 10.1007/s00702-004-0263-3; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Jowaed A, 2010, J NEUROSCI, V30, P6355, DOI 10.1523/JNEUROSCI.6119-09.2010; Khandelwal PJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-47; Khodr CE, 2011, BRAIN RES, V1395, P94, DOI 10.1016/j.brainres.2011.04.036; Kiely AP, 2013, ACTA NEUROPATHOL, V125, P753, DOI 10.1007/s00401-013-1096-7; Klucken J, 2012, AUTOPHAGY, V8, P754, DOI 10.4161/auto.19371; Koprich JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017698; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kruger R, 1999, ANN NEUROL, V45, P611, DOI 10.1002/1531-8249(199905)45:5<611::AID-ANA9>3.0.CO;2-X; Lee BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023939; Lee HJ, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.45; Leng Y, 2006, J NEUROSCI, V26, P7502, DOI 10.1523/JNEUROSCI.0096-06.2006; Lo Bianco C, 2004, P NATL ACAD SCI USA, V101, P17510, DOI 10.1073/pnas.0405313101; Lo Bianco C, 2002, P NATL ACAD SCI USA, V99, P10813, DOI 10.1073/pnas.152339799; Mak SK, 2010, J BIOL CHEM, V285, P13621, DOI 10.1074/jbc.M109.074617; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Matsumoto L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015522; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; McCormack AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012122; McCormack AL, 2009, CURR PROTEIN PEPT SC, V10, P476, DOI 10.2174/138920309789351912; Miller DW, 2004, NEUROLOGY, V62, P1835, DOI 10.1212/01.WNL.0000127517.33208.F4; Ochiai H, 2012, P NATL ACAD SCI USA, V109, P10915, DOI 10.1073/pnas.1202768109; Park JS, 2011, HUM MUTAT, V32, P956, DOI 10.1002/humu.21527; Paul S, 2011, J BIOL CHEM, V286, P38427, DOI 10.1074/jbc.M111.255224; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Puschmann A, 2013, PARKINSONISM RELAT D, V19, P407, DOI 10.1016/j.parkreldis.2013.01.020; Raichur A, 2006, NEUROSCIENCE, V142, P859, DOI 10.1016/j.neuroscience.2006.06.052; Ross NT, IDENTIFICATION OF A; Rott R, 2014, CNS NEUROL DISORD-DR, V13, P630, DOI 10.2174/18715273113126660195; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Sato A, 2006, J CELL PHYSIOL, V209, P172, DOI 10.1002/jcp.20719; Sato K, 2014, J STROKE CEREBROVASC, V23, P1554, DOI 10.1016/j.jstrokecerebrovasdis.2013.12.051; Scoles DR, 2012, HUM MOL GENET, V21, P5048, DOI 10.1093/hmg/dds349; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Su LHJ, 2010, DIS MODEL MECH, V3, P194, DOI 10.1242/dmm.004267; Takahashi M, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.14; Tofaris GK, 2011, P NATL ACAD SCI USA, V108, P17004, DOI 10.1073/pnas.1109356108; Tong YR, 2010, P NATL ACAD SCI USA, V107, P9879, DOI 10.1073/pnas.1004676107; Touchman JW, 2001, GENOME RES, V11, P78, DOI 10.1101/gr.165801; Usenovic M, 2012, HUM MOL GENET, V21, P3785, DOI 10.1093/hmg/dds206; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Xia Y, 1996, ANN NEUROL, V40, P207, DOI 10.1002/ana.410400212; Xiong N, 2011, NEUROSCIENCE, V199, P292, DOI 10.1016/j.neuroscience.2011.10.031; Yeger-Lotem E, 2009, NAT GENET, V41, P316, DOI 10.1038/ng.337; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	71	15	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136930	10.1371/journal.pone.0136930	http://dx.doi.org/10.1371/journal.pone.0136930			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317803	gold, Green Published, Green Submitted			2022-12-26	WOS:000360299100175
J	Haverinen-Shaughnessy, U; Shaughnessy, RJ				Haverinen-Shaughnessy, Ulla; Shaughnessy, Richard J.			Effects of Classroom Ventilation Rate and Temperature on Students' Test Scores	PLOS ONE			English	Article							PERFORMANCE; SCHOOLS; HEALTH	Using a multilevel approach, we estimated the effects of classroom ventilation rate and temperature on academic achievement. The analysis is based on measurement data from a 70 elementary school district (140 fifth grade classrooms) from Southwestern United States, and student level data (N = 3109) on socioeconomic variables and standardized test scores. There was a statistically significant association between ventilation rates and mathematics scores, and it was stronger when the six classrooms with high ventilation rates that were indicated as outliers were filtered (>7.1 l/s per person). The association remained significant when prior year test scores were included in the model, resulting in less unexplained variability. Students' mean mathematics scores (average 2286 points) were increased by up to eleven points (0.5%) per each liter per second per person increase in ventilation rate within the range of 0.9-7.1 l/s per person (estimated effect size 74 points). There was an additional increase of 12-13 points per each 1 degrees C decrease in temperature within the observed range of 20-25 degrees C (estimated effect size 67 points). Effects of similar magnitude but higher variability were observed for reading and science scores. In conclusion, maintaining adequate ventilation and thermal comfort in classrooms could significantly improve academic achievement of students.	[Haverinen-Shaughnessy, Ulla; Shaughnessy, Richard J.] Univ Tulsa, Indoor Air Program, Tulsa, OK 74104 USA; [Haverinen-Shaughnessy, Ulla] Natl Inst Hlth & Welf, Dept Hlth Protect, Kuopio 70701, Finland	University of Tulsa; Finland National Institute for Health & Welfare	Shaughnessy, RJ (corresponding author), Univ Tulsa, Indoor Air Program, 600 S Coll Ave, Tulsa, OK 74104 USA.	rjstulsau@aol.com	Haverinen-Shaughnessy, Ulla/O-5688-2015	Haverinen-Shaughnessy, Ulla/0000-0002-9456-7256	Cleaning Industry Research Institute International (Albany NY, USA); ISSA-The Worldwide Cleaning Industry Association (Lincolnwood IL, USA) as a part of project "Clean standards research for schools K-12"	Cleaning Industry Research Institute International (Albany NY, USA); ISSA-The Worldwide Cleaning Industry Association (Lincolnwood IL, USA) as a part of project "Clean standards research for schools K-12"	The data collection was supported by a collaborative grant from the Cleaning Industry Research Institute International (Albany NY, USA) and ISSA-The Worldwide Cleaning Industry Association (Lincolnwood IL, USA) as a part of project "Clean standards research for schools K-12". The authors had no funding for data analyses and publication of the results.	[Anonymous], 1997, EXP FACT HDB; [Anonymous], 2007, D6245 ASTM; ASHRAE, 2004, 6212004 ASHRAE; ASHRAE, 1992, 551992 ASHRAE; Bako-Biro Z, 2012, BUILD ENVIRON, V48, P215, DOI 10.1016/j.buildenv.2011.08.018; Balfanz R., 2012, CHRONIC ABSENTEEISM; Bearg D. W., 1993, INDOOR AIR QUALITY H; DUNN R., 1990, J MULTICULT COUNS D, V18, P68; Ewing N J, 1992, ROEPER REV, V14; Haverinen-Shaughnessy U, 2011, INDOOR AIR, V21, P121, DOI 10.1111/j.1600-0668.2010.00686.x; Haverinen-Shaughnessy U., 2012, BR J ED RES, V2, P42; Haverinen-Shaughnessy U, 2015, BUILDING ENV; Maddalena R, 2015, INDOOR AIR, V25, P362, DOI 10.1111/ina.12149; Mendell MJ, 2013, INDOOR AIR, V23, P515, DOI 10.1111/ina.12042; Mendell MJ, 2005, INDOOR AIR, V15, P27, DOI 10.1111/j.1600-0668.2004.00320.x; Persily A.K., 1997, ASHRAE T, V103, P193; Rivkin SG, 2005, ECONOMETRICA, V73, P417, DOI 10.1111/j.1468-0262.2005.00584.x; Satish U, 2012, ENVIRON HEALTH PERSP, V120, P1671, DOI 10.1289/ehp.1104789; Sellstrom E, 2006, J EPIDEMIOL COMMUN H, V60, P149, DOI 10.1136/jech.2005.036707; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; Sundell J, 2011, INDOOR AIR, V21, P191, DOI 10.1111/j.1600-0668.2010.00703.x; Tudor-Locke C, 2009, J PHYS ACT HEALTH, V6, P347, DOI 10.1123/jpah.6.3.347; Turunen M, 2014, INT J HYG ENVIR HEAL, V217, P733, DOI 10.1016/j.ijheh.2014.03.002; US EPA, 2013, HEAT VENT AIR COND H; Wargocki P, 2007, HVAC&R RES, V13, P193, DOI 10.1080/10789669.2007.10390951	25	65	66	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136165	10.1371/journal.pone.0136165	http://dx.doi.org/10.1371/journal.pone.0136165			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317643	gold, Green Submitted, Green Published			2022-12-26	WOS:000360299100062
J	Zhao, YD; Chu, L; Lin, K; Granton, E; Yin, L; Peng, J; Hsin, M; Wu, LC; Yu, A; Waddell, T; Keshavjee, S; Granton, J; de Perrot, M				Zhao, Yidan D.; Chu, Lei; Lin, Kathleen; Granton, Elise; Yin, Li; Peng, Jenny; Hsin, Michael; Wu, Licun; Yu, Amy; Waddell, Thomas; Keshavjee, Shaf; Granton, John; de Perrot, Marc			A Biochemical Approach to Understand the Pathogenesis of Advanced Pulmonary Arterial Hypertension: Metabolomic Profiles of Arginine, Sphingosine-1-Phosphate, and Heme of Human Lung	PLOS ONE			English	Article							PHARMACOLOGICAL TARGETS; SPHINGOLIPID METABOLISM; NITRIC-OXIDE; COLLAGEN; RESISTANCE; STRATEGY; PROLINE; CELLS	Pulmonary arterial hypertension (PAH) is a vascular disease characterized by persistent precapillary pulmonary hypertension (PH), leading to progressive right heart failure and premature death. The pathological mechanisms underlying this condition remain elusive. Analysis of global metabolomics from lung tissue of patients with PAH (n = 8) and control lung tissue (n = 8) leads to a better understanding of disease progression. Using a combination of high-throughput liquid-and-gas-chromatography-based mass spectrometry, we showed unbiased metabolomic profiles of disrupted arginine pathways with increased Nitric oxide (NO) and decreased arginine. Our results also showed specific metabolic pathways and genetic profiles with increased Sphingosine-1-phosphate (S1P) metabolites as well as increased Heme metabolites with altered oxidative pathways in the advanced stage of the human PAH lung. The results suggest that PAH has specific metabolic pathways contributing to the vascular remodeling in severe pulmonary hypertension. Profiling metabolomic alterations of the PAH lung has provided a new understanding of the pathogenic mechanisms of PAH, which benefits therapeutic targeting to specific metabolic pathways involved in the progression of PAH.	[Zhao, Yidan D.; Chu, Lei; Lin, Kathleen; Granton, Elise; Yin, Li; Peng, Jenny; Hsin, Michael; Wu, Licun; Yu, Amy; Waddell, Thomas; Keshavjee, Shaf; de Perrot, Marc] Univ Toronto, Latner Thorac Surg Res Labs, Toronto, ON, Canada; [Zhao, Yidan D.; Chu, Lei; Lin, Kathleen; Granton, Elise; Yin, Li; Peng, Jenny; Hsin, Michael; Wu, Licun; Yu, Amy; Waddell, Thomas; Keshavjee, Shaf; de Perrot, Marc] Univ Toronto, Div Thorac Surg, Univ Hlth Network, Toronto, ON, Canada; [Granton, John] Univ Toronto, Toronto Gen Hosp, Univ Hlth Network, Clin Studies Resource Ctr, Toronto, ON M5G 1L7, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Zhao, YD (corresponding author), Univ Toronto, Latner Thorac Surg Res Labs, Toronto, ON, Canada.	Yidanzhao@gmail.com; marc.deperrot@uhn.on.ca	Wu, Licun/AAL-9596-2021	Wu, Licun/0000-0003-4803-9361; de Perrot, Marc/0000-0003-2000-9427; Keshavjee, Shaf/0000-0003-4547-8094; Zhao, Yidan/0000-0002-7304-1802	TGH Hospital Foundation	TGH Hospital Foundation	This work received funding from the TGH Hospital Foundation made possible through donations from Bayer Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi Taimur, 2013, Handb Exp Pharmacol, P201, DOI 10.1007/978-3-7091-1511-4_10; ADAMS E, 1980, ANNU REV BIOCHEM, V49, P1005, DOI 10.1146/annurev.bi.49.070180.005041; Airola Michael V, 2013, Handb Exp Pharmacol, P57, DOI 10.1007/978-3-7091-1368-4_3; Archer SL, 2010, CIRCULATION, V121, P2661, DOI 10.1161/CIRCULATIONAHA.109.916098; Balint B, 2001, EUR RESPIR J, V17, P1201, DOI 10.1183/09031936.01.00072501; Brittain EL, 2014, CHEST, V146, P1478, DOI 10.1378/chest.14-0809; Chen Jinhu, 2014, Int J Endocrinol, V2014, P203930, DOI 10.1155/2014/203930; Closs EI, 2002, CURR OPIN NEPHROL HY, V11, P99, DOI 10.1097/00041552-200201000-00015; Couttas TA, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-9; Delgado A, 2012, ANTI-CANCER AGENT ME, V12, P285, DOI 10.2174/187152012800228643; Fessel Joshua P, 2012, Pulm Circ, V2, P201, DOI 10.4103/2045-8932.97606; Fox Charles J, 2011, Perspect Vasc Surg Endovasc Ther, V23, P112, DOI 10.1177/1531003511400627; Galie N, 2014, TURK KARDIYOL DERN A, V42, P1; Gillespie MN, 2010, ADV EXP MED BIOL, V661, P375, DOI 10.1007/978-1-60761-500-2_24; Hansmann G, 2007, CIRCULATION, V115, P1275, DOI 10.1161/CIRCULATIONAHA.106.663120; Hassoun PM, 2013, 5 WORLD S PULM HYP N; Humbert M, 2010, CIRCULATION, V122, P156, DOI 10.1161/CIRCULATIONAHA.109.911818; Kajiwara K, 2012, MOL MICROBIOL, V86, P1246, DOI 10.1111/mmi.12056; Kepka-Lenhart D, 2000, AM J PHYSIOL-REG I, V279, pR2237; KERR JS, 1987, AM REV RESPIR DIS, V135, P300; Kliment CR, 2011, INT J CLIN EXP PATHO, V4, P349; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Mori M, 2004, J NUTR, V134, p2820S, DOI 10.1093/jn/134.10.2820S; Oo ML, 2011, J CLIN INVEST, V121, P2290, DOI 10.1172/JCI45403; POIANI GJ, 1990, J APPL PHYSIOL, V68, P1542, DOI 10.1152/jappl.1990.68.4.1542; Pugh ME, 2011, J HEART LUNG TRANSPL, V30, P904, DOI 10.1016/j.healun.2011.02.016; Russo S B, 2013, Handb Exp Pharmacol, P373, DOI 10.1007/978-3-7091-1511-4_19; Ryland LK, 2011, CANCER BIOL THER, V11, P138, DOI 10.4161/cbt.11.2.14624; Sarady-Andrews JK, 2005, AM J PHYSIOL-LUNG C, V289, pL1131, DOI 10.1152/ajplung.00458.2004; Simon PM, 2006, PULM PHARMACOL THER, V19, P242, DOI 10.1016/j.pupt.2005.07.001; Sutendra G, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001327; Takeda Y, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-22; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; Thomas M, 2010, ADV EXP MED BIOL, V661, P475, DOI 10.1007/978-1-60761-500-2_31; Tuder RM, 2012, AM J RESP CRIT CARE, V185, P260, DOI 10.1164/rccm.201108-1536PP; Wood KC, 2008, FREE RADICAL BIO MED, V44, P1506, DOI 10.1016/j.freeradbiomed.2008.01.008; Xu RH, 2005, CANCER RES, V65, P613; Xu WL, 2004, FASEB J, V18, P1746, DOI 10.1096/fj.04-2317fje; Yang CX, 2012, J BIOL CHEM, V287, P40598, DOI 10.1074/jbc.M112.406850; Zhao YD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088727; Zhao YY, 2009, J CLIN INVEST, V119, P2009, DOI 10.1172/JCI33338; Zuckerbraun BS, 2011, CARDIOVASC RES, V89, P542, DOI 10.1093/cvr/cvq370	42	26	29	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0134958	10.1371/journal.pone.0134958	http://dx.doi.org/10.1371/journal.pone.0134958			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317340	Green Published, Green Submitted, gold			2022-12-26	WOS:000360299100019
J	Bonner, K; Welch, E; Elder, K; Cohn, J				Bonner, Kimberly; Welch, Emily; Elder, Kate; Cohn, Jennifer			Impact of Pneumococcal Conjugate Vaccine Administration in Pediatric Older Age Groups in Low and Middle Income Countries: A Systematic Review	PLOS ONE			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; STREPTOCOCCUS-PNEUMONIAE; IMMUNOGENICITY; CHILDREN; SAFETY; MENINGITIS; QUALITY; GRADE	Introduction Pneumococcal conjugate vaccine (PCV) is included in the World Health Organization's routine immunization schedule and is recommended by WHO for vaccination in high-risk children up to 60 months. However, many countries do not recommend vaccination in older age groups, nor have donors committed to supporting extended age group vaccination. To better inform decision-making, this systematic review examines the direct impact of extended age group vaccination in children over 12 months in low and middle income countries. Methods An a priori protocol was used. Using pre-specified terms, a search was conducted using PubMed, LILACS, Cochrane Infectious Diseases Group Specialized Register, Cochrane Central Register of Controlled Trials, CAB Abstracts, clinicaltrials.gov and the International Symposium on Pneumococci and Pneumococcal Diseases abstracts. The primary outcome was disease incidence, with antibody titers and nasopharyngeal carriage included as secondary outcomes. Results Eighteen studies reported on disease incidence, immune response, and nasopharyngeal carriage. PCV administered after 12 months of age led to significant declines in invasive pneumococcal disease. Immune response to vaccine type serotypes was significantly higher for those vaccinated at older ages than the unimmunized at the established 0.2ug/ml and 0.35ug/ml thresholds. Vaccination administered after one year of age significantly reduced VT carriage with odds ratios ranging from 0.213 to 0.69 over four years. A GRADE analysis indicated that the studies were of high quality. Discussion PCV administration in children over 12 months leads to significant protection. The direct impact of PCV administration, coupled with the large cohort of children missed in first year vaccination, indicates that countries should initiate or expand PCV immunization for extended age group vaccinations. Donors should support implementation of PCV as part of delayed or interrupted immunization for older children. For countries to effectively implement extended age vaccinations, access to affordably-priced PCV is critical.	[Bonner, Kimberly; Cohn, Jennifer] Access Campaign, Medecins Sans Frontieres, Geneva, Switzerland; [Elder, Kate] Access Campaign, Medecins Sans Frontieres, New York, NY USA; [Welch, Emily] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Cohn, Jennifer] Univ Penn, Sch Med, Div Infect Dis, Philadelphia, PA 19104 USA	Doctors Without Borders; Boston University; University of Pennsylvania	Cohn, J (corresponding author), Access Campaign, Medecins Sans Frontieres, Geneva, Switzerland.	Jecohn6@gmail.com		Bonner, Kimberly/0000-0002-6942-4050				Andrade AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098128; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P129; [Anonymous], 2014, WHO UNICEF COV EST 2; Bosch-Capblanch X, 2012, TROP MED INT HEALTH, V17, P697, DOI 10.1111/j.1365-3156.2012.02989.x; Pirez MC, 2011, PEDIATR INFECT DIS J, V30, P669, DOI 10.1097/INF.0b013e3182152bf1; CDC, VACC CHILDR PROGR CD; Costa Isabel de Camargo, 2008, Rev. Saúde Pública, V42, P844, DOI 10.1590/S0034-89102008005000048; de Waroux OL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086136; Dicko A, 2012, ISPPD 8; Domingues CMAS, 2014, LANCET RESP MED, V2, P464, DOI 10.1016/S2213-2600(14)70060-8; Domingues CM, 2014, ISPPD 9, V9; Dotres CP, 2014, VACCINE, V32, P5266, DOI 10.1016/j.vaccine.2014.06.094; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hammitt LL, 2014, LANCET GLOB HEALTH, V2, pE397, DOI 10.1016/S2214-109X(14)70224-4; Hammitt LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085459; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Hornshoj L, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001509; Iriso R, 2008, ANN TROP PAEDIATR, V28, P211, DOI 10.1179/146532808X335660; Klugman KP, 2014, LANCET GLOB HEALTH, V2, pE365, DOI 10.1016/S2214-109X(14)70241-4; Lagos RM, 2011, HUM VACCINES, V7, P511, DOI 10.4161/hv.7.5.14634; Laiwani S, 2014, CLIN VACCINE IMMUNOL, V21, P1292, DOI 10.1128/CVI.00068-14; Makenga G, 2014, ISPPD 9; Mohamud AN, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-865; Musher DM, 2012, CLIN INFECT DIS, V55, P265, DOI 10.1093/cid/cis364; Odusanya OO, 2014, HUM VACC IMMUNOTHER, V10, P757, DOI 10.4161/hv.27276; Ota MOC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042997; PAHO, REV FUND PRIC 2014 V; Poolman JT, 2010, CLIN VACCINE IMMUNOL, V17, P134, DOI 10.1128/CVI.00289-09; Roca A, 2012, CLIN INFECT DIS, V55, P816, DOI 10.1093/cid/cis554; Roca A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072198; Roca A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001107; Simonsen L, 2011, MBIO, V2, DOI 10.1128/mBio.00309-10; Thanee C, 2011, VACCINE, V29, P5886, DOI 10.1016/j.vaccine.2011.06.072; UNICEF, SUPPL LOG GAVI; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Watanabe H, 2007, INTERNAL MED, V46, P1395, DOI 10.2169/internalmedicine.46.0149; Wells G, NEWCASTLE OTTAWA QUA; World Health Organization, 2014, GLOB IMM DAT	39	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135270	10.1371/journal.pone.0135270	http://dx.doi.org/10.1371/journal.pone.0135270			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332848	Green Published, Green Submitted, gold			2022-12-26	WOS:000360613800025
J	Maixenchs, M; Boene, H; Anselmo, R; Mindu, C; Alonso, P; Menendez, C; Macete, E; Pool, R; Letang, E; Naniche, D; Munguambe, K				Maixenchs, Maria; Boene, Helena; Anselmo, Rui; Mindu, Carolina; Alonso, Pedro; Menendez, Clara; Macete, Eusebio; Pool, Robert; Letang, Emilio; Naniche, Denise; Munguambe, Khatia			Post-ART Symptoms Were Not the Problem: A Qualitative Study on Adherence to ART in HIV-Infected Patients in a Mozambican Rural Hospital	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; SOUTH-AFRICA; BARRIERS; TANZANIA; METAANALYSIS; CHALLENGES; SERVICES; DISTRICT; DISEASE	Objective The objective of this qualitative study was to explore how clinical symptoms may affect adherence to antiretroviral therapy (ART) in HIV patients, and to explore factors, perceptions and attitudes related to adherence to therapy. Design A qualitative study was carried out in the context of the prospective cohort study "Evaluation of Immune Reconstitution Following Initiation of Highly Active Antiretroviral Treatment in Manhica, Mozambique". In-depth Interviews were conducted twice in a sub-sample of the study cohort (51 participants), at six-month intervals. Results Most participants (73%) knew that AIDS is a chronic disease and that ART does not cure it. Nine participants (18%) were non-adherent at some point and two (4%) abandoned ART. All participants but five reported having symptoms after starting ART, mainly attributed to pills needing time to act and body's reaction to the treatment. In spite of the perceived severity of the symptoms, only two people reported they discontinued the treatment due to symptoms. Almost all participants reported feeling comfortable with the HIV clinic organization and procedures, but afraid of staff being hostile if they did not follow the rules or if the health worker visited their home. Family was one of the most important source of support according participants. Almost all participants with children said that a decisive factor to follow the treatment was the desire to be able to look after them. Conclusions Experiencing symptoms after starting treatment was not a barrier to adherence to ART. Factors related to adherence included control measures set up by the health facility (exhaustive follow up, support, information) and family and community support. Indirect ART-related expenses did jeopardise adherence.	[Maixenchs, Maria; Boene, Helena; Anselmo, Rui; Mindu, Carolina; Macete, Eusebio; Munguambe, Khatia] CISM, Manhica, Mozambique; [Maixenchs, Maria; Alonso, Pedro; Menendez, Clara; Pool, Robert; Letang, Emilio; Naniche, Denise] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain; [Munguambe, Khatia] Eduardo Mondlane Univ, Fac Med, Maputo, Mozambique; [Pool, Robert] Univ Amsterdam, Ctr Social Sci & Global Hlth, Amsterdam, Netherlands; [Letang, Emilio] Swiss Trop & Publ Hlth Inst, Basel, Switzerland	Centro de Investigacao em Saude de Manhica; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Eduardo Mondlane University; University of Amsterdam; University of Basel; Swiss Tropical & Public Health Institute	Maixenchs, M (corresponding author), CISM, Manhica, Mozambique.	maria.maixenchs@manhica.net	Menéndez, Clara/Q-3446-2016; Alonso, Pedro L/AAZ-3645-2020; Naniche, Denise S/S-1814-2018	Menéndez, Clara/0000-0002-2641-6907; Alonso, Pedro L/0000-0003-3292-3443; Naniche, Denise S/0000-0002-4495-6325; Maixenchs, Maria/0000-0002-5782-8197	Fundacio "la Caixa''; Agencia Catalana de Cooperacio al Desenvolupament (ACCD); Spanish Agency for International Cooperation and Development; Spanish Ministry of Education and Science (Ramon y Cajal)	Fundacio "la Caixa''(La Caixa FoundationEuropean Commission); Agencia Catalana de Cooperacio al Desenvolupament (ACCD); Spanish Agency for International Cooperation and Development(Spanish Government); Spanish Ministry of Education and Science (Ramon y Cajal)(Spanish Government)	Financial support was received from the Fundacio "la Caixa'' and the Agencia Catalana de Cooperacio al Desenvolupament (ACCD). The Centro de Investigacao em Saude de Manhica receives core funding from the Spanish Agency for International Cooperation and Development. DN was supported by a grant from the Spanish Ministry of Education and Science (Ramon y Cajal). Funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Dakkak I, 2013, AIDS CARE, V25, P400, DOI 10.1080/09540121.2012.712667; [Anonymous], EP FACT SHEETS HIV A; [Anonymous], 2003, ADHERENCE LONG TERM; Audu B, 2014, AIDS CARE, V26, P270, DOI 10.1080/09540121.2013.819410; Baranoski AS, 2014, AIDS CARE, V26, P26, DOI 10.1080/09540121.2013.802282; Barfod TS, 2006, HIV MED, V7, P285, DOI 10.1111/j.1468-1293.2006.00387.x; Bezabhe WM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097353; French MA, 2004, AIDS, V18, P1615, DOI 10.1097/01.aids.0000131375.21070.06; Gonzalez R, 2012, HIV MED, V13, P581, DOI 10.1111/j.1468-1293.2012.01018.x; Gonzalez R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132053; Grant E, 2008, AIDS CARE, V20, P1155, DOI 10.1080/09540120701854634; Hardon A., 2006, ACCESS ADHERENCE CHA; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Instituto Nacional de Estadistica, 2007, TERC REC GER POP HAB; Letang E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016946; Letang E, 2010, JAIDS-J ACQ IMM DEF, V53, P589, DOI 10.1097/QAI.0b013e3181bc476f; Lyimo RA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-716; Merten S, 2010, TROP MED INT HEALTH, V15, P16, DOI 10.1111/j.1365-3156.2010.02510.x; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Murray LK, 2009, AIDS CARE, V21, P78, DOI 10.1080/09540120802032643; Nachega JB, 2012, PATIENT PREFER ADHER, V6, P887, DOI 10.2147/PPA.S38897; National AIDS Council-Republic of Mozambique, 2012, GLOB AIDS RESP PROGR; Ncama BP, 2008, INT J NURS STUD, V45, P1757, DOI 10.1016/j.ijnurstu.2008.06.006; Nhacolo AQ, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-291; Nyanzi-Wakholi B, 2012, AIDS CARE, V24, P137, DOI 10.1080/09540121.2011.596518; Olowookere SA, 2008, J INFECT DEV COUNTR, V2, P369; Orrell C, 2003, AIDS, V17, P1369, DOI 10.1097/00002030-200306130-00011; Ortego C, 2011, AIDS BEHAV, V15, P1381, DOI 10.1007/s10461-011-9942-x; Rasschaert F, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-364; Republica de Mozambique, 2008, ROND VIG EP HIV 2007; Roura M, 2009, AIDS PATIENT CARE ST, V23, P203, DOI 10.1089/apc.2008.0129; Sacoor C, 2013, INT J EPIDEMIOL, V42, P1309, DOI 10.1093/ije/dyt148; Tomori C, 2014, AIDS CARE, V26, P907, DOI 10.1080/09540121.2013.861574; *UNAIDS WHO, 2008, REP GLOB AIDS EP; UNAIDS-WHO, 2014, GAP REP; UNGASS, 2010, UN GEN ASS SPEC SESS; Vervoort SCJM, 2007, AIDS, V21, P271, DOI 10.1097/QAD.0b013e328011cb20; Ware NC, 2009, PLOS MED, V6, P39, DOI 10.1371/journal.pmed.1000011; Watt MH, 2009, SOC SCI MED, V68, P1793, DOI 10.1016/j.socscimed.2009.02.037; Zaidi J, 2012, AIDS, V29, P997	40	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137336	10.1371/journal.pone.0137336	http://dx.doi.org/10.1371/journal.pone.0137336			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ4ZT	26332680	Green Published, Green Submitted, gold			2022-12-26	WOS:000360613800123
J	Gaynes, JA; Otsuna, H; Campbell, DS; Manfredi, JP; Levine, EM; Chien, CB				Gaynes, John A.; Otsuna, Hideo; Campbell, Douglas S.; Manfredi, John P.; Levine, Edward M.; Chien, Chi-Bin			The RNA Binding Protein Igf2bp1 Is Required for Zebrafish RGC Axon Outgrowth In Vivo	PLOS ONE			English	Article							ACTIN MESSENGER-RNA; BETA-ACTIN; CELL-MIGRATION; GROWTH CONES; SIGNALING MECHANISMS; ARBOR FORMATION; VG1 RBP; LOCALIZATION; TRANSLATION; EXPRESSION	Attractive growth cone turning requires Igf2bp1-dependent local translation of beta-actin mRNA in response to external cues in vitro. While in vivo studies have shown that Igf2bp1 is required for cell migration and axon terminal branching, a requirement for Igf2bp1 function during axon outgrowth has not been demonstrated. Using a timelapse assay in the zebrafish retinotectal system, we demonstrate that the beta-actin 3'UTR is sufficient to target local translation of the photoconvertible fluorescent protein Kaede in growth cones of pathfinding retinal ganglion cells (RGCs) in vivo. Igf2bp1 knockdown reduced RGC axonal outgrowth and tectal coverage and retinal cell survival. RGC-specific expression of a phosphomimetic Igf2bp1 reduced the density of axonal projections in the optic tract while sparing RGCs, demonstrating for the first time that Igf2bp1 is required during axon outgrowth in vivo. Therefore, regulation of local translation mediated by Igf2bp proteins may be required at all stages of axon development.	[Gaynes, John A.; Levine, Edward M.; Chien, Chi-Bin] Univ Utah, Med Ctr, Program Neurosci, Salt Lake City, UT 84112 USA; [Gaynes, John A.; Otsuna, Hideo; Campbell, Douglas S.; Levine, Edward M.; Chien, Chi-Bin] Univ Utah, Med Ctr, Dept Neurobiol & Anat, Salt Lake City, UT USA; [Gaynes, John A.; Levine, Edward M.] Univ Utah, Med Ctr, Dept Ophthalmol Visual Sci, John A Moran Ctr, Salt Lake City, UT USA; [Campbell, Douglas S.] Max Planck Inst Brain Res, Frankfurt, Germany; [Manfredi, John P.] Sfida BioLog Inc, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Max Planck Society	Levine, EM (corresponding author), Univ Utah, Med Ctr, Program Neurosci, Salt Lake City, UT 84112 USA.	ed.levine@utah.edu	Levine, Edward/N-3878-2015	Levine, Edward/0000-0003-1725-2805; Campbell, Douglas/0000-0002-7371-9484	National Institutes of Health (NIH) [EY012873, EY013760]; NEI Vision Core grant [P30-EY014800]; Research to Prevent Blindness, Inc.; Sfida BioLogic, Inc.; NATIONAL EYE INSTITUTE [P30EY014800, R01EY012873, R01EY013760] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI Vision Core grant; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); Sfida BioLogic, Inc.; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was funded by National Institutes of Health (NIH) (http://www.nih.gov) grants EY012873 to Chi-Bin Chien, EY013760 to Ed Levine, and NEI Vision Core grant P30-EY014800. This work was supported in part by an unrestricted grant to the Department of Ophthalmology & Visual Sciences by Research to Prevent Blindness, Inc. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Sfida BioLogic, Inc. provided support in the form of salary for the author JM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Akten B, 2011, P NATL ACAD SCI USA, V108, P10337, DOI 10.1073/pnas.1104928108; Baraban M, 2013, J NEUROSCI, V33, P15726, DOI 10.1523/JNEUROSCI.1510-13.2013; Caceres A, 2012, CURR OPIN CELL BIOL, V24, P547, DOI 10.1016/j.ceb.2012.05.011; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chao JA, 2010, GENE DEV, V24, P148, DOI 10.1101/gad.1862910; De Felice E, 2014, J ANAT, V224, P564, DOI 10.1111/joa.12168; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; Donnelly CJ, 2013, J NEUROSCI, V33, P3311, DOI 10.1523/JNEUROSCI.1722-12.2013; Donnelly CJ, 2011, EMBO J, V30, P4665, DOI 10.1038/emboj.2011.347; FurutaniSeiki M, 1996, DEVELOPMENT, V123, P229; Git A, 2002, RNA, V8, P1319, DOI 10.1017/S135583820202705X; Gomez TM, 2014, J NEUROCHEM, V129, P221, DOI 10.1111/jnc.12506; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hansen TVO, 2004, MOL CELL BIOL, V24, P4448, DOI 10.1128/MCB.24.10.4448-4464.2004; Hornberg H, 2013, J NEUROSCI, V33, P10384, DOI 10.1523/JNEUROSCI.5858-12.2013; Hornberg H, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00081; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Jung HS, 2012, NAT REV NEUROSCI, V13, P308, DOI 10.1038/nrn3210; Kalous A, 2014, DEV NEUROBIOL, V74, P303, DOI 10.1002/dneu.22110; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; KISLAUSKIS EH, 1994, J CELL BIOL, V127, P441, DOI 10.1083/jcb.127.2.441; Kolodkin Alex L, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a001727; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lauderdale JD, 1997, MOL CELL NEUROSCI, V9, P293, DOI 10.1006/mcne.1997.0624; Leung KM, 2008, NAT PROTOC, V3, P1318, DOI 10.1038/nprot.2008.113; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Leung LC, 2013, NAT NEUROSCI, V16, P166, DOI 10.1038/nn.3290; Lin AC, 2007, EMBO J, V26, P3729, DOI 10.1038/sj.emboj.7601808; Manns RPC, 2012, J NEUROSCI, V32, P8554, DOI 10.1523/JNEUROSCI.5964-11.2012; Oberman F, 2007, RNA, V13, P1558, DOI 10.1261/rna.559507; Patel VL, 2012, GENE DEV, V26, P43, DOI 10.1101/gad.177428.111; Piper M, 2006, NEURON, V49, P215, DOI 10.1016/j.neuron.2005.12.008; Pittman AJ, 2008, DEVELOPMENT, V135, P2865, DOI 10.1242/dev.025049; Randlett O, 2011, NEURON, V70, P266, DOI 10.1016/j.neuron.2011.03.013; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Ross AF, 1997, MOL CELL BIOL, V17, P2158, DOI 10.1128/MCB.17.4.2158; Sasaki Y, 2010, J NEUROSCI, V30, P9349, DOI 10.1523/JNEUROSCI.0499-10.2010; Shestakova EA, 2001, P NATL ACAD SCI USA, V98, P7045, DOI 10.1073/pnas.121146098; Stohr N, 2012, CELL ADHES MIGR, V6, P312, DOI 10.4161/cam.20628; STUERMER CAO, 1988, J NEUROSCI, V8, P4513; Tada M, 2012, DEVELOPMENT, V139, P3897, DOI 10.1242/dev.073007; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Vacaru AM, 2014, J CELL SCI, V127, P485, DOI 10.1242/jcs.140194; Wan Y, 2012, IEEE PAC VIS SYMP, P201, DOI 10.1109/PacificVis.2012.6183592; Welshhans K, 2011, J NEUROSCI, V31, P9800, DOI 10.1523/JNEUROSCI.0166-11.2011; Willis DE, 2007, J CELL BIOL, V178, P965, DOI 10.1083/jcb.200703209; Yaniv K, 2003, DEVELOPMENT, V130, P5649, DOI 10.1242/dev.00810; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang HL, 2001, NEURON, V31, P261, DOI 10.1016/S0896-6273(01)00357-9; Zhang HL, 1999, J CELL BIOL, V147, P59, DOI 10.1083/jcb.147.1.59; Zhang QH, 1999, MECH DEVELOP, V88, P101, DOI 10.1016/S0925-4773(99)00162-8; Zolessi FR, 2006, NEURAL DEV, V1, DOI 10.1186/1749-8104-1-2	53	12	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0134751	10.1371/journal.pone.0134751	http://dx.doi.org/10.1371/journal.pone.0134751			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325373	Green Published, Green Submitted, gold			2022-12-26	WOS:000360437700014
J	Hirano, M; Satake, W; Ihara, K; Tsuge, I; Kondo, S; Saida, K; Betsui, H; Okubo, K; Sakamoto, H; Ueno, S; Ikuno, Y; Ishihara, R; Iwahashi, H; Ohishi, M; Mano, T; Yamashita, T; Suzuki, Y; Nakamura, Y; Kusunoki, S; Toda, T				Hirano, Makito; Satake, Wataru; Ihara, Kenji; Tsuge, Ikuya; Kondo, Shuji; Saida, Ken; Betsui, Hiroyuki; Okubo, Kazuhiro; Sakamoto, Hikaru; Ueno, Shuichi; Ikuno, Yasushi; Ishihara, Ryu; Iwahashi, Hiromi; Ohishi, Mitsuru; Mano, Toshiyuki; Yamashita, Toshihide; Suzuki, Yutaka; Nakamura, Yusaku; Kusunoki, Susumu; Toda, Tatsushi			The First Nationwide Survey and Genetic Analyses of Bardet-Biedl Syndrome in Japan	PLOS ONE			English	Article							MUTATIONS; DIAGNOSIS; PATIENT; BBS1	Bardet-Biedl syndrome (BBS) is an autosomal recessive disorder characterized by central obesity, mental impairment, rod-cone dystrophy, polydactyly, hypogonadism in males, and renal abnormalities. The causative genes have been identified as BBS1-19. In Western countries, this disease is often reported, but remains undiagnosed in many patients until later in life, while only a few patients with no mutations identified have been reported in Japan. We thus conducted the first nationwide survey of BBS in Japan by sending questionnaires to 2,166 clinical departments with board-certified specialists and found 7 patients with clinically definite BBS. We performed exome analyses combined with analyses of mRNA and protein in these patients. We identified 2 novel mutations in the BBS5 gene (p.R89X and IVS7-27 T>G) in 2 sibling patients. The latter mutation that resided far from the authentic splicing site was associated with skipping of exon 8. We also found 3 previously reported mutations in the BBS2 (p.R413X and p.R480X) and BBS7 (p.C243Y) genes in 2 patients. To our knowledge, a nationwide survey of BBS has not been reported in any other country. In addition, this is the first study to identify genetic alterations in Japanese patients with BBS. Our results indicate that BBS in Japan is genetically heterogeneous and at least partly shares genetic features with BBS in other countries.	[Hirano, Makito; Sakamoto, Hikaru; Ueno, Shuichi; Nakamura, Yusaku] Kinki Univ, Sakai Hosp, Fac Med, Dept Neurol, Sakai, Osaka, Japan; [Hirano, Makito; Ueno, Shuichi; Kusunoki, Susumu] Kinki Univ, Fac Med, Dept Neurol, Osakasayama, Japan; [Satake, Wataru; Toda, Tatsushi] Kobe Univ, Div Neurol Mol Brain Sci, Grad Sch Med, Kobe, Hyogo 657, Japan; [Ihara, Kenji; Okubo, Kazuhiro] Kyushu Univ, Grad Sch Med, Dept Pediat, Fukuoka 812, Japan; [Tsuge, Ikuya] Fujita Hlth Univ, Dept Pediat, Toyoake, Aichi, Japan; [Kondo, Shuji] Univ Tokushima, Dept Pediat, Tokushima 770, Japan; [Saida, Ken] Natl Ctr Child Hlth & Dev, Dept Nephrol, Tokyo, Japan; [Betsui, Hiroyuki] Haga Red Cross Hosp, Dept Pediat, Mooka, Tochigi, Japan; [Ikuno, Yasushi] Osaka Univ, Grad Sch Med, Dept Ophthalmol, Suita, Osaka, Japan; [Ishihara, Ryu] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Gastrointestinal Oncol, Osaka, Japan; [Iwahashi, Hiromi] Osaka Univ, Dept Metab Med, Grad Sch Med, Suita, Osaka, Japan; [Ohishi, Mitsuru] Osaka Univ, Dept Geriatr Med, Grad Sch Med, Suita, Osaka, Japan; [Mano, Toshiyuki] Osaka Med Ctr, Dept Pediat Neurol, Izumi, Japan; [Mano, Toshiyuki] Res Inst Maternal & Child Hlth, Izumi, Japan; [Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Suita, Osaka, Japan; [Suzuki, Yutaka] Univ Tokyo, Dept Computat Biol, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan	Kindai University (Kinki University); Kindai University (Kinki University); Kobe University; Kyushu University; Fujita Health University; Tokushima University; National Center for Child Health & Development - Japan; Osaka University; Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka University; Osaka University; Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka University; University of Tokyo	Hirano, M (corresponding author), Kinki Univ, Sakai Hosp, Fac Med, Dept Neurol, Sakai, Osaka, Japan.	hirano_makito@yahoo.co.jp	/ABA-5207-2021; Ihara, Kenji/AAE-3890-2020	/0000-0002-4686-6147; Ihara, Kenji/0000-0002-8831-1991; Yamashita, Toshihide/0000-0003-4559-7018	Ministry of Education, Culture, Sports, Science and Technology of Japan [25461297]; Health and Labour Science Research Grants (Research in Intractable Diseases) [10103346]; Grants-in-Aid for Scientific Research [25461297, 24591515, 26461613] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health and Labour Science Research Grants (Research in Intractable Diseases); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	MH recieved Grants-in-Aids for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (25461297) and Health and Labour Science Research Grants (Research in Intractable Diseases, 10103346).	Badano JL, 2003, HUM MOL GENET, V12, P1651, DOI 10.1093/hmg/ddg188; Beales PL, 1999, J MED GENET, V36, P437; Beales PL, 2003, AM J HUM GENET, V72, P1187, DOI 10.1086/375178; Hirano M, 2011, CLIN MED INSIGHT-CAS, V4, P17, DOI 10.4137/CCRep.S6622; Iannello S, 2002, Obes Rev, V3, P123, DOI 10.1046/j.1467-789X.2002.00055.x; Janssen S, 2011, HUM GENET, V129, P79, DOI 10.1007/s00439-010-0902-8; NAKAMURA F, 1990, J GASTROEN HEPATOL, V5, P206, DOI 10.1111/j.1440-1746.1990.tb01826.x; Saida K, 2014, BRAIN DEV-JPN, V36, P721, DOI 10.1016/j.braindev.2013.10.013; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Tonomura Y, 2009, CLIN NEUROL NEUROSUR, V111, P102, DOI 10.1016/j.clineuro.2008.08.008; Wang J, 2002, MOL CELL, V10, P951, DOI 10.1016/S1097-2765(02)00635-4; Wang X, 2013, J MED GENET, V50, P674, DOI 10.1136/jmedgenet-2013-101558; Yamada K, 2000, PEDIATR NEUROSURG, V33, P323, DOI 10.1159/000055979; Zaghloul NA, 2009, J CLIN INVEST, V119, P428, DOI 10.1172/JCI37041	14	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136317	10.1371/journal.pone.0136317	http://dx.doi.org/10.1371/journal.pone.0136317			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325687	Green Submitted, Green Published, gold			2022-12-26	WOS:000360437700038
J	Hung, YC; Tseng, YJ; Hu, WL; Chen, HJ; Li, TC; Tsai, PY; Chen, HP; Huang, MH; Su, FY				Hung, Yu-Chiang; Tseng, Ying-Jung; Hu, Wen-Long; Chen, Hsuan-Ju; Li, Tsai-Chung; Tsai, Pei-Yuan; Chen, Hsin-Ping; Huang, Meng-Hsuan; Su, Fang-Yen			Demographic and Prescribing Patterns of Chinese Herbal Products for Individualized Therapy for Ischemic Heart Disease in Taiwan: Population-Based Study	PLOS ONE			English	Article							GEGEN DECOCTION PROTECTS; SMOOTH-MUSCLE-CELLS; SALVIA-MILTIORRHIZA; CARDIOVASCULAR-DISEASE; PUERARIA-LOBATA; DANSHEN; MEDICINE; FORMULA; RADIX; PHARMACOLOGY	Objective Combinations of Chinese herbal products (CHPs) are widely used for ischemic heart disease (IHD) in Taiwan. We analyzed the usage and frequency of CHPs prescribed for patients with IHD. Methods A nationwide population-based cross-sectional study was conducted, 53531 patients from a random sample of one million in the National Health Insurance Research Database (NHIRD) from 2000 to 2010 were enrolled. Descriptive statistics, the multiple logistic regression method and Poisson regression analysis were employed to estimate the adjusted odds ratios (aORs) and adjusted risk ratios (aRRs) for utilization of CHPs. Results The mean age of traditional Chinese medicine (TCM) nonusers was significantly higher than that of TCM users. Zhi-Gan-Cao-Tang (24.85%) was the most commonly prescribed formula CHPs, followed by Xue-Fu-Zhu-Yu-Tang (16.53%) and Sheng-Mai-San (16.00%). The most commonly prescribed single CHPs were Dan Shen (29.30%), Yu Jin (7.44%), and Ge Gen (6.03%). After multivariate adjustment, patients with IHD younger than 29 years had 2.62 times higher odds to use TCM than those 60 years or older. Residents living in Central Taiwan, having hyperlipidemia or cardiac dysrhythmias also have higher odds to use TCM. On the contrary, those who were males, who had diabetes mellitus (DM), hypertension, stroke, myocardial infarction (MI) were less likely to use TCM. Conclusions Zhi-Gan-Cao-Tang and Dan Shen are the most commonly prescribed CHPs for IHD in Taiwan. Our results should be taken into account by physicians when devising individualized therapy for IHD. Further large-scale, randomized clinical trials are warranted in order to determine the effectiveness and safety of these herbal medicines.	[Hung, Yu-Chiang; Tseng, Ying-Jung; Hu, Wen-Long; Tsai, Pei-Yuan; Chen, Hsin-Ping; Huang, Meng-Hsuan; Su, Fang-Yen] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Chinese Med, Kaohsiung 833, Taiwan; [Hung, Yu-Chiang; Tseng, Ying-Jung; Hu, Wen-Long; Tsai, Pei-Yuan; Chen, Hsin-Ping; Huang, Meng-Hsuan; Su, Fang-Yen] Chang Gung Univ, Coll Med, Sch Tradit Chinese Med, Kaohsiung 833, Taiwan; [Hung, Yu-Chiang] I Shou Univ, Sch Chinese Med Post Baccalaureate, Kaohsiung 84001, Taiwan; [Hu, Wen-Long] Fooyin Univ, Coll Nursing, Kaohsiung 831, Taiwan; [Hu, Wen-Long] Kaohsiung Med Univ, Coll Med, Kaohsiung 807, Taiwan; [Chen, Hsuan-Ju] China Med Univ Hosp, Management Off Hlth Data, Taichung 40447, Taiwan; [Chen, Hsuan-Ju] China Med Univ, Coll Med, Taichung 40402, Taiwan; [Li, Tsai-Chung] China Med Univ, Coll Publ Hlth, Grad Inst Biostat, Taichung 40402, Taiwan; [Li, Tsai-Chung] Asia Univ, Coll Hlth Sci, Dept Healthcare Adm, Taichung 41354, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; I Shou University; Fooyin University; Kaohsiung Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan	Hung, YC (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Chinese Med, 123 Dapi Rd, Kaohsiung 833, Taiwan.	e120845@cgmh.org.tw; tcli@mail.cmu.edu.tw	Li, Tsai-Chung/P-2052-2015; Hung, yu-chiang/ABE-7636-2020; Hu, Wen-Long/N-1660-2014	Li, Tsai-Chung/0000-0002-3346-7462; Hu, Wen-Long/0000-0001-9549-6202	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW104-TDU-B-212-113002]; Academia Sinica Taiwan Biobank, Stroke Biosignature Project [BM104010092]; NRPB Stroke Clinical Trial Consortium [MOST 103-2325-B-039-006]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; Ministry of Science and Technology of Taiwan (National Science Council) [NSC101-2632-B-039-001-MY3]; China Medical University Hospital	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; Academia Sinica Taiwan Biobank, Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; Ministry of Science and Technology of Taiwan (National Science Council); China Medical University Hospital	The use of National Health Insurance Research Database (NHIRD) was supported by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW104-TDU-B-212-113002), China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project (BM104010092), NRPB Stroke Clinical Trial Consortium (MOST 103-2325-B-039-006), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, Katsuzo and Kiyo Aoshima Memorial Funds, Japan, and the Ministry of Science and Technology of Taiwan (National Science Council) (NSC101-2632-B-039-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, TAIWAN J CLIN CHINES, V14, P308; Cai RL, 2011, J ETHNOPHARMACOL, V133, P177, DOI 10.1016/j.jep.2010.09.013; Chang LC, 2008, J CLIN PHARM THER, V33, P243, DOI 10.1111/j.1365-2710.2008.00911.x; Chen HY, 2011, J ETHNOPHARMACOL, V137, P1261, DOI 10.1016/j.jep.2011.07.053; Chiu PY, 2012, PHYTOMEDICINE, V19, P99, DOI 10.1016/j.phymed.2011.07.002; Chiu PY, 2011, PHYTOMEDICINE, V18, P916, DOI 10.1016/j.phymed.2011.03.006; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Hu F, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-249; Hu F, 2012, PHYTOMEDICINE, V19, P1051, DOI 10.1016/j.phymed.2012.07.007; Hu SS, 2012, BIOMED ENVIRON SCI, V25, P251, DOI 10.3967/0895-3988.2012.03.001; Hung YC, 2010, BBA-PROTEINS PROTEOM, V1804, P1310, DOI 10.1016/j.bbapap.2010.02.001; Hung YC, 2009, J ETHNOPHARMACOL, V124, P463, DOI 10.1016/j.jep.2009.05.020; Kankeu HT, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-31; Koon CM, 2011, J ETHNOPHARMACOL, V138, P175, DOI 10.1016/j.jep.2011.08.073; Kuukasjarvi P, 2006, INT J TECHNOL ASSESS, V22, P219, DOI 10.1017/S026646230605104X; Liao Yueh-Hsiang, 2013, Evid Based Complement Alternat Med, V2013, P984876, DOI 10.1155/2013/984876; Liao YH, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-146; Liu HX, 2011, J TRADIT CHIN MED, V31, P269, DOI 10.1016/S0254-6272(12)60002-8; Liu L, 2004, CHEM PHARM BULL, V52, P1295, DOI 10.1248/cpb.52.1295; Ministry of Health and Welfare (MOHW), 2014, 2013 STAT CAUS DEATH; MOHW, 2014, 2012 STAT CAUS DEATH; Ng CF, 2011, J ETHNOPHARMACOL, V137, P1366, DOI 10.1016/j.jep.2011.08.006; Pratt C, 2010, PRIMARY CARE, V37, P325, DOI 10.1016/j.pop.2010.02.009; Tam WY, 2009, J ALTERN COMPLEM MED, V15, P415, DOI 10.1089/acm.2008.0400; Tao WY, 2013, J ETHNOPHARMACOL, V145, P1, DOI 10.1016/j.jep.2012.09.051; Wan AKS, 2008, J NAT PROD, V71, P1825, DOI 10.1021/np800119k; Wang NY, 2001, AM J CHINESE MED, V29, P367, DOI 10.1142/S0192415X01000381; Wang XY, 2011, J ETHNOPHARMACOL, V135, P662, DOI 10.1016/j.jep.2011.03.070; Wang YQ, 2013, PHARM BIOL, V51, P1219, DOI 10.3109/13880209.2013.784920; World Health Organization (WHO), 2014, CARD DIS CVDS; Wu L, 2010, J PHARMACEUT BIOMED, V52, P438, DOI 10.1016/j.jpba.2010.01.021; Yao K, 2012, WORLD J INTEGRATED T, V2012, P1029; Zhang YA, 2010, FOOD CHEM TOXICOL, V48, P2656, DOI 10.1016/j.fct.2010.06.036; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630	34	30	32	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0137058	10.1371/journal.pone.0137058	http://dx.doi.org/10.1371/journal.pone.0137058			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322893	Green Published, Green Submitted, gold			2022-12-26	WOS:000360435500062
J	Juan, CJ; Cheng, CC; Chiu, SC; Jen, YM; Liu, YJ; Chiu, HC; Kao, HW; Wang, CW; Chung, HW; Huang, GS; Hsu, HH				Juan, Chun-Jung; Cheng, Cheng-Chieh; Chiu, Su-Chin; Jen, Yee-Min; Liu, Yi-Jui; Chiu, Hui-Chu; Kao, Hung-Wen; Wang, Chih-Wei; Chung, Hsiao-Wen; Huang, Guo-Shu; Hsu, Hsian-He			Temporal Evolution of Parotid Volume and Parotid Apparent Diffusion Coefficient in Nasopharyngeal Carcinoma Patients Treated by Intensity-Modulated Radiotherapy Investigated by Magnetic Resonance Imaging: A Pilot Study	PLOS ONE			English	Article							SALIVARY-GLAND FUNCTION; RADIATION-INDUCED CHANGES; INTRAVOXEL INCOHERENT MOTION; NECK-CANCER; WEIGHTED MRI; ORAL-CANCER; HEAD; INJURY; IRRADIATION; THERAPY	Purpose To concurrently quantify the radiation-induced changes and temporal evolutions of parotid volume and parotid apparent diffusion coefficient (ADC) in nasopharyngeal carcinoma (NPC) patients treated by intensity-modulated radiotherapy by usingmagnetic resonance imaging (MRI). Materials and Methods A total of 11 NPC patients (9 men and 2 women; 48.7 +/- 11.7 years, 22 parotid glands) were enrolled. Radiation dose, parotid sparing volume, severity of xerostomia, and radiation-to-MR interval (RMI) was recorded. MRI studies were acquired four times, including one before and three after radiotherapy. The parotid volume and the parotid ADC weremeasured. Statistical analysis was performed using SPSS and MedCalc. Bonferroni correction was applied formultiple comparisons. A P value less than 0.05 was considered as statistically significant. Results The parotid volume was 26.2 +/- 8.0 cm(3) before radiotherapy. The parotid ADC was 0.8 +/- 0.15 x 10(-3) mm(2)/sec before radiotherapy. The parotid glands received a radiation dose of 28.7 +/- 4.1 Gy and a PSV of 44.1 +/- 12.6%. The parotid volume was significantly smaller at MR stage 1 and stage 2 as compared to pre-RT stage (P < .005). The volume reduction ratio was 31.2 +/- 13.0%, 26.1 +/- 13.5%, and 17.1 +/- 16.6% at stage 1, 2, and 3, respectively. The parotid ADC was significantly higher at all post-RT stages as compared to pre-RT stage reciprocally (P < .005 at stage 1 and 2, P < .05 at stage 3). The ADC increase ratio was 35.7 +/- 17.4%, 27.0 +/- 12.8%, and 20.2 +/- 16.6% at stage 1, 2, and 3, respectively. The parotid ADC was negatively correlated to the parotid volume (R = -0.509; P < .001). The parotid ADC was positively associated with the radiation dose significantly (R-2 = 0.212; P = .0001) and was negatively associated with RMI significantly (R-2 = 0.203; P = .00096) significantly. Multiple regression analysis further showed that the post-RT parotid ADC was related to the radiation dose and RMI significantly (R-2 = 0.3580; P < .0001). At MR stage 3, the parotid volume was negatively associated with the dry mouth grade significantly (R-2 = 0.473; P < .0001), while the parotid ADC was positively associated with the dry mouth grade significantly (R-2 = 0.288; P = .015). Conclusion Our pilot study successfully demonstrates the concurrent changes and temporal evolution of parotid volume and parotid ADC quantitatively in NPC patients treated by IMRT. Our results suggest that the reduction of parotid volume and increase of parotid ADC are dominated by the effect of acinar loss rather than edema at early to intermediate phases and the following recovery of parotid volume and ADC toward the baseline values might reflect the acinar regeneration of parotid glands.	[Juan, Chun-Jung; Kao, Hung-Wen; Wang, Chih-Wei; Chung, Hsiao-Wen; Huang, Guo-Shu; Hsu, Hsian-He] Natl Def Med Ctr, Dept Radiol, Taipei, Taiwan; [Juan, Chun-Jung; Cheng, Cheng-Chieh; Chiu, Su-Chin; Kao, Hung-Wen; Wang, Chih-Wei; Chung, Hsiao-Wen; Huang, Guo-Shu; Hsu, Hsian-He] Triserv Gen Hosp, Dept Radiol, Taipei, Taiwan; [Cheng, Cheng-Chieh; Chiu, Su-Chin; Chung, Hsiao-Wen] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Jen, Yee-Min] Natl Def Med Ctr, Dept Radiat Oncol, Taipei, Taiwan; [Jen, Yee-Min] Triserv Gen Hosp, Dept Radiat Oncol, Taipei, Taiwan; [Liu, Yi-Jui] Feng Chia Univ, Dept Automat Control Engn, Taichung 40724, Taiwan; [Chiu, Hui-Chu] Chung Hua Univ, PhD Program Technol Management, Hsinchu, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Taiwan University; National Defense Medical Center; Tri-Service General Hospital; Feng Chia University; Chung Hua University	Juan, CJ (corresponding author), Natl Def Med Ctr, Dept Radiol, Taipei, Taiwan.	peterjuancj@yahoo.com.tw	Juan, Chun-Jung/AAE-8438-2020; Liu, Yi-Jui/AAH-8540-2020	Liu, Yi-Jui/0000-0001-5865-6836; Chung, Hsiao-Wen/0000-0001-7127-1244	National Science Council [NSC-100-2314-B-016-009]; Tri-Service General Hospital [TSGH-C104-049]	National Science Council(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital	CJJ received the funding partly from National Science Council (NSC-100-2314-B-016-009) and Tri-Service General Hospital (TSGH-C104-049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker M, 1997, RADIOGRAPHICS, V17, P5, DOI 10.1148/radiographics.17.1.9017796; Brown PJ, 1997, J SMALL ANIM PRACT, V38, P234, DOI 10.1111/j.1748-5827.1997.tb03353.x; Buus S, 2004, RADIOTHER ONCOL, V73, P289, DOI 10.1016/j.radonc.2004.09.009; CAIRNCROSS JG, 1980, ANN NEUROL, V7, P385, DOI 10.1002/ana.410070419; Chang HC, 2014, EUR RADIOL, V24, P2069, DOI 10.1007/s00330-014-3265-z; Chen HC, 2004, OTOLARYNG HEAD NECK, V130, P388, DOI 10.1016/j.otohns.2003.08.010; Cheng CC, 2013, MAGN RESON IMAGING, V31, P1278, DOI 10.1016/j.mri.2013.03.018; Coppes RP, 2001, BRIT J CANCER, V85, P1055, DOI 10.1054/bjoc.2001.2038; COX JD, 1995, INT J RADIAT ONCOL, V31, P1341, DOI 10.1016/0360-3016(95)00060-C; CRUMP M, 1990, BONE MARROW TRANSPL, V6, P259; Dirix P, 2008, INT J RADIAT ONCOL, V71, P1365, DOI 10.1016/j.ijrobp.2007.12.011; Dirix P, 2006, CANCER-AM CANCER SOC, V107, P2525, DOI 10.1002/cncr.22302; GUSTAFSSON H, 1995, ACTA ONCOL, V34, P193, DOI 10.3109/02841869509093955; Houweling AC, 2011, RADIOTHER ONCOL, V100, P386, DOI 10.1016/j.radonc.2011.08.020; Jen YM, 2006, ORAL SURG ORAL MED O, V101, P322, DOI 10.1016/j.tripleo.2005.01.011; Juan C, 2009, RADIOLOGY, V253; Juan CJ, 2009, EUR RADIOL, V19, P94, DOI 10.1007/s00330-008-1104-9; Konings AWT, 2005, INT J RADIAT ONCOL, V62, P1187, DOI 10.1016/j.ijrobp.2004.12.051; Konings AWT, 2005, INT J RADIAT ONCOL, V62, P1090, DOI 10.1016/j.ijrobp.2004.12.035; Lee FKH, 2011, RADIAT RES, V175, P291, DOI 10.1667/RR2370.1; Lee N, 2002, INT J RADIAT ONCOL, V53, P12, DOI 10.1016/S0360-3016(02)02724-4; Li C, 2015, ZHONGHUA ER BI YAN H, V50, P5; Li J, 2005, INT J RADIAT ONCOL, V62, P1510, DOI 10.1016/j.ijrobp.2005.04.029; Lin ZX, 2011, THYROID, V21, P19, DOI 10.1089/thy.2010.0229; Liu YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124118; Luo CB, 2006, EUR ARCH OTO-RHINO-L, V263, P644, DOI 10.1007/s00405-006-0028-8; Marzi S, 2015, J MAGN RESON IMAGING, V41, P974, DOI 10.1002/jmri.24626; Mukherjee P, 2001, RADIOLOGY, V219, P756, DOI 10.1148/radiology.219.3.r01jn48756; Munter MW, 2004, INT J RADIAT ONCOL, V58, P175, DOI 10.1016/S0360-3016(03)01437-8; Nagler RM, 2002, ORAL DIS, V8, P141, DOI 10.1034/j.1601-0825.2002.02838.x; Nishimura Y, 2005, JPN J CLIN ONCOL, V35, P375, DOI 10.1093/jjco/hyi108; Nomayr A, 2001, EUR RADIOL, V11, P1807; PIERPAOLI C, 1993, RADIOLOGY, V189, P439, DOI 10.1148/radiology.189.2.8210373; Radfar L, 2003, ORAL SURG ORAL MED O, V96, P267, DOI 10.1016/S1079-2104(03)00369-X; Sandrasegaran K, 2009, AM J ROENTGENOL, V193, P1556, DOI 10.2214/AJR.09.2436; Siala W, 2009, CANCER RADIOTHER, V13, P709, DOI 10.1016/j.canrad.2009.05.006; SIMOVIC S, 1977, J FR OTORHINOLARYNG, V26, P541; STEPHENS LC, 1986, AM J PATHOL, V124, P469; Studer G, 2005, INT J RADIAT ONCOL, V63, pS361, DOI 10.1016/j.ijrobp.2005.07.617; Sumi M, 2002, AM J ROENTGENOL, V178, P959, DOI 10.2214/ajr.178.4.1780959; Takahashi S, 1998, INT J EXP PATHOL, V79, P293, DOI 10.1046/j.1365-2613.1998.710405.x; Teshima K, 2010, JPN J CLIN ONCOL, V40, P42, DOI 10.1093/jjco/hyp113; Thoeny HC, 2004, J MAGN RESON IMAGING, V20, P786, DOI 10.1002/jmri.20196; Tomitaka E, 2011, JPN J CLIN ONCOL, V41, P503, DOI 10.1093/jjco/hyq236; VANANDEL JG, 1982, CLIN RADIOL, V33, P95, DOI 10.1016/S0009-9260(82)80368-1; Wada A, 2009, AM J NEURORADIOL, V30, P53, DOI 10.3174/ajnr.A1322; Wang YXJ, 2010, RADIOLOGY, V254, P210, DOI 10.1148/radiol.09090428; Wang ZH, 2009, LARYNGOSCOPE, V119, P1966, DOI 10.1002/lary.20601; Xiao WW, 2011, CANCER-AM CANCER SOC, V117, P1874, DOI 10.1002/cncr.25754; Zhang L, 2001, J MAGN RESON IMAGING, V14, P223, DOI 10.1002/jmri.1177; Zhang YY, 2013, ACTA RADIOL, V54, P928, DOI 10.1177/0284185113491089	51	22	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0137073	10.1371/journal.pone.0137073	http://dx.doi.org/10.1371/journal.pone.0137073			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26323091	gold, Green Published, Green Submitted			2022-12-26	WOS:000360435500064
J	Stecklov, G; Weinreb, AA; Sana, M				Stecklov, Guy; Weinreb, Alexander A.; Sana, Mariano			Family Planning for Strangers: An Experiment on the Validity of Reported Contraceptive Use	PLOS ONE			English	Article							SEXUAL-BEHAVIOR; SENSITIVE BEHAVIOR; EXPENDITURE DATA; ADOLESCENTS; QUALITY; INTERVIEWERS; FERTILITY; SOCIOLOGY; KNOWLEDGE; COUNTRIES	Sterilization levels reported in the Dominican Republic appear well above what we would normally expect given prevailing patterns in the region. We suspect that the use of strangers as interviewers-the normative approach in data collection in both developed and developing country settings-may be partly responsible for this result, and may underlie a long history of bias in family planning data. We present findings from a field experiment conducted in a Dominican town in 2010, where interviewer assignment was randomized by level of preexisting level of familiarity between interviewer and respondent. In our data, sterilization use is higher when the interviewer is an outsider, as opposed to someone known to the respondent or from the same community. In addition, high sterilization use is correlated with a propensity of respondents to present themselves in a positive light to interviewers. These results call into question the routine use of strangers and outsiders as interviewers in demographic and health surveys.	[Stecklov, Guy] Hebrew Univ Jerusalem, Dept Sociol & Anthropol, Jerusalem, Israel; [Weinreb, Alexander A.] Univ Texas Austin, Dept Sociol, Austin, TX 78712 USA; [Weinreb, Alexander A.] Univ Texas Austin, Populat Res Ctr, Austin, TX 78712 USA; [Sana, Mariano] Vanderbilt Univ, Dept Sociol, Nashville, TN 37235 USA	Hebrew University of Jerusalem; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Vanderbilt University	Stecklov, G (corresponding author), Hebrew Univ Jerusalem, Dept Sociol & Anthropol, Jerusalem, Israel.	Stecklov@huji.ac.il	Weinreb, Alex/L-3187-2018		NIH [1R21HD054731-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042849] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD054731] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by NIH Grant 1R21HD054731-01A1.	Agar M.H, 1980, PROFESSIONAL STRANGE; Ali MM, 2005, SOC SCI MED, V60, P1175, DOI 10.1016/j.socscimed.2004.07.002; AXINN WG, 1991, SOCIOL METHOD RES, V20, P187, DOI 10.1177/0049124191020002001; Becker S, 2001, STUD FAMILY PLANN, V32, P111, DOI 10.1111/j.1728-4465.2001.00111.x; BECKER S, 1995, STUD FAMILY PLANN, V26, P233, DOI 10.2307/2137848; Biemer PP, 1991, MEASUREMENT ERROR SU; Blanc AK, 1998, STUD FAMILY PLANN, V29, P106, DOI 10.2307/172153; Blanc AK, 2002, STUD FAMILY PLANN, V33, P127, DOI 10.1111/j.1728-4465.2002.00127.x; Bollen KA, 2002, POP STUD-J DEMOG, V56, P81, DOI 10.1080/00324720213796; Bollen KA, 1989, STRUCTURAL EQUATIONS; Brea JA, 2003, POPULATION DYNAMICS; Cameron AC, 2008, REV ECON STAT, V90, P414, DOI 10.1162/rest.90.3.414; Chen K-H, 1976, CULTURE NATALITY FAM, P241; CLELAND J, 1973, STUD FAMILY PLANN, V4, P42, DOI 10.2307/1964829; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; Cleland J, 2013, LANCET, V381, P1604, DOI 10.1016/S0140-6736(13)60588-7; CRESSEY PG, 1983, URBAN LIFE, V12, P102, DOI 10.1177/0098303983012001007; EVERHART RB, 1977, AM EDUC RES J, V14, P1; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Frye M, 2012, AM J SOCIOL, V117, P1565, DOI 10.1086/664542; Giddens Anthony, 1990, CONSEQUENCES MODERNI; Gill GJ.O.K, 1993, MED ANTHR Q; GREEN EC, 1988, STUD FAMILY PLANN, V19, P109, DOI 10.2307/1966495; Greene William H, 2003, ECONOMETRIC ANAL, V5th; Hox JJ, 1991, MEASUREMENT ERROR SU; Jansen SC, 1980, QUALITATIVE SOCIOLOG, V2, P22; Johnson-Hanks J, 2005, CURR ANTHROPOL, V46, P363, DOI 10.1086/428799; Launiala A, 2009, ANTHR MATTERS; Levy MJ, 1972, MODERNIZATION LATECO; Lind Amy, 2010, DEV SEXUAL RIGHTS GL; LOAIZA E, 1995, STUD FAMILY PLANN, V26, P39, DOI 10.2307/2138050; Luke N, 2011, DEMOGRAPHY, P1; Marcus G, 1992, REREADING CULTURAL A; MASSEY DS, 1987, INT MIGR REV, V21, P1498, DOI 10.2307/2546522; Mayoni JR, 1983, ANTHROPOLOGICA, V25, P221; Meijer E, 2000, ECON LETT, V69, P277, DOI 10.1016/S0165-1765(00)00328-1; Mensch BS, 2008, INT FAM PLAN PERSPEC, V34, P169, DOI 10.1363/ifpp.34.169.08; Mensch BS, 2003, DEMOGRAPHY, V40, P247, DOI 10.1353/dem.2003.0017; NASH D, 1963, SOUTHWEST J ANTHROP, V19, P149, DOI 10.1086/soutjanth.19.2.3629165; O'Barr WM, 1973, SURVEY RES AFRICA; O'Muircheartaigh C, 1998, J ROY STAT SOC A STA, V161, P63, DOI 10.1111/1467-985X.00090; Paulhus DL, 2003, J PERS SOC PSYCHOL, V84, P890, DOI 10.1037/0022-3514.84.4.890; Plummer ML, 2004, SEX TRANSM INFECT, V80, P49, DOI 10.1136/sti.2004.011924; Plummer ML, 2004, TROP MED INT HEALTH, V9, P737, DOI 10.1111/j.1365-3156.2004.01254.x; Potter JE, 8675020 AG INT DEV; Poulin M, 2010, DEMOGR RES, V22, P237, DOI 10.4054/DemRes.2010.22.11; Powdermaker Hortense, 1966, STRANGER FRIEND WAY; Rodriguez LA, 2015, FIELD METHOD, V27, P163, DOI 10.1177/1525822X14549315; Rogers EM, 1999, COMMUN THEOR, V9, P58, DOI 10.1111/j.1468-2885.1999.tb00162.x; Sana M, POPULATION IN PRESS; Sana M, 2008, SOCIOL METHOD RES, V36, P515, DOI 10.1177/0049124107313857; Silverman, 2004, QUALITATIVE RES THEO, P141; Simmel G., 1950, SOCIOLOGY G SIMMEL; Simmel G, 1906, AM J SOCIOL, V11, P441, DOI 10.1086/211418; STONE L, 1984, HUM ORGAN, V43, P27, DOI 10.17730/humo.43.1.6wl5k01724878166; SUDMAN S, 1974, J MARKETING RES, V11, P128, DOI 10.2307/3150549; Sullivan TM, 2006, J BIOSOC SCI, V38, P501, DOI 10.1017/S0021932005026647; Tourangeau Roger, 2000, PSYCHOL SURVEY RESPO; Vaessen M, 2005, HOUSEHOLD SAMPLE SUR; Weinreb AA, 2011, RESULTS METHODOLOGIC; Weinreb AA, 2006, AM SOCIOL REV, V71, P1014, DOI 10.1177/000312240607100607; Westoff C. F., 1988, International Family Planning Perspectives, V14, P45, DOI 10.2307/2947679; Yoder PS, 1997, MED ANTHROPOL Q, V11, P131, DOI 10.1525/maq.1997.11.2.131; Zimmerman L, 2015, AFRICAN POPULATION S, V29, P1699, DOI 10.11564/29-1-719	64	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136972	10.1371/journal.pone.0136972	http://dx.doi.org/10.1371/journal.pone.0136972			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ2MT	26322898	Green Submitted, gold, Green Published			2022-12-26	WOS:000360435500056
J	Chen, DQ; Wang, SW; Xiong, BL; Cao, BB; Deng, XP				Chen, Daoqian; Wang, Shiwen; Xiong, Binglin; Cao, Beibei; Deng, Xiping			Carbon/Nitrogen Imbalance Associated with Drought-Induced Leaf Senescence in Sorghum bicolor	PLOS ONE			English	Article							NITRATE REDUCTASE-ACTIVITY; ABSCISIC-ACID; NITROGEN AVAILABILITY; GLUTAMINE-SYNTHETASE; GENE-EXPRESSION; MESSENGER-RNA; WATER-STRESS; PLANTS; CARBON; ARABIDOPSIS	Drought stress triggers mature leaf senescence, which supports plant survival and remobilization of nutrients; yet leaf senescence also critically decreases post-drought crop yield. Drought generally results in carbon/nitrogen imbalance, which is reflected in the increased carbon: nitrogen (C:N) ratio in mature leaves, and which has been shown to be involved in inducing leaf senescence under normal growth conditions. Yet the involvement of the carbon/nitrogen balance in regulation of drought-induced leaf senescence is unclear. To investigate the role of carbon/nitrogen balance in drought-induced senescence, sorghum seedlings were subjected to a gradual soil drought treatment. Leaf senescence symptoms and the C: N ratio, which was indicated by the ratio of non-structural carbohydrate to total N content, were monitored during drought progression. In this study, leaf senescence developed about 12 days after the start of drought treatment, as indicated by various senescence symptoms including decreasing photosynthesis, photosystem II photochemistry efficiency (Fv/Fm) and chlorophyll content, and by the differential expression of senescence marker genes. The C: N ratio was significantly enhanced 10 to 12 days into drought treatment. Leaf senescence occurred in the older (lower) leaves, which had higher C: N ratios, but not in the younger (upper) leaves, which had lower C: N ratios. In addition, a detached leaf assay was conducted to investigate the effect of carbon/nitrogen availability on drought-induced senescence. Exogenous application of excess sugar combined with limited nitrogen promoted drought-induced leaf senescence. Thus our results suggest that the carbon/nitrogen balance may be involved in the regulation of drought-induced leaf senescence.	[Chen, Daoqian; Deng, Xiping] Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China; [Wang, Shiwen; Deng, Xiping] Northwest A&F Univ, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling 712100, Shaanxi, Peoples R China; [Xiong, Binglin] Chinese Acad Sci, Inst Soil & Water Conservat, Yangling 712100, Shaanxi, Peoples R China; [Xiong, Binglin] Minist Water Resources, Yangling 712100, Shaanxi, Peoples R China; [Cao, Beibei] Northwest A&F Univ, Coll Nat Resources & Environm, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources; Northwest A&F University - China	Wang, SW (corresponding author), Northwest A&F Univ, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling 712100, Shaanxi, Peoples R China.	shiwenwang@ms.iswc.ac.cn	Wang, Shiwen/AAA-9751-2019	Wang, Shiwen/0000-0003-3195-5531; deng, xi ping/0000-0003-4577-9217; Chen, Daoqian/0000-0002-1339-6767	West Light Foundation of the Chinese Academy of Sciences; Chinese Universities Scientific Fund [Z109021202]; National Basic Research Program of China [2015CB150402]	West Light Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese Universities Scientific Fund; National Basic Research Program of China(National Basic Research Program of China)	This study was supported by West Light Foundation of the Chinese Academy of Sciences, http://english.cas.cn/, Wang; Chinese Universities Scientific Fund (Z109021202), http://www.moe.gov.cn/publicfiles/business/htmlfiles/moe/moe_2792/index.html, Wang; and National Basic Research Program of China (2015CB150402), http://www.most.gov.cn/eng/, Deng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguera E, 2010, PHYSIOL PLANTARUM, V138, P256, DOI 10.1111/j.1399-3054.2009.01336.x; Aoyama S, 2014, PLANT CELL PHYSIOL, V55, P293, DOI 10.1093/pcp/pcu002; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CLEGG K. M., 1956, Journal of the Science of Food and Agriculture, V7, P40, DOI 10.1002/jsfa.2740070108; Coruzzi GM, 2001, CURR OPIN PLANT BIOL, V4, P247, DOI 10.1016/S1369-5266(00)00168-0; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Dai N, 1999, PLANT CELL, V11, P1253, DOI 10.1105/tpc.11.7.1253; Abreu ME, 2008, ENVIRON EXP BOT, V64, P105, DOI 10.1016/j.envexpbot.2007.12.016; ENGELS C, 1994, ANN BOT-LONDON, V73, P211, DOI 10.1006/anbo.1994.1025; Ferrario-Mery S, 1998, PLANT PHYSIOL, V117, P293, DOI 10.1104/pp.117.1.293; Foyer CH, 1998, PLANT PHYSIOL, V117, P283, DOI 10.1104/pp.117.1.283; Ishiyama K, 2004, J BIOL CHEM, V279, P16598, DOI 10.1074/jbc.M313710200; Juvany M, 2012, J INTEGR PLANT BIOL, V54, P584, DOI 10.1111/j.1744-7909.2012.01141.x; Khanna-Chopra R, 2012, PROTOPLASMA, V249, P469, DOI 10.1007/s00709-011-0308-z; Kiba T, 2012, PLANT CELL, V24, P245, DOI 10.1105/tpc.111.092221; Lara MEB, 2004, PLANT CELL, V16, P1276, DOI 10.1105/tpc.018929; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Liu P, 2014, J EXP BOT, V65, P4747, DOI 10.1093/jxb/eru220; Martin T, 2002, PLANT PHYSIOL, V128, P472, DOI 10.1104/pp.010475; Miao Y, 2004, PLANT MOL BIOL, V55, P853, DOI 10.1007/s11103-005-2142-1; Munne-Bosch S, 2004, FUNCT PLANT BIOL, V31, P203, DOI 10.1071/FP03236; Nio SA, 2011, PLANT PHYSIOL BIOCH, V49, P1126, DOI 10.1016/j.plaphy.2011.05.011; Ogbaga CC, 2011, PHYSIOL PLANTARUM, V152, P389; Ono K, 1996, PLANT CELL PHYSIOL, V37, P1083, DOI 10.1093/oxfordjournals.pcp.a029057; Palenchar PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r91; Pinto-Marijuan M, 2014, J EXP BOT, V65, P3845, DOI 10.1093/jxb/eru086; Pourtau N, 2004, PLANTA, V219, P765, DOI 10.1007/s00425-004-1279-5; Reguera M, 2013, PLANT PHYSIOL, V163, P1609, DOI 10.1104/pp.113.227702; Rivero RM, 2007, P NATL ACAD SCI USA, V104, P19631, DOI 10.1073/pnas.0709453104; Robredo A, 2011, ENVIRON EXP BOT, V71, P399, DOI 10.1016/j.envexpbot.2011.02.011; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Schildhauer J, 2008, PLANT BIOLOGY, V10, P76, DOI 10.1111/j.1438-8677.2008.00075.x; SHANER DL, 1976, PLANT PHYSIOL, V58, P505, DOI 10.1104/pp.58.4.505; Wingler A, 2008, PLANT BIOLOGY, V10, P50, DOI 10.1111/j.1438-8677.2008.00086.x; Wingler A, 2006, J EXP BOT, V57, P391, DOI 10.1093/jxb/eri279; Wingler A, 2015, J EXP BOT, V66, P355, DOI 10.1093/jxb/eru426; Wingler A, 2012, PLANT PHYSIOL, V158, P1241, DOI 10.1104/pp.111.191908; Xu WZ, 2014, ACTA PHYSIOL PLANT, V36, P1033, DOI 10.1007/s11738-013-1481-9; Xu ZZ, 2006, J PLANT GROWTH REGUL, V25, P252, DOI 10.1007/s00344-006-0043-4; Yang JC, 2003, PLANT CELL ENVIRON, V26, P1621, DOI 10.1046/j.1365-3040.2003.01081.x; YEMM EW, 1954, BIOCHEM J, V57, P508, DOI 10.1042/bj0570508; YEMM EW, 1955, ANALYST, V80, P209, DOI 10.1039/an9558000209; ZHANG HS, 2013, PLANT MOL BIOL, V82, P539, DOI DOI 10.1007/s11103-012-9980-4	44	40	48	8	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137026	10.1371/journal.pone.0137026	http://dx.doi.org/10.1371/journal.pone.0137026			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317421	Green Published, gold			2022-12-26	WOS:000360299100196
J	Famulare, M				Famulare, Michael			Has Wild Poliovirus Been Eliminated from Nigeria?	PLOS ONE			English	Article							VACCINE-DERIVED POLIOVIRUSES; POLIOMYELITIS ERADICATION; SURVEILLANCE; PROGRESS; STRATEGY	Wild poliovirus type 3 (WPV3) has not been seen anywhere since the last case of WPV3-associated paralysis in Nigeria in November 2012. At the time of writing, the most recent case of wild poliovirus type 1 (WPV1) in Nigeria occurred in July 2014, and WPV1 has not been seen in Africa since a case in Somalia in August 2014. No cases associated with circulating vaccine-derived type 2 poliovirus (cVDPV2) have been detected in Nigeria since November 2014. Has WPV1 been eliminated from Africa? Has WPV3 been eradicated globally? Has Nigeria interrupted cVDPV2 transmission? These questions are difficult because polio surveillance is based on paralysis and paralysis only occurs in a small fraction of infections. This report provides estimates for the probabilities of poliovirus elimination in Nigeria given available data as of March 31, 2015. It is based on a model of disease transmission that is built from historical polio incidence rates and is designed to represent the uncertainties in transmission dynamics and poliovirus detection that are fundamental to interpreting long time periods without cases. The model estimates that, as of March 31, 2015, the probability of WPV1 elimination in Nigeria is 84%, and that if WPV1 has not been eliminated, a new case will be detected with 99% probability by the end of 2015. The probability of WPV3 elimination (and thus global eradication) is > 99%. However, it is unlikely that the ongoing transmission of cVDPV2 has been interrupted; the probability of cVDPV2 elimination rises to 83% if no new cases are detected by April 2016.	Inst Dis Modeling, Bellevue, WA 98005 USA		Famulare, M (corresponding author), Inst Dis Modeling, Bellevue, WA 98005 USA.	mfamulare@intven.com		Famulare, Michael/0000-0001-9275-7454	Global Good, Bellevue, WA, USA; Institute for Disease Modeling (Global Good)	Global Good, Bellevue, WA, USA; Institute for Disease Modeling (Global Good)	This work was supported by Global Good, Bellevue, WA, USA. The Institute for Disease Modeling (which is funded by Global Good) provided support in the form of a salary for author MF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions" section.	Alexander JP, 1997, J INFECT DIS, V175, pS176, DOI 10.1093/infdis/175.Supplement_1.S176; Anderson DF, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2799998; Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P278; [Anonymous], 2013, MMWR-MORBID MORTAL W, V59, P802; [Anonymous], 2014, NIGERIA POLIO SITUAT; [Anonymous], 2005, DECISION THEORY BRIE; [Anonymous], 2015, POLIO IN SOMALIA; [Anonymous], 2015, GLOBAL POLIO ERADICA; [Anonymous], 2013, 2014 NIG POL ER EM P; Bahl S, 2014, MMWR-MORBID MORTAL W, V63, pCOVER1; Burns CC, 2013, J VIROL, V87, P4907, DOI 10.1128/JVI.02954-12; Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, V57, P942; Debanne SM, 1998, MATH BIOSCI, V150, P83, DOI 10.1016/S0025-5564(98)00007-8; DEGROOT MH, 1986, PROBABILITY STAT; Diop OM, 2014, MMWR-MORBID MORTAL W, V63, P242; Dunkle Stacie, 2012, Morbidity and Mortality Weekly Report, V61, P899; Eichner E, 1996, AM J EPIDEMIOL, V143, P816, DOI 10.1093/oxfordjournals.aje.a008820; Etsano A, 2014, MMWR-MORBID MORTAL W, V63, P1059; Etsano A, 2013, MMWR-MORBID MORTAL W, V62, P1009; Fine P, 2011, CLIN INFECT DIS, V52, P911, DOI 10.1093/cid/cir007; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Hovi T, 2012, EPIDEMIOL INFECT, V140, P1, DOI 10.1017/S095026881000316X; Hull BP, 1997, J INFECT DIS, V175, pS113, DOI 10.1093/infdis/175.Supplement_1.S113; Kalkowska DA, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0791-5; Kalkowska DA, 2012, AM J EPIDEMIOL, V175, P936, DOI 10.1093/aje/kwr399; Kew OM, 2014, MMWR-MORBID MORTAL W, V63, P1031; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; Mangal TD, 2014, LANCET GLOB HEALTH, V2, pE90, DOI 10.1016/S2214-109X(13)70168-2; Nathanson N, 2010, AM J EPIDEMIOL, V172, P1213, DOI 10.1093/aje/kwq320; Shulman LM, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.7.20709; Smith SJ, 2004, B WHO, V82; Sutter RW, 2006, CURR TOP MICROBIOL, V304, P195; Tebbens RJD, 2013, RISK ANAL, V33, P680, DOI 10.1111/risa.12022; Upfill-Brown AM, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-92; WHO SAGE Polio Working Group, 2014, OPV CESS PLAN TOPV C; World Health Organization, 2015, GLOB POL ER IN DAT M	36	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135765	10.1371/journal.pone.0135765	http://dx.doi.org/10.1371/journal.pone.0135765			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317401	Green Submitted, Green Published, gold			2022-12-26	WOS:000360299100044
J	Ibanez, G; Bernard, JY; Rondet, C; Peyre, H; Forhan, A; Kaminski, M; Saurel-Cubizolles, MJ				Ibanez, Gladys; Bernard, Jonathan Y.; Rondet, Claire; Peyre, Hugo; Forhan, Anne; Kaminski, Monique; Saurel-Cubizolles, Marie-Josephe		EDEN Mother-Child Cohort Study Grp	Effects of Antenatal Maternal Depression and Anxiety on Children's Early Cognitive Development: A Prospective Cohort Study	PLOS ONE			English	Article							POSTNATAL DEPRESSION; MENTAL-HEALTH; PRETERM BIRTH; PREGNANCY; STRESS; RISK; PSYCHOPATHOLOGY; MODEL; AGE; DETERMINANTS	Introduction Studies have shown that depression or anxiety occur in 10-20% of pregnant women. These disorders are often undertreated and may affect mothers and children's health. This study investigates the relation between antenatal maternal depression, anxiety and children's early cognitive development among 1380 two-year-old children and 1227 three-yearold children. Methods In the French EDEN Mother-Child Cohort Study, language ability was assessed with the Communicative Development Inventory at 2 years of age and overall development with the Ages and Stages Questionnaire at 3 years of age. Multiple regressions and structural equation modeling were used to examine links between depression, anxiety during pregnancy and child cognitive development. Results We found strong significant associations between maternal antenatal anxiety and poorer children's cognitive development at 2 and 3 years. Antenatal maternal depression was not associated with child development, except when antenatal maternal anxiety was also present. Both postnatal maternal depression and parental stimulation appeared to play mediating roles in the relation between antenatal maternal anxiety and children's cognitive development. At 3 years, parental stimulation mediated 13.2% of the effect of antenatal maternal anxiety while postnatal maternal depression mediated 26.5%. Discussion The partial nature of these effects suggests that other mediators may play a role. Implications for theory and research on child development are discussed.	[Ibanez, Gladys; Kaminski, Monique; Saurel-Cubizolles, Marie-Josephe] Paris Descartes Univ, Obstetr Perinatal & Pediat Epidemiol Res Team, Ctr Epidemiol & Biostat, INSERM,U1153, Paris, France; [Ibanez, Gladys; Rondet, Claire] Univ Paris 06, Sch Med, Dept Gen Practice, Paris, France; [Bernard, Jonathan Y.; Forhan, Anne] INSERM, U1018, Ctr Res Epidemiol & Populat Hlth CESP, Team Epidemiol Diabet Obes & Kidney Dis Lifelong, F-94807 Villejuif, France; [Bernard, Jonathan Y.; Forhan, Anne] Univ Paris Sud, UMRS 1018, F-94807 Villejuif, France; [Peyre, Hugo] Ecole Normale Super, CNRS, Lab Sci Cognit & Psycholinguist, EHESS, Paris, France; [Peyre, Hugo] Hop Robert Debre, APHP, Serv Psychopathol Enfant & Adolescent, F-75019 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite de Franche-Comte; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Ibanez, G (corresponding author), Paris Descartes Univ, Obstetr Perinatal & Pediat Epidemiol Res Team, Ctr Epidemiol & Biostat, INSERM,U1153, Paris, France.	gladys.ibanez@upmc.fr	Annesi-Maesano, Isabella/D-9173-2016; Bernard, Jonathan/T-7064-2017; Lepeule, Johanna/N-2579-2013; Dargent-Molina, Patricia/N-3887-2017; Heude, Barbara/G-3095-2016; Charles, Marie Aline/S-1866-2019; de Lauzon-Guillain, Blandine/P-4659-2016; FRITEL, Xavier/K-8566-2012; Charles, Marie Aline/F-8567-2017; Peyre, Hugo/A-5656-2018; Saurel-Cubizolles, Marie-Josephe/D-1571-2014	Annesi-Maesano, Isabella/0000-0002-6340-9300; Bernard, Jonathan/0000-0002-6418-983X; Lepeule, Johanna/0000-0001-8907-197X; Dargent-Molina, Patricia/0000-0001-8596-6899; Heude, Barbara/0000-0002-1565-1629; Charles, Marie Aline/0000-0003-4025-4390; de Lauzon-Guillain, Blandine/0000-0001-5887-8842; FRITEL, Xavier/0000-0002-4987-8127; Charles, Marie Aline/0000-0003-4025-4390; , Gladys/0000-0002-5592-699X; Peyre, Hugo/0000-0001-8757-0783; Germa, Alice/0000-0002-0505-4986; Saurel-Cubizolles, Marie-Josephe/0000-0002-2210-974X; HANKARD, Regis/0000-0001-8450-5839	Fondation pour la Recherche Medicale (FRM); French Ministry of Research: IFR program; INSERM Nutrition Research Program; French Ministry of Health Perinatality Program; French Agency for Environment Security (AFFSET); French National Institute for Population Health Surveillance (INVS); Paris-Sud University; Nestle; Mutuelle Generale de l'Education Nationale (MGEN); French Speaking Association for the Study of Diabetes and Metabolism (Alfediam); National Agency for Research (ANR); Institute of Research in Public Health (IRESP: Cohort program); Nestle Nutrition and Guigoz; French Group of General Pediatrics; French Epidemiological Research Group for Pediatrics; French National Institute for Health Education (INPES)	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); French Ministry of Research: IFR program(Ministry of Research, France); INSERM Nutrition Research Program(Institut National de la Sante et de la Recherche Medicale (Inserm)); French Ministry of Health Perinatality Program; French Agency for Environment Security (AFFSET)(French National Research Agency (ANR)); French National Institute for Population Health Surveillance (INVS); Paris-Sud University; Nestle(Nestle SA); Mutuelle Generale de l'Education Nationale (MGEN); French Speaking Association for the Study of Diabetes and Metabolism (Alfediam); National Agency for Research (ANR)(French National Research Agency (ANR)); Institute of Research in Public Health (IRESP: Cohort program); Nestle Nutrition and Guigoz(Nestle SA); French Group of General Pediatrics; French Epidemiological Research Group for Pediatrics; French National Institute for Health Education (INPES)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by Fondation pour la Recherche Medicale (FRM), French Ministry of Research: IFR program, INSERM Nutrition Research Program, French Ministry of Health Perinatality Program, French Agency for Environment Security (AFFSET), French National Institute for Population Health Surveillance (INVS), Paris-Sud University, French National Institute for Health Education (INPES), Nestle, Mutuelle Generale de l'Education Nationale (MGEN), French Speaking Association for the Study of Diabetes and Metabolism (Alfediam), National Agency for Research (ANR), the Institute of Research in Public Health (IRESP: Cohort program) and Nestle Nutrition and Guigoz, the French Group of General Pediatrics, and the French Epidemiological Research Group for Pediatrics.	Alder J, 2007, J MATERN-FETAL NEO M, V20, P189, DOI 10.1080/14767050701209560; Ammerman RT, 2014, ARCH WOMENS MENT HLT; Austin MP, 2005, EARLY HUM DEV, V81, P917, DOI 10.1016/j.earlhumdev.2005.07.005; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Bernard JY, 2013, J PEDIATR-US, V163, P36, DOI 10.1016/j.jpeds.2012.11.090; Bricker D, 1999, AGES STAGES QUESTION, V2; Brouwers EPM, 2001, J PSYCHOSOM RES, V51, P659, DOI 10.1016/S0022-3999(01)00245-8; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Deave T, 2008, BJOG-INT J OBSTET GY, V115, P1043, DOI 10.1111/j.1471-0528.2008.01752.x; DiPietro JA, 2006, CHILD DEV, V77, P573, DOI 10.1111/j.1467-8624.2006.00891.x; Drouillet P, 2009, BRIT J NUTR, V101, P583, DOI 10.1017/S0007114508025038; Fenson L., 1993, MACARTHUR COMMUNICAT; Fily A, 2006, PEDIATRICS, V117, P357, DOI 10.1542/peds.2005-0236; Fisher M, 2010, AUST NZ J PSYCHIAT, V44, P1057, DOI 10.3109/00048674.2010.509311; FUHRER R, 1989, Psychiatrie and Psychobiologie, V4, P163; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Goodman SH, 1999, PSYCHOL REV, V106, P458, DOI 10.1037/0033-295X.106.3.458; Gray PH, 2013, EARLY HUM DEV, V89, P625, DOI 10.1016/j.earlhumdev.2013.04.005; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Guedeney N, 1998, EUR PSYCHIAT, V13, P83, DOI 10.1016/S0924-9338(98)80023-0; Gutierrez-Galve L, 2015, PEDIATRICS; Hanington L, 2012, CHILD CARE HLTH DEV, V38, P520, DOI 10.1111/j.1365-2214.2011.01270.x; Hinnant JB, 2003, CHILD DEV, V84, P3; Ibanez G, 2012, EARLY HUM DEV, V88, P643, DOI 10.1016/j.earlhumdev.2012.01.014; Jackson-Maldonado D., 2003, MACARTHUR INVENTARIO; Jensen SKG, 2014, DEPRESS ANXIETY, V31, P599, DOI 10.1002/da.22147; Kane P, 2004, CLIN PSYCHOL REV, V24, P339, DOI 10.1016/j.cpr.2004.03.004; Keim SA, 2011, EARLY HUM DEV, V87, P373, DOI 10.1016/j.earlhumdev.2011.02.004; Kern S., 2003, GLOSSA, V85, P48; Koutra K, 2013, SOC PSYCH PSYCH EPID, V48, P1335, DOI 10.1007/s00127-012-0636-0; Leigh B, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-24; Loomans EM, 2012, DEV PSYCHOBIOL, V54, P441, DOI 10.1002/dev.20606; Lukasiewicz M, 2008, ALCOHOL ALCOHOLISM, V43, P287, DOI 10.1093/alcalc/agm183; Mennes M, 2006, NEUROSCI BIOBEHAV R, V30, P1078, DOI 10.1016/j.neubiorev.2006.04.003; Miszkurka M, 2012, SOC PSYCH PSYCH EPID, V47, P1639, DOI 10.1007/s00127-011-0469-2; Mulder EJH, 2002, EARLY HUM DEV, V70, P3, DOI 10.1016/S0378-3782(02)00075-0; O'Connor TG, 2002, J AM ACAD CHILD PSY, V41, P1470, DOI 10.1097/00004583-200212000-00019; Pawlby S, 2011, BRIT J PSYCHIAT, V199, P106, DOI 10.1192/bjp.bp.110.087734; Petzoldt J, 2014, ARCH DIS CHILD, V99, P800, DOI 10.1136/archdischild-2013-305562; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reising MM, 2013, J CHILD FAM STUD, P22; Smith T, 2012, MCN-AM J MATERN-CHIL, V37, P80, DOI 10.1097/NMC.0b013e3182446401; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Spielberger CD, 1993, INVENTAIRE ANXIETE T; Squires J, 1997, J PEDIATR PSYCHOL, V22, P313, DOI 10.1093/jpepsy/22.3.313; Squires J, 2009, ASQ 3 AGES STAGES QU; Van den Bergh BRH, 2011, DEV MED CHILD NEUROL, V53, P19, DOI 10.1111/j.1469-8749.2011.04057.x; Van den Bergh BRH, 2005, NEUROSCI BIOBEHAV R, V29, P237, DOI 10.1016/j.neubiorev.2004.10.007; Wu J, 2002, AM J OBSTET GYNECOL, V187, P864, DOI 10.1067/mob.2002.127126	51	47	47	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135849	10.1371/journal.pone.0135849	http://dx.doi.org/10.1371/journal.pone.0135849			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ0PO	26317609	Green Published, gold, Green Submitted			2022-12-26	WOS:000360299100046
J	Kal, EC; van der Kamp, J; Houdijk, H; Groet, E; van Bennekom, CAM; Scherder, EJA				Kal, E. C.; van der Kamp, J.; Houdijk, H.; Groet, E.; van Bennekom, C. A. M.; Scherder, E. J. A.			Stay Focused! The Effects of Internal and External Focus of Attention on Movement Automaticity in Patients with Stroke	PLOS ONE			English	Article							COGNITIVE-MOTOR INTERFERENCE; WORKING-MEMORY; STOPS WALKING; EMG ACTIVITY; PERFORMANCE; PREDICTOR; FEEDBACK; TALKING; PEOPLE; REACH	Dual-task performance is often impaired after stroke. This may be resolved by enhancing patients' automaticity of movement. This study sets out to test the constrained action hypothesis, which holds that automaticity of movement is enhanced by triggering an external focus (on movement effects), rather than an internal focus (on movement execution). Thirty-nine individuals with chronic, unilateral stroke performed a one-leg-stepping task with both legs in single-and dual-task conditions. Attentional focus was manipulated with instructions. Motor performance (movement speed), movement automaticity (fluency of movement), and dual-task performance (dual-task costs) were assessed. The effects of focus on movement speed, single- and dual-task movement fluency, and dual-task costs were analysed with generalized estimating equations. Results showed that, overall, single-task performance was unaffected by focus (p = .341). Regarding movement fluency, no main effects of focus were found in single- or dual-task conditions (p's >= .13). However, focus by leg interactions suggested that an external focus reduced movement fluency of the paretic leg compared to an internal focus (single-task conditions: p = .068; dual-task conditions: p = .084). An external focus also tended to result in inferior dual-task performance (beta = -2.38, p = .065). Finally, a near-significant interaction (beta = 2.36, p = .055) suggested that dual-task performance was more constrained by patients' attentional capacity in external focus conditions. We conclude that, compared to an internal focus, an external focus did not result in more automated movements in chronic stroke patients. Contrary to expectations, trends were found for enhanced automaticity with an internal focus. These findings might be due to patients' strong preference to use an internal focus in daily life. Future work needs to establish the more permanent effects of learning with different attentional foci on re-automating motor control after stroke.	[Kal, E. C.; Houdijk, H.; Groet, E.; van Bennekom, C. A. M.] Heliomare Rehabil Ctr, Res & Dev, Wijk Aan Zee, Netherlands; [Kal, E. C.; van der Kamp, J.; Houdijk, H.; Scherder, E. J. A.] Vrije Univ Amsterdam, Fac Behav & Human Movement Sci, Amsterdam, Netherlands; [van der Kamp, J.] Univ Hong Kong, Inst Human Performance, Hong Kong, Hong Kong, Peoples R China; [van Bennekom, C. A. M.] Univ Amsterdam, Acad Med Ctr, Coronel Inst Occupat & Environm Hlth, NL-1105 AZ Amsterdam, Netherlands	Vrije Universiteit Amsterdam; University of Hong Kong; University of Amsterdam; Academic Medical Center Amsterdam	Kal, EC (corresponding author), Heliomare Rehabil Ctr, Res & Dev, Wijk Aan Zee, Netherlands.	e.kal@heliomare.nl	Houdijk, Han/GXV-2986-2022	Houdijk, Han/0000-0002-7069-1973; van der Kamp, John/0000-0002-3826-1973; van Bennekom, coen/0000-0002-9754-261X; Kal, Elmar/0000-0002-1481-3016				ABERNETHY B, 1988, J HUM MOVEMENT STUD, V14, P101; Abernethy B, 2012, HDB SPORT PSYCHOL, P245, DOI [10.1002/9781118270011, DOI 10.1002/9781118270011.CHL]; Al-Yahya E, 2011, NEUROSCI BIOBEHAV R, V35, P715, DOI 10.1016/j.neubiorev.2010.08.008; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Beauchet O, 2009, EUR J NEUROL, V16, P786, DOI 10.1111/j.1468-1331.2009.02612.x; Beilock SL, 2001, J EXP PSYCHOL GEN, V130, P701, DOI 10.1037/0096-3445.130.4.701; Bohannon RW, 1997, AGE AGEING, V26, P15, DOI 10.1093/ageing/26.1.15; Brinckenkamp R, 2007, D2 AANDACHTS CONCENR; Cirstea AC, 2007, NEUROREHAB NEURAL RE, V21, P398, DOI 10.1177/1545968306298414; Culbertson W. C., 2005, TOL DX TOWER LONDON; D'Elia L.F., 1996, COLOR TRAILS TEST; DEMEURISSE G, 1980, EUR NEUROL, V19, P382, DOI 10.1159/000115178; Durham KF, 2014, PHYSIOTHERAPY, V100, P108, DOI 10.1016/j.physio.2013.03.004; Durham K, 2009, PHYSIOTHER RES INT, V14, P77, DOI 10.1002/pri.431; Fasoli SE, 2002, AM J OCCUP THER, V56, P380, DOI 10.5014/ajot.56.4.380; Flansbjer UB, 2005, J REHABIL MED, V37, P75, DOI 10.1080/16501970410017215; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Hogan N, 2009, J MOTOR BEHAV, V41, P529, DOI 10.3200/35-09-004-RC; HOLM S, 1979, SCAND J STAT, V6, P65; Hreljac A, 2000, GAIT POSTURE, V11, P199, DOI 10.1016/S0966-6362(00)00045-X; Huxhold O, 2006, BRAIN RES BULL, V69, P294, DOI 10.1016/j.brainresbull.2006.01.002; Hyndman D, 2004, J NEUROL NEUROSUR PS, V75, P994, DOI 10.1136/jnnp.2003.016014; Johnson L, 2013, PHYS THER, V93, P957, DOI 10.2522/ptj.20120300; Kal EC, 2013, HUM MOVEMENT SCI, V32, P527, DOI 10.1016/j.humov.2013.04.001; Kleynen M, 2013, CLIN REHABIL, V27, P160, DOI 10.1177/0269215512448381; Kok R. M., 2002, DUTCH TRANSLATION MI; Kramer J.H, 2007, DELIS KAPLAN EXECUTI; Lohse KR, 2010, HUM MOVEMENT SCI, V29, P542, DOI 10.1016/j.humov.2010.05.001; Malthotra N, 2015, PSYCHOL SPORT EXERC, V18, P1; Masters R. S. W., 2005, INT SOC SPORT PSYCHO; Maurer H, 2013, HUM MOVEMENT SCI, V32, P730, DOI 10.1016/j.humov.2013.02.001; Maxwell JP, 2003, CONSCIOUS COGN, V12, P376, DOI 10.1016/S1053-8100(03)00005-9; McCulloch Karen, 2007, J Neurol Phys Ther, V31, P104; McNevin NH, 2003, PSYCHOL RES-PSYCH FO, V67, P22, DOI 10.1007/s00426-002-0093-6; Orrell AJ, 2009, NEUROREHAB NEURAL RE, V23, P177, DOI 10.1177/1545968308317752; Plummer P, 2013, ARCH PHYS MED REHAB, V94, P2565, DOI 10.1016/j.apmr.2013.08.002; Poolton JM, 2006, J SPORT SCI, V24, P89, DOI 10.1080/02640410500130854; Schmand B., 2008, TIJDSCHR GERONTOL GE, V39, P65; Thomas JR, 2000, J EXP CHILD PSYCHOL, V75, P228, DOI 10.1006/jecp.1999.2535; UNESCO, 2006, INT STAND CLASS ED I; Vance J, 2004, J MOTOR BEHAV, V36, P450, DOI 10.3200/JMBR.36.4.450-459; Wechsler D., 2012, WAIS 4 NEDERLANDSTAL; Wechsler D, 2005, WAIS 3 NEDERLANDSTAL; Weiss SM, 2008, J SPORT SCI, V26, P1049, DOI 10.1080/02640410802098874; Wulf G, 2001, Q J EXP PSYCHOL-A, V54, P1143, DOI 10.1080/02724980143000118; Wulf G, 2013, INT REV SPORT EXER P, V6, P77, DOI 10.1080/1750984X.2012.723728; Zachry T, 2005, BRAIN RES BULL, V67, P304, DOI 10.1016/j.brainresbull.2005.06.035	47	31	33	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136917	10.1371/journal.pone.0136917	http://dx.doi.org/10.1371/journal.pone.0136917			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ0PO	26317437	Green Published, Green Submitted, gold			2022-12-26	WOS:000360299100172
J	Kim, Y; Kong, KA				Kim, Yuna; Kong, Kyoung Ae			Do Hypertensive Individuals Who Are Aware of Their Disease Follow Lifestyle Recommendations Better than Those Who Are Not Aware?	PLOS ONE			English	Article							JOINT NATIONAL COMMITTEE; POTASSIUM INTAKE; SODIUM-INTAKE; 7TH REPORT; ASSOCIATION; CONSUMPTION; PATTERNS; HEALTH; PREVALENCE; TRENDS	Lifestyle modification is the first step in hypertension management. Our objective was to assess adherence to lifestyle recommendations by individuals who were aware of their hypertension and to identify characteristics associated with non-adherence. Using data from the Korea National Health and Nutrition Examination Survey conducted in 2010-2012, we compared the adherence to six lifestyle recommendations of hypertensive subjects aware of the status of their condition with that of those who were not aware, based on survey regression analysis. The characteristics associated with non-adherence were assessed by multiple logistic regression analysis. Of all hypertensive subjects, <20% adhered to a healthy diet and reduced salt intake and about 80% moderated alcohol consumption and did not smoke. Half of all subjects maintained normal body weight and engaged in physical activity. Most lifestyle features of aware hypertensive Koreans did not differ greatly from those of hypertensive individuals who were not aware. Reduction in salt intake was slightly more prevalent among those aware of their hypertensive status. Obesity was more prevalent among the aware hypertensive subjects, and the prevalence of obesity increased with the duration of hypertension. Male gender, younger age, residence in a rural area, low income, and the use of antihypertensive medication were associated with non-adherence to lifestyle recommendations by hypertensive individuals. Many hypertensive Koreans do not comply with lifestyle recommendations for the management of hypertension. The association between the use of antihypertensive medications and non-adherence suggested an over-reliance on medication rather than a commitment to a healthy lifestyle. Our study highlights that efforts encouraging healthy lifestyles, as the first step in hypertension management, need to be increased.	[Kim, Yuna] Korea Ctr Dis Control & Prevent, Div Hlth & Nutr Survey, Cheongju, Chungcheongbuk, South Korea; [Kim, Yuna] Seoul Natl Univ, Coll Nursing, Seoul, South Korea; [Kong, Kyoung Ae] Ewha Womans Univ, Med Ctr, Clin Trial Ctr, Seoul, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Seoul National University (SNU); Ewha Womans University	Kong, KA (corresponding author), Ewha Womans Univ, Med Ctr, Clin Trial Ctr, Seoul, South Korea.	kkong@ewha.ac.kr	Kim, Yuna/GXV-6765-2022					[Anonymous], 2012, KOR HLTH STAT 2012 K; Antman EM, 2014, CIRCULATION, V129, pE660, DOI 10.1161/CIR.0000000000000051; Appel LJ, 2006, HYPERTENSION, V47, P296, DOI 10.1161/01.HYP.0000202568.01167.B6; Banegas JR, 2012, HYPERTENSION, V60, P898, DOI 10.1161/HYPERTENSIONAHA.112.193078; Baustista LE, 2010, CHRONIC DIS EPIDEMIO; Bihan H, 2010, J NUTR, V140, P823, DOI 10.3945/jn.109.118273; Brown IJ, 2009, INT J EPIDEMIOL, V38, P791, DOI 10.1093/ije/dyp139; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Cogswell ME, 2012, AM J CLIN NUTR, V96, P647, DOI 10.3945/ajcn.112.034413; Crispim SP, 2011, BRIT J NUTR, V105, P447, DOI 10.1017/S0007114510003648; Drewnowski A, 2015, NUTR J, V14, DOI 10.1186/1475-2891-14-3; Du SF, 2014, AM J CLIN NUTR, V99, P334, DOI 10.3945/ajcn.113.059121; FRA, 2012, EU LGBT SURV; Gee ME, 2012, AM J CARDIOL, V109, P570, DOI 10.1016/j.amjcard.2011.09.051; Heymann AD, 2011, ISR MED ASSOC J, V13, P553; Hu HH, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/526949; Institute for Health Metrics and Evaluation, 2019, GBD DAT, DOI DOI 10.6069/VFWJ-JF14; Kim HI, 2013, NUTR RES, V33, P789, DOI 10.1016/j.nutres.2013.07.014; Korean Ministry of Health & Welfare, 2011, NAT HLTH PEOPL 2020; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lallukka T, 2010, EUR J CLIN NUTR, V64, P324, DOI 10.1038/ejcn.2009.155; Lee HS, 2013, J HUM HYPERTENS, V27, P298, DOI 10.1038/jhh.2012.43; Lee HS, 2010, CLIN EXP HYPERTENS, V32, P166, DOI 10.3109/10641960903254497; Lee K, 2010, PUBLIC HEALTH, V124, P698, DOI 10.1016/j.puhe.2010.07.004; Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Mayen AL, 2014, AM J CLIN NUTR, V100, P1520, DOI 10.3945/ajcn.114.089029; Mercado CI, 2015, AM J CLIN NUTR, V101, P376, DOI 10.3945/ajcn.113.081604; Neutel CI, 2008, CAN J CARDIOL, V24, P199; Redmond N, 2011, HYPERTENSION, V57, P383, DOI 10.1161/HYPERTENSIONAHA.110.161950; Scheltens T, 2010, J HUM HYPERTENS, V24, P561, DOI 10.1038/jhh.2010.26; Slavin JL, 2012, ADV NUTR, V3, P506, DOI 10.3945/an.112.002154; The Korean Nutrition Society, 2010, DIET REF INT KOR 201; Tsubyama-Kasaoka N, 2013, J NUTR SCI VITAMINOL, V59, P584, DOI 10.3177/jnsv.59.584; van Mierlo LAJ, 2010, ARCH INTERN MED, V170, P1501, DOI 10.1001/archinternmed.2010.284; Weir MR, 2000, ARCH INTERN MED, V160, P481, DOI 10.1001/archinte.160.4.481	36	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136858	10.1371/journal.pone.0136858	http://dx.doi.org/10.1371/journal.pone.0136858			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317336	Green Published, gold, Green Submitted			2022-12-26	WOS:000360299100155
J	Liu, F; Yang, YN; Xie, X; Li, XM; Ma, X; Fu, ZY; Chen, BD; Huang, Y; Shan, CF; Ma, YT; Gao, XM				Liu, Fen; Yang, Yi-Ning; Xie, Xiang; Li, Xiao-Mei; Ma, Xiang; Fu, Zhen-Yan; Chen, Bang-Dang; Huang, Ying; Shan, Chun-Fang; Ma, Yi-Tong; Gao, Xiao-Ming			Prevalence of Congenital Heart Disease in Xinjiang Multi-Ethnic Region of China	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; SCIENTIFIC STATEMENT; CURRENT KNOWLEDGE; NATURAL-HISTORY; RISK-FACTORS; DEFECTS; POPULATION; ANOMALIES; COUNCIL; BIRTH	Background The prevalence and risk factors of congenital heart disease among Xinjiang, northwestern part of China is currently unknown. Methods This multiple-ethnic, community-based, cross-sectional study was conducted to estimate the prevalence and distribution of congenital heart disease (CHD) in Xinjiang, northwestern part of China. Four major ethnics, Uygur, Han, Kazak, and Hui children in this region were investigated during February 2010 and May 2012. Results A total of 14,530 children (0-18 yr) were examined. Of these children, 240 (boys, 43.8%, and girls, 56.3%) were identified with CHD, giving an overall prevalence of 16.5 parts per thousand(17.7 parts per thousand in Uygur, 6.9 parts per thousand in Han, 11.4 parts per thousand in Kazak, and 38.1 parts per thousand in Hui Chinese, respectively). Ventricular septal defect (VSD, 29.2%), atrial septal defect (ASD, 20.8%), patent ductus arteriosus (PDA, 13.7%), acleistocardia (13.7%), Bicuspid aortic valve (7.9%), pulmonary valve stenosis (5.4%), and tetralogy of fallot (TOF, 4.2%) were common cyanotic and cyanotic defects observed. Compared to non-CHD children, children with CHD had a higher percentage of history of abortion, CHD history of family, consanguinity and premature birth (all P<0.05). In CHD children, 24% of mothers caught a cold, 10% had a febrile illness and 6.7% received antibiotic treatment during the first trimester of pregnancy, that were higher than non-CHD group (all P<0.05). Conclusion The overall prevalence of CHD in four ethnic children at ages 0-18 yr in Xinjiang was 16.5 parts per thousand. VSD, ASD and TOF were the most common acyanotic and cyanotic congenital heart defects, respectively. This study also identified some modifiable risk factors that may contribute to the incidence of CHD among the 4 ethnic groups.	[Liu, Fen; Yang, Yi-Ning; Chen, Bang-Dang; Ma, Yi-Tong; Gao, Xiao-Ming] Xinjiang Med Univ, Clin Med Res Inst, Xinjiang Key Lab Cardiovasc Dis, Affiliated Hosp 1, Urumqi, Peoples R China; [Liu, Fen; Yang, Yi-Ning; Xie, Xiang; Li, Xiao-Mei; Ma, Xiang; Fu, Zhen-Yan; Chen, Bang-Dang; Huang, Ying; Shan, Chun-Fang; Ma, Yi-Tong] Xinjiang Med Univ, Dept Cardiol, Affiliated Hosp 1, Urumqi, Peoples R China; [Gao, Xiao-Ming] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia	Xinjiang Medical University; Xinjiang Medical University; Baker Heart and Diabetes Institute	Ma, YT (corresponding author), Xinjiang Med Univ, Clin Med Res Inst, Xinjiang Key Lab Cardiovasc Dis, Affiliated Hosp 1, Urumqi, Peoples R China.	myt_xj@sina.com; xiaoming.gao@bakeridi.edu.au	xie, xiang/AAG-2128-2021		Science and Technology Program of Xinjiang Uygur Autonomous Region, China [201233138]	Science and Technology Program of Xinjiang Uygur Autonomous Region, China	This work was supported financially by a grant from the Science and Technology Program of Xinjiang Uygur Autonomous Region, China (Grant No. 201233138; website: http://www.xjkjt.gov.cn/www. xjkjt.gov.cn/zxgz/kjzj/xmrcxq/index.htm). YTM received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badaruddoza, 1994, CLIN GENET, V45, P288; Bernier Pierre-Luc, 2010, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V13, P26, DOI 10.1053/j.pcsu.2010.02.005; Botto LD, 2001, EPIDEMIOLOGY, V12, P485, DOI 10.1097/00001648-200109000-00004; Contran RS, 1999, PATHOLOGIC BASIS DIS, V6th, P543; Dolk H, 2011, CIRCULATION, V123, P841, DOI 10.1161/CIRCULATIONAHA.110.958405; Dolk H, 2010, ADV EXP MED BIOL, V686, P349, DOI 10.1007/978-90-481-9485-8_20; GIBSON S, 1952, AMA AM J DIS CHILD, V83, P317, DOI 10.1001/archpedi.1952.02040070063007; Grech V, 1999, J PAEDIATR CHILD H, V35, P387, DOI 10.1046/j.1440-1754.1999.00388.x; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Hu Z, 2014, J THORAC CARDIOV SUR, V148, P596, DOI 10.1016/j.jtcvs.2013.08.067; Hussain S, 2014, J PAK MED ASSOC, V64, P175; Jenkins KJ, 2007, CIRCULATION, V115, P2995, DOI 10.1161/CIRCULATIONAHA.106.183216; Kapoor R, 2008, INDIAN PEDIATR, V45, P309; KIDD L, 1993, CIRCULATION, V87, P38; Koyak Z, 2012, CIRCULATION, V126, P1944, DOI 10.1161/CIRCULATIONAHA.112.104786; Marelli AJ, 2007, CIRCULATION, V115, P163, DOI 10.1161/CIRCULATIONAHA.106.627224; MIAO CY, 1988, J AM COLL CARDIOL, V12, P224, DOI 10.1016/0735-1097(88)90378-6; MITCHELL SC, 1971, CIRCULATION, V43, P323, DOI 10.1161/01.CIR.43.3.323; NADERI S, 1979, OBSTET GYNECOL, V53, P195; Nikyar B, 2011, IRAN J PEDIATR, V21, P307; Patel SS, 2013, PEDIATR CARDIOL, V34, P1535, DOI 10.1007/s00246-013-0775-4; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Robida A, 1997, INT J CARDIOL, V60, P19, DOI 10.1016/S0167-5273(97)00067-3; Shan J., 2010, CONGENITAL HEART DIS; Shieh JTC, 2012, AM J MED GENET A, V158A, P1236, DOI 10.1002/ajmg.a.35272; STUCKEY D, 1956, BRIT HEART J, V18, P519; van der Bom T, 2011, NAT REV CARDIOL, V8, P50, DOI 10.1038/nrcardio.2010.166; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Zhang YL, 2011, J ULTRAS MED, V30, P989, DOI 10.7863/jum.2011.30.7.989; Zhao QM, 2013, ACTA PAEDIATR, V102, P397, DOI 10.1111/apa.12170	30	22	26	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0133961	10.1371/journal.pone.0133961	http://dx.doi.org/10.1371/journal.pone.0133961			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317413	Green Published, Green Submitted, gold			2022-12-26	WOS:000360299100012
J	Nagpure, NS; Rashid, I; Pathak, AK; Singh, M; Pati, R; Singh, SP; Sarkar, UK				Nagpure, Naresh Sahebrao; Rashid, Iliyas; Pathak, Ajey Kumar; Singh, Mahender; Pati, Rameshwar; Singh, Shri Prakash; Sarkar, Uttam Kumar			FMiR: A Curated Resource of Mitochondrial DNA Information for Fish	PLOS ONE			English	Article							GENOME DATABASE; CONTROL REGION; RIBOSOMAL-RNA; PATTERNS; MICROSATELLITES; FREQUENCY; SEQUENCES; REPEATS; RICE	Mitochondrial genome sequences have been widely used for evolutionary and phylogenetic studies. Among vertebrates, fish are an important, diverse group, and their mitogenome sequences are growing rapidly in public repositories. To facilitate mitochondrial genome analysis and to explore the valuable genetic information, we developed the Fish Mitogenome Resource (FMiR) database to provide a workbench for mitogenome annotation, species identification and microsatellite marker mining. The microsatellites are also known as simple sequence repeats (SSRs) and used as molecular markers in studies on population genetics, gene duplication and marker assisted selection. Here, easy-to-use tools have been implemented for mining SSRs and for designing primers to identify species/habitat specific markers. In addition, FMiR can analyze complete or partial mitochondrial genome sequence to identify species and to deduce relational distances among sequences across species. The database presently contains curated mitochondrial genomes from 1302 fish species belonging to 297 families and 47 orders reported from saltwater and freshwater ecosystems. In addition, the database covers information on fish species such as conservation status, ecosystem, family, distribution and occurrence downloaded from the FishBase and IUCN Red List databases. Those fish information have been used to browse mitogenome information for the species belonging to a particular category. The database is scalable in terms of content and inclusion of other analytical modules.	[Nagpure, Naresh Sahebrao; Rashid, Iliyas; Singh, Mahender; Pati, Rameshwar] Natl Bur Fish Genet Resources, Div Mol Biol & Biotechnol, Lucknow 226002, Uttar Pradesh, India; [Pathak, Ajey Kumar; Singh, Shri Prakash; Sarkar, Uttam Kumar] Natl Bur Fish Genet Resources, Div Fish Taxon & Resources, Lucknow 226002, Uttar Pradesh, India	Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Fish Genetic Resources; Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Fish Genetic Resources	Singh, M (corresponding author), Natl Bur Fish Genet Resources, Div Mol Biol & Biotechnol, Lucknow 226002, Uttar Pradesh, India.	mahender@scientist.com	Rashid, Iliyas/AAW-9086-2020	Rashid, Iliyas/0000-0001-7186-8200; Scaria, Vinod/0000-0001-7644-7181; Singh, Mahender/0000-0001-5335-5460; PATI, RAMESHWAR/0000-0002-9487-2058	National Agricultural Innovation Project [30(68)/2009/Bio-informatics/NAIP/OM]	National Agricultural Innovation Project	All the funding was provided by National Agricultural Innovation Project (File No. 30(68)/2009/Bio-informatics/NAIP/O&M) for establishment of National Agricultural Bioinformatics Grid for National Agricultural Research and Education System in India. Dr. N.S. Nagpure was the Principal Investigator for the fisheries domain project. The project aimed at capacity building in fish bioinformatics and ended on 30th June, 2014. The role of the funders was only to create infrastructure and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arnason U, 2002, P NATL ACAD SCI USA, V99, P8151, DOI 10.1073/pnas.102164299; Belyi VA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001198; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bernardi G, 2014, B MAR SCI, V90, P533, DOI 10.5343/bms.2013.1036; Bernatchez L, 1992, MOL ECOL, V1, P161, DOI 10.1111/j.1365-294X.1992.tb00172.x; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Carapelli A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S2-S8; de Meo PD, 2012, NUCLEIC ACIDS RES, V40, pD1168, DOI 10.1093/nar/gkr1144; de Vasconcelos ATR, 2005, BIOINFORMATICS, V21, P2566, DOI 10.1093/bioinformatics/bti326; Froese R., 2021, FISHBASE WORLD WIDE; Gerber AS, 2001, ANNU REV GENET, V35, P539, DOI 10.1146/annurev.genet.35.102401.091106; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010; Irwin DM, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0188-x; IUCN, 2014, FISH COS STAT IUCN R; Iwasaki W, 2013, MOL BIOL EVOL, V30, P2531, DOI 10.1093/molbev/mst141; Khan HA, 2008, GENET MOL RES, V7, P1392, DOI 10.4238/vol7-4gmr514; Kogelnik AM, 1996, NUCLEIC ACIDS RES, V24, P177, DOI 10.1093/nar/24.1.177; Lee YS, 2008, NUCLEIC ACIDS RES, V36, pD938, DOI 10.1093/nar/gkm763; Miya M, 2003, MOL PHYLOGENET EVOL, V26, P121, DOI 10.1016/S1055-7903(02)00332-9; Miya M, 2000, MOL PHYLOGENET EVOL, V17, P437, DOI 10.1006/mpev.2000.0839; Nagpure NS, 2015, MITOCHONDR DNA, V26, P195, DOI 10.3109/19401736.2014.892075; Nagpure NS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-630; Nagpure NS, 2012, BIOINFORMATION, V8, P1005, DOI 10.6026/97320630081005; OBrien EA, 2009, NUCLEIC ACIDS RES, V37, pD946, DOI 10.1093/nar/gkn819; OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Rajendrakumar P, 2007, BIOINFORMATICS, V23, P1, DOI 10.1093/bioinformatics/btl547; Ramsden SD, 2003, TRENDS ECOL EVOL, V18, P607, DOI 10.1016/j.tree.2003.09.020; Rostami S, 2013, VET PARASITOL, V197, P141, DOI 10.1016/j.vetpar.2013.07.001; Rozen S, 2000, Methods Mol Biol, V132, P365; Rubino F, 2012, NUCLEIC ACIDS RES, V40, pD1150, DOI 10.1093/nar/gkr1086; Sablok G, 2013, DNA RES, V20, P127, DOI 10.1093/dnares/dss038; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Schuler GD, 1996, METHOD ENZYMOL, V266, P141; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; von der Heyden S, 2011, J EVOLUTION BIOL, V24, P2505, DOI 10.1111/j.1420-9101.2011.02382.x; Wolfsberg TG, 2001, TRENDS BIOCHEM SCI, V26, P199, DOI 10.1016/S0968-0004(00)01773-4	43	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136711	10.1371/journal.pone.0136711	http://dx.doi.org/10.1371/journal.pone.0136711			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317619	Green Published, gold, Green Submitted			2022-12-26	WOS:000360299100126
J	van Agthoven, T; Dorssers, LCJ; Lehmann, U; Kreipe, H; Looijenga, LHJ; Christgen, M				van Agthoven, Ton; Dorssers, Lambert C. J.; Lehmann, Ulrich; Kreipe, Hans; Looijenga, Leendert H. J.; Christgen, Matthias			Breast Cancer Anti-Estrogen Resistance 4 (BCAR4) Drives Proliferation of IPH-926 lobular Carcinoma Cells	PLOS ONE			English	Article							TAMOXIFEN RESISTANCE; ENDOCRINE RESISTANCE; PROGNOSTIC VALUE; DOWNSTREAM; ACTIVATION; MUTATIONS; PHENOTYPE; PATHWAYS; PROTEIN; GENES	Background Most breast cancers depend on estrogenic growth stimulation. Functional genetic screenings in in vitro cell models have identified genes, which override growth suppression induced by anti-estrogenic drugs like tamoxifen. Using that approach, we have previously identified Breast Cancer Anti-Estrogen Resistance 4 (BCAR4) as a mediator of cell proliferation and tamoxifen-resistance. Here, we show high level of expression and function of BCAR4 in human breast cancer. Methods BCAR4 mRNA expression was evaluated by (q) RT-PCR in a panel of human normal tissues, primary breast cancers and cell lines. A new antibody raised against C78-I97 of the putative BCAR4 protein and used for western blot and immunoprecipitation assays. Furthermore, siRNA-mediated gene silencing was implemented to study the function of BCAR4 and its downstream targets ERBB2/3. Results Except for placenta, all human normal tissues tested were BCAR4-negative. In primary breast cancers, BCAR4 expression was comparatively rare (10%), but associated with enhanced proliferation. Relative high BCAR4 mRNA expression was identified in IPH-926, a cell line derived from an endocrine-resistant lobular breast cancer. Moderate BCAR4 expression was evident in MDA-MB-134 and MDA-MB-453 breast cancer cells. BCAR4 protein was detected in breast cancer cells with ectopic (ZR-75-1-BCAR4) and endogenous (IPH-926, MDA-MB-453) BCAR4 mRNA expression. Knockdown of BCAR4 inhibited cell proliferation. A similar effect was observed upon knockdown of ERBB2/3 and exposure to lapatinib, implying that BCAR4 acts in an ERBB2/3-dependent manner. Conclusion BCAR4 encodes a functional protein, which drives proliferation of endocrine-resistant breast cancer cells. Lapatinib, a clinically approved EGFR/ERBB2 inhibitor, counteracts BCAR4-driven tumor cell growth, a clinical relevant observation.	[van Agthoven, Ton; Dorssers, Lambert C. J.; Looijenga, Leendert H. J.] Erasmus MC Canc Inst, Dept Pathol, Rotterdam, Netherlands; [Lehmann, Ulrich; Kreipe, Hans; Christgen, Matthias] Hannover Med Sch, Inst Pathol, Hannover, Germany	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Hannover Medical School	van Agthoven, T (corresponding author), Erasmus MC Canc Inst, Dept Pathol, Rotterdam, Netherlands.	a.vanagthoven@erasmusmc.nl	Looijenga, Leendert/B-8145-2019	Looijenga, Leendert/0000-0002-8146-1911	Hannelore-Munke-Fellowship	Hannelore-Munke-Fellowship	MC was supported by a Hannelore-Munke-Fellowship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ademuyiwa FO, 2011, BREAST CANCER RES TR, V126, P797, DOI 10.1007/s10549-010-1329-6; Angulo L, 2013, HUM REPROD, V28, P430, DOI 10.1093/humrep/des412; Bai YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079901; Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Chen G, 2013, NUCLEIC ACIDS RES, V41, pD983, DOI 10.1093/nar/gks1099; Cheung KL, 2007, BREAST, V16, P327, DOI 10.1016/j.breast.2007.03.004; Christgen M, 2008, INT J CANCER, V123, P2239, DOI 10.1002/ijc.23806; Christgen M, 2013, CANCER SCI, V104, P1726, DOI 10.1111/cas.12276; Christgen M, 2013, GENE CHROMOSOME CANC, V52, P69, DOI 10.1002/gcc.22007; Christgen M, 2012, LAB INVEST, V92, P1635, DOI 10.1038/labinvest.2012.126; Christgen M, 2009, J PATHOL, V217, P620, DOI 10.1002/path.2495; Cuzick J, 2010, LANCET ONCOL, V11, P1135, DOI 10.1016/S1470-2045(10)70257-6; Droog M, 2013, EUR J PHARMACOL, V717, P47, DOI 10.1016/j.ejphar.2012.11.071; Droufakou S, 2001, INT J CANCER, V92, P404, DOI 10.1002/ijc.1208; ENGEL LW, 1978, CANCER RES, V38, P3352; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Godinho MFE, 2012, BRIT J CANCER, V107, P947, DOI 10.1038/bjc.2012.351; Godinho MFE, 2010, BRIT J CANCER, V103, P1284, DOI 10.1038/sj.bjc.6605884; Godinho M, 2011, J CELL PHYSIOL, V226, P1741, DOI 10.1002/jcp.22503; Hayes EL, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0542-y; Hoefnagel LDC, 2012, CANCER-AM CANCER SOC, V118, P4929, DOI 10.1002/cncr.27518; Hollestelle A, 2010, BREAST CANCER RES TR, V121, P53, DOI 10.1007/s10549-009-0460-8; Krech T, 2012, CANCER LETT, V315, P153, DOI 10.1016/j.canlet.2011.09.038; Meijer D, 2006, MOL CANCER RES, V4, P379, DOI 10.1158/1541-7786.MCR-05-0156; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Riggins RB, 2007, CANCER LETT, V256, P1, DOI 10.1016/j.canlet.2007.03.016; Ross JS, 2013, CLIN CANCER RES, V19, P2668, DOI 10.1158/1078-0432.CCR-13-0295; van Agthoven T, 2012, INT J CANCER, V131, P1998, DOI 10.1002/ijc.27489; van Agthoven T, 2009, J CLIN ONCOL, V27, P542, DOI 10.1200/JCO.2008.17.1462; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Xia WL, 2002, ONCOGENE, V21, P6255, DOI 10.1038/sj.onc.1205794; Xing Z, 2014, CELL, V159, P1110, DOI 10.1016/j.cell.2014.10.013	33	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136845	10.1371/journal.pone.0136845	http://dx.doi.org/10.1371/journal.pone.0136845			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317614	Green Published, gold, Green Submitted			2022-12-26	WOS:000360299100150
J	Van Sinderen, ML; Steinberg, GR; Jorgensen, SB; Honeyman, J; Chow, JD; Herridge, KA; Winship, AL; Dimitriadis, E; Jones, MEE; Simpson, ER; Boon, WC				Van Sinderen, Michelle L.; Steinberg, Gregory R.; Jorgensen, Sebastian B.; Honeyman, Jane; Chow, Jenny D.; Herridge, Kerrie A.; Winship, Amy L.; Dimitriadis, Evdokia; Jones, Margaret E. E.; Simpson, Evan R.; Boon, Wah Chin			Effects of Estrogens on Adipokines and Glucose Homeostasis in Female Aromatase Knockout Mice	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; DEFICIENT ARKO MICE; INSULIN-RESISTANCE; ADIPOSE-TISSUE; HEPATIC GLUCONEOGENESIS; STEROID-HORMONES; IN-VIVO; METABOLISM; LEPTIN; INFLAMMATION	The maintenance of glucose homeostasis within the body is crucial for constant and precise performance of energy balance and is sustained by a number of peripheral organs. Estrogens are known to play a role in the maintenance of glucose homeostasis. Aromatase knockout (ArKO) mice are estrogen-deficient and display symptoms of dysregulated glucose metabolism. We aim to investigate the effects of estrogen ablation and exogenous estrogen administration on glucose homeostasis regulation. Six month-old female wildtype, ArKO, and 17 beta-estradiol (E2) treated ArKO mice were subjected to whole body tolerance tests, serum examination of estrogen, glucose and insulin, ex-vivo muscle glucose uptake, and insulin signaling pathway analyses. Female ArKO mice display increased body weight, gonadal (omental) adiposity, hyperinsulinemia, and liver triglycerides, which were ameliorated upon estrogen treatment. Tolerance tests revealed that estrogen-deficient ArKO mice were pyruvate intolerant hence reflecting dysregulated hepatic gluconeogenesis. Analyses of skeletal muscle, liver, and adipose tissues supported a hepatic-based glucose dysregulation, with a down-regulation of Akt phosphorylation (a key insulin signaling pathway molecule) in the ArKO liver, which was improved with E2 treatment. Concurrently, estrogen treatment lowered ArKO serum leptin and adiponectin levels and increased inflammatory adipokines such as tumour necrosis factor alpha (TNF alpha) and interleukin 6 (IL6). Furthermore, estrogen deficiency resulted in the infiltration of CD45 macrophages into gonadal adipose tissues, which cannot be reversed by E2 treatment. This study describes the effects of estrogens on glucose homeostasis in female ArKO mice and highlights a primary phenotype of hepatic glucose dysregulation and a parallel estrogen modified adipokine profile.	[Van Sinderen, Michelle L.; Chow, Jenny D.; Herridge, Kerrie A.; Winship, Amy L.; Dimitriadis, Evdokia; Jones, Margaret E. E.; Simpson, Evan R.; Boon, Wah Chin] MIMR PHI Inst Med Res, Clayton, Vic 3180, Australia; [Boon, Wah Chin] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3000, Australia; [Van Sinderen, Michelle L.; Chow, Jenny D.; Jones, Margaret E. E.; Boon, Wah Chin] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia; [Steinberg, Gregory R.; Jorgensen, Sebastian B.; Honeyman, Jane] Univ Melbourne, St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Steinberg, Gregory R.; Jorgensen, Sebastian B.; Honeyman, Jane] Univ Melbourne, Dept Med, Fitzroy, Vic 3065, Australia	Prince Henry's Institute of Medical Research; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Monash University; St. Vincent's Institute of Medical Research; University of Melbourne; University of Melbourne	Boon, WC (corresponding author), MIMR PHI Inst Med Res, Clayton, Vic 3180, Australia.	wah.chin.boon@florey.edu.au	dimitriadis, e/AAD-7601-2021	Winship, Amy/0000-0001-7848-1447; Dimitriadis, Eva/0000-0001-8698-1927; Steinberg, Gregory/0000-0001-5425-8275; dimitriadis, eva/0000-0003-1425-950X; Jones, Margaret/0000-0002-0678-3187	Australian National Health and Medical Research Council [338510, 628553, 441100]; Monash Postgraduate Scholarship; Fred P. Archer Fellowship; Victorian Government through the Operational Infrastructure Scheme	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Monash Postgraduate Scholarship; Fred P. Archer Fellowship; Victorian Government through the Operational Infrastructure Scheme	This research was supported by Australian National Health and Medical Research Council project grants ID 338510, and 628553 and program grant 441100. MLS was supported by Monash Postgraduate Scholarship; WCB was supported by a Fred P. Archer Fellowship. The authors acknowledge the support of the Victorian Government through the Operational Infrastructure Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardawi MSM, 2005, FERTIL STERIL, V83, P1708, DOI 10.1016/j.fertnstert.2004.11.077; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Chow JD, 2001, J ENDOCRINOL, V210, P323; Combs TP, 2003, DIABETES, V52, P268, DOI 10.2337/diabetes.52.2.268; Cutolo M, 1996, J CLIN ENDOCR METAB, V81, P820, DOI 10.1210/jc.81.2.820; D'Eon TM, 2005, J BIOL CHEM, V280, P35983, DOI 10.1074/jbc.M507339200; Dahlman I, 2005, J CLIN ENDOCR METAB, V90, P5834, DOI 10.1210/jc.2005-0369; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Fisher CR, 1998, P NATL ACAD SCI USA, V95, P6965, DOI 10.1073/pnas.95.12.6965; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Gabriely I, 2002, DIABETES, V51, P2951, DOI 10.2337/diabetes.51.10.2951; Gao XL, 2008, CHINESE MED J-PEKING, V121, P701, DOI 10.1097/00029330-200804020-00008; Jelenik T, 2013, ENDOCRINOLOGY, V154, P989, DOI 10.1210/en.2013-1112; Jones MEE, 2000, P NATL ACAD SCI USA, V97, P12735, DOI 10.1073/pnas.97.23.12735; Jones MEE, 2006, TRENDS ENDOCRIN MET, V17, P53, DOI 10.1016/j.tem.2006.01.004; Jones MEE, 2001, J STEROID BIOCHEM, V79, P3, DOI 10.1016/S0960-0760(01)00136-4; Jorgensen SB, 2009, AM J PHYSIOL-ENDOC M, V297, pE57, DOI 10.1152/ajpendo.90744.2008; Kim JH, 2014, ENDOCR J, V61, P1055, DOI 10.1507/endocrj.EJ14-0262; Kristensen K, 1999, BIOCHEM BIOPH RES CO, V259, P624, DOI 10.1006/bbrc.1999.0842; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Lindmark S, 2006, CLIN ENDOCRINOL, V65, P301, DOI 10.1111/j.1365-2265.2006.02593.x; Machinal F, 1999, ENDOCRINOLOGY, V140, P1567, DOI 10.1210/en.140.4.1567; Macotela Y, 2009, DIABETES, V58, P803, DOI 10.2337/db08-1054; Mauvais-Jarvis F, 2013, ENDOCR REV, V34, P309, DOI 10.1210/er.2012-1055; Misso ML, 2003, ENDOCRINOLOGY, V144, P1474, DOI 10.1210/en.2002-221123; Nordlie RC, 1999, ANNU REV NUTR, V19, P379, DOI 10.1146/annurev.nutr.19.1.379; Norris AW, 2003, J CLIN INVEST, V112, P608, DOI 10.1172/JCI200317305; Nuttall FQ, 2008, DIABETES-METAB RES, V24, P438, DOI 10.1002/dmrr.863; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Riant E, 2009, ENDOCRINOLOGY, V150, P2109, DOI 10.1210/en.2008-0971; Robertson KM, 1999, P NATL ACAD SCI USA, V96, P7986, DOI 10.1073/pnas.96.14.7986; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Samy N, 2009, DIS MARKERS, V26, P163, DOI [10.3233/DMA-2009-0627, 10.1155/2009/465203]; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Stubbins RE, 2012, DIABETES OBES METAB, V14, P58, DOI 10.1111/j.1463-1326.2011.01488.x; Tanaka M, 2001, HORM RES, V56, P98, DOI 10.1159/000048099; Tanko LB, 2006, CLIMACTERIC, V9, P169, DOI 10.1080/13697130600738765; Tibbetts TA, 1999, BIOL REPROD, V60, P1158, DOI 10.1095/biolreprod60.5.1158; Van Sinderen ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087230; Van Sinderen ML, 2009, MENOPAUSE, V16, P582, DOI 10.1097/gme.0b013e31818fb20b; Wang Q, 2014, CLIN SCI, V127, P91, DOI 10.1042/CS20130670; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Winkler G, 2002, DIABETES RES CLIN PR, V56, P93, DOI 10.1016/S0168-8227(01)00355-2; Wood GW, 1997, MOL REPROD DEV, V46, P62, DOI 10.1002/(SICI)1098-2795(199701)46:1<62::AID-MRD10>3.0.CO;2-5	45	18	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136143	10.1371/journal.pone.0136143	http://dx.doi.org/10.1371/journal.pone.0136143			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317527	Green Published, gold			2022-12-26	WOS:000360299100061
J	Shuto, Y; Asai, A; Nagao, M; Sugihara, H; Oikawa, S				Shuto, Yuki; Asai, Akira; Nagao, Mototsugu; Sugihara, Hitoshi; Oikawa, Shinichi			Repetitive Glucose Spikes Accelerate Atherosclerotic Lesion Formation in C57BL/6 Mice	PLOS ONE			English	Article							PROTEIN-KINASE-C; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; POSTPRANDIAL HYPERGLYCEMIA; DIFFERENT SUSCEPTIBILITIES; ADHESION MOLECULES; ENDOTHELIAL-CELL; VASCULAR-DISEASE; TOLERANCE; MORTALITY	Background A number of epidemiological studies demonstrated that postprandial hyperglycemia is a risk factor for cardiovascular disease in individuals with impaired glucose tolerance. Although several laboratory studies have addressed the plausible causal role of postprandial acute hyperglycemia (glucose spikes) in the development of atherosclerosis, there is little convincing evidence in vivo whether the atherosclerotic lesion formation can be accelerated solely by glucose spikes. Here, we assessed the effect of repetitive glucose spikes on atherosclerotic lesion formation in mice. Methods Female C57BL/6 mice were fed an atherogenic diet from 8 to 28 weeks of age. During the atherogenic diet feeding period, the mice orally received a glucose solution (50 mg glucose/mouse; G group) or water (Wgroup) twice daily, 6 days a week. Atherosclerotic lesion formation in the aortic sinus was quantitatively analyzed in serial cross-sections by oil red O staining. Results G group mice showed transient increases in blood glucose level (similar to 5 mmol/L above W group), and the levels returned to levels similar to those in W group mice within 60 min. No significant differences in glucose tolerance, insulin sensitivity, and plasma lipid profiles were observed after the 20-week repetitive administration between the 2 groups. G group mice showed an approximately 4-fold greater atherosclerotic lesion size in the aortic sinus than W group mice. Gene expression levels of Cd68 and Icam1 in the thoracic aorta were higher in G group mice than in W group mice. Conclusions These results indicate that glucose spikes can accelerate atherosclerotic lesion formation, with little influence on other metabolic disorders. Repetitive glucose administration in wild-type mice may serve as a simple and useful approach to better understanding the causal role of glycemic spikes in the development of atherosclerosis.	[Shuto, Yuki; Asai, Akira; Nagao, Mototsugu; Sugihara, Hitoshi; Oikawa, Shinichi] Nippon Med Sch, Grad Sch Med, Dept Endocrinol Diabet & Metab, Tokyo 113, Japan; [Asai, Akira] Tohoku Univ, Food & Hlth Sci Res Unit, Grad Sch Agr Sci, Sendai, Miyagi 980, Japan	Nippon Medical School; Tohoku University	Oikawa, S (corresponding author), Nippon Med Sch, Grad Sch Med, Dept Endocrinol Diabet & Metab, 1-1-5 Sendagi, Tokyo 113, Japan.	shinich@nms.ac.jp	Nagao, Mototsugu/D-3473-2018	Nagao, Mototsugu/0000-0001-6880-5161; Asai, Akira/0000-0003-2557-9111	Merck Co.; Sanofi; Japan Society for the Promotion of Science [C26460497]	Merck Co.(Merck & Company); Sanofi(Sanofi-Aventis); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by research grants from Merck & Co. (to YS) and Sanofi (to YS), and a Grant-in-Aid for Scientific Research (C26460497) from the Japan Society for the Promotion of Science (to AA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai A, 2013, ATHEROSCLEROSIS, V231, P421, DOI 10.1016/j.atherosclerosis.2013.10.009; Azuma K, 2006, ARTERIOSCL THROM VAS, V26, P2275, DOI 10.1161/01.ATV.0000239488.05069.03; Beckman JA, 2013, EUR HEART J, V34, P2444, DOI 10.1093/eurheartj/eht142; Borch-Johnsen K, 2001, ARCH INTERN MED, V161, P397, DOI 10.1001/archinte.161.3.397; Ceriello A, 2004, DIABETES, V53, P701, DOI 10.2337/diabetes.53.3.701; Ceriello A, 2005, DIABETES, V54, P1, DOI 10.2337/diabetes.54.1.1; Ceriello A, 2008, DIABETES, V57, P1349, DOI 10.2337/db08-0063; Chait A, 2009, J LIPID RES, V50, pS335, DOI 10.1194/jlr.R800059-JLR200; Chiasson JL, 2003, JAMA-J AM MED ASSOC, V290, P486, DOI 10.1001/jama.290.4.486; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; Gerich JE, 2003, ARCH INTERN MED, V163, P1306, DOI 10.1001/archinte.163.11.1306; Goldberg IJ, 2006, ARTERIOSCL THROM VAS, V26, P1693, DOI 10.1161/01.ATV.0000231521.76545.f6; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Kanter JE, 2007, CIRC RES, V100, P769, DOI 10.1161/01.RES.0000259589.34348.74; Kawano H, 1999, J AM COLL CARDIOL, V34, P146, DOI 10.1016/S0735-1097(99)00168-0; Mita T, 2007, BIOCHEM BIOPH RES CO, V358, P679, DOI 10.1016/j.bbrc.2007.04.118; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Nagao M, 2015, ENDOCR J, V62, P371, DOI 10.1507/endocrj.EJ14-0241; Nagao M, 2012, J DIABETES INVEST, V3, P245, DOI 10.1111/j.2040-1124.2011.00175.x; Nakagami T, 2004, DIABETOLOGIA, V47, P385, DOI 10.1007/s00125-004-1334-6; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; PAIGEN B, 1987, ATHEROSCLEROSIS, V64, P215, DOI 10.1016/0021-9150(87)90249-8; PAIGEN B, 1985, ATHEROSCLEROSIS, V57, P65, DOI 10.1016/0021-9150(85)90138-8; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; Piconi L, 2006, DIABETES-METAB RES, V22, P198, DOI 10.1002/dmrr.613; Quagliaro L, 2005, ATHEROSCLEROSIS, V183, P259, DOI 10.1016/j.atherosclerosis.2005.03.015; Quagliaro L, 2003, DIABETES, V52, P2795, DOI 10.2337/diabetes.52.11.2795; Saydah SH, 2001, DIABETES CARE, V24, P1397, DOI 10.2337/diacare.24.8.1397; Standl E, 2011, DIABETES CARE, V34, pS120, DOI 10.2337/dc11-s206; Tominaga M, 1999, DIABETES CARE, V22, P920, DOI 10.2337/diacare.22.6.920; Wu KK, 2007, ATHEROSCLEROSIS, V191, P241, DOI 10.1016/j.atherosclerosis.2006.08.030	31	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136840	10.1371/journal.pone.0136840	http://dx.doi.org/10.1371/journal.pone.0136840			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313920	Green Published, Green Submitted, gold			2022-12-26	WOS:000360144000100
J	Donoviel, MS; Hait, NC; Ramachandran, S; Maceyka, M; Takabe, K; Milstien, S; Oravecz, T; Spiegel, S				Donoviel, Michael S.; Hait, Nitai C.; Ramachandran, Subramaniam; Maceyka, Michael; Takabe, Kazuaki; Milstien, Sheldon; Oravecz, Tamas; Spiegel, Sarah			Spinster 2, a sphingosine-1-phosphate transporter, plays a critical role in inflammatory and autoimmune diseases	FASEB JOURNAL			English	Article						export; lymphopenia; innate immunity; adaptive immunity	SPHINGOSINE KINASE 1; LYMPHOCYTE EGRESS; SPNS2; BLOOD; MODEL; DRUG; MICE; TNF	Sphingosine 1-phosphate (S1P) is a pleiotropic bioactive sphingolipid metabolite that regulates numerous processes important for immune responses. S1P is made within cells and must be transported out of cells to exert its effects through activation of 5 specific cell surface GPCRs in an autocrine or paracrine fashion. Spinster 2 (Spns2) transports S1P out of cells, and its deletion in mice reduces circulating levels of S1P, alters immune cell trafficking, and induces lymphopenia. Here we examined the effects of Spns2 deletion on adaptive immune responses and in autoimmune disease models. Airway inflammation and hypersensitivity as well as delayed-type contact hypersensitivity were attenuated in Spns2(-/-) mice. Similarly, Spns2 deletion reduced dextran sodium sulfate- and oxazolone-induced colitis. Intriguingly, Spns2(-/-) mice were protected from the development of experimental autoimmune encephalopathy, a model of the autoimmune disease multiple sclerosis. Deletion of Spns2 also strongly alleviated disease development in collagen-induced arthritis. These results point to a broad role for Spns2-mediated S1P transport in the initiation and development of adaptive immune related disorders.	[Donoviel, Michael S.; Oravecz, Tamas] Lexicon Pharmaceut Inc, The Woodlands, TX USA; [Hait, Nitai C.; Ramachandran, Subramaniam; Maceyka, Michael; Takabe, Kazuaki; Milstien, Sheldon; Spiegel, Sarah] Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Takabe, Kazuaki] Virginia Commonwealth Univ, Sch Med, Dept Surg, Richmond, VA 23298 USA; [Takabe, Kazuaki] Virginia Commonwealth Univ, Sch Med, Massey Canc Ctr, Richmond, VA 23298 USA	Lexicon Pharmaceuticals; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Spiegel, S (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, POB 980614,1101 E Marshall St, Richmond, VA 23298 USA.	sspiegel@vcu.edu	Maceyka, Michael/B-9277-2008	Takabe, Kazuaki/0000-0002-6435-4241	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences [R01 GM043880]; NIH National Cancer Institute Cancer Center [P30CA016059, S10RR031535]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043880] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences; NIH National Cancer Institute Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge A. M. Digeorge-Foushee, K. Millerchip, and J. Hazelwood for their help in some of the experiments. The authors also thank the Pathology Department of Lexicon Pharmaceuticals for help in preparing slides from tissue sections. This study was supported by U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences Grant R01 GM043880. The authors thank J. Allegood for skillful sphingolipid analyses and the Virginia Commonwealth University Lipidomics Core, which is supported in part by funding from NIH National Cancer Institute Cancer Center Support Grant P30CA016059 and shared resource Grant S10RR031535.	Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Baker DA, 2010, J IMMUNOL, V185, P2570, DOI 10.4049/jimmunol.1000644; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Chen J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004688; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; DEARMAN RJ, 1994, IMMUNOLOGY, V81, P551; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Fleming KK, 2005, J NEUROIMMUNOL, V170, P71, DOI 10.1016/j.jneuroim.2005.08.020; Fukuhara S, 2012, J CLIN INVEST, V122, P1416, DOI 10.1172/JCI60746; Haberberger RV, 2009, J ALLERGY CLIN IMMUN, V124, P933, DOI 10.1016/j.jaci.2009.06.034; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Harris DP, 2011, MOL CELL BIOL, V31, P63, DOI 10.1128/MCB.00468-10; Hisano Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038941; Hisano Y, 2011, J BIOL CHEM, V286, P1758, DOI 10.1074/jbc.M110.171116; Hoglund PJ, 2011, MOL BIOL EVOL, V28, P1531, DOI 10.1093/molbev/msq350; Jacobsson JA, 2007, GENOMICS, V90, P595, DOI 10.1016/j.ygeno.2007.03.017; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Kitano M, 2006, ARTHRITIS RHEUM-US, V54, P742, DOI 10.1002/art.21668; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Mendoza A, 2012, CELL REP, V2, P1104, DOI 10.1016/j.celrep.2012.09.021; Michaud J, 2006, FEBS LETT, V580, P4607, DOI 10.1016/j.febslet.2006.07.035; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Nagahashi M, 2013, FASEB J, V27, P1001, DOI 10.1096/fj.12-219618; Nakae S, 2007, J ALLERGY CLIN IMMUN, V119, P680, DOI 10.1016/j.jaci.2006.11.701; Nijnik A, 2012, J IMMUNOL, V189, P102, DOI 10.4049/jimmunol.1200282; Nishi T, 2014, BBA-MOL CELL BIOL L, V1841, P759, DOI 10.1016/j.bbalip.2013.07.012; Osborne N, 2008, CURR BIOL, V18, P1882, DOI 10.1016/j.cub.2008.10.061; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Price MM, 2013, J ALLERGY CLIN IMMUN, V131, P501, DOI 10.1016/j.jaci.2012.07.014; Salojin KV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098151; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Snider AJ, 2009, FASEB J, V23, P143, DOI 10.1096/fj.08-118109; Takabe K, 2014, J LIPID RES, V55, P1839, DOI 10.1194/jlr.R046656; Vogel P, 2008, VET PATHOL, V45, P264, DOI 10.1354/vp.45-2-264; Vogel P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004112; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41	39	51	56	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					5018	5028		10.1096/fj.15-274936	http://dx.doi.org/10.1096/fj.15-274936			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26324848	Green Published			2022-12-26	WOS:000365523600026
J	Pandhare, J; Dash, S; Jones, B; Villalta, F; Dash, C				Pandhare, Jui; Dash, Sabyasachi; Jones, Bobby; Villalta, Fernando; Dash, Chandravanu			A Novel Role of Proline Oxidase in HIV-1 Envelope Glycoprotein-induced Neuronal Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SIGNAL-TRANSDUCTION; CHEMOKINE RECEPTOR; GENETIC-VARIATION; OXIDATIVE STRESS; CELL SURVIVAL; APOPTOSIS; P53; NEUROPATHOGENESIS; METABOLISM	Proline oxidase (POX) catalytically converts proline to pyrroline- 5-carboxylate. This catabolic conversion generates reactive oxygen species (ROS) that triggers cellular signaling cascades including autophagy and apoptosis. This study for the first time demonstrates a role of POX in HIV-1 envelope glycoprotein (gp120)-induced neuronal autophagy. HIV-1 gp120 is a neurotoxic factor and is involved in HIV-1-associated neurological disorders. However, the mechanism of gp120-mediated neurotoxicity remains unclear. Using SH-SY5Y neuroblastoma cells as a model, this study demonstrates that gp120 treatment induced POX expression and catalytic activity. Concurrently, gp120 also increased intracellular ROS levels. However, increased ROS had a minimal effect on neuronal apoptosis. Further investigation indicated that the immediate cellular response to increased ROS paralleled with induction of autophagy markers, beclin-1 and LC3-II. These data lead to the hypothesis that neuronal autophagy is activated as a cellular protective response to the toxic effects of gp120. A direct and functional role of POX in gp120-mediated neuronal autophagy was examined by inhibition and overexpression studies. Inhibition of POX activity by a competitive inhibitor "dehydroproline" decreased ROS levels concomitant with reduced neuronal autophagy. Conversely, overexpression of POX in neuronal cells increased ROS levels and activated ROS-dependent autophagy. Mechanistic studies suggest that gp120 induces POX by targeting p53. Luciferase reporter assays confirm that p53 drives POX transcription. Furthermore, data demonstrate that gp120 induces p53 via binding to the CXCR4 co-receptor. Collectively, these results demonstrate a novel role of POX as a stress response metabolic regulator in HIV-1 gp120-associated neuronal autophagy.	[Pandhare, Jui; Dash, Sabyasachi; Jones, Bobby; Villalta, Fernando; Dash, Chandravanu] Meharry Med Coll, Ctr AIDS Hlth Dispar Res, Nashville, TN 37208 USA; [Pandhare, Jui; Dash, Sabyasachi; Jones, Bobby; Villalta, Fernando; Dash, Chandravanu] Meharry Med Coll, Sch Grad Studies & Res, Nashville, TN 37208 USA; [Jones, Bobby; Villalta, Fernando] Meharry Med Coll, Dept Microbiol & Immunol, Nashville, TN 37208 USA; [Dash, Chandravanu] Meharry Med Coll, Dept Biochem & Canc, Nashville, TN 37208 USA	Meharry Medical College; Meharry Medical College; Meharry Medical College; Meharry Medical College	Pandhare, J (corresponding author), 1005 Dr DB Todd Jr,Blvd Old Hosp Bldg,Rm 5023, Nashville, TN 37208 USA.	jpandhare@mmc.edu	Dash, Sabyasachi/ABG-1337-2020; Regan, Clinton/E-6250-2012	Dash, Sabyasachi/0000-0003-3966-9396; Villalta, Fernando/0000-0002-6232-0574; Dash, Chandravanu/0000-0003-4466-8355; Pandhare, Jui/0000-0002-0356-064X	National Institutes of Health [G12MD007586]; Vanderbilt Clinical and Translational Science Award [UL1RR024975]; Center for Research Resources [U54 RR026140]; NIMHD (National Institute of Minority Health and Health Disparities); NIMHD (Meharry Translational Research Center for Research Resources) [U54 Grant MD007593]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975, U54RR026140] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007281, P30AI110527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM059994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA030896, R03DA033892, R24DA021471, R03DA037779, R00DA024558] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007586, U54MD007593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Clinical and Translational Science Award; Center for Research Resources; NIMHD (National Institute of Minority Health and Health Disparities); NIMHD (Meharry Translational Research Center for Research Resources); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	We acknowledge National Institutes of Health Grants G12MD007586 (to RCMI (Research Centers in Minority Institutions)), UL1RR024975 (a Vanderbilt Clinical and Translational Science Award), and U54 RR026140 (Center for Research Resources) and U54 Grant MD007593 NIMHD (National Institute of Minority Health and Health Disparities; Meharry Translational Research Center for Research Resources), which support the core facilities used for flow cytometry, microscopy, and other experiments.	Acquas E, 2004, NEUROTOX RES, V5, P605; ADAMS E, 1980, ANNU REV BIOCHEM, V49, P1005, DOI 10.1146/annurev.bi.49.070180.005041; Agrawal L, 2010, BRAIN RES, V1306, P116, DOI 10.1016/j.brainres.2009.09.113; Albright AV, 2003, J NEUROVIROL, V9, P222, DOI 10.1080/13550280390194073; Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI [10.1089/ars.2008.2270, 10.1089/ARS.2008.2270]; Bardi G, 2006, J NEUROVIROL, V12, P211, DOI 10.1080/13550280600848373; BRIDGER GJ, 1995, J MED CHEM, V38, P366, DOI 10.1021/jm00002a019; Castedo M, 2003, ANN NY ACAD SCI, V1010, P19, DOI 10.1196/annals.1299.004; Castedo M, 2001, J EXP MED, V194, P1097, DOI 10.1084/jem.194.8.1097; Chen G, 2012, AUTOPHAGY, V8, P1577, DOI 10.4161/auto.21376; Cherra SJ, 2008, FUTUR NEUROL, V3, P309, DOI 10.2217/14796708.3.3.309; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Clifford DB, 2000, ARCH NEUROL-CHICAGO, V57, P321, DOI 10.1001/archneur.57.3.321; Clift IC, 2014, MOL PHARMACOL, V85, P542, DOI 10.1124/mol.113.089714; Cohen SM, 1997, BRAIN RES, V761, P271, DOI 10.1016/S0006-8993(97)00352-1; DE CLERCQ E, 1994, ANTIMICROB AGENTS CH, V38, P668, DOI 10.1128/AAC.38.4.668; Donald SP, 2001, CANCER RES, V61, P1810; Espert L, 2006, J CLIN INVEST, V116, P2161, DOI 10.1172/JCI26185; Finkel T, 2012, J BIOL CHEM, V287, P4434, DOI 10.1074/jbc.R111.271999; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; FREMEAU RT, 1992, NEURON, V8, P915, DOI 10.1016/0896-6273(92)90206-S; Garden GA, 2005, BIOCHEM BIOPH RES CO, V331, P799, DOI 10.1016/j.bbrc.2005.03.185; Gogos JA, 1999, NAT GENET, V21, P434, DOI 10.1038/7777; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Hendrix CW, 2000, ANTIMICROB AGENTS CH, V44, P1667, DOI 10.1128/AAC.44.6.1667-1673.2000; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Hu SX, 2009, J NEUROVIROL, V15, P401, DOI 10.3109/13550280903296346; Ichimura Y, 2008, AUTOPHAGY, V4, P1063, DOI 10.4161/auto.6826; Jacquet H, 2005, MOL PSYCHIATR, V10, P479, DOI 10.1038/sj.mp.4001597; Jana A, 2004, J NEUROSCI, V24, P9531, DOI 10.1523/JNEUROSCI.3085-04.2004; Jayadev S, 2007, J NEUROIMMUNE PHARM, V2, P359, DOI 10.1007/s11481-007-9095-x; Joska JA, 2010, J NEUROVIROL, V16, P101, DOI 10.3109/13550281003682513; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Khan MZ, 2003, J NEUROVIROL, V9, P300, DOI 10.1080/13550280390201010; Khan MZ, 2005, MOL CELL NEUROSCI, V30, P58, DOI 10.1016/j.mcn.2005.05.007; Kimura S, 2009, METHOD ENZYMOL, V452, P1, DOI 10.1016/S0076-6879(08)03601-X; Lee Jin-A, 2012, Exp Neurobiol, V21, P1, DOI 10.5607/en.2012.21.1.1; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Li LL, 2015, CELL MOL NEUROBIOL, V35, P615, DOI 10.1007/s10571-015-0166-x; Liu H, 2002, P NATL ACAD SCI USA, V99, P16859, DOI 10.1073/pnas.232186099; Liu H, 2002, P NATL ACAD SCI USA, V99, P3717, DOI 10.1073/pnas.042700699; Liu W, 2012, AUTOPHAGY, V8, P1407, DOI 10.4161/auto.21152; Liu W, 2012, CANCER RES, V72, P3677, DOI 10.1158/0008-5472.CAN-12-0080; Louboutin JP, 2012, SCI WORLD J, P1, DOI 10.1100/2012/482575; Maxwell SA, 2000, P NATL ACAD SCI USA, V97, P13009, DOI 10.1073/pnas.230445997; McArthur JC, 2010, ANN NEUROL, V67, P699, DOI 10.1002/ana.22053; Meucci O, 1998, P NATL ACAD SCI USA, V95, P14500, DOI 10.1073/pnas.95.24.14500; Mocchetti I, 2012, NEUROTOX RES, V21, P79, DOI 10.1007/s12640-011-9279-2; Nath A, 2002, J INFECT DIS, V186, pS193, DOI 10.1086/344528; Pandhare J, 2006, J BIOL CHEM, V281, P2044, DOI 10.1074/jbc.M507867200; Pandhare J, 2009, J CELL BIOCHEM, V107, P759, DOI 10.1002/jcb.22174; Paterlini M, 2005, NAT NEUROSCI, V8, P1586, DOI 10.1038/nn1562; Perfettini JL, 2005, CELL DEATH DIFFER, V12, P916, DOI 10.1038/sj.cdd.4401584; Phang JM, 2008, AMINO ACIDS, V35, P681, DOI 10.1007/s00726-008-0063-4; Phang JM, 2008, J NUTR, V138, p2008S, DOI 10.1093/jn/138.10.2008S; Phang JM, 2010, ANNU REV NUTR, V30, P441, DOI 10.1146/annurev.nutr.012809.104638; Phang JM, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00060; PHANG JM, 1985, CURR TOP CELL REGUL, V25, P91; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Rao VR, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-13; Renick SE, 1999, J NEUROSCI, V19, P21, DOI 10.1523/JNEUROSCI.19-01-00021.1999; Scherz-Shouval R, 2010, P NATL ACAD SCI USA, V107, P18511, DOI 10.1073/pnas.1006124107; Steiner J, 2006, ANTIOXID REDOX SIGN, V8, P2089, DOI 10.1089/ars.2006.8.2089; Tanida I, 2011, ANTIOXID REDOX SIGN, V14, P2201, DOI 10.1089/ars.2010.3482; Tanida I, 2011, MICROBIOL IMMUNOL, V55, P1, DOI 10.1111/j.1348-0421.2010.00271.x; Thomas AG, 2009, J NEUROVIROL, V15, P449, DOI 10.3109/13550280903350598; Twu C, 2002, P NATL ACAD SCI USA, V99, P14386, DOI 10.1073/pnas.212327899; Valcour V, 2004, NEUROLOGY, V63, P822, DOI 10.1212/01.WNL.0000134665.58343.8D; van Spronsen M, 2010, CURR NEUROL NEUROSCI, V10, P207, DOI 10.1007/s11910-010-0104-8; Vermes I, 2000, J IMMUNOL METHODS, V243, P167, DOI 10.1016/S0022-1759(00)00233-7; Vivithanaporn P, 2010, NEUROLOGY, V75, P1150, DOI 10.1212/WNL.0b013e3181f4d5bb; Wan Zhi-Tao, 2010, Virologica Sinica, V25, P307, DOI 10.1007/s12250-010-3148-7; Wyse ATS, 2011, METAB BRAIN DIS, V26, P159, DOI 10.1007/s11011-011-9246-x; Xilouri M, 2010, CNS NEUROL DISORD-DR, V9, P701, DOI 10.2174/187152710793237421; Yang YJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013427; YEH GC, 1988, J BIOL CHEM, V263, P13083; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Zabirnyk O, 2010, CARCINOGENESIS, V31, P446, DOI 10.1093/carcin/bgp299; Zhou DJ, 2011, J INFECT DIS, V203, P1647, DOI 10.1093/infdis/jir163	79	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25439	25451		10.1074/jbc.M115.652776	http://dx.doi.org/10.1074/jbc.M115.652776			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26330555	Green Published, hybrid			2022-12-26	WOS:000362962800020
J	Ainaoui, N; Hantelys, F; Renaud-Gabardos, E; Bunel, M; Lopez, F; Pujol, F; Planes, R; Bahraoui, E; Pichereaux, C; Burlet-Schiltz, O; Parini, A; Garmy-Susini, B; Prats, AC				Ainaoui, Nadera; Hantelys, Fransky; Renaud-Gabardos, Edith; Bunel, Morgane; Lopez, Frederic; Pujol, Francoise; Planes, Remi; Bahraoui, Elmostafa; Pichereaux, Carole; Burlet-Schiltz, Odile; Parini, Angelo; Garmy-Susini, Barbara; Prats, Anne-Catherine			Promoter-Dependent Translation Controlled by p54(nrb) and hnRNPM during Myoblast Differentiation	PLOS ONE			English	Article							RIBOSOME ENTRY SITE; CAP-INDEPENDENT TRANSLATION; TRANS-ACTING FACTORS; SPLICING REGULATORY PROTEIN; TRACT-BINDING-PROTEIN; MESSENGER-RNA; MEDIATED TRANSLATION; POLYPYRIMIDINE TRACT; GENE-EXPRESSION; IN-VIVO	Fibroblast growth factor 1 (FGF1) is induced during myoblast differentiation at both transcriptional and translational levels. Here, we identify hnRNPM and p54(nrb)/NONO present in protein complexes bound to the FGF1 promoter and to the mRNA internal ribosome entry site (IRES). Knockdown or overexpression of these proteins indicate that they cooperate in activating IRES-dependent translation during myoblast differentiation, in a promoter-dependent manner. Importantly, mRNA transfection and promoter deletion experiments clearly demonstrate the impact of the FGF1 promoter on the activation of IRES-dependent translation via p54(nrb) and hnRNPM. Accordingly, knockdown of either p54 or hnRNPM also blocks endogenous FGF1 induction and myotube formation, demonstrating the physiological relevance of this mechanism and the role of these two proteins in myogenesis. Our study demonstrates the cooperative function of hnRNPM and p54(nrb) as regulators of IRES-dependent translation and indicates the involvement of a promoter-dependent mechanism.	[Ainaoui, Nadera; Hantelys, Fransky; Renaud-Gabardos, Edith; Bunel, Morgane; Pujol, Francoise; Prats, Anne-Catherine] TRADGENE, UPS EA4554, Toulouse, France; [Lopez, Frederic] UPS, INSERM, UMR CRCT U1037, Toulouse, France; [Planes, Remi; Bahraoui, Elmostafa] UPS, INSERM, UMR CRCT U1043, Toulouse, France; [Pichereaux, Carole; Burlet-Schiltz, Odile] UPS, CNRS, UMR IPBS U5282, Toulouse, France; [Parini, Angelo; Garmy-Susini, Barbara] UPS, CNRS, UMR I2MC U1048, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Prats, AC (corresponding author), TRADGENE, UPS EA4554, Toulouse, France.	Anne-Catherine.Prats@inserm.fr	Hantelys, Haingo Fransky Mitchell/AAZ-3856-2020; Prats, Anne-Catherine/E-5051-2016; Garmy-Susini, Barbara/B-9735-2014	Hantelys, Haingo Fransky Mitchell/0000-0003-3504-2916; Prats, Anne-Catherine/0000-0002-5282-3776; GARMY-SUSINI, Barbara/0000-0001-6100-2294; Pichereaux, Carole/0000-0002-7559-5358; BAHRAOUI, ELMOSTAFA/0000-0003-1852-389X; Schiltz, Odile/0000-0002-3606-2356; Renaud-Gabardos, Edith/0000-0003-4209-2559; Parini, Angelo/0000-0002-9848-8838	Association Francaise contre les Myopathies [16966]; Association pour la Recherche sur le Cancer [PJA-20131200230]; Ligue pour la Recherche Contre le Cancer; Fondation de l'Avenir [ET0-583]; Region Midi-Pyrenees [11052677]; Fonds Europeen du Developpement Regional (grant REFBIO-VEMT); Canceropole Grand Sud-Ouest; Institut National du Cancer (grant RIBOCAN) [2008-039]	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue pour la Recherche Contre le Cancer; Fondation de l'Avenir; Region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie); Fonds Europeen du Developpement Regional (grant REFBIO-VEMT); Canceropole Grand Sud-Ouest; Institut National du Cancer (grant RIBOCAN)	This work has been funded by Association Francaise contre les Myopathies (grant 16966), Association pour la Recherche sur le Cancer (grant PJA-20131200230), Ligue pour la Recherche Contre le Cancer, Canceropole Grand Sud-Ouest, Institut National du Cancer (grant RIBOCAN no. 2008-039), Fondation de l'Avenir (grant ET0-583), Region Midi-Pyrenees (grant 11052677), Fonds Europeen du Developpement Regional (grant REFBIO-VEMT). There was no commercial funder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird SD, 2007, NUCLEIC ACIDS RES, V35, P4664, DOI 10.1093/nar/gkm483; Basu A, 1997, MOL CELL BIOL, V17, P677, DOI 10.1128/MCB.17.2.677; Bonnal S, 2005, J BIOL CHEM, V280, P4144, DOI 10.1074/jbc.M411492200; Bonnal S, 2003, J BIOL CHEM, V278, P39330, DOI 10.1074/jbc.M305580200; Bouyssie D, 2007, MOL CELL PROTEOMICS, V6, P1621, DOI 10.1074/mcp.T600069-MCP200; Braunschweig U, 2013, CELL, V152, P1252, DOI 10.1016/j.cell.2013.02.034; Braunstein S, 2007, MOL CELL, V28, P501, DOI 10.1016/j.molcel.2007.10.019; Chotani MA, 1997, CELL GROWTH DIFFER, V8, P999; CHOTANI MA, 1995, NUCLEIC ACIDS RES, V23, P434, DOI 10.1093/nar/23.3.434; Cobbold LC, 2008, MOL CELL BIOL, V28, P40, DOI 10.1128/MCB.01298-07; Conte C, 2009, NUCLEIC ACIDS RES, V37, P5267, DOI 10.1093/nar/gkp550; DATAR KV, 1993, NUCLEIC ACIDS RES, V21, P439, DOI 10.1093/nar/21.3.439; Dobbyn HC, 2008, ONCOGENE, V27, P1167, DOI 10.1038/sj.onc.1210723; DONG BH, 1993, NUCLEIC ACIDS RES, V21, P4085, DOI 10.1093/nar/21.17.4085; Emili A, 2002, RNA, V8, P1102, DOI 10.1017/S1355838202025037; Evans JR, 2003, ONCOGENE, V22, P8012, DOI 10.1038/sj.onc.1206645; GARCIABLANCO MA, 1989, GENE DEV, V3, P1874, DOI 10.1101/gad.3.12a.1874; Holcik M, 2003, MOL CELL BIOL, V23, P280, DOI 10.1128/MCB.23.1.280-288.2003; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hovhannisyan RH, 2007, J BIOL CHEM, V282, P36265, DOI 10.1074/jbc.M704188200; Jain RA, 2008, DEVELOPMENT, V135, P973, DOI 10.1242/dev.015438; JANG SK, 1990, GENE DEV, V4, P1560, DOI 10.1101/gad.4.9.1560; Jo OD, 2008, J BIOL CHEM, V283, P23274, DOI 10.1074/jbc.M801185200; Kameoka S, 2004, EMBO J, V23, P1782, DOI 10.1038/sj.emboj.7600187; Kim YK, 2000, J MOL BIOL, V304, P119, DOI 10.1006/jmbi.2000.4179; Lewis SM, 2008, ONCOGENE, V27, P1033, DOI 10.1038/sj.onc.1210777; Lewis SM, 2007, MOL BIOL CELL, V18, P1302, DOI 10.1091/mbc.E06-06-0515; Lin JC, 2007, P NATL ACAD SCI USA, V104, P2235, DOI 10.1073/pnas.0611015104; Lisse TS, 2014, BONE RES, V2; Lopez F, 2003, PROTEOMICS, V3, P402, DOI 10.1002/pmic.200390055; Madiai F, 1999, J BIOL CHEM, V274, P11937, DOI 10.1074/jbc.274.17.11937; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Marko M, 2010, EXP CELL RES, V316, P390, DOI 10.1016/j.yexcr.2009.10.021; Martineau Y, 2004, MOL CELL BIOL, V24, P7622, DOI 10.1128/MCB.24.17.7622-7635.2004; Michelotti EF, 1996, MOL CELL BIOL, V16, P2350, DOI 10.1128/mcb.16.5.2350; Mitchell SA, 2003, MOL CELL, V11, P757, DOI 10.1016/S1097-2765(03)00093-5; Miura P, 2005, J BIOL CHEM, V280, P32997, DOI 10.1074/jbc.M503994200; Miura P, 2010, HUM MOL GENET, V19, P1211, DOI 10.1093/hmg/ddp591; Morfoisse F, 2014, CELL REP, V6, P155, DOI 10.1016/j.celrep.2013.12.011; MYERS RL, 1995, ONCOGENE, V11, P785; MYERS RL, 1993, ONCOGENE, V8, P341; Pandit S, 2008, CURR OPIN CELL BIOL, V20, P260, DOI 10.1016/j.ceb.2008.03.001; Payson RA, 1998, J STEROID BIOCHEM, V66, P93, DOI 10.1016/S0960-0760(98)00051-X; Pickering BM, 2003, NUCLEIC ACIDS RES, V31, P639, DOI 10.1093/nar/gkg146; Prats AC, 2013, MICROVASCULAR RES; Roy R, 2014, NUCLEIC ACIDS RES, V42, P12483, DOI 10.1093/nar/gku953; Semler BL, 2008, TRENDS MICROBIOL, V16, P1, DOI 10.1016/j.tim.2007.11.001; Shiroki K, 2002, NUCLEIC ACIDS RES, V30, P2851, DOI 10.1093/nar/gkf408; Spriggs KA, 2005, CELL DEATH DIFFER, V12, P585, DOI 10.1038/sj.cdd.4401642; Stoneley M, 2000, NUCLEIC ACIDS RES, V28, P687, DOI 10.1093/nar/28.3.687; Trcek T, 2011, CELL, V147, P1484, DOI 10.1016/j.cell.2011.11.051; Vera M, 2014, ELIFE, V3, DOI 10.7554/eLife.03164; Xodo Luigi, 2008, Nucleic Acids Symp Ser (Oxf), P159, DOI 10.1093/nass/nrn081	53	14	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136466	10.1371/journal.pone.0136466	http://dx.doi.org/10.1371/journal.pone.0136466			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332123	Green Published, gold, Green Submitted			2022-12-26	WOS:000360613800057
J	Chiang, TH; Lee, YC; Liao, WC; Chung, JH; Chiu, HM; Tu, CH; Chen, SC; Wu, MS				Chiang, Tsung-Hsien; Lee, Yi-Chia; Liao, Wan-Chung; Chung, Jui-Hung; Chiu, Han-Mo; Tu, Chia-Hung; Chen, Su-Chiu; Wu, Ming-Shiang			Timing and Risk Factors for a Positive Fecal Immunochemical Test in Subsequent Screening for Colorectal Neoplasms	PLOS ONE			English	Article							OCCULT BLOOD-TEST; ESTROGEN PLUS PROGESTIN; METABOLIC SYNDROME; ADVANCED ADENOMAS; CANCER; PERFORMANCE; PREVALENCE; SEX; HEMOGLOBIN; GUIDELINES	Background Following a negative test, the performance of fecal immunochemical testing in the subsequent screening round is rarely reported. It is crucial to allocate resources to participants who are more likely to test positive subsequently following an initial negative result. Objective To identify risk factors associated with a positive result in subsequent screening. Methods Dataset was composed of consecutive participants who voluntarily underwent fecal tests and colonoscopy in a routine medical examination at the National Taiwan University Hospital between January 2007 and December 2011. Risk factor assessment of positive fecal test in subsequent screening was performed by using the Cox proportional hazards models. Results Our cohort consisted of 3783 participants during a 5-year period. In three rounds of subsequent testing, 3783, 1537, and 624 participants underwent fecal tests, respectively; 5.7%, 5.1%, and 3.9% tested positive, respectively, and the positive predictive values were 40.2%, 20.3%, and 20.8%, respectively. Age >= 60 years (adjusted hazard ratio: 1.53, 95% CI: 1.21-1.93) and male gender (1.32, 95% CI: 1.02-1.69) were risk factors; however, an interaction between age and gender was noted. Men had higher risk than women when they were <60 years of age (p = 0.002), while this difference was no longer observed when >= 60 years of age (p = 0.74). The optimal interval of screening timing for participant with baseline negative fecal test was 2 years. Conclusions Following a negative test, older age and male gender are risk factors for a positive result in the subsequent rounds while the gender difference diminishes with age. Biennial screening is sufficient following a negative fecal test.	[Chiang, Tsung-Hsien; Lee, Yi-Chia; Chiu, Han-Mo; Tu, Chia-Hung; Wu, Ming-Shiang] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan; [Chiang, Tsung-Hsien; Tu, Chia-Hung] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Chiang, Tsung-Hsien] Natl Taiwan Univ Hosp, Dept Integrated Diagnost & Therapeut, Taipei, Taiwan; [Liao, Wan-Chung; Chung, Jui-Hung; Chen, Su-Chiu] Natl Taipei Univ Nursing & Hlth Sci, Dept Hlth Care Management, Taipei, Taiwan; [Wu, Ming-Shiang] Natl Taiwan Univ, Coll Med, Dept Primary Care Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taipei University of Nursing & Health Science (NTUNHS); National Taiwan University	Chen, SC (corresponding author), Natl Taipei Univ Nursing & Hlth Sci, Dept Hlth Care Management, Taipei, Taiwan.	suchiu@ntunhs.edu.tw; mingshiang@ntu.edu.tw	Chiu, Han-Mo/AAY-6809-2020	LEE, YI-CHIA/0000-0002-8160-1216; Chiang, Tsung-Hsien/0000-0003-1308-9756; Wu, Ming-Shiang/0000-0002-1940-6428; CHIU, HAN-MO/0000-0003-2786-8056	National Taiwan University Hospital	National Taiwan University Hospital(National Taiwan University)	This study was supported by research grants from the National Taiwan University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison JE, 2007, JNCI-J NATL CANCER I, V99, P1462, DOI 10.1093/jnci/djm150; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Botteri E, 2008, JAMA-J AM MED ASSOC, V300, P2765, DOI 10.1001/jama.2008.839; Brenner H, 2007, GUT, V56, P1585, DOI 10.1136/gut.2007.122739; Brenner H, 2010, ANN INTERN MED, V152, P697, DOI 10.7326/0003-4819-152-11-201006010-00002; Chang LC, 2014, GASTROINTEST ENDOSC, V79, P961, DOI 10.1016/j.gie.2013.11.035; Chiang TH, 2014, GASTROENTEROLOGY, V147, P1317, DOI 10.1053/j.gastro.2014.08.043; Chiang TH, 2011, CAN MED ASSOC J, V183, P1474, DOI 10.1503/cmaj.101248; Chiu HM, 2009, CLIN GASTROENTEROL H, V7, P463, DOI 10.1016/j.cgh.2008.11.026; Chiu HM, 2015, CANCER; Chlebowski RT, 2004, NEW ENGL J MED, V350, P991, DOI 10.1056/NEJMoa032071; Crotta S, 2012, CLIN GASTROENTEROL H, V10, P633, DOI 10.1016/j.cgh.2012.02.030; Denters MJ, 2012, GASTROENTEROLOGY, V142, P497, DOI 10.1053/j.gastro.2011.11.024; Faivre J, 2004, GASTROENTEROLOGY, V126, P1674, DOI 10.1053/j.gastro.2004.02.018; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ferlitsch M, 2011, JAMA-J AM MED ASSOC, V306, P1352, DOI 10.1001/jama.2011.1362; Foster PA, 2013, INT J COLORECTAL DIS, V28, P737, DOI 10.1007/s00384-012-1628-y; Hol L, 2010, GUT, V59, P62, DOI 10.1136/gut.2009.177089; Jorgensen OD, 2002, GUT, V50, P29, DOI 10.1136/gut.50.1.29; Kirkegaard H, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5504; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Lee JK, 2014, ANN INTERN MED, V160, P171, DOI 10.7326/M13-1484; Lieberman DA, 2005, CLIN GASTROENTEROL H, V3, P798, DOI 10.1016/S1542-3565(05)00405-2; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Morikawa T, 2005, GASTROENTEROLOGY, V129, P422, DOI 10.1053/j.gastro.2005.05.056; Rex DK, 2009, AM J GASTROENTEROL, V104, P739, DOI 10.1038/ajg.2009.104; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Schoenfeld P, 2005, NEW ENGL J MED, V352, P2061, DOI 10.1056/NEJMoa042990; Smith A, 2006, CANCER, V107, P2152, DOI 10.1002/cncr.22230; Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182; van Rossum LG, 2008, GASTROENTEROLOGY, V135, P82, DOI 10.1053/j.gastro.2008.03.040; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; World Endoscopy Organization, 5 FITTER WORLD END O	35	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136890	10.1371/journal.pone.0136890	http://dx.doi.org/10.1371/journal.pone.0136890			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332318	Green Published, Green Submitted, gold			2022-12-26	WOS:000360613800079
J	Kongkaew, S; Yotmanee, P; Rungrotmongkol, T; Kaiyawet, N; Meeprasert, A; Kaburaki, T; Noguchi, H; Takeuchi, F; Kungwan, N; Hannongbua, S				Kongkaew, Sirilak; Yotmanee, Pathumwadee; Rungrotmongkol, Thanyada; Kaiyawet, Nopporn; Meeprasert, Arthitaya; Kaburaki, Toshikatsu; Noguchi, Hiroshi; Takeuchi, Fujio; Kungwan, Nawee; Hannongbua, Supot			Molecular Dynamics Simulation Reveals the Selective Binding of Human Leukocyte Antigen Alleles Associated with BehCet's Disease	PLOS ONE			English	Article							HLA-B ALLELES; CLASS-I; JAPANESE PATIENTS; MICA ANTIBODIES; GENE-A; HLA-B-ASTERISK-5101; COMPLEX; POLYMORPHISM; REGION	Behcet's disease (BD), a multi-organ inflammatory disorder, is associated with the presence of the human leukocyte antigen (HLA) HLA-B*51 allele in many ethnic groups. The possible antigen involvement of the major histocompatibility complex class I chain related gene A transmembrane (MICA-TM) nonapeptide (AAAAAIFVI) has been reported in BD symptomatic patients. This peptide has also been detected in HLA-A*26:01 positive patients. To investigate the link of BD with these two specific HLA alleles, molecular dynamics (MD) simulations were applied on the MICA-TM nonapeptide binding to the two BD-associated HLA alleles in comparison with the two non-BD-associated HLA alleles (B*35:01 and A*11:01). The MD simulations were applied on the four HLA/MICA-TM peptide complexes in aqueous solution. As a result, stabilization for the incoming MICA-TM was found to be predominantly contributed from van der Waals interactions. The P2/P3 residue close to the N-terminal and the P9 residue at the C-terminal of the MICA-TM nonapeptide served as the anchor for the peptide accommodated at the binding groove of the BD associated HLAs. The MM/PBSA free energy calculation predicted a stronger binding of the HLA/peptide complexes for the BD-associated HLA alleles than for the non-BD-associated ones, with a ranked binding strength of B*51:01 > B*35:01 and A*26:01 > A*11:01. Thus, the HLAs associated with BD pathogenesis expose the binding efficiency with the MICA-TM nonapeptide tighter than the non-associated HLA alleles. In addition, the residues 70, 73, 99, 146, 147 and 159 of the two BD-associated HLAs provided the conserved interaction for the MICA-TM peptide binding.	[Kongkaew, Sirilak] Chulalongkorn Univ, Fac Sci, Program Biotechnol, Bangkok, Thailand; [Yotmanee, Pathumwadee] Ramkhamhang Univ, Dept Chem, Fac Sci, Bangkok, Thailand; [Rungrotmongkol, Thanyada; Meeprasert, Arthitaya] Chulalongkorn Univ, Dept Biochem, Fac Sci, Bangkok, Thailand; [Rungrotmongkol, Thanyada] Chulalongkorn Univ, PhD Program Bioinformat & Computat Biol, Fac Sci, Bangkok, Thailand; [Kaiyawet, Nopporn; Hannongbua, Supot] Chulalongkorn Univ, Computat Chem Unit Cell, Dept Chem, Fac Sci, Bangkok, Thailand; [Kaburaki, Toshikatsu] Univ Tokyo, Dept Ophthalmol, Tokyo 113, Japan; [Noguchi, Hiroshi] Univ Shizuoka, Sch Pharmaceut Sci, Shizuoka 4228526, Japan; [Takeuchi, Fujio] Univ Tokyo, Fac Med, Dept Internal Med, Tokyo 113, Japan; [Kungwan, Nawee] Chiang Mai Univ, Dept Chem, Fac Sci, Chiang Mai 50000, Thailand	Chulalongkorn University; Ramkhamhaeng University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; University of Tokyo; University of Shizuoka; University of Tokyo; Chiang Mai University	Hannongbua, S (corresponding author), Chulalongkorn Univ, Computat Chem Unit Cell, Dept Chem, Fac Sci, Bangkok, Thailand.	Supot.h@chula.ac.th	Kaburaki, Toshikatsu/AAH-7091-2020; Noguchi, Hiroshi/AAV-8527-2020	Kongkaew, Sirilak/0000-0002-8045-2773; kungwan, nawee/0000-0002-2960-6853	Asia Research Center fund, Chulalongkorn University; Anniversary Chulalongkorn University Fund; Faculty of Science Ramkhamhaeng University; Thailand Research Fund [IRG5780008]; Ministry of Education, Culture, Sport, Science and Technology of Japan [23406031]; JSPS Bilateral Joint Research Projects; Chulalongkorn University	Asia Research Center fund, Chulalongkorn University; Anniversary Chulalongkorn University Fund; Faculty of Science Ramkhamhaeng University; Thailand Research Fund(Thailand Research Fund (TRF)); Ministry of Education, Culture, Sport, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS Bilateral Joint Research Projects; Chulalongkorn University(Chulalongkorn University)	This work was supported by Asia Research Center fund, Chulalongkorn University. SK thanks the 100th Anniversary Chulalongkorn University Fund for Doctoral Scholarship. PY accepted the Research Grant 2014 from Faculty of Science Ramkhamhaeng University. TR thanks the Thailand Research Fund (IRG5780008). TK, HN and FT received the funding support of Grants-in-Aid for Science Research from the Ministry of Education, Culture, Sport, Science and Technology of Japan (no. 23406031) and were supported by JSPS Bilateral Joint Research Projects. NKa and AM thank the Ratchadaphiseksomphot Endowment Fund from Chulalongkorn University for Postdoctoral fellowship.	Alvarez-Marquez A, 2009, TRANSPLANTATION, V87, P94, DOI 10.1097/TP.0b013e31818bd790; Baharav E, 2012, ISR MED ASSOC J, V14, P424; BENACERR.B, 1972, SCIENCE, V175, P273, DOI 10.1126/science.175.4019.273; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Blicher T, 2005, ACTA CRYSTALLOGR D, V61, P1031, DOI 10.1107/S0907444905013090; Case D.A., 2008, AMBER10; Chambers JC, 2001, J AM COLL CARDIOL, V37, P517, DOI 10.1016/S0735-1097(00)01137-2; Chung Y M, 1990, J Formos Med Assoc, V89, P413; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Chambrun MP, 2012, AUTOIMMUN REV, V11, P687, DOI 10.1016/j.autrev.2011.11.026; de Menthon M, 2009, ARTHRIT CARE RES, V61, P1287, DOI 10.1002/art.24642; Decha P, 2008, BIOPHYS J, V95, P128, DOI 10.1529/biophysj.107.127456; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Ergun T, 2001, J AM ACAD DERMATOL, V45, P904, DOI 10.1067/mjd.2001.117728; Guillot B, 2002, J MOL LIQ, V101, P219, DOI 10.1016/S0167-7322(02)00094-6; Holland CJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00172; Hughes T, 2013, NAT GENET, V45, P319, DOI 10.1038/ng.2551; Itoh Y, 2006, TISSUE ANTIGENS, V67, P390, DOI 10.1111/j.1399-0039.2006.00586.x; Kaburaki T, 2010, CLIN EXP RHEUMATOL, V28, pS39; Kaburaki T, 2010, GRAEF ARCH CLIN EXP, V248, P709, DOI 10.1007/s00417-009-1234-z; Kaneko Fumio, 1997, Yonsei Medical Journal, V38, P444; Kang EH, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3292; Kaya TI, 2012, PATHOLOG RES INT, V2012; Kurata R, 2014, MOJ IMMUNOL, V1; Lehner T, 1999, ANN MED INTERNE, V150, P483; Link J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036779; Macdonald IK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001149; MADRIGAL JA, 1993, TISSUE ANTIGENS, V41, P72, DOI 10.1111/j.1399-0039.1993.tb01982.x; Maenaka K, 2000, J IMMUNOL, V165, P3260, DOI 10.4049/jimmunol.165.6.3260; Marshall SE, 2004, BEST PRACT RES CL RH, V18, P291, DOI 10.1016/j.berh.2004.02.008; Menssen R, 1999, J MOL BIOL, V285, P645, DOI 10.1006/jmbi.1998.2363; Mizuki N, 1999, ARTHRITIS RHEUM, V42, P1961, DOI 10.1002/1529-0131(199909)42:9<1961::AID-ANR23>3.0.CO;2-7; MIZUKI N, 1993, AM J OPHTHALMOL, V116, P406, DOI 10.1016/S0002-9394(14)71396-0; Mizuki N, 1997, P NATL ACAD SCI USA, V94, P1298, DOI 10.1073/pnas.94.4.1298; Mizuki N, 1997, TISSUE ANTIGENS, V50, P57, DOI 10.1111/j.1399-0039.1997.tb02835.x; Mizuki N, 2007, JPN J OPHTHALMOL, V51, P431, DOI 10.1007/s10384-007-0473-y; Nunthaboot N, 2010, J CHEM INF MODEL, V50, P1410, DOI 10.1021/ci100038g; OHNO S, 1982, ARCH OPHTHALMOL-CHIC, V100, P1455; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; PARHAM P, 1988, P NATL ACAD SCI USA, V85, P4005, DOI 10.1073/pnas.85.11.4005; Remmers EF, 2010, NAT GENET, V42, P698, DOI 10.1038/ng.625; Ren PY, 2002, J COMPUT CHEM, V23, P1497, DOI 10.1002/jcc.10127; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Rungrotmongkol T, 2010, J MOL GRAPH MODEL, V29, P347, DOI 10.1016/j.jmgm.2010.09.010; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saadoun D, 2010, ARTHRITIS RHEUM-US, V62, P2806, DOI 10.1002/art.27568; Suarez-Alvarez B, 2006, TRANSPL IMMUNOL, V17, P43, DOI 10.1016/j.trim.2006.09.014; Tanaka T, 1999, OCUL IMMUNOL INFLAMM, V7, P69, DOI 10.1076/ocii.7.2.69.4018; Terasaki PI, 2007, AM J TRANSPLANT, V7, P408, DOI 10.1111/j.1600-6143.2006.01644.x; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; Wallace GR, 1999, IMMUNOGENETICS, V49, P613, DOI 10.1007/s002510050656; Wang Q, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001025; Yasuoka H, 2004, ARTHRITIS RHEUM-US, V50, P3658, DOI 10.1002/art.20597	53	17	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135575	10.1371/journal.pone.0135575	http://dx.doi.org/10.1371/journal.pone.0135575			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331842	Green Published, gold, Green Submitted			2022-12-26	WOS:000360613800034
J	Luo, MY; Duan, CJ; Qiu, JP; Li, WR; Zhu, DY; Cai, WL				Luo, Mingyue; Duan, Chaijie; Qiu, Jianping; Li, Wenru; Zhu, Dongyun; Cai, Wenli			Diagnostic Value of Multidetector CT and Its Multiplanar Reformation, Volume Rendering and Virtual Bronchoscopy Postprocessing Techniques for Primary Trachea and Main Bronchus Tumors	PLOS ONE			English	Article							PICTORIAL ESSAY; ROW CT; AIRWAYS; ANGIOGRAPHY; MDCT	Purpose To evaluate the diagnostic value of multidetector CT (MDCT) and its multiplanar reformation (MPR), volume rendering (VR) and virtual bronchoscopy (VB) postprocessing techniques for primary trachea and main bronchus tumors. Methods Detection results of 31 primary trachea and main bronchus tumors with MDCT and its MPR, VR and VB postprocessing techniques, were analyzed retrospectively with regard to tumor locations, tumor morphologies, extramural invasions of tumors, longitudinal involvements of tumors, morphologies and extents of luminal stenoses, distances between main bronchus tumors and trachea carinae, and internal features of tumors. The detection results were compared with that of surgery and pathology. Results Detection results with MDCT and its MPR, VR and VB were consistent with that of surgery and pathology, included tumor locations (tracheae, n = 19; right main bronchi, n = 6; left main bronchi, n = 6), tumor morphologies (endoluminal nodes with narrow bases, n = 2; endoluminal nodes with wide bases, n = 13; both intraluminal and extraluminal masses, n = 16), extramural invasions of tumors (brokethrough only serous membrane, n = 1; 4.0 mm-56.0 mm, n = 14; no clear border with right atelectasis, n = 1), longitudinal involvements of tumors (3.0 mm, n = 1; 5.0 mm-68.0 mm, n = 29; whole right main bronchus wall and trachea carina, n = 1), morphologies of luminal stenoses (irregular, n = 26; circular, n = 3; eccentric, n = 1; conical, n = 1) and extents (mild, n = 5; moderate, n = 7; severe, n = 19),distances between main bronchus tumors and trachea carinae (16.0 mm, n = 1; invaded trachea carina, n = 1; >20.0 mm, n = 10), and internal features of tumors (fairly homogeneous densities with rather obvious enhancements, n = 26; homogeneous density with obvious enhancement, n = 1; homogeneous density without obvious enhancement, n = 1; not enough homogeneous density with obvious enhancement, n = 1; punctate calcification with obvious enhancement, n = 1; low density without obvious enhancement, n = 1). Conclusion MDCT and its MPR, VR and VB images have respective advantages and disadvantages. Their combination could complement to each other to accurately detect locations, natures (benignancy, malignancy or low malignancy), and quantities (extramural invasions, longitudinal involvements, extents of luminal stenoses, distances between main bronchus tumors and trachea carinae) of primary trachea and main bronchus tumors with crucial information for surgical treatment, are highly useful diagnostic methods for primary trachea and main bronchus tumors.	[Luo, Mingyue; Qiu, Jianping; Li, Wenru; Zhu, Dongyun] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Radiol, Guangzhou 510275, Guangdong, Peoples R China; [Duan, Chaijie] Tsinghua Univ, Grad Sch Shenzhen, Biomed Engn Res Ctr, Shenzhen 518057, Guangdong, Peoples R China; [Cai, Wenli] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Cai, Wenli] Harvard Univ, Sch Med, Boston, MA USA	Sun Yat Sen University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Luo, MY (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 6, Dept Radiol, Guangzhou 510275, Guangdong, Peoples R China.	myluo720@163.com			National Natural Science Foundation of China [81230035]; Guangdong Provincial Science and Technology Programs [2013B051000016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Science and Technology Programs	This study was supported by National Natural Science Foundation of China (81230035) [http://www.nsfc.gov.cn/]; and Guangdong Provincial Science and Technology Programs (2013B051000016) [http://pro.gdstc.gov.cn/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar T, 2015, JPN J RADIOL, V33, P51, DOI 10.1007/s11604-014-0380-3; Adali F, 2010, ANN THORAC MED, V5, P104, DOI 10.4103/1817-1737.62474; Asano F, 2010, CLIN CHEST MED, V31, P75, DOI 10.1016/j.ccm.2009.08.007; Beigelman-Aubry C, 2009, RADIOL CLIN N AM, V47, P185, DOI 10.1016/j.rcl.2009.01.001; Boiselle PM, 2002, AM J ROENTGENOL, V179, P301, DOI 10.2214/ajr.179.2.1790301; Chan MY, 2009, IEEE T VIS COMPUT GR, V15, P1283, DOI 10.1109/TVCG.2009.172; De Filippo M, 2008, RADIOL MED, V113, P945, DOI 10.1007/s11547-008-0325-y; De Wever W, 2004, EUR RESPIR J, V23, P776, DOI 10.1183/09031936.04.00099804; Du Zhen-zong, 2009, Zhonghua Zhongliu Zazhi, V31, P152, DOI 10.3760/cma.j.issn.0253-3766.2009.02.018; Espinosa LA, 2010, AM J ROENTGENOL, V194, P70, DOI 10.2214/AJR.09.2380; Ferretti GR, 2009, RADIOL CLIN N AM, V47, P227, DOI 10.1016/j.rcl.2008.11.010; Hoppe H, 2002, AM J ROENTGENOL, V178, P1195, DOI 10.2214/ajr.178.5.1781195; Javidan-Nejad C, 2010, RADIOL CLIN N AM, V48, P157, DOI 10.1016/j.rcl.2009.10.003; Kim YK, 2007, AM J ROENTGENOL, V189, P393, DOI 10.2214/AJR.07.2079; Kim YH, 2009, RADIOLOGY, V250, P767, DOI 10.1148/radiol.2502071872; Laroia AT, 2010, WORLD J RADIOL, V2, P237, DOI 10.4329/wjr.v2.i7.237; Lawler LP, 2001, RADIOGRAPHICS, V21, P1257, DOI 10.1148/radiographics.21.5.g01se021257; Lee KS, 2010, J THORAC IMAG, V25, P112, DOI 10.1097/RTI.0b013e3181d7e721; Lei ZQ, 2009, ADV THER, V26, P976, DOI 10.1007/s12325-009-0071-0; Marchesin S, 2010, IEEE T VIS COMPUT GR, V16, P560, DOI 10.1109/TVCG.2010.30; Marom EM, 2001, AM J ROENTGENOL, V176, P707, DOI 10.2214/ajr.176.3.1760707; Naidich DP, 1997, J THORAC IMAG, V12, P11, DOI 10.1097/00005382-199701000-00003; Ravenel JG, 2001, J THORAC IMAG, V16, P269, DOI 10.1097/00005382-200110000-00008; Sodhi KS, 2008, INDIAN J PEDIATR, V75, P511, DOI 10.1007/s12098-008-0080-z; Yang Yi-meng, 2012, Zhonghua Jie He He Hu Xi Za Zhi, V35, P176	25	11	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137329	10.1371/journal.pone.0137329	http://dx.doi.org/10.1371/journal.pone.0137329			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332466	Green Published, gold, Green Submitted			2022-12-26	WOS:000360613800121
J	Mansara, PP; Deshpande, RA; Vaidya, MM; Kaul-Ghanekar, R				Mansara, Prakash P.; Deshpande, Rashmi A.; Vaidya, Milind M.; Kaul-Ghanekar, Ruchika			Differential Ratios of Omega Fatty Acids (AA/EPA plus DHA) Modulate Growth, Lipid Peroxidation and Expression of Tumor Regulatory MARBPs in Breast Cancer Cell Lines MCF7 and MDA-MB-231	PLOS ONE			English	Article							FISH-OIL; EICOSAPENTAENOIC ACID; DOCOSAHEXAENOIC ACID; GENETIC-VARIATION; ARACHIDONIC-ACID; CORN-OIL; N-3; ACTIVATION; SMAR1; DIET	Omega 3 (n3) and Omega 6 (n6) polyunsaturated fatty acids (PUFAs) have been reported to exhibit opposing roles in cancer progression. Our objective was to determine whether different ratios of n6/n3 (AA/EPA+DHA) FAs could modulate the cell viability, lipid peroxidation, total cellular fatty acid composition and expression of tumor regulatory Matrix Attachment Region binding proteins (MARBPs) in breast cancer cell lines and in noncancerous, MCF10A cells. Low ratios of n6/n3 (1:2.5, 1:4, 1:5, 1:10) FA decreased the viability and growth of MDA-MB-231 and MCF7 significantly compared to the non-cancerous cells (MCF10A). Contrarily, higher n6/n3 FA (2.5:1, 4:1, 5:1, 10:1) decreased the survival of both the cancerous and non-cancerous cell types. Lower ratios of n6/n3 selectively induced LPO in the breast cancer cells whereas the higher ratios induced in both cancerous and non-cancerous cell types. Interestingly, compared to higher n6/n3 FA ratios, lower ratios increased the expression of tumor suppressor MARBP, SMAR1 and decreased the expression of tumor activator Cux/CDP in both breast cancer and non-cancerous, MCF10A cells. Low n6/n3 FAs significantly increased SMAR1 expression which resulted into activation of p21WAF1/CIP1 in MDA-MB-231 and MCF7, the increase being ratio dependent in MDA-MB-231. These results suggest that increased intake of n3 fatty acids in our diet could help both in the prevention as well as management of breast cancer.	[Mansara, Prakash P.; Deshpande, Rashmi A.; Kaul-Ghanekar, Ruchika] Bharati Vidyapeeth Univ, Interact Res Sch Hlth Affairs IRSHA, Cell & Translat Res Lab, Pune 411043, Maharashtra, India; [Vaidya, Milind M.] Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc ACTREC, Kharghar 410210, Navi Mumbai, India	Bharati Vidyapeeth Deemed University; Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital	Kaul-Ghanekar, R (corresponding author), Bharati Vidyapeeth Univ, Interact Res Sch Hlth Affairs IRSHA, Cell & Translat Res Lab, Med Coll Campus, Pune 411043, Maharashtra, India.	ruchika.kaulghanekar@gmail.com		MANSARA, PRAKASH/0000-0002-2851-448X	Department of Biotechnology, Government of India [BT/PR-11868/FNS/20/402/2009]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by Department of Biotechnology, Government of India, Grant Number: BT/PR-11868/FNS/20/402/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUELELA SH, 1989, CANCER RES, V49, P1434; Aggarwal BB, 2006, EXPERT OPIN THER TAR, V10, P87, DOI 10.1517/14728222.10.1.87; Alessandri JM, 2008, LIPIDS, V43, P19, DOI 10.1007/s11745-007-3117-6; BEGIN ME, 1986, JNCI-J NATL CANCER I, V77, P1053; BEGIN ME, 1988, J NATL CANCER I, V80, P188, DOI 10.1093/jnci/80.3.188; BEGIN ME, 1986, PROG LIPID RES, V25, P573, DOI 10.1016/0163-7827(86)90116-5; Bernard-Gallon DJ, 2002, BRIT J NUTR, V87, P281, DOI 10.1079/BJN2002522; Brown MD, 2006, BRIT J CANCER, V94, P842, DOI 10.1038/sj.bjc.6603030; Calder PC, 2005, BIOCHEM SOC T, V33, P423, DOI 10.1042/BST0330423; Cao Y, 2000, P NATL ACAD SCI USA, V97, P11280, DOI 10.1073/pnas.200367597; Chattopadhyay Samit, 2007, Subcell Biochem, V41, P213; Corsetto PA, 2012, CELL BIOCHEM BIOPHYS, V64, P45, DOI 10.1007/s12013-012-9365-y; DAS UN, 1987, FREE RADICAL BIO MED, V3, P9, DOI 10.1016/0891-5849(87)90033-5; Das UN, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-159; Datta K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042224; Deshpande R, 2013, J MOL BIOCH, V2, P26; Donaldson MS, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-19; Ewaschuk JB, 2012, LIPIDS, V47, P1019, DOI 10.1007/s11745-012-3717-7; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Finstad HS, 2000, J LIPID RES, V41, P554; Friesen RW, 2009, J NUTR, V139, P2344, DOI 10.3945/jn.109.112565; Galande S, 2002, CURR CANCER DRUG TAR, V2, P157, DOI 10.2174/1568009023333917; German JB, 2003, J NUTR, V133, p2078S, DOI 10.1093/jn/133.6.2078S; Giltay EJ, 2004, J ENDOCRINOL, V182, P399, DOI 10.1677/joe.0.1820399; Candela CG, 2011, NUTR HOSP, V26, P323, DOI [10.1590/S0212-16112011000200013, 10.3305/nh.2011.26.2.5117]; Goodstine SL, 2003, J NUTR, V133, P1409; Hardman WE, 2001, CLIN CANCER RES, V7, P2041; Harnack K, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-8; HilakiviClarke L, 1996, JNCI-J NATL CANCER I, V88, P1821, DOI 10.1093/jnci/88.24.1821; Iyer SV, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053532, 10.1371/journal.pone.0059613]; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Kacik M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112081; Kansal S, 2012, NUTR CANCER, V64, P559, DOI 10.1080/01635581.2012.675619; Kansal S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/832025; Kansal S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084627; Kaul R, 2003, INT J CANCER, V103, P606, DOI 10.1002/ijc.10881; Kaul-Ghanekar R, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-350; Kim JK, 2006, J BIOL CHEM, V281, P6760, DOI 10.1074/jbc.M511024200; Kris-Etherton PM, 2009, PROSTAG LEUKOTR ESS, V81, P99, DOI 10.1016/j.plefa.2009.05.011; Lever E, 2010, J PATHOL, V220, P114, DOI 10.1002/path.2651; Liu JJ, 2014, NUTRIENTS, V6, P5184, DOI 10.3390/nu6115184; MADHAVI N, 1994, CANCER LETT, V84, P31, DOI 10.1016/0304-3835(94)90355-7; Mahadik SP, 1996, PROSTAG LEUKOTR ESS, V55, P65, DOI 10.1016/S0952-3278(96)90147-7; Maillard V, 2002, INT J CANCER, V98, P78, DOI 10.1002/ijc.10130; Malonia SK, 2011, BBA-REV CANCER, V1815, P1, DOI 10.1016/j.bbcan.2010.08.003; MANKU MS, 1983, LIPIDS, V18, P906, DOI 10.1007/BF02534572; Manna S, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-6; Mansara Prakash, 2015, J Med Case Rep, V9, P148, DOI 10.1186/s13256-015-0619-3; Merendino N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/310186; Michl P, 2005, CANCER CELL, V7, P521, DOI 10.1016/j.ccr.2005.05.018; Nakamura MT, 2004, LIPIDS, V39, P1077, DOI 10.1007/s11745-004-1333-0; Nepveu A, 2001, GENE, V270, P1, DOI 10.1016/S0378-1119(01)00485-1; Pachikian BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023365; SAGAR PS, 1995, PROSTAG LEUKOTR ESS, V53, P287, DOI 10.1016/0952-3278(95)90129-9; Sansregret L, 2008, GENE, V412, P84, DOI 10.1016/j.gene.2008.01.017; Sarotra P, 2010, LIPIDS, V45, P785, DOI 10.1007/s11745-010-3459-3; Shin S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/568671; Signori C, 2011, CANCER RES, V71, P6091, DOI 10.1158/0008-5472.CAN-11-0977; Simopoulos AP, 2006, BIOMED PHARMACOTHER, V60, P502, DOI 10.1016/j.biopha.2006.07.080; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Simopoulos AP, 2008, ASIA PAC J CLIN NUTR, V17, P131; Singh K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000660; Sjakste N, 2004, EXP ONCOL, V26, P170; Skerrett P J, 2003, Prev Cardiol, V6, P38, DOI 10.1111/j.1520-037X.2003.00959.x; Stoll BA, 2002, BRIT J NUTR, V87, P193, DOI [10.1079/BJN2001512, 10.1079/BJNBJN2001512]; Sun H, 2008, CANCER RES, V68, P2912, DOI 10.1158/0008-5472.CAN-07-2305; Vadnais C, 2014, BIOL OPEN, V3, P937, DOI 10.1242/bio.20148193; Vessby B, 2003, CURR OPIN LIPIDOL, V14, P15, DOI 10.1097/00041433-200302000-00004; Wang J, 2001, J NEUROCHEM, V77, P804, DOI 10.1046/j.1471-4159.2001.00271.x; Wani KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107315; Wu M, 2005, INT J CANCER, V117, P340, DOI 10.1002/ijc.21238; Xia SH, 2006, P NATL ACAD SCI USA, V103, P12499, DOI 10.1073/pnas.0605394103; Zhu Q, 2004, MOL CELL BIOL, V24, P4810, DOI 10.1128/MCB.24.11.4810-4823.2004	74	35	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136542	10.1371/journal.pone.0136542	http://dx.doi.org/10.1371/journal.pone.0136542			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325577	Green Submitted, Green Published, gold			2022-12-26	WOS:000360437700048
J	Verma, RK; Gralla, J; Klinger-Gratz, PP; Schankath, A; Jung, S; Mordasini, P; Zubler, C; Arnold, M; Buehlmann, M; Lang, MF; El-Koussy, M; Hsieh, K				Verma, Rajeev Kumar; Gralla, Jan; Klinger-Gratz, Pascal Pedro; Schankath, Adrian; Jung, Simon; Mordasini, Pasquale; Zubler, Christoph; Arnold, Marcel; Buehlmann, Monika; Lang, Matthias F.; El-Koussy, Marwan; Hsieh, Kety			Infarction Distribution Pattern in Acute Stroke May Predict the Extent of Leptomeningeal Collaterals	PLOS ONE			English	Article							CT ANGIOGRAPHY; ENDOVASCULAR THERAPY; FLOW; IMPACT; HYPERINTENSITY; THROMBOLYSIS; SCORE	Objective The aim of this study was to evaluate whether the distribution pattern of early ischemic changes in the initial MRI allows a practical method for estimating leptomeningeal collateralization in acute ischemic stroke (AIS). Methods Seventy-four patients with AIS underwent MRI followed by conventional angiogram and mechanical thrombectomy. Diffusion restriction in Diffusion weighted imaging (DWI) and correlated T2-hyperintensity of the infarct were retrospectively analyzed and subdivided in accordance with Alberta Stroke Program Early CT score (ASPECTS). Patients were angiographically graded in collateralization groups according to the method of Higashida, and dichotomized in 2 groups: 29 subjects with collateralization grade 3 or 4 (well-collateralized group) and 45 subjects with grade 1 or 2 (poorly-collateralized group). Individual ASPECTS areas were compared among the groups. Results Means for overall DWI-ASPECTS were 6.34 vs. 4.51 (well vs. poorly collateralized groups respectively), and for T2-ASPECTS 9.34 vs 8.96. A significant difference between groups was found for DWI-ASPECTS (p<0.001), but not for T2-ASPECTS (p = 0.088). Regarding the individual areas, only insula, M1-M4 and M6 showed significantly fewer infarctions in the well-collateralized group (p-values <0.001 to 0.015). 89% of patients in the well-collateralized group showed 0-2 infarctions in these six areas (44.8% with 0 infarctions), while 59.9% patients of the poor-collateralized group showed 3-6 infarctions. Conclusion Patients with poor leptomeningeal collateralization show more infarcts on the initial MRI, particularly in the ASPECTS areas M1 to M4, M6 and insula. Therefore DWI abnormalities in these areas may be a surrogate marker for poor leptomeningeal collaterals and may be useful for estimation of the collateral status in routine clinical evaluation.	[Verma, Rajeev Kumar; Gralla, Jan; Klinger-Gratz, Pascal Pedro; Schankath, Adrian; Mordasini, Pasquale; Zubler, Christoph; Lang, Matthias F.; El-Koussy, Marwan; Hsieh, Kety] Univ Bern, Inselspital, Univ Inst Diagnost & Intervent Neuroradiol, CH-3010 Bern, Switzerland; [Verma, Rajeev Kumar] Spital Netz Bern, Tiefenau Hosp, Inst Radiol, Bern, Switzerland; [Jung, Simon; Arnold, Marcel; Buehlmann, Monika] Univ Bern, Inselspital, Dept Neurol, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Verma, RK (corresponding author), Univ Bern, Inselspital, Univ Inst Diagnost & Intervent Neuroradiol, CH-3010 Bern, Switzerland.	verma@gmx.ch	Mordasini, Pasquale/H-8321-2015					Bang OY, 2008, J NEUROL NEUROSUR PS, V79, P625, DOI 10.1136/jnnp.2007.132100; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Cho AH, 2008, STROKE, V39, P3424, DOI 10.1161/STROKEAHA.108.516740; Christoforidis GA, 2005, AM J NEURORADIOL, V26, P1789; Frolich AMJ, 2014, EUR RADIOL, V24, P390, DOI 10.1007/s00330-013-3024-6; Galimanis A, 2012, STROKE, V43, P1052, DOI 10.1161/STROKEAHA.111.639112; Higashida RT, 2003, STROKE, V34, pE109, DOI 10.1161/01.STR.0000082721.62796.09; Jung S, 2013, BRAIN, V136, P3554, DOI 10.1093/brain/awt246; Kim SJ, 2014, ANN NEUROL, V76, P356, DOI 10.1002/ana.24211; Kufner A, 2013, EUR J NEUROL, V20, P281, DOI 10.1111/j.1468-1331.2012.03841.x; Liebeskind DS, 2014, STROKE, V45, P2036, DOI 10.1161/STROKEAHA.114.004781; Liebeskind DS, 2014, STROKE, V45, P759, DOI 10.1161/STROKEAHA.113.004072; Liebeskind DS, 2003, STROKE, V34, P2279, DOI 10.1161/01.STR.0000086465.41263.06; Lima FO, 2010, STROKE, V41, P2316, DOI 10.1161/STROKEAHA.110.592303; Malik N, 2014, J STROKE CEREBROVASC, V23, P2018, DOI 10.1016/j.jstrokecerebrovasdis.2014.02.018; Marks MP, 2014, STROKE, V45, P1035, DOI 10.1161/STROKEAHA.113.004085; Menon BK, 2013, J CEREBR BLOOD F MET, V33, P365, DOI 10.1038/jcbfm.2012.171; Nicoli F, 2014, NEURORADIOLOGY, V56, P117, DOI 10.1007/s00234-013-1310-2; Pexman JHW, 2001, AM J NEURORADIOL, V22, P1534; Qureshi Adnan I, 2008, J Vasc Interv Neurol, V1, P70; Ramaiah SS, 2014, J STROKE CEREBROVASC, V23, P399, DOI 10.1016/j.jstrokecerebrovasdis.2013.03.012; Shin NY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107379; Souza LCS, 2012, AM J NEURORADIOL, V33, P1331, DOI 10.3174/ajnr.A2985; Verma RK, 2014, EUR J RADIOL, V83, P1448, DOI 10.1016/j.ejrad.2014.05.001; Yeo LLL, 2015, AM J NEURORADIOL, V36, P289, DOI 10.3174/ajnr.A4117	25	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137292	10.1371/journal.pone.0137292	http://dx.doi.org/10.1371/journal.pone.0137292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327519	Green Published, Green Submitted, gold			2022-12-26	WOS:000360437700108
J	Bozic, M; Alvarez, A; de Pablo, C; Sanchez-Nino, MD; Ortiz, A; Dolcet, X; Encinas, M; Fernandez, E; Valdivielso, JM				Bozic, Milica; Alvarez, Angeles; de Pablo, Carmen; Sanchez-Nino, Maria-Dolores; Ortiz, Alberto; Dolcet, Xavier; Encinas, Mario; Fernandez, Elvira; Manuel Valdivielso, Jose			Impaired Vitamin D Signaling in Endothelial Cell Leads to an Enhanced Leukocyte-Endothelium Interplay: Implications for Atherosclerosis Development	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; D-RECEPTOR ACTIVATION; 3RD NATIONAL-HEALTH; KAPPA-B ACTIVITY; 1,25-DIHYDROXYVITAMIN D-3; DOWN-REGULATION; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; ADHESION MOLECULES; NITRIC-OXIDE; INTERLEUKIN-6	Endothelial cell activation leading to leukocyte recruitment and adhesion plays an essential role in the initiation and progression of atherosclerosis. Vitamin D has cardioprotective actions, while its deficiency is a risk factor for the progression of cardiovascular damage. Our aim was to assess the role of basal levels of vitamin D receptor (VDR) on the early leukocyte recruitment and related endothelial cell-adhesion-molecule expression, as essential prerequisites for the onset of atherosclerosis. Knockdown of VDR in endothelial cells (shVDR) led to endothelial cell activation, characterized by upregulation of VCAM-1, ICAM-1 and IL-6, decreased peripheral blood mononuclear cell (PBMC) rolling velocity and increased PBMC rolling flux and adhesion to the endothelium. shVDR cells showed decreased I kappa B alpha levels and accumulation of p65 in the nucleus compared to shRNA controls. Inhibition of NF-kappa B activation with super-repressor I kappa B alpha blunted all signs of endothelial cell activation caused by downregulation of VDR in endothelial cells. In vivo, deletion of VDR led to significantly larger aortic arch and aortic root lesions in apoE(-/-) mice, with higher macrophage content. apoE(-/-) VDR-/- mice showed higher aortic expression of VCAM-1, ICAM-1 and IL-6 when compared to apoE(-/-) VDR+/+ mice. Our data demonstrate that lack of VDR signaling in endothelial cells leads to a state of endothelial activation with increased leukocyte-endothelial cell interactions that may contribute to the more severe plaque accumulation observed in apoE(-/-) VDR-/- mice. The results reveal an important role for basal levels of endothelial VDR in limiting endothelial cell inflammation and atherosclerosis.	[Bozic, Milica; Fernandez, Elvira; Manuel Valdivielso, Jose] IRB Lleida, Nephrol Res Dept, Lleida, Spain; [Alvarez, Angeles; de Pablo, Carmen] Univ Valencia, Dept Pharmacol, Valencia, Spain; [Alvarez, Angeles; de Pablo, Carmen] Univ Valencia, CIBERehd, Valencia, Spain; [Sanchez-Nino, Maria-Dolores; Ortiz, Alberto] UAM, Sch Med, IIS Fdn Jimenez Diaz, Madrid, Spain; [Sanchez-Nino, Maria-Dolores; Ortiz, Alberto] IRSIN, Madrid, Spain; [Dolcet, Xavier] Univ Lleida, Hosp Univ Arnau Vilanova, Pathol & Mol Genet Dept, Pathol Grp, Lleida, Spain; [Dolcet, Xavier; Encinas, Mario] IRB Lleida, Lleida, Spain; [Encinas, Mario] Univ Lleida, Dept Expt Med, Lleida, Spain	Institut de Recerca Biomedica - IRB Lleida; University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Valencia; Autonomous University of Madrid; Fundacion Jimenez Diaz; Universitat de Lleida; University Hospital Arnau de Vilanova; Universitat de Lleida	Valdivielso, JM (corresponding author), IRB Lleida, Nephrol Res Dept, Lleida, Spain.	valdivielso@medicina.udl.cat	Giráldez, Elvira Dolores Fernández/D-3358-2009; Sanchez-Niño, Maria Dolores/B-7350-2019; Valdivielso, Jose M/B-5673-2009; Dolcet, Xavi/B-5665-2009; ortiz, alberto/Y-7582-2018; Alvarez, Angeles/ABF-4589-2020; Encinas, Mario/B-5600-2009; Bozic, Milica/B-7425-2009	Giráldez, Elvira Dolores Fernández/0000-0001-5236-1762; Sanchez-Niño, Maria Dolores/0000-0001-7110-6409; Valdivielso, Jose M/0000-0003-1343-0184; Dolcet, Xavi/0000-0003-1921-0449; ortiz, alberto/0000-0002-9805-9523; Encinas, Mario/0000-0003-3509-7431; Bozic, Milica/0000-0002-6064-1446; Alvarez, Angeles/0000-0002-2301-9746	Fondo de Investigaciones Sanitarias [PS12/01770, FIS PI13/00047]; ISCIII-RETIC [REDinREN RD12/0021]; Comunidad de Madrid [S2010/BMD-2378]; CYTED IBERERC; Programa Intensificacion Actividad Investigadora (ISCIII); MSDN by Sara Borrell; REDinREN [RD12/0021/0026]	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); ISCIII-RETIC(Instituto de Salud Carlos III); Comunidad de Madrid(Comunidad de Madrid); CYTED IBERERC; Programa Intensificacion Actividad Investigadora (ISCIII); MSDN by Sara Borrell; REDinREN	This work was supported by Fondo de Investigaciones Sanitarias (http://www.isciii.es/) grants PS12/01770, FIS PI13/00047, ISCIII-RETIC REDinREN RD12/0021, Comunidad de Madrid S2010/BMD-2378, and CYTED IBERERC. AO was supported by Programa Intensificacion Actividad Investigadora (ISCIII) and MSDN by Sara Borrell. MB was supported by the REDinREN (RD12/0021/0026).	Beer TM, 2004, MOL CANCER THER, V3, P373; Bergada L, 2014, LAB INVEST, V94, P608, DOI 10.1038/labinvest.2014.57; Bikle DD, 2010, TRENDS ENDOCRIN MET, V21, P375, DOI 10.1016/j.tem.2010.01.003; Blankenberg S, 2003, ATHEROSCLEROSIS, V170, P191, DOI 10.1016/S0021-9150(03)00097-2; Bouis Diane, 2001, Angiogenesis, V4, P91, DOI 10.1023/A:1012259529167; Bozic M, 2011, J AM SOC NEPHROL, V22, P1099, DOI 10.1681/ASN.2010070701; Brewer LC, 2011, CURR DRUG TARGETS, V12, P54; Brown AJ, 1999, AM J PHYSIOL-RENAL, V277, pF157, DOI 10.1152/ajprenal.1999.277.2.F157; Cardus A, 2006, KIDNEY INT, V69, P1377, DOI 10.1038/sj.ki.5000304; Cardus A, 2007, J BONE MINER RES, V22, P860, DOI 10.1359/JBMR.070305; Cardus A, 2009, ATHEROSCLEROSIS, V204, P85, DOI 10.1016/j.atherosclerosis.2008.08.020; Chen SC, 2011, CIRCULATION, V124, P1838, DOI 10.1161/CIRCULATIONAHA.111.032680; D'Ambrosio D, 1998, J CLIN INVEST, V101, P252, DOI 10.1172/JCI1050; Danzaki K, 2012, ARTERIOSCL THROM VAS, V32, P273, DOI 10.1161/ATVBAHA.111.229997; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; De Pablo C, 2013, J INFECT DIS, V208, P1448, DOI 10.1093/infdis/jit340; De Pablo C, 2012, ANTIVIR THER, V17, P1615, DOI 10.3851/IMP2357; De Pablo C, 2010, AIDS, V24, P1259, DOI 10.1097/QAD.0b013e32833a2b02; de Winther MPJ, 2005, ARTERIOSCL THROM VAS, V25, P904, DOI 10.1161/01.ATV.0000160340.72641.87; Dong XY, 2003, J BIOL CHEM, V278, P49378, DOI 10.1074/jbc.M308448200; Dusso AS, 2005, AM J PHYSIOL-RENAL, V289, pF8, DOI 10.1152/ajprenal.00336.2004; EMEIS JJ, 1988, BLOOD, V71, P1669; ETTINGER WH, 1995, J GERONTOL A-BIOL, V50, pM137, DOI 10.1093/gerona/50A.3.M137; Flammer AJ, 2012, CIRCULATION, V126, P753, DOI 10.1161/CIRCULATIONAHA.112.093245; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Forman JP, 2007, HYPERTENSION, V49, P1063, DOI 10.1161/HYPERTENSIONAHA.107.087288; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Gareus R, 2008, CELL METAB, V8, P372, DOI 10.1016/j.cmet.2008.08.016; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Gonzalez-Navarro H, 2010, J AM COLL CARDIOL, V55, P2258, DOI 10.1016/j.jacc.2010.01.026; Gurlek A, 2002, ENDOCR REV, V23, P763, DOI 10.1210/er.2001-0044; Gutierrez H, 2005, DEVELOPMENT, V132, P1713, DOI 10.1242/dev.01702; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; Huber SA, 1999, ARTERIOSCL THROM VAS, V19, P2364, DOI 10.1161/01.ATV.19.10.2364; Kallay E, 2001, CARCINOGENESIS, V22, P1429, DOI 10.1093/carcin/22.9.1429; Kassi E, 2013, CIRCULATION, V128, P2517, DOI 10.1161/CIRCULATIONAHA.113.002654; Krieglstein CF, 2001, AM J HYPERTENS, V14, p44S, DOI 10.1016/S0895-7061(01)02069-6; Lu XH, 2004, J CELL BIOCHEM, V92, P833, DOI 10.1002/jcb.20143; LUSCINSKAS FW, 1994, J CELL BIOL, V125, P1417, DOI 10.1083/jcb.125.6.1417; Martinez-Miguel P, 2014, AM J PHYSIOL-ENDOC M, V307, pE1085, DOI 10.1152/ajpendo.00156.2014; Martins D, 2007, ARCH INTERN MED, V167, P1159, DOI 10.1001/archinte.167.11.1159; McIntyre TM, 2003, CURR OPIN HEMATOL, V10, P150, DOI 10.1097/00062752-200303000-00009; MERKE J, 1989, J CLIN INVEST, V83, P1903, DOI 10.1172/JCI114097; MERKE J, 1987, CALCIFIED TISSUE INT, V41, P112, DOI 10.1007/BF02555253; Mestas J, 2008, TRENDS CARDIOVAS MED, V18, P228, DOI 10.1016/j.tcm.2008.11.004; Molinari C, 2011, CELL PHYSIOL BIOCHEM, V27, P661, DOI 10.1159/000330075; Moynagh Paul N, 2005, J Cell Sci, V118, P4589, DOI 10.1242/jcs.02579; Narvaez CJ, 2009, ENDOCRINOLOGY, V150, P651, DOI 10.1210/en.2008-1118; Ni W, 2014, HYPERTENSION, V64, DOI 10.1161/HYPERTENSIONAHA.114.03971; Pallares J, 2009, ANAL QUANT CYTOL, V31, P217; Panizo S, 2013, NEPHROL DIAL TRANSPL, V28, P2735, DOI 10.1093/ndt/gft268; Porsti IH, 2008, KIDNEY INT, V74, P1371, DOI 10.1038/ki.2008.424; Roff M, 1996, J BIOL CHEM, V271, P7844, DOI 10.1074/jbc.271.13.7844; Sanchez-Nino MD, 2012, AM J PHYSIOL-RENAL, V302, pF647, DOI 10.1152/ajprenal.00090.2011; Schieffer B, 2004, CIRCULATION, V110, P3493, DOI 10.1161/01.CIR.0000148135.08582.97; Schmidt N, 2014, J NUTR, V144, P638, DOI 10.3945/jn.113.189118; Schmidt N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035316; Schuett H, 2009, THROMB HAEMOSTASIS, V102, P215, DOI 10.1160/TH09-05-0297; Scragg R, 2007, AM J HYPERTENS, V20, P713, DOI 10.1016/j.amjhyper.2007.01.017; Somjen D, 2005, CIRCULATION, V111, P1666, DOI 10.1161/01.CIR.0000160353.27927.70; Sun J, 2006, AM J PHYSIOL-ENDOC M, V291, pE315, DOI 10.1152/ajpendo.00590.2005; Szeto FL, 2012, MOL ENDOCRINOL, V26, P1091, DOI 10.1210/me.2011-1329; Thomas MC, 2010, CIRC RES, V107, P888, DOI 10.1161/CIRCRESAHA.110.219279; Valcheva P, 2014, ATHEROSCLEROSIS, V235, P247, DOI 10.1016/j.atherosclerosis.2014.05.911; Valdivielso JM, 2009, EXPERT OPIN THER TAR, V13, P29, DOI [10.1517/14728220802564390, 10.1517/14728220802564390 ]; van Etten E, 2005, J STEROID BIOCHEM, V97, P93, DOI 10.1016/j.jsbmb.2005.06.002; Vanhoutte PM, 1997, EUR HEART J, V18, pE19, DOI 10.1016/S0195-668X(97)90005-1; VELDHUIS GJ, 1995, J CLIN ONCOL, V13, P2585, DOI 10.1200/JCO.1995.13.10.2585; Verhave G, 2010, NETH J MED, V68, P113; Watson C, 1996, CLIN EXP IMMUNOL, V105, P112, DOI 10.1046/j.1365-2249.1996.d01-717.x; Weber K, 2013, J ANIM PHYSIOL AN N, V97, P675, DOI 10.1111/j.1439-0396.2012.01308.x; Weng S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054625; Wong KE, 2011, J BIOL CHEM, V286, P33804, DOI 10.1074/jbc.M111.257568; Wong KE, 2009, AM J PHYSIOL-ENDOC M, V296, pE820, DOI 10.1152/ajpendo.90763.2008; Wu SP, 2010, AM J PATHOL, V177, P686, DOI 10.2353/ajpath.2010.090998; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391; YU XP, 1995, P NATL ACAD SCI USA, V92, P10990, DOI 10.1073/pnas.92.24.10990; Zittermann A, 2003, J AM COLL CARDIOL, V41, P105, DOI 10.1016/S0735-1097(02)02624-4	78	36	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136863	10.1371/journal.pone.0136863	http://dx.doi.org/10.1371/journal.pone.0136863			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322890	Green Published, gold, Green Submitted			2022-12-26	WOS:000360435500044
J	Chen, CM; Yang, JM; Lai, JY; Li, H; Yuan, JJ; Abbasi, NU				Chen, Changming; Yang, Jiemin; Lai, Jiayu; Li, Hong; Yuan, Jiajin; Abbasi, Najam ul Hasan			Correlating Gray Matter Volume with Individual Difference in the Flanker Interference Effect	PLOS ONE			English	Article							EVENT-RELATED FMRI; GO/NO-GO TASKS; RESPONSE-INHIBITION; ATTENTIONAL CONTROL; ANTERIOR CINGULATE; UNIQUE COMPONENTS; COGNITIVE CONTROL; BRAIN; CONFLICT; ACTIVATION	The Eriksen Flanker task has been widely used as a measurement of cognitive control, however till now information is still scarce about how the neuroanatomical properties are related to performance in this task. Using voxel-based morphometry technique (VBM), the current study identified a set of distributed areas where the gray matter volume (GM) correlated positively with participants' efficiency in interference inhibition. These areas included the bilateral prefrontal gyri, left insula and inferior temporal gyrus, the left inferior parietal lobule. Further analysis using a novel machine learning algorithm with balanced cross-validation procedure confirmed that in these areas the GM-behavioral association was unlikely a byproduct of outlier values, instead, the gray matter volume could predict reliably participants' interference inhibition efficiency. These results underscore the importance of the fronto-parietal and insula systems to the brain functioning of interference inhibition from the neuroanatomical perspective.	[Chen, Changming; Yang, Jiemin; Li, Hong; Yuan, Jiajin] Southwest Univ, Sch Psychol, Chongqing, Peoples R China; [Chen, Changming; Yang, Jiemin; Yuan, Jiajin] Minist Educ, Key Lab Cognit & Personal SWU, Chongqing, Peoples R China; [Lai, Jiayu] Hope Primary Sch, Chongqing, Peoples R China; [Li, Hong] Shenzhen Univ, Res Ctr Brain Funct & Psychol Sci, Shenzhen, Guangdong, Peoples R China; [Abbasi, Najam ul Hasan] Nanchang Normal Univ, Dept Educ, Nanchang, Jiangxi, Peoples R China; [Abbasi, Najam ul Hasan] Univ Sindh, Dept Psychol, Jamshoro, Sindh, Pakistan	Southwest University - China; Shenzhen University; Nanchang Normal University; University of Sindh	Li, H (corresponding author), Southwest Univ, Sch Psychol, Chongqing, Peoples R China.	lihongwrm@vip.sina.com; yuanjiaj@swu.edu.cn	Abbasi, Najam ul Hasan/D-3165-2018	Abbasi, Najam ul Hasan/0000-0002-3795-230X; Yuan, Jiajin/0000-0002-5630-2230	National Natural Science Foundation of China [NSFC31170989, 31371042, 31271088, 81171289]; Natural Science Foundation of Chongqing [cstc2012jjA40063]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Chongqing(Natural Science Foundation of Chongqing)	This research was funded by the National Natural Science Foundation of China (NSFC31170989,31371042,31271088,81171289), and the Natural Science Foundation of Chongqing (cstc2012jjA40063).	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bellgrove MA, 2004, NEUROPSYCHOLOGIA, V42, P1910, DOI 10.1016/j.neuropsychologia.2004.05.007; Blasi G, 2006, EUR J NEUROSCI, V23, P1658, DOI 10.1111/j.1460-9568.2006.04680.x; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Brett M, 2002, NEUROIMAGE, V16, pS497, DOI DOI 10.1016/S1053-8119(02)90010-8; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; Casey BJ, 2000, P NATL ACAD SCI USA, V97, P8728, DOI 10.1073/pnas.97.15.8728; Cieslik EC, 2015, NEUROSCI BIOBEHAV R, V48, P22, DOI 10.1016/j.neubiorev.2014.11.003; Cohen JR, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00047; Colcombe SJ, 2005, PSYCHOL AGING, V20, P363, DOI 10.1037/0882-7974.20.3.363; Cole MW, 2013, NAT NEUROSCI, V16, P1348, DOI 10.1038/nn.3470; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Coull JT, 1998, J NEUROSCI, V18, P7426; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craig AD, 2010, BRAIN STRUCT FUNCT, V214, P563, DOI 10.1007/s00429-010-0248-y; Criaud M, 2013, NEUROSCI BIOBEHAV R, V37, P11, DOI 10.1016/j.neubiorev.2012.11.003; Cuadra MB, 2005, IEEE T MED IMAGING, V24, P1548, DOI 10.1109/TMI.2005.857652; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Eckert MA, 2009, HUM BRAIN MAPP, V30, P2530, DOI 10.1002/hbm.20688; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fan J, 2003, NEUROIMAGE, V18, P42, DOI 10.1006/nimg.2002.1319; Fan J, 2007, J NEUROSCI, V27, P2272, DOI 10.1523/JNEUROSCI.3470-06.2007; Fruhholz S, 2011, NEUROIMAGE, V54, P622, DOI 10.1016/j.neuroimage.2010.07.071; Grajewska BZV, 2011, BRAIN RES, V1421, P52, DOI 10.1016/j.brainres.2011.09.022; Hazeltine E, 2003, NEUROPSYCHOLOGIA, V41, P1208, DOI 10.1016/S0028-3932(03)00040-X; Hazeltine E, 2000, J COGNITIVE NEUROSCI, V12, P118, DOI 10.1162/089892900563984; Hester R, 2004, NEUROIMAGE, V23, P202, DOI 10.1016/j.neuroimage.2004.05.024; Hirose S, 2012, J NEUROSCI, V32, P9059, DOI 10.1523/JNEUROSCI.0540-12.2012; Huyser C, 2011, J CHILD PSYCHOL PSYC, V52, P1251, DOI 10.1111/j.1469-7610.2011.02439.x; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Kim SH, 2012, NEUROSCI RES, V74, P256, DOI 10.1016/j.neures.2012.08.008; King JA, 2012, J NEUROSCI, V32, P8192, DOI 10.1523/JNEUROSCI.0934-12.2012; Klein TA, 2013, FRONT HUM NEUROSCI, V7, DOI [10.3389/fnhum.2013.00014, 10.3389/fnins.2013.00113]; Liston C, 2006, NEURON, V50, P643, DOI 10.1016/j.neuron.2006.04.015; Luks TL, 2010, NEUROPSYCHOLOGIA, V48, P165, DOI 10.1016/j.neuropsychologia.2009.09.001; Madsen K, 2011, PSYCHOPHARMACOLOGY, V213, P573, DOI 10.1007/s00213-010-1926-4; Mansouri FA, 2009, NAT REV NEUROSCI, V10, P141, DOI 10.1038/nrn2538; Mcnab F, 2008, NEUROPSYCHOLOGIA, V46, P2668, DOI 10.1016/j.neuropsychologia.2008.04.023; Menon Vinod, 2010, Brain Struct Funct, V214, P655, DOI 10.1007/s00429-010-0262-0; Milham MP, 2002, BRAIN COGNITION, V49, P277, DOI 10.1006/brcg.2001.1501; Nagamatsu LS, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-37; Nee DE, 2007, COGN AFFECT BEHAV NE, V7, P1, DOI 10.3758/CABN.7.1.1; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; Ochsner KN, 2009, J COGNITIVE NEUROSCI, V21, P1841, DOI 10.1162/jocn.2009.21129; Power JD, 2013, CURR OPIN NEUROBIOL, V23, P223, DOI 10.1016/j.conb.2012.12.009; Qin SZ, 2014, NAT NEUROSCI, V17, P1263, DOI 10.1038/nn.3788; Qin SZ, 2014, BIOL PSYCHIAT, V75, P892, DOI 10.1016/j.biopsych.2013.10.006; Shen S, 2013, J MAGN RESON IMAGING, V37, P1468, DOI 10.1002/jmri.23927; Simmonds DJ, 2008, NEUROPSYCHOLOGIA, V46, P224, DOI 10.1016/j.neuropsychologia.2007.07.015; Supekar K, 2013, P NATL ACAD SCI USA, V110, P8230, DOI 10.1073/pnas.1222154110; Ullsperger M, 2001, NEUROIMAGE, V14, P1387, DOI 10.1006/nimg.2001.0935; Wager TD, 2005, NEUROIMAGE, V27, P323, DOI 10.1016/j.neuroimage.2005.01.054; Ye Z, 2009, NEUROIMAGE, V48, P280, DOI 10.1016/j.neuroimage.2009.06.032; Zanto TP, 2013, TRENDS COGN SCI, V17, P602, DOI 10.1016/j.tics.2013.10.001; Zhu DC, 2010, NEUROIMAGE, V50, P810, DOI 10.1016/j.neuroimage.2009.12.087	60	10	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136877	10.1371/journal.pone.0136877	http://dx.doi.org/10.1371/journal.pone.0136877			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322974	Green Submitted, Green Published, gold			2022-12-26	WOS:000360435500045
J	Ebner, S; Mangge, H; Langhof, H; Halle, M; Siegrist, M; Aigner, E; Paulmichl, K; Paulweber, B; Datz, C; Sperl, W; Kofler, B; Weghuber, D				Ebner, Sabine; Mangge, Harald; Langhof, Helmut; Halle, Martin; Siegrist, Monika; Aigner, Elmar; Paulmichl, Katharina; Paulweber, Bernhard; Datz, Christian; Sperl, Wolfgang; Kofler, Barbara; Weghuber, Daniel			Mitochondrial Haplogroup T Is Associated with Obesity in Austrian Juveniles and Adults	PLOS ONE			English	Article							DNA VARIANT; METABOLIC SYNDROME; MTDNA HAPLOGROUPS; DISEASE; RISK; AGE; POLYMORPHISMS; DISCORDANT; PARAMETERS	Background Recent publications have reported contradictory data regarding mitochondrial DNA (mtDNA) variation and its association with body mass index. The aim of the present study was to compare the frequencies of mtDNA haplogroups as well as control region (CR) polymorphisms of obese juveniles (n = 248) and obese adults (n = 1003) versus normal weight controls (njuvenile = 266, nadults = 595) in a well-defined, ethnically homogenous, age-matched comparative cohort of Austrian Caucasians. Methodology and Principal Findings Using SNP analysis and DNA sequencing, we identified the nine major European mitochondrial haplogroups and CR polymorphisms. Of these, only the T haplogroup frequency was increased in the juvenile obese cohort versus the control subjects [11.7% in obese vs. 6.4% in controls], although statistical significance was lost after adjustment for sex and age. Similar data were observed in a local adult cohort, in which haplogroup T was found at a significantly higher frequency in the overweight and obese subjects than in the normal weight group [9.7% vs. 6.2%, p = 0.012, adjusted for sex and age]. When all obese subjects were considered together, the difference in the frequency of haplogroup T was even more clearly seen [10.1% vs. 6.3%, p = 0.002, OR (95% CI) 1.71 (1.2-2.4), adjusted for sex and age]. The frequencies of the T haplogroup-linked CR polymorphisms C16294T and the C16296T were found to be elevated in both the juvenile and the adult obese cohort compared to the controls. Nevertheless, no mtDNA haplogroup or CR polymorphism was robustly associated with any of several investigated metabolic and cardiovascular parameters (e.g., blood pressure, blood glucose concentration, triglycerides, cholesterol) in all obese subjects. Conclusions and Significance By investigation of this large ethnically and geographically homogenous cohort of Middle European Caucasians, only mtDNA haplogroup T was identified as an obesity risk factor.	[Ebner, Sabine; Paulmichl, Katharina; Sperl, Wolfgang; Kofler, Barbara; Weghuber, Daniel] Paracelsus Med Univ, Dept Pediat, Salzburg, Austria; [Mangge, Harald] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Mangge, Harald] BioTechMed Graz, Graz, Austria; [Langhof, Helmut] Klin Schonsicht, Berchtesgaden, Germany; [Halle, Martin; Siegrist, Monika] Tech Univ Munich, Klinikum Rechts Isar, Dept Prevent Rehabil & Sports Med, D-80290 Munich, Germany; [Aigner, Elmar; Paulweber, Bernhard] Paracelsus Med Univ, Dept Internal Med, Salzburg, Austria; [Aigner, Elmar; Paulmichl, Katharina; Weghuber, Daniel] Paracelsus Med Univ, Obes Res Unit, Salzburg, Austria; [Aigner, Elmar; Paulmichl, Katharina; Weghuber, Daniel] Salzburger Landeskliniken, Salzburg, Austria; [Datz, Christian] Gen Hosp Oberndorf, Dept Internal Med, Oberndorf, Austria; [Halle, Martin] DZHK German Ctr Cardiovasc Res, Munich, Germany; [Halle, Martin] Tech Univ Munich, Klinikum Rechts Isar, Else Kroner Fresenius Zentrum, D-80290 Munich, Germany	Paracelsus Private Medical University; Medical University of Graz; Technical University of Munich; Paracelsus Private Medical University; Paracelsus Private Medical University; German Centre for Cardiovascular Research; Technical University of Munich	Weghuber, D (corresponding author), Paracelsus Med Univ, Dept Pediat, Salzburg, Austria.	d.weghuber@salk.at	Weghuber, Daniel/AAN-1422-2020	Halle, Martin/0000-0003-3065-530X; Kofler, Barbara/0000-0002-1198-4776; Mangge, Harald/0000-0003-4067-247X	German Society of Paediatric Gastroenterology, Hepatology and Nutrition (GPGE); European Commission [279153]; "Gesellschaft zur Forderung Padiatrischer Forschung und Fortbildung" at the Department of Pediatrics, Paracelsus Medical University; PMU-Forschungsforderungsfonds [E13/17/086-AIG]	German Society of Paediatric Gastroenterology, Hepatology and Nutrition (GPGE); European Commission(European CommissionEuropean Commission Joint Research Centre); "Gesellschaft zur Forderung Padiatrischer Forschung und Fortbildung" at the Department of Pediatrics, Paracelsus Medical University; PMU-Forschungsforderungsfonds	This study was supported by a start-up research grant by the German Society of Paediatric Gastroenterology, Hepatology and Nutrition (GPGE) to Daniel Weghuber (www.gpge.de). Daniel Weghuber and Katharina Paulmichl would like to acknowledge support by a grant from the European Commission (FP7 contract 279153, Beta-JUDO; http://www.cordis.europa.eu/fp7), and a grant by the "Gesellschaft zur Forderung Padiatrischer Forschung und Fortbildung" at the Department of Pediatrics, Paracelsus Medical University (www.salk.at). ElmarAigner is supported by PMU-Forschungsforderungsfonds (E13/17/086-AIG; www.pmu.ac.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner E, 2010, EUR J CLIN INVEST, V40, P155, DOI 10.1111/j.1365-2362.2009.02238.x; Castro MG, 2007, MITOCHONDRION, V7, P354, DOI 10.1016/j.mito.2007.06.002; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Dubut V, 2004, EUR J HUM GENET, V12, P293, DOI 10.1038/sj.ejhg.5201145; Ebner S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027192; Feder J, 2007, EUR J HUM GENET, V15, P498, DOI 10.1038/sj.ejhg.5201764; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Gill-Randall R, 2001, DIABETIC MED, V18, P413, DOI 10.1046/j.1464-5491.2001.00477.x; Grant SFA, 2012, INT J OBESITY, V36, P80, DOI 10.1038/ijo.2011.206; Hatzfeld JJ, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110136; Kenney MC, 2014, BBA-MOL BASIS DIS, V1842, P208, DOI 10.1016/j.bbadis.2013.10.016; Knoll N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094882; Kofler B, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-35; Kurian AK, 2007, ETHNIC DIS, V17, P143; Mangge H, 2014, OBESITY, V22, P195, DOI 10.1002/oby.20491; Mensah GA, 2005, CIRCULATION, V111, P1233, DOI 10.1161/01.CIR.0000158136.76824.04; Mueller EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052367; Mueller EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016455; Mueller EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006370; Mustelin L, 2008, AM J PHYSIOL-ENDOC M, V295, pE148, DOI 10.1152/ajpendo.00580.2007; Nardelli C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/631082; Naukkarinen J, 2014, DIABETOLOGIA, V57, P167, DOI 10.1007/s00125-013-3066-y; Palmieri VO, 2011, NUTRITION, V27, P773, DOI 10.1016/j.nut.2010.08.016; Park KS, 2008, DIABETOLOGIA, V51, P602, DOI 10.1007/s00125-008-0933-z; Parker E, 2005, AM J PHYSIOL-ENDOC M, V289, pE1110, DOI 10.1152/ajpendo.00600.2004; Pietilainen KH, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050051; Pyle A, 2005, ANN NEUROL, V57, P564, DOI 10.1002/ana.20417; Ramachandrappa S, 2011, J CLIN INVEST, V121, P2080, DOI 10.1172/JCI46044; Rose G, 2001, EUR J HUM GENET, V9, P701, DOI 10.1038/sj.ejhg.5200703; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Samuels DC, 2006, AM J HUM GENET, V78, P713, DOI 10.1086/502682; Saxena R, 2006, AM J HUM GENET, V79, P54, DOI 10.1086/504926; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Soto-Hermida A, 2014, MITOCHONDRION, V15, P18, DOI 10.1016/j.mito.2014.03.001; Torroni A, 1996, GENETICS, V144, P1835; Weitgasser R, 2004, BIOMED PHARMACOTHER, V58, P619, DOI 10.1016/j.biopha.2004.09.010; Weng SW, 2005, J CLIN ENDOCR METAB, V90, P5037, DOI 10.1210/jc.2005-0227; Wiesbauer M, 2006, ELECTROPHORESIS, V27, P3864, DOI 10.1002/elps.200600086; Wortmann SB, 2009, PEDIATR RES, V65, P103, DOI 10.1203/PDR.0b013e31818d1c8a; Yang TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021595; Zelzer S, 2011, CLIN CHIM ACTA, V412, P1345, DOI 10.1016/j.cca.2011.03.031	43	21	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0135622	10.1371/journal.pone.0135622	http://dx.doi.org/10.1371/journal.pone.0135622			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322975	Green Published, gold, Green Submitted			2022-12-26	WOS:000360435500009
J	Horje, CSHT; Bruijnen, R; Roovers, L; Groenen, MJM; Joosten, FBM; Wahab, PJ				Horje, C. S. Horjus Talabur; Bruijnen, R.; Roovers, L.; Groenen, M. J. M.; Joosten, F. B. M.; Wahab, P. J.			Contrast Enhanced Abdominal Ultrasound in the Assessment of Ileal Inflammation in Crohn's Disease: A Comparison with MR Enterography	PLOS ONE			English	Article							BOWEL WALL VASCULARITY; MAGNETIC-RESONANCE; COMPUTED-TOMOGRAPHY; INTESTINAL INFLAMMATION; ENDOSCOPIC ACTIVITY; ULCERATIVE-COLITIS; ULTRASONOGRAPHY; CLASSIFICATION; ENTEROCLYSIS; VALIDATION	Background and Aims To prospectively examine the feasibility and accuracy of Contrast Enhanced Ultrasound (CEUS) in the assessment of Crohn's disease (CD) activity in the terminal ileum in comparison to Magnetic Resonance Enterography (MRE), using endoscopy as a reference standard. Methods 105 consecutive patients with alleged clinically active CD were assessed by MRE and CEUS. CEUS of the terminal ileum was performed using an intravenous microbubble contrast enhancer. Accuracy values of CEUS and MRE for the presence of active terminal ileitis were evaluated using the Receiver Operating Characteristic method, using endoscopic findings as a reference standard. Sensitivity and specificity values of MRE and CEUS were compared by the McNemar test. Results CEUS was feasible in 98% of patients, MRE in all. Optimal diagnostic accuracy in CEUS was obtained at a peak intensity value of 10%, showing 100% sensitivity, 92% specificity and an accuracy of 99% in demonstrating ileal mucosal inflammation. For MRE, overall sensitivity, specificity and accuracy were, 87%, 100%, and 88%, respectively. CEUS and MRE were highly correlated in assessing length and wall thickness of the terminal ileum. CEUS identified 11 of 16 MRE-detected strictures, but no fistulae. Conclusion The accuracy of CEUS is comparable to that of MRE in the assessment of active, uncomplicated terminal ileal CD and therefore a valuable bedside alternative to MRE in the follow-up of these patients.	[Horje, C. S. Horjus Talabur; Groenen, M. J. M.; Wahab, P. J.] Rijnstate Hosp, Dept Gastroenterol, Arnhem, Netherlands; [Bruijnen, R.; Joosten, F. B. M.] Rijnstate Hosp, Dept Radiol, Arnhem, Netherlands; [Roovers, L.] Rijnstate Hosp, Dept Epidemiol & Stat, Arnhem, Netherlands	Rijnstate Hospital; Rijnstate Hospital; Rijnstate Hospital	Horje, CSHT (corresponding author), Rijnstate Hosp, Dept Gastroenterol, Arnhem, Netherlands.	chthorje@rijnstate.nl						Ansari A, 2003, SCAND J GASTROENTERO, V38, P1184, DOI 10.1080/00365520310006018; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BRAHME F, 1970, GUT, V11, P928, DOI 10.1136/gut.11.11.928; Cipriano LE, 2012, INFLAMM BOWEL DIS, V18, P1240, DOI 10.1002/ibd.21862; CRAMABOHBOUTH G, 1989, GUT, V30, P1236, DOI 10.1136/gut.30.9.1236; Daperno M, 2004, GASTROINTEST ENDOSC, V60, P505, DOI 10.1016/S0016-5107(04)01878-4; De Franco A, 2012, ABDOM IMAGING, V37, P359, DOI 10.1007/s00261-011-9831-9; Drews BH, 2009, EUR RADIOL, V19, P1379, DOI 10.1007/s00330-008-1290-5; Fraquelli M, 2005, RADIOLOGY, V236, P95, DOI 10.1148/radiol.2361040799; Girlich C, 2009, CLIN HEMORHEOL MICRO, V43, P141, DOI 10.3233/CH-2009-1228; HARVEY RF, 1980, LANCET, V1, P514; Hassan C, 2003, INT J COLORECTAL DIS, V18, P121, DOI 10.1007/s00384-002-0455-y; Israeli E, 2013, ALIMENT PHARM THER, V38, P513, DOI 10.1111/apt.12410; Karoui S, 2010, J CROHNS COLITIS, V4, P334, DOI 10.1016/j.crohns.2009.12.011; Lee SS, 2009, RADIOLOGY, V251, P751, DOI 10.1148/radiol.2513081184; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Leyendecker JR, 2009, RADIOGRAPHICS, V29, P1827, DOI 10.1148/rg.296095510; Maconi G, 1998, GUT, V43, P645, DOI 10.1136/gut.43.5.645; Malago R, 2012, RADIOL MED, V117, P268, DOI 10.1007/s11547-011-0783-5; Paredes JM, 2013, J CROHNS COLITIS, V7, P192, DOI 10.1016/j.crohns.2012.03.017; Martinez MJ, 2009, ABDOM IMAGING, V34, P141, DOI 10.1007/s00261-008-9365-y; Miao YM, 2002, CLIN RADIOL, V57, P913, DOI 10.1053/crad.2002.1059; Migaleddu V, 2011, ABDOM IMAGING, V36, P142, DOI 10.1007/s00261-010-9622-8; Migaleddu V, 2009, GASTROENTEROLOGY, V137, P43, DOI 10.1053/j.gastro.2009.03.062; Moreno N, 2014, J CROHNS COLITIS, V8, P1079, DOI 10.1016/j.crohns.2014.02.008; Negaard A, 2007, EUR RADIOL, V17, P2294, DOI 10.1007/s00330-007-0648-4; Panes J, 2011, ALIMENT PHARM THER, V34, P125, DOI 10.1111/j.1365-2036.2011.04710.x; Pauls S, 2006, EUR RADIOL, V16, P2410, DOI 10.1007/s00330-006-0330-2; Peloquin JM, 2008, AM J GASTROENTEROL, V103, P2015, DOI 10.1111/j.1572-0241.2008.01920.x; Quaia E, 2007, EUR RADIOL, V17, P1995, DOI 10.1007/s00330-007-0623-0; Quaia E, 2013, EUR RADIOL, V23, P1650, DOI 10.1007/s00330-012-2754-1; Reimund JM, 1999, GASTROEN CLIN BIOL, V23, P740; Rimola J, 2009, GUT, V58, P1113, DOI 10.1136/gut.2008.167957; Ripolles T, 2013, EUR J RADIOL, V82, pE525, DOI 10.1016/j.ejrad.2013.05.043; Ripolles T, 2011, INSIGHTS IMAGING, V2, P639, DOI 10.1007/s13244-011-0124-1; Ripolles T, 2013, J CROHNS COLITIS, V7, P120, DOI 10.1016/j.crohns.2012.03.002; Ripolles T, 2009, RADIOLOGY, V253, P241, DOI 10.1148/radiol.2531082269; Saevik F, 2014, INFLAMMATORY BOWEL D; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Sinha R, 2009, CLIN RADIOL, V64, P341, DOI 10.1016/j.crad.2008.08.006; Sostegni R, 2003, ALIMENT PHARM THER, V17, P11, DOI 10.1046/j.1365-2036.17.s2.17.x; Stange EF, 2006, GUT, V55, DOI 10.1136/gut.2005.081950a; Steward MJ, 2012, EUR J RADIOL, V81, P2080, DOI 10.1016/j.ejrad.2011.07.013; Takenaka K, 2014, GASTROENTEROLOGY, V147, P334, DOI 10.1053/j.gastro.2014.04.008; van Bodegraven Ad A, 2010, Ned Tijdschr Geneeskd, V154, pA1899; WAKEFIELD AJ, 1989, LANCET, V2, P1057	46	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136105	10.1371/journal.pone.0136105	http://dx.doi.org/10.1371/journal.pone.0136105			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322970	Green Published, Green Submitted, gold			2022-12-26	WOS:000360435500015
J	Pscheidt, C; Nagel, G; Zitt, E; Kramar, R; Concin, H; Lhotta, K				Pscheidt, Constanze; Nagel, Gabriele; Zitt, Emanuel; Kramar, Reinhard; Concin, Hans; Lhotta, Karl			Sex- and Time-Dependent Patterns in Risk Factors of End-Stage Renal Disease: A Large Austrian Cohort with up to 20 Years of Follow-Up	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GAMMA-GLUTAMYL-TRANSFERASE; BODY-MASS INDEX; METABOLIC SYNDROME; BLOOD-PRESSURE; MEN; WOMEN; ALBUMINURIA; LIPIDS	Objective We investigated the association between metabolic factors and End-Stage Renal Disease (ESRD) and quantified the magnitude of their influence dependent on sex and time of exposure up to 20 years. Material and Methods A prospective cohort study was conducted to determine risk factors for the development of ESRD. From 1988 to 2005 185,341 persons (53.9% women) participated in the "Vorarlberg Health Monitoring and Promotion Programme" (VHM&PP). Data on body mass index (BMI), fasting blood glucose (FBG), systolic (BPsys) and diastolic (BPdia) blood pressure, total cholesterol (TC), triglycerides (TG), gamma-glutamyltransferase (GGT) and smoking status were collected. Data of the population-based VHM&PP were merged with the Austrian Dialysis and Transplant Registry. Cox proportional hazards models were applied to calculate hazard ratios (HRs) for ESRD, stratified by sex and 5-year time intervals. Results During a mean follow-up of 17.5 years 403 patients (39.1% women) developed ESRD. Significant risk factors were: BMI (per 1 kg/m2) HR 1.04 (95% CI 1.01-1.06), FBG (per 1 mmol/L) HR 1.09 (1.05-1.12), BPsys (per 5 mmHg) HR 1.10 (1.07-1.14), BPdia (per 5 mmHg) HR 1.09 (1.03-1.15), TG (per 1 mmol/L) HR 1.07 (1.02-1.13), TC (per 1 mmol/L) HR 1.22 (1.13-1.32). We observed a sex-specific risk pattern with an increased ESRD risk for men for increasing TG and smoking, and for women for increasing BMI and GGT. In time interval analyses BPsys and TC were associated with early ESRD onset, whereas BMI, FBG, BPdia and GGT were associated with later onset. Conclusions Anthropometric and metabolic factors are differentially associated with the long-term risk for ESRD in a sex- and time-dependent manner. Consideration of these patterns in preventive and therapeutic strategies could have an impact on ESRD incidence.	[Pscheidt, Constanze; Nagel, Gabriele; Concin, Hans] Agcy Prevent & Social Med, Bregenz, Austria; [Pscheidt, Constanze; Nagel, Gabriele] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany; [Zitt, Emanuel; Lhotta, Karl] Acad Teaching Hosp Feldkirch, Dept Nephrol & Dialysis, Feldkirch, Austria; [Zitt, Emanuel; Lhotta, Karl] Acad Teaching Hosp Feldkirch, Vorarlberg Inst Vasc Invest & Treatment, Feldkirch, Austria; [Kramar, Reinhard] Austrian Dialysis & Transplant Registry, Rohr, Austria	Ulm University	Lhotta, K (corresponding author), Acad Teaching Hosp Feldkirch, Dept Nephrol & Dialysis, Feldkirch, Austria.	karl.lhotta@lkhf.at	vhmpp, aks/F-9756-2012; Nagel, Gabriele/C-3635-2012; Zitt, Emanuel/ABE-1926-2020	Nagel, Gabriele/0000-0001-6185-8535; Zitt, Emanuel/0000-0001-6944-6041	state government of Vorarlberg; Austrian Society of Nephrology; Hans Drexel	state government of Vorarlberg; Austrian Society of Nephrology; Hans Drexel	This study was supported by a grant from Hans Drexel to the Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT). The Vorarlberg Health Monitoring & Promotion Programme (VHM&PP) is funded by the state government of Vorarlberg. The Austrian Dialysis- and Transplantregistry (OEDTR) is funded by the Austrian Society of Nephrology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balogun W O, 2008, Afr J Med Med Sci, V37, P177; Boucquemont J, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-45; Chang TI, 2013, AM J KIDNEY DIS, V61, pS4, DOI 10.1053/j.ajkd.2012.12.016; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368; Eckardt KU, 2013, LANCET, V382, P158, DOI 10.1016/S0140-6736(13)60439-0; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hsu CY, 2009, ARCH INTERN MED, V169, P342, DOI 10.1001/archinternmed.2008.605; Hsu CY, 2005, ARCH INTERN MED, V165, P923, DOI 10.1001/archinte.165.8.923; Kastarinen M, 2010, J INTERN MED, V267, P612, DOI 10.1111/j.1365-2796.2009.02197.x; Klag MJ, 1996, NEW ENGL J MED, V334, P13, DOI 10.1056/NEJM199601043340103; Klenk J, 2009, EUR J EPIDEMIOL, V24, P83, DOI 10.1007/s10654-009-9312-4; Liyanage T, 2015, LANCET, V385, P1975, DOI 10.1016/S0140-6736(14)61601-9; McMahon GM, 2014, J AM SOC NEPHROLOGY; Meisinger C, 2005, J INTERN MED, V258, P527, DOI 10.1111/j.1365-2796.2005.01572.x; Muntner P, 2000, KIDNEY INT, V58, P293, DOI 10.1046/j.1523-1755.2000.00165.x; Nagel G, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-177; Panwar B, 2014, KIDNEY INT; Rahman M, 2014, CLIN J AM SOC NEPHRO, V9, P1190, DOI 10.2215/CJN.09320913; Ruttmann E, 2005, CIRCULATION, V112, P2130, DOI 10.1161/CIRCULATIONAHA.105.552547; Ryu S, 2007, CLIN CHEM, V53, P71, DOI 10.1373/clinchem.2006.078980; Society AD, 2014, FAST PLASM GLUC AM D; Sun F, 2010, NEPHROLOGY, V15, P84, DOI 10.1111/j.1440-1797.2009.01150.x; Targher G, 2010, NUTR METAB CARDIOVAS, V20, P583, DOI 10.1016/j.numecd.2009.05.012; Thomas G, 2011, CLIN J AM SOC NEPHRO, V6, P2364, DOI 10.2215/CJN.02180311; Tozawa M, 2003, HYPERTENSION, V41, P1341, DOI 10.1161/01.HYP.0000069699.92349.8C; Tozawa M, 2007, HYPERTENS RES, V30, P937, DOI 10.1291/hypres.30.937; Turin TC, 2012, J AM SOC NEPHROL, V23, P1569, DOI 10.1681/ASN.2012020164; Ulmer H, 2003, EUR HEART J, V24, P1004, DOI 10.1016/S0195-668X(03)00170-2; Vivante A, 2012, ARCH INTERN MED, V172, P1644, DOI 10.1001/2013.jamainternmed.85; Watanabe H, 2010, DIABETES-METAB RES, V26, P26, DOI 10.1002/dmrr.1058; WHO, 2014, BMI CLASS; Wimmer F, 2003, NEPHROL DIAL TRANSPL, V18, P1562, DOI 10.1093/ndt/gfg184	33	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0135052	10.1371/journal.pone.0135052	http://dx.doi.org/10.1371/journal.pone.0135052			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322515	gold, Green Published, Green Submitted			2022-12-26	WOS:000360435500005
J	Yoo, DH; Song, SW; Yun, TJ; Kim, TM; Lee, SH; Kim, JH; Sohn, CH; Park, SH; Park, CK; Kim, IH; Choi, SH				Yoo, Dong Hyun; Song, Sang Woo; Yun, Tae Jin; Kim, Tae Min; Lee, Se-Hoon; Kim, Ji-Hoon; Sohn, Chul-Ho; Park, Sung-Hye; Park, Chul-Kee; Kim, Il Han; Choi, Seung Hong			MR Imaging Evaluation of Intracerebral Hemorrhages and T2 Hyperintense White Matter Lesions Appearing after Radiation Therapy in Adult Patients with Primary Brain Tumors	PLOS ONE			English	Article							LOW-GRADE GLIOMA; CENTRAL-NERVOUS-SYSTEM; INDUCED TELANGIECTASIA; RANDOMIZED-TRIAL; FOLLOW-UP; RADIOTHERAPY; CHILDREN; MALFORMATIONS; CHEMOTHERAPY; VASCULOPATHY	The purpose of our study was to determine the frequency and severity of intracerebral hemorrhages and T2 hyperintense white matter lesions (WMLs) following radiation therapy for brain tumors in adult patients. Of 648 adult brain tumor patients who received radiation therapy at our institute, magnetic resonance (MR) image data consisting of a gradient echo (GRE) and FLAIR T2-weighted image were available three and five years after radiation therapy in 81 patients. Intracerebral hemorrhage was defined as a hypointense dot lesion appearing on GRE images after radiation therapy. The number and size of the lesions were evaluated. The T2 hyperintense WMLs observed on the FLAIR sequences were graded according to the extent of the lesion. Intracerebral hemorrhage was detected in 21 (25.9%) and 35 (43.2) patients in the three-and five-year follow-up images, respectively. The number of intracerebral hemorrhages per patient tended to increase as the follow-up period increased, whereas the size of the intracerebral hemorrhages exhibited little variation over the course of follow-up. T2 hyperintense WMLs were observed in 27 (33.3%) and 32 (39.5) patients in the three and five year follow-up images, respectively. The age at the time of radiation therapy was significantly higher (p < 0.001) in the patients with T2 hyperintense WMLs than in those without lesions. Intracerebral hemorrhages are not uncommon in adult brain tumor patients undergoing radiation therapy. The incidence and number of intracerebral hemorrhages increased over the course of follow-up. T2 hyperintense WMLs were observed in more than one-third of the study population.	[Yoo, Dong Hyun; Yun, Tae Jin; Kim, Ji-Hoon; Sohn, Chul-Ho; Choi, Seung Hong] Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea; [Song, Sang Woo; Park, Chul-Kee] Seoul Natl Univ Hosp, Dept Neurosurg, Seoul 110744, South Korea; [Kim, Tae Min; Lee, Se-Hoon] Seoul Natl Univ Hosp, Dept Internal Med, Canc Res Inst, Seoul 110744, South Korea; [Park, Sung-Hye] Seoul Natl Univ Hosp, Dept Pathol, Seoul 110744, South Korea; [Kim, Il Han] Seoul Natl Univ Hosp, Dept Radiat Oncol, Canc Res Inst, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Park, CK (corresponding author), Seoul Natl Univ Hosp, Dept Neurosurg, Seoul 110744, South Korea.	nsckpark@snu.ac.kr; ihkim@snu.ac.kr; verocay@snuh.org	Park, Chul-Kee/J-5499-2012; Park, Chul-Kee/O-7842-2019; Sohn, ChulHo/AAV-4565-2021; Kim, Ji-hoon/D-5754-2012	Park, Chul-Kee/0000-0002-2350-9876; Kim, Ji-hoon/0000-0002-6349-6950	Korea Healthcare Technology R&D Projects, Ministry for Health, Welfare Family Affairs [HI13C0015]; Research Center Program of IBS (Institute for Basic Science) in Korea	Korea Healthcare Technology R&D Projects, Ministry for Health, Welfare Family Affairs; Research Center Program of IBS (Institute for Basic Science) in Korea	This study was supported by a grant from Korea Healthcare Technology R&D Projects, Ministry for Health, Welfare & Family Affairs, grant number HI13C0015 (http://www.mw.go.kr/), recipient SHC, and the Research Center Program of IBS (Institute for Basic Science) in Korea (no grant number, http://www.ibs.re.kr/), recipient SHC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALL WS, 1992, AM J NEURORADIOL, V13, P761; BRANTZAWADZKI M, 1985, AM J NEURORADIOL, V6, P675; BRANTZAWADZKI M, 1980, AM J ROENTGENOL, V134, P51, DOI 10.2214/ajr.134.1.51; Chan MSM, 2006, AM J NEURORADIOL, V27, P548; Douw L, 2009, LANCET NEUROL, V8, P810, DOI 10.1016/S1474-4422(09)70204-2; GAENSLER EHL, 1994, RADIOLOGY, V193, P629, DOI 10.1148/radiology.193.3.7972799; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Johannesen TB, 2003, RADIOTHER ONCOL, V69, P169, DOI 10.1016/S0167-8140(03)00192-0; Karim ABMF, 2002, INT J RADIAT ONCOL, V52, P316, DOI 10.1016/S0360-3016(01)02692-X; Kato H, 2002, STROKE, V33, P1536, DOI 10.1161/01.STR.0000018012.65108.86; Koike S, 2004, RADIOLOGY, V230, P93, DOI 10.1148/radiol.2301021143; Laperriere N, 2002, RADIOTHER ONCOL, V64, P259, DOI 10.1016/S0167-8140(02)00078-6; Lee BCP, 1999, AM J NEURORADIOL, V20, P1239; MEYER JS, 1992, J NEUROL SCI, V110, P1; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; OI S, 1990, Neurologia Medico-Chirurgica, V30, P36, DOI 10.2176/nmc.30.36; POUSSAINT TY, 1995, AM J NEURORADIOL, V16, P693; Pozzati E, 1996, NEUROSURGERY, V39, P677, DOI 10.1097/00006123-199610000-00004; Rabin BM, 1996, RADIOGRAPHICS, V16, P1055, DOI 10.1148/radiographics.16.5.8888390; Reddick WE, 2009, AM J NEURORADIOL, V30, P1947, DOI 10.3174/ajnr.A1733; Surma-aho O, 2001, NEUROLOGY, V56, P1285, DOI 10.1212/WNL.56.10.1285; TSURUDA JS, 1987, AM J ROENTGENOL, V149, P165, DOI 10.2214/ajr.149.1.165; Tsushima Y, 2003, AM J NEURORADIOL, V24, P88; VALK PE, 1991, AM J NEURORADIOL, V12, P45; van den Bent MJ, 2005, LANCET, V366, P985, DOI 10.1016/S0140-6736(05)67070-5; Wang YXJ, 2010, RADIOLOGY, V254, P210, DOI 10.1148/radiol.09090428; WILSON DA, 1991, RADIOLOGY, V180, P205, DOI 10.1148/radiology.180.1.2052695	27	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136795	10.1371/journal.pone.0136795	http://dx.doi.org/10.1371/journal.pone.0136795			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322780	gold, Green Published, Green Submitted			2022-12-26	WOS:000360435500037
J	Dalmia, N; Klimstra, WB; Mason, C; Ramsay, AJ				Dalmia, Neha; Klimstra, William B.; Mason, Carol; Ramsay, Alistair J.			DNA-Launched Alphavirus Replicons Encoding a Fusion of Mycobacterial Antigens Acr and Ag85B Are Immunogenic and Protective in a Murine Model of TB Infection	PLOS ONE			English	Article							VENEZUELAN EQUINE ENCEPHALITIS; TUBERCULOSIS VACCINE; IMMUNE-RESPONSES; ENHANCED IMMUNOGENICITY; INTERFERON-GAMMA; RHESUS MACAQUES; CELL RESPONSES; BOOST STRATEGY; VIRUS; EXPRESSION	There is an urgent need for effective prophylactic measures against Mycobacterium tuberculosis (Mtb) infection, particularly given the highly variable efficacy of Bacille Calmette-Guerin (BCG), the only licensed vaccine against tuberculosis (TB). Most studies indicate that cell-mediated immune responses involving both CD4+ and CD8+ T cells are necessary for effective immunity against Mtb. Genetic vaccination induces humoral and cellular immune responses, including CD4+ and CD8+ T-cell responses, against a variety of bacterial, viral, parasitic and tumor antigens, and this strategy may therefore hold promise for the development of more effective TB vaccines. Novel formulations and delivery strategies to improve the immunogenicity of DNA-based vaccines have recently been evaluated, and have shown varying degrees of success. In the present study, we evaluated DNA-launched Venezuelan equine encephalitis replicons (Vrep) encoding a novel fusion of the mycobacterial antigens a-crystallin (Acr) and antigen 85B (Ag85B), termed Vrep-Acr/Ag85B, for their immunogenicity and protective efficacy in a murine model of pulmonary TB. Vrep-Acr/Ag85B generated antigen-specific CD4+ and CD8+ T cell responses that persisted for at least 10 wk post-immunization. Interestingly, parenterally administered Vrep-Acr/Ag85B also induced T cell responses in the lung tissues, the primary site of infection, and inhibited bacterial growth in both the lungs and spleens following aerosol challenge with Mtb. DNA-launched Vrep may, therefore, represent an effective approach to the development of gene-based vaccines against TB, particularly as components of heterologous prime-boost strategies or as BCG boosters.	[Dalmia, Neha; Mason, Carol; Ramsay, Alistair J.] LSU Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA 70112 USA; [Klimstra, William B.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ramsay, AJ (corresponding author), LSU Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA 70112 USA.	aramsa@lsuhsc.edu			National Institutes of Health [R01 AI058810, PO1 HL076100, R01 AI083383, R01 AA 011760]; Louisiana Vaccine Center - Louisiana Board of Regents; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083383, R01AI058810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011760] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Vaccine Center - Louisiana Board of Regents; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by National Institutes of Health grants R01 AI058810 (AJR), PO1 HL076100 (AJR and CM), R01 AI083383 (WBK), R01 AA 011760 (CM) and the Louisiana Vaccine Center funded by the Louisiana Board of Regents. National Institutes of Health (www.nih.gov), Louisiana Board of Regents (regents.louisiana.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Atkins Gregory J., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000859; Auten MW, 2012, VACCINE, V30, P2768, DOI 10.1016/j.vaccine.2012.02.020; Balasuriya UBR, 2000, J VIROL, V74, P10623, DOI 10.1128/JVI.74.22.10623-10630.2000; Barry G, 2010, J VIROL, V84, P7369, DOI 10.1128/JVI.02310-09; Barry G, 2009, J GEN VIROL, V90, P1382, DOI 10.1099/vir.0.007336-0; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Belyakov IM, 2009, J IMMUNOL, V183, P6883, DOI 10.4049/jimmunol.0901466; Berglund P, 1998, NAT BIOTECHNOL, V16, P562, DOI 10.1038/nbt0698-562; Beverley PCL, 2014, MUCOSAL IMMUNOL, V7, P20, DOI 10.1038/mi.2013.99; Brice GT, 2007, MICROBES INFECT, V9, P1439, DOI 10.1016/j.micinf.2007.07.009; Britton WJ, 2003, IMMUNOL CELL BIOL, V81, P34, DOI 10.1046/j.0818-9641.2002.01143.x; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; D'Souza S, 2003, INFECT IMMUN, V71, P483, DOI 10.1128/IAI.71.1.483-493.2003; Dalmia N, 2012, EXPERT REV VACCINES, V11, P1221, DOI [10.1586/erv.12.94, 10.1586/ERV.12.94]; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; de Haan L, 2001, VACCINE, V19, P2898, DOI 10.1016/S0264-410X(00)00556-9; Derrick SC, 2005, INFECT IMMUN, V73, P7727, DOI 10.1128/IAI.73.11.7727-7735.2005; Dupuis M, 2000, J IMMUNOL, V165, P2850, DOI 10.4049/jimmunol.165.5.2850; FLYNN JL, 1992, P NATL ACAD SCI USA, V89, P12013, DOI 10.1073/pnas.89.24.12013; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Garcia I, 1997, EUR J IMMUNOL, V27, P3182, DOI 10.1002/eji.1830271215; Gardner JP, 2000, J VIROL, V74, P11849, DOI 10.1128/JVI.74.24.11849-11857.2000; Genesca M, 2007, J IMMUNOL, V179, P4732, DOI 10.4049/jimmunol.179.7.4732; Gilbert SC, 2006, VACCINE, V24, P4554, DOI 10.1016/j.vaccine.2005.08.048; Giri M, 2004, CLIN MICROBIOL REV, V17, P370, DOI 10.1128/CMR.17.2.370-389.2004; Goonetilleke NP, 2003, J IMMUNOL, V171, P1602, DOI 10.4049/jimmunol.171.3.1602; Hesseling AC, 2007, VACCINE, V25, P14, DOI 10.1016/j.vaccine.2006.07.020; Jeyanathan M, 2013, MUCOSAL IMMUNOL, V6, P612, DOI 10.1038/mi.2012.103; Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC; Kalams SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029231; Kalsdorf B, 2009, AM J RESP CRIT CARE, V180, P1262, DOI 10.1164/rccm.200907-1011OC; Kaufmann SHE, 2010, IMMUNITY, V33, P567, DOI 10.1016/j.immuni.2010.09.015; Kirman JR, 2003, INFECT IMMUN, V71, P575, DOI 10.1128/IAI.71.1.575-579.2003; Knudsen ML, 2012, J VIROL, V86, P4082, DOI 10.1128/JVI.06535-11; Leitner WW, 2003, J CLIN INVEST, V112, P22, DOI 10.1172/JCI200319069; Li ML, 2004, INT REV IMMUNOL, V23, P7, DOI 10.1080/08830180490265529; Li ZM, 2006, VACCINE, V24, P4565, DOI 10.1016/j.vaccine.2005.08.021; Ljungberg K, 2007, J VIROL, V81, P13412, DOI 10.1128/JVI.01799-07; Lu S, 2008, EXPERT REV VACCINES, V7, P175, DOI 10.1586/14760584.7.2.175; MacDonald GH, 2000, J VIROL, V74, P914, DOI 10.1128/JVI.74.2.914-922.2000; McShane H, 2011, PHILOS T R SOC B, V366, P2782, DOI 10.1098/rstb.2011.0097; McShane H, 2009, SWISS MED WKLY, V139, P156, DOI smw-12374; Powell K, 2004, NAT BIOTECHNOL, V22, P799, DOI 10.1038/nbt0704-799; Purkayastha A, 2002, INFECT IMMUN, V70, P1518, DOI 10.1128/IAI.70.3.1518-1529.2002; Pushko P, 1997, VIROLOGY, V239, P389, DOI 10.1006/viro.1997.8878; Radosevic K, 2007, INFECT IMMUN, V75, P4105, DOI 10.1128/IAI.00004-07; Ramshaw IA, 2000, IMMUNOL TODAY, V21, P163, DOI 10.1016/S0167-5699(00)01612-1; Rosati M, 2008, VACCINE, V26, P5223, DOI 10.1016/j.vaccine.2008.03.090; Roupie V, 2007, INFECT IMMUN, V75, P941, DOI 10.1128/IAI.01137-06; Scanga CA, 2000, J EXP MED, V192, P347, DOI 10.1084/jem.192.3.347; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Shi LB, 2003, P NATL ACAD SCI USA, V100, P241, DOI 10.1073/pnas.0136863100; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Thompson JM, 2006, P NATL ACAD SCI USA, V103, P3722, DOI 10.1073/pnas.0600287103; Thompson JM, 2008, VACCINE, V26, P4267, DOI 10.1016/j.vaccine.2008.05.046; Ulmer JB, 2006, TRENDS MOL MED, V12, P216, DOI 10.1016/j.molmed.2006.03.007; VORDERMEIER HM, 1993, IMMUNOLOGY, V80, P6; Wang S, 2008, VACCINE, V26, P3946, DOI 10.1016/j.vaccine.2008.04.025; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Weiss WR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001063; Wilkinson KA, 2010, EUR J IMMUNOL, V40, P2139, DOI 10.1002/eji.201040731; World Health Organization, WHO GLOB TUB REP 201; Xing Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005856; Yin J, 2009, J VIROL, V83, P10036, DOI 10.1128/JVI.01209-09; Ying YA, 1996, J BACTERIOL, V178, P4484, DOI 10.1128/jb.178.15.4484-4492.1996; Young SL, 2010, IMMUNOL CELL BIOL, V88, P651, DOI 10.1038/icb.2010.25; Zhang YG, 2007, J VIROL, V81, P11246, DOI 10.1128/JVI.01282-07	70	5	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136635	10.1371/journal.pone.0136635	http://dx.doi.org/10.1371/journal.pone.0136635			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317509	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000360299100117
J	De Paepe, AL; Crombez, G; Legrain, V				De Paepe, Annick L.; Crombez, Geert; Legrain, Valery			From a Somatotopic to a Spatiotopic Frame of Reference for the Localization of Nociceptive Stimuli	PLOS ONE			English	Article							REGIONAL PAIN SYNDROME; PRIMARY SOMATOSENSORY CORTEX; EXOGENOUS SPATIAL ATTENTION; TEMPORAL-ORDER JUDGMENT; NEGLECT-LIKE SYMPTOMS; PRIOR ENTRY; BODY REPRESENTATION; TACTILE STIMULI; SYNDROME CRPS; SPACE	To react efficiently to potentially threatening stimuli, we have to be able to localize these stimuli in space. In daily life we are constantly moving so that our limbs can be positioned at the opposite side of space. Therefore, a somatotopic frame of reference is insufficient to localize nociceptive stimuli. Here we investigated whether nociceptive stimuli are mapped into a spatiotopic frame of reference, and more specifically a peripersonal frame of reference, which takes into account the position of the body limbs in external space, as well as the occurrence of external objects presented near the body. Two temporal order judgment (TOJ) experiments were conducted, during which participants had to decide which of two nociceptive stimuli, one applied to either hand, had been presented first while their hands were either uncrossed or crossed over the body midline. The occurrence of the nociceptive stimuli was cued by uninformative visual cues. We found that the visual cues prioritized the perception of nociceptive stimuli applied to the hand laying in the cued side of space, irrespective of posture. Moreover, the influence of the cues was smaller when they were presented far in front of participants' hands as compared to when they were presented in close proximity. Finally, participants' temporal sensitivity was reduced by changing posture. These findings are compatible with the existence of a peripersonal frame of reference for the localization of nociceptive stimuli. This allows for the construction of a stable representation of our body and the space closely surrounding our body, enabling a quick and efficient reaction to potential physical threats.	[De Paepe, Annick L.; Crombez, Geert] Univ Ghent, Dept Experimental Clin & Hlth Psychol, B-9000 Ghent, Belgium; [Legrain, Valery] Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium	Ghent University; Universite Catholique Louvain	De Paepe, AL (corresponding author), Univ Ghent, Dept Experimental Clin & Hlth Psychol, B-9000 Ghent, Belgium.	Annick.DePaepe@Ugent.be	Crombez, Geert/O-2268-2013	Crombez, Geert/0000-0002-4744-8561; De Paepe, Annick/0000-0002-9366-3692	Research Foundation Flanders (FWO, Belgium); Fund for Scientific Research of the French speaking Community of Belgium (F.R.S.-FNRS)	Research Foundation Flanders (FWO, Belgium)(FWO); Fund for Scientific Research of the French speaking Community of Belgium (F.R.S.-FNRS)(Fonds de la Recherche Scientifique - FNRS)	A.L. De Paepe is supported by the Research Foundation Flanders (FWO, Belgium, http://www.fwo.be). V. Legrain is supported by the Fund for Scientific Research of the French speaking Community of Belgium (F.R.S.-FNRS, http://www.fnrs.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglioti S, 1999, J COGNITIVE NEUROSCI, V11, P67, DOI 10.1162/089892999563256; Azanon E, 2008, CURR BIOL, V18, P1044, DOI 10.1016/j.cub.2008.06.045; Bultitude JH, 2010, EXP BRAIN RES, V204, P409, DOI 10.1007/s00221-009-2107-8; CAIRNEY PT, 1975, ACTA PSYCHOL, V39, P329, DOI 10.1016/0001-6918(75)90025-6; Churyukanov M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035817; De Paepe AL, 2014, NEUROPSYCHOLOGIA, V56, P219, DOI 10.1016/j.neuropsychologia.2014.01.016; De Ruddere L, 2013, PAIN, V154, P669, DOI 10.1016/j.pain.2012.12.018; De Ruddere L, 2011, PAIN, V152, P2342, DOI 10.1016/j.pain.2011.06.028; DREW F, 1896, AM J PSYCHOL, V7, P533, DOI DOI 10.2307/1411848; Durnez W, 2015, J PAIN, V16, P135, DOI 10.1016/j.jpain.2014.10.012; Frettloh J, 2006, PAIN, V124, P184, DOI 10.1016/j.pain.2006.04.010; Galer BS, 1999, J PAIN SYMPTOM MANAG, V18, P213, DOI 10.1016/S0885-3924(99)00076-7; GALER BS, 1995, J PAIN SYMPTOM MANAG, V10, P385, DOI 10.1016/0885-3924(95)00061-3; Gallace A, 2011, PAIN, V152, P1418, DOI 10.1016/j.pain.2011.02.029; GRAZIANO MSA, 1994, SCIENCE, V266, P1054, DOI 10.1126/science.7973661; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; GRAZIANO MSA, 1994, COGNITIVE NEUROSCIEN, P1021; HOLM S, 1979, SCAND J STAT, V6, P65; Holmes NP, 2006, BRAIN RES, V1077, P108, DOI 10.1016/j.brainres.2005.11.010; Inui K, 2006, CEREB CORTEX, V16, P355, DOI 10.1093/cercor.bhi114; Kennett S, 2002, PERCEPT PSYCHOPHYS, V64, P1083, DOI 10.3758/BF03194758; Kennett S, 2001, J COGNITIVE NEUROSCI, V13, P462, DOI 10.1162/08989290152001899; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Legrain V, 2012, PAIN, V153, P948, DOI 10.1016/j.pain.2011.12.010; Legrain V, 2011, PROG NEUROBIOL, V93, P111, DOI 10.1016/j.pneurobio.2010.10.005; Lewis JS, 2007, PAIN, V133, P111, DOI 10.1016/j.pain.2007.03.013; Longo MR, 2010, NEUROPSYCHOLOGIA, V48, P655, DOI 10.1016/j.neuropsychologia.2009.08.022; Mancini F, 2013, CURR BIOL, V23, P496, DOI 10.1016/j.cub.2013.02.008; Mancini F, 2012, J NEUROSCI, V32, P17155, DOI 10.1523/JNEUROSCI.3059-12.2012; Moseley GL, 2012, BRAIN, V135, P3676, DOI 10.1093/brain/aws297; Moseley GL, 2009, BRAIN, V132, P3142, DOI 10.1093/brain/awp224; Mouraux A, 2010, PAIN, V150, P199, DOI 10.1016/j.pain.2010.04.026; Mouraux A, 2014, NEUROSCI LETT, V561, P69, DOI 10.1016/j.neulet.2013.12.017; Pagel B, 2009, DEVELOPMENTAL SCI, V12, P929, DOI 10.1111/j.1467-7687.2009.00845.x; Pinheiro J, 2001, MIXED EFFECTS MODELS; Roder B, 2004, CURR BIOL, V14, P121, DOI 10.1016/j.cub.2003.12.054; Sambo CF, 2013, PAIN, V154, P242, DOI 10.1016/j.pain.2012.10.010; Shore DI, 2005, PERCEPTION, V34, P1251, DOI 10.1068/p3313; Shore DI, 2002, COGNITIVE BRAIN RES, V14, P153, DOI 10.1016/S0926-6410(02)00070-8; Shore DI, 2001, PSYCHOL SCI, V12, P205, DOI 10.1111/1467-9280.00337; SMANIA N, 1995, NEUROLOGY, V45, P1725, DOI 10.1212/WNL.45.9.1725; Spence C, 2001, CAN J EXP PSYCHOL, V55, P133, DOI 10.1037/h0087360; Spence C, 2001, J EXP PSYCHOL GEN, V130, P799, DOI 10.1037//0096-3445.130.4.799; Spence C., 2004, CROSSMODAL SPACE CRO; Spence C, 2004, COGN AFFECT BEHAV NE, V4, P148, DOI 10.3758/CABN.4.2.148; Stein BE., 1993, MERGING SENSES; Sumitani M, 2007, NEUROLOGY, V68, P128, DOI 10.1212/01.wnl.0000250242.99683.57; Van Damme S, 2009, BRAIN RES, V1253, P100, DOI 10.1016/j.brainres.2008.11.072; van Elk M, 2013, CONSCIOUS COGN, V22, P545, DOI 10.1016/j.concog.2013.02.006; VANDERIET K, 1987, PAIN, V30, P395, DOI 10.1016/0304-3959(87)90027-3; Verbruggen F, 2010, P NATL ACAD SCI USA, V107, P13966, DOI 10.1073/pnas.1001957107; West B. T., 2007, LINEAR MIXED MODELS; Yamamoto S, 2001, NAT NEUROSCI, V4, P759, DOI 10.1038/89559	53	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137120	10.1371/journal.pone.0137120	http://dx.doi.org/10.1371/journal.pone.0137120			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317671	Green Submitted, Green Published, gold			2022-12-26	WOS:000360299100206
J	Weikard, R; Demasius, W; Hadlich, F; Kuhn, C				Weikard, Rosemarie; Demasius, Wiebke; Hadlich, Frieder; Kuehn, Christa			Different Blood Cell-Derived Transcriptome Signatures in Cows Exposed to Vaccination Pre- or Postpartum	PLOS ONE			English	Article							PERIPARTURIENT DAIRY-COWS; MITOCHONDRIAL COMPLEX I; BODY CONDITION SCORE; RNA-SEQ EXPERIMENTS; MILK-PRODUCTION; NEUTROPHIL FUNCTION; MAMMARY-GLAND; ALTERNATIVE ACTIVATION; MYCOBACTERIUM-BOVIS; ARGININE METABOLISM	Periparturient cows have been found to reveal immunosuppression, frequently associated with increased susceptibility to uterine and mammary infections. To improve understanding of the causes and molecular regulatory mechanisms accounting for this phenomenon around calving, we examined the effect of an antigen challenge on gene expression modulation on cows prior to (BC) or after calving (AC) using whole transcriptome sequencing (RNAseq). The transcriptome analysis of the cows' blood identified a substantially higher number of loci affected in BC cows (2,235) in response to vaccination compared to AC cows (208) and revealed a divergent transcriptional profile specific for each group. In BC cows, a variety of loci involved in immune defense and cellular signaling processes were transcriptionally activated, whereas protein biosynthesis and posttranslational processes were tremendously impaired in response to vaccination. Furthermore, energy metabolism in the blood cells of BC cows was shifted from oxidative phosphorylation to the glycolytic system. In AC cows, the number and variety of regulated pathways involved in immunomodulation and maintenance of immnunocompetence are considerably lower after vaccination, and upregulation of arginine degradation was suggested as an immunosuppressive mechanism. Elevated transcript levels of erythrocyte-specific genes involved in gas exchange processes were a specific transcriptional signature in AC cows pointing to hematopoiesis activation. The divergent and substantially lower magnitude of transcriptional modulation in response to vaccination in AC cows provides evidence for a suppressed immune capacity of early lactating cows on the molecular level and demonstrates that an efficient immune response of cows is related to their physiological and metabolic status.	[Weikard, Rosemarie; Demasius, Wiebke; Hadlich, Frieder; Kuehn, Christa] Leibniz Inst Farm Anim Biol FBN, Inst Genome Biol, Dummerstorf, Germany	Forschungsinstitut fur Nutztierbiologie (FBN)	Weikard, R (corresponding author), Leibniz Inst Farm Anim Biol FBN, Inst Genome Biol, Dummerstorf, Germany.	weikard@fbn-dummerstorf.de		Kuehn, Christa/0000-0002-0216-424X	German Ministry of Food, Agriculture, and Consumer Protection (BMELV) through the Federal Office for Agriculture and Food (BLE) [2810HS27]	German Ministry of Food, Agriculture, and Consumer Protection (BMELV) through the Federal Office for Agriculture and Food (BLE)	This study was funded by the German Ministry of Food, Agriculture, and Consumer Protection (BMELV) through the Federal Office for Agriculture and Food (BLE), grant number 2810HS27. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlaud GJ, 2001, IMMUNOL REV, V180, P136, DOI 10.1034/j.1600-065X.2001.1800112.x; Auffray I, 2001, BLOOD, V97, P2872, DOI 10.1182/blood.V97.9.2872; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; BELL AW, 1995, J ANIM SCI, V73, P2804, DOI 10.2527/1995.7392804x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Bruce LJ, 2003, BLOOD, V101, P4180, DOI 10.1182/blood-2002-09-2824; Burvenich C, 2007, J DAIRY SCI, V90, pE39, DOI 10.3168/jds.2006-696; Buttchereit N, 2012, J ANIM BREED GENET, V129, P280, DOI 10.1111/j.1439-0388.2011.00976.x; CAI TQ, 1994, AM J VET RES, V55, P934; Cammann C, 2012, CLIN CELL IMMUNOL S, V012; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Carbonneau E, 2012, J DAIRY SCI, V95, P6503, DOI 10.3168/jds.2012-5643; Demasius W, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-93; Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058; Drackley JK, 2005, ITAL J ANIM SCI, V4, P323, DOI 10.4081/ijas.2005.323; Everts B, 2012, BLOOD, V120, P1422, DOI 10.1182/blood-2012-03-419747; FERREIRA GC, 1995, J BIOENERG BIOMEMBR, V27, P151, DOI 10.1007/BF02110030; Gameiro PA, 2013, J BIOL CHEM, V288, P12967, DOI 10.1074/jbc.M112.396796; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Graugnard DE, 2012, J DAIRY SCI, V95, P1749, DOI 10.3168/jds.2011-4579; Hammon DS, 2006, VET IMMUNOL IMMUNOP, V113, P21, DOI 10.1016/j.vetimm.2006.03.022; Hammon HM, 2007, J DAIRY SCI, V90, P3247, DOI 10.3168/jds.2006-748; Hammon HM, 2010, J DAIRY SCI, V93, P3007, DOI 10.3168/jds.2009-2931; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Ingvartsen KL, 2000, J DAIRY SCI, V83, P1573, DOI 10.3168/jds.S0022-0302(00)75029-6; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jonsson NN, 2013, J DAIRY SCI, V96, P2283, DOI 10.3168/jds.2012-6173; Kamarajugadda S, 2012, MOL CELL BIOL, V32, P1893, DOI 10.1128/MCB.06248-11; Kaminski M, 2007, MOL CELL BIOL, V27, P3625, DOI 10.1128/MCB.02295-06; Kaminski MM, 2010, J IMMUNOL, V184, P4827, DOI 10.4049/jimmunol.0901662; KEHRLI ME, 1989, AM J VET RES, V50, P207; Kehrli ME, 2001, VET CLIN N AM-FOOD A, V17, P495, DOI 10.1016/S0749-0720(15)30003-7; Kimura K, 1999, J DAIRY SCI, V82, P2385, DOI 10.3168/jds.S0022-0302(99)75489-5; Kimura K, 1999, J DAIRY SCI, V82, P315, DOI 10.3168/jds.S0022-0302(99)75238-0; Koopman WJH, 2007, AM J PHYSIOL-CELL PH, V293, pC22, DOI 10.1152/ajpcell.00194.2006; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Kuhn C, 2002, ARCH TIERZUCHT, V45, P317; LeBlanc SJ, 2011, THERIOGENOLOGY, V76, P1610, DOI 10.1016/j.theriogenology.2011.07.017; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu ZB, 2014, J BIOL CHEM, V289, P29739, DOI 10.1074/jbc.M114.584821; Lu CW, 2008, J BIOL CHEM, V283, P28106, DOI 10.1074/jbc.M803508200; Mallard BA, 1998, J DAIRY SCI, V81, P585, DOI 10.3168/jds.S0022-0302(98)75612-7; Marchetti V, 2011, SCI REP-UK, V1, DOI 10.1038/srep00076; Marelli-Berg FM, 2012, IMMUNOLOGY, V136, P363, DOI 10.1111/j.1365-2567.2012.03583.x; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McLoughlin KE, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00396; MCNAMARA JP, 1986, J DAIRY SCI, V69, P3032, DOI 10.3168/jds.S0022-0302(86)80766-4; Mermelstein F, 1996, GENE DEV, V10, P1033, DOI 10.1101/gad.10.8.1033; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x; Nalpas NC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-230; Nonnecke BJ, 2003, J DAIRY SCI, V86, P2359, DOI 10.3168/jds.S0022-0302(03)73829-6; Palsson-McDermott EM, 2013, BIOESSAYS, V35, P965, DOI 10.1002/bies.201300084; Pantel A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001759; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Pearce EL, 2010, CURR OPIN IMMUNOL, V22, P314, DOI 10.1016/j.coi.2010.01.018; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Prigione A, 2014, STEM CELLS, V32, P364, DOI 10.1002/stem.1552; Pryce JE, 2001, J DAIRY SCI, V84, P1508, DOI 10.3168/jds.S0022-0302(01)70184-1; Racine R, 2009, IMMUNOL LETT, V125, P79, DOI 10.1016/j.imlet.2009.06.003; Reynolds CK, 2003, J DAIRY SCI, V86, P1201, DOI 10.3168/jds.S0022-0302(03)73704-7; Ripoll VM, 2012, FASEB J, V26, P3550, DOI 10.1096/fj.11-199935; Satchwell TJ, 2011, BLOOD, V118, P182, DOI 10.1182/blood-2010-10-314187; Sheeran FL, 2010, BBA-BIOENERGETICS, V1797, P1138, DOI 10.1016/j.bbabio.2010.04.002; Sheldon IM, 2004, ANIM REPROD SCI, V82-3, P295, DOI 10.1016/j.anireprosci.2004.04.006; Shepardson KM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004378; SIEBERT PD, 1987, P NATL ACAD SCI USA, V84, P6735, DOI 10.1073/pnas.84.19.6735; Ster C, 2012, J DAIRY SCI, V95, P708, DOI 10.3168/jds.2011-4695; Tal MC, 2011, IMMUNOL REV, V243, P215, DOI 10.1111/j.1600-065X.2011.01038.x; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Urosevic N, 2003, IMMUNOL CELL BIOL, V81, P224, DOI 10.1046/j.1440-1711.2003.01156.x; Van Dyken SJ, 2013, ANNU REV IMMUNOL, V31, P317, DOI 10.1146/annurev-immunol-032712-095906; Wallner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094102; Wang RN, 2012, IMMUNOL REV, V249, P14, DOI 10.1111/j.1600-065X.2012.01155.x; Wathes DC, 2009, PHYSIOL GENOMICS, V39, P1, DOI 10.1152/physiolgenomics.00064.2009; Weikard R, 2012, PHYSIOL GENOMICS, V44, P728, DOI 10.1152/physiolgenomics.00007.2012; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Xiao H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001494; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zerbe H, 2000, THERIOGENOLOGY, V54, P771, DOI 10.1016/S0093-691X(00)00389-7; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	89	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136927	10.1371/journal.pone.0136927	http://dx.doi.org/10.1371/journal.pone.0136927			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317664	gold, Green Published, Green Submitted			2022-12-26	WOS:000360299100174
J	Santos, SD; Galatro, TFD; Watanabe, RA; Oba-Shinjo, SM; Marie, SKN; Fujita, A				Santos, Suzana de Siqueira; de Almeida Galatro, Thais Fernanda; Watanabe, Rodrigo Akira; Oba-Shinjo, Sueli Mieko; Nagahashi Marie, Suely Kazue; Fujita, Andre			CoGA: An R Package to Identify Differentially Co-Expressed Gene Sets by Analyzing the Graph Spectra	PLOS ONE			English	Article							EXPRESSION; LINKS	Gene set analysis aims to identify predefined sets of functionally related genes that are differentially expressed between two conditions. Although gene set analysis has been very successful, by incorporating biological knowledge about the gene sets and enhancing statistical power over gene-by-gene analyses, it does not take into account the correlation (association) structure among the genes. In this work, we present CoGA (Co-expression Graph Analyzer), an R package for the identification of groups of differentially associated genes between two phenotypes. The analysis is based on concepts of Information Theory applied to the spectral distributions of the gene co-expression graphs, such as the spectral entropy to measure the randomness of a graph structure and the Jensen-Shannon divergence to discriminate classes of graphs. The package also includes common measures to compare gene co-expression networks in terms of their structural properties, such as centrality, degree distribution, shortest path length, and clustering coefficient. Besides the structural analyses, CoGA also includes graphical interfaces for visual inspection of the networks, ranking of genes according to their "importance" in the network, and the standard differential expression analysis. We show by both simulation experiments and analyses of real data that the statistical tests performed by CoGA indeed control the rate of false positives and is able to identify differentially co-expressed genes that other methods failed.	[Santos, Suzana de Siqueira; Fujita, Andre] Univ Sao Paulo, Inst Math & Stat, Dept Comp Sci, Sao Paulo, Brazil; [de Almeida Galatro, Thais Fernanda; Watanabe, Rodrigo Akira; Oba-Shinjo, Sueli Mieko; Nagahashi Marie, Suely Kazue] Univ Sao Paulo, Sch Med, Dept Neurol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Fujita, A (corresponding author), Univ Sao Paulo, Inst Math & Stat, Dept Comp Sci, Sao Paulo, Brazil.	fujita@ime.usp.br	Galatro, Thais/J-7564-2016; Marie, Suely Kazue Nagahashi/D-1870-2012; Galatro, Thais/C-9934-2013; Oba-Shinjo, Sueli M./C-4017-2012; de Siqueira Santos, Suzana/AAY-4362-2020; Fujita, Andre/Q-1271-2019	Galatro, Thais/0000-0002-3811-7680; Marie, Suely Kazue Nagahashi/0000-0003-4419-7928; Oba-Shinjo, Sueli M./0000-0002-1650-5973; de Siqueira Santos, Suzana/0000-0002-0535-0734; Fujita, Andre/0000-0002-7756-7051; Akira Watanabe, Rodrigo/0000-0003-2240-6506	Sao Paulo Research Foundation [2014/09576-5, 2013/03447-6, 2011/50761-2, 2012/25417-9]; National Council for Scientific and Technological Development [304020/2013-3, 473063/2013-1]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Nucleo de Apoio a Pesquisa-Pro-Reitoria de Pesquisa da Universidade de Sao Paulo	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Nucleo de Apoio a Pesquisa-Pro-Reitoria de Pesquisa da Universidade de Sao Paulo	This work was supported by Sao Paulo Research Foundation 2014/09576-5 (http://www.fapesp.br/, AF), Sao Paulo Research Foundation 2013/03447-6 (http://www.fapesp.br/, AF), Sao Paulo Research Foundation 2011/50761-2 (http://www.fapesp.br/, AF), Sao Paulo Research Foundation 2012/25417-9 (http://www.fapesp.br/, SSS), National Council for Scientific and Technological Development 304020/2013-3 (http://www.cnpq.br/, AF), National Council for Scientific and Technological Development 473063/2013-1 (http://www.cnpq.br/, AF), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (AF), and Nucleo de Apoio a Pesquisa-Pro-Reitoria de Pesquisa da Universidade de Sao Paulo (AF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar D, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002955; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chan WY, 2000, AM J PATHOL, V156, P409, DOI 10.1016/S0002-9440(10)64744-X; Choi Y, 2009, BIOINFORMATICS, V25, P2780, DOI 10.1093/bioinformatics/btp502; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; de la Fuente A, 2010, TRENDS GENET, V26, P326, DOI 10.1016/j.tig.2010.05.001; Huber RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057793; Hudson NJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000382; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kato K, 2003, INT J GYNECOL PATHOL, V22, P334, DOI 10.1097/01.pgp.0000092129.10100.5e; Keller MP, 2008, GENOME RES, V18, P706, DOI 10.1101/gr.074914.107; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Liu BH, 2010, BIOINFORMATICS, V26, P2637, DOI 10.1093/bioinformatics/btq471; Pearson K, 1920, BIOMETRIKA, V13, P25, DOI 10.1093/biomet/13.1.25; Purow BW, 2005, CANCER RES, V65, P2353, DOI 10.1158/0008-5472.CAN-04-1890; Rahmatallah Y, 2014, BIOINFORMATICS, V30, P360, DOI 10.1093/bioinformatics/btt687; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Silverman B.W., 1986, DENSITY ESTIMATION S; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Stockhausen MT, 2010, NEURO-ONCOLOGY, V12, P199, DOI 10.1093/neuonc/nop022; Sturges HA, 1926, J AM STAT ASSOC, V21, P65, DOI 10.1080/01621459.1926.10502161; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049949; Tesson BM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-497; Van Mieghem P., 2010, GRAPH SPECTRA COMPLE; Watson M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-509; Yang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079729; Yu H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-315; Zhang XH, 2012, CANCER SCI, V103, P181, DOI 10.1111/j.1349-7006.2011.02154.x	31	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0135831	10.1371/journal.pone.0135831	http://dx.doi.org/10.1371/journal.pone.0135831			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313749	gold, Green Published, Green Submitted			2022-12-26	WOS:000360144000027
J	Mailu, BM; Li, L; Arthur, J; Nelson, TM; Ramasamy, G; Fritz-Wolf, K; Becker, K; Gardner, MJ				Mailu, Boniface M.; Li, Ling; Arthur, Jen; Nelson, Todd M.; Ramasamy, Gowthaman; Fritz-Wolf, Karin; Becker, Katja; Gardner, Malcolm J.			Plasmodium Apicoplast Gln-tRNA(Gln) Biosynthesis Utilizes a Unique GatAB Amidotransferase Essential for Erythrocytic Stage Parasites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASE; GLUTAMINYL-TRANSFER-RNA; PLASTID-LIKE DNA; ASPARAGINYL-TRANSFER-RNA; AMINO-ACID; THERMUS-THERMOPHILUS; MALARIA PARASITES; GENOME SEQUENCE; ASP-TRNA(ASN) AMIDOTRANSFERASE; GLU-TRNA(GLN) AMIDOTRANSFERASE	The malaria parasite Plasmodium falciparum apicoplast indirect aminoacylation pathway utilizes a non-discriminating glutamyl-tRNA synthetase to synthesize Glu-tRNA(Gln) and a glutaminyl-tRNA amidotransferase to convert Glu-tRNA(Gln) to Gln-tRNA(Gln). Here, we show that Plasmodium falciparum and other apicomplexans possess a unique heterodimeric glutamyl-tRNA amidotransferase consisting of GatA and GatB subunits (GatAB). We localized the P. falciparum GatA and GatB subunits to the apicoplast in blood stage parasites and demonstrated that recombinant GatAB converts Glu-tRNA(Gln) to Gln-tRNA(Gln) in vitro. We demonstrate that the apicoplast GatAB-catalyzed reaction is essential to the parasite blood stages because we could not delete the Plasmodium berghei gene encoding GatA in blood stage parasites in vivo. A phylogenetic analysis placed the split between Plasmodium GatB, archaeal GatE, and bacterial GatB prior to the phylogenetic divide between bacteria and archaea. Moreover, Plasmodium GatA also appears to have emerged prior to the bacterial-archaeal phylogenetic divide. Thus, although GatAB is found in Plasmodium, it emerged prior to the phylogenetic separation of archaea and bacteria.	[Mailu, Boniface M.; Li, Ling; Arthur, Jen; Nelson, Todd M.; Ramasamy, Gowthaman; Gardner, Malcolm J.] Ctr Infect Dis Res, Seattle, WA 98109 USA; [Gardner, Malcolm J.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Fritz-Wolf, Karin; Becker, Katja] Univ Giessen, Interdisciplinary Res Ctr, Dept Biochem & Mol Biol, D-35392 Giessen, Germany; [Fritz-Wolf, Karin] Max Planck Inst Med Res, D-69120 Heidelberg, Germany	Center for Infectious Disease Research; Walter Reed Army Institute of Research (WRAIR); University of Washington; University of Washington Seattle; Justus Liebig University Giessen; Max Planck Society	Gardner, MJ (corresponding author), J Craig Venter Inst, 4120 Capricorn Lane, La Jolla, CA 92037 USA.	mjgardner1@mac.com			King Abdullah University of Science and Technology OCRF (GCR) [FIC/2010/09]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081097] Funding Source: NIH RePORTER	King Abdullah University of Science and Technology OCRF (GCR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Geoffrey McFadden for providing anti-ACP antibody, J. Lapointe and A. Weiner for plasmids expressing CCA-adding enzyme, and Y. M. Hou for the pGFIB vector. We thank MR4 for providing P. falciparum 3D7 parasites contributed by Dan Carucci and Alister Craig. The unpublished P. berghei genome sequence data were produced by the Pathogen Sequencing Group at the Wellcome Trust Sanger Institute and can be obtained on line. The unpublished C. velia and V. brassicaformis ortholog sequences were graciously provided by Arnab Pain and Hifzur Ansari of King Abdullah University of Science and Technology. The Chromera and Vitrella sequencing project was funded by a King Abdullah University of Science and Technology OCRF (GCR) award (FIC/2010/09) to Arnab Pain. We also thank Jonathan Eisen and Dongying Wu for their consulting on the phylogenetic analyses.	Akochy PM, 2004, J BACTERIOL, V186, P767, DOI 10.1128/JB.186.3.767-776.2004; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Araiso Y, 2014, NUCLEIC ACIDS RES, V42, P6052, DOI 10.1093/nar/gku234; Arisue N, 2012, MOL BIOL EVOL, V29, P2095, DOI 10.1093/molbev/mss082; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Bailly M, 2007, MOL CELL, V28, P228, DOI 10.1016/j.molcel.2007.08.017; Bailly M, 2006, NUCLEIC ACIDS RES, V34, P6083, DOI 10.1093/nar/gkl622; Becker HD, 2000, BIOCHEMISTRY-US, V39, P3216, DOI 10.1021/bi992573y; Becker HD, 1997, BIOCHEMISTRY-US, V36, P8785, DOI 10.1021/bi970392v; Becker HD, 2000, FEBS LETT, V476, P140, DOI 10.1016/S0014-5793(00)01697-5; Becker HD, 1998, P NATL ACAD SCI USA, V95, P12832, DOI 10.1073/pnas.95.22.12832; Bhatt TK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-644; Bour T, 2009, J BIOL CHEM, V284, P18893, DOI 10.1074/jbc.M109.015297; Brayton KA, 2007, PLOS PATHOG, V3, P1401, DOI 10.1371/journal.ppat.0030148; Brinkmann H, 2005, SYST BIOL, V54, P743, DOI 10.1080/10635150500234609; Brown JR, 1999, J MOL EVOL, V49, P485, DOI 10.1007/PL00006571; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cathopoulis TJT, 2007, ANAL BIOCHEM, V360, P151, DOI 10.1016/j.ab.2006.10.019; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Chuawong P, 2006, BIOCHEMISTRY-US, V45, P8079, DOI 10.1021/bi060189c; Crabb BS, 1996, P NATL ACAD SCI USA, V93, P7289, DOI 10.1073/pnas.93.14.7289; Curnow AW, 1998, P NATL ACAD SCI USA, V95, P12838, DOI 10.1073/pnas.95.22.12838; Curnow AW, 1997, P NATL ACAD SCI USA, V94, P11819, DOI 10.1073/pnas.94.22.11819; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Duchene AM, 2005, P NATL ACAD SCI USA, V102, P16484, DOI 10.1073/pnas.0504682102; FEAGIN JE, 1992, NUCLEIC ACIDS RES, V20, P879, DOI 10.1093/nar/20.4.879; Feng L, 2005, J BIOL CHEM, V280, P8150, DOI 10.1074/jbc.M411098200; Foth BJ, 2003, SCIENCE, V299, P705, DOI 10.1126/science.1078599; Frechin M, 2009, GENE DEV, V23, P1119, DOI 10.1101/gad.518109; GARDNER MJ, 1994, GENE, V144, P307, DOI 10.1016/0378-1119(94)90395-6; GARDNER MJ, 1991, MOL BIOCHEM PARASIT, V44, P115, DOI 10.1016/0166-6851(91)90227-W; GARDNER MJ, 1991, MOL BIOCHEM PARASIT, V48, P77, DOI 10.1016/0166-6851(91)90166-4; Gardner MJ, 2005, SCIENCE, V309, P134, DOI 10.1126/science.1110439; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Goodman CD, 2013, EXPERT OPIN THER TAR, V17, P167, DOI 10.1517/14728222.2013.739158; Gunther S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005510; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall N, 2002, NATURE, V419, P527, DOI 10.1038/nature01095; Harpel MR, 2002, BIOCHEMISTRY-US, V41, P6398, DOI 10.1021/bi012126u; Hopkins J, 1999, PROTIST, V150, P283, DOI 10.1016/S1434-4610(99)70030-1; Jackson KE, 2011, TRENDS PARASITOL, V27, P467, DOI 10.1016/j.pt.2011.05.005; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Labaied M, 2007, MOL BIOCHEM PARASIT, V153, P158, DOI 10.1016/j.molbiopara.2007.03.001; LAMOUR V, 1994, P NATL ACAD SCI USA, V91, P8670, DOI 10.1073/pnas.91.18.8670; LAPOINTE J, 1986, J BACTERIOL, V165, P88, DOI 10.1128/jb.165.1.88-93.1986; Mailu BM, 2013, J BIOL CHEM, V288, P32539, DOI 10.1074/jbc.M113.507467; Martinsen ES, 2008, MOL PHYLOGENET EVOL, V47, P261, DOI 10.1016/j.ympev.2007.11.012; Mikolajczak SA, 2008, MOL BIOCHEM PARASIT, V158, P213, DOI 10.1016/j.molbiopara.2007.12.006; Min B, 2002, P NATL ACAD SCI USA, V99, P2678, DOI 10.1073/pnas.012027399; Nagaraja VA, 2009, INT J PARASITOL, V39, P559, DOI 10.1016/j.ijpara.2008.10.011; Nakamura A, 2010, NUCLEIC ACIDS RES, V38, P672, DOI 10.1093/nar/gkp955; Nakamura A, 2006, SCIENCE, V312, P1954, DOI 10.1126/science.1127156; Pain A, 2005, SCIENCE, V309, P131, DOI 10.1126/science.1110418; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pino P, 2010, MOL MICROBIOL, V76, P706, DOI 10.1111/j.1365-2958.2010.07128.x; Plaimas K, 2013, INFECT GENET EVOL, V20, P389, DOI 10.1016/j.meegid.2013.09.019; PREISER P, 1995, NUCLEIC ACIDS RES, V23, P4329, DOI 10.1093/nar/23.21.4329; Raczniak G, 2001, J BIOL CHEM, V276, P45862, DOI 10.1074/jbc.M109494200; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Rampias T, 2010, NUCLEIC ACIDS RES, V38, P5774, DOI 10.1093/nar/gkq336; Roy H, 2003, P NATL ACAD SCI USA, V100, P9837, DOI 10.1073/pnas.1632156100; Salazar JC, 2003, P NATL ACAD SCI USA, V100, P13863, DOI 10.1073/pnas.1936123100; Salazar JC, 2001, FEBS LETT, V500, P129, DOI 10.1016/S0014-5793(01)02600-X; Schmitt E, 2005, STRUCTURE, V13, P1421, DOI 10.1016/j.str.2005.06.016; Seeber F, 2002, INT J PARASITOL, V32, P1207, DOI 10.1016/S0020-7519(02)00022-X; Sheppard K, 2008, NUCLEIC ACIDS RES, V36, P1813, DOI 10.1093/nar/gkn015; Sheppard K, 2008, METHODS, V44, P139, DOI 10.1016/j.ymeth.2007.06.010; Sheppard K, 2007, J BIOL CHEM, V282, P11866, DOI 10.1074/jbc.M700398200; Shin S, 2002, EMBO J, V21, P2509, DOI 10.1093/emboj/21.11.2509; Skouloubris S, 2003, P NATL ACAD SCI USA, V100, P11297, DOI 10.1073/pnas.1932482100; SRIVASTAVA DK, 1986, SCIENCE, V234, P1081, DOI 10.1126/science.3775377; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tumbula DL, 2000, NATURE, V407, P106, DOI 10.1038/35024120; van Dooren GG, 2005, MOL MICROBIOL, V57, P405, DOI 10.1111/j.1365-2958.2005.04699.x; Vaughan AM, 2009, CELL MICROBIOL, V11, P506, DOI 10.1111/j.1462-5822.2008.01270.x; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wilson RJM, 1996, J MOL BIOL, V261, P155, DOI 10.1006/jmbi.1996.0449; WU YM, 1995, P NATL ACAD SCI USA, V92, P973, DOI 10.1073/pnas.92.4.973; Yeh E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001138; Zuegge J, 2001, GENE, V280, P19, DOI 10.1016/S0378-1119(01)00776-4	86	10	10	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29629	29641		10.1074/jbc.M115.655100	http://dx.doi.org/10.1074/jbc.M115.655100			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26318454	hybrid, Green Published			2022-12-26	WOS:000366613400043
J	Gong, LH; Liu, M; Zeng, T; Shi, XL; Yuan, C; Andreasen, PA; Huang, MD				Gong, Lihu; Liu, Min; Zeng, Tu; Shi, Xiaoli; Yuan, Cai; Andreasen, Peter A.; Huang, Mingdong			Crystal Structure of the Michaelis Complex between Tissue-type Plasminogen Activator and Plasminogen Activators Inhibitor-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASE COMPLEX; TERNARY COMPLEX; HIGH-RESOLUTION; UROKINASE-TYPE; SERPIN; ANTITHROMBIN; REVEALS; HEPARIN; SPECIFICITY; MECHANISM	Thrombosis is a leading cause of death worldwide. Recombinant tissue-type plasminogen activator (tPA) is the Food and Drug Administration-approved thrombolytic drug. tPA is rapidly inactivated by endogenous plasminogen activator inhibitor-1 (PAI-1). Engineering on tPA to reduce its inhibition by PAI-1 without compromising its thrombolytic effect is a continuous effort. Precise details, with atomic resolution, of the molecular interactions between tPA and PAI-1 remain unknown despite previous extensive studies. Here, we report the crystal structure of the tPA.PAI-1 Michaelis complex, which shows significant differences from the structure of its urokinase-type plasminogen activator analogue, the uPA.PAI-1 Michaelis complex. The PAI-1 reactive center loop adopts a unique kinked conformation. The structure provides detailed interactions between tPA 37- and 60-loops with PAI-1. On the tPA side, the S2 and S1 beta pockets open up to accommodate PAI-1. This study provides structural basis to understand the specificity of PAI-1 and to design newer generation of thrombolytic agents with reduced PAI-1 inactivation.	[Gong, Lihu; Liu, Min; Zeng, Tu; Shi, Xiaoli; Yuan, Cai; Huang, Mingdong] Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Fujian, Peoples R China; [Gong, Lihu; Liu, Min; Zeng, Tu; Shi, Xiaoli; Yuan, Cai; Huang, Mingdong] Chinese Acad Sci, Fujian Inst Res Struct Matter, Danish Chinese Ctr Proteases & Canc, Fuzhou 350002, Fujian, Peoples R China; [Gong, Lihu; Liu, Min; Huang, Mingdong] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Andreasen, Peter A.] Aarhus Univ, Dept Mol Biol & Genet, Danish Chinese Ctr Proteases & Canc, DK-8000 Aarhus C, Denmark	Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS; Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Aarhus University	Huang, MD (corresponding author), Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Fujian, Peoples R China.	mhuang@fjirsm.ac.cn	Huang, Mingdong/J-4278-2017	Huang, Mingdong/0000-0003-0085-9141	National Natural Science Foundation of China [31170707, 31370737]; CAS/SAFEA; Chinese Academy of Sciences; Aarhus University Research Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS/SAFEA(Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences); Aarhus University Research Foundation	This work was supported by Grants 31170707 and 31370737 from the National Natural Science Foundation of China and the CAS/SAFEA. International Partnership Program for Creative Research Teams. The authors declare that they have no conflicts of interest with the contents of this article.; Awarded a Chinese Academy of Sciences visiting professorship for senior international scientists.; Awarded an Aarhus University Research Foundation visiting professorship.	Baruah DB, 2006, VASC PHARMACOL, V44, P1, DOI 10.1016/j.vph.2005.09.003; BENNETT WF, 1991, J BIOL CHEM, V266, P5191; BUSSO N, 1987, CANCER RES, V47, P364; Butenas S, 1997, BIOCHEMISTRY-US, V36, P2123, DOI 10.1021/bi9617670; Cazzolli G, 2014, P NATL ACAD SCI USA, V111, P15414, DOI 10.1073/pnas.1407528111; Cesari M, 2010, CARDIOVASC THER, V28, pe72, DOI 10.1111/j.1755-5922.2010.00171.x; Croucher DR, 2008, NAT REV CANCER, V8, P535, DOI 10.1038/nrc2400; Dekker RJ, 1999, J MOL BIOL, V293, P613, DOI 10.1006/jmbi.1999.3178; DeLano WL, 2004, PYMOL MOL GRAPHICS S; Dementiev A, 2003, J BIOL CHEM, V278, P37881, DOI 10.1074/jbc.M305195200; Dupont DM, 2009, FRONT BIOSCI-LANDMRK, V14, P1337, DOI 10.2741/3312; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FESTOFF BW, 1990, J CELL PHYSIOL, V144, P272, DOI 10.1002/jcp.1041440213; Grotta JC, 2001, ARCH NEUROL-CHICAGO, V58, P2009, DOI 10.1001/archneur.58.12.2009; HAMSTEN A, 1985, NEW ENGL J MED, V313, P1557, DOI 10.1056/NEJM198512193132501; Hatcher MA, 2011, ANN PHARMACOTHER, V45, P364, DOI 10.1345/aph.1P525; Ibarra CA, 2004, J BIOL CHEM, V279, P3643, DOI 10.1074/jbc.M310601200; Johnson DJD, 2006, EMBO J, V25, P2029, DOI 10.1038/sj.emboj.7601089; Johnson DJD, 2010, P NATL ACAD SCI USA, V107, P645, DOI 10.1073/pnas.0910144107; Katz BA, 2001, J MOL BIOL, V307, P1451, DOI 10.1006/jmbi.2001.4516; KEIJER J, 1991, BLOOD, V78, P401; KEYT BA, 1994, P NATL ACAD SCI USA, V91, P3670, DOI 10.1073/pnas.91.9.3670; Kohler HP, 2000, NEW ENGL J MED, V342, P1792, DOI 10.1056/NEJM200006153422406; Korin N, 2012, SCIENCE, V337, P738, DOI 10.1126/science.1217815; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lamba D, 1996, J MOL BIOL, V258, P117, DOI 10.1006/jmbi.1996.0238; Lapchak Paul A, 2002, Curr Neurol Neurosci Rep, V2, P38, DOI 10.1007/s11910-002-0051-0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; Li W, 2012, BLOOD, V120, P459, DOI 10.1182/blood-2012-03-415869; Lin ZH, 2013, CHEM BIOL, V20, P253, DOI 10.1016/j.chembiol.2013.01.002; Lin ZH, 2011, J BIOL CHEM, V286, P7027, DOI 10.1074/jbc.M110.204537; MADISON EL, 1990, J BIOL CHEM, V265, P21423; MADISON EL, 1990, P NATL ACAD SCI USA, V87, P3530, DOI 10.1073/pnas.87.9.3530; MADISON EL, 1989, NATURE, V339, P721, DOI 10.1038/339721a0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nienaber V, 2000, J BIOL CHEM, V275, P7239, DOI 10.1074/jbc.275.10.7239; Olson ST, 2001, BIOCHEMISTRY-US, V40, P11742, DOI 10.1021/bi0107290; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Raskob GE, 2014, THROMB RES, V134, P931, DOI 10.1016/j.thromres.2014.08.014; REFINO CJ, 1993, THROMB HAEMOSTASIS, V70, P313; Renatus M, 1997, EMBO J, V16, P4797, DOI 10.1093/emboj/16.16.4797; Renatus M, 1997, J BIOL CHEM, V272, P21713, DOI 10.1074/jbc.272.35.21713; Sharp AM, 1999, STRUCTURE, V7, P111, DOI 10.1016/S0969-2126(99)80018-5; Sichler K, 2003, J BIOL CHEM, V278, P4121, DOI 10.1074/jbc.M210722200; Stout TJ, 2000, BIOCHEMISTRY-US, V39, P8460, DOI 10.1021/bi000290w; Tachias K, 1997, J BIOL CHEM, V272, P14580, DOI 10.1074/jbc.272.23.14580; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Van de Craen B, 2012, THROMB RES, V130, P576, DOI 10.1016/j.thromres.2012.06.023; Vaughan Douglas E, 2011, Trans Am Clin Climatol Assoc, V122, P312; Vindigni A, 2000, PROTEIN SCI, V9, P619; Wang Qingcai, 2003, BMC Biochem, V4, P5, DOI 10.1186/1471-2091-4-5; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Xue Y, 2012, J THROMB HAEMOST, V10, P1385, DOI 10.1111/j.1538-7836.2012.04765.x; Ye S, 2001, NAT STRUCT BIOL, V8, P979, DOI 10.1038/nsb1101-979; Yu HY, 2013, CHINESE J STRUC CHEM, V32, P961; Zhao BY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115872; Zhao GX, 2006, PROTEIN EXPRES PURIF, V49, P71, DOI 10.1016/j.pep.2006.05.005	58	33	37	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					25795	25804		10.1074/jbc.M115.677567	http://dx.doi.org/10.1074/jbc.M115.677567			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26324706	hybrid, Green Published			2022-12-26	WOS:000363527300002
J	Edye, ME; Brough, D; Allan, SM				Edye, Michelle E.; Brough, David; Allan, Stuart M.			Acid-dependent Interleukin-1 (IL-1) Cleavage Limits Available Pro-IL-1 beta for Caspase-1 Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY RESPONSE; NLRP3 INFLAMMASOME; DANGER SIGNAL; RECEPTOR; PH; PROTEINASE-3; ACTIVATION; IL-1-BETA; ARTHRITIS; DISEASES	Noncommunicable diseases such as cardiovascular disease (stroke and heart attack), cancer, chronic respiratory disease, and diabetes are a leading cause of death and disability worldwide and are worsened by inflammation. IL-1 is a driver of inflammation and implicated in many noncommunicable diseases. Acidosis is also a key feature of the inflammatory microenvironment; therefore it is vital to explore IL-1 signaling under acidic conditions. A HEK-IL-1 reporter assay and brain endothelial cell line were used to explore activity of mature IL-1 alpha and IL-1 alpha at pH 7.4 and pH 6.2, an acidic pH that can be reached under inflammatory or ischemic conditions, alongside cathepsin D-cleaved 20-kDa IL-1 beta produced under acidic conditions. We report that mature IL-1 signaling at IL-1 receptor type 1 (IL-1R1) is maintained at pH 6.2, but the activity of the decoy receptor, IL-1R2, is reduced. Additionally, cathepsin D-cleaved 20-kDa IL-1 beta was minimally active at IL-1R1 and was not further cleaved to highly active 17-kDa IL-1 beta. Therefore formation of the 20-kDa form of IL-1 beta may prevent the generation of mature bioactive IL-1 beta and thus may limit inflammation.	[Edye, Michelle E.; Brough, David; Allan, Stuart M.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Brough, D (corresponding author), Univ Manchester, Fac Life Sci, AV Hill Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	david.brough@manchester.ac.uk	Allan, Stuart/AAL-1245-2020	Allan, Stuart/0000-0001-9646-4456; Brough, David/0000-0002-2250-2381; Edye, Michelle/0000-0003-0727-8366	Biotechnology and Biological Sciences Research Council; Pfizer; Biotechnology and Biological Sciences Research Council [1118598] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Pfizer(Pfizer); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council and Pfizer. The authors declare that they have no conflicts of interest with the contents of this article.	Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Angell SY, 2012, SCIENCE, V337, P1456, DOI 10.1126/science.1228293; Arend WP, 1998, ANNU REV IMMUNOL, V16, P27, DOI 10.1146/annurev.immunol.16.1.27; Baroja-Mazo A, 2014, NAT IMMUNOL, V15, P738, DOI 10.1038/ni.2919; BLACK RA, 1988, J BIOL CHEM, V263, P9437; Coeshott C, 1999, P NATL ACAD SCI USA, V96, P6261, DOI 10.1073/pnas.96.11.6261; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Denes A, 2011, CEREBROVASC DIS, V32, P517, DOI 10.1159/000332205; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Edye ME, 2013, J BIOL CHEM, V288, P30485, DOI 10.1074/jbc.M113.478941; Garlanda C, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00180; Guma M, 2009, ARTHRITIS RHEUM-US, V60, P3642, DOI 10.1002/art.24959; HAZUDA DJ, 1991, J BIOL CHEM, V266, P7081; Joosten LAB, 2009, ARTHRITIS RHEUM, V60, P3651, DOI 10.1002/art.25006; Kellum JA, 2004, AM J PHYSIOL-REG I, V286, pR686, DOI 10.1152/ajpregu.00564.2003; Menkin V, 1937, AM J PATHOL, V13, P25; NEMOTO EM, 1981, STROKE, V12, P77, DOI 10.1161/01.STR.12.1.77; Netea MG, 2015, ANNU REV IMMUNOL, V33, P49, DOI 10.1146/annurev-immunol-032414-112306; Rajamaki K, 2013, J BIOL CHEM, V288, P13410, DOI 10.1074/jbc.M112.426254; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shimizu K, 2015, J IMMUNOL, V194, P3156, DOI 10.4049/jimmunol.1402155; Smith DE, 2003, IMMUNITY, V18, P87, DOI 10.1016/S1074-7613(02)00514-9; Takenouchi T., 2014, INFLAMMASOME, V1, P76, DOI DOI 10.2478/INFL-2014-0008; Takenouchi T, 2011, J NEUROCHEM, V117, P712, DOI 10.1111/j.1471-4159.2011.07240.x; WANG RIH, 1955, J NEUROPHYSIOL, V18, P130, DOI 10.1152/jn.1955.18.2.130; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110; Zheng Y, 2013, IMMUNITY, V38, P285, DOI 10.1016/j.immuni.2013.01.008	29	11	14	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25374	25381		10.1074/jbc.M115.667162	http://dx.doi.org/10.1074/jbc.M115.667162			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26324708	Green Published, hybrid			2022-12-26	WOS:000362962800015
J	Mishanina, TV; Yadav, PK; Ballou, DP; Banerjee, R				Mishanina, Tatiana V.; Yadav, Prannod K.; Ballou, David P.; Banerjee, Ruma			Transient Kinetic Analysis of Hydrogen Sulfide Oxidation Catalyzed by Human Sulfide Quinone Oxidoreductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFANE SULFUR; H2S BIOGENESIS; THIOSULFATE; OXIDASE	The first step in the mitochondrial sulfide oxidation pathway is catalyzed by sulfide quinone oxidoreductase (SQR), which belongs to the family of flavoprotein disulfide oxidoreductases. During the catalytic cycle, the flavin cofactor is intermittently reduced by sulfide and oxidized by ubiquinone, linking H2S oxidation to the electron transfer chain and to energy metabolism. Human SQR can use multiple thiophilic acceptors, including sulfide, sulfite, and glutathione, to form as products, hydrodisulfide, thiosulfate, and glutathione persulfide, respectively. In this study, we have used transient kinetics to examine the mechanism of the flavin reductive half-reaction and have determined the redox potential of the bound flavin to be -123 +/- 7 mV. We observe formation of an unusually intense charge-transfer (CT) complex when the enzyme is exposed to sulfide and unexpectedly, when it is exposed to sulfite. In the canonical reaction, sulfide serves as the sulfur donor and sulfite serves as the acceptor, forming thiosulfate. We show that thiosulfate is also formed when sulfide is added to the sulfite-induced CT intermediate, representing a new mechanism for thiosulfate formation. The CT complex is formed at a kinetically competent rate by reaction with sulfide but not with sulfite. Our study indicates that sulfide addition to the active site disulfide is preferred under normal turnover conditions. However, under pathological conditions when sulfite concentrations are high, sulfite could compete with sulfide for addition to the active site disulfide, leading to attenuation of SQR activity and to an alternate route for thiosulfate formation.	[Mishanina, Tatiana V.; Yadav, Prannod K.; Ballou, David P.; Banerjee, Ruma] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, 4220C MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Regan, Clinton/E-6250-2012; Yadav, Pramod K./A-6166-2010	Yadav, Pramod K./0000-0003-0026-1684; Mishanina, Tatiana/0000-0001-7400-3501	National Institutes of Health [GM112455]; American Heart Association [14POST18760003]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM112455 (to R. B.) and by a postdoctoral fellowship from the American Heart Association (14POST18760003) (to P. K. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	ABRAMOVITZ AS, 1976, J BIOL CHEM, V251, P5327; Argyrou A, 2004, PROG NUCLEIC ACID RE, V78, P89, DOI 10.1016/S0079-6603(04)78003-4; Banerjee R, 2015, METHOD ENZYMOL, V554, P189, DOI 10.1016/bs.mie.2014.11.016; Brito JA, 2009, BIOCHEMISTRY-US, V48, P5613, DOI 10.1021/bi9003827; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; GHISLA S, 1974, BIOCHEMISTRY-US, V13, P589, DOI 10.1021/bi00700a029; Ghisla S, 2004, EUR J BIOCHEM, V271, P494, DOI 10.1046/j.1432-1033.2003.03946.x; Giles GI, 2002, BIOL CHEM, V383, P375, DOI 10.1515/BC.2002.042; Goubern M, 2007, FASEB J, V21, P1699, DOI 10.1096/fj.06-7407com; HEVESI L, 1973, BIOCHEMISTRY-US, V12, P290, DOI 10.1021/bi00726a018; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; Jackson MR, 2012, BIOCHEMISTRY-US, V51, P6804, DOI 10.1021/bi300778t; Kabil O, 2014, ANNU REV NUTR, V34, P171, DOI 10.1146/annurev-nutr-071813-105654; Kabil O, 2014, BBA-PROTEINS PROTEOM, V1844, P1355, DOI 10.1016/j.bbapap.2014.01.002; Kabil O, 2011, ANTIOXID REDOX SIGN, V15, P363, DOI 10.1089/ars.2010.3781; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Kimura H, 2010, ANTIOXID REDOX SIGN, V12, P1111, DOI 10.1089/ars.2009.2919; Libiad M, 2014, J BIOL CHEM, V289, P30901, DOI 10.1074/jbc.M114.602664; Marcia M, 2009, P NATL ACAD SCI USA, V106, P9625, DOI 10.1073/pnas.0904165106; Mishanina AV, 2015, NAT CHEM BIOL, V11, P457, DOI 10.1038/nchembio.1834; Polhemus DJ, 2014, CIRC RES, V114, P730, DOI 10.1161/CIRCRESAHA.114.300505; POWELL MA, 1986, SCIENCE, V233, P563, DOI 10.1126/science.233.4763.563; SAHLMAN L, 1986, EUR J BIOCHEM, V156, P479, DOI 10.1111/j.1432-1033.1986.tb09606.x; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; SHIH VE, 1977, NEW ENGL J MED, V297, P1022, DOI 10.1056/NEJM197711102971902; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; STIPANUK MH, 1982, BIOCHEM J, V206, P267, DOI 10.1042/bj2060267; THORPE C, 1976, J BIOL CHEM, V251, P7726; URBAN PF, 1969, EUR J BIOCHEM, V9, P519, DOI 10.1111/j.1432-1033.1969.tb00640.x; Vitvitsky V, 2015, J BIOL CHEM, V290, P8310, DOI 10.1074/jbc.M115.639831; Vitvitsky V, 2012, ANTIOXID REDOX SIGN, V17, P22, DOI 10.1089/ars.2011.4310; Wagner MA, 2000, BIOCHEMISTRY-US, V39, P8813, DOI 10.1021/bi000349z; WILLIAMSON G, 1982, J BIOL CHEM, V257, P4314; Yadav PK, 2013, J BIOL CHEM, V288, P20002, DOI 10.1074/jbc.M113.466177; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213	35	44	45	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					25072	25080		10.1074/jbc.M115.682369	http://dx.doi.org/10.1074/jbc.M115.682369			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26318450	hybrid, Green Published			2022-12-26	WOS:000362598300035
J	Kushniarevich, A; Utevska, O; Chuhryaeva, M; Agdzhoyan, A; Dibirova, K; Uktveryte, I; Mols, M; Mulahasanovic, L; Pshenichnov, A; Frolova, S; Shanko, A; Metspalu, E; Reidla, M; Tambets, K; Tamm, E; Koshel, S; Zaporozhchenko, V; Atramentova, L; Kucinskas, V; Davydenko, O; Goncharova, O; Evseeva, I; Churnosov, M; Pocheshchova, E; Yunusbayev, B; Khusnutdinova, E; Marjanovic, D; Rudan, P; Rootsi, S; Yankovsky, N; Endicott, P; Kassian, A; Dybo, A; Tyler-Smith, C; Balanovska, E; Metspalu, M; Kivisild, T; Villems, R; Balanovsky, O				Kushniarevich, Alena; Utevska, Olga; Chuhryaeva, Marina; Agdzhoyan, Anastasia; Dibirova, Khadizhat; Uktveryte, Ingrida; Moels, Maert; Mulahasanovic, Lejla; Pshenichnov, Andrey; Frolova, Svetlana; Shanko, Andrey; Metspalu, Ene; Reidla, Maere; Tambets, Kristiina; Tamm, Erika; Koshel, Sergey; Zaporozhchenko, Valery; Atramentova, Lubov; Kucinskas, Vaidutis; Davydenko, Oleg; Goncharova, Olga; Evseeva, Irina; Churnosov, Michail; Pocheshchova, Elvira; Yunusbayev, Bayazit; Khusnutdinova, Elza; Marjanovic, Damir; Rudan, Pavao; Rootsi, Siiri; Yankovsky, Nick; Endicott, Phillip; Kassian, Alexei; Dybo, Anna; Tyler-Smith, Chris; Balanovska, Elena; Metspalu, Mait; Kivisild, Toomas; Villems, Richard; Balanovsky, Oleg		Genographic Consortium	Genetic Heritage of the Balto-Slavic Speaking Populations: A Synthesis of Autosomal, Mitochondrial and Y-Chromosomal Data	PLOS ONE			English	Article							GEOGRAPHIC STRUCTURE; DNA VARIABILITY; EASTERN; DIVERSITY; EXPANSION; EUROPEANS; IDENTITY; GERMANY; TREE	The Slavic branch of the Balto-Slavic sub-family of Indo-European languages underwent rapid divergence as a result of the spatial expansion of its speakers from Central-East Europe, in early medieval times. This expansion-mainly to East Europe and the northern Balkans-resulted in the incorporation of genetic components from numerous autochthonous populations into the Slavic gene pools. Here, we characterize genetic variation in all extant ethnic groups speaking Balto-Slavic languages by analyzing mitochondrial DNA (n = 6,876), Y-chromosomes (n = 6,079) and genome-wide SNP profiles (n = 296), within the context of other European populations. We also reassess the phylogeny of Slavic languages within the Balto-Slavic branch of Indo-European. We find that genetic distances among Balto-Slavic populations, based on autosomal and Y-chromosomal loci, show a high correlation (0.9) both with each other and with geography, but a slightly lower correlation (0.7) with mitochondrial DNA and linguistic affiliation. The data suggest that genetic diversity of the present-day Slavs was predominantly shaped in situ, and we detect two different substrata: 'central-east European' for West and East Slavs, and 'south-east European' for South Slavs. A pattern of distribution of segments identical by descent between groups of East-West and South Slavs suggests shared ancestry or a modest gene flow between those two groups, which might derive from the historic spread of Slavic people.	[Kushniarevich, Alena; Metspalu, Ene; Reidla, Maere; Tambets, Kristiina; Tamm, Erika; Yunusbayev, Bayazit; Rootsi, Siiri; Metspalu, Mait; Kivisild, Toomas; Villems, Richard] Estonian Bioctr, Evolutionary Biol Grp, Tartu, Estonia; [Kushniarevich, Alena; Davydenko, Oleg] Natl Acad Sci Belarus, Inst Cytol & Genet, Minsk, BELARUS; [Utevska, Olga; Atramentova, Lubov] Kharkov Natl Univ, Dept Genet & Cytol, Kharkov, Ukraine; [Utevska, Olga; Chuhryaeva, Marina; Agdzhoyan, Anastasia; Dibirova, Khadizhat; Zaporozhchenko, Valery; Yankovsky, Nick; Balanovsky, Oleg] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia; [Chuhryaeva, Marina; Agdzhoyan, Anastasia; Dibirova, Khadizhat; Pshenichnov, Andrey; Frolova, Svetlana; Shanko, Andrey; Zaporozhchenko, Valery; Evseeva, Irina; Balanovska, Elena; Balanovsky, Oleg] Russian Acad Sci, Med Genet Res Ctr, Moscow, Russia; [Uktveryte, Ingrida; Kucinskas, Vaidutis] Vilnius State Univ, Fac Med, Dept Human & Med Genet, Vilnius, Lithuania; [Moels, Maert] Univ Tartu, Inst Stat Math, EE-50090 Tartu, Estonia; [Mulahasanovic, Lejla] Ctr Genom & Transcript CeGaT GmbH, Tubingen, Germany; [Mulahasanovic, Lejla] Univ Sarajevo, Fac Pharm, Sarajevo 71000, Bosnia & Herceg; [Metspalu, Ene; Reidla, Maere; Tamm, Erika; Kivisild, Toomas; Villems, Richard] Univ Tartu, Inst Mol & Cell Biol, Dept Evolutionary Biol, EE-50090 Tartu, Estonia; [Koshel, Sergey] Moscow MV Lomonosov State Univ, Fac Geog, Moscow, Russia; [Churnosov, Michail] Belgorod State Univ, Belgorod, Russia; [Pocheshchova, Elvira] Kuban State Med Univ, Krasnodar, Russia; [Evseeva, Irina] Northern State Med Univ, Arkhangel, Russia; [Goncharova, Olga] Natl Acad Sci Belarus, Hist Inst, Minsk, BELARUS; [Yunusbayev, Bayazit; Khusnutdinova, Elza] RAS, Ufa Res Ctr, Inst Biochem & Genet, Ufa, Bashkortostan, Russia; [Khusnutdinova, Elza] Bashkir State Univ, Dept Genet & Fundamental Med, Ufa 450074, Bashkortostan, Russia; [Marjanovic, Damir] Int Burch Univ, Sarajevo, Bosnia & Herceg; [Marjanovic, Damir; Rudan, Pavao] Inst Anthropol Res, Zagreb, Croatia; [Endicott, Phillip] Musee Homme Paris, Paris, France; [Kassian, Alexei; Dybo, Anna] Russian Acad Sci, Inst Linguist, Moscow, Russia; [Kassian, Alexei] Russian Presidential Acad Natl Econ & Publ Adm, Sch Adv Studies Humanities, Moscow, Russia; [Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Kivisild, Toomas] Univ Cambridge, Dept Archaeol & Anthropol, Cambridge, England; [Villems, Richard] Estonian Acad Sci, EE-200103 Tallinn, Estonia	Estonian Biocentre; National Academy of Sciences of Belarus (NASB); Institute of Genetics & Cytology of the National Academy of Sciences of Belarus; Ministry of Education & Science of Ukraine; VN Karazin Kharkiv National University; Russian Academy of Sciences; Vavilov Institute of General Genetics; Research Centre for Medical Genetics; Russian Academy of Sciences; Vilnius University; University of Tartu; CeGaT; University of Sarajevo; University of Tartu; Lomonosov Moscow State University; Belgorod State University; Kuban State Medical University; Northern State Medical University; National Academy of Sciences of Belarus (NASB); Institute of History of the National Academy of Sciences of Belarus; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; Bashkir State University; Institute for Anthropological Research Zagreb; Museum National d'Histoire Naturelle (MNHN); Institute of Linguistics, Russian Academy of Sciences; Russian Academy of Sciences; Russian Presidential Academy of National Economy & Public Administration; Wellcome Trust Sanger Institute; University of Cambridge; Estonian Academy of Sciences	Kushniarevich, A (corresponding author), Estonian Bioctr, Evolutionary Biol Grp, Tartu, Estonia.	lkushniarevich@gmail.com	Koshel, Sergey M/B-2662-2012; Tambets, Kristiina/M-2568-2019; Yunusbaev, Bayazit/T-5444-2019; KUČINSKAS, Vaidutis/A-4798-2013; Kassian, Alexei S./C-7281-2015; Yankovsky, Nick/AAU-9657-2021; Metspalu, Mait/G-8671-2015; Kivisild, Toomas/P-5889-2017; Tamm, Erika/G-2818-2017; Haak, Wolfgang/Z-4947-2019; Agdzhoyan, Anastasia/G-1540-2014; Churnosov, Mikhail/W-1313-2017; Dybo, Anna/F-8623-2016; Khusnutdinova, Elza Kamilevna/A-4810-2013; Santos, Fabrício Rodrigues/H-2370-2011; Bertranpetit, Jaume/F-8550-2012	Koshel, Sergey M/0000-0002-4540-2922; Tambets, Kristiina/0000-0002-8173-6380; Kassian, Alexei S./0000-0003-1129-2611; Metspalu, Mait/0000-0003-3099-9161; Kivisild, Toomas/0000-0002-6297-7808; Tamm, Erika/0000-0003-0694-3598; Haak, Wolfgang/0000-0003-2475-2007; Agdzhoyan, Anastasia/0000-0002-8776-2934; Churnosov, Mikhail/0000-0003-1254-6134; Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; Santos, Fabrício Rodrigues/0000-0001-9088-1750; Utevska, Olga/0000-0002-5787-0467; Yankovsky, Nikolay/0000-0002-2467-2683; Javed, Asif/0000-0002-6945-9624; Adler, Christina/0000-0002-4731-5291; Bertranpetit, Jaume/0000-0003-0100-0590; mele, marta/0000-0001-8874-6453; Cooper, Alan/0000-0002-7738-7851; Marjanovic, Damir/0000-0002-7472-4525; zalloua, pierre/0000-0002-8494-5081; Atramentova, Lubov/0000-0002-7143-9411; Yunusbayev, Bayazit/0000-0002-6035-8763; merchant, nirav/0000-0002-1988-8180; Shanko, Andrei/0000-0001-9801-9911; Dybo, Anna/0000-0002-6077-7183; Endicott, Phillip/0000-0003-2452-8507	Russian Science Foundation [14-14-00827]; Programme of the Presidium of Russian Academy of Sciences "Molecular and cell biology"; Russian Foundation For Basic Research [13-04-01711, 13-06-00670, 13-04-90420]; Ukrainian State Fund for Fundamental Researches [F53.4/071]; European Union European Regional Development Fund through the Centre of Excellence in Genomics; European Commission [205419 ECOGENE]; Estonian Basic Research Grant [SF 0270177s08]; Estonian Research Council [IUT24-1]; Wellcome Trust [098051]; LITGEN project - European Social Fund under the Global Grant Measure [VP1-3.1-SMM-07-K-01-013]; Center for Genomics and Transcriptomics (CeGaT GmbH)	Russian Science Foundation(Russian Science Foundation (RSF)); Programme of the Presidium of Russian Academy of Sciences "Molecular and cell biology"; Russian Foundation For Basic Research(Russian Foundation for Basic Research (RFBR)); Ukrainian State Fund for Fundamental Researches(State Fund for Fundamental Research (SFFR)); European Union European Regional Development Fund through the Centre of Excellence in Genomics; European Commission(European CommissionEuropean Commission Joint Research Centre); Estonian Basic Research Grant; Estonian Research Council(Estonian Research Council); Wellcome Trust(Wellcome TrustEuropean Commission); LITGEN project - European Social Fund under the Global Grant Measure; Center for Genomics and Transcriptomics (CeGaT GmbH)	This work was supported by Russian Science Foundation (grant 14-14-00827 to OB, M. Chuhryaeva, AA and VZ), Programme of the Presidium of Russian Academy of Sciences "Molecular and cell biology", Russian Foundation For Basic Research (grants 13-04-01711, 13-06-00670, 13-04-90420); Ukrainian State Fund for Fundamental Researches (grant F53.4/071); the European Union European Regional Development Fund through the Centre of Excellence in Genomics to the Estonian Biocentre; by the European Commission grant 205419 ECOGENE to the Estonian Biocentre; the Estonian Basic Research Grant SF 0270177s08 and by Institutional Research Funding to the Estonian Biocentre from the Estonian Research Council IUT24-1; the European Commission grant 205419 ECOGENE to the Estonian Biocentre; the Wellcome Trust 098051 to CTS; the Lithuanian part was supported by the LITGEN project (VP1-3.1-SMM-07-K-01-013), funded by the European Social Fund under the Global Grant Measure. Center for Genomics and Transcriptomics (CeGaT GmbH) provided support in the form of salaries for author LM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of LM are articulated in the 'author contributions' section.	Alekseeva T., 2011, VOSTOCHNYE SLAVIANE; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; [Anonymous], 2010, J LANGUAGE RELATIONS, V3, P79; Balanovska EV, 2011, GENOFOND RUSSKOGO SE, P27; Balanovsky O, 2008, AM J HUM GENET, V82, P236, DOI 10.1016/j.ajhg.2007.09.019; Balanovsky O, 2011, MOL BIOL EVOL, V28, P2905, DOI 10.1093/molbev/msr126; Barford P. M., 2001, EARLY SLAVS CULTURE; Behar D, 2013, HUM BIOL OPEN ACCESS; Behar DM, 2010, NATURE, V466, P238, DOI 10.1038/nature09103; Birnbaum H., 1975, COMMON SLAVIC PROGR; Blazek V, 2007, AUGUST SCHLEICHER SE, P35; Bouckaert R, 2012, SCIENCE, V337, P957, DOI 10.1126/science.1219669; Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010; BUNAK VV, 1965, PROISKHOZHDENIE ETNI; CAVALLISFORZA LL, 1993, SCIENCE, V259, P639, DOI 10.1126/science.8430313; Curta Florin, 2001, HIST ARCHAEOLOGY LOW, DOI DOI 10.1017/CBO9780511496295; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fortson Benjamin W., 2004, INDOEUROPEAN LANGUAG; Gray RD, 2003, NATURE, V426, P435, DOI 10.1038/nature02029; Grzybowski T, 2007, FORENSIC SCI INT-GEN, V1, P141, DOI 10.1016/j.fsigen.2007.01.010; Heather Peter, 2010, EMPIRES BARBARIANS F; Hellenthal G, 2014, SCIENCE, V343, P747, DOI 10.1126/science.1243518; Jozef Rostafinski, 1908, PIERWOTNYCH SIEDZIBA; Juras A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110839; Karachanak S, 2012, INT J LEGAL MED, V126, P497, DOI 10.1007/s00414-011-0589-y; Karmin M, 2015, GENOME RES, V25, P459, DOI 10.1101/gr.186684.114; Kasperaviciute D, 2004, ANN HUM GENET, V68, P438, DOI 10.1046/j.1529-8817.2003.00119.x; Kasperaviciute Dalia, 2002, Journal of Applied Genetics, V43, P255; Kayser M, 2005, HUM GENET, V117, P428, DOI 10.1007/s00439-005-1333-9; Khrunin AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058552; Koshel S. M., 2012, SOVREMENNAYA GEOGRAF, P158; Kovacevic L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105090; Kushniarevich A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066499; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Luca F, 2007, AM J PHYS ANTHROPOL, V132, P132, DOI 10.1002/ajpa.20500; Mallory J. P., 2006, OXFORD INTRO PROTO I; Malyarchuk B, 2008, MOL BIOL EVOL, V25, P1651, DOI 10.1093/molbev/msn114; Malyarchuk BA, 2003, ANN HUM GENET, V67, P412, DOI 10.1046/j.1469-1809.2003.00042.x; Malyarchuk BA, 2002, ANN HUM GENET, V66, P261, DOI 10.1017/S0003480002001161; Malyarchuk B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010285; Manco J., 2013, ANCESTRAL JOURNEYS P; Mielnik-Sikorska M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054360; Morozova I, 2012, AM J PHYS ANTHROPOL, V147, P341, DOI 10.1002/ajpa.21649; Nakhleh L, 2005, T PHILOL SOC, V103, P171, DOI 10.1111/j.1467-968X.2005.00149.x; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Novotna P, 2007, BALTISTICA, V42, P323; Novotna P, BALTISTICA, V42, P185; Novotna P, BALTISTICA, V42, P323; Palamara PF, 2012, AM J HUM GENET, V91, P809, DOI 10.1016/j.ajhg.2012.08.030; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pericic M, 2005, MOL BIOL EVOL, V22, P1964, DOI 10.1093/molbev/msi185; Pogodin AL, 1901, ISTORII SLAVYANSKIKH; Ralph P, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001555; Rebala K, 2007, J HUM GENET, V52, P406, DOI 10.1007/s10038-007-0125-6; Rebala K, 2013, EUR J HUM GENET, V21, P415, DOI 10.1038/ejhg.2012.190; Rexova K, 2003, CLADISTICS, V19, P120, DOI 10.1016/S0748-3007(02)00147-0; Ringe D, 2002, T PHILOL SOC, V100, P59, DOI 10.1111/1467-968X.00091; Rootsi S, 2007, EUR J HUM GENET, V15, P204, DOI 10.1038/sj.ejhg.5201748; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Schafarik PJ, 1843, SLAWISCHE ALTERTHUME; Schleicher August, 1862, COMPENDIUM VERGLEICH, VII; Sedov V. V., 1982, VOSTOCHNYE SLAVIANE; Sedov VV, 1979, PROISHOZHEDNIE RANNY; Sedov VV, 2002, SLAVIANE ISTORIKO AR; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Starostin SA, 2007, OPREDELENIE USTOJCHI, P827; Sussex R., 2006, THE SLAVIC LANGUAGES; Toporov VN, 1962, LINGVISTICHESKIJ ANA; Underhill PA, 2015, EUR J HUM GENET, V23, P124, DOI 10.1038/ejhg.2014.50; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Veeramah KR, 2011, EUR J HUM GENET, V19, P995, DOI 10.1038/ejhg.2011.65; Wichmann S, 2014, ASJP; Wozniak M, 2010, AM J PHYS ANTHROPOL, V142, P540, DOI 10.1002/ajpa.21253; Yunusbayev B, 2015, PLOSGENET, DOI [10.1101/005850, DOI 10.1101/005850]; Yunusbayev B, 2012, MOL BIOL EVOL, V29, P359, DOI 10.1093/molbev/msr221	77	65	71	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135820	10.1371/journal.pone.0135820	http://dx.doi.org/10.1371/journal.pone.0135820			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CQ4ZT	26332464	Green Published, gold			2022-12-26	WOS:000360613800041
J	Sato, M; Sasaki, N; Ato, M; Hirakawa, S; Sato, K; Sato, K				Sato, Miwa; Sasaki, Naoki; Ato, Manabu; Hirakawa, Satoshi; Sato, Kiichi; Sato, Kae			Microcirculation-on-a-Chip: A Microfluidic Platform for Assaying Blood- and Lymphatic-Vessel Permeability	PLOS ONE			English	Article							BRAIN-BARRIER MODEL; IN-VITRO MODEL; ENDOTHELIAL-CELLS; SHEAR-STRESS; MICROVASCULAR TUBES; DRUG-DELIVERY; HISTAMINE; SYSTEM; ADHESION; FLOW	We developed a microfluidic model of microcirculation containing both blood and lymphatic vessels for examining vascular permeability. The designed microfluidic device harbors upper and lower channels that are partly aligned and are separated by a porous membrane, and on this membrane, blood vascular endothelial cells (BECs) and lymphatic endothelial cells (LECs) were cocultured back-to-back. At cell-cell junctions of both BECs and LECs, claudin-5 and VE-cadherin were detected. The permeability coefficient measured here was lower than the value reported for isolated mammalian venules. Moreover, our results showed that the flow culture established in the device promoted the formation of endothelial cell-cell junctions, and that treatment with histamine, an inflammation-promoting substance, induced changes in the localization of tight and adherens junction-associated proteins and an increase in vascular permeability in the microdevice. These findings indicated that both BECs and LECs appeared to retain their functions in the microfluidic coculture platform. Using this microcirculation device, the vascular damage induced by habu snake venom was successfully assayed, and the assay time was reduced from 24 h to 30 min. This is the first report of a microcirculation model in which BECs and LECs were cocultured. Because the micromodel includes lymphatic vessels in addition to blood vessels, the model can be used to evaluate both vascular permeability and lymphatic return rate.	[Sato, Miwa; Sasaki, Naoki; Sato, Kae] Japan Womens Univ, Dept Chem & Biol Sci, Fac Sci, Bunkyo Ku, Tokyo 112, Japan; [Ato, Manabu] Natl Inst Infect Dis, Dept Immunol, Shinjuku Ku, Tokyo 1628640, Japan; [Hirakawa, Satoshi] Hamamatsu Univ Sch Med, Dept Dermatol, Hamamatsu, Shizuoka 4313192, Japan; [Sato, Kiichi] Gunma Univ, Sch Sci & Technol, Div Mol Sci, Kiryu, Gunma, Japan	Japan Womens University; National Institute of Infectious Diseases (NIID); Hamamatsu University School of Medicine; Gunma University	Sato, K (corresponding author), Japan Womens Univ, Dept Chem & Biol Sci, Fac Sci, Bunkyo Ku, Tokyo 112, Japan.	satouk@fc.jwu.ac.jp	Sato, Kae/J-4592-2015; Ato, Manabu/K-6452-2019	Sato, Kae/0000-0002-1618-2086; SASAKI, Naoki/0000-0003-1267-1744; Ato, Manabu/0000-0002-3178-2645	Tokyo Ohka Foundation for the Promotion of Science and Technology; Banyu Foundation Research Grant; Science Research Promotion Fund; Suzuken Memorial Foundation; JSPSJSPS [24350035, 25600065]; Core Research for Evolutional Science and Technology (JST, CREST) Program	Tokyo Ohka Foundation for the Promotion of Science and Technology(Tokyo Ohka Foundation for the Promotion of Science and Technology); Banyu Foundation Research Grant; Science Research Promotion Fund; Suzuken Memorial Foundation; JSPSJSPS; Core Research for Evolutional Science and Technology (JST, CREST) Program	This work was supported in part by Tokyo Ohka Foundation for the Promotion of Science and Technology (to Kae S, http://www.tok-foundation.or.jp/), Banyu Foundation Research Grant (to Kae S, http://www.banyu-zaidan.or.jp/), The Science Research Promotion Fund (to Kae S, http://www.shigaku.go.jp/s_shikin_menu.htm), Suzuken Memorial Foundation (to Kae S, http://www.suzukenzaidan.or.jp/), a Grant-in-Aid for Scientific Research (JSPS, KAKENHI; Grant Numbers 24350035 to Kiichi S and 25600065 to Kae S, https://www.jsps.go.jp/english/e-grants/grants01.html), and the Core Research for Evolutional Science and Technology (JST, CREST) Program (to Kae S, http://www.jst.go.jp/kisoken/crest/en/).	Amerongen GPV, 1998, CIRC RES, V83, P1115, DOI 10.1161/01.RES.83.11.1115; Bertrand N, 2014, ADV DRUG DELIVER REV, V66, P2, DOI 10.1016/j.addr.2013.11.009; Booth R, 2014, ANN BIOMED ENG, V42, P2379, DOI 10.1007/s10439-014-1086-5; Booth R, 2012, LAB CHIP, V12, P1784, DOI 10.1039/c2lc40094d; Breiteneder-Geleff S, 1999, AM J PATHOL, V154, P385, DOI 10.1016/S0002-9440(10)65285-6; Breslin Jerome W., 2009, Lymphatic Research and Biology, V7, P229, DOI 10.1089/lrb.2009.0015; Chan KLS, 2014, J BIOMED MATER RES A, V102, P3186, DOI 10.1002/jbm.a.34990; Chen C, 2013, INFLAMMATION, V36, P309, DOI 10.1007/s10753-012-9548-0; Chen MB, 2013, INTEGR BIOL-UK, V5, P1262, DOI 10.1039/c3ib40149a; Chen MB, 2013, LAB CHIP, V13, P2591, DOI [10.1039/c3lc00051f, 10.1039/c31c00051f]; Chrobak KM, 2006, MICROVASC RES, V71, P185, DOI 10.1016/j.mvr.2006.02.005; Chueh BH, 2007, ANAL CHEM, V79, P3504, DOI 10.1021/ac062118p; Daly SM, 2013, J BIOPHOTONICS, V6, P217, DOI 10.1002/jbio.201200071; Dixon JB, 2006, MICROCIRCULATION, V13, P597, DOI 10.1080/10739680600893909; Farmer PJ, 2001, AM J PHYSIOL-LUNG C, V280, pL732, DOI 10.1152/ajplung.2001.280.4.L732; Granger DN, 2010, INFLAMMATION MICROCI, DOI DOI 10.4199/C00013ED1V01Y201006ISP008; Griep LM, 2013, BIOMED MICRODEVICES, V15, P145, DOI 10.1007/s10544-012-9699-7; Guo M, 2008, AM J PHYSIOL-CELL PH, V294, pC977, DOI 10.1152/ajpcell.90607.2007; Harris ES, 2010, CURR OPIN CELL BIOL, V22, P651, DOI 10.1016/j.ceb.2010.07.006; Imura Y, 2009, ANAL SCI, V25, P1403, DOI 10.2116/analsci.25.1403; Kano MR, 2009, CANCER SCI, V100, P173, DOI 10.1111/j.1349-7006.2008.01003.x; Kawai Y, 2010, AM J PHYSIOL-CELL PH, V298, pC647, DOI 10.1152/ajpcell.00249.2009; Kim S, 2013, LAB CHIP, V13, P1489, DOI 10.1039/c3lc41320a; Kondo H, 1960, JAPAN J MED SCI BIOL, V13, P43; Kumar P, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001112; Laschke MW, 2011, EUR CELLS MATER, V22, P147, DOI 10.22203/eCM.v022a12; Lee H, 2014, MICROVASC RES, V91, P90, DOI 10.1016/j.mvr.2013.12.001; Maeda H, 2013, ADV DRUG DELIVER REV, V65, P71, DOI 10.1016/j.addr.2012.10.002; Margaris KN, 2012, J R SOC INTERFACE, V9, P601, DOI 10.1098/rsif.2011.0751; Morine N, 2008, TOXICON, V51, P345, DOI 10.1016/j.toxicon.2007.10.009; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Ono N, 2005, AM J PHYSIOL-HEART C, V289, pH1676, DOI 10.1152/ajpheart.01084.2004; Prabhakarpandian B, 2013, LAB CHIP, V13, P1093, DOI 10.1039/c2lc41208j; Price GM, 2008, MICROVASC RES, V76, P46, DOI 10.1016/j.mvr.2008.02.003; Qi D, 2012, EUR PHYS J-SPEC TOP, V204, P85, DOI 10.1140/epjst/e2012-01554-x; Reed AL, 2013, PHARM RES-DORDR, V30, P3271, DOI 10.1007/s11095-013-1218-x; Rigor RR, 2013, MED RES REV, V33, P911, DOI 10.1002/med.21270; Saito Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/804675; SARIA A, 1983, N-S ARCH PHARMACOL, V324, P212, DOI 10.1007/BF00503897; Sasaki N., 2013, P 17 INT C MIN SYST, V2013, P1818; Sasaki N, 2012, ELECTROPHORESIS, V33, P1729, DOI 10.1002/elps.201100691; Shao JB, 2010, BIOMED MICRODEVICES, V12, P81, DOI 10.1007/s10544-009-9362-0; Song JW, 2011, P NATL ACAD SCI USA, V108, P15342, DOI 10.1073/pnas.1105316108; Song JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005756; Srigunapalan S, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3530598; Tanaka Y, 2007, ANAL SCI, V23, P261, DOI 10.2116/analsci.23.261; Theakston RDG, 2003, TOXICON, V41, P541, DOI 10.1016/S0041-0101(02)00393-8; Thompson VF, 2000, ANAL BIOCHEM, V279, P170, DOI 10.1006/abio.1999.4475; Tsuji T, 2002, LAB INVEST, V82, P555, DOI 10.1038/labinvest.3780450; van der Meer AD, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3366720; Wong KHK, 2013, J BIOMED MATER RES A, V101, P2181, DOI 10.1002/jbm.a.34524; Wu MH, 2001, J PHYSIOL-LONDON, V532, P785, DOI 10.1111/j.1469-7793.2001.0785e.x; Yeon JH, 2012, LAB CHIP, V12, P2815, DOI [10.1039/c2lc40131b, 10.1039/C2LC40131B]; Young EWK, 2010, ANAL CHEM, V82, P808, DOI 10.1021/ac901560w; Zhang Xiao-Yu, 2014, Cancer Biology Medicine, V11, P247, DOI 10.7497/j.issn.2095-3941.2014.04.003; Zheng Y, 2012, P NATL ACAD SCI USA, V109, P9342, DOI 10.1073/pnas.1201240109	56	79	79	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137301	10.1371/journal.pone.0137301	http://dx.doi.org/10.1371/journal.pone.0137301			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332321	Green Published, gold, Green Submitted			2022-12-26	WOS:000360613800119
J	Horowitz, J; Patton, J				Horowitz, Justin; Patton, James			I Meant to Do That: Determining the Intentions of Action in the Face of Disturbances	PLOS ONE			English	Article							OPTIMAL FEEDBACK-CONTROL; ARM; POINT; ADAPTATION; STIFFNESS; DYNAMICS	Our actions often do not match our intentions when there are external disturbances such as turbulence. We derived a novel modeling approach for determining this motor intent from targeted reaching motions that are disturbed by an unexpected force. First, we demonstrated how to mathematically invert both feedforward (predictive) and feedback controls to obtain an intended trajectory. We next examined the model's sensitivity to a realistic range of parameter uncertainties, and found that the expected inaccuracy due to all possible parameter mis-estimations was less than typical movement-to-movement variations seen when humans reach to similar targets. The largest sensitivity arose mainly from uncertainty in joint stiffnesses. Humans cannot change their intent until they acquire sensory feedback, therefore we tested the hypothesis that a straight-line intent should be evident for at least the first 120 milliseconds following the onset of a disturbance. As expected, the intended trajectory showed no change from undisturbed reaching for more than 150 milliseconds after the disturbance onset. Beyond this point, however, we detected a change in intent in five out of eight subjects, surprisingly even when the hand is already near the target. Knowing such an intent signal is broadly applicable: enhanced human-machine interaction, the study of impaired intent in neural disorders, the real-time determination (and manipulation) of error in training, and complex systems that embody planning such as brain machine interfaces, team sports, crowds, or swarms. In addition, observing intent as it changes might act as a window into the mechanisms of planning, correction, and learning.	[Horowitz, Justin; Patton, James] Univ Illinois, Bioengn, Chicago, IL 60607 USA; [Patton, James] Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Shirley Ryan AbilityLab	Patton, J (corresponding author), Univ Illinois, Bioengn, Chicago, IL 60607 USA.	pattonj@uic.edu			National of Institutes of Health (nih.gov) [US NIH NINDS1 R01 NS053606]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053606] Funding Source: NIH RePORTER	National of Institutes of Health (nih.gov)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Research was supported by National of Institutes of Health (nih.gov) grant US NIH NINDS1 R01 NS053606. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burdet E, 2006, BIOL CYBERN, V94, P20, DOI 10.1007/s00422-005-0025-9; Crevecoeur F, 2014, PLOS COMPUT BIOL, V10, DOI [10.1371/journal.pcbi.1003869, 10.1371/journal.pcbi.1003996]; Dempster W.T., 1955, SPACE REQUIREMENTS S; FELDMAN AG, 1995, BEHAV BRAIN SCI, V18, P723, DOI 10.1017/S0140525X0004070X; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Franklin DW, 2007, J NEUROSCI, V27, P7705, DOI 10.1523/JNEUROSCI.0968-07.2007; Franklin DW, 2003, J NEUROPHYSIOL, V90, P3270, DOI 10.1152/jn.01112.2002; Fryar C. D., 2012, VITAL HLTH STAT, V11, P1; Gawthrop P, 2011, BIOL CYBERN, V104, P31, DOI 10.1007/s00422-010-0416-4; Gomi H, 1998, J NEUROSCI, V18, P8965; Gomi H, 1997, BIOL CYBERN, V76, P163, DOI 10.1007/s004220050329; Guadagnoli MA, 2004, J MOTOR BEHAV, V36, P212, DOI 10.3200/JMBR.36.2.212-224; Hodgson AJ, 2000, IEEE T SYST MAN CY C, V30, P105, DOI 10.1109/5326.827459; MATLAB, 2008, VERS 7 6 0 324 R2008; Patton JL, 2006, EXP BRAIN RES, V168, P368, DOI 10.1007/s00221-005-0097-8; Patton JL, 2004, IEEE T BIO-MED ENG, V51, P636, DOI 10.1109/TBME.2003.821035; Pruszynski JA, 2012, EXP BRAIN RES, V218, P341, DOI 10.1007/s00221-012-3041-8; Saltelli A, 2010, COMPUT PHYS COMMUN, V181, P259, DOI 10.1016/j.cpc.2009.09.018; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; STUNKARD AJ, 1981, AM J CLIN NUTR, V34, P1593, DOI 10.1093/ajcn/34.8.1593; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; van Eesbeek S, 2010, J BIOMECH, V43, P2539, DOI 10.1016/j.jbiomech.2010.05.017; Winter D., 2009, BIOMECHANICS MOTOR C, V4th	24	5	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137289	10.1371/journal.pone.0137289	http://dx.doi.org/10.1371/journal.pone.0137289			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327405	Green Submitted, gold, Green Published			2022-12-26	WOS:000360437700107
J	Liu, YJ; Li, K; Yang, L; Tang, ST; Wang, XX; Cao, GQ; Li, S; Lei, HY; Zhang, X				Liu, Yong-jun; Li, Kang; Yang, Li; Tang, Shao-tao; Wang, Xin-xing; Cao, Guo-qing; Li, Shuai; Lei, Hai-yan; Zhang, Xi			Dendritic Cells Regulate Treg-Th17 Axis in Obstructive Phase of Bile Duct Injury in Murine Biliary Atresia	PLOS ONE			English	Article							DELTA-T CELLS; TH17 CELLS; CD4(+); EXPRESSION; INFECTION; INFANTS; TYPE-1; MODEL; IL-17; TIME	Several cell types are considered to be effector cells in bile duct injury in rhesus rotavirus (RRV)-induced experimental biliary atresia (BA). Here, we identified an increased T helper 17 (Th17) cell population in a BA mode. By depleting the Th17 cells, the BA symptoms (onset of jaundice, acholic stools and retarded growth) were attenuated and the survival rate was improved. Furthermore, we found that in mice with BA, the percentage of CD4(+)CD25(high)Foxp3(+) T regulatory (Treg) cells decreased along with the increased percentage of Th17 cells. However, the absolute numbers of Treg and Th17 cells were both increased in liver of RRV-injected mice compared to saline-injected mice. The proportion of Th17 cells at 7 days post-infection was decreased if Treg cells isolated from normal adult mice, but not Treg cells from the livers of mice with BA, were intraperitoneally transferred on day 5 of life. In vitro experiments also showed that Treg cells from mice with BA had a diminished suppressive effect on Th17 cell generation. To determine the mechanisms, we investigated the production of cytokines in the liver. The level of IL-6, which has been shown to be abundantly secreted by activated dendritic cells (DCs), was remarkably elevated. Importantly, in a Treg/Th17 cell suppression assay, IL-6 was demonstrated to paralyze the Treg cells' suppressive effect on Th17 cells and eventually the unrestrained increase of Th17 cells contributed to bile duct injury. In conclusion, the DC-regulated Treg-Th17 axis, probably in conjunction with other effector T cells, aggravates progressive inflammatory injury at the time of ductal obstruction.	[Liu, Yong-jun; Li, Kang; Yang, Li; Tang, Shao-tao; Wang, Xin-xing; Cao, Guo-qing; Li, Shuai; Lei, Hai-yan; Zhang, Xi] Huazhong Univ Sci & Technol, Dept Pediat Surg, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Tang, ST (corresponding author), Huazhong Univ Sci & Technol, Dept Pediat Surg, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China.	tshaotao83@126.com	Yang, Li/Y-4002-2018; Yang, Li/L-7334-2019		National Natural Science Foundation of China [30973137, 81270481]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant No. 30973137 and 81270481, http://www.nsfc.gov.cn/Portal0/). Dr. YJL, KL, LY, STT, XXW, GQC, SL, HYL, and XZ have no conflicts of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu R, 2013, IMMUNOL REV, V252, P89, DOI 10.1111/imr.12035; Bleier JI, 2006, J IMMUNOL, V176, P7189, DOI 10.4049/jimmunol.176.12.7189; Brindley SM, 2012, HEPATOLOGY, V55, P1130, DOI 10.1002/hep.24807; Gaffen SL, 2008, CYTOKINE, V43, P402, DOI 10.1016/j.cyto.2008.07.017; Ghoneim EM, 2011, HEPATOL RES, V41, P763, DOI 10.1111/j.1872-034X.2011.00832.x; Hammerich L, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/345803; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Huang YH, 2007, LAB INVEST, V87, P66, DOI 10.1038/labinvest.3700490; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lages CS, 2012, HEPATOLOGY, V56, P219, DOI 10.1002/hep.25662; Li J, 2011, J CLIN INVEST, V121, P4244, DOI 10.1172/JCI57728; Licata LA, 2013, J LEUKOCYTE BIOL, V94, P813, DOI 10.1189/jlb.0313137; Loong CC, 2002, EVIDENCE EARLY INVOL; Lu BR, 2010, GASTROENTEROLOGY, V139, P1753, DOI 10.1053/j.gastro.2010.07.042; Mack CL, 2007, GASTROENTEROLOGY, V133, P278, DOI 10.1053/j.gastro.2007.04.032; Mack CL, 2005, CLIN IMMUNOL, V115, P200, DOI 10.1016/j.clim.2005.01.012; Mack CL, 2004, PEDIATR RES, V56, P79, DOI 10.1203/01.PDR.0000130480.51066.FB; Maher BM, 2013, INFECT IMMUN, V81, P4478, DOI 10.1128/IAI.01026-13; Miethke AG, 2010, J HEPATOL, V52, P718, DOI 10.1016/j.jhep.2009.12.027; Muranski P, 2013, BLOOD, V121, P2402, DOI 10.1182/blood-2012-09-378653; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Petersen C, 1997, J PEDIATR SURG, V32, P1190, DOI 10.1016/S0022-3468(97)90680-1; Qiu Y, 2014, PLOS PATHOG, V3; Rong G, 2009, CLIN EXP IMMUNOL, V156, P217, DOI 10.1111/j.1365-2249.2009.03898.x; Saxena V, 2011, SCI TRANSL MED, V102, p102r; Schmidl C, 2011, EUR J IMMUNOL, V41, P1491, DOI 10.1002/eji.201041067; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Smith KA, 2014, EUR J IMMUNOL, V44, P150, DOI 10.1002/eji.201343746; Tucker RM, 2013, J HEPATOL, V59, P790, DOI 10.1016/j.jhep.2013.05.010; Wu J, 2013, TRANSPLANTATION, V95, P434, DOI 10.1097/TP.0b013e31827a48f5; Yamazaki S, 2006, IMMUNOL REV, V212, P314, DOI 10.1111/j.0105-2896.2006.00422.x; Yang Y, 2013, PEDIATR SURG INT, V29, P1249, DOI 10.1007/s00383-013-3421-6; Zhao L, 2010, J DIGEST DIS, V11, P126, DOI 10.1111/j.1751-2980.2010.00428.x	33	12	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136214	10.1371/journal.pone.0136214	http://dx.doi.org/10.1371/journal.pone.0136214			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325187	Green Published, Green Submitted, gold			2022-12-26	WOS:000360437700034
J	Srivastava, A; Tiwari, R; Srivastava, V; Singh, TB; Asthana, RK				Srivastava, Akanksha; Tiwari, Ratnakar; Srivastava, Vikas; Singh, Tej Bali; Asthana, Ravi Kumar			Fresh Water Cyanobacteria Geitlerinema sp CCC728 and Arthrospira sp CCC729 as an Anticancer Drug Resource	PLOS ONE			English	Article							MARINE NATURAL-PRODUCTS; DISCOVERY; APOPTOSIS; CELLS; SPIRULINA; LYNGBYA	An increasing number of cancer patients worldwide, especially in third world countries, have raised concern to explore natural drug resources, such as the less explored fresh water filamentous cyanobacteria. Six strains of cyanobacteria (Phormidium sp. CCC727, Geitlerinema sp. CCC728, Arthrospira sp. CCC729, Phormidium sp. CCC731, Phormidium sp. CCC730, and Leptolyngbya sp. CCC732) were isolated (paddy fields and ponds in the Banaras Hindu University, campus) and five strains screened for anticancer potential using human colon adenocarcinoma (HT29) and human kidney adenocarcinoma (A498) cancer cell lines. Geitlerinema sp. CCC728 and Arthrospira sp. CCC729 were the most potent as determined by examination of morphological features and by inhibition of growth by graded concentrations of crude extracts and thin-layer chromatography (TLC) eluates. Cell cycle analysis and multiplex assays using cancer biomarkers also confirmed Geitlerinema sp. CCC728 and Arthrospira sp. CCC729 as cancer drug resources. Apoptotic studies in the cells of A498 (cancer) and MCF-10A (normal human epithelial) exposed to crude extracts and TLC fractions revealed no significant impact on MCF-10A cells emphasizing its importance in the development of anticancer drug. Identification of biomolecules from these extracts are in progress.	[Srivastava, Akanksha; Asthana, Ravi Kumar] Banaras Hindu Univ, Ctr Adv Study Bot, Fac Sci, Varanasi 221005, Uttar Pradesh, India; [Tiwari, Ratnakar; Singh, Tej Bali] Banaras Hindu Univ, Inst Med Sci, Div Stat, Varanasi 221005, Uttar Pradesh, India; [Srivastava, Vikas] Indian Inst Toxicol Res, Council Sci & Ind Res, Lucknow 226001, Uttar Pradesh, India	Banaras Hindu University (BHU); Banaras Hindu University (BHU); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR)	Asthana, RK (corresponding author), Banaras Hindu Univ, Ctr Adv Study Bot, Fac Sci, Varanasi 221005, Uttar Pradesh, India.	asthana.ravi@gmail.com		Tiwari, Ratnakar/0000-0001-8130-8960	Council of Scientific and Industrial Research, New Delhi [38(1364)/13/EMR II]; Akanksha Srivastava, from the Center of Advanced Study in Botany Banaras, Hindu University [Bot./2012-2013/CAS-SRF/80970]	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); Akanksha Srivastava, from the Center of Advanced Study in Botany Banaras, Hindu University	This work was supported by the Council of Scientific and Industrial Research, New Delhi, (Ref. no. 38(1364)/13/EMR II dated 1/10/2013) and Akanksha Srivastava, from the Center of Advanced Study in Botany Banaras, Hindu University, in the form of SRF (Bot./2012-2013/CAS-SRF/80970).	Andrianasolo EH, 2005, ORG LETT, V7, P1375, DOI 10.1021/ol050188x; Bernard C, 2009, ENVIRON TOXICOL, V26, P260; Burja AM, 2001, TETRAHEDRON, V57, P9347, DOI 10.1016/S0040-4020(01)00931-0; Catassi A, 2006, CELL MOL LIFE SCI, V63, P2377, DOI 10.1007/s00018-006-6264-7; Chu WL, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-53; Costa M, 2012, MAR DRUGS, V10, P2181, DOI 10.3390/md10102181; Cragg GM, 1997, J NAT PROD, V60, P52, DOI 10.1021/np9604893; da Rocha Adriana B., 2001, Current Opinion in Pharmacology, V1, P364; Desikachary T. V., 1959, CYANOPHYTA DESIKACHA; Doan NT, 2000, J APPL PHYCOL, V12, P409; Engene N, 2010, J PHYCOL, V46, P591, DOI 10.1111/j.1529-8817.2010.00840.x; Gerwick WH, 2012, CHEM BIOL, V19, P85, DOI 10.1016/j.chembiol.2011.12.014; Harrigan GG, 1998, J NAT PROD, V61, P1221, DOI 10.1021/np9801211; HOSHAW RW, 1973, HDB PHYCOLOGICAL MET, P54; Lee HU, 2014, SCI REP-UK, V4, DOI 10.1038/srep04665; Martins RF, 2008, MAR DRUGS, V6, P1, DOI 10.3390/md6010001; Mayer AMS, 2011, COMP BIOCHEM PHYS C, V153, P191, DOI 10.1016/j.cbpc.2010.08.008; Medina RA, 2008, J AM CHEM SOC, V130, P6324, DOI 10.1021/ja801383f; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; Nunnery JK, 2010, CURR OPIN BIOTECH, V21, P787, DOI 10.1016/j.copbio.2010.09.019; Oftedal L, 2010, MAR DRUGS, V8, P2659, DOI 10.3390/md8102659; Plaza A, 2006, J ORG CHEM, V71, P6898, DOI 10.1021/jo061044e; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Salvador LA, 2010, J NAT PROD, V73, P1606, DOI 10.1021/np100467d; Sambrook J., 2001, MOL CLONING LAB MANU; Schwartzman D, 2008, ASTROBIOLOGY, V8, P187, DOI 10.1089/ast.2006.0074; Stewart B, 2014, WORLD CANC REPORT 20; Tan LT, 2007, PHYTOCHEMISTRY, V68, P954, DOI 10.1016/j.phytochem.2007.01.012; Tan LT, 2013, DRUG DISCOV TODAY, V18, P863, DOI 10.1016/j.drudis.2013.05.010; Tan LT, 2010, J APPL PHYCOL, V22, P659, DOI 10.1007/s10811-010-9506-x; Wu LC, 2005, J AGR FOOD CHEM, V53, P4207, DOI 10.1021/jf0479517	31	12	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136838	10.1371/journal.pone.0136838	http://dx.doi.org/10.1371/journal.pone.0136838			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325186	Green Published, Green Submitted, gold			2022-12-26	WOS:000360437700067
J	Fortini, LB; Cropper, WP; Zarin, DJ				Fortini, Lucas B.; Cropper, Wendell P., Jr.; Zarin, Daniel J.			Modeling the Complex Impacts of Timber Harvests to Find Optimal Management Regimes for Amazon Tidal Floodplain Forests	PLOS ONE			English	Article							RAIN-FOREST; POPULATION-DYNAMICS; DENSITY-DEPENDENCE; YIELD REGULATION; LOGGING DAMAGE; GROWTH; RECOVERY; SUSTAINABILITY; REGENERATION; FIELD	At the Amazon estuary, the oldest logging frontier in the Amazon, no studies have comprehensively explored the potential long-term population and yield consequences of multiple timber harvests over time. Matrix population modeling is one way to simulate long-term impacts of tree harvests, but this approach has often ignored common impacts of tree harvests including incidental damage, changes in post-harvest demography, shifts in the distribution of merchantable trees, and shifts in stand composition. We designed a matrix-based forest management model that incorporates these harvest-related impacts so resulting simulations reflect forest stand dynamics under repeated timber harvests as well as the realities of local smallholder timber management systems. Using a wide range of values for management criteria (e.g., length of cutting cycle, minimum cut diameter), we projected the long-term population dynamics and yields of hundreds of timber management regimes in the Amazon estuary, where small-scale, unmechanized logging is an important economic activity. These results were then compared to find optimal stand-level and species-specific sustainable timber management (STM) regimes using a set of timber yield and population growth indicators. Prospects for STM in Amazonian tidal floodplain forests are better than for many other tropical forests. However, generally high stock recovery rates between harvests are due to the comparatively high projected mean annualized yields from fast-growing species that effectively counterbalance the projected yield declines from other species. For Amazonian tidal floodplain forests, national management guidelines provide neither the highest yields nor the highest sustained population growth for species under management. Our research shows that management guidelines specific to a region's ecological settings can be further refined to consider differences in species demographic responses to repeated harvests. In principle, such fine-tuned management guidelines could make management more attractive, thus bridging the currently prevalent gap between tropical timber management practice and regulation.	[Fortini, Lucas B.] US Geol Survey, Pacific Isl Ecosyst Res Ctr, Honolulu, HI 96818 USA; [Cropper, Wendell P., Jr.] Univ Florida, Sch Forest Resources & Conservat, Gainesville, FL USA; [Zarin, Daniel J.] Climate & Land Use Alliance, San Francisco, CA USA	United States Department of the Interior; United States Geological Survey; State University System of Florida; University of Florida	Fortini, LB (corresponding author), US Geol Survey, Pacific Isl Ecosyst Res Ctr, Honolulu, HI 96818 USA.	lfortini@usgs.gov	Cropper, Wendell P/E-5952-2010	Cropper, Wendell P/0000-0001-7851-7382; Fortini, Lucas/0000-0002-5781-7295	Tropical Conservation and Development Program at the University of Florida; NSF Working Forest in the Tropics IGERT; NSF DDI program; South East AGEP; EPA STAR program [FP-91688001]; USGS Pacific Island Ecosystems Research Center	Tropical Conservation and Development Program at the University of Florida; NSF Working Forest in the Tropics IGERT(National Science Foundation (NSF)); NSF DDI program; South East AGEP; EPA STAR program(United States Environmental Protection Agency); USGS Pacific Island Ecosystems Research Center	This research was supported by the Tropical Conservation and Development Program at the University of Florida, the NSF Working Forest in the Tropics IGERT, the NSF DDI program, the South East AGEP, the EPA STAR program (FP-91688001), and the USGS Pacific Island Ecosystems Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AB, 1990, EXTRACTION FOREST MA, P65; Asner GP, 2004, ECOL APPL, V14, pS280; BARROS AC, 1995, FOREST ECOL MANAG, V77, P87, DOI 10.1016/0378-1127(95)03574-T; Blundell AG, 2004, ECOLOGY, V85, P704, DOI 10.1890/01-4101; Broadbent EN, 2006, ECOL APPL, V16, P1148, DOI 10.1890/1051-0761(2006)016[1148:ROFSAS]2.0.CO;2; Caswell, 2000, MATRIX POPULATION MO; Chapman CA, 1997, BIOTROPICA, V29, P396, DOI 10.1111/j.1744-7429.1997.tb00035.x; Condit R, 1998, AM NAT, V152, P495, DOI 10.1086/286186; Cropper WP, 2006, ECOL MODEL, V198, P487, DOI 10.1016/j.ecolmodel.2006.05.034; Dauber E, 2005, FOREST ECOL MANAG, V214, P294, DOI 10.1016/j.foreco.2005.04.019; Figueira A, 2008, J GEOPHYS RES-BIOGEO, P113; Finegan B, 1999, FOREST ECOL MANAG, V121, P177, DOI 10.1016/S0378-1127(98)00550-7; Fortini LB, 2006, FOREST ECOL MANAG, V231, P78, DOI 10.1016/j.foreco.2006.04.038; Fortini LB, 2011, FOREST ECOL MANAG, V261, P551, DOI 10.1016/j.foreco.2010.11.007; Fortini LB, 2014, J FOREST ECON, V20, P223, DOI 10.1016/j.jfe.2014.06.001; Fortini LB, 2010, OECOLOGIA, V162, P923, DOI 10.1007/s00442-009-1524-5; Freckleton RP, 2003, J APPL ECOL, V40, P846, DOI 10.1046/j.1365-2664.2003.00842.x; Fredericksen TS, 2000, FOREST ECOL MANAG, V131, P47, DOI 10.1016/S0378-1127(99)00199-1; Fredericksen TS, 2003, BIODIVERS CONSERV, V12, P1445, DOI 10.1023/A:1023673625940; Gardiner BA, 1997, FORESTRY, V70, P233, DOI 10.1093/forestry/70.3.233; Glauner R, 2003, CAN J FOREST RES, V33, P521, DOI [10.1139/x03-013, 10.1139/X03-013]; Gourlet-Fleury S, 2005, FOREST ECOL MANAG, V209, P69, DOI 10.1016/j.foreco.2005.01.010; Haefner J. W., 1996, MODELING BIOL SYSTEM; Holm JA, 2008, BIOTROPICA, V40, P550, DOI 10.1111/j.1744-7429.2008.00412.x; Jackson SM, 2002, FOREST ECOL MANAG, V166, P271, DOI 10.1016/S0378-1127(01)00681-8; Johns JS, 1996, FOREST ECOL MANAG, V89, P59, DOI 10.1016/S0378-1127(96)03869-8; Kammesheidt L, 2001, J APPL ECOL, V38, P756, DOI 10.1046/j.1365-2664.2001.00629.x; Keefe K, 2009, FOREST ECOL MANAG, V258, P1950, DOI 10.1016/j.foreco.2009.07.037; Lentini M., 2005, FATOS FLORESTAIS AMA; Lima E, 2006, ENVIRONMENT, V48, P26, DOI 10.3200/ENVT.48.1.26-38; Luckert MK, 2005, CAN J FOREST RES, V35, P356, DOI [10.1139/x04-172, 10.1139/X04-172]; MACEDO DS, 1993, BIOTROPICA, V25, P151, DOI 10.2307/2389179; Morris W. F., 2002, QUANTITATIVE CONSERV; Pena-Claros M, 2008, FOREST ECOL MANAG, V256, P1458, DOI 10.1016/j.foreco.2007.11.013; Phillips PD, 2004, ECOL MODEL, V173, P335, DOI 10.1016/j.ecolmodel.2003.09.023; Pinard MA, 1996, BIOTROPICA, V28, P278, DOI 10.2307/2389193; Pinedo-Vasquez M, 2001, HUM ECOL, V29, P219, DOI 10.1023/A:1011064031078; Rice R., 2001, SUSTAINABLE FOREST M; Rockwell CA, 2007, FOREST ECOL MANAG, V242, P108, DOI 10.1016/j.foreco.2006.12.028; Rondon XJ, 2009, FOREST ECOL MANAG, V257, P588, DOI 10.1016/j.foreco.2008.09.051; Schmidt IB, 2011, J APPL ECOLOGY; Schongart J, 2008, FOREST ECOL MANAG, V256, P46, DOI 10.1016/j.foreco.2008.03.037; Schulze M, 2008, FOREST ECOL MANAG, V256, P1443, DOI 10.1016/j.foreco.2008.02.051; Schulze M, 2006, FOREST ECOL MANAG, V236, P56, DOI 10.1016/j.foreco.2006.08.333; Sears RR, 2007, HUM ECOL, V35, P697, DOI 10.1007/s10745-006-9109-y; Sears RR, 2004, BIOL RESOURCE MANAGE, P258; Sears RR, 2003, NEW FORESTRY FLOODPL; SEYDACK AHW, 1995, FOREST ECOL MANAG, V77, P139, DOI 10.1016/0378-1127(95)03577-W; SILVA JNM, 1995, FOREST ECOL MANAG, V71, P267, DOI 10.1016/0378-1127(94)06106-S; Sist P, 2002, FOREST ECOL MANAG, V165, P85, DOI 10.1016/S0378-1127(01)00649-1; Sist P, 2007, FOREST ECOL MANAG, V243, P199, DOI 10.1016/j.foreco.2007.02.014; Valle D, 2006, FOREST ECOL MANAG, V236, P127, DOI 10.1016/j.foreco.2006.08.340; van Gardingen PR, 2006, FOREST ECOL MANAG, V231, P184, DOI 10.1016/j.foreco.2006.05.047; Wang S, 2004, FOREST POLICY ECON, V6, P205, DOI 10.1016/j.forpol.2004.03.004; Wittmann F, 2003, J BIOGEOGR, V30, P1533, DOI 10.1046/j.1365-2699.2003.00966.x; Zarin DJ, 2007, CONSERV BIOL, V21, P916, DOI 10.1111/j.1523-1739.2007.00670.x; Zarin DJ, 1998, AGROFOREST SYST, V41, P307, DOI 10.1023/A:1006072421536	57	6	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136740	10.1371/journal.pone.0136740	http://dx.doi.org/10.1371/journal.pone.0136740			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322896	Green Published, gold, Green Submitted			2022-12-26	WOS:000360435500032
J	Johansson, MM; Van Geystelen, A; Larmuseau, MHD; Djurovic, S; Andreassen, OA; Agartz, I; Jazin, E				Johansson, Martin M.; Van Geystelen, Anneleen; Larmuseau, Maarten H. D.; Djurovic, Srdjan; Andreassen, Ole A.; Agartz, Ingrid; Jazin, Elena			Microarray Analysis of Copy Number Variants on the Human Y Chromosome Reveals Novel and Frequent Duplications Overrepresented in Specific Haplogroups	PLOS ONE			English	Article							MALE-SPECIFIC REGION; MALE-INFERTILITY; SPERMATOGENIC IMPAIRMENT; MOSAIC LOSS; DELETION; GENOME; POPULATION; ASSOCIATION; SELECTION; CANCER	Background The human Y chromosome is almost always excluded from genome-wide investigations of copy number variants (CNVs) due to its highly repetitive structure. This chromosome should not be forgotten, not only for its well-known relevance in male fertility, but also for its involvement in clinical phenotypes such as cancers, heart failure and sex specific effects on brain and behaviour. Results We analysed Y chromosome data from Affymetrix 6.0 SNP arrays and found that the signal intensities for most of 8179 SNP/CN probes in the male specific region (MSY) discriminated between a male, background signals in a female and an isodicentric male containing a large deletion of the q-arm and a duplication of the p-arm of the Y chromosome. Therefore, this SNP/CN platform is suitable for identification of gain and loss of Y chromosome sequences. In a set of 1718 males, we found 25 different CNV patterns, many of which are novel. We confirmed some of these variants by PCR or qPCR. The total frequency of individuals with CNVs was 14.7%, including 9.5% with duplications, 4.5% with deletions and 0.7% exhibiting both. Hence, a novel observation is that the frequency of duplications was more than twice the frequency of deletions. Another striking result was that 10 of the 25 detected variants were significantly overrepresented in one or more haplogroups, demonstrating the importance to control for haplogroups in genome-wide investigations to avoid stratification. NO-M214( xM175) individuals presented the highest percentage (95%) of CNVs. If they were not counted, 12.4% of the rest included CNVs, and the difference between duplications (8.9%) and deletions (2.8%) was even larger. Conclusions Our results demonstrate that currently available genome-wide SNP platforms can be used to identify duplications and deletions in the human Y chromosome. Future association studies of the full spectrum of Y chromosome variants will demonstrate the potential involvement of gain or loss of Y chromosome sequence in different human phenotypes.	[Johansson, Martin M.; Jazin, Elena] Uppsala Univ, Dept Organismal Biol, EBC, Uppsala, Sweden; [Van Geystelen, Anneleen; Larmuseau, Maarten H. D.] Katholieke Univ Leuven, Dept Biol, Lab Socioecol & Social Evolut, Leuven, Belgium; [Larmuseau, Maarten H. D.] Katholieke Univ Leuven, Dept Imaging & Pathol, Forens Biomed Sci, Leuven, Belgium; [Djurovic, Srdjan] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Djurovic, Srdjan] Univ Bergen, Dept Clin Sci, NORMENT, KG Jebsen Ctr Psychosis Res, Bergen, Norway; [Andreassen, Ole A.; Agartz, Ingrid] Univ Oslo, Oslo Univ Hosp, Div Mental Hlth & Addict, NORMENT,KG Jebsen Ctr Psychosis Res, Oslo, Norway; [Andreassen, Ole A.; Agartz, Ingrid] Univ Oslo, Inst Clin Med, Oslo, Norway; [Agartz, Ingrid] Diakonhjemmet Hosp, Dept Psychiat Res, Oslo, Norway	Uppsala University; KU Leuven; KU Leuven; University of Oslo; University of Bergen; University of Oslo; University of Oslo; Diakonhjemmet Hospital	Johansson, MM (corresponding author), Uppsala Univ, Dept Organismal Biol, EBC, Uppsala, Sweden.	martin.johansson@ebc.uu.se; elena.jazin@ebc.uu.se	Andreassen, Ole A./AAY-7531-2020; Larmuseau, Maarten/GSJ-0393-2022	Djurovic, Srdjan/0000-0002-8140-8061; Larmuseau, Maarten H.D./0000-0002-5974-7235; Agartz, Ingrid/0000-0002-9839-5391	Swedish Research Foundation [K2012-61X-22089-01-3]; KG Jebsen Foundation; Research Council of Norway [213837, 223273]; KU Leuven BOF Centre of Excellence Financing on 'Eco and socio evolutionary dynamics' [PF/2010/07]; KU Leuven BOF-GOA 'New approaches to the social dynamics of long-term fertility change' [3H130264]	Swedish Research Foundation; KG Jebsen Foundation; Research Council of Norway(Research Council of Norway); KU Leuven BOF Centre of Excellence Financing on 'Eco and socio evolutionary dynamics'; KU Leuven BOF-GOA 'New approaches to the social dynamics of long-term fertility change'	This study was funded by the Swedish Research Foundation, grant name: Sex determination factors in the brain encoded in the Y chromosome (Project number K2012-61X-22089-01-3) (EJ), the KG Jebsen Foundation and the Research Council of Norway (Project numbers 213837 and 223273) (IA), the KU Leuven BOF Centre of Excellence Financing on 'Eco and socio evolutionary dynamics' (Project number PF/2010/07) and the KU Leuven BOF-GOA 'New approaches to the social dynamics of long-term fertility change' (Project number 3H130264) (MHDL). MHDL is a postdoctoral fellow of the FWO Vlaanderen (Research Foundation Flanders).	Aston KI, 2014, ANDROLOGY-US, V2, P315, DOI 10.1111/j.2047-2927.2014.00188.x; Athanasiu L, 2010, J PSYCHIATR RES, V44, P748, DOI 10.1016/j.jpsychires.2010.02.002; Betran Esther, 2012, Int J Evol Biol, V2012, P207958, DOI 10.1155/2012/207958; Bray SM, 2010, P NATL ACAD SCI USA, V107, P16222, DOI 10.1073/pnas.1004381107; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Djurovic S, 2010, J AFFECT DISORDERS, V126, P312, DOI 10.1016/j.jad.2010.04.007; Dumanski JP, 2015, SCIENCE, V347, P81, DOI 10.1126/science.1262092; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elhaik E, 2013, GENOME BIOL EVOL, V5, P1021, DOI 10.1093/gbe/evt066; Ferlin A, 2005, J MED GENET, V42, P209, DOI 10.1136/jmg.2004.025833; Ferlin A, 2007, J CLIN ENDOCR METAB, V92, P762, DOI 10.1210/jc.2006-1981; Fietz SA, 2012, P NATL ACAD SCI USA, V109, P11836, DOI 10.1073/pnas.1209647109; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Forsberg LA, 2014, NAT GENET, V46, P624, DOI 10.1038/ng.2966; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hallast P, 2015, MOL BIOL EVOL, V32, P661, DOI 10.1093/molbev/msu327; Hallast P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003666; Hughes JF, 2010, NATURE, V463, P536, DOI 10.1038/nature08700; Jamain S, 2002, MOL PSYCHIATR, V7, P217, DOI 10.1038/sj.mp.4000968; Jangravi Z, 2013, J PROTEOME RES, V12, P6, DOI 10.1021/pr300864k; Jobling MA, 2008, CYTOGENET GENOME RES, V123, P253, DOI 10.1159/000184715; Jorgez CJ, 2011, J CLIN ENDOCR METAB, V96, pE674, DOI 10.1210/jc.2010-2018; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; Kido T, 2010, GENES-BASEL, V1, P283, DOI 10.3390/genes1020283; King TE, 2009, TRENDS GENET, V25, P351, DOI 10.1016/j.tig.2009.06.003; Kozina V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023174; Krausz C, 2010, GENES-BASEL, V1, P308, DOI 10.3390/genes1020308; Lange J, 2009, CELL, V138, P855, DOI 10.1016/j.cell.2009.07.042; Larmuseau MHD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2400; Larmuseau MHD, 2012, EUR J HUM GENET, V20, P434, DOI 10.1038/ejhg.2011.218; Lin YW, 2005, GENOMICS, V86, P431, DOI 10.1016/j.ygeno.2005.07.003; Lopes AM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003349; Lou HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027341; Lu CC, 2011, HUM MOL GENET, V20, P4411, DOI 10.1093/hmg/ddr369; Mancini TI, 2012, MOL SYNDROMOL, V3, P39, DOI 10.1159/000338468; Mangs AH, 2007, CURR GENOMICS, V8, P129, DOI 10.2174/138920207780368141; Mao XY, 2010, CANCER RES, V70, P5207, DOI 10.1158/0008-5472.CAN-09-4074; Martinez-Moczygemba M, 2008, J EXP MED, V205, P2711, DOI 10.1084/jem.20080759; McCarthy MM, 2011, NAT NEUROSCI, V14, P677, DOI 10.1038/nn.2834; Mensah MA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004578; Mulle JG, 2010, AM J HUM GENET, V87, P229, DOI 10.1016/j.ajhg.2010.07.013; Plaseski T, 2008, GENET TEST, V12, P595, DOI 10.1089/gte.2008.0068; Qureshi SJ, 1996, MOL HUM REPROD, V2, P775, DOI 10.1093/molehr/2.10.775; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Repnikova EA, 2013, FORENSIC SCI INT-GEN, V7, P475, DOI 10.1016/j.fsigen.2013.05.008; Repping S, 2006, NAT GENET, V38, P463, DOI 10.1038/ng1754; Repping S, 2003, NAT GENET, V35, P247, DOI 10.1038/ng1250; Repping S, 2004, GENOMICS, V83, P1046, DOI 10.1016/j.ygeno.2003.12.018; Riggs Erin Rooney, 2014, Curr Genet Med Rep, V2, P146; Rimol LM, 2010, BIOL PSYCHIAT, V68, P41, DOI 10.1016/j.biopsych.2010.03.036; Rozen SG, 2012, AM J HUM GENET, V91, P890, DOI 10.1016/j.ajhg.2012.09.003; Siggberg L, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-84; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Sin HS, 2010, HUM REPROD, V25, P2396, DOI 10.1093/humrep/deq191; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Talseth-Palmer BA, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-10; Tozzo P, 2013, J FORENSIC LEG MED, V20, P387, DOI 10.1016/j.jflm.2013.03.012; Van Geystelen A, 2013, FORENSIC SCI INT-GEN, V7, P573, DOI 10.1016/j.fsigen.2013.03.010; Van Geystelen A, 2014, ELECTROPHORESIS, V35, P3102, DOI 10.1002/elps.201300459; Van Geystelen A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-101; van Oven M, 2014, HUM MUTAT, V35, P187, DOI 10.1002/humu.22468; Venkatachalam R, 2011, INT J CANCER, V129, P1635, DOI 10.1002/ijc.25821; Watkins WS, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-39; Yuen RKC, 2014, FERTIL STERIL, V101, P1079, DOI 10.1016/j.fertnstert.2013.12.027	64	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0137223	10.1371/journal.pone.0137223	http://dx.doi.org/10.1371/journal.pone.0137223			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322892	Green Published, gold, Green Submitted			2022-12-26	WOS:000360435500068
J	Budd, KE; Mccoy, F; Monecke, S; Cormican, P; Mitchell, J; Keane, OM				Budd, Kathleen E.; Mccoy, Finola; Monecke, Stefan; Cormican, Paul; Mitchell, Jennifer; Keane, Orla M.			Extensive Genomic Diversity among Bovine-Adapted Staphylococcus aureus: Evidence for a Genomic Rearrangement within CC97	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; METHICILLIN-RESISTANT; CLINICAL MASTITIS; GENES; PATHOGEN; MILK; POPULATION; ADAPTATION; EVOLUTION; INSIGHTS	Staphylococcus aureus is an important pathogen associated with both human and veterinary disease and is a common cause of bovine mastitis. Genomic heterogeneity exists between S. aureus strains and has been implicated in the adaptation of specific strains to colonise particular mammalian hosts. Knowledge of the factors required for host specificity and virulence is important for understanding the pathogenesis and management of S. aureus mastitis. In this study, a panel of mastitis-associated S. aureus isolates (n = 126) was tested for resistance to antibiotics commonly used to treat mastitis. Over half of the isolates (52%) demonstrated resistance to penicillin and ampicillin but all were susceptible to the other antibiotics tested. S. aureus isolates were further examined for their clonal diversity by Multi-Locus Sequence Typing (MLST). In total, 18 different sequence types (STs) were identified and eBURST analysis demonstrated that the majority of isolates grouped into clonal complexes CC97, CC151 or sequence type (ST) 136. Analysis of the role of recombination events in determining S. aureus population structure determined that ST diversification through nucleotide substitutions were more likely to be due to recombination compared to point mutation, with regions of the genome possibly acting as recombination hotspots. DNA microarray analysis revealed a large number of differences amongst S. aureus STs in their variable genome content, including genes associated with capsule and biofilm formation and adhesion factors. Finally, evidence for a genomic arrangement was observed within isolates from CC97 with the ST71-like subgroup showing evidence of an IS431 insertion element having replaced approximately 30 kb of DNA including the ica operon and histidine biosynthesis genes, resulting in histidine auxotrophy. This genomic rearrangement may be responsible for the diversification of ST71 into an emerging bovine adapted subgroup.	[Budd, Kathleen E.; Cormican, Paul; Keane, Orla M.] TEAGASC, AGRIC, Anim & Biosci Dept, Dunsany, Meath, Ireland; [Budd, Kathleen E.; Mitchell, Jennifer] Univ Coll Dublin, Sch Vet Med, Dublin 4, Ireland; [Mccoy, Finola] Anim Hlth Ireland, Carrick On Shannon, Leitrim, Ireland; [Monecke, Stefan] Alere Technol GmbH, D-07749 Jena, Germany	Teagasc; University College Dublin; Alere	Keane, OM (corresponding author), TEAGASC, AGRIC, Anim & Biosci Dept, Dunsany, Meath, Ireland.	orla.keane@teagasc.ie	KEANE, ORLA/AAQ-1148-2021; Mitchell, Jennifer/H-6612-2019	Mitchell, Jennifer/0000-0003-4956-1530; Keane, Orla/0000-0002-9507-2191	Teagasc Walsh Fellowship Scheme [6082]; Alere Technologies GmbH	Teagasc Walsh Fellowship Scheme; Alere Technologies GmbH	Funding from the Teagasc Walsh Fellowship Scheme (grant number 6082) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Alere Technologies GmbH provided support in the form of salaries for authors (SM), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "authors contributions" section.	Andrews JM, 2008, J ANTIMICROB CHEMOTH, V62, P256, DOI 10.1093/jac/dkn194; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bannerman DD, 2009, J ANIM SCI, V87, P10, DOI 10.2527/jas.2008-1187; Barkema HW, 2006, J DAIRY SCI, V89, P1877, DOI 10.3168/jds.S0022-0302(06)72256-1; Biggs A, 2009, MASTITIS DAIRY CATTL; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brody T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003074; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; CLSI, 2008, PERFORMANCE STANDARD; Cue D, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00038; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Everitt RG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4956; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fernandez G, 2013, VET RES COMMUN, V37, P259, DOI 10.1007/s11259-013-9570-1; Fessler A, 2010, J ANTIMICROB CHEMOTH, V65, P619, DOI 10.1093/jac/dkq021; Fitzgerald JR, 2001, P NATL ACAD SCI USA, V98, P8821, DOI 10.1073/pnas.161098098; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Herron LL, 2002, INFECT IMMUN, V70, P3978, DOI 10.1128/IAI.70.7.3978-3981.2002; Herron-Olson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001120; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jamrozy DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040458; Juhasz-Kaszanyitzky E, 2007, EMERG INFECT DIS, V13, P630, DOI 10.3201/eid1304.060833; Kaneko J, 1997, BIOSCI BIOTECH BIOCH, V61, P541, DOI 10.1271/bbb.61.541; Kaneko J, 2004, BIOSCI BIOTECH BIOCH, V68, P981, DOI 10.1271/bbb.68.981; KAPUR V, 1995, J CLIN MICROBIOL, V33, P376, DOI 10.1128/JCM.33.2.376-380.1995; Keane OM, 2013, VET REC, V173, P17, DOI 10.1136/vr.101308; Kumar Shukla S, 2012, J ANTIBIOT; Lam TJGM, 1996, AM J VET RES, V57, P39; Lindsay Jodi A., 2006, Functional & Integrative Genomics, V6, P186, DOI 10.1007/s10142-005-0019-7; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; MILES H, 1992, J DAIRY SCI, V75, P596, DOI 10.3168/jds.S0022-0302(92)77797-2; Monecke S, 2005, CLIN MICROBIOL INFEC, V11, P825, DOI 10.1111/j.1469-0691.2005.01243.x; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Monecke S, 2007, VET MICROBIOL, V125, P128, DOI 10.1016/j.vetmic.2007.05.016; Nubel U, 2008, P NATL ACAD SCI USA, V105, P14130, DOI 10.1073/pnas.0804178105; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Pyorala S, 1997, J DAIRY SCI, V80, P2820, DOI 10.3168/jds.S0022-0302(97)76246-5; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Robinson DA, 2004, J BACTERIOL, V186, P1060, DOI 10.1128/JB.186.4.1060-1064.2004; RUDIN L, 1974, J BACTERIOL, V118, P155, DOI 10.1128/JB.118.1.155-164.1974; Ruimy R, 2008, J BACTERIOL, V190, P3962, DOI 10.1128/JB.01947-07; Schlotter K, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-42; Smyth DS, 2009, J MED MICROBIOL, V58, P1343, DOI 10.1099/jmm.0.009837-0; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; Sung JML, 2008, MICROBIOL-SGM, V154, P1949, DOI 10.1099/mic.0.2007/015289-0; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; van Belkum A, 2006, J CLIN MICROBIOL, V44, P1555, DOI 10.1128/JCM.44.4.1555-1557.2006; Viana D, 2010, MOL MICROBIOL, V77, P1583, DOI 10.1111/j.1365-2958.2010.07312.x; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Yamada T, 2005, VET MICROBIOL, V110, P97, DOI 10.1016/j.vetmic.2005.07.006; Zadoks RN, 2002, J CLIN MICROBIOL, V40, P3894, DOI 10.1128/JCM.40.11.3894-3902.2002; Zhang LF, 2012, J MOL EVOL, V75, P43, DOI 10.1007/s00239-012-9520-5; Zou D, 2000, BIOSCI BIOTECH BIOCH, V64, P2631, DOI 10.1271/bbb.64.2631; Zschock M, 2000, J DAIRY RES, V67, P429, DOI 10.1017/S0022029900004325	58	30	30	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0134592	10.1371/journal.pone.0134592	http://dx.doi.org/10.1371/journal.pone.0134592			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317849	gold, Green Published			2022-12-26	WOS:000360299100016
J	Deng, YT; Kang, WB; Zhao, JN; Liu, G; Zhao, MG				Deng, Ya-ting; Kang, Wen-bo; Zhao, Jian-ning; Liu, Gang; Zhao, Ming-gao			Osteoprotective Effect of Echinocystic Acid, a Triterpone Component from Eclipta prostrata, in Ovariectomy-Induced Osteoporotic Rats	PLOS ONE			English	Article							SAUDI POSTMENOPAUSAL WOMEN; BONE TURNOVER MARKERS; VITAMIN-D STATUS; NF-KAPPA-B; IN-VITRO; OSTEOCLAST DIFFERENTIATION; MINERAL DENSITY; MICE; CELLS; INFLAMMATION	Echinocystic acid (EA) is a natural triterpone enriched in various herbs and has been used for medicinal purposes in China. In the present study, we systematically examined the effects of EA on ovariectomy-induced osteoporosis in rats for the first time. Three-month-old female ovariectomy (OVX) Sprague-Dawley rats were used to evaluate the osteoprotective effect of EA. Results showed that administration of EA (5 or 15 mg/kg/day) for 12 weeks prevented lower levels of maximum stress and Young's modulus of femur induced by OVX. EA also recovered bone metabolic biomarkers levels in OVX rats, including osteocalcin, alkaline phosphatese, deoxypyridinoline, and urinary calcium and phosphorus. EA (5 and 15 mg/kg/day) could prevent the alteration of total bone mineral density in the femur caused by OVX. However, only high dose (15 mg/kg/day) of EA significantly improved trabecular architecture, as evidenced by higher levels of bone volume/tissue volume, trabecula number, and trabecula thickness, and lower levels of trabecula separation and structure model index compared with OVX rats. In addition, EA treatment decresed the serum levels of IL-1 beta and TNF-alpha in OVX rats. In conclusion, EA could prevent reduction of bone mass and strength and improve the cancellous bone structure and biochemical properties in OVX rats. Hence, EA may serve as a new candidate or a leading compound for antiosteoporosis.	[Deng, Ya-ting; Zhao, Ming-gao] Fourth Mil Med Univ, Sch Pharm, Dept Pharmacol, Xian 710032, Peoples R China; [Kang, Wen-bo; Zhao, Jian-ning; Liu, Gang] Second Mil Med Univ, Clin Sch Nanjing, Jinling Hosp, Dept Orthoped, Nanjing, Jiangsu, Peoples R China	Air Force Military Medical University; Naval Medical University	Zhao, JN (corresponding author), Second Mil Med Univ, Clin Sch Nanjing, Jinling Hosp, Dept Orthoped, Nanjing, Jiangsu, Peoples R China.	jnzhao2002@163.com; liugene@hotmail.com; minggao@fmmu.edu.cn		Zhao, Ming-gao/0000-0002-7539-3887	National Natural Science Foundation of China [81403064]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China No. 81403064. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuohashish HM, 2015, ACTA PHARMACOL SIN, V36, P209, DOI 10.1038/aps.2014.111; Al-Daghri NM, 2014, INT J CLIN EXP MED, V7, P3528; Al-Daghri NM, 2014, INT J CLIN EXP MED, V7, P2812; Bhattacharya A, 2007, J NUTR BIOCHEM, V18, P372, DOI 10.1016/j.jnutbio.2006.07.002; Bian Q, 2012, MENOPAUSE, V19, P225, DOI 10.1097/gme.0b013e3182272ef1; Bouxsein Mary L, 2003, Clin Cornerstone, VSuppl 2, pS13; Chan BY, 2008, BONE, V43, P567, DOI 10.1016/j.bone.2008.04.018; Chiba H, 2003, J NUTR, V133, P1892, DOI 10.1093/jn/133.6.1892; DAVICCO MJ, 1992, REPROD NUTR DEV, V32, P313, DOI 10.1051/rnd:19920401; Devareddy L, 2006, BONE, V38, P686, DOI 10.1016/j.bone.2005.10.024; Fu HJ, 2014, J MED CHEM, V57, P4692, DOI 10.1021/jm5002293; Joh EH, 2014, ARCH PHARM RES, V37, P225, DOI 10.1007/s12272-013-0092-8; Joh EH, 2012, BIOCHEM PHARMACOL, V84, P331, DOI 10.1016/j.bcp.2012.04.020; Kim TH, 2011, J NUTR BIOCHEM, V22, P8, DOI 10.1016/j.jnutbio.2009.11.002; Lee SU, 2008, PHARMACOL RES, V58, P290, DOI 10.1016/j.phrs.2008.08.008; Leung F, 2009, BMJ CASE REP, V2009; Li NH, 2013, J ORTHOP SCI, V18, P478, DOI 10.1007/s00776-013-0362-9; Lim DW, 2013, NUTRIENTS, V5, P2734, DOI 10.3390/nu5072734; Liu SB, 2014, NEUROMOL MED, V16, P350, DOI 10.1007/s12017-013-8280-8; Liu ZG, 2009, J ETHNOPHARMACOL, V123, P74, DOI 10.1016/j.jep.2009.02.025; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McNamara LM, 2010, J R SOC INTERFACE, V7, P353, DOI 10.1098/rsif.2009.0282; Min C, 2010, STUDY ANTIOSTEOPOROT; Moriwaki S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097177; Neviaser AS, 2008, J ORTHOP TRAUMA, V22, P346, DOI 10.1097/BOT.0b013e318172841c; Polat B, 2013, EUR J PHARMACOL, V718, P469, DOI 10.1016/j.ejphar.2013.07.033; RIGGS BL, 1990, NEW ENGL J MED, V322, P802, DOI 10.1056/NEJM199003223221203; Ryu S, 2013, PLANTA MED, V79, P1031, DOI 10.1055/s-0032-1328767; Shen Y, 2010, J NAT MED-TOKYO, V64, P336, DOI 10.1007/s11418-010-0416-7; Tan H, 2014, J AGR FOOD CHEM, V62, P836, DOI 10.1021/jf402735u; Tong XH, 2004, CANCER LETT, V212, P21, DOI 10.1016/j.canlet.2004.03.035; Tsuji M, 2009, J BONE MINER METAB, V27, P673, DOI 10.1007/s00774-009-0088-0; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; TURNER CH, 1995, J DENT RES, V74, P1475, DOI 10.1177/00220345950740080701; Wang H, 2013, EUR J MED CHEM, V64, P160, DOI 10.1016/j.ejmech.2013.03.041; Wang QW, 2011, EUR J DRUG METAB PH, V35, P131, DOI 10.1007/s13318-010-0015-8; Wang ZQ, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/356260; Wu JM, 2010, FITOTERAPIA, V81, P8, DOI 10.1016/j.fitote.2009.06.015; Zhang R, 2009, BONE, V45, P553, DOI 10.1016/j.bone.2008.08.127; Zhang R, 2014, J ETHNOPHARMACOL, V155, P104, DOI 10.1016/j.jep.2014.04.031; Zhao Y, 2011, MENOPAUSE, V18, P690, DOI 10.1097/gme.0b013e3181fd7f4b	41	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136572	10.1371/journal.pone.0136572	http://dx.doi.org/10.1371/journal.pone.0136572			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317835	Green Published, gold, Green Submitted			2022-12-26	WOS:000360299100104
J	Kim, A; Servetas, SL; Kang, J; Kim, J; Jang, S; Cha, HJ; Lee, WJ; Kim, J; Romero-Gallo, J; Peek, RM; Merrell, DS; Cha, JH				Kim, Aeryun; Servetas, Stephanie L.; Kang, Jieun; Kim, Jinmoon; Jang, Sungil; Cha, Ho Jin; Lee, Wan Jin; Kim, June; Romero-Gallo, Judith; Peek, Richard M., Jr.; Merrell, D. Scott; Cha, Jeong-Heon			Helicobacter pylori bab Paralog Distribution and Association with cagA, vacA, and homA/B Genotypes in American and South Korean Clinical Isolates	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; GEOGRAPHIC ORIGIN; INFECTION; ADHESIN; GENE; POLYMORPHISMS; DISEASE; COLONIZATION; EXPRESSION; EVOLUTION	Helicobacter pylori genetic variation is a crucial component of colonization and persistence within the inhospitable niche of the gastric mucosa. As such, numerous H. pylori genes have been shown to vary in terms of presence and genomic location within this pathogen. Among the variable factors, the Bab family of outer membrane proteins (OMPs) has been shown to differ within subsets of strains. To better understand genetic variation among the bab genes and to determine whether this variation differed among isolates obtained from different geographic locations, we characterized the distribution of the Bab family members in 80 American H. pylori clinical isolates (AH) and 80 South Korean H. pylori clinical isolates (KH). Overall, we identified 23 different bab genotypes (19 in AH and 11 in KH), but only 5 occurred in greater than 5 isolates. Regardless of strain origin, a strain in which locus A and locus B were both occupied by a bab gene was the most common (85%); locus C was only occupied in those isolates that carried bab paralog at locus A and B. While the babA/babB/genotype predominated in the KH (78.8%), no single genotype could account for greater than 40% in the AH collection. In addition to basic genotyping, we also identified associations between bab genotype and well known virulence factors cagA and vacA. Specifically, significant associations between babA at locus A and the cagA EPIYA-ABD motif (P<0.0001) and the vacA s1/i1/m1 allele (P< 0.0001) were identified. Log-linear modeling further revealed a three-way association between bab carried at locus A, vacA, and number of OMPs from the HOM family (P<0.002). En masse this study provides a detailed characterization of the bab genotypes from two distinct populations. Our analysis suggests greater variability in the AH, perhaps due to adaptation to a more diverse host population. Furthermore, when considering the presence or absence of both the bab and homA/B paralogs at their given loci and the vacA genotype, an association was observed. Our results highlight the multifactorial nature of H. pylori mediated disease and the importance of considering how the specific combinations of H. pylori virulence genes and their multiple interactions with the host will collectively impact disease progression.	[Kim, Aeryun; Kang, Jieun; Kim, Jinmoon; Jang, Sungil; Cha, Ho Jin; Lee, Wan Jin; Kim, June; Cha, Jeong-Heon] Yonsei Univ, Coll Dent, Oral Sci Res Ctr, Dept Oral Biol, Seoul 120749, South Korea; [Kim, Aeryun; Kang, Jieun; Kim, Jinmoon; Cha, Jeong-Heon] Yonsei Univ, Coll Dent, Dept Appl Life Sci, Plus Project BK21, Seoul 120749, South Korea; [Servetas, Stephanie L.; Merrell, D. Scott] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA; [Romero-Gallo, Judith; Peek, Richard M., Jr.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37240 USA; [Romero-Gallo, Judith; Peek, Richard M., Jr.] Vanderbilt Univ, Dept Med, Nashville, TN 37240 USA	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Uniformed Services University of the Health Sciences - USA; Vanderbilt University; Vanderbilt University	Merrell, DS (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	douglas.merrell@usuhs.edu; jcha@yuhs.ac	Servetas, Stephanie/AAN-7263-2020	Servetas, Stephanie/0000-0002-4924-4511; Cha, Jeong-Heon/0000-0002-9385-2653; Jang, Sungil/0000-0001-6144-6899	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2014R1A2A1A11051054]; NATIONAL CANCER INSTITUTE [R01CA077955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2014R1A2A1A11051054).	Abadi ATB, 2013, INTERN EMERG MED, V8, P497, DOI 10.1007/s11739-011-0631-6; Abdullah Shahla M, 2012, Arab J Gastroenterol, V13, P166, DOI 10.1016/j.ajg.2012.12.001; Ahuja V, 2002, GASTROENTEROLOGY, V123, P653, DOI 10.1053/gast.2002.35224; Alfizah H, 2012, HELICOBACTER, V17, P340, DOI 10.1111/j.1523-5378.2012.00956.x; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Alm RA, 2000, INFECT IMMUN, V68, P4155, DOI 10.1128/IAI.68.7.4155-4168.2000; Ando T, 2002, J CLIN MICROBIOL, V40, P239, DOI 10.1128/JCM.40.1.239-246.2002; Aspholm-Hurtig M, 2004, SCIENCE, V305, P519, DOI 10.1126/science.1098801; Backstrom A, 2004, P NATL ACAD SCI USA, V101, P16923, DOI 10.1073/pnas.0404817101; Beswick EJ, 2006, WORLD J GASTROENTERO, V12, P5599, DOI 10.3748/wjg.v12.i35.5599; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; Bridge DR, 2013, GUT MICROBES, V4, P101, DOI 10.4161/gmic.23797; Colbeck JC, 2006, INFECT IMMUN, V74, P4375, DOI 10.1128/IAI.00485-06; de Jonge R, 2004, J MED MICROBIOL, V53, P375, DOI 10.1099/jmm.0.45551-0; Felsenstein J., 2009, PHYLIP PHYLOGENY INF; Gerhard M, 1999, P NATL ACAD SCI USA, V96, P12778, DOI 10.1073/pnas.96.22.12778; Gwack J, 2006, BRIT J CANCER, V95, P639, DOI 10.1038/sj.bjc.6603309; Hennig EE, 2006, INFECT IMMUN, V74, P3046, DOI 10.1128/IAI.74.5.3046-3051.2006; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; Armitano RI, 2013, INFECT GENET EVOL, V16, P377, DOI 10.1016/j.meegid.2013.02.024; Jang S, 2010, J CLIN MICROBIOL, V48, P559, DOI 10.1128/JCM.01501-09; Jones KR, 2011, J CLIN MICROBIOL, V49, P101, DOI 10.1128/JCM.01782-10; Jones KR, 2009, J CLIN MICROBIOL, V47, P959, DOI 10.1128/JCM.02330-08; Jung SW, 2009, J CLIN MICROBIOL, V47, P3241, DOI 10.1128/JCM.00293-09; Kalaf EA, 2013, SAUDI J GASTROENTERO, V19, P69, DOI 10.4103/1319-3767.108474; Kang J, 2012, J CLIN MICROBIOL, V50, P1082, DOI 10.1128/JCM.06293-11; Kawai M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-104; Liu H, 2015, INT J MED MICROBIOL, V305, P392, DOI 10.1016/j.ijmm.2015.03.002; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; Matteo MJ, 2011, INT J MOL EPIDEMIOL, V2, P286; Nagasawa S, 2013, FORENSIC SCI INT, V229, P7, DOI 10.1016/j.forsciint.2013.02.028; Nell S, 2014, MBIO, V5, DOI 10.1128/mBio.02281-14; Ohno T, 2011, J INFECT DIS, V203, P726, DOI 10.1093/infdis/jiq090; Oleastro M, 2006, INFECT IMMUN, V74, P4064, DOI 10.1128/IAI.00123-06; Oleastro M, 2008, J INFECT DIS, V198, P1379, DOI 10.1086/592166; Oleastro Monica, 2013, Biology (Basel), V2, P1110, DOI 10.3390/biology2031110; Oleastro M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-248; Pride DT, 2002, J MOL BIOL, V316, P629, DOI 10.1006/jmbi.2001.5311; Pride DT, 2001, INFECT IMMUN, V69, P1160, DOI 10.1128/IAI.69.2.1160-1171.2001; Sheu SM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-89; Shin A, 2005, BRIT J CANCER, V92, P1273, DOI 10.1038/sj.bjc.6602467; Solnick JV, 2004, P NATL ACAD SCI USA, V101, P2106, DOI 10.1073/pnas.0308573100; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Tokudome S, 2007, ASIAN PAC J CANCER P, V8, P462; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Torres LE, 2009, WORLD J GASTROENTERO, V15, P204, DOI 10.3748/wjg.15.204; Wada A, 2004, J BIOCHEM, V136, P741, DOI 10.1093/jb/mvh181; Yamaoka Y, 2006, GUT, V55, P775, DOI 10.1136/gut.2005.083014; Yamaoka Y, 2002, GASTROENTEROLOGY, V123, P1992, DOI 10.1053/gast.2002.37074; Zhang XS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004621	50	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137078	10.1371/journal.pone.0137078	http://dx.doi.org/10.1371/journal.pone.0137078			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317221	Green Submitted, Green Published, gold			2022-12-26	WOS:000360299100202
J	Mortaz, E; Adcock, IM; Ricciardolo, FLM; Varahram, M; Jamaati, H; Velayati, AA; Folkerts, G; Garssen, J				Mortaz, Esmaeil; Adcock, Ian M.; Ricciardolo, Fabio L. M.; Varahram, Mohammad; Jamaati, Hamidreza; Velayati, Ali Akbar; Folkerts, Gert; Garssen, Johan			Anti-Inflammatory Effects of Lactobacillus Rahmnosus and Bifidobacterium Breve on Cigarette Smoke Activated Human Macrophages	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; MURINE MODEL; ALVEOLAR MACROPHAGES; PROBIOTICS; NEUTROPHILS; RELEASE; HMGB1; INFLAMMASOME; RECOGNITION; RESPONSES	Background Chronic obstructive pulmonary disease (COPD) is a major global health problem with cigarette smoke (CS) as the main risk factor for its development. Airway inflammation in COPD involves the increased expression of inflammatory mediators such as CXCL-8 and IL-1 beta which are important mediators for neutrophil recruitment. Macrophages are an important source of these mediators in COPD. Lactobacillus rhamnosus (L. rhamnosus) and Befidobacterium breve (B. breve) attenuate the development of 'allergic asthma' in animals but their effects in COPD are unknown. Objective To determine the anti-inflammatory effects of L. rhamnosus and B. breve on CS and Toll-like receptor (TLR) activation. Design We stimulated the human macrophage cell line THP-1 with CS extract in the presence and absence of L. rhamnosus and B. breve and measured the expression and release of inflammatory mediators by RT-qPCR and ELISA respectively. An activity assay and Western blotting were used to examine NF-kappa B activation. Results Both L. rhamnosus and B. breve were efficiently phagocytized by human macrophages. L. rhamnosus and B. breve significantly suppressed the ability of CS to induce the expression of IL-1 beta, IL-6, IL-10, IL-23, TNF alpha, CXCL-8 and HMGB1 release (all p<0.05) in human THP-1 macrophages. Similar suppression of TLR4- and TLR9-induced CXCL8 expression was also observed (p<0.05). The effect of L. rhamnosus and B. breve on inflammatory mediator release was associated with the suppression of CS-induced NF-kappa B activation (p<0.05). Conclusions This data indicate that these probiotics may be useful anti-inflammatory agents in CS-associated disease such as COPD.	[Mortaz, Esmaeil; Adcock, Ian M.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Cell & Mol Biol Grp, Airways Dis Sect,Fac Med, London, England; [Mortaz, Esmaeil; Jamaati, Hamidreza] Shahid Beheshti Univ Med Sci, Chron Resp Res Ctr, Natl Res & Inst TB & Lung Dis NRITLD, Tehran, Iran; [Mortaz, Esmaeil] Shahid Beheshti Univ Med Sci, Fac Med, Dept Immunol, Tehran, Iran; [Ricciardolo, Fabio L. M.] Univ Turin, Dept Clin & Biol Sci, Turin, Italy; [Varahram, Mohammad; Velayati, Ali Akbar] Shahid Beheshti Univ Med Sci, Mycobacteriol Res Ctr MRC, Natl Res Inst TB & Lung Dis NRITLD, Tehran, Iran; [Folkerts, Gert; Garssen, Johan] Univ Utrecht, Fac Sci, Div Pharmacol, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [Garssen, Johan] Nutricia Res Ctr Specialized Nutr, Utrecht, Netherlands	Imperial College London; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; University of Turin; Shahid Beheshti University Medical Sciences; Utrecht University	Adcock, IM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Cell & Mol Biol Grp, Airways Dis Sect,Fac Med, Dovehouse St, London, England.	ian.adcock@imperial.ac.uk	Varahram, Mohammad/A-1395-2018; Adcock, Ian/L-3217-2019; jamaati, hamidreza/G-4098-2017; Ricciardolo, F. L. M./K-5330-2018; Velayati, Ali Akbar/H-1448-2017; garssen, johan/I-7159-2016; mortaz, esmael/G-7647-2017	Varahram, Mohammad/0000-0002-8033-1867; jamaati, hamidreza/0000-0002-9372-3253; Ricciardolo, F. L. M./0000-0003-1826-5018; mortaz, esmael/0000-0002-6689-3556; Adcock, Ian/0000-0003-2101-8843; Mortaz, Esmaeil/0000-0003-0250-087X; Velayati, Ali Akbar/0000-0001-9398-5838	MRC [G1001367/1]; Wellcome Trust [093080/Z/10/Z]; Interuniversity Attraction Poles (IAP) Project [P7/30]; NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton NHS Foundation Trust and Imperial College London; ERS Long Term Fellowship [LTRF 2013-2052]	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Interuniversity Attraction Poles (IAP) Project(Belgian Federal Science Policy Office); NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton NHS Foundation Trust and Imperial College London; ERS Long Term Fellowship	IMA is supported by the MRC (G1001367/1), the Wellcome Trust (093080/Z/10/Z) and by Interuniversity Attraction Poles (IAP) Project P7/30. Research by IMA is also supported by the NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton NHS Foundation Trust and Imperial College London. EM is supported by an ERS Long Term Fellowship (LTRF 2013-2052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock IM, 2011, RESPIRATION, V81, P265, DOI 10.1159/000324601; Barnes PJ, 2010, SCIENCE, V330, P40, DOI 10.1126/science.1196017; Barnes PJ, 2004, LANCET, V364, P985, DOI 10.1016/S0140-6736(04)17025-6; Bezerra FS, 2011, RESP PHYSIOL NEUROBI, V177, P120, DOI 10.1016/j.resp.2011.03.023; Black H, 2007, CHEST, V131, P524, DOI 10.1378/chest.06-1074; Blidberg K, 2012, INNATE IMMUN-LONDON, V18, P503, DOI 10.1177/1753425911423270; Caglar E, 2005, ORAL DIS, V11, P131, DOI 10.1111/j.1601-0825.2005.01109.x; Celli BR, 2012, AM J RESP CRIT CARE, V185, P1065, DOI 10.1164/rccm.201110-1792OC; Chaichalotornkul S, 2015, BIOCHEM BIOPH RES CO, V456, P92, DOI 10.1016/j.bbrc.2014.11.040; Cosio MG, 2009, NEW ENGL J MED, V360, P2396; D'Souza AL, 2012, BMJ-BRIT MED J; Di Stefano A, 2014, THORAX, V69, P516, DOI 10.1136/thoraxjnl-2012-203062; DREVETS DA, 1995, J IMMUNOL METHODS, V187, P69, DOI 10.1016/0022-1759(95)00168-A; FAO/WHO Codex Alimentarius Commission, 2001, EXPERT CONSULTATION, P1; Gorbach SL, 2000, AM J GASTROENTEROL, V95, pS2, DOI 10.1016/S0002-9270(99)00806-0; Guarner F, 2012, J CLIN GASTROENTEROL, V46, P468, DOI 10.1097/MCG.0b013e3182549092; Heijink IH, 2015, AM J RESP CELL MOL, V52, P554, DOI 10.1165/rcmb.2013-0505OC; Hodge S, 2003, IMMUNOL CELL BIOL, V81, P289, DOI 10.1046/j.1440-1711.2003.t01-1-01170.x; Hodge S, 2007, AM J RESP CELL MOL, V37, P748, DOI 10.1165/rcmb.2007-0025OC; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Hosoya T, 2014, PLOS ONE, V30; Hougee S, 2010, INT ARCH ALLERGY IMM, V151, P107, DOI 10.1159/000236000; Isolauri E, 2004, BEST PRACT RES CL GA, V18, P299, DOI 10.1016/j.bpg.2003.10.006; Jan RL, 2011, BR J NUTR, V14, P1; Kalliomaki M, 2010, J NUTR, V140, p713S, DOI 10.3945/jn.109.113761; Keely S, 2012, MUCOSAL IMMUNOL, V5, P7, DOI 10.1038/mi.2011.55; Keely S, 2014, CHEST, V145, P199, DOI 10.1378/chest.13-2077; Kirkham PA, 2011, AM J RESP CRIT CARE, V184, P796, DOI 10.1164/rccm.201010-1605OC; Lin YP, 2008, INFLAMM BOWEL DIS, V14, P1068, DOI 10.1002/ibd.20448; Ma DL, 2004, INFECT IMMUN, V72, P5308, DOI 10.1128/IAI.72.9.5308-5314.2004; Marteau PR, 2001, AM J CLIN NUTR, V73, p430S, DOI 10.1093/ajcn/73.2.430s; Miettinen M, 2012, GUT MICROBES, V3, P510, DOI 10.4161/gmic.21736; Morelli L, 2002, DIGEST LIVER DIS, V34, pS8, DOI 10.1016/S1590-8658(02)80156-6; Mortaz E, 2011, BBA-MOL BASIS DIS, V1812, P1104, DOI 10.1016/j.bbadis.2011.06.002; Mortaz E, 2010, EUR RESPIR J, V36, P1143, DOI 10.1183/09031936.00062209; Mortaz E, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/751068; Mortaz E, 2012, BBA-MOL BASIS DIS, V1822, P1154, DOI 10.1016/j.bbadis.2012.03.006; Oelschlaeger TA, 2010, INT J MED MICROBIOL, V300, P57, DOI 10.1016/j.ijmm.2009.08.005; Pan SJ, 2010, PEDIAT ALLERG IMM-UK, V21, pE659, DOI 10.1111/j.1399-3038.2010.01061.x; Pons AR, 2005, EUR RESPIR J, V25, P647, DOI 10.1183/09031936.05.00062304; Pouwels SD, 2014, MUCOSAL IMMUNOL, V7, P215, DOI 10.1038/mi.2013.77; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rennard SI, 2006, LANCET, V367, P1216, DOI 10.1016/S0140-6736(06)68516-4; Ruane D, 2013, J EXP MED, V210, P1871, DOI 10.1084/jem.20122762; Sagar S, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-46; Sagar S, 2014, BBA-MOL BASIS DIS, V1842, P573, DOI 10.1016/j.bbadis.2014.01.005; Saiwichai T, 2010, SE ASIAN J TROP MED, V41, P250; Salminen S, 1998, BRIT J NUTR, V80, pS147, DOI 10.1079/BJN19980108; Stringer KA, 2007, AM J PHYSIOL-LUNG C, V292, pL1572, DOI 10.1152/ajplung.00325.2006; Tanaka A, 2011, LETT APPL MICROBIOL, V53, P35, DOI 10.1111/j.1472-765X.2011.03079.x; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Tsung A, 2014, J INTERN MED, V276, P425, DOI 10.1111/joim.12276; Tzanakis NE, 2010, WORLD J GASTROENTERO, V16, P299, DOI 10.3748/wjg.v16.i3.299; van Bergenhenegouwen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089121; Verdu EF, 2004, GASTROENTEROLOGY, V127, P826, DOI 10.1053/j.gastro.2004.06.007; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; Youn HN, 2012, ANTIVIR RES, V93, P138, DOI 10.1016/j.antiviral.2011.11.004; Zhang YH, 2014, J THORAC DIS, V6, P734, DOI 10.3978/j.issn.2072-1439.2014.04.31	58	52	67	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136455	10.1371/journal.pone.0136455	http://dx.doi.org/10.1371/journal.pone.0136455			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317628	Green Published, gold			2022-12-26	WOS:000360299100086
J	Piao, Y; Li, Y; Xu, Q; Liu, JW; Xing, CZ; Xie, XD; Yuan, Y				Piao, Ying; Li, Ying; Xu, Qian; Liu, Jing-wei; Xing, Cheng-zhong; Xie, Xiao-dong; Yuan, Yuan			Association of MTOR and AKT Gene Polymorphisms with Susceptibility and Survival of Gastric Cancer	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; PI3K/AKT/MTOR PATHWAY; RISK; ALCOHOL; TRANSLATION; ACTIVATION; CARCINOMA; 3-KINASE	Background The phosphoinositide 3-kinase (PI3K)/protein kinase B (PKB, AKT)/mammalian target of rapamycin (mTOR) signaling pathway plays a critical role in angiogenesis and cell growth, proliferation, metabolism, migration, differentiation, and apoptosis. Genetic diversity in key factors of this pathway may influence protein function and signal transduction, contributing to disease initiation and progression. Studies suggest that MTOR rs1064261 and AKT rs1130233 polymorphisms are associated with risk and/or prognosis of multiple cancer types. However, this relationship with gastric cancer (GC) remains unclear. The aim of this study was to investigate the role of MTOR and AKT polymorphisms in the risk and prognosis of GC. Methods The Sequenom MassARRAY platform was used to genotype 1842 individuals for MTOR rs1064261 T -> C and AKT rs1130233 G -> A polymorphisms. ELISA was used to detect Helicobacter pylori antibodies in serum. Immunohistochemical analysis was used to detect total and phosphorylated MTOR and AKT proteins. Results The MTOR rs1064261 (TC+CC) genotype and the AKT rs1130233 (GA+AA) genotype were associated with increased risk of GC in men (P = 0.049, P = 0.030). In H. pylori-negative individuals, the AKT rs1130233 GA and (GA+AA) genotypes were related to increased risk of atrophic gastritis (AG; P = 0.012, P = 0.024). Notably, the AKT rs1130233 (GA+AA) genotype demonstrated significant interactions with H. pylori in disease progression from healthy controls (CON) to AG (P = 0.013) and from AG to GC (P = 0.049). Additionally, for individuals with the AKT rs1130233 variant, those in the H. pylori-positive group had higher levels of phosphorylated AKT (p-AKT) expression. The AKT rs1130233 genotype was found to be associated with clinicopathological parameters including lymph node metastasis and alcohol drinking (P<0.05). Conclusion MTOR rs1064261 and AKT rs1130233 polymorphisms were associated with increased GC risk in males and increased AG risk in H. pylori-negative individuals. A significant interaction existed between the AKT rs1130233 genotype and H. pylori infection in CON -> AG -> GC disease progression. The AKT rs1130233 genotype influenced p-AKT protein expression in H. pylori-infected individuals.	[Piao, Ying; Li, Ying; Xu, Qian; Liu, Jing-wei; Xing, Cheng-zhong; Yuan, Yuan] China Med Univ, Affiliated Hosp 1, Canc Inst & Gen Surg, Tumor Etiol & Screening Dept, Shenyang, Peoples R China; [Piao, Ying; Li, Ying; Xu, Qian; Liu, Jing-wei; Xing, Cheng-zhong; Yuan, Yuan] China Med Univ, Key Lab Canc Etiol & Prevent, Liaoning Prov Educ Dept, Shenyang, Peoples R China; [Piao, Ying; Xie, Xiao-dong] Gen Hosp Shenyang Mil Reg, Dept Oncol, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University	Yuan, Y (corresponding author), China Med Univ, Affiliated Hosp 1, Canc Inst & Gen Surg, Tumor Etiol & Screening Dept, Shenyang, Peoples R China.	yyuan3@mail.cmu.edu.cn	Yuan, Yuan/GVS-5120-2022		National Key Basic Research Program of China (973 Program) [2010CB529304]; National Natural Science Foundation of China [31200968]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Key Basic Research Program of China (973 Program ref no. 2010CB529304), the National Natural Science Foundation of China (Ref No. 31200968).	Ali Z, 2012, J NANOSCI NANOTECHNO, V12, P8241, DOI 10.1166/jnn.2012.6692; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Arcaro A, 2007, CURR GENOMICS, V8, P271, DOI 10.2174/138920207782446160; Avan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108057; Brenner Hermann, 2009, V472, P467, DOI 10.1007/978-1-60327-492-0_23; Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x; Cao Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050302; De Marco C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055362; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Duell EJ, 2011, AM J CLIN NUTR, V94, P1266, DOI 10.3945/ajcn.111.012351; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Giovannetti E, 2010, MOL CANCER THER, V9, P581, DOI 10.1158/1535-7163.MCT-09-0665; Gong YH, 2010, EUR J CLIN MICROBIOL, V29, P907, DOI 10.1007/s10096-010-0944-9; Harris SL, 2005, P NATL ACAD SCI USA, V102, P16297, DOI 10.1073/pnas.0508390102; He J, 2013, MOL CARCINOGEN, V52, P70, DOI 10.1002/mc.22013; Hemmings BA, 1997, SCIENCE, V275, P628, DOI 10.1126/science.275.5300.628; Isomoto H, 2010, TOHOKU J EXP MED, V220, P3, DOI 10.1620/tjem.220.3; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang BH, 2009, ADV CANCER RES, V102, P19, DOI 10.1016/S0065-230X(09)02002-8; Kim MJ, 2012, J SURG ONCOL, V105, P167, DOI 10.1002/jso.22071; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Li QX, 2013, CLIN CANCER RES, V19, P6252, DOI 10.1158/1078-0432.CCR-13-1093; Li QX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071968; Lochhead P, 2008, BRIT MED BULL, V85, P87, DOI 10.1093/bmb/ldn007; Martin KA, 2002, ADV CANCER RES, V86, P1, DOI 10.1016/S0065-230X(02)86001-8; Moy KA, 2010, CANCER EPIDEM BIOMAR, V19, P2287, DOI 10.1158/1055-9965.EPI-10-0362; Nakayama M, 2009, J BIOL CHEM, V284, P1612, DOI 10.1074/jbc.M806981200; Sanghera KP, 2011, MOL CELL NEUROSCI, V47, P145, DOI 10.1016/j.mcn.2011.03.010; Shao JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097085; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Stiles B, 2002, MOL CELL BIOL, V22, P3842, DOI 10.1128/MCB.22.11.3842-3851.2002; Stolte M, 2001, CAN J GASTROENTEROL, V15, P591, DOI 10.1155/2001/367832; Tabassam FH, 2009, CELL MICROBIOL, V11, P70, DOI 10.1111/j.1462-5822.2008.01237.x; Tapia O, 2014, VIRCHOWS ARCH, V465, P25, DOI 10.1007/s00428-014-1588-4; Tramacere I, 2012, ANN ONCOL, V23, P28, DOI 10.1093/annonc/mdr135; Wang XT, 2014, J CANCER RES CLIN, V140, P1399, DOI 10.1007/s00432-014-1663-x; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; Wang YQ, 2014, INFORM SYST, V44, P1, DOI 10.1016/j.is.2014.02.003; Xu M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060080; Xu Q, 2013, GENE, V529, P104, DOI 10.1016/j.gene.2013.07.070; Xu Q, 2009, INT J ONCOL, V35, P1313, DOI 10.3892/ijo_00000449; Yu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021415; Zhang XA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092135; Zhu ML, 2013, J THORAC ONCOL, V8, P788, DOI 10.1097/JTO.0b013e31828916c6	46	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136447	10.1371/journal.pone.0136447	http://dx.doi.org/10.1371/journal.pone.0136447			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317520	Green Published, gold, Green Submitted			2022-12-26	WOS:000360299100085
J	Silva, APC; Macedo, AA; Costa, LF; Rocha, CE; Garcia, LNN; Farias, JRD; Gomes, PPR; Teixeira, GC; Fonseca, KWJ; Maia, ARF; Neves, GG; Romao, EL; Silva, TMA; Mol, JPS; Oliveira, RM; Araujo, MSS; Nascimento, EF; Martins, OA; Brandao, HM; Paixao, TA; Santos, RL				Silva, Ana Patrcia C.; Macedo, Auricelio A.; Costa, Luciana F.; Rocha, Claudia E.; Garcia, Luize N. N.; Farias, Jade R. D.; Gomes, Priscilla P. R.; Teixeira, Gustavo C.; Fonseca, Kessler W. J.; Maia, Andrea R. F.; Neves, Gabriela G.; Romao, Everton L.; Silva, Teane M. A.; Mol, Juliana P. S.; Oliveira, Renata M.; Araujo, Marcio S. S.; Nascimento, Ernane F.; Martins-Filho, Olindo A.; Brandao, Humberto M.; Paixao, Tatiane A.; Santos, Renato L.			Encapsulated Brucella ovis Lacking a Putative ATP-Binding Cassette Transporter (Delta abcBA) Protects against Wild Type Brucella ovis in Rams	PLOS ONE			English	Article							LIVE VACCINE; INFECTION; MICE; PCR; DIAGNOSIS; INSULIN	This study aimed to evaluate protection induced by the vaccine candidate B. ovis Delta abcBA against experimental challenge with wild type B. ovis in rams. Rams were subcutaneously immunized with B. ovis Delta abcBA encapsulated with sterile alginate or with the non encapsulated vaccine strain. Serum, urine, and semen samples were collected during two months after immunization. The rams were then challenged with wild type B. ovis (ATCC25840), and the results were compared to non immunized and experimentally challenged rams. Immunization, particularly with encapsulated B. ovis Delta abcBA, prevented infection, secretion of wild type B. ovis in the semen and urine, shedding of neutrophils in the semen, and the development of clinical changes, gross and microscopic lesions induced by the wild type B. ovis reference strain. Collectively, our data indicates that the B. ovis Delta abcBA strain is an exceptionally good vaccine strain for preventing brucellosis caused by B. ovis infection in rams.	[Silva, Ana Patrcia C.; Macedo, Auricelio A.; Garcia, Luize N. N.; Farias, Jade R. D.; Gomes, Priscilla P. R.; Teixeira, Gustavo C.; Fonseca, Kessler W. J.; Maia, Andrea R. F.; Neves, Gabriela G.; Romao, Everton L.; Silva, Teane M. A.; Mol, Juliana P. S.; Nascimento, Ernane F.; Santos, Renato L.] Univ Fed Minas Gerais, Escola Vet, Dept Clin & Cirurgia Vet, BR-31270901 Belo Horizonte, MG, Brazil; [Costa, Luciana F.; Rocha, Claudia E.; Paixao, Tatiane A.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Patol Geral, BR-31270901 Belo Horizonte, MG, Brazil; [Oliveira, Renata M.] Univ Estadual Maranhao, Dept Patol, BR-65057630 Sao Luis, MA, Brazil; [Araujo, Marcio S. S.; Martins-Filho, Olindo A.] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, BR-30190002 Belo Horizonte, MG, Brazil; [Brandao, Humberto M.] Embrapa Gado Leite, BR-36038330 Juiz De Fora, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Estadual do Maranhao; Fundacao Oswaldo Cruz; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Santos, RL (corresponding author), Univ Fed Minas Gerais, Escola Vet, Dept Clin & Cirurgia Vet, BR-31270901 Belo Horizonte, MG, Brazil.	rsantos@vet.ufmg.br	Gomes, Teane Milagres Augusto/AAP-2686-2021; Martins-Filho, Olindo Assis/ABE-6278-2021; de Lima Santos, Renato/A-1134-2008; Farias Filho, J.R./AAI-4847-2020; Brandão, Humberto m/C-2831-2017	Gomes, Teane Milagres Augusto/0000-0002-3752-8613; Martins-Filho, Olindo Assis/0000-0002-5494-4889; de Lima Santos, Renato/0000-0002-4830-0470; Farias Filho, J.R./0000-0003-1843-8695; Brandão, Humberto m/0000-0002-7405-3928; Mol, Juliana/0000-0002-6946-8213	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brazil); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil); CNPq; CAPES	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Work in RLS lab is supported by CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil), FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brazil), and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil). RLS and OAMF have fellowships from CNPq. APCS has a scholarship from CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas-Gamboa AM, 2009, INFECT IMMUN, V77, P877, DOI 10.1128/IAI.01017-08; Arenas-Gamboa AM, 2008, INFECT IMMUN, V76, P2448, DOI 10.1128/IAI.00767-07; Arenas-Gamboa AM, 2009, J WILDLIFE DIS, V45, P165, DOI 10.7589/0090-3558-45.1.165; Banai M, 2002, VET MICROBIOL, V90, P497, DOI 10.1016/S0378-1135(02)00231-6; Blandino A, 1999, J BIOSCI BIOENG, V88, P686, DOI 10.1016/S1389-1723(00)87103-0; Blasco J. M., 1990, Animal brucellosis., P351; Blasco JM, 1997, PREV VET MED, V31, P275, DOI 10.1016/S0167-5877(96)01110-5; Carvalho CA, 2012, SMALL RUMINANT RES, V102, P213, DOI 10.1016/j.smallrumres.2011.08.004; Cassataro J, 2007, VACCINE, V25, P4437, DOI 10.1016/j.vaccine.2007.03.028; Corbel M.J., 2006, BRUCELLOSIS HUMANS A; Costa EA, 2012, ARQ BRAS MED VET ZOO, V64, P751, DOI 10.1590/S0102-09352012000300029; Avila-Calderon ED, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/743509; Davis DS, 2002, VET MICROBIOL, V90, P533, DOI 10.1016/S0378-1135(02)00233-X; Estein SM, 2009, VACCINE, V27, P6704, DOI 10.1016/j.vaccine.2009.08.097; Franco MP, 2007, LANCET INFECT DIS, V7, P775, DOI 10.1016/S1473-3099(07)70286-4; Garrity G. M., 2001, BERGEYS MANUAL SYSTE, V2; Grillo MJ, 2000, BIOLOGICALS, V28, P119, DOI 10.1006/biol.2000.0249; Hanes J, 1997, ADV DRUG DELIVER REV, V28, P97, DOI 10.1016/S0169-409X(97)00053-7; JANSEN BC, 1980, ONDERSTEPOORT J VET, V47, P263; Lantier F, 1985, BRUCELLA MELITENSIS, P247; MARIN CM, 1990, RES VET SCI, V48, P209, DOI 10.1016/S0034-5288(18)30992-5; Marschutz MK, 2000, BIOMATERIALS, V21, P1499, DOI 10.1016/S0142-9612(00)00039-9; Matrone M, 2009, BRAZ J MICROBIOL, V40, P480, DOI 10.1590/S1517-838220090003000010; Moustacas VS, 2014, SCI WORLD J, DOI 10.1155/2014/241452; Murillo M, 2001, VACCINE, V19, P4099, DOI 10.1016/S0264-410X(01)00177-3; Nielsen K, 2002, VET MICROBIOL, V90, P447, DOI 10.1016/S0378-1135(02)00229-8; Olsen SC, 2013, REV SCI TECH OIE, V32, P207; Poester FP, 2013, REV SCI TECH OIE, V32, P105; Qiu B, 2003, BIOMATERIALS, V24, P11, DOI 10.1016/S0142-9612(02)00227-2; Robinson A., 2003, GUIDELINES COORDINAT; Sa JC, 2012, VET MICROBIOL, V159, P130, DOI 10.1016/j.vetmic.2012.03.029; Sancho P, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-61; Santos RL, 2013, PESQUI VET BRASIL, V33, P759, DOI 10.1590/S0100-736X2013000600012; Schurig GG, 2002, VET MICROBIOL, V90, P479, DOI 10.1016/S0378-1135(02)00255-9; Silva APC, 2013, VET MICROBIOL, V167, P546, DOI 10.1016/j.vetmic.2013.09.003; Silva APC, 2015, CLIN VACCIN IN PRESS; Silva TMA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114532; Silva TMA, 2011, INFECT IMMUN, V79, P1706, DOI 10.1128/IAI.01109-10; Soler-Llorens P, 2014, VET RES, V45, DOI 10.1186/s13567-014-0072-0; Takenaga M, 2002, J CONTROL RELEASE, V79, P81, DOI 10.1016/S0168-3659(01)00518-1; Thoen C. O., 1993, P236; VERSHILOVA P, 1961, B WORLD HEALTH ORGAN, V24, P85; Visscher G E, 1987, J Biomater Appl, V2, P118; Xavier MN, 2010, VET MICROBIOL, V145, P158, DOI 10.1016/j.vetmic.2010.02.037	44	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136865	10.1371/journal.pone.0136865	http://dx.doi.org/10.1371/journal.pone.0136865			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317399	Green Published, gold, Green Submitted			2022-12-26	WOS:000360299100156
J	Subramanian, M; Ozcan, L; Ghorpade, DS; Ferrante, AW; Tabas, I				Subramanian, Manikandan; Ozcan, Lale; Ghorpade, Devram Sampat; Ferrante, Anthony W., Jr.; Tabas, Ira			Suppression of Adaptive Immune Cell Activation Does Not Alter Innate Immune Adipose Inflammation or Insulin Resistance in Obesity	PLOS ONE			English	Article							REGULATORY T-CELLS; DIET-INDUCED OBESITY; DENDRITIC CELLS; TISSUE MACROPHAGES; MICE; SENSITIVITY; MECHANISMS; MYD88; IL-33; PROLIFERATION	Obesity-induced inflammation in visceral adipose tissue (VAT) is a major contributor to insulin resistance and type 2 diabetes. Whereas innate immune cells, notably macrophages, contribute to visceral adipose tissue (VAT) inflammation and insulin resistance, the role of adaptive immunity is less well defined. To address this critical gap, we used a model in which endogenous activation of T cells was suppressed in obese mice by blocking MyD88-mediated maturation of CD11c(+) antigen-presenting cells. VAT CD11c(+) cells from Cd11cCre(+)Myd88(fl/fl) vs. control Myd88(fl/fl) mice were defective in activating T cells in vitro, and VAT T and B cell activation was markedly reduced in Cd11cCre(+)Myd88(fl/fl) obese mice. However, neither macrophage-mediated VAT inflammation nor systemic inflammation were altered in Cd11cCre(+)Myd88(fl/fl) mice, thereby enabling a focused analysis on adaptive immunity. Unexpectedly, fasting blood glucose, plasma insulin, and the glucose response to glucose and insulin were completely unaltered in Cd11cCre(+)Myd88(fl/fl) vs. control obese mice. Thus, CD11c(+) cells activate VAT T and B cells in obese mice, but suppression of this process does not have a discernible effect on macrophage-mediated VAT inflammation or systemic glucose homeostasis.	[Subramanian, Manikandan; Ozcan, Lale; Ghorpade, Devram Sampat; Ferrante, Anthony W., Jr.; Tabas, Ira] Columbia Univ, Dept Med, New York, NY 10032 USA; [Tabas, Ira] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Tabas, Ira] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Subramanian, M (corresponding author), Columbia Univ, Dept Med, New York, NY 10032 USA.	ms4144@cumc.columbia.edu	Ferrante, Anthony/AAC-7763-2019	Ferrante, Anthony/0000-0001-9272-2593; Ozcan, Lale/0000-0002-2710-7057; Subramanian, Manikandan/0000-0002-2608-3890	American Heart Association Scientist Development Grant [11SDG5300022]; New York Obesity and Nutrition Research Center Pilot and Feasibility Grant [DK26687]; National Institutes of Health [HL075662, HL106019]; NIH/NIDDK Center [5P30DK063608]; Office of the Director, National Institutes of Health [S10OD020056]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106019, R01HL075662, P01HL087123, R01HL132412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026687, R01DK101942, P30DK063608, R01DK066525] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020056] Funding Source: NIH RePORTER	American Heart Association Scientist Development Grant(American Heart Association); New York Obesity and Nutrition Research Center Pilot and Feasibility Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIDDK Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by an American Heart Association Scientist Development Grant (11SDG5300022) and a New York Obesity and Nutrition Research Center Pilot and Feasibility Grant (DK26687) to LO, and National Institutes of Health grants HL075662 and HL106019 to IT. Studies reported in this publication used the resources of the CCTI/DERC Flow Core facility funded in part by NIH/NIDDK Center grant 5P30DK063608, and by the Office of the Director, National Institutes of Health, under Shared Instrumentation grant S10OD020056. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoras ALB, 2003, J INVEST ALLERG CLIN, V13, P181; Ballak DB, 2013, CYTOKINE, V62, P96, DOI 10.1016/j.cyto.2013.02.009; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bertola A, 2012, DIABETES, V61, P2238, DOI 10.2337/db11-1274; Caspar-Bauguil S, 2005, FEBS LETT, V579, P3487, DOI 10.1016/j.febslet.2005.05.031; Cho KW, 2014, CELL REP, V9, P605, DOI 10.1016/j.celrep.2014.09.004; DeFuria J, 2013, P NATL ACAD SCI USA, V110, P5133, DOI 10.1073/pnas.1215840110; Deng T, 2013, CELL METAB, V17, P411, DOI 10.1016/j.cmet.2013.02.009; Deng ZB, 2009, DIABETES, V58, P2498, DOI 10.2337/db09-0216; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Goldrath AW, 2004, P NATL ACAD SCI USA, V101, P16885, DOI 10.1073/pnas.0407417101; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hosoi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012537; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; Jang MH, 2006, J IMMUNOL, V176, P803, DOI 10.4049/jimmunol.176.2.803; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Khare A, 2011, APOPTOSIS, V16, P334, DOI 10.1007/s10495-010-0569-6; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; Liu XG, 2011, NAT IMMUNOL, V12, P416, DOI 10.1038/ni.2015; Mantegazza AR, 2014, P NATL ACAD SCI USA, V111, P15508, DOI 10.1073/pnas.1412998111; Melcher M, 2008, J IMMUNOL, V180, P8048, DOI 10.4049/jimmunol.180.12.8048; Montes VN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067709; Morris DL, 2013, DIABETES, V62, P2762, DOI 10.2337/db12-1404; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Priceman SJ, 2013, P NATL ACAD SCI USA, V110, P13079, DOI 10.1073/pnas.1311557110; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Senn JJ, 2002, DIABETES, V51, P3391, DOI 10.2337/diabetes.51.12.3391; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Stefanovic-Racic M, 2012, DIABETES, V61, P2330, DOI 10.2337/db11-1523; Stolarczyk E, 2013, CELL METAB, V17, P520, DOI 10.1016/j.cmet.2013.02.019; Subramanian M, 2013, J CLIN INVEST, V123, P179, DOI 10.1172/JCI64617; Takeuchi O, 2002, CURR TOP MICROBIOL, V270, P155; Turnquist HR, 2011, J IMMUNOL, V187, P4598, DOI 10.4049/jimmunol.1100519; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Vasanthakumar A, 2015, NAT IMMUNOL, V16, P276, DOI 10.1038/ni.3085; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wentworth JM, 2010, DIABETES, V59, P1648, DOI 10.2337/db09-0287; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wu LDH, 2012, METABOLISM, V61, P1633, DOI 10.1016/j.metabol.2012.04.015; Xia S, 2011, J BIOL CHEM, V286, P23591, DOI 10.1074/jbc.M111.237123; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yang HW, 2010, J IMMUNOL, V185, P1836, DOI 10.4049/jimmunol.1000021; Yu MJ, 2014, J EXP MED, V211, P887, DOI 10.1084/jem.20131314	49	11	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135842	10.1371/journal.pone.0135842	http://dx.doi.org/10.1371/journal.pone.0135842			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317499	Green Published, gold, Green Submitted			2022-12-26	WOS:000360299100045
J	Song, JW; Guan, M; Zhao, ZW; Zhang, JJ				Song, Jianwen; Guan, Ming; Zhao, Zhenwen; Zhang, Junjie			Type I Interferons Function as Autocrine and Paracrine Factors to Induce Autotaxin in Response to TLR Activation	PLOS ONE			English	Article							LYSOPHOSPHATIDIC ACID; LYSOPHOSPHOLIPASE-D; GENE-EXPRESSION; RECEPTOR; CELLS; MOTILITY; IDENTIFICATION; CHEMOTAXIS; ALPHA/BETA; REGULATOR	Lysophosphatidic acid (LPA) is an important phospholipid mediator in inflammation and immunity. However, the mechanism of LPA regulation during inflammatory response is largely unknown. Autotaxin (ATX) is the key enzyme to produce extracellular LPA from lysophosphatidylcholine (LPC). In this study, we found that ATX was induced in monocytic THP-1 cells by TLR4 ligand lipopolysaccharide (LPS), TLR9 ligand CpG oligonucleotide, and TLR3 ligand poly(I:C), respectively. The ATX induction by TLR ligand was abolished by the neutralizing antibody against IFN-beta or the knockdown of IFNAR1, indicating that type I IFN autocrine loop is responsible for the ATX induction upon TLR activation. Both IFN-beta and IFN-alpha were able to induce ATX expression via the JAK-STAT and PI3K-AKT pathways but with different time-dependent manners. The ATX induction by IFN-beta was dramatically enhanced by IFN-gamma, which had no significant effect on ATX expression alone, suggesting a synergy effect between type I and type II IFNs in ATX induction. Extracellular LPA levels were significantly increased when THP-1 cells were treated with IFN-alpha/beta or TLR ligands. In addition, the type I IFN-mediated ATX induction was identified in human monocyte-derived dendritic cells (moDCs) stimulated with LPS or poly(I: C), and IFN-alpha/beta could induce ATX expression in human peripheral blood mononuclear cells (PBMCs) and monocytes isolated form blood samples. These results suggest that, in response to TLR activation, ATX is induced through a type I INF autocrine-paracrine loop to enhance LPA generation.	[Song, Jianwen; Zhang, Junjie] Beijing Normal Univ, Coll Life Sci, Inst Cell Biol, Key Lab Cell Proliferat & Regulat Biol,Minist Edu, Beijing 100875, Peoples R China; [Guan, Ming; Zhao, Zhenwen] Chinese Acad Sci, Inst Chem, Key Lab Analyt Chem Living Biosyst, Beijing 100080, Peoples R China	Beijing Normal University; Chinese Academy of Sciences; Institute of Chemistry, CAS	Zhang, JJ (corresponding author), Beijing Normal Univ, Coll Life Sci, Inst Cell Biol, Key Lab Cell Proliferat & Regulat Biol,Minist Edu, Beijing 100875, Peoples R China.	jjzhang@bnu.edu.cn		Zhang, Junjie/0000-0001-8809-1485	National Nature Science Foundation of China [31470765]; Science and Technology Program of Beijing Municipality [Z131100005213009]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Program of Beijing Municipality	This work was supported in part by the National Nature Science Foundation of China (No. 31470765) and the Science and Technology Program of Beijing Municipality (No. Z131100005213009).	ABRAMOVICH C, 1994, EMBO J, V13, P5871, DOI 10.1002/j.1460-2075.1994.tb06932.x; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bagga S, 2004, BLOOD, V104, P4080, DOI 10.1182/blood-2004-03-1166; Bai ZB, 2013, J IMMUNOL, V190, P2036, DOI 10.4049/jimmunol.1202025; Benesch MGK, 2014, FEBS LETT, V588, P2712, DOI 10.1016/j.febslet.2014.02.009; Benesch MG, 2014, FEBS LETT; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bourgoin SG, 2010, CURR OPIN INVEST DR, V11, P515; Coccia EM, 2004, EUR J IMMUNOL, V34, P796, DOI 10.1002/eji.200324610; Colonna M, 2002, CURR OPIN IMMUNOL, V14, P373, DOI 10.1016/S0952-7915(02)00349-7; Croze E, 1996, J BIOL CHEM, V271, P33165, DOI 10.1074/jbc.271.52.33165; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Fotopoulou S, 2010, DEV BIOL, V339, P451, DOI 10.1016/j.ydbio.2010.01.007; Gough DJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000361; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Houben AJS, 2011, CANCER METAST REV, V30, P557, DOI 10.1007/s10555-011-9319-7; Idzko M, 2004, J IMMUNOL, V172, P4480, DOI 10.4049/jimmunol.172.7.4480; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jin YX, 2003, EUR J IMMUNOL, V33, P2083, DOI 10.1002/eji.200323711; Kanda H, 2008, NAT IMMUNOL, V9, P415, DOI 10.1038/ni1573; Knowlden S, 2014, J IMMUNOL, V192, P851, DOI 10.4049/jimmunol.1302831; Koh JS, 1998, J CLIN INVEST, V102, P716, DOI 10.1172/JCI1002; Kondo M, 2014, CLIN CHIM ACTA, V433, P128, DOI 10.1016/j.cca.2014.03.006; Kumar A, 2006, IMMUNOLOGY, V117, P11, DOI 10.1111/j.1365-2567.2005.02258.x; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Li S, 2012, FEBS LETT, V586, P792, DOI 10.1016/j.febslet.2012.01.044; Li S, 2009, BIOCHEM BIOPH RES CO, V378, P264, DOI 10.1016/j.bbrc.2008.11.047; Martino A, 2006, HAEMATOLOGICA, V91, P1273; Nikitopoulou I, 2012, J EXP MED, V209, P923, DOI 10.1084/jem.20112012; Noguchi K, 2009, CURR OPIN PHARMACOL, V9, P15, DOI 10.1016/j.coph.2008.11.010; Noppert SJ, 2007, IMMUNOL CELL BIOL, V85, P446, DOI 10.1038/sj.icb.7100099; Panther E, 2002, J IMMUNOL, V169, P4129, DOI 10.4049/jimmunol.169.8.4129; Park GY, 2013, AM J RESP CRIT CARE, V188, P928, DOI 10.1164/rccm.201306-1014OC; Piemonti L, 2000, J IMMUNOL, V164, P4443, DOI 10.4049/jimmunol.164.9.4443; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Rosskopf D, 1998, AM J PHYSIOL-CELL PH, V274, pC1573, DOI 10.1152/ajpcell.1998.274.6.C1573; Rubenfeld J, 2006, AM J PHYSIOL-LUNG C, V290, pL66, DOI 10.1152/ajplung.00473.2004; Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0; Sevastou I, 2013, BBA-MOL CELL BIOL L, V1831, P42, DOI 10.1016/j.bbalip.2012.07.019; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Silvennoinen O, 1993, INTERFERON INDUCED N; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; Takeda K., 2004, SEMINARS IMMUNOLOGY; Takeshita F, 2004, SEMIN IMMUNOL, V16, P17, DOI 10.1016/j.smim.2003.10.009; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Teo K, 2014, BIOCHEM J, V463, P157, DOI 10.1042/BJ20140680; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Tou JS, 2005, CELL SIGNAL, V17, P77, DOI 10.1016/j.cellsig.2004.06.003; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Watanabe N, 2007, J CLIN GASTROENTEROL, V41, P616, DOI 10.1097/01.mcg.0000225642.90898.0e; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yung YC, 2014, J LIPID RES, V55, P1192, DOI 10.1194/jlr.R046458; Zhang YF, 2012, J IMMUNOL, V189, P3914, DOI 10.4049/jimmunol.1201604; Zhao ZW, 2009, J CHROMATOGR B, V877, P3739, DOI 10.1016/j.jchromb.2009.08.032; Zheng YH, 2001, J IMMUNOL, V166, P2317, DOI 10.4049/jimmunol.166.4.2317; Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588	64	30	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136629	10.1371/journal.pone.0136629	http://dx.doi.org/10.1371/journal.pone.0136629			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313906	Green Published, Green Submitted, gold			2022-12-26	WOS:000360144000076
J	Cebey-Lopez, M; Herberg, J; Pardo-Seco, J; Gomez-Carballa, A; Martinon-Torres, N; Salas, A; Martinon-Sanchez, JM; Gormley, S; Sumner, E; Fink, C; Martinon-Torres, F				Cebey-Lopez, Miriam; Herberg, Jethro; Pardo-Seco, Jacobo; Gomez-Carballa, Alberto; Martinon-Torres, Nazareth; Salas, Antonio; Maria Martinon-Sanchez, Jose; Gormley, Stuart; Sumner, Edward; Fink, Colin; Martinon-Torres, Federico		GENDRES Network	Viral Co-Infections in Pediatric Patients Hospitalized with Lower Tract Acute Respiratory Infections	PLOS ONE			English	Article							HUMAN BOCAVIRUS INFECTION; HUMAN CORONAVIRUSES 229E; PARAINFLUENZA VIRUSES 1; HUMAN METAPNEUMOVIRUS; SYNCYTIAL VIRUS; CLINICAL-SAMPLES; PCR ASSAYS; CHILDREN; INFANTS; RNA	Background Molecular techniques can often reveal a broader range of pathogens in respiratory infections. We aim to investigate the prevalence and age pattern of viral co-infection in children hospitalized with lower tract acute respiratory infection (LT-ARI), using molecular techniques. Methods A nested polymerase chain reaction approach was used to detect Influenza (A, B), metapneumovirus, respiratory syncytial virus (RSV), parainfluenza (1-4), rhinovirus, adenovirus (A-F), bocavirus and coronaviruses (NL63, 229E, OC43) in respiratory samples of children with acute respiratory infection prospectively admitted to any of the GENDRES network hospitals between 2011-2013. The results were corroborated in an independent cohort collected in the UK. Results A total of 204 and 97 nasopharyngeal samples were collected in the GENDRES and UK cohorts, respectively. In both cohorts, RSV was the most frequent pathogen (52.9% and 36.1% of the cohorts, respectively). Co-infection with multiple viruses was found in 92 samples (45.1%) and 29 samples (29.9%), respectively; this was most frequent in the 12-24 months age group. The most frequently observed co-infection patterns were RSV-Rhinovirus (23 patients, 11.3%, GENDRES cohort) and RSV-bocavirus/bocavirus-influenza (5 patients, 5.2%, UK cohort). Conclusion The presence of more than one virus in pediatric patients admitted to hospital with LT-ARI is very frequent and seems to peak at 12-24 months of age. The clinical significance of these findings is unclear but should warrant further analysis.	[Cebey-Lopez, Miriam; Pardo-Seco, Jacobo; Gomez-Carballa, Alberto; Martinon-Torres, Nazareth; Salas, Antonio; Maria Martinon-Sanchez, Jose; Martinon-Torres, Federico] Hosp Clin Univ, Grp Invest Genet Vacunas Infecc & Pediat GENVIP, Galicia, Spain; [Cebey-Lopez, Miriam; Pardo-Seco, Jacobo; Gomez-Carballa, Alberto; Martinon-Torres, Nazareth; Salas, Antonio; Maria Martinon-Sanchez, Jose; Martinon-Torres, Federico] Univ Santiago de Compostela USC, Galicia, Spain; [Herberg, Jethro; Gormley, Stuart] Univ London Imperial Coll Sci Technol & Med, Div Infect Dis, Paediat Sect, London, England; [Pardo-Seco, Jacobo; Gomez-Carballa, Alberto; Salas, Antonio] Univ Santiago de Compostela, Unidade Xenet, Dept Anat Patol & Ciencias Forenses, Galicia, Spain; [Pardo-Seco, Jacobo; Gomez-Carballa, Alberto; Salas, Antonio] Univ Santiago de Compostela, Inst Ciencias Forenses, GMX, Galicia, Spain; [Cebey-Lopez, Miriam; Pardo-Seco, Jacobo; Gomez-Carballa, Alberto; Martinon-Torres, Nazareth; Maria Martinon-Sanchez, Jose; Martinon-Torres, Federico] Hosp Clin Univ Santiago, Dept Pediat, Translat Pediat & Infect Dis Sect, Santiago De Compostela, Galicia, Spain; [Sumner, Edward; Fink, Colin] Univ Warwick, Micropathol Ltd, Coventry CV4 7AL, W Midlands, England	Universidade de Santiago de Compostela; Imperial College London; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; University of Warwick	Cebey-Lopez, M (corresponding author), Hosp Clin Univ, Grp Invest Genet Vacunas Infecc & Pediat GENVIP, Galicia, Spain.		Martinon-Torres, Federico/E-4982-2016; Cebey, Miriam/K-9347-2014; Pardo-Seco, Jacobo J/G-3752-2016; Calvo, Cristina/T-5028-2018; Salas, Antonio/U-2029-2019; Salas, Antonio/E-3977-2012; Moreno Galarraga, Laura/B-2460-2017; Gómez-Carballa, Alberto/I-4610-2014	Martinon-Torres, Federico/0000-0002-9023-581X; Cebey, Miriam/0000-0003-0599-7519; Pardo-Seco, Jacobo J/0000-0002-8059-8908; Calvo, Cristina/0000-0002-6503-3423; Salas, Antonio/0000-0002-2336-702X; Salas, Antonio/0000-0002-2336-702X; Moreno Galarraga, Laura/0000-0003-0293-0749; Gómez-Carballa, Alberto/0000-0003-0927-1272; Herberg, Jethro/0000-0001-6941-6491	Spanish Government [PI10/00540]; Regional Galician funds [10 PXIB 918 184 PR]; Ministerio de Ciencia e Innovacion [SAF2011-26983]; Plan Galego IDT, Xunta de Galicia [EM 2012/045]; Instituto de Investigacion Sanitaria de Santiago de Compostela; Instituto Carlos III (Intensificacion de la actividad investigadora); European Union's seventh Framework program under ECGA [279185]; Imperial College Comprehensive Biomedical Research Centre; Wellcome Trust Centre for Respiratory Infection at Imperial College (DMPED) [P26077]	Spanish Government(Spanish GovernmentEuropean Commission); Regional Galician funds; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Plan Galego IDT, Xunta de Galicia; Instituto de Investigacion Sanitaria de Santiago de Compostela; Instituto Carlos III (Intensificacion de la actividad investigadora)(Instituto de Salud Carlos III); European Union's seventh Framework program under ECGA; Imperial College Comprehensive Biomedical Research Centre; Wellcome Trust Centre for Respiratory Infection at Imperial College (DMPED)	This work was supported by the Spanish Government (Research Program Health Research Fund (FIS; PI10/00540) National Plan I + D + I and FEDER funds), Regional Galician funds (Promotion of Research Project 10 PXIB 918 184 PR) (FMT), Ministerio de Ciencia e Innovacion (SAF2011-26983) and the Plan Galego IDT, Xunta de Galicia (EM 2012/045) (AS). MC research activities have been supported by grants from Instituto de Investigacion Sanitaria de Santiago de Compostela. FMT research activities have been supported by grants from Instituto Carlos III (Intensificacion de la actividad investigadora). Additional funding was received from the European Union's seventh Framework program under ECGA no. 279185 (EUCLIDS) during the production of this paper. JH was supported by the Imperial College Comprehensive Biomedical Research Centre and the Wellcome Trust Centre for Respiratory Infection at Imperial College (DMPED P26077 to JAH).	Aguilar JC, 2000, J CLIN MICROBIOL, V38, P1191, DOI 10.1128/JCM.38.3.1191-1195.2000; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2007, CLIN INFECT DIS, V44, P904, DOI 10.1086/512196; Allard A, 2001, J CLIN MICROBIOL, V39, P498, DOI 10.1128/JCM.39.2.498-505.2001; Avellon A, 2001, J VIROL METHODS, V92, P113, DOI 10.1016/S0166-0934(00)00269-X; Bellau-Pujol S, 2005, J VIROL METHODS, V126, P53, DOI 10.1016/j.jviromet.2005.01.020; Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; Bezerra PGM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018928; Bonzel L, 2008, PEDIATR INFECT DIS J, V27, P589, DOI 10.1097/INF.0b013e3181694fb9; Brand HK, 2012, PEDIATR PULM, V47, P393, DOI 10.1002/ppul.21552; Brieu N, 2008, PEDIATR INFECT DIS J, V27, P969, DOI 10.1097/INF.0b013e31817acfaa; Canducci F, 2008, J MED VIROL, V80, P716, DOI 10.1002/jmv.21108; Choi EH, 2006, CLIN INFECT DIS, V43, P585, DOI 10.1086/506350; Chorazy ML, 2013, PEDIAT INFECT DIS J; Chung JY, 2006, EMERG INFECT DIS, V12, P1254, DOI 10.3201/eid1708.060261; Dingle KE, 2004, J CLIN MICROBIOL, V42, P1003, DOI 10.1128/JCM.42.3.1003-1011.2004; do Amaral de Leon C, 2013, PEDIAT PULMONOL; Echevarria JE, 1998, J CLIN MICROBIOL, V36, P1388; Freymuth F, 2006, J MED VIROL, V78, P1498, DOI 10.1002/jmv.20725; Garcia-Garcia M L, 2007, An Pediatr (Barc), V67, P212, DOI 10.1157/13108941; Garcia-Garcia ML, 2006, PEDIATR PULM, V41, P863, DOI 10.1002/ppul.20456; Gaunt ER, 2010, J CLIN MICROBIOL, V48, P2940, DOI 10.1128/JCM.00636-10; Greensill J, 2003, EMERG INFECT DIS, V9, P372, DOI 10.3201/eid0903.020289; Huang GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064254; Huijskens EG, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-276; Jartti T, 2004, J MED VIROL, V72, P695, DOI 10.1002/jmv.20027; Jevsnik M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-365; Kahn JS, 2007, CURR OPIN PHARMACOL, V7, P478, DOI 10.1016/j.coph.2007.07.004; Lazar I, 2004, EMERG INFECT DIS, V10, P1318, DOI 10.3201/eid1007.030983; Maertzdorf J, 2004, J CLIN MICROBIOL, V42, P981, DOI 10.1128/JCM.42.3.981-986.2004; Mahony JB, 2008, CLIN MICROBIOL REV, V21, P716, DOI 10.1128/CMR.00037-07; Manning A, 2006, J INFECT DIS, V194, P1283, DOI 10.1086/508219; Marguet C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004596; Mullins JA, 2004, EMERG INFECT DIS, V10, P700, DOI 10.3201/eid1004.030555; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; MYINT S, 1994, MOL CELL PROBE, V8, P357, DOI 10.1006/mcpr.1994.1052; Nokso-Koivisto J, 2002, J MED VIROL, V66, P417, DOI 10.1002/jmv.2161; Peng D, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-155; Schildgen O, 2008, CLIN MICROBIOL REV, V21, P291, DOI 10.1128/CMR.00030-07; Steininger C, 2001, J CLIN MICROBIOL, V39, P129, DOI 10.1128/JCM.39.1.129-133.2001; Suryadevara M, 2011, CLIN PEDIATR, V50, P513, DOI 10.1177/0009922810394834; Tan BH, 2009, J MED VIROL, V81, P82, DOI 10.1002/jmv.21361; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; van der Zalm MM, 2009, J PEDIATR-US, V154, P396, DOI 10.1016/j.jpeds.2008.08.036; van Elden LJR, 2003, J CLIN MICROBIOL, V41, P4378, DOI 10.1128/JCM.41.9.4378-4381.2003; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472; Wolf DG, 2006, PEDIATR INFECT DIS J, V25, P320, DOI 10.1097/01.inf.0000207395.80657.cf	47	48	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136526	10.1371/journal.pone.0136526	http://dx.doi.org/10.1371/journal.pone.0136526			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332375	Green Published, Green Submitted, gold			2022-12-26	WOS:000360613800060
J	Gore, RJ; Diallo, S; Padilla, J				Gore, Ross Joseph; Diallo, Saikou; Padilla, Jose			You Are What You Tweet: Connecting the Geographic Variation in America's Obesity Rate to Twitter Content	PLOS ONE			English	Article							BODY-MASS INDEX; PHYSICAL-ACTIVITY; PUBLIC-HEALTH; RECOMMENDATIONS; REDUCTION; EXERCISE; PATTERNS	We conduct a detailed investigation of the relationship among the obesity rate of urban areas and expressions of happiness, diet and physical activity on social media. We do so by analyzing a massive, geo-tagged data set comprising over 200 million words generated over the course of 2012 and 2013 on the social network service Twitter. Among many results, we show that areas with lower obesity rates: (1) have happier tweets and frequently discuss (2) food, particularly fruits and vegetables, and (3) physical activities of any intensity. Additionally, we provide evidence that each of these results offer different and unique insight into the variation of the obesity rate in urban areas within the United States. Our work shows how the contents of social media may potentially be used to estimate real-time, population-scale measures of factors related to obesity.	[Gore, Ross Joseph; Diallo, Saikou; Padilla, Jose] Old Dominion Univ, Virginia Modeling Anal & Simulat Ctr, Norfolk, VA 23529 USA	Old Dominion University	Gore, RJ (corresponding author), Old Dominion Univ, Virginia Modeling Anal & Simulat Ctr, Norfolk, VA 23529 USA.	rgore@odu.edu						Akcora C.G., 2010, P 1 WORKSH SOC MED A, P62, DOI DOI 10.1145/1964858.1964867; Balabantaray RC., 2012, INT J APPL INFORM SY, V4, P48, DOI DOI 10.5120/IJAIS12-450651; Boillot A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052708, 10.1371/journal.pone.0064417]; Bollen J., 2011, ICWSM, P450; Broniatowski DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083672; Carwile JL, 2011, ENVIRON RES, V111, P825, DOI 10.1016/j.envres.2011.05.014; Cawley J, 2012, J HEALTH ECON, V31, P219, DOI 10.1016/j.jhealeco.2011.10.003; Dodds PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026752; Dodds PS, 2010, J HAPPINESS STUD, V11, P441, DOI 10.1007/s10902-009-9150-9; Drewnowski A, 2004, AM J PREV MED, V27, P154, DOI 10.1016/j.amepre.2004.06.011; Finkelstein EA, 2012, AM J PREV MED, V42, P563, DOI 10.1016/j.amepre.2011.10.026; Food U., 2014, NUTR DAT DIET STUD 1; Fuhrman J, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-51; Fulgoni VL, 2009, J NUTR, V139, P1549, DOI 10.3945/jn.108.101360; Goncalves B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112074; Guenther PM, 2008, J AM DIET ASSOC, V108, P1896, DOI 10.1016/j.jada.2008.08.016; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Holmberg K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106086; Huberman B., 2008, 1 MONDAY, V14, P1, DOI [10.5210/fm.v14i1.2317, DOI 10.5210/FM.V14I1.2317]; Jones DA, 1998, ARCH FAM MED, V7, P285; Mohammad S. M., 2014, COMPUTATIONAL INTELL; Mohammad Saif, 2013, P 7 INT WORKSH SEM E; National Center for Health Statistics, 1994, PLAN OP 3 NAT HLTH N; Newby P, 2003, AM J CLIN NUTR, V77, P1417, DOI 10.1093/ajcn/77.6.1417; Ogden CL, 2012, PREVALENCE OBESITY U; Ross R, 2004, OBES RES, V12, P789, DOI 10.1038/oby.2004.95; Shah NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033308; Sintsova V., 2013, 4 WORKSHOP COMPUTATI; Smith, 2010, P INT AAAI C WEB SOC; Smith A., 2012, PEW INTERNET AM LIFE, P4; Togo P, 2001, INT J OBESITY, V25, P1741, DOI 10.1038/sj.ijo.0801819; Trogdon JG, 2012, OBESITY, V20, P214, DOI 10.1038/oby.2011.169; Tsai AG, 2011, OBES REV, V12, P50, DOI 10.1111/j.1467-789X.2009.00708.x; Turk AM, 2011, BEST PRACTICES GUIDE; USD of Health, 1996, PHYS ACT HLTH REP SU; Variyam JN., 1998, USDAS HLTH EATING IN; Weltman A, 2008, J CLIN ENDOCR METAB, V93, P4711, DOI 10.1210/jc.2008-0998; Weyer C, 1998, INT J OBESITY, V22, P1071, DOI 10.1038/sj.ijo.0800728; Wing RR, 1999, MED SCI SPORT EXER, V31, pS547, DOI 10.1097/00005768-199911001-00010	39	75	75	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0133505	10.1371/journal.pone.0133505	http://dx.doi.org/10.1371/journal.pone.0133505			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332588	Green Published, gold, Green Submitted			2022-12-26	WOS:000360613800004
J	Blum, SE; Heller, ED; Sela, S; Elad, D; Edery, N; Leitner, G				Blum, Shlomo E.; Heller, Elimelech D.; Sela, Shlomo; Elad, Daniel; Edery, Nir; Leitner, Gabriel			Genomic and Phenomic Study of Mammary Pathogenic Escherichia coli	PLOS ONE			English	Article							BOVINE-MASTITIS; VIRULENCE FACTORS; DAIRY-COWS; ANTIMICROBIAL RESISTANCE; EPITHELIAL-CELLS; STRAINS; YERSINIABACTIN; SUSCEPTIBILITY; IDENTIFICATION; VISUALIZATION	Escherichia coli is a major etiological agent of intra-mammary infections (IMI) in cows, leading to acute mastitis and causing great economic losses in dairy production worldwide. Particular strains cause persistent IMI, leading to recurrent mastitis. Virulence factors of mammary pathogenic E. coli (MPEC) involved pathogenesis of mastitis as well as those differentiating strains causing acute or persistent mastitis are largely unknown. This study aimed to identify virulence markers in MPEC through whole genome and phenome comparative analysis. MPEC strains causing acute (VL2874 and P4) or persistent (VL2732) mastitis were compared to an environmental strain (K71) and to the genomes of strains representing different E. coli pathotypes. Intra-mammary challenge in mice confirmed experimentally that the strains studied here have different pathogenic potential, and that the environmental strain K71 is non-pathogenic in the mammary gland. Analysis of whole genome sequences and predicted proteomes revealed high similarity among MPEC, whereas MPEC significantly differed from the non-mammary pathogenic strain K71, and from E. coli genomes from other pathotypes. Functional features identified in MPEC genomes and lacking in the non-mammary pathogenic strain were associated with synthesis of lipopolysaccharide and other membrane antigens, ferric-dicitrate iron acquisition and sugars metabolism. Features associated with cytotoxicity or intra-cellular survival were found specifically in the genomes of strains from severe and acute (VL2874) or persistent (VL2732) mastitis, respectively. MPEC genomes were relatively similar to strain K-12, which was subsequently shown here to be possibly pathogenic in the mammary gland. Phenome analysis showed that the persistent MPEC was the most versatile in terms of nutrients metabolized and acute MPEC the least. Among phenotypes unique to MPEC compared to the non-mammary pathogenic strain were uric acid and D-serine metabolism. This study reveals virulence factors and phenotypic characteristics of MPEC that may play a role in pathogenesis of E. coli mastitis.	[Blum, Shlomo E.; Heller, Elimelech D.] Robert H Smith Fac Agr Food & Environm, Dept Anim Sci, IL-7610001 Rehovot, Israel; [Blum, Shlomo E.; Leitner, Gabriel] Kimron Vet Inst, Natl Mastitis Reference Ctr, Dept Bacteriol, IL-50250 Bet Dagan, Israel; [Sela, Shlomo] ARO, Microbial Food Safety Res Unit, Dept Food Qual & Safety, Inst Postharvest & Food Sci,Volcani Ctr, Bet Dagan, Israel; [Blum, Shlomo E.; Elad, Daniel] Kimron Vet Inst, Dept Bacteriol, IL-50250 Bet Dagan, Israel; [Edery, Nir] Kimron Vet Inst, Dept Pathol, IL-50250 Bet Dagan, Israel	Kimron Veterinary Institute; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Kimron Veterinary Institute; Kimron Veterinary Institute	Blum, SE (corresponding author), Robert H Smith Fac Agr Food & Environm, Dept Anim Sci, IL-7610001 Rehovot, Israel.	shlomo.blum@mail.huji.ac.il		Sela (Saldinger), Shlomo/0000-0002-9141-9696	Israeli Dairy Board	Israeli Dairy Board	This work was supported by research grants from the Israeli Dairy Board. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RA, 2011, VET RES COMMUN, V35, P89, DOI 10.1007/s11259-010-9455-5; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERSON JC, 1977, VET PATHOL, V14, P618, DOI 10.1177/030098587701400608; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Blum S, 2008, VET MICROBIOL, V132, P135, DOI 10.1016/j.vetmic.2008.05.012; Blum S, 2012, J BACTERIOL, V194, P3732, DOI 10.1128/JB.00535-12; Blum SE, 2014, VET J, V201, P72, DOI 10.1016/j.tvjl.2014.04.008; Blum SE, 2013, VET MICROBIOL, V163, P305, DOI 10.1016/j.vetmic.2012.12.037; Bochner BR, 2009, FEMS MICROBIOL REV, V33, P191, DOI 10.1111/j.1574-6976.2008.00149.x; Bradley AJ, 2002, VET J, V164, P116, DOI 10.1053/tvjl.2002.0724; BRAMLEY AJ, 1976, J DAIRY RES, V43, P205, DOI 10.1017/S0022029900015752; Browning DF, 2013, MOL MICROBIOL, V87, P939, DOI 10.1111/mmi.12144; Burvenich C, 2003, VET RES, V34, P521, DOI 10.1051/vetres:2003023; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; CHANDLER RL, 1977, J COMP PATHOL, V87, P471, DOI 10.1016/0021-9975(77)90036-6; Chaturvedi KS, 2014, ACS CHEM BIOL, V9, P551, DOI 10.1021/cb400658k; Chen CY, 2007, PLASMID, V57, P29, DOI 10.1016/j.plasmid.2006.05.005; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Connolly JP, 2014, ISME J, P1; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Dego OK, 2012, VET MICROBIOL, V155, P291, DOI 10.1016/j.vetmic.2011.08.016; Dogan B, 2006, VET MICROBIOL, V116, P270, DOI 10.1016/j.vetmic.2006.04.023; Dogan B, 2012, VET MICROBIOL, V159, P163, DOI 10.1016/j.vetmic.2012.03.033; Dopfer D, 2001, VET MICROBIOL, V80, P285, DOI 10.1016/S0378-1135(01)00307-8; Dopfer D, 2000, VET MICROBIOL, V74, P331, DOI 10.1016/S0378-1135(00)00191-7; Dopfer D, 1999, J DAIRY SCI, V82, P80, DOI 10.3168/jds.S0022-0302(99)75211-2; Fernandes JBC, 2011, J VET DIAGN INVEST, V23, P1146, DOI 10.1177/1040638711425581; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Halasa T, 2009, LIVEST SCI, V124, P295, DOI 10.1016/j.livsci.2009.02.019; Hancock V, 2008, MICROBIOL-SGM, V154, P167, DOI 10.1099/mic.0.2007/011981-0; HILL AW, 1979, VET REC, V105, P299, DOI 10.1136/vr.105.13.299; Hogan J, 2003, VET RES, V34, P507, DOI 10.1051/vetres:2003022; Hogeveen H, 2011, NEW ZEAL VET J, V59, P16, DOI 10.1080/00480169.2011.547165; Huja S, 2015, MBIO, V6, DOI 10.1128/mBio.01681-14; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Keseler IM, 2013, NUCLEIC ACIDS RES, V41, pD605, DOI 10.1093/nar/gks1027; Koli P, 2011, MBIO, V2; Le Marechal C, 2011, DAIRY SCI TECHNOL, V91, P247, DOI 10.1007/s13594-011-0009-6; Leekitcharoenphon P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S6; Leimbach A, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00182-15; Leitner G, 2011, INT DAIRY J, V21, P279, DOI 10.1016/j.idairyj.2010.11.013; Lin J, 1999, CLIN DIAGN LAB IMMUN, V6, P966, DOI 10.1128/CDLI.6.6.966-969.1999; Liu YX, 2014, RES MICROBIOL, V165, P273, DOI 10.1016/j.resmic.2014.03.007; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Moritz RL, 2006, J CLIN MICROBIOL, V44, P4038, DOI 10.1128/JCM.01172-06; Notebaert S, 2006, VET QUART, V28, P2, DOI 10.1080/01652176.2006.9695201; Porcherie A, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-14; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; R Development Core Team, 2014, R LANG ENV STAT COMP; Richards VP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119799; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sabri M, 2006, MICROBIOL-SGM, V152, P745, DOI 10.1099/mic.0.28682-0; Schubert S, 2004, INT J MED MICROBIOL, V294, P83, DOI 10.1016/j.ijmm.2004.06.026; Seroussi E, 2013, IMMUNOGENETICS, V65, P861, DOI 10.1007/s00251-013-0738-1; Shpigel NY, 2008, CURR OPIN MICROBIOL, V11, P60, DOI 10.1016/j.mib.2008.01.004; Silanikove N, 2007, BIOCHEM BIOPH RES CO, V363, P561, DOI 10.1016/j.bbrc.2007.08.188; Srinivasan V, 2007, VET MICROBIOL, V124, P319, DOI 10.1016/j.vetmic.2007.04.040; Suojala L, 2011, VET MICROBIOL, V147, P383, DOI 10.1016/j.vetmic.2010.07.011; Vaas LAI, 2013, BIOINFORMATICS, V29, P1823, DOI 10.1093/bioinformatics/btt291; Vaas LAI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034846; Vesth T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060120; Vigil PD, 2011, INFECT IMMUN, V79, P2335, DOI 10.1128/IAI.00110-11; Wang XX, 2011, APPL ENVIRON MICROB, V77, P5577, DOI 10.1128/AEM.05068-11; Wattam AR, 2014, NUCLEIC ACIDS RES, V42, pD581, DOI 10.1093/nar/gkt1099; Wenz JR, 2006, J DAIRY SCI, V89, P3408, DOI 10.3168/jds.S0022-0302(06)72377-3; White LJ, 2010, VET RES, V41, DOI 10.1051/vetres/2009061; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	69	27	30	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136387	10.1371/journal.pone.0136387	http://dx.doi.org/10.1371/journal.pone.0136387			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327312	gold, Green Published, Green Submitted			2022-12-26	WOS:000360437700040
J	Manoharan, B; Neale, HC; Hancock, JT; Jackson, RW; Arnold, DL				Manoharan, Bharani; Neale, Helen C.; Hancock, John T.; Jackson, Robert W.; Arnold, Dawn L.			The Identification of Genes Important in Pseudomonas syringae pv. phaseolicola Plant Colonisation Using In Vitro Screening of Transposon Libraries	PLOS ONE			English	Article							AIR-LIQUID INTERFACE; EFFECTOR PROTEINS; SECRETION SYSTEM; VIRULENCE; MUTANTS; PATHOGENESIS; SEQUENCE; BIOFILM	The bacterial plant pathogen Pseudomonas syringae pv. phaseolicola (Pph) colonises the surface of common bean plants before moving into the interior of plant tissue, via wounds and stomata. In the intercellular spaces the pathogen proliferates in the apoplastic fluid and forms microcolonies (biofilms) around plant cells. If the pathogen can suppress the plant's natural resistance response, it will cause halo blight disease. The process of resistance suppression is fairly well understood, but the mechanisms used by the pathogen in colonisation are less clear. We hypothesised that we could apply in vitro genetic screens to look for changes in motility, colony formation, and adhesion, which are proxies for infection, microcolony formation and cell adhesion. We made transposon (Tn) mutant libraries of Pph strains 1448A and 1302A and found 106/1920 mutants exhibited alterations in colony morphology, motility and biofilm formation. Identification of the insertion point of the Tn identified within the genome highlighted, as expected, a number of altered motility mutants bearing mutations in genes encoding various parts of the flagellum. Genes involved in nutrient biosynthesis, membrane associated proteins, and a number of conserved hypothetical protein (CHP) genes were also identified. A mutation of one CHP gene caused a positive increase in in planta bacterial growth. This rapid and inexpensive screening method allows the discovery of genes important for in vitro traits that can be correlated to roles in the plant interaction.	[Manoharan, Bharani; Neale, Helen C.; Hancock, John T.; Arnold, Dawn L.] Univ W England, Fac Hlth & Appl Sci, Ctr Res Biosci, Bristol BS16 1QY, Avon, England; [Jackson, Robert W.] Univ Reading, Sch Biol Sci, Reading RG6 6UR, Berks, England	University of West England; University of Reading	Arnold, DL (corresponding author), Univ W England, Fac Hlth & Appl Sci, Ctr Res Biosci, Frenchay Campus, Bristol BS16 1QY, Avon, England.	dawn.arnold@uwe.ac.uk	Jackson, Robert W/C-2973-2009; Arnold, Dawn/AAF-3484-2021	Jackson, Robert W/0000-0002-2042-4105; 	University of the West of England, Bristol; Biotechnology and Biological Sciences Research Council [BB/J014796/1]; Biotechnology and Biological Sciences Research Council [BB/J015350/1] Funding Source: researchfish; BBSRC [BB/J014796/1, BB/J015350/1] Funding Source: UKRI	University of the West of England, Bristol; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the University of the West of England, Bristol (http://www.uwe.ac.uk/) (BM and DLA) and Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/) (BB/J014796/1) (HCN, RWJ and DLA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Arnold DL, 2011, MOL PLANT PATHOL, V12, P617, DOI [10.1111/j.1364-3703.2010.00697.x, 10.1111/J.1364-3703.2010.00697.X]; Bender CL, 1999, MICROBIOL MOL BIOL R, V63, P266, DOI 10.1128/MMBR.63.2.266-292.1999; Bhagwat AA, 2009, MICROBIOL-SGM, V155, P229, DOI 10.1099/mic.0.023747-0; Bittel P, 2007, CURR OPIN PLANT BIOL, V10, P335, DOI 10.1016/j.pbi.2007.04.021; Boch J, 2002, MOL MICROBIOL, V44, P73, DOI 10.1046/j.1365-2958.2002.02877.x; Brooks DM, 2004, MOL PLANT MICROBE IN, V17, P162, DOI 10.1094/MPMI.2004.17.2.162; Burns BP, 2000, ARCH BIOCHEM BIOPHYS, V380, P78, DOI 10.1006/abbi.2000.1920; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Confer AW, 2013, VET MICROBIOL, V163, P207, DOI 10.1016/j.vetmic.2012.08.019; Cullinane M, 2005, MICROBIOL-SGM, V151, P3071, DOI 10.1099/mic.0.27958-0; CUPPELS DA, 1986, APPL ENVIRON MICROB, V51, P323, DOI 10.1128/AEM.51.2.323-327.1986; Dasgupta N, 2003, MOL MICROBIOL, V50, P809, DOI 10.1046/j.1365-2958.2003.03740.x; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gallie J, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002109; Giddens SR, 2007, P NATL ACAD SCI USA, V104, P18247, DOI 10.1073/pnas.0706739104; Godfrey SAC, 2010, MOL PLANT MICROBE IN, V23, P1294, DOI 10.1094/MPMI-05-10-0114; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; HARSHEY RM, 1994, MOL MICROBIOL, V13, P389, DOI 10.1111/j.1365-2958.1994.tb00433.x; Hirano SS, 2000, MICROBIOL MOL BIOL R, V64, P624, DOI 10.1128/MMBR.64.3.624-653.2000; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jarrell KF, 2008, NAT REV MICROBIOL, V6, P466, DOI 10.1038/nrmicro1900; Kanda E, 2011, MOL GENET GENOMICS, V285, P163, DOI 10.1007/s00438-010-0594-8; Keen N.T., 1992, MOL PLANT PATHOLOGY; KING EO, 1954, J LAB CLIN MED, V44, P301; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Koza A, 2009, MICROBIOL-SGM, V155, P1397, DOI 10.1099/mic.0.025064-0; Laue RE, 2000, MICROBIOL-UK, V146, P2469, DOI 10.1099/00221287-146-10-2469; Le Breton Y, 2013, INFECT IMMUN, V81, P862, DOI 10.1128/IAI.00837-12; LINDGREN PB, 1986, J BACTERIOL, V168, P512, DOI 10.1128/jb.168.2.512-522.1986; LINDOW SE, 1993, APPL ENVIRON MICROB, V59, P1593, DOI 10.1128/AEM.59.5.1593-1601.1993; Lovell HC, 2011, MOL PLANT PATHOL, V12, P167, DOI 10.1111/j.1364-3703.2010.00658.x; Manoil C, 2000, METHOD ENZYMOL, V326, P35; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; Morris CE, 2008, ISME J, V2, P321, DOI 10.1038/ismej.2007.113; Naito K, 2008, MOL PLANT MICROBE IN, V21, P1165, DOI 10.1094/MPMI-21-9-1165; Pitman AR, 2005, CURR BIOL, V15, P2230, DOI 10.1016/j.cub.2005.10.074; Porter SL, 2011, NAT REV MICROBIOL, V9, P153, DOI 10.1038/nrmicro2505; Qin AP, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-69; Rodionov DA, 2003, J BIOL CHEM, V278, P41148, DOI 10.1074/jbc.M305837200; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sarris PF, 2010, MOL PLANT PATHOL, V11, P795, DOI 10.1111/j.1364-3703.2010.00644.x; Schreiber KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041461; Schreiber KJ, 2011, MOL MICROBIOL, V80, P364, DOI 10.1111/j.1365-2958.2011.07571.x; Shah DSH, 2000, J BACTERIOL, V182, P5218, DOI 10.1128/JB.182.18.5218-5224.2000; Shyntum DY, 2015, MOL PLANT MICROBE IN, V28, P420, DOI 10.1094/MPMI-07-14-0219-R; SOMLYAI G, 1986, PHYSIOL MOL PLANT P, V29, P369, DOI 10.1016/S0048-4059(86)80053-4; Spiers AJ, 2003, MOL MICROBIOL, V50, P15, DOI 10.1046/j.1365-2958.2003.03670.x; Tans-Kersten J, 2001, J BACTERIOL, V183, P3597, DOI 10.1128/JB.183.12.3597-3605.2001; Taylor JD, 1996, PLANT PATHOL, V45, P469, DOI 10.1046/j.1365-3059.1996.d01-147.x; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	52	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137355	10.1371/journal.pone.0137355	http://dx.doi.org/10.1371/journal.pone.0137355			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325299	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000360437700112
J	McAuliffe, PF; Evans, KW; Akcakanat, A; Chen, K; Zheng, XF; Zhao, H; Eterovic, AK; Sangai, T; Holder, AM; Sharma, C; Chen, HQ; Do, KA; Tarco, E; Gagea, M; Naff, KA; Sahin, A; Multani, AS; Black, DM; Mittendorf, EA; Bedrosian, I; Mills, GB; Gonzalez-Angulo, AM; Meric-Bernstam, F				McAuliffe, Priscilla F.; Evans, Kurt W.; Akcakanat, Argun; Chen, Ken; Zheng, Xiaofeng; Zhao, Hao; Eterovic, Agda Karina; Sangai, Takafumi; Holder, Ashley M.; Sharma, Chandeshwar; Chen, Huiqin; Do, Kim-Anh; Tarco, Emily; Gagea, Mihai; Naff, Katherine A.; Sahin, Aysegul; Multani, Asha S.; Black, Dalliah M.; Mittendorf, Elizabeth A.; Bedrosian, Isabelle; Mills, Gordon B.; Gonzalez-Angulo, Ana Maria; Meric-Bernstam, Funda			Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes	PLOS ONE			English	Article							HUMAN TUMOR XENOGRAFTS; CELL LUNG-CANCER; NEOADJUVANT CHEMOTHERAPY; IMMUNODEFICIENT MICE; PANCREATIC-CANCER; LARGE PANEL; NUDE-MICE; MODELS; SURVIVAL; GROWTH	Background Breast cancer patients who are resistant to neoadjuvant chemotherapy (NeoCT) have a poor prognosis. There is a pressing need to develop in vivo models of chemo resistant tumors to test novel therapeutics. We hypothesized that patient-derived breast cancer xenografts (BCXs) from chemo-naive and chemotherapy-exposed tumors can provide high fidelity in vivo models for chemoresistant breast cancers. Methods Patient tumors and BCXs were characterized with short tandem repeat DNA fingerprinting, reverse phase protein arrays, molecular inversion probe arrays, and next generation sequencing. Results Forty-eight breast cancers (24 post-chemotherapy, 24 chemo-naive) were implanted and 13 BCXs were established (27%). BCX engraftment was higher in TNBC compared to hormone-receptor positive cancer (53.8% vs. 15.6%, p = 0.02), in tumors from patients who received NeoCT (41.7% vs. 8.3%, p = 0.02), and in patients who had progressive disease on NeoCT (85.7% vs. 29.4%, p = 0.02). Twelve patients developed metastases after surgery; in five, BCXs developed before distant relapse. Patients whose tumors developed BCXs had a lower recurrence-free survival (p = 0.015) and overall survival (p<0.001). Genomic losses and gains could be detected in the BCX, and three models demonstrated a transformation to induce mouse tumors. However, overall, somatic mutation profiles including potential drivers were maintained upon implantation and serial passaging. One BCX model was cultured in vitro and re-implanted, maintaining its genomic profile. Conclusions BCXs can be established from clinically aggressive breast cancers, especially in TNBC patients with poor response to NeoCT. Future studies will determine the potential of in vivo models for identification of genotype-phenotype correlations and individualization of treatment.	[McAuliffe, Priscilla F.; Sangai, Takafumi; Holder, Ashley M.; Sharma, Chandeshwar; Black, Dalliah M.; Mittendorf, Elizabeth A.; Bedrosian, Isabelle; Meric-Bernstam, Funda] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Evans, Kurt W.; Akcakanat, Argun; Tarco, Emily; Meric-Bernstam, Funda] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX 77030 USA; [Chen, Ken; Zheng, Xiaofeng; Zhao, Hao] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Sci, Houston, TX 77030 USA; [Eterovic, Agda Karina; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Chen, Huiqin; Do, Kim-Anh] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Gagea, Mihai; Naff, Katherine A.] Univ Texas MD Anderson Canc Ctr, Dept Vet Med & Surg, Houston, TX 77030 USA; [Sahin, Aysegul] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Multani, Asha S.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Gonzalez-Angulo, Ana Maria] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Meric-Bernstam, F (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA.	fmeric@mdanderson.org	Akcakanat, Argun/AFU-2090-2022; Chen, Ken/AAU-1432-2021	Chen, Ken/0000-0003-4013-5279; Akcakanat, Argun/0000-0002-4012-9840; Holder, Ashley/0000-0002-6506-5871	National Institutes of Health [T32 CA009599]; MD Anderson Cancer Center Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy; MD Anderson Stand Up to Cancer Dream Team Translational Research Grant, a Program of the Entertainment Industry Foundation [SU2C-AACR-DT0209 01]; MD Anderson Women's Cancers Moonshot Program; Susan G. Komen Foundation for the Cure grant [SAC10006]; Nellie B. Connally Breast Cancer Research Endowment; Barr funds; MD Anderson Cancer Center support grant [P30 CA016672];  [UL1TR000371]; NATIONAL CANCER INSTITUTE [T32CA009599, P30CA016672] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MD Anderson Cancer Center Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy; MD Anderson Stand Up to Cancer Dream Team Translational Research Grant, a Program of the Entertainment Industry Foundation; MD Anderson Women's Cancers Moonshot Program; Susan G. Komen Foundation for the Cure grant; Nellie B. Connally Breast Cancer Research Endowment; Barr funds; MD Anderson Cancer Center support grant; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by National Institutes of Health T32 CA009599 (PFM, AMH, FMB), the MD Anderson Cancer Center Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy (FMB, KWE, AKE, HZ, KC, GBM), MD Anderson Stand Up to Cancer Dream Team Translational Research Grant, a Program of the Entertainment Industry Foundation SU2C-AACR-DT0209 01 (GBM, AA, FMB), MD Anderson Women's Cancers Moonshot Program (KWE, FMB), Susan G. Komen Foundation for the Cure grant SAC10006 (FMB, KAD), UL1TR000371 (FMB, KC, KAD), the Nellie B. Connally Breast Cancer Research Endowment (KWE, AA, FMB), the Barr funds, and the MD Anderson Cancer Center support grant (P30 CA016672).	Akcakanat A, 2008, CANCER-AM CANCER SOC, V112, P2352, DOI 10.1002/cncr.23456; Bergamaschi A, 2009, MOL ONCOL, V3, P469, DOI 10.1016/j.molonc.2009.07.003; Caudle AS, 2010, J CLIN ONCOL, V28, P1821, DOI 10.1200/JCO.2009.25.3286; Chen K, 2015, CLIN CHEM, V61, P544, DOI 10.1373/clinchem.2014.231100; Cottu P, 2012, BREAST CANCER RES TR, V133, P595, DOI 10.1007/s10549-011-1815-5; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Efron B, 2002, GENET EPIDEMIOL, V23, P70, DOI 10.1002/gepi.1124; Garber K, 2009, J NATL CANCER I, V101, P6, DOI 10.1093/jnci/djn481; Garrido-Laguna I, 2011, CLIN CANCER RES, V17, P5793, DOI 10.1158/1078-0432.CCR-11-0341; Gonzalez-Angulo AM, 2011, MOL CANCER THER, V10, P1093, DOI 10.1158/1535-7163.MCT-10-1089; Hao CC, 2015, CANCER LETT, V357, P179, DOI 10.1016/j.canlet.2014.11.024; Hassan B, 2013, SURG ONCOL CLIN N AM, V22, P641, DOI 10.1016/j.soc.2013.06.008; Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001; Hidalgo M, 2011, MOL CANCER THER, V10, P1311, DOI 10.1158/1535-7163.MCT-11-0233; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hylander BL, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-110; Ilie M, 2015, CANCER MED-US, V4, P201, DOI 10.1002/cam4.357; Julien S, 2012, CLIN CANCER RES, V18, P5314, DOI 10.1158/1078-0432.CCR-12-0372; Klinghammer K, 2015, INT J CANCER, V136, P2940, DOI 10.1002/ijc.29344; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kuerer HM, 1999, J CLIN ONCOL, V17, P460, DOI 10.1200/JCO.1999.17.2.460; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Liedtke C, 2009, ANN ONCOL, V20, P1953, DOI 10.1093/annonc/mdp263; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Lin MT, 2010, BIOTECHNIQUES, V48, P211, DOI 10.2144/000113363; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Marangoni E, 2007, CLIN CANCER RES, V13, P3989, DOI 10.1158/1078-0432.CCR-07-0078; Meric-Bernstam F, 2014, CLIN CANCER RES, V20, P3870, DOI 10.1158/1078-0432.CCR-13-1507; Meric-Bernstam F, 2014, MOL CANCER THER, V13, P1382, DOI 10.1158/1535-7163.MCT-13-0482; Monsma DJ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-125; Moro M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/568567; Morton CL, 2007, NAT PROTOC, V2, P247, DOI 10.1038/nprot.2007.25; Pathak S, 1997, BRIT J CANCER, V76, P1134, DOI 10.1038/bjc.1997.524; Pathak S, 1998, CANCER, V83, P1891, DOI 10.1002/(SICI)1097-0142(19981101)83:9<1891::AID-CNCR3>3.0.CO;2-U; Morelli MP, 2012, J CLIN ONCOL, V30, pE45, DOI 10.1200/JCO.2011.36.9678; Pounds S, 2003, BIOINFORMATICS, V19, P1236, DOI 10.1093/bioinformatics/btg148; Rajeshkumar NV, 2011, CLIN CANCER RES, V17, P2799, DOI 10.1158/1078-0432.CCR-10-2580; Ring BZ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-74; Rothenberg-Thurley M, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.49.49; Rubio-Viqueira B, 2006, CLIN CANCER RES, V12, P4652, DOI 10.1158/1078-0432.CCR-06-0113; Ryba T, 2011, NAT PROTOC, V6, P870, DOI 10.1038/nprot.2011.328; Symmans WF, 2007, J CLIN ONCOL, V25, P4414, DOI 10.1200/JCO.2007.10.6823; Thompson PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023543; Uronis JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038422; Vargo-Gogola T, 2007, NAT REV CANCER, V7, P659, DOI 10.1038/nrc2193; Visonneau S, 1998, AM J PATHOL, V152, P1299; Wang Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r246; Weroha SJ, 2014, CLIN CANCER RES, V20, P1288, DOI 10.1158/1078-0432.CCR-13-2611; Wichert S, 2004, BIOINFORMATICS, V20, P5, DOI 10.1093/bioinformatics/btg364; Zhang XM, 2013, CANCER RES, V73, P4885, DOI 10.1158/0008-5472.CAN-12-4081	51	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136851	10.1371/journal.pone.0136851	http://dx.doi.org/10.1371/journal.pone.0136851			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325287	gold, Green Submitted, Green Published			2022-12-26	WOS:000360437700068
J	Schult, N; Reineking, T; Kluss, T; Zetzsche, C				Schult, Niclas; Reineking, Thomas; Kluss, Thorsten; Zetzsche, Christoph			Information-Driven Active Audio-Visual Source Localization	PLOS ONE			English	Article							TRACKING; INTEGRATION; MODELS	We present a system for sensorimotor audio-visual source localization on a mobile robot. We utilize a particle filter for the combination of audio-visual information and for the temporal integration of consecutive measurements. Although the system only measures the current direction of the source, the position of the source can be estimated because the robot is able to move and can therefore obtain measurements from different directions. These actions by the robot successively reduce uncertainty about the source's position. An information gain mechanism is used for selecting the most informative actions in order to minimize the number of actions required to achieve accurate and precise position estimates in azimuth and distance. We show that this mechanism is an efficient solution to the action selection problem for source localization, and that it is able to produce precise position estimates despite simplified unisensory preprocessing. Because of the robot's mobility, this approach is suitable for use in complex and cluttered environments. We present qualitative and quantitative results of the system's performance and discuss possible areas of application.	[Schult, Niclas; Reineking, Thomas; Kluss, Thorsten; Zetzsche, Christoph] Univ Bremen, Cognit Neuroinformat, D-28359 Bremen, Germany	University of Bremen	Schult, N (corresponding author), Univ Bremen, Cognit Neuroinformat, D-28359 Bremen, Germany.	niclasschult@googlemail.com	Kluss, Thorsten/AAR-7406-2020		German Research Foundation [SFB-TR8]	German Research Foundation(German Research Foundation (DFG))	This study has been supported by German Research Foundation (SFB-TR8 "Spatial Cognition" A5-[ActionSpace]) (http://www.sfbtr8.uni-bremen.de/en/home/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; [Anonymous], 1987, M IOC SPEECH GROUP A; Bar-Shalom Y., 2004, ESTIMATION APPL TRAC; Breebaart J, 2010, J AUDIO ENG SOC, V58, P126; Brunelli R., 2009, TEMPLATE MATCHING TE; Brungart DS, 1999, J ACOUST SOC AM, V106, P1465, DOI 10.1121/1.427180; Calvert G., 2004, HDB MULTISENSORY PRO; Cha Z, 2008, IEEE T MULTIMEDIA, V10, P538, DOI 10.1109/TMM.2008.917406; Chen SY, 2011, INT J ROBOT RES, V30, P1343, DOI 10.1177/0278364911410755; Dalal N., 2005, IEEE COMPUTER SOC C, V1, P886, DOI DOI 10.1109/CVPR.2005.177; Doucet A., 2001, SEQUENTIAL MONTE CAR; Gehrig T, 2005, IEEE WORK APPL SIG, P118, DOI 10.1109/ASPAA.2005.1540183; GLASBERG BR, 1990, HEARING RES, V47, P103, DOI 10.1016/0378-5955(90)90170-T; Hanke M, 2009, NEUROINFORMATICS, V7, P37, DOI 10.1007/s12021-008-9041-y; Hosmer Jr DW, 2004, APPL LOGISTIC REGRES; Hu GN, 2007, IEEE T AUDIO SPEECH, V15, P396, DOI 10.1109/TASL.2006.881700; Hyvarinen A, 2010, TOP COGN SCI, V2, P251, DOI 10.1111/j.1756-8765.2009.01057.x; Iwaya Y., 2003, Acoustical Science and Technology, V24, P322, DOI 10.1250/ast.24.322; Kalman RE., 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Klemen J, 2012, NEUROSCI BIOBEHAV R, V36, P111, DOI 10.1016/j.neubiorev.2011.04.015; Lang S., 2003, P INT C MULT INT VAN, P28, DOI DOI 10.1145/958432.958441; Li T, 2006, IEEE T SIGNAL PROCES, V54, P3991, DOI 10.1109/TSP.2006.880213; Liang ZW, 2008, APPL ACOUST, V69, P673, DOI 10.1016/j.apacoust.2007.04.001; Meyer GF, 2001, NEUROREPORT, V12, P2557, DOI 10.1097/00001756-200108080-00053; Nickel K, 2005, P 7 INT C MULT INT I, P61, DOI DOI 10.1145/1088463.1088477; Okuno HG, 2002, LECT NOTES ARTIF INT, V2358, P725; Portello A, 2011, IEEE INT C INT ROBOT, P137, DOI [10.1109/IROS.2011.6048515, 10.1109/IROS.2011.6094842]; Reineking T., 2014, BELIEF FUNCTIONS THE; Schnupp J., 2011, AUDITORY NEUROSCIENC; Seilheimer RL, 2014, CURR OPIN NEUROBIOL, V25, P38, DOI 10.1016/j.conb.2013.11.008; Shapiro L, 2011, NEW PROBL PHILOS, P1; Slaney M, 1993, APPLE COMPUT PERCEPT, V35; Thrun S, 2001, ARTIF INTELL, V128, P99, DOI 10.1016/S0004-3702(01)00069-8; Valin JM, 2007, ROBOT AUTON SYST, V55, P216, DOI 10.1016/j.robot.2006.08.004; Valin JM, 2003, IROS 2003: PROCEEDINGS OF THE 2003 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-4, P1228; Vermaak J, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL I, PROCEEDINGS, P741, DOI 10.1109/ICCV.2001.937600; Wang D, 2006, COMPUTATIONAL AUDITO, V147; Ward DB, 2003, IEEE T SPEECH AUDI P, V11, P826, DOI 10.1109/TSA.2003.818112; WIGHTMAN FL, 1989, J ACOUST SOC AM, V85, P868, DOI 10.1121/1.397558; WIGHTMAN FL, 1992, J ACOUST SOC AM, V91, P1648, DOI 10.1121/1.402445; Wuerger SM, 2003, PERCEPT PSYCHOPHYS, V65, P1188, DOI 10.3758/BF03194844; Yost W A., 2000, FUNDAMENTALS HEARING; Zetzsche C, 2008, COGN PROCESS, V9, P283, DOI 10.1007/s10339-008-0214-2; Zotkin DN, 2002, EURASIP J APPL SIG P, V2002, P1154, DOI 10.1155/S1110865702206058	44	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137057	10.1371/journal.pone.0137057	http://dx.doi.org/10.1371/journal.pone.0137057			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327619	Green Published, Green Submitted, gold			2022-12-26	WOS:000360437700087
J	Lopez-Gongora, M; Escartin, A; Martinez-Horta, S; Fernandez-Bobadilla, R; Querol, L; Romero, S; Mananas, MA; Riba, J				Lopez-Gongora, Mariana; Escartin, Antonio; Martinez-Horta, Saul; Fernandez-Bobadilla, Ramon; Querol, Luis; Romero, Sergio; Mananas, Miquel Angel; Riba, Jordi			Neurophysiological Evidence of Compensatory Brain Mechanisms in Early-Stage Multiple Sclerosis	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; COGNITIVE DYSFUNCTION; ERROR-DETECTION; ATTENTION SYSTEM; IMPAIRMENT; PERFORMANCE; ACTIVATION; DISABILITY; SEVERITY; SUBTYPES	Multiple sclerosis (MS) is a chronic central nervous system disorder characterized by white matter inflammation, demyelination and neurodegeneration. Although cognitive dysfunction is a common manifestation, it may go unnoticed in recently-diagnosed patients. Prior studies suggest MS patients develop compensatory mechanisms potentially involving enhanced performance monitoring. Here we assessed the performance monitoring system in early-stage MS patients using the error-related negativity (ERN), an event-related brain potential (ERP) observed following behavioral errors. Twenty-seven early-stage MS patients and 31 controls were neuropsychologically assessed. Electroencephalography recordings were obtained while participants performed: a) a stop task and b) an auditory oddball task. Behavior and ERP measures were assessed. No differences in performance were found between groups in most neuropsychological tests or in behavior or ERP components in the auditory oddball task. However, the amplitude of the ERN associated with stop errors in the stop task was significantly higher in patients. ERN amplitude correlated positively with scores on the Expanded Disability Status Scale and the Multiple Sclerosis Severity Score, and negatively with the time since last relapse. Patients showed higher neuronal recruitment in tasks involving performance monitoring. Results suggest the development of compensatory brain mechanisms in early-stage MS and reflect the sensitivity of the ERN to detect these changes.	[Lopez-Gongora, Mariana; Escartin, Antonio; Querol, Luis] Univ Autonoma Barcelona, Dept Neurol, Multiple Sclerosis Unit, Hosp Santa Creu & St Pau, E-08193 Barcelona, Spain; [Lopez-Gongora, Mariana; Escartin, Antonio] Univ Autonoma Barcelona, Dept Med, E-08193 Barcelona, Spain; [Lopez-Gongora, Mariana; Escartin, Antonio; Querol, Luis] Biomed Res Inst IIB St Pau, Multiple Sclerosis Res Grp, Barcelona, Spain; [Martinez-Horta, Saul; Fernandez-Bobadilla, Ramon] Univ Autonoma Barcelona, Dept Neurol, Movement Disorders Unit, Hosp Santa Creu & St Pau, E-08193 Barcelona, Spain; [Martinez-Horta, Saul; Fernandez-Bobadilla, Ramon] Biomed Res Inst IIB St Pau, Parkinsons Dis & Movement Disorders Res Grp, Barcelona, Spain; [Romero, Sergio; Mananas, Miquel Angel] Univ Politecn Cataluna, BarcelonaTech UPC, Dept Automat Control ESAII, Biomed Engn Res Ctr CREB, Barcelona, Spain; [Romero, Sergio; Mananas, Miquel Angel] CIBER Bioingn Biomat & Nanomed CIBER BBN, Barcelona, Spain; [Riba, Jordi] Biomed Res Inst IIB St Pau, Human Neuropsychopharmacol Grp, Barcelona, Spain; [Riba, Jordi] Univ Autonoma Barcelona, Ctr Invest Medicaments, Serv Farmacol Clin, Hosp Santa Creu & St Pau, E-08193 Barcelona, Spain; [Riba, Jordi] Univ Autonoma Barcelona, Dept Farmacol & Terapeut, E-08193 Barcelona, Spain; [Riba, Jordi] CIBERSAM, Ctr Invest Biomed Red Salud Mental, Barcelona, Spain	Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Universitat Politecnica de Catalunya; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona	Escartin, A (corresponding author), Univ Autonoma Barcelona, Dept Neurol, Multiple Sclerosis Unit, Hosp Santa Creu & St Pau, E-08193 Barcelona, Spain.	aescartin@santpau.cat	Romero, Sergio/K-9236-2016; martinez-horta, saul/ABA-4265-2020; Querol, Luis/H-2119-2015; Mañanas, Miguel Angel/AAI-2961-2021	Querol, Luis/0000-0002-4289-8264; Fernandez-Bobadilla, Ramon/0000-0002-5045-732X; Riba, Jordi/0000-0002-9375-8421; Mananas, Miguel Angel/0000-0001-9836-6083; Martinez-Horta, Saul/0000-0003-0125-7249	Bayer Hispania SL; Instituto de Salud Carlos III, Ministry of Economy and Competitiveness [FIS JR13/00014]	Bayer Hispania SL; Instituto de Salud Carlos III, Ministry of Economy and Competitiveness	This work was supported by Bayer Hispania SL who was not involved in the conception of the study, data collection or preparation of the article. LQ is supported by a Juan Rodes research contract (FIS JR13/00014) from the Instituto de Salud Carlos III, Ministry of Economy and Competitiveness.	Achiron A, 2003, J NEUROL NEUROSUR PS, V74, P443, DOI 10.1136/jnnp.74.4.443; Amato MP, 2006, J NEUROL SCI, V245, P41, DOI 10.1016/j.jns.2005.08.019; Amato MP, 2001, ARCH NEUROL-CHICAGO, V58, P1602, DOI 10.1001/archneur.58.10.1602; Aminoff JC, 2001, J CLIN NEUROPHYSIOL, V18, P372, DOI 10.1097/00004691-200107000-00009; Beck A., 1993, BECK ANXIETY INVENTO; Belouchrani A, 1997, IEEE T SIGNAL PROCES, V45, P434, DOI 10.1109/78.554307; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Deloire MSA, 2006, MULT SCLER J, V12, P445, DOI 10.1191/1352458506ms1289oa; Ellger T, 2002, J NEUROL SCI, V205, P35, DOI 10.1016/S0022-510X(02)00278-2; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Glanz BI, 2007, MULT SCLER J, V13, P1004, DOI 10.1177/1352458507077943; Hankomaki E, 2014, ACTA NEUROL SCAND, V129, P184, DOI 10.1111/ane.12161; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Kappos L, 1998, LANCET, V352, P1491, DOI 10.1016/S0140-6736(98)10039-9; Kramer UM, 2007, J NEUROSCI, V27, P14190, DOI 10.1523/JNEUROSCI.4229-07.2007; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Luu P, 2001, CLIN NEUROPHYSIOL, V112, P1295, DOI 10.1016/S1388-2457(01)00559-4; Mainero C, 2004, NEUROIMAGE, V21, P858, DOI 10.1016/j.neuroimage.2003.10.004; Marco-Pallares J, 2010, NEUROIMAGE, V53, P962, DOI 10.1016/j.neuroimage.2010.02.012; Penner IK, 2003, J NEUROL, V250, P461, DOI 10.1007/s00415-003-1025-0; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Potagas C, 2008, J NEUROL SCI, V267, P100, DOI 10.1016/j.jns.2007.10.002; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; Reuter F, 2011, J NEUROL NEUROSUR PS, V82, P1157, DOI 10.1136/jnnp.2010.213744; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Romero S, 2008, COMPUT BIOL MED, V38, P348, DOI 10.1016/j.compbiomed.2007.12.001; Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144, DOI 10.1212/01.WNL.0000156155.19270.F8; Sadiq S., 2005, MERRITTS NEUROLOGY, P94; Simoes-Franklin C, 2010, HUM BRAIN MAPP, V31, P458, DOI 10.1002/hbm.20879; Staffen W, 2002, BRAIN, V125, P1275, DOI 10.1093/brain/awf125; Sundgren M, 2015, CLIN NEUROPHYSIOL, V126, P689, DOI 10.1016/j.clinph.2014.07.024; Urbach TP, 2002, PSYCHOPHYSIOLOGY, V39, P791, DOI 10.1111/1469-8986.3960791; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI 10.1037/0033-295x.111.4.931	37	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136786	10.1371/journal.pone.0136786	http://dx.doi.org/10.1371/journal.pone.0136786			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322632	Green Published, gold, Green Submitted			2022-12-26	WOS:000360435500036
J	Maier, T; Haraszti, T				Maier, Timo; Haraszti, Tamas			Reversibility and Viscoelastic Properties of Micropillar Supported and Oriented Magnesium Bundled F-Actin	PLOS ONE			English	Article							SEMIFLEXIBLE POLYMERS; ENTANGLED NETWORKS; BIOMIMETIC MODELS; CORTEX MODELS; MUSCLE ACTIN; FILAMENTS; ELASTICITY; PROTEINS; BINDING; PROBE	Filamentous actin is one of the most important cytoskeletal elements. Not only is it responsible for the elastic properties of many cell types, but it also plays a vital role in cellular adhesion and motility. Understanding the bundling kinetics of actin filaments is important in the formation of various cytoskeletal structures, such as filopodia and stress fibers. Utilizing a unique pillar-structured microfluidic device, we investigated the time dependence of bundling kinetics of pillar supported free-standing actin filaments. Microparticles attached to the filaments allowed the measurement of thermal motion, and we found that bundling takes place at lower concentrations than previously found in 3-dimensional actin gels, i.e. actin filaments formed bundles in the presence of 5-12 mM of magnesium chloride in a time-dependent manner. The filaments also displayed long term stability for up to hours after removing the magnesium ions from the buffer, which suggests that there is an extensive hysteresis between cation induced crosslinking and decrosslinking.	[Maier, Timo; Haraszti, Tamas] Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, D-70569 Stuttgart, Germany; [Maier, Timo; Haraszti, Tamas] Heidelberg Univ, Inst Phys Chem, Dept Biophys Chem, D-69120 Heidelberg, Germany	Max Planck Society; Ruprecht Karls University Heidelberg	Haraszti, T (corresponding author), Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, Heisenberg Str 3, D-70569 Stuttgart, Germany.	tamas.haraszti@uni-heidelberg.de		Haraszti, Tamas/0000-0002-7095-4358	Max Planck Society; ERC Advanced grant "SynAd" [294852]	Max Planck Society(Max Planck Society); ERC Advanced grant "SynAd"	This work was financially supported by the Max Planck Society. Part of the research leading to these results has received funding from the ERC Advanced grant "SynAd" (No 294852). This work is also part of the excellence cluster CellNetwork at the University of Heidelberg (http://www.cellnetworks.uni-hd.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini TE, 2003, P NATL ACAD SCI USA, V100, P8634, DOI 10.1073/pnas.1533355100; Bendix PM, 2008, BIOPHYS J, V94, P3126, DOI 10.1529/biophysj.107.117960; CANDE WZ, 1986, METHOD ENZYMOL, V134, P473; Colby R.H., 2003, POLYM PHYS; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Deme B, 2000, EUR PHYS J E, V2, P125, DOI 10.1007/s101890050046; Dichtl MA, 1999, NEW J PHYS, V1, DOI 10.1088/1367-2630/1/1/318; Dichtl MA, 2002, P NATL ACAD SCI USA, V99, P6533, DOI 10.1073/pnas.052432499; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; Haraszti T, 2009, CHEMPHYSCHEM, V10, P2777, DOI 10.1002/cphc.200900581; Haraszti Tamas, 2009, Biophysical Reviews and Letters, V4, P17, DOI 10.1142/S1793048009001009; He J, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.011908; HOUK TW, 1974, ANAL BIOCHEM, V62, P66, DOI 10.1016/0003-2697(74)90367-4; Hu XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031385; ISAMBERT H, 1995, J BIOL CHEM, V270, P11437, DOI 10.1074/jbc.270.19.11437; Jahne B., 2002, DIGITAL IMAGE PROCES; JANMEY PA, 1994, J BIOL CHEM, V269, P32503; Jones E, 2001, SCIPY OPEN SOURCE SC, DOI [10.1126/science.1063852, DOI 10.1126/SCIENCE.1063852]; Kasza KE, 2010, BIOPHYS J, V99, P1091, DOI 10.1016/j.bpj.2010.06.025; Keller M, 2003, PHILOS T R SOC A, V361, P699, DOI 10.1098/rsta.2002.1158; Kierfeld J, 2006, J COMPUT THEOR NANOS, V3, P898, DOI 10.1166/jctn.2006.006; Lieleg O, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.108101; Lodish H., 1999, MOL CELL BIOL; Luan Y, 2008, BIOPHYS J, V94, P688, DOI 10.1529/biophysj.107.112417; MACLEANFLETCHER S, 1980, BIOCHEM BIOPH RES CO, V96, P18, DOI 10.1016/0006-291X(80)91175-4; Maier T, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-144; Maier T, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.011501; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; MEEUSEN RL, 1979, J CELL BIOL, V82, P57, DOI 10.1083/jcb.82.1.57; Mohrdieck C, 2007, SMALL, V3, P1015, DOI 10.1002/smll.200600565; Morse DC, 1998, MACROMOLECULES, V31, P7044, DOI 10.1021/ma980304u; MULLER O, 1991, MACROMOLECULES, V24, P3111; PARDEE JD, 1982, METHOD CELL BIOL, V24, P271; Pelletier V, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.188303; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; POLLARD TD, 1986, ANNU REV BIOCHEM, V55, P987, DOI 10.1146/annurev.bi.55.070186.005011; Roos WH, 2003, CHEMPHYSCHEM, V4, P872, DOI 10.1002/cphc.200300712; STOSSEL TP, 1993, SCIENCE, V260, P1086, DOI 10.1126/science.8493552; Streichfuss M, 2011, NANO LETT, V11, P3676, DOI 10.1021/nl201630y; Tang JX, 1996, J BIOL CHEM, V271, P8556, DOI 10.1074/jbc.271.15.8556; Tang JX, 1999, BIOPHYS J, V76, P2208, DOI 10.1016/S0006-3495(99)77376-5; Tempel M, 1996, PHYS REV E, V54, P1802, DOI 10.1103/PhysRevE.54.1802; Thoresen T, 2011, BIOPHYS J, V100, P2698, DOI 10.1016/j.bpj.2011.04.031; Uhde J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.268101; Wang H, 2010, CYTOSKELETON, V67, P456, DOI 10.1002/cm.20458; Weisse S, 2011, PHYS CHEM CHEM PHYS, V13, P13395, DOI 10.1039/c1cp20153k; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153	47	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136432	10.1371/journal.pone.0136432	http://dx.doi.org/10.1371/journal.pone.0136432			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322783	gold, Green Submitted, Green Published			2022-12-26	WOS:000360435500019
J	Gui, X; Zhang, ZY; Liu, ST; Ma, YH; Zhang, P; He, X; Li, YY; Zhang, J; Li, HF; Rui, YK; Liu, LM; Cao, WD				Gui, Xin; Zhang, Zhiyong; Liu, Shutong; Ma, Yuhui; Zhang, Peng; He, Xiao; Li, Yuanyuan; Zhang, Jing; Li, Huafen; Rui, Yukui; Liu, Liming; Cao, Weidong			Fate and Phytotoxicity of CeO2 Nanoparticles on Lettuce Cultured in the Potting Soil Environment	PLOS ONE			English	Article							CERIUM OXIDE NANOPARTICLES; RARE-EARTH-ELEMENTS; NANOMATERIALS; TOXICITY; PLANTS; BIOTRANSFORMATION; ZNO; L.	Cerium oxide nanoparticles (CeO2 NPs) have been shown to have significant interactions in plants. Previous study reported the specific-species phytotoxicity of CeO2 NPs by lettuce (Lactuca sativa), but their physiological impacts and vivo biotransformation are not yet well understood, especially in relative realistic environment. Butterhead lettuce were germinated and grown in potting soil for 30 days cultivation with treatments of 0, 50, 100, 1000 mg CeO2 NPs per kg soil. Results showed that lettuce in 100 mg.kg(-1) treated groups grew significantly faster than others, but significantly increased nitrate content. The lower concentrations treatment had no impact on plant growth, compared with the control. However, the higher concentration treatment significantly deterred plant growth and biomass production. The stress response of lettuce plants, such as Superoxide dismutase (SOD), Peroxidase (POD), Malondialdehyde(MDA) activity was disrupted by 1000 mg.kg(-1) CeO2 NPs treatment. In addition, the presence of Ce (III) in the roots of butterhead lettuce explained the reason of CeO2 NPs phytotoxicity. These findings demonstrate CeO2 NPs modification of nutritional quality, antioxidant defense system, the possible transfer into the food chain and biotransformation in vivo.	[Gui, Xin; Liu, Shutong; Li, Huafen; Rui, Yukui; Liu, Liming] China Agr Univ, Coll Resources & Environm Sci, Beijing 100093, Peoples R China; [Zhang, Zhiyong; Ma, Yuhui; Zhang, Peng; He, Xiao; Li, Yuanyuan] Chinese Acad Sci, Inst High Energy Phys, Key Lab Biomed Effects Nanomat & Nanosafety, Beijing 100049, Peoples R China; [Zhang, Zhiyong; Ma, Yuhui; Zhang, Peng; He, Xiao; Li, Yuanyuan] Chinese Acad Sci, Inst High Energy Phys, Key Lab Nucl Analyt Tech, Beijing 100049, Peoples R China; [Zhang, Jing] Chinese Acad Sci, Inst High Energy Phys, Beijing Synchrotron Radiat Facil, Beijing 100049, Peoples R China; [Rui, Yukui] Univ Massachusetts, Stockbridge Sch Agr, Amherst, MA 01003 USA; [Cao, Weidong] Chinese Acad Agr Sci, Inst Agr Resource & Reg Planning, Beijing 100081, Peoples R China	China Agricultural University; Chinese Academy of Sciences; Institute of High Energy Physics, CAS; Chinese Academy of Sciences; Institute of High Energy Physics, CAS; Chinese Academy of Sciences; Institute of High Energy Physics, CAS; University of Massachusetts System; University of Massachusetts Amherst; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS	Rui, YK (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Beijing 100093, Peoples R China.	ruiyukui@163.com	Zhang, Peng/H-9461-2018; He, Xiao/D-6584-2014; He, Xiao/K-8033-2019	Zhang, Peng/0000-0002-2774-5534; He, Xiao/0000-0002-5188-4382; Li, Yuanyuan/0000-0002-9286-9664; Zhang, Zhiyong/0000-0001-9753-0873; Ma, Yuhui/0000-0002-7031-4596	Key National Natural Science Foundation of China [41130526]; National Natural Science Foundation of China [41371471]	Key National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the Key National Natural Science Foundation of China (No.41130526) and the National Natural Science Foundation of China (No.41371471). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIANCONI A, 1987, PHYS REV B, V35, P806, DOI 10.1103/PhysRevB.35.806; Cassee FR, 2011, CRIT REV TOXICOL, V41, P213, DOI 10.3109/10408444.2010.529105; CATALDO DA, 1975, COMMUN SOIL SCI PLAN, V6, P71, DOI 10.1080/00103627509366547; Chai MW, 2013, PLANT GROWTH REGUL, V71, P171, DOI 10.1007/s10725-013-9817-4; Cui D, 2014, ENVIRON SCI-NANO, V1, P459, DOI [10.1039/c4en00025k, 10.1039/C4EN00025K]; Dimkpa CO, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-1125-9; Gantt B, 2014, ENVIRON SCI TECHNOL, V48, P10607, DOI 10.1021/es502169p; IRIGOYEN JJ, 1992, PHYSIOL PLANTARUM, V84, P55, DOI 10.1111/j.1399-3054.1992.tb08764.x; Krystofova O, 2013, INT J ENV RES PUB HE, V10, P47, DOI 10.3390/ijerph10010047; Kunhikrishnan A, 2015, CRIT REV ENV SCI TEC, V45, P277, DOI 10.1080/10643389.2013.852407; Lawrence NJ, 2011, NANO LETT, V11, P2666, DOI 10.1021/nl200722z; Lee J, 2010, ACS NANO, V4, P3580, DOI 10.1021/nn100866w; Lee WM, 2012, CHEMOSPHERE, V86, P491, DOI 10.1016/j.chemosphere.2011.10.013; Lopez-Moreno ML, 2010, ENVIRON SCI TECHNOL, V44, P7315, DOI 10.1021/es903891g; Ma CX, 2013, ACS SUSTAIN CHEM ENG, V1, P768, DOI 10.1021/sc400098h; Ma YH, 2010, CHEMOSPHERE, V78, P273, DOI 10.1016/j.chemosphere.2009.10.050; Miralles P, 2012, ENVIRON SCI TECHNOL, V46, P9224, DOI 10.1021/es202995d; Morales MI, 2013, J AGR FOOD CHEM, V61, P6224, DOI 10.1021/jf401628v; Olson B.J.S.C., 2007, ASSAYS DETERMINATION, DOI [10.1002/0471140864.ps0304s48, DOI 10.1002/0471140864.PS0304S48]; Ouzounidou G, 2013, HORTIC SCI, V40, P119, DOI 10.17221/15/2013-HORTSCI; Priester JH, 2012, P NATL ACAD SCI USA, V109, pE2451, DOI 10.1073/pnas.1205431109; Rico CM, 2013, ENVIRON SCI TECHNOL, V47, P14110, DOI 10.1021/es4033887; Saadat-Monfared A, 2014, COLLOID SURFACE A, V441, P752, DOI 10.1016/j.colsurfa.2012.10.064; Schwabe F, 2013, CHEMOSPHERE, V91, P512, DOI 10.1016/j.chemosphere.2012.12.025; Tyler G, 2004, PLANT SOIL, V267, P191, DOI 10.1007/s11104-005-4888-2; Wang Q, 2012, METALLOMICS, V4, P1105, DOI 10.1039/c2mt20149f; Xia T, 2008, ACS NANO, V2, P2121, DOI 10.1021/nn800511k; Yuan DG, 2001, CHEMOSPHERE, V43, P327, DOI 10.1016/S0045-6535(00)00142-9; Zhang P, 2015, NANOTOXICOLOGY, V9, P1, DOI 10.3109/17435390.2013.855829; Zhang P, 2012, ACS NANO, V6, P9943, DOI 10.1021/nn303543n; Zhang ZY, 2011, METALLOMICS, V3, P816, DOI 10.1039/c1mt00049g; Zhao LJ, 2013, J AGR FOOD CHEM, V61, P11945, DOI 10.1021/jf404328e; Zhao LJ, 2012, ACS NANO, V6, P9615, DOI 10.1021/nn302975u	33	65	67	6	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0134261	10.1371/journal.pone.0134261	http://dx.doi.org/10.1371/journal.pone.0134261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317617	Green Published, Green Submitted, gold			2022-12-26	WOS:000360299100014
J	Kim, YJ; Lee, DH; Ahn, J; Chung, WJ; Jang, YJ; Seong, KS; Moon, JH; Ha, TY; Jung, CH				Kim, Yang-Ji; Lee, Da-Hye; Ahn, Jiyun; Chung, Woo-Jae; Jang, Young Jin; Seong, Ki-Seung; Moon, Jae-Hak; Ha, Tae Youl; Jung, Chang Hwa			Pharmacokinetics, Tissue Distribution, and Anti-Lipogenic/Adipogenic Effects of Allyl-Isothiocyanate Metabolites	PLOS ONE			English	Article							CHEMOPREVENTIVE AGENTS; CRUCIFEROUS VEGETABLES; BENZYL ISOTHIOCYANATE; SIGNALING PATHWAY; NITRIC-OXIDE; CANCER; SULFORAPHANE; GLUTATHIONE; ACTIVATION; ARREST	Allyl-isothiocyanate (AITC) is an organosulfur phytochemical found in abundance in common cruciferous vegetables such as mustard, wasabi, and cabbage. Although AITC is metabolized primarily through the mercapturic acid pathway, its exact pharmacokinetics remains undefined and the biological function of AITC metabolites is still largely unknown. In this study, we evaluated the inhibitory effects of AITC metabolites on lipid accumulation in vitro and elucidated the pharmacokinetics and tissue distribution of AITC metabolites in rats. We found that AITC metabolites generally conjugate with glutathione (GSH) or N-acetylcysteine (NAC) and are distributed in most organs and tissues. Pharmacokinetic analysis showed a rapid uptake and complete metabolism of AITC following oral administration to rats. Although AITC has been reported to exhibit anti-tumor activity in bladder cancer, the potential bioactivity of its metabolites has not been explored. We found that GSH-AITC and NAC-AITC effectively inhibit adipogenic differentiation of 3T3-L1 preadipocytes and suppress expression of PPAR-gamma, C/EBP alpha, and FAS, which are up-regulated during adipogenesis. GSH-AITC and NAC-AITC also suppressed oleic acid-induced lipid accumulation and lipogenesis in hepatocytes. Our findings suggest that AITC is almost completely metabolized in the liver and rapidly excreted in urine through the mercapturic acid pathway following administration in rats. AITC metabolites may exert anti-obesity effects through suppression of adipogenesis or lipogenesis.	[Kim, Yang-Ji; Lee, Da-Hye; Ahn, Jiyun; Ha, Tae Youl; Jung, Chang Hwa] Korea Univ Sci & Technol, Dept Food Biotechnol, Songnam 463746, South Korea; [Ahn, Jiyun; Jang, Young Jin; Seong, Ki-Seung; Ha, Tae Youl; Jung, Chang Hwa] Korea Food Res Inst, Metab Mech Res Grp, Songnam 463746, South Korea; [Chung, Woo-Jae] Sungkyunkwan Univ, Dept Genet Engn, Suwon 440746, South Korea; [Moon, Jae-Hak] Chonnam Natl Univ, Dept Food Sci & Technol, Gwangju 500757, South Korea	Korea Food Research Institute (KFRI); Sungkyunkwan University (SKKU); Chonnam National University	Ha, TY (corresponding author), Korea Univ Sci & Technol, Dept Food Biotechnol, Songnam 463746, South Korea.	tyhap@kfri.re.kr; chjung@kfri.re.kr	Jang, Young Jin/AAT-1192-2020		Korea Food Research Institute of South Korea [E0143033653]	Korea Food Research Institute of South Korea	This study was supported by a grant (E0143033653) from the Korea Food Research Institute of South Korea (www.kfri.re.kr). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2014, J NUTR BIOCHEM, V25, P1026, DOI 10.1016/j.jnutbio.2014.05.006; Bakan I, 2012, CURR OPIN LIPIDOL, V23, P226, DOI 10.1097/MOL.0b013e328352dd03; Bhattacharya A, 2012, CARCINOGENESIS, V33, P394, DOI 10.1093/carcin/bgr283; Bollard M, 1997, FOOD CHEM TOXICOL, V35, P933, DOI 10.1016/S0278-6915(97)00103-8; Brandenburg LO, 2010, INFLAMM RES, V59, P443, DOI 10.1007/s00011-009-0116-5; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; BRUGGEMAN IM, 1986, TOXICOL APPL PHARM, V83, P349, DOI 10.1016/0041-008X(86)90312-1; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Choi KM, 2014, J NUTR BIOCHEM, V25, P201, DOI 10.1016/j.jnutbio.2013.10.007; Choi KM, 2012, OBESITY, V20, P1365, DOI 10.1038/oby.2011.388; Chung FL, 1998, CANCER EPIDEM BIOMAR, V7, P103; Conaway CC, 2002, CURR DRUG METAB, V3, P233, DOI 10.2174/1389200023337496; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Fimognari C, 2012, MUTAT RES-REV MUTAT, V750, P107, DOI 10.1016/j.mrrev.2011.12.001; Gao Y, 2015, CURR MED CHEM; Ippoushi K, 2002, LIFE SCI, V71, P411, DOI 10.1016/S0024-3205(02)01685-5; Jeong WS, 2004, PHARM RES-DORDR, V21, P661, DOI 10.1023/B:PHAM.0000022413.43212.cf; JIAO D, 1994, CANCER EPIDEM BIOMAR, V3, P487; Kassahun K, 1997, CHEM RES TOXICOL, V10, P1228, DOI 10.1021/tx970080t; Kumar GN, 2001, MED RES REV, V21, P397, DOI 10.1002/med.1016; Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058; Lee JH, 2012, BIOCHEM BIOPH RES CO, V426, P492, DOI 10.1016/j.bbrc.2012.08.107; Li F, 2009, J NUTR, V139, P1685, DOI 10.3945/jn.109.108191; Luang-In V, 2014, MOL NUTR FOOD RES, V58, P875, DOI 10.1002/mnfr.201300377; Mori N, 2013, J NUTR SCI VITAMINOL, V59, P56, DOI 10.3177/jnsv.59.56; MOSS EJ, 1985, CHEM-BIOL INTERACT, V55, P139, DOI 10.1016/S0009-2797(85)80124-1; Myzak MC, 2006, CURR DRUG TARGETS, V7, P443, DOI 10.2174/138945006776359467; O'Neill HM, 2013, MOL CELL ENDOCRINOL, V366, P135, DOI 10.1016/j.mce.2012.06.019; Okulicz M, 2010, PLANT FOOD HUM NUTR, V65, P217, DOI 10.1007/s11130-010-0183-3; Rose P, 2005, NITRIC OXIDE-BIOL CH, V12, P237, DOI 10.1016/j.niox.2005.03.001; Sticha KRK, 2002, CARCINOGENESIS, V23, P1433, DOI 10.1093/carcin/23.9.1433; Sultana T, 2003, J FOOD AGRIC ENVIRON, V1, P117; Tsai SC, 2012, INT J ONCOL, V41, P2065, DOI 10.3892/ijo.2012.1640; Tseng E, 2004, EXP BIOL MED, V229, P835, DOI 10.1177/153537020422900817; Verhoeven DTH, 1996, CANCER EPIDEM BIOMAR, V5, P733; Wu X, 2009, ACTA PHARMACOL SIN, V30, P501, DOI 10.1038/aps.2009.50; Xiao D, 2003, CARCINOGENESIS, V24, P891, DOI 10.1093/carcin/bgg023; Yamasaki M, 2013, NUTR RES PRACT, V7, P267, DOI 10.4162/nrp.2013.7.4.267; Zhang YS, 2000, CARCINOGENESIS, V21, P1175, DOI 10.1093/carcin/21.6.1175; Zhang YS, 2010, MOL NUTR FOOD RES, V54, P127, DOI 10.1002/mnfr.200900323	40	24	24	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0132151	10.1371/journal.pone.0132151	http://dx.doi.org/10.1371/journal.pone.0132151			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317351	gold, Green Published, Green Submitted			2022-12-26	WOS:000360299100003
J	Nakagawa, S; Nishihara, K; Miyata, H; Shinke, H; Tomita, E; Kajiwara, M; Matsubara, T; Iehara, N; Igarashi, Y; Yamada, H; Fukatsu, A; Yanagita, M; Matsubara, K; Masuda, S				Nakagawa, Shunsaku; Nishihara, Kumiko; Miyata, Hitomi; Shinke, Haruka; Tomita, Eri; Kajiwara, Moto; Matsubara, Takeshi; Iehara, Noriyuki; Igarashi, Yoshinobu; Yamada, Hiroshi; Fukatsu, Atsushi; Yanagita, Motoko; Matsubara, Kazuo; Masuda, Satohiro			Molecular Markers of Tubulointerstitial Fibrosis and Tubular Cell Damage in Patients with Chronic Kidney Disease	PLOS ONE			English	Article							INJURY MOLECULE-1; TRANSPLANT BIOPSIES; MICROARRAY ANALYSIS; RENAL FIBROSIS; EXPRESSION; BIOMARKER; IDENTIFICATION; REJECTION; PATHWAY; KIM-1	In chronic kidney disease (CKD), progressive nephron loss causes glomerular sclerosis, as well as tubulointerstitial fibrosis and progressive tubular injury. In this study, we aimed to identify molecular changes that reflected the histopathological progression of renal tubulointerstitial fibrosis and tubular cell damage. A discovery set of renal biopsies were obtained from 48 patients with histopathologically confirmed CKD, and gene expression profiles were determined by microarray analysis. The results indicated that hepatitis A virus cellular receptor 1 (also known as Kidney Injury Molecule-1, KIM-1), lipocalin 2 (also known as neutrophil gelatinase-associated lipocalin, NGAL), SRY-box 9, WAP four-disulfide core domain 2, and NK6 homeobox 2 were differentially expressed in CKD. Their expression levels correlated with the extent of tubulointerstitial fibrosis and tubular cell injury, determined by histopathological examination. The expression of these 5 genes was also increased as kidney damage progressed in a rodent unilateral ureteral obstruction model of CKD. We calculated a molecular score using the microarray gene expression profiles of the biopsy specimens. The composite area under the receiver operating characteristics curve plotted using this molecular score showed a high accuracy for diagnosing tubulointerstitial fibrosis and tubular cell damage. The robust sensitivity of this score was confirmed in a validation set of 5 individuals with CKD. These findings identified novel molecular markers with the potential to contribute to the detection of tubular cell damage and tubulointerstitial fibrosis in the kidney.	[Nakagawa, Shunsaku; Nishihara, Kumiko; Shinke, Haruka; Tomita, Eri; Kajiwara, Moto; Matsubara, Kazuo; Masuda, Satohiro] Kyoto Univ Hosp, Dept Clin Pharmacol & Therapeut, Sakyo Ku, Kyoto 6068507, Japan; [Miyata, Hitomi; Matsubara, Takeshi; Iehara, Noriyuki; Fukatsu, Atsushi; Yanagita, Motoko] Kyoto Univ Hosp, Grad Sch Med, Dept Nephrol, Sakyo Ku, Kyoto 6068507, Japan; [Igarashi, Yoshinobu; Yamada, Hiroshi] Natl Inst Biomed Innovat Hlth & Nutr, Toxicogen Informat Project, Ibaraki, Osaka 5670085, Japan	Kyoto University; Kyoto University	Masuda, S (corresponding author), Kyushu Univ Hosp, Dept Pharm, Higashi Ku, Fukuoka 8128582, Japan.	satomsdb@pharm.med.kyushu-u.ac.jp	FUKATSU, ATSUSHI/R-7941-2019; Masuda, Satohiro/E-6691-2010; Yanagita, Motoko/AAJ-7731-2021	Masuda, Satohiro/0000-0002-3589-5989; Yanagita, Motoko/0000-0002-0339-9008; Nakagawa, Shunsaku/0000-0002-1285-122X	Ministry of Health, Labour and Welfare of Japan [08062855]; Funding Program for Next Generation World-Leading Researchers (NEXT Program) [LS073]; Ministry of Education, Science, Culture, Sports, and Technology of Japan (MEXT) of Japan; Grants-in-Aid for Scientific Research [14J07845, 26860101] Funding Source: KAKEN	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Funding Program for Next Generation World-Leading Researchers (NEXT Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Culture, Sports, and Technology of Japan (MEXT) of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for Research on Biological Markers for New Drug Development and Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan (08062855 to S. Masuda); by a Funding Program for Next Generation World-Leading Researchers (NEXT Program: LS073 to S. Masuda) initiated by the Council for Science and Technology Policy of the Japan Society for the Promotion of Science; and by a Grant-in-Aid for Scientific Research (KAKENHI) from the Ministry of Education, Science, Culture, Sports, and Technology of Japan (MEXT) of Japan.	Asada N, 2011, J CLIN INVEST, V121, P3981, DOI 10.1172/JCI57301; Bien-Willner GA, 2007, HUM MOL GENET, V16, P1143, DOI 10.1093/hmg/ddm061; Bunnag S, 2009, J AM SOC NEPHROL, V20, P1149, DOI 10.1681/ASN.2008080863; Ding H, 2012, J AM SOC NEPHROL, V23, P801, DOI 10.1681/ASN.2011060614; Einecke G, 2010, J CLIN INVEST, V120, P1862, DOI 10.1172/JCI41789; Fabian SL, 2012, AM J PATHOL, V180, P1441, DOI 10.1016/j.ajpath.2011.12.039; Galgano MT, 2006, MODERN PATHOL, V19, P847, DOI 10.1038/modpathol.3800612; Hanley KP, 2008, J BIOL CHEM, V283, P14063, DOI 10.1074/jbc.M707390200; Hellstrom I, 2010, CANCER LETT, V296, P43, DOI 10.1016/j.canlet.2010.03.013; Hosohata K, 2011, TOXICOLOGY, V290, P82, DOI 10.1016/j.tox.2011.08.019; Humphreys BD, 2013, J CLIN INVEST, V123, P4023, DOI 10.1172/JCI45361; Ichimura T, 1998, J BIOL CHEM, V273, P4135, DOI 10.1074/jbc.273.7.4135; Kessaris N, 2001, NEURON, V31, P677, DOI 10.1016/S0896-6273(01)00430-5; KIRCHHOFF C, 1991, BIOL REPROD, V45, P350, DOI 10.1095/biolreprod45.2.350; LeBleu VS, 2013, NAT MED, V19, P227, DOI 10.1038/nm.2989; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mueller TF, 2007, AM J TRANSPLANT, V7, P2712, DOI 10.1111/j.1600-6143.2007.02005.x; Naesens M, 2011, KIDNEY INT, V80, P1364, DOI 10.1038/ki.2011.245; Nakagawa S, 2010, BIOCHEM PHARMACOL, V79, P67, DOI 10.1016/j.bcp.2009.07.015; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Nickolas TL, 2012, KIDNEY INT, V82, P718, DOI 10.1038/ki.2012.195; Nishihara K, 2010, AM J PHYSIOL-RENAL, V298, pF923, DOI 10.1152/ajprenal.00567.2009; Remuzzi G, 1998, NEW ENGL J MED, V339, P1448, DOI 10.1056/NEJM199811123392007; Rodriguez-Segui S, 2012, J CLIN INVEST, V122, P3469, DOI 10.1172/JCI65751; Sarwal M, 2003, NEW ENGL J MED, V349, P125, DOI 10.1056/NEJMoa035588; Schaffer AE, 2010, DEV CELL, V18, P1022, DOI 10.1016/j.devcel.2010.05.015; Schwab K, 2004, AM J NEPHROL, V24, P438, DOI 10.1159/000080188; Vaidya VS, 2010, NAT BIOTECHNOL, V28, P478, DOI 10.1038/nbt.1623; van Timmeren MM, 2007, J PATHOL, V212, P209, DOI 10.1002/path.2175; Wu CF, 2013, AM J PATHOL, V182, P118, DOI 10.1016/j.ajpath.2012.09.009; Xu PC, 2011, NEPHROL DIAL TRANSPL, V26, P3229, DOI 10.1093/ndt/gfr023; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144	32	73	77	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136994	10.1371/journal.pone.0136994	http://dx.doi.org/10.1371/journal.pone.0136994			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317775	Green Submitted, Green Published, gold			2022-12-26	WOS:000360299100191
J	Shinsky, SA; Cosgrove, MS				Shinsky, Stephen A.; Cosgrove, Michael S.			Unique Role of the WD-40 Repeat Protein 5 (WDR5) Subunit within the Mixed Lineage Leukemia 3 (MLL3) Histone Methyltransferase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; LYSINE 4; BIOLOGICAL MACROMOLECULES; H3K4 TRIMETHYLATION; STRUCTURAL BASIS; UCSF CHIMERA; FAMILY; GENE; METHYLATION; DOMAIN	The MLL3 (mixed lineage leukemia 3) protein is a member of the human SET1 family of histone H3 lysine 4 methyltransferases and contains the conserved WDR5 interaction (Win) motif and the catalytic suppressor of variegation, enhancer of zeste, trithorax (SET) domain. The human SET1 family includes MLL1-4 and SETd1A/B, which all interact with a conserved subcomplex containing WDR5, RbBP5, Ash2L, and DPY-30 (WRAD) to form the minimal core complex required for full methyltransferase activity. However, recent evidence suggests that the WDR5 subunit may not be utilized in an identical manner within all SET1 family core complexes. Although the roles of WDR5 within the MLL1 core complex have been extensively studied, not much is known about the roles of WDR5 in other SET1 family core complexes. In this investigation, we set out to characterize the roles of the WDR5 subunit in the MLL3 core complex. We found that unlike MLL1, the MLL3 SET domain assembles with the RbBP5/Ash2L heterodimer independently of the Win motif-WDR5 interaction. Furthermore, we observed that WDR5 inhibits the monomethylation activity of the MLL3 core complex, which is dependent on the Win motif. We also found evidence suggesting that the WRAD subcomplex catalyzes weak H3K4 monomethylation within the context of the MLL3 core complex. Furthermore, solution structures of the MLL3 core complex assembled with and without WDR5 by small angle x-ray scattering show similar overall topologies. Together, this work demonstrates a unique role for WDR5 in modulating the enzymatic activity of the MLL3 core complex.	[Shinsky, Stephen A.; Cosgrove, Michael S.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Cosgrove, MS (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA.	cosgrovm@upstate.edu	Regan, Clinton/E-6250-2012	Shinsky, Stephen/0000-0001-5437-1729	National Institutes of Health [2R01CA140522]; NATIONAL CANCER INSTITUTE [R01CA140522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 2R01CA140522 (to M. S. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Dharmarajan V, 2012, J BIOL CHEM, V287, P27275, DOI 10.1074/jbc.M112.364125; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Goo YH, 2003, MOL CELL BIOL, V23, P140, DOI 10.1128/MCB.23.1.140-149.2003; He XX, 2015, NUCLEIC ACIDS RES, V43, P3712, DOI 10.1093/nar/gkv214; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; JONES RS, 1993, MOL CELL BIOL, V13, P6357, DOI 10.1128/MCB.13.10.6357; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Liu CC, 2015, BIOCHEM J, V467, P415, DOI 10.1042/BJ20141392; Mersman DP, 2012, J BIOL CHEM, V287, P2652, DOI 10.1074/jbc.M111.280867; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Niedermeyer THJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044913; Nielsen SS, 2009, J APPL CRYSTALLOGR, V42, P959, DOI 10.1107/S0021889809023863; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Patel A, 2008, J BIOL CHEM, V283, P32162, DOI 10.1074/jbc.M806317200; Patel A, 2008, J BIOL CHEM, V283, P32158, DOI 10.1074/jbc.C800164200; Patel A, 2014, J BIOL CHEM, V289, P868, DOI 10.1074/jbc.M113.501064; Patel A, 2011, J BIOL CHEM, V286, P3359, DOI 10.1074/jbc.M110.174524; Patel A, 2009, J BIOL CHEM, V284, P24242, DOI 10.1074/jbc.M109.014498; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shinsky SA, 2015, J BIOL CHEM, V290, P6361, DOI 10.1074/jbc.M114.627646; Shinsky SA, 2014, J MOL BIOL, V426, P2283, DOI 10.1016/j.jmb.2014.03.011; Song JJ, 2008, J BIOL CHEM, V283, P35258, DOI 10.1074/jbc.M806900200; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; STASSEN MJ, 1995, MECH DEVELOP, V52, P209, DOI 10.1016/0925-4773(95)00402-M; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2003, REP PROG PHYS, V66, P1735, DOI 10.1088/0034-4885/66/10/R05; Takahashi Y, 2011, P NATL ACAD SCI USA, V108, P20526, DOI 10.1073/pnas.1109360108; TSCHIERSCH B, 1994, EMBO J, V13, P3822, DOI 10.1002/j.1460-2075.1994.tb06693.x; van Nuland R, 2013, MOL CELL BIOL, V33, P2067, DOI 10.1128/MCB.01742-12; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yang YW, 2014, ELIFE, V3, DOI 10.7554/eLife.02046; Yang Z, 2012, J STRUCT BIOL, V179, P269, DOI 10.1016/j.jsb.2011.09.006; Zhang P, 2015, GENE DEV, V29, P123, DOI 10.1101/gad.254870.114; Zhao HY, 2011, METHODS, V54, P16, DOI 10.1016/j.ymeth.2011.01.010	56	19	20	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					25819	25833		10.1074/jbc.M115.684142	http://dx.doi.org/10.1074/jbc.M115.684142			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26324722	Green Published, hybrid			2022-12-26	WOS:000363527300004
J	Mann, E; Ovchinnikova, OG; King, JD; Whitfield, C				Mann, Evan; Ovchinnikova, Olga G.; King, Jerry D.; Whitfield, Chris			Bacteriophage-mediated Glucosylation Can Modify Lipopolysaccharide O-Antigens Synthesized by an ATP-binding Cassette (ABC) Transporter-dependent Assembly Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; SHIGELLA-FLEXNERI; SALMONELLA-TYPHIMURIUM; KLEBSIELLA-PNEUMONIAE; POLYSACCHARIDE; BIOSYNTHESIS; GENES; CHAIN; CORE; CONVERSION	Lysogenic bacteriophages may encode enzymes that modify the structures of lipopolysaccharide O-antigen glycans, altering the structure of the bacteriophage receptor and resulting in serotype conversion. This can enhance virulence and has implications for antigenic diversity and vaccine development. Side chain glucosylation is a common modification strategy found in a number of bacterial species. To date, glucosylation has only been observed in O-antigens synthesized by Wzy-dependent pathways, one of the two most prevalent O-antigen synthesis systems. Here we exploited a heterologous system to study the glucosylation potential of a model O-antigen produced in an ATP-binding cassette (ABC) transporter-dependent system. Although O-antigen production is cryptic in Escherichia coli K-12, because of a mutation in the synthesis genes, it possesses a prophage glucosylation cluster, which modifies the GlcNAc residue in an alpha-L-Rha-(1 -> 3)-D-GlcNAc motif found in the original O16 antigen. Raoultella terrigena ATCC 33257 produces an O-antigen possessing the same disaccharide motif, but its assembly uses an ABC transporter-dependent system. E. coli harboring the R. terrigena O-antigen biosynthesis genes produced an O-antigen displaying reduced reactivity toward antisera raised against the native R. terrigena repeat structure, indicative of an altered chemical structure. Structural determination using NMR revealed the addition of glucose side chains to the repeat units. O-antigen modification was dependent on a functional ABC transporter, consistent with modification in the periplasm, and was eliminated by deletion of the glucosylation genes from the E. coli chromosome, restoring native level antisera sensitivity and structure. There are therefore no intrinsic mechanistic barriers for bacteriophage-mediated O-antigen glucosylation in ABC transporter-dependent pathways.	[Mann, Evan; Ovchinnikova, Olga G.; King, Jerry D.; Whitfield, Chris] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Whitfield, C (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada.	cwhitfie@uoguelph.ca		Mann, Evan/0000-0003-4685-7264	Natural Sciences and Engineering Research Council of Canada; Alexander Graham Bell Canada Graduate Scholarship from Natural Sciences and Engineering Research Council of Canada; Canada Research Chair	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alexander Graham Bell Canada Graduate Scholarship from Natural Sciences and Engineering Research Council of Canada; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported by funding (to C. W.) from the Natural Sciences and Engineering Research Council of Canada. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of an Alexander Graham Bell Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada.; Recipient of a Canada Research Chair.	Adams MM, 2001, MICROBIOL-UK, V147, P851, DOI 10.1099/00221287-147-4-851; ALEXEYEV MF, 1995, BIOTECHNIQUES, V18, P52; Allison GE, 2000, TRENDS MICROBIOL, V8, P17, DOI 10.1016/S0966-842X(99)01646-7; Bogomolnaya LM, 2008, MOL MICROBIOL, V70, P1105, DOI 10.1111/j.1365-2958.2008.06461.x; Cuthbertson L, 2010, MICROBIOL MOL BIOL R, V74, P341, DOI 10.1128/MMBR.00009-10; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; Davies MR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003568; Greenfield LK, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.412577; Guan S, 1999, MICROBIOL-UK, V145, P1263, DOI 10.1099/13500872-145-5-1263; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hagelueken G, 2015, NAT STRUCT MOL BIOL, V22, P50, DOI 10.1038/nsmb.2935; HAMMERLING G, 1970, EUR J BIOCHEM, V15, P48, DOI 10.1111/j.1432-1033.1970.tb00974.x; HELANDER IM, 1992, MOL MICROBIOL, V6, P2857, DOI 10.1111/j.1365-2958.1992.tb01465.x; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Iguchi A, 2015, DNA RES, V22, P101, DOI 10.1093/dnares/dsu043; Izquierdo L, 2003, J BACTERIOL, V185, P1634, DOI 10.1128/JB.185.5.1634-1641.2003; JANSSON PE, 1991, J CHEM INF COMP SCI, V31, P508, DOI 10.1021/ci00004a013; King JD, 2014, P NATL ACAD SCI USA, V111, P6407, DOI 10.1073/pnas.1400814111; Knirel YA, 2015, BIOCHEMISTRY-MOSCOW+, V80, P901, DOI 10.1134/S0006297915070093; Kondakova A N, 2010, Bioorg Khim, V36, P429; Kos V, 2009, J BIOL CHEM, V284, P2947, DOI 10.1074/jbc.M807213200; Kubler-Kielb J, 2010, CARBOHYD RES, V345, P1600, DOI 10.1016/j.carres.2010.05.006; Kul'shin V A, 1987, Mol Gen Mikrobiol Virusol, P44; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lerouge I, 2002, FEMS MICROBIOL REV, V26, P17, DOI 10.1111/j.1574-6976.2002.tb00597.x; LIU D, 1994, MICROBIOL-UK, V140, P49, DOI 10.1099/13500872-140-1-49; Lundborg M, 2010, GLYCOBIOLOGY, V20, P366, DOI 10.1093/glycob/cwp185; MACPHERSON DF, 1994, MOL MICROBIOL, V11, P281, DOI 10.1111/j.1365-2958.1994.tb00308.x; MAKELA PH, 1988, IMMUNOL LETT, V19, P217, DOI 10.1016/0165-2478(88)90145-9; MAKELA PH, 1966, J BACTERIOL, V91, P1115; Martinic M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025557; Mavris M, 1997, MOL MICROBIOL, V26, P939, DOI 10.1046/j.1365-2958.1997.6301997.x; Mertens K, 2010, INNATE IMMUN-LONDON, V16, P366, DOI 10.1177/1753425909350057; NAKANO Y, 1995, GENE, V162, P157, DOI 10.1016/0378-1119(95)00320-6; NIKAIDO H, 1971, J BIOL CHEM, V246, P3902; Panis G, 2007, J BIOL CHEM, V282, P21798, DOI 10.1074/jbc.M701827200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rahman MM, 1997, J BACTERIOL, V179, P2126, DOI 10.1128/jb.179.7.2126-2131.1997; Rojas-Macias MA, 2015, GLYCOBIOLOGY, V25, P341, DOI 10.1093/glycob/cwu116; Rondini S, 2015, INFECT IMMUN, V83, P996, DOI 10.1128/IAI.03079-14; Ruan X, 2012, GLYCOBIOLOGY, V22, P288, DOI 10.1093/glycob/cwr150; RUDEN U, 1974, EUR J BIOCHEM, V48, P11, DOI 10.1111/j.1432-1033.1974.tb03737.x; SASAKI T, 1974, J BIOL CHEM, V249, P761; Sawitzke JA, 2007, METHOD ENZYMOL, V421, P171, DOI 10.1016/S0076-6879(06)21015-2; Stenutz R, 2006, FEMS MICROBIOL REV, V30, P382, DOI 10.1111/j.1574-6976.2006.00016.x; STEVENSON G, 1994, J BACTERIOL, V176, P4144, DOI 10.1128/JB.176.13.4144-4156.1994; STOCKER BAD, 1960, ANN I PASTEUR PARIS, V98, P505; Sun QZ, 2014, GLYCOBIOLOGY, V24, P305, DOI 10.1093/glycob/cwt115; TAKESHITA M, 1971, J BIOL CHEM, V246, P3920; Theillet FX, 2011, GLYCOBIOLOGY, V21, P109, DOI 10.1093/glycob/cwq136; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Vinogradov E, 2002, J BIOL CHEM, V277, P25070, DOI 10.1074/jbc.M202683200; West NP, 2005, SCIENCE, V307, P1313, DOI 10.1126/science.1108472; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600; Willis LM, 2013, P NATL ACAD SCI USA, V110, P20753, DOI 10.1073/pnas.1312637110; WRIGHT A, 1971, J BACTERIOL, V105, P927, DOI 10.1128/JB.105.3.927-936.1971	58	20	20	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25561	25570		10.1074/jbc.M115.660803	http://dx.doi.org/10.1074/jbc.M115.660803			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26330553	Green Published, hybrid			2022-12-26	WOS:000362962800030
J	Robitaille, J; Chen, JK; Jolicoeur, M				Robitaille, Julien; Chen, Jingkui; Jolicoeur, Mario			A Single Dynamic Metabolic Model Can Describe mAb Producing CHO Cell Batch and Fed-Batch Cultures on Different Culture Media	PLOS ONE			English	Article							FLUX BALANCE ANALYSIS; ANTIBODY-PRODUCTION; IN-SILICO; DESIGN; GROWTH; KINASE; STATE	CHO cell culture high productivity relies on optimized culture medium management under fed-batch or perfused chemostat strategies enabling high cell densities. In this work, a dynamic metabolic model for CHO cells was further developed, calibrated and challenged using datasets obtained under four different culture conditions, including two batch and two fed-batch cultures comparing two different culture media. The recombinant CHO-DXB11 cell line producing the EG2-hFc monoclonal antibody was studied. Quantification of extracellular substrates and metabolites concentration, viable cell density, monoclonal antibody concentration and intracellular concentration of metabolite intermediates of glycolysis, pentose-phosphate and TCA cycle, as well as of energetic nucleotides, were obtained for model calibration. Results suggest that a single model structure with a single set of kinetic parameter values is efficient at simulating viable cell behavior in all cases under study, estimating the time course of measured and non-measured intracellular and extracellular metabolites. Model simulations also allowed performing dynamic metabolic flux analysis, showing that the culture media and the fed-batch strategies tested had little impact on flux distribution. This work thus paves the way to an in silico platform allowing to assess the performance of different culture media and fed-batch strategies.	[Robitaille, Julien; Chen, Jingkui; Jolicoeur, Mario] Ecole Polytech, Dept Chem Engn, Res Lab Appl Metab Engn, Montreal, PQ H3C 3A7, Canada	Universite de Montreal; Polytechnique Montreal	Jolicoeur, M (corresponding author), Ecole Polytech, Dept Chem Engn, Res Lab Appl Metab Engn, CP 6079,Ctr Ville Stn, Montreal, PQ H3C 3A7, Canada.	mario.jolicoeur@polymtl.ca			Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Research Network Grant program [NETGP380070-08]; Canada Research Chair program [950-201896]; Monoclonal Antibody Network (MabNet)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Network Grant program; Canada Research Chair program(Canada Research Chairs); Monoclonal Antibody Network (MabNet)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC), Canada Research Network Grant program, grant no. NETGP380070-08 [http://www.nserc-crsng.gc.ca/]; the Canada Research Chair program, grant no. 950-201896 [http://www.chairschaires.gc.ca/home-accueil-fra.aspx], and the Monoclonal Antibody Network (MabNet). The funders had no role in that research.	Agrawal Vishal, 2012, Methods Mol Biol, V911, P287, DOI 10.1007/978-1-61779-968-6_18; Ahn WS, 2011, METAB ENG, V13, P598, DOI 10.1016/j.ymben.2011.07.002; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Butler M, 2005, APPL MICROBIOL BIOT, V68, P283, DOI 10.1007/s00253-005-1980-8; CASTRO PML, 1992, APPL MICROBIOL BIOT, V38, P84; Cloutier M, 2008, BIOTECHNOL BIOENG, V99, P189, DOI 10.1002/bit.21543; Cloutier M, 2007, PHYTOCHEMISTRY, V68, P2393, DOI 10.1016/j.phytochem.2007.04.028; Dash RK, 2008, IEEE T BIO-MED ENG, V55, P1298, DOI 10.1109/TBME.2007.913422; Dean J, 2013, BIOTECHNOL BIOENG, V110, P1735, DOI 10.1002/bit.24826; Dorka P, 2007, THESIS U WATERLOO AN; Dorka P, 2009, BIOPROC BIOSYST ENG, V32, P183, DOI 10.1007/s00449-008-0236-2; Europa AF, 2000, BIOTECHNOL BIOENG, V67, P25, DOI 10.1002/(SICI)1097-0290(20000105)67:1<25::AID-BIT4>3.0.CO;2-K; Gao JY, 2007, BIOTECHNOL PROGR, V23, P168, DOI 10.1021/bp060089y; Ghorbaniaghdam A, 2014, PLOS ONE, P9; Ghorbaniaghdam A, 2014, J THEOR BIOL, V357, P112, DOI 10.1016/j.jtbi.2014.04.035; Ghorbaniaghdam A, 2013, BIOPROC BIOSYST ENG, V36, P469, DOI 10.1007/s00449-012-0804-3; Goudar C, 2010, METAB ENG, V12, P138, DOI 10.1016/j.ymben.2009.10.007; Hacker DL, 2009, BIOTECHNOL ADV, V27, P1023, DOI 10.1016/j.biotechadv.2009.05.008; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Herwig C, 2002, BIOPROC BIOSYST ENG, V24, P395, DOI 10.1007/s00449-001-0277-2; Kim JY, 2012, APPL MICROBIOL BIOT, V93, P917, DOI 10.1007/s00253-011-3758-5; Leite TC, 2011, FEBS LETT, V585, P92, DOI 10.1016/j.febslet.2010.11.009; Lequeux G, 2010, BIOMED RES INT; LLORENTE P, 1970, EUR J BIOCHEM, V13, P45, DOI 10.1111/j.1432-1033.1970.tb00897.x; Mahadevan R, 2002, BIOPHYS J, V83, P1331, DOI 10.1016/S0006-3495(02)73903-9; Mailier J, 2011, BIOTECHNOL BIOENG, V108, P1108, DOI 10.1002/bit.23030; Martinez VS, 2013, BIOTECHNOL BIOENG, V110, P660, DOI 10.1002/bit.24728; MORRIS MD, 1991, TECHNOMETRICS, V33, P161, DOI 10.2307/1269043; Mulukutla BC, 2012, METAB ENG, V14, P138, DOI 10.1016/j.ymben.2011.12.006; Mulukutla BC, 2010, TRENDS BIOTECHNOL, V28, P476, DOI 10.1016/j.tibtech.2010.06.005; Naderi S, 2011, BIOTECHNOL PROGR, V27, P1197, DOI 10.1002/btpr.647; Nolan RP, 2011, METAB ENG, V13, P108, DOI 10.1016/j.ymben.2010.09.003; Nyberg GB, 1999, BIOTECHNOL BIOENG, V62, P324, DOI 10.1002/(SICI)1097-0290(19990205)62:3<324::AID-BIT9>3.3.CO;2-3; Parampalli A, 2007, CYTOTECHNOLOGY, V54, P57, DOI 10.1007/s10616-007-9074-3; Poliquin PO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069146; Provost A, 2006, BIOPROC BIOSYST ENG, V29, P349, DOI 10.1007/s00449-006-0083-y; Provost A, 2004, J PROCESS CONTR, V14, P717, DOI 10.1016/j.jprocont.2003.12.004; Quek LE, 2010, METAB ENG, V12, P161, DOI 10.1016/j.ymben.2009.09.002; Sandadi S, 2006, BIOTECHNOL PROGR, V22, P595, DOI 10.1021/bp050300q; Segel IH., 1993, ENZYME KINETICS BEHA; Selvarasu S, 2012, BIOTECHNOL BIOENG, V109, P1415, DOI 10.1002/bit.24445; Sen S, 2013, CYTOTECHNOLOGY, V65, P233, DOI 10.1007/s10616-012-9480-z; Sengupta N, 2011, BIOTECHNOL BIOENG, V108, P82, DOI 10.1002/bit.22890; Sheikh K, 2005, BIOTECHNOL PROGR, V21, P112, DOI 10.1021/bp0498138; Sheikholeslami Z, 2013, J BIOTECHNOL, V164, P469, DOI 10.1016/j.jbiotec.2013.01.025; Sin G, 2009, BIOTECHNOL PROGR, V25, P1043, DOI 10.1002/btpr.166; Templeton N, 2013, BIOTECHNOL BIOENG, V110, P2013, DOI 10.1002/bit.24858; Valancin A, 2013, BIOTECHNOL BIOENG, V110, P924, DOI 10.1002/bit.24747; Wong DCF, 2005, BIOTECHNOL BIOENG, V89, P164, DOI 10.1002/bit.20317; XIE LZ, 1994, CYTOTECHNOLOGY, V15, P17, DOI 10.1007/BF00762376; Xing ZZ, 2008, BIOTECHNOL PROGR, V24, P675, DOI 10.1021/bp070466m; Xing ZZ, 2010, BIOTECHNOL PROGR, V26, P208, DOI 10.1002/btpr.284; Zhang HF, 2013, CYTOTECHNOLOGY, V65, P363, DOI 10.1007/s10616-012-9488-4	53	41	42	31	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136815	10.1371/journal.pone.0136815	http://dx.doi.org/10.1371/journal.pone.0136815			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331955	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000360613800075
J	Abitbol, M; Hitte, C; Bosse, P; Blanchard-Gutton, N; Thomas, A; Martignat, L; Blot, S; Tiret, L				Abitbol, Marie; Hitte, Christophe; Bosse, Philippe; Blanchard-Gutton, Nicolas; Thomas, Anne; Martignat, Lionel; Blot, Stephane; Tiret, Laurent			A COLQ Missense Mutation in Sphynx and Devon Rex Cats with Congenital Myasthenic Syndrome	PLOS ONE			English	Article							MUSCULAR-DYSTROPHY; NEUROMUSCULAR-JUNCTION; ANIMAL-MODELS; TAIL SUBUNIT; COLLAGEN Q; ACETYLCHOLINESTERASE; GRAVIS; DEFICIENCY; DOGS; PATHOGENESIS	An autosomal recessive neuromuscular disorder characterized by skeletal muscle weakness, fatigability and variable electromyographic or muscular histopathological features has been described in the two related Sphynx and Devon Rex cat breeds (Felis catus). Collection of data from two affected Sphynx cats and their relatives pointed out a single disease candidate region on feline chromosome C2, identified following a genome-wide SNP-based homozygosity mapping strategy. In that region, we further identified COLQ (collagen-like tail subunit of asymmetric acetylcholinesterase) as a good candidate gene, since COLQ mutations were identified in affected humans and dogs with endplate acetylcholinesterase deficiency leading to a synaptic form of congenital myasthenic syndrome (CMS). A homozygous c.1190G>A missense variant located in exon 15 of COLQ, leading to a C397Y substitution, was identified in the two affected cats. C397 is a highly-conserved residue from the C-terminal domain of the protein; its mutation was previously shown to produce CMS in humans, and here we confirmed in an affected Sphynx cat that it induces a loss of acetylcholinesterase clustering at the neuromuscular junction. Segregation of the c. 1190G>A variant was 100% consistent with the autosomal recessive mode of inheritance of the disorder in our cat pedigree; in addition, an affected, unrelated Devon Rex cat recruited thereafter was also homozygous for the variant. Genotyping of a panel of 333 cats from 14 breeds failed to identify a single carrier in non-Sphynx and non-Devon Rex cats. Finally, the percentage of healthy carriers in a European subpanel of 81 genotyped Sphynx cats was estimated to be low (3.7%) and 14 control Devon Rex cats were genotyped as wild-type individuals. Altogether, these results strongly support that the neuromuscular disorder reported in Sphynx and Devon Rex breeds is a CMS caused by a unique c.1190G>A missense mutation, presumably transmitted through a founder effect, which strictly and slightly disseminated in these two breeds. The presently available DNA test will help owners avoid matings at risk.	[Abitbol, Marie; Bosse, Philippe; Blanchard-Gutton, Nicolas; Blot, Stephane; Tiret, Laurent] INSERM, IMRB, U955, F-94000 Creteil, France; [Abitbol, Marie; Bosse, Philippe; Blanchard-Gutton, Nicolas; Blot, Stephane; Tiret, Laurent] Univ Paris Est, Ecole Natl Vet Alfort, F-94700 Maisons Alfort, France; [Abitbol, Marie; Bosse, Philippe; Blanchard-Gutton, Nicolas; Blot, Stephane; Tiret, Laurent] Fac Med, F-94000 Creteil, France; [Abitbol, Marie; Bosse, Philippe; Blanchard-Gutton, Nicolas; Blot, Stephane; Tiret, Laurent] Etab Francais Sang, F-94017 Creteil, France; [Abitbol, Marie; Bosse, Philippe; Blanchard-Gutton, Nicolas; Blot, Stephane; Tiret, Laurent] Hop Univ Henri Mondor, AP HP, DHU Pepsy, F-94000 Creteil, France; [Abitbol, Marie; Bosse, Philippe; Blanchard-Gutton, Nicolas; Blot, Stephane; Tiret, Laurent] Ctr Reference Malad Neuromusculaires GNMH, F-94000 Creteil, France; [Hitte, Christophe] Univ Rennes 1, CNRS, UMR6290, IGDR, Rennes, France; [Thomas, Anne] Antagene, Anim Genet Lab, La Tour De Salvagny, France; [Martignat, Lionel] ONIRIS, UP Securite Sanit Biotechnol Reprod, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Ecole Nationale Veterinaire d'Alfort (ENVA); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique	Abitbol, M (corresponding author), INSERM, IMRB, U955, E10, F-94000 Creteil, France.	m.abitbol@vet-alfort.fr	Tiret, Laurent/K-3877-2017; Blot, Stephane/K-7573-2019; Blot, Stephane/F-7420-2011	Tiret, Laurent/0000-0001-8573-8335; Abitbol, Marie/0000-0002-5615-7897; Hitte, Christophe/0000-0003-1714-437X; Bosse, Philippe/0000-0001-5701-6415; Blot, Stephane/0000-0002-8982-0317	LOOF (Livre Officiel des Origines Felines); Antagene; Morris Animal Foundation [D14FE-563]	LOOF (Livre Officiel des Origines Felines); Antagene; Morris Animal Foundation	This work was specifically supported by the LOOF (Livre Officiel des Origines Felines, www.loof.asso.fr). Purchase of the Illumina Infinium Feline 63K iSelect DNA array was allowed thanks to the Morris Animal Foundation (Grant-In-Aid Agreement no D14FE-563). Support for the development of the Illumina Infinium Feline 63K iSelect DNA array was provided by the Morris Animal Foundation (www.morrisanimalfoundation.org) via a donation from Hill's Pet Food, Inc. Medical genetics tools were partly provided by the CNM Project (www.labradorcnm.com). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Antagene provided support in the form of salary for author [AT] and research materials (DNA collection), but had no additional role in the study design, data analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alhaddad H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053537; [Anonymous], 2007, MUSCLE BIOPSY; Arredondo J, 2014, HUM GENET, V133, P599, DOI 10.1007/s00439-013-1391-3; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Carville L., 1995, THESIS; CASAL ML, 1994, J AM ANIM HOSP ASSOC, V30, P600; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Collins CA, 2003, INT J EXP PATHOL, V84, P165, DOI 10.1046/j.1365-2613.2003.00354.x; Corpet F., 1988, NUCLEIC ACIDS RES, V16, P22; Dickinson PJ, 2005, J VET INTERN MED, V19, P920, DOI 10.1892/0891-6640(2005)19[920:CMGISM]2.0.CO;2; Engel AG, 2007, NEUROTHERAPEUTICS, V4, P252, DOI 10.1016/j.nurt.2007.01.001; Engel AG, 2015, LANCET NEUROL, V14, P420, DOI 10.1016/S1474-4422(14)70201-7; Gandolfi B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067105; Gandolfi B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053173; Gandolfi B, 2010, MAMM GENOME, V21, P509, DOI 10.1007/s00335-010-9290-6; Ito M, 2012, MOL THER, V20, P1384, DOI 10.1038/mt.2012.34; JOHNSON RP, 1975, J SMALL ANIM PRACT, V16, P641, DOI 10.1111/j.1748-5827.1975.tb05790.x; Kimbell LM, 2004, J BIOL CHEM, V279, P10997, DOI 10.1074/jbc.M305462200; Kraner S, 2002, NEUROGENETICS, V4, P87, DOI 10.1007/s10048-002-0134-8; KREJCI E, 1991, EMBO J, V10, P1285, DOI 10.1002/j.1460-2075.1991.tb08070.x; le Chevoir M, 2012, JAVMA-J AM VET MED A, V241, P1194, DOI 10.2460/javma.241.9.1194; Lipinski MJ, 2008, GENOMICS, V91, P12, DOI 10.1016/j.ygeno.2007.10.009; Littink KW, 2009, INVEST OPHTH VIS SCI, V50, P2344, DOI 10.1167/iovs.08-2553; MALIK R, 1993, J SMALL ANIM PRACT, V34, P539, DOI 10.1111/j.1748-5827.1993.tb03544.x; Martin PT, 2008, NEUROMUSCULAR DISORD, V18, P942, DOI 10.1016/j.nmd.2008.08.002; Menotti-Raymond M, 2008, GENOMICS, V91, P1, DOI 10.1016/j.ygeno.2007.08.008; Mihaylova V, 2008, BRAIN, V131, P747, DOI 10.1093/brain/awm325; MILLER LM, 1983, J AM VET MED ASSOC, V182, P694; Neto OA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110888; Nigro Vincenzo, 2014, Acta Myol, V33, P1; ODA K, 1984, MUSCLE NERVE, V7, P705, DOI 10.1002/mus.880070904; Ohno K, 1998, P NATL ACAD SCI USA, V95, P9654, DOI 10.1073/pnas.95.16.9654; Ohno K, 2013, CHEM-BIOL INTERACT, V203, P335, DOI 10.1016/j.cbi.2012.08.020; Pond G., 1972, COMPLETE CAT ENCY; Proschowsky HF, 2007, J HERED, V98, P539, DOI 10.1093/jhered/esm026; Rinz CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106425; ROBINSON R, 1992, VET REC, V130, P302, DOI 10.1136/vr.130.14.302-a; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wang ZJ, 2009, ILAR J, V50, P187, DOI 10.1093/ilar.50.2.187; Wargon I, 2012, NEUROMUSCULAR DISORD, V22, P318, DOI 10.1016/j.nmd.2011.09.002; Willet CE, 2014, ANIM GENET, V45, P614, DOI 10.1111/age.12169	42	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137019	10.1371/journal.pone.0137019	http://dx.doi.org/10.1371/journal.pone.0137019			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327126	gold, Green Published, Green Submitted			2022-12-26	WOS:000360437700082
J	Demonbreun, AR; Swanson, KE; Rossi, AE; Deveaux, HK; Earley, JU; Allen, MV; Arya, P; Bhattacharyya, S; Band, H; Pytel, P; McNally, EM				Demonbreun, Alexis R.; Swanson, Kaitlin E.; Rossi, Ann E.; Deveaux, H. Kieran; Earley, Judy U.; Allen, Madison V.; Arya, Priyanka; Bhattacharyya, Sohinee; Band, Hamid; Pytel, Peter; McNally, Elizabeth M.			Eps 15 Homology Domain (EHD)-1 Remodels Transverse Tubules in Skeletal Muscle	PLOS ONE			English	Article							CENTRONUCLEAR MYOPATHY; SARCOPLASMIC-RETICULUM; MUSCULAR-DYSTROPHY; AMPHIPHYSIN-2 BIN1; CA2+ RELEASE; PROTEINS; MICE; CELLS; MUTATIONS; DYSFERLIN	We previously showed that Eps15 homology domain-containing 1 (EHD1) interacts with ferlin proteins to regulate endocytic recycling. Myoblasts from Ehd1-null mice were found to have defective recycling, myoblast fusion, and consequently smaller muscles. When expressed in C2C12 cells, an ATPase dead-EHD1 was found to interfere with BIN1/amphiphysin 2. We now extended those findings by examining Ehd1-heterozygous mice since these mice survive to maturity in normal Mendelian numbers and provide a ready source of mature muscle. We found that heterozygosity of EHD1 was sufficient to produce ectopic and excessive T-tubules, including large intracellular aggregates that contained BIN1. The disorganized T-tubule structures in Ehd1-heterozygous muscle were accompanied by marked elevation of the T-tubule-associated protein DHPR and reduction of the triad linker protein junctophilin 2, reflecting defective triads. Consistent with this, Ehd1-heterozygous muscle had reduced force production. Introduction of ATPase dead-EHD1 into mature muscle fibers was sufficient to induce ectopic T-tubule formation, seen as large BIN1 positive structures throughout the muscle. Ehd1-heterozygous mice were found to have strikingly elevated serum creatine kinase and smaller myofibers, but did not display findings of muscular dystrophy. These data indicate that EHD1 regulates the maintenance of T-tubules through its interaction with BIN1 and links T-tubules defects with elevated creatine kinase and myopathy.	[Demonbreun, Alexis R.; Earley, Judy U.; Allen, Madison V.; McNally, Elizabeth M.] Northwestern Univ, Ctr Genet Med, Chicago, IL 60611 USA; [Swanson, Kaitlin E.; Pytel, Peter] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Rossi, Ann E.; Deveaux, H. Kieran] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Arya, Priyanka] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE USA; [Bhattacharyya, Sohinee; Band, Hamid] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Dept Pathol & Microbiol, Omaha, NE USA	Northwestern University; University of Chicago; University of Chicago; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Demonbreun, AR (corresponding author), Northwestern Univ, Ctr Genet Med, Chicago, IL 60611 USA.	alexis.demonbreun@northwestern.edu	Band, Hamid/AAF-4701-2020; Bhattacharyya, Sohinee/AAN-6414-2021; McNally, Elizabeth/W-4909-2019	Demonbreun, Alexis/0000-0001-6823-125X; McNally, Elizabeth/0000-0002-1221-719X	National Institutes of Health [CA105489, CA116552, NS047726, NS072027, AR052646]; NATIONAL CANCER INSTITUTE [R01CA116552, R01CA105489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR052646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047726, P01NS072027] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants CA105489 and CA116552 (to HB), and NS047726, NS072027, and AR052646 (to EMM).	Andersson DC, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-9; Behringer M, 2014, MED HYPOTHESES, V83, P758, DOI 10.1016/j.mehy.2014.10.005; BESSMAN SP, 1981, SCIENCE, V211, P448, DOI 10.1126/science.6450446; Bitoun M, 2005, NAT GENET, V37, P1207, DOI 10.1038/ng1657; Bitoun M, 2007, ANN NEUROL, V62, P666, DOI 10.1002/ana.21235; BLOCK BA, 1988, J CELL BIOL, V107, P2587, DOI 10.1083/jcb.107.6.2587; Brancaccio P, 2010, CLIN CHEM LAB MED, V48, P757, DOI 10.1515/CCLM.2010.179; Cai BS, 2013, J BIOL CHEM, V288, P30172, DOI 10.1074/jbc.M113.488627; Capote J, 2010, AM J PHYSIOL-CELL PH, V298, pC1077, DOI 10.1152/ajpcell.00428.2009; CHOU SM, 1980, ARCH NEUROL-CHICAGO, V37, P257, DOI 10.1001/archneur.1980.00500540035002; Cowling BS, 2014, J CLIN INVEST, V124, P1350, DOI 10.1172/JCI71206; Daumke O, 2007, NATURE; Demonbreun AR, 2014, AM J PATHOL, V184, P248, DOI 10.1016/j.ajpath.2013.09.009; DiFranco M, 2009, J VIS EXP; Doherty KR, 2008, J BIOL CHEM, V283, P20252, DOI 10.1074/jbc.M802306200; Dowling J, 2014, NEUROTHERAPEUTICS, V11, P773, DOI 10.1007/s13311-014-0300-3; FLUCHER BE, 1992, DEV BIOL, V154, P245, DOI 10.1016/0012-1606(92)90065-O; Franzini-Armstrong C, 1998, ANN NY ACAD SCI, V853, P20, DOI 10.1111/j.1749-6632.1998.tb08253.x; Galbiati F, 2001, J BIOL CHEM, V276, P21425, DOI 10.1074/jbc.M100828200; George M, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-3; Grose WE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039233; Gudmundsson H, 2010, CIRC RES, V107, P84, DOI 10.1161/CIRCRESAHA.110.216713; Han J, 2013, SCI CHINA LIFE SCI, V56, P647, DOI 10.1007/s11427-013-4490-4; Heydemann A, 2005, NEUROMUSCULAR DISORD, V15, P601, DOI 10.1016/j.nmd.2005.05.004; Hirata Y, 2006, BIOPHYS J, V90, P4418, DOI 10.1529/biophysj.105.076570; Hong TT, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000312; Ito K, 2001, J CELL BIOL, V154, P1059, DOI 10.1083/jcb.200105040; Jakobsson J, 2011, J NEUROSCI, V31, P13972, DOI 10.1523/JNEUROSCI.1289-11.2011; Jayasinghe ID, 2013, J CELL SCI, V126, P4048, DOI 10.1242/jcs.131565; JORGENSEN AO, 1989, J CELL BIOL, V109, P135, DOI 10.1083/jcb.109.1.135; Kerr JP, 2013, P NATL ACAD SCI USA, V110, P20831, DOI 10.1073/pnas.1307960110; Klinge L, 2010, MUSCLE NERVE, V41, P166, DOI 10.1002/mus.21166; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Liu N, 2011, J CLIN INVEST, V121, P3258, DOI 10.1172/JCI46267; LIU ZQ, 1991, APPL OPTICS, V30, P1369, DOI 10.1364/AO.30.001369; Marg A, 2012, TRAFFIC, V13, P1286, DOI 10.1111/j.1600-0854.2012.01386.x; Mate SE, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-19; Nicot AS, 2007, NAT GENET, V39, P1134, DOI 10.1038/ng2086; Pant S, 2009, NAT CELL BIOL, V11, P1399, DOI 10.1038/ncb1986; PORTER KR, 1957, J BIOPHYS BIOCHEM CY, V3, P269, DOI 10.1083/jcb.3.2.269; Posey AD, 2014, DEV BIOL, V387, P179, DOI 10.1016/j.ydbio.2014.01.004; Posey AD, 2011, J BIOL CHEM, V286, P7379, DOI 10.1074/jbc.M110.157222; Rainey MA, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-37; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Straub V, 1997, J CELL BIOL, V139, P375, DOI 10.1083/jcb.139.2.375; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; Tjondrokoesoemo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025740; WATKINS SC, 1988, NATURE, V333, P863, DOI 10.1038/333863a0	49	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136679	10.1371/journal.pone.0136679	http://dx.doi.org/10.1371/journal.pone.0136679			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325203	Green Published, Green Submitted, gold			2022-12-26	WOS:000360437700056
J	Itoh, M; Nakayama, K; Noguchi, R; Kamohara, K; Furukawa, K; Uchihashi, K; Toda, S; Oyama, J; Node, K; Morita, S				Itoh, Manabu; Nakayama, Koichi; Noguchi, Ryo; Kamohara, Keiji; Furukawa, Kojirou; Uchihashi, Kazuyoshi; Toda, Shuji; Oyama, Jun-ichi; Node, Koichi; Morita, Shigeki			Scaffold-Free Tubular Tissues Created by a Bio-3D Printer Undergo Remodeling and Endothelialization when Implanted in Rat Aortae	PLOS ONE			English	Article							VASCULAR GRAFT; ACCESS; SPHEROIDS; DESIGN	Background Small caliber vascular prostheses are not clinically available because synthetic vascular prostheses lack endothelial cells which modulate platelet activation, leukocyte adhesion, thrombosis, and the regulation of vasomotor tone by the production of vasoactive substances. We developed a novel method to create scaffold-free tubular tissue from multicellular spheroids (MCS) using a "Bio-3D printer"-based system. This system enables the creation of pre-designed three-dimensional structures using a computer controlled robotics system. With this system, we created a tubular structure and studied its biological features. Methods and Results Using a "Bio-3D printer," we made scaffold-free tubular tissues (inner diameter of 1.5 mm) from a total of 500 MCSs (2.5x 10(4) cells per one MCS) composed of human umbilical vein endothelial cells (40%), human aortic smooth muscle cells (10%), and normal human dermal fibroblasts (50%). The tubular tissues were cultured in a perfusion system and implanted into the abdominal aortas of F344 nude rats. We assessed the flow by ultrasonography and performed histological examinations on the second (n = 5) and fifth (n = 5) day after implantation. All grafts were patent and remodeling of the tubular tissues (enlargement of the lumen area and thinning of the wall) was observed. A layer of endothelial cells was confirmed five days after implantation. Conclusions The scaffold-free tubular tissues made of MCS using a Bio-3D printer underwent remodeling and endothelialization. Further studies are warranted to elucidate the underlying mechanism of endothelialization and its function, as well as the long-term results.	[Itoh, Manabu; Noguchi, Ryo; Kamohara, Keiji; Furukawa, Kojirou; Morita, Shigeki] Saga Univ, Fac Med, Dept Thorac & Cardiovasc Surg, Saga 840, Japan; [Nakayama, Koichi] Saga Univ, Fus Grad Sch Sci & Engn, Biomed Engn Course Adv Technol, Saga 840, Japan; [Oyama, Jun-ichi; Node, Koichi] Saga Univ, Fac Med, Dept Cardiovasc Med, Saga 840, Japan; [Uchihashi, Kazuyoshi; Toda, Shuji] Saga Univ, Fac Med, Dept Pathol & Microbiol, Saga 840, Japan	Saga University; Saga University; Saga University; Saga University	Morita, S (corresponding author), Saga Univ, Fac Med, Dept Thorac & Cardiovasc Surg, Saga 840, Japan.	moritash@cc.saga-u.ac.jp		Nakayama, Koichi/0000-0002-7324-8862	Science and Technology Grants for Scientific Research (JP) Grant [25293298, 50555084]	Science and Technology Grants for Scientific Research (JP) Grant	This work was supported by Science and Technology Grants for Scientific Research (JP) Grant Nos. 25293298 and 50555084.	Ao PY, 2000, EUR J VASC ENDOVASC, V20, P241, DOI 10.1053/ejvs.2000.1177; Chang TT, 2009, TISSUE ENG PT A, V15, P559, DOI 10.1089/ten.tea.2007.0434; Cleary MA, 2012, TRENDS MOL MED, V18, P394, DOI 10.1016/j.molmed.2012.04.013; Daenens K, 2009, J VASC SURG, V49, P1210, DOI 10.1016/j.jvs.2008.12.009; Faries PL, 2000, J VASC SURG, V32, P1080, DOI 10.1067/mva.2000.111279; Ferrari ER, 2006, CURR OPIN CARDIOL, V21, P584; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Hodges TC, 1997, J VASC SURG, V26, P1009, DOI 10.1016/S0741-5214(97)70014-4; Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kelm JM, 2006, TISSUE ENG, V12, P2151, DOI 10.1089/ten.2006.12.2151; Kelm JM, 2010, J BIOTECHNOL, V148, P46, DOI 10.1016/j.jbiotec.2010.03.002; Kelm JM, 2005, J BIOTECHNOL, V118, P213, DOI 10.1016/j.jbiotec.2005.03.016; Kelm JM, 2003, BIOTECHNOL BIOENG, V83, P173, DOI 10.1002/bit.10655; Kelm JM, 2004, TISSUE ENG, V10, P201, DOI 10.1089/107632704322791853; L'Heureux N, 1998, FASEB J, V12, P47, DOI 10.1096/fasebj.12.1.47; L'Heureux N, 2007, NEW ENGL J MED, V357, P1451, DOI 10.1056/NEJMc071536; Layer PG, 2002, TRENDS NEUROSCI, V25, P131, DOI 10.1016/S0166-2236(00)02036-1; Mancuso L, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/4/045011; Marga F, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/2/022001; McAllister TN, 2009, LANCET, V373, P1440, DOI 10.1016/S0140-6736(09)60248-8; Nakayama K, 2013, BIOFABRICATION: MICRO- AND NANO-FABRICATION, PRINTING, PATTERNING, AND ASSEMBLIES, P1; Nakayama Y, 2004, CELL TRANSPLANT, V13, P439, DOI 10.3727/000000004783983828; Nemeno-Guanzon JG, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/956345; Norotte C, 2009, BIOMATERIALS, V30, P5910, DOI 10.1016/j.biomaterials.2009.06.034; PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835; Rosas SE, 2003, J VASC SURG, V37, P1036, DOI 10.1067/mva.2003.257; Sanchez-Bustamante CD, 2008, TISSUE ENG PT A, V14, P1969, DOI 10.1089/ten.tea.2007.0302; Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047; Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717; Steffens L, 2009, J CELL MOL MED, V13, P3380, DOI 10.1111/j.1582-4934.2008.00418.x; Teebken OE, 2002, EUR J VASC ENDOVASC, V23, P475, DOI 10.1053/ejvs.2002.1654; TOMIZAWA Y, 1995, ARTIF ORGANS, V19, P39, DOI 10.1111/j.1525-1594.1995.tb02242.x; TOWNES PL, 1955, J EXP ZOOL, V128, P53, DOI 10.1002/jez.1401280105; Watanabe T, 2011, J BIOMED MATER RES B, V98B, P120, DOI 10.1002/jbm.b.31841; Wilson HV, 1907, J EXP ZOOL, V5, P245, DOI 10.1002/jez.1400050204; Yamanami M, 2013, J ARTIF ORGANS, V16, P59, DOI 10.1007/s10047-012-0676-y; Yamanami M, 2010, J BIOMED MATER RES B, V92B, P156, DOI 10.1002/jbm.b.31501; Zilla P, 2007, BIOMATERIALS, V28, P5009, DOI 10.1016/j.biomaterials.2007.07.017	39	139	152	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136681	10.1371/journal.pone.0136681	http://dx.doi.org/10.1371/journal.pone.0136681			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325298	gold, Green Published, Green Submitted			2022-12-26	WOS:000360437700057
J	Esteve-Gassent, MD; Smith, TC; Small, CM; Thomas, DP; Seshu, J				Esteve-Gassent, Maria D.; Smith, Trever C., II; Small, Christina M.; Thomas, Derek P.; Seshu, J.			Absence of sodA Increases the Levels of Oxidation of Key Metabolic Determinants of Borrelia burgdorferi	PLOS ONE			English	Article							LYME-DISEASE SPIROCHETE; METHYL VIOLOGEN PARAQUAT; GENE-EXPRESSION; SUPEROXIDE-DISMUTASE; IXODES-SCAPULARIS; ESCHERICHIA-COLI; PROTEOME ANALYSIS; MAMMALIAN HOST; NITRIC-OXIDE; STRUCTURAL PROTEOMICS	Borrelia burgdorferi, the causative agent of Lyme disease, alters its gene expression in response to environmental signals unique to its tick vector or vertebrate hosts. B. burgdorferi carries one superoxide dismutase gene (sodA) capable of controlling intracellular superoxide levels. Previously, sodA was shown to be essential for infection of B. burgdorferi in the C3H/HeN model of Lyme disease. We employed two-dimensional electrophoresis (2DE) and immunoblot analysis with antibodies specific to carbonylated proteins to identify targets that were differentially oxidized in the soluble fractions of the sodA mutant compared to its isogenic parental control strain following treatment with an endogenous superoxide generator, methyl viologen (MV, paraquat). HPLC-ESI-MS/MS analysis of oxidized proteins revealed that several proteins of the glycolytic pathway (BB0057, BB0020, BB0348) exhibited increased carbonylation in the sodA mutant treated with MV. Levels of ATP and NAD/NADH were reduced in the sodA mutant compared with the parental strain following treatment with MV and could be attributed to increased levels of oxidation of proteins of the glycolytic pathway. In addition, a chaperone, HtpG (BB0560), and outer surface protein A (OspA, BBA15) were also observed to be oxidized in the sodA mutant. Immunoblot analysis revealed reduced levels of Outer surface protein C (OspC), Decorin binding protein A (DbpA), fibronectin binding protein (BBK32), RpoS and BosR in the sodA mutant compared to the control strains. Viable sodA mutant spirochetes could not be recovered from both gp91/phox(-/-) and iNOS deficient mice while borrelial DNA was detected in multiple tissues samples from infected mice at significantly lower levels compared to the parental strain. Taken together, these observations indicate that the increased oxidation of select borrelial determinants and reduced levels of critical pathogenesis-associated lipoproteins contribute to the in vivo deficit of the sodA mutant in the mouse model of Lyme disease. This study, utilizing the sodA mutant, has provided insights into adaptive capabilities critical for survival of B. burgdorferi in its hosts.	[Esteve-Gassent, Maria D.; Smith, Trever C., II; Thomas, Derek P.; Seshu, J.] Univ Texas San Antonio, South Texas Ctr Emerging Infect Dis, San Antonio, TX 78249 USA; [Smith, Trever C., II; Seshu, J.] Univ Texas San Antonio, Ctr Excellence Infect Genom, San Antonio, TX 78249 USA; [Esteve-Gassent, Maria D.; Small, Christina M.] Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA; [Thomas, Derek P.] Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA	University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA); Texas A&M University System; Texas A&M University College Station	Seshu, J (corresponding author), Univ Texas San Antonio, South Texas Ctr Emerging Infect Dis, San Antonio, TX 78249 USA.	j.seshu@utsa.edu	Esteve-Gassent, Maria/AAF-2597-2020	Esteve-Gassent, Maria/0000-0001-5921-2794; Brock, Christina/0000-0001-9204-8252; Smith II, Trever/0000-0002-1651-313X	Public Health Service Grant from the National Institute Of Allergy and Infectious Diseases [SC1AI078559]; Army Research Office of DoD [W911NF-11-1-0136]; Faculty Research Award from UTSA; American Heart Association Institutional Mass Spectrometry Laboratory at the University of Texas Health Science Center-San Antonio - NIH [AHA-0825175F, P30 CA54174]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SC1AI078559] Funding Source: NIH RePORTER	Public Health Service Grant from the National Institute Of Allergy and Infectious Diseases; Army Research Office of DoD; Faculty Research Award from UTSA; American Heart Association Institutional Mass Spectrometry Laboratory at the University of Texas Health Science Center-San Antonio - NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding provided by Public Health Service Grant Number SC1AI078559 from the National Institute Of Allergy and Infectious Diseases, Army Research Office of DoD, Grant Number: W911NF-11-1-0136 and Faculty Research Award from UTSA (JS) and a post-doctoral fellowship (AHA-0825175F) from American Heart Association Institutional Mass Spectrometry Laboratory at the University of Texas Health Science Center-San Antonio supported by NIH grant P30 CA54174 (MDEG).	Aguirre JD, 2013, J BIOL CHEM, V288, P8468, DOI 10.1074/jbc.M112.433540; Akins DR, 1998, J CLIN INVEST, V101, P2240, DOI 10.1172/JCI2325; Alverson J, 2003, MOL MICROBIOL, V48, P1665, DOI 10.1046/j.1365-2958.2003.03537.x; Anderton JM, 2004, INFECT IMMUN, V72, P2035, DOI 10.1128/IAI.72.4.2035-2044.2004; Batinic-Haberle I, 2008, FREE RADICAL RES, V42, P618, DOI 10.1080/10715760802209639; Bourret TJ, 2011, MOL MICROBIOL, V81, P259, DOI 10.1111/j.1365-2958.2011.07691.x; Boylan JA, 2003, P NATL ACAD SCI USA, V100, P11684, DOI 10.1073/pnas.2032956100; Boylan JA, 2008, MOL MICROBIOL, V68, P786, DOI 10.1111/j.1365-2958.2008.06204.x; Boylan Julie A., 2008, V431, P213; Brooks CS, 2003, INFECT IMMUN, V71, P3371, DOI 10.1128/IAI.71.6.3371-3383.2003; Burtnick MN, 2007, MOL MICROBIOL, V65, P277, DOI 10.1111/j.1365-2958.2007.05813.x; Caimano MJ, 2005, J BACTERIOL, V187, P7845, DOI 10.1128/JB.187.22.7845-7852.2005; Caimano MJ, 2004, INFECT IMMUN, V72, P6433, DOI 10.1128/IAI.72.11.6433-6445.2004; Caimano MJ, 2007, MOL MICROBIOL; Calmano MJ, 2007, MOL MICROBIOL, V65, P1193, DOI 10.1111/j.1365-2958.2007.05860.x; Carroll JA, 2000, INFECT IMMUN, V68, P6677, DOI 10.1128/IAI.68.12.6677-6684.2000; Carroll JA, 1999, INFECT IMMUN, V67, P3181, DOI 10.1128/IAI.67.7.3181-3187.1999; Coleman JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000676; Desnues B, 2003, EMBO REP, V4, P400, DOI 10.1038/sj.embor.embor799; Dulebohn DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093141; Esteve-Gassent MD, 2009, MOL MICROBIOL, V71, P594, DOI 10.1111/j.1365-2958.2008.06549.x; Fikrig E, 2006, MICROBES INFECT, V8, P1390, DOI 10.1016/j.micinf.2005.12.022; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Gil F, 2007, RES MICROBIOL, V158, P529, DOI 10.1016/j.resmic.2007.05.004; Giro M, 2006, MICROBIOL-SGM, V152, P1119, DOI 10.1099/mic.0.28612-0; Grimm D, 2004, P NATL ACAD SCI USA, V101, P3142, DOI 10.1073/pnas.0306845101; Guan JQ, 2005, TRENDS BIOCHEM SCI, V30, P583, DOI 10.1016/j.tibs.2005.08.007; Guo BP, 1998, MOL MICROBIOL, V30, P711, DOI 10.1046/j.1365-2958.1998.01103.x; Hara MR, 2006, BBA-MOL BASIS DIS, V1762, P502, DOI 10.1016/j.bbadis.2006.01.012; Hayes BM, 2014, MBIO, V5, DOI 10.1128/mBio.01017-14; Hubner A, 2001, P NATL ACAD SCI USA, V98, P12724, DOI 10.1073/pnas.231442498; Hyde JA, 2007, J BACTERIOL, V189, P437, DOI 10.1128/JB.01109-06; Hyde JA, 2006, MICROBIOL-SGM, V152, P2599, DOI 10.1099/mic.0.28996-0; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; JONES RW, 1976, BIOCHEM SOC T, V4, P671, DOI 10.1042/bst0040671; Karna SLR, 2013, INFECT IMMUN, V81, P2972, DOI 10.1128/IAI.00494-13; Karna SLR, 2011, INFECT IMMUN, V79, P732, DOI 10.1128/IAI.00882-10; Korshunov SS, 2002, MOL MICROBIOL, V43, P95, DOI 10.1046/j.1365-2958.2002.02719.x; Labandeira-Rey M, 2001, INFECT IMMUN, V69, P446, DOI 10.1128/IAI.69.1.446-455.2001; Labandeira-Rey M, 2003, INFECT IMMUN, V71, P4608, DOI 10.1128/IAI.71.8.4608-4613.2003; Lynch M, 2000, MICROBES INFECT, V2, P1245, DOI 10.1016/S1286-4579(00)01278-8; Ma JF, 1998, J BACTERIOL, V180, P1741, DOI 10.1128/JB.180.7.1741-1749.1998; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; Maruskova M, 2008, INFECT IMMUN; Maruskova M, 2008, INFECT IMMUN, V76, P391, DOI 10.1128/IAI.01118-07; Miller CL, 2013, MOL MICROBIOL, V88, P105, DOI 10.1111/mmi.12171; Nakajima H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704199200; Narasimhan S, 2004, P NATL ACAD SCI USA, V101, P1141, DOI 10.1073/pnas.0307669100; Narasimhan S, 2002, INSECT MOL BIOL, V11, P641, DOI 10.1046/j.1365-2583.2002.00375.x; Narasimhan S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000451; Norris SJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-209; Norris Steven J, 2012, Open Neurol J, V6, P119, DOI 10.2174/1874205X01206010119; Nowalk AJ, 2006, PROTEOMICS, V6, P2121, DOI 10.1002/pmic.200500187; Nowalk AJ, 2006, INFECT IMMUN, V74, P3864, DOI 10.1128/IAI.00189-06; Ojaimi C, 2003, INFECT IMMUN, V71, P1689, DOI 10.1128/IAI.71.4.1689-1705.2003; Pal U, 2004, CELL, V119, P457, DOI 10.1016/j.cell.2004.10.027; Pal U, 2004, J CLIN INVEST, V113, P220, DOI 10.1172/JCI200419894; Peterson CN, 2012, GENE DEV, V26, P548, DOI 10.1101/gad.183517.111; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; Probert WS, 1998, MOL MICROBIOL, V30, P1003, DOI 10.1046/j.1365-2958.1998.01127.x; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Raju BVS, 2011, INFECT IMMUN, V79, P3407, DOI 10.1128/IAI.05234-11; Ramamoorthi N, 2005, NATURE, V436, P573, DOI 10.1038/nature03812; Reinheckel T, 2000, ARCH BIOCHEM BIOPHYS, V376, P59, DOI 10.1006/abbi.1999.1680; Revel AT, 2002, P NATL ACAD SCI USA, V99, P1562, DOI 10.1073/pnas.032667699; Roggenkamp A, 1997, INFECT IMMUN, V65, P4705, DOI 10.1128/IAI.65.11.4705-4710.1997; Samuels DS, 2011, ANNU REV MICROBIOL, V65, P479, DOI 10.1146/annurev.micro.112408.134040; Sanjuan E, 2009, INFECT IMMUN; Sanjuan E, 2009, INFECT IMMUN, V77, P5149, DOI 10.1128/IAI.00673-09; Santiviago CA, 2002, MOL MICROBIOL, V46, P687, DOI 10.1046/j.1365-2958.2002.03204.x; Seshu J, 2006, MOL MICROBIOL, V59, P1591, DOI 10.1111/j.1365-2958.2005.05042.x; Seshu J, 2004, MOL MICROBIOL, V54, P1352, DOI 10.1111/j.1365-2958.2004.04352.x; Seshu J, 2004, INFECT IMMUN, V72, P1580, DOI 10.1128/IAI.72.3.1580-1586.2004; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI [10.1172/JCI200421681, 10.1172/JCI21681]; STEVENSON B, 1995, INFECT IMMUN, V63, P4535, DOI 10.1128/IAI.63.11.4535-4539.1995; Thomas Derek P., 2006, Infectious Disorders - Drug Targets, V6, P335, DOI 10.2174/187152606779025815; Thomas DP, 2009, J PROTEOMICS, V73, P342, DOI 10.1016/j.jprot.2009.10.003; Troxell B, 2012, J BIOL CHEM, V287, P19284, DOI 10.1074/jbc.M112.344903; Van Laar TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038171; Wang XH, 2009, ANTIMICROB AGENTS CH, V53, P1395, DOI 10.1128/AAC.01087-08; Xu GH, 2007, CHEM REV, V107, P3514, DOI 10.1021/cr0682047; Yang XF, 2000, MOL MICROBIOL, V37, P1470, DOI 10.1046/j.1365-2958.2000.02104.x; Yang XFF, 2003, P NATL ACAD SCI USA, V100, P11001, DOI 10.1073/pnas.1834315100; Young M, 2009, PROTEOMICS, V9, P2578, DOI 10.1002/pmic.200800713; Yu LX, 1998, P NATL ACAD SCI USA, V95, P7993, DOI 10.1073/pnas.95.14.7993	88	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136707	10.1371/journal.pone.0136707	http://dx.doi.org/10.1371/journal.pone.0136707			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322513	Green Published, gold, Green Submitted			2022-12-26	WOS:000360435500029
J	Cox, R; Phillips, O; Fukumoto, J; Fukumoto, I; Parthasarathy, PT; Mandry, M; Cho, Y; Lockey, R; Kolliputi, N				Cox, Ruan, Jr.; Phillips, Oluwakemi; Fukumoto, Jutaro; Fukumoto, Itsuko; Parthasarathy, Prasanna Tamarapu; Mandry, Maria; Cho, Young; Lockey, Richard; Kolliputi, Narasaiah			Resolvins Decrease Oxidative Stress Mediated Macrophage and Epithelial Cell Interaction through Decreased Cytokine Secretion	PLOS ONE			English	Article							ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; PRORESOLVING LIPID MEDIATORS; ANIMAL-MODELS; PULMONARY INFLAMMATION; EDEMA FLUID; TNF-ALPHA; EXPRESSION; NEUTROPHILS; ADHESION	Background Inflammation is a key hallmark of ALI and is mediated through ungoverned cytokine signaling. One such cytokine, interleukin-1beta (IL-1 beta) has been demonstrated to be the most bioactive cytokine in ALI patients. Macrophages are the key players responsible for IL-1 beta secretion into the alveolar space. Following the binding of IL-1 beta to its receptor, "activated" alveolar epithelial cells show enhanced barrier dysfunction, adhesion molecule expression, cytokine secretion, and leukocyte attachment. More importantly, it is an important communication molecule between the macrophage and alveolar epithelium. While the molecular determinants of this inflammatory event have been well documented, endogenous resolution processes that decrease IL-1 beta secretion and resolve alveolar epithelial cell activation and tissue inflammation have not been well characterized. Lipid mediator Aspirin-Triggered Resolvin D1 (AT-RvD1) has demonstrated potent pro-resolutionary effects in vivo models of lung injury; however, the contribution of the alveoli to the protective benefits of this molecule has not been well documented. In this study, we demonstrate that AT-RvD1 treatment lead to a significant decrease in oxidant induced macrophage IL-1 beta secretion and production, IL-1 beta-mediated cytokine secretion, adhesion molecule expression, leukocyte adhesion and inflammatory signaling. Methods THP-1 macrophages were treated with hydrogen peroxide and extracellular ATP in the presence or absence of AT-RvD1 (1000-0.1 nM). A549 alveolar-like epithelial cells were treated with IL-1 beta (10 ng/mL) in the presence or absence of AT-RvD1 (0.1 mu M). Following treatment, cell lysate and cell culture supernatants were collected for Western blot, qPCR and ELISA analysis of pro-inflammatory molecules. Functional consequences of IL-1 beta induced alveolar epithelial cell and macrophage activation were also measured following treatment with IL-1 beta +/- AT-RvD1. Results Results demonstrate that macrophages exposed to H2O2 and ATP in the presence of resolvins show decreased IL-1 beta production and activity. A549 cells treated with IL-1 beta in the presence of AT-RvD1 show a reduced level of proinflammatory cytokines IL-6 and IL-8. Further, IL-1 beta-mediated adhesion molecule expression was also reduced with AT-RvD1 treatment, which was correlated with decreased leukocyte adhesion. AT-RvD1 treatment demonstrated reduced MAP-Kinase signaling. Taken together, our results demonstrate AT-RvD1 treatment reduced IL-1 beta-mediated alveolar epithelial cell activation. This is a key step in unraveling the protective effects of resolvins, especially AT-RvD1, during injury.	[Cox, Ruan, Jr.; Phillips, Oluwakemi; Fukumoto, Jutaro; Fukumoto, Itsuko; Parthasarathy, Prasanna Tamarapu; Mandry, Maria; Cho, Young; Lockey, Richard; Kolliputi, Narasaiah] Univ S Florida, Dept Internal Med, Div Allergy & Immunol, Morsani Coll Med, Tampa, FL 33612 USA; [Cox, Ruan, Jr.; Kolliputi, Narasaiah] Univ S Florida, Dept Mol Med, Morsani Coll Med, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Kolliputi, N (corresponding author), Univ S Florida, Dept Internal Med, Div Allergy & Immunol, Morsani Coll Med, Tampa, FL 33612 USA.	nkollipu@health.usf.edu			American Heart Association National Scientist Development Grant [09SDG2260957]; National Institutes of Health [R01 HL105932]; American Heart Association predoctoral fellowship award [13PRE17070137]; American Heart Association postdoctoral fellowship award [14POST18200004]; Joy McCann Culverhouse Endowment to the Division of Allergy and Immunology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105932] Funding Source: NIH RePORTER	American Heart Association National Scientist Development Grant(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association predoctoral fellowship award(American Heart Association); American Heart Association postdoctoral fellowship award(American Heart Association); Joy McCann Culverhouse Endowment to the Division of Allergy and Immunology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NK was funded by the American Heart Association National Scientist Development Grant 09SDG2260957 and National Institutes of Health R01 HL105932 and the Joy McCann Culverhouse Endowment to the Division of Allergy and Immunology. RC was funded by the American Heart Association predoctoral fellowship award 13PRE17070137. JF was funded by the American Heart Association postdoctoral fellowship award 14POST18200004.	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; Arita M, 2005, P NATL ACAD SCI USA, V102, P7671, DOI 10.1073/pnas.0409271102; Casilli F, 2005, BIOCHEM PHARMACOL, V69, P385, DOI 10.1016/j.bcp.2004.10.007; Chen Ya-feng, 2011, Zhonghua Xin Xue Guan Bing Za Zhi, V39, P1039; Cox Jr R, 2015, AM J RESP CELL MOL B, DOI [10.1165/rcmb.2014-0339OC, DOI 10.1165/RCMB.2014-03390C]; Davis BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033304; Deng JC, 2011, COMPR PHYSIOL, V1, P81, DOI 10.1002/cphy.c090011; Eickmeier O, 2013, MUCOSAL IMMUNOL, V6, P256, DOI 10.1038/mi.2012.66; Emadi S, 2005, BLOOD, V105, P464, DOI 10.1182/blood-2003-12-4415; FLICK M R, 1986, Critical Care Clinics, V2, P455; Fukumoto J, 2013, AM J PHYSIOL-CELL PH, V305, pC182, DOI 10.1152/ajpcell.00086.2013; Ganter MT, 2008, CIRC RES, V102, P804, DOI 10.1161/CIRCRESAHA.107.161067; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Kallet RH, 2013, RESP CARE, V58, P123, DOI 10.4187/respcare.01963; Kim H, 2008, EXP MOL MED, V40, P167, DOI 10.3858/emm.2008.40.2.167; Klesney-Tait J, 2013, J CLIN INVEST, V123, P138, DOI 10.1172/JCI64181; Kolliputi N, 2012, J CELL PHYSIOL, V227, P3310, DOI 10.1002/jcp.24026; Kolliputi N, 2010, J IMMUNOL, V184, P5819, DOI 10.4049/jimmunol.0902766; Lagishetty V, 2014, DYSREGULATION CLOCK, pC999; Lee JW, 2007, J BIOL CHEM, V282, P24109, DOI 10.1074/jbc.M700821200; Levitt Joseph E, 2009, J Intensive Care Med, V24, P151, DOI 10.1177/0885066609332603; Levy BD, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00390; Lichtenstein A, 2000, CRIT CARE MED, V28, P1497, DOI 10.1097/00003246-200005000-00040; Looney MR, 2006, CRIT CARE MED, V34, pS132, DOI 10.1097/01.CCM.0000214287.58444.2D; Matthay MA, 1999, CRIT CARE MED, V27, P2028, DOI 10.1097/00003246-199909000-00055; Matthay MA, 2005, AM J RESP CELL MOL, V33, P319, DOI 10.1165/rcmb.F305; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; McVerry BJ, 2004, AM J RESP CRIT CARE, V170, P987, DOI 10.1164/rccm.200405-684oc; Meager A, 1999, CYTOKINE GROWTH F R, V10, P27, DOI 10.1016/S1359-6101(98)00024-0; Miller EJ, 1996, CRIT CARE MED, V24, P1448, DOI 10.1097/00003246-199609000-00004; Mulligan MS, 1996, P ASSOC AM PHYSICIAN, V108, P198; Nagato A, 2009, EXP LUNG RES, V35, P713, DOI 10.3109/01902140902853184; Okutani D, 2007, AM J PHYSIOL-LUNG C, V292, pL144, DOI 10.1152/ajplung.00002.2006; Pritchard KA, 2004, AM J PHYSIOL-LUNG C, V286, pL705, DOI 10.1152/ajplung.00288.2002; Rocker GM, 2000, CRIT CARE MED, V28, P3354, DOI 10.1097/00003246-200009000-00043; Rogerio AP, 2012, J IMMUNOL, V189, P1983, DOI 10.4049/jimmunol.1101665; Schmausser B, 2004, INFECT IMMUN, V72, P6773, DOI 10.1128/IAI.72.12.6773-6779.2004; Serhan CN, 2008, ANNU REV PATHOL-MECH, V3, P279, DOI 10.1146/annurev.pathmechdis.3.121806.151409; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Silva E, 2007, INTENS CARE MED, V33, P1829, DOI 10.1007/s00134-007-0748-2; SIMPSON JF, 1991, AM REV RESPIR DIS, V143, P585, DOI 10.1164/ajrccm/143.3.585; Steiner MK, 2009, CIRC RES, V104, P236, DOI 10.1161/CIRCRESAHA.108.182014; Su X, 2011, INFLAMM RES, V60, P619, DOI 10.1007/s00011-011-0313-x; Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11; Wang HM, 2008, EUR SURG RES, V40, P305, DOI 10.1159/000121471; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Ware LB, 2001, AM J RESP CRIT CARE, V163, P1376, DOI 10.1164/ajrccm.163.6.2004035; Ware LB, 2013, SEMIN RESP CRIT CARE, V34, P439, DOI 10.1055/s-0033-1351163; Waxman AB, 2009, AM J RESP CELL MOL, V41, P385, DOI 10.1165/rcmb.2008-0302OC; Westphalen K, 2014, NATURE, V506, P503, DOI 10.1038/nature12902; Wung BS, 2005, J BIOMED SCI, V12, P91, DOI 10.1007/s11373-004-8170-z; Yacoubian S, 2007, NAT CLIN PRACT RHEUM, V3, P570, DOI 10.1038/ncprheum0616; Yang CM, 2010, J CELL PHYSIOL, V224, P516, DOI 10.1002/jcp.22153; Yang HZ, 2012, AM J PATHOL, V180, P275, DOI 10.1016/j.ajpath.2011.09.019	56	26	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136755	10.1371/journal.pone.0136755	http://dx.doi.org/10.1371/journal.pone.0136755			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317859	Green Submitted, gold, Green Published			2022-12-26	WOS:000360299100136
J	Dietz, J; Susser, S; Berkowski, C; Perner, D; Zeuzem, S; Sarrazin, C				Dietz, Julia; Susser, Simone; Berkowski, Caterina; Perner, Dany; Zeuzem, Stefan; Sarrazin, Christoph			Consideration of Viral Resistance for Optimization of Direct Antiviral Therapy of Hepatitis C Virus Genotype 1-Infected Patients	PLOS ONE			English	Article							DACLATASVIR PLUS SOFOSBUVIR; NS5A INHIBITOR BMS-790052; TREATMENT-NAIVE PATIENTS; IN-VITRO; CHRONIC HCV; OPEN-LABEL; POLYMERASE INHIBITORS; PEGYLATED INTERFERON; EXPERIENCED PATIENTS; VARIANTS RESISTANT	Different highly effective interferon-free treatment options for chronic hepatitis C virus (HCV) infection are currently available. Pre-existence of resistance associated variants (RAVs) to direct antiviral agents (DAAs) reduces sustained virologic response (SVR) rates by 3-53% in hepatitis C virus (HCV) genotype 1 infected patients depending on different predictors and the DAA regimen used. Frequencies of single and combined resistance to NS3, NS5A and NS5B inhibitors and consequences for the applicability of different treatment regimens are unknown. Parallel population based sequencing of HCV NS3, NS5A and NS5B genes in 312 treatment-naive Caucasian HCV genotype 1 infected patients showed the presence of major resistant variants in 20.5% (NS3), 11.9% (NS5A), and 22.1% (NS5B) with important differences for HCV subtypes. In NS3, Q80K was observed in 34.7% and 2.1% of subtype 1a and 1b patients, respectively while other RAVs to second generation protease inhibitors were detected rarely (1.4%). Within NS5A RAVs were observed in 7.1% of subtype 1a and 17.6% in subtype 1b infected patients. RAVs to non-nucleoside NS5B inhibitors were observed in 3.5% and 44.4% of subtype 1a and 1b patients, respectively. Considering all three DAA targets all subtype 1a and 98.6% of subtype 1b infected patients were wildtype for at least one interferon free DAA regimen currently available. In conclusion, baseline resistance testing allows the selection of at least one RAVs-free treatment option for nearly all patients enabling a potentially cost- and efficacy-optimized treatment of chronic hepatitis C.	[Dietz, Julia; Susser, Simone; Berkowski, Caterina; Perner, Dany; Zeuzem, Stefan; Sarrazin, Christoph] Goethe Univ Hosp, Med Dept 1, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital	Sarrazin, C (corresponding author), Goethe Univ Hosp, Med Dept 1, Frankfurt, Germany.	sarrazin@em.uni-frankfurt.de	Zeuzem, Stefan/AAE-7435-2019		DZIF (Deutsches Zentrum fur Infektionsforschung) [TTU 05.902]; Janssen-Cilag GmbH	DZIF (Deutsches Zentrum fur Infektionsforschung); Janssen-Cilag GmbH	This study was supported by a DZIF (Deutsches Zentrum fur Infektionsforschung) (http://www.dzif.de/forschung/hepatitis/) grant entitled "Geno- & phenotypic NS3, NS5A and NS5B inhibitor resistance analysis" to Christoph Sarrazin and Stefan Zeuzem (TTU 05.902). Further support was obtained in part from Janssen-Cilag GmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Bartels DJ, 2013, J VIROL, V87, P1544, DOI 10.1128/JVI.02294-12; Bartenschlager R, 2013, NAT REV MICROBIOL, V11, P482, DOI 10.1038/nrmicro3046; De Luca A, 2014, CURR OPIN PHARMACOL, V18, P9, DOI 10.1016/j.coph.2014.07.016; DeGoey DA, 2014, J MED CHEM, V57, P2047, DOI 10.1021/jm401398x; Dietz J, 2013, J VIROL, V87, P6172, DOI 10.1128/JVI.02778-12; Donaldson EF, 2015, HEPATOLOGY, V61, P56, DOI 10.1002/hep.27375; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Fridell RA, 2011, HEPATOLOGY, V54, P1924, DOI 10.1002/hep.24594; Fridell RA, 2010, ANTIMICROB AGENTS CH, V54, P3641, DOI 10.1128/AAC.00556-10; Gaudieri S, 2009, HEPATOLOGY, V49, P1069, DOI 10.1002/hep.22773; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hsu CS, 2013, NEW ENGL J MED, V369, P678, DOI 10.1056/NEJMc1307641; Kati W, 2015, ANTIMICROB AGENTS CH, V59, P1510, DOI 10.1128/AAC.04619-14; Kolykhalov AA, 1997, SCIENCE, V277, P570, DOI 10.1126/science.277.5325.570; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Kowdley KV, 2013, LANCET, V381, P2100, DOI 10.1016/S0140-6736(13)60247-0; Krishnan P, 2014, J HEPATOL, V60, pS498, DOI 10.1016/S0168-8278(14)61390-8; Krishnan P, 2015, ANTIMICROB AGENTS CH, V59, P979, DOI 10.1128/AAC.04226-14; Krishnan P, 2014, HEPATOLOGY, V60, p1134A; Kuntzen T, 2008, HEPATOLOGY, V48, P1769, DOI 10.1002/hep.22549; Kwo P, 2015, J HEPATOL, V62, pS270, DOI 10.1016/S0168-8278(15)30168-9; Lawitz E, 2015, J HEPATOL, V62, pS264, DOI 10.1016/S0168-8278(15)30158-6; Lawitz E, 2014, LANCET, V384, P1756, DOI 10.1016/S0140-6736(14)61036-9; Lawitz EJ, 2012, J HEPATOL, V57, P24, DOI 10.1016/j.jhep.2011.12.029; Lenz O, 2015, J HEPATOL, V62, P1008, DOI 10.1016/j.jhep.2014.11.032; Lenz O, 2010, ANTIMICROB AGENTS CH, V54, P1878, DOI 10.1128/AAC.01452-09; Lim SR, 2012, ANTIMICROB AGENTS CH, V56, P271, DOI 10.1128/AAC.05636-11; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lok AS, 2014, J HEPATOL, V60, P490, DOI 10.1016/j.jhep.2013.10.019; Manns M, 2014, LANCET, V384, P1597, DOI 10.1016/S0140-6736(14)61059-X; McPhee F, 2013, HEPATOLOGY, V58, P902, DOI 10.1002/hep.26388; McPhee F, 2012, ANTIMICROB AGENTS CH, V56, P3670, DOI 10.1128/AAC.00308-12; Nelson DR, 2015, HEPATOLOGY, V61, P1127, DOI 10.1002/hep.27726; Pilot-Matias T, 2015, ANTIMICROB AGENTS CH, V59, P988, DOI 10.1128/AAC.04227-14; Poordad F, 2015, J HEPATOL, V62, pS261, DOI 10.1016/S0168-8278(15)30154-9; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Poordad F, 2013, NEW ENGL J MED, V368, P45, DOI 10.1056/NEJMoa1208809; Sarrazin C, 2015, J HEPATOL, V62, pS620, DOI 10.1016/S0168-8278(15)30976-4; Sarrazin C, 2015, ANTIVIR RES, V116, P10, DOI 10.1016/j.antiviral.2015.01.003; Sarrazin C, 2014, HEPATOLOGY, V60, p1128A; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Sarrazin C, 2011, GASTROENTEROLOGY, V141, P1656, DOI 10.1053/j.gastro.2011.07.019; Schneider MD, 2014, ANTIVIR RES, V105, P64, DOI 10.1016/j.antiviral.2014.02.011; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Suzuki F, 2012, J CLIN VIROL, V54, P352, DOI 10.1016/j.jcv.2012.04.024; Suzuki Y, 2013, J HEPATOL, V58, P655, DOI 10.1016/j.jhep.2012.09.037; Svarovskaia ES, 2014, HEPATOLOGY, V60, p218A; Svarovskaia ES, 2014, CLIN INFECT DIS, V59, P1666, DOI 10.1093/cid/ciu697; Tong X, 2014, J INFECT DIS, V209, P668, DOI 10.1093/infdis/jit562; Vermehren J, 2012, BEST PRACT RES CL GA, V26, P487, DOI 10.1016/j.bpg.2012.09.011; Wyles DL, 2015, J HEPATOL, V62, pS263, DOI 10.1016/S0168-8278(15)30155-0; Zeuzem S, 2014, NEW ENGL J MED, V370, P1993, DOI 10.1056/NEJMoa1316145; Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561	56	62	67	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0134395	10.1371/journal.pone.0134395	http://dx.doi.org/10.1371/journal.pone.0134395			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317755	gold, Green Published, Green Submitted			2022-12-26	WOS:000360299100015
J	Filtz, EA; Emery, A; Lu, HR; Forster, CL; Karasch, C; Hallstrom, TC				Filtz, Emma A.; Emery, Ann; Lu, Huarui; Forster, Colleen L.; Karasch, Chris; Hallstrom, Timothy C.			Rb1 and Pten Co-Deletion in Osteoblast Precursor Cells Causes Rapid Lipoma Formation in Mice	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PTEN; TRANSCRIPTION FACTOR; RETINOBLASTOMA GENE; PROGENITOR CELLS; BONE-DEVELOPMENT; ADIPOSE-TISSUE; LACKING PTEN; OSTEOSARCOMA; DIFFERENTIATION; INACTIVATION	The Rb and Pten tumor suppressor genes are important regulators of bone development and both are frequently mutated in the bone cancer osteosarcoma (OS). To determine if Rb1 and Pten synergize as tumor suppressor genes for osteosarcoma, we co-deleted them in osteoprogenitor cells. Surprisingly, we observed rapid development of adipogenic but not osteosarcoma tumors in the Delta Rb1/Pten mice solo deleted mice also developed lipoma tumors but at a much reduced frequency and later onset than those co-deleted for Rb1. Pten deletion also led to a marked increase in adipocytes in the bone marrow. To better understand the function of Pten in bone development in vivo, we conditionally deleted Pten in OSX+ osteoprogenitor cells using OSX-Cre mice. mu CT analysis revealed a significant thickening of the calvaria and an increase in trabeculae volume and number in the femur, consistent with increased bone formation in thesemice. To determine if Pten and Rb1 deletion actively promotes adipogenic differentiation, we isolated calvarial cells from Pten(fl/fl) and Pten(fl/fl); Rb1(fl/fl) mice, infected them with CRE or GFP expressing adenovirus, treated with differentiation media. We observed slightly increased adipogenic, and osteogenic differentiation in the Delta Pten cells. Both phenotypes were greatly increased upon Rb1/Pten co-deletion. This was accompanied by an increase in expression of genes required for adipogenesis. These data indicate that Pten deletion in osteoblast precursors is sufficient to promote frequent adipogenic, but only rare osteogenic tumors. Rb1 hetero- or homo-zygous co-deletion greatly increases the incidence and the rapidity of onset of adipogenic tumors, again, with only rare osteosarcoma tumors.	[Filtz, Emma A.; Lu, Huarui; Karasch, Chris; Hallstrom, Timothy C.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Emery, Ann] Univ Minnesota, Sch Dent, Diagnost & Biol Sci, Minneapolis, MN 55455 USA; [Forster, Colleen L.] Univ Minnesota, Acad Hlth Ctr, BioNet, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Hallstrom, TC (corresponding author), Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA.	halls026@umn.edu			National Institutes of Health [R01CA168622]; Children's Cancer Research Fund, Minneapolis, MN; NATIONAL CANCER INSTITUTE [R01CA168622] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Cancer Research Fund, Minneapolis, MN; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was funded by grants to T.H. from National Institutes of Health (R01CA168622) and the Children's Cancer Research Fund, Minneapolis, MN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman SD, 2008, P NATL ACAD SCI USA, V105, P11851, DOI 10.1073/pnas.0805462105; Broege A, 2013, J BIOL CHEM, V288, P37230, DOI 10.1074/jbc.M113.496950; Calo E, 2010, NATURE, V466, P1110, DOI 10.1038/nature09264; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chen JQ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085161, 10.1371/journal.pone.0101277]; Chen X, 2014, CELL REP, V7, P104, DOI 10.1016/j.celrep.2014.03.003; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; Daikoku T, 2011, GYNECOL ONCOL, V122, P424, DOI 10.1016/j.ygyno.2011.04.022; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Egan KP, 2012, HISTOPATHOLOGY, V61, P1168, DOI 10.1111/j.1365-2559.2012.04333.x; Fajas L, 2002, DEV CELL, V3, P39, DOI 10.1016/S1534-5807(02)00190-9; Ford-Hutchinson AF, 2007, J BONE MINER RES, V22, P1245, DOI 10.1359/JBMR.070420; Freeman SS, 2008, CANCER-AM CANCER SOC, V113, P1453, DOI 10.1002/cncr.23782; Guntur AR, 2011, DEVELOPMENT, V138, P1433, DOI 10.1242/dev.058016; Gutierrez GM, 2008, P NATL ACAD SCI USA, V105, P18402, DOI 10.1073/pnas.0805925105; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Hoshi K, 1999, BONE, V25, P639, DOI 10.1016/S8756-3282(99)00223-9; Hsieh SC, 2009, MOL CARCINOGEN, V48, P545, DOI 10.1002/mc.20491; Iyer S, 2013, J CLIN INVEST, V123, P3409, DOI 10.1172/JCI68049; Kurlawalla-Martinez C, 2005, MOL CELL BIOL, V25, P2498, DOI 10.1128/MCB.25.6.2498-2510.2005; Lee JS, 2006, J BONE MINER RES, V21, P921, DOI 10.1359/JBMR.060303; Lee MH, 1996, GENE DEV, V10, P1621, DOI 10.1101/gad.10.13.1621; Levine RA, 2002, VET PATHOL, V39, P372, DOI 10.1354/vp.39-3-372; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liu XM, 2007, P NATL ACAD SCI USA, V104, P2259, DOI 10.1073/pnas.0604153104; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu HR, 2013, J BIOL CHEM, V288, P23833, DOI 10.1074/jbc.M112.447276; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Moriarity BS, 2015, NAT GENET, V47, P615, DOI 10.1038/ng.3293; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Parlee SD, 2014, METHOD ENZYMOL, V537, P93, DOI 10.1016/B978-0-12-411619-1.00006-9; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Sanchez-Gurmaches J, 2012, CELL METAB, V16, P348, DOI 10.1016/j.cmet.2012.08.003; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Thomas DM, 2001, MOL CELL, V8, P303, DOI 10.1016/S1097-2765(01)00327-6; Tiozzo C, 2012, J CLIN INVEST, V122, P3862, DOI 10.1172/JCI61334; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; WADAYAMA B, 1994, CANCER RES, V54, P3042; Walkley CR, 2008, GENE DEV, V22, P1662, DOI 10.1101/gad.1656808; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; Wijesekara N, 2005, MOL CELL BIOL, V25, P1135, DOI 10.1128/MCB.25.3.1135-1145.2005; Wirt SE, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-9; Xie CC, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0360-y; Yang G, 2008, DEVELOPMENT, V135, P3587, DOI 10.1242/dev.028118	46	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136729	10.1371/journal.pone.0136729	http://dx.doi.org/10.1371/journal.pone.0136729			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317218	Green Submitted, Green Published, gold			2022-12-26	WOS:000360299100130
J	Lieblein-Boff, JC; Johnson, EJ; Kennedy, AD; Lai, CS; Kuchan, MJ				Lieblein-Boff, Jacqueline C.; Johnson, Elizabeth J.; Kennedy, Adam D.; Lai, Chron-Si; Kuchan, Matthew J.			Exploratory Metabolomic Analyses Reveal Compounds Correlated with Lutein Concentration in Frontal Cortex, Hippocampus, and Occipital Cortex of Human Infant Brain	PLOS ONE			English	Article							PIGMENT OPTICAL-DENSITY; NERVOUS-SYSTEM MYELINATION; MACULAR PIGMENT; VISUAL-CORTEX; LYSOPHOSPHATIDIC ACID; TAURINE DEPRIVATION; COGNITIVE FUNCTION; OLDER-ADULTS; HOMOCARNOSINE; CAROTENOIDS	Lutein is a dietary carotenoid well known for its role as an antioxidant in the macula, and recent reports implicate a role for lutein in cognitive function. Lutein is the dominant carotenoid in both pediatric and geriatric brain tissue. In addition, cognitive function in older adults correlated with macular and postmortem brain lutein concentrations. Furthermore, lutein was found to preferentially accumulate in the infant brain in comparison to other carotenoids that are predominant in diet. While lutein is consistently related to cognitive function, the mechanisms by which lutein may influence cognition are not clear. In an effort to identify potential mechanisms through which lutein might influence neurodevelopment, an exploratory study relating metabolite signatures and lutein was completed. Post-mortem metabolomic analyses were performed on human infant brain tissues in three regions important for learning and memory: the frontal cortex, hippocampus, and occipital cortex. Metabolomic profiles were compared to lutein concentration, and correlations were identified and reported here. A total of 1276 correlations were carried out across all brain regions. Of 427 metabolites analyzed, 257 were metabolites of known identity. Unidentified metabolite correlations (510) were excluded. In addition, moderate correlations with xenobiotic relationships (2) or those driven by single outliers (3) were excluded from further study. Lutein concentrations correlated with lipid pathway metabolites, energy pathway metabolites, brain osmolytes, amino acid neurotransmitters, and the antioxidant homocarnosine. These correlations were often brain region-specific. Revealing relationships between lutein and metabolic pathways may help identify potential candidates on which to complete further analyses and may shed light on important roles of lutein in the human brain during development.	[Lieblein-Boff, Jacqueline C.; Lai, Chron-Si; Kuchan, Matthew J.] Abbott Nutr, Res & Dev, Columbus, OH 43215 USA; [Johnson, Elizabeth J.] Tufts Univ, Jean Mayer United States Dept Agr, Human Nutr Res Ctr Aging, Antioxidants Res Lab, Boston, MA 02111 USA; [Kennedy, Adam D.] Metabolon Inc, Durham, NC USA	Tufts University; United States Department of Agriculture (USDA); Metabolon	Lieblein-Boff, JC (corresponding author), Abbott Nutr, Res & Dev, Columbus, OH 43215 USA.	jacqueline.boff@abbott.com			Abbott Nutrition; Metabolon, Inc.	Abbott Nutrition(Abbott Laboratories); Metabolon, Inc.	This work was funded by Abbott Nutrition. Co-authors Jacqueline C. Lieblein-Boff, Chron-Si Lai, and Matthew J. Kuchan are employed by Abbott Nutrition, therefore Abbott Nutrition provided support in the form of salaries for authors JCL-B, C-SL, and MJK, and approved the study design and decision to publish initiated by these authors. Co-author Adam D. Kennedy is employed by Metabolon, Inc., which provided salary support to ADK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the "author contributions" section.	ABRAHAM D, 1962, ARCH BIOCHEM BIOPHYS, V99, P210, DOI 10.1016/0003-9861(62)90002-4; Albrecht J, 2005, NEUROCHEM RES, V30, P1615, DOI 10.1007/s11064-005-8986-6; BARBIN G, 1993, NEUROSCI LETT, V152, P150, DOI 10.1016/0304-3940(93)90505-F; Barker FM, 2011, INVEST OPHTH VIS SCI, V52, P3934, DOI 10.1167/iovs.10-5898; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Bian QN, 2012, FREE RADICAL BIO MED, V53, P1298, DOI 10.1016/j.freeradbiomed.2012.06.024; Birdsall T C, 1998, Altern Med Rev, V3, P128; Birgbauer E, 2006, CELL MOL LIFE SCI, V63, P2695, DOI 10.1007/s00018-006-6155-y; BONE RA, 1985, VISION RES, V25, P1531, DOI 10.1016/0042-6989(85)90123-3; BOURRE JM, 1978, NEUROSCI LETT, V7, P225, DOI 10.1016/0304-3940(78)90172-6; Bovier ER, 2015, ARCH BIOCHEM BIOPHYS, V572, P54, DOI 10.1016/j.abb.2014.11.012; Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; BRODY BA, 1987, J NEUROPATH EXP NEUR, V46, P283, DOI 10.1097/00005072-198705000-00005; Cheng JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044106; Dingledine R., 1999, BASIC NEUROCHEMISTRY, V6th; DOBBING J, 1973, ARCH DIS CHILD, V48, P757, DOI 10.1136/adc.48.10.757; Dwyer JH, 2001, CIRCULATION, V103, P2922, DOI 10.1161/01.CIR.103.24.2922; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Feeney J, 2013, NEUROBIOL AGING, V34, P2449, DOI 10.1016/j.neurobiolaging.2013.05.007; Fisher SK, 2002, J NEUROCHEM, V82, P736, DOI 10.1046/j.1471-4159.2002.01041.x; Flint AC, 1998, NEURON, V20, P43, DOI 10.1016/S0896-6273(00)80433-X; Gonzalez S, 2003, J INVEST DERMATOL, V121, P399, DOI 10.1046/j.1523-1747.2003.12355.x; Gossage CP, 2002, AM J CLIN NUTR, V76, P193, DOI 10.1093/ajcn/76.1.193; GREEN TR, 1991, BIOCHIM BIOPHYS ACTA, V1073, P91, DOI 10.1016/0304-4165(91)90187-L; Gruszecki WI, 2005, BBA-MOL BASIS DIS, V1740, P108, DOI 10.1016/j.bbadis.2004.11.015; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Johnson Elizabeth J, 2013, J Aging Res, V2013, P951786, DOI 10.1155/2013/951786; Johnson EJ, 2012, AM J CLIN NUTR, V96, p1161S, DOI 10.3945/ajcn.112.034611; Kingsbury MA, 2003, NAT NEUROSCI, V6, P1292, DOI 10.1038/nn1157; KINNEY HC, 1988, J NEUROPATH EXP NEUR, V47, P217, DOI 10.1097/00005072-198805000-00003; KIRSCHFELD K, 1982, PROC R SOC SER B-BIO, V216, P71, DOI 10.1098/rspb.1982.0061; KOHEN R, 1988, P NATL ACAD SCI USA, V85, P3175, DOI 10.1073/pnas.85.9.3175; Li SY, 2012, NEUROBIOL DIS, V45, P624, DOI 10.1016/j.nbd.2011.10.008; Li SY, 2009, INVEST OPHTH VIS SCI, V50, P836, DOI 10.1167/iovs.08-2310; McNulty H, 2008, AM J CARDIOL, V101, p20D, DOI 10.1016/j.amjcard.2008.02.004; McNulty HP, 2007, BBA-BIOMEMBRANES, V1768, P167, DOI 10.1016/j.bbamem.2006.09.010; NEURINGER M, 1994, ADV EXP MED BIOL, V359, P385; Nogaroli L, 2009, NEUROCHEM RES, V34, P182, DOI 10.1007/s11064-008-9772-z; PALACKAL T, 1986, J NEUROSCI RES, V15, P223, DOI 10.1002/jnr.490150212; Palombo P, 2007, SKIN PHARMACOL PHYS, V20, P199, DOI 10.1159/000101807; Perrone CE, 2012, J NUTRIGENET NUTRIGE, V5, P132, DOI 10.1159/000339347; Perrone S, 2013, BRAIN SUSCEPTIBILITY, DOI [10.3109/14767058.2013.796170, DOI 10.3109/14767058.2013.796170]; Perry A, 2009, J FOOD COMPOS ANAL, V22, P9, DOI 10.1016/j.jfca.2008.07.006; PISANO JJ, 1961, J BIOL CHEM, V236, P499; Renzi LM, 2014, NEUROBIOL AGING, V35, P1695, DOI 10.1016/j.neurobiolaging.2013.12.024; Represa A, 2005, TRENDS NEUROSCI, V28, P278, DOI 10.1016/j.tins.2005.03.010; Rubin LP, 2012, J PERINATOL, V32, P418, DOI 10.1038/jp.2011.87; Schweigert FJ, 2004, EUR J NUTR, V43, P39, DOI 10.1007/s00394-004-0439-5; Sha W, 2010, FASEB J, V24, P2962, DOI 10.1096/fj.09-154054; Shivaraj MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042935; Socaciu C, 2000, CHEM PHYS LIPIDS, V106, P79, DOI 10.1016/S0009-3084(00)00135-3; STURMAN JA, 1994, ADV EXP MED BIOL, V359, P369; Tabakman R, 2002, J NEUROSCI RES, V68, P463, DOI 10.1002/jnr.10228; Tanaka T, 2012, MOLECULES, V17, P3202, DOI 10.3390/molecules17033202; Torkhovskaya TI, 2007, BIOCHEMISTRY-MOSCOW+, V72, P125, DOI 10.1134/S0006297907020010; Vishwanathan R, 2014, J PEDIATR GASTR NUTR, V59, P659, DOI 10.1097/MPG.0000000000000389; Vishwanathan R, 2014, AGE AGEING, V43, P271, DOI 10.1093/ageing/aft210; Vishwanathan R, 2013, NUTR NEUROSCI, V16, P21, DOI 10.1179/1476830512Y.0000000024; WADE JV, 1988, J NEUROCHEM, V51, P740, DOI 10.1111/j.1471-4159.1988.tb01807.x; Wisniewska A, 2003, CELL MOL BIOL LETT, V8, P147; Wisniewska A, 2006, FREE RADICAL BIO MED, V40, P1820, DOI 10.1016/j.freeradbiomed.2006.01.016; Yeum KJ, 1996, AM J CLIN NUTR, V64, P594, DOI 10.1093/ajcn/64.4.594	62	43	46	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136904	10.1371/journal.pone.0136904	http://dx.doi.org/10.1371/journal.pone.0136904			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317757	gold, Green Submitted, Green Published			2022-12-26	WOS:000360299100167
J	Liu, HL; White, J; Crawford, F; Jin, NY; Ju, XW; Liu, KT; Jiang, CY; Marrack, P; Zhang, GY; Kappler, JW				Liu, Haolin; White, Janice; Crawford, Frances; Jin, Niyun; Ju, Xiangwu; Liu, Kangtai; Jiang, Chengyu; Marrack, Philippa; Zhang, Gongyi; Kappler, John W.			A Rapid Method to Characterize Mouse IgG Antibodies and Isolate Native Antigen Binding IgG B Cell Hybridomas	PLOS ONE			English	Article							IMMUNOGLOBULIN; SWITCH; VARIANTS; RECEPTOR	B cell hybridomas are an important source of monoclonal antibodies. In this paper, we developed a high-throughput method to characterize mouse IgG antibodies using surface plasmon resonance technology. This assay rapidly determines their sub-isotypes, whether they bind native antigen and their approximate affinities for the antigen using only 50 mu l of hybridoma cell culture supernatant. Moreover, we found that mouse hybridomas secreting IgG antibodies also have membrane form IgG expression without Ig alpha. Based on this surface IgG, we used flow cytometry to isolate rare gamma 2a isotype switched variants from a gamma 2b antibody secreting hybridoma cell line. Also, we used fluorescent antigen to single cell sort antigen binding hybridoma cells from bulk mixture of fused hybridoma cells instead of the traditional multi-microwell plate screening and limiting dilution sub-cloning thus saving time and labor. The IgG monoclonal antibodies specific for the native antigen identified with these methods are suitable for in vivo therapeutic uses, but also for sandwich ELISA assays, histology, flow cytometry, immune precipitation and x-ray crystallography.	[Liu, Haolin; Crawford, Frances; Jin, Niyun; Marrack, Philippa; Kappler, John W.] Natl Jewish Ctr Immunol & Resp Med, Howard Hughes Med Inst, Denver, CO 80206 USA; [Liu, Haolin; White, Janice; Crawford, Frances; Jin, Niyun; Marrack, Philippa; Zhang, Gongyi; Kappler, John W.] Natl Jewish Hlth, Dept Biomed Res, Denver, CO USA; [Liu, Haolin; White, Janice; Crawford, Frances; Jin, Niyun; Marrack, Philippa; Zhang, Gongyi; Kappler, John W.] Univ Colorado Denver, Dept Immunol & Microbiol, Denver, CO USA; [Ju, Xiangwu; Liu, Kangtai; Jiang, Chengyu] Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, Beijing 100730, Peoples R China	Howard Hughes Medical Institute; National Jewish Health; National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Kappler, JW (corresponding author), Natl Jewish Ctr Immunol & Resp Med, Howard Hughes Med Inst, Denver, CO 80206 USA.	kapplerj@njhealth.org	Marrack, Philippa/AHE-6316-2022	Marrack, Philippa/0000-0003-1883-3687	Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI074491, R01AI018785] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Howard Hughes Medical Institute (to John W. Kappler).	BAUMHACKEL H, 1982, J IMMUNOL, V128, P1217; BERZOFSKY JA, 1976, J IMMUNOL, V116, P270; Bruce SR, 2003, RNA, V9, P1264, DOI 10.1261/rna.5820103; Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008; FAGUET GB, 1993, J IMMUNOL METHODS, V165, P217, DOI 10.1016/0022-1759(93)90347-A; FLASPOHLER JA, 1990, J IMMUNOL, V144, P2802; Hammers CM, 2014, J INVEST DERMATOL, V134, DOI 10.1038/jid.2013.521; Hong X, 2010, P NATL ACAD SCI USA, V107, P14568, DOI 10.1073/pnas.1008832107; Jones LS, 2005, J BIOL CHEM, V280, P13406, DOI 10.1074/jbc.M500687200; Karlsson R, 1997, J IMMUNOL METHODS, V200, P121, DOI 10.1016/S0022-1759(96)00195-0; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kovari LC, 1995, STRUCTURE, V3, P1291, DOI 10.1016/S0969-2126(01)00266-0; LIESEGANG B, 1978, P NATL ACAD SCI USA, V75, P3901, DOI 10.1073/pnas.75.8.3901; Morrison SJ, 1997, DEVELOPMENT, V124, P1929; NEUBERGER MS, 1981, P NATL ACAD SCI-BIOL, V78, P1138, DOI 10.1073/pnas.78.2.1138; Price PW, 2009, J IMMUNOL METHODS, V343, P28, DOI 10.1016/j.jim.2009.01.005; SCHWAB C, 1992, J IMMUNOL METHODS, V147, P125, DOI 10.1016/S0022-1759(12)80037-8; VENKITARAMAN AR, 1991, NATURE, V352, P777, DOI 10.1038/352777a0; Wang HL, 2008, CELL RES, V18, P290, DOI 10.1038/cr.2008.15; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245	20	8	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136613	10.1371/journal.pone.0136613	http://dx.doi.org/10.1371/journal.pone.0136613			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317987	gold, Green Published, Green Submitted			2022-12-26	WOS:000360299100113
J	Mikosik, A; Henc, I; Ruckemann-Dziurdzinska, K; Ckowiak, JEF; Ploszynska, A; Balcerska, A; Bryl, E; Witkowski, JM				Mikosik, Anna; Henc, Izabella; Ruckemann-Dziurdzinska, Katarzyna; Ckowiak, Joanna E. Fr; Ploszynska, Anna; Balcerska, Anna; Bryl, Ewa; Witkowski, Jacek M.			Increased mu-Calpain Activity in Blasts of Common B-Precursor Childhood Acute Lymphoblastic Leukemia Correlates with Their Lower Susceptibility to Apoptosis	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; CELL-DEATH; CONVENTIONAL CALPAINS; LYMPHOMA-CELLS; BONE-MARROW; C-MYC; CALPASTATIN; EXPRESSION; ACTIVATION; INDUCTION	Childhood acute lymphoblastic leukemia (ALL) blasts are characterized by inhibited apoptosis promoting fast disease progress. It is known that in chronic lymphocytic and acute myeloid leukemias the reduced apoptosis is strongly related with the activity of calpain-calpastatin system (CCS) composed of cytoplasmic proteases-calpains-performing the modulatory proteolysis of key proteins involved in cell proliferation and apoptosis, and of their endogenous inhibitor-calpastatin. Here, the CCS protein abundance and activity was for the first time studied in childhood ALL blasts and in control bone marrow CD19(+) B cells by semi-quantitative flow cytometry and western blotting of calpastatin fragments resulting from endogenous calpain activity. Significantly higher mu-calpain (CAPN1) gene transcription, protein amounts and activity (but not those of m-calpain), with calpastatin amount and transcription of its gene (CAST) greatly varying were observed in CD19(+) ALL blasts compared to control cells. Significant inverse relation between the amount/activity of calpain and spontaneous apoptosis was noted. Patients older than 10 years (considered at higher risk) displayed increased amounts and activities of blast calpain. Finally, treatment of blasts with the tripeptide calpain inhibitors II and IV significantly and in dose-dependent fashion increased the percentage of blasts entering apoptosis. Together, these findings make the CCS a potential new predictive tool and therapeutic target in childhood ALL.	[Mikosik, Anna; Ckowiak, Joanna E. Fr; Witkowski, Jacek M.] Med Univ Gdansk, Dept Pathophysiol, Gdansk, Poland; [Henc, Izabella; Ruckemann-Dziurdzinska, Katarzyna; Bryl, Ewa] Med Univ Gdansk, Dept Pathol & Expt Rheumatol, Gdansk, Poland; [Ploszynska, Anna; Balcerska, Anna] Med Univ Gdansk, Clin Pediat Hematol & Oncol, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk	Witkowski, JM (corresponding author), Med Univ Gdansk, Dept Pathophysiol, Gdansk, Poland.	jawit@gumed.edu.pl	Bzoma, Izabella/AAE-3704-2020; Witkowski, Jacek M./B-8488-2013	Bzoma, Izabella/0000-0001-7417-4810; Witkowski, Jacek M./0000-0003-2906-1109; Mikosik-Roczynska, Anna/0000-0002-7211-1514; Bryl, Ewa/0000-0002-1410-4287; Ruckemann-Dziurdzinska, Katarzyna/0000-0002-5018-0818	Polish Ministry of Science and Higher Education [2 P05E 103 30, 02-0058/07/262]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by Polish Ministry of Science and Higher Education grant No 2 P05E 103 30 (to AP) and by a statutory (ST-58) grant from Polish Ministry of Science and Higher Education 02-0058/07/262 (to JMW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo A, 2000, BLOOD, V96, P2240, DOI 10.1182/blood.V96.6.2240.h8002240_2240_2245; Bedner E, 1999, CYTOMETRY, V35, P181, DOI 10.1002/(SICI)1097-0320(19990301)35:3<181::AID-CYTO1>3.0.CO;2-5; BERGER R, 1992, CANCER GENET CYTOGEN, V61, P201, DOI 10.1016/0165-4608(92)90087-O; Bhojwani D, 2013, LANCET ONCOL, V14, pE205, DOI 10.1016/S1470-2045(12)70580-6; Melo RDC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085926; Catusse J, 2010, J CELL PHYSIOL, V225, P792, DOI 10.1002/jcp.22284; Cheng G, 2003, PHARMACOL RES, V48, P571, DOI 10.1016/S1043-6618(03)00245-7; Choi J, 2007, BLOOD, V109, P471, DOI 10.1182/blood-2006-07-032557; Chua BT, 2000, J BIOL CHEM, V275, P5131, DOI 10.1074/jbc.275.7.5131; Feldhahn N, 2005, J EXP MED, V201, P1837, DOI 10.1084/jem.20042101; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Fulda S, 2009, BRIT J HAEMATOL, V145, P441, DOI 10.1111/j.1365-2141.2009.07603.x; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; GUROFF G, 1964, J BIOL CHEM, V239, P149; Hanna RA, 2008, NATURE, V456, P409, DOI 10.1038/nature07451; Hochberg J, 2013, BRIT J HAEMATOL, V161, P27, DOI 10.1111/bjh.12239; Hunger SP, 2011, PEDIATR BLOOD CANCER, V56, P984, DOI 10.1002/pbc.22996; JOHANSSON B, 1994, LEUKEMIA, V8, P953; Kaminskyy V, 2008, TOXICOL LETT, V177, P168, DOI 10.1016/j.toxlet.2008.01.009; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Leloup L, 2011, EXPERT OPIN THER TAR, V15, P309, DOI 10.1517/14728222.2011.553611; Li HB, 2012, EXP HEMATOL, V40, P548, DOI 10.1016/j.exphem.2012.02.002; Lin CW, 2002, LEUKEMIA RES, V26, P551, DOI 10.1016/S0145-2126(01)00170-9; Lo Nigro L, 2013, J PEDIAT HEMATOL ONC, V35, P245, DOI 10.1097/MPH.0b013e31828f8746; Loncarevic IF, 1999, GENE CHROMOSOME CANC, V24, P272, DOI 10.1002/(SICI)1098-2264(199903)24:3<272::AID-GCC13>3.3.CO;2-L; Lopatniuk P, 2011, ACTA BIOCHIM POL, V58, P287; Lu T, 2002, BBA-MOL CELL RES, V1590, P16, DOI 10.1016/S0167-4889(02)00193-3; Lucio P, 1999, LEUKEMIA, V13, P419, DOI 10.1038/sj.leu.2401279; Malempati S, 2006, LEUKEMIA, V20, P1572, DOI 10.1038/sj.leu.2404317; Mikosik A, 2007, FOLIA HISTOCHEM CYTO, V45, P343; Mikosik A, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-27; Mittal MK, 2007, PEDIATR EMERG CARE, V23, P397, DOI 10.1097/01.pec.0000278391.94634.95; Momeni HR, 2011, CELL J, V13, P65; MORRISJONES PH, 1990, ARCH DIS CHILD, V65, P638, DOI 10.1136/adc.65.6.638; Mowafi F, 2008, PEDIATR BLOOD CANCER, V50, P812, DOI 10.1002/pbc.21370; Nakagawa Y, 2004, LEUKEMIA RES, V28, P487, DOI 10.1016/j.leukres.2003.10.013; Niapour M, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2011.50; Niapour M, 2008, J BIOL CHEM, V283, P21371, DOI 10.1074/jbc.M801462200; Panzer-Grumayer ER, 2000, BLOOD, V95, P790, DOI 10.1182/blood.V95.3.790.003k48_790_794; Pegahi R, 2005, EUR CYTOKINE NETW, V16, P223; Ploszynska A, 2012, FOLIA HISTOCHEM CYTO, V50, P304, DOI 10.5603/FHC.2012.0040; Porn-Ares MI, 1998, CELL DEATH DIFFER, V5, P1028, DOI 10.1038/sj.cdd.4400424; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Pui CH, 2007, NAT REV DRUG DISCOV, V6, P149, DOI 10.1038/nrd2240; Pui CH, 2010, J FORMOS MED ASSOC, V109, P777, DOI 10.1016/S0929-6646(10)60123-4; Pui CH, 2009, NEW ENGL J MED, V360, P2730, DOI 10.1056/NEJMoa0900386; Reverter D, 2001, TRENDS CARDIOVAS MED, V11, P222, DOI 10.1016/S1050-1738(01)00112-8; Sanchez-Sanchez F, 2007, J BIOL CHEM, V282, P27810, DOI 10.1074/jbc.M609608200; SCHWARZBENMEIR N, 1994, BIOCHEM J, V304, P365, DOI 10.1042/bj3040365; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Smith TPL, 2001, J ANIM SCI, V79, P552; Sorimachi H, 1997, BIOCHEM J, V328, P721, DOI 10.1042/bj3280721; Sorimachi H, 2011, P JPN ACAD B-PHYS, V87, P287, DOI 10.2183/pjab.87.287; South ST, 2006, CANCER GENET CYTOGEN, V168, P177, DOI 10.1016/j.cancergencyto.2005.12.005; Storr SJ, 2011, NAT REV CANCER, V11, P364, DOI 10.1038/nrc3050; Tan Y, 2006, J BIOL CHEM, V281, P17689, DOI 10.1074/jbc.M601978200; Tompa P, 2002, J BIOL CHEM, V277, P9022, DOI 10.1074/jbc.C100700200; Trehan A, 2009, J PEDIAT HEMATOL ONC, V31, P424, DOI 10.1097/MPH.0b013e3181a1c12b; Volm H, 1999, ANTICANCER RES, V19, P4327; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Witkowski JM, 2002, BLOOD, V100, P1802, DOI 10.1182/blood-2001-11-0073; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Zhu DM, 2000, CLIN CANCER RES, V6, P2456	63	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136615	10.1371/journal.pone.0136615	http://dx.doi.org/10.1371/journal.pone.0136615			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317226	gold, Green Published, Green Submitted			2022-12-26	WOS:000360299100114
J	Simpson-Abelson, MR; Childs, EE; Ferreira, MC; Bishu, S; Conti, HR; Gaffen, SL				Simpson-Abelson, Michelle R.; Childs, Erin E.; Ferreira, M. Carolina; Bishu, Shrinivas; Conti, Heather R.; Gaffen, Sarah L.			C/EBP beta Promotes Immunity to Oral Candidiasis through Regulation of beta-Defensins	PLOS ONE			English	Article							NF-KAPPA-B; CHRONIC MUCOCUTANEOUS CANDIDIASIS; IL-17 RECEPTOR; TH17 CELLS; SEQUENTIAL PHOSPHORYLATION; BETA-DEFENSIN-2 EXPRESSION; OROPHARYNGEAL CANDIDIASIS; SIGNAL-TRANSDUCTION; AIRWAY EPITHELIUM; ALBICANS	Humans or mice subjected to immunosuppression, such as corticosteroids or anti-cytokine biologic therapies, are susceptible to mucosal infections by the commensal fungus Candida albicans. Recently it has become evident that the Th17/IL-17 axis is essential for immunity to candidiasis, but the downstream events that control immunity to this fungus are poorly understood. The CCAAT/Enhancer Binding Protein-beta (C/EBP beta) transcription factor is important for signaling by multiple inflammatory stimuli, including IL-17. C/EBP beta is regulated in a variety of ways by IL-17, and controls several downstream IL-17 target genes. However, the role of C/EBP beta in vivo is poorly understood, in part because C/EBP beta-deficient mice are challenging to breed and work with. In this study, we sought to understand the role of C/EBP beta in the context of an IL-17-dependent immune response, using C. albicans infection as a model system. Confirming prior findings, we found that C/EBP beta is required for immunity to systemic candidiasis. In contrast, C/EBP beta(-/-) mice were resistant to oropharyngeal candidiasis (OPC), in a manner indistinguishable from immunocompetent WT mice. However, C/EBP beta(-/-) mice experienced more severe OPC than WT mice in the context of cortisone-induced immunosuppression. Expression of the antimicrobial peptide beta-defensin (BD)-3 correlated strongly with susceptibility in C/EBP beta(-/-) mice, but no other IL-17-dependent genes were associated with susceptibility. Therefore, C/EBP beta contributes to immunity to mucosal candidiasis during cortisone immunosuppression in a manner linked to beta-defensin 3 expression, but is apparently dispensable for the IL-17-dependent response.	[Simpson-Abelson, Michelle R.; Childs, Erin E.; Ferreira, M. Carolina; Bishu, Shrinivas; Conti, Heather R.; Gaffen, Sarah L.] Univ Pittsburgh, Div Rheumatol & Clin Immunol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gaffen, SL (corresponding author), Univ Pittsburgh, Div Rheumatol & Clin Immunol, Pittsburgh, PA 15260 USA.	sarah.gaffen@pitt.edu	Bishu, Shrinivas/S-6084-2019	Bishu, Shrinivas/0000-0003-4823-5805; Ferreira dos Santos, Maria/0000-0003-0231-6538	NIH [DE022550, DE023815, AI107825, F32-AI098423]; Arthritis Foundation;  [F32-DE023293]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI098423, R01AI107825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022550, R01DE023815, F32DE023293] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	SLG was supported by NIH grants DE022550, DE023815 and AI107825. MSA was supported by the Arthritis Foundation and NIH grant F32-AI098423. HRC was supported by F32-DE023293. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Boisson B, 2013, IMMUNITY, V39, P676, DOI 10.1016/j.immuni.2013.09.002; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Browne SK, 2010, CURR OPIN ALLERGY CL, V10, P534, DOI 10.1097/ACI.0b013e3283402b41; Conti HR, 2011, MUCOSAL IMMUNOL, V4, P448, DOI 10.1038/mi.2011.5; Conti Heather R, 2014, Curr Protoc Immunol, V105, DOI 10.1002/0471142735.im1906s105; Conti HR, 2014, J EXP MED, V211, P2075, DOI 10.1084/jem.20130877; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Cortez DM, 2007, AM J PHYSIOL-HEART C, V293, pH3356, DOI 10.1152/ajpheart.00928.2007; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Feng Z, 2005, J DENT RES, V84, P445, DOI 10.1177/154405910508400509; Ferreira MC, 2014, INFECT IMMUN, V82, P1030, DOI 10.1128/IAI.01389-13; Fidel P L Jr, 2011, Adv Dent Res, V23, P45, DOI 10.1177/0022034511399284; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Hernandez-Santos N, 2013, MUCOSAL IMMUNOL, V6, P900, DOI 10.1038/mi.2012.128; Hernandez-Santos N, 2012, CELL HOST MICROBE, V11, P425, DOI 10.1016/j.chom.2012.04.008; Ho AW, 2010, J IMMUNOL, V185, P1063, DOI 10.4049/jimmunol.0903739; Huang F, 2007, J IMMUNOL, V179, P6504, DOI 10.4049/jimmunol.179.10.6504; Huber R, 2012, CELL SIGNAL, V24, P1287, DOI 10.1016/j.cellsig.2012.02.007; Huppler AR, 2014, J IMMUNOL, V192, P1745, DOI 10.4049/jimmunol.1302265; Huppler AR, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3893; Jurevic RJ, 2003, J CLIN MICROBIOL, V41, P90, DOI 10.1128/JCM.41.1.90-96.2003; Kamai Y, 2001, ANTIMICROB AGENTS CH, V45, P3195, DOI 10.1128/AAC.45.11.3195-3197.2001; Kao CY, 2008, J BIOL CHEM, V283, P15309, DOI [10.1074/jbc.M708289200, 10.1074/jbc.M804331200]; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Lee AYS, 2015, CYTOKINE, V72, P97, DOI 10.1016/j.cyto.2014.11.029; Liu Y, 2015, GENOME RES; Lu Q, 2006, J INVEST DERMATOL, V126, P2049, DOI 10.1038/sj.jid.5700346; Maitra A, 2007, P NATL ACAD SCI USA, V104, P7506, DOI 10.1073/pnas.0611589104; Mathews M, 1999, INFECT IMMUN, V67, P2740, DOI 10.1128/IAI.67.6.2740-2745.1999; Milner JD, 2013, NAT REV IMMUNOL, V13, P635, DOI 10.1038/nri3493; Pandiyan P, 2014, BIOL PROCED ONLINE, V16, DOI 10.1186/1480-9222-16-4; Patel DN, 2007, J BIOL CHEM, V282, P27229, DOI 10.1074/jbc.M703250200; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Puel A, 2010, CURR OPIN IMMUNOL, V22, P467, DOI 10.1016/j.coi.2010.06.009; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Ruddy MJ, 2004, J BIOL CHEM, V279, P2559, DOI 10.1074/jbc.M308809200; Schofield DA, 2004, J INFECT DIS, V190, P1327, DOI 10.1086/423856; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Shen F, 2008, CYTOKINE, V41, P92, DOI 10.1016/j.cyto.2007.11.013; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; Shen F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000066; Solis NV, 2012, NAT PROTOC, V7, P637, DOI 10.1038/nprot.2012.011; Suarez-Carmona M, 2014, CYTOKINE GROWTH FACT; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102; Tomalka J, 2015, J IMMUNOL, V194, P1788, DOI 10.4049/jimmunol.1203239; Tsukada J, 2011, CYTOKINE, V54, P6, DOI 10.1016/j.cyto.2010.12.019; Uematsu S, 2007, J IMMUNOL, V179, P5378, DOI 10.4049/jimmunol.179.8.5378; Whibley N, 2014, EUR J IMMUNOL, V44, P1069, DOI 10.1002/eji.201343604; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525	51	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136538	10.1371/journal.pone.0136538	http://dx.doi.org/10.1371/journal.pone.0136538			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317211	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000360299100098
J	Sugiyama, T; Pramanik, MK; Yumura, S				Sugiyama, Tatsuroh; Pramanik, Md. Kamruzzaman; Yumura, Shigehiko			Microtubule-Mediated Inositol Lipid Signaling Plays Critical Roles in Regulation of Blebbing	PLOS ONE			English	Article							DICTYOSTELIUM CELLS; PLASMA-MEMBRANE; MYOSIN-II; ZEBRAFISH GASTRULATION; EUKARYOTIC CHEMOTAXIS; AMEBOID MOVEMENT; DISTINCT MODES; MIGRATION; ACTIN; MOTILITY	Cells migrate by extending pseudopods such as lamellipodia and blebs. Although the signals leading to lamellipodia extension have been extensively investigated, those for bleb extension remain unclear. Here, we investigated signals for blebbing in Dictyostelium cells using a newly developed assay to induce blebbing. When cells were cut into two pieces with a microneedle, the anucleate fragments vigorously extended blebs. This assay enabled us to induce blebbing reproducibly, and analyses of knockout mutants and specific inhibitors identified candidate molecules that regulate blebbing. Blebs were also induced in anucleate fragments of leukocytes, indicating that this assay is generally applicable to animal cells. After cutting, microtubules in the anucleate fragments promptly depolymerized, followed by the extension of blebs. Furthermore, when intact cells were treated with a microtubule inhibitor, they frequently extended blebs. The depolymerization of microtubules induced the delocalization of inositol lipid phosphatidylinositol 3,4,5-trisphosphate from the cell membrane. PI3 kinase-null cells frequently extended blebs, whereas PTEN-null cells extended fewer blebs. From these observations, we propose a model in which microtubules play a critical role in bleb regulation via inositol lipid metabolism.	[Sugiyama, Tatsuroh; Pramanik, Md. Kamruzzaman; Yumura, Shigehiko] Yamaguchi Univ, Grad Sch Med, Dept Funct Mol Biol, Yamaguchi, Japan; [Pramanik, Md. Kamruzzaman] Bangladesh Atom Energy Commiss, Microbiol & Ind Irradiat Div, IFRB, AERE, Dhaka, Bangladesh	Yamaguchi University	Yumura, S (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Funct Mol Biol, Yamaguchi, Japan.	yumura@yamaguchi-u.ac.jp	yumura, shigehiko/E-8672-2013	yumura, shigehiko/0000-0001-8249-0100; Pramanik, Md Kamruzzaman/0000-0002-7332-3316				Bergert M, 2012, P NATL ACAD SCI USA, V109, P14434, DOI 10.1073/pnas.1207968109; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Derivery E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002462; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; Diz-Munoz A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000544; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; FINK RD, 1988, DEV BIOL, V129, P179, DOI 10.1016/0012-1606(88)90172-8; Funamoto S, 2001, J CELL BIOL, V153, P795, DOI 10.1083/jcb.153.4.795; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Gadea G, 2007, J CELL BIOL, V178, P23, DOI 10.1083/jcb.200701120; Hoeller O, 2007, CURR BIOL, V17, P813, DOI 10.1016/j.cub.2007.04.004; Iijima M, 2004, J BIOL CHEM, V279, P16606, DOI 10.1074/jbc.M312098200; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Insall R, 2013, CURR OPIN CELL BIOL, V25, P526, DOI 10.1016/j.ceb.2013.04.009; Itoh G, 2007, J CELL SCI, V120, P4302, DOI 10.1242/jcs.015875; Janetopoulos C, 2005, DEV CELL, V8, P467, DOI 10.1016/j.devcel.2005.02.010; Kelly CV, 2009, J BIOL PHYS, V35, P279, DOI 10.1007/s10867-009-9167-7; King JS, 2010, J CELL SCI, V123, P2246, DOI 10.1242/jcs.063735; KITANISHI T, 1984, PROTOPLASMA, V120, P185, DOI 10.1007/BF01282599; KURIYAMA R, 1982, CELL MOTIL CYTOSKEL, V2, P257, DOI 10.1002/cm.970020306; Langridye PD, 2006, EXP CELL RES, V312, P2009, DOI 10.1016/j.yexcr.2006.03.007; Loomis WF, 2014, DEV BIOL, V391, P1, DOI 10.1016/j.ydbio.2014.04.001; Paluch EK, 2013, CURR OPIN CELL BIOL, V25, P582, DOI 10.1016/j.ceb.2013.05.005; Petrie RJ, 2012, J CELL BIOL, V197, P439, DOI 10.1083/jcb.201201124; Pierini LM, 2003, CURR PROTOC CELL BIO; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; Pletjushkina OJ, 2001, CELL MOTIL CYTOSKEL, V48, P235, DOI 10.1002/cm.1012.abs; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pramanik MK, 2009, GENES CELLS, V14, P821, DOI 10.1111/j.1365-2443.2009.01312.x; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Rehberg M, 2005, MOL BIOL CELL, V16, P2759, DOI 10.1091/mbc.E05-01-0069; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Shiratsuchi A, 2002, J BIOCHEM, V132, P381, DOI 10.1093/oxfordjournals.jbchem.a003233; Sixt M, 2012, J CELL BIOL, V197, P346, DOI 10.1083/jcb.201204039; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; SWANSON JA, 1982, CELL, V28, P225, DOI 10.1016/0092-8674(82)90340-3; Tang L, 2008, GENE DEV, V22, P2278, DOI 10.1101/gad.1694508; Tarbashevich K, 2011, DEV BIOL, V349, P169, DOI 10.1016/j.ydbio.2010.10.016; Tinevez JY, 2009, P NATL ACAD SCI USA, V106, P18581, DOI 10.1073/pnas.0903353106; Tournaviti S, 2007, J CELL SCI, V120, P3820, DOI 10.1242/jcs.011130; Tvorogova A V, 2012, Tsitologiia, V54, P742; Van Haastert PJM, 2010, J CELL SCI, V123, P3031, DOI 10.1242/jcs.071118; Vidali L, 2006, MOL BIOL CELL, V17, P2377, DOI 10.1091/mbc.e05-10-0955; Wang Y, 2011, DEV GROWTH DIFFER, V53, P495, DOI 10.1111/j.1440-169X.2011.01265.x; Weiser DC, 2007, GENE DEV, V21, P1559, DOI 10.1101/gad.1535007; Weiser DC, 2009, DEVELOPMENT, V136, P2375, DOI 10.1242/dev.034892; Yoshida K, 2006, J CELL SCI, V119, P3833, DOI 10.1242/jcs.03152; YUMURA S, 1984, J CELL BIOL, V99, P894, DOI 10.1083/jcb.99.3.894; Yumura S, 1998, J CELL SCI, V111, P2097; YUMURA S, 1992, J CELL BIOL, V117, P1231, DOI 10.1083/jcb.117.6.1231; Yumura S, 2003, INT REV CYTOL, V224, P173, DOI 10.1016/S0074-7696(05)24005-6; Yumura S, 2001, J CELL BIOL, V154, P137, DOI 10.1083/jcb.200011013; YUMURA S, 1995, CELL STRUCT FUNCT, V20, P185, DOI 10.1247/csf.20.185; Zatulovskiy E, 2014, J CELL BIOL, V204, P1027, DOI 10.1083/jcb.201306147; Zhao SY, 2014, FEBS OPEN BIO, V4, P190, DOI 10.1016/j.fob.2014.02.003; Zhou QQ, 2010, CURR BIOL, V20, P1881, DOI 10.1016/j.cub.2010.09.048	58	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137032	10.1371/journal.pone.0137032	http://dx.doi.org/10.1371/journal.pone.0137032			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317626	gold, Green Submitted, Green Published			2022-12-26	WOS:000360299100198
J	Lei, HY; Zhou, XL; Ruan, ZR; Sun, WC; Eriani, G; Wang, ED				Lei, Hui-Yan; Zhou, Xiao-Long; Ruan, Zhi-Rong; Sun, Wei-Cheng; Eriani, Gilbert; Wang, En-Duo			Calpain Cleaves Most Components in the Multiple Aminoacyl-tRNA Synthetase Complex and Affects Their Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MESSENGER-RNA; P43 COMPONENT; TRANSLATION; AUTOPHAGY; ACTIVATION; EXPRESSION; APOPTOSIS; MTOR; DIFFERENTIATION	Nine aminoacyl-tRNA synthetases (aaRSs) and three scaffold proteins form a super multiple aminoacyl-tRNA synthetase complex (MSC) in the human cytoplasm. Domains that have been added progressively to MSC components during evolution are linked by unstructured flexible peptides, producing an elongated and multiarmed MSC structure that is easily attacked by proteases in vivo. A yeast two-hybrid screen for proteins interacting with LeuRS, a representative MSC member, identified calpain 2, a calcium-activated neutral cysteine protease. Calpain 2 and calpain 1 could partially hydrolyze most MSC components to generate specific fragments that resembled those reported previously. The cleavage sites of calpain in ArgRS, GlnRS, and p43 were precisely mapped. After cleavage, their N-terminal regions were removed. Sixty-three amino acid residues were removed from the N terminus of ArgRS to form ArgRS Delta N63; GlnRS formed GlnRS Delta N198, and p43 formed p43 Delta N106. GlnRS Delta N198 had a much weaker affinity for its substrates, tRNA(Gln) and glutamine. p43 Delta N106 was the same as the previously reported p43-derived apoptosis-released factor. The formation of p43 Delta N106 by calpain depended on Ca2+ and could be specifically inhibited by calpeptin and by RNAi of the regulatory subunit of calpain in vivo. These results showed, for the first time, that calpain plays an essential role in dissociating the MSC and might regulate the canonical and non-canonical functions of certain components of the MSC.	[Lei, Hui-Yan; Zhou, Xiao-Long; Ruan, Zhi-Rong; Sun, Wei-Cheng; Wang, En-Duo] Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Lei, Hui-Yan; Zhou, Xiao-Long; Ruan, Zhi-Rong; Sun, Wei-Cheng; Wang, En-Duo] Univ Chinese Acad Sci, Beijing 100039, Peoples R China; [Sun, Wei-Cheng; Wang, En-Duo] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China; [Eriani, Gilbert] Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & Reactivite ARN,UPR9002, F-67084 Strasbourg, France	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; ShanghaiTech University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Wang, ED (corresponding author), Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, State Key Lab Mol Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	edwang@sibcb.ac.cn	Ruan, Zhi-Rong/GYI-8935-2022	Eriani, Gilbert/0000-0002-8518-4675; Ruan, Zhi-Rong/0000-0002-1806-2942; Lei, Huiyan/0000-0001-8274-7690	National Key Basic Research Foundation of China [2012CB911000]; National Natural Science Foundation of China [31130064, 91440204]; Committee of Science and Technology in Shanghai Grant [12JC1409700]	National Key Basic Research Foundation of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Committee of Science and Technology in Shanghai Grant	This work was supported by National Key Basic Research Foundation of China Grant 2012CB911000, National Natural Science Foundation of China Grants 31130064 and 91440204, and Committee of Science and Technology in Shanghai Grant 12JC1409700. The authors declare that they have no conflicts of interest with the contents of this article.	Beltran L, 2011, P NATL ACAD SCI USA, V108, P16217, DOI 10.1073/pnas.1107692108; Bonfils G, 2012, MOL CELL, V46, P105, DOI 10.1016/j.molcel.2012.02.009; Chakraborti S, 2012, INDIAN J BIOCHEM BIO, V49, P316; Choi JW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001351; Chondrogianni N, 2015, AGEING RES REV, V23, P37, DOI 10.1016/j.arr.2014.12.003; Conacci-Sorrell M, 2010, CELL, V142, P480, DOI 10.1016/j.cell.2010.06.037; Decuypere JP, 2011, AUTOPHAGY, V7, P1472, DOI 10.4161/auto.7.12.17909; Demarchi F, 2006, J CELL BIOL, V175, P595, DOI 10.1083/jcb.200601024; DENNEY RM, 1977, ARCH BIOCHEM BIOPHYS, V183, P156, DOI 10.1016/0003-9861(77)90430-1; DEUTSCHER MP, 1984, J CELL BIOL, V99, P373, DOI 10.1083/jcb.99.2.373; Dias J, 2013, J BIOL CHEM, V288, P23979, DOI 10.1074/jbc.M113.489922; ESCALANTE C, 1993, J BIOL CHEM, V268, P6014; Fu YY, 2014, P NATL ACAD SCI USA, V111, P15084, DOI 10.1073/pnas.1408836111; Grant TD, 2012, NUCLEIC ACIDS RES, V40, P3723, DOI 10.1093/nar/gkr1223; Guo M, 2014, TOP CURR CHEM, V344, P89, DOI 10.1007/128_2013_424; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hata S, 2012, J BIOCHEM, V151, P417, DOI 10.1093/jb/mvs002; Kaminska M, 2009, J BIOL CHEM, V284, P6053, DOI 10.1074/jbc.M809636200; Kim JH, 2014, J CELL SCI, V127, P4483, DOI 10.1242/jcs.154930; Kim JH, 2014, TOP CURR CHEM, V344, P119, DOI 10.1007/128_2013_479; Kim K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081734; Ko YG, 2001, J BIOL CHEM, V276, P23028, DOI 10.1074/jbc.M101544200; Ko YG, 2001, J BIOL CHEM, V276, P6030, DOI 10.1074/jbc.M006189200; Ledoux S, 2008, METHODS, V44, P74, DOI 10.1016/j.ymeth.2007.08.001; Ling C, 2005, J BIOL CHEM, V280, P34755, DOI 10.1074/jbc.M413511200; Medina DL, 2015, NAT CELL BIOL, V17, P288, DOI 10.1038/ncb3114; Mellgren R. L., 1990, INTRACELLULAR CALCIU, P91; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; NORCUM MT, 1989, J BIOL CHEM, V264, P15043; Park MC, 2012, P NATL ACAD SCI USA, V109, pE640, DOI 10.1073/pnas.1200194109; Perona JJ, 2014, TOP CURR CHEM, V344, P1, DOI 10.1007/128_2013_456; Quevillon S, 1997, J BIOL CHEM, V272, P32573, DOI 10.1074/jbc.272.51.32573; Ray PS, 2007, TRENDS BIOCHEM SCI, V32, P158, DOI 10.1016/j.tibs.2007.02.003; Sajish M, 2015, NATURE, V519, P370, DOI 10.1038/nature14028; Shalak V, 2001, J BIOL CHEM, V276, P23769, DOI 10.1074/jbc.M100489200; Shalak V, 2007, J BIOL CHEM, V282, P10935, DOI 10.1074/jbc.M611737200; Shalini S, 2015, CELL DEATH DIFFER, V22, P526, DOI 10.1038/cdd.2014.216; Sorimachi H, 2011, P JPN ACAD B-PHYS, V87, P287, DOI 10.2183/pjab.87.287; Tan Y, 2006, J BIOL CHEM, V281, P17689, DOI 10.1074/jbc.M601978200; Vosler PS, 2011, P NATL ACAD SCI USA, V108, P18102, DOI 10.1073/pnas.1112635108; Wang CF, 2012, MOL CELL BIOL, V32, P3321, DOI 10.1128/MCB.00296-12; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Yang F, 2014, J BIOL CHEM, V289, P20953, DOI 10.1074/jbc.M114.562454; Yao P, 2014, TOP CURR CHEM, V344, P167, DOI 10.1007/128_2013_422; Yao P, 2012, CELL, V149, P88, DOI 10.1016/j.cell.2012.02.018; Zheng YG, 2006, BIOCHEMISTRY-US, V45, P1338, DOI 10.1021/bi051675n; Zhou XL, 2008, J BIOL CHEM, V283, P36608, DOI 10.1074/jbc.M806745200	50	8	8	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26314	26327		10.1074/jbc.M115.681999	http://dx.doi.org/10.1074/jbc.M115.681999			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26324710	Green Published, hybrid			2022-12-26	WOS:000363527300047
J	Jastrzebska, B; Chen, YY; Orban, T; Jin, H; Hofmann, L; Palczewski, K				Jastrzebska, Beata; Chen, Yuanyuan; Orban, Tivadar; Jin, Hui; Hofmann, Lukas; Palczewski, Krzysztof			Disruption of Rhodopsin Dimerization with Synthetic Peptides Targeting an Interaction Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; CRYSTAL-STRUCTURE; TRANSMEMBRANE PEPTIDES; TRANSDUCIN INTERACTION; PROJECTION STRUCTURE; OPIOID RECEPTOR; GPCR; OLIGOMERIZATION; DIMERS; ACTIVATION	Although homo- and heterodimerizations of G protein-coupled receptors (GPCRs) are well documented, GPCR monomers are able to assemble in different ways, thus causing variations in the interactive interface between receptor monomers among different GPCRs. Moreover, the functional consequences of this phenomenon, which remain to be clarified, could be specific for different GPCRs. Synthetic peptides derived from transmembrane (TM) domains can interact with a full-length GPCR, blocking dimer formation and affecting its function. Here we used peptides corresponding to TM helices of bovine rhodopsin (Rho) to investigate the Rho dimer interface and functional consequences of its disruption. Incubation of Rho with TM1, TM2, TM4, and TM5 peptides in rod outer segment (ROS) membranes shifted the resulting detergent-solubilized protein migration through a gel filtration column toward smaller molecular masses with a reduced propensity for dimer formation in a cross-linking reaction. Binding of these TM peptides to Rho was characterized by both mass spectrometry and a label-free assay from which dissociation constants were calculated. A BRET (bioluminescence resonance energy transfer) assay revealed that the physical interaction between Rho molecules expressed in membranes of living cells was blocked by the same four TM peptides identified in our in vitro experiments. Although disruption of the Rho dimer/oligomer had no effect on the rates of G protein activation, binding of G(t) to the activated receptor stabilized the dimer. However, TM peptide-induced disruption of dimer/oligomer decreased receptor stability, suggesting that Rho supramolecular organization could be essential for ROS stabilization and receptor trafficking.	[Jastrzebska, Beata; Chen, Yuanyuan; Orban, Tivadar; Jin, Hui; Hofmann, Lukas; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University	Jastrzebska, B (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	bxj27@case.edu; kxp65@case.edu	Regan, Clinton/E-6250-2012; Hofmann, Lukas/AAN-2880-2021	Hofmann, Lukas/0000-0003-0157-0526; Chen, Yuanyuan/0000-0001-9625-1610	National Institutes of Health [EY008061, EY019478]; Swiss National Science Foundation [P1SKP3_158634]; NATIONAL EYE INSTITUTE [R01EY008061, R01EY019478, K99EY024992, R29EY008061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY008061 and EY019478. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Doc.Mobility Fellowship P1SKP3_158634 from the Swiss National Science Foundation.	Albizu L, 2010, NAT CHEM BIOL, V6, P587, DOI [10.1038/nchembio.396, 10.1038/NCHEMBIO.396]; Baneres JL, 2003, J MOL BIOL, V329, P815, DOI 10.1016/S0022-2836(03)00439-X; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575; Breitwieser GE, 2004, CIRC RES, V94, P17, DOI 10.1161/01.RES.0000110420.68526.19; Chabre M, 2005, BIOCHEMISTRY-US, V44, P9395, DOI 10.1021/bi050720o; Chabre M, 2003, NATURE, V426, P30, DOI 10.1038/426030b; Chabre M, 2009, TRENDS PHARMACOL SCI, V30, P182, DOI 10.1016/j.tips.2009.01.003; Chen YY, 2014, J BIOL CHEM, V289, P9288, DOI 10.1074/jbc.M114.551713; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Comar WD, 2014, J AM CHEM SOC, V136, P8342, DOI 10.1021/ja501948w; Corley SC, 2011, BIOPHYS J, V100, P2946, DOI 10.1016/j.bpj.2011.05.015; Cottet Martin, 2012, Front Endocrinol (Lausanne), V3, P92, DOI 10.3389/fendo.2012.00092; Dell'Orco D, 2011, BIOCHEM J, V440, P263, DOI 10.1042/BJ20110871; FAHMY K, 1993, BIOCHEMISTRY-US, V32, P7229, DOI 10.1021/bi00079a020; Fanelli F, 2013, PROG MOL BIOL TRANSL, V117, P105, DOI 10.1016/B978-0-12-386931-9.00005-2; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Ferre S, 2015, TRENDS PHARMACOL SCI, V36, P145, DOI 10.1016/j.tips.2015.01.002; Ferre S, 2014, PHARMACOL REV, V66, P413, DOI 10.1124/pr.113.008052; Filipek S, 2004, PHOTOCH PHOTOBIO SCI, V3, P628, DOI 10.1039/b315661c; Fotiadis D, 2004, FEBS LETT, V564, P281, DOI 10.1016/S0014-5793(04)00194-2; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Goc A, 2008, BIOCHEMISTRY-US, V47, P12409, DOI 10.1021/bi8015444; Gorinski N, 2012, MOL PHARMACOL, V82, P448, DOI 10.1124/mol.112.079137; Gunkel M, 2015, STRUCTURE, V23, P628, DOI 10.1016/j.str.2015.01.015; Guo W, 2003, J BIOL CHEM, V278, P4385, DOI 10.1074/jbc.C200679200; Harikumar KG, 2007, J BIOL CHEM, V282, P30363, DOI 10.1074/jbc.M702325200; Harikumar KG, 2006, BIOCHEMISTRY-US, V45, P14706, DOI 10.1021/bi061107n; Hayashi R, 2006, J BIOCHEM, V139, P981, DOI 10.1093/jb/mvj117; Hebert TE, 1996, J BIOL CHEM, V271, P16384, DOI 10.1074/jbc.271.27.16384; Heck M, 2001, J BIOL CHEM, V276, P10000, DOI 10.1074/jbc.M009475200; Hernanz-Falcon P, 2004, NAT IMMUNOL, V5, P216, DOI 10.1038/ni1027; Huang JY, 2013, NAT STRUCT MOL BIOL, V20, P419, DOI 10.1038/nsmb.2504; Ianoul A, 2005, NAT CHEM BIOL, V1, P196, DOI 10.1038/nchembio726; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Jastrzebska B, 2004, J BIOL CHEM, V279, P54663, DOI 10.1074/jbc.M408691200; Jastrzebska B, 2006, J BIOL CHEM, V281, P11917, DOI 10.1074/jbc.M600422200; Jastrzebska Beata, 2015, Methods Mol Biol, V1271, P221, DOI 10.1007/978-1-4939-2330-4_15; Jastrzebska B, 2013, AMINO ACIDS, V45, P1303, DOI 10.1007/s00726-013-1593-y; Jastrzebska B, 2013, J STRUCT BIOL, V182, P164, DOI 10.1016/j.jsb.2013.02.014; Jastrzebska B, 2013, FASEB J, V27, P1572, DOI 10.1096/fj.12-225383; Jastrzebska B, 2011, J STRUCT BIOL, V176, P387, DOI 10.1016/j.jsb.2011.08.016; Jastrzebska B, 2010, BIOCHEM J, V428, P1, DOI 10.1042/BJ20100270; Knepp AM, 2012, BIOCHEMISTRY-US, V51, P1819, DOI 10.1021/bi3001598; Kota P, 2006, P NATL ACAD SCI USA, V103, P3054, DOI 10.1073/pnas.0510982103; Lambert NA, 2014, J PHYSIOL-LONDON, V592, P2443, DOI 10.1113/jphysiol.2014.272997; Lee LTO, 2014, FASEB J, V28, P2632, DOI 10.1096/fj.13-246868; Lee WK, 2009, BIOCHEM BIOPH RES CO, V390, P815, DOI 10.1016/j.bbrc.2009.10.055; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Mancia F, 2008, EMBO REP, V9, P363, DOI 10.1038/embor.2008.27; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Mansoor SE, 2006, P NATL ACAD SCI USA, V103, P3060, DOI 10.1073/pnas.0511010103; Marsango S, 2015, J BIOL CHEM, V290, P15146, DOI 10.1074/jbc.M114.630681; Maurice P, 2011, TRENDS PHARMACOL SCI, V32, P514, DOI 10.1016/j.tips.2011.05.006; McMillin SM, 2011, J BIOL CHEM, V286, P28584, DOI 10.1074/jbc.M111.259788; Milligan G, 2008, BRIT J PHARMACOL, V153, pS216, DOI 10.1038/sj.bjp.0707490; Milligan G, 2003, LIFE SCI, V74, P181, DOI 10.1016/j.lfs.2003.09.005; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Muller DJ, 2008, PHARMACOL REV, V60, P43, DOI 10.1124/pr.107.07111; Nemoto W, 2005, PROTEINS, V58, P644, DOI 10.1002/prot.20332; Ng HKH, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00010; Nickell S, 2007, J CELL BIOL, V177, P917, DOI 10.1083/jcb.200612010; Okada Tetsuji, 2006, P243; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P48; Periole X, 2012, J AM CHEM SOC, V134, P10959, DOI 10.1021/ja303286e; Ramon E, 2003, VISION RES, V43, P3055, DOI 10.1016/j.visres.2003.08.009; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rivero-Muller A, 2013, PROG MOL BIOL TRANSL, V117, P163, DOI 10.1016/B978-0-12-386931-9.00007-6; Ruprecht JJ, 2004, EMBO J, V23, P3609, DOI 10.1038/sj.emboj.7600374; Salahpour Ali, 2012, Front Endocrinol (Lausanne), V3, P105, DOI 10.3389/fendo.2012.00105; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Salon JA, 2011, PHARMACOL REV, V63, P901, DOI 10.1124/pr.110.003350; SCHERTLER GFX, 1993, NATURE, V362, P770, DOI 10.1038/362770a0; SCHERTLER GFX, 1995, P NATL ACAD SCI USA, V92, P11578, DOI 10.1073/pnas.92.25.11578; Selent J, 2011, CURR MED CHEM, V18, P4588, DOI 10.2174/092986711797379320; Simpson LM, 2010, CURR OPIN PHARMACOL, V10, P30, DOI 10.1016/j.coph.2009.11.001; Tena-Campos M, 2014, CURR PROTEIN PEPT SC, V15, P648, DOI 10.2174/1389203715666140901094248; Vela L, 2011, ASSAY DRUG DEV TECHN, V9, P532, DOI 10.1089/adt.2010.0345; Vobornik D, 2009, BIOCHEM BIOPH RES CO, V382, P85, DOI 10.1016/j.bbrc.2009.02.144; WALD G, 1953, J GEN PHYSIOL, V37, P189, DOI 10.1085/jgp.37.2.189; White JF, 2007, P NATL ACAD SCI USA, V104, P12199, DOI 10.1073/pnas.0705312104; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wimley WC, 2000, BIOCHEMISTRY-US, V39, P4432, DOI 10.1021/bi992746j; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Xue L, 2015, NAT CHEM BIOL, V11, P134, DOI [10.1038/nchembio.1711, 10.1038/NCHEMBIO.1711]	89	62	62	1	22	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25728	25744		10.1074/jbc.M115.662684	http://dx.doi.org/10.1074/jbc.M115.662684			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26330551	hybrid, Green Published			2022-12-26	WOS:000362962800044
J	Lai, CWK; Law, HKW				Lai, Christopher W. K.; Law, Helen K. W.			Mammographic Breast Density in Chinese Women: Spatial Distribution and Autocorrelation Patterns	PLOS ONE			English	Article							SEGMENTATION; CANCER; RISK; TISSUE; TOOL	Mammographic breast density (MBD) is a strong risk factor for breast cancer. The spatial distribution of MBD in the breast is variable and dependent on physiological, genetic, environmental and pathological factors. This pilot study aims to define the spatial distribution and autocorrelation patterns of MBD in Chinese women aged 40-60. By analyzing their digital mammographic images using a public domain Java image processing program for segmentation and quantification of MBD, we found their left and right breasts were symmetric to each other in regard to their breast size (Total Breast Area), the amount of BMD (overall PD) and Moran's I values. Their MBD was also spatially autocorrelated together in the anterior part of the breast in those with a smaller breast size, while those with a larger breast size tend to have their MBD clustered near the posterior part of the breast. Finally, we observed that the autocorrelation pattern of MBD was dispersed after a 3-year observation period.	[Lai, Christopher W. K.; Law, Helen K. W.] Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Hong Kong, HKSAR, Peoples R China	Hong Kong Polytechnic University	Lai, CWK (corresponding author), Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Hong Kong, HKSAR, Peoples R China.	chris.lai@polyu.edu.hk	Lai, Christopher Wai Keung/A-3852-2014	Lai, Christopher Wai Keung/0000-0002-8010-7232	HKCRRT Research Fund [HKCRRT 2013]	HKCRRT Research Fund	This work is supported partly by the HKCRRT Research Fund (HKCRRT 2013), www.hkcrrt.org. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Couwenberg AM, 2014, CANCER CAUSE CONTROL, V25, P1037, DOI 10.1007/s10552-014-0404-4; Ferrari RJ, 2004, MED BIOL ENG COMPUT, V42, P378, DOI 10.1007/BF02344714; Ferrari RJ, 2004, MED BIOL ENG COMPUT, V42, P201, DOI 10.1007/BF02344632; Ganesan K, 2013, COMPUT METH PROG BIO, V110, P48, DOI 10.1016/j.cmpb.2012.10.020; Haars G, 2005, CANCER EPIDEM BIOMAR, V14, P2634, DOI 10.1158/1055-9965.EPI-05-0824; Habel LA, 2007, MENOPAUSE, V14, P891, DOI 10.1097/gme.0b013e318032569c; Harris HR, 2011, AM J EPIDEMIOL; Heine JJ, 2008, CANCER EPIDEM BIOMAR, V17, P3090, DOI 10.1158/1055-9965.EPI-08-0170; Heine JJ, 2011, ACAD RADIOL, V18, P547, DOI 10.1016/j.acra.2010.12.007; Iatrakis G, 2011, J Med Life, V4, P310; Kallenberg MGJ, 2011, PHYS MED BIOL, V56, P2715, DOI 10.1088/0031-9155/56/9/005; Li JM, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3238; Lokate M, 2011, BREAST CANCER RES, V13, P1; Malkov S, 2010, LECT NOTES COMPUT SC, V6136, P402, DOI 10.1007/978-3-642-13666-5_54; Nickson C, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3474; Oliver A, 2010, J DIGIT IMAGING, V23, P527, DOI 10.1007/s10278-009-9217-5; Pereira SMP, 2011, CANCER EPIDEM BIOMAR, V20, P1718, DOI 10.1158/1055-9965.EPI-11-0423; Pereira SMP, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2318; Stone J, 2003, CANCER EPIDEM BIOMAR, V12, P625; TURNBULL AE, 1993, CLIN RADIOL, V48, P38, DOI 10.1016/S0009-9260(05)80105-9; Ursin G, 2003, CANCER EPIDEM BIOMAR, V12, P332; Vachon CM, 2007, CANCER RES, V67, P8412, DOI 10.1158/0008-5472.CAN-07-1076	22	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136881	10.1371/journal.pone.0136881	http://dx.doi.org/10.1371/journal.pone.0136881			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332221	Green Published, Green Submitted, gold			2022-12-26	WOS:000360613800078
J	Pomeroy, LW; Bjornstad, ON; Kim, H; Jumbo, SD; Abdoulkadiri, S; Garabed, R				Pomeroy, Laura W.; Bjornstad, Ottar N.; Kim, Hyeyoung; Jumbo, Simon Dickmu; Abdoulkadiri, Souley; Garabed, Rebecca			Serotype-Specific Transmission and Waning Immunity of Endemic Foot-and-Mouth Disease Virus in Cameroon	PLOS ONE			English	Article							ECONOMIC-IMPACTS; INFECTION; DYNAMICS; SPREAD; LIVESTOCK; EPIDEMIC; CATTLE; FORCE; OUTBREAKS	Foot-and-mouth disease virus (FMDV) causes morbidity and mortality in a range of animals and threatens local economies by acting as a barrier to international trade. The outbreak in the United Kingdom in 2001 that cost billions to control highlighted the risk that the pathogen poses to agriculture. In response, several mathematical models have been developed to parameterize and predict both transmission dynamics and optimal disease control. However, a lack of understanding of the multi-strain etiology prevents characterization of multi-strain dynamics. Here, we use data from FMDV serology in an endemic setting to probe strain-specific transmission and immunodynamics. Five serotypes of FMDV affect cattle in the Far North Region of Cameroon. We fit both catalytic and reverse catalytic models to serological data to estimate the force of infection and the rate of waning immunity, and to detect periods of sustained transmission. For serotypes SAT2, SAT3, and type A, a model assuming life-long immunity fit better. For serotypes SAT1 and type O, the better-fit model suggests that immunity may wane over time. Our analysis further indicates that type O has the greatest force of infection and the longest duration of immunity. Estimates for the force of infection were time-varying and indicated that serotypes SAT1 and O displayed endemic dynamics, serotype A displayed epidemic dynamics, and SAT2 and SAT3 did not sustain local chains of transmission. Since these results were obtained from the same population at the same time, they highlight important differences in transmission specific to each serotype. They also show that immunity wanes at rates specific to each serotype, which influences patterns of local persistence. Overall, this work shows that viral serotypes can differ significantly in their epidemiological and immunological characteristics. Patterns and processes that drive transmission in endemic settings must consider complex viral dynamics for accurate representation and interpretation.	[Pomeroy, Laura W.; Garabed, Rebecca] Ohio State Univ, Dept Vet Prevent Med, Columbus, OH 43210 USA; [Bjornstad, Ottar N.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Bjornstad, Ottar N.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Bjornstad, Ottar N.] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Bjornstad, Ottar N.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Kim, Hyeyoung] Ohio State Univ, Dept Geog, Columbus, OH 43210 USA; [Jumbo, Simon Dickmu; Abdoulkadiri, Souley] Lanavet, Lab Natl Vet, Garoua, Cameroon; [Garabed, Rebecca] Ohio State Univ, Publ Hlth Preparedness Infect Dis Program, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Pomeroy, LW (corresponding author), Ohio State Univ, Dept Vet Prevent Med, Columbus, OH 43210 USA.	pomeroy.26@osu.edu	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257; Garabed, Rebecca/0000-0002-8964-3576	Eunice Kennedy Shriver National Institute of Child Health & Human Development [R24-HD058484]; National Science Foundation [DEB-1015908]; Ohio State University Initiative in Population Research; Direct For Biological Sciences [1015908] Funding Source: National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD058484] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Science Foundation(National Science Foundation (NSF)); Ohio State University Initiative in Population Research; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by award R24-HD058484 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (http://www.nichd.nih.gov/Pages/index.aspx), awarded to the Ohio State University Initiative in Population Research and RG, and by award DEB-1015908 from the National Science Foundation (http://www.nsf.gov), awarded to RG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Alexandersen S, 2003, J COMP PATHOL, V129, P1, DOI 10.1016/S0021-9975(03)00041-0; ANDERSON R M, 1991; Bajardi P, 2012, J R SOC INTERFACE, V9, P2814, DOI 10.1098/rsif.2012.0289; Boender GJ, 2010, EPIDEMICS-NETH, V2, P36, DOI 10.1016/j.epidem.2010.03.001; Bronsvoort BMDC, 2006, VET REC, V159, P299; Buhnerkempe MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091724; Carpenter TE, 2011, J VET DIAGN INVEST, V23, P26, DOI 10.1177/104063871102300104; CUNLIFFE HR, 1964, CORNELL VET, V54, P501; Doel TR, 2003, VIRUS RES, V91, P81, DOI 10.1016/S0168-1702(02)00261-7; Doran RJ, 2005, PREV VET MED, V70, P133, DOI 10.1016/j.prevetmed.2005.03.002; Ehizibolo DO, 2014, TRANSBOUND EMERG DIS, V61, P500, DOI 10.1111/tbed.12054; Ferrari MJ, 2010, EPIDEMIOL INFECT, V138, P108, DOI 10.1017/S0950268809990173; Garland AJM, 1974, INHIBITORY ACTIVITY; Garner MG, 2005, AUST VET J, V83, P758, DOI 10.1111/j.1751-0813.2005.tb11589.x; GRENFELL BT, 1985, J HYG-CAMBRIDGE, V95, P419, DOI 10.1017/S0022172400062859; GRIFFITHS D. A., 1974, Applied Statistics, V23, P330, DOI 10.2307/2347126; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Hens N, 2010, EPIDEMIOL INFECT, V138, P802, DOI 10.1017/S0950268809990781; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Knight-Jones TJD, 2013, PREV VET MED, V112, P161, DOI 10.1016/j.prevetmed.2013.07.013; Lavine JS, 2012, VACCINE, V30, P544, DOI 10.1016/j.vaccine.2011.11.065; Leforban Y, 1999, VACCINE, V17, P1755, DOI 10.1016/S0264-410X(98)00445-9; Lindstrom T, 2012, J R SOC INTERFACE, V9, P1287, DOI 10.1098/rsif.2011.0625; Long GH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001224; Ludi A, 2016, TRANSBOUND EMERG DIS, V63, pE27, DOI 10.1111/tbed.12227; Muench H., CATALYTIC MODELS EPI, P8928; Njoya A, 1997, WORLD ANIM REV, P12; Profitos JMH, 2013, PASTORALISM, V3, DOI 10.1186/2041-7136-3-8; R Development Core Team, 2012, R LANG ENV STAT COMP; Reiner RC, 2014, P NATL ACAD SCI USA, V111, pE2694, DOI 10.1073/pnas.1314933111; Rodriguez LL, 2011, EXPERT REV VACCINES, V10, P377, DOI [10.1586/erv.11.4, 10.1586/ERV.11.4]; RStudio, 2014, RSTUDIO INT DEV ENV; Rweyemamu M, 2008, TRANSBOUND EMERG DIS, V55, P57, DOI 10.1111/j.1865-1682.2007.01013.x; Seignobos O., 2000, ATLAS PROVINCE EXTRE; Ster IC, 2012, EPIDEMICS-NETH, V4, P158, DOI 10.1016/j.epidem.2012.07.002; Thompson D, 2002, REV SCI TECH OIE, V21, P675, DOI 10.20506/rst.21.3.1353; Tildesley MJ, 2008, P ROY SOC B-BIOL SCI, V275, P1459, DOI 10.1098/rspb.2008.0006; Tildesley MJ, 2012, PREV VET MED, V104, P224, DOI 10.1016/j.prevetmed.2011.11.007; Vernon MC, 2012, PREV VET MED, V105, P110, DOI 10.1016/j.prevetmed.2011.12.016; Ward MP, 2009, PREV VET MED, V91, P55, DOI 10.1016/j.prevetmed.2009.05.005; Wu JY, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1018	42	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136642	10.1371/journal.pone.0136642	http://dx.doi.org/10.1371/journal.pone.0136642			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327324	Green Published, Green Submitted, gold			2022-12-26	WOS:000360437700051
J	Sablon-Carrazana, M; Fernandez, I; Bencomo, A; Lara-Martinez, R; Rivera-Marrero, S; Dominguez, G; Perez-Perera, R; Jimenez-Garcia, LF; Altamirano-Bustamante, NF; Diaz-Delgado, M; Vedrenne, F; Rivillas-Acevedo, L; Pasten-Hidalgo, K; Segura-Valdez, MD; Islas-Andrade, S; Garrido-Magana, E; Perera-Pintado, A; Prats-Capote, A; Rodriguez-Tanty, C; Altamirano-Bustamante, MM				Sablon-Carrazana, Marquiza; Fernandez, Isaac; Bencomo, Alberto; Lara-Martinez, Reyna; Rivera-Marrero, Suchitil; Dominguez, Guadalupe; Perez-Perera, Rafaela; Felipe Jimenez-Garcia, Luis; Altamirano-Bustamante, Nelly F.; Diaz-Delgado, Massiel; Vedrenne, Fernand; Rivillas-Acevedo, Lina; Pasten-Hidalgo, Karina; de Lourdes Segura-Valdez, Maria; Islas-Andrade, Sergio; Garrido-Magana, Eulalia; Perera-Pintado, Alejandro; Prats-Capote, Anais; Rodriguez-Tanty, Chryslaine; Altamirano-Bustamante, Myriam M.			Drug Development in Conformational Diseases: A Novel Family of Chemical Chaperones that Bind and Stabilise Several Polymorphic Amyloid Structures	PLOS ONE			English	Article							BOVINE SERUM-ALBUMIN; PROTEIN-STRUCTURE SIMILARITY; TAU AGGREGATION INHIBITORS; PAIRED HELICAL FILAMENTS; SOLID-PHASE SYNTHESIS; PS GRAFT SUPPORTS; FIBRIL FORMATION; MOLECULAR CHAPERONES; GUIDING PRINCIPLES; ALZHEIMERS-DISEASE	The increasing prevalence of conformational diseases, including Alzheimer's disease, type 2 Diabetes Mellitus and Cancer, poses a global challenge at many different levels. It has devastating effects on the sufferers as well as a tremendous economic impact on families and the health system. In this work, we apply a cross-functional approach that combines ideas, concepts and technologies from several disciplines in order to study, in silico and in vitro, the role of a novel chemical chaperones family (NCHCHF) in processes of protein aggregation in conformational diseases. Given that Serum Albumin (SA) is the most abundant protein in the blood of mammals, and Bovine Serum Albumin (BSA) is an off-the-shelf protein available in most labs around the world, we compared the ligandability of BSA: NCHCHF with the interaction sites in the Human Islet Amyloid Polypeptide (hIAPP): NCHCHF, and in the amyloid pharmacophore fragments (A beta 17-42 and A beta 16-21): NCHCHF. We posit that the merging of this interaction sites is a meta-structure of pharmacophore which allows the development of chaperones that can prevent protein aggregation at various states from: stabilizing the native state to destabilizing oligomeric state and protofilament. Furthermore to stabilize fibrillar structures, thus decreasing the amount of toxic oligomers in solution, as is the case with the NCHCHF. The paper demonstrates how a set of NCHCHF can be used for studying and potentially treating the various physiopathological stages of a conformational disease. For instance, when dealing with an acute phase of cytotoxicity, what is needed is the recruitment of cytotoxic oligomers, thus chaperone F, which accelerates fiber formation, would be very useful; whereas in a chronic stage it is better to have chaperones A, B, C, and D, which stabilize the native and fibril structures halting self-catalysis and the creation of cytotoxic oligomers as a consequence of fiber formation. Furthermore, all the chaperones are able to protect and recondition the cerebellar granule cells (CGC) from the cytotoxicity produced by the hIAPP(20-29) fragment or by a low potassium medium, regardless of their capacity for accelerating or inhibiting in vitro formation of fibers. In vivo animal experiments are required to study the impact of chemical chaperones in cognitive and metabolic syndromes.	[Sablon-Carrazana, Marquiza; Bencomo, Alberto; Rivera-Marrero, Suchitil; Perez-Perera, Rafaela; Diaz-Delgado, Massiel; Rodriguez-Tanty, Chryslaine] Ctr Neurociencias Cuba, Dept Neurodiagnost, Havana, Cuba; [Sablon-Carrazana, Marquiza; Fernandez, Isaac; Bencomo, Alberto; Vedrenne, Fernand; Rivillas-Acevedo, Lina; Islas-Andrade, Sergio; Altamirano-Bustamante, Myriam M.] Inst Mexicano Seguro Social, Hosp Cardiol, Unidad Invest Med Enfermedades Metab, Ctr Med Nacl Siglo 21, Mexico City, DF, Mexico; [Fernandez, Isaac] Inst Politecn Nacl, Dept Microbiol, Escuela Nacl Ciencias Biol, Mexico City, DF, Mexico; [Lara-Martinez, Reyna; Felipe Jimenez-Garcia, Luis; de Lourdes Segura-Valdez, Maria] Univ Nacl Autonoma Mexico, Lab Nanobiol Celular, Dept Biol Celular, Fac Ciencias, Mexico City, DF, Mexico; [Dominguez, Guadalupe] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City, DF, Mexico; [Altamirano-Bustamante, Nelly F.; Pasten-Hidalgo, Karina] Inst Nacl Pediat SS, Serv Endocrinol, Mexico City, DF, Mexico; [Pasten-Hidalgo, Karina] Catedra Conacyt, Mexico City, DF, Mexico; [Garrido-Magana, Eulalia] IMSS, Serv Endocrinol, Hosp Pediat, CMNXXI, Mexico City, DF, Mexico; [Perera-Pintado, Alejandro; Prats-Capote, Anais] Ctr Invest Clin, Havana, Cuba	Instituto Mexicano del Seguro Social; Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Instituto Mexicano del Seguro Social	Rodriguez-Tanty, C (corresponding author), Ctr Neurociencias Cuba, Dept Neurodiagnost, Havana, Cuba.	chris@cneuro.edu.cu; myriamab@unam.mx	Rivillas-Acevedo, Lina/AAE-8801-2020; /ABI-8453-2020; Altamirano, Myriam/GPW-5376-2022; Rivera, Suchitil/AAI-1632-2021	/0000-0002-9402-4219; Rivera, Suchitil/0000-0002-1186-5734	Mexico's National Council of Science and Technology (CONACYT) [SALUD-2010-C02-151942]; Institute of Science and Technology of Mexico City (ICYTDF); Cuba's National Science and Technology Program (PNCT) [31200]	Mexico's National Council of Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Institute of Science and Technology of Mexico City (ICYTDF); Cuba's National Science and Technology Program (PNCT)	Funding for this study was provided by Mexico's National Council of Science and Technology (CONACYT) SALUD-2010-C02-151942, Institute of Science and Technology of Mexico City (ICYTDF), and Cuba's National Science and Technology Program (PNCT, 31200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babcock JJ, 2013, INT J BIOL MACROMOL, V53, P42, DOI 10.1016/j.ijbiomac.2012.10.030; Bartolini M, 2010, CHEMBIOCHEM, V11, P1018, DOI 10.1002/cbic.200900666; Bhattacharya M, 2011, J PHYS CHEM B, V115, P4195, DOI 10.1021/jp111528c; Blancas S, 2011, NEUROCHEM INT, V58, P934, DOI 10.1016/j.neuint.2011.03.017; Blancas-Mejia LM, 2015, J BIOL CHEM, V290, P4953, DOI 10.1074/jbc.M114.615401; Breinbauer R, 2002, ANGEW CHEM INT EDIT, V41, P2879; BREITNER JCS, 1995, NEUROBIOL AGING, V16, P523, DOI 10.1016/0197-4580(95)00049-K; Bulic B, 2007, ANGEW CHEM INT EDIT, V46, P9215, DOI 10.1002/anie.200704051; Bulic B, 2009, ANGEW CHEM INT EDIT, V48, P1741, DOI 10.1002/anie.200802621; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Hard T, 2012, J MOL BIOL, V421, P441, DOI 10.1016/j.jmb.2011.12.062; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Herczenik E, 2008, FASEB J, V22, P2115, DOI 10.1096/fj.07-099671; Holm NK, 2007, BBA-PROTEINS PROTEOM, V1774, P1128, DOI 10.1016/j.bbapap.2007.06.008; Hood CA, 2008, J PEPT SCI, V14, P97, DOI 10.1002/psc.921; Jiang L, 2013, ELIFE, V2, DOI 10.7554/eLife.00857; Juarez J, 2009, J PHYS CHEM B, V113, P10521, DOI 10.1021/jp902224d; Kates SA, 1996, PEPTIDE RES, V9, P106; Kates SA, 1998, BIOPOLYMERS, V47, P365, DOI 10.1002/(SICI)1097-0282(1998)47:5<365::AID-BIP4>3.0.CO;2-8; Khurana R, 2003, BIOPHYS J, V85, P1135, DOI 10.1016/S0006-3495(03)74550-0; Koch MA, 2003, BIOL CHEM, V384, P1265, DOI 10.1515/BC.2003.140; Koch MA, 2005, DRUG DISCOV TODAY, V10, P471, DOI 10.1016/S1359-6446(05)03419-7; Konrat R, 2009, CELL MOL LIFE SCI, V66, P3625, DOI 10.1007/s00018-009-0117-0; Landau M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001080; Larbig G, 2007, CURR ALZHEIMER RES, V4, P315; Lendel C, 2009, BIOCHEMISTRY-US, V48, P8322, DOI 10.1021/bi901285x; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Mogk A, 1999, EMBO J, V18, P6934, DOI 10.1093/emboj/18.24.6934; Moran J, 1999, J NEUROCHEM, V73, P568, DOI 10.1046/j.1471-4159.1999.0730568.x; Naranjo Y, 2012, MOL BIOSYST, V8, P411, DOI 10.1039/c1mb05367a; Papp E, 2006, HANDB EXP PHARM, V172, P405; Pickhardt A, 2007, CURR ALZHEIMER RES, V4, P397, DOI 10.2174/156720507781788765; Pickhardt M, 2005, J BIOL CHEM, V280, P3628, DOI 10.1074/jbc.M410984200; Pickhardt M, 2007, BIOCHEMISTRY-US, V46, P10016, DOI 10.1021/bi700878g; Sablon CM, 2014, Google Patents, Patent No. [WO20141313, 20141313]; Sablon CM, [No title captured], Patent No. [EP2436666B1, 2436666B1]; Sablon CM, 2010, Google Patents, Patent No. [US20120321560, 20120321560]; Sablon CM, 2010, Google Patents, Patent No. [WO2010118706A2, 2010118706]; Sablon CM, [No title captured], Patent No. [WO2010118706A4, 2010118706]; Sablon CM, 2010, Google Patents, Patent No. [EP2436666A2, 2436666]; Sacchettini JC, 2002, NAT REV DRUG DISCOV, V1, P267, DOI 10.1038/nrd769; Scheibel T, 2006, HANDB EXP PHARM, V172, P199; Seong IS, 2000, FEBS LETT, V477, P224, DOI 10.1016/S0014-5793(00)01808-1; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Tjernberg LO, 1999, J BIOL CHEM, V274, P12619, DOI 10.1074/jbc.274.18.12619; Tomoyasu T, 2013, J BIOSCI BIOENG, V115, P15, DOI 10.1016/j.jbiosc.2012.08.001; Vetri V, 2011, ARCH BIOCHEM BIOPHYS, V508, P13, DOI 10.1016/j.abb.2011.01.024; Welch WJ, 2004, SEMIN CELL DEV BIOL, V15, P31, DOI 10.1016/j.semcdb.2003.12.011; Westermark P, 2007, AMYLOID, V14, P179, DOI 10.1080/13506120701460923; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Zahn R, 1996, J MOL BIOL, V261, P43, DOI 10.1006/jmbi.1996.0440	52	10	10	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0135292	10.1371/journal.pone.0135292	http://dx.doi.org/10.1371/journal.pone.0135292			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327208	gold, Green Submitted, Green Published			2022-12-26	WOS:000360437700017
J	Fernandez-Palomeque, C; Grau, A; Perello, J; Sanchis, P; Isern, B; Prieto, RM; Costa-Bauza, A; Caldes, OJ; Bonnin, O; Garcia-Raja, A; Bethencourt, A; Grases, F				Fernandez-Palomeque, Carlos; Grau, Andres; Perello, Joan; Sanchis, Pilar; Isern, Bernat; Prieto, Rafel M.; Costa-Bauza, Antonia; Caldes, Onofre J.; Bonnin, Oriol; Garcia-Raja, Ana; Bethencourt, Armando; Grases, Felix			Relationship between Urinary Level of Phytate and Valvular Calcification in an Elderly Population: A Cross-Sectional Study	PLOS ONE			English	Article							CORONARY-ARTERY CALCIFICATION; MITRAL ANNULAR CALCIFICATION; CHRONIC KIDNEY-DISEASE; VASCULAR CALCIFICATION; INOSITOL HEXAKISPHOSPHATE; CARDIOVASCULAR RISK; DIALYSIS PATIENTS; DIETARY PHYTATE; BREAST-CANCER; CALCIUM	Pathological calcification generally consists of the formation of solid deposits of hydroxyapatite (calcium phosphate) in soft tissues. Supersaturation is the thermodynamic driving force for crystallization, so it is believed that higher blood levels of calcium and phosphate increase the risk of cardiovascular calcification. However several factors can promote or inhibit the natural process of pathological calcification. This cross-sectional study evaluated the relationship between physiological levels of urinary phytate and heart valve calcification in a population of elderly out subjects. A population of 188 elderly subjects (mean age: 68 years) was studied. Valve calcification was measured by echocardiography. Phytate determination was performed from a urine sample and data on blood chemistry, end-systolic volume, concomitant diseases, cardiovascular risk factors, medication usage and food were obtained. The study population was classified in three tertiles according to level of urinary phytate: low (<0.610 mu M), intermediate (0.61-1.21 mu M), and high (>1.21 mu M). Subjects with higher levels of urinary phytate had less mitral annulus calcification and were less likely to have diabetes and hypercholesterolemia. In the multivariate analysis, age, serum phosphorous, leukocytes total count and urinary phytate excretion appeared as independent factors predictive of presence of mitral annulus calcification. There was an inverse correlation between urinary phytate content and mitral annulus calcification in our population of elderly out subjects. These results suggest that consumption of phytate-rich foods may help to prevent cardiovascular calcification evolution.	[Fernandez-Palomeque, Carlos; Grau, Andres; Caldes, Onofre J.; Bonnin, Oriol; Garcia-Raja, Ana; Bethencourt, Armando] Hosp Univ Son Espases, IdISPa, Palma Of Mallorca 07120, Spain; [Perello, Joan; Sanchis, Pilar; Isern, Bernat; Prieto, Rafel M.; Costa-Bauza, Antonia; Grases, Felix] Univ Balearic Isl, Lab Renal Lithiasis Res, Inst Hlth Sci Res IUNICS IdISPa, Palma Of Mallorca 07122, Spain; [Prieto, Rafel M.; Costa-Bauza, Antonia; Grases, Felix] Inst Salud Carlos III, CIBERobn CB06 03, Madrid 28029, Spain	Hospital Universitari Son Espases; Institut Investigacio Sanitaria Illes Balears (IdISBa); Institut Investigacio Sanitaria Illes Balears (IdISBa); Universitat de les Illes Balears; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Grases, F (corresponding author), Univ Balearic Isl, Lab Renal Lithiasis Res, Inst Hlth Sci Res IUNICS IdISPa, Palma Of Mallorca 07122, Spain.	fgrases@uib.es	Isern, Bernat/ABF-3751-2021; Fernandez-Palomeque, Carlos/A-4019-2011; Perello, Joan/A-7387-2019; Sanchis, Pilar/AAH-4684-2020; Prieto, Rafel M./J-3995-2017	Fernandez-Palomeque, Carlos/0000-0002-6881-4487; Perello, Joan/0000-0003-2671-3386; Prieto, Rafel M./0000-0001-8814-900X; Costa-Bauza, Antonia/0000-0003-0647-4154; Sanchis, Pilar/0000-0003-0618-0594; Grases, Felix/0000-0001-5636-9139; Sanchis, Pilar/0000-0001-8565-1811	Ministerio de Economia y Competitividad (Gobierno de Espana) [PI14/00853]; FEDER funds (European Union); Ministerio de Educacion y Cultura (Gobierno de Espana); Conselleria d'Innovacio i Energia del (Govern de les Illes Balears); Conselleria de Educacio, Cultura i Universitats (Govern de les Illes Balears) [PD/009/2013]	Ministerio de Economia y Competitividad (Gobierno de Espana); FEDER funds (European Union)(European Commission); Ministerio de Educacion y Cultura (Gobierno de Espana); Conselleria d'Innovacio i Energia del (Govern de les Illes Balears); Conselleria de Educacio, Cultura i Universitats (Govern de les Illes Balears)	This work was supported by grant PI14/00853 from the Ministerio de Economia y Competitividad (Gobierno de Espana), and by FEDER funds (European Union). JP expresses his appreciation to Ministerio de Educacion y Cultura (Gobierno de Espana) for the fellowship of the FPU program. BI expresses his appreciation to the Conselleria d'Innovacio i Energia del (Govern de les Illes Balears) for the doctoral fellowship. PS express her appreciation for the postdoctoral fellowship PD/009/2013 to the Conselleria de Educacio, Cultura i Universitats (Govern de les Illes Balears) and the European Social Fund through the ESF Operational Programme of the Balearic Islands 2013-2017.	Agarwal S, 2013, DIABETES CARE, V36, P972, DOI 10.2337/dc12-1548; Amann K, 2008, CLIN J AM SOC NEPHRO, V3, P1599, DOI 10.2215/CJN.02120508; Blacher J, 2001, HYPERTENSION, V38, P938, DOI 10.1161/hy1001.096358; Braun J, 1996, AM J KIDNEY DIS, V27, P394, DOI 10.1016/S0272-6386(96)90363-7; Budoff MJ, 2013, J AM COLL CARDIOL, V61, P1231, DOI 10.1016/j.jacc.2012.12.035; BUNCE CM, 1993, BIOCHEM J, V289, P667, DOI 10.1042/bj2890667; DALEYYATES PT, 1991, CALCIFIED TISSUE INT, V49, P433, DOI 10.1007/BF02555856; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Eiseman J, 2011, METABOLISM, V60, P1465, DOI 10.1016/j.metabol.2011.02.015; ELLIOTT RJ, 1994, CALCIFIED TISSUE INT, V54, P268, DOI 10.1007/BF00295949; Elmariah S, 2013, AM HEART J, V166, P904, DOI 10.1016/j.ahj.2013.08.015; Freeman RV, 2005, CIRCULATION, V111, P3316, DOI 10.1161/CIRCULATIONAHA.104.486738; Giachelli CM, 2004, J AM SOC NEPHROL, V15, P2959, DOI 10.1097/01.ASN.0000145894.57533.C4; Grases F, 2003, CLIN CHIM ACTA, V334, P131, DOI 10.1016/S0009-8981(03)00227-4; Grases F, 2006, FRONT BIOSCI-LANDMRK, V11, P136, DOI 10.2741/1786; Grases F, 2004, ANAL CHIM ACTA, V510, P41, DOI 10.1016/j.aca.2003.12.061; Grases F, 2009, J PERIODONTAL RES, V44, P616, DOI 10.1111/j.1600-0765.2008.01168.x; Grases F, 2001, BIOFACTORS, V15, P53, DOI 10.1002/biof.5520150105; Grases F, 2001, J NUTR BIOCHEM, V12, P595, DOI 10.1016/S0955-2863(01)00178-4; Grases F, 2001, BRIT J NUTR, V86, P225, DOI 10.1079/BJN2001389; Grases F, 2000, BJU INT, V85, P138, DOI 10.1046/j.1464-410x.2000.00324.x; Grases F, 2008, FRONT BIOSCI-LANDMRK, V13, P7115, DOI 10.2741/3214; Hanke H, 2001, ACTA CHIR BELG, V101, P162; Hou LF, 2013, EUR J EPIDEMIOL, V28, P735, DOI 10.1007/s10654-013-9842-7; Kauppila LI, 1997, ATHEROSCLEROSIS, V132, P245, DOI 10.1016/S0021-9150(97)00106-8; Kizer JR, 2005, STROKE, V36, P2533, DOI 10.1161/01.STR.0000190005.09442.ad; Korkmaz L, 2012, TURK KARDIYOL DERN A, V40, P223, DOI 10.5543/tkda.2012.37801; Kwak SM, 2014, ARTERIOSCL THROM VAS, V34, P1763, DOI 10.1161/ATVBAHA.114.303440; Moe SM, 2008, J AM SOC NEPHROL, V19, P213, DOI 10.1681/ASN.2007080854; Peacock M, 2010, CLIN J AM SOC NEPHRO, V5, pS23, DOI 10.2215/CJN.05910809; Potter SM., 1995, J NUTR S, V125, P606; Prieto RM, 2010, EUR J NUTR, V49, P321, DOI 10.1007/s00394-009-0087-x; Reslerova M, 2003, AM J KIDNEY DIS, V41, pS96, DOI 10.1053/ajkd.2003.50094; Rosenhek R, 2000, NEW ENGL J MED, V343, P611, DOI 10.1056/NEJM200008313430903; Rossi A, 2014, HEART VESSELS, V29, P776, DOI 10.1007/s00380-013-0433-z; Schlemmer U, 2009, MOL NUTR FOOD RES, V53, pS330, DOI 10.1002/mnfr.200900099; Shears SB, 2001, CELL SIGNAL, V13, P151, DOI 10.1016/S0898-6568(01)00129-2; Varol E, 2014, BLOOD COAGUL FIBRIN, V25, P557, DOI 10.1097/MBC.0000000000000094; Vliegenthart R, 2005, CIRCULATION, V112, P572, DOI 10.1161/CIRCULATIONAHA.104.488916; ZHOU JR, 1995, CRIT REV FOOD SCI, V35, P495, DOI 10.1080/10408399509527712	40	20	20	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136560	10.1371/journal.pone.0136560	http://dx.doi.org/10.1371/journal.pone.0136560			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322979	Green Submitted, Green Published, gold			2022-12-26	WOS:000360435500021
J	Staron, R; Van Swelm, RPL; Lipinski, P; Gajowiak, A; Lenartowicz, M; Bednarz, A; Gajewska, M; Pieszka, M; Laarakkers, CMM; Swinkels, DW; Starzynski, RR				Staron, Robert; Van Swelm, Rachel P. L.; Lipinski, Pawel; Gajowiak, Anna; Lenartowicz, Malgorzata; Bednarz, Aleksandra; Gajewska, Malgorzata; Pieszka, Marek; Laarakkers, Coby M. M.; Swinkels, Dorine W.; Starzynski, Rafal R.			Urinary Hepcidin Levels in Iron-Deficient and Iron-Supplemented Piglets Correlate with Hepcidin Hepatic mRNA and Serum Levels and with Body Iron Status	PLOS ONE			English	Article							EXPRESSION; QUANTIFICATION; UTILITY; ANEMIA; KIDNEY; ASSAYS; GENE; 1ST	Among livestock, domestic pig (Sus scrofa) is a species, in which iron metabolism has been most intensively examined during last decade. The obvious reason for studying the regulation of iron homeostasis especially in young pigs is neonatal iron deficiency anemia commonly occurring in these animals. Moreover, supplementation of essentially all commercially reared piglets with iron entails a need for monitoring the efficacy of this routine practice followed in the swine industry for several decades. Since the discovery of hepcidin many studies confirmed its role as key regulator of iron metabolism and pointed out the assessment of its concentrations in biological fluids as diagnostic tool for iron-related disorder. Here we demonstrate that urine hepcidin-25 levels measured by a combination of weak cation exchange chromatography and time-of-flight mass spectrometry (WCX-TOF MS) are highly correlated with mRNA hepcidin expression in the liver and plasma hepcidin-25 concentrations in anemic and iron-supplemented 28-day old piglets. We also found a high correlation between urine hepcidin level and hepatic non-heme iron content. Our results show that similarly to previously described transgenic mouse models of iron disorders, young pigs constitute a convenient animal model to explore accuracy and relationship between indicators for assessing systemic iron status.	[Staron, Robert; Lipinski, Pawel; Gajowiak, Anna; Starzynski, Rafal R.] Inst Genet & Anim Breeding PAS, Dept Mol Biol, Jastrzebiec, Poland; [Lenartowicz, Malgorzata; Bednarz, Aleksandra] Jagiellonian Univ, Inst Zool, Dept Genet & Evolut, PL-30060 Krakow, Poland; [Gajewska, Malgorzata] Warsaw Univ Life Sci, Fac Vet Med, Dept Physiol Sci, Warsaw, Poland; [Pieszka, Marek] Natl Res Inst Anim Prod, Dept Anim Nutr & Feed Sci, Krakow, Poland; [Van Swelm, Rachel P. L.; Laarakkers, Coby M. M.; Swinkels, Dorine W.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med LGEM 830, NL-6525 ED Nijmegen, Netherlands	Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences; Jagiellonian University; Warsaw University of Life Sciences; National Research Institute of Animal Production; Radboud University Nijmegen	Lipinski, P (corresponding author), Inst Genet & Anim Breeding PAS, Dept Mol Biol, Jastrzebiec, Poland.	p.lipinski@ighz.pl; r.starzynski@ighz.pl	van Swelm, Rachel PL/P-6063-2015; Swinkels, Dorine W./H-8098-2014	Swinkels, Dorine W./0000-0002-1040-9446; Bednarz, Aleksandra/0000-0003-2256-2998; Gajewska, Malgorzata/0000-0001-7249-8627; , Rafal/0000-0002-7470-0507	National Science Centre [2012/05/E/NZ5/02126]	National Science Centre(National Science Centre, Poland)	This work was supported by The National Science Centre, grant no. 2012/05/E/NZ5/02126 (https://www.ncn.gov.pl/?language = en).	Coyne DW, 2011, KIDNEY INT, V80, P240, DOI 10.1038/ki.2011.141; Egeli AK, 1999, RES VET SCI, V66, P179, DOI 10.1053/rvsc.1998.0223; Frazer DM, 2002, GASTROENTEROLOGY, V123, P835, DOI 10.1053/gast.2002.35353; Ganz T, 2008, BLOOD, V112, P4292, DOI 10.1182/blood-2008-02-139915; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Ganz T, 2009, SEMIN HEMATOL, V46, P387, DOI 10.1053/j.seminhematol.2009.06.001; Gutschow P, 2015, HAEMATOLOGICA, V100, P167, DOI 10.3324/haematol.2014.116723; Ho J, 2011, CLIN J AM SOC NEPHRO, V6, P2340, DOI 10.2215/CJN.01000211; Kemna EHJM, 2007, CLIN CHEM, V53, P620, DOI 10.1373/clinchem.2006.079186; Konz T, 2014, METALLOMICS, V6, P1583, DOI 10.1039/c4mt00063c; Kroot JJC, 2011, CLIN CHEM, V57, P1650, DOI 10.1373/clinchem.2009.140053; Kroot JJC, 2010, CLIN CHEM, V56, P1570, DOI 10.1373/clinchem.2010.149187; Kroot JJC, 2009, HAEMATOL-HEMATOL J, V94, P1748, DOI 10.3324/haematol.2009.010322; Kroot JJC, 2009, ANAL BIOCHEM, V389, P124, DOI 10.1016/j.ab.2009.03.039; Kulaksiz H, 2005, J ENDOCRINOL, V184, P361, DOI 10.1677/joe.1.05729; Laarakkers CMM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075518; Lin L, 2007, BLOOD, V110, P2182, DOI 10.1182/blood-2007-04-087593; Lipinski P, 2010, AM J PATHOL, V177, P1233, DOI 10.2353/ajpath.2010.091020; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Moulouel B, 2013, KIDNEY INT, V84, P756, DOI 10.1038/ki.2013.142; Nicolas G, 2002, P NATL ACAD SCI USA, V99, P4596, DOI 10.1073/pnas.072632499; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Peters HPE, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-70; Peters JC, 2008, J ANIM SCI, V86, P2261, DOI 10.2527/jas.2007-0577; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Rincker MJ, 2005, J ANIM SCI, V83, P2137; Starzynski RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064022; Svoboda M., 2005, Folia Veterinaria, V49, P104; Szabo P, 2002, J VET MED A, V49, P390, DOI 10.1046/j.1439-0442.2002.00448.x; Tjalsma H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016762; Veuthey T, 2008, AM J PHYSIOL-RENAL, V295, pF1213, DOI 10.1152/ajprenal.90216.2008; World Health Organization, 2004, GLOB BURD DIS 2004 U	34	12	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136695	10.1371/journal.pone.0136695	http://dx.doi.org/10.1371/journal.pone.0136695			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26323096	Green Published, Green Submitted, gold			2022-12-26	WOS:000360435500028
J	Davis, A; Taylor, J; Cohen, E				Davis, Arran; Taylor, Jacob; Cohen, Emma			Social Bonds and Exercise: Evidence for a Reciprocal Relationship	PLOS ONE			English	Article							SYNCHRONY; PAIN; PERFORMANCE; PLACEBO; SCALE	In two experimental studies, we investigated mechanisms hypothesized to underpin two pervasive and interrelated phenomena: that certain forms of group movement and exercise lead to social bonding and that social bonding can lead to enhanced exercise performance. In Study 1, we manipulated synchrony and exercise intensity among rowers and found that, compared with low intensity exercise, moderate intensity exercise led to significantly higher levels of cooperation in an economic game; no effect of synchrony vs. non-synchrony was found. In Study 2, we investigated the effects of bonding on performance, using synchrony as a cue of existing supportive social bonds among participants. An elite, highly bonded team of rugby players participated in solo, synchronized, and non-synchronized warm-up sessions; participants' anaerobic performance significantly improved after the brief synchronous warm-up relative to the non-synchronous warm-up. The findings substantiate claims concerning the reciprocal links between group exercise and social bonding, and may help to explain the ubiquity of collective physical activity across cultural domains as varied as play, ritual, sport, and dance.	[Davis, Arran; Taylor, Jacob; Cohen, Emma] Univ Oxford, Inst Cognit & Evolutionary Anthropol, Oxford OX2 6PN, England; [Cohen, Emma] Univ Oxford Wadham Coll, Oxford OX1 3PN, England	University of Oxford; University of Oxford	Davis, A (corresponding author), Univ Oxford, Inst Cognit & Evolutionary Anthropol, 64 Banbury Rd, Oxford OX2 6PN, England.	arran.davis@anthro.ox.ac.uk		Davis, Arran/0000-0002-8561-7768; Taylor, Jacob/0000-0001-9367-0369	British Academy [MD130076]; University of Oxford [132/117]	British Academy; University of Oxford	This work was supported by British Academy (http://www.britac.ac.uk/) Fellowship number MD130076 to EC; and the John Fell Fund (https://www.admin.ox.ac.uk/pras/jff/) award, University of Oxford [number 132/117] to EC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARON A, 1992, J PERS SOC PSYCHOL, V63, P596, DOI 10.1037/0022-3514.63.4.596; Bastian B, 2014, PSYCHOL SCI, V25, P2079, DOI 10.1177/0956797614545886; Beedie CJ, 2009, SPORTS MED, V39, P313, DOI 10.2165/00007256-200939040-00004; Benedetti F, 2013, PHYSIOL REV, V93, P1207, DOI 10.1152/physrev.00043.2012; Bingel U, 2008, PHYSIOLOGY, V23, P371, DOI 10.1152/physiol.00024.2008; Boecker H, 2008, CEREB CORTEX, V18, P2523, DOI 10.1093/cercor/bhn013; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; Buehler A, 2012, FIELDWORK RELIG, V7, P70, DOI 10.1558/fiel.v7i1.70; Carron AV, 2002, J SPORT EXERCISE PSY, V24, P168, DOI 10.1123/jsep.24.2.168; Cohen E, GROUP EXERCISE SOCIA; Cohen E, 2014, RELIG BRAIN BEHAV, V4, P20, DOI 10.1080/2153599X.2012.741075; Cohen EEA, 2010, BIOL LETTERS, V6, P106, DOI 10.1098/rsbl.2009.0670; Dietrich A, 2004, BRIT J SPORT MED, V38, P536, DOI 10.1136/bjsm.2004.011718; Dunbar RIM, 2012, PHILOS T R SOC B, V367, P1837, DOI 10.1098/rstb.2011.0217; Dunbar RIM, 2010, BEHAVIOUR, V147, P775, DOI 10.1163/000579510X501151; Durkheim E., 1995, ELEMENTARY FORMS REL; DUTTON DG, 1974, J PERS SOC PSYCHOL, V30, P510, DOI 10.1037/h0037031; Eisenberger NI, 2011, P NATL ACAD SCI USA, V108, P11721, DOI 10.1073/pnas.1108239108; Fattore L, 2010, EXP NEUROL, V224, P23, DOI 10.1016/j.expneurol.2010.03.020; Fischer R, 2013, HUM NATURE-INT BIOS, V24, P115, DOI 10.1007/s12110-013-9167-y; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Humphrey N, 2012, CURR BIOL, V22, pR695, DOI 10.1016/j.cub.2012.06.018; Julien D, 2000, CAN J BEHAV SCI, V32, P84, DOI 10.1037/h0087103; KEVERNE EB, 1989, PSYCHONEUROENDOCRINO, V14, P155, DOI 10.1016/0306-4530(89)90065-6; Lakens D, 2011, SOC COGNITION, V29, P1, DOI 10.1521/soco.2011.29.1.1; Machin AJ, 2011, BEHAVIOUR, V148, P985, DOI 10.1163/000579511X596624; Master SL, 2009, PSYCHOL SCI, V20, P1316, DOI 10.1111/j.1467-9280.2009.02444.x; MCAULEY E, 1994, J SPORT EXERCISE PSY, V16, P163, DOI 10.1123/jsep.16.2.163; McNeil W. H., 1995, KEEPING TOGETHER TIM; Naugle KM, 2014, MED SCI SPORT EXER, V46, P817, DOI 10.1249/MSS.0000000000000143; Noakes TD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00082; PLINER P, 1974, J EXP SOC PSYCHOL, V10, P17, DOI 10.1016/0022-1031(74)90053-5; Pollak KA, 2014, EXP PHYSIOL, V99, P368, DOI 10.1113/expphysiol.2013.075812; Pollo A, 2008, EUR J NEUROSCI, V28, P379, DOI 10.1111/j.1460-9568.2008.06344.x; Raichlen DA, 2013, EUR J APPL PHYSIOL, V113, P869, DOI 10.1007/s00421-012-2495-5; Raichlen DA, 2012, J EXP BIOL, V215, P1331, DOI 10.1242/jeb.063677; Reddish P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071182; Reddish P, 2014, RELIG BRAIN BEHAV, V4, P3, DOI 10.1080/2153599X.2013.764545; Sullivan P, 2013, INT J SPORT EXERC PS, V11, P286, DOI 10.1080/1612197X.2013.750139; Sullivan PJ, 2014, GROUP DYN-THEOR RES, V18, P122, DOI 10.1037/gdn0000001; Tarr B, SYNCHRONY EXER UNPUB; TOBIN J, 1958, ECONOMETRICA, V26, P24, DOI 10.2307/1907382; Valdesolo P, 2010, J EXP SOC PSYCHOL, V46, P693, DOI 10.1016/j.jesp.2010.03.004; van Baaren RB, 2004, PSYCHOL SCI, V15, P71, DOI 10.1111/j.0963-7214.2004.01501012.x; Velicer W.F., 2000, PROBLEMS SOLUTIONS H, P41, DOI [10.1007/978-1-4615-4397-8_3, DOI 10.1007/978-1-4615-4397-8_3]; Wheatley T, 2012, SOC PERSONAL PSYCHOL, V6, P589, DOI 10.1111/j.1751-9004.2012.00450.x; WHITE GL, 1981, J PERS SOC PSYCHOL, V41, P56, DOI 10.1037/0022-3514.41.1.56; Wiltermuth SS, 2009, PSYCHOL SCI, V20, P1, DOI 10.1111/j.1467-9280.2008.02253.x; Xygalatas D, 2013, PSYCHOL SCI, V24, P1602, DOI 10.1177/0956797612472910; Yee TW, 2010, J STAT SOFTW, V32, P1	53	29	29	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136705	10.1371/journal.pone.0136705	http://dx.doi.org/10.1371/journal.pone.0136705			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ0PO	26317514	Green Published, Green Submitted, gold			2022-12-26	WOS:000360299100125
J	Ellison, MA; Thurman, G; Gearheart, CM; Seewald, RH; Porter, CC; Ambruso, DR				Ellison, Michael A.; Thurman, Gail; Gearheart, Christy M.; Seewald, Ryan H.; Porter, Christopher C.; Ambruso, Daniel R.			INF-gamma Enhances Nox2 Activity by Upregulating phox Proteins When Applied to Differentiating PLB-985 Cells but Does Not Induce Nox2 Activity by Itself	PLOS ONE			English	Article							CHRONIC GRANULOMATOUS-DISEASE; RESPIRATORY BURST OXIDASE; COLONY-STIMULATING FACTOR; NEUTROPHIL CYTOCHROME-B; INTERFERON-GAMMA; NADPH OXIDASE; CYTOSOLIC COMPONENT; GENE-EXPRESSION; LEUKEMIA; METABOLISM	Background The cytokine and drug interferon-gamma enhances superoxide anion production by the antimicrobicidal Nox2 enzyme of neutrophils. Because mature neutrophils have a short lifespan, we hypothesized that the effects of interferon-gamma on these cells might be mediated by its prolonged exposure to differentiating neutrophil precursors in the bone marrow rather than its brief exposure to mature circulating neutrophils. Effects of INF-gamma on Nox2 Activity To address this possibility we exposed the myeloid PLB-985 cell line to interferon-gamma for 3 days in the presence of dimethyl sulfoxide which induces terminal differentiation of these cells. Interferon-gamma was found to enhance superoxide production by Nox2 in a concentration dependent manner. In contrast, application of interferon-gamma alone for 3 days failed to induce detectible Nox2 activity. Additionally, application of interferon-gamma for 3 hours to pre-differentiated PLB-985 cells, which models studies using isolated neutrophils, was much less effective at enhancing superoxide anion production. Effects of INF-gamma on phox Protein Levels Addition of interferon-gamma during differentiation was found to upregulate the Nox2 proteins gp91phox and p47phox in concert with elevated transcription of their genes. The p22phox protein was upregulated in the absence of increased transcription presumably reflecting stabilization resulting from binding to the elevated gp91phox. Thus, increased levels of gp91phox, p47phox and p22phox likely account for the interferon-gamma mediated enhancement of dimethyl sulfoxide-induced Nox2 activity. In contrast, although interferon-gamma alone also increased various phox proteins and their mRNAs, the pattern was very different to that seen with interferon-gamma plus dimethyl sulfoxide. In particular, p47phox was not induced thus explaining the inability of interferon-gamma alone to enhance Nox2 activity. Short application of interferon-gamma to already differentiated cells failed to increase any phox proteins. Conclusions Our findings indicate that interferon-gamma has complex effects on phox protein expression and that these are different in cells undergoing terminal differentiation. Understanding these changes may indicate additional therapeutic uses for this cytokine in human disorders.	[Ellison, Michael A.; Thurman, Gail; Gearheart, Christy M.; Seewald, Ryan H.; Porter, Christopher C.; Ambruso, Daniel R.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA; [Ambruso, Daniel R.] Univ Colorado Denver, Dept Pediat, Aurora, CO USA; [Ambruso, Daniel R.] Univ Colorado Denver, Dept Pathol, Aurora, CO USA; [Ambruso, Daniel R.] Childrens Hosp Colorado, Ctr Canc & Blood Disorders, Transfus Serv, Aurora, CO USA; [Ambruso, Daniel R.] Hematol Oncol & Bone Marrow Transplantat Labs, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado	Ambruso, DR (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA.	Daniel.ambruso@ucdenver.edu	Porter, Christopher/AAE-8918-2020	Porter, Christopher/0000-0001-8774-0180	Horizon Pharma Ireland Ltd; Stacey True Memorial Trust; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER	Horizon Pharma Ireland Ltd; Stacey True Memorial Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study received support from Horizon Pharma Ireland Ltd and the Stacey True Memorial Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlin A, 1997, BLOOD, V89, P3396, DOI 10.1182/blood.V89.9.3396; Ambruso DR, 2012, BIOCHIM BIOPHYS ACTA, V1823, P306, DOI [10.1016/j.bbamcr.2011.11.014, DOI 10.1016/J.BBAMCR.2011.11.014]; Ambruso DR, 2012, KENDIG CHERNICKS DIS, V8; BERTON G, 1986, BIOCHEM BIOPH RES CO, V138, P1276, DOI 10.1016/S0006-291X(86)80421-1; CASSATELLA MA, 1990, J BIOL CHEM, V265, P20241; CASSATELLA MA, 1991, J BIOL CHEM, V266, P22079; CASSATELLA MA, 1988, IMMUNOLOGY, V63, P499; DINAUER MC, 1990, J CLIN INVEST, V86, P1729, DOI 10.1172/JCI114898; Drexler HG, 2003, LEUKEMIA, V17, P416, DOI 10.1038/sj.leu.2402799; Ellis TN, 2004, IMMUNOLOGY, V112, P2, DOI 10.1111/j.1365-2567.2004.01849.x; GALLAGHER R, 1979, BLOOD, V54, P713; GUPTA JW, 1992, CANCER RES, V52, P2530; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kuhns DB, 2010, NEW ENGL J MED, V363, P2600, DOI 10.1056/NEJMoa1007097; Leavey PJ, 1998, BLOOD, V92, P4366, DOI 10.1182/blood.V92.11.4366.423k23_4366_4374; LETO TL, 1991, J BIOL CHEM, V266, P19812; LEVY R, 1990, J IMMUNOL, V145, P2595; NEWBURGER PE, 1988, P NATL ACAD SCI USA, V85, P5215, DOI 10.1073/pnas.85.14.5215; PARKOS CA, 1989, BLOOD, V73, P1416; PARKOS CA, 1987, J CLIN INVEST, V80, P732, DOI 10.1172/JCI113128; Pedruzzi E, 2002, BRIT J HAEMATOL, V117, P719, DOI 10.1046/j.1365-2141.2002.03521.x; Peterson VM, 1994, PHAGOCYTE FUNCTION P; PORTER CD, 1994, BLOOD, V84, P2767; Rosenthal J, 1996, BLOOD, V88, P4321; SEGAL AW, 1987, NATURE, V326, P88, DOI 10.1038/326088a0; TENNENBERG SD, 1993, J LEUKOCYTE BIOL, V53, P301, DOI 10.1002/jlb.53.3.301; TSUNAWAKI S, 1994, BIOCHEM BIOPH RES CO, V199, P1378, DOI 10.1006/bbrc.1994.1383; TUCKER KA, 1987, BLOOD, V70, P372; VERHOEVEN AJ, 1989, BLOOD, V73, P1686; WIENTJES FB, 1993, BIOCHEM J, V296, P557, DOI 10.1042/bj2960557	30	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136766	10.1371/journal.pone.0136766	http://dx.doi.org/10.1371/journal.pone.0136766			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317224	Green Published, gold, Green Submitted			2022-12-26	WOS:000360299100138
J	Kigawa, K; Izumizaki, M; Tsukada, S; Hakuta, N				Kigawa, Kazuyoshi; Izumizaki, Masahiko; Tsukada, Setsuro; Hakuta, Naoyuki			Proprioceptive Interaction between the Two Arms in a Single-Arm Pointing Task	PLOS ONE			English	Article							LIMB POSITION-SENSE; HUMAN ELBOW JOINT; BODY-IMAGE; MUSCLE THIXOTROPY; TENDON VIBRATION; HUMAN FOREARM; ILLUSIONS; MOVEMENT; REPRESENTATION; CONTRACTION	Proprioceptive signals coming from both arms are used to determine the perceived position of one arm in a two-arm matching task. Here, we examined whether the perceived position of one arm is affected by proprioceptive signals from the other arm in a one-arm pointing task in which participants specified the perceived position of an unseen reference arm with an indicator paddle. Both arms were hidden from the participant's view throughout the study. In Experiment 1, with both arms placed in front of the body, the participants received 70-80 Hz vibration to the elbow flexors of the reference arm (=right arm) to induce the illusion of elbow extension. This extension illusion was compared with that when the left arm elbow flexors were vibrated or not. The degree of the vibration-induced extension illusion of the right arm was reduced in the presence of left arm vibration. In Experiment 2, we found that this kinesthetic interaction between the two arms did not occur when the left arm was vibrated in an abducted position. In Experiment 3, the vibration-induced extension illusion of one arm was fully developed when this arm was placed at an abducted position, indicating that the brain receives increased proprioceptive input from a vibrated arm even if the arm was abducted. Our results suggest that proprioceptive interaction between the two arms occurs in a one-arm pointing task when the two arms are aligned with one another. The position sense of one arm measured using a pointer appears to include the influences of incoming information from the other arm when both arms were placed in front of the body and parallel to one another.	[Kigawa, Kazuyoshi; Izumizaki, Masahiko; Tsukada, Setsuro; Hakuta, Naoyuki] Showa Univ, Sch Med, Dept Physiol, Tokyo 142, Japan; [Kigawa, Kazuyoshi; Hakuta, Naoyuki] Showa Univ, Fujigaoka Hosp, Dept Orthopaed Surg, Yokohama, Kanagawa 227, Japan; [Tsukada, Setsuro] Showa Univ, Sch Med, Dept Neurol, Tokyo 142, Japan	Showa University; Showa University; Showa University	Izumizaki, M (corresponding author), Showa Univ, Sch Med, Dept Physiol, Tokyo 142, Japan.	masahiko@med.showa-u.ac.jp						ALLEBECK P, 1976, J PSYCHOSOM RES, V20, P583, DOI 10.1016/0022-3999(76)90060-X; Allen TJ, 2007, J PHYSIOL-LONDON, V580, P423, DOI 10.1113/jphysiol.2006.125161; Allen TJ, 2010, J PHYSIOL-LONDON, V588, P1369, DOI 10.1113/jphysiol.2010.187732; Benson PJ, 1999, BEHAV RES METH INS C, V31, P446, DOI 10.3758/BF03200725; Cafri G., 2004, PSYCHOL MEN MASCULIN, V5, P18, DOI [DOI 10.1037/1524-9220.5.1.18, 10.1037/1524-9220.5.1.18]; CRASKE B, 1977, SCIENCE, V196, P71, DOI 10.1126/science.841342; Duclos C, 2007, GAIT POSTURE, V26, P595, DOI 10.1016/j.gaitpost.2006.12.005; Ferrer-Garcia M, 2008, BEHAV RES METHODS, V40, P394, DOI 10.3758/BRM.40.2.394; Gandevia SC, 1999, J PHYSIOL-LONDON, V514, P609, DOI 10.1111/j.1469-7793.1999.609ae.x; GOODWIN GM, 1972, BRAIN, V95, P705, DOI 10.1093/brain/95.4.705; Gooey K, 2000, EXP BRAIN RES, V133, P340, DOI 10.1007/s002210000380; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; GREGORY JE, 1988, J NEUROPHYSIOL, V59, P1220, DOI 10.1152/jn.1988.59.4.1220; Hakuta N, 2014, EXP BRAIN RES, V232, P2197, DOI 10.1007/s00221-014-3911-3; Inui N, 2011, J PHYSIOL-LONDON, V589, P5775, DOI 10.1113/jphysiol.2011.219949; Ishihara Y, 2004, MUSCLE NERVE, V30, P486, DOI 10.1002/mus.20133; Izumizaki M, 2010, J PHYSIOL-LONDON, V588, P2789, DOI 10.1113/jphysiol.2010.192336; Khan MA, 2006, NEUROSCI BIOBEHAV R, V30, P1106, DOI 10.1016/j.neubiorev.2006.05.002; LACKNER JR, 1983, J NEUROSCI, V3, P2280; LACKNER JR, 1984, EXP NEUROL, V85, P107, DOI 10.1016/0014-4886(84)90165-1; Longo MR, 2012, CURR DIR PSYCHOL SCI, V21, P140, DOI 10.1177/0963721411434982; Longo MR, 2010, P NATL ACAD SCI USA, V107, P11727, DOI 10.1073/pnas.1003483107; Longo MR, 2010, NEUROPSYCHOLOGIA, V48, P655, DOI 10.1016/j.neuropsychologia.2009.08.022; Proske U, 2014, J PHYS FITNESS SPORT, V3, P509, DOI [10.7600/jpfsm.3.509, DOI 10.7600/JPFSM.3.509]; Proske U, 2014, EXP BRAIN RES, V232, P3397, DOI 10.1007/s00221-014-4088-5; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; ROLL JP, 1989, EXP BRAIN RES, V76, P213; Sekihara C, 2007, MUSCLE NERVE, V35, P781, DOI 10.1002/mus.20779; Tsay A, 2015, EXP BRAIN RES, V233, P2635, DOI 10.1007/s00221-015-4334-5; Tsay A, 2014, J PHYSIOL-LONDON, V592, P2679, DOI 10.1113/jphysiol.2013.269365; Tsuge M, 2012, EXP BRAIN RES, V223, P541, DOI 10.1007/s00221-012-3281-7; Walsh LD, 2013, J PHYSIOL-LONDON, V591, P6103, DOI 10.1113/jphysiol.2013.259127; WANN JP, 1992, EXP BRAIN RES, V91, P162; White O, 2009, EXP BRAIN RES, V192, P113, DOI 10.1007/s00221-008-1561-z; Yasuda T, 2006, EUR J APPL PHYSIOL, V96, P511, DOI 10.1007/s00421-005-0102-8	35	5	5	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137031	10.1371/journal.pone.0137031	http://dx.doi.org/10.1371/journal.pone.0137031			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317518	Green Published, gold, Green Submitted			2022-12-26	WOS:000360299100197
J	Noritake, K; Aki, T; Funakoshi, T; Unuma, K; Uemura, K				Noritake, Kanako; Aki, Toshihiko; Funakoshi, Takeshi; Unuma, Kana; Uemura, Koichi			Direct Exposure to Ethanol Disrupts Junctional Cell-Cell Contact and Hippo-YAP Signaling in HL-1 Murine Atrial Cardiomyocytes	PLOS ONE			English	Article							GAP-JUNCTIONS; CONNEXIN EXPRESSION; DEPENDENT MANNER; HEART-FAILURE; LIVING CELLS; PATHWAY; PROTEIN; APOPTOSIS; ALCOHOL; COMMUNICATION	Direct exposure of cardiomyocytes to ethanol causes cardiac damage such as cardiac arrythmias and apoptotic cell death. Cardiomyocytes are connected to each other through intercalated disks (ID), which are composed of a gap junction (GJ), adherens junction, and desmosome. Changes in the content as well as the subcellular localization of connexin43 (Cx43), the main component of the cardiac GJ, are reportedly involved in cardiac arrythmias and subsequent damage. Recently, the hippo-YAP signaling pathway, which links cellular physical status to cell proliferation, differentiation, and apoptosis, has been implicated in cardiac homeostasis under physiological as well as pathological conditions. This study was conducted to explore the possible involvement of junctional intercellular communication, mechanotransduction through cytoskeletal organization, and the hippo-YAP pathway in cardiac damage caused by direct exposure to ethanol. HL-1 murine atrial cardiac cells were used since these cells retain cardiac phenotypes through ID formation and subsequent synchronous contraction. Cells were exposed to 0.5-2% ethanol; significant apoptotic cell death was observed after exposure to 2% ethanol for 48 hours. A decrease in Cx43 levels was already observed after 3 hours exposure to 2% ethanol, suggesting a rapid degradation of this protein. Upon exposure to ethanol, Cx43 translocated into lysosomes. Cellular cytoskeletal organization was also dysregulated by ethanol, as demonstrated by the disruption of myofibrils and intermediate filaments. Coinciding with the loss of cell-cell adherence, decreased phosphorylation of YAP, a hippo pathway effector, was also observed in ethanol-treated cells. Taken together, the results provide evidence that cells exposed directly to ethanol show 1) impaired cell-cell adherence/communication, 2) decreased cellular mechanotransduction by the cytoskeleton, and 3) a suppressed hippo-YAP pathway. Suppression of hippo-YAP pathway signaling should be effective in maintaining cellular homeostasis in cardiomyocytes exposed to ethanol.	[Noritake, Kanako; Aki, Toshihiko; Funakoshi, Takeshi; Unuma, Kana; Uemura, Koichi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Forens Med, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Aki, T (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Forens Med, Tokyo, Japan.	aki.legm@tmd.ac.jp			MEXT KAKENHI [25460862, 25460863];  [13J08099]	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); 	This work was supported by a Grant-in-Aid for JSPS Fellows (grant number 13J08099 to KN) and MEXT KAKENHI (grant number 25460862 to TA and grant number 25460863 to K. Uemura).	Ai X, 2005, CIRC RES, V96, P54, DOI 10.1161/01.RES.0000152325.07495.5a; Beardslee MA, 1998, CIRC RES, V83, P629, DOI 10.1161/01.RES.83.6.629; Bejarano E, 2012, MOL BIOL CELL, V23, P2156, DOI 10.1091/mbc.E11-10-0844; Boengler K, 2005, CARDIOVASC RES, V67, P234, DOI 10.1016/j.cardiores.2005.04.014; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burstein B, 2009, CIRC RES, V105, P1213, DOI 10.1161/CIRCRESAHA.108.183400; Catarino S, 2011, BIOCHEM J, V437, P255, DOI 10.1042/BJ20102059; Chen DB, 2000, LIFE SCI, V67, P1683, DOI 10.1016/S0024-3205(00)00759-1; Chen SN, 2014, CIRC RES, V114, P454, DOI 10.1161/CIRCRESAHA.114.302810; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Dias P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090266; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; ELFOULY MH, 1987, EXP CELL RES, V168, P422, DOI 10.1016/0014-4827(87)90014-0; Falcon-Perez JM, 2005, J CELL SCI, V118, P5243, DOI 10.1242/jcs.02633; Falk MM, 2014, FEBS LETT, V588, P1221, DOI 10.1016/j.febslet.2014.01.031; Fong JT, 2012, AUTOPHAGY, V8, P794, DOI 10.4161/auto.19390; Guan ZJ, 2004, J CARDIOVASC PHARM, V44, P696, DOI 10.1097/00005344-200412000-00012; Gumbiner BM, 2014, J CELL SCI, V127, P709, DOI 10.1242/jcs.140103; Hata Y, 2013, MAR DRUGS, V11, P896, DOI 10.3390/md11030896; Heallen T, 2013, DEVELOPMENT, V140, P4683, DOI 10.1242/dev.102798; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Hesketh GG, 2010, CIRC RES, V106, P1153, DOI 10.1161/CIRCRESAHA.108.182147; Hills CE, 2009, CELL PHYSIOL BIOCHEM, V24, P177, DOI 10.1159/000233244; Ilanges A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078880; Kameritsch P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.105; Lai YJ, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-72; Laonigro I, 2009, EUR J HEART FAIL, V11, P453, DOI 10.1093/eurjhf/hfp037; Ma H, 2010, J MOL CELL CARDIOL, V49, P322, DOI 10.1016/j.yjmcc.2010.03.017; Nakase T, 2003, STROKE, V34, P1987, DOI 10.1161/01.STR.0000079814.72027.34; Noorman M, 2009, J MOL CELL CARDIOL, V47, P23, DOI 10.1016/j.yjmcc.2009.03.016; Noritake K, 2012, TOXICOL IN VITRO, V26, P849, DOI 10.1016/j.tiv.2012.04.027; Oyamada M, 2013, BBA-BIOMEMBRANES, V1828, P118, DOI 10.1016/j.bbamem.2011.12.031; Reits EAJ, 1997, EMBO J, V16, P6087, DOI 10.1093/emboj/16.20.6087; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; Salah Z, 2013, CELL CYCLE, V12, P3817, DOI 10.4161/cc.26672; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Severs NJ, 2004, BBA-BIOMEMBRANES, V1662, P138, DOI 10.1016/j.bbamem.2003.10.019; Sheikh F, 2009, TRENDS CARDIOVAS MED, V19, P182, DOI 10.1016/j.tcm.2009.12.001; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Smyth JW, 2010, J CLIN INVEST, V120, P266, DOI 10.1172/JCI39740; Subach OM, 2011, NAT METHODS, V8, P771, DOI 10.1038/nmeth.1664; Valiunas V, 2002, CIRC RES, V91, P104, DOI 10.1161/01.RES.0000025638.24255.AA; Vinken M, 2012, TOXICOL SCI, V125, P175, DOI 10.1093/toxsci/kfr277; Walker RK, 2013, ALCOHOL CLIN EXP RES, V37, P1253, DOI 10.1111/acer.12109; Xin M, 2013, P NATL ACAD SCI USA, V110, P13839, DOI 10.1073/pnas.1313192110; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zhuo L, 2013, TOXICOLOGY, V310, P61, DOI 10.1016/j.tox.2013.05.013	47	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136952	10.1371/journal.pone.0136952	http://dx.doi.org/10.1371/journal.pone.0136952			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317911	Green Submitted, Green Published, gold			2022-12-26	WOS:000360299100184
J	Sanfelix-Gimeno, G; Hurtado, I; Sanfelix-Genoves, J; Baixauli-Perez, C; Rodriguez-Bernal, CL; Peiro, S				Sanfelix-Gimeno, Gabriel; Hurtado, Isabel; Sanfelix-Genoves, Jose; Baixauli-Perez, Cristobal; Rodriguez-Bernal, Clara L.; Peiro, Salvador			Overuse and Underuse of Antiosteoporotic Treatments According to Highly Influential Osteoporosis Guidelines: A Population-Based Cross-Sectional Study in Spain	PLOS ONE			English	Article							HEALTH-CARE SERVICES; FRACTURE RISK-FACTORS; POSTMENOPAUSAL WOMEN; VERTEBRAL FRACTURE; ESOSVAL COHORT; UNITED-STATES; VALENCIA; QUALITY; PROBABILITY; PREVALENCE	Inappropriate prescribing of antiosteoporotic medications has been observed; however, the joint study of both overuse and underuse has barely been attempted. Spain, with its high utilization rates, constitutes a good example to assess differences in over and under use according to diverse highly-influential osteoporosis guidelines (HIOG) worldwide. We used data of a population-based cross-sectional study including 824 post-menopausal women >= 50 years old living in the city of Valencia, Spain and aimed to estimate the percentage of women eligible for treatment, and the proportion of overuse and underuse of antiosteoporotic treatment according to HIOG. The prevalence of antiosteoporotic treatment in postmenopausal women >= 50 in Valencia was 20.9% (95% CI: 17.6-24.4). The type of antiosteoporotic drugs prescribed varied greatly depending on the medical specialty responsible of the initial prescription. When applying the HIOG, the percentage of women 50 and over who should be treated varied from less than 9% to over 44%. In real terms, from the approximately eight million women of 50 years old and over in Spain, the number eligible for treatment would range from 0.7 to 3.8 million, depending on the guideline used. A huge proportion of inappropriate treatments was found when applying these guidelines to the Spanish population, combining a high overuse (42-78% depending on the guideline used) and underuse (7-41%). In conclusion, we found that the pharmacological management of osteoporosis in women of 50 and over in this population combines an important overuse and, to a lesser extent, underuse, although the level of inappropriateness varied strikingly depending on the CPG used. It seems urgent to reduce treatment overuse without neglecting underuse, as is urgent an attempt to reach wider agreement worldwide regarding osteoporosis management, in order to facilitate appropriate treatment and development of policies to reduce effectively treatment inappropriateness.	[Sanfelix-Gimeno, Gabriel; Hurtado, Isabel; Sanfelix-Genoves, Jose; Baixauli-Perez, Cristobal; Rodriguez-Bernal, Clara L.; Peiro, Salvador] Ctr Publ Hlth Res FISABIO, Hlth Serv Res Unit, Valencia, Spain; [Sanfelix-Gimeno, Gabriel; Hurtado, Isabel; Sanfelix-Genoves, Jose; Baixauli-Perez, Cristobal; Rodriguez-Bernal, Clara L.; Peiro, Salvador] Red Invest Serv Salud Enfermedades Cronicas REDIS, Valencia, Spain; [Sanfelix-Genoves, Jose] Fdn Invest Hosp Clin Univ, Inst Invest Sanitaria INCLIVA, Valencia, Spain		Sanfelix-Gimeno, G (corresponding author), Ctr Publ Hlth Res FISABIO, Hlth Serv Res Unit, Valencia, Spain.	sanfelix_gab@gva.es	Hurtado, Isabel/I-3395-2017; Sanfélix-Gimeno, Gabriel/E-9140-2012; Rodriguez-Bernal, Clara/ABF-9659-2021; Peiro, Salvador/H-5778-2017	Hurtado, Isabel/0000-0002-8475-8112; Sanfélix-Gimeno, Gabriel/0000-0001-7098-4576; Rodriguez-Bernal, Clara/0000-0003-2617-8635; Peiro, Salvador/0000-0002-3902-569X; Baixauli Perez, Cristobal/0000-0002-7567-0995	Ministry of Health of the Autonomous Government of Valencia [0018/2005]; Sanofi-Aventis	Ministry of Health of the Autonomous Government of Valencia; Sanofi-Aventis(Sanofi-Aventis)	The FRAVO study was funded by the Ministry of Health of the Autonomous Government of Valencia (Project 0018/2005) and a non-conditioned research grant from Sanofi-Aventis. None of the sponsors were involved in the design and conduct of the study; collection, management, analysis, or interpretation of the data; and preparation, review, or approval of the manuscript. The views expressed in this article are those of the authors and do not necessarily represent the views of the Center for Public Health Research (CSISP-FISABIO), Red de Investigacion en Servicios de Salud en Enfermedades Cronicas (REDISSEC), Valencia, Spain; or Fundacion de Investigacion del Hospital Clinico Universitario - Instituto de Investigacion Sanitaria INCLIVA. Valencia, Spain. No additional funding and support declared in our competing interest statement are specific to this study.	Andrade SE, 2003, ARCH INTERN MED, V163, P2052, DOI 10.1001/archinte.163.17.2052; [Anonymous], 2008, OST MAN AT PRIM; [Anonymous], 2010, GUIA PRACT CLIN OST; [Anonymous], 2006, DOC CLIN SEMERGEN OS; Bolland MJ, 2010, J CLIN ENDOCR METAB, V95, P1856, DOI 10.1210/jc.2009-2157; Chan KS, 2013, MED CARE RES REV, V70, P473, DOI 10.1177/1077558713492202; Chassin MR, 1998, JAMA-J AM MED ASSOC, V280, P1000, DOI 10.1001/jama.280.11.1000; de Felipe R, 2010, ATEN PRIM, V42, P559, DOI 10.1016/j.aprim.2009.10.022; Diez-Perez A, 2011, BONE, V49, P493, DOI 10.1016/j.bone.2011.05.007; Eisenberg JM, 2002, MED CARE, V40, P1016, DOI 10.1097/00005650-200211000-00004; Emery DJ, 2013, JAMA INTERN MED, V173, P823, DOI 10.1001/jamainternmed.2013.3804; Salgueiro ME, 2013, MATURITAS, V74, P74, DOI 10.1016/j.maturitas.2012.10.002; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Grupo de trabajo de la Guia de Practica Clinica sobre Osteoporosis y Prevencion de Fracturas por Fragilidad-Guia Salud. Guia de Practica Clinica sobre Osteoporosis yPrevencion de Fracturas por Fragilidad, 2010, GUIA PRACT CLIN OST; Hernlund E, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0136-1; Hurtado I, 2014, J CLIN ENDOCR METAB, V99, P142, DOI 10.1210/jc.2013-3448; Kale MS, 2013, JAMA INTERN MED, V173, P142, DOI 10.1001/2013.jamainternmed.1022; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Kanis JA, 2012, OSTEOPOROSIS INT, V23, P2239, DOI 10.1007/s00198-012-1964-3; Keyhani S, 2008, HEALTH SERV RES, V43, P1923, DOI 10.1111/j.1475-6773.2008.00920.x; Korenstein D, 2012, ARCH INTERN MED, V172, P171, DOI 10.1001/archinternmed.2011.772; Leslie WD, 2012, OSTEOPOROSIS INT, V23, P1623, DOI 10.1007/s00198-011-1630-1; Lipitz-Snyderman A, 2013, JAMA INTERN MED, V173, P1277, DOI 10.1001/jamainternmed.2013.6181; Liu SK, 2013, J AM GERIATR SOC, V61, P1855, DOI 10.1111/jgs.12507; Martinez JMO, 2008, REV CLIN ESP, V208, P247, DOI 10.1157/13119919; National Institute for Clinical Excellence (NICE), 2011, NICE TECHN APPR GUID, V217; National Osteoporosis Foundation (NOF), 2010, CLIN GUID PREV TREAT; National Osteoporosis Guideline Group (NOGG) on behalf of the Bone Research Society British Geriatrics Society British Orthopaedic Association British Society of Rheumatology National Osteoporosis Society Osteoporosis 2000 Osteoporosis Dorset Primary Care Rheumatology Society Royal College of Physicians and Society for Endocrinology, 2010, OST 2000 OST DORS PR; Naves M, 2003, OSTEOPOROSIS INT, V14, P520, DOI 10.1007/s00198-003-1405-4; Papaioannou A, 2010, CAN MED ASSOC J, V182, P1864, DOI 10.1503/cmaj.100771; PARK RE, 1986, AM J PUBLIC HEALTH, V76, P766, DOI 10.2105/AJPH.76.7.766; Edo LP, 2011, REUMATOL CLIN, V7, P357, DOI 10.1016/j.reuma.2011.05.013; Richards M, 2010, EXTENT CAUSES INT VA; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sanfelix-Genoves J, 2013, OSTEOPOROSIS INT, V24, P1045, DOI 10.1007/s00198-012-2018-6; Sanfelix-Genoves J, 2012, OSTEOPOROSIS INT, V23, P2129, DOI 10.1007/s00198-011-1819-3; Sanfelix-Genoves J, 2014, MED CLIN-BARCELONA, V142, P15, DOI 10.1016/j.medcli.2012.10.025; Sanfelix-Genoves J, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-20; Sanfelix-Genoves J, 2010, BONE, V47, P610, DOI 10.1016/j.bone.2010.06.015; Sanfelix-Gimeno G, 2013, BONE, V52, P393, DOI 10.1016/j.bone.2012.10.022; Smetana GW, 2007, ARCH INTERN MED, V167, P10, DOI 10.1001/archinte.167.1.10; Wang L, 2013, PRIM HEALTH CARE RES, V14, P1, DOI 10.1017/S1463423612000114	42	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135475	10.1371/journal.pone.0135475	http://dx.doi.org/10.1371/journal.pone.0135475			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ0PO	26317872	Green Published, Green Submitted, gold			2022-12-26	WOS:000360299100032
J	Wang, XY; Huang, ZX; Chen, YG; Lu, X; Zhu, P; Wen, K; Fu, N; Liu, BY				Wang, Xiang-Yu; Huang, Zhao-Xia; Chen, Yi-Guo; Lu, Xiao; Zhu, Ping; Wen, Kun; Fu, Ning; Liu, Bei-Yi			A Multiple Antigenic Peptide Mimicking Peptidoglycan Induced T Cell Responses to Protect Mice from Systemic Infection with Staphylococcus aureus	PLOS ONE			English	Article							IMMUNE-RESPONSES; VACCINE; INTERLEUKIN-17A; HOST; EPITOPES; SURVIVAL; ANTIBODY; GAMMA; IMMUNIZATION; NEUTROPHIL	Due to the enormous capacity of Staphylococcus aureus to acquire antibiotic resistance, it becomes imperative to develop vaccines for decreasing the risk of its life-threatening infections. Peptidoglycan (PGN) is a conserved and major component of S. aureus cell wall. However, it has not been used as a vaccine candidate since it is a thymus-independent antigen. In this study, we synthesized a multiple antigenic peptide, named MAP27, which comprised four copies of a peptide that mimics the epitope of PGN. After immunization with MAP27 five times and boosting with heat-inactivated bacterium one time, anti-MAP27 serum bound directly to S. aureus or PGN. Immunization with MAP27 decreased the bacterial burden in organs of BALB/c mice and significantly prolonged their survival time after S. aureus lethal-challenge. The percentage of IFN-gamma(+)CD3(+) T cells and IL-17(+)CD4(+) T cells in spleen, as well as the levels of IFN-gamma, IL-17A/F and CCL3 in spleen and lung, significantly increased in the MAP27-immunized mice after infection. Moreover, in vitro incubation of heat-inactivated S. aureus with splenocytes isolated from MAP27-immunized mice stimulated the production of IFN-gamma and IL-17A/F. Our findings demonstrated that MAP27, as a thymus-dependent antigen, is efficient at eliciting T cell-mediated responses to protect mice from S. aureus infection. This study sheds light on a possible strategy to design vaccines against S. aureus.	[Wang, Xiang-Yu; Huang, Zhao-Xia; Chen, Yi-Guo; Lu, Xiao; Zhu, Ping; Fu, Ning; Liu, Bei-Yi] Southern Med Univ, Sch Basic Med Sci, Dept Immunol, Guangzhou, Guangdong, Peoples R China; [Wen, Kun; Fu, Ning] Southern Med Univ, Zhujiang Hosp, Lab Emerging Infect Dis, Guangzhou, Guangdong, Peoples R China; [Wen, Kun; Fu, Ning] Southern Med Univ, Zhujiang Hosp, Div Lab Med, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Liu, BY (corresponding author), Southern Med Univ, Sch Basic Med Sci, Dept Immunol, Guangzhou, Guangdong, Peoples R China.	lbydodo@163.com	WEN, Kun/AAD-7962-2019	WEN, Kun/0000-0002-4331-0661	National Natural Science Foundation of China [31270980]; Guangdong Natural Science Foundation [S2012010009562]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This research was supported by National Natural Science Foundation of China (Grant No: 31270980) to BYL and Guangdong Natural Science Foundation (Grant No: S2012010009562) to BYL. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amexis G, 2007, VIRAL IMMUNOL, V20, P657, DOI 10.1089/vim.2007.0029; Archer NK, 2013, INFECT IMMUN, V81, P2070, DOI 10.1128/IAI.00084-13; Bhattacharya P, 2014, CLIN IMMUNOL, V153, P187, DOI 10.1016/j.clim.2014.04.014; Bolesta E, 2005, CANCER RES, V65, P3410, DOI 10.1158/0008-5472.CAN-04-2164; Broker BM, 2014, INT J MED MICROBIOL, V304, P204, DOI 10.1016/j.ijmm.2013.11.008; Broughan J, 2011, EXPERT REV VACCINES, V10, P695, DOI [10.1586/ERV.11.54, 10.1586/erv.11.54]; Chen YG, 2011, J MED MICROBIOL, V60, P995, DOI 10.1099/jmm.0.028647-0; Chen Z, 2013, J IMMUNOL, V190, P5256, DOI 10.4049/jimmunol.1201675; Cheng P, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-38; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Elshabrawy HA, 2014, J VIROL, V88, P4353, DOI 10.1128/JVI.03050-13; Elshabrawy HA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050366; Farooq SM, 2013, CNS NEUROSCI THER, V19, P503, DOI 10.1111/cns.12087; Farooq SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048635; FITCH FW, 1993, ANNU REV IMMUNOL, V11, P29, DOI 10.1146/annurev.immunol.11.1.29; Fleuridor R, 2001, J IMMUNOL, V166, P1087, DOI 10.4049/jimmunol.166.2.1087; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Foster TJ, 2009, VET DERMATOL, V20, P456, DOI 10.1111/j.1365-3164.2009.00825.x; Fowler VG, 2014, CLIN MICROBIOL INFEC, V20, P66, DOI 10.1111/1469-0691.12570; Fujita Y, 2011, CHEM CENT J, V5, DOI 10.1186/1752-153X-5-48; Hanke ML, 2013, J IMMUNOL, V190, P2159, DOI 10.4049/jimmunol.1202348; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Holley MM, 2012, J IMMUNOL, V188, P1360, DOI 10.4049/jimmunol.1101660; Ishida W, 2013, BRIT J OPHTHALMOL, V97, P492, DOI 10.1136/bjophthalmol-2012-302639; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Joshi A, 2012, HUM VACC IMMUNOTHER, V8, P336, DOI DOI 10.4161/HV.18946; Karpus WJ, 1997, J IMMUNOL, V158, P4129; Lin L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000703; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Lowy FD, 2011, NEW ENGL J MED, V364, P1987, DOI 10.1056/NEJMp1100251; Ma JH, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-227; Mahajan B, 2010, INFECT IMMUN, V78, P4613, DOI 10.1128/IAI.00533-10; Miron N, 2014, IMMUNOL INVEST, V43, P267, DOI 10.3109/08820139.2013.868474; Montgomery CP, 2014, INFECT IMMUN, V82, P2125, DOI 10.1128/IAI.01491-14; Monzavi-Karbassi B, 2001, INT IMMUNOL, V13, P1361, DOI 10.1093/intimm/13.11.1361; Murphy AG, 2014, J IMMUNOL, V192, P3697, DOI 10.4049/jimmunol.1303420; Narita K, 2010, INFECT IMMUN, V78, P4234, DOI 10.1128/IAI.00447-10; Oscherwitz J, 2010, J IMMUNOL, V185, P3661, DOI 10.4049/jimmunol.1001749; Ota S, 2002, CANCER RES, V62, P1471; Sato E, 2000, J LAB CLIN MED, V135, P161, DOI 10.1067/mlc.2000.104307; Schmaler M, 2011, J IMMUNOL, V186, P443, DOI 10.4049/jimmunol.1001407; Spellberg B, 2008, INFECT IMMUN, V76, P4574, DOI 10.1128/IAI.00700-08; TAM JP, 1988, P NATL ACAD SCI USA, V85, P5409, DOI 10.1073/pnas.85.15.5409; Uppada SB, 2011, VACCINE, V29, P9352, DOI 10.1016/j.vaccine.2011.09.129; Vollmer W, 2010, TRENDS MICROBIOL, V18, P59, DOI 10.1016/j.tim.2009.12.004; Wang YH, 2011, VACCINE, V29, P8619, DOI 10.1016/j.vaccine.2011.09.016; WOLPE SD, 1989, FASEB J, V3, P2565, DOI 10.1096/fasebj.3.14.2687068; Zhao YX, 1998, IMMUNOLOGY, V93, P80; Zuo QF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081212	50	5	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136888	10.1371/journal.pone.0136888	http://dx.doi.org/10.1371/journal.pone.0136888			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317210	Green Submitted, gold, Green Published			2022-12-26	WOS:000360299100162
J	Zou, J; Shankar, N				Zou, Jun; Shankar, Nathan			Roles of TLR/MyD88/MAPK/NF-kappa B Signaling Pathways in the Regulation of Phagocytosis and Proinflammatory Cytokine Expression in Response to E. faecalis Infection	PLOS ONE			English	Article							ENTEROCOCCUS-FAECALIS; LIPOTEICHOIC ACID; BACTERIA; MACROPHAGES; SEPSIS; EPIDEMIOLOGY; CONTRIBUTES; ACTIVATION; MECHANISMS; PATHOGENS	Enterococcus faecalis is a commensal bacterium residing in the gastrointestinal tract of mammals, but in certain situations it is also an opportunistic pathogen which can cause serious disease. Macrophages have been shown to play a critical role in controlling infections by commensal enterococci and also have an important role in mediating chromosomal instability and promoting colon cancer during high-level enterococcal colonization in genetically susceptible mice. However, the molecular mechanisms involved in the interaction of macrophages with enterococci during infection are not fully understood. In this study, using BMDM and RAW264.7 macrophages we show that enterococcal infection activates ERK, JNK and p38 MAPK as well as NF-kappa B, and drives polarization of macrophages towards the M1 phenotype. Inhibition of NF-kappa B activation significantly reduced the expression of TNF-alpha and IL-1 beta, as did the inhibition of ERK, JNK and p38 MAPK, although to differing extent. Enterococci-induced activation of these pathways and subsequent cytokine expression was contact dependent, modest compared to activation by E. coli and, required the adaptor protein MyD88. Phagocytosis of enterococci by macrophages was enhanced by preopsonization with E. faecalis antiserum and involved the ERK and JNK signaling pathways, with the adaptor protein MyD88 as an important mediator. This study of the interaction of macrophages with enterococci could provide a foundation for studying the pathogenesis of infection by this opportunistic pathogen and to developing new therapeutic approaches to combat enterococcal infection.	[Zou, Jun; Shankar, Nathan] Univ Oklahoma, Hlth Sci Ctr, Dept Pharmaceut Sci, Oklahoma City, OK 73106 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Shankar, N (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Pharmaceut Sci, Oklahoma City, OK 73106 USA.	nathan-shankar@ouhsc.edu	ZOU, JUN/AAD-3904-2019		University of Oklahoma	University of Oklahoma	The authors received no specific funding for this work. Part of this work was supported through a President's Associates Presidential Professorship awarded to NS by the University of Oklahoma.	Baik JE, 2008, J ENDODONT, V34, P975, DOI 10.1016/j.joen.2008.05.005; Bar K, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-145; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Boldrick JC, 2002, P NATL ACAD SCI USA, V99, P972, DOI 10.1073/pnas.231625398; Caamano J, 2002, CLIN MICROBIOL REV, V15, P414, DOI 10.1128/CMR.15.3.414-429.2002; CELADA A, 1984, J EXP MED, V160, P55, DOI 10.1084/jem.160.1.55; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; DZIWISCH L, 1988, MED MICROBIOL IMMUN, V177, P101; Edmond MB, 1996, CLIN INFECT DIS, V23, P1234, DOI 10.1093/clinids/23.6.1234; Fazal N, 2012, FEMS IMMUNOL MED MIC, V64, P191, DOI 10.1111/j.1574-695X.2011.00881.x; Fisher K, 2009, MICROBIOL-SGM, V155, P1749, DOI 10.1099/mic.0.026385-0; Fitzgerald ML, 2000, J IMMUNOL, V164, P2692, DOI 10.4049/jimmunol.164.5.2692; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Hermann C, 2002, EUR J IMMUNOL, V32, P541, DOI 10.1002/1521-4141(200202)32:2<541::AID-IMMU541>3.0.CO;2-P; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Imajo M, 2006, IUBMB LIFE, V58, P312, DOI 10.1080/15216540600746393; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Leendertse M, 2008, J IMMUNOL, V180, P4865, DOI 10.4049/jimmunol.180.7.4865; Leendertse Masja, 2009, Innate Immun, V15, P3, DOI 10.1177/1753425908100238; McBride SM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000582; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; O'Shea JJ, 2002, NAT REV IMMUNOL, V2, P37, DOI 10.1038/nri702; Papasian CJ, 2002, INFECT IMMUN, V70, P6628, DOI 10.1128/IAI.70.12.6628-6637.2002; Park OJ, 2013, J LEUKOCYTE BIOL, V94, P1275, DOI 10.1189/jlb.1012522; Saito S, 2006, CLIN VACCINE IMMUNOL, V13, P876, DOI 10.1128/CVI.00075-06; Sands KE, 1997, JAMA-J AM MED ASSOC, V278, P234, DOI 10.1001/jama.278.3.234; Shankar V, 1999, INFECT IMMUN, V67, P193, DOI 10.1128/IAI.67.1.193-200.1999; Theilacker C, 2006, INFECT IMMUN, V74, P5703, DOI 10.1128/IAI.00570-06; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Underhill DM, 2012, NAT REV IMMUNOL, V12, P492, DOI 10.1038/nri3244; Wang SG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097523; Wang XM, 2015, GUT, V64, P459, DOI 10.1136/gutjnl-2014-307213; Yang YH, 2013, TRANSL ONCOL, V6, P596, DOI 10.1593/tlo.13412; Zou J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112010; Zou J, 2014, INFECT IMMUN, V82, P5132, DOI 10.1128/IAI.02426-14	37	22	27	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136947	10.1371/journal.pone.0136947	http://dx.doi.org/10.1371/journal.pone.0136947			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317438	Green Submitted, gold, Green Published			2022-12-26	WOS:000360299100180
J	Gupta, S; Rao, AR; Varadwaj, PK; De, S; Mohapatra, T				Gupta, Saurabh; Rao, Atmakuri Ramakrishna; Varadwaj, Pritish Kumar; De, Sachinandan; Mohapatra, Trilochan			Extrapolation of Inter Domain Communications and Substrate Binding Cavity of Camel HSP70 1A: A Molecular Modeling and Dynamics Simulation Study	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; CHAPERONE ACTIVITY; INTERDOMAIN COMMUNICATION; SERINE PROTEINASE; STRUCTURAL BASIS; MECHANISM; SYSTEM; SERVER; HSC70	Heat shock protein 70 (HSP70) is an important chaperone, involved in protein folding, refolding, translocation and complex remodeling reactions under normal as well as stress conditions. However, expression of HSPA1A gene in heat and cold stress conditions associates with other chaperons and perform its function. Experimental structure for Camel HSP70 protein (cHSP70) has not been reported so far. Hence, we constructed 3D models of cHSP70 through multi-template comparative modeling with HSP110 protein of S. cerevisiae (open state) and with HSP70 protein of E. coli 70kDa DnaK (close state) and relaxed them for 100 nanoseconds (ns) using all-atom Molecular Dynamics (MD) Simulation. Two stable conformations of cHSP70 with Substrate Binding Domain (SBD) in open and close states were obtained. The collective mode analysis of different transitions of open state to close state and vice versa was examined via Principal Component Analysis (PCA) and Minimum Distance Matrix (MDM). The results provide mechanistic representation of the communication between Nucleotide Binding Domain (NBD) and SBD to identify the role of sub domains in conformational change mechanism, which leads the chaperone cycle of cHSP70. Further, residues present in the chaperon functioning site were also identified through protein-peptide docking. This study provides an overall insight into the inter domain communication mechanism and identification of the chaperon binding cavity, which explains the underlying mechanism involved during heat and cold stress conditions in camel.	[Gupta, Saurabh; Rao, Atmakuri Ramakrishna] ICAR Indian Agr Stat Res Inst, Ctr Agr Bioinformat, New Delhi 110012, India; [Gupta, Saurabh; Varadwaj, Pritish Kumar] Indian Inst Informat Technol, Dept Bioinformat, Allahabad 210012, Uttar Pradesh, India; [De, Sachinandan] ICAR Natl Dairy Res Inst, Anim Biotechnol Ctr, Karnal 132001, India; [Mohapatra, Trilochan] ICAR Cent Rice Res Inst, Cuttack 753006, Odisha, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Statistics Research Institute; Indian Institute of Information Technology Allahabad; Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - National Rice Research Institute	Rao, AR (corresponding author), ICAR Indian Agr Stat Res Inst, Ctr Agr Bioinformat, Lib Ave, New Delhi 110012, India.	rao.cshl.work@gmail.com	Varadwaj, Pritish Kumar/AAS-2394-2020; Gupta, Saurabh/F-9004-2017	Varadwaj, Pritish Kumar/0000-0001-5706-2411; Gupta, Saurabh/0000-0002-1327-7389; Rao, Atmakuri Ramakrishna/0000-0002-3914-6248; De, Sachinandan/0000-0002-3182-0904	World Bank-funded National Agricultural Innovation Project (NAIP) [NAIP/Comp-4/C4/C-30033/2008-09]; CABin scheme of ICAR-IASRI [Agril.Edn.4-1/2013-AP]	World Bank-funded National Agricultural Innovation Project (NAIP); CABin scheme of ICAR-IASRI	The study received financial support from World Bank-funded National Agricultural Innovation Project (NAIP) grant NAIP/Comp-4/C4/C-30033/2008-09 and CABin scheme of ICAR-IASRI grant Agril.Edn.4-1/2013-A&P.	Abdallah H. R., 2012, Emirates Journal of Food and Agriculture, V24, P272; Aggarwal A, 2012, SPRINGER SCI BUSINES, DOI [10.1007/978-81-322-0879-2, DOI 10.1007/978-81-322-0879-2]; Ahmad S, 2010, PAK VET J, V30, P191; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Balsera MA, 1996, J PHYS CHEM-US, V100, P2567, DOI 10.1021/jp9536920; Banerjee D, 2014, CELL STRESS CHAPERON, V19, P401, DOI 10.1007/s12192-013-0469-0; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Brehmer D, 2001, NAT STRUCT BIOL, V8, P427, DOI 10.1038/87588; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; Chang YW, 2008, J BIOL CHEM, V283, P15502, DOI 10.1074/jbc.M708992200; Chiappori F, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002844; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Garbuz DG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027205; Grosberg A.Y., 1994, STAT PHYS MACROMOLEC; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HUNENBERGER PH, 1995, J MOL BIOL, V252, P492, DOI 10.1006/jmbi.1995.0514; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; Kakkar V, 2014, DIS MODEL MECH, V7, P421, DOI 10.1242/dmm.014563; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kaur H, 2007, PROTEIN PEPTIDE LETT, V14, P626; Kishore A, 2014, CELL STRESS CHAPERON, V19, P613, DOI 10.1007/s12192-013-0486-z; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Lou HF, 2006, J PHYS CHEM B, V110, P12796, DOI 10.1021/jp061976m; Maisuradze GG, 2009, J MOL BIOL, V385, P312, DOI 10.1016/j.jmb.2008.10.018; Maupetit J, 2009, NUCLEIC ACIDS RES, V37, pW498, DOI 10.1093/nar/gkp323; Mayer MP, 2010, MOL CELL, V39, P321, DOI 10.1016/j.molcel.2010.07.012; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mintseris J, 2007, PROTEINS, V69, P511, DOI 10.1002/prot.21502; MORSHAUSER RC, 1995, BIOCHEMISTRY-US, V34, P6261, DOI 10.1021/bi00019a001; Nicolai A, 2010, J CHEM THEORY COMPUT, V6, P2501, DOI 10.1021/ct1002169; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pierce BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024657; Polier S, 2008, CELL, V133, P1068, DOI 10.1016/j.cell.2008.05.022; Prasad CVSS, 2013, APPL BIOCHEM BIOTECH, V170, P1996, DOI 10.1007/s12010-013-0342-8; Prasad CVSS, 2013, BIOINFORMATION, V9, P1, DOI 10.6026/97320630009001; Prasad CVSS, 2012, BIOINFORMATION, V8, P673, DOI 10.6026/97320630008673; Qi RF, 2013, NAT STRUCT MOL BIOL, V20, P900, DOI 10.1038/nsmb.2583; Raveh B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018934; Robert J, 2003, DEV COMP IMMUNOL, V27, P449, DOI 10.1016/S0145-305X(02)00160-X; Sanchez R, 2000, METH MOL B, V143, P97; Schuermann JP, 2008, MOL CELL, V31, P232, DOI 10.1016/j.molcel.2008.05.006; Silver JT, 2012, CELL STRESS CHAPERON, V17, P1, DOI 10.1007/s12192-011-0290-6; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Xu XP, 2012, J BIOL CHEM, V287, P5661, DOI 10.1074/jbc.M111.275057	53	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136630	10.1371/journal.pone.0136630	http://dx.doi.org/10.1371/journal.pone.0136630			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313938	Green Published, gold, Green Submitted			2022-12-26	WOS:000360144000077
J	Liao, RR; Wang, Z; Chen, Q; Tu, YY; Chen, ZL; Wang, QS; Yang, CS; Zhang, XZ; Pan, YC				Liao, Rongrong; Wang, Zhen; Chen, Qiang; Tu, Yingying; Chen, Zhenliang; Wang, Qishan; Yang, Changsuo; Zhang, Xiangzhe; Pan, Yuchun			An Efficient Genotyping Method in Chicken Based on Genome Reducing and Sequencing	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; LINKAGE DISEQUILIBRIUM; WIDE ASSOCIATION; SNP DISCOVERY; POPULATION; MICROARRAYS; EXTENT; LOCI	Single nucleotide polymorphisms (SNPs) are essential for identifying the genetic mechanisms of complex traits. In the present study, we applied genotyping by genome reducing and sequencing (GGRS) method to construct a 252-plex sequencing library for SNP discovery and genotyping in chicken. The library was successfully sequenced on an Illumina HiSeq 2500 sequencer with a paired-end pattern; approximately 400 million raw reads were generated, and an average of approximately 1.4 million good reads per sample were generated. A total of 91,767 SNPs were identified after strict filtering, and all of the 252 samples and all of the chromosomes were well represented. Compared with the Illumina 60K chicken SNP chip data, approximately 34,131 more SNPs were identified using GGRS, and a higher SNP density was found using GGRS, which could be beneficial for downstream analysis. Using the GGRS method, more than 3528 samples can be sequenced simultaneously, and the cost is reduced to $ 18 per sample. To the best of our knowledge, this study describes the first report of such highly multiplexed sequencing in chicken, indicating potential applications for genome-wide association and genomic selection in chicken.	[Liao, Rongrong; Wang, Zhen; Chen, Zhenliang; Wang, Qishan; Zhang, Xiangzhe; Pan, Yuchun] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China; [Chen, Qiang] Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming, Yunnan, Peoples R China; [Tu, Yingying; Yang, Changsuo] Shanghai Acad Agr Sci, Natl Poultry Engn Res Ctr, Anim Husb & Vet Res Inst, Shanghai, Peoples R China; [Wang, Qishan; Zhang, Xiangzhe; Pan, Yuchun] Shanghai Jiao Tong Univ, Key Lab Vet Biotechnol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Kunming University of Science & Technology; Shanghai Academy of Agricultural Sciences; Shanghai Jiao Tong University	Zhang, XZ (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China.	xiangzhezhang@sjtu.edu.cn; panyuchun1963@aliyun.com			National Natural Science Foundation of China [31101706]; China Agriculture Research Systems [CARS-41-K05]; National 948 Project of China [2012-Z26, 2014-Z29]; Agriculture Development through Science and Technology Key Project of Shanghai [2012 (2-3)]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research Systems; National 948 Project of China; Agriculture Development through Science and Technology Key Project of Shanghai	The National Natural Science Foundation of China (31101706) http://www.nsfc.gov.cn/publish/portal1/ XZ, China Agriculture Research Systems (CARS-41-K05) http://119.253.58.231/ XZ, the National 948 Project of China (2012-Z26, 2014-Z29) http://www.stee.agri.gov.cn/ YP and Agriculture Development through Science and Technology Key Project of Shanghai (grant No. 2012 (2-3)) http://en.shac.gov.cn/ YP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasht B, 2007, ANIM GENET, V38, P491, DOI 10.1111/j.1365-2052.2007.01642.x; Aerts J, 2007, CYTOGENET GENOME RES, V117, P338, DOI 10.1159/000103196; Albrechtsen A, 2010, MOL BIOL EVOL, V27, P2534, DOI 10.1093/molbev/msq148; Andolfatto P, 2011, GENOME RES, V21, P610, DOI 10.1101/gr.115402.110; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bellott DW, 2010, NATURE, V466, P612, DOI 10.1038/nature09172; Chen Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067500; De Donato M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062137; Ellegren H, 2005, TRENDS ECOL EVOL, V20, P180, DOI 10.1016/j.tree.2005.01.015; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gresham D, 2008, NAT REV GENET, V9, P291, DOI 10.1038/nrg2335; Groenen MAM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-274; Guillot G, 2009, BIOINFORMATICS, V25, P552, DOI 10.1093/bioinformatics/btn665; Kerstens HHD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-94; Kranis A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-59; Li GQ, 2014, POULTRY SCI, V93, P2983, DOI 10.3382/ps.2014-04164; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mao XY, 2007, CURR GENOMICS, V8, P219; Megens HJ, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-86; Miller MM, 1996, P NATL ACAD SCI USA, V93, P3958, DOI 10.1073/pnas.93.9.3958; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Perez-Enciso M, 2010, ANIM GENET, V41, P561, DOI 10.1111/j.1365-2052.2010.02057.x; Qanbari S, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-103; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Rao YS, 2008, HEREDITAS, V145, P251, DOI 10.1111/j.1601-5223.2008.02043.x; Robasky K, 2014, NAT REV GENET, V15, P56, DOI 10.1038/nrg3655; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Seo DW, 2015, MOL BIOL REP, V42, P471, DOI 10.1007/s11033-014-3790-5; Sun YF, 2014, G3-GENES GENOM GENET, V4, P1167, DOI 10.1534/g3.114.011338; Sundstrom H, 2004, GENETICS, V167, P377, DOI 10.1534/genetics.167.1.377; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Wong GKS, 2004, NATURE, V432, P717, DOI 10.1038/nature03156; Yan YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104652; Yang YM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101025	37	5	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0137010	10.1371/journal.pone.0137010	http://dx.doi.org/10.1371/journal.pone.0137010			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313744	Green Submitted, Green Published, gold			2022-12-26	WOS:000360144000111
J	Crall, JD; Gravish, N; Mountcastle, AM; Combes, SA				Crall, James D.; Gravish, Nick; Mountcastle, Andrew M.; Combes, Stacey A.			BEEtag: A Low-Cost, Image-Based Tracking System for the Study of Animal Behavior and Locomotion	PLOS ONE			English	Article							FLIGHT; IDENTIFICATION; INDIVIDUALS; BUMBLEBEES	A fundamental challenge common to studies of animal movement, behavior, and ecology is the collection of high-quality datasets on spatial positions of animals as they change through space and time. Recent innovations in tracking technology have allowed researchers to collect large and highly accurate datasets on animal spatiotemporal position while vastly decreasing the time and cost of collecting such data. One technique that is of particular relevance to the study of behavioral ecology involves tracking visual tags that can be uniquely identified in separate images or movie frames. These tags can be located within images that are visually complex, making them particularly well suited for longitudinal studies of animal behavior and movement in naturalistic environments. While several software packages have been developed that use computer vision to identify visual tags, these software packages are either (a) not optimized for identification of single tags, which is generally of the most interest for biologists, or (b) suffer from licensing issues, and therefore their use in the study of animal behavior has been limited. Here, we present BEEtag, an opensource, image-based tracking system in Matlab that allows for unique identification of individual animals or anatomical markers. The primary advantages of this system are that it (a) independently identifies animals or marked points in each frame of a video, limiting error propagation, (b) performs well in images with complex backgrounds, and (c) is low-cost. To validate the use of this tracking system in animal behavior, we mark and track individual bumblebees (Bombus impatiens) and recover individual patterns of space use and activity within the nest. Finally, we discuss the advantages and limitations of this software package and its application to the study of animal movement, behavior, and ecology.	[Crall, James D.; Gravish, Nick; Mountcastle, Andrew M.; Combes, Stacey A.] Harvard Univ, Concord Field Stn, Organism & Evolutionary Biol, Bedford, MA 01730 USA; [Gravish, Nick] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Crall, JD (corresponding author), Harvard Univ, Concord Field Stn, Organism & Evolutionary Biol, Bedford, MA 01730 USA.	james.crall@gmail.com		Gravish, Nicholas/0000-0002-9391-2476	NSF GRFP fellowship; NSF CAREER grant [IOS-1253677]; James S. McDonnell foundation; Direct For Biological Sciences [1253677] Funding Source: National Science Foundation	NSF GRFP fellowship(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF CAREER grant(National Science Foundation (NSF)NSF - Office of the Director (OD)); James S. McDonnell foundation; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by an NSF GRFP fellowship to James Crall and an NSF CAREER grant to Stacey Combes (IOS-1253677). Nick Gravish would like to acknowledge funding from the James S. McDonnell foundation.	ALDRIDGE HDJN, 1988, J MAMMAL, V69, P379, DOI 10.2307/1381393; Atcheson B., 2010, P 15 INT WORKSH VIS, P41; Berman GJ, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0672; Bonter DN, 2011, J FIELD ORNITHOL, V82, P1, DOI 10.1111/j.1557-9263.2010.00302.x; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Combes SA, 2012, J EXP BIOL, V215, P903, DOI 10.1242/jeb.059394; Daley MA, 2006, P NATL ACAD SCI USA, V103, P15681, DOI 10.1073/pnas.0601473103; de Chaumont F, 2012, NAT METHODS, V9, P410, DOI [10.1038/NMETH.1924, 10.1038/nmeth.1924]; Dell AI, 2014, TRENDS ECOL EVOL, V29, P417, DOI 10.1016/j.tree.2014.05.004; Dennis RL, 2008, POULTRY SCI, V87, P1939, DOI 10.3382/ps.2007-00311; Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100; DUDLEY R, 1990, J EXP BIOL, V148, P19; Fiala M, 2005, PROC CVPR IEEE, P590; Hedrick TL, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/3/034001; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Kain J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2908; Mersch DP, 2013, SCIENCE, V340, P1090, DOI 10.1126/science.1234316; Pankiw T, 2003, J COMP PHYSIOL A, V189, P675, DOI 10.1007/s00359-003-0442-y; Perez-Escudero A, 2014, NAT METHODS, V11, P743, DOI [10.1038/NMETH.2994, 10.1038/nmeth.2994]; Ravi S, 2013, J EXP BIOL, V216, P4299, DOI 10.1242/jeb.090845; Ristroph L, 2009, J EXP BIOL, V212, P1324, DOI 10.1242/jeb.025502; Ropert-Coudert Y, 2005, FRONT ECOL ENVIRON, V3, P437, DOI 10.2307/3868660; SEELEY TD, 1991, BEHAV ECOL SOCIOBIOL, V28, P277, DOI 10.1007/BF00175101; Sockman KW, 2001, GEN COMP ENDOCR, V122, P205, DOI 10.1006/gcen.2001.7626; Stelzer RJ, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-93; Wakeling JM, 1997, J EXP BIOL, V200, P543	27	65	65	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136487	10.1371/journal.pone.0136487	http://dx.doi.org/10.1371/journal.pone.0136487			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332211	Green Published, Green Submitted, gold			2022-12-26	WOS:000360613800058
J	Ketha, H; Singh, RJ; Grebe, SK; Bergstralh, EJ; Rule, AD; Lieske, JC; Kumar, R				Ketha, Hemamalini; Singh, Ravinder J.; Grebe, Stefan K.; Bergstralh, Eric J.; Rule, Andrew D.; Lieske, John C.; Kumar, Rajiv			Altered Calcium and Vitamin D Homeostasis in First-Time Calcium Kidney Stone-Formers	PLOS ONE			English	Article							IDIOPATHIC INFANTILE HYPERCALCEMIA; TANDEM MASS-SPECTROMETRY; D 24-HYDROXYLASE GENE; ABSORPTIVE HYPERCALCIURIA; PRIMARY HYPERPARATHYROIDISM; DIAGNOSTIC-CRITERIA; CYP24A1; NEPHROLITHIASIS; MUTATIONS; 1,25-DIHYDROXYVITAMIN-D3	Background Elevated serum 1,25-dihydroxyvitamin D (1,25(OH)(2)D) concentrations have been reported among cohorts of recurrent calcium (Ca) kidney stone-formers and implicated in the pathogenesis of hypercalciuria. Variations in Ca and vitamin D metabolism, and excretion of urinary solutes among first-time male and female Ca stone-formers in the community, however, have not been defined. Methods In a 4-year community-based study we measured serum Ca, phosphorus (P), 25-hydroxyvitamin D (25(OH) D), 1,25(OH)(2)D, 24,25-dihydroxyvitamin D (24,25(OH)(2)D), parathyroid hormone (PTH), and fibroblast growth factor-23 (FGF-23) concentrations in first-time Ca stoneformers and age-and gender frequency-matched controls. Results Serum Ca and 1,25(OH)(2)D were increased in Ca stone-formers compared to controls (P = 0.01 and P = 0.001). Stone-formers had a lower serum 24,25(OH)(2)D/25(OH)D ratio compared to controls (P = 0.008). Serum PTH and FGF-23 concentrations were similar in the groups. Urine Ca excretion was similar in the two groups (P = 0.82). In controls, positive associations between serum 25(OH)D and 24,25(OH)(2)D, FGF-23 and fractional phosphate excretion, and negative associations between serum Ca and PTH, and FGF-23 and 1,25(OH)(2)D were observed. In SF associations between FGF-23 and fractional phosphate excretion, and FGF-23 and 1,25(OH)(2)D, were not observed. 1,25(OH)(2)D concentrations associated more weakly with FGF-23 in SF compared with C (P < 0.05). Conclusions Quantitative differences in serum Ca and 1,25(OH)(2)D and reductions in 24-hydroxylation of vitamin D metabolites are present in first-time SF and might contribute to first-time stone risk.	[Ketha, Hemamalini; Rule, Andrew D.; Lieske, John C.; Kumar, Rajiv] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55902 USA; [Ketha, Hemamalini; Rule, Andrew D.; Lieske, John C.; Kumar, Rajiv] Mayo Clin, Dept Med, Rochester, MN USA; [Ketha, Hemamalini; Singh, Ravinder J.; Grebe, Stefan K.; Lieske, John C.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Singh, Ravinder J.; Bergstralh, Eric J.; Rule, Andrew D.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Kumar, Rajiv] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Kumar, R (corresponding author), Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55902 USA.	rkumar@mayo.edu	Lieske, John/ABA-4829-2020	Ketha, Hemamalini/0000-0002-4720-7485; Kumar, Rajiv/0000-0003-3497-3057	Mayo Clinic O'Brien Urology Research Center [U54 DK100227]; Rare Kidney Stone Consortium [U54DK083908]; NIDDK; National Center for Advancing Translational Sciences (NCATS), NIH Training Grant [T32 DK007013, R21-AR058003, R21-AR060869]; Falk Foundation; Mayo Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR060869, R21AR058003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007013, U54DK100227, U54DK083908, P50DK083007] Funding Source: NIH RePORTER	Mayo Clinic O'Brien Urology Research Center; Rare Kidney Stone Consortium; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Advancing Translational Sciences (NCATS), NIH Training Grant; Falk Foundation; Mayo Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by the Mayo Clinic O'Brien Urology Research Center (U54 DK100227), the Rare Kidney Stone Consortium (U54DK083908), a member of the NIH Rare Diseases Clinical Research Network (RDCRN), the NIDDK and the National Center for Advancing Translational Sciences (NCATS), NIH Training Grant T32 DK007013, R21-AR058003, R21-AR060869, a grant from the Falk Foundation, and the Mayo Foundation.	BROADUS AE, 1984, J CLIN ENDOCR METAB, V58, P161, DOI 10.1210/jcem-58-1-161; BROADUS AE, 1980, NEW ENGL J MED, V302, P421, DOI 10.1056/NEJM198002213020801; BROADUS AE, 1984, NEW ENGL J MED, V311, P73, DOI 10.1056/NEJM198407123110201; COE FL, 1992, NEW ENGL J MED, V327, P1141, DOI 10.1056/NEJM199210153271607; COE FL, 1979, NEW ENGL J MED, V300, P337, DOI 10.1056/NEJM197902153000703; Dauber A, 2012, J CLIN ENDOCR METAB, V97, pE268, DOI 10.1210/jc.2011-1972; DELUCA HF, 1983, ANNU REV BIOCHEM, V52, P411, DOI 10.1146/annurev.bi.52.070183.002211; DELUCA HF, 1972, NEW ENGL J MED, V287, P250, DOI 10.1056/NEJM197208032870511; Dinour D, 2013, J UROLOGY, V190, P552, DOI 10.1016/j.juro.2013.02.3188; GARABEDIAN M, 1972, P NATL ACAD SCI USA, V69, P1673, DOI 10.1073/pnas.69.7.1673; Jacobs TP, 2014, J CLIN ENDOCR METAB, V99, P708, DOI 10.1210/jc.2013-3802; KAPLAN RA, 1977, J CLIN INVEST, V59, P756, DOI 10.1172/JCI108696; KUMAR R, 1984, PHYSIOL REV, V64, P478, DOI 10.1152/physrev.1984.64.2.478; KUMAR R, 1978, J BIOL CHEM, V253, P3804; LEMANN J, 1989, J UROLOGY, V141, P715, DOI 10.1016/S0022-5347(17)40993-1; Lieske JC, 2006, KIDNEY INT, V69, P760, DOI 10.1038/sj.ki.5000150; Lieske JC, 2014, CLIN J AM SOC NEPHRO, V9, P943, DOI 10.2215/CJN.08210813; Moe OW, 2005, J AM SOC NEPHROL, V16, P729, DOI 10.1681/ASN.2004100888; Netzel BC, 2011, CLIN CHEM, V57, P431, DOI 10.1373/clinchem.2010.157115; O'Seaghdha CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003796; PAK CYC, 1974, J CLIN INVEST, V54, P387, DOI 10.1172/JCI107774; PAK CYC, 1980, AM J MED, V69, P19, DOI 10.1016/0002-9343(80)90495-7; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Ryan ZC, 2013, P NATL ACAD SCI USA, V110, P6199, DOI 10.1073/pnas.1221255110; Sakhaee K, 2008, CURR OPIN NEPHROL HY, V17, P304, DOI 10.1097/MNH.0b013e3282f8b34d; Sayers J, 2013, OA NEPHROLOGY, V1, p[6, 1]; Schlingmann KP, 2011, NEW ENGL J MED, V365, P410, DOI 10.1056/NEJMoa1103864; Scott P, 1998, J AM SOC NEPHROL, V9, P425; Scott P, 1999, J AM SOC NEPHROL, V10, P1007; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Stamatelou KK, 2003, KIDNEY INT, V63, P1817, DOI 10.1046/j.1523-1755.2003.00917.x; Strathmann FG, 2011, CLIN CHEM, V57, P1279, DOI 10.1373/clinchem.2010.161174; Taylor EN, 2015, CLIN J AM SOC NEPHRO, V10, P667, DOI 10.2215/CJN.07060714; Tebben PJ, 2012, J CLIN ENDOCR METAB, V97, pE423, DOI 10.1210/jc.2011-1935; Thorleifsson G, 2009, NAT GENET, V41, P926, DOI 10.1038/ng.404; Wolf P, 2014, ENDOCR PRACT, V20, pE91, DOI 10.4158/EP13479.CR	36	22	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137350	10.1371/journal.pone.0137350	http://dx.doi.org/10.1371/journal.pone.0137350			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332888	Green Published, Green Submitted, gold			2022-12-26	WOS:000360613800126
J	Koester, DC; Freeman, EW; Brown, JL; Wildt, DE; Terrell, KA; Franklin, AD; Crosier, AE				Koester, Diana C.; Freeman, Elizabeth W.; Brown, Janine L.; Wildt, David E.; Terrell, Kimberly A.; Franklin, Ashley D.; Crosier, Adrienne E.			Motile Sperm Output by Male Cheetahs (Acinonyx jubatus) Managed Ex Situ Is Influenced by Public Exposure and Number of Care-Givers	PLOS ONE			English	Article							FREE-RANGING CHEETAHS; NORTH-AMERICAN ZOOS; CAT FELIS-CATUS; DOMESTIC CAT; REPRODUCTIVE TRAITS; EJACULATE TRAITS; SEASONAL-CHANGES; STRESS; SPERMATOZOA; PITUITARY	The collective cheetah (Acinonyx jubatus) population in zoological institutions has never been self-sustaining because of challenges in natural reproduction. A retrospective analysis of North American zoo-breeding records has revealed that >90% of litters produced since 2003 occurred in facilities 'off-display' from the public. We examined seminal, endocrine, and behavioral traits of 29 adult male cheetahs that were: 1) managed in public exhibit or off-display facilities; 2) maintained by different numbers of cheetah-specific care-givers; and 3) living adjacent to varying numbers of adult conspecifics. Cheetahs housed off-display produced more total motile sperm/ejaculate (P = 0.04) than on-exhibit males. This finding was mirrored in our laboratory's historical records where two-fold more total motile sperm (P < 0.01) were measured in ejaculates from individuals with no public exposure (n = 43) compared to on-exhibit (n = 116) counterparts. Males at institutions with <= 3 care-givers also produced more total motile sperm/ejaculate (P < 0.03) and spent more time behaviorally active (P < 0.01) than at facilities using >3 care-givers. Exposure to high numbers of conspecifics within the same institution did not impact (P > 0.05) seminal traits, and presence of the public, care-giver number, or animals/facility had no influence (P > 0.05) on androgen or glucocorticoid excretion or other behavioral metrics. Findings indicate that male cheetahs are sensitive to general public exposure and too many care-givers, resulting in compromised motile sperm output/ejaculate with mechanism of action unrelated to altered androgen or glucocorticoid excretion.	[Koester, Diana C.; Freeman, Elizabeth W.; Brown, Janine L.; Wildt, David E.; Terrell, Kimberly A.; Franklin, Ashley D.; Crosier, Adrienne E.] Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA 22630 USA; [Koester, Diana C.] George Mason Univ, Dept Environm Sci & Policy, Fairfax, VA 22030 USA; [Freeman, Elizabeth W.] George Mason Univ, New Century Coll, Fairfax, VA 22030 USA; [Terrell, Kimberly A.] Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA; [Franklin, Ashley D.] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; George Mason University; George Mason University; Tulane University; University System of Maryland; University of Maryland College Park	Koester, DC (corresponding author), Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA 22630 USA.	KoesterD@si.edu	Franklin, Ashley D/J-3069-2015	Franklin, Ashley D/0000-0002-0818-5156	William H. Donner Foundation Inc.; Smithsonian Pre-doctoral Research Fellowship Program; George Mason University Presidential Scholar Award in the Department of Environmental Science and Policy	William H. Donner Foundation Inc.; Smithsonian Pre-doctoral Research Fellowship Program; George Mason University Presidential Scholar Award in the Department of Environmental Science and Policy	This research was supported by the William H. Donner Foundation Inc., the Smithsonian Pre-doctoral Research Fellowship Program, and the George Mason University Presidential Scholar Award in the Department of Environmental Science and Policy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILERA G, 1994, FRONT NEUROENDOCRIN, V15, P321, DOI 10.1006/frne.1994.1013; Aitken-Palmer C, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.112.099044; Baker K, 2013, J ZOO AQUAR RES, V1, P35; Bartos L, 1998, COMP BIOCHEM PHYS A, V120, P373, DOI 10.1016/S1095-6433(98)10038-7; Brown JL, 2001, J REP FER S, P71; BROWN JL, 1991, J REPROD FERTIL, V91, P29; CARLSTEAD K, 1993, ZOO BIOL, V12, P321, DOI 10.1002/zoo.1430120403; Carlstead K, 2009, ZOO BIOL, V28, P589, DOI 10.1002/zoo.20289; Caro T., 1994, CHEETAHS SERENGETI P; CARO TM, 1987, ETHOLOGY, V74, P52; CARO TM, 1993, ZOO BIOL, V12, P19, DOI 10.1002/zoo.1430120105; Christofoletti MD, 2010, EUR J WILDLIFE RES, V56, P561, DOI 10.1007/s10344-009-0350-8; Comizzoli P, 2009, REPROD DOMEST ANIM, V44, P47, DOI 10.1111/j.1439-0531.2009.01373.x; Crosier AE, 2007, REPROD FERT DEVELOP, V19, P370, DOI 10.1071/RD06057; Crosier AE, 2011, BIOL REPROD, V85, P243, DOI 10.1095/biolreprod.110.089417; Crosier AE, 2006, CRYOBIOLOGY, V52, P169, DOI 10.1016/j.cryobiol.2005.10.011; Dalmau A, 2007, J WILDLIFE MANAGE, V71, P190, DOI 10.2193/2005-492; DONOGHUE AM, 1992, BIOL REPROD, V46, P1047, DOI 10.1095/biolreprod46.6.1047; Durant S, ACINONYX JUBATUS IUC; EATON R L, 1970, Journal of Wildlife Management, V34, P56, DOI 10.2307/3799492; Ganan N, 2010, REPRODUCTION, V139, P275, DOI 10.1530/REP-09-0259; Grafen A., 2002, MODERN STAT LIFE SCI; Graham LH, 1996, ZOO BIOL, V15, P71, DOI 10.1002/(SICI)1098-2361(1996)15:1<71::AID-ZOO7>3.0.CO;2-9; Grisham J, 2013, CHEETAH ACINONYX JUB; HOAGLIN DC, 1987, J AM STAT ASSOC, V82, P1147, DOI 10.1080/01621459.1987.10478551; HOWARD JG, 1990, J ANDROL, V11, P204; Howard JG, 1997, BIOL REPROD, V56, P1059, DOI 10.1095/biolreprod56.4.1059; Jasnow AM, 2001, HORM BEHAV, V40, P428, DOI 10.1006/hbeh.2001.1708; JOHNSTON LA, 1994, J REPROD FERTIL, V102, P229; Jurke MH, 1997, ZOO BIOL, V16, P133, DOI 10.1002/(SICI)1098-2361(1997)16:2<133::AID-ZOO4>3.0.CO;2-B; KASSON BG, 1985, J BIOL CHEM, V260, P5302; Kwon WS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054192; LAURENSON MK, 1993, ZOO BIOL, V12, P31, DOI 10.1002/zoo.1430120106; LINDBURG DG, 1993, ZOO BIOL, V12, P97, DOI 10.1002/zoo.1430120109; Linklater WL, 2010, ANIM CONSERV, V13, P104, DOI 10.1111/j.1469-1795.2009.00308.x; Marker L, 2012, INT CHEETAH STUDBOOK; Marker LL, 2008, J ZOOL, V274, P226, DOI 10.1111/j.1469-7998.2007.00375.x; MARKERKRAUS L, 1993, ZOO BIOL, V12, P5, DOI 10.1002/zoo.1430120104; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; MASON JW, 1956, SCIENCE, V124, P983, DOI 10.1126/science.124.3229.983; MEIDAN R, 1985, ENDOCRINOLOGY, V116, P416, DOI 10.1210/endo-116-1-416; Munson L, 2005, J WILDLIFE DIS, V41, P542, DOI 10.7589/0090-3558-41.3.542; Munson L, 1999, J ZOO WILDLIFE MED, V30, P342; MUNSON L, 1993, ZOO BIOL, V12, P105, DOI 10.1002/zoo.1430120110; Nelson RJ., 2005, INTRO BEHAV ENDOCRIN; Neubauer K, 2004, BIOL REPROD, V71, P1517, DOI 10.1095/biolreprod.104.031062; OBRIEN SJ, 1985, SCIENCE, V227, P1428, DOI 10.1126/science.2983425; OBRIEN SJ, 1983, SCIENCE, V221, P459, DOI 10.1126/science.221.4609.459; OBRIEN SJ, 1987, P NATL ACAD SCI USA, V84, P508, DOI 10.1073/pnas.84.2.508; OSKINA IN, 1992, COMP BIOCHEM PHYS A, V101, P665, DOI 10.1016/0300-9629(92)90341-M; Pukazhenthi B, 2000, CRYOBIOLOGY, V40, P139, DOI 10.1006/cryo.2000.2233; Pukazhenthi BS, 2001, J REP FER S, P423; Pukazhenthi BS, 2006, THERIOGENOLOGY, V66, P112, DOI 10.1016/j.theriogenology.2006.03.020; PURI S, 1985, ARCH ANDROLOGY, V14, P263, DOI 10.3109/01485018508988309; Quirke T, 2012, APPL ANIM BEHAV SCI, V142, P189, DOI 10.1016/j.applanim.2012.09.007; Reber SO, 2007, ENDOCRINOLOGY, V148, P670, DOI 10.1210/en.2006-0983; Romero LM, 2002, GEN COMP ENDOCR, V128, P1; ROTH TL, 1995, J EXP ZOOL, V271, P323, DOI 10.1002/jez.1402710410; Scott LV, 1998, LIFE SCI, V62, P1985, DOI 10.1016/S0024-3205(98)00027-7; SLIWA L, 1994, ARCH ANDROLOGY, V33, P145; Smith RF, 2002, DOMEST ANIM ENDOCRIN, V23, P75, DOI 10.1016/S0739-7240(02)00147-9; Sokal R. R., 2012, BIOMETRY; Swanson WF, 1996, J ZOO WILDLIFE MED, V27, P234; Terio KA, 2004, J WILDLIFE DIS, V40, P259, DOI 10.7589/0090-3558-40.2.259; Terrell KA, 2012, CRYOBIOLOGY, V64, P110, DOI 10.1016/j.cryobiol.2011.12.006; Terrell KA, 2010, BIOL REPROD, V83, P833, DOI 10.1095/biolreprod.110.085639; Uschold-Schmidt N, 2012, PSYCHONEUROENDOCRINO, V37, P1676, DOI 10.1016/j.psyneuen.2012.02.015; Vick MM, 2012, STRESS, V15, P52, DOI 10.3109/10253890.2011.578267; Wells A, 2004, J ZOO WILDLIFE MED, V35, P8, DOI 10.1638/02-084; Wielebnowski N, 1998, ZOO BIOL, V17, P193, DOI 10.1002/(SICI)1098-2361(1998)17:3<193::AID-ZOO4>3.0.CO;2-4; Wielebnowski N, 1996, ZOO BIOL, V15, P353, DOI 10.1002/(SICI)1098-2361(1996)15:4<353::AID-ZOO1>3.0.CO;2-A; Wielebnowski NC, 2002, ZOO BIOL, V21, P77, DOI 10.1002/zoo.10005; Wielebnowski NC, 2002, ANIM CONSERV, V5, P291, DOI 10.1017/S1367943002004043; Wielebnowski NC, 1999, ZOO BIOL, V18, P335, DOI 10.1002/(SICI)1098-2361(1999)18:4<335::AID-ZOO8>3.0.CO;2-X; Wildt David E., 1997, International Zoo Yearbook, V35, P164, DOI 10.1111/j.1748-1090.1997.tb01207.x; WILDT DE, 1983, BIOL REPROD, V29, P1019, DOI 10.1095/biolreprod29.4.1019; WILDT DE, 1987, NATURE, V329, P328, DOI 10.1038/329328a0; WILDT DE, 1988, BIOL REPROD, V38, P245, DOI 10.1095/biolreprod38.2.245; WILDT DE, 1993, ZOO BIOL, V12, P45, DOI 10.1002/zoo.1430120107; WILDT DE, 1987, BIOL REPROD, V36, P351, DOI 10.1095/biolreprod36.2.351; Wildt DE, 2012, ASS ZOOS AQUARIU AUG; Wingfield JC, 2013, ANIM BEHAV, V85, P1127, DOI 10.1016/j.anbehav.2013.02.018; Young KM, 2004, GEN COMP ENDOCR, V137, P148, DOI 10.1016/j.ygcen.2004.02.016; Ziegler-Meeks, 2009, HUSBANDRY MANUAL CHE	84	22	22	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135847	10.1371/journal.pone.0135847	http://dx.doi.org/10.1371/journal.pone.0135847			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332582	Green Published, Green Submitted, gold			2022-12-26	WOS:000360613800042
J	Lemaire, M; Silva, LFN; Lemarie, CA; Bolt, AM; Molina, MF; Krohn, RM; Smits, JE; Lehoux, S; Mann, KK				Lemaire, Maryse; Silva, Luis Fernando Negro; Lemarie, Catherine A.; Bolt, Alicia M.; Molina, Manuel Flores; Krohn, Regina M.; Smits, Judit E.; Lehoux, Stephanie; Mann, Koren K.			Arsenic Exposure Increases Monocyte Adhesion to the Vascular Endothelium, a Pro-Atherogenic Mechanism	PLOS ONE			English	Article							KAPPA-B ACTIVATION; DRINKING-WATER; ATHEROSCLEROTIC LESIONS; PLATELETS TRIGGERS; REACTIVE OXYGEN; PLASMA-LEVELS; P-SELECTIN; EXPRESSION; VCAM-1; INTEGRIN	Epidemiological studies have shown that arsenic exposure increases atherosclerosis, but the mechanisms underlying this relationship are unknown. Monocytes, macrophages and platelets play an important role in the initiation of atherosclerosis. Circulating monocytes and macrophages bind to the activated vascular endothelium and migrate into the subendothelium, where they become lipid-laden foam cells. This process can be facilitated by platelets, which favour monocyte recruitment to the lesion. Thus, we assessed the effects of low-to-moderate arsenic exposure on monocyte adhesion to endothelial cells, platelet activation and platelet-monocyte interactions. We observed that arsenic induces human monocyte adhesion to endothelial cells in vitro. These findings were confirmed ex vivo using a murine organ culture system at concentrations as low as 10 ppb. We found that both cell types need to be exposed to arsenic to maximize monocyte adhesion to the endothelium. This adhesion process is specific to monocyte/endothelium interactions. Hence, no effect of arsenic on platelet activation or platelet/leukocyte interaction was observed. We found that arsenic increases adhesion of mononuclear cells via increased CD29 binding to VCAM-1, an adhesion molecule found on activated endothelial cells. Similar results were observed in vivo, where arsenic-exposed mice exhibit increased VCAM-1 expression on endothelial cells and increased CD29 on circulating monocytes. Interestingly, expression of adhesion molecules and increased binding can be inhibited by antioxidants in vitro and in vivo. Together, these data suggest that arsenic might enhance atherosclerosis by increasing monocyte adhesion to endothelial cells, a process that is inhibited by antioxidants.	[Lemaire, Maryse; Bolt, Alicia M.; Molina, Manuel Flores; Mann, Koren K.] McGill Univ, Lady Davis Inst Med Res, Dept Oncol, Montreal, PQ, Canada; [Silva, Luis Fernando Negro; Lemarie, Catherine A.] McGill Univ, Dept Med, Lady Davis Inst Med Res, Div Expt Med, Montreal, PQ, Canada; [Lemarie, Catherine A.; Lehoux, Stephanie] McGill Univ, Dept Med, Lady Davis Inst Med Res, Montreal, PQ, Canada; [Krohn, Regina M.; Smits, Judit E.] Univ Calgary, Fac Vet Med, Dept Ecosyst & Publ Hlth, Calgary, AB, Canada	Lady Davis Institute; McGill University; Lady Davis Institute; McGill University; Lady Davis Institute; McGill University; University of Calgary	Mann, KK (corresponding author), McGill Univ, Lady Davis Inst Med Res, Dept Oncol, Montreal, PQ, Canada.	koren.mann@mcgill.ca	Smits, Judit/E-8225-2012	Lemarie, Catherine/0000-0002-3897-4287; Smits, Judit/0000-0001-5341-4088	Canadian Institutes of Health Research [MOP-115000, CIHR 102498, MFE-120914]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Institutes of Health Research [KKM: MOP-115000; SL: CIHR 102498]. ML is supported by a fellowship from the Canadian Institutes of Health Research [MFE-120914].	Abernathy CO, 2003, J NUTR, V133, p1536S, DOI 10.1093/jn/133.5.1536S; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; ATSDR, 2006, TOX PROF ARS FED PRO; Barchowsky A, 1996, FREE RADICAL BIO MED, V21, P783, DOI 10.1016/0891-5849(96)00174-8; Barchowsky A, 1999, FREE RADICAL BIO MED, V27, P1405, DOI 10.1016/S0891-5849(99)00186-0; BARDY N, 1995, CIRC RES, V77, P684, DOI 10.1161/01.RES.77.4.684; Blankenberg S, 2003, ATHEROSCLEROSIS, V170, P191, DOI 10.1016/S0021-9150(03)00097-2; Blann AD, 2003, EUR HEART J, V24, P2166, DOI 10.1016/j.ehj.2003.08.021; Bunderson M, 2004, TOXICOL APPL PHARM, V201, P32, DOI 10.1016/j.taap.2004.04.008; Chen Y, 2007, ENVIRON HEALTH PERSP, V115, P1415, DOI 10.1289/ehp.10277; Cook-Mills JM, 2005, ANTIOXID REDOX SIGNA, V15; Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871; de Almeida MC, 2000, MEM I OSWALDO CRUZ, V95, P221, DOI 10.1590/S0074-02762000000200014; Deem TL, 2004, BLOOD, V104, P2385, DOI 10.1182/blood-2004-02-0665; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Drechsler M, 2010, CIRCULATION, V122, P1837, DOI 10.1161/CIRCULATIONAHA.110.961714; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; ENGEL RR, 1994, ARCH ENVIRON HEALTH, V49, P418, DOI 10.1080/00039896.1994.9954996; Eriksson EE, 2001, FASEB J, V15, P1149, DOI 10.1096/fj.00-0537com; Gailer J, 2000, CHEM RES TOXICOL, V13, P1135, DOI 10.1021/tx000050h; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; HAWRYLOWICZ CM, 1991, J EXP MED, V174, P785, DOI 10.1084/jem.174.4.785; HealthCanada, 2006, GUID CAN DRINK WAT Q; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; Herren B, 1998, MOL BIOL CELL, V9, P1589, DOI 10.1091/mbc.9.6.1589; Hossain E, 2013, TOXICOL APPL PHARM, V273, P651, DOI 10.1016/j.taap.2013.10.012; Hughes PE, 1998, TRENDS CELL BIOL, V8, P359, DOI 10.1016/S0962-8924(98)01339-7; Huo Y, 2001, ACTA PHYSIOL SCAND, V173, P35, DOI 10.1046/j.1365-201X.2001.00882.x; Huo YQ, 2003, NAT MED, V9, P61, DOI 10.1038/nm810; Huo YQ, 2000, CIRC RES, V87, P153, DOI 10.1161/01.RES.87.2.153; Iiyama K, 1999, CIRC RES, V85, P199, DOI 10.1161/01.RES.85.2.199; Imhof BA, 2004, NAT REV IMMUNOL, V4, P432, DOI 10.1038/nri1375; Medrano MJ, 2010, ENVIRON RES, V110, P448, DOI 10.1016/j.envres.2009.10.002; Kim SR, 2008, BBA-MOL CELL RES, V1783, P886, DOI 10.1016/j.bbamcr.2008.01.004; Krohn RM, 2015, J NUTR BIOC IN PRESS; Lee MY, 2002, TOXICOL APPL PHARM, V179, P83, DOI 10.1006/taap.2001.9356; Lemaire M, 2014, TOXICOL SCI, V142, P477, DOI 10.1093/toxsci/kfu197; Lemaire M, 2011, TOXICOL SCI, V122, P211, DOI 10.1093/toxsci/kfr097; Lemarie A, 2006, J IMMUNOL, V177, P3019, DOI 10.4049/jimmunol.177.5.3019; Lemarie CA, 2003, CIRC RES, V93, P207, DOI 10.1161/01.RES.0000086942.13523.88; Lessner SM, 2002, AM J PATHOL, V160, P2145, DOI 10.1016/S0002-9440(10)61163-7; MARUI N, 1993, J CLIN INVEST, V92, P1866, DOI 10.1172/JCI116778; Matheny HE, 2000, J IMMUNOL, V164, P6550, DOI 10.4049/jimmunol.164.12.6550; Moon KA, 2013, ANN INTERN MED, V159, P649, DOI 10.7326/0003-4819-159-10-201311190-00719; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Nakashima Y, 1998, ARTERIOSCL THROM VAS, V18, P842, DOI 10.1161/01.ATV.18.5.842; Nordberg GF, 2007, HANDBOOK ON THE TOXICOLOGY OF METALS, 3RD EDITION, P445, DOI 10.1016/B978-012369413-3/50078-1; Nordstrom DK, 2002, SCIENCE, V296, P2143, DOI 10.1126/science.1072375; Orr AW, 2006, MOL BIOL CELL, V17, P4686, DOI 10.1091/mbc.E06-04-0289; Peter K, 1999, Thromb Haemost, V82 Suppl 1, P38; Puig-Kroger A, 2000, J IMMUNOL, V165, P4338, DOI 10.4049/jimmunol.165.8.4338; Riou S, 2007, CIRC RES, V100, P1226, DOI 10.1161/01.RES.0000265231.59354.2c; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; Schober A, 2002, CIRCULATION, V106, P1523, DOI 10.1161/01.CIR.0000028590.02477.6F; Shih PT, 1999, CIRC RES, V84, P345, DOI 10.1161/01.RES.84.3.345; Simeonova PP, 2003, ENVIRON HEALTH PERSP, V111, P1744, DOI 10.1289/ehp.6332; Smith KR, 2001, AM J PHYSIOL-LUNG C, V280, pL442, DOI 10.1152/ajplung.2001.280.3.L442; Srivastava RK, 2013, TOXICOL APPL PHARM, V272, P879, DOI 10.1016/j.taap.2013.08.004; Srivastava S, 2009, TOXICOL APPL PHARM, V241, P90, DOI 10.1016/j.taap.2009.08.004; von Hundelshausen P, 2001, CIRCULATION, V103, P1772, DOI 10.1161/01.CIR.103.13.1772; Werr J, 2000, J LEUKOCYTE BIOL, V68, P553; WHO W, 2008, GUID DRINK WAT QUAL, P306; Wu F, 2012, AM J EPIDEMIOL, V175, P1252, DOI 10.1093/aje/kwr464; Yuan Y, 2013, RADIAT RES, V179, P62, DOI 10.1667/RR3119.1	64	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136592	10.1371/journal.pone.0136592	http://dx.doi.org/10.1371/journal.pone.0136592			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332580	Green Submitted, Green Published, gold			2022-12-26	WOS:000360613800062
J	Stanturf, JA; Goodrick, SL; Warren, ML; Charnley, S; Stegall, CM				Stanturf, John A.; Goodrick, Scott L.; Warren, Melvin L., Jr.; Charnley, Susan; Stegall, Christie M.			Social Vulnerability and Ebola Virus Disease in Rural Liberia	PLOS ONE			English	Article							PRINCIPAL COMPONENT ANALYSIS; ADAPTIVE CAPACITY; STOPPING RULES; NUMBER; RETENTION; HEALTH; LEVEL	The Ebola virus disease (EVD) epidemic that has stricken thousands of people in the three West African countries of Liberia, Sierra Leone, and Guinea highlights the lack of adaptive capacity in post-conflict countries. The scarcity of health services in particular renders these populations vulnerable to multiple interacting stressors including food insecurity, climate change, and the cascading effects of disease epidemics such as EVD. However, the spatial distribution of vulnerable rural populations and the individual stressors contributing to their vulnerability are unknown. We developed a Social Vulnerability Classification using census indicators and mapped it at the district scale for Liberia. According to the Classification, we estimate that districts having the highest social vulnerability lie in the north and west of Liberia in Lofa, Bong, Grand Cape Mount, and Bomi Counties. Three of these counties together with the capital Monrovia and surrounding Montserrado and Margibi counties experienced the highest levels of EVD infections in Liberia. Vulnerability has multiple dimensions and a classification developed from multiple variables provides a more holistic view of vulnerability than single indicators such as food insecurity or scarcity of health care facilities. Few rural Liberians are food secure and many cannot reach a medical clinic in <80 minutes. Our results illustrate how census and household survey data, when displayed spatially at a sub-county level, may help highlight the location of the most vulnerable households and populations. Our results can be used to identify vulnerability hotspots where development strategies and allocation of resources to address the underlying causes of vulnerability in Liberia may be warranted. We demonstrate how social vulnerability index approaches can be applied in the context of disease outbreaks, and our methods are relevant elsewhere.	[Stanturf, John A.; Goodrick, Scott L.; Stegall, Christie M.] US Forest Serv, Ctr Forest Disturbance Sci, Athens, GA 30602 USA; [Warren, Melvin L., Jr.] US Forest Serv, Ctr Bottomland Hardwoods Res, Oxford, MS USA; [Charnley, Susan] US Forest Serv, Goods Serv & Values Program, Portland, OR USA	United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service	Stanturf, JA (corresponding author), US Forest Serv, Ctr Forest Disturbance Sci, Athens, GA 30602 USA.	jstanturf@fs.fed.us	Stanturf, John A./M-4171-2019	Stanturf, John A./0000-0002-6828-9459	Liberia Mission; US Congress; US Agency, for International Development through the US Forest Service Office of International Programs	Liberia Mission; US Congress; US Agency, for International Development through the US Forest Service Office of International Programs(United States Agency for International Development (USAID))	Funding for travel was provided to JAS, SLG, and MLW by the Liberia Mission, US Agency, for International Development through the US Forest Service Office of International Programs. All other funding was internal Forest Service appropriated funding from the US Congress. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abson DJ, 2012, APPL GEOGR, V35, P515, DOI 10.1016/j.apgeog.2012.08.004; [Anonymous], 2014, R LANG ENV STAT COMP; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Bandalos DL, 2009, STATISTICAL AND METHODOLOGICAL MYTHS AND URBAN LEGENDS: DOCTRINE, VERITY AND FABLE IN THE ORGANIZATIONAL AND SOCIAL SCIENCES, P61; Bartkowiak A., 1991, APPL STOCH MOD DATA, V55, P64; Bausch DG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003056; Beauducel A., 2001, METHODS PSYCHOL RES, V6, P141; Boko M, 2007, IPCC WGII 4 ASSESSME; Brooks N, 2005, GLOBAL ENVIRON CHANG, V15, P151, DOI 10.1016/j.gloenvcha.2004.12.006; Bruce B, 2004, LIBERIA CHALLENGES P; Cangelosi R, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-2; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Charrad M, 2014, J STAT SOFTW, V61, P1; Collier P, 2013, J CONFLICT RESOLUT, V57, P65, DOI 10.1177/0022002712464847; Cutter SL, 2003, SOC SCI QUART, V84, P242, DOI 10.1111/1540-6237.8402002; Cutter SL, 2008, P NATL ACAD SCI USA, V105, P2301, DOI 10.1073/pnas.0710375105; Dixon R. K., 2003, Mitigation and Adaptation Strategies for Global Change, V8, P93, DOI 10.1023/A:1026001626076; Ellis S, 2007, THE MASK OF ANARCHY; Fauci AS, 2014, NEW ENGL J MED, V371, P1084, DOI 10.1056/NEJMp1409494; Fekete A, 2012, NAT HAZARDS, V61, P1161, DOI 10.1007/s11069-011-9973-7; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; FERRE L, 1995, COMPUT STAT DATA AN, V19, P669, DOI 10.1016/0167-9473(94)00020-J; Frazier TG, 2014, APPL GEOGR, V51, P158, DOI 10.1016/j.apgeog.2014.04.004; Government of Liberia, 2007, COMPR ASS AGR SECT, V2; Government of Liberia, 2008, LIB VIS ACC EC GROWT; Government of Liberia, 2009, 2008 POP HOUS CENS F; Government of Liberia, 2010, STAT FOOD NUTR INS L; Hahn MB, 2009, GLOBAL ENVIRON CHANG, V19, P74, DOI 10.1016/j.gloenvcha.2008.11.002; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hegre H, 2009, J CONFLICT RESOLUT, V53, P598, DOI 10.1177/0022002709336459; Hinkel J, 2011, GLOBAL ENVIRON CHANG, V21, P198, DOI 10.1016/j.gloenvcha.2010.08.002; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Independent Evaluation Group, 2013, LIB COUNTR PROGR EV; Independent Evaluation Group, 2012, LIBERIA WORLD BANK G; JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574; Johnson Sirleaf E, 2014, BBC NEWSHOUR    1019; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; Kelly PM, 2000, CLIMATIC CHANGE, V47, P325, DOI 10.1023/A:1005627828199; Kieh GeorgeKlay., 2009, INT J WORLD PEACE, V26, P7; MacNeil A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001546; Organization for Economic Cooperation and Development, 2001, DAC GUID POV RED; Oxford Poverty and Human Development Initiative, 2014, LIB COUNTR BRIEF MUL; Patil VH, 2008, J BUS RES, V61, P162, DOI 10.1016/j.jbusres.2007.05.008; Peres-Neto PR, 2005, COMPUT STAT DATA AN, V49, P974, DOI 10.1016/j.csda.2004.06.015; Peterson AT, 2007, J MAMMAL, V88, P1544, DOI 10.1644/06-MAMM-A-280R1.1; Pigott DM, 2014, ELIFE, V3, DOI [10.7554/eLife.02851, 10.7554/eLife.04395]; Pourrut X, 2005, MICROBES INFECT, V7, P1005, DOI 10.1016/j.micinf.2005.04.006; Reaves EJ, 2014, MMWR-MORBID MORTAL W, V63, P959; Saez AM, 2015, EMBO MOL MED, V7, P17, DOI 10.15252/emmm.201404792; Salehyan I, 2006, INT ORGAN, V60, P335, DOI 10.1017/S0020818306060103; Sokal R.R., 2012, BIOMETRY; Stevens J.P., 2009, APPL MULTIVARIATE ST, V5th edition.; Thomas MR, 2015, EC IMPACT EBOLA SUBS; Tsimpo C, 2012, POVERTY POLICY RESPO, P60; United Nations, 2014, HUM DEV REP 2014; Varpilah ST, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-11; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Wisner B., 2004, AT RISK; Wolf S, 2013, INT J CLIM CHANG STR, V5, P54, DOI 10.1108/17568691311299363; World Health Organization, 2015, EBOL RESP ROADM SIT; Zebardast E, 2013, NAT HAZARDS, V65, P1331, DOI 10.1007/s11069-012-0412-1	61	31	32	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137208	10.1371/journal.pone.0137208	http://dx.doi.org/10.1371/journal.pone.0137208			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ2NK	26325519	gold, Green Published, Green Submitted			2022-12-26	WOS:000360437700103
J	Trebotic, LK; Klimek, P; Thomas, A; Fenzl, A; Leitner, K; Springer, S; Kiefer, FW; Kautzky-Willer, A				Trebotic, Lana Kosi; Klimek, Peter; Thomas, Anita; Fenzl, Anna; Leitner, Karoline; Springer, Stefanie; Kiefer, Florian W.; Kautzky-Willer, Alexandra			Circulating Betatrophin Is Strongly Increased in Pregnancy and Gestational Diabetes Mellitus	PLOS ONE			English	Article							BETA-CELL PROLIFERATION; TRIGLYCERIDE-METABOLISM; GLUCOSE; HOMEOSTASIS; RESISTANCE; ANGPTL3; OBESITY; WOMEN; RISK; 1ST	Aims/hypothesis Betatrophin has recently been introduced as a novel hormone and promotor of beta cell proliferation and improved glucose tolerance in mouse models of insulin resistance. In obese and diabetic humans altered levels were reported and a role in pathophysiology of metabolic diseases was therefore hypothesized. However its release and regulation in women with gestational diabetes mellitus (GDM), as well as its associations with markers of obesity, glucose and lipid metabolism during pregnancy still remain unclear. Methods Circulating betatrophin was quantified in 21 women with GDM and 19 pregnant body mass index-matched women with normal glucose tolerance (NGT) as well as 10 healthy age-matched non-pregnant women by enzyme-linked immunosorbent assay. Additionally we performed radioimmunassay (RIA) to confirm the results. Results Betatrophin concentrations measured by ELISA were significantly higher in GDM than in NGT (29.3 +/- 4.4 ng/ml vs. 18.1 +/- 8.7 ng/ml, p<0.001) which was confirmed by RIA. Betatrophin did not correlate with BMI or insulin resistance but showed a weak association with leptin levels in pregnancy and negative relationship with fasting C-peptide levels in all women. Moreover it correlated significantly with lipid parameters including triglycerides and total cholesterol in pregnancy, as well as estrogen, progesteron and birth weight. Conclusions/interpretation Circulating betatrophin concentrations are dramatically increased in pregnancy and are significantly higher in GDM versus pregnant NGT. In the light of the previously reported role in lipid metabolism, betatrophin may represent a novel endocrine regulator of lipid alterations in pregnancy. However additional studies are needed to elucidate whether hormonal factors, such as estrogen, control the production of betatrophin and if targeting betatrophin could hold promise in the fight against metabolic disease.	[Trebotic, Lana Kosi; Thomas, Anita; Fenzl, Anna; Leitner, Karoline; Kiefer, Florian W.; Kautzky-Willer, Alexandra] Med Univ Vienna, Dept Med 3, Gender Med Unit, Clin Div Endocrinol & Metab, Vienna, Austria; [Springer, Stefanie] Med Univ Vienna, Clin Div Gynaecol & Obstret, Vienna, Austria; [Klimek, Peter] Med Univ Vienna, Sect Sci Complex Syst, CEMSIIS, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Kautzky-Willer, A (corresponding author), Med Univ Vienna, Dept Med 3, Gender Med Unit, Clin Div Endocrinol & Metab, Vienna, Austria.	alexandra.kautzky-willer@meduniwien.ac.at	Klimek, Peter/AAC-2723-2019	Klimek, Peter/0000-0003-1187-6713; Kautzky-Willer, Alexandra/0000-0002-3520-4105; Thomas, Anita/0000-0002-1679-3098; Kiefer, Florian/0000-0003-2191-025X	FFG, Vienna, Austria	FFG, Vienna, Austria	Initial funding for this research was provided by FFG, Vienna, Austria.	Bao W, 2015, METABOLISM, V64, P756, DOI 10.1016/j.metabol.2015.01.013; Catalano PM, 2011, AM J OBSTET GYNECOL, V204, P479, DOI 10.1016/j.ajog.2010.11.039; Ebert T, 2015, EUR J ENDOCRINOL, V173, P1, DOI 10.1530/EJE-14-0815; Fenzl A, 2014, DIABETOLOGIA, V57, P1204, DOI 10.1007/s00125-014-3208-x; GABBE SG, 1986, NEW ENGL J MED, V315, P1025, DOI 10.1056/NEJM198610163151609; Gomez-Ambrosi J, 2014, J CLIN ENDOCR METAB, V99, pE2004, DOI 10.1210/jc.2014-1568; Gusarova V, 2014, CELL, V159, P691, DOI 10.1016/j.cell.2014.09.027; Harreiter J, 2014, WOMENS HEALTH, V10, P91, DOI [10.2217/WHE.13.69, 10.2217/whe.13.69]; Harville EW, 2011, EPIDEMIOLOGY, V22, P724, DOI 10.1097/EDE.0b013e318225c960; Herrera E, 2010, BEST PRACT RES CL EN, V24, P515, DOI 10.1016/j.beem.2010.05.006; Hu H, 2014, DIABETES CARE, V37, P2718, DOI 10.2337/dc14-0602; Jiao Y, 2014, DIABETES, V63, P1283, DOI 10.2337/db13-1435; Kalter-Leibovici O, 2012, DIABETIC MED, V29, P748, DOI 10.1111/j.1464-5491.2011.03516.x; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Kugelberg Elisabeth, 2013, Nat Rev Endocrinol, V9, P379, DOI 10.1038/nrendo.2013.98; Lickert H, 2013, CELL METAB, V18, P5, DOI 10.1016/j.cmet.2013.06.006; Mankuta D, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-58; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Metzger BE, 2007, DIABETES CARE, V30, pS251, DOI 10.2337/dc07-s225; Musunuru K, 2010, NEW ENGL J MED, V363, P2220, DOI 10.1056/NEJMoa1002926; Schaefer-Graf UM, 2008, DIABETES CARE, V31, P1858, DOI 10.2337/dc08-0039; Tokumoto S, 2015, DIABETIC MED, V32, P653, DOI 10.1111/dme.12696; Wang Y, 2013, P NATL ACAD SCI USA, V110, P16109, DOI 10.1073/pnas.1315292110; Wawrusiewicz-Kurylonek N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131171; Yi P, 2013, CELL, V153, P747, DOI 10.1016/j.cell.2013.04.008; Yilmaz H, 2015, EXP CLIN ENDOCR DIAB, V123, P376, DOI 10.1055/s-0035-1549888; Zhang R, 2012, BIOCHEM BIOPH RES CO, V424, P786, DOI 10.1016/j.bbrc.2012.07.038; Zhang Y, 2006, PHYSIOL BEHAV, V88, P249, DOI 10.1016/j.physbeh.2006.05.038	28	45	48	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136701	10.1371/journal.pone.0136701	http://dx.doi.org/10.1371/journal.pone.0136701			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325425	Green Published, Green Submitted, gold			2022-12-26	WOS:000360437700058
J	Winter, BJ; O'Connell, HE; Bowden, S; Carey, M; Eisen, DP				Winter, Benjamin J.; O'Connell, Helen E.; Bowden, Scott; Carey, Marcus; Eisen, Damon P.			A Case Control Study Reveals that Polyomaviruria Is Significantly Associated with Interstitial Cystitis and Vesical Ulceration	PLOS ONE			English	Article							HEMORRHAGIC CYSTITIS; INFECTIOUS AGENTS; BK-VIRUS; REPLICATION; CIDOFOVIR; TRANSPLANTATION; SODIUM	Objectives To investigate whether polyomaviruses contribute to interstitial cystitis pathogenesis. Subjects and Methods A prospective study was performed with 50 interstitial cystitis cases compared with 50 age-matched, disease-free controls for the frequency of polyomaviruria. Associations between polyomaviruria and disease characteristics were analysed in cases. Polyomavirus in urine and bladder tissue was detected with species (JC virus vs. BK virus) specific, real-time PCR. Results Case patients were reflective of interstitial cystitis epidemiology with age range from 26-88 years (median 58) and female predominance (41/50 F). There was a significant increase in the frequency of polyomavirus shedding between cases and controls (p<0.02). Polyomavirus shedding, in particular BK viruria, was associated with vesical ulceration, a marker of disease severity, among interstitial cystitis cases after adjustment for age and sex (OR 6.8, 95% CI 1.89-24.4). There was a significant association among cases between the presence of BK viruria and response to intravesical Clorpactin therapy (OR 4.50, 95% CI 1.17-17.4). Conclusion The presence of polyomaviruria was found to be associated with the ulcerative form of interstitial cystitis. Clorpactin, which has anti-DNA virus activity, was more likely to improve symptoms in the presence of BK viruria. These data from this pilot study suggest associations between polyomaviruria and interstitial cystitis warranting further investigation.	[Winter, Benjamin J.] Univ Melbourne, Fac Med Dent & Hlth Sci, Parkville, Vic 3052, Australia; [O'Connell, Helen E.] Royal Melbourne Hosp, Dept Surg, Parkville, Vic 3050, Australia; [Bowden, Scott] Victorian Infect Dis Reference Lab, North Melbourne, Vic, Australia; [Carey, Marcus] Royal Womens Hosp, Dept Urogynaecol, Parkville, Vic, Australia; [Eisen, Damon P.] Royal Melbourne Hosp, Doherty Inst, Victorian Infect Dis Serv, Melbourne, Vic, Australia; [Eisen, Damon P.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia	University of Melbourne; Royal Melbourne Hospital; Victorian Infectious Diseases Reference Laboratory; Royal Melbourne Hospital; Royal Melbourne Hospital; University of Melbourne	Eisen, DP (corresponding author), Royal Melbourne Hosp, Doherty Inst, Victorian Infect Dis Serv, Melbourne, Vic, Australia.	damon.eisen@mh.org.au	eisen, damon/AAC-7433-2019	Eisen, Damon/0000-0002-8987-4358				Abrams P, 2002, AM J OBSTET GYNECOL, V187, P116, DOI 10.1067/mob.2002.125704; Al-Hadithi HN, 2005, J UROLOGY, V174, P151, DOI 10.1097/01.ju.0000161605.14804.a9; Bernhoff E, 2008, AM J TRANSPLANT, V8, P1413, DOI 10.1111/j.1600-6143.2008.02269.x; Berry SH, 2011, J UROLOGY, V186, P540, DOI 10.1016/j.juro.2011.03.132; Duncan JL, 1997, UROLOGY, V49, P48, DOI 10.1016/S0090-4295(99)80331-8; Egli A, 2009, J INFECT DIS, V199, P837, DOI 10.1086/597126; Eisen DP, 2009, CLIN INFECT DIS, V48, pE86, DOI 10.1086/597827; Farasati NA, 2005, TRANSPLANTATION, V79, P116, DOI 10.1097/01.TP.0000149338.97084.5F; Fioriti D, 2005, INT J IMMUNOPATH PH, V18, P799, DOI 10.1177/039463200501800424; Gilis L, 2014, BONE MARROW TRANSPL, V49, P664, DOI 10.1038/bmt.2013.235; HIRAOKA A, 1991, BONE MARROW TRANSPL, V7, P107; Jiang MX, 2009, VIROLOGY, V384, P266, DOI 10.1016/j.virol.2008.09.027; KLEIN RJ, 1987, LANCET, V1, P281; Lubeck DP, 2001, UROLOGY, V57, P62, DOI 10.1016/S0090-4295(01)01126-8; Nickeleit V, 2003, CURR OPIN NEPHROL HY, V12, P599, DOI 10.1097/00041552-200311000-00005; Ottem DP, 2005, UROLOGY, V66, P494, DOI 10.1016/j.urology.2005.04.011; SANT GR, 1994, UROL CLIN N AM, V21, P73; Sharma BN, 2011, ANTIVIR RES, V92, P115, DOI 10.1016/j.antiviral.2011.07.012; Simon LJ, 1997, UROLOGY, V49, P64, DOI 10.1016/S0090-4295(99)80334-3; van der Aa F, 2014, MED HYPOTHESES, V83, P317, DOI 10.1016/j.mehy.2014.06.004; Zabihi N, 2007, J UROLOGY, V177, P149, DOI 10.1016/j.juro.2006.08.095; Zhong S, 2007, J CLIN MICROBIOL, V45, P193, DOI 10.1128/JCM.01645-06	22	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137310	10.1371/journal.pone.0137310	http://dx.doi.org/10.1371/journal.pone.0137310			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325074	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000360437700110
J	Arefin, B; Kucerova, L; Krautz, R; Kranenburg, H; Parvin, F; Theopold, U				Arefin, Badrul; Kucerova, Lucie; Krautz, Robert; Kranenburg, Holger; Parvin, Farjana; Theopold, Ulrich			Apoptosis in Hemocytes Induces a Shift in Effector Mechanisms in the Drosophila Immune System and Leads to a Pro-Inflammatory State	PLOS ONE			English	Article							GENE; EXPRESSION; INCREASES; INFECTION; REVEALS; SIGNALS; PROTEIN; GROWTH; CELLS	Apart from their role in cellular immunity via phagocytosis and encapsulation, Drosophila hemocytes release soluble factors such as antimicrobial peptides, and cytokines to induce humoral responses. In addition, they participate in coagulation and wounding, and in development. To assess their role during infection with entomopathogenic nematodes, we depleted plasmatocytes and crystal cells, the two classes of hemocytes present in naive larvae by expressing proapoptotic proteins in order to produce hemocyte-free (Hml-apo, originally called Hemo(less)) larvae. Surprisingly, we found that Hml-apo larvae are still resistant to nematode infections. When further elucidating the immune status of Hml-apo larvae, we observe a shift in immune effector pathways including massive lamellocyte differentiation and induction of Toll-as well as repression of imd signaling. This leads to a pro-inflammatory state, characterized by the appearance of melanotic nodules in the hemolymph and to strong developmental defects including pupal lethality and leg defects in escapers. Further analysis suggests that most of the phenotypes we observe in Hml-apo larvae are alleviated by administration of antibiotics and by changing the food source indicating that they are mediated through the microbiota. Biochemical evidence identifies nitric oxide as a key phylogenetically conserved regulator in this process. Finally we show that the nitric oxide donor L-arginine similarly modifies the response against an early stage of tumor development in fly larvae.	[Arefin, Badrul; Kucerova, Lucie; Krautz, Robert; Parvin, Farjana; Theopold, Ulrich] Stockholm Univ, Dept Mol Biosci, Wenner Gren Inst, S-10691 Stockholm, Sweden; [Kranenburg, Holger] Univ Munster, Inst Neurobiol, D-48149 Munster, Germany	Stockholm University; University of Munster	Theopold, U (corresponding author), Stockholm Univ, Dept Mol Biosci, Wenner Gren Inst, S-10691 Stockholm, Sweden.	uli.theopold@su.se	Arefin, Badrul/P-9532-2018; Theopold, Ulrich/P-7205-2015; Kucerova, Lucie/N-1176-2016; Arefin, Badrul/AAZ-9621-2021	Arefin, Badrul/0000-0003-1117-9125; Theopold, Ulrich/0000-0002-1009-8254; Kucerova, Lucie/0000-0002-6382-4467; Krautz, Robert/0000-0003-0457-1348	Cancerfonden [CAN 2013/546]; Vetenskapsradet [VR-2010-5988]; KAW [KAW2012.0058]; STINT [IG2011-2042]	Cancerfonden(Swedish Cancer Society); Vetenskapsradet(Swedish Research Council); KAW; STINT	Funding was provided by Cancerfonden CAN 2013/546, https://www.cancerfonden.se/, Vetenskapsradet VR-2010-5988, www.vr.se, KAW KAW2012.0058, www.wallenberg.com/kaw/, STINT IG2011-2042, http://www.stint.se/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arefin B, 2014, J INNATE IMMUN, V6, P192, DOI 10.1159/000353734; Battinelli E, 2000, BLOOD, V95, P3451, DOI 10.1182/blood.V95.11.3451.011k34_3451_3459; Battinelli E, 2001, P NATL ACAD SCI USA, V98, P14458, DOI 10.1073/pnas.241427398; Becker T, 2010, NATURE, V463, P369, DOI 10.1038/nature08698; Benmimoun B, 2012, DEVELOPMENT, V139, P1713, DOI 10.1242/dev.080259; Bidla G, 2007, J CELL SCI, V120, P1209, DOI 10.1242/jcs.03420; Bidla G, 2009, J INNATE IMMUN, V1, P301, DOI 10.1159/000168009; Brennan CA, 2007, CURR BIOL, V17, P67, DOI 10.1016/j.cub.2006.11.026; Caceres L, 2011, GENE DEV, V25, P1476, DOI 10.1101/gad.2064111; Charroux B, 2009, P NATL ACAD SCI USA, V106, P9797, DOI 10.1073/pnas.0903971106; Dantoft W, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-99; Defaye A, 2009, J INNATE IMMUN, V1, P322, DOI 10.1159/000210264; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dobes P, 2012, FLY, V6, P75, DOI 10.4161/fly.19553; Dragojlovic-Munther M, 2012, DEVELOPMENT, V139, P3752, DOI 10.1242/dev.074203; Dzik JM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00544; Eleftherianos I, 2011, J INNATE IMMUN, V3, P28, DOI 10.1159/000321931; Perez-Cobas AE, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv022; Fors L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108795; Glittenberg MT, 2011, DIS MODEL MECH, V4, P515, DOI 10.1242/dmm.006627; Goto A, 2003, DEV BIOL, V264, P582, DOI 10.1016/j.ydbio.2003.06.001; Hauling T, 2014, BIOL OPEN, V3, P250, DOI 10.1242/bio.20146494; Hyrsl P, 2011, J INNATE IMMUN, V3, P65, DOI 10.1159/000320634; Kraaijeveld AR, 2011, DEV COMP IMMUNOL, V35, P857, DOI 10.1016/j.dci.2011.03.019; Krautz R, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00342; Kurucz E, 2003, P NATL ACAD SCI USA, V100, P2622, DOI 10.1073/pnas.0436940100; Kuzin B, 1996, CELL, V87, P639, DOI 10.1016/S0092-8674(00)81384-7; LEMAITRE B, 1995, EMBO J, V14, P536, DOI 10.1002/j.1460-2075.1995.tb07029.x; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Makhijani K, 2011, DEVELOPMENT, V138, P5379, DOI 10.1242/dev.067322; Markus R, 2005, IMMUNOL LETT, V101, P108, DOI 10.1016/j.imlet.2005.03.021; Scherfer C, 2006, DEV BIOL, V295, P156, DOI 10.1016/j.ydbio.2006.03.019; Schmid MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102568; Shia AKH, 2009, J CELL SCI, V122, P4505, DOI 10.1242/jcs.049155; Shim J, 2012, NAT CELL BIOL, V14, P394, DOI 10.1038/ncb2453; Simpson SJ, 2015, ANNU REV ENTOMOL, V60, P293, DOI 10.1146/annurev-ento-010814-020917; Williams MJ, 2007, J IMMUNOL, V178, P4711, DOI 10.4049/jimmunol.178.8.4711; Wing JP, 2001, MECH DEVELOP, V102, P193, DOI 10.1016/S0925-4773(01)00316-1	39	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136593	10.1371/journal.pone.0136593	http://dx.doi.org/10.1371/journal.pone.0136593			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322507	Green Published, Green Submitted, gold			2022-12-26	WOS:000360435500023
J	Kraemer, N; Issa-Jahns, L; Neubert, G; Ravindran, E; Mani, S; Ninnemann, O; Kaindl, AM				Kraemer, Nadine; Issa-Jahns, Lina; Neubert, Gerda; Ravindran, Ethiraj; Mani, Shyamala; Ninnemann, Olaf; Kaindl, Angela M.			Novel Alternative Splice Variants of Mouse Cdk5rap2	PLOS ONE			English	Article								Autosomal recessive primary microcephaly (MCPH) is a rare neurodevelopmental disorder characterized by a pronounced reduction of brain volume and intellectual disability. A current model for the microcephaly phenotype invokes a stem cell proliferation and differentiation defect, which has moved the disease into the spotlight of stem cell biology and neurodevelopmental science. Homozygous mutations of the Cyclin-dependent kinase-5 regulatory subunit-associated protein 2 gene CDK5RAP2 are one genetic cause of MCPH. To further characterize the pathomechanism underlying MCPH, we generated a conditional Cdk5rap2 LoxP/hCMV Cre mutant mouse. Further analysis, initiated on account of a lack of a microcephaly phenotype in these mutant mice, revealed the presence of previously unknown splice variants of the Cdk5rap2 gene that are at least in part accountable for the lack of microcephaly in the mice.	[Kraemer, Nadine; Issa-Jahns, Lina; Neubert, Gerda; Ravindran, Ethiraj; Ninnemann, Olaf; Kaindl, Angela M.] Charite, Inst Cell Biol & Neurobiol, D-13353 Berlin, Germany; [Kraemer, Nadine; Issa-Jahns, Lina; Neubert, Gerda; Ravindran, Ethiraj; Kaindl, Angela M.] Charite, Dept Pediat Neurol, D-13353 Berlin, Germany; [Mani, Shyamala] Indian Inst Sci, Ctr Neurosci, Bangalore 560012, Karnataka, India; [Kaindl, Angela M.] Charite, Sozialpadiatr Zentrum SPZ, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Indian Institute of Science (IISC) - Bangalore; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kraemer, N (corresponding author), Charite, Inst Cell Biol & Neurobiol, D-13353 Berlin, Germany.	nadine.kraemer@charite.de; angela.kaindl@charite.de		Kraemer, Nadine/0000-0002-7002-5161; Kaindl, Angela/0000-0001-9454-206X	German Research Foundation [SFB665]; Sonnenfeld Stiftung; Federal Ministry of Education and research (BMBF); Berlin Institute of Health (BIH); Academic Exchange Service (DAAD)	German Research Foundation(German Research Foundation (DFG)); Sonnenfeld Stiftung; Federal Ministry of Education and research (BMBF)(Federal Ministry of Education & Research (BMBF)); Berlin Institute of Health (BIH); Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by German Research Foundation (SFB665), http://www.sfb665.de/; Sonnenfeld Stiftung, http://www.sonnenfeld-stiftung.de/; Federal Ministry of Education and research (BMBF); Berlin Institute of Health (BIH), http://www.bmbf.de/en/; Academic Exchange Service (DAAD), https://www.daad.de/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Fong KW, 2008, MOL BIOL CELL, V19, P115, DOI 10.1091/mbc.E07-04-0371; Issa L, 2013, CEREB CORTEX, V23, P2245, DOI 10.1093/cercor/bhs212; Kaindl AM, 2010, PROG NEUROBIOL, V90, P363, DOI 10.1016/j.pneurobio.2009.11.002; Kraemer N, 2015, CELL CYCLE, V14, P2044, DOI 10.1080/15384101.2015.1044169; Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410; Mahmood S, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-39; Moynihan L, 2000, AM J HUM GENET, V66, P724, DOI 10.1086/302777; Nagy ZP, 2003, REPROD BIOMED ONLINE; Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011	11	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136684	10.1371/journal.pone.0136684	http://dx.doi.org/10.1371/journal.pone.0136684			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322982	Green Published, Green Accepted, gold			2022-12-26	WOS:000360435500027
J	Ray, A; Yuan, CY; Miller, NM; Mei, H; Dittel, BN				Ray, Avijit; Yuan, Cheng-Yin; Miller, Nichole M.; Mei, Hong; Dittel, Bonnie N.			2B4 Is Dispensable for T-Dependent B Cell Immune Responses, but Its Deficiency Leads to Enhanced T-Independent Responses Due to an Increase in Peritoneal Cavity B1b Cells	PLOS ONE			English	Article							SLAM; CD48; SAP; NK; RECEPTORS; CD244; LYMPHOCYTES; DIFFERENTIATION; ACTIVATION; EXPRESSION	The signaling lymphocyte activation molecule (SLAM) family plays important roles in adaptive immune responses. Herein, we evaluated whether the SLAM family member 2B4 (CD244) plays a role in immune cell development, homeostasis and antibody responses. We found that the splenic cellularity in Cd244(-/-) mice was significantly reduced due to a reduction in both CD4 T cells and follicular (Fo) B cells; whereas, the number of peritoneal cavity B cells was increased. These findings led us to examine whether 2B4 modulates B cell immune responses. When we examined T-dependent B cell responses, while there was no difference in the kinetics or magnitude of the antigen-specific IgM and IgG(1) antibody response there was a reduction in bone marrow (BM) memory, but not plasma cells in Cd244(-/-) mice. When we evaluated T-independent immune responses, we found that antigen-specific IgM and IgG(3) were elevated in the serum following immunization. These data indicate that 2B4 dampens T-independent B cell responses due to a reduction in peritoneal cavity B cells, but has minimal impact on T-dependent B cell responses.	[Ray, Avijit; Miller, Nichole M.; Mei, Hong; Dittel, Bonnie N.] BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI 53233 USA; [Yuan, Cheng-Yin; Dittel, Bonnie N.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	Versiti Blood Center of Wisconsin; Medical College of Wisconsin	Dittel, BN (corresponding author), BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI 53233 USA.	bonnie.dittel@bcw.edu	Yuan, Cheng Yin/AAT-3750-2021; Ray, Avijit/K-5611-2015	Ray, Avijit/0000-0002-1732-9836	National Institutes of Health [R01 AI069358, R56 AI106672-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069358, R56AI106672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by National Institutes of Health grants R01 AI069358 and R56 AI106672-01.	Alugupalli KR, 2008, CURR TOP MICROBIOL, V319, P105; Alugupalli KR, 2004, IMMUNITY, V21, P379, DOI 10.1016/j.immuni.2004.06.019; Basu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067587; Basu S, 2011, J IMMUNOL, V187, P5720, DOI 10.4049/jimmunol.1102195; Boles KS, 2001, IMMUNOL REV, V181, P234, DOI 10.1034/j.1600-065X.2001.1810120.x; Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; Chen RY, 2004, MOL CELL BIOL, V24, P5144, DOI 10.1128/MCB.24.12.5144-5156.2004; De Salort J, 2011, IMMUNOL LETT, V134, P129, DOI 10.1016/j.imlet.2010.09.021; Dellabona P, 2014, EUR J IMMUNOL, V44, P2230, DOI 10.1002/eji.201344399; Elishmereni M, 2011, INT J BIOCHEM CELL B, V43, P25, DOI 10.1016/j.biocel.2010.09.001; Fagarasan S, 2000, SCIENCE, V290, P89, DOI 10.1126/science.290.5489.89; Gao N, 2005, J IMMUNOL, V174, P4113, DOI 10.4049/jimmunol.174.7.4113; Gao N, 2001, J IMMUNOL, V167, P2011, DOI 10.4049/jimmunol.167.4.2011; Hoffmann JC, 1998, CELL BIOL INT, V22, P21, DOI 10.1006/cbir.1997.0208; KATO K, 1992, J EXP MED, V176, P1241, DOI 10.1084/jem.176.5.1241; Klyushnenkova EN, 1996, CELL IMMUNOL, V174, P90, DOI 10.1006/cimm.1996.0297; Latchman Y, 1998, EUR J IMMUNOL, V28, P4325, DOI 10.1002/(SICI)1521-4141(199812)28:12<4325::AID-IMMU4325>3.0.CO;2-T; Liu DY, 2014, J EXP MED, V211, P297, DOI 10.1084/jem.20130902; Martin F, 2001, CURR OPIN IMMUNOL, V13, P195, DOI 10.1016/S0952-7915(00)00204-1; Moran M, 1998, IMMUNITY, V9, P787, DOI 10.1016/S1074-7613(00)80644-5; Perez-Quintero LA, 2014, J EXP MED, V211, P727, DOI 10.1084/jem.20132038; Pillai S, 2005, ANNU REV IMMUNOL, V23, P161, DOI 10.1146/annurev.immunol.23.021704.115728; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Ray Avijit, 2010, J Vis Exp, DOI 10.3791/1488; Romero X, 2004, TISSUE ANTIGENS, V64, P132, DOI 10.1111/j.1399-0039.2004.00247.x; Roncagalli R, 2005, NAT IMMUNOL, V6, P1002, DOI 10.1038/ni1242; Srivastava B, 2005, J EXP MED, V202, P1225, DOI 10.1084/jem.20051038; THORLEYLAWSON DA, 1982, CELL, V30, P415, DOI 10.1016/0092-8674(82)90239-2; Vaidya SV, 2005, J IMMUNOL, V174, P800, DOI 10.4049/jimmunol.174.2.800; Vargas-Inchaustegui DA, 2012, J IMMUNOL, V189, P1878, DOI 10.4049/jimmunol.1201026; Veillette A, 2006, IMMUNOL REV, V214, P22, DOI 10.1111/j.1600-065X.2006.00453.x; Zhao F, 2012, IMMUNITY, V36, P1003, DOI 10.1016/j.immuni.2012.05.017	32	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0137314	10.1371/journal.pone.0137314	http://dx.doi.org/10.1371/journal.pone.0137314			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26323020	Green Published, Green Submitted, gold			2022-12-26	WOS:000360435500070
J	Peron, JPS; de Brito, AA; Pelatti, M; Brandao, WN; Vitoretti, LB; Greiffo, FR; da Silveira, EC; Oliveira, MC; Maluf, M; Evangelista, L; Halpern, S; Nisenbaum, MG; Perin, P; Czeresnia, CE; Camara, NOS; Aimbire, F; Vieira, RD; Zatz, M; de Oliveira, APL				Schatzmann Peron, Jean Pierre; de Brito, Aurileia Aparecida; Pelatti, Mayra; Brandao, Wesley Nogueira; Vitoretti, Luana Beatriz; Greiffo, Flavia Regina; da Silveira, Elaine Cristina; Oliveira-Junior, Manuel Carneiro; Maluf, Mariangela; Evangelista, Lucila; Halpern, Silvio; Nisenbaum, Marcelo Gil; Perin, Paulo; Czeresnia, Carlos Eduardo; Saraiva Camara, Niels Olsen; Aimbire, Flavio; Vieira, Rodolfo de Paula; Zatz, Mayana; Ligeiro de Oliveira, Ana Paula			Human Tubal-Derived Mesenchymal Stromal Cells Associated with Low Level Laser Therapy Significantly Reduces Cigarette Smoke-Induced COPD in C57BL/6 mice	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; STEM-CELLS; INDOLEAMINE 2,3-DIOXYGENASE; AIRWAY INFLAMMATION; LUNG; FIBROSIS; RECOVERY; ASTHMA	Cigarette smoke-induced chronic obstructive pulmonary disease is a very debilitating disease, with a very high prevalence worldwide, which results in a expressive economic and social burden. Therefore, new therapeutic approaches to treat these patients are of unquestionable relevance. The use of mesenchymal stromal cells (MSCs) is an innovative and yet accessible approach for pulmonary acute and chronic diseases, mainly due to its important immunoregulatory, anti-fibrogenic, anti-apoptotic and pro-angiogenic. Besides, the use of adjuvant therapies, whose aim is to boost or synergize with their function should be tested. Low level laser (LLL) therapy is a relatively new and promising approach, with very low cost, no invasiveness and no side effects. Here, we aimed to study the effectiveness of human tube derived MSCs (htMSCs) cell therapy associated with a 30mW/3J-660 nm LLL irradiation in experimental cigarette smoke-induced chronic obstructive pulmonary disease. Thus, C57BL/6 mice were exposed to cigarette smoke for 75 days (twice a day) and all experiments were performed on day 76. Experimental groups receive htMSCS either intraperitoneally or intranasally and/or LLL irradiation either alone or in association. We show that co-therapy greatly reduces lung inflammation, lowering the cellular infiltrate and pro-inflammatory cytokine secretion (IL-1 beta, IL-6, TNF-alpha and KC), which were followed by decreased mucus production, collagen accumulation and tissue damage. These findings seemed to be secondary to the reduction of both NF-kappa B and NF-AT activation in lung tissues with a concomitant increase in IL-10. In summary, our data suggests that the concomitant use of MSCs + LLLT may be a promising therapeutic approach for lung inflammatory diseases as COPD.	[Schatzmann Peron, Jean Pierre; Brandao, Wesley Nogueira] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Neuroimmune Interact Lab, Sao Paulo, SP, Brazil; [de Brito, Aurileia Aparecida; Vitoretti, Luana Beatriz; Greiffo, Flavia Regina; da Silveira, Elaine Cristina; Zatz, Mayana] Nove Julho Univ UNINOVE, Lab Pulm & Exercise Immunol LABPEI, Sao Paulo, SP, Brazil; [Pelatti, Mayra; Oliveira-Junior, Manuel Carneiro; Vieira, Rodolfo de Paula; Ligeiro de Oliveira, Ana Paula] Univ Sao Paulo, Div Human Genome, Res Ctr, Biosci Inst, Sao Paulo, SP, Brazil; [Maluf, Mariangela; Perin, Paulo] CEERH Specialized Ctr Human Reprod, Div Reprod Med, Sao Paulo, SP, Brazil; [Evangelista, Lucila; Halpern, Silvio; Nisenbaum, Marcelo Gil; Czeresnia, Carlos Eduardo] Div Reprod Med Celula Mater, Sao Paulo, SP, Brazil; [Saraiva Camara, Niels Olsen] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Lab Transplantat Immunobiol, Sao Paulo, SP, Brazil; [Aimbire, Flavio] Univ Fed Sao Paulo, Dept Sci & Technol, Sao Jose Dos Campos, SP, Brazil	Universidade de Sao Paulo; Universidade Nove de Julho; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	de Oliveira, APL (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Neuroimmune Interact Lab, Sao Paulo, SP, Brazil.	apligeiro@gmail.com	de Oliveira Junior, Manoel Carneiro/P-5597-2019; de Paula Vieira, Rodolfo/E-9315-2011; Aimbire, Flavio/E-6193-2012; Zatz, Mayana/M-5338-2015; Brandão, Wesley N/K-5919-2017; Peron, Jean Pierre S/F-9248-2012; camara, niels olsen saraiva/AAX-3269-2020; Camara, Niels OS/G-8336-2011	de Oliveira Junior, Manoel Carneiro/0000-0002-1698-9920; de Paula Vieira, Rodolfo/0000-0001-6379-1143; Aimbire, Flavio/0000-0002-4290-541X; Zatz, Mayana/0000-0003-3970-8025; Brandão, Wesley N/0000-0001-9306-3251; camara, niels olsen saraiva/0000-0001-5436-1248; Camara, Niels OS/0000-0001-5436-1248; Peron, Jean Pierre/0000-0003-1638-8866; Brito, Aurileia/0000-0001-9683-4410; Ligeiro de Oliveira, Ana Paula/0000-0001-6089-5107	FAPESP (Fundacao de Apoio a Pesquisa do Estado de Sao Paulo) [2011/18703-2, 2012/16498-5]	FAPESP (Fundacao de Apoio a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Financial support from FAPESP (Fundacao de Apoio a Pesquisa do Estado de Sao Paulo) grants # 2011/18703-2 for Peron JPS and 2012/16498-5 for Ligeiro de Oliveira AP.	Al Jumah MA, 2012, INT J MOL SCI, V13, P9298, DOI 10.3390/ijms13079298; Alves ACA, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4296; Atsuta I, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt322; Barnes PJ, 2008, REV SERIES CYTOKINE, V118; Biselli PJC, 2011, BRAZ J MED BIOL RES, V44, P460, DOI 10.1590/S0100-879X2011007500040; Bluestone JA, 2007, NAT REV IMMUNOL, V7, P650, DOI 10.1038/nri2137; Clark EA, 2014, STEM CELLS, V32, P1074, DOI 10.1002/stem.1623; Croitoru-Lamoury J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014698; Curley GF, 2013, ANESTHESIOLOGY, V118, P924, DOI 10.1097/ALN.0b013e318287ba08; de Frutos S, 2007, J BIOL CHEM, V282, P15081, DOI 10.1074/jbc.M702679200; de Lima FM, 2014, J LASERS MED SCI, V5, P63; Di Stefano A, 2014, THORAX, V69, P516, DOI 10.1136/thoraxjnl-2012-203062; Eduardo CP, 2008, LASERS SURG MED, V40; Einstein O, 2006, EXP NEUROL, V198, P275, DOI 10.1016/j.expneurol.2005.11.007; Figeac F, 2014, STEM CELLS, V32, P216, DOI 10.1002/stem.1560; Ge W, 2010, TRANSPLANTATION, V90, P1312, DOI 10.1097/TP.0b013e3181fed001; Guan XJ, 2013, J CELL BIOCHEM, V114, P323, DOI 10.1002/jcb.24377; Hizume DC, 2012, RESP PHYSIOL NEUROBI, V181, P167, DOI 10.1016/j.resp.2012.03.005; Inamdar AC, 2013, EXP LUNG RES, V39, P315, DOI 10.3109/01902148.2013.816803; Jazedje T, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-46; John G, 2014, CLIN SCI, V126, P207, DOI 10.1042/CS20130117; Jones BJ, 2007, PLACENTA, V28, P1174, DOI 10.1016/j.placenta.2007.07.001; Kerkis I, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-35; Kubo H, 2012, STEM CELL TRANSL MED, V1, P627, DOI 10.5966/sctm.2012-0065; Lin F, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-16; Lino-dos-Santos-Franco A, 2010, TOXICOL LETT, V197, P211, DOI 10.1016/j.toxlet.2010.05.022; Longhini-dos-Santos N, 2013, STEM CELL REV REP, V9, P210, DOI 10.1007/s12015-012-9419-y; Morse D, 2014, ANNU REV PHYSIOL, V76, P493, DOI 10.1146/annurev-physiol-021113-170411; Oton-Leite AF, 2013, SPEC CARE DENT, V33, P294, DOI 10.1111/j.1754-4505.2012.00303.x; Park M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08616; Peron JPS, 2012, STEM CELL REV REP, V8, P940, DOI 10.1007/s12015-011-9338-3; Leal ECP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089453; Plass CA, 2012, LASER SURG MED, V44, P705, DOI 10.1002/lsm.22075; Postma DS, 2014, CLIN CHEST MED, V35, P143, DOI 10.1016/j.ccm.2013.09.010; Rastrick JMD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054128; Rennard SI, 2004, NEW ENGL J MED, V350, P965, DOI 10.1056/NEJMp048022; Schweitzer KS, 2011, AM J RESP CRIT CARE, V183, P215, DOI 10.1164/rccm.201001-0126OC; Secco M, 2013, STEM CELL REV REP, V9, P93, DOI 10.1007/s12015-012-9380-9; Semedo P, 2009, STEM CELLS, V27, P3063, DOI 10.1002/stem.214; Silva RA, 2010, EUR RESPIR J, V35, P994, DOI 10.1183/09031936.00049509; Silva VR, 2014, RESP PHYSIOL NEUROBI, V194, P37, DOI 10.1016/j.resp.2014.01.008; Stessuk Talita, 2013, Rev. Bras. Hematol. Hemoter., V35, P352, DOI 10.5581/1516-8484.20130113; Tamaki T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091257; Vashishta A, 2009, J NEUROSCI, V29, P15331, DOI 10.1523/JNEUROSCI.4873-09.2009; Vieira RP, 2007, AM J RESP CRIT CARE, V176, P871, DOI 10.1164/rccm.200610-1567OC; Vieira RP, 2011, AM J RESP CRIT CARE, V184, P215, DOI 10.1164/rccm.201011-1762OC; Weiss DJ, 2014, PLACEBO CONTROLLED R; Wu J, 2013, NANOSCALE RES LETT, V8, P1, DOI 10.1186/1556-276X-8-5; Zhang XM, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-138; Zucconi E, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/715251	50	17	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136942	10.1371/journal.pone.0136942	http://dx.doi.org/10.1371/journal.pone.0136942			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322981	gold, Green Published, Green Submitted			2022-12-26	WOS:000360435500051
J	Barennes, H; Phimmasane, M; Rajaonarivo, C				Barennes, Hubert; Phimmasane, Maniphet; Rajaonarivo, Christian			Insect Consumption to Address Undernutrition, a National Survey on the Prevalence of Insect Consumption among Adults and Vendors in Laos	PLOS ONE			English	Article							CROSS-SECTIONAL SURVEY; THIAMIN DEFICIENCY; YOUNG-CHILDREN; EDIBLE INSECTS; ENTOMOPHAGY; WOMEN; NUTRITION; VIENTIANE; THAILAND; BERIBERI	Background Insect consumption (entomophagy) is a potentially high nutritious and healthy source of food with high fat, protein, vitamin, fiber and micronutrient content. At least 2 billion people globally eat insects (over 1900 edible species) though this habit is regarded negatively by others. There is a limited amount of data on the perception and consumption of insects. We conducted a national cross-sectional survey in the Lao People's Democratic Republic (Laos) to assess the prevalence and characteristics of insect consumption among adult lay people and insect vendors. Methods We conducted a multi stage randomized national survey in 1303 households in 96 villages in 16 Lao provinces. Three insect vendors or collectors per village were also included. A standardized pretested questionnaire addressed the following issues: socioeconomic characteristics, type of insects consumed and frequency of consumption, reasons and trends in consumption as well as reports on side effects, over the last 10 years. Results A total of 1059 adults (Sex ratio F/M: 1.2, 30 ethnic groups), and 256 vendors were enrolled. A total of 1025 (96.8%) lay people were currently insect consumers, 135 (13.0%) daily or weekly consumers, and 322 (31.1%) consumed several times per month. For the majority (575, 55.6%) the consumption was infrequent (less than a few times per year) and only 22 (2%) had never eaten insects. Consumption started in childhood. Insect availability was seasonal (670, 63.2%) and respondents would have eaten more insects, if they had been more available (919, 86.7%). Hmong and Leu ethnic groups had significantly lower consumption levels than the general population. Eggs of weaver ants, short-tailed crickets, crickets, grasshoppers, and cicadas were the top 5 insects consumed. Consumption had decreased in the last decade, mostly due to less availability (869; 84.0%) and change of life (29; 5.5%). Of 1059, 80 (7.5%) reported allergy problems and 106 (10.0%) reported some use in traditional medicine. A total of 874 (82.6%) were regular collectors. Insect vendors (Sex ratio F/M: 5.3) were also collectors (185; 72.2%). They dedicated a mean time of 4.7 hours during the last harvesting period. The majority sold insects at markets (141, 55.0%). They had earned, on average, USD 6.0 the day before. Five insects (weaver ant eggs; bamboo worms; short-tailed crickets; crickets; wasps) represented 85% of the market. Conclusion Entomophagy is general in Laos, and well accepted despite a decreasing trend in consumption over the last decade. Its contribution to the Lao diet is limited to a minority of frequent consumers. Income through insect sales benefits mostly women. Consumption varies according to ethnicity, residence and season. Development of insect farming is still at an early stage. It could however increase availability of insects and contribute to the generation of income.	[Barennes, Hubert; Phimmasane, Maniphet; Rajaonarivo, Christian] Inst Francophonie Med Trop, Viangchan, Laos; [Barennes, Hubert] Agence Natl Rech VIH & Hepatites Phnom Penh, Phnom Penh, Cambodia; [Barennes, Hubert] Univ Bordeaux, Ctr INSERM Epidemiol Biostat U897, ISPED, F-33000 Bordeaux, France; [Barennes, Hubert] Inst Pasteur, Epidemiol Unit, Phnom Penh, Cambodia	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia	Barennes, H (corresponding author), Inst Francophonie Med Trop, Viangchan, Laos.	barenneshub@yahoo.fr			Institut pour la Francophonie de Medecine Tropicale (Vientiane); Food and Agriculture Organization of the United Nations	Institut pour la Francophonie de Medecine Tropicale (Vientiane); Food and Agriculture Organization of the United Nations	The survey was supported by Institut pour la Francophonie de Medecine Tropicale (Vientiane) and funds from Food and Agriculture Organization of the United Nations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold H., 2013, EDIBLE INSECTS FUTUR, V171, P1; Barennes H, 2009, EUR J CLIN NUTR, V63, P323, DOI 10.1038/sj.ejcn.1602928; Barennes H, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003581; Barennes H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030634; Barennes H, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1379; Berger J, 2013, FOOD NUTR BULL, V34, pS133, DOI 10.1177/15648265130342S115; Christensen DL, 2006, INT J FOOD SCI NUTR, V57, P198, DOI 10.1080/09637480600738252; Coghlan B, 2014, ASIA PAC J CLIN NUTR, V23, P105, DOI 10.6133/apjcn.2014.23.1.16; de Sa J, 2013, MATERN CHILD NUTR, V9, P452, DOI 10.1111/j.1740-8709.2012.00406.x; Department of Statistics-Ministry of Planning and Investment, 2007, LAND COV CHANG QUEEN, P1; Doung-ngern P., 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P130; Fontaneto D, 2011, ECOL FOOD NUTR, V50, P351, DOI 10.1080/03670244.2011.586316; Holmes W, 2007, ASIA PAC J CLIN NUTR, V16, P537; Khounnorath S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000969; Knowles J, 2013, BRIT J NUTR, V110, P2285, DOI 10.1017/S000711451300158X; Kounnavong Sengchanh, 2011, Trop Med Health, V39, P95, DOI 10.2149/tmh.2011-13; Kounnavong S, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-129; Lensvelt EJS, 2014, ECOL FOOD NUTR, V53, P543, DOI 10.1080/03670244.2013.879865; Mayxay M, 2007, TROP MED INT HEALTH, V12, P363, DOI 10.1111/j.1365-3156.2006.01804.x; Mayxay M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-275; Megido RC, 2016, J SCI FOOD AGR, V96, P627, DOI 10.1002/jsfa.7133; Nadeau L, 2015, ECOL FOOD NUTR, V54, P200, DOI 10.1080/03670244.2014.930032; Perks C, 2006, B WORLD HEALTH ORGAN, V84, P132, DOI 10.2471/BLT.05.025403; Phengxay M, 2007, PEDIATR INT, V49, P260, DOI 10.1111/j.1442-200X.2007.02354.x; Rumpold BA, 2013, MOL NUTR FOOD RES, V57, P802, DOI 10.1002/mnfr.201200735; Schweigert FJ, 2003, NUTR J, V2, DOI 10.1186/1475-2891-2-17; Shantibala T, 2014, J INSECT SCI, V14, DOI 10.1093/jis/14.1.14; Soukaloun D, 2003, ANN TROP PAEDIATR, V23, P181, DOI 10.1179/027249303322296493; Tracy JM, 2011, MT SINAI J MED, V78, P773, DOI 10.1002/msj.20286; UNICEF, 2009, STATE WORLDS CHILDRE; UNICEF, 2015, LAOS SIT CHILDR; United Nations Development Program, 2014, HUM DEV REP 2014; Yhoung-Aree J, 2004, ECOLOGICAL IMPLICATIONS OF MINLIVESTOCK: POTENTIAL OF INSECTS RODENTS FROGS AND SNAILS, P415; YhoungAree J, 1997, ECOL FOOD NUTR, V36, P133, DOI 10.1080/03670244.1997.9991511	34	31	33	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136458	10.1371/journal.pone.0136458	http://dx.doi.org/10.1371/journal.pone.0136458			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317772	gold, Green Submitted, Green Published			2022-12-26	WOS:000360299100087
J	Damos, P; Soulopoulou, P				Damos, Petros; Soulopoulou, Polyxeni			Do Insect Populations Die at Constant Rates as They Become Older? Contrasting Demographic Failure Kinetics with Respect to Temperature According to the Weibull Model	PLOS ONE			English	Article							ANARSIA-LINEATELLA LEPIDOPTERA; DROSOPHILA-MELANOGASTER; LIFE-SPAN; MORTALITY-RATES; AGE; EVOLUTION; RELIABILITY; SURVIVAL; GELECHIIDAE; SENESCENCE	Temperature implies contrasting biological causes of demographic aging in poikilotherms. In this work, we used the reliability theory to describe the consistency of mortality with age in moth populations and to show that differentiation in hazard rates is related to extrinsic environmental causes such as temperature. Moreover, experiments that manipulate extrinsic mortality were used to distinguish temperature-related death rates and the pertinence of the Weibull aging model. The Newton-Raphson optimization method was applied to calculate parameters for small samples of ages at death by estimating the maximum likelihoods surfaces using scored gradient vectors and the Hessian matrix. The study reveals for the first time that the Weibull function is able to describe contrasting biological causes of demographic aging for moth populations maintained at different temperature regimes. We demonstrate that at favourable conditions the insect death rate accelerates as age advances, in contrast to the extreme temperatures in which each individual drifts toward death in a linear fashion and has a constant chance of passing away. Moreover, slope of hazard rates shifts towards a constant initial rate which is a pattern demonstrated by systems which are not wearing out (e.g. non-aging) since the failure, or death, is a random event independent of time. This finding may appear surprising, because, traditionally, it was mostly thought as rule that in aging population force of mortality increases exponentially until all individuals have died. Moreover, in relation to other studies, we have not observed any typical decelerating aging patterns at late life (mortality leveling-off), but rather, accelerated hazard rates at optimum temperatures and a stabilized increase at the extremes. In most cases, the increase in aging-related mortality was simulated reasonably well according to the Weibull survivorship model that is applied. Moreover, semi log- probability hazard rate model illustrations and maximum likelihoods may be usefully in defining periods of mortality leveling off and provide clear evidence that environmental variability may affect parameter estimates and insect population failure rate. From a reliability theory standpoint, failure rates vary according to a linear function of age at the extremes indicating that the life system (i.e., population) is able to eliminate earlier failure and/or to keep later failure rates constant. The applied model was able to identify the major correlates of extended longevity and to suggest new ideas for using demographic concepts in both basic and applied population biology and aging.	[Damos, Petros] Aristotle Univ Thessaloniki, Dept Crop Prod, Fac Agr Forestry & Nat Environm, GR-54006 Thessaloniki, Greece; [Soulopoulou, Polyxeni] Univ Aegean, Dept Environm, Mitilini, Lesvos, Greece	Aristotle University of Thessaloniki; University of Aegean	Damos, P (corresponding author), Aristotle Univ Thessaloniki, Dept Crop Prod, Fac Agr Forestry & Nat Environm, GR-54006 Thessaloniki, Greece.	petrosdamos@gmail.com	Damos, Petros/AAJ-3397-2020	Damos, Petros/0000-0002-4055-0977				Abernethy R.B., 2000, NEW WEIBULL HDB, VFourth; ABRAMS PA, 1993, EVOLUTION, V47, P877, DOI 10.1111/j.1558-5646.1993.tb01241.x; Aghdam HR, 2009, ENVIRON ENTOMOL, V38, P885, DOI 10.1603/022.038.0343; Barlow R. E., 1975, STAT THEORY RELIABIL; Bogdanoff JL, 1985, PROBABILISTIC MODELS; BROOKS A, 1994, SCIENCE, V263, P668, DOI 10.1126/science.8303273; BROWN KS, 1974, J GERONTOL, V29, P46, DOI 10.1093/geronj/29.1.46; Carey J. R., 2003, LONGEVITY BIOL DEMOG, DOI [10.1515/9780691224084, DOI 10.1515/9780691224084]; Carey JR., 1993, APPL DEMOGRAPHY BIOL; CAREY JR, 2005, LONGEVITY FRAILTY, P1, DOI DOI 10.1007/3-540-27388-3_1; Chi H., 2005, TWOSEX MSCHART COMPU; Curtsinger JW, 2002, MECH AGEING DEV, V123, P81, DOI 10.1016/S0047-6374(01)00345-1; CURTSINGER JW, 1992, SCIENCE, V258, P461, DOI 10.1126/science.1411541; Damos P., 2009, PHYSIOL ENTOMOL, V35, P67; Damos PT, 2008, J ECON ENTOMOL, V101, P1557, DOI 10.1603/0022-0493(2008)101[1557:TBAMOA]2.0.CO;2; Damos P, 2014, J INSECT SCI, V14, DOI 10.1093/jis/14.1.59; Damos P, 2013, J ECON ENTOMOL, V106, P675, DOI 10.1603/EC11327; Damos Petros, 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/123405; Devroye L., 1986, NONUNIFORM RANDOM VA; Duyck PF, 2010, BIOL J LINN SOC, V101, P345, DOI 10.1111/j.1095-8312.2010.01497.x; ECONOMOS AC, 1980, J SOC BIOL STRUCT, V3, P317, DOI 10.1016/0140-1750(80)90039-1; ECONOMOS AC, 1979, AGE, V2, P74, DOI 10.1007/BF02432250; Finch CE, 1990, LONGEVITY SENESCENCE; FUKUI HH, 1993, EXP GERONTOL, V28, P585, DOI 10.1016/0531-5565(93)90048-I; Gavrilov L.A., 1991, BIOL LIFE SPAN QUANT; Gavrilov LA, 2004, ANN NY ACAD SCI, V1019, P509, DOI 10.1196/annals.1297.094; Gavrilov LA, 2001, J THEOR BIOL, V213, P527, DOI 10.1006/jtbi.2001.2430; Gavrilov LA, 2003, BIOGERONTOLOGY, V34-35, P19; GAVRILOV LA, 2003, SCIENCE, V2003, P1; Gavrilov LA, 2011, N AM ACTUAR J, V15, P432, DOI 10.1080/10920277.2011.10597629; Gompertz B., 1825, PHILOS T ROYAL SOC L, V115, P515, DOI [DOI 10.1098/RSTL.1825.0026, 10.1098/rstl.1825.0026]; Haghani Mostafa, 2006, Insect Science, V13, P477, DOI 10.1111/j.1744-7917.2006.00118.x; Hughes KA, 2005, ANNU REV ENTOMOL, V50, P421, DOI 10.1146/annurev.ento.50.071803.130409; Jin KL, 2010, AGING DIS, V1, P72; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Lawless J.F, 1982, STAT MODELS METHODS; Lee EW, 2003, STAT METHODS SURVIVA, Vthird, DOI DOI 10.1002/0471458546; MANN NR, 1970, TECHNOMETRICS, V12, P345, DOI 10.2307/1267239; Martin TG, 2005, ECOL LETT, V8, P1235, DOI 10.1111/j.1461-0248.2005.00826.x; MATLAB, 2012, MATLAB STAT TOOLB RE; Morgan B. J. T., 2008, APPL STOCHASTIC MODE; Mueller L. D., 2011, DOES AGING STOP; Muller HG, 2004, AGING CELL, V3, P125, DOI 10.1111/j.1474-9728.2004.00096.x; Novoseltsev VN, 2011, ADV GERONTOL, V1, P95; Patel JK., 1976, HDB STAT DISTRIBUTIO; Pletcher SD, 1998, EVOLUTION, V52, P454, DOI [10.2307/2411081, 10.1111/j.1558-5646.1998.tb01645.x]; PROMISLOW DEL, 1990, J ZOOL, V220, P417, DOI 10.1111/j.1469-7998.1990.tb04316.x; R Core Team, 2012, R LANG ENV STAT COMP; Rausand M., 2004, SYSTEM RELIABILITY T; Rauser CL, 2006, AGEING RES REV, V5, P14, DOI 10.1016/j.arr.2005.06.003; Ricklefs RE, 2002, J GERONTOL A-BIOL, V57, pB69, DOI 10.1093/gerona/57.2.B69; Ricklefs RE, 1998, AM NAT, V152, P24, DOI 10.1086/286147; Scholz F., 2008, INFERENCE WEIBULL DI; Shahrestani P, 2012, REJUV RES, V12, P1; Strehler BL, 1978, TIME CELLS AND AGING; THOMAN DR, 1970, TECHNOMETRICS, V12, P363, DOI 10.2307/1267240; Tuljapurkar S., 2008, ASIA PACIFIC J RISK, V3, P37; Van Voorhies WA, 2004, J APPL PHYSIOL, V97, P1915, DOI 10.1152/japplphysiol.00505.2004; Vanfleteren JR, 1998, J GERONTOL A-BIOL, V53, pB393, DOI 10.1093/gerona/53A.6.B393; Vargas RI, 2000, ANN ENTOMOL SOC AM, V93, P75, DOI 10.1603/0013-8746(2000)093[0075:CDOTHF]2.0.CO;2; VAUPEL JW, 1986, POP STUD-J DEMOG, V40, P147, DOI 10.1080/0032472031000141896; Venables WN., 2002, MODERN APPL STAT S 4; Vieira C, 2000, GENETICS, V154, P213; Wang MH, 2004, AGING CELL, V3, P133, DOI 10.1111/j.1474-9728.2004.00098.x; WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293; [No title captured], DOI DOI 10.1016/B978-012369391-4/50006-0	66	11	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0127328	10.1371/journal.pone.0127328	http://dx.doi.org/10.1371/journal.pone.0127328			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317217	gold, Green Published			2022-12-26	WOS:000360299100002
J	Janik, P; Berdynski, M; Safranow, K; Zekanowski, C				Janik, Piotr; Berdynski, Mariusz; Safranow, Krzysztof; Zekanowski, Cezary			Association of ADORA1 rs2228079 and ADORA2A rs5751876 Polymorphisms with Gilles de la Tourette Syndrome in the Polish Population	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; ADENOSINE A(2A); RECEPTOR HETEROMERIZATION; DOPAMINE-D-2; CAFFEINE; RAT; LOCALIZATION; NEUROBIOLOGY; MUTATIONS; TICS	Background Gilles de la Tourette syndrome (GTS) is a neurodevelopmental disorder characterized by motor and vocal tics. Hyperactivity of dopaminergic transmission is considered a prime abnormality in the pathophysiology of tics. There are reciprocal antagonistic interactions between adenosine and dopamine transmission. The aim of the study was to analyze the association of two polymorphisms, rs2228079 in ADORA1 and rs5751876 in ADORA2A, with the risk of GTS and co-morbid disorders. Material and Methods A total of 162 Polish GTS patients and 270 healthy persons were enrolled in the study. Two polymorphisms were selected on the basis of knowledge of SNPs frequencies in ADORA1 and ADORA2A. Chi-square test was used for allelic and genotypic association studies. Association of genotypes with age of tic onset was analyzed with Mann-Whitney test. Multivariate logistic regression was used to find independent predictors of GTS risk. Results We found that the risk of GTS was associated with rs2228079 and rs5751876 polymorphisms. The GG+GT genotypes of rs2228079 in ADORA1 were underrepresented in GTS patients (p = 0.011), whereas T allele of rs5751876 in ADORA2A was overrepresented (p = 0.017). The GG genotype of rs2228079 was associated with earlier age of tic onset (p = 0.046). We found also that the minor allele G of rs2228079 was more frequent in GTS patients with depression as compared to the patients without depression (p = 0.015). Also the genotype GG was significantly more frequent in patients with obsessive compulsive disorder/behavior (OCD/OCB, p = 0.021) and depression (p = 0.032), as compared to the patients without these co-morbidities. The minor allele T frequency of rs5751876 was lower in GTS patients with co-morbid attention deficit hyperactivity disorder (p = 0.022), and TT+TC genotypes were less frequent in the non-OCD anxiety disorder group (p = 0.045). Conclusion ADORA1 and ADORA2A variants are associated with the risk of GTS, co-morbid disorders, and may affect the age of tic onset.	[Janik, Piotr] Med Univ Warsaw, Dept Neurol, Warsaw, Poland; [Berdynski, Mariusz; Zekanowski, Cezary] Polish Acad Sci, Mossakowski Med Res Ctr, Dept Neurodegenerat Disorders, Warsaw, Poland; [Safranow, Krzysztof] Pomeranian Med Univ, Dept Biochem & Med Chem, Szczecin, Poland	Medical University of Warsaw; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Pomeranian Medical University	Janik, P (corresponding author), Med Univ Warsaw, Dept Neurol, Warsaw, Poland.	piotr.janik@wum.edu.pl	Janik, Piotr/M-5836-2018; Berdyński, Mariusz/W-2382-2018; Safranow, Krzysztof/B-5127-2015	Janik, Piotr/0000-0002-2701-191X; Berdyński, Mariusz/0000-0003-2076-4318; Safranow, Krzysztof/0000-0001-9415-2758; Zekanowski, Cezary/0000-0001-7332-8494				Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Alexander GM, 2004, DEV PSYCHOPATHOL, V16, P407, DOI 10.1017/S095457940404458X; American Psychiatric Association, 2000, DIAGNOSTIC AND STATI; Antoniou K, 2005, PSYCHOPHARMACOLOGY, V183, P154, DOI 10.1007/s00213-005-0173-6; Behura SK, 2013, BIOL REV, V88, P49, DOI 10.1111/j.1469-185X.2012.00242.x; Berardelli A, 2003, J NEUROL, V250, P781, DOI 10.1007/s00415-003-1102-4; Burd L, 1999, J PERINAT MED, V27, P295, DOI 10.1515/JPM.1999.042; Canals M, 2003, J BIOL CHEM, V278, P46741, DOI 10.1074/jbc.M306451200; Cavanna AE, 2013, NEUROSCI BIOBEHAV R, V37, P1008, DOI 10.1016/j.neubiorev.2012.10.011; Ciruela F, 2006, J NEUROSCI, V26, P2080, DOI 10.1523/JNEUROSCI.3574-05.2006; Ciruela F, 2004, ANAL CHEM, V76, P5354, DOI 10.1021/ac049295f; Ciruela F, 2011, BBA-BIOMEMBRANES, V1808, P1245, DOI 10.1016/j.bbamem.2011.02.007; Cohen SC, 2013, NEUROSCI BIOBEHAV R, V37, P997, DOI 10.1016/j.neubiorev.2012.11.013; Daly JW, 1998, DRUG ALCOHOL DEPEN, V51, P199, DOI 10.1016/S0376-8716(98)00077-5; de Alvarenga PG, 2012, CNS SPECTRUMS, V17, P87, DOI 10.1017/S1092852912000491; Deng H, 2012, NAT REV NEUROL, V8, P203, DOI 10.1038/nrneurol.2012.26; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; El Yacoubi M, 2003, NEUROPHARMACOLOGY, V45, P977, DOI 10.1016/S0028-3908(03)00254-5; Ercan-Sencicek AG, 2010, NEW ENGL J MED, V362, P1901, DOI 10.1056/NEJMoa0907006; Felling RJ, 2011, J NEUROSCI, V31, P12387, DOI 10.1523/JNEUROSCI.0150-11.2011; Ferraro L, 2012, BRAIN RES, V1476, P96, DOI 10.1016/j.brainres.2012.01.032; Ferre S, 1997, TRENDS NEUROSCI, V20, P482, DOI 10.1016/S0166-2236(97)01096-5; Ferre Sergi, 2007, ScientificWorldJournal, V7, P74; Ferre S, 2007, BRAIN RES REV, V55, P55, DOI 10.1016/j.brainresrev.2007.01.007; FREDHOLM BB, 1995, PHARMACOL TOXICOL, V76, P228, DOI 10.1111/j.1600-0773.1995.tb00135.x; Fredholm BB, 2005, INT REV NEUROBIOL, V63, P191, DOI 10.1016/S0074-7742(05)63007-3; Fuxe K, 1998, BRAIN RES REV, V26, P258, DOI 10.1016/S0165-0173(97)00049-0; Hauser RA, 2011, LANCET NEUROL, V10, P221, DOI 10.1016/S1474-4422(11)70012-6; Hettinger BD, 2001, J COMP NEUROL, V431, P331, DOI 10.1002/1096-9861(20010312)431:3<331::AID-CNE1074>3.0.CO;2-W; Hoekstra PJ, 2004, CELL MOL LIFE SCI, V61, P886, DOI 10.1007/s00018-003-3320-4; Hunt R, 2009, METHODS MOL BIOL, V578, P23, DOI 10.1007/978-1-60327-411-1_2; HYDE TM, 1992, NEUROLOGY, V42, P652, DOI 10.1212/WNL.42.3.652; Kudlacek O, 2003, NEUROPSYCHOPHARMACOL, V28, P1317, DOI 10.1038/sj.npp.1300181; Kull B, 1999, BIOCHEM PHARMACOL, V58, P1035, DOI 10.1016/S0006-2952(99)00184-7; Kumer SC, 1996, J NEUROCHEM, V67, P443; Lawson-Yuen A, 2008, EUR J HUM GENET, V16, P614, DOI 10.1038/sj.ejhg.5202006; Lebowitz ER, 2012, EUR CHILD ADOLES PSY, V21, P451, DOI 10.1007/s00787-012-0278-5; LECKMAN JF, 1987, ARCH GEN PSYCHIAT, V44, P100; LeWitt PA, 2008, ANN NEUROL, V63, P295, DOI 10.1002/ana.21315; Martino D, 2009, MOVEMENT DISORD, V24, P1267, DOI 10.1002/mds.22504; Mort M, 2008, HUM MUTAT, V29, P1037, DOI 10.1002/humu.20763; Muller-Vahl KR, 2008, ACTA PAEDIATR, V97, P442, DOI 10.1111/j.1651-2227.2008.00675.x; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; O'Rourke JA, 2011, AM J MED GENET B, V156B, P553, DOI 10.1002/ajmg.b.31195; Ochiishi T, 1999, J COMP NEUROL, V411, P301; PALMER TM, 1995, NEUROPHARMACOLOGY, V34, P683, DOI 10.1016/0028-3908(95)00044-7; Paschou P, 2013, INT REV NEUROBIOL, V112, P155, DOI 10.1016/B978-0-12-411546-0.00006-8; Paschou P, 2013, NEUROSCI BIOBEHAV R, V37, P1026, DOI 10.1016/j.neubiorev.2013.01.016; Petek E, 2001, AM J HUM GENET, V68, P848, DOI 10.1086/319523; Robertson Mary M., 2003, P443; Robertson MM, 2006, J PSYCHOSOM RES, V61, P349, DOI 10.1016/j.jpsychores.2006.07.019; Robertson MM, 2000, BRAIN, V123, P425, DOI 10.1093/brain/123.3.425; Sebastiao AM, 2000, TRENDS PHARMACOL SCI, V21, P341, DOI 10.1016/S0165-6147(00)01517-0; Shinohara M, 2013, NEUROLOGY, V80, P1571, DOI 10.1212/WNL.0b013e31828f18d8; Singer HS, 2010, MED HYPOTHESES, V74, P862, DOI 10.1016/j.mehy.2009.11.028; State MW, 2011, CURR OPIN GENET DEV, V21, P302, DOI 10.1016/j.gde.2011.01.007; Verkerk AJMH, 2003, GENOMICS, V82, P1, DOI 10.1016/S0888-7543(03)00097-1; Waldman YY, 2010, NUCLEIC ACIDS RES, V38, P2964, DOI 10.1093/nar/gkq009; Wang DX, 2005, PHARMACOGENET GENOM, V15, P693, DOI 10.1097/01.fpc.0000178311.02878.83	60	19	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136754	10.1371/journal.pone.0136754	http://dx.doi.org/10.1371/journal.pone.0136754			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317759	Green Submitted, Green Published, gold			2022-12-26	WOS:000360299100135
J	Kari, JT; Pehkonen, J; Hirvensalo, M; Yang, XL; Hutri-Kahonen, N; Raitakari, OT; Tammelin, TH				Kari, Jaana T.; Pehkonen, Jaakko; Hirvensalo, Mirja; Yang, Xiaolin; Hutri-Kahonen, Nina; Raitakari, Olli T.; Tammelin, Tuija H.			Income and Physical Activity among Adults: Evidence from Self-Reported and Pedometer-Based Physical Activity Measurements	PLOS ONE			English	Article							ECONOMIC COSTS; PARTICIPATION; INACTIVITY; HEALTH; OBESITY; BURDEN; DETERMINANTS; MORTALITY; SPORTS; RISK	This study examined the relationship between income and physical activity by using three measures to illustrate daily physical activity: the self-reported physical activity index for leisure-time physical activity, pedometer-based total steps for overall daily physical activity, and pedometer-based aerobic steps that reflect continuous steps for more than 10 min at a time. The study population consisted of 753 adults from Finland (mean age 41.7 years; 64% women) who participated in 2011 in the follow-up of the ongoing Young Finns study. Ordinary least squares models were used to evaluate the associations between income and physical activity. The consistency of the results was explored by using register-based income information from Statistics Finland, employing the instrumental variable approach, and dividing the pedometer-based physical activity according to weekdays and weekend days. The results indicated that higher income was associated with higher self-reported physical activity for both genders. The results were robust to the inclusion of the control variables and the use of register-based income information. However, the pedometer-based results were gender-specific and depended on the measurement day (weekday vs. weekend day). In more detail, the association was positive for women and negative or non-existing for men. According to the measurement day, among women, income was positively associated with aerobic steps despite the measurement day and with totals steps measured on the weekend. Among men, income was negatively associated with aerobic steps measured on weekdays. The results indicate that there is an association between income and physical activity, but the association is gender-specific and depends on the measurement type of physical activity.	[Kari, Jaana T.; Yang, Xiaolin; Tammelin, Tuija H.] LIKES Res Ctr Sport & Hlth Sci, Jyvaskyla, Finland; [Kari, Jaana T.; Pehkonen, Jaakko] Univ Jyvaskyla, Sch Business & Econ, Jyvaskyla, Finland; [Hirvensalo, Mirja] Univ Jyvaskyla, Dept Sport Sci, Jyvaskyla, Finland; [Hutri-Kahonen, Nina] Univ Tampere, Dept Pediat, FIN-33101 Tampere, Finland; [Hutri-Kahonen, Nina] Tampere Univ Hosp, Tampere, Finland; [Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Raitakari, Olli T.] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, FIN-20520 Turku, Finland	University of Jyvaskyla; University of Jyvaskyla; Tampere University; Tampere University; Tampere University Hospital; University of Turku; University of Turku	Kari, JT (corresponding author), LIKES Res Ctr Sport & Hlth Sci, Jyvaskyla, Finland.	jaana.kari@likes.fi	Raitakari, Olli/AAQ-7389-2021	Kari, Jaana/0000-0001-5205-7031; Pehkonen, Jaakko/0000-0002-9684-7139	Finnish Ministry of Education and Culture; Juho Vainio Foundation; Academy of Finland [134309, 126925, 121584, 124282, 129378, 117797, 41071]; Social Insurance Institution of Finland; Turku University Hospital Medical Fund; Sigrid Juselius Foundation; Paavo Nurmi Foundation; Finnish Foundation of Cardiovascular Research; Finnish Cultural Foundation; Tampere Tuberculosis Foundation; Emil Aaltonen Foundation; Kuopio University Hospital Medical Fund; Tampere University Hospital Medical Fund	Finnish Ministry of Education and Culture; Juho Vainio Foundation; Academy of Finland(Academy of Finland); Social Insurance Institution of Finland; Turku University Hospital Medical Fund; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Paavo Nurmi Foundation; Finnish Foundation of Cardiovascular Research; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Tampere Tuberculosis Foundation; Emil Aaltonen Foundation; Kuopio University Hospital Medical Fund; Tampere University Hospital Medical Fund	This study was funded by the Finnish Ministry of Education and Culture and the Juho Vainio Foundation, The Young Finns Study has been financially supported by the Academy of Finland: grants 134309 (Eye), 126925, 121584, 124282, 129378 (Salve), 117797 (Gendi), and 41071 (Skidi); the Social Insurance Institution of Finland, Kuopio, Tampere and Turku University Hospital Medical Funds, Juho Vainio Foundation, Sigrid Juselius Foundation, Paavo Nurmi Foundation, Finnish Foundation of Cardiovascular Research and Finnish Cultural Foundation, Tampere Tuberculosis Foundation and Emil Aaltonen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrave D, 2015, J EPIDEMIOL COMMUN H, V69, P738, DOI 10.1136/jech-2014-205230; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; [Anonymous], 1996, JAMA, V276, P241; Blair SN, 1999, MED SCI SPORT EXER, V31, pS646, DOI 10.1097/00005768-199911001-00025; Brown H, 2011, SOC SCI MED, V73, P383, DOI 10.1016/j.socscimed.2011.06.001; CAULEY JA, 1991, MED SCI SPORT EXER, V23, P343; Colditz GA, 1999, MED SCI SPORT EXER, V31, pS663, DOI 10.1097/00005768-199911001-00026; Eberth B, 2010, ECON MODEL, V27, P822, DOI 10.1016/j.econmod.2009.10.003; EU. Special Eurobarometer 412, 2014, SPEC EUR, V412, P1, DOI [10.2766/73002, DOI 10.2766/73002]; Ewing BT, 1998, ECON LETT, V59, P113, DOI 10.1016/S0165-1765(98)00006-8; Farrell L, 2002, J ROY STAT SOC A STA, V165, P335, DOI 10.1111/1467-985X.00626; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Helldan A, 2013, HLTH BEHAV HLTH FINN; Hendelman D, 2000, MED SCI SPORT EXER, V32, pS442, DOI 10.1097/00005768-200009001-00002; Hirvensalo M, 2011, SCAND J PUBLIC HEALT, V39, P669, DOI 10.1177/1403494811420324; Humphreys BR, 2006, 0613 INT ASS SPORT E; Humphreys BR, 2007, CONTEMP ECON POLICY, V25, P538, DOI 10.1111/j.1465-7287.2007.00079.x; Humphreys BR, 2011, BE J ECON ANAL POLI, V11, DOI 10.2202/1935-1682.2522; Hyytinen A, 2013, SOC SCI MED, V96, P129, DOI 10.1016/j.socscimed.2013.07.019; Katzmarzyk PT, 2000, CAN MED ASSOC J, V163, P1435; Katzmarzyk PT, 2004, CAN J APPL PHYSIOL, V29, P90, DOI 10.1139/h04-008; Kohl Harold W 3rd, 2012, Lancet, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Kosteas VD, 2012, J LABOR RES, V33, P225, DOI 10.1007/s12122-011-9129-2; Kuehnle D, 2014, J HEALTH ECON, V36, P137, DOI 10.1016/j.jhealeco.2014.03.011; Laaksonen M, 2003, J EPIDEMIOL COMMUN H, V57, P711, DOI 10.1136/jech.57.9.711; Lechner M, 2009, J HEALTH ECON, V28, P839, DOI 10.1016/j.jhealeco.2009.05.003; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Leisure Gronau R., 1977, J POLITICAL EC, V85, P1099, DOI [10.3386/w0137, DOI 10.3386/W0137]; LONG JE, 1991, REV ECON STAT, V73, P525, DOI 10.2307/2109580; MCCONNELL KE, 1992, AM J AGR ECON, V74, P918, DOI 10.2307/1243189; Meltzer DO, 2010, J HEALTH ECON, V29, P347, DOI 10.1016/j.jhealeco.2010.03.005; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Parks SE, 2003, J EPIDEMIOL COMMUN H, V57, P29, DOI 10.1136/jech.57.1.29; Raitakari OT, 2008, INT J EPIDEMIOL, V37, P1220, DOI 10.1093/ije/dym225; Ridder G, 2007, HBK ECON, V2, P5469, DOI 10.1016/S1573-4412(07)06075-8; Ruhm CJ, 2000, Q J ECON, V115, P617, DOI 10.1162/003355300554872; Sebastiao E, 2012, PUBLIC HEALTH, V126, P967, DOI 10.1016/j.puhe.2012.07.004; Stevenson B, 2010, REV ECON STAT, V92, P284, DOI 10.1162/rest.2010.11623; Tammelin T, 2003, AM J PREV MED, V24, P22, DOI 10.1016/S0749-3797(02)00575-5; Telama R, 2005, AM J PREV MED, V28, P267, DOI 10.1016/j.amepre.2004.12.003; Tudor-Locke C, 2004, SPORTS MED, V34, P1, DOI 10.2165/00007256-200434010-00001; Tudor-Locke C, 2002, MED SCI SPORT EXER, V34, P2045, DOI 10.1097/00005768-200212000-00027; Tudor-Locke C, 2002, SPORTS MED, V32, P795, DOI 10.2165/00007256-200232120-00004; Sluijs EMF, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-53; Vanhees L, 2005, EUR J CARDIOV PREV R, V12, P102, DOI 10.1097/00149831-200504000-00004; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1	48	40	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135651	10.1371/journal.pone.0135651	http://dx.doi.org/10.1371/journal.pone.0135651			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ0PO	26317865	Green Published, Green Submitted, gold			2022-12-26	WOS:000360299100040
J	Kim, S; Jung, J; Jung, JH; Kim, SK; Kim, RB; Hahm, JR				Kim, Sungsu; Jung, Jaehoon; Jung, Jung Hwa; Kim, Soo Kyoung; Kim, Rock-Bum; Hahm, Jong Ryeal			Risk Factors of Bone Mass Loss at the Lumbar Spine: A Longitudinal Study in Healthy Korean Pre- and Perimenopausal Women Older than 40 Years	PLOS ONE			English	Article							MINERAL DENSITY; POSTMENOPAUSAL WOMEN; OSTEOPOROTIC FRACTURES; URIC-ACID; FAT MASS; BODY-COMPOSITION; LIPID PROFILE; SERUM-LIPIDS; MEN; ASSOCIATION	Longitudinal studies on bone mass decline for healthy women are sparse. We performed a retrospective longitudinal study to evaluate the factor associated with bone mass changes at the lumbar spine in healthy Korean pre- and perimenopausal women over the age of 40. We examined the relation of blood tests including thyroid function tests at baseline and follow-up to the annual percentage changes in average BMD of L2-L4 (A%Delta LSBMD). Four hundred and forty-three subjects without diseases or medications pertaining to bone metabolism were analyzed. The mean A%Delta LSBMD in these subjects was -0.45%/ year. Though a significant correlation was observed between the A%Delta LSBMD and age, serum thyroid-stimulating hormone (TSH) level, total cholesterol (TC) level, low-density lipoprotein cholesterol (LDL-C) level, and estimated glomerular filtration rate (eGFR) at baseline and follow-up, there was a weak correlation between A%Delta LSBMD and these variables. From multiple linear regression analyses, the percent body fat, age, serum TSH level, serum uric acid level, and the menopause at follow-up were showed to have a significant association with the A%Delta LSBMD. Unlike age, percent body fat, and menopause at follow-up, which had a negative association with the A%Delta LSBMD, serum TSH level and serum uric acid level, had a positive association with the A%Delta LSBMD. The results from our study showed that the notable risk factors of BMD loss at the lumbar spine in population of our study were advancing age, menopause, higher percent body fat, lower normal TSH, and lower serum uric acid levels.	[Kim, Sungsu; Jung, Jaehoon; Jung, Jung Hwa; Kim, Soo Kyoung; Hahm, Jong Ryeal] Gyeongsang Natl Univ, Sch Med, Dept Internal Med, Div Endocrinol, Jinju, South Korea; [Kim, Sungsu; Jung, Jaehoon; Jung, Jung Hwa; Kim, Soo Kyoung; Hahm, Jong Ryeal] Gyeonsang Natl Univ Hosp, Jinju, South Korea; [Jung, Jaehoon; Jung, Jung Hwa; Kim, Soo Kyoung; Hahm, Jong Ryeal] Gyeongsang Natl Univ, Sch Med, Inst Hlth Sci, Jinju, South Korea; [Kim, Rock-Bum] Dong A Univ, Ctr Environm Hlth, Busan, South Korea	Gyeongsang National University; Gyeongsang National University; Dong A University	Kim, SK (corresponding author), Gyeongsang Natl Univ, Sch Med, Dept Internal Med, Div Endocrinol, Jinju, South Korea.	9854008@naver.com; jrhahm@hanmail.net			Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education Science and Technology [NRF-2012-0000305, 2012R1A1A4A01015109]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education Science and Technology	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education Science and Technology (NRF-2012-0000305) (2012R1A1A4A01015109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe E, 2003, CELL, V115, P151, DOI 10.1016/S0092-8674(03)00771-2; Bauer DC, 1997, J CLIN ENDOCR METAB, V82, P2931, DOI 10.1210/jc.82.9.2931; Brownbill RA, 2006, J WOMENS HEALTH, V15, P261, DOI 10.1089/jwh.2006.15.261; Chan KA, 2000, LANCET, V355, P2185, DOI 10.1016/S0140-6736(00)02400-4; COMPSTON JE, 1992, CLIN ENDOCRINOL, V37, P426, DOI 10.1111/j.1365-2265.1992.tb02354.x; Cui LH, 2005, OSTEOPOROSIS INT, V16, P1975, DOI 10.1007/s00198-005-1977-2; Dennison EM, 2007, QJM-INT J MED, V100, P297, DOI 10.1093/qjmed/hcm023; ENSRUD KE, 1995, J BONE MINER RES, V10, P1778; Finkelstein JS, 2008, J CLIN ENDOCR METAB, V93, P861, DOI 10.1210/jc.2007-1876; Glantzounis GK, 2005, CURR PHARM DESIGN, V11, P4145, DOI 10.2174/138161205774913255; Grimnes G, 2008, THYROID, V18, P1147, DOI 10.1089/thy.2008.0158; Hannan MT, 2000, J BONE MINER RES, V15, P710, DOI 10.1359/jbmr.2000.15.4.710; Ho-Pham LT, 2014, J CLIN ENDOCR METAB, V99, P30, DOI 10.1210/jc.2013-3190; Hsu YH, 2006, AM J CLIN NUTR, V83, P146; Hughes DE, 1996, NAT MED, V2, P1132, DOI 10.1038/nm1096-1132; Jeong IK, 2010, CALCIFIED TISSUE INT, V87, P507, DOI 10.1007/s00223-010-9427-3; JONES G, 1994, BRIT MED J, V309, P691, DOI 10.1136/bmj.309.6956.691; Kim DJ, 2006, CLIN ENDOCRINOL, V64, P86, DOI 10.1111/j.1365-2265.2005.02422.x; Kim JH, 2012, OSTEOPOROSIS INT, V23, P2009, DOI 10.1007/s00198-011-1808-6; Lee EY, 2012, J CLIN ENDOCR METAB, V97, P3310, DOI 10.1210/jc.2012-1488; Lin JD, 2011, ENDOCR RES, V36, P1, DOI 10.3109/07435800.2010.514877; Makovey J, 2013, BONE, V52, P400, DOI 10.1016/j.bone.2012.10.025; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; Morin S, 2009, OSTEOPOROSIS INT, V20, P363, DOI 10.1007/s00198-008-0688-x; Morris MS, 2007, BONE, V40, P1128, DOI 10.1016/j.bone.2006.12.001; Nabipour I, 2011, J BONE MINER RES, V26, P955, DOI 10.1002/jbmr.286; Namwongprom S, 2013, INT J WOMENS HEALTH, V5, P87, DOI 10.2147/IJWH.S41884; POUILLES JM, 1993, CALCIFIED TISSUE INT, V52, P340, DOI 10.1007/BF00310195; Recker R, 2000, J BONE MINER RES, V15, P1965, DOI 10.1359/jbmr.2000.15.10.1965; Riggs BL, 1998, J BONE MINER RES, V13, P763, DOI 10.1359/jbmr.1998.13.5.763; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Sendur OF, 2009, JOINT BONE SPINE, V76, P514, DOI 10.1016/j.jbspin.2009.02.005; Sheu Yahtyng, 2011, Curr Osteoporos Rep, V9, P67, DOI 10.1007/s11914-011-0051-6; Sugiura M, 2008, OSTEOPOROSIS INT, V19, P211, DOI 10.1007/s00198-007-0457-2; Tsouli SG, 2006, METABOLISM, V55, P1293, DOI 10.1016/j.metabol.2006.05.013; Wang PS, 2000, JAMA-J AM MED ASSOC, V283, P3211, DOI 10.1001/jama.283.24.3211; Yamaguchi T, 2002, ENDOCR J, V49, P211, DOI 10.1507/endocrj.49.211	37	13	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136283	10.1371/journal.pone.0136283	http://dx.doi.org/10.1371/journal.pone.0136283			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317525	Green Published, gold, Green Submitted			2022-12-26	WOS:000360299100069
J	Yamada, Y; Eto, M; Ito, Y; Mochizuki, S; Son, BK; Ogawa, S; Iijima, K; Kaneki, M; Kozaki, K; Toba, K; Akishita, M; Ouchi, Y				Yamada, Yoko; Eto, Masato; Ito, Yuki; Mochizuki, Satoru; Son, Bo-Kyung; Ogawa, Sumito; Iijima, Katsuya; Kaneki, Masao; Kozaki, Koichi; Toba, Kenji; Akishita, Masahiro; Ouchi, Yasuyoshi			Suppressive Role of PPAR gamma-Regulated Endothelial Nitric Oxide Synthase in Adipocyte Lipolysis	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; INSULIN-RESISTANCE; S-NITROSYLATION; DISEASE; EXPRESSION; OBESITY; GENE; MICE; DIET; STEATOHEPATITIS	Introduction Metabolic syndrome causes insulin resistance and is associated with risk factor clustering, thereby increasing the risk of atherosclerosis. Recently, endothelial nitric oxide synthase deficient (eNOS-/-) mice have been reported to show metabolic disorders. Interestingly, eNOS has also been reported to be expressed in non-endothelial cells including adipocytes, but the functions of eNOS in adipocytes remain unclear. Methods and Results The eNOS expression was induced with adipocyte differentiation and inhibition of eNOS/NO enhanced lipolysis in vitro and in vivo. Furthermore, the administration of a high fat diet (HFD) was able to induce non-alcoholic steatohepatitis (NASH) in eNOS-/- mice but not in wild type mice. A PPAR. antagonist increased eNOS expression in adipocytes and suppressed HFD-induced fatty liver changes. Conclusions eNOS-/- mice induce NASH development, and these findings provide new insights into the therapeutic approach for fatty liver disease and related disorders.	[Yamada, Yoko; Eto, Masato; Ito, Yuki; Mochizuki, Satoru; Son, Bo-Kyung; Ogawa, Sumito; Iijima, Katsuya; Akishita, Masahiro; Ouchi, Yasuyoshi] Univ Tokyo, Dept Geriatr Med, Grad Sch Med, Tokyo, Japan; [Kaneki, Masao] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anesthesia Crit Care & Pain Med,Shriners Hos, Boston, MA USA; [Kozaki, Koichi; Toba, Kenji] Kyorin Univ, Sch Med, Dept Geriatr Med, Tokyo, Japan	University of Tokyo; Harvard University; Harvard Medical School; Massachusetts General Hospital; Kyorin University	Eto, M (corresponding author), Univ Tokyo, Dept Geriatr Med, Grad Sch Med, Tokyo, Japan.	meto-tky@umin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science (JSPS)	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology (to M.E.) and by a Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) Fellows (to Y.Y.).	Arendt BM, 2009, J NUTR, V139, P691, DOI 10.3945/jn.108.101782; Auwerx J, 1999, DIABETOLOGIA, V42, P1033, DOI 10.1007/s001250051268; Cook S, 2004, DIABETES, V53, P2067, DOI 10.2337/diabetes.53.8.2067; Cornier MA, 2011, CIRCULATION, V124, P1996, DOI 10.1161/CIR.0b013e318233bc6a; DAY CP, 1994, BBA-LIPID LIPID MET, V1215, P33, DOI 10.1016/0005-2760(94)90089-2; Duplain H, 2001, CIRCULATION, V104, P342, DOI 10.1161/01.CIR.104.3.342; Fabbrini E, 2009, P NATL ACAD SCI USA, V106, P15430, DOI 10.1073/pnas.0904944106; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; Foster MW, 2003, TRENDS MOL MED, V9, P160, DOI 10.1016/S1471-4914(03)00028-5; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lowenstein CJ, 2006, J CLIN INVEST, V116, P2075, DOI 10.1172/JCI29406; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Malinowski JM, 2000, CLIN THER, V22, P1151, DOI 10.1016/S0149-2918(00)83060-X; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Miles PDG, 2000, J CLIN INVEST, V105, P287, DOI 10.1172/JCI8538; Mukherjee R, 1997, NATURE, V386, P407, DOI 10.1038/386407a0; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Oemar BS, 1998, CIRCULATION, V97, P2494, DOI 10.1161/01.CIR.97.25.2494; Peter A, 2011, AM J PHYSIOL-ENDOC M, V300, pE321, DOI 10.1152/ajpendo.00306.2010; Ribiere C, 1996, BIOCHEM BIOPH RES CO, V222, P706, DOI 10.1006/bbrc.1996.0824; Saltiel AR, 1996, DIABETES, V45, P1661, DOI 10.2337/diabetes.45.12.1661; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; Teli MR, 1995, HEPATOLOGY, V22, P1714, DOI 10.1002/hep.1840220616; TERAMOTO K, 1993, TRANSPLANTATION, V55, P737, DOI 10.1097/00007890-199304000-00010; Tessari P, 2009, NUTR METAB CARDIOVAS, V19, P291, DOI 10.1016/j.numecd.2008.12.015; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Yamauchi T, 2001, J CLIN INVEST, V108, P1001, DOI 10.1172/JCI12864; Yamauchi T, 2001, J BIOL CHEM, V276, P41245, DOI 10.1074/jbc.M103241200; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200	36	6	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136597	10.1371/journal.pone.0136597	http://dx.doi.org/10.1371/journal.pone.0136597			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317347	gold, Green Published, Green Submitted			2022-12-26	WOS:000360299100107
J	Zhao, JX; Wang, B; You, GX; Wang, Y; Chen, G; Wang, Q; Zhang, XG; Zhao, L; Zhou, H; He, YZ				Zhao, Jing-xiang; Wang, Bo; You, Guo-xing; Wang, Ying; Chen, Gan; Wang, Quan; Zhang, Xi-gang; Zhao, Lian; Zhou, Hong; He, Yue-zhong			Hypertonic Saline Dextran Ameliorates Organ Damage in Beagle Hemorrhagic Shock	PLOS ONE			English	Article							ADHESION MOLECULE-1 EXPRESSION; CARBON-DIOXIDE DIFFERENCE; FLUID RESUSCITATION; 6-PERCENT DEXTRAN-70; 7.5-PERCENT NACL; TRAUMA PATIENTS; EFFICACY; NEUTROPHIL; SALINE/DEXTRAN; HYPOTENSION	Objective The goal of this study was to investigate the effect of hypertonic saline with 6% Dextran-70 (HSD) resuscitation on organ damage and the resuscitation efficiency of the combination of HSD and lactated ringers (LR) in a model of hemorrhage shock in dogs. Methods Beagles were bled to hold their mean arterial pressure (MAP) at 50 +/- 5 mmHg for 1 h. After hemorrhage, beagles were divided into three groups (n = 7) to receive pre-hospital resuscitation for 1 h (R1): HSD (4 ml/kg), LR (40 ml/kg), and HSD+LR (a combination of 4 ml/kg HSD and 40 ml/kg LR). Next, LR was transfused into all groups as in-hospital resuscitation (R2). After two hours of observation (R3), autologous blood was transfused. Hemodynamic responses and systemic oxygenation were measured at predetermined phases. Three days after resuscitation, the animals were sacrificed and tissues including kidney, lung, liver and intestinal were obtained for pathological analysis. Results Although the initial resuscitation with HSD was shown to be faster than LR with regard to an ascending MAP, the HSD group showed a similar hemodynamic performance compared to the LR group throughout the experiment. Compared with the LR group, the systemic oxygenation performance in the HSD group was similar but showed a lower venous-to-arterial CO2 gradient (Pv-aCO(2)) at R3 (p < 0.05). Additionally, the histology score of the kidneys, lungs and liver were significantly lower in the HSD group than in the LR group (p < 0.05). The HSD+LR group showed a superior hemodynamic response but higher extravascular lung water (EVLW) and lower arterial oxygen tension (PaO2) than the other groups (p < 0.05). The HSD+LR group showed a marginally improved systemic oxygenation performance and lower histology score than other groups. Conclusions Resuscitation after hemorrhagic shock with a bolus of HSD showed a similar hemodynamic response compared with LR at ten times the volume of HSD, but HSD showed superior efficacy in organ protection. Our findings suggest that resuscitation with the combination of HSD and LR in the pre-hospital setting is an effective treatment.	[Zhao, Jing-xiang; Wang, Bo; You, Guo-xing; Wang, Ying; Chen, Gan; Wang, Quan; Zhao, Lian; Zhou, Hong] Acad Mil Med Sci, Inst Transfus Med, Beijing, Peoples R China; [Zhang, Xi-gang] Chinese Peoples Liberat Army 307 Hosp, Emergency Dept, Beijing, Peoples R China; [He, Yue-zhong] Acad Mil Med Sci, Sci & Technol Dept, Beijing, Peoples R China	Academy of Military Medical Sciences - China; Academy of Military Medical Sciences - China	Zhao, L (corresponding author), Acad Mil Med Sci, Inst Transfus Med, 27th Taiping Rd, Beijing, Peoples R China.	zhaolian@bmi.ac.cn; zhouhtt1966@163.com; yzhe751@163.com	Chen, Gan/O-8508-2019; zhao, jing/B-3868-2019	Chen, Gan/0000-0003-4586-4526; 	Capital Health Project of Beijing Science and Technology Commission [Z121100005312014]; National High Technology Research and Development Program of China [2012AA021902]	Capital Health Project of Beijing Science and Technology Commission; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by grants from Capital Health Project of Beijing Science and Technology Commission (Z121100005312014) and the National High Technology Research and Development Program of China (No. 2012AA021902).	Alam HB, 2007, SURG CLIN N AM, V87, P55, DOI 10.1016/j.suc.2006.09.015; Alam HB, 2000, J SURG RES, V94, P145, DOI 10.1006/jsre.2000.6011; Alam HB, 2001, J AM COLL SURGEONS, V193, P255, DOI 10.1016/S1072-7515(01)01004-3; [Anonymous], 2013, UK AMB SERV CLIN PRA; Baker AJ, 2009, J NEUROTRAUM, V26, P1227, DOI 10.1089/neu.2008.0868; Banerjee A, 2013, SHOCK, V39, P366, DOI 10.1097/SHK.0b013e3182894016; BEHRMAN SW, 1991, J TRAUMA, V31, P589, DOI 10.1097/00005373-199105000-00001; BICKELL WH, 1992, ANN EMERG MED, V21, P1077, DOI 10.1016/S0196-0644(05)80648-1; Boldt J, 2006, SHOCK, V25, P103, DOI 10.1097/01.shk.0000189595.35661.40; Boldt J, 2010, INTENS CARE MED, V36, P1299, DOI 10.1007/s00134-010-1912-7; Bruscagin V, 2002, J TRAUMA, V52, P1147, DOI 10.1097/00005373-200206000-00021; Bulger EM, 2007, ANN SURG, V245, P635, DOI 10.1097/01.sla.0000251367.44890.ae; Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; Cabrales P, 2007, SHOCK, V27, P380, DOI 10.1097/01.shk.0000239782.71516.ba; Cuschieri J, 2005, INTENS CARE MED, V31, P818, DOI 10.1007/s00134-005-2602-8; De Backer D, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-27; Deitch EA, 2003, SHOCK, V19, P328, DOI 10.1097/00024382-200304000-00006; Delano MJ, 2015, SHOCK, V44, P25, DOI 10.1097/SHK.0000000000000368; Deree J, 2007, J TRAUMA, V62, P104, DOI 10.1097/TA.0b013e31802d96cb; Dubick MA, 2003, J TRAUMA, V54, pS43, DOI 10.1097/01.TA.0000064514.42470.3B; Dubick MA, 2006, SHOCK, V25, P321, DOI 10.1097/01.shk.0000209525.50990.28; DUBICK MA, 1994, J TRAUMA, V36, P323, DOI 10.1097/00005373-199403000-00007; Elgjo GI, 2000, CRIT CARE MED, V28, P163, DOI 10.1097/00003246-200001000-00027; HANNON JP, 1989, CIRC SHOCK, V29, P205; Junger WG, 2012, SHOCK, V38, P341, DOI 10.1097/SHK.0b013e3182635aca; Kerger H, 1999, AM J PHYSIOL-HEART C, V276, pH2035, DOI 10.1152/ajpheart.1999.276.6.H2035; MATTOX KL, 1991, ANN SURG, V213, P482, DOI 10.1097/00000658-199105000-00014; MAZZONI MC, 1990, CIRC SHOCK, V31, P407; Monnet X, 2007, INTENS CARE MED, V33, P448, DOI 10.1007/s00134-006-0498-6; Monnet X, 2013, CRIT CARE MED, V41, P1412, DOI 10.1097/CCM.0b013e318275cece; Orso CO, 1999, J TRAUMA, V46, P417; Parlakpinar H, 2007, INT J UROL, V14, P743, DOI 10.1111/j.1442-2042.2007.01806.x; PRIST R, 1992, CIRC SHOCK, V36, P13; Rhee P, 2003, J TRAUMA, V54, pS52, DOI 10.1097/01.TA.0000064507.80390.10; Riddez L, 2001, MIL MED, V166, P695, DOI 10.1093/milmed/166.8.695; Rizoli SB, 2006, ANN SURG, V243, P47, DOI 10.1097/01.sla.0000193608.93127.b1; SAUAIA A, 1994, ARCH SURG-CHICAGO, V129, P39; SONDEEN JL, 1990, RESUSCITATION, V20, P231, DOI 10.1016/0300-9572(90)90006-Z; Stapley SA, 2002, SHOCK, V17, P146, DOI 10.1097/00024382-200202000-00011; Sun LL, 1999, SHOCK, V11, P416; Tollofsrud S, 1998, ACTA ANAESTH SCAND, V42, P145, DOI 10.1111/j.1399-6576.1998.tb05100.x; Vallee F, 2008, INTENS CARE MED, V34, P2218, DOI 10.1007/s00134-008-1199-0; VASSAR MJ, 1991, ARCH SURG-CHICAGO, V126, P1065; Wade CE, 1997, SURGERY, V122, P609, DOI 10.1016/S0039-6060(97)90135-5; Wade CE, 1996, CLIN CHEM, V42, P779; Wade CE, 2003, J TRAUMA, V54, pS144, DOI 10.1097/01.TA.0000047223.62617.AB; Wade CE, 2003, J TRAUMA, V55, P413, DOI 10.1097/01.TA.0000057247.02378.5E; WADE CE, 1989, CIRC SHOCK, V29, P193; Wenzel V, 2004, NEW ENGL J MED, V350, P105, DOI 10.1056/NEJMoa025431; Yang DJ, 2014, EUR REV MED PHARMACO, V18, P3069; ZHANG HB, 1993, AM REV RESPIR DIS, V148, P867, DOI 10.1164/ajrccm/148.4_Pt_1.867; Zhang YD, 2013, SCI WORLD J, DOI 10.1155/2013/130134; Zhao L, 2009, RESUSCITATION, V80, P253, DOI 10.1016/j.resuscitation.2008.10.014	53	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136012	10.1371/journal.pone.0136012	http://dx.doi.org/10.1371/journal.pone.0136012			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317867	Green Submitted, Green Published, gold			2022-12-26	WOS:000360299100056
J	Elbl, P; Navarro, BV; de Oliveira, LF; Almeida, J; Mosini, C; dos Santos, ALW; Rossi, M; Floh, EIS				Elbl, Paula; Navarro, Bruno V.; de Oliveira, Leandro F.; Almeida, Juliana; Mosini, C.; dos Santos, Andre L. W.; Rossi, Magdalena; Floh, Eny I. S.			Identification and Evaluation of Reference Genes for Quantitative Analysis of Brazilian Pine (Araucaria angustifolia Bertol. Kuntze) Gene Expression	PLOS ONE			English	Article							REAL-TIME PCR; RT-PCR; ACCURATE NORMALIZATION; TRANSCRIPTOME ANALYSIS; SOMATIC EMBRYOGENESIS; VALIDATION; QUANTIFICATION; TISSUES	Quantitative analysis of gene expression is a fundamental experimental approach in many fields of plant biology, but it requires the use of internal controls representing constitutively expressed genes for reliable transcript quantification. In this study, we identified fifteen putative reference genes from an A. angustifolia transcriptome database. Variation in transcript levels was first evaluated in silico by comparing read counts and then by quantitative real-time PCR (qRT-PCR), resulting in the identification of six candidate genes. The consistency of transcript abundance was also calculated applying geNorm and NormFinder software packages followed by a validation approach using four target genes. The results presented here indicate that a diverse set of samples should ideally be used in order to identify constitutively expressed genes, and that the use of any two reference genes in combination, of the six tested genes, is sufficient for effective expression normalization. Finally, in agreement with the in silico prediction, a comprehensive analysis of the qRT-PCR data combined with validation analysis revealed that AaEIF4B-L and AaPP2A are the most suitable reference genes for comparative studies of A. angustifolia gene expression.	[Elbl, Paula; Navarro, Bruno V.; de Oliveira, Leandro F.; Almeida, Juliana; Mosini, C.; dos Santos, Andre L. W.; Rossi, Magdalena; Floh, Eny I. S.] Univ Sao Paulo, Inst Biociencias, Dept Bot, Sao Paulo, Brazil	Universidade de Sao Paulo	Floh, EIS (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Bot, Sao Paulo, Brazil.	enyfloh@usp.br	de Oliveira, Leandro Francisco/ACG-6315-2022; ALMEIDA, JULIANA/G-4796-2013; Rossi, Magdalena/B-7847-2012; de Oliveira, Leandro Francisco/I-4521-2012; Iochevet Segal Floh, Eny/D-9526-2012	de Oliveira, Leandro Francisco/0000-0002-5318-2771; ALMEIDA, JULIANA/0000-0002-2085-9993; Rossi, Magdalena/0000-0003-3650-772X; de Oliveira, Leandro Francisco/0000-0002-5318-2771; Iochevet Segal Floh, Eny/0000-0001-6529-2065; Navarro, Bruno/0000-0001-9289-4328	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [02437/09-0]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/51659-7]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [307238/2013-0]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (02437/09-0), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2011/51659-7) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(307238/2013-0).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; BECWAR MR, 1989, IN VITRO CELL DEV B, V25, P575, DOI 10.1007/BF02623571; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chi XY, 2012, MOL GENET GENOMICS, V287, P167, DOI 10.1007/s00438-011-0665-5; Cruz F, 2009, MOL BREEDING, V23, P607, DOI 10.1007/s11032-009-9259-x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Czechowski T, 2004, PLANT J, V38, P366, DOI 10.1111/j.1365-313X.2004.02051.x; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; de Vega-Bartol JJ, 2013, PLANT CELL REP, V32, P715, DOI 10.1007/s00299-013-1407-4; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Elbl P, 2015, PLANT CELL TISS ORG, V120, P903, DOI 10.1007/s11240-014-0523-3; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Faccioli P, 2007, PLANT MOL BIOL, V63, P679, DOI 10.1007/s11103-006-9116-9; Gachon C, 2004, J EXP BOT, V55, P1445, DOI 10.1093/jxb/erh181; Galli V, 2015, GENE, V554, P205, DOI 10.1016/j.gene.2014.10.049; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Huang LK, 2014, BIOENERG RES, V7, P1201, DOI 10.1007/s12155-014-9457-1; Iskandar HM, 2004, PLANT MOL BIOL REP, V22, P325, DOI 10.1007/BF02772676; Jo L, 2014, TREE PHYSIOL, V34, P94, DOI 10.1093/treephys/tpt102; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Majumdar R, 2013, PLANT CELL PHYSL; Mhamdi A, 2012, ARCH BIOCHEM BIOPHYS, V525, P181, DOI 10.1016/j.abb.2012.04.015; Milone DH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-438; Minocha R, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00175; Morrison T, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl639; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Narsai R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-56; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Perini P, 2014, MOL BREEDING, V34, P829, DOI 10.1007/s11032-014-0078-3; Quadrana L, 2013, PLANT MOL BIOL, V81, P309, DOI 10.1007/s11103-012-0001-4; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Salzman RA, 1999, PLANT MOL BIOL REP, V17, P11, DOI 10.1023/A:1007520314478; Schlogl PS, 2012, GENET MOL BIOL, V35, P172, DOI 10.1590/S1415-47572012005000005; Schlogl PS, 2012, PLANT CELL TISS ORG, V108, P173, DOI 10.1007/s11240-011-0023-7; Steiner N, 2008, FUNCT PLANT SCI BIOT, V2, P20; Steiner N, 2012, PLANT CELL TISS ORG, V109, P41, DOI 10.1007/s11240-011-0071-z; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wu Tao, 2012, African Journal of Agricultural Research, V7, P3701; Yang HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042438	51	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136714	10.1371/journal.pone.0136714	http://dx.doi.org/10.1371/journal.pone.0136714			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313945	Green Published, gold, Green Submitted			2022-12-26	WOS:000360144000089
J	Deranieh, RM; Shi, YH; Tarsio, M; Chen, Y; McCaffery, JM; Kane, PM; Greenberg, ML				Deranieh, Rania M.; Shi, Yihui; Tarsio, Maureen; Chen, Yan; McCaffery, J. Michael; Kane, Patricia M.; Greenberg, Miriam L.			Perturbation of the Vacuolar ATPase A NOVEL CONSEQUENCE OF INOSITOL DEPLETION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V-ATPASE; PHOSPHATIDYLINOSITOL 3,5-BISPHOSPHATE; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; LIPID KINASE; V-0 SUBUNIT; H+-ATPASE; YEAST; MEMBRANE; PROTEIN	Depletion of inositol has profound effects on cell function and has been implicated in the therapeutic effects of drugs used to treat epilepsy and bipolar disorder. We have previously shown that the anticonvulsant drug valproate (VPA) depletes inositol by inhibiting myo-inositol-3-phosphate synthase, the enzyme that catalyzes the first and rate-limiting step of inositol biosynthesis. To elucidate the cellular consequences of inositol depletion, we screened the yeast deletion collection for VPA-sensitive mutants and identified mutants in vacuolar sorting and the vacuolar ATPase (V-ATPase). Inositol depletion caused by starvation of ino1 Delta cells perturbed the vacuolar structure and decreased V-ATPase activity and proton pumping in isolated vacuolar vesicles. VPA compromised the dynamics of phosphatidylinositol 3,5-bisphosphate (PI3,5P(2)) and greatly reduced V-ATPase proton transport in inositol-deprived wild-type cells. Osmotic stress, known to increase PI3,5P(2) levels, did not restore PI3,5P(2) homeostasis nor did it induce vacuolar fragmentation in VPA-treated cells, suggesting that perturbation of the V-ATPase is a consequence of altered PI3,5P(2) homeostasis under ino-sitol-limiting conditions. This study is the first to demonstrate that inositol depletion caused by starvation of an inositol synthesis mutant or by the inositol-depleting drug VPA leads to perturbation of the V-ATPase.	[Deranieh, Rania M.; Shi, Yihui; Chen, Yan; Greenberg, Miriam L.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Tarsio, Maureen; Kane, Patricia M.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [McCaffery, J. Michael] Johns Hopkins Univ, Dept Biol, Integrated Imaging Ctr, Baltimore, MD 21218 USA	Wayne State University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Johns Hopkins University	Greenberg, ML (corresponding author), Wayne State Univ, Dept Biol Sci, 5047 Gullen Mall, Detroit, MI 48202 USA.	mlgreen@sun.science.wayne.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [DK 081367, GM 50322]; Fulbright Scholarship; Wayne State University Graduate Research Fellowship; Graduate Research Funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fulbright Scholarship; Wayne State University Graduate Research Fellowship; Graduate Research Funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant DK 081367 (to M. L. G.) and Grant GM 50322 (to P. M. K.). This work was also supported by a Fulbright Scholarship, a Wayne State University Graduate Research Fellowship, and Graduate Research Funds (to R. M. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Baars TL, 2007, MOL BIOL CELL, V18, P3873, DOI 10.1091/mbc.E07-03-0205; BECKER GW, 1977, J BIOL CHEM, V252, P8684; BERRIDGE MJ, 1989, PROC R SOC SER B-BIO, V238, P235, DOI 10.1098/rspb.1989.0079; BLAIR HC, 1989, SCIENCE, V245, P855, DOI 10.1126/science.2528207; Bonangelino CJ, 2002, J CELL BIOL, V156, P1015, DOI 10.1083/jcb.200201002; Botelho RJ, 2008, MOL BIOL CELL, V19, P4273, DOI 10.1091/mbc.E08-04-0405; BOWDEN CL, 1995, J CLIN PSYCHIAT, V56, P3; Breton S, 2007, AM J PHYSIOL-RENAL, V292, pF1, DOI 10.1152/ajprenal.00340.2006; Brown D, 2009, J EXP BIOL, V212, P1762, DOI 10.1242/jeb.028803; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Cagnac O, 2010, J BIOL CHEM, V285, P33914, DOI 10.1074/jbc.M110.116590; Calabresi P, 2007, TRENDS PHARMACOL SCI, V28, P188, DOI 10.1016/j.tips.2007.02.005; Chan CY, 2012, J BIOL CHEM, V287, P10236, DOI 10.1074/jbc.M111.321133; Chang HJ, 2002, GENETICS, V162, P29; Chow CY, 2009, AM J HUM GENET, V84, P85, DOI 10.1016/j.ajhg.2008.12.010; Clement S, 2001, NATURE, V409, P92, DOI 10.1038/35051094; Cooke FT, 1998, CURR BIOL, V8, P1219, DOI 10.1016/S0960-9822(07)00513-1; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; Cunningham MO, 2003, NEUROPHARMACOLOGY, V45, P907, DOI 10.1016/S0028-3908(03)00270-3; Deranieh RM, 2013, J BIOL CHEM, V288, P26822, DOI 10.1074/jbc.M113.479121; Deranieh RM, 2009, BIOCHEM SOC T, V37, P1099, DOI 10.1042/BST0371099; Di Giovanni J, 2010, NEURON, V67, P268, DOI 10.1016/j.neuron.2010.06.024; Diakov TT, 2013, JOVE-J VIS EXP, DOI 10.3791/50261; Dove SK, 2004, EMBO J, V23, P1922, DOI 10.1038/sj.emboj.7600203; Dove SK, 1997, NATURE, V390, P187, DOI 10.1038/36613; Duex JE, 2006, J CELL BIOL, V172, P693, DOI 10.1083/jcb.200512105; Efe JA, 2005, CURR OPIN CELL BIOL, V17, P402, DOI 10.1016/j.ceb.2005.06.002; El Far O, 2011, J NEUROCHEM, V117, P603, DOI 10.1111/j.1471-4159.2011.07234.x; El Far O, 2011, M S-MED SCI, V27, P28, DOI 10.1051/medsci/201127128; Gary JD, 2002, MOL BIOL CELL, V13, P1238, DOI 10.1091/mbc.01-10-0498; Gaspar ML, 2006, J BIOL CHEM, V281, P22773, DOI 10.1074/jbc.M603548200; HANSON BA, 1980, J BACTERIOL, V142, P79, DOI 10.1128/JB.142.1.79-89.1980; HELL JW, 1988, EMBO J, V7, P3023, DOI 10.1002/j.1460-2075.1988.tb03166.x; HENRY SA, 1977, J BACTERIOL, V130, P472, DOI 10.1128/JB.130.1.472-484.1977; Henry SA, 2014, CHEM PHYS LIPIDS, V180, P23, DOI 10.1016/j.chemphyslip.2013.12.013; Hiesinger PR, 2005, CELL, V121, P607, DOI 10.1016/j.cell.2005.03.012; Ho CY, 2015, J BIOL CHEM, V290, P9919, DOI 10.1074/jbc.M114.613984; Jesch SA, 2005, J BIOL CHEM, V280, P9106, DOI 10.1074/jbc.M411770200; Jesch SA, 2006, J BIOL CHEM, V281, P24070, DOI 10.1074/jbc.M604541200; Jesch SA, 2010, J BIOL CHEM, V285, P41947, DOI 10.1074/jbc.M110.188607; Jiang F, 1997, MOL MICROBIOL, V26, P481, DOI 10.1046/j.1365-2958.1997.5841950.x; Jiranek V, 1998, MICROBIOL-UK, V144, P2739, DOI 10.1099/00221287-144-10-2739; Ju SL, 2003, MOL MICROBIOL, V49, P1595, DOI 10.1046/j.1365-2958.2003.03641.x; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kane PM, 2007, J BIOENERG BIOMEMBR, V39, P415, DOI 10.1007/s10863-007-9112-z; KANE PM, 1995, J BIOL CHEM, V270, P17025; KANE PM, 1992, J BIOL CHEM, V267, P447; Kartner N, 2010, J BIOL CHEM, V285, P37476, DOI 10.1074/jbc.M110.123281; Kotoulas A, 2011, MOL VIS, V17, P2776; Li SC, 2014, MOL BIOL CELL, V25, P1251, DOI 10.1091/mbc.E13-10-0563; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; Liu ML, 2005, J BIOL CHEM, V280, P36978, DOI 10.1074/jbc.M505296200; LOTSCHER HR, 1984, BIOCHEMISTRY-US, V23, P4140, DOI 10.1021/bi00313a020; Lowe M, 2005, TRAFFIC, V6, P711, DOI 10.1111/j.1600-0854.2005.00311.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Martin ED, 2004, EPILEPSIA, V45, P436, DOI 10.1111/j.0013-9580.2004.58303.x; Martin ED, 2004, NEUROPHARMACOLOGY, V46, P555, DOI 10.1016/j.neuropharm.2003.10.013; Michell RH, 2006, TRENDS BIOCHEM SCI, V31, P52, DOI 10.1016/j.tibs.2005.11.013; Michell RH, 2013, FEBS J, V280, P6281, DOI 10.1111/febs.12452; Mira NP, 2010, OMICS, V14, P525, DOI 10.1089/omi.2010.0072; MORIYAMA Y, 1990, J BIOCHEM, V108, P689, DOI 10.1093/oxfordjournals.jbchem.a123264; MORIYAMA Y, 1992, J EXP BIOL, V172, P171; Nunez LR, 2008, J BIOL CHEM, V283, P34204, DOI 10.1074/jbc.M806391200; Odorizzi G, 2000, TRENDS BIOCHEM SCI, V25, P229, DOI 10.1016/S0968-0004(00)01543-7; Oluwatosin YE, 1998, MOL CELL BIOL, V18, P1534, DOI 10.1128/MCB.18.3.1534; Orij R, 2009, MICROBIOL-SGM, V155, P268, DOI 10.1099/mic.0.022038-0; Perucca E, 2002, CNS DRUGS, V16, P695, DOI 10.2165/00023210-200216100-00004; Poea-Guyon S, 2013, J CELL BIOL, V203, P283, DOI 10.1083/jcb.201303104; Rieder SE, 1996, MOL BIOL CELL, V7, P985, DOI 10.1091/mbc.7.6.985; ROBERTS CJ, 1991, METHOD ENZYMOL, V194, P644; Santiago TC, 2003, J BIOL CHEM, V278, P38723, DOI 10.1074/jbc.M303008200; Sbrissa D, 1999, J BIOL CHEM, V274, P21589, DOI 10.1074/jbc.274.31.21589; SCHULDINER S, 1995, PHYSIOL REV, V75, P369, DOI 10.1152/physrev.1995.75.2.369; Shimohama S, 1998, NEUROSCI LETT, V245, P159, DOI 10.1016/S0304-3940(98)00209-2; Strahl T, 2007, BBA-MOL CELL BIOL L, V1771, P353, DOI 10.1016/j.bbalip.2007.01.015; Tabke K, 2014, BIOCHEM J, V462, P185, DOI 10.1042/BJ20131293; Taylor GS, 2000, P NATL ACAD SCI USA, V97, P8910, DOI 10.1073/pnas.160255697; Vaden DL, 2001, J BIOL CHEM, V276, P15466, DOI 10.1074/jbc.M004179200; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Weisman LS, 2003, ANNU REV GENET, V37, P435, DOI 10.1146/annurev.genet.37.050203.103207; YAMAMOTO A, 1995, MOL BIOL CELL, V6, P525, DOI 10.1091/mbc.6.5.525; Yoshida S, 2010, NEUROSCI RES, V68, P322, DOI 10.1016/j.neures.2010.08.010; Zhang ZS, 2010, NEURON, V68, P1097, DOI 10.1016/j.neuron.2010.11.035; Zieger M, 2012, MOL BIOL CELL, V23, P3438, DOI 10.1091/mbc.E12-05-0347	84	15	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27460	27472		10.1074/jbc.M115.683706	http://dx.doi.org/10.1074/jbc.M115.683706			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26324718	hybrid, Green Published			2022-12-26	WOS:000365757500003
J	Costa-Silva, GJ; Rodriguez, MS; Roxo, FF; Foresti, F; Oliveira, C				Costa-Silva, Guilherme J.; Rodriguez, Monica S.; Roxo, Fabio F.; Foresti, Fausto; Oliveira, Claudio			Using Different Methods to Access the Difficult Task of Delimiting Species in a Complex Neotropical Hyperdiverse Group	PLOS ONE			English	Article							SILURIFORMES LORICARIIDAE; CHARACIFORMES CHARACIDAE; RINELORICARIA SILURIFORMES; DNA BARCODE; BASIN; RIVER; SPECIATION; DIVERSITY; TAXONOMY; MODEL	The genus Rineloricaria is a Neotropical freshwater fish group with a long and problematic taxonomic history, attributed to the large number of species and the pronounced similarity among them. In the present work, taxonomic information and different molecular approaches were used to identify species boundaries and characterize independent evolutionary units. We analyzed 228 samples assembled in 53 distinct morphospecies. A general mixed yule-coalescent (GMYC) analysis indicated the existence of 70 entities, while BOLD system analyses showed the existence of 56 distinct BINs. When we used a new proposed integrative taxonomy approach, mixing the results obtained by each analysis, we identified 73 OTUs. We suggest that Rineloricaria probably has some complexity in the known species and several species not formally described yet. Our data suggested that other hyperdiverse fish groups with wide distributions can be further split into many new evolutionary taxonomic units.	[Costa-Silva, Guilherme J.; Roxo, Fabio F.; Foresti, Fausto; Oliveira, Claudio] Univ Estadual Paulista, Dept Morfol, Lab Biol Genet Peixes, Botucatu, SP, Brazil; [Rodriguez, Monica S.] Univ Fed Vicosa, Rio Paranaiba, MG, Brazil	Universidade Estadual Paulista; Universidade Federal de Vicosa	Costa-Silva, GJ (corresponding author), Univ Estadual Paulista, Dept Morfol, Lab Biol Genet Peixes, Botucatu, SP, Brazil.	costasilvagj@gmail.com	Oliveira, Claudio/D-7713-2012; Fapesp, Biota/F-8655-2017	Oliveira, Claudio/0000-0002-7010-8880; Fapesp, Biota/0000-0002-9887-8449	Brazilian agency FAPESP (Fundacao de Amparo a pesquisa do Estado de Sao Paulo) [proc. 2014/05051-5, proc. 2007/04071-2]; Brazilian agency CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [proc. 441347/2014-2]	Brazilian agency FAPESP (Fundacao de Amparo a pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian agency CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by the Brazilian agencies FAPESP (Fundacao de Amparo a pesquisa do Estado de Sao Paulo, proc. 2014/05051-5 to FFR, proc. 2007/04071-2 to GJCS) and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, proc. 441347/2014-2 to FFR).	Abell R, 2008, BIOSCIENCE, V58, P403, DOI 10.1641/B580507; Baldwin CC, 2011, ZOOKEYS, P21, DOI 10.3897/zookeys.79.1045; Barraclough TG, 2009, BIOL LETTERS, V5, P425, DOI 10.1098/rsbl.2009.0091; Becker S, 2011, MITOCHONDR DNA, V22, P3, DOI 10.3109/19401736.2010.535528; Bellafronte E, 2013, NEOTROP ICHTHYOL, V11, P497, DOI 10.1590/S1679-62252013000300003; Benine RC, 2009, NEOTROP ICHTHYOL, V7, P161, DOI 10.1590/S1679-62252009000200005; Covain R, 2007, ZOOTAXA, P1, DOI 10.11646/zootaxa.1462.1.1; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; de Queiroz L. J., 2013, PEIXES RIO MADEIRA; Drummond AJ, 2010, GENEIOUS; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EVERS H.G., 2005, CATFISH ATLAS, V1; Fichberg I, 2008, NEOTROP ICHTHYOL, V6, P347, DOI 10.1590/S1679-62252008000300008; Fontaneto D, 2007, PLOS BIOL, V5, P914, DOI 10.1371/journal.pbio.0050087; Fricke R, 2014, CATALOG FISHES ONLIN; Ghazzi MS, 2008, IHERINGIA SER ZOOL, V98, P100, DOI 10.1590/S0073-47212008000100014; Hausmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084518; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Ingenito LFS, 2008, NEOTROP ICHTHYOL, V6, P355, DOI 10.1590/S1679-62252008000300009; Kashiwagi T, 2012, MOL PHYLOGENET EVOL, V64, P212, DOI 10.1016/j.ympev.2012.03.020; Kekkonen M, 2014, MOL ECOL RESOUR, V14, P706, DOI 10.1111/1755-0998.12233; Liao YC, 2011, ZOOTAXA, P32; Marques DF, 2013, NEOTROP ICHTHYOL, V11, P459, DOI 10.1590/S1679-62252013000200015; Mayr E, 1940, AM NAT, V74, P249, DOI 10.1086/280892; Melo BF, 2011, NEOTROP ICHTHYOL, V9, P49, DOI 10.1590/S1679-62252011000100002; Menezes NA, 2007, PEIXES AGUA DOCE MAT; Ornelas-Garcia Claudia Patricia, 2008, BMC Evol Biol, V8, P340, DOI 10.1186/1471-2148-8-340; Pereira LHG, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-20; Pereira LHG, 2011, MITOCHONDR DNA, V22, P71, DOI 10.3109/19401736.2010.532213; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Quattro JM, 2006, MAR BIOL, V148, P1143, DOI 10.1007/s00227-005-0151-x; R Core Team, 2021, R LANGUAGE ENV STAT; Rambaut A, 2014, TRACER BEAST; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Reis RE, 1983, IHERINGIA SER ZOOL, V80, P61; Reis Roberto E., 2001, Ichthyological Exploration of Freshwaters, V12, P319; Rodriguez MS, 2008, NEOTROP ICHTHYOL, V6, P367, DOI 10.1590/S1679-62252008000300010; Rodriguez MS, 2008, COPEIA, P333, DOI 10.1643/CI-06-218; Roxo FF, 2012, ZOOTAXA, P1; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Smith PJ, 2011, J FISH BIOL, V78, P355, DOI 10.1111/j.1095-8649.2010.02846.x; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Talavera G, 2013, METHODS ECOL EVOL, V4, P1101, DOI 10.1111/2041-210X.12107; Vera-Alcaraz HS, 2012, NEOTROP ICHTHYOL, V10, P285, DOI 10.1590/S1679-62252012000200006; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia X, 2009, PHYLOGENETIC HDB PRA, V2, P611, DOI [10.1017/CBO9780511819049.022, DOI 10.1017/CBO9780511819049.022]; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3	50	47	48	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135075	10.1371/journal.pone.0135075	http://dx.doi.org/10.1371/journal.pone.0135075			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332320	Green Submitted, Green Published, gold			2022-12-26	WOS:000360613800019
J	Wei, L; Xiang, XG; Wang, YZ; Li, ZY				Wei, Lai; Xiang, Xiao-guo; Wang, Yin-zheng; Li, Zhen-yu			Phylogenetic Relationships and Evolution of the Androecia in Ruteae (Rutaceae)	PLOS ONE			English	Article							COMPARATIVE FLORAL STRUCTURE; CLADISTIC-ANALYSIS; ONTOGENY; AURANTIOIDEAE; CLASSIFICATION; SUBFAMILIES; ORANGE; LEGUMINOSAE; SYSTEMATICS; MORPHOLOGY	Ruta, which belongs to tribe Ruteae, is the type genus of the subfamily Rutoideae and the family Rutaceae. Molecular systematic studies have shown that the genera in Ruteae are closer related to Aurantioideae than to most other genera of Rutoideae, some of the genera traditionally placed in Ruteae have been shown to be nested within the Aurantioideae clade, but the diagnostic characters for determining new patterns in the relationship are poor. In this study, we investigated the floral development of Boenninghausenia in Ruteae (sensu stricto), Haplophyllum in the basal position of Aurantioideae and Murraya in traditional Aurantioideae using scanning electron microscopy. The androecium of Boenninghausenia is obdiplostemony. As androecia in other genera within Ruteae (s.s.) are also obdiplostemonous, reconstruction of the ancestral state indicates that obdiplostemony is an ancestral character in this clade. Because the androecia of Haplophyllum and Murraya are also obdiplostemonous, obdiplostemony is also an ancestral character in Aurantioideae clade. The ancestral state reconstruction indicates this character can serve as a synapomorphy of the Ruteae-Aurantioideae clade. The results of our work also shed light on the evolution of the androecium in Rutaceae, as the obdiplostemony of this group is clearly derived from haplostemony in the ancestral genera in Rutaceae and has develop into polyandry by increasing antepetalous stamens.	[Wei, Lai] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Wei, Lai; Xiang, Xiao-guo; Wang, Yin-zheng; Li, Zhen-yu] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China	Beijing Normal University; Chinese Academy of Sciences; Institute of Botany, CAS	Wang, YZ (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	wangyz@ibcas.ac.cn; Lizy@ibcas.ac.cn			National Natural Science Foundation of China [31200149]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was financially supported by the National Natural Science Foundation of China (Grant no. 31200149). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, ANTHER FORM FUNCTION; Appelhans MS, 2011, ANN BOT-LONDON, V107, P1259, DOI 10.1093/aob/mcr076; Appelhans MS, 2012, J BIOGEOGR, V39, P1235, DOI 10.1111/j.1365-2699.2012.02686.x; Bayer RJ, 2009, AM J BOT, V96, P668, DOI 10.3732/ajb.0800341; Bayly MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072493; Bello MA, 2008, ANN BOT-LONDON, V101, P1491, DOI [10.1093/aob/mcm228, 10.1093/aob/mcn073]; Caris P, 2006, PLANT SYST EVOL, V257, P223, DOI 10.1007/s00606-005-0373-x; Chase MW, 1999, AM J BOT, V86, P1191, DOI 10.2307/2656983; Corner E. J. H., 1976, SEEDS DICOTYLEDONS; Cronquist A, 1993, INTEGRATE SYSTEM CLA; DA SILVA MFGF, 1988, PLANT SYST EVOL, V161, P97; DECRAENE LPR, 1995, BOT J LINN SOC, V118, P193, DOI 10.1016/S0024-4074(05)80002-6; Decraene LPR, 1996, AM J BOT, V83, P201, DOI 10.2307/2445939; Dickson A, 1865, T BOT SOC EDINBURG, V8, P86; Endress PK, 2006, ADV BOT RES, V44, P1, DOI 10.1016/S0065-2296(06)44001-5; Endress PK, 2010, ANN BOT-LONDON, V106, P687, DOI 10.1093/aob/mcq171; Endress PK, 2000, INT J PLANT SCI, V161, pS237, DOI 10.1086/317571; Engler A, 1896, DIA NATURLICHEN PFLA; Engler H.G.A., 1931, NATURLICHEN PFLANZEN, P187; Erbar C, 1997, INT J PLANT SCI, V158, pS49, DOI 10.1086/297506; Gonzalez FA, 2010, AM J BOT, V97, P191, DOI 10.3732/ajb.0900194; GREGOR HJ, 1989, PLANT SYST EVOL, V162, P251, DOI 10.1007/BF00936920; Groppo M, 2008, AM J BOT, V95, P985, DOI 10.3732/ajb.2007313; Kaplan D. R., 1984, CLADISTICS PERSPECTI, P51; Kirchoff BK, 2003, INT J PLANT SCI, V164, P505, DOI 10.1086/375421; Kubitzki K., 2011, V10, P276; Leins P., 2010, FLOWER FRUIT MORPHOL; LORD EM, 1985, BOT GAZ, V146, P320, DOI 10.1086/337531; Maddison WP, 2019, MESQUITE MODULAR SYS; Manafzadeh S, 2014, J BIOGEOGR, V41, P366, DOI 10.1111/jbi.12185; Matthews ML, 2012, BOT J LINN SOC, V170, P299, DOI [10.1111/j.1095-8339.2012.01299.x, 10.1111/j.1095-8339.20]; Matthews ML, 2005, BOT J LINN SOC, V149, P129, DOI 10.1111/j.1095-8339.2005.00445.x; Matthews ML, 2001, ANN BOT-LONDON, V88, P439, DOI 10.1006/anbo.2001.1494; MOORE J. A., 1936, New Phytologist, V35, P318, DOI 10.1111/j.1469-8137.1936.tb06885.x; Morton CM, 2003, AM J BOT, V90, P1463, DOI 10.3732/ajb.90.10.1463; Morton CM, 2014, ANN MO BOT GARD, V99, P620, DOI 10.3417/2010034; Mou FJ, 2012, J SYST EVOL, V50, P460, DOI 10.1111/j.1759-6831.2012.00193.x; Poon WS, 2007, SYST BOT, V32, P837, DOI 10.1600/036364407783390692; Ronse De Craene LP., 2010, FLORAL DIAGRAMS AID; Salvo G, 2008, MOL PHYLOGENET EVOL, V49, P736, DOI 10.1016/j.ympev.2008.09.004; Samuel R, 2001, PLANT BIOLOGY, V3, P77, DOI 10.1055/s-2001-11747; Scott KD, 2000, PLANT SYST EVOL, V223, P15, DOI 10.1007/BF00985324; Sehr EM, 2009, INT J PLANT SCI, V170, P845, DOI 10.1086/599074; Stebbins G.L., 1974, FLOWERING PLANTS EVO, DOI 10.4159/harvard.9780674864856; Stebbins G. L., 1973, BREVIORA, V418, P1; Stuessy T.F., 2009, PLANT TAXONOMY SYSTE; THORNE RF, 1992, BOT REV, V58, P225, DOI 10.1007/BF02858611; Tucker SC, 2000, INT J PLANT SCI, V161, P537, DOI 10.1086/314278; Tucker SC, 2005, INT J PLANT SCI, V166, P557, DOI 10.1086/429848; Wei L, 2012, PLANT BIOLOGY, V14, P190, DOI 10.1111/j.1438-8677.2011.00475.x; Xu FX, 2010, ANN BOT-LONDON, V106, P591, DOI 10.1093/aob/mcq158; Zhou QY, 2006, INT J PLANT SCI, V167, P201, DOI 10.1086/498352; Zhou QY, 2002, AUST J BOT, V50, P633, DOI 10.1071/BT02015	53	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137190	10.1371/journal.pone.0137190	http://dx.doi.org/10.1371/journal.pone.0137190			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332986	Green Submitted, Green Published, gold			2022-12-26	WOS:000360613800107
J	Allen, A; Breadon, E; Byrne, A; Mallon, T; Skuce, R; Groussaud, P; Dainty, A; Graham, J; Jones, K; Pollock, L; Whatmore, A				Allen, Adrian; Breadon, Eleanor; Byrne, Andrew; Mallon, Thomas; Skuce, Robin; Groussaud, Pauline; Dainty, Amanda; Graham, Judith; Jones, Kerri; Pollock, Lorraine; Whatmore, Adrian			Molecular Epidemiology of Brucella abortus in Northern Ireland-1991 to 2012	PLOS ONE			English	Article							TANDEM-REPEAT MARKERS; UNITED-STATES; IDENTIFICATION; OUTBREAK; MELITENSIS; MANAGEMENT; DIVERSITY; EVOLUTION; CATTLE; LEVEL	Background Brucellosis is the most common bacterial zoonoses worldwide. Bovine brucellosis caused by Brucella abortus has far reaching animal health and economic impacts at both the local and national levels. Alongside traditional veterinary epidemiology, the use of molecular typing has recently been applied to inform on bacterial population structure and identify epidemiologically-linked cases of infection. Multi-locus variable number tandem repeat VNTR analysis (MLVA) was used to investigate the molecular epidemiology of a well-characterised Brucella abortus epidemic in Northern Ireland involving 387 herds between 1991 and 2012. Results MLVA identified 98 unique B. abortus genotypes from disclosing isolates in the 387 herds involved in the epidemic. Clustering algorithms revealed the relatedness of many of these genotypes. Combined with epidemiological information on chronology of infection and geographic location, these genotype data helped to identify 7 clonal complexes which underpinned the outbreak over the defined period. Hyper-variability of some VNTR loci both within herds and individual animals led to detection of multiple genotypes associated with single outbreaks. However with dense sampling, these genotypes could still be associated with specific clonal complexes thereby permitting inference of epidemiological links. MLVA-based epidemiological monitoring data were congruent with an independent classical veterinary epidemiology study carried out in the same territory. Conclusions MLVA is a useful tool in ongoing disease surveillance of B. abortus outbreaks, especially when combined with accurate epidemiological information on disease tracings, geographical clustering of cases and chronology of infection.	[Allen, Adrian; Breadon, Eleanor; Byrne, Andrew; Mallon, Thomas; Skuce, Robin; Jones, Kerri; Pollock, Lorraine] Agri Food & Biosci Inst AFBI, AFBI Stormont, Belfast, Antrim, North Ireland; [Skuce, Robin] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [Groussaud, Pauline; Dainty, Amanda; Whatmore, Adrian] Anim & Plant Hlth Agcy APHA, Dept Bacteriol, OIE WHO FAO Reference Lab Brucellosis, Addlestone, Surrey, England; [Graham, Judith] Vet Serv, Dept Agr & Rural Dev, Belfast, Antrim, North Ireland	Agri-Food & Biosciences Institute; Queens University Belfast; Animal & Plant Health Agency UK; Food & Agriculture Organization of the United Nations (FAO)	Allen, A (corresponding author), Agri Food & Biosci Inst AFBI, AFBI Stormont, Belfast, Antrim, North Ireland.	Adrian.Allen@afbini.gov.uk	Byrne, Andrew/N-3894-2015; Allen, Adrian R/C-6242-2009; Whatmore, Adrian M/C-7744-2011	Byrne, Andrew/0000-0003-0296-4586; Whatmore, Adrian M/0000-0003-4218-156X	Department of Agriculture and Rural Development, Northern Ireland; Department of Environment, Food and Rural Affairs (DEFRA) [SE0311, SE0313, SB1400]	Department of Agriculture and Rural Development, Northern Ireland; Department of Environment, Food and Rural Affairs (DEFRA)(Department for Environment, Food & Rural Affairs (DEFRA))	This work was funded by the Department of Agriculture and Rural Development, Northern Ireland www.dardni.gov.uk, and the Department of Environment, Food and Rural Affairs (DEFRA) under projects SE0311, SE0313 and SB1400 www.	Abernethy DA, 2011, PREV VET MED, V98, P223, DOI 10.1016/j.prevetmed.2010.11.002; Abernethy DA, 2006, VET REC, V158, P717, DOI 10.1136/vr.158.21.717; Adone R, 2013, REV SCI TECH OIE, V32, P199; Alton G. G., 1988, TECHNIQUES BRUCELLOS, P13; Alvarez J, 2011, RES VET SCI, V90, P208, DOI 10.1016/j.rvsc.2010.05.028; Biek R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003008; Bricker BJ, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-15; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Crawford R. P., 1990, Animal brucellosis., P131; Aparicio ED, 2013, REV SCI TECH OIE, V32, P53; Dixon P.M., 2002, ENCY ENV, VVolume 3, P1796, DOI DOI 10.1002/9780470057339.VAR046; Dorneles EMS, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-186; Foster JT, 2009, J BACTERIOL, V191, P2864, DOI 10.1128/JB.01581-08; Garofolo G, 2013, INFECT GENET EVOL, V19, P59, DOI 10.1016/j.meegid.2013.06.021; Godfroid J, 2013, REV SCI TECH OIE, V32, P27; Gwida M, 2012, COMP IMMUNOL MICROB, V35, P181, DOI 10.1016/j.cimid.2011.12.012; Gyuranecz M, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-76; Higgins J, 2012, APPL ENVIRON MICROB, V78, P3674, DOI 10.1128/AEM.00045-12; Houston R, 2001, REV SCI TECH OIE, V20, P652, DOI 10.20506/rst.20.2.1293; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jiang H, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-256; Kilic S, 2011, J CLIN MICROBIOL, V49, P3276, DOI 10.1128/JCM.02538-10; Kulakov YK, 2010, VACCINE, V28, pF41, DOI 10.1016/j.vaccine.2010.03.051; Le Fleche P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-9; Leiser OP, 2013, VET MICROBIOL, V166, P1, DOI 10.1016/j.vetmic.2013.02.025; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Pearson T, 2009, INFECT GENET EVOL, V9, P1010, DOI 10.1016/j.meegid.2009.05.014; Poester FP, 2013, REV SCI TECH OIE, V32, P105; Ragan V, 2013, REV SCI TECH OIE, V32, P189; Reyes JF, 2012, INFECT GENET EVOL, V12, P811, DOI 10.1016/j.meegid.2011.05.018; Scholz HC, 2013, REV SCI TECH OIE, V32, P149; Scott JC, 2007, APPL ENVIRON MICROB, V73, P7331, DOI 10.1128/AEM.00976-07; Skuce RA, 2010, VET REC, V167, P684, DOI 10.1136/vr.c5108; Spratt BG, 2004, FEMS MICROBIOL LETT, V241, P129, DOI 10.1016/j.femsle.2004.11.015; Stringer LA, 2008, PREV VET MED, V84, P72, DOI 10.1016/j.prevetmed.2007.11.005; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Wattam AR, 2014, J BACTERIOL, V196, P920, DOI 10.1128/JB.01091-13; Whatmore AM, 2006, J CLIN MICROBIOL, V44, P1982, DOI 10.1128/JCM.02039-05; Whatmore AM, 2009, INFECT GENET EVOL, V9, P1168, DOI 10.1016/j.meegid.2009.07.001	39	15	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136721	10.1371/journal.pone.0136721	http://dx.doi.org/10.1371/journal.pone.0136721			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325586	Green Published, Green Submitted, gold			2022-12-26	WOS:000360437700059
J	Banziger, T; Hosoya, G; Scherer, KR				Banziger, Tanja; Hosoya, Georg; Scherer, Klaus R.			Path Models of Vocal Emotion Communication	PLOS ONE			English	Article							LENS MODEL; MUSIC PERFORMANCE; PERSONALITY JUDGMENTS; CUE UTILIZATION; EXPRESSION; VOICE; SPEECH; PERCEPTION; ACCURACY; PERSPECTIVE	We propose to use a comprehensive path model of vocal emotion communication, encompassing encoding, transmission, and decoding processes, to empirically model data sets on emotion expression and recognition. The utility of the approach is demonstrated for two data sets from two different cultures and languages, based on corpora of vocal emotion enactment by professional actors and emotion inference by naive listeners. Lens model equations, hierarchical regression, and multivariate path analysis are used to compare the relative contributions of objectively measured acoustic cues in the enacted expressions and subjective voice cues as perceived by listeners to the variance in emotion inference from vocal expressions for four emotion families (fear, anger, happiness, and sadness). While the results confirm the central role of arousal in vocal emotion communication, the utility of applying an extended path modeling framework is demonstrated by the identification of unique combinations of distal cues and proximal percepts carrying information about specific emotion families, independent of arousal. The statistical models generated show that more sophisticated acoustic parameters need to be developed to explain the distal underpinnings of subjective voice quality percepts that account for much of the variance in emotion inference, in particular voice instability and roughness. The general approach advocated here, as well as the specific results, open up new research strategies for work in psychology (specifically emotion and social perception research) and engineering and computer science (specifically research and development in the domain of affective computing, particularly on automatic emotion detection and synthetic emotion expression in avatars).	[Banziger, Tanja] Mid Sweden Univ, Dept Psychol, Ostersund, Sweden; [Hosoya, Georg] Free Univ Berlin, Dept Educ Sci & Psychol, Berlin, Germany; [Scherer, Klaus R.] Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland	Mid-Sweden University; Free University of Berlin; University of Geneva	Scherer, KR (corresponding author), Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland.	Klaus.Scherer@unige.ch	Hosoya, Georg/AAY-2498-2020	Hosoya, Georg/0000-0002-8130-2259	Swiss National Science Foundation [100014-122491]; European Research Council Advanced grant [230331]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council Advanced grant(European Research Council (ERC))	The research program as a whole was supported by funds from Swiss National Science Foundation grant (100014-122491) and European Research Council Advanced grant (no. 230331). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 2012, J PERS SOC PSYCHOL, V103, P718, DOI 10.1037/a0029395; Anolli L, 2008, J CROSS CULT PSYCHOL, V39, P565, DOI 10.1177/0022022108321178; B?nziger T., 2010, BLUEPRINT AFFECTIVE, P271, DOI DOI 10.1037/A0025827; BACHOROWSKI JA, 1995, PSYCHOL SCI, V6, P219, DOI 10.1111/j.1467-9280.1995.tb00596.x; Banziger T, 2014, J NONVERBAL BEHAV, V38, P31, DOI 10.1007/s10919-013-0165-x; Banziger T, 2012, EMOTION, V12, P1161, DOI 10.1037/a0025827; Banse R, 1996, J PERS SOC PSYCHOL, V70, P614, DOI 10.1037/0022-3514.70.3.614; Bernieri FJ, 2001, LEA SER PER CLIN PSY, P67; Boersma P., 2010, PRAAT DOING PHONETIC; Brunswik E., 1956, PERCEPTION REPRESENT; Cartei V, 2014, HORM BEHAV, V66, P569, DOI 10.1016/j.yhbeh.2014.08.006; Chuenwattanapranithi S, 2008, PHONETICA, V65, P210, DOI 10.1159/000192793; DUNCAN OD, 1966, AM J SOCIOL, V72, P1, DOI 10.1086/224256; Eyben F, IEEE TRANSACTIONS ON; GIFFORD R, 1994, J PERS SOC PSYCHOL, V66, P398, DOI 10.1037/0022-3514.66.2.398; Goudbeek M, 2010, J ACOUST SOC AM, V128, P1322, DOI 10.1121/1.3466853; HAMMOND KR, 1964, PSYCHOL REV, V71, P438, DOI 10.1037/h0040736; Hawk ST, 2009, EMOTION, V9, P293, DOI 10.1037/a0015178; Hirschmuller S, 2013, J PERS SOC PSYCHOL, V104, P335, DOI 10.1037/a0030383; HURSCH CJ, 1964, PSYCHOL REV, V71, P42, DOI 10.1037/h0041729; Juslin P., 1998, FUNCTIONALIST PERSPE; Juslin PN, 2006, J EXP PSYCHOL-APPL, V12, P79, DOI 10.1037/1076-898X.12.2.79; Juslin PN, 2001, EMOTION, V1, P381, DOI 10.1037//1528-3542.1.4.381; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; Juslin PN, 2000, J EXP PSYCHOL HUMAN, V26, P1797, DOI 10.1037//0096-1523.26.6.1797; Juslin PN, 1997, MUSIC PERCEPT, V14, P383; Kappas A, 1991, FUNDAMENTALS NONVERB, P200; Karelaia N, 2008, PSYCHOL BULL, V134, P404, DOI 10.1037/0033-2909.134.3.404; Ko SJ, 2015, PSYCHOL SCI, V26, P3, DOI 10.1177/0956797614553009; Min CS, 2011, COGNITION EMOTION, V25, P1376, DOI 10.1080/02699931.2010.544865; Muthen B., 2010, MPLUS USERS GUIDE; Nestler S, 2012, J PERS SOC PSYCHOL, V103, P689, DOI 10.1037/a0029461; OHALA JJ, 1984, PHONETICA, V41, P1, DOI 10.1159/000261706; Patel S., 2013, HDB NONVERBAL COMMUN, P167; Patel S, 2011, BIOL PSYCHOL, V87, P93, DOI 10.1016/j.biopsycho.2011.02.010; Reynolds DJ, 2001, PERS SOC PSYCHOL B, V27, P187, DOI 10.1177/0146167201272005; Rule NO, 2013, J PERS SOC PSYCHOL, V104, P409, DOI 10.1037/a0031050; Sauter DA, 2010, Q J EXP PSYCHOL, V63, P2251, DOI 10.1080/17470211003721642; Scherer KR, 2013, STRUNGMANN FORUM REP, P107; Scherer KR, 2011, INT J PSYCHOL, V46, P401, DOI 10.1080/00207594.2011.626049; Scherer KR, 2009, COGNITION EMOTION, V23, P1307, DOI 10.1080/02699930902928969; SCHERER KR, 1986, PSYCHOL BULL, V99, P143, DOI 10.1037/0033-2909.99.2.143; Scherer KR, 2003, SPEECH COMMUN, V40, P227, DOI 10.1016/S0167-6393(02)00084-5; Scherer KR, 2003, SER AFFECTIVE SCI, P433; Scherer KR, 2001, J CROSS CULT PSYCHOL, V32, P76, DOI 10.1177/0022022101032001009; SCHERER KR, 1978, EUR J SOC PSYCHOL, V8, P467, DOI 10.1002/ejsp.2420080405; Shuman V, 2013, FRONT PSYCHOL, V4, DOI [10.3389/fpsyg.2013.00261, 10.3389/fpsyg.2013.00922]; Spackman MP, 2009, COGNITION EMOTION, V23, P1565, DOI 10.1080/02699930802536268; Stanislavski K., 1988, ACTOR PREPARES; TARTTER VC, 1980, PERCEPT PSYCHOPHYS, V27, P24, DOI 10.3758/BF03199901; Thayer R. E., 1978, MOTIV EMOTION, V2, DOI [10.1007/BF00992729, DOI 10.1007/BF00992729]; TUCKER LR, 1964, PSYCHOL REV, V71, P528, DOI 10.1037/h0047061; Van Bezooijen RA., 1984, THESIS; Wu, 2007, ED MEASUREMENT ISSUE, V26, P33, DOI DOI 10.1111/J.1745-3992.2007.00099.X	54	34	34	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136675	10.1371/journal.pone.0136675	http://dx.doi.org/10.1371/journal.pone.0136675			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ2NK	26325076	Green Published, Green Submitted, gold			2022-12-26	WOS:000360437700055
J	Deere, JA; Coulson, T; Smallegange, IM				Deere, Jacques A.; Coulson, Tim; Smallegange, Isabel M.			Life History Consequences of the Facultative Expression of a Dispersal Life Stage in the Phoretic Bulb Mite (Rhizoglyphus robini)	PLOS ONE			English	Article							TRADE-OFFS; QUANTITATIVE-ANALYSIS; MALE MORPHS; BEHAVIOR; FLIGHT; EVOLUTION; DIMORPHISM; PHYSIOLOGY; GROWTH; ACARI	Life history traits play an important role in population dynamics and correlate, both positively and negatively, with dispersal in a wide range of taxa. Most invertebrate studies on trade-offs between life history traits and dispersal have focused on dispersal via flight, yet much less is known about how life history trade-offs influence species that disperse by other means. In this study, we identify effects of investing in dispersal morphology (dispersal expression) on life history traits in the male dimorphic bulb mite (Rhizoglyphus robini). This species has a facultative juvenile life stage (deutonymph) during which individuals can disperse by phoresy. Further, adult males are either fighters (which kill other mites) or benign scramblers. Here, in an experiment, we investigate the effects of investing in dispersal on size at maturity, sex and male morph ratio, and female lifetime reproductive success. We show that life history traits correlate negatively with the expression of the dispersal stage. Remarkably, all males that expressed the dispersal life stage developed into competitive fighters and none into scramblers. This suggests that alternative, male reproductive strategies and dispersal should not be viewed in isolation but considered concurrently.	[Deere, Jacques A.; Coulson, Tim] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Deere, Jacques A.; Smallegange, Isabel M.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam IBED, Amsterdam, Netherlands	University of Oxford; University of Amsterdam	Deere, JA (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	j.a.deere@uva.nl	Deere, Jacques/I-4721-2019; Coulson, Tim/AAL-8148-2021; Smallegange, Isabel M./A-8198-2010	Deere, Jacques/0000-0001-6736-2223; Coulson, Tim/0000-0001-9371-9003; Smallegange, Isabel M./0000-0001-6218-7358	European Research Council Advanced Grant [249872]; MacGillavry Fellowship from the University of Amsterdam; Meer vrouwelijke onderzoekers als universitair docent (MEERVOUD) grant [836.13.001]; Netherlands Organisation for Scientific Research (NWO) [864.13.005]; Natural Environment Research Council [NE/K014218/1, NE/I023783/2, 1136795, NE/I023791/2, NE/E015921/1, NE/I023783/1, NE/G004390/2, NE/H007148/2, NE/I023791/1, NE/G004390/1, 1221700, NE/H007148/1] Funding Source: researchfish; NERC [NE/I023791/2, NE/G004390/2, NE/H007148/2, NE/G004390/1, NE/I023783/2, NE/I023791/1, NE/K014218/1, NE/E015921/1, NE/I023783/1] Funding Source: UKRI	European Research Council Advanced Grant(European Research Council (ERC)); MacGillavry Fellowship from the University of Amsterdam; Meer vrouwelijke onderzoekers als universitair docent (MEERVOUD) grant; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the European Research Council Advanced Grant, grant no. 249872 (http://erc.europa.eu/) to TC, a MacGillavry Fellowship from the University of Amsterdam (http://www.uva.nl/en) to IS, a Meer vrouwelijke onderzoekers als universitair docent (MEERVOUD) grant no. 836.13.001 to IS, and a VIDI grant no. 864.13.005 from the Netherlands Organisation for Scientific Research (NWO) (http://www.nwo.nl/en) to IS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benton TG, 2005, P ROY SOC B-BIOL SCI, V272, P1351, DOI 10.1098/rspb.2005.3081; Bonte D, 2012, BIOL REV, V87, P290, DOI 10.1111/j.1469-185X.2011.00201.x; Bonte D, 2010, OIKOS, V119, P560, DOI 10.1111/j.1600-0706.2009.17943.x; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Bystrom P, 2004, OIKOS, V104, P109, DOI 10.1111/j.0030-1299.2004.12759.x; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Coulson T, 2010, J ANIM ECOL, V79, P1226, DOI 10.1111/j.1365-2656.2010.01734.x; Diaz A, 2000, EXP APPL ACAROL, V24, P85, DOI 10.1023/A:1006304300657; DIXON AFG, 1993, J ANIM ECOL, V62, P182, DOI 10.2307/5492; Fadamiro HY, 1996, J INSECT BEHAV, V9, P339, DOI 10.1007/BF02213876; Friedenberg NA, 2003, ECOL LETT, V6, P953, DOI 10.1046/j.1461-0248.2003.00524.x; Fronhofer EA, 2014, EVOLUTION, V68, P1838, DOI 10.1111/evo.12339; Gade G, 2002, PHYSIOL ENTOMOL, V27, P51, DOI 10.1046/j.1365-3032.2002.00268.x; GERSON U, 1983, ACAROLOGIA, V24, P439; GROSS MR, 1991, ECOLOGY, V72, P1180, DOI 10.2307/1941091; Hanski I, 2006, J ANIM ECOL, V75, P91, DOI 10.1111/j.1365-2656.2005.01024.x; Hector KL, 2012, J ANIM ECOL, V81, P583, DOI 10.1111/j.1365-2656.2011.01942.x; HOUCK MA, 1991, ANNU REV ENTOMOL, V36, P611, DOI 10.1146/annurev.en.36.010191.003143; Huss M, 2013, FRESHWATER BIOL, V58, P1416, DOI 10.1111/fwb.12138; Le Galliard JF, 2012, MOL ECOL, V21, P505, DOI 10.1111/j.1365-294X.2011.05410.x; Leigh DM, 2014, EXP APPL ACAROL, V64, P159, DOI 10.1007/s10493-014-9822-y; LI JB, 1994, HEREDITY, V72, P10, DOI 10.1038/hdy.1994.2; Lukasik P, 2010, BEHAV ECOL, V21, P270, DOI 10.1093/beheco/arp186; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Min KJ, 2004, J INSECT PHYSIOL, V50, P531, DOI 10.1016/j.jinsphys.2004.03.009; Nichols J., 2001, DISPERSAL; NISHIGAKI J, 1991, APPL ENTOMOL ZOOL, V26, P255, DOI 10.1303/aez.26.255; Ozgul A, 2010, NATURE, V466, P482, DOI 10.1038/nature09210; Perez-Mendoza J, 2011, J ECON ENTOMOL, V104, P443, DOI 10.1603/EC10430; R Core Team, 2021, R LANGUAGE ENV STAT; RADWAN J, 1995, HEREDITY, V74, P669, DOI 10.1038/hdy.1995.91; Radwan J, 2000, ETHOLOGY, V106, P53, DOI 10.1046/j.1439-0310.2000.00498.x; RANKIN MA, 1992, ANNU REV ENTOMOL, V37, P533, DOI 10.1146/annurev.en.37.010192.002533; ROFF D, 1977, J ANIM ECOL, V46, P443, DOI 10.2307/3822; ROFF DA, 1991, AM ZOOL, V31, P243; Roff Derek, 2002, pi; Ronce O, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P119; Smallegange IM, 2012, J EVOLUTION BIOL, V25, P972, DOI 10.1111/j.1420-9101.2012.02490.x; Smallegange IM, 2014, AM NAT, V183, P784, DOI 10.1086/675817; Smallegange IM, 2011, ECOLOGY, V92, P755, DOI 10.1890/09-2069.1; Smallegange IM, 2011, NATURWISSENSCHAFTEN, V98, P339, DOI 10.1007/s00114-011-0773-4; Smallegange IM, 2011, EVOL ECOL, V25, P857, DOI 10.1007/s10682-010-9446-6; Stacey P.B., 1990, COOPERATIVE BREEDING; Stearns S.C., 1992, pi; Stevens VM, 2014, ECOL LETT, V17, P1039, DOI 10.1111/ele.12303; Stevens VM, 2012, ECOL LETT, V15, P74, DOI 10.1111/j.1461-0248.2011.01709.x; Stillwell RC, 2010, P ROY SOC B-BIOL SCI, V277, P3819, DOI 10.1098/rspb.2010.0895; Yano S, 2002, EXP APPL ACAROL, V27, P1, DOI 10.1023/A:1021518221031; Zera AJ, 1997, ANNU REV ENTOMOL, V42, P207, DOI 10.1146/annurev.ento.42.1.207; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006	50	10	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136872	10.1371/journal.pone.0136872	http://dx.doi.org/10.1371/journal.pone.0136872			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325395	Green Submitted, gold, Green Published			2022-12-26	WOS:000360437700069
J	He, SL; Yang, Y; Morrell, PL; Yi, TS				He, Shui-Lian; Yang, Yang; Morrell, Peter L.; Yi, Ting-Shuang			Nucleotide Sequence Diversity and Linkage Disequilibrium of Four Nuclear Loci in Foxtail Millet (Setaria italica)	PLOS ONE			English	Article							L. P. BEAUV.; SCALE GENOTYPING APPLICATIONS; GENOME-WIDE ASSOCIATION; POPULATION-STRUCTURE; GENETIC DIVERSITY; MOLECULAR DIVERSITY; COMMON MILLET; ORYZA-SATIVA; RECOMBINATION; WILD	Foxtail millet (Setaria italica (L.) Beauv) is one of the earliest domesticated grains, which has been cultivated in northern China by 8,700 years before present (YBP) and across Eurasia by 4,000 YBP. Owing to a small genome and diploid nature, foxtail millet is a tractable model crop for studying functional genomics of millets and bioenergy grasses. In this study, we examined nucleotide sequence diversity, geographic structure, and levels of linkage disequilibrium at four nuclear loci (ADH1, G3PDH, IGS1 and TPI1) in representative samples of 311 landrace accessions across its cultivated range. Higher levels of nucleotide sequence and haplotype diversity were observed in samples from China relative to other sampled regions. Genetic assignment analysis classified the accessions into seven clusters based on nucleotide sequence polymorphisms. Intralocus LD decayed rapidly to half the initial value within similar to 1.2 kb or less.	[He, Shui-Lian; Yang, Yang; Yi, Ting-Shuang] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, China Southwestern Germplasm Bank Wild Species, Kunming, Yunnan, Peoples R China; [He, Shui-Lian] Yunnan Agr Univ, Landscape & Hort Coll, Kunming, Yunnan, Peoples R China; [Morrell, Peter L.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN USA	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Yunnan Agricultural University; University of Minnesota System; University of Minnesota Twin Cities	Yi, TS (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, China Southwestern Germplasm Bank Wild Species, Kunming, Yunnan, Peoples R China.	tingshuangyi@mail.kib.ac.cn	Morrell, Peter/E-2059-2011	Morrell, Peter/0000-0001-6282-1582	Talent Project of Yunnan Province [2011CI042]; Research Foundation for Doctoral Program of Yunnan Agriculture University	Talent Project of Yunnan Province; Research Foundation for Doctoral Program of Yunnan Agriculture University	This study was supported by grants from the Talent Project of Yunnan Province (Project No. 2011CI042) and the Research Foundation for Doctoral Program of Yunnan Agriculture University.	Andolfatto P, 2000, GENETICS, V156, P257; Aranzana MJ, 2005, PLOS GENET, V1, P531, DOI 10.1371/journal.pgen.0010060; Austin DF, 2006, ECON BOT, V60, P143, DOI 10.1663/0013-0001(2006)60[143:FMSPFI]2.0.CO;2; Bai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073514; Bakker EG, 2006, MOL ECOL, V15, P1405, DOI 10.1111/j.1365-294X.2006.02884.x; Benabdelmouna A, 2001, THEOR APPL GENET, V103, P668, DOI 10.1007/s001220100596; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Bevan MW, 2010, CURR OPIN BIOTECH, V21, P211, DOI 10.1016/j.copbio.2010.03.006; Buckler ES, 2001, GENET RES, V77, P213, DOI 10.1017/S0016672301005158; d'Ennequin ML, 2000, THEOR APPL GENET, V100, P1061, DOI 10.1007/s001220051387; Doust AN, 2009, PLANT PHYSIOL, V149, P137, DOI 10.1104/pp.108.129627; Doyle J. J., 1987, PHYTOCHEM B, P11; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; ERLAND S, 1994, NEW PHYTOL, V126, P525, DOI 10.1111/j.1469-8137.1994.tb04251.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Fukunaga K, 1997, THEOR APPL GENET, V95, P751, DOI 10.1007/s001220050621; Fukunaga K, 2002, GENET RESOUR CROP EV, V49, P95, DOI 10.1023/A:1013852007770; Gao M, 1988, ACTA AGRON SIN, V14, P132; Hudson RR, 2000, GENETICS, V155, P2011; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Hudson RR, 2001, GENETICS, V159, P1805; HUDSON RR, 1987, GENET RES, V50, P245, DOI 10.1017/S0016672300023776; HUDSON RR, 1985, GENETICS, V111, P147; Jia GQ, 2013, NAT GENET, V45, P957, DOI 10.1038/ng.2673; JUSUF M, 1985, THEOR APPL GENET, V71, P385, DOI 10.1007/BF00251177; KAWASE M, 1982, THEOR APPL GENET, V63, P117, DOI 10.1007/BF00303690; Keightley PD, 2006, NATURE, V443, P89, DOI 10.1038/nature05049; KIHARA H., 1942, Bot. Mag., V56, P62; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; Kossover O, 2009, J HERED, V100, P432, DOI 10.1093/jhered/esp014; Kumari K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067742; Lata C, 2013, CRIT REV BIOTECHNOL, V33, P328, DOI 10.3109/07388551.2012.716809; LI HW, 1945, J AM SOC AGRON, V37, P32; Li PH, 2011, J EXP BOT, V62, P3031, DOI 10.1093/jxb/err096; Li Y, 1996, GENET RESOUR CROP EV, V43, P377, DOI 10.1007/BF00132958; Li Y, 1998, GENET RESOUR CROP EV, V45, P279, DOI 10.1023/A:1008600123509; Lin JZ, 2002, GENETICS, V162, P2007; Liu ZL, 2014, CROP SCI, V54, P659, DOI 10.2135/cropsci2012.11.0646; Liu ZL, 2011, CROP SCI, V51, P1655, DOI 10.2135/cropsci2010.11.0643; Lu HY, 2009, P NATL ACAD SCI USA, V106, P7367, DOI 10.1073/pnas.0900158106; Martin G, 2006, GENETICS, V172, P593, DOI 10.1534/genetics.104.039982; Mather KA, 2007, GENETICS, V177, P2223, DOI 10.1534/genetics.107.079616; Morrell PL, 2007, P NATL ACAD SCI USA, V104, P3289, DOI 10.1073/pnas.0611377104; Morrell PL, 2005, P NATL ACAD SCI USA, V102, P2442, DOI 10.1073/pnas.0409804102; Muthamilarasan M, 2015, THEOR APPL GENET, V128, P1, DOI 10.1007/s00122-014-2399-3; Muthamilarasan M, 2014, DNA RES, V21, P41, DOI 10.1093/dnares/dst039; Nasu H, 2007, VEG HIST ARCHAEOBOT, V16, P481, DOI 10.1007/s00334-006-0068-4; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Nordborg M, 2002, NAT GENET, V30, P190, DOI 10.1038/ng813; Pandey G, 2013, DNA RES, V20, P197, DOI 10.1093/dnares/dst002; Pritchard JK, 2000, GENETICS, V155, P945; Rakshit S, 2007, THEOR APPL GENET, V114, P731, DOI 10.1007/s00122-006-0473-1; RAO KEP, 1987, ECON BOT, V41, P108, DOI 10.1007/BF02859358; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Ross-Ibarra J, 2007, J EVOLUTION BIOL, V20, P800, DOI 10.1111/j.1420-9101.2006.01275.x; SAKAMOTO S, 1987, JARQ-JPN AGR RES Q, V21, P84; Schontz D, 1998, PLANT BREEDING, V117, P231, DOI 10.1111/j.1439-0523.1998.tb01931.x; Schontz D, 1999, PLANT BREEDING, V118, P190, DOI 10.1046/j.1439-0523.1999.118002190.x; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; Song BH, 2009, GENETICS, V181, P1021, DOI 10.1534/genetics.108.095364; Sun X., 2009, SEED WORLD, V4, P47; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Teshima KM, 2006, GENOME RES, V16, P702, DOI 10.1101/gr.5105206; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thornton K, 2003, BIOINFORMATICS, V19, P2325, DOI 10.1093/bioinformatics/btg316; Till-Bottraud I, 1992, THEOR APPL GENET, V83, P940, DOI 10.1007/BF00232954; Toleno DM, 2007, BIOINFORMATICS, V23, P1807, DOI 10.1093/bioinformatics/btm260; Turrill WB, 1926, NATURE, V118, P392, DOI 10.1038/118392a0; Vetriventhan M, 2014, EUPHYTICA, V196, P423, DOI 10.1007/s10681-013-1044-6; Wachowiak W, 2009, TREE GENET GENOMES, V5, P117, DOI 10.1007/s11295-008-0188-3; Wall JD, 1999, GENET RES, V74, P65, DOI 10.1017/S0016672399003870; Wang CF, 2012, G3-GENES GENOM GENET, V2, P769, DOI 10.1534/g3.112.002907; Wang CF, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-90; WANG RL, 1995, AM J BOT, V82, P308, DOI 10.2307/2445576; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Yadav CB, 2014, DNA RES; Yang XY, 2012, P NATL ACAD SCI USA, V109, P3726, DOI 10.1073/pnas.1115430109; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Zhang S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-78	83	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137088	10.1371/journal.pone.0137088	http://dx.doi.org/10.1371/journal.pone.0137088			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325578	Green Published, gold, Green Submitted			2022-12-26	WOS:000360437700092
J	Boussaha, M; Esquerre, D; Barbieri, J; Djari, A; Pinton, A; Letaief, R; Salin, G; Escudie, F; Roulet, A; Fritz, S; Samson, F; Grohs, C; Bernard, M; Klopp, C; Boichard, D; Rocha, D				Boussaha, Mekki; Esquerre, Diane; Barbieri, Johanna; Djari, Anis; Pinton, Alain; Letaief, Rabia; Salin, Gerald; Escudie, Frederic; Roulet, Alain; Fritz, Sebastien; Samson, Franck; Grohs, Cecile; Bernard, Maria; Klopp, Christophe; Boichard, Didier; Rocha, Dominique			Genome-Wide Study of Structural Variants in Bovine Holstein, Montbeliarde and Normande Dairy Breeds	PLOS ONE			English	Article							COPY NUMBER VARIATIONS; COMMON DELETION POLYMORPHISMS; SEGMENTAL DUPLICATIONS; SCALE VARIATION; BLACK ANGUS; SHORT-READ; CATTLE; POPULATION; SNP; SEQUENCE	High-throughput sequencing technologies have offered in recent years new opportunities to study genome variations. These studies have mostly focused on single nucleotide polymorphisms, small insertions or deletions and on copy number variants. Other structural variants, such as large insertions or deletions, tandem duplications, translocations, and inversions are less well-studied, despite that some have an important impact on phenotypes. In the present study, we performed a large-scale survey of structural variants in cattle. We report the identification of 6,426 putative structural variants in cattle extracted from whole-genome sequence data of 62 bulls representing the three major French dairy breeds. These genomic variants affect DNA segments greater than 50 base pairs and correspond to deletions, inversions and tandem duplications. Out of these, we identified a total of 547 deletions and 410 tandem duplications which could potentially code for CNVs. Experimental validation was carried out on 331 structural variants using a novel high-throughput genotyping method. Out of these, 255 structural variants (77%) generated good quality genotypes and 191 (75%) of them were validated. Gene content analyses in structural variant regions revealed 941 large deletions removing completely one or several genes, including 10 single-copy genes. In addition, some of the structural variants are located within quantitative trait loci for dairy traits. This study is a pan-genome assessment of genomic variations in cattle and may provide a new glimpse into the bovine genome architecture. Our results may also help to study the effects of structural variants on gene expression and consequently their effect on certain phenotypes of interest.	[Boussaha, Mekki; Letaief, Rabia; Fritz, Sebastien; Grohs, Cecile; Boichard, Didier; Rocha, Dominique] INRA, UMR1313, Genet Anim & Biol Integrat, Jouy En Josas, France; [Boussaha, Mekki; Letaief, Rabia; Fritz, Sebastien; Grohs, Cecile; Boichard, Didier; Rocha, Dominique] AgroParisTech, UMR1313, Genet Anim & Biol Integrat, Jouy En Josas, France; [Esquerre, Diane; Barbieri, Johanna; Pinton, Alain; Salin, Gerald; Escudie, Frederic; Roulet, Alain] INRA, Genet Physiol & Syst Elevage UMR1388, F-31326 Castanet Tolosan, France; [Esquerre, Diane; Barbieri, Johanna; Pinton, Alain; Salin, Gerald; Escudie, Frederic; Roulet, Alain] Univ Toulouse, INPT, ENSAT, Genet Physiol & Syst Elevage UMR1388, Castanet Tolosan, France; [Esquerre, Diane; Barbieri, Johanna; Pinton, Alain; Salin, Gerald; Escudie, Frederic; Roulet, Alain] Univ Toulouse, INPT, ENVT, Genet Physiol & Syst Elevage UMR1388, Toulouse, France; [Djari, Anis; Bernard, Maria; Klopp, Christophe] INRA, SIGENAE, UR 875, INRA Auzeville, F-31326 Castanet Tolosan, France; [Fritz, Sebastien] Union Natl Cooperat Agr Elevage & Inseminat Anim, Paris, France; INRA, UR1077, Math Informat & Genome, Jouy En Josas, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; INRAE; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Boussaha, M (corresponding author), INRA, UMR1313, Genet Anim & Biol Integrat, Jouy En Josas, France.	mekki.boussaha@jouy.inra.fr	Klopp, Christophe/J-3164-2019; Pinton, Alain/AAQ-1648-2020; Rocha, Dominique/R-5546-2019; Boichard, Didier/AAD-8675-2020	Klopp, Christophe/0000-0001-7126-5477; Pinton, Alain/0000-0002-0809-7180; Rocha, Dominique/0000-0003-4998-9641; Boichard, Didier/0000-0003-0361-2961; FRITZ, Sebastien/0000-0002-3378-1048; Bernard, Maria/0000-0001-9005-5563; boussaha, mekki/0000-0002-5432-4604; Roulet, Alain/0000-0002-2824-9954	INRA; Agence Nationale de la Recherche [ANR-10-GENM-018]; Apis-Gene	INRA; Agence Nationale de la Recherche(French National Research Agency (ANR)); Apis-Gene	This work was funded by INRA, the Agence Nationale de la Recherche (contract ANR-10-GENM-018) and Apis-Gene. The funders had no role in study design, data collection and analysis, decision to publish, or in preparation of the manuscript.	Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Allais-Bonnet A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063512; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bae JS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-232; Barris W, 2012, ANIM PROD SCI, V52, P133, DOI 10.1071/AN11095; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bickhart DM, 2012, GENOME RES, V22, P778, DOI 10.1101/gr.133967.111; Boichard D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034130; Canavez FC, 2012, J HERED, V103, P342, DOI 10.1093/jhered/esr153; Capitan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049084; Choi JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101127; Choi JW, 2013, MAMM GENOME, V24, P151, DOI 10.1007/s00335-013-9449-z; Cicconardi F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-124; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Daetwyler HD, 2014, NAT GENET, V46, P858, DOI 10.1038/ng.3034; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Drogemuller C, 2001, GENOME RES, V11, P1699, DOI 10.1101/gr.182501; Durkin K, 2012, NATURE, V482, P81, DOI 10.1038/nature10757; Eck SH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r82; Fadista J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-284; Falush D, 2003, GENETICS, V164, P1567; Feuk L, 2006, HUM MOL GENET, V15, pR57, DOI 10.1093/hmg/ddl057; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Flisikowski K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015116; Fritz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065550; Gautier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013038; Glatzer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067992; Glazov EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006349; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Hirano T, 2000, GENOME RES, V10, P659, DOI 10.1101/gr.10.5.659; Hou YL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-376; Hou YL, 2012, FUNCT INTEGR GENOMIC, V12, P81, DOI 10.1007/s10142-011-0252-1; Hou YL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-127; Hu ZL, 2007, NUCLEIC ACIDS RES, V35, pD604, DOI 10.1093/nar/gkl946; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jansen S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-446; Jiang L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-131; Jiang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048732; Kadri NK, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004049; Kijas JW, 2011, GENE, V482, P73, DOI 10.1016/j.gene.2011.04.011; Koch CT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077841; Koks S, 2014, MAMM GENOME, V25, P363, DOI 10.1007/s00335-014-9511-5; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Larkin DM, 2012, P NATL ACAD SCI USA, V109, P7693, DOI 10.1073/pnas.1114546109; Lee HJ, 2014, GENOME BIOL EVOL, V6, P1366, DOI 10.1093/gbe/evu102; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao XP, 2013, GENOME, V56, P592, DOI 10.1139/gen-2013-0082; Liu GE, 2008, DEV BIOLOGICALS, V132, P231, DOI 10.1159/000317165; Liu GE, 2011, MAMM GENOME, V22, P111, DOI 10.1007/s00335-010-9308-0; Liu GE, 2010, GENOME RES, V20, P693, DOI 10.1101/gr.105403.110; Liu GE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-571; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McClure M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059251; McDaneld TG, 2014, J ANIM SCI, V92, P1378, DOI 10.2527/jas.2013-6821; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Meyers SN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-337; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Ohba Y, 2000, GENOMICS, V68, P229, DOI 10.1006/geno.2000.6298; Pritchard JK, 2000, GENETICS, V155, P945; Sato S, 2003, J BIOL CHEM, V278, P15123, DOI 10.1074/jbc.C300054200; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Seroussi E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-673; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Shin DH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-240; Sonstegard TS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054872; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Stothard P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-559; Sugimoto M, 2003, ANIM GENET, V34, P191, DOI 10.1046/j.1365-2052.2003.00990.x; Tsuda K, 2013, GENOMICS, V102, P372, DOI 10.1016/j.ygeno.2013.08.002; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Venhoranta H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075659; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Wiedemar N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093435; Xu LY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-683; Xu LY, 2014, FUNCT INTEGR GENOMIC, V14, P333, DOI 10.1007/s10142-014-0371-6; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zhan BJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-557; Zhang LZ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-480; Zhang Q, 2014, MOL GENET GENOMICS; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	89	42	43	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135931	10.1371/journal.pone.0135931	http://dx.doi.org/10.1371/journal.pone.0135931			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317361	gold, Green Published, Green Submitted			2022-12-26	WOS:000360299100051
J	Koryachko, A; Matthiadis, A; Muhammad, D; Foret, J; Brady, SM; Ducoste, JJ; Tuck, J; Long, TA; Williams, C				Koryachko, Alexandr; Matthiadis, Anna; Muhammad, Durreshahwar; Foret, Jessica; Brady, Siobhan M.; Ducoste, Joel J.; Tuck, James; Long, Terri A.; Williams, Cranos			Clustering and Differential Alignment Algorithm: Identification of Early Stage Regulators in the Arabidopsis thaliana Iron Deficiency Response	PLOS ONE			English	Article							GENE-EXPRESSION DATA; TIME-SERIES DATA; TRANSCRIPTIONAL REGULATION; STRESS RESPONSES; NETWORKS; HOMEOSTASIS; ROOTS; ASSOCIATION; MATURATION; INFERENCE	Time course transcriptome datasets are commonly used to predict key gene regulators associated with stress responses and to explore gene functionality. Techniques developed to extract causal relationships between genes from high throughput time course expression data are limited by low signal levels coupled with noise and sparseness in time points. We deal with these limitations by proposing the Cluster and Differential Alignment Algorithm (CDAA). This algorithm was designed to process transcriptome data by first grouping genes based on stages of activity and then using similarities in gene expression to predict influential connections between individual genes. Regulatory relationships are assigned based on pairwise alignment scores generated using the expression patterns of two genes and some inferred delay between the regulator and the observed activity of the target. We applied the CDAA to an iron deficiency time course microarray dataset to identify regulators that influence 7 target transcription factors known to participate in the Arabidopsis thaliana iron deficiency response. The algorithm predicted that 7 regulators previously unlinked to iron homeostasis influence the expression of these known transcription factors. We validated over half of predicted influential relationships using qRT-PCR expression analysis in mutant backgrounds. One predicted regulator-target relationship was shown to be a direct binding interaction according to yeast one-hybrid (Y1H) analysis. These results serve as a proof of concept emphasizing the utility of the CDAA for identifying unknown or missing nodes in regulatory cascades, providing the fundamental knowledge needed for constructing predictive gene regulatory networks. We propose that this tool can be used successfully for similar time course datasets to extract additional information and infer reliable regulatory connections for individual genes.	[Koryachko, Alexandr; Tuck, James; Williams, Cranos] N Carolina State Univ, Elect & Comp Engn, Raleigh, NC 27695 USA; [Matthiadis, Anna; Muhammad, Durreshahwar; Long, Terri A.] N Carolina State Univ, Plant & Microbial Biol, Raleigh, NC 27695 USA; [Foret, Jessica; Brady, Siobhan M.] Univ Calif Davis, Plant Biol, Davis, CA 95616 USA; [Ducoste, Joel J.] N Carolina State Univ, Civil Construct & Environm Engn, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of California System; University of California Davis; University of North Carolina; North Carolina State University	Long, TA (corresponding author), N Carolina State Univ, Plant & Microbial Biol, Raleigh, NC 27695 USA.	terri_long@ncsu.edu; cmwilli5@ncsu.edu	Tuck, James M/I-3418-2018; Brady, Siobhan/AAY-1729-2021; Ducoste, Joel/A-1964-2016; Long, Terri/AAA-1984-2020	Tuck, James M/0000-0001-8975-0294; Ducoste, Joel/0000-0002-3021-3942; Long, Terri/0000-0001-7846-0195; Matthiadis, Anna/0000-0002-2465-8451; Brady, Siobhan/0000-0001-9424-8055	National Science Foundation [1247427]; National Science Foundation Graduate Research Fellowship [1252376]	National Science Foundation(National Science Foundation (NSF)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	This work was supported by National Science Foundation (www.nsf.gov) grant no. 1247427: CW JJD TAL JT and National Science Foundation Graduate Research Fellowship (www.nsf.gov) grant no. 1252376: AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BARKER NA, 2011, COMPUTATIONAL BIOL B, V8, P152, DOI DOI 10.1109/TCBB.2009.48; Barr MS, 2012, PLANT SIGNAL BEHAV, V7, P205, DOI 10.4161/psb.18893; Bickel DR, 2005, BIOINFORMATICS, V21, P1121, DOI 10.1093/bioinformatics/bti140; Brady SM, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.114; Buckhout TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-147; Datta S, 2006, PLANT CELL, V18, P70, DOI 10.1105/tpc.105.038182; Dinneny JR, 2008, SCIENCE, V320, P942, DOI 10.1126/science.1153795; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Gao MJ, 2009, PLANT CELL, V21, P54, DOI 10.1105/tpc.108.061309; Gaudinier A, 2011, NAT METHODS, V8, P1053, DOI [10.1038/NMETH.1750, 10.1038/nmeth.1750]; Grillet L, 2013, FRONT PLANT SCI, V4; Gustafsson M, 2009, ANN NY ACAD SCI, V1158, P265, DOI 10.1111/j.1749-6632.2008.03764.x; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Iyer-Pascuzzi AS, 2011, DEV CELL, V21, P770, DOI 10.1016/j.devcel.2011.09.009; Jiang YJ, 2014, PLANT CELL, V26, P230, DOI 10.1105/tpc.113.117838; Jiang YJ, 2012, MOL PLANT, V5, P1375, DOI 10.1093/mp/sss080; Kabir M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S56; Karas B, 2009, PLANT PHYSIOL, V151, P1175, DOI 10.1104/pp.109.143867; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kobayashi T, 2012, ANNU REV PLANT BIOL, V63, P131, DOI 10.1146/annurev-arplant-042811-105522; Kwon AT, 2003, BIOINFORMATICS, V19, P905, DOI 10.1093/bioinformatics/btg106; Lin W.-D., 2011, PLANT PHYSIOL, P110; Long TA, 2010, PLANT CELL, V22, P2219, DOI 10.1105/tpc.110.074096; Ma PCH, 2008, IEEE T FUZZY SYST, V16, P455, DOI 10.1109/TFUZZ.2007.894969; Ma Patrick C H, 2007, J Bioinform Comput Biol, V5, P651, DOI 10.1142/S0219720007002692; Misra A, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-126; Nie J, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-53; Opgen-Rhein R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-37; Palmer CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003953; Ram R., 2006, COMP INT BIOINF COMP, P1, DOI [10.1109/CIBCB.2006.330982, DOI 10.1109/CIBCB.2006.330982]; Redestig H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-454; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosa BA, 2012, BIOINFORMATICS, V28, P2773, DOI 10.1093/bioinformatics/bts511; Roschzttardtz H, 2011, PLANT CELL, V23, P2725, DOI 10.1105/tpc.111.088088; Rueda L, 2008, LECT NOTES COMPUT SC, V5410, P100, DOI 10.1007/978-3-540-92273-5_6; Schafer J, 2005, BIOINFORMATICS, V21, P754, DOI 10.1093/bioinformatics/bti062; Schmitt WA, 2004, GENOME RES, V14, P1654, DOI 10.1101/gr.2439804; Selote D, 2014, PLANT PHYSIOL, P114; Shi YX, 2007, BIOINFORMATICS, V23, P755, DOI 10.1093/bioinformatics/btl676; Sima C, 2009, CURR GENOMICS, V10, P416, DOI 10.2174/138920209789177610; Singh KB, 1998, PLANT PHYSIOL, V118, P1111, DOI 10.1104/pp.118.4.1111; Sivitz AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044843; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Stacey MG, 2008, PLANT PHYSIOL, V146, P589, DOI 10.1104/pp.107.108183; Willmann MR, 2011, PLANT PHYSIOL, V155, P1871, DOI 10.1104/pp.110.171355; Windram O, 2012, PLANT CELL, V24, P3530, DOI 10.1105/tpc.112.102046; Wolfe CJ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-227; Yuan YX, 2008, CELL RES, V18, P385, DOI 10.1038/cr.2008.26; Zhang J, 2015, PLANT CELL, V27, P787, DOI 10.1105/tpc.114.132704; Zhao WT, 2006, BIOINFORMATICS, V22, P2129, DOI 10.1093/bioinformatics/btl364; Zheng Y, 2006, INT J DATA MIN BIOIN, V1, P111, DOI 10.1504/IJDMB.2006.010851	52	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136591	10.1371/journal.pone.0136591	http://dx.doi.org/10.1371/journal.pone.0136591			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317202	Green Published, Green Submitted, gold			2022-12-26	WOS:000360299100106
J	Mouzaki, A; Rodi, M; Dimisianos, N; Emmanuil, A; Kalavrizioti, D; Lagoudaki, R; Grigoriadis, NC; Papathanasopoulos, P				Mouzaki, Athanasia; Rodi, Maria; Dimisianos, Nikolaos; Emmanuil, Andreas; Kalavrizioti, Dimitra; Lagoudaki, Rosa; Grigoriadis, Nikolaos C.; Papathanasopoulos, Panagiotis			Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; BLOOD MONONUCLEAR-CELLS; T-CELLS; CEREBROSPINAL-FLUID; AUTOIMMUNE INFLAMMATION; B-CELLS; NEUROMYELITIS-OPTICA; CYTOKINE PROFILE; DISEASE; INTERLEUKIN-17	Background/Aim Multiple sclerosis (MS) is an inflammatory, demyelinating disease of the central nervous system. Effector T helper cells, mainly Th1 and Th17, cytotoxic T-cells, B-cells, macrophages, microglia, and the cytokines they secrete, are implicated in the initiation and maintenance of a deregulated immune response to myelin antigens and the ensuing immune-mediated demyelination. In this study, we investigated whether signature cytokines exist in MS patients at presentation to gain an insight into the underlying immunopathogenic processes at the early stage of the disease. Methods We collected serum and cerebrospinal fluid (CSF) samples from 123 patients at presentation, eventually diagnosed with MS or non-inflammatory (NIND) or inflammatory neurological diseases (IND) or symptomatic controls (SC). The levels of cytokines IFN-gamma, TNF-alpha, TGF-beta 1, IL-2, IL-4, IL-6, IL-10 and IL-17 were measured, and cytokine ratios, such as Th1/Th2, Th1/Th17, and Type-1/Type-2, were calculated. All parameters were tested for their correlations with the intrathecal IgG synthesis. Results Cytokine levels in CSF were lower than in serum in all the patients, with the exception of IL6. Serum or CSF cytokine levels of MS patients did not differ significantly from NIND or SC, with the exception of serum IFN-gamma and TNF-alpha that were significantly higher in NIND. IND patients presented with the highest levels of all cytokines in serum and CSF, with the exception of serum IL-10 and CSF IL-17. MS patients had a significantly lower serum Th1/Th2 ratio compared to the NIND and IND groups, and significantly lower serum Type-1/Type-2, IFN-gamma/IL-10 and CSF Th1/Th17 ratios compared to IND patients. MS patients had a significantly higher CSF IL-17/IL-10 ratio compared to IND patients. The IgG index was higher in MS patients compared to the control groups; the differences reached statistical significance between the MS and the NIND and SC groups. Reiber-Felgenhauer analysis of the QIgG and QAlb indices revealed higher intrathecal IgG synthesis in MS patients, and higher blood-CSF barrier dysfunction in IND patients. The IgG index correlated with CSF IL-4 in MS patients only. Conclusions We found no signature cytokines or profiles thereof in MS patients at presentation. Only IND patients presented with a clear Th1 cytokine polarization in serum and CSF. The parameters that distinguished MS patients from patients with other neurological disorders were IgG intrathecal synthesis, the IgG index and its correlation with CSF IL-4 levels.	[Mouzaki, Athanasia; Rodi, Maria; Kalavrizioti, Dimitra] Univ Patras, Sch Med, Dept Internal Med, Div Hematol, GR-26110 Patras, Greece; [Dimisianos, Nikolaos; Papathanasopoulos, Panagiotis] Patras Univ Hosp, Dept Neurol, Patras, Greece; [Emmanuil, Andreas] Patras Univ Hosp, Hematol Lab, Patras, Greece; [Lagoudaki, Rosa; Grigoriadis, Nikolaos C.] AHEPA Univ Hosp, Dept Neurol, Thessaloniki, Greece	University of Patras; University of Patras; University of Patras; Aristotle University of Thessaloniki; Ahepa University Hospital	Mouzaki, A (corresponding author), Univ Patras, Sch Med, Dept Internal Med, Div Hematol, GR-26110 Patras, Greece.	mouzaki@upatras.gr		Rodi, Maria/0000-0001-6578-0851	Greek General Secretariat of Research and Technology "Cooperation" grant [09SYN-21-69]; Genesis Pharma S.A.	Greek General Secretariat of Research and Technology "Cooperation" grant; Genesis Pharma S.A.	This work was supported by the Greek General Secretariat of Research and Technology "Cooperation" grant 09SYN-21-69 (O.P. Competitiveness & Entrepreneurship, EPAN II) to AM, and by an unconditional grant by Genesis Pharma S.A. to ND. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alatab S, 2011, MINERVA MED, V102, P461; Avery DT, 2008, J IMMUNOL, V181, P1767, DOI 10.4049/jimmunol.181.3.1767; Awad A, 2010, J NEUROIMMUNOL, V219, P1, DOI 10.1016/j.jneuroim.2009.09.002; Barun B, 2012, CLIN IMMUNOL, V142, P31, DOI 10.1016/j.clim.2011.04.005; Chatzantoni K, 2004, J AUTOIMMUN, V23, P169, DOI 10.1016/j.jaut.2004.05.007; Chatzantoni K., 2009, NEUROVASCULAR MED PU, P345; Chen Z, 2008, CYTOKINE, V41, P71, DOI 10.1016/j.cyto.2007.09.009; Codarri L, 2010, CURR OPIN NEUROL, V23, P205, DOI 10.1097/WCO.0b013e3283391feb; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Deraos G, 2008, J MED CHEM, V51, P7834, DOI 10.1021/jm800891n; Disanto G, 2012, NEUROLOGY, V78, P823, DOI 10.1212/WNL.0b013e318249f6f0; Edwards LJ, 2010, CYTOKINE, V50, P19, DOI 10.1016/j.cyto.2009.12.003; Frisullo G, 2008, CYTOKINE, V44, P22, DOI 10.1016/j.cyto.2008.08.007; Graber JJ, 2008, J NEUROIMMUNOL, V196, P124, DOI 10.1016/j.jneuroim.2008.02.008; Gutcher I, 2007, J CLIN INVEST, V117, P1119, DOI 10.1172/JCI31720; Han Q, 2012, P NATL ACAD SCI USA, V109, P1607, DOI 10.1073/pnas.1117194109; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Johansson-Lindbom B, 2002, J IMMUNOL, V168, P3165, DOI 10.4049/jimmunol.168.7.3165; Kallaur AP, 2013, MOL MED REP, V7, P1010, DOI 10.3892/mmr.2013.1256; Kebir H, 2009, ANN NEUROL, V66, P390, DOI 10.1002/ana.21748; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lassmann H., 2010, CLIN EXP NEUROIMMUNO, V1, P2, DOI [10.1111/j.1759-1961.2009.00003.x, DOI 10.1111/J.1759-1961.2009.00003.X]; Liao W, 2011, CURR OPIN IMMUNOL, V23, P598, DOI 10.1016/j.coi.2011.08.003; Lublin FD, 2008, NEUROLOGY CLIN PRACT, P1583; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; MAIMONE D, 1991, J NEUROIMMUNOL, V32, P67, DOI 10.1016/0165-5728(91)90073-G; Martins TB, 2011, AM J CLIN PATHOL, V136, P696, DOI 10.1309/AJCP7UBK8IBVMVNR; Matusevicius D, 1999, MULT SCLER J, V5, P101, DOI 10.1177/135245859900500206; Panitsas FP, 2004, BLOOD, V103, P2645, DOI 10.1182/blood-2003-07-2268; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Ponomarev ED, 2007, J NEUROSCI, V27, P10714, DOI 10.1523/JNEUROSCI.1922-07.2007; Reiber H, 2001, J NEUROL SCI, V184, P101, DOI 10.1016/S0022-510X(00)00501-3; Saruhan-Direskeneli G, 2003, J NEUROIMMUNOL, V145, P127, DOI 10.1016/j.jneuroim.2003.08.040; Sriram S, 2005, ANN NEUROL, V58, P939, DOI 10.1002/ana.20743; Teunissen C, 2013, MULT SCLER J, V19, P1802, DOI 10.1177/1352458513488232; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Wang KC, 2013, J INTERF CYTOK RES, V33, P58, DOI 10.1089/jir.2012.0040; Weissert R, 2013, J NEUROIMMUNE PHARM, V8, P857, DOI 10.1007/s11481-013-9467-3; Wekerle H, 2006, MCALPINES MULTIPLE S, P491; Wu AM, 2012, CAN J NEUROL SCI, V39, P813, DOI 10.1017/S0317167100015663; ZAMVIL SS, 1990, ANNU REV IMMUNOL, V8, P579, DOI 10.1146/annurev.iy.08.040190.003051; Zozulya AL, 2008, NAT CLIN PRACT NEURO, V4, P384, DOI 10.1038/ncpneuro0832	43	17	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135434	10.1371/journal.pone.0135434	http://dx.doi.org/10.1371/journal.pone.0135434			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317430	Green Submitted, Green Published, gold			2022-12-26	WOS:000360299100028
J	Sanchez-Antolin, G; Almohalla-Alvarez, C; Bueno, P; Almansa, R; Iglesias, V; Rico, L; Ortega, A; Munoz-Conejero, E; Garcia-Pajares, F; Bermejo-Martin, JF				Sanchez-Antolin, Gloria; Almohalla-Alvarez, Carolina; Bueno, Pilar; Almansa, Raquel; Iglesias, Veronica; Rico, Lucia; Ortega, Alicia; Munoz-Conejero, Eva; Garcia-Pajares, Felix; Bermejo-Martin, Jesus F.			Evidence of Active Pro-Fibrotic Response in Blood of Patients with Cirrhosis	PLOS ONE			English	Article							CHRONIC LIVER-DISEASE; LARGE GENE LISTS; HEPATOCELLULAR-CARCINOMA; HEPATIC-FIBROSIS; EXPRESSION; MECHANISMS; SIGNATURE; MARKERS; SYSTEM	The role of systemic immunity in the pathogenesis of cirrhosis is not fully understood. Analysis of transcriptomic profiles in blood is an easy approach to obtain a wide picture of immune response at the systemic level. We studied gene expression profiles in blood from thirty cirrhotic patients and compared them against those of eight healthy volunteers. Most of our patients were male [n = 21, 70%] in their middle ages [57.4 +/- 6.8 yr]. Alcohol abuse was the most frequent cause of cirrhosis (n = 22, 73%). Eleven patients had hepatocellular carcinoma (36.7%). Eight patients suffered from hepatitis C virus infection (26.7%). We found a signature constituted by 3402 genes which were differentially expressed in patients compared to controls (2802 over-expressed and 600 under-expressed). Evaluation of this signature evidenced the existence of an active pro-fibrotic transcriptomic program in the cirrhotic patients, involving the [extra-cellular matrix (ECM)-receptor interaction] & [TGF-beta signaling] pathways along with the [Cell adhesion molecules] pathway. This program coexists with alterations in pathways participating in [Glycine, serine and threonine metabolism], [Phenylalanine metabolism], [Tyrosine metabolism], [ABC transporters], [Purine metabolism], [Arachidonic acid metabolism]. In consequence, our results evidence the coexistence in blood of a genomic program mediating pro-fibrotic mechanisms and metabolic alterations in advanced cirrhosis. Monitoring expression levels of the genes involved in these programs could be of interest for predicting/monitoring cirrhosis evolution. These genes could constitute therapeutic targets in this disease.	[Sanchez-Antolin, Gloria; Almohalla-Alvarez, Carolina; Garcia-Pajares, Felix] Hosp Univ Rio Hortega, Unidad Trasplante Hepaico, Unidad Hepatol, Valladolid, Spain; [Bueno, Pilar] Hosp Clin Univ Valladolid, Serv Analisis Clin, Valladolid, Spain; [Almansa, Raquel; Iglesias, Veronica; Rico, Lucia; Ortega, Alicia; Bermejo-Martin, Jesus F.] Hosp Clin Univ Valladolid IECSCYL, Invest Med Infecc & Inmunidad IMI, Valladolid, Spain; [Munoz-Conejero, Eva] Escuela Enfermeria Univ Valladolid, Valladolid, Spain	Hospital del Rio Hortega	Sanchez-Antolin, G (corresponding author), Hosp Univ Rio Hortega, Unidad Trasplante Hepaico, Unidad Hepatol, Valladolid, Spain.	gloriasanchez_antolin@hotmail.com	Almansa, Raquel/T-3414-2019; Bermejo-Martin, Jesus F/J-4574-2019	Bermejo-Martin, Jesus F/0000-0002-7998-6268; Almansa, Raquel/0000-0002-4144-7808; Sanchez Antolin, Gloria/0000-0003-2108-4971; Almohalla, Carolina/0000-0002-7295-0027	Consejeria de Sanidad de Castilla y Leon, Proyectos de la Gerencia REgional de Salud; Instituto de SAlud Carloss III, Spain, EMER 07/050	Consejeria de Sanidad de Castilla y Leon, Proyectos de la Gerencia REgional de Salud; Instituto de SAlud Carloss III, Spain, EMER 07/050	This work was supported by the Consejeria de Sanidad de Castilla y Leon, Proyectos de la Gerencia REgional de Salud, (https://www.saludcastillayleon.es/es) and the Instituto de SAlud Carloss III, Spain, EMER 07/050, (www.isciii.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad W, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-41; Almansa R, 2015, J INFECTION, V70, P445, DOI 10.1016/j.jinf.2014.12.010; Aravinthan A, 2014, EXP GERONTOL, V60, P37, DOI 10.1016/j.exger.2014.09.011; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Chaussabel D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-84; Estep JM, 2010, DIGEST DIS SCI, V55, P496, DOI 10.1007/s10620-009-0919-9; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kasprzycka M, 2015, CELL ADHES MIGR, V9, P83, DOI 10.4161/19336918.2014.994901; Kovalszky I, 1998, SCAND J GASTROENTERO, V33, P51, DOI 10.1080/003655298750026561; Lebensztejn DM, 2006, WORLD J GASTROENTERO, V12, P3338, DOI 10.3748/wjg.v12.i21.3338; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Okina E, 2009, SCAND J MED SCI SPOR, V19, P479, DOI 10.1111/j.1600-0838.2009.00941.x; Pivonello C, 2014, INFECT AGENTS CANCER, V9, DOI 10.1186/1750-9378-9-27; Puche JE, 2013, COMPR PHYSIOL, V3, P1473, DOI 10.1002/cphy.c120035; Sacerdoti D, 2015, PROSTAG OTH LIPID M, V120, P80, DOI 10.1016/j.prostaglandins.2015.05.008; Sales G, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-20; Sands CJ, 2015, AM J GASTROENTEROL, V110, P159, DOI 10.1038/ajg.2014.370; Scarpellini A, 2014, J AM SOC NEPHROL, V25, P1013, DOI 10.1681/ASN.2013050563; Shi M, 2014, EUR J CANCER, V50, P928, DOI 10.1016/j.ejca.2013.11.026; Tamayo E, 2014, CRIT CARE, V18, DOI 10.1186/cc13910; Tatrai P, 2006, LAB INVEST, V86, P1149, DOI 10.1038/labinvest.3700475; Tessari P, 2010, CURR OPIN CLIN NUTR, V13, P81, DOI 10.1097/MCO.0b013e32833383af; Utsunomiya T, 2007, WORLD J GASTROENTERO, V13, P383, DOI 10.3748/wjg.v13.i3.383; Yokomori H, 2015, MICRON, V76, P52, DOI 10.1016/j.micron.2015.03.009; Yue Beatrice, 2014, J Glaucoma, V23, pS20, DOI 10.1097/IJG.0000000000000108; Zhang B, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-30; Zhou WC, 2014, WORLD J GASTROENTERO, V20, P7312, DOI 10.3748/wjg.v20.i23.7312; Zhu CH, 2015, INT J CLIN EXP MED, V8, P5989	29	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137128	10.1371/journal.pone.0137128	http://dx.doi.org/10.1371/journal.pone.0137128			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317806	Green Published, gold, Green Submitted			2022-12-26	WOS:000360299100207
J	Tapia, G; Boas, H; de Muinck, EJ; Cinek, O; Stene, LC; Torjesen, PA; Rasmussen, T; Ronningen, KS				Tapia, German; Boas, Hakon; de Muinck, Eric J.; Cinek, Ondrej; Stene, Lars C.; Torjesen, Peter A.; Rasmussen, Trond; Ronningen, Kjersti S.			Saffold Virus, a Human Cardiovirus, and Risk of Persistent Islet Autoantibodies in the Longitudinal Birth Cohort Study MIDIA	PLOS ONE			English	Article							GENETIC RISK; CHILDREN; INFECTIONS; ENTEROVIRUS; CIRCULATION; PARECHOVIRUS; PATHOGENESIS; AUTOIMMUNITY; POPULATION; DIARRHEA	The aim of this study was to describe the frequency and distribution of Saffold virus in longitudinal stool samples from children, and test for association with development of persistent autoantibodies predictive of type 1 diabetes. A cohort of Norwegian children carrying the HLA genotype associated with highest risk of type 1 diabetes ("DR4-DQ8/DR3-DQ2") was followed with monthly stool samples from 3 to 35 months of age. Blood samples were tested for autoantibodies to insulin, glutamic acid decarboxylase(65) and Islet Antigen-2. 2077 stool samples from 27 children with >= 2 repeatedly positive islet autoantibodies (cases), and 53 matched controls were analysed for Saffold virus genomic RNA by semi-quantitative realtime reverse transcriptase PCR. Saffold virus was found in 53 of 2077 (2.6%) samples, with similar proportions between cases (2.5%) and controls (2.6%). The probability of being infected by 3 years of age was 28% (95% CI 0.18-0.40). Viral quantities ranged from <1 to almost 10(5) copies/mu l. Estimated odds ratio between islet autoimmunity and infection episodes prior to seroconversion was 1.98 (95% CI: 0.57-6.91, p = 0.29). Saffold virus had no statistically significant association with islet autoimmunity.	[Tapia, German; Boas, Hakon] Norwegian Inst Publ Hlth, Div Epidemiol, Dept Genes & Environm, Oslo, Norway; [de Muinck, Eric J.] Univ Oslo, Dept Biosci, CEES, Oslo, Norway; [Cinek, Ondrej] Charles Univ Prague, Fac Med 2, Dept Paediat, Prague, Czech Republic; [Cinek, Ondrej] Univ Hosp Motol, Prague, Czech Republic; [Stene, Lars C.] Norwegian Inst Publ Hlth, Div Epidemiol, Dept Chron Dis, Oslo, Norway; [Torjesen, Peter A.] Oslo Univ Hosp, Dept Med Biochem, Hormone Lab, Oslo, Norway; [Rasmussen, Trond] Norwegian Inst Publ Hlth, Div Inst Resources, Dept IT & EHlth, Oslo, Norway; [Ronningen, Kjersti S.] Oslo Univ Hosp, Dept Pediat Res, Oslo, Norway	Norwegian Institute of Public Health (NIPH); University of Oslo; Charles University Prague; Motol University Hospital; Norwegian Institute of Public Health (NIPH); University of Oslo; Norwegian Institute of Public Health (NIPH); University of Oslo	Boas, H (corresponding author), Norwegian Inst Publ Hlth, Div Epidemiol, Dept Genes & Environm, Oslo, Norway.	hakon.boas@fhi.no	Tapia, German/AAS-8467-2020; Cinek, Ondrej/AAF-6664-2020	Tapia, German/0000-0002-1770-1183; Cinek, Ondrej/0000-0002-0526-8714; de Muinck, Eric/0000-0001-5606-3172; Boas, Hakon/0000-0002-5917-1563	Research Council of Norway [205086/F20, 185610/V40, 166515/V50]; Ministry of Health of the Czech Republic [IGA MZ 11465-5]; Project for the Conceptual Development of Research Organization [00064203]	Research Council of Norway(Research Council of Norway); Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Project for the Conceptual Development of Research Organization	This work was supported by The Research Council of Norway (grant numbers 205086/F20 to GT, 185610/V40 to HB, 166515/V50 to KSR)m the Ministry of Health of the Czech Republic (IGA MZ 11465-5 to OC) and the Project for the Conceptual Development of Research Organization 00064203 (University Hospital Motol, Prague, Czech Republic). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2008, EMERG INFECT DIS, V14, P834, DOI 10.3201/eid1405.071675; Bjornvold M, 2008, DIABETOLOGIA, V51, P589, DOI 10.1007/s00125-008-0932-0; Blinkova O, 2009, J CLIN MICROBIOL, V47, P3507, DOI 10.1128/JCM.01062-09; Blinkova O, 2009, J VIROL, V83, P4631, DOI 10.1128/JVI.02085-08; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Chiu CY, 2008, P NATL ACAD SCI USA, V105, P14124, DOI 10.1073/pnas.0805968105; Cinek O, 2006, J CLIN VIROL, V35, P33, DOI 10.1016/j.jcv.2005.03.007; CRAIGHEAD JE, 1968, SCIENCE, V162, P913, DOI 10.1126/science.162.3856.913; Drexler JF, 2008, EMERG INFECT DIS, V14, P1398, DOI 10.3201/eid1409.080570; Galama J, 2011, EMERG INFECT DIS, V17, P1572, DOI 10.3201/eid1708.101953; Himeda T, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-110; Jones MS, 2007, J CLIN MICROBIOL, V45, P2144, DOI 10.1128/JCM.00174-07; Khamrin P, 2013, INFECT GENET EVOL, V13, P339, DOI 10.1016/j.meegid.2012.11.004; Khamrin P, 2011, EMERG INFECT DIS, V17, P1150, DOI [10.3201/eid1706.101983, 10.3201/eid/1706.101983]; Knip M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007690; Kolehmainen P, 2013, J MED VIROL, V85, P1619, DOI 10.1002/jmv.23659; McCartney SA, 2011, J CLIN INVEST, V121, P1497, DOI 10.1172/JCI44005; Naeem A, 2014, J GEN VIROL, V95, P1945, DOI 10.1099/vir.0.066498-0; Nielsen ACY, 2012, EMERG INFECT DIS, V18, P1694, DOI 10.3201/eid1810.120793; Nielsen ACY, 2012, EMERG INFECT DIS, V18, P7, DOI 10.3201/eid1801.110725; PETROV PA, 1970, AM J TROP MED HYG, V19, P146, DOI 10.4269/ajtmh.1970.19.146; Ren LL, 2010, EMERG INFECT DIS, V16, P1158, DOI 10.3201/eid1607.091682; Ren LL, 2009, EMERG INFECT DIS, V15, P1509, DOI 10.3201/eid1509.081531; Richer MJ, 2008, FRONT BIOSCI-LANDMRK, V13, P4241, DOI 10.2741/3002; Simonen-Tikka ML, 2011, DIABETOLOGIA, V54, P2995, DOI 10.1007/s00125-011-2305-3; Simonen-Tikka ML, 2013, J MED VIROL, V85, P1678, DOI 10.1002/jmv.23625; Stanway G, 2000, REV MED VIROL, V10, P57, DOI 10.1002/(SICI)1099-1654(200001/02)10:1&lt;57::AID-RMV266&gt;3.0.CO;2-H; Stene LC, 2007, J AUTOIMMUN, V29, P44, DOI 10.1016/j.jaut.2007.04.003; Stene LC, 2010, DIABETES, V59, P3174, DOI 10.2337/db10-0866; Tapia G, 2011, PEDIATR DIABETES, V12, P58, DOI 10.1111/j.1399-5448.2010.00658.x; Tapia G, 2011, DIABETES CARE, V34, P151, DOI 10.2337/dc10-1413; Tauriainen S, 2011, SEMIN IMMUNOPATHOL, V33, P45, DOI 10.1007/s00281-010-0207-y; Witso E, 2007, VIRUS RES, V123, P19, DOI 10.1016/j.virusres.2006.07.015; Zoll J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000416	34	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136849	10.1371/journal.pone.0136849	http://dx.doi.org/10.1371/journal.pone.0136849			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317929	gold, Green Published, Green Submitted			2022-12-26	WOS:000360299100153
J	Nazareth, TM; Machado, G				Nazareth, Tais M.; Machado, Glauco			Egg Production Constrains Chemical Defenses in a Neotropical Arachnid	PLOS ONE			English	Article							TRADE-OFFS; ECOLOGICAL IMMUNOLOGY; EVOLUTIONARY ECOLOGY; PHASMID INSECT; REPRODUCTION; COSTS; HARVESTMAN; OPILIONES; PREDATION; SIZE	Female investment in large eggs increases the demand for fatty acids, which are allocated for yolk production. Since the biosynthetic pathway leading to fatty acids uses the same precursors used in the formation of polyketides, allocation trade-offs are expected to emerge. Therefore, egg production should constrain the investment in chemical defenses based on polyketides, such as benzoquinones. We tested this hypothesis using the harvestman Acutiosoma longipes, which produces large eggs and releases benzoquinones as chemical defense. We predicted that the amount of secretion released by ovigerous females (OFs) would be smaller than that of non-ovigerous females (NOF). We also conducted a series of bioassays in the field and in the laboratory to test whether egg production renders OFs more vulnerable to predation. OFs produce less secretion than NOFs, which is congruent with the hypothesis that egg production constrains the investment in chemical defenses. Results of the bioassays show that the secretion released by OFs is less effective in deterring potential predators (ants and spiders) than the secretion released by NOFs. In conclusion, females allocate resources to chemical defenses in a way that preserves a primary biological function related to reproduction. However, the trade-off between egg and secretion production makes OFs vulnerable to predators. We suggest that egg production is a critical moment in the life of harvestman females, representing perhaps the highest cost of reproduction in the group.	[Nazareth, Tais M.] Univ Sao Paulo, Programa Posgrad Ecol, Dept Ecol, Inst Biociencias, BR-05508900 Sao Paulo, SP, Brazil; [Machado, Glauco] Univ Sao Paulo, LAGE, Dept Ecol, Inst Biociencias, BR-05508900 Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Machado, G (corresponding author), Univ Sao Paulo, LAGE, Dept Ecol, Inst Biociencias, Rua Matao,Trav 14,321, BR-05508900 Sao Paulo, SP, Brazil.	glaucom@ib.usp.br	Machado, Glauco/D-6983-2012		Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [11/50800-8, 99/05446-8, 02/00381-0, 12/50229-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors were supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (TMN: 11/50800-8; GM: 99/05446-8; 02/00381-0; 12/50229-1) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).	[Anonymous], 1981, CHEM DEFENSES ARTHRO; BAZZAZ FA, 1987, BIOSCIENCE, V37, P58, DOI 10.2307/1310178; BERENBAUM MR, 1995, P NATL ACAD SCI USA, V92, P2, DOI 10.1073/pnas.92.1.2; BOWNES M, 1986, ANNU REV ENTOMOL, V31, P507, DOI 10.1146/annurev.en.31.010186.002451; Bundy JG, 2009, METABOLOMICS, V5, P3, DOI 10.1007/s11306-008-0152-0; Buzatto BA, 2007, J ANIM ECOL, V76, P937, DOI 10.1111/j.1365-2656.2007.01273.x; Buzatto BA, 2011, EVOL ECOL, V25, P331, DOI 10.1007/s10682-010-9431-0; Cox RM, 2010, FUNCT ECOL, V24, P1262, DOI 10.1111/j.1365-2435.2010.01756.x; Dziminski MA, 2009, FUNCT ECOL, V23, P164, DOI 10.1111/j.1365-2435.2008.01480.x; Eisner T, 1997, J EXP BIOL, V200, P2493; Eisner T., 2005, SECRET WEAPONS DEFEN; Fox CW, 2000, ANNU REV ENTOMOL, V45, P341, DOI 10.1146/annurev.ento.45.1.341; French SS, 2007, FUNCT ECOL, V21, P1115, DOI 10.1111/j.1365-2435.2007.01311.x; French SS, 2009, INTEGR COMP BIOL, V49, P246, DOI 10.1093/icb/icp032; Gilbert JDJ, 2010, AM NAT, V176, P212, DOI 10.1086/653661; Gnaspini P, 1996, J ZOOL, V239, P417, DOI 10.1111/j.1469-7998.1996.tb05933.x; Gnaspini Pedro, 2007, P455; Harshman LG, 2007, TRENDS ECOL EVOL, V22, P80, DOI 10.1016/j.tree.2006.10.008; HARVELL CD, 1986, AM NAT, V128, P810, DOI 10.1086/284607; Helfman G.S., 1990, Advances in the Study of Behavior, V19, P249, DOI 10.1016/S0065-3454(08)60205-3; Higginson AD, 2011, J ANIM ECOL, V80, P384, DOI 10.1111/j.1365-2656.2010.01786.x; HILL CS, 1985, J CHEM ECOL, V11, P1083, DOI 10.1007/BF01020677; Ivanisevic J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028059; Knowles SCL, 2009, FUNCT ECOL, V23, P405, DOI 10.1111/j.1365-2435.2008.01507.x; Kreiter N, 1996, J ARACHNOL, V24, P24; Kreiter NA, 2001, OECOLOGIA, V127, P417, DOI 10.1007/s004420000607; Machado G, 2000, J NAT HIST, V34, P587, DOI 10.1080/002229300299453; Machado G, 2005, J CHEM ECOL, V31, P2519, DOI 10.1007/s10886-005-7611-0; Machado G, 1998, J ZOOL, V246, P359, DOI 10.1111/j.1469-7998.1998.tb00166.x; Machado Glauco, 2007, P414; MAGNHAGEN C, 1991, TRENDS ECOL EVOL, V6, P183, DOI 10.1016/0169-5347(91)90210-O; MCCAULEY DE, 1986, AM NAT, V127, P112, DOI 10.1086/284472; MEINWALD J, 1966, SCIENCE, V151, P79, DOI 10.1126/science.151.3706.79; Moreno-Garcia M, 2013, B ENTOMOL RES, V103, P127, DOI 10.1017/S000748531200048X; Morgan ED, 2004, BIOSYNTHESIS INSECTS; Morrongiello JR, 2012, J ANIM ECOL, V81, P806, DOI 10.1111/j.1365-2656.2012.01961.x; Neilson EH, 2013, TRENDS PLANT SCI, V18, P250, DOI 10.1016/j.tplants.2013.01.001; Pankewitz F, 2008, BIOL REV, V83, P209, DOI 10.1111/j.1469-185X.2008.00040.x; Polis GA, 1998, ECOLOGY, V79, P2560, DOI 10.1890/0012-9658(1998)079[2560:PAAMCO]2.0.CO;2; Bascunan-Garcia AP, 2010, J INSECT PHYSIOL, V56, P204, DOI 10.1016/j.jinsphys.2009.10.005; Requena GS, 2015, OIKOS, V124, P372, DOI 10.1111/oik.01641; Requena GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046701; Rocha DFO, 2013, MOLECULES, V18, P11429, DOI 10.3390/molecules180911429; Roff Derek, 2002, pi; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Smiseth PT, 2012, EVOLUTION OF PARENTAL CARE, P1; Stahlschmidt ZR, 2013, FUNCT ECOL, V27, P800, DOI 10.1111/1365-2435.12071; Stamp N, 2003, Q REV BIOL, V78, P23, DOI 10.1086/367580; Stearns S.C., 1992, pi; Tomaino-Gomes GA, 2008, THESIS U ESTADUAL CA; Trougakos LP, 2002, CHEMOECOLOGY OF INSECT EGGS AND EGG DEPOSITION, P3; Williams TD, 2005, BIOSCIENCE, V55, P39, DOI 10.1641/0006-3568(2005)055[0039:MUTCOE]2.0.CO;2; WILLIAMS TD, 1994, BIOL REV, V69, P35, DOI 10.1111/j.1469-185X.1994.tb01485.x	53	11	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0134908	10.1371/journal.pone.0134908	http://dx.doi.org/10.1371/journal.pone.0134908			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331946	Green Submitted, Green Published, gold			2022-12-26	WOS:000360613800015
J	Sevane, N; Canon, J; Gil, I; Dunner, S				Sevane, Natalia; Canon, Javier; Gil, Ignacio; Dunner, Susana			Transcriptomic Characterization of Innate and Acquired Immune Responses in Red-Legged Partridges (Alectoris rufa): A Resource for Immunoecology and Robustness Selection	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DISEASE RESISTANCE; ANTIBODY-RESPONSE; VIRUS; MODEL; WILD; DIFFERENTIATION; RESPONSIVENESS; ORGANIZATION; EXPRESSION	Present and future challenges for wild partridge populations include the resistance against possible disease transmission after restocking with captive-reared individuals, and the need to cope with the stress prompted by new dynamic and challenging scenarios. Selection of individuals with the best immune ability may be a good strategy to improve general immunity, and hence adaptation to stress. In this study, non-infectious challenges with phytohemagglutinin (PHA) and sheep red blood cells allowed the classification of red-legged partridges (Alectoris rufa) according to their overall immune responses (IR). Skin from the area of injection of PHA and spleen, both from animals showing extreme high and low IR, were selected to investigate the transcriptional profiles underlying the different ability to cope with pathogens and external aggressions. RNA-seq yielded 97 million raw reads from eight sequencing libraries and approximately 84% of the processed reads were mapped to the reference chicken genome. Differential expression analysis identified 1488 up- and 107 down-regulated loci in individuals with high IR versus low IR. Partridges displaying higher innate IR show an enhanced activation of host defence gene pathways complemented with a tightly controlled desensitization that facilitates the return to cellular homeostasis. These findings indicate that the immune system ability to respond to aggressions (either diseases or stress produced by environmental changes) involves extensive transcriptional and post-transcriptional regulations, and expand our understanding on the molecular mechanisms of the avian immune system, opening the possibility of improving disease resistance or robustness using genome assisted selection (GAS) approaches for increased IR in partridges by using genes such as AVN or BF2 as markers. This study provides the first transcriptome sequencing data of the Alectoris genus, a resource for molecular ecology that enables integration of genomic tools in further studies.	[Sevane, Natalia; Canon, Javier; Gil, Ignacio; Dunner, Susana] Univ Complutense, Fac Vet, Dept Prod Anim, E-28040 Madrid, Spain	Complutense University of Madrid	Sevane, N (corresponding author), Univ Complutense, Fac Vet, Dept Prod Anim, E-28040 Madrid, Spain.	nsevane@ucm.es	Cañón, Javier/M-5704-2018; Sevane, Natalia/R-1920-2018; Dunner, Susana/H-3124-2015	Cañón, Javier/0000-0003-1137-0958; Sevane, Natalia/0000-0003-4766-6291; 	Centre for Industrial Technological Development (CDTI) [IDI-2011-0754]; European Social Fund [PTQ-11-04753]	Centre for Industrial Technological Development (CDTI); European Social Fund(European Social Fund (ESF))	This project was founded by the Centre for Industrial Technological Development (CDTI) (IDI-2011-0754). NS is recipient of an INNCORPORA-Torres Quevedo contract (PTQ-11-04753) funded by the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaansen-Tennekes R, 2009, POULTRY SCI, V88, P1879, DOI 10.3382/ps.2009-00150; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2009417 SEC EUR COMM; Apostolova MD, 2002, J BIOL CHEM, V277, P34471, DOI 10.1074/jbc.M205827200; BirdLife International. Alectoris rufa, AL RUF IUCN RED LIST; Biscarini F, 2010, ANIM GENET, V41, P26, DOI 10.1111/j.1365-2052.2009.01960.x; Bonneaud C, 2011, P NATL ACAD SCI USA, V108, P7899, DOI 10.1073/pnas.1018580108; Bovenhuis H, 2002, POULTRY SCI, V81, P309, DOI 10.1093/ps/81.3.309; Brodeur JF, 2009, J IMMUNOL, V182, P4844, DOI 10.4049/jimmunol.0803679; Bronte V, 2013, IMMUNITY, V39, P806, DOI 10.1016/j.immuni.2013.10.010; Chazara O, 2011, MOL IMMUNOL, V48, P1263, DOI 10.1016/j.molimm.2011.03.009; Cogliani C, 2011, MICROBE, V6, P274, DOI DOI 10.1128/MICROBE.6.274.1; Cotter PF, 2005, POULTRY SCI, V84, P220, DOI 10.1093/ps/84.2.220; D'Souza SJA, 2002, J BIOL CHEM, V277, P10626, DOI 10.1074/jbc.M111956200; Davison F, 2008, AVIAN IMMUNOLOGY, P1; Fang ZH, 2006, HISTOL HISTOPATHOL, V21, P403, DOI 10.14670/HH-21.403; Garaud S, 2008, J IMMUNOL, V181, P2010, DOI 10.4049/jimmunol.181.3.2010; Goff L.A., 2012, R PACKAGE VERSION 2; Grasman KA, 2010, METHODS MOL BIOL, V598, P387, DOI 10.1007/978-1-60761-401-2_25; Haertel E, 2014, SEMIN IMMUNOL, V26, P321, DOI 10.1016/j.smim.2014.01.005; Hangalapura BN, 2004, POULTRY SCI, V83, P765, DOI 10.1093/ps/83.5.765; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kaiser P, 2008, DEV BIOLOGICALS, V132, P57, DOI 10.1159/000317144; Kaiser P, 2010, AVIAN PATHOL, V39, P309, DOI 10.1080/03079457.2010.508777; Kaufman J, 2008, AVIAN IMMUNOLOGY, P159, DOI 10.1016/B978-012370634-8.50011-1; Kaufman J, 2013, MOL IMMUNOL, V55, P159, DOI 10.1016/j.molimm.2012.10.030; Keestra AM, 2010, J IMMUNOL, V185, P460, DOI 10.4049/jimmunol.0901921; Kondo T, 2012, BIOCHEM BIOPH RES CO, V422, P501, DOI 10.1016/j.bbrc.2012.05.028; KUNNAS TA, 1992, ENDOCRINOLOGY, V130, P3421, DOI 10.1210/en.130.6.3421; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lei W, 2014, J THORAC DIS, V6, P979, DOI 10.3978/j.issn.2072-1439.2014.06.34; Li GC, 2003, DEV CELL, V4, P865, DOI 10.1016/S1534-5807(03)00159-X; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Libri V, 2008, J IMMUNOL, V181, P5847, DOI 10.4049/jimmunol.181.9.5847; Lu JV, 2014, SEMIN CELL DEV BIOL, V35, P33, DOI 10.1016/j.semcdb.2014.07.003; Luo CL, 2014, INFECT GENET EVOL, V21, P351, DOI 10.1016/j.meegid.2013.12.004; Luo J, 2014, POULTRY SCI, V93, P848, DOI 10.3382/ps.2013-03624; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; McEwen BS, 2010, ANN NY ACAD SCI, V1186, P190, DOI 10.1111/j.1749-6632.2009.05331.x; Meitern R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-533; Millan J, 2004, J WILDLIFE MANAGE, V68, P701, DOI 10.2193/0022-541X(2004)068[0701:ACOTHF]2.0.CO;2; Millan J., 2009, Wildlife Biology in Practice, V5, P70; Ontiveros D, 2000, BIOL CONSERV, V93, P19, DOI 10.1016/S0006-3207(99)00117-2; Owen JP, 2008, IMMUNOGENETICS, V60, P621, DOI 10.1007/s00251-008-0314-2; Patterson H, 2014, CLIN EXP IMMUNOL, V176, P1, DOI 10.1111/cei.12248; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; RANE SG, 1994, ONCOGENE, V9, P2415; *SAS I INC, 2009, STAT AN SAS STAT SOF; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; SCHUURS AHWM, 1990, J STEROID BIOCHEM, V35, P157, DOI 10.1016/0022-4731(90)90270-3; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sild E, 2011, BRAIN BEHAV IMMUN, V25, P1349, DOI 10.1016/j.bbi.2011.03.020; Smith J, 2015, J VIROL, V89, P2469, DOI 10.1128/JVI.02828-14; Starnes T, 2006, EXP HEMATOL, V34, P1101, DOI 10.1016/j.exphem.2006.05.015; Stockhammer OW, 2009, J IMMUNOL, V182, P5641, DOI 10.4049/jimmunol.0900082; Strbo N, 2014, ADV WOUND CARE, V3, P492, DOI 10.1089/wound.2012.0435; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Traver D, 2003, ADV IMMUNOL, V81, P253; Villanua D, 2007, J HELMINTHOL, V81, P101, DOI 10.1017/S0022149X07251211; Villanua D, 2008, EUR J WILDLIFE RES, V54, P199, DOI 10.1007/s10344-007-0130-2; Walker BA, 2011, P NATL ACAD SCI USA, V108, P8396, DOI 10.1073/pnas.1019496108; Wang WH, 2015, J APPL GENET, V56, P365, DOI 10.1007/s13353-014-0269-y; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Webster LMI, 2011, MOL ECOL, V20, P920, DOI 10.1111/j.1365-294X.2010.04906.x; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wolf M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00213	69	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136776	10.1371/journal.pone.0136776	http://dx.doi.org/10.1371/journal.pone.0136776			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331304	gold, Green Published			2022-12-26	WOS:000360613800070
J	Bischof, J; Muller, S; Borufka, L; Asghari, F; Moller, S; Holzhuter, SA; Nizze, H; Ibrahim, SM; Jaster, R				Bischof, Julia; Mueller, Sarah; Borufka, Luise; Asghari, Farahnaz; Moeller, Steffen; Holzhueter, Stephanie-Anna; Nizze, Horst; Ibrahim, Saleh M.; Jaster, Robert			Quantitative Trait Locus Analysis Implicates CD4(+)/CD44(high) Memory T Cells in the Pathogenesis of Murine Autoimmune Pancreatitis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DIAGNOSTIC-CRITERIA; JAPANESE POPULATION; MRL/MP-MOUSE; SUSCEPTIBILITY; INFLAMMATION; RISK; GENE; IDENTIFICATION; POLYMORPHISMS	The mouse strain MRL/MpJ is prone to spontaneously develop autoimmune pancreatitis (AIP). To elucidate the genetic control towards the development of the phenotype and to characterize contributions of immunocompetent cell types, MRL/MpJ mice were interbred with three additional strains (BXD2/TYJ, NZM2410/J, CAST/EIJ) for four generations in an advanced intercross line. Cellular phenotypes were determined by flow cytometric quantification of splenic leukocytes and complemented by the histopathological evaluation of pancreatic lesions. An Illumina SNP array was used for genotyping. QTL analyses were performed with the R implementation of HAPPY. Out of 41 leukocyte subpopulations (B cells, T cells and dendritic cells), only three were significantly associated with AIP: While CD4(+)/CD44(high) memory T cells and CD4(+)/CD69(+) T helper (Th) cells correlated positively with the disease, the cytotoxic T cell phenotype CD8(+)/CD44(low) showed a negative correlation. A QTL for AIP on chromosome 2 overlapped with QTLs for CD4(+)/CD44(high) and CD8(+)/CD44(high) memory T cells, FoxP3(+)/CD4(+) and FoxP3(+)/CD8(+) regulatory T cells (Tregs), and CD8(+)/CD69(+) cytotoxic T cells. On chromosome 6, overlapping QTLs for AIP and CD4(+)/IL17(+) Th17 cells and again FoxP3(+)/CD8(+) Tregs were observed. In conclusion, CD4(+)/CD44(high) memory T cells are the only leukocyte subtype that could be linked to AIP both by correlation studies and from observed overlapping QTL. The potential role of this cell type in the pathogenesis of AIP warrants further investigations.	[Bischof, Julia; Asghari, Farahnaz; Moeller, Steffen; Ibrahim, Saleh M.] Med Univ Lubeck, Dept Dermatol, D-23562 Lubeck, Germany; [Mueller, Sarah; Borufka, Luise; Asghari, Farahnaz; Jaster, Robert] Univ Rostock, Med Ctr, Div Gastroenterol, Dept Med 2, D-18057 Rostock, Germany; [Holzhueter, Stephanie-Anna; Nizze, Horst] Univ Rostock, Med Ctr, Inst Pathol, D-18057 Rostock, Germany	University of Lubeck; University of Rostock; University of Rostock	Jaster, R (corresponding author), Univ Rostock, Med Ctr, Div Gastroenterol, Dept Med 2, E Heydemann Str 6, D-18057 Rostock, Germany.	jaster@med.uni-rostock.de	Möller, Steffen/B-5368-2013; Ibrahim, Saleh/AAO-9541-2020	Möller, Steffen/0000-0002-7187-4683; Ibrahim, Saleh/0000-0001-7827-2290; Bischof, Julia/0000-0002-6672-6571; Asghari, Farahnaz/0000-0003-3847-5514	Deutsche Forschungsgemeinschaft (DFG), Bonn, Germany [DFG EXC306/1, IB 24/9-1, JA 819/5-1]	Deutsche Forschungsgemeinschaft (DFG), Bonn, Germany(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (DFG; http://www.dfg.de/en/index.jsp), 53170 Bonn, Germany; grants DFG EXC306/1 and IB 24/9-1 to Saleh Ibrahim and JA 819/5-1 to Robert Jaster. The funder had no role in study design, data collection, analysis and interpretation, decision to publish, and preparation of the manuscript.	Aparisi L, 2005, GUT, V54, P703, DOI 10.1136/gut.2004.047142; Asghari F, 2011, J MED GENET, V48, P557, DOI 10.1136/jmg.2011.089730; Bang SY, 2010, ARTHRITIS RHEUM-US, V62, P369, DOI 10.1002/art.27272; Chang MC, 2007, CLIN CHEM, V53, P1700, DOI 10.1373/clinchem.2007.085951; Chang MC, 2014, J GASTROEN HEPATOL, V29, P2038, DOI 10.1111/jgh.12649; Devarajan P, 2013, IMMUNOL RES, V57, P12, DOI 10.1007/s12026-013-8448-1; Emmrich J, 2012, CURR PHARM DESIGN, V18, P4542, DOI 10.2174/138161212802502134; Fitzner B, 2009, PANCREATOLOGY, V9, P233, DOI 10.1159/000199434; Franke A, 2010, NAT GENET, V42, P292, DOI 10.1038/ng.553; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Hart PA, 2015, GASTROENTEROLOGY, V149, P39, DOI 10.1053/j.gastro.2015.03.010; Hart PA, 2013, GUT, V62, P1607, DOI 10.1136/gutjnl-2012-302886; KANNO H, 1992, CLIN EXP IMMUNOL, V89, P68; Kawa S, 2002, GASTROENTEROLOGY, V122, P1264, DOI 10.1053/gast.2002.33022; Kawakami N, 2005, J IMMUNOL, V175, P69, DOI 10.4049/jimmunol.175.1.69; Kloppel G, 2010, J GASTROENTEROL, V45, P787, DOI 10.1007/s00535-010-0265-x; Lohr JM, 2010, AM J GASTROENTEROL, V105, P2060, DOI 10.1038/ajg.2010.141; Ludwig RJ, 2012, J INVEST DERMATOL, V132, P1409, DOI 10.1038/jid.2011.466; Miyoshi H, 2008, PANCREAS, V36, P133, DOI 10.1097/MPA.0b013e3181577553; Moller S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S12-S5; Mott R, 2000, P NATL ACAD SCI USA, V97, P12649, DOI 10.1073/pnas.230304397; Naldi L, 2005, J INVEST DERMATOL, V125, P61, DOI 10.1111/j.0022-202X.2005.23681.x; Okada Y, 2014, LUPUS, V23, P1112, DOI 10.1177/0961203314536249; Okazaki K, 2000, GASTROENTEROLOGY, V118, P573, DOI 10.1016/S0016-5085(00)70264-2; Ota M, 2011, DIS MARKERS, V31, P223, DOI [10.3233/DMA-2011-0820, 10.1155/2011/264747]; Park DH, 2008, GASTROENTEROLOGY, V134, P440, DOI 10.1053/j.gastro.2007.11.023; Ranea LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075611; Sattler A, 2009, BLOOD, V113, P1948, DOI 10.1182/blood-2008-02-139147; Schwaiger T, 2014, GUT, V63, P494, DOI 10.1136/gutjnl-2012-303635; Shimosegawa T, 2011, PANCREAS, V40, P352, DOI 10.1097/MPA.0b013e3182142fd2; Sorg H, 2008, AM J PHYSIOL-GASTR L, V295, pG1274, DOI 10.1152/ajpgi.90341.2008; Umemura T, 2006, GUT, V55, P1367, DOI 10.1136/gut.2006.095059; Umemura T, 2008, AM J GASTROENTEROL, V103, P588, DOI 10.1111/j.1572-0241.2007.01750.x; Wahren-Herlenius M, 2013, LANCET, V382, P819, DOI 10.1016/S0140-6736(13)60954-X; Yamamoto M, 2005, RHEUMATOLOGY, V44, P227, DOI 10.1093/rheumatology/keh447; Zen Y, 2007, HEPATOLOGY, V45, P1538, DOI 10.1002/hep.21697; Zhang LZ, 2011, PANCREAS, V40, P1172, DOI 10.1097/MPA.0b013e318233bec5	37	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136298	10.1371/journal.pone.0136298	http://dx.doi.org/10.1371/journal.pone.0136298			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325540	Green Published, Green Submitted, gold			2022-12-26	WOS:000360437700037
J	Potas, JR; de Castro, NG; Maddess, T; de Souza, MN				Potas, Jason Robert; de Castro, Newton Goncalves; Maddess, Ted; de Souza, Marcio Nogueira			Waveform Similarity Analysis: A Simple Template Comparing Approach for Detecting and Quantifying Noisy Evoked Compound Action Potentials	PLOS ONE			English	Article							PERIPHERAL-NERVE REGENERATION; CAT; AXONS	Experimental electrophysiological assessment of evoked responses from regenerating nerves is challenging due to the typical complex response of events dispersed over various latencies and poor signal-to-noise ratio. Our objective was to automate the detection of compound action potential events and derive their latencies and magnitudes using a simple cross-correlation template comparison approach. For this, we developed an algorithm called Waveform Similarity Analysis. To test the algorithm, challenging signals were generated in vivo by stimulating sural and sciatic nerves, whilst recording evoked potentials at the sciatic nerve and tibialis anterior muscle, respectively, in animals recovering from sciatic nerve transection. Our template for the algorithm was generated based on responses evoked from the intact side. We also simulated noisy signals and examined the output of the Waveform Similarity Analysis algorithm with imperfect templates. Signals were detected and quantified using Waveform Similarity Analysis, which was compared to event detection, latency and magnitude measurements of the same signals performed by a trained observer, a process we called Trained Eye Analysis. The Waveform Similarity Analysis algorithm could successfully detect and quantify simple or complex responses from nerve and muscle compound action potentials of intact or regenerated nerves. Incorrectly specifying the template outperformed Trained Eye Analysis for predicting signal amplitude, but produced consistent latency errors for the simulated signals examined. Compared to the trained eye, Waveform Similarity Analysis is automatic, objective, does not rely on the observer to identify and/or measure peaks, and can detect small clustered events even when signal-to-noise ratio is poor. Waveform Similarity Analysis provides a simple, reliable and convenient approach to quantify latencies and magnitudes of complex waveforms and therefore serves as a useful tool for studying evoked compound action potentials in neural regeneration studies.	[Potas, Jason Robert; Maddess, Ted] Australian Natl Univ, John Curtin Sch Med Res, Dept Neurosci, Canberra, ACT 2601, Australia; [Potas, Jason Robert] Australian Natl Univ, Sch Med, Canberra, ACT, Australia; [Potas, Jason Robert; de Castro, Newton Goncalves] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, RJ, Brazil; [de Souza, Marcio Nogueira] Univ Fed Rio de Janeiro, COPPE, Biomed Engn Program, BR-21945 Rio De Janeiro, RJ, Brazil	Australian National University; John Curtin School of Medical Research; Australian National University; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Potas, JR (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Dept Neurosci, Canberra, ACT 2601, Australia.	jason.potas@anu.edu.au	Souza, Marcio N/I-3683-2012; Maddess, Teddy L/A-3200-2008; Castro, Newton/AGX-7014-2022; Potas, Jason/B-1327-2011; Souza, Marcio N/G-8547-2017; Castro, Newton G/C-3263-2009	Souza, Marcio N/0000-0001-9409-3786; Maddess, Teddy L/0000-0003-4591-3658; Castro, Newton/0000-0001-9570-7428; Potas, Jason/0000-0002-1973-8211; Souza, Marcio N/0000-0001-9409-3786; Castro, Newton G/0000-0001-9570-7428	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	JP was supported with a postdoctoral fellowship from Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (http://www.faperj.br/) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdulGhani MA, 1996, J PHYSIOL-LONDON, V495, P113, DOI 10.1113/jphysiol.1996.sp021578; ARCHIBALD SJ, 1995, J NEUROSCI, V15, P4109; BAKER M, 1992, J PHYSIOL-LONDON, V451, P539, DOI 10.1113/jphysiol.1992.sp019178; Fugleholm K, 2000, J PERIPHER NERV SYST, V5, P82, DOI 10.1046/j.1529-8027.2000.00008.x; FUGLEHOLM K, 1994, J NEUROSCI, V14, P2659; Kim S, 2007, J NEUROSCI METH, V165, P165, DOI 10.1016/j.jneumeth.2007.05.033; Krarup C, 2004, MUSCLE NERVE, V29, P465, DOI 10.1002/mus.10524; Moldovan M, 2006, BRAIN, V129, P2471, DOI 10.1093/brain/awl184; Sorensen J, 2001, BRAIN RES, V903, P185, DOI 10.1016/S0006-8993(01)02441-6; Vleggeert-Lankamp CLAM, 2007, J NEUROSURG, V107, P1168, DOI 10.3171/JNS-07/12/1168; Walbeehm ET, 2003, J PERIPHER NERV SYST, V8, P108, DOI 10.1046/j.1529-8027.2003.03014.x; Yadav R, 2011, IEEE ENG MED BIO, P7545, DOI 10.1109/IEMBS.2011.6091860; Zhang PM, 2004, J NEUROSCI METH, V135, P55, DOI 10.1016/j.jneumeth.2003.12.001	13	2	2	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136992	10.1371/journal.pone.0136992	http://dx.doi.org/10.1371/journal.pone.0136992			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325291	Green Submitted, gold, Green Published			2022-12-26	WOS:000360437700079
J	Tarczewska, A; Kozlowska, M; Dobryszycki, P; Kaus-Drobek, M; Dadlez, M; Ozyhar, A				Tarczewska, Aneta; Kozlowska, Malgorzata; Dobryszycki, Piotr; Kaus-Drobek, Magdalena; Dadlez, Michal; Ozyhar, Andrzej			Insight into the Unfolding Properties of Chd64, a Small, Single Domain Protein with a Globular Core and Disordered Tails	PLOS ONE			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; MOLTEN-GLOBULE; ACTIN-BINDING; CH DOMAINS; STATES; CALPONIN	Two major lipophilic hormones, 20-hydroxyecdysone (20E) and juvenile hormone (JH), govern insect development and growth. While the mode of action of 20E is well understood, some understanding of JH-dependent signalling has been attained only in the past few years, and the crosstalk of the two hormonal pathways remains unknown. Two proteins, the calponin-like Chd64 and immunophilin FKBP39 proteins, have recently been found to play pivotal roles in the formation of dynamic, multiprotein complex that cross-links these two signalling pathways. However, the molecular mechanism of the interaction remains unexplored. The aim of this work was to determine structural elements of Chd64 to provide an understanding of molecular basis of multiple interactions. We analysed Chd64 in two unrelated insect species, Drosophila melanogaster (DmChd64) and Tribolium castaneum (TcChd64). Using hydrogen-deuterium exchange mass spectrometry (HDX-MS), we showed that both Chd64 proteins have disordered tails that outflank the globular core. The folds of the globular cores of both Chd64 resemble the calponin homology (CH) domain previously resolved by crystallography. Monitoring the unfolding of DmChd64 and TcChd64 by far-ultraviolet (UV) circular dichroism (CD) spectroscopy, fluorescence spectroscopy and size-exclusion chromatography (SEC) revealed a highly complex process. Chd64 unfolds and forms of a molten globule (MG)-like intermediate state. Furthermore, our data indicate that in some conditions, Chd64 may exists in discrete structural forms, indicating that the protein is pliable and capable of easily acquiring different conformations. The plasticity of Chd64 and the existence of terminal intrinsically disordered regions (IDRs) may be crucial for multiple interactions with many partners.	[Tarczewska, Aneta; Kozlowska, Malgorzata; Dobryszycki, Piotr; Ozyhar, Andrzej] Wroclaw Univ Technol, Dept Biochem, Fac Chem, PL-50370 Wroclaw, Poland; [Kaus-Drobek, Magdalena; Dadlez, Michal] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland	Wroclaw University of Science & Technology; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Ozyhar, A (corresponding author), Wroclaw Univ Technol, Dept Biochem, Fac Chem, Wybrzeze Wyspianskiego 27, PL-50370 Wroclaw, Poland.	andrzej.ozyhar@pwr.edu.pl		OZYHAR, Andrzej/0000-0002-5874-784X; Dadlez, Michal/0000-0001-8811-5176; Kaus-Drobek, Magdalena/0000-0001-6202-4567	National Science Centre grant [2012/05/B/NZ1/00659]	National Science Centre grant(National Science Centre, Poland)	The work was supported by the National Science Centre grant (2012/05/B/NZ1/00659). The publication fee was covered by Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews P, 1970, Methods Biochem Anal, V18, P1, DOI 10.1002/9780470110362.ch1; Banuelos S, 1998, STRUCTURE, V6, P1419, DOI 10.1016/S0969-2126(98)00141-5; Begg GE, 2001, CURR PROTOC PROTEIN; Chalmers Michael J, 2007, J Biomol Tech, V18, P194; Chouard T, 2011, NATURE, V471, P151, DOI 10.1038/471151a; DEHAEN C, 1987, ANAL BIOCHEM, V166, P235, DOI 10.1016/0003-2697(87)90570-7; DeLano WL, 2002, PYMOL USERS MANUAL; Dobryszycki P, 1999, BBA-PROTEIN STRUCT M, V1431, P338, DOI 10.1016/S0167-4838(99)00055-2; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Gimona M, 2002, FEBS LETT, V513, P98, DOI 10.1016/S0014-5793(01)03240-9; Gimona M, 1998, J CELL SCI, V111, P1813; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Kozlowska M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096809; Li YP, 2007, J BIOL CHEM, V282, P37605, DOI 10.1074/jbc.M704595200; OHGUSHI M, 1983, FEBS LETT, V164, P21, DOI 10.1016/0014-5793(83)80010-6; Oldfield CJ, 2014, ANNU REV BIOCHEM, V83, P553, DOI 10.1146/annurev-biochem-072711-164947; Privalov P L, 1979, Adv Protein Chem, V33, P167, DOI 10.1016/S0065-3233(08)60460-X; Riddiford L M, 2000, Vitam Horm, V60, P1, DOI 10.1016/S0083-6729(00)60016-X; Riddiford LM, 2008, J INSECT PHYSIOL, V54, P895, DOI 10.1016/j.jinsphys.2008.01.014; Sitkiewicz E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076353; Stradal T, 1998, FEBS LETT, V431, P134, DOI 10.1016/S0014-5793(98)00751-0; Tanford C, 1968, Adv Protein Chem, V23, P121, DOI 10.1016/S0065-3233(08)60401-5; Tcherkasskaya O, 2001, PROTEINS, V44, P244, DOI 10.1002/prot.1089; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Uversky VN, 2013, FEBS LETT, V587, P1891, DOI 10.1016/j.febslet.2013.04.042; Uversky Vladimir N, 2012, Methods Mol Biol, V896, P179, DOI 10.1007/978-1-4614-3704-8_11; UVERSKY VN, 1993, BIOCHEMISTRY-US, V32, P13288, DOI 10.1021/bi00211a042; UVERSKY VN, 1994, BIOCHEMISTRY-US, V33, P2782, DOI 10.1021/bi00176a006; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Uversky VN, 1996, FOLD DES, V1, P117, DOI 10.1016/S1359-0278(96)00020-X; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	31	5	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137074	10.1371/journal.pone.0137074	http://dx.doi.org/10.1371/journal.pone.0137074			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325194	Green Submitted, Green Published, gold			2022-12-26	WOS:000360437700089
J	Alba, P; Feltrin, F; Cordaro, G; Porrero, MC; Kraushaar, B; Argudin, MA; Nykasenoja, S; Monaco, M; Stegger, M; Aarestrup, FM; Butaye, P; Franco, A; Battisti, A				Alba, Patricia; Feltrin, Fabiola; Cordaro, Gessica; Concepcion Porrero, Maria; Kraushaar, Britta; Argudin, Maria Angeles; Nykasenoja, Suvi; Monaco, Monica; Stegger, Marc; Aarestrup, Frank M.; Butaye, Patrick; Franco, Alessia; Battisti, Antonio			Livestock-Associated Methicillin Resistant and Methicillin Susceptible Staphylococcus aureus Sequence Type (CC)1 in European Farmed Animals: High Genetic Relatedness of Isolates from Italian Cattle Herds and Humans	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; MULTIPLEX PCR ASSAY; LONG-TERM; MRSA; IDENTIFICATION; PREVALENCE; DATABASE; STRAINS; REGION; MECA	Methicillin-resistant Staphylococcus aureus (MRSA) Sequence Type (ST)1, Clonal Complex( CC) 1, SCCmec V is one of the major Livestock-Associated (LA-) lineages in pig farming industry in Italy and is associated with pigs in other European countries. Recently, it has been increasingly detected in Italian dairy cattle herds. The aim of this study was to analyse the differences between ST1 MRSA and methicillin-susceptible S. aureus (MSSA) from cattle and pig herds in Italy and Europe and human isolates. Sixty-tree animal isolates from different holdings and 20 human isolates were characterized by pulsed-field gel electrophoresis (PFGE), spa-typing, SCCmec typing, and by micro-array analysis for several virulence, antimicrobial resistance, and strain/host-specific marker genes. Three major PFGE clusters were detected. The bovine isolates shared a high (>= 90% to 100%) similarity with human isolates and carried the same SCCmec type IVa. They often showed genetic features typical of human adaptation or present in human-associated CC1: Immune evasion cluster (IEC) genes sak and scn, or sea; sat and aphA3-mediated aminoglycoside resistance. Contrary, typical markers of porcine origin in Italy and Spain, like erm(A) mediated macrolide-lincosamide-streptograminB, and of vga(A)-mediated pleuromutilin resistance were always absent in human and bovine isolates. Most of ST(CC) 1 MRSA from dairy cattle were multidrug-resistant and contained virulence and immunomodulatory genes associated with full capability of colonizing humans. As such, these strains may represent a greater human hazard than the porcine strains. The zoonotic capacity of CC1 LA-MRSA from livestock must be taken seriously and measures should be implemented at farm-level to prevent spill-over.	[Alba, Patricia; Feltrin, Fabiola; Cordaro, Gessica; Franco, Alessia; Battisti, Antonio] Ist Zooprofilatt Sperimentale Lazio & Toscana M A, Diagnost Dept, Rome, Italy; [Concepcion Porrero, Maria] Univ Complutense Madrid, VISAVET Hlth Surveillance Ctr, Madrid, Spain; [Kraushaar, Britta] BfR Fed Inst Risk Assessment, Berlin, Germany; [Argudin, Maria Angeles; Butaye, Patrick] Vet & Agrochem Res Ctr VAR CODA CERVA, Groeselenberg, Belgium; [Nykasenoja, Suvi] Finnish Food Safety Author Evira, Helsinki, Finland; [Monaco, Monica] Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, I-00161 Rome, Italy; [Stegger, Marc] Statens Serum Inst, Dept Microbiol & Infect Control, DK-2300 Copenhagen, Denmark; [Aarestrup, Frank M.] Tech Univ Denmark, Natl Food Inst, DK-2800 Lyngby, Denmark; [Butaye, Patrick] Ross Univ, Sch Vet Med, Dept Biosci, Basseterre, St Kitts & Nevi; [Franco, Alessia] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Poultry Dis, Merelbeke, Belgium; [Argudin, Maria Angeles] Univ Libre Bruxelles, Dept Microbiol, Hop Erasme Labo Reference MRSA Staphylocoques, Brussels, Belgium	IZS Lazio e Toscana; Complutense University of Madrid; Federal Institute for Risk Assessment; Finnish Food Authority; Istituto Superiore di Sanita (ISS); Statens Serum Institut; Technical University of Denmark; Ghent University; Universite Libre de Bruxelles	Battisti, A (corresponding author), Ist Zooprofilatt Sperimentale Lazio & Toscana M A, Diagnost Dept, Rome, Italy.	antonio.battisti@izslt.it	Monaco, Monica/AAC-9666-2021; Butaye, Patrick/AAJ-8240-2020; MONACO, MONICA/C-8819-2016; studies, IT VISAVET Account for bibliometric/C-3115-2014; Alba, Patricia/T-3593-2018; Battisti, Antonio/AAQ-9243-2021; Argudin Regueiro, Maria Angeles/A-9684-2012	Monaco, Monica/0000-0002-6628-1621; MONACO, MONICA/0000-0002-6628-1621; studies, IT VISAVET Account for bibliometric/0000-0003-3319-0050; Alba, Patricia/0000-0002-9621-0955; Battisti, Antonio/0000-0003-1308-199X; Franco, Alessia/0000-0001-6968-973X; Aarestrup, Frank/0000-0002-7116-2723; Argudin Regueiro, Maria Angeles/0000-0003-4026-6447; Stegger, Marc/0000-0003-0321-1180; Butaye, Patrick/0000-0003-0780-6384	EMIDA ERA-NET (FP7-KBBE) European Union first transnational research call, Project "LA-MRSA" [68]	EMIDA ERA-NET (FP7-KBBE) European Union first transnational research call, Project "LA-MRSA"	Funded by EMIDA ERA-NET (FP7-KBBE) European Union first transnational research call, Project "LA-MRSA" (acronym title), ID 68.	Argudin MA, 2011, J MED MICROBIOL, V60, P172, DOI 10.1099/jmm.0.021758-0; Baron F, 2004, J FOOD PROTECT, V67, P2302, DOI 10.4315/0362-028X-67.10.2302; Battisti A, 2010, VET MICROBIOL, V142, P361, DOI 10.1016/j.vetmic.2009.10.008; Cortimiglia C, 2015, J DAIRY SCI, V98, P2307, DOI 10.3168/jds.2014-8923; Derbise A, 1996, PLASMID, V35, P174, DOI 10.1006/plas.1996.0020; Deurenberg RH, 2009, EMERG INFECT DIS, V15, P727, DOI 10.3201/eid1505.071618; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; European Medicines Agency, 2014, EMA3339212014; Franco A, 2011, J ANTIMICROB CHEMOTH, V66, P1231, DOI 10.1093/jac/dkr115; Gentry DR, 2008, ANTIMICROB AGENTS CH, V52, P4507, DOI 10.1128/AAC.00915-08; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Juhasz-Kaszanyitzky E, 2007, EMERG INFECT DIS, V13, P630, DOI 10.3201/eid1304.060833; Katayama Y, 2001, ANTIMICROB AGENTS CH, V45, P1955, DOI 10.1128/AAC.45.7.1955-1963.2001; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Larsen AR, 2009, J CLIN MICROBIOL, V47, P73, DOI 10.1128/JCM.01557-08; Luini M, 2015, VET MICROBIOL, V178, P270, DOI 10.1016/j.vetmic.2015.05.010; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Merialdi G, 2013, RES VET SCI, V94, P425, DOI 10.1016/j.rvsc.2012.10.020; Monaco M, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-258; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Mulvey MR, 2001, J CLIN MICROBIOL, V39, P3481, DOI 10.1128/JCM.39.10.3481-3485.2001; Murchan S, 2003, J CLIN MICROBIOL, V41, P1574, DOI 10.1128/JCM.41.4.1574-1585.2003; Otter JA, 2009, EUR J CLIN MICROBIOL, V28, P835, DOI 10.1007/s10096-008-0698-9; Pilla R, 2012, VET REC, V170, DOI 10.1136/vr.100510; Shin CK, 1996, J MICROBIOL BIOTECHN, V6, P219; Stegger M, 2012, CLIN MICROBIOL INFEC, V18, P395, DOI 10.1111/j.1469-0691.2011.03715.x; Strommenger B, 2003, J CLIN MICROBIOL, V41, P4089, DOI 10.1128/JCM.41.9.4089-4094.2003; SU YC, 1995, APPL ENVIRON MICROB, V61, P1438, DOI 10.1128/AEM.61.4.1438-1443.1995; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Vignaroli C, 2009, EMERG INFECT DIS, V15, P995, DOI 10.3201/eid1506.081632; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005	32	76	78	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0137143	10.1371/journal.pone.0137143	http://dx.doi.org/10.1371/journal.pone.0137143			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322785	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000360435500067
J	Karstens, S; Joos, S; Hill, JC; Krug, K; Szecsenyi, J; Steinhauser, J				Karstens, Sven; Joos, Stefanie; Hill, Jonathan C.; Krug, Katja; Szecsenyi, Joachim; Steinhaeuser, Jost			General Practitioners Views of Implementing a Stratified Treatment Approach for Low Back Pain in Germany: A Qualitative Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; HEALTH-CARE-SYSTEM; IMPACT BACK; START BACK; INTERVENTION; MANAGEMENT; THERAPY	Background and Objective The STarT Back stratified primary care approach has demonstrated clinical and cost effectiveness in the UK, and is commonly used by General Practitioners (GPs). However, it remains unknown how this approach could be implemented into the German healthcare system. The aim of this study was therefore to explore the views and perceptions of German GPs in respect to using a stratified primary care for low back pain (LBP). Methods A 90-minute think-tank workshop was conducted with 14 male and five female GPs, during which the STarT-Back-Screening-Tool (SBST) and related research evidence was presented. This was followed by two focus groups, based on a semi-structured interview guideline to identify potential implementation barriers and opportunities. Discussions were audiotaped, transcribed and coded using a content analysis approach. Results For the three deductively developed main themes, 15 subthemes emerged: (1) application of the SBST, with the following subthemes: which health profession should administer it, patients known to the GP practice, the reason for the GP consultation, scoring the tool, the tool format, and the anticipated impact on GP practice; (2) psychologically informed physiotherapy, with subthemes including: provision by a physiotherapist, anticipated impact, the skills of physiotherapists, management of patients with severe psychosocial problems, referral and remuneration; (3) the management of low-risk patients, with subthemes including: concern about the appropriate advising health professional, information and media, length of consultation, and local exercise venues. Conclusions The attitudes of GPs towards stratified primary care for LBP indicated positive support for pilot-testing in Germany. However, there were mixed reactions to the ability of German physiotherapists to manage high-risk patients and handle their complex clinical needs. GPs also mentioned practical difficulties in providing extended advice to low-risk patients, which nevertheless could be addressed by involvement of specifically trained medical assistants.	[Karstens, Sven; Joos, Stefanie; Krug, Katja; Szecsenyi, Joachim] Univ Heidelberg Hosp, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany; [Hill, Jonathan C.] Keele Univ, Inst Primary Care & Hlth Sci, Keele ST5 5BG, Staffs, England; [Steinhaeuser, Jost] Univ Hosp Schleswig Holstein, Inst Family Med, Lubeck, Germany	Ruprecht Karls University Heidelberg; Keele University; University of Kiel; Schleswig Holstein University Hospital	Karstens, S (corresponding author), Univ Heidelberg Hosp, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany.	sven.karstens@med.uni-heidelberg.de	Hill, Jonathan/AAT-2744-2020; Karstens, Sven/AAF-7211-2020; Krug, Katja/AAV-5840-2020	Karstens, Sven/0000-0001-7403-3452; Krug, Katja/0000-0002-9795-7954	young scientists programme of the German network 'Health Services Research Baden-Wurttemberg' of the Ministry of Science, Research and Arts; Ministry of Employment and Social Order, Family, Women and Senior Citizens, Baden-Wurttemberg; Deutsche Forschungsgemeinschaft (DFG); Ruprecht-Karls-Universitat Heidelberg	young scientists programme of the German network 'Health Services Research Baden-Wurttemberg' of the Ministry of Science, Research and Arts; Ministry of Employment and Social Order, Family, Women and Senior Citizens, Baden-Wurttemberg; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg	The study was funded by the young scientists programme of the German network 'Health Services Research Baden-Wurttemberg' (http://www. versorgungsforschung-bw.de) of the Ministry of Science, Research and Arts in collaboration with the Ministry of Employment and Social Order, Family, Women and Senior Citizens, Baden-Wurttemberg. Study design and preliminary results were discussed at the young scientists academy. We acknowledge financial support by Deutsche Forschungsgemeinschaft (DFG) and Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing (http://www.ub.uni-heidelberg. de/service/openaccess/publikationsfonds.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balague F, 2012, LANCET, V379, P482, DOI 10.1016/S0140-6736(11)60610-7; Beaton DE, 2007, RECOMMENDATIONS CROS; Brunner E, 2013, DISABIL REHABIL, V35, P1, DOI 10.3109/09638288.2012.683848; Burton AK, 1999, SPINE, V24, P2484, DOI 10.1097/00007632-199912010-00010; Carlsen B, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-26; Chento J-F, 2014, VERSORGUNGS REPORT 2, P155; Foster NE, 2014, ANN FAM MED, V12, P102, DOI 10.1370/afm.1625; Foster NE, 2013, BEST PRACT RES CL RH, V27, P649, DOI 10.1016/j.berh.2013.10.005; Freund T, 2015, INT J NURSING STUDIE; Hauser W, 2007, SCHMERZ, V21, P539, DOI 10.1007/s00482-007-0553-4; Hill JC, 2008, ARTHRIT RHEUM-ARTHR, V59, P632, DOI 10.1002/art.23563; Hill JC, 2011, LANCET, V378, P1560, DOI 10.1016/S0140-6736(11)60937-9; Hsu C, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-276; Institute of Primary Care and Health Sciences KU, START BACK TRANSL; Institute of Primary Care and Health Sciences KU, START BACJ SB TOOL O; Jager C, 2014, Z EVIDENZ FORTBILD Q, V108, P270, DOI 10.1016/j.zefq.2013.08.014; Jensen IB, 2009, PAIN, V142, P202, DOI 10.1016/j.pain.2008.12.015; Karstens S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061587; Keele IT Services, KEEL START BACK SCRE; Koch K, 2011, DTSCH ARZTEBL INT, V108, P255, DOI 10.3238/arztebl.2011.0255; Koch K, 2010, DTSCH ARZTEBL INT, V107, P427, DOI 10.3238/arztebl.2010.0427; Korzilius H., 2011, DTSCH ARZTEBL INT, V108, P984; Krueger RA, 1998, FOCUS GROUP KIT, V1-6; Laux G., 2010, ERGEBNISSE CONTENT P, P2006; Mafi JN, 2013, JAMA INTERN MED, V173, P1573, DOI 10.1001/jamainternmed.2013.8992; Main CJ, 2012, PHYSIOTHERAPY, V98, P110, DOI 10.1016/j.physio.2011.03.003; Mayring P., 2000, FORUM QUALITATIVE SO, V1, P1, DOI [10.17169/fqs-1.2.1089, DOI 10.17169/FQS-22.2.3826]; NHMRC, 2003, NAT HLTH MED RES COU; Nielsen M, 2014, PHYS THER, V94, P197, DOI 10.2522/ptj.20130047; Onwuegbuzie A.J., 2009, INT J QUALITATIVE ME, V8, P1, DOI [10.1177/160940690900800301, DOI 10.1177/160940690900800301]; Sanders T, 2014, J HEALTH ORGAN MANAG, V28, P96, DOI 10.1108/JHOM-10-2011-0102; Sanders T, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-65; Sanders T, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-49; Schiltenwolf M, 2006, EUR SPINE J, V15, P1083, DOI 10.1007/s00586-005-0008-5; Schmidt CO, 2007, KLINIKARZT, V36, P680; Smeets RJEM, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-5; Sowden G, 2012, FAM PRACT, V29, P50, DOI 10.1093/fampra/cmr037; van Bokhoven MA, 2003, QUAL SAF HEALTH CARE, V12, P215, DOI 10.1136/qhc.12.3.215; van der Zee J, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-94; Wenig CM, 2009, EUR J PAIN, V13, P280, DOI 10.1016/j.ejpain.2008.04.005; Wensing M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101981	41	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136119	10.1371/journal.pone.0136119	http://dx.doi.org/10.1371/journal.pone.0136119			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322985	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000360435500016
J	Bufalino, A; Cervigne, NK; de Oliveira, CE; Fonseca, FP; Rodrigues, PC; Macedo, CCS; Sobral, LM; Miguel, MC; Lopes, MA; Leme, AFP; Lambert, DW; Salo, TA; Kowalski, LP; Graner, E; Coletta, RD				Bufalino, Andreia; Cervigne, Nilva K.; de Oliveira, Carine Ervolino; Fonseca, Felipe Paiva; Rodrigues, Priscila Campioni; Soares Macedo, Carolina Carneiro; Sobral, Lays Martin; Miguel, Marcia Costa; Lopes, Marcio Ajudarte; Paes Leme, Adriana Franco; Lambert, Daniel W.; Salo, Tuula A.; Kowalski, Luiz Paulo; Graner, Edgard; Coletta, Ricardo D.			Low miR-143/miR-145 Cluster Levels Induce Activin A Overexpression in Oral Squamous Cell Carcinomas, Which Contributes to Poor Prognosis	PLOS ONE			English	Article							PROSTATE-CANCER PROGRESSION; HUMAN BREAST; TGF-BETA; MESENCHYMAL TRANSITION; PROLIFERATION; EXPRESSION; GROWTH; METASTASIS; APOPTOSIS; INVASION	Deregulated expression of activin A is reported in several tumors, but its biological functions in oral squamous cell carcinoma (OSCC) are unknown. Here, we investigate whether activin A can play a causal role in OSCCs. Activin A expression was assessed by qPCR and immunohistochemistry in OSCC tissues. Low activin A-expressing cells were treated with recombinant activin A and assessed for apoptosis, proliferation, adhesion, migration, invasion and epithelial-mesenchymal transition (EMT). Those phenotypes were also evaluated in high activin A-expressing cells treated with follistatin (an activin A antagonist) or stably expressing shRNA targeting activin A. Transfections of microRNA mimics were performed to determine whether the overexpression of activin A is regulated by miR-143/miR-145 cluster. Activin A was overexpressed in OSCCs in comparison with normal oral mucosa, and high activin A levels were significantly associated with lymph node metastasis, tumor differentiation and poor survival. High activin A levels promoted multiple properties associated with malignant transformation, including decreased apoptosis and increased proliferation, migration, invasion and EMT. Both miR-143 and miR-145 were markedly downregulated in OSCC cell lines and in clinical specimens, and inversely correlated to activin A levels. Forced expression of miR-143 and miR-145 in OSCC cells significantly decreased the expression of activin A. Overexpression of activin A in OSCCs, which is controlled by downregulation of miR-143/miR-145 cluster, regulates apoptosis, proliferation and invasiveness, and it is clinically correlated with lymph node metastasis and poor survival.	[Bufalino, Andreia; Cervigne, Nilva K.; de Oliveira, Carine Ervolino; Fonseca, Felipe Paiva; Rodrigues, Priscila Campioni; Soares Macedo, Carolina Carneiro; Sobral, Lays Martin; Miguel, Marcia Costa; Lopes, Marcio Ajudarte; Salo, Tuula A.; Graner, Edgard; Coletta, Ricardo D.] Univ Estadual Campinas, Sch Dent, Dept Oral Diag, Piracicaba, SP, Brazil; [Miguel, Marcia Costa] Univ Fed Rio Grande do Norte, Dept Dent, BR-59072970 Natal, RN, Brazil; [Paes Leme, Adriana Franco] CNPEM, Brazilian Biociences Natl Lab, Campinas, SP, Brazil; [Lambert, Daniel W.] Univ Sheffield, Sch Clin Dent, Integrated Biosci, Sheffield, S Yorkshire, England; [Lambert, Daniel W.] Univ Sheffield, Sheffield Canc Ctr, Sheffield, S Yorkshire, England; [Salo, Tuula A.] Univ Oulu, Inst Dent, Dept Diagnost & Oral Med, Oulu, Finland; [Salo, Tuula A.] Univ Oulu, Oulu Univ Hosp, Oulu, Finland; [Salo, Tuula A.] Univ Oulu, Med Res Ctr, Oulu, Finland; [Salo, Tuula A.] Univ Helsinki, Inst Dent, Helsinki, Finland; [Kowalski, Luiz Paulo] AC Camargo Canc Ctr, Dept Head & Neck Surg & Otorhinolaryngol, Sao Paulo, SP, Brazil	Universidade Estadual de Campinas; Universidade Federal do Rio Grande do Norte; University of Sheffield; University of Sheffield; University of Oulu; University of Oulu; University of Oulu; University of Helsinki; A.C.Camargo Cancer Center	Coletta, RD (corresponding author), Univ Estadual Campinas, Sch Dent, Dept Oral Diag, Piracicaba, SP, Brazil.	coletta@fop.unicamp.br	, tuula/ABG-2051-2021; MIGUEL, MÁRCIA COSTA/C-4059-2014; Fonseca, Felipe P/C-4158-2012; Bufalino, Andreia/H-7047-2014; Lopes, Marcio Ajudarte/AAV-1018-2020; Cervigne, Nilva K/L-1341-2016; Leme, Adriana F Paes/C-9679-2012; Coletta, Ricardo D./B-4909-2015; Kowalski, Luiz P/D-1701-2012; de Oliveira, Carine Ervolino/I-3087-2013; Graner, Edgard/K-4411-2012; Sobral, Lays M/G-4831-2012; Graner, Edgard/P-4651-2019	Fonseca, Felipe P/0000-0002-6657-4547; Bufalino, Andreia/0000-0002-6714-6253; Cervigne, Nilva K/0000-0002-6129-9136; Leme, Adriana F Paes/0000-0001-7959-147X; Coletta, Ricardo D./0000-0001-5285-3046; Kowalski, Luiz P/0000-0002-0481-156X; Graner, Edgard/0000-0002-4737-7935; Sobral, Lays M/0000-0002-8731-850X; Salo, Tuula/0000-0001-6039-0088; Carneiro Soares Macedo, Carolina/0000-0002-9858-8206; Campioni Rodrigues, Priscila/0000-0003-2770-1248; Ajudarte Lopes, Marcio/0000-0001-6677-0065; Miguel, Marcia/0000-0002-6661-2566	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP, Sao Paulo, Brazil [2010/52547-1, 2011/00691-7, 2013/01607-6]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq, Brasilia, Brazil [302464/2011-5, 473825/2013-9]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES, Brasilia, Brazil [AUXPE-PVES-570/2013]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP, Sao Paulo, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq, Brasilia, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES, Brasilia, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP, Sao Paulo, Brazil (2010/52547-1, 2011/00691-7 and 2013/01607-6); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq, Brasilia, Brazil (302464/2011-5 and 473825/2013-9); and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES, Brasilia, Brazil (AUXPE-PVES-570/2013).	Agostini M, 2014, MOL CANCER THER, V13, P585, DOI 10.1158/1535-7163.MCT-12-1136; Alam H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-32; Antsiferova M, 2012, J CELL SCI, V125, P3929, DOI 10.1242/jcs.094789; Burdette JE, 2005, CANCER RES, V65, P7968, DOI 10.1158/0008-5472.CAN-04-3553; Chang KP, 2010, ANN SURG ONCOL, V17, P1945, DOI 10.1245/s10434-010-0926-2; Chen XQ, 2010, CANCER RES, V70, P2728, DOI 10.1158/0008-5472.CAN-09-3718; Chen YG, 2006, EXP BIOL MED, V231, P534; Cheng JC, 2014, BIOCHEM BIOPH RES CO, V443, P537, DOI 10.1016/j.bbrc.2013.12.010; Chiyomaru T, 2010, BRIT J CANCER, V102, P883, DOI 10.1038/sj.bjc.6605570; Deli A, 2008, WORLD J GASTROENTERO, V14, P1699, DOI 10.3748/wjg.14.1699; Drebber U, 2011, INT J ONCOL, V39, P409, DOI 10.3892/ijo.2011.1036; Ferreira MC, 2008, MOL HUM REPROD, V14, P301, DOI 10.1093/molehr/gan016; Gold E, 2012, MOL CELL ENDOCRINOL, V359, P107, DOI 10.1016/j.mce.2011.07.005; Hofland J, 2012, ENDOCRINOLOGY, V153, P5726, DOI 10.1210/en.2011-2065; Kang HY, 2009, J BONE MINER RES, V24, P1180, DOI [10.1359/JBMR.090219, 10.1359/jbmr.090219]; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; Kelner N, 2015, HEAD NECK-J SCI SPEC, V37, P479, DOI 10.1002/hed.23627; Kim YI, 2009, ONCOL REP, V21, P491, DOI 10.3892/or_00000249; Le Bras GF, 2014, LAB INVEST, V94, P1134, DOI 10.1038/labinvest.2014.97; Le Bras GF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027063; Li Y, 2014, J CLIN ENDOCR METAB, V99, pE2216, DOI 10.1210/jc.2014-2118; Moustakas A, 2014, BBA-GEN SUBJECTS, V1840, P2621, DOI 10.1016/j.bbagen.2014.02.004; Murakami M, 2010, MOL BIOL REP, V37, P1279, DOI 10.1007/s11033-009-9502-x; Ottley E, 2012, CYTOKINE GROWTH F R, V23, P119, DOI 10.1016/j.cytogfr.2012.04.004; Reis FM, 2004, MOL CELL ENDOCRINOL, V225, P77, DOI 10.1016/j.mce.2004.02.016; Sachdeva M, 2010, CANCER RES, V70, P378, DOI 10.1158/0008-5472.CAN-09-2021; Schmittgen TD, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh040; Seder CW, 2009, NEOPLASIA, V11, P388, DOI 10.1593/neo.81582; Shao Y, 2013, ONCOL LETT, V6, P1636, DOI 10.3892/ol.2013.1621; Sobral LM, 2011, ORAL ONCOL, V47, P840, DOI 10.1016/j.oraloncology.2011.06.011; Spizzo R, 2010, CELL DEATH DIFFER, V17, P246, DOI 10.1038/cdd.2009.117; Takagi T, 2009, ONCOLOGY-BASEL, V77, P12, DOI 10.1159/000218166; Tsai JH, 2013, GENE DEV, V27, P2192, DOI 10.1101/gad.225334.113; Valdimarsdottir G, 2005, APMIS, V113, P773, DOI 10.1111/j.1600-0463.2005.apm_3181.x; Wang BD, 2009, TOXICOLOGY, V258, P176, DOI 10.1016/j.tox.2009.01.023; Warnakulasuriya S, 2010, ORAL ONCOL, V46, P407, DOI 10.1016/j.oraloncology.2010.02.015; Wei JL, 2015, MOL MED REP, V11, P571, DOI 10.3892/mmr.2014.2675; Weiss A, 2013, WIRES DEV BIOL, V2, P47, DOI 10.1002/wdev.86; Wu DY, 2013, MOL MED REP, V8, P626, DOI 10.3892/mmr.2013.1501; Xu GH, 2013, NEURAL REGEN RES, V8, P1016, DOI 10.3969/j.issn.1673-5374.2013.11.007; Yoshinaga K, 2008, ANN SURG ONCOL, V15, P96, DOI 10.1245/s10434-007-9631-1	41	45	46	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136599	10.1371/journal.pone.0136599	http://dx.doi.org/10.1371/journal.pone.0136599			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317418	Green Published, gold, Green Accepted			2022-12-26	WOS:000360299100108
J	Filograna, R; Civiero, L; Ferrari, V; Codolo, G; Greggio, E; Bubacco, L; Beltramini, M; Bisaglia, M				Filograna, Roberta; Civiero, Laura; Ferrari, Vanni; Codolo, Gaia; Greggio, Elisa; Bubacco, Luigi; Beltramini, Mariano; Bisaglia, Marco			Analysis of the Catecholaminergic Phenotype in Human SH-SY5Y and BE(2)-M17 Neuroblastoma Cell Lines upon Differentiation	PLOS ONE			English	Article							NEURO-BLASTOMA CELLS; ACID-INDUCED DIFFERENTIATION; TRANS-RETINOIC ACID; IN-VITRO; DOPAMINERGIC-NEURONS; PROTEIN; EXPRESSION; OUTGROWTH; NEUROTOXICITY; STAUROSPORINE	Human cell lines are often used to investigate cellular pathways relevant for physiological or pathological processes or to evaluate cell toxicity or protection induced by different compounds, including potential drugs. In this study, we analyzed and compared the differentiating activities of three agents (retinoic acid, staurosporine and 12-O-tetradecanoylphorbol-13-acetate) on the human neuroblastoma SH-SY5Y and BE(2)-M17 cell lines; the first cell line is largely used in the field of neuroscience, while the second is still poorly characterized. After evaluating their effects in terms of cell proliferation and morphology, we investigated their catecholaminergic properties by assessing the expression profiles of the major genes involved in catecholamine synthesis and storage and the cellular concentrations of the neurotransmitters dopamine and noradrenaline. Our results demonstrate that the two cell lines possess similar abilities to differentiate and acquire a neuron-like morphology. The most evident effects in SH-SY5Y cells were observed in the presence of staurosporine, while in BE(2)-M17 cells, retinoic acid induced the strongest effects. Undifferentiated SH-SY5Y and BE(2)-M17 cells are characterized by the production of both NA and DA, but their levels are considerably higher in BE(2)-M17 cells. Moreover, the NAergic phenotype appears to be more pronounced in SH-SY5Y cells, while BE(2)-M17 cells have a more prominent DAergic phenotype. Finally, the catecholamine concentration strongly increases upon differentiation induced by staurosporine in both cell lines. In conclusion, in this work the catecholaminergic phenotype of the human BE(2)-M17 cell line upon differentiation was characterized for the first time. Our data suggest that SH-SY5Y and BE(2)-M17 represent two alternative cell models for the neuroscience field.	[Filograna, Roberta; Civiero, Laura; Ferrari, Vanni; Greggio, Elisa; Bubacco, Luigi; Beltramini, Mariano; Bisaglia, Marco] Univ Padua, Mol Physiol & Biophys Unit, Dept Biol, Padua, Italy; [Codolo, Gaia] Univ Padua, Gen Pathol Unit, Dept Biol, Padua, Italy	University of Padua; University of Padua	Beltramini, M (corresponding author), Univ Padua, Mol Physiol & Biophys Unit, Dept Biol, Padua, Italy.	mariano.beltramini@unipd.it; marco.bisaglia@unipd.it	Civiero, Laura/K-7665-2016; Civiero, Laura/GXG-2968-2022; Bubacco, Luigi/B-5602-2012	Civiero, Laura/0000-0002-5334-155X; Bubacco, Luigi/0000-0001-7927-9208; CODOLO, GAIA/0000-0002-7793-2549	University of Padova [PRAT2010-103503, PRAT2012-124045]; Italian Ministry of Education, University and Research [PRIN2010-M2JARJ]	University of Padova; Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants obtained from the University of Padova (PRAT2010-103503, PRAT2012-124045) and the Italian Ministry of Education, University and Research (PRIN2010-M2JARJ).	Andres D, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-49; Baker M, 2015, NATURE, V521, P274, DOI 10.1038/521274a; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; BIEDLER JL, 1978, CANCER RES, V38, P3751; Bradbury A, 2015, NATURE, V518, P27, DOI 10.1038/518027a; Chinta SJ, 2005, INT J BIOCHEM CELL B, V37, P942, DOI 10.1016/j.biocel.2004.09.009; CICCARONE V, 1989, CANCER RES, V49, P219; Clagett-Dame M, 2006, J NEUROBIOL, V66, P739, DOI 10.1002/neu.20241; Daniele F, 2015, JOVE-J VIS EXP, DOI 10.3791/52267; Datki Z, 2003, BRAIN RES BULL, V62, P223, DOI 10.1016/j.brainresbull.2003.09.011; Fagerstrom S, 1996, CELL GROWTH DIFFER, V7, P775; Grimm J, 2004, P NATL ACAD SCI USA, V101, P13891, DOI 10.1073/pnas.0405340101; JALAVA A, 1993, J CELL PHYSIOL, V155, P301, DOI 10.1002/jcp.1041550211; JALAVA A, 1992, FEBS LETT, V300, P114, DOI 10.1016/0014-5793(92)80176-H; Kim SN, 2000, J CELL PHYSIOL, V182, P421, DOI 10.1002/(SICI)1097-4652(200003)182:3<421::AID-JCP13>3.0.CO;2-2; Korecka JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063862; Kume T, 2008, NEUROSCI LETT, V443, P199, DOI 10.1016/j.neulet.2008.07.079; LELI U, 1992, J NEUROCHEM, V58, P1191, DOI 10.1111/j.1471-4159.1992.tb11328.x; LELI U, 1993, J NEUROCHEM, V60, P289, DOI 10.1111/j.1471-4159.1993.tb05850.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopes FM, 2010, BRAIN RES, V1337, P85, DOI 10.1016/j.brainres.2010.03.102; Melino G, 1997, J NEURO-ONCOL, V31, P65, DOI 10.1023/A:1005733430435; PAHLMAN S, 1981, INT J CANCER, V28, P583, DOI 10.1002/ijc.2910280509; PAHLMAN S, 1983, CELL DIFFER DEV, V12, P165, DOI 10.1016/0045-6039(83)90006-4; PAHLMAN S, 1984, CELL DIFFER DEV, V14, P135, DOI 10.1016/0045-6039(84)90038-1; Radio NM, 2008, NEUROTOXICOLOGY, V29, P361, DOI 10.1016/j.neuro.2008.02.011; RETTIG WJ, 1987, CANCER RES, V47, P1383; ROSS RA, 1983, J NATL CANCER I, V71, P741; Shi BX, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3491470; SPINELLI W, 1982, CANCER RES, V42, P5067; Uemura K, 2003, J NEUROSCI RES, V73, P166, DOI 10.1002/jnr.10641; Webster NJ, 2001, MOL BRAIN RES, V89, P50, DOI 10.1016/S0169-328X(01)00061-4; Xie HR, 2010, CHINESE MED J-PEKING, V123, P1086, DOI 10.3760/cma.j.issn.0366-6999.2010.08.021; Zhao H, 2012, MOL CELL BIOCHEM, V363, P309, DOI 10.1007/s11010-011-1183-9	34	42	43	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136769	10.1371/journal.pone.0136769	http://dx.doi.org/10.1371/journal.pone.0136769			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317353	Green Published, gold, Green Submitted			2022-12-26	WOS:000360299100139
J	Kerbrat, S; Vingert, B; Junier, MP; Castellano, F; Renault-Mihara, F; Tavares, SD; Surenaud, M; Noizat-Pirenne, F; Boczkowski, J; Guellaen, G; Chneiweiss, H; Le Gouvello, S				Kerbrat, Stephane; Vingert, Benoit; Junier, Marie-Pierre; Castellano, Flavia; Renault-Mihara, Francois; Tavares, Silvina Dos Reis; Surenaud, Mathieu; Noizat-Pirenne, France; Boczkowski, Jorge; Guellaen, Georges; Chneiweiss, Herve; Le Gouvello, Sabine			Absence of the Adaptor Protein PEA-15 Is Associated with Altered Pattern of Th Cytokines Production by Activated CD4+T Lymphocytes In Vitro, and Defective Red Blood Cell Alloimmune Response In Vivo	PLOS ONE			English	Article							MATURE DENDRITIC CELLS; ERK MAP KINASE; CYCLE PROGRESSION; EFFECTOR FUNCTION; CUTTING EDGE; SIGNAL; EXPRESSION; DIFFERENTIATION; INTERLEUKIN-2; GROWTH	TCR-dependent and costimulation signaling, cell division, and cytokine environment are major factors driving cytokines expression induced by CD4+ T cell activation. PEA-15 15 (Protein Enriched in Astrocyte / 15kDa) is an adaptor protein that regulates death receptor-induced apoptosis and proliferation signaling by binding to FADD and relocating ERK1/2 to the cytosol, respectively. By using PEA-15-deficient mice, we examined the role of PEA-15 in TCR-dependent cytokine production in CD4+ T cells. TCR-stimulated PEA-15-deficient CD4+ T cells exhibited defective progression through the cell cycle associated with impaired expression of cyclin E and phosphoRb, two ERK1/2-dependent proteins of the cell cycle. Accordingly, expression of the division cycle-dependent cytokines IL-2 and IFN gamma, a Th1 cytokine, was reduced in stimulated PEA-15-deficient CD4+ T cells. This was associated with abnormal subcellular compartmentalization of activated ERK1/2 in PEA-15-deficient T cells. Furthermore, in vitro TCR-dependent differentiation of naive CD4(+) CD62L+ PEA-15-deficient T cells was associated with a lower production of the Th2 cytokine, IL-4, whereas expression of the Th17-associated molecule IL4I1 was enhanced. Finally, a defective humoral response was shown in PEA-15-deficient mice in a model of red blood cell alloimmunization performed with Poly IC, a classical adjuvant of Th1 response in vivo. Collectively, our data suggest that PEA-15 contributes to the specification of the cytokine pattern of activated Th cells, thus highlighting a potential new target to interfere with T cell functional polarization and subsequent immune response.	[Kerbrat, Stephane; Castellano, Flavia; Noizat-Pirenne, France; Boczkowski, Jorge; Guellaen, Georges; Le Gouvello, Sabine] Univ Paris Est, Creteil, France; [Kerbrat, Stephane; Vingert, Benoit; Castellano, Flavia; Surenaud, Mathieu; Noizat-Pirenne, France; Boczkowski, Jorge; Guellaen, Georges; Le Gouvello, Sabine] Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France; [Vingert, Benoit; Noizat-Pirenne, France] Etab Francais Sang, Creteil, France; [Junier, Marie-Pierre; Renault-Mihara, Francois; Tavares, Silvina Dos Reis; Chneiweiss, Herve] INSERM, U1130, Neurosci Paris Seine, IBPS, Paris, France; [Junier, Marie-Pierre; Renault-Mihara, Francois; Tavares, Silvina Dos Reis; Chneiweiss, Herve] Univ Paris 06, UM119, Neurosci Paris Seine, IBPS, Paris, France; [Junier, Marie-Pierre; Renault-Mihara, Francois; Tavares, Silvina Dos Reis; Chneiweiss, Herve] CNRS, UMR8246, Neurosci Paris Seine, IBPS, Paris, France; [Castellano, Flavia; Le Gouvello, Sabine] Hop H Mondor A Chenevier, AP HP, Pole Biol Pathol, Creteil, France	Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Chneiweiss, H (corresponding author), INSERM, U1130, Neurosci Paris Seine, IBPS, Paris, France.	herve.chneiweiss@inserm.fr; sabine.le-gouvello@hmn.aphp.fr	Boczkowski, Jorge/S-7474-2018; Castellano, Flavia/Q-2847-2018; , Renault-Mihara/L-3320-2013; herve, chneiweiss/Q-6818-2019	Boczkowski, Jorge/0000-0001-6619-5785; herve, chneiweiss/0000-0001-7675-5061; SURENAUD, Mathieu/0000-0002-3312-7871; Castellano, Flavia/0000-0001-9389-6704; VINGERT, Benoit/0000-0003-4156-2504; le gouvello, sabine/0000-0001-8147-2322	Association pour la recherche contre le cancer [3500]; Assistance-publique hopitaux de paris; Inserm; Legs Poix	Association pour la recherche contre le cancer(Fondation ARC pour la Recherche sur le Cancer); Assistance-publique hopitaux de paris; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Legs Poix	This work was supported by Association pour la recherche contre le cancer (grant no 3500) (HC); Assistance-publique hopitaux de paris (SLG); Inserm (HC and SLG); and Legs Poix (SLG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Appleman LJ, 2002, J IMMUNOL, V168, P2729, DOI 10.4049/jimmunol.168.6.2729; Appleman LJ, 2000, J IMMUNOL, V164, P144, DOI 10.4049/jimmunol.164.1.144; ARAUJO H, 1993, J BIOL CHEM, V268, P5911; Ben-Sasson SZ, 2001, J IMMUNOL, V166, P112, DOI 10.4049/jimmunol.166.1.112; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Boulland ML, 2007, BLOOD, V110, P220, DOI 10.1182/blood-2006-07-036210; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Chang CF, 2012, J IMMUNOL, V189, P721, DOI 10.4049/jimmunol.1103015; Decker EL, 1998, J BIOL CHEM, V273, P26923, DOI 10.1074/jbc.273.41.26923; DEFRANCE T, 1992, J EXP MED, V175, P671, DOI 10.1084/jem.175.3.671; Diehn M, 2002, P NATL ACAD SCI USA, V99, P11796, DOI 10.1073/pnas.092284399; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Fang LW, 2004, J BIOL CHEM, V279, P13, DOI 10.1074/jbc.M303860200; Fiory F, 2009, AM J PHYSIOL-ENDOC M, V297, pE592, DOI 10.1152/ajpendo.00228.2009; Formstecher E, 2001, DEV CELL, V1, P239, DOI 10.1016/S1534-5807(01)00035-1; Gett AV, 1998, P NATL ACAD SCI USA, V95, P9488, DOI 10.1073/pnas.95.16.9488; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; Gomez-Rodriguez J, 2014, J EXP MED, V211, P529, DOI 10.1084/jem.20131459; Goplen N, 2012, FASEB J, V26, P1934, DOI 10.1096/fj.11-196477; Gudmundsdottir H, 1999, J IMMUNOL, V162, P5212; Guillot-Delost M, 2012, J IMMUNOL, V188, P981, DOI 10.4049/jimmunol.1101592; Hendrickson JE, 2006, TRANSFUSION, V46, P1526, DOI 10.1111/j.1537-2995.2006.00946.x; Janardhan SV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024931; Jorritsma PJ, 2003, J IMMUNOL, V170, P2427, DOI 10.4049/jimmunol.170.5.2427; Kitsberg D, 1999, J NEUROSCI, V19, P8244; Laouar Y, 2000, IMMUNITY, V13, P291, DOI 10.1016/S1074-7613(00)00029-7; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Liu HP, 2013, EUR J IMMUNOL, V43, P1716, DOI 10.1002/eji.201242889; Lohoff M, 2010, J BIOL CHEM, V285, P1643, DOI 10.1074/jbc.M109.011585; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Luo XR, 2008, J IMMUNOL, V180, P2757, DOI 10.4049/jimmunol.180.5.2757; Lyons AB, 2000, J IMMUNOL METHODS, V243, P147, DOI 10.1016/S0022-1759(00)00231-3; Mace PD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2687; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Mor A, 2008, EUR J IMMUNOL, V38, P1493, DOI 10.1002/eji.200838292; Mullen AC, 2001, CURR BIOL, V11, P1695, DOI 10.1016/S0960-9822(01)00533-4; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Oldenhove G, 2003, J EXP MED, V198, P259, DOI 10.1084/jem.20030654; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pastorino S, 2010, FASEB J, V24, P2818, DOI 10.1096/fj.09-144295; Pouyssegur J, 2002, BIOCHEM PHARMACOL, V64, P755, DOI 10.1016/S0006-2952(02)01135-8; Richter A, 1999, J EXP MED, V190, P1439, DOI 10.1084/jem.190.10.1439; Riley JL, 2002, P NATL ACAD SCI USA, V99, P11790, DOI 10.1073/pnas.162359999; ROONEY JW, 1995, IMMUNITY, V2, P473, DOI 10.1016/1074-7613(95)90028-4; ROUSSET F, 1992, P NATL ACAD SCI USA, V89, P1890, DOI 10.1073/pnas.89.5.1890; Santarlasci V, 2012, IMMUNITY, V36, P201, DOI 10.1016/j.immuni.2011.12.013; Scarlata CM, 2015, EUR J IMMUNOL, V45, P474, DOI 10.1002/eji.201444897; Schade AE, 2004, J IMMUNOL, V172, P5828, DOI 10.4049/jimmunol.172.10.5828; SKERKA C, 1995, J BIOL CHEM, V270, P22500, DOI 10.1074/jbc.270.38.22500; Tan AHM, 2010, J IMMUNOL, V184, P1849, DOI 10.4049/jimmunol.0901509; Torii S, 2006, CANCER SCI, V97, P697, DOI 10.1111/j.1349-7006.2006.00244.x; van den Brink MRM, 1999, J BIOL CHEM, V274, P11178, DOI 10.1074/jbc.274.16.11178; Yamane H, 2005, J EXP MED, V202, P793, DOI 10.1084/jem.20051304; Yamashita M, 2005, J BIOL CHEM, V280, P29409, DOI 10.1074/jbc.M502333200; Yu J, 2007, AM J HEMATOL, V82, P691, DOI 10.1002/ajh.20959; Zimring JC, 2005, BLOOD, V106, P1105, DOI 10.1182/blood-2005-03-1040	60	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136885	10.1371/journal.pone.0136885	http://dx.doi.org/10.1371/journal.pone.0136885			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317969	Green Published, gold, Green Submitted			2022-12-26	WOS:000360299100161
J	Ferreira, WAS; Araujo, MD; Anselmo, NP; de Oliveira, EHC; Brito, JRN; Burbano, RR; Harada, ML; Borges, BD				Silva Ferreira, Wallax Augusto; Araujo, Mariana Diniz; Anselmo, Nilson Praia; Correa de Oliveira, Edivaldo Herculano; Nascimento Brito, Jose Reginaldo; Burbano, Rommel Rodriguez; Harada, Maria Lucia; Borges, Barbara do Nascimento			Expression Analysis of Genes Involved in the RB/E2F Pathway in Astrocytic Tumors	PLOS ONE			English	Article							CPG-ISLAND METHYLATION; SQUAMOUS-CELL CARCINOMA; CYCLE REGULATORY GENES; DNA-REPLICATION; PROMOTER HYPERMETHYLATION; GLIOBLASTOMA-MULTIFORME; RETINOBLASTOMA PROTEIN; BMI-1 ONCOPROTEIN; PROGNOSTIC VALUE; EMERGING ROLES	Astrocytic gliomas, which are derived from glial cells, are considered the most common primary neoplasias of the central nervous system (CNS) and are histologically classified as low grade (I and II) or high grade (III and IV). Recent studies have shown that astrocytoma formation is the result of the deregulation of several pathways, including the RB/E2F pathway, which is commonly deregulated in various human cancers via genetic or epigenetic mechanisms. On the basis of the assumption that the study of the mechanisms controlling the INK4/ARF locus can help elucidate the molecular pathogenesis of astrocytic tumors, identify diagnostic and prognostic markers, and help select appropriate clinical treatments, the present study aimed to evaluate and compare methylation patterns using bisulfite sequencing PCR and evaluate the gene expression profile using real-time PCR in the genes CDKN2A, CDKN2B, CDC6, Bmi-1, CCND1, and RB1 in astrocytic tumors. Our results indicate that all the evaluated genes are not methylated independent of the tumor grade. However, the real-time PCR results indicate that these genes undergo progressive deregulation as a function of the tumor grade. In addition, the genes CDKN2A, CDKN2B, and RB1 were underexpressed, whereas CDC6, Bmi-1, and CCND1 were overexpressed; the increase in gene expression was significantly associated with decreased patient survival. Therefore, we propose that the evaluation of the expression levels of the genes involved in the RB/E2F pathway can be used in the monitoring of patients with astrocytomas in clinical practice and for the prognostic indication of disease progression.	[Silva Ferreira, Wallax Augusto; Araujo, Mariana Diniz; Anselmo, Nilson Praia; Harada, Maria Lucia; Borges, Barbara do Nascimento] Univ Fed Par UFPA, Fed Univ Para, Inst Biol Sci, Francisco Mauro Salzano Mol Biol Lab, Belem, Para, Brazil; [Correa de Oliveira, Edivaldo Herculano] Evandro Chagas Inst, Tissue Culture & Cytogenet Lab, Belem, Para, Brazil; [Nascimento Brito, Jose Reginaldo] Ophir Loyola Hosp, Belem, Para, Brazil; [Burbano, Rommel Rodriguez] UFPA, Human Cytogenet Lab, Inst Biol Sci, Belem, Para, Brazil; [Borges, Barbara do Nascimento] Fed Rural Univ Amazonia, Socioenvironm & Water Management Inst, Agr Technol Ctr, Belem, Para, Brazil	Universidade Federal do Para; Instituto Evandro Chagas; Universidade Federal do Para; Universidade Federal Rural da Amazonia (UFRA)	Borges, BD (corresponding author), Univ Fed Par UFPA, Fed Univ Para, Inst Biol Sci, Francisco Mauro Salzano Mol Biol Lab, Belem, Para, Brazil.	barbara.borges@ufra.edu.br	de Oliveira, Edivaldo H. C./C-3368-2013; Burbano, Rommel R/C-4149-2012; Borges, Barbara N/G-1355-2012; Ferreira, Wallax A S/O-8395-2018	de Oliveira, Edivaldo H. C./0000-0001-6315-3352; Burbano, Rommel R/0000-0002-4872-234X; Borges, Barbara N/0000-0002-5989-8287; Ferreira, Wallax/0000-0002-9645-2292; Brito, Jose Reginaldo Nascimento/0000-0001-8130-250X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [483032/2010-7]; Universidade Federal do Para (UFPA); Fundacao Amazonia de Amparo a Estudos e Pesquisas do Para [132/2010]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Universidade Federal do Para (UFPA); Fundacao Amazonia de Amparo a Estudos e Pesquisas do Para(Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA))	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes), and by research funds from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (483032/2010-7), Universidade Federal do Para (UFPA) and from Fundacao Amazonia de Amparo a Estudos e Pesquisas do Para (132/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdouh M, 2009, J NEUROSCI, V29, P8884, DOI 10.1523/JNEUROSCI.0968-09.2009; Agherbi H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005622; Amato A, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-79; Bastian PJ, 2007, EUR UROL, V51, P665, DOI 10.1016/j.eururo.2006.08.008; Bello MJ, 2004, CANC THER, V2, P187; Bleeker FE, 2012, J NEURO-ONCOL, V108, P11, DOI 10.1007/s11060-011-0793-0; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Borges BD, 2013, TUMOR BIOL, V34, P2127, DOI 10.1007/s13277-013-0742-y; Borges BD, 2010, IN VIVO, V24, P579; Borges BN, 2010, THESIS FEDERAL U PAR; Borlado LR, 2008, CARCINOGENESIS, V29, P237, DOI 10.1093/carcin/bgm268; Cam H, 2003, CANCER CELL, V3, P311, DOI 10.1016/S1535-6108(03)00080-1; Cao LH, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-55; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chen RH, 2010, CANCER CELL, V17, P362, DOI 10.1016/j.ccr.2009.12.049; Chiba T, 2008, CANCER RES, V68, P7742, DOI 10.1158/0008-5472.CAN-07-5882; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chow LML, 2011, CANCER CELL, V19, P305, DOI 10.1016/j.ccr.2011.01.039; Coschi CH, 2010, GENE DEV, V24, P1351, DOI 10.1101/gad.1917610; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Costello JF, 1996, CANCER RES, V56, P2405; Deshpande A, 2005, ONCOGENE, V24, P2909, DOI 10.1038/sj.onc.1208618; Di Fiore R, 2013, J CELL PHYSIOL, V228, P1676, DOI 10.1002/jcp.24329; Diehl JA, 2002, CANCER BIOL THER, V1, P226, DOI 10.4161/cbt.72; Esteller M, 2000, CANCER RES, V60, P4366; Feng CJ, 2013, TECHNOL CANCER RES T, V12, P173, DOI 10.7785/tcrt.2012.500302; Ferreira WAS, 2015, J GENET GENOME RES, V2, P012; Gonzalez MA, 2005, NAT REV CANCER, V5, P135, DOI 10.1038/nrc1548; Gonzalez S, 2006, CELL CYCLE, V5, P1382, DOI 10.4161/cc.5.13.2901; Gonzalez-Gomez P, 2003, BRIT J CANCER, V88, P109, DOI 10.1038/sj.bjc.6600737; Gonzalez-Gomez P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/549742; Green BM, 2010, SCIENCE, V329, P943, DOI 10.1126/science.1190966; GREGER V, 1994, HUM GENET, V94, P491; Halaban R, 2005, CANCER METAST REV, V24, P339, DOI 10.1007/s10555-005-1582-z; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hateboer G, 1998, MOL CELL BIOL, V18, P6679, DOI 10.1128/MCB.18.11.6679; Hayry V, 2010, BRIT J CANCER, V102, P892, DOI 10.1038/sj.bjc.6605544; He S, 2009, DEV BIOL, V328, P257, DOI 10.1016/j.ydbio.2009.01.020; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hosen N, 2007, STEM CELLS, V25, P1635, DOI 10.1634/stemcells.2006-0229; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jiang LL, 2009, ACTA BIOCH BIOPH SIN, V41, P527, DOI 10.1093/abbs/gmp040; Jin F, 2009, NUCLEIC ACIDS RES, V37, P4826, DOI 10.1093/nar/gkp510; Kanellou P, 2009, BRIT J DERMATOL, V160, P1215, DOI 10.1111/j.1365-2133.2009.09079.x; Karakaidos P, 2004, AM J PATHOL, V165, P1351, DOI 10.1016/S0002-9440(10)63393-7; Kawamata N, 2005, EUR J HAEMATOL, V74, P424, DOI 10.1111/j.1600-0609.2005.00417.x; Kim JH, 2004, CANCER LETT, V203, P217, DOI 10.1016/j.canlet.2003.07.009; Kim YH, 2011, BRAIN PATHOL, V21, P645, DOI 10.1111/j.1750-3639.2011.00492.x; Knudsen ES, 2008, NAT REV CANCER, V8, P714, DOI 10.1038/nrc2401; Knudsen ES, 2010, CLIN CANCER RES, V16, P1094, DOI 10.1158/1078-0432.CCR-09-0787; Lau E, 2006, EMBO REP, V7, P425, DOI 10.1038/sj.embor.7400624; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; Li AFY, 2008, AM J CLIN PATHOL, V130, P535, DOI 10.1309/TLLVXK9HVA89CHPE; Li J, 2010, AM J PATHOL, V176, P699, DOI 10.2353/ajpath.2010.090502; Li SKM, 2008, J BIOL CHEM, V283, P16545, DOI 10.1074/jbc.M709604200; Liontos M, 2007, CANCER RES, V67, P10899, DOI 10.1158/0008-5472.CAN-07-2837; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lukacs RU, 2010, CELL STEM CELL, V7, P682, DOI 10.1016/j.stem.2010.11.013; Manning AL, 2011, TRENDS CELL BIOL, V21, P433, DOI 10.1016/j.tcb.2011.05.003; Manning AL, 2010, GENE DEV, V24, P1364, DOI 10.1101/gad.1917310; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Mihic-Probst D, 2007, INT J CANCER, V121, P1764, DOI 10.1002/ijc.22891; Mizuarai S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-31; Munoz Jorge, 2012, ISRN Neurol, V2012, P576578, DOI 10.5402/2012/576578; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Ohta S, 2001, ONCOL REP, V8, P1063; Ohta T, 2006, ONCOL REP, V16, P957; OhtaniFujita N, 1997, CANCER GENET CYTOGEN, V98, P43, DOI 10.1016/S0165-4608(96)00395-0; Park IK, 2004, J CLIN INVEST, V113, P175, DOI 10.1172/JCI200420800; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pinheiro DD, 2015, TRANSL GASTROIN CANC, V4, P265, DOI 10.3978/j.issn.2224-4778.2015.05.04; Pinyol M, 2006, INT J CANCER, V119, P2768, DOI 10.1002/ijc.22146; Poi M. J., 2013, MOL CARCINOG; Riemenschneider MJ, 2010, ACTA NEUROPATHOL, V120, P567, DOI 10.1007/s00401-010-0736-4; Riemenschneider MJ, 2009, INT J MOL SCI, V10, P184, DOI 10.3390/ijms10010184; Rohde C, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn083; SAKAI T, 1991, AM J HUM GENET, V48, P880; Sakellariou S, 2008, ANTICANCER RES, V28, P1079; SAMBROOK J, 2000, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Schuringa JJ, 2010, CURR OPIN HEMATOL, V17, P294, DOI 10.1097/MOH.0b013e328338c439; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Silva J, 2006, CLIN CANCER RES, V12, P6929, DOI 10.1158/1078-0432.CCR-06-0788; Simpson DJ, 2000, CANCER RES, V60, P1211; Skiriute D, 2014, J CANCER, V5, P446, DOI 10.7150/jca.9140; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Stirzaker C, 1997, CANCER RES, V57, P2229; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Ushio Y, 2003, FRONT BIOSCI, V8, pE281, DOI 10.2741/865; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Voncken JW, 2005, J BIOL CHEM, V280, P5178, DOI 10.1074/jbc.M407155200; Vrzalikova K, 2008, J CANCER RES CLIN, V134, P1037, DOI 10.1007/s00432-008-0361-y; Wang JY, 2012, J NEURO-ONCOL, V106, P473, DOI 10.1007/s11060-011-0692-4; Wemmert S, 2009, INT J ONCOL, V34, P1743, DOI 10.3892/ijo_00000305; Witkiewicz AK, 2011, CELL CYCLE, V10, P2497, DOI 10.4161/cc.10.15.16776; Wolter M, 2001, J NEUROPATH EXP NEUR, V60, P1170, DOI 10.1093/jnen/60.12.1170; Yan Z, 1998, P NATL ACAD SCI USA, V95, P3603, DOI 10.1073/pnas.95.7.3603; Yin D, 2009, MOL CANCER RES, V7, P665, DOI 10.1158/1541-7786.MCR-08-0270; Yu J, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-65; Zacharek SJ, 2011, CELL STEM CELL, V9, P272, DOI 10.1016/j.stem.2011.07.007; Zolota V, 2008, NEUROPATHOLOGY, V28, P35, DOI 10.1111/j.1440-1789.2007.00844.x	111	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137259	10.1371/journal.pone.0137259	http://dx.doi.org/10.1371/journal.pone.0137259			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317630	Green Submitted, Green Published, gold			2022-12-26	WOS:000360299100214
J	Yang, WF; Chen, M; Zheng, MF; He, ZG; Zhang, XX; Qiu, YS; Xu, WB; Ma, LL; Lin, ZY; Hu, WJ; Zeng, J				Yang, Weifeng; Chen, Min; Zheng, Minfang; He, Zhigang; Zhang, Xinxing; Qiu, Yusheng; Xu, Wangbin; Ma, Lili; Lin, Zhiyu; Hu, Wangjiang; Zeng, Jian			Influence of a Decaying Cyclonic Eddy on Biogenic Silica and Particulate Organic Carbon in the Tropical South China Sea Based on Th-234-U-238 Disequilibrium	PLOS ONE			English	Article							SMALL-VOLUME TECHNIQUE; MESOSCALE EDDIES; PARTICLE EXPORT; PHYTOPLANKTON DYNAMICS; WATER COLUMN; OCEAN; FLUX; VARIABILITY; LEE; ENHANCEMENT	Eddies play a critical role in regulating the biological pump by pumping new nutrients to the euphotic zone. However, the effects of cyclonic eddies on particle export are not well understood. Here, biogenic silica (BSi) and particulate organic carbon (POC) exports were examined inside and outside a decaying cyclonic eddy using Th-234-U-238 disequilibria in the tropical South China Sea. For the eddy and outside stations, the average concentrations of BSi in the euphotic zone were 0.17 +/- 0.09 mu mol L-1 (mean +/- sd, n = 20) and 0.21 +/- 0.06 mu mol L-1 (n = 34). The POC concentrations were 1.42 +/- 0.56 mu mol L-1 (n = 34) and 1.30 +/- 0.46 mu mol L-1 (n = 51). Both BSi and POC abundances did not show change at the 95% confidence level. Based on the 234Th-238U model, BSi export fluxes in the eddy averaged 0.18 +/- 0.15 mmol Si m(-2) d(-1), which was comparable with the 0.40 +/- 0.20 mmol Si m(-2) d(-1) outside the eddy. Similarly, the average POC export fluxes were 1.5 +/- 1.4 mmol C m(-2) d(-1) and 1.9 +/- 1.3 mmol C m(-2) d(-1) for the eddy and outside stations. From these results we concluded that cyclonic eddies in their decaying phase have little effect on the abundance and export of biogenic particles.	[Yang, Weifeng; Chen, Min; Qiu, Yusheng] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China; [Yang, Weifeng; Chen, Min; Zheng, Minfang; He, Zhigang; Zhang, Xinxing; Qiu, Yusheng; Xu, Wangbin; Ma, Lili; Lin, Zhiyu; Hu, Wangjiang; Zeng, Jian] Xiamen Univ, Coll Ocean & Earth Sci, Xiamen, Peoples R China	Xiamen University; Xiamen University	Yang, WF (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	wyang@xmu.edu.cn	Chen, Min/B-7763-2012; Yang, Weifeng/G-3996-2010	Chen, Min/0000-0003-0369-694X; Yang, Weifeng/0000-0002-9339-1746	National Natural Science Foundation of China [41125020, 41476061]; State Oceanic Administration grant [GASI-03-01-02-02]; China Ocean Mineral Resources R & D Association grant [DY125-13-E-01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Oceanic Administration grant; China Ocean Mineral Resources R & D Association grant	This study was supported by National Natural Science Foundation of China (41125020) to MC and (41476061) to WY, State Oceanic Administration grant (GASI-03-01-02-02) and China Ocean Mineral Resources R & D Association grant (DY125-13-E-01) to WY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacon MP, 1996, DEEP-SEA RES PT II, V43, P1133, DOI 10.1016/0967-0645(96)00016-1; Benitez-Nelson CR, 2007, SCIENCE, V316, P1017, DOI 10.1126/science.1136221; Benitez-Nelson CR, 2001, J RADIOANAL NUCL CH, V248, P795, DOI 10.1023/A:1010621618652; Brown SL, 2008, DEEP-SEA RES PT II, V55, P1321, DOI 10.1016/j.dsr2.2008.02.012; Buesseler K, 1998, DEEP-SEA RES PT II, V45, P2461, DOI 10.1016/S0967-0645(98)80022-2; Buesseler KO, 2008, DEEP-SEA RES PT II, V55, P1426, DOI 10.1016/j.dsr2.2008.02.007; Buesseler KO, 2006, MAR CHEM, V100, P213, DOI 10.1016/j.marchem.2005.10.013; BUESSELER KO, 1992, DEEP-SEA RES, V39, P1115, DOI 10.1016/0198-0149(92)90060-7; BUESSELER KO, 1995, DEEP-SEA RES PT II, V42, P777, DOI 10.1016/0967-0645(95)00043-P; Cai PH, 2002, SCI CHINA SER D, V45, P103, DOI 10.1007/BF02879787; Cai PH, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027792; Cai PH, 2006, MAR CHEM, V100, P282, DOI 10.1016/j.marchem.2005.10.016; Cai PH, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004268; Cardona Y, 2012, OCEAN MODEL, V42, P1, DOI 10.1016/j.ocemod.2011.11.004; Charette MA, 1999, DEEP-SEA RES PT II, V46, P885, DOI 10.1016/S0967-0645(99)00006-5; Chen J, 1998, CHIN SCI B CHIN VER, V43, P639; CHEN JH, 1986, EARTH PLANET SC LETT, V80, P241, DOI 10.1016/0012-821X(86)90108-1; Chen M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025186; Chen YFL, 2005, DEEP-SEA RES PT I, V52, P319, DOI 10.1016/j.dsr.2004.11.001; Chen YLL, 2007, J OCEANOGR, V63, P671, DOI 10.1007/s10872-007-0059-9; COCHRAN JK, 1995, J GEOPHYS RES-OCEANS, V100, P4399, DOI 10.1029/94JC01954; Conley DJ, 1998, MAR CHEM, V63, P39, DOI 10.1016/S0304-4203(98)00049-8; Du C, 2013, BIOGEOSCI DISCUSS, V10, P6939, DOI DOI 10.5194/BGD-10-6939-2013; Dunne JP, 1997, DEEP-SEA RES PT II, V44, P2049, DOI 10.1016/S0967-0645(97)00063-5; Ewart CS, 2008, DEEP-SEA RES PT II, V55, P1334, DOI 10.1016/j.dsr2.2008.02.013; FALKOWSKI PG, 1991, NATURE, V352, P55, DOI 10.1038/352055a0; Guo LD, 2002, MAR CHEM, V78, P103, DOI 10.1016/S0304-4203(02)00012-9; Jeong HJ, 2004, AQUAT MICROB ECOL, V36, P171, DOI 10.3354/ame036171; Kara AB, 2000, J GEOPHYS RES-OCEANS, V105, P16803, DOI 10.1029/2000JC900072; Krause JW, 2010, LIMNOL OCEANOGR, V55, P569, DOI 10.4319/lo.2009.55.2.0569; Landry MR, 2008, DEEP-SEA RES PT II, V55, P1348, DOI 10.1016/j.dsr2.2008.02.001; Letelier RM, 2000, J GEOPHYS RES-OCEANS, V105, P28723, DOI 10.1029/1999JC000306; Lin II, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043872; Lin Z, 2011, THESIS XIAMEN U; Liu KK, 2002, DEEP-SEA RES PT I, V49, P1387, DOI 10.1016/S0967-0637(02)00035-3; Ma Q, 2005, ACTA OCEANOL SIN, V24, P97; Maiti K, 2008, DEEP-SEA RES PT II, V55, P1445, DOI 10.1016/j.dsr2.2008.02.008; McGillicuddy DJ, 2007, SCIENCE, V316, P1021, DOI 10.1126/science.1136256; McGillicuddy DJ, 1998, NATURE, V394, P263, DOI 10.1038/28367; McGillicuddy DJ, 1997, DEEP-SEA RES PT I, V44, P1427, DOI 10.1016/S0967-0637(97)00024-1; Moran SB, 2003, LIMNOL OCEANOGR, V48, P1018, DOI 10.4319/lo.2003.48.3.1018; Moran SB, 1999, MAR CHEM, V67, P33, DOI 10.1016/S0304-4203(99)00047-X; Mourino-Carballido B, 2006, LIMNOL OCEANOGR, V51, P2675, DOI 10.4319/lo.2006.51.6.2675; Mourino-Carballido B, 2009, DEEP-SEA RES PT I, V56, P1242, DOI 10.1016/j.dsr.2009.03.001; Murray JW, 1996, DEEP-SEA RES PT II, V43, P1095, DOI 10.1016/0967-0645(96)00036-7; Oschlies A, 1998, NATURE, V394, P266, DOI 10.1038/28373; Ragueneau O, 2005, CONT SHELF RES, V25, P697, DOI 10.1016/j.csr.2004.09.017; Resplandy L, 2012, DEEP-SEA RES PT I, V68, P24, DOI 10.1016/j.dsr.2012.05.015; Rii YM, 2008, DEEP-SEA RES PT II, V55, P1275, DOI 10.1016/j.dsr2.2008.01.013; Savoye N, 2006, MAR CHEM, V100, P234, DOI 10.1016/j.marchem.2005.10.014; Siegel DA, 1999, J GEOPHYS RES-OCEANS, V104, P13359, DOI 10.1029/1999JC900051; Van der Loeff MR, 2006, MAR CHEM, V100, P190, DOI 10.1016/j.marchem.2005.10.012; Verdeny E, 2008, DEEP-SEA RES PT II, V55, P1461, DOI 10.1016/j.dsr2.2008.02.009; Wan S, 2010, CHINESE SCI BULL, V40, P881; Xiu P, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006800; Xiu P, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005657; Yang WF, 2009, CHINESE SCI BULL, V54, P2118, DOI 10.1007/s11434-009-0043-4; Zhang R, 2014, DEEP-SEA RES PT I, V83, P24, DOI 10.1016/j.dsr.2013.08.006; Zhou KB, 2013, EARTH PLANET SC LETT, V381, P198, DOI 10.1016/j.epsl.2013.07.039	59	15	15	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136948	10.1371/journal.pone.0136948	http://dx.doi.org/10.1371/journal.pone.0136948			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317555	Green Submitted, gold, Green Published			2022-12-26	WOS:000360299100181
J	Yang, XD; Yan, WJ; Tian, Y; Ma, P; Opperman, LA; Wang, XF				Yang, Xiudong; Yan, Wenjuan; Tian, Ye; Ma, Pan; Opperman, Lynne A.; Wang, Xiaofang			Family with sequence similarity member 20C is the primary but not the only kinase for the small-integrin-binding ligand N-linked glycoproteins in bone	FASEB JOURNAL			English	Article						phosphorylation; biomineralization; mass spectrometry; hypophosphatemic rickets; ASARM	DENTIN MATRIX PROTEIN-1; O-GLYCOSYLATION SITES; POSTTRANSLATIONAL MODIFICATIONS; IN-VITRO; RAT BONE; BIOLOGICAL IMPLICATIONS; SIBLING PROTEINS; PHOSPHORYLATION; OSTEOPONTIN; SIALOPROTEIN	Recent studies have identified family with sequence similarity member 20C (FAM20C) as a kinase that phosphorylates the Ser in Ser-X-Glu/phospho-Ser (pSer) motifs in the small-integrin-binding ligand N-linked glycoproteins (SIBLINGs). There is no in vivo evidence that validates this finding, and it is unclear whether FAM20C is the only kinase for SIBLINGs. We extracted bone noncollagenous proteins (NCPs) from Fam20C-knockout (KO) mice and analyzed the phosphorylation levels. The total NCPs were separated into osteopontin-, bone sialoprotein-, and dentin matrix protein-1-enriched fractions by anion-exchange chromatography and analyzed by SDS-PAGE, native PAGE, and Western immunoblot analysis. The NCP phosphorylation level in the KO mice was lower than that in the wild-type (WT). On the native gel, the SIBLINGs from KO mice showed a lower migration rate (M-r) than those from the WT. Calf intestine phosphatase treatment shifted SIBLINGs from the WT mice to the level adjacent to the KO, but failed to shift the latter, suggesting a phosphorylation loss of SIBLINGs in the KO mice. Mass spectrometry identified less pSers in the SIBLINGs from the KO mice [ including the region of the acidic Ser- and aspartate-richmotif (ASARM) peptides]. In an intriguing finding, several pSers in the Ser-X-Glu motifs in the KO mice maintained their phosphorylation, whereas several others in non-Ser-X-Glumotifs did not. Phospho-Tyrs and phospho-Thrs in the SIBLINGs did not appear to be associated with FAM20C. Our results indicate that FAM20C is the primary, but not the only, kinase for the SIBLINGs.-Yang, X., Yan, W., Tian, Y., Ma, P., Opperman, L. A., Wang, X. Familywith sequence similarity member 20C is the primary but not the only kinase for the small-integrin-binding ligand N-linked glycoproteins in bone. FASEB J. 30, 121-128 (2016). www.fasebj.org	[Yang, Xiudong; Yan, Wenjuan; Tian, Ye; Ma, Pan; Opperman, Lynne A.; Wang, Xiaofang] Texas A&M Univ, Baylor Coll Dent, Dept Biomed Sci, Dallas, TX 75246 USA; [Yang, Xiudong; Yan, Wenjuan; Tian, Ye; Ma, Pan; Opperman, Lynne A.; Wang, Xiaofang] Texas A&M Univ, Baylor Coll Dent, Ctr Craniofacial Res & Diag, Dallas, TX 75246 USA; [Yan, Wenjuan] Southern Med Univ, Guangzhou, Guangdong, Peoples R China; [Tian, Ye] Sichuan Univ, Chengdu, Sichuan, Peoples R China; [Ma, Pan] Capital Med Univ, Beijing, Peoples R China	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Southern Medical University - China; Sichuan University; Capital Medical University	Wang, XF (corresponding author), Texas A&M Univ, Baylor Coll Dent, Dept Biomed Sci, 3302 Gaston Ave, Dallas, TX 75246 USA.	xwang@bcd.tamhsc.edu		Wang, Xiaofang/0000-0002-7370-7192; Opperman, Lynne/0000-0002-6200-7799	U.S. National Institutes of Health (NIH) National Institute of Dental and Craniofacial Research [R03DE23873-01]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE023873] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Dental and Craniofacial Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors thank Dr. C. Qin (Texas A&M University Baylor College of Dentistry) for critical review of the manuscript, and J. Santa Cruz for assistance with the editing of the article. This work was supported by U.S. National Institutes of Health (NIH) National Institute of Dental and Craniofacial Research Grant R03DE23873-01 (to X.W.). The authors declare no conflicts of interest.	Addison WN, 2010, J BONE MINER RES, V25, P695, DOI 10.1359/jbmr.090832; Baht GS, 2010, BIOCHEM J, V428, P385, DOI 10.1042/BJ20091864; Barros NMT, 2013, J BONE MINER RES, V28, P688, DOI 10.1002/jbmr.1766; Bordoli MR, 2014, CELL, V158, P1033, DOI 10.1016/j.cell.2014.06.048; BOSKEY AL, 1993, BONE MINER, V22, P147, DOI 10.1016/S0169-6009(08)80225-5; Christensen B, 2005, BIOCHEM J, V390, P285, DOI 10.1042/BJ20050341; Curtin P, 2009, BIOCHEMISTRY-US, V48, P6876, DOI 10.1021/bi900066b; Deshpande AS, 2011, BIOMACROMOLECULES, V12, P2933, DOI 10.1021/bm2005214; GEORGE A, 1993, J BIOL CHEM, V268, P12624; Gericke A, 2005, CALCIFIED TISSUE INT, V77, P45, DOI 10.1007/s00223-004-1288-1; He G, 2003, NAT MATER, V2, P552, DOI 10.1038/nmat945; Huang BZ, 2008, EUR J ORAL SCI, V116, P104, DOI 10.1111/j.1600-0722.2008.00522.x; Ishikawa HO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042988; Jono S, 2000, J BIOL CHEM, V275, P20197, DOI 10.1074/jbc.M909174199; Keykhosravani M, 2005, BIOCHEMISTRY-US, V44, P6990, DOI 10.1021/bi050109p; LINDE A, 1980, J BIOL CHEM, V255, P5931; Liu SG, 2007, J ENDOCRINOL, V192, P261, DOI 10.1677/joe.1.07059; Nalbant D, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-11; PRINCE CW, 1987, J BIOL CHEM, V262, P2900; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; Qin CL, 2001, EUR J ORAL SCI, V109, P133, DOI 10.1034/j.1600-0722.2001.00001.x; Qin CL, 2003, J BIOL CHEM, V278, P34700, DOI 10.1074/jbc.M305315200; Qin CL, 2003, EUR J ORAL SCI, V111, P235, DOI 10.1034/j.1600-0722.2003.00043.x; Ramos-Molina B, 2015, MOL ENDOCRINOL, V29, P756, DOI 10.1210/me.2014-1394; Razzouk S, 2002, BONE, V30, P40, DOI 10.1016/S8756-3282(01)00637-8; RICHARDSON WS, 1978, J BIOL CHEM, V253, P8042; Rowe PSN, 2012, CRIT REV EUKAR GENE, V22, P61, DOI 10.1615/CritRevEukarGeneExpr.v22.i1.50; Saito T, 1997, BONE, V21, P305, DOI 10.1016/S8756-3282(97)00149-X; Salih E, 2004, J BIOL CHEM, V279, P19808, DOI 10.1074/jbc.M310299200; Salih E, 1996, J BIOL CHEM, V271, P16897, DOI 10.1074/jbc.271.28.16897; SFEIR C, 1995, J BONE MINER RES, V10, P607; Simpson MA, 2007, AM J HUM GENET, V81, P906, DOI 10.1086/522240; SORENSEN ES, 1995, PROTEIN SCI, V4, P2040, DOI 10.1002/pro.5560041009; Sun Y, 2010, J BIOL CHEM, V285, P31713, DOI 10.1074/jbc.M110.137059; Tagliabracci VS, 2014, P NATL ACAD SCI USA, V111, P5520, DOI 10.1073/pnas.1402218111; Tagliabracci VS, 2012, SCIENCE, V336, P1150, DOI 10.1126/science.1217817; VANVELDHOVEN PP, 1987, ANAL BIOCHEM, V161, P45, DOI 10.1016/0003-2697(87)90649-X; Veis A, 1997, CRIT REV ORAL BIOL M, V8, P360, DOI 10.1177/10454411970080040101; Wang XF, 2012, J BIOL CHEM, V287, P35934, DOI 10.1074/jbc.M112.386862; Wang XF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002708; Wang XF, 2010, J HISTOCHEM CYTOCHEM, V58, P957, DOI 10.1369/jhc.2010.956565; Yuan BZ, 2013, J BONE MINER RES, V28, P56, DOI 10.1002/jbmr.1738	42	20	21	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					121	128		10.1096/fj.15-273607	http://dx.doi.org/10.1096/fj.15-273607			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26324849	Green Published			2022-12-26	WOS:000367621000014
J	Kolappan, S; Ng, D; Yang, GX; Harn, T; Craig, L				Kolappan, Subramania; Ng, Dixon; Yang, Guixiang; Harn, Tony; Craig, Lisa			Crystal Structure of the Minor Pilin CofB, the Initiator of CFA/III Pilus Assembly in Enterotoxigenic Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II SECRETION SYSTEM; FACTOR ANTIGEN-III; TOXIN-COREGULATED-PILUS; IV PILUS; PSEUDOMONAS-AERUGINOSA; COLONIZATION FACTOR; NEISSERIA-MENINGITIDIS; PATHOGENIC NEISSERIA; PROTEIN SECRETION; X-RAY	Type IV pili are extracellular polymers of the major pilin subunit. These subunits are held together in the pilus filament by hydrophobic interactions among their N-terminal alpha-helices, which also anchor the pilin subunits in the inner membrane prior to pilus assembly. Type IV pilus assembly involves a conserved group of proteins that span the envelope of Gram-negative bacteria. Among these is a set of minor pilins, so named because they share their hydrophobic N-terminal polymerization/membrane anchor segment with the major pilins but are much less abundant. Minor pilins influence pilus assembly and retraction, but their precise functions are not well defined. The Type IV pilus systems of enterotoxigenic Escherichia coli and Vibrio cholerae are among the simplest of Type IV pilus systems and possess only a single minor pilin. Here we show that the enterotoxigenic E. coli minor pilins CofB and LngB are required for assembly of their respective Type IV pili, CFA/III and Longus. Low levels of the minor pilins are optimal for pilus assembly, and CofB can be detected in the pilus fraction. We solved the 2.0 angstrom crystal structure of N-terminally truncated CofB, revealing a pilin-like protein with an extended C-terminal region composed of two discrete domains connected by flexible linkers. The C-terminal region is required for CofB to initiate pilus assembly. We propose a model for CofB-initiated pilus assembly with implications for understanding filament growth in more complex Type IV pilus systems as well as the related Type II secretion system.	[Kolappan, Subramania; Ng, Dixon; Yang, Guixiang; Harn, Tony; Craig, Lisa] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Craig, L (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada.	licraig@sfu.ca		Craig, Lisa/0000-0001-8515-9915	Canadian Institutes of Health Research Grant [MOP-125959]	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP-125959 (to L. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Aas FE, 2007, MOL MICROBIOL, V63, P69, DOI 10.1111/j.1365-2958.2006.05482.x; Anantha RP, 1998, INFECT IMMUN, V66, P122, DOI 10.1128/IAI.66.1.122-131.1998; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Aroeti B, 2012, GUT MICROBES, V3, P267, DOI 10.4161/gmic.19814; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bernard SC, 2014, NAT MED, V20, P725, DOI 10.1038/nm.3563; Berry JL, 2015, FEMS MICROBIOL REV, V39, P134, DOI 10.1093/femsre/fuu001; Bieber D, 1998, SCIENCE, V280, P2114, DOI 10.1126/science.280.5372.2114; Blank TE, 2001, J BACTERIOL, V183, P4435, DOI 10.1128/JB.183.15.4435-4450.2001; Bleves S, 1998, MOL MICROBIOL, V27, P31, DOI 10.1046/j.1365-2958.1998.00653.x; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Brissac T, 2012, INFECT IMMUN, V80, P3297, DOI 10.1128/IAI.00369-12; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Burrows LL, 2005, MOL MICROBIOL, V57, P878, DOI 10.1111/j.1365-2958.2005.04703.x; Carbonnelle E, 2006, MOL MICROBIOL, V61, P1510, DOI 10.1111/j.1365-2958.2006.05341.x; Cehovin A, 2013, P NATL ACAD SCI USA, V110, P3065, DOI 10.1073/pnas.1218832110; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chiang P, 2008, MICROBIOL-SGM, V154, P114, DOI 10.1099/mic.0.2007/011320-0; Cisneros DA, 2012, MOL MICROBIOL, V86, P805, DOI 10.1111/mmi.12033; Cisneros DA, 2012, EMBO J, V31, P1041, DOI 10.1038/emboj.2011.454; Collins RF, 2004, J BIOL CHEM, V279, P39750, DOI 10.1074/jbc.M405971200; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Craig L, 2003, MOL CELL, V11, P1139, DOI 10.1016/S1097-2765(03)00170-9; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Douzi B, 2012, PHILOS T R SOC B, V367, P1059, DOI 10.1098/rstb.2011.0204; Durand E, 2003, J BACTERIOL, V185, P2749, DOI 10.1128/JB.185.9.2749-2758.2003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVANS DG, 1977, INFECT IMMUN, V18, P330, DOI 10.1128/IAI.18.2.330-337.1977; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Franz LP, 2011, ACTA CRYSTALLOGR D, V67, P124, DOI 10.1107/S0907444910051954; Giltner CL, 2012, MICROBIOL MOL BIOL R, V76, P740, DOI 10.1128/MMBR.00035-12; Giltner CL, 2010, J MOL BIOL, V398, P444, DOI 10.1016/j.jmb.2010.03.028; GIRON JA, 1994, MOL MICROBIOL, V12, P71, DOI 10.1111/j.1365-2958.1994.tb00996.x; Gold VAM, 2015, ELIFE, V4, DOI 10.7554/eLife.07380; Gomez-Duarte OG, 2007, J BACTERIOL, V189, P9145, DOI 10.1128/JB.00722-07; Gonzalez A, 2008, J APPL CRYSTALLOGR, V41, P176, DOI 10.1107/S0021889807057822; Hartung S, 2011, J BIOL CHEM, V286, P44254, DOI 10.1074/jbc.M111.297242; Helaine S, 2005, MOL MICROBIOL, V55, P65, DOI 10.1111/j.1365-2958.2004.04372.x; Helaine S, 2007, P NATL ACAD SCI USA, V104, P15888, DOI 10.1073/pnas.0707581104; HONDA T, 1984, INFECT IMMUN, V43, P959, DOI 10.1128/IAI.43.3.959-965.1984; HONDA T, 1989, INFECT IMMUN, V57, P3452, DOI 10.1128/IAI.57.11.3452-3457.1989; HONDA T, 1989, INFECT IMMUN, V57, P2799, DOI 10.1128/IAI.57.9.2799-2803.1989; Horiuchi T, 1998, J BACTERIOL, V180, P4613, DOI 10.1128/JB.180.17.4613-4620.1998; Imhaus AF, 2014, EMBO J, V33, P1767, DOI 10.15252/embj.201488031; Jain S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016624; Kabsch H., 1993, J APPL CRYSTALLOGR, V26, P795; KAUFMAN MR, 1991, GENE DEV, V5, P1834, DOI 10.1101/gad.5.10.1834; Kawahara K, 2015, ACTA CRYSTALLOGR F, V71, P663, DOI 10.1107/S2053230X15005890; Kirn TJ, 2005, INFECT IMMUN, V73, P4461, DOI 10.1128/IAI.73.8.4461-4470.2005; Kolappan S, 2012, J BACTERIOL, V194, P2725, DOI 10.1128/JB.00282-12; Korotkov KV, 2008, NAT STRUCT MOL BIOL, V15, P462, DOI 10.1038/nsmb.1426; Korotkov KV, 2012, NAT REV MICROBIOL, V10, P336, DOI 10.1038/nrmicro2762; Kuchma SL, 2012, J BACTERIOL, V194, P5388, DOI 10.1128/JB.00899-12; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LEVINE MM, 1984, INFECT IMMUN, V44, P409, DOI 10.1128/IAI.44.2.409-420.1984; Li J, 2012, J MOL BIOL, V418, P47, DOI 10.1016/j.jmb.2012.02.017; Lieberman JA, 2012, J BACTERIOL, V194, P1646, DOI 10.1128/JB.06330-11; Lim MS, 2010, MOL MICROBIOL, V77, P755, DOI 10.1111/j.1365-2958.2010.07244.x; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; Mazariego-Espinosa K, 2010, J BACTERIOL, V192, P2791, DOI 10.1128/JB.01595-09; McLaughlin LS, 2012, CURR OPIN STRUC BIOL, V22, P208, DOI 10.1016/j.sbi.2012.02.005; Megli CJ, 2011, J MOL BIOL, V409, P146, DOI 10.1016/j.jmb.2011.03.027; Melville S, 2013, MICROBIOL MOL BIOL R, V77, P323, DOI 10.1128/MMBR.00063-12; Misic AM, 2010, J MOL BIOL, V400, P1011, DOI 10.1016/j.jmb.2010.05.066; Morand PC, 2004, EMBO J, V23, P2009, DOI 10.1038/sj.emboj.7600200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nguyen Y, 2010, J MOL BIOL, V395, P491, DOI 10.1016/j.jmb.2009.10.070; NUNN DN, 1991, P NATL ACAD SCI USA, V88, P3281, DOI 10.1073/pnas.88.8.3281; PARGE HE, 1995, NATURE, V378, P32, DOI 10.1038/378032a0; Park HSM, 2001, MOL MICROBIOL, V42, P293, DOI 10.1046/j.1365-2958.2001.02629.x; PASLOSKE BL, 1988, MOL MICROBIOL, V2, P489, DOI 10.1111/j.1365-2958.1988.tb00055.x; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; Piepenbrink KH, 2014, J BIOL CHEM, V289, P4334, DOI 10.1074/jbc.M113.534404; Reichow SL, 2011, CHANNELS, V5, P215, DOI 10.4161/chan.5.3.15268; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Sauvonnet N, 2000, EMBO J, V19, P2221, DOI 10.1093/emboj/19.10.2221; Schmidt SA, 2001, J BACTERIOL, V183, P4848, DOI 10.1128/JB.183.16.4848-4859.2001; STROM MS, 1992, J BACTERIOL, V174, P7345, DOI 10.1128/jb.174.22.7345-7351.1992; STROM MS, 1991, J BIOL CHEM, V266, P1656; Takhar HK, 2013, J BIOL CHEM, V288, P9721, DOI 10.1074/jbc.M113.453506; TANIGUCHI T, 1995, INFECT IMMUN, V63, P724, DOI 10.1128/IAI.63.2.724-728.1995; Taniguchi T, 2001, INFECT IMMUN, V69, P5864, DOI 10.1128/IAI.69.9.5864-5873.2001; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; TONJUM T, 1995, MOL MICROBIOL, V16, P451, DOI 10.1111/j.1365-2958.1995.tb02410.x; Tripathi SA, 2007, J BACTERIOL, V189, P4401, DOI 10.1128/JB.00008-07; Winther-Larsen HC, 2005, MOL MICROBIOL, V56, P903, DOI 10.1111/j.1365-2958.2005.04591.x; Yanez ME, 2008, J MOL BIOL, V375, P471, DOI 10.1016/j.jmb.2007.10.035; Nguyen Y, 2015, J BIOL CHEM, V290, P601, DOI 10.1074/jbc.M114.616904; Yuen ASW, 2013, MOL MICROBIOL, V90, P898, DOI 10.1111/mmi.12407; ZHANG HZ, 1994, J BACTERIOL, V176, P6885, DOI 10.1128/JB.176.22.6885-6891.1994	94	16	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					25805	25818		10.1074/jbc.M115.676106	http://dx.doi.org/10.1074/jbc.M115.676106			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26324721	hybrid, Green Published			2022-12-26	WOS:000363527300003
J	Bernard, K; Logsdon, NJ; Ravi, S; Xie, N; Persons, BP; Rangarajan, S; Zmijewski, JW; Mitra, K; Liu, G; Darley-Usmar, VM; Thannickal, VJ				Bernard, Karen; Logsdon, Naomi J.; Ravi, Saranya; Xie, Na; Persons, Benjamin P.; Rangarajan, Sunad; Zmijewski, Jaroslaw W.; Mitra, Kasturi; Liu, Gang; Darley-Usmar, Victor M.; Thannickal, Victor J.			Metabolic Reprogramming Is Required for Myofibroblast Contractility and Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; TRANSCRIPTION FACTOR-A; SKELETAL-MUSCLE; GROWTH-FACTOR; TGF-BETA; PULMONARY-FIBROSIS; MITOCHONDRIAL BIOGENESIS; GLUCOSE-METABOLISM; ENERGY-METABOLISM; COACTIVATOR PGC-1	Contraction is crucial in maintaining the differentiated phenotype of myofibroblasts. Contraction is an energy-dependent mechanism that relies on the production of ATP by mitochondria and/or glycolysis. Although the role of mitochondrial biogenesis in the adaptive responses of skeletal muscle to exercise is well appreciated, mechanisms governing energetic adaptation of myofibroblasts are not well understood. Our study demonstrates induction of mitochondrial biogenesis and aerobic glycolysis in response to the differentiation-inducing factor transforming growth factor beta 1 (TGF-beta 1). This metabolic reprogramming is linked to the activation of the p38 mitogen-activated protein kinase (MAPK) pathway. Inhibition of p38 MAPK decreased accumulation of active peroxisome proliferator- activated receptor gamma coactivator 1 alpha in the nucleus and altered the translocation of mitochondrial transcription factor A to the mitochondria. Genetic or pharmacologic approaches that block mitochondrial biogenesis or glycolysis resulted in decreased contraction and reduced expression of TGF-beta 1-induced alpha-smooth muscle actin and collagen alpha-2(I) but not of fibronectin or collagen alpha-1(I). These data indicate a critical role for TGF-beta 1-induced metabolic reprogramming in regulating myofibroblast-specific contractile signaling and support the concept of integrating bioenergetics with cellular differentiation.	[Bernard, Karen; Logsdon, Naomi J.; Xie, Na; Persons, Benjamin P.; Rangarajan, Sunad; Zmijewski, Jaroslaw W.; Liu, Gang; Thannickal, Victor J.] Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA; [Ravi, Saranya; Darley-Usmar, Victor M.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Mitra, Kasturi] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Ravi, Saranya; Darley-Usmar, Victor M.] Univ Alabama Birmingham, Ctr Free Rad Biol & Med, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Bernard, K (corresponding author), Div Pulm Allergy & Crit Care Med, 901 19th St South,BMRII 464, Birmingham, AL 35294 USA.	kbernard@uab.edu	Rangarajan, Sunad/AAQ-5285-2021	Rangarajan, Sunad/0000-0001-5313-4828; Liu, Gang/0000-0003-2615-131X; , Gang/0000-0002-6999-7633; Darley-Usmar, Victor/0000-0001-8921-7086	National Institutes of Health Grants [P01 HL114470, R01 AG046210]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL114470, T32HL105346, R01HL105473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG046210] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL114470 and R01 AG046210. The authors declare that they have no conflicts of interest with the content of this article.	Amat R, 2009, J BIOL CHEM, V284, P21872, DOI 10.1074/jbc.M109.022749; Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; Arora PD, 1999, AM J PATHOL, V154, P871, DOI 10.1016/S0002-9440(10)65334-5; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Barrientos A, 1999, J BIOL CHEM, V274, P16188, DOI 10.1074/jbc.274.23.16188; Brooks GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI 10.1113/jphysiol.2009.178350; Carter AB, 1999, J BIOL CHEM, V274, P30858, DOI 10.1074/jbc.274.43.30858; Chacko BK, 2010, BIOCHEM J, V432, P9, DOI 10.1042/BJ20100308; CHEN W, 1992, BIOCHIMIE, V74, P867, DOI 10.1016/0300-9084(92)90070-U; Cheresh P, 2013, BBA-MOL BASIS DIS, V1832, P1028, DOI 10.1016/j.bbadis.2012.11.021; DAVIES KJA, 1981, ARCH BIOCHEM BIOPHYS, V209, P539, DOI 10.1016/0003-9861(81)90312-X; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; Dong XC, 2002, J BIOL CHEM, V277, P43309, DOI 10.1074/jbc.M206958200; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; Erecinska M, 1977, Adv Exp Med Biol, V94, P271; Felton VM, 2009, AM J PHYSIOL-LUNG C, V297, pL805, DOI 10.1152/ajplung.00009.2009; FITTS RH, 1975, AM J PHYSIOL, V228, P1029, DOI 10.1152/ajplegacy.1975.228.4.1029; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Fu MHH, 2009, PHYSIOL GENOMICS, V40, P34, DOI 10.1152/physiolgenomics.00115.2009; GELLERICH FN, 1993, BIOCHIM BIOPHYS ACTA, V1142, P217, DOI 10.1016/0005-2728(93)90150-E; Gordon JW, 2001, J APPL PHYSIOL, V90, P389, DOI 10.1152/jappl.2001.90.1.389; GUPPY M, 1993, EUR J BIOCHEM, V212, P95, DOI 10.1111/j.1432-1033.1993.tb17637.x; HARDING AE, 1991, TRENDS NEUROSCI, V14, P132, DOI 10.1016/0166-2236(91)90081-5; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hodge T, 1997, J MEMBRANE BIOL, V157, P271, DOI 10.1007/s002329900235; Horowitz JC, 2004, J BIOL CHEM, V279, P1359, DOI 10.1074/jbc.M306248200; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jain M, 2013, J BIOL CHEM, V288, P770, DOI 10.1074/jbc.M112.431973; KAYAR SR, 1986, EUR J APPL PHYSIOL O, V54, P578, DOI 10.1007/BF00943344; Knutti D, 2001, P NATL ACAD SCI USA, V98, P9713, DOI 10.1073/pnas.171184698; Kraft CS, 2006, AM J PHYSIOL-CELL PH, V290, pC1119, DOI 10.1152/ajpcell.00463.2005; LARSSON NG, 1994, BIOCHEM BIOPH RES CO, V200, P1374, DOI 10.1006/bbrc.1994.1603; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; LOOS JA, 1973, EXP CELL RES, V79, P136, DOI 10.1016/0014-4827(73)90498-9; Manthey CL, 1998, J LEUKOCYTE BIOL, V64, P409, DOI 10.1002/jlb.64.3.409; Negmadjanov U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123046; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Nemoto S, 1998, MOL CELL BIOL, V18, P3518, DOI 10.1128/MCB.18.6.3518; PARISI MA, 1993, MOL CELL BIOL, V13, P1951, DOI 10.1128/MCB.13.3.1951; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; Phan SH, 2003, AM J RESP CELL MOL, V29, pS87; Piomboni P, 2012, INT J ANDROL, V35, P109, DOI 10.1111/j.1365-2605.2011.01218.x; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Radisky DC, 2007, J CELL BIOCHEM, V101, P830, DOI 10.1002/jcb.21186; Roberts DJ, 2015, CELL DEATH DIFFER, V22, P248, DOI 10.1038/cdd.2014.173; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Ronty MJ, 2006, J INVEST DERMATOL, V126, P2387, DOI 10.1038/sj.jid.5700427; Salabei JK, 2014, NAT PROTOC, V9, P421, DOI 10.1038/nprot.2014.018; Sandbo N, 2011, AM J PHYSIOL-LUNG C, V301, pL656, DOI 10.1152/ajplung.00166.2011; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Scharenberg MA, 2014, J CELL SCI, V127, P1079, DOI 10.1242/jcs.142075; Smith PC, 2006, J PERIODONTAL RES, V41, P418, DOI 10.1111/j.1600-0765.2006.00886.x; Sun M, 2012, SCAND J MED SCI SPOR, V22, P764, DOI 10.1111/j.1600-0838.2011.01314.x; Terman A, 2010, ANTIOXID REDOX SIGN, V12, P503, DOI 10.1089/ars.2009.2598; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Vaishnavi SN, 2010, P NATL ACAD SCI USA, V107, P17757, DOI 10.1073/pnas.1010459107; Vander Heiden MG, 2000, P NATL ACAD SCI USA, V97, P4666, DOI 10.1073/pnas.090082297; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yang Y, 2014, ALLERGY, V69, P699, DOI 10.1111/all.12403; Zheng J, 2012, ONCOL LETT, V4, P1151, DOI 10.3892/ol.2012.928; Zhou Y, 2013, J CLIN INVEST, V123, P1096, DOI 10.1172/JCI66700	66	103	105	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25427	25438		10.1074/jbc.M115.646984	http://dx.doi.org/10.1074/jbc.M115.646984			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26318453	hybrid, Green Published			2022-12-26	WOS:000362962800019
J	Ahuja, P; Nair, S; Narayan, S; Gratzl, M				Ahuja, Punkaj; Nair, Sumitha; Narayan, Sreenath; Gratzl, Miklos			Functional Imaging of Chemically Active Surfaces with Optical Reporter Microbeads	PLOS ONE			English	Article							SCANNING ELECTROCHEMICAL MICROSCOPY; SINGLE LIVING CELLS; SELECTIVE OPTODES; PEBBLE SENSORS; FABRICATION; VISUALIZATION; DIOXIDE; PROBE; IONS	We have developed a novel approach to allow for continuous imaging of concentration fields that evolve at surfaces due to release, uptake, and mass transport of molecules, without significant interference of the concentration fields by the chemical imaging itself. The technique utilizes optical "reporter" microbeads immobilized in a thin layer of transparent and inert hydrogel on top of the surface. The hydrogel has minimal density and therefore diffusion in and across it is like in water. Imaging the immobilized microbeads over time provides quantitative concentration measurements at each location where an optical reporter resides. Using image analysis in post-processing these spatially discrete measurements can be transformed into contiguous maps of the dynamic concentration field across the entire surface. If the microbeads are small enough relative to the dimensions of the region of interest and sparsely applied then chemical imaging will not noticeably affect the evolution of concentration fields. In this work colorimetric optode microbeads a few micrometers in diameter were used to image surface concentration distributions on the millimeter scale.	[Ahuja, Punkaj; Nair, Sumitha; Narayan, Sreenath; Gratzl, Miklos] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA	Case Western Reserve University	Gratzl, M (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.	miklos.gratzl@case.edu						Amemiya S, 2006, ANAL BIOANAL CHEM, V386, P458, DOI 10.1007/s00216-006-0510-6; Atamanchuk D, 2014, LIMNOL OCEANOGR-METH, V12, P63, DOI 10.4319/lom.2014.12.63; BALDINI F, 1992, SENSOR ACTUAT B-CHEM, V7, P752, DOI 10.1016/0925-4005(92)80398-H; Bard A. J., 2012, SCANNING ELECTROCHEM, V2nd; BARD AJ, 1989, ANAL CHEM, V61, P132, DOI 10.1021/ac00177a011; Black M, 2005, MEAS SCI TECHNOL, V16, P174, DOI 10.1088/0957-0233/16/1/023; Buhlmann P, 1998, CHEM REV, V98, P1593, DOI 10.1021/cr970113+; Bychkova V, 2009, ANAL CHEM, V81, P2325, DOI 10.1021/ac8024619; Clark HA, 1999, ANAL CHEM, V71, P4831, DOI 10.1021/ac990629o; Conn P.M., 2012, IMAGING SPECTROSCOPI; Crank J, 2009, MATH DIFFUSION; Cussler E.L., 1997, DIFFUSION MASS TRANS; DELBIANCO A, 1993, SENSOR ACTUAT B-CHEM, V11, P347, DOI 10.1016/0925-4005(93)85274-E; DICKERT FL, 1988, ANAL CHEM, V60, P1377, DOI 10.1021/ac00165a005; ENGSTROM RC, 1989, ANAL CHEM, V61, pA1099, DOI 10.1021/ac00194a002; Grime JMA, 2008, P NATL ACAD SCI USA, V105, P14277, DOI 10.1073/pnas.0803720105; Institute of Electrical and Electronics Engineers, 1998, AUT FAC GEST REC 199; Kim G, 2010, ANAL CHEM, V82, P2165, DOI 10.1021/ac9024544; KURATLI M, 1994, ANAL CHEM, V66, P85, DOI 10.1021/ac00073a016; KURATLI M, 1993, ANAL CHEM, V65, P3473, DOI 10.1021/ac00071a023; LEE CM, 1990, P NATL ACAD SCI USA, V87, P1740, DOI 10.1073/pnas.87.5.1740; LEE DT, 1980, INT J COMPUT INF SCI, V9, P219, DOI 10.1007/BF00977785; Lee YEK, 2009, WIRES NANOMED NANOBI, V1, P98, DOI 10.1002/wnan.2; Liu B, 2000, P NATL ACAD SCI USA, V97, P9855, DOI 10.1073/pnas.97.18.9855; *MATHW INC, 2003, MATLAB; Moding Everett, 2009, Journal of Sensors, DOI 10.1155/2009/235158; Pahler M, 2011, CHEMPHYSCHEM, V12, P2798, DOI 10.1002/cphc.201100428; Pust SE, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/10/105709; Rudd NC, 2005, ANAL CHEM, V77, P6205, DOI 10.1021/ac050800y; Samson E, 2003, MATER STRUCT, V36, P156, DOI 10.1007/BF02479554; SCHANTZ EJ, 1962, BIOCHEMISTRY-US, V1, P658, DOI 10.1021/bi00910a019; Sheth Disha B., MULTIELECTRODE PLATF; Si D, 2012, ANAL CHEM, V84, P978, DOI 10.1021/ac202521e; Suzuki K, 2002, ANAL CHEM, V74, P5766, DOI 10.1021/ac0259414; Tohda K, 2006, ANAL SCI, V22, P383, DOI 10.2116/analsci.22.383; Torisawa YS, 2005, ONCOL REP, V13, P1107; WEST SJ, 1992, ANAL CHEM, V64, P533, DOI 10.1021/ac00029a016; Yasukawa T, 2000, ELECTROANAL, V12, P653, DOI 10.1002/1521-4109(200005)12:9<653::AID-ELAN653>3.0.CO;2-S	38	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136970	10.1371/journal.pone.0136970	http://dx.doi.org/10.1371/journal.pone.0136970			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332766	Green Published, gold, Green Submitted			2022-12-26	WOS:000360613800084
J	Gu, YF; Shi, JQ; Cao, P; Yuan, W; Wu, HQ; Yang, LL; Tian, Y; Liang, L				Gu, Yifei; Shi, Jueqian; Cao, Peng; Yuan, Wen; Wu, Huiqiao; Yang, Lili; Tian, Ye; Liang, Lei			Clinical and Imaging Predictors of Surgical Outcome in Multilevel Cervical Ossification of Posterior Longitudinal Ligament: An Analysis of 184 Patients	PLOS ONE			English	Article							MAGNETIC-RESONANCE IMAGES; SIGNAL INTENSITY CHANGES; OPEN-DOOR LAMINOPLASTY; SPONDYLOTIC MYELOPATHY; SPINAL-CORD; FOLLOW-UP; MINOR TRAUMA; PROGNOSTIC-FACTORS; SURGERY; STRATEGY	Objective To investigate the clinical and imaging predictors of surgical outcomes in patients with ossification of the posterior longitudinal ligament (OPLL). Materials and Methods From May 2010 to April 2012, a total of 200 consecutive patients with cervical OPLL were recruited for this study. Of them, 184 patients (130 men and 54 women) who could be tracked for more than 24 months after surgery were finally included for analysis. Their demographic, clinical and radiological data were collected preoperatively. The recovery ratio in terms of JOA score was used to assess the outcome of the patients preoperatively and at 2 years postoperatively. A JOA recovery rate less than 50% was considered a poor outcome. Results Compared with good outcome group, an older mean age at operation, a longer mean duration of symptoms, a lower mean pre-operativer JOA score, and a higher proportion of diabetics were observed in poor outcome group. Patients in poor outcome group were more likely to present kyphotic cervical alignment, smaller mean transverse area of the spinal cord, and intramedullary signal abnormalities. The result of multivariate stepwise logistic regression showed that a longer duration of symptoms and the presence of T1 hypo-intensity intramedullary changes on MRI were significant risk factors of lower JOA recovery ratios. Conclusion A longer duration of symptom, T1 hypointensity on MRI and a history of minor trauma were highly predictive of a poor outcome for patients undergoing surgical treatment of OPLL. Age at operation, the history of diabetes, the preoperative JOA score, the transverse area of the spinal cord and T2 hyper-intensity on MRI were also associated with the prognosis of OPLL.	[Gu, Yifei; Cao, Peng; Yuan, Wen; Wu, Huiqiao; Yang, Lili; Tian, Ye; Liang, Lei] Second Mil Med Univ, Dept Spine Surg, Changzheng Hosp, Shanghai, Peoples R China; [Shi, Jueqian] Shanghai Chest Hosp, Dept Radiol, Shanghai, Peoples R China	Naval Medical University; Shanghai Jiao Tong University	Cao, P (corresponding author), Second Mil Med Univ, Dept Spine Surg, Changzheng Hosp, Shanghai, Peoples R China.	mdpinocao@gmail.com; yuanwen_spine@126.com			Joint Research Project on Major Diseases of Shanghai Health System [2013ZYJB0502]	Joint Research Project on Major Diseases of Shanghai Health System	This study was supported by a grant from the Joint Research Project on Major Diseases of Shanghai Health System (No. 2013ZYJB0502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvin B, 2013, SPINE, V38, P1170, DOI 10.1097/BRS.0b013e31828e23a8; Chatley A, 2009, J NEUROSURG-SPINE, V11, P562, DOI 10.3171/2009.6.SPINE091; Chen Y, 2011, J SPINAL DISORD TECH, V24, P24, DOI 10.1097/BSD.0b013e3181c7e91e; Chiba K, 2006, SPINE, V31, P2998, DOI 10.1097/01.brs.0000250307.78987.6b; Choi S, 2005, J SPINAL DISORD TECH, V18, P309, DOI 10.1097/01.bsd.0000161236.94894.fc; de Rota JJF, 2007, J NEUROSURG-SPINE, V6, P17, DOI 10.3171/spi.2007.6.1.4; Eaton SEM, 2001, LANCET, V358, P35, DOI 10.1016/S0140-6736(00)05268-5; Fujimori T, 2014, SPINE, V39, P58, DOI 10.1097/BRS.0000000000000054; Fujimura Y, 1998, J SPINAL DISORD, V11, P16; Fujiyoshi T, 2008, SPINE, V33, pE990, DOI 10.1097/BRS.0b013e318188b300; GOTO S, 1995, SPINE, V20, P2247, DOI 10.1097/00007632-199510001-00012; HIRABAYASHI K, 1981, SPINE, V6, P354, DOI 10.1097/00007632-198107000-00005; Inamasu J, 2009, J NEUROSURG SCI, V53, P93; Iwasaki M, 2002, J NEUROSURG, V96, P180, DOI 10.3171/spi.2002.96.2.0180; Iwasaki M, 2007, SPINE, V32, P654, DOI 10.1097/01.brs.0000257566.91177.cb; Iwasaki M, 2007, SPINE, V32, P647, DOI 10.1097/01.brs.0000257560.91147.86; Kalb S, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2010.12.FOCUS10265; Kato Y, 1998, J NEUROSURG, V89, P217, DOI 10.3171/jns.1998.89.2.0217; KATOH S, 1995, PARAPLEGIA, V33, P330, DOI 10.1038/sc.1995.74; Kim HJ, 2008, J BONE JOINT SURG BR, V90B, P1468, DOI 10.1302/0301-620X.90B11.20632; Lee SE, 2015, GLOB SPINE J, V5, P124, DOI 10.1055/s-0034-1397340; Lee SE, 2013, J NEUROSURG-SPINE, V18, P465, DOI 10.3171/2013.1.SPINE12779; Li H, 2008, EUR SPINE J, V17, P1277, DOI 10.1007/s00586-008-0740-8; Nouri A, 2015, SPINE, V40, P1092, DOI 10.1097/BRS.0000000000000919; Ogawa Y, 2004, J NEUROSURG-SPINE, V1, P168, DOI 10.3171/spi.2004.1.2.0168; OHSHIO I, 1993, SPINE, V18, P1140, DOI 10.1097/00007632-199307000-00005; Papadopoulos CA, 2004, ORTHOPEDICS, V27, P1087; Park YS, 2006, NEUROL MED-CHIR, V46, P231, DOI 10.2176/nmc.46.231; RAMANAUSKAS WL, 1989, J COMPUT ASSIST TOMO, V13, P399, DOI 10.1097/00004728-198905000-00005; Scardino FB, 2010, EUR SPINE J, V19, P699, DOI 10.1007/s00586-009-1267-3; Shedid D, 2007, NEUROSURGERY, V60, P7, DOI 10.1227/01.NEU.0000215430.86569.C4; SIMPSON JM, 1993, J BONE JOINT SURG AM, V75A, P1823, DOI 10.2106/00004623-199312000-00013; Steinmetz MP, 2007, NEUROSURGERY, V60, P90, DOI 10.1227/01.NEU.0000215553.49728.B0; Sun QZ, 2015, J SPINAL DISORD TECH, V28, pE304, DOI 10.1097/BSD.0b013e31828b2b59; Sun QZ, 2012, ORTHOPEDICS, V35, pE403, DOI 10.3928/01477447-20120222-38; Sun QZ, 2011, EUR SPINE J, V20, P1466, DOI 10.1007/s00586-011-1813-7; Tetreault LA, 2013, J BONE JOINT SURG AM, V95A, P1659, DOI 10.2106/JBJS.L.01323; Vedantam A, 2011, J NEUROSURG-SPINE, V15, P660, DOI 10.3171/2011.8.SPINE11452; Wada E, 1999, SPINE, V24, P455, DOI 10.1097/00007632-199903010-00009; Wang XW, 2012, EUR SPINE J, V21, P314, DOI 10.1007/s00586-011-1996-y; Yoo DS, 2010, WORLD NEUROSURG, V73, P50, DOI 10.1016/j.surneu.2009.05.021; Yoon ST, 2013, SPINE, V38, pS232, DOI 10.1097/BRS.0b013e3182a7eb55; Yu FB, 2015, J SPINAL DISORD TECH, V28, P389, DOI 10.1097/BSD.0000000000000031	43	25	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136042	10.1371/journal.pone.0136042	http://dx.doi.org/10.1371/journal.pone.0136042			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327216	gold, Green Published, Green Submitted			2022-12-26	WOS:000360437700028
J	Lehndal, L; Agren, J				Lehndal, Lina; Agren, Jon			Herbivory Differentially Affects Plant Fitness in Three Populations of the Perennial Herb Lythrum salicaria along a Latitudinal Gradient	PLOS ONE			English	Article							ENVIRONMENTAL CONTEXT INFLUENCES; PURPLE LOOSESTRIFE; INSECT HERBIVORES; ARABIDOPSIS-LYRATA; DEFENSE EVOLUTION; SIMULATED LEAF; RESISTANCE; TOLERANCE; DAMAGE; ARCHITECTURE	Herbivory can negatively and selectively affect plant fitness by reducing growth, survival and reproductive output, thereby influencing plant population dynamics and evolution. Latitudinal variation in intensity of herbivory is common, but the extent to which it translates into corresponding variation in effects on plant performance is still poorly known. We tested the hypothesis that variation in the fitness-consequences of herbivory mirror differences in intensity of herbivory among three natural populations of the perennial herb Lythrum salicaria along a latitudinal gradient from southern to northernmost Sweden. We documented intensity of herbivory and examined its effect on survival, growth and reproductive output over two years by experimentally removing herbivores with insecticide. The intensity of herbivory and the effects of herbivory on plant fitness were strongest in the southern population, intermediate in the central population and weakest in the northern population. The mean proportion of the leaf area removed ranged from 11% in the southern to 3% in the northern population. Herbivore removal increased plant height 1.5-fold in the southern and 1.2-fold in the central population, the proportion plants flowering 4-fold in the southern and 2-fold in the central population, and seed production per flower 1.6-fold in the southern and 1.2-fold in the central population, but did not affect plant fitness in the northern population. Herbivore removal thus affected the relative fecundity of plants in the three populations: In the control, seed output per plant was 8.6 times higher in the northern population compared to the southern population, whereas after herbivore removal it was 2.5 times higher in the southern population. The results demonstrate that native herbivores may strongly affect the demographic structure of L. salicaria populations and thereby shape geographic patterns of seed production. They further suggest that the strength of herbivore-mediated selection varies among populations and decreases towards the north.	[Lehndal, Lina; Agren, Jon] Uppsala Univ, Plant Ecol & Evolut, Dept Ecol & Genet, Evolutionary Biol Ctr, Uppsala, Sweden	Uppsala University	Lehndal, L (corresponding author), Uppsala Univ, Plant Ecol & Evolut, Dept Ecol & Genet, Evolutionary Biol Ctr, Uppsala, Sweden.	lina.lehndal@ebc.uu.se	Ågren, Jon/E-6093-2011	Ågren, Jon/0000-0001-9573-2463	Svenska Vaxtgeografiska Sallskapet; Regnells botaniska resestipendium; Uddeholms resestipendium; Swedish research Council	Svenska Vaxtgeografiska Sallskapet; Regnells botaniska resestipendium; Uddeholms resestipendium; Swedish research Council(Swedish Research CouncilEuropean Commission)	This study was financially supported by Svenska Vaxtgeografiska Sallskapet, Regnells botaniska resestipendium, and Uddeholms resestipendium to LL and by a grant from the Swedish research Council to JA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2012, SCIENCE, V338, P113, DOI 10.1126/science.1225977; Agren J, 2013, P NATL ACAD SCI USA, V110, P18202, DOI 10.1073/pnas.1301421110; Alonso C, 1996, J ECOL, V84, P495, DOI 10.2307/2261472; [Anonymous], 2014, R LANG ENV STAT COMP; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; BLOSSEY B, 1995, BIOL CONTROL, V5, P47, DOI 10.1006/bcon.1995.1006; Castillo G, 2013, ECOL RES, V28, P663, DOI 10.1007/s11284-013-1059-4; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; CRAWLEY MJ, 1989, ANNU REV ENTOMOL, V34, P531, DOI 10.1146/annurev.en.34.010189.002531; Didiano TJ, 2014, J ECOL, V102, P584, DOI 10.1111/1365-2745.12227; Dobzhansky T., 1950, American Scientist, V38, P209; Garcia MB, 2002, AM J BOT, V89, P1295, DOI 10.3732/ajb.89.8.1295; Grevstad FS, 2006, BIOL CONTROL, V39, P1, DOI 10.1016/j.biocontrol.2006.03.007; Hamback PA, 2003, FUNCT ECOL, V17, P87, DOI 10.1046/j.1365-2435.2003.00699.x; Hamback PA, 2000, ECOLOGY, V81, P1784, DOI 10.1890/0012-9658(2000)081[1784:ARIDTP]2.0.CO;2; Heisswolf A, 2005, ECOL ENTOMOL, V30, P299, DOI 10.1111/j.0307-6946.2005.00706.x; Hodkinson ID, 2005, BIOL REV, V80, P489, DOI 10.1017/S1464793105006767; Hulten E., 1986, ATLAS N EUROPEAN VAS, V1-3; Hunt-Joshi TR, 2004, ECOL APPL, V14, P1574, DOI 10.1890/03-5181; Juenger T, 2005, EVOL ECOL, V19, P79, DOI 10.1007/s10682-004-8090-4; Katovich EJS, 2001, WEED SCI, V49, P190, DOI 10.1614/0043-1745(2001)049[0190:EOGSFO]2.0.CO;2; Knight TM, 2003, AM J BOT, V90, P1207, DOI 10.3732/ajb.90.8.1207; Kolb A, 2007, OIKOS, V116, P864, DOI 10.1111/j.2007.0030-1299.15608.x; Lehndal L, 2015, J EVOLUTION BIOL, V28, P576, DOI 10.1111/jeb.12589; Loe G, 2007, OIKOS, V116, P134, DOI 10.1111/j.2006.0030-1299.15022.x; Maron JL, 2006, P R SOC B, V273, P2575, DOI 10.1098/rspb.2006.3587; Olsson K, 2002, J EVOLUTION BIOL, V15, P983, DOI 10.1046/j.1420-9101.2002.00457.x; Pennings SC, 2005, ECOLOGY, V86, P2310, DOI 10.1890/04-1022; Pennings SC, 2009, ECOLOGY, V90, P183, DOI 10.1890/08-0222.1; Puentes A, 2012, OECOLOGIA, V169, P1033, DOI 10.1007/s00442-012-2276-1; Rasmann S, 2011, ECOL LETT, V14, P476, DOI 10.1111/j.1461-0248.2011.01609.x; Schat M, 2005, ENVIRON ENTOMOL, V34, P906, DOI 10.1603/0046-225X-34.4.906; Schemske DW, 2009, ANNU REV ECOL EVOL S, V40, P245, DOI 10.1146/annurev.ecolsys.39.110707.173430; Stenberg JA, 2006, OECOLOGIA, V148, P414, DOI 10.1007/s00442-006-0390-7; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; von Euler T, 2014, ECOLOGY, V95, P495, DOI 10.1890/13-0528.1; Wieski K, 2014, ECOGRAPHY, V37, P763, DOI 10.1111/ecog.00498; Wise MJ, 2007, AM NAT, V169, P443, DOI 10.1086/512044	38	20	21	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0135939	10.1371/journal.pone.0135939	http://dx.doi.org/10.1371/journal.pone.0135939			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325383	Green Published, Green Submitted, gold			2022-12-26	WOS:000360437700025
J	Liu, Q; Li, R; Zhou, RL; Li, J; Gu, Q				Liu, Qing; Li, Rui; Zhou, Renlai; Li, Juan; Gu, Quan			Abnormal Resting-State Connectivity at Functional MRI in Women with Premenstrual Syndrome	PLOS ONE			English	Article							MENSTRUAL-CYCLE PHASE; DISORDER; STRESS; REACTIVITY	Objectives Premenstrual syndrome (PMS) refers to a series of cycling and relapsing physical, emotion and behavior syndromes that occur in the luteal phase and resolve soon after the onset of menses. Although PMS is widely recognized, its neural mechanism is still unclear. Design To address this question, we measured brain activity for women with PMS and women without PMS (control group) using resting-state functional magnetic resonance imaging (rs-fMRI). In addition, the participants should complete the emotion scales (Beck Anxiety Inventory, BAI; Beck Depression Inventory, BDI, before the scanning) as well as the stress perception scale (Visual analog scale for stress, VAS, before and after the scanning). Results The results showed that compared with the control group, the PMS group had decreased connectivity in the middle frontal gyrus (MFG) and theparahippocampalgyrus (PHG), as well as increased connectivity in the left medial/superior temporal gyri (MTG/STG) and pre-centralgyrus within the default mode network (DMN); in addition, the PMS group had higher anxiety and depression scale scores, together with lower stress perception scores. Finally, there were significantly positive correlations between the stress perception scores and functional connectivity in the MFG and cuneus. The BDI scores in the PMS group were correlated negatively with the functional connectivity in the MFG and precuneus and correlated positively with the functional connectivity in the MTG. Conclusion These findings suggest that compared with normal women, women with PMS displayed abnormal stress sensitivity, which was reflected in the decreased and increased functional connectivity within the DMN, blunted stress perception and higher depression.	[Liu, Qing; Zhou, Renlai; Gu, Quan] Beijing Normal Univ, Beijing Key Lab Appl Expt Psychol, Sch Psychol, Beijing 100875, Peoples R China; [Zhou, Renlai] Nanjing Univ, Sch Social & Behav Sci, Dept Psychol, Nanjing 210008, Jiangsu, Peoples R China; [Liu, Qing; Zhou, Renlai; Gu, Quan] Beijing Normal Univ, Res Ctr Emot Regulat, Beijing 100875, Peoples R China; [Zhou, Renlai] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Zhou, Renlai] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing 100875, Peoples R China; [Li, Rui; Li, Juan] Chinese Acad Sci, Inst Psychol, Ctr Aging Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China	Beijing Normal University; Nanjing University; Beijing Normal University; Beijing Normal University; Beijing Normal University; Chinese Academy of Sciences; Institute of Psychology, CAS	Zhou, RL (corresponding author), Beijing Normal Univ, Beijing Key Lab Appl Expt Psychol, Sch Psychol, Beijing 100875, Peoples R China.	rlzhou@nju.edu.cn	liu, qingqing/HHD-0360-2022; Liu, Qing/GWC-9222-2022; Zhou, Renlai/ABA-1226-2021	Zhou, Renlai/0000-0001-7035-7097; li, rui/0000-0002-4101-5415	National Basic Research Program of China [2011CB505101]; key lab open project of Beijing University of Chinese Medicine [2011-SYSKFKT03]; Shangshan funding	National Basic Research Program of China(National Basic Research Program of China); key lab open project of Beijing University of Chinese Medicine; Shangshan funding	The work was funded by the National Basic Research Program of China (No. 2011CB505101) and the key lab open project of Beijing University of Chinese Medicine (2011-SYSKFKT03), as well as the Shangshan funding. The authors would like to express their gratitude for the support of the project.	Bancroft J, 1993, PSYCHOL MED MONO S24; Bannbers E, 2012, J AFFECT DISORDERS, V142, P347, DOI 10.1016/j.jad.2012.04.006; Bluhm RL, 2009, J PSYCHIATR NEUROSCI, V34, P187; Brosschot JF, 2010, NEUROSCI BIOBEHAV R, V35, P46, DOI 10.1016/j.neubiorev.2010.01.004; CHAPMAN JP, 1987, J ABNORM PSYCHOL, V96, P89, DOI 10.1037/0021-843X.96.2.89; [陈春萍 Chen Chunping], 2011, [中国科学. 生命科学, Scientia Sinica Vitae], V41, P1049; Daniels JK, 2010, J PSYCHIATR NEUROSCI, V35, P258, DOI 10.1503/jpn.090010; Epperson CN, 2007, NEUROPSYCHOPHARMACOL, V32, P2190, DOI 10.1038/sj.npp.1301351; Gingnell M, 2012, HORM BEHAV, V62, P400, DOI 10.1016/j.yhbeh.2012.07.005; Hellhammer J, 2012, PSYCHONEUROENDOCRINO, V37, P119, DOI 10.1016/j.psyneuen.2011.05.012; Hjelmervik H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103492; Ismail KMK, 2005, CURR OBSTET GYNAECOL, V15, P25, DOI DOI 10.1007/S13224-011-0117-5; Kirschbaum C, 1999, PSYCHOSOM MED, V61, P154, DOI 10.1097/00006842-199903000-00006; Klatzkin RR, 2014, J PSYCHOSOM RES, V76, P46, DOI 10.1016/j.jpsychores.2013.11.002; Lanius RA, 2010, ACTA PSYCHIAT SCAND, V121, P33, DOI 10.1111/j.1600-0447.2009.01391.x; Ossewaarde L, 2010, PSYCHONEUROENDOCRINO, V35, P47, DOI 10.1016/j.psyneuen.2009.08.011; Petersen N, 2014, NEUROIMAGE, V90, P24, DOI 10.1016/j.neuroimage.2013.12.016; Protopopescu X, 2008, J AFFECT DISORDERS, V108, P87, DOI 10.1016/j.jad.2007.09.015; Sripada RK, 2012, PSYCHOSOM MED, V74, P904, DOI 10.1097/PSY.0b013e318273bf33; Wang X., 1999, CHIN MENT HLTH J, V12, P238	20	19	21	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136029	10.1371/journal.pone.0136029	http://dx.doi.org/10.1371/journal.pone.0136029			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ2NK	26325510	Green Published, gold, Green Submitted			2022-12-26	WOS:000360437700026
J	Mosnier, A; Caini, S; Daviaud, I; Nauleau, E; Bui, TT; Debost, E; Bedouret, B; Agius, G; van der Werf, S; Lina, B; Cohen, JM				Mosnier, Anne; Caini, Saverio; Daviaud, Isabelle; Nauleau, Elodie; Bui, Tan Tai; Debost, Emmanuel; Bedouret, Bernard; Agius, Gerard; van der Werf, Sylvie; Lina, Bruno; Cohen, Jean Marie		GROG Network	Clinical Characteristics Are Similar across Type A and B Influenza Virus Infections	PLOS ONE			English	Article							SEASONAL INFLUENZA; SURVEILLANCE; POPULATION; GUANGZHOU; LINEAGES; VICTORIA; FEATURES; ILLNESS; STRAINS; BURDEN	Background Studies that aimed at comparing the clinical presentation of influenza patients across virus types and subtypes/lineages found divergent results, but this was never investigated using data collected over several years in a countrywide, primary care practitioners-based influenza surveillance system. Methods The IBVD (Influenza B in Vircases Database) study collected information on signs and symptoms at disease onset from laboratory-confirmed influenza patients of any age who consulted a sentinel practitioner in France. We compared the clinical presentation of influenza patients across age groups (0-4, 5-14, 15-64 and 65+ years), virus types (A, B) and subtypes/lineages (A(H3N2), pandemic A(H1N1), B Victoria, B Yamagata). Results Overall, 14,423 influenza cases (23.9% of which were influenza B) were included between 2003-2004 and 2012-2013. Influenza A and B accounted for over 50% of total influenza cases during eight and two seasons, respectively. There were minor differences in the distribution of signs and symptoms across influenza virus types and subtypes/lineages. Compared to patients aged 0-4 years, those aged 5-14 years were more likely to have been infected with type B viruses (OR 2.15, 95% CI 1.87-2.47) while those aged 15-64 years were less likely (OR 0.83, 95% CI 0.73-0.96). Males and influenza patients diagnosed during the epidemic period were less likely to be infected with type B viruses. Conclusions Despite differences in age distribution, the clinical illness produced by the different influenza virus types and subtypes is indistinguishable among patients that consult a general practitioner for acute respiratory infections.	[Mosnier, Anne; Caini, Saverio; Daviaud, Isabelle; Nauleau, Elodie; Bui, Tan Tai; Cohen, Jean Marie] Open Rome Organize & Promote Epidemiol Network, Paris, France; [Debost, Emmanuel; Bedouret, Bernard] GROG Network, Paris, France; [Agius, Gerard] Ctr Hosp Univ Poitiers, Lab Virol, Poitiers, France; [van der Werf, Sylvie] Univ Paris Diderot, Ctr Natl Reference Virus Influenza, Genet Mol Virus Resp, Inst Pasteur,CNRS UMR 3569,Sorbonne Paris Cite, Paris, France; [Lina, Bruno] Univ Lyon 1, Hosp Civils Lyon & Virpath, Ctr Natl Reference Virus Influenza, CBPE, F-69365 Lyon, France	CHU Poitiers; Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Mosnier, A (corresponding author), Open Rome Organize & Promote Epidemiol Network, Paris, France.	amos@openrome.org; enauleau@openrome.org	Caini, Saverio/AAI-3788-2020; lina, bruno/N-3663-2019	Caini, Saverio/0000-0002-2262-1102; lina, bruno/0000-0002-8959-2123; van der WERF, Sylvie/0000-0002-1148-4456	GSK Biologicals SA	GSK Biologicals SA(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	IBVD study was funded by GSK Biologicals SA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biere B, 2010, J CLIN MICROBIOL, V48, P1425, DOI 10.1128/JCM.02116-09; Chi CY, 2008, PEDIATR INFECT DIS J, V27, P640, DOI 10.1097/INF.0b013e31816be008; Daley AJ, 2000, J PAEDIATR CHILD H, V36, P332, DOI 10.1046/j.1440-1754.2000.00533.x; Glezen WP, 2013, AM J PUBLIC HEALTH, V103, pE43, DOI 10.2105/AJPH.2012.301137; Gordon A, 2010, CLIN INFECT DIS, V50, P1462, DOI 10.1086/652647; HANNOUN C, 1989, EUR J EPIDEMIOL, V5, P285, DOI 10.1007/BF00144828; Heymann DL, 2008, CONTROL COMMUNICABLE; Hite LK, 2007, INT J INFECT DIS, V11, P40, DOI 10.1016/j.ijid.2005.10.008; Hu Jen-Jan, 2004, Journal of Microbiology Immunology and Infection, V37, P95; Irving SA, 2012, INFLUENZA OTHER RESP, V6, P37, DOI 10.1111/j.1750-2659.2011.00263.x; Kiertiburanakul S, 2014, JPN J INFECT DIS, V67, P33, DOI 10.7883/yoken.67.33; Kilbourne ED, 1975, INFLUENZA VIRUS INFL; Lemaitre M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-162; Meerhoff T J, 2004, Euro Surveill, V9, P34; Mertz D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5061; Peltola V, 2003, CLIN INFECT DIS, V36, P299, DOI 10.1086/345909; Purakayastha DR, 2013, INDIAN J MED RES, V138, P962; Richard SA, 2010, VACCINE, V28, P2693, DOI 10.1016/j.vaccine.2010.01.053; Schnepf N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023514; Shaw MW, 2002, VIROLOGY, V303, P1, DOI 10.1006/viro.2002.1719; Shen CF, 2008, J MICROBIOL IMMUNOL, V41, P294; Steininger C, 2002, J CLIN MICROBIOL, V40, P2051, DOI 10.1128/JCM.40.6.2051-2056.2002; Tan Y, 2013, J VIROL, V87, P12447, DOI 10.1128/JVI.01039-13; Van Cauteren D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-947; VanWormer JJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-231; Webster RG, 2013, TEXTBOOK OF INFLUENZA, 2ND EDITION, P1, DOI 10.1002/9781118636817; WHO, 2011, INF MOL DIAGN INFL V; Wie SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062685; Yang ZF, 2012, JPN J INFECT DIS, V65, P208, DOI 10.7883/yoken.65.208; Yap J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-12	30	63	63	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136186	10.1371/journal.pone.0136186	http://dx.doi.org/10.1371/journal.pone.0136186			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325069	Green Published, gold, Green Submitted			2022-12-26	WOS:000360437700033
J	Saito, Y; Fujiwara, T; Ohashi, K; Okitsu, Y; Fukuhara, N; Onishi, Y; Ishizawa, K; Harigae, H				Saito, Yo; Fujiwara, Tohru; Ohashi, Keiichi; Okitsu, Yoko; Fukuhara, Noriko; Onishi, Yasushi; Ishizawa, Kenichi; Harigae, Hideo			High-Throughput siRNA Screening to Reveal GATA-2 Upstream Transcriptional Mechanisms in Hematopoietic Cells	PLOS ONE			English	Article							GENE-EXPRESSION; STEM; MUTATIONS; CITED2; DIFFERENTIATION; IDENTIFICATION; DEFICIENCY; REGULATORS; NETWORK	Hematopoietic stem cells can self-renew and differentiate into all blood cell types. The transcription factor GATA-2 is expressed in both hematopoietic stem and progenitor cells and is essential for cell proliferation, survival, and differentiation. Recently, evidence from studies of aplastic anemia, MonoMAC syndrome, and lung cancer has demonstrated a mechanistic link between GATA-2 and human pathophysiology. GATA-2-dependent disease processes have been extensively analyzed; however, the transcriptional mechanisms upstream of GATA-2 remain less understood. Here, we conducted high-throughput small-interferingRNA (siRNA) library screening and showed that YN-1, a human erythroleukemia cell line, expressed high levels of GATA-2 following the activation of the hematopoietic-specific 1S promoter. As transient luciferase reporter assay in YN-1 cells revealed the highest promoter activity in the 1S promoter fused with GATA-2 intronic enhancer (+9.9 kb/1S); therefore, we established a cell line capable of stably expressing +9.9 kb/1S-Luciferase. Subsequently, we screened 995 transcription factor genes and revealed that CITED2 acts as a GATA-2 activator in human hematopoietic cells. These results provide novel insights into and further identify the regulatory mechanism of GATA-2.	[Saito, Yo; Fujiwara, Tohru; Ohashi, Keiichi; Okitsu, Yoko; Fukuhara, Noriko; Onishi, Yasushi; Ishizawa, Kenichi; Harigae, Hideo] Tohoku Univ, Dept Hematol & Rheumatol, Grad Sch Med, Sendai, Miyagi 980, Japan; [Fujiwara, Tohru; Harigae, Hideo] Tohoku Univ, Mol Hematol Oncol, Grad Sch Med, Sendai, Miyagi 980, Japan; [Ishizawa, Kenichi] Yamagata Univ, Dept Hematol & Cell Therapy, Fac Med, Yamagata 990, Japan	Tohoku University; Tohoku University; Yamagata University	Harigae, H (corresponding author), Tohoku Univ, Dept Hematol & Rheumatol, Grad Sch Med, Sendai, Miyagi 980, Japan.	harigae@med.tohoku.ac.jp	Fujiwara, Tohru/GOG-9775-2022		KANAE Foundation for the Promotion of Medical Science; Sanofi KK; Chugai Pharmaceutical Co., Ltd.	KANAE Foundation for the Promotion of Medical Science; Sanofi KK; Chugai Pharmaceutical Co., Ltd.	This study was supported by KANAE Foundation for the Promotion of Medical Science (TF) (http://www.kanae-zaidan.com) which receives financial support from Sanofi KK, and by a research grant from Chugai Pharmaceutical Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bresnick EH, 2010, J BIOL CHEM, V285, P31087, DOI 10.1074/jbc.R110.159079; Chen Y, 2007, BLOOD, V110, P2889, DOI 10.1182/blood-2007-01-066316; Cortes-Lavaud X, 2012, BLOOD, V120, DOI 10.1182/blood.V120.21.1233.1233; Dickinson RE, 2011, BLOOD, V118, P2656, DOI 10.1182/blood-2011-06-360313; Ding XL, 2012, STEM CELLS DEV, V21, P121, DOI 10.1089/scd.2010.0539; DORFMAN DM, 1992, J BIOL CHEM, V267, P1279; ENDO K, 1993, BRIT J HAEMATOL, V85, P653, DOI 10.1111/j.1365-2141.1993.tb03205.x; EVANS T, 1988, P NATL ACAD SCI USA, V85, P5976, DOI 10.1073/pnas.85.16.5976; Ezoe S, 2002, BLOOD, V100, P3512, DOI 10.1182/blood-2002-04-1177; Fujimaki S, 2001, BRIT J HAEMATOL, V113, P52, DOI 10.1046/j.1365-2141.2001.02736.x; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Fujiwara T, 2014, ANN HEMATOL, V93, P1515, DOI 10.1007/s00277-014-2090-4; Fujiwara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040959; Guiu J, 2013, J EXP MED, V210, P71, DOI 10.1084/jem.20120993; Harigae H, 2006, TOHOKU J EXP MED, V210, P1, DOI 10.1620/tjem.210.1; Hsu AP, 2011, BLOOD, V118, P2653, DOI 10.1182/blood-2011-05-356352; Johnson KD, 2012, J CLIN INVEST, V122, P3692, DOI 10.1172/JCI61623; Kamata M, 2014, HAEMATOLOGICA, V99, P1686, DOI 10.3324/haematol.2014.105692; Khandekar M, 2007, DEVELOPMENT, V134, P1703, DOI 10.1242/dev.001297; KOEFFLER HP, 1980, BLOOD, V56, P265; Korthuis PM, 2015, LEUKEMIA, V29, P625, DOI 10.1038/leu.2014.259; Kranc KR, 2009, CELL STEM CELL, V5, P659, DOI 10.1016/j.stem.2009.11.001; Kranc KR, 2003, MOL CELL BIOL, V23, P7658, DOI 10.1128/MCB.23.21.7658-7666.2003; Kumar MS, 2012, CELL, V149, P642, DOI 10.1016/j.cell.2012.02.059; Lim KC, 2000, NAT GENET, V25, P209, DOI 10.1038/76080; MARTIN DIK, 1990, NATURE, V344, P444, DOI 10.1038/344444a0; Minegishi N, 1998, J BIOL CHEM, V273, P3625, DOI 10.1074/jbc.273.6.3625; Moriguchi T, 2014, INT J HEMATOL, V100, P417, DOI 10.1007/s12185-014-1568-0; Orkin SH, 2008, CELL, V132, P712, DOI 10.1016/j.cell.2008.02.013; Ostergaard P, 2011, NAT GENET, V43, P929, DOI 10.1038/ng.923; Pan XQ, 2000, J BIOCHEM, V127, P105, DOI 10.1093/oxfordjournals.jbchem.a022570; Rodrigues NP, 2005, BLOOD, V106, P477, DOI 10.1182/blood-2004-08-2989; Sanalkumar R, 2014, P NATL ACAD SCI USA, V111, pE1091, DOI 10.1073/pnas.1400065111; Snow JW, 2011, BLOOD, V117, P4769, DOI 10.1182/blood-2010-10-313031; Snow JW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001103; Trompouki E, 2011, CELL, V147, P577, DOI 10.1016/j.cell.2011.09.044; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; Wozniak RJ, 2007, J BIOL CHEM, V282, P14665, DOI 10.1074/jbc.M700792200; YAMAMOTO M, 1990, GENE DEV, V4, P1650, DOI 10.1101/gad.4.10.1650; Zeng WH, 2004, BLOOD, V103, P325, DOI 10.1182/blood-2003-02-0490	41	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137079	10.1371/journal.pone.0137079	http://dx.doi.org/10.1371/journal.pone.0137079			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325290	Green Published, gold, Green Submitted			2022-12-26	WOS:000360437700090
J	Carmel, MS; Kahane, N; Oberman, F; Miloslavski, R; Sela-Donenfeld, D; Kalcheim, C; Yisraeli, JK				Carmel, Michal Shoshkes; Kahane, Nitza; Oberman, Froma; Miloslavski, Rachel; Sela-Donenfeld, Dalit; Kalcheim, Chaya; Yisraeli, Joel K.			A Novel Role for VICKZ Proteins in Maintaining Epithelial Integrity during Embryogenesis	PLOS ONE			English	Article							MESSENGER-RNA LOCALIZATION; NEURAL CREST MIGRATION; CELL-MIGRATION; BINDING PROTEIN-3; VG1 RBP; EXPRESSION; BETA; CANCER; GROWTH; CARCINOMA	Background VICKZ (IGF2BP1,2,3/ZBP1/Vg1RBP/IMP1,2,3) proteins bind RNA and help regulate many RNA-mediated processes. In the midbrain region of early chick embryos, VICKZ is expressed in the neural folds and along the basal surface of the neural epithelium, but, upon neural tube closure, is down-regulated in prospective cranial neural crest (CNC) cells, concomitant with their emigration and epithelial-to-mesenchymal transition (EMT). Electroporation of constructs that modulate cVICKZ expression demonstrates that this down-regulation is both necessary and sufficient for CNC EMT. These results suggest that VICKZ down-regulation in CNC cell-autonomously promotes EMT and migration. Reduction of VICKZ throughout the embryo, however, inhibits CNC migration non-cell-autonomously, as judged by transplantation experiments in Xenopus embryos. Results and Conclusions Given the positive role reported for VICKZ proteins in promoting cell migration of chick embryo fibroblasts and many types of cancer cells, we have begun to look for specific mRNAs that could mediate context-specific differences. We report here that the laminin receptor, integrin alpha 6, is down-regulated in the dorsal neural tube when CNC cells emigrate, this process is mediated by cVICKZ, and integrin alpha 6 mRNA is found in VICKZ ribonucleoprotein complexes. Significantly, prolonged inhibition of cVICKZ in either the neural tube or the nascent dermomyotome sheet, which also dynamically expresses cVICKZ, induces disruption of these epithelia. These data point to a previously unreported role for VICKZ in maintaining epithelial integrity.	[Carmel, Michal Shoshkes; Oberman, Froma; Miloslavski, Rachel; Yisraeli, Joel K.] Hebrew Univ Jerusalem, Fac Med, Dept Dev Biol & Canc Res, Jerusalem, Israel; [Kahane, Nitza; Kalcheim, Chaya] Hebrew Univ Jerusalem, Fac Med, IMRIC, Dept Med Neurobiol, Jerusalem, Israel; [Sela-Donenfeld, Dalit] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Koret Sch Vet Med, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Yisraeli, JK (corresponding author), Hebrew Univ Jerusalem, Fac Med, Dept Dev Biol & Canc Res, Jerusalem, Israel.	yisraeli@cc.huji.ac.il	Shoshkes Carmel, Michal/AAY-5113-2021; Yisraeli, Joel/S-2031-2019	Shoshkes Carmel, Michal/0000-0002-8406-2158; Yisraeli, Joel/0000-0001-6538-6686; Sela-Donenfeld, Dalit/0000-0001-7498-061X	Israel Science Foundation; Company of Biologists Travel Fellowship	Israel Science Foundation(Israel Science Foundation); Company of Biologists Travel Fellowship	Funded by Israel Science Foundation (JKY) and Company of Biologists Travel Fellowship (MSC).	Adereth Y, 2005, NAT CELL BIOL, V7, P1240, DOI 10.1038/ncb1335; Alfandari D, 2010, CELL ADHES MIGR, V4, P553, DOI 10.4161/cam.4.4.12202; Bell JL, 2013, CELL MOL LIFE SCI, V70, P2657, DOI 10.1007/s00018-012-1186-z; Borchers A, 2001, DEVELOPMENT, V128, P3049; BRONNERFRASER M, 1992, DEVELOPMENT, V115, P197; Chen CL, 2013, J CLIN INVEST, V123, P2832, DOI 10.1172/JCI65859; DALE L, 1987, DEVELOPMENT, V99, P527; Davidson B, 2014, HUM PATHOL, V45, P1520, DOI 10.1016/j.humpath.2014.03.005; Donnelly CJ, 2011, EMBO J, V30, P4665, DOI 10.1038/emboj.2011.347; DUBAND JL, 1987, DEVELOPMENT, V101, P461; Epstein M, 1997, DEVELOPMENT, V124, P3805; Farina KL, 2003, J CELL BIOL, V160, P77, DOI 10.1083/jcb.200206003; Findeis-Hosey JJ, 2012, BIOTECH HISTOCHEM, V87, P24, DOI 10.3109/10520295.2011.591831; Gu W, 2012, J CELL SCI, V125, P81, DOI 10.1242/jcs.086132; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HAY ED, 1995, AM J KIDNEY DIS, V26, P678, DOI 10.1016/0272-6386(95)90610-X; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Jayaseelan S, 2014, METHODS, V67, P13, DOI 10.1016/j.ymeth.2013.11.001; Kahane N, 2013, DEVELOPMENT, V140, P1740, DOI 10.1242/dev.092726; Kalcheim C, 2005, CURR OPIN GENET DEV, V15, P371, DOI 10.1016/j.gde.2005.05.004; KLEIN G, 1988, CELL, V55, P331, DOI 10.1016/0092-8674(88)90056-6; Kobel M, 2007, ONCOGENE, V26, P7584, DOI 10.1038/sj.onc.1210563; Kobel M, 2009, MODERN PATHOL, V22, P469, DOI 10.1038/modpathol.2008.206; Lederer M, 2014, SEMIN CANCER BIOL, V29, P3, DOI 10.1016/j.semcancer.2014.07.006; Matthews HK, 2008, DEVELOPMENT, V135, P1771, DOI 10.1242/dev.017350; McLennan R, 2015, DEVELOPMENT, V142, P2014, DOI 10.1242/dev.117507; McLennan R, 2012, DEVELOPMENT, V139, P2935, DOI 10.1242/dev.081471; Milet C, 2012, DEV BIOL, V366, P22, DOI 10.1016/j.ydbio.2012.01.013; Mongroo PS, 2011, CANCER RES, V71, P2172, DOI 10.1158/0008-5472.CAN-10-3295; Monsonego-Ornan E, 2012, DEV BIOL, V364, P162, DOI 10.1016/j.ydbio.2012.01.028; MOODY SA, 1987, DEV BIOL, V122, P300, DOI 10.1016/0012-1606(87)90296-X; Natkunam Y, 2007, HAEMATOLOGICA, V92, P176, DOI 10.3324/haematol.10724; Oberman F, 2007, RNA, V13, P1558, DOI 10.1261/rna.559507; Oleynikov Y, 2003, CURR BIOL, V13, P199, DOI 10.1016/S0960-9822(03)00044-7; Patel VL, 2012, GENE DEV, V26, P43, DOI 10.1101/gad.177428.111; Samanta S, 2012, ONCOGENE, V31, P4689, DOI 10.1038/onc.2011.620; Sasaki Y, 2010, J NEUROSCI, V30, P9349, DOI 10.1523/JNEUROSCI.0499-10.2010; Shigdar S, 2011, CANCER SCI, V102, P991, DOI 10.1111/j.1349-7006.2011.01897.x; SOROKIN L, 1990, J CELL BIOL, V111, P1265, DOI 10.1083/jcb.111.3.1265; Theveneau E, 2013, NAT CELL BIOL, V15, P763, DOI 10.1038/ncb2772; Theveneau E, 2012, DEV BIOL, V366, P34, DOI 10.1016/j.ydbio.2011.12.041; Tzu J, 2008, INT J BIOCHEM CELL B, V40, P199, DOI 10.1016/j.biocel.2007.07.015; Ulmer B, 2013, CELL REP, V3, P615, DOI 10.1016/j.celrep.2013.02.015; Vainer G, 2008, J PATHOL, V215, P445, DOI 10.1002/path.2376; Walter O, 2009, HUM PATHOL, V40, P1528, DOI 10.1016/j.humpath.2009.05.005; Wang WG, 2004, CANCER RES, V64, P8585, DOI 10.1158/0008-5472.CAN-04-1136; Weston JA, 2015, DEV BIOL, V401, P37, DOI 10.1016/j.ydbio.2014.12.035; Yaniv K, 2003, DEVELOPMENT, V130, P5649, DOI 10.1242/dev.00810; Yisraeli JK, 2005, BIOL CELL, V97, P87; Zhang QH, 1999, MECH DEVELOP, V88, P101, DOI 10.1016/S0925-4773(99)00162-8	50	6	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136408	10.1371/journal.pone.0136408	http://dx.doi.org/10.1371/journal.pone.0136408			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317350	Green Submitted, Green Published, gold			2022-12-26	WOS:000360299100083
J	Hovick, TJ; Dahlgren, DK; Papes, M; Elmore, RD; Pitman, JC				Hovick, Torre J.; Dahlgren, David K.; Papes, Monica; Elmore, R. Dwayne; Pitman, James C.			Predicting Greater Prairie-Chicken Lek Site Suitability to Inform Conservation Actions	PLOS ONE			English	Article							SPECIES DISTRIBUTION; ENERGY DEVELOPMENT; WIND ENERGY; IMPACTS; BIODIVERSITY; POPULATIONS; VEGETATION; LOCATION; HABITAT; NESTS	The demands of a growing human population dictates that expansion of energy infrastructure, roads, and other development frequently takes place in native rangelands. Particularly, transmission lines and roads commonly divide rural landscapes and increase fragmentation. This has direct and indirect consequences on native wildlife that can be mitigated through thoughtful planning and proactive approaches to identifying areas of high conservation priority. We used nine years (2003-2011) of Greater Prairie-Chicken (Tympanuchus cupido) lek locations totaling 870 unique leks sites in Kansas and seven geographic information system (GIS) layers describing land cover, topography, and anthropogenic structures to model habitat suitability across the state. The models obtained had low omission rates (<0.18) and high area under the curve scores (AUC>0.81), indicating high model performance and reliability of predicted habitat suitability for Greater Prairie-Chickens. We found that elevation was the most influential in predicting lek locations, contributing three times more predictive power than any other variable. However, models were improved by the addition of land cover and anthropogenic features (transmission lines, roads, and oil and gas structures). Overall, our analysis provides a hierarchal understanding of Greater Prairie-Chicken habitat suitability that is broadly based on geomorphological features followed by land cover suitability. We found that when land features and vegetation cover are suitable for Greater Prairie-Chickens, fragmentation by anthropogenic sources such as roadways and transmission lines are a concern. Therefore, it is our recommendation that future human development in Kansas avoid areas that our models identified as highly suitable for Greater Prairie-Chickens and focus development on land cover types that are of lower conservation concern.	[Hovick, Torre J.] N Dakota State Univ, Sch Nat Resource Sci, Range Program, Fargo, ND 58105 USA; [Dahlgren, David K.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Papes, Monica] Oklahoma State Univ, Dept Integrat Biol, Stillwater, OK 74078 USA; [Elmore, R. Dwayne] Oklahoma State Univ, Dept Nat Resource Ecol & Management, Stillwater, OK 74078 USA; [Pitman, James C.] Western Assoc Fish & Wildlife Agencies, Emporia, KS USA	North Dakota State University Fargo; Utah System of Higher Education; Utah State University; Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater	Hovick, TJ (corresponding author), N Dakota State Univ, Sch Nat Resource Sci, Range Program, Fargo, ND 58105 USA.	torre.hovick@gmail.com			USDA-AFRI (United States Department of Agriculture - Agriculture and Food Research Initiative) [2010-85101-20457]; Oklahoma Agricultural Experiment Station	USDA-AFRI (United States Department of Agriculture - Agriculture and Food Research Initiative); Oklahoma Agricultural Experiment Station	This work was supported by funding from USDA-AFRI (United States Department of Agriculture - Agriculture and Food Research Initiative) Managed Ecosystems grant #2010-85101-20457 and by the Oklahoma Agricultural Experiment Station.	Dzialak MR, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00325.1; ESRI, 2011, ARCGIS DESKT REL 10; Ferrier S, 2002, SYST BIOL, V51, P331, DOI 10.1080/10635150252899806; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hagen CA, 2004, WILDLIFE SOC B, V32, P69, DOI 10.2193/0091-7648(2004)32[69:GFMLPP]2.0.CO;2; Hamerstrom Jr F. N., 1973, WISCONSIN DEP NATURA, V64; Holloran MJ, 2010, J WILDLIFE MANAGE, V74, P65, DOI 10.2193/2008-291; Hovick TJ, 2015, RANGELAND ECOL MANAG, V68, P186, DOI 10.1016/j.rama.2015.01.009; Hovick TJ, 2014, J APPL ECOL, V51, P1680, DOI 10.1111/1365-2664.12331; International Energy Agency, WORLD EN OUTL 2009; Jarnevich CS, 2011, ENVIRON MANAGE, V47, P926, DOI 10.1007/s00267-011-9651-2; Jimenez-Valverde A, 2012, GLOBAL ECOL BIOGEOGR, V21, P498, DOI 10.1111/j.1466-8238.2011.00683.x; Johnsgard PA, 2002, GRASSLAND GROUSE THE, P1; Jones NF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081391; Loss SR, 2013, BIOL CONSERV, V168, P201, DOI 10.1016/j.biocon.2013.10.007; McDonald RI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006802; Mcnew LB, 2014, CONSERV BIOL, V28, P1089, DOI 10.1111/cobi.12258; Mcnew LB, 2012, J WILDLIFE MANAGE, V76, P38, DOI 10.1002/jwmg.237; Niemuth ND, 2000, J WILDLIFE MANAGE, V64, P278, DOI 10.2307/3803000; Obermeyer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026698; Patten MA, 2007, TALL TIMB FIRE ECOL, P149; Rodriguez JP, 2007, DIVERS DISTRIB, V13, P243, DOI 10.1111/j.1472-4642.2007.00356.x; Pearce-Higgins JW, 2012, J APPL ECOL, V49, P386, DOI 10.1111/j.1365-2664.2012.02110.x; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pitman JC, 2005, J WILDLIFE MANAGE, V69, P1259, DOI 10.2193/0022-541X(2005)069[1259:LASOLP]2.0.CO;2; Polak T, 2014, J APPL ECOL, V51, P726, DOI 10.1111/1365-2664.12243; Pruett CL, 2009, CONSERV BIOL, V23, P1253, DOI 10.1111/j.1523-1739.2009.01254.x; Pruett CL, 2009, BIOSCIENCE, V59, P257, DOI 10.1525/bio.2009.59.3.10; Robbins MB, 2002, N AM BIRDS, P2; ROBEL RI, 1970, J RANGE MANAGE, V23, P295, DOI 10.2307/3896225; Sawyer H, 2009, ECOL APPL, V19, P2016, DOI 10.1890/08-2034.1; SCHROEDER MA, 1993, BEHAV ECOL, V4, P266, DOI 10.1093/beheco/4.3.266; Schroeder MA, 1993, BIRDS N AM ACCOUNT; Schroeder MA, 2011, WILDLIFE SOC B, V29, P24; Svedarsky WD, 2000, WILDLIFE BIOL, V6, P277, DOI 10.2981/wlb.2000.027; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Winder VL, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00206.1; Winder VL, 2015, CONDOR, V117, P284, DOI 10.1650/CONDOR-14-98.1; With KA, 2008, BIOL CONSERV, V141, P3152, DOI 10.1016/j.biocon.2008.09.025	43	14	14	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137021	10.1371/journal.pone.0137021	http://dx.doi.org/10.1371/journal.pone.0137021			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317349	Green Published, Green Submitted, gold			2022-12-26	WOS:000360299100195
J	Hu, YQ; Su, ZY; Li, WB; Li, JP; Ke, XD				Hu, Yanqiu; Su, Zhiyao; Li, Wenbin; Li, Jingpeng; Ke, Xiandong			Influence of Tree Species Composition and Community Structure on Carbon Density in a Subtropical Forest	PLOS ONE			English	Article							SOIL ORGANIC-CARBON; ECOSYSTEM SERVICES; BIOMASS; STOCK; VEGETATION; CLIMATE	We assessed the impact of species composition and stand structure on the spatial variation of forest carbon density using data collected from a 4-ha plot in a subtropical forest in southern China. We found that 1) forest biomass carbon density significantly differed among communities, reflecting a significant effect of community structure and species composition on carbon accumulation; 2) soil organic carbon density increased whereas stand biomass carbon density decreased across communities, indicating that different mechanisms might account for the accumulation of stand biomass carbon and soil organic carbon in the subtropical forest; and 3) a small number of tree individuals of the medium- and large-diameter class contributed predominantly to biomass carbon accumulation in the community, whereas a large number of seedlings and saplings were responsible for a small proportion of the total forest carbon stock. These findings demonstrate that both biomass carbon and soil carbon density in the subtropical forest are sensitive to species composition and community structure, and that heterogeneity in species composition and stand structure should be taken into account to ensure accurate forest carbon accounting.	[Hu, Yanqiu; Su, Zhiyao; Li, Wenbin; Li, Jingpeng; Ke, Xiandong] South China Agr Univ, Coll Forestry, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Su, ZY (corresponding author), South China Agr Univ, Coll Forestry, Guangzhou, Guangdong, Peoples R China.	zysu@scau.edu.cn	Li, Wenbin/ABD-9849-2021	Li, Wenbin/0000-0003-2474-5595; Su, Zhiyao/0000-0003-4534-7502	Forestry Science and Technology Innovation Program of Guangdong Province [2011KJCX031-02]	Forestry Science and Technology Innovation Program of Guangdong Province	This research is funded by the Forestry Science and Technology Innovation Program of Guangdong Province (2011KJCX031-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, COMM FOR TREE VOL TA; Augusto L, 2002, ANN FOREST SCI, V59, P233, DOI 10.1051/forest:2002020; Beets PN, 2011, FOREST ECOL MANAG, V262, P1119, DOI 10.1016/j.foreco.2011.06.012; Ellison D, 2011, ENVIRON SCI POLICY, V14, P1062, DOI 10.1016/j.envsci.2011.07.001; Fang J. Y., 2007, SCI CHINA, V37, P804; Gibbs HK, 2007, ENVIRON RES LETT, V2; Guo ZD, 2010, FOREST ECOL MANAG, V259, P1225, DOI 10.1016/j.foreco.2009.09.047; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Kurz WA, 2009, ECOL MODEL, V220, P480, DOI 10.1016/j.ecolmodel.2008.10.018; Le Toan T, 2011, REMOTE SENS ENVIRON, V115, P2850, DOI 10.1016/j.rse.2011.03.020; LIU GH, 2000, ACTA ECOLOGICA SINIC, V20, P733; Maslin M, 2011, NATURE, V475, P445, DOI 10.1038/475445a; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Oueslati I, 2013, PEDOSPHERE, V23, P48, DOI 10.1016/S1002-0160(12)60079-4; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Perdan S, 2011, ENERG POLICY, V39, P6040, DOI 10.1016/j.enpol.2011.07.003; Reich PB, 2011, NAT CLIM CHANGE, V1, P346; Rolecek J, 2009, J VEG SCI, V20, P596, DOI 10.1111/j.1654-1103.2009.01062.x; [方运霆 Fang Yunting], 2004, [生态学报, Acta Ecologica Sinica], V24, P135; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Schwenk WS, 2012, ECOL APPL, V22, P1612, DOI 10.1890/11-0864.1; Somogyi Z, 2007, EUR J FOREST RES, V126, P197, DOI 10.1007/s10342-006-0125-7; Stockmann Keith D, 2012, Carbon Balance Manag, V7, P1, DOI 10.1186/1750-0680-7-1; van Breugel M, 2011, FOREST ECOL MANAG, V262, P1648, DOI 10.1016/j.foreco.2011.07.018; Watanabe MDB, 2011, ENVIRON SCI POLICY, V14, P594, DOI 10.1016/j.envsci.2011.05.013; Watson C., 2009, FOREST CARBON ACCOUN; [徐新良 XU Xinliang], 2007, [地理科学进展, Progress in Geography], V26, P1	27	24	28	6	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136984	10.1371/journal.pone.0136984	http://dx.doi.org/10.1371/journal.pone.0136984			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317523	gold, Green Submitted, Green Published			2022-12-26	WOS:000360299100189
J	Shrestha, M; Xiao, Y; Robinson, H; Schubot, FD				Shrestha, Manisha; Xiao, Yi; Robinson, Howard; Schubot, Florian D.			Structural Analysis of the Regulatory Domain of ExsA, a Key Transcriptional Regulator of the Type Three Secretion System in Pseudomonas aeruginosa	PLOS ONE			English	Article							VIBRIO-CHOLERAE TOXT; BLEB-NICHE FORMATION; SELF-ASSOCIATION; DNA-BINDING; SALMONELLA-TYPHIMURIUM; ADAPTIVE IMMUNITY; EFFECTOR PROTEINS; CRYSTAL-STRUCTURE; GENE-EXPRESSION; DENDRITIC CELLS	Pseudomonas aeruginosa employs a type three secretion system to facilitate infections in mammalian hosts. The operons encoding genes of structural components of the secretion machinery and associated virulence factors are all under the control of the AraC-type transcriptional activator protein, ExsA. ExsA belongs to a unique subfamily of AraC-proteins that is regulated through protein-protein contacts rather than small molecule ligands. Prior to infection, ExsA is inhibited through a direct interaction with the anti-activator ExsD. To activate ExsA upon host cell contact this interaction is disrupted by the anti-antiactivator protein ExsC. Here we report the crystal structure of the regulatory domain of ExsA, which is known to mediate ExsA dimerization as well as ExsD binding. The crystal structure suggests two models for the ExsA dimer. Both models confirmed the previously shown involvement of helix alpha-3 in ExsA dimerization but one also suggest a role for helix alpha-2. These structural data are supported by the observation that a mutation in alpha-2 greatly diminished the ability of ExsA to activate transcription in vitro. Additional in vitro transcription studies revealed that a conserved pocket, used by AraC and the related ToxT protein for the binding of small molecule regulators, although present in ExsA is not involved in binding of ExsD.	[Shrestha, Manisha; Xiao, Yi; Schubot, Florian D.] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24060 USA; [Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Virginia Polytechnic Institute & State University; United States Department of Energy (DOE); Brookhaven National Laboratory	Schubot, FD (corresponding author), Virginia Polytech Inst & State Univ, Dept Biol Sci, Washington St, Blacksburg, VA 24060 USA.	fschubot@vt.edu		Schubot, Florian/0000-0002-7403-4735	Public Health Service grant from the National Institute of Allergy and Infectious Diseases [1R21AI101774]; Department of Energy Office of Biological and Environmental Research; NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	Public Health Service grant from the National Institute of Allergy and Infectious Diseases; Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Funding was provided by Public Health Service grant 1R21AI101774 to FDS from the National Institute of Allergy and Infectious Diseases. Funding for data collected at beamline 29 NSLS is provided by Department of Energy Office of Biological and Environmental Research and NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aepfelbacher M, 2005, REV PHYSIOL BIOCH P, V152, P65, DOI 10.1007/s10254-004-0035-3; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Angus AA, 2010, INFECT IMMUN, V78, P4500, DOI 10.1128/IAI.00417-10; Barison N, 2013, CELL MICROBIOL, V15, P1809, DOI 10.1111/cmi.12178; Beckert U, 2014, BIOCHEM BIOPH RES CO, V450, P870, DOI 10.1016/j.bbrc.2014.06.088; Brutinel ED, 2008, MOL MICROBIOL, V68, P657, DOI 10.1111/j.1365-2958.2008.06179.x; Brutinel ED, 2012, J BACTERIOL, V194, P2564, DOI 10.1128/JB.00106-12; Brutinel ED, 2010, J BACTERIOL, V192, P1479, DOI 10.1128/JB.01457-09; Brutinel ED, 2009, J BACTERIOL, V191, P3811, DOI 10.1128/JB.00002-09; Bueno SM, 2005, CRIT REV IMMUNOL, V25, P389, DOI 10.1615/CritRevImmunol.v25.i5.40; Dacheux D, 2000, INFECT IMMUN, V68, P2916, DOI 10.1128/IAI.68.5.2916-2924.2000; Darwin KH, 2000, MOL MICROBIOL, V35, P949, DOI 10.1046/j.1365-2958.2000.01772.x; Darwin KH, 2001, EMBO J, V20, P1850, DOI 10.1093/emboj/20.8.1850; Dasgupta N, 2004, MOL MICROBIOL, V53, P297, DOI 10.1111/j.1365-2958.2004.04128.x; Dewoody RS, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00004; Diaz MR, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00089; Egan SM, 2002, J BACTERIOL, V184, P5529, DOI 10.1128/JB.184.20.5529-5532.2002; Ehrbar K, 2002, INT J MED MICROBIOL, V291, P479; Ellermeier JR, 2007, CURR OPIN MICROBIOL, V10, P24, DOI 10.1016/j.mib.2006.12.002; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans DJ, 1998, INFECT IMMUN, V66, P1453, DOI 10.1128/IAI.66.4.1453-1459.1998; FinckBarbancon V, 1997, MOL MICROBIOL, V25, P547, DOI 10.1046/j.1365-2958.1997.4891851.x; Furukawa S, 2006, J BACTERIOL, V188, P1211, DOI 10.1128/JB.188.4.1211-1217.2006; Garau J, 2003, CURR OPIN INFECT DIS, V16, P135, DOI 10.1097/00001432-200304000-00010; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Griffith KL, 2002, J MOL BIOL, V322, P237, DOI 10.1016/S0022-2836(02)00782-9; Hauser AR, 1999, INFECT IMMUN, V67, P5530, DOI 10.1128/IAI.67.10.5530-5537.1999; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Hritonenko V, 2011, MICROB PATHOGENESIS, V51, P305, DOI 10.1016/j.micpath.2011.08.001; Hsia RC, 1997, MOL MICROBIOL, V25, P351, DOI 10.1046/j.1365-2958.1997.4701834.x; Johnson LE, 2009, TRANSPL INFECT DIS, V11, P227, DOI 10.1111/j.1399-3062.2009.00380.x; Kane CD, 2002, J BACTERIOL, V184, P4409, DOI 10.1128/JB.184.16.4409-4419.2002; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; King JM, 2012, J BACTERIOL, V194, P2573, DOI 10.1128/JB.00107-12; Laskowski MA, 2006, INFECT IMMUN, V74, P4462, DOI 10.1128/IAI.00575-06; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Lin PC, 2013, BIOMETALS, V26, P1067, DOI 10.1007/s10534-013-9676-5; Lowden MJ, 2010, P NATL ACAD SCI USA, V107, P2860, DOI 10.1073/pnas.0915021107; Lykken GL, 2006, J BACTERIOL, V188, P6832, DOI 10.1128/JB.00884-06; Maresso AW, 2007, CELL MICROBIOL, V9, P97, DOI 10.1111/j.1462-5822.2006.00770.x; Marsden AE, 2014, J BACTERIOL, V196, P3546, DOI 10.1128/JB.01969-14; McCaw ML, 2002, MOL MICROBIOL, V46, P1123, DOI 10.1046/j.1365-2958.2002.03228.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Medina E, 1999, INFECT IMMUN, V67, P1093, DOI 10.1128/IAI.67.3.1093-1099.1999; Nallamsetty S, 2005, PROTEIN SCI, V14, P2964, DOI 10.1110/ps.051718605; Ni L, 2013, NUCLEIC ACIDS RES, V41, P1998, DOI 10.1093/nar/gks1207; Paquette N, 2012, P NATL ACAD SCI USA, V109, P12710, DOI 10.1073/pnas.1008203109; Pilonieta MC, 2008, J BACTERIOL, V190, P2249, DOI 10.1128/JB.01824-07; Plano GV, 2013, IMMUNOL RES, V57, P237, DOI 10.1007/s12026-013-8454-3; Plano GV, 2004, MOL MICROBIOL, V54, P287, DOI 10.1111/j.1365-2958.2004.04306.x; Raymond B, 2013, TRENDS MICROBIOL, V21, P430, DOI 10.1016/j.tim.2013.06.008; Rhee S, 1998, P NATL ACAD SCI USA, V95, P10413, DOI 10.1073/pnas.95.18.10413; Rietsch A, 2006, MOL MICROBIOL, V59, P807, DOI 10.1111/j.1365-2958.2005.04990.x; Rietsch A, 2005, P NATL ACAD SCI USA, V102, P8006, DOI 10.1073/pnas.0503005102; Roy-Burman A, 2001, J INFECT DIS, V183, P1767, DOI 10.1086/320737; Saliba AM, 2002, MICROB PATHOGENESIS, V33, P153, DOI 10.1006/mpat.2002.0522; Sato H, 2004, MOL MICROBIOL, V53, P1279, DOI 10.1111/j.1365-2958.2004.04194.x; Shafikhani SH, 2008, CELL MICROBIOL, V10, P994, DOI 10.1111/j.1462-5822.2007.01102.x; Shafikhani SH, 2006, P NATL ACAD SCI USA, V103, P15605, DOI 10.1073/pnas.0605949103; Shen DK, 2008, MICROBIOL-SGM, V154, P2195, DOI 10.1099/mic.0.2007/013680-0; Soisson SM, 1997, J MOL BIOL, V273, P226, DOI 10.1006/jmbi.1997.1314; Soisson SM, 1997, SCIENCE, V276, P421, DOI 10.1126/science.276.5311.421; Sun Y, 2012, J IMMUNOL, V188, P1884, DOI 10.4049/jimmunol.1102148; Taliaferro LP, 2012, J MOL BIOL, V419, P139, DOI 10.1016/j.jmb.2012.03.019; Tang XY, 2006, MOL PLANT MICROBE IN, V19, P1159, DOI 10.1094/MPMI-19-1159; Thibault J, 2009, J BIOL CHEM, V284, P15762, DOI 10.1074/jbc.M109.003533; Thomson JJ, 2014, J BACTERIOL, V196, P3872, DOI 10.1128/JB.01824-14; Tobar JA, 2006, INFECT IMMUN, V74, P6438, DOI 10.1128/IAI.00063-06; Tosi T, 2013, RES MICROBIOL, V164, P605, DOI 10.1016/j.resmic.2013.03.019; Urbanowski ML, 2005, P NATL ACAD SCI USA, V102, P9930, DOI 10.1073/pnas.0504405102; Vakulskas CA, 2010, J BACTERIOL, V192, P3597, DOI 10.1128/JB.00129-10; Vakulskas CA, 2009, J BACTERIOL, V191, P6654, DOI 10.1128/JB.00902-09; Vallis AJ, 1999, INFECT IMMUN, V67, P914, DOI 10.1128/IAI.67.2.914-920.1999; Ventre I, 2006, P NATL ACAD SCI USA, V103, P171, DOI 10.1073/pnas.0507407103; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Vogelaar NJ, 2010, BIOCHEMISTRY-US, V49, P5870, DOI 10.1021/bi100432e; Weldon JE, 2006, PROTEIN SCI, V15, P2828, DOI 10.1110/ps.062327506; Wickstrum JR, 2004, J BACTERIOL, V186, P6277, DOI 10.1128/JB.186.18.6277-6285.2004; Yahr TL, 2006, MOL MICROBIOL, V62, P631, DOI 10.1111/j.1365-2958.2006.05412.x; Yahr TL, 2004, MOL CELL, V16, P497, DOI 10.1016/j.molcel.2004.11.009; Zhang Y, 2011, INFECT IMMUN, V79, P4322, DOI 10.1128/IAI.05396-11; Zheng ZD, 2007, J BIOL CHEM, V282, P6136, DOI 10.1074/jbc.M611664200; Zolfaghar I, 2006, INFECT IMMUN, V74, P3880, DOI 10.1128/IAI.01891-05	87	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136533	10.1371/journal.pone.0136533	http://dx.doi.org/10.1371/journal.pone.0136533			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317977	gold, Green Published, Green Submitted			2022-12-26	WOS:000360299100097
J	Wolsan, M; Suzuki, S; Asahara, M; Motokawa, M				Wolsan, Mieczyslaw; Suzuki, Satoshi; Asahara, Masakazu; Motokawa, Masaharu			Tooth Size Variation in Pinniped Dentitions	PLOS ONE			English	Article							DOG NYCTEREUTES-PROCYONOIDES; BADGER MELES-MELES; FOX VULPES-VULPES; SEXUAL-DIMORPHISM; RED FOX; BODY-SIZE; VARIABILITY; PATTERNS; TEETH; EVOLUTIONARY	It is contentious whether size variation among mammalian teeth is heterogeneous or homogeneous, whether the coefficient of variation is reliable, and whether the standard deviation of log-transformed data and the residual of standard deviation on mean variable size are useful replacements for the coefficient of variation. Most studies of tooth size variation have been on mammals with complex-crowned teeth, with relatively little attention paid to taxa with simple-crowned teeth, such as Pinnipedia. To fill this gap in knowledge and to resolve the existing controversies, we explored the variation of linear size variables (length and width) for all teeth from complete permanent dentitions of four pinniped species, two phocids (Histriophoca fasciata, Phoca largha) and two otariids (Callorhinus ursinus, Eumetopias jubatus). Size variation among these teeth was mostly heterogeneous both along the toothrow and among species. The incisors, canines, and mesial and distal postcanines were often relatively highly variable. The levels of overall dental size variation ranged from relatively low as in land carnivorans (Phoca largha and both otariids) to high (Histriophoca fasciata). Sexual size dimorphism varied among teeth and among species, with teeth being, on average, larger in males than in females. This dimorphism was more pronounced, and the canines were larger and more dimorphic relative to other teeth in the otariids than in the phocids. The coefficient of variation quantified variation reliably in most cases. The standard deviation of log-transformed data was redundant with the coefficient of variation. The residual of standard deviation on mean variable size was inaccurate when size variation was considerably heterogeneous among the compared variables, and was incomparable between species and between sexes. The existing hypotheses invoking developmental fields, occlusal complexity, and the relative timing of tooth formation and sexually dimorphic hormonal activity do not adequately explain the differential size variation along the pinniped toothrow.	[Wolsan, Mieczyslaw; Suzuki, Satoshi; Motokawa, Masaharu] Kyoto Univ, Kyoto Univ Museum, Kyoto, Japan; [Wolsan, Mieczyslaw] Polish Acad Sci, Museum & Inst Zool, PL-00679 Warsaw, Poland; [Asahara, Masakazu] Kyoto Univ, Grad Sch Sci, Dept Zool, Kyoto, Japan	Kyoto University; Polish Academy of Sciences; Museum & Institute of Zoology of the Polish Academy of Sciences; Kyoto University	Wolsan, M (corresponding author), Kyoto Univ, Kyoto Univ Museum, Kyoto, Japan.	wolsan@miiz.waw.pl	Wolsan, Mieczysław/C-2717-2012	Wolsan, Mieczysław/0000-0002-2083-7743; Suzuki, Satoshi/0000-0001-6490-5720; Asahara, Masakazu/0000-0002-2069-2134	National Science Centre [2012/05/B/NZ8/02687]; Japan Society for the Promotion of Science [11J01149]	National Science Centre(National Science Centre, Poland); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Partial support for this work came from the National Science Centre (www.ncn.gov.pl) through grant 2012/05/B/NZ8/02687 to MW. MA was supported during part of this study by a Japan Society for the Promotion of Science (www.jsps.go.jp) research fellowship for young scientists (11J01149). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge Hermann, 1994, Zoologische Abhandlungen (Dresden), V48, P103; Asahara M, 2014, MAMM STUDY, V39, P181, DOI 10.3106/041.039.0308; Asahara M, 2013, ECOL EVOL, V3, P278, DOI 10.1002/ece3.436; Bateson W., 1894, MAT STUDY VARIATION; Best D. J., 1975, Applied Statistics, V24, P377, DOI 10.2307/2347111; Bonner J.T., 2006, WHY SIZE MATTERS; BRIGGS K, 1975, J MAMMAL, V56, P224, DOI 10.2307/1379622; Butler PM, 1939, P ZOOL SOC LOND B-SY, V109, P1; COCHARD LR, 1981, AM J PHYS ANTHROPOL, V54, P139, DOI 10.1002/ajpa.1330540117; Cope Dana A., 1993, P211; CREIGHTON GK, 1980, J ZOOL, V191, P435; Darwin C.R., 1859, ORIGIN SPECIES MEANS; Dayan T, 2002, PALEOBIOLOGY, V28, P508, DOI 10.1666/0094-8373(2002)028<0508:VACOSA>2.0.CO;2; Freedman L., 1963, Journal of Mammalogy, V44, P24, DOI 10.2307/1377165; GINGERICH P D, 1979, Primates, V20, P141, DOI 10.1007/BF02373833; Gingerich P.D., 1977, PATTERNS EVOLUTION I, V5, P591, DOI DOI 10.1016/S0920-5446(08)70335-2; GINGERICH PD, 1974, J PALEONTOL, V48, P895; GINGERICH PD, 1979, J MAMMAL, V60, P691, DOI 10.2307/1380186; GINGERICH PD, 1977, AM J PHYS ANTHROPOL, V47, P395, DOI 10.1002/ajpa.1330470308; GINGERICH PD, 1979, AM J PHYS ANTHROPOL, V51, P457, DOI 10.1002/ajpa.1330510318; GOULD SJ, 1975, AM ZOOL, V15, P351; Hillson S., 2005, TEETH, V2nd ed., DOI 10.1017/CBO9780511614477; Hlusko LJ, 2006, AM J PHYS ANTHROPOL, V131, P420, DOI 10.1002/ajpa.20435; Kerley G.I.H., 1987, NOAA Technical Report NMFS, V51, P121; KIESER JA, 1988, AM J PRIMATOL, V14, P141, DOI 10.1002/ajp.1350140205; Kim SI, 2012, J VET MED SCI, V74, P1609, DOI 10.1292/jvms.12-0281; Kurten B., 1964, Acta Zoologica Fennica, V108, P1; KURTEN BJORN, 1966, ACTA ZOOL FENNICA, V115, P1; LAWS R. M., 1953, FALKLAND ISLANDS DEPENDENCIES SURVEY SCI REPT, V2, P1; Linnaeus C, 1767, SYSTEMA NATURAE REGN, VI, DOI 10.5962/bhl.title.542; LUPS P, 1988, ACTA THERIOL, V33, P21; LUPS P, 1990, Z SAUGETIERKD, V55, P16; Meiri S, 2005, FUNCT ECOL, V19, P337, DOI 10.1111/j.1365-2435.2005.00964.x; Miller EH, 2007, J MAMMAL, V88, P1325, DOI 10.1644/06-MAMM-A-243R.1; Miller EH, 2009, J MAMMAL, V90, P491, DOI 10.1644/08-MAMM-A-055.1; Pallas PS, 1811, ZOOGRAPHIA ROSSO ASI, V1; PENGILLY D, 1984, J MAMMAL, V65, P34, DOI 10.2307/1381197; Peters R. H., 1983, CAMBRIDGE STUDIES EC; Plavcan J. Michael, 1993, P239; Polly PD, 1998, BIOL J LINN SOC, V64, P83; Prevosti FJ, 2006, J ZOOL, V270, P636, DOI 10.1111/j.1469-7998.2006.00187.x; R Core Team, 2021, R LANGUAGE ENV STAT; Scheffe V. B., 1964, Fishery Bulletin Fish and Wildlife Service US, V63, P293; Schreber JCD, 1776, SAUGTHIERE ABBILDUNG, V3, P300; Smith RJ, 1999, J HUM EVOL, V36, P423, DOI 10.1006/jhev.1998.0281; Suzuki S, 2012, J ZOOL, V288, P57, DOI 10.1111/j.1469-7998.2012.00924.x; Szuma E, 2008, J ZOOL SYST EVOL RES, V46, P73, DOI 10.1111/j.1439-0469.2007.00418.x; SZUMA E, 1994, ACTA THERIOL, V39, P201, DOI 10.4098/AT.arch.94-23; Szuma E, 2000, ANN ZOOL FENN, V37, P113; Szuma E, 2008, ACTA THERIOL, V53, P289, DOI 10.1007/BF03195193; Szuma E, 2008, ANN ZOOL FENN, V45, P185, DOI 10.5735/086.045.0304; Turner W, 1888, REPORT SCI RESULTS V, V26, P1; VANVALEN L, 1970, DEV BIOL, V23, P456, DOI 10.1016/0012-1606(70)90110-7; VANVALEN L, 1962, EVOLUTION, V16, P272; Wolsan M., 1993, P770; WOLSAN M, 1985, ACTA THERIOL, V30, P79, DOI 10.4098/AT.arch.85-3; Wolsan M., 1993, P699; Yablokov A.V, 1974, VARIABILITY MAMMALS; ZHANG YY, 1982, AM J PHYS ANTHROPOL, V59, P21; Zimmermann EAW, 1783, GEOGRAPHISCHE GESCH, V3	60	5	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137100	10.1371/journal.pone.0137100	http://dx.doi.org/10.1371/journal.pone.0137100			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317362	Green Published, gold, Green Submitted			2022-12-26	WOS:000360299100203
J	Yin, J; Wang, Y; Yin, HL; Chen, WP; Jin, GF; Ma, HX; Dai, JC; Chen, JP; Jiang, Y; Wang, H; Liu, ZA; Hu, ZB; Shen, HB				Yin, Jian; Wang, Yi; Yin, Hanlu; Chen, Wenping; Jin, Guangfu; Ma, Hongxia; Dai, Juncheng; Chen, Jiaping; Jiang, Yue; Wang, Hui; Liu, Zhian; Hu, Zhibin; Shen, Hongbing			Circulating Tumor Cells Enriched by the Depletion of Leukocytes with Bi-Antibodies in Non-Small Cell Lung Cancer: Potential Clinical Application	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; PERIPHERAL-BLOOD; STEM-CELLS; GROWTH; EXPRESSION	Background It has been considered that the detection methods for circulating tumor cells (CTCs) based on epithelial cell adhesion molecule (EpCAM) underestimate the number of CTCs and may miss a metastatic subpopulation with cancer stem cell (CSC) properties. Therefore, we investigated EpCAM-positive and - negative CTCs in non-small cell lung cancer (NSCLC) patients at different stages, assessed the clinical value of these CTCs and explored their capacity in the following CSC model. Methods CTCs were enriched by the depletion of leukocytes with bi-antibodies using a magnetic bead separation technique and then identified by the expression of EpCAM and cytokeratin 7 and 8 using multi-parameter flow cytometry. We determined the distribution of CTCs classified by the expression of EpCAM in 46 NSCLC patients with stages I to IV, assessed the diagnostic value of these CTCs by longitudinal monitoring in 4 index patients during adjuvant therapy and characterized the stemness of these CTCs by the expression of CXCR4 and CD133 in 10 patients. Results EpCAM- negative (E-) CTCs were detected to be significantly higher than EpCAM- positive (E+) CTCs in stage IV (p = 0.003). The patients with the percentage of E- CTCs more than 95% (r > 95%) were detected to be significantly increased from 13.3% in stage I-II to 61.1% in stage IV (p = 0.006). Kaplan-Meier analysis indicated that the patients with r > 95% had significantly shorter survival time than those with r <= 0.95 (p = 0.041). Longitudinal monitoring of CTCs indicated that the patients with a high percentage of E-CTCs in the blood were not responsive to either chemotherapy or targeted therapy. Further characterization of CTCs revealed that a stem-like subpopulation of CXCR4+CD133+CTCs were detected to be significantly more prevalent in E-CTCs than that in E+CTCs (p = 0.005). Conclusions The enrichment of CTCs by the depletion of leukocytes with bi-antibodies is a valuable method for estimating the number of CTCs, which can be potentially applied in predicting the prognosis, monitoring the therapeutic effect of NSCLC patients and further analyzing the biology of CTCs.	[Yin, Jian; Yin, Hanlu; Jin, Guangfu; Ma, Hongxia; Dai, Juncheng; Chen, Jiaping; Jiang, Yue; Wang, Hui; Liu, Zhian; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Wang, Yi; Chen, Wenping] Nanjing Chest Hosp, Dept Resp Dis, Nanjing, Jiangsu, Peoples R China; [Yin, Jian; Yin, Hanlu; Jin, Guangfu; Ma, Hongxia; Dai, Juncheng; Chen, Jiaping; Jiang, Yue; Wang, Hui; Liu, Zhian; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Sch Publ Hlth, Ctr Canc, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Liu, ZA (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.	liuz@njmu.edu.cn; zhibin_hu@njmu.edu.cn; hbshen@njmu.edu.cn		Shen, Hongbing/0000-0002-2581-5906	Jiangsu Natural Science Foundation [BK20141435]; Introduction of Talent Foundation [2011RC11]; Medical Science and Technology Development Foundation, Nanjing Department of Health [YKK13088]; Key Program of the National Natural Science Foundation of China [81230067]; National Key Basic Research Program [2013CB911400]	Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Introduction of Talent Foundation; Medical Science and Technology Development Foundation, Nanjing Department of Health; Key Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program(National Basic Research Program of China)	This work is supported by Jiangsu Natural Science Foundation (BK20141435); The Introduction of Talent Foundation (2011RC11); Medical Science and Technology Development Foundation, Nanjing Department of Health (YKK13088); The Key Program of the National Natural Science Foundation of China (81230067); National Key Basic Research Program Grant (2013CB911400).	Alix-Panabieres C, 2014, NAT REV CANCER, V14, P623, DOI 10.1038/nrc3820; Alix-Panabieres C, 2013, CLIN CHEM, V59, P110, DOI 10.1373/clinchem.2012.194258; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Bertran E, 2009, CELL SIGNAL, V21, P1595, DOI 10.1016/j.cellsig.2009.06.006; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen Z, 2014, NAT REV CANCER, V14, P535, DOI 10.1038/nrc3775; Ettinger DS, 2013, J NATL COMPR CANC NE, V11, P645, DOI 10.6004/jnccn.2013.0084; Fusi A, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-52; Gallaher J, 2014, CANCER RES, V74, P426, DOI 10.1158/0008-5472.CAN-13-0759; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hofman V, 2011, INT J CANCER, V129, P1651, DOI 10.1002/ijc.25819; Jung MJ, 2013, ONCOGENE, V32, P209, DOI 10.1038/onc.2012.37; Krebs MG, 2012, J THORAC ONCOL, V7, P306, DOI 10.1097/JTO.0b013e31823c5c16; Krebs MG, 2011, J CLIN ONCOL, V29, P1556, DOI 10.1200/JCO.2010.28.7045; Liu ZA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-70; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Molloy TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032426; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Plaks V, 2013, SCIENCE, V341, P1186, DOI 10.1126/science.1235226; Sher YP, 2005, CLIN CANCER RES, V11, P173; Smirnov DA, 2005, CANCER RES, V65, P4993, DOI 10.1158/0008-5472.CAN-04-4330; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Weller P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113706; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522	25	13	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137076	10.1371/journal.pone.0137076	http://dx.doi.org/10.1371/journal.pone.0137076			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317979	Green Submitted, Green Published, gold			2022-12-26	WOS:000360299100201
J	Sharma, BK; Kolhe, R; Black, SM; Keller, JR; Mivechi, NF; Satyanarayana, A				Sharma, Bal Krishan; Kolhe, Ravindra; Black, Stephen M.; Keller, Jonathan R.; Mivechi, Nahid F.; Satyanarayana, Ande			Inhibitor of differentiation 1 transcription factor promotes metabolic reprogramming in hepatocellular carcinoma cells	FASEB JOURNAL			English	Article						glucose metabolism; glutamine metabolism; liver cancer; c-Myc; Hif1 alpha	LOOP-HELIX PROTEINS; C-MYC; ID PROTEINS; CANCER; EXPRESSION; HYPOXIA; GROWTH; HIF; TRANSACTIVATION; GLUTAMINE	Reprograming of metabolism is one of the central hallmarks of cancer. The majority of cancer cells depend on high rates of glycolysis and glutaminolysis for their growth and survival. A number of oncogenes and tumor suppressors have been connected to the regulation of altered glucose and glutamine metabolism in cancer cells. For example, the oncogene c-Myc plays vital roles in cancer cell metabolic adaptation by directly regulating various genes that participate in aerobic glycolysis and glutaminolysis. Inhibitor of differentiation 1 (Id1) is a helix-loop-helix transcription factor that plays important roles in cell proliferation, differentiation, and cell fate determination. Overexpression of Id1 causes intestinal adenomas and thymic lymphomas in mice, suggesting that Id1 could function as an oncogene. Despite it being an oncogene, whether Id1 plays any prominent role in cancer cell metabolic reprograming is unknown. Here, we demonstrate that Id1 is strongly expressed in human and mouse liver tumors and in hepatocellular carcinoma (HCC) cell lines, whereas its expression is very low or undetectable in normal liver tissues. In HCC cells, Id1 expression is regulated by the MAPK/ERK pathway at the transcriptional level. Knockdown of Id1 suppressed aerobic glycolysis and glutaminolysis, suggesting that Id1 promotes a metabolic shift toward aerobic glycolysis. At the molecular level, Id1 mediates its metabolic effects by regulating the expression levels of c-Myc. Knockdown of Id1 resulted in down-regulation (similar to 75%) of c-Myc, whereas overexpression of Id1 strongly induced (3-fold) c-Myc levels. Interestingly, knockdown of c-Myc resulted in down-regulation (similar to 60%) of Id1, suggesting a positive feedback-loop regulatory mechanism between Id1 and c-Myc. Under anaerobic conditions, both Id1 and c-Myc are down-regulated (50-70%), and overexpression of oxygen-insensitive hypoxia-inducible factor 1 alpha (Hif1 alpha) or its downstream target Mxi1 resulted in a significant reduction of c-Myc and Id1 (similar to 70%), suggesting that Hif1 alpha suppresses Id1 and c-Myc under anaerobic conditions via Mxi1. Together, our findings indicate a prominent novel role for Id1 in liver cancer cell metabolic adaptation.	[Sharma, Bal Krishan; Satyanarayana, Ande] Georgia Regents Univ, Mol Oncol & Biomarkers Program, Dept Biochem & Mol Biol, Augusta, GA 30912 USA; [Mivechi, Nahid F.] Georgia Regents Univ, Ctr Canc, Augusta, GA 30912 USA; [Kolhe, Ravindra] Georgia Regents Univ, Dept Pathol, Augusta, GA 30912 USA; [Black, Stephen M.] Georgia Regents Univ, Vasc Biol Ctr, Program Pulm Vasc Dis, Augusta, GA 30912 USA; [Keller, Jonathan R.] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Mouse Canc & Genet Program, Basic Sci Program, Frederick, MD USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Satyanarayana, A (corresponding author), Georgia Regents Univ, Ctr Canc, Dept Biochem & Mol Biol, Mol Oncol & Biomarkers Program, 1410 Laney Walker Blvd,Room CN3150, Augusta, GA 30912 USA.	sande@gru.edu	Sharma, Bal Krishan/AAF-6935-2020; Keller, Jonathan R./O-6677-2018	KOLHE, RAVINDRA/0000-0002-8283-2403	U.S. National Institutes of Health (NIH) National Cancer Institute [K22CA168828]; NIH National Heart, Lung, and Blood Institute [HL060190]; NATIONAL CANCER INSTITUTE [ZIABC010001, K22CA168828, R01CA132640, R01CA062130] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067841, R01HL060190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK105565] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Jingling Yuan, Ashis Mondal, and Kimya Jones for technical help and Dr. Rhea-Beth Markowitz for reviewing and editing the manuscript. This research is supported by a grant from the U.S. National Institutes of Health (NIH) National Cancer Institute Grant K22CA168828 to A.S. and NIH National Heart, Lung, and Blood Institute Grant HL060190 to S.M.B. The authors declare no conflicts of interest.	AHMED SA, 1994, J IMMUNOL METHODS, V170, P211, DOI 10.1016/0022-1759(94)90396-4; Ahn CS, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0128-2; BENEZRA R, 1990, ANN NY ACAD SCI, V599, P1, DOI 10.1111/j.1749-6632.1990.tb42359.x; Bounpheng MA, 1999, FASEB J, V13, P2257, DOI 10.1096/fasebj.13.15.2257; Corn PG, 2005, CANCER BIOL THER, V4, P1285, DOI 10.4161/cbt.4.11.2299; Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Hensley CT, 2013, J CLIN INVEST, V123, P3678, DOI 10.1172/JCI69600; Hu CJ, 2007, MOL BIOL CELL, V18, P4528, DOI 10.1091/mbc.E06-05-0419; Huang LE, 2008, CELL DEATH DIFFER, V15, P672, DOI 10.1038/sj.cdd.4402302; Kim D, 1999, MOL CELL BIOL, V19, P8240; Lasorella A, 2001, ONCOGENE, V20, P8326, DOI 10.1038/sj.onc.1205093; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Manrique I, 2015, CANCER LETT, V356, P899, DOI 10.1016/j.canlet.2014.10.035; Maruyama H, 1999, AM J PATHOL, V155, P815, DOI 10.1016/S0002-9440(10)65180-2; Miller DM, 2012, CLIN CANCER RES, V18, P5546, DOI 10.1158/1078-0432.CCR-12-0977; Nam HS, 2009, CELL STEM CELL, V5, P515, DOI 10.1016/j.stem.2009.08.017; Norton JD, 2000, J CELL SCI, V113, P3897; O'Toole PJ, 2003, J BIOL CHEM, V278, P45770, DOI 10.1074/jbc.M306056200; Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200; Ouyang XS, 2002, J UROLOGY, V167, P2598, DOI 10.1016/S0022-5347(05)65044-6; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Perry SS, 2007, BLOOD, V110, P2351, DOI 10.1182/blood-2007-01-069914; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; Satyanarayana A, 2008, MOL BIOL CELL, V19, P65, DOI 10.1091/mbc.E07-06-0525; Schindl M, 2001, CANCER RES, V61, P5703; Sears RC, 2004, CELL CYCLE, V3, P1133, DOI 10.4161/cc.3.9.1145; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Sikder HA, 2003, CANCER CELL, V3, P525, DOI 10.1016/S1535-6108(03)00141-7; Wagner K, 2006, P NATL ACAD SCI USA, V103, P6338, DOI 10.1073/pnas.0508143103; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wassmann K, 2003, EMBO J, V22, P797, DOI 10.1093/emboj/cdg071; Wice BM, 1998, J BIOL CHEM, V273, P25310, DOI 10.1074/jbc.273.39.25310; Williams SA, 2011, CELL, V146, P917, DOI 10.1016/j.cell.2011.07.040; Zebedee Z, 2001, ONCOGENE, V20, P8317, DOI 10.1038/sj.onc.1205092; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001	40	23	24	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					262	275		10.1096/fj.15-277749	http://dx.doi.org/10.1096/fj.15-277749			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26330493	Green Published			2022-12-26	WOS:000367621000026
J	Olfson, E; Cottrell, CE; Davidson, NO; Gurnett, CA; Heusel, JW; Stitziel, NO; Chen, LS; Hartz, S; Nagarajan, R; Saccone, NL; Bierut, LJ				Olfson, Emily; Cottrell, Catherine E.; Davidson, Nicholas O.; Gurnett, Christina A.; Heusel, Jonathan W.; Stitziel, Nathan O.; Chen, Li-Shiun; Hartz, Sarah; Nagarajan, Rakesh; Saccone, Nancy L.; Bierut, Laura J.			Identification of Medically Actionable Secondary Findings in the 1000 Genomes	PLOS ONE			English	Article							INCIDENTAL FINDINGS; FAMILIAL HYPERCHOLESTEROLEMIA; PATIENT AUTONOMY; VARIANT CLASSIFICATION; ACMG RECOMMENDATIONS; SEQUENCE VARIATION; CLINICAL GENOMICS; MUTATION DATABASE; GENETIC RESEARCH; CANCER	The American College of Medical Genetics and Genomics (ACMG) recommends that clinical sequencing laboratories return secondary findings in 56 genes associated with medically actionable conditions. Our goal was to apply a systematic, stringent approach consistent with clinical standards to estimate the prevalence of pathogenic variants associated with such conditions using a diverse sequencing reference sample. Candidate variants in the 56 ACMG genes were selected from Phase 1 of the 1000 Genomes dataset, which contains sequencing information on 1,092 unrelated individuals from across the world. These variants were filtered using the Human Gene Mutation Database (HGMD) Professional version and defined parameters, appraised through literature review, and examined by a clinical laboratory specialist and expert physician. Over 70,000 genetic variants were extracted from the 56 genes, and filtering identified 237 variants annotated as disease causing by HGMD Professional. Literature review and expert evaluation determined that 7 of these variants were pathogenic or likely pathogenic. Furthermore, 5 additional truncating variants not listed as disease causing in HGMD Professional were identified as likely pathogenic. These 12 secondary findings are associated with diseases that could inform medical follow-up, including cancer predisposition syndromes, cardiac conditions, and familial hypercholesterolemia. The majority of the identified medically actionable findings were in individuals from the European (5/379) and Americas (4/181) ancestry groups, with fewer findings in Asian (2/286) and African (1/246) ancestry groups. Our results suggest that medically relevant secondary findings can be identified in approximately 1% (12/1092) of individuals in a diverse reference sample. As clinical sequencing laboratories continue to implement the ACMG recommendations, our results highlight that at least a small number of potentially important secondary findings can be selected for return. Our results also confirm that understudied populations will not reap proportionate benefits of genomic medicine, highlighting the need for continued research efforts on genetic diseases in these populations.	[Olfson, Emily; Chen, Li-Shiun; Hartz, Sarah; Bierut, Laura J.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Cottrell, Catherine E.; Heusel, Jonathan W.; Nagarajan, Rakesh] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Cottrell, Catherine E.; Nagarajan, Rakesh; Saccone, Nancy L.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Davidson, Nicholas O.] Washington Univ, Sch Med, Dept Med, Div Gastroenterol, St Louis, MO 63110 USA; [Gurnett, Christina A.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Stitziel, Nathan O.] Washington Univ, Sch Med, Dept Med, Div Cardiovasc, St Louis, MO 63110 USA; [Stitziel, Nathan O.] Washington Univ, Sch Med, Div Stat Genom, St Louis, MO USA; [Nagarajan, Rakesh] Pierian DX, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Bierut, LJ (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.	laura@wustl.edu	Stitziel, Nathan/AAL-8413-2021; Heusel, Jon/AAC-8050-2021; Hartz, Sarah M/AAD-7662-2020; Cottrell, Cathy/AGG-3565-2022; Bierut, Laura Jean/W-6806-2019; Hartz, Sarah/AAD-4073-2019	Stitziel, Nathan/0000-0002-4963-8211; Cottrell, Cathy/0000-0002-2974-0235; Bierut, Laura Jean/0000-0002-9952-4810; Hartz, Sarah/0000-0002-5429-3799; Gurnett, Christina/0000-0001-9129-315X	National Institutes of Health (NIH) [T32GM07200, UL1TR000448, TL1TR000449, F30AA023685]; NIH [UL1TR000448, P30DK052574, R03HD068649, R01AR067715, K08HL114642, K08DA030398, R01DA038076, K08DA032680, KL2TR000450, R01DA026911, P01CA089392, U19CA148127, P30CA091842, R01DA036583, R01DA025888, U10AA008401]; Buehrle Family Foundation; Gale Family Foundation;  [R01DK56260];  [R01HL38180]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000449, UL1TR000448] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR067715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056260, P30DK052574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K08DA032680, R01DA036583] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Buehrle Family Foundation; Gale Family Foundation; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Ms. Olfson was supported by T32GM07200, UL1TR000448, TL1TR000449, and F30AA023685 from the National Institutes of Health (NIH). Dr. Davidson was supported by R01DK56260, R01HL38180 and Digestive Disease Research Core Center P30DK052574 from NIH; the Buehrle Family Foundation (http://buehrlefamilyfoundation.org/), and the Gale Family Foundation for hereditary GI cancer. Dr. Gurnett was supported by R03HD068649 and R01AR067715 from NIH. Dr. Stitziel was supported by K08HL114642 from NIH. Dr. Chen was supported by K08DA030398 and R01DA038076 from NIH. Dr. Hartz was supported by K08DA032680, KL2TR000450, and UL1TR000448 from NIH. Dr. Saccone was supported by R01DA026911 from NIH. Dr. Bierut was supported by P01CA089392, U19CA148127, P30CA091842, R01DA036583, R01DA025888 and U10AA008401 from NIH. The NIH and other funding sources did not have a role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Dr. Nagarajan is the Chief Informatics Officer for Pierian Dx and Drs. Cottrell and Heusel are consultants for Pierian Dx. Pierian Dx provided support in the form of salaries for authors RN, CEC and JH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amendola LM, 2015, GENOME RES, V25, P305, DOI 10.1101/gr.183483.114; Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; Baker M, 2012, NATURE, V491, P171, DOI 10.1038/491171a; Bauce B, 2002, J AM COLL CARDIOL, V40, P341, DOI 10.1016/S0735-1097(02)01946-0; Berg JS, 2013, GENET MED, V15, P36, DOI 10.1038/gim.2012.112; Beroud C, 2000, HUM MUTAT, V15, P86, DOI 10.1002/(SICI)1098-1004(200001)15:1<86::AID-HUMU16>3.0.CO;2-4; Bollinger JM, 2012, GENET MED, V14, P451, DOI 10.1038/gim.2011.66; Cassa CA, 2013, HUM MUTAT, V34, P1216, DOI 10.1002/humu.22375; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Cox MGPJ, 2011, CIRCULATION, V123, P2690, DOI 10.1161/CIRCULATIONAHA.110.988287; Daneshjou R, 2014, BIOCOMPUT-PAC SYM, P229; Ng D, 2013, CIRC-CARDIOVASC GENE, V6, P337, DOI 10.1161/CIRCGENETICS.113.000039; Dorschner MO, 2013, AM J HUM GENET, V93, P631, DOI 10.1016/j.ajhg.2013.08.006; Easton DF, 2007, AM J HUM GENET, V81, P873, DOI 10.1086/521032; FAGIN JA, 1993, J CLIN INVEST, V91, P179, DOI 10.1172/JCI116168; Fokkema IFAC, 2005, HUM MUTAT, V26, P63, DOI 10.1002/humu.20201; Garcia-Garcia AB, 2011, ATHEROSCLEROSIS, V218, P423, DOI 10.1016/j.atherosclerosis.2011.07.106; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Green RC, 2013, JAMA-J AM MED ASSOC, V310, P365, DOI 10.1001/jama.2013.41703; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; Johnston JJ, 2012, AM J HUM GENET, V91, P97, DOI 10.1016/j.ajhg.2012.05.021; Kirmani S, 1993, GENEREVIEWS R; Klitzman R, 2013, JAMA-J AM MED ASSOC, V310, P369, DOI 10.1001/jama.2013.41709; Kohane IS, 2006, JAMA-J AM MED ASSOC, V296, P212, DOI 10.1001/jama.296.2.212; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kuznetsov SG, 2008, NAT MED, V14, P875, DOI 10.1038/nm.1719; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Loeys B. L., 1993, GENEREVIEWS R; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; MALKIN D, 1992, NEW ENGL J MED, V326, P1309, DOI 10.1056/NEJM199205143262002; McEwen JE, 2012, ETHICAL CONSIDERATIO; McGuire AL, 2013, SCIENCE, V340, P1047, DOI 10.1126/science.1240156; McNally E, 1993, GENEREVIEWS R; Murphy J, 2008, AM J BIOETHICS, V8, P36, DOI 10.1080/15265160802513093; Napolitano C., 1993, GENEREVIEWS R; Neil A, 2008, EUR HEART J, V29, P2625, DOI 10.1093/eurheartj/ehn422; OMIM Online Mendelian Inheritance in Man, 2012, OMIM ONL MEND INH MA; Petrucelli N., 1993, GENE REV, P1993; Piippo K, 2000, J AM COLL CARDIOL, V35, P1919, DOI 10.1016/S0735-1097(00)00636-7; Plon SE, 2008, HUM MUTAT, V29, P1282, DOI 10.1002/humu.20880; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Ross LF, 2013, JAMA-J AM MED ASSOC, V310, P367, DOI 10.1001/jama.2013.41700; Schneider K., 1993, GENEREVIEWS; Schwartz PJ, 2009, CIRCULATION, V120, P1761, DOI 10.1161/CIRCULATIONAHA.109.863209; Sen-Chowdhry S, 2005, J CARDIOVASC ELECTR, V16, P927, DOI 10.1111/j.1540-8167.2005.40842.x; Stenson Peter D, 2009, Hum Genomics, V4, P69; Stephens K., 1993, GENEREVIEWS; Szabo C, 2000, HUM MUTAT, V16, P123, DOI 10.1002/1098-1004(200008)16:2<123::AID-HUMU4>3.0.CO;2-Y; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Versmissen J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2423; Watson M, 2013, GENET MED, V15, P664, DOI 10.1038/gim.2013.82; Wolf SM, 2008, J LAW MED ETHICS, V36, P219, DOI 10.1111/j.1748-720X.2008.00266.x; Wolf SM, 2013, SCIENCE, V340, P1049, DOI 10.1126/science.1239119; Wolf SM, 2012, GENET MED, V14, P355, DOI 10.1038/gim.2012.26; Xue YL, 2012, AM J HUM GENET, V91, P1022, DOI 10.1016/j.ajhg.2012.10.015; Youngblom E, 1993, FAMILIAL HYPERCHOLES	59	59	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135193	10.1371/journal.pone.0135193	http://dx.doi.org/10.1371/journal.pone.0135193			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332594	Green Published, gold, Green Submitted			2022-12-26	WOS:000360613800022
J	Tas, H; Nguyen, CT; Patel, R; Kim, NH; Kuhlman, TE				Tas, Huseyin; Nguyen, Cac T.; Patel, Ravish; Kim, Neil H.; Kuhlman, Thomas E.			An Integrated System for Precise Genome Modification in Escherichia coli	PLOS ONE			English	Article							SUBTILIS SACB GENE; BACILLUS-SUBTILIS; TETRACYCLINE RESISTANCE; CHROMOSOMAL INTEGRATION; PHIC31 INTEGRASE; DIVISION CYCLE; HUMAN-CELLS; DNA; SELECTION; EXPRESSION	We describe an optimized system for the easy, effective, and precise modification of the Escherichia coli genome. Genome changes are introduced first through the integration of a 1.3 kbp Landing Pad consisting of a gene conferring resistance to tetracycline (tetA) or the ability to metabolize the sugar galactose (galK). The Landing Pad is then excised as a result of double-strand breaks by the homing endonuclease I-SceI, and replaced with DNA fragments bearing the desired change via lambda-Red mediated homologous recombination. Repair of the double strand breaks and counterselection against the Landing Pad (using NiCl2 for tetA or 2-deoxy-galactose for galK) allows the isolation of modified bacteria without the use of additional antibiotic selection. We demonstrate the power of this method to make a variety of genome modifications: the exact integration, without any extraneous sequence, of the lac operon (similar to 6.5 kbp) to any desired location in the genome and without the integration of antibiotic markers; the scarless deletion of ribosomal rm operons (similar to 6 kbp) through either intrachromosomal or oligonucleotide recombination; and the in situ fusion of native genes to fluorescent reporter genes without additional perturbation.	[Tas, Huseyin; Nguyen, Cac T.; Kim, Neil H.; Kuhlman, Thomas E.] Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA; [Tas, Huseyin; Kuhlman, Thomas E.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL USA; [Nguyen, Cac T.; Kim, Neil H.; Kuhlman, Thomas E.] Univ Illinois, Dept Phys, Urbana, IL USA; [Patel, Ravish] Univ Illinois, Dept Mol & Cellular Biol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Kuhlman, TE (corresponding author), Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA.	tkuhlman@illinois.edu	TAS, HUSEYIN/AHA-5112-2022	TAS, HUSEYIN/0000-0003-4804-2237	Center for the Physics of Living Cells NSF Physics Frontier Center [PHY 1430124]; Department of Physics at the University of Illinois at Urbana-Champaign; Direct For Mathematical & Physical Scien [1430124] Funding Source: National Science Foundation	Center for the Physics of Living Cells NSF Physics Frontier Center; Department of Physics at the University of Illinois at Urbana-Champaign; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the Center for the Physics of Living Cells NSF Physics Frontier Center (PHY 1430124) and startup funds from the Department of Physics at the University of Illinois at Urbana-Champaign.	Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; BLOMFIELD IC, 1991, MOL MICROBIOL, V5, P1447, DOI 10.1111/j.1365-2958.1991.tb00791.x; BOCHNER BR, 1980, J BACTERIOL, V143, P926, DOI 10.1128/JB.143.2.926-933.1980; BREMER H, 1977, J THEOR BIOL, V69, P645, DOI 10.1016/0022-5193(77)90373-3; Bremer H, 1996, ESCHERICHIA COLI SAL, V1, P1553; CALOS MP, 1981, MOL GEN GENET, V183, P559, DOI 10.1007/BF00268783; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; COOPER S, 1968, J MOL BIOL, V31, P519, DOI 10.1016/0022-2836(68)90425-7; Costantino N, 2003, P NATL ACAD SCI USA, V100, P15748, DOI 10.1073/pnas.2434959100; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; GAY P, 1983, J BACTERIOL, V153, P1424, DOI 10.1128/JB.153.3.1424-1431.1983; Gomaa AA, 2014, MBIO, V5, DOI 10.1128/mBio.00928-13; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Groth AC, 2000, P NATL ACAD SCI USA, V97, P5995, DOI 10.1073/pnas.090527097; Haldimann A, 2001, J BACTERIOL, V183, P6384, DOI 10.1128/JB.183.21.6384-6393.2001; Hatoum-Aslan A, 2013, J BIOL CHEM, V288, P27888, DOI 10.1074/jbc.M113.499244; HELMSTETTER CE, 1968, J MOL BIOL, V31, P507, DOI 10.1016/0022-2836(68)90424-5; Herring CD, 2003, GENE, V311, P153, DOI 10.1016/S0378-1119(03)00585-7; Jiang WY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003844; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jiang WZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt780; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Keravala A, 2006, MOL THER, V13, pS201, DOI 10.1016/j.ymthe.2006.08.596; Kuhlman TE, 2010, BIOENG BUGS, V1, P296, DOI DOI 10.4161/BBUG.1.4.12386; Kuhlman TE, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.42; Kuhlman TE, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1193; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Li MZ, 2005, NAT GENET, V37, P311, DOI 10.1038/ng1505; Li XT, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt1075; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; MALOY SR, 1981, J BACTERIOL, V145, P1110, DOI 10.1128/JB.145.2.1110-1111.1981; Mosberg JA, 2010, GENETICS, V186, P791, DOI 10.1534/genetics.110.120782; Narayanan K, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng051; Orford M, 2000, Nucleic Acids Res, V28, pE84, DOI 10.1093/nar/28.18.e84; Pelicic V, 1996, J BACTERIOL, V178, P1197, DOI 10.1128/jb.178.4.1197-1199.1996; Podolsky T, 1996, PLASMID, V36, P112, DOI 10.1006/plas.1996.0038; Pohl T, 2007, BIOCHEMISTRY-US, V46, P10694, DOI 10.1021/bi701057t; Posfai G, 1999, NUCLEIC ACIDS RES, V27, P4409, DOI 10.1093/nar/27.22.4409; Rivero-Muller A, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm250; Ryu YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094266; Sabri S, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-60; Sekhavati MH, 2013, CELL J, V14, P264; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; St-Pierre F, 2013, ACS SYNTH BIOL, V2, P537, DOI 10.1021/sb400021j; Stringer AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044841; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Yu BJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn359; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597	52	20	24	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136963	10.1371/journal.pone.0136963	http://dx.doi.org/10.1371/journal.pone.0136963			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332675	gold, Green Published, Green Submitted			2022-12-26	WOS:000360613800083
J	Al-Shehri, SS; Knox, CL; Liley, HG; Cowley, DM; Wright, JR; Henman, MG; Hewavitharana, AK; Charles, BG; Shaw, PN; Sweeney, EL; Duley, JA				Al-Shehri, Saad S.; Knox, Christine L.; Liley, Helen G.; Cowley, David M.; Wright, John R.; Henman, Michael G.; Hewavitharana, Amitha K.; Charles, Bruce G.; Shaw, Paul N.; Sweeney, Emma L.; Duley, John A.			Breastmilk-Saliva Interactions Boost Innate Immunity by Regulating the Oral Microbiome in Early Infancy	PLOS ONE			English	Article							XANTHINE-OXIDASE; HYDROGEN-PEROXIDE; LACTOPEROXIDASE SYSTEM; ANTIBACTERIAL PROPERTIES; PHYSIOLOGICAL ROLES; NITRIC-OXIDE; BOVINE-MILK; OXIDOREDUCTASE; NUCLEOTIDES; THIOCYANATE	Introduction Xanthine oxidase (XO) is distributed in mammals largely in the liver and small intestine, but also is highly active in milk where it generates hydrogen peroxide (H2O2). Adult human saliva is low in hypoxanthine and xanthine, the substrates of XO, and high in the lactoperoxidase substrate thiocyanate, but saliva of neonates has not been examined. Results Median concentrations of hypoxanthine and xanthine in neonatal saliva (27 and 19 mu M respectively) were ten-fold higher than in adult saliva (2.1 and 1.7 mu M). Fresh breastmilk contained 27.3 +/- 12.2 mu MH2O2 but mixing baby saliva with breastmilk additionally generated > 40 mu MH2O2, sufficient to inhibit growth of the opportunistic pathogens Staphylococcus aureus and Salmonella spp. Oral peroxidase activity in neonatal saliva was variable but low (median 7 U/L, range 2-449) compared to adults (620 U/L, 48-1348), while peroxidase substrate thiocyanate in neonatal saliva was surprisingly high. Baby but not adult saliva also contained nucleosides and nucleobases that encouraged growth of the commensal bacteria Lactobacillus, but inhibited opportunistic pathogens; these nucleosides/bases may also promote growth of immature gut cells. Transition from neonatal to adult saliva pattern occurred during the weaning period. A survey of saliva from domesticated mammals revealed wide variation in nucleoside/base patterns. Discussion and Conclusion During breast-feeding, baby saliva reacts with breastmilk to produce reactive oxygen species, while simultaneously providing growth-promoting nucleotide precursors. Milk thus plays more than a simply nutritional role in mammals, interacting with infant saliva to produce a potent combination of stimulatory and inhibitory metabolites that regulate early oral- and hence gut-microbiota. Consequently, milk-saliva mixing appears to represent unique biochemical synergism which boosts early innate immunity.	[Al-Shehri, Saad S.; Hewavitharana, Amitha K.; Charles, Bruce G.; Shaw, Paul N.; Duley, John A.] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia; [Al-Shehri, Saad S.] Taif Univ, Coll Appl Med Sci, At Taif, Saudi Arabia; [Knox, Christine L.; Sweeney, Emma L.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Fac Hlth, Brisbane, Qld 4001, Australia; [Liley, Helen G.; Cowley, David M.; Henman, Michael G.; Duley, John A.] Mater Res Inst, Mater Hlth Serv, Brisbane, Qld, Australia; [Wright, John R.] Univ Queensland, Sch Vet Sci, Gatton, Australia	University of Queensland; Taif University; Queensland University of Technology (QUT); Mater Health Services; Mater Research; University of Queensland	Al-Shehri, SS (corresponding author), Univ Queensland, Sch Pharm, Brisbane, Qld, Australia.	sa.alshehri@tu.edu.sa	Liley, Helen Gwendolin/C-5608-2011; Shaw, Paul N/G-4418-2010; Shaw, Paul/Q-8454-2019; Hewavitharana, Amitha K/A-5533-2008; Cowley, David M/M-9674-2013; Wright, John/D-7974-2013	Liley, Helen Gwendolin/0000-0002-8249-9516; Shaw, Paul N/0000-0001-7154-592X; Shaw, Paul/0000-0001-7154-592X; Hewavitharana, Amitha K/0000-0003-2935-9941; Cowley, David M/0000-0002-4153-934X; Knox, Christine/0000-0003-3997-6812; Sweeney, Emma/0000-0002-3199-6432	National Health and Medical Research Council (Australia) [1043282]; Golden Casket Community Program (Queensland), Mater Children's Hospital Grant [200110]; Taif University, Saudi Arabia; QUT scholarship	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Golden Casket Community Program (Queensland), Mater Children's Hospital Grant; Taif University, Saudi Arabia; QUT scholarship	This project was supported financially by the National Health and Medical Research Council (Australia), Project Grant no. 1043282 [http://www.nhmrc.gov.au/]. The funding was received by JAD. Additional support was received from the Golden Casket Community Program (Queensland), Mater Children's Hospital Grant no. 200110 [https://tatts.com/goldencasket/about/community] by SSA. S. Al-Shehri was a recipient of a PhD scholarship from Taif University, Saudi Arabia, which is greatly acknowledged. ELS was a recipient of a QUT scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; ABADEH S, 1992, BIOCHIM BIOPHYS ACTA, V1117, P25, DOI 10.1016/0304-4165(92)90157-P; Agarwal A, 2011, CRIT REV BIOTECHNOL, V31, P264, DOI 10.3109/07388551.2010.527823; Akinbi H, 2010, J PEDIATR GASTR NUTR, V51, P347, DOI 10.1097/MPG.0b013e3181e07f0a; Al-Kerwi EAA, 2005, ASIA PAC J CLIN NUTR, V14, P428; Al-Shehri S, 2013, J CHROMATOGR B, V931, P140, DOI 10.1016/j.jchromb.2013.05.001; Arsene-Ploetze F, 2006, J BACTERIOL, V188, P4777, DOI 10.1128/JB.00195-06; Benboubetra M, 2004, J DAIRY SCI, V87, P1580, DOI 10.3168/jds.S0022-0302(04)73311-1; Brondino CD, 2006, CURR OPIN CHEM BIOL, V10, P109, DOI 10.1016/j.cbpa.2006.01.034; BROWN AM, 1995, BBA-GEN SUBJECTS, V1245, P248, DOI 10.1016/0304-4165(95)00093-Q; Claud EC, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-20; Delgado S, 2011, FEMS IMMUNOL MED MIC, V62, P225, DOI 10.1111/j.1574-695X.2011.00806.x; El-Chemaly S, 2003, AM J RESP CRIT CARE, V167, P425, DOI 10.1164/rccm.200206-531OC; Fox PF, 2006, INT DAIRY J, V16, P500, DOI 10.1016/j.idairyj.2005.09.013; Gaetani GF, 1996, BLOOD, V87, P1595, DOI 10.1182/blood.V87.4.1595.bloodjournal8741595; Godber BLJ, 2000, J BIOL CHEM, V275, P7757, DOI 10.1074/jbc.275.11.7757; GOTHEFORS L, 1975, INFECT IMMUN, V11, P1210, DOI 10.1128/IAI.11.6.1210-1215.1975; Graham S, 1996, BRIT J CLIN PHARMACO, V41, P299, DOI 10.1046/j.1365-2125.1996.03116.x; Gritz EC, 2015, FRONT PEDIATR, V3, DOI 10.3389/fped.2015.00017; Harrison R, 2006, INT DAIRY J, V16, P546, DOI 10.1016/j.idairyj.2005.08.016; Harrison R, 2004, DRUG METAB REV, V36, P363, DOI 10.1081/DMR-120037569; Haukioja A, 2004, J MED MICROBIOL, V53, P855, DOI 10.1099/jmm.0.45548-0; He XS, 2014, ISME J, V8, P564, DOI 10.1038/ismej.2013.172; Heegaard CW, 1997, J PEDIATR GASTR NUTR, V25, P159, DOI 10.1097/00005176-199708000-00006; Ihalin R, 2006, ARCH BIOCHEM BIOPHYS, V445, P261, DOI 10.1016/j.abb.2005.07.004; Kilstrup M, 2005, FEMS MICROBIOL REV, V29, P555, DOI 10.1016/j.femsre.2005.04.006; Kochanska B, 2000, ACTA BIOCHIM POL, V47, P877; Lahti M, 1999, J CHEM EDUC, V76, P1281; Liao KY, 2011, PEDIATR NEONATOL, V52, P93, DOI 10.1016/j.pedneo.2011.02.012; Maia LB, 2011, J BIOL INORG CHEM, V16, P443, DOI 10.1007/s00775-010-0741-z; Millar TM, 1998, FEBS LETT, V427, P225, DOI 10.1016/S0014-5793(98)00430-X; Millar TM, 2002, REDOX REP, V7, P65, DOI 10.1179/135100002125000280; OHLSSON PI, 1986, ACTA CHEM SCAND B, V40, P358, DOI 10.3891/acta.chem.scand.40b-0358; Osterman K L, 2000, J Hum Lact, V16, P297, DOI 10.1177/089033440001600405; Pan Q, 2011, INVEST OPHTH VIS SCI, V52, P1723, DOI 10.1167/iovs.10-5866; Peglow S, 2011, J HEPATO-BIL-PAN SCI, V18, P137, DOI 10.1007/s00534-010-0328-7; REITER B, 1981, ANIM PROD, V32, P297, DOI 10.1017/S0003356100027197; ROBINSON JL, 1980, J DAIRY SCI, V63, P865, DOI 10.3168/jds.S0022-0302(80)83017-7; Rodriguez-Serrano F, 2007, J NUTR, V137, P879, DOI 10.1093/jn/137.4.879; ROTH S, 1987, CELL IMMUNOL, V108, P417, DOI 10.1016/0008-8749(87)90224-3; Shin K, 2001, AM J CLIN NUTR, V73, P984; Silanikove N, 2005, FREE RADICAL BIO MED, V38, P1139, DOI 10.1016/j.freeradbiomed.2004.12.011; Silanikove N, 2007, BIOCHEM BIOPH RES CO, V363, P561, DOI 10.1016/j.bbrc.2007.08.188; Silvestre D, 2008, J HUM LACT, V24, P371, DOI 10.1177/0890334408319158; Stevens CR, 2000, LANCET, V356, P829, DOI 10.1016/S0140-6736(00)02660-X; TENOVUO J, 1976, J DENT RES, V55, P661, DOI 10.1177/00220345760550042001; THOMAS EL, 1994, INFECT IMMUN, V62, P529, DOI 10.1128/IAI.62.2.529-535.1994; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Tully D B, 2001, J Hum Lact, V17, P152, DOI 10.1177/089033440101700212; UAUY R, 1994, J NUTR, V124, pS1436, DOI 10.1093/jn/124.suppl_8.1436S; Van Gysel M, 2012, EUR J PEDIATR, V171, P1231, DOI 10.1007/s00431-012-1750-4; Vorbach C, 2003, TRENDS IMMUNOL, V24, P512, DOI 10.1016/S1471-4906(03)00237-0; Wan AKL, 2003, ORAL MICROBIOL IMMUN, V18, P72, DOI 10.1034/j.1399-302X.2003.00044.x; Wang M, 2015, J PEDIAT GASTROENTER; Yamamoto T, 2011, CLIN CHIM ACTA, V412, P1712, DOI 10.1016/j.cca.2011.06.006; Yener FYG, 2009, J FOOD SCI, V74, pM73, DOI 10.1111/j.1750-3841.2009.01057.x	56	54	55	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0135047	10.1371/journal.pone.0135047	http://dx.doi.org/10.1371/journal.pone.0135047			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325665	gold, Green Published, Green Submitted			2022-12-26	WOS:000360437700016
J	Sokolovska, N; Teytaud, O; Rizkalla, S; Consortium, M; Clement, K; Zucker, JD				Sokolovska, Nataliya; Teytaud, Olivier; Rizkalla, Salwa; Consortium, MicroObese; Clement, Karine; Zucker, Jean-Daniel			Sparse Zero-Sum Games as Stable Functional Feature Selection	PLOS ONE			English	Article							APPROXIMATIONS	In large-scale systems biology applications, features are structured in hidden functional categories whose predictive power is identical. Feature selection, therefore, can lead not only to a problem with a reduced dimensionality, but also reveal some knowledge on functional classes of variables. In this contribution, we propose a framework based on a sparse zero-sum game which performs a stable functional feature selection. In particular, the approach is based on feature subsets ranking by a thresholding stochastic bandit. We provide a theoretical analysis of the introduced algorithm. We illustrate by experiments on both synthetic and real complex data that the proposed method is competitive from the predictive and stability viewpoints.	[Sokolovska, Nataliya; Rizkalla, Salwa; Clement, Karine; Zucker, Jean-Daniel] Hop La Pitie Salpetriere, Assistance Publ Hop Paris, ICAN, Inst Cardiometab & Nutr, Paris, France; [Sokolovska, Nataliya; Rizkalla, Salwa; Clement, Karine; Zucker, Jean-Daniel] Univ Paris 06, Sorbonne Univ, UMR S 1166, ICAN,NutriOm Team, Paris, France; [Sokolovska, Nataliya; Rizkalla, Salwa; Clement, Karine; Zucker, Jean-Daniel] INSERM, UMR S U1166, NutriOm Team, Paris, France; [Teytaud, Olivier] Univ Paris 11, LRI, INRIA Saclay, F-91405 Orsay, France; [Zucker, Jean-Daniel] UMI UMMISCO, Inst Dev Res, Bondy, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Cadi Ayyad University of Marrakech; Hanoi University of Science & Technology; Institut de Recherche pour le Developpement (IRD); University Cheikh Anta Diop Dakar; University of Yaounde I	Sokolovska, N (corresponding author), Hop La Pitie Salpetriere, Assistance Publ Hop Paris, ICAN, Inst Cardiometab & Nutr, Paris, France.	nataliya.sokolovska@upmc.fr	Clément, karine/R-1120-2017; ZUCKER, Jean-Daniel/K-3008-2016	ZUCKER, Jean-Daniel/0000-0002-5597-7922; Sokolovska, Nataliya/0000-0001-8841-1725				ALTHOFER I, 1994, LINEAR ALGEBRA APPL, V199, P339, DOI 10.1016/0024-3795(94)90357-3; Althofer I, 1994, ON SPARSE APPROXIMAT; Audibert J-Y, 2010, J MACHINE LEARNING R, V11, P2635; Auer P, 2003, SIAM J COMPUT, V32, P48, DOI 10.1137/S0097539701398375; Auger D, 2014, ACML; Chevaleyre Y, 2013, ICML; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Daskalakis C, 2006, PROCEEDINGS OF THE T; Delage E., 2009, ACM SIGKDD INTL CONF; Dernoncourt D, 2012, CAP; Dessi N, 2013, BIOMED RESEARCH INTE; Fudenberg D., 1991, GAME THEORY; Ganzfried S, 2011, NATIONAL CONFERENCE; Ganzfried S., 2011, AAMAS; Gaudel R, 2010, ICML; GRIGORIADIS MD, 1995, OPER RES LETT, V18, P53, DOI 10.1016/0167-6377(95)00032-0; Haury AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028210; Hofmeister T, 1996, LINEAR ALGEBRA APPL, V240, P9, DOI 10.1016/0024-3795(94)00175-8; Huang J, 2008, STAT SINICA, V18, P1603; Huang KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120317; Kalyanakrishnan S, 2012, ICML; Kalyanaraman S, 2007, LECT NOTES COMPUT SC, V4698, P323; Koller D., 1994, Proceedings of the Twenty-Sixth Annual ACM Symposium on the Theory of Computing, P750, DOI 10.1145/195058.195451; Koller D, 1996, GAME ECON BEHAV, V14, P247, DOI 10.1006/game.1996.0051; Le Chatelier E, 2011, NATURE; LEMKE CE, 1964, J SOC IND APPL MATH, V12, P413, DOI 10.1137/0112033; Meloni S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.067101; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Radlinski F., 2008, ICML; Shoham Y., 2009, MULTIAGENT SYSTEMS A; Somol P, 2010, IEEE T PATTERN ANAL, V32, P1921, DOI 10.1109/TPAMI.2010.34; Teytaud O, 2011, LECT NOTES COMPUT SC, V6624, P153, DOI 10.1007/978-3-642-20525-5_16; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Wang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040218; Waugh K, 2009, AAMAS; Wen-Bo D, 2012, COMMUNICATIONS IN TH, V58; Zhang HF, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/18006	39	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0134683	10.1371/journal.pone.0134683	http://dx.doi.org/10.1371/journal.pone.0134683			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325268	Green Submitted, Green Published, gold			2022-12-26	WOS:000360437700013
J	Clark, R; Freedberg, M; Hazeltine, E; Voss, MW				Clark, Rachel; Freedberg, Michael; Hazeltine, Eliot; Voss, Michelle W.			Are There Age-Related Differences in the Ability to Learn Configural Responses?	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; OLDER-ADULTS; ASSOCIATIVE RECOGNITION; INDIVIDUAL-DIFFERENCES; SERIAL PATTERNS; HUMAN STRIATUM; IMPLICIT; SEQUENCE; MEMORY; YOUNG	Age is often associated with a decline in cognitive abilities that are important for maintaining functional independence, such as learning new skills. Many forms of motor learning appear to be relatively well preserved with age, while learning tasks that involve associative binding tend to be negatively affected. The current study aimed to determine whether age differences exist on a configural response learning task, which includes aspects of motor learning and associative binding. Young (M = 24 years) and older adults (M = 66.5 years) completed a modified version of a configural learning task. Given the requirement of associative binding in the configural relationships between responses, we predicted older adults would show significantly less learning than young adults. Older adults demonstrated lower performance (slower reaction time and lower accuracy). However, contrary to our prediction, older adults showed similar rates of learning as indexed by a configural learning score compared to young adults. These results suggest that the ability to acquire knowledge incidentally about configural response relationships is largely unaffected by cognitive aging. The configural response learning task provides insight into the task demands that constrain learning abilities in older adults.	[Clark, Rachel; Freedberg, Michael; Hazeltine, Eliot; Voss, Michelle W.] Univ Iowa, Interdisciplinary Grad Program Neurosci, Iowa City, IA 52242 USA; [Hazeltine, Eliot; Voss, Michelle W.] Univ Iowa, Dept Psychol & Brain Sci, Iowa City, IA USA; [Voss, Michelle W.] Univ Iowa, AMBI, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa	Voss, MW (corresponding author), Univ Iowa, Interdisciplinary Grad Program Neurosci, Iowa City, IA 52242 USA.	michelle-voss@uiowa.edu		Freedberg, Michael/0000-0003-3738-8259	University of Iowa	University of Iowa	This research was funded by MV's start-up funds provided by the University of Iowa.	Bates D, NLS NONLINEAR LEAST; Bates D, LME4 LINEAR MIXED EF; Chalfonte BL, 1996, MEM COGNITION, V24, P403, DOI 10.3758/BF03200930; CHERRY KE, 1995, PSYCHOL AGING, V10, P379, DOI 10.1037/0882-7974.10.3.379; Dennis NA, 2006, EXP BRAIN RES, V175, P153, DOI 10.1007/s00221-006-0534-3; Ebner NC, 2008, BEHAV RES METHODS, V40, P130, DOI [10.3758/BRM.40.1.130, 10.3738/BRM.40.1.130]; EICHENBAUM H, 1995, CURR DIR PSYCHOL SCI, V4, P19, DOI 10.1111/1467-8721.ep10770954; Faust ME, 1999, PSYCHOL BULL, V125, P777, DOI 10.1037/0033-2909.125.6.777; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frensch PA., 1998, HDB IMPLICIT LEARNIN, P47; Gaillard V, 2014, CLIN EEG NEUROSCI, V45, P50, DOI 10.1177/1550059413516757; Gaillard V, 2009, EUR J COGN PSYCHOL, V21, P255, DOI 10.1080/09541440802257423; Gobel EW, 2013, NEUROPSYCHOLOGY, V27, P314, DOI 10.1037/a0032305; Grafton ST, 1998, J COGNITIVE NEUROSCI, V7, P497; Gunning-Dixon FM, 1998, AM J NEURORADIOL, V19, P1501; Hannula DE, 2006, J NEUROSCI, V26, P8352, DOI 10.1523/JNEUROSCI.5222-05.2006; Hazeltine E, 2007, J EXP PSYCHOL HUMAN, V33, P1451, DOI 10.1037/0096-1523.33.6.1451; Hertzog Christopher, 2008, Psychol Sci Public Interest, V9, P1, DOI 10.1111/j.1539-6053.2009.01034.x; HOWARD DV, 1989, PSYCHOL AGING, V4, P357, DOI 10.1037/0882-7974.4.3.357; HOWARD DV, 1992, PSYCHOL AGING, V7, P232, DOI 10.1037/0882-7974.7.2.232; Howard JH, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00817; Howard JH, 2004, NEUROPSYCHOLOGY, V18, P124, DOI 10.1037/0894-4105.18.1.124; Howard JH, 1997, PSYCHOL AGING, V12, P634, DOI 10.1037/0882-7974.12.4.634; Howard MW, 2006, PSYCHON B REV, V13, P439, DOI 10.3758/BF03193867; Kilb A, 2011, J EXP PSYCHOL LEARN, V37, P706, DOI 10.1037/a0022525; King BR, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00142; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; Light LL, 2004, MEM COGNITION, V32, P1182, DOI 10.3758/BF03196891; Magezi DA, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00002; Minear M, 2004, BEHAV RES METH INS C, V36, P630, DOI 10.3758/BF03206543; Naveh-Benjamin M, 2000, J EXP PSYCHOL LEARN, V26, P1170, DOI 10.1037/0278-7393.26.5.1170; Naveh-Benjamin M, 2009, MEMORY, V17, P220, DOI 10.1080/09658210802222183; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Old SR, 2008, PSYCHOL AGING, V23, P104, DOI 10.1037/0882-7974.23.1.104; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pinheiro J., 2006, MIXED EFFECTS MODELS; Pinheiro J., NLME LINEAR NONLINEA; Provyn JP, 2007, PSYCHOL AGING, V22, P846, DOI 10.1037/0882-7974.22.4.846; Raz N, 2003, AM J NEURORADIOL, V24, P1849; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Reber PJ, 2013, NEUROPSYCHOLOGIA, V51, P2026, DOI 10.1016/j.neuropsychologia.2013.06.019; Rhodes MG, 2008, PSYCHOL AGING, V23, P239, DOI 10.1037/0882-7974.23.2.239; Rieckmann A, 2010, NEUROIMAGE, V50, P1303, DOI 10.1016/j.neuroimage.2010.01.015; Salthouse TA, 1999, AGING NEUROPSYCHOL C, V6, P1, DOI 10.1076/anec.6.1.1.789; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Sanchez DJ, 2010, PSYCHON B REV, V17, P790, DOI 10.3758/PBR.17.6.790; Schendan HE, 2003, NEURON, V37, P1013, DOI 10.1016/S0896-6273(03)00123-5; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seger CA, 2006, NEUROSCIENTIST, V12, P285, DOI 10.1177/1073858405285632; SEIBEL R, 1963, J EXP PSYCHOL, V66, P215, DOI 10.1037/h0048914; Seidler RD, 2007, BEHAV BRAIN RES, V183, P118, DOI 10.1016/j.bbr.2007.05.024; Seidler RD, 2006, BRAIN RES BULL, V70, P337, DOI 10.1016/j.brainresbull.2006.06.008; Shea CH, 2006, PHYS THER, V86, P478, DOI 10.1093/ptj/86.4.478; Stillman CM, 2014, J GERONTOL B; Team R. D. C, 2011, R LANG ENV STAT COMP; Tombaugh TN, 2005, ARCH CLIN NEUROPSYCH, V20, P485, DOI 10.1016/j.acn.2004.11.004; Voelcker-Rehage C, 2008, EUR REV AGING PHYS A, V5, P5, DOI 10.1007/s11556-008-0030-9; Wifall T, 2014, J EXP PSYCHOL GEN, V143, P312, DOI 10.1037/a0030865	58	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137260	10.1371/journal.pone.0137260	http://dx.doi.org/10.1371/journal.pone.0137260			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ0PO	26317773	Green Published, Green Submitted, gold			2022-12-26	WOS:000360299100215
J	Li, XH; Liang, Q; Zhuang, L; Zhang, XM; Chen, TW; Li, LJ; Liu, J; Calimente, H; Wei, YN; Hu, JN				Li, Xinghui; Liang, Qi; Zhuang, Ling; Zhang, Xiaoming; Chen, Tianwu; Li, Liangjun; Liu, Jun; Calimente, Horea; Wei, Yinan; Hu, Jiani			Preliminary Study of MR Diffusion Tensor Imaging of the Liver for the Diagnosis of Hepatocellular Carcinoma	PLOS ONE			English	Article							B-VALUE; HEALTHY-VOLUNTEERS; HEPATIC-LESIONS; WEIGHTED MRI; WHITE-MATTER; TRACTOGRAPHY; BRAIN; MOTOR; STIMULATION; DIRECTIONS	Objectives To evaluate the feasibility of differentiating between hepatocellular carcinomas (HCC) and healthy liver using diffusion tensor imaging (DTI). Material and Methods All subjects underwent an abdominal examination on a 3.0T MRI scanner. Two radiologists independently scored the image quality (IQ). An optimal set of DTI parameters was obtained from a group of fifteen volunteers with multiple b-values (100, 300, 500, and 800 s/mm(2)) and various diffusion-encoding directions (NED = 6, 9, and 12) using two way ANOVA analysis. Eighteen Patients with HCC underwent DTI scans with the optimized parameters. Fractional anisotropy(FA) and average apparent diffusion coefficient (ADC) values were measured. The differences of FA and ADC values between liver healthy region and HCC lesion were compared through paired t tests. Results There were no significant changes in liver IQ and FA/ADC values with increased NED (P > 0.05), whereas the liver IQ and FA/ADC values decreased significantly with increased b-values(P < 0.05). Good IQ, acceptable scan time and reasonable FA/ADC values were acquired using NED = 9 with b-value of (0,300) s/mm(2). Using the optimized DTI sequence, ADC value of the tumor lesion was significantly lower than that of the healthy liver region (1.30 +/- 0.34x10(-3) vs 1.52 +/- 0.27x10(-3) mm(2)/s, P = 0.013), whereas the mean FA value of the tumor lesion (0.42 +/- 0.11) was significantly higher than the normal liver region (0.32 +/- 0.10) (P = 0.004). Conclusion Either FA or ADC value from DTI can be used to differentiate HCC from healthy liver. HCC lead to higher FA value and lower ADC value on DTI than healthy liver.	[Li, Xinghui; Zhang, Xiaoming; Chen, Tianwu; Li, Liangjun] North Sichuan Med Coll, Dept Radiol, Sichuan Key Lab Med Imaging, Affiliated Hosp, Nanchong 637000, Peoples R China; [Liang, Qi] North Sichuan Med Coll, Dept Lab, Affiliated Hosp, Nanchong 637000, Peoples R China; [Zhuang, Ling] Wayne State Univ, Dept Radiat Oncol, Detroit, MI 48201 USA; [Liu, Jun] Cent South Univ, Xiangya Hosp 2, Dept Radiol, Changsha 410011, Hunan, Peoples R China; [Calimente, Horea; Wei, Yinan; Hu, Jiani] Wayne State Univ, Dept Radiol, Detroit, MI 48201 USA	North Sichuan Medical University; North Sichuan Medical University; Wayne State University; Central South University; Wayne State University	Zhang, XM (corresponding author), North Sichuan Med Coll, Dept Radiol, Sichuan Key Lab Med Imaging, Affiliated Hosp, Nanchong 637000, Peoples R China.	cjr.zhxm@vip.163.com; liujungreen@gmail.com	Zhang, Xiao Ming/H-7104-2019; liu, jun/AAW-9645-2020	Zhang, Xiao Ming/0000-0001-5327-8506; liu, jun/0000-0002-0344-4745				Bagadia A, 2011, J CLIN NEUROSCI, V18, P633, DOI 10.1016/j.jocn.2010.08.026; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Bauer JS, 2006, RADIOLOGY, V241, P399, DOI 10.1148/radiol.2412051330; Beddy P, 2011, RADIOLOGY, V258, P583, DOI 10.1148/radiol.10100912; Bello L, 2008, NEUROIMAGE, V39, P369, DOI 10.1016/j.neuroimage.2007.08.031; Bonekamp S, 2011, J CLIN GASTROENTEROL, V45, P885, DOI 10.1097/MCG.0b013e318223bd2c; Boulanger Y, 2003, NMR BIOMED, V16, P132, DOI 10.1002/nbm.818; Bruegel M, 2008, EUR RADIOL, V18, P477, DOI 10.1007/s00330-007-0785-9; Chuck NC, 2013, J CLIN IMAG SCI, V3, DOI 10.4103/2156-7514.122323; Cosottini M, 2010, J COMPUT ASSIST TOMO, V34, P746, DOI 10.1097/RCT.0b013e3181e35129; Erturk SM, 2014, ACTA RADIOL, V55, P654, DOI 10.1177/0284185113504916; Gauvain KM, 2001, AM J ROENTGENOL, V177, P449, DOI 10.2214/ajr.177.2.1770449; Guggenberger R, 2012, EUR J RADIOL, V81, pE775, DOI 10.1016/j.ejrad.2012.03.017; Hasan KM, 2001, J MAGN RESON IMAGING, V13, P769, DOI 10.1002/jmri.1107; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kinoshita M, 2008, NEUROIMAGE, V43, P29, DOI 10.1016/j.neuroimage.2008.06.041; Koh DM, 2007, AM J ROENTGENOL, V188, P1622, DOI 10.2214/AJR.06.1403; Kovanlikaya I, 2011, EUR J RADIOL, V77, P383, DOI 10.1016/j.ejrad.2009.08.012; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; Lee Y, 2015, MAGN RESON MED, V73, P1602, DOI 10.1002/mrm.25253; Li XH, 2014, J MAGN RESON IMAGING, V40, P58, DOI 10.1002/jmri.24329; Maesawa S, 2010, WORLD NEUROSURG, V74, P153, DOI 10.1016/j.wneu.2010.03.022; Marusyk Andriy, 2010, Biochim Biophys Acta, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Meng X, 2013, CLIN RADIOL, V68, P815, DOI 10.1016/j.crad.2013.03.009; Moteki T, 2002, J MAGN RESON IMAGING, V15, P564, DOI 10.1002/jmri.10101; Ni H, 2006, AM J NEURORADIOL, V27, P1776; Okada T, 2006, RADIOLOGY, V240, P849, DOI 10.1148/radiol.2403050916; Saupe N, 2009, AM J ROENTGENOL, V192, pW282, DOI 10.2214/AJR.08.1340; Skorpil M, 2007, MAGN RESON IMAGING, V25, P406, DOI 10.1016/j.mri.2006.09.017; Sugita R, 2010, WORLD J GASTROENTERO, V16, P832, DOI 10.3748/wjg.v16.i7.832; Szczepankiewicz F, 2015, NEUROIMAGE, V104, P241, DOI 10.1016/j.neuroimage.2014.09.057; Taouli B, 2003, RADIOLOGY, V226, P71, DOI 10.1148/radiol.2261011904; Taouli B, 2008, J MAGN RESON IMAGING, V28, P89, DOI 10.1002/jmri.21227; Testa ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101944; Thoeny HC, 2005, RADIOLOGY, V235, P911, DOI 10.1148/radiol.2353040554; Tosun M, 2013, EUR J RADIOL, V82, P203, DOI 10.1016/j.ejrad.2012.09.009; Xia Y, 2010, J MAGN RESON IMAGING, V32, P733, DOI 10.1002/jmri.22278; Zheng ZF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113469; Zhu FP, 2012, NEUROSURGERY, V71, P1170, DOI 10.1227/NEU.0b013e318271bc61	40	20	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135568	10.1371/journal.pone.0135568	http://dx.doi.org/10.1371/journal.pone.0135568			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317346	Green Published, Green Submitted, gold			2022-12-26	WOS:000360299100035
J	Cherian, MA; Baydoun, HH; Al-Saleem, J; Shkriabai, N; Kvaratskhelia, M; Green, P; Ratner, L				Cherian, Mathew A.; Baydoun, Hicham H.; Al-Saleem, Jacob; Shkriabai, Nikoloz; Kvaratskhelia, Mamuka; Green, Patrick; Ratner, Lee			Akt Pathway Activation by Human T-cell Leukemia Virus Type 1 Tax Oncoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN-BINDING MOTIF; NF-KAPPA-B; TUMOR-SUPPRESSOR PROTEIN; HUMAN-PAPILLOMAVIRUS E6; PDZ DOMAIN; HTLV-2 TAX2; TRANSFORMING ACTIVITY; HUMAN HOMOLOG; GROWTH; PTEN	Human T-cell leukemia virus (HTLV) type 1, the etiological agent of adult T-cell leukemia, expresses the viral oncoprotein Tax1. In contrast, HTLV-2, which expresses Tax2, is non-leukemogenic. One difference between these homologous proteins is the presence of a C-terminal PDZ domain-binding motif (PBM) in Tax1, previously reported to be important for non-canonical NF kappa B activation. In contrast, this study finds no defect in non-canonical NF kappa B activity by deletion of the Tax1 PBM. Instead, Tax1 PBM was found to be important for Akt activation. Tax1 attenuates the effects of negative regulators of the PI3K-Akt-mammalian target of rapamycin pathway, phosphatase and tensin homologue (PTEN), and PHLPP. Tax1 competes with PTEN for binding to DLG-1, unlike a PBM deletion mutant of Tax1. Forced membrane expression of PTEN or PHLPP overcame the effects of Tax1, as measured by levels of Akt phosphorylation, and rates of Akt dephosphorylation. The current findings suggest that Akt activation may explain the differences in transforming activity of HTLV-1 and -2.	[Cherian, Mathew A.; Baydoun, Hicham H.; Ratner, Lee] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA; [Al-Saleem, Jacob; Shkriabai, Nikoloz; Kvaratskhelia, Mamuka; Green, Patrick] Ohio State Univ, Ctr Retrovirus Res, Columbus, OH 43210 USA; [Shkriabai, Nikoloz; Kvaratskhelia, Mamuka] Ohio State Univ, Dept Pharmaceut & Pharmaceut Chem, Columbus, OH 43210 USA; [Green, Patrick] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA	Washington University (WUSTL); University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Ratner, L (corresponding author), Washington Univ, Sch Med, Dept Med, 660 S Euclid Ave,Box 8069, St Louis, MO 63110 USA.	lratner@dom.wustl.edu	Regan, Clinton/E-6250-2012	Cherian, Mathew/0000-0002-0380-2012; Ratner, Lee/0000-0003-2744-7294	National Institutes of Health [CA94056, CA100730, CA63413, T32 HL07088]; Lymphoma and Leukemia Foundation [LLS6067-10]; American Society of Hematology Research Training Award; Lymphoma Research Foundation [LRF307181203]; NATIONAL CANCER INSTITUTE [P01CA100730, P50CA094056, R01CA063417] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lymphoma and Leukemia Foundation; American Society of Hematology Research Training Award; Lymphoma Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA94056, CA100730, and CA63413 and Grant T32 HL07088 (to M. C.). This work was also supported by Lymphoma and Leukemia Foundation Grant LLS6067-10, American Society of Hematology Research Training Award for Fellows, and Lymphoma Research Foundation Grant LRF307181203 (to H. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Adachi M, 2003, FEBS LETT, V554, P77, DOI 10.1016/S0014-5793(03)01109-8; Adey NB, 2000, CANCER RES, V60, P35; Akagi T, 1997, ONCOGENE, V14, P2071, DOI 10.1038/sj.onc.1201045; Arpin-Andre C, 2007, J BIOL CHEM, V282, P33132, DOI 10.1074/jbc.M702279200; Barre B, 2010, CELL CYCLE, V9, P4795, DOI 10.4161/cc.9.24.14245; Barre B, 2010, MOL CELL, V38, P524, DOI 10.1016/j.molcel.2010.03.018; Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008; Ciminale V, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00398; Comb WC, 2012, MOL CELL, V45, P719, DOI 10.1016/j.molcel.2012.01.010; Contreras-Paredes A, 2009, VIROLOGY, V383, P78, DOI 10.1016/j.virol.2008.09.040; Currer R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00406; Dissinger N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112762; Endo K, 2002, J VIROL, V76, P2648, DOI 10.1128/JVI.76.6.2648-2653.2002; Feuer G, 2005, ONCOGENE, V24, P5996, DOI 10.1038/sj.onc.1208971; Fukuda R, 2005, P NATL ACAD SCI USA, V102, P15213, DOI 10.1073/pnas.0507184102; Gallo RC, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-17; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; GRASSMANN R, 1992, J VIROL, V66, P4570, DOI 10.1128/JVI.66.7.4570-4575.1992; Grm HS, 2004, J GEN VIROL, V85, P2815, DOI 10.1099/vir.0.80035-0; GROSSMAN WJ, 1995, P NATL ACAD SCI USA, V92, P1057, DOI 10.1073/pnas.92.4.1057; Higuchi M, 2007, J VIROL, V81, P11900, DOI 10.1128/JVI.00532-07; Higuchi M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-117; Kiyono T, 1997, P NATL ACAD SCI USA, V94, P11612, DOI 10.1073/pnas.94.21.11612; Kwon H, 2005, J BIOL CHEM, V280, P35713, DOI 10.1074/jbc.M504848200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Le SS, 1997, P NATL ACAD SCI USA, V94, P6670, DOI 10.1073/pnas.94.13.6670; Leslie NR, 2001, BIOCHEM J, V357, P427, DOI 10.1042/0264-6021:3570427; Li X, 2011, EMBO REP, V12, P818, DOI 10.1038/embor.2011.106; Lin EI, 2013, J NEUROSCI, V33, P12067, DOI 10.1523/JNEUROSCI.0816-13.2013; Makokha GN, 2013, CANCER SCI, V104, P313, DOI 10.1111/cas.12087; Molina JR, 2012, ONCOGENE, V31, P1264, DOI 10.1038/onc.2011.324; Nakagawa S, 2000, MOL CELL BIOL, V20, P8244, DOI 10.1128/MCB.20.21.8244-8253.2000; Ohashi M, 2004, VIROLOGY, V320, P52, DOI 10.1016/j.virol.2003.11.014; Okajima M, 2008, VIRUS GENES, V37, P231, DOI 10.1007/s11262-008-0259-4; ORNSTEIN L, 1964, ANN NY ACAD SCI, V121, P321, DOI 10.1111/j.1749-6632.1964.tb14207.x; Peloponese JM, 2006, J BIOL CHEM, V281, P8927, DOI 10.1074/jbc.M510598200; POIESZ BJ, 1981, NATURE, V294, P268, DOI 10.1038/294268a0; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Ren T, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00287; Robek MD, 1999, J VIROL, V73, P4856, DOI 10.1128/JVI.73.6.4856-4865.1999; Rocha S, 2003, MOL CELL BIOL, V23, P4713, DOI 10.1128/MCB.23.13.4713-4727.2003; Romanelli MG, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00271; Schumm K, 2006, EMBO J, V25, P4820, DOI 10.1038/sj.emboj.7601343; Shoji T, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-83; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sotelo NS, 2012, J CELL BIOCHEM, V113, P2661, DOI 10.1002/jcb.24141; Suzuki T, 1999, ONCOGENE, V18, P5967, DOI 10.1038/sj.onc.1203008; TANAKA A, 1990, P NATL ACAD SCI USA, V87, P1071, DOI 10.1073/pnas.87.3.1071; Tsubata C, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-46; Wu XY, 2000, P NATL ACAD SCI USA, V97, P4233, DOI 10.1073/pnas.97.8.4233; Wu Y, 2000, J BIOL CHEM, V275, P21477, DOI 10.1074/jbc.M909741199; Wu YT, 2011, J BIOL CHEM, V286, P14190, DOI 10.1074/jbc.M111.219923; Xiao GT, 2001, EMBO J, V20, P6805, DOI 10.1093/emboj/20.23.6805; Xie L, 2006, BLOOD, V107, P1980, DOI 10.1182/blood-2005-03-1333	54	19	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26270	26281		10.1074/jbc.M115.684746	http://dx.doi.org/10.1074/jbc.M115.684746			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26324707	Green Published, hybrid			2022-12-26	WOS:000363527300043
J	Bakoyannis, G; Yiannoutsos, CT				Bakoyannis, Giorgos; Yiannoutsos, Constantin T.			Impact of and Correction for Outcome Misclassification in Cumulative Incidence Estimation	PLOS ONE			English	Article							SAMPLING-BASED APPROACH; HIV-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; COMPETING RISKS; FOLLOW-UP; PATIENTS LOST; SCALE-UP; DEATH; SURVIVAL; AFRICA	Cohort studies and clinical trials may involve multiple events. When occurrence of one of these events prevents the observance of another, the situation is called "competing risks". A useful measure in such studies is the cumulative incidence of an event, which is useful in evaluating interventions or assessing disease prognosis. When outcomes in such studies are subject to misclassification, the resulting cumulative incidence estimates may be biased. In this work, we study the mechanism of bias in cumulative incidence estimation due to outcome misclassification. We show that even moderate levels of misclassification can lead to seriously biased estimates in a frequently unpredictable manner. We propose an easy to use estimator for correcting this bias that is uniformly consistent. Extensive simulations suggest that this method leads to unbiased estimates in practical settings. The proposed method is useful, both in settings where misclassification probabilities are known by historical data or can be estimated by other means, and for performing sensitivity analyses when the misclassification probabilities are not precisely known.	[Bakoyannis, Giorgos; Yiannoutsos, Constantin T.] Indiana Univ, Fairbanks Sch Publ Hlth, Dept Biostat, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Yiannoutsos, CT (corresponding author), Indiana Univ, Fairbanks Sch Publ Hlth, Dept Biostat, 410 West 10th St,Suite 3000, Indianapolis, IN 46202 USA.	cyiannou@iupui.edu	Bakoyannis, Giorgos/AAW-8304-2020	Bakoyannis, Giorgos/0000-0002-2789-2497	National Institutes of Health [U01-AI069911, R01-AI102710]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002529, UL1TR001108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102710, U01AI069911] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant U01-AI069911 "East Africa IeDEA Regional Consortium" to CTY, and National Institutes of Health grant R01-AI102710 "Statistical Designs and Methods for Double-Sampling for HIV/AIDS". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALEN OO, 1978, SCAND J STAT, V5, P141; Andersen PK, 2012, INT J EPIDEMIOL, V41, P861, DOI 10.1093/ije/dyr213; Bakoyannis G, 2012, STAT METHODS MED RES, V21, P257, DOI 10.1177/0962280210394479; BARRON BA, 1977, BIOMETRICS, V33, P414, DOI 10.2307/2529795; DiCiccio TJ, 1996, STAT SCI, V11, P189; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; FLANDERS WD, 1992, EPIDEMIOLOGY, V3, P3, DOI 10.1097/00001648-199201000-00002; Geng EH, 2008, JAMA-J AM MED ASSOC, V300, P506, DOI 10.1001/jama.300.5.506; Geng EH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021797; Geng Elvin H, 2010, Curr HIV/AIDS Rep, V7, P234, DOI 10.1007/s11904-010-0061-5; Geng EH, 2010, TROP MED INT HEALTH, V15, P63, DOI 10.1111/j.1365-3156.2010.02507.x; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Gerver SM, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-29; GREENLAND S, 1980, AM J EPIDEMIOL, V112, P564, DOI 10.1093/oxfordjournals.aje.a113025; Ha J, 2012, LIFETIME DATA ANAL, V18, P58, DOI 10.1007/s10985-011-9210-4; Henriques J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031706; Hinchliffe SR, 2013, CANCER EPIDEMIOL, V37, P11, DOI 10.1016/j.canep.2012.08.012; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; Kiragga AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083524; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; QUADE D, 1980, AM J EPIDEMIOL, V111, P503, DOI 10.1093/oxfordjournals.aje.a112930; ROGAN WJ, 1978, AM J EPIDEMIOL, V107, P71, DOI 10.1093/oxfordjournals.aje.a112510; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Touloumi G, 2006, JAIDS-J ACQ IMM DEF, V42, P554, DOI 10.1097/01.qai.0000230321.85911.db; Van Rompaye B, 2012, EPIDEMIOLOGY, V23, P194, DOI 10.1097/EDE.0b013e3182454cad; Van Rompaye B, 2010, BIOSTATISTICS, V11, P546, DOI 10.1093/biostatistics/kxq011; Yiannoutsos CT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003843	28	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137454	10.1371/journal.pone.0137454	http://dx.doi.org/10.1371/journal.pone.0137454			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331616	Green Published, Green Submitted, gold			2022-12-26	WOS:000360613800132
J	Carls, MG; Larsen, ML; Holland, LG				Carls, Mark G.; Larsen, Marie L.; Holland, Larry G.			Spilled Oils: Static Mixtures or Dynamic Weathering and Bioavailability?	PLOS ONE			English	Article							PRINCE-WILLIAM-SOUND; EXXON-VALDEZ OIL; POLYCYCLIC AROMATIC-HYDROCARBONS; SITE-SPECIFIC CONTAMINANTS; CRUDE-OIL; MEMBRANE DEVICES; RAINBOW-TROUT; FISH EMBRYOS; MUSSEL BEDS; PART II	Polynuclear aromatic hydrocarbons (PAHs) from sequestered MV Selendang Ayu oil were biologically available in 2008, 3.6 y after it was spilled along Unalaska Island, Alaska. Thermodynamically driven weathering was the most probable mechanism of organism exposure to PAHs. Alkane and PAH composition in oil changed over time as smaller constituents were preferentially lost, indicative of weathering. In contrast, composition of the largest compounds (biomarkers) including triterpanes, hopanes, and steranes remained unchanged. Smaller molecules (the PAHs) lost from stranded oil were observed in indigenous mussels and passive samplers deployed in July 2008. Concentration and composition of PAHs were significantly different than in a non-oiled reference area and patterns observed in mussels were repeated in passive samplers deployed in three zones (intertidal, subtidal, and water). Thus, hydrocarbons lost from one compartment (sequestered whole oil) were detectable in another (mussels and passive samplers) implying aqueous transfer. Quantities of mobile oil constituents were small, yielding uptake concentrations that are likely inconsequential for mussels, but the sensitivity provided by bioaccumulation and passive sampler uptake ensured that dissolved hydrocarbons were detectable.	[Carls, Mark G.; Larsen, Marie L.; Holland, Larry G.] NOAA, Auke Bay Labs, NMFS, Juneau, AK 99802 USA	National Oceanic Atmospheric Admin (NOAA) - USA	Carls, MG (corresponding author), NOAA, Auke Bay Labs, NMFS, Juneau, AK 99802 USA.	mark.carls@noaa.gov						[Anonymous], 2010, OIL BUDGET CALCULATO; [Anonymous], 2005, ALEUTIANS W COASTAL; Bence AE, 1995, ASTM STP, V1219; BLUMER M, 1973, DEEP-SEA RES, V20, P239, DOI 10.1016/0011-7471(73)90014-4; Boehm PD, 2005, MAR POLLUT BULL, V50, P740, DOI 10.1016/j.marpolbul.2005.02.002; Boehm PD, 2004, ENVIRON TOXICOL CHEM, V23, P2916, DOI 10.1897/03-514.1; Carls MG, 2006, ENVIRON SCI TECHNOL, V40, P4233, DOI 10.1021/es052498g; Carls MG, 2004, T AM FISH SOC, V133, P834, DOI 10.1577/T03-125.1; Carls MG, 2004, ENVIRON TOXICOL CHEM, V23, P1416, DOI 10.1897/03-395; Carls MG, 2004, MAR ENVIRON RES, V57, P359, DOI 10.1016/j.marenvres.2003.11.002; Carls MG, 2001, MAR ENVIRON RES, V51, P167, DOI 10.1016/S0141-1136(00)00103-3; Carls MG, 2007, SELENDANG AYU OIL RI; Carls MG, 2010, HUM ECOL RISK ASSESS, V15, P1084; Dubansky B, 2013, ENVIRON SCI TECHNOL, V47, P5074, DOI 10.1021/es400458p; Dubansky B, 2012, INTEGR COMP BIOL, V52, pE49; Faksness L-G, 2002, STF66A02028 SINTEF A; Farwell AJ, 2006, ENVIRON TOXICOL CHEM, V25, P3266, DOI 10.1897/05-637R1.1; Flint PL, 2009, CHRONIC EXPOSURE SEA; GILFILLAN ES, 1978, J FISH RES BOARD CAN, V35, P630, DOI 10.1139/f78-110; Gundlach ER, 1981, P 1981 OIL SPILL C; Harji RR, 2008, ENVIRON INT, V34, P959, DOI 10.1016/j.envint.2008.02.006; Heintz RA, 1999, ENVIRON TOXICOL CHEM, V18, P494, DOI 10.1002/etc.5620180318; Incardona JP, 2009, ENVIRON SCI TECHNOL, V43, P201, DOI 10.1021/es802270t; Incardona JP, 2005, ENVIRON HEALTH PERSP, V113, P1755, DOI 10.1289/ehp.8230; Incardona JP, 2004, TOXICOL APPL PHARM, V196, P191, DOI 10.1016/j.taap.2003.11.026; Kelly EN, 2009, P NATL ACAD SCI USA, V106, P22346, DOI 10.1073/pnas.0912050106; Larsen ML, 2010, STANDARD OPERATING P; Larsen ML, 2008, STANDARD OPERATING P; Livingstone D.R., 1991, Advances in Comparative and Environmental Physiology, V7, P45; Lu ZM, 2012, ISME J, V6, P451, DOI 10.1038/ismej.2011.91; Marty GD, 1997, CAN J ZOOL, V75, P989, DOI 10.1139/z97-120; Mauseth GS, 2008, 2008 INT OIL SPILL C; Mitra S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL049505; Neff JM, 2006, ENVIRON TOXICOL CHEM, V25, P947, DOI 10.1897/05-339R.1; Page DS, 2006, MAR POLLUT BULL, V52, P367, DOI 10.1016/j.marpolbul.2005.08.027; Page DS, 2005, MAR ENVIRON RES, V60, P422, DOI 10.1016/j.marenvres.2005.01.002; Reddy CM, 2002, ENVIRON SCI TECHNOL, V36, P4754, DOI 10.1021/es020656n; Rhodes S, 2005, ECOTOX ENVIRON SAFE, V60, P247, DOI 10.1016/j.ecoenv.2004.08.002; Short JW, 2007, ENVIRON SCI TECHNOL, V41, P1245, DOI 10.1021/es0620033; Short JW, 2008, MAR ENVIRON RES, V66, P487, DOI 10.1016/j.marenvres.2008.08.007; Short JW, 2006, ENVIRON SCI TECHNOL, V40, P3723, DOI 10.1021/es0601134; Short JW, 1997, ENVIRON SCI TECHNOL, V31, P2375, DOI 10.1021/es960985d; Short JW, 2004, ENVIRON SCI TECHNOL, V38, P19, DOI 10.1021/es0348694; Short JW, 1996, AM FISH S S, V18, P140; Springman KR, 2008, MAR ENVIRON RES, V66, P477, DOI 10.1016/j.marenvres.2008.07.001; STEGEMAN JJ, 1978, J FISH RES BOARD CAN, V35, P668, DOI 10.1139/f78-117; Sundberg H, 2006, CAN J FISH AQUAT SCI, V63, P1320, DOI 10.1139/F06-034; TEAL JM, 1992, MAR POLLUT BULL, V24, P607, DOI 10.1016/0025-326X(92)90281-A; TEAL JM, 1984, ENVIRON MANAGE, V8, P27, DOI 10.1007/BF01867871; VANDERMEULEN JH, 1994, CAN J FISH AQUAT SCI, V51, P845, DOI 10.1139/f94-083; VENKATESAN MI, 1988, MAR CHEM, V25, P1, DOI 10.1016/0304-4203(88)90011-4; Wang Z, 2007, OIL SPILL ENVIRONMENTAL FORENSICS: FINGERPRINTING AND SOURCE IDENTIFICATION, P1; Whitehead A, 2013, INTEGR COMP BIOL, V53, P635, DOI 10.1093/icb/ict080; Whitehead A, 2012, P NATL ACAD SCI USA, V109, P20298, DOI 10.1073/pnas.1109545108; Zhao MX, 2003, ORG GEOCHEM, V34, P131, DOI 10.1016/S0146-6380(02)00142-0	55	5	5	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0134448	10.1371/journal.pone.0134448	http://dx.doi.org/10.1371/journal.pone.0134448			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332909	Green Published, gold, Green Submitted			2022-12-26	WOS:000360613800008
J	Carvalho, DS; Andrade, RFS; Pinho, STR; Goes-Neto, A; Lobao, TCP; Bomfim, GC; El-Hani, CN				Carvalho, Daniel S.; Andrade, Roberto F. S.; Pinho, Suani T. R.; Goes-Neto, Aristoteles; Lobao, Thierry C. P.; Bomfim, Gilberto C.; El-Hani, Charbel N.			What are the Evolutionary Origins of Mitochondria? A Complex Network Approach	PLOS ONE			English	Article							ALPHA-PROTEOBACTERIA; COMMUNITY STRUCTURE; COMMON ANCESTOR; ATP SYNTHASE; ORGANELLE; PHYLOGENY	Mitochondria originated endosymbiotically from an Alphaproteobacteria-like ancestor. However, it is still uncertain which extant group of Alphaproteobacteria is phylogenetically closer to the mitochondrial ancestor. The proposed groups comprise the order Rickettsiales, the family Rhodospirillaceae, and the genus Rickettsia. In this study, we apply a new complex network approach to investigate the evolutionary origins of mitochondria, analyzing protein sequences modules in a critical network obtained through a critical similarity threshold between the studied sequences. The dataset included three ATP synthase subunits (4, 6, and 9) and its alphaproteobacterial homologs (b, a, and c). In all the subunits, the results gave no support to the hypothesis that Rickettsiales are closely related to the mitochondrial ancestor. Our findings support the hypothesis that mitochondria share a common ancestor with a clade containing all Alphaproteobacteria orders, except Rickettsiales.	[Carvalho, Daniel S.; Bomfim, Gilberto C.; El-Hani, Charbel N.] Univ Fed Bahia, Dept Gen Biol, Inst Biol, Salvador, BA, Brazil; [Andrade, Roberto F. S.; Pinho, Suani T. R.] Univ Fed Bahia, Gen Phys Dept, Inst Phys, Salvador, BA, Brazil; [Goes-Neto, Aristoteles] State Univ Feira de Santana, Dept Biol Sci, Feira De Santana, BA, Brazil; [Lobao, Thierry C. P.] Univ Fed Bahia, Dept Math, Inst Math, Salvador, BA, Brazil	Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade Estadual de Feira de Santana; Universidade Federal da Bahia	El-Hani, CN (corresponding author), Univ Fed Bahia, Dept Gen Biol, Inst Biol, Salvador, BA, Brazil.	charbel.elhani@gmail.com	El-Hani, Charbel/Q-1364-2019; Andrade, Roberto Fernandes Silva/R-9088-2019; Goes-Neto, Aristoteles/A-6955-2013	Andrade, Roberto Fernandes Silva/0000-0002-9323-1400; Goes-Neto, Aristoteles/0000-0002-7692-6243; Carvalho, Daniel/0000-0001-6590-4287	CNPq [111828/2011-2, 101238/2012-6, 57386/2008-9, 308148/2013-4, 301259/2010-0]; FAPESB [534/2013, PNX 0006/2009]; RFSA; CNPq (INCT-SC); FAPESB/CNPQ [PNX 0016/2009]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESB(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); RFSA; CNPq (INCT-SC)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESB/CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	DSC has received during the work scientific training grants from CNPq (contract ns. 111828/2011-2 and 101238/2012-6) and master grant from FAPESB (contract n. 534/2013). RFSA, STRP and TCPL are partially supported by FAPESB (contract n. PNX 0006/2009). STRP is also supported by CNPq (INCT-CITECS, contract n. 57386/2008-9), and RFSA, by CNPq (INCT-SC). AGN is supported by CNPq (contract n. 308148/2013-4). CNEH is partially supported by FAPESB/CNPQ (contract n. PNX 0016/2009) and CNPq (contract n. 301259/2010-0).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson SGE, 1999, CURR OPIN MICROBIOL, V2, P535, DOI 10.1016/S1369-5274(99)00013-2; Andrade RFS, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.046101; Andrade RFS, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001131; Andrade RFS, 2009, INT J BIFURCAT CHAOS, V19, P2677, DOI 10.1142/S0218127409024396; Atteia A, 2009, MOL BIOL EVOL, V26, P1533, DOI 10.1093/molbev/msp068; Bapteste E, 2013, TRENDS GENET, V29, P439, DOI 10.1016/j.tig.2013.05.007; Bastian M., 2009, INT AAAI C WEBL SOC, V8, P361, DOI DOI 10.13140/2.1.1341.1520; Chang X, 2010, GENOMICS, V95, P339, DOI 10.1016/j.ygeno.2010.03.006; Esposti M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096566; Devenish RJ, 2000, BBA-BIOENERGETICS, V1458, P428, DOI 10.1016/S0005-2728(00)00092-X; Esser C, 2004, MOL BIOL EVOL, V21, P1643, DOI 10.1093/molbev/msh160; Ferla MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083383; Fitzpatrick DA, 2006, MOL BIOL EVOL, V23, P74, DOI 10.1093/molbev/msj009; Goes-Neto A, 2010, BIOSYSTEMS, V101, P59, DOI 10.1016/j.biosystems.2010.04.006; Gray MW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011403; Gupta RS, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-106; Gupta RS, 2005, CRIT REV MICROBIOL, V31, P101, DOI 10.1080/10408410590922393; Luo HW, 2013, MBIO, V4, DOI 10.1128/mBio.00373-13; Lynch M, 2006, SCIENCE, V311, P1727, DOI 10.1126/science.1118884; McInerney JO, 2014, NAT REV MICROBIOL, V12, P449, DOI 10.1038/nrmicro3271; Muller M, 2012, MICROBIOL MOL BIOL R, V76, P444, DOI 10.1128/MMBR.05024-11; Nartsissov YR, 2006, J THEOR BIOL, V242, P300, DOI 10.1016/j.jtbi.2006.02.018; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Le PT, 2014, TRENDS MICROBIOL, V22, P147, DOI 10.1016/j.tim.2013.12.006; Rodriguez-Ezpeleta N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030520; Sallstrom B, 2005, CURR OPIN MICROBIOL, V8, P579, DOI 10.1016/j.mib.2005.08.002; SCHWARTZ RM, 1978, SCIENCE, V199, P395, DOI 10.1126/science.202030; Thiergart T, 2012, GENOME BIOL EVOL, V4, P466, DOI 10.1093/gbe/evs018; Thrash JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00013; Viklund J, 2012, MOL BIOL EVOL, V29, P599, DOI 10.1093/molbev/msr203; Wang Z, 2015, SCI REP-UK, V5, DOI 10.1038/srep07949; Williams KP, 2007, J BACTERIOL, V189, P4578, DOI 10.1128/JB.00269-07; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; Zimorski V, 2014, CURR OPIN MICROBIOL, V22, P38, DOI 10.1016/j.mib.2014.09.008	35	14	14	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0134988	10.1371/journal.pone.0134988	http://dx.doi.org/10.1371/journal.pone.0134988			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332127	Green Published, Green Submitted, gold			2022-12-26	WOS:000360613800017
J	Chan, HHL; Siewerdsen, JH; Vescan, A; Daly, MJ; Prisman, E; Irish, JC				Chan, Harley H. L.; Siewerdsen, Jeffrey H.; Vescan, Allan; Daly, Michael J.; Prisman, Eitan; Irish, Jonathan C.			3D Rapid Prototyping for Otolaryngology-Head and Neck Surgery: Applications in Image-Guidance, Surgical Simulation and Patient-Specific Modeling	PLOS ONE			English	Article							BEAM COMPUTED-TOMOGRAPHY; DEMONS DEFORMABLE REGISTRATION; SKULL BASE; MANDIBULAR RECONSTRUCTION; GUIDED SURGERY; C-ARM; ACCURACY; BONE; RELIABILITY; TRACKING	The aim of this study was to demonstrate the role of advanced fabrication technology across a broad spectrum of head and neck surgical procedures, including applications in endoscopic sinus surgery, skull base surgery, and maxillofacial reconstruction. The initial case studies demonstrated three applications of rapid prototyping technology are in head and neck surgery: i) a mono-material paranasal sinus phantom for endoscopy training ii) a multi-material skull base simulator and iii) 3D patient-specific mandible templates. Digital processing of these phantoms is based on real patient or cadaveric 3D images such as CT or MRI data. Three endoscopic sinus surgeons examined the realism of the endoscopist training phantom. One experienced endoscopic skull base surgeon conducted advanced sinus procedures on the high-fidelity multi-material skull base simulator. Ten patients participated in a prospective clinical study examining patient-specific modeling for mandibular reconstructive surgery. Qualitative feedback to assess the realism of the endoscopy training phantom and high-fidelity multi-material phantom was acquired. Conformance comparisons using assessments from the blinded reconstructive surgeons measured the geometric performance between intra-operative and pre-operative reconstruction mandible plates. Both the endoscopy training phantom and the high-fidelity multi-material phantom received positive feedback on the realistic structure of the phantom models. Results suggested further improvement on the soft tissue structure of the phantom models is necessary. In the patient-specific mandible template study, the pre-operative plates were judged by two blinded surgeons as providing optimal conformance in 7 out of 10 cases. No statistical differences were found in plate fabrication time and conformance, with pre-operative plating providing the advantage of reducing time spent in the operation room. The applicability of common model design and fabrication techniques across a variety of otolaryngological sub-specialties suggests an emerging role for rapid prototyping technology in surgical education, procedure simulation, and clinical practice.	[Chan, Harley H. L.; Daly, Michael J.; Irish, Jonathan C.] Univ Hlth Network, TECHNA Inst, Toronto, ON, Canada; [Irish, Jonathan C.] Univ Hlth Network, Dept Surg Oncol, Toronto, ON, Canada; [Daly, Michael J.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Siewerdsen, Jeffrey H.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Vescan, Allan; Irish, Jonathan C.] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada; [Vescan, Allan] Mt Sinai Hosp, Dept Otolaryngol, Toronto, ON M5G 1X5, Canada; [Prisman, Eitan] Univ British Columbia, Vancouver Gen Hosp, Vancouver, BC V5Z 1M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Johns Hopkins University; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of British Columbia	Irish, JC (corresponding author), Univ Hlth Network, TECHNA Inst, Toronto, ON, Canada.	jonathan.irish@uhn.on.ca		Daly, Michael/0000-0002-2217-4146; Prisman, Eitan/0000-0001-7201-6181	TECHNA-Guided Therapeutics (GTx) Program at the University Health Network; Hatch Engineering Fellowship Fund; RACH Fund; Princess Margaret Cancer Foundation; National Institutes of Health [R01-CA127944-02]; NATIONAL CANCER INSTITUTE [R01CA127444] Funding Source: NIH RePORTER	TECHNA-Guided Therapeutics (GTx) Program at the University Health Network; Hatch Engineering Fellowship Fund; RACH Fund; Princess Margaret Cancer Foundation(University of Toronto); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by the TECHNA-Guided Therapeutics (GTx) Program at the University Health Network, including The Kevin and Sandra Sullivan Chair in Surgical Oncology, The Hatch Engineering Fellowship Fund, The RACH Fund, The Princess Margaret Cancer Foundation and National Institutes of Health (R01-CA127944-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora H, 2005, ARCH OTOLARYNGOL, V131, P217, DOI 10.1001/archotol.131.3.217; Balachandran R, 2012, INT J COMPUT ASS RAD, V7, P315, DOI 10.1007/s11548-011-0639-4; Balachandran R, 2009, IEEE T BIO-MED ENG, V56, P37, DOI 10.1109/TBME.2008.2002110; Balachandran R, 2008, OTOL NEUROTOL, V29, P1050, DOI 10.1097/MAO.0b013e3181859a08; Barghan S, 2012, AUST DENT J, V57, P109, DOI 10.1111/j.1834-7819.2011.01663.x; Bichlmeier CP, 2008, INT WORKSH AUGM ENV, P45; Bill J S, 2004, Mund Kiefer Gesichtschir, V8, P135, DOI 10.1007/s10006-004-0541-0; Bittner JG, 2010, GASTROINTEST ENDOSC, V71, P357, DOI 10.1016/j.gie.2009.08.033; Blanco RT, 2005, EUR J RADIOL, V56, P130, DOI 10.1016/j.ejrad.2005.03.033; Brown GA, 2002, J ORTHOP TRAUMA, V16, P347, DOI 10.1097/00005131-200205000-00010; Caire F, 2010, STEREOT FUNCT NEUROS, V88, P109, DOI 10.1159/000280823; Chen G, 2010, CHINESE MED J-PEKING, V123, P2576, DOI 10.3760/cma.j.issn.0366-6999.2010.18.016; Cohen A, 2009, ORAL SURG ORAL MED O, V108, P661, DOI 10.1016/j.tripleo.2009.05.023; Daly MJ, 2010, PROC SPIE, V7625, DOI 10.1117/12.844212; Das S, 2008, AM J RHINOL, V22, P166, DOI 10.2500/ajr.2008.22.3152; De Man B, 1999, IEEE T NUCL SCI, V46, P691, DOI 10.1109/23.775600; Desilets DJ, 2011, GASTROINTEST ENDOSC, V73, P861, DOI 10.1016/j.gie.2011.01.063; Dixon BJ, 2011, LARYNGOSCOPE, V121, P2060, DOI 10.1002/lary.22153; Dreiseidler T, 2010, ORAL SURG ORAL MED O, V110, P94, DOI 10.1016/j.tripleo.2010.03.013; El-Beialy AR, 2011, AM J ORTHOD DENTOFAC, V140, P157, DOI 10.1016/j.ajodo.2010.03.030; Enquobahrie A, 2008, INT J COMPUT ASS RAD, V3, P395, DOI 10.1007/s11548-008-0243-4; Fitzpatrick JM, 1998, IEEE T MED IMAGING, V17, P694, DOI 10.1109/42.736021; Garrido BJ, 2011, SPINE J, V11, P331, DOI 10.1016/j.spinee.2011.03.007; Genden E, 1996, AM J OTOLARYNG, V17, P219, DOI 10.1016/S0196-0709(96)90085-X; Gibson A, 2003, APPL OPTICS, V42, P3109, DOI 10.1364/AO.42.003109; Hamming NM, 2009, MED PHYS, V36, P1800, DOI 10.1118/1.3117609; Hanna EY, 2007, ARCH OTOLARYNGOL, V133, P1209, DOI 10.1001/archotol.133.12.1209; Heiland M, 2007, ORAL SURG ORAL MED O, V104, P814, DOI 10.1016/j.tripleo.2007.04.031; Isaacs Seth, 2009, Otolaryngol Clin North Am, V42, P765, DOI 10.1016/j.otc.2009.08.014; Klatt J, 2011, J CRANIO MAXILL SURG, V39, P244, DOI 10.1016/j.jcms.2010.06.009; Labadie RF, 2005, OTOL NEUROTOL, V26, P557, DOI 10.1097/01.mao.0000178117.61537.5b; Labadie RF, 2010, OTOL NEUROTOL, V31, P94, DOI 10.1097/MAO.0b013e3181c2f81a; Labadie RF, 2009, INT J COMPUT ASS RAD, V4, P273, DOI 10.1007/s11548-009-0292-3; Lee JH, 2004, INT J ORAL MAX SURG, V33, P150, DOI 10.1054/ijom.2003.0487; Liang X, 2010, EUR J RADIOL, V75, P265, DOI 10.1016/j.ejrad.2009.03.042; Murayama Y, 2011, NEUROSURGERY, V68, P1427, DOI 10.1227/NEU.0b013e31820b4f1c; Nithiananthan S, 2009, MED PHYS, V36, P4755, DOI 10.1118/1.3223631; Nithiananthan S, 2011, MED PHYS, V38, P1785, DOI 10.1118/1.3555037; Nogueira JF, 2010, BRAZ J OTORHINOLAR, V76, P129, DOI 10.1590/S1808-86942010000100021; Poeschl PW, 2013, CLIN ORAL INVEST, V17, P317, DOI 10.1007/s00784-012-0704-6; Pohlenz P, 2008, J ORAL MAXIL SURG, V66, P324, DOI 10.1016/j.joms.2007.03.032; Pohlenz P, 2007, ORAL SURG ORAL MED O, V103, P412, DOI 10.1016/j.tripleo.2006.05.008; Pohlenz P, 2009, J ORAL MAXIL SURG, V67, P515, DOI 10.1016/j.joms.2008.06.086; Prisman E, 2011, INT FORUM ALLERGY RH, V1, P70, DOI 10.1002/alr.20007; Rabie A, 2011, J CRANIOFAC SURG, V22, P1466, DOI 10.1097/SCS.0b013e31821d1982; Ro EY, 2007, LARYNGOSCOPE, V117, P759, DOI 10.1097/mlg.0b013e318031f0cf; Schafer S, 2010, MED PHYS, V37, P694, DOI 10.1118/1.3284540; Sielhorst T, 2008, J DISP TECHNOL, V4, P451, DOI 10.1109/JDT.2008.2001575; Siewerdsen JH, 2005, PROC SPIE, V5744, P789, DOI 10.1117/12.595690; Singare S, 2004, MED ENG PHYS, V26, P671, DOI 10.1016/j.medengphy.2004.06.001; Timock AM, 2011, AM J ORTHOD DENTOFAC, V140, P734, DOI 10.1016/j.ajodo.2011.06.021; Uneri A, 2012, INT J COMPUT ASS RAD, V7, P159, DOI 10.1007/s11548-011-0636-7; Warren FM, 2007, OTOL NEUROTOL, V28, P325, DOI 10.1097/01.mao.0000253287.86737.2e; Weersink RA, 2011, MED PHYS, V38, P6458, DOI 10.1118/1.3658569; Wise SK, 2008, AM J RHINOL, V22, P635, DOI 10.2500/ajr.2008.22.3242; Woodworth BA, 2008, J LARYNGOL OTOL, V122, P361, DOI 10.1017/S0022215107000485; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zain-Alabdeen EH, 2012, DENTOMAXILLOFAC RAD, V41, P185, DOI [10.1259/dmfr/24985981, 10.1259/dmfr/24985971]	58	56	58	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136370	10.1371/journal.pone.0136370	http://dx.doi.org/10.1371/journal.pone.0136370			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331717	Green Published, Green Submitted, gold			2022-12-26	WOS:000360613800053
J	Heald, SLM; Nusbaum, HC				Heald, Shannon L. M.; Nusbaum, Howard C.			Variability in Vowel Production within and between Days	PLOS ONE			English	Article							TRAINING JAPANESE LISTENERS; R-VERTICAL-BAR; SLEEP; COARTICULATION; CONSOLIDATION; FATIGUE; CONTEXT; SPOKEN	Although the acoustic variability of speech is often described as a problem for phonetic recognition, there is little research examining acoustic-phonetic variability over time. We measured naturally occurring acoustic variability in speech production at nine specific time points (three per day over three days) to examine daily change in production as well as change across days for citation-form vowels. Productions of seven different vowels (/EE/, /IH/, /AH/, /UH/, /AE/, /OO/, /EH/) were recorded at 9AM, 3PM and 9PM over the course of each testing day on three different days, every other day, over a span of five days. Results indicate significant systematic change in F1 and F0 values over the course of a day for each of the seven vowels recorded, whereas F2 and F3 remained stable. Despite this systematic change within a day, however, talkers did not show significant changes in F0, F1, F2, and F3 between days, demonstrating that speakers are capable of producing vowels with great reliability over days without any extrinsic feedback besides their own auditory monitoring. The data show that in spite of substantial day-to-day variability in the specific listening and speaking experiences of these participants and thus exposure to different acoustic tokens of speech, there is a high degree of internal precision and consistency for the production of citation form vowels.	[Heald, Shannon L. M.; Nusbaum, Howard C.] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA	University of Chicago	Heald, SLM (corresponding author), Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA.	smbowdre@uchicago.edu						Akahane-Yamada R., 1996, P 3 JOINT M AC SOC A; Barrett J, 2002, EXP BRAIN RES, V146, P531, DOI 10.1007/s00221-002-1229-z; Bes F, 2009, SLEEP, V32, P392, DOI 10.1093/sleep/32.3.392; Blatter K, 2007, PHYSIOL BEHAV, V90, P196, DOI 10.1016/j.physbeh.2006.09.009; Boersma P., 1993, IFA P, V17, P97; Boersma P., 2016, PRAAT DOING PHONETIC; Bradlow AR, 1997, J ACOUST SOC AM, V101, P2299, DOI 10.1121/1.418276; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Broughton R. J., 1997, SLEEP RES ONLINE SRO, V1, P166; Butcher A., 1976, J PHONETICS, V4, P59; CATFORD JC, 1970, MOD LANG J, V54, P477, DOI 10.2307/321767; Colquhoun W., 1971, BIOL RHYTHMS HUMAN P, P39; COOPER WE, 1974, J ACOUST SOC AM, V56, P617, DOI 10.1121/1.1903300; Dalby J., 1998, P EUR SPEECH COMM AS, P25; DELATTRE PC, 1955, J ACOUST SOC AM, V27, P769, DOI 10.1121/1.1908024; DIENER HC, 1988, PROG BRAIN RES, V76, P253; Elman JL, 1986, INVARIANCE VARIABILI, P360; ENOKA RM, 1989, J NEUROPHYSIOL, V62, P1344, DOI 10.1152/jn.1989.62.6.1344; Evans BG, 2007, J ACOUST SOC AM, V121, P3814, DOI 10.1121/1.2722209; Fenn KM, 2003, NATURE, V425, P614, DOI 10.1038/nature01951; FLANAGAN JL, 1955, J ACOUST SOC AM, V27, P613, DOI 10.1121/1.1907979; FOWLER CA, 1993, LANG SPEECH, V36, P171, DOI 10.1177/002383099303600304; Francis AL, 2002, J EXP PSYCHOL HUMAN, V28, P349, DOI 10.1037//0096-1523.28.2.349; GELFER MP, 1991, J VOICE, V5, P158, DOI 10.1016/S0892-1997(05)80179-1; Gribble PA, 2004, PERCEPT MOTOR SKILL, V99, P1035, DOI 10.2466/pms.99.3.1035-1045; Holt LL, 2000, J ACOUST SOC AM, V108, P710, DOI 10.1121/1.429604; Kostyk BE, 1998, J VOICE, V12, P287, DOI 10.1016/S0892-1997(98)80019-2; Kuhl P. K., 1995, SPEECH PERCEPTION LI, P433; Labov W., 2006, PHONOLOGY SOUND CHAN; LEHISTE I, 1961, J ACOUST SOC AM, V33, P419, DOI 10.1121/1.1908681; Liberman A. M., 1967, MODELS PERCEPTION SP; LINDBLOM B, 1963, J ACOUST SOC AM, V35, P1773, DOI 10.1121/1.1918816; LIVELY SE, 1994, J ACOUST SOC AM, V96, P2076, DOI 10.1121/1.410149; MANN VA, 1980, PERCEPT PSYCHOPHYS, V28, P407, DOI 10.3758/BF03204884; Miller J. L., 1981, PERSPECTIVES STUDY S, P39; Minors DS, 2013, CIRCADIAN RHYTHMS HU; MOON SJ, 1994, J ACOUST SOC AM, V96, P40, DOI 10.1121/1.410492; Nusbaum H., 1997, TALKER VARIABILITY S, P109; OHMAN SEG, 1966, J ACOUST SOC AM, V39, P151, DOI 10.1121/1.1909864; Perkell J, 1997, SPEECH COMMUN, V22, P227, DOI 10.1016/S0167-6393(97)00026-5; PETERSON GE, 1952, J ACOUST SOC AM, V24, P175, DOI 10.1121/1.1906875; Press W. H., 1992, ART SCI COMPUTING; Purcell DW, 2006, J ACOUST SOC AM, V120, P966, DOI 10.1121/1.2217714; RECASENS D, 1989, SPEECH COMMUN, V8, P293, DOI 10.1016/0167-6393(89)90012-5; REPP BH, 1982, PSYCHOL BULL, V92, P81, DOI 10.1037/0033-2909.92.1.81; STEMPLE JC, 1994, J VOICE, V8, P271, DOI 10.1016/S0892-1997(05)80299-1; Stevens K. N., 1963, J SPEECH HEARING RES; Stevens Kenneth N., 1998, ACOUSTIC PHONETICS; STRANGE W, 1989, J ACOUST SOC AM, V85, P2135, DOI 10.1121/1.397863; Traunmuller H, 2000, J ACOUST SOC AM, V107, P3438, DOI 10.1121/1.429414; TULLER B, 1994, J EXP PSYCHOL HUMAN, V20, P3, DOI 10.1037/0096-1523.20.1.3; VANSUMMERS W, 1988, J ACOUST SOC AM, V84, P917, DOI 10.1121/1.396660; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8	53	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136791	10.1371/journal.pone.0136791	http://dx.doi.org/10.1371/journal.pone.0136791			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ4ZT	26331478	Green Published, gold, Green Submitted			2022-12-26	WOS:000360613800071
J	Loevinsohn, M				Loevinsohn, Michael			The 2001-03 Famine and the Dynamics of HIV in Malawi: A Natural Experiment	PLOS ONE			English	Article							POPULATION-BASED SURVEYS; SEXUAL-BEHAVIOR; YOUNG-PEOPLE; PREVALENCE; MIGRATION; AFRICA; SURVEILLANCE; DECLINES; PARTNERSHIPS; REDUCTIONS	Background Food security has deteriorated for many people in developing regions facing high and volatile food prices. Without effective and equitable responses, the situation is likely to worsen due to diminishing access to land and water, competition from non-food uses of agricultural products, and the effects of climate change and variability. Understanding how this will affect the burden and distribution of major diseases such as HIV is critical. This study makes use of the near-experimental conditions created by the Malawi famine to shed new light on this issue. Methods Multilevel, random intercept models were used to relate the change in HIV prevalence at antenatal surveillance sites over the course of the famine to the proportion of rural households requiring food aid in the surrounding district at the famine's peak. Similar models were used to relate this indicator of rural hunger to changes in the composition of the antenatal population. The extent and direction of migration were estimated from a household survey conducted 1-2 years after the famine. Findings At rural sites, the change in HIV prevalence was positively and non-linearly related to the extent of rural hunger (P = 0.016), consistent with contemporary accounts of increased transactional sex and with hunger compromising immune function. At non-rural sites, prevalence declined as rural hunger increased (P = 0.006), concentrated in women who self-identified as farmers (P = 0.010). This finding is consistent with contemporary accounts of migration in search of food and work from villages where HIV risk was lower to towns and cities where it was higher. Corroborating this interpretation, the proportion of farmers in the antenatal population was found to rise at non-rural sites as rural hunger increased in the surrounding district (P = 0.015) whereas the proportion fell with increasing rural hunger at rural sites (P<0.001). The models suggest migrants were predominantly farming women under 25 years (P = 0.010). The household survey confirmed that there was a surge of rural-to-urban migration during the famine, particularly by women under 25 years. Migration to less affected rural areas also increased. Conclusion The Malawi famine appears to have had a substantial effect on HIV's dynamics and demography. Poverty and inequality, commonly considered structural determinants of HIV epidemics, can change rapidly, apparently transmitting their effects with little lag. Epidemic patterns risk being misread if such social and economic change is ignored. Many studies examining HIV prevalence declines have implicated sexual behaviour change but do not appear to have adequately considered the contribution of rural-urban migration. The evidence from Malawi, which links actions that undermined people's food security to changes in the prevalence and distribution of HIV infections, suggests new opportunities for prevention.	Univ Sussex, Inst Dev Studies, Brighton, E Sussex, England	University of Sussex	Loevinsohn, M (corresponding author), Univ Sussex, Inst Dev Studies, Brighton, E Sussex, England.	mloevinsohn@gmail.com			ESRC [ES/I021620/1] Funding Source: UKRI; Economic and Social Research Council [ES/I021620/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		[Anonymous], 2015, AIDS IND SURV; [Anonymous], 2006, AIDS ECOLOGY POVERTY; Bello GA, 2006, SEX TRANSM INFECT, V82, pI9, DOI 10.1136/sti.2005.016030; Bello G, 2011, SEX TRANSM INFECT, V87, P296, DOI 10.1136/sti.2010.043786; Browne W., 2009, MCMC ESTIMATION MLWI; Bryceson D. F, 2004, SOCIAL PATHWAYS HIV; Bryceson DF, 2006, J MOD AFR STUD, V44, P173, DOI 10.1017/S0022278X06001595; Bryceson DF, 2002, WORLD DEV, V30, P725, DOI 10.1016/S0305-750X(02)00006-2; CHRISTIANSEN R, 1984, DEV CHANGE, V15, P125, DOI 10.1111/j.1467-7660.1984.tb00176.x; Clark S, 2004, STUD FAMILY PLANN, V35, P149, DOI 10.1111/j.1728-4465.2004.00019.x; Conroy AC, 2006, POVERTY, AIDS AND HUNGER: BREAKING THE POVERTY TRAP IN MALAWI, P1, DOI 10.1057/9780230627703; DECOSAS J, 1995, LANCET, V346, P826, DOI 10.1016/S0140-6736(95)91631-8; Devereux S, 2002, IDS BULL-I DEV STUD, V33, P70, DOI 10.1111/j.1759-5436.2002.tb00046.x; Devereux S, 2003, MALAWI FOOD CRISIS I, DOI 10.1.1.359.6681; Devereux S, 2007, ROUTL STUD DEV ECON, V52, P143; Ellis F, 2003, WORLD DEV, V31, P1495, DOI 10.1016/S0305-750X(03)00111-6; FAO & WFP, 2014, STAT FOOD INS WORLD; Frankenberger T., 2003, LIVELIHOOD EROSION T; Garnett GP, 1996, J INFECT DIS, V174, pS150, DOI 10.1093/infdis/174.Supplement_2.S150; George CK, 2005, SOCIAL CONTEXT ASSES; Gillespie S, 2007, AIDS, V21, pS5, DOI 10.1097/01.aids.0000300531.74730.72; Gillespie S, 2009, FOOD SECUR, V1, P261, DOI 10.1007/s12571-009-0027-x; Gouws E, 2008, SEX TRANSM INFECT, V84, pI17, DOI 10.1136/sti.2008.030452; Gouws E, 2008, AIDS, V22, pS5, DOI 10.1097/01.aids.0000341773.86500.9d; GREENLAND S, 1987, AM J EPIDEMIOL, V125, P761, DOI 10.1093/oxfordjournals.aje.a114593; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Gregson S, 2010, INT J EPIDEMIOL, V39, P1311, DOI 10.1093/ije/dyq055; Haggblade S, 2009, 100 MICH STAT U; Hallett T B, 2006, Sex Transm Infect, V82 Suppl 1, pi1; Halperin DT, 2004, LANCET, V364, P4, DOI 10.1016/S0140-6736(04)16606-3; Hargrove JW, 2011, EPIDEMICS-NETH, V3, P88, DOI 10.1016/j.epidem.2011.02.004; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hossain N, 2011, DEV POLICY REV, V29, P565, DOI 10.1111/j.1467-7679.2011.00547.x; Itano N., 2012, CHRISTIAN SCI M 0515; Kamowa O., 2002, LIVING ABYSS HUNGER; Kishor S., 2004, PROFILING DOMESTIC V; Lee J, 2009, ANN ACAD MED SINGAP, V38, P714; Loevinsohn M, 2013, NATURAL EXPT UNDER A; Loevinsohn M, 2012, SEASONALITY, RURAL LIVELIHOODS AND DEVELOPMENT, P56; Lumey LH, 2011, ANNU REV PUBL HEALTH, V32, P237, DOI 10.1146/annurev-publhealth-031210-101230; Lurie MN, 2003, SEX TRANSM DIS, V30, P149, DOI 10.1097/00007435-200302000-00011; Mandala Elias C, 2005, END CHIDYERANO HIST, P165; Michelo C, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-279; Montana LS, 2008, SEX TRANSM INFECT, V84, pI78, DOI 10.1136/sti.2008.030106; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Munthali A., 2006, CURRENT ISSUES RURAL, P23; MVAC, 2002, MAL EM FOOD SEC ASS; MVAC, 2003, MAL EM FOOD SEC ASS; National AIDS Commission, 2003, HIV SENT SURV REP 20; National Statistical Office, 2005, INT HOUS SURV 2004 2; National Statistical Office, 1998, POP HOUS CENS FIN RE; National Statistical Office ORC Macro, 2001, MAL DEM HLTH SURV 20; Ngwira N., 2001, HIV AIDS AGR FOOD SE; Pascoe SJS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115290; Piot P, 2008, LANCET, V372, P845, DOI 10.1016/S0140-6736(08)60888-0; PISON G, 1993, J ACQ IMMUN DEF SYND, V6, P196; Porter JR., 2014, CLIMATE CHANGE 2014; Potts Deborah, 2012, WHATEVER HAPPENED AF; Rabe-Hesketh S, 2005, J ECONOMETRICS, V128, P301, DOI 10.1016/j.jeconom.2004.08.017; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; RENEWAL, 2003, HIV AIDS FOOD CRIS S; Rusike J, 2010, FOOD POLICY, V35, P98, DOI 10.1016/j.foodpol.2009.10.004; Sandoy IF, 2006, TROP MED INT HEALTH, V11, P917, DOI 10.1111/j.1365-3156.2006.01629.x; Schabenberger O., 2004, STAT METHODS SPATIAL; Sen A.K., 1981, POVERTY FAMINES; Shah MK, 2002, IMPACT HIV AIDS AGR; Stein Z., 1975, FAMINE HUM DEV DUTCH; Stringer EM, 2008, B WORLD HEALTH ORGAN, V86, P697, DOI 10.2471/BLT.07.045260; SUSSER M, 1981, AM J CLIN NUTR, V34, P784, DOI 10.1093/ajcn/34.4.784; SUSSER M, 1991, AM J EPIDEMIOL, V133, P635, DOI 10.1093/oxfordjournals.aje.a115939; Tsai AC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001203; Ukoumunne OC, 2001, STAT MED, V20, P417, DOI 10.1002/1097-0258(20010215)20:3<417::AID-SIM802>3.0.CO;2-G; UNAIDS, 2011, WORLD AIDS DAY REP 2; VAC, 2003, ID IMP HIV AIDS FOOD; Vaughan M., 2007, STORY AFRICAN FAMINE; Vermeulen SJ, 2012, ENVIRON SCI POLICY, V15, P136, DOI 10.1016/j.envsci.2011.09.003; von Braun J., 1999, FAMINE AFRICA CAUSES; Walker PT, 2008, SEX TRANSM INFECT, V84, pII42, DOI 10.1136/sti.2008.029975; Weiser SD, 2007, PLOS MED, V4, P1589, DOI 10.1371/journal.pmed.0040260; WHO, 2002, CHOL MAL DIS OUTBR R; World Bank, 2007, MAL POV VULN ASS INV; World Food Programme, 2003, 10200 EMOP WORLD FOO; Zulu LC, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-285	83	16	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135108	10.1371/journal.pone.0135108	http://dx.doi.org/10.1371/journal.pone.0135108			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ4ZT	26332405	Green Published, Green Submitted, gold			2022-12-26	WOS:000360613800020
J	Lovell, R; Towlson, C; Parkin, G; Portas, M; Vaeyens, R; Cobley, S				Lovell, Ric; Towlson, Chris; Parkin, Guy; Portas, Matt; Vaeyens, Roel; Cobley, Stephen			Soccer Player Characteristics in English Lower-League Development Programmes: The Relationships between Relative Age, Maturation, Anthropometry and Physical Fitness	PLOS ONE			English	Article							YOUTH SOCCER; BIOLOGICAL MATURATION; RUNNING SPEED; SUCCESS; PERFORMANCE; MATURITY; TESTS	The relative age effect (RAE) and its relationships with maturation, anthropometry, and physical performance characteristics were examined across a representative sample of English youth soccer development programmes. Birth dates of 1,212 players, chronologically age-grouped (i.e., U9's-U18's), representing 17 professional clubs (i.e., playing in Leagues 1 & 2) were obtained and categorised into relative age quartiles from the start of the selection year (Q1 = Sep-Nov; Q2 = Dec-Feb; Q3 = Mar-May; Q4 = Jun-Aug). Players were measured for somatic maturation and performed a battery of physical tests to determine aerobic fitness (Multi-Stage Fitness Test [MSFT]), Maximal Vertical Jump (MVJ), sprint (10 & 20m), and agility (T-Test) performance capabilities. Odds ratio's (OR) revealed Q1 players were 5.3 times (95% confidence intervals [CI]: 4.08-6.83) more likely to be selected than Q4's, with a particularly strong RAE bias observed in U9 (OR: 5.56) and U13-U16 squads (OR: 5.45-6.13). Multivariate statistical models identified few between quartile differences in anthropometric and fitness characteristics, and confirmed chronological age-group and estimated age at peak height velocity (APHV) as covariates. Assessment of practical significance using magnitude-based inferences demonstrated body size advantages in relatively older players (Q1 vs. Q4) that were very-likely small (Effect Size [ES]: 0.53-0.57), and likely to very-likely moderate (ES: 0.62-0.72) in U12 and U14 squads, respectively. Relatively older U12-U14 players also demonstrated small advantages in 10m (ES: 0.31-0.45) and 20m sprint performance (ES: 0.36-0.46). The data identify a strong RAE bias at the entry-point to English soccer developmental programmes. RAE was also stronger circa-PHV, and relatively older players demonstrated anaerobic performance advantages during the pubescent period. Talent selectors should consider motor function and maturation status assessments to avoid premature and unwarranted drop-out of soccer players within youth development programmes.	[Lovell, Ric] Univ Western Sydney, Sch Sci & Hlth, Penrith, NSW 1797, Australia; [Towlson, Chris] Univ Hull, Dept Sport Hlth & Exercise Sci, Kingston Upon Hull HU6 7RX, N Humberside, England; [Parkin, Guy] Profootball Support, Huddersfield, W Yorkshire, England; [Portas, Matt] Univ Teesside, Sport & Exercise Dept, Middlesbrough, Cleveland, England; [Vaeyens, Roel] Univ Ghent, Dept Movement & Sports Sci, B-9000 Ghent, Belgium; [Cobley, Stephen] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia	Western Sydney University; University of Hull; University of Teesside; Ghent University; University of Sydney	Lovell, R (corresponding author), Univ Western Sydney, Sch Sci & Hlth, Penrith, NSW 1797, Australia.	r.lovell@uws.edu.au	Cobley, Stephen P/I-5686-2017; Towlson, Christopher/AAP-9835-2020; Lovell, Ric/I-9973-2019	Cobley, Stephen P/0000-0001-6099-392X; Lovell, Ric/0000-0001-5859-0267; Towlson, Christopher/0000-0001-5960-0324	Pro-football	Pro-football	Pro-football Support provided support in the form of salaries for authors [RL, GP, MP]. GP is the director of the agency (Pro-Football Support) contracted by the clubs in this study to under take anthropometric, somatic maturation and fitness assessments of the players registered with each Football Club. The specific roles of these authors are articulated in the 'author contributions' section.	Augste C, 2011, J SPORT SCI, V29, P983, DOI 10.1080/02640414.2011.574719; Barnsley R.H., 1992, RELAT AGE EFF FOOTBA, V27, P77, DOI [DOI 10.1177/101269029202700105, 10.1177/101269029202700105]; Berthoin S, 1994, J SPORT SCI, V12, P355, DOI 10.1080/02640419408732181; Buchheit M, 2010, INT J SPORTS MED, V31, P818, DOI 10.1055/s-0030-1262838; Butterfield SA, 2004, PERCEPT MOTOR SKILL, V99, P225, DOI 10.2466/pms.99.1.225-234; Carling C, 2009, SCAND J MED SCI SPOR, V19, P3, DOI 10.1111/j.1600-0838.2008.00867.x; Cobley S, 2009, SPORTS MED, V39, P235, DOI 10.2165/00007256-200939030-00005; Deprez D, 2013, INT J SPORTS MED, V34, P897, DOI 10.1055/s-0032-1333262; Deprez D, 2012, INT J SPORTS MED, V33, P987, DOI 10.1055/s-0032-1311654; Deprez DN, 2015, J STRENGTH COND RES, V29, P1692, DOI 10.1519/JSC.0000000000000806; Faude O, 2012, J SPORT SCI, V30, P625, DOI 10.1080/02640414.2012.665940; Helsen WF, 2000, AM J HUM BIOL, V12, P729, DOI 10.1002/1520-6300(200011/12)12:6<729::AID-AJHB2>3.0.CO;2-7; Helsen WF, 1998, AM J HUM BIOL, V10, P791, DOI 10.1002/(SICI)1520-6300(1998)10:6&lt;791::AID-AJHB10&gt;3.0.CO;2-1; Helsen WF, 2005, J SPORT SCI, V23, P629, DOI 10.1080/02640410400021310; Hirose N, 2009, J SPORT SCI, V27, P1159, DOI 10.1080/02640410903225145; Hopkins W.G., 2006, SPORTSCIENCE, V10, P46; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; Malina R.M., 2004, GROWTH MATURATION PH, V2nd ed., DOI DOI 10.1016/j.jsams.2011.04.003; Malina RM, 2007, BRIT J SPORT MED, V41, P290, DOI 10.1136/bjsm.2006.031294; Malina RM, 2014, J SPORT SCI, V32, P424, DOI 10.1080/02640414.2013.828850; Mendez-Villanueva A, 2011, J SPORT SCI, V29, P477, DOI 10.1080/02640414.2010.536248; Mendez-Villanueva A, 2010, PEDIATR EXERC SCI, V22, P497, DOI 10.1123/pes.22.4.497; Mirwald RL, 2002, MED SCI SPORT EXER, V34, P689, DOI 10.1097/00005768-200204000-00020; Mujika I, 2009, J SPORT SCI, V27, P1153, DOI 10.1080/02640410903220328; O'Brien TD, 2009, EXP PHYSIOL, V94, P731, DOI 10.1113/expphysiol.2008.045062; Ross WD, 1991, PHYSL TESTING ELITEA, P223; Simmons C, 2001, J SPORT SCI, V19, P677, DOI 10.1080/02640410152475801; Sporis G, 2010, J STRENGTH COND RES, V24, P679, DOI 10.1519/JSC.0b013e3181c4d324; TANNER JM, 1966, ARCH DIS CHILD, V41, P613, DOI 10.1136/adc.41.220.613; Till K., 2010, TALENT DEV EXCELLENC, V2, P193; Vaeyens R, 2005, J SPORT SCI, V23, P747, DOI 10.1080/02640410400022052; Vandendriessche JB, 2012, J SPORT SCI, V30, P1695, DOI 10.1080/02640414.2011.652654	33	102	109	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137238	10.1371/journal.pone.0137238	http://dx.doi.org/10.1371/journal.pone.0137238			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331852	Green Published, Green Submitted, gold			2022-12-26	WOS:000360613800114
J	Owusu, R; Asante, KP; Mahama, E; Awini, E; Anyorigiya, T; Dosoo, D; Amu, A; Jakpa, G; Ofei, E; Segbaya, S; Oduro, AR; Gyapong, M; Hodgson, A; Bart-Plange, C; Owusu-Agyei, S				Owusu, Ruth; Asante, Kwaku Poku; Mahama, Emmanuel; Awini, Elizabeth; Anyorigiya, Thomas; Dosoo, David; Amu, Alberta; Jakpa, Gabriel; Ofei, Emmanuel; Segbaya, Sylvester; Oduro, Abraham Rexford; Gyapong, Margaret; Hodgson, Abraham; Bart-Plange, Constance; Owusu-Agyei, Seth			Glucose-6-Phosphate Dehydrogenase Deficiency and Haemoglobin Drop after Sulphadoxine-Pyrimethamine Use for Intermittent Preventive Treatment of Malaria during Pregnancy in Ghana - A Cohort Study	PLOS ONE			English	Article							CHLORPROGUANIL-DAPSONE-ARTESUNATE; PLASMODIUM-FALCIPARUM MALARIA; PHASE-III TRIAL; G6PD DEFICIENCY; AFRICAN CHILDREN; DOUBLE-BLIND; NEONATAL-MORTALITY; BIRTH-WEIGHT; ANEMIA; WOMEN	Background Sulphadoxine-Pyrimethamine (SP) is still the only recommended antimalarial for use in intermittent preventive treatment of malaria during pregnancy (IPTp) in some malaria endemic countries including Ghana. SP has the potential to cause acute haemolysis in G6PD deficient people resulting in significant haemoglobin (Hb) drop but there is limited data on post SP-IPTp Hb drop. This study determined the difference, if any in proportions of women with significant acute haemoglobin drop between G6PD normal, partial deficient and full deficient women after SP-IPTp. Methods and Findings Prospectively, 1518 pregnant women who received SP for IPTp as part of their normal antenatal care were enrolled. Their G6PD status were determined at enrollment followed by assessments on days 3, 7,14 and 28 to document any adverse effects and changes in postIPTp haemoglobin (Hb) levels. The three groups were comparable at baseline except for their mean Hb (10.3 g/dL for G6PD normal, 10.8 g/dL for G6PD partial deficient and 10.8 g/dL for G6PD full defect women). The prevalence of G6PD full defect was 2.3% and 17.0% for G6PD partial defect. There was no difference in the proportions with fractional Hb drop >= 20% as compared to their baseline value post SP-IPTp among the 3 groups on days 3, 7, 14. The G6PD full defect group had the highest median fractional drop at day 7. There was a weak negative correlation between G6PD activity and fractional Hb drop. There was no statistical difference between the three groups in the proportions of those who started the study with Hb >= 8g/dl whose Hb level subsequently fell below 8g/dl post-SP IPTp. No study participant required transfusion or hospitalization for severe anaemia. Conclusions There was no significant difference between G6PD normal and deficient women in proportions with significant acute haemoglobin drop post SP-IPTp and lower G6PD enzyme activity was not strongly associated with significant acute drug-induced haemoglobin drop post SP-IPTp but a larger study is required to confirm consistency of findings.	[Owusu, Ruth; Asante, Kwaku Poku; Mahama, Emmanuel; Dosoo, David; Jakpa, Gabriel; Owusu-Agyei, Seth] Kintampo Hlth Res Ctr, Ghana Hlth Serv, Kintampo, Ghana; [Awini, Elizabeth; Amu, Alberta; Ofei, Emmanuel; Gyapong, Margaret] Dodowa Hlth Res Ctr, Ghana Hlth Serv, Dodowa, Ghana; [Anyorigiya, Thomas; Oduro, Abraham Rexford] Navrongo Hlth Res Ctr, Ghana Hlth Serv, Navrongo, Ghana; [Segbaya, Sylvester] AngloGold Ashanti Malaria Control Program, Obuasi, Ghana; [Hodgson, Abraham] Ghana Hlth Serv, Div Res & Dev, Accra, Ghana; [Bart-Plange, Constance] Ghana Hlth Serv, Natl Malaria Control Programme, Korle Bu, Accra, Ghana	Ghana Health Service; Kintampo Health Research Centre; Ghana Health Service; Ghana Health Service; Navrongo Health Research Center; Ghana Health Service; Ghana Health Service	Owusu, R (corresponding author), Komfo Anokye Teaching Hosp, Publ Hlth Unit, Kumasi, Ghana.	ruthowusu1@yahoo.com		Gyapong, Margaret/0000-0002-4818-3497; ODURO, ABRAHAM/0000-0002-4191-7419; Owusu-Agyei, Seth/0000-0002-0807-1781	Global Fund [GHN-405-G04-M]; National Malaria Control Programme, Ghana	Global Fund; National Malaria Control Programme, Ghana	The study was commissioned by the National Malaria Control Programme, Ghana Health Service with funding from the Global Fund. Grant number: GHN-405-G04-M http://portfolio.theglobafund.org/en/Grant/Index/GHN-405-G04-M. The funding was provided to the Ministry of Health/Ghana Health Service and assessed through the National Malaria Control Programme, Ghana. CBP and SS are the authors who were employees of the National Malaria Control Programme at the time of the study. The Global Fund had no role in study design, data collection, analysis, decision to publish or preparation of the manuscript.	Adisa R A, 2011, Niger J Physiol Sci, V26, P207; Alloueche A, 2004, LANCET, V363, P1843, DOI 10.1016/S0140-6736(04)16350-2; Asa OO, 2008, MATERN CHILD HLTH J, V12, P692, DOI 10.1007/s10995-008-0319-3; Beutler E, 2007, AM J TROP MED HYG, V77, P779, DOI 10.4269/ajtmh.2007.77.779; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; Carter N, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-241; CHAN TK, 1976, BRIT MED J, V2, P1227, DOI 10.1136/bmj.2.6046.1227; DODOO ANO, 2005, INT J RISK SAF MED, V17, P13; Eisele TP, 2012, LANCET INFECT DIS, V12, P942, DOI 10.1016/S1473-3099(12)70222-0; Gies S, 2009, TROP MED INT HEALTH, V14, P174, DOI 10.1111/j.1365-3156.2008.02215.x; Glover-Amengor Mary, 2005, Ghana Med J, V39, P102; Johnson MK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007246; Luzzatto L, 2014, BRIT J HAEMATOL, V164, P469, DOI 10.1111/bjh.12665; May J, 2000, TROP MED INT HEALTH, V5, P119, DOI 10.1046/j.1365-3156.2000.00529.x; Menendez C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009438; Mockenhaupt FP, 2003, TROP MED INT HEALTH, V8, P118, DOI 10.1046/j.1365-3156.2003.01008.x; Mockenhaupt FP, 2000, T ROY SOC TROP MED H, V94, P477, DOI 10.1016/S0035-9203(00)90057-9; Ofori Mf, 2009, Ghana Med J, V43, P13; Ouedraogo S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-348; Pamba A, 2012, BLOOD, V120, P4123, DOI 10.1182/blood-2012-03-416032; Premji Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006682; Schantz-Dunn Julianna, 2009, Rev Obstet Gynecol, V2, P186; Shekalaghe SA, 2010, ANTIMICROB AGENTS CH, V54, P1762, DOI 10.1128/AAC.01135-09; Tiono AB, 2009, AM J TROP MED HYG, V81, P969, DOI 10.4269/ajtmh.2009.09-0351; WHO, 2010, GUID TREATM MAL, V2nd; WHO, 2012, UPD WHO POL REC INT; Wilson NO, 2011, AM J TROP MED HYG, V85, P12, DOI 10.4269/ajtmh.2011.10-0512; Youngster I, 2010, DRUG SAFETY, V33, P713, DOI 10.2165/11536520-000000000-00000	28	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136828	10.1371/journal.pone.0136828	http://dx.doi.org/10.1371/journal.pone.0136828			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327623	Green Published, gold, Green Submitted			2022-12-26	WOS:000360437700065
J	Qi, Y; Dai, XF; Zhang, H; He, Y; Zhang, YY; Han, JJ; Zhu, P; Zhang, YX; Zheng, QX; Li, X; Zhao, C; Pang, JJ				Qi, Yan; Dai, Xufeng; Zhang, Hua; He, Ying; Zhang, Yangyang; Han, Juanjuan; Zhu, Ping; Zhang, Yuxin; Zheng, Qinxiang; Li, Xia; Zhao, Chen; Pang, Jijing			Trans-Corneal Subretinal Injection in Mice and Its Effect on the Function and Morphology of the Retina	PLOS ONE			English	Article							MEDIATED GENE-THERAPY; MOUSE MODEL; RD10 MOUSE; IN-VIVO; DEGENERATION; VECTOR; PHOTORECEPTOR; VISION; RESCUE; TRANSDUCTION	Purpose To introduce a practical method of subretinal injection in mice and evaluate injection-induced retinal detachment (RD) and damage using a dynamic imaging system, electrophysiology, and histology. Methods After full dilation of a 2-month-old C57BL/6J mouse pupil, the cornea near the limbus was punctured with a 30 1/2-gague disposable beveled needle. A 33 1/2-gauge blunt needle was inserted through the corneal perforation into the anterior chamber, avoiding the lens before going deeper into the vitreous cavity, and penetrating the inner retina to reach the subretinal space. The mice were divided into four groups: in group 1, about 80-100% of the retina was filled with subretinally injected solution; in group 2, approximately 50-70% of the retina was filled with injected solution; in group 3, the procedures were stopped before solution injection; and non-injected eyes were used as the negative control in group 4. An optical coherence tomography (OCT) imaging system was used to monitor retinal reattachment during the first three days following the injections. Histological and functional changes were examined by light microscopy and electroretinography (ERG) at five weeks post-injection. Results After a short-term training, a 70% success rate with 50% or more coverage (i.e., retinal blebs occupied 50% or more retinal area and filled with the injected solution) with minimal injection-related damages can be achieved. Bleb formation was associated with retinal detachment (RD) between the neuroretina and the retinal pigment epithelium (RPE) layer. Partial RD could be observed at post-injection day 1, and by day 2 most of the retina had reattached. At 5 weeks post-injection, compared to uninjected control group 4, the b-wave amplitudes of ERG decreased 22% in group 1, 16% in group 2, and 7% in group 3; the b-wave amplitudes were statistically different between the uninjected group and the groups with either 50-70% or 80-100% coverage. The subretinal injection-induced RD reattached and became stable at five weeks post-injection, although some photoreceptor damage could still be observed in and around the injection sites, especially in 80-100% coverage group. Conclusions Trans-corneal subretinal injection is effective and practical, although subretinal injection-related damages can cause some morphological and functional loss.	[Qi, Yan; Dai, Xufeng; Zhang, Hua; He, Ying; Zhang, Yangyang; Han, Juanjuan; Zheng, Qinxiang; Pang, Jijing] Wenzhou Med Univ, Hosp Eye, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; [Han, Juanjuan] Shanxi Med Univ, Fenyang Coll, Fenyang, Shanxi, Peoples R China; [Zhu, Ping; Zhang, Yuxin; Pang, Jijing] Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA; [Zhang, Yuxin; Zhao, Chen; Pang, Jijing] Nanjing Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China; [Li, Xia] Guangxi Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanning, Guangxi, Peoples R China	Wenzhou Medical University; Shanxi Medical University; State University System of Florida; University of Florida; Nanjing Medical University; Guangxi Medical University	Pang, JJ (corresponding author), Wenzhou Med Univ, Hosp Eye, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China.	jpangoph@hotmail.com	zhang, yangyang/GZG-7467-2022		National Natural Science Foundation of China [81371060, 81260155]; Wenzhou Medical University, Wenzhou, China [QTJ11018]; Wenzhou Science and Technology Bureau, China [Y20140352, Y20140355]; NIH [EY023543, EY021721]; UF FEO award; FFB; MVRF; RPB Inc.; Jiangsu Province Foundation for Research Innovative Team; NATIONAL EYE INSTITUTE [R21EY023543, R21EY018331, P30EY021721] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wenzhou Medical University, Wenzhou, China; Wenzhou Science and Technology Bureau, China; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UF FEO award; FFB; MVRF; RPB Inc.; Jiangsu Province Foundation for Research Innovative Team; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by grants from the National Natural Science Foundation of China (81371060 and 81260155), a retinal gene therapy study grant from Wenzhou Medical University, Wenzhou, China (QTJ11018), scientific research funds from Wenzhou Science and Technology Bureau, China (Y20140352 and Y20140355), the Jiangsu Province Foundation for Research Innovative Team, NIH grants EY023543, EY021721, UF FEO award, FFB, MVRF, and RPB Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SA, 2013, CURR TOP MEMBR, V72, P231, DOI 10.1016/B978-0-12-417027-8.00007-6; Bennett J, 1996, NAT MED, V2, P649, DOI 10.1038/nm0696-649; Cideciyan AV, 2009, NEW ENGL J MED, V361, P725, DOI 10.1056/NEJMc0903652; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Dai XF, 2014, INVEST OPHTH VIS SCI, V55, P1724, DOI 10.1167/iovs.13-13654; Gouras P, 2002, INVEST OPHTH VIS SCI, V43, P3307; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; Kong FS, 2010, EXP EYE RES, V90, P546, DOI 10.1016/j.exer.2010.01.011; Lai Chooi-May, 2004, Genet Vaccines Ther, V2, P3, DOI 10.1186/1479-0556-2-3; Li WS, 2009, MOL VIS, V15, P267; Li X, 2011, INVEST OPHTH VIS SCI, V52, P7, DOI 10.1167/iovs.10-6138; Mao HY, 2012, HUM GENE THER, V23, P356, DOI 10.1089/hum.2011.213; Nour M, 2003, INVEST OPHTH VIS SCI, V44, P4505, DOI 10.1167/iovs.03-0453; Pang J, 2010, GENE THER, V17, P815, DOI 10.1038/gt.2010.29; Pang JJ, 2008, INVEST OPHTH VIS SCI, V49, P4278, DOI 10.1167/iovs.07-1622; Pang JJ, 2008, VISION RES, V48, P377, DOI 10.1016/j.visres.2007.08.009; Pang JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035250; Pang JJ, 2011, MOL THER, V19, P234, DOI 10.1038/mt.2010.273; Pang JJ, 2006, MOL VIS, V12, P756; Pang JJ, 2006, MOL THER, V13, P565, DOI 10.1016/j.ymthe.2005.09.001; Stieger K, 2010, CURR OPIN MOL THER, V12, P471; Takahashi M, 1999, J VIROL, V73, P7812, DOI 10.1128/JVI.73.9.7812-7816.1999; Timmers A, 2001, MOL VIS, V7, P131; Wert KJ, 2012, JOVE-J VIS EXP, DOI 10.3791/4286; Yao HL, 2014, NEURAL REGEN RES, V9, P1047, DOI 10.4103/1673-5374.133169; Zeng R, 2012, INVEST OPHTH VIS SCI, V53, P1685, DOI 10.1167/iovs.11-8241; Zheng QX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044855	27	27	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136523	10.1371/journal.pone.0136523	http://dx.doi.org/10.1371/journal.pone.0136523			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317758	Green Published, Green Submitted, gold			2022-12-26	WOS:000360299100095
J	Shafiei, SS; Solati-Hashjin, M; Samadikuchaksaraei, A; Kalantarinejad, R; Asadi-Eydivand, M; Abu Osman, NA				Shafiei, Seyedeh Sara; Solati-Hashjin, Mehran; Samadikuchaksaraei, Ali; Kalantarinejad, Reza; Asadi-Eydivand, Mitra; Abu Osman, Noor Azuan			Epigallocatechin Gallate/Layered Double Hydroxide Nanohybrids: Preparation, Characterization, and In Vitro Anti-Tumor Study	PLOS ONE			English	Article							LAYERED DOUBLE HYDROXIDES; CONTROLLED-RELEASE; INTERCALATION; CANCER; PREVENTION; PATHWAYS; DRUGS	In recent years, nanotechnology in merging with biotechnology has been employed in the area of cancer management to overcome the challenges of chemopreventive strategies in order to gain promising results. Since most biological processes occur in nano scale, nanoparticles can act as carriers of certain drugs or agents to deliver it to specific cells or targets. In this study, we intercalated Epigallocatechin-3-Gallate (EGCG), the most abundant polyphenol in green tea, into Ca/Al-NO3 Layered double hydroxide (LDH) nanoparticles, and evaluated its efficacy compared to EGCG alone on PC3 cell line. The EGCG loaded LDH nanohybrids were characterized by X-ray diffraction, Fourier transform infrared spectroscopy, transmission electron microscopy (TEM) and nanosizer analyses. The anticancer activity of the EGCG-loaded LDH was investigated in prostate cancer cell line (PC3) while the release behavior of EGCG from LDH was observed at pH 7.45 and 4.25. Besides enhancing of apoptotic activity of EGCG, the results showed that intercalation of EGCG into LDH can improve the anti-tumor activity of EGCG over 5-fold dose advantages in in-vitro system. Subsequently, the in-vitro release data showed that EGCG-loaded LDH had longer release duration compared to physical mixture, and the mechanism of diffusion through the particle was rate-limiting step. Acidic attack was responsible for faster release of EGCG molecules from LDH at pH of 4.25 compared to pH of 7.4. The results showed that Ca/Al-LDH nanoparticles could be considered as an effective inorganic host matrix for the delivery of EGCG to PC3 cells with controlled release properties.	[Shafiei, Seyedeh Sara] Natl Inst Genet Engn & Biotechnol, Inst Med Biotechnol, Dept Stem Cell & Regenerat Med, Tehran 14965161, Iran; [Solati-Hashjin, Mehran] Amirkabir Univ Technol, Biomat Ctr Excellence, Tehran 15914, Iran; [Shafiei, Seyedeh Sara; Solati-Hashjin, Mehran; Asadi-Eydivand, Mitra; Abu Osman, Noor Azuan] Univ Malaya, Dept Biomed Engn, Fac Engn, Kuala Lumpur 50603, Malaysia; [Samadikuchaksaraei, Ali] Iran Univ Med Sci, Cellular & Mol Res Ctr, Tehran, Iran; [Samadikuchaksaraei, Ali] Iran Univ Med Sci, Fac Adv Technol Med, Dept Tissue Engn & Regenerat Med, Tehran, Iran; [Samadikuchaksaraei, Ali] Iran Univ Med Sci, Fac Allied Med, Dept Med Biotechnol, Tehran, Iran; [Kalantarinejad, Reza] Converging Technol Res Ctr, Tehran, Iran	Amirkabir University of Technology; Universiti Malaya; Iran University of Medical Sciences; Iran University of Medical Sciences; Iran University of Medical Sciences	Shafiei, SS (corresponding author), Natl Inst Genet Engn & Biotechnol, Inst Med Biotechnol, Dept Stem Cell & Regenerat Med, Tehran 14965161, Iran.	sarashafiei@aut.ac.ir; azaun@um.edu.my	Shafiei, Seyedeh Sara/R-7755-2017; Asadi-Eydivand, Mitra/H-4092-2019; Samadikuchaksaraei, Ali/H-6402-2019; ABU OSMAN, NOOR AZUAN/B-9265-2010; Solati-Hashjin, Mehran/X-8822-2019	Asadi-Eydivand, Mitra/0000-0002-7809-7880; Samadikuchaksaraei, Ali/0000-0002-2108-9927; ABU OSMAN, NOOR AZUAN/0000-0002-2853-4421; Solati-Hashjin, Mehran/0000-0002-1187-1237; Shafiei, Seyedeh Sara/0000-0002-4517-5969	High Impact Research Grant from the University of Malaya (UM) [UM.C/HIR/MOHE/ENG/10 D000010-16001]	High Impact Research Grant from the University of Malaya (UM)	This study was supported by High Impact Research Grant UM.C/HIR/MOHE/ENG/10 D000010-16001 from the University of Malaya (UM).	Ambrogi V, 2001, INT J PHARM, V220, P23, DOI 10.1016/S0378-5173(01)00629-9; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Bugatti V, 2011, APPL CLAY SCI, V52, P34, DOI 10.1016/j.clay.2011.01.025; Choi SJ, 2008, J PHYS CHEM SOLIDS, V69, P1528, DOI 10.1016/j.jpcs.2007.10.140; Choy JH, 2004, BIOMATERIALS, V25, P3059, DOI 10.1016/j.biomaterials.2003.09.083; Costantino U, 1997, SOLID STATE IONICS, V97, P203, DOI 10.1016/S0167-2738(97)00043-X; Dong H, 2014, APPL CLAY SCI, DOI [10.1016/j.clay.2014.04.28, DOI 10.1016/J.CLAY.2014.04.28]; Fang JY, 2006, J DERMATOL SCI, V42, P101, DOI 10.1016/j.jdermsci.2005.12.010; GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245; Hsieh DS, 2011, BIOMATERIALS, V32, P7633, DOI 10.1016/j.biomaterials.2011.06.073; Khan N, 2006, CANCER RES, V66, P2500, DOI 10.1158/0008-5472.CAN-05-3636; Kong XG, 2010, APPL CLAY SCI, V49, P324, DOI 10.1016/j.clay.2010.06.017; Li L, 2014, BIOMATERIALS, V35, P3331, DOI 10.1016/j.biomaterials.2013.12.095; MIYATA S, 1983, CLAY CLAY MINER, V31, P305, DOI 10.1346/CCMN.1983.0310409; Pan DK, 2010, CHEM ENG SCI, V65, P3762, DOI 10.1016/j.ces.2010.03.013; Rives V, 2014, APPL CLAY SCI, V88-89, P239, DOI 10.1016/j.clay.2013.12.002; Shafiei SS, 2013, ADV APPL CERAM, V112, P59, DOI 10.1179/1743676112Y.0000000045; Siddiqui IA, 2008, CHEM-BIOL INTERACT, V171, P122, DOI 10.1016/j.cbi.2007.03.001; Siddiqui IA, 2009, CANCER RES, V69, P1712, DOI 10.1158/0008-5472.CAN-08-3978; Sparks D. L., 1989, KINETICS SOIL CHEM P; Stuart EC, 2006, LIFE SCI, V79, P2329, DOI 10.1016/j.lfs.2006.07.036; Wang ZL, 2005, J SOLID STATE CHEM, V178, P736, DOI 10.1016/j.jssc.2004.11.005; Xia SJ, 2008, J SOLID STATE CHEM, V181, P2610, DOI 10.1016/j.jssc.2008.06.009; Xu ZP, 2001, CHEM MATER, V13, P4564, DOI 10.1021/cm010347g; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641	25	23	24	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136530	10.1371/journal.pone.0136530	http://dx.doi.org/10.1371/journal.pone.0136530			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317853	Green Published, Green Submitted, gold			2022-12-26	WOS:000360299100096
J	Song, WJ; Son, MY; Lee, HW; Seo, H; Kim, JH; Chung, SH				Song, Woo-Joo; Son, Mi-Young; Lee, Hye-Won; Seo, Hyemyung; Kim, Jeong Hee; Chung, Sul-Hee			Enhancement of BACE1 Activity by p25/Cdk5-Mediated Phosphorylation in Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; CYCLIN-DEPENDENT KINASE-5; BETA-SECRETASE ACTIVITY; DOWN-SYNDROME; MULTIVESICULAR BODIES; HEPARAN-SULFATE; BASAL SECRETION; PRIMARY NEURONS; INCREASE BACE1; P25	The activity of beta-site amyloid precursor protein (APP) cleaving enzyme 1 (BACE1) is elevated during aging and in sporadic Alzheimer's disease (AD), but the underlying mechanisms of this change are not well understood. p25/Cyclin-dependent kinase 5 (Cdk5) has been implicated in the pathogenesis of several neurodegenerative diseases, including AD. Here, we describe a potential mechanism by which BACE activity is increased in AD brains. First, we show that BACE1 is phosphorylated by the p25/Cdk5 complex at Thr252 and that this phosphorylation increases BACE1 activity. Then, we demonstrate that the level of phospho-BACE1 is increased in the brains of AD patients and in mammalian cells and transgenic mice that overexpress p25. Furthermore, the fraction of p25 prepared from iodixanol gradient centrifugation was unexpectedly protected by protease digestion, suggesting that p25/Cdk5-mediated BACE1 phosphorylation may occur in the lumen. These results reveal a link between p25 and BACE1 in AD brains and suggest that upregulated Cdk5 activation by p25 accelerates AD pathogenesis by enhancing BACE1 activity via phosphorylation.	[Song, Woo-Joo; Chung, Sul-Hee] Kyung Hee Univ, Sch Med, Neurodegenerat Control Res Ctr, Dept Biochem & Mol Biol, Seoul, South Korea; [Song, Woo-Joo; Son, Mi-Young; Lee, Hye-Won; Chung, Sul-Hee] Inje Univ, Inst Brain Sci & Technol, Busan, South Korea; [Seo, Hyemyung] Hanyang Univ, Coll Sci & Technol, Div Mol & Life Sci, Ansan, Gyeonggi Do, South Korea; [Kim, Jeong Hee] Kyung Hee Univ, Sch Dent, Dept Oral Biochem & Mol Biol, Seoul, South Korea; [Kim, Jeong Hee] Kyung Hee Univ, Dept Life & Nanopharmaceut Sci, Seoul, South Korea	Kyung Hee University; Inje University; Hanyang University; Kyung Hee University; Kyung Hee University	Kim, JH (corresponding author), Kyung Hee Univ, Sch Dent, Dept Oral Biochem & Mol Biol, Seoul, South Korea.	jhkimh@khu.ac.kr; sulchung@khu.ac.kr		Kim, Jeong Hee/0000-0002-3884-4503	Korea Healthcare Technology R&D Project, Ministry of Health, Welfare, & Family Affairs, Republic of Korea [A092004]; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology [2012R1A1A2040129]; BIO & Medical Technology Development Program of National Research Foundation of Korea grant (MEST) [2012M3A9C6049936]	Korea Healthcare Technology R&D Project, Ministry of Health, Welfare, & Family Affairs, Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology; BIO & Medical Technology Development Program of National Research Foundation of Korea grant (MEST)	This work was supported by grants from the Korea Healthcare Technology R&D Project, Ministry of Health, Welfare, & Family Affairs, Republic of Korea (A092004 to WJS), from the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (2012R1A1A2040129 to SHC) and from the BIO & Medical Technology Development Program of National Research Foundation of Korea grant (MEST, 2012M3A9C6049936 to JHK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlijanian MK, 2000, P NATL ACAD SCI USA, V97, P2910, DOI 10.1073/pnas.040577797; Apelt J, 2004, INT J DEV NEUROSCI, V22, P475, DOI 10.1016/j.ijdevneu.2004.07.006; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Cataldo AM, 2004, NEUROBIOL AGING, V25, P1263, DOI 10.1016/j.neurobiolaging.2004.02.027; CHUNG SH, 1995, J BIOL CHEM, V270, P16714, DOI 10.1074/jbc.270.28.16714; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Cruz JC, 2006, J NEUROSCI, V26, P10536, DOI 10.1523/JNEUROSCI.3133-06.2006; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Ditaranto K, 2001, NEUROBIOL DIS, V8, P19, DOI 10.1006/nbdi.2000.0364; Fader CM, 2009, CELL DEATH DIFFER, V16, P70, DOI 10.1038/cdd.2008.168; Fischer A, 2005, NEURON, V48, P825, DOI 10.1016/j.neuron.2005.10.033; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Fukumoto H, 2004, AM J PATHOL, V164, P719, DOI 10.1016/S0002-9440(10)63159-8; Giusti-Rodriguez P, 2011, J NEUROSCI, V31, P15751, DOI 10.1523/JNEUROSCI.3588-11.2011; Harada H, 2006, NEUROSCI RES, V54, P24, DOI 10.1016/j.neures.2005.10.001; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Hong L, 2000, SCIENCE, V290, P150, DOI 10.1126/science.290.5489.150; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Iijima K, 2000, J NEUROCHEM, V75, P1085, DOI 10.1046/j.1471-4159.2000.0751085.x; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Lee HW, 2007, NEUROSCI LETT, V421, P178, DOI 10.1016/j.neulet.2007.01.082; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Lee SY, 2004, P NATL ACAD SCI USA, V101, P546, DOI 10.1073/pnas.0307813100; Leuba G, 2005, DEMENT GERIATR COGN, V19, P171, DOI 10.1159/000083496; Lin P, 1998, J CELL BIOL, V141, P1515, DOI 10.1083/jcb.141.7.1515; Liu L, 2013, NEUROBIOL AGING, V34, P540, DOI 10.1016/j.neurobiolaging.2012.05.017; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Marlow L, 2003, J MOL NEUROSCI, V20, P233, DOI 10.1385/JMN:20:3:233; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2011, NEUROBIOL DIS, V43, P38, DOI 10.1016/j.nbd.2011.01.021; Noble W, 2003, NEURON, V38, P555, DOI 10.1016/S0896-6273(03)00259-9; Park JH, 2012, J NEUROCHEM, V122, P1081, DOI 10.1111/j.1471-4159.2012.07861.x; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; PERRY G, 1991, J NEUROSCI, V11, P3679; Preece P, 2003, MOL BRAIN RES, V116, P155, DOI 10.1016/S0169-328X(03)00233-X; Ryoo SR, 2007, J BIOL CHEM, V282, P34850, DOI 10.1074/jbc.M707358200; Sadleir KR, 2012, J BIOL CHEM, V287, P7224, DOI 10.1074/jbc.M111.333914; Schmechel A, 2004, J BIOL CHEM, V279, P39710, DOI 10.1074/jbc.M402785200; Seo H, 2004, ANN NEUROL, V56, P319, DOI 10.1002/ana.20207; Sidera C, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-25; SNOW AD, 1990, AM J PATHOL, V137, P1253; Son MY, 2010, MOL CELLS, V29, P51, DOI 10.1007/s10059-010-0016-0; Stockley JH, 2008, CELL MOL LIFE SCI, V65, P3265, DOI 10.1007/s00018-008-8271-3; Stockley JH, 2006, FEBS LETT, V580, P6550, DOI 10.1016/j.febslet.2006.10.076; Sultana R, 2007, NEUROCHEM RES, V32, P655, DOI 10.1007/s11064-006-9123-x; Sun XL, 2012, J NEUROCHEM, V120, P62, DOI 10.1111/j.1471-4159.2011.07515.x; Swatton JE, 2004, EUR J NEUROSCI, V19, P2711, DOI 10.1111/j.0953-816X.2004.03365.x; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Tandon A, 2003, J NEUROCHEM, V86, P572, DOI 10.1046/j.1471-4159.2003.01865.x; Tseng HC, 2002, FEBS LETT, V523, P58, DOI 10.1016/S0014-5793(02)02934-4; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wen Y, 2008, NEURON, V57, P680, DOI 10.1016/j.neuron.2008.02.024; Westmeyer GG, 2004, J BIOL CHEM, V279, P53205, DOI 10.1074/jbc.M410378200; Yang AJ, 1998, J NEUROSCI RES, V52, P691, DOI 10.1002/(SICI)1097-4547(19980615)52:6<691::AID-JNR8>3.0.CO;2-3; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Yasojima K, 2001, BRAIN RES, V919, P115, DOI 10.1016/S0006-8993(01)03008-6; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Yu WH, 2004, INT J BIOCHEM CELL B, V36, P2531, DOI 10.1016/j.biocel.2004.05.010	60	43	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136950	10.1371/journal.pone.0136950	http://dx.doi.org/10.1371/journal.pone.0136950			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317805	Green Submitted, gold, Green Published			2022-12-26	WOS:000360299100183
J	Vagberg, M; Norgren, N; Dring, A; Lindqvist, T; Birgander, R; Zetterberg, H; Svenningsson, A				Vagberg, Mattias; Norgren, Niklas; Dring, Ann; Lindqvist, Thomas; Birgander, Richard; Zetterberg, Henrik; Svenningsson, Anders			Levels and Age Dependency of Neurofilament Light and Glial Fibrillary Acidic Protein in Healthy Individuals and Their Relation to the Brain Parenchymal Fraction	PLOS ONE			English	Article							CSF NEUROFILAMENT; CEREBROSPINAL-FLUID; N-ACETYLASPARTATE; ATROPHY; DAMAGE	Background Neurofilament light (NFL) and Glial Fibrillary Acidic Protein (GFAP) are integral parts of the axonal and astrocytal cytoskeletons respectively and are released into the cerebrospinal fluid (CSF) in cases of cellular damage. In order to interpret the levels of these biomarkers in disease states, knowledge on normal levels in the healthy is required. Another biomarker for neurodegeneration is brain atrophy, commonly measured as brain parenchymal fraction (BPF) using magnetic resonance imaging (MRI). Potential correlations between levels of NFL, GFAP and BPF in healthy individuals have not been investigated. Objectives To present levels of NFL and GFAP in healthy individuals stratified for age, and investigate the correlation between them as well as their correlation with BPF. Methods The CSF was analysed in 53 healthy volunteers aged 21 to 70 (1 sample missing for GFAP analysis) and 48 of the volunteers underwent determination of BPF using MRI. Results Mean (+/- SD) NFL was 355 ng/L (+/- 214), mean GFAP was 421 ng/L (+/- 129) and mean BPF was 0.867 (+/- 0.035). All three biomarkers correlated with age. NFL also correlated with both GFAP and BPF. When controlled for age, only the correlation between NFL and GFAP retained statistical significance. Conclusions This study presents data on age-stratified levels of NFL and GFAP in the CSF of healthy individuals. There is a correlation between levels of NFL and GFAP and both increase with age. A correlation between NFL and BPF was also found, but did not retain statistical significance if controlled for age.	[Vagberg, Mattias; Dring, Ann; Svenningsson, Anders] Umea Univ, Dept Pharmacol & Clin Neurosci, Sect Neurosci, Umea, Sweden; [Norgren, Niklas] UmanDiagnost AB, Umea, Sweden; [Lindqvist, Thomas; Birgander, Richard] Umea Univ, Dept Radiat Sci, Sect Diagnost Radiol, Umea, Sweden; [Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, London, England	Umea University; Umea University; University of Gothenburg; University of London; University College London	Vagberg, M (corresponding author), Umea Univ, Dept Pharmacol & Clin Neurosci, Sect Neurosci, Umea, Sweden.	mattias.vagberg@umu.se		Svenningsson, Anders/0000-0003-0663-2220	BiogenIdec AB; Neuro Sweden; Umea University; Vasterbotten County Council (ALF); UmanDiagnostics AB	BiogenIdec AB; Neuro Sweden; Umea University; Vasterbotten County Council (ALF); UmanDiagnostics AB	The study was partially funded by unrestricted research grants from BiogenIdec AB and Neuro Sweden. Financial support was further provided through a regional agreement between Umea University and Vasterbotten County Council (ALF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. UmanDiagnostics AB provided support in the form of salaries for author NN, supplied NFL-kits for the study and provided lab-space for NFL analysis, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Appelman APA, 2010, CEREBROVASC DIS, V29, P28, DOI 10.1159/000255971; Fisher E, 2002, NEUROLOGY, V59, P1412, DOI 10.1212/01.WNL.0000036271.49066.06; Fotenos AF, 2005, NEUROLOGY, V64, P1032, DOI 10.1212/01.WNL.0000154530.72969.11; Guez M, 2003, J NEUROTRAUM, V20, P853, DOI 10.1089/089771503322385782; Hjalmarsson C, 2014, J CENT NERV SYST DIS, V6, P51, DOI 10.4137/JCNSD.S13821; Khalil M, 2013, MULT SCLER J, V19, P436, DOI 10.1177/1352458512458010; Knoops AJG, 2009, HIPPOCAMPUS, V19, P1115, DOI 10.1002/hipo.20575; Kuhle J, 2011, NEUROLOGY, V76, P1206, DOI 10.1212/WNL.0b013e31821432ff; Kuhle J, 2013, MULT SCLER J, V19, P1597, DOI 10.1177/1352458513482374; Lee MK, 1996, ANNU REV NEUROSCI, V19, P187, DOI 10.1146/annurev.ne.19.030196.001155; Moscufo N, 2011, NEUROBIOL AGING, V32, P646, DOI 10.1016/j.neurobiolaging.2009.04.010; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Norgren N, 2004, NEUROLOGY, V63, P1586, DOI 10.1212/01.WNL.0000142988.49341.D1; ROSENGREN LE, 1994, J NEUROSCI METH, V51, P197, DOI 10.1016/0165-0270(94)90011-6; Skillback T, 2014, NEUROLOGY, V83, P1945, DOI 10.1212/WNL.0000000000001015; Skillback T, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt212; Teunissen CE, 2009, NEUROLOGY, V72, P1322, DOI 10.1212/WNL.0b013e3181a0fe3f; Vagberg M, 2013, AM J NEURORADIOL, V34, P498, DOI 10.3174/ajnr.A3262	18	74	74	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135886	10.1371/journal.pone.0135886	http://dx.doi.org/10.1371/journal.pone.0135886			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317831	Green Published, Green Submitted, gold			2022-12-26	WOS:000360299100048
J	Wong, S; Mosabbir, AA; Truong, K				Wong, Stanley; Mosabbir, Abdullah A.; Truong, Kevin			An Engineered Split Intein for Photoactivated Protein Trans-Splicing	PLOS ONE			English	Article							FLUORESCENT PROTEIN; DNAE INTEIN; IN-VIVO; DOMAIN; LIGHT; CA2+; ACTIVATION; SEMISYNTHESIS; PHOTOTROPIN; MECHANISMS	Protein splicing is mediated by inteins that auto-catalytically join two separated protein fragments with a peptide bond. Here we engineered a genetically encoded synthetic photoactivatable intein (named LOVInC), by using the light-sensitive LOV2 domain from Avena sativa as a switch to modulate the splicing activity of the split DnaE intein from Nostoc punctiforme. Periodic blue light illumination of LOVInC induced protein splicing activity in mammalian cells. To demonstrate the broad applicability of LOVInC, synthetic protein systems were engineered for the light-induced reassembly of several target proteins such as fluorescent protein markers, a dominant positive mutant of RhoA, caspase-7, and the genetically encoded Ca2+ indicator GCaMP2. Spatial precision of LOVInC was demonstrated by targeting activity to specific mammalian cells. Thus, LOVInC can serve as a general platform for engineering light-based control for modulating the activity of many different proteins.	[Wong, Stanley; Mosabbir, Abdullah A.; Truong, Kevin] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada; [Truong, Kevin] Univ Toronto, Edward S Rogers Sr Dept Elect & Comp Engn, Toronto, ON M5S 3G4, Canada	University of Toronto; University of Toronto	Truong, K (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, 164 Coll St, Toronto, ON M5S 3G9, Canada.	kevin.truong@utoronto.ca		Truong, Kevin/0000-0002-9520-2144	Canadian Cancer Society Research Institute [701936]; NSERC [05322-14]	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by a grant from the Canadian Cancer Society Research Institute (#701936), received by KT, and NSERC (#05322-14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript (website: http://www.cancer.ca/en/?region = on).	Adam E, 2002, J MOL MICROB BIOTECH, V4, P479; Berrade L, 2010, CHEMBIOCHEM, V11, P1368, DOI 10.1002/cbic.201000157; Binschik J, 2011, ANGEW CHEM INT EDIT, V50, P3249, DOI 10.1002/anie.201007078; Bittl R, 2003, BIOCHEMISTRY-US, V42, P8506, DOI 10.1021/bi034123i; Bocker JK, 2015, ANGEW CHEM INT EDIT, V54, P2116, DOI 10.1002/anie.201409848; Buskirk AR, 2004, P NATL ACAD SCI USA, V101, P10505, DOI 10.1073/pnas.0402762101; Callahan BP, 2011, NAT STRUCT MOL BIOL, V18, P630, DOI 10.1038/nsmb.2041; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Crosson S, 2003, BIOCHEMISTRY-US, V42, P2, DOI 10.1021/bi026978l; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Gogarten JP, 2002, ANNU REV MICROBIOL, V56, P263, DOI 10.1146/annurev.micro.56.012302.160741; Huala E, 1997, SCIENCE, V278, P2120, DOI 10.1126/science.278.5346.2120; Iwai H, 2006, FEBS LETT, V580, P1853, DOI 10.1016/j.febslet.2006.02.045; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jung D, 2015, CHEM COMMUN, V51, P9670, DOI 10.1039/c5cc01067e; Kottke T, 2003, BIOCHEMISTRY-US, V42, P9854, DOI 10.1021/bi034863r; Lee J, 2008, SCIENCE, V322, P438, DOI 10.1126/science.1159052; Mills E, 2012, ACS SYNTH BIOL, V1, P75, DOI 10.1021/sb200008j; Mills E, 2010, CELL CALCIUM, V48, P195, DOI 10.1016/j.ceca.2010.08.009; Mootz HD, 2003, J AM CHEM SOC, V125, P10561, DOI 10.1021/ja0362813; Mootz HD, 2009, CHEMBIOCHEM, V10, P2579, DOI 10.1002/cbic.200900370; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nicastri MC, 2013, BIOCHEMISTRY-US, V52, P5920, DOI 10.1021/bi400736c; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; Perler FB, 2005, IUBMB LIFE, V57, P469, DOI 10.1080/15216540500163343; Pham E, 2011, CHEM BIOL, V18, P880, DOI 10.1016/j.chembiol.2011.04.014; Ren W, 2015, J AM CHEM SOC, V137, P2155, DOI 10.1021/ja508597d; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Saleh L, 2006, CHEM REC, V6, P183, DOI 10.1002/tcr.20082; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Skretas G, 2005, PROTEIN SCI, V14, P523, DOI 10.1110/ps.04996905; Srinivasula SM, 1998, J BIOL CHEM, V273, P10107, DOI 10.1074/jbc.273.17.10107; Strickland D, 2008, P NATL ACAD SCI USA, V105, P10709, DOI 10.1073/pnas.0709610105; Strickland D, 2010, NAT METHODS, V7, P623, DOI [10.1038/NMETH.1473, 10.1038/nmeth.1473]; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Tinevez JY, 2009, P NATL ACAD SCI USA, V106, P18581, DOI 10.1073/pnas.0903353106; Truong K, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-8; Tyszkiewicz AB, 2008, NAT METHODS, V5, P303, DOI [10.1038/nmeth.1189, 10.1038/NMETH.1189]; Vila-Perello M, 2008, ANGEW CHEM INT EDIT, V47, P7764, DOI 10.1002/anie.200802502; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Wang Q, 2008, STRUCTURE, V16, P1817, DOI 10.1016/j.str.2008.10.008; Wong S, 2012, PROTEIN ENG DES SEL; Wong SSC, 2012, CELL CALCIUM, V51, P57, DOI 10.1016/j.ceca.2011.10.006; Wong SSC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014274; Wood DW, 2014, J BIOL CHEM, V289, P14512, DOI 10.1074/jbc.R114.552653; Wood DW, 1999, NAT BIOTECHNOL, V17, P889, DOI 10.1038/12879; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yeh BJ, 2007, NATURE, V447, P596, DOI 10.1038/nature05851; Zeidler MP, 2004, NAT BIOTECHNOL, V22, P871, DOI 10.1038/nbt979; Zettler J, 2009, FEBS LETT, V583, P909, DOI 10.1016/j.febslet.2009.02.003; Zheng Changyu, 2008, V434, P205, DOI 10.1007/978-1-60327-248-3_13	55	28	29	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135965	10.1371/journal.pone.0135965	http://dx.doi.org/10.1371/journal.pone.0135965			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317656	gold, Green Published, Green Submitted			2022-12-26	WOS:000360299100054
J	King, C; McCollum, ED; Mankhambo, L; Colbourn, T; Beard, J; Burgess, DCH; Costello, A; Izadnegahdar, R; Lufesi, N; Masache, G; Mwansambo, C; Nambiar, B; Johnson, E; Platt, R; Mukanga, D				King, Carina; McCollum, Eric D.; Mankhambo, Limangeni; Colbourn, Tim; Beard, James; Burgess, Debbie C. Hay; Costello, Anthony; Izadnegahdar, Raza; Lufesi, Norman; Masache, Gibson; Mwansambo, Charles; Nambiar, Bejoy; Johnson, Eric; Platt, Robert; Mukanga, David			Can We Predict Oral Antibiotic Treatment Failure in Children with Fast-Breathing Pneumonia Managed at the Community Level? A Prospective Cohort Study in Malawi	PLOS ONE			English	Article							CHILDHOOD PNEUMONIA; RESPIRATORY-INFECTIONS; AFRICAN CHILDREN; GLOBAL BURDEN; RISK-FACTORS; AMOXICILLIN; COTRIMOXAZOLE; THERAPY; MORTALITY; STANDARD	Background Pneumonia is the leading cause of infectious death amongst children globally, with the highest burden in Africa. Early identification of children at risk of treatment failure in the community and prompt referral could lower mortality. A number of clinical markers have been independently associated with oral antibiotic failure in childhood pneumonia. This study aimed to develop a prognostic model for fast-breathing pneumonia treatment failure in sub-Saharan Africa. Method We prospectively followed a cohort of children (2-59 months), diagnosed by community health workers with fast-breathing pneumonia using World Health Organisation (WHO) integrated community case management guidelines. Cases were followed at days 5 and 14 by study data collectors, who assessed a range of pre-determined clinical features for treatment outcome. We built the prognostic model using eight pre-defined parameters, using multivariable logistic regression, validated through bootstrapping. Results We assessed 1,542 cases of which 769 were included (32% ineligible; 19% defaulted). The treatment failure rate was 15% at day 5 and relapse was 4% at day 14. Concurrent malaria diagnosis (OR: 1.62; 95% CI: 1.06, 2.47) and moderate malnutrition (OR: 1.88; 95% CI: 1.09, 3.26) were associated with treatment failure. The model demonstrated poor calibration and discrimination (c-statistic: 0.56). Conclusion This study suggests that it may be difficult to create a pragmatic community-level prognostic child pneumonia tool based solely on clinical markers and pulse oximetry in an HIV and malaria endemic setting. Further work is needed to identify more accurate and reliable referral algorithms that remain feasible for use by community health workers.	[King, Carina; McCollum, Eric D.; Colbourn, Tim; Beard, James; Costello, Anthony; Nambiar, Bejoy] UCL, Inst Global Hlth, London, England; [McCollum, Eric D.] Johns Hopkins Sch Med, Div Pulmonol, Dept Pediat, Baltimore, MD USA; [Mankhambo, Limangeni; Masache, Gibson] Parent & Child Hlth Initiat, Lilongwe, Malawi; [Burgess, Debbie C. Hay; Izadnegahdar, Raza; Mukanga, David] Bill & Melinda Gates Fdn, Seattle, WA USA; [Lufesi, Norman] Minist Hlth, Acute Resp Infect Unit, Lilongwe, Malawi; [Mwansambo, Charles] Minist Hlth, Lilongwe, Malawi; [Johnson, Eric] Kaiser Permanente Northwest, Ctr Hlth Res, Portland, OR USA; [Platt, Robert] McGill Univ, Montreal, PQ, Canada	University of London; University College London; Johns Hopkins University; Johns Hopkins Medicine; Bill & Melinda Gates Foundation; Kaiser Permanente; McGill University	King, C (corresponding author), UCL, Inst Global Hlth, London, England.	c.king@ucl.ac.uk	Colbourn, Tim/AAE-6645-2019; McCollum, Eric D./AAE-7120-2020	Colbourn, Tim/0000-0002-6917-6552; Nambiar, Bejoy/0000-0002-1742-522X	Bill & Melinda Gates Foundation [23591]; National Institutes of Health National Heart Lung and Blood Institute [T32 HL072748-11]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL072748] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Bill & Melinda Gates Foundation [#23591]. EDM received additional funding from the National Institutes of Health National Heart Lung and Blood Institute (T32 HL072748-11).	Addo-Yobo E, 2004, LANCET, V364, P1141, DOI 10.1016/S0140-6736(04)17100-6; Ahmed S, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19305; [Anonymous], 2013, CAR SICK CHILD COMM; Awasthi S, 2004, BMJ-BRIT MED J, V328, P791; Demers AM, 2000, PEDIATR INFECT DIS J, V19, P424, DOI 10.1097/00006454-200005000-00007; Eric DM, 2014, AM THOR SOC INT C; Fox MP, 2013, CLIN INFECT DIS, V56, P978, DOI 10.1093/cid/cis1201; Fu LY, 2006, PEDIATRICS, V118, pE1822, DOI 10.1542/peds.2005-2673; Garcia MS, 2009, INT J ANTIMICROB AG, V34; Graham SM, 2008, B WORLD HEALTH ORGAN, V86, P349, DOI 10.2471/BLT.07.048512; Grant GB, 2009, LANCET INFECT DIS, V9, P185, DOI 10.1016/S1473-3099(09)70044-1; Hazir T, 2002, LANCET, V360, P835; Jeena P, 2006, B WORLD HEALTH ORGAN, V84, P269; Kallander K, 2004, ACTA TROP, V90, P211, DOI 10.1016/j.actatropica.2003.11.013; Khuluza F, 2014, MALAWI MED J, V26, P38; Liu L, 2014, LANCET; Malalwi Go, 2008, INTEGRATED MANAGEMEN; Mamtani M, 2009, PEDIATR PULM, V44, P379, DOI 10.1002/ppul.21014; McCollum ED, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0392-x; McNally LM, 2007, LANCET, V369, P1440, DOI 10.1016/S0140-6736(07)60670-9; Menendez R, 2004, THORAX, V59, P960, DOI 10.1136/thx.2003.017756; National Statistical Office (NSO) and ICF Macro, 2011, MAL DEM HLTH SURV 20; Niessen L, 2009, B WORLD HEALTH ORGAN, V87, P472, DOI 10.2471/BLT.08.050872; Noorani QA, 2006, INT J TUBERC LUNG D, V10, P932; Rasmussen ZA, 2005, B WORLD HEALTH ORGAN, V83, P10; REDD SC, 1992, LANCET, V340, P1140, DOI 10.1016/0140-6736(92)93160-O; Roca A, 2006, TROP MED INT HEALTH, V11, P373, DOI 10.1111/j.1365-3156.2006.01566.x; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Sazawal S, 2003, LANCET INFECT DIS, V3, P547, DOI 10.1016/S1473-3099(03)00737-0; Team RDC, R LANG ENV STAT COMP; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Yeboah-Antwi K, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000340; Zar HJ, 2003, PEDIATR PULM, V36, P457, DOI 10.1002/ppul.10345	34	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136839	10.1371/journal.pone.0136839	http://dx.doi.org/10.1371/journal.pone.0136839			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313752	Green Published, gold, Green Submitted			2022-12-26	WOS:000360144000099
J	Chatterjee, A; Caballero-Franco, C; Bakker, D; Totten, S; Jardim, A				Chatterjee, Abhishek; Caballero-Franco, Celia; Bakker, Dannika; Totten, Stephanie; Jardim, Armando			Pore-forming Activity of the Escherichia coli Type III Secretion System Protein EspD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-INSERTION; INTIMATE ATTACHMENT; PEDESTAL FORMATION; EPITHELIAL-CELLS; TRANSLOCATION; CHOLESTEROL; EFFECTOR; TIR; DOMAIN; ROLES	Enterohemorrhagic Escherichia coli is a causative agent of gastrointestinal and diarrheal diseases. Pathogenesis associated with enterohemorrhagic E. coli involves direct delivery of virulence factors from the bacteria into epithelial cell cytosol via a syringe-like organelle known as the type III secretion system. The type III secretion system protein EspD is a critical factor required for formation of a translocation pore on the host cell membrane. Here, we show that recombinant EspD spontaneously integrates into large unilamellar vesicle (LUV) lipid bilayers; however, pore formation required incorporation of anionic phospholipids such as phosphatidylserine and an acidic pH. Leakage assays performed with fluorescent dextrans confirmed that EspD formed a structure with an inner diameter of similar to 2.5 nm. Protease mapping indicated that the two transmembrane helical hairpin of EspD penetrated the lipid layer positioning the N- and C-terminal domains on the extralumenal surface of LUVs. Finally, a combination of glutaraldehyde cross-linking and rate zonal centrifugation suggested that EspD in LUV membranes forms an similar to 280-320-kDa oligomeric structure consisting of similar to 6-7 subunits.	[Jardim, Armando] McGill Univ, Inst Parasitol, Quebec City, PQ H9X 3V9, Canada; McGill Univ, Ctr Host Parasite Interact, Quebec City, PQ H9X 3V9, Canada	McGill University; McGill University	Jardim, A (corresponding author), McGill Univ, Inst Parasitol, Macdonald Campus 21,111 Lakeshore Rd, Quebec City, PQ H9X 3V9, Canada.	armando.jardim@mcgill.ca			Natural Science and Engineering Research Council of Canada [RGPIN 238294-11]; Canada Foundation for Innovation New Opportunities Program; Regroupements Strategiques from the Fonds de Recherche sur Nature et les Technologies Quebec (FQRNT)	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation New Opportunities Program; Regroupements Strategiques from the Fonds de Recherche sur Nature et les Technologies Quebec (FQRNT)	This work was supported by Natural Science and Engineering Research Council of Canada Grant RGPIN 238294-11, Canada Foundation for Innovation New Opportunities Program, and a Regroupements Strategiques from the Fonds de Recherche sur Nature et les Technologies Quebec (FQRNT). The authors declare that they have no conflicts of interest with the contents of this article.	Abul-Milh M, 2001, INFECT IMMUN, V69, P7356, DOI 10.1128/IAI.69.12.7356-7364.2001; Allen-Vercoe E, 2006, CELL MICROBIOL, V8, P613, DOI 10.1111/j.1462-5822.2005.00654.x; Barrera FN, 2011, J MOL BIOL, V413, P359, DOI 10.1016/j.jmb.2011.08.010; Barta ML, 2012, J MOL BIOL, V417, P395, DOI 10.1016/j.jmb.2012.01.026; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Borthakur A, 2006, AM J PHYSIOL-GASTR L, V290, pG30, DOI 10.1152/ajpgi.00302.2005; Campellone KG, 2007, MOL MICROBIOL, V63, P1468, DOI 10.1111/j.1365-2958.2007.05602.x; Caputo GA, 2003, BIOCHEMISTRY-US, V42, P3265, DOI 10.1021/bi026696l; Chattopadhyay A, 2008, BIOPHYS J, V95, P166, DOI 10.1529/biophysj.107.124206; Crane JK, 2005, CELL DEATH DIFFER, V12, P115, DOI 10.1038/sj.cdd.4401531; Daniell SJ, 2003, MOL MICROBIOL, V49, P301, DOI 10.1046/j.1365-2958.2003.03555.x; Daniell SJ, 2001, INFECT IMMUN, V69, P4055, DOI 10.1128/IAI.69.6.4055-4064.2001; Dasanayake D, 2011, MOL MICROBIOL, V81, P734, DOI 10.1111/j.1365-2958.2011.07727.x; Dawson JP, 2002, J MOL BIOL, V316, P799, DOI 10.1006/jmbi.2001.5353; DeVinney R, 1999, CURR OPIN MICROBIOL, V2, P83, DOI 10.1016/S1369-5274(99)80014-9; Dohlich K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003881; DONNENBERG MS, 1993, J BACTERIOL, V175, P4670, DOI 10.1128/JB.175.15.4670-4680.1993; Faudry E, 2006, BIOCHEMISTRY-US, V45, P8117, DOI 10.1021/bi060452+; Foster DB, 2000, INFECT IMMUN, V68, P3108, DOI 10.1128/IAI.68.6.3108-3115.2000; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Garmendia J, 2005, INFECT IMMUN, V73, P2573, DOI 10.1128/IAI.73.5.2573-2585.2005; Geisse NA, 2004, BIOCHEM J, V381, P911, DOI 10.1042/BJ20031719; Gilbert RJC, 2014, TRENDS BIOCHEM SCI, V39, P510, DOI 10.1016/j.tibs.2014.09.002; Goosney DL, 2000, CURR BIOL, V10, P735, DOI 10.1016/S0960-9822(00)00543-1; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Hartland EL, 2000, MOL MICROBIOL, V35, P1483, DOI 10.1046/j.1365-2958.2000.01814.x; Hayward RD, 2005, MOL MICROBIOL, V56, P590, DOI 10.1111/j.1365-2958.2005.04568.x; He X, 2013, SCI REP-UK, V3, DOI 10.1038/srep03416; Hodges K, 2006, AM J PHYSIOL-GASTR L, V291, pG959, DOI 10.1152/ajpgi.00274.2005; Hume PJ, 2003, MOL MICROBIOL, V49, P425, DOI 10.1046/j.1365-2958.2003.03559.x; Ide T, 2001, CELL MICROBIOL, V3, P669, DOI 10.1046/j.1462-5822.2001.00146.x; JARVIS KG, 1995, P NATL ACAD SCI USA, V92, P7996, DOI 10.1073/pnas.92.17.7996; Jepson MA, 2003, CELL MICROBIOL, V5, P773, DOI 10.1046/j.1462-5822.2003.00315.x; Johnson JE, 2003, J BIOL CHEM, V278, P514, DOI 10.1074/jbc.M206072200; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kaul P, 1996, PROTEIN SCI, V5, P687; Knutton S, 1998, EMBO J, V17, P2166, DOI 10.1093/emboj/17.8.2166; Kresse AU, 1999, INFECT IMMUN, V67, P4834, DOI 10.1128/IAI.67.9.4834-4842.1999; Lafont F, 2002, EMBO J, V21, P4449, DOI 10.1093/emboj/cdf457; Lai LC, 1997, INFECT IMMUN, V65, P2211, DOI 10.1128/IAI.65.6.2211-2217.1997; LEENHOUTS JM, 1995, FEBS LETT, V370, P189, DOI 10.1016/0014-5793(95)00823-R; Luo WS, 2011, J BACTERIOL, V193, P2972, DOI 10.1128/JB.00153-11; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Marteau P, 2001, APPL ENVIRON MICROB, V67, P4939, DOI 10.1128/AEM.67.10.4939-4942.2001; MCDANIEL TK, 1995, P NATL ACAD SCI USA, V92, P1664, DOI 10.1073/pnas.92.5.1664; McGhie EJ, 2002, MOL MICROBIOL, V44, P1309, DOI 10.1046/j.1365-2958.2002.02958.x; MEL SF, 1993, BIOCHEMISTRY-US, V32, P2082, DOI 10.1021/bi00059a028; Mellies JL, 2007, INFECT IMMUN, V75, P4199, DOI 10.1128/IAI.01927-06; Mota LJ, 2005, ANN MED, V37, P234, DOI 10.1080/07853890510037329; Musse AA, 2006, J BIOL CHEM, V281, P885, DOI 10.1074/jbc.M511140200; Neves BC, 2003, INFECT IMMUN, V71, P2130, DOI 10.1128/IAI.71.4.2130-2141.2003; Nougayrede JP, 2003, CELL MICROBIOL, V5, P359, DOI 10.1046/j.1462-5822.2003.00281.x; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pallen MJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-9; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; Riff JD, 2005, INFECT IMMUN, V73, P7113, DOI 10.1128/IAI.73.11.7113-7125.2005; Romano FB, 2011, BIOCHEMISTRY-US, V50, P7117, DOI 10.1021/bi200905x; Rosenberger CM, 2000, CURR BIOL, V10, pR823, DOI 10.1016/S0960-9822(00)00788-0; ROSENSHINE I, 1992, EMBO J, V11, P3551, DOI 10.1002/j.1460-2075.1992.tb05438.x; Russo TA, 2003, MICROBES INFECT, V5, P449, DOI 10.1016/S1286-4579(03)00049-2; Schoehn G, 2003, EMBO J, V22, P4957, DOI 10.1093/emboj/cdg499; Schroeder RJ, 1998, J BIOL CHEM, V273, P1150, DOI 10.1074/jbc.273.2.1150; Shaw RK, 2005, INFECT IMMUN, V73, P1243, DOI 10.1128/IAI.73.2.1243-1251.2005; Shaw RK, 2002, MICROBIOL-SGM, V148, P1355, DOI 10.1099/00221287-148-5-1355; Thomson AR, 2014, SCIENCE, V346, P485, DOI 10.1126/science.1257452; Tu XL, 2003, MOL MICROBIOL, V47, P595, DOI 10.1046/j.1365-2958.2003.03329.x; VANDERGOOT FG, 1991, NATURE, V354, P408, DOI 10.1038/354408a0; Wachter C, 1999, MOL MICROBIOL, V31, P1695, DOI 10.1046/j.1365-2958.1999.01303.x; Wager B, 2013, BIOPHYS J, V104, P1445, DOI 10.1016/j.bpj.2013.02.018; Wainwright LA, 1998, MOL MICROBIOL, V27, P1247, DOI 10.1046/j.1365-2958.1998.00771.x; Wolff C, 1998, MOL MICROBIOL, V28, P143, DOI 10.1046/j.1365-2958.1998.00782.x; ZACHOWSKI A, 1993, BIOCHEM J, V294, P1	72	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25579	25594		10.1074/jbc.M115.648204	http://dx.doi.org/10.1074/jbc.M115.648204			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26324713	Green Published, hybrid			2022-12-26	WOS:000362962800032
J	Blackman, LM; Cullerne, DP; Torrena, P; Taylor, J; Hardham, AR				Blackman, Leila M.; Cullerne, Darren P.; Torrena, Pernelyn; Taylor, Jen; Hardham, Adrienne R.			RNA-Seq Analysis of the Expression of Genes Encoding Cell Wall Degrading Enzymes during Infection of Lupin (Lupinus angustifolius) by Phytophthora parasitica	PLOS ONE			English	Article							CARBOHYDRATE-BINDING MODULES; CELLULOSE-BINDING; FUNCTIONAL-CHARACTERIZATION; IMMUNOGOLD LOCALIZATION; RHAMNOGALACTURONAN II; PHYSIOLOGICAL ROLES; GLYCOSIDE HYDROLASE; CALLOSE DEPOSITION; ASPERGILLUS-NIGER; PECTATE-LYASE	RNA-Seq analysis has shown that over 60% (12,962) of the predicted transcripts in the Phytophthora parasitica genome are expressed during the first 60 h of lupin root infection. The infection transcriptomes included 278 of the 431 genes encoding P. parasitica cell wall degrading enzymes. The transcriptome data provide strong evidence of global transcriptional cascades of genes whose encoded proteins target the main categories of plant cell wall components. A major cohort of pectinases is predominantly expressed early but as infection progresses, the transcriptome becomes increasingly dominated by transcripts encoding cellulases, hemicellulases, beta-1,3-glucanases and glycoproteins. The most highly expressed P. parasitica carbohydrate active enzyme gene contains two CBM1 cellulose binding modules and no catalytic domains. The top 200 differentially expressed genes include beta-1,4-glucosidases, beta-1,4-glucanases, beta-1,4-galactanases, a beta-1,3-glucanase, an alpha-1,4-polygalacturonase, a pectin deacetylase and a pectin methylesterase. Detailed analysis of gene expression profiles provides clues as to the order in which linkages within the complex carbohydrates may come under attack. The gene expression profiles suggest that (i) demethylation of pectic homogalacturonan occurs before its deacetylation; (ii) cleavage of the backbone of pectic rhamnogalacturonan I precedes digestion of its side chains; (iii) early attack on cellulose microfibrils by non-catalytic cellulose-binding proteins and enzymes with auxiliary activities may facilitate subsequent attack by glycosyl hydrolases and enzymes containing CBM1 cellulose-binding modules; (iv) terminal hemicellulose backbone residues are targeted after extensive internal backbone cleavage has occurred; and (v) the carbohydrate chains on glycoproteins are degraded late in infection. A notable feature of the P. parasitica infection transcriptome is the high level of transcription of genes encoding enzymes that degrade beta-1,3-glucanases during middle and late stages of infection. The results suggest that high levels of beta-1,3-glucanases may effectively degrade callose as it is produced by the plant during the defence response.	[Blackman, Leila M.; Cullerne, Darren P.; Torrena, Pernelyn; Hardham, Adrienne R.] Australian Natl Univ, Plant Sci Div, Res Sch Biol, Coll Med Biol & Environm, Canberra, ACT, Australia; [Cullerne, Darren P.; Taylor, Jen] CSIRO, Agr Flagship, Canberra, ACT, Australia	Australian National University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Blackman, LM (corresponding author), Australian Natl Univ, Plant Sci Div, Res Sch Biol, Coll Med Biol & Environm, Canberra, ACT, Australia.	leila.blackman@anu.edu.au	Cullerne, Darren/A-7080-2011; Hardham, Adrienne/C-9674-2009; Taylor, Jennifer M/A-1686-2010	Cullerne, Darren/0000-0001-9784-0492; Taylor, Jennifer M/0000-0003-4231-0181	Australian Research Council Discovery Grant [DP110102156]	Australian Research Council Discovery Grant(Australian Research Council)	This research was conducted with the support of the Australian Research Council Discovery Grant DP110102156. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 2004, MICROBIOL-SGM, V150, P2029, DOI 10.1099/mic.0.26980-0; Adhikari B. N., 2013, PLoS ONE, V8, pe75072, DOI 10.1371/journal.pone.0075072; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arantes V, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-4; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Attard A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-538; Avila M, 2009, MICROBIOL-SGM, V155, P2739, DOI 10.1099/mic.0.027789-0; Baumann MJ, 2007, PLANT CELL, V19, P1947, DOI 10.1105/tpc.107.051391; Benen JAE, 1999, EUR J BIOCHEM, V259, P577, DOI 10.1046/j.1432-1327.1999.00080.x; Biely P, 2012, BIOTECHNOL ADV, V30, P1575, DOI 10.1016/j.biotechadv.2012.04.010; Blackman LM, 2008, MOL PLANT PATHOL, V9, P495, DOI 10.1111/J.1364-3703.2008.00478.X; Blackman LM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-785; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; BONHOFF A, 1987, PLANTA, V172, P101, DOI 10.1007/BF00403034; Bonnin E, 2008, CARBOHYD POLYM, V74, P411, DOI 10.1016/j.carbpol.2008.03.014; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brito N, 2006, MOL PLANT MICROBE IN, V19, P25, DOI 10.1094/MPMI-19-0025; Brouwer H, 2014, FUNGAL GENET BIOL, V72, P192, DOI 10.1016/j.fgb.2014.08.011; Brunner F, 2002, PHYTOCHEMISTRY, V59, P689, DOI 10.1016/S0031-9422(02)00045-6; Brunner PC, 2013, MOL BIOL EVOL, V30, P1337, DOI 10.1093/molbev/mst041; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Cannon MC, 2008, P NATL ACAD SCI USA, V105, P2226, DOI 10.1073/pnas.0711980105; Cano-Canchola C, 2000, FUNGAL GENET BIOL, V29, P145, DOI 10.1006/fgbi.2000.1196; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Clavaud C, 2009, CHEMISTRY, BIOCHEMISTRY, AND BIOLOGY OF (1-->3)-BETA-GLUCANS AND RELATED POLYSACCHARIDES, P387; COOPER RM, 1975, PHYSIOL PLANT PATHOL, V5, P135, DOI 10.1016/0048-4059(75)90017-X; COOPER RM, 1983, BIOCH PLANT PATHOLOG, P101; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Cuskin F, 2012, P NATL ACAD SCI USA, V109, P20889, DOI 10.1073/pnas.1212034109; de Vries RP, 2001, MICROBIOL MOL BIOL R, V65, P497, DOI 10.1128/MMBR.65.4.497-522.2001; de Vries RP, 2000, CARBOHYD RES, V327, P401, DOI 10.1016/S0008-6215(00)00066-5; De Wet BJM, 2008, APPL MICROBIOL BIOT, V77, P975, DOI 10.1007/s00253-007-1235-y; DEISING H, 1995, CAN J BOT, V73, pS624, DOI 10.1139/b95-304; DIN N, 1991, BIO-TECHNOL, V9, P1096, DOI 10.1038/nbt1191-1096; Douaiher MN, 2007, PLANT PATHOL, V56, P79, DOI 10.1111/j.1365-3059.2006.01460.x; Douaiher MN, 2007, EUR J PLANT PATHOL, V117, P71, DOI 10.1007/s10658-006-9073-9; DUDLER R, 1990, PLANT MOL BIOL, V14, P415, DOI 10.1007/BF00028777; Eastwood DC, 2011, SCIENCE, V333, P762, DOI 10.1126/science.1205411; Enkerli K, 1997, CAN J BOT, V75, P1509, DOI 10.1139/b97-865; Enkerli K, 1997, CAN J BOT, V75, P1493, DOI 10.1139/b97-864; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Frankova L, 2013, J EXP BOT, V64, P3519, DOI 10.1093/jxb/ert201; Fu HT, 2013, FUNGAL BIOL-UK, V117, P673, DOI 10.1016/j.funbio.2013.07.003; Gan PHP, 2009, MOL GENET GENOMICS, V281, P565, DOI 10.1007/s00438-009-0431-0; Gao DH, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-5; Garbe J, 2012, J INNATE IMMUN, V4, P121, DOI 10.1159/000334775; Georgelis N, 2014, CARBOHYD POLYM, V100, P17, DOI 10.1016/j.carbpol.2013.04.094; Grover A, 2012, CRIT REV PLANT SCI, V31, P57, DOI 10.1080/07352689.2011.616043; Hardham AR, 2010, FUNCT PLANT BIOL, V37, P919, DOI 10.1071/FP10073; Hardham AR, 2005, MOL PLANT PATHOL, V6, P589, DOI 10.1111/J.1364-3703.2005.00308.X; Haverkort AJ, 2008, POTATO RES, V51, P47, DOI 10.1007/s11540-008-9089-y; Hayden KJ, 2014, TREE GENET GENOMES, V10, P489, DOI 10.1007/s11295-014-0698-0; Hemsworth GR, 2013, CURR OPIN STRUC BIOL, V23, P660, DOI 10.1016/j.sbi.2013.05.006; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Huckelhoven R, 2007, ANNU REV PHYTOPATHOL, V45, P101, DOI 10.1146/annurev.phyto.45.062806.094325; Hurlbert JC, 2001, J BACTERIOL, V183, P2093, DOI 10.1128/JB.183.6.2093-2100.2001; Isshiki A, 2001, MOL PLANT MICROBE IN, V14, P749, DOI 10.1094/MPMI.2001.14.6.749; Jiang RHY, 2012, ANNU REV PHYTOPATHOL, V50, P295, DOI 10.1146/annurev-phyto-081211-172912; Jiang T, 2013, BIOCHEM BIOPH RES CO, V438, P193, DOI 10.1016/j.bbrc.2013.07.051; Jones RW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023555; JONES TM, 1972, PHYSIOL PLANT PATHOL, V2, P153, DOI 10.1016/0048-4059(72)90023-9; Kebdani N, 2010, NEW PHYTOL, V185, P248, DOI 10.1111/j.1469-8137.2009.03048.x; KOCH JL, 1989, PLANT PHYSIOL, V91, P816, DOI 10.1104/pp.91.3.816; Kovacs K, 2011, J ENVIRON MANAGE, V92, P1292, DOI 10.1016/j.jenvman.2010.12.018; Kubicek CP, 2014, ANNU REV PHYTOPATHOL, V52, P427, DOI 10.1146/annurev-phyto-102313-045831; Larroque M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-605; Le Berre JY, 2008, NEW PHYTOL, V177, P480, DOI 10.1111/j.1469-8137.2007.02269.x; Lee I, 2000, ULTRAMICROSCOPY, V82, P213, DOI 10.1016/S0304-3991(99)00158-8; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Levesque CA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r73; Lima PD, 2012, FEMS YEAST RES, V12, P685, DOI 10.1111/j.1567-1364.2012.00819.x; Limberg G, 2000, CARBOHYD RES, V327, P293, DOI 10.1016/S0008-6215(00)00067-7; Liu HL, 2005, MOL PLANT MICROBE IN, V18, P1296, DOI 10.1094/MPMI-18-1296; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Luna E, 2011, MOL PLANT MICROBE IN, V24, P183, DOI 10.1094/MPMI-07-10-0149; Marcus SE, 2010, PLANT J, V64, P191, DOI 10.1111/j.1365-313X.2010.04319.x; Marcus SE, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-60; MARTINEZ MJ, 1991, FEMS MICROBIOL LETT, V81, P145, DOI 10.1016/0378-1097(91)90294-K; Mateos FV, 1997, MOL PLANT MICROBE IN, V10, P1045, DOI 10.1094/MPMI.1997.10.9.1045; McLeod A, 2003, FUNGAL GENET BIOL, V38, P250, DOI 10.1016/S1087-1845(02)00523-6; Melida H, 2013, EUKARYOT CELL, V12, P194, DOI 10.1128/EC.00288-12; Minic Z, 2008, PLANTA, V227, P723, DOI 10.1007/s00425-007-0668-y; Molgaard A, 2000, STRUCTURE, V8, P373, DOI 10.1016/S0969-2126(00)00118-0; Nakajima M, 2012, APPL ENVIRON MICROB, V78, P5682, DOI 10.1128/AEM.00483-12; O'Connell RJ, 2012, NAT GENET, V44, P1060, DOI 10.1038/ng.2372; O'Neill MA, 2004, ANNU REV PLANT BIOL, V55, P109, DOI 10.1146/annurev.arplant.55.031903.141750; Pabst M, 2013, PLANT J, V76, P61, DOI 10.1111/tpj.12271; Parenicova L, 2000, FEBS LETT, V467, P333, DOI 10.1016/S0014-5793(00)01173-X; Pitson SM, 1997, ENZYME MICROB TECH, V21, P182, DOI 10.1016/S0141-0229(96)00263-3; Pogorelko G, 2013, PLANT PHYSIOL, V162, P9, DOI 10.1104/pp.113.214460; Pritchard L, 2014, MOL PLANT PATHOL, V15, P865, DOI 10.1111/mpp.12210; Nguyen QB, 2011, MOL MICROBIOL, V81, P1008, DOI 10.1111/j.1365-2958.2011.07746.x; Robold AV, 1998, CAN J MICROBIOL, V44, P1161, DOI 10.1139/cjm-44-12-1161; Rogers LM, 2000, P NATL ACAD SCI USA, V97, P9813, DOI 10.1073/pnas.160271497; Savory EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035796; SCOTTCRAIG JS, 1990, PLANT CELL, V2, P1191, DOI 10.1105/tpc.2.12.1191; Seifert GJ, 2007, ANNU REV PLANT BIOL, V58, P137, DOI 10.1146/annurev.arplant.58.032806.103801; Selig MJ, 2009, CELLULOSE, V16, P711, DOI 10.1007/s10570-009-9322-0; Socquet-Juglard D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054196; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Soriano M, 2006, MICROBIOL-SGM, V152, P617, DOI 10.1099/mic.0.28562-0; Stals I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040854; Tamayo-Ramos JA, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-26; Tenberge KB, 1999, MYCOL RES, V103, P1103, DOI 10.1017/S095375629800820X; Tian CG, 2009, P NATL ACAD SCI USA, V106, P22157, DOI 10.1073/pnas.0906810106; Underwood W, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00085; van Munster JM, 2014, FUNGAL GENET BIOL, V72, P34, DOI 10.1016/j.fgb.2014.04.006; Van West Pieter, 2006, Mycologist, V20, P99, DOI 10.1016/j.mycol.2006.06.004; Vardakou M., 2004, Innovative Food Science & Emerging Technologies, V5, P107, DOI 10.1016/S1466-8564(03)00044-4; Veneault-Fourrey C, 2014, FUNGAL GENET BIOL, V72, P168, DOI 10.1016/j.fgb.2014.08.007; Vincken JP, 2003, PLANT PHYSIOL, V132, P1781, DOI 10.1104/pp.103.022350; Voigt CA, 2009, CHEMISTRY, BIOCHEMISTRY, AND BIOLOGY OF (1-->3)-BETA-GLUCANS AND RELATED POLYSACCHARIDES, P525; Williamson G, 1998, MICROBIOL-SGM, V144, P2011, DOI 10.1099/00221287-144-8-2011; Wu CH, 2008, MOL PLANT MICROBE IN, V21, P480, DOI 10.1094/MPMI-21-4-0480; Yan HZ, 2006, FUNGAL GENET BIOL, V43, P430, DOI 10.1016/j.fgb.2006.01.010; Yeoman CJ, 2010, ADV APPL MICROBIOL, V70, P1, DOI 10.1016/S0065-2164(10)70001-0; Yu YT, 2010, J PHYTOPATHOL, V158, P344, DOI 10.1111/j.1439-0434.2009.01614.x; Zerillo MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072572; Zhao Q, 2014, ANNU REV PHYTOPATHOL, V52, P69, DOI 10.1146/annurev-phyto-082712-102237; Zhao ZT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-274; Zheng AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2427	122	36	36	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136899	10.1371/journal.pone.0136899	http://dx.doi.org/10.1371/journal.pone.0136899			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332397	gold, Green Submitted, Green Published			2022-12-26	WOS:000360613800080
J	Langen, CD; White, T; Ikram, MA; Vernooij, MW; Niessen, WJ				Langen, Carolyn D.; White, Tonya; Ikram, M. Arfan; Vernooij, Meike W.; Niessen, Wiro J.			Integrated Analysis and Visualization of Group Differences in Structural and Functional Brain Connectivity: Applications in Typical Ageing and Schizophrenia	PLOS ONE			English	Article							WHITE-MATTER ABNORMALITIES; RESTING-STATE NETWORKS; FMRI DATA; HUMAN CONNECTOME; MOTION ARTIFACT; LOW-FREQUENCY; PARCELLATION; ORGANIZATION; ARCHITECTURE; TUTORIAL	Structural and functional brain connectivity are increasingly used to identify and analyze group differences in studies of brain disease. This study presents methods to analyze uniand bi-modal brain connectivity and evaluate their ability to identify differences. Novel visualizations of significantly different connections comparing multiple metrics are presented. On the global level, "bi-modal comparison plots" show the distribution of uni-and bi-modal group differences and the relationship between structure and function. Differences between brain lobes are visualized using "worm plots". Group differences in connections are examined with an existing visualization, the "connectogram". These visualizations were evaluated in two proof-of-concept studies: (1) middle-aged versus elderly subjects; and (2) patients with schizophrenia versus controls. Each included two measures derived from diffusion weighted images and two from functional magnetic resonance images. The structural measures were minimum cost path between two anatomical regions according to the "Statistical Analysis of Minimum cost path based Structural Connectivity" method and the average fractional anisotropy along the fiber. The functional measures were Pearson's correlation and partial correlation of mean regional time series. The relationship between structure and function was similar in both studies. Uni-modal group differences varied greatly between connectivity types. Group differences were identified in both studies globally, within brain lobes and between regions. In the aging study, minimum cost path was highly effective in identifying group differences on all levels; fractional anisotropy and mean correlation showed smaller differences on the brain lobe and regional levels. In the schizophrenia study, minimum cost path and fractional anisotropy showed differences on the global level and within brain lobes; mean correlation showed small differences on the lobe level. Only fractional anisotropy and mean correlation showed regional differences. The presented visualizations were helpful in comparing and evaluating connectivity measures on multiple levels in both studies.	[Langen, Carolyn D.; Niessen, Wiro J.] Erasmus MC, Biomed Imaging Grp Rotterdam, Dept Radiol, Rotterdam, Netherlands; [Langen, Carolyn D.; Niessen, Wiro J.] Erasmus MC, Biomed Imaging Grp Rotterdam, Dept Med Informat, Rotterdam, Netherlands; [White, Tonya] Erasmus MC, Dept Child & Adolescent Psychiat, Rotterdam, Netherlands; [Niessen, Wiro J.] Delft Univ Technol, Fac Sci Appl, Imaging Phys, Delft, Netherlands; [Ikram, M. Arfan; Vernooij, Meike W.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [White, Tonya; Ikram, M. Arfan; Vernooij, Meike W.] Erasmus MC, Dept Radiol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Delft University of Technology; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Langen, CD (corresponding author), Erasmus MC, Biomed Imaging Grp Rotterdam, Dept Radiol, Rotterdam, Netherlands.	c.langen@erasmusmc.nl	Ikram, M. Arfan/AAM-5225-2021; White, Tonya/AAU-2226-2021; Vernooij, Meike Willemijn/E-4061-2016	White, Tonya/0000-0003-0271-1896; Niessen, Wiro/0000-0002-5822-1995; Vernooij, Meike/0000-0003-4658-2176	ZonMw TOP [91211021]	ZonMw TOP	This study is financially supported through ZonMw TOP project number: 91211021, awarded to TW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Angrilli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004507; Betzel R.F., 2013, PHYS REV E, V1, P353, DOI [DOI 10.1103/PhysRevE.72.026132, 10.1017/nws.2013.19, DOI 10.1017/NWS.2013.19]; Betzel RF, 2014, NEUROIMAGE, V102, P345, DOI 10.1016/j.neuroimage.2014.07.067; Blumensath T, 2013, NEUROIMAGE, V76, P313, DOI 10.1016/j.neuroimage.2013.03.024; Bowman FD, 2012, NEUROIMAGE, V62, P1769, DOI 10.1016/j.neuroimage.2012.05.032; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Calhoun VD, 2009, NEUROIMAGE, V45, pS163, DOI 10.1016/j.neuroimage.2008.10.057; Cammoun L, 2012, J NEUROSCI METH, V203, P386, DOI 10.1016/j.jneumeth.2011.09.031; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craddock RC, 2013, NAT METHODS, V10, P524, DOI [10.1038/nmeth.2482, 10.1038/NMETH.2482]; Crossley NA, 2014, BRAIN, V137, P2382, DOI 10.1093/brain/awu132; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; de Boer R, 2011, NEUROIMAGE, V55, P557, DOI 10.1016/j.neuroimage.2010.12.012; de Reus MA, 2013, NEUROIMAGE, V80, P397, DOI 10.1016/j.neuroimage.2013.03.053; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fornito A, 2012, NEUROIMAGE, V62, P2296, DOI 10.1016/j.neuroimage.2011.12.090; Fornito A, 2011, BIOL PSYCHIAT, V70, P64, DOI 10.1016/j.biopsych.2011.02.019; Gao XY, 2010, GENET EPIDEMIOL, V34, P100, DOI 10.1002/gepi.20430; Gibson G, 2010, NAT GENET, V42, P558, DOI 10.1038/ng0710-558; Gollub RL, 2013, NEUROINFORMATICS, V11, P367, DOI 10.1007/s12021-013-9184-3; Hagmann P, 2010, J NEUROSCI METH, V194, P34, DOI 10.1016/j.jneumeth.2010.01.014; Hollingshead AB, 2007, AM J PUBLIC HEALTH, V97, P1756; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Honey CJ, 2010, NEUROIMAGE, V52, P766, DOI 10.1016/j.neuroimage.2010.01.071; Ikram MA, 2008, NEUROBIOL AGING, V29, P882, DOI 10.1016/j.neurobiolaging.2006.12.012; Ikram MA, 2011, EUR J EPIDEMIOL, V26, P811, DOI 10.1007/s10654-011-9624-z; Ingalhalikar M, 2014, P NATL ACAD SCI USA, V111, P823, DOI 10.1073/pnas.1316909110; Jbabdi S, 2008, INT J BIOMED IMAGING, V2008, DOI 10.1155/2008/320195; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kaiser M, 2011, NEUROIMAGE, V57, P892, DOI 10.1016/j.neuroimage.2011.05.025; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Kubicki M, 2005, CURR OPIN PSYCHIATR, V18, P121, DOI 10.1097/00001504-200503000-00004; Li MX, 2012, HUM GENET, V131, P747, DOI 10.1007/s00439-011-1118-2; Liang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032766; Margulies DS, 2013, NEUROIMAGE, V80, P445, DOI 10.1016/j.neuroimage.2013.04.111; Nakamura K, 2012, PSYCHIAT RES-NEUROIM, V202, P233, DOI 10.1016/j.pscychresns.2011.09.006; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Pruim RHR, 2015, NEUROIMAGE, V112, P278, DOI 10.1016/j.neuroimage.2015.02.063; Robinson EC, 2010, NEUROIMAGE, V50, P910, DOI 10.1016/j.neuroimage.2010.01.019; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Shen X, 2013, NEUROIMAGE, V82, P403, DOI 10.1016/j.neuroimage.2013.05.081; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2013, TRENDS COGN SCI, V17, P666, DOI 10.1016/j.tics.2013.09.016; Smith SM, 2012, NEUROIMAGE, V62, P1257, DOI 10.1016/j.neuroimage.2012.01.022; Smith SM, 2012, P NATL ACAD SCI USA, V109, P3131, DOI 10.1073/pnas.1121329109; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sporns Olaf, 2013, Dialogues Clin Neurosci, V15, P247; Sripada CS, 2014, P NATL ACAD SCI USA, V111, P14259, DOI 10.1073/pnas.1407787111; STERNBERG S, 1969, AM SCI, V57, P421; Tadayonnejad R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096033; van den Heuvel MP, 2010, HUM BRAIN MAPP, V31, P631, DOI 10.1002/hbm.20893; van Horn JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037454; Varoquaux G, 2013, NEUROIMAGE, V80, P405, DOI 10.1016/j.neuroimage.2013.04.007; Wee CY, 2012, NEUROIMAGE, V59, P2045, DOI 10.1016/j.neuroimage.2011.10.015; White T, 2015, EUR PSYCHIAT, V30, DOI 10.1016/j.eurpsy.2014.10.003; White T, 2001, NEUROIMAGE, V13, P577, DOI 10.1006/nimg.2000.0716; White T, 2013, SCHIZOPHRENIA BULL, V39, P1077, DOI 10.1093/schbul/sbs106; White T, 2009, PSYCHIAT RES-NEUROIM, V174, P110, DOI 10.1016/j.pscychresns.2009.04.014; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zhou J, 2012, NEURON, V73, P1216, DOI 10.1016/j.neuron.2012.03.004; Zhu DJ, 2014, NEUROIMAGE, V102, P184, DOI 10.1016/j.neuroimage.2013.09.071; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012	69	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137484	10.1371/journal.pone.0137484	http://dx.doi.org/10.1371/journal.pone.0137484			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331844	Green Published, gold, Green Submitted			2022-12-26	WOS:000360613800134
J	Xu, J; Xing, XJ; Tian, YS; Peng, RH; Xue, Y; Zhao, W; Yao, QH				Xu, Jing; Xing, Xiao-Juan; Tian, Yong-Sheng; Peng, Ri-He; Xue, Yong; Zhao, Wei; Yao, Quan-Hong			Transgenic Arabidopsis Plants Expressing Tomato Glutathione S-Transferase Showed Enhanced Resistance to Salt and Drought Stress	PLOS ONE			English	Article							OVER-EXPRESSION; ABSCISIC-ACID; HEAVY-METAL; TOLERANCE; GENE; PROLINE; ROLES; OVEREXPRESSION; MECHANISMS; SEEDLINGS	Although glutathione S-transferases (GST, EC 2.5.1.18) are involved in response to abiotic stress, limited information is available regarding gene function in tomato. In this study, a GST gene from tomato, designated LeGSTU2, was cloned and functionally characterized. Expression profile analysis results showed that it was expressed in roots and flowers, and the transcription was induced by salt, osmotic, and heat stress. The gene was then introduced to Arabidopsis by Agrobacterium tumefaciens-mediated transformation. Transgenic Arabidopsis plants were normal in terms of growth and maturity compared with wild-type plants. Transgenic plants also showed an enhanced resistance to salt and osmotic stress induced by NaCl and mannitol. The increased tolerance of transgenic plants was correlated with the changes in proline, malondialdehyde and antioxidative emzymes activities. Our results indicated that the gene from tomato plays a positive role in improving tolerance to salinity and drought stresses in Arabidopsis.	[Xu, Jing; Xing, Xiao-Juan; Tian, Yong-Sheng; Peng, Ri-He; Xue, Yong; Zhao, Wei; Yao, Quan-Hong] Shanghai Acad Agr Sci, Biotechnol Res Inst, Shanghai 201106, Peoples R China	Shanghai Academy of Agricultural Sciences	Yao, QH (corresponding author), Shanghai Acad Agr Sci, Biotechnol Res Inst, Shanghai 201106, Peoples R China.	yaoquanhong_sh@126.com			Shanghai Rising-Star Program [14QB1403400]; Shanghai Natural Science Foundation [13ZR1460600]; National Natural Science Foundation [31300237, 31401458]; Youth Talents Growth Plan of Shanghai Academy of Agricultural Sciences [2015-1-26]	Shanghai Rising-Star Program; Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Youth Talents Growth Plan of Shanghai Academy of Agricultural Sciences	The research study was sponsored by Shanghai Rising-Star Program [Grant No: 14QB1403400], Shanghai Natural Science Foundation [Grant No: 13ZR1460600] National Natural Science Foundation [Grant No: 31300237, 31401458], and Youth Talents Growth Plan of Shanghai Academy of Agricultural Sciences [Grant No: 2015-1-26]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels D, 2001, TRENDS PLANT SCI, V6, P284, DOI 10.1016/S1360-1385(01)01983-5; BARTLING D, 1993, EUR J BIOCHEM, V216, P579, DOI 10.1111/j.1432-1033.1993.tb18177.x; Bianchi MW, 2002, PHYSIOL PLANTARUM, V116, P96, DOI 10.1034/j.1399-3054.2002.1160112.x; Chen CY, 2007, PLANT PHYSIOL, V145, P1619, DOI 10.1104/pp.107.109876; Chen JH, 2012, PLANT PHYSIOL, V158, P340, DOI 10.1104/pp.111.181875; Chi YH, 2011, DNA RES, V18, P1, DOI 10.1093/dnares/dsq031; Cummins I, 1999, PLANT J, V18, P285, DOI 10.1046/j.1365-313X.1999.00452.x; Cummins I, 2011, DRUG METAB REV, V43, P266, DOI 10.3109/03602532.2011.552910; Dalton DA, 2009, PLANT PHYSIOL, V150, P521, DOI 10.1104/pp.109.136630; Diao GP, 2011, PLANT MOL BIOL REP, V29, P77, DOI 10.1007/s11105-010-0212-2; Dixon David P, 2010, Arabidopsis Book, V8, pe0131, DOI 10.1199/tab.0131; Ezaki B, 2000, PLANT PHYSIOL, V122, P657, DOI 10.1104/pp.122.3.657; Hoque MA, 2010, BIOSCI BIOTECH BIOCH, V74, P2124, DOI 10.1271/bbb.100393; Hu ZL, 2011, BIOL PLANTARUM, V55, P27, DOI 10.1007/s10535-011-0004-z; Jain M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-73; Jakab G, 2005, PLANT PHYSIOL, V139, P267, DOI 10.1104/pp.105.065698; Ji W, 2010, BIOTECHNOL LETT, V32, P1173, DOI 10.1007/s10529-010-0269-x; Jiang HW, 2010, PLANT PHYSIOL, V154, P1646, DOI 10.1104/pp.110.159152; Jiang Y, 2007, J EXP BOT, V58, P3591, DOI 10.1093/jxb/erm207; Kangasjarvi S, 2012, J EXP BOT, V63, P1619, DOI 10.1093/jxb/err402; KISHOR PBK, 1995, PLANT PHYSIOL, V108, P1387, DOI 10.1104/pp.108.4.1387; Kumar S, 2013, J HAZARD MATER, V248, P228, DOI 10.1016/j.jhazmat.2013.01.004; Lan T, 2009, PLANT CELL, V21, P3749, DOI 10.1105/tpc.109.070219; Le Martret B, 2011, PLANT BIOTECHNOL J, V9, P661, DOI 10.1111/j.1467-7652.2011.00611.x; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; Matysik J, 2002, CURR SCI INDIA, V82, P525; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Moons A, 2003, FEBS LETT, V553, P427, DOI 10.1016/S0014-5793(03)01077-9; OREGAN BP, 1993, S AFR J BOT, V59, P98, DOI 10.1016/S0254-6299(16)30780-3; Roxas VP, 2000, PLANT CELL PHYSIOL, V41, P1229, DOI 10.1093/pcp/pcd051; Saijo Y, 2000, PLANT J, V23, P319, DOI 10.1046/j.1365-313x.2000.00787.x; Sytykiewicz H, 2011, INT J MOL SCI, V12, P7982, DOI 10.3390/ijms12117982; Takesawa T, 2002, MOL BREEDING, V9, P93, DOI 10.1023/A:1026718308155; Xu J, 2010, PLANTA, V231, P1251, DOI 10.1007/s00425-010-1122-0; Yang GY, 2014, PLANT CELL TISS ORG, V117, P99, DOI 10.1007/s11240-014-0424-5; Yu T, 2003, J PLANT PHYSIOL, V160, P1305, DOI 10.1078/0176-1617-01205; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	39	65	75	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136960	10.1371/journal.pone.0136960	http://dx.doi.org/10.1371/journal.pone.0136960			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327625	gold, Green Published, Green Submitted			2022-12-26	WOS:000360437700076
J	Zhang, B; Cowden, D; Zhang, F; Yuan, J; Siedlak, S; Abouelsaad, M; Zeng, L; Zhou, XF; O'Toole, J; Das, AS; Kofskey, D; Warren, M; Bian, ZH; Cui, YQ; Tan, T; Kresak, A; Wyza, RE; Petersen, RB; Wang, GX; Kong, QZ; Wang, XL; Sedor, J; Zhu, XW; Zhu, H; Zou, WQ				Zhang, Bo; Cowden, Daniel; Zhang, Fan; Yuan, Jue; Siedlak, Sandra; Abouelsaad, Mai; Zeng, Liang; Zhou, Xuefeng; O'Toole, John; Das, Alvin S.; Kofskey, Diane; Warren, Miriam; Bian, Zehua; Cui, Yuqi; Tan, Tao; Kresak, Adam; Wyza, Robert E.; Petersen, Robert B.; Wang, Gong-Xian; Kong, Qingzhong; Wang, Xinglong; Sedor, John; Zhu, Xiongwei; Zhu, Hua; Zou, Wen-Quan			Prion Protein Protects against Renal Ischemia/Reperfusion Injury	PLOS ONE			English	Article							REGULATED KINASE ACTIVATION; HEME OXYGENASE; NITRIC-OXIDE; CASPASE-3 ACTIVATION; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; ISCHEMIA; BRAIN; KIDNEY; TISSUE	The cellular prion protein (PrPC), a protein most noted for its link to prion diseases, has been found to play a protective role in ischemic brain injury. To investigate the role of PrPC in the kidney, an organ highly prone to ischemia/reperfusion (IR) injury, we examined wildtype (WT) and PrPC knockout (KO) mice that were subjected to 30-min of renal ischemia followed by 1, 2, or 3 days of reperfusion. Renal dysfunction and structural damage was more severe in KO than in WT mice. While PrP was undetectable in KO kidneys, Western blotting revealed an increase in PrP in IR-injuredWT kidneys compared to sham-treated kidneys. Compared to WT, KO kidneys exhibited increases in oxidative stress markers heme oxygenase-1, nitrotyrosine, and Ne-(carboxymethyl) lysine, and decreases in mitochondrial complexes I and III. Notably, phosphorylated extracellular signal-regulated kinase (pERK) staining was predominantly observed in tubular cells from KO mice following 2 days of reperfusion, a time at which significant differences in renal dysfunction, histological changes, oxidative stress, and mitochondrial complexes between WT and KO mice were observed. Our study provides the first evidence that PrPC may play a protective role in renal IR injury, likely through its effects on mitochondria and ERK signaling pathways.	[Zhang, Bo] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Inst Organ Transplantat, Wuhan 430074, Hubei, Peoples R China; [Cowden, Daniel; Zhang, Fan; Yuan, Jue; Siedlak, Sandra; Abouelsaad, Mai; Zeng, Liang; Das, Alvin S.; Kofskey, Diane; Warren, Miriam; Petersen, Robert B.; Kong, Qingzhong; Wang, Xinglong; Zhu, Xiongwei; Zou, Wen-Quan] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Dept Pathol, Cleveland, OH 44106 USA; [Zhang, Bo; Zhou, Xuefeng; Bian, Zehua; Cui, Yuqi; Tan, Tao] Ohio State Univ, Dept Surg, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Zeng, Liang; Wang, Gong-Xian; Zou, Wen-Quan] Nanchang Univ, Affiliated Hosp 1, Dept Urol, Nanchang, Jiangxi, Peoples R China; [Zou, Wen-Quan] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Natl Prion Dis Pathol Surveillance Ctr, Cleveland, OH 44106 USA; [O'Toole, John; Sedor, John] Case Western Reserve Univ, Kidney Dis Res Ctr, Cleveland, OH 44106 USA; [Petersen, Robert B.; Kong, Qingzhong; Zou, Wen-Quan] Case Western Reserve Univ, Dept Neurol, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Kong, Qingzhong; Zou, Wen-Quan] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Natl Ctr Regenerat Med, Cleveland, OH 44106 USA; [O'Toole, John; Sedor, John] Case Western Reserve Univ, Dept Physiol & Med, Cleveland, OH 44106 USA; [O'Toole, John; Sedor, John] Case Western Reserve Univ, Dept Biophys, Cleveland, OH 44106 USA; [Kresak, Adam; Wyza, Robert E.] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Human Tissue Procurement Facil HTPF, Cleveland, OH 44106 USA; [Kresak, Adam; Wyza, Robert E.] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Comprehens Canc Ctr Tissue Resources Core, Cleveland, OH 44106 USA; [Zhang, Bo] Minist Hlth, Key Lab, Wuhan, Hubei, Peoples R China; [Zhang, Bo] Minist Educ, Key Lab, Wuhan, Hubei, Peoples R China; [Petersen, Robert B.] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Dept Neurosci, Cleveland, OH 44106 USA; [Zhang, Fan] Shandong Univ, Dept Neurosurg, Jinan 250100, Peoples R China; [Zou, Wen-Quan] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China	Huazhong University of Science & Technology; Case Western Reserve University; Case Western Reserve University Hospital; University System of Ohio; Ohio State University; Nanchang University; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University Hospital; Shandong University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Zhu, XW (corresponding author), Case Western Reserve Univ, Univ Hosp Case Med Ctr, Dept Pathol, Cleveland, OH 44106 USA.	xiongwei.zhu@case.edu; hua.zhu@osumc.edu; wenquan.zou@case.edu	Zhu, Hua/G-4409-2010; Zhu, Xiongwei/A-9629-2009; Zou, Wenquan/ABF-2875-2020; Zou, Wenquan/GWQ-3489-2022; Cui, Yuqi/U-5914-2017; Das, Alvin S./X-4408-2019	Zhu, Xiongwei/0000-0003-2092-6508; Das, Alvin S./0000-0003-2313-977X; Zhu, Hua/0000-0001-7136-7326	National Institute of Health [NS062787, NS087588]; CJD Foundation; University Hospitals Case Medical Center; American Heart Association [12SDG12070714]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS087588, R01NS062787] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CJD Foundation; University Hospitals Case Medical Center; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by National Institute of Health (http://grants.nih.gov/grants/oer.htm) grants number NS062787 and NS087588 to WQZ. Additional funding to WQZ was obtained from the CJD Foundation (http://www.cjdfoundation.org/) and bridge funding from University Hospitals Case Medical Center (http://www.uhhospitals.org/case). HZ received a Scientist Development Grant number 12SDG12070714 from the American Heart Association (http://my.americanheart.org/fundingopportunities). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Adding Case Medical Center, and case (see above).	Alderliesten M, 2007, AM J PATHOL, V171, P452, DOI 10.2353/ajpath.2007.060805; Aragno M, 2003, KIDNEY INT, V64, P836, DOI 10.1046/j.1523-1755.2003.00152.x; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BENDHEIM PE, 1992, NEUROLOGY, V42, P149, DOI 10.1212/WNL.42.1.149; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; Bounhar Y, 2001, J BIOL CHEM, V276, P39145, DOI 10.1074/jbc.C100443200; BREZIS M, 1995, NEW ENGL J MED, V332, P647, DOI 10.1056/NEJM199503093321006; Brown DR, 1998, J NEUROCHEM, V70, P1686; Brown DR, 1999, BIOCHEM J, V344, P1, DOI 10.1042/0264-6021:3440001; Brown DR, 2000, BIOCHEM J, V345, P767; Brown DR, 2002, J NEUROSCI RES, V67, P211, DOI 10.1002/jnr.10118; Tabara LC, 2014, EXPERT REV MOL MED, V16, DOI 10.1017/erm.2014.14; Chatterjee PK, 1999, EXP NEPHROL, V7, P438; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Chiao H, 1997, J CLIN INVEST, V99, P1165, DOI 10.1172/JCI119272; Cruthirds DL, 2003, ARCH BIOCHEM BIOPHYS, V412, P27, DOI 10.1016/S0003-9861(03)00039-0; Deng JP, 2001, KIDNEY INT, V60, P2118, DOI 10.1046/j.1523-1755.2001.00043.x; Goligorsky MS, 2002, KIDNEY INT, V61, P855, DOI 10.1046/j.1523-1755.2002.00233.x; Graner E, 2000, FEBS LETT, V482, P257, DOI 10.1016/S0014-5793(00)02070-6; Heemann U, 2000, AM J PATHOL, V156, P287, DOI 10.1016/S0002-9440(10)64729-3; Jang HS, 2013, BBA-MOL BASIS DIS, V1832, P1998, DOI 10.1016/j.bbadis.2013.07.001; Kaizu T, 2003, KIDNEY INT, V63, P1393, DOI 10.1046/j.1523-1755.2003.00882.x; Khader A, 2014, TRANSPLANTATION, V98, P148, DOI 10.1097/TP.0000000000000194; Kirkinezos IG, 2001, SEMIN CELL DEV BIOL, V12, P449, DOI 10.1006/scdb.2001.0282; KRETZSCHMAR HA, 1986, DNA-J MOLEC CELL BIO, V5, P315, DOI 10.1089/dna.1986.5.315; Lee KS, 2001, J NEUROCHEM, V79, P79, DOI 10.1046/j.1471-4159.2001.00529.x; Li JH, 2011, NEPHROL DIAL TRANSPL, V26, P469, DOI 10.1093/ndt/gfq466; Lo RKH, 2003, J BIOL CHEM, V278, P52154, DOI 10.1074/jbc.M307299200; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; Martins VR, 1997, NAT MED, V3, P1376, DOI 10.1038/nm1297-1376; McLennan NF, 2004, AM J PATHOL, V165, P227, DOI 10.1016/S0002-9440(10)63291-9; Miquel J, 1998, EXP GERONTOL, V33, P113, DOI 10.1016/S0531-5565(97)00060-0; Mitsios N, 2007, J NEUROSCI RES, V85, P602, DOI 10.1002/jnr.21142; Montie HL, 2005, BBA-MOL BASIS DIS, V1741, P314, DOI 10.1016/j.bbadis.2005.04.007; Morimoto K, 2001, KIDNEY INT, V60, P1858, DOI 10.1046/j.1523-1755.2001.01000.x; MOSER M, 1995, NEURON, V14, P509, DOI 10.1016/0896-6273(95)90307-0; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Nath KA, 2006, KIDNEY INT, V70, P432, DOI 10.1038/sj.ki.5001565; NATH KA, 1992, J CLIN INVEST, V90, P267, DOI 10.1172/JCI115847; Negro A, 2001, MOL CELL NEUROSCI, V17, P521, DOI 10.1006/mcne.2000.0953; Noiri E, 2001, AM J PHYSIOL-RENAL, V281, pF948, DOI 10.1152/ajprenal.0071.2001; Nowak G, 2002, J BIOL CHEM, V277, P43377, DOI 10.1074/jbc.M206373200; Pat B, 2005, KIDNEY INT, V67, P931, DOI 10.1111/j.1523-1755.2005.00157.x; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rahman NA, 2009, TRANSPL P, V41, P3603, DOI 10.1016/j.transproceed.2009.04.008; REDDY S, 1995, BIOCHEMISTRY-US, V34, P10872, DOI 10.1021/bi00034a021; Requena JR, 1997, J BIOL CHEM, V272, P17473, DOI 10.1074/jbc.272.28.17473; Ruan YL, 2014, KIDNEY INT, V86, P525, DOI 10.1038/ki.2014.80; Sawe N, 2008, J NEUROSCI RES, V86, P1659, DOI 10.1002/jnr.21604; Schneider B, 2003, P NATL ACAD SCI USA, V100, P13326, DOI 10.1073/pnas.2235648100; Schrier RW, 2004, J CLIN INVEST, V114, P5, DOI 10.1172/JC1200422353; Shyu WC, 2005, J NEUROSCI, V25, P8967, DOI 10.1523/JNEUROSCI.1115-05.2005; Spudich A, 2005, NEUROBIOL DIS, V20, P442, DOI 10.1016/j.nbd.2005.04.002; Starkov AA, 2003, J NEUROCHEM, V86, P1101, DOI 10.1046/j.1471-4159.2003.01908.x; Steele AD, 2009, PRION, V3, P240, DOI 10.4161/pri.3.4.10135; Sumudhu W, 2001, CURR BIOL, V11, P519, DOI 10.1016/S0960-9822(01)00147-6; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Wei QQ, 2012, AM J PHYSIOL-RENAL, V303, pF1487, DOI 10.1152/ajprenal.00352.2012; Weise J, 2006, STROKE, V37, P1296, DOI 10.1161/01.STR.0000217262.03192.d4; Weise J, 2004, NEUROSCI LETT, V372, P146, DOI 10.1016/j.neulet.2004.09.030; Xiao Xiangzhu, 2014, J Clin Cell Immunol, V5; Xiao XZ, 2009, AM J PATHOL, V174, P1602, DOI 10.2353/ajpath.2009.081045; Yang Y, 2014, NEUROSCI LETT, V568, P44, DOI 10.1016/j.neulet.2014.03.037; Zager RA, 2012, J AM SOC NEPHROL, V23, P1048, DOI 10.1681/ASN.2011121147; Zanetti F, 2014, CARDIOVASC RES, V104, P93, DOI 10.1093/cvr/cvu194; Zhuang SG, 2008, J PHARMACOL EXP THER, V325, P732, DOI 10.1124/jpet.108.136358; Zhuang SG, 2007, AM J PHYSIOL-RENAL, V292, pF440, DOI 10.1152/ajprenal.00170.2006; Zhuang SG, 2006, J PHARMACOL EXP THER, V319, P991, DOI 10.1124/jpet.106.107367	68	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136923	10.1371/journal.pone.0136923	http://dx.doi.org/10.1371/journal.pone.0136923			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327228	Green Published, Green Submitted, gold			2022-12-26	WOS:000360437700072
J	Sadoul, B; Martin, O; Prunet, P; Friggens, NC				Sadoul, Bastien; Martin, Olivier; Prunet, Patrick; Friggens, Nicolas C.			On the Use of a Simple Physical System Analogy to Study Robustness Features in Animal Sciences	PLOS ONE			English	Article							PLASMA-CORTISOL RESPONSE; RAINBOW-TROUT; CLIMATE-CHANGE; STRESS; REPRODUCTION; CONFINEMENT; ALLOSTASIS; BIOLOGY; COSTS; WATER	Environmental perturbations can affect the health, welfare, and fitness of animals. Being able to characterize and phenotype adaptive capacity is therefore of growing scientific concern in animal ecology and in animal production sciences. Terms borrowed from physics are commonly used to describe adaptive responses of animals facing an environmental perturbation, but no quantitative characterization of these responses has been made. Modeling the dynamic responses to an acute challenge was used in this study to facilitate the characterization of adaptive capacity and therefore robustness. A simple model based on a spring and damper was developed to simulate the dynamic responses of animals facing an acute challenge. The parameters characterizing the spring and the damper can be interpreted in terms of stiffness and resistance to the change of the system. The model was tested on physiological and behavioral responses of rainbow trout facing an acute confinement challenge. The model has proven to properly fit the different responses measured in this study and to quantitatively describe the different temporal patterns for each statistical individual in the study. It provides therefore a new way to explicitly describe, analyze and compare responses of individuals facing an acute perturbation. This study suggests that such physical models may be usefully applied to characterize robustness in many other biological systems.	[Sadoul, Bastien; Prunet, Patrick] INRA, LPGP Fish Physiol & Genom, UR1037, F-35042 Rennes, France; [Martin, Olivier; Friggens, Nicolas C.] INRA, Modelisat Syst Appl Ruminants, UMR0791, Paris, France; [Martin, Olivier; Friggens, Nicolas C.] AgroParisTech, Modelisat Syst Appl Ruminants, UMR0791, Paris, France	INRAE; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Sadoul, B (corresponding author), INRA, LPGP Fish Physiol & Genom, UR1037, F-35042 Rennes, France.	bastiensadoul@hotmail.fr	Martin, Olivier/F-3775-2011	Martin, Olivier/0000-0001-7375-2850; Sadoul, Bastien/0000-0001-5968-3983	Institut National de la Recherche Agronomique; Region Bretagne [30000675]	Institut National de la Recherche Agronomique; Region Bretagne(Region Bretagne)	This work was supported by funds from the Institut National de la Recherche Agronomique. The first author received a fellowship from the Region Bretagne with grant number 30000675. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auperin B, 1997, GEN COMP ENDOCR, V108, P35, DOI 10.1006/gcen.1997.6938; Codrea MC, 2011, J ANIM SCI, V89, P3089, DOI 10.2527/jas.2010-3753; de Goede DM, 2013, NJAS-WAGEN J LIFE SC, V64-65, P1, DOI 10.1016/j.njas.2012.03.001; Desnoyers M, 2009, J DAIRY SCI, V92, P3894, DOI 10.3168/jds.2008-1784; Ellis T, 2004, J FISH BIOL, V65, P1233, DOI 10.1111/j.0022-1112.2004.00499.x; Fertuck KC, 2003, PHYSIOL GENOMICS, V15, P127, DOI 10.1152/physiolgenomics.00058.2003; Friggens NC, 2012, 2012 JOINT ANN M PHO, P671; Hojsgaard S, 2010, J DAIRY SCI, V93, P582, DOI 10.3168/jds.2009-2445; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Knap PW, 2005, AUST J EXP AGR, V45, P763, DOI 10.1071/EA05041; Korte SM, 2007, PHYSIOL BEHAV, V92, P422, DOI 10.1016/j.physbeh.2006.10.018; Korte SM, 2005, NEUROSCI BIOBEHAV R, V29, P3, DOI 10.1016/j.neubiorev.2004.08.009; Lesne A, 2008, BIOL REV, V83, P509, DOI 10.1111/j.1469-185X.2008.00052.x; Marques S. P. C., 2012, COMPUTATIONAL VISCOE; Marshall JAR, 2015, CURR ZOOL, V61, P242, DOI 10.1093/czoolo/61.2.242; Mellor DJ, 2000, BIOLOGY OF ANIMAL STRESS, P171, DOI 10.1079/9780851993591.0171; Nikooyan AA, 2011, P I MECH ENG H, V225, P1121, DOI 10.1177/0954411911424210; Pankhurst NW, 2011, MAR FRESHWATER RES, V62, P1015, DOI 10.1071/MF10269; Pottinger TG, 1999, GEN COMP ENDOCR, V116, P122, DOI 10.1006/gcen.1999.7355; Quillet E, 2014, ANIM GENET, V45, P223, DOI 10.1111/age.12126; Sadoul B, 2014, MULTIVARIATE ANAL US; Sauvant D, 2010, PROD ANIM, V23, P5; Schuring E, 2012, APPETITE, V59, P601, DOI 10.1016/j.appet.2012.07.003; Strandberg E., 2009, Breeding for robustness in cattle, P17; Takase M, 2014, FISH PHYSIOL BIOCHEM, V40, P385, DOI 10.1007/s10695-013-9851-1; Tedeschi LO, 2006, AGR SYST, V89, P225, DOI 10.1016/j.agsy.2005.11.004; TENNAPEL J, 2006, UTILISING INTRINSIC; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Walker JJ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001341; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325; Wilson GS, 2005, BIOSENS BIOELECTRON, V20, P2388, DOI 10.1016/j.bios.2004.12.003; Wingfield JC, 2013, ANIM BEHAV, V85, P1127, DOI 10.1016/j.anbehav.2013.02.018; Zeeman M L, 2003, Reprod Biomed Online, V7, P295	35	8	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0137333	10.1371/journal.pone.0137333	http://dx.doi.org/10.1371/journal.pone.0137333			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322508	Green Published, gold			2022-12-26	WOS:000360435500071
J	Struchiner, CJ; Rocklov, J; Wilder-Smith, A; Massad, E				Struchiner, Claudio Jose; Rockloev, Joacim; Wilder-Smith, Annelies; Massad, Eduardo			Increasing Dengue Incidence in Singapore over the Past 40 Years: Population Growth, Climate and Mobility	PLOS ONE			English	Article							AEDES-AEGYPTI; VIRUS; URBANIZATION; EPIDEMIOLOGY; SURVEILLANCE; TEMPERATURE; INFECTION; EMERGENCE; IMPACT	In Singapore, the frequency and magnitude of dengue epidemics have increased significantly over the past 40 years. It is important to understand the main drivers for the rapid increase in dengue incidence. We studied the relative contributions of putative drivers for the rise of dengue in Singapore: population growth, climate parameters and international air passenger arrivals from dengue endemic countries, for the time period of 1974 until 2011. We used multivariable Poisson regression models with the following predictors: Annual Population Size; Aedes Premises Index; Mean Annual Temperature; Minimum and Maximum Temperature Recorded in each year; Annual Precipitation and Annual Number of Air Passengers arriving from dengue-endemic South-East Asia to Singapore. The relative risk (RR) of the increase in dengue incidence due to population growth over the study period was 42.7, while the climate variables (mean and minimum temperature) together explained an RR of 7.1 (RR defined as risk at the end of the time period relative to the beginning and goodness of fit associated with the model leading to these estimates assessed by pseudo-R2 equal to 0.83). Estimating the extent of the contribution of these individual factors on the increasing dengue incidence, we found that population growth contributed to 86% while the residual 14% was explained by increase in temperature. We found no correlation with incoming air passenger arrivals into Singapore from dengue endemic countries. Our findings have significant implications for predicting future trends of the dengue epidemics given the rapid urbanization with population growth in many dengue endemic countries. It is time for policy-makers and the scientific community alike to pay more attention to the negative impact of urbanization and urban climate on diseases such as dengue.	[Struchiner, Claudio Jose] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil; [Struchiner, Claudio Jose] Univ Estado Rio De Janeiro, Inst Social Med, Rio De Janeiro, Brazil; [Rockloev, Joacim; Wilder-Smith, Annelies] Umea Univ, Dept Publ Hlth & Clin Med, Epidemiol & Global Hlth Unit, Umea, Sweden; [Wilder-Smith, Annelies] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore; [Massad, Eduardo] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil; [Massad, Eduardo] LIM01 HCFMUSP, Sao Paulo, Brazil; [Massad, Eduardo] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	Fundacao Oswaldo Cruz; Universidade do Estado do Rio de Janeiro; Umea University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Universidade de Sao Paulo; Universidade de Sao Paulo; University of London; London School of Hygiene & Tropical Medicine	Wilder-Smith, A (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Epidemiol & Global Hlth Unit, Umea, Sweden.	anneliesws@gmail.com	Massad, Eduardo/B-1169-2012; Wilder-Smith, Annelies/F-8751-2015; Struchiner, Claudio J/M-9360-2013; Struchiner, Claudio Jose/HGB-9492-2022	Massad, Eduardo/0000-0002-7200-2916; Struchiner, Claudio J/0000-0003-2114-847X; Rocklov, Joacim/0000-0003-4030-0449	European Commission [282589]; Brazilian Research Council (CNPq); State of Rio de Janeiro Research Funding Agency (FAPERJ)	European Commission(European CommissionEuropean Commission Joint Research Centre); Brazilian Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); State of Rio de Janeiro Research Funding Agency (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	The research was funded by the European Commission under the 7th Framework, Grant Agreement Number: 282589. CJS was partially funded by The Brazilian Research Council (CNPq) and the State of Rio de Janeiro Research Funding Agency (FAPERJ).	Bennett SN, 2006, J GEN VIROL, V87, P885, DOI 10.1099/vir.0.81309-0; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Coker RJ, 2011, LANCET, V377, P599, DOI 10.1016/S0140-6736(10)62004-1; Descloux E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001470; Earnest A, 2012, EPIDEMIOL INFECT, V140, P1244, DOI 10.1017/S095026881100183X; Egger JR, 2008, B WORLD HEALTH ORGAN, V86, P187, DOI 10.2471/BLT.07.040170; Fahrmeir L., 2013, REGRESSION, DOI DOI 10.1007/978-3-642-34333-9; Fokianos K, 2009, J AM STAT ASSOC, V104, P1430, DOI 10.1198/jasa.2009.tm08270; GUBLER DJ, 1978, AM J TROP MED HYG, V27, P581, DOI 10.4269/ajtmh.1978.27.581; Gubler DJ, 2001, ENVIRON HEALTH PERSP, V109, P223, DOI 10.2307/3435012; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326; Harrell FE, 2001, REGRESSION MODELING; Hii YL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001908; Ibarra AMS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078263; Jaenisch T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002320; Jones P., 2008, CRU TIME SERIES TS H; Kedem KF, 2002, REGRESSION MODELS TI; Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108; Lee KS, 2012, INFECT GENET EVOL, V12, P77, DOI 10.1016/j.meegid.2011.10.012; Lee KS, 2010, EMERG INFECT DIS, V16, P847, DOI 10.3201/eid1605.091006; Li YJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003301; Liu-Helmersson J, 2014, PLOS ONE PRINT; Messer WB, 2003, EMERG INFECT DIS, V9, P800; Messer William B., 2002, American Journal of Tropical Medicine and Hygiene, V66, P765; Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Oki M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048258; Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/eid1206.051210; RCore Team, 2020, R LANG ENV STAT COMP; Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853; Reiter P, 1996, B SOC PATHOL EXOT, V89, P120; Rigau-Perez Jose G., 2001, American Journal of Tropical Medicine and Hygiene, V64, P67; Schreiber MJ, 2009, J VIROL, V83, P4163, DOI 10.1128/JVI.02445-08; SCOTT TW, 1993, J MED ENTOMOL, V30, P94, DOI 10.1093/jmedent/30.1.94; Steel A, 2010, VIROLOGY, V405, P505, DOI 10.1016/j.virol.2010.05.033; Stoddard ST, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003003; Wilcox Bruce A., 2005, Environmental Health and Preventive Medicine, V10, P263, DOI 10.1007/BF02897701; Wilder-Smith A, 2012, GLOBAL HLTH ACTION, V5; Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002; Yew YW, 2009, ANN ACAD MED SINGAP, V38, P667	42	81	83	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136286	10.1371/journal.pone.0136286	http://dx.doi.org/10.1371/journal.pone.0136286			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322517	Green Published, Green Accepted, gold			2022-12-26	WOS:000360435500017
J	Cortes, LA; Castro, L; Pesce, B; Maya, JD; Ferreira, J; Castro-Castillo, V; Parra, E; Jara, JA; Lopez-Munoz, R				Cortes, Leonel A.; Castro, Lorena; Pesce, Barbara; Maya, Juan D.; Ferreira, Jorge; Castro-Castillo, Vicente; Parra, Eduardo; Jara, Jose A.; Lopez-Munoz, Rodrigo			Novel Gallate Triphenylphosphonium Derivatives with Potent Antichagasic Activity	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI; IN-VITRO; GALLIC ACID; MITOCHONDRIAL BIOENERGETICS; OXIDATIVE STRESS; CHAGAS-DISEASE; CELL-DEATH; VIVO; ANTIOXIDANTS; BENZNIDAZOLE	Chagas disease is one of the most neglected tropical diseases in the world, affecting nearly 15 million people, primarily in Latin America. Only two drugs are used for the treatment of this disease, nifurtimox and benznidazole. These drugs have limited efficacy and frequently induce adverse effects, limiting their usefulness. Consequently, new drugs must be found. In this study, we demonstrated the in vitro trypanocidal effects of a series of four gallic acid derivatives characterized by a gallate group linked to a triphenylphosphonium (TPP+) moiety (a delocalized cation) via a hydrocarbon chain of 8, 10, 11, or 12 atoms (TPP+-C-8, TPP+C10, TPP+-C-11, and TPP+-C-12, respectively). We analyzed parasite viability in isolated parasites (by MTT reduction and flow cytometry) and infected mammalian cells using T. cruzi Y strain trypomastigotes. Among the four derivatives, TPP+-C-10 and TPP+-C-12 were the most potent in both models, with EC50 values (in isolated parasites) of 1.0 +/- 0.6 and 1.0 +/- 0.7 mu M, respectively, and were significantly more potent than nifurtimox (EC50 = 4.1 +/- 0.6 mu M). At 1 mu M, TPP+-C-10 and TPP+-C-12 induced markers of cell death, such as phosphatidylserine exposure and propidium iodide permeabilization. In addition, at 1 mu M, TPP+-C-10 and TPP+-C-12 significantly decreased the number of intracellular amastigotes (TPP+-C-10: 24.3%, TPP+-C-12: 19.0% of control measurements, as measured by DAPI staining) and the parasite's DNA load (C-10: 10%, C-12: 13% of control measurements, as measured by qPCR). Based on the previous mode of action described for these compounds in cancer cells, we explored their mitochondrial effects in isolated trypomastigotes. TPP+-C-10 and TPP+-C-12 were the most potent compounds, significantly altering mitochondrial membrane potential at 1 mu M (measured by JC-1 fluorescence) and inducing mitochondrial transition pore opening at 5 mu M. Taken together, these results indicate that the TPP+-C-10 and TPP+-C-12 derivatives of gallic acid are promising trypanocidal agents with mitochondrial activity.	[Cortes, Leonel A.; Castro, Lorena; Pesce, Barbara; Maya, Juan D.; Ferreira, Jorge] Univ Chile, Fac Med, ICBM, Programa Farmacol Mol & Clin, Santiago 7, Chile; [Castro-Castillo, Vicente] Univ Metropolitana Ciencias Educ, Fac Ciencias Basicas, Dept Quim, Santiago, Chile; [Parra, Eduardo] Univ Tarapac, Lab Expt Biomed, Iquique, Chile; [Jara, Jose A.] Univ Chile, Fac Odontol, ICOD, Unidad Farmacol & Farmacogenet, Santiago, Chile; [Lopez-Munoz, Rodrigo] Univ Austral Chile, Inst Farmacol & Morfofisiol, Fac Ciencias Vet, Valdivia, Chile	Universidad de Chile; Universidad Metropolitana de Ciencias de la Educacion (UMCE); Universidad de Chile; Universidad Austral de Chile	Jara, JA (corresponding author), Univ Chile, Fac Odontol, ICOD, Unidad Farmacol & Farmacogenet, Santiago, Chile.	jsandovalj@u.uchile.cl; lopez@uach.cl	maya, Juan Diego/GNW-3307-2022; Lopez-Muñoz, Rodrigo/I-1097-2013; Castro, Vicente/I-8444-2017; Jara, Jose/GQB-5331-2022; Maya, Juan D/H-9561-2013; Jara, Jose/K-1936-2014	Lopez-Muñoz, Rodrigo/0000-0003-1825-8563; Castro, Vicente/0000-0002-7165-8569; Maya, Juan D/0000-0003-3934-6319; 	Consejo Nacional de Ciencia y Tecnologia (CONICYT-Chile) [FONDECYT 11110182, FONDECYT 1130772, FONDECYT 1130189]; Academy Insertion Grant [791220004]; Vicerrectoria de Investigacion y Desarrollo, Universidad de Chile [U-INICIA 11/07, U-INICIA 2014]	Consejo Nacional de Ciencia y Tecnologia (CONICYT-Chile)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Academy Insertion Grant; Vicerrectoria de Investigacion y Desarrollo, Universidad de Chile	This work was supported by the following grants from the Consejo Nacional de Ciencia y Tecnologia (CONICYT-Chile: http://www.conicyt.cl): FONDECYT 11110182 (RLM), FONDECYT 1130772 (JF), FONDECYT 1130189 (JDM), and the Academy Insertion Grant 791220004 (JAJ). The following grants were obtained from the Vicerrectoria de Investigacion y Desarrollo, Universidad de Chile (http://www.uchile.cl/investigacion): U-INICIA 11/07 (RLM) and U-INICIA 2014 (JAJ). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFFRANCHINO JL, 1986, COMP BIOCHEM PHYS B, V85, P381, DOI 10.1016/0305-0491(86)90016-7; Aufderheide AC, 2004, P NATL ACAD SCI USA, V101, P2034, DOI 10.1073/pnas.0307312101; Bern C, 2011, NEW ENGL J MED, V364, P2527, DOI 10.1056/NEJMct1014204; Boiani M, 2010, BIOCHEM PHARMACOL, V79, P1736, DOI 10.1016/j.bcp.2010.02.009; Carranza JC, 2009, J BIOENERG BIOMEMBR, V41, P299, DOI 10.1007/s10863-009-9228-4; Chagas C., 1909, Memorias do Instituto Oswaldo Cruz, V1; Cossarizza A., 2001, CURR PROTOC CYTOM, DOI [10.1002/0471142956.cy0914s13, DOI 10.1002/0471142956.CY0914S13]; DENICOLASEOANE A, 1992, MOL BIOCHEM PARASIT, V54, P43, DOI 10.1016/0166-6851(92)90093-Y; Desoti VC, 2012, MAR DRUGS, V10, P1631, DOI 10.3390/md10081631; Diaz MV, 2014, ACTA TROP, V134, P1, DOI 10.1016/j.actatropica.2014.02.012; Fang J, 2003, ARCH BIOCHEM BIOPHYS, V414, P294, DOI 10.1016/S0003-9861(03)00196-6; Faundez M, 2005, ANTIMICROB AGENTS CH, V49, P126, DOI 10.1128/AAC.49.1.126-130.2005; Finichiu PG, 2013, J BIOENERG BIOMEMBR, V45, P165, DOI 10.1007/s10863-012-9493-5; GADELHA FR, 1989, MOL BIOCHEM PARASIT, V34, P117, DOI 10.1016/0166-6851(89)90003-0; Gottlieb E, 2003, CELL DEATH DIFFER, V10, P709, DOI 10.1038/sj.cdd.4401231; Gourley PL, 2005, TECHNOL CANCER RES T, V4, P585, DOI 10.1177/153303460500400602; Guida MC, 2007, EXP PARASITOL, V117, P188, DOI 10.1016/j.exppara.2007.04.015; Hotez PJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001498; Huang LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108286; Ibrahim HMS, 2011, J ANTIMICROB CHEMOTH, V66, P111, DOI 10.1093/jac/dkq401; Inacio JDF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003093; Jara JA, 2014, J MED CHEM, V57, P2440, DOI 10.1021/jm500174v; Jauslin ML, 2003, FASEB J, V17, P1972, DOI 10.1096/fj.03-0240fje; Jimenez V, 2014, PHYTOMEDICINE, V21, P1411, DOI 10.1016/j.phymed.2014.06.005; Jones SM, 2004, BIOORGAN MED CHEM, V12, P683, DOI 10.1016/j.bmc.2003.11.023; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Koide T, 1998, PLANTA MED, V64, P27, DOI 10.1055/s-2006-957360; LETELIER ME, 1990, EXP PARASITOL, V71, P357, DOI 10.1016/0014-4894(90)90061-G; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Barreiro SL, 2013, J AGR FOOD CHEM, V61, P6533, DOI 10.1021/jf400981x; Menna-Barreto RFS, 2007, PARASITOL RES, V101, P895, DOI 10.1007/s00436-007-0556-1; Menna-Barreto RFS, 2009, FREE RADICAL BIO MED, V47, P644, DOI 10.1016/j.freeradbiomed.2009.06.004; Menna-Barreto RFS, 2009, MICRON, V40, P157, DOI 10.1016/j.micron.2008.08.003; Molina-Berrios A, 2013, ACTA TROP, V127, P6, DOI 10.1016/j.actatropica.2013.03.006; Fidalgo LM, 2011, PHARM RES-DORDR, V28, P2758, DOI 10.1007/s11095-011-0586-3; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murphy MP, 2007, ANNU REV PHARMACOL, V47, P629, DOI 10.1146/annurev.pharmtox.47.120505.105110; Nose M, 1998, BIOL PHARM BULL, V21, P583, DOI 10.1248/bpb.21.583; Olszewska A, 2013, IUBMB LIFE, V65, P273, DOI 10.1002/iub.1147; Paes LS, 2011, CURR PHARM DESIGN, V17, P2074, DOI 10.2174/138161211796904786; Luque-Ortega JR, 2010, J MED CHEM, V53, P1788, DOI 10.1021/jm901677h; Ross MF, 2005, BIOCHEMISTRY-MOSCOW+, V70, P222, DOI 10.1007/s10541-005-0104-5; Menna-Barreto RFS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/614014; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; SHAPIRO TA, 1995, ANNU REV MICROBIOL, V49, P117, DOI 10.1146/annurev.mi.49.100195.001001; SHAPIRO TA, 1989, J BIOL CHEM, V264, P4173; Silva TM, 2011, J BIOENERG BIOMEMBR, V43, P409, DOI 10.1007/s10863-011-9369-0; Smirlis D, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-107; Smith RAJ, 2011, ANTIOXID REDOX SIGN, V15, P3021, DOI 10.1089/ars.2011.3969; Taladriz A, 2012, J MED CHEM, V55, P2606, DOI 10.1021/jm2014259; Veiga-Santos P, 2010, PARASITOLOGY, V137, P1661, DOI 10.1017/S003118201000034X; VERCESI AE, 1991, J BIOL CHEM, V266, P14431; WHO strategic and technical advisory group for tuberculosis (STAG-TB), 2010, WHO STRAT TECHN ADV, P9; WHO TDR, 2012, RES PRIOR CHAG DIS H, P975	54	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136852	10.1371/journal.pone.0136852	http://dx.doi.org/10.1371/journal.pone.0136852			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317199	gold, Green Submitted, Green Published			2022-12-26	WOS:000360299100154
J	Dunn, TW; Sossin, WS				Dunn, Tyler William; Sossin, Wayne S.			Decline in the Recovery from Synaptic Depression in Heavier Aplysia Results from Decreased Serotonin-Induced Novel PKC Activation	PLOS ONE			English	Article							C APL-II; GILL-WITHDRAWAL REFLEX; PROTEIN-KINASE CS; ISOFORM SPECIFICITY; TRANSMITTER RELEASE; BEHAVIORAL-CHANGES; SENSORY NEURONS; FACILITATION; DISHABITUATION; TRANSLOCATION	The defensive withdrawal reflexes of Aplysia are important behaviors for protecting the animal from predation. Habituation and dishabituation allow for experience-dependent tuning of these reflexes and the mechanisms underlying these forms of behavioral plasticity involve changes in transmitter release from the sensory to motor neuron synapses through homosynaptic depression and the serotonin-mediated recovery from depression, respectively. Interestingly, dishabituation is reduced in older animals with no corresponding change in habituation. Here we show that the cultured sensory neurons of heavier animals (greater than 120g) that form synaptic connections with motor neurons have both reduced recovery from depression and reduced novel PKC Apl II activation with 5HT. The decrease in the recovery from depression correlated better with the size of the animal than the age of the animal. Much of this change in PKC activation and synaptic facilitation following depression can be rescued by direct activation of PKC Apl II with phorbol dibutyrate, suggesting a change in the signal transduction pathway upstream of PKC Apl II activation in the sensory neurons of larger animals.	[Dunn, Tyler William; Sossin, Wayne S.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada	McGill University	Sossin, WS (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada.	wayne.sossin@mcgill.ca			Natural Science and Engineering Research Council of Canada [171404]	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding provided by Natural Science and Engineering Research Council of Canada grant 171404 to WSS, http://www.nserc-crsng.gc.ca/index_eng.asp. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmedov K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084793; Antonov I, 1999, J NEUROSCI, V19, P10438; Antonov I, 2010, J NEUROSCI, V30, P5781, DOI 10.1523/JNEUROSCI.4947-09.2010; Armitage BA, 1998, J NEUROSCI, V18, P8770; BAILEY CH, 1983, BEHAV NEURAL BIOL, V38, P70, DOI 10.1016/S0163-1047(83)90399-0; CASTELLUCCI V, 1970, SCIENCE, V167, P1745, DOI 10.1126/science.167.3926.1745; CASTELLUCCI VF, 1974, P NATL ACAD SCI USA, V71, P5004, DOI 10.1073/pnas.71.12.5004; Chitwood RA, 2001, J PHYSIOL-LONDON, V534, P501, DOI 10.1111/j.1469-7793.2001.00501.x; Dumitriu B, 2006, J NEUROPHYSIOL, V95, P2713, DOI 10.1152/jn.00642.2005; Dunn TW, 2013, J NEUROPHYSIOL, V110, P2071, DOI 10.1152/jn.00217.2013; Dunn TW, 2012, J NEUROPHYSIOL, V107, P292, DOI 10.1152/jn.00767.2011; Farah CA, 2008, MOL CELL BIOL, V28, P4719, DOI 10.1128/MCB.00178-08; Farah CA, 2011, JOVE-J VIS EXP, DOI 10.3791/2516; Farah CA, 2009, J NEUROSCI, V29, P10281, DOI 10.1523/JNEUROSCI.1533-09.2009; Gerdes R, 2006, J AM ASSOC LAB ANIM, V45, P40; GHIRARDI M, 1992, NEURON, V9, P479, DOI 10.1016/0896-6273(92)90185-G; Johnson PM, 1999, MAR FRESHW BEHAV PHY, V32, P147, DOI 10.1080/10236249909379045; Kadakkuzha BM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-880; Kempsell AT, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00084; KRIEGSTEIN AR, 1977, J EXP ZOOL, V199, P275, DOI 10.1002/jez.1401990212; Lee YS, 2009, P NATL ACAD SCI USA, V106, P14634, DOI 10.1073/pnas.0907502106; Manseau F, 2001, J NEUROSCI, V21, P1247; Nagakura I, 2010, J NEUROCHEM, V115, P994, DOI 10.1111/j.1471-4159.2010.06986.x; PENNINGS SC, 1990, MAR ECOL PROG SER, V62, P95, DOI 10.3354/meps062095; Pepio AM, 2001, J BIOL CHEM, V276, P3846, DOI 10.1074/jbc.M006339200; PERETZ B, 1982, J NEUROBIOL, V13, P141, DOI 10.1002/neu.480130206; RANKIN CH, 1988, J NEUROSCI, V8, P197; RATTAN KS, 1981, J NEUROBIOL, V12, P469, DOI 10.1002/neu.480120506; RAYPORT SG, 1986, NEUROSCIENCE, V17, P283, DOI 10.1016/0306-4522(86)90247-2; Sossin WS, 2007, LEARN MEMORY, V14, P236, DOI 10.1101/lm.469707; Stommes D, 2005, CONTEMP TOP LAB ANIM, V44, P31; WINKLER LINDSAY R., 1962, PACIFIC SCI, V16, P286; Zhao YL, 2006, J NEUROSCI, V26, P8847, DOI 10.1523/JNEUROSCI.1919-06.2006; Zhao YL, 2002, J NEUROSCI, V22, P10671	34	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136907	10.1371/journal.pone.0136907	http://dx.doi.org/10.1371/journal.pone.0136907			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317974	gold, Green Published, Green Submitted			2022-12-26	WOS:000360299100169
J	Fatykhova, D; Rabes, A; Machnik, C; Guruprasad, K; Pache, F; Berg, J; Toennies, M; Bauer, TT; Schneider, P; Schimek, M; Eggeling, S; Mitchell, TJ; Mitchell, AM; Hilker, R; Hain, T; Suttorp, N; Hippenstiel, S; Hocke, AC; Opitz, B				Fatykhova, Diana; Rabes, Anne; Machnik, Christoph; Guruprasad, Kunchur; Pache, Florence; Berg, Johanna; Toennies, Mario; Bauer, Torsten T.; Schneider, Paul; Schimek, Maria; Eggeling, Stephan; Mitchell, Timothy J.; Mitchell, Andrea M.; Hilker, Rolf; Hain, Torsten; Suttorp, Norbert; Hippenstiel, Stefan; Hocke, Andreas C.; Opitz, Bastian			Serotype 1 and 8 Pneumococci Evade Sensing by Inflammasomes in Human Lung Tissue	PLOS ONE			English	Article							PNEUMONIAE VIRULENCE FACTORS; STREPTOCOCCUS-PNEUMONIAE; NLRP3 INFLAMMASOME; PORE FORMATION; HOST-DEFENSE; PNEUMOLYSIN; MICE; COLONIZATION; PATHOGENESIS; CONTRIBUTES	Streptococcus pneumoniae is a major cause of pneumonia, sepsis and meningitis. The pore-forming toxin pneumolysin is a key virulence factor of S. pneumoniae, which can be sensed by the NLRP3 inflammasome. Among the over 90 serotypes, serotype 1 pneumococci (particularly MLST306) have emerged across the globe as a major cause of invasive disease. The cause for its particularity is, however, incompletely understood. We therefore examined pneumococcal infection in human cells and a human lung organ culture system mimicking infection of the lower respiratory tract. We demonstrate that different pneumococcal serotypes differentially activate inflammasome-dependent IL-1 beta production in human lung tissue and cells. Whereas serotype 2, 3, 6B, 9N pneumococci expressing fully haemolytic pneumolysins activate NLRP3 inflammasome-dependent responses, serotype 1 and 8 strains expressing non-haemolytic toxins are poor activators of IL-1 beta production. Accordingly, purified haemolytic pneumolysin but not serotype 1-associated non-haemolytic toxin activates strong IL-1 beta production in human lungs. Our data suggest that the evasion of inflammasome-dependent innate immune responses by serotype 1 pneumococci might contribute to their ability to cause invasive diseases in humans.	[Fatykhova, Diana; Rabes, Anne; Machnik, Christoph; Pache, Florence; Berg, Johanna; Suttorp, Norbert; Hippenstiel, Stefan; Hocke, Andreas C.; Opitz, Bastian] Charite, Dept Internal Med Infect Dis & Pulm Med, D-13353 Berlin, Germany; [Guruprasad, Kunchur] Ctr Cellular & Mol Biol, Bioinformat, Hyderabad 500007, Telangana, India; [Toennies, Mario; Bauer, Torsten T.] HELIOS Klinikum Emil von Behring, Lungenklin Heckeshorn, D-14165 Berlin, Germany; [Schneider, Paul] DRK Clin, Dept Gen & Thorac Surg, D-13359 Berlin, Germany; [Schimek, Maria; Eggeling, Stephan] Vivantes Klinikum Neukolln, Dept Thorac Surg, D-12351 Berlin, Germany; [Mitchell, Timothy J.; Mitchell, Andrea M.] Univ Birmingham, Sch Infect & Immun, Inst Microbiol & Infect, Birmingham B15 2TT, W Midlands, England; [Hilker, Rolf; Hain, Torsten] Univ Giessen, Inst Med Microbiol, D-35392 Giessen, Germany; [Hilker, Rolf] Univ Giessen, Dept Bioinformat & Syst Biol, D-35392 Giessen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Helios Kliniken; VIivantes Klinikum Neukolln; University of Birmingham; Justus Liebig University Giessen; Justus Liebig University Giessen	Hocke, AC (corresponding author), Charite, Dept Internal Med Infect Dis & Pulm Med, Augustenburger Pl 1, D-13353 Berlin, Germany.	andreas.hocke@charite.de; bastian.opitz@charite.de		Rabes, Anne/0000-0003-0495-5931; Fatykhova, Diana/0000-0003-4474-2025; Hippenstiel, Stefan/0000-0002-5146-1064; Mitchell, Andrea/0000-0002-2530-4460; Suttorp, Norbert/0000-0002-3958-1151; Opitz, Bastian/0000-0003-1276-836X; Mitchell, Timothy/0000-0002-8309-5556	Deutsche Forschungsgemeinschaft [GRK1673/B5, OP 86/7-2, SFB-TR84]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (www.dfg.de)(GRK1673/B5 to A.R. and B.O., OP 86/7-2 to B.O., SFB-TR84 project B01 to T.H. and to N.S., project Z1a to A.C.H., project B06 to A.C.H and S.H., and project A01/A05 to B.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bewley MA, 2014, MBIO, V5, DOI 10.1128/mBio.01710-14; CANVIN JR, 1995, J INFECT DIS, V172, P119, DOI 10.1093/infdis/172.1.119; Davis KM, 2011, J CLIN INVEST, V121, P3666, DOI 10.1172/JCI57761; Eitel J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030379; Fang RD, 2011, J IMMUNOL, V187, P4890, DOI 10.4049/jimmunol.1100381; Gilbert RJC, 1999, CELL, V97, P647, DOI 10.1016/S0092-8674(00)80775-8; Harboe ZB, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000081; Harvey RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103625; Hocke AC, 2013, AM J RESP CRIT CARE, V188, P882, DOI 10.1164/rccm.201305-0954LE; Hoegen T, 2011, J IMMUNOL, V187, P5440, DOI 10.4049/jimmunol.1100790; Husemann P, 2010, BIOINFORMATICS, V26, P570, DOI 10.1093/bioinformatics/btp690; Jefferies JMC, 2007, J INFECT DIS, V196, P936, DOI 10.1086/520091; Kadioglu A, 2002, INFECT IMMUN, V70, P2886, DOI 10.1128/IAI.70.6.2886-2890.2002; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Karlstrom A, 2011, J INFECT DIS, V204, P1358, DOI 10.1093/infdis/jir522; Kirkham LAS, 2006, J CLIN MICROBIOL, V44, P151, DOI 10.1128/JCM.44.1.151-159.2006; Knepper J, 2013, MBIO, V4, DOI 10.1128/mBio.00601-13; Koppe U, 2012, CELL MICROBIOL, V14, P460, DOI 10.1111/j.1462-5822.2011.01746.x; Koppe U, 2012, J IMMUNOL, V188, P811, DOI 10.4049/jimmunol.1004143; Lamb KE, 2014, VACCINE, V32, P4356, DOI 10.1016/j.vaccine.2013.05.079; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Lauw FN, 2002, J IMMUNOL, V168, P372, DOI 10.4049/jimmunol.168.1.372; Le Hello S, 2010, J CLIN MICROBIOL, V48, P2968, DOI 10.1128/JCM.01615-09; Lemon JK, 2015, MBIO, V6, DOI 10.1128/mBio.02110-14; Lock RA, 1996, MICROB PATHOGENESIS, V21, P71, DOI 10.1006/mpat.1996.0044; Lujan M, 2010, EUR RESPIR J, V36, P1073, DOI 10.1183/09031936.00176309; Marimon JM, 2009, CLIN MICROBIOL INFEC, V15, P875, DOI 10.1111/j.1469-0691.2009.02883.x; McNeela EA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001191; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Mitchell AM, 2010, CLIN MICROBIOL INFEC, V16, P411, DOI 10.1111/j.1469-0691.2010.03183.x; Normark BH, 2001, J INFECT DIS, V184, P861, DOI 10.1086/323339; Noske N, 2009, J IMMUNOL, V183, P1952, DOI 10.4049/jimmunol.0804383; Opitz B, 2004, J BIOL CHEM, V279, P36426, DOI 10.1074/jbc.M403861200; Opitz B, 2010, AM J RESP CRIT CARE, V181, P1294, DOI 10.1164/rccm.200909-1427SO; Pracht D, 2005, INFECT IMMUN, V73, P2680, DOI 10.1128/IAI.73.5.2680-2689.2005; Rabes A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117022; Rijneveld AW, 2001, J IMMUNOL, V167, P5240, DOI 10.4049/jimmunol.167.9.5240; Rossjohn J, 1997, CELL, V89, P685, DOI 10.1016/S0092-8674(00)80251-2; RUBINS JB, 1995, J CLIN INVEST, V95, P142, DOI 10.1172/JCI117631; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shak JR, 2013, MBIO, V4, DOI 10.1128/mBio.00655-13; Sjostrom K, 2006, CLIN INFECT DIS, V42, P451, DOI 10.1086/499242; Sonnen AFP, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140044; Staples M, 2015, EPIDEMIOL INFECT, V143, P325, DOI 10.1017/S0950268814000648; Szymanski KV, 2012, EUR RESPIR J, V40, P1458, DOI 10.1183/09031936.00186911; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Weinberger DM, 2010, CLIN INFECT DIS, V51, P692, DOI 10.1086/655828; Weinheimer VK, 2012, J INFECT DIS, V206, P1685, DOI 10.1093/infdis/jis455; Witzenrath M, 2011, J IMMUNOL, V187, P434, DOI 10.4049/jimmunol.1003143; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	53	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137108	10.1371/journal.pone.0137108	http://dx.doi.org/10.1371/journal.pone.0137108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317436	Green Published, Green Submitted, gold			2022-12-26	WOS:000360299100204
J	He, JT; Dong, L; Xu, W; Bai, KW; Lu, CH; Wu, YN; Huang, Q; Zhang, LL; Wang, T				He, Jintian; Dong, Li; Xu, Wen; Bai, Kaiwen; Lu, Changhui; Wu, Yanan; Huang, Qiang; Zhang, Lili; Wang, Tian			Dietary Tributyrin Supplementation Attenuates Insulin Resistance and Abnormal Lipid Metabolism in Suckling Piglets with Intrauterine Growth Retardation	PLOS ONE			English	Article							LIVER-X-RECEPTOR; POLYUNSATURATED FATTY-ACIDS; HEPATIC STEATOSIS; SKELETAL-MUSCLE; GENE-EXPRESSION; RESTRICTION; LIPOPROTEIN; IMPROVES; BUTYRATE; MICE	Intrauterine growth retardation (IUGR) is associated with insulin resistance and lipid disorder. Tributyrin (TB), a pro-drug of butyrate, can attenuate dysfunctions in body metabolism. In this study, we investigated the effects of TB supplementation on insulin resistance and lipid metabolism in neonatal piglets with IUGR. Eight neonatal piglets with normal birth weight (NBW) and 16 neonatal piglets with IUGR were selected, weaned on the 7th day, and fed basic milk diets (NBW and IUGR groups) or basic milk diets supplemented with 0.1% tributyrin (IT group, IUGR piglets) until day 21 (n = 8). Relative parameters for lipid metabolism and mRNA expression were measured. Piglets with IUGR showed higher (P < 0.05) concentrations of insulin in the serum, higher (P < 0.05) HOMA-IR and total cholesterol, triglycerides (TG), non-esterified fatty acid (NEFA) in the liver, and lower (P < 0.05) enzyme activities (hepatic lipase [HL], lipoprotein lipase [LPL], total lipase [TL]) and concentration of glycogen in the liver than the NBW group. TB supplementation decreased (P < 0.05) the concentrations of insulin, HOMA-IR, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol in the serum, and the concentrations of TG and NEFA in the liver, and increased (P < 0.05) enzyme activities (HL, LPL, and TL) and concentration of glycogen in the liver of the IT group. The mRNA expression for insulin signal transduction pathway and hepatic lipogenic pathway (including transcription factors and nuclear factors) was significantly (P < 0.05) affected in the liver by IUGR, which was efficiently (P < 0.05) attenuated by diets supplemented with TB. TB supplementation has therapeutic potential for attenuating insulin resistance and abnormal lipid metabolism in IUGR piglets by increasing enzyme activities and upregulating mRNA expression, leading to an early improvement in the metabolic efficiency of IUGR piglets.	[He, Jintian; Dong, Li; Xu, Wen; Bai, Kaiwen; Lu, Changhui; Wu, Yanan; Huang, Qiang; Zhang, Lili; Wang, Tian] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Wang, T (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	tianwangnjau@163.com			National Natural Science Foundation of China [31201808]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grant number no. 31201808, http://www.nsfc.gov.cn/, full name "National Natural Science Foundation of China", received by Tian Wang. The funder supported and paid for the study design, animal experiment, lab experiment and publishing.	Ann S, 2013, OBESITY; Brenseke B, 2013, J PREGNANCY, V2013, DOI 10.1155/2013/368461; Brown Laura D, 2011, Front Biosci (Schol Ed), V3, P428, DOI 10.2741/s162; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; BUCOLO G, 1973, CLIN CHEM, V19, P476; Cresci GA, 2014, ALCOHOL CLIN EXP RES, V38, P1489, DOI 10.1111/acer.12428; Dentin R, 2006, J NUTR, V136, P1145, DOI 10.1093/jn/136.5.1145; Djiane J, 2008, J PHYSIOL PHARMACOL, V59, P55; Dong L, 2015, CLIN NUTR; Edelman MJ, 2003, CANCER CHEMOTH PHARM, V51, P439, DOI 10.1007/s00280-003-0580-5; Evagelidou EN, 2007, EUR J ENDOCRINOL, V156, P271, DOI 10.1530/eje.1.02337; Friedman A., 2005, P 15 EUR S POULTR NU; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; GIRARD JR, 1973, J CLIN INVEST, V52, P3190, DOI 10.1172/JCI107519; Guilbert J J, 2003, Educ Health (Abingdon), V16, P230; Hay W.W., 2001, NEOREVIEWS, V2, pe129, DOI [10.1542/neo.2-6-e129, DOI 10.1542/NEO.2-6-E129]; He QH, 2011, MOL BIOSYST, V7, P2147, DOI 10.1039/c1mb05024a; Hou YQ, 2014, BRIT J NUTR, V111, P1748, DOI 10.1017/S0007114514000038; Hu TH, 2005, ENDOCRINOLOGY, V146, P5380, DOI 10.1210/en.2005-0591; Jaquet D, 1998, J CLIN ENDOCR METAB, V83, P1243, DOI 10.1210/jc.83.4.1243; Jump DB, 2005, J NUTR, V135, P2503, DOI 10.1093/jn/135.11.2503; Kim HJ, 2002, ANN NY ACAD SCI, V967, P34; Kuroiwa-Trzmielina J, 2009, INT J CANCER, V124, P2520, DOI 10.1002/ijc.24212; Lim K, 2011, PEDIATR RES, V70, P339, DOI 10.1203/PDR.0b013e31822a65a3; Lin G, 2012, J NUTR, V142, P990, DOI 10.3945/jn.111.153411; Liu C, 2013, J NUTR BIOCHEM, V24, P954, DOI 10.1016/j.jnutbio.2012.06.016; Liu J, 2014, J ANIM PLANT SCI, V24, P63; Longo S, 2014, EARLY HUM DEV, V90, pS42, DOI 10.1016/S0378-3782(14)70014-3; Lu H, 2012, J ANIM SCI, V90, P430, DOI 10.2527/jas.53817; Magee TR, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.05.022; Marcil VR, 2002, AM J PHYSIOL-GASTR L, V283, pG340, DOI 10.1152/ajpgi.00440.2001; Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9; Miyoshi M, 2011, CLIN NUTR, V30, P252, DOI 10.1016/j.clnu.2010.09.012; Mortensen OH, 2010, PEDIATR RES, V67, P47, DOI 10.1203/PDR.0b013e3181c4735c; Musso G, 2009, PROG LIPID RES, V48, P1, DOI 10.1016/j.plipres.2008.08.001; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Vinolo MAR, 2012, AM J PHYSIOL-ENDOC M, V303, pE272, DOI 10.1152/ajpendo.00053.2012; Ramsay JE, 2004, J HYPERTENS, V22, P2177, DOI 10.1097/00004872-200411000-00021; Saleem T, 2011, ITAL J PEDIATR, V37, DOI 10.1186/1824-7288-37-41; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Su J, 2006, J PHARMACOL EXP THER, V316, P62, DOI 10.1124/jpet.105.090464; Suliburska J, 2014, EUR J NUTR, V53, P387, DOI 10.1007/s00394-013-0533-7; Valsamakis G, 2006, ANN NY ACAD SCI, V1092, P138, DOI 10.1196/annals.1365.012; Vanni E, 2010, DIGEST LIVER DIS, V42, P320, DOI 10.1016/j.dld.2010.01.016; Vielwerth SE, 2008, DIABETOLOGIA, V51, P1483, DOI 10.1007/s00125-008-1037-5; Wang JJ, 2008, J NUTR, V138, P60, DOI 10.1093/jn/138.1.60; Wang T, 2005, BIOL NEONATE, V88, P66, DOI 10.1159/000084645; Wang YX, 2012, BRIT J NUTR, V108, P1371, DOI 10.1017/S0007114511006763; World Health Organization, 1995, MAT ANTHR PREGN OUTC; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156; Yamamoto T, 2007, J BIOL CHEM, V282, P11687, DOI 10.1074/jbc.M611911200; YOKODE M, 1990, SCIENCE, V250, P1273, DOI 10.1126/science.2244210; Yoshikawa T, 2003, MOL ENDOCRINOL, V17, P1240, DOI 10.1210/me.2002-0190; Yu XX, 2005, HEPATOLOGY, V42, P362, DOI 10.1002/hep.20783; Zhang H, 2014, BRIT J NUTR, V112, P876, DOI 10.1017/S000711451400155X	55	46	49	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136848	10.1371/journal.pone.0136848	http://dx.doi.org/10.1371/journal.pone.0136848			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317832	Green Published, Green Submitted, gold			2022-12-26	WOS:000360299100152
J	Jonas, JB; Wang, YX; Zhang, Q; Liu, Y; Xu, L; Wei, WB				Jonas, Jost B.; Wang, Ya Xing; Zhang, Qi; Liu, Yi; Xu, Liang; Wei, Wen Bin			Macular Bruch's Membrane Length and Axial Length. The Beijing Eye Study	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; SUBFOVEAL CHOROIDAL THICKNESS; ZONE PARAPAPILLARY ATROPHY; OPEN-ANGLE GLAUCOMA; BETA-ZONE; HIGH MYOPIA; FUNDUS PHOTOGRAPHY; RETINAL FEATURES; FOVEA DISTANCE; DISC MARGIN	Purpose To assess whether macular Bruch's membrane gets lengthened in axial myopia. Methods Using the enhanced depth imaging mode of spectral-domain optical coherence tomography and examining a subgroup of participants of the population-based cross-sectional Beijing Eye Study, we measured the length of Bruch's membrane ("MacBMLength") from the fovea to the temporal edge of parapapillary gamma zone, and the distance between the fovea and the temporal optic disc border. Parapapillary gamma zone was defined as the parapapillary region without Bruch's membrane. We additionally measured ocular biometric parameters and assessed non-ophthalmologic variables. Results Measurements of MacBMLength were performed on 322 individuals. MacBMLength (mean: 3.99 +/- 0.33 mm; range: 3.17-4.93 mm) was not significantly associated with any systemic parameter or ocular biometric parameter. Gamma zone width (mean: 0.18 +/- 0.30mm; range: 0.00-2.61mm) was associated (multivariate analysis; correlation coefficient r: 0.80) with longer axial length (P<0.001; standardized correlation coefficient beta: 0.60; non-standardized correlation coefficient B:0.11; 95% CI:0.09,0.14) and with longer fovea-optic disc border distance (P<0.001; beta: 0.28; B: 0.19; 95% CI:0.14,0.25), but not with MacBMLength (P = 0.42). Fovea-temporal disc border distance (mean: 4.16 +/- 0.44mm; range: 3.17-5.86mm) was associated (overall correlation coefficient: 0.68) with longer axial length (P<0.001; beta: 0.36; B: 0.10; 95% CI: 0.06, 0.13), after adjusting for flatter anterior chamber depth (P = 0.003; beta:-0.14; B:-0.14; 95% CI: -0.23,-0.05) and wider parapapillary gamma zone (P<0.001; beta: 0.42; B: 0.62; 95% CI: 0.44,0.81). Conclusions In contrast to parapapillary gamma zone width and fovea-disc border distance, MacBM-Length was not significantly associated with axial length. Axial elongation associated increase in fovea-disc distance may predominantly occur through development or elongation of parapapillary gamma zone, while macular Bruch's membrane may mostly be independent of axial elongation.	[Jonas, Jost B.; Wang, Ya Xing; Zhang, Qi; Liu, Yi; Xu, Liang] Capital Med Univ, Beijing Inst Ophthalmol, Beijing Tongren Hosp, Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, D-69115 Heidelberg, Germany; [Wei, Wen Bin] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China	Capital Medical University; Ruprecht Karls University Heidelberg; Capital Medical University	Wei, WB (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China.	tr_weiwenbin@163.com	wang, YA XING/K-9671-2016; wei, wei/HHR-8613-2022	wang, YA XING/0000-0003-2749-7793; 	State Natural Sciences Fund [81041018]; Natural Sciences Fund of Beijing government [7092021, 7112031]	State Natural Sciences Fund(National Natural Science Foundation of China (NSFC)); Natural Sciences Fund of Beijing government	Supported by State Natural Sciences Fund (81041018) and the Natural Sciences Fund of Beijing government (7092021; 7112031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 2013, AM J OPHTHALMOL, V155, P927, DOI 10.1016/j.ajo.2012.12.014; BENNETT AG, 1994, GRAEF ARCH CLIN EXP, V232, P361, DOI 10.1007/BF00175988; Chauhan BC, 2013, OPHTHALMOLOGY, V120, P535, DOI 10.1016/j.ophtha.2012.09.055; Chui TYP, 2011, VISION RES, V51, P2132, DOI 10.1016/j.visres.2011.08.008; Chui TYP, 2008, INVEST OPHTH VIS SCI, V49, P4679, DOI 10.1167/iovs.08-2135; Dai Y, 2013, INVEST OPHTH VIS SCI, V54, P2013, DOI 10.1167/iovs.12-11255; De Silva DJ, 2006, INVEST OPHTH VIS SCI, V47, P4683, DOI 10.1167/iovs.06-0152; Guist G, 1934, COINCIDENT OPHTHALMO; Hayashi K, 2012, INVEST OPHTH VIS SCI, V53, P1499, DOI 10.1167/iovs.11-8572; Heine, 1899, ARCH AUGENHEILKD, V38, P277; JONAS JB, 1988, GRAEF ARCH CLIN EXP, V226, P213, DOI 10.1007/BF02181183; Jonas JB, 2014, ACTA OPHTHALMOL, V92, pE470, DOI 10.1111/aos.12372; Jonas JB, 2014, ACTA OPHTHALMOL, V92, pe273, DOI 10.1111/aos.12324; Jonas JB, 2013, INVEST OPHTH VIS SCI, V54, P1295, DOI 10.1167/iovs.12-11352; Jonas JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047237; Kim YW, 2014, OPHTHALMOLOGY, V121, P1341, DOI 10.1016/j.ophtha.2014.01.008; Kitaguchi Y, 2007, JPN J OPHTHALMOL, V51, P456, DOI 10.1007/s10384-007-0477-7; Knaapi L, 2015, ACTA OPHTHALMOL, V93, P339, DOI 10.1111/aos.12554; Lee KYC, 2010, INVEST OPHTH VIS SCI, V51, P666, DOI 10.1167/iovs.09-3663; Lee M, 2014, GRAEF ARCH CLIN EXP, V252, P307, DOI 10.1007/s00417-013-2513-2; Li KY, 2010, INVEST OPHTH VIS SCI, V51, P6858, DOI 10.1167/iovs.10-5499; LITTMANN H, 1982, KLIN MONATSBL AUGENH, V180, P286, DOI 10.1055/s-2008-1055068; Manjunath V, 2011, OPHTHALMOLOGY, V118, P531, DOI 10.1016/j.ophtha.2010.07.013; Na Jung Hwa, 2010, Korean J Ophthalmol, V24, P353, DOI 10.3341/kjo.2010.24.6.353; Nonaka A, 2011, INVEST OPHTH VIS SCI, V52, P6706, DOI 10.1167/iovs.11-7580; Norman RE, 2010, EXP EYE RES, V90, P277, DOI 10.1016/j.exer.2009.11.001; Olsen TW, 1998, AM J OPHTHALMOL, V125, P237, DOI 10.1016/S0002-9394(99)80096-8; Panda-Jonas S, 2014, ACTA OPHTHALMOL, V92, P59, DOI 10.1111/j.1755-3768.2012.02570.x; Park SC, 2012, OPHTHALMOLOGY, V119, P3, DOI 10.1016/j.ophtha.2011.07.012; Park SC, 2010, INVEST OPHTH VIS SCI, V51, P6408, DOI 10.1167/iovs.09-5100; Reis ASC, 2012, OPHTHALMOLOGY, V119, P738, DOI 10.1016/j.ophtha.2011.09.054; Shao L, 2014, AM J OPHTHALMOL, V158, P702, DOI 10.1016/j.ajo.2014.05.023; Takahashi A, 2013, JPN J OPHTHALMOL, V57, P233, DOI 10.1007/s10384-012-0224-6; van de Put MAJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062518; Vurgese S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029692; Wang YX, 2010, AM J OPHTHALMOL, V150, P917, DOI 10.1016/j.ajo.2010.06.037; Wei WB, 2013, OPHTHALMOLOGY, V120, P175, DOI 10.1016/j.ophtha.2012.07.048; Xu L, 2007, OPHTHALMOLOGY, V114, P121, DOI 10.1016/j.ophtha.2006.05.071; You QS, 2015, BEIJING E S IN PRESS	39	42	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136833	10.1371/journal.pone.0136833	http://dx.doi.org/10.1371/journal.pone.0136833			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317992	Green Published, Green Submitted, gold			2022-12-26	WOS:000360299100145
J	Li, SZ; Zhou, XJ; Li, HB; Liu, YF; Zhu, LY; Guo, JJ; Liu, XQ; Fan, YL; Chen, JT; Chen, RM				Li, Suzhen; Zhou, Xiaojin; Li, Hongbo; Liu, Yuanfeng; Zhu, Liying; Guo, Jinjie; Liu, Xiaoqing; Fan, Yunliu; Chen, Jingtang; Chen, Rumei			Overexpression of ZmIRT1 and ZmZIP3 Enhances Iron and Zinc Accumulation in Transgenic Arabidopsis	PLOS ONE			English	Article							METAL TRANSPORTER; DEFICIENCY RESPONSES; RICE PLANTS; OVER-EXPRESSION; GENE-EXPRESSION; HOMEOSTASIS; THALIANA; NICOTIANAMINE; ROOTS; IRT1	Iron and zinc are important micronutrients for both the growth and nutrient availability of crop plants, and their absorption is tightly controlled by a metal uptake system. Zinc-regulated transporters, iron-regulated transporter-like proteins (ZIP), is considered an essential metal transporter for the acquisition of Fe and Zn in graminaceous plants. Several ZIPs have been identified in maize, although their physiological function remains unclear. In this report, ZmIRT1 was shown to be specifically expressed in silk and embryo, whereas ZmZIP3 was a leaf-specific gene. Both ZmIRT1 and ZmZIP3 were shown to be localized to the plasma membrane and endoplasmic reticulum. In addition, transgenic Arabidopsis plants overexpressing ZmIRT1 or ZmZIP3 were generated, and the metal contents in various tissues of transgenic and wild-type plants were examined based on ICP-OES and Zinpyr-1 staining. The Fe and Zn concentration increased in roots and seeds of ZmIRT1-overexpressing plants, while the Fe content in shoots decreased. Overexpressing ZmZIP3 enhanced Zn accumulation in the roots of transgenic plants, while that in shoots was repressed. In addition, the transgenic plants showed altered tolerance to various Fe and Zn conditions compared with wild-type plants. Furthermore, the genes associated with metal uptake were stimulated in ZmIRT1 transgenic plants, while those involved in intra-and intercellular translocation were suppressed. In conclusion, ZmIRT1 and ZmZIP3 are functional metal transporters with different ion selectivities. Ectopic overexpression of ZmIRT1 may stimulate endogenous Fe uptake mechanisms, which may facilitate metal uptake and homeostasis. Our results increase our understanding of the functions of ZIP family transporters in maize.	[Li, Suzhen; Li, Hongbo; Liu, Yuanfeng; Zhu, Liying; Guo, Jinjie; Chen, Jingtang] Agr Univ Hebei, Dept Agron, Hebei Subctr, Chinese Natl Maize Improvement Ctr, Baoding, Peoples R China; [Li, Suzhen; Zhou, Xiaojin; Liu, Xiaoqing; Fan, Yunliu; Chen, Rumei] Chinese Acad Agr Sci, Dept Crop Genom & Genet Improvement, Biotechnol Res Inst, Beijing 100193, Peoples R China	Hebei Agricultural University; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Chen, JT (corresponding author), Agr Univ Hebei, Dept Agron, Hebei Subctr, Chinese Natl Maize Improvement Ctr, Baoding, Peoples R China.	chenjingtang@126.com; chenrumei@caas.cn			National Special Program for GMO Development of China [2014ZX08003-002]; National Natural Science Foundation of China [31101095]	National Special Program for GMO Development of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Special Program for GMO Development of China (grant number 2014ZX08003-002) and by the National Natural Science Foundation of China (grant number 31101095).	An P, 2012, HUM MOL GENET, V21, P2124, DOI 10.1093/hmg/dds028; Broadley MR, 2007, NEW PHYTOL, V173, P677, DOI 10.1111/j.1469-8137.2007.01996.x; Casterline JE, 1997, J NUTR, V127, P1966, DOI 10.1093/jn/127.10.1966; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Colangelo EP, 2006, CURR OPIN PLANT BIOL, V9, P322, DOI 10.1016/j.pbi.2006.03.015; Colangelo EP, 2004, PLANT CELL, V16, P3400, DOI 10.1105/tpc.104.024315; Connolly EL, 2002, PLANT CELL, V14, P1347, DOI 10.1105/tpc.001263; Curie C, 2001, NATURE, V409, P346, DOI 10.1038/35053080; Curie C, 2009, ANN BOT-LONDON, V103, P1, DOI 10.1093/aob/mcn207; Deinlein U, 2012, PLANT CELL, V24, P708, DOI 10.1105/tpc.111.095000; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Erikson KA, 2004, J NUTR BIOCHEM, V15, P335, DOI 10.1016/j.jnutbio.2003.12.006; Gainza-Cortes F, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-111; Ghandilyan A, 2006, PHYSIOL PLANTARUM, V126, P407, DOI 10.1111/j.1399-3054.2006.00646.x; Grotz N, 2006, BBA-MOL CELL RES, V1763, P595, DOI 10.1016/j.bbamcr.2006.05.014; Hanikenne M, 2008, NATURE, V453, P391, DOI 10.1038/nature06877; Henriques R, 2002, PLANT MOL BIOL, V50, P587, DOI 10.1023/A:1019942200164; Hindt MN, 2012, BBA-MOL CELL RES, V1823, P1521, DOI 10.1016/j.bbamcr.2012.03.010; Hussain D, 2004, PLANT CELL, V16, P1327, DOI 10.1105/tpc.020487; Inoue H, 2009, J BIOL CHEM, V284, P3470, DOI 10.1074/jbc.M806042200; Ishimaru Y, 2006, PLANT J, V45, P335, DOI 10.1111/j.1365-313X.2005.02624.x; Ishimaru Y, 2007, J EXP BOT, V58, P2909, DOI 10.1093/jxb/erm147; Ivanov R, 2012, MOL PLANT, V5, P27, DOI 10.1093/mp/ssr065; Jakoby M, 2004, FEBS LETT, V577, P528, DOI 10.1016/j.febslet.2004.10.062; Klatte M, 2009, PLANT PHYSIOL, V150, P257, DOI 10.1104/pp.109.136374; Kobayashi T, 2012, ANNU REV PLANT BIOL, V63, P131, DOI 10.1146/annurev-arplant-042811-105522; Lanquar V, 2005, EMBO J, V24, P4041, DOI 10.1038/sj.emboj.7600864; Lee S. H., 2010, MOL CELLS, V29, P311, DOI DOI 10.1007/s10059-010-0053-8; Lee S, 2010, PLANT MOL BIOL, V73, P507, DOI 10.1007/s11103-010-9637-0; Lee S, 2009, P NATL ACAD SCI USA, V106, P22014, DOI 10.1073/pnas.0910950106; Lee S, 2009, PLANT PHYSIOL, V150, P786, DOI 10.1104/pp.109.135418; Lee S, 2009, PLANT CELL ENVIRON, V32, P408, DOI 10.1111/j.1365-3040.2009.01935.x; Li SZ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-114; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Nishida S, 2011, PLANT CELL PHYSIOL, V52, P1433, DOI 10.1093/pcp/pcr089; Nozoye T, 2011, J BIOL CHEM, V286, P5446, DOI 10.1074/jbc.M110.180026; Ogo Y, 2007, PLANT J, V51, P366, DOI 10.1111/j.1365-313X.2007.03149.x; PAHLSSON AMB, 1989, WATER AIR SOIL POLL, V47, P287, DOI 10.1007/BF00279329; Palmgren MG, 2008, TRENDS PLANT SCI, V13, P464, DOI 10.1016/j.tplants.2008.06.005; PRICE AH, 1991, PLANT CELL ENVIRON, V14, P477, DOI 10.1111/j.1365-3040.1991.tb01517.x; Ramesh SA, 2004, PLANT MOL BIOL, V54, P373, DOI 10.1023/B:PLAN.0000036370.70912.34; Santi S, 2005, PLANT PHYSIOL BIOCH, V43, P287, DOI 10.1016/j.plaphy.2005.02.007; Santi S, 2008, J EXP BOT, V59, P697, DOI 10.1093/jxb/erm351; Santi S, 2009, NEW PHYTOL, V183, P1072, DOI 10.1111/j.1469-8137.2009.02908.x; Sinclair SA, 2007, NEW PHYTOL, V174, P39, DOI 10.1111/j.1469-8137.2007.02030.x; Sinclair SA, 2012, BBA-MOL CELL RES, V1823, P1553, DOI 10.1016/j.bbamcr.2012.05.016; Stein AJ, 2010, PLANT SOIL, V335, P133, DOI 10.1007/s11104-009-0228-2; Tan S, 2015, TRANSGENIC RES, V24, P109, DOI 10.1007/s11248-014-9822-z; Thomine S, 2003, PLANT J, V34, P685, DOI 10.1046/j.1365-313X.2003.01760.x; Varotto C, 2002, PLANT J, V31, P589, DOI 10.1046/j.1365-313X.2002.01381.x; Vert G, 2001, PLANT J, V26, P181, DOI 10.1046/j.1365-313x.2001.01018.x; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; Walker EL, 2008, CURR OPIN PLANT BIOL, V11, P530, DOI 10.1016/j.pbi.2008.06.013; Wang N, 2013, MOL PLANT, V6, P503, DOI 10.1093/mp/sss089; Wu HL, 2012, PLANT PHYSIOL, V158, P790, DOI 10.1104/pp.111.190983; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yuan YX, 2008, CELL RES, V18, P385, DOI 10.1038/cr.2008.26	58	23	30	4	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136647	10.1371/journal.pone.0136647	http://dx.doi.org/10.1371/journal.pone.0136647			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317616	Green Submitted, Green Published, gold			2022-12-26	WOS:000360299100118
J	Okazawa, Y; Miyazaki, T; Yokoi, G; Ishizaki, Y; Nishikawa, A; Tonozuka, T				Okazawa, Yuka; Miyazaki, Takatsugu; Yokoi, Gaku; Ishizaki, Yuichi; Nishikawa, Atsushi; Tonozuka, Takashi			Crystal Structure and Mutational Analysis of Isomaltodextranase, a Member of Glycoside Hydrolase Family 27	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULES; ARTHROBACTER-GLOBIFORMIS T6; BETA-L-ARABINOPYRANOSIDASE; HUMAN ALPHA-GALACTOSIDASE; X-RAY; ISOMALTO-DEXTRANASE; MOLECULAR-BASIS; ACTIVE-SITE; MECHANISM; SPECIFICITY	Arthrobacter globiformis T6 isomalto-dextranase (AgIMD) is an enzyme that liberates isomaltose from the non-reducing end of a polymer of glucose, dextran. AgIMD is classified as a member of the glycoside hydrolase family (GH) 27, which comprises mainly alpha-galactosidases and alpha-N-acetylgalactosaminidases, whereas AgIMD does not show alpha-galactosidase or alpha-N-acetylgalactosaminidase activities. Here, we determined the crystal structure of AgIMD. AgIMD consists of the following three domains: A, C, and D. Domains A and C are identified as a (beta/alpha)(8)-barrel catalytic domain and an antiparallel beta-structure, respectively, both of which are commonly found in GH27 enzymes. However, domain A of AgIMD has subdomain B, loop-1, and loop-2, all of which are not found in GH27 human alpha-galactosidase. AgIMD in a complex with trisaccharide panose shows that Asp-207, a residue in loop-1, is involved in subsite + 1. Kinetic parameters of the wild-type and mutant enzymes for the small synthetic saccharide p-nitrophenyl alpha-isomaltoside and the polysaccharide dextran were compared, showing that Asp-207 is important for the catalysis of dextran. Domain D is classified as carbohydrate-binding module (CBM) 35, and an isomaltose molecule is seen in this domain in the AgIMD-isomaltose complex. Domain D is highly homologous to CBM35 domains found in GH31 and GH66 enzymes. The results here indicate that some features found in GH13, -31, and -66 enzymes, such as subdomain B, residues at the subsite + 1, and the CBM35 domain, are also observed in the GH27 enzyme AgIMD and thus provide insights into the evolutionary relationships among GH13, -27, -31, -36, and -66 enzymes.	[Okazawa, Yuka; Miyazaki, Takatsugu; Yokoi, Gaku; Ishizaki, Yuichi; Nishikawa, Atsushi; Tonozuka, Takashi] Tokyo Univ Agr & Technol, Dept Appl Biol Sci, Fuchu, Tokyo 1838509, Japan	Tokyo University of Agriculture & Technology	Tonozuka, T (corresponding author), Tokyo Univ Agr & Technol, Dept Appl Biol Sci, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.	tonozuka@cc.tuat.ac.jp	Miyazaki, Takatsugu/M-1498-2016; Nishikawa, Atsushi/E-6766-2013; Tonozuka, Takashi/D-2268-2013	Miyazaki, Takatsugu/0000-0003-1809-0641; Nishikawa, Atsushi/0000-0003-4325-1160; Tonozuka, Takashi/0000-0002-5422-7548	Japan Society for the Promotion of Science [26660277]; Grants-in-Aid for Scientific Research [26660277] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-aid for Scientific Research 26660277 (to T. T.) of the Japan Society for the Promotion of Science. This work was performed with the approval of the Photon Factory Advisory Committee (No. 2014G512), the National Laboratory for High Energy Physics, Tsukuba, Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Abe A, 2005, FEBS J, V272, P6145, DOI 10.1111/j.1742-4658.2005.05013.x; Aghajari N, 2002, BIOCHEMISTRY-US, V41, P4273, DOI 10.1021/bi0160516; Akita M, 2004, ACTA CRYSTALLOGR D, V60, P572, DOI 10.1107/S090744490400006X; Allouch J, 2004, STRUCTURE, V12, P623, DOI 10.1016/j.str.2004.02.020; Chen M, 2014, J PHYS CHEM B, V118, P2306, DOI 10.1021/jp408767j; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Comfort DA, 2007, BIOCHEMISTRY-US, V46, P3319, DOI 10.1021/bi061521n; Copeland A, 2009, STAND GENOMIC SCI, V1, P119, DOI [10.4056/sigs.17259, 10.4056/sigs.29547]; Correia MAS, 2010, BIOCHEMISTRY-US, V49, P6193, DOI 10.1021/bi1006139; DAGNALL BH, 1995, BIOCHEM J, V311, P349, DOI 10.1042/bj3110349; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Garman SC, 2004, J MOL BIOL, V337, P319, DOI 10.1016/j.jmb.2004.01.035; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; Guce AI, 2010, J BIOL CHEM, V285, P3625, DOI 10.1074/jbc.M109.060145; Hart DO, 2000, BIOCHEMISTRY-US, V39, P9826, DOI 10.1021/bi0008074; Hashimoto T., 2006, Journal of Applied Glycoscience, V53, P233; Hashimoto Y, 2001, J BACTERIOL, V183, P5050, DOI 10.1128/JB.183.17.5050-5057.2001; Hayacibara MF, 2004, CARBOHYD RES, V339, P2127, DOI 10.1016/j.carres.2004.05.031; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hondoh H, 2008, J MOL BIOL, V378, P913, DOI 10.1016/j.jmb.2008.03.016; Ichinose H, 2009, J BIOL CHEM, V284, P25097, DOI 10.1074/jbc.M109.022723; KACHURIN AM, 1995, BIOCHEM J, V308, P955, DOI 10.1042/bj3080955; Khalikova E, 2005, MICROBIOL MOL BIOL R, V69, P306, DOI 10.1128/MMBR.69.2.306-325.2005; KIM YK, 1995, BIOSCI BIOTECH BIOCH, V59, P1367, DOI 10.1271/bbb.59.1367; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lansky S, 2014, ACTA CRYSTALLOGR D, V70, P2994, DOI 10.1107/S139900471401863X; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lopez-Casado G, 2008, CURR OPIN PLANT BIOL, V11, P329, DOI 10.1016/j.pbi.2008.02.010; Lovering AL, 2005, J BIOL CHEM, V280, P2105, DOI 10.1074/jbc.M410468200; Miyazaki T, 2015, BIOCHEM J, V469, P145, DOI 10.1042/BJ20150261; Montanier C, 2009, P NATL ACAD SCI USA, V106, P3065, DOI 10.1073/pnas.0808972106; Nihira T, 2005, BIOCHEMISTRY-US, V44, P9456, DOI 10.1021/bi050079q; Okuyama M, 2006, FEBS LETT, V580, P2707, DOI 10.1016/j.febslet.2006.04.025; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rigden DJ, 2002, FEBS LETT, V523, P17, DOI 10.1016/S0014-5793(02)02879-X; SAWAI T, 1974, J BIOCHEM-TOKYO, V75, P105, DOI 10.1093/oxfordjournals.jbchem.a130363; SAWAI T, 1981, CARBOHYD RES, V89, P289, DOI 10.1016/S0008-6215(00)85254-4; Suzuki N, 2014, J BIOL CHEM, V289, P12040, DOI 10.1074/jbc.M114.547992; TAKAYANAGI T, 1987, AGR BIOL CHEM TOKYO, V51, P2337; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Tonozuka T., 2004, Journal of Applied Glycoscience, V51, P27; Tonozuka T, 2012, ENZYME MICROB TECH, V51, P359, DOI 10.1016/j.enzmictec.2012.08.004; Tsukagoshi H, 2014, J BIOL CHEM, V289, P10843, DOI 10.1074/jbc.M114.555383; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vu B, 2009, MOLECULES, V14, P2535, DOI 10.3390/molecules14072535; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	48	11	13	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26339	26349		10.1074/jbc.M115.680942	http://dx.doi.org/10.1074/jbc.M115.680942			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26330557	hybrid, Green Published			2022-12-26	WOS:000363527300049
J	Erickson, JR; Nichols, CB; Uchinoumi, H; Stein, ML; Bossuyt, J; Bers, DM				Erickson, Jeffrey R.; Nichols, C. Blake; Uchinoumi, Hitoshi; Stein, Matthew L.; Bossuyt, Julie; Bers, Donald M.			S-Nitrosylation Induces Both Autonomous Activation and Inhibition of Calcium/Calmodulin-dependent Protein Kinase II delta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE VENTRICULAR MYOCYTES; RETICULUM CALCIUM LEAK; NITRIC-OXIDE; RYANODINE RECEPTOR; HEART-FAILURE; AUTOPHOSPHORYLATION SITES; CAMKII ACTIVATION; CELL APOPTOSIS; CALMODULIN; PHOSPHORYLATION	NO is known to modulate calcium handling and cellular signaling in the myocardium, but key targets for NO in the heart remain unidentified. Recent reports have implied that NO can activate calcium/calmodulin (Ca2+/CaM)-dependent protein kinase II (CaMKII) in neurons and the heart. Here we use our novel sensor of CaMKII activation, Camui, to monitor changes in the conformation and activation of cardiac CaMKII (CaMKII delta) activity after treatment with the NO donor S-nitrosoglutathione (GSNO). We demonstrate that exposure to NO after Ca2+/CaM binding to CaMKII delta results in autonomous kinase activation, which is abolished by mutation of the Cys-290 site. However, exposure of CaMKII delta to GSNO prior to Ca2+/CaM exposure strongly suppresses kinase activation and conformational change by Ca2+/CaM. This NO-induced inhibition was ablated by mutation of the Cys-273 site. We found parallel effects of GSNO on CaM/CaMKII delta binding and CaMKII delta-dependent ryanodine receptor activation in adult cardiac myocytes. We conclude that NO can play a dual role in regulating cardiac CaMKII delta activity.	[Erickson, Jeffrey R.] Univ Otago, Dept Physiol, Dunedin 9016, New Zealand; [Nichols, C. Blake; Uchinoumi, Hitoshi; Stein, Matthew L.; Bossuyt, Julie; Bers, Donald M.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA	University of Otago; University of California System; University of California Davis	Bers, DM (corresponding author), Univ Calif Davis, Dept Pharmacol, 451 Hlth Sci Dr, Davis, CA 95616 USA.	dmbers@ucdavis.edu	Regan, Clinton/E-6250-2012	Bossuyt, Julie/0000-0001-8874-4765; Bers, Donald/0000-0002-2237-9483	National Institutes of Health [P01-HL080101, R01-HL030077, R01-HL103933, F32-HL126331]; Royal Marsden Grant [UOO1303]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105242, R01HL103933, P01HL080101, R01HL092097, R01HL030077, F32HL126331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Marsden Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported, in whole or in part, by National Institutes of Health Grants P01-HL080101 and R01-HL030077 (to D. M. B.), R01-HL103933 (to J. B.), and F32-HL126331 (to C. B. N.). This work was also supported by Royal Marsden Grant UOO1303 (to J. R. E.). The authors declare that they have no conflicts of interest with the contents of this article.	Anderson ME, 2011, J MOL CELL CARDIOL, V51, P468, DOI 10.1016/j.yjmcc.2011.01.012; Bers DM, 2009, J CARDIOVASC PHARM, V54, P180, DOI 10.1097/FJC.0b013e3181a25078; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Burger DE, 2009, CIRCULATION, V120, P1345, DOI 10.1161/CIRCULATIONAHA.108.846402; COLBRAN RJ, 1993, J BIOL CHEM, V268, P7163; COLBRAN RJ, 1990, J BIOL CHEM, V265, P11213; Coultrap SJ, 2014, FEBS LETT, V588, P4672, DOI 10.1016/j.febslet.2014.10.039; Coultrap SJ, 2014, J BIOL CHEM, V289, P19458, DOI 10.1074/jbc.M114.558254; Curran J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087495; Cutler MJ, 2012, P NATL ACAD SCI USA, V109, P18186, DOI 10.1073/pnas.1210565109; Erickson JR, 2008, J CARDIOVASC ELECTR, V19, P1332, DOI 10.1111/j.1540-8167.2008.01295.x; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Erickson JR, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00059; Erickson JR, 2013, NATURE, V502, P372, DOI 10.1038/nature12537; Erickson JR, 2011, CIRC RES, V109, P729, DOI 10.1161/CIRCRESAHA.111.247148; Gonzalez DR, 2007, P NATL ACAD SCI USA, V104, P20612, DOI 10.1073/pnas.0706796104; Guo T, 2006, CIRC RES, V99, P398, DOI 10.1161/01.RES.0000236756.06252.13; Gutierrez DA, 2013, CARDIOVASC RES, V100, P392, DOI 10.1093/cvr/cvt201; Jian Z, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005046; Kohlhaas M, 2006, CIRC RES, V98, P235, DOI 10.1161/01.RES.0000200739.90811.9f; LAI Y, 1987, P NATL ACAD SCI USA, V84, P5710, DOI 10.1073/pnas.84.16.5710; Li YX, 2002, CIRC RES, V90, P309, DOI 10.1161/hh0302.105660; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; Pellicena P, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00021; Picht E, 2007, AM J PHYSIOL-CELL PH, V293, pC1073, DOI 10.1152/ajpcell.00586.2006; Purohit A, 2013, CIRCULATION, V128, P1748, DOI 10.1161/CIRCULATIONAHA.113.003313; Rokita AG, 2012, CIRCULATION, V126, P2125, DOI 10.1161/CIRCULATIONAHA.112.124990; SU ZZ, 1995, J BIOL CHEM, V270, P29117, DOI 10.1074/jbc.270.49.29117; van Oort RJ, 2010, CIRCULATION, V122, P2669, DOI 10.1161/CIRCULATIONAHA.110.982298; Wang HL, 2010, J PHYSIOL-LONDON, V588, P2905, DOI 10.1113/jphysiol.2010.192617; Yang Y, 2014, CIRC RES, V114, P295, DOI 10.1161/CIRCRESAHA.114.302857; Yang YB, 2006, AM J PHYSIOL-HEART C, V291, pH3065, DOI 10.1152/ajpheart.00353.2006; Zhang DM, 2014, J PHYSIOL-LONDON, V592, P971, DOI 10.1113/jphysiol.2013.264697; Zhang T, 2004, CARDIOVASC RES, V63, P476, DOI 10.1016/j.cardiores.2004.04.026; Zhu LJ, 2014, VASC PHARMACOL, V60, P75, DOI 10.1016/j.vph.2014.01.001; Zhu WZ, 2007, J BIOL CHEM, V282, P10833, DOI 10.1074/jbc.M611507200	36	64	66	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25646	25656		10.1074/jbc.M115.650234	http://dx.doi.org/10.1074/jbc.M115.650234			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26316536	Green Published, hybrid			2022-12-26	WOS:000362962800037
J	Tapia-Armijos, MF; Homeier, J; Espinosa, CI; Leuschner, C; de la Cruz, M				Fernanda Tapia-Armijos, Maria; Homeier, Juergen; Ivan Espinosa, Carlos; Leuschner, Christoph; de la Cruz, Marcelino			Deforestation and Forest Fragmentation in South Ecuador since the 1970s-Losing a Hotspot of Biodiversity	PLOS ONE			English	Article							LAND-COVER CLASSIFICATION; HABITAT FRAGMENTATION; TROPICAL DEFORESTATION; PROTECTED AREAS; RAIN-FORESTS; DYNAMICS; PATTERNS; AMAZON; VEGETATION; LANDSCAPE	Deforestation and fragmentation are major components of global change; both are contributing to the rapid loss of tropical forest area with important implications for ecosystem functioning and biodiversity conservation. The forests of South Ecuador are a biological 'hotspot' due to their high diversity and endemism levels. We examined the deforestation and fragmentation patterns in this area of high conservation value using aerial photographs and Aster satellite scenes. The registered annual deforestation rates of 0.75% (1976-1989) and 2.86% (1989-2008) for two consecutive survey periods, the decreasing mean patch size and the increasing isolation of the forest fragments show that the area is under severe threat. Approximately 46% of South Ecuador's original forest cover had been converted by 2008 into pastures and other anthropogenic land cover types. We found that deforestation is more intense at lower elevations (premontane evergreen forest and shrubland) and that the deforestation front currently moves in upslope direction. Improved awareness of the spatial extent, dynamics and patterns of deforestation and forest fragmentation is urgently needed in biologically diverse areas like South Ecuador.	[Fernanda Tapia-Armijos, Maria; Ivan Espinosa, Carlos] Univ Tecn Particular Loja, Dept Ciencias Nat, Secc Ecol & Sistemat, Loja, Ecuador; [Fernanda Tapia-Armijos, Maria; Homeier, Juergen; Leuschner, Christoph] Univ Gottingen, Plant Ecol, Albrecht von Haller Inst Plant Sci, D-37073 Gottingen, Germany; [de la Cruz, Marcelino] Univ Rey Juan Carlos, Area Biodiversidad & Conservac, Dept Biol & Geol, ESCET, Madrid, Spain	Universidad Tecnica Particular de Loja; University of Gottingen; Universidad Rey Juan Carlos	Tapia-Armijos, MF (corresponding author), Univ Tecn Particular Loja, Dept Ciencias Nat, Secc Ecol & Sistemat, Loja, Ecuador.	mftapia@utpl.edu.ec	Espinosa, Carlos Ivan/AAI-1305-2019; de la Cruz, Marcelino/M-6124-2015; Homeier, Jürgen/G-1662-2011	Espinosa, Carlos Ivan/0000-0002-5330-4505; de la Cruz, Marcelino/0000-0002-9080-4525; Homeier, Jürgen/0000-0001-5676-3267	Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion (SENESCYT) [PIC 08 - 000139]; Universidad Tecnica Particular de Loja (UTPL); Agencia Espanola de Cooperacion Internacional para el Desarrollo (AECID) [A/012436/07, A/021000/08]; German Research Foundation (DFG) [FOR 816, HO 3296/2]	Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion (SENESCYT); Universidad Tecnica Particular de Loja (UTPL); Agencia Espanola de Cooperacion Internacional para el Desarrollo (AECID); German Research Foundation (DFG)(German Research Foundation (DFG))	This research, MFT and CIE were financially supported by the Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion (SENESCYT - http://www.educacionsuperior.gob.ec/) - Project PIC 08 - 000139 and the Universidad Tecnica Particular de Loja (UTPL - utpl.edu.ec), MFT was financially supported by the the Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion (SENESCYT - http://www.educacionsuperior.gob.ec/) scholarship program 2010, MC was financially supported by the Agencia Espanola de Cooperacion Internacional para el Desarrollo (AECID - http://www.aecid.es/ES) grants A/012436/07 and A/021000/08, MFT and JH were financially supported by the German Research Foundation (DFG - http://www.dfg.de/en/) research unit FOR 816 (project HO 3296/2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS M, 2002, ASTER USER HDB ADV S; Aide TM, 2013, BIOTROPICA, V45, P262, DOI 10.1111/j.1744-7429.2012.00908.x; [Anonymous], 2010, GEOGR BULL; Armenteras D, 2003, BIOL CONSERV, V113, P245, DOI 10.1016/S0006-3207(02)00359-2; Balslev H, 2002, BOT AUTROECUATORIANA; Barthlott W, 2005, NOVA ACT LC, V92, P61; Bendix J, 2006, CLIMATE RES, V30, P133, DOI 10.3354/cr030133; Bendix J., 1992, ERDKUNDE, V46, P118; Brehm G, 2005, J BIOGEOGR, V32, P1621, DOI 10.1111/j.1365-2699.2005.01304.x; Brehm G., 2008, V198, P15; Brodie J, 2012, TRENDS ECOL EVOL, V27, P145, DOI 10.1016/j.tree.2011.09.008; Brook BW, 2003, NATURE, V424, P420, DOI 10.1038/nature01795; Brummitt N, 2003, CONSERV BIOL, V17, P1442, DOI 10.1046/j.1523-1739.2003.02344.x; Canale GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041671; Cayuela L, 2006, FOREST ECOL MANAG, V226, P208; Chavez PS, 1996, PHOTOGRAMM ENG REM S, V62, P1025; Chuvieco S. E, 2010, TELEDETECCION AMBIEN; CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B; Cueva J, 2010, COBERTURA VEGETAL US; DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258; Eastman JR, 2012, IDRISI SELVA EDITION; Echeverria C, 2006, BIOL CONSERV, V130, P481, DOI 10.1016/j.biocon.2006.01.017; Ellingson LJ, 2000, FOREST ECOL MANAG, V137, P41, DOI 10.1016/S0378-1127(99)00311-4; Emck P., 2007, THESIS U ERLANGEN NU; Espinosa C. I., 2012, Ecosistemas, V21, P167; Eva HD, 2012, REMOTE SENS-BASEL, V4, P1369, DOI 10.3390/rs4051369; Fahrig L, 2002, ECOL APPL, V12, P346, DOI 10.1890/1051-0761(2002)012[0346:EOHFOT]2.0.CO;2; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; FAO, 2011, STAT WORLDS FOR 2011, P179; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Fearnside PM, 2004, ECOL APPL, V14, P982, DOI 10.1890/03-5225; Ferraz G, 2003, P NATL ACAD SCI USA, V100, P14069, DOI 10.1073/pnas.2336195100; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Foody GM, 2002, REMOTE SENS ENVIRON, V80, P185, DOI 10.1016/S0034-4257(01)00295-4; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Gottlicher D, 2009, INT J REMOTE SENS, V30, P1867, DOI 10.1080/01431160802541531; Hansen AJ, 2007, ECOL APPL, V17, P974, DOI 10.1890/05-1098; Hawbaker TJ, 2006, ECOL APPL, V16, P1222, DOI 10.1890/1051-0761(2006)016[1222:RDHGAL]2.0.CO;2; Homeier J., 2008, V198, P87; Homeier J., 2013, ECOL STUD, V221, P93, DOI DOI 10.1007/978-3-642-38137-9; Homeier J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047128; Iniguez-Armijos C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105869; Janzen D.H., 1988, P130; Jokisch BD, 2002, GEOGR REV, V92, P235, DOI 10.2307/4140972; Kauffman JB, 2003, FOREST ECOL MANAG, V176, P1, DOI 10.1016/S0378-1127(02)00227-X; Keating PL, 1998, PHYS GEOGR, V19, P221, DOI 10.1080/02723646.1998.10642648; Knowlton JL, 2011, ECOL APPL, V21, P2974, DOI 10.1890/10-1886.1; Kouki J, 2001, SCAND J FOREST RES, P27, DOI 10.1080/028275801300090564; Lambin E, 2003, ANNU REV ENV RESOUR, V28; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Lu D, 2004, INT J REMOTE SENS, V25, P2365, DOI 10.1080/0143116031000139863; Macedo MN, 2012, P NATL ACAD SCI USA, V109, P1341, DOI 10.1073/pnas.1111374109; Macleod RD, 1998, PHOTOGRAMM ENG REM S, V64, P207; Maldonado N., 2002, BOT NICA AUSTROECUAT, P28; Marquette CM, 1998, HUM ECOL, V26, P573, DOI 10.1023/A:1018797325069; McGarigal K, 2002, COMPUTER SOFTWARE PR; Mena CF, 2008, PHOTOGRAMM ENG REM S, V74, P737, DOI 10.14358/PERS.74.6.737; Mendoza JE, 2002, LANDSCAPE URBAN PLAN, V59, P147, DOI 10.1016/S0169-2046(02)00012-9; MILLETTE TL, 1995, GLOBAL ENVIRON CHANG, V5, P367, DOI 10.1016/0959-3780(95)00071-U; Ministerio del Ambiente del Ecuador, 2010, RES BIOSF EC LUG EXC; Ministerio del Ambiente del Ecuador Sistema de Clasificacion de los Ecosistemas del Ecuador Continental, 2012, SUBS PATR NAT, P136; Noske NM, 2008, BASIC APPL ECOL, V9, P4, DOI 10.1016/j.baae.2007.06.014; PALA V, 1995, PHOTOGRAMM ENG REM S, V61, P935; Pan WKY, 2004, AGR ECOSYST ENVIRON, V101, P117, DOI 10.1016/j.agee.2003.09.022; Peters T, 2013, ECOSYSTEM SERVICES B, V221, P19, DOI [10.1007/978-3-642-38137-9_2, DOI 10.1007/978-3-642-38137-9_2]; Portillo-Quintero CA, 2010, BIOL CONSERV, V143, P144, DOI 10.1016/j.biocon.2009.09.020; Puyravaud JP, 2003, FOREST ECOL MANAG, V177, P593, DOI 10.1016/S0378-1127(02)00335-3; Riano D, 2003, IEEE T GEOSCI REMOTE, V41, P1056, DOI 10.1109/TGRS.2003.811693; Richter M., 2003, ERDKUNDE, V57, P161, DOI DOI 10.3112/ERDKUNDE.2003.03.01; RodriguezMahecha J. V, 2004, HOTSPOTS REVISITED E, P80; Rudel TK, 2002, ANN ASSOC AM GEOGR, V92, P87, DOI 10.1111/1467-8306.00281; Santos BA, 2008, BIOL CONSERV, V141, P249, DOI 10.1016/j.biocon.2007.09.018; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Schowengerdt RA, 2007, REMOTE SENSING: MODELS AND METHODS FOR IMAGE PROCESSING, 3RD EDITION, P1; Schulz JJ, 2010, APPL GEOGR, V30, P436, DOI 10.1016/j.apgeog.2009.12.003; Sierra R, 2002, LANDSCAPE URBAN PLAN, V59, P95, DOI 10.1016/S0169-2046(02)00006-3; Sierra R, 1998, HUM ECOL, V26, P135, DOI 10.1023/A:1018753018631; Sierra R, 2000, APPL GEOGR, V20, P1, DOI 10.1016/S0143-6228(99)00014-4; SKOLE D, 1993, SCIENCE, V260, P1905, DOI 10.1126/science.260.5116.1905; Southgate D., 1990, Staff Paper - Department of Agricultural and Applied Economics, University of Minnesota; Tabarelli M, 2012, BIOL CONSERV, V155, P136, DOI 10.1016/j.biocon.2012.06.020; Tabarelli M, 2010, CONSERV BIOL, V24, P1654, DOI 10.1111/j.1523-1739.2010.01529.x; Tapia-Armijos MF, 2011, COBERTURA VEGETAL US; Thies B, 2012, J LAND USE SCI, P1; Torracchi E, 2000, AVANCES ANALISIS ESP, P275; Toutin T, 2004, INT J REMOTE SENS, V25, P1893, DOI 10.1080/0143116031000101611; Trejo I, 2000, BIOL CONSERV, V94, P133, DOI 10.1016/S0006-3207(99)00188-3; Valencia R., 2000, LIBRO ROJO PLANTAS E; Vina A, 2004, AMBIO, V33, P118, DOI 10.1639/0044-7447(2004)033[0118:SCDAOD]2.0.CO;2; VITOUSEK PM, 1994, ECOLOGY, V75, P1861, DOI 10.2307/1941591; Weigend M, 2002, BOT REV, V68, P38, DOI 10.1663/0006-8101(2002)068[0038:OOTBOT]2.0.CO;2; Weigend Maximilian, 2004, Rev. peru biol., V11, P127; Werner Florian A., 2005, Ecotropica (Bonn), V11, P21; Wolf K, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003876; Wunder S, 2000, EC DEFORESTATION EXA; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8; Young AG, 2000, CONSERV BIOL SER, V4, P335	98	129	141	1	126	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0133701	10.1371/journal.pone.0133701	http://dx.doi.org/10.1371/journal.pone.0133701			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332681	gold, Green Published			2022-12-26	WOS:000360613800005
J	Hu, XX; Fu, L; Li, Y; Lin, ZB; Liu, X; Wang, JF; Chen, YX; Wang, ZP; Zhang, X; Ou, ZJ; Ou, JS				Hu, Xiao-Xia; Fu, Li; Li, Yan; Lin, Ze-Bang; Liu, Xiang; Wang, Jing-Feng; Chen, Yang-Xin; Wang, Zhi-Ping; Zhang, Xi; Ou, Zhi-Jun; Ou, Jing-Song			The Cardioprotective Effect of Vitamin E (Alpha-Tocopherol) Is Strongly Related to Age and Gender in Mice	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; RANDOMIZED CONTROLLED-TRIAL; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; E SUPPLEMENTATION; CORONARY-DISEASE; HEART-DISEASE; E CONSUMPTION; RAT HEARTS; RISK	Vitamin E (VitE) only prevented cardiovascular diseases in some patients and the mechanisms remain unknown. VitE levels can be affected by aging and gender. We hypothesize that age and gender can influence VitE's cardioprotective effect. Mice were divided into 4 groups according to age and gender, and each group of mice were divided into a control group and a VitE group. The mice were administered water or VitE for 21 days; Afterward, the cardiac function and myocardial infarct size and cardiomyocyte apoptosis were measured after myocardial ischemia reperfusion(MI/R). VitE may significantly improved cardiac function in young male mice and aged female mice by enhancing ERK1/2 activity and reducing JNK activity. Enhanced expression of HSP90 and Bcl-2 were also seen in young male mice. No changes in cardiac function and cardiac proteins were detected in aged male mice and VitE was even liked to exert a reverse effect in cardiac function in young mice by enhancing JNK activity and reducing Bcl-2 expression. Those effects were in accordance with the changes of myocardial infarction size and cardiomyocyte apoptosis in each group of mice. VitE may reduce MI/R injury by inhibiting cardiomyocyte apoptosis in young male mice and aged female mice but not in aged male mice. VitE was possibly harmful for young female mice, shown as increased cardiomyocyte apoptosis after MI/R. Thus, we speculated that the efficacy of VitE in cardiac protection was associated with age and gender.	[Hu, Xiao-Xia; Fu, Li; Li, Yan; Lin, Ze-Bang; Liu, Xiang; Wang, Zhi-Ping; Zhang, Xi; Ou, Jing-Song] Sun Yat Sen Univ, Affiliated Hosp 1, Div Cardiac Surg, Guangzhou 510080, Guangdong, Peoples R China; [Hu, Xiao-Xia; Fu, Li; Li, Yan; Lin, Ze-Bang; Liu, Xiang; Wang, Zhi-Ping; Zhang, Xi; Ou, Zhi-Jun; Ou, Jing-Song] Sun Yat Sen Univ, sAffiliated Hosp 1, Key Lab Assisted Circulat, Minist Hlth, Guangzhou 510080, Guangdong, Peoples R China; [Hu, Xiao-Xia; Fu, Li; Li, Yan; Lin, Ze-Bang; Liu, Xiang; Ou, Zhi-Jun; Ou, Jing-Song] Sun Yat Sen Univ, Affiliated Hosp 1, Guangdong Prov Engn Lab Diag & Treatment Vasc Dis, Guangzhou 510080, Guangdong, Peoples R China; [Ou, Zhi-Jun] Sun Yat Sen Univ, Affiliated Hosp 1, Div Hypertens & Vasc Dis, Guangzhou 510080, Guangdong, Peoples R China; [Wang, Jing-Feng; Chen, Yang-Xin] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Cardiol, Guangzhou 510120, Guangdong, Peoples R China; [Wang, Jing-Feng; Chen, Yang-Xin] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangdong Prov Key Lab Arrhythmia & Electrophysio, Guangzhou 510120, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Ou, ZJ (corresponding author), Sun Yat Sen Univ, sAffiliated Hosp 1, Key Lab Assisted Circulat, Minist Hlth, Guangzhou 510080, Guangdong, Peoples R China.	Zhijunou@163.com; oujs@mail.sysu.edu.cn	wang, jing/GRS-7509-2022; Fu, Liwu/AAE-8835-2020		National Natural Science Foundation of China [30971261, 81170271, 81370370, 81325001]; Changjiang Scholars Program from Ministry of Education of China; Guangdong Pearl River Scholars Program; Program of National Key Clinical Specialties; Sun Yat-Sen University Clinical Research 5010 Program; Ministry of Human Resources and Social Security of China; Guangdong Natural Science Fund Committee, China [S2011010004378]; Guangzhou Government for Scientific Research Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Changjiang Scholars Program from Ministry of Education of China; Guangdong Pearl River Scholars Program; Program of National Key Clinical Specialties; Sun Yat-Sen University Clinical Research 5010 Program; Ministry of Human Resources and Social Security of China; Guangdong Natural Science Fund Committee, China; Guangzhou Government for Scientific Research Foundation	This study was supported by the National Natural Science Foundation of China (30971261, 81170271, 81370370 and Distinguished Young Scholar 81325001), the Changjiang Scholars Program from Ministry of Education of China, the Guangdong Pearl River Scholars Program, the Program of National Key Clinical Specialties, the Sun Yat-Sen University Clinical Research 5010 Program, the Science and Technology Research for the Returned Overseas Chinese Scholars from the Ministry of Human Resources and Social Security of China (2011), the Guangdong Natural Science Fund Committee, China (S2011010004378) and the Guangzhou Government for Scientific Research Foundation for Returned Overseas Chinese Scholars.	Altavilla D, 2000, CARDIOVASC RES, V47, P515, DOI 10.1016/S0008-6363(00)00124-3; Boaz M, 2000, LANCET, V356, P1213, DOI 10.1016/S0140-6736(00)02783-5; Chae CU, 2012, CIRC-HEART FAIL, V5, P176, DOI 10.1161/CIRCHEARTFAILURE.111.963793; Coombes JS, 2000, ACTA PHYSIOL SCAND, V169, P261, DOI 10.1046/j.1365-201x.2000.00740.x; Coombes JS, 2000, INT J VITAM NUTR RES, V70, P293, DOI 10.1024/0300-9831.70.6.293; Das J, 2011, BIOCHEM PHARMACOL, V81, P891, DOI 10.1016/j.bcp.2011.01.008; Du Y, 2005, LIFE SCI, V77, P2770, DOI 10.1016/j.lfs.2005.03.027; Hak AE, 2003, CIRCULATION, V108, P802, DOI 10.1161/01.CIR.0000084546.82738.89; Jeong JJ, 2009, FOOD CHEM TOXICOL, V47, P1569, DOI 10.1016/j.fct.2009.03.044; Kamzalov S, 2004, EXP GERONTOL, V39, P1199, DOI 10.1016/j.exger.2004.04.007; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Liao XL, 2013, J CARDIOVASC PHARM, V61, P430, DOI 10.1097/FJC.0b013e318288a68d; Mohanty I, 2004, BASIC CLIN PHARMACOL, V94, P184, DOI 10.1111/j.1742-7843.2004.pto940405.x; Mukherjee S, 2008, BBA-MOL BASIS DIS, V1782, P498, DOI 10.1016/j.bbadis.2008.05.002; Ou ZJ, 2010, AM J PHYSIOL-ENDOC M, V298, pE1131, DOI 10.1152/ajpendo.00107.2010; RIMM EB, 1993, NEW ENGL J MED, V328, P1450, DOI 10.1056/NEJM199305203282004; Rodrigo R, 2012, INTERACT CARDIOV TH, V15, P209, DOI 10.1093/icvts/ivs154; STAMPFER MJ, 1993, NEW ENGL J MED, V328, P1444, DOI 10.1056/NEJM199305203282003; Stephens NG, 1996, LANCET, V347, P781, DOI 10.1016/S0140-6736(96)90866-1; Traber MG, 2007, AM J CLIN NUTR, V85, p293S, DOI 10.1093/ajcn/85.1.293S; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Vardi M, 2013, J LIPID RES, V54, P2307, DOI 10.1194/jlr.R026641; Yang F, 2011, J HEART LUNG TRANSPL, V30, P928, DOI 10.1016/j.healun.2011.04.001; Yang JH, 2014, CELL STRESS CHAPERON, V19, P33, DOI 10.1007/s12192-013-0432-0; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302; Zhao Y, 2007, CANCER LETT, V247, P345, DOI 10.1016/j.canlet.2006.05.015	26	11	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137405	10.1371/journal.pone.0137405	http://dx.doi.org/10.1371/journal.pone.0137405			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331272	Green Published, gold, Green Submitted			2022-12-26	WOS:000360613800130
J	Lee, WH; Schaffner-Reckinger, E; Tsoukatos, DC; Aylward, K; Moussis, V; Tsikaris, V; Trypou, P; Egot, M; Baruch, D; Kieffer, N; Bachelot-Loza, C				Lee, Wen Hwa; Schaffner-Reckinger, Elisabeth; Tsoukatos, Demokritos C.; Aylward, Kelly; Moussis, Vassilios; Tsikaris, Vassilios; Trypou, Paraskevi; Egot, Marion; Baruch, Dominique; Kieffer, Nelly; Bachelot-Loza, Christilla			Inhibition of alpha IIb beta 3 Ligand Binding by an alpha IIb Peptide that Clasps the Hybrid Domain to the beta I Domain of beta 3	PLOS ONE			English	Article							PLATELET INTEGRIN ALPHA(IIB)BETA(3); GLYCOPROTEIN-IIB; CONFORMATIONAL-CHANGES; FIBRINOGEN BINDING; STRUCTURAL BASIS; CELL-ADHESION; ACTIVATION; RECEPTOR; ALPHA-V-BETA-3; AGGREGATION	Agonist-stimulated platelet activation triggers conformational changes of integrin alpha IIb beta 3, allowing fibrinogen binding and platelet aggregation. We have previously shown that an octapeptide, (p1)YMESRADR(8), corresponding to amino acids 313-320 of the beta-ribbon extending from the beta-propeller domain of alpha IIb, acts as a potent inhibitor of platelet aggregation. Here we have performed in silico modelling analysis of the interaction of this peptide with alpha IIb beta 3 in its bent and closed (not swing-out) conformation and show that the peptide is able to act as a substitute for the beta-ribbon by forming a clasp restraining the beta 3 hybrid and beta I domains in a closed conformation. The involvement of species-specific residues of the beta 3 hybrid domain (E356 and K384) and the beta 1 domain (E297) as well as an intrapeptide bond (pE315-pR317) were confirmed as important for this interaction by mutagenesis studies of alpha IIb beta 3 expressed in CHO cells and native or substituted peptide inhibitory studies on platelet functions. Furthermore, NMR data corroborate the above results. Our findings provide insight into the important functional role of the alpha IIb beta-ribbon in preventing integrin alpha IIb beta 3 head piece opening, and highlight a potential new therapeutic approach to prevent integrin ligand binding.	[Lee, Wen Hwa] Univ Oxford, SGC, Oxford, England; [Schaffner-Reckinger, Elisabeth; Kieffer, Nelly] Univ Luxembourg, Lab Biol & Physiol Integree, CNRS, GDRE ITI, Luxembourg, Luxembourg; [Tsoukatos, Demokritos C.; Moussis, Vassilios; Tsikaris, Vassilios; Trypou, Paraskevi] Univ Ioannina, Dept Chem, Sect Organ Chem & Biochem, Ioannina, Greece; [Aylward, Kelly; Egot, Marion; Baruch, Dominique; Bachelot-Loza, Christilla] INSERM, UMR S 1140, Fac Pharm, Paris, France; [Aylward, Kelly; Egot, Marion; Baruch, Dominique; Bachelot-Loza, Christilla] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Kieffer, Nelly] Jiao Tong Univ, Sch Med, CNRS LIA 124, Sino French Res Ctr Life Sci & Genom, Shanghai 200030, Peoples R China	University of Oxford; University of Luxembourg; University of Ioannina; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Shanghai Jiao Tong University	Bachelot-Loza, C (corresponding author), INSERM, UMR S 1140, Fac Pharm, Paris, France.	christilla.bachelot-loza@parisdescartes.fr	Lee, Wen Hwa/G-1250-2013; Tsikaris, Vassilios/AAM-6235-2021; Baruch, Dominique/ABA-1791-2020; baruch, dominique/F-8189-2013; Lee, Wen Hwa/GZA-8183-2022	Lee, Wen Hwa/0000-0002-4098-5225; Baruch, Dominique/0000-0003-2835-5500; Lee, Wen Hwa/0000-0002-4098-5225; Bachelot-Loza, Christilla/0000-0002-6264-902X; Moussis, Vassilios/0000-0003-0658-8637	"Programme Egide Platon" of the Ministry of Foreign Affairs, France; Joint Research and Technology Program of the General Secretariat for Research and Technology, Greece; Region Ile-de-France (CORDDIM); AbbVie [1097737]; Boehringer Ingelheim; Canada Foundation for Innovation; Canadian Institutes for Health Research; Genome Canada; GlaxoSmithKline; Janssen; Lilly Canada; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer; Takeda; Wellcome Trust	"Programme Egide Platon" of the Ministry of Foreign Affairs, France; Joint Research and Technology Program of the General Secretariat for Research and Technology, Greece; Region Ile-de-France (CORDDIM)(Region Ile-de-France); AbbVie(AbbVie); Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission)	This study was generously supported by "Programme Egide Platon" of the Ministry of Foreign Affairs, France and the Joint Research and Technology Program of the General Secretariat for Research and Technology, Greece; M.E. is supported by the Region Ile-de-France (CORDDIM). The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Boehringer Ingelheim, the Canada Foundation for Innovation, the Canadian Institutes for Health Research, Genome Canada, GlaxoSmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda, and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair BD, 2005, J CELL BIOL, V168, P1109, DOI 10.1083/jcb.200410068; Adair BD, 2002, P NATL ACAD SCI USA, V99, P14059, DOI 10.1073/pnas.212498199; Armstrong PC, 2012, THROMB HAEMOSTASIS, V107, P808, DOI 10.1160/TH11-10-0727; Atherton E., 1990, SOLID PHASE PEPTIDE; Beglova N, 2002, NAT STRUCT BIOL, V9, P282, DOI 10.1038/nsb779; Biris N, 2003, EUR J BIOCHEM, V270, P3760, DOI 10.1046/j.1432-1033.2003.03762.x; Bledzka K, 2013, CIRC RES, V112, P1189, DOI 10.1161/CIRCRESAHA.112.300570; CARRELL NA, 1985, J BIOL CHEM, V260, P1743; Cheng M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081609; Choi WS, 2013, BLOOD, V122, P4165, DOI 10.1182/blood-2013-04-499194; Coller BS, 2008, BLOOD, V112, P3011, DOI 10.1182/blood-2008-06-077891; Derrick JM, 1997, BIOCHEM J, V325, P309, DOI 10.1042/bj3250309; FRELINGER AL, 1988, J BIOL CHEM, V263, P12397; HARFENIST EJ, 1988, BLOOD, V71, P132; HONDA S, 1995, J BIOL CHEM, V270, P11947, DOI 10.1074/jbc.270.20.11947; Kamata T, 2010, J BIOL CHEM, V285, P38428, DOI 10.1074/jbc.M110.139667; Kok RJ, 2002, BIOCONJUGATE CHEM, V13, P128, DOI 10.1021/bc015561+; Lau TL, 2008, J BIOL CHEM, V283, P16162, DOI 10.1074/jbc.M801748200; Legendre P, 2006, J THROMB HAEMOST, V4, P236, DOI 10.1111/j.1538-7836.2005.01653.x; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Mitchell WB, 2007, BLOOD, V109, P3725, DOI 10.1182/blood-2006-11-058420; Mitsios JV, 2004, EUR J BIOCHEM, V271, P855, DOI 10.1111/j.1432-1033.2004.03990.x; Nishida N, 2006, IMMUNITY, V25, P583, DOI 10.1016/j.immuni.2006.07.016; Papamichael ND, 2009, J PHARMACOL EXP THER, V329, P634, DOI 10.1124/jpet.108.150086; Pearce AC, 2004, BIOCHEM J, V378, P193, DOI 10.1042/BJ20031298; PFAFF M, 1994, J BIOL CHEM, V269, P20233; Provasi D, 2009, PROTEINS, V77, P477, DOI 10.1002/prot.22463; Rand ML, 1999, THROMB HAEMOSTASIS, V82, P1680; SAMANEN J, 1991, J MED CHEM, V34, P3114, DOI 10.1021/jm00114a022; Schaffner-Reckinger E, 1998, J BIOL CHEM, V273, P12623, DOI 10.1074/jbc.273.20.12623; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Stanica RM, 2008, J PEPT SCI, V14, P1195, DOI 10.1002/psc.1060; Stewart JM, 1984, PRINCIPLES PEPTIDE S; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Vijayan KV, 2003, FEBS LETT, V540, P41, DOI 10.1016/S0014-5793(03)00170-4; Vomund AN, 2008, BIOCHEMISTRY-US, V47, P11616, DOI 10.1021/bi8015108; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; Zhu JQ, 2013, J CELL BIOL, V201, P1053, DOI 10.1083/jcb.201212037; Zhu J, 2009, MOL CELL, V34, P234, DOI 10.1016/j.molcel.2009.02.022	41	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0134952	10.1371/journal.pone.0134952	http://dx.doi.org/10.1371/journal.pone.0134952			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332040	Green Submitted, Green Published, gold			2022-12-26	WOS:000360613800016
J	Townhill, BL; Maxwell, D; Engelhard, GH; Simpson, SD; Pinnegar, JK				Townhill, Bryony L.; Maxwell, David; Engelhard, Georg H.; Simpson, Stephen D.; Pinnegar, John K.			Historical Arctic Logbooks Provide Insights into Past Diets and Climatic Responses of Cod	PLOS ONE			English	Article							GADUS-MORHUA; NORWEGIAN COD; LIFE-HISTORY; FISH STOCKS; SEA; DYNAMICS; CAPELIN; GROWTH; SHIFTS; ZOOPLANKTON	Gadus morhua (Atlantic cod) stocks in the Barents Sea are currently at levels not seen since the 1950s. Causes for the population increase last century, and understanding of whether such large numbers will be maintained in the future, are unclear. To explore this, we digitised and interrogated historical cod catch and diet datasets from the Barents Sea. Seventeen years of catch data and 12 years of prey data spanning 1930-1959 cover unexplored spatial and temporal ranges, and importantly capture the end of a previous warm period, when temperatures were similar to those currently being experienced. This study aimed to evaluate cod catch per unit effort and prey frequency in relation to spatial, temporal and environmental variables. There was substantial spatio-temporal heterogeneity in catches through the time series. The highest catches were generally in the 1930s and 1940s, although at some localities more cod were recorded late in the 1950s. Generalized Additive Models showed that environmental, spatial and temporal variables are all valuable descriptors of cod catches, with the highest occurring from 15-45 degrees E longitude and 73-77 degrees N latitude, at bottom temperatures between 2 and 4 degrees C and at depths between 150 and 250 m. Cod diets were highly variable during the study period, with frequent changes in the relative frequencies of different prey species, particularly Mallotus villosus (capelin). Environmental variables were particularly good at describing the importance of capelin and Clupea harengus (herring) in the diet. These new analyses support existing knowledge about how the ecology of the region is controlled by climatic variability. When viewed in combination with more recent data, these historical relationships will be valuable in forecasting the future of Barents Sea fisheries, and in understanding how environments and ecosystems may respond.	[Townhill, Bryony L.; Maxwell, David; Engelhard, Georg H.; Pinnegar, John K.] Ctr Environm Fisheries & Aquaculture Sci Cefas, Lowestoft, Suffolk, England; [Simpson, Stephen D.] Univ Exeter, Coll Life & Environm Sci, Biosci, Exeter, Devon, England	Centre for Environment Fisheries & Aquaculture Science; University of Exeter	Townhill, BL (corresponding author), Ctr Environm Fisheries & Aquaculture Sci Cefas, Lowestoft, Suffolk, England.	bryony.townhill@cefas.co.uk		Pinnegar, John/0000-0001-5061-9520; Engelhard, Georg H./0000-0002-7821-7029; Simpson, Stephen/0000-0002-4856-6164	Cefas Seedcorn [DP332]; NERC Fellowship [NE/J500616/2]; Natural Environment Research Council [NE/J500616/2] Funding Source: researchfish; NERC [NE/J500616/2] Funding Source: UKRI	Cefas Seedcorn; NERC Fellowship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Work was funded by Cefas Seedcorn grant number DP332 entitled Trawling Through Time DM. Funding was provided to SS through a NERC Fellowship (NE/J500616/2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agenorov VK, 1946, GIDROMETEOIXDAT, P1; Beaugrand G, 2002, MAR ECOL PROG SER, V232, P197, DOI 10.3354/meps232197; Beaugrand G, 2003, GLOBAL CHANGE BIOL, V9, P801, DOI 10.1046/j.1365-2486.2003.00632.x; Beverton R., 1965, INT COMMISSION NW AT, V6, P225; BEVERTON RJH, 1994, ICES MAR SC, V198, P482; Blacker RW, 1957, MINISTRY AGR FISHERI, VII; Bogstad B, 2013, MAR BIOL RES, V9, P895, DOI 10.1080/17451000.2013.775451; Boitsov VD, 2012, ICES J MAR SCI, V69, P833, DOI 10.1093/icesjms/fss075; Brander KM, 2010, J FISH BIOL, V77, P1899, DOI 10.1111/j.1095-8649.2010.02782.x; Brown WW, 1946, HULL B MARINE BIOL, V3; Cefas, CEF FISH STOM REC 20; Corlett J., 1965, Special Publications International Commission for the Northwest Atlantic Fisheries, V6, P373; DALPADADO P, 1991, POLAR RES, V10, P443, DOI 10.1111/j.1751-8369.1991.tb00665.x; Dalpadado P, 1996, MAR ECOL PROG SER, V144, P175, DOI 10.3354/meps144175; Dolgov AV, 2007, IMR PINRO REPORT SER, P44; Drinkwater KF, 2011, PROG OCEANOGR, V90, P47, DOI 10.1016/j.pocean.2011.02.006; Drinkwater KF, 2006, PROG OCEANOGR, V68, P134, DOI 10.1016/j.pocean.2006.02.011; Ellingsen IH, 2008, CLIMATIC CHANGE, V87, P155, DOI 10.1007/s10584-007-9369-6; Engelhard GH, 2014, GLOBAL CHANGE BIOL, V20, P2473, DOI 10.1111/gcb.12513; Engelhard GH, 2011, ICES J MAR SCI, V68, P1090, DOI 10.1093/icesjms/fsr031; Engelhard GH, 2011, ICES J MAR SCI, V68, P580, DOI 10.1093/icesjms/fsq183; Furevik T., 2002, FISKEN HAVET; Genner MJ, 2010, GLOBAL CHANGE BIOL, V16, P517, DOI 10.1111/j.1365-2486.2009.02027.x; Gjosaeter H, 1998, SARSIA, V83, P453, DOI 10.1080/00364827.1998.10420445; Godo OR, 2003, FISH FISH, V4, P121, DOI 10.1046/j.1467-2979.2003.00112.x; GRAHAM M., 1953, ARCTIC, V6, P252; HARVEY JOHN, 1965, INT COMM NORTHWEST ATLANTIC FISH SPEC PUBLICATION, V6, P869; Helle K, 1999, ICES J MAR SCI, V56, P15, DOI 10.1006/jmsc.1998.0427; Helle K, 2002, ENVIRON BIOL FISH, V65, P341, DOI 10.1023/A:1020581415071; Hiddink JG, 2008, GLOBAL CHANGE BIOL, V14, P453, DOI 10.1111/j.1365-2486.2007.01518.x; Hjort J, 1914, CONSEIL PERMANENT IN; Huse G, 2008, CLIMATIC CHANGE, V87, P177, DOI 10.1007/s10584-007-9347-z; Hylen A, 2002, ICES MARINE SCI S, V215, P534; ICES, 2014, ADV JUN 2014 ECOREGI; ICES, 1949, RAPP PROC VERB REUN; ICES, 2014, ICES REP ARCT FISH W; Jensen ADS, 1939, BIOL MEDDELELSER, VXIV, P8; Johannesen E, NW ATL FISH ORG SCI; Johannesen E, 2012, MAR ECOL PROG SER, V458, P181, DOI 10.3354/meps09818; Kerr RA, 2000, SCIENCE, V288, P1984, DOI 10.1126/science.288.5473.1984; Keup-Thiel E, 2006, BOREAL ENVIRON RES, V11, P329; Kjesbu OS, 2014, P NATL ACAD SCI USA, V111, P3478, DOI 10.1073/pnas.1316342111; Lee A., 1956, Polar Record, V8, P109; Orlova EL, 2005, ICES J MAR SCI, V62, P1281, DOI 10.1016/j.icesjms.2005.05.020; Orlova EL, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2014.00074; Ottersen G, 2014, ICES J MAR SCI, V71, P2064, DOI 10.1093/icesjms/fsu037; Ottersen G, 2013, MAR ECOL PROG SER, V480, P205, DOI 10.3354/meps10249; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pinnegar J. K., 2014, DAPSTOM INTEGRATED D; Prozorkevich D, 2013, IMR PINRO JOINT REPO, V4, P38; R Core Team, 2021, R LANGUAGE ENV STAT; Rose GA, 2004, CAN J FISH AQUAT SCI, V61, P1553, DOI 10.1139/F04-173; SAETERSDAL G, 1987, FISH RES, V5, P253; Sagarin R, 2001, SCIENCE, V294, P811, DOI 10.1126/science.1064218; Simpson SD, 2011, CURR BIOL, V21, P1565, DOI 10.1016/j.cub.2011.08.016; Steffensen E, 1969, METEORLOGISKE ANN, V5, P263; Stempniewicz L, 2007, DEEP-SEA RES PT II, V54, P2934, DOI 10.1016/j.dsr2.2007.08.012; Stenevik EK, 2007, MAR POLICY, V31, P19, DOI 10.1016/j.marpol.2006.05.001; Stiansen JE, 2006, JOINT PINRO IMR REPO; Sundby S, 2008, ICES J MAR SCI, V65, P953, DOI 10.1093/icesjms/fsn085; Vines TH, 2014, CURR BIOL, V24, P94, DOI 10.1016/j.cub.2013.11.014; Wang HY, 2014, MAR ECOL PROG SER, V514, P217, DOI 10.3354/meps10943; Wood S, 2014, MIXED GAM COMPUTATIO; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Yamanouchi T, 2011, POLAR SCI, V5, P53, DOI 10.1016/j.polar.2010.10.002; Yaragina NA, 2009, MAR BIOL RES, V5, P75, DOI 10.1080/17451000802512739; Zatsepin VI, 1939, FISHERIES RES BOARD, V1064; Zubov MN, 1948, THE CTR ARCTIC	68	10	10	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135418	10.1371/journal.pone.0135418	http://dx.doi.org/10.1371/journal.pone.0135418			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331271	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000360613800030
J	Kong, LN; Guo, Y; Qin, B; Peng, X; Zhu, WF				Kong, Ling-Na; Guo, Ying; Qin, Bo; Peng, Xin; Zhu, Wen-Fen			Development of Self-Management Indicators for Chronic Hepatitis B Patients on Antiviral Therapy: Results of a Chinese Delphi Panel Survey	PLOS ONE			English	Article							VIRUS INFECTION; DISEASE; INSTRUMENT; ADHERENCE; HISTORY; PEOPLE	Objective This study aimed to develop a set of indicators that could be used to measure and monitor the self-management performance for chronic hepatitis B (CHB) patients on antiviral therapy in China. Methods A two-round Delphi study via e-mail correspondence was conducted, with a group of 30 Chinese experts. The Delphi questionnaire consisted of 53 indicators identified from a literature review. Experts rated and scored the importance of indicators on a five-point Likert scale. Consensus was considered to be reached if a median score in the top tertile (4-5) and >= 80% of panel ratings in the top tertile (4-5) after Round 2. The included indicators were validated with a group of 106 CHB patients. Results The response rates for the first and second rounds were 90.9% (n=30) and 86.7% (n=26), respectively. Three new indicators were suggested in the first round. 55 indicators were included in the second round after modified. 45 (81.8%) indicators achieved on the level of consensus, all of which had an inter-quartile range of 1 or below. The final set included 4 domains and 45 indicators which were well accepted and understandable by CHB patients. Conclusion This Delphi study produced a set of 45 self-management indicators for CHB patients on antiviral therapy in China. These indicators could be used to measure and monitor the patients' self-management performance, with the goal of improving the quality of life in this population.	[Kong, Ling-Na; Qin, Bo] Chongqing Univ, Dept Infect Dis, Affiliated Hosp Chongqing Med 1, Chongqing 630044, Peoples R China; [Kong, Ling-Na; Zhu, Wen-Fen] Chongqing Med Univ, Coll Nursing, Chongqing, Peoples R China; [Guo, Ying] Harbin Med Univ, Dept Internal Med, Outpatient Dept, Affiliated Hosp 2, Harbin, Peoples R China; [Peng, Xin] Jilin Univ, Sch Nursing, Changchun 130023, Peoples R China	Chongqing University; Chongqing Medical University; Harbin Medical University; Jilin University	Qin, B (corresponding author), Chongqing Univ, Dept Infect Dis, Affiliated Hosp Chongqing Med 1, Chongqing 630044, Peoples R China.	cqqinbo@126.com						Aronson BD, 2012, AM J PHARM EDUC, V76, DOI 10.5688/ajpe767125; Barlow J, 2002, PATIENT EDUC COUNS, V48, P177, DOI 10.1016/S0738-3991(02)00032-0; Bonner JE, 2012, J VIRAL HEPATITIS, V19, P316, DOI 10.1111/j.1365-2893.2011.01550.x; Cai SF, 2012, CHI MOD MED, V19, P144; Chen KH, 2008, J ADV NURS, V64, P595, DOI 10.1111/j.1365-2648.2008.04821.x; Cooke GS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5429; Corbin J. S A, 1988, UNENDING WORK AND CA; Dalkey NC, 1969, THE DELPHI METHOD AN; Deane KHO, 2003, BRIT J OCCUPATIONAL, V66, P247, DOI DOI 10.1177/030802260306600603; Foundation DH, 2009, CHRONIC HEPATITIS B; Fry M, 2012, PSYCHOL HEALTH, V27, P460, DOI 10.1080/08870446.2011.592982; Fung J, 2011, J ANTIMICROB CHEMOTH, V66, P2715, DOI 10.1093/jac/dkr388; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Giang L, 2012, WORLD J HEPATOL, V4, P43, DOI 10.4254/wjh.v4.i2.43; Groessl EJ, 2011, J VIRAL HEPATITIS, V18, P358, DOI 10.1111/j.1365-2893.2010.01328.x; Groessl EJ, 2008, J GEN INTERN MED, V23, P1959, DOI 10.1007/s11606-008-0790-y; Kamezaki H, 2013, INT J MED SCI, V10, P567, DOI 10.7150/ijms.5795; Kleynen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100227; Li H, 2014, INT J NURS STUD, V51, P208, DOI 10.1016/j.ijnurstu.2013.05.012; Li HX, 2008, CHIN J PRACL NURS, V24, P43; Liaw YF, 2012, HEPATOL INT, V6, P531, DOI 10.1007/s12072-012-9365-4; Lin CW, 2013, J HEPATOL, V58, P730, DOI 10.1016/j.jhep.2012.11.045; Lin CC, 2008, RES NURS HEALTH, V31, P370, DOI 10.1002/nur.20258; Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01; Lu FM, 2009, CHINESE MED J-PEKING, V122, P3, DOI 10.3760/cma.j.issn.0366-6999.2009.01.001; Maarsingh OR, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-12; McGinn CA, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-105; Palter VN, 2011, AM J SURG, V201, P251, DOI 10.1016/j.amjsurg.2010.01.031; Petersen J, 2012, EXPERT REV GASTROENT, V6, P683, DOI [10.1586/egh.12.52, 10.1586/EGH.12.52]; Powell C, 2003, J ADV NURS, V41, P376, DOI 10.1046/j.1365-2648.2003.02537.x; Shen J, 2012, CHIN NURS SCI, V26, P1963; Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009; Stevens Bonnie, 2006, BMC Pediatr, V6, P1, DOI 10.1186/1471-2431-6-1; Stoller EP, 2009, AM J HEALTH BEHAV, V33, P376, DOI 10.5993/AJHB.33.4.4; Tolsgaard MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057687; Xu W., 2011, J NURS SCI, V26, P38; YANG J, 2013, J APPL MATH, DOI DOI 10.1155/2013/; Yang YF, 2009, NURS J CHIN PLA, V26, P27; Zhang CH, 2013, RESP CARE, V58, P1931, DOI 10.4187/respcare.02269; Zhao X, 2013, PHYSIOLOGICAL AND SU	40	13	13	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0134125	10.1371/journal.pone.0134125	http://dx.doi.org/10.1371/journal.pone.0134125			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ2NK	26327606	Green Submitted, Green Published, gold			2022-12-26	WOS:000360437700010
J	Ao, M; Miyauchi, M; Furusho, H; Inubushi, T; Kitagawa, M; Nagasaki, A; Sakamoto, S; Kozai, K; Takata, T				Ao, Min; Miyauchi, Mutsumi; Furusho, Hisako; Inubushi, Toshihiro; Kitagawa, Masae; Nagasaki, Atsuhiro; Sakamoto, Shinichi; Kozai, Katsuyuki; Takata, Takashi			Dental Infection of Porphyromonas gingivalis Induces Preterm Birth in Mice	PLOS ONE			English	Article							PREGNANT MICE; PREMATURE; WEIGHT; PROSTAGLANDINS; INFLAMMATION; MORTALITY; BACTERIA; INCREASE; OUTCOMES; LABOR	Background Epidemiological studies have revealed a link between dental infection and preterm birth or low birth weight (PTB/LBW), however, the underlying mechanisms remain unclear. Progress in understanding the associated mechanisms has been limited in part by lack of an animal model for chronic infection-induced PTB/LBW, mimicking pregnancy under conditions of periodontitis. We aimed to establish a mouse model of chronic periodontitis in order to investigate the link between periodontitis and PTB/LBW. Methods To establish chronic inflammation beginning with dental infection, we surgically opened mouse (female, 8 weeks old) 1st molar pulp chambers and directly infected with w83 strain Porphyromonas gingivalis (P.g.), a keystone periodontal pathogen. Mating was initiated at 6 wks post-infection, by which time dental granuloma tissue had developed and live P.g. was cultured from extracted tooth root, which serves as a persistent source of P.g. The gestational day (gd) and birth weight were recorded during for P.g.-infected and control mice, and serum and placental tissues were collected at gd 15 to evaluate the systemic and local conditions during pregnancy. Results Dental infection with P.g. significantly increased circulating TNF-alpha (2.5-fold), IL-17 (2-fold), IL-6 (2-fold) and IL-1 alpha (2-fold). The P.g.-infected group delivered at gd 18.25 vs. gd 20.45 in the non-infected control (NC) group (p < 0.01), and pups exhibited LBW compared to controls (p < 0.01). P.g. was localized to placental tissues by immunohistochemistry and PCR, and defects in placental tissues of P.g. infected mice included premature rupture of membrane, placental detachment, degenerative changes in trophoblasts and endothelial cells, including necrotic areas. P.g. infection caused significantly increased numbers of polymorphonuclear leukocytes (PMNLs) and macrophages in placental tissues, associated with increased local expression of pro-inflammatory mediators including TNF-alpha and COX-2. Further placental tissue damage was indicated in P.g. infectedmice by decreased CD-31 in endothelial cells, increased expression of 8OHdG, an indicator of oxidative DNA damage, and cleaved caspase-3, a marker of apoptosis. In vitro, P.g. lipopolysaccharide significantly increased expression of COX-2, IL-8 and TNF-alpha, in HTR-8 trophoblasts in an NF-kappa B-dependent fashion. Conclusions Our novel mouse model supports previous epidemiological studies signifying dental infection as predisposing factor for PTB/LBW. We demonstrate PTB and LBW in infected mice, translocation of P.g to placental tissues, increased circulating and local pro-inflammatory markers, and the capability of P.g. LPS to directly induce cytokine production in trophoblasts, in vitro. These findings further underscore the importance of local and systemic infections and inflammation during pregnancy and suggest that prevention and/or elimination of dental infections such as marginal or periapical periodontitis before pregnancy may have a beneficial effect on PTB/LBW.	[Ao, Min; Miyauchi, Mutsumi; Furusho, Hisako; Inubushi, Toshihiro; Nagasaki, Atsuhiro; Sakamoto, Shinichi; Takata, Takashi] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Oral & Maxillofacial Pathobiol, Hiroshima 7348553, Japan; [Ao, Min; Kozai, Katsuyuki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Pediat Dent, Hiroshima 7348553, Japan; [Kitagawa, Masae] Hiroshima Univ, Hiroshima Univ Hosp, Ctr Oral Clin Examinat, Hiroshima 7348553, Japan	Hiroshima University; Hiroshima University; Hiroshima University	Takata, T (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Oral & Maxillofacial Pathobiol, Hiroshima 7348553, Japan.	ttakata@hiroshima-u.ac.jp	Furusho, Hisako/H-2351-2019; Miyauchi, Mutsumi/G-5268-2019		 [26670802]		This work was supported by Grants-in-Aid for Scientific Research (C). Research Project number: 26670802 https://www.jsps.go.jp/english/e-grants/grants01.html.	Ao M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110519; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; BATTAGLI.FC, 1967, J PEDIATR-US, V71, P159, DOI 10.1016/S0022-3476(67)80066-0; Behrman RE, 2007, PRETERM BIRTH CAUSES; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Boggess KA, 2005, AM J OBSTET GYNECOL, V192, P554, DOI 10.1016/j.ajog.2004.09.001; Carroll S, 1996, CURR OPIN OBSTET GYN, V8, P441; COLLINS JG, 1994, INFECT IMMUN, V62, P4356, DOI 10.1128/IAI.62.10.4356-4361.1994; Elovitz MA, 2003, AM J PATHOL, V163, P2103, DOI 10.1016/S0002-9440(10)63567-5; Furusho H, 2013, J GASTROENTEROL; HAMADA S, 1994, MOLECULAR PATHOGENESIS OF PERIODONTAL DISEASE, P105; Han YPW, 2004, INFECT IMMUN, V72, P2272, DOI 10.1128/IAI.72.4.2272-2279.2004; Inubushi T, 2012, J BIOL CHEM, V287, P23527, DOI 10.1074/jbc.M111.324673; Jayaprakash K, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-193; Katz J, 2009, J DENT RES, V88, P575, DOI 10.1177/0022034509338032; Kaur M, 2014, J PERIODONTOL, V85, P1684, DOI 10.1902/jop.2014.140248; KOOPS BL, 1982, J PEDIATR-US, V101, P969; LeBlanc MM, 2012, EQUINE VET J, V44, P8, DOI 10.1111/j.2042-3306.2011.00502.x; Leon R, 2007, J PERIODONTOL, V78, P1249, DOI 10.1902/jop.2007.060368; Li Y, 2011, PLACENTA, V32, P11, DOI 10.1016/j.placenta.2010.10.007; Lin DM, 2003, INFECT IMMUN, V71, P5163, DOI 10.1128/IAI.71.9.5163-5168.2003; Mwaniki MK, 2012, LANCET, V379, P445, DOI 10.1016/S0140-6736(11)61577-8; Nath CA, 2010, AM J REPROD IMMUNOL, V63, P144, DOI 10.1111/j.1600-0897.2009.00773.x; Offenbacher S, 1996, J PERIODONTOL, V67, P1103, DOI 10.1902/jop.1996.67.10s.1103; Olson DM, 2007, FRONT BIOSCI-LANDMRK, V12, P1329, DOI 10.2741/2151; Olson DM, 2003, BEST PRACT RES CL OB, V17, P717, DOI 10.1016/S1521-6934(03)00069-5; Ouhara K, 2015, ORAL DIS, V21, P626, DOI 10.1111/odi.12326; Pereira CV, 2011, J PERIODONTOL, V82, P1767, DOI 10.1902/jop.2011.110063; Platt MJ, 2014, PUBLIC HEALTH, V128, P399, DOI 10.1016/j.puhe.2014.03.010; Puchner K, 2012, ARCH GYNECOL OBSTET, V285, P37, DOI 10.1007/s00404-011-1909-7; Horliana ACRT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098271; Saito D, 2009, J ENDODONT, V35, P1518, DOI 10.1016/j.joen.2009.08.005; Sakata M, 2008, OBSTET GYNECOL SURV, V63, P651, DOI 10.1097/OGX.0b013e318181a79f; Wang PL, 2002, CRIT REV ORAL BIOL M, V13, P132, DOI 10.1177/154411130201300204; Wang WJ, 2014, HUM REPROD, V29, P946, DOI 10.1093/humrep/deu014; WILCOX AJ, 1992, AM J PUBLIC HEALTH, V82, P378, DOI 10.2105/AJPH.82.3.378; Yoshimura M, 2000, INFECT IMMUN, V68, P6912, DOI 10.1128/IAI.68.12.6912-6916.2000	37	56	60	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0137249	10.1371/journal.pone.0137249	http://dx.doi.org/10.1371/journal.pone.0137249			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322971	Green Published, Green Submitted, gold			2022-12-26	WOS:000360435500069
J	Moreno, J; Hidalgo, M; Duarte, C; Sanabria, O; Gabastou, JM; Ibarz-Pavon, AB				Moreno, Jaime; Hidalgo, Melissa; Duarte, Carolina; Sanabria, Olga; Gabastou, Jean Marc; Ibarz-Pavon, Ana Belen			Characterization of Carriage Isolates of Neisseria meningitides in the Adolescents and Young Adults Population of Bogota (Colombia)	PLOS ONE			English	Article							MENINGOCOCCAL DISEASE; IDENTIFICATION; PREVALENCE; CHILDREN; CLONES; RISK; AGE	Background Meningococcal carriage studies are important to improve our understanding of the epidemiology of meningococcal disease. The aim of this study was to determine the prevalence of meningococcal carriage and the phenotypic and genotypic characteristics of isolates collected from a sample of students in the city of Bogota, Colombia. Materials and Methods A total of 1459 oropharyngeal samples were collected from students aged 15-21 years attending secondary schools and universities. Swabs were plated on a Thayer Martin agar and N. meningitidis was identified by standard microbiology methods and PCR. Results The overall carriage prevalence was 6.85%. Carriage was associated with cohabitation with smokers, and oral sex practices. Non-groupable and serogroup Y isolates were the most common capsule types found. Isolates presented a high genetic diversity, and circulation of the hypervirulent clonal complexes ST-23, ST-32 and ST-41/44 were detected. Conclusion The meningococcal carriage rate was lower than those reported in Europe and Africa, but higher than in other Latin American countries. Our data also revealed antigenic and genetic diversity of the isolates and the circulation of strains belonging to clonal complexes commonly associated with meningococcal disease.	[Moreno, Jaime; Hidalgo, Melissa; Duarte, Carolina; Sanabria, Olga] Inst Nacl Salud, Grp Microbiol, Bogota, Colombia; [Gabastou, Jean Marc; Ibarz-Pavon, Ana Belen] Pan Amer Hlth Org, Washington, DC USA	Instituto Nacional de Salud (Colombia); Pan American Health Organization	Moreno, J (corresponding author), Inst Nacl Salud, Grp Microbiol, Bogota, Colombia.	jmoreno@ins.gov.co		Trotter, Caroline/0000-0003-4000-2708	Sanofi-Pasteur, through the Pan-American Health and Education Foundation (PAHEF)	Sanofi-Pasteur, through the Pan-American Health and Education Foundation (PAHEF)	This study was supported by Sanofi-Pasteur, through the Pan-American Health and Education Foundation (PAHEF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad R, 2014, EPIDEMIOL INFECT, V142, P2461, DOI 10.1017/S0950268814001149; Abad R, 2009, J INFECTION, V59, P104, DOI 10.1016/j.jinf.2009.06.001; Agudelo CI, 2008, EMERG INFECT DIS, V14, P990, DOI 10.3201/eid1406.071357; Ala'Aldeen DAA, 2011, EMERG INFECT DIS, V17, P1761, DOI 10.3201/eid1709.101762; Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P794; Araya P, 2015, EMERG INFECT DIS, V21, P339, DOI 10.3201/eid2102.140746; Beddek AJ, 2009, INFECT IMMUN, V77, P2989, DOI 10.1128/IAI.00181-09; Caugant DA, 2008, INFECT GENET EVOL, V8, P558, DOI 10.1016/j.meegid.2008.04.002; Caugant DA, 2007, FEMS MICROBIOL REV, V31, P52, DOI 10.1111/j.1574-6976.2006.00052.x; Caugant DA, 2009, VACCINE, V27, pB64, DOI 10.1016/j.vaccine.2009.04.061; Chang Qiuzhi, 2012, Clin Epidemiol, V4, P237, DOI 10.2147/CLEP.S28410; Christensen H, 2010, LANCET INFECT DIS, V10, P853, DOI 10.1016/S1473-3099(10)70251-6; Claus H, 2005, J INFECT DIS, V191, P1263, DOI 10.1086/428590; Claus H, 2002, MICROBIOL-SGM, V148, P1813, DOI 10.1099/00221287-148-6-1813; Climent Y, 2010, J CLIN MICROBIOL, V48, P802, DOI 10.1128/JCM.01653-09; de los Monteros LEED, 2009, SALUD PUBLICA MEXICO, V51, P114, DOI 10.1590/S0036-36342009000200006; Esposito S, 2013, EUR J CLIN MICROBIOL, V32, P1129, DOI 10.1007/s10096-013-1856-2; Harrison LH, 1999, JAMA-J AM MED ASSOC, V281, P1906, DOI 10.1001/jama.281.20.1906; Instituto Nacional de Salud, AISL INV STREPT PNEU; Jounio U, 2012, J CLIN MICROBIOL, V50, P264, DOI 10.1128/JCM.05385-11; Kristiansen PA, 2011, CLIN VACCINE IMMUNOL, V18, P435, DOI 10.1128/CVI.00479-10; Leimkugel J, 2007, PLOS MED, V4, P535, DOI 10.1371/journal.pmed.0040101; Lourenço Maria Cristina S., 2006, Braz J Infect Dis, V10, P154, DOI 10.1590/S1413-86702006000200015; MacLennan J, 2006, EMERG INFECT DIS, V12, P950; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; National Association of State Public Health Veterinarians Inc. (NASPHV), 2005, MMWR Recomm Rep, V54, P1; Safadi MAP, 2014, EMERG INFECT DIS, V20, P806, DOI 10.3201/eid2005.130948; Pinzon-Redondo H, 2014, J HEALTH POPUL NUTR, V32, P539; Read RC, 2014, CLIN MICROBIOL INFEC, V20, P391, DOI 10.1111/1469-0691.12647; Rodriguez P, 2014, VACCINE, V32, P5677, DOI 10.1016/j.vaccine.2014.08.015; Sorhouet-Pereira C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058065; Soriano-Gabarro M, 2011, EXPERT REV ANTI-INFE, V9, P761, DOI [10.1586/ERI.11.89, 10.1586/eri.11.89]; STANWELLSMITH RE, 1994, EPIDEMIOL INFECT, V112, P315, DOI 10.1017/S0950268800057733; Taha MK, 2000, J CLIN MICROBIOL, V38, P855, DOI 10.1128/JCM.38.2.855-857.2000; Taha MK, 2007, FEMS MICROBIOL REV, V31, P37, DOI 10.1111/j.1574-6976.2006.00054.x; Tayal SC, 1997, J INFECTION, V34, P101, DOI 10.1016/S0163-4453(97)92357-4; Trotter CL, 2007, LANCET INFECT DIS, V7, P797, DOI 10.1016/S1473-3099(07)70288-8; Urra E, 2005, EUR J CLIN MICROBIOL, V24, P51, DOI 10.1007/s10096-004-1257-7; von Gottberg A, 2008, CLIN INFECT DIS, V46, P377, DOI 10.1086/525260; WEDEGE E, 1990, J MED MICROBIOL, V31, P195, DOI 10.1099/00222615-31-3-195; Yazdankhah SP, 2004, J CLIN MICROBIOL, V42, P5146, DOI 10.1128/JCM.42.11.5146-5153.2004	41	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0135497	10.1371/journal.pone.0135497	http://dx.doi.org/10.1371/journal.pone.0135497			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322796	Green Published, gold			2022-12-26	WOS:000360435500007
J	Sasai-Sakuma, T; Kinoshita, A; Inoue, Y				Sasai-Sakuma, Taeko; Kinoshita, Akihiko; Inoue, Yuichi			Polysomnographic Assessment of Sleep Comorbidities in Drug-Naive Narcolepsy-Spectrum Disorders-A Japanese Cross-Sectional Study	PLOS ONE			English	Article							PERIODIC LEG MOVEMENTS; REM-SLEEP; BEHAVIOR DISORDER; IDIOPATHIC HYPERSOMNIA; LATENCY TEST; LIMB MOVEMENTS; CATAPLEXY; POPULATION; ATONIA; DIAGNOSIS	This is a large cross-sectional study which aimed to investigate comorbidity rate, degree of sleep-related breathing disorder, polysomnigraphically diagnosible rapid eye movement sleep behavior disorder/rapid eye movement sleep without atonia and periodic limb movements during sleep in Japanese drug-naive patients with narcolepsy-spectrum disorders. A total of 158 consecutive drug naive patients with narcolepsy with cataplexy, 295 patients with narcolepsy without cataplexy and 395 patients with idiopathic hypersomnia without long sleep time were enrolled. From retrospectively analyzed data of nocturnal polysomnography and multiple sleep latency test, higher rates of periodic limb movements during sleep (> = 15 h(-1)) (10.2%) and polysomnographically diagnosable rapid eye movement sleep behavior disorder (1.9%) were found in patients with narcolepsy with cataplexy. They had more severe periodic limb movements during sleep especially during rapid eye movement sleep and higher percentages of rapid eye movement sleep without atonia than the other two patient groups. In the present large sample study, Japanese drug naive patients with narcolepsy with cataplexy showed the highest comorbidity rates of periodic limb movements during sleep, polysomnographically diagnosable rapid eye movement sleep behavior disorder and rapid eye movement sleep without atonia among those with the other narcolepsy-spectrum disorders; the rates were lower than those for Western patients.	[Sasai-Sakuma, Taeko; Inoue, Yuichi] Tokyo Med Univ, Dept Somnol, Tokyo 1608402, Japan; [Sasai-Sakuma, Taeko] Tokyo Med & Dent Univ, Grad Sch Hlth Sci, Div Biomed Lab Sci, Dept Life Sci & Bio informat, Tokyo, Japan; [Kinoshita, Akihiko; Inoue, Yuichi] Neuropsychiat Res Inst, Japan Somnol Ctr, Tokyo, Japan	Tokyo Medical University; Tokyo Medical & Dental University (TMDU)	Sasai-Sakuma, T (corresponding author), Tokyo Med Univ, Dept Somnol, Tokyo 1608402, Japan.	taeko_ssi@yahoo.co.jp	Sasai-Sakuma, Taeko/V-7623-2019		MEXT/JSPS KAKENHI [24791435, 15K19499]; Charitable Trust Laboratory Medicine Research Foundation of Japan	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Charitable Trust Laboratory Medicine Research Foundation of Japan	This study was supported by a MEXT/JSPS KAKENHI Grant-in-Aid for Young Scientists (No. 24791435), MEXT/JSPS KAKENHI Grant-in-Aid for Young Scientists (No. 15K19499) and a grant from the Charitable Trust Laboratory Medicine Research Foundation of Japan to Dr. Taeko Sasai-Sakuma.	Aldrich MS, 1996, NEUROLOGY, V46, P393, DOI 10.1212/WNL.46.2.393; American Academy of Sleep Medicine, 2014, INT CLASS SLEEP DIS, V3rd; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; Bahammam A, 2007, ACTA NEUROL SCAND, V115, P351, DOI 10.1111/j.1600-0404.2006.00754.x; CARSKADON MA, 1986, SLEEP, V9, P519, DOI 10.1093/sleep/9.4.519; Cipolli C, 2011, SLEEP MED, V12, P635, DOI 10.1016/j.sleep.2010.12.016; Dauvilliers Y, 2003, J NEUROL NEUROSUR PS, V74, P1667, DOI 10.1136/jnnp.74.12.1667; Dauvilliers Y, 2003, CLIN NEUROPHYSIOL, V114, P2000, DOI 10.1016/S1388-2457(03)00203-7; Dauvilliers Y, 2007, J SLEEP RES, V16, P333, DOI 10.1111/j.1365-2869.2007.00601.x; DelRosso LM, 2013, J CLIN SLEEP MED, V9, P675, DOI 10.5664/jcsm.2836; Ferri R, 2008, SLEEP, V31, P1409; Ferri R, 2006, SLEEP, V29, P1587, DOI 10.1093/sleep/29.12.1587; Franceschini C, 2011, SLEEP MED, V12, pS59, DOI 10.1016/j.sleep.2011.10.013; Frauscher B, 2013, J CLIN SLEEP MED, V9, P805, DOI 10.5664/jcsm.2926; Frauscher B, 2012, SLEEP, V35, P835, DOI 10.5665/sleep.1886; Hong SC, 2000, SLEEP MED, V1, P33, DOI 10.1016/S1389-9457(99)00007-6; Iber C., 2007, AASM MANUAL SCORING; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Khalil A, 2013, J CLIN SLEEP MED, V9, P1039, DOI 10.5664/jcsm.3078; Knudsen S, 2010, BRAIN, V133, P568, DOI 10.1093/brain/awp320; Littner MR, 2005, SLEEP, V28, P113, DOI 10.1093/sleep/28.1.113; Luppi PH, 2011, SLEEP MED REV, V15, P153, DOI 10.1016/j.smrv.2010.08.002; Mignot E, 1997, SLEEP, V20, P1012; Mignot E, 2002, ARCH NEUROL-CHICAGO, V59, P1553, DOI 10.1001/archneur.59.10.1553; Montplaisir J, 2000, SLEEP MED, V1, P163, DOI 10.1016/S1389-9457(00)00014-9; Nakamura A, 2007, J APPL PHYSIOL, V102, P241, DOI 10.1152/japplphysiol.00679.2006; Nevsimalova S, 2013, J NEUROL, V260, P767, DOI 10.1007/s00415-012-6702-4; Nomura T, 2008, MOVEMENT DISORD, V23, P2363, DOI 10.1002/mds.22274; Oka Y, 2006, SLEEP, V29, P1439, DOI 10.1093/sleep/29.11.1439; Partinen M, 2005, PRINCIPLES PRACTICE, P626; Pataka AD, 2012, EUR J NEUROL, V19, P696, DOI 10.1111/j.1468-1331.2011.03610.x; Pizza F, 2013, EUR NEUROL, V70, P22, DOI 10.1159/000348719; Pizza F, 2013, J SLEEP RES, V22, P185, DOI 10.1111/j.1365-2869.2012.01061.x; Roth T, 2013, J CLIN SLEEP MED, V9, P955, DOI 10.5664/jcsm.3004; Sakurai T, 2005, SLEEP MED REV, V9, P231, DOI 10.1016/j.smrv.2004.07.007; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sansa G, 2010, SLEEP MED, V11, P93, DOI 10.1016/j.sleep.2009.02.009; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Sasai T, 2009, SLEEP MED, V10, P961, DOI 10.1016/j.sleep.2008.12.007; Sasai-Sakuma T, 2014, SLEEP MED, V15, P1009, DOI 10.1016/j.sleep.2014.02.010; SCHENCK CH, 1992, ANN NEUROL, V32, P3, DOI 10.1002/ana.410320103; Scofield H, 2008, SLEEP, V31, P1221; Silber MH, 2002, SLEEP, V25, P197, DOI 10.1093/sleep/25.2.197; Silber MH, 2001, NEUROLOGY, V56, P1616, DOI 10.1212/WNL.56.12.1616; Takei Y, 2012, CLIN NEUROPHYSIOL, V123, P137, DOI 10.1016/j.clinph.2011.05.024; Tan EK, 2001, MOVEMENT DISORD, V16, P577, DOI 10.1002/mds.1102; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080	47	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136988	10.1371/journal.pone.0136988	http://dx.doi.org/10.1371/journal.pone.0136988			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322978	gold, Green Published, Green Submitted			2022-12-26	WOS:000360435500057
J	Lin, TY; Huang, WL; Lee, WY; Luo, CW				Lin, Ting-Yu; Huang, Wei-Lin; Lee, Wei-Yu; Luo, Ching-Wei			Identifying a Neuromedin U Receptor 2 Splice Variant and Determining Its Roles in the Regulation of Signaling and Tumorigenesis In Vitro	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; CENTRAL-NERVOUS-SYSTEM; HORMONE-RECEPTOR; GROWTH-FACTOR; HETERODIMERIZATION; IDENTIFICATION; CANCER; OLIGOMERIZATION; DIMERIZATION; INHIBITION	Neuromedin U (NMU) activates two G protein-coupled receptors, NMUR1 and NMUR2; this signaling not only controls many physiological responses but also promotes tumorigenesis in diverse tissues. We recently identified a novel truncated NMUR2 derived by alternative splicing, namely NMUR2S, from human ovarian cancer cDNA. Sequence analysis, cell surface ELISA and immunocytochemical staining using 293T cells indicated that NMUR2S can be expressed well on the cell surface as a six-transmembrane protein. Receptor pull-down and fluorescent resonance energy transfer assays demonstrated that NMUR1, NMUR2 and this newly discovered NMUR2S can not only form homomeric complexes but also heteromeric complexes with each other. Although not activated by NMU itself, functional assay in combination with receptor quantification and radio-ligand binding in 293T cells indicated that NMUR2S does not alter the translocation and stability of NMUR1 or NMUR2, but rather effectively dampens their signaling by blocking their NMU binding capability through receptor heterodimerization. We further demonstrated that NMU signaling is significantly up-regulated in human ovarian cancers, whereas expression of NMUR2S can block endogenous NMU signaling and further lead to suppression of proliferation in SKOV-3 ovarian cancer cells. In contrast, in monocytic THP-1 cells that express comparable levels of NMUR1 and NMUR2S, depletion of NMUR2S restored both the signaling and effect of NMU. Thus, these results not only reveal the presence of previously uncharacterized heteromeric relationships among NMU receptors but also provide NMUR2S as a potential therapeutic target for the future treatment of NMU signaling-mediated cancers.	[Luo, Ching-Wei] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Luo, CW (corresponding author), Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan.	cwluo@ym.edu.tw		Lin, Ting-Yu/0000-0002-0300-0386	Ministry of Science and Technology, Taiwan [MOST 103-2314-B-010-006-MY3, MOST 103-2627-M-400-001]; National Health Research Institutes, Taiwan [NHRI-EX102-10034BI]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This work was supported by MOST 103-2314-B-010-006-MY3 and MOST 103-2627-M-400-001 - from Ministry of Science and Technology, Taiwan (http://www.most.gov.tw/mp.aspx) and NHRI-EX102-10034BI from National Health Research Institutes, Taiwan (http://www.nhri.org.tw/) for CWL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, JNCI-J NATL CANCER I, V103, P1287, DOI [10.1093/jnci/djr342, DOI 10.1093/JNCI/DJR342]; Bakker RA, 2006, MOL PHARMACOL, V69, P1194, DOI 10.1124/mol.105.019299; Bellucci F, 2004, EUR J PHARMACOL, V499, P229, DOI 10.1016/j.ejphar.2004.07.075; Benkirane M, 1997, J BIOL CHEM, V272, P30603, DOI 10.1074/jbc.272.49.30603; Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575; Einstein R, 2008, P NATL ACAD SCI USA, V105, P5230, DOI 10.1073/pnas.0801319105; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Fujii R, 2000, J BIOL CHEM, V275, P21068, DOI 10.1074/jbc.M001546200; Grammatopoulos DK, 1999, MOL ENDOCRINOL, V13, P2189, DOI 10.1210/me.13.12.2189; Grosse R, 1997, MOL ENDOCRINOL, V11, P1305, DOI 10.1210/me.11.9.1305; Guivarc'H D, 1998, ENDOCRINOLOGY, V139, P4213, DOI 10.1210/en.139.10.4213; Guo W, 2005, P NATL ACAD SCI USA, V102, P17495, DOI 10.1073/pnas.0508950102; Hebert TE, 1998, BIOCHEM CELL BIOL, V76, P1, DOI 10.1139/bcb-76-1-1; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Hosoya M, 2000, J BIOL CHEM, V275, P29528, DOI 10.1074/jbc.M004261200; Howard AD, 2000, NATURE, V406, P70, DOI 10.1038/35017610; Hsu SH, 2007, AM J PHYSIOL-ENDOC M, V293, pE1021, DOI 10.1152/ajpendo.00003.2007; Ivanov TR, 2002, ENDOCRINOLOGY, V143, P3813, DOI 10.1210/en.2002-220121; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Karpa KD, 2000, MOL PHARMACOL, V58, P677, DOI 10.1124/mol.58.4.677; Ketterer K, 2009, CANCER LETT, V277, P72, DOI 10.1016/j.canlet.2008.11.028; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lavoie C, 2002, J BIOL CHEM, V277, P35402, DOI 10.1074/jbc.M204163200; Lin TY, 2013, AM J PHYSIOL-ENDOC M, V304, pE800, DOI 10.1152/ajpendo.00548.2012; MAGGI CA, 1990, BRIT J PHARMACOL, V99, P186, DOI 10.1111/j.1476-5381.1990.tb14675.x; Markovic D, 2013, METHOD ENZYMOL, V520, P323, DOI 10.1016/B978-0-12-391861-1.00015-0; Marshall FH, 1999, TRENDS PHARMACOL SCI, V20, P396, DOI 10.1016/S0165-6147(99)01383-8; Mary S, 2013, J BIOL CHEM, V288, P24656, DOI 10.1074/jbc.M113.453423; Mellado M, 2001, EMBO J, V20, P2497, DOI 10.1093/emboj/20.10.2497; Mitchell JD, 2009, BRIT J PHARMACOL, V158, P87, DOI 10.1111/j.1476-5381.2009.00252.x; Prinster SC, 2005, PHARMACOL REV, V57, P289, DOI 10.1124/pr.57.3.1; Raddatz R, 2000, J BIOL CHEM, V275, P32452, DOI 10.1074/jbc.M004613200; Seck T, 2005, MOL ENDOCRINOL, V19, P2132, DOI 10.1210/me.2004-0472; Shan LX, 2000, J BIOL CHEM, V275, P39482, DOI 10.1074/jbc.C000522200; Shetzline SE, 2004, BLOOD, V104, P1833, DOI 10.1182/blood-2003-10-3577; SHIKATA J, 1992, SPINE, V17, P1534, DOI 10.1097/00007632-199212000-00021; Takahashi K, 2006, CANCER RES, V66, P9408, DOI 10.1158/0008-5472.CAN-06-1349; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Wu Y, 2007, ONCOGENE, V26, P765, DOI 10.1038/sj.onc.1209835; Zhu XY, 1998, BIOCHEMISTRY-US, V37, P15773, DOI 10.1021/bi981162z	40	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136836	10.1371/journal.pone.0136836	http://dx.doi.org/10.1371/journal.pone.0136836			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317338	Green Published, Green Submitted, gold			2022-12-26	WOS:000360299100147
J	Mir, AR; Uddin, M; Khan, F; Alam, K; Ali, A				Mir, Abdul Rouf; Uddin, Moin; Khan, Farzana; Alam, Khursheed; Ali, Asif			Dicarbonyl Induced Structural Perturbations Make Histone H1 Highly Immunogenic and Generate an Auto-Immune Response in Cancer	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; PROTEIN CROSS-LINKING; IN-VITRO; MAILLARD REACTION; NONENZYMATIC GLYCATION; CONFORMATIONAL-CHANGES; SERUM-ALBUMIN; RAGE LIGANDS; METHYLGLYOXAL; BIOMARKERS	Increased oxidative stress under hyperglycemic conditions, through the interaction of AGEs with RAGE receptors and via activation of interleukin mediated transcription signalling, has been reported in cancer. Proteins modifications are being explored for their roles in the development and progression of cancer and autoantibody response against them is gaining interest as a probe for early detection of the disease. This study has analysed the changes in histone H1 upon modification by methylglyoxal (MG) and its implications in auto-immuno-pathogenesis of cancer. Modified histone showed modifications in the aromatic residues, changed tyrosine microenvironment, intermolecular cross linking and generation of AGEs. It showed masking of hydrophobic patches and a hypsochromic shift in the in ANS specific fluorescence. MG aggressively oxidized histone H1 leading to the accumulation of reactive carbonyls. Far UV CD measurements showed di-carbonyl induced enhancement of the alpha structure and the induction of beta sheet conformation; and thermal denaturation (Tm) studies confirmed the thermal stability of the modified histone. FTIR analysis showed amide I band shift, generation of a carboxyethyl group and N-C alpha vibrations in the modified histone. LCMS analysis confirmed the formation of N epsilon-(carboxyethyl) lysine and electron microscopic studies revealed the amorphous aggregate formation. The modified histone showed altered cooperative binding with DNA. Modified H1 induced high titre antibodies in rabbits and the IgG isolated form sera of rabbits immunized with modified H1 exhibited specific binding with its immunogen in Western Blot analysis. IgG isolated from the sera of patients with lung cancer, prostate cancer, breast cancer and cancer of head and neck region showed better recognition for neo-epitopes on the modified histone, reflecting the presence of circulating autoantibodies in cancer. Since reports suggest a link between AGE-RAGE axis and carcinogenesis, glycoxidation of histone H1 and its immunogenicity paves ways for understanding role of glycoxidatively damaged nuclear proteins in cancer.	[Mir, Abdul Rouf; Uddin, Moin; Khan, Farzana; Alam, Khursheed; Ali, Asif] Aligarh Muslim Univ, Fac Med, Jawaharlal Nehru Med Coll, Dept Biochem, Aligarh, Uttar Pradesh, India	Aligarh Muslim University	Uddin, M (corresponding author), Aligarh Muslim Univ, Fac Med, Jawaharlal Nehru Med Coll, Dept Biochem, Aligarh, Uttar Pradesh, India.	moin_u@rediffmail.com	MIR, ABDUL ROUF/ABD-7542-2020	MIR, ABDUL ROUF/0000-0002-2897-4419; Alam, Khursheed/0000-0001-9729-9966	DST under its FIST programme	DST under its FIST programme	Authors are thankful to the Department of science and Technology(DST) for instrument facilities created with the financial help from DST under its FIST programme.	Abe R, 2008, CURR PHARM DESIGN, V14, P940, DOI 10.2174/138161208784139765; Ahmad S, 2011, BIOCHEM BIOPH RES CO, V407, P568, DOI 10.1016/j.bbrc.2011.03.064; Ali Rashid, 2002, Methods Mol Biol, V186, P171; Anderson KS, 2005, J PROTEOME RES, V4, P1123, DOI 10.1021/pr0500814; Ansari N.A., 2013, ISRN BIOCH; Ansari NA, 2009, HUM IMMUNOL, V70, P417, DOI 10.1016/j.humimm.2009.03.015; Arfat MY, 2014, INT J BIOL MACROMOL, V69, P408, DOI 10.1016/j.ijbiomac.2014.05.069; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Bouma B, 2003, J BIOL CHEM, V278, P41810, DOI 10.1074/jbc.M303925200; CARDAMONE M, 1992, BIOCHEM J, V282, P589, DOI 10.1042/bj2820589; Chellan P, 1999, ARCH BIOCHEM BIOPHYS, V368, P98, DOI 10.1006/abbi.1999.1291; Chervona Y, 2012, AM J CANCER RES, V2, P589; Correcirc DH, 2009, J BIOCH, V3, P164, DOI DOI 10.1038/NPR0T.2006.204; Dalle-Donne I, 2006, J CELL MOL MED, V10, P389, DOI 10.1111/j.1582-4934.2006.tb00407.x; DANNA JA, 1974, BIOCHEMISTRY-US, V13, P2093, DOI 10.1021/bi00707a015; Dixit K, 2011, HUM IMMUNOL, V72, P219, DOI 10.1016/j.humimm.2010.12.004; Ehrlich H, 2009, INT J BIOL MACROMOL, V44, P51, DOI 10.1016/j.ijbiomac.2008.10.001; Ghosh S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074336; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Guedes S, 2011, ANAL BIOANAL CHEM, V399, P3529, DOI 10.1007/s00216-011-4679-y; Hawkins CL, 2009, FREE RADICAL BIO MED, V46, P965, DOI 10.1016/j.freeradbiomed.2009.01.007; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Iram A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072075; Ishimaru D, 2003, BIOCHEMISTRY-US, V42, P9022, DOI 10.1021/bi034218k; Jiao L, 2011, CANCER EPIDEM BIOMAR, V20, P1430, DOI 10.1158/1055-9965.EPI-11-0066; Kalea AZ, 2011, FRONT BIOSCI-LANDMRK, V16, P2756, DOI 10.2741/3884; Kang JH, 2006, J BIOCHEM MOL BIOL, V39, P335; Kang R, 2012, P NATL ACAD SCI USA, V109, P7031, DOI 10.1073/pnas.1113865109; Khan MA, 2012, SCAND J RHEUMATOL, V41, P426, DOI 10.3109/03009742.2012.698300; Khan TA, 2011, INT J PEPT RES THER, V17, P271, DOI 10.1007/s10989-011-9267-7; Kishore D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050380; Ko SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110542; Krechler T, 2010, CLIN BIOCHEM, V43, P882, DOI 10.1016/j.clinbiochem.2010.04.004; Kuleva N V, 2006, Tsitologiia, V48, P515; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LO TWC, 1994, J BIOL CHEM, V269, P32299; Logsdon CD, 2007, CURR MOL MED, V7, P777, DOI 10.2174/156652407783220697; Lu HL, 2008, J PROTEOME RES, V7, P1388, DOI 10.1021/pr700818f; Luo XG, 2011, BREAST CANC FOCUSING; Mir AR, 2014, INT J BIOL MACROMOL, V69, P260, DOI 10.1016/j.ijbiomac.2014.05.057; Nagaraj RH, 1996, J BIOL CHEM, V271, P19338, DOI 10.1074/jbc.271.32.19338; Pashikanti S, 2011, FREE RADICAL BIO MED, V50, P1410, DOI 10.1016/j.freeradbiomed.2011.01.034; Pedersen JW, 2011, LABMEDICINE, V42, P623, DOI 10.1309/LM2T3OU3RZRTHKSN; Roberts MJ, 2003, MUTAT RES-FUND MOL M, V522, P45, DOI 10.1016/S0027-5107(02)00232-4; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sattarahmady N, 2008, CARBOHYD RES, V343, P2229, DOI 10.1016/j.carres.2008.04.036; Schmitt A, 2005, ANAL BIOCHEM, V338, P201, DOI 10.1016/j.ab.2004.12.003; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; Soussi T, 2000, CANCER RES, V60, P1777; Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17; Stopper H, 2003, CANCER LETT, V190, P151, DOI 10.1016/S0304-3835(02)00626-2; Talasz H, 2002, J CELL BIOCHEM, V85, P24, DOI 10.1002/jcb.10103; TARKKA T, 1993, BIOCHIM BIOPHYS ACTA, V1180, P294, DOI 10.1016/0925-4439(93)90053-4; Van Heijst JWJ, 2005, ANN NY ACAD SCI, V1043, P725, DOI 10.1196/annals.1333.084; Wandall HH, 2010, CANCER RES, V70, P1306, DOI 10.1158/0008-5472.CAN-09-2893; WELLSKNECHT KJ, 1995, J ORG CHEM, V60, P6246, DOI 10.1021/jo00125a001; Wolffe AP, 1997, BIOESSAYS, V19, P249, DOI 10.1002/bies.950190311; Wondrak GT, 2000, BIOCHEM J, V351, P769, DOI 10.1042/0264-6021:3510769; Zhang G, 2011, J AGR FOOD CHEM, V59, P12037, DOI 10.1021/jf202515k	59	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136197	10.1371/journal.pone.0136197	http://dx.doi.org/10.1371/journal.pone.0136197			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317779	gold, Green Submitted, Green Published			2022-12-26	WOS:000360299100063
J	Buehring, GC; Shen, HM; Jensen, HM; Jin, DL; Hudes, M; Block, G				Buehring, Gertrude Case; Shen, Hua Min; Jensen, Hanne M.; Jin, Diana L.; Hudes, Mark; Block, Gladys			Exposure to Bovine Leukemia Virus Is Associated with Breast Cancer: A Case-Control Study	PLOS ONE			English	Article							RISK; DNA; CELLS; MILK; IDENTIFICATION; PASTEURIZATION; IRRADIATION; ENVIRONMENT; INFECTION; REPAIR	Background Age, reproductive history, hormones, genetics, and lifestyle are known risk factors for breast cancer, but the agents that initiate cellular changes from normal to malignant are not understood. We previously detected bovine leukemia virus (BLV), a common oncogenic virus of cattle, in the breast epithelium of humans. The objective of this study was to determine whether the presence of BLV DNA in human mammary epithelium is associated with breast cancer. Methods This was a case-control study of archival formalin fixed paraffin embedded breast tissues from 239 donors, received 2002-2008 from the Cooperative Human Tissue Network. Case definition as breast cancer versus normal (women with no history of breast cancer) was established through medical records and examination of tissues by an anatomical pathologist. Breast exposure to BLV was determined by in situ-PCR detection of a biomarker, BLV DNA, localized within mammary epithelium. Results The frequency of BLV DNA in mammary epithelium from women with breast cancer (59%) was significantly higher than in normal controls (29%) (multiply-adjusted odds ratio = 3.07, confidence interval = 1.66-5.69, p = .0004, attributable risk = 37%). In women with premalignant breast changes the frequency of BLV DNA was intermediate (38%) between that of women with breast cancer and normal controls (p for trend < .001). Conclusions Among the specimens in this study, the presence of amplified BLV DNA was significantly associated with breast cancer. The odds ratio magnitude was comparable to those of well-established breast cancer risk factors related to reproductive history, hormones, and lifestyle and was exceeded only by risk factors related to genetics (familial breast cancer), high dose ionizing radiation, and age. These findings have the potential for primary and secondary prevention of breast cancer.	[Buehring, Gertrude Case; Shen, Hua Min; Jin, Diana L.] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA; [Jensen, Hanne M.] Univ Calif Davis, Dept Pathol & Lab Med, Davis Med Ctr, Sacramento, CA 95817 USA; [Hudes, Mark] Univ Calif Berkeley, Atkins Ctr Weight & Hlth, Berkeley, CA 94720 USA; [Block, Gladys] Univ Calif Berkeley, Sch Publ Hlth, Div Community Hlth & Human Dev, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Davis; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Buehring, GC (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.	buehring@berkeley.edu	Block, Gladys/E-3304-2010	Block, Gladys/0000-0001-6722-930X	Breast Cancer Research Program of the University of California [6PB-0075]; Department of Defense Breast Cancer Research Program (DAMD) [17-02-1-0320]	Breast Cancer Research Program of the University of California; Department of Defense Breast Cancer Research Program (DAMD)(United States Department of Defense)	This study was funded by a grant (#6PB-0075) from the Breast Cancer Research Program of the University of California to GCB and a grant from the Department of Defense Breast Cancer Research Program (DAMD 17-02-1-0320) to GCB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2015, CANC FACTS FIG 2015; APHIS, 2008, BOV LEUK VIR BLV US; APHIS Veterinary Service Center for Epidemiology and Animal Health USDA, 1999, BOV LEUK VIR BLV US; ARMSTRONG B, 1975, INT J CANCER, V15, P617, DOI 10.1002/ijc.2910150411; Barba M, 2006, CANCER CAUSE CONTROL, V17, P395, DOI 10.1007/s10552-005-0481-5; BAUMGARTENER L, 1976, J AM VET MED ASSOC, V169, P1189; Bondy Melissa L., 2003, Cancer, V97, P230, DOI 10.1002/cncr.11018; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; BRINTON LA, 1983, BRIT J CANCER, V47, P757, DOI 10.1038/bjc.1983.128; Buehring GC, 2003, AIDS RES HUM RETROV, V19, P1105, DOI 10.1089/088922203771881202; BUEHRING GC, 1994, LAB INVEST, V71, P359; Buehring GC, 2014, EMERG INFECT DIS, V20, P772, DOI 10.3201/eid2005.131298; Carlson Laurie Winn, 2001, CATTLE INFORMAL SOCI; CARROLL KK, 1968, CAN MED ASSOC J, V98, P590; Chartsbin, CURR WORLDW TOT MILK; Chu TY, 1999, GENE CHROMOSOME CANC, V24, P127, DOI 10.1002/(SICI)1098-2264(199902)24:2<127::AID-GCC5>3.0.CO;2-8; CHUNG YS, 1986, AUST VET J, V63, P379, DOI 10.1111/j.1751-0813.1986.tb02908.x; Clamp A, 2002, LANCET ONCOL, V3, P611, DOI 10.1016/S1470-2045(02)00875-6; Clarke CA, 2012, JNCI-J NATL CANCER I, V104, P1094, DOI 10.1093/jnci/djs264; Clemons M, 2000, CANCER TREAT REV, V26, P291, DOI 10.1053/ctrv.2000.0174; Cooper JK, 2007, IN VITRO CELL DEV-AN, V43, P344, DOI 10.1007/s11626-007-9060-2; Coyle YM, 2004, BREAST CANCER RES TR, V84, P273, DOI 10.1023/B:BREA.0000019964.33963.09; de Parseval N, 2005, CYTOGENET GENOME RES, V110, P318, DOI 10.1159/000084964; Dong JY, 2011, BREAST CANCER RES TR, V127, P23, DOI 10.1007/s10549-011-1467-5; Duncan RB, 2005, J VET DIAGN INVEST, V17, P190, DOI 10.1177/104063870501700217; FERRER JF, 1981, SCIENCE, V213, P1014, DOI 10.1126/science.6267692; Fitzgibbons PL, 1998, ARCH PATHOL LAB MED, V122, P1053; Gillet N, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-18; Globcan, EST AG STAND BREAST; Haoudi A, 2003, J BIOL CHEM, V278, P37736, DOI 10.1074/jbc.M301649200; Heaphy CM, 2009, BREAST CANCER RES TR, V118, P229, DOI 10.1007/s10549-009-0504-0; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; HOSMER DW, 1989, APPL LOGISTIC REGRES; Kamihira S, 2005, CLIN LAB HAEMATOL, V27, P235, DOI 10.1111/j.1365-2257.2005.00698.x; Kao SY, 1999, J VIROL, V73, P4299, DOI 10.1128/JVI.73.5.4299-4304.1999; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES; Lairmore MD, 2014, ANNU REV ANIM BIOSCI, V2, P189, DOI 10.1146/annurev-animal-022513-114117; Lee LC, 2012, CAN VET J, V53, P283; Lundgren B, 1977, CANCER, V40, P722; Moore PS, 2010, NAT REV CANCER, V10, P878, DOI 10.1038/nrc2961; Murakami H, 2011, VIRUS RES, V156, P107, DOI 10.1016/j.virusres.2011.01.004; Nelson HD, 2002, JAMA-J AM MED ASSOC, V288, P872, DOI 10.1001/jama.288.7.872; Nuovo GJ, 1996, PCR SITU HYBRIDIZATI, P193; Park HU, 2006, ONCOGENE, V25, P438, DOI 10.1038/sj.onc.1209059; Philpott SM, 1999, J NATL CANCER I, V91, P933, DOI 10.1093/jnci/91.11.933; RADKE K, 1992, MICROB PATHOGENESIS, V12, P319, DOI 10.1016/0882-4010(92)90095-6; Reyes RA, 1996, J VIROL, V70, P4961, DOI 10.1128/JVI.70.8.4961-4965.1996; Robert-Guroff M, 2000, VITAL BACTERIAL PARA, P475; Salmons B, 2013, INT J CANCER, V133, P1530, DOI 10.1002/ijc.28210; SCHWARTZ I, 1994, VET RES, V25, P521; Sellers TA, 2008, CANCER CAUSE CONTROL, V19, P805, DOI 10.1007/s10552-008-9143-8; Singletary SE, 2003, ANN SURG, V237, P474, DOI 10.1097/00000658-200304000-00007; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Tang KW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3513; TRICHOPOULOS D, 1972, JNCI-J NATL CANCER I, V48, P605; Van Der Maaten M J, 1975, Bibl Haematol, P360; VONFOURNIER D, 1980, CANCER-AM CANCER SOC, V45, P2198; Wise LA, 2009, CANCER CAUSE CONTROL, V20, P1083, DOI 10.1007/s10552-009-9332-0; Zhao XR, 2007, GENOMICS, V89, P502, DOI 10.1016/j.ygeno.2006.12.007	59	85	89	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0134304	10.1371/journal.pone.0134304	http://dx.doi.org/10.1371/journal.pone.0134304			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332838	Green Submitted, Green Published, gold			2022-12-26	WOS:000360613800007
J	Dong, XB; Dai, GS; Ulgiati, S; Na, RS; Zhang, XS; Kang, MY; Wang, XC				Dong, Xiaobin; Dai, Guangshuo; Ulgiati, Sergio; Na, Risu; Zhang, Xinshi; Kang, Muyi; Wang, Xuechao			On the Relationship between Economic Development, Environmental Integrity and Well-Being: The Point of View of Herdsmen in Northern China Grassland	PLOS ONE			English	Article							ECOSYSTEM SERVICES; INNER-MONGOLIA; DEGRADATION; DRIVERS; ECOLOGY; SCIENCE	Inner Mongolia is among the most important regions in terms of contribution to the socioeconomic development of China. Furthermore, its grassland is a major ecological barrier for Northern China. The present study evaluates the changes in ecosystem services availability and human wellbeing based on a survey on864 herdsmen of the grassland and 20 governmental officials. The survey provided the following results: (1) The supporting and provisioning services of the grassland have recently declined, thus affecting the herdsmen's wellbeing. The intensity of grazing, coal exploitation and tourism development heavily limits the availability of ecosystem services, among which provisioning ones are perceived as the most important. Below a certain threshold, grazing and mining are likely to promote the improvement of herdsmen's wellbeing, while trespassing that point, the enhancement of the herdsmen's living standards is curbed. (2) The herdsmen's cultural exchange, health conditions and social relations are better now than before; however, the threats on herdsmen's health and safety have increased. (3) A better income is among the most urgent herdsmen's needs. Livestock revenues did not increase at the same rate as the damage to the grassland and human risk exposure did. (4) The governmental ecological compensation policy did not entirely solve the problem of grassland desertification and environmental degradation, although it is also true that the degree of implementation and effectiveness of government policies is related to the still insufficient herdsmen's understanding and acceptance of these policies.	[Dong, Xiaobin; Dai, Guangshuo; Zhang, Xinshi; Kang, Muyi; Wang, Xuechao] Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China; [Dong, Xiaobin; Dai, Guangshuo; Zhang, Xinshi; Kang, Muyi; Wang, Xuechao] Beijing Normal Univ, Coll Resources Sci & Technol, Beijing 100875, Peoples R China; [Ulgiati, Sergio] Parthenope Univ, Dept Sci & Technol, I-80133 Naples, Italy; [Na, Risu] Xilinguol Vocat Coll, Xilinhot 026000, Peoples R China	Beijing Normal University; Beijing Normal University; Parthenope University Naples	Dong, XB (corresponding author), Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China.	xbdong@bnu.edu.cn; dgsh@mailbnu.edu.cn	Ulgiati, Sergio/ABE-9420-2020; Wang, Xue-Chao/J-5860-2019	Wang, Xue-Chao/0000-0003-4431-0900; Ulgiati, Sergio/0000-0001-6159-4947	National Natural Science Foundation of China [41030535, 41271549]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (41030535, 41271549).	[Anonymous], 2011, STAT YB XIL; Balmford A., 2008, EC ECOSYSTEMS BIODIV; BARNES JI, 2003, EC RETURNS LAND USE; Cai X, 2005, THESIS CHINESE ACAD; Cao SX, 2007, AMBIO, V36, P409, DOI 10.1579/0044-7447(2007)36[409:DBSAEC]2.0.CO;2; Cao Xin, 2006, Zhiwu Shengtai Xuebao, V30, P268; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Cheng S, 2013, J MUC NATL SCI EDITI, V22, P23; Costanza R, 1997, NATURES SERVICE SOC; Cox ME, 2006, ECOL SOC, V11; Dai SF, 2002, INT J COAL GEOL, V51, P237, DOI 10.1016/S0166-5162(02)00098-8; Dai SF, 2010, INT J COAL GEOL, V81, P320, DOI 10.1016/j.coal.2009.03.005; Daw T, 2011, ENVIRON CONSERV, V38, P370, DOI 10.1017/S0376892911000506; Deacon H. J., 1978, S AFRICAN ARCHAEOLOG, V33, P39, DOI DOI 10.2307/3888251; Deutsch L, 2003, ECOL ECON, V44, P205, DOI 10.1016/S0921-8009(02)00274-4; Dong XB, 2014, ENERG POLICY, V67, P767, DOI [10.1, 10.1016/j.enpol.2013.11.038]; Du G, 2009, INT J COAL GEOL, V78, P16, DOI 10.1016/j.coal.2008.10.004; Ellis JE, 1992, GRASSLANDS GRASSLAND, P9; Environmental Protection Agency, 1997, SPEC REP ENV END DIS; [冯亚芬 FENG Yafen], 2009, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V23, P181; Finkelman RB, 2002, INT J COAL GEOL, V50, P425, DOI 10.1016/S0166-5162(02)00125-8; Folke C, 1996, ECOL APPL, V6, P1018, DOI 10.2307/2269584; Guhn M., 2010, ED REPORT CANADIAN I; Hill K., 2005, VALUE HIGHER ED INDI; Hirschberg JG, 1998, DEP EC WORKING PAPER, V654; Hoffmann C, 2008, CATENA, V75, P182, DOI 10.1016/j.catena.2008.06.003; Jiang Ye, 2010, Chinese Journal of Plant Ecology, V34, P1132, DOI 10.3773/j.issn.1005-264x.2010.10.002; Junquera B, 2001, RESOUR CONSERV RECY, V33, P51, DOI 10.1016/S0921-3449(01)00057-X; Le Maitre DC, 2007, FRONT ECOL ENVIRON, V5, P261, DOI 10.1890/1540-9295(2007)5[261:LESAWR]2.0.CO;2; Le Maitre DC., 2008, ADV SUSTAINABILITY S, P339; Levinson A, 2012, J PUBLIC ECON, V96, P869, DOI 10.1016/j.jpubeco.2012.06.007; Ling F, 2013, HAIHE WATER RESOURCE, V1, P16; Liu X, 2011, NO ENV, V23, P65; Liu Z, 2006, METEOROLOGICAL SCI I, V1, P27; Lu F, 2012, THESIS INNER MONGOLI; Millennium Ecosystem Assessment, 2005, EC HUM WELLB BIOD SY; Millennium Ecosystem Assessment, 2005, MILL EC ASS SER; Ni T, 2011, 60 PERCENT ORDINARY; Normile D, 2007, SCIENCE, V317, P314, DOI 10.1126/science.317.5836.314; Qiao G, 2004, J INNER MONGOLIA FIN, V2, P44; Rahaman T, 2005, 200506 WIDER UN U; Robinson DT, 2012, COMPUT ENVIRON URBAN, V36, P164, DOI 10.1016/j.compenvurbsys.2011.10.002; Rodriguez JP, 2006, ECOL SOC, V11; Shackleton C., 2008, LINKS ECOSYSTEM SERV; Shi JG, 2010, CHINESE AGR SCI B, V26, P318; Smith LM, 2013, ECOL INDIC, V28, P79, DOI 10.1016/j.ecolind.2012.02.032; Smyth R, 2008, ECOL ECON, V68, P547, DOI 10.1016/j.ecolecon.2008.05.017; Sneath D, 1998, SCIENCE, V281, P1147, DOI 10.1126/science.281.5380.1147; Summers JK, 2012, AMBIO, V41, P327, DOI 10.1007/s13280-012-0256-7; The Economics of Ecosystems and Biodiversity (TEEB), 2009, CLIM ISS UPD; Tong Chuan, 2006, Shengtaixue Zazhi, V25, P259; Van Landeghem B, 2012, J ECON BEHAV ORGAN, V81, P571, DOI 10.1016/j.jebo.2011.08.001; Wainger LA, 2004, ENVIRON MONIT ASSESS, V94, P69, DOI 10.1023/B:EMAS.0000016880.31332.e1; Wang G, 2013, ECOLOGICAL EC, V2, P89; Wang H, 2012, J ANHUI AGR SCI, V40, P7839; Wang Ming-jun, 2010, Shengtaixue Zazhi, V29, P862; Wendland KJ, 2010, ECOL ECON, V69, P2093, DOI 10.1016/j.ecolecon.2009.01.002; Wu JG, 2013, LANDSCAPE ECOL, V28, P999, DOI 10.1007/s10980-013-9894-9; XIE G.D., 2001, J NATURAL RESOURCES, V16, P47, DOI DOI 10.3321/J.ISSN:1000-3037.2001.01.009; Yang Y, 2008, CENTRAL S FOREST INV, V27, P58; Yu S, 2007, W RES, V21, P51; Zhang D, 2005, THESIS CHINA U MININ; [赵士洞 ZHAO Shidong], 2006, [地球科学进展, Advance in Earth Sciences], V21, P895; Zhao YouYi, 2008, Acta Prataculturae Sinica, V17, P143; Zhou G, 2002, NE CHINA TRANSECT NE	65	25	28	4	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0134786	10.1371/journal.pone.0134786	http://dx.doi.org/10.1371/journal.pone.0134786			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ4ZT	26331721	Green Published, Green Submitted, gold			2022-12-26	WOS:000360613800013
J	Gaimster, H; Summers, D				Gaimster, Hannah; Summers, David			Regulation of Indole Signalling during the Transition of E. coli from Exponential to Stationary Phase	PLOS ONE			English	Article							ESCHERICHIA-COLI; CATABOLITE REPRESSION; TRYPTOPHANASE; EXPRESSION; ACIDS	During the transition from exponential to stationary phase E. coli produces a substantial quantity of the small, aromatic signalling molecule indole. In LB medium the supernatant indole concentration reaches a maximum of 0.5-1 mM. At this concentration indole has been implicated in many processes inducing acid resistance and the modulation of virulence. It has recently been shown that cell-associated indole transiently reaches a very high concentration (approx. 60 mM) during stationary phase entry, presumably because indole is being produced more rapidly than it can leave the cell. It is proposed that this indole pulse inhibits growth and cell division, causing the culture to enter stationary phase before nutrients are completely exhausted, with benefits for survival in long-term stationary phase. This study asks how E. coli cells rapidly upregulate indole production during stationary phase entry and why the indole pulse has a duration of only 10-15 min. We find that at the start of the pulse tryptophanase synthesis is triggered by glucose depletion and that this is correlates with the up-regulation of indole synthesis. The magnitude and duration of the resulting indole pulse are dependent upon the availability of exogenous tryptophan. Indole production stops when all the available tryptophan is depleted and the cell-associated indole equilibrates with the supernatant.	[Gaimster, Hannah; Summers, David] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England	University of Cambridge	Gaimster, H (corresponding author), UEA, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	h.gaimster@uea.ac.uk		Gaimster, Hannah/0000-0002-8593-0746	Biotechnology and Biological Sciences Research Council [PCAG-EJNF]; Biotechnology and Biological Sciences Research Council [BB/F002912/1] Funding Source: researchfish; BBSRC [BB/F002912/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	HG was funded by a Biotechnology and Biological Sciences Research Council Doctoral Training Grant studentship (http://www.bbsrc.ac.uk/home/home.aspx), grant number PCAG-EJNF.	BOTSFORD JL, 1971, J BACTERIOL, V105, P303, DOI 10.1128/JB.105.1.303-312.1971; Chant EL, 2007, MOL MICROBIOL, V63, P35, DOI 10.1111/j.1365-2958.2006.05481.x; Chimerel C, 2012, BIOCH BIOPHYSICA ACT, V1818; DEELEY MC, 1981, J BACTERIOL, V147, P787, DOI 10.1128/JB.147.3.787-796.1981; Di Martino P, 2003, CAN J MICROBIOL, V49, P443, DOI 10.1139/W03-056; Field CM, 2011, J THEOR BIOL, V291, P119, DOI 10.1016/j.jtbi.2011.09.006; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Gaimster H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093168; Gong F, 2002, J BIOL CHEM, V277, P17095, DOI 10.1074/jbc.M201213200; Hirakawa H, 2005, MOL MICROBIOL, V55, P1113, DOI 10.1111/j.1365-2958.2004.04449.x; Hirakawa H, 2010, MICROB PATHOGENESIS, V49, P90, DOI 10.1016/j.micpath.2010.05.002; ISAACS H, 1994, MICROBIOL-UK, V140, P2125, DOI 10.1099/13500872-140-8-2125; KAZARINOFF MN, 1980, J BIOL CHEM, V255, P6228; Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x; Li G, 2013, MICROBIOL-SGM, V159, P402, DOI 10.1099/mic.0.064139-0; NEWTON WA, 1965, J BIOL CHEM, V240, P1211; SUMMERS DK, 1993, MOL MICROBIOL, V8, P1031, DOI 10.1111/j.1365-2958.1993.tb01648.x; Walters M, 2006, INT J MED MICROBIOL, V296, P125, DOI 10.1016/j.ijmm.2006.01.041; Winzer K, 2002, CURR OPIN MICROBIOL, V5, P216, DOI 10.1016/S1369-5274(02)00304-1; Wyeth FJS, 1919, BIOCHEM J, V13, P10, DOI 10.1042/bj0130010; YANOFSKY C, 1991, J BACTERIOL, V173, P6009, DOI 10.1128/jb.173.19.6009-6017.1991	21	16	16	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136691	10.1371/journal.pone.0136691	http://dx.doi.org/10.1371/journal.pone.0136691			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332864	Green Published, gold			2022-12-26	WOS:000360613800066
J	Mori, Y; Yoshino, Y; Ochi, S; Yamazaki, K; Kawabe, K; Abe, M; Kitano, T; Ozaki, Y; Yoshida, T; Numata, S; Mori, T; Iga, J; Kuroda, N; Ohmori, T; Ueno, S				Mori, Yoko; Yoshino, Yuta; Ochi, Shinichiro; Yamazaki, Kiyohiro; Kawabe, Kentaro; Abe, Masao; Kitano, Tomoji; Ozaki, Yuki; Yoshida, Taku; Numata, Shusuke; Mori, Takaaki; Iga, Junichi; Kuroda, Norio; Ohmori, Tetsuro; Ueno, Shu-ichi			TREM2 mRNA Expression in Leukocytes Is Increased in Alzheimer's Disease and Schizophrenia	PLOS ONE			English	Article							QUANTITATIVE PCR; ASSOCIATION; DEMENTIA; DAP12; NEURODEGENERATION; ACTIVATION; PROTEIN; VARIANT; P.R47H; BLOOD	TREM2 and TYROBP are causal genes for Nasu-Hakola disease (NHD), a rare autosomal recessive disease characterized by bone lesions and early-onset progressive dementia. TREM2 forms a receptor signaling complex with TYROBP, which triggers the activation of immune responses in macrophages and dendritic cells, and the functional polymorphism of TREM2 is reported to be associated with neurodegenerative disorders such as Alzheimer's disease (AD). The objective of this study was to reveal the involvement of TYROBP and TREM2 in the pathophysiology of AD and schizophrenia. Methods: We investigated the mRNA expression level of the 2 genes in leukocytes of 26 patients with AD and 24 with schizophrenia in comparison with age-matched controls. Moreover, we performed gene association analysis between these 2 genes and schizophrenia. Results: No differences were found in TYROBP mRNA expression in patients with AD and schizophrenia; however, TREM2 mRNA expression was increased in patients with AD and schizophrenia compared with controls (P < 0.001). There were no genetic associations of either gene with schizophrenia in Japanese patients. Conclusion: TREM2 expression in leukocytes is elevated not only in AD but also in schizophrenia. Inflammatory processes involving TREM2 may occur in schizophrenia, as observed in neurocognitive disorders such as AD. TREM2 expression in leukocytes may be a novel biomarker for neurological and psychiatric disorders.	[Mori, Yoko; Yoshino, Yuta; Ochi, Shinichiro; Yamazaki, Kiyohiro; Kawabe, Kentaro; Abe, Masao; Kitano, Tomoji; Ozaki, Yuki; Yoshida, Taku; Mori, Takaaki; Iga, Junichi; Ueno, Shu-ichi] Ehime Univ, Grad Sch Med, Dept Neuropsychiat Mol & Funct, Toon, Ehime, Japan; [Numata, Shusuke; Ohmori, Tetsuro] Univ Tokushima, Course Integrated Brain Sci, Inst Hlth Biosci, Dept Psychiat,Med Informat,Grad Sch, Tokushima 770, Japan; [Kuroda, Norio] Kuroda Hosp, Masaki, Ehime, Japan	Ehime University; Tokushima University	Mori, Y (corresponding author), Ehime Univ, Grad Sch Med, Dept Neuropsychiat Mol & Funct, Toon, Ehime, Japan.	yoko-m@m.ehime-u.ac.jp	Kawabe, Kentaro/AAC-6933-2022; Ochi, Shinichiro/S-3318-2019; Iga, Jun-ichi/I-1650-2019	Kawabe, Kentaro/0000-0002-6569-7828; Ochi, Shinichiro/0000-0003-2263-3477; Iga, Jun-ichi/0000-0003-4409-3096	Japanese Ministry of Health, Labour and Welfare; Japanese Ministry of Education, Culture, Sports, Science and Technology; Ehime Graduate University of Medicine's Good Practice Fund; Grants-in-Aid for Scientific Research [15K09809] Funding Source: KAKEN	Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ehime Graduate University of Medicine's Good Practice Fund; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by a Health and Labor Science Research Grant from the Japanese Ministry of Health, Labour and Welfare; a Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology; and the Ehime Graduate University of Medicine's Good Practice Fund.	Al-Hakeim HK, 2015, J AFFECT DISORDERS, V182, P106, DOI 10.1016/j.jad.2015.04.044; Avramopoulos D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116696; Cady J, 2014, JAMA NEUROL, V71, P449, DOI 10.1001/jamaneurol.2013.6237; Cantoni C, 2015, ACTA NEUROPATHOL, V129, P429, DOI 10.1007/s00401-015-1388-1; Carrol ED, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-20; Chouery E, 2008, HUM MUTAT, V29, pE194, DOI 10.1002/humu.20836; Colonna M, 2003, J CLIN INVEST, V111, P313, DOI 10.1172/JCI200317745; Daws MR, 2001, EUR J IMMUNOL, V31, P783, DOI 10.1002/1521-4141(200103)31:3<783::AID-IMMU783>3.0.CO;2-U; Dickerson F, 2013, SCHIZOPHR RES, V143, P198, DOI 10.1016/j.schres.2012.10.041; Doorduin J, 2009, J NUCL MED, V50, P1801, DOI 10.2967/jnumed.109.066647; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frank S, 2008, GLIA, V56, P1438, DOI 10.1002/glia.20710; Giraldo M, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.02.016; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hakola H P, 1972, Acta Psychiatr Scand Suppl, V232, P1; Hickman SE, 2014, BIOCHEM PHARMACOL, V88, P495, DOI 10.1016/j.bcp.2013.11.021; Hu N, 2014, J ALZHEIMERS DIS, V38, P497, DOI 10.3233/JAD-130854; Kaifu T, 2003, J CLIN INVEST, V111, P323, DOI 10.1172/JCI200316923; Kiialainen A, 2005, NEUROBIOL DIS, V18, P314, DOI 10.1016/j.nbd.2004.09.007; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lue LF, 2015, BRAIN PATHOL, V25, P469, DOI 10.1111/bpa.12190; Masel J, 2011, CURR BIOL, V21, pR837, DOI 10.1016/j.cub.2011.08.007; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Miyashita A, 2014, J ALZHEIMERS DIS, V41, P1031, DOI 10.3233/JAD-140225; Monji A, 2013, PROG NEURO-PSYCHOPH, V42, P115, DOI 10.1016/j.pnpbp.2011.12.002; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Neumann H, 2007, J NEUROIMMUNOL, V184, P92, DOI 10.1016/j.jneuroim.2006.11.032; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Paradowska-Gorycka A, 2013, HUM IMMUNOL, V74, P730, DOI 10.1016/j.humimm.2013.02.003; Rayaprolu S, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-19; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Takahashi N, 2013, NEUROBIOL DIS, V53, P49, DOI 10.1016/j.nbd.2012.11.001; Uranova NA, 2011, SCHIZOPHR RES TREAT, V2011, DOI 10.1155/2011/325789; Watanabe S, 2015, J PSYCHIATR RES, V66-67, P1, DOI 10.1016/j.jpsychires.2015.03.004	35	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136835	10.1371/journal.pone.0136835	http://dx.doi.org/10.1371/journal.pone.0136835			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332043	Green Published, Green Submitted, gold			2022-12-26	WOS:000360613800076
J	Niehaus, AJ; Mlisana, K; Gandhi, NR; Mathema, B; Brust, JCM				Niehaus, Abraham J.; Mlisana, Koleka; Gandhi, Neel R.; Mathema, Barun; Brust, James C. M.			High Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR CHARACTERIZATION; ETHIONAMIDE; STRAINS	Background Drug-resistant tuberculosis (TB) remains extremely difficult to treat because there are often few remaining active medications and limited diagnostic options to detect resistance. Resistance to isoniazid is typically caused by mutations in either katG or the inhA promoter. inhA mutations confer low-level resistance to isoniazid and cross-resistance to ethionamide while katG mutations confer high-level isoniazid resistance and no cross-resistance. Line Probe Assays (LPAs) that detect mutations in katG and inhA are currently performed on all positive TB cultures in KwaZulu-Natal province, South Africa, but the frequency of inhA mutations in drug-resistant TB patients has not been examined. Methods We sought to determine the proportion of patients who could potentially benefit from high-dose isoniazid and who may be resistant to ethionamide. We reviewed 994 LPA (Hain MTBDRplus) results at the TB reference laboratory in KwaZulu-Natal to determine the frequency of mutations in either katG or the inhA promoter. We stratified these results by drug-resistance category (i.e., MDR-TB, pre-XDR-TB, and XDR-TB) as determined by phenotypic drug-susceptibility testing. Results Among MDR-and XDR-TB isolates, the prevalence of inhA mutations without a concurrent katG mutation was 14.8% and 10.3% respectively. The prevalence of inhA mutations with OR without a katG mutation was 30.3% and 82.8%, respectively. Conclusion More than 10% of patients with MDR- and XDR-TB may benefit from high-dose isoniazid. Although ethionamide is empirically included in all MDR- and XDR-TB regimens, nearly a third of MDR-TB patients and a majority of XDR-TB patients likely have resistance to ethionamide. Laboratories performing line probe assays should report specific band patterns so that clinicians may adjust treatment regimens accordingly.	[Niehaus, Abraham J.; Mlisana, Koleka] Natl Hlth Lab Serv, Dept Med Microbiol, Durban, South Africa; [Niehaus, Abraham J.; Mlisana, Koleka] Univ KwaZulu Natal, Durban, South Africa; [Gandhi, Neel R.] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Gandhi, Neel R.] Emory Univ, Rollins Sch Publ Hlth, Dept Global Hlth, Atlanta, GA 30322 USA; [Gandhi, Neel R.] Emory Univ, Dept Med, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Mathema, Barun] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Brust, James C. M.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Brust, James C. M.] Montefiore Med Ctr, Bronx, NY 10467 USA	University of Kwazulu Natal; Emory University; Rollins School Public Health; Emory University; Rollins School Public Health; Emory University; Rollins School Public Health; Columbia University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Brust, JCM (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA.	jcmbrust@gmail.com	Niehaus, Abraham/AAD-3483-2022; Niehaus, Abraham/B-4918-2010; Mlisana, Koleka/N-6204-2013	Niehaus, Abraham/0000-0002-2793-1855; Niehaus, Abraham/0000-0002-2793-1855; Mlisana, Koleka/0000-0002-8436-3268; Mathema, Barun/0000-0003-2772-479X	Albert Einstein College of Medicine Center for Global Health; National Institutes of Health [K23AI083088, K24AI114444]; Einstein-Montefiore Center for AIDS Research [P30 AI051519]; Emory Center for AIDS Research [P30 AI050409]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409, K23AI083088, K24AI114444, R01AI089349, P30AI051519, R01AI087465] Funding Source: NIH RePORTER	Albert Einstein College of Medicine Center for Global Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Einstein-Montefiore Center for AIDS Research; Emory Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by a pilot grant from the Albert Einstein College of Medicine Center for Global Health. JCMB and NRG are each supported by the National Institutes of Health (K23AI083088 and K24AI114444, respectively). Additional support for this study was provided by the Einstein-Montefiore and Emory Centers for AIDS Research (P30 AI051519 and P30 AI050409, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate D, 2014, INT J TUBERC LUNG D, V18, P946, DOI 10.5588/ijtld.13.0926; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Chihota VN, 2012, J CLIN MICROBIOL, V50, P995, DOI 10.1128/JCM.05832-11; Conradie F, 2014, SAMJ S AFR MED J, V104, P164, DOI 10.7196/SAMJ.7263; Falzon D, 2011, EUR RESPIR J, V38, P516, DOI 10.1183/09031936.00073611; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gandhi NR, 2014, EMERG INFECT DIS, V20, P426, DOI 10.3201/eid2003.131083; Guo HL, 2006, J MED MICROBIOL, V55, P1527, DOI 10.1099/jmm.0.46718-0; Herrera L, 2004, INT J ANTIMICROB AG, V23, P572, DOI 10.1016/j.ijantimicag.2003.09.032; Jagielski T, 2014, J ANTIMICROB CHEMOTH, V69, P2369, DOI 10.1093/jac/dku161; Katiyar SK, 2008, INT J TUBERC LUNG D, V12, P139; Morlock GP, 2003, ANTIMICROB AGENTS CH, V47, P3799, DOI 10.1128/AAC.47.12.3799-3805.2003; Muller B, 2011, INT J TUBERC LUNG D, V15, P344; Sandgren A, 2009, PLOS MED, V6, P132, DOI 10.1371/journal.pmed.1000002; Van Deun A, 2010, AM J RESP CRIT CARE, V182, P684, DOI 10.1164/rccm.201001-0077OC; Varghese B, 2014, MICROBIAL DRUG RESIS; Vilcheze C, 2007, ANNU REV MICROBIOL, V61, P35, DOI 10.1146/annurev.micro.61.111606.122346; World Health Organization, 2014, WHOHTMTB201408; Zhang Y, 2009, INT J TUBERC LUNG D, V13, P1320	19	27	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135003	10.1371/journal.pone.0135003	http://dx.doi.org/10.1371/journal.pone.0135003			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332235	Green Published, Green Submitted, gold			2022-12-26	WOS:000360613800018
J	Wu, WJ; Gu, SP; Sun, C; He, W; Xie, XH; Li, X; Ye, WD; Qin, CL; Chen, YP; Xiao, J; Liu, C				Wu, Weijie; Gu, Shuping; Sun, Cheng; He, Wei; Xie, Xiaohua; Li, Xihai; Ye, Wenduo; Qin, Chunlin; Chen, Yiping; Xiao, Jing; Liu, Chao			Altered FGF Signaling Pathways Impair Cell Proliferation and Elevation of Palate Shelves	PLOS ONE			English	Article							CRANIAL NEURAL CREST; SECONDARY PALATE; CLEFT-PALATE; GROWTH-FACTOR; TRANSCRIPTION FACTOR; MAMMALIAN PALATE; MICE; MORPHOGENESIS; TOOTH; PALATOGENESIS	In palatogenesis, palatal shelves are patterned along the mediolateral axis as well as the anteroposterior axis before the onset of palatal fusion. Fgf10 specifically expressed in lateral mesenchyme of palate maintains Shh transcription in lateral epithelium, while Fgf7 activated in medial mesenchyme by Dlx5, suppressed the expansion of Shh expression to medial epithelium. How FGF signaling pathways regulate the cell behaviors of developing palate remains elusive. In our study, we found that when Fgf8 is ectopically expressed in the embryonic palatal mesenchyme, the elevation of palatal shelves is impaired and the posterior palatal shelves are enlarged, especially in the medial side. The palatal deformity results from the drastic increase of cell proliferation in posterior mesenchyme and decrease of cell proliferation in epithelium. The expression of mesenchymal Fgf10 and epithelial Shh in the lateral palate, as well as the Dlx5 and Fgf7 transcription in the medial mesenchyme are all interrupted, indicating that the epithelial-mesenchymal interactions during palatogenesis are disrupted by the ectopic activation of mesenchymal Fgf8. Besides the altered Fgf7, Fgf10, Dlx5 and Shh expression pattern, the reduced Osr2 expression domain in the lateral mesenchyme also suggests an impaired mediolateral patterning of posterior palate. Moreover, the ectopic Fgf8 expression up-regulates pJak1 throughout the palatal mesenchyme and pErk in the medial mesenchyme, but down-regulates pJak2 in the epithelium, suggesting that during normal palatogenesis, the medial mesenchymal cell proliferation is stimulated by FGF/Erk pathway, while the epithelial cell proliferation is maintained through FGF/Jak2 pathway.	[Wu, Weijie] Shanghai Zhongshan Hosp, Dept Stomatol, Shanghai, Peoples R China; [Wu, Weijie; Gu, Shuping; Sun, Cheng; He, Wei; Li, Xihai; Ye, Wenduo; Chen, Yiping; Liu, Chao] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA; [Wu, Weijie; Gu, Shuping; Sun, Cheng; He, Wei; Li, Xihai; Ye, Wenduo; Chen, Yiping; Liu, Chao] Tulane Univ, Sch Sci & Engn, New Orleans, LA 70118 USA; [Xie, Xiaohua; Qin, Chunlin; Liu, Chao] Baylor Coll Dent, Texas A&M Hlth Sci Ctr, Dept Biomed Sci, Dallas, TX 75246 USA; [He, Wei] Zunyi Med Univ, Affiliated Stomatol Hosp, Dept Oral & Maxillofacial Surg, Zunyi, Peoples R China; [Xie, Xiaohua] Harbin Med Univ, Affiliated Hosp 2, Inst Hard Tissue Dev & Regenerat, Dept Endodont, Harbin, Peoples R China; [Li, Xihai] Fujian Univ Tradit Chinese Med, Acad Integrat Med, Fuzhou, Peoples R China; [Xiao, Jing; Liu, Chao] Dalian Med Univ, Coll Stomatol, Dept Oral Biol, Dalian, Peoples R China	Fudan University; Tulane University; Tulane University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Zunyi Medical University; Harbin Medical University; Fujian University of Traditional Chinese Medicine; Dalian Medical University	Xiao, J (corresponding author), Dalian Med Univ, Coll Stomatol, Dept Oral Biol, Dalian, Peoples R China.	xiaoj@dlmedu.edu.cn; cliu@bcd.tamhsc.edu			National Institutes of Health [R01 DE14044, R01 DE022549]; National Science Foundation of China [81271120]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014044, R01DE022549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding was provided by the National Institutes of Health Grants (R01 DE14044) to Y.C., National Institutes of Health Grants (R01 DE022549) to C.Q., and the National Science Foundation of China Research Grant (No. 81271120) to J.X.	Ahn Y, 2010, DEVELOPMENT, V137, P3221, DOI 10.1242/dev.054668; Almaidhan A, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-3; Bellmunt J, 2013, NAT REV CLIN ONCOL, V10, P557, DOI 10.1038/nrclinonc.2013.155; Bush JO, 2012, DEVELOPMENT, V139, P231, DOI 10.1242/dev.067082; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chen JQ, 2009, DEV BIOL, V334, P174, DOI 10.1016/j.ydbio.2009.07.015; Dudas M, 2007, ACTA HISTOCHEM, V109, P1, DOI 10.1016/j.acthis.2006.05.009; Economou AD, 2012, NAT GENET, V44, P348, DOI 10.1038/ng.1090; Enomoto H, 2010, DEVELOPMENT, V137, P4029, DOI 10.1242/dev.050591; Gao Y, 2009, DEV BIOL, V328, P200, DOI 10.1016/j.ydbio.2009.01.008; Goetz R, 2013, NAT REV MOL CELL BIO, V14, P166, DOI 10.1038/nrm3528; Gritli-Linde A, 2007, DEV BIOL, V301, P309, DOI 10.1016/j.ydbio.2006.07.042; Gu SP, 2008, MECH DEVELOP, V125, P729, DOI 10.1016/j.mod.2008.04.003; Gu SP, 2008, DEV DYNAM, V237, P1509, DOI 10.1002/dvdy.21534; Guo LF, 1996, GENE DEV, V10, P165, DOI 10.1101/gad.10.2.165; Han J, 2009, DEVELOPMENT, V136, P4225, DOI 10.1242/dev.036723; He FL, 2008, DEVELOPMENT, V135, P3871, DOI 10.1242/dev.025767; He FL, 2011, DEV BIOL, V350, P511, DOI 10.1016/j.ydbio.2010.12.021; Hilliard SA, 2005, J ANAT, V207, P655, DOI 10.1111/j.1469-7580.2005.00474.x; Hosokawa R, 2009, J EXP ZOOL PART B, V312B, P343, DOI 10.1002/jez.b.21274; Lan Y, 2004, DEVELOPMENT, V131, P3207, DOI 10.1242/dev.01175; Lan Y, 2007, GENESIS, V45, P618, DOI 10.1002/dvg.20334; Lan Y, 2009, DEVELOPMENT, V136, P1387, DOI 10.1242/dev.028167; Lanner F, 2010, DEVELOPMENT, V137, P3351, DOI 10.1242/dev.050146; Li JY, 2011, DEVELOPMENT, V138, P1977, DOI 10.1242/dev.061341; Li Q, 2007, INT J DEV BIOL, V51, P167, DOI 10.1387/ijdb.062212ql; Lin CX, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003231; Liu WJ, 2008, DEVELOPMENT, V135, P3959, DOI 10.1242/dev.025304; Matsumura K, 2011, BIOCHEM BIOPH RES CO, V404, P1076, DOI 10.1016/j.bbrc.2010.12.116; Pantalacci S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-116; PRESNELL JK, 1997, HUMASONS ANIMAL TISS; Rice R, 2004, J CLIN INVEST, V113, P1692, DOI 10.1172/JCI200420384; Riley BM, 2007, P NATL ACAD SCI USA, V104, P4512, DOI 10.1073/pnas.0607956104; Snyder-Warwick AK, 2010, P NATL ACAD SCI USA, V107, P2515, DOI 10.1073/pnas.0913985107; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Wang C, 2013, J BIOL CHEM, V288, P22174, DOI 10.1074/jbc.M113.463620; Welsh IC, 2009, DEV BIOL, V336, P53, DOI 10.1016/j.ydbio.2009.09.028; Xiong W, 2009, DEV BIOL, V330, P131, DOI 10.1016/j.ydbio.2009.03.021; Yu L, 2005, DEVELOPMENT, V132, P4397, DOI 10.1242/dev.02013; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200; Zhang ZY, 2002, DEVELOPMENT, V129, P4135; Zhou J, 2013, DEVELOPMENT, V140, P4709, DOI 10.1242/dev.099028	42	17	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136951	10.1371/journal.pone.0136951	http://dx.doi.org/10.1371/journal.pone.0136951			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332583	Green Submitted, Green Published, gold			2022-12-26	WOS:000360613800082
J	Yang, ZY; Dong, WJ; Xiu, JF; Dai, RF; Chou, JM				Yang, Zhiyong; Dong, Wenjie; Xiu, Jinfeng; Dai, Rufeng; Chou, Jieming			Structural Path Analysis of Fossil Fuel Based CO2 Emissions: A Case Study for China	PLOS ONE			English	Article							INPUT-OUTPUT-ANALYSIS; REGIONAL CONSUMPTION ACTIVITIES; GLOBAL ENVIRONMENTAL-IMPACT; INTERNATIONAL-TRADE; RESPONSIBILITY; DECOMPOSITION; POLLUTION; CONSUMER; PRODUCER; IMPORTS	Environmentally extended input-output analysis (EEIOA) has long been used to quantify global and regional environmental impacts and to clarify emission transfers. Structural path analysis (SPA), a technique based on EEIOA, is especially useful for measuring significant flows in this environmental-economic system. This paper constructs an imports-adjusted single-region input-output (SRIO) model considering only domestic final use elements, and it uses the SPA technique to highlight crucial routes along the production chain in both final use and sectoral perspectives. The results indicate that future mitigation policies on household consumption should change direct energy use structures in rural areas, cut unreasonable demand for power and chemical products, and focus on urban areas due to their consistently higher magnitudes than rural areas in the structural routes. Impacts originating from government spending should be tackled by managing onsite energy use in 3 major service sectors and promoting cleaner fuels and energy-saving techniques in the transport sector. Policies on investment should concentrate on sectoral interrelationships along the production chain by setting up standards to regulate upstream industries, especially for the services, construction and equipment manufacturing sectors, which have high demand pulling effects. Apart from the similar methods above, mitigating policies in exports should also consider improving embodied technology and quality in manufactured products to achieve sustainable development. Additionally, detailed sectoral results in the coal extraction industry highlight the onsite energy use management in large domestic companies, emphasize energy structure rearrangement, and indicate resources and energy safety issues. Conclusions based on the construction and public administration sectors reveal that future mitigation in secondary and tertiary industries should be combined with upstream emission intensive industries in a systematic viewpoint to achieve sustainable development. Overall, SPA is a useful tool in empirical studies, and it can be used to analyze national environmental impacts and guide future mitigation policies.	[Yang, Zhiyong; Dong, Wenjie; Xiu, Jinfeng; Dai, Rufeng; Chou, Jieming] Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China; [Yang, Zhiyong; Dong, Wenjie; Dai, Rufeng; Chou, Jieming] Beijing Normal Univ Zhuhai, Future Earth Res Inst, Zhuhai, Guangdong, Peoples R China	Beijing Normal University; Beijing Normal University; Beijing Normal University Zhuhai	Chou, JM (corresponding author), Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China.	choujm@bnu.edu.cn			National Basic Program for Global Change Research of China [2012CB9557]; National Natural Science Foundation of China [41175125, 41330527]; National level Major Incubation Project of Guangdong Province, China [2014GKXM058]	National Basic Program for Global Change Research of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National level Major Incubation Project of Guangdong Province, China	This work is funded by the National Basic Program for Global Change Research of China (2012CB9557, http://www.973.gov.cn/Default_3.aspx), the National Natural Science Foundation of China (41175125 and 41330527, http://www.nsfc.gov.cn/), and the National level Major Incubation Project of Guangdong Province, China (2014GKXM058, http://govinfonew.nlc.gov.cn/gdfz/govShow2015-016143086-TC0000000004.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew R, 2009, ECON SYST RES, V21, P311, DOI 10.1080/09535310903541751; Arto I, 2014, ECOL ECON, V97, P93, DOI 10.1016/j.ecolecon.2013.11.005; Atkinson G, 2011, GLOBAL ENVIRON CHANG, V21, P563, DOI 10.1016/j.gloenvcha.2010.11.009; Bai Y., 2015, XIJINPING ACTIVELY P; Boden T. A., 2013, GLOBAL REGIONAL NATL, DOI [10.3334/CDIAC/00001_V2013, DOI 10.3334/CDIAC/00001_V2013]; DEFOURNY J, 1984, ECON J, V94, P111, DOI 10.2307/2232220; EIA, US EN INF ADM INT EN; Fan Y, 2007, ECOL ECON, V62, P683, DOI 10.1016/j.ecolecon.2006.08.016; Gallego B., 2005, ECON SYST RES, V17, P365, DOI [10.1080/ 09535310500283492, 10.1080/09535310500283492, DOI 10.1080/09535310500283492]; GCEC, 2014, NEW CLIM EC GLOB REP, P42; General Administration of Customs of the People's Republic of China (GAC), 2021, CHIN CUST STAT DAT; Guan DB, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/2/024010; Guan D, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036540; Guan D, 2008, GLOBAL ENVIRON CHANG, V18, P626, DOI 10.1016/j.gloenvcha.2008.08.001; Hertwich EG, 2010, MULTIREGIONAL INPUT; Huang YA, 2009, ECON SYST RES, V21, P217, DOI 10.1080/09535310903541348; Joos F, 2008, P NATL ACAD SCI USA, V105, P1425, DOI 10.1073/pnas.0707386105; Kan HD, 2009, ENVIRON HEALTH PERSP, V117, pA187, DOI 10.1289/ehp.12737; Kanemoto K, 2014, GLOBAL ENVIRON CHANG, V24, P52, DOI 10.1016/j.gloenvcha.2013.09.008; Kanemoto K, 2012, ENVIRON SCI TECHNOL, V46, P172, DOI 10.1021/es202239t; Le Quere C, 2014, EARTH SYST SCI DATA, V6, P235, DOI 10.5194/essd-6-235-2014; Lenzen M., 2003, Structural Change and Economic Dynamics, V14, P1, DOI 10.1016/S0954-349X(02)00025-5; Lenzen M, 2012, NATURE, V486, P109, DOI 10.1038/nature11145; Lenzen M, 2002, J CLEAN PROD, V10, P545, DOI 10.1016/S0959-6526(02)00007-0; Lenzen M., 2004, ECON SYST RES, V16, P391, DOI [DOI 10.1080/0953531042000304272, 10.1080/0953531042000304272]; Lenzen M, 2007, ECOL ECON, V61, P27, DOI 10.1016/j.ecolecon.2006.05.018; Lenzen M, 2007, ECOL MODEL, V200, P334, DOI 10.1016/j.ecolmodel.2006.07.041; Lenzen M, 2013, ECOL ECON, V94, P78, DOI 10.1016/j.ecolecon.2013.06.018; Lenzen M, 2010, ECOL ECON, V70, P261, DOI 10.1016/j.ecolecon.2010.04.005; Marques A, 2013, ECOL ECON, V89, P162, DOI 10.1016/j.ecolecon.2013.02.020; Marques A, 2012, ECOL ECON, V84, P57, DOI 10.1016/j.ecolecon.2012.09.010; Miller RE, 2009, INPUT OUTPUT ANAL FD, P69; Minx JC, 2009, ECON SYST RES, V21, P187, DOI 10.1080/09535310903541298; Nakamura D, 2014, CHINA US AGREE LIMIT; NBSC, NAT BUR STAT CHIN 20; NBSC, 2007, INPUT OUTPUT TABLES; NBSC, 2008, EN STAT YB CHINA; Oshita Y, 2012, ENERG ECON, V34, P1041, DOI 10.1016/j.eneco.2011.08.013; Peters G, 2006, CONSTRUCTION CHINESE, p[1501, 3]; Peters G.P., 2006, ECON SYST RES, V18, P155, DOI DOI 10.1080/09535310600653008; Peters GP, 2007, ENVIRON SCI TECHNOL, V41, P5939, DOI 10.1021/es070108f; Peters GP, 2006, J IND ECOL, V10, P89, DOI 10.1162/jiec.2006.10.3.89; Peters GP, 2012, NAT CLIM CHANGE, V2, P2, DOI 10.1038/nclimate1332; Rodrigues J, 2008, ECOL ECON, V66, P533, DOI 10.1016/j.ecolecon.2007.12.010; Rodrigues J, 2006, ECOL ECON, V59, P256, DOI 10.1016/j.ecolecon.2005.10.002; Rypdal K., 2006, 2006 IPCC GUIDELINES; Sheng B, 2002, POLITICAL EC ANAL CH, P480; Shui B, 2006, ENERG POLICY, V34, P4063, DOI 10.1016/j.enpol.2005.09.010; Song L, 2012, RISING CHINA GLOBAL, P71; Song R, 2015, GHG PROTOCOL TOOL EN; Sonis M, 1997, REG SCI URBAN ECON, V27, P325, DOI 10.1016/S0166-0462(96)02165-5; Su B, 2013, ENERG POLICY, V56, P83, DOI 10.1016/j.enpol.2013.01.041; Tans P, EARTH SYSTEM RES LA; Treloar G.J., 1997, EC SYSTEMS RES, V9, P375, DOI [DOI 10.1080/09535319700000032, 10.1080/09535319700000032]; Treloar G.J., 2001, CONSTR MANAG ECON, V19, P49, DOI [10.1080/014461901452076, DOI 10.1080/014461901452076]; Tukker A, 2013, ENVIRON SCI TECHNOL, V47, P1775, DOI 10.1021/es303217f; Turner K, 2007, ECOL ECON, V62, P37, DOI 10.1016/j.ecolecon.2006.12.002; UNSD, UN STAST DIV; Waugh FV, 1950, ECONOMETRICA, V18, P142, DOI 10.2307/1907265; Weber CL, 2008, ENERG POLICY, V36, P3572, DOI 10.1016/j.enpol.2008.06.009; Wiedmann T, 2007, ECOL ECON, V61, P15, DOI 10.1016/j.ecolecon.2006.12.003; Wiedmann T, 2009, ECOL ECON, V69, P211, DOI 10.1016/j.ecolecon.2009.08.026; Wood R, 2009, ENERG ECON, V31, P335, DOI 10.1016/j.eneco.2008.11.003; Yang ZY, 2015, J CLEAN PROD, V103, P793, DOI 10.1016/j.jclepro.2014.03.053; Zhang M, 2009, ECOL ECON, V68, P2122, DOI 10.1016/j.ecolecon.2009.02.005; Zhang YG, 2013, ENERG ECON, V40, P967, DOI 10.1016/j.eneco.2013.05.025; Zhang YG, 2012, ENVIRON RESOUR ECON, V51, P371, DOI 10.1007/s10640-011-9503-9; Zhang YG, 2009, ECOL ECON, V68, P2399, DOI 10.1016/j.ecolecon.2009.03.014	68	27	29	3	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135727	10.1371/journal.pone.0135727	http://dx.doi.org/10.1371/journal.pone.0135727			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332222	Green Published, Green Submitted, gold			2022-12-26	WOS:000360613800038
J	Augustinos, AA; Kyritsis, GA; Papadopoulos, NT; Abd-Alla, AMM; Caceres, C; Bourtzis, K				Augustinos, Antonios A.; Kyritsis, Georgios A.; Papadopoulos, Nikos T.; Abd-Alla, Adly M. M.; Caceres, Carlos; Bourtzis, Kostas			Exploitation of the Medfly Gut Microbiota for the Enhancement of Sterile Insect Technique: Use of Enterobacter sp in Larval Diet-Based Probiotic Applications	PLOS ONE			English	Article							CANDIDATUS ERWINIA DACICOLA; FRUIT-FLY; BACTROCERA-DORSALIS; DIPTERA TEPHRITIDAE; CERATITIS-CAPITATA; BACTERIAL COMMUNITIES; CULTIVABLE BACTERIA; INTESTINAL-TRACT; DIVERSITY; POPULATIONS	The Mediterranean fruit fly (medfly), Ceratitis capitata, is a pest of worldwide substantial economic importance, as well as a Tephritidae model for sterile insect technique (SIT) applications. The latter is partially due to the development and utilization of genetic sexing strains (GSS) for this species, such as the Vienna 8 strain, which is currently used in mass rearing facilities worldwide. Improving the performance of such a strain both in mass rearing facilities and in the field could significantly enhance the efficacy of SIT and reduce operational costs. Recent studies have suggested that the manipulation of gut symbionts can have a significant positive effect on the overall fitness of insect strains. We used culture-based approaches to isolate and characterize gut-associated bacterial species of the Vienna 8 strain under mass rearing conditions. We also exploited one of the isolated bacterial species, Enterobacter sp., as dietary supplement (probiotic) to the larval diet, and we assessed its effects on fitness parameters under the standard operating procedures used in SIT operational programs. Probiotic application of Enterobacter sp. resulted in improvement of both pupal and adult productivity, as well as reduced rearing duration, particularly for males, without affecting pupal weight, sex ratio, male mating competitiveness, flight ability and longevity under starvation.	[Augustinos, Antonios A.; Kyritsis, Georgios A.; Abd-Alla, Adly M. M.; Caceres, Carlos; Bourtzis, Kostas] Seibersdorf, Joint FAO IAEA Programme Nucl Tech Food & Agr, Insect Pest Control Lab, Vienna, Austria; [Augustinos, Antonios A.] Univ Patras, Dept Environm & Nat Resources Management, Agrinion, Greece; [Kyritsis, Georgios A.; Papadopoulos, Nikos T.] Univ Thessaly, Lab Entomol & Agr Zool, Dept Agr Crop Prod & Rural Environm, N Ionia Magnisia, Greece	International Atomic Energy Agency; University of Patras; University of Thessaly	Bourtzis, K (corresponding author), Seibersdorf, Joint FAO IAEA Programme Nucl Tech Food & Agr, Insect Pest Control Lab, Vienna, Austria.	K.Bourtzis@iaea.org	Augustinos, Antonios/C-1318-2019; Papadopoulos, Nikos T./B-9156-2011; Papadopoulos, Nikos/AAJ-1721-2020	Augustinos, Antonios/0000-0003-3682-6077; Papadopoulos, Nikos T./0000-0003-2480-8189; Papadopoulos, Nikos/0000-0003-2480-8189; ABD-ALLA, Adly/0000-0001-7540-4462	Joint FAO/IAEA Programme of Nuclear Techniques in Food and Agriculture	Joint FAO/IAEA Programme of Nuclear Techniques in Food and Agriculture	This study was supported by the Joint FAO/IAEA Programme of Nuclear Techniques in Food and Agriculture.	Aharon Y, 2013, APPL ENVIRON MICROB, V79, P303, DOI 10.1128/AEM.02761-12; BAUMANN P, 1995, ANNU REV MICROBIOL, V49, P55, DOI 10.1146/annurev.mi.49.100195.000415; Behar A, 2008, J INSECT PHYSIOL, V54, P1377, DOI 10.1016/j.jinsphys.2008.07.011; Behar A, 2008, MOL ECOL, V17, P1375, DOI 10.1111/j.1365-294X.2008.03674.x; Behar A, 2005, MOL ECOL, V14, P2637, DOI 10.1111/j.1365-294X.2005.02615.x; Ben Ami E, 2010, ISME J, V4, P28, DOI 10.1038/ismej.2009.82; Ben-Yosef M, 2014, J EVOLUTION BIOL, V27, P2695, DOI 10.1111/jeb.12527; Ben-Yosef M, 2008, PHYSIOL ENTOMOL, V33, P145, DOI 10.1111/j.1365-3032.2008.00617.x; Ben-Yosef M, 2010, P ROY SOC B-BIOL SCI, V277, P1545, DOI 10.1098/rspb.2009.2102; Bourtzis K, 2003, CONT T ENT, P217; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; Caceres C, 2002, GENETICA, V116, P107, DOI 10.1023/A:1020967810703; CALKINS CO, 1983, FLA ENTOMOL, V66, P512, DOI 10.2307/3494025; Capuzzo C, 2005, INT J SYST EVOL MICR, V55, P1641, DOI 10.1099/ijs.0.63653-0; Crotti E, 2010, APPL ENVIRON MICROB, V76, P6963, DOI 10.1128/AEM.01336-10; Douglas AE, 2015, ANNU REV ENTOMOL, V60, P17, DOI 10.1146/annurev-ento-010814-020822; Douglas AE, 2013, J CHEM ECOL, V39, P952, DOI 10.1007/s10886-013-0308-x; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Estes AM, 2012, ENVIRON ENTOMOL, V41, P265, DOI 10.1603/EN11245; Estes AM, 2009, APPL ENVIRON MICROB, V75, P7097, DOI 10.1128/AEM.00778-09; FAO/IAEA/USDA, 2014, PRODUCT QUALITY CONT; Florez LV, 2015, NAT PROD REP, V32, P904, DOI 10.1039/c5np00010f; Franz G, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P427, DOI 10.1007/1-4020-4051-2_16; Gavriel S, 2011, J APPL ENTOMOL, V135, P564, DOI 10.1111/j.1439-0418.2010.01605.x; Hamden H, 2013, J ECON ENTOMOL, V106, P641, DOI 10.1603/EC12362; Kaltenpoth M, 2006, INT J SYST EVOL MICR, V56, P1403, DOI 10.1099/ijs.0.64117-0; Kikuchi Y, 2011, APPL ENVIRON MICROB, V77, P4075, DOI 10.1128/AEM.00358-11; Klassen W, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P39, DOI 10.1007/1-4020-4051-2_2; Kounatidis I, 2009, APPL ENVIRON MICROB, V75, P3281, DOI 10.1128/AEM.02933-08; Morrow JL, 2015, MICROB ECOL, V70, P498, DOI 10.1007/s00248-015-0571-1; Nash WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086029; Prabhakar CS, 2013, PHYTOPARASITICA, V41, P193, DOI 10.1007/s12600-012-0278-5; Prabhakar CS, 2009, J GEN APPL MICROBIOL, V55, P479; Pramanik M. K., 2014, Research Journal of Microbiology, V9, P278; Reed DW, 2002, APPL ENVIRON MICROB, V68, P3759, DOI 10.1128/AEM.68.8.3759-3770.2002; Sacchetti P, 2014, ANN APPL BIOL, V164, P138, DOI 10.1111/aab.12088; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Saridaki A, 2010, CURR OPIN MICROBIOL, V13, P67, DOI 10.1016/j.mib.2009.11.005; Savio C, 2012, INT J SYST EVOL MICR, V62, P179, DOI 10.1099/ijs.0.030668-0; Shi ZH, 2012, INT J MOL SCI, V13, P6266, DOI 10.3390/ijms13056266; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TANAKA N, 1969, J ECON ENTOMOL, V62, P967, DOI 10.1093/jee/62.4.967; Thaochan N, 2013, PHILIPP AGRIC SCI, V96, P384; Wang H, 2011, J APPL MICROBIOL, V110, P1390, DOI 10.1111/j.1365-2672.2011.05001.x; Wang HX, 2014, PEST MANAG SCI, V70, P80, DOI 10.1002/ps.3528; Watanabe K, 2014, P NATL ACAD SCI USA, V111, P7433, DOI 10.1073/pnas.1402476111; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Zchori-Fein E, 2012, FRONT MICROBIOL SER, pIX	49	101	104	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136459	10.1371/journal.pone.0136459	http://dx.doi.org/10.1371/journal.pone.0136459			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325068	Green Submitted, Green Published, gold			2022-12-26	WOS:000360437700044
J	Chen, WQ; Xu, XY; Wang, LJ; Bai, G; Xiang, WP				Chen, Wenqi; Xu, Xiaoyan; Wang, Lingjuan; Bai, Ge; Xiang, Wenpei			Low Expression of Mfn2 Is Associated with Mitochondrial Damage and Apoptosis of Ovarian Tissues in the Premature Ovarian Failure Model	PLOS ONE			English	Article							DYNAMICS; CELLS; INSUFFICIENCY; ATRESIA; FUSION; GENES; ATP	Background This study aimed to construct a working model for detecting the mitochondrial damage and expression of Mfn2. It furthermore explored the pathogenesis of premature ovarian failure (POF) induced by cisplatin. Method Forty young female mice were divided randomly into two groups. The first was the treatment group intraperitoneally administered cisplatin (1.5mg/kg). The untreated control group was likewise injected with physiological saline for 10 days. One month later, we observed the ovarian weight and morphological changes, particularly the development of follicles and concentration of sex hormones. Immunohistochemistry and western blotting were used to measure the two groups. We later evaluated ovarian cell apoptosis with TUNEL and analyzed Bcl-2 and Bax levels. We used transmission electron microscopy in order to observe the ultrastructure of ovarian cells. The phosphomolybdic acid colorimetric method was used to measure the ATP content in the ovarian tissue. Finally, the mitochondrial membrane potential of ovarian cells was detected with JC-1 dye. Results The cisplatin resulted in a decline of body weight, reduced ovarian weight significantly, and resulted in disorders of the extrous cycle. The follicles' number decreased within the tissue's stromal hyperplasia. Moreover, E-2 levels were reduced, and elevated gonadotropin levels were observed. However, Mfn2 was present in the cell's cytoplasm in both groups. Nevertheless, the Mfn2 levels and the expression of Bcl-2 were significantly decreased (p<0.05), but the expression of Bax and the apoptosis index (AI) was increased. In addition, the ATP levels (35.2 +/- 5.7 mu mol/g) of the control group were significantly higher (13.5 +/- 3.8 mu mol/g). Lastly, an obvious impairment of mitochondrial function and structure was observed. Conclusion The intreperitoneal injection of cisplatin, when administered for 10 days, establishes a POF model. Thus, the above results suggest that lower expression of Mfn2 may be involved in the mechanism of premature ovarian failure by affecting both the mitochondria's energy metabolism and its apoptosis. This decides the termination of the follicles' development.	[Chen, Wenqi; Wang, Lingjuan; Bai, Ge; Xiang, Wenpei] Huazhong Univ Sci & Technol, Family Planning Res Inst, Tongji Med Coll, Wuhan 430030, Peoples R China; [Xu, Xiaoyan] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Obstet & Gynecol, Tongji Med Coll, Wuhan 430030, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Xiang, WP (corresponding author), Huazhong Univ Sci & Technol, Family Planning Res Inst, Tongji Med Coll, Wuhan 430030, Peoples R China.	wpxiang2010@gmail.com			Fundamental Research Funds for the Central Universities	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by "the Fundamental Research Funds for the Central Universities".	Abed RMM, 2012, INDIAN J MICROBIOL, V52, P88, DOI 10.1007/s12088-011-0239-6; Bonomi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042423; Cha KY, 2005, FERTIL STERIL, V84, P1712, DOI 10.1016/j.fertnstert.2005.06.036; de Brito OM, 2010, EMBO J, V29, P2715, DOI 10.1038/emboj.2010.177; Duarte A, 2012, PLOS ONE, V7, P1; Escobar-Henriques M, 2013, BBA-MOL CELL RES, V1833, P162, DOI 10.1016/j.bbamcr.2012.07.016; Givvimani S, 2015, INT J CARDIOL, V187, P325, DOI 10.1016/j.ijcard.2015.03.352; Guo JQ, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-18; Jin M, 2012, SCI CHINA LIFE SCI, V55, P677, DOI 10.1007/s11427-012-4355-2; Li D, 2013, ANIM REPROD SCI, V137, P205, DOI 10.1016/j.anireprosci.2012.11.011; Li Lin, 2009, Zhonghua Fu Chan Ke Za Zhi, V44, P191; Lin PF, 2012, MOL REPROD DEV, V79, P423, DOI 10.1002/mrd.22045; Liu C, 2014, BIOCHEM BIOPH RES CO, V450, P500, DOI 10.1016/j.bbrc.2014.06.005; Liu JB, 2014, MOL CELLS, V37, P865, DOI 10.14348/molcells.2014.0145; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Nasrallah CM, 2014, NAT REV ENDOCRINOL, V10, P650, DOI 10.1038/nrendo.2014.160; Ngoh GA, 2012, J BIOL CHEM, V287, P20321, DOI 10.1074/jbc.M112.359174; Munoz JP, 2013, EMBO J, V32, P2348, DOI 10.1038/emboj.2013.168; Pang W, 2013, PLACENTA, V34, P613, DOI 10.1016/j.placenta.2013.03.013; Paradies G, 2015, ARCH TOXICOL, V89, P923, DOI 10.1007/s00204-015-1475-z; Ray Wilson Z, 2012, Hand (N Y), V7, P59, DOI 10.1007/s11552-011-9378-9; Scorrano L, 2013, EUR J CLIN INVEST, V43, P886, DOI 10.1111/eci.12135; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Sullivan SD, 2011, SEMIN REPROD MED, V29, P283, DOI 10.1055/s-0031-1280914; Tarazona AM, 2006, REPROD DOMEST ANIM, V41, P5, DOI 10.1111/j.1439-0531.2006.00615.x; Tian Y, 2015, CELL BIOL INT, V39, P584, DOI 10.1002/cbin.10426; Tsujimoto Y, 1997, CELL DEATH DIFFER, V4, P429, DOI 10.1038/sj.cdd.4400262; Van Blerkom J, 2011, MITOCHONDRION, V11, P797, DOI 10.1016/j.mito.2010.09.012; Verma S, 2015, J BIOMOL STRUCT DYN, V33, P1094, DOI 10.1080/07391102.2014.931823; Vidoni S, 2013, ANTIOXID REDOX SIGN, V19, P379, DOI 10.1089/ars.2012.4800; Vujovic S, 2012, SRP ARK CELOK LEK, V140, P806, DOI 10.2298/SARH1212806V; Wakai T, 2014, MOL HUM REPROD, V20, P1090, DOI 10.1093/molehr/gau064; Wang Q, 2010, PLOS ONE, V28; Welt CK, 2008, CLIN ENDOCRINOL, V68, P499, DOI 10.1111/j.1365-2265.2007.03073.x; Yucebilgin MS, 2004, AUST NZ J OBSTET GYN, V44, P6, DOI 10.1111/j.1479-828X.2004.00143.x; Zamaraeva MV, 2005, CELL DEATH DIFFER, V12, P1390, DOI 10.1038/sj.cdd.4401661; Zhang G, 2015, REPROD DOMEST ANIM, V50, P465, DOI 10.1111/rda.12514; Zhao N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125680	38	15	17	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136421	10.1371/journal.pone.0136421	http://dx.doi.org/10.1371/journal.pone.0136421			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327438	Green Published, gold, Green Submitted			2022-12-26	WOS:000360437700041
J	Molaei, G; Armstrong, PM; Abadam, CF; Akaratovic, KI; Kiser, JP; Andreadis, TG				Molaei, Goudarz; Armstrong, Philip M.; Abadam, Charles F.; Akaratovic, Karen I.; Kiser, Jay P.; Andreadis, Theodore G.			Vector-Host Interactions of Culiseta melanura in a Focus of Eastern Equine Encephalitis Virus Activity in Southeastern Virginia	PLOS ONE			English	Article							WEST-NILE-VIRUS; POTENTIAL MOSQUITO VECTORS; FIELD-COLLECTED MOSQUITOS; MARYLAND FRESHWATER SWAMP; UPSTATE NEW-YORK; FEEDING PATTERNS; ENCEPHALOMYELITIS VIRUS; UNITED-STATES; WILD BIRDS; MASSACHUSETTS	Eastern equine encephalitis virus (EEEV) causes a highly pathogenic mosquito-borne zoonosis that is responsible for sporadic outbreaks of severe illness in humans and equines in the eastern USA. Culiseta (Cs.) melanura is the primary vector of EEEV in most geographic regions but its feeding patterns on specific avian and mammalian hosts are largely unknown in the mid-Atlantic region. The objectives of our study were to: 1) identify avian hosts of Cs. melanura and evaluate their potential role in enzootic amplification of EEEV, 2) assess spatial and temporal patterns of virus activity during a season of intense virus transmission, and 3) investigate the potential role of Cs. melanura in epidemic/epizootic transmission of EEEV to humans and equines. Accordingly, we collected mosquitoes at 55 sites in Suffolk, Virginia in 2013, and identified the source of blood meals in engorged mosquitoes by nucleotide sequencing PCR products of the mitochondrial cytochrome b gene. We also examined field-collected mosquitoes for evidence of infection with EEEV using Vector Test, cell culture, and PCR. Analysis of 188 engorged Cs. melanura sampled from April through October 2013 indicated that 95.2%, 4.3%, and 0.5% obtained blood meals from avian, mammalian, and reptilian hosts, respectively. American Robin was the most frequently identified host for Cs. melanura (42.6% of blood meals) followed by Northern Cardinal (16.0%), European Starling (11.2%), Carolina Wren (4.3%), and Common Grackle (4.3%). EEEV was detected in 106 mosquito pools of Cs. melanura, and the number of virus positive pools peaked in late July with 22 positive pools and a Maximum Likelihood Estimation (MLE) infection rate of 4.46 per 1,000 mosquitoes. Our findings highlight the importance of Cs. melanura as a regional EEEV vector based on frequent feeding on virus-competent bird species. A small proportion of blood meals acquired from mammalian hosts suggests the possibility that this species may occasionally contribute to epidemic/epizootic transmission of EEEV.	[Molaei, Goudarz; Armstrong, Philip M.; Andreadis, Theodore G.] Connecticut Agr Expt Stn, Ctr Vector Biol & Zoonot Dis, New Haven, CT 06504 USA; [Abadam, Charles F.; Akaratovic, Karen I.; Kiser, Jay P.] Suffolk Mosquito Control, Dept Publ Works, Suffolk, VA USA	Connecticut Agricultural Experiment Station	Molaei, G (corresponding author), Connecticut Agr Expt Stn, Ctr Vector Biol & Zoonot Dis, New Haven, CT 06504 USA.	Goudarz.Molaei@ct.gov	Armstrong, Philip/GWU-8253-2022	Akaratovic, Karen/0000-0001-6999-9818	Division of Mosquito Control, City of Suffolk's Department of Public Works, VA; Centers for Disease Control and Prevention [U50/CCU6806-01-1]; USDA NIFA [1043]	Division of Mosquito Control, City of Suffolk's Department of Public Works, VA; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); USDA NIFA(United States Department of Agriculture (USDA))	Funding for this research was provided in part by the Division of Mosquito Control, City of Suffolk's Department of Public Works, VA; Laboratory Capacity for Infectious Diseases Cooperative Agreement Number U50/CCU6806-01-1 from the Centers for Disease Control and Prevention issued to CAES, and USDA NIFA Multi-state Research Project 1043.	Apperson CS, 2004, VECTOR-BORNE ZOONOT, V4, P71, DOI 10.1089/153036604773083013; Armstrong PM, 2012, VECTOR-BORNE ZOONOT, V12, P872, DOI 10.1089/vbz.2012.1008; Armstrong PM, 2010, EMERG INFECT DIS, V16, P1869, DOI 10.3201/eid1612.100640; BAST TF, 1973, AM J TROP MED HYG, V22, P109, DOI 10.4269/ajtmh.1973.22.109; CARTER V, 1977, WATER RESOUR BULL, V13, P1; Cleckner HL, 2011, REMOTE SENS-BASEL, V3, P2663, DOI 10.3390/rs3122663; Cohen SB, 2009, AM J TROP MED HYG, V81, P452, DOI 10.4269/ajtmh.2009.81.452; Conover WJ, 1980, PRACTICAL NONPARAMET, p[369, 494]; CRANS WJ, 1994, J MED ENTOMOL, V31, P711, DOI 10.1093/jmedent/31.5.711; DALRYMPLE JM, 1972, AM J EPIDEMIOL, V96, P129, DOI 10.1093/oxfordjournals.aje.a121439; EDMAN JD, 1971, J MED ENTOMOL, V8, P687, DOI 10.1093/jmedent/8.6.687; EMORD DE, 1984, J MED ENTOMOL, V21, P395, DOI 10.1093/jmedent/21.4.395; Estep LK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057879; Estep LK, 2011, AM J TROP MED HYG, V84, P718, DOI 10.4269/ajtmh.2011.10-0586; Heckscher Christopher M., 2000, Northeastern Naturalist, V7, P113, DOI 10.1656/1092-6194(2000)007[0113:FDBOTG]2.0.CO;2; Howard JJ, 2004, J MED ENTOMOL, V41, P1090, DOI 10.1603/0022-2585-41.6.1090; HUTTO RL, 1995, CONSERV BIOL, V9, P1041, DOI [10.1046/j.1523-1739.1995.9051041.x, 10.1046/j.1523-1739.1995.9051033.x-i1]; Joseph SR, 1969, U MD AGR EXP STN B, VA-161, P1; KOMAR N, 1994, ANN NY ACAD SCI, V740, P157, DOI 10.1111/j.1749-6632.1994.tb19866.x; Komar N, 1999, AM J TROP MED HYG, V60, P387, DOI 10.4269/ajtmh.1999.60.387; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; Loftin KC, 2006, J ENVIRON HEALTH, V68, P33; LORD RD, 1970, AM J EPIDEMIOL, V92, P73, DOI 10.1093/oxfordjournals.aje.a121181; MAIN AJ, 1988, AM J TROP MED HYG, V38, P208, DOI 10.4269/ajtmh.1988.38.208; Martin K, 1973, THESIS U ALBERTA EDM; Molaei G, 2006, EMERG INFECT DIS, V12, P468, DOI 10.3201/eid1203.051004; Molaei G, 2008, J MED ENTOMOL, V45, P1143, DOI 10.1603/0022-2585(2008)45[1143:HPOPMV]2.0.CO;2; Molaei G, 2006, J MED ENTOMOL, V43, P1088, DOI 10.1603/0022-2585(2006)43[1088:IOAAMB]2.0.CO;2; Molaei G, 2006, AM J TROP MED HYG, V75, P1140, DOI 10.4269/ajtmh.2006.75.1140; Molaei G, 2013, VECTOR-BORNE ZOONOT, V13, P312, DOI 10.1089/vbz.2012.1099; Morris C. D., 1988, The arboviruses: epidemiology and ecology. Volume III., P1; MORRIS CD, 1975, AM J TROP MED HYG, V24, P986, DOI 10.4269/ajtmh.1975.24.986; NASCI RS, 1981, J MED ENTOMOL, V18, P493, DOI 10.1093/jmedent/18.6.493; Nasci RS, 1996, J AM MOSQUITO CONTR, V12, P167; Poole A, BIRDS N AM ONLINE; REITER P, 1987, J AM MOSQUITO CONTR, V3, P325; Sallabanks R, 1995, ANN REPORT SUS UNPUB; SAUGSTAD ES, 1972, AM J EPIDEMIOL, V96, P114, DOI 10.1093/oxfordjournals.aje.a121437; Scott T. W., 1989, Advances in Virus Research, V37, P277, DOI 10.1016/S0065-3527(08)60838-6; Slaff M, 1989, PUBLICATIONS; Tenbroeck C, 1935, J EXP MED, V62, P677, DOI 10.1084/jem.62.5.677; Vaidyanathan R, 1997, J MED ENTOMOL, V34, P346, DOI 10.1093/jmedent/34.3.346	42	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136743	10.1371/journal.pone.0136743	http://dx.doi.org/10.1371/journal.pone.0136743			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327226	Green Published, gold			2022-12-26	WOS:000360437700061
J	Ye, M; Yang, TL; Qing, P; Lei, X; Qiu, J; Liu, GY				Ye, Ming; Yang, Tianliang; Qing, Peng; Lei, Xu; Qiu, Jiang; Liu, Guangyuan			Changes of Functional Brain Networks in Major Depressive Disorder: A Graph Theoretical Analysis of Resting-State fMRI	PLOS ONE			English	Article							DEFAULT-MODE-NETWORK; DRUG-NAIVE; MODULAR ORGANIZATION; MEDICATION-NAIVE; NEURAL ACTIVITY; CONNECTIVITY; 1ST-EPISODE; METAANALYSIS; MRI; CINGULATE	Recent developments in graph theory have heightened the need for investigating the disruptions in the topological structure of functional brain network in major depressive disorder (MDD). In this study, we employed resting-state functional magnetic resonance imaging (fMRI) and graph theory to examine the whole-brain functional networks among 42 MDD patients and 42 healthy controls. Our results showed that compared with healthy controls, MDD patients showed higher local efficiency and modularity. Furthermore, MDD patients showed altered nodal centralities of many brain regions, including hippocampus, temporal cortex, anterior cingulate gyrus and dorsolateral prefrontal gyrus, mainly located in default mode network and cognitive control network. Together, our results suggested that MDD was associated with disruptions in the topological structure of functional brain networks, and provided new insights concerning the pathophysiological mechanisms of MDD.	[Ye, Ming; Qing, Peng] Southwest Univ, Fac Comp & Informat Sci, Chongqing, Peoples R China; [Ye, Ming; Liu, Guangyuan] Southwest Univ, Coll Elect & Informat Engn, Chongqing, Peoples R China; [Yang, Tianliang; Lei, Xu; Qiu, Jiang] Southwest Univ, Fac Psychol, Chongqing, Peoples R China; [Yang, Tianliang; Lei, Xu; Qiu, Jiang] Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China	Southwest University - China; Southwest University - China; Southwest University - China	Lei, X (corresponding author), Southwest Univ, Fac Psychol, Chongqing, Peoples R China.	xlei@swu.edu.cn; liugy@swu.edu.cn		Liu, Guangyuan/0000-0002-8058-5947	National Natural Science Foundation of China [61472330]; Fundamental Research Funds for the Central Universities [XDJK2012C023, SWU111047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was funded by the National Natural Science Foundation of China (61472330) and the Fundamental Research Funds for the Central Universities (XDJK2012C023 and SWU111047).	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Alexander-Bloch AF, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00147; Baggio HC, 2014, HUM BRAIN MAPP, V35, P4620, DOI 10.1002/hbm.22499; Ballmaier M, 2004, AM J PSYCHIAT, V161, P99, DOI 10.1176/appi.ajp.161.1.99; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bora E, 2012, J AFFECT DISORDERS, V138, P9, DOI 10.1016/j.jad.2011.03.049; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cullen KR, 2009, NEUROSCI LETT, V460, P227, DOI 10.1016/j.neulet.2009.05.022; Disner SG, 2011, NAT REV NEUROSCI, V12, P467, DOI 10.1038/nrn3027; Drevets WC, 2001, CURR OPIN NEUROBIOL, V11, P240, DOI 10.1016/S0959-4388(00)00203-8; Drevets WC, 2002, PHARMACOL BIOCHEM BE, V71, P431, DOI 10.1016/S0091-3057(01)00687-6; Duman RS, 2001, NEUROPSYCHOPHARMACOL, V25, P836, DOI 10.1016/S0893-133X(01)00358-X; Ebert D, 1996, BIOL PSYCHIAT, V39, P1044, DOI 10.1016/0006-3223(95)00320-7; First M. B., 1997, STRUCTURED CLIN INTE; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; Gotlib IH, 2008, CURR DIR PSYCHOL SCI, V17, P159, DOI 10.1111/j.1467-8721.2008.00567.x; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Guo WB, 2012, J PSYCHIATR RES, V46, P1366, DOI 10.1016/j.jpsychires.2012.07.003; Guo WB, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000560; Guo WB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091102; Hamilton JP, 2008, MOL PSYCHIATR, V13, P993, DOI 10.1038/mp.2008.57; Hamilton JP, 2008, BIOL PSYCHIAT, V63, P1155, DOI 10.1016/j.biopsych.2007.12.015; Hamilton JP, 2012, AM J PSYCHIAT, V169, P693, DOI 10.1176/appi.ajp.2012.11071105; Hamilton JP, 2011, BIOL PSYCHIAT, V70, P327, DOI 10.1016/j.biopsych.2011.02.003; Hamilton JP, 2011, NEUROBIOLOGY DEPRESS, P57, DOI DOI 10.1201/B11232-4; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Jin CW, 2011, NEUROSCI LETT, V503, P105, DOI 10.1016/j.neulet.2011.08.017; Koechlin E, 2007, TRENDS COGN SCI, V11, P229, DOI 10.1016/j.tics.2007.04.005; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Leistedt SJJ, 2009, HUM BRAIN MAPP, V30, P2207, DOI 10.1002/hbm.20662; Lisiecka D, 2011, INT J NEUROPSYCHOPH, V14, P521, DOI 10.1017/S1461145710001513; Liu Chun-Hong, 2012, PLoS One, V7, pe48181, DOI 10.1371/journal.pone.0048181; Liu F, 2013, J AFFECT DISORDERS, V146, P401, DOI 10.1016/j.jad.2012.10.001; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039516; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lord A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041282; Mayberg HS, 2014, RECIPROCAL LIMBIC CO, V156, P675; Meunier D., 2009, FRONT NEUROINFORM, V30, DOI [10.3389/neuro.11.037.2009, 10.3389/neuro.11.037.2009.eCollection2009]; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sacher J, 2012, J AFFECT DISORDERS, V140, P142, DOI 10.1016/j.jad.2011.08.001; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Sheline YI, 2010, P NATL ACAD SCI USA, V107, P11020, DOI 10.1073/pnas.1000446107; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Singh MK, 2013, BIOL PSYCHIAT, V74, P777, DOI 10.1016/j.biopsych.2013.03.005; Sun Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096505; Tagliazucchi E, 2013, NEUROIMAGE, V70, P327, DOI 10.1016/j.neuroimage.2012.12.073; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wang JH, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00016; Wang L, 2014, PSYCHOL MED, V44, P1417, DOI 10.1017/S0033291713002031; Wang L, 2012, J AFFECT DISORDERS, V142, P6, DOI 10.1016/j.jad.2012.04.013; Wang LH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039845, 10.1371/journal.pone.0051769, 10.1371/journal.pone.0045491, 10.1371/journal.pone.0044596]; Wei XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114603; WILLIAMS JBW, 1988, ARCH GEN PSYCHIAT, V45, P742; Wu QZ, 2011, HUM BRAIN MAPP, V32, P1290, DOI 10.1002/hbm.21108; Yao ZJ, 2009, J AFFECT DISORDERS, V115, P430, DOI 10.1016/j.jad.2008.10.013; Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018; Zhu XL, 2012, BIOL PSYCHIAT, V71, P611, DOI 10.1016/j.biopsych.2011.10.035	63	85	90	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0133775	10.1371/journal.pone.0133775	http://dx.doi.org/10.1371/journal.pone.0133775			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327292	gold, Green Published, Green Submitted			2022-12-26	WOS:000360437700007
J	Fagoonee, S; Famulari, ES; Silengo, L; Tolosano, E; Altruda, F				Fagoonee, Sharmila; Famulari, Elvira Smeralda; Silengo, Lorenzo; Tolosano, Emanuela; Altruda, Fiorella			Long Term Liver Engraftment of Functional Hepatocytes Obtained from Germline Cell-Derived Pluripotent Stem Cells	PLOS ONE			English	Article							NEONATAL MOUSE TESTIS; DIRECTED DIFFERENTIATION; GENERATION; REGENERATION; HEMOCHROMATOSIS; TRANSPLANTATION; MONOCROTALINE; REPOPULATION; MICE	One of the major hurdles in liver gene and cell therapy is availability of ex vivo-expanded hepatocytes. Pluripotent stem cells are an attractive alternative. Here, we show that hepatocyte precursors can be isolated from male germline cell-derived pluripotent stem cells (GPSCs) using the hepatoblast marker, Liv2, and induced to differentiate into hepatocytes in vitro. These cells expressed hepatic-specific genes and were functional as demonstrated by their ability to secrete albumin and produce urea. When transplanted in the liver parenchyma of partially hepatectomised mice, Liv2-sorted cells showed regional and heterogeneous engraftment in the injected lobe. Moreover, approximately 50% of Y chromosomepositive, GPSC-derived cells were found in the female livers, in the region of engraftment, even one month after cell injection. This is the first study showing that Liv2-sorted GPSCs-derived hepatocytes can undergo long lasting engraftment in the mouse liver. Thus, GPSCs might offer promise for regenerative medicine.	[Fagoonee, Sharmila] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Ctr Mol Biotechnol, Inst Biostruct & Bioimages CNR, Turin, Italy; [Famulari, Elvira Smeralda; Silengo, Lorenzo; Tolosano, Emanuela; Altruda, Fiorella] Univ Turin, Ctr Mol Biotechnol, Dept Mol Biotechnol & Hlth Sci, Turin, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Turin; University of Turin	Fagoonee, S (corresponding author), Univ Turin, Dept Mol Biotechnol & Hlth Sci, Ctr Mol Biotechnol, Inst Biostruct & Bioimages CNR, Turin, Italy.	sharmila.fagoonee@unito.it; fiorella.altruda@unito.it	Fagoonee, Sharmila/L-1940-2019; Tolosano, Emanuela/L-8080-2019	Fagoonee, Sharmila/0000-0001-6070-6716; Tolosano, Emanuela/0000-0002-1622-2340	PRIN (Progetti di Rilevante Interesse Nazionale) [2010B5B2NL 003]	PRIN (Progetti di Rilevante Interesse Nazionale)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This study was funded by PRIN (Progetti di Rilevante Interesse Nazionale) to FA (Grant number: 2010B5B2NL 003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2008, STEM CELLS, V26, P1117, DOI 10.1634/stemcells.2007-1102; Baba S, 2007, STEM CELLS, V25, P1375, DOI 10.1634/stemcells.2006-0574; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Carvalho KAT, 2008, TRANSPL P, V40, P839, DOI 10.1016/j.transproceed.2008.03.004; Chinzei R, 2002, HEPATOLOGY, V36, P22, DOI 10.1053/jhep.2002.34136; Cho CH, 2008, FASEB J, V22, P898, DOI 10.1096/fj.06-7764com; De Chiara L, 2014, J AM SOC NEPHROL, V25, P316, DOI 10.1681/ASN.2013040367; Dressel R, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-31; Duncan AW, 2009, GASTROENTEROLOGY, V137, P466, DOI 10.1053/j.gastro.2009.05.044; Fagoonee S, 2011, ORGANOGENESIS, V7, P116, DOI 10.4161/org.7.2.16284; Fagoonee S, 2010, STEM CELLS DEV, V19, P1183, DOI 10.1089/scd.2009.0496; Fox IJ, 1998, NEW ENGL J MED, V338, P1422, DOI 10.1056/NEJM199805143382004; Fuller R, 2008, INT J HEAT MASS TRAN, V51, P5650, DOI 10.1016/j.ijheatmasstransfer.2008.04.021; Gabriel E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044912; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Guan K, 2007, CIRC RES, V100, P1615, DOI 10.1161/01.RES.0000269182.22798.d9; Ikeda O, 2009, J SURG RES, V152, P218, DOI 10.1016/j.jss.2008.02.059; Joseph B, 2006, HEPATOLOGY, V44, P1411, DOI 10.1002/hep.21416; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; Ning LA, 2010, HUM REPROD, V25, P3101, DOI 10.1093/humrep/deq269; Pettinato G, 2014, SCI REP-UK, V4, DOI 10.1038/srep07402; Sancho-Bru P, 2011, J HEPATOL, V54, P98, DOI 10.1016/j.jhep.2010.06.014; Sandhu JS, 2001, AM J PATHOL, V159, P1323, DOI 10.1016/S0002-9440(10)62519-9; Song ZH, 2009, CELL RES, V19, P1233, DOI 10.1038/cr.2009.107; Soto-Gutierrez A, 2007, NAT PROTOC, V2, P347, DOI 10.1038/nprot.2007.18; Streckfuss-Bomeke K, 2009, STEM CELL RES, V2, P139, DOI 10.1016/j.scr.2008.09.001; Takashimizu I, 2009, THESCIENTIFICWORLDJO, V9, P190, DOI 10.1100/tsw.2009.18; Tolosano E, 2005, BLOOD, V105, P3353, DOI 10.1182/blood-2004-07-2814; Watanabe T, 2002, DEV BIOL, V250, P332, DOI 10.1006/dbio.2002.0781; Witek RP, 2005, CELL TRANSPLANT, V14, P41, DOI 10.3727/000000005783983278; YOKOYAMA HO, 1953, CANCER RES, V13, P80; Yoshimoto M, 2009, EXP HEMATOL, V37, P1400, DOI 10.1016/j.exphem.2009.09.006; Yu Y, 2012, LIVER TRANSPLANT, V18, P9, DOI 10.1002/lt.22467; Zhou XY, 1998, P NATL ACAD SCI USA, V95, P2492, DOI 10.1073/pnas.95.5.2492	35	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136762	10.1371/journal.pone.0136762	http://dx.doi.org/10.1371/journal.pone.0136762			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26323094	gold, Green Published, Green Submitted			2022-12-26	WOS:000360435500034
J	Butler, TM; Johnson-Camacho, K; Peto, M; Wang, NJ; Macey, TA; Korkola, JE; Koppie, TM; Corless, CL; Gray, JW; Spellman, PT				Butler, Timothy M.; Johnson-Camacho, Katherine; Peto, Myron; Wang, Nicholas J.; Macey, Tara A.; Korkola, James E.; Koppie, Theresa M.; Corless, Christopher L.; Gray, Joe W.; Spellman, Paul T.			Exome Sequencing of Cell-Free DNA from Metastatic Cancer Patients Identifies Clinically Actionable Mutations Distinct from Primary Disease	PLOS ONE			English	Article							CIRCULATING TUMOR DNA; BREAST-CANCER; PLASMA DNA; ACQUIRED-RESISTANCE; SENSITIVE DETECTION; COLORECTAL-CANCER; POINT MUTATIONS; NUCLEIC-ACIDS; BLOOD; EVOLUTION	The identification of the molecular drivers of cancer by sequencing is the backbone of precision medicine and the basis of personalized therapy; however, biopsies of primary tumors provide only a snapshot of the evolution of the disease and may miss potential therapeutic targets, especially in the metastatic setting. A liquid biopsy, in the form of cell-free DNA (cfDNA) sequencing, has the potential to capture the inter-and intra-tumoral heterogeneity present in metastatic disease, and, through serial blood draws, track the evolution of the tumor genome. In order to determine the clinical utility of cfDNA sequencing we performed whole-exome sequencing on cfDNA and tumor DNA from two patients with metastatic disease; only minor modifications to our sequencing and analysis pipelines were required for sequencing and mutation calling of cfDNA. The first patient had metastatic sarcoma and 47 of 48 mutations present in the primary tumor were also found in the cell-free DNA. The second patient had metastatic breast cancer and sequencing identified an ESR1 mutation in the cfDNA and metastatic site, but not in the primary tumor. This likely explains tumor progression on Anastrozole. Significant heterogeneity between the primary and metastatic tumors, with cfDNA reflecting the metastases, suggested separation from the primary lesion early in tumor evolution. This is best illustrated by an activating PIK3CA mutation (H1047R) which was clonal in the primary tumor, but completely absent from either the metastasis or cfDNA. Here we show that cfDNA sequencing supplies clinically actionable information with minimal risks compared to metastatic biopsies. This study demonstrates the utility of whole-exome sequencing of cell-free DNA from patients with metastatic disease. cfDNA sequencing identified an ESR1 mutation, potentially explaining a patient's resistance to aromatase inhibition, and gave insight into how metastatic lesions differ from the primary tumor.	[Butler, Timothy M.; Johnson-Camacho, Katherine; Peto, Myron; Wang, Nicholas J.; Macey, Tara A.; Korkola, James E.; Koppie, Theresa M.; Corless, Christopher L.; Gray, Joe W.; Spellman, Paul T.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA	Oregon Health & Science University	Spellman, PT (corresponding author), Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA.	spellmap@ohsu.edu	Gray, Joe/AAX-9549-2020	, James/0000-0002-0030-6216; Butler, Timothy/0000-0001-5803-1035	Ion Torrent/ThermoFisher	Ion Torrent/ThermoFisher	Chritopher Corless received honoraria and research support from Ion Torrent/ThermoFisher. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Aparicio S, 2013, NEW ENGL J MED, V368, P842, DOI 10.1056/NEJMra1204892; Beadling C, 2011, J MOL DIAGN, V13, P504, DOI 10.1016/j.jmoldx.2011.04.003; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Board RE, 2010, BREAST CANCER RES TR, V120, P461, DOI 10.1007/s10549-010-0747-9; Chan KCA, 2013, CLIN CHEM, V59, P211, DOI 10.1373/clinchem.2012.196014; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Crowley E, 2013, NAT REV CLIN ONCOL, V10, P472, DOI 10.1038/nrclinonc.2013.110; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Fleischhacker M, 2007, BBA-REV CANCER, V1775, P181, DOI 10.1016/j.bbcan.2006.10.001; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Frattini M, 2008, CANCER LETT, V263, P170, DOI 10.1016/j.canlet.2008.03.021; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Leary RJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004742; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Misale S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007947; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Nakamura T, 2012, J THORAC ONCOL, V7, P1369, DOI 10.1097/JTO.0b013e31825f2821; Newman AM, 2014, NAT MED, V20, P552, DOI 10.1038/nm.3519; Robinson DR, 2013, NAT GENET, V45, P1446, DOI 10.1038/ng.2823; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Shinozaki M, 2007, CLIN CANCER RES, V13, P2068, DOI 10.1158/1078-0432.CCR-06-2120; SORENSON GD, 1994, CANCER EPIDEM BIOMAR, V3, P67; Spano D, 2012, SEMIN CANCER BIOL, V22, P234, DOI 10.1016/j.semcancer.2012.03.006; Swisher EM, 2005, AM J OBSTET GYNECOL, V193, P662, DOI 10.1016/j.ajog.2005.01.054; Taniguchi K, 2011, CLIN CANCER RES, V17, P7808, DOI 10.1158/1078-0432.CCR-11-1712; Toy W, 2013, NAT GENET, V45, P1439, DOI 10.1038/ng.2822; VASIOUKHIN V, 1994, BRIT J HAEMATOL, V86, P774, DOI 10.1111/j.1365-2141.1994.tb04828.x	34	79	83	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136407	10.1371/journal.pone.0136407	http://dx.doi.org/10.1371/journal.pone.0136407			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317216	Green Submitted, Green Published, gold			2022-12-26	WOS:000360299100082
J	Ji, YC; Gray, RA; Fenton, FH				Ji, Yanyan Claire; Gray, Richard A.; Fenton, Flavio H.			Implementation of Contraction to Electrophysiological Ventricular Myocyte Models, and Their Quantitative Characterization via Post-Extrasystolic Potentiation	PLOS ONE			English	Article							CARDIAC RESYNCHRONIZATION THERAPY; HEART; MODULATION; MUSCLE; DYNAMICS; DEPENDENCE; EFFICACY; CAMKII; CA2+; CRT	Heart failure (HF) affects over 5 million Americans and is characterized by impairment of cellular cardiac contractile function resulting in reduced ejection fraction in patients. Electrical stimulation such as cardiac resynchronization therapy (CRT) and cardiac contractility modulation (CCM) have shown some success in treating patients with HF. Computer simulations have the potential to help improve such therapy (e.g. suggest optimal lead placement) as well as provide insight into the underlying mechanisms which could be beneficial. However, these myocyte models require a quantitatively accurate excitation-contraction coupling such that the electrical and contraction predictions are correct. While currently there are close to a hundred models describing the detailed electrophysiology of cardiac cells, the majority of cell models do not include the equations to reproduce contractile force or they have been added ad hoc. Here we present a systematic methodology to couple first generation contraction models into electrophysiological models via intracellular calcium and then compare the resulting model predictions to experimental data. This is done by using a post-extrasystolic pacing protocol, which captures essential dynamics of contractile forces. We found that modeling the dynamic intracellular calcium buffers is necessary in order to reproduce the experimental data. Furthermore, we demonstrate that in models the mechanism of the post-extrasystolic potentiation is highly dependent on the calcium released from the Sarcoplasmic Reticulum. Overall this study provides new insights into both specific and general determinants of cellular contractile force and provides a framework for incorporating contraction into electrophysiological models, both of which will be necessary to develop reliable simulations to optimize electrical therapies for HF.	[Ji, Yanyan Claire; Fenton, Flavio H.] Georgia Inst Technol, Dept Phys, Atlanta, GA 30332 USA; [Gray, Richard A.] US FDA, Off Sci & Engn Labs, Ctr Devices & Radiol Hlth, Silver Spring, MD USA	University System of Georgia; Georgia Institute of Technology; US Food & Drug Administration (FDA)	Ji, YC (corresponding author), Georgia Inst Technol, Dept Phys, Atlanta, GA 30332 USA.	yji47@gatech.edu			National Science Foundation [1347015]	National Science Foundation(National Science Foundation (NSF))	The authors acknowledge the National Science Foundation grant number: 1347015, http://www.nsf.gov/.FHF received the grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Blinova K, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12106; Borggrefe MM, 2008, EUR HEART J, V29, P1019, DOI 10.1093/eurheartj/ehn020; Bueno-Orovio A, 2008, J THEOR BIOL, V253, P544, DOI 10.1016/j.jtbi.2008.03.029; Burkhoff D, 2005, AM J PHYSIOL-HEART C, V288, pH2550, DOI 10.1152/ajpheart.01311.2004; Burkhoff D, 2001, Heart Fail Rev, V6, P27, DOI 10.1023/A:1009851107189; Butter C, 2007, EUR J HEART FAIL, V9, P955, DOI 10.1016/j.ejheart.2007.05.012; Cooper J, 2009, AUTOMATIC VALIDATION; Cooper J, 2011, PROG BIOPHYS MOL BIO, V107, P74, DOI 10.1016/j.pbiomolbio.2011.06.002; COOPER MW, 1993, CIRCULATION, V88, P2962, DOI 10.1161/01.CIR.88.6.2962; De Lazzari C, 2010, EUR REV MED PHARMACO, V14, P969; DOBRUNZ LE, 1995, BIOPHYS J, V69, P189, DOI 10.1016/S0006-3495(95)79889-7; Faber GM, 2000, BIOPHYS J, V78, P2392, DOI 10.1016/S0006-3495(00)76783-X; Fenton F.H., 2008, SCHOLARPEDIA, V3, P1868, DOI [10.4249/scholarpedia.1868, DOI 10.4249/SCHOLARPEDIA.1868]; Fink M, 2008, PROG BIOPHYS MOL BIO, V96, P357, DOI 10.1016/j.pbiomolbio.2007.07.011; Flore V, 2015, J ELECTROCARDIOL, V48, P578, DOI 10.1016/j.jelectrocard.2015.02.004; Fox JJ, 2002, AM J PHYSIOL-HEART C, V282, pH516, DOI 10.1152/ajpheart.00612.2001; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Grandi E, 2010, J MOL CELL CARDIOL, V48, P112, DOI 10.1016/j.yjmcc.2009.09.019; Hund TJ, 2004, CIRCULATION, V110, P3168, DOI 10.1161/01.CIR.0000147231.69595.D3; Iribe G, 2006, PHILOS T R SOC A, V364, P1107, DOI 10.1098/rsta.2006.1758; Ismail H, 2010, INT J CARDIOVAS IMAG, V26, P197, DOI 10.1007/s10554-009-9556-9; Iyer V, 2004, BIOPHYS J, V87, P1507, DOI 10.1529/biophysj.104.043299; Kuschyk J, 2015, INT J CARDIOL, V183, P76, DOI 10.1016/j.ijcard.2014.12.178; LANDESBERG A, 1994, AM J PHYSIOL, V267, pH779, DOI 10.1152/ajpheart.1994.267.2.H779; Livshitz LM, 2007, AM J PHYSIOL-HEART C, V292, pH2854, DOI 10.1152/ajpheart.01347.2006; Mahajan A, 2008, BIOPHYS J, V94, P392, DOI 10.1529/biophysj.106.98160; Matsuoka S, 2003, JPN J PHYSIOL, V53, P105, DOI 10.2170/jjphysiol.53.105; Mentz RJ, 2015, J CARD FAIL, V21, P24, DOI 10.1016/j.cardfail.2014.11.003; Miri R, 2009, IEEE T BIO-MED ENG, V56, P2573, DOI 10.1109/TBME.2009.2027692; Negroni JA, 1996, J MOL CELL CARDIOL, V28, P915, DOI 10.1006/jmcc.1996.0086; Niederer SA, 2009, EXP PHYSIOL, V94, P529, DOI 10.1113/expphysiol.2008.045880; Niederer SA, 2011, CARDIOVASC RES, V89, P336, DOI 10.1093/cvr/cvq318; O'Hara T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002061; Potse M, 2012, J CARDIOVASC TRANSL, V5, P146, DOI 10.1007/s12265-011-9343-6; Priebe L, 1998, CIRC RES, V82, P1206, DOI 10.1161/01.RES.82.11.1206; Rice JJ, 1999, AM J PHYSIOL-HEART C, V276, pH1734, DOI 10.1152/ajpheart.1999.276.5.H1734; Sermesant M, 2012, MED IMAGE ANAL, V16, P201, DOI 10.1016/j.media.2011.07.003; Shannon TR, 2004, BIOPHYS J, V87, P3351, DOI 10.1529/biophysj.104.047449; Shea JB, 2003, CIRCULATION, V108, pE64, DOI 10.1161/01.CIR.0000085657.09097.38; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; van't Sant J, 2015, J ELECTROCARDIOL, V48, P601, DOI 10.1016/j.jelectrocard.2015.01.015; WIER WG, 1986, J PHYSIOL-LONDON, V376, P507, DOI 10.1113/jphysiol.1986.sp016167; YUE DT, 1985, CIRC RES, V56, P340, DOI 10.1161/01.RES.56.3.340	44	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135699	10.1371/journal.pone.0135699	http://dx.doi.org/10.1371/journal.pone.0135699			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317204	Green Published, Green Submitted, gold			2022-12-26	WOS:000360299100042
J	Olson, JC; Takahashi, A; Glotzbecker, MP; Snyder, BD				Olson, J. Casey; Takahashi, Ayuko; Glotzbecker, Michael P.; Snyder, Brian D.			Extent of Spine Deformity Predicts Lung Growth and Function in Rabbit Model of Early Onset Scoliosis	PLOS ONE			English	Article							THORACIC INSUFFICIENCY SYNDROME; PROSTHETIC TITANIUM RIB; RADIAL ALVEOLAR COUNT; PULMONARY-FUNCTION; EXPANSION THORACOPLASTY; FUSED RIBS; CHILDREN; REGISTRATION; HYPOPLASIA; PARAMETERS	Early onset deformity of the spine and chest wall (initiated < 8 years of age) is associated with increased morbidity at adulthood relative to adolescent onset deformity of comparable severity. Presumably, inhibition of thoracic growth during late stage alveolarization leads to an irreversible loss of pulmonary growth and thoracic function; however the natural history of this disease from onset to adulthood has not been well characterized. In this study we establish a rabbit model of early onset scoliosis to establish the extent that thoracic deformity affects structural and functional respiratory development. Using a surgical right unilateral rib-tethering procedure, rib fusion with early onset scoliosis was induced in 10 young New Zealand white rabbits (3 weeks old). Progression of spine deformity, functional residual capacity, total lung capacity, and lung mass was tracked through longitudinal breath-hold computed tomography imaging up to skeletal maturity (28 weeks old). Additionally at maturity forced vital capacity and regional specific volume were calculated as functional measurements and histo-morphometry performed with the radial alveolar count as a measure of acinar complexity. Data from tethered rib rabbits were compared to age matched healthy control rabbits (N = 8). Results show unilateral rib-tethering created a progressive spinal deformity ranging from 30 degrees to 120 degrees curvature, the severity of which was strongly associated with pulmonary growth and functional outcomes. At maturity rabbits with deformity greater than the median (55 degrees) had decreased body weight (89%), right (59%) and left (86%) lung mass, right (74%) and left (69%) radial alveolar count, right lung volume at total lung capacity (60%), and forced vital capacity (75%). Early treatment of spinal deformity in children may prevent pulmonary complications in adulthood and these results provide a basis for the prediction of pulmonary development from thoracic structure. This model may also have future use as a platform to evaluate treatment effectiveness.	[Olson, J. Casey; Snyder, Brian D.] Beth Israel Deaconess Med Ctr, Ctr Adv Orthopaed Studies, Boston, MA 02215 USA; [Olson, J. Casey; Takahashi, Ayuko] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Glotzbecker, Michael P.; Snyder, Brian D.] Boston Childrens Hosp, Dept Orthopaed Surg, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Boston University; Harvard University; Boston Children's Hospital	Olson, JC (corresponding author), Beth Israel Deaconess Med Ctr, Ctr Adv Orthopaed Studies, Boston, MA 02215 USA.	olsonjc@bu.edu		Subbian, Selvakumar/0000-0003-2021-8632	National Institutes of Health [1R21AR057880-01]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR057880] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health #1R21AR057880-01 received by BDS. The funders had no role study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society, 2005, Am J Respir Crit Care Med, V172, P1463; ASKENAZI SS, 1979, ARCH DIS CHILD, V54, P614, DOI 10.1136/adc.54.8.614; BATES JHT, 1992, IEEE T BIO-MED ENG, V39, P94, DOI 10.1109/10.108133; BOFFA P, 1984, THORAX, V39, P681, DOI 10.1136/thx.39.9.681; BRANTHWAITE MA, 1986, BRIT J DIS CHEST, V80, P360, DOI 10.1016/0007-0971(86)90089-6; Campbell RM, 2003, J BONE JOINT SURG AM, V85A, P399, DOI 10.2106/00004623-200303000-00001; Campbell RM, 2007, J BONE JOINT SURG AM, V89A, P108, DOI 10.2106/JBJS.F.00270; Campbell Robert M Jr, 2004, J Bone Joint Surg Am, V86-A Suppl 1, P51; COONEY TP, 1982, THORAX, V37, P572, DOI 10.1136/thx.37.8.572; DAVIES G, 1971, ARCH DIS CHILD, V46, P623, DOI 10.1136/adc.46.249.623; Dimeglio A., 1990, RACHIS CROISSANCE; DUNNILL M. S., 1962, THORAX, V17, P329, DOI 10.1136/thx.17.4.329; Emans JB, 2005, SPINE, V30, pS58, DOI 10.1097/01.brs.0000175194.31986.2f; Fuld MK, 2008, J APPL PHYSIOL, V104, P1177, DOI 10.1152/japplphysiol.00212.2007; Guerrero T, 2007, INT J RADIAT ONCOL, V67, P879, DOI 10.1016/j.ijrobp.2006.10.037; Herring MJ, 2014, AM J PHYSIOL-LUNG C, V307, pL338, DOI 10.1152/ajplung.00094.2014; HSIA CCW, 1994, J CLIN INVEST, V94, P405, DOI 10.1172/JCI117337; Hsia CCW, 2004, J APPL PHYSIOL, V97, P1992, DOI 10.1152/japplphysiol.00530.2004; Hsia CCW, 2012, J APPL PHYSIOL, V113, P937, DOI 10.1152/japplphysiol.00289.2012; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Kaczka DW, 2011, ANN BIOMED ENG, V39, P1112, DOI 10.1007/s10439-010-0214-0; Karol LA, 2008, J BONE JOINT SURG AM, V90A, P1272, DOI 10.2106/JBJS.G.00184; Karol LA, 2011, CLIN ORTHOP RELAT R, V469, P1323, DOI 10.1007/s11999-010-1622-z; Kovar J, 2002, J APPL PHYSIOL, V93, P629, DOI 10.1152/japplphysiol.01044.2001; LAUZON AM, 1991, J APPL PHYSIOL, V71, P1159, DOI 10.1152/jappl.1991.71.3.1159; Mayer OH, 2009, J PEDIATR ORTHOPED, V29, P35, DOI 10.1097/BPO.0b013e3181929c8b; Mehta HP, 2006, SPINE, V31, P2654, DOI 10.1097/01.brs.0000244613.66055.b6; Mehta HP, 2010, SPINE, V35, P153, DOI 10.1097/BRS.0b013e3181c4b8c7; Motoyama EK, 2006, SPINE, V31, P284, DOI 10.1097/01.brs.0000197203.76653.d0; Narayanan M, 2012, AM J RESP CRIT CARE, V185, P186, DOI 10.1164/rccm.201107-1348OC; OWANGEIRAKA JW, 1984, EUR J PEDIATR, V142, P198, DOI 10.1007/BF00442448; PEHRSSON K, 1992, SPINE, V17, P1091, DOI 10.1097/00007632-199209000-00014; PEHRSSON K, 1992, SPINE, V17, P714, DOI 10.1097/00007632-199206000-00012; Ravikumar P, 2004, J APPL PHYSIOL, V97, P1567, DOI 10.1152/japplphysiol.00396.2004; Redding GJ, 2011, CLIN ORTHOP RELAT R, V469, P1330, DOI 10.1007/s11999-010-1621-0; SCOTT JC, 1955, J BONE JOINT SURG BR, V37, P400, DOI 10.1302/0301-620X.37B3.400; Skaggs DL, 2009, SPINE, V34, P2530, DOI 10.1097/BRS.0b013e3181bd09f5; Vitale MG, 2008, J PEDIATR ORTHOPED, V28, P239, DOI 10.1097/BPO.0b013e31816521bb; Yilmaz C, 2009, J APPL PHYSIOL, V107, P1569, DOI 10.1152/japplphysiol.00503.2009; Yin YB, 2011, PHYS MED BIOL, V56, P203, DOI 10.1088/0031-9155/56/1/013; Yin YB, 2009, MED PHYS, V36, P4213, DOI 10.1118/1.3193526	41	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136941	10.1371/journal.pone.0136941	http://dx.doi.org/10.1371/journal.pone.0136941			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317230	Green Published, gold, Green Submitted			2022-12-26	WOS:000360299100178
J	Tanaka, H; Sirich, TL; Plummer, NS; Weaver, DS; Meyer, TW				Tanaka, Hisae; Sirich, Tammy L.; Plummer, Natalie S.; Weaver, Daniel S.; Meyer, Timothy W.			An Enlarged Profile of Uremic Solutes	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; CHRONIC KIDNEY-DISEASE; PROTEIN-BOUND SOLUTES; HEMODIALYSIS-PATIENTS; METABOLOMIC ANALYSIS; TOXINS; SERUM; ACID; POLYPHENOLS; EXCRETION	Better knowledge of the uremic solutes that accumulate when the kidneys fail could lead to improved renal replacement therapy. This study employed the largest widely available metabolomic platform to identify such solutes. Plasma and plasma ultrafiltrate from 6 maintenance hemodialysis (HD) patients and 6 normal controls were first compared using a platform combining gas and liquid chromatography with mass spectrometry. Further studies compared plasma from 6 HD patients who had undergone total colectomy and 9 with intact colons. We identified 120 solutes as uremic including 48 that had not been previously reported to accumulate in renal failure. Combination of the 48 newly identified solutes with those identified in previous reports yielded an extended list of more than 270 uremic solutes. Among the solutes identified as uremic in the current study, 9 were shown to be colon-derived, including 6 not previously identified as such. Literature search revealed that many uremic phenyl and indole solutes, including most of those shown to be colon-derived, come from plant foods. Some of these compounds can be absorbed directly from plant foods and others are produced by colon microbial metabolism of plant polyphenols that escape digestion in the small intestine. A limitation of the metabolomic method was that it underestimated the elevation in concentration of uremic solutes which were measured using more quantitative assays.	[Tanaka, Hisae; Sirich, Tammy L.; Plummer, Natalie S.; Meyer, Timothy W.] VA Palo Alto HCS, Dept Med, Palo Alto, CA 94304 USA; [Tanaka, Hisae; Sirich, Tammy L.; Plummer, Natalie S.; Meyer, Timothy W.] Stanford Univ, Palo Alto, CA 94304 USA; [Weaver, Daniel S.] SRI Int, Bioinformat Res Grp, Menlo Pk, CA 94025 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; SRI International	Meyer, TW (corresponding author), VA Palo Alto HCS, Dept Med, Palo Alto, CA 94304 USA.	twmeyer@stanford.edu			National Institutes of Health (US) [R21 DK84439, R01 DK8012]; SRI International; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK084439] Funding Source: NIH RePORTER; Veterans Affairs [IK2CX001036] Funding Source: NIH RePORTER	National Institutes of Health (US)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SRI International; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	Funded by R21 DK84439 and R01 DK8012 from the National Institutes of Health (US) at www.nih.gov. SRI International provided support in the form of salary for author DSW but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Aronov PA, 2011, J AM SOC NEPHROL, V22, P1769, DOI 10.1681/ASN.2010121220; Biesaga M, 2007, J SEP SCI, V30, P2929, DOI 10.1002/jssc.200700247; Boelaert J, 2014, METABOLOMICS, V10, P425, DOI 10.1007/s11306-013-0592-z; Boldyrev AA, 2013, PHYSIOL REV, V93, P1803, DOI 10.1152/physrev.00039.2012; Cardona F, 2013, J NUTR BIOCHEM, V24, P1415, DOI 10.1016/j.jnutbio.2013.05.001; Caspi R, 2014, NUCLEIC ACIDS RES, V42, pD459, DOI 10.1093/nar/gkt1103; CATHCARTRAKE W, 1975, AM J CLIN NUTR, V28, P1110, DOI 10.1093/ajcn/28.10.1110; Clase CM, 2013, SEMIN DIALYSIS, V26, P546, DOI 10.1111/sdi.12099; Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; Dou L, 2015, J AM SOC NEPHROL, V26, P876, DOI 10.1681/ASN.2013121283; Duranton F, 2012, J AM SOC NEPHROL, V23, P1258, DOI 10.1681/ASN.2011121175; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fagugli RM, 2002, AM J KIDNEY DIS, V40, P339, DOI 10.1053/ajkd.2002.34518; Goldstein DS, 2003, J PHARMACOL EXP THER, V305, P800, DOI 10.1124/jpet.103.049270; Itoh Y, 2012, ANAL BIOANAL CHEM, V403, P1841, DOI 10.1007/s00216-012-5929-3; Kalim S, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000542; Kikuchi K, 2010, J CHROMATOGR B, V878, P1662, DOI 10.1016/j.jchromb.2009.11.040; Lindner A, 2002, AM J KIDNEY DIS, V39, P134, DOI 10.1053/ajkd.2002.29904; Lindner HA, 2008, BIOCHIMIE, V90, P773, DOI 10.1016/j.biochi.2007.12.006; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Meyer TW, 2012, KIDNEY INT, V81, P949, DOI 10.1038/ki.2011.504; Meyer TW, 2004, J AM SOC NEPHROL, V15, P1927, DOI 10.1097/01.asn.0000131521.62256.f0; Mogk A, 2010, SCIENCE, V327, P966, DOI 10.1126/science.1187274; NIWA T, 1983, J CHROMATOGR, V277, P25, DOI 10.1016/S0378-4347(00)84820-3; Niwa T, 2011, MASS SPECTROM REV, V30, P510, DOI 10.1002/mas.20323; Poesen R, 2013, SEMIN DIALYSIS, V26, P323, DOI 10.1111/sdi.12082; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Raj DSC, 2000, BLOOD PURIFICAT, V18, P97, DOI 10.1159/000014431; Rhee EP, 2010, J AM SOC NEPHROL, V21, P1041, DOI 10.1681/ASN.2009111132; ROBOZ J, 1990, CLIN CHEM, V36, P2082; Sass JO, 2006, AM J HUM GENET, V78, P401, DOI 10.1086/500563; Sato E, 2011, EUR J CLIN INVEST, V41, P241, DOI 10.1111/j.1365-2362.2010.02398.x; Schepers E, 2010, BLOOD PURIFICAT, V29, P130, DOI 10.1159/000245639; Sirich TL, 2014, J AM SOC NEPHROL, V25, P615, DOI 10.1681/ASN.2013060597; Sirich TL, 2013, KIDNEY INT, V84, P585, DOI 10.1038/ki.2013.154; SJOLIN J, 1987, METABOLISM, V36, P1175, DOI 10.1016/0026-0495(87)90245-9; Toyohara T, 2010, HYPERTENS RES, V33, P944, DOI 10.1038/hr.2010.113; Tsao R, 2010, NUTRIENTS, V2, P1231, DOI 10.3390/nu2121231; Tucker BM, 2015, J RENAL NUTR, V25, P257, DOI 10.1053/j.jrn.2014.09.003; Uribarri J, 2000, NEPHRON, V86, P105, DOI 10.1159/000045726; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Vanholder R, 2014, J AM SOC NEPHROL, V25, P1897, DOI 10.1681/ASN.2013101062; VINE JH, 1987, PLANT PHYSIOL, V85, P419, DOI 10.1104/pp.85.2.419; Williamson G, 2010, BRIT J NUTR, V104, pS48, DOI 10.1017/S0007114510003946; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wood A, 2011, MOL NUTR FOOD RES, V55, pS7, DOI 10.1002/mnfr.201000408; Yeung CK, 2014, KIDNEY INT, V85, P522, DOI 10.1038/ki.2013.399; YOUNG VR, 1972, J BIOL CHEM, V247, P3592; Yu B, 2014, CLIN J AM SOC NEPHRO, V9, P1410, DOI 10.2215/CJN.11971113	50	47	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135657	10.1371/journal.pone.0135657	http://dx.doi.org/10.1371/journal.pone.0135657			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317986	Green Published, gold, Green Submitted			2022-12-26	WOS:000360299100041
J	Nobach, D; Bourg, M; Herzog, S; Lange-Herbst, H; Encarnacao, JA; Eickmann, M; Herden, C				Nobach, Daniel; Bourg, Manon; Herzog, Sibylle; Lange-Herbst, Hildburg; Encarnacao, Jorge A.; Eickmann, Markus; Herden, Christiane			Shedding of Infectious Borna Disease Virus-1 in Living Bicolored White-Toothed Shrews	PLOS ONE			English	Article							EMERGING VIRAL-INFECTIONS; RESERVOIR HOSTS; RATS; BATS; ENCEPHALITIS; REPLICATION; GERMANY; RISK	Background Many RNA viruses arise from animal reservoirs, namely bats, rodents and insectivores but mechanisms of virus maintenance and transmission still need to be addressed. The bicolored white-toothed shrew (Crocidura leucodon) has recently been identified as reservoir of the neurotropic Borna disease virus 1 (BoDV-1). Principal Findings Six out of eleven wild living bicoloured white-toothed shrews were trapped and revealed to be naturally infected with BoDV-1. All shrews were monitored in captivity in a long-term study over a time period up to 600 days that differed between the individual shrews. Interestingly, all six animals showed an asymptomatic course of infection despite virus shedding via various routes indicating a highly adapted host-pathogen interaction. Infectious virus and viral RNA were demonstrated in saliva, urine, skin swabs, lacrimal fluid and faeces, both during the first 8 weeks of the investigation period and for long time shedding after more than 250 days in captivity. Conclusions The various ways of shedding ensure successful virus maintenance in the reservoir population but also transmission to accidental hosts such as horses and sheep. Naturally BoDV-1infected living shrews serve as excellent tool to unravel host and pathogen factors responsible for persistent viral co-existence in reservoir species while maintaining their physiological integrity despite high viral load in many organ systems.	[Nobach, Daniel; Bourg, Manon; Herden, Christiane] Univ Giessen, Inst Vet Pathol, D-35390 Giessen, Germany; [Herzog, Sibylle; Lange-Herbst, Hildburg] Univ Giessen, Inst Virol, Giessen, Germany; [Encarnacao, Jorge A.] Univ Giessen, Dept Anim Ecol & Systemat, Mammalian Ecol Grp, Giessen, Germany; [Eickmann, Markus] Univ Marburg, Inst Virol, D-35032 Marburg, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen; Philipps University Marburg	Herden, C (corresponding author), Univ Giessen, Inst Vet Pathol, D-35390 Giessen, Germany.	Christiane.Herden@vetmed.uni-giessen.de	Encarnação, Jorge A./I-8644-2018	Encarnação, Jorge A./0000-0001-8766-0607; Herden, Christiane/0000-0003-1858-2267	Margarete Ammon Stiftung	Margarete Ammon Stiftung	HLH was funded by the Margarete Ammon Stiftung (http://www.ammon-stiftung.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUTISTA JR, 1994, BRAIN RES BULL, V34, P31, DOI 10.1016/0361-9230(94)90183-X; Bourg M, 2013, EMERG INFECT DIS, V19, P2064, DOI 10.3201/eid1912.131076; Brandes G, 2011, HISTOCHEM CELL BIOL, V135, P397, DOI 10.1007/s00418-011-0796-0; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Choate JR, 1998, J MAMMAL, V79, P1416; Cutler SJ, 2010, EMERG INFECT DIS, V16, P1, DOI 10.3201/eid1601.081467; de la Torre JC, 2006, NAT REV MICROBIOL, V4, P777, DOI 10.1038/nrmicro1489; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; Duarte LC, 2003, EVOLUTION, V57, P638; Durrwald R, 2006, MICROBES INFECT, V8, P917, DOI 10.1016/j.micinf.2005.08.013; Durrwald R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093659; Eickmann M, 2003, SCIENCE, V302, P1504; Encarnacao JA, 2013, J WILDLIFE DIS, V49, P860, DOI 10.7589/2012-10-262; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Griffin DE, 2010, PROG NEUROBIOL, V91, P95, DOI 10.1016/j.pneurobio.2009.12.003; Hallensleben W, 1998, J VIROL, V72, P4379, DOI 10.1128/JVI.72.5.4379-4386.1998; Herden C, 2000, BRAIN PATHOL, V10, P39; Herden C., 2013, FIELDS VIROLOGY, P1124; HERZOG S, 1984, MED MICROBIOL IMMUN, V173, P171, DOI 10.1007/BF02122108; HERZOG S, 1980, MED MICROBIOL IMMUN, V168, P153, DOI 10.1007/BF02122849; Herzog S, 2010, J CLIN MICROBIOL, V48, P2282, DOI 10.1128/JCM.00145-10; Hilbe M, 2006, EMERG INFECT DIS, V12, P675, DOI 10.3201/eid1204.051418; Hoffmann B, 2015, NEW ENGL J MED, V373, P154, DOI 10.1056/NEJMoa1415627; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kolodziejek J, 2005, J GEN VIROL, V86, P385, DOI 10.1099/vir.0.80587-0; Kramer K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041476; Puorger ME, 2010, VET PATHOL, V47, P236, DOI 10.1177/0300985809351849; Rubin SA, 1999, BRAIN RES BULL, V48, P23, DOI 10.1016/S0361-9230(98)00133-6; Schindler AR, 2007, MOL CELL PROBE, V21, P47, DOI 10.1016/j.mcp.2006.08.001; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Schwarz AC, 2009, EMERG INFECT DIS, V15, P1032, DOI 10.3201/eid1507.081413; Sejvar JJ, 2006, CURR OPIN NEUROL, V19, P350, DOI 10.1097/01.wco.0000236613.74462.4c; SPRANKEL H, 1978, MED MICROBIOL IMMUN, V165, P1, DOI 10.1007/BF02121228; Tyler KL, 2009, ARCH NEUROL-CHICAGO, V66, P1065, DOI 10.1001/archneurol.2009.189; Tyler KL, 2009, ARCH NEUROL-CHICAGO, V66, P939, DOI 10.1001/archneurol.2009.153; Vahlenkamp TW, 2002, J VIROL, V76, P9735, DOI 10.1128/JVI.76.19.9735-9743.2002; Werner-Keiss N, 2008, NEUROPATH APPL NEURO, V34, P590, DOI 10.1111/j.1365-2990.2008.00940.x; Wong S, 2007, REV MED VIROL, V17, P67, DOI 10.1002/rmv.520	39	36	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0137018	10.1371/journal.pone.0137018	http://dx.doi.org/10.1371/journal.pone.0137018			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313904	gold, Green Published, Green Submitted			2022-12-26	WOS:000360144000112
J	Claisse, JT; Pondella, DJ; Love, M; Zahn, LA; Williams, CM; Bull, AS				Claisse, Jeremy T.; Pondella, Daniel J.; Love, Milton, II; Zahn, Laurel A.; Williams, Chelsea M.; Bull, Ann S.			Impacts from Partial Removal of Decommissioned Oil and Gas Platforms on Fish Biomass and Production on the Remaining Platform Structure and Surrounding Shell Mounds	PLOS ONE			English	Article							OFFSHORE PETROLEUM PLATFORMS; SECONDARY PRODUCTION; SPATIAL-PATTERNS; CALIFORNIA OIL; ASSEMBLAGES; GROWTH; TEMPERATURE; VARIABILITY; RECRUITMENT; CHANNEL	When oil and gas platforms become obsolete they go through a decommissioning process. This may include partial removal (from the surface to 26 m depth) or complete removal of the platform structure. While complete removal would likely eliminate most of the existing fish biomass and associated secondary production, we find that the potential impacts of partial removal would likely be limited on all but one platform off the coast of California. On average 80% of fish biomass and 86% of secondary fish production would be retained after partial removal, with above 90% retention expected for both metrics on many platforms. Partial removal would likely result in the loss of fish biomass and production for species typically found residing in the shallow portions of the platform structure. However, these fishes generally represent a small proportion of the fishes associated with these platforms. More characteristic of platform fauna are the primarily deeper-dwelling rockfishes (genus Sebastes). "Shell mounds" are biogenic reefs that surround some of these platforms resulting from an accumulation of mollusk shells that have fallen from the shallow areas of the platforms mostly above the depth of partial removal. We found that shell mounds are moderately productive fish habitats, similar to or greater than natural rocky reefs in the region at comparable depths. The complexity and areal extent of these biogenic habitats, and the associated fish biomass and production, will likely be reduced after either partial or complete platform removal. Habitat augmentation by placing the partially removed platform superstructure or some other additional habitat enrichment material (e.g., rock boulders) on the seafloor adjacent to the base of partially removed platforms provides additional options to enhance fish production, potentially mitigating reductions in shell mound habitat.	[Claisse, Jeremy T.; Pondella, Daniel J.; Zahn, Laurel A.; Williams, Chelsea M.] Occidental Coll, Dept Biol, Vantuna Res Grp, Los Angeles, CA 90041 USA; [Love, Milton, II] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Bull, Ann S.] Bur Ocean Energy Management, Pacific Reg, Environm Sci Sect, Camarillo, CA USA	Occidental College; University of California System; University of California Santa Barbara	Claisse, JT (corresponding author), Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA.	jtclaisse@cpp.edu			United States Department of the Interior, Bureau of Ocean Energy Management, Environmental Studies Program, Washington, District of Columbia [M12AC00003]	United States Department of the Interior, Bureau of Ocean Energy Management, Environmental Studies Program, Washington, District of Columbia	Funding was provided by the United States Department of the Interior, Bureau of Ocean Energy Management, Environmental Studies Program, Washington, District of Columbia under Agreement Number M12AC00003.	Ajemian MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126354; Benke AC, 2010, RIVER RES APPL, V26, P36, DOI 10.1002/rra.1290; Bernstein BB, 2010, EVALUATING ALTERNATI; Blanchette CA, 2007, J EXP MAR BIOL ECOL, V340, P126, DOI 10.1016/j.jembe.2006.09.022; Bomkamp RE, 2004, MAR BIOL, V146, P201, DOI 10.1007/s00227-004-1413-8; Bram JB, 2005, J EXP MAR BIOL ECOL, V317, P223, DOI 10.1016/j.jembe.2004.12.003; BULL AS, 1994, B MAR SCI, V55, P1086; Carlisle J. G., 1964, CALIF DEP FISH GAME, V124, P93; Chapman DW, 1968, METHODS ASSESSMENT F, P182; Claisse JT, 2014, P NATL ACAD SCI USA, V111, P15462, DOI 10.1073/pnas.1411477111; Fowler AM, 2014, OCEAN COAST MANAGE, V87, P20, DOI 10.1016/j.ocecoaman.2013.10.019; Fowler AM, 2015, P NATL ACAD SCI USA, V112, pE102, DOI 10.1073/pnas.1422274112; Gallaway BJ, 2009, REV FISH SCI, V17, P48, DOI 10.1080/10641260802160717; Gislason H, 2010, FISH FISH, V11, P149, DOI 10.1111/j.1467-2979.2009.00350.x; Haddon M., 2011, MODELING QUANTITATIV, V2nd; Hamilton SL, 2010, P NATL ACAD SCI USA, V107, P18272, DOI 10.1073/pnas.0908091107; Helvey M, 2002, ICES J MAR SCI, V59, pS266, DOI 10.1006/jmsc.2002.1226; Holbrook SJ, 2000, ECOLOGICAL ISSUES RE, P1; IVLEV VS, 1966, J FISH RES BOARD CAN, V23, P1727, DOI 10.1139/f66-160; Kamimura Y, 2011, AQUAT ECOL, V45, P367, DOI 10.1007/s10452-011-9360-1; Langhamer O, 2012, SCI WORLD J, DOI 10.1100/2012/386713; Love M. S., 2002, ROCKFISHES NE PACIFI; Love MS, 2006, FISH B-NOAA, V104, P542; Love MS, 2012, B MAR SCI, V88, P863, DOI 10.5343/bms.2011.1101; Love M, 2009, ENVIRON BIOL FISH, V84, P55, DOI 10.1007/s10641-008-9389-8; Love MS, 2006, FISH B-NOAA, V104, P383; LOVE MS, 1991, ENVIRON BIOL FISH, V30, P225, DOI 10.1007/BF02296891; Love MS, 1999, B MAR SCI, V65, P497; Love MS, 2003, OCS STUD MMS; Macreadie PI, 2011, FRONT ECOL ENVIRON, V9, P455, DOI 10.1890/100112; Martin CJB, 2010, MAR COAST FISH, V2, P180, DOI 10.1577/C09-037.1; MBC, 1987, OCS STUD MMS, P1; MMS, 2003, FIN REP ASS PHYS CHA, P1; O'Leary M, 2010, RECOLUTIONS GEOMETRY; Page HM, 2007, MAR ECOL PROG SER, V344, P245, DOI 10.3354/meps06929; PAGE HM, 1987, J EXP MAR BIOL ECOL, V111, P159, DOI 10.1016/0022-0981(87)90053-0; Parente V, 2006, ENERG POLICY, V34, P1992, DOI 10.1016/j.enpol.2005.02.008; Scarborough Bull A., 1993, DIVING SCI, P117; Scarborough-Bull A, 2008, AM FISH S S, V49, P899; Schroeder DM, 2004, OCEAN COAST MANAGE, V47, P21, DOI 10.1016/j.ocecoaman.2004.03.002; Stephen CD, 1990, FISHERY MANAGEMENT P, V3; Waters T.F., 1977, Advances in Ecological Research, V10, P91, DOI 10.1016/S0065-2504(08)60235-4; Wilson JR, 2008, ESTUAR COAST SHELF S, V79, P483, DOI 10.1016/j.ecss.2008.05.001; Wilson JC, 2009, WIND ENERGY, V12, P203, DOI 10.1002/we.324	44	34	34	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135812	10.1371/journal.pone.0135812	http://dx.doi.org/10.1371/journal.pone.0135812			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332384	gold, Green Published, Green Submitted			2022-12-26	WOS:000360613800040
J	Komatsu, T; Dacheux, D; Kreppel, F; Nagata, K; Wodrich, H				Komatsu, Tetsuro; Dacheux, Denis; Kreppel, Florian; Nagata, Kyosuke; Wodrich, Harald			A Method for Visualization of Incoming Adenovirus Chromatin Complexes in Fixed and Living Cells	PLOS ONE			English	Article							TEMPLATE-ACTIVATING FACTOR; PROTEIN-VII; CORE PROTEINS; EARLY PHASE; FACTOR-I; DNA; TRANSCRIPTION; REPLICATION; EXPRESSION; RESOLUTION	Inside the adenovirus virion, the genome forms a chromatin-like structure with viral basic core proteins. Core protein VII is the major DNA binding protein and was shown to remain associated with viral genomes upon virus entry even after nuclear delivery. It has been suggested that protein VII plays a regulatory role in viral gene expression and is a functional component of viral chromatin complexes in host cells. As such, protein VII could be used as a maker to track adenoviral chromatin complexes in vivo. In this study, we characterize a new monoclonal antibody against protein VII that stains incoming viral chromatin complexes following nuclear import. Furthermore, we describe the development of a novel imaging system that uses Template Activating Factor-I (TAF-I/SET), a cellular chromatin protein tightly bound to protein VII upon infection. This setup allows us not only to rapidly visualize protein VII foci in fixed cells but also to monitor their movement in living cells. These powerful tools can provide novel insights into the spatio-temporal regulation of incoming adenoviral chromatin complexes.	[Komatsu, Tetsuro; Dacheux, Denis; Wodrich, Harald] Univ Bordeaux, MFP CNRS UMR 5234, Microbiol Fondamentale & Pathogenicite, F-33076 Bordeaux, France; [Komatsu, Tetsuro; Nagata, Kyosuke] Univ Tsukuba, Dept Infect Biol, Fac Med, Tsukuba, Ibaraki 3058575, Japan; [Dacheux, Denis] Bordeaux INP, MCMP, UMR 5234, F-33000 Bordeaux, France; [Kreppel, Florian] Univ Ulm, Dept Gene Therapy, D-89081 Ulm, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; University of Tsukuba; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Ulm University	Wodrich, H (corresponding author), Univ Bordeaux, MFP CNRS UMR 5234, Microbiol Fondamentale & Pathogenicite, F-33076 Bordeaux, France.	harald.wodrich@u-bordeaux.fr	Dacheux, Denis/AGF-5359-2022; Wodrich, Harald/P-1777-2019	Wodrich, Harald/0000-0002-4764-1708; DACHEUX, Denis/0000-0002-9956-4839; Komatsu, Tetsuro/0000-0003-3963-8792	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Equipe FRM 2011 Projet [DEQ20110421299]; CNRS/University of Bordeaux	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Equipe FRM 2011 Projet; CNRS/University of Bordeaux(Centre National de la Recherche Scientifique (CNRS))	This work was in part supported by grants from the Equipe FRM 2011 Projet DEQ20110421299 (HW) and from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (KN) and by institutional funding (CNRS/University of Bordeaux to HW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURG JL, 1983, J VIROL, V46, P749, DOI 10.1128/JVI.46.3.749-755.1983; Cassany A, 2015, J VIROL, V89, P1719, DOI 10.1128/JVI.02639-14; CHATTERJEE PK, 1986, EMBO J, V5, P1633, DOI 10.1002/j.1460-2075.1986.tb04406.x; Giberson AN, 2012, NUCLEIC ACIDS RES, V40, P2369, DOI 10.1093/nar/gkr1076; Glotzer JB, 2001, J VIROL, V75, P2421, DOI 10.1128/JVI.75.5.2421-2434.2001; Greber UF, 1997, EMBO J, V16, P5998, DOI 10.1093/emboj/16.19.5998; Haruki H, 2006, J VIROL, V80, P794, DOI 10.1128/JVI.80.2.794-801.2006; Haruki H, 2003, FEBS LETT, V555, P521, DOI 10.1016/S0014-5793(03)01336-X; Johnson JS, 2004, J VIROL, V78, P6459, DOI 10.1128/JVI.78.12.6459-6468.2004; Kato K, 2007, NUCLEIC ACIDS RES, V35, P705, DOI 10.1093/nar/gkl1077; Kawase H, 1996, GENES CELLS, V1, P1045, DOI 10.1046/j.1365-2443.1996.d01-223.x; Komatsu T, 2011, NUCLEIC ACIDS RES, V39, P889, DOI 10.1093/nar/gkq783; Kreppel F, 2002, HUM GENE THER, V13, P1151, DOI 10.1089/104303402320138934; Martinez R, 2015, J VIROL, V89, P2121, DOI 10.1128/JVI.02257-14; Martinez R, 2013, METHODS MOL BIOL, V1064, P211, DOI 10.1007/978-1-62703-601-6_15; Miyaji-Yamaguchi M, 1999, J MOL BIOL, V290, P547, DOI 10.1006/jmbi.1999.2898; Miyanari Y, 2013, NAT STRUCT MOL BIOL, V20, P1321, DOI 10.1038/nsmb.2680; Nagata K, 1998, EXP CELL RES, V240, P274, DOI 10.1006/excr.1997.3930; NAGATA K, 1995, P NATL ACAD SCI USA, V92, P4279, DOI 10.1073/pnas.92.10.4279; Okuwaki M, 2001, J MOL BIOL, V311, P41, DOI 10.1006/jmbi.2001.4812; Puntener D, 2011, J VIROL, V85, P481, DOI 10.1128/JVI.01571-10; Russell WC, 2009, J GEN VIROL, V90, P1, DOI 10.1099/vir.0.003087-0; Schiedner G, 2000, HUM GENE THER, V11, P2105, DOI 10.1089/104303400750001417; Schreiner S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002549; Wang IH, 2013, CELL HOST MICROBE, V14, P468, DOI 10.1016/j.chom.2013.09.004; Wodrich H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000808; Xue YM, 2005, J VIROL, V79, P2474, DOI 10.1128/JVI.79.4.2474-2483.2005	27	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137102	10.1371/journal.pone.0137102	http://dx.doi.org/10.1371/journal.pone.0137102			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332038	Green Published, gold, Green Submitted			2022-12-26	WOS:000360613800096
J	Chang, JS; Kuo, HP; Chang, KLB; Kong, ZL				Chang, Jenq-Sheng; Kuo, Hsiang-Ping; Chang, Ke Liang B.; Kong, Zwe-Ling			Apoptosis of Hepatocellular Carcinoma Cells Induced by Nanoencapsulated Polysaccharides Extracted from Antrodia Camphorata	PLOS ONE			English	Article							CHITOSAN NANOPARTICLES; SILICA NANOPARTICLES; GENE-EXPRESSION; DRUG-DELIVERY; TOXICITY; GROWTH; MITOCHONDRIA; INDUCTION; CHEMISTRY; NECROSIS	Antrodia camphorata is a well-known medicinal mushroom in Taiwan and has been studied for decades, especially with focus on anti-cancer activity. Polysaccharides are the major bioactive compounds reported with anti-cancer activity, but the debates on how they target cells still remain. Research addressing the encapsulation of polysaccharides from A. camphorata extract (ACE) to enhance anti-cancer activity is rare. In this study, ACE polysaccharides were nano-encapsulated in chitosan-silica and silica (expressed as ACE/CS and ACE/S, respectively) to evaluate the apoptosis effect on a hepatoma cell line (Hep G2). The results showed that ACE polysaccharides, ACE/CS and ACE/S all could damage the Hep G2 cell membrane and cause cell death, especially in the ACE/CS group. In apoptosis assays, DNA fragmentation and sub-G(1) phase populations were increased, and the mitochondrial membrane potential decreased significantly after treatments. ACE/CS and ACE/S could also increase reactive oxygen species (ROS) generation, induce Fas/APO-1 (apoptosis antigen 1) expression and elevate the proteolytic activities of caspase-3, caspase-8 and caspase-9 in Hep G2 cells. Unsurprisingly, ACE/CS induced a similar apoptosis mechanism at a lower dosage (ACE polysaccharides = 13.2 mu g/mL) than those of ACE/S (ACE polysaccharides = 21.2 mu g/mL) and ACE polysaccharides (25 mu g/mL). Therefore, the encapsulation of ACE polysaccharides by chitosan-silica nanoparticles may provide a viable approach for enhancing anti-tumor efficacy in liver cancer cells.	[Chang, Jenq-Sheng; Kuo, Hsiang-Ping; Chang, Ke Liang B.; Kong, Zwe-Ling] Natl Taiwan Ocean Univ, Dept Food Sci, Keelung, Taiwan	National Taiwan Ocean University	Kong, ZL (corresponding author), Natl Taiwan Ocean Univ, Dept Food Sci, Keelung, Taiwan.	kongzl@mail.ntou.edu.tw	Kong, Zwe-Ling/E-8763-2013; Kong, Zwe-Ling/AAB-5328-2019; Kong, Zwe-Ling/AAB-5261-2019	Kong, Zwe-Ling/0000-0002-4877-6524; Kong, Zwe-Ling/0000-0002-4877-6524; 	Ministry of Science and technology [NSC 97-2313-B-019-006-MY3, NSC 97-2221-E-019-001]	Ministry of Science and technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the National Science Council Taiwan, which was renamed to the Ministry of Science and technology since 2014. Grant numbers were NSC 97-2313-B-019-006-MY3 (for Z. L. Kong) and NSC 97-2221-E-019-001 (for K. L. B. Chang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbe C, 2004, ADV MATER, V16, P1959, DOI 10.1002/adma.200400771; Bodnar M, 2005, BIOMACROMOLECULES, V6, P2521, DOI 10.1021/bm0502258; Borchers AT, 2008, EXP BIOL MED, V233, P259, DOI 10.3181/0708-MR-227; Borchers AT, 2004, EXP BIOL MED, V229, P393, DOI 10.1177/153537020422900507; Cai XJ, 2011, CYTOTECHNOLOGY, V63, P319, DOI 10.1007/s10616-011-9366-5; Carolina A, 2013, CAN J VET RES, V77, P136; Chang JS, 2007, ENVIRON SCI TECHNOL, V41, P2064, DOI 10.1021/es062347t; Chang JS, 2006, CHEM MATER, V18, P702, DOI 10.1021/cm052161d; Chou CT, 2013, AMINO ACIDS, V45, P811, DOI 10.1007/s00726-013-1524-y; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Coradin T, 2003, CHEMBIOCHEM, V4, P251, DOI 10.1002/cbic.200390044; Foldbjerg R, 2009, TOXICOL LETT, V190, P156, DOI 10.1016/j.toxlet.2009.07.009; Geethangili M, 2011, EVIDENCE BASED COMPL, V2011; Hardman R, 2006, ENVIRON HEALTH PERSP, V114, P165, DOI 10.1289/ehp.8284; Hseu YC, 2004, NUTR CANCER, V48, P189, DOI 10.1207/s15327914nc4802_9; Hsiao G, 2003, J AGR FOOD CHEM, V51, P3302, DOI 10.1021/jf021159t; Hsu YL, 2005, CANCER LETT, V221, P77, DOI 10.1016/j.canlet.2004.08.012; Huang GJ, 2012, FOOD CHEM, V132, P709, DOI 10.1016/j.foodchem.2011.11.004; Janes KA, 2001, J CONTROL RELEASE, V73, P255, DOI 10.1016/S0168-3659(01)00294-2; Kong ZL, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1945-2; Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b; Latchoumycandane C, 2012, J BIOL CHEM, V287, P17693, DOI 10.1074/jbc.M111.300012; Lee IH, 2002, FEMS MICROBIOL LETT, V209, P63, DOI 10.1111/j.1574-6968.2002.tb11110.x; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lin LN, 2010, CYTOTECHNOLOGY, V62, P377, DOI 10.1007/s10616-010-9295-8; Liu JJ, 2004, TOXICOL APPL PHARM, V201, P186, DOI 10.1016/j.taap.2004.05.016; Lozano MV, 2008, BIOMACROMOLECULES, V9, P2186, DOI 10.1021/bm800298u; Maes Michael, 2012, Inflammopharmacology, V20, P127, DOI 10.1007/s10787-011-0111-7; Mi FL, 2007, BIOMACROMOLECULES, V8, P892, DOI 10.1021/bm060998b; Mignotte B, 1998, EUR J BIOCHEM, V252, P1, DOI 10.1046/j.1432-1327.1998.2520001.x; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mou HB, 2011, TOXICOL IN VITRO, V25, P1027, DOI 10.1016/j.tiv.2011.03.023; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Peng CC, 2007, J ETHNOPHARMACOL, V109, P93, DOI 10.1016/j.jep.2006.07.009; Shim W, 2012, ACS NANO, V6, P7665, DOI 10.1021/nn301113f; Slowing II, 2007, ADV FUNCT MATER, V17, P1225, DOI 10.1002/adfm.200601191; Song TY, 2003, J AGR FOOD CHEM, V51, P1571, DOI 10.1021/jf0209701; Tepper CG, 2000, EXP CELL RES, V260, P9, DOI 10.1006/excr.2000.4990; Wang GJ, 2003, LIFE SCI, V73, P2769, DOI 10.1016/S0024-3205(03)00669-6; Wang X, 2008, CA-CANCER J CLIN, V58, P97, DOI 10.3322/CA.2007.0003; Yang HL, 2006, CANCER LETT, V231, P215, DOI 10.1016/j.canlet.2005.02.004; Zhang H, 2004, BIOMACROMOLECULES, V5, P2461, DOI 10.1021/bm0496211	42	16	21	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136782	10.1371/journal.pone.0136782	http://dx.doi.org/10.1371/journal.pone.0136782			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327534	Green Submitted, gold, Green Published			2022-12-26	WOS:000360437700064
J	Liu, YN; Kujawinski, EB				Liu, Yina; Kujawinski, Elizabeth B.			Chemical Composition and Potential Environmental Impacts of Water-Soluble Polar Crude Oil Components Inferred from ESI FT-ICR MS	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; POLYCYCLIC AROMATIC-HYDROCARBONS; ELECTROSPRAY-IONIZATION; HORIZON OIL; MASS-SPECTROMETRY; SOLUBILITY ENHANCEMENT; NSO COMPOUNDS; EXXON-VALDEZ; FUEL-OIL; TOXICITY	Polar petroleum components enter marine environments through oil spills and natural seepages each year. Lately, they are receiving increased attention due to their potential toxicity to marine organisms and persistence in the environment. We conducted a laboratory experiment and employed state-of-the-art Fourier-transform ion cyclotron resonance mass spectrometry (FT-ICR-MS) to characterize the polar petroleum components within two operationally-defined seawater fractions: the water-soluble fraction (WSF), which includes only water-soluble molecules, and the water-accommodated fraction (WAF), which includes WSF and microscopic oil droplets. Our results show that compounds with higher heteroatom (N, S, O) to carbon ratios (NSO:C) than the parent oil were selectively partitioned into seawater in both fractions, reflecting the influence of polarity on aqueous solubility. WAF and WSF were compositionally distinct, with unique distributions of compounds across a range of hydrophobicity. These compositional differences will likely result in disparate impacts on environmental health and organismal toxicity, and thus highlight the need to distinguish between these often-interchangeable terminologies in toxicology studies. We use an empirical model to estimate hydrophobicity character for individual molecules within these complex mixtures and provide an estimate of the potential environmental impacts of different crude oil components.	[Liu, Yina; Kujawinski, Elizabeth B.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Liu, YN (corresponding author), Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA.	yina.liu@whoi.edu	Liu, Yina/C-1522-2017	Liu, Yina/0000-0002-3485-7542	Gulf of Mexico Research Initiative (GOMRI) Project [161684]	Gulf of Mexico Research Initiative (GOMRI) Project	This study is funded by the Gulf of Mexico Research Initiative (GOMRI) Project # 161684 to Dr. Elizabeth B. Kujawinski.	Aeppli C, 2012, ENVIRON SCI TECHNOL, V46, P8799, DOI 10.1021/es3015138; Akaishi FM, 2004, ARCH ENVIRON CON TOX, V46, P244, DOI 10.1007/s00244-003-2260-1; Alkindi AYA, 1996, J FISH BIOL, V49, P1291; ANDERSON JW, 1974, MAR BIOL, V27, P75, DOI 10.1007/BF00394763; Arnot JA, 2006, ENVIRON REV, V14, P257, DOI 10.1139/a06-005; Atlas RM, 2011, ENVIRON SCI TECHNOL, V45, P6709, DOI 10.1021/es2013227; Bellas J, 2013, CHEMOSPHERE, V90, P1103, DOI 10.1016/j.chemosphere.2012.09.015; Bhatia MP, 2010, GEOCHIM COSMOCHIM AC, V74, P3768, DOI 10.1016/j.gca.2010.03.035; Bianchi TS, 2014, ENVIRON SCI TECHNOL, V48, P9288, DOI 10.1021/es501547b; BOEHM P D, 1974, Marine Pollution Bulletin, V5, P101, DOI 10.1016/0025-326X(74)90256-2; BOEHM PD, 1976, ESTUAR COAST MAR SCI, V4, P93, DOI 10.1016/0302-3524(76)90010-4; BOEHM PD, 1973, GEOCHIM COSMOCHIM AC, V37, P2459, DOI 10.1016/0016-7037(73)90292-5; BOYLAN DB, 1971, NATURE, V230, P44, DOI 10.1038/230044a0; Camilli R, 2010, SCIENCE, V330, P201, DOI 10.1126/science.1195223; Carls MG, 2008, AQUAT TOXICOL, V88, P121, DOI 10.1016/j.aquatox.2008.03.014; CHIOU CT, 1986, ENVIRON SCI TECHNOL, V20, P502, DOI 10.1021/es00147a010; CHIOU CT, 1987, ENVIRON SCI TECHNOL, V21, P1231, DOI 10.1021/es00165a012; Corilo YE, 2013, ANAL CHEM, V85, P9064, DOI 10.1021/ac401604u; Diercks AR, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045046; Dittmar T, 2008, LIMNOL OCEANOGR-METH, V6, P230, DOI 10.4319/lom.2008.6.230; Dubinsky EA, 2013, ENVIRON SCI TECHNOL, V47, P10860, DOI 10.1021/es401676y; GIRLING AE, 1989, CHEMOSPHERE, V19, P1635, DOI 10.1016/0045-6535(89)90507-9; GRIFFIN LF, 1977, APPL ENVIRON MICROB, V33, P1092, DOI 10.1128/AEM.33.5.1092-1096.1977; Gutierrez T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067717; Hughey CA, 2004, ORG GEOCHEM, V35, P863, DOI 10.1016/j.orggeochem.2004.02.008; Hughey CA, 2002, ORG GEOCHEM, V33, P743, DOI 10.1016/S0146-6380(02)00038-4; Incardona JP, 2013, AQUAT TOXICOL, V142, P303, DOI 10.1016/j.aquatox.2013.08.011; Incardona JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030116; JAFFE R, 1991, ENVIRON POLLUT, V69, P237, DOI 10.1016/0269-7491(91)90147-O; Jones D.L, 2017, FATHOM TOOLBOX MATLA; Ke L, 2009, CHEMOSPHERE, V76, P1102, DOI 10.1016/j.chemosphere.2009.04.022; Kennedy CJ, 2005, J EXP MAR BIOL ECOL, V323, P43, DOI 10.1016/j.jembe.2005.02.021; Koch BP, 2005, GEOCHIM COSMOCHIM AC, V69, P3299, DOI 10.1016/j.gca.2005.02.027; Kujawinski EB, 2002, ENVIRON FORENSICS, V3, P207, DOI 10.1006/enfo.2002.0109; Kujawinski EB, 2006, ANAL CHEM, V78, P4363, DOI 10.1021/ac0600306; Kujawinski EB, 2011, ENVIRON SCI TECHNOL, V45, P1298, DOI 10.1021/es103838p; Kujawinski EB, 2011, ANNU REV MAR SCI, V3, P567, DOI 10.1146/annurev-marine-120308-081003; Kujawinski EB, 2009, GEOCHIM COSMOCHIM AC, V73, P4384, DOI 10.1016/j.gca.2009.04.033; Lubcke-von Varel U, 2011, ENVIRON SCI TECHNOL, V45, P2384, DOI 10.1021/es103381y; Marshall AG, 2008, P NATL ACAD SCI USA, V105, P18090, DOI 10.1073/pnas.0805069105; Mason OU, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00332; Mason OU, 2012, ISME J, V6, P1715, DOI 10.1038/ismej.2012.59; McKenna AM, 2014, ENERG FUEL, V28, P2454, DOI 10.1021/ef5002452; McKenna AM, 2013, ENVIRON SCI TECHNOL, V47, P7530, DOI 10.1021/es305284t; McNutt MK, 2012, P NATL ACAD SCI USA, V109, P20260, DOI 10.1073/pnas.1112139108; Meharg AA, 1998, ENVIRON POLLUT, V99, P29, DOI 10.1016/S0269-7491(97)00180-2; Melbye AG, 2009, ENVIRON TOXICOL CHEM, V28, P1815, DOI 10.1897/08-545.1; Meylan WM, 1999, ENVIRON TOXICOL CHEM, V18, P664, DOI 10.1002/etc.5620180412; MEYLAN WM, 1995, J PHARM SCI-US, V84, P83, DOI 10.1002/jps.2600840120; Meylan WM, 1996, ENVIRON TOXICOL CHEM, V15, P100, DOI 10.1002/etc.5620150205; National Research Council, 2003, OIL SEA INP FAT EFF; Ohwada K, 2003, MAR POLLUT BULL, V47, P78, DOI 10.1016/S0025-326X(03)00112-7; Peacock EE, 2005, ENVIRON FORENSICS, V6, P273, DOI 10.1080/15275920500194480; Peterson CH, 2003, SCIENCE, V302, P2082, DOI 10.1126/science.1084282; Ray PZ, 2014, J HAZARD MATER, V280, P636, DOI 10.1016/j.jhazmat.2014.08.059; Reddy CM, 2012, P NATL ACAD SCI USA, V109, P20229, DOI 10.1073/pnas.1101242108; Reemtsma T, 2010, J MASS SPECTROM, V45, P382, DOI 10.1002/jms.1722; ROSSI SS, 1976, ENVIRON POLLUT, V10, P9, DOI 10.1016/0013-9327(76)90091-4; Ryerson T.B., 2012, P NATL ACAD SCI; Singer MM, 2000, MAR POLLUT BULL, V40, P1007, DOI 10.1016/S0025-326X(00)00045-X; Sleighter RL, 2008, MAR CHEM, V110, P140, DOI 10.1016/j.marchem.2008.04.008; Soule MCK, 2010, ORG GEOCHEM, V41, P725, DOI 10.1016/j.orggeochem.2010.05.017; Southam AD, 2007, ANAL CHEM, V79, P4595, DOI 10.1021/ac062446p; Stanford LA, 2007, ENVIRON SCI TECHNOL, V41, P2696, DOI 10.1021/es0624063; Tanaka S, 1997, ANAL CHIM ACTA, V337, P351, DOI 10.1016/S0003-2670(96)00422-9; Tejeda-Agredano MC, 2014, ENVIRON POLLUT, V184, P435, DOI 10.1016/j.envpol.2013.09.031; US EPA, 2012, EST PROGR INT SUIT M, V167; Wandruszka RV, 2000, GEOCHEM T, V1, P1, DOI [10.1186/1467-4866-1-10, DOI 10.1186/1467-4866-1-10]	68	33	33	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136376	10.1371/journal.pone.0136376	http://dx.doi.org/10.1371/journal.pone.0136376			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327219	Green Published, Green Submitted, gold			2022-12-26	WOS:000360437700039
J	Schmittmann, VD; Jahfari, S; Borsboom, D; Savi, AO; Waldorp, LJ				Schmittmann, Verena D.; Jahfari, Sara; Borsboom, Denny; Savi, Alexander O.; Waldorp, Lourens J.			Making Large-Scale Networks from fMRI Data	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; STRUCTURAL CONNECTIVITY; BRAIN NETWORKS; SMALL-WORLD; ARCHITECTURE; REGRESSION; EFFICIENCY; ALGORITHM; SYSTEM; GRAPHS	Pairwise correlations are currently a popular way to estimate a large-scale network (> 1000 nodes) from functional magnetic resonance imaging data. However, this approach generally results in a poor representation of the true underlying network. The reason is that pairwise correlations cannot distinguish between direct and indirect connectivity. As a result, pairwise correlation networks can lead to fallacious conclusions; for example, one may conclude that a network is a small-world when it is not. In a simulation study and an application to resting-state fMRI data, we compare the performance of pairwise correlations in large-scale networks (2000 nodes) against three other methods that are designed to filter out indirect connections. Recovery methods are evaluated in four simulated network topologies (small world or not, scale-free or not) in scenarios where the number of observations is very small compared to the number of nodes. Simulations clearly show that pairwise correlation networks are fragmented into separate unconnected components with excessive connectedness within components. This often leads to erroneous estimates of network metrics, like small-world structures or low betweenness centrality, and produces too many low-degree nodes. We conclude that using partial correlations, informed by a sparseness penalty, results in more accurate networks and corresponding metrics than pairwise correlation networks. However, even with these methods, the presence of hubs in the generating network can be problematic if the number of observations is too small. Additionally, we show for resting-state fMRI that partial correlations are more robust than correlations to different parcellation sets and to different lengths of time-series.	[Schmittmann, Verena D.] Tilburg Univ, Dept Methodol & Stat Social & Behav Sci, NL-5000 LE Tilburg, Netherlands; [Jahfari, Sara] Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands; [Borsboom, Denny; Savi, Alexander O.; Waldorp, Lourens J.] Univ Amsterdam, Psychol Methods Social & Behav Sci, Amsterdam, Netherlands	Tilburg University; Vrije Universiteit Amsterdam; University of Amsterdam	Schmittmann, VD (corresponding author), Tilburg Univ, Dept Methodol & Stat Social & Behav Sci, NL-5000 LE Tilburg, Netherlands.	v.d.schmittmann@uvt.nl	Savi, Alexander O./AAD-2195-2020	Savi, Alexander O./0000-0002-9271-7476; Borsboom, Denny/0000-0001-9720-4162	Netherlands Organization for Scientific Research (NWO) [451-03-068]; Mosaic grant from the Netherlands Organization for Scientific Research (NWO) [017.005.107]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Mosaic grant from the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by innovational research grant no. 451-03-068 (VDS and DB) from the Netherlands Organization for Scientific Research (NWO), and by Mosaic grant no 017.005.107 (SJ) from the Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Behrens TEJ, 2012, CURR OPIN NEUROBIOL, V22, P144, DOI 10.1016/j.conb.2011.08.005; Bollobas B., 1998, MODERN GRAPH THEORY; Buckner RL, 2007, NEUROIMAGE, V37, P1091, DOI 10.1016/j.neuroimage.2007.01.010; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cammoun L, 2012, J NEUROSCI METH, V203, P386, DOI 10.1016/j.jneumeth.2011.09.031; Cribben I, 2012, NEUROIMAGE, V61, P907, DOI 10.1016/j.neuroimage.2012.03.070; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Davidsen J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.128701; de Jong RM, 2000, ECONOMETRICA, V68, P407; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Drton M, 2008, J STAT PLAN INFER, V138, P1179, DOI 10.1016/j.jspi.2007.05.035; Epskamp S, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i04; Friedman J., 2011, GLASSO GRAPHICAL LAS; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Friston KJ, 2000, NEUROIMAGE, V12, P196, DOI 10.1006/nimg.2000.0609; Gates KM, 2012, NEUROIMAGE, V63, P310, DOI 10.1016/j.neuroimage.2012.06.026; Gerhard Stephan, 2011, Front Neuroinform, V5, P3, DOI 10.3389/fninf.2011.00003; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Itahashi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094115; Iyer SP, 2013, NEUROIMAGE, V75, P165, DOI 10.1016/j.neuroimage.2013.02.054; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jones B, 2005, BIOMETRIKA, V92, P779, DOI 10.1093/biomet/92.4.779; Langford E, 2001, AM STAT, V55, P322, DOI 10.1198/000313001753272286; Lauritzen S.L.., 1996, GRAPHICAL MODELS; Lemoine C, 2008, IEEE T ELECTROMAGN C, V50, P227, DOI 10.1109/TEMC.2008.919037; Marrelec G, 2006, NEUROIMAGE, V32, P228, DOI 10.1016/j.neuroimage.2005.12.057; Meinshausen N, 2006, ANN STAT, V34, P1436, DOI 10.1214/009053606000000281; Meunier D., 2009, FRONT NEUROINFORM, V30, DOI [10.3389/neuro.11.037.2009, 10.3389/neuro.11.037.2009.eCollection2009]; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Opgen-Rhein R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-37; Opsahl T, 2009, SOC NETWORKS, V31, P155, DOI 10.1016/j.socnet.2009.02.002; Pircalabelu E, ANN APPL STAT UNDER; R Core Team, 2012, R LANG ENV STAT COMP; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Schafer J, 2012, CORPCOR EFFICIENT ES; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Telesford QK, 2011, BRAIN CONNECT, V1, P367, DOI [10.1089/brain.2011.0038, 10.1089/brain.2011.0055]; Valdes-Sosa PA, 2005, PHILOS T R SOC B, V360, P969, DOI 10.1098/rstb.2005.1654; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Varoquaux G., 2010, ADV NEURAL INFORM PR, P2334; Varoquaux G, 2013, NEUROIMAGE, V80, P405, DOI 10.1016/j.neuroimage.2013.04.007; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Worsley K.J., 2001, FUNCTIONAL MRI AN IN, P251, DOI [10.1093/acprof:oso/ 9780192630711.003.0014, DOI 10.1093/ACPROF:OSO/9780192630711.003.0014]; Zalesky A, 2012, NEUROIMAGE, V60, P2096, DOI 10.1016/j.neuroimage.2012.02.001	59	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0129074	10.1371/journal.pone.0129074	http://dx.doi.org/10.1371/journal.pone.0129074			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325185	gold, Green Published, Green Submitted			2022-12-26	WOS:000360437700001
J	Liang, ZX; Liang, Y				Liang, Zhu-Xing; Liang, Yi			Significance of Polarization Charges and Isomagnetic Surface in Magnetohydrodynamics	PLOS ONE			English	Article							MAGNETIC-FIELD LINES; MOTION	From the frozen-in field lines concept, a highly conducting fluid can move freely along, but not traverse to, magnetic field lines. We discuss this topic and find that in the study of the frozen-in field lines concept, the effects of inductive and capacitive reactance have been omitted. When admitted, the relationships among the motional electromotive field, the induced electric field, the eddy electric current, and the magnetic field becomes clearer. We emphasize the importance of isomagnetic surfaces and polarization charges, and show analytically that whether a conducting fluid can freely traverse magnetic field lines or not depends solely on the magnetic gradient along the path of the fluid. If a fluid does not change its density distribution and shape (can be regarded as a quasi-rigid body) and moves along isomagnetic surface, it can freely traverse magnetic field lines without any magnetic drag, no matter how strong the magnetic field is. Besides theoretical analysis, we also present experimental results to support our analysis. The main purpose of this work is to correct a fallacy among some astrophysicists.			Liang, ZX (corresponding author), 18-4-102 Shuixiehuadu, Shijiazhuang 050035, Hebei, Peoples R China.	zx.liang55@hotmail.com		Liang, Zhu-Xing/0000-0002-2645-7856				AKASOFU SI, 1978, SPACE SCI REV, V21, P489, DOI 10.1007/BF00240906; ALFVEN H, 1958, TELLUS, V10, P104, DOI 10.1111/j.2153-3490.1958.tb01991.x; ALFVEN H, 1976, J GEOPHYS RES-SPACE, V81, P4019, DOI 10.1029/JA081i022p04019; Alfven H, 1942, NATURE, V150, P405, DOI 10.1038/150405d0; Alfven H, 1963, COSMICAL ELECTRODYNA, Vsecond edition, P110; Alfven H, 1963, COSMICAL ELECTRODYNA, Vsecond edition, P190; BACKUS G, 1956, ASTROPHYS J, V123, P508, DOI 10.1086/146187; Bateman G, 1978, MHD INSTABILITIES, P30; Bellan PM, 2006, FUNDAMENTALS PLASMA, P100; Bittencourt JA, 2004, FUNDAMENTALS PLASMA, Vthird edition, P315; Bittencourt JA, 2004, FUNDAMENTALS PLASMA, Vthird edition, P312; Bittencourt JA, 2004, FUNDAMENTALS PLASMA, Vthird edition, P51; Boyd TJM, 2003, PHYS PLASMAS, P79; Falthammar CG, 2006, AM J PHYS, V74, P454, DOI 10.1119/1.2180285; Falthammar CG, 2007, EOSTR, V88, P169; Feynman RP, 1964, THE FEYNMAN LECTURES, V2, P13; GOLDREICH P, 1969, ASTROPHYS J, V157, P869, DOI 10.1086/150119; Goldston RJ, 1995, INTRO PLASMA PHYS, P124; Goldston RJ, 1995, INTRO PLASMA PHYS, P118; Ivonin IA, 1998, PHYS PLASMAS, V5, P2893, DOI 10.1063/1.873011; Li D, 2006, PLASMA PHYS, P69; Liang ZX, 2009, YOTUDOU; Liang ZX, 2009, YOUTUBE; Lundin R, 2005, ANN GEOPHYS-GERMANY, V23, P2565, DOI 10.5194/angeo-23-2565-2005; Lyne AG, 2005, PULSAR ASTRONOMY, Vthird, P23; Ma JC, 2012, FUNDAMENTALS PLASMA, Vsecond, P188; NEWCOMB WA, 1958, ANN PHYS-NEW YORK, V3, P347, DOI 10.1016/0003-4916(58)90024-1; NORTHROP TG, 1963, REV GEOPHYS, V1, P283, DOI 10.1029/RG001i003p00283; STERN DP, 1966, SPACE SCI REV, V6, P147; VASYLIUNAS VM, 1972, J GEOPHYS RES, V77, P6271, DOI 10.1029/JA077i031p06271; Zheng CK, 2009, PLASMA PHYS, P79	31	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136936	10.1371/journal.pone.0136936	http://dx.doi.org/10.1371/journal.pone.0136936			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322894	gold, Green Published, Green Submitted			2022-12-26	WOS:000360435500050
J	Rouver, WN; Delgado, NTB; Menezes, JB; Santos, RL; Moyses, MR				Rouver, Wender Nascimento; Banhos Delgado, Nathalie Tristao; Menezes, Jussara Bezerra; Santos, Roger Lyrio; Moyses, Margareth Ribeiro			Testosterone Replacement Therapy Prevents Alterations of Coronary Vascular Reactivity Caused by Hormone Deficiency Induced by Castration	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; LIPOPROTEIN-LIPASE; GENDER-DIFFERENCES; VASODILATION; ANDROGENS; ARTERY; INHIBITION; RELAXATION; BRADYKININ; CHANNELS	The present study aimed to determine the effects of chronic treatment with different doses of testosterone on endothelium-dependent coronary vascular reactivity in male rats. Adult male rats were divided into four experimental groups: control (SHAM), castrated (CAST), castrated and immediately treated subcutaneously with a physiological dose (0.5 mg/kg/ day, PHYSIO group) or supraphysiological dose (2.5 mg/kg/day, SUPRA group) of testosterone for 15 days. Systolic blood pressure (SBP) was assessed at the end of treatment through tail plethysmography. After euthanasia, the heart was removed and coronary vascular reactivity was assessed using the Langendorff retrograde perfusion technique. A dose-response curve for bradykinin (BK) was constructed, followed by inhibition with 100 mu M L-NAME, 2.8 mu M indomethacin (INDO), L-NAME + INDO, or L-NAME + INDO + 0.75 mu M clotrimazole (CLOT). We observed significant endothelium-dependent, BK-induced coronary vasodilation, which was abolished in the castrated group and restored in the PHYSIO and SUPRA groups. Furthermore, castration modulated the lipid and hormonal profiles and decreased body weight, and testosterone therapy restored all of these parameters. Our results revealed an increase in SBP in the SUPRA group. In addition, our data led us to conclude that physiological concentrations of testosterone may play a beneficial role in the cardiovascular system by maintaining an environment that is favourable for the activity of an endothelium-dependent vasodilator without increasing SBP.	[Rouver, Wender Nascimento; Banhos Delgado, Nathalie Tristao; Menezes, Jussara Bezerra; Santos, Roger Lyrio; Moyses, Margareth Ribeiro] Univ Fed Espirito Santo, Fed Univ Espirito Santo, Dept Physiol Sci, Vitoria, Brazil	Universidade Federal do Espirito Santo	Santos, RL (corresponding author), Univ Fed Espirito Santo, Fed Univ Espirito Santo, Dept Physiol Sci, Vitoria, Brazil.	rogerlyrio@hotmail.com; mmoyses51@gmail.com	Rouver, Wender do Nascimento/AAH-7048-2020; dos Santos, Roger Lyrio/AAH-7100-2020	Rouver, Wender do Nascimento/0000-0002-4336-7422; dos Santos, Roger Lyrio/0000-0003-4316-7196; Tristao Banhos Delgado, Nathalie/0000-0001-7501-8940				ADAMS MR, 1995, ARTERIOSCL THROM VAS, V15, P562, DOI 10.1161/01.ATV.15.5.562; Baldo MP, 2011, PHARMACOL REP, V63, P975, DOI 10.1016/S1734-1140(11)70613-2; BARROW SE, 1986, BRIT J PHARMACOL, V87, P243, DOI 10.1111/j.1476-5381.1986.tb10177.x; Bissoli NS, 2009, PHARMACOL RES, V59, P379, DOI 10.1016/j.phrs.2009.03.001; Bourghardt J, 2010, ENDOCRINOLOGY, V151, P5428, DOI 10.1210/en.2010-0663; Bucci M, 2009, EUR UROL, V56, P378, DOI 10.1016/j.eururo.2008.05.014; Claudio ERG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064806; Deenadayalu V, 2012, AM J PHYSIOL-HEART C, V302, pH115, DOI 10.1152/ajpheart.00046.2011; dos Santos RL, 2014, HORM MOL BIOL CLIN I, V18, P89, DOI 10.1515/hmbci-2013-0048; Farhat MY, 1996, FASEB J, V10, P615, DOI 10.1096/fasebj.10.5.8621060; Feletou M, 2006, ARTERIOSCL THROM VAS, V26, P1215, DOI 10.1161/01.ATV.0000217611.81085.c5; Fischer M, 2002, CARDIOVASC RES, V53, P672, DOI 10.1016/S0008-6363(01)00479-5; FORSTERMANN U, 1993, EUR HEART J, V14, P10; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; FUSTER V, 1992, NEW ENGL J MED, V326, P310; Gomes HL, 2012, CAN J PHYSIOL PHARM, V90, P75, DOI [10.1139/Y11-102, 10.1139/y11-102]; Lee HK, 2013, WORLD J MENS HEALTH, V31, P136, DOI 10.5534/wjmh.2013.31.2.136; Liu PY, 2003, ENDOCR REV, V24, P313, DOI 10.1210/er.2003-0005; Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9; MELCHERT RB, 1995, MED SCI SPORT EXER, V27, P1252; Meyrelles SS, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-211; Michel T, 2010, PFLUG ARCH EUR J PHY, V459, P807, DOI 10.1007/s00424-009-0765-9; MOMBOULI JV, 1992, CIRC RES, V71, P137, DOI 10.1161/01.RES.71.1.137; Mosca Lori, 2007, Circulation, V115, P1481, DOI 10.1161/CIRCULATIONAHA.107.181546; Moyses MR, 2001, BRAZ J MED BIOL RES, V34, P949, DOI 10.1590/S0100-879X2001000700014; OKANE KPJ, 1994, BRIT J CLIN PHARMACO, V38, P311, DOI 10.1111/j.1365-2125.1994.tb04359.x; Ozkor MA, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/156146; Perusquia M, 2012, AM J PHYSIOL-HEART C, V298, pH1301; Puttabyatappa Y, 2013, J PHARMACOL EXP THER, V345, P7, DOI 10.1124/jpet.112.201947; Ramirez ME, 1997, METABOLISM, V46, P179, DOI 10.1016/S0026-0495(97)90299-7; Ramirez-Rosas MB, 2011, STEROIDS, V76, P409, DOI 10.1016/j.steroids.2010.12.012; Reckelhoff JF, 1999, HYPERTENSION, V34, P920, DOI 10.1161/01.HYP.34.4.920; Reckelhoff JF, 2000, HYPERTENSION, V35, P480, DOI 10.1161/01.HYP.35.1.480; SALT PJ, 1972, EUR J PHARMACOL, V20, P329, DOI 10.1016/0014-2999(72)90194-X; Santos RL, 2010, ACTA PHYSIOL, V200, P203, DOI 10.1111/j.1748-1716.2010.02140.x; Santos RL, 2004, BRAZ J MED BIOL RES, V37, P569, DOI 10.1590/S0100-879X2004000400014; Skogastierna C, 2014, EUR J PREV CARDIOL, V21, P1049, DOI 10.1177/2047487313481755; Tep-areenan P, 2002, BRIT J PHARMACOL, V135, P735, DOI 10.1038/sj.bjp.0704522; Toot JD, 2011, GENDER MED, V8, P40, DOI 10.1016/j.genm.2011.01.002; Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008; Wu FCW, 2003, ENDOCR REV, V24, P183, DOI 10.1210/er.2001-0025; Zhou P, 2008, EUR J PHARMACOL, V593, P87, DOI 10.1016/j.ejphar.2008.07.014	43	12	13	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0137111	10.1371/journal.pone.0137111	http://dx.doi.org/10.1371/journal.pone.0137111			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322637	gold, Green Published, Green Submitted			2022-12-26	WOS:000360435500066
J	Tarnawski, L; Xian, XJ; Monnerat, G; Macaulay, IC; Malan, D; Borgman, A; Wu, SM; Fleischmann, BK; Jovinge, S				Tarnawski, Laura; Xian, Xiaojie; Monnerat, Gustavo; Macaulay, Iain C.; Malan, Daniela; Borgman, Andrew; Wu, Sean M.; Fleischmann, Bernd K.; Jovinge, Stefan			Integrin Based Isolation Enables Purification of Murine Lineage Committed Cardiomyocytes	PLOS ONE			English	Article							EXPRESSION; DIFFERENTIATION; ALPHA; HEART	In contrast to mature cardiomyocytes which have limited regenerative capacity, pluripotent stem cells represent a promising source for the generation of new cardiomyocytes. The tendency of pluripotent stem cells to form teratomas and the heterogeneity fromvarious differentiation stages and cardiomyocyte cell sub-types, however, are major obstacles to overcome before this type of therapy could be applied in a clinical setting. Thus, the identification of extracellularmarkers for specific cardiomyocyte progenitors and mature subpopulations is of particular importance. The delineation of cardiomyocyte surfacemarker patterns not only serves as a means to derive homogeneous cell populations by FACS, but is also an essential tool to understand cardiac development. By using single-cell expression profiling in early mouse embryonic hearts, we found that a combination of integrin alpha-1, alpha-5, alpha-6 and N-cadherin enables isolation of lineage committed murine cardiomyocytes. Additionally, we were able to separate trabecular cardiomyocytes from solid ventricular myocardium and atrial murine cells. These cells exhibit expected subtype specific phenotype confirmed by electrophysiological analysis. We show that integrin expression can be used for the isolation of living, functional and lineage-specific murine cardiomyocytes.	[Tarnawski, Laura; Xian, Xiaojie; Jovinge, Stefan] Lund Univ, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, Lund, Sweden; [Jovinge, Stefan] Van Andel Res Inst, Grand Rapids, MI USA; [Monnerat, Gustavo; Malan, Daniela; Fleischmann, Bernd K.] Univ Bonn, Inst Physiol 1, Life & Brain Ctr, Dept Cardiac Surg, D-53115 Bonn, Germany; [Monnerat, Gustavo] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil; [Macaulay, Iain C.] Univ Oxford, Haematopoiet Stem Cell Lab, Weatherall Inst Mol Med, Oxford, England; [Wu, Sean M.] Inst Stem Cell Biol & Regenerat Med, Stanford, CA USA; [Wu, Sean M.] Stanford Cardiovasc Inst, Stanford, CA USA; [Wu, Sean M.] Stanford Univ, Dept Med, Sch Med, Div Cardiol, Stanford, CA 94305 USA; [Fleischmann, Bernd K.] Univ Bonn, Pharma Ctr Bonn, Bonn, Germany; [Borgman, Andrew; Jovinge, Stefan] Spectrum Hlth Fredrik Meijer Heart & Vasc Inst, Grand Rapids, MI USA	Lund University; Van Andel Institute; University of Bonn; Universidade Federal do Rio de Janeiro; University of Oxford; Stanford University; University of Bonn	Tarnawski, L (corresponding author), Lund Univ, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, Lund, Sweden.	laura.tarnawski@vai.org	monnerat, gustavo/E-3398-2015; Monnerat, Gustavo/J-6907-2019; Tarnawski, Laura/AAA-2254-2022; Tarnawski, Laura/ABB-1979-2020	monnerat, gustavo/0000-0002-1010-6314; Tarnawski, Laura/0000-0001-7993-0232; Wu, Sean/0000-0002-0000-3821; Macaulay, Iain/0000-0002-6761-757X	National Institutes of Health, National Heart, Lung, and Blood Institute [K08 HL081086, U01 HL009976-05]; National Institutes of Health Director's New Innovator's Award [DP2 OD004411]; Swedish Heart- and Lung Foundation; Swedish Research Council; European FP7 grant under CardioCell consortium; Richard and Hellen DeVos Foundation; German Research Foundation [FL 276/7-1/7-2]; Science without Borders program of The Brazilian National Council for Scientific and Technological Development; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL081086, F32HL009976] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [DP1LM012179] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004411] Funding Source: NIH RePORTER	National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health Director's New Innovator's Award; Swedish Heart- and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); European FP7 grant under CardioCell consortium; Richard and Hellen DeVos Foundation; German Research Foundation(German Research Foundation (DFG)); Science without Borders program of The Brazilian National Council for Scientific and Technological Development; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health, National Heart, Lung, and Blood Institute [grant number K08 HL081086, U01 HL009976-05], http://www.nih.gov/about/almanac/archive/2003/organization/NHLBI.htm, the National Institutes of Health Director's New Innovator's Award [DP2 OD004411], https://commonfund.nih.gov/newinnovator/index [to SMW], the Swedish Heart- and Lung Foundation, http://www.hjart-lungfonden.se/Om-Hjart-lungfonden/About-HLF/, the Swedish Research Council, http://www.vr.se/, the European FP7 grant under CardioCell consortium, http://ec.europa.eu/research/fp7/index_en.cfm, the Richard and Hellen DeVos Foundation, http://www.centerfornonprofitexcellence.org/grantmakers-directory/richard-and-helen-devos-foundation [to SJ], the German Research Foundation [grant number FL 276/7-1/7-2], http://www.dfg.de/en/ [toBKF], and the Science without Borders program of The Brazilian National Council for Scientific and Technological Development, http://www.cienciasemfronteiras.gov.br/web/csf-eng/ [to GM]. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, R LANG ENV STAT COMP; COLLO G, 1995, CELL ADHES COMMUN, V3, P101, DOI 10.3109/15419069509081280; Feiner L, 2001, DEVELOPMENT, V128, P3061; Henningsen A., 2013, CENSREG CENSORED REG; Hierck BP, 1996, DEV DYNAM, V206, P100, DOI 10.1002/(SICI)1097-0177(199605)206:1<100::AID-AJA9>3.0.CO;2-M; Jensen B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044231; Ji GJ, 1999, FASEB J, V13, P313, DOI 10.1096/fasebj.13.2.313; King T, 2002, DEV DYNAM, V225, P212, DOI 10.1002/dvdy.10142; Lal Hind, 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P109, DOI 10.2174/187152507780363223; Lowell CA, 2011, METHODS MOL BIOL, V757, P369, DOI 10.1007/978-1-61779-166-6_22; Luo Y, 2003, J CELL SCI, V116, P1471, DOI 10.1242/jcs.00339; Maitra N, 2000, CARDIOVASC RES, V47, P715, DOI 10.1016/S0008-6363(00)00140-1; Malan D, 2009, STEM CELLS, V27, P88, DOI 10.1634/stemcells.2008-0335; Misfeldt AM, 2009, DEV BIOL, V333, P78, DOI 10.1016/j.ydbio.2009.06.033; Moorman AFM, 2003, PHYSIOL REV, V83, P1223, DOI 10.1152/physrev.00006.2003; Morales MO, 2005, MICROSC MICROANAL, V11, P260, DOI 10.1017/S1431927605050518; Ponten A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082403; Ross RS, 2001, CIRC RES, V88, P1112, DOI 10.1161/hh1101.091862; Samsa LA, 2013, AM J MED GENET C, V163, P157, DOI 10.1002/ajmg.c.31366; Small EM, 2004, TRENDS CARDIOVAS MED, V14, P13, DOI 10.1016/j.tcm.2003.09.005; VanDusen NJ, 2012, DIFFERENTIATION, V84, DOI 10.1016/j.diff.2012.03.002; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Zammit PS, 2000, DEV DYNAM, V217, P75, DOI 10.1002/(SICI)1097-0177(200001)217:1<75::AID-DVDY7>3.0.CO;2-L	24	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0135880	10.1371/journal.pone.0135880	http://dx.doi.org/10.1371/journal.pone.0135880			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26323090	Green Published, gold, Green Submitted			2022-12-26	WOS:000360435500010
J	Zhang, YQ; Xu, Q; Alos, J; Liu, H; Xu, QZ; Yang, HS				Zhang, Yingqiu; Xu, Qiang; Alos, Josep; Liu, Hui; Xu, Qinzeng; Yang, Hongsheng			Short-Term Fidelity, Habitat Use and Vertical Movement Behavior of the Black Rockfish Sebastes schlegelii as Determined by Acoustic Telemetry	PLOS ONE			English	Article							HOME-RANGE SIZE; ARTIFICIAL REEFS; SITE FIDELITY; ACTIVITY PATTERNS; STOCK ENHANCEMENT; FISH ASSEMBLAGE; MARINE RESERVE; DIEL BEHAVIOR; ROCKY REEF; DESIGN	The recent miniaturization of acoustic tracking devices has allowed fishery managers and scientists to collect spatial and temporal data for sustainable fishery management. The spatial and temporal dimensions of fish behavior (movement and/or vertical migrations) are particularly relevant for rockfishes (Sebastes spp.) because most rockfish species are long-lived and have high site fidelity, increasing their vulnerability to overexploitation. In this study, we describe the short-term (with a tracking period of up to 46 d) spatial behavior, as determined by acoustic tracking, of the black rockfish Sebastes schlegelii, a species subject to overexploitation in the Yellow Sea of China. The average residence index (the ratio of detected days to the total period from release to the last detection) in the study area was 0.92 +/- 0.13, and most of the tagged fish were detected by only one region of the acoustic receiver array, suggesting relatively high site fidelity to the study area. Acoustic tracking also suggested that this species is more frequently detected during the day than at night in our study area. However, the diel detection periodicity (24 h) was only evident for certain periods of the tracking time, as revealed by a continuous wavelet transform. The habitat selection index of tagged S. schlegelii suggested that S. schlegelii preferred natural reefs, mixed sand/artificial reef bottoms and mixed bottoms of boulder, cobble, gravel and artificial reefs. The preference of this species for the artificial reefs that were recently deployed in the study area suggests that artificial seascapes may be effective management tools to attract individuals. The vertical movement of tagged S. schlegelii was mostly characterized by bottom dwelling behavior, and there was high individual variability in the vertical migration pattern. Our results have important implications for S. schlegelii catchability, the implementation of marine protected areas, and the identification of key species habitats, and our study provides novel information for future studies on the sustainability of this important marine resource in eastern China.	[Zhang, Yingqiu; Xu, Qiang; Liu, Hui; Xu, Qinzeng; Yang, Hongsheng] Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China; [Zhang, Yingqiu; Liu, Hui] Univ Chinese Acad Sci, Beijing, Peoples R China; [Alos, Josep] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Biol & Ecol Fishes, Berlin, Germany	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB)	Xu, Q (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China.	xuqiangcas@126.com; hshyang@qdio.ac.cn		Alos, Josep/0000-0003-4385-9539	Ministry of Sciences and Technology of the People's Republic of China [2011BAD13B02]; State Oceanic Administration People's Republic of China [201205023, 201305043]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA11020404]; Marie Curie Post-Doc grant (FP7-PEOPLE-IEF) [327160]	Ministry of Sciences and Technology of the People's Republic of China(Ministry of Science and Technology, China); State Oceanic Administration People's Republic of China; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Marie Curie Post-Doc grant (FP7-PEOPLE-IEF)	HY was supported through the National Key Technology Research and Development Program (grant no. 2011BAD13B02) provided by Ministry of Sciences and Technology of the People's Republic of China (URL: http://www.most.gov.cn/eng/), the Non-Profit Marine Sector (grant no. 201205023, 201305043) provided by State Oceanic Administration People's Republic of China (URL: http://www.soa.gov.cn/english/) and the Strategic Priority Research Program of the Chinese Academy of Sciences (grant no. XDA11020404) provided by Chinese Academy of Sciences (URL: http://english.cas.cn/). JA was supported through a Marie Curie Post-Doc grant (FP7-PEOPLE-2012-IEF, grant no. 327160). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis D, 2008, ESTUAR COAST SHELF S, V79, P758, DOI 10.1016/j.ecss.2008.06.019; Abernethy KE, 2007, CAN J FISH AQUAT SCI, V64, P1595, DOI 10.1139/F07-125; Addis DT, 2013, FISH RES, V147, P349, DOI 10.1016/j.fishres.2013.07.011; Aho K, 2014, ECOLOGY, V95, P631, DOI 10.1890/13-1452.1; Alos J, 2012, MAR ECOL PROG SER, V460, P207, DOI 10.3354/meps09755; Alos J, 2012, J APPL ICHTHYOL, V28, P606, DOI 10.1111/j.1439-0426.2012.01955.x; Alos J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048030; Alos J, 2011, MAR ECOL PROG SER, V427, P173, DOI 10.3354/meps09042; Arena PT, 2007, HYDROBIOLOGIA, V580, P157, DOI 10.1007/s10750-006-0456-x; Baine M, 2001, OCEAN COAST MANAGE, V44, P241, DOI 10.1016/S0964-5691(01)00048-5; Baskett ML, 2006, CAN J FISH AQUAT SCI, V63, P1214, DOI 10.1139/F06-013; Bertrand S, 2004, ICES J MAR SCI, V61, P1127, DOI 10.1016/j.icesjms.2004.07.016; Bertrand S, 2007, ECOL APPL, V17, P331, DOI 10.1890/06-0303; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Botsford LW, 2009, REV FISH BIOL FISHER, V19, P69, DOI 10.1007/s11160-008-9092-z; Botsford LW, 2003, ECOL APPL, V13, pS25; Bridger CJ, 2003, REV FISH SCI, V11, P13, DOI 10.1080/16226510390856510; Cabanellas-Reboredo M, 2014, ICES J MAR SCI, V71, P1760, DOI 10.1093/icesjms/fst206; Carr MH, 1997, FISHERIES, V22, P28, DOI 10.1577/1548-8446(1997)022<0028:ARTIOC>2.0.CO;2; Chin BS, 2013, REV FISH SCI, V21, P286, DOI 10.1080/10641262.2013.837364; Chin BS, 2010, ICHTHYOL RES, V57, P278, DOI 10.1007/s10228-010-0165-3; Claisse JT, 2014, P NATL ACAD SCI USA, V111, P15462, DOI 10.1073/pnas.1411477111; Clements S, 2005, N AM J FISH MANAGE, V25, P429, DOI 10.1577/M03-224.1; Conrad JL, 2011, J FISH BIOL, V78, P395, DOI 10.1111/j.1095-8649.2010.02874.x; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; Crook DA, 2004, J FISH BIOL, V64, P258, DOI 10.1111/j.1095-8649.2004.00282.x; Deegan LA, 2005, DECLINE FISHERIES RE, P67; Ding Z, 2007, RIZHAO QIANSAN ISLET; Espinoza M, 2011, FISH RES, V108, P364, DOI 10.1016/j.fishres.2011.01.011; Farmer NA, 2013, MOV ECOL, V1, DOI 10.1186/2051-3933-1-7; Garcia-Charton JA, 2001, MAR BIOL, V138, P917, DOI 10.1007/s002270000524; Gaucherel C., 2011, Computational Ecology and Software, V1, P69; Gauthier S, 2002, J FISH BIOL, V61, P1135, DOI 10.1006/jfbi.2002.2128; [龚政 Gong Zheng], 2002, [河海大学学报. 自然科学版, Journal of Hohai University. Natural Sciences], V30, P5; Green KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098976; Green KM, 2011, MAR ECOL PROG SER, V436, P219, DOI 10.3354/meps09263; Greene HG, 2011, CONT SHELF RES, V31, pS39, DOI 10.1016/j.csr.2010.11.004; Hannah RW, 2011, N AM J FISH MANAGE, V31, P483, DOI 10.1080/02755947.2011.591239; Hart TD, 2010, FISH B-NOAA, V108, P466; Heupel MR, 2006, MAR FRESHWATER RES, V57, P1, DOI 10.1071/MF05091; Heupel MR, 2005, MAR TECHNOL SOC J, V39, P10, DOI 10.4031/002533205787521749; HILBORN R, 1992; How JR, 2012, MAR FRESHWATER RES, V63, P312, DOI 10.1071/MF11194; Jadot C, 2006, ICES J MAR SCI, V63, P128, DOI 10.1016/j.icesjms.2005.06.010; Jenkins JA, 2014, FISHERIES, V39, P415, DOI 10.1080/03632415.2014.924408; Jorgensen SJ, 2006, MAR ECOL PROG SER, V327, P157, DOI 10.3354/meps327157; Kang K.M., 2006, FISH AQUAT SCI, V9, P91, DOI DOI 10.5657/FAS.2006.9.2.091; Koeck B, 2014, MAR ENVIRON RES, V94, P38, DOI 10.1016/j.marenvres.2013.12.002; Koeck B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069303; Kramer DL, 1999, ENVIRON BIOL FISH, V55, P65, DOI 10.1023/A:1007481206399; KRIEGER KJ, 1993, FISH B-NOAA, V91, P87; Leitao F, 2009, FISHERIES MANAG ECOL, V16, P88, DOI 10.1111/j.1365-2400.2008.00646.x; Levin PS, 2006, CONSERV BIOL, V20, P1181, DOI 10.1111/j.1523-1739.2006.00400.x; Li L, 2012, RIZHAO QIANSAN ISLAN; Linden A, 2011, ECOLOGY, V92, P1414, DOI 10.1890/10-1831.1; Liu H, 2015, CHIN J OCEANOL LIMN, V33, P107, DOI 10.1007/s00343-015-4049-2; Liu Lan, 2012, Marine Environmental Science, V31, P918; Lorenzen K, 2010, B MAR SCI, V86, P169; Lu HJ, 2014, CHIN J OCEANOL LIMN, V32, P810, DOI 10.1007/s00343-014-3252-x; Magnuson-Ford K, 2009, BIOL CONSERV, V142, P1787, DOI 10.1016/j.biocon.2009.03.020; Maraun D, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.016707; March D, 2010, MAR ECOL PROG SER, V400, P195, DOI 10.3354/meps08410; MELLAS EJ, 1985, CAN J FISH AQUAT SCI, V42, P488, DOI 10.1139/f85-066; Meyer CG, 2007, MAR ECOL PROG SER, V333, P13, DOI 10.3354/meps333013; Mitamura H, 2009, FISHERIES SCI, V75, P1133, DOI 10.1007/s12562-009-0142-9; Mittelbach GG, 2014, CAN J FISH AQUAT SCI, V71, P927, DOI 10.1139/cjfas-2013-0558; Mullon C, 2005, FISH FISH, V6, P111, DOI 10.1111/j.1467-2979.2005.00181.x; Myers RA, 2005, PHILOS T R SOC B, V360, P13, DOI 10.1098/rstb.2004.1573; Nakagawa M, 2007, AQUACULTURE, V263, P295, DOI 10.1016/j.aquaculture.2006.10.023; Nakagawa Masahiro, 2008, Bulletin of Fisheries Research Agency, P223; NMFS, 2008, PREL SCI CONCL REV S; Olsen EM, 2012, ECOL EVOL, V2, P1549, DOI 10.1002/ece3.244; Padman L, 2005, TIDE MODEL DRIVER TM; Parker SJ, 2008, AQUAT BIOL, V2, P57, DOI 10.3354/ab00036; Parker SJ, 2000, FISHERIES, V25, P22, DOI 10.1577/1548-8446(2000)025<0022:MOPR>2.0.CO;2; Parkinson EA, 2004, CAN J FISH AQUAT SCI, V61, P1658, DOI 10.1139/F04-101; Parsons D, 2005, MAR TECHNOL SOC J, V39, P56, DOI 10.4031/002533205787521703; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pauly D, 2003, SCIENCE, V302, P1359, DOI 10.1126/science.1088667; Payne NL, 2010, MAR ECOL PROG SER, V419, P295, DOI 10.3354/meps08864; Pedersen MW, 2013, METHODS ECOL EVOL, V4, P920, DOI 10.1111/2041-210X.12086; Percival D. B., 2000, COMMUNICATIONS STAT, V10, P594; Post JR, 2008, ECOL APPL, V18, P1038, DOI 10.1890/07-0465.1; Reynolds BF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012130; Rilov G, 1998, MAR ENVIRON RES, V45, P431, DOI 10.1016/S0141-1136(98)00106-8; Rilov G, 2000, MAR BIOL, V136, P931, DOI 10.1007/s002279900250; Simpfendorfer CA, 2002, CAN J FISH AQUAT SCI, V59, P23, DOI 10.1139/F01-191; Simpfendorfer CA, 2008, CAN J FISH AQUAT SCI, V65, P482, DOI 10.1139/F07-180; Stanley RD, 1999, FISH B-NOAA, V97, P320; Starr RM, 2002, FISH B-NOAA, V100, P324; Sun L, 2010, EVALUATION ARTIFICIA; Syc TS, 2012, FISH B-NOAA, V110, P458; Topping DT, 2005, MAR BIOL, V147, P301, DOI 10.1007/s00227-005-1573-1; Villegas-Rios D, 2013, J SEA RES, V80, P61, DOI 10.1016/j.seares.2013.02.009; Williams GD, 2010, MAR POLICY, V34, P1010, DOI 10.1016/j.marpol.2010.02.008; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; [谢飞 XIE Fei], 2007, [河海大学学报. 自然科学版, Journal of Hohai University. Natural Sciences], V35, P718; Xu BD, 2005, FISH RES, V71, P79, DOI 10.1016/j.fishres.2004.07.011; Zuur Alain F., 2009, P1	100	118	120	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0134381	10.1371/journal.pone.0134381	http://dx.doi.org/10.1371/journal.pone.0134381			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322604	Green Published, gold			2022-12-26	WOS:000360435500001
J	Aylward, FO; Khadempour, L; Tremmel, DM; McDonald, BR; Nicora, CD; Wu, S; Moore, RJ; Orton, DJ; Monroe, ME; Piehowski, PD; Purvine, SO; Smith, RD; Lipton, MS; Burnum-Johnson, KE; Currie, CR				Aylward, Frank O.; Khadempour, Lily; Tremmel, Daniel M.; McDonald, Bradon R.; Nicora, Carrie D.; Wu, Si; Moore, Ronald J.; Orton, Daniel J.; Monroe, Matthew E.; Piehowski, Paul D.; Purvine, Samuel O.; Smith, Richard D.; Lipton, Mary S.; Burnum-Johnson, Kristin E.; Currie, Cameron R.			Enrichment and Broad Representation of Plant Biomass-Degrading Enzymes in the Specialized Hyphal Swellings of Leucoagaricus gongylophorus, the Fungal Symbiont of Leaf-Cutter Ants	PLOS ONE			English	Article							ARYL-ALCOHOL OXIDASE; CUTTING ANTS; FECAL PROTEINASES; GROWING ANT; ATTA-TEXANA; DEGRADATION; CELLULOSE; DATABASE; GARDENS	Leaf-cutter ants are prolific and conspicuous constituents of Neotropical ecosystems that derive energy from specialized fungus gardens they cultivate using prodigious amounts of foliar biomass. The basidiomycetous cultivar of the ants, Leucoagaricus gongylophorus, produces specialized hyphal swellings called gongylidia that serve as the primary food source of ant colonies. Gongylidia also contain plant biomass-degrading enzymes that become concentrated in ant digestive tracts and are deposited within fecal droplets onto fresh foliar material as ants incorporate it into the fungus garden. Although the enzymes concentrated by L. gongylophorus within gongylidia are thought to be critical to the initial degradation of plant biomass, only a few enzymes present in these hyphal swellings have been identified. Here we use proteomic methods to identify proteins present in the gongylidia of three Atta cephalotes colonies. Our results demonstrate that a diverse but consistent set of enzymes is present in gongylidia, including numerous plant biomass-degrading enzymes likely involved in the degradation of polysaccharides, plant toxins, and proteins. Overall, gongylidia contained over three quarters of all biomass-degrading enzymes identified in the L. gongylophorus genome, demonstrating that the majority of the enzymes produced by this fungus for biomass breakdown are ingested by the ants. We also identify a set of 40 of these enzymes enriched in gongylidia compared to whole fungus garden samples, suggesting that certain enzymes may be particularly important in the initial degradation of foliar material. Our work sheds light on the complex interplay between leaf-cutter ants and their fungal symbiont that allows for the host insects to occupy an herbivorous niche by indirectly deriving energy from plant biomass.	[Aylward, Frank O.; Khadempour, Lily; Tremmel, Daniel M.; McDonald, Bradon R.; Currie, Cameron R.] Univ Wisconson Madison, Dept Bacteriol, Madison, WI USA; [Aylward, Frank O.; Khadempour, Lily; Tremmel, Daniel M.; McDonald, Bradon R.; Currie, Cameron R.] Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Madison, WI USA; [Nicora, Carrie D.; Wu, Si; Moore, Ronald J.; Orton, Daniel J.; Monroe, Matthew E.; Piehowski, Paul D.; Purvine, Samuel O.; Smith, Richard D.; Lipton, Mary S.; Burnum-Johnson, Kristin E.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA	United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Aylward, FO (corresponding author), Univ Hawaii Manoa, Ctr Microbial Oceanog Res & Educ, Honolulu, HI 96822 USA.	faylward@hawaii.edu; currie@bact.wisc.edu	Lipton, Mary S/H-3913-2012; Piehowski, Paul D/AAH-5497-2019; Monroe, Matthew/L-1157-2019; Smith, Richard D/J-3664-2012; Burnum, Kristin E/B-1308-2011; Purvine, Samuel O/O-3358-2017	Piehowski, Paul D/0000-0001-5108-2227; Smith, Richard D/0000-0002-2381-2349; Burnum, Kristin E/0000-0002-2722-4149; Purvine, Samuel O/0000-0002-2257-2400; Orton, Daniel/0000-0002-0253-6859; Aylward, Frank/0000-0002-1279-4050; Tremmel, Daniel/0000-0002-1725-5582; McDonald, Bradon/0000-0002-6150-8735	U.S. Department of Energy (DOE), Office of Biological and Environmental Research, Genomic Science Program under the Pacific Northwest National Laboratory (PNNL) Pan-omics Program; DOE [DE-AC05-76RLO01830]; National Science Foundation [DEB-0747002, MCB-0702025, MCB-0731822]; DOE Great Lakes Bioenergy Research Center (DOE Office of Science) [BER DE-FC02-07ER64494]; Division Of Environmental Biology [0747002] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215] Funding Source: NIH RePORTER	U.S. Department of Energy (DOE), Office of Biological and Environmental Research, Genomic Science Program under the Pacific Northwest National Laboratory (PNNL) Pan-omics Program(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); DOE Great Lakes Bioenergy Research Center (DOE Office of Science)(United States Department of Energy (DOE)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Proteomics measurements were supported by the U.S. Department of Energy (DOE), Office of Biological and Environmental Research, Genomic Science Program under the Pacific Northwest National Laboratory (PNNL) Pan-omics Program, and were performed in the Environmental Molecular Science Laboratory, a U.S. DOE national scientific user facility at PNNL in Richland, WA. Battelle operates PNNL for the DOE under contract DE-AC05-76RLO01830. This work was also supported by National Science Foundation grants DEB-0747002, MCB-0702025, and MCB-0731822 to CRC and the DOE Great Lakes Bioenergy Research Center (DOE Office of Science BER DE-FC02-07ER64494).	Abril AB, 2002, ECOL LETT, V5, P325, DOI 10.1046/j.1461-0248.2002.00327.x; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Aylward FO, 2014, MBIO, V5, DOI 10.1128/mBio.02077-14; Aylward FO, 2013, APPL ENVIRON MICROB, V79, P3770, DOI 10.1128/AEM.03833-12; Aylward FO, 2012, ISME J, V6, P1688, DOI 10.1038/ismej.2012.10; Aylward Frank O., 2012, Insects, V3, P41, DOI 10.3390/insects3010041; BACCI M, 1995, ANTON LEEUW INT J G, V67, P385, DOI 10.1007/BF00872939; Barrasa JM, 1998, APPL ENVIRON MICROB, V64, P325; BASS M, 1995, PHYSIOL ENTOMOL, V20, P1, DOI 10.1111/j.1365-3032.1995.tb00793.x; Belt Thomas, 1911, NATURALIST NICARAGUA; Borodovsky M, 2002, CURRENT PROTOCOLS BI; BOYD ND, 1975, INSECT BIOCHEM, V5, P619, DOI 10.1016/0020-1790(75)90043-8; BOYD ND, 1975, J INSECT PHYSIOL, V21, P1815, DOI 10.1016/0022-1910(75)90247-4; CHAPELA IH, 1994, SCIENCE, V266, P1691, DOI 10.1126/science.266.5191.1691; Cherrett J.M., 1989, P93; Costa AN, 2008, J VEG SCI, V19, P849, DOI 10.3170/2008-8-18461; Currie CR, 2001, P ROY SOC B-BIOL SCI, V268, P1033, DOI 10.1098/rspb.2001.1605; De Siqueira CG, 1998, APPL ENVIRON MICROB, V64, P4820; Fernandez-Marin H, 2007, INSECT SOC, V54, P64, DOI 10.1007/s00040-007-0907-z; Fernandez-Marin H, 2009, P ROY SOC B-BIOL SCI, V276, P2263, DOI 10.1098/rspb.2009.0184; Frith MC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-80; Grell MN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-928; Holldobler B., 2009, SUPERORGANISM; Huang EL, 2014, ENV MICROBIOL REP, V6, P389, DOI 10.1111/1758-2229.12163; Kelly RT, 2006, ANAL CHEM, V78, P7796, DOI 10.1021/ac061133r; Kim S, 2008, J PROTEOME RES, V7, P3354, DOI 10.1021/pr8001244; Kooij PW, 2011, INSECT SOC, V58, P145, DOI 10.1007/s00040-010-0127-9; Lange L, 2014, APPL MICROBIOL BIOT, V98, P4839, DOI 10.1007/s00253-014-5708-5; Levasseur A, 2008, FUNGAL GENET BIOL, V45, P638, DOI 10.1016/j.fgb.2008.01.004; Licht HHD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6675; Licht HHDF, 2013, P NATL ACAD SCI USA, V110, P583, DOI 10.1073/pnas.1212709110; Licht HHD, 2010, EVOLUTION, V64, P2055, DOI 10.1111/j.1558-5646.2010.00948.x; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Maiolica A, 2005, PROTEOMICS, V5, P3847, DOI 10.1002/pmic.200402010; MARTIN MM, 1969, ANN ENTOMOL SOC AM, V62, P1386, DOI 10.1093/aesa/62.6.1386; MARTIN MM, 1975, J INSECT PHYSIOL, V21, P1887, DOI 10.1016/0022-1910(75)90219-X; MARTIN MM, 1976, COMP BIOCHEM PHYS A, V53, P331, DOI 10.1016/S0300-9629(76)80150-8; Moller IE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017506; MUHEIM A, 1990, ENZYME MICROB TECH, V12, P204, DOI 10.1016/0141-0229(90)90039-S; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Piehowski PD, 2013, PROTEOMICS, V13, P766, DOI 10.1002/pmic.201200096; R Core Team, 2021, R LANGUAGE ENV STAT; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Rodrigues A, 2008, MICROB ECOL, V56, P604, DOI 10.1007/s00248-008-9380-0; Rodrigues A, 2005, FOLIA MICROBIOL, V50, P421, DOI 10.1007/BF02931424; Ronhede S, 2004, MYCOL RES, V108, P101, DOI 10.1017/S0953756203008931; Schiott M, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-156; Scott JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009922; Semenova TA, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-15; Suen G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002007; Suen G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001129; WEBER NA, 1966, SCIENCE, V153, P587, DOI 10.1126/science.153.3736.587	52	18	19	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0134752	10.1371/journal.pone.0134752	http://dx.doi.org/10.1371/journal.pone.0134752			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317212	Green Published, Green Submitted, gold			2022-12-26	WOS:000360299100018
J	Bonney, A; Mayne, DJ; Jones, BD; Bott, L; Andersen, SEJ; Caputi, P; Weston, KM; Iverson, DC				Bonney, Andrew; Mayne, Darren J.; Jones, Bryan D.; Bott, Lawrence; Andersen, Stephen E. J.; Caputi, Peter; Weston, Kathryn M.; Iverson, Don C.			Area-Level Socioeconomic Gradients in Overweight and Obesity in a Community-Derived Cohort of Health Service Users - A Cross-Sectional Study	PLOS ONE			English	Article							BODY-MASS INDEX; EDUCATION; WEIGHT; WOMEN	Background Overweight and obesity lead to higher probability of individuals accessing primary care but adiposity estimates are rarely available at regional levels to inform health service planning. This paper analyses a large, community-derived clinical database of objectively measured body mass index (BMI) to explore relationships with area-level socioeconomic disadvantage for informing regional level planning activities. Materials and Methods The study included 91776 adults who had BMI objectively measured between 1 July 2009 and 30 June 2011 by a single pathology provider. Demographic data and BMI were extracted and matched to 2006 national census socioeconomic data using geocoding. Adjusted odds-ratios for overweight and obesity were calculated using sex-stratified logistic regression models with socioeconomic disadvantage of census collection district of residence as the independent variable. Results The prevalence of overweight or obesity was 79.2%(males) and 65.8%(females); increased with age to 74 years; and was higher in rural (74%) versus urban areas (71.4%) (p<0.001). Increasing socioeconomic disadvantage was associated with increasing prevalence of overweight (p<0.0001), obesity (p<0.0001) and overweight or obesity (p<0.0001) in women and obesity (p<0.0001) in men. Socioeconomic disadvantage was unrelated to overweight (p = 0.2024) and overweight or obesity (p = 0.4896) in males. Conclusion It is feasible to link routinely-collected clinical data, representative of a discrete population, with geographic distribution of disadvantage, and to obtain meaningful area-level information useful for targeting interventions to improve population health. Our results demonstrate novel area-level socioeconomic gradients in overweight and obesity relevant to regional health service planning.	[Bonney, Andrew; Andersen, Stephen E. J.; Weston, Kathryn M.] Univ Wollongong, Grad Sch Med, Wollongong, NSW 2522, Australia; [Mayne, Darren J.] Illawarra Shoalhaven Local Hlth Dist, Publ Hlth, Wollongong, NSW 2500, Australia; [Mayne, Darren J.] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia; [Mayne, Darren J.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Jones, Bryan D.] Sonic Healthcare Ltd, N Ryde, NSW 2113, Australia; [Bott, Lawrence; Andersen, Stephen E. J.] Southern IML Pathol, Wollongong, NSW 2500, Australia; [Caputi, Peter] Univ Wollongong, Ctr Hlth Initiat, Wollongong, NSW 2522, Australia; [Iverson, Don C.] Swinburne Univ Technol, Fac Hlth Arts & Design, Hawthorn, Vic 3122, Australia	University of Wollongong; University of Wollongong; University of Sydney; University of Wollongong; Swinburne University of Technology	Weston, KM (corresponding author), Univ Wollongong, Grad Sch Med, Wollongong, NSW 2522, Australia.	kathw@uow.edu.au	Bonney, Andrew/Y-5212-2019	Bonney, Andrew/0000-0003-2477-1646; Mayne, Darren/0000-0002-9370-3463	Sonic Healthcare; Southern; IML Pathology	Sonic Healthcare; Southern; IML Pathology	Three authors (BDJ, LB, SEJA) are affiliated with Sonic Healthcare or its subsidiary, Southern. IML Pathology. BDJ is Manager in information technology at Sonic Healthcare; LB is Chief Executive Officer at Southern. IML Pathology Ltd; SEJA is Consultant Pathologist at Southern. IML Pathology Ltd. The funding organisations, Sonic Healthcare and Southern. IML Pathology, provided support in the form of salaries for authors BDJ, LB and SEJA and access to the data, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Australian Bureau of Statistics, 2012, AUSTR HLTH SURV 1 RE; Australian Bureau of Statistics, 2013, MAPP SEIFA; Australian Bureau of Statistics, 2011, CENS DICT 2006 REISS; Australian Bureau of Statistics, 2013, IND REL SOC DIS; Australian Bureau of Statistics, 2011, POP AG SEX REG AUSTR; Australian Bureau of Statistics, 2014, REM STRUCT; Australian Bureau of Statistics, 2014, 2006 CENS DAT; Ball K, 2012, INT J OBESITY, V36, P855, DOI 10.1038/ijo.2011.183; Ball K, 2005, SOC SCI MED, V60, P1987, DOI 10.1016/j.socscimed.2004.08.056; Barr M, 2008, NSW POPULATION HLTH, V2; Bazemore A, 2010, J AM BOARD FAM MED, V23, P22, DOI 10.3122/jabfm.2010.01.090097; Brennan SL, 2010, J MENS HEALTH, V7, P31, DOI 10.1016/j.jomh.2009.10.004; Brown A, 2007, PUBLIC HEALTH, V121, P603, DOI 10.1016/j.puhe.2007.01.008; Butler DC, 2010, AUST J RURAL HEALTH, V18, P199, DOI 10.1111/j.1440-1584.2010.01154.x; CRIQUI MH, 1979, AM J EPIDEMIOL, V109, P394, DOI 10.1093/oxfordjournals.aje.a112695; Doherty E, 2012, ECON SOC REV, V43, P227; Drewnowski A, 2007, SOC SCI MED, V65, P2458, DOI 10.1016/j.socscimed.2007.07.001; El-Sayed AM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-18; Gill T, 2010, STATE KNOWLEDGE ASSE; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Hoad V, 2010, AUST NZ J PUBL HEAL, V34, P214, DOI 10.1111/j.1753-6405.2010.00509.x; IOM (Institute of Medicine), 2012, PRIM CAR PUBL HLTH E; Keegan THM, 2012, AM J PUBLIC HEALTH, V102, P689, DOI 10.2105/AJPH.2011.300150; Kifle T, 2012, INT J PUBLIC HEALTH, V57, P135, DOI 10.1007/s00038-011-0288-y; King T, 2006, INT J OBESITY, V30, P281, DOI 10.1038/sj.ijo.0803176; Kopelman P, 2007, OBES REV, V8, P13, DOI 10.1111/j.1467-789X.2007.00311.x; Littenberg Benjamin, 2006, BMC Med Res Methodol, V6, P20, DOI 10.1186/1471-2288-6-20; Markwick A, 2013, AUST NZ J PUBL HEAL, V37, P32, DOI 10.1111/1753-6405.12007; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Mealing NM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-26; Mobley LR, 2004, J WOMENS HEALTH, V13, P519, DOI 10.1089/1540999041281034; Peeters A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003667; Rajgopal R, 2002, J NUTR EDUC BEHAV, V34, P26, DOI 10.1016/S1499-4046(06)60225-X; Roth C, 2014, BMC MED INFORM DECIS, V14, DOI 10.1186/1472-6947-14-36; Roth C, 2013, STUD HEALTH TECHNOL, V192, P1100, DOI 10.3233/978-1-61499-289-9-1100; Springer KW, 2011, J HEALTH SOC BEHAV, V52, P212, DOI 10.1177/0022146510393972; WHO, 2010, GLOB STAT REP NONC D; Williams LK, 2013, AM J HEALTH PROMOT, V28, P59, DOI 10.4278/ajhp.120316-QUAN-143; World Health Organization, 2014, BMI CLASS GLOB DAT B	39	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137261	10.1371/journal.pone.0137261	http://dx.doi.org/10.1371/journal.pone.0137261			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ0PO	26317861	Green Published, gold, Green Submitted			2022-12-26	WOS:000360299100216
J	Boothalingam, S; Allan, C; Allen, P; Purcell, D				Boothalingam, Sriram; Allan, Chris; Allen, Prudence; Purcell, David			Cochlear Delay and Medial Olivocochlear Functioning in Children with Suspected Auditory Processing Disorder	PLOS ONE			English	Article							STIMULUS-FREQUENCY; OTOACOUSTIC EMISSIONS; EFFERENT REFLEX; FILTER SHAPES; TUNING CURVES; HUMAN ADULTS; HUMANS; HEARING; SUPPRESSION; SPEECH	Behavioral manifestations of processing deficits associated with auditory processing disorder (APD) have been well documented. However, little is known about their anatomical underpinnings, especially cochlear processing. Cochlear delays, a proxy for cochlear tuning, measured using stimulus frequency otoacoustic emission (SFOAE) group delay, and the influence of the medial olivocochlear (MOC) system activation at the auditory periphery was studied in 23 children suspected with APD (sAPD) and 22 typically developing (TD) children. Results suggest that children suspected with APD have longer SFOAE group delays (possibly due to sharper cochlear tuning) and reduced MOC function compared to TD children. Other differences between the groups include correlation between MOC function and SFOAE delay in quiet in the TD group, and lack thereof in the sAPD group. MOC-mediated changes in SFOAE delay were in opposite directions between groups: increase in delay in TD vs. reduction in delay in the sAPD group. Longer SFOAE group delays in the sAPD group may lead to longer cochlear filter ringing, and potential increase in forward masking. These results indicate differences in cochlear and MOC function between sAPD and TD groups. Further studies are warranted to explore the possibility of cochlea as a potential site for processing deficits in APD.	[Boothalingam, Sriram; Allan, Chris; Allen, Prudence; Purcell, David] Univ Western Ontario, Natl Ctr Audiol, London, ON, Canada; [Allen, Prudence; Purcell, David] Univ Western Ontario, Sch Commun Sci & Disorders, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Boothalingam, S (corresponding author), Northwestern Univ, Roxelyn & Richard Pepper Dept Commun Sci & Disord, Evanston, IL 60208 USA.	sriram@northwestern.edu		Boothalingam, Sriram/0000-0003-3901-3071	Western Graduate Research Scholarship; Natural Sciences and Engineering Research Council of Canada [RGPIN-05320-2007]; Ontario Research Fund (LEF) [RE-03009]; Canada Foundation for Innovation (CFI) [11419]	Western Graduate Research Scholarship; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Research Fund (LEF); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation)	This work was supported by Western Graduate Research Scholarship (S.B.); Natural Sciences and Engineering Research Council of Canada (RGPIN-05320-2007) (D.P.); Ontario Research Fund (LEF#RE-03009) (National Centre for Audiology); and Canada Foundation for Innovation (CFI#11419) (National Centre for Audiology).	AAA, 2010, AM AC AUD CLIN PRACT; Abdala C, 2003, J ACOUST SOC AM, V114, P932, DOI 10.1121/1.1590973; Abdala C, 1996, HEARING RES, V98, P38, DOI 10.1016/0378-5955(96)00046-9; Abdala C, 2000, J ACOUST SOC AM, V107, P446, DOI 10.1121/1.428315; Abdala C, 2013, J ACOUST SOC AM, V133, P938, DOI 10.1121/1.4773265; Abdala C, 2012, JARO-J ASSOC RES OTO, V13, P403, DOI 10.1007/s10162-012-0319-2; Abrams DA, 2009, J NEUROSCI, V29, P7686, DOI 10.1523/JNEUROSCI.5242-08.2009; Allen P, 2014, INT J PEDIATR OTORHI, V78, P198, DOI 10.1016/j.ijporl.2013.10.048; ASHA American Speech-Language-Hearing Association, 2005, CENTR AUD PROC DIS, DOI 10.1044/policy.TR2005-00043; Backus BC, 2006, J ACOUST SOC AM, V119, P2889, DOI 10.1121/1.2169918; Badri R, 2011, J ACOUST SOC AM, V129, P852, DOI 10.1121/1.3523476; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergevin C, 2008, J COMP PHYSIOL A, V194, P665, DOI 10.1007/s00359-008-0338-y; Bhagat SP, 2014, NEUROSCI LETT, V559, P132, DOI 10.1016/j.neulet.2013.11.059; Boothalingam S, 2015, J ACOUST SOC AM, V137, P724, DOI 10.1121/1.4906250; Boothalingam S, 2014, NEUROSCI LETT, V580, P56, DOI 10.1016/j.neulet.2014.07.048; Boothalingam S, 2012, INT J AUDIOL, V51, P892, DOI 10.3109/14992027.2012.709641; Butler BE, 2011, INT J AUDIOL, V50, P530, DOI 10.3109/14992027.2011.582167; Chermak G D, 1999, J Am Acad Audiol, V10, P289; Clarke EM, 2006, EAR HEARING, V27, P153, DOI 10.1097/01.aud.0000204311.73871.41; Dhar S, 2009, CLIN NEUROPHYSIOL, V120, P959, DOI 10.1016/j.clinph.2009.02.172; Don M, 1998, J ACOUST SOC AM, V104, P2280, DOI 10.1121/1.423741; Dragicevic CD, 2015, JARO-J ASSOC RES OTO, V16, P223, DOI 10.1007/s10162-015-0509-9; Dubno JR, 2003, J ACOUST SOC AM, V113, P2084, DOI 10.1121/1.1555611; Feeney MP, 1999, J SPEECH LANG HEAR R, V42, P1029, DOI 10.1044/jslhr.4205.1029; FESTEN JM, 1983, J ACOUST SOC AM, V73, P652, DOI 10.1121/1.388957; Francis NA, 2010, HEARING RES, V267, P36, DOI 10.1016/j.heares.2010.04.009; Garinis AC, 2008, INT J AUDIOL, V47, P607, DOI 10.1080/14992020802129402; GLASBERG BR, 1986, J ACOUST SOC AM, V79, P1020, DOI 10.1121/1.393374; GUINAN JJ, 1988, HEARING RES, V33, P97, DOI 10.1016/0378-5955(88)90023-8; Guinan JJ, 2003, JARO-J ASSOC RES OTO, V4, P521, DOI 10.1007/s10162-002-3037-3; Guinan JJ, 1990, MECH BIOPHYSICS HEAR, P170; Guinan JJ, 2006, EAR HEARING, V27, P589, DOI 10.1097/01.aud.0000240507.83072.e7; Hamilton S., 2007, ANALOG ELECT COMPANI; Hornickel J, 2013, J NEUROSCI, V33, P3500, DOI 10.1523/JNEUROSCI.4205-12.2013; Ivey R.G., 1969, TESTS CNS FUNCTION; Katz J., 1998, STAGGERED SPONDAIC W, Vfifth; Moore BCJ, 2003, OTOL NEUROTOL, V24, P243, DOI 10.1097/00129492-200303000-00019; Moore D.R., 2006, AUDIOLOGICAL MED, V4, P4, DOI [DOI 10.1080/16513860600568573, 10.1080/16513860600568573]; Moore DR, 2007, J COMMUN DISORD, V40, P295, DOI 10.1016/j.jcomdis.2007.03.005; Moore DR, 2010, PEDIATRICS, V126, pE382, DOI 10.1542/peds.2009-2826; Muchnik C, 2004, AUDIOL NEURO-OTOL, V9, P107, DOI 10.1159/000076001; Oppenhiem AV, 1997, SIGNALS SYSTEMS; PATTERSON RD, 1982, J ACOUST SOC AM, V72, P1788, DOI 10.1121/1.388652; Pinheiro M. L., 1977, CENTRAL AUDITORY DYS, P43; Purdy Suzanne C, 2002, J Am Acad Audiol, V13, P367; Quaranta N, 2005, ACTA OTO-LARYNGOL, V125, P520, DOI 10.1080/00016480510026214; Ruggero MA, 1997, J ACOUST SOC AM, V101, P2151, DOI 10.1121/1.418265; Schairer KS, 2006, J ACOUST SOC AM, V120, P901, DOI 10.1121/1.2214147; SHAILER MJ, 1983, J ACOUST SOC AM, V74, P467, DOI 10.1121/1.389812; Shera CA, 1999, J ACOUST SOC AM, V105, P782, DOI 10.1121/1.426948; SHERA CA, 1993, J ACOUST SOC AM, V93, P3333, DOI 10.1121/1.405717; Shera CA, 2003, J ACOUST SOC AM, V113, P2762, DOI 10.1121/1.1557211; Shera CA, 2002, P NATL ACAD SCI USA, V99, P3318, DOI 10.1073/pnas.032675099; Shera CA, 2013, J ACOUST SOC AM, V133, P2224, DOI 10.1121/1.4792129; Sisto R, 2008, J ACOUST SOC AM, V124, P2995, DOI 10.1121/1.2990711; Walsh EJ, 1998, J NEUROSCI, V18, P3859; Walsh KP, 2014, HEARING RES, V312, P143, DOI 10.1016/j.heares.2014.03.012; Zhao W, 2012, J NEUROPHYSIOL, V108, P25, DOI 10.1152/jn.00051.2012	59	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136906	10.1371/journal.pone.0136906	http://dx.doi.org/10.1371/journal.pone.0136906			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317850	Green Published, Green Submitted, gold			2022-12-26	WOS:000360299100168
J	Hu, W; Wei, YX; Xia, ZQ; Yan, Y; Hou, XW; Zou, ML; Lu, C; Wang, WQ; Peng, M				Hu, Wei; Wei, Yunxie; Xia, Zhiqiang; Yan, Yan; Hou, Xiaowan; Zou, Meiling; Lu, Cheng; Wang, Wenquan; Peng, Ming			Genome-Wide Identification and Expression Analysis of the NAC Transcription Factor Family in Cassava	PLOS ONE			English	Article							FACTOR GENE FAMILY; STRESS-RESPONSIVE GENES; NO-APICAL-MERISTEM; COMPREHENSIVE ANALYSIS; DROUGHT TOLERANCE; LEAF SENESCENCE; FUNCTIONAL-ANALYSIS; REGULATES SALT; GRAIN-YIELD; ARABIDOPSIS	NAC [no apical meristem (NAM), Arabidopsis transcription activation factor [ATAF1/2] and cup-shaped cotyledon (CUC2)] proteins is one of the largest groups of plant specific transcription factors and plays a crucial role in plant growth, development, and adaption to the environment. Currently, no information is known about the NAC family in cassava. In this study, 96 NAC genes (MeNACs) were identified from the cassava genome. Phylogenetic analysis of the NACs from cassava and Arabidopsis showed that MeNAC proteins can be clustered into 16 subgroups. Gene structure analysis found that the number of introns of MeNAC genes varied from 0 to 5, with the majority of MeNAC genes containing two introns, indicating a small gene structure diversity of cassava NAC genes. Conserved motif analysis revealed that all of the identified MeNACs had the conserved NAC domain and/or NAM domain. Global expression analysis suggested that MeNAC genes exhibited different expression profiles in different tissues between wild subspecies and cultivated varieties, indicating their involvement in the functional diversity of different accessions. Transcriptome analysis demonstrated that MeNACs had a widely transcriptional response to drought stress and that they had differential expression profiles in different accessions, implying their contribution to drought stress resistance in cassava. Finally, the expression of twelve MeNAC genes was analyzed under osmotic, salt, cold, ABA, and H2O2 treatments, indicating that cassava NACs may represent convergence points of different signaling pathways. Taken together, this work found some excellent tissue-specific and abiotic stress-responsive candidate MeNAC genes, which would provide a solid foundation for functional investigation of the NAC family, crop improvement and improved understanding of signal transduction in plants. These data bring new insight on the complexity of the transcriptional control of MeNAC genes and support the hypothesis that NACs play an important role in plant growth, development, and adaption of environment.	[Hu, Wei; Wei, Yunxie; Xia, Zhiqiang; Yan, Yan; Hou, Xiaowan; Zou, Meiling; Lu, Cheng; Wang, Wenquan; Peng, Ming] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Key Lab Biol & Genet Resources Trop Crops, Haikou 571101, Hainan, Peoples R China	Chinese Academy of Tropical Agricultural Sciences	Hu, W (corresponding author), Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Key Lab Biol & Genet Resources Trop Crops, Xueyuan Rd 4, Haikou 571101, Hainan, Peoples R China.	huwei2010916@126.com; wangwenquan@itbb.org.cn; mmpeng_2000@yahoo.com		Wang, Wenquan/0000-0002-7603-3437	'973' Program of the Ministry of Science and Technology of China [2010CB126600]; '863' Program of the Ministry of Science and Technology of China [2012AA101204-2]; Natural Science Foundation of Hainan Province [314122, 20153048]; National Nonprofit Institute Research Grant of CATAS-ITBB [ITBB2015ZD04, ITBB2015ZY09]; Major Technology Project of Hainan [ZDZX2013023-1]; International Science & Technology Cooperation Program of China [2013DFA32020]; International Science and Technology Cooperation Plan [2011DFB31690]	'973' Program of the Ministry of Science and Technology of China(National Basic Research Program of China); '863' Program of the Ministry of Science and Technology of China(National High Technology Research and Development Program of China); Natural Science Foundation of Hainan Province; National Nonprofit Institute Research Grant of CATAS-ITBB; Major Technology Project of Hainan; International Science & Technology Cooperation Program of China; International Science and Technology Cooperation Plan	This work was supported by the '973' Program of the Ministry of Science and Technology of China (2010CB126600), the '863' Program of the Ministry of Science and Technology of China (2012AA101204-2), the Natural Science Foundation of Hainan Province (314122, 20153048), the National Nonprofit Institute Research Grant of CATAS-ITBB (ITBB2015ZD04, ITBB2015ZY09), the Major Technology Project of Hainan (ZDZX2013023-1), the International Science & Technology Cooperation Program of China (2013DFA32020), and the International Science and Technology Cooperation Plan (2011DFB31690).	Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; Alaba OA, 2015, G3-GENES GENOM GENET, V5, P133, DOI 10.1534/g3.114.015008; Balazadeh S, 2011, MOL PLANT, V4, P346, DOI 10.1093/mp/ssq080; Balazadeh S, 2010, PLANT J, V62, P250, DOI 10.1111/j.1365-313X.2010.04151.x; Cenci A, 2014, PLANT MOL BIOL, V85, P63, DOI 10.1007/s11103-013-0169-2; Chung PJ, 2009, PLANT SIGNAL BEHAV, V4, P675, DOI 10.4161/psb.4.7.9075; Costa A, 2010, PLANT J, V62, P760, DOI 10.1111/j.1365-313X.2010.04190.x; De Clercq I, 2013, PLANT CELL, V25, P3472, DOI 10.1105/tpc.113.117168; Delessert C, 2005, PLANT J, V43, P745, DOI 10.1111/j.1365-313X.2005.02488.x; Le DT, 2011, DNA RES, V18, P263, DOI 10.1093/dnares/dsr015; Fang YJ, 2008, MOL GENET GENOMICS, V280, P547, DOI 10.1007/s00438-008-0386-6; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fujita M, 2004, PLANT J, V39, P863, DOI 10.1111/j.1365-313X.2004.02171.x; Garapati P, 2015, PLANT PHYSIOL, V168, P1122, DOI 10.1104/pp.15.00567; Guo YF, 2006, PLANT J, V46, P601, DOI 10.1111/j.1365-313X.2006.02723.x; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; Hu HH, 2008, PLANT MOL BIOL, V67, P169, DOI 10.1007/s11103-008-9309-5; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; Jensen MK, 2008, PLANT J, V56, P867, DOI 10.1111/j.1365-313X.2008.03646.x; Jensen MK, 2007, PLANT MOL BIOL, V65, P137, DOI 10.1007/s11103-007-9204-5; Jeong JS, 2013, PLANT BIOTECHNOL J, V11, P101, DOI 10.1111/pbi.12011; Jeong JS, 2010, PLANT PHYSIOL, V153, P185, DOI 10.1104/pp.110.154773; Jiang GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109415; Jiang HL, 2009, PLANT SIGNAL BEHAV, V4, P464, DOI [10.1104/pp.109.135269, 10.4161/psb.4.5.8543]; Kikuchi K, 2000, MOL GEN GENET, V262, P1047, DOI 10.1007/PL00008647; Kim HJ, 2014, J EXP BOT, V65, P4023, DOI 10.1093/jxb/eru112; Kim SG, 2008, PLANT J, V55, P77, DOI 10.1111/j.1365-313X.2008.03493.x; Kim SG, 2007, PLANTA, V226, P647, DOI 10.1007/s00425-007-0513-3; Kim SG, 2010, GENOMICS, V95, P56, DOI 10.1016/j.ygeno.2009.09.003; Kim SY, 2007, NUCLEIC ACIDS RES, V35, P203, DOI 10.1093/nar/gkl1068; Kim YS, 2013, PLANT CELL PHYSIOL, V54, P1660, DOI 10.1093/pcp/pct113; Kim YS, 2006, PLANT CELL, V18, P3132, DOI 10.1105/tpc.106.043018; Ko JH, 2007, PLANT J, V50, P1035, DOI 10.1111/j.1365-313X.2007.03109.x; Kou XH, 2012, J EXP BOT, V63, P6139, DOI 10.1093/jxb/ers266; Kunieda T, 2008, PLANT CELL, V20, P2631, DOI 10.1105/tpc.108.060160; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee S, 2012, PLANT J, V70, P831, DOI 10.1111/j.1365-313X.2012.04932.x; Li XL, 2014, PLANT CELL REP, V33, P767, DOI 10.1007/s00299-014-1602-y; Liu TK, 2014, PLANT MOL BIOL REP, V32, P1041, DOI 10.1007/s11105-014-0712-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu PL, 2007, PLANT MOL BIOL, V63, P289, DOI 10.1007/s11103-006-9089-8; Mittler R, 2015, PLANT CELL, V27, P64, DOI 10.1105/tpc.114.133090; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Ng S, 2013, PLANT CELL, V25, P3450, DOI 10.1105/tpc.113.113985; Nuruzzaman M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00248; Nuruzzaman M, 2012, MOL GENET GENOMICS, V287, P389, DOI 10.1007/s00438-012-0686-8; Nuruzzaman M, 2010, GENE, V465, P30, DOI 10.1016/j.gene.2010.06.008; Okogbenin E, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00093; Oliveira EJ, 2014, GENET MOL RES, V13, P6683, DOI 10.4238/2014.August.28.13; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Ooka H, 2003, DNA RES, V10, P239, DOI 10.1093/dnares/10.6.239; Pandurangaiah M, 2014, MOL BIOTECHNOL, V56, P758, DOI 10.1007/s12033-014-9754-0; Park J, 2011, PLANT PHYSIOL, V156, P537, DOI 10.1104/pp.111.177071; Perera PIP, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plu022; Puranik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064594; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Puranik S, 2011, PLANT SIGNAL BEHAV, V6, P1588, DOI 10.4161/psb.6.10.17130; Puranik S, 2011, MOL BIOTECHNOL, V49, P138, DOI 10.1007/s12033-011-9385-7; Ren T, 2000, PLANT CELL, V12, P1917, DOI 10.1105/tpc.12.10.1917; Rushton PJ, 2008, PLANT PHYSIOL, V147, P280, DOI 10.1104/pp.107.114041; Sablowski RWM, 1998, CELL, V92, P93, DOI 10.1016/S0092-8674(00)80902-2; Saga H, 2012, MOL PLANT MICROBE IN, V25, P684, DOI 10.1094/MPMI-09-11-0244; Sakuraba Y, 2015, PLANT CELL; Salcedo A, 2014, TROP PLANT BIOL, V7, P53, DOI 10.1007/s12042-014-9137-5; Sanghera GS, 2011, CURR GENOMICS, V12, P30, DOI 10.2174/138920211794520178; Seo PJ, 2010, PLANT SIGNAL BEHAV, V5, P481, DOI 10.4161/psb.11083; Shahnejat-Bushehri S, 2012, PLANT SIGNAL BEHAV, V7, P1518, DOI 10.4161/psb.22092; Shang HH, 2013, J INTEGR PLANT BIOL, V55, P663, DOI 10.1111/jipb.12085; Shiriga K, 2014, META GENE, V2, P407, DOI 10.1016/j.mgene.2014.05.001; Singh AK, 2013, DNA RES, V20, P403, DOI 10.1093/dnares/dst019; Song SY, 2011, PLANTA, V234, P331, DOI 10.1007/s00425-011-1403-2; Souer E, 1996, CELL, V85, P159, DOI 10.1016/S0092-8674(00)81093-4; Sperotto RA, 2009, PLANTA, V230, P985, DOI 10.1007/s00425-009-1000-9; Takasaki H, 2010, MOL GENET GENOMICS, V284, P173, DOI 10.1007/s00438-010-0557-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tao P, 2014, MOL GENET GENOMICS, V289, P1131, DOI 10.1007/s00438-014-0874-9; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Van Ha C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114107; Wang G, 2014, BMC PLANT BIOL, V14, DOI [10.1186/s12870-014-0219-1, 10.1186/s12862-014-0186-z]; Wang N, 2013, PLANT CELL REP, V32, P61, DOI 10.1007/s00299-012-1340-y; Wang WQ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6110; Wang XE, 2009, MOL PLANT MICROBE IN, V22, P1227, DOI 10.1094/MPMI-22-10-1227; Wu AH, 2012, PLANT CELL, V24, P482, DOI 10.1105/tpc.111.090894; Wu YR, 2009, CELL RES, V19, P1279, DOI 10.1038/cr.2009.108; Xie Q, 2000, GENE DEV, V14, P3024, DOI 10.1101/gad.852200; Xie Q, 1999, PLANT MOL BIOL, V39, P647, DOI 10.1023/A:1006138221874; Xu ZY, 2013, PLANT CELL, V25, P4708, DOI 10.1105/tpc.113.119099; Yang SD, 2011, PLANT CELL, V23, P2155, DOI 10.1105/tpc.111.084913; Yao DX, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S15-S10; You J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122027; Zeng CY, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0207-5; Zhao PJ, 2015, J EXP BOT, V66, P1477, DOI 10.1093/jxb/eru507; Zheng XN, 2009, BIOCHEM BIOPH RES CO, V379, P985, DOI 10.1016/j.bbrc.2008.12.163; Zhong RQ, 2007, PLANTA, V225, P1603, DOI 10.1007/s00425-007-0498-y; Zhu MK, 2014, PLANT CELL REP, V33, P1851, DOI 10.1007/s00299-014-1662-z; Zidenga T, 2012, PLANT PHYSIOL, V159, P1396, DOI 10.1104/pp.112.200345	98	54	57	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136993	10.1371/journal.pone.0136993	http://dx.doi.org/10.1371/journal.pone.0136993			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317631	Green Submitted, gold, Green Published			2022-12-26	WOS:000360299100190
J	Muller, C; Hochhaus, NM; Fontana, X; Luhmann, HJ; White, R				Mueller, Christina; Hochhaus, Nina M.; Fontana, Xavier; Luhmann, Heiko J.; White, Robin			SncRNA715 Inhibits Schwann Cell Myelin Basic Protein Synthesis	PLOS ONE			English	Article							PERIPHERAL NERVOUS-SYSTEM; RNA TRANSPORT; INJURY; NEUREGULIN-1; MECHANISMS; DEFICIENT; GENES; DICER; MICE; SHOW	Myelin basic proteins (MBP) are major constituents of the myelin sheath in the central nervous system (CNS) and the peripheral nervous system (PNS). In the CNS Mbp translation occurs locally at the axon-glial contact site in a neuronal activity-dependent manner. Recently we identified the small non-coding RNA 715 (sncRNA715) as a key inhibitor of Mbp translation during transport in oligodendrocytes. Mbp mRNA localization in Schwann cells has been observed, but has not been investigated in much detail. Here we could confirm translational repression of Mbp mRNA in Schwann cells. We show that sncRNA715 is expressed and its levels correlate inversely with MBP in cultured Schwann cells and in the sciatic nerve in vivo. Furthermore we could reduce MBP protein levels in cultured Schwann cells by increasing the levels of the inhibitory sncRNA715. Our findings suggest similarities in sncRNA715-mediated translational repression of Mbp mRNA in oligodendrocytes and Schwann cells.	[Mueller, Christina; Hochhaus, Nina M.; Luhmann, Heiko J.; White, Robin] Johannes Gutenberg Univ Mainz, Inst Physiol, Univ Med Ctr, D-55122 Mainz, Germany; [Fontana, Xavier] UCL, MRC, Mol Cell Biol Lab, London, England; [Fontana, Xavier] UCL, UCL Canc Inst, London, England	Johannes Gutenberg University of Mainz; University of London; University College London; University of London; University College London	White, R (corresponding author), Johannes Gutenberg Univ Mainz, Inst Physiol, Univ Med Ctr, D-55122 Mainz, Germany.	white@uni-mainz.de	Luhmann, Heiko J./N-8797-2019	Luhmann, Heiko J./0000-0002-7934-8661	Deutsche Forschungsgemeinschaft (DFG) [WH168/3-1]; FTN (Focus Program Translational Neuroscience, Mainz) scholarship	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); FTN (Focus Program Translational Neuroscience, Mainz) scholarship	This work was funded by the Deutsche Forschungsgemeinschaft (DFG, http://www.dfg.de/) grant WH168/3-1 to RW. CM received an FTN (Focus Program Translational Neuroscience, Mainz) scholarship.	Arthur-Farraj P, 2011, GLIA, V59, P720, DOI 10.1002/glia.21144; Bala Usman, 2014, BMC Res Notes, V7, P714, DOI 10.1186/1756-0500-7-714; Bauer NM, 2012, EMBO REP, V13, P827, DOI 10.1038/embor.2012.97; Bremer J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012450; Gould M, 1995, NUMBER SCHMIDT LANTE, V98, P85; Griffiths IR, 1989, EXPRESSION MYELIN PR, V352, P345; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grigoryan T, 2015, BIOESSAYS, V37, P502, DOI 10.1002/bies.201400172; Hall S, 2005, J BONE JOINT SURG BR, V87B, P1309, DOI 10.1302/0301-620X.87B10.16700; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; JUNG M, 1995, EUR J NEUROSCI, V7, P1245, DOI 10.1111/j.1460-9568.1995.tb01115.x; Kent T, 2009, RNA, V15, P14, DOI 10.1261/rna.1384709; Kirschner DA, 1980, NATURE; MARTINI R, 1995, J NEUROSCI, V15, P4488; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Muller C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00169; Nave KA, 2014, ANNU REV CELL DEV BI, V30, P503, DOI 10.1146/annurev-cellbio-100913-013101; Navel KA, 2006, CURR OPIN NEUROBIOL, V16, P492, DOI 10.1016/j.conb.2006.08.008; Newbern J, 2010, SEMIN CELL DEV BIOL, V21, P922, DOI 10.1016/j.semcdb.2010.08.008; Pereira JA, 2010, J NEUROSCI, V30, P6763, DOI 10.1523/JNEUROSCI.0801-10.2010; Pfaffl MW, 2002, RELATIVE EXPRESSION, V30; ROSENBLUTH J, 1980, J COMP NEUROL, V194, P639, DOI 10.1002/cne.901940310; Schmid D, 2014, ASN NEURO, V6, DOI 10.1042/AN20130031; Smith-Slatas C, 2000, MOL CELL NEUROSCI, V15, P343, DOI 10.1006/mcne.1999.0829; STAUGAITIS SM, 1990, J CELL BIOL, V110, P1719, DOI 10.1083/jcb.110.5.1719; TRAPP BD, 1987, P NATL ACAD SCI USA, V84, P7773, DOI 10.1073/pnas.84.21.7773; Verrier JD, 2010, J NEUROSCI RES, V88, P2558, DOI 10.1002/jnr.22418; Verrier JD, 2009, GLIA, V57, P1265, DOI 10.1002/glia.20846; Viader A, 2011, J NEUROSCI, V31, P17358, DOI 10.1523/JNEUROSCI.3931-11.2011; WATABE K, 1995, J NEUROSCI RES, V41, P279, DOI 10.1002/jnr.490410215; Wei HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056842; White R, 2012, J BIOL CHEM, V287, P1742, DOI 10.1074/jbc.M111.235010; YOSHINO J, 1985, BRAIN RES, V325, P199, DOI 10.1016/0006-8993(85)90316-6; Yun B, 2010, J NEUROSCI, V30, P7722, DOI 10.1523/JNEUROSCI.0876-10.2010	35	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136900	10.1371/journal.pone.0136900	http://dx.doi.org/10.1371/journal.pone.0136900			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317513	Green Submitted, Green Published, gold			2022-12-26	WOS:000360299100165
J	Park, JA; Gardner, C; Chang, MI; Kim, DH; Jang, YS				Park, Jeong-A; Gardner, Caleb; Chang, Myo-In; Kim, Do-Hoon; Jang, Young-Soo			Fuel Use and Greenhouse Gas Emissions from Offshore Fisheries of the Republic of Korea	PLOS ONE			English	Article							CARBON FOOTPRINT	Greenhouse Gas (GHG) emissions from the offshore fisheries industry in the Republic of Korea (Korea) were examined in response to growing concerns about global warming and the contribution of emissions from different industrial sectors. Fuel usage and GHG emissions (CO2, CH4, N2O) were analysed using the 'Tier 1' method provided by the Intergovernmental Panel on Climate Change (IPCC) from the offshore fishery, which is the primary domestic seafood production sector in Korea. In 2013, fuel usage in the offshore fishery accounted for 59.7% (557,463 KL) of total fuel consumption of fishing vessels in Korea. Fuel consumption and thus GHG emissions were not stable through time in this industry, increasing by 2.4% p.a. for three consecutive years, from 2011 to 2013, despite a decrease in the number of vessels operating. GHG emissions generated in offshore fisheries also changed through time and increased from 1,442,975 tCO(2)e/year in 2011 to 1,477,279 tCO(2)e/year in 2013. Changes in both fuel use and GHG emissions per kg offshore fish production appeared to be associated with decreasing catch rates by the fleet, which in turn were a reflection of decrease in fish biomass. Another important feature of GHG emissions in this industry was the high variation in GHG emission per kg fish product among different fishing methods. The long line fishery had approximately three times the emissions of the average production while the jigging fishery was more than two times higher than the average. Lowest emissions were from the trawl sector, which is regarded as having greatest environmental impact using traditional biodiversity metrics although had lowest environmental impact in terms of fuel and GHG emission metrics used in this study. The observed deterioration in fuel efficiency of the offshore fishery each year is of concern but also demonstrates that fuel efficiency can change, which shows there is opportunity to improve efficiency with changes to fishery management and harvesting operations.	[Park, Jeong-A; Gardner, Caleb] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Park, Jeong-A; Kim, Do-Hoon; Jang, Young-Soo] Pukyong Natl Univ, Dept Marine & Fisheries Business & Econ, Busan, South Korea; [Chang, Myo-In] Minist Oceans & Fisheries Korea, Sejong, South Korea	University of Tasmania; Pukyong National University	Jang, YS (corresponding author), Pukyong Natl Univ, Dept Marine & Fisheries Business & Econ, Busan, South Korea.	ysjang@pknu.ac.kr	Gardner, Caleb/I-7086-2013	Gardner, Caleb/0000-0003-0324-4337				Brasil. Ministerio da Saude, 2014, GUID BAL NUTR IND, P1; Choi J., 2012, J APPL MATH, V2012, P1, DOI DOI 10.1371/J0URNAL.P0NE.0037059; Crilly R, 2013, MAR POLICY, V37, P20, DOI 10.1016/j.marpol.2012.04.018; Ellingsen H, 2009, MAR POLICY, V33, P479, DOI 10.1016/j.marpol.2008.11.003; FAO (Food and Agriculture Organization), 2011, CONS FISH FISH PROD; Farmery A, 2014, J CLEAN PROD, V64, P368, DOI 10.1016/j.jclepro.2013.10.016; Food and Agriculture Organization (FAO), 2012, STAT WORLD FISH AQ 2; Gardner C, 2015, FISH RES, V161, P285, DOI 10.1016/j.fishres.2014.08.015; IPCC, 2019, REF 2006 IPCC GUID N, V5, P1; Jo J. H., 2010, STUDY IMPLEMENTATION, P1; Kang YJ, 2004, J KOR FISH RES, V21, P27; Kang YS, 2000, J KOR FISH BUS ADM, V31, P115; KangYeonSil, 2012, [the Journal of Korean Island, 한국도서연구], V24, P115; Lee HD, 2009, J KOR FISHERIES TREN, V7, P7; 이지훈, 2011, [Korean Journal of Fisheries and Aquatic Sciences, 한국수산과학회지], V44, P383; Lee K, 2009, BIOTECHNOL LETT, V31, P31, DOI 10.1007/s10529-008-9837-8; Lee Kwang-Nam, 2014, [The Journal of Fisheries Business Administration, 수산경영론집], V45, P73, DOI 10.12939/FBA.2014.45.2.073; Lee Kwang-Nam, 2012, [The Journal of Fisheries Business Administration, 수산경영론집], V43, P49; 박성욱, 2013, [Journal of the Korean Society of Fisheries and Ocean Technology, 수산해양기술연구], V49, P291, DOI 10.3796/KSFT.2012.49.3.291; 박성욱, 2012, [Journal of the Korean Society of Fisheries and Ocean Technology, 수산해양기술연구], V48, P360, DOI 10.3796/KSFT.2012.48.4.360; Maunder MN, 2001, CAN J FISH AQUAT SCI, V58, P795, DOI 10.1139/cjfas-58-4-795; National Federation of Fisheries Cooperatives(SUHYUP) Korea, 2011, TAX FREE OIL SAL DAT; NFRID(National Fisheries Research and Development Institute Korea), 2010, KOR COAST OFFSH FISH, P1; Statistics Korea, 2013, FISH PROD STAT; Statistics Korea, 2011, FISH MAN RES STAT; The Bank of Korea, 2012, INFORM INT EC, V37, P1; Vazquez-Rowe I, 2013, J CLEAN PROD, V44, P200, DOI 10.1016/j.jclepro.2012.11.049; Young-Il AN, 2014, [Journal of the Korean Society of Fisheries and Ocean Technology, 수산해양기술연구], V50, P326, DOI 10.3796/KSFT.2014.50.3.326; 권유정, 2008, [Journal of the Korean Society of Fisheries and Ocean Technology, 수산해양기술연구], V44, P194; Ziegler F, 2013, J IND ECOL, V17, P103, DOI 10.1111/j.1530-9290.2012.00485.x; 이지훈, 2013, [Journal of the Korean Society of Fisheries and Ocean Technology, 수산해양기술연구], V49, P282, DOI 10.3796/KSFT.2012.49.3.282	31	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0133778	10.1371/journal.pone.0133778	http://dx.doi.org/10.1371/journal.pone.0133778			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317341	Green Submitted, Green Published, gold			2022-12-26	WOS:000360299100011
J	Trela, Z; Burdach, Z; Siemieniuk, A; Przestalski, S; Karcz, W				Trela, Zenon; Burdach, Zbigniew; Siemieniuk, Agnieszka; Przestalski, Stanislaw; Karcz, Waldemar			Effect of Trimethyltin Chloride on Slow Vacuolar (SV) Channels in Vacuoles from Red Beet (Beta vulgaris L.) Taproots	PLOS ONE			English	Article							ORGANOTIN COMPOUNDS; ION CHANNELS; TRIBUTYLTIN CHLORIDE; ERYTHROCYTE-MEMBRANE; ORGANIC TIN; TRIPHENYLTIN; TOXICITY; INHIBITION; MECHANISMS; TRANSPORT	In the present study, patch-clamp techniques have been used to investigate the effect of trimethyltin chloride (Met(3)SnCl) on the slow vacuolar (SV) channels in vacuoles from red beet (Beta vulgaris L.) taproots. Activity of SV channels has been measured in whole-vacuole and cytosolic side-out patch configurations. It was found that addition of trimethyltin chloride to the bath solution suppressed, in a concentration-dependent manner, SV currents in red beet vacuoles. The time constant, tau, increased significantly in the presence of the organotin. When single channel activity was analyzed, only little channel activity could be recorded at 100 mu M Met(3)SnCl. Trimethyltin chloride added to the bath medium significantly decreased (by ca. threefold at 100 mu M Met3SnCl and at 100 mV voltage, as compared to the control medium) the open probability of single channels. Single channel recordings obtained in the presence and absence of trimethyltin chloride showed that the organotin only slightly (by < 10%) decreased the unitary conductance of single channels. It was also found that Met3SnCl significantly diminished the number of SV channel openings, whereas it did not change the opening times of the channels. Taking into account the above and the fact that under the here applied experimental conditions (pH = 7.5) Met(3)SnCl is a non-dissociated (more lipophilic) compound, we suggest that the suppression of SV currents observed in the presence of the organotin results probably from its hydrophobic properties allowing this compound to translocate near the selectivity filter of the channel.	[Trela, Zenon; Przestalski, Stanislaw] Wroclaw Univ Environm & Life Sci, Dept Phys & Biophys, PL-50375 Wroclaw, Poland; [Burdach, Zbigniew; Siemieniuk, Agnieszka; Karcz, Waldemar] Univ Silesia, Fac Biol & Environm Protect, Dept Plant Physiol, PL-40032 Katowice, Poland	Wroclaw University of Environmental & Life Sciences; University of Silesia in Katowice	Karcz, W (corresponding author), Univ Silesia, Fac Biol & Environm Protect, Dept Plant Physiol, Jagiellonska 28, PL-40032 Katowice, Poland.	waldemar.karcz@us.edu.pl	Trela, Zenon/B-5592-2017; Trela, Zenon/ABB-9717-2021	Trela, Zenon/0000-0002-8249-6825; Karcz, Waldemar/0000-0001-7630-1553; Siemieniuk, Agnieszka/0000-0003-4530-3956				Arnold CG, 1997, ENVIRON SCI TECHNOL, V31, P2596, DOI 10.1021/es970009+; Barkla BJ, 1996, ANNU REV PLANT PHYS, V47, P159, DOI 10.1146/annurev.arplant.47.1.159; Bernat P, 2014, WORLD J MICROB BIOT, V30, P2343, DOI 10.1007/s11274-014-1659-3; BERTL A, 1992, SCIENCE, V258, P873, DOI 10.1126/science.1439795; Bethke PC, 1997, PLANT J, V11, P1227, DOI 10.1046/j.1365-313X.1997.11061227.x; Bonarska-Kujawa D, 2012, ECOTOX ENVIRON SAFE, V78, P232, DOI 10.1016/j.ecoenv.2011.11.027; Burda K, 2002, APPL ORGANOMET CHEM, V16, P148, DOI 10.1002/aoc.272; Burdach Z, 2014, ACTA BIOCHIM POL, V61, P213; Caratozzolo R, 2007, APPL ORGANOMET CHEM, V21, P66, DOI 10.1002/aoc.1175; Carpaneto A, 2003, EUR BIOPHYS J BIOPHY, V32, P60, DOI 10.1007/s00249-002-0268-5; Carpaneto A, 1999, FEBS LETT, V442, P129, DOI 10.1016/S0014-5793(98)01642-1; Ceccariglia S, 2014, NEUROSCIENCE, V274, P273, DOI 10.1016/j.neuroscience.2014.05.047; Chen JF, 2011, NEUROTOXICOL TERATOL, V33, P721, DOI 10.1016/j.ntt.2011.09.003; Chicano JJ, 2002, BBA-BIOMEMBRANES, V1558, P70, DOI 10.1016/S0005-2736(01)00426-6; Corvino V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088294; COYAUD L, 1987, BIOCHIM BIOPHYS ACTA, V902, P263, DOI 10.1016/0005-2736(87)90304-X; Crowe A.J., 1987, APPL ORGANOMET CHEM, V1, P143, DOI [10.1002/aoc.590010206, DOI 10.1002/AOC.590010206]; DAVIES JM, 1995, J MEMBRANE BIOL, V145, P75; Dobrovinskaya OR, 1999, J MEMBRANE BIOL, V167, P127, DOI 10.1007/s002329900477; ERNST WHO, 1992, ACTA BOT NEERL, V41, P229, DOI 10.1111/j.1438-8677.1992.tb01332.x; Evans C. J., 1998, CHEM TIN, P442; FARGASOVA A, 1994, BIOLOGIA, V49, P307; Fent K, 1996, SCI TOTAL ENVIRON, V185, P151, DOI 10.1016/0048-9697(95)05048-5; FENT K, 1995, WATER RES, V29, P1631, DOI 10.1016/0043-1354(94)00349-C; Florea AM, 2005, TOXICOLOGY, V216, P1, DOI 10.1016/j.tox.2005.05.029; Florea AM, 2005, CELL CALCIUM, V37, P251, DOI 10.1016/j.ceca.2004.10.005; Gabrielska J, 1997, Z NATURFORSCH C, V52, P209; Gabrielska J, 2004, APPL ORGANOMET CHEM, V18, P9, DOI 10.1002/aoc.561; Gutla PVK, 2012, J EXP BOT, V63, P6187, DOI 10.1093/jxb/ers272; Gutla PVK, 2010, THESIS U PADUA; HAMASAKI T, 1995, APPL ORGANOMET CHEM, V9, P95, DOI 10.1002/aoc.590090202; HEDRICH R, 1987, NATURE, V329, P833, DOI 10.1038/329833a0; Hedrich R, 2012, PHYSIOL REV, V92, P1777, DOI 10.1152/physrev.00038.2011; Hedrich R, 2011, MOL PLANT, V4, P428, DOI 10.1093/mp/ssr017; Hoch M, 2001, APPL GEOCHEM, V16, P719, DOI 10.1016/S0883-2927(00)00067-6; Isayenkov S, 2010, FEBS LETT, V584, P1982, DOI 10.1016/j.febslet.2010.02.050; Kannan K, 1996, ENVIRON TOXICOL CHEM, V15, P1492, DOI [10.1002/etc.5620150911, 10.1897/1551-5028(1996)015&lt;1492:TAIDPI&gt;2.3.CO;2]; Kleszczynska H, 1997, Z NATURFORSCH C, V52, P65; Kleszczynska H, 1998, BIOCHEM MOL BIOL INT, V44, P305; Kleszczynska H, 1999, FOLIA HISTOCHEM CYTO, V37, P1; Kotake Y, 2012, BIOL PHARM BULL, V35, P1876, DOI 10.1248/bpb.b212017; Lespes G, 2009, J ENVIRON MANAGE, V90, pS60, DOI 10.1016/j.jenvman.2008.07.019; Miskiewicz J, 2010, EUR BIOPHYS J BIOPHY, V39, P1397, DOI 10.1007/s00249-010-0594-y; MOONEY HM, 1995, J IND MICROBIOL, V14, P265, DOI 10.1007/BF01569938; Murkowski A., 2008, ACTA AGROPHYS, V11, P131; Paganetto A, 2001, PLANT CELL ENVIRON, V24, P1329, DOI 10.1046/j.1365-3040.2001.00777.x; Pagliarani A, 2013, TOXICOL IN VITRO, V27, P978, DOI 10.1016/j.tiv.2012.12.002; Peiter E, 2011, CELL CALCIUM, V50, P120, DOI 10.1016/j.ceca.2011.02.002; Pottosin II, 2007, J EXP BOT, V58, P1559, DOI 10.1093/jxb/erm035; Pottosin I, 2014, J PLANT PHYSIOL, V171, P732, DOI 10.1016/j.jplph.2013.11.013; Przestalski S, 2000, ACTA BIOCHIM POL, V47, P627, DOI 10.18388/abp.2000_3984; Rascio N, 2011, PLANT SCI, V180, P169, DOI 10.1016/j.plantsci.2010.08.016; Reid BJ, 2000, ENVIRON POLLUT, V108, P103, DOI 10.1016/S0269-7491(99)00206-7; Schoenknecht Gerald, 2013, Plants-Basel, V2, P589, DOI 10.3390/plants2040589; SCHULZLESSDORF B, 1995, PLANTA, V197, P655; Song ZH, 2001, B ENVIRON CONTAM TOX, V67, P368; TAIZ L, 1992, J EXP BIOL, V172, P113; Tang XJ, 2010, TOXICOLOGY, V271, P45, DOI 10.1016/j.tox.2010.02.013; Trela Z, 2012, CR BIOL, V335, P722, DOI 10.1016/j.crvi.2012.11.004; van den Wijngaard PWJ, 2001, FEBS LETT, V488, P100, DOI 10.1016/S0014-5793(00)02394-2; Veltman K, 2006, MAR ENVIRON RES, V61, P511, DOI 10.1016/j.marenvres.2006.02.005; von Ballmoos C, 2004, P NATL ACAD SCI USA, V101, P11239, DOI 10.1073/pnas.0402869101; Zhang LP, 2006, SCI CHINA SER B, V49, P560, DOI 10.1007/s11426-006-2021-x; Zylka R, 2009, CELL BIOL INT, V33, P801, DOI 10.1016/j.cellbi.2009.04.016	64	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136346	10.1371/journal.pone.0136346	http://dx.doi.org/10.1371/journal.pone.0136346			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317868	Green Submitted, Green Published, gold			2022-12-26	WOS:000360299100072
J	Yang, LP; Jiang, FJ; Wu, GS; Deng, K; Wen, M; Zhou, XJ; Hong, XC; Zhu, MX; Luo, HR				Yang, Li-Ping; Jiang, Fang-Jie; Wu, Gui-Sheng; Deng, Ke; Wen, Meng; Zhou, Xiaoju; Hong, Xuechuan; Zhu, Michael X.; Luo, Huai-Rong			Acute Treatment with a Novel TRPC4/C5 Channel Inhibitor Produces Antidepressant and Anxiolytic-Like Effects in Mice	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; PREFRONTAL CORTEX; ANXIETY DISORDERS; ANIMAL-MODELS; C-FOS; TRPC5; BEHAVIOR; MECHANISMS; AMYGDALA; PATHOPHYSIOLOGY	Transient receptor potential canonical (TRPC) channels are widely expressed in brain and involved in various aspects of brain function. Both TRPC4 and TRPC5 have been implicated in innate fear function, which represents a key response to environmental stress. However, to what extent the TRPC4/C5 channels are involved in psychiatric disorders remains unexplored. Here, we tested the antidepressant and anxiolytic-like effects of a newly identified TRPC4/C5 inhibitor, M084. We show that a single intraperitoneal administration of M084 at 10 mg/kg body weight to C57BL/6 male mice significantly shortened the immobility time in forced swim test and tail suspension test within as short as 2 hours. The M084-treated mice spent more time exploring in illuminated and open areas in light/dark transition test and elevated plus maze test. In mice subjected to chronic unpredictable stress, M084 treatment reversed the enhanced immobility time in forced swim test and decreased the latency to feed in novelty suppressed feeding test. The treatment of M084 increased BDNF expression in both mRNA and protein levels, as well as phosphorylation levels of AKT and ERK, in prefrontal cortex. Our results indicate that M084 exerts rapid antidepressant and anxiolytic-like effects at least in part by acting on BDNF and its downstream signaling. We propose M084 as a lead compound for further druggability research.	[Yang, Li-Ping; Jiang, Fang-Jie; Wu, Gui-Sheng; Deng, Ke; Luo, Huai-Rong] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming 650201, Yunnan, Peoples R China; [Yang, Li-Ping; Jiang, Fang-Jie] Univ Chinese Acad Sci, Beijing 100039, Peoples R China; [Yang, Li-Ping] Yunnan Inst Tradit Chinese Med & Mat Med, Kunming 650223, Yunnan, Peoples R China; [Wen, Meng; Zhou, Xiaoju; Hong, Xuechuan] Wuhan Univ, Key Lab Combinatorial Biosynth & Drug Discovery, State Key Lab Virol, Minist Educ,Sch Pharmaceut Sci, Wuhan 430071, Peoples R China; [Zhu, Michael X.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Wuhan University; University of Texas System; University of Texas Health Science Center Houston	Luo, HR (corresponding author), Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming 650201, Yunnan, Peoples R China.	luohuairong@mail.kib.ac.cn	Luo, Huai-Rong/ABE-7525-2021	zhou, xiaoju/0000-0003-0797-1312; hong, xuechuan/0000-0001-6834-3278	Yunnan provincial government [20080A007, 2012FB181, 2014BC011]; 100 Talents Program of the Chinese Academy of Sciences; National Natural Science Foundation of China [81373254, 21390402, 81228021]; Natural Science Foundation of Hubei Province [2014CFB704]; Applied Basic Research Program of Wuhan Municipal Bureau of Science and Technology; US National Institutes of Health [R01 DK081654, R01 NS092377]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS092377] Funding Source: NIH RePORTER	Yunnan provincial government; 100 Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province); Applied Basic Research Program of Wuhan Municipal Bureau of Science and Technology; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was partially supported by the Yunnan provincial government (20080A007, 2012FB181 and 2014BC011), the 100 Talents Program of the Chinese Academy of Sciences, the National Natural Science Foundation of China (81373254, 21390402, and 81228021), the Natural Science Foundation of Hubei Province (2014CFB704), the Applied Basic Research Program of Wuhan Municipal Bureau of Science and Technology, and the grants from US National Institutes of Health (R01 DK081654 and R01 NS092377). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Baldwin DS, 2005, J PSYCHOPHARMACOL, V19, P567, DOI 10.1177/0269881105059253; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Castren E, 2010, DEV NEUROBIOL, V70, P289, DOI 10.1002/dneu.20758; Davare MA, 2009, J NEUROSCI, V29, P9794, DOI 10.1523/JNEUROSCI.1544-09.2009; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Du J, 2014, FASEB J, V28, P4677, DOI 10.1096/fj.14-251652; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Duman RS, 2012, TRENDS NEUROSCI, V35, P47, DOI 10.1016/j.tins.2011.11.004; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; First M, 2011, J MOL NEUROSCI, V45, P246, DOI 10.1007/s12031-011-9515-5; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; Heldt SA, 2010, J NEUROSCI, V30, P7139, DOI 10.1523/JNEUROSCI.0693-10.2010; Idayu NF, 2011, PHYTOMEDICINE, V18, P402, DOI 10.1016/j.phymed.2010.08.011; Jiang LH, 2011, CURR DRUG TARGETS, V12, P724; Kaczmarek JS, 2012, P NATL ACAD SCI USA, V109, P7888, DOI 10.1073/pnas.1205869109; Karege F, 2007, BIOL PSYCHIAT, V61, P240, DOI 10.1016/j.biopsych.2006.04.036; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kovacs KJ, 2008, J NEUROENDOCRINOL, V20, P665, DOI 10.1111/j.1365-2826.2008.01734.x; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Krishnan V, 2011, CURR TOP BEHAV NEURO, V7, P121, DOI 10.1007/7854_2010_108; Li BJ, 2013, J BIOCHEM MOL TOXIC, V27, P486, DOI 10.1002/jbt.21510; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Miller BA, 2006, J MEMBRANE BIOL, V209, P31, DOI 10.1007/s00232-005-0839-3; Muller MB, 2004, TRENDS MOL MED, V10, P409, DOI 10.1016/j.molmed.2004.06.007; Pedersen AG, 2005, INT CLIN PSYCHOPHARM, V20, P139, DOI 10.1097/00004850-200505000-00003; Petit-Demouliere B, 2005, PSYCHOPHARMACOLOGY, V177, P245, DOI 10.1007/s00213-004-2048-7; Phelan KD, 2012, MOL PHARMACOL, V81, P384, DOI 10.1124/mol.111.075341; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Puram SV, 2011, GENE DEV, V25, P2659, DOI 10.1101/gad.174060.111; Qi XL, 2009, BEHAV BRAIN RES, V199, P203, DOI 10.1016/j.bbr.2008.11.051; Ressler KJ, 2000, DEPRESS ANXIETY, V12, P2, DOI 10.1002/1520-6394(2000)12:1+<2::AID-DA2>3.3.CO;2-W; Riccio A, 2014, J NEUROSCI, V34, P3653, DOI 10.1523/JNEUROSCI.2274-13.2014; Riccio A, 2009, CELL, V137, P761, DOI 10.1016/j.cell.2009.03.039; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Samuels B. A., 2011, NEUROMETHODS, V63, P107; Schmidt HD, 2007, BEHAV PHARMACOL, V18, P391, DOI 10.1097/FBP.0b013e3282ee2aa8; Selvaraj S, 2010, CNS NEUROL DISORD-DR, V9, P94, DOI 10.2174/187152710790966650; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Sukumar P, 2012, CIRC RES, V111, P191, DOI [10.1161/CIRCRESAHA.112.270751, 10.1161/circresaha.112.270751]; Tsiokas L, 1999, P NATL ACAD SCI USA, V96, P3934, DOI 10.1073/pnas.96.7.3934; Vialou V, 2014, J NEUROSCI, V34, P3878, DOI 10.1523/JNEUROSCI.1787-13.2014; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Wang SP, 2011, J NEUROPHYSIOL, V106, P1515, DOI 10.1152/jn.00025.2011; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097; Wu D, 2008, J BIOL CHEM, V283, P416, DOI 10.1074/jbc.M703177200; Yip H, 2004, HISTOCHEM CELL BIOL, V122, P553, DOI 10.1007/s00418-004-0720-y; Zhu JM, 2013, BIOORGAN MED CHEM, V21, P4218, DOI 10.1016/j.bmc.2013.05.001; Zhu Y, 2015, BR J PHARM; Zunszain PA, 2013, MOL PSYCHIATR, V18, P1236, DOI 10.1038/mp.2013.87	51	36	38	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136255	10.1371/journal.pone.0136255	http://dx.doi.org/10.1371/journal.pone.0136255			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317356	Green Published, Green Submitted, gold			2022-12-26	WOS:000360299100067
J	Balagopal, A; Barin, B; Quinn, J; Rogers, R; Sulkowski, MS; Stock, PG				Balagopal, Ashwin; Barin, Burc; Quinn, Jeffrey; Rogers, Rodney; Sulkowski, Mark S.; Stock, Peter G.			Immunologic Predictors of Liver Transplantation Outcomes in HIV-HCV Co-Infected Persons	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-C; MICROBIAL TRANSLOCATION; DISEASE; INTERLEUKIN-10; PROGRESSION; ACTIVATION; RECIPIENTS; CHALLENGE; STAGE	Liver disease is a leading cause of mortality among HIV-infected persons in the highly active anti-retroviral therapy (HAART) era. Hepatitis C Virus (HCV) co-infection is prevalent in, and worsened by HIV; consequently many co-infected persons require liver transplantation (LT). Despite the need, post-LT outcomes are poor in co-infection. We examined predictors of outcomes post-LT. Immunologic biomarkers of immune activation, microbial translocation, and Th1/Th2 skewing were measured pre-LT in participants enrolled in a cohort of HIV infected persons requiring solid organ transplant (HIVTR). Predictive biomarkers were analyzed in Cox-proportional hazards models; multivariate models included known predictors of outcome and biomarkers from univariate analyses. Sixty-nine HIV-HCV co-infected persons with available pre-LT samples were tested: median (IQR) CD4+ T-cell count was 286 (210-429) cells mm(-3); 6 (9%) had detectable HIV RNA. Median (IQR) follow-up was 2.1 (0.7-4.0) years, 29 (42%) people died, 35 (51%) had graft loss, 22 (32%) were treated for acute rejection, and 14 (20%) had severe recurrent HCV. In multivariate models, sCD14 levels were significantly lower in persons with graft loss post-LT (HR 0.10 [95% CI 0.02-0.68]). IL-10 levels were higher in persons with rejection (HR 2.10 [95% CI 1.01-4.34]). No markers predicted severe recurrent HCV. Monocyte activation pre-LT may be mechanistically linked to graft health in HIV-HCV co-infection.	[Balagopal, Ashwin; Quinn, Jeffrey; Sulkowski, Mark S.] Johns Hopkins Univ, Dept Med, Baltimore, MD 21205 USA; [Barin, Burc] EMMES Corp, Rockville, MD 20850 USA; [Rogers, Rodney; Stock, Peter G.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94122 USA	Johns Hopkins University; Emmes Corporation; University of California System; University of California San Francisco	Balagopal, A (corresponding author), Johns Hopkins Univ, Dept Med, Baltimore, MD 21205 USA.	abalago1@jhmi.edu		Quinn, Jeffrey/0000-0002-4734-5108	National Institute of Drug Abuse [DA 016078, DA 034621]; Johns Hopkins Center for AIDS Research [AI 094189]; National Institute of Allergy and Infectious Diseases [AI 052748]; EMMES; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI052748, P30AI094189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016078, K24DA034621] Funding Source: NIH RePORTER	National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Johns Hopkins Center for AIDS Research; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EMMES; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the National Institute of Drug Abuse: DA 016078 (AB); DA 034621 (MSS) Johns Hopkins Center for AIDS Research: AI 094189 (AB and MSS) National Institute of Allergy and Infectious Diseases: AI 052748 (PGS). EMMES provided support in the form of salary for author BB and other EMMES employees involved in the study design, data collection and analysis, and preparation of the manuscript. The EMMES Corporation otherwise did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balagopal A, 2008, GASTROENTEROLOGY, V135, P226, DOI 10.1053/j.gastro.2008.03.022; Balagopal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041258; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Charlton M, 2015, GASTROENTEROLOGY, V149, P649, DOI 10.1053/j.gastro.2015.05.010; Chattergoon MA, 2011, J INFECT DIS, V204, P1730, DOI 10.1093/infdis/jir642; Chen Y, 2008, TRANSPL P, V40, P2691, DOI 10.1016/j.transproceed.2008.08.014; Copaci Ionel, 2006, J Gastrointestin Liver Dis, V15, P363; Fox AN, 2012, SEMIN LIVER DIS, V32, P177, DOI 10.1055/s-0032-1316474; French AL, 2013, J INFECT DIS, V208, P679, DOI 10.1093/infdis/jit225; Goedert JJ, 2002, BLOOD, V100, P1584; Gras J, 2007, LIVER TRANSPLANT, V13, P426, DOI 10.1002/lt.21084; Limketkai BN, 2012, JAMA-J AM MED ASSOC, V308, P370, DOI 10.1001/jama.2012.7844; Louis H, 2000, HEPATOLOGY, V31, P381, DOI 10.1002/hep.510310218; Marchetti G, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-79; Meuleman P, 2006, CLIN CHIM ACTA, V366, P156, DOI 10.1016/j.cca.2005.09.022; Miro JM, 2012, AM J TRANSPLANT, V12, P1866, DOI 10.1111/j.1600-6143.2012.04028.x; Redd AD, 2013, AIDS RES HUM RETROV, V29, P1026, DOI [10.1089/aid.2013.0004, 10.1089/AID.2013.0004]; Sandler NG, 2011, GASTROENTEROLOGY, V141, P1220, DOI 10.1053/j.gastro.2011.06.063; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Subramanian A, 2010, GASTROENTEROLOGY, V138, P159, DOI 10.1053/j.gastro.2009.09.053; Terrault NA, 2012, LIVER TRANSPLANT, V18, P716, DOI 10.1002/lt.23411; Thomas DL, 2008, ANNU REV MED, V59, P473, DOI 10.1146/annurev.med.59.081906.081110; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; Thompson K, 1998, HEPATOLOGY, V28, P1597, DOI 10.1002/hep.510280620; Wan Renhua, 2012, Front Biosci (Elite Ed), V4, P2121; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Zhang LJ, 2006, WORLD J GASTROENTERO, V12, P1681, DOI 10.3748/wjg.v12.i11.1681	27	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0135882	10.1371/journal.pone.0135882	http://dx.doi.org/10.1371/journal.pone.0135882			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313939	Green Submitted, Green Published, gold			2022-12-26	WOS:000360144000029
J	del Toro, FJ; Aguilar, E; Hernandez-Walias, FJ; Tenllado, F; Chung, BN; Canto, T				del Toro, Francisco J.; Aguilar, Emmanuel; Hernandez-Walias, Francisco J.; Tenllado, Francisco; Chung, Bong-Nam; Canto, Tomas			High Temperature, High Ambient CO2 Affect the Interactions between Three Positive-Sense RNA Viruses and a Compatible Host Differentially, but not Their Silencing Suppression Efficiencies	PLOS ONE			English	Article							CUCUMBER-MOSAIC-VIRUS; ELEVATED CO2; NICOTIANA-BENTHAMIANA; TRANSIENT EXPRESSION; 20S PROTEASOME; PROTEIN; PLANT; ARABIDOPSIS; DEFENSE; TOBACCO	We compared infection of Nicotiana benthamiana plants by the positive-sense RNA viruses Cucumber mosaic virus (CMV), Potato virus Y (PVY), and by a Potato virus X (PVX) vector, the latter either unaltered or expressing the CMV 2b protein or the PVY HCPro suppressors of silencing, at 25 degrees C vs. 30 degrees C, or at standard (similar to 401 parts per million, ppm) vs. elevated (970 ppm) CO2 levels. We also assessed the activities of their suppressors of silencing under those conditions. We found that at 30 degrees C, accumulation of the CMV isolate and infection symptoms remained comparable to those at 25 degrees C, whereas accumulation of the PVY isolate and those of the three PVX constructs decreased markedly, even when expressing the heterologous suppressors 2b or HCPro, and plants had either very attenuated or no symptoms. Under elevated CO2 plants grew larger, but contained less total protein/unit of leaf area. In contrast to temperature, infection symptoms remained unaltered for the five viruses at elevated CO2 levels, but viral titers in leaf disks as a proportion of the total protein content increased in all cases, markedly for CMV, and less so for PVY and the PVX constructs. Despite these differences, we found that neither high temperature nor elevated CO2 prevented efficient suppression of silencing by their viral suppressors in agropatch assays. Our results suggest that the strength of antiviral silencing at high temperature or CO2 levels, or those of the viral suppressors that counteract it, may not be the main determinants of the observed infection outcomes.	[del Toro, Francisco J.; Aguilar, Emmanuel; Hernandez-Walias, Francisco J.; Tenllado, Francisco; Canto, Tomas] CSIC, Ctr Invest Biol, Dept Biol Medioambiental, E-28040 Madrid, Spain; [Chung, Bong-Nam] Natl Inst Hort & Herbal Sci, Agr Res Ctr Climate Change, Jeju 690150, Jeju Island, South Korea	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea	Chung, BN (corresponding author), Natl Inst Hort & Herbal Sci, Agr Res Ctr Climate Change, 281 Ayeon Ro, Jeju 690150, Jeju Island, South Korea.	chbn7567@korea.kr; tomas.canto@cib.csic.es	peralo, francisco tenllado/E-5804-2016	peralo, francisco tenllado/0000-0002-5349-7642; AGUILAR PARRAS, EMMANUEL/0000-0002-4814-4623	Rural Development Administration (RDA) of the Republic of Korea [PJ009461]; Spanish Council for Scientific Research (CSIC); Spanish Ministry of Economy and Competitiveness (MINECO) [BIO2013-47940-R]	Rural Development Administration (RDA) of the Republic of Korea(Rural Development Administration (RDA), Republic of Korea); Spanish Council for Scientific Research (CSIC); Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government)	This work was supported by grant PJ009461 from the Rural Development Administration (RDA) of the Republic of Korea (http://www.rda.go.kr/foreign/eng/), in cooperation with the Spanish Council for Scientific Research (CSIC; www.csic.es), and also by grant BIO2013-47940-R from the Spanish Ministry of Economy and Competitiveness (MINECO; http://www.mineco.gob.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballut L, 2005, J GEN VIROL, V86, P2595, DOI 10.1099/vir.0.81107-0; CANTO T, 1995, PLANT DIS, V79, P234, DOI 10.1094/PD-79-0234; Canto T, 2002, MOL PLANT MICROBE IN, V15, P1137, DOI 10.1094/MPMI.2002.15.11.1137; Canto T, 2009, GLOBAL CHANGE BIOL, V15, P1884, DOI 10.1111/j.1365-2486.2008.01820.x; Chellappan P, 2005, PLANT PHYSIOL, V138, P1828, DOI 10.1104/pp.105.066563; Cillo F, 2002, J VIROL, V76, P10654, DOI 10.1128/JVI.76.21.10654-10664.2002; del Toro F, 2014, MOL PLANT MICROBE IN, V27, P1331, DOI 10.1094/MPMI-05-14-0155-R; Del Toro F, 2014, MOL PLANT PATHOL, V15, P848, DOI 10.1111/mpp.12136; den Boon JA, 2010, CELL HOST MICROBE, V8, P77, DOI 10.1016/j.chom.2010.06.010; Dielen AS, 2011, MOL PLANT PATHOL, V12, P137, DOI 10.1111/j.1364-3703.2010.00654.x; Dujovny G, 2009, PLANT BIOTECHNOL J, V7, P49, DOI 10.1111/j.1467-7652.2008.00373.x; Feng JL, 2006, ACTA BIOCH BIOPH SIN, V38, P669, DOI [10.1111/j.1745-7270.2006.00216.x, 10.1111/J.1745-7270.2006.00216.x]; Garcia D, 2014, CELL HOST MICROBE, V16, P391, DOI 10.1016/j.chom.2014.08.001; Gonzalez I, 2010, MOL PLANT MICROBE IN, V23, P294, DOI 10.1094/MPMI-23-3-0294; Huang L, 2012, PLANT BIOLOGY, V14, P905, DOI 10.1111/j.1438-8677.2012.00582.x; Hull R., 2002, MATTHEWS PLANT VIROL; Jin YS, 2007, J VIROL, V81, P12881, DOI 10.1128/JVI.00913-07; Johansen LK, 2001, PLANT PHYSIOL, V126, P930, DOI 10.1104/pp.126.3.930; Lakatos L, 2006, EMBO J, V25, P2768, DOI 10.1038/sj.emboj.7601164; Liu LJ, 2010, PLANT J, V61, P893, DOI 10.1111/j.1365-313X.2009.04109.x; Lu R, 2003, EMBO J, V22, P5690, DOI 10.1093/emboj/cdg546; Matros A, 2006, PLANT CELL ENVIRON, V29, P126, DOI 10.1111/j.1365-3040.2005.01406.x; Moreno AA, 2011, BIOL RES, V44, P75, DOI 10.4067/S0716-97602011000100010; Nakahara KS, 2012, P NATL ACAD SCI USA, V109, P10113, DOI 10.1073/pnas.1201628109; Pacheco R, 2012, MOL PLANT MICROBE IN, V25, P709, DOI 10.1094/MPMI-11-11-0305; Pantaleo V, 2007, J VIROL, V81, P3797, DOI 10.1128/JVI.02383-06; Parmar VM, 2012, ADV EXP MED BIOL, V738, P153, DOI 10.1007/978-1-4614-1680-7_10; Prasch CM, 2013, PLANT PHYSIOL, V162, P1849, DOI 10.1104/pp.113.221044; Pritchard SG, 1999, GLOB CHANGE BIOL, V5, P807, DOI 10.1046/j.1365-2486.1999.00268.x; Qu F, 2005, J VIROL, V79, P15209, DOI 10.1128/JVI.79.24.15209-15217.2005; RIZZO TM, 1990, MOL GEN GENET, V222, P249, DOI 10.1007/BF00633825; Sahana N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052546; Schwach F, 2005, PLANT PHYSIOL, V138, P1842, DOI 10.1104/pp.105.063537; Sun YC, 2013, PLANT SCI, V210, P128, DOI 10.1016/j.plantsci.2013.05.014; Szittya G, 2003, EMBO J, V22, P633, DOI 10.1093/emboj/cdg74; Fernandez FT, 2013, MOL PLANT PATHOL, V14, P530, DOI 10.1111/mpp.12025; Velazquez K, 2010, PLANT PATHOL, V59, P982, DOI 10.1111/j.1365-3059.2010.02315.x; Verchot J, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00066; Voinnet O, 2000, CELL, V103, P157, DOI 10.1016/S0092-8674(00)00095-7; Wei TY, 2010, J VIROL, V84, P799, DOI 10.1128/JVI.01824-09; Ye LF, 2010, PLANT SCI, V179, P219, DOI 10.1016/j.plantsci.2010.05.004; Zhang S, 2015, J EXP BOT, V66, P1951, DOI 10.1093/jxb/eru538; Zhang XC, 2012, J VIROL, V86, P6847, DOI 10.1128/JVI.00497-12; Zhong SH, 2013, P NATL ACAD SCI USA, V110, P9171, DOI 10.1073/pnas.1219655110	44	27	27	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136062	10.1371/journal.pone.0136062	http://dx.doi.org/10.1371/journal.pone.0136062			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313753	Green Submitted, gold, Green Published			2022-12-26	WOS:000360144000039
J	Nemeth, Z; Cziraki, A; Szabados, S; Biri, B; Keki, S; Koller, A				Nemeth, Zoltan; Cziraki, Attila; Szabados, Sandor; Biri, Bernadett; Keki, Sandor; Koller, Akos			Elevated Levels of Asymmetric Dimethylarginine (ADMA) in the Pericardial Fluid of Cardiac Patients Correlate with Cardiac Hypertrophy	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; CHRONIC KIDNEY-DISEASE; NITRIC-OXIDE; L-ARGININE; ANGIOTENSIN-II; HEART; INCREASE; RISK; ENDOTHELIN-1; ACCUMULATION	Background Pericardial fluid (PF) contains several biologically active substances, which may provide information regarding the cardiac conditions. Nitric oxide (NO) has been implicated in cardiac remodeling. We hypothesized that L-arginine (L-Arg) precursor of NO-synthase (NOS) and asymmetric dimethylarginine (ADMA), an inhibitor of NOS, are present in PF of cardiac patients and their altered levels may contribute to altered cardiac morphology. Methods L-Arg and ADMA concentrations in plasma and PF, and echocardiographic parameters of patients undergoing coronary artery bypass graft (CABG, n = 28) or valve replacement (VR, n = 25) were determined. Results We have found LV hypertrophy in 35.7% of CABG, and 80% of VR patients. In all groups, plasma and PF L-Arg levels were higher than that of ADMA. Plasma L-Arg level was higher in CABG than VR (75.7 +/- 4.6 mu mol/L vs. 58.1 +/- 4.9 mu mol/L, p = 0.011), whereas PF ADMA level was higher in VR than CABG (0.9 +/- 0.0 mu mol/L vs. 0.7 +/- 0.0 mu mol/L, p = 0.009). L-Arg/ADMA ratio was lower in the VR than CABG (VRplasma: 76.1 +/- 6.6 vs. CABGplasma: 125.4 +/- 10.7, p = 0.004; VRPF: 81.7 +/- 4.8 vs. CABGPF: 110.4 +/- 7.2, p = 0.009). There was a positive correlation between plasma L-Arg and ADMA in CABG (r = 0.539, p = 0.015); and plasma and PF L-Arg in CABG (r = 0.357, p = 0.031); and plasma and PF ADMA in VR (r = 0.529, p = 0.003); and PF L-Arg and ADMA in both CABG and VR (CABG: r = 0.468, p = 0.006; VR: r = 0.371, p = 0.034). The following echocardiographic parameters were higher in VR compared to CABG: interventricular septum (14.7 +/- 0.5mm vs. 11.9 +/- 0.4mm, p = 0.000); posterior wall thickness (12.6 +/- 0.3 mm vs. 11.5 +/- 0.2 mm, p = 0.000); left ventricular (LV) mass (318.6 +/- 23.5 g vs. 234.6 +/- 12.3 g, p = 0.007); right ventricular (RV) (33.9 +/- 0.9 cm(2) vs. 29.7 +/- 0.7 cm(2), p = 0.004); right atrial (18.6 +/- 1.0 cm(2) vs. 15.4 +/- 0.6 cm(2), p = 0.020); left atrial (19.8 +/- 1.0 cm(2) vs. 16.9 +/- 0.6 cm(2), p = 0.033) areas. There was a positive correlation between plasma ADMA and RV area (r = 0.453, p = 0.011); PF ADMA and end-diastolic (r = 0.434, p = 0.015) and systolic diameter of LV (r = 0.487, p = 0.007); and negative correlation between PF ADMA and LV ejection fraction (r = -0.445, p = 0.013) in VR. Conclusion We suggest that elevated levels of ADMA in the PF of patients indicate upregulated RAS and reduced bioavailability of NO, which can contribute to the development of cardiac hypertrophy and remodeling.	[Nemeth, Zoltan; Koller, Akos] Univ Pecs, Sch Med, Dept Pathophysiol & Gerontol, Pecs, Hungary; [Nemeth, Zoltan; Koller, Akos] Univ Pecs, Sch Med, Szentagothai Res Ctr, Pecs, Hungary; [Cziraki, Attila; Szabados, Sandor] Univ Pecs, Sch Med, Inst Heart, Pecs, Hungary; [Biri, Bernadett; Keki, Sandor] Univ Debrecen, Fac Sci, Dept Appl Chem, Debrecen, Hungary; [Koller, Akos] Univ Phys Educ, Inst Nat Sci, Budapest, Hungary; [Koller, Akos] New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA	University of Pecs; University of Pecs; University of Pecs; University of Debrecen; University of Physical Education; New York Medical College	Koller, A (corresponding author), Univ Pecs, Sch Med, Dept Pathophysiol & Gerontol, Pecs, Hungary.	koller@nymc.edu	Ákos, Koller/Q-4672-2019	Cziraki MD.PhD. Professor., Attila/0000-0002-8231-3312	Hungarian Scientific Research Fund (OTKA) [K 108444, SROP-4.2.2.A-11/1/KONV-2012-0024, SPOR-4.2.2.A11/1/KONV-2012-0017]	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This study is sponsored by the Hungarian Scientific Research Fund (OTKA) K 108444, SROP-4.2.2.A-11/1/KONV-2012-0024, and SPOR-4.2.2.A11/1/KONV-2012-0017.	Ajtay Z, 2009, INT J MOL MED, V23, P651, DOI 10.3892/ijmm_00000176; AMANO J, 1993, CLIN SCI, V85, P165, DOI 10.1042/cs0850165; Baue A E, 1972, Ann Thorac Surg, V14, P81; Ben-Horin S, 2005, AM J MED, V118, P636, DOI 10.1016/j.amjmed.2005.01.066; Bode-Boger SM, 2007, PHARMACOL THERAPEUT, V114, P295, DOI 10.1016/j.pharmthera.2007.03.002; Celik M, 2012, CARDIOL J, V19, P29, DOI 10.5603/CJ.2012.0006; Chambers JB, 2009, EUR J ECHOCARDIOGR, V10, pI11, DOI 10.1093/ejechocard/jen240; Cziraki A, 2012, J CARDIOTHORAC SURG, V7, DOI 10.1186/1749-8090-7-23; Gomes RAD, 2008, ARQ BRAS CARDIOL, V91, P172, DOI 10.1590/S0066-782X2008001500006; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Fazekas L, 1999, LIFE SCI, V65, P1005, DOI 10.1016/S0024-3205(99)00331-8; Fernandez Angel L, 2008, Interact Cardiovasc Thorac Surg, V7, P373, DOI 10.1510/icvts.2007.168302; Gaasch WH, 2007, CIRCULATION, V116, P591, DOI 10.1161/CIRCULATIONAHA.107.716647; Gad MZ, 2010, BIOMARKERS, V15, P746, DOI 10.3109/1354750X.2010.519784; Garcia Jose Antonio Dias, 2008, Arq Bras Cardiol, V90, P409; Gelb BD, 2011, J CLIN INVEST, V121, P844, DOI 10.1172/JCI46399; GIBSON AT, 1978, J PHYSIOL-LONDON, V277, P367, DOI 10.1113/jphysiol.1978.sp012277; Hedner T, 2002, BLOOD PRESSURE, V11, P197, DOI 10.1080/08037050213763; HORKAY F, 1995, J CARDIOVASC PHARM, V26, pS502; Horkay F, 1997, LIFE SCI, V62, P267, DOI 10.1016/S0024-3205(97)01105-3; Horowitz JD, 2007, J CHROMATOGR B, V851, P42, DOI 10.1016/j.jchromb.2006.09.023; Hunter JC, 2009, J MOL CELL CARDIOL, V47, P810, DOI 10.1016/j.yjmcc.2009.09.012; HUTCHIN P, 1971, ARCH SURG-CHICAGO, V102, P28; Kielstein JT, 2002, J AM SOC NEPHROL, V13, P170, DOI 10.1681/ASN.V131170; Lu TM, 2003, CLIN CARDIOL, V26, P458, DOI 10.1002/clc.4960261006; Luneburg N, 2011, J NUTR, V141, P2186, DOI 10.3945/jn.111.148197; Luo ZM, 2010, HYPERTENSION, V56, P498, DOI 10.1161/HYPERTENSIONAHA.110.152959; Mancia G, 2014, BLOOD PRESSURE, V23, P3, DOI 10.3109/08037051.2014.868629; Matsushita K, 2009, J AM SOC NEPHROL, V20, P2617, DOI 10.1681/ASN.2009010025; Mihout F, 2011, J PATHOL, V223, P37, DOI 10.1002/path.2769; Mittermayer F, 2006, ARTERIOSCL THROM VAS, V26, P2536, DOI 10.1161/01.ATV.0000242801.38419.48; MOLLER P, 1983, GERONTOLOGY, V29, P1; Namiki A, 2003, JPN HEART J, V44, P633, DOI 10.1536/jhj.44.633; Napora M, 2012, POL ARCH MED WEWN, V122, P226, DOI 10.20452/pamw.1222; Ngo DTM, 2007, NITRIC OXIDE-BIOL CH, V16, P197, DOI 10.1016/j.niox.2006.10.003; Nonaka S, 2005, J CHROMATOGR A, V1066, P41, DOI 10.1016/j.chroma.2005.01.052; Pecchini P, 2012, J NEPHROL, V25, P1016, DOI 10.5301/jn.5000085; Pope AJ, 2009, PHARMACOL RES, V60, P461, DOI 10.1016/j.phrs.2009.07.016; Ronden RA, 2012, AM J PHYSIOL-RENAL, V303, pF149, DOI 10.1152/ajprenal.00045.2012; SADOSHIMA J, 1993, CIRC RES, V73, P413, DOI 10.1161/01.RES.73.3.413; Shah AM, 2000, PHARMACOL THERAPEUT, V86, P49, DOI 10.1016/S0163-7258(99)00072-8; Sharma V, 2012, AM J PHYSIOL-GASTR L, V303, pG435, DOI 10.1152/ajpgi.00268.2011; Sibal L, 2010, CURR CARDIOL REV, V6, P82, DOI 10.2174/157340310791162659; Simko F, 2000, PHYSIOL RES, V49, P37; Speeckaert MM, 2012, CLIN CHEM LAB MED, V50, P1597, DOI 10.1515/cclm-2012-0033; Teerlink T, 2005, VASC MED, V10, pS73, DOI 10.1191/1358863x05vm597oa; Teerlink T, 2007, J CHROMATOGR B, V851, P21, DOI 10.1016/j.jchromb.2006.07.024; Tirziu D, 2007, J CLIN INVEST, V117, P3188, DOI 10.1172/JCI32024; Toth J, 2007, HYPERTENSION, V49, P563, DOI 10.1161/01.HYP.0000256764.86208.3d; Turbucz P, 1998, J CARDIOVASC PHARM, V31, pS287, DOI 10.1097/00005344-199800001-00080; Ueda Seiji, 2007, Clin Exp Nephrol, V11, P115, DOI 10.1007/s10157-007-0471-x; Valkonen VP, 2001, LANCET, V358, P2127, DOI 10.1016/S0140-6736(01)07184-7; VALLANCE P, 1992, LANCET, V339, P572; VATNER DE, 1984, J CLIN INVEST, V73, P1473, DOI 10.1172/JCI111351; Veresh Z, 2008, HYPERTENSION, V52, P960, DOI 10.1161/HYPERTENSIONAHA.108.116731; Veresh Z, 2012, J VASC RES, V49, P363, DOI 10.1159/000337485; Visser M, 2010, EUR J HEART FAIL, V12, P1274, DOI 10.1093/eurjhf/hfq158; Wandt B, 1999, HEART, V82, P192, DOI 10.1136/hrt.82.2.192; Wolf C, 2012, INT J CARDIOL, V156, P289, DOI 10.1016/j.ijcard.2010.11.003; Zamora E, 2012, J AM COLL CARDIOL, V59, P1709, DOI 10.1016/j.jacc.2011.11.066; Zeller M, 2008, ARTERIOSCL THROM VAS, V28, P954, DOI 10.1161/ATVBAHA.108.162768; Zoccali C, 2002, KIDNEY INT, V62, P339, DOI 10.1046/j.1523-1755.2002.00437.x; Zsuga J, 2007, CEREBROVASC DIS, V23, P388, DOI 10.1159/000101461	63	12	13	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0135498	10.1371/journal.pone.0135498	http://dx.doi.org/10.1371/journal.pone.0135498			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313940	gold, Green Published, Green Submitted			2022-12-26	WOS:000360144000017
J	Santarriaga, S; Petersen, A; Ndukwe, K; Brandt, A; Gerges, N; Scaglione, JB; Scaglione, KM				Santarriaga, Stephanie; Petersen, Amber; Ndukwe, Kelechi; Brandt, Anthony; Gerges, Nashaat; Scaglione, Jamie Bruns; Scaglione, Kenneth Matthew			The Social Amoeba Dictyostelium discoideum Is Highly Resistant to Polyglutamine Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRANUCLEAR INCLUSIONS; CHAPERONE ACTIVITY; LEA PROTEINS; HUNTINGTIN; EXPRESSION; PROTEOME; DISEASES; NEURODEGENERATION; PROTEOSTASIS; EXPANSION	The expression, misfolding, and aggregation of long repetitive amino acid tracts are a major contributing factor in a number of neurodegenerative diseases, including C9ORF72 amyotrophic lateral sclerosis/frontotemporal dementia, fragile X tremor ataxia syndrome, myotonic dystrophy type 1, spinocerebellar ataxia type 8, and the nine polyglutamine diseases. Protein aggregation is a hallmark of each of these diseases. In model organisms, including yeast, worms, flies, mice, rats, and human cells, expression of proteins with the long repetitive amino acid tracts associated with these diseases recapitulates the protein aggregation that occurs in human disease. Here we show that the model organism Dictyostelium discoideum has evolved to normally encode long polyglutamine tracts and express these proteins in a soluble form. We also show that Dictyostelium has the capacity to suppress aggregation of a polyglutamine-expanded Huntingtin construct that aggregates to suppress aggregation of proteins with long polyglutamine tracts.	[Santarriaga, Stephanie; Ndukwe, Kelechi; Brandt, Anthony; Scaglione, Jamie Bruns; Scaglione, Kenneth Matthew] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Petersen, Amber; Gerges, Nashaat] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Santarriaga, Stephanie; Petersen, Amber; Ndukwe, Kelechi; Brandt, Anthony; Gerges, Nashaat; Scaglione, Jamie Bruns; Scaglione, Kenneth Matthew] Med Coll Wisconsin, Neuroscience Res Ctr, Neurosci Res Ctr, Milwaukee, WI 53226 USA; [Scaglione, Jamie Bruns] Carroll Univ, Dept Computat & Phys Sci, Waukesha, WI 53186 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Scaglione, KM (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	mscaglione@mcw.edu		Ndukwe, Kelechi/0000-0003-2940-2081; Scaglione, Kenneth/0000-0002-3858-9418	National Institutes of Health from the NINDS [R00 NS073936]; Research and Education Program, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS073936] Funding Source: NIH RePORTER	National Institutes of Health from the NINDS; Research and Education Program, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R00 NS073936 from the NINDS (to K. M. S.). This work was also supported by a grant from the Research and Education Program, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin (to K. M. S. and N. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Bilen J, 2007, PLOS GENET, V3, P1950, DOI 10.1371/journal.pgen.003177; Brehme M, 2014, CELL REP, V9, P1135, DOI 10.1016/j.celrep.2014.09.042; Carra S, 2005, HUM MOL GENET, V14, P1659, DOI 10.1093/hmg/ddi174; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Duennwald Martin L, 2013, Methods Mol Biol, V1017, P153, DOI 10.1007/978-1-62703-438-8_11; DURE L, 1989, PLANT MOL BIOL, V12, P475, DOI 10.1007/BF00036962; Eaton SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072457; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Fey P, 2007, NAT PROTOC, V2, P1307, DOI 10.1038/nprot.2007.178; Fuchs M, 2010, BIOCHEM J, V425, P245, DOI 10.1042/BJ20090907; Garay-Arroyo A, 2000, J BIOL CHEM, V275, P5668, DOI 10.1074/jbc.275.8.5668; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Hoekstra FA, 2001, CRYOBIOLOGY, V43, P140, DOI 10.1006/cryo.2001.2358; Kappe G, 2010, CELL STRESS CHAPERON, V15, P457, DOI 10.1007/s12192-009-0155-4; Kayatekin C, 2014, P NATL ACAD SCI USA, V111, P12085, DOI 10.1073/pnas.1412504111; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Koirala S, 2010, J CELL BIOL, V191, P1127, DOI 10.1083/jcb.201005046; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Li SH, 1998, HUM MOL GENET, V7, P777, DOI 10.1093/hmg/7.5.777; Liu GB, 2015, J BIOTECHNOL, V207, P39, DOI 10.1016/j.jbiotec.2015.05.003; Liu Y, 2011, FEBS LETT, V585, P630, DOI 10.1016/j.febslet.2011.01.020; Malinovska L, 2015, P NATL ACAD SCI USA, V112, pE2620, DOI 10.1073/pnas.1504459112; Marsh JL, 2009, J BIOL CHEM, V284, P7431, DOI 10.1074/jbc.R800065200; Matsumoto G, 2005, J CELL BIOL, V171, P75, DOI 10.1083/jcb.200504050; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Morimoto RI, 2014, J GERONTOL A-BIOL, V69, pS33, DOI 10.1093/gerona/glu049; Muralidharan V, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2306; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Pang KM, 1999, PLASMID, V41, P187, DOI 10.1006/plas.1999.1391; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Petersen A, 2015, SCI REP-UK, V5, DOI 10.1038/srep11135; Rines DR, 2011, COLD SPRING HARB PRO, V2011; Ripaud L, 2014, P NATL ACAD SCI USA, V111, P18219, DOI 10.1073/pnas.1421313111; Robertson AL, 2010, P NATL ACAD SCI USA, V107, P10424, DOI 10.1073/pnas.0914773107; Scala C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046150; Switonski PM, 2012, MOL NEUROBIOL, V46, P430, DOI 10.1007/s12035-012-8316-3; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004; Yang S, 2014, NEURON, V81, P349, DOI 10.1016/j.neuron.2013.12.002; Yu ZM, 2011, INT REV NEUROBIOL, V99, P191, DOI 10.1016/B978-0-12-387003-2.00008-2; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602	42	21	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25571	25578		10.1074/jbc.M115.676247	http://dx.doi.org/10.1074/jbc.M115.676247			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26330554	hybrid, Green Published			2022-12-26	WOS:000362962800031
J	Gilman, CA; Imburgia, MJ; Bartlett, MD; King, DR; Crosby, AJ; Irschick, DJ				Gilman, Casey A.; Imburgia, Michael J.; Bartlett, Michael D.; King, Daniel R.; Crosby, Alfred J.; Irschick, Duncan J.			Geckos as Springs: Mechanics Explain Across-Species Scaling of Adhesion	PLOS ONE			English	Article							CLINGING ABILITY; HABITAT USE; MORPHOLOGY; REPTILIA; FORCE; PERFORMANCE; BEARING; PAD	One of the central controversies regarding the evolution of adhesion concerns how adhesive force scales as animals change in size, either among or within species. A widely held view is that as animals become larger, the primary mechanism that enables them to climb is increasing pad area. However, prior studies show that much of the variation in maximum adhesive force remains unexplained, even when area is accounted for. We tested the hypothesis that maximum adhesive force among pad-bearing gecko species is not solely dictated by toepad area, but also depends on the ratio of toepad area to gecko adhesive system compliance in the loading direction, where compliance (C) is the change in extension (Delta) relative to a change in force (F) while loading a gecko's adhesive system (C = d Delta/dF). Geckos are well-known for their ability to climb on a range of vertical and overhanging surfaces, and range in mass from several grams to over 300 grams, yet little is understood of the factors that enable adhesion to scale with body size. We examined the maximum adhesive force of six gecko species that vary in body size (similar to 2-100 g). We also examined changes between juveniles and adults within a single species (Phelsuma grandis). We found that maximum adhesive force and toepad area increased with increasing gecko size, and that as gecko species become larger, their adhesive systems become significantly less compliant. Additionally, our hypothesis was supported, as the best predictor of maximum adhesive force was not toepad area or compliance alone, but the ratio of toepad area to compliance. We verified this result using a synthetic "model gecko" system comprised of synthetic adhesive pads attached to a glass substrate and a synthetic tendon (mechanical spring) of finite stiffness. Our data indicate that increases in toepad area as geckos become larger cannot fully account for increased adhesive abilities, and decreased compliance must be included to explain the scaling of adhesion in animals with dry adhesion systems.	[Gilman, Casey A.; Irschick, Duncan J.] Univ Massachusetts, Grad Program Organism & Evolutionary Biol, Amherst, MA 01003 USA; [Imburgia, Michael J.; Bartlett, Michael D.; King, Daniel R.; Crosby, Alfred J.] Univ Massachusetts, Polymer Sci & Engn Dept, Amherst, MA 01003 USA; [Irschick, Duncan J.] Univ Massachusetts, Dept Biol, Amherst, MA USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Crosby, AJ (corresponding author), Univ Massachusetts, Polymer Sci & Engn Dept, Amherst, MA 01003 USA.	crosby@mail.pse.umass.edu; irschick@bio.umass.edu	King, Daniel/K-6804-2019; Bartlett, Michael/A-7061-2017	King, Daniel/0000-0002-1377-5556; Bartlett, Michael/0000-0002-7391-5135; Crosby, Alfred/0000-0001-8850-8869	Human Frontiers Science Program [RGP -0034-2012]; HFSP	Human Frontiers Science Program(Human Frontier Science Program); HFSP(Human Frontier Science Program)	This work was supported by Human Frontiers Science Program grant to D. Irschick, A. Crosby and W. Federle (RGP -0034-2012, www.hfsp.org). HFSP provided funding and the authors have shown them the data in the form of a presentation in the summer of 2014 at a meeting; however, they have not participated in any aspect of the science.	Arzt E, 2003, P NATL ACAD SCI USA, V100, P10603, DOI 10.1073/pnas.1534701100; Autumn K, 2006, AM SCI, V94, P124, DOI 10.1511/2006.58.124; Autumn K, 2002, P NATL ACAD SCI USA, V99, P12252, DOI 10.1073/pnas.192252799; Autumn K, 2000, NATURE, V405, P681, DOI 10.1038/35015073; Autumn K, 2008, PHILOS T R SOC A, V366, P1575, DOI 10.1098/rsta.2007.2173; BARQUINS M, 1983, J APPL POLYM SCI, V28, P2647, DOI 10.1002/app.1983.070280816; Bartlett MD, 2013, LANGMUIR, V29, P11022, DOI 10.1021/la4013526; Bartlett MD, 2012, ADV FUNCT MATER, V22, P4985, DOI 10.1002/adfm.201201344; Bartlett MD, 2012, ADV MATER, V24, P1078, DOI 10.1002/adma.201104191; Bauer A.M., 1986, P363; BAUER AM, 1988, CAN J ZOOL, V66, P1583, DOI 10.1139/z88-231; Bergmann PJ, 2005, J EXP ZOOL PART A, V303A, P785, DOI 10.1002/jez.a.210; Creton C, 2007, MRS BULL, V32, P466, DOI 10.1557/mrs2007.79; Elstrott J, 2004, BIOL J LINN SOC, V83, P389, DOI 10.1111/j.1095-8312.2004.00402.x; ERNST V, 1966, J MORPHOL, V120, P233, DOI 10.1002/jmor.1051200303; Federle W, 2006, J R SOC INTERFACE, V3, P689, DOI 10.1098/rsif.2006.0135; Gamble C, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039429, 10.1371/journal.pone.0035982]; Gillies AG, 2014, J EXP BIOL, V217, P283, DOI 10.1242/jeb.092015; Gorb SN, 1998, P ROY SOC B-BIOL SCI, V265, P747, DOI 10.1098/rspb.1998.0356; Huber G, 2005, BIOL LETTERS, V1, P2, DOI 10.1098/rsbl.2004.0254; Irschick DJ, 2005, BIOL J LINN SOC, V85, P211, DOI 10.1111/j.1095-8312.2005.00486.x; Irschick DJ, 1996, BIOL J LINN SOC, V59, P21, DOI 10.1111/j.1095-8312.1996.tb01451.x; Irschick DJ, 2006, J COMP PHYSIOL A, V192, P1169, DOI 10.1007/s00359-006-0145-2; Jeong HE, 2009, NANO TODAY, V4, P335, DOI 10.1016/j.nantod.2009.06.004; Johnson K. L., 1985, CONTACT MECH, DOI 10.1201/b17110-2; King DR, 2014, ADV MATER, V26, P4345, DOI 10.1002/adma.201306259; Lee H, 2007, NATURE, V448, P338, DOI 10.1038/nature05968; Meiri S, 2010, J ZOOL, V281, P218, DOI 10.1111/j.1469-7998.2010.00696.x; Peattie AM, 2007, P NATL ACAD SCI USA, V104, P18595, DOI 10.1073/pnas.0707591104; Russell A.P., 1976, Linnean Soc Symp Ser, V3, P217; Russell AP, 2014, ACTA ZOOL-STOCKHOLM, V95, P299, DOI 10.1111/azo.12028; Russell AP, 2002, INTEGR COMP BIOL, V42, P1154, DOI 10.1093/icb/42.6.1154; RUSSELL AP, 1986, CAN J ZOOL, V64, P948, DOI 10.1139/z86-144; Sameoto D, 2010, SMART MATER STRUCT, V19, DOI 10.1088/0964-1726/19/10/103001; Scherge M., 2001, BIOL MICRO NANOTRIBO; Webster NB, 2009, ACTA ZOOL-STOCKHOLM, V90, P18, DOI 10.1111/j.1463-6395.2008.00324.x; WILLIAMS EE, 1982, SCIENCE, V215, P1509, DOI 10.1126/science.215.4539.1509	37	26	26	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0134604	10.1371/journal.pone.0134604	http://dx.doi.org/10.1371/journal.pone.0134604			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331621	gold, Green Submitted, Green Published			2022-12-26	WOS:000360613800012
J	Prause, N; Park, J; Leung, S; Miller, G				Prause, Nicole; Park, Jaymie; Leung, Shannon; Miller, Geoffrey			Women's Preferences for Penis Size: A New Research Method Using Selection among 3D Models	PLOS ONE			English	Article							UNITED-STATES; LENGTHENING PROCEDURES; CATEGORY KNOWLEDGE; SEXUAL HEALTH; HUMAN VAGINA; CONDOM USE; YOUNG MEN; INTERCOURSE; EXPERIENCE; DIMENSIONS	Women's preferences for penis size may affect men's comfort with their own bodies and may have implications for sexual health. Studies of women's penis size preferences typically have relied on their abstract ratings or selecting amongst 2D, flaccid images. This study used haptic stimuli to allow assessment of women's size recall accuracy for the first time, as well as examine their preferences for erect penis sizes in different relationship contexts. Women (N = 75) selected amongst 33, 3D models. Women recalled model size accurately using this method, although they made more errors with respect to penis length than circumference. Women preferred a penis of slightly larger circumference and length for one-time (length = 6.4 inches/16.3 cm, circumference = 5.0 inches/12.7 cm) versus long-term (length = 6.3 inches/16.0 cm, circumference = 4.8 inches/12.2 cm) sexual partners. These first estimates of erect penis size preferences using 3D models suggest women accurately recall size and prefer penises only slightly larger than average.	[Prause, Nicole; Park, Jaymie; Leung, Shannon] Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90089 USA; [Miller, Geoffrey] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA	University of California System; University of California Los Angeles; University of New Mexico	Prause, N (corresponding author), Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90089 USA.	nicole.prause@gmail.com	Miller, Geoffrey/C-4145-2008	Miller, Geoffrey/0000-0002-6026-5372; Leung, Shannon/0000-0002-0855-3780				Althof SE, 2003, UROLOGY, V61, P888, DOI 10.1016/S0090-4295(03)00041-4; Anderson Sarah L, 2008, J Forensic Leg Med, V15, P306, DOI 10.1016/j.jflm.2007.12.007; Armstrong EA, 2012, AM SOCIOL REV, V77, P435, DOI 10.1177/0003122412445802; Awwad Z, 2005, INT J IMPOT RES, V17, P191, DOI 10.1038/sj.ijir.3901272; Backman K, TINKERCAD; Barnhart KT, 2006, HUM REPROD, V21, P1618, DOI 10.1093/humrep/del022; Baskin LS, 1997, J UROLOGY, V158, P1113, DOI 10.1016/S0022-5347(01)64400-8; Berman JR, 2000, EUR UROL, V38, P20, DOI 10.1159/000020247; Boas M, 2006, EUR J ENDOCRINOL, V154, P125, DOI 10.1530/eje.1.02066; Brody S, 2010, J SEX MED, V7, P2774, DOI 10.1111/j.1743-6109.2009.01469.x; Bunzeck N, 2012, HUM BRAIN MAPP, V33, P1309, DOI 10.1002/hbm.21288; Cheng PS, 2001, HORM RES, V55, P278, DOI 10.1159/000050013; Choi IH, 2011, ASIAN J ANDROL, V13, P710, DOI 10.1038/aja.2011.75; Crosby RA, 2013, J PRIM PREV, V34, P109, DOI 10.1007/s10935-013-0294-3; Dixson BJ, 2007, AM J HUM BIOL, V19, P88, DOI 10.1002/ajhb.20584; Dixson BJ, 2014, EVOL HUM BEHAV, V35, P73, DOI 10.1016/j.evolhumbehav.2013.10.003; Eisenman Russell, 2001, BMC Womens Health, V1, P1, DOI 10.1186/1472-6874-1-1; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Eschenbach DA, 2001, J INFECT DIS, V183, P913, DOI 10.1086/319251; Evans S, 2008, PHYSIOL BEHAV, V93, P783, DOI 10.1016/j.physbeh.2007.11.033; Fennell J, 2014, CONTRACEPTION, V89, P264, DOI 10.1016/j.contraception.2013.11.012; FISHER WA, 1983, J SEX RES, V19, P377, DOI 10.1080/00224498309551199; Francken AB, 2002, EUR UROL, V42, P426, DOI 10.1016/S0302-2838(02)00396-2; Furr KD, 1991, ANNALS OF SEX RESEAR, V4, P265; Gaissert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043062; Gaissert N, 2010, J VISION, V10, DOI 10.1167/10.11.2; Gebhard P, 1979, THE KINSEY DATA MARG; Grov C, 2010, ARCH SEX BEHAV, V39, P788, DOI 10.1007/s10508-008-9439-5; Herbenick D, 2014, J SEX MED, V11, P93, DOI 10.1111/jsm.12244; Herbenick D, 2013, J SEX MED, V10, P1516, DOI 10.1111/jsm.12124; Hoeken Z, 2012, REPLICATORG; Johnston L, 2014, PSYCHOLOGY OF MEN MA; Johnston L, 2014, PSYCHOL MEN MASCULIN, V15, P225, DOI 10.1037/a0033264; Jonason PK, 2011, J SEX RES, V48, P486, DOI 10.1080/00224499.2010.497984; Kang DH, 2012, AESTHET PLAST SURG, V36, P813, DOI 10.1007/s00266-012-9891-4; Khan S, 2012, BJU INT, V109, P740, DOI 10.1111/j.1464-410X.2011.10338.x; Kissinger P, 2013, SEX TRANSM INFECT, V89, pA38, DOI 10.1136/sextrans-2013-051184.0119; Kvalem I. L., 2014, CYBERPSYCHOLOGY, V8, DOI [10.5817/CP2014-4-4, DOI 10.5817/CP2014-4-4]; Lang P. J., 2008, TECHNICAL REPORT A 8; Lawrance KA, 1995, PERS RELATIONSHIP, V2, P267, DOI 10.1111/j.1475-6811.1995.tb00092.x; Lawson R, 2014, ATTEN PERCEPT PSYCHO, V76, P541, DOI 10.3758/s13414-013-0559-1; Lee AJ, 2014, EVOL HUM BEHAV, V35, P193, DOI 10.1016/j.evolhumbehav.2014.01.003; Li NP, 2006, J PERS SOC PSYCHOL, V90, P468, DOI 10.1037/0022-3514.90.3.468; Little AC, 2002, P ROY SOC B-BIOL SCI, V269, P1095, DOI 10.1098/rspb.2002.1984; LOCKE SD, 1995, J SOC BEHAV PERS, V10, P255; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Lykins AD, 2008, ARCH SEX BEHAV, V37, P219, DOI 10.1007/s10508-007-9208-x; Mautz BS, 2013, P NATL ACAD SCI USA, V110, P6925, DOI 10.1073/pnas.1219361110; Mondaini N, 2002, INT J IMPOT RES, V14, P283, DOI 10.1038/sj.ijir.3900887; Nabil N, 2013, UROL INT, V90, P465, DOI 10.1159/000347044; Norman JF, 2011, ATTEN PERCEPT PSYCHO, V73, P908, DOI 10.3758/s13414-010-0053-y; Nugteren HM, 2010, J SEX MARITAL THER, V36, P109, DOI 10.1080/00926230903554438; Nummenmaa L, 2012, ARCH SEX BEHAV, V41, P1439, DOI 10.1007/s10508-012-9911-0; Pendergrass PB, 2003, GYNECOL OBSTET INVES, V55, P110, DOI 10.1159/000070184; Peter J, 2014, COMPUT HUM BEHAV, V36, P297, DOI 10.1016/j.chb.2014.03.071; Ponchietti R, 2001, EUR UROL, V39, P183, DOI 10.1159/000052434; Prah P, 2014, SEX TRANSM INFECT, V90, P90, DOI 10.1136/sextrans-2013-051360; RICHTERS J, 1995, VENEREOLOGY, V8, P77; Royer HR, 2013, J PEDIATR ADOL GYNEC, V26, P109, DOI 10.1016/j.jpag.2012.11.007; Schneider T, 2001, UROLOGY, V57, P314, DOI 10.1016/S0090-4295(00)00925-0; Sengezer M, 2002, ANN PLAS SURG, V48, P381; Shah J, 2002, BJU INT, V90, P586, DOI 10.1046/j.1464-410X.2002.02974.x; Siminoski K, 1993, ANN SEX RES, V6, P231, DOI DOI 10.1007/BF00849563; SIMPSON JA, 1991, J PERS SOC PSYCHOL, V60, P870, DOI 10.1037/0022-3514.60.6.870; Simpson VJ, 2014, ARCH SEX BEHAV, V43, P1367, DOI 10.1007/s10508-014-0289-z; SOPER DE, 1991, CONTRACEPTION, V44, P21, DOI 10.1016/0010-7824(91)90103-M; Soylemez H, 2012, INT J IMPOT RES, V24, P126, DOI 10.1038/ijir.2011.53; Spector IP, 1996, J SEX MARITAL THER, V22, P175; Stulhofer A, 2006, ARCH SEX BEHAV, V35, P5, DOI 10.1007/s10508-006-8989-7; Tiggemann M, 2008, J HEALTH PSYCHOL, V13, P1163, DOI 10.1177/1359105308095971; Udelson D, 1999, INT J IMPOT RES, V11, P327, DOI 10.1038/sj.ijir.3900443; Vardi Y, 2000, UROLOGY, V56, P1035, DOI 10.1016/S0090-4295(00)00850-5; Veale D, 2014, J SEX MED, V11, P84, DOI 10.1111/jsm.12294; Wallen K, 2011, HORM BEHAV, V59, P780, DOI 10.1016/j.yhbeh.2010.12.004; Wallraven C, 2014, PSYCHON B REV, V21, P995, DOI 10.3758/s13423-013-0577-y; Wallraven C, 2014, PSYCHON B REV, V21, P976, DOI 10.3758/s13423-013-0563-4; WEIS DL, 1985, ARCH SEX BEHAV, V14, P421, DOI 10.1007/BF01542003; Wessells H, 1996, J UROLOGY, V156, P995, DOI 10.1016/S0022-5347(01)65682-9; Yildirim I, 2013, COGNITION, V126, P135, DOI 10.1016/j.cognition.2012.08.005; Zink T, 2010, J EMERG MED, V39, P113, DOI 10.1016/j.jemermed.2008.08.024	80	26	26	4	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0133079	10.1371/journal.pone.0133079	http://dx.doi.org/10.1371/journal.pone.0133079			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ4ZT	26332467	Green Submitted, gold, Green Published			2022-12-26	WOS:000360613800003
J	Ueyama, T; Donishi, T; Ukai, S; Yamamoto, Y; Ishida, T; Tamagawa, S; Hotomi, M; Shinosaki, K; Yamanaka, N; Kaneoke, Y				Ueyama, Takashi; Donishi, Tomohiro; Ukai, Satoshi; Yamamoto, Yuta; Ishida, Takuya; Tamagawa, Shunji; Hotomi, Muneki; Shinosaki, Kazuhiro; Yamanaka, Noboru; Kaneoke, Yoshiki			Alterations of Regional Cerebral Blood Flow in Tinnitus Patients as Assessed Using Single-Photon Emission Computed Tomography	PLOS ONE			English	Article							SCORE IMAGING-SYSTEM; ALZHEIMERS-DISEASE; SPECT; PERFUSION; DISCRIMINATION; STIMULATION; MECHANISMS; ANATOMY; NETWORK; CORTEX	Tinnitus is the perception of phantom sound without an external auditory stimulus. Using neuroimaging techniques, such as positron emission tomography, electroencephalography, magnetoencephalography, and functional magnetic resonance imaging (fMRI), many studies have demonstrated that abnormal functions of the central nervous system are closely associated with tinnitus. In our previous research, we reported using resting-state fMRI that several brain regions, including the rectus gyrus, cingulate gyrus, thalamus, hippocampus, caudate, inferior temporal gyrus, cerebellar hemisphere, and medial superior frontal gyrus, were associated with tinnitus distress and loudness. To reconfirm these results and probe target regions for repetitive transcranial magnetic stimulation (rTMS), we investigated the regional cerebral blood flow (rCBF) between younger tinnitus patients (<60 years old) and the age-matched controls using single-photon emission computed tomography and easy Z-score imaging system. Compared with that of controls, the rCBF of tinnitus patients was significantly lower in the bilateral medial superior frontal gyri, left middle occipital gyrus and significantly higher in the bilateral cerebellar hemispheres and vermis, bilateral middle temporal gyri, right fusiform gyrus. No clear differences were observed between tinnitus patients with normal and impaired hearing. Regardless of the assessment modality, similar brain regions were identified as characteristic in tinnitus patients. These regions are potentially involved in the pathophysiology of chronic subjective tinnitus.	[Ueyama, Takashi; Yamamoto, Yuta] Wakayama Med Univ, Grad Sch, Dept Anat & Cell Biol, Wakayama, Japan; [Donishi, Tomohiro; Ishida, Takuya; Kaneoke, Yoshiki] Wakayama Med Univ, Grad Sch, Dept Syst Neurophysiol, Wakayama, Japan; [Ukai, Satoshi; Shinosaki, Kazuhiro] Wakayama Med Univ, Grad Sch, Dept Neuropsychiat, Wakayama, Japan; [Tamagawa, Shunji; Hotomi, Muneki; Yamanaka, Noboru] Wakayama Med Univ, Grad Sch, Dept Otolaryngol Head & Neck Surg, Wakayama, Japan	Wakayama Medical University; Wakayama Medical University; Wakayama Medical University; Wakayama Medical University	Ueyama, T (corresponding author), Wakayama Med Univ, Grad Sch, Dept Anat & Cell Biol, Wakayama, Japan.	tueyama@wakayama-med.ac.jp	Yamamoto, Yuta/R-1143-2019	Yamamoto, Yuta/0000-0001-5225-6989; Ukai, Satoshi/0000-0002-9776-8379	Grants-in-Aid for Scientific Research [24590895, 15K19291] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Adjamian P, 2009, HEARING RES, V253, P15, DOI 10.1016/j.heares.2009.04.001; Arnold W, 1996, ORL J OTO-RHINO-LARY, V58, P195, DOI 10.1159/000276835; AXELSSON A, 1989, British Journal of Audiology, V23, P53, DOI 10.3109/03005368909077819; Baguley D, 2013, LANCET, V382, P1600, DOI 10.1016/S0140-6736(13)60142-7; Bauer CA, 2013, HEARING RES, V295, P130, DOI 10.1016/j.heares.2012.03.009; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Burton H, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-3; Chan Yvonne, 2009, Discov Med, V8, P133; Elgoyhen AB, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00001; Farhadi M, 2010, J CEREBR BLOOD F MET, V30, P864, DOI 10.1038/jcbfm.2009.254; Fujii K, 2011, J EPIDEMIOL, V21, P299, DOI 10.2188/jea.JE20100124; Gardner A, 2002, NUCL MED COMMUN, V23, P429, DOI 10.1097/00006231-200205000-00002; Geven LI, 2014, NEUROSCIENCE, V256, P117, DOI 10.1016/j.neuroscience.2013.10.015; Husain FT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026639; Husain FT, 2011, BRAIN RES, V1369, P74, DOI 10.1016/j.brainres.2010.10.095; JASTREBOFF PJ, 1990, NEUROSCI RES, V8, P221, DOI 10.1016/0168-0102(90)90031-9; Kanetaka H, 2004, EUR J NUCL MED MOL I, V31, P975, DOI 10.1007/s00259-004-1491-3; Kleinjung T, 2005, OTOLARYNG HEAD NECK, V132, P566, DOI 10.1016/j.otohns.2004.09.134; Langguth B, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00015; Laureano MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087839; Lockwood AH, 1999, CEREB CORTEX, V9, P65, DOI 10.1093/cercor/9.1.65; Mahmoudian Saeid, 2013, Int Tinnitus J, V18, P20, DOI 10.5935/0946-5448.20130004; Mahmoudian S, 2012, J RES MED SCI, V17, P242; Matsuda H, 2007, AM J NEURORADIOL, V28, P731; Matsuda H, 2004, NUCL MED COMMUN, V25, P67, DOI 10.1097/00006231-200401000-00010; Matsuda H, 2007, J NUCL MED, V48, P1289, DOI 10.2967/jnumed.106.037218; Matsuda H, 2007, NUCL MED COMMUN, V28, P199, DOI 10.1097/MNM.0b013e328013eb8b; Maudoux A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036222; Mizumura Sunao, 2006, Radiat Med, V24, P545, DOI 10.1007/s11604-006-0056-8; Newman CW, 1996, ARCH OTOLARYNGOL, V122, P143; Pastor MA, 2008, J NEUROPHYSIOL, V100, P1699, DOI 10.1152/jn.01156.2007; Pastor MA, 2002, J NEUROSCI, V22, P10501; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Sataloff RT, 1996, AM J OTOL, V17, P909; Shulman, 1995, Int Tinnitus J, V1, P13; Siedentopf CM, 2007, NEUROSCI LETT, V411, P189, DOI 10.1016/j.neulet.2006.08.049; Takahashi S, 2015, NEUROCASE, V21, P339, DOI 10.1080/13554794.2014.893000; Tunkel D. E., 2014, OTOLARYNG HEAD NE S2, V151, pS1, DOI DOI 10.1177/0194599814545325; Ueyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067778; Vesterager V, 1997, BRIT MED J, V314, P728, DOI 10.1136/bmj.314.7082.728; Yamamoto Y, 2015, PHYSL GENOMICS; Yonekura Y, 1996, Ann Nucl Med, V10, P177	43	15	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137291	10.1371/journal.pone.0137291	http://dx.doi.org/10.1371/journal.pone.0137291			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332128	Green Published, Green Submitted, gold			2022-12-26	WOS:000360613800117
J	Amat-ur-Rasool, H; Ahmed, M				Amat-ur-Rasool, Hafsa; Ahmed, Mehboob			Designing Second Generation Anti-Alzheimer Compounds as Inhibitors of Human Acetylcholinesterase: Computational Screening of Synthetic Molecules and Dietary Phytochemicals	PLOS ONE			English	Article							CHOLINESTERASE-INHIBITORS; TORPEDO-CALIFORNICA; DRUG-DELIVERY; DISEASE; GALANTHAMINE; ALKALOIDS; COMPLEX; PLANTS; WEB	Alzheimer's disease (AD), a big cause of memory loss, is a progressive neurodegenerative disorder. The disease leads to irreversible loss of neurons that result in reduced level of acetylcholine neurotransmitter (ACh). The reduction of ACh level impairs brain functioning. One aspect of AD therapy is to maintain ACh level up to a safe limit, by blocking acetylcholinesterase (AChE), an enzyme that is naturally responsible for its degradation. This research presents an in-silico screening and designing of hAChE inhibitors as potential anti-Alzheimer drugs. Molecular docking results of the database retrieved (synthetic chemicals and dietary phytochemicals) and self-drawn ligands were compared with Food and Drug Administration (FDA) approved drugs against AD as controls. Furthermore, computational ADME studies were performed on the hits to assess their safety. Human AChE was found to be most approptiate target site as compared to commonly used Torpedo AChE. Among the tested dietry phytochemicals, berberastine, berberine, yohimbine, sanguinarine, elemol and naringenin are the worth mentioning phytochemicals as potential anti-Alzheimer drugs The synthetic leads were mostly dual binding site inhibitors with two binding subunits linked by a carbon chain i.e. second generation AD drugs. Fifteen new heterodimers were designed that were computationally more efficient inhibitors than previously reported compounds. Using computational methods, compounds present in online chemical databases can be screened to design more efficient and safer drugs against cognitive symptoms of AD.	[Amat-ur-Rasool, Hafsa; Ahmed, Mehboob] Univ Punjab, Dept Microbiol & Mol Genet, Lahore, Pakistan; [Amat-ur-Rasool, Hafsa] Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore, Pakistan	University of Punjab; National Center of Excellence in Molecular Biology - Pakistan; University of Punjab	Ahmed, M (corresponding author), Univ Punjab, Dept Microbiol & Mol Genet, Lahore, Pakistan.	mehboob.mmg@pu.edu.pk	Ahmed, Mehboob/M-1936-2019	Ahmed, Mehboob/0000-0002-6363-9050; Amat Ur Rasool, D. Hafsa/0000-0001-9664-3796				Abascal K, 2002, ALTERNATIVE COMPLEME, V8, P284; Alzheimer's Disease International, DEM STAT 2015; Amat-ur-Rasool H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119854; [Anonymous], 2012, CONSUMER REPORTS; ASHANI Y, 1992, BIOCHEM BIOPH RES CO, V184, P719, DOI 10.1016/0006-291X(92)90649-6; Bartolucci C, 2001, PROTEINS, V42, P182, DOI 10.1002/1097-0134(20010201)42:2<182::AID-PROT50>3.0.CO;2-1; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Boado RJ, 1998, J PHARM SCI-US, V87, P1308, DOI 10.1021/js9800836; Cavalli A, 2008, J MED CHEM, V51, P347, DOI 10.1021/jm7009364; Cheung J, 2012, J MED CHEM, V55, P10282, DOI 10.1021/jm300871x; Cummings JL, 2002, JAMA-J AM MED ASSOC, V287, P2335, DOI 10.1001/jama.287.18.2335; DAVIES P, 1976, LANCET, V2, P1403; Duke J, DR DUKES PHYTOCHEMIC; Dvir H, 2002, BIOCHEMISTRY-US, V41, P10810, DOI 10.1021/bi020151+; FARNSWORTH NR, 1967, J PHARM SCI-US, V56, P23, DOI 10.1002/jps.2600560104; Giacobini E, 1998, NEUROCHEM INT, V32, P413, DOI 10.1016/S0197-0186(97)00124-1; Greenblatt HM, 1999, FEBS LETT, V463, P321, DOI 10.1016/S0014-5793(99)01637-3; Grutzendler J, 2001, DRUGS, V61, P41, DOI 10.2165/00003495-200161010-00005; Heinrich M, 2004, J ETHNOPHARMACOL, V92, P147, DOI 10.1016/j.jep.2004.02.012; Heo HJ, 2004, DEMENT GERIATR COGN, V17, P151, DOI 10.1159/000076349; Hoffmann D., 2003, MED HERBALISM SCI PR; Holland D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042325; Houghton PJ, 2006, NAT PROD REP, V23, P181, DOI 10.1039/b508966m; Imanshahidi M, 2008, PHYTOTHER RES, V22, P999, DOI 10.1002/ptr.2399; Iversen L, 1977, SYNAPSES, P137; Jann MW, 2000, PHARMACOTHERAPY, V20, P1, DOI 10.1592/phco.20.1.1.34664; Ji HF, 2011, MOLECULES, V16, P6732, DOI 10.3390/molecules16086732; Kaduszkiewicz H, 2005, BMJ-BRIT MED J, V331, P321, DOI 10.1136/bmj.331.7512.321; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim J, 2010, J NEUROCHEM, V112, P1415, DOI 10.1111/j.1471-4159.2009.06562.x; Kryger G, 1999, STRUCTURE, V7, P297, DOI 10.1016/S0969-2126(99)80040-9; KUTCHAN TM, 1995, PLANT CELL, V7, P1059, DOI 10.2307/3870057; Lanctot Krista L, 2009, Ther Adv Neurol Disord, V2, P163, DOI 10.1177/1756285609102724; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; Mendelsohn LD, 2004, J CHEM INF COMP SCI, V44, P2225, DOI 10.1021/ci040123t; Monte MM, 2006, J MOL NEUROSCI, V30, P85; Mroue MA, 1996, J NAT PROD, V59, P890, DOI 10.1021/np960070c; Mukherjee PK, 2007, PHYTOTHER RES, V21, P1142, DOI 10.1002/ptr.2224; NIA, ALZH DIS ALZH BAS 20; Potestio R, 2010, NUCLEIC ACIDS RES, V38, pW41, DOI 10.1093/nar/gkq293; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schulz V, 2003, PHYTOMEDICINE, V10, P74, DOI 10.1078/1433-187X-00302; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; Winblad B, 2004, ALZ DIS ASSOC DIS, V18, pS2, DOI 10.1097/01.wad.0000127495.10774.a4; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086	46	23	24	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136509	10.1371/journal.pone.0136509	http://dx.doi.org/10.1371/journal.pone.0136509			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325402	gold, Green Published, Green Submitted			2022-12-26	WOS:000360437700047
J	Barennes, H; Frichittavong, A; Gripenberg, M; Koffi, P				Barennes, Hubert; Frichittavong, Amphonexay; Gripenberg, Marissa; Koffi, Paulin			Evidence of High Out of Pocket Spending for HIV Care Leading to Catastrophic Expenditure for Affected Patients in Lao People's Democratic Republic	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT; HEALTH EXPENDITURE; FINANCIAL BURDEN; ARV TREATMENT; HIV/AIDS; COSTS; THERAPY; ACCESS; SERVICES; BARRIERS	Background The scaling up of antiviral treatment (ART) coverage in the past decade has increased access to care for numerous people living with HIV/AIDS (PLWHA) in low-resource settings. Out-of-pocket payments (OOPs) represent a barrier for healthcare access, adherence and ART effectiveness, and can be economically catastrophic for PLWHA and their family. We evaluated OOPs of PLWHA attending outpatient and inpatient care units and estimated the financial burden for their households in the Lao People's Democratic Republic. We assumed that such OOPs may result in catastrophic health expenses in this context with fragile economical balance and low health insurance coverage. Methods We conducted a cross-sectional survey of a randomized sample of routine outpatients and a prospective survey of consecutive new inpatients at two referral hospitals (Setthathirat in the capital city, Savannaket in the province). After obtaining informed consent, PLWHA were interviewed using a standardized 82-item questionnaire including information on socio-economic characteristics, disease history and coping strategies. All OOPs occurring during a routine visit or a hospital stay were recorded. Household capacity-to-pay (overall income minus essential expenses), direct and indirect OOPs, OOPs per outpatient visit and per inpatient stay as well as catastrophic spending (greater than or equal to 40% of the capacity-to-pay) were calculated. A multivariate analysis of factors associated with catastrophic spending was conducted. Results A total of 320 PLWHA [280 inpatients and 40 outpatients; 132 (41.2%) defined as poor, and 269 (84.1%) on ART] were enrolled. Monthly median household income, essential expenses and capacity-to-pay were US$147.0 (IQR: 86-242), $126 (IQR: 82-192) and $14 (IQR: 19-80), respectively. At the provincial hospital OOPs were higher during routine visits, but three fold lower during hospitalization than in the central hospital ($21.0 versus $18.5 and $110.8 versus $329.8 respectively (p<0.01). The most notable OOPs were related to transportation and to loss of income. A total of 150 patients (46.8%; 95% CI: 41.3-52.5) were affected by catastrophic health expenses; 36 outpatients (90.0%; 95% CI: 76.3-97.2) and 114 inpatients (40.7%; 95% CI: 34.9-46.7). A total of 141 (44.0%) patients had contracted loans, and 127 (39.6%) had to sell some of their assets. In the multivariate analysis, being of Lao Loum ethnic group (Coef. -1.4; p = 0.04); being poor (Coef. -1.0; p = 0.01) and living more than 100 km away from the hospital (Coef. -1.0; p = 0.002) were positively associated with catastrophic spending. Conversely being in the highest wealth quartile (Coef. 1.6; p<0.001), living alone (Coef. 1.1; p = 0.04), attending the provincial hospital (Coef. 1.0; p = 0.002), and being on ART (Coef. 1.2; p = 0.003), were negatively associated with catastrophic spending. Conclusion PLWHA's households face catastrophic OOPs that are not directly attributable to the cost of ART or to follow-up tests, particularly during a hospitalization period. Transportation, distance to healthcare and time spent at the health facility are the major contributors for OOPs and for indirect opportunity costs. Being on ART and attending the provincial hospital were associated with a lower risk of catastrophic spending. Decentralization of care, access to ART and alleviation of OOPs are crucial factors to successfully decrease the household burden of HIV-AIDS expenses.	[Barennes, Hubert; Frichittavong, Amphonexay; Koffi, Paulin] Inst Francophonie Med Trop, Viangchan, Laos; [Barennes, Hubert; Gripenberg, Marissa] Inst Pasteur, Epidemiol Unit, Phnom Penh, Cambodia; [Barennes, Hubert] Agence Natl Rech VIH & Ies Hepatites, Phnom Penh, Cambodia; [Barennes, Hubert] Univ Bordeaux, Ctr INSERM U897 Epidemiol Biostat, ISPED, Bordeaux, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Barennes, H (corresponding author), Inst Francophonie Med Trop, Viangchan, Laos.	barenneshub@yahoo.fr						Akkhavong K, 2014, LAO PEOPLES DEMOCRAT, P1; Angeletti C, 2014, HIV MED, V15, P165, DOI 10.1111/hiv.12097; Anh DT, 2014, J ACQUIR IMMUNE DEFI; Araujo DV, 2013, SCI WORLD J, DOI 10.1155/2013/864962; Barennes H, 2014, BMC PEDIATR, V14, DOI 10.1186/s12887-014-0300-9; Beauliere A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011213; Bikilla AD, 2009, COST EFF RESOUR ALLO, V7, P6, DOI DOI 10.1186/1478-7547-7-6; Bila Blandine, 2008, Sante, V18, P187; Boufkhed S, 2014, Bull Soc Pathol Exot, V107, P292, DOI 10.1007/s13149-014-0374-5; Boyer S, 2009, B WORLD HEALTH ORGAN, V87, P279, DOI 10.2471/BLT.07.049643; Broughton E, 2014, NURS RES PRACT, V2014, DOI 10.1155/2014/232046; Chen RY, 2006, CLIN INFECT DIS, V42, P1003, DOI 10.1086/500453; Choi JW, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-014-0675-1; Duraisamy P, 2006, AIDS CARE, V18, P121, DOI 10.1080/09540120500159359; Hansana V, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-617; Minh VH, 2013, SOC SCI MED, V96, P258, DOI 10.1016/j.socscimed.2012.11.028; Kitajima T, 2003, AIDS, V17, P2375, DOI 10.1097/00002030-200311070-00013; Kouanda S, 2010, AIDS CARE, V22, P1146, DOI 10.1080/09540121003605047; Lao Ministry of Health, 2015, LAO NAT HLTH ACC REP, P2; Lao Ministry of Health, 2013, SECT REF FRAM LAO PD, P2; Lao Ministry of Health, 2015, HLTH FIN ST IN PRESS, P2; Lao PDR Ministry of Health, 2014, KEY FEAT OFF SOC HLT, P1; Li Y, 2012, B WORLD HEALTH ORGAN, V90, P664, DOI 10.2471/BLT.12.102178; Nguyen LT, 2014, CLINICOECONOMIC OUTC, V6, P101, DOI 10.2147/CEOR.S57028; Lopera MM, 2011, AIDS CARE, V23, P1602, DOI 10.1080/09540121.2011.579938; Minh HV, 2015, PROGR UNIVERSAL HLTH; Moon S, 2008, AIDS CARE, V20, P984, DOI 10.1080/09540120701768446; Morineau G, 2009, AIDS PATIENT CARE ST, V23, P669, DOI 10.1089/apc.2008.0241; Ngorsuraches S, 2015, APPL HEALTH ECON HEA, V13, P389, DOI 10.1007/s40258-015-0165-6; Paboriboune P, 2012, FIELD ACTION SCI REP; Pannarunothai S, 1997, SOC SCI MED, V44, P1781, DOI 10.1016/S0277-9536(96)00287-0; Pinto AD, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18055; Posse M, 2008, TROP MED INT HEALTH, V13, P904, DOI 10.1111/j.1365-3156.2008.02091.x; Posse M, 2009, AIDS PATIENT CARE ST, V23, P867, DOI 10.1089/apc.2009.0050; Prakongsai P, 2009, ADV HEALTH ECON HEAL, V21, P57, DOI 10.1108/S0731-2199(2009)0000021006; Rajagopalan N, 2009, AM J INFECT DIS, V5, P219, DOI 10.3844/ajidsp.2009.219.224; Richter LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086225; The World Bank, 2015, WORLD BANK LAO PDR; Thuan NBT, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-283; Tran BX, 2013, TROP MED INT HEALTH, V18, P212, DOI 10.1111/tmi.12032; UNAIDS, 2013, LAO PDR COUNTR REP P, P1; Van Damme W, 2004, TROP MED INT HEALTH, V9, P273, DOI 10.1046/j.1365-3156.2003.01194.x; Vun MC, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18905; World Bank: Vientiane Office, 2015, GOV EXP HLTH LAO PDR; World Organization for Animal Health (OIE), 2015, LANDSCAPE HIV RAPID, P1; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Yiengprugsawan Vasoontara, 2010, Australas epidemiol, V17, P24; Zachariah R, 2008, T ROY SOC TROP MED H, V102, P288, DOI 10.1016/j.trstmh.2007.12.007; Zhou F, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-6	49	25	25	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136664	10.1371/journal.pone.0136664	http://dx.doi.org/10.1371/journal.pone.0136664			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ2NK	26327558	Green Published, gold, Green Submitted			2022-12-26	WOS:000360437700053
J	Bennett, S; Singh, S; Rodriguez, D; Ozawa, S; Singh, K; Chhabra, V; Dhingra, N				Bennett, Sara; Singh, Suneeta; Rodriguez, Daniela; Ozawa, Sachiko; Singh, Kriti; Chhabra, Vibha; Dhingra, Neeraj			Transitioning a Large Scale HIV/AIDS Prevention Program to Local Stakeholders: Findings from the Avahan Transition Evaluation	PLOS ONE			English	Article							SUSTAINABILITY; PEPFAR	Background Between 2009-2013 the Bill and Melinda Gates Foundation transitioned its HIV/AIDS prevention initiative in India from being a stand-alone program outside of government, to being fully government funded and implemented. We present an independent prospective evaluation of the transition. Methods The evaluation drew upon (1) a structured survey of transition readiness in a sample of 80 targeted HIV prevention programs prior to transition; (2) a structured survey assessing institutionalization of program features in a sample of 70 targeted intervention (TI) programs, one year post-transition; and (3) case studies of 15 TI programs. Findings Transition was conducted in 3 rounds. While the 2009 transition round was problematic, subsequent rounds were implemented more smoothly. In the 2011 and 2012 transition rounds, Avahan programs were well prepared for transition with the large majority of TI program staff trained for transition, high alignment with government clinical, financial and managerial norms, and strong government commitment to the program. One year post transition there were significant program changes, but these were largely perceived positively. Notable negative changes were: limited flexibility in program management, delays in funding, commodity stock outs, and community member perceptions of a narrowing in program focus. Service coverage outcomes were sustained at least six months post-transition. Interpretation The study suggests that significant investments in transition preparation contributed to a smooth transition and sustained service coverage. Notwithstanding, there were substantive program changes post-transition. Five key lessons for transition design and implementation are identified.	[Bennett, Sara; Rodriguez, Daniela; Ozawa, Sachiko] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Singh, Suneeta; Singh, Kriti; Chhabra, Vibha] Amaltas Consulting Pvt Ltd, New Delhi 110016, India; [Dhingra, Neeraj] Govt India, Dept Aids Control, Minist Hlth & Family Welf, New Delhi 110001, India	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Bennett, S (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, 615 N Wolfe St, Baltimore, MD 21205 USA.	sbennett@jhu.edu	Singh, Kriti/ABE-3814-2020; Ozawa, Sachiko/Z-4944-2019	Ozawa, Sachiko/0000-0001-7608-9038; bennett, sara/0000-0001-8094-8798	Bill and Melinda Gates Foundation [OPPGH5190]; Amaltas Consulting Pvt. Ltd.	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Amaltas Consulting Pvt. Ltd.	This study was funded by grant # OPPGH5190 from the Bill and Melinda Gates Foundation (http://www.gatesfoundation.org). Foundation staff advised the study team, but did not substantively affect the study design, instruments, interpretation of data or decision to publish. Two staff members of the Foundation reviewed the manuscript, and some of the comments were incorporated depending on whether the research team perceived them to be of relevant and accurate. The authors confirm that Amaltas Consulting Pvt. Ltd. provided support in the form of salaries for authors SS, KS and VC but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2010, AV COMM MIN PROGR HI; [Anonymous], 2010, DEP AIDS CONTR ANN R; Bennett S, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.7360; Brundage SC., 2011, TERRA NOVA ACHIEVE S; Collins C, 2013, LANCET GLOB HEALTH, V1, pE319, DOI 10.1016/S2214-109X(13)70092-5; Fox Ashley M, 2011, J Int AIDS Soc, V14 Suppl 2, pS5, DOI 10.1186/1758-2652-14-S2-S5; Goosby E, 2012, JAIDS-J ACQ IMM DEF, V60, pS158, DOI 10.1097/QAI.0b013e31825d057c; Government of India, 2009, MEM COOP NAT AIDS CO; Government of India, 2006, MEM COOP NAT AIDS CO; Gruen RL, 2008, LANCET, V372, P1579, DOI 10.1016/S0140-6736(08)61659-1; Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10; Kavanagh MM, 2014, JAIDS-J ACQ IMM DEF, V65, P247, DOI 10.1097/QAI.0000000000000093; Mabuchi S, 2012, INT J HLTH PLANN MAN; National AIDS Control Organization, 2006, NAT AIDS CONTR PROGR; Scheirer MA, 2005, AM J EVAL, V26, P320, DOI 10.1177/1098214005278752; Scheirer MA, 2011, AM J PUBLIC HEALTH, V101, P2059, DOI 10.2105/AJPH.2011.300193; Sgaier SK, 2013, HEALTH AFFAIR, V32, P1265, DOI 10.1377/hlthaff.2012.0646; Stirman SW, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-17; The World Bank, 2013, IMPL COMPL RES REP C; Tran NT, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-44; UNAIDS, 2012, COUNTR OWN SUST AIDS; Verma R, 2010, SEX TRANSM INFECT, V86, pI76, DOI 10.1136/sti.2009.039115	22	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136177	10.1371/journal.pone.0136177	http://dx.doi.org/10.1371/journal.pone.0136177			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327591	Green Published, Green Submitted, gold			2022-12-26	WOS:000360437700032
J	Braun, FCM; van den Brandt, J; Thomas, S; Lange, S; Schrank, J; Gand, C; Przybylski, GK; Schmoeckel, K; Broker, BM; Schmidt, CA; Grabarczyk, P				Braun, Floriane C. M.; van den Brandt, Jens; Thomas, Soeren; Lange, Sandra; Schrank, Juliane; Gand, Claudia; Przybylski, Grzegorz K.; Schmoeckel, Katrin; Broeker, Barbara M.; Schmidt, Christian A.; Grabarczyk, Piotr			In Vivo Silencing of A20 via TLR9-Mediated Targeted SiRNA Delivery Potentiates Antitumor Immune Response	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; DENDRITIC CELLS; UBIQUITIN; ACTIVATION; INDUCTION; RECEPTOR; TNFAIP3	A20 is an ubiquitin-editing enzyme that ensures the transient nature of inflammatory signaling pathways induced by cytokines like TNF-alpha and IL-1 or pathogens via Toll-like receptor (TLR) pathways. It has been identified as a negative regulator of dendritic cell (DC) maturation and attenuator of their immunostimulatory properties. Ex vivo A20-depleted dendritic cells showed enhanced expression of pro-inflammatory cytokines and costimulatory molecules, which resulted in hyperactivation of tumor-infiltrating T lymphocytes and inhibition of regulatory T cells. In the present study, we demonstrate that a synthetic molecule consisting of a CpG oligonucleotide TLR9 agonist linked to A20-specific siRNAs silences its expression in TLR9(+) mouse dendritic cells in vitro and in vivo. In the B16 mouse melanoma tumor model, silencing of A20 enhances the CpG-triggered induction of NF kappa B activity followed by elevated expression of IL-6, TNF-alpha and IL-12. This leads to potentiated antitumor immune responses manifested by increased numbers of tumor-specific cytotoxic T cells, high levels of tumor cell apoptosis and delayed tumor growth. Our findings confirm the central role of A20 in controlling the immunostimulatory potency of DCs and provide a strategy for simultaneous A20 silencing and TLR activation in vivo.	[Braun, Floriane C. M.; Thomas, Soeren; Lange, Sandra; Schrank, Juliane; Gand, Claudia; Przybylski, Grzegorz K.; Schmidt, Christian A.; Grabarczyk, Piotr] Univ Med Greifswald, Clin Internal Med C, Dept Mol Hematol, Greifswald, Germany; [van den Brandt, Jens] Ernst Moritz Arndt Univ Greifswald, Cent Core, Greifswald, Germany; [van den Brandt, Jens] Ernst Moritz Arndt Univ Greifswald, Res Facil Lab Anim, Greifswald, Germany; [Przybylski, Grzegorz K.] Polish Acad Sci, Inst Human Genet, PL-60479 Poznan, Poland; [Schmoeckel, Katrin; Broeker, Barbara M.] Ernst Moritz Arndt Univ Greifswald, Inst Immunol & Transfus Med, Greifswald, Germany	Greifswald Medical School; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Polish Academy of Sciences; Institute of Human Genetics of the Polish Academy of Sciences; Ernst Moritz Arndt Universitat Greifswald	Grabarczyk, P (corresponding author), Univ Med Greifswald, Clin Internal Med C, Dept Mol Hematol, Greifswald, Germany.	pgrabarczyk@yahoo.com	Bröker, Barbara M/O-4850-2015	Bröker, Barbara M/0000-0002-5020-8542; Przybylski, Grzegorz/0000-0001-5783-1567; Lange, Sandra/0000-0003-0725-3652	German Jose Carreras Leukemia Foundation [DJCLS F 12/04]; Research Association for Molecular Medicine, University of Greifswald, Germany	German Jose Carreras Leukemia Foundation; Research Association for Molecular Medicine, University of Greifswald, Germany	The work was supported by the following: German Jose Carreras Leukemia Foundation (DJCLS F 12/04), FCMB, https://www.carrerasstiftung.de/; and Research Association for Molecular Medicine, University of Greifswald, Germany, FCMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breckpot K, 2009, J IMMUNOL, V182, P860, DOI 10.4049/jimmunol.182.2.860; Chanudet E, 2009, J PATHOL, V217, P420, DOI 10.1002/path.2466; De Valck D, 1999, ONCOGENE, V18, P4182, DOI 10.1038/sj.onc.1202787; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; Ferlazzo G, 2003, EUR J IMMUNOL, V33, P306, DOI 10.1002/immu.200310004; Fleshman JW., 2000, PORT SITE WOUND RECU; Giordano M, 2014, P NATL ACAD SCI USA, V111, P11115, DOI 10.1073/pnas.1406259111; Gray RC, 2007, J LEUKOCYTE BIOL, V81, P1075, DOI 10.1189/jlb.1006606; Herrmann A, 2014, J CLIN INVEST, V124, P2977, DOI 10.1172/JCI73174; Heyninck K, 2005, TRENDS BIOCHEM SCI, V30, P1, DOI 10.1016/j.tibs.2004.11.001; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Katsuda M, 2011, INT J ONCOL, V39, P1295, DOI 10.3892/ijo.2011.1146; Kim R, 2006, CANCER RES, V66, P5527, DOI 10.1158/0008-5472.CAN-05-4128; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; Kool M, 2011, IMMUNITY, V35, P82, DOI 10.1016/j.immuni.2011.05.013; Kortylewski M, 2009, NAT BIOTECHNOL, V27, P925, DOI 10.1038/nbt.1564; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Lippens S, 2011, CELL DEATH DIFFER, V18, P1845, DOI 10.1038/cdd.2011.55; Malynn BA, 2009, J EXP MED, V206, P977, DOI 10.1084/jem.20090765; Martin F, 2011, NAT GENET, V43, P822, DOI 10.1038/ng.916; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Rahman SMA, 2010, BIOORGAN MED CHEM, V18, P3474, DOI 10.1016/j.bmc.2010.03.076; Santulli-Marotto S, 2003, CANCER RES, V63, P7483; Siders WM, 2003, MOL THER, V7, P498, DOI 10.1016/S1525-0016(03)00044-3; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Smyth MJ, 2002, NAT REV CANCER, V2, P850, DOI 10.1038/nrc928; Snead NM, 2013, NUCLEIC ACIDS RES, V41, P6209, DOI 10.1093/nar/gkt200; Song XT, 2008, NAT MED, V14, P258, DOI 10.1038/nm1721; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Vereecke L, 2010, J EXP MED, V207, P1513, DOI 10.1084/jem.20092474; Warger T, 2006, BLOOD, V108, P544, DOI 10.1182/blood-2005-10-4015; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wooldridge James E., 2003, Current Opinion in Oncology, V15, P440, DOI 10.1097/00001622-200311000-00006; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1	35	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0135444	10.1371/journal.pone.0135444	http://dx.doi.org/10.1371/journal.pone.0135444			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327508	Green Published, gold, Green Submitted			2022-12-26	WOS:000360437700020
J	Gsell, M; Fankl, A; Klug, L; Mascher, G; Schmidt, C; Hrastnik, C; Zellnig, G; Daum, G				Gsell, Martina; Fankl, Ariane; Klug, Lisa; Mascher, Gerald; Schmidt, Claudia; Hrastnik, Claudia; Zellnig, Guenther; Daum, Guenther			A Yeast Mutant Deleted of GPH1 Bears Defects in Lipid Metabolism	PLOS ONE			English	Article							PHOSPHATIDYLSERINE DECARBOXYLASE ACTIVITY; CROSS-PATHWAY REGULATION; SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID BIOSYNTHESIS; GLYCOGEN-PHOSPHORYLASE; PHOSPHATIDYLETHANOLAMINE; GENE; METHYLATION; IDENTIFICATION; MEMBRANE	In a previous study we demonstrated up-regulation of the yeast GPH1 gene under conditions of phosphatidylethanolamine (PE) depletion caused by deletion of the mitochondrial (M) phosphatidylserine decarboxylase 1 (PSD1) (Gsell et al., 2013, PLoS One. 8(10): e77380. doi: 10.1371/journal.pone.0077380). Gph1p has originally been identified as a glycogen phosphorylase catalyzing degradation of glycogen to glucose in the stationary growth phase of the yeast. Here we show that deletion of this gene also causes decreased levels of phosphatidylcholine (PC), triacylglycerols and steryl esters. Depletion of the two non-polar lipids in Delta gph1 strain leads to lack of lipid droplets, and decrease of the PC level results in instability of the plasma membrane. In vivo labeling experiments revealed that formation of PC via both pathways of biosynthesis, the cytidine diphosphate (CDP)choline and the methylation route, is negatively affected by a.gph1 mutation, although expression of genes involved is not down regulated. Altogether, Gph1p besides its function as a glycogen mobilizing enzyme appears to play a regulatory role in yeast lipid metabolism.	[Gsell, Martina; Fankl, Ariane; Klug, Lisa; Mascher, Gerald; Schmidt, Claudia; Hrastnik, Claudia; Daum, Guenther] Graz Univ Technol, Inst Biochem, NaWi Graz, A-8010 Graz, Austria; [Zellnig, Guenther] Karl Franzens Univ Graz, Inst Plant Sci, NaWi Graz, Graz, Austria	Graz University of Technology; University of Graz	Daum, G (corresponding author), Graz Univ Technol, Inst Biochem, NaWi Graz, Petersgasse 12-2, A-8010 Graz, Austria.	guenther.daum@tugraz.at			Austrian Science Fund FWF [21429]; Austrian Science Fund FWF (DK Molecular Enzymology) [W901-B05]; Austrian Science Fund (FWF) [P 26133, W 901] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Science Fund FWF (DK Molecular Enzymology); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund FWF (project 21429 and DK Molecular Enzymology W901-B05 to GD).	Athenstaedt K, 2005, J BIOL CHEM, V280, P37301, DOI 10.1074/jbc.M507261200; Birner R, 2003, MOL BIOL CELL, V14, P370, DOI 10.1091/mbc.E02-05-0263; Birner R, 2001, MOL BIOL CELL, V12, P997, DOI 10.1091/mbc.12.4.997; BROEKHUYSE RM, 1968, BIOCHIM BIOPHYS ACTA, V152, P307, DOI 10.1016/0005-2760(68)90038-6; Carman GM, 2007, BBA-MOL CELL BIOL L, V1771, P322, DOI 10.1016/j.bbalip.2006.05.006; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; CARSON MA, 1984, J BIOL CHEM, V259, P6267; Chen M, 2007, BBA-MOL CELL BIOL L, V1771, P310, DOI 10.1016/j.bbalip.2006.05.017; DAUM G, 1982, J BIOL CHEM, V257, P3028; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; Favre C, 2008, FREE RADICAL BIO MED, V45, P1446, DOI 10.1016/j.freeradbiomed.2008.08.021; FOLCH J, 1957, J BIOL CHEM, V226, P497; Francois J, 2001, FEMS MICROBIOL REV, V25, P125, DOI 10.1016/S0168-6445(00)00059-0; Gaspar ML, 2007, BBA-MOL CELL BIOL L, V1771, P241, DOI 10.1016/j.bbalip.2006.06.011; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Gsell M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077380; HAID A, 1983, METHOD ENZYMOL, V96, P192; HARDY TA, 1993, J BIOL CHEM, V268, P23799; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; HWANG PK, 1989, MOL CELL BIOL, V9, P1659, DOI 10.1128/MCB.9.4.1659; INOKOSHI J, 1994, MOL GEN GENET, V244, P90, DOI 10.1007/BF00280191; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kim NR, 2013, APPL MICROBIOL BIOT, V97, P8227, DOI 10.1007/s00253-013-4985-8; KODAKI T, 1987, J BIOL CHEM, V262, P15428; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li GL, 2007, BBA-MOL CELL BIOL L, V1771, P432, DOI 10.1016/j.bbalip.2006.06.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCGRAW P, 1989, GENETICS, V122, P317; Nebauer R, 2007, FEBS J, V274, P6180, DOI 10.1111/j.1742-4658.2007.06138.x; Patton-Vogt J, 2007, BBA-MOL CELL BIOL L, V1771, P337, DOI 10.1016/j.bbalip.2006.04.013; Pichler H, 2001, EUR J BIOCHEM, V268, P2351, DOI 10.1046/j.1432-1327.2001.02116.x; Ploier B, 2013, J BIOL CHEM, V288, P36061, DOI 10.1074/jbc.M113.509927; Rajakumari S, 2008, PROG LIPID RES, V47, P157, DOI 10.1016/j.plipres.2008.01.001; Rajakumari S, 2010, J BIOL CHEM, V285, P15769, DOI 10.1074/jbc.M109.076331; Riekhof WR, 2006, J BIOL CHEM, V281, P36588, DOI 10.1074/jbc.M608851200; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Schneiter Roger, 2006, Methods Mol Biol, V313, P75; SERRANO R, 1988, METHOD ENZYMOL, V157, P533; SUMMERS EF, 1988, GENETICS, V120, P909; Takahashi T, 2001, MOL GENET GENOMICS, V265, P1112, DOI 10.1007/s004380100510; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; TROTTER PJ, 1995, J BIOL CHEM, V270, P6062, DOI 10.1074/jbc.270.11.6062; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; Usher J, 2009, APPL ENVIRON MICROB, V75, P4573, DOI 10.1128/AEM.00351-09; van den Hazel HB, 1999, J BIOL CHEM, V274, P1934, DOI 10.1074/jbc.274.4.1934; Voelker DR, 2000, BBA-MOL CELL BIOL L, V1486, P97, DOI 10.1016/S1388-1981(00)00051-2; Wilson WA, 2010, CAN J MICROBIOL, V56, P408, DOI [10.1139/W10-027, 10.1139/w10-027]; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602	52	7	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136957	10.1371/journal.pone.0136957	http://dx.doi.org/10.1371/journal.pone.0136957			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327557	Green Submitted, Green Published, gold			2022-12-26	WOS:000360437700075
J	Horicks, F; Van Den Steen, G; Houben, S; Englert, Y; Demeestere, I				Horicks, Florence; Van Den Steen, Geraldine; Houben, Sarah; Englert, Yvon; Demeestere, Isabelle			Folliculogenesis Is Not Fully Inhibited during GnRH Analogues Treatment in Mice Challenging Their Efficiency to Preserve the Ovarian Reserve during Chemotherapy in This Model	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; FOLLICLE-STIMULATING-HORMONE; LHRH ANTAGONIST CETRORELIX; LUTEINIZING-HORMONE; FERTILITY PRESERVATION; INDUCED GONADOTOXICITY; POSTMENOPAUSAL WOMEN; CANCER-PATIENTS; MOUSE OVARIES; FOLLOW-UP	As many chemotherapy regimens induce follicular depletion, fertility preservation became a major concern in young cancer patients. By maintaining follicles at the resting stage, gonadotropin-releasing hormone analogues (GnRHa) were proposed as an ovarian-protective option during chemotherapy. However, their efficacy and mechanisms of action remain to be elucidated. Mice were dosed with cyclophosphamide (Cy, 100-500mg/kg i.p) to quantify follicular depletion and evaluate apoptosis at different times. We observed a dose-dependent depletion of the follicular reserve within 24 hours after Cy injection with a mean follicular loss of 45% at the dose of 200mg/kg. Apoptosis occurs in the granulosa cells of growing follicles within 12 hours after Cy treatment, while no apoptosis was detected in resting follicles suggesting that chemotherapy acutely affects both resting and growing follicles through different mechanisms. We further tested the ability of both GnRH agonist and antagonist to inhibit oestrus cycles, follicular growth and FSH secretion in mice and to protect ovarian reserve against chemotherapy. Although GnRHa were efficient to disrupt oestrus cycles, they failed to inhibit follicular development, irrespective of the doses and injection sites (sc or im). Around 20% of healthy growing follicles were still observed during GnRHa treatment and serum FSH levels were not reduced either by antagonist or agonist. GnRHa had no effect on Cy-induced follicular damages. Thus, we showed that GnRHa were not as efficient at inhibiting the pituitary-gonadal axis in mice as in human. Furthermore, the acute depletion of primordial follicles observed after chemotherapy does not support the hypothesis that the ovary may be protected by gonadotropin suppression.	[Horicks, Florence; Van Den Steen, Geraldine; Houben, Sarah; Englert, Yvon; Demeestere, Isabelle] Univ Libre Bruxelles, Res Lab Human Reprod, Brussels, Belgium; [Englert, Yvon; Demeestere, Isabelle] Free Univ Brussels, Erasme Hosp, Dept Gynecol & Obstet, B-1050 Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Horicks, F (corresponding author), Univ Libre Bruxelles, Res Lab Human Reprod, Brussels, Belgium.	fhoricks@ulb.ac.be		Demeestere, Isabelle/0000-0002-3192-6565; Houben, Sarah/0000-0002-9363-8016	Belgian grant [FNRS-Televie 7.4621.14]; Le Fonds Emile DEFAY; Belgian 'Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture' (FRIA) [18101/18102]	Belgian grant; Le Fonds Emile DEFAY; Belgian 'Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture' (FRIA)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the Belgian grant FNRS-Televie 7.4621.14 and 'Le Fonds Emile DEFAY'; FH is a research fellow supported by the Belgian 'Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture' (FRIA) 18101/18102; and ID is a research associate at the 'Fonds National pour la Recherche Scientifique' (FNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATAYA K, 1995, BIOL REPROD, V52, P365, DOI 10.1095/biolreprod52.2.365; ATAYA KM, 1985, CANCER RES, V45, P3651; BOKSER L, 1990, BRIT J CANCER, V61, P861, DOI 10.1038/bjc.1990.192; Browne HN, 2011, FERTIL STERIL, V96, P180, DOI 10.1016/j.fertnstert.2011.04.008; Byers SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035538; CHAPMAN RM, 1981, BLOOD, V58, P849; COUZINET B, 1991, CLIN ENDOCRINOL, V34, P477, DOI 10.1111/j.1365-2265.1991.tb00328.x; Danforth DR, 2005, FERTIL STERIL, V83, P1333, DOI 10.1016/j.fertnstert.2004.12.030; De Vos M, 2010, LANCET, V376, P911, DOI 10.1016/S0140-6736(10)60355-8; Decanter C, 2014, FERTIL STERIL, V102, P483, DOI 10.1016/j.fertnstert.2014.05.014; Del Mastro L, 2014, CANCER TREAT REV, V40, P675, DOI 10.1016/j.ctrv.2013.12.001; Demeestere I, 2012, OBSTET GYNECOL INT, V2012, DOI DOI 10.1155/2012/961232; Demeestere I, 2013, J CLIN ONCOL, V31, P903, DOI 10.1200/JCO.2012.42.8185; Desmeules P, 2006, TOXICOL SCI, V90, P500, DOI 10.1093/toxsci/kfj086; Detti L, 2014, FERTIL STERIL, V101, P1157, DOI 10.1016/j.fertnstert.2013.12.028; Ezoe K, 2014, REPROD BIOL, V14, P238, DOI 10.1016/j.repbio.2014.04.007; GLODE LM, 1981, LANCET, V1, P1132; Gosden RG, 1997, HUM REPROD, V12, P2483, DOI 10.1093/humrep/12.11.2483; Gougeon A, 1996, ENDOCR REV, V17, P121, DOI 10.1210/er.17.2.121; Hasky N, 2015, HUM REPROD, V30, P1089, DOI 10.1093/humrep/dev037; Hayden C, 2008, EUR J ENDOCRINOL, V159, pS17, DOI 10.1530/EJE-08-0354; Horvath JE, 2002, P NATL ACAD SCI USA, V99, P15048, DOI 10.1073/pnas.232579499; Huang YH, 2009, GYNECOL ONCOL, V112, P409, DOI 10.1016/j.ygyno.2008.09.044; Hutt K., 2014, TALK WORLD C REPR BI; Kalich-Philosoph L, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005402; Kerr JB, 2012, MOL CELL, V48, P343, DOI 10.1016/j.molcel.2012.08.017; Kiesel LA, 2002, CLIN ENDOCRINOL, V56, P677, DOI 10.1046/j.1365-2265.2002.01291.x; Kovacs M, 2001, P NATL ACAD SCI USA, V98, P12197, DOI 10.1073/pnas.211442598; Lemos CNCD, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-51; Loren AW, 2013, J CLIN ONCOL, V31, P2500, DOI 10.1200/JCO.2013.49.2678; MATIKAINEN T, 1992, J CLIN ENDOCR METAB, V75, P820, DOI 10.1210/jc.75.3.820; Matsuo Go, 2007, Kurume Medical Journal, V54, P25, DOI 10.2739/kurumemedj.54.25; Meirow D, 2000, MOL CELL ENDOCRINOL, V169, P123, DOI 10.1016/S0303-7207(00)00365-8; Meirow D, 2004, HUM REPROD, V19, P1294, DOI 10.1093/humrep/deh257; Meirow D, 2010, CLIN OBSTET GYNECOL, V53, P727, DOI 10.1097/GRF.0b013e3181f96b54; MONTZ FJ, 1991, CANCER RES, V51, P2124; Moore HCF, 2015, NEW ENGL J MED, V372, P923, DOI 10.1056/NEJMoa1413204; Morgan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070117; Oktem O, 2007, CANCER RES, V67, P10159, DOI 10.1158/0008-5472.CAN-07-2042; Razzano A, 2014, GYNECOL ENDOCRINOL, V30, P822, DOI 10.3109/09513590.2014.944153; Roness H, 2013, CELL CYCLE, V12, P3245, DOI 10.4161/cc.26358; Roti ECR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042293; SHARPE KL, 1990, ENDOCRINOLOGY, V127, P25, DOI 10.1210/endo-127-1-25; Singh P, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-26; Sobinoff AP, 2012, TOXICOL SCI, V128, P258, DOI 10.1093/toxsci/kfs137; Tan SJ, 2010, EUR J OBSTET GYN R B, V149, P182, DOI 10.1016/j.ejogrb.2009.12.028; Turner NH, 2013, ANN ONCOL, V24, P2224, DOI 10.1093/annonc/mdt196; van Casteren JIJ, 2000, BIOL REPROD, V62, P886, DOI 10.1095/biolreprod62.4.886; Zhao XJ, 2010, GYNECOL ONCOL, V118, P69, DOI 10.1016/j.ygyno.2010.03.021	49	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137164	10.1371/journal.pone.0137164	http://dx.doi.org/10.1371/journal.pone.0137164			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325271	Green Submitted, gold, Green Published			2022-12-26	WOS:000360437700101
J	Markovic-Lipkovski, J; Zivotic, M; Muller, CA; Tampe, B; Cirovic, S; Vjestica, J; Tomanovic, N; Zeisberg, M; Muller, GA				Markovic-Lipkovski, Jasmina; Zivotic, Maja; Mueller, Claudia A.; Tampe, Bjoern; Cirovic, Sanja; Vjestica, Jelena; Tomanovic, Nada; Zeisberg, Michael; Mueller, Gerhard A.			Variable Expression of Neural Cell Adhesion Molecule Isoforms in Renal Tissue: Possible Role in Incipient Renal Fibrosis	PLOS ONE			English	Article							STRUCTURAL BASIS; NCAM; FGFR1; MYOFIBROBLASTS; IDENTIFICATION; REGENERATION; FIBROBLASTS; ACTIVATION; MECHANISMS; BINDING	Rare neural cell adhesion molecule (NCAM) positive cells have been previously described within the normal human adult kidney interstitium, speculating that they could increase in the interstitium with incipient interstitial renal fibrosis (IRF). In the present study, among 93 biopsy samples of various kidney diseases, NCAM(+) interstitial cells were detected in 62.4% cases. An increased number of NCAM(+) cells was significantly observed only in incipient IRF compared to normal renal tissues and advanced IRF stages (p<0.001), independently of underlying diseases (p = 0.657). All three major NCAM isoforms' RT-PCR bands were visible either in normal or in kidneys with incipient IRF, albeit their mRNA expression levels measured by qRT-PCR were different. Applying qRT-PCR on pure NCAM(+) cells population, obtained by laser capture microdissection, significant mRNA over-expression of NCAM(140kD) isoform was found in NCAM(+) cells within incipient IRF (p = 0.004), while NCAM(120kD) and NCAM(180kD) isoforms were not changed significantly (p = 0.750; p = 0.704; respectively). Simultaneously, qRT-PCR also showed significant aSMA (p = 0.014) and SLUG (p = 0.004) mRNAs up-regulation within the NCAM(+) cells of incipient IRF, as well as highly decreased matrix metalloproteinases (MMP) -2 and -9 mRNAs (p = 0.028; p = 0.036; respectively). However, using double immunofluorescence MMP-9 could still be detectable on the protein level in rare NCAM(+) cells within the incipient IRF. Further characterization of NCAM(+) cells by double immunofluorescent labeling revealed their association with molecules involved in fibrosis. Fibroblast growth factor receptor 1 (FGFR1) and alpha 5 beta 1 integrin were extensively expressed on NCAM(+) cells within the incipient IRF areas, whereas human epididymis protein-4 (HE4) was found to be present in few NCAM(+) cells of both normal and interstitium with incipient fibrosis. Heterogeneity of NCAM(+) interstitial cells in normal and incipient IRF, concerning molecules related to fibrosis and variable expression of NCAM isoforms, could suggest diverse role of NCAM(+) cells in homeostasis and in regulation of renal fibrosis in diseased kidneys.	[Markovic-Lipkovski, Jasmina; Zivotic, Maja; Cirovic, Sanja; Vjestica, Jelena; Tomanovic, Nada] Univ Belgrade, Fac Med, Inst Pathol, Belgrade, Serbia; [Mueller, Claudia A.] Univ Tubingen, ZMF, Sect Transplantat Immunol & Immunohematol, Univ Med Clin, Tubingen, Germany; [Mueller, Claudia A.; Tampe, Bjoern; Zeisberg, Michael; Mueller, Gerhard A.] Univ Gottingen, Med Ctr, Dept Nephrol & Rheumatol, D-37073 Gottingen, Germany	University of Belgrade; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Gottingen	Markovic-Lipkovski, J (corresponding author), Univ Belgrade, Fac Med, Inst Pathol, Belgrade, Serbia.	acal@matf.bg.ac.rs	Tampe, Björn/ABA-6091-2021; Zivotic, Maja/N-9508-2017	Tampe, Björn/0000-0002-4357-9863; Zivotic, Maja/0000-0002-5833-6661	Alexander von Humboldt Foundation; DAAD Foundation [451-03-01858/2013-09/6]; Ministry of Education, Science and Technological Development of the Republic of Serbia [OI 175047]	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); DAAD Foundation(Deutscher Akademischer Austausch Dienst (DAAD)); Ministry of Education, Science and Technological Development of the Republic of Serbia	The authors are grateful to Alexander von Humboldt Foundation, DAAD Foundation (bilateral PPP-DAAD project between Serbia and Germany, number 451-03-01858/2013-09/6) and Ministry of Education, Science and Technological Development of the Republic of Serbia (project OI 175047), for the major financial support necessary for material and reagents during research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buzhor E, 2013, AM J PATHOL, V183, P1621, DOI 10.1016/j.ajpath.2013.07.034; Chhikara N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047672; Cirovic S, 2014, INT J CLIN EXP PATHO, V7, P1402; Salgado AD, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/849684; Diestel S, 2005, J NEUROCHEM, V95, P1777, DOI 10.1111/j.1471-4159.2005.03475.x; Francavilla C, 2009, J CELL BIOL, V187, P1101, DOI 10.1083/jcb.200903030; Harari-Steinberg O, 2013, EMBO MOL MED, V5, P1556, DOI 10.1002/emmm.201201584; Kiselyov VV, 2005, J NEUROCHEM, V94, P1169, DOI 10.1111/j.1471-4159.2005.03284.x; Kiselyov VV, 2003, STRUCTURE, V11, P691, DOI 10.1016/S0969-2126(03)00096-0; KLEIN G, 1988, DEVELOPMENT, V102, P749; Kochoyan A, 2008, PROTEIN SCI, V17, P1698, DOI 10.1110/ps.035964.108; LeBleu VS, 2013, NAT MED, V19, P227, DOI 10.1038/nm.2989; Lehembre F, 2008, EMBO J, V27, P2603, DOI 10.1038/emboj.2008.178; Lindquist JA, 2013, NEPHROL DIAL TRANSPL, V28, P2678, DOI 10.1093/ndt/gft247; Lv SS, 2014, DIABETES VASC DIS RE, V11, P251, DOI 10.1177/1479164114531300; Markovic-Lipkovski J, 2007, NEPHROL DIAL TRANSPL, V22, P1558, DOI 10.1093/ndt/gfm006; Meran S, 2011, INT J EXP PATHOL, V92, P158, DOI 10.1111/j.1365-2613.2011.00764.x; Mikami S, 2011, LAB INVEST, V91, P1443, DOI 10.1038/labinvest.2011.111; Norman JT, 1999, EXP NEPHROL, V7, P167; Souma T, 2016, J AM SOC NEPHROL, V27, P428, DOI 10.1681/ASN.2014121184; Strutz F, 2006, NEPHROL DIAL TRANSPL, V21, P3368, DOI 10.1093/ndt/gfl199; Strutz F, 2006, J AM SOC NEPHROL, V17, P2992, DOI 10.1681/ASN.2006050420; Sugimoto H, 2012, NAT MED, V18, P396, DOI 10.1038/nm.2629; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Tur MK, 2013, AM J PATHOL, V182, P1205, DOI 10.1016/j.ajpath.2012.12.027; Vansthertem D, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/193259; Zeisberg M, 2015, CLIN J AM SOC NEPHRO, V10, P1831, DOI 10.2215/CJN.00640114; Zeisberg M, 2013, AM J PHYSIOL-CELL PH, V304, pC216, DOI 10.1152/ajpcell.00328.2012; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793	29	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137028	10.1371/journal.pone.0137028	http://dx.doi.org/10.1371/journal.pone.0137028			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327314	gold, Green Submitted, Green Published			2022-12-26	WOS:000360437700084
J	Alexander, JS; Gopalaswamy, AM; Shi, K; Riordan, P				Alexander, Justine S.; Gopalaswamy, Arjun M.; Shi, Kun; Riordan, Philip			Face Value: Towards Robust Estimates of Snow Leopard Densities	PLOS ONE			English	Article							ELUSIVE CARNIVORES; POPULATION-SIZE; CAPTURE; MODELS; ABUNDANCE; INFERENCE; CONSERVATION; INFORMATION; QILIANSHAN; MOVEMENTS	When densities of large carnivores fall below certain thresholds, dramatic ecological effects can follow, leading to oversimplified ecosystems. Understanding the population status of such species remains a major challenge as they occur in low densities and their ranges are wide. This paper describes the use of non-invasive data collection techniques combined with recent spatial capture-recapture methods to estimate the density of snow leopards Panthera uncia. It also investigates the influence of environmental and human activity indicators on their spatial distribution. A total of 60 camera traps were systematically set up during a three-month period over a 480 km(2) study area in Qilianshan National Nature Reserve, Gansu Province, China. We recorded 76 separate snow leopard captures over 2,906 trap-days, representing an average capture success of 2.62 captures/100 trap-days. We identified a total number of 20 unique individuals from photographs and estimated snow leopard density at 3.31 (SE = 1.01) individuals per 100 km(2). Results of our simulation exercise indicate that our estimates from the Spatial Capture Recapture models were not optimal to respect to bias and precision (RMSEs for density parameters less or equal to 0.87). Our results underline the critical challenge in achieving sufficient sample sizes of snow leopard captures and recaptures. Possible performance improvements are discussed, principally by optimising effective camera capture and photographic data quality.	[Alexander, Justine S.; Shi, Kun; Riordan, Philip] Beijing Forestry Univ, Wildlife Inst, Sch Nat Conservat, Beijing, Peoples R China; [Gopalaswamy, Arjun M.] Univ Oxford, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, Dept Zool, Abingdon, Oxon, England; [Riordan, Philip] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Riordan, Philip] Wildlife Borders UK, Bampton OX13 5QL, Oxon, England	Beijing Forestry University; University of Oxford; University of Oxford	Shi, K (corresponding author), Beijing Forestry Univ, Wildlife Inst, Sch Nat Conservat, Beijing, Peoples R China.	kunshi@bjfu.edu.cn	Riordan, Philip/AAY-6420-2020; Margalida, Antoni/A-2723-2011	Margalida, Antoni/0000-0002-0576-3993; Riordan, Philip/0000-0001-6285-8596; Alexander, Justine Shanti/0000-0002-7474-9247	National Geographic Society Young Explorer Grant. NGS YEgrant [9236-12]; Star Foundation; China's State Forestry Department; National Natural Science Foundation of China [31470567]	National Geographic Society Young Explorer Grant. NGS YEgrant(National Geographic Society); Star Foundation; China's State Forestry Department; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was suppoted by 1. National Geographic Society Young Explorer Grant. NGS YEgrant #9236-12. (http://www.nationalgeographic.com/explorers/grants-programs/young-explorers). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 2. The Star Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 3. China's State Forestry Department. 4. National Natural Science Foundation of China (Grant No. 31470567). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 2015, BIOL CONSERV, V187, P1, DOI 10.1016/j.biocon.2015.04.002; Amstrup SC, 2005, HANDBOOK OF CAPTURE-RECAPTURE ANALYSIS, P1; [Anonymous], 2014, R LANG ENV STAT COMP; Bagchi S, 2004, ANIM CONSERV, V7, P121, DOI 10.1017/S1367943003001148; Blomqvist L., 1980, INT PEDIGREE BOOK SN, V2, P159; Bolker B, 2008, ECOLOGICAL MODELS DA; Borchers DL, 2008, BIOMETRICS, V64, P377, DOI 10.1111/j.1541-0420.2007.00927.x; Buckland S.T., 2001, pi; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chandler RB, 2013, ANN APPL STAT, V7, P936, DOI 10.1214/12-AOAS610; Dias BNO, 2010, ENRIQUECIMENTO AMBIE; Efford MG, 2013, OIKOS, V122, P918, DOI 10.1111/j.1600-0706.2012.20440.x; ESRI, 2014, ARCGIS GEOST AN METH; ESTES JA, 1974, SCIENCE, V185, P1058, DOI 10.1126/science.185.4156.1058; Fox J.L, 1989, REV STATUS ECOLOGY S; FOX JL, 1991, BIOL CONSERV, V55, P283, DOI 10.1016/0006-3207(91)90033-6; Gardner B, 2009, ECOLOGY, V90, P1106, DOI 10.1890/07-2112.1; Gerber BD, 2014, POPUL ECOL, V56, P463, DOI 10.1007/s10144-014-0431-8; Gopalaswamy A., 2014, SPACECAP R PACKAGE E; Gopalaswamy AM, 2012, ANIM CONSERV, V15, P669, DOI 10.1111/j.1469-1795.2012.00565.x; Gopalaswamy AM, 2013, CAPTURE RECAPTURE MO; Gopalaswamy AM, 2015, METHODS ECOL EVOL, pn/a; Gopalaswamy AM, 2012, METHODS ECOL EVOL, V3, P1067, DOI 10.1111/j.2041-210X.2012.00241.x; Gopalaswamy AM, 2012, ECOLOGY, V93, P1741, DOI 10.1890/11-2110.1; Jackson, 1996, HOME RANGE MOVEMENTS; Jackson R., 2008, IUCN RED LIST THREAT, DOI 10.2305/IUCN.UK.2008.RLTS.T22732A9381126.en; Jackson RM, 2006, WILDLIFE SOC B, V34, P772, DOI 10.2193/0091-7648(2006)34[772:ESLPAU]2.0.CO;2; Janecka JE, 2008, ANIM CONSERV, V11, P401, DOI 10.1111/j.1469-1795.2008.00195.x; Janecka JE, 2011, J MAMMAL, V92, P771, DOI 10.1644/10-MAMM-A-036.1; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Karanth KU, 2006, ECOLOGY, V87, P2925, DOI 10.1890/0012-9658(2006)87[2925:ATPDUP]2.0.CO;2; Karanth KK, 2013, BIOL CONSERV, V166, P175, DOI 10.1016/j.biocon.2013.06.027; Karanth KK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050433; Karanth KU, 2004, P NATL ACAD SCI USA, V101, P4854, DOI 10.1073/pnas.0306210101; KARANTH KU, 1995, BIOL CONSERV, V71, P333, DOI 10.1016/0006-3207(94)00057-W; Karanth KU, 1998, ECOLOGY, V79, P2852; Lovari S, 2013, J ZOOL, V291, P127, DOI 10.1111/jzo.12053; Lovari S, 2009, ANIM CONSERV, V12, P559, DOI 10.1111/j.1469-1795.2009.00285.x; Lyngdoh S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088349; McCarthy KP, 2008, J WILDLIFE MANAGE, V72, P1826, DOI 10.2193/2008-040; McCarthy T, 2003, SNOW LEOPARD SURVIVA; McCarthy TM, 2005, BIOL CONSERV, V124, P527, DOI 10.1016/j.biocon.2005.03.003; Mccarthy TM., 2014, SNOW LEOPARD SURVIVA, P1; McNab BK, 2000, CAN J ZOOL, V78, P2227, DOI 10.1139/cjz-78-12-2227; Miller Brian, 2001, Endangered Species Update, V18, P202; Mishra C, 2004, J APPL ECOL, V41, P344, DOI 10.1111/j.0021-8901.2004.00885.x; Ngoprasert D., 2012, BIOTROPICA, V1, P1; OTIS DL, 1978, WILDLIFE MONOGR, P1; Quantum GIS Development Team, 2014, QUANT GIS GOEGR INF; Reich BJ, 2014, ENVIRONMETRICS, pn/a; Riordan P, 2010, SNOW LEOPARD CHINA P; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Royle JA, 2013, METHODS ECOL EVOL, V4, P520, DOI 10.1111/2041-210X.12039; Royle JA, 2009, ECOLOGY, V90, P3233, DOI 10.1890/08-1481.1; Royle JA, 2014, SPATIAL CAPTURE-RECAPTURE, P1; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; Sharma K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101319; Shehzad W, 2012, PLOS ONE, V7, P1, DOI DOI 10.1371/J0UMAL.P0NE.0032104; Shrestha B., 2008, PREY ABUNDANCE PREY; Soisalo MK, 2006, BIOL CONSERV, V129, P487, DOI 10.1016/j.biocon.2005.11.023; Sollmann R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034575; Sollmann R, 2012, MAMM BIOL, V77, P41, DOI 10.1016/j.mambio.2011.06.011; Sollmann R, 2011, BIOL CONSERV, V144, P1017, DOI 10.1016/j.biocon.2010.12.011; Soule ME, 2003, CONSERV BIOL, V17, P1238, DOI 10.1046/j.1523-1739.2003.01599.x; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Wang GH, 2003, PLANT ECOL, V165, P169, DOI 10.1023/A:1022236115186; WILSON KR, 1985, J MAMMAL, V66, P13, DOI 10.2307/1380951; Wilton CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111257; Yang Q, 2009, QILIAN MOUNTAIN NATL, V2012, P75	70	47	56	2	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0134815	10.1371/journal.pone.0134815	http://dx.doi.org/10.1371/journal.pone.0134815			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322682	Green Published, gold			2022-12-26	WOS:000360435500002
J	White, MJ; Kodaman, NM; Harder, RH; Asselbergs, FW; Vaughan, DE; Brown, NJ; Moore, JH; Williams, SM				White, Marquitta J.; Kodaman, Nuri M.; Harder, Reed H.; Asselbergs, Folkert W.; Vaughan, Douglas E.; Brown, Nancy J.; Moore, Jason H.; Williams, Scott M.			Genetics of Plasminogen Activator Inhibitor-1 (PAI-1) in a Ghanaian Population	PLOS ONE			English	Article							CIRCADIAN CLOCK GENES; PLASMA T-PA; MYOCARDIAL-INFARCTION; ANGIOTENSIN PEPTIDES; 4G/5G POLYMORPHISM; INSULIN-RESISTANCE; HUMAN TREHALASE; CANDIDATE GENE; SNP SELECTION; ASSOCIATION	Plasminogen activator inhibitor 1 (PAI-1), a major modulator of the fibrinolytic system, is an important factor in cardiovascular disease (CVD) susceptibility and severity. PAI-1 is highly heritable, but the few genes associated with it explain only a small portion of its variation. Studies of PAI-1 typically employ linear regression to estimate the effects of genetic variants on PAI-1 levels, but PAI-1 is not normally distributed, even after transformation. Therefore, alternative statistical methods may provide greater power to identify important genetic variants. Additionally, most genetic studies of PAI-1 have been performed on populations of European descent, limiting the generalizability of their results. We analyzed >30,000 variants for association with PAI-1 in a Ghanaian population, using median regression, a non-parametric alternative to linear regression. Three variants associated with median PAI-1, the most significant of which was in the gene arylsulfatase B (ARSB) (p = 1.09 x 10(-7)). We also analyzed the upper quartile of PAI-1, the most clinically relevant part of the distribution, and found 19 SNPs significantly associated in this quartile. Of note an association was found in period circadian clock 3 (PER3). Our results reveal novel associations with median and elevated PAI-1 in an understudied population. The lack of overlap between the two analyses indicates that the genetic effects on PAI-1 are not uniform across its distribution. They also provide evidence of the generalizability of the circadian pathway's effect on PAI-1, as a recent meta-analysis performed in Caucasian populations identified another circadian clock gene (ARNTL).	[White, Marquitta J.; Kodaman, Nuri M.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37235 USA; [White, Marquitta J.; Kodaman, Nuri M.; Harder, Reed H.; Moore, Jason H.; Williams, Scott M.] Dartmouth Coll, Dept Genet, Hanover, NH 03755 USA; [White, Marquitta J.; Kodaman, Nuri M.; Harder, Reed H.; Moore, Jason H.; Williams, Scott M.] Dartmouth Coll, Inst Quantitat Biomed Sci, Hanover, NH 03755 USA; [Asselbergs, Folkert W.] Univ Med Ctr Utrecht, Dept Heart & Lungs, NL-3584 CX Utrecht, Netherlands; [Asselbergs, Folkert W.] UCL, Inst Cardiovasc Sci, London, England; [Asselbergs, Folkert W.] ICIN Netherlands Heart Inst, Durrer Ctr Cardiogenet Res, Utrecht, Netherlands; [Vaughan, Douglas E.] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Brown, Nancy J.] Vanderbilt Univ, Dept Med, Nashville, TN 37235 USA	Vanderbilt University; Dartmouth College; Dartmouth College; Utrecht University; Utrecht University Medical Center; University of London; University College London; Northwestern University; Feinberg School of Medicine; Vanderbilt University	Williams, SM (corresponding author), Dartmouth Coll, Dept Genet, Hanover, NH 03755 USA.	scott.williams@dartmouth.edu	Moore, Jason H./AAV-9645-2021; Williams, Scott/Q-4812-2019; Asselbergs, Folkert W./ABD-6752-2021	Moore, Jason H./0000-0002-5015-1099; Williams, Scott/0000-0002-4835-9544; Asselbergs, Folkert W./0000-0002-1692-8669	National Institutes of Health [5P20GM103534-04, 5R01LM010098-06]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103534, T32GM080178] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010098] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Funding provided by National Institutes of Health, http://www.nih.gov/, 5P20GM103534-04, JHM and National Institutes of Health, http://www.nih.gov/, 5R01LM010098-06, JHM, FWA, SMW.	Abboud N, 2010, GENET TEST MOL BIOMA, V14, P23, DOI 10.1089/gtmb.2009.0039; Alessi MC, 2004, ARCH MAL COEUR VAISS, V97, P673; Aso Y, 2007, FRONT BIOSCI-LANDMRK, V12, P2957, DOI 10.2741/2285; Asselbergs FW, 2007, GENOMICS, V89, P362, DOI 10.1016/j.ygeno.2006.11.004; Asselbergs FW, 2008, SEMIN THROMB HEMOST, V34, P562, DOI 10.1055/s-0028-1103367; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bentley L, 2003, J MED GENET, V40, P249, DOI 10.1136/jmg.40.4.249; Bhattacharyya S, 2012, J NUTR BIOCHEM, V23, P1058, DOI 10.1016/j.jnutbio.2011.05.012; Bhattacharyya S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033250; BOOTH NA, 1994, BAILLIERE CLIN HAEM, V7, P559, DOI 10.1016/S0950-3536(05)80099-X; BraunFahrlander C, 1997, PEDIATR ALLERGY IMMU, V8, P75, DOI 10.1111/j.1399-3038.1997.tb00147.x; Briollais L, 2014, HUM GENET; Brown NJ, 1999, HYPERTENSION, V34, P285, DOI 10.1161/01.HYP.34.2.285; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Cesari M, 1999, ARTERIOSCL THROM VAS, V19, P316, DOI 10.1161/01.ATV.19.2.316; Cheng B, 2011, P NATL ACAD SCI USA, V108, P17147, DOI 10.1073/pnas.1112998108; Chong NW, 2006, FEBS LETT, V580, P4469, DOI 10.1016/j.febslet.2006.07.014; Ciarleglio CM, 2008, J BIOL RHYTHM, V23, P330, DOI 10.1177/0748730408320284; de Lange M, 2001, LANCET, V357, P101, DOI 10.1016/S0140-6736(00)03541-8; Festa A, 2003, CIRCULATION, V107, P2422, DOI 10.1161/01.CIR.0000066908.82782.3A; Guess J, 2009, INTEGR CANCER THER, V8, P329, DOI 10.1177/1534735409352029; Hossain GS, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000134; Huang J, 2012, BLOOD, V120, P4873, DOI 10.1182/blood-2012-06-436188; ISO H, 1993, THROMB HAEMOSTASIS, V70, P475; Iwai N, 1998, ATHEROSCLEROSIS, V136, P109, DOI 10.1016/S0021-9150(97)00191-3; John O.O., 2009, SCI AFRICANA, V8, P61, DOI [10.14419/ijasp.v3i2.4686, DOI 10.14419/IJASP.V3I2.4686]; Juhan-Vague I, 2003, J THROMB HAEMOST, V1, P2322, DOI 10.1046/j.1538-7836.2003.00458.x; Juhan-Vague I, 2000, ANN MED, V32, P78; Kawasaki T, 2000, BLOOD, V96, P153, DOI 10.1182/blood.V96.1.153.013k11_153_160; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Koenker R., 2010, ECONOMETRIC SOC MONO, V2005, P295; KONKLE BA, 1990, J BIOL CHEM, V265, P21867; Liu L, 2013, HUM GENET, V132, P139, DOI 10.1007/s00439-012-1231-x; Lutsey PL, 2006, J THROMB HAEMOST, V4, P2629, DOI 10.1111/j.1538-7836.2006.02237.x; Matthews KA, 2005, AM HEART J, V149, P1066, DOI 10.1016/j.ahj.2004.08.027; Muller YL, 2013, HUM GENET, V132, P697, DOI 10.1007/s00439-013-1278-3; Munson M, 1996, PROTEIN SCI, V5, P1584, DOI 10.1002/pro.5560050813; NORMANT E, 1995, J BIOL CHEM, V270, P20543, DOI 10.1074/jbc.270.35.20543; Ocaranza MP, 2012, INT J HYPERTENS, V2012, DOI [10.1155/2012/594361, DOI 10.1155/2012/594361]; Organization WH, 2016, GLOBAL STATUS REPORT; Ouyang YH, 2009, BIOCHEM BIOPH RES CO, V379, P621, DOI 10.1016/j.bbrc.2008.12.134; Peetz D, 2004, THROMB HAEMOSTASIS, V92, P344, DOI 10.1160/TH04-01-0001; Penrod NM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016639; Pereira HJV, 2012, PEPTIDES, V33, P67, DOI 10.1016/j.peptides.2011.12.001; Philippe C, 1997, AM J HUM GENET, V61, P520, DOI 10.1086/515505; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RCore Team, 2020, R LANG ENV STAT COMP; Ridker PM, 1997, CIRCULATION, V95, P59, DOI 10.1161/01.CIR.95.1.59; RONA G, 1966, CAN MED ASSOC J, V95, P1012; Schoenhard JA, 2008, HUM GENET, V124, P479, DOI 10.1007/s00439-008-0573-x; Schoenhard JA, 2003, J MOL CELL CARDIOL, V35, P473, DOI 10.1016/S0022-2828(03)00051-8; Skurk T, 2001, HORM METAB RES, V33, P196, DOI 10.1055/s-2001-14948; Sorensen BS, 2010, ACTA ONCOL, V49, P895, DOI 10.3109/02841861003614343; StataCorp, 2021, STATA STAT SOFTWARE; Stow LR, 2011, J AM SOC NEPHROL, V22, P598, DOI 10.1681/ASN.2010080803; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wende H, 2000, IMMUNOGENETICS, V51, P703, DOI 10.1007/s002510000187; Williams PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028764; Williams SM, 2007, ETHNIC DIS, V17, P492; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166	65	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136379	10.1371/journal.pone.0136379	http://dx.doi.org/10.1371/journal.pone.0136379			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322636	Green Published, gold, Green Submitted			2022-12-26	WOS:000360435500018
J	Chen, HH; Horng, MH; Yeh, SY; Lin, IC; Yeh, CJ; Muo, CH; Sung, FC; Kao, CH				Chen, Hsin-Hung; Horng, Ming-Hwarng; Yeh, Su-Yin; Lin, I-Ching; Yeh, Chih-Jung; Muo, Chih-Hsin; Sung, Fung-Chang; Kao, Chia-Hung			Glycemic Control with Thiazolidinedione Is Associated with Fracture of T2DM Patients	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; COMBINATION THERAPY; CONTROLLED-TRIAL; BONE-FORMATION; ROSIGLITAZONE; RISK; METAANALYSIS; REPAGLINIDE; METFORMIN; WOMEN	Objective Diabetes is a common diseases and a major problem worldwide. Diabetic osteopathy might be elevated in diabetic patients and is usually caused by bone fracture. Several diabetes medications, such as thiazolidinediones (TZDs), could lead to increased risks of fracture. Methods We used the nationwide database to identified 32466 patients who had developed type 2 diabetes from 2000 to 2010 as the diabetic cohort and, from that group, we selected 3427 diabetic patients who had developed bone fracture to survey the possible risk factors, includng commonly used diabetes medication. Results We found that TZDs might present increased risks for fracture in patients who used it for an extended period (7 to 730 days before the index date), especially in female patients younger than 64 years old, for whom the risk was elevated from a 1.74- to a 2.58-fold odds ratio. Conclusions We recommend that clinics follow up with non-osteoporotic female patients younger than 64 years old who are using TZDs, to avoid the associated risks of fracture.	[Chen, Hsin-Hung; Yeh, Chih-Jung] Chung Shan Med Univ, Sch Publ Hlth, Taichung, Taiwan; [Chen, Hsin-Hung; Lin, I-Ching] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chen, Hsin-Hung] Changhua Christian Hosp, Div Endocrinol & Metab, Changhua, Taiwan; [Chen, Hsin-Hung] Nantou Christian Hosp, Div Endocrinol & Metab, Nantou, Taiwan; [Horng, Ming-Hwarng] Changhua Christian Hosp, Div Crit Care Med, Dept Internal Med, Changhua, Taiwan; [Horng, Ming-Hwarng] Yuanlin Christian Hosp, Changhua Christian Med Fdn, Changhua, Taiwan; [Yeh, Su-Yin] Asia Univ, Dept Healthcare Adm, Taichung, Taiwan; [Lin, I-Ching] Changhua Christian Hosp, Dept Family Med, Changhua, Taiwan; [Yeh, Chih-Jung] Chung Shan Med Univ, Educ & Res Geriatr & Gerontol, Taichung, Taiwan; [Muo, Chih-Hsin] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Muo, Chih-Hsin] China Med Univ, Coll Med, Taichung, Taiwan; [Sung, Fung-Chang; Kao, Chia-Hung] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Sung, Fung-Chang; Kao, Chia-Hung] China Med Univ, Sch Med, Coll Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Changhua Christian Hospital; Changhua Christian Hospital; Asia University Taiwan; Changhua Christian Hospital; Chung Shan Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Yeh, CJ (corresponding author), Chung Shan Med Univ, Sch Publ Hlth, Taichung, Taiwan.	chh2019@gmail.com; d10040@mail.cmuh.org.tw	Yeh, Cj/AFC-0951-2022		Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW104-TDU-B-212-113002]; China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project [BM104010092]; NRPB Stroke Clinical Trial Consortium [MOST 103-2325-B-039 -006]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; Taiwan Ministry of Health and Welfare surcharge of tobacco products; China Medical University Hospital Cancer Research Center of Excellence (Taiwan) [MOHW104-TDU-B-212-124-002]; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; Taiwan Ministry of Health and Welfare surcharge of tobacco products; China Medical University Hospital Cancer Research Center of Excellence (Taiwan); CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	This study is supported in part by the Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW104-TDU-B-212-113002); the China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project (BM104010092); the NRPB Stroke Clinical Trial Consortium(MOST 103-2325-B-039 -006); the Tseng-Lien Lin Foundation, Taichung, Taiwan; the Taiwan Brain Disease Foundation, Taipei, Taiwan; the Katsuzo and Kiyo Aoshima Memorial Funds, Japan; the Taiwan Ministry of Health and Welfare surcharge of tobacco products; the China Medical University Hospital Cancer Research Center of Excellence (MOHW104-TDU-B-212-124-002, Taiwan); and the CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ali AA, 2005, ENDOCRINOLOGY, V146, P1226, DOI 10.1210/en.2004-0735; Arlt W, 2001, J BIOL CHEM, V276, P16767, DOI 10.1074/jbc.M100040200; Bazelier Marloes T, 2013, Front Endocrinol (Lausanne), V4, P11, DOI 10.3389/fendo.2013.00011; Berberoglu Z, 2007, J CLIN ENDOCR METAB, V92, P3523, DOI 10.1210/jc.2007-0431; BOUILLON R, 1991, CALCIFIED TISSUE INT, V49, P155, DOI 10.1007/BF02556109; COZEN L, 1972, CLIN ORTHOP RELAT R, P134; Damsbo P, 1999, DIABETES RES CLIN PR, V45, P31, DOI 10.1016/S0168-8227(99)00057-1; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Grey A, 2007, J CLIN ENDOCR METAB, V92, P1305, DOI 10.1210/jc.2006-2646; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Kahn SE, N ENGL J MED, V355, P2427; Khazai NB, 2009, CURR OPIN ENDOCRINOL, V16, P435, DOI 10.1097/MED.0b013e328331c7eb; Lecka-Czernik Beata, 2010, Curr Osteoporos Rep, V8, P178, DOI 10.1007/s11914-010-0027-y; Lin MC, 2013, ANN ONCOL, V24, P1675, DOI 10.1093/annonc/mdt016; LODER RT, 1988, CLIN ORTHOP RELAT R, P210; Loke YK, 2009, CAN MED ASSOC J, V180, P32, DOI 10.1503/cmaj.080486; Madsbad S, 2001, DIABETIC MED, V18, P395, DOI 10.1046/j.1464-5491.2001.00490.x; Mayne D, 2010, AGE AGEING, V39, P522, DOI 10.1093/ageing/afq081; Raskin P, 2000, DIABETES CARE, V23, P979, DOI 10.2337/diacare.23.7.979; Rosenstock J, 2002, DIABETES CARE, V25, P1529, DOI 10.2337/diacare.25.9.1529; Schwartz AV, 2012, DIABETES CARE, V35, P1525, DOI 10.2337/dc11-2184; Simpson CM, 2012, EXPERT OPIN DRUG SAF, V11, P215, DOI 10.1517/14740338.2012.639359; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Zhu ZN, 2014, BONE, V68, P115, DOI 10.1016/j.bone.2014.08.010	25	13	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135530	10.1371/journal.pone.0135530	http://dx.doi.org/10.1371/journal.pone.0135530			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317995	Green Published, Green Submitted, gold			2022-12-26	WOS:000360299100033
J	de Guzman, RC; Tsuda, SM; Ton, MTN; Zhang, X; Esker, AR; Van Dyke, ME				de Guzman, Roche C.; Tsuda, Shanel M.; Ton, Minh-Thi N.; Zhang, Xiao; Esker, Alan R.; Van Dyke, Mark E.			Binding Interactions of Keratin-Based Hair Fiber Extract to Gold, Keratin, and BMP-2	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; BOVINE SERUM-ALBUMIN; DISULFIDE BONDS; LIGAND-BINDING; ELECTROSTATIC INTERACTIONS; INTERMEDIATE-FILAMENTS; SURFACE; ADSORPTION; SULFUR; INTEGRIN	Hair-derived keratin biomaterials composed mostly of reduced keratin proteins (kerateines) have demonstrated their utility as carriers of biologics and drugs for tissue engineering. Electrostatic forces between negatively-charged keratins and biologic macromolecules allow for effective drug retention; attraction to positively-charged growth factors like bone morphogenetic protein 2 (BMP-2) has been used as a strategy for osteoinduction. In this study, the intermolecular surface and bulk interaction properties of kerateines were investigated. Thiol-rich kerateines were chemisorbed onto gold substrates to form an irreversible 2-nm rigid layer for surface plasmon resonance analysis. Kerateine-to-kerateine cohesion was observed in pH-neutral water with an equilibrium dissociation constant (K-D) of 1.8 x 10(-4) M, indicating that non-coulombic attractive forces (i.e. hydrophobic and van der Waals) were at work. The association of BMP-2 to kerateine was found to be greater (K-D = 1.1 x 10(-7) M), within the range of specific binding. Addition of salts (phosphate-buffered saline; PBS) shortened the Debye length or the electrostatic field influence which weakened the kerateine-BMP-2 binding (K-D = 3.2 x 10(-5) M). BMP-2 in bulk kerateine gels provided a limited release in PBS (similar to 10% dissociation in 4 weeks), suggesting that electrostatic intermolecular attraction was significant to retain BMP-2 within the keratin matrix. Complete dissociation between kerateine and BMP-2 occurred when the PBS pH was lowered (to 4.5), below the keratin isoelectric point of 5.3. This phenomenon can be attributed to the protonation of keratin at a lower pH, leading to positive-positive repulsion. Therefore, the dynamics of kerateine-BMP-2 binding is highly dependent on pH and salt concentration, as well as on BMP-2 solubility at different pH and molarity. The study findings may contribute to our understanding of the release kinetics of drugs from keratin biomaterials and allow for the development of better, more clinically relevant BMP-2-conjugated systems for bone repair and regeneration.	[de Guzman, Roche C.; Tsuda, Shanel M.; Ton, Minh-Thi N.; Van Dyke, Mark E.] Virginia Polytech Inst & State Univ, Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA; [Zhang, Xiao; Esker, Alan R.] Virginia Polytech Inst & State Univ, Dept Chem, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	de Guzman, RC (corresponding author), Hofstra Univ, Dept Engn, Hempstead, NY 11550 USA.	roche.c.deguzman@hofstra.edu	de Guzman, Roche C./K-8832-2015	de Guzman, Roche C./0000-0001-6051-4765; Esker, Alan/0000-0003-1440-5933				Adamson AW, 1997, PHYS CHEM SURFACES, Vxxi; Alting AC, 2000, J AGR FOOD CHEM, V48, P5001, DOI 10.1021/jf000474h; [Anonymous], 2008, HDB SURFACE PLASMON, P1; [Anonymous], INFUSE BONE GRAFT PR; Arkhangelsky E, 2007, J MEMBRANE SCI, V305, P176, DOI 10.1016/j.memsci.2007.08.007; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Aubin-Tam ME, 2013, METHODS MOL BIOL, V1025, P19, DOI 10.1007/978-1-62703-462-3_3; Baier SK, 2005, COMPR REV FOOD SCI F, V4, P43, DOI 10.1111/j.1541-4337.2005.tb00072.x; Belcarz A, 2009, J BIOMED MATER RES B, V89B, P102, DOI 10.1002/jbm.b.31192; Berezhkovskiy LM, 2001, BIOPHYS CHEM, V91, P319, DOI 10.1016/S0301-4622(01)00147-8; Bernot KM, 2005, J CELL BIOL, V168, P965, DOI 10.1083/jcb.200408116; Bigott-Hennkens HM, 2008, Q J NUCL MED MOL IM, V52, P245; Bocedi A, 2004, IUBMB LIFE, V56, P609, DOI 10.1080/15216540400016286; Bolton EE, 2010, ANN REP COMP CHEM, V4, P217, DOI 10.1016/S1574-1400(08)00012-1; Bousquet O, 2001, J CELL BIOL, V155, P747, DOI 10.1083/jcb.200104063; Bukar N, 2014, CHEM COMMUN, V50, P4947, DOI 10.1039/c4cc01423e; Bulaj G, 2005, BIOTECHNOL ADV, V23, P87, DOI 10.1016/j.biotechadv.2004.09.002; Carreno-Fuentes L, 2014, LANGMUIR, V30, P14991, DOI 10.1021/la503704a; Castner DG, 1996, LANGMUIR, V12, P5083, DOI 10.1021/la960465w; Chen Lin, 2001, Curr Protoc Protein Sci, VChapter 18, DOI 10.1002/0471140864.ps1806s23; CHIARI M, 1991, ELECTROPHORESIS, V12, P376, DOI 10.1002/elps.1150120510; Chung BM, 2013, CURR OPIN CELL BIOL, V25, P600, DOI 10.1016/j.ceb.2013.06.008; de Guzman RC, 2013, BIOMATERIALS, V34, P1644, DOI 10.1016/j.biomaterials.2012.11.002; de Guzman RC, 2011, BIOMATERIALS, V32, P8205, DOI 10.1016/j.biomaterials.2011.07.054; DeChancie J, 2007, J AM CHEM SOC, V129, P5419, DOI 10.1021/ja066950n; DEFEIJTER JA, 1978, BIOPOLYMERS, V17, P1759, DOI 10.1002/bip.1978.360170711; Dias GJ, 2010, J BIOMED MATER RES A, V95A, P1084, DOI 10.1002/jbm.a.32908; Digilio G, 2014, EUR J MED CHEM, V79, P13, DOI 10.1016/j.ejmech.2014.03.064; Doliska A, 2013, CARBOHYD POLYM, V93, P246, DOI 10.1016/j.carbpol.2012.02.075; Eble JA, 1998, BIOCHEMISTRY-US, V37, P10945, DOI 10.1021/bi980175+; FLORENCE TM, 1980, BIOCHEM J, V189, P507, DOI 10.1042/bj1890507; Foegeding A, 2005, ROY SOC CH, P3; Freundlich H, 1906, ADSORPTION LOSUNGEN; FUGGLE JC, 1980, J ELECTRON SPECTROSC, V21, P275, DOI 10.1016/0368-2048(80)85056-0; GARYBOBO CM, 1968, J GEN PHYSIOL, V52, P825, DOI 10.1085/jgp.52.5.825; Ge SR, 1998, J BIOMAT SCI-POLYM E, V9, P131; GILBERT HF, 1995, METHOD ENZYMOL, V251, P8, DOI 10.1016/0076-6879(95)51107-5; Gilbert JB, 2013, P NATL ACAD SCI USA, V110, P6651, DOI 10.1073/pnas.1222325110; Glatz C E, 1990, Bioprocess Technol, V9, P329; Goddard DR, 1935, J BIOL CHEM, V112, P361; Goldman RD, 2012, J STRUCT BIOL, V177, P14, DOI 10.1016/j.jsb.2011.11.017; Hakkinen H, 2012, NAT CHEM, V4, P443, DOI [10.1038/NCHEM.1352, 10.1038/nchem.1352]; Hill P, 2010, BIOMATERIALS, V31, P585, DOI 10.1016/j.biomaterials.2009.09.076; Holmberg A, 2005, ELECTROPHORESIS, V26, P501, DOI 10.1002/elps.200410070; Honda Y, 2014, CELL STRUCT FUNCT, V39, P31, DOI 10.1247/csf.13021; Hulme EC, 2010, BRIT J PHARMACOL, V161, P1219, DOI 10.1111/j.1476-5381.2009.00604.x; Jokinen J, 2004, J BIOL CHEM, V279, P31956, DOI 10.1074/jbc.M401409200; Ke S, 2007, BIOCONJUGATE CHEM, V18, P2109, DOI 10.1021/bc700204k; Klueh U, 2000, J BIOMED MATER RES, V53, P621, DOI 10.1002/1097-4636(2000)53:6<621::AID-JBM2>3.0.CO;2-Q; Kou J, 2010, COLLOID SURFACE A, V368, P75, DOI 10.1016/j.colsurfa.2010.07.017; Kreplak L, 2004, EXP CELL RES, V301, P77, DOI 10.1016/j.yexcr.2004.08.021; Kukic P, 2010, FUTURE MED CHEM, V2, P647, DOI 10.4155/FMC.10.6; Kumar S, 2002, CHEMBIOCHEM, V3, P604, DOI 10.1002/1439-7633(20020703)3:7<604::AID-CBIC604>3.0.CO;2-X; Landry JP, 2012, ASSAY DRUG DEV TECHN, V10, P250, DOI 10.1089/adt.2011.0406; Langmuir I, 1916, J AM CHEM SOC, V38, P2221, DOI 10.1021/ja02268a002; Li FY, 2011, J CONTROL RELEASE, V152, pE92, DOI 10.1016/j.jconrel.2011.08.144; Li YL, 2003, NAT STRUCT BIOL, V10, P482, DOI 10.1038/nsb930; Lusiana, 2011, EUR J PHARM BIOPHARM, V78, P432, DOI 10.1016/j.ejpb.2011.01.022; Lv ZJ, 2009, NANOSCALE RES LETT, V4, P1403, DOI 10.1007/s11671-009-9412-9; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; McArthur S. L., 2014, SURFACE ANAL TECHNIQ, P9, DOI DOI 10.1007/978-3-319-01360-2_2; McArthur SL, 2001, BIOMATERIALS, V22, P3295, DOI 10.1016/S0142-9612(01)00166-1; McArthur SL, 2000, COLLOID SURFACE B, V17, P37, DOI 10.1016/S0927-7765(99)00086-7; Mogosanu GD, 2014, CURR DRUG TARGETS, V15, P518, DOI 10.2174/1389450115666140307154143; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; MORTON TA, 1995, ANAL BIOCHEM, V227, P176, DOI 10.1006/abio.1995.1268; Nghiem LD, 2006, J MEMBRANE SCI, V286, P52, DOI 10.1016/j.memsci.2006.09.011; OShannessy DJ, 1996, ANAL BIOCHEM, V236, P275, DOI 10.1006/abio.1996.0167; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; PETHIG R, 1984, IEEE T ELECTR INSUL, V19, P453, DOI 10.1109/TEI.1984.298769; Peyton CC, 2012, J SURG RES, V178, P545, DOI 10.1016/j.jss.2012.07.053; Plowman JE, 2003, PROTEOMICS, V3, P942, DOI 10.1002/pmic.200300419; Popescu C, 2009, INT REV CEL MOL BIO, V277, P137, DOI 10.1016/S1937-6448(09)77004-2; Pritchett TJ, 1996, ELECTROPHORESIS, V17, P1195, DOI 10.1002/elps.1150170705; Raina S, 1997, ANNU REV MICROBIOL, V51, P179, DOI 10.1146/annurev.micro.51.1.179; Richter JR, 2012, ACTA BIOMATER, V8, P274, DOI 10.1016/j.actbio.2011.08.020; Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o; Rodriguez JA, 2003, J AM CHEM SOC, V125, P276, DOI 10.1021/ja021007e; Samba R., 2013, OPEN SURF SCI J, V5, P17, DOI DOI 10.2174/1876531901305010017; SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937; Saul JM, 2011, J BIOMED MATER RES A, V98A, P544, DOI 10.1002/jbm.a.33147; Scheufler C, 1999, J MOL BIOL, V287, P103, DOI 10.1006/jmbi.1999.2590; Schuck P, 2010, METHODS MOL BIOL, V627, P15, DOI 10.1007/978-1-60761-670-2_2; Sinha N, 2002, CURR PROTEIN PEPT SC, V3, P601, DOI 10.2174/1389203023380431; Siriwardana K, 2015, J PHYS CHEM C, V119, P2910, DOI 10.1021/jp512440z; Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753; Srinivasan B, 2010, J BIOMED MATER RES B, V92B, P5, DOI 10.1002/jbm.b.31483; Stillman Martin J., 1999, Metal-Based Drugs, V6, P277, DOI 10.1155/MBD.1999.277; Tachibana A, 2006, J BIOSCI BIOENG, V102, P425, DOI 10.1263/jbb.102.425; Technologies SC, 2007, PROD INF SHEET REC H; Thilagar S, 2009, J BIOMED MATER RES B, V88B, P12, DOI 10.1002/jbm.b.31024; Tulpar A, 2004, J PHYS CHEM B, V108, P1667, DOI 10.1021/jp0347668; Uludag H, 1999, ANN NY ACAD SCI, V875, P369, DOI 10.1111/j.1749-6632.1999.tb08519.x; VANTRIEST A, 1990, J PHYS-CONDENS MAT, V2, P8733, DOI 10.1088/0953-8984/2/44/001; Vasconcelos A, 2013, CURR DRUG TARGETS, V14, P612, DOI 10.2174/1389450111314050010; Walczak M, 2013, PHARMACOL REP, V65, P1294, DOI 10.1016/S1734-1140(13)71487-7; WALL JS, 1971, J AGR FOOD CHEM, V19, P619, DOI 10.1021/jf60176a003; Wojdyr M, 2010, J APPL CRYSTALLOGR, V43, P1126, DOI 10.1107/S0021889810030499; WORLEY CG, 1995, J VAC SCI TECHNOL A, V13, P2281, DOI 10.1116/1.579510; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Zhang Z, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035001	101	17	17	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137233	10.1371/journal.pone.0137233	http://dx.doi.org/10.1371/journal.pone.0137233			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317522	Green Published, Green Submitted, gold			2022-12-26	WOS:000360299100213
J	Liu, YY; Rzeszutek, E; van der Voort, M; Wu, CH; Thoen, E; Skaar, I; Bulone, V; Dorrestein, PC; Raaijmakers, JM; de Bruijn, I				Liu, Yiying; Rzeszutek, Elzbieta; van der Voort, Menno; Wu, Cheng-Hsuan; Thoen, Even; Skaar, Ida; Bulone, Vincent; Dorrestein, Pieter C.; Raaijmakers, Jos M.; de Bruijn, Irene			Diversity of Aquatic Pseudomonas Species and Their Activity against the Fish Pathogenic Oomycete Saprolegnia	PLOS ONE			English	Article							CYCLIC LIPOPEPTIDE SURFACTANTS; BIOSYNTHESIS; PARASITICA; AUSTRALIS; BACTERIA; INFECTIONS; INHIBITION; NETWORKING; DISCOVERY; DICLINA	Emerging fungal and oomycete pathogens are increasingly threatening animals and plants globally. Amongst oomycetes, Saprolegnia species adversely affect wild and cultivated populations of amphibians and fish, leading to substantial reductions in biodiversity and food productivity. With the ban of several chemical control measures, new sustainable methods are needed to mitigate Saprolegnia infections in aquaculture. Here, PhyloChip-based community analyses showed that the Pseudomonadales, particularly Pseudomonas species, represent one of the largest bacterial orders associated with salmon eggs from a commercial hatchery. Among the Pseudomonas species isolated from salmon eggs, significantly more biosurfactant producers were retrieved from healthy salmon eggs than from Saprolegnia-infected eggs. Subsequent in vivo activity bioassays showed that Pseudomonas isolate H6 significantly reduced salmon egg mortality caused by Saprolegnia diclina. Live colony mass spectrometry showed that strain H6 produces a viscosin-like lipopeptide surfactant. This biosurfactant inhibited growth of Saprolegnia in vitro, but no significant protection of salmon eggs against Saprolegniosis was observed. These results indicate that live inocula of aquatic Pseudomonas strains, instead of their bioactive compound, can provide new (micro) biological and sustainable means to mitigate oomycete diseases in aquaculture.	[Liu, Yiying; Raaijmakers, Jos M.; de Bruijn, Irene] Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands; [Liu, Yiying; van der Voort, Menno] Wageningen Univ, Lab Phytopathol, NL-6700 AP Wageningen, Netherlands; [Rzeszutek, Elzbieta; Bulone, Vincent] Royal Inst Technol, Sch Biotechnol, Div Glycosci, Stockholm, Sweden; [Wu, Cheng-Hsuan; Dorrestein, Pieter C.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Wu, Cheng-Hsuan] Boston Univ, Dept Chem, Boston, MA 02215 USA; [Thoen, Even; Skaar, Ida] Norwegian Vet Inst, Oslo, Norway; [Thoen, Even] Norwegian Univ Life Sci, Oslo, Norway; [Dorrestein, Pieter C.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Dorrestein, Pieter C.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA; [Dorrestein, Pieter C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Wageningen University & Research; Royal Institute of Technology; University of California System; University of California San Diego; Boston University; Norwegian Veterinary Institute; Norwegian University of Life Sciences; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego	de Bruijn, I (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands.	i.debruijn@nioo.knaw.nl	de Bruijn, Irene/A-7437-2014; Dorrestein, Pieter/ABF-2930-2020; Bulone, Vincent/C-8492-2019; Bulone, Vincent/D-7469-2013; Raaijmakers, Jos M/D-1574-2014; KNAW, NIOO-KNAW/A-4320-2012	de Bruijn, Irene/0000-0002-4889-3253; Bulone, Vincent/0000-0003-2809-4160; Raaijmakers, Jos M/0000-0003-1608-6614; KNAW, NIOO-KNAW/0000-0002-3835-159X	SAPRO (Sustainable Approaches to Reduce Oomycete (Saprolegnia) Infections in Aquaculture) [238550]; Marie Curie Initial Training Network - European Commission; ParaFishControl (Advanced Tools and Research Strategies for Parasite Control in European farmed fish) [634429]; Research and Innovation action - European Commission under HORIZON; BE-Basic Foundation [F07.003.01]	SAPRO (Sustainable Approaches to Reduce Oomycete (Saprolegnia) Infections in Aquaculture); Marie Curie Initial Training Network - European Commission; ParaFishControl (Advanced Tools and Research Strategies for Parasite Control in European farmed fish); Research and Innovation action - European Commission under HORIZON; BE-Basic Foundation	This work was financially supported by SAPRO (Sustainable Approaches to Reduce Oomycete (Saprolegnia) Infections in Aquaculture, 238550), a Marie Curie Initial Training Network funded by the European Commission under Framework Program 7; ParaFishControl (Advanced Tools and Research Strategies for Parasite Control in European farmed fish, 634429), a Research and Innovation action funded by the European Commission under HORIZON 2020; and BE-Basic Foundation (project number F07.003.01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Allah AMA, 1998, WATER RES, V32, P944, DOI 10.1016/S0043-1354(97)00223-6; Abu-Ghunmi L, 2014, J SURFACTANTS DETERG, V17, P833, DOI 10.1007/s11743-014-1584-3; Austin B., 2012, BACTERIAL FISH PATHO, DOI DOI 10.1007/978-94-007-4884-2; Bly JE, 1997, J FISH DIS, V20, P35, DOI 10.1046/j.1365-2761.1997.d01-104.x; Bruno DW, 2011, FISH DISEASES AND DISORDERS, VOL 3: VIRAL, BACTERIAL AND FUNGAL INFECTIONS, 2ND EDITION, P669, DOI 10.1079/9781845935542.0669; Carbajal-Gonzalez MT, 2011, DIS AQUAT ORGAN, V96, P125, DOI 10.3354/dao02391; Cheng X, 2015, ENV MICROBIOL REP, V7, P139, DOI 10.1111/1758-2229.12231; Das SK, 2012, J ENVIRON BIOL, V33, P545; de Bruijn I, 2008, J BACTERIOL, V190, P2777, DOI 10.1128/JB.01563-07; de Bruijn I, 2007, MOL MICROBIOL, V63, P417, DOI 10.1111/j.1365-2958.2006.05525.x; de Souza JT, 2003, APPL ENVIRON MICROB, V69, P7161, DOI 10.1128/AEM.69.12.7161-7172.2003; Nguyen DD, 2013, P NATL ACAD SCI USA, V110, pE2611, DOI 10.1073/pnas.1303471110; FAO (Food and Agriculture Organization of the United Nations), 2014, STAT WORLD FISH AQ 2; Fernandez-Beneitez MJ, 2008, FEMS MICROBIOL LETT, V279, P23, DOI 10.1111/j.1574-6968.2007.01002.x; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Garces ME, 2015, DIS AQUAT ORGAN, V113, P41, DOI 10.3354/dao02815; Gozlan RE, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00062; HATAI K, 1992, J WILDLIFE DIS, V28, P532, DOI 10.7589/0090-3558-28.4.532; Hatai K., 1988, Bulletin of the European Association of Fish Pathologists, V8, P27; Hatai K, 1994, SALMON SAPROLEGNIASI; Hussein MMA, 2001, FISH PATHOL, V36, P73, DOI 10.3147/jsfp.36.73; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Krugner-Higby L, 2010, DIS AQUAT ORGAN, V91, P57, DOI 10.3354/dao02237; Lategan MJ, 2004, AQUACULTURE, V240, P19, DOI 10.1016/j.aquaculture.2004.04.009; Lategan MJ, 2004, AQUACULTURE, V235, P77, DOI 10.1016/j.aquaculture.2003.09.014; Lategan MJ, 2003, J FISH DIS, V26, P147, DOI 10.1046/j.1365-2761.2003.00443.x; Liu Y, 2014, ISME J, V8, P2002, DOI 10.1038/ismej.2014.44; Loch TP, 2012, J FISH DIS, V35, P39, DOI 10.1111/j.1365-2761.2011.01322.x; Loper JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002784; Martel A, 2013, P NATL ACAD SCI USA, V110, P15325, DOI 10.1073/pnas.1307356110; Nielsen TH, 2003, APPL ENVIRON MICROB, V69, P861, DOI 10.1128/AEM.69.2.861-868.2003; Phillips AJ, 2008, TRENDS MICROBIOL, V16, P13, DOI 10.1016/j.tim.2007.10.013; Pierce CY, 2007, CHEM COMMUN, P807, DOI 10.1039/b613200f; Raaijmakers JM, 2006, MOL PLANT MICROBE IN, V19, P699, DOI 10.1094/MPMI-19-0699; Rademaker J. L. W., 1998, MOL MICROBIAL ECOLOG, P1; Sarmiento-Ramirez JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085853; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Song CX, 2014, FEMS MICROBIOL LETT, V356, P166, DOI 10.1111/1574-6968.12404; van de Mortel JE, 2009, APPL ENVIRON MICROB, V75, P4950, DOI 10.1128/AEM.00241-09; van den Berg AH, 2013, FUNGAL BIOL REV, V27, P33, DOI 10.1016/j.fbr.2013.05.001; Van West Pieter, 2006, Mycologist, V20, P99, DOI 10.1016/j.mycol.2006.06.004; Versalovic James, 1994, Methods in Molecular and Cellular Biology, V5, P25; Verschuere L, 2000, MICROBIOL MOL BIOL R, V64, P655, DOI 10.1128/MMBR.64.4.655-671.2000; Watrous J, 2012, P NATL ACAD SCI USA, V109, pE1743, DOI 10.1073/pnas.1203689109; Woodhams DC, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-8	45	28	30	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136241	10.1371/journal.pone.0136241	http://dx.doi.org/10.1371/journal.pone.0136241			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317985	gold, Green Published, Green Submitted			2022-12-26	WOS:000360299100065
J	Okoro, EU; Zhang, HF; Guo, ZM; Yang, F; Smith, C; Yang, H				Okoro, Emmanuel U.; Zhang, Hongfeng; Guo, Zhongmao; Yang, Fang; Smith, Carlie, Jr.; Yang, Hong			A Subregion of Reelin Suppresses Lipoprotein-Induced Cholesterol Accumulation in Macrophages	PLOS ONE			English	Article							TRANSPORTER A1 EXPRESSION; FOAM CELL-FORMATION; APOLIPOPROTEIN-E; TANGIER-DISEASE; DOWN-REGULATION; VLDL RECEPTOR; BINDING; PROTEIN; INDUCTION; FRAGMENT	Activation of apolipoprotein E receptor-2 (apoER2) and very low density lipoprotein receptor (VLDLR) inhibits foam cell formation. Reelin is a ligand of these receptors. Here we generated two reelin subregions containing the receptor binding domain with or without its C-terminal region (R5-6C and R5-6, respectively) and studied the impact of these peptides on macrophage cholesterol metabolism. We found that both R5-6C and R5-6 can be secreted by cells. Purified R5-6 protein can bind apoER2 and VLDLR. Overexpression of apoER2 in macrophages increased the amount of R5-6 bound to the cell surface. Treatment of macrophages with 0.2 mu g/ml R5-6 elevated ATP binding cassette A1 (ABCA1) protein level by similar to 72% and apoAI-mediated cholesterol efflux by similar to 39%. In addition, the medium harvested from cells overexpressing R5-6 or R5-6C (R5-6- and R5-6C-conditioned media, respectively) also up-regulated ABCA1 protein expression, which was associated with accelerated cholesterol efflux and enhanced phosphorylation of phosphatidylinositol 3 kinase (PI3K) and specificity protein-1 (Sp1) in macrophages. The increased ABCA1 expression and cholesterol efflux by R5-6- and R5-6C-conditioned media were diminished by Sp1 or PI3K inhibitors mithramycin A and LY294002. Further, the cholesterol accumulation induced by apoB-containing, apoE-free lipoproteins was significantly less in macrophages incubated with R5-6- or R5-6C-conditioned medium than in those incubated with control conditioned medium. Knockdown of apoER2 or VLDLR attenuated the inhibitory role of R5-6-conditioned medium against lipoprotein-induced cholesterol accumulation. These results suggest that the reelin subregion R5-6 can serve as a tool for studying the role of apoER2 and VLDLR in atherogenesis.	[Okoro, Emmanuel U.; Zhang, Hongfeng; Guo, Zhongmao; Yang, Fang; Smith, Carlie, Jr.; Yang, Hong] Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA; [Zhang, Hongfeng] Cent Hosp Wuhan, Dept Pathol, Wuhan, Peoples R China; [Yang, Fang] Wuhan Univ, Sch Basic Med Sci, Wuhan 430072, Peoples R China	Meharry Medical College; Wuhan University	Yang, H (corresponding author), Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA.	hyang@mmc.edu			US National Institutes of Health [SC1HL101431]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [SC1HL101431] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007586] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by the US National Institutes of Health SC1HL101431 (HY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], J HUAZHONG U SCI TEC; Baitsch D, 2011, ARTERIOSCL THROM VAS, V31, P1160, DOI 10.1161/ATVBAHA.111.222745; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Chen W, 2001, J BIOL CHEM, V276, P43564, DOI 10.1074/jbc.M107938200; Chen XP, 2011, J BIOL CHEM, V286, P8917, DOI 10.1074/jbc.M110.214429; Chen XP, 2012, J BIOL CHEM, V287, P3751, DOI 10.1074/jbc.M111.310888; deBergeyck V, 1997, MOL BRAIN RES, V50, P85, DOI 10.1016/S0169-328X(97)00166-6; FOLCH J, 1957, J BIOL CHEM, V226, P497; Guo M, 2000, BIOCHEM PHARMACOL, V60, P635, DOI 10.1016/S0006-2952(00)00379-8; Herz J, 2009, J LIPID RES, V50, pS287, DOI 10.1194/jlr.R800077-JLR200; Hiltunen TP, 1998, CIRCULATION, V97, P1079, DOI 10.1161/01.CIR.97.11.1079; Hodgkinson CP, 2002, BIOCHEMISTRY-US, V41, P561, DOI 10.1021/bi010719z; Jossin Y, 2004, J NEUROSCI, V24, P514, DOI 10.1523/JNEUROSCI.3408-03.2004; Kabanova S, 2009, INT J MED SCI, V6, P156; Korporaal SJA, 2009, ARTERIOSCL THROM VAS, V29, P372, DOI 10.1161/ATVBAHA.108.173278; Lambert de RC, 1998, ADV ANAT EMBRYOL CEL, V150, P1; Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; Lin XH, 2013, J BIOL CHEM, V288, P14815, DOI 10.1074/jbc.M113.466565; Lutter S, 2012, J CELL BIOL, V197, P837, DOI 10.1083/jcb.201110132; Nakano Y, 2007, J BIOL CHEM, V282, P20544, DOI 10.1074/jbc.M702300200; Okoro EU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044430; Orso E, 2000, NAT GENET, V24, P192, DOI 10.1038/72869; Quinn KL, 2011, ARTERIOSCL THROM VAS, V31, P2070, DOI 10.1161/ATVBAHA.111.227116; Ramesh S, 2011, J CLIN INVEST, V121, P120, DOI 10.1172/JCI39828; Shashkin P, 2005, CURR PHARM DESIGN, V11, P3061, DOI 10.2174/1381612054865064; Shen GQ, 2007, AM J HUM GENET, V81, P780, DOI 10.1086/521581; Singaraja RR, 2002, J CLIN INVEST, V110, P35, DOI 10.1172/JCI200215748; Smalheiser NR, 2000, P NATL ACAD SCI USA, V97, P1281, DOI 10.1073/pnas.97.3.1281; Tacken PJ, 2000, BIOCHEM J, V347, P357, DOI 10.1042/0264-6021:3470357; Tacken PJ, 2002, ATHEROSCLEROSIS, V162, P103, DOI 10.1016/S0021-9150(01)00697-9; TAKAHASHI S, 1995, J BIOL CHEM, V270, P15747, DOI 10.1074/jbc.270.26.15747; Van Eck M, 2005, ATHEROSCLEROSIS, V183, P230, DOI 10.1016/j.atherosclerosis.2005.03.045; Van Eck M, 2006, ARTERIOSCL THROM VAS, V26, P929, DOI 10.1161/01.ATV.0000208364.22732.16; Van Eck M, 2002, P NATL ACAD SCI USA, V99, P6298, DOI 10.1073/pnas.092327399; Vashist SK, 2015, BIOSENS BIOELECTRON, V67, P73, DOI 10.1016/j.bios.2014.06.058; WALKER KW, 1992, J IMMUNOL METHODS, V154, P121, DOI 10.1016/0022-1759(92)90219-J; Waltmann MD, 2014, BBA-MOL BASIS DIS, V1842, P1395, DOI 10.1016/j.bbadis.2014.05.009; Wang ZF, 2009, FREE RADICAL BIO MED, V47, P1221, DOI 10.1016/j.freeradbiomed.2009.08.001; White-Adams TC, 2009, ARTERIOSCL THROM VAS, V29, P1602, DOI 10.1161/ATVBAHA.109.187393; Wu DF, 2007, J LIPID RES, V48, P2571, DOI 10.1194/jlr.M700217-JLR200; Yang H, 2003, FREE RADICAL BIO MED, V35, P266, DOI 10.1016/S0891-5849(03)00277-6; Yang XV, 2009, P NATL ACAD SCI USA, V106, P274, DOI 10.1073/pnas.0807594106; Yasui N, 2007, P NATL ACAD SCI USA, V104, P9988, DOI 10.1073/pnas.0700438104; Zhao YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021453	45	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136895	10.1371/journal.pone.0136895	http://dx.doi.org/10.1371/journal.pone.0136895			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317415	Green Submitted, Green Published, gold			2022-12-26	WOS:000360299100164
J	Zhao, Y; Zhang, MJ; Shi, CX; Zhang, Y; Cai, WP; Zhao, QX; Li, Y; Li, HQ; Liu, X; Chen, LM; Ma, Y; Zhang, FJ; Liu, ZF; Wu, ZY				Zhao, Yan; Zhang, Mingjie; Shi, Cynthia X.; Zhang, Yao; Cai, Weiping; Zhao, Qingxia; Li, Yong; Li, Huiqin; Liu, Xia; Chen, Limeng; Ma, Ye; Zhang, Fujie; Liu, Zhongfu; Wu, Zunyou			Renal Function in Chinese HIV-Positive Individuals following Initiation of Antiretroviral Therapy	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; INFECTED PATIENTS; RISK-FACTORS; PREVALENCE; COHORT; ASSOCIATION; TENOFOVIR; METAANALYSIS; NEPHROPATHY	Aim To identify the prevalence and predictors of abnormal renal function among HIV-positive Chinese patients prior to antiretroviral therapy (ART) initiation and to evaluate subsequent changes in renal function after ART exposure. Methods We conducted a nationwide cohort study of subjects who enrolled in the national Chinese ART program from January 1, 2012 to December 31, 2012. We estimated the glomerular filtration rate (eGFR) of subjects prior to and after initiating ART. Risk factors for abnormal renal function, as defined by eGFR < 60 ml/min/1.73m(2), at baseline and follow-up were assessed by logistic regression and Cox proportional hazards regression models, respectively. Results Among 41,862 subjects, at ART baseline, 3.3% had a baseline eGFR < 60 ml/min/1.73m(2) and 24.2% had eGFR = 60-90 ml/min/1.73m(2). Adjusted baseline risk factors for baseline eGFR < 60 ml/min/1.73m(2) were older age (Adjusted odds ratio [AOR] = 5.19, 95% confidence interval [CI]: 4.52-5.67), female (AOR = 1.68, 95% CI: 1.47-1.93), hemoglobin < 120g/L (AOR = 1.68, 95% CI: 1.47-1.93), blood glucose > 6.1 mmol/L (AOR = 1.46, 95% CI: 1.25-1.72), and hepatitis C co-infection (AOR = 1.36, 95% CI: 1.06-1.73). Among subjects with baseline eGFR > 90 ml/min/1.73m(2), the incidence of the eGFR falling to < 60 ml/min/1.73m(2) was 0.92/100 person-years after a median of 15.0 months of ART. Being on a tenofovir with lopinavir/ritonavir regimen (Adjusted hazard ratio [AHR] = 3.02, 95% CI: 1.96-4.66) and having an unsuppressed viral load (AHR = 2.70, 95% CI: 1.80-4.03) were independent predictors for eGFR < 60 ml/min/1.73m(2) after ART initiation as well as older age, female, and hemoglobin < 120 g/L. Conclusion A high proportion of HIV-positive subjects in China presented with abnormal renal function prior to ART initiation. But the incidence of the eGFR decrease after ART was low. Patient renal function should be regularly monitored by eGFR before initiating and during ART.	[Zhao, Yan; Zhang, Mingjie; Shi, Cynthia X.; Zhang, Yao; Liu, Xia; Ma, Ye; Zhang, Fujie; Liu, Zhongfu; Wu, Zunyou] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Cai, Weiping] Guangzhou 8th Hosp, Guangzhou, Guangdong, Peoples R China; [Zhao, Qingxia] Zhengzhou 6th Hosp, Zhengzhou, Henan, Peoples R China; [Li, Yong] Longtan Hosp, Guangxi, Peoples R China; [Li, Huiqin] Ctr AIDS Care, Kunming, Yunnan, Peoples R China; [Chen, Limeng] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Zhang, FJ (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	zhang.fujie.t@gmail.com; zhongfuliu@163.com	Burdmann, Emmanuel/B-7023-2009; Burdmann, Emmanuel/AAY-1966-2020	Burdmann, Emmanuel/0000-0002-7644-8579; 	Chinese Government AIDS Program	Chinese Government AIDS Program	This study was supported by Chinese Government AIDS Program. The funding organizations had no role in the design of this study, in the analysis, or interpretation of data, or in the final decision to submit the manuscript for publication. The contents of this paper are solely the responsibility of the authors and do not necessarily represent the official views of the affiliated institutions.	Ando M, 2012, CLIN EXP NEPHROL, V16, P363, DOI 10.1007/s10157-012-0585-7; Bruggeman Leslie A, 2009, Curr Infect Dis Rep, V11, P479, DOI 10.1007/s11908-009-0069-4; Cailhol J, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-40; Cao Y, 2013, NEPHROLOGY, V18, P307, DOI 10.1111/nep.12031; Cooper RD, 2010, CLIN INFECT DIS, V51, P496, DOI 10.1086/655681; Dabrowska MM, 2012, CURR HIV RES, V10, P247, DOI 10.2174/157016212800618147; del Palacio M, 2012, CURR HIV RES, V10, P521, DOI 10.2174/157016212802429802; Fafin C, 2012, NEPHRON CLIN PRACT, V120, pC205, DOI 10.1159/000342377; Gupta SK, 2005, CLIN INFECT DIS, V40, P1559, DOI 10.1086/430257; Ibrahim F, 2012, AM J KIDNEY DIS, V60, P539, DOI 10.1053/j.ajkd.2012.03.006; Islam FM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-234; Izzedine H, 2007, NEPHROL DIAL TRANSPL, V22, P2757, DOI 10.1093/ndt/gfm404; Kalayjian RC, 2012, AIDS, V26, P1907, DOI 10.1097/QAD.0b013e328357f5ed; Kalayjian RC, 2010, ADV CHRONIC KIDNEY D, V17, P59, DOI 10.1053/j.ackd.2009.08.013; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Longenecker CT, 2009, AIDS, V23, P1089, DOI 10.1097/QAD.0b013e32832a3f24; Lucas GM, 2004, AIDS, V18, P541, DOI 10.1097/00002030-200402200-00022; Lucas GM, 2008, J INFECT DIS, V197, P1548, DOI 10.1086/587994; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Ministry of Health Working Group on Clinical AIDS Treatment, 2012, CHIN FREE ANT THER M; Monteagudo-Chu Maricelle O, 2012, J Pharm Pract, V25, P552; Naicker S, 2010, CLIN NEPHROL, V74, pS51; Orlando G, 2006, HIV MED, V7, P549, DOI 10.1111/j.1468-1293.2006.00420.x; Peters PJ, 2008, KIDNEY INT, V74, P925, DOI 10.1038/ki.2008.305; Rasch MG, 2012, SCAND J INFECT DIS, V44, P689, DOI 10.3109/00365548.2012.673730; Rocco MV, 2012, AM J KIDNEY DIS, V60, P857, DOI 10.1053/j.ajkd.2012.07.005; Ryom L, 2013, J INFECT DIS, V207, P1359, DOI 10.1093/infdis/jit043; Winston JA, 2010, ADV CHRONIC KIDNEY D, V17, P19, DOI 10.1053/j.ackd.2009.08.006; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zuo L, 2005, AM J KIDNEY DIS, V45, P463, DOI 10.1053/j.ajkd.2004.11.012	30	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135462	10.1371/journal.pone.0135462	http://dx.doi.org/10.1371/journal.pone.0135462			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317657	Green Submitted, Green Published, gold			2022-12-26	WOS:000360299100030
J	Zheng, SS; Lu, Q; Xu, YH; Wang, XN; Shen, JL; Wang, W				Zheng, Shengsheng; Lu, Qiang; Xu, Yuanhong; Wang, Xiaonan; Shen, Jilong; Wang, Wei			GdCl3 Attenuates Schistosomiasis japonicum Egg-Induced Granulomatosis Accompanied by Decreased Macrophage Infiltration in Murine Liver	PLOS ONE			English	Article							KUPFFER CELLS; OPPOSING ROLES; IL-13 RECEPTOR; DECOY RECEPTOR; GROWTH-FACTOR; UP-REGULATION; ACTIVATION; INFLAMMATION; EXPRESSION; DEPLETION	Early-stage hepatic granuloma and advanced-stage fibrosis are important characteristics of schistosomiasis. The direct consequences of gadolinium chloride (GdCl3) in egg-induced granuloma formation have not been reported, although GdCl3 is known to block the macrophages. In present study, mice were infected with 15 Schistosoma japonicum (S. japonicum) cercariae and treated with GdCl3 (10 mg/kg body weight) twice weekly from day 21 to day 42 post-infection during the onset of egg-laying towards early granuloma formation. Histochemical staining showed that repeated injection of GdCl3 decreased macrophages infiltration in liver of mice infected with S. japonicum. Macrophage depletion by GdCl3 during the initial phase attenuated liver pathological injury characterized by smaller granuloma size and decreased immune inflammation as well as less fibrogenesis. In addition, IL-13R alpha 2 expression was reduced by GdCl3 in liver of mice infected with S. japonicum. The results suggest that GdCl3 depleted macrophages, which attenuated helminth infected immune responses involving with IL-13R alpha 2 signal. These findings would highlight a therapeutic potential via manipulating IL-13R alpha 2+ macrophage in schistosomiasis.	[Zheng, Shengsheng; Wang, Xiaonan; Shen, Jilong; Wang, Wei] Anhui Med Univ, Dept Pathobiol, Key Labs Zoonoses Anhui Prov, Hefei 230032, Peoples R China; [Lu, Qiang] Anhui Med Univ, Dept Clin Med, Hefei 230032, Peoples R China; [Xu, Yuanhong] Anhui Med Univ, Dept Lab Diagnost, Affiliated Hosp 1, Hefei 230032, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University	Wang, W (corresponding author), Anhui Med Univ, Dept Pathobiol, Key Labs Zoonoses Anhui Prov, Hefei 230032, Peoples R China.	aydwwei@163.com			Natural Science Foundation of China [30940061, 81171606]; Foundation of Anhui Medical University [XJ201012]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Anhui Medical University	This work was supported by the Natural Science Foundation of China (No. 30940061 and No. 81171606) and the Foundation of Anhui Medical University (No. XJ201012).	Andrade ZA, 2009, PARASITE IMMUNOL, V31, P656, DOI 10.1111/j.1365-3024.2009.01157.x; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304; Barron L, 2011, EUR J IMMUNOL, V41, P2509, DOI 10.1002/eji.201141869; Bernard J, 2001, LAB INVEST, V81, P1223, DOI 10.1038/labinvest.3780336; Bilzer M, 2006, LIVER INT, V26, P1175, DOI 10.1111/j.1478-3231.2006.01342.x; Brunner SM, 2013, TRANSPLANT RES, V2, DOI 10.1186/2047-1440-2-16; Chen MG, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-6; Chuah C, 2014, TRENDS PARASITOL, V30, P141, DOI 10.1016/j.pt.2013.12.009; Dang H, 2014, INT J ENV RES PUB HE, V11, P2278, DOI 10.3390/ijerph110202278; Donaldson DD, 1998, J IMMUNOL, V161, P2317; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Dunne DW, 2005, NAT REV IMMUNOL, V5, P420, DOI 10.1038/nri1601; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Friedman SL, 2005, J CLIN INVEST, V115, P29, DOI 10.1172/JCI200523928; Greenwald B, 2005, GASTROENTEROL NURS, V28, P206; Greenwald Beverly, 2005, Gastroenterol Nurs, V28, P203, DOI 10.1097/00001610-200505000-00002; HARDONK MJ, 1992, J LEUKOCYTE BIOL, V52, P296, DOI 10.1002/jlb.52.3.296; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Hershey GKK, 2003, J ALLERGY CLIN IMMUN, V111, P677, DOI 10.1067/mai.2003.1333; Hu Y, 2014, INT J ENV RES PUB HE, V11, P701, DOI 10.3390/ijerph110100701; HUSZTIK E, 1980, BRIT J EXP PATHOL, V61, P624; Kaplan MH, 1998, J IMMUNOL, V160, P1850; King CH, 2010, ACTA TROP, V113, P95, DOI 10.1016/j.actatropica.2009.11.012; Kolios G, 2006, WORLD J GASTROENTERO, V12, P7413, DOI 10.3748/wjg.v12.i46.7413; Liu Y, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00116; Liu Y, 2011, J IMMUNOL, V187, P2814, DOI 10.4049/jimmunol.1003260; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Magalhaes A, 2004, MEM I OSWALDO CRUZ, V99, P21, DOI 10.1590/S0074-02762004000900004; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mentink-Kane MM, 2004, P NATL ACAD SCI USA, V101, P586, DOI 10.1073/pnas.0305064101; Mentink-Kane MM, 2004, IMMUNOL REV, V202, P191, DOI 10.1111/j.0105-2896.2004.00210.x; Mizgerd JP, 1996, J LEUKOCYTE BIOL, V59, P189, DOI 10.1002/jlb.59.2.189; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Muriel P, 2003, J APPL TOXICOL, V23, P103, DOI 10.1002/jat.892; Qi Y, 2012, IMMUNOL LETT, V144, P60, DOI 10.1016/j.imlet.2012.03.007; RAGHEB S, 1989, J IMMUNOL, V142, P3239; Rivera CA, 2001, AM J PHYSIOL-GASTR L, V281, pG200, DOI 10.1152/ajpgi.2001.281.1.G200; Schuppan D, 2013, J CLIN INVEST, V123, P1887, DOI 10.1172/JCI66028; Smith P, 2004, J IMMUNOL, V173, P1240, DOI 10.4049/jimmunol.173.2.1240; Sugimoto R, 2005, LIVER INT, V25, P420, DOI 10.1111/j.1478-3231.2005.01087.x; Tacke F, 2014, J HEPATOL, V60, P1090, DOI 10.1016/j.jhep.2013.12.025; Tucker Matthew S, 2013, Curr Protoc Immunol, V103, DOI 10.1002/0471142735.im1901s103; Tyner JW, 2005, NAT MED, V11, P1180, DOI 10.1038/nm1303; VanRooijen N, 1996, HEPATOLOGY, V23, P1239; Wang W, 2009, CHINESE MED J-PEKING, V122, P1650, DOI 10.3760/cma.j.issn.0366-6999.2009.14.009; Weng HL, 2009, HEPATOLOGY, V50, P230, DOI 10.1002/hep.22934; Wynn TA, 2004, IMMUNOL REV, V201, P156, DOI 10.1111/j.0105-2896.2004.00176.x; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240; Zhou XN, 2005, ACTA TROP, V96, P97, DOI 10.1016/j.actatropica.2005.07.005	52	2	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0132222	10.1371/journal.pone.0132222	http://dx.doi.org/10.1371/journal.pone.0132222			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317423	Green Published, gold, Green Submitted			2022-12-26	WOS:000360299100004
J	Martinez-Garcia, PM; Rodriguez-Palenzuela, P; Arrebola, E; Carrion, VJ; Gutierrez-Barranquero, JA; Perez-Garcia, A; Ramos, C; Cazorla, FM; de Vicente, A				Manuel Martinez-Garcia, Pedro; Rodriguez-Palenzuela, Pablo; Arrebola, Eva; Carrion, Victor J.; Antonio Gutierrez-Barranquero, Jose; Perez-Garcia, Alejandro; Ramos, Cayo; Cazorla, Francisco M.; de Vicente, Antonio			Bioinformatics Analysis of the Complete Genome Sequence of the Mango Tree Pathogen Pseudomonas syringae pv. syringae UMAF0158 Reveals Traits Relevant to Virulence and Epiphytic Lifestyle	PLOS ONE			English	Article							III SECRETION SYSTEMS; GENE-CLUSTER; VI SECRETION; HYPERSENSITIVE RESPONSE; PHASEOLICOLA 1448A; COPPER RESISTANCE; EFFECTOR PROTEINS; PLANT-PATHOGENS; TOMATO; HOST	The genome sequence of more than 100 Pseudomonas syringae strains has been sequenced to date; however only few of them have been fully assembled, including P. syringae pv. syringae B728a. Different strains of pv. syringae cause different diseases and have different host specificities; so, UMAF0158 is a P. syringae pv. syringae strain related to B728a but instead of being a bean pathogen it causes apical necrosis of mango trees, and the two strains belong to different phylotypes of pv. syringae and clades of P. syringae. In this study we report the complete sequence and annotation of P. syringae pv. syringae UMAF0158 chromosome and plasmid pPSS158. A comparative analysis with the available sequenced genomes of other 25 P. syringae strains, both closed (the reference genomes DC3000, 1448A and B728a) and draft genomes was performed. The 5.8 Mb UMAF0158 chromosome has 59.3% GC content and comprises 5017 predicted protein-coding genes. Bioinformatics analysis revealed the presence of genes potentially implicated in the virulence and epiphytic fitness of this strain. We identified several genetic features, which are absent in B728a, that may explain the ability of UMAF0158 to colonize and infect mango trees: the mangotoxin biosynthetic operon mbo, a gene cluster for cellulose production, two different type III and two type VI secretion systems, and a particular T3SS effector repertoire. A mutant strain defective in the rhizobial-like T3SS Rhc showed no differences compared to wild-type during its interaction with host and non-host plants and worms. Here we report the first complete sequence of the chromosome of a pv. syringae strain pathogenic to a woody plant host. Our data also shed light on the genetic factors that possibly determine the pathogenic and epiphytic lifestyle of UMAF0158. This work provides the basis for further analysis on specific mechanisms that enable this strain to infect woody plants and for the functional analysis of host specificity in the P. syringae complex.	[Manuel Martinez-Garcia, Pedro; Rodriguez-Palenzuela, Pablo] Univ Politecn Madrid, Ctr Biotecnol Genom Plantas UPM INIA, Madrid, Spain; [Arrebola, Eva] Univ Malaga, Consejo Super Invest Cient, Inst Hortofruticultura Subtrop & Mediterranea La, Estn Expt La Mayora, E-29071 Malaga, Spain; [Carrion, Victor J.; Antonio Gutierrez-Barranquero, Jose; Perez-Garcia, Alejandro; Cazorla, Francisco M.; de Vicente, Antonio] Univ Malaga, Consejo Super Invest Cient, Inst Hortofruticultura Subtrop & Mediterranea La, Dept Microbiol,Fac Ciencias, E-29071 Malaga, Spain; [Manuel Martinez-Garcia, Pedro; Ramos, Cayo] Univ Malaga, Consejo Super Invest Cient, Inst Hortofruticultura Subtrop & Mediterranea La, Area Genet,Fac Ciencias, E-29071 Malaga, Spain	Universidad Politecnica de Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental La Mayora (EELM); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM)	de Vicente, A (corresponding author), Univ Malaga, Consejo Super Invest Cient, Inst Hortofruticultura Subtrop & Mediterranea La, Dept Microbiol,Fac Ciencias, E-29071 Malaga, Spain.	adevicente@uma.es	Perez-Garcia, Alejandro/D-9373-2013; Arrebola, Eva/AGY-5955-2022; Carrion, Victor/GPG-1248-2022; RODRIGUEZ-PALENZUELA, PABLO/A-9149-2012; RAMOS, CAYO/G-3818-2011; de Vicente, Antonio/G-4405-2011; Bravo, Victor Carrion/A-9387-2014; Arrebola-Diez, Eva/H-1628-2011; Barranquero, Jose Antonio Gutiérrez/AAS-5444-2021; Gutierrez Barranquero, Jose Antonio/K-7745-2014; Cazorla, Francisco M./G-3907-2011	Perez-Garcia, Alejandro/0000-0002-1065-0360; Arrebola, Eva/0000-0002-2308-7829; RODRIGUEZ-PALENZUELA, PABLO/0000-0002-4963-9177; RAMOS, CAYO/0000-0002-2362-5041; de Vicente, Antonio/0000-0003-2716-9861; Bravo, Victor Carrion/0000-0002-4093-0355; Arrebola-Diez, Eva/0000-0002-2308-7829; Barranquero, Jose Antonio Gutiérrez/0000-0003-1810-699X; Gutierrez Barranquero, Jose Antonio/0000-0003-1810-699X; Martinez Garcia, Pedro Manuel/0000-0002-2119-2465; Cazorla, Francisco M./0000-0003-0798-0964	Consejeria de Innovacion, Ciencia y Empresa, Secretaria General de Universidades, Investigacion y Tecnologia, Junta de Andalucia, Spain [P07-AGR-2471, P12-AGR-1473]; FEDER; ESF; Campus de Excelencia Internacional Andalucia Tech	Consejeria de Innovacion, Ciencia y Empresa, Secretaria General de Universidades, Investigacion y Tecnologia, Junta de Andalucia, Spain; FEDER(European Commission); ESF(European Commission); Campus de Excelencia Internacional Andalucia Tech	This study was supported by funding from Consejeria de Innovacion, Ciencia y Empresa, Secretaria General de Universidades, Investigacion y Tecnologia, Junta de Andalucia, Spain (Incentivos a Proyectos de Excelencia P07-AGR-2471 and P12-AGR- 1473), cofinanced by FEDER funds (EU). This work was developed during EA hired in the CSIC by the program mode JAEDoc "Junta para la Ampliacion de Estudios" cofinanced by ESF. PMMG was supported by the Campus de Excelencia Internacional Andalucia Tech. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abby SS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002983; Adaikkalam V, 2002, MICROBIOL-SGM, V148, P2857, DOI 10.1099/00221287-148-9-2857; Agrios GN, 2005, PLANT PATHOLOGY; Aguilera S, 2007, J BACTERIOL, V189, P2834, DOI 10.1128/JB.01845-06; Arrebola E, 2003, PHYSIOL MOL PLANT P, V63, P117, DOI 10.1016/j.pmpp.2003.11.003; Arrebola E, 2007, MOL PLANT MICROBE IN, V20, P500, DOI 10.1094/MPMI-20-5-0500; Arrebola E, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-10; Arrebola E, 2009, INT MICROBIOL, V12, P87, DOI 10.2436/20.1501.01.85; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; BARRAS F, 1994, ANNU REV PHYTOPATHOL, V32, P201, DOI 10.1146/annurev.py.32.090194.001221; Barret M, 2011, MICROBIOL-SGM, V157, P1726, DOI 10.1099/mic.0.048645-0; Bartoli C, 2015, MOL PLANT PATHOL, V16, P137, DOI 10.1111/mpp.12167; Bender CL, 1999, MICROBIOL MOL BIOL R, V63, P266, DOI 10.1128/MMBR.63.2.266-292.1999; Berge O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105547; Berti AD, 2009, J BACTERIOL, V191, P4594, DOI 10.1128/JB.00457-09; Bose M., 2006, In Silico Biology, V6, P223; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Buttner D, 2012, MICROBIOL MOL BIOL R, V76, P262, DOI 10.1128/MMBR.05017-11; Bull CT, 2010, J PLANT PATHOL, V92, P551; Cabiscol Elisa, 2000, International Microbiology, V3, P3; Cai RM, 2011, INFECT GENET EVOL, V11, P1738, DOI 10.1016/j.meegid.2011.07.012; Carrion VJ, 2013, APPL ENVIRON MICROB, V79, P756, DOI 10.1128/AEM.03007-12; Carrion VJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036709; Cazorla FM, 2008, MICROB ECOL, V56, P283, DOI 10.1007/s00248-007-9346-7; Cazorla FM, 2002, PHYTOPATHOLOGY, V92, P909, DOI 10.1094/PHYTO.2002.92.8.909; Cazorla FM, 1998, PHYTOPATHOLOGY, V88, P614, DOI 10.1094/PHYTO.1998.88.7.614; Charkowski AO, 1998, J BACTERIOL, V180, P5211, DOI 10.1128/JB.180.19.5211-5217.1998; Clarke CR, 2010, MOL PLANT MICROBE IN, V23, P198, DOI 10.1094/MPMI-23-2-0198; Coburn B, 2007, CLIN MICROBIOL REV, V20, P535, DOI 10.1128/CMR.00013-07; Colburn-Clifford JM, 2010, APPL ENVIRON MICROB, V76, P7392, DOI 10.1128/AEM.01742-10; COSTACURTA A, 1995, CRIT REV MICROBIOL, V21, P1, DOI 10.3109/10408419509113531; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; DENNY TP, 1995, ANNU REV PHYTOPATHOL, V33, P173, DOI 10.1146/annurev.py.33.090195.001133; Egan F, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00034; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fouts DE, 2002, P NATL ACAD SCI USA, V99, P2275, DOI 10.1073/pnas.032514099; Gardan L, 1999, INT J SYST BACTERIOL, V49, P469, DOI 10.1099/00207713-49-2-469; Gazi AD, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-188; Glasner JD, 2003, NUCLEIC ACIDS RES, V31, P147, DOI 10.1093/nar/gkg125; GLICKMANN E, 1995, APPL ENVIRON MICROB, V61, P793, DOI 10.1128/AEM.61.2.793-796.1995; Grant SR, 2006, ANNU REV MICROBIOL, V60, P425, DOI 10.1146/annurev.micro.60.080805.142251; Green S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010224; GUERINOT ML, 1994, ANNU REV MICROBIOL, V48, P743, DOI 10.1146/annurev.micro.48.1.743; Gutierrez-Barranquero JA, 2013, PHYTOPATHOLOGY, V103, P1115, DOI 10.1094/PHYTO-04-13-0093-R; Gutierrez-Barranquero JA, 2013, APPL ENVIRON MICROB, V79, P1028, DOI 10.1128/AEM.02644-12; HIRANO SS, 1990, ANNU REV PHYTOPATHOL, V28, P155, DOI 10.1146/annurev.py.28.090190.001103; Hoss S, 2012, ENVIRON TOXICOL CHEM, V31, P1525, DOI 10.1002/etc.1843; Jani AJ, 2010, CELL HOST MICROBE, V8, P2, DOI 10.1016/j.chom.2010.06.012; Joardar V, 2005, J BACTERIOL, V187, P6488, DOI 10.1128/JB.187.18.6488-6498.2005; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Juhas M, 2008, CELL MICROBIOL, V10, P2377, DOI 10.1111/j.1462-5822.2008.01187.x; Kennelly MM, 2007, PLANT DIS, V91, P4, DOI 10.1094/PD-91-0004; Krahn D, 2011, NAT PROD REP, V28, P1854, DOI [10.1039/c1np00048a, 10.1039/C1NP00048A]; Krewulak KD, 2008, BBA-BIOMEMBRANES, V1778, P1781, DOI 10.1016/j.bbamem.2007.07.026; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lamichhane JR, 2014, ADV AGRON, V126, P235, DOI 10.1016/B978-0-12-800132-5.00004-3; Lee J, 2012, PLANT PHYSIOL, V158, P1803, DOI 10.1104/pp.111.190686; Li JY, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-31; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lindeberg M, 2012, TRENDS MICROBIOL, V20, P199, DOI 10.1016/j.tim.2012.01.003; LINDGREN PB, 1986, J BACTERIOL, V168, P512, DOI 10.1128/jb.168.2.512-522.1986; Lindow SE, 1985, ENG ORGANISMS ENV SC, P23; Martinez-Garcia PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119317; Marcelletti S, 2014, PHYTOPATHOLOGY, V104, P1274, DOI 10.1094/PHYTO-12-13-0344-R; Matas IM, 2014, MOL PLANT MICROBE IN, V27, P424, DOI 10.1094/MPMI-07-13-0206-R; Matthysse AG, 2008, CAN J MICROBIOL, V54, P241, DOI [10.1139/W08-005, 10.1139/w08-005]; Mhedbi-Hajri N, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-67; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Mur LAJ, 2008, J EXP BOT, V59, P501, DOI 10.1093/jxb/erm239; Mutka AM, 2013, PLANT J, V74, P746, DOI 10.1111/tpj.12157; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; PenalozaVazquez A, 1997, J BACTERIOL, V179, P4464, DOI 10.1128/jb.179.14.4464-4472.1997; Perez-Martinez I, 2010, APPL ENVIRON MICROB, V76, P3611, DOI 10.1128/AEM.00133-10; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Pradhan BB, 2012, MOL PLANT MICROBE IN, V25, P1157, DOI 10.1094/MPMI-02-12-0049-R; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Reinhardt JA, 2009, GENOME RES, V19, P294, DOI 10.1101/gr.083311.108; Rodriguez-Palenzuela P, 2010, ENVIRON MICROBIOL, V12, P1604, DOI 10.1111/j.1462-2920.2010.02207.x; Sarkar SF, 2006, GENETICS, V174, P1041, DOI 10.1534/genetics.106.060996; Sarris PF, 2010, MOL PLANT PATHOL, V11, P795, DOI 10.1111/j.1364-3703.2010.00644.x; Schell MA, 2007, MOL MICROBIOL, V64, P1466, DOI 10.1111/j.1365-2958.2007.05734.x; Schellenberg B, 2010, MOL PLANT MICROBE IN, V23, P1287, DOI 10.1094/MPMI-04-10-0094; Scholz-Schroeder BK, 2001, MOL PLANT MICROBE IN, V14, P336, DOI 10.1094/MPMI.2001.14.3.336; Silby MW, 2011, FEMS MICROBIOL REV, V35, P652, DOI 10.1111/j.1574-6976.2011.00269.x; Studholme DJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-395; Sudo T, 1996, BIOCHEM J, V319, P99, DOI 10.1042/bj3190099; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; Vinatzer BA, 2006, MOL MICROBIOL, V62, P26, DOI 10.1111/j.1365-2958.2006.05350.x; Volksch B, 1998, J BASIC MICROB, V38, P135; Voth DE, 2012, FUTURE MICROBIOL, V7, P241, DOI [10.2217/fmb.11.150, 10.2217/FMB.11.150]; Wensing A, 2010, APPL ENVIRON MICROB, V76, P2704, DOI 10.1128/AEM.02979-09; Zhang LL, 2007, MOL MICROBIOL, V65, P121, DOI 10.1111/j.1365-2958.2007.05775.x; Zhang XX, 2013, EVOLUTION, V67, P3161, DOI 10.1111/evo.12183; Zheng XY, 2012, CELL HOST MICROBE, V11, P587, DOI 10.1016/j.chom.2012.04.014; Zumaquero A, 2010, J BACTERIOL, V192, P4474, DOI 10.1128/JB.00260-10	99	25	25	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136101	10.1371/journal.pone.0136101	http://dx.doi.org/10.1371/journal.pone.0136101			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313942	Green Submitted, Green Published, gold			2022-12-26	WOS:000360144000041
J	Ullman, C; Mathonet, P; Oleksy, A; Diamandakis, A; Tomei, L; Demartis, A; Nardi, C; Sambucini, S; Missineo, A; Alt, K; Hagemeyer, CE; Harris, M; Hedt, A; Weis, R; Gehlsen, KR				Ullman, Christopher; Mathonet, Pascale; Oleksy, Arkadiusz; Diamandakis, Agata; Tomei, Licia; Demartis, Anna; Nardi, Chiara; Sambucini, Sonia; Missineo, Antonino; Alt, Karen; Hagemeyer, Christoph E.; Harris, Matt; Hedt, Amos; Weis, Roland; Gehlsen, Kurt R.			High Affinity Binders to EphA2 Isolated from Abdurin Scaffold Libraries; Characterization, Binding and Tumor Targeting	PLOS ONE			English	Article							IN-VITRO SELECTION; ANTIBODY FRAGMENTS; PROTEINS; LIGAND; PEPTIDES; EFFICACY; DOMAINS; PK	Abdurins are a novel antibody-like scaffold derived from the engineering of a single isolated CH2 domain of human IgG. Previous studies established the prolonged serum half-life of Abdurins, the result of a retained FcRn binding motif. Here we present data on the construction of large, diverse, phage-display and cell-free DNA display libraries and the isolation of high affinity binders to the cancer target, membrane-bound ephrin receptor tyrosine kinase class A2 (EphA2). Antigen binding regions were created by designing combinatorial libraries into the structural loops and Abdurins were selected using phage display methods. Initial binders were reformatted into new maturation libraries and low nanomolar binders were isolated using cell-free DNA display, CIS display. Further characterization confirmed binding of the Abdurins to both human and murine EphA2 proteins and exclusively to cell lines that expressed EphA2, followed by rapid internalization. Two different EphA2 binders were labeled with Cu-64, using a bifunctional MeCOSar chelator, and administered to mice bearing tumors from transplanted human prostate cancer cells, followed by PET/CT imaging. The anti-EphA2 Abdurins localized in the tumors as early as 4 hours after injection and continued to accumulate up to 48 hours when the imaging was completed. These data demonstrate the ability to isolate high affinity binders from the engineered Abdurin scaffold, which retain a long serum half-life, and specifically target tumors in a xenograft model.	[Ullman, Christopher; Mathonet, Pascale; Oleksy, Arkadiusz; Diamandakis, Agata] Isogenica Ltd, Cambridge, England; [Tomei, Licia; Demartis, Anna; Nardi, Chiara; Sambucini, Sonia; Missineo, Antonino] IRBM Sci Pk, Rome, Italy; [Alt, Karen; Hagemeyer, Christoph E.] Baker IDI, Vasc Biotechnol, Melbourne, Vic, Australia; [Harris, Matt; Hedt, Amos] Clar Pharmaceut Ltd, Sydney, NSW, Australia; [Weis, Roland] VTU Technol, Grambach, Austria; [Gehlsen, Kurt R.] Res Corp Technol Inc, Tucson, AZ 85711 USA	Isogenica Limited	Gehlsen, KR (corresponding author), Res Corp Technol Inc, Tucson, AZ 85711 USA.	kgehlsen@rctech.com	Hagemeyer, Christoph/E-8958-2011; Alt, Karen/E-8364-2019	Hagemeyer, Christoph/0000-0002-7114-4023; Alt, Karen/0000-0002-6252-1931	Research Corporation Technologies, Inc.; Isogenica, Ltd.; IRBM Science Park; Baker IDI; Clarity Pharmaceuticals; VTU Technology Ltd.	Research Corporation Technologies, Inc.; Isogenica, Ltd.; IRBM Science Park; Baker IDI; Clarity Pharmaceuticals; VTU Technology Ltd.	This study was funded and sponsored by Research Corporation Technologies, Inc. and the research activities directed by KRG. KRG and the authors made the decision to publish this work. Research Corporation Technologies, Inc., Isogenica, Ltd., IRBM Science Park, Baker IDI, Clarity Pharmaceuticals and VTU Technology Ltd. provided support in the form of salaries for the authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Annunziata CM, 2013, INVEST NEW DRUG, V31, P77, DOI 10.1007/s10637-012-9801-2; Ansuini H, 2009, J ONCOL, V2009, DOI 10.1155/2009/951917; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Chapman AP, 2002, ADV DRUG DELIVER REV, V54, P531, DOI 10.1016/S0169-409X(02)00026-1; Di Bartolo NM, 2001, J CHEM SOC DALTON, P2303, DOI 10.1039/b103242a; Diem MD, 2014, PROTEIN ENG DES SEL, V27, P419, DOI 10.1093/protein/gzu016; Dimitrov DS, 2009, MABS, V1, P26, DOI 10.4161/mabs.1.1.7480; Eldridge B, 2009, PROTEIN ENG DES SEL, V22, P691, DOI 10.1093/protein/gzp052; Erickson HK, 2012, AAPS J, V14, P799, DOI 10.1208/s12248-012-9386-x; FELICI F, 1991, J MOL BIOL, V222, P301, DOI 10.1016/0022-2836(91)90213-P; Firer MA, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-70; Fishburn CS, 2008, J PHARM SCI-US, V97, P4167, DOI 10.1002/jps.21278; Gehlsen KR, 2012, MABS, V4, P1; Gong R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042288; Gong R, 2011, J BIOL CHEM, V286, P27288, DOI 10.1074/jbc.M111.254219; Graff CP, 2003, CANCER RES, V63, P1288; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Lin-Cereghino J, 2005, BIOTECHNIQUES, V38, P44, DOI 10.2144/05381BM04; Muchekehu R, 2013, TRANSL ONCOL, V6, P562, DOI 10.1593/tlo.13409; Naatsaari L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039720; Odegrip R, 2004, P NATL ACAD SCI USA, V101, P2806, DOI 10.1073/pnas.0400219101; Paterson BM, 2014, DALTON T, V43, P1386, DOI 10.1039/c3dt52647j; Pluckthun A, 2015, ANNU REV PHARMACOL, V55, P489, DOI 10.1146/annurev-pharmtox-010611-134654; Ramsland PA, 2011, J IMMUNOL, V187, P3208, DOI 10.4049/jimmunol.1101467; Schellenberger V, 2009, NAT BIOTECHNOL, V27, P1186, DOI 10.1038/nbt.1588; Schmidt MM, 2009, MOL CANCER THER, V8, P2861, DOI 10.1158/1535-7163.MCT-09-0195; Scott AM, 2007, P NATL ACAD SCI USA, V104, P4071, DOI 10.1073/pnas.0611693104; Tandon M, 2011, EXPERT OPIN THER TAR, V15, P31, DOI 10.1517/14728222.2011.538682; Ulrichts H, 2011, BLOOD, V118, P757, DOI 10.1182/blood-2010-11-317859; Wang S, 2012, J MED CHEM, V55, P2427, DOI 10.1021/jm201743s; Weidle UH, 2013, CANCER GENOM PROTEOM, V10, P155; Weis R, 2004, FEMS YEAST RES, V5, P179, DOI 10.1016/j.femsyr.2004.06.016; Worn A, 2001, J MOL BIOL, V305, P989, DOI 10.1006/jmbi.2000.4265; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V387, P387, DOI 10.1016/j.bbrc.2009.07.044; Zahnd C, 2010, CANCER RES, V70, P1595, DOI 10.1158/0008-5472.CAN-09-2724	36	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0135278	10.1371/journal.pone.0135278	http://dx.doi.org/10.1371/journal.pone.0135278			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313909	gold, Green Published, Green Submitted			2022-12-26	WOS:000360144000016
J	Brown, AC; Dysart, MM; Clarke, KC; Stabenfeldt, SE; Barker, TH				Brown, Ashley C.; Dysart, Marilyn M.; Clarke, Kimberly C.; Stabenfeldt, Sarah E.; Barker, Thomas H.			Integrin alpha 3 beta 1 Binding to Fibronectin Is Dependent on the Ninth Type III Repeat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION; SYNERGY SITE; MESENCHYMAL TRANSITION; BIOLOGICAL-ACTIVITY; BETA-CATENIN; RECEPTOR; DOMAINS; BETA-1-INTEGRIN; SPECIFICITY; ADSORPTION	Fibronectin(Fn) is a promiscuous ligand for numerous cell adhesion receptors or integrins. The vast majority of Fn-integrin interactions are mediated through the Fn Arg-Gly-Asp (RGD) motif located within the tenth type III repeat. In the case of integrins alpha IIb beta 3 and alpha 5 beta 1, the integrin binds RGD and the synergy site (PHSRN) located within the adjacent ninth type III repeat. Prior work has shown that these synergy-dependent integrins are exquisitely sensitive to perturbations in the Fn integrin binding domain conformation. Our own prior studies of epithelial cell responses to recombinant fragments of the Fn integrin binding domain led us to hypothesize that integrin alpha 3 beta 1 binding may also be modulated by the synergy site. To explore this hypothesis, we created a variety of recombinant variants of the Fn integrin binding domain: (i) a previously reported (Leu -> Pro) stabilizing mutant (FnIII9'10), (ii) an Arg to Ala synergy site mutation (FnIII9(R)->(A)10), (iii) a two-Gly (FnIII9(2G)10) insertion, and (iv) a four-Gly (FNIII9(4G)10) insertion in the interdomain linker region and used surface plasmon resonance to determine binding kinetics of integrin alpha 3 beta 1 to the Fn fragments. Integrin alpha 3 beta 1 had the highest affinity for FnIII9'10 and FnIII9(2G)10. Mutation within the synergy site decreased integrin alpha 3 beta 1 binding 17-fold, and the four-Gly insertion decreased binding 39-fold compared with FnIII9'10. Cell attachment studies demonstrate that alpha 3 beta 1-mediated epithelial cell binding is greater on FnIII9'10 compared with the other fragments. These studies suggest that the presence and spacing of the RGD and synergy sites modulate integrin alpha 3 beta 1 binding to Fn.	[Brown, Ashley C.] N Carolina State Univ, Dept Biomed Engn, Raleigh, NC 27606 USA; [Brown, Ashley C.] Univ N Carolina, Raleigh, NC 27606 USA; [Dysart, Marilyn M.; Barker, Thomas H.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Dysart, Marilyn M.; Barker, Thomas H.] Emory Univ, Atlanta, GA 30332 USA; [Clarke, Kimberly C.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Stabenfeldt, Sarah E.] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA; [Barker, Thomas H.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University of North Carolina; North Carolina State University; University of North Carolina; University System of Georgia; Georgia Institute of Technology; Emory University; University System of Georgia; Georgia Institute of Technology; Arizona State University; Arizona State University-Tempe; University System of Georgia; Georgia Institute of Technology	Barker, TH (corresponding author), Georgia Tech, Wallace H Coulter Dept Biomed Engn, 950 Atlantic Dr,Ste 4015, Atlanta, GA 30332 USA.	thomas.barker@bme.gatech.edu			National Institutes of Health Grants [R01EB011566, R01HL127283]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL127283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB011566] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grants R01EB011566 and R01HL127283. The authors declare that they have no conflicts of interest with the contents of this article.	Altroff H, 2001, J BIOL CHEM, V276, P38885, DOI 10.1074/jbc.M105868200; Altroff H, 2004, J BIOL CHEM, V279, P55995, DOI 10.1074/jbc.M406976200; AOTA S, 1994, J BIOL CHEM, V269, P24756; Bachan P., 2009, C68 ALVEOLAR EPITHEL, pA4996; Baneyx G, 2002, P NATL ACAD SCI USA, V99, P5139, DOI 10.1073/pnas.072650799; Barker TH, 2005, J BIOL CHEM, V280, P36483, DOI 10.1074/jbc.M504663200; Brown AC, 2013, J PATHOL, V229, P25, DOI 10.1002/path.4114; Brown AC, 2011, TISSUE ENG PT A, V17, P139, DOI 10.1089/ten.TEA.2010.0199; Cao LZ, 2012, P NATL ACAD SCI USA, V109, P7251, DOI 10.1073/pnas.1118088109; Carson AE, 2009, REGEN MED, V4, P593, DOI 10.2217/RME.09.30; Chada D, 2006, ANN BIOMED ENG, V34, P1542, DOI 10.1007/s10439-006-9161-1; Clause KC, 2013, CURR OPIN BIOTECH, V24, P830, DOI 10.1016/j.copbio.2013.04.011; DANEN EHJ, 1995, J BIOL CHEM, V270, P21612, DOI 10.1074/jbc.270.37.21612; Eble JA, 1998, BIOCHEMISTRY-US, V37, P10945, DOI 10.1021/bi980175+; ELICES MJ, 1991, J CELL BIOL, V112, P169, DOI 10.1083/jcb.112.1.169; ELICES MJ, 1989, P NATL ACAD SCI USA, V86, P9906, DOI 10.1073/pnas.86.24.9906; ERICKSON HP, 1994, P NATL ACAD SCI USA, V91, P10114, DOI 10.1073/pnas.91.21.10114; Grant RP, 1997, J BIOL CHEM, V272, P6159, DOI 10.1074/jbc.272.10.6159; Herard AL, 1996, AM J PHYSIOL-LUNG C, V271, pL726, DOI 10.1152/ajplung.1996.271.5.L726; Hodivala-Dilke KM, 1998, J CELL BIOL, V142, P1357, DOI 10.1083/jcb.142.5.1357; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; HUMPHRIES MJ, 1990, J CELL SCI, V97, P585; Joss L, 1998, ANAL BIOCHEM, V261, P203, DOI 10.1006/abio.1998.2744; KAUFMANN R, 1989, J CELL BIOL, V109, P1807, DOI 10.1083/jcb.109.4.1807; Khew ST, 2007, TISSUE ENG, V13, P2451, DOI 10.1089/ten.2007.0063; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; Kim Y, 2009, J CELL BIOL, V184, P309, DOI 10.1083/jcb.200806067; KOTELIANSKY VE, 1981, EUR J BIOCHEM, V119, P619, DOI 10.1111/j.1432-1033.1981.tb05652.x; Krammer A, 2002, MATRIX BIOL, V21, P139, DOI 10.1016/S0945-053X(01)00197-4; Kreidberg JA, 1996, DEVELOPMENT, V122, P3537; Litvinovich SV, 1998, J MOL BIOL, V280, P245, DOI 10.1006/jmbi.1998.1863; Lubman RL, 2000, AM J PHYSIOL-LUNG C, V279, pL183, DOI 10.1152/ajplung.2000.279.1.L183; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; MARDON HJ, 1994, FEBS LETT, V340, P197, DOI 10.1016/0014-5793(94)80137-1; Markowski MC, 2012, J BIOMED MATER RES A, V100A, P2119, DOI 10.1002/jbm.a.34068; Martino MM, 2009, BIOMATERIALS, V30, P1089, DOI 10.1016/j.biomaterials.2008.10.047; Morton TA, 1998, METHOD ENZYMOL, V295, P268; MOULD AP, 1995, J BIOL CHEM, V270, P26270, DOI 10.1074/jbc.270.44.26270; Mould AP, 1997, J BIOL CHEM, V272, P17283, DOI 10.1074/jbc.272.28.17283; Myszka DG, 1998, TRENDS BIOCHEM SCI, V23, P149, DOI 10.1016/S0968-0004(98)01183-9; NARASIMHAN C, 1989, BIOCHEMISTRY-US, V28, P5041, DOI 10.1021/bi00438a021; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Pereira P, 2008, COLLOID SURFACE B, V64, P1, DOI 10.1016/j.colsurfb.2007.12.015; Petrie TA, 2006, BIOMATERIALS, V27, P5459, DOI 10.1016/j.biomaterials.2006.06.027; PITT WG, 1993, J BIOMAT SCI-POLYM E, V4, P337, DOI 10.1163/156856293X00609; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; RAO SP, 1992, INFECT IMMUN, V60, P3652, DOI 10.1128/IAI.60.9.3652-3657.1992; Redick SD, 2000, J CELL BIOL, V149, P521, DOI 10.1083/jcb.149.2.521; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Sheppard D, 2003, PHYSIOL REV, V83, P673, DOI 10.1152/physrev.00033.2002; Smith ML, 2007, PLOS BIOL, V5, P2243, DOI 10.1371/journal.pbio.0050268; SRIRAMARAO P, 1993, J BIOL CHEM, V268, P22036; Stabenfeldt SE, 2010, BLOOD, V116, P1352, DOI 10.1182/blood-2009-11-251801; UNDERWOOD PA, 1993, J CELL SCI, V104, P793; WOLFF C, 1989, ARCH BIOCHEM BIOPHYS, V268, P536, DOI 10.1016/0003-9861(89)90320-2	56	23	23	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25534	25547		10.1074/jbc.M115.656702	http://dx.doi.org/10.1074/jbc.M115.656702			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26318455	Green Published, hybrid			2022-12-26	WOS:000362962800028
J	Karassek, S; Starost, L; Solbach, J; Greune, L; Sano, Y; Kanda, T; Kim, K; Schmidt, MA				Karassek, Sascha; Starost, Laura; Solbach, Johanna; Greune, Lilo; Sano, Yasuteru; Kanda, Takashi; Kim, KwangSik; Schmidt, M. Alexander			Pertussis Toxin Exploits Specific Host Cell Signaling Pathways for Promoting Invasion and Translocation of Escherichia coli K1 RS218 in Human Brain-derived Microvascular Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE PROTEIN-A; CENTRAL-NERVOUS-SYSTEM; ISLET-ACTIVATING PROTEIN; IN-VIVO; NEUROTRANSMITTER RECEPTORS; VASCULAR-PERMEABILITY; BACTERIAL-MENINGITIS; SYMPATHETIC NEURONS; NEONATAL MENINGITIS; ADP-RIBOSYLATION	Pertussis toxin (PTx), an AB5 toxin and major virulence factor of the whooping cough-causing pathogen Bordetella pertussis, has been shown to affect the blood-brain barrier. Dysfunction of the blood-brain barrier may facilitate penetration of bacterial pathogens into the brain, such as Escherichia coli K1 (RS218). In this study, we investigated the influence of PTx on blood-brain barrier permissiveness to E. coli infection using human brain-derived endothelial HBMEC and TY10 cells as in vitro models. Our results indicate that PTx acts at several key points of host cell intracellular signaling pathways, which are also affected by E. coli K1 RS218 infection. Application of PTx increased the expression of the pathogen binding receptor gp96. Further, we found an activation of STAT3 and of the small GTPase Rac1, which have been described as being essential for bacterial invasion involving host cell actin cytoskeleton rearrangements at the bacterial entry site. In addition, we showed that PTx induces a remarkable relocation of VE-cadherin and beta-catenin from intercellular junctions. The observed changes in host cell signaling molecules were accompanied by differences in intracellular calcium levels, which might act as a second messenger system for PTx. In summary, PTx not only facilitates invasion of E. coli K1 RS218 by activating essential signaling cascades; it also affects intercellular barriers to increase paracellular translocation.	[Karassek, Sascha; Starost, Laura; Solbach, Johanna; Greune, Lilo; Schmidt, M. Alexander] Univ Munster, Ctr Mol Biol Inflammat, Inst Infectiol, D-48149 Munster, Germany; [Sano, Yasuteru; Kanda, Takashi] Yamaguchi Univ, Grad Sch Med, Dept Neurol & Clin Neurosci, Yamaguchi, Japan; [Kim, KwangSik] Johns Hopkins Univ, Sch Med, Pediat Infect Dis Div, Baltimore, MD 21287 USA	University of Munster; Yamaguchi University; Johns Hopkins University	Schmidt, MA (corresponding author), Univ Munster, Zentrum Mol Biol Entzundung, Inst Infektiol, Von Esmarch Str 56, D-48149 Munster, Germany.	infekt@uni-muenster.de			Deutsche Forschungsgemeinschaft [DFG SFB629 B03, GRK1409]; Cells-in-Motion Cluster of Excellence [EXC 1003-CiM]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cells-in-Motion Cluster of Excellence	This work was supported by Deutsche Forschungsgemeinschaft Grants DFG SFB629 B03 and GRK1409 and by the Cells-in-Motion Cluster of Excellence (EXC 1003-CiM). The authors declare that they have no conflicts of interest with the contents of this article.	AMIEL SA, 1976, BRIT J EXP PATHOL, V57, P653; Arimoto H, 2000, J NEUROIMMUNOL, V104, P15, DOI 10.1016/S0165-5728(99)00242-8; Armstrong G. D., 1994, INFECT IMMUN, V62, P2236; BRENNAN MJ, 1988, J BIOL CHEM, V263, P4895; Bruckener KE, 2003, J CELL SCI, V116, P1837, DOI 10.1242/jcs.00378; Chen HM, 1997, J NEUROPHYSIOL, V78, P3484, DOI 10.1152/jn.1997.78.6.3484; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; ELBAYA A, 1995, MICROB PATHOGENESIS, V18, P173; Fan HK, 2004, SHOCK, V22, P57, DOI 10.1097/01.shk.0000129759.58490.d6; Geier DA, 2004, BRAIN DEV-JPN, V26, P296, DOI 10.1016/S0387-7604(03)00169-4; Grant CC, 1998, PEDIATRICS, V102, P986, DOI 10.1542/peds.102.4.986; Heininger U, 2004, PEDIATRICS, V114, pE9, DOI 10.1542/peds.114.1.e9; Houdouin V, 2008, ARCH PEDIATRIE, V15, pS138, DOI 10.1016/S0929-693X(08)75497-6; Houdouin V, 2008, CLIN MICROBIOL INFEC, V14, P685, DOI 10.1111/j.1469-0691.2008.02019.x; Jeong SW, 2000, P NATL ACAD SCI USA, V97, P907, DOI 10.1073/pnas.97.2.907; Jeong SW, 1998, NEURON, V21, P1201, DOI 10.1016/S0896-6273(00)80636-4; KATADA T, 1982, J BIOL CHEM, V257, P7210; KATADA T, 1982, P NATL ACAD SCI-BIOL, V79, P3129, DOI 10.1073/pnas.79.10.3129; Khan NA, 2002, J BIOL CHEM, V277, P15607, DOI 10.1074/jbc.M112224200; Khan NA, 2007, CELL MICROBIOL, V9, P169, DOI 10.1111/j.1462-5822.2006.00779.x; Kim KJ, 2005, J BIOL CHEM, V280, P1360, DOI 10.1074/jbc.M410176200; Kim KS, 2003, NAT REV NEUROSCI, V4, P376, DOI 10.1038/nrn1103; Kim KS, 2001, INFECT IMMUN, V69, P5217, DOI 10.1128/IAI.69.9.5217-5222.2001; Kim KS, 2002, J INFECT DIS, V186, pS220, DOI 10.1086/344284; Kim KS, 2008, NAT REV MICROBIOL, V6, P625, DOI 10.1038/nrmicro1952; Kim YV, 2008, CELL TISSUE RES, V332, P427, DOI 10.1007/s00441-008-0598-4; Krishnan S, 2014, MICROBES INFECT, V16, P540, DOI 10.1016/j.micinf.2014.06.002; Krishnan S, 2014, J INFECT DIS, V209, P409, DOI 10.1093/infdis/jit499; Krishnan S, 2013, CELL MICROBIOL, V15, P63, DOI 10.1111/cmi.12026; Krishnan S, 2012, CELL MICROBIOL, V14, P1415, DOI 10.1111/j.1462-5822.2012.01805.x; Kugler S, 2007, CELL MICROBIOL, V9, P619, DOI 10.1111/j.1462-5822.2006.00813.x; Maeda T., 2013, CLIN EXP NEUROIMMUNO, V4, P326, DOI [10.1111/cen3.12045, DOI 10.1111/CEN3.12045]; Maruvada R, 2008, CELL MICROBIOL, V10, P2326, DOI 10.1111/j.1462-5822.2008.01214.x; Maruvada R, 2012, INFECT IMMUN, V80, P2035, DOI 10.1128/IAI.06320-11; Mittal R, 2010, AM J PATHOL, V176, P1292, DOI 10.2353/ajpath.2010.090851; Mittal R, 2010, CELL MICROBIOL, V12, P67, DOI 10.1111/j.1462-5822.2009.01379.x; Nishida M., 2010, J BIOL CHEM, P285; PRASADARAO NV, 1993, J BIOL CHEM, V268, P10356; Prasadarao NV, 1996, INFECT IMMUN, V64, P146, DOI 10.1128/IAI.64.1.146-153.1996; QUAGLIARELLO V, 1992, NEW ENGL J MED, V327, P864, DOI 10.1056/NEJM199209173271208; Racke MK, 2005, TRENDS IMMUNOL, V26, P289, DOI 10.1016/j.it.2005.03.012; Richard JF, 2011, BRAIN PATHOL, V21, P661, DOI 10.1111/j.1750-3639.2011.00490.x; Sano Y., 2012, CLIN EXP NEUROIMMUNO, V3, P1; Schellenberg AE, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-10; Seidel G, 2011, INT J MED MICROBIOL, V301, P204, DOI 10.1016/j.ijmm.2010.08.018; Shin S, 2005, BIOCHEM BIOPH RES CO, V330, P1199, DOI 10.1016/j.bbrc.2005.03.097; Sukumaran SK, 2003, J INFECT DIS, V188, P1295, DOI 10.1086/379042; Sunakawa Keisuke, 2010, Kansenshogaku Zasshi, V84, P33; Teng CH, 2005, INFECT IMMUN, V73, P2923, DOI 10.1128/IAI.73.5.2923-2931.2005; Toft-Hansen H, 2006, J IMMUNOL, V177, P7242, DOI 10.4049/jimmunol.177.10.7242; TOKUYASU KT, 1980, HISTOCHEM J, V12, P381, DOI 10.1007/BF01011956; Wang Y, 2004, MICROB PATHOGENESIS, V37, P287, DOI 10.1016/j.micpath.2004.09.002; Wang Y, 2002, PEDIATR RES, V51, P559, DOI 10.1203/00006450-200205000-00003; Wessel F, 2014, NAT IMMUNOL, V15, P223, DOI 10.1038/ni.2824; Xie Y, 2004, FEMS IMMUNOL MED MIC, V42, P271, DOI 10.1016/j.femsim.2004.09.001; Zaidi AKM, 2009, CLIN INFECT DIS, V48, pS129, DOI 10.1086/596491	56	6	7	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24835	24843		10.1074/jbc.M115.650101	http://dx.doi.org/10.1074/jbc.M115.650101			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26324705	Green Published, hybrid			2022-12-26	WOS:000362598300018
J	Sun, YB; Jiang, CQ; Cheng, KK; Zhang, WS; Leung, GM; Lam, TH; Schooling, CM				Sun, Yangbo; Jiang, Chao Qiang; Cheng, Kar Keung; Zhang, Wei Sen; Leung, Gabriel M.; Lam, Tai Hing; Schooling, C. Mary			Nut Consumption and Cardiovascular Risk in Older Chinese: The Guangzhou Biobank Cohort Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MEDITERRANEAN DIET; PREVENTION; HEALTH; MORTALITY; WOMEN	Objectives In Western contexts nut consumption is associated with better health. We examined the associations of nut consumption with cardiovascular disease risk in the non-Western setting of Southern China. Methods In the Guangzhou Biobank Cohort Study we used multivariable linear regression to examine the associations of baseline nut (mainly peanuts) consumption (none (n = 6688), <3 portions/week (n = 2596) and >= 3 portions/week (n = 2444)) with follow-up assessment of Framingham cardiovascular disease score (excluding smoking) and its components in older Chinese (>= 50 years) (follow-up 57.8%). Results Nut consumption was not associated with Framingham score (>= 3 portions/week compared to none: 0.02 95% confidence interval (CI) -0.11 to 0.15), systolic blood pressure (-0.66 mmHg 95% CI -1.94, 0.62), diastolic blood pressure (-0.69 mmHg 95% CI -1.44, 0.07), HDL-cholesterol (-0.01 mmol/L 95% CI -0.02, 0.005), LDL-cholesterol (-0.01 mmol/L 95% CI -0.05, 0.02) or fasting glucose (0.04 mmol/L 95% CI -0.02, 0.09), adjusted for baseline values, energy intake, age, sex, phase of recruitment, socio-economic position, lifestyle and baseline health status. Conclusions Observations concerning the benefits of nut consumption may be contextually specific, perhaps depending on the type of nut consumed.	[Sun, Yangbo; Leung, Gabriel M.; Lam, Tai Hing; Schooling, C. Mary] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Jiang, Chao Qiang; Zhang, Wei Sen] Guangzhou 12 Hosp, Guangzhou, Guangdong, Peoples R China; [Cheng, Kar Keung] Univ Birmingham, Dept Publ Hlth & Epidemiol, Birmingham, W Midlands, England; [Schooling, C. Mary] CUNY, Sch Publ Hlth, New York, NY 10021 USA	University of Hong Kong; University of Birmingham; City University of New York (CUNY) System	Lam, TH (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China.	hrmrlth@hkucc.hku.hk	Cheng, Kar/AAL-8899-2021; Lam, Tai Hing/C-4317-2009	Cheng, Kar/0000-0002-1516-1857; Schooling, Mary/0000-0001-9933-5887; Lam, Tai Hing/0000-0002-2033-9971; Leung, Gabriel/0000-0002-2503-6283	University of Hong Kong Foundation for Development and Research, Hong Kong; University of Hong Kong University Research Committee Strategic Research Theme Public Health, Hong Kong; Guangzhou Public Health Bureau, and Guangzhou Science and Technology Committee, Guangzhou, China; University of Birmingham, Birmingham, United Kingdom; Bureau of Guangzhou Science and Technology [2012J5100041, 2013J4100031]	University of Hong Kong Foundation for Development and Research, Hong Kong(University of Hong Kong); University of Hong Kong University Research Committee Strategic Research Theme Public Health, Hong Kong; Guangzhou Public Health Bureau, and Guangzhou Science and Technology Committee, Guangzhou, China; University of Birmingham, Birmingham, United Kingdom; Bureau of Guangzhou Science and Technology	This work was supported by the University of Hong Kong Foundation for Development and Research, Hong Kong; The University of Hong Kong University Research Committee Strategic Research Theme Public Health, Hong Kong; Guangzhou Public Health Bureau, and Guangzhou Science and Technology Committee, Guangzhou, China; and The University of Birmingham, Birmingham, United Kingdom. Key technology collaboration project funded by the Bureau of Guangzhou Science and Technology (Grant 2012J5100041; 2013J4100031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshin A, 2014, AM J CLIN NUTR, V100, P278, DOI 10.3945/ajcn.113.076901; [Anonymous], 2013, BMJ BRIT MED J; [Anonymous], 2014, AM HEART ASS DIET LI; Blomhoff R, 2006, BRIT J NUTR, V96, pS52, DOI 10.1017/BJN20061864; Chowdhury R, 2014, ANN INTERN MED, V160, P398, DOI 10.7326/M13-1788; Colpo E, 2013, J NUTR METAB, V2013, P1; de Lorgeril M, 1999, CIRCULATION, V99, P779, DOI 10.1161/01.CIR.99.6.779; Elhayany A, 2010, DIABETES OBES METAB, V12, P204, DOI 10.1111/j.1463-1326.2009.01151.x; Ellsworth JL, 2001, NUTR METAB CARDIOVAS, V11, P372; Elwell-Sutton T, 2011, J EPIDEMIOL COMMUN H, V65, pA331, DOI 10.1136/jech.2011.142976l.25; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; FRASER GE, 1992, ARCH INTERN MED, V152, P1416, DOI 10.1001/archinte.152.7.1416; Freudenheim JL, 1999, AM J CLIN NUTR, V69, p1315S; Goff D. C., 2013, CIRCULATION; Gonzalez CA, 2006, BRIT J NUTR, V96, pS87, DOI 10.1017/BJN20061868; Holland B., 1991, MCCANCE WIDDOWSONS C, V5; Hsu-Hage B H, 1992, Asia Pac J Clin Nutr, V1, P211; Institute of Nutrition and Food Safety China CDC, 2002, CHIN FOOD COMP 2002, V1; Jiang CQ, 2006, INT J EPIDEMIOL, V35, P844, DOI 10.1093/ije/dyl131; Kris-Etherton PN, 2008, J NUTR, V138, p1746S; Li SC, 2011, METABOLISM, V60, P474, DOI 10.1016/j.metabol.2010.04.009; Li TY, 2009, J NUTR, V139, P1333, DOI 10.3945/jn.108.103622; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Luo C, 2014, AM J CLIN NUTR, V100, P256, DOI 10.3945/ajcn.113.076109; Ma L, 2014, THROMB RES; Martinez-Lapiscina EH, 2010, NUTR METAB CARDIOVAS, V20, P359, DOI 10.1016/j.numecd.2009.04.013; Mejia SB, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004660; Nouran MG, 2010, PUBLIC HEALTH NUTR, V13, P1581, DOI 10.1017/S1368980009992837; Sabate J, 2010, ARCH INTERN MED, V170, P821, DOI 10.1001/archinternmed.2010.79; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Schooling CM, 2006, ARCH INTERN MED, V166, P1498, DOI 10.1001/archinte.166.14.1498; Schuitemaker GE, 2001, EUR J CLIN PHARMACOL, V56, P857, DOI 10.1007/s002280000247; Sesso HD, 2008, JAMA-J AM MED ASSOC, V300, P2123, DOI 10.1001/jama.2008.600; Shi ZQ, 2014, NUTR METAB CARDIOVAS, V24, P1262, DOI 10.1016/j.numecd.2014.06.009; Villegas R, 2008, AM J CLIN NUTR, V87, P162, DOI 10.1093/ajcn/87.1.162; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yun-Qi Weng JY, 2014, EXP CLIN CARDIOL, V20, P3770; Zhou DH, 2014, AM J CLIN NUTR, V100, P270, DOI 10.3945/ajcn.113.079152	38	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137178	10.1371/journal.pone.0137178	http://dx.doi.org/10.1371/journal.pone.0137178			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332759	Green Published, gold			2022-12-26	WOS:000360613800104
J	Valacca, C; Tassone, E; Mignatti, P				Valacca, Cristina; Tassone, Evelyne; Mignatti, Paolo			TIMP-2 Interaction with MT1-MMP Activates the AKT Pathway and Protects Tumor Cells from Apoptosis	PLOS ONE			English	Article							TYPE-1 MATRIX-METALLOPROTEINASE; GROWTH-PROMOTING ACTIVITY; BREAST-CARCINOMA CELLS; TISSUE INHIBITOR; EXTRACELLULAR-MATRIX; COLORECTAL-CANCER; ENDOTHELIAL-CELLS; BLADDER-CANCER; SIGNALING AXIS; EXPRESSION	Membrane-type 1 matrix metalloproteinase (MT1-MMP), a transmembrane proteinase with an extracellular catalytic domain and a short cytoplasmic tail, degrades a variety of extracellular matrix (ECM) components. In addition, MT1-MMP activates intracellular signaling through proteolysis-dependent and independent mechanisms. We have previously shown that binding of tissue inhibitor of metalloproteinases-2 (TIMP-2) to MT1-MMP controls cell proliferation and migration, as well as tumor growth in vivo by activating the Ras-extracellular signal regulated kinase-1 and -2 (ERK1/2) pathway through a mechanism that requires the cytoplasmic but not the proteolytic domain of MT1-MMP. Here we show that in MT1-MMP expressing cells TIMP-2 also induces rapid and sustained activation of AKT in a dose-and time-dependent manner and by a mechanism independent of the proteolytic activity of MT1-MMP. Fibroblast growth factor receptor-1 mediates TIMP-2 induction of ERK1/2 but not of AKT activation; however, Ras activation is necessary to transduce the TIMP-2-activated signal to both the ERK1/2 and AKT pathways. ERK1/2 and AKT activation by TIMP-2 binding to MT1-MMP protects tumor cells from apoptosis induced by serum starvation. Conversely, TIMP-2 upregulates apoptosis induced by three-dimensional type I collagen in epithelial cancer cells. Thus, TIMP-2 interaction with MT1-MMP provides tumor cells with either pro-or anti-apoptotic signaling depending on the extracellular environment and apoptotic stimulus.	[Valacca, Cristina; Tassone, Evelyne] NYU, Sch Med, Dept Cardiothorac Surg, New York, NY USA; [Mignatti, Paolo] NYU, Sch Med, Dept Med, New York, NY 10018 USA; [Mignatti, Paolo] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University; New York University; New York University	Mignatti, P (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10018 USA.	mignap01@nyumc.org		Tassone, Evelyne/0000-0003-0631-007X; Mignatti, Paolo/0000-0002-8157-457X	 [R01 CA136715-0101];  [3R01CA136715-03S1]; NATIONAL CANCER INSTITUTE [P30CA016087, R01CA136715] Funding Source: NIH RePORTER	; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by R01 CA136715-0101 and 3R01CA136715-03S1 (http://www.nih.gov). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal E, 2013, CELL SIGNAL, V25, P1711, DOI 10.1016/j.cellsig.2013.03.025; Annabi B, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-8; Baker EA, 2006, BRIT J ORAL MAX SURG, V44, P482, DOI 10.1016/j.bjoms.2005.10.005; Baker EA, 2000, BRIT J SURG, V87, P1215, DOI 10.1046/j.1365-2168.2000.01531.x; Belkaid A, 2007, NEOPLASIA, V9, P332, DOI 10.1593/neo.07142; Castellano Esther, 2011, Genes Cancer, V2, P261, DOI 10.1177/1947601911408079; Chan KM, 2012, DEV CELL, V22, P1176, DOI 10.1016/j.devcel.2012.04.014; CORCORAN ML, 1995, J BIOL CHEM, V270, P13453, DOI 10.1074/jbc.270.22.13453; D'Alessio S, 2008, J BIOL CHEM, V283, P87, DOI 10.1074/jbc.M705492200; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Galvez BG, 2002, J CELL BIOL, V159, P509, DOI 10.1083/jcb.200205026; Grignon DJ, 1996, CANCER RES, V56, P1654; HAYAKAWA T, 1994, CELL STRUCT FUNCT, V19, P109, DOI 10.1247/csf.19.109; HAYAKAWA T, 1994, J CELL SCI, V107, P2373; HAYAKAWA T, 1992, FEBS LETT, V298, P29, DOI 10.1016/0014-5793(92)80015-9; Hernandez-Barrantes S, 2000, J BIOL CHEM, V275, P12080, DOI 10.1074/jbc.275.16.12080; Hoegy SE, 2001, J BIOL CHEM, V276, P3203, DOI 10.1074/jbc.M008157200; Holmbeck K, 2005, J CELL SCI, V118, P147, DOI 10.1242/jcs.01581; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Kanayama H, 1998, CANCER, V82, P1359, DOI 10.1002/(SICI)1097-0142(19980401)82:7<1359::AID-CNCR20>3.0.CO;2-4; Katz M, 2007, BIOCH BIOPHYS ACTA; Larsen MB, 2005, SCAND J IMMUNOL, V61, P449, DOI 10.1111/j.1365-3083.2005.01585.x; Lehti K, 2005, GENE DEV, V19, P979, DOI 10.1101/gad.1294605; Lehti K, 2009, J CELL SCI, V122, P126, DOI 10.1242/jcs.035279; Liu YL, 2010, BONE, V47, P916, DOI 10.1016/j.bone.2010.07.022; LUO BH, 2007, ANN REV IMMUNOL; Maquoi E, 2012, ONCOGENE, V31, P480, DOI 10.1038/onc.2011.249; Murawaki Y, 1999, CLIN CHIM ACTA, V281, P109, DOI 10.1016/S0009-8981(98)00215-0; MURPHY AN, 1993, J CELL PHYSIOL, V157, P351, DOI 10.1002/jcp.1041570219; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Olex AL, 2014, GENE, V542, P38, DOI 10.1016/j.gene.2014.03.022; Onguchi T, 2009, AM J PATHOL, V174, P1564, DOI 10.2353/ajpath.2009.080452; Pasieka Zbigniew, 2004, Endocr Regul, V38, P57; Proulx-Bonneau S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021511; Ree AH, 1997, CLIN CANCER RES, V3, P1623; Remacle A, 2000, INT J CANCER, V89, P118, DOI 10.1002/(SICI)1097-0215(20000320)89:2<118::AID-IJC3>3.0.CO;2-8; Rozanov DV, 2001, J BIOL CHEM, V276, P25705, DOI 10.1074/jbc.M007921200; Ruokolainen H, 2006, MODERN PATHOL, V19, P208, DOI 10.1038/modpathol.3800506; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Seo DW, 2003, CELL, V114, P171, DOI 10.1016/S0092-8674(03)00551-8; Sina A, 2010, J CELL COMMUN SIGNAL, V4, P31, DOI 10.1007/s12079-009-0084-0; Soulie P, 2005, ONCOGENE, V24, P1689, DOI 10.1038/sj.onc.1208360; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Sugiyama N, 2010, P NATL ACAD SCI USA, V107, P15786, DOI 10.1073/pnas.0914459107; Tang Y, 2013, DEV CELL, V25, P402, DOI 10.1016/j.devcel.2013.04.011; Tassone E, 2014, J CELL PHYSL; Theret N, 1998, AM J PATHOL, V153, P945, DOI 10.1016/S0002-9440(10)65636-2; Ueno H, 1997, CANCER RES, V57, P2055; Uhich D, 2004, PLAST RECONSTR SURG, V114, P229, DOI 10.1097/01.PRS.0000129079.19089.6C; Valente P, 1998, INT J CANCER, V75, P246, DOI 10.1002/(SICI)1097-0215(19980119)75:2<246::AID-IJC13>3.0.CO;2-B; VISSCHER DW, 1994, INT J CANCER, V59, P339, DOI 10.1002/ijc.2910590308; Yamashita K, 1996, FEBS LETT, V396, P103, DOI 10.1016/0014-5793(96)01066-6; Zhai YL, 2005, CANCER RES, V65, P6543, DOI 10.1158/0008-5472.CAN-05-0231; Zucker S, 1998, INT J CANCER, V75, P780, DOI 10.1002/(SICI)1097-0215(19980302)75:5<780::AID-IJC19>3.0.CO;2-A; Zucker S, 1998, J BIOL CHEM, V273, P1216, DOI 10.1074/jbc.273.2.1216	56	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136797	10.1371/journal.pone.0136797	http://dx.doi.org/10.1371/journal.pone.0136797			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331622	Green Published, Green Submitted, gold			2022-12-26	WOS:000360613800072
J	Watanabe, S; Ohbayashi, R; Kanesaki, Y; Saito, N; Chibazakura, T; Soga, T; Yoshikawa, H				Watanabe, Satoru; Ohbayashi, Ryudo; Kanesaki, Yu; Saito, Natsumi; Chibazakura, Taku; Soga, Tomoyoshi; Yoshikawa, Hirofumi			Intensive DNA Replication and Metabolism during the Lag Phase in Cyanobacteria	PLOS ONE			English	Article							PRINCIPAL SIGMA-FACTOR; SP STRAIN PCC7942; GROWTH-PHASE; ESCHERICHIA-COLI; STATIONARY-PHASE; CHLAMYDOMONAS-REINHARDTII; CHLOROPLAST DIVISION; SYNCHRONOUS GROWTH; PLASTID NUCLEOIDS; GENE-EXPRESSION	Unlike bacteria such as Escherichia coli and Bacillus subtilis, several species of freshwater cyanobacteria are known to contain multiple chromosomal copies per cell, at all stages of their cell cycle. We have characterized the replication of multi-copy chromosomes in the cyanobacterium Synechococcus elongatus PCC 7942 (hereafter Synechococcus 7942). In Synechococcus 7942, the replication of multi-copy chromosome is asynchronous, not only among cells but also among multi-copy chromosomes. This suggests that DNA replication is not tightly coupled to cell division in Synechococcus 7942. To address this hypothesis, we analysed the relationship between DNA replication and cell doubling at various growth phases of Synechococcus 7942 cell culture. Three distinct growth phases were characterised in Synechococcus 7942 batch culture: lag phase, exponential phase, and arithmetic ( linear) phase. The chromosomal copy number was significantly higher during the lag phase than during the exponential and linear phases. Likewise, DNA replication activity was higher in the lag phase cells than in the exponential and linear phase cells, and the lag phase cells were more sensitive to nalidixic acid, a DNA gyrase inhibitor, than cells in other growth phases. To elucidate physiological differences in Synechococcus 7942 during the lag phase, we analysed the metabolome at each growth phase. In addition, we assessed the accumulation of central carbon metabolites, amino acids, and DNA precursors at each phase. The results of these analyses suggest that Synechococcus 7942 cells prepare for cell division during the lag phase by initiating intensive chromosomal DNA replication and accumulating metabolites necessary for the subsequent cell division and elongation steps that occur during the exponential growth and linear phases.	[Watanabe, Satoru; Ohbayashi, Ryudo; Chibazakura, Taku; Yoshikawa, Hirofumi] Tokyo Univ Agr, Dept Biosci, Tokyo, Japan; [Ohbayashi, Ryudo; Yoshikawa, Hirofumi] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol CREST, Saitama 3320012, Japan; [Kanesaki, Yu] Tokyo Univ Agr, Genome Res Ctr, Tokyo, Japan; [Saito, Natsumi; Soga, Tomoyoshi] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan	Tokyo University of Agriculture; Japan Science & Technology Agency (JST); Tokyo University of Agriculture; Keio University	Yoshikawa, H (corresponding author), Tokyo Univ Agr, Dept Biosci, Tokyo, Japan.	hiyoshik@nodai.ac.jp	Ohbayashi, Ryudo/AAZ-4841-2020; Kanesaki, Yu/J-3817-2017	Kanesaki, Yu/0000-0003-3537-9789; Ohbayashi, Ryudo/0000-0001-6359-0122	MEXT-Supported Program for the Strategic Research Foundation at Private Universities [S1311017]; Ministry of Education, Culture, Sports, Science and Technology of Japan [24780082, 25850056]; Grants-in-Aid for Scientific Research [25850056] Funding Source: KAKEN	MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2013-2017 (S1311017) to Tokyo University of Agriculture (HY) in the study data collection and analysis (http://www.mext.go.jp/component/a_menu/education/detail/__icsFiles/afieldfile/2013/07/11/1267810_6. pdf); Grants-in-Aid 24780082 from the Ministry of Education, Culture, Sports, Science and Technology of Japan to YK in the study data collection and analysis (https://kaken.nii.ac.jp/d/p/24780082.en.html), and Grants-in-Aid 25850056 from the Ministry of Education, Culture, Sports, Science and Technology of Japan to SW in the study data collection and analysis (https://kaken.nii.ac.jp/d/p/25850056.en.html).	Asayama M, 1996, J BIOCHEM, V120, P752; BAUMGARTNER BJ, 1989, PLANT PHYSIOL, V89, P1011, DOI 10.1104/pp.89.3.1011; BENDICH AJ, 1987, BIOESSAYS, V6, P279, DOI 10.1002/bies.950060608; Berla BM, 2012, APPL ENVIRON MICROB, V78, P5448, DOI 10.1128/AEM.01174-12; BINDER BJ, 1995, APPL ENVIRON MICROB, V61, P708, DOI 10.1128/AEM.61.2.708-717.1995; BOFFEY SA, 1979, PLANT PHYSIOL, V64, P502, DOI 10.1104/pp.64.3.502; BROEDEL SE, 1991, GENE, V109, P71, DOI 10.1016/0378-1119(91)90590-8; CASTENHOLZ RW, 1988, METHOD ENZYMOL, V167, P68; Chen AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047837; COOPER S, 1968, J MOL BIOL, V31, P519, DOI 10.1016/0022-2836(68)90425-7; CUTLER RG, 1966, J BACTERIOL, V91, P469, DOI 10.1128/JB.91.2.469-476.1966; DEMARSAC NT, 1993, FEMS MICROBIOL LETT, V104, P119; FERRETTI JJ, 1968, J BACTERIOL, V95, P1400, DOI 10.1128/JB.95.4.1400-1406.1968; Foster JS, 2007, ARCH MICROBIOL, V187, P265, DOI 10.1007/s00203-006-0193-6; Fuszard Matthew A, 2013, Aquat Biosyst, V9, P5, DOI 10.1186/2046-9063-9-5; Gerhardt P., 1994, METHODS GEN MOL BACT, P224; Griese M, 2011, FEMS MICROBIOL LETT, V323, P124, DOI 10.1111/j.1574-6968.2011.02368.x; Hein S, 2013, RNA BIOL, V10, P852, DOI 10.4161/rna.24160; Imamura S, 2006, J BIOL CHEM, V281, P2668, DOI 10.1074/jbc.M509639200; Jain IH, 2012, P NATL ACAD SCI USA, V109, P13638, DOI 10.1073/pnas.1211144109; Kabeya Y, 2013, PLANT PHYSIOL, V161, P2102, DOI 10.1104/pp.113.216291; KUROIWA T, 1991, INT REV CYTOL, V128, P1; LAMPPA GK, 1980, PLANTA, V148, P437, DOI [10.1007/BF00552656, 10.1007/BF02395311]; MANN N, 1974, J GEN MICROBIOL, V83, P399; MIYAMURA S, 1986, PROTOPLASMA, V133, P66, DOI 10.1007/BF01293188; Mori T, 1996, P NATL ACAD SCI USA, V93, P10183, DOI 10.1073/pnas.93.19.10183; Llorens JMN, 2010, FEMS MICROBIOL REV, V34, P476, DOI 10.1111/j.1574-6976.2010.00213.x; Nimura K, 2001, J BACTERIOL, V183, P1320, DOI 10.1128/JB.183.4.1320-1328.2001; de Alda JAGO, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5937; Ohashi Y, 2008, MOL BIOSYST, V4, P135, DOI 10.1039/b714176a; Ohbayashi R, 2013, FEMS MICROBIOL LETT, V344, P138, DOI 10.1111/1574-6968.12166; Pinto FL, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-79; Powikrowska M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00424; Rolfe MD, 2012, J BACTERIOL, V194, P686, DOI 10.1128/JB.06112-11; Saito N, 2009, J BIOL CHEM, V284, P16442, DOI 10.1074/jbc.M109.002089; Sakai A, 2004, INT REV CYTOL, V238, P59, DOI 10.1016/S0074-7696(04)38002-2; Sato M, 2007, J BACTERIOL, V189, P3751, DOI 10.1128/JB.01722-06; Schneider D, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-39; Sen A, 2000, ARCH MICROBIOL, V173, P352, DOI 10.1007/s002030000153; SHEHATA TE, 1970, J BACTERIOL, V103, P789, DOI 10.1128/JB.103.3.789-792.1970; Suzuki S, 2004, J BIOL CHEM, V279, P13234, DOI 10.1074/jbc.M313358200; TANAKA K, 1992, BIOCHIM BIOPHYS ACTA, V1132, P94, DOI 10.1016/0167-4781(92)90060-D; VAULOT D, 1995, SCIENCE, V268, P1480, DOI 10.1126/science.268.5216.1480; Wang JD, 2009, NAT REV MICROBIOL, V7, P822, DOI 10.1038/nrmicro2202; Watanabe S, 2012, MOL MICROBIOL, V83, P856, DOI 10.1111/j.1365-2958.2012.07971.x; Yehudai-Resheff S, 2007, PLANT CELL, V19, P1023, DOI 10.1105/tpc.106.045427	46	28	31	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136800	10.1371/journal.pone.0136800	http://dx.doi.org/10.1371/journal.pone.0136800			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331851	gold, Green Published, Green Submitted			2022-12-26	WOS:000360613800074
J	Zhang, Y; Shi, JL; Liu, LP; Gao, ZH; Che, JX; Shao, DY; Liu, YL				Zhang, Yan; Shi, Junling; Liu, Laping; Gao, Zhenhong; Che, Jinxin; Shao, Dongyan; Liu, Yanlin			Bioconversion of Pinoresinol Diglucoside and Pinoresinol from Substrates in the Phenylpropanoid Pathway by Resting Cells of Phomopsis sp.XP-8	PLOS ONE			English	Article							BREAST-CANCER RISK; MAMMALIAN LIGNANS; PLANT LIGNANS; BIOTRANSFORMATION; (+)-PINORESINOL; ENTEROLACTONE; PHENYLALANINE; BIOSYNTHESIS; METABOLISM	Pinoresinol diglucoside (PDG) and pinoresinol (Pin) are normally produced by plant cells via the phenylpropanoid pathway. This study reveals the existence of a related pathway in Phomopsis sp. XP-8, a PDG-producing fungal strain isolated from the bark of the Tu-chung tree (Eucommiaulmoides Oliv.). After addition of 0.15 g/L glucose to Phomopsis sp. XP-8, PDG and Pin formed when phenylalanine, tyrosine, leucine, cinnamic acid, and p-coumaric acid were used as the substrates respectively. No PDG formed in the absence of glucose, but Pin was detected after addition of all these substrates except leucine. In all systems in the presence of glucose, production of PDG and/or Pin and the accumulation of phenylalanine, cinnamic acid, or p-coumaric acid correlated directly with added substrate in a time- and substrate concentration-dependent manner. After analysis of products produced after addition of each substrate, the mass flow sequence for PDG and Pin biosynthesis was defined as: glucose to phenylalanine, phenylalanine to cinnamic acid, then to p-coumaric acid, and finally to Pin or PDG. During the bioconversion, the activities of four key enzymes in the phenylpropanoid pathway were also determined and correlated with accumulation of their corresponding products. PDG production by Phomopsis sp. exhibits greater efficiency and cost effectiveness than the currently-used plant-based system and will pave the way for large scale production of PDG and/or Pin for medical applications.	[Zhang, Yan; Liu, Laping; Gao, Zhenhong; Che, Jinxin] Northwest A&F Univ, Coll Food Sci & Engn, Yangling 712100, Shaanxi Provinc, Peoples R China; [Shi, Junling; Shao, Dongyan] Northwestern Polytech Univ, Sch Life Sci, Key Lab Space Biosci & Biotechnol, 127 Youyi West Rd, Xian 710072, Shaanxi Provinc, Peoples R China; [Liu, Yanlin] Northwest A&F Univ, Coll Enol, Yangling 712100, Shaanxi Provinc, Peoples R China	Northwest A&F University - China; Northwestern Polytechnical University; Northwest A&F University - China	Shi, JL (corresponding author), Northwestern Polytech Univ, Sch Life Sci, Key Lab Space Biosci & Biotechnol, 127 Youyi West Rd, Xian 710072, Shaanxi Provinc, Peoples R China.	sjlshi2004@aliyun.com			National Natural Science Foundation of China (NSFC) [31201408]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (NSFC) No. 31201408.	Adlercreutz H, 2002, LANCET ONCOL, V3, P364, DOI 10.1016/S1470-2045(02)00777-5; Charles JS, 1976, J AM CHEM SOC, V98, P5412; Charles JS, 1978, US Patent, Patent No. [4:103-106, 4103106]; Dixon RA, 2002, MOL PLANT PATHOL, V3, P371, DOI 10.1046/j.1364-3703.2002.00131.x; Donnez D, 2009, TRENDS BIOTECHNOL, V27, P706, DOI 10.1016/j.tibtech.2009.09.005; During A, 2012, J NUTR, V142, P1798, DOI 10.3945/jn.112.162453; Eudes A, 2014, CURR OPIN BIOTECH, V26, P189, DOI 10.1016/j.copbio.2014.01.002; Heinonen S, 2001, J AGR FOOD CHEM, V49, P3178, DOI 10.1021/jf010038a; Horn-Ross PL, 2001, AM J EPIDEMIOL, V154, P434, DOI 10.1093/aje/154.5.434; Horn-Ross PL, 2003, J NATL CANCER I, V95, P1158, DOI 10.1093/jnci/djg015; Jeandet P, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/579089; Kanehisa Laboratories, 2015, BIOS PLANT SEC MET R; Kaul S, 2012, PHYTOCHEM REV, V11, P487, DOI 10.1007/s11101-012-9260-6; Khan W, 2003, J PLANT PHYSIOL, V160, P859, DOI 10.1078/0176-1617-00905; Luo LF, 2010, J ETHNOPHARMACOL, V129, P238, DOI 10.1016/j.jep.2010.03.019; Marienhagen J, 2013, J BIOTECHNOL, V163, P166, DOI 10.1016/j.jbiotec.2012.06.001; Redmile-Gordon MA, 2013, SOIL BIOL BIOCHEM, V67, P166, DOI 10.1016/j.soilbio.2013.08.017; Ro DK, 2004, J BIOL CHEM, V279, P2600, DOI 10.1074/jbc.M309951200; Saleem M, 2005, NAT PROD REP, V22, P696, DOI 10.1039/b514045p; Satake H, 2013, J AGR FOOD CHEM, V61, P11721, DOI 10.1021/jf4007104; Shi JL, 2012, APPL MICROBIOL BIOT, V93, P1475, DOI 10.1007/s00253-011-3613-8; Suzuki S, 2007, J WOOD SCI, V53, P273, DOI 10.1007/s10086-007-0892-x; Umezawa T., 2005, KAGAKU SEIBUTSU, V43, P461; Wikul A, 2012, BIOORG MED CHEM LETT, V22, P5215, DOI 10.1016/j.bmcl.2012.06.068; Winkel BSJ, 2004, ANNU REV PLANT BIOL, V55, P85, DOI 10.1146/annurev.arplant.55.031903.141714; Xiao JB, 2009, ARCH BIOL SCI, V61, P811, DOI 10.2298/ABS0904811X; Xie J, 2013, BREAST CANCER RES TR, V139, P801, DOI 10.1007/s10549-013-2586-y; Xie LH, 2003, CHEM PHARM BULL, V51, P508, DOI 10.1248/cpb.51.508; Zhang JH, 2013, APPL MICROBIOL BIOT, V97, P9941, DOI 10.1007/s00253-013-5212-3; Zhang Y, 2015, APPL MICROBIOL BIOT, V99, P4629, DOI 10.1007/s00253-015-6491-7	30	8	9	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137066	10.1371/journal.pone.0137066	http://dx.doi.org/10.1371/journal.pone.0137066			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331720	Green Published, Green Submitted, gold			2022-12-26	WOS:000360613800093
J	Becnel, LB; Darlington, YF; Ochsner, SA; Easton-Marks, JR; Watkins, CM; McOwiti, A; Kankanamge, WH; Wise, MW; DeHart, M; Margolis, RN; McKenna, NJ				Becnel, Lauren B.; Darlington, Yolanda F.; Ochsner, Scott A.; Easton-Marks, Jeremy R.; Watkins, Christopher M.; McOwiti, Apollo; Kankanamge, Wasula H.; Wise, Michael W.; DeHart, Michael; Margolis, Ronald N.; McKenna, Neil J.			Nuclear Receptor Signaling Atlas: Opening Access to the Biology of Nuclear Receptor Signaling Pathways	PLOS ONE			English	Article							BREAST-CANCER CELLS; GENE-EXPRESSION; ER-ALPHA; ESTROGEN; COREGULATORS; NETWORKS; RESOURCE	Signaling pathways involving nuclear receptors (NRs), their ligands and coregulators, regulate tissue-specific transcriptomes in diverse processes, including development, metabolism, reproduction, the immune response and neuronal function, as well as in their associated pathologies. The Nuclear Receptor Signaling Atlas (NURSA) is a Consortium focused around a Hub website (www.nursa.org) that annotates and integrates diverse 'omics datasets originating from the published literature and NURSA-funded Data Source Projects (NDSPs). These datasets are then exposed to the scientific community on an Open Access basis through user-friendly data browsing and search interfaces. Here, we describe the redesign of the Hub, version 3.0, to deploy "Web 2.0" technologies and add richer, more diverse content. The Molecule Pages, which aggregate information relevant to NR signaling pathways from myriad external databases, have been enhanced to include resources for basic scientists, such as post-translational modification sites and targeting miRNAs, and for clinicians, such as clinical trials. A portal to NURSA's Open Access, PubMed-indexed journal Nuclear Receptor Signaling has been added to facilitate manuscript submissions. Datasets and information on reagents generated by NDSPs are available, as is information concerning periodic new NDSP funding solicitations. Finally, the new website integrates the Transcriptomine analysis tool, which allows for mining of millions of richly annotated public transcriptomic data points in the field, providing an environment for dataset re-use and citation, bench data validation and hypothesis generation. We anticipate that this new release of the NURSA database will have tangible, long term benefits for both basic and clinical research in this field.	[Becnel, Lauren B.; Darlington, Yolanda F.; Easton-Marks, Jeremy R.; Watkins, Christopher M.; McOwiti, Apollo; Kankanamge, Wasula H.; DeHart, Michael] Dan L Duncan Comprehens Canc Ctr, Biomed Informat Grp, Houston, TX USA; [Ochsner, Scott A.; McKenna, Neil J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Wise, Michael W.; Margolis, Ronald N.] NIDDK, Div Diabet & Metab Dis, Bethesda, MD USA; [Becnel, Lauren B.; Darlington, Yolanda F.; Ochsner, Scott A.; Easton-Marks, Jeremy R.; Watkins, Christopher M.; McOwiti, Apollo; Kankanamge, Wasula H.; Wise, Michael W.; DeHart, Michael; McKenna, Neil J.] Nucl Receptor Signaling Atlas NURSA Informat Hub, Bethesda, MD USA	Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	McKenna, NJ (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, One Baylor Plaza, Houston, TX 77030 USA.	nmckenna@bcm.edu	Margolis, Ronald N/O-7773-2015	Margolis, Ronald N/0000-0002-8956-0455; Easton-Marks, Jeremy/0000-0002-2263-7454; Ochsner, Scott/0000-0003-1099-7863	National Institute of Diabetes Digestive and Kidney Diseases; Eunice Kennedy Shriver National Institute of Child Health and Development [DK097748]; National Institutes of Health Big Data To Knowledge (BD2K) program [DK097748-S1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097748] Funding Source: NIH RePORTER	National Institute of Diabetes Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Eunice Kennedy Shriver National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health Big Data To Knowledge (BD2K) program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	NURSA is supported by grants from the National Institute of Diabetes Digestive and Kidney Diseases and the Eunice Kennedy Shriver National Institute of Child Health and Development (DK097748) and by the National Institutes of Health Big Data To Knowledge (BD2K) program (DK097748-S1).	Bhat-Nakshatri P, 2008, MOL CELL BIOL, V28, P7487, DOI 10.1128/MCB.00799-08; Bollen J, 2006, SCIENTOMETRICS, V69, P669, DOI 10.1007/s11192-006-0176-z; Chang EC, 2006, ENDOCRINOLOGY, V147, P4831, DOI 10.1210/en.2006-0563; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; De Mattia E, 2013, PHARMACOGENOMICS, V14, P2035, DOI [10.2217/pgs.13.214, 10.2217/PGS.13.214]; Delfosse V, 2015, ACTA PHARMACOL SIN, V36, P88, DOI 10.1038/aps.2014.133; Gilman AG, 2002, NATURE, V420, P703, DOI 10.1038/nature01304; Hewitt SC, 2010, FASEB J, V24, P4660, DOI 10.1096/fj.10-163428; Hsia EY, 2010, ADV DRUG DELIVER REV, V62, P1227, DOI 10.1016/j.addr.2010.09.016; Jelinsky SA, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-27; Malinen M, 2013, MOL CELL ENDOCRINOL, V365, P270, DOI 10.1016/j.mce.2012.10.028; Margolis R, 2014, J AM MED INFORM ASSN, V21, P957, DOI 10.1136/amiajnl-2014-002974; Martinez E, 1997, NUCLEIC ACIDS RES, V25, P163, DOI 10.1093/nar/25.1.163; Maslov S, 2008, J NEUROSCI, V28, P11103, DOI 10.1523/JNEUROSCI.0002-08.2008; Mathijs K, 2009, TOXICOL SCI, V112, P374, DOI 10.1093/toxsci/kfp229; McKenna Neil J, 2014, Nucl Recept Signal, V12, pe006, DOI 10.1621/nrs.12006; McKenna Neil J, 2005, Sci STKE, V2005, ptr22, DOI 10.1126/stke.2992005tr22; McKenna NJ, 2009, MOL ENDOCRINOL, V23, P740, DOI 10.1210/me.2009-0135; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Moggs JG, 2005, J MOL ENDOCRINOL, V34, P535, DOI 10.1677/jme.1.01677; Moggs JG, 2004, ENVIRON HEALTH PERSP, V112, P1589, DOI 10.1289/ehp.7345; Mouchiroud L, 2014, CELL METAB, V20, P26, DOI 10.1016/j.cmet.2014.03.027; Naciff JM, 2010, TOXICOLOGY, V270, P137, DOI 10.1016/j.tox.2010.02.008; Nott SL, 2009, J BIOL CHEM, V284, P15277, DOI 10.1074/jbc.M900365200; Ochsner SA, 2012, PHYSIOL GENOMICS, V44, P853, DOI 10.1152/physiolgenomics.00033.2012; Schulman IG, 2010, ADV DRUG DELIVER REV, V62, P1307, DOI 10.1016/j.addr.2010.07.002; Snyder EM, 2009, BIOL REPROD, V81, P707, DOI 10.1095/biolreprod.109.079053; Tolhurst RS, 2011, BREAST CANCER RES TR, V128, P357, DOI 10.1007/s10549-010-1122-6; Vroling B, 2012, NUCLEIC ACIDS RES, V40, pD377, DOI 10.1093/nar/gkr960	30	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0135615	10.1371/journal.pone.0135615	http://dx.doi.org/10.1371/journal.pone.0135615			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325041	gold, Green Submitted, Green Published			2022-12-26	WOS:000360437700022
J	Gao, CL; Cai, Y; Zhang, XB; Huang, HL; Wang, J; Wang, YJ; Tong, XG; Wang, JH; Wu, JL				Gao, Chunlin; Cai, Ying; Zhang, Xuebin; Huang, Huiling; Wang, Jin; Wang, Yajing; Tong, Xiaoguang; Wang, Jinhuan; Wu, Jialing			Ischemic Preconditioning Mediates Neuroprotection against Ischemia in Mouse Hippocampal CA1 Neurons by Inducing Autophagy	PLOS ONE			English	Article							NEONATAL HYPOXIA-ISCHEMIA; CEREBRAL-ISCHEMIA; PLASMINOGEN-ACTIVATOR; SIGNALING PATHWAY; CELL-DEATH; PROTECTS; INJURY; DAMAGE; BRAIN; INHIBITION	The hippocampal CA1 region is sensitive to hypoxic and ischemic injury but can be protected by ischemic preconditioning (IPC). However, the mechanism through which IPC protects hippocampal CA1 neurons is still under investigation. Additionally, the role of autophagy in determining the fate of hippocampal neurons is unclear. Here, we examined whether IPC induced autophagy to alleviate hippocampal CA1 neuronal death in vitro and in vivo with oxygen glucose deprivation (OGD) and bilateral carotid artery occlusion (BCCAO) models. Survival of hippocampal neurons increased from 51.5% +/- 6.3% in the non-IPC group (55 min of OGD) to 77.3% +/- 7.9% in the IPC group (15 min of OGD, followed by 55 min of OGD 24 h later). The number of hippocampal CA1 layer neurons increased from 182 +/- 26 cells/mm(2) in the non-IPC group (20 min of BCCAO) to 278 +/- 55 cells/mm(2) in the IPC group (1 min x 3 BCCAO, followed by 20 min of BCCAO 24 h later). Akt phosphorylation and microtubule-associated protein light chain 3 (LC3)-II/LC3-I expression were increased in the preconditioning group. Moreover, the protective effects of IPC were abolished only by inhibiting the activity of autophagy, but not by blocking the activation of Akt in vitro. Using in vivo experiments, we found that LC3 expression was upregulated, accompanied by an increase in neuronal survival in hippocampal CA1 neurons in the preconditioning group. The neuroprotective effects of IPC on hippocampal CA1 neurons were completely inhibited by treatment with 3-MA. In contrast, hippocampal CA3 neurons did not show changes in autophagic activity or beneficial effects of IPC. These data suggested that IPC may attenuate ischemic injury in hippocampal CA1 neurons through induction of Akt-independent autophagy.	[Gao, Chunlin; Wang, Jin; Wang, Yajing; Wu, Jialing] Tianjin Huanhu Hosp, Dept Neurol, Tianjin Key Lab Cerebrovasc & Neurodegenerat Dis, Tianjin, Peoples R China; [Cai, Ying; Huang, Huiling] Tianjin Huanhu Hosp, Dept Neurosci, Tianjin Key Lab Cerebrovasc & Neurodegenerat Dis, Tianjin Neurosurg Inst, Tianjin, Peoples R China; [Zhang, Xuebin] Tianjin Huanhu Hosp, Dept Pathol, Tianjin Key Lab Cerebrovasc & Neurodegenerat Dis, Tianjin, Peoples R China; [Tong, Xiaoguang; Wang, Jinhuan] Tianjin Huanhu Hosp, Dept Neurosurg, Tianjin Key Lab Cerebrovasc & Neurodegenerat Dis, Tianjin Neurosurg Inst, Tianjin, Peoples R China		Wu, JL (corresponding author), Tianjin Huanhu Hosp, Dept Neurol, Tianjin Key Lab Cerebrovasc & Neurodegenerat Dis, Tianjin, Peoples R China.	wywjl2009@hotmail.com			Tianjin Public Health Bureau [2013KG122]; Tianjin Municipal Science and Technology Commission [13JCYBJC23200, 13ZCZDSY01600]	Tianjin Public Health Bureau; Tianjin Municipal Science and Technology Commission	The work reported in this article was generously supported by grants from Tianjin Public Health Bureau (2013KG122) to J.W. (http://www.tjwsj.gov.cn), Tianjin Municipal Science and Technology Commission (13JCYBJC23200) to J.W. (http://www.tstc.gov.cn), and (13ZCZDSY01600) to X.T. (http://www.tstc.gov.cn).	An J, 2008, BLOOD, V112, P2787, DOI 10.1182/blood-2008-02-141630; Carloni S, 2010, AUTOPHAGY, V6, P366, DOI 10.4161/auto.6.3.11261; Carloni S, 2008, NEUROBIOL DIS, V32, P329, DOI 10.1016/j.nbd.2008.07.022; Cohen MV, 2006, CARDIOVASC RES, V70, P231, DOI 10.1016/j.cardiores.2005.10.021; Cui DR, 2013, NEUROSCIENCE, V246, P117, DOI 10.1016/j.neuroscience.2013.04.054; Dirnagl U, 2008, NEUROPHARMACOLOGY, V55, P334, DOI 10.1016/j.neuropharm.2008.02.017; Echeverry R, 2010, J CLIN INVEST, V120, P2194, DOI 10.1172/JCI41722; Fan QW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001017; Fan Y, 2008, EXP NEUROL, V212, P415, DOI 10.1016/j.expneurol.2008.04.032; Feng YZ, 2010, BRAIN RES, V1325, P1, DOI 10.1016/j.brainres.2010.02.029; Galle AA, 2013, BRAIN RES, V1498, P1, DOI 10.1016/j.brainres.2012.12.026; Ginet V, 2009, AM J PATHOL, V175, P1962, DOI 10.2353/ajpath.2009.090463; Giricz Z, 2012, J CARDIOVASC PHARM, V60, P125, DOI 10.1097/FJC.0b013e318256ce10; Gu WW, 2013, ACTA PHARMACOL SIN, V34, P1007, DOI 10.1038/aps.2013.30; Jeffs GJ, 2008, EXP NEUROL, V210, P268, DOI 10.1016/j.expneurol.2007.10.013; Ji LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069910; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; Lehotsky J, 2009, ANAT REC, V292, P2002, DOI 10.1002/ar.20970; Lin J, 2013, CLIN CANCER RES, V19, P1760, DOI 10.1158/1078-0432.CCR-12-3072; Papadakis M, 2013, NAT MED, V19, P351, DOI 10.1038/nm.3097; PEDIGO NW, 1975, J PHARMACOL EXP THER, V193, P845; PETITO CK, 1987, NEUROLOGY, V37, P1281, DOI 10.1212/WNL.37.8.1281; Qi ZF, 2012, CNS NEUROSCI THER, V18, P965, DOI 10.1111/cns.12016; Sheng R, 2010, AUTOPHAGY, V6, P482, DOI 10.4161/auto.6.4.11737; Surendra H, 2013, J MOL CELL CARDIOL, V60, P142, DOI 10.1016/j.yjmcc.2013.04.010; Tu XK, 2015, J MOL NEUROSCI, V55, P912, DOI 10.1007/s12031-014-0446-9; Tu YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075872; Wang P, 2012, AUTOPHAGY, V8, P77, DOI 10.4161/auto.8.1.18274; Wang RM, 2009, BRAIN RES, V1255, P32, DOI 10.1016/j.brainres.2008.12.011; Wu JL, 2010, AM J PATHOL, V177, P2576, DOI 10.2353/ajpath.2010.100466; Xiang J, 2010, CAN J PHYSIOL PHARM, V88, P907, DOI [10.1139/Y10-069, 10.1139/y10-069]; Yan WJ, 2013, ACTA PHARMACOL SIN, V34, P636, DOI 10.1038/aps.2013.18; Yang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096509; Zhang XN, 2013, AUTOPHAGY, V9, P1321, DOI 10.4161/auto.25132; Zhou CF, 2011, NEUROCHEM INT, V59, P749, DOI 10.1016/j.neuint.2011.08.008	35	18	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137146	10.1371/journal.pone.0137146	http://dx.doi.org/10.1371/journal.pone.0137146			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325184	Green Submitted, Green Published, gold			2022-12-26	WOS:000360437700100
J	Aguera, ML; Martin-Malo, A; Alvarez-Lara, MA; Garcia-Montemayor, VE; Canton, P; Soriano, S; Aljama, P				Luisa Agueera, Maria; Martin-Malo, Alejandro; Antonia Alvarez-Lara, Maria; Eugenia Garcia-Montemayor, Victoria; Canton, Petra; Soriano, Sagrario; Aljama, Pedro			Efficiency of Original versus Generic Intravenous Iron Formulations in Patients on Haemodialysis	PLOS ONE			English	Article							ERYTHROPOIESIS-STIMULATING AGENTS; ANEMIA MANAGEMENT; MORTALITY; DISEASE; DRUGS; OUTCOMES	Aims The appropriate use of intravenous (IV) iron is essential to minimise the requirements for erythropoiesis-stimulating agents (ESAs). The clinical efficacy of generic IV iron compared to the original formulation is controversial. We evaluated the changes that were induced after switching from a generic IV iron to an original formulation in a stable, prevalent haemodialysis (HD) population. Methods A total of 342 patients were included, and the follow-up period was 56 weeks for each formulation. Anaemia parameters and doses of ESA and IV iron were prospectively recorded before and after the switch from generic to original IV iron. Results To maintain the same haemoglobin (Hb) levels after switching from the generic to the original formulation, the requirements for IV iron doses were reduced by 34.3% (from 52.8 +/- 33.9 to 34.7 +/- 31.8mg/week, p<0.001), and the ESA doses were also decreased by 12.5% (from 30.6 +/- 23.6 to 27 +/- 21 mu g/week, p<0.001). The erythropoietin resistance index declined from 8.4 +/- 7.7 to 7.4 +/- 6.7 IU/kg/week/g/dl after the switch from the generic to the original drug (p = 0.001). After the switch, the transferrin saturation ratio (TSAT) and serum ferritin levels rose by 6.8%(p<0.001) and 12.4%(p = 0.001), respectively. The mortality rate was similar for both periods. Conclusions The iron and ESA requirements are lower with the original IV iron compared to the generic drug. In addition, the uses of the original formulation results in higher ferritin and TSAT levels despite the lower dose of IV iron. Further studies are necessary to analyse the adverse effects of higher IV iron dosages.	[Luisa Agueera, Maria; Martin-Malo, Alejandro; Antonia Alvarez-Lara, Maria; Soriano, Sagrario; Aljama, Pedro] Hosp Univ Reina Sofia, Serv Nefrol, Cordoba, Spain; [Luisa Agueera, Maria; Martin-Malo, Alejandro; Antonia Alvarez-Lara, Maria; Soriano, Sagrario; Aljama, Pedro] Univ Cordoba, Inst Maimonides Invest Biomed Cordoba IMIBIC, Cordoba, Spain; [Luisa Agueera, Maria; Martin-Malo, Alejandro; Antonia Alvarez-Lara, Maria; Soriano, Sagrario; Aljama, Pedro] Inst Salud Carlos III, RedInRen, Madrid, Spain; [Eugenia Garcia-Montemayor, Victoria; Canton, Petra] SOCODI SL, Dialysis Unit, Cordoba, Spain	Hospital Universitario Reina Sofia - Cordoba; Universidad de Cordoba; Instituto de Salud Carlos III	Aguera, ML (corresponding author), Hosp Univ Reina Sofia, Serv Nefrol, Cordoba, Spain.	marisa.aguera@gmail.com		Aguera Morales, Maria Luisa/0000-0002-7736-908X	Fundacion Nefrologica, Hospital Universitario Reina Sofia, Cordoba, Spain	Fundacion Nefrologica, Hospital Universitario Reina Sofia, Cordoba, Spain	This study was supported by the Fundacion Nefrologica, Hospital Universitario Reina Sofia, Cordoba, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2015, KIDNEY INT, V88, P905, DOI 10.1038/ki.2015.163; [Anonymous], 2013, EU CLIN TRIALS REGIS; Bailie GR, 2015, KIDNEY INT, V87, P162, DOI 10.1038/ki.2014.275; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Brissot P, 2012, BBA-GEN SUBJECTS, V1820, P403, DOI 10.1016/j.bbagen.2011.07.014; Brookhart MA, 2010, JAMA-J AM MED ASSOC, V303, P857, DOI 10.1001/jama.2010.206; Charytan DM, 2015, J AM SOC NEPHROL, V26, P1238, DOI 10.1681/ASN.2014090922; Connor JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125272; Davit BM, 2009, ANN PHARMACOTHER, V43, P1583, DOI 10.1345/aph.1M141; Dunne S, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-1; Eduardo Toblli Jorge, 2012, Inflammation & Allergy Drug Targets, V11, P66; Feldman HI, 2004, J AM SOC NEPHROL, V15, P1623, DOI 10.1097/01.ASN.0000128009.69594.BE; Fishbane S, 2014, NEPHROL DIAL TRANSPL, V29, P255, DOI 10.1093/ndt/gft269; Freburger JK, 2012, AM J MED, V125, P906, DOI 10.1016/j.amjmed.2012.03.011; Fuller DS, 2013, AM J KIDNEY DIS, V62, P1213, DOI 10.1053/j.ajkd.2013.09.006; Gaweda AE, 2015, NEPHROL DIAL TRANSPL, V30, P187, DOI 10.1093/ndt/gfu104; Gaweda AE, 2014, J AM SOC NEPHROL, V25, P159, DOI 10.1681/ASN.2013010089; Group KAW, 2012, KIDNEY INT, V2, P279, DOI DOI 10.1038/kisup.2012.37; Harrison JJ, 2012, TRANSPLANTATION, V93, P657, DOI 10.1097/TP.0b013e3182445e9d; Ichii H, 2012, AM J NEPHROL, V36, P50, DOI 10.1159/000339285; Kalantar-Zadeh K, 2005, J AM SOC NEPHROL, V16, P3070, DOI 10.1681/ASN.2005040423; Kesselheim AS, 2008, JAMA-J AM MED ASSOC, V300, P2514, DOI 10.1001/jama.2008.758; Koulouridis I, 2013, AM J KIDNEY DIS, V61, P44, DOI 10.1053/j.ajkd.2012.07.014; Kshirsagar AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078930; Locatelli F, 2014, NEPHRON CLIN PRACT, V128, P323, DOI 10.1159/000366478; Locatelli F, 2013, NEPHROL DIAL TRANSPL, V28, P1346, DOI 10.1093/ndt/gft033; Lopez-Gomez JM, 2008, KIDNEY INT, V74, pS75, DOI 10.1038/ki.2008.523; Martin-Malo A, 2012, NEPHROL DIAL TRANSPL, V27, P2465, DOI 10.1093/ndt/gfr711; Miskulin DC, 2014, CLIN J AM SOC NEPHRO, V9, P1930, DOI 10.2215/CJN.03370414; Nishio A, 2013, BLOOD PURIFICAT, V36, P29, DOI 10.1159/000350583; Pai AB, 2011, BIOMETALS, V24, P603, DOI 10.1007/s10534-011-9409-6; Panichi V, 2011, NEPHROL DIAL TRANSPL, V26, P2641, DOI 10.1093/ndt/gfq802; Ramsey S., 2013, WHO GUIDELINE COUNTR; Rosati A, 2015, J NEPHROL, V28, P603, DOI 10.1007/s40620-014-0127-3; Rostoker G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115096; Rottembourg J, 2011, NEPHROL DIAL TRANSPL, V26, P3262, DOI 10.1093/ndt/gfr024; Schellekens H, 2011, REGUL TOXICOL PHARM, V59, P176, DOI 10.1016/j.yrtph.2010.09.021; Slotki I, 2015, J AM SOC NEPHROL, V26, P2612, DOI 10.1681/ASN.2015010052; Stauffer ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084943; Szczech LA, 2008, KIDNEY INT, V74, P791, DOI 10.1038/ki.2008.295; van der Meersch A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023611; Vaziri ND, 2013, AM J KIDNEY DIS, V61, P992, DOI 10.1053/j.ajkd.2012.10.027; Zhou J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043655; Zitt E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114144	44	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0135967	10.1371/journal.pone.0135967	http://dx.doi.org/10.1371/journal.pone.0135967			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322790	Green Published, Green Submitted, gold			2022-12-26	WOS:000360435500013
J	Fertner, M; Sanchez, J; Boklund, A; Stryhn, H; Dupont, N; Toft, N				Fertner, Mette; Sanchez, Javier; Boklund, Anette; Stryhn, Henrik; Dupont, Nana; Toft, Nils			Persistent Spatial Clusters of Prescribed Antimicrobials among Danish Pig Farms - A Register-Based Study	PLOS ONE			English	Article							AIRBORNE TRANSMISSION; PRRS VIRUS; HERDS; EPIDEMIOLOGY; SURVEILLANCE; CONSUMPTION; STATISTICS; INFECTION; BACTERIA; ANIMALS	The emergence of pathogens resistant to antimicrobials has prompted political initiatives targeting a reduction in the use of veterinary antimicrobials in Denmark, especially for pigs. This study elucidates the tendency of pig farms with a significantly higher antimicrobial use to remain in clusters in certain geographical regions of Denmark. Animal Daily Doses/100 pigs/day were calculated for all three age groups of pigs (weaners, finishers and sows) for each quarter during 2012-13 in 6,143 commercial indoor pig producing farms. The data were split into four time periods of six months. Repeated spatial cluster analyses were performed to identify persistent clusters, i.e. areas included in a significant cluster throughout all four time periods. Antimicrobials prescribed for weaners did not result in any persistent clusters. In contrast, antimicrobial use in finishers clustered persistently in two areas (157 farms), while those issued for sows clustered in one area (51 farms). A multivariate analysis including data on antimicrobial use for weaners, finishers and sows as three separate outcomes resulted in three persistent clusters (551 farms). Compared to farms outside the clusters during this period, weaners, finishers and sows on farms within these clusters had 19%, 104% and 4% higher use of antimicrobials, respectively. Production type, farm type and farm size seemed to have some bearing on the clustering effect. Adding these factors as categorical covariates one at a time in the multivariate analysis reduced the persistent clusters by 24.3%, 30.5% and 34.1%, respectively.	[Fertner, Mette; Boklund, Anette; Toft, Nils] Tech Univ Denmark, Natl Vet Inst, Epidemiol Sect, Frederiksberg, Denmark; [Sanchez, Javier; Stryhn, Henrik] Univ Prince Edward Isl, Atlantic Vet Coll, Dept Hlth Management, Ctr Vet Epidemiol Res, Charlottetown, PE C1A 4P3, Canada; [Dupont, Nana] Univ Copenhagen, Dept Large Anim Sci, Frederiksberg, Denmark	Technical University of Denmark; University of Prince Edward Island; University of Copenhagen	Fertner, M (corresponding author), Tech Univ Denmark, Natl Vet Inst, Epidemiol Sect, Frederiksberg, Denmark.	memun@vet.dtu.dk	Boklund, Anette/HGE-8502-2022; sanchez, javier/AAA-4179-2022	Toft, Nils/0000-0002-0265-3764; Stryhn, Henrik/0000-0002-4284-9999; Boklund, Anette/0000-0001-6359-3403; Fertner, Mette Ely/0000-0001-6697-5327				Aarestrup FM, 1999, INT J ANTIMICROB AG, V12, P279, DOI 10.1016/S0924-8579(99)90059-6; [Anonymous], 2014, DK5332014; [Anonymous], 2014, DK5342014; [Anonymous], 2015, SPF HLTH REGULATIONS; [Anonymous], 2010, DK13192010; [Anonymous], 2014, STAT ANAL SYSTEM SOF; [Anonymous], 2011, DK10852011; [Anonymous], 2014, DK1782014; Baekbo P, 2012, TRANSBOUND EMERG DIS, V59, P60, DOI 10.1111/j.1865-1682.2011.01288.x; Brown IH, 2000, VET MICROBIOL, V74, P29, DOI 10.1016/S0378-1135(00)00164-4; Christiansen JP, 2011, HLTH PIGS BIOSECURIT, V5, P25; Danmap 2012, 2013, US ANT AG OCC ANT; Dunlop RH, 1998, PREV VET MED, V34, P247, DOI 10.1016/S0167-5877(97)00093-7; Dupont N, 2014, DANSK VETTIDSSKRI, V97, P33; Elvstrom Anders, 2015, COMMUNICATION; Garcia-Migura L, 2014, VET MICROBIOL, V170, P1, DOI 10.1016/j.vetmic.2014.01.013; Hybschmann GK, 2011, PREV VET MED, V98, P190, DOI 10.1016/j.prevetmed.2010.10.005; Jensen VF, 2012, J VET PHARMACOL THER, V35, P33, DOI 10.1111/j.1365-2885.2011.01291.x; Jensen VF, 2004, PREV VET MED, V64, P201, DOI 10.1016/j.prevetmed.2004.04.001; Kristensen CS, 2004, VET MICROBIOL, V98, P243, DOI 10.1016/j.vetmic.2003.10.026; Kristensen CS, 2004, VET MICROBIOL, V99, P197, DOI 10.1016/j.vetmic.2004.01.005; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Kulldorff M, 2014, INFORM MANAGEMENT SE; Kulldorff M, 2007, STAT MED, V26, P1824, DOI 10.1002/sim.2818; Kulldorff M, 2006, STAT MED, V25, P3929, DOI 10.1002/sim.2490; Kulldorff M, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-58; Maes D, 2000, VET RES, V31, P313, DOI 10.1051/vetres:2000122; Moore JE, 2012, PREV VET MED, V107, P286, DOI 10.1016/j.prevetmed.2012.09.006; Mortensen S, 2002, PREV VET MED, V53, P83, DOI 10.1016/S0167-5877(01)00260-4; Nielsen E. O., 2002, Dansk Veterinartidsskrift, V85, P6; Patanasatienkul T, 2015, PREV VET MED, V120, P219, DOI 10.1016/j.prevetmed.2015.03.006; R Core Team, 2014, LANG ENV STAT COMP; Sibila M, 2009, VET J, V181, P221, DOI 10.1016/j.tvjl.2008.02.020; Stege H, 2003, PREV VET MED, V57, P105, DOI 10.1016/S0167-5877(02)00233-7; Taylor DJ, 2006, PIG DIS; van der Fels-Klerx HJ, 2011, J ANIM SCI, V89, P1922, DOI 10.2527/jas.2010-3046; Vigre H, 2010, PREV VET MED, V93, P98, DOI 10.1016/j.prevetmed.2009.10.010	37	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136834	10.1371/journal.pone.0136834	http://dx.doi.org/10.1371/journal.pone.0136834			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317206	Green Submitted, Green Published, gold			2022-12-26	WOS:000360299100146
J	Thompson, JW; Wei, JQ; Appau, K; Wang, HL; Yu, H; Spiga, MG; Graham, RM; Webster, KA				Thompson, John W.; Wei, Jianqin; Appau, Kweku; Wang, Huilan; Yu, Hong; Spiga, Maria G.; Graham, Regina M.; Webster, Keith A.			Bnip3 Binds and Activates p300: Possible Role in Cardiac Transcription and Myocyte Morphology	PLOS ONE			English	Article							HISTONE ACETYLTRANSFERASE ACTIVITY; PERMEABILITY TRANSITION PORE; CELL-DEATH; HEART-FAILURE; ISCHEMIA/REPERFUSION INJURY; DILATED CARDIOMYOPATHY; MAMMALIAN TARGET; IN-VIVO; MITOCHONDRIAL; HYPOXIA	Bnip3 is a hypoxia-regulated member of the Bcl-2 family of proteins that is implicated in apoptosis, programmed necrosis, autophagy and mitophagy. Mitochondria are thought to be the primary targets of Bnip3 although its activities may extend to the ER, cytoplasm, and nucleus. Bnip3 is induced in the heart by ischemia and pressure-overload, and may contribute to cardiomyopathy and heart failure. Only mitochondrial-dependent programmed death actions have been described for Bnip3 in the heart. Here we describe a novel activity of Bnip3 in cultured cardiac myocytes and transgenic mice overexpressing Bnip3 in the heart (Bnip3-TG). In cultured myocytes Bnip3 bound and activated the acetyltransferase p300, increased acetylation of histones and the transcription factor GATA4, and conferred p300 and GATA4-sensitive cellular morphological changes. In intact Bnip3-TG hearts Bnip3 also bound p300 and GATA4 and conferred enhanced GATA4 acetylation. Bnip3-TG mice underwent age-dependent ventricular dilation and heart failure that was partially prevented by p300 inhibition with curcumin. The results suggest that Bnip3 regulates cardiac gene expression and perhaps myocyte morphology by activating nuclear p300 acetyltransferase activity and hyperacetylating histones and p300-selective transcription factors.	[Thompson, John W.; Wei, Jianqin; Appau, Kweku; Wang, Huilan; Spiga, Maria G.; Graham, Regina M.; Webster, Keith A.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Thompson, John W.; Wei, Jianqin; Appau, Kweku; Wang, Huilan; Spiga, Maria G.; Graham, Regina M.; Webster, Keith A.] Univ Miami, Miller Sch Med, Vasc Biol Inst, Miami, FL 33136 USA; [Yu, Hong] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Dept Cardiol, Hangzhou 310003, Zhejiang, Peoples R China	University of Miami; University of Miami; Zhejiang University	Webster, KA (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA.	kwebster@med.miami.edu		graham, regina/0000-0003-0103-2971; Webster, Keith A/0000-0002-6431-3642	NHLBI [HL072924, HL44578]; American Heart Association, Greater Southeast Affiliate Postdoctoral grant [12090006]; Walter G. Ross Distinguished Chair in vascular biology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072924, R29HL044578, R01HL044578] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association, Greater Southeast Affiliate Postdoctoral grant; Walter G. Ross Distinguished Chair in vascular biology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by NHLBI grants # HL072924 and HL44578 (KAW) and by a Walter G. Ross Distinguished Chair in vascular biology (KAW). JWT was supported by American Heart Association, Greater Southeast Affiliate Postdoctoral grant #12090006.	Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; BOYD JM, 1994, CELL, V79, P341, DOI 10.1016/0092-8674(94)90202-X; Burton TR, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.100; Burton TR, 2009, J NEUROSCI, V29, P4189, DOI 10.1523/JNEUROSCI.5747-08.2009; Burton TR, 2006, INT J CANCER, V118, P1660, DOI 10.1002/ijc.21547; Cesselli D, 2001, CIRC RES, V89, P279, DOI 10.1161/hh1501.094115; Chaanine AH, 2013, CIRC-HEART FAIL, V6, P572, DOI 10.1161/CIRCHEARTFAILURE.112.000200; Chen G, 1997, J EXP MED, V186, P1975, DOI 10.1084/jem.186.12.1975; Chen M, 2002, J BIOL CHEM, V277, P29181, DOI 10.1074/jbc.M204951200; Diwan A, 2007, J CLIN INVEST, V117, P2825, DOI 10.1172/JCI32490; Dorn GW, 2010, J CARDIOVASC TRANSL, V3, P374, DOI 10.1007/s12265-010-9174-x; Giatromanolaki A, 2004, CLIN CANCER RES, V10, P5566, DOI 10.1158/1078-0432.CCR-04-0076; Graham RM, 2007, ANTIOXID REDOX SIGN, V9, P1309, DOI 10.1089/ars.2007.1726; Graham RM, 2014, ONCOTARGET, V5, P1162, DOI 10.18632/oncotarget.1699; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Kubasiak LA, 2002, P NATL ACAD SCI USA, V99, P12825, DOI 10.1073/pnas.202474099; Kubl DA, 2007, BIOCHEM J, V405, P407, DOI 10.1042/BJ20070319; Li Y, 2007, J BIOL CHEM, V282, P35803, DOI 10.1074/jbc.M705231200; Liang QR, 2001, J BIOL CHEM, V276, P30245, DOI 10.1074/jbc.M102174200; Maillet M, 2013, NAT REV MOL CELL BIO, V14, P38, DOI 10.1038/nrm3495; Martin LJ, 2011, J NEUROSCI, V31, P359, DOI 10.1523/JNEUROSCI.2225-10.2011; Miyamoto S, 2006, CIRCULATION, V113, P679, DOI 10.1161/CIRCULATIONAHA.105.585182; Morimoto T, 2008, J CLIN INVEST, V118, P868, DOI 10.1172/JCI33160; Nakajima K, 2004, EMBO J, V23, P3216, DOI 10.1038/sj.emboj.7600333; Quinsay MN, 2010, AUTOPHAGY, V6, P855, DOI 10.4161/auto.6.7.13005; Ray R, 2000, J BIOL CHEM, V275, P1439, DOI 10.1074/jbc.275.2.1439; Regula KM, 2002, CIRC RES, V91, P226, DOI 10.1161/01.RES.0000029232.42227.16; Sciarretta S, 2011, PEDIATR CARDIOL, V32, P275, DOI 10.1007/s00246-010-9855-x; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P3100, DOI 10.1073/pnas.97.7.3100; Sunagawa Y, 2010, J BIOL CHEM, V285, P9556, DOI 10.1074/jbc.M109.070458; Takaya T, 2008, J BIOL CHEM, V283, P9828, DOI 10.1074/jbc.M707391200; Tamai T, 2013, J BIOL CHEM, V288, P10176, DOI 10.1074/jbc.M112.423640; Thompson JW, 2012, LIFE SCI, V91, P223, DOI 10.1016/j.lfs.2012.03.034; van Berlo JH, 2013, J CLIN INVEST, V123, P37, DOI 10.1172/JCI62839; van Oort RJ, 2006, CIRCULATION, V114, P298, DOI 10.1161/CIRCULATIONAHA.105.608968; Wang YN, 2008, J MOL CELL CARDIOL, V45, P812, DOI 10.1016/j.yjmcc.2008.07.016; Webster KA, 1999, J CLIN INVEST, V104, P239; Webster KA, 2006, ANTIOXID REDOX SIGN, V8, P1667, DOI 10.1089/ars.2006.8.1667; Wei JQ, 2008, CIRCULATION, V118, P934, DOI 10.1161/CIRCULATIONAHA.107.760488; Wei JQ, 2011, J BIOL CHEM, V286, P13995, DOI 10.1074/jbc.M110.211334; Wencker D, 2003, J CLIN INVEST, V111, P1497, DOI 10.1172/JCI200317664; Xu J, 2006, J BIOL CHEM, V281, P9152, DOI 10.1074/jbc.M510217200; Yamashita K, 2001, J BIOL CHEM, V276, P12645, DOI 10.1074/jbc.M011344200; Yoshida Y, 2010, CIRC J, V74, P156, DOI 10.1253/circj.CJ-09-0050; Zhang J, 2011, ANTIOXID REDOX SIGN, V14, P1959, DOI 10.1089/ars.2010.3772	45	16	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136847	10.1371/journal.pone.0136847	http://dx.doi.org/10.1371/journal.pone.0136847			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317696	gold, Green Submitted, Green Published			2022-12-26	WOS:000360299100151
J	Pang, T; Guo, LL; Shim, D; Cannon, N; Tang, S; Chen, JH; Xia, XL; Yin, WL; Carlson, JE				Pang, Tao; Guo, Lili; Shim, Donghwan; Cannon, Nathaniel; Tang, Sha; Chen, Jinhuan; Xia, Xinli; Yin, Weilun; Carlson, John E.			Characterization of the Transcriptome of the Xerophyte Ammopiptanthus mongolicus Leaves under Drought Stress by 454 Pyrosequencing	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; GENE-EXPRESSION; SIGNAL-TRANSDUCTION; PROTEIN-KINASE; ARABIDOPSIS-THALIANA; REGULATORY NETWORKS; CELLULAR-RESPONSES; ROOT TRANSCRIPTOME; ABIOTIC STRESSES; PLANT-RESPONSES	Background Ammopiptanthus mongolicus (Maxim. Ex Kom.) Cheng f., an endangered ancient legume species, endemic to the Gobi desert in north-western China. As the only evergreen broadleaf shrub in this area, A. mongolicus plays an important role in the region's ecological-environmental stability. Despite the strong potential of A. mongolicus in providing new insights on drought tolerance, sequence information on the species in public databases remains scarce. To both learn about the role of gene expression in drought stress tolerance in A. mongolicus and to expand genomic resources for the species, transcriptome sequencing of stress-treated A. mongolicus plants was performed. Results Using 454 pyrosequencing technology, 8,480 and 7,474 contigs were generated after de novo assembly of RNA sequences from leaves of untreated and drought-treated plants, respectively. After clustering using TGICL and CAP3 programs, a combined assembly of all reads produced a total of 11,357 putative unique transcripts (PUTs). Functional annotation and classification of the transcripts were conducted by aligning the 11,357 PUTs against the public protein databases and nucleotide database (Nt). Between control and drought-treated plants, 1,620 differentially expressed genes (DEGs) were identified, of which 1,106 were up-regulated and 514 were down-regulated. The differential expression of twenty candidate genes in metabolic pathways and transcription factors families related to stress-response were confirmed by quantitative real-time PCR. Representatives of several large gene families, such as WRKY and P5CS, were identified and verified in A. mongolicus for the first time. Conclusions The additional transcriptome resources, gene expression profiles, functional annotations, and candidate genes provide a more comprehensive understanding of the stress response pathways in xeric-adapted plant species such as A. mongolicus.	[Pang, Tao; Guo, Lili; Tang, Sha; Chen, Jinhuan; Xia, Xinli; Yin, Weilun] Beijing Forestry Univ, Coll Biol Sci & Technol, Natl Engn Lab Tree Breeding, Key Lab Silviculture & Conservat, Beijing, Peoples R China; [Guo, Lili] Henan Univ Sci & Technol, Coll Agr, Luoyang, Peoples R China; [Shim, Donghwan; Cannon, Nathaniel; Carlson, John E.] Penn State Univ, Dept Ecosyst Sci & Management, Schatz Ctr Tree Mol Genet, University Pk, PA 16802 USA; [Shim, Donghwan] Korea Forest Res Inst, Dept Forest Genet Resources, Suwon 441350, South Korea	Beijing Forestry University; Henan University of Science & Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Korea Forest Research Institute (KFRI)	Xia, XL (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, Natl Engn Lab Tree Breeding, Key Lab Silviculture & Conservat, Beijing, Peoples R China.	xiaxl@bjfu.edu.cn; yinwl@bjfu.edu.cn; jec16@psu.edu	Shim, Donghwan/AAN-3014-2020	, Sha/0000-0002-5825-9598; Yin, Weilun/0000-0002-6754-5772	National Natural Science Foundation of China [31070597, 31270656]; Scientific Research and Graduate Training Joint Programs from BMEC (Stress Resistance Mechanism of Poplar)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research and Graduate Training Joint Programs from BMEC (Stress Resistance Mechanism of Poplar)	work was supported by the following: The National Natural Science Foundation of China (31070597, 31270656), http://www.nsfc.gov.cn/; and Scientific Research and Graduate Training Joint Programs from BMEC (Stress Resistance Mechanism of Poplar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 1997, PLANT CELL, V9, P1859, DOI 10.1105/tpc.9.10.1859; Agarwal PK, 2010, BIOL PLANTARUM, V54, P201, DOI 10.1007/s10535-010-0038-7; Alexandersson E, 2010, PLANT J, V61, P650, DOI 10.1111/j.1365-313X.2009.04087.x; Ali GM, 2006, J PROTEOME RES, V5, P396, DOI 10.1021/pr050291g; Askari H, 2006, PROTEOMICS, V6, P2542, DOI 10.1002/pmic.200500328; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Bhushan D, 2007, MOL CELL PROTEOMICS, V6, P1868, DOI 10.1074/mcp.M700015-MCP200; Bota J, 2004, NEW PHYTOL, V162, P671, DOI 10.1111/j.1469-8137.2004.01056.x; Cao PX, 2009, PLANT MOL BIOL, V69, P529, DOI 10.1007/s11103-008-9434-1; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Chen JH, 2011, PLANT GROWTH REGUL, V63, P259, DOI 10.1007/s10725-010-9523-4; Chen M, 2007, BIOCHEM BIOPH RES CO, V353, P299, DOI 10.1016/j.bbrc.2006.12.027; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cowan KJ, 2003, J EXP BIOL, V206, P1107, DOI 10.1242/jeb.00220; Dani V, 2005, PROTEOMICS, V5, P737, DOI 10.1002/pmic.200401119; Dinakar C, 2012, PLANT SCI, V182, P29, DOI 10.1016/j.plantsci.2011.01.018; Eulgem T, 2006, PLOS PATHOG, V2, P1028, DOI 10.1371/journal.ppat.0020126; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI 10.1051/agro:2008021; Gahlan P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-126; Ge XJ, 2005, ANN BOT-LONDON, V95, P843, DOI 10.1093/aob/mci089; Gechev TS, 2012, CELL MOL LIFE SCI, V69, P3175, DOI 10.1007/s00018-012-1088-0; Guo LL, 2011, AFR J BIOTECHNOL, V10, P3715; Hiremath PJ, 2011, PLANT BIOTECHNOL J, V9, P922, DOI 10.1111/j.1467-7652.2011.00625.x; Hsiao YY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-360; Huang DQ, 2008, J EXP BOT, V59, P2991, DOI 10.1093/jxb/ern155; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kiegerl S, 2000, PLANT CELL, V12, P2247, DOI 10.1105/tpc.12.11.2247; Kimura M, 2003, PHOTOCHEM PHOTOBIOL, V77, P226, DOI 10.1562/0031-8655(2003)077&lt;0226:IOAGRB&gt;2.0.CO;2; Kizis D, 2001, FEBS LETT, V498, P187, DOI 10.1016/S0014-5793(01)02460-7; Kulik A, 2011, OMICS, V15, P859, DOI 10.1089/omi.2011.0091; Levee V, 2009, NEW PHYTOL, V184, P48, DOI 10.1111/j.1469-8137.2009.02955.x; Li B, 2013, PLANT PHYSIOL BIOCH, V67, P7, DOI 10.1016/j.plaphy.2013.02.016; Liang HY, 2011, TREE GENET GENOMES, V7, P941, DOI 10.1007/s11295-011-0386-2; Liu G.-H., 1998, B BOT RES, V18, P341; Liu MQ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-88; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Liu RL, 2010, PLANT GROWTH REGUL, V60, P163, DOI 10.1007/s10725-009-9432-6; Liu YH, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00282; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo X, 2013, J EXP BOT, V64, P2155, DOI 10.1093/jxb/ert073; Ma SS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r49; Mao XG, 2010, J EXP BOT, V61, P683, DOI 10.1093/jxb/erp331; Mohammadi M, 2007, PLANT CELL ENVIRON, V30, P630, DOI 10.1111/j.1365-3040.2007.01645.x; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Pandey GK, 2007, CELL RES, V17, P411, DOI 10.1038/cr.2007.39; Pang T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-488; Prentis PJ, 2010, ANN BOT-LONDON, V106, P1009, DOI 10.1093/aob/mcq201; Qiu Q, 2011, TREE PHYSIOL, V31, P452, DOI 10.1093/treephys/tpr015; Robaglia C, 2012, CURR OPIN PLANT BIOL, V15, P301, DOI 10.1016/j.pbi.2012.01.012; Ruiz-Lozano J. M., 2008, MYCORRHIZA STATE ART, P185, DOI [10.1007/978-3-540- 78826-3_10, DOI 10.1007/978-3-540-78826-3_10]; Schachtman DP, 2008, TRENDS PLANT SCI, V13, P281, DOI 10.1016/j.tplants.2008.04.003; Shen YG, 2003, THEOR APPL GENET, V106, P923, DOI 10.1007/s00122-002-1131-x; Shi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063993; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Szekely G, 2008, PLANT J, V53, P11, DOI 10.1111/j.1365-313X.2007.03318.x; Tang S, 2013, PLANT MOL BIOL, V83, P539, DOI 10.1007/s11103-013-0107-3; Todd J, 2008, PLANT SCI, V175, P799, DOI 10.1016/j.plantsci.2008.08.004; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Wang HB, 2005, J PLANT PHYSIOL, V162, P81, DOI 10.1016/j.jplph.2004.07.006; Wang JM, 2014, MOL BIOL REP, V41, P8231, DOI 10.1007/s11033-014-3725-1; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei Q, 2012, PLANT CELL TISS ORG, V110, P359, DOI 10.1007/s11240-012-0157-2; Wei Q, 2011, PLANT CELL TISS ORG, V105, P309, DOI 10.1007/s11240-010-9869-3; Wu YQ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-671; Xie L, 2012, INT J PLANT SCI, V173, P944, DOI 10.1086/667232; Xu DL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-133; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang HY, 2011, PLANT SIGNAL BEHAV, V6, P652, DOI 10.4161/psb.6.5.14945; Zhang JT, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030355, 10.1371/journal.pone.0041657]; Zhang XF, 2013, PLANT MOL BIOL, V83, P205, DOI 10.1007/s11103-013-0082-8; Zhang XT, 2013, MOL BIOL REP, V40, P1407, DOI 10.1007/s11033-012-2184-9; Zhao Y, 2013, PLANTA, V237, P755, DOI 10.1007/s00425-012-1783-y; Zhou G, 2012, PLANT MOL BIOL REP, V30, P349, DOI 10.1007/s11105-011-0343-0; Zhou QY, 2008, PLANT BIOTECHNOL J, V6, P486, DOI 10.1111/j.1467-7652.2008.00336.x; Zhou YJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-266; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	83	6	7	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136495	10.1371/journal.pone.0136495	http://dx.doi.org/10.1371/journal.pone.0136495			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313687	Green Published, Green Submitted, gold			2022-12-26	WOS:000360144000062
J	Tauseef, M; Farazuddin, M; Sukriti, S; Rajput, C; Meyer, JO; Ramasamy, SK; Mehta, D				Tauseef, Mohammad; Farazuddin, Mohammad; Sukriti, Sukriti; Rajput, Charu; Meyer, James Otto; Ramasamy, Suresh Kumar; Mehta, Dolly			Transient receptor potential channel 1 maintains adherens junction plasticity by suppressing sphingosine kinase 1 expression to induce endothelial hyperpermeability	FASEB JOURNAL			English	Article						acute lung injury; thrombin; TRPC; VE-cadherin	OPERATED CA2+ ENTRY; LUNG VASCULAR-PERMEABILITY; VE-CADHERIN; TRPC1 EXPRESSION; INDUCED INCREASE; KAPPA-B; ACTIVATION; SPHINGOSINE-1-PHOSPHATE; SEPSIS; INFLUX	Stability of endothelial cell (EC) adherens junctions (AJs) is central for prevention of tissue edema, the hallmark of chronic inflammatory diseases including acute respiratory distress syndrome. Here, we demonstrate a previously unsuspected role of sphingosine kinase 1 (SPHK1) in the mechanism by which transient receptor potential channel 1 (Trpc1)-mediated Ca2+ entry destabilizes AJs. Trpc(-/-) monolayers showed a 2.2-fold increase in vascular endothelial (VE)-cadherin cell-surface expression above wild-type (WT) monolayers. Thrombin increased endothelial permeability (evident by a 5-fold increase in interendothelial gap area and 60% decrease in transendothelial electrical resistance) in WT but not Trpc1(-/-) ECs. Trpc1(-/-) mice resisted the hyperpermeability effects of the edemagenic agonists used and exhibited 60% less endotoxin-induced mortality. Because sphingosine-1-phosphate (S1P) strengthens AJs, we determined if TRPC1 functioned by inhibiting SPHK1 activity, which generates S1P. Intriguingly, Trpc1(-/-) ECs or ECs transducing a TRPC1-inactive mutant showed a 1.5-fold increase in basal SPHK1 expression compared with WT ECs, resulting in a 2-fold higher S1P level. SPHK1 inhibitor SK1-I decreased basal transendothelial electrical resistance more in WT ECs (48 and 72% reduction at 20 and 50 mu M, respectively) than in Trpc1(-/-) ECs. However, SK1-I pretreatment rescued thrombin-induced EC permeability in Trpc1(-/-) ECs. Thus, TRPC1 suppression of basal SPHK1 activity enables EC-barrier destabilization by edemagenic agonists.-Tauseef, M., Farazuddin, M., Sukriti, S., Rajput, C., Meyer, J. O., Ramasamy, S. K., Mehta, D. Transient receptor potential channel 1 maintains adherens junction plasticity by suppressing sphingosine kinase 1 expression to induce endothelial hyperpermeability. FASEB J. 30, 102-110 (2016). www.fasebj.org	[Mehta, Dolly] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA; Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mehta, D (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, 835 S Wolcott Ave, Chicago, IL 60612 USA.	dmehta@uic.edu	Farazuddin, Mohammad/AAI-2580-2021	Baweja, Sukriti/0000-0002-8677-9857	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [HL-71794, HL-84153, HL-060678]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL060678, R01HL084153, R01HL071794, P01HL077806, T32HL007829] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grants HL-71794, HL-84153, and HL-060678. The authors thank I. S Ambudkar (NIH) for providing TRPC1 mutant constructs and V. Natarajan (University of Illinois, Chicago, IL, USA) for his gift of SPHK1 luciferase promoter. The authors also thank L. Birnbaumer (NIH) and A. Dietrich (Walther-Straub-Institute for Pharmacology and Toxicology, Munich, Germany) for providing TRPC1<SUP>-/-</SUP> mice.	Ahmmed GU, 2004, J BIOL CHEM, V279, P20941, DOI 10.1074/jbc.M313975200; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; BARNARD JW, 1995, J IMMUNOL, V155, P4876; Beech DJ, 2013, CIRC J, V77, P570, DOI 10.1253/circj.CJ-13-0154; Chavez A, 2015, J CELL SCI, V128, P878, DOI 10.1242/jcs.154476; Chavez A, 2011, INT REV CEL MOL BIO, V290, P205, DOI 10.1016/B978-0-12-386037-8.00001-6; Cioffi DL, 2006, MICROCIRCULATION, V13, P709, DOI 10.1080/10739680600930354; Cioffi DL, 2011, ANTIOXID REDOX SIGN, V15, P1567, DOI 10.1089/ars.2010.3740; Cioffi DL, 2009, ANTIOXID REDOX SIGN, V11, P765, DOI 10.1089/ARS.2008.2221; Daneshjou N, 2015, J CELL BIOL, V209, P181, DOI 10.1083/jcb.20140910803202015c; DebRoy A, 2014, J BIOL CHEM, V289, P24188, DOI 10.1074/jbc.M114.570051; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Dietrich A, 2005, PFLUG ARCH EUR J PHY, V451, P72, DOI 10.1007/s00424-005-1460-0; Dietrich A, 2010, THROMB HAEMOSTASIS, V103, P262, DOI 10.1160/TH09-08-0517; Earley S, 2015, PHYSIOL REV, V95, P645, DOI 10.1152/physrev.00026.2014; Gavard Julie, 2014, Cell Adh Migr, V8, P158; Goel M, 2002, J BIOL CHEM, V277, P48303, DOI 10.1074/jbc.M207882200; Gong H., 2015, J CLIN INVEST, V125, P1364; Gong HX, 2015, J CLIN INVEST, V125, P652, DOI 10.1172/JCI77701; Gong HX, 2014, J EXP MED, V211, P579, DOI 10.1084/jem.20131190; Harikumar KB, 2014, NAT IMMUNOL, V15, P231, DOI 10.1038/ni.2810; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Jho D, 2005, CIRC RES, V96, P1282, DOI 10.1161/01.RES.0000171894.03801.03; Kaneider NC, 2007, NAT IMMUNOL, V8, P1303, DOI 10.1038/ni1525; Kim EY, 2014, FASEB J, V28, P4347, DOI 10.1096/fj.14-251611; Kini V, 2010, J BIOL CHEM, V285, P33082, DOI 10.1074/jbc.M110.142034; Knezevic N, 2009, J EXP MED, V206, P2761, DOI 10.1084/jem.20090652; Komarova YA, 2012, MOL CELL, V48, P914, DOI 10.1016/j.molcel.2012.10.011; Kowalczyk Andrew P, 2012, Subcell Biochem, V60, P197, DOI 10.1007/978-94-007-4186-7_9; Kusaba T, 2010, P NATL ACAD SCI USA, V107, P19308, DOI 10.1073/pnas.1008544107; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Marfe G, 2015, MINI-REV MED CHEM, V15, P300, DOI 10.2174/1389557515666150227105415; Mathew B, 2011, FASEB J, V25, P3388, DOI 10.1096/fj.11-183970; McVerry BJ, 2004, AM J RESP CRIT CARE, V170, P987, DOI 10.1164/rccm.200405-684oc; Mehta D, 2005, J BIOL CHEM, V280, P17320, DOI 10.1074/jbc.M411674200; Mehta D, 2003, J BIOL CHEM, V278, P33492, DOI 10.1074/jbc.M302401200; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Mehta D, 2014, AM J PHYSIOL-LUNG C, V307, pL924, DOI 10.1152/ajplung.00318.2014; Natarajan V, 2013, AM J RESP CELL MOL, V49, P6, DOI 10.1165/rcmb.2012-0411TR; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Paria BC, 2004, AM J PHYSIOL-LUNG C, V287, pL1303, DOI 10.1152/ajplung.00240.2004; Paria BC, 2006, J BIOL CHEM, V281, P20715, DOI 10.1074/jbc.M600722200; Paugh SW, 2008, BLOOD, V112, P1382, DOI 10.1182/blood-2008-02-138958; Rajput C, 2013, J BIOL CHEM, V288, P4241, DOI 10.1074/jbc.M112.440396; Sammani S, 2010, AM J RESP CELL MOL, V43, P394, DOI 10.1165/rcmb.2009-0223OC; Singh I, 2007, J BIOL CHEM, V282, P7833, DOI 10.1074/jbc.M608288200; Song LB, 2011, CLIN CANCER RES, V17, P1839, DOI 10.1158/1078-0432.CCR-10-0720; Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974; St Amant EV, 2012, CIRC RES, V111, P739, DOI 10.1161/CIRCRESAHA.112.269654; Sukriti S, 2014, PULM CIRC, V4, P535, DOI 10.1086/677356; Sun XG, 2013, AM J PHYSIOL-LUNG C, V305, pL467, DOI 10.1152/ajplung.00010.2013; Sundivakkam PC, 2012, MOL PHARMACOL, V81, P510, DOI 10.1124/mol.111.074658; Tauseef M, 2008, CIRC RES, V103, P1164, DOI 10.1161/01.RES.0000338501.84810.51; Tauseef M, 2012, J EXP MED, V209, P1953, DOI 10.1084/jem.20111355; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Vogel SM, 2000, PHYSIOL GENOMICS, V4, P137, DOI 10.1152/physiolgenomics.2000.4.2.137; Wadgaonkar R, 2009, AM J PHYSIOL-LUNG C, V296, pL603, DOI 10.1152/ajplung.90357.2008; Xiong YQ, 2014, CURR TOP MICROBIOL, V378, P85, DOI 10.1007/978-3-319-05879-5_4; Zhao YDD, 2009, CIRC RES, V105, P696, DOI 10.1161/CIRCRESAHA.109.199778	60	14	18	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					102	110		10.1096/fj.15-275891	http://dx.doi.org/10.1096/fj.15-275891			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26316271	Green Published			2022-12-26	WOS:000367621000012
J	Fehr, N; Dietz, C; Polyhach, Y; von Hagens, T; Jeschke, G; Paulsen, H				Fehr, Niklas; Dietz, Carsten; Polyhach, Yevhen; von Hagens, Tona; Jeschke, Gunnar; Paulsen, Harald			Modeling of the N-terminal Section and the Lumenal Loop of Trimeric Light Harvesting Complex II (LHCII) by Using EPR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPHYLL-A/B-COMPLEX; AMINO-ACID-RESIDUES; CRYSTAL-STRUCTURE; PROTEIN; STATE; DEER; PHOTOPROTECTION; DOMAIN; CORE	The major light harvesting complex II (LHCII) of green plants plays a key role in the absorption of sunlight, the regulation of photosynthesis, and in preventing photodamage by excess light. The latter two functions are thought to involve the lumenal loop and the N-terminal domain. Their structure and mobility in an aqueous environment are only partially known. Electron paramagnetic resonance (EPR) has been used to measure the structure of these hydrophilic protein domains in detergent-solubilized LHCII. A new technique is introduced to prepare LHCII trimers in which only one monomer is spin-labeled. These heterogeneous trimers allow to measure intra-molecular distances within one LHCII monomer in the context of a trimer by using double electron-electron resonance (DEER). These data together with data from electron spin echo envelope modulation (ESEEM) allowed to model the N-terminal protein section, which has not been resolved in current crystal structures, and the lumenal loop domain. The N-terminal domain covers only a restricted area above the superhelix in LHCII, which is consistent with the "Velcro" hypothesis to explain thylakoid grana stacking (Standfuss, J., van Terwisscha Scheltinga, A. C., Lamborghini, M., and Kuhlbrandt, W. (2005) EMBOJ. 24, 919-928). The conformation of the lumenal loop domain is surprisingly different between LHCII monomers and trimers but not between complexes with and without neoxanthin bound.	[Fehr, Niklas; Dietz, Carsten; Paulsen, Harald] Johannes Gutenberg Univ Mainz, Dept Gen Bot, D-55128 Mainz, Germany; [Polyhach, Yevhen; von Hagens, Tona; Jeschke, Gunnar] ETH, Dept Phys Chem, CH-8093 Zurich, Switzerland	Johannes Gutenberg University of Mainz; Swiss Federal Institutes of Technology Domain; ETH Zurich	Paulsen, H (corresponding author), Johannes Gutenberg Univ Mainz, Dept Gen Bot, D-55128 Mainz, Germany.	paulsen@uni-mainz.de	Paulsen, Harald/D-3742-2011	Jeschke, Gunnar/0000-0001-6853-8585	Schweizer Nationalfonds Grant [200020_14441]; Deutsche Forschungsgemeinschaft Grant [PA 324/9-1]	Schweizer Nationalfonds Grant; Deutsche Forschungsgemeinschaft Grant(German Research Foundation (DFG))	This work was supported by Schweizer Nationalfonds Grant 200020_14441 (to G. J.) and Deutsche Forschungsgemeinschaft Grant PA 324/9-1 (to H. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Adamian L, 2005, PROTEINS, V59, P496, DOI 10.1002/prot.20456; Alonso-Garcia N, 2015, ACTA CRYSTALLOGR D, V71, P969, DOI 10.1107/S1399004715002485; Belgio E, 2013, PHYS CHEM CHEM PHYS, V15, P12253, DOI 10.1039/c3cp51925b; Bellafiore S, 2005, NATURE, V433, P892, DOI 10.1038/nature03286; Bleicken S, 2014, MOL CELL, V56, P496, DOI 10.1016/j.molcel.2014.09.022; CASHMORE AR, 1984, P NATL ACAD SCI-BIOL, V81, P2960, DOI 10.1073/pnas.81.10.2960; Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397; Dockter C, 2012, J BIOL CHEM, V287, P2915, DOI 10.1074/jbc.M111.307728; Dockter C, 2009, P NATL ACAD SCI USA, V106, P18485, DOI 10.1073/pnas.0906462106; Hagelueken G, 2012, APPL MAGN RESON, V42, P377, DOI 10.1007/s00723-012-0314-0; Hobe S, 2000, EUR J BIOCHEM, V267, P616, DOI 10.1046/j.1432-1327.2000.01060.x; HOBE S, 1994, EMBO J, V13, P3423, DOI 10.1002/j.1460-2075.1994.tb06647.x; Hobe S, 2006, J BIOL CHEM, V281, P25156, DOI 10.1074/jbc.M604828200; Hovmoller S, 2002, ACTA CRYSTALLOGR D, V58, P768, DOI 10.1107/S0907444902003359; Ilioaia C, 2011, J BIOL CHEM, V286, P27247, DOI 10.1074/jbc.M111.234617; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2005, J BIOL CHEM, V280, P18623, DOI 10.1074/jbc.M501171200; Jeschke G, 2004, APPL MAGN RESON, V26, P223, DOI 10.1007/BF03166574; Jeschke G, 2013, PROG NUCL MAG RES SP, V72, P42, DOI 10.1016/j.pnmrs.2013.03.001; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; Kucerka N, 2008, BIOPHYS J, V95, P2356, DOI 10.1529/biophysj.108.132662; Lillington JED, 2011, J MOL BIOL, V405, P427, DOI 10.1016/j.jmb.2010.10.053; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Minagawa J, 2011, BBA-BIOENERGETICS, V1807, P897, DOI 10.1016/j.bbabio.2010.11.005; Pan XW, 2013, CURR OPIN STRUC BIOL, V23, P515, DOI 10.1016/j.sbi.2013.04.004; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Polyhach Y, 2012, PHYS CHEM CHEM PHYS, V14, P10762, DOI 10.1039/c2cp41520h; Polyhach Y, 2011, PHYS CHEM CHEM PHYS, V13, P2356, DOI 10.1039/c0cp01865a; Raba M, 2014, STRUCTURE, V22, P769, DOI 10.1016/j.str.2014.03.011; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruhle W, 2004, METH MOL B, V274, P93; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Shabestari MH, 2014, BIOPHYS J, V106, P1349, DOI 10.1016/j.bpj.2013.11.4506; SHIMANOUCHI T, 1955, J CHEM PHYS, V23, P707, DOI 10.1063/1.1742083; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; SUGETA H, 1967, BIOPOLYMERS, V5, P673, DOI 10.1002/bip.1967.360050708; Sunku K, 2013, J BIOL CHEM, V288, P19796, DOI 10.1074/jbc.M113.456111; Volkov A, 2009, BIOPHYS J, V96, P1124, DOI 10.1016/j.bpj.2008.09.047; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Zubik M, 2011, BBA-BIOENERGETICS, V1807, P1237, DOI 10.1016/j.bbabio.2011.06.011	41	18	18	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26007	26020		10.1074/jbc.M115.669804	http://dx.doi.org/10.1074/jbc.M115.669804			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26316535	Green Published, hybrid			2022-12-26	WOS:000363527300022
J	Lin, YH; Doms, AG; Cheng, E; Kim, B; Evans, TR; Machner, MP				Lin, Yi-Han; Doms, Alexandra G.; Cheng, Eric; Kim, Byoungkwan; Evans, Timothy R.; Machner, Matthias P.			Host Cell-catalyzed S-Palmitoylation Mediates Golgi Targeting of the Legionella Ubiquitin Ligase GobX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PALMITOYLATION; PNEUMOPHILA GENOME; EFFECTOR PROTEINS; FATTY-ACYLATION; GTPASE RAB1; LOCALIZATION; SYSTEM; FAMILY; 2-BROMOPALMITATE; TRAFFICKING	The facultative intracellular pathogen Legionella pneumophila, the causative agent of Legionnaires disease, infects and replicates within human alveolar macrophages. L. pneumophila delivers almost 300 effector proteins into the besieged host cell that alter signaling cascades and create conditions that favor intracellular bacterial survival. In order for the effectors to accomplish their intracellular mission, their activity needs to be specifically directed toward the correct host cell protein or target organelle. Here, we show that the L. pneumophila effector GobX possesses E3 ubiquitin ligase activity that is mediated by a central region homologous to mammalian U-box domains. Furthermore, we demonstrate that GobX exploits host cell S-palmitoylation to specifically localize to Golgi membranes. The hydrophobic palmitate moiety is covalently attached to a cysteine residue at position 175, which is part of an amphipathic alpha-helix within the C-terminal region of GobX. Site-directed mutagenesis of cysteine 175 or residues on the hydrophobic face of the amphipathic helix strongly attenuated palmitoylation and Golgi localization of GobX. Together, our study provides evidence that the L. pneumophila effector GobX exploits two post-translational modification pathways of host cells, ubiquitination and S-palmitoylation.	[Lin, Yi-Han; Doms, Alexandra G.; Cheng, Eric; Kim, Byoungkwan; Evans, Timothy R.; Machner, Matthias P.] Eunice Kennedy Shriver NICHD, Microbial Pathogenesis Unit, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Machner, MP (corresponding author), Eunice Kennedy Shriver NICHD, Cell Biol & Metab Program, Bldg 18,Rm 101,18 Lib Dr, Bethesda, MD 20892 USA.	machnerm@mail.nih.gov	Lin, Yi-Han/Q-6352-2018	Machner, Matthias/0000-0002-6971-7451; Lin, Yi-Han/0000-0002-0469-8069	National Institutes of Health from the Intramural Research Program [1ZIAHD008893-04]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008893] Funding Source: NIH RePORTER	National Institutes of Health from the Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant 1ZIAHD008893-04 from the Intramural Research Program. The authors declare that they have no conflicts of interest with the contents of this article.	BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Brombacher E, 2009, J BIOL CHEM, V284, P4846, DOI 10.1074/jbc.M807505200; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Charron G, 2009, CURR OPIN CHEM BIOL, V13, P382, DOI 10.1016/j.cbpa.2009.07.010; Charron G, 2009, J AM CHEM SOC, V131, P4967, DOI 10.1021/ja810122f; Conibear E, 2010, J CELL SCI, V123, P4007, DOI 10.1242/jcs.059287; Conover GM, 2003, MOL MICROBIOL, V48, P305, DOI 10.1046/j.1365-2958.2003.03400.x; Davda D, 2013, ACS CHEM BIOL, V8, P1912, DOI 10.1021/cb400380s; de Felipe KS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000117; de Felipe KS, 2005, J BACTERIOL, V187, P7716, DOI 10.1128/JB.187.22.7716-7726.2005; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Derre I, 2004, INFECT IMMUN, V72, P3048, DOI 10.1128/IAI.72.5.3048-3053.2004; Dowen RH, 2009, J BIOL CHEM, V284, P15867, DOI 10.1074/jbc.M900519200; Ensminger AW, 2010, INFECT IMMUN, V78, P3905, DOI 10.1128/IAI.00344-10; Ensminger AW, 2009, CURR OPIN MICROBIOL, V12, P67, DOI 10.1016/j.mib.2008.12.004; FEELEY JC, 1979, J CLIN MICROBIOL, V10, P437, DOI 10.1128/JCM.10.4.437-441.1979; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Gaspar AH, 2014, P NATL ACAD SCI USA, V111, P4560, DOI 10.1073/pnas.1316376111; Ge JN, 2011, CELL MICROBIOL, V13, P1870, DOI 10.1111/j.1462-5822.2011.01710.x; Graham J M, 2001, Curr Protoc Cell Biol, VChapter 3, DOI [10.1002/0471143030.cb0303s04, 10.1002/0471143030.cb0305s06, 10.1002/0471143030.cb0304s04]; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Hammond GRV, 2014, J CELL BIOL, V205, P113, DOI 10.1083/jcb.201312072; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Henry SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095021; Hernandez JL, 2013, CURR OPIN CHEM BIOL, V17, P20, DOI 10.1016/j.cbpa.2012.11.023; Hicks SW, 2011, CELL HOST MICROBE, V10, P9, DOI 10.1016/j.chom.2011.06.003; Hsu FS, 2014, P NATL ACAD SCI USA, V111, P10538, DOI 10.1073/pnas.1402605111; Huang L, 2011, CELL MICROBIOL, V13, P227, DOI 10.1111/j.1462-5822.2010.01531.x; Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034; Ivanov SS, 2010, J BIOL CHEM, V285, P34686, DOI 10.1074/jbc.M110.170746; Kagan JC, 2004, J EXP MED, V199, P1201, DOI 10.1084/jem.20031706; Ku B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003082; Kubori T, 2008, MOL MICROBIOL, V67, P1307, DOI 10.1111/j.1365-2958.2008.06124.x; Kubori T, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00145; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lucas M, 2014, P NATL ACAD SCI USA, V111, pE3514, DOI 10.1073/pnas.1405391111; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; Martin BR, 2012, NAT METHODS, V9, P84, DOI [10.1038/NMETH.1769, 10.1038/nmeth.1769]; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; Neunuebel MR, 2012, J BACTERIOL, V194, P1389, DOI 10.1128/JB.06306-11; Neunuebel MR, 2011, SCIENCE, V333, P453, DOI 10.1126/science.1207193; Nimchuk Z, 2000, CELL, V101, P353, DOI 10.1016/S0092-8674(00)80846-6; O'Connor TJ, 2011, P NATL ACAD SCI USA, V108, P14733, DOI 10.1073/pnas.1111678108; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Ohno Y, 2012, MOL BIOL CELL, V23, P4543, DOI 10.1091/mbc.E12-05-0336; Price CTD, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00131; Ragaz C, 2008, CELL MICROBIOL, V10, P2416, DOI 10.1111/j.1462-5822.2008.01219.x; Reinicke AT, 2005, J BIOL CHEM, V280, P14620, DOI 10.1074/jbc.M500076200; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Schroeder G. N., 2015, INFECT IMMUN, DOI [10.1128/IAI.00785-1, DOI 10.1128/IAI.00785-1]; Shevchuk O, 2009, INT J MED MICROBIOL, V299, P489, DOI 10.1016/j.ijmm.2009.03.006; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Urwyler S, 2009, TRAFFIC, V10, P76, DOI 10.1111/j.1600-0854.2008.00851.x; Voth DE, 2012, FUTURE MICROBIOL, V7, P241, DOI [10.2217/fmb.11.150, 10.2217/FMB.11.150]; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Weber Stefan S., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020046; Yount JS, 2013, CURR OPIN CHEM BIOL, V17, P27, DOI 10.1016/j.cbpa.2012.11.008; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhou QJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4552	62	42	44	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25766	25781		10.1074/jbc.M115.637397	http://dx.doi.org/10.1074/jbc.M115.637397			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26316537	hybrid, Green Published			2022-12-26	WOS:000362962800047
J	Bonilha, L; Gleichgerrcht, E; Fridriksson, J; Rorden, C; Breedlove, JL; Nesland, T; Paulus, W; Helms, G; Focke, NK				Bonilha, Leonardo; Gleichgerrcht, Ezequiel; Fridriksson, Julius; Rorden, Chris; Breedlove, Jesse L.; Nesland, Travis; Paulus, Walter; Helms, Gunther; Focke, Niels K.			Reproducibility of the Structural Brain Connectome Derived from Diffusion Tensor Imaging	PLOS ONE			English	Article							TRACTOGRAPHY; NETWORKS; RECONSTRUCTION; CONNECTIVITY; VARIABILITY; RELIABILITY; DISORDERS; EPILEPSY; DISEASE; MR	Rationale Disruptions of brain anatomical connectivity are believed to play a central role in several neurological and psychiatric illnesses. The structural brain connectome is typically derived from diffusion tensor imaging (DTI), which may be influenced by methodological factors related to signal processing, MRI scanners and biophysical properties of neuroanatomical regions. In this study, we evaluated how these variables affect the reproducibility of the structural connectome. Methods Twenty healthy adults underwent 3 MRI scanning sessions (twice in the same MRI scanner and a third time in a different scanner unit) within a short period of time. The scanning sessions included similar T1 weighted and DTI sequences. Deterministic or probabilistic tractography was performed to assess link weight based on the number of fibers connecting gray matter regions of interest (ROI). Link weight and graph theory network measures were calculated and reproducibility was assessed through intra-class correlation coefficients, assuming each scanning session as a rater. Results Connectome reproducibility was higher with data from the same scanner. The probabilistic approach yielded larger reproducibility, while the individual variation in the number of tracked fibers from deterministic tractography was negatively associated with reproducibility. Links connecting larger and anatomically closer ROIs demonstrated higher reproducibility. In general, graph theory measures demonstrated high reproducibility across scanning sessions. Discussion Anatomical factors and tractography approaches can influence the reproducibility of the structural connectome and should be factored in the interpretation of future studies. Our results demonstrate that connectomemapping is a largely reproducible technique, particularly as it relates to the geometry of network architecture measured by graph theory methods.	[Bonilha, Leonardo; Gleichgerrcht, Ezequiel; Breedlove, Jesse L.; Nesland, Travis] Med Univ S Carolina, Dept Neurol, Charleston, SC 29425 USA; [Fridriksson, Julius] Univ S Carolina, Dept Commun Sci & Disorders, Columbia, SC 29208 USA; [Rorden, Chris] Univ S Carolina, Dept Psychol, Columbia, SC 29208 USA; [Paulus, Walter] Univ Gottingen, Dept Clin Neurophysiol, D-37073 Gottingen, Germany; [Helms, Gunther] Univ Gottingen, MR Res, Dept Cognit Neurol, D-37073 Gottingen, Germany; [Focke, Niels K.] Univ Tubingen, Dept Neurol Epileptol, Tubingen, Germany; [Focke, Niels K.] Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany	Medical University of South Carolina; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Gottingen; University of Gottingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Bonilha, L (corresponding author), Med Univ S Carolina, Dept Neurol, Charleston, SC 29425 USA.	bonilha@musc.edu	Focke, Niels/AAO-7012-2020; Helms, Gunther/A-9114-2010; Paulus, Walter/A-3544-2009	Helms, Gunther/0000-0002-1371-5123; Paulus, Walter/0000-0001-5549-8377; Breedlove, Jesse/0000-0002-8665-1204	National Institute on Deafness and Other Communication Disorders (NIDCD) [DC014021]; American Heart Association (AHA) [5SFDRN26030003]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC014021] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); American Heart Association (AHA)(American Heart Association); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported in part by the National Institute on Deafness and Other Communication Disorders (NIDCD), grant number DC014021 (LB) and by the American Heart Association (AHA), grant number 5SFDRN26030003 (LB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Besseling RMH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034125; Buchanan CR, 2014, NEUROIMAGE, V86, P231, DOI 10.1016/j.neuroimage.2013.09.054; Cheng H, 2012, NEUROIMAGE, V61, P1153, DOI 10.1016/j.neuroimage.2012.03.036; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Danielian LE, 2010, NEUROIMAGE, V49, P1572, DOI 10.1016/j.neuroimage.2009.08.062; Dauguet J, 2007, NEUROIMAGE, V37, P530, DOI 10.1016/j.neuroimage.2007.04.067; Deco G, 2014, NEURON, V84, P892, DOI 10.1016/j.neuron.2014.08.034; Duda JT, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00046; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fornito A, 2015, NAT REV NEUROSCI, V16, P159, DOI 10.1038/nrn3901; Fornito A, 2013, NEUROIMAGE, V80, P426, DOI 10.1016/j.neuroimage.2013.04.087; Garyfallidis E, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00175; Gerhard Stephan, 2011, Front Neuroinform, V5, P3, DOI 10.3389/fninf.2011.00003; Griffa A, 2013, NEUROIMAGE, V80, P515, DOI 10.1016/j.neuroimage.2013.04.056; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2010, J NEUROSCI METH, V194, P34, DOI 10.1016/j.jneumeth.2010.01.014; Heiervang E, 2006, NEUROIMAGE, V33, P867, DOI 10.1016/j.neuroimage.2006.07.037; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Kaiser M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00484; Lee CY, 2014, BRAIN RES, V1588, P73, DOI 10.1016/j.brainres.2014.09.002; Leergaard TB, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00014; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; Magnotta VA, 2012, BRAIN CONNECT, V2, P345, DOI 10.1089/brain.2012.0112; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Osborne J.W., 2008, BEST PRACT QUANT MET, DOI DOI 10.4135/9781412995627.D18; Quan MN, 2013, SCHIZOPHR RES, V145, P1, DOI 10.1016/j.schres.2012.11.028; Richardson MP, 2012, J NEUROL NEUROSUR PS, V83, P1238, DOI 10.1136/jnnp-2011-301944; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2013, NEUROIMAGE, V80, P53, DOI 10.1016/j.neuroimage.2013.03.023; Sporns O, 2012, NEUROIMAGE, V62, P881, DOI 10.1016/j.neuroimage.2011.08.085; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Tabesh A, 2011, MAGN RESON MED, V65, P823, DOI 10.1002/mrm.22655; Vaessen MJ, 2010, NEUROIMAGE, V51, P1106, DOI 10.1016/j.neuroimage.2010.03.011; Vollmar C, 2010, NEUROIMAGE, V51, P1384, DOI 10.1016/j.neuroimage.2010.03.046; Wang JY, 2012, NEUROIMAGE, V60, P1127, DOI 10.1016/j.neuroimage.2011.12.062; Wang R., 2007, P INT SOC MAG RESON, V15, P3720; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223	41	59	59	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135247	10.1371/journal.pone.0135247	http://dx.doi.org/10.1371/journal.pone.0135247			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332788	Green Submitted, Green Published, gold			2022-12-26	WOS:000360613800024
J	Del Chierico, F; Vernocchi, P; Petrucca, A; Paci, P; Fuentes, S; Pratico, G; Capuani, G; Masotti, A; Reddel, S; Russo, A; Vallone, C; Salvatori, G; Buffone, E; Signore, F; Rigon, G; Dotta, A; Miccheli, A; de Vos, WM; Dallapiccola, B; Putignani, L				Del Chierico, Federica; Vernocchi, Pamela; Petrucca, Andrea; Paci, Paola; Fuentes, Susana; Pratico, Giulia; Capuani, Giorgio; Masotti, Andrea; Reddel, Sofia; Russo, Alessandra; Vallone, Cristina; Salvatori, Guglielmo; Buffone, Elsa; Signore, Fabrizio; Rigon, Giuliano; Dotta, Andrea; Miccheli, Alfredo; de Vos, Willem M.; Dallapiccola, Bruno; Putignani, Lorenza			Phylogenetic and Metabolic Tracking of Gut Microbiota during Perinatal Development	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; PRETERM INFANTS; GENE-EXPRESSION; DELIVERY MODE; DIVERSITY; BACTERIAL; FECES; COMMUNITIES; SUCCESSION; ECOLOGY	The colonization and development of gut microbiota immediately after birth is highly variable and depends on several factors, such as delivery mode and modality of feeding during the first months of life. A cohort of 31 mother and neonate pairs, including 25 at-term caesarean (CS) and 6 vaginally (V) delivered neonates (DNs), were included in this study and 121 meconium/faecal samples were collected at days 1 through 30 following birth. Operational taxonomic units (OTUs) were assessed in 69 stool samples by phylogenetic microarray HITChip and inter- and intra-individual distributions were established by inter-OTUs correlation matrices and OTUs co-occurrence or co-exclusion networks. H-1-NMR metabolites were determined in 70 stool samples, PCA analysis was performed on 55 CS DNs samples, and metabolome/OTUs co-correlations were assessed in 45 CS samples, providing an integrated map of the early microbiota OTUs-metabolome. A microbiota "core" of OTUs was identified that was independent of delivery mode and lactation stage, suggesting highly specialized communities that act as seminal colonizers of microbial networks. Correlations among OTUs, metabolites, and OTUs-metabolites revealed metabolic profiles associated with early microbial ecological dynamics, maturation of milk components, and host physiology.	[Del Chierico, Federica; Vernocchi, Pamela; Petrucca, Andrea; Reddel, Sofia; Russo, Alessandra; Putignani, Lorenza] Bambino Gesu Pediat Hosp, IRCCS, Unit Metagen, Rome, Italy; [Vernocchi, Pamela] Univ Bologna, Interdipartimental Ctr Ind Res CIRI AGRIFOOD, Alma Mater Studiorum, Bologna, Italy; [Petrucca, Andrea] St Andrea Hosp, Dept Diagnost Sci, Rome, Italy; [Paci, Paola] CNR, Inst Syst Anal & Informat Antonio Ruberti, Rome, Italy; [Fuentes, Susana; de Vos, Willem M.] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands; [Pratico, Giulia; Capuani, Giorgio; Miccheli, Alfredo] Univ Roma La Sapienza, Dept Chem, I-00185 Rome, Italy; [Masotti, Andrea] Bambino Gesu Pediat Hosp, IRCCS, Rome, Italy; [Vallone, Cristina; Signore, Fabrizio; Rigon, Giuliano] San Camillo Hosp, Dept Obstet & Gyneacol, Rome, Italy; [Salvatori, Guglielmo; Dotta, Andrea] Bambino Gesu Pediat Hosp, Dept Neonatol, IRCCS, Rome, Italy; [Buffone, Elsa] San Camillo Hosp, Dept Neonatol, Rome, Italy; [de Vos, Willem M.] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland; [de Vos, Willem M.] Univ Helsinki, Dept Bacteriol & Immunol, Helsinki, Finland; [Dallapiccola, Bruno] Bambino Gesu Pediat Hosp, IRCCS, Sci Directorate, Rome, Italy; [Putignani, Lorenza] Bambino Gesu Pediat Hosp, IRCCS, Unit Parasitol, Rome, Italy	IRCCS Bambino Gesu; University of Bologna; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Consiglio Nazionale delle Ricerche (CNR); Wageningen University & Research; Sapienza University Rome; IRCCS Bambino Gesu; IRCCS Bambino Gesu; University of Helsinki; University of Helsinki; IRCCS Bambino Gesu; IRCCS Bambino Gesu	Putignani, L (corresponding author), Bambino Gesu Pediat Hosp, IRCCS, Unit Metagen, Rome, Italy.	lorenza.putignani@opbg.net	Putignani, Lorenza/K-3409-2016; Del Chierico, Federica/J-4373-2016; Masotti, Andrea/D-5306-2009; Capuani, Giorgio/B-7738-2015; Del Chierico, Federica/AAS-4078-2020; Vernocchi, Pamela/K-2534-2016; Pratico, Giulia/B-4824-2015	Putignani, Lorenza/0000-0003-0134-2830; Del Chierico, Federica/0000-0002-4204-4736; Masotti, Andrea/0000-0002-2511-5088; Capuani, Giorgio/0000-0002-6992-2578; Del Chierico, Federica/0000-0002-4204-4736; Vernocchi, Pamela/0000-0001-8007-5632; Pratico, Giulia/0000-0003-4604-8838	Ministry of Health, Ricerca Corrente Bambino Gesu Children's Hospital; Netherlands Organization for Scientific Research (NWO)	Ministry of Health, Ricerca Corrente Bambino Gesu Children's Hospital; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was supported by a grant from the Ministry of Health, Ricerca Corrente (RC201302P002991) Bambino Gesu Children's Hospital and Spinoza and Gravity grants to WMdV of the Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlerberth I, 2009, ACTA PAEDIATR, V98, P229, DOI 10.1111/j.1651-2227.2008.01060.x; Avershina E, 2014, FEMS MICROBIOL ECOL, V87, P280, DOI 10.1111/1574-6941.12223; Azad MB, 2013, CAN MED ASSOC J, V185, P385, DOI 10.1503/cmaj.121189; Ballard O, 2013, PEDIATR CLIN N AM, V60, P49, DOI 10.1016/j.pcl.2012.10.002; BENNO Y, 1986, MICROBIOL IMMUNOL, V30, P521, DOI 10.1111/j.1348-0421.1986.tb02978.x; Brasili E, 2013, J NUTR, V143, P1549, DOI 10.3945/jn.113.177105; CATASSI C, 1995, J PEDIATR GASTR NUTR, V21, P383, DOI 10.1097/00005176-199511000-00003; Chassard C, 2014, CURR OPIN BIOTECH, V26, P141, DOI 10.1016/j.copbio.2013.12.012; Chassard C, 2013, CURR OPIN CLIN NUTR, V16, P453, DOI 10.1097/MCO.0b013e3283619e63; Chisholm RA, 2010, P NATL ACAD SCI USA, V107, P15821, DOI 10.1073/pnas.1009387107; Chow J, 2014, J PROTEOME RES, V13, P2534, DOI 10.1021/pr500011w; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Davila AM, 2013, PHARMACOL RES, V68, P95, DOI 10.1016/j.phrs.2012.11.005; Del Chierico F, 2012, J PROTEOMICS, V75, P4580, DOI 10.1016/j.jprot.2012.02.018; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Duggan Christopher G, 2008, NUTR PEDIAT BASIC SC; Duncan SH, 2007, APPL ENVIRON MICROB, V73, P1073, DOI 10.1128/AEM.02340-06; Fallani M, 2010, J PEDIATR GASTR NUTR, V51, P77, DOI 10.1097/MPG.0b013e3181d1b11e; Favier CF, 2003, ANAEROBE, V9, P219, DOI 10.1016/j.anaerobe.2003.07.001; Favier CF, 2002, APPL ENVIRON MICROB, V68, P219, DOI 10.1128/AEM.68.1.219-226.2002; Fouhy F, 2012, GUT MICROBES, V3, P203, DOI 10.4161/gmic.20169; Gosalbes MJ, 2013, CLIN EXP ALLERGY, V43, P198, DOI 10.1111/cea.12063; Greiner T, 2011, TRENDS ENDOCRIN MET, V22, P117, DOI 10.1016/j.tem.2011.01.002; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Gueimonde M, 2006, J PEDIATR GASTR NUTR, V42, P166, DOI 10.1097/01.mpg.0000189346.25172.fd; He Y, 2014, MUCOSAL IMMUNOL, V7, P1326, DOI 10.1038/mi.2014.20; Jackson JE, 1991, USERS GUIDE PRINCIPA; Jacobs DM, 2008, NMR BIOMED, V21, P615, DOI 10.1002/nbm.1233; Jacquot A, 2011, J PEDIATR-US, V158, P390, DOI 10.1016/j.jpeds.2010.09.007; Jahan-Mihan A, 2011, NUTRIENTS, V3, P574, DOI 10.3390/nu3050574; Jakobsson HE, 2014, GUT, V63, P559, DOI 10.1136/gutjnl-2012-303249; Jalanka-Tuovinen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023035; Jeraldo P, 2012, P NATL ACAD SCI USA, V109, P9692, DOI 10.1073/pnas.1206721109; Jia W, 2008, NAT REV DRUG DISCOV, V7, P123, DOI 10.1038/nrd2505; Jimenez E, 2005, CURR MICROBIOL, V51, P270, DOI 10.1007/s00284-005-0020-3; Joseph H, MECH SUCCESSION NATU; Jost T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044595; Khodayar-Pardo P, 2014, J PERINATOL, V34, P599, DOI 10.1038/jp.2014.47; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Lahti L, 2011, IEEE ACM T COMPUT BI, V8, P217, DOI 10.1109/TCBB.2009.38; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; LaTuga MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027858; Le Gall G, 2011, J PROTEOME RES, V10, P4208, DOI 10.1021/pr2003598; Lindahl Paul A., 2009, V6, P133, DOI [10.1039/BK9781847559159-00133, 10.1039/9781847559159-00133]; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; MacFarlane G.T., 1991, LARGE INTESTINE PHYS, P51; Macfarlane GT, 1997, SCAND J GASTROENTERO, V32, P3, DOI 10.1080/00365521.1997.11720708; Madan JC, 2012, CURR OPIN PEDIATR, V24, P753, DOI 10.1097/MOP.0b013e32835a1ac8; Magne F, 2006, FEMS MICROBIOL ECOL, V57, P128, DOI 10.1111/j.1574-6941.2006.00097.x; Marchesi JR, 2007, J PROTEOME RES, V6, P546, DOI 10.1021/pr060470d; Marcobal A, 2010, J AGR FOOD CHEM, V58, P5334, DOI 10.1021/jf9044205; Martinez I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069621; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Matschiavelli N, 2012, J BACTERIOL, V194, P5377, DOI 10.1128/JB.00881-12; Matthews TJ, 2014, ECOL EVOL, V4, P2263, DOI 10.1002/ece3.1092; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; Miller TL, 1996, APPL ENVIRON MICROB, V62, P1589, DOI 10.1128/AEM.62.5.1589-1592.1996; Moles L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066986; Mondot S, 2013, DIGEST DIS, V31, P278, DOI 10.1159/000354678; Mshvildadze M, 2010, J PEDIATR-US, V156, P20, DOI 10.1016/j.jpeds.2009.06.063; Nauta AJ, 2013, AM J CLIN NUTR, V98, p586S, DOI 10.3945/ajcn.112.039644; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Nyangale EP, 2012, J PROTEOME RES, V11, P5573, DOI 10.1021/pr300637d; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Park HK, 2005, J MICROBIOL, V43, P345; Pettersson J, 2008, BIOL PHARM BULL, V31, P1192, DOI 10.1248/bpb.31.1192; Pfefferle Petra Ina, 2014, F1000Prime Rep, V6, P11, DOI 10.12703/P6-11; Putignani L, 2014, PEDIATR RES, V76, P2, DOI 10.1038/pr.2014.49; Ragsdale SW, 2006, CHEM REV, V106, P3317, DOI 10.1021/cr0503153; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; RASMUSSEN HS, 1988, SCAND J GASTROENTERO, V23, P178, DOI 10.3109/00365528809103964; Relman DA, 2012, NUTR REV, V70, pS2, DOI 10.1111/j.1753-4887.2012.00489.x; Salonen A, 2013, J NUTR, V143, P1549, DOI [10.3945/jn.113.177105, DOI 10.3945/JN.113.177105]; Saric J, 2008, J PROTEOME RES, V7, P352, DOI 10.1021/pr070340k; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; SAVAGE DC, 1972, AM J CLIN NUTR, V25, P1372; Schwiertz A, 2003, PEDIATR RES, V54, P393, DOI 10.1203/01.PDR.0000078274.74607.7A; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Sellitto M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033387; Stecher B, 2011, CURR OPIN MICROBIOL, V14, P82, DOI 10.1016/j.mib.2010.10.003; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; Tan PK, 2003, NUCLEIC ACIDS RES, V31, P5676, DOI 10.1093/nar/gkg763; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Vaishampayan PA, 2010, GENOME BIOL EVOL, V2, P53, DOI 10.1093/gbe/evp057; Valles Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004406; Walter J, 2011, ANNU REV MICROBIOL, V65, P411, DOI 10.1146/annurev-micro-090110-102830; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Young VB, 2012, CURR OPIN GASTROEN, V28, P63, DOI 10.1097/MOG.0b013e32834d61e9; Zaneveld J, 2008, CURR OPIN CHEM BIOL, V12, P109, DOI 10.1016/j.cbpa.2008.01.015	89	63	63	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137347	10.1371/journal.pone.0137347	http://dx.doi.org/10.1371/journal.pone.0137347			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332837	gold, Green Published			2022-12-26	WOS:000360613800125
J	Saritas-Yildirim, B; Pliner, HA; Ochoa, A; Silva, EM				Saritas-Yildirim, Banu; Pliner, Hannah A.; Ochoa, Angelica; Silva, Elena M.			Genome-Wide Identification and Expression of Xenopus F-Box Family of Proteins	PLOS ONE			English	Article							CELL-CYCLE; UBIQUITIN LIGASES; DNA-DAMAGE; DEGRADATION; SCF; DATABASE; SEL-10; NOTCH; DIFFERENTIATION; HYBRIDIZATION	Protein degradation via the multistep ubiquitin/26S proteasome pathway is a rapid way to alter the protein profile and drive cell processes and developmental changes. Many key regulators of embryonic development are targeted for degradation by E3 ubiquitin ligases. The most studied family of E3 ubiquitin ligases is the SCF ubiquitin ligases, which use F-box adaptor proteins to recognize and recruit target proteins. Here, we used a bioinformatics screen and phylogenetic analysis to identify and annotate the family of F-box proteins in the Xenopus tropicalis genome. To shed light on the function of the F-box proteins, we analyzed expression of F-box genes during early stages of Xenopus development. Many F-box genes are broadly expressed with expression domains localized to diverse tissues including brain, spinal cord, eye, neural crest derivatives, somites, kidneys, and heart. All together, our genome-wide identification and expression profiling of the Xenopus F-box family of proteins provide a foundation for future research aimed to identify the precise role of F-box dependent E3 ubiquitin ligases and their targets in the regulatory circuits of development.	[Saritas-Yildirim, Banu; Pliner, Hannah A.; Ochoa, Angelica; Silva, Elena M.] Georgetown Univ, Dept Biol, Washington, DC 20057 USA	Georgetown University	Silva, EM (corresponding author), Georgetown Univ, Dept Biol, Washington, DC 20057 USA.	elena.silva@georgetown.edu	; Pliner, Hannah Andersen/F-3608-2015	Klymkowsky, Mike/0000-0001-5816-9771; Ochoa, Angelica/0000-0003-0615-1654; Pliner, Hannah Andersen/0000-0003-1484-6501	National Institutes of Health [HD060698]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD060698] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health #HD060698 to EMS, http://www.nichd.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Asada S, 2008, INT J MOL MED, V22, P95; Boix-Perales H, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-27; Bowes JB, 2010, NUCLEIC ACIDS RES, V38, pD607, DOI 10.1093/nar/gkp953; Craig KL, 1999, PROG BIOPHYS MOL BIO, V72, P299, DOI 10.1016/S0079-6107(99)00010-3; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Fotovati A, 2011, J ANAT, V218, P668, DOI 10.1111/j.1469-7580.2011.01370.x; Gagne JM, 2002, P NATL ACAD SCI USA, V99, P11519, DOI 10.1073/pnas.162339999; Galli F, 2010, J CELL SCI, V123, P2423, DOI 10.1242/jcs.061010; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Harper JW, 2012, MOL CELL PROTEOMICS, V11, P1541, DOI 10.1074/mcp.R112.021154; HEMMATIBRIVANLOU A, 1990, DEVELOPMENT, V110, P325; Ho MS, 2008, CELL MOL LIFE SCI, V65, P1977, DOI 10.1007/s00018-008-7592-6; Jia LJ, 2009, PIGM CELL MELANOMA R, V22, P518, DOI 10.1111/j.1755-148X.2009.00611.x; Jin JP, 2005, METHOD ENZYMOL, V399, P287, DOI 10.1016/S0076-6879(05)99020-4; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Karpinka JB, 2015, NUCLEIC ACIDS RES, V43, pD756, DOI 10.1093/nar/gku956; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Kondo T, 2004, J BIOL CHEM, V279, P27315, DOI 10.1074/jbc.M314023200; Kuiken HJ, 2012, J CELL MOL MED, V16, P2140, DOI 10.1111/j.1582-4934.2012.01524.x; Lander R, 2011, J CELL BIOL, V194, P17, DOI 10.1083/jcb.201012085; Liu J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000527; Matsuda Y, 2015, CYTOGENET GENOME RES, V145, P187, DOI 10.1159/000381292; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Pontius J, 2003, NCBI HDB BETHESDA NA; RAMBAUT A, 2006, FIGTREE; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Saritas-Yildirim B, 2014, GENESIS, V52, P287, DOI 10.1002/dvg.22771; Snyder JL, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-15; Uno Y, 2013, HEREDITY, V111, P430, DOI 10.1038/hdy.2013.65; Vernon AE, 2006, DEVELOPMENT, V133, P3359, DOI 10.1242/dev.02504; von Arnim A G, 2001, Sci STKE, V2001, ppe2, DOI 10.1126/stke.2001.97.pe2; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Wu GY, 2001, MOL CELL BIOL, V21, P7403, DOI 10.1128/MCB.21.21.7403-7415.2001	42	2	2	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136929	10.1371/journal.pone.0136929	http://dx.doi.org/10.1371/journal.pone.0136929			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327321	gold, Green Submitted, Green Published			2022-12-26	WOS:000360437700073
J	Shrestha, A; Carraro, G; El Agha, E; Mukhametshina, R; Chao, CM; Rizvanov, A; Barreto, G; Bellusci, S				Shrestha, Amit; Carraro, Gianni; El Agha, Elie; Mukhametshina, Regina; Chao, Cho-Ming; Rizvanov, Albert; Barreto, Guillermo; Bellusci, Saverio			Generation and Validation of miR-142 Knock Out Mice	PLOS ONE			English	Article							LUNG DEVELOPMENT; MICRORNAS; DIFFERENTIATION; CELLS; P300	microRNA-142 (miR-142) is an important regulator of many biological processes and associated signaling pathways during embryonic development, homeostasis and disease. The miR-142 hairpin gives rise to the "guide strand" miR-142-3p and the sister "passenger" strand miR-142-5p. miR-142-3p has been shown to play critical, non-redundant functions in the development of the hematopoietic lineage. We have recently reported that miR-142-3p is critical for the control of Wnt signaling in the mesenchyme of the developing lung. miR-142-5p has been proposed to control adaptive growth in cardiomyocytes postnatally and its increase is associated with extensive apoptosis and cardiac dysfunction in a murine heart failure model. Using homologous recombination, we now report the generation and validation of miR-142-null mice. miR-142-null mice show a significant decrease in th expression levels of both the 3p and 5p isoforms. The expression of Bzrap1, a gene immediately flanking miR-142 is not altered while the expression of a long non-coding RNA embedded within the miR-142 gene is decreased. miR-142-null newborn pups appear normal and are normally represented indicating absence of embryonic lethality. At embryonic day 18.5, miR-142-null lungs display increased Wnt signaling associated with the up-regulation of Apc and p300, two previously reported targets of miR-142-3p and -5p, respectively. Adult miR-142-null animals display impaired hematopoietic lineage formation identical to previously reported miR-142 gene trap knockdown mice. We report, for the first time, the homologous recombination-based miR-142-null mice that will be useful for the scientific community working on the diverse biological functions of miR-142.	[Shrestha, Amit; El Agha, Elie; Mukhametshina, Regina; Chao, Cho-Ming; Bellusci, Saverio] Univ Giessen, Excellence Cluster Cardiopulm Syst, German Ctr Lung Res, Giessen, Hessen, Germany; [Shrestha, Amit; El Agha, Elie; Mukhametshina, Regina; Chao, Cho-Ming; Bellusci, Saverio] Marburg Lung Ctr, Giessen, Hessen, Germany; [Carraro, Gianni] Cedars Sinai Med Ctr, Lung & Regenerat Med Inst, Dept Med, Los Angeles, CA 90048 USA; [Rizvanov, Albert; Bellusci, Saverio] Kazan Volga Reg Fed Univ, Inst Fundamental Med & Biol, Kazan, Russia; [Barreto, Guillermo] Max Planck Inst, LOEWE Res Grp Lung Canc Epigenet, Bad Nauheim, Germany; [Bellusci, Saverio] Univ So Calif, Keck Sch Med, Saban Res Inst Childrens Hosp Los Angeles, Dev Biol Program,Div Surg, Los Angeles, CA 90033 USA	Justus Liebig University Giessen; Cedars Sinai Medical Center; Kazan Federal University; Max Planck Society; Children's Hospital Los Angeles; University of Southern California	Bellusci, S (corresponding author), Univ Giessen, Excellence Cluster Cardiopulm Syst, German Ctr Lung Res, Giessen, Hessen, Germany.	Saverio.Bellusci@innere.med.uni-giessen.de	Chao, Cho-Ming/GVT-4288-2022; Rizvanov, Albert/H-4486-2013; Barreto, Guillermo/U-5718-2017	Rizvanov, Albert/0000-0002-9427-5739; Barreto, Guillermo/0000-0002-7777-4712; Carraro, Gianni/0000-0003-0824-7692; El Agha, Elie/0000-0001-7504-3417	Deutsche Forschungsgemeinschaft [BE4443/4-1, BE4443/6-1]; Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz; Universtat Klinikum Giessen Marburg; University of Giessen Marburg Lung Center; competitive growth of Kazan Federal University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz; Universtat Klinikum Giessen Marburg; University of Giessen Marburg Lung Center; competitive growth of Kazan Federal University	SB was supported by grants from the Deutsche Forschungsgemeinschaft (BE4443/4-1 and BE4443/6-1), Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz, the Universtat Klinikum Giessen Marburg, the University of Giessen Marburg Lung Center, as well as the program of competitive growth of Kazan Federal University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Carraro G, 2014, DEVELOPMENT, V141, P1272, DOI 10.1242/dev.105908; Chapnik E, 2014, ELIFE, V3, DOI 10.7554/eLife.01964; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chiou GY, 2013, MOL CELL, V52, P693, DOI 10.1016/j.molcel.2013.11.009; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fan HB, 2014, BLOOD, V124, P1320, DOI 10.1182/blood-2013-12-545012; Herriges MJ, 2014, GENE DEV, V28, P1363, DOI 10.1101/gad.238782.114; Isobe T, 2014, ELIFE, V3, DOI 10.7554/eLife.01977; Kaduthanam S, 2013, LUNG CANCER, V80, P223, DOI 10.1016/j.lungcan.2013.01.013; Kramer NJ, 2015, BLOOD, V125, P3720, DOI 10.1182/blood-2014-10-603951; Merkerova M, 2008, EUR J HAEMATOL, V81, P304, DOI 10.1111/j.1600-0609.2008.01111.x; Nimmo R, 2013, DEV CELL, V26, P237, DOI 10.1016/j.devcel.2013.06.023; Sharma S, 2012, EMBO MOL MED, V4, P617, DOI 10.1002/emmm.201200234; Sun YP, 2011, BLOOD, V117, P6172, DOI 10.1182/blood-2010-12-325647; Sun YN, 2000, P NATL ACAD SCI USA, V97, P12613, DOI 10.1073/pnas.220158597; Trobaugh DW, 2014, NATURE, V506, P245, DOI 10.1038/nature12869; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494	19	20	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136913	10.1371/journal.pone.0136913	http://dx.doi.org/10.1371/journal.pone.0136913			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327117	gold, Green Published, Green Submitted			2022-12-26	WOS:000360437700071
J	Suzuki, H; Misaki, M; Krueger, F; Bodurka, J				Suzuki, Hideo; Misaki, Masaya; Krueger, Frank; Bodurka, Jerzy			Neural Responses to Truth Telling and Risk Propensity under Asymmetric Information	PLOS ONE			English	Article							THEORY-OF-MIND; DECISION-MAKING; FUNCTIONAL CONNECTIVITY; BASOLATERAL AMYGDALA; SOCIAL INFORMATION; PREFRONTAL CORTEX; TRUST; BRAIN; AUTISM; TRUSTWORTHINESS	Trust is multi-dimensional because it can be characterized by subjective trust, trust antecedent, and behavioral trust. Previous research has investigated functional brain responses to subjective trust (e.g., a judgment of trustworthiness) or behavioral trust (e.g., decisions to trust) in perfect information, where all relevant information is available to all participants. In contrast, we conducted a novel examination of the patterns of functional brain activity to a trust antecedent, specifically truth telling, in asymmetric information, where one individual has more information than others, with the effect of varying risk propensity. We used functional magnetic resonance imaging (fMRI) and recruited 13 adults, who played the Communication Game, where they served as the "Sender" and chose either truth telling (true advice) or lie telling (false advice) regarding the best payment allocation for their partner. Our behavioral results revealed that subjects with recreational high risk tended to choose true advice. Moreover, fMRI results yielded that the choices of true advice were associated with increased cortical activation in the anterior rostral medial and frontopolar prefrontal cortices, middle frontal cortex, temporoparietal junction, and precuneus. Furthermore, when we specifically evaluated a role of the bilateral amygdala as the region of interest (ROI), decreased amygdala response was associated with high risk propensity, regardless of truth telling or lying. In conclusion, our results have implications for how differential functions of the cortical areas may contribute to the neural processing of truth telling.	[Suzuki, Hideo; Misaki, Masaya; Bodurka, Jerzy] Laureate Inst Brain Res, Tulsa, OK 74136 USA; [Krueger, Frank] George Mason Univ, Mol Neurosci Dept, Fairfax, VA 22030 USA; [Bodurka, Jerzy] Univ Oklahoma, Coll Engn, Norman, OK 73019 USA	Laureate Institute for Brain Research, Inc.; George Mason University; University of Oklahoma System; University of Oklahoma - Norman	Bodurka, J (corresponding author), Laureate Inst Brain Res, Tulsa, OK 74136 USA.	jbodurka@laureateinstitute.org	Misaki, Masaya/H-3042-2013	Misaki, Masaya/0000-0002-6829-4311	Laureate Institute for Brain Research; William K. Warren Foundation	Laureate Institute for Brain Research; William K. Warren Foundation	This research was supported by the Laureate Institute for Brain Research and the William K. Warren Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2001, J COGNITIVE NEUROSCI, V13, P232, DOI 10.1162/089892901564289; Ahn HN, 2001, J COUNS PSYCHOL, V48, P251, DOI 10.1037//0022-0167.48.3.251; AKERLOF GA, 1970, Q J ECON, V84, P488, DOI 10.2307/1879431; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Baas D, 2008, NEUROIMAGE, V40, P719, DOI 10.1016/j.neuroimage.2007.12.039; Bachevalier J, 1997, EXP BRAIN RES, V115, P430, DOI 10.1007/PL00005713; Barbas H, 1999, J COMP NEUROL, V410, P343, DOI 10.1002/(SICI)1096-9861(19990802)410:3<343::AID-CNE1>3.0.CO;2-1; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Bodurka J, 2004, MAGNET RESON MED, V51, P165, DOI 10.1002/mrm.10693; Bohnet I, 2004, J ECON BEHAV ORGAN, V55, P467, DOI 10.1016/j.jebo.2003.11.004; Braver TS, 2002, NEUROIMAGE, V15, P523, DOI 10.1006/nimg.2001.1019; Broekhof E, 2015, J AUTISM DEV DISORD, V45, P2035, DOI 10.1007/s10803-015-2363-3; Burnett S, 2009, J COGNITIVE NEUROSCI, V21, P1736, DOI 10.1162/jocn.2009.21121; Burnett S, 2009, EUR J NEUROSCI, V29, P1294, DOI 10.1111/j.1460-9568.2009.06674.x; Carrington SJ, 2009, HUM BRAIN MAPP, V30, P2313, DOI 10.1002/hbm.20671; Ciaramidaro A, 2007, NEUROPSYCHOLOGIA, V45, P3105, DOI 10.1016/j.neuropsychologia.2007.05.011; Cook KS, 2005, SOC PSYCHOL QUART, V68, P121, DOI 10.1177/019027250506800202; Couture SM, 2006, SCHIZOPHRENIA BULL, V32, pS44, DOI 10.1093/schbul/sbl029; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; CRAWFORD VP, 1982, ECONOMETRICA, V50, P1431, DOI 10.2307/1913390; Crowley TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012835; Das TK, 2004, J BUS PSYCHOL, V19, P85, DOI 10.1023/B:JOBU.0000040274.23551.1b; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; De Jong BA, 2012, J APPL PSYCHOL, V97, P391, DOI 10.1037/a0026483; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; Dirks KT, 1999, J APPL PSYCHOL, V84, P445, DOI 10.1037/0021-9010.84.3.445; Eckert MA, 2009, HUM BRAIN MAPP, V30, P2530, DOI 10.1002/hbm.20688; Engell AD, 2007, J COGNITIVE NEUROSCI, V19, P1508, DOI 10.1162/jocn.2007.19.9.1508; First M., 2010, STRUCTURED CLIN INTE; Freeman JB, 2014, J NEUROSCI, V34, P10573, DOI 10.1523/JNEUROSCI.5063-13.2014; Friston K, 2012, NEUROIMAGE, V61, P1300, DOI 10.1016/j.neuroimage.2012.04.018; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Ganis G, 2003, CEREB CORTEX, V13, P830, DOI 10.1093/cercor/13.8.830; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Gneezy U, 2005, AM ECON REV, V95, P384, DOI 10.1257/0002828053828662; Gobbini MI, 2007, J COGNITIVE NEUROSCI, V19, P1803, DOI 10.1162/jocn.2007.19.11.1803; Greene JD, 2009, P NATL ACAD SCI USA, V106, P12506, DOI 10.1073/pnas.0900152106; Hansen M. H., 2002, INT FOOD AGRIBUS MAN, V5, P41, DOI [10.1016/s1096-7508(02)00069-1, DOI 10.1016/S1096-7508(02)00069-1]; Holt CA, 2002, AM ECON REV, V92, P1644, DOI 10.1257/000282802762024700; Hooker CI, 2011, J ABNORM PSYCHOL, V120, P98, DOI 10.1037/a0020630; Jaarsma P, 2012, MED HEALTH CARE PHIL, V15, P271, DOI 10.1007/s11019-011-9363-7; Joe GW, 2001, PSYCHIATR SERV, V52, P1223, DOI 10.1176/appi.ps.52.9.1223; Kana RK, 2009, SOC NEUROSCI-UK, V4, P135, DOI 10.1080/17470910802198510; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Koscik TR, 2011, NEUROPSYCHOLOGIA, V49, P602, DOI 10.1016/j.neuropsychologia.2010.09.023; Krueger F, 2008, PHILOS T R SOC B, V363, P3859, DOI 10.1098/rstb.2008.0165; Krueger F, 2007, P NATL ACAD SCI USA, V104, P20084, DOI 10.1073/pnas.0710103104; Krupnick JL, 1996, J CONSULT CLIN PSYCH, V64, P532, DOI 10.1037/0022-006X.64.3.532; Lambert MJ, 1994, ENCYCL PSYCHOTHER, P143; LaPorta R, 1997, AM ECON REV, V87, P333; Ledley DR, 2010, MAKING COGNITIVE BEH, V2nd; Li CSR, 2009, ALCOHOL CLIN EXP RES, V33, P740, DOI 10.1111/j.1530-0277.2008.00891.x; Lissek S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002023; Luborsky L, 1997, NIDA Res Monogr, V165, P233; Lusher D, 2014, SMALL GR RES, V45, P3, DOI 10.1177/1046496413510362; Mahy CEV, 2014, DEV COGN NEUROS-NETH, V9, P68, DOI 10.1016/j.dcn.2014.01.002; Moretto G, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00593; NAYYAR PR, 1990, STRATEGIC MANAGE J, V11, P513, DOI 10.1002/smj.4250110703; O'Nions E, 2014, DEVELOPMENTAL SCI, V17, P786, DOI 10.1111/desc.12167; Orsini CA, 2015, J NEUROSCI, V35, P1368, DOI 10.1523/JNEUROSCI.3586-14.2015; PARKS CD, 1995, J CONFLICT RESOLUT, V39, P718, DOI 10.1177/0022002795039004006; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pinkham AE, 2008, SCHIZOPHR RES, V99, P164, DOI 10.1016/j.schres.2007.10.024; Platek SM, 2009, NEUROPSYCHOLOGIA, V47, P289, DOI 10.1016/j.neuropsychologia.2008.07.018; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rissman J, 2004, NEUROIMAGE, V23, P752, DOI 10.1016/j.neuroimage.2004.06.035; Rode J, 2010, GAME ECON BEHAV, V68, P325, DOI 10.1016/j.geb.2009.05.008; Safran J. D., 2000, NEGOTIATING THERAPEU; Said CP, 2009, J COGNITIVE NEUROSCI, V21, P519, DOI 10.1162/jocn.2009.21041; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Soane E, 2010, J RISK RES, V13, P303, DOI 10.1080/13669870902987024; Sommer M, 2007, NEUROIMAGE, V35, P1378, DOI 10.1016/j.neuroimage.2007.01.042; Staples DS, 2008, INFORM SYST J, V18, P617, DOI 10.1111/j.1365-2575.2007.00244.x; Talairach J., 1988, COPLANAR STEREOTAXIC; Todorov A, 2008, SOC COGN AFFECT NEUR, V3, P303, DOI 10.1093/scan/nsn033; Tomlin D, 2006, SCIENCE, V312, P1047, DOI 10.1126/science.1125596; van Honk J, 2013, P NATL ACAD SCI USA, V110, P2506, DOI 10.1073/pnas.1217316110; Volz KG, 2005, BRAIN RES BULL, V67, P403, DOI 10.1016/j.brainresbull.2005.06.011; Weller JA, 2011, J BEHAV DECIS MAKING, V24, P180, DOI 10.1002/bdm.677; Whalen PJ, 2007, TRENDS COGN SCI, V11, P499, DOI 10.1016/j.tics.2007.08.016; Whalen PJ, 2001, EMOTION, V1, P70, DOI 10.1037/1528-3542.1.1.70; Winston JS, 2002, NAT NEUROSCI, V5, P277, DOI 10.1038/nn816; Wood JN, 2003, NAT REV NEUROSCI, V4, P139, DOI 10.1038/nrn1033; Yan PS, 2009, AM J DRUG ALCOHOL AB, V35, P284, DOI 10.1080/00952990902968569; Younga L, 2008, NEUROIMAGE, V40, P1912, DOI 10.1016/j.neuroimage.2008.01.057	87	3	3	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137014	10.1371/journal.pone.0137014	http://dx.doi.org/10.1371/journal.pone.0137014			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ2NK	26325581	Green Submitted, Green Published, gold			2022-12-26	WOS:000360437700081
J	Tu, T; Meng, K; Luo, HY; Turunen, O; Zhang, LJ; Cheng, YL; Su, XY; Ma, R; Shi, PJ; Wang, YR; Yang, PL; Yao, B				Tu, Tao; Meng, Kun; Luo, Huiying; Turunen, Ossi; Zhang, Lujia; Cheng, Yanli; Su, Xiaoyun; Ma, Rui; Shi, Pengjun; Wang, Yaru; Yang, Peilong; Yao, Bin			New Insights into the Role of T3 Loop in Determining Catalytic Efficiency of GH28 Endo-Polygalacturonases	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; ACTIVE-SITE; MOLECULAR-DYNAMICS; ASPERGILLUS-NIGER; CRYSTAL-STRUCTURE; ENDOPOLYGALACTURONASE II; CONFORMATIONAL-CHANGES; PECTIN METHYLESTERASE; STRUCTURAL INSIGHTS; GLYCOSIDE HYDROLASE	Intramolecular mobility and conformational changes of flexible loops have important roles in the structural and functional integrity of proteins. The Achaetomium sp. Xz8 endo-polygalacturonase (PG8fn) of glycoside hydrolase (GH) family 28 is distinguished for its high catalytic activity (28,000 U/mg). Structure modeling indicated that PG8fn has a flexible T3 loop that folds partly above the substrate in the active site, and forms a hydrogen bond to the substrate by a highly conserved residue Asn94 in the active site cleft. Our research investigates the catalytic roles of Asn94 in T3 loop which is located above the catalytic residues on one side of the substrate. Molecular dynamics simulation performed on the mutant N94A revealed the loss of the hydrogen bond formed by the hydroxyl group at O34 of pentagalacturonic acid and the crucial ND2 of Asn94 and the consequent detachment and rotation of the substrate away from the active site, and that on N94Q caused the substrate to drift away from its place due to the longer side chain. In line with the simulations, site-directed mutagenesis at this site showed that this position is very sensitive to amino acid substitutions. Except for the altered K-m values from 0.32 (wild type PG8fn) to 0.75-4.74 mg/ml, all mutants displayed remarkably lowered kcat (similar to 3-20,000 fold) and kcat/Km (similar to 8-187,500 fold) values and significantly increased Delta(Delta G) values (5.92-33.47 kJ/mol). Taken together, Asn94 in the GH28 T3 loop has a critical role in positioning the substrate in a correct way close to the catalytic residues.	[Tu, Tao; Meng, Kun; Luo, Huiying; Cheng, Yanli; Su, Xiaoyun; Ma, Rui; Shi, Pengjun; Wang, Yaru; Yang, Peilong; Yao, Bin] Chinese Acad Agr Sci, Feed Res Inst, Key Lab Feed Biotechnol, Minist Agr, Beijing 100081, Peoples R China; [Turunen, Ossi] Aalto Univ, Sch Chem Technol, Dept Biotechnol & Chem Technol, FI-00076 Aalto, Finland; [Zhang, Lujia] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China	Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Aalto University; East China University of Science & Technology	Yao, B (corresponding author), Chinese Acad Agr Sci, Feed Res Inst, Key Lab Feed Biotechnol, Minist Agr, Beijing 100081, Peoples R China.	binyao@caas.cn	Turunen, Ossi/HHN-4776-2022; Zhang, Lujia/ABI-3724-2020	Zhang, Lujia/0000-0003-3566-917X	Recommended International Advanced Agricultural Science and Technology Plan of China (948 program) [2014-S1]; National High Technology Research and Development Program of China (863 program) [2012AA022208, 2013AA102803]	Recommended International Advanced Agricultural Science and Technology Plan of China (948 program); National High Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China)	This work was supported by the Recommended International Advanced Agricultural Science and Technology Plan of China (948 program, grant no. 2014-S1) and the National High Technology Research and Development Program of China (863 program, grant nos. 2012AA022208 and 2013AA102803).	Abbott DW, 2008, MICROBIOL MOL BIOL R, V72, P301, DOI 10.1128/MMBR.00038-07; Abbott DW, 2007, J MOL BIOL, V368, P1215, DOI 10.1016/j.jmb.2007.02.083; Arab-Jaziri F, 2012, FEBS J, V279, P3598, DOI 10.1111/j.1742-4658.2012.08720.x; Bonivento D, 2008, PROTEINS, V70, P294, DOI 10.1002/prot.21610; Cho SW, 2001, J MOL BIOL, V311, P863, DOI 10.1006/jmbi.2001.4919; Doucet N, 2009, BIOCHEMISTRY-US, V48, P7160, DOI 10.1021/bi900830g; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Federici L, 2001, P NATL ACAD SCI USA, V98, P13425, DOI 10.1073/pnas.231473698; Guilfoyle AP, 2014, FEBS J, V281, P2254, DOI 10.1111/febs.12779; Gupta S, 2008, BIORESOURCE TECHNOL, V99, P937, DOI 10.1016/j.biortech.2007.03.009; Gutierrez-Fernandez J, 2014, J STRUCT BIOL, V187, P215, DOI 10.1016/j.jsb.2014.07.007; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jayani RS, 2005, PROCESS BIOCHEM, V40, P2931, DOI 10.1016/j.procbio.2005.03.026; Kamerlin SCL, 2010, PROTEINS, V78, P1339, DOI 10.1002/prot.22654; Karimaki J, 2004, PROTEIN ENG DES SEL, V17, P861, DOI 10.1093/protein/gzh099; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Mercadante D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087581; Mercadante D, 2013, BIOPHYS J, V104, P1731, DOI 10.1016/j.bpj.2013.02.049; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Muilu J, 1998, PROTEINS, V31, P434; Okoniewska M, 2000, BIOCHEM J, V349, P169, DOI 10.1042/0264-6021:3490169; Paes G, 2007, PROTEIN ENG DES SEL, V20, P15, DOI 10.1093/protein/gzl049; Paes G, 2012, COMPUT STRUCT BIOTEC, V1, DOI 10.5936/csbj.201207001; Paes G, 2012, BIOTECHNOL ADV, V30, P564, DOI 10.1016/j.biotechadv.2011.10.003; Pages S, 2000, J BIOL CHEM, V275, P29348, DOI 10.1074/jbc.M910112199; Pickersgill R, 1998, J BIOL CHEM, V273, P24660, DOI 10.1074/jbc.273.38.24660; Pollet A, 2009, PROTEINS, V77, P395, DOI 10.1002/prot.22445; Santa H, 2005, BBA-PROTEINS PROTEOM, V1749, P65, DOI 10.1016/j.bbapap.2005.02.007; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P195, DOI 10.1107/S0907444901019291; Sharma N, 2013, REV ENVIRON SCI BIO, V12, P45, DOI 10.1007/s11157-012-9276-9; Shimizu T, 2002, BIOCHEMISTRY-US, V41, P6651, DOI 10.1021/bi025541a; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tu T, 2014, APPL MICROBIOL BIOT, V98, P5019, DOI 10.1007/s00253-014-5533-x; Tu T, 2013, FOOD CHEM, V141, P2974, DOI 10.1016/j.foodchem.2013.05.132; van Pouderoyen G, 2003, FEBS LETT, V554, P462, DOI 10.1016/S0014-5793(03)01221-3; van Santen Y, 1999, J BIOL CHEM, V274, P30474, DOI 10.1074/jbc.274.43.30474; Venkitakrishnan RP, 2004, BIOCHEMISTRY-US, V43, P16046, DOI 10.1021/bi048119y; Vieira DS, 2012, J MOL MODEL, V18, P1473, DOI 10.1007/s00894-011-1172-7; Voragen AGJ, 2009, STRUCT CHEM, V20, P263, DOI 10.1007/s11224-009-9442-z; Wan Q, 2014, ACTA CRYSTALLOGR D, V70, P11, DOI 10.1107/S1399004713023626	45	15	17	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0135413	10.1371/journal.pone.0135413	http://dx.doi.org/10.1371/journal.pone.0135413			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327390	Green Published, gold			2022-12-26	WOS:000360437700019
J	Zhou, J; Xu, WZ; Wong, JWC; Yong, XY; Yan, BH; Zhang, XY; Jia, HH				Zhou, Jun; Xu, Weizhong; Wong, Jonathan W. C.; Yong, Xiaoyu; Yan, Binghua; Zhang, Xueying; Jia, Honghua			Ultrasonic and Thermal Pretreatments on Anaerobic Digestion of Petrochemical Sludge: Dewaterability and Degradation of PAHs	PLOS ONE			English	Article							WASTE-ACTIVATED-SLUDGE; EXTRACELLULAR POLYMERIC SUBSTANCES; URBAN SLUDGE; BIODEGRADATION; REMOVAL; MATRIX; FLOCS; EPS	Effects of different pretreatment methods on sludge dewaterability and polycyclic aromatic hydrocarbons (PAHs) degradation during petrochemical sludge anaerobic digestion were studied. Results showed that the total biogas production volume in the thermal pretreatment system was 4 and 5 times higher than that in the ultrasound pretreatment and in the control system, and the corresponding volatile solid removal efficiencies reached 28%, 15%, and 8%. Phenanthrene, paranaphthalene, fluoranthene, benzofluoranthene, and benzopyrene removal rates reached 43.3%, 55.5%, 30.6%, 42.9%, and 41.7%, respectively, in the thermal pretreatment system, which were much higher than those in the ultrasound pretreatment and in the control system. Moreover, capillary suction time (CST) of sludge increased after pretreatment, and then reduced after 20 days of anaerobic digestion, indicating that sludge dewaterability was greatly improved after anaerobic digestion. The decrease of protein and polysaccharide in the sludge could improve sludge dewaterability during petrochemical sludge anaerobic digestion. This study suggested that thermal pretreatment might be a promising enhancement method for petrochemical sludge solubilization, thus contributing to degradation of the PAHs, biogas production, and improvement of dewaterability during petrochemical sludge anaerobic digestion.	[Zhou, Jun; Yong, Xiaoyu; Jia, Honghua] Nanjing Tech Univ, Coll Biotechnol & Pharmaceut Engn, Nanjing, Jiangsu, Peoples R China; [Xu, Weizhong; Zhang, Xueying] Nanjing Tech Univ, Coll Environm, Nanjing, Jiangsu, Peoples R China; [Wong, Jonathan W. C.] Hong Kong Baptist Univ, Sinoforest Appl Res Ctr Pearl River Delta Environ, Dept Biol, Hong Kong, Hong Kong, Peoples R China; [Yan, Binghua] Chinese Acad Sci, Qingdao Inst Bioenergy & Bio Proc Technol, Lab Waste Valorisat & Water Reuse, Qingdao, Peoples R China	Nanjing Tech University; Nanjing Tech University; Hong Kong Baptist University; Chinese Academy of Sciences	Zhang, XY (corresponding author), Nanjing Tech Univ, Coll Environm, Nanjing, Jiangsu, Peoples R China.	xueyingzhang@njtech.edu.cn; hhjia@njtech.edu.cn	Yan, Binghua/ACD-0393-2022; Yong, Xiao-Yu/HGD-7622-2022; Yong, Xiao-Yu/M-5203-2013	Yan, Binghua/0000-0003-3255-6559; Yong, Xiao-Yu/0000-0001-7267-6067	National Basic Research Program of China [2013CB733500]; National Natural Science Foundation of China [21307058, 21207065]; Jiangsu Province Science Foundation for Youths [BK20130931]; Natural Science Foundation of the Jiangsu Higher Education Institutions of China [13KJB610006]; Chinese Academy of Environmental and Application of Microbial Key Laboratory Fund Project [KLCAS-2013-05]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Science Foundation for Youths; Natural Science Foundation of the Jiangsu Higher Education Institutions of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Environmental and Application of Microbial Key Laboratory Fund Project	This work was supported by the National Basic Research Program of China (2013CB733500), the National Natural Science Foundation of China (No. 21307058; 21207065), the Jiangsu Province Science Foundation for Youths (No. BK20130931), the Natural Science Foundation of the Jiangsu Higher Education Institutions of China (No. 13KJB610006), and the Chinese Academy of Environmental and Application of Microbial Key Laboratory Fund Project (KLCAS-2013-05).	American Public Health Association (APHA), 2005, STANDARD METHODS EXA; Appels L, 2008, PROG ENERG COMBUST, V34, P755, DOI 10.1016/j.pecs.2008.06.002; Barret M, 2012, PEDOSPHERE, V22, P508, DOI 10.1016/S1002-0160(12)60035-6; Barret M, 2010, WATER RES, V44, P3797, DOI 10.1016/j.watres.2010.04.031; Bernal-Martinez A, 2005, PROCESS BIOCHEM, V40, P3244, DOI 10.1016/j.procbio.2005.03.028; Bernal-Martinez A, 2007, CHEMOSPHERE, V68, P1013, DOI 10.1016/j.chemosphere.2007.02.019; Bonten LTC, 1999, CHEMOSPHERE, V38, P3627, DOI 10.1016/S0045-6535(98)00574-8; Bougrier C, 2008, CHEM ENG J, V139, P236, DOI 10.1016/j.cej.2007.07.099; Burgess JE, 2008, WATER SA, V34, P343; Chen JL, 2014, BIOTECHNOL ADV, V32, P1523, DOI 10.1016/j.biotechadv.2014.10.005; Chen YG, 2001, WATER RES, V35, P2615, DOI 10.1016/S0043-1354(00)00565-0; FROLUND B, 1995, APPL MICROBIOL BIOT, V43, P755, DOI 10.1007/s002530050481; Gao YZ, 2004, CHEMOSPHERE, V55, P1169, DOI 10.1016/j.chemosphere.2004.01.037; Gaudy A.F., 1962, IND WATER WASTES, V7, P17; Guo JB, 2014, CHEMOSPHERE, V101, P66, DOI 10.1016/j.chemosphere.2013.12.007; Haritash AK, 2009, J HAZARD MATER, V169, P1, DOI 10.1016/j.jhazmat.2009.03.137; Houghton JI, 2001, WATER SCI TECHNOL, V44, P373, DOI 10.2166/wst.2001.0792; Li XY, 2007, WATER RES, V41, P1022, DOI 10.1016/j.watres.2006.06.037; Liu XM, 2010, ENVIRON SCI TECHNOL, V44, P4355, DOI 10.1021/es9016766; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma XY, 2013, EXP THERM FLUID SCI, V48, P238, DOI 10.1016/j.expthermflusci.2013.03.006; Mahmoud A, 2011, WATER RES, V45, P2795, DOI 10.1016/j.watres.2011.02.029; Neyens E, 2004, J HAZARD MATER, V106, P83, DOI 10.1016/j.jhazmat.2003.11.014; Novak JT, 2003, WATER RES, V37, P3136, DOI 10.1016/S0043-1354(03)00171-4; Nzila A, 2013, ENVIRON POLLUT, V178, P474, DOI 10.1016/j.envpol.2013.03.042; Pilli S, 2011, ULTRASON SONOCHEM, V18, P1, DOI 10.1016/j.ultsonch.2010.02.014; Rani RU, 2014, ULTRASON SONOCHEM, V21, P1065, DOI 10.1016/j.ultsonch.2013.11.007; Rani RU, 2012, BIORESOURCE TECHNOL, V126, P107, DOI 10.1016/j.biortech.2012.09.027; Ruiz B, 2014, WASTE MANAGE, V34, P2063, DOI 10.1016/j.wasman.2014.06.026; Tiehm A, 2001, WATER RES, V35, P2003, DOI 10.1016/S0043-1354(00)00468-1; Yeom IT, 2002, WATER SCI TECHNOL, V46, P421, DOI 10.2166/wst.2002.0641; Yu GH, 2008, ENVIRON SCI TECHNOL, V42, P7944, DOI 10.1021/es8016717; Yu GH, 2007, APPL MICROBIOL BIOT, V77, P605, DOI 10.1007/s00253-007-1204-5; Yu GH, 2010, J HAZARD MATER, V175, P510, DOI 10.1016/j.jhazmat.2009.10.035; Yu GH, 2010, WATER RES, V44, P797, DOI 10.1016/j.watres.2009.10.021; Zhou J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102688	36	8	10	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136162	10.1371/journal.pone.0136162	http://dx.doi.org/10.1371/journal.pone.0136162			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327510	Green Published, gold, Green Submitted			2022-12-26	WOS:000360437700031
J	Simmons, R; Malyuta, R; Chentsova, N; Medoeva, A; Kruglov, Y; Yurchenko, A; Copas, A; Porter, K				Simmons, Ruth; Malyuta, Ruslan; Chentsova, Nelli; Medoeva, Antonia; Kruglov, Yuri; Yurchenko, Alexander; Copas, Andrew; Porter, Kholoud		CASCADE Collaboration EuroCoord	HIV Testing and Diagnosis Rates in Kiev, Ukraine: April 2013-March 2014	PLOS ONE			English	Article							EASTERN-EUROPE; EPIDEMIC; SEROCONVERSION; PREDICTORS; HIV/AIDS	Objective Data from Ukraine on risk factors for HIV acquisition are limited. We describe the characteristics of individuals testing for HIV in the main testing centres of the Ukrainian capital Kiev, including HIV risk factors, testing rates, and positivity rates. Methods As part of a larger study to estimate HIV incidence within Kiev City, we included questions on possible risk factors for HIV acquisition and testing history to existing systems in 4 infectious disease clinics. Data were provided by the person requesting an HIV test using a handheld electronic tablet. All persons (>= 16yrs) presenting for an HIV test April 2013-March 2014 were included. Rates per 100,000 were calculated using region-specific denominators for Kiev. Results During the study period 6370 individuals tested for HIV, equivalent to a testing rate of 293.2 per 100,000. Of these, 467 (7.8%) were HIV-positive, with the highest proportion positive among 31-35 year olds (11.2%), males (9.4%), people who inject drugs (PWID) (17.9%) and men who have sex with men (MSM) (24.1%). Using published population size estimates of MSM, diagnosis rates for MSM ranged from 490.6to 1548.3/100,000. A higher proportion of heterosexual women compared to heterosexual men reported contact with PWID, (16% vs. 4.7%) suggesting a bridging in risk between PWID and their sexual partners. Conclusion Collection of HIV risk factor information in Kiev, essential for the purposes of developing effective HIV prevention and response tools, is feasible. The high percentage of MSM among those testing positive for HIV, may indicate a significant level of undisclosed sex between men in national figures.	[Simmons, Ruth; Copas, Andrew; Porter, Kholoud] UCL, Clin Trials Unit, MRC, London, England; [Malyuta, Ruslan] Perinatal Prevent AIDS Initiat, Odessa, Ukraine; [Chentsova, Nelli; Medoeva, Antonia; Yurchenko, Alexander] Kyiv City AIDS Ctr, Kiev, Ukraine; [Kruglov, Yuri] Inst Epidemiol, Kiev, Ukraine	Medical Research Council Clinical Trials Unit; University of London; University College London; National Academy of Medical Sciences of Ukraine; L. V. Gromashevsky Institute of Epidemiology & Infectious Diseases of the National Academy of Medical Sciences of Ukraine	Porter, K (corresponding author), UCL, Clin Trials Unit, MRC, London, England.	kholoud.porter@ucl.ac.uk	Muga, Roberto/AAY-8655-2021; Guiguet, Marguerite/L-8480-2018; DEL AMO VALERO, JULIA/M-7020-2015; DORRUCCI, MARIA/C-6485-2016; rezza, giovanni/D-4393-2016	Muga, Roberto/0000-0001-6301-431X; DEL AMO VALERO, JULIA/0000-0002-3104-540X; DORRUCCI, MARIA/0000-0002-8543-6430; rezza, giovanni/0000-0003-0268-6790; Porter, Kholoud/0000-0002-9226-6206; Copas, Andrew/0000-0001-8968-5963	European Union Seventh Framework Programme (FP7) under EuroCoord grant [260694]; Medical Research Council [MC_UU_12023/23, MC_UU_12023/15] Funding Source: researchfish; MRC [MC_UU_12023/15] Funding Source: UKRI	European Union Seventh Framework Programme (FP7) under EuroCoord grant; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was conducted on behalf of a CASCADE Collaboration in EuroCoord, funded from the European Union Seventh Framework Programme (FP7/2007-2013) under EuroCoord grant agreement no 260694.	AIDS Alliance, 2010, ANAL REPORT BAS SOC; AIDS Alliance, 2014, MARP COV 2012; [Anonymous], 2010, HIV AIDS SURV EUR 20; [Anonymous], HIV AIDS SURV EUR 20; Barnett T, 2000, SOC SCI MED, V51, P1387, DOI 10.1016/S0277-9536(00)00104-0; Bolshov Y., 2012, ANAL REPORT BEHAV MO; Burchell AN, 2003, INT J STD AIDS, V14, P601, DOI 10.1258/095646203322301059; Clark F, 2014, LANCET, V383, P500, DOI 10.1016/S0140-6736(14)60169-0; Dehne KL, 1999, AIDS, V13, P741, DOI 10.1097/00002030-199905070-00002; Fernyak SE, 2002, JAIDS-J ACQ IMM DEF, V31, P63, DOI 10.1097/00126334-200209010-00009; Gaventa M., 2013, KEEPING WOMEN WHO US; Giaquinto C, 2006, AIDS, V20, P1419, DOI 10.1097/01.aids.0000233576.33973.b3; Hightow LB, 2004, SEX TRANSM DIS, V31, P455, DOI 10.1097/01.olq.0000135984.27593.5f; Kelly JA, 2003, INT J STD AIDS, V14, P361, DOI 10.1258/095646203765371231; Leaity S, 2000, AIDS, V14, P547, DOI 10.1097/00002030-200003310-00010; Marcus U, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-919; Ministry of Health of Ukraine, 2010, UKR NAT REP MON PROG; Nieburg P, 2012, INJECTION DRUG USE U; Organisation World Health, 2010, SCAL HIV TEST COUNS; Pinkman S, 2010, MAKING HARM REDUCTIO; Remis RS, 2009, AIDS, V23, P493, DOI 10.1097/QAD.0b013e328323ad5f; Schwarcz SK, 1997, SEX TRANSM DIS, V24, P347, DOI 10.1097/00007435-199707000-00007; State Statistics Service of Ukraine, 2013, UKR CENS; Stern D, 2012, URKAINE TAKES AIM GA; UNAIDS, 2009, HIDD HIV EP MSM E EU; UNAIDS, 2010, GLOB REP UNAIDS REP; United Nations, 2004, AIDS E EUR COMM IND	27	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0137062	10.1371/journal.pone.0137062	http://dx.doi.org/10.1371/journal.pone.0137062			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322977	Green Published, gold, Green Submitted			2022-12-26	WOS:000360435500063
J	Willner, M; Fior, G; Marschner, M; Birnbacher, L; Schock, J; Braun, C; Fingerle, AA; Noel, PB; Rummeny, EJ; Pfeiffer, F; Herzen, J				Willner, Marian; Fior, Gabriel; Marschner, Mathias; Birnbacher, Lorenz; Schock, Jonathan; Braun, Christian; Fingerle, Alexander A.; Noel, Peter B.; Rummeny, Ernst J.; Pfeiffer, Franz; Herzen, Julia			Phase-Contrast Hounsfield Units of Fixated and Non-Fixated Soft-Tissue Samples	PLOS ONE			English	Article							SKIN EXCISION SPECIMENS; QUANTITATIVE PHASE; RAY; TOMOGRAPHY; ABSORPTION; SHRINKAGE	X-ray phase-contrast imaging is a novel technology that achieves high soft-tissue contrast. Although its clinical impact is still under investigation, the technique may potentially improve clinical diagnostics. In conventional attenuation-based X-ray computed tomography, radiological diagnostics are quantified by Hounsfield units. Corresponding Hounsfield units for phase-contrast imaging have been recently introduced, enabling a setup-independent comparison and standardized interpretation of imaging results. Thus far, the experimental values of few tissue types have been reported; these values have been determined from fixated tissue samples. This study presents phase-contrast Hounsfield units for various types of non-fixated human soft tissues. A large variety of tissue specimens ranging from adipose, muscle and connective tissues to liver, kidney and pancreas tissues were imaged by a grating interferometer with a rotating-anode X-ray tube and a photon-counting detector. Furthermore, we investigated the effects of formalin fixation on the quantitative phase-contrast imaging results.	[Willner, Marian; Fior, Gabriel; Marschner, Mathias; Birnbacher, Lorenz; Schock, Jonathan; Pfeiffer, Franz; Herzen, Julia] Tech Univ Munich, Dept Phys, Garching, Germany; [Willner, Marian; Fior, Gabriel; Marschner, Mathias; Birnbacher, Lorenz; Schock, Jonathan; Noel, Peter B.; Pfeiffer, Franz; Herzen, Julia] Tech Univ Munich, Inst Med Engn, Garching, Germany; [Braun, Christian] Univ Munich, Inst Forens Med, Munich, Germany; [Fingerle, Alexander A.; Rummeny, Ernst J.] Tech Univ Munich, Dept Diagnost & Intervent Radiol, D-80290 Munich, Germany	Technical University of Munich; Technical University of Munich; University of Munich; Technical University of Munich	Willner, M (corresponding author), Tech Univ Munich, Dept Phys, Garching, Germany.	marian.willner@ph.tum.de		Noel, Peter/0000-0002-9671-6171	DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP); DFG Gottfried Wilhelm Leibniz program; European Research Council (ERC, FP7) [StG 240142]; Karlsruhe Nano Micro Facility (KNMF); Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT)	DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP)(German Research Foundation (DFG)); DFG Gottfried Wilhelm Leibniz program(German Research Foundation (DFG)); European Research Council (ERC, FP7)(European Research Council (ERC)); Karlsruhe Nano Micro Facility (KNMF); Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT)	The authors acknowledge financial support through the DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP), the DFG Gottfried Wilhelm Leibniz program and the European Research Council (ERC, FP7, StG 240142). M.W. further acknowledges the Graduate School of Information Science in Health (GSISH). This work was carried out with the support of the Karlsruhe Nano Micro Facility (KNMF, www.kit.edu/knmf), a Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT).	Bravin A, 2013, PHYS MED BIOL, V58, pR1, DOI 10.1088/0031-9155/58/1/R1; Buesa RJ, 2008, ANN DIAGN PATHOL, V12, P387, DOI 10.1016/j.anndiagpath.2008.07.004; Chabior M, 2011, MED PHYS, V38, P1189, DOI 10.1118/1.3553408; Dauendorffer JN, 2009, BRIT J DERMATOL, V160, P810, DOI 10.1111/j.1365-2133.2008.08994.x; Donath T, 2010, INVEST RADIOL, V45, P445, DOI 10.1097/RLI.0b013e3181e21866; FOX CH, 1985, J HISTOCHEM CYTOCHEM, V33, P845, DOI 10.1177/33.8.3894502; GOLOMB FM, 1991, PLAST RECONSTR SURG, V88, P804, DOI 10.1097/00006534-199111000-00010; Grandl S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097101; Gregory N, 2003, ARCH DERMATOL, V139, P542, DOI 10.1001/archderm.139.4.542; Herzen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083369; Herzen J, 2009, OPT EXPRESS, V17, P10010, DOI 10.1364/OE.17.010010; HESLINGA FJ, 1962, J HISTOCHEM CYTOCHEM, V10, P704, DOI 10.1177/10.6.704; Hetterich H, 2014, RADIOLOGY, V271, P870, DOI 10.1148/radiol.14131554; HUDSONPEACOCK MJ, 1995, J AM ACAD DERMATOL, V32, P1010, DOI 10.1016/0190-9622(95)91341-6; ICRU, 1989, 44 ICRU; Kiernan J.A., 2000, MICROSC TODAY, V1, P8, DOI [10.1017/S1551929500057060, DOI 10.1017/S1551929500057060]; Momose A, 2005, JPN J APPL PHYS 1, V44, P6355, DOI 10.1143/JJAP.44.6355; Momose A, 2006, JPN J APPL PHYS 1, V45, P5254, DOI 10.1143/JJAP.45.5254; Pfeiffer F, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108105; Pfeiffer F, 2006, NAT PHYS, V2, P258, DOI 10.1038/nphys265; Qi ZH, 2010, PHYS MED BIOL, V55, P2669, DOI 10.1088/0031-9155/55/9/016; Schulz G, 2010, J R SOC INTERFACE, V7, P1665, DOI 10.1098/rsif.2010.0281; Thuring T, 2013, SKELETAL RADIOL, V42, P827, DOI 10.1007/s00256-013-1606-7; Weitkamp T, 2005, OPT EXPRESS, V13, P6296, DOI 10.1364/OPEX.13.006296; Willner M, 2014, PHYS MED BIOL, V59, P1557, DOI 10.1088/0031-9155/59/7/1557; WOODARD HQ, 1986, BRIT J RADIOL, V59, P1209, DOI 10.1259/0007-1285-59-708-1209; Zanette I, 2011, PHYS STATUS SOLIDI A, V208, P2526, DOI 10.1002/pssa.201184276; Zhou SA, 2008, PHYS MEDICA, V24, P129, DOI 10.1016/j.ejmp.2008.05.006	28	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0137016	10.1371/journal.pone.0137016	http://dx.doi.org/10.1371/journal.pone.0137016			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322638	Green Published, gold, Green Submitted			2022-12-26	WOS:000360435500060
J	Ferguson, KK; McElrath, TF; Mukherjee, B; Loch-Caruso, R; Meeker, JD				Ferguson, Kelly K.; McElrath, Thomas F.; Mukherjee, Bhramar; Loch-Caruso, Rita; Meeker, John D.			Associations between Maternal Biomarkers of Phthalate Exposure and Inflammation Using Repeated Measurements across Pregnancy	PLOS ONE			English	Article							DI-(2-ETHYLHEXYL) PHTHALATE; OXIDATIVE STRESS; PRETERM BIRTH; BISPHENOL-A; METABOLITES; CYTOKINES; WOMEN	Phthalate exposure is prevalent in populations worldwide, including pregnant women. Maternal urinary metabolite concentrations have been associated with adverse reproductive outcomes, but underlying mechanisms remain unclear. Here we investigate inflammation as a possible pathway by examining phthalates in association with inflammation biomarkers, including C-reactive protein (CRP) and a panel of cytokines (IL-1 beta, IL-6, IL-10, and TNF-alpha) in a repeated measures analysis of pregnant women (N = 480). Urinary phthalate metabolites and plasma inflammation biomarkers were measured from samples collected at up to four visits per subject during gestation (median 10, 18, 26, and 35 weeks). Associations were examined using mixed models to account for within-individual correlation of measures. Few statistically significant associations or clear trends were observed, although in full models mono-carboxypropyl phthalate (MCPP) was significantly (percent change with interquartile range increase in exposure [%Delta] = 8.89, 95% confidence interval [CI] = 3.28, 14.8), and mono-benzyl phthalate (MBzP) was suggestively (%Delta = 6.79, 95% CI = -1.21, 15.4) associated with IL-6. Overall these findings show little evidence of an association between phthalate exposure and peripheral inflammation in pregnant women. To investigate inflammation as a mechanism of phthalate effects in humans, biomarkers from target tissues or fluids, though difficult to measure in large-scale studies, may be necessary to detect effects.	[Ferguson, Kelly K.; Loch-Caruso, Rita; Meeker, John D.] Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA; [McElrath, Thomas F.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Maternal Fetal Med, Boston, MA 02115 USA; [Mukherjee, Bhramar] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Michigan System; University of Michigan	Meeker, JD (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA.	meekerj@umich.edu	Ferguson, Kelly/C-3745-2019	Ferguson, Kelly/0000-0001-8467-3250; Meeker, John/0000-0001-8357-5085	National Institute of Environmental Health Sciences, National Institutes of Health [R01ES018872, P42ES017198, P01ES022844, P30ES017885]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES017198, P01ES022844, T32ES007062, R01ES018872, P30ES017885] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding for this project was provided by the National Institute of Environmental Health Sciences, National Institutes of Health, grant numbers R01ES018872, P42ES017198, P01ES022844, and P30ES017885. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen R, 2005, OBSTET GYNECOL, V106, P802, DOI 10.1097/01.AOG.0000178750.84837.ed; Arbuckle TE, 2014, ENVIRON INT, V68, P55, DOI 10.1016/j.envint.2014.02.010; de Renzy-Martin KT, 2014, REPRODUCTION, V147, P443, DOI 10.1530/REP-13-0461; Engel SM, 2010, ENVIRON HEALTH PERSP, V118, P565, DOI 10.1289/ehp.0901470; Ferguson KK, 2014, AM J REPROD IMMUNOL, V72, P326, DOI 10.1111/aji.12265; Ferguson KK, 2014, ENVIRON INT, V70, P118, DOI 10.1016/j.envint.2014.05.016; Ferguson KK, 2014, ENVIRON SCI TECHNOL, V48, P7018, DOI 10.1021/es502076j; Ferguson KK, 2014, JAMA PEDIATR, V168, P61, DOI 10.1001/jamapediatrics.2013.3699; Ferguson KK, 2012, ENVIRON SCI TECHNOL, V46, P477, DOI 10.1021/es202340b; Ferguson KK, 2011, ENVIRON RES, V111, P718, DOI 10.1016/j.envres.2011.02.002; Ferguson KK, 2014, ENV HLTH PERSPECTIVE; Frederiksen H, 2007, MOL NUTR FOOD RES, V51, P899, DOI 10.1002/mnfr.200600243; Guo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039008; Hansen JS, 2007, TOXICOLOGY, V232, P79, DOI 10.1016/j.tox.2006.12.011; He M, 2013, IMMUNOPHARM IMMUNOT, V35, P390, DOI 10.3109/08923973.2013.787432; Hodyl NA, 2011, PRENATAL PROGRAMMING; Hornung RW, 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Hurst CH, 2003, TOXICOL SCI, V74, P297, DOI 10.1093/toxsci/kfg145; Jepsen KF, 2004, TOXICOL IN VITRO, V18, P265, DOI 10.1016/j.tiv.2003.09.008; Jiang YN, 2006, STAT MED, V25, P1323, DOI 10.1002/sim.2283; Just AC, 2012, AM J RESP CRIT CARE, V186, P830, DOI 10.1164/rccm.201203-0398OC; Kimber I, 2010, TOXICOLOGY, V271, P73, DOI 10.1016/j.tox.2010.03.020; Kobrosly RW, 2014, ENVIRON HEALTH PERSP, V122, P521, DOI 10.1289/ehp.1307063; Kuo CH, 2013, ALLERGY, V68, P870, DOI 10.1111/all.12162; Larsen ST, 2007, TOXICOLOGY, V235, P119, DOI 10.1016/j.tox.2007.03.010; Latini G, 2005, TOXICOL SCI, V85, P743, DOI 10.1093/toxsci/kfi131; Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202; Lewis RC, 2013, CHEMOSPHERE, V93, P2390, DOI 10.1016/j.chemosphere.2013.08.038; Luppi P, 2003, VACCINE, V21, P3352, DOI 10.1016/S0264-410X(03)00331-1; Martin Joyce A, 2011, Natl Vital Stat Rep, V60, P1; Meeker JD, 2009, ENVIRON HEALTH PERSP, V117, P1587, DOI 10.1289/ehp.0800522; Nishioka J, 2012, INFLAMM RES, V61, P69, DOI 10.1007/s00011-011-0390-x; Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x; Shin IS, 2014, TOXICOL APPL PHARM, V274, P402, DOI 10.1016/j.taap.2013.12.009; Silva MJ, 2004, B ENVIRON CONTAM TOX, V72, P1226, DOI 10.1007/s00128-004-0374-4; Swan SH, 2010, INT J ANDROL, V33, P259, DOI 10.1111/j.1365-2605.2009.01019.x; Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100; Team RC, 2014, R LANG ENV STAT COMP; Vadillo-Ortega F, 2014, MED HYPOTHESES, V82, P219, DOI 10.1016/j.mehy.2013.11.042; Vetrano AM, 2010, PEDIATR RES, V68, P134, DOI 10.1203/00006450-201011001-00260; Wei SQ, 2010, OBSTET GYNECOL, V116, P393, DOI 10.1097/AOG.0b013e3181e6dbc0; Whyatt RM, 2009, PEDIATRICS, V124, pE1213, DOI 10.1542/peds.2009-0325; Zota AR, 2014, ENVIRON HEALTH PERSP, V122, P235, DOI 10.1289/ehp.1306681	43	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135601	10.1371/journal.pone.0135601	http://dx.doi.org/10.1371/journal.pone.0135601			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317519	Green Published, Green Submitted, gold			2022-12-26	WOS:000360299100037
J	Graf, PM; Wilson, RP; Qasem, L; Hacklander, K; Rosell, F				Graf, Patricia M.; Wilson, Rory P.; Qasem, Lama; Hacklaender, Klaus; Rosell, Frank			The Use of Acceleration to Code for Animal Behaviours; A Case Study in Free-Ranging Eurasian Beavers Castor fiber	PLOS ONE			English	Article							DOUBLY LABELED WATER; REPRODUCTIVE SUCCESS; WEDDELL SEALS; TRIAXIAL ACCELEROMETER; FORAGING BEHAVIOR; PAW PREFERENCE; METABOLIC-RATE; CLASSIFICATION; MOVEMENT; PATTERNS	Recent technological innovations have led to the development of miniature, accelerometer-containing electronic loggers which can be attached to free-living animals. Accelerometers provide information on both body posture and dynamism which can be used as descriptors to define behaviour. We deployed tri-axial accelerometer loggers on 12 free-ranging Eurasian beavers Castor fiber in the county of Telemark, Norway, and on four captive beavers ( two Eurasian beavers and two North American beavers C. canadensis) to corroborate acceleration signals with observed behaviours. By using random forests for classifying behavioural patterns of beavers from accelerometry data, we were able to distinguish seven behaviours; standing, walking, swimming, feeding, grooming, diving and sleeping. We show how to apply the use of acceleration to determine behaviour, and emphasise the ease with which this non-invasive method can be implemented. Furthermore, we discuss the strengths and weaknesses of this, and the implementation of accelerometry on animals, illustrating limitations, suggestions and solutions. Ultimately, this approach may also serve as a template facilitating studies on other animals with similar locomotor modes and deliver new insights into hitherto unknown aspects of behavioural ecology.	[Graf, Patricia M.; Rosell, Frank] Telemark Univ Coll, Fac Arts & Sci, Dept Environm Sci, Bo I Telemark, Norway; [Graf, Patricia M.; Hacklaender, Klaus] Univ Nat Resources & Life Sci, Inst Wildlife Biol & Game Management, Dept Integrat Biol & Biodivers Res, Vienna, Austria; [Wilson, Rory P.; Qasem, Lama] Swansea Univ, Coll Sci, Biosci, Swansea Moving Anim Res Team, Swansea, W Glam, Wales	University College of Southeast Norway; University of Natural Resources & Life Sciences, Vienna; Swansea University	Graf, PM (corresponding author), Telemark Univ Coll, Fac Arts & Sci, Dept Environm Sci, Bo I Telemark, Norway.	patricia.m.graf@hit.no	Hackländer, Klaus/ABC-4327-2020	Hacklander, Klaus/0000-0002-6774-435X				Amelineau F, 2014, J EXP BIOL, V217, P876, DOI 10.1242/jeb.097915; Arai Nobuaki, 2000, Polar Bioscience, V13, P95; BEUTLER FJ, 1966, SIAM REV, V8, P328, DOI 10.1137/1008065; BEVAN RM, 1995, FUNCT ECOL, V9, P40, DOI 10.2307/2390088; Bidder OR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088609; Bidder OR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050556; Bidder OR, 2012, ZOOLOGY, V115, P58, DOI 10.1016/j.zool.2011.09.003; Bishop C. M, 2006, PATTERN RECOGNITION; Bradshaw R. H., 1996, Animal Science (Pencaitland), V62, P547; Breiman L., 2001, MACH LEARN, V45, P5; Brown DD, 2013, ANIM BIOTELEM, V1, P20, DOI DOI 10.1186/2050-3385-1-20; Butler PJ, 2004, FUNCT ECOL, V18, P168, DOI 10.1111/j.0269-8463.2004.00821.x; Byrnes G, 2011, J MAMMAL, V92, P444, DOI 10.1644/10-MAMM-A-048.1; Campbell HA, 2013, J EXP BIOL, V216, P4501, DOI 10.1242/jeb.089805; Campbell RD, 2005, BEHAV ECOL SOCIOBIOL, V58, P597, DOI 10.1007/s00265-005-0942-6; Campbell RD, 2013, GLOBAL CHANGE BIOL, V19, P1311, DOI 10.1111/gcb.12114; Curry A, 2014, NATURE, V513, P157, DOI 10.1038/513157a; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Davis RW, 1999, SCIENCE, V283, P993, DOI 10.1126/science.283.5404.993; DeRuiter SL, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0223; Duriez O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084887; Elliott KH, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0919; Elliott KH, 2014, MOV ECOL, V2, DOI 10.1186/s40462-014-0017-2; Fahlman A, 2008, AQUAT BIOL, V2, P75, DOI 10.3354/ab00039; Fossette S, 2012, FUNCT ECOL, V26, P324, DOI 10.1111/j.1365-2435.2011.01960.x; Fossette S, 2010, J EXP BIOL, V213, P4074, DOI 10.1242/jeb.048207; Gerencser L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077814; Gleiss AC, 2011, FUNCT ECOL, V25, P595, DOI 10.1111/j.1365-2435.2010.01801.x; Gleiss AC, 2011, METHODS ECOL EVOL, V2, P23, DOI 10.1111/j.2041-210X.2010.00057.x; Grunewalder S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049120; Grundy E, 2009, COMPUT GRAPH FORUM, V28, P815, DOI 10.1111/j.1467-8659.2009.01469.x; Guven M, 2003, INT J NEUROSCI, V113, P1675, DOI 10.1080/00207450390249258; Haarberg O, 2006, J ZOOL, V270, P201, DOI 10.1111/j.1469-7998.2006.00142.x; Halsey LG, 2009, J FIELD ORNITHOL, V80, P171, DOI 10.1111/j.1557-9263.2009.00219.x; Herr J, 2004, J ZOOL, V262, P257, DOI 10.1017/S0952836903004606; Koskela E, 1997, J ANIM ECOL, V66, P341, DOI 10.2307/5980; Lagarde F, 2008, ANIM BEHAV, V75, P319, DOI 10.1016/j.anbehav.2007.01.010; Manning A., 2012, INTRO ANIMAL BEHAV, V6th; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; Martiskainen P, 2009, APPL ANIM BEHAV SCI, V119, P32, DOI 10.1016/j.applanim.2009.03.005; McClune DW, 2014, ANIM BIOTELEM, V2, P5, DOI [DOI 10.1186/2050-3385-2-5, 10.1186/2050-3385-2-5]; Michel KE, 2011, AM J VET RES, V72, P866, DOI 10.2460/ajvr.72.7.866; Mitani Y, 2004, MAR ECOL PROG SER, V281, P275, DOI 10.3354/meps281275; Moreau M, 2009, APPL ANIM BEHAV SCI, V119, P158, DOI 10.1016/j.applanim.2009.04.008; Naito Y, 2010, POLAR SCI, V4, P309, DOI 10.1016/j.polar.2010.05.009; Nathan R, 2012, J EXP BIOL, V215, P986, DOI 10.1242/jeb.058602; Nishizawa H, 2013, J ETHOL, V31, P315, DOI 10.1007/s10164-013-0381-1; Olstad O, 1937, NYTT MAGASIN NATURVI, V77, P217; PATENAUDE F, 1984, CAN J ZOOL, V62, P1872, DOI 10.1139/z84-273; Preston T, 2012, RES VET SCI, V93, P412, DOI 10.1016/j.rvsc.2011.08.005; Qasem L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031187; Ringgenberg N, 2010, APPL ANIM BEHAV SCI, V128, P37, DOI 10.1016/j.applanim.2010.09.018; Robert B, 2009, COMPUT ELECTRON AGR, V67, P80, DOI 10.1016/j.compag.2009.03.002; Roitberg Bernard D., 2007, Entomological Research, V37, P14, DOI 10.1111/j.1748-5967.2007.00045.x; Ropert-Coudert Y, 2004, ANIM BEHAV, V67, P985, DOI 10.1016/j.anbehav.2003.09.010; Rosell F, 1999, WILDLIFE BIOL, V5, P119, DOI 10.2981/wlb.1999.015; Rosell F, 2001, WILDLIFE SOC B, V29, P269; Rothwell ES, 2011, ZOO BIOL, V30, P579, DOI 10.1002/zoo.20364; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005379; Sato K, 2003, J EXP BIOL, V206, P1461, DOI 10.1242/jeb.00265; Sato K, 2002, J EXP BIOL, V205, P1189; Shepard ELC, 2009, P ROY SOC B-BIOL SCI, V276, P3149, DOI 10.1098/rspb.2009.0683; Shepard Emily L. C., 2010, Endangered Species Research, V10, P47, DOI 10.3354/esr00084; Spiegel O, 2015, AM NAT, V185, pE44, DOI 10.1086/679314; Sutherland WJ, 1998, ANIM BEHAV, V56, P801, DOI 10.1006/anbe.1998.0896; Tanida H, 2011, ANIM SCI J, V82, P792, DOI 10.1111/j.1740-0929.2011.00903.x; Tsai LS, 1930, SCIENCE, V72, P436, DOI 10.1126/science.72.1869.436; Tsuda Y, 2006, ECOL FRESHW FISH, V15, P264, DOI 10.1111/j.1600-0633.2006.00147.x; Viviant M, 2010, POLAR BIOL, V33, P713, DOI 10.1007/s00300-009-0750-y; Vos M, 2003, BEHAV ECOL, V14, P236, DOI 10.1093/beheco/14.2.236; Wang YW, 2015, MOV ECOL, V3, DOI 10.1186/s40462-015-0030-0; Watanabe S, 2005, APPL ANIM BEHAV SCI, V94, P117, DOI 10.1016/j.applanim.2005.01.010; WATERS NS, 1994, BEHAV BRAIN RES, V63, P195, DOI 10.1016/0166-4328(94)90091-4; Weimerskirch H, 2006, OECOLOGIA, V146, P681, DOI 10.1007/s00442-005-0226-x; Whitney Nicholas M., 2010, Endangered Species Research, V10, P71, DOI 10.3354/esr00247; Williams TM, 2014, SCIENCE, V346, P81, DOI 10.1126/science.1254885; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; Wilson RP, 2012, P ROY SOC B-BIOL SCI, V279, P975, DOI 10.1098/rspb.2011.1544; Wilson RP, 2002, ANIM BEHAV, V63, P85, DOI 10.1006/anbe.2001.1883; Wilson RP, 2008, ENDANGER SPECIES RES, V10, P29, DOI [10.3354/esr00091, DOI 10.3354/ESR00091]; Wilsson L, 1971, VILTREVY, V8, P115; Yoda K, 2007, MAR BIOL, V151, P1951, DOI 10.1007/s00227-007-0631-2; Yoda K, 1999, J EXP BIOL, V202, P3121	84	45	45	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136751	10.1371/journal.pone.0136751	http://dx.doi.org/10.1371/journal.pone.0136751			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317623	Green Published, Green Submitted, gold			2022-12-26	WOS:000360299100134
J	Liu, JX; Hou, JY; Jiang, C; Li, G; Lu, H; Meng, FY; Shi, LC				Liu, Jinxin; Hou, Jingyi; Jiang, Chao; Li, Geng; Lu, Heng; Meng, Fanyun; Shi, Linchun			Deep Sequencing of the Scutellaria baicalensis Georgi Transcriptome Reveals Flavonoid Biosynthetic Profiling and Organ-Specific Gene Expression	PLOS ONE			English	Article							HAIRY ROOT CULTURES; MOLECULAR-CLONING; RNA-SEQ; CINNAMATE 4-HYDROXYLASE; FUNCTIONAL EXPRESSION; ARABIDOPSIS-THALIANA; PURIFICATION; BAICALIN; SYNTHASE; WOGONIN	Scutellaria baicalensis Georgi has long been used in traditional medicine to treat various such widely varying diseases and has been listed in the Chinese Pharmacopeia, the Japanese Pharmacopeia, the Korean Pharmacopoeia and the European Pharmacopoeia. Flavonoids, especially wogonin, wogonoside, baicalin, and baicalein, are its main functional ingredients with various pharmacological activities. Although pharmaological studies for these flavonoid components have been well conducted, the molecular mechanism of their biosynthesis remains unclear in S. baicalensis. In this study, Illumina/Solexa deep sequencing generated more than 91 million paired-end reads and 49,507 unigenes from S. baicalensis roots, stems, leaves and flowers. More than 70% unigenes were annotated in at least one of the five public databases and 13,627 unigenes were assigned to 3,810 KEGG genes involved in 579 different pathways. 54 unigenes that encode 12 key enzymes involved in the pathway of flavonoid biosynthesis were discovered. One baicalinase and three baicalein 7-O-glucuronosyltransferases genes potentially involved in the transformation between baicalin/wogonoside and baicalein/wogonin were identified. Four candidate 6-hydroxylase genes for the formation of baicalin/baicalein and one candidate 8-O-methyltransferase gene for the biosynthesis of wogonoside/wogonin were also recognized. Our results further support the conclusion that, in S. baicalensis, 3,5,7-trihydroxyflavone was the precursor of the four above compounds. Then, the differential expression models and simple sequence repeats associated with these genes were carefully analyzed. All of these results not only enrich the gene resource but also benefit research into the molecular genetics and functional genomics in S. baicalensis.	[Liu, Jinxin; Hou, Jingyi] Chengde Med Univ, Inst Tradit Chinese Med, Key Lab Tradit Chinese Med Res & Dev Hebei Prov, Chengde 067000, Peoples R China; [Liu, Jinxin; Hou, Jingyi; Jiang, Chao; Li, Geng; Lu, Heng; Meng, Fanyun] Beijing Normal Univ, Beijing Area Major Lab Protect & Utilizat Tradit, Beijing 100875, Peoples R China; [Liu, Jinxin; Hou, Jingyi; Jiang, Chao; Li, Geng; Lu, Heng; Meng, Fanyun] China Acad Chinese Med Sci, State Key Lab Breeding Base Dao Di Herbs, Beijing 100700, Peoples R China; [Shi, Linchun] Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Plant Dev, Beijing 100193, Peoples R China	Chengde Medical University; Beijing Normal University; China Academy of Chinese Medical Sciences; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Peking Union Medical College	Meng, FY (corresponding author), Beijing Normal Univ, Beijing Area Major Lab Protect & Utilizat Tradit, Beijing 100875, Peoples R China.	mfy@bnu.edu.cn; lcshi@implad.ac.cn			Projects in the National Science & Technology Pillar Program - Ministry of Science and Technology of the People's Republic of China [2012BAI29B02]; Fundamental Research Funds for the Central Universities - Beijing Normal University [2012LZD06]; Research Fund for the Doctoral Program - Chengde Medical University [201502]; Natural Science Foundation - National Natural Science Foundation of China [81303158]; Major Scientific and Technological Special Project for "Significant New Drugs Creation" - Ministry of Science and Technology of the People's Republic of China [2014ZX09304307001]	Projects in the National Science & Technology Pillar Program - Ministry of Science and Technology of the People's Republic of China; Fundamental Research Funds for the Central Universities - Beijing Normal University; Research Fund for the Doctoral Program - Chengde Medical University; Natural Science Foundation - National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Scientific and Technological Special Project for "Significant New Drugs Creation" - Ministry of Science and Technology of the People's Republic of China	This work was supported by the Projects in the National Science & Technology Pillar Program funded by the Ministry of Science and Technology of the People's Republic of China (www.most.gov.cn) to FM [Grant number: 2012BAI29B02], the Fundamental Research Funds for the Central Universities funded by the Beijing Normal University (www.bnu.edu.cn) to FM [Grant number: 2012LZD06], the Research Fund for the Doctoral Program funded by the Chengde Medical University (www.cdmc.edu.cn) to JL [Grant number: 201502], the Natural Science Foundation for the Youth funded by the National Natural Science Foundation of China (www.nsfc.gov.cn) to LS [Grant number: 81303158] and the Major Scientific and Technological Special Project for "Significant New Drugs Creation" funded by the Ministry of Science and Technology of the People's Republic of China (www.most.gov.cn) to LS [Grant number: 2014ZX09304307001]. All the funders are noncommercial funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYABE SI, 1988, ARCH BIOCHEM BIOPHYS, V261, P458, DOI 10.1016/0003-9861(88)90362-1; Bai SL, 2013, PLANT CELL PHYSIOL, V54, P1132, DOI 10.1093/pcp/pct067; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chen S, 2001, CELL PROLIFERAT, V34, P293, DOI 10.1046/j.0960-7722.2001.00213.x; Chen Y, 2009, TOXICOLOGY, V259, P10, DOI 10.1016/j.tox.2009.01.010; Chiou SJ, 2010, PLANTA, V232, P963, DOI 10.1007/s00425-010-1229-3; Committee JPE, 2006, JAP PHARM; Costa MA, 2003, PHYTOCHEMISTRY, V64, P1097, DOI 10.1016/S0031-9422(03)00517-X; Dong LL, 2012, FOOD CHEM, V131, P1422, DOI 10.1016/j.foodchem.2011.10.013; Fischer TC, 2003, ARCH BIOCHEM BIOPHYS, V412, P223, DOI 10.1016/S0003-9861(03)00013-4; Food K. Drug Administration, 2008, KOR PHARM 9; Gao J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064643; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hamarsheh O, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-189; Harborne J.B., 1999, HDB NATURAL FLAVONOI, V1; Harborne J.B, 1999, HDB NATURAL FLAVONOI, V1; Hirotani M, 2000, PLANTA, V210, P1006, DOI 10.1007/PL00008158; Hoffmann L, 2004, PLANT CELL, V16, P1446, DOI 10.1105/tpc.020297; Huang WH, 2006, BIOSCI BIOTECH BIOCH, V70, P2371, DOI 10.1271/bbb.50698; IKEGAMI F, 1995, BIOL PHARM BULL, V18, P1531, DOI 10.1248/bpb.18.1531; Ikemoto S, 2000, UROLOGY, V55, P951, DOI 10.1016/S0090-4295(00)00467-2; JAY M, 1985, EUR J BIOCHEM, V153, P321, DOI 10.1111/j.1432-1033.1985.tb09304.x; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; KHOURI HE, 1987, J CHROMATOGR, V407, P291, DOI 10.1016/S0021-9673(01)92626-3; Kim JH, 2006, PLANT SCI, V170, P897, DOI 10.1016/j.plantsci.2005.12.013; Kim YO, 2001, J ETHNOPHARMACOL, V77, P183, DOI 10.1016/S0378-8741(01)00283-5; KOES RE, 1994, BIOESSAYS, V16, P123, DOI 10.1002/bies.950160209; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Latunde-Dada AO, 2001, J BIOL CHEM, V276, P1688, DOI 10.1074/jbc.M006277200; Lei W, 2011, GENET MOL RES, V10, P3385, DOI 10.4238/2011.November.22.7; Lei W, 2010, GENET MOL BIOL, V33, P285, DOI 10.1590/S1415-47572010005000031; LEVVY GA, 1954, BIOCHEM J, V58, P462, DOI 10.1042/bj0580462; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li X., 1994, FLORA CHINA, P50; Li-Weber M, 2009, CANCER TREAT REV, V35, P57, DOI 10.1016/j.ctrv.2008.09.005; Lim BO, 2003, J ETHNOPHARMACOL, V84, P23, DOI 10.1016/S0378-8741(02)00257-X; Lin CC, 1996, AM J CHINESE MED, V24, P31, DOI 10.1142/S0192415X96000050; Liu JJ, 2003, INT J CANCER, V106, P559, DOI 10.1002/ijc.11267; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lou Qian, 2014, J Exp Bot, V65, P3157, DOI 10.1093/jxb/eru168; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Medicines EDftQo Commission EP, 2009, EUROPEAN PHARMACOPOE; Mizutani M, 1997, PLANT PHYSIOL, V113, P755, DOI 10.1104/pp.113.3.755; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; MOUSTAFA E, 1967, PHYTOCHEMISTRY, V6, P625, DOI 10.1016/S0031-9422(00)86001-X; NAGAI T, 1995, ANTIVIR RES, V26, P11, DOI 10.1016/0166-3542(94)00062-D; Nagashima S, 2000, PHYTOCHEMISTRY, V53, P533, DOI 10.1016/S0031-9422(99)00593-2; Park NI, 2011, FUNCT INTEGR GENOMIC, V11, P491, DOI 10.1007/s10142-011-0229-0; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schoenbohm C, 2000, BIOL CHEM, V381, P749, DOI 10.1515/BC.2000.095; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Taira Z, 2004, FOOD CHEM TOXICOL, V42, P803, DOI 10.1016/j.fct.2003.12.017; Tanner GJ, 2003, J BIOL CHEM, V278, P31647, DOI 10.1074/jbc.M302783200; TOGURI T, 1993, PLANT MOL BIOL, V23, P933, DOI 10.1007/BF00021810; Verma M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103583; Wang Hong-zhi, 2007, Zhongguo Zhong Yao Za Zhi, V32, P1637; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084105; WELLE R, 1991, EUR J BIOCHEM, V196, P423, DOI 10.1111/j.1432-1033.1991.tb15833.x; Wellmann F, 2002, EUR J BIOCHEM, V269, P4134, DOI 10.1046/j.1432-1033.2002.03108.x; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Xiao JB, 2014, BIOTECHNOL ADV, V32, P1145, DOI 10.1016/j.biotechadv.2014.04.006; Xie DY, 2003, SCIENCE, V299, P396, DOI 10.1126/science.1078540; Xu H, 2010, BIORESOURCE TECHNOL, V101, P9715, DOI 10.1016/j.biortech.2010.07.083; Yang HX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064799, 10.1371/journal.pone.0064058]; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063168	74	16	18	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136397	10.1371/journal.pone.0136397	http://dx.doi.org/10.1371/journal.pone.0136397			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317778	gold, Green Published, Green Submitted			2022-12-26	WOS:000360299100079
J	Priya, PP; Grover, M; Tatu, US; Natarajan, V				Priya, P. Padma; Grover, Manish; Tatu, Utpal S.; Natarajan, Vasant			Characterization of Precursor PfHsp60 in Plasmodium falciparum Cytosol during Its Asexual Development in Human Erythrocytes	PLOS ONE			English	Article							MITOCHONDRIAL PROTEINS; MALARIA; IDENTIFICATION; EXPRESSION; HSP60; LOCALIZATION; APICOPLAST; EVOLUTION; PARASITES; ENZYMES	Mitochondrial heat shock protein 60 (Hsp60) is a nuclear encoded gene product that gets post-translationally translocated into the mitochondria. Using multiple approaches such as immunofluorescence experiments, isoelectric point analysis with two-dimensional gel electrophoresis, and mass spectrometric identification of the signal peptide, we show that Hsp60 from Plasmodium falciparum (PfHsp60) accumulates in the parasite cytoplasm during the ring, trophozoite, and schizont stages of parasite development before being imported into the parasite mitochondria. Using co-immunoprecipitation experiments with antibodies specific to cytoplasmic PfHsp90, PfHsp70-1, and PfHsp60, we show association of precursor PfHsp60 with cytoplasmic chaperone machinery. Metabolic labeling involving pulse and chase indicates translocation of the precursor pool into the parasite mitochondrion during chase. Analysis of results obtained with Geldanamycin treatment confirmed precursor PfHsp60 to be one of the clients for PfHsp90. Cytosolic chaperones bind precursor PfHsp60 prior to its import into the mitochondrion of the parasite. Our data suggests an inefficient co-ordination in the synthesis and translocation of mitochondrial PfHsp60 during asexual growth of malaria parasite in human erythrocytes.	[Priya, P. Padma; Natarajan, Vasant] Indian Inst Sci, Dept Phys, Bangalore 560012, Karnataka, India; [Priya, P. Padma; Grover, Manish; Tatu, Utpal S.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Natarajan, V (corresponding author), Indian Inst Sci, Dept Phys, Bangalore 560012, Karnataka, India.	vasant@physics.iisc.ernet.in	Priya, S/GQH-7176-2022; PRIYA, PADMA/ABC-3121-2021	Tatu, Utpal/0000-0003-0404-8872; GROVER, MANISH/0000-0002-1625-7930	DST [201]; UGC [F.4-2/2006(BSR)/13-610/2012(BSR)]	DST(Department of Science & Technology (India)); UGC(University Grants Commission, India)	This work was supported by DST 201 (http://dst.gov.in/) and UGC, Dr. D. S. KOTHARI POST DOCTORAL FELLOWSHIP Ref No: F.4-2/2006(BSR)/13-610/2012(BSR) (http://www.ugc.ac.in/).	Adams KL, 2003, MOL PHYLOGENET EVOL, V29, P380, DOI 10.1016/S1055-7903(03)00194-5; Akide-Ndunge OB, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-113; ANDERSON L, 1981, P NATL ACAD SCI-BIOL, V78, P2407, DOI 10.1073/pnas.78.4.2407; [Anonymous], GENOME BIOL; [Anonymous], NATURE; [Anonymous], 2000, METHODS MALARIA RES; Banumathy G, 2003, J BIOL CHEM, V278, P18336, DOI 10.1074/jbc.M211309200; Belles C, 1999, INFECT IMMUN, V67, P4191, DOI 10.1128/IAI.67.8.4191-4200.1999; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chandra D, 2007, J BIOL CHEM, V282, P31289, DOI 10.1074/jbc.M702777200; Das A, 1997, MOL BIOCHEM PARASIT, V88, P95, DOI 10.1016/S0166-6851(97)00081-9; Deponte M, 2012, MOL BIOCHEM PARASIT, V186, P95, DOI 10.1016/j.molbiopara.2012.09.007; Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; FRY M, 1991, PARASITOLOGY, V102, P17, DOI 10.1017/S0031182000060297; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Grallert H, 2001, J STRUCT BIOL, V135, P95, DOI 10.1006/jsbi.2001.4387; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Grover M, 2013, PARASITE, V20, DOI 10.1051/parasite/2012002; Gupta Radhey S, 2008, Novartis Found Symp, V291, P59; Haider A, 2015, MOL MICROBIOL, V96, P796, DOI 10.1111/mmi.12972; HARTL FU, 1992, ANNU REV BIOPH BIOM, V21, P293, DOI 10.1146/annurev.bb.21.060192.001453; Hatherley R, 2015, BIOCHEM BIOPH RES CO, V456, P440, DOI 10.1016/j.bbrc.2014.11.103; Itoh H, 2002, EUR J BIOCHEM, V269, P5931, DOI 10.1046/j.1432-1033.2002.03317.x; Khan IU, 1998, P NATL ACAD SCI USA, V95, P10425, DOI 10.1073/pnas.95.18.10425; Kobayashi T, 2007, MITOCHONDRION, V7, P125, DOI 10.1016/j.mito.2006.11.021; Kulzer S, 2012, CELL MICROBIOL, V14, P1784, DOI 10.1111/j.1462-5822.2012.01840.x; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lefebvre-Legendre L, 2003, MOL MICROBIOL, V47, P1329, DOI 10.1046/j.1365-2958.2003.03371.x; MacRae JI, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-67; MARTIN J, 1992, SCIENCE, V258, P995, DOI 10.1126/science.1359644; Miller LH, 2013, NAT MED, V19, P156, DOI 10.1038/nm.3073; MIZZEN LA, 1989, J BIOL CHEM, V264, P20664; Motoyama S, 2004, SHOCK, V22, P234, DOI 10.1097/01.shk.0000132459.68561.f4; Nagaraj VA, 2009, MOL BIOCHEM PARASIT, V168, P109, DOI 10.1016/j.molbiopara.2009.05.008; Neckers L, 2002, TRENDS MOL MED, V8, pS55, DOI 10.1016/S1471-4914(02)02316-X; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Osterloh A, 2004, J BIOL CHEM, V279, P47906, DOI 10.1074/jbc.M408440200; Pallavi R, 2010, J BIOL CHEM, V285, P37964, DOI 10.1074/jbc.M110.155317; Pfister G, 2005, J CELL SCI, V118, P1587, DOI 10.1242/jcs.02292; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Sanchez GI, 1999, EXP PARASITOL, V93, P181, DOI 10.1006/expr.1999.4455; Sato S, 2005, MOL BIOCHEM PARASIT, V141, P133, DOI 10.1016/j.molbiopara.2005.01.010; Sato S, 2004, PROTIST, V155, P117, DOI 10.1078/1434461000169; Sato S, 2003, MOL BIOCHEM PARASIT, V130, P155, DOI 10.1016/S0166-6851(03)00166-X; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Syin C, 1996, MOL BIOCHEM PARASIT, V79, P13, DOI 10.1016/0166-6851(96)02633-3; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Vaidya AB, 2009, ANNU REV MICROBIOL, V63, P249, DOI 10.1146/annurev.micro.091208.073424; van Dooren GG, 2005, MOL MICROBIOL, V57, P405, DOI 10.1111/j.1365-2958.2005.04699.x; van Dooren GG, 2006, FEMS MICROBIOL REV, V30, P596, DOI 10.1111/j.1574-6976.2006.00027.x; Vilasi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097657; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Wilairat P., 1985, Annali dell'Istituto Superiore di Sanita, V21, P299; Wu Y, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-105	56	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136401	10.1371/journal.pone.0136401	http://dx.doi.org/10.1371/journal.pone.0136401			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317863	Green Published, gold, Green Accepted			2022-12-26	WOS:000360299100080
J	Salaets, T; Richter, J; Brady, P; Jimenez, J; Nagatomo, T; Deprest, J; Toelen, J				Salaets, Thomas; Richter, Jute; Brady, Paul; Jimenez, Julio; Nagatomo, Taro; Deprest, Jan; Toelen, Jaan			Transcriptome Analysis of the Preterm Rabbit Lung after Seven Days of Hyperoxic Exposure	PLOS ONE			English	Article							RECEPTOR-GAMMA AGONIST; BRONCHOPULMONARY DYSPLASIA; NEONATAL HYPEROXIA; PREMATURE-INFANTS; RAT MODEL; INJURY; EXPRESSION; ROSIGLITAZONE; INFLAMMATION; ACTIVATION	The neonatal management of preterm born infants often results in damage to the developing lung and subsequent morbidity, referred to as bronchopulmonary dysplasia (BPD). Animal models may help in understanding the molecular processes involved in this condition and define therapeutic targets. Our goal was to identify molecular pathways using the earlier described preterm rabbit model of hyperoxia induced lung-injury. Transcriptome analysis by mRNA-sequencing was performed on lungs from preterm rabbit pups born at day 28 of gestation (term: 31 days) and kept in hyperoxia (95% O-2) for 7 days. Controls were preterm pups kept in normoxia. Transcriptomic data were analyzed using Array Studio and Ingenuity Pathway Analysis (IPA), in order to identify the central molecules responsible for the observed transcriptional changes. We detected 2217 significantly dysregulated transcripts following hyperoxia, of which 90% could be identified. Major pathophysiological dysregulations were found in inflammation, lung development, vascular development and reactive oxygen species (ROS) metabolism. To conclude, amongst the many dysregulated transcripts, major changes were found in the inflammatory, oxidative stress and lung developmental pathways. This information may be used for the generation of new treatment hypotheses for hyperoxia-induced lung injury and BPD.	[Salaets, Thomas; Toelen, Jaan] Univ Hosp Leuven, Dept Pediat, Leuven, Belgium; [Richter, Jute; Jimenez, Julio; Nagatomo, Taro; Deprest, Jan; Toelen, Jaan] Katholieke Univ Leuven, Dept Dev & Regenerat, Res Unit Fetus Placenta Neonate, Grp Biomed Sci, Leuven, Belgium; [Richter, Jute; Deprest, Jan] Univ Hosp Leuven, Dept Obstet & Gynecol, Leuven, Belgium; [Brady, Paul] Katholieke Univ Leuven, Grp Biomed Sci, Dept Genet, Leuven, Belgium; [Jimenez, Julio] Clin Alemana, Dept Ginecol & Obstet, Santiago, Chile; [Nagatomo, Taro] Ehime Prefectural Cent Hosp, Dept Neonatol, Matsuyama, Ehime, Japan	KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; Clinica Alemana	Deprest, J (corresponding author), Katholieke Univ Leuven, Dept Dev & Regenerat, Res Unit Fetus Placenta Neonate, Grp Biomed Sci, Leuven, Belgium.	Jan.Deprest@uzleuven.be	Jimenez, Julio/AAN-9679-2020	Richter, Jute/0000-0001-8415-6747; Jimenez, Julio/0000-0001-6260-2814; Salaets, Thomas/0000-0002-0971-5147; Deprest, Jan/0000-0002-4920-945X	Fonds Wetenschappelijk Onderzoek Vlaanderen [1801207]; Flemish Hercules foundation [AKUL/09/033]; KU Leuven [OT/13/115]; European Commission via its Erasmus Joint Doctoral program [2013-0040]; University Hospitals Leuven	Fonds Wetenschappelijk Onderzoek Vlaanderen(FWO); Flemish Hercules foundation; KU Leuven(KU Leuven); European Commission via its Erasmus Joint Doctoral program; University Hospitals Leuven	JDP was a beneficiary of a fundamental clinical research grant of the Fonds Wetenschappelijk Onderzoek Vlaanderen (1801207), and JT from the "Klinische Opleidings- en Onderzoeks-Raad" of the University Hospitals Leuven. Our experimental program is supported by the Flemish Hercules foundation (large infrastructure investments AKUL/09/033), by the KU Leuven (OT/13/115) and by the European Commission via its Erasmus Joint Doctoral program (2013-0040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins GB, 2007, CIRC RES, V100, P1686, DOI 10.1161/01.RES.0000267856.00713.0a; Auten RL, 2001, AM J PHYSIOL-LUNG C, V281, pL336, DOI 10.1152/ajplung.2001.281.2.L336; Bhandari V, 2014, BIRTH DEFECTS RES A, V100, P189, DOI 10.1002/bdra.23220; Bhattacharya S, 2014, AM J PHYSIOL-LUNG C, V307, pL516, DOI 10.1152/ajplung.00200.2014; Bhattacharya S, 2013, PEDIATR RES, V73, P514, DOI 10.1038/pr.2013.7; Boucherat O, 2007, PHYSIOL GENOMICS, V32, P128, DOI 10.1152/physiolgenomics.00108.2007; Capelari DN, 2012, REGUL PEPTIDES, V177, P97, DOI 10.1016/j.regpep.2012.05.092; Chang YS, 2014, AM J RESP CELL MOL, V51, P391, DOI 10.1165/rcmb.2013-0385OC; Chess PR, 2006, SEMIN PERINATOL, V30, P171, DOI 10.1053/j.semperi.2006.05.003; Cho HY, 2006, ANTIOXID REDOX SIGN, V8, P76, DOI 10.1089/ars.2006.8.76; Coalson JJ, 2006, SEMIN PERINATOL, V30, P179, DOI 10.1053/j.semperi.2006.05.004; Couroucli XI, 2011, TOXICOL APPL PHARM, V256, P83, DOI 10.1016/j.taap.2011.06.018; D'Angio CT, 1999, EXP LUNG RES, V25, P443; Das H, 2006, P NATL ACAD SCI USA, V103, P6653, DOI 10.1073/pnas.0508235103; De Langhe SP, 2005, DEV BIOL, V277, P316, DOI 10.1016/j.ydbio.2004.09.023; Debeer A, 2010, EARLY HUM DEV, V86, P99, DOI 10.1016/j.earlhumdev.2010.01.025; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Jensen EA, 2014, BIRTH DEFECTS RES A, V100, P145, DOI 10.1002/bdra.23235; Jiang JS, 2012, NEONATOLOGY, V101, P47, DOI 10.1159/000329451; Jin Y, 2011, AM J PHYSIOL-LUNG C, V300, pL151, DOI 10.1152/ajplung.00170.2010; Jobe AH, 2011, CURR OPIN PEDIATR, V23, P167, DOI 10.1097/MOP.0b013e3283423e6b; Kapadia VS, 2013, PEDIATRICS, V132, pE1488, DOI 10.1542/peds.2013-0978; Konigshoff M, 2010, AM J RESP CELL MOL, V42, P21, DOI 10.1165/rcmb.2008-0485TR; Kunig AM, 2006, AM J PHYSIOL-LUNG C, V291, pL1068, DOI 10.1152/ajplung.00093.2006; Lee HJ, 2014, YONSEI MED J, V55, P99, DOI 10.3349/ymj.2014.55.1.99; Mascaretti RS, 2009, CLINICS, V64, P1099, DOI 10.1590/S1807-59322009001100010; Mataloun Marta M. G. B., 2006, J. Pediatr. (Rio J.), V82, P179, DOI [10.2223/JPED.1471, 10.1590/S0021-75572006000300005]; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; PRINGLE KC, 1986, CLIN OBSTET GYNECOL, V29, P502, DOI 10.1097/00003081-198609000-00006; Rehan VK, 2006, PEDIATR PULM, V41, P558, DOI 10.1002/ppul.20407; Rehan VK, 2010, AM J PHYSIOL-LUNG C, V299, pL672, DOI 10.1152/ajplung.00240.2010; Richter J, 2014, AM J PHYSIOL-LUNG C, V306, pL277, DOI 10.1152/ajplung.00315.2013; Rutter M, 2008, THE NEWBORN LUNG, V1st, P3; Schmolzer GM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5980; Shivanna B, 2011, J PHARMACOL EXP THER, V339, P106, DOI 10.1124/jpet.111.182980; Simon DM, 2006, FASEB J, V20, P1507, DOI 10.1096/fj.05-5410fje; Su BH, 2005, J FORMOS MED ASSOC, V104, P244; TSAN MF, 1995, EXP LUNG RES, V21, P589, DOI 10.3109/01902149509031761; Vento G, 2009, INTENS CARE MED, V35, P2115, DOI 10.1007/s00134-009-1646-6; Viscardi RM, 2012, SEMIN FETAL NEONAT M, V17, P30, DOI 10.1016/j.siny.2011.08.002; vom Hove M, 2014, J PEDIATR-US, V164, P40, DOI 10.1016/j.jpeds.2013.07.045; Wang Y, 2009, PEDIATR RES, V65, P150, DOI 10.1203/PDR.0b013e3181938c40; Wani MA, 1999, J BIOL CHEM, V274, P21180, DOI 10.1074/jbc.274.30.21180; Weichelt U, 2013, EUR RESPIR J, V41, P966, DOI 10.1183/09031936.00012412; Weng TT, 2006, AM J PHYSIOL-LUNG C, V291, pL1027, DOI 10.1152/ajplung.00435.2005; WHITE C W, 1989, Biotherapy (Dordrecht), V1, P361, DOI 10.1007/BF02171012	47	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136569	10.1371/journal.pone.0136569	http://dx.doi.org/10.1371/journal.pone.0136569			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317699	Green Published, gold, Green Submitted			2022-12-26	WOS:000360299100103
J	Shi, FF; Len, YM; Gong, YP; Shi, R; Yang, X; Naren, D; Yan, TY				Shi, Fangfang; Len, Yamei; Gong, Yuping; Shi, Rui; Yang, Xi; Naren, Duolan; Yan, Tianyou			Ribavirin Inhibits the Activity of mTOR/eIF4E, ERK/Mnk1/eIF4E Signaling Pathway and Synergizes with Tyrosine Kinase Inhibitor Imatinib to Impair Bcr-Abl Mediated Proliferation and Apoptosis in Ph plus Leukemia	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; PHILADELPHIA-CHROMOSOME; TRANSLATION INITIATION; EIF4E; COMBINATION; MNK; ACTIVATION; PROMOTES; SURVIVAL; CANCERS	The eukaryotic translation initiation factor 4E (eIF4E), which is the main composition factor of eIF4F translation initiation complex, influences the growth of tumor through modulating cap-dependent protein translation. Previous studies reported that ribavirin could suppress eIF4E-controlled translation and reduce the synthesis of onco-proteins. Here, we investigated the anti-leukemic effects of ribavirin alone or in combination with tyrosine kinase inhibitor imatinib in Philadelphia chromosome positive (Ph+) leukemia cell lines SUP-B15 (Ph+ acute lymphoblastic leukemia cell line, Ph+ ALL) and K562 (chronic myelogenous leukemia cell line, CML). Our results showed that ribavirin had anti-proliferation effect; it down-regulated the phosphorylation levels of Akt, mTOR, 4EBP1, and eIF4E proteins in the mTOR/eIF4E signaling pathway, and MEK, ERK, Mnk1 and eIF4E proteins in ERK/Mnk1/eIF4E signaling pathway; reduced the expression of Mcl-1 (a translation substrates of eIF4F translation initiation complex) at protein synthesis level not mRNA transcriptional level; and induced cell apoptosis in both SUP-B15 and K562. 7-Methyl-guanosine cap affinity assay further demonstrated that ribavirin remarkably increased the eIF4E binding to 4EBP1 and decreased the combination of eIF4E with eIF4G, consequently resulting in a major inhibition of eIF4F complex assembly. The combination of ribavirin with imatinib enhanced antileukemic effects mentioned above, indicating that two drugs have synergistic anti-leukemic effect. Consistent with the cell lines, similar results were observed in Ph+ acute lymphoblastic primary leukemic blasts; however, the anti-proliferative role of ribavirin in other types of acute primary leukemic blasts was not obvious, which indicated that the anti-leukemic effect of ribavirin was different in cell lineages.	[Shi, Fangfang; Len, Yamei; Gong, Yuping; Shi, Rui; Yang, Xi; Naren, Duolan; Yan, Tianyou] Sichuan Univ, Dept Hematol, West China Hosp, Chengdu 610064, Sichuan, Peoples R China	Sichuan University	Gong, YP (corresponding author), Sichuan Univ, Dept Hematol, West China Hosp, Chengdu 610064, Sichuan, Peoples R China.	gongyuping2010@aliyun.com		Shi, Rui/0000-0003-1664-468X	Doctoral Fund of the Ministry of Education [20120181110008]; Foundation of the Science & Technology Department of Sichuan Province [2013SZ0025]; Foundation of the Administration of traditional Chinese medicine of Sichuan Province [2014A038]	Doctoral Fund of the Ministry of Education(Ministry of Education, China); Foundation of the Science & Technology Department of Sichuan Province; Foundation of the Administration of traditional Chinese medicine of Sichuan Province	This work was supported by the Doctoral Fund of the Ministry of Education (No. 20120181110008), Foundation of the Science & Technology Department of Sichuan Province (No. 2013SZ0025), Foundation of the Administration of traditional Chinese medicine of Sichuan Province (No. 2014A038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assouline S, 2009, BLOOD, V114, P257, DOI 10.1182/blood-2009-02-205153; Coloff JL, 2011, CANCER RES, V71, P5204, DOI 10.1158/0008-5472.CAN-10-4531; Culjkovic B, 2008, J CELL BIOL, V181, P51, DOI 10.1083/jcb.200707018; de Labarthe A, 2007, BLOOD, V109, P1408, DOI 10.1182/blood-2006-03-011908; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Fielding AK, 2011, HEMATOL-AM SOC HEMAT, P231, DOI 10.1182/asheducation-2011.1.231; Goetz C, 2010, MOL THER, V18, P1937, DOI 10.1038/mt.2010.145; Graff JR, 2009, CANCER RES, V69, P3866, DOI 10.1158/0008-5472.CAN-08-3472; Guo Y, 2012, CANCER BIOL THER, V13, P1244, DOI 10.4161/cbt.21460; Hay N, 2010, P NATL ACAD SCI USA, V107, P13975, DOI 10.1073/pnas.1008908107; Hsieh AC, 2010, CLIN CANCER RES, V16, P4914, DOI 10.1158/1078-0432.CCR-10-0433; Kentsis A, 2005, RNA, V11, P1762, DOI 10.1261/rna.2238705; Kentsis A, 2004, P NATL ACAD SCI USA, V101, P18105, DOI 10.1073/pnas.0406927102; Kokeny S, 2009, ANTICANCER RES, V29, P1971; Kraljacic BC, 2011, LEUKEMIA, V25, P1197, DOI 10.1038/leu.2011.57; Lee HJ, 2011, CANCER-AM CANCER SOC, V117, P1583, DOI 10.1002/cncr.25690; Li SG, 1999, J EXP MED, V189, P1399, DOI 10.1084/jem.189.9.1399; Meng HT, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-18; Messina V, 2010, BIOL REPROD, V83, P607, DOI 10.1095/biolreprod.110.085050; Muta D, 2011, J NEURO-ONCOL, V101, P33, DOI 10.1007/s11060-010-0233-6; Pettersson F, 2011, CLIN CANCER RES, V17, P2874, DOI 10.1158/1078-0432.CCR-10-2334; Prabhu S, 2007, ONCOGENE, V26, P1188, DOI 10.1038/sj.onc.1209901; Shi FF, 2015, ANTI-CANCER DRUG, V26, P410, DOI 10.1097/CAD.0000000000000200; Silva RLA, 2008, CELL CYCLE, V7, P553, DOI 10.4161/cc.7.5.5486; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Tamburini J, 2009, BLOOD, V114, P1618, DOI 10.1182/blood-2008-10-184515; Tan K, 2008, BIOCHEM BIOPH RES CO, V375, P341, DOI 10.1016/j.bbrc.2008.07.163; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Yanada M, 2006, J CLIN ONCOL, V24, P460, DOI 10.1200/JCO.2005.03.2177; Zhang M, 2008, MOL CELL BIOL, V28, P6496, DOI 10.1128/MCB.00477-08; Zhao YX, 2008, J BIOL CHEM, V283, P36344, DOI 10.1074/jbc.M803580200; Zhou Y, 2003, PROG PHARM SCI, V27, P314	32	27	28	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136746	10.1371/journal.pone.0136746	http://dx.doi.org/10.1371/journal.pone.0136746			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317515	Green Published, Green Submitted, gold			2022-12-26	WOS:000360299100133
J	Xiong, W; Li, ZG; Liu, HJ; Xue, C; Zhang, RF; Wu, HS; Li, R; Shen, QR				Xiong, Wu; Li, Zhigang; Liu, Hongjun; Xue, Chao; Zhang, Ruifu; Wu, Huasong; Li, Rong; Shen, Qirong			The Effect of Long-Term Continuous Cropping of Black Pepper on Soil Bacterial Communities as Determined by 454 Pyrosequencing	PLOS ONE			English	Article							MICROBIAL COMMUNITY; BIOORGANIC FERTILIZER; FUSARIUM-WILT; DIVERSITY; RHIZOSPHERE; FUNGAL; REPLANT; CUCUMBER; GROWTH; ROOT	In the present study, 3 replanted black pepper orchards with continuously cropping histories for 10, 21, and 55 years in tropical China, were selected for investigating the effect of monoculture on soil physiochemical properties, enzyme activities, bacterial abundance, and bacterial community structures. Results showed long-term continuous cropping led to a significant decline in soil pH, organic matter contents, enzymatic activities, and resulted in a decrease in soil bacterial abundance. 454 pyrosequencing analysis of 16S rRNA genes revealed that the Acidobacteria and Proteobacteria were the main phyla in the replanted black pepper orchard soils, comprising up to 73.82% of the total sequences; the relative abundances of Bacteroidetes and Firmicutes phyla decreased with long-term continuous cropping; and at genus level, the Pseudomonas abundance significantly depleted after 21 years continuous cropping. In addition, bacterial diversity significantly decreased after 55 years black pepper continuous cropping; obvious variations for community structures across the 3 time-scale replanted black pepper orchards were observed, suggesting monoculture duration was the major determinant for bacterial community structure. Overall, continuous cropping during black pepper cultivation led to a significant decline in soil pH, organic matter contents, enzymatic activities, resulted a decrease in soil bacterial abundance, and altered soil microbial community membership and structure, which in turn resulted in black pepper poor growth in the continuous cropping system.	[Xiong, Wu; Li, Zhigang; Wu, Huasong] Chinese Acad Trop Agr Sci, Spice & Beverage Res Inst, Wanning 571533, Hainan, Peoples R China; [Xiong, Wu; Liu, Hongjun; Xue, Chao; Li, Rong; Shen, Qirong] Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Solid Organ Waste, Natl Engn Res Ctr Organ Based Fertilizers, Jiangsu Key Lab Solid Organ Waste Utilizat, Nanjing 210095, Jiangsu, Peoples R China; [Zhang, Ruifu] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Key Lab Microbial Resources Collect & Preservat, Minist Agr, Beijing 100081, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Nanjing Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs	Wu, HS (corresponding author), Chinese Acad Trop Agr Sci, Spice & Beverage Res Inst, Wanning 571533, Hainan, Peoples R China.	wuhuasong2000@163.com; lirong@njau.edu.cn	Shen, Qirong/AAB-6531-2020; Zhang, Ruifu/HDN-0417-2022; Zhang, Ruifu/HDN-0340-2022		National Key Basic Research Program of China [2015CB150500]; Natural Science Foundation of China [31301857]; Innovative Research Team Development Plan of the Ministry of Education of China [IRT1256]; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions; 111 project [B12009]	National Key Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative Research Team Development Plan of the Ministry of Education of China; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions; 111 project(Ministry of Education, China - 111 Project)	This study was financially supported by the National Key Basic Research Program of China (2015CB150500), Natural Science Foundation of China (31301857), the Innovative Research Team Development Plan of the Ministry of Education of China under Grant IRT1256, the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions and the 111 project (B12009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alef K., 1995, METHODS APPL SOIL MI, P350; Aravind R, 2009, LETT APPL MICROBIOL, V48, P58, DOI 10.1111/j.1472-765X.2008.02486.x; Barak P, 1997, PLANT SOIL, V197, P61, DOI 10.1023/A:1004297607070; CATSKA V, 1982, PLANT SOIL, V69, P187, DOI 10.1007/BF02374514; Chen HQ, 2009, SOIL TILL RES, V106, P85, DOI 10.1016/j.still.2009.09.009; Chen LH, 2012, J SCI FOOD AGR, V92, P2465, DOI 10.1002/jsfa.5653; Chen L, 2014, EUR J SOIL BIOL, V62, P121, DOI 10.1016/j.ejsobi.2014.03.006; Ehrenfeld JG, 2005, ANNU REV ENV RESOUR, V30, P75, DOI 10.1146/annurev.energy.30.050504.144212; Fierer N, 2013, SCIENCE, V342, P621, DOI 10.1126/science.1243768; Fuentes M, 2009, EUR J AGRON, V30, P228, DOI 10.1016/j.eja.2008.10.005; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; Gianfreda L, 2005, SCI TOTAL ENVIRON, V341, P265, DOI 10.1016/j.scitotenv.2004.10.005; Guo H, 2014, CROP PROT, V62, P1, DOI 10.1016/j.cropro.2014.03.020; Guo XW, 2011, BIOTECHNOL BIOTEC EQ, V25, P2334, DOI 10.5504/BBEQ.2011.0045; Huang LF, 2013, J CHEM ECOL, V39, P232, DOI 10.1007/s10886-013-0244-9; Johnsen K, 2001, BIOL FERT SOILS, V33, P443, DOI 10.1007/s003740100351; KENNEDY AC, 1995, PLANT SOIL, V170, P75, DOI 10.1007/BF02183056; Kuramae EE, 2012, FEMS MICROBIOL ECOL, V79, P12, DOI 10.1111/j.1574-6941.2011.01192.x; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Li CG, 2010, PLANT SOIL, V330, P423, DOI 10.1007/s11104-009-0216-6; Li PeiDong, 2012, African Journal of Agricultural Research, V7, P1870; Li XG, 2014, SOIL BIOL BIOCHEM, V72, P11, DOI 10.1016/j.soilbio.2014.01.019; Li Z, CHINESE J TROPICAL C, V33, P1245; Liu X, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086610, 10.1371/journal.pone.0087996]; Lu LH, 2013, SOIL BIOL BIOCHEM, V65, P186, DOI 10.1016/j.soilbio.2013.05.025; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Nannipieri P, 2003, EUR J SOIL SCI, V54, P655, DOI 10.1046/j.1351-0754.2003.0556.x; Qiu MH, 2012, BIOL FERT SOILS, V48, P807, DOI 10.1007/s00374-012-0675-4; Quadros P. D. de, 2012, Diversity, V4, P375, DOI 10.3390/d4040375; Reeves DW, 1997, SOIL TILL RES, V43, P131, DOI 10.1016/S0167-1987(97)00038-X; Rietz DN, 2003, SOIL BIOL BIOCHEM, V35, P845, DOI 10.1016/S0038-0717(03)00125-1; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Rumberger A, 2007, SOIL BIOL BIOCHEM, V39, P1645, DOI 10.1016/j.soilbio.2007.01.023; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Shen ZZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098420; SHIPTON PJ, 1977, ANNU REV PHYTOPATHOL, V15, P387, DOI 10.1146/annurev.py.15.090177.002131; Sindhu SS, 1999, BIOL FERT SOILS, V29, P62, DOI 10.1007/s003740050525; Srinivasan K, 2007, CRIT REV FOOD SCI, V47, P735, DOI 10.1080/10408390601062054; Sun YB, 2012, J ENVIRON SCI, V24, P1799, DOI 10.1016/S1001-0742(11)61010-3; Vessey JK, 2003, PLANT SOIL, V255, P571, DOI 10.1023/A:1026037216893; Waldrop MP, 2000, SOIL BIOL BIOCHEM, V32, P1837, DOI 10.1016/S0038-0717(00)00157-7; Xiong Weili, 2014, ABSTR APPL ANAL, V2014, P1; Yadvinder-Singh, 2004, SOIL SCI SOC AM J, V68, P854; Yang JI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046420; Zhang MK, 2004, GEODERMA, V118, P167, DOI 10.1016/S0016-7061(03)00191-5; Zhang W, 2013, MICROB ECOL, V66, P385, DOI 10.1007/s00248-012-0160-5; Zhang X, 2013, PLANT SOIL ENVIRON, V59, P80, DOI 10.17221/613/2012-PSE; Zhou JZ, 2011, ISME J, V5, P1303, DOI 10.1038/ismej.2011.11; Zhou XG, 2012, FEMS MICROBIOL ECOL, V80, P469, DOI 10.1111/j.1574-6941.2012.01312.x; Zu Chao, 2014, Agricultural Sciences, V5, P466	52	91	100	8	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136946	10.1371/journal.pone.0136946	http://dx.doi.org/10.1371/journal.pone.0136946			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317364	Green Published, gold, Green Submitted			2022-12-26	WOS:000360299100179
J	Griese, JJ; Kositzki, R; Schrapers, P; Branca, RMM; Nordstrom, A; Lehtio, J; Haumann, M; Hogbom, M				Griese, Julia J.; Kositzki, Ramona; Schrapers, Peer; Branca, Rui M. M.; Nordstrom, Anders; Lehtio, Janne; Haumann, Michael; Hogbom, Martin			Structural Basis for Oxygen Activation at a Heterodinuclear Manganese/Iron Cofactor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IB RIBONUCLEOTIDE REDUCTASE; METHANE MONOOXYGENASE HYDROXYLASE; ABSORPTION FINE-STRUCTURE; TYROSYL RADICAL COFACTOR; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; ACTIVE-SITE; PROTEIN R2; MANGANESE(IV)/IRON(III) COFACTOR; CORYNEBACTERIUM-AMMONIAGENES	Two recently discovered groups of prokaryotic di-metal carboxylate proteins harbor a heterodinuclear Mn/Fe cofactor. These are the class Ic ribonucleotide reductase R2 proteins and a group of oxidases that are found predominantly in pathogens and extremophiles, called R2-like ligand-binding oxidases (R2lox). We have recently shown that the Mn/Fe cofactor of R2lox self-assembles from Mn-II and Fe-II in vitro and catalyzes formation of a tyrosine-valine ether cross-link in the protein scaffold (Griese, J. J., Roos, K., Cox, N., Shafaat, H. S., Branca, R.M., Lehtio , J., Graslund, A., Lubitz, W., Siegbahn, P. E., and Hogbom, M. (2013) Proc. Natl. Acad. Sci. U.S.A. 110, 1718917194). Here, we present a detailed structural analysis of R2lox in the nonactivated, reduced, and oxidized resting Mn/Fe- and Fe/Fe-bound states, as well as the nonactivated Mn/Mn-bound state. X-ray crystallography and x-ray absorption spectroscopy demonstrate that the active site ligand configuration of R2lox is essentially the same regardless of cofactor composition. Both the Mn/Fe and the diiron cofactor activate oxygen and catalyze formation of the ether cross-link, whereas the dimanganese cluster does not. The structures delineate likely routes for gated oxygen and substrate access to the active site that are controlled by the redox state of the cofactor. These results suggest that oxygen activation proceeds via similar mechanisms at the Mn/Fe and Fe/Fe center and that R2lox proteins might utilize either cofactor in vivo based on metal availability.	[Griese, Julia J.; Hogbom, Martin] Stockholm Univ, Dept Biochem & Biophys, Stockholm Ctr Biomembrane Res, SE-10691 Stockholm, Sweden; [Kositzki, Ramona; Schrapers, Peer; Haumann, Michael] Free Univ Berlin, Inst Expt Phys, D-14195 Berlin, Germany; [Branca, Rui M. M.; Lehtio, Janne] Karolinska Inst, Sci Life Lab, Dept Oncol Pathol, Canc Prote Mass Spectrometry, SE-17121 Solna, Sweden; [Nordstrom, Anders] Umea Univ, Dept Mol Biol, SE-90187 Umea, Sweden	Stockholm University; Free University of Berlin; Karolinska Institutet; Umea University	Hogbom, M (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Stockholm Ctr Biomembrane Res, SE-10691 Stockholm, Sweden.	hogbom@dbb.su.se	MIchael, Haumann/A-7087-2013; Griese, Julia Johanna/GQB-0023-2022	Griese, Julia Johanna/0000-0003-3686-3062; Branca, Rui/0000-0003-3890-6476; Hogbom, Martin/0000-0001-5574-9383; Nordstrom, Anders/0000-0003-3676-817X; Lehtio, Janne/0000-0002-8100-9562	Swedish Research Council and European Union FP7 Project GlycoHit; Swedish Foundation for Strategic Research; Jane and Dan Olsson Foundations; Deutsche Forschungsgemeinschaft Grant [Ha3265/6-1]; Heisenberg Fellowship; Deutsches Bundesministerium fur Bildung und Forschung within Rontgen-Angstrom Cluster [05K14KE1]; Swedish Research Council; Knut and Alice Wallenberg Foundation; European Community's Seventh Framework Programme [283570]	Swedish Research Council and European Union FP7 Project GlycoHit; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Jane and Dan Olsson Foundations; Deutsche Forschungsgemeinschaft Grant(German Research Foundation (DFG)); Heisenberg Fellowship(German Research Foundation (DFG)); Deutsches Bundesministerium fur Bildung und Forschung within Rontgen-Angstrom Cluster; Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); European Community's Seventh Framework Programme(European Commission)	Supported by the Swedish Research Council and European Union FP7 Project GlycoHit.; Supported by the Swedish Foundation for Strategic Research and the Jane and Dan Olsson Foundations.; Supported by Deutsche Forschungsgemeinschaft Grant Ha3265/6-1, by a Heisenberg Fellowship, and Deutsches Bundesministerium fur Bildung und Forschung Grant 05K14KE1 within the Rontgen-Angstrom Cluster.; Supported by the Swedish Research Council, the Swedish Foundation for Strategic Research, the Knut and Alice Wallenberg Foundation, and European Community's Seventh Framework Programme FP7/2007-2013 under Grant Agreement 283570 ( for BioStruct-X). To whom correspondence should be addressed: Stockholm Center for Biomembrane Research, Dept. of Biochemistry and Biophysics, Stockholm University, SE-106 91 Stockholm, Sweden. E-mail: hogbom@dbb.su.se.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Andersson CS, 2012, CHEM BIODIVERS, V9, P1981, DOI 10.1002/cbdv.201100428; Andersson CS, 2012, J AM CHEM SOC, V134, P123, DOI 10.1021/ja209678x; Andersson CS, 2009, P NATL ACAD SCI USA, V106, P5633, DOI 10.1073/pnas.0812971106; Andersson ME, 1999, J AM CHEM SOC, V121, P2346, DOI 10.1021/ja982280c; Ando N, 2011, P NATL ACAD SCI USA, V108, P21046, DOI 10.1073/pnas.1112715108; ATKIN CL, 1973, J BIOL CHEM, V248, P7464; Bailey LJ, 2008, P NATL ACAD SCI USA, V105, P19194, DOI 10.1073/pnas.0807948105; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Boal AK, 2012, BIOCHEMISTRY-US, V51, P3861, DOI 10.1021/bi201925t; Boal AK, 2010, SCIENCE, V329, P1526, DOI 10.1126/science.1190187; Bollinger JM, 1997, J AM CHEM SOC, V119, P5976, DOI 10.1021/ja970319s; Bradley JM, 2014, J BIOL INORG CHEM, V19, P775, DOI 10.1007/s00775-014-1136-3; BUNKER G, 1987, BIOCHEMISTRY-US, V26, P4708, DOI 10.1021/bi00389a017; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cotruvo JA, 2013, J AM CHEM SOC, V135, P4027, DOI 10.1021/ja312457t; Cotruvo JA, 2011, ANNU REV BIOCHEM, V80, P733, DOI 10.1146/annurev-biochem-061408-095817; Cotruvo JA, 2011, BIOCHEMISTRY-US, V50, P1672, DOI 10.1021/bi101881d; Cotruvo JA, 2010, BIOCHEMISTRY-US, V49, P1297, DOI 10.1021/bi902106n; Cox N, 2010, J AM CHEM SOC, V132, P11197, DOI 10.1021/ja1036995; Crona M, 2011, J BIOL CHEM, V286, P33053, DOI 10.1074/jbc.M111.278119; Dassama LMK, 2013, J AM CHEM SOC, V135, P16758, DOI 10.1021/ja407438p; Dassama LMK, 2013, BIOCHEMISTRY-US, V52, P6424, DOI 10.1021/bi400819x; Dassama LMK, 2012, J AM CHEM SOC, V134, P2520, DOI 10.1021/ja211314p; Dau H, 2003, ANAL BIOANAL CHEM, V376, P562, DOI 10.1007/s00216-003-1982-2; Dau H, 2008, COORDIN CHEM REV, V252, P273, DOI 10.1016/j.ccr.2007.09.001; DEWITT JG, 1995, INORG CHEM, V34, P2505, DOI 10.1021/ic00114a007; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Elango N, 1997, PROTEIN SCI, V6, P556; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eriksson M, 1998, BIOCHEMISTRY-US, V37, P13359, DOI 10.1021/bi981380s; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gon S, 2006, ANTIOXID REDOX SIGN, V8, P735, DOI 10.1089/ars.2006.8.735; Grabolle M, 2006, J BIOL CHEM, V281, P4580, DOI 10.1074/jbc.M509724200; Griese JJ, 2013, P NATL ACAD SCI USA, V110, P17189, DOI 10.1073/pnas.1304368110; Hammerstad M, 2014, ACS CHEM BIOL, V9, P526, DOI 10.1021/cb400757h; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Hogbom M, 2004, SCIENCE, V305, P245, DOI 10.1126/science.1098419; Hogbom M, 2003, P NATL ACAD SCI USA, V100, P3209, DOI 10.1073/pnas.0536684100; Hogbom M, 2002, BIOCHEMISTRY-US, V41, P1381, DOI 10.1021/bi011429l; Hogbom M, 2010, J BIOL INORG CHEM, V15, P339, DOI 10.1007/s00775-009-0606-5; Huque Y, 2000, J BIOL CHEM, V275, P25365, DOI 10.1074/jbc.M002751200; Jiang W, 2007, SCIENCE, V316, P1188, DOI 10.1126/science.1141179; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; KLOCKENKAMPER R, 1997, CHEM ANAL, V140; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee SJ, 2013, NATURE, V494, P380, DOI 10.1038/nature11880; LEE SK, 1993, J AM CHEM SOC, V115, P6450, DOI 10.1021/ja00067a086; Leidel N, 2012, BBA-BIOENERGETICS, V1817, P430, DOI 10.1016/j.bbabio.2011.12.008; Li N, 2012, BIOCHEMISTRY-US, V51, P7908, DOI 10.1021/bi300912n; Li N, 2011, J AM CHEM SOC, V133, P6158, DOI 10.1021/ja2013517; Liang AD, 2014, BIOCHEMISTRY-US, V53, P7368, DOI 10.1021/bi500892n; LIU WT, 1993, INORG CHEM, V32, P4102, DOI 10.1021/ic00071a023; Logan DT, 1996, STRUCTURE, V4, P1053, DOI 10.1016/S0969-2126(96)00112-8; Lundin D, 2012, J BIOL CHEM, V287, P20565, DOI 10.1074/jbc.M112.367458; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; Monje-Casas F, 2001, J BIOL CHEM, V276, P18031, DOI 10.1074/jbc.M011728200; NORDLUND P, 1993, J MOL BIOL, V232, P123, DOI 10.1006/jmbi.1993.1374; Nordlund P, 1995, CURR OPIN STRUC BIOL, V5, P758, DOI 10.1016/0959-440X(95)80008-5; NORDLUND P, 1990, NATURE, V345, P593, DOI 10.1038/345593a0; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Notomista E, 2003, J MOL EVOL, V56, P435, DOI 10.1007/s00239-002-2414-1; Pandelia ME, 2013, J AM CHEM SOC, V135, P15801, DOI 10.1021/ja405047b; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reschke S, 2013, BIOCHEMISTRY-US, V52, P8295, DOI 10.1021/bi4008512; Reschke S, 2013, J BIOL CHEM, V288, P29736, DOI 10.1074/jbc.M113.497453; Roos K, 2011, J BIOL INORG CHEM, V16, P553, DOI 10.1007/s00775-011-0755-1; ROSENZWEIG AC, 1993, NATURE, V366, P537, DOI 10.1038/366537a0; ROSENZWEIG AC, 1995, CHEM BIOL, V2, P409, DOI 10.1016/1074-5521(95)90222-8; Rosenzweig AC, 1997, PROTEINS, V29, P141, DOI 10.1002/(SICI)1097-0134(199710)29:2<141::AID-PROT2>3.3.CO;2-W; Sazinsky MH, 2006, ACCOUNTS CHEM RES, V39, P558, DOI 10.1021/ar030204v; Sazinsky MH, 2006, BIOCHEMISTRY-US, V45, P15392, DOI 10.1021/bi0618969; Sazinsky MH, 2004, J BIOL CHEM, V279, P30600, DOI 10.1074/jbc.M400710200; SCARROW RC, 1987, J AM CHEM SOC, V109, P7857, DOI 10.1021/ja00259a039; SCARROW RC, 1986, J AM CHEM SOC, V108, P6832, DOI 10.1021/ja00281a077; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Shafaat HS, 2014, J AM CHEM SOC, V136, P13399, DOI 10.1021/ja507435t; Shu LJ, 1996, J BIOL INORG CHEM, V1, P297, DOI 10.1007/s007750050057; Shu LJ, 1997, SCIENCE, V275, P515, DOI 10.1126/science.275.5299.515; Sigfridsson KGV, 2013, J BIOL CHEM, V288, P9648, DOI 10.1074/jbc.M112.438796; SJOBERG BM, 1977, J BIOL CHEM, V252, P536; Stolle P, 2010, FEBS J, V277, P4849, DOI 10.1111/j.1742-4658.2010.07885.x; Stubble J, 2003, CURR OPIN CHEM BIOL, V7, P183, DOI 10.1016/S1367-5931(03)00025-5; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Theil EC, 2006, J BIOL INORG CHEM, V11, P803, DOI 10.1007/s00775-006-0125-6; THELANDER L, 1973, J BIOL CHEM, V248, P4591; Vassinova N, 2000, MICROBIOL-SGM, V146, P3171, DOI 10.1099/00221287-146-12-3171; Voegtli WC, 2003, J AM CHEM SOC, V125, P15822, DOI 10.1021/ja0370387; Voevodskaya N, 2007, FEBS LETT, V581, P3351, DOI 10.1016/j.febslet.2007.06.023; Voevodskaya N, 2009, J BIOL CHEM, V284, P4555, DOI 10.1074/jbc.M807190200; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang WX, 2014, J AM CHEM SOC, V136, P9754, DOI 10.1021/ja504688z; Wang WX, 2014, J AM CHEM SOC, V136, P2244, DOI 10.1021/ja412351b; Warui DM, 2011, J AM CHEM SOC, V133, P3316, DOI 10.1021/ja111607x; Whittington DA, 2001, J AM CHEM SOC, V123, P827, DOI 10.1021/ja003240n; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wriggers W, 2001, J APPL CRYSTALLOGR, V34, P773, DOI 10.1107/S0021889801012869; Younker JM, 2008, J AM CHEM SOC, V130, P15022, DOI 10.1021/ja804365e; ZABINSKY SI, 1995, PHYS REV B, V52, P2995, DOI 10.1103/PhysRevB.52.2995; Zhang Y, 2011, BIOCHEMISTRY-US, V50, P5615, DOI 10.1021/bi200348q	108	23	23	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25254	25272		10.1074/jbc.M115.675223	http://dx.doi.org/10.1074/jbc.M115.675223			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26324712	Green Published, hybrid			2022-12-26	WOS:000362962800005
J	Salvarelli, E; Krupka, M; Rivas, G; Mingorance, J; Gomez-Puertas, P; Alfonso, C; Rico, AI				Salvarelli, Estefania; Krupka, Marcin; Rivas, German; Mingorance, Jesus; Gomez-Puertas, Paulino; Alfonso, Carlos; Isabel Rico, Ana			The Cell Division Protein FtsZ from Streptococcus pneumoniae Exhibits a GTPase Activity Delay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASSEMBLY DYNAMICS; STRUCTURAL INSIGHTS; SIZE-DISTRIBUTION; LIGHT-SCATTERING; POLYMERIZATION; POLYMERS; RING; ULTRACENTRIFUGATION; LOCALIZATION; ENERGETICS	The cell division protein FtsZ assembles in vitro by a mechanism of cooperative association dependent on GTP, monovalent cations, and Mg2+. We have analyzed the GTPase activity and assembly dynamics of Streptococcus pneumoniae FtsZ (SpnFtsZ). SpnFtsZ assembled in an apparently cooperative process, with a higher critical concentration than values reported for other FtsZ proteins. It sedimented in the presence of GTP as a high molecular mass polymer with a well defined size and tended to form double-stranded filaments in electron microscope preparations. GTPase activity depended on K+ and Mg2+ and was inhibited by Na+. GTP hydrolysis exhibited a delay that included a lag phase followed by a GTP hydrolysis activation step, until reaction reached the GTPase rate. The lag phase was not found in polymer assembly, suggesting a transition from an initial non-GTP-hydrolyzing polymer that switches to a GTP-hydrolyzing polymer, supporting models that explain FtsZ polymer cooperativity.	[Salvarelli, Estefania; Mingorance, Jesus] Hosp Univ La Paz, IdiPAZ, Microbiol Serv, Madrid 28046, Spain; [Salvarelli, Estefania; Gomez-Puertas, Paulino] Univ Autonoma Madrid, Biomol Informat SL, E-28049 Madrid, Spain; [Krupka, Marcin; Isabel Rico, Ana] CSIC, Ctr Nacl Biotecnol, E-28049 Madrid, Spain; [Gomez-Puertas, Paulino] CSIC, Ctr Biol Mol Sever Ochoa, Mol Modelling Grp, E-28049 Madrid, Spain; [Rivas, German; Alfonso, Carlos] CSIC, Ctr Invest Biol, E-28040 Madrid, Spain	Hospital Universitario La Paz; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Salvarelli, E (corresponding author), Hosp Univ La Paz, IdiPAZ, Microbiol Serv, Paseo La Castellana 261, Madrid 28046, Spain.	esalvarelli@gmail.com	Rico, Ana Isabel/A-5242-2010; Rivas, German/AFL-7528-2022; Mingorance, Jesus/B-7562-2009; Gomez-Puertas, Paulino/G-8821-2014; Rivas, German/AAG-7458-2022; Alfonso, Carlos/K-1316-2014	Rico, Ana Isabel/0000-0001-6021-3970; Rivas, German/0000-0003-3450-7478; Mingorance, Jesus/0000-0001-6173-5711; Gomez-Puertas, Paulino/0000-0003-3131-729X; Rivas, German/0000-0003-3450-7478; Alfonso, Carlos/0000-0001-7165-4800	Spanish Government [BIO2011-28941-C03, BIO2011-28941-C01]; Torres Quevedo Program [PTQ-11-05049]; La Caixa Foundation	Spanish Government(Spanish GovernmentEuropean Commission); Torres Quevedo Program; La Caixa Foundation(La Caixa Foundation)	This work was supported in part by Spanish Government GrantsBIO2011-28941-C03 (to G. R. and C. A.) and BIO2011-28941-C01. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Torres Quevedo Program Grant PTQ-11-05049 to Biomol Informatics S.L. To whom correspondence should be addressed: Servicio de Microbiologia, Hospital Universitario La Paz, IdiPAZ, Paseo de La Castellana, 261, 28046 Madrid, Spain. E-mail: esalvarelli@gmail.corn.; Ph.D. fellow of the La Caixa Foundation International Fellowship Programme (La Caixa/CNB).	Ahijado-Guzman R, 2013, J BIOL CHEM, V288, P27358, DOI 10.1074/jbc.M113.482943; Ariza A, 2012, J PROTEOMICS, V77, P504, DOI 10.1016/j.jprot.2012.09.030; Biteen JS, 2012, CHEMPHYSCHEM, V13, P1007, DOI 10.1002/cphc.201100686; Caplan MR, 2003, J BIOL CHEM, V278, P13784, DOI 10.1074/jbc.M300860200; Chen Y, 2007, J BIOL CHEM, V282, P27736, DOI 10.1074/jbc.M703788200; Chen YD, 2009, BIOCHEMISTRY-US, V48, P6664, DOI 10.1021/bi8022653; Chen YD, 2005, J BIOL CHEM, V280, P22549, DOI 10.1074/jbc.M500895200; Chen YD, 2005, BIOPHYS J, V88, P505, DOI 10.1529/biophysj.104.044149; Cole JL, 2004, METHOD ENZYMOL, V384, P212; CORTON JC, 1987, J BACTERIOL, V169, P1; Elsen NL, 2012, J AM CHEM SOC, V134, P12342, DOI 10.1021/ja303564a; Fadda D, 2007, J BACTERIOL, V189, P1288, DOI 10.1128/JB.01168-06; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; Gonzalez JM, 2003, J BIOL CHEM, V278, P37664, DOI 10.1074/jbc.M305230200; Gonzalez JM, 2005, P NATL ACAD SCI USA, V102, P1895, DOI 10.1073/pnas.0409517102; Guo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012680; Hernandez-Rocamora VM, 2013, J BIOL CHEM, V288, P24625, DOI 10.1074/jbc.M113.483222; Huecas S, 2003, J BIOL CHEM, V278, P46146, DOI 10.1074/jbc.M307128200; Huecas S, 2008, BIOPHYS J, V94, P1796, DOI 10.1529/biophysj.107.115493; Jamous C, 2014, J BIOMOL STRUCT DYN, V32, P916, DOI 10.1080/07391102.2013.799436; Jimenez M, 2011, J BIOL CHEM, V286, P11236, DOI 10.1074/jbc.M110.194365; Lara B, 2005, MOL MICROBIOL, V55, P699, DOI 10.1111/j.1365-2958.2004.04432.x; Li Z, 2007, EMBO J, V26, P4694, DOI 10.1038/sj.emboj.7601895; Martin-Garcia F, 2012, FEBS LETT, V586, P1236, DOI 10.1016/j.febslet.2012.03.042; Massidda O, 2013, ENVIRON MICROBIOL, V15, P3133, DOI 10.1111/1462-2920.12189; Mendieta J, 2009, J MOL BIOL, V390, P17, DOI 10.1016/j.jmb.2009.05.018; Mingorance J, 2001, MOL MICROBIOL, V41, P83, DOI 10.1046/j.1365-2958.2001.02498.x; Mingorance J, 2010, TRENDS MICROBIOL, V18, P348, DOI 10.1016/j.tim.2010.06.001; Miraldi ER, 2008, BIOPHYS J, V95, P2470, DOI 10.1529/biophysj.107.126219; Montecinos-Franjola F, 2014, BBA-PROTEINS PROTEOM, V1844, P1193, DOI 10.1016/j.bbapap.2014.03.012; Monterroso B, 2013, METHODS, V59, P349, DOI 10.1016/j.ymeth.2012.12.014; Monterroso B, 2012, BIOCHEMISTRY-US, V51, P6108, DOI 10.1021/bi300891q; Monterroso B, 2012, BIOCHEMISTRY-US, V51, P4541, DOI 10.1021/bi300401b; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; Natale P, 2013, ENVIRON MICROBIOL, V15, P3169, DOI 10.1111/1462-2920.12227; Natarajan K, 2013, BIOCHEMISTRY-US, V52, P3543, DOI 10.1021/bi400170f; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; Oliva MA, 2003, J BIOL CHEM, V278, P33562, DOI 10.1074/jbc.M303798200; Oliva MA, 2007, J MOL BIOL, V373, P1229, DOI 10.1016/j.jmb.2007.08.056; OZOLS J, 1990, METHOD ENZYMOL, V182, P587; Rico AI, 2013, J BIOL CHEM, V288, P20830, DOI 10.1074/jbc.R113.479519; Rivas G, 2000, J BIOL CHEM, V275, P11740, DOI 10.1074/jbc.275.16.11740; Romberg L, 2001, J BIOL CHEM, V276, P11743, DOI 10.1074/jbc.M009033200; Rueda S, 2003, J BACTERIOL, V185, P3344, DOI 10.1128/JB.185.11.3344-3351.2003; Salvarelli E, 2011, FEBS LETT, V585, P3880, DOI 10.1016/j.febslet.2011.10.046; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Si FW, 2013, BIOPHYS J, V105, P1976, DOI 10.1016/j.bpj.2013.09.030; Small E, 2003, MICROBIOL-SGM, V149, P2235, DOI 10.1099/mic.0.26126-0; Stricker J, 2002, P NATL ACAD SCI USA, V99, P3171, DOI 10.1073/pnas.052595099	51	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					25081	25089		10.1074/jbc.M115.650077	http://dx.doi.org/10.1074/jbc.M115.650077			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26330552	hybrid, Green Published			2022-12-26	WOS:000362598300036
J	Pollegioni, P; Woeste, KE; Chiocchini, F; Del Lungo, S; Olimpieri, I; Tortolano, V; Clark, J; Hemery, GE; Mapelli, S; Malvolti, ME				Pollegioni, Paola; Woeste, Keith E.; Chiocchini, Francesca; Del Lungo, Stefano; Olimpieri, Irene; Tortolano, Virginia; Clark, Jo; Hemery, Gabriel E.; Mapelli, Sergio; Malvolti, Maria Emilia			Ancient Humans Influenced the Current Spatial Genetic Structure of Common Walnut Populations in Asia	PLOS ONE			English	Article							JUGLANS-REGIA L.; MULTIPLE-REGRESSION; CROP DOMESTICATION; DIVERSITY; HISTORY; TECHNOLOGY; SOFTWARE; PATTERNS; CAUCASUS; DISTANCE	Common walnut (Juglans regia L) is an economically important species cultivated worldwide for its wood and nuts. It is generally accepted that J. regia survived and grew spontaneously in almost completely isolated stands in its Asian native range after the Last Glacial Maximum. Despite its natural geographic isolation, J. regia evolved over many centuries under the influence of human management and exploitation. We evaluated the hypothesis that the current distribution of natural genetic resources of common walnut in Asia is, at least in part, the product of ancient anthropogenic dispersal, human cultural interactions, and afforestation. Genetic analysis combined with ethno-linguistic and historical data indicated that ancient trade routes such as the Persian Royal Road and Silk Road enabled long-distance dispersal of J. regia from Iran and Trans-Caucasus to Central Asia, and from Western to Eastern China. Ancient commerce also disrupted the local spatial genetic structure of autochthonous walnut populations between Tashkent and Samarkand (Central-Eastern Uzbekistan), where the northern and central routes of the Northern Silk Road converged. A significant association between ancient language phyla and the genetic structure of walnut populations is reported even after adjustment for geographic distances that could have affected both walnut gene flow and human commerce over the centuries. Beyond the economic importance of common walnut, our study delineates an alternative approach for understanding how the genetic resources of long-lived perennial tree species may be affected by the interaction of geography and human history.	[Pollegioni, Paola; Chiocchini, Francesca; Olimpieri, Irene; Tortolano, Virginia; Malvolti, Maria Emilia] CNR, Inst Agroenvironm & Forest Biol, Porano, Terni, Italy; [Woeste, Keith E.] Purdue Univ, Dept Forestry & Nat Resources, US Forest Serv, USDA,Hardwood Tree Improvement & Regenerat Ctr, W Lafayette, IN 47907 USA; [Del Lungo, Stefano] CNR, Inst Archaeol & Monumental Heritage, Potenza, Italy; [Clark, Jo] Earth Trust, Abingdon, Oxon, England; [Hemery, Gabriel E.] Sylva Fdn, Little Wittenham, Oxon, England; [Mapelli, Sergio] CNR, Inst Agr Biol & Biotechnol, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Purdue University System; Purdue University; Purdue University West Lafayette Campus; United States Department of Agriculture (USDA); United States Forest Service; Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR)	Pollegioni, P (corresponding author), CNR, Inst Agroenvironm & Forest Biol, Porano, Terni, Italy.	paola.pollegioni@ibaf.cnr.it	Del+Lungo, Stefano/AAK-9915-2021; Hemery, Gabriel/AAX-9424-2020	Hemery, Gabriel/0000-0002-0839-9293; Chiocchini, Francesca/0000-0002-5122-8756; DEL LUNGO, Stefano/0000-0001-7326-462X	European Community in the framework of the Seventh Framework Programme under the Marie Curie Actions COFUND project "I-MOVE" [267232, 206405]	European Community in the framework of the Seventh Framework Programme under the Marie Curie Actions COFUND project "I-MOVE"	This study was supported by the European Community in the framework of the Seventh Framework Programme under the Marie Curie Actions COFUND project "I-MOVE" (N. 267232) Grant number 206405.	Aradhya MK, 2005, DARWINS HARVEST ORIG, P143; Ashuri Y., 2006, MINORITY LANGUAGES C, V1, P12; Aubaile F., 2012, REV ETHNOECOLOGIE, V1, P1; Beer R, 2008, QUATERNARY SCI REV, V27, P621, DOI 10.1016/j.quascirev.2007.11.012; Belle EMS, 2007, AM J PHYS ANTHROPOL, V133, P1137, DOI 10.1002/ajpa.20622; Bocharnikov V, 2012, WORLD FORESTS, V12, P251, DOI 10.1007/978-94-007-2144-9_7; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Bucci G, 2007, MOL ECOL, V16, P2137, DOI 10.1111/j.1365-294X.2007.03275.x; CARRION JS, 1992, J BIOGEOGR, V19, P623, DOI 10.2307/2845705; Christian D, 2000, J WORLD HIST, V11, P1, DOI 10.1353/jwh.2000.0004; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Dehghan B., 2009, Journal of Applied Horticulture (Lucknow), V11, P56; DI COSMO N., 1999, CAMBRIDGE HIST ANCIE, P885, DOI DOI 10.1017/CHOL9780521470308.015; Diamond J, 2003, SCIENCE, V300, P597, DOI 10.1126/science.1078208; Djamali M., PALEORIENT, V36, P175, DOI [DOI 10.3406/PALEO.2010.5394, 10.3406/paleo.2010.5394]; Dwyer AM, 2007, PHONOLOGY 1, V37, P1; Dwyer AM, 2005, POL STUD, V15, P1; Dyer RJ, 2004, MOL ECOL, V13, P1713, DOI 10.1111/j.1365-294X.2004.02177.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Francis G, 2006, STANFORD PROGRAM INT; French David, 1998, IRAN, V36, P15; Fuller DQ, 2007, ANN BOT-LONDON, V100, P903, DOI 10.1093/aob/mcm048; Fuller DQ, 2010, WORLD ARCHAEOL, V42, P13, DOI 10.1080/00438240903429680; Gordon R. G., 2005, ETHNOLOGUE LANGUAGES, V15th; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Guillot G, 2013, METHODS ECOL EVOL, V4, P336, DOI 10.1111/2041-210x.12018; Gunn BF, 2010, AM J BOT, V97, P660, DOI 10.3732/ajb.0900114; Gupta AK, 2004, CURR SCI INDIA, V87, P54; Hasandust M, 2000, NAMEYE FARHANGESTAN, V4, P135; Hemery GE, 2005, FORESTRY, V78, P121, DOI 10.1093/forestry/cpi012; Henn BM, 2012, P NATL ACAD SCI USA, V109, P17758, DOI 10.1073/pnas.1212380109; Janick J, 2003, ACTA HORTIC, P19, DOI 10.17660/ActaHortic.2003.620.1; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Khanazarov A. A., 2003, Schweizerische Zeitschrift fur Forstwesen, V154, P226, DOI 10.3188/szf.2003.0226; Laufer B., 1919, MUS NAT HIST PUBL201, V15, P185; Lichstein JW, 2007, PLANT ECOL, V188, P117, DOI 10.1007/s11258-006-9126-3; Maffi L, 2005, ANNU REV ANTHROPOL, V34, P599, DOI 10.1146/annurev.anthro.34.081804.120437; Mani BR, 2008, PRAGDHARA, V18, P229; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; MANTEL N, 1967, CANCER RES, V27, P209; Marston JM, 2009, J ARCHAEOL SCI, V36, P2192, DOI 10.1016/j.jas.2009.06.002; McGranahan G., 1991, ACTA HORTIC, V290, P907, DOI [10.17660/ActaHortic.1991.290.20, DOI 10.17660/ACTAHORTIC.1991.290.20]; Miller AJ, 2011, AM J BOT, V98, P1389, DOI 10.3732/ajb.1000522; Molnar TJ, 2011, ANN REP N NUT GROW A, V101, P56; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Perales HR, 2005, P NATL ACAD SCI USA, V102, P949, DOI 10.1073/pnas.0408701102; Pollegioni P, 2014, TREE GENET GENOMES, V10, P1027, DOI 10.1007/s11295-014-0740-2; Pritchard JK, 2000, GENETICS, V155, P945; Rong- Ting X, 1990, ACTA HORTIC, V284, P353; Ruhlen M., 1991, GUIDE WORLDS LANGUAG, V1; Sims-Williams Nicholas, 1996, CINA IRAN ALESSANDRO, P45; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; Turnbull JW, 2009, ENCY LIFE SUPPORT SY, VII, P48; Vahdati K, 2014, ACTA HORTIC, V1032, P19; Warnock P, 1991, ANATOLIAN STUDIES, V41, P107, DOI DOI 10.2307/3642933; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Westengen OT, 2014, P NATL ACAD SCI USA, V111, P14100, DOI 10.1073/pnas.1401646111; Wiesehofer Josef., 2001, ANCIENT PERSIA 550 B; Wilkinson KN, 2012, J FIELD ARCHAEOL, V37, P20, DOI 10.1179/0093469011Z.0000000002; Zeder MA, 2006, EVOL ANTHROPOL, V15, P105, DOI 10.1002/evan.20101; Zohary D., 2000, DOMESTICATION PLANTS, DOI 10.1006/anbo.2001.1505	62	33	36	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135980	10.1371/journal.pone.0135980	http://dx.doi.org/10.1371/journal.pone.0135980			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CQ4ZT	26332919	Green Published, Green Submitted, gold			2022-12-26	WOS:000360613800046
J	Roth, M; Zhao, F; Zhong, J; Lardinois, D; Tamm, M				Roth, Michael; Zhao, Feng; Zhong, Jun; Lardinois, Didier; Tamm, Michael			Serum IgE Induced Airway Smooth Muscle Cell Remodeling Is Independent of Allergens and Is Prevented by Omalizumab	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX PROTEINS; ASTHMA; PROLIFERATION; EXPRESSION	Background Airway wall remodeling in allergic asthma is reduced after treatment with humanized anti-IgE-antibodies. We reported earlier that purified IgE, without the presence of allergens, is sufficient to induce airway wall remodeling due to airway smooth muscle cell (ASMC) activity deposing extracellular matrix. Objective We postulate that IgE contained in serum of allergic asthma patients, in the absence of allergens, stimulates ASMC remodeling activities and can be prevented by anti-IgE antibodies. Methods Isolated human ASMC were exposed to serum obtained from: (i) healthy controls, or patients with (ii) allergic asthma, (iii) non-allergic asthma, and (iv) atopic non-asthma patients. Proliferation and the deposition of collagens and fibronectin were determined after 3 and 5 days. Results Serum from patients with allergies significantly stimulated: (i) ASMC proliferation, (ii) deposition of collagen type-I (48 hours) and (iii) of fibronectin (24 hours). One hour pre-incubation with Omalizumab prevented these three effects of allergic serum, but had no significant effect on serum from healthy donors or non-allergic asthma patients. Interestingly, the addition of allergens did not further increase any of the IgE effects. Conclusion and Clinical Relevance Our data provides experimental evidence that the beneficial effect of Omalizumab on airway wall remodeling and improved lung function may be due to its direct action on IgE bound ASMC.	[Roth, Michael; Zhao, Feng; Zhong, Jun] Univ Basel, Pulm Cell Res, Dept Biomed, Basel, Switzerland; [Roth, Michael; Tamm, Michael] Univ Basel Hosp, Dept Internal Med, Pneumol, CH-4031 Basel, Switzerland; [Zhao, Feng] 4th Mil Med Univ, Xijing Hosp, Dept Resp Dis, Xian, Peoples R China; [Lardinois, Didier] Univ Basel Hosp, Dept Thorac Surg, CH-4031 Basel, Switzerland	University of Basel; University of Basel; Air Force Military Medical University; University of Basel	Roth, M (corresponding author), Univ Basel, Pulm Cell Res, Dept Biomed, Basel, Switzerland.	michael.roth@usb.ch	Roth, Michael/H-8657-2019	Roth, Michael/0000-0002-8139-2821	Novartis Pharma Schweiz AG [CIGE025A]	Novartis Pharma Schweiz AG	MT received support from Novartis Pharma Schweiz AG, CIGE025A, an unrestricted research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	[Anonymous], 2002, BIODRUGS, V16, P380; Baena-Cagnani CE, 2015, CURR OPIN ALLERGY CL; Barnes N, 2013, J ASTHMA, V50, P529, DOI 10.3109/02770903.2013.790419; Chan YC, 2014, J ALLERGY CLIN IMMUN, V134, P1394, DOI 10.1016/j.jaci.2014.06.029; Chang TW, 2007, ADV IMMUNOL, V93, P63, DOI 10.1016/S0065-2776(06)93002-8; Girodet PO, 2011, PHARMACOL THERAPEUT, V130, P325, DOI 10.1016/j.pharmthera.2011.02.001; Halayko AJ, 2003, RESP PHYSIOL NEUROBI, V137, P209, DOI 10.1016/S1569-9048(03)00148-4; Hirst SJ, 2000, AM J RESP CELL MOL, V23, P335, DOI 10.1165/ajrcmb.23.3.3990; Hoshino M, 2012, RESPIRATION, V83, P520, DOI 10.1159/000334701; Humbert M, 2014, J ALLER CL IMM-PRACT, V2, P525, DOI 10.1016/j.jaip.2014.03.010; Jesudason EC, 2009, THORAX, V64, P541, DOI 10.1136/thx.2008.107094; Johnson PRA, 2006, AM J RESP CRIT CARE, V173, P32, DOI 10.1164/rccm.200406-703OC; Johnson PRA, 2004, J ALLERGY CLIN IMMUN, V113, P690, DOI 10.1016/j.jaci.2003.12.312; Johnson PRA, 2001, AM J RESP CRIT CARE, V164, P474, DOI 10.1164/ajrccm.164.3.2010109; Lambers C, 2014, BIOCHEM PHARMACOL, V91, P400, DOI 10.1016/j.bcp.2014.07.026; Lambrecht BN, 2013, EUR J IMMUNOL, V43, P3125, DOI 10.1002/eji.201343730; Nam YH, 2012, J INVEST ALLERG CLIN, V22, P20; Ozgur ES, 2013, J ASTHMA, V50, P687, DOI 10.3109/02770903.2013.792348; Plopper CG, 2007, TOXICOL PATHOL, V35, P97, DOI 10.1080/01926230601132030; Prakash YS, 2013, AM J PHYSIOL-LUNG C, V305, pL912, DOI 10.1152/ajplung.00259.2013; Rabe KF, 2011, ALLERGY, V66, P1142, DOI 10.1111/j.1398-9995.2011.02617.x; Redhu NS, 2013, ALLERGY ASTHMA CL IM, V9, DOI 10.1186/1710-1492-9-41; Redhu NS, 2013, PULM PHARMACOL THER, V26, P86, DOI 10.1016/j.pupt.2012.04.004; Riccio AM, 2012, INT J IMMUNOPATH PH, V25, P475, DOI 10.1177/039463201202500217; Roth M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056015; Roth M, 2010, ANN ALLERG ASTHMA IM, V104, P152, DOI 10.1016/j.anai.2009.11.022; Schieck M, 2014, J ALLERGY CLIN IMMUN, V133, P888, DOI 10.1016/j.jaci.2013.08.048; Schulman ES, 2001, AM J RESP CRIT CARE, V164, pS6, DOI 10.1164/ajrccm.164.supplement_1.2103025; Tajiri T, 2014, ANN ALLERG ASTHMA IM, V113, P470, DOI 10.1016/j.anai.2014.06.004; Ward JE, 2008, EUR RESPIR J, V32, P362, DOI 10.1183/09031936.00119307; Yamauchi Eri, 2008, Allergol Int, V57, P73, DOI 10.2332/allergolint.O-06-481	31	35	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136549	10.1371/journal.pone.0136549	http://dx.doi.org/10.1371/journal.pone.0136549			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332463	Green Published, Green Submitted, gold			2022-12-26	WOS:000360613800061
J	Calkins, TL; Piermarini, PM				Calkins, Travis L.; Piermarini, Peter M.			Pharmacological and Genetic Evidence for Gap Junctions as Potential New Insecticide Targets in the Yellow Fever Mosquito, Aedes aegypti	PLOS ONE			English	Article							RENAL TUBULES; ANOPHELES-GAMBIAE; CHANNELS; CELLS; COMMUNICATION; PERMEABILITY; EXPRESSION; INNEXINS; SEIZURES	The yellow fever mosquito Aedes aegypti is an important vector of viral diseases that impact global health. Insecticides are typically used to manage mosquito populations, but the evolution of insecticide resistance is limiting their effectiveness. Thus, identifying new molecular and physiological targets in mosquitoes is needed to facilitate insecticide discovery and development. Here we test the hypothesis that gap junctions are valid molecular and physiological targets for new insecticides. Gap junctions are intercellular channels that mediate direct communication between neighboring cells and consist of evolutionarily distinct proteins in vertebrate (connexins) and invertebrate (innexins) animals. We show that the injection of pharmacological inhibitors of gap junctions (i.e., carbenoxolone, meclofenamic acid, or mefloquine) into the hemolymph of adult female mosquitoes elicits dose-dependent toxic effects, with mefloquine showing the greatest potency. In contrast, when applied topically to the cuticle, carbenoxolone was the only inhibitor to exhibit full efficacy. In vivo urine excretion assays demonstrate that both carbenoxolone and mefloquine inhibit the diuretic output of adult female mosquitoes, suggesting inhibition of excretory functions as part of their mechanism of action. When added to the rearing water of 1st instar larvae, carbenoxolone and meclofenamic acid both elicit dose-dependent toxic effects, with meclofenamic acid showing the greatest potency. Injecting a double-stranded RNA cocktail against innexins into the hemolymph of adult female mosquitoes knock down whole-animal innexin mRNA expression and decreases survival of the mosquitoes. Taken together these data indicate that gap junctions may provide novel molecular and physiological targets for the development of insecticides.	[Calkins, Travis L.; Piermarini, Peter M.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Entomol, Wooster, OH 44691 USA	University System of Ohio; Ohio State University	Piermarini, PM (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Entomol, Wooster, OH 44691 USA.	piermarini.1@osu.edu	Piermarini, Peter/AAO-5666-2021	Piermarini, Peter/0000-0003-1020-5774	National Institutes of Health [R03DK090186]; Mosquito Research Foundation [2014-03]; Ohio Agricultural Research and Development Center SEEDS [2014-078]; Ohio Mosquito Control Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK090186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mosquito Research Foundation; Ohio Agricultural Research and Development Center SEEDS; Ohio Mosquito Control Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health, R03DK090186, http://www.nih.gov/; Mosquito Research Foundation, 2014-03, http://www.mosquitoresearch.org/; Ohio Agricultural Research and Development Center SEEDS, 2014-078, oardc.osu.edu/seeds; Ohio Mosquito Control Association, Grant-In-Aid, http://www.ohiomosquito.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anava S, 2009, INSECT BIOCHEM MOLEC, V39, P224, DOI 10.1016/j.ibmb.2008.12.002; Beyenbach KW, 2011, ACTA PHYSIOL, V202, P387, DOI 10.1111/j.1748-1716.2010.02195.x; Calkins TL, 2015, COMP BIOCHEM PHYS B, V183, P11, DOI 10.1016/j.cbpb.2014.11.013; Cao FL, 1998, J CELL SCI, V111, P31; Carlen PL, 2000, BRAIN RES REV, V32, P235, DOI 10.1016/S0165-0173(99)00084-3; CDC, 2015, CHIK VIR US; CDC, 2013, W NIL VIR PREV CONTR; Connors BW, 2012, EPILEPSY CURR, V12, P66, DOI 10.5698/1535-7511-12.2.66; Cruikshank SJ, 2004, P NATL ACAD SCI USA, V101, P12364, DOI 10.1073/pnas.0402044101; Drake LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015578; Giuliani F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069212; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lu HL, 2011, INSECT BIOCHEM MOLEC, V41, P135, DOI 10.1016/j.ibmb.2010.10.003; Luo KJ, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.0106; Muller P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000286; Nachman RJ, 1997, PEPTIDES, V18, P53, DOI 10.1016/S0196-9781(96)00233-1; Ning N, 2013, HUM EXP TOXICOL, V32, P1164, DOI 10.1177/0960327112472997; Phelan P, 2001, BIOESSAYS, V23, P388, DOI 10.1002/bies.1057; Piermarini PM, 2014, GEN COMP ENDOCR, V203, P43, DOI 10.1016/j.ygcen.2013.11.020; Piermarini PM, 2011, AM J PHYSIOL-REG I, V301, pR1318, DOI 10.1152/ajpregu.00223.2011; Piermarini PM, 2010, AM J PHYSIOL-REG I, V298, pR642, DOI 10.1152/ajpregu.00729.2009; Powers AM, 2015, J GEN VIROL, V96, P1, DOI 10.1099/vir.0.070136-0; Pridgeon JW, 2009, J MED ENTOMOL, V46, P335, DOI 10.1603/033.046.0219; Ramsay JA, 1953, J EXP BIOL; Raphemot R, 2014, INSECT BIOCHEM MOLEC, V51, P10, DOI 10.1016/j.ibmb.2014.05.002; Raphemot R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064905; Revuelta L, 2009, INSECT BIOCHEM MOLEC, V39, P913, DOI 10.1016/j.ibmb.2009.11.001; Rozen S, 1998, PRIMER3; Sangaletti R, 2014, AM J PHYSIOL-CELL PH, V307, pC966, DOI 10.1152/ajpcell.00246.2014; Srinivas M, 2003, MOL PHARMACOL, V63, P1389, DOI 10.1124/mol.63.6.1389; SWENSON KI, 1989, CELL, V57, P145, DOI 10.1016/0092-8674(89)90180-3; Thailayil J, 2011, P NATL ACAD SCI USA, V108, P13677, DOI 10.1073/pnas.1104738108; Tice CM, 2001, PEST MANAG SCI, V57, P3, DOI 10.1002/1526-4998(200101)57:1<3::AID-PS269>3.0.CO;2-6; Tolle Michael A, 2009, Curr Probl Pediatr Adolesc Health Care, V39, P97, DOI 10.1016/j.cppeds.2009.01.001; Weng XH, 2008, J EXP BIOL, V211, P409, DOI 10.1242/jeb.011213; WHO, 2014, YELL FEV, P1; Zhou XX, 2009, PESTIC BIOCHEM PHYS, V93, P77, DOI 10.1016/j.pestbp.2008.11.007	37	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137084	10.1371/journal.pone.0137084	http://dx.doi.org/10.1371/journal.pone.0137084			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325403	gold, Green Submitted, Green Published			2022-12-26	WOS:000360437700091
J	Inselman, WM; Datta, S; Jenks, JA; Jensen, KC; Grovenburg, TW				Inselman, Will M.; Datta, Shubham; Jenks, Jonathan A.; Jensen, Kent C.; Grovenburg, Troy W.			Buteo Nesting Ecology: Evaluating Nesting of Swainson's Hawks in the Northern Great Plains	PLOS ONE			English	Article							WEST-NILE-VIRUS; SITE SELECTION; HABITAT USE; POPULATIONS; SURVIVAL; PRODUCTIVITY; INFECTION; VALLEY; COVER	Swainson's hawks (Buteo swainsoni) are long-distance migratory raptors that nest primarily in isolated trees located in areas of high grassland density. In recent years, anthropogenic conversion of grassland habitat has raised concerns about the status of the breeding population in the northern Great Plains. In 2013, we initiated a study to investigate the influence of extrinsic factors influencing Swainson's hawk nesting ecology in north-central South Dakota and south-central North Dakota. Using ground and aerial surveys, we located and monitored nesting Swainson's hawk pairs: 73 in 2013 and 120 in 2014. We documented 98 successful breeding attempts that fledged 163 chicks; 1.52 and 1.72 fledglings per successful nest in 2013 and 2014, respectively. We used Program MARK to evaluate the influence of land cover on nest survival. The top model, SDist2Farm+%Hay, indicated that nest survival (fledging at least one chick) decreased as nests were located farther from farm sites and as the percent of hay cover increased within 1200-m of the nest site (34.4%; 95% CI = 27.6%-42.3%). We used logistic regression analysis to evaluate the influence of landscape variables on nest-site selection; Swainson's hawks selected for nest sites located closer to roads. We suggest that tree belts associated with farm sites, whether occupied or not, provide critical breeding sites for Swainson's hawks. Additionally, poor breeding success may be related to the late migratory behavior of this species which requires them to occupy marginal habitat due to other raptors occupying the most suitable habitat prior to Swainson's hawks arriving to the breeding grounds.	[Inselman, Will M.; Datta, Shubham; Jenks, Jonathan A.; Jensen, Kent C.; Grovenburg, Troy W.] S Dakota State Univ, Dept Nat Resource Management, Brookings, SD 57007 USA	South Dakota State University	Inselman, WM (corresponding author), S Dakota State Univ, Dept Nat Resource Management, Brookings, SD 57007 USA.	will.inselman@sdstate.edu	Jenks, Jonathan A/B-7321-2009		Agriculture Experiment Station at South Dakota State University; North Dakota Department of Game and Fish, State Wildlife Grant [T-36-R]	Agriculture Experiment Station at South Dakota State University; North Dakota Department of Game and Fish, State Wildlife Grant	Funding for this study was provided by the Agriculture Experiment Station at South Dakota State University and the North Dakota Department of Game and Fish, State Wildlife Grant T-36-R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN DE, 1995, J RAPTOR RES, V29, P158; BABCOCK KW, 1995, J RAPTOR RES, V29, P193; Barber-Meyer SM, 2008, WILDLIFE MONOGR, P1, DOI 10.2193/2008-004; BECHARD MJ, 1982, CONDOR, V84, P153, DOI 10.2307/1367658; BECHARD MJ, 1990, J FIELD ORNITHOL, V61, P159; BEDNARZ JC, 1988, CONDOR, V90, P311, DOI 10.2307/1368559; Beyer H. L, 2012, GEOSPATIAL MODELLING; Briggs CW, 2011, J WILDLIFE MANAGE, V75, P1307, DOI 10.1002/jwmg.167; Bryce SA., 1996, ECOREGIONS N DAKOTA; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Datta Shubham, 2015, Prairie Naturalist, V47, P38; Devries JH, 2003, J WILDLIFE MANAGE, V67, P551, DOI 10.2307/3802713; ENGLAND AS, 1995, J RAPTOR RES, V29, P179; ESRI, 2011, ARCGIS DESKT REL 10; Fair J., 2010, ORNITHOLOGICAL COUNC; Fyfe R.W., 1976, Occasional Pap Can Wildl Serv, VNo. 23, P1; GILMER DS, 1984, CONDOR, V86, P12, DOI 10.2307/1367335; Hagen SK, 2005, N DAKOTA COMPREHENSI; HANSEN RW, 1995, J RAPTOR RES, V29, P166; Hosmer DW, 2013, APPL LOGISTIC REGRES, V398; HOUSTON CS, 1995, J RAPTOR RES, V29, P198; Inselman WM., 2015, THESIS S DAKOTA STAT; Johnson MD, 2008, WEST N AM NATURALIST, V68, P444, DOI 10.3398/1527-0904-68.4.444; Johnston CA, 2013, WETLANDS, V33, P175, DOI 10.1007/s13157-012-0365-x; LOKEMOEN JT, 1976, CONDOR, V78, P464, DOI 10.2307/1367095; McConnell S, 2008, WILSON J ORNITHOL, V120, P708, DOI 10.1676/07-048.1; Nemeth N, 2006, J WILDLIFE DIS, V42, P1, DOI 10.7589/0090-3558-42.1.1; Neter J., 1996, APPL LINEAR STAT MOD; Nishida C, 2013, J RAPTOR RES, V47, P377, DOI 10.3356/JRR-12-16.2; North Dakota State Climate Office, 2010, 30 YEAR AV 1981 2010; R Core Team, 2020, R LANG ENV STAT COMP; ROTHFELS M, 1983, CAN J ZOOL, V61, P60, DOI 10.1139/z83-006; SCHMUTZ JK, 1980, CAN J ZOOL, V58, P1075, DOI 10.1139/z80-151; SCHMUTZ JK, 1987, J RANGE MANAGE, V40, P438, DOI 10.2307/3899606; SCHMUTZ JK, 1989, CONDOR, V91, P362, DOI 10.2307/1368315; SMALLWOOD KS, 1995, J RAPTOR RES, V29, P172; South Dakota Department of Game Fish and Parks, 2005, S DAK ALL BIRD CONS; Stout WE, 2005, AVIAN DIS, V49, P371, DOI 10.1637/7335-012805R1.1; U.S. Fish and Wildlife Service, 2011, BIRDS MAN CONC 2011; United States Department of Agriculture, 2010, USDA S DAK ANN STAT; United States Department of Agriculture, 2014, CONS PROGR REP STAT; USDA National Agricultrual Statistics Service, 2014, CROPL DAT LAYER; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; WOODBRIDGE B, 1995, J RAPTOR RES, V29, P202; Wright CK, 2013, P NATL ACAD SCI USA, V110, P4134, DOI 10.1073/pnas.1215404110	45	5	5	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137045	10.1371/journal.pone.0137045	http://dx.doi.org/10.1371/journal.pone.0137045			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327440	Green Published, Green Submitted, gold			2022-12-26	WOS:000360437700085
J	Jobst, BJ; Wielputz, MO; Triphan, SMF; Anjorin, A; Ley-Zaporozhan, J; Kauczor, HU; Biederer, J; Ley, S; Sedlaczek, O				Jobst, Bertram J.; Wielpuetz, Mark O.; Triphan, Simon M. F.; Anjorin, Angela; Ley-Zaporozhan, Julia; Kauczor, Hans-Ulrich; Biederer, Juergen; Ley, Sebastian; Sedlaczek, Oliver			Morpho-Functional 1H-MRI of the Lung in COPD: Short-Term Test-Retest Reliability	PLOS ONE			English	Article							OBSTRUCTIVE-PULMONARY-DISEASE; QUANTITATIVE COMPUTED-TOMOGRAPHY; CYSTIC-FIBROSIS; PROTON MRI; PERFUSION; EMPHYSEMA; CT; AGREEMENT; DYSFUNCTION; CAPABILITY	Purpose Non-invasive end-points for interventional trials and tailored treatment regimes in chronic obstructive pulmonary disease (COPD) for monitoring regionally different manifestations of lung disease instead of global assessment of lung function with spirometry would be valuable. Proton nuclear magnetic resonance imaging (1H-MRI) allows for a radiation-free assessment of regional structure and function. The aim of this study was to evaluate the short-term reproducibility of a comprehensive morpho-functional lungMRI protocol in COPD. Materials and Methods 20 prospectively enrolled COPD patients (GOLD I-IV) underwent 1H-MRI of the lung at 1.5T on two consecutive days, including sequences for morphology, 4D contrast-enhanced perfusion, and respiratory mechanics. Image quality and COPD-related morphological and functional changes were evaluated in consensus by three chest radiologists using a dedicated MRI-based visual scoring system. Test-retest reliability was calculated per each individual lung lobe for the extent of large airway (bronchiectasis, wall thickening, mucus plugging) and small airway abnormalities (tree in bud, peripheral bronchiectasis, mucus plugging), consolidations, nodules, parenchymal defects and perfusion defects. The presence of tracheal narrowing, dystelectasis, pleural effusion, pulmonary trunk ectasia, right ventricular enlargement and, finally, motion patterns of diaphragma and chest wall were addressed. Results Median global scores [10(Q1:8.00; Q3:16.00) vs. 11(Q1:6.00; Q3:15.00)] as well as category subscores were similar between both timepoints, and kappa statistics indicated "almost perfect" global agreement (kappa = 0.86, 95% CI = 0.81-0.91). Most subscores showed at least "substantial" agreement of MRI1 and MRI2 (kappa = 0.64-1.00), whereas the agreement for the diagnosis of dystelectasis/effusion (kappa = 0.42, 95% CI = 0.00-0.93) was "moderate" and of tracheal abnormalities (kappa = 0.21, 95% CI = 0.00-0.75) "fair". Most MRI acquisitions showed at least diagnostic quality at MRI1 (276 of 278) and MRI2 (259 of 264). Conclusion Morpho-functional 1H-MRI can be obtained with reproducible image quality and high short-term test-retest reliability for COPD-related morphological and functional changes of the lung. This underlines its potential value for the monitoring of regional lung characteristics in COPD trials.	[Jobst, Bertram J.; Wielpuetz, Mark O.; Triphan, Simon M. F.; Anjorin, Angela; Ley-Zaporozhan, Julia; Kauczor, Hans-Ulrich; Biederer, Juergen; Ley, Sebastian; Sedlaczek, Oliver] Univ Heidelberg Hosp, Dept Diagnost & Intervent Radiol, Heidelberg, Germany; [Jobst, Bertram J.; Wielpuetz, Mark O.; Triphan, Simon M. F.; Anjorin, Angela; Ley-Zaporozhan, Julia; Kauczor, Hans-Ulrich; Biederer, Juergen; Ley, Sebastian; Sedlaczek, Oliver] Translat Lung Res Ctr Heidelberg TLRC, Heidelberg, Germany; [Jobst, Bertram J.; Wielpuetz, Mark O.; Anjorin, Angela; Kauczor, Hans-Ulrich; Sedlaczek, Oliver] Heidelberg Univ, Dept Diagnost & Intervent Radiol Nucl Med, Thoraxklin, Heidelberg, Germany; [Triphan, Simon M. F.] Res Ctr Magnet Resonance Bavaria MRB, Wurzburg, Germany; [Ley-Zaporozhan, Julia] Univ Hosp Munich, Inst Clin Radiol, Munich, Germany; [Biederer, Juergen] Cty Hosp Gross Gerau, Dept Radiol, Radiol Darmstadt, Gross Gerau, Germany; [Ley, Sebastian] Surg Hosp Dr Rinecker, Dept Diagnost & Intervent Radiol, Munich, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Wurzburg; University of Munich	Jobst, BJ (corresponding author), Univ Heidelberg Hosp, Dept Diagnost & Intervent Radiol, Heidelberg, Germany.	bertram.jobst@med.uni-heidelberg.de	Kauczor, Hans-Ulrich/AAU-5955-2021; Wielpütz, Mark Oliver/ADP-0499-2022; Ley, Sebastian/I-3426-2013; Wielpuetz, Mark/ABE-1790-2020; Kauczor, HU/AAX-6033-2021	Wielpütz, Mark Oliver/0000-0001-6962-037X; Ley, Sebastian/0000-0001-9269-2670; Wielpuetz, Mark/0000-0001-6962-037X; 	Competence Network on Asthma/COPD (ASCONET) through a grant from the Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF) of the federal government of Germany [01GI0870]	Competence Network on Asthma/COPD (ASCONET) through a grant from the Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF) of the federal government of Germany	This work has been supported by the Competence Network on Asthma/COPD (ASCONET) through a grant from the Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF) of the federal government of Germany (01GI0870, www.bmbf.de/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflict of interest with regard to the study at hand.	Barr R Graham, 2011, Proc Am Thorac Soc, V8, P522, DOI 10.1513/pats.201101-008MW; Biederer J, 2012, INSIGHTS IMAGING, V3, P355, DOI 10.1007/s13244-011-0146-8; Biederer J, 2012, INSIGHTS IMAGING, V3, P373, DOI 10.1007/s13244-011-0142-z; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Coxson Harvey O, 2008, Proc Am Thorac Soc, V5, P940, DOI 10.1513/pats.200806-057QC; Coxson HO, 2005, ACAD RADIOL, V12, P1457, DOI 10.1016/j.acra.2005.08.013; Dournes G, 2015, RADIOLOGY, V276, P258, DOI 10.1148/radiol.15141655; Eichinger M, 2006, EUR RADIOL, V16, P2147, DOI 10.1007/s00330-006-0257-7; Eichinger M, 2012, EUR J RADIOL, V81, P1321, DOI 10.1016/j.ejrad.2011.02.045; Fan L, 2013, EUR RADIOL, V23, P1234, DOI 10.1007/s00330-012-2729-2; GAY SB, 1994, INVEST RADIOL, V29, P848, DOI 10.1097/00004424-199409000-00009; Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC; Henderson AC, 2007, RESP PHYSIOL NEUROBI, V155, P234, DOI 10.1016/j.resp.2006.05.009; Hopkins SR, 2012, J APPL PHYSIOL, V113, P328, DOI 10.1152/japplphysiol.00320.2012; Hueper K, 2013, INVEST RADIOL, V48, P223, DOI 10.1097/RLI.0b013e318281057d; Iwasawa T, 2000, J THORAC IMAG, V15, P191, DOI 10.1097/00005382-200007000-00007; Iwasawa T, 2002, EUR RESPIR J, V19, P225, DOI 10.1183/09031936.02.00044602; Johnson KM, 2013, MAGN RESON MED, V70, P1241, DOI 10.1002/mrm.24570; Kauczor HU, 2011, J THORAC IMAG, V26, P290, DOI 10.1097/RTI.0b013e3182277113; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Ley-Zaporozhan J, 2007, EUR J RADIOL, V63, P76, DOI 10.1016/j.ejrad.2007.01.020; Ley-Zaporozhan J, 2010, J MAGN RESON IMAGING, V32, P1340, DOI 10.1002/jmri.22376; Ley-Zaporozhan J, 2010, EUR J RADIOL, V73, P43, DOI 10.1016/j.ejrad.2008.09.029; Ley-Zaporozhan J, 2008, MAGN RESON IMAGING C, V16, P291, DOI 10.1016/j.mric.2008.02.014; Lynch DA, RADIOLOGY IN PRESS; Miller GW, 2014, NMR BIOMED, V27, P1542, DOI 10.1002/nbm.3156; OSWALDMAMMOSSER M, 1995, CHEST, V107, P1193, DOI 10.1378/chest.107.5.1193; Puderbach M, 2007, INVEST RADIOL, V42, P715, DOI 10.1097/RLI.0b013e318074fd81; Puderbach M, 2007, EUR RADIOL, V17, P716, DOI 10.1007/s00330-006-0373-4; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Sergiacomi G, 2003, IN VIVO, V17, P319; Sommer G, 2014, EUR J RADIOL, V83, P600, DOI 10.1016/j.ejrad.2013.11.012; Suga K, 1999, JMRI-J MAGN RESON IM, V10, P510, DOI 10.1002/(SICI)1522-2586(199910)10:4<510::AID-JMRI3>3.0.CO;2-G; Tan RT, 1998, CHEST, V113, P1250, DOI 10.1378/chest.113.5.1250; Thieme SF, 2012, EUR J RADIOL, V81, P360, DOI 10.1016/j.ejrad.2010.11.037; van der Meer RW, 2005, RADIOLOGY, V235, P798, DOI 10.1148/radiol.2353040593; Wells JM, 2012, NEW ENGL J MED, V367, P913, DOI 10.1056/NEJMoa1203830; Wielputz M, 2012, DIAGN INTERV RADIOL, V18, P344, DOI 10.4261/1305-3825.DIR.5365-11.0; Wielputz MO, 2014, AM J RESP CRIT CARE, V189, P956, DOI 10.1164/rccm.201309-1659OC; Wielputz MO, 2014, RESPIRATION, V87, P294, DOI 10.1159/000357448; Xia Y, 2014, COPD, V11, P510, DOI 10.3109/15412555.2014.948990	42	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137282	10.1371/journal.pone.0137282	http://dx.doi.org/10.1371/journal.pone.0137282			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327295	Green Published, gold, Green Submitted			2022-12-26	WOS:000360437700106
J	Nielsen, MA; Resende, M; de Jongh, WA; Ditlev, SB; Mordmuller, B; Houard, S; Ndam, NT; Agerbaek, MO; Hamborg, M; Massougbodji, A; Issifou, S; Strobaek, A; Poulsen, L; Leroy, O; Kremsner, PG; Chippaux, JP; Luty, AJF; Deloron, P; Theander, TG; Dyring, C; Salanti, A				Nielsen, Morten A.; Resende, Mafalda; de Jongh, Willem A.; Ditlev, Sisse B.; Mordmueller, Benjamin; Houard, Sophie; Ndam, Nicaise Tuikue; Agerbaek, Mette O.; Hamborg, Mette; Massougbodji, Achille; Issifou, Saddou; Strobaek, Anette; Poulsen, Lars; Leroy, Odile; Kremsner, Peter G.; Chippaux, Jean-Philippe; Luty, Adrian J. F.; Deloron, Philippe; Theander, Thor G.; Dyring, Charlotte; Salanti, Ali			The Influence of Sub-Unit Composition and Expression System on the Functional Antibody Response in the Development of a VAR2CSA Based Plasmodium falciparum Placental Malaria Vaccine	PLOS ONE			English	Article							VARIANT SURFACE-ANTIGENS; CHONDROITIN SULFATE-A; INFECTED ERYTHROCYTES; PREGNANCY; ADHESION; PARASITES; EPITOPES; INSIGHT; DOMAINS; TARGETS	The disease caused by Plasmodium falciparum (Pf) involves different clinical manifestations that, cumulatively, kill hundreds of thousands every year. Placental malaria (PM) is one such manifestation in which Pf infected erythrocytes (IE) bind to chondroitin sulphate A (CSA) through expression of VAR2CSA, a parasite-derived antigen. Protection against PM is mediated by antibodies that inhibit binding of IE in the placental intervillous space. VAR2CSA is a large antigen incompatible with large scale recombinant protein expression. Vaccines based on sub-units encompassing the functionally constrained receptor-binding domains may, theoretically, circumvent polymorphisms, reduce the risk of escape-mutants and induce cross-reactive antibodies. However, the sub-unit composition and small differences in the borders, may lead to exposure of novel immuno-dominant antibody epitopes that lead to non-functional antibodies, and furthermore influence the folding, stability and yield of expression. Candidate antigens from the pre-clinical development expressed in High-Five insect cells using the baculovirus expression vector system were transitioned into the Drosophila Schneider-2 cell (S2) expression-system compliant with clinical development. The functional capacity of antibodies against antigens expressed in High-Five cells or in S2 cells was equivalent. This enabled an extensive down-selection of S2 insect cell-expressed antigens primarily encompassing the minimal CSA-binding region of VAR2CSA. In general, we found differential potency of inhibitory antibodies against antigens with the same borders but of different var2csa sequences. Likewise, we found that subtle size differences in antigens of the same sequence gave varying levels of inhibitory antibodies. The study shows that induction of a functional response against recombinant subunits of the VAR2CSA antigen is unpredictable, demonstrating the need for large-scale screening in order to identify antigens that induce a broadly strain-transcending antibody response.	[Nielsen, Morten A.; Resende, Mafalda; Ditlev, Sisse B.; Agerbaek, Mette O.; Hamborg, Mette; Theander, Thor G.; Salanti, Ali] Univ Copenhagen, Ctr Med Parasitol, Dept Immunol & Microbiol, Fac Hlth & Med Sci, Copenhagen, Denmark; [Nielsen, Morten A.; Resende, Mafalda; Ditlev, Sisse B.; Agerbaek, Mette O.; Hamborg, Mette; Theander, Thor G.; Salanti, Ali] Rigshosp, Dept Infect Dis, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark; [de Jongh, Willem A.; Strobaek, Anette; Poulsen, Lars; Dyring, Charlotte] SCION DTU Sci Pk, Biotechnol ExpreS2, Horsholm, Denmark; [Mordmueller, Benjamin; Kremsner, Peter G.] Univ Tubingen, Inst Tropenmed, Tubingen, Germany; [Mordmueller, Benjamin; Kremsner, Peter G.] Ctr Rech Med Lambarene, Lambarene, Gabon; [Houard, Sophie; Leroy, Odile] Univ Klinikum Heidelberg, European Vaccine Initiat, Heidelberg, Germany; [Ndam, Nicaise Tuikue; Chippaux, Jean-Philippe; Luty, Adrian J. F.; Deloron, Philippe] Inst Rech Dev, Mere & Enfant Face Infect Trop UMR216, Paris, France; [Ndam, Nicaise Tuikue; Chippaux, Jean-Philippe; Luty, Adrian J. F.; Deloron, Philippe] Univ Paris 05, PRES Sorbonne Paris Cite, Paris, France; [Massougbodji, Achille; Issifou, Saddou; Chippaux, Jean-Philippe; Luty, Adrian J. F.] Univ Abomey Calavi, Fac Sci Sante, Ctr Etud & Rech Paludisme Associe Grossesse & Enf, Cotonou, Benin	University of Copenhagen; Rigshospitalet; University of Copenhagen; Eberhard Karls University of Tubingen; Ruprecht Karls University Heidelberg; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Abomey Calavi	Nielsen, MA (corresponding author), Univ Copenhagen, Ctr Med Parasitol, Dept Immunol & Microbiol, Fac Hlth & Med Sci, Copenhagen, Denmark.	mortenn@sund.ku.dk	Mordmüller, Benjamin/A-5749-2010; Theander, Thor/F-6714-2015; Deloron, Philippe/G-6305-2010; Luty, Adrian/CAH-2547-2022	Mordmüller, Benjamin/0000-0001-9101-2768; Theander, Thor/0000-0002-3509-7514; Deloron, Philippe/0000-0003-4705-2484; Poulsen, Lars/0000-0001-9106-8956; Luty, Adrian John Frederick/0000-0001-8830-3425; Tuikue Ndam, Nicaise/0000-0003-2646-2513; Chippaux, Jean-Philippe/0000-0002-1976-8568; Salanti, Ali/0000-0003-2207-5575; Ditlev, Sisse Bolm/0000-0003-4417-9711; Agerbaek, Mette Orskov/0000-0001-5865-2034; Nielsen, Morten Agertoug/0000-0003-2668-4992	European Union [304815]; Danish Advanced Technology Foundation [005-2011-1]; Expres2ion Biotechnologies	European Union(European Commission); Danish Advanced Technology Foundation; Expres2ion Biotechnologies	The research leading to these results has received funding from the European Union Seventh Framework Programme, FP7-HEALTH-2012-INNOVATION under grant agreement no 304815 (http://ec.europa.eu/research/fp7/index_en.cfm?pg=health) and the Danish Advanced Technology Foundation under grant number 005-2011-1 (http://innovationsfonden.dk/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Expres2ion Biotechnologies provided support in the form of salaries for authors [WAdeJ, AS, LP, CD], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000398; Andersen P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040042; Barfod L, 2007, MOL MICROBIOL, V63, P335, DOI 10.1111/j.1365-2958.2006.05503.x; Beeson JG, 2007, AM J TROP MED HYG, V77, P22, DOI 10.4269/ajtmh.2007.77.22; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Clausen TM, 2012, J BIOL CHEM, V287, P23332, DOI 10.1074/jbc.M112.348839; Ditlev SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043663; Duffy PE, 2003, INFECT IMMUN, V71, P6620, DOI 10.1128/IAI.71.11.6620-6623.2003; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Fried M, 2013, INFECT IMMUN, V81, P487, DOI 10.1128/IAI.01106-12; Haase RN, 2006, INFECT IMMUN, V74, P3035, DOI 10.1128/IAI.74.5.3035-3038.2006; Halbroth BR, 2015, ADV PARASIT, V88, P1, DOI 10.1016/bs.apar.2015.03.001; Lambert LH, 2014, INFECT IMMUN, V82, P4842, DOI 10.1128/IAI.02097-14; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Ndam NT, 2015, EMERG INFECT DIS, V21, P813, DOI 10.3201/eid2105.141626; Nielsen MA, 2002, J IMMUNOL, V168, P3444, DOI 10.4049/jimmunol.168.7.3444; Nielsen MA, 2009, INFECT IMMUN, V77, P2482, DOI 10.1128/IAI.00159-09; Oleinikov AV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031011; Olotu A, 2013, NEW ENGL J MED, V368, P1111, DOI 10.1056/NEJMoa1207564; Rask TS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000933; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Salanti A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-11; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; The malERA Consultative Group on Vaccine, 2011, PLOS MED, V8, DOI [10.1371/journal.pmed.1000398, DOI 10.1371/J0URNAL.PMED.1000398]; Tutterrow YL, 2012, INFECT IMMUN, V80, P1479, DOI 10.1128/IAI.00071-12; WHO, 2013, WHO MAL VACC TECHN R; Wright KE, 2014, NATURE, V515, P427, DOI 10.1038/nature13715	30	26	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0135406	10.1371/journal.pone.0135406	http://dx.doi.org/10.1371/journal.pone.0135406			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327283	Green Published, gold, Green Submitted			2022-12-26	WOS:000360437700018
J	Pacana, T; Cazanave, S; Verdianelli, A; Patel, V; Min, HK; Mirshahi, F; Quinlivan, E; Sanyal, AJ				Pacana, Tommy; Cazanave, Sophie; Verdianelli, Aurora; Patel, Vaishali; Min, Hae-Ki; Mirshahi, Faridoddin; Quinlivan, Eoin; Sanyal, Arun J.			Dysregulated Hepatic Methionine Metabolism Drives Homocysteine Elevation in Diet-Induced Nonalcoholic Fatty Liver Disease	PLOS ONE			English	Article							AMINO-ACID-METABOLISM; NITRIC-OXIDE SYNTHASE; ONE-CARBON METABOLISM; OXIDATIVE STRESS; DNA METHYLATION; LIQUID-CHROMATOGRAPHY; INSULIN-RESISTANCE; MASS-SPECTROMETRY; FOLLOW-UP; STEATOHEPATITIS	Methionine metabolism plays a central role in methylation reactions, production of glutathione and methylarginines, and modulating homocysteine levels. The mechanisms by which these are affected in NAFLD are not fully understood. The aim is to perform a metabolomic, molecular and epigenetic analyses of hepatic methionine metabolism in diet-induced NAFLD. Female 129S1/SvlmJ; C57Bl/6J mice were fed a chow (n = 6) or high-fat high-cholesterol (HFHC) diet (n = 8) for 52 weeks. Metabolomic study, enzymatic expression and DNA methylation analyses were performed. HFHC diet led to weight gain, marked steatosis and extensive fibrosis. In the methionine cycle, hepatic methionine was depleted (30%, p<0.01) while s-adenosylmethionine (SAM)/methionine ratio (p<0.05), s-adenosylhomocysteine (SAH) (35%, p<0.01) and homocysteine (25%, p<0.01) were increased significantly. SAH hydrolase protein levels decreased significantly (p<0.01). Serine, a substrate for both homocysteine remethylation and transsulfuration, was depleted (45%, p<0.01). In the transsulfuration pathway, cystathionine and cysteine trended upward while glutathione decreased significantly (p<0.05). In the transmethylation pathway, levels of glycine N-methyltransferase (GNMT), the most abundant methyltransferase in the liver, decreased. The phosphatidylcholine (PC)/phosphatidylethanolamine (PE) ratio increased significantly (p<0.01), indicative of increased phosphatidylethanolamine methyltransferase (PEMT) activity. The protein levels of protein arginine methytransferase 1 (PRMT1) increased significantly, but its products, monomethylarginine (MMA) and asymmetric dimethylarginine (ADMA), decreased significantly. Circulating ADMA increased and approached significance (p<0.06). Protein expression of methionine adenosyltransferase 1A, cystathionine beta-synthase, gamma-glutamylcysteine synthetase, betaine-homocysteine methyltransferase, and methionine synthase remained unchanged. Although gene expression of the DNA methyltransferase Dnmt3a decreased, the global DNA methylation was unaltered. Among individual genes, only HMG-CoA reductase (Hmgcr) was hypermethylated, and no methylation changes were observed in fatty acid synthase (Fasn), nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (Nf kappa b1), c-Jun, B-cell lymphoma 2 (Bcl-2) and Caspase 3. NAFLD was associated with hepatic methionine deficiency and homocysteine elevation, resulting mainly from impaired homocysteine remethylation, and aberrancy in methyltransferase reactions. Despite increased PRMT1 expression, hepatic ADMA was depleted while circulating ADMA was increased, suggesting increased export to circulation.	[Pacana, Tommy; Cazanave, Sophie; Verdianelli, Aurora; Patel, Vaishali; Min, Hae-Ki; Mirshahi, Faridoddin; Sanyal, Arun J.] Virginia Commonwealth Univ, Sch Med, Dept Internal Med, Div Gastroenterol Hepatol & Nutr, Richmond, VA 23298 USA; [Quinlivan, Eoin] Univ Florida, Gen Clin Res Ctr, Biomed Mass Spectrometry Lab, Gainesville, FL USA	Virginia Commonwealth University; State University System of Florida; University of Florida	Pacana, T (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Internal Med, Div Gastroenterol Hepatol & Nutr, Med Coll Virginia Campus, Richmond, VA 23298 USA.	tpacana@mcvh-vcu.edu; asanyal@mcvh-vcu.edu	Quinlivan, Eoin/AAJ-1979-2021; Quinlivan, Eoin P/B-8454-2008	Quinlivan, Eoin/0000-0002-0908-1762; Quinlivan, Eoin P/0000-0002-0908-1762	National Institutes of Health [RO1 DK 081450-03, T32 DK 007150-37]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK081450, T32DK007150] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by two grants from the National Institutes of Health to Dr. Sanyal: RO1 DK 081450-03 and T32 DK 007150-37.	[Anonymous], 2008, BIOMARKER METHODS IN; ARAKI A, 1987, J CHROMATOGR-BIOMED, V422, P43, DOI 10.1016/0378-4347(87)80438-3; Austin RC, 2004, CELL DEATH DIFFER, V11, pS56, DOI 10.1038/sj.cdd.4401451; Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; Bugianesi E, 2010, CURR PHARM DESIGN, V16, P1941, DOI 10.2174/138161210791208875; Carmiel-Haggai M, 2004, FASEB J, V18, P136, DOI 10.1096/fj.04-2291fje; Cheng JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044106; Cheung O, 2008, HEPATOLOGY, V48, P1810, DOI 10.1002/hep.22569; Cook RJ, 2000, AM J CLIN NUTR, V72, P1419; Dahlhoff C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057387; Dasarathy S, 2009, AM J PHYSIOL-GASTR L, V297, pG567, DOI 10.1152/ajpgi.00042.2009; Davis SR, 2004, AM J PHYSIOL-ENDOC M, V286, pE272, DOI 10.1152/ajpendo.00351.2003; Ekroos K, 2003, J LIPID RES, V44, P2181, DOI 10.1194/jlr.D300020-JLR200; Ekroos K, 2002, ANAL CHEM, V74, P941, DOI 10.1021/ac015655c; Finkelstein JD, 2003, AM J CLIN NUTR, V77, P1094, DOI 10.1093/ajcn/77.5.1094; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Fujita K, 2010, ALCOHOL CLIN EXP RES, V34, pS18, DOI 10.1111/j.1530-0277.2008.00756.x; Garcia-Tevijano ER, 2001, HYPERTENSION, V38, P1217, DOI 10.1161/hy1101.099499; Gregory JF, 2000, AM J CLIN NUTR, V72, P1535; Gulsen M, 2005, J GASTROEN HEPATOL, V20, P1448, DOI 10.1111/j.1440-1746.2005.03891.x; Ha SK, 2010, EXP ANIM TOKYO, V59, P595, DOI 10.1538/expanim.59.595; Hajer GR, 2007, HEART, V93, P216, DOI 10.1136/hrt.2006.093971; Henkel AS, 2009, J BIOL CHEM, V284, P31807, DOI 10.1074/jbc.M109.017970; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kalhan SC, 2011, CLIN SCI, V121, P179, DOI 10.1042/CS20110060; Kasumov T, 2011, METABOLISM, V60, P776, DOI 10.1016/j.metabol.2010.07.027; Kathirvel E, 2010, AM J PHYSIOL-GASTR L, V299, pG1068, DOI 10.1152/ajpgi.00249.2010; Kikuchi G, 2008, P JPN ACAD B-PHYS, V84, P246, DOI [10.2183/pjab.84.246, 10.2183/pjab/84.246]; Kwon DY, 2009, J NUTR, V139, P63, DOI 10.3945/jn.108.094771; Lazo M, 2008, SEMIN LIVER DIS, V28, P339, DOI 10.1055/s-0028-1091978; Lazo M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6891; Lu SC, 2008, J GASTROEN HEPATOL, V23, pS73, DOI 10.1111/j.1440-1746.2007.05289.x; Martinez-Chantar ML, 2008, HEPATOLOGY, V47, P1191, DOI 10.1002/hep.22159; Mato JM, 2008, ANNU REV NUTR, V28, P273, DOI 10.1146/annurev.nutr.28.061807.155438; Mato JM, 2007, HEPATOLOGY, V45, P1306, DOI 10.1002/hep.21650; Matte C, 2009, INT J DEV NEUROSCI, V27, P337, DOI 10.1016/j.ijdevneu.2009.03.005; Pogribny IP, 2009, J HEPATOL, V51, P176, DOI 10.1016/j.jhep.2009.03.021; Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; Quinlivan EP, 2008, ANAL BIOCHEM, V373, P383, DOI 10.1016/j.ab.2007.09.031; Quinlivan EP, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn534; Rafiq N, 2009, CLIN GASTROENTEROL H, V7, P234, DOI 10.1016/j.cgh.2008.11.005; de Carvalho SCR, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-37; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rolo AP, 2012, FREE RADICAL BIO MED, V52, P59, DOI 10.1016/j.freeradbiomed.2011.10.003; Rubio-Aliaga I, 2011, PHYSIOL GENOMICS, V43, P408, DOI 10.1152/physiolgenomics.00179.2010; Sass G, 2001, J CLIN INVEST, V107, P439, DOI 10.1172/JCI10613; Sibal L, 2010, CURR CARDIOL REV, V6, P82, DOI 10.2174/157340310791162659; Soderberg C, 2010, HEPATOLOGY, V51, P595, DOI 10.1002/hep.23314; Spruss A, 2011, ANTIOXID REDOX SIGN, V14, P2121, DOI 10.1089/ars.2010.3263; Stahlman M, 2009, J CHROMATOGR B, V877, P2664, DOI 10.1016/j.jchromb.2009.02.037; Stead LM, 2006, AM J CLIN NUTR, V83, P5; Vanni E, 2010, DIGEST LIVER DIS, V42, P320, DOI 10.1016/j.dld.2010.01.016; Videla LA, 2004, CLIN SCI, V106, P261, DOI 10.1042/CS20030285; Wan GH, 2000, BIOSCI BIOTECH BIOCH, V64, P555, DOI 10.1271/bbb.64.555; Wang LQ, 2004, CIRC RES, V94, P1318, DOI 10.1161/01.RES.0000129182.46440.4a; Williams KT, 2010, BIOFACTORS, V36, P19, DOI 10.1002/biof.71; Yun KU, 2013, EUR J NUTR, V52, P127, DOI 10.1007/s00394-011-0294-0	59	65	76	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136822	10.1371/journal.pone.0136822	http://dx.doi.org/10.1371/journal.pone.0136822			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322888	Green Published, Green Submitted, gold			2022-12-26	WOS:000360435500038
J	Almela, MJ; Lozano, S; Lelievre, J; Colmenarejo, G; Coteron, JM; Rodrigues, J; Gonzalez, C; Herreros, E				Jesus Almela, Maria; Lozano, Sonia; Lelievre, Joel; Colmenarejo, Gonzalo; Miguel Coteron, Jose; Rodrigues, Janneth; Gonzalez, Carolina; Herreros, Esperanza			A New Set of Chemical Starting Points with Plasmodium falciparum Transmission-Blocking Potential for Antimalarial Drug Discovery	PLOS ONE			English	Article							MALARIA; IDENTIFICATION; INHIBITORS; ASSAY; IDENTIFY; PARASITE; ATP	The discovery of new antimalarials with transmission blocking activity remains a key issue in efforts to control malaria and eventually eradicate the disease. Recently, high-throughput screening (HTS) assays have been successfully applied to Plasmodium falciparum asexual stages to screen millions of compounds, with the identification of thousands of new active molecules, some of which are already in clinical phases. The same approach has now been applied to identify compounds that are active against P. falciparum gametocytes, the parasite stage responsible for transmission. This study reports screening results for the Tres Cantos Antimalarial Set (TCAMS), of approximately 13,533 molecules, against P. falciparum stage V gametocytes. Secondary confirmation and cytotoxicity assays led to the identification of 98 selective molecules with dual activity against gametocytes and asexual stages. Hit compounds were chemically clustered and analyzed for appropriate physicochemical properties. The TCAMS chemical space around the prioritized hits was also studied. A selection of hit compounds was assessed ex vivo in the standard membrane feeding assay and demonstrated complete block in transmission. As a result of this effort, new chemical structures not connected to previously described antimalarials have been identified. This new set of compounds may serve as starting points for future drug discovery programs as well as tool compounds for identifying new modes of action involved in malaria transmission.	[Jesus Almela, Maria; Lozano, Sonia; Lelievre, Joel; Miguel Coteron, Jose; Rodrigues, Janneth; Gonzalez, Carolina; Herreros, Esperanza] GlaxoSmithKline, Madrid 28760, Spain; [Jesus Almela, Maria] Univ Nacl Educ Distancia, E-28040 Madrid, Spain; [Colmenarejo, Gonzalo] GlaxoSmithKline, Basic Res Ctr, Computat Chem Dept, Madrid 28760, Spain	GlaxoSmithKline; Universidad Nacional de Educacion a Distancia (UNED); GlaxoSmithKline	Herreros, E (corresponding author), GlaxoSmithKline, Tres Cantos Medicines Dev Campus Dis Dev World, Madrid 28760, Spain.	esperanza.a.herreros@gsk.com	Colmenarejo, Gonzalo/Q-6535-2018; Herreros, Esperanza/GQH-7182-2022	Colmenarejo, Gonzalo/0000-0002-8249-4547; Gonzalez Cortes, Carolina/0000-0002-8103-8996; Rodrigues, Janneth/0000-0001-9693-1958	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	The funder, GlaxoSmithKline, provided support in the form of salaries for authors [MJA, SL, JL, GC, JMC, JR, CG and EH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Avery VM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-190; Jimenez-Diaz MB, 2014, P NATL ACAD SCI USA, V111, pE5455, DOI 10.1073/pnas.1414221111; Bowman JD, 2014, ANTIMICROB AGENTS CH, V58, P811, DOI 10.1128/AAC.01500-13; Calderon F, 2011, ACS MED CHEM LETT, V2, P741, DOI 10.1021/ml200135p; Cree IA, 1997, TOXICOL IN VITRO, V11, P553, DOI 10.1016/S0887-2333(97)00060-X; Crowther GJ, 2011, MOL BIOCHEM PARASIT, V175, P21, DOI 10.1016/j.molbiopara.2010.08.005; D'Alessandro S, 2013, J ANTIMICROB CHEMOTH, V68, P2048, DOI 10.1093/jac/dkt165; Delves MJ, 2013, ANTIMICROB AGENTS CH, V57, P3268, DOI 10.1128/AAC.00325-13; Duffy S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-408; Flannery EL, 2013, NAT REV MICROBIOL, V11, P849, DOI 10.1038/nrmicro3138; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; Guiguemde WA, 2010, NATURE, V465, P311, DOI 10.1038/nature09099; KANGAS L, 1984, MED BIOL, V62, P338; Lelievre J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035019; Lucantoni L, 2013, ANTIMICROB AGENTS CH, V57, P6050, DOI 10.1128/AAC.00870-13; Miret S, 2006, J BIOMOL SCREEN, V11, P184, DOI 10.1177/1087057105283787; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Open access Malaria Box, 2015, OP ACC MAL BOX; Plouffe D, 2008, P NATL ACAD SCI USA, V105, P9059, DOI 10.1073/pnas.0802982105; Prole DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032264; RDKit, 2014, CHEM MACH LEARN SOFT; Ruecker A, 2014, ANTIMICROB AGENTS CH, V58, P7292, DOI 10.1128/AAC.03666-14; Sanders NG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105817; Smith TG, 2000, PARASITOLOGY, V121, P127, DOI 10.1017/S0031182099006265; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Vaidya AB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6521; VANHUYSSEN W, 1993, TROP MED PARASITOL, V44, P329; Wells TNC, 2009, NAT REV DRUG DISCOV, V8, P879, DOI 10.1038/nrd2972; Wetzel S, 2009, NAT CHEM BIOL, V5, P581, DOI 10.1038/nchembio.187; WHO, 2013, WORLD MALARIA REPORT 2013, P1	32	49	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135139	10.1371/journal.pone.0135139	http://dx.doi.org/10.1371/journal.pone.0135139			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317851	Green Published, Green Submitted, gold			2022-12-26	WOS:000360299100024
J	Kaur, G; Singh, S; Singh, H; Dutta, MCT; Kaur, H; Kaur, H; Bender, K; Snedden, WA; Kapoor, S; Pareek, A; Singh, P				Kaur, Gundeep; Singh, Supreet; Singh, Harpreet; Chawla, Mrinalini; Dutta, Tanima; Kaur, Harsimran; Bender, Kyle; Snedden, W. A.; Kapoor, Sanjay; Pareek, Ashwani; Singh, Prabhjeet			Characterization of Peptidyl-Prolyl Cis-Trans Isomerase- and Calmodulin-Binding Activity of a Cytosolic Arabidopsis thaliana Cyclophilin AtCyp19-3	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; HEAT-SHOCK; FUNCTIONAL-CHARACTERIZATION; CHLOROPLAST CYCLOPHILIN; RESPONSIVE CYCLOPHILIN; EXPRESSION; REDOX; GENE; STRESS; FAMILY	Cyclophilins, which bind to immunosuppressant cyclosporin A (CsA), are ubiquitous proteins and constitute a multigene family in higher organisms. Several members of this family are reported to catalyze cis-trans isomerisation of the peptidyl-prolyl bond, which is a rate limiting step in protein folding. The physiological role of these proteins in plants, with few exceptions, is still a matter of speculation. Although Arabidopsis genome is predicted to contain 35 cyclophilin genes, biochemical characterization, imperative for understanding their cellular function(s), has been carried only for few of the members. The present study reports the biochemical characterization of an Arabidopsis cyclophilin, AtCyp19-3, which demonstrated that this protein is enzymatically active and possesses peptidyl-prolyl cis-trans isomerase (PPIase) activity that is specifically inhibited by CsA with an inhibition constant (Ki) of 18.75 nM. The PPIase activity of AtCyp19-3 was also sensitive to Cu2+, which covalently reacts with the sulfhydryl groups, implying redox regulation. Further, using calmodulin (CaM) gel overlay assays it was demonstrated that in vitro interaction of AtCyp19-3 with CaM is Ca2+-dependent, and CaM-binding domain is localized to 35-70 amino acid residues in the N-terminus. Bimolecular fluorescence complementation assays showed that AtCyp19-3 interacts with CaM in vivo also, thus, validating the in vitro observations. However, the PPIase activity of the Arabidopsis cyclophilin was not affected by CaM. The implications of these findings are discussed in the context of Ca2+ signaling and cyclophilin activity in Arabidopsis.	[Kaur, Gundeep; Singh, Supreet; Singh, Harpreet; Dutta, Tanima; Kaur, Harsimran; Singh, Prabhjeet] Guru Nanak Dev Univ, Dept Biotechnol, Amritsar 143005, Punjab, India; [Singh, Harpreet] Hans Raj Mahila Maha Vidayalaya, Dept Bioinformat, Jalandhar, Punjab, India; [Chawla, Mrinalini; Kapoor, Sanjay] Univ Delhi, Interdiscipinary Ctr Plant Genom, New Delhi, India; [Chawla, Mrinalini; Kapoor, Sanjay] Univ Delhi, Dept Plant Mol Biol, New Delhi, India; [Bender, Kyle; Snedden, W. A.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Pareek, Ashwani] Nehru Univ, Sch Life Sci, Stress Physiol & Mol Biol Lab, New Delhi, India	Guru Nanak Dev University; University of Delhi; University of Delhi; Queens University - Canada; Jawaharlal Nehru University, New Delhi	Singh, P (corresponding author), Guru Nanak Dev Univ, Dept Biotechnol, Amritsar 143005, Punjab, India.	singhprabhjeet62@gmail.com	Bender, Kyle/AAJ-5993-2020; Bender, Kyle W/V-4678-2017; Dutta, Tanima/N-7222-2015	Bender, Kyle/0000-0002-1805-8097; Bender, Kyle W/0000-0002-1805-8097; Dutta, Tanima/0000-0002-2801-0687; SINGH, HARPREET/0000-0001-7202-3912; Kapoor, Sanjay/0000-0002-0283-1137	University Grants Commission, Govt. of India; Department of Biotechnology, Govt. of India; Council of Industrial and Scientific Research, Govt. of India	University Grants Commission, Govt. of India(University Grants Commission, India); Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); Council of Industrial and Scientific Research, Govt. of India	GK, TD and HK are thankful to University Grants Commission, Govt. of India, Department of Biotechnology, Govt. of India and Council of Industrial and Scientific Research, Govt. of India for the award of fellowships. Financial assistance for this work from the Department of Biotechnology, Govt. of India is gratefully acknowledged.	Ahn JC, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-253; Alberto AI, 1984, PHOTOSYNTH RES, V5, P215, DOI [10.1007/BF00030021, DOI 10.1007/BF00030021]; Bender KW, 2013, PLANT PHYSIOL, V163, P486, DOI 10.1104/pp.113.221069; Berardini TZ, 2001, SCIENCE, V291, P2405, DOI 10.1126/science.1057144; BIRNEY E, 1993, NUCLEIC ACIDS RES, V21, P5803, DOI 10.1093/nar/21.25.5803; Bouche N, 2002, J BIOL CHEM, V277, P21851, DOI 10.1074/jbc.M200268200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREIMAN A, 1992, J BIOL CHEM, V267, P21293; Campos BM, 2013, PLANT PHYSIOL, V162, P1311, DOI 10.1104/pp.113.218339; Chen AP, 2007, PLANT CELL REP, V26, P237, DOI 10.1007/s00299-006-0238-y; Cho H, 1997, BIOCHEMISTRY-US, V36, P382, DOI 10.1021/bi9624604; Chou IT, 1997, PLANT MOL BIOL, V35, P873, DOI 10.1023/A:1005930024796; Coaker G, 2005, SCIENCE, V308, P548, DOI 10.1126/science.1108633; COMPTON LA, 1992, EUR J BIOCHEM, V206, P927, DOI 10.1111/j.1432-1033.1992.tb17002.x; Daum S, 2009, BIOCHEMISTRY-US, V48, P6268, DOI 10.1021/bi9007287; DeFalco TA, 2010, BIOCHEM J, V425, P27, DOI 10.1042/BJ20091147; Dominguez-Solis JR, 2008, P NATL ACAD SCI USA, V105, P16386, DOI 10.1073/pnas.0808204105; Dornan J, 1999, J BIOL CHEM, V274, P34877, DOI 10.1074/jbc.274.49.34877; E.coli Genomic DNA Extraction, 2011, BIOPROTOCOL BIO, V101, pe97; Eidne KA, 2002, TRENDS ENDOCRIN MET, V13, P415, DOI 10.1016/S1043-2760(02)00669-0; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; Fu A, 2007, P NATL ACAD SCI USA, V104, P15947, DOI 10.1073/pnas.0707851104; Fulgosi H, 1998, EMBO J, V17, P1577, DOI 10.1093/emboj/17.6.1577; Galat S, 1998, RIVIERE PEPTIDYL PRO; GASSER CS, 1990, P NATL ACAD SCI USA, V87, P9519, DOI 10.1073/pnas.87.24.9519; Gottschalk M, 2008, PLANTA, V228, P687, DOI 10.1007/s00425-008-0771-8; Gourlay LJ, 2007, J BIOL CHEM, V282, P24851, DOI 10.1074/jbc.M702714200; Grebe M, 2000, PLANT CELL, V12, P343, DOI 10.1105/tpc.12.3.343; Hanahisa Y, 1998, BIOL PHARM BULL, V21, P1222; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; HAYANO T, 1991, BIOCHEMISTRY-US, V30, P3041, DOI 10.1021/bi00226a009; He Z, 2004, PLANT PHYSIOL, V134, P1; Kang B, 2013, PLANT J, V74, P86, DOI 10.1111/tpj.12106; KIEFFER LJ, 1992, J BIOL CHEM, V267, P5503; KOFRON JL, 1991, BIOCHEMISTRY-US, V30, P6127, DOI 10.1021/bi00239a007; Krajewska B, 2008, J ENZYM INHIB MED CH, V23, P535, DOI [10.1080/14756360701743051, 10.1080/14756360701743051 ]; Kumari S, 2012, PLANT SIGNAL BEHAV, V8, P25; Kumari S, 2009, MOL BIOTECHNOL, V42, P195, DOI 10.1007/s12033-009-9153-0; Kurek I, 2002, PLANT MOL BIOL, V48, P369, DOI 10.1023/A:1014023329807; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laxa M, 2007, BIOCHEM J, V401, P287, DOI 10.1042/BJ20061092; Lee LY, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-24; Li BB, 2010, J PROTEOME RES, V9, P4242, DOI 10.1021/pr100560v; LIPPUNER V, 1994, J BIOL CHEM, V269, P7863; LUAN S, 1994, PLANT CELL, V6, P885, DOI 10.1105/tpc.6.6.885; MARIVET J, 1992, PLANT SCI, V84, P171, DOI 10.1016/0168-9452(92)90131-5; Motohashi K, 2003, J BIOL CHEM, V278, P31848, DOI 10.1074/jbc.M304258200; O'Neil T, 1990, TRENDS BIOCHEM SCI, P54; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pogorelko GV, 2014, GENE, V538, P12, DOI 10.1016/j.gene.2014.01.029; Popescu SC, 2007, P NATL ACAD SCI USA, V104, P4730, DOI 10.1073/pnas.0611615104; Quig D, 1998, Altern Med Rev, V3, P262; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Romano PGN, 2004, PLANT PHYSIOL, V134, P1268, DOI 10.1104/pp.103.022160; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904; Sekhar K, 2010, PLANT CELL ENVIRON, V33, P1324, DOI 10.1111/j.1365-3040.2010.02151.x; Sekhon SS, 2013, ACTA CRYSTALLOGR D, V69, P555, DOI 10.1107/S0907444912051529; Shapiguzov A, 2006, FEBS LETT, V580, P3671, DOI 10.1016/j.febslet.2006.05.054; Sharma AD, 2003, J PLANT BIOCHEM BIOT, V12, P77, DOI 10.1007/BF03263165; Sharma AD, 2003, CURRENT SCI, V84, P912; Sheldon PS, 1996, BIOCHEM J, V315, P965, DOI 10.1042/bj3150965; Singh P., 2013, STRESS SIGNALING PLA, P1, DOI DOI 10.1007/978-1-4614-6372-6_1; Snedden WA, 2001, NEW PHYTOL, V51, P35; Trivedi DK, 2012, PLANT SIGNAL BEHAV, V7, P1653, DOI 10.4161/psb.22306; Trupkin SA, 2012, PLANT J, V71, P712, DOI 10.1111/j.1365-313X.2012.05013.x; Vasudevan D, 2012, PLANT CELL, V24, P2666, DOI 10.1105/tpc.111.093781; Villalobos V, 2007, ANNU REV BIOMED ENG, V9, P321, DOI 10.1146/annurev.bioeng.9.060906.152044; Virdi AS, 2011, PLANT SIGNAL BEHAV, V6, P393, DOI 10.4161/psb.6.3.13867; Virdi AS, 2009, FEBS LETT, V583, P767, DOI 10.1016/j.febslet.2009.01.025; WOLENSKI JS, 1995, TRENDS CELL BIOL, V5, P310, DOI 10.1016/S0962-8924(00)89053-4; Wu HC, 2012, PLANT CELL ENVIRON, V35, P1543, DOI 10.1111/j.1365-3040.2012.02508.x; Yang TB, 2010, J BIOL CHEM, V285, P7119, DOI 10.1074/jbc.M109.035659; Zhong SL, 2008, TRANSGENIC RES, V17, P985, DOI 10.1007/s11248-008-9199-y	76	19	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136692	10.1371/journal.pone.0136692	http://dx.doi.org/10.1371/journal.pone.0136692			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317213	Green Published, gold, Green Submitted			2022-12-26	WOS:000360299100122
J	Su, XM; Chu, YP; Kordower, JH; Li, B; Cao, H; Huang, L; Nishida, M; Song, L; Wang, DF; Federoff, HJ				Su, Xiaomin; Chu, Yaping; Kordower, Jeffrey H.; Li, Bin; Cao, Hong; Huang, Liang; Nishida, Maki; Song, Lei; Wang, Difei; Federoff, Howard J.			PGC-1 alpha Promoter Methylation in Parkinson's Disease	PLOS ONE			English	Article							SKELETAL-MUSCLE CELLS; INDUCED ER STRESS; NF-KAPPA-B; DNA METHYLATION; ALPHA-SYNUCLEIN; TRANSCRIPTIONAL REPRESSION; MITOCHONDRIAL BIOGENESIS; PROTEIN PALMITOYLATION; TRANSGENIC MICE; NEURODEGENERATION	The etiopathogenesis of sporadic Parkinson's disease (PD) remains elusive although mitochondrial dysfunction has long been implicated. Recent evidence revealed reduced expression of peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) and downstream regulated nuclear encoded respiratory complex genes in affected brain tissue from PD patients. We sought to determine whether epigenetic modification of the PGC-1 alpha gene could account for diminished expression. In substantia nigra from PD patients but not control subjects, we show significant promoter-proximal non-canonical cytosine methylation of the PGC-1 alpha gene but not an adjacent gene. As neuroinflammation is a prominent feature of PD and a mediator of epigenetic change, we evaluated whether the pro-inflammatory fatty acid, palmitate, would stimulate PGC-1 alpha promoter methylation in different cell types from the CNS. Indeed, in mouse primary cortical neurons, microglia and astrocytes, palmitate causes PGC-1 alpha gene promoter non-canonical cytosine methylation, reduced expression of the gene and reduced mitochondrial content. Moreover, intracerebroventricular (ICV) injection of palmitate to transgenic human alpha-synuclein mutant mice resulted in increased PGC-1 alpha promoter methylation, decreased PGC-1 alpha expression and reduced mitochondrial content in substantia nigra. Finally we provide evidence that dysregulation of ER stress and inflammatory signaling is associated with PGC-1 alpha promoter methylation. Together, these data strengthen the connection between saturated fatty acids, neuroflammation, ER stress, epigenetic alteration and bioenergetic compromise in PD.	[Su, Xiaomin; Li, Bin; Cao, Hong; Huang, Liang; Federoff, Howard J.] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA; [Chu, Yaping; Kordower, Jeffrey H.] Rush Univ, Dept Neurol Sci, Med Ctr, Chicago, IL 60612 USA; [Nishida, Maki; Song, Lei; Wang, Difei] Georgetown Univ, Med Ctr, Innovat Ctr Biomed Informat, Washington, DC 20007 USA; [Federoff, Howard J.] Georgetown Univ, Med Ctr, Dept Neurol, Washington, DC 20007 USA	Georgetown University; Rush University; Georgetown University; Georgetown University	Federoff, HJ (corresponding author), Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA.	federoff@uci.edu	Song, Lei/F-6946-2018; Wang, Difei/E-7066-2010		Department of Defense [WX81XWH-11-49-0126]	Department of Defense(United States Department of Defense)	WX81XWH-11-49-0126 (Federoff, Howard J), Department of Defense, 'PGC-1 alpha Therapy for Parkinsonian Neurodegeneration'.	Baldwin AC, 2012, AM J PHYSIOL-ENDOC M, V302, pE1390, DOI 10.1152/ajpendo.00519.2011; Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011; Bartoszewski R, 2008, J BIOL CHEM, V283, P12154, DOI 10.1074/jbc.M707610200; Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354; Bjorkqvist M, 2009, NEURON, V64, P21, DOI 10.1016/j.neuron.2009.09.034; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Burdge GC, 2014, CURR OPIN CLIN NUTR, V17, P156, DOI 10.1097/MCO.0000000000000023; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Chen H, 2003, AM J EPIDEMIOL, V157, P1007, DOI 10.1093/aje/kwg073; Chestnut BA, 2011, J NEUROSCI, V31, P16619, DOI 10.1523/JNEUROSCI.1639-11.2011; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; Eisele PS, 2013, J BIOL CHEM, V288, P2246, DOI 10.1074/jbc.M112.375253; Eschbach J, 2015, ANN NEUROL, V77, P15, DOI 10.1002/ana.24294; Feng J, 2005, J NEUROSCI RES, V79, P734, DOI 10.1002/jnr.20404; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grunau C, 2000, NUCLEIC ACIDS RES, V28, P1053, DOI 10.1093/nar/28.5.1053; Guo JU, 2014, NAT NEUROSCI, V17, P215, DOI 10.1038/nn.3607; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hermann A, 2004, J BIOL CHEM, V279, P48350, DOI 10.1074/jbc.M403427200; Homayoun P, 1997, J NEUROCHEM, V69, P199; Hsiao YH, 2014, INT J MOL SCI, V15, P20876, DOI 10.3390/ijms151120876; Hu G, 2007, DIABETES CARE, V30, P842, DOI 10.2337/dc06-2011; Hu P, 2006, MOL CELL BIOL, V26, P3071, DOI 10.1128/MCB.26.8.3071-3084.2006; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; JANETZKY B, 1994, NEUROSCI LETT, V169, P126, DOI 10.1016/0304-3940(94)90372-7; Karmi A, 2010, DIABETES, V59, P2171, DOI 10.2337/db09-0138; Li L, 2011, DIABETES, V60, P157, DOI 10.2337/db10-0331; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Logroscino G, 1996, ANN NEUROL, V39, P89, DOI 10.1002/ana.410390113; Lu M, 2012, CLIN EXP PHARMACOL P, V39, P577, DOI 10.1111/j.1440-1681.2011.05650.x; Morris JK, 2010, AM J PHYSIOL-REG I, V299, pR1082, DOI 10.1152/ajpregu.00449.2010; Mudo G, 2012, CELL MOL LIFE SCI, V69, P1153, DOI 10.1007/s00018-011-0850-z; Nicolai E, 1999, J NUCL CARDIOL, V6, P270, DOI 10.1016/S1071-3581(99)90038-7; Nijland PG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0170-2; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606; Qiu CX, 2011, HYPERTENSION, V57, P1094, DOI 10.1161/HYPERTENSIONAHA.111.171249; Richfield EK, 2002, EXP NEUROL, V175, P35, DOI 10.1006/exnr.2002.7882; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Salvado L, 2013, DIABETOLOGIA, V56, P1372, DOI 10.1007/s00125-013-2867-3; Santiago JA, 2013, TRENDS MOL MED, V19, P176, DOI 10.1016/j.molmed.2013.01.002; Sczelecki S, 2014, AM J PHYSIOL-ENDOC M, V306, pE157, DOI 10.1152/ajpendo.00578.2013; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Siegmund KD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000895; Soyal S, 2006, DIABETOLOGIA, V49, P1477, DOI 10.1007/s00125-006-0268-6; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Wan ZX, 2014, OBESITY, V22, P730, DOI 10.1002/oby.20605; Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059	61	63	67	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0134087	10.1371/journal.pone.0134087	http://dx.doi.org/10.1371/journal.pone.0134087			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317511	Green Published, gold			2022-12-26	WOS:000360299100013
J	Teixeira, LGD; Malavolta, L; Bersanetti, PA; Schreier, S; Carmona, AK; Nakaie, CR				Teixeira, Luis Gustavo D.; Malavolta, Luciana; Bersanetti, Patrcia A.; Schreier, Shirley; Carmona, Adriana K.; Nakaie, Clovis R.			Conformational Properties of Seven Toac-Labeled Angiotensin I Analogues Correlate with Their Muscle Contraction Activity and Their Ability to Act as ACE Substrates	PLOS ONE			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; AMINO-ACID TOAC; CONVERTING-ENZYME; AQUEOUS-SOLUTION; CIRCULAR-DICHROISM; MAGNETIC-RESONANCE; BRADYKININ ANALOGS; PEPTIDE-SYNTHESIS; PH-DEPENDENCE; FLUORESCENCE	Conformational properties of the angiotensin II precursor, angiotensin I (AngI) and analogues containing the paramagnetic amino acid TOAC (2,2,6,6-tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid) at positions 0, 1, 3, 5, 8, 9, and 10, were examined by EPR, CD, and fluorescence. The conformational data were correlated to their activity in muscle contraction experiments and to their properties as substrates of the angiotensin I-converting enzyme (ACE). Biological activity studies indicated that TOAC(0)-AngI and TOAC(1)-AngI maintained partial potency in guinea pig ileum and rat uterus. Kinetic parameters revealed that only derivatives labeled closer to the N-terminus (positions 0, 1, 3, and 5) were hydrolyzed by ACE, indicating that peptides bearing the TOAC moiety far from the ACE cleavage site (Phe(8)-His(9) peptide bond) were susceptible to hydrolysis, albeit less effectively than the parent compound. CD spectra indicated that AngI exhibited a flexible structure resulting from equilibrium between different conformers. While the conformation of N-terminally-labeled derivatives was similar to that of the native peptide, a greater propensity to acquire folded structures was observed for internally-labeled, as well as C-terminally labeled, analogues. These structures were stabilized in secondary structure-inducing agent, TFE. Different analogues gave rise to different beta-turns. EPR spectra in aqueous solution also distinguished between N-terminally, internally-, and C-terminally labeled peptides, yielding narrower lines, indicative of greater mobility for the former. Interestingly, the spectra of peptides labeled at, or close, to the C-terminus, showed that the motion in this part of the peptides was intermediate between that of N-terminally and internally-labeled peptides, in agreement with the suggestion of turn formation provided by the CD spectra. Quenching of the Tyr(4) fluorescence by the differently positioned TOAC residues corroborated the data obtained by the other spectroscopic techniques. Lastly, we demonstrated the feasibility of monitoring the progress of ACE-catalyzed hydrolysis of TOAC-labeled peptides by following time-dependent changes in their EPR spectra.	[Teixeira, Luis Gustavo D.; Carmona, Adriana K.; Nakaie, Clovis R.] Univ Fed Sao Paulo, Escola Paulista Med, Dept Biophys, Sao Paulo, SP, Brazil; [Malavolta, Luciana] Santa Casa Sao Paulo Sch Med Sci, Dept Physiol Sci, Sao Paulo, SP, Brazil; [Bersanetti, Patrcia A.] Univ Fed Sao Paulo, Dept Hlth & Informat, Sao Paulo, SP, Brazil; [Schreier, Shirley] Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Nakaie, CR (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Biophys, Sao Paulo, SP, Brazil.	cnakaie@unifesp.br	Carmona, Adriana K/D-2240-2012; Schreier, Shirley/F-7001-2014; Bersanetti, Patrícia A/B-9703-2012	Carmona, Adriana K/0000-0003-3311-5456; Bersanetti, Patrícia A/0000-0002-9262-2151	Sao Paulo State Research Foundation (FAPESP); Brazilian National Council for Scientific and Technological Research (CNPq)	Sao Paulo State Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian National Council for Scientific and Technological Research (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors' research is supported by the Sao Paulo State Research Foundation (FAPESP) and by the Brazilian National Council for Scientific and Technological Research (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGUS CW, 1973, BIOCHIM BIOPHYS ACTA, V309, P169, DOI 10.1016/0005-2744(73)90328-8; Barany G, 1980, THE PEPTIDES ANALYSI; Barbosa SR, 1999, FEBS LETT, V446, P45, DOI 10.1016/S0014-5793(99)00172-6; Bersanetti PA, 2004, BIOCHEMISTRY-US, V43, P15729, DOI 10.1021/bi048423r; Bettio A, 2002, J PEPT SCI, V8, P671, DOI 10.1002/psc.428; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; CATT KJK, 1993, CELLULAR MOL BIOL RE; Chatterjee A, 2010, INT J INTEGR BIOL, V9, P21; CORDOPATIS P, 1983, EXPERIENTIA, V39, P106, DOI 10.1007/BF01960656; Teixeira LGDD, 2007, FEBS LETT, V581, P2411, DOI 10.1016/j.febslet.2007.04.058; EHLERS MRW, 1991, BIOCHEMISTRY-US, V30, P7118, DOI 10.1021/bi00243a012; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; FOX JW, 1980, ARCH BIOCHEM BIOPHYS, V201, P375, DOI 10.1016/0003-9861(80)90525-1; Galanis AS, 2004, BIOPOLYMERS, V76, P512, DOI 10.1002/bip.20163; GALARDY RE, 1976, BIOCHEMISTRY-US, V15, P2303, DOI 10.1021/bi00656a009; GLICKSON JD, 1973, BIOCHEMISTRY-US, V12, P3684, DOI 10.1021/bi00743a018; Jahli PR, 2008, ANAL BIOCHEM, V374, P346, DOI 10.1016/j.ab.2007.11.038; JULIANO L, 1974, BIOCHEMISTRY-US, V13, P2445, DOI 10.1021/bi00708a032; LINTNER K, 1977, BIOCHEMISTRY-US, V16, P806, DOI 10.1021/bi00623a037; Lopes DD, 2008, INT J PEPT RES THER, V14, P121, DOI 10.1007/s10989-007-9120-1; Lopes DD, 2013, AMINO ACIDS, V44, P835, DOI 10.1007/s00726-012-1405-9; MARCHETTO R, 1993, J AM CHEM SOC, V115, P11042, DOI 10.1021/ja00076a093; Marshall GR, 1972, PROGR PEPTIDE RES, P15; McNulty JC, 2000, BIO MAGN RE, V19, P277; NAKAIE CR, 1983, BIOCHIM BIOPHYS ACTA, V742, P63, DOI 10.1016/0167-4838(83)90359-X; Nakaie CR, 2001, FEBS LETT, V497, P103, DOI 10.1016/S0014-5793(01)02449-8; NAKAIE CR, 1981, BRAZ J MED BIOL RES, V14, P173; Nakaie CR, 2002, PEPTIDES, V23, P65, DOI 10.1016/S0196-9781(01)00580-0; Oliveira L, 2007, PHYSIOL REV, V87, P565, DOI 10.1152/physrev.00040.2005; OLIVEIRA MCF, 1977, BIOCHEMISTRY-US, V16, P2606, DOI 10.1021/bi00631a005; OPARIL S, 1974, CIRC RES, V34, P19, DOI 10.1161/01.RES.34.1.19; PAIVA ACM, 1960, BIOCHEM PHARMACOL, V5, P187, DOI 10.1016/0006-2952(60)90062-9; PAIVA TB, 1963, BIOCHEMISTRY-US, V2, P1327, DOI 10.1021/bi00906a026; Passos-Silva DG, 2015, TRENDS PHARMACOL SCI, V36, P310, DOI 10.1016/j.tips.2015.03.001; Perczel A., 1996, CIRCULAR DICHROISM C, P285; Santos EL, 2008, INT IMMUNOPHARMACOL, V8, P293, DOI 10.1016/j.intimp.2007.07.029; Schreier S, 2004, BIOPOLYMERS, V74, P389, DOI 10.1002/bip.20092; SCHREIER S, 1978, BIOCHIM BIOPHYS ACTA, V515, P375; Schreier Shirley, 2012, Biophys Rev, V4, P45, DOI 10.1007/s12551-011-0064-5; Shafer AM, 2008, PEPTIDES, V29, P1919, DOI 10.1016/j.peptides.2008.08.002; Spyroulias GA, 2003, EUR J BIOCHEM, V270, P2163, DOI 10.1046/j.1432-1033.2003.03573.x; TIMMERMANS PBMWM, 1993, PHARMACOL REV, V45, P205; Toniolo C, 1998, BIOPOLYMERS, V47, P153, DOI 10.1002/(SICI)1097-0282(1998)47:2<153::AID-BIP4>3.0.CO;2-T; Venkateshwaran TG, 1998, J PHARMACEUT BIOMED, V17, P57, DOI 10.1016/S0731-7085(97)00160-X; Vieira RFF, 2009, BIOPOLYMERS, V92, P525, DOI 10.1002/bip.21295; WU CSC, 1982, BIOCHEMISTRY-US, V21, P4556, DOI 10.1021/bi00262a007; YANG HYT, 1970, BIOCHIM BIOPHYS ACTA, V214, P374, DOI 10.1016/0005-2795(70)90017-6; ZHOU N, 1991, J PROTEIN CHEM, V10, P333, DOI 10.1007/BF01025632	48	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136608	10.1371/journal.pone.0136608	http://dx.doi.org/10.1371/journal.pone.0136608			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317625	Green Published, Green Submitted, gold			2022-12-26	WOS:000360299100110
J	Al-Saari, N; Gao, F; Rohul, AAKM; Sato, K; Sato, K; Mino, S; Suda, W; Oshima, K; Hattori, M; Ohkuma, M; Meirelles, PM; Thompson, FL; Thompson, C; Filho, GMA; Gomez-Gil, B; Sawabe, T; Sawabe, T				Al-Saari, Nurhidayu; Gao, Feng; Rohul, Amin A. K. M.; Sato, Kazumichi; Sato, Keisuke; Mino, Sayaka; Suda, Wataru; Oshima, Kenshiro; Hattori, Masahira; Ohkuma, Moriya; Meirelles, Pedro M.; Thompson, Fabiano L.; Thompson, Cristiane; Filho, Gilberto M. A.; Gomez-Gil, Bruno; Sawabe, Toko; Sawabe, Tomoo			Advanced Microbial Taxonomy Combined with Genome-Based-Approaches Reveals that Vibrio astriarenae sp nov., an Agarolytic Marine Bacterium, Forms a New Clade in Vibrionaceae	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; DEOXYRIBONUCLEIC-ACID; HYBRIDIZATION; AGARASE; IDENTIFICATION; PURIFICATION; NEIGHBOR; STAIN	Advances in genomic microbial taxonomy have opened the way to create a more universal and transparent concept of species but is still in a transitional stage towards becoming a defining robust criteria for describing new microbial species with minimum features obtained using both genome and classical polyphasic taxonomies. Here we performed advanced microbial taxonomies combined with both genome-based and classical approaches for new agarolytic vibrio isolates to describe not only a novel Vibrio species but also a member of a new Vibrio clade. Two novel vibrio strains (Vibrio astriarenae sp. nov. C7(T) and C20) showing agarolytic, halophilic and fermentative metabolic activity were isolated from a seawater sample collected in a coral reef in Okinawa. Intraspecific similarities of the isolates were identical in both sequences on the 16S rRNA and pyrH genes, but the closest relatives on the molecular phylogenetic trees on the basis of 16S rRNA and pyrH gene sequences were V. hangzhouensis JCM 15146(T) (97.8% similarity) and V. agarivorans CECT 5085(T) (97.3% similarity), respectively. Further multilocus sequence analysis (MLSA) on the basis of 8 protein coding genes (ftsZ, gapA, gyrB, mreB, pyrH, recA, rpoA, and topA) obtained by the genome sequences clearly showed the V. astriarenae strain C7(T) and C20 formed a distinct new clade protruded next to V. agarivorans CECT 5085(T). The singleton V. agarivorans has never been included in previous MLSA of Vibrionaceae due to the lack of some gene sequences. Now the gene sequences are completed and analysis of 100 taxa in total provided a clear picture describing the association of V. agarivorans into pre-existing concatenated network tree and concluded its relationship to our vibrio strains. Experimental DNA-DNA hybridization (DDH) data showed that the strains C7(T) and C20 were conspecific but were separated from all of the other Vibrio species related on the basis of both 16S rRNA and pyrH gene phylogenies (e.g., V. agarivorans CECT 5085(T), V. hangzhouensis JCM 15146(T) V. maritimus LMG 25439(T), and V. variabilis LMG 25438(T)). In silico DDH data also supported the genomic relationship. The strains C7(T) also had less than 95% average amino acid identity (AAI) and average nucleotide identity (ANI) towards V. maritimus C210, V. variabilis C206, and V. mediterranei AK1(T), V. brasiliensis LMG 20546(T), V. orientalis ATCC 33934(T), and V. sinaloensis DSM 21326. The name Vibrio astriarenae sp. nov. is proposed with C7 as the type strains. Both V. agarivorans CECT 5058(T) and V. astriarenae C7(T) are members of the newest clade of Vibrionaceae named Agarivorans.	[Al-Saari, Nurhidayu; Gao, Feng; Rohul, Amin A. K. M.; Sato, Kazumichi; Sato, Keisuke; Mino, Sayaka; Sawabe, Tomoo] Hokkaido Univ, Fac Fisheries, Microbiol Lab, Hakodate, Hokkaido 041, Japan; [Suda, Wataru; Oshima, Kenshiro; Hattori, Masahira] Univ Tokyo, Grad Sch Frontier Sci, Lab Metagen, Kashiwa, Chiba, Japan; [Suda, Wataru] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan; [Hattori, Masahira] Waseda Univ, Grad Sch Adv Sci & Engn, Tokyo, Japan; [Ohkuma, Moriya] RIKEN BioResource Ctr, Japan Collect Microorganisms, Div Microbe, Ibaraki, Japan; [Meirelles, Pedro M.; Thompson, Fabiano L.; Thompson, Cristiane] Univ Fed Rio de Janeiro, COPPE, SAGE, Inst Biol, BR-21945 Rio De Janeiro, Brazil; [Filho, Gilberto M. A.] Inst Pesquisas Jardim Bot Rio de Janeiro, Rio De Janeiro, Brazil; [Gomez-Gil, Bruno] CIAD, AC Mazatlan Unit Aquaculture & Environm Managemen, Mazatlan, Mexico; [Sawabe, Toko] Hakodate Jr Coll, Dept Food & Nutr, Hakodate, Hokkaido, Japan	Hokkaido University; University of Tokyo; Keio University; Waseda University; RIKEN; Universidade Federal do Rio de Janeiro; Jardim Botanico do Rio de Janeiro; CIAD - Centro de Investigacion en Alimentacion y Desarrollo	Al-Saari, N (corresponding author), Hokkaido Univ, Fac Fisheries, Microbiol Lab, Minato Cho, Hakodate, Hokkaido 041, Japan.	hidayu@fish.hokudai.ac.jp	Meirelles, Pedro/GRY-0806-2022; Al-saari, Nurhidayu/V-3466-2019; Suda, Wataru/AAF-4469-2019; Ohkuma, Moriya/A-8100-2011; Meirelles, Pedro/AAK-5942-2021; Thompson, Cristiane C/I-5783-2016; Meirelles, Pedro/AAL-4542-2020; Hattori, Masahira/C-6958-2016; Hattori, Masahira/AAD-3785-2019; Gomez-Gil, Bruno/AAD-8658-2020	Meirelles, Pedro/0000-0002-1306-0331; Hattori, Masahira/0000-0001-9467-0344; Gomez-Gil, Bruno/0000-0002-3695-3597; Thompson, Fabiano/0000-0002-7562-1683; Al-saari, Nurhidayu/0000-0002-2952-7039	Genome Information Upgrading Program of National BioResource Project from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Strategic Japanese-Brazilian Cooperative Program, Biomass and Bioenergy; JSPS-CAPES bilateral cooperative program; Kaken [26660168]; CAPES; CNPq; FAPERJ; CAPES [4848-14-9CAPES/JSPS]	Genome Information Upgrading Program of National BioResource Project from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Strategic Japanese-Brazilian Cooperative Program, Biomass and Bioenergy; JSPS-CAPES bilateral cooperative program; Kaken(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Genome Information Upgrading Program of National BioResource Project from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (MH and MO), Strategic Japanese-Brazilian Cooperative Program, Biomass and Bioenergy (TS and FLT), JSPS-CAPES bilateral cooperative program (TS and FLT), and Kaken (26660168) (TS). FLT and CCT thank CAPES, CNPq, and FAPERJ for funding. PMM thanks CAPES for the PhD scholarship (4848-14-9CAPES/JSPS), and MARA for the PhD education loan to NA.	Achtman M, 2008, NAT REV MICROBIOL, V6, P431, DOI 10.1038/nrmicro1872; Amaral GRS, 2015, ANTON LEEUW INT J G, V107, P1351, DOI 10.1007/s10482-015-0414-6; Amaral GRS, 2014, INT J SYST EVOL MICR, V64, P357, DOI 10.1099/ijs.0.057927-0; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bandelt HJ, 1992, MOL PHYLOGENET EVOL, V1, P242, DOI 10.1016/1055-7903(92)90021-8; Barton L. L., 2005, STRUCTURAL FUNCTIONA, P3; Baumann P, 1984, BERGEYS MANUAL SYSTE, V1, P516; Boucher Y, 2006, BIOLOGY OF VIBRIOS, P84; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CHEN LCM, 1994, J APPL PHYCOL, V6, P35, DOI 10.1007/BF02185902; Chimetto LA, 2011, INT J SYST EVOL MICR, V61, P3009, DOI 10.1099/ijs.0.026997-0; Dipakkore S, 2005, J APPL PHYCOL, V17, P331, DOI 10.1007/s10811-005-7291-8; EZAKI T, 1988, J CLIN MICROBIOL, V26, P1708, DOI 10.1128/JCM.26.9.1708-1713.1988; EZAKI T, 1989, INT J SYST BACTERIOL, V39, P224, DOI 10.1099/00207713-39-3-224; Gomez-Gil B, 2003, INT J SYST EVOL MICR, V53, P1569, DOI 10.1099/ijs.0.02670-0; Gupta V, 2013, BIOMASS BIOENERG, V49, P290, DOI 10.1016/j.biombioe.2012.12.027; HIDAKA T, 1968, Bulletin of the Misaki Marine Biological Institute Kyoto University, V12, P125; HOLT JG, 1994, BERGEYS MANUAL DETER, P190; Hu Z, 2009, J APPL MICROBIOL, V106, P181, DOI 10.1111/j.1365-2672.2008.03990.x; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; KITATSUKAMOTO K, 1993, INT J SYST BACTERIOL, V43, P8, DOI 10.1099/00207713-43-1-8; Konstantinidis KT, 2005, J BACTERIOL, V187, P6258, DOI 10.1128/JB.187.18.6258-6264.2005; Kornberg HL, 2001, J MOL MICROB BIOTECH, V3, P355; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leifson E., 1963, J BACTERIOL, V82, P33; Macian MC, 2004, SYST APPL MICROBIOL, V27, P535, DOI 10.1078/0723202041748127; Macian MC, 2001, INT J SYST EVOL MICR, V51, P2031, DOI 10.1099/00207713-51-6-2031; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; Matsumura Y, 2014, INT J HYDROGEN ENERG, V39, P7270, DOI 10.1016/j.ijhydene.2014.02.164; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; MEINKOTH J, 1984, ANAL BIOCHEM, V138, P267, DOI 10.1016/0003-2697(84)90808-X; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; OPPENHEIMER CH, 1952, J MAR RES, V11, P10; OSTLE AG, 1982, APPL ENVIRON MICROB, V44, P238, DOI 10.1128/AEM.44.1.238-241.1982; Pascual J, 2010, INT J SYST EVOL MICR, V60, P154, DOI 10.1099/ijs.0.010702-0; Rossello-Mora R, 2015, SYST APPL MICROBIOL, V38, P1; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sawabe T, 1998, INT J SYST BACTERIOL, V48, P573, DOI 10.1099/00207713-48-2-573; Sawabe T, 2007, J BACTERIOL, V189, P7932, DOI 10.1128/JB.00693-07; Sawabe T, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00414; TAMAOKA J, 1984, FEMS MICROBIOL LETT, V25, P125, DOI 10.1016/0378-1097(84)90059-4; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson CC, 2015, ARCH MICROBIOL, V197, P359, DOI 10.1007/s00203-014-1071-2; Thompson CC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-913; Thompson CC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-258; Thompson FL, 2005, APPL ENVIRON MICROB, V71, P5107, DOI 10.1128/AEM.71.9.5107-5115.2005; Thompson FL, 2003, INT J SYST EVOL MICR, V53, P245, DOI 10.1099/ijs.0.02447-0; Thompson JR, 2006, BIOLOGY OF VIBRIOS, P190; Tindall BJ, 2010, INT J SYST EVOL MICR, V60, P249, DOI 10.1099/ijs.0.016949-0; Vandamme P, 2014, ANTON LEEUW INT J G, V106, P57, DOI 10.1007/s10482-014-0148-x; WEST M, 1977, J CLIN MICROBIOL, V6, P414; Xu XW, 2009, INT J SYST EVOL MICR, V59, P2099, DOI 10.1099/ijs.0.008698-0	52	27	27	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136279	10.1371/journal.pone.0136279	http://dx.doi.org/10.1371/journal.pone.0136279			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313925	gold, Green Published, Green Submitted			2022-12-26	WOS:000360144000052
J	Larmann, J; Jurk, K; Janssen, H; Muller, M; Herzog, C; Lorenz, A; Schmitz, M; Nofer, JR; Theilmeier, G				Larmann, Jan; Jurk, Kerstin; Janssen, Henrike; Mueller, Martin; Herzog, Christine; Lorenz, Anika; Schmitz, Martina; Nofer, Jerzy-Roch; Theilmeier, Gregor			Hepatic Overexpression of Soluble Urokinase Receptor (uPAR) Suppresses Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (LDLR-/-) Mice	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR; NEOINTIMA FORMATION; GENE-TRANSFER; IN-VIVO; PLAQUE RUPTURE; MACROPHAGES; EXPRESSION; INJURY; METALLOPROTEINASES; MECHANISMS	Objective Atherosclerosis, a chronic inflammatory disease, arises from metabolic disorders and is driven by inappropriate recruitment and proliferation of monocytes macrophages and vascular smooth-muscle-cells. The receptor for the urokinase-type plasminogen activator (uPAR, Plaur) regulates the proteolytic activation of plasminogen. It is also a coactivator of integrins and facilitates leukocyte-endothelial interactions and vascular smooth-muscle-cell migration. The role of uPAR in atherogenesis remains elusive. Methods and Results We generated C57Bl6J low-density lipoprotein receptor (LDL) and uPAR double knockout (uPAR(-/-) LDLR-/-) mice to test the role of uPAR in two distinct atherosclerosis models. In LDLR-/- mice, hepatic overexpression following hydrodynamic transfection of soluble uPAR that competes with endogenous membrane-bound uPAR was performed as an interventional strategy. Aortic root atherosclerotic lesions induced by feeding a high-fat diet were smaller and comprised less macrophages and vascular smooth-muscle-cells in double knockout mice and animals overexpressing soluble uPAR when compared to controls. In contrast, lesion size, lipid-, macrophage-, and vascular smooth muscle cell content of guide-wire-induced intima lesions in the carotid artery were not affected by uPAR deficiency. Adhesion of uPAR(-/-)-macrophages to TNFa-stimulated endothelial cells was decreased in vitro accompanied by reduced VCAM-1 expression on primary endothelial cells. Hepatic overexpression of soluble full-length murine uPAR in LDLR-/- mice led to a reduction of diet-induced atherosclerotic lesion formation and monocyte recruitment into plaques. Ex vivo incubation with soluble uPAR protein also inhibited adhesion of macrophages to TNF alpha-stimulat endothelial cells in vitro. Conclusion uPAR-deficiency as well as competitive soluble uPAR reduced diet-promoted but not guide-wire induced atherosclerotic lesions in mice by preventing monocyte recruitment and vascular smooth-muscle-cell infiltration. Soluble uPAR may represent a therapeutic tool for the modulation of hyperlipidemia-associated atherosclerotic lesion formation.	[Larmann, Jan; Janssen, Henrike; Mueller, Martin; Herzog, Christine; Lorenz, Anika; Theilmeier, Gregor] Hannover Med Sch, Dept Anesthesiol & Intens Care Med, Hannover, Germany; [Larmann, Jan] Univ Heidelberg Hosp, Dept Anesthesiol, Heidelberg, Germany; [Jurk, Kerstin] Univ Med Ctr, Ctr Thrombosis & Hemostasis CTH, Mainz, Germany; [Schmitz, Martina] Univ Munster, Inst Anat, D-48149 Munster, Germany; [Nofer, Jerzy-Roch] Univ Hosp Munster, Ctr Lab Med, Munster, Germany; [Theilmeier, Gregor] Carl von Ossietzky Univ Oldenburg, Fac Med & Hlth Sci, Dept Hlth Serv Sci, D-26111 Oldenburg, Germany	Hannover Medical School; Ruprecht Karls University Heidelberg; Johannes Gutenberg University of Mainz; University of Munster; University of Munster; Carl von Ossietzky Universitat Oldenburg	Theilmeier, G (corresponding author), Hannover Med Sch, Dept Anesthesiol & Intens Care Med, Hannover, Germany.	gregor.theilmeier@uni-oldenburg.de	Larmann, Jan/ABI-3699-2020; Jurk, Kerstin/AAT-7768-2020; Larmann, Jan/B-4034-2011	Larmann, Jan/0000-0003-3365-4572; Larmann, Jan/0000-0003-3365-4572	Interdisziplinares Zentrum Klinische Forschung (IZKF), Munster [The1/68/04(C12)]; Deutsche Forschungsgemeinschaft (DFG) [TH667/3-1]	Interdisziplinares Zentrum Klinische Forschung (IZKF), Munster; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Interdisziplinares Zentrum Klinische Forschung (IZKF), Munster (http://campus.uni-muenster.de/izkf.html), grant: The1/68/04(C12) to GT, and Deutsche Forschungsgemeinschaft, (DFG) (www.dfg.de), grant (TH667/3-1) to GT.	Anaraki PK, 2014, STEM CELLS DEV, V23, P352, DOI 10.1089/scd.2013.0318; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Chen W, 2012, INT J CARDIOL, V161, P103, DOI 10.1016/j.ijcard.2011.12.094; DeGeest B, 1997, CIRCULATION, V96, P4349; Dewerchin M, 1996, J CLIN INVEST, V97, P870, DOI 10.1172/JCI118489; Farris SD, 2011, J BIOL CHEM, V286, P22665, DOI 10.1074/jbc.M110.202135; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Hui, 2008, CURR DRUG TARGETS, V9, P251; ISHIBASHI S, 1994, J CLIN INVEST, V93, P1885, DOI 10.1172/JCI117179; Kiyan J, 2007, ATHEROSCLEROSIS, V195, P254, DOI 10.1016/j.atherosclerosis.2006.12.030; Kiyan Y, 2014, J MOL CELL CARDIOL, V66, P72, DOI 10.1016/j.yjmcc.2013.11.005; Larmann J, 2005, ANESTHESIOLOGY, V103, P1149; Larmann J, 2010, ANESTHESIOLOGY, V113, P610, DOI 10.1097/ALN.0b013e3181e99bfc; LINDNER V, 1993, CIRC RES, V73, P792, DOI 10.1161/01.RES.73.5.792; May AE, 1998, J EXP MED, V188, P1029, DOI 10.1084/jem.188.6.1029; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Plekhanova O, 2001, ATHEROSCLEROSIS, V159, P297, DOI 10.1016/S0021-9150(01)00511-1; Quarck R, 2001, CIRCULATION, V103, P2495; SHAH PK, 1995, CIRCULATION, V92, P1565; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Steins MB, 2004, BLOOD COAGUL FIBRIN, V15, P383, DOI 10.1097/01.mbc.0000114441.59147.56; Svensson PA, 2008, INT J MOL MED, V22, P459, DOI 10.3892/ijmm_00000043; Theilmeier G, 2002, CARDIOVASC RES, V55, P385, DOI 10.1016/S0008-6363(02)00409-1; Theilmeier G, 2006, CIRCULATION, V114, P1403, DOI 10.1161/CIRCULATIONAHA.105.607135; Vorup-Jensen T, 2001, MOL THER, V3, P867, DOI 10.1006/mthe.2001.0335; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Ye X, 2003, J THROMB HAEMOST, V1, P103, DOI 10.1046/j.1538-7836.2003.00024.x	28	2	2	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0131854	10.1371/journal.pone.0131854	http://dx.doi.org/10.1371/journal.pone.0131854			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313756	Green Published, gold, Green Submitted			2022-12-26	WOS:000360144000003
J	Gowda, RN; Redfern, R; Frikeche, J; Pinglay, S; Foster, JW; Lema, C; Cope, L; Chakravarti, S				Gowda, Ranjita N.; Redfern, Rachel; Frikeche, Jihane; Pinglay, Sudarshan; Foster, James William; Lema, Carolina; Cope, Leslie; Chakravarti, Shukti			Functions of Peptidoglycan Recognition Proteins (Pglyrps) at the Ocular Surface: Bacterial Keratitis in Gene-Targeted Mice Deficient in Pglyrp-2,-3 and-4	PLOS ONE			English	Article							INNATE IMMUNITY; CORNEA; INFLAMMATION; NEUTROPHILS; EXPRESSION; RECEPTORS; DEFENSE	Purpose Functions of antimicrobial peptidoglycan recognition proteins (Pglyrp1-4) at the ocular surface are poorly understood. Earlier, we reported an antibacterial role for Pglyrp-1 in Pseudomonas aeruginosa keratitis. Here we investigated functions of three other related genes Pglyrp-2, -3 and -4 in a mouse model of P. aeruginosa keratitis. Methods Wild type (WT) and each of the Pglyrp-null genotypes were challenged with P. aeruginosa keratitis. The eyes were scored in a blinded manner 24 and 48h post infection. Viable bacterial counts and inflammatory factors (IL-12, TNF-alpha, IFN-gamma, CCL2, IL-6 and IL-10) were measured in whole eye homogenates using cytometric bead arrays. Expressions of Pglyrp-1-4, mouse beta defensins (mBD)-2,-3, cathelicidin-related antimicrobial peptide (CRAMP) were determined by qRTPCR in total RNA extracts of uninfected and infected eyes of WT and each of the Pglyrp-null mouse types. Results The Pglyrp-2(-/-) mice showed reduced disease and lower induction of pro-inflammatory TNF-alpha (p = 0.02) than WT or the other Pglyrp null mice. Viable bacterial yield was significantly lower in the Pglyrp-2(-/-) (p = 0.0007) and the Pglyrp-4(-/-) (p = 0.098) mice. With regards to expression of these antimicrobial genes, Pglyrp-2 expression was induced after infection in WT mice. Pglyrp-3 expression was low before and after infection in WT mice, while Pglyrp-4 expression was slightly elevated after infection in WT, Pglyrp-2 and -3 null mice. Pglyrp-1 expression was slightly elevated after infection in all genotypes without statistical significance. Transcripts for antimicrobial peptides mBD2, mBD3 and CRAMP were elevated in infected Pglyrp-2(-/-) males without statistical significance. Conclusions Efficient resolution of keratitis in the Pglyrp-2(-/-) mice may be due to a reduced pro-inflammatory microenvironment and synergistic antibacterial activities of defensins, CRAMP and Pglyrp-1. Therefore, in ocular infections the pro-inflammatory functions of Pglyrp-2 must be regulated to benefit the host.	[Gowda, Ranjita N.; Frikeche, Jihane; Pinglay, Sudarshan; Foster, James William; Chakravarti, Shukti] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Redfern, Rachel; Lema, Carolina] Univ Houston, Coll Optometry, Ocular Surface Inst, Houston, TX USA; [Chakravarti, Shukti] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD USA; [Chakravarti, Shukti] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Cope, Leslie] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; University of Houston System; University of Houston; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Chakravarti, S (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	schakra1@jhmi.edu	Foster, James/AAK-2225-2020; Lema, Carolina/AFK-5176-2022; Lema, Carolina/AAG-3773-2022	Foster, James/0000-0002-8500-7994; Pinglay, Sudarshan/0000-0002-8781-1476; FRIKECHE, Jihane/0000-0003-1291-6908	National Eye Institute of the National Institutes of Health (NIH) [EY021585]; National Institutes of Health [EY11654, EY023628, P30-CAOO6973]; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R56EY011654, R01EY023628, R21EY021585, R01EY011654] Funding Source: NIH RePORTER	National Eye Institute of the National Institutes of Health (NIH); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by SC grant number EY021585 from National Eye Institute (https://www.nei.nih.gov) of the National Institutes of Health (NIH)(http://www.nih.gov/); SC grant number EY11654 from National Institutes of Health (http://www.nih.gov/); RR grant number EY023628 from National Institutes of Health (http://www.nih.gov/) and P30-CAOO6973 (LC) from the National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dziarski R, 2003, BLOOD, V102, P689, DOI 10.1182/blood-2002-12-3853; Dziarski R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-232; Ghosh A, 2009, INVEST OPHTH VIS SCI, V50, P4185, DOI 10.1167/iovs.08-3040; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lee EJ, 2003, INVEST OPHTH VIS SCI, V44, P5220, DOI 10.1167/iovs.03-0229; Liu C, 2000, J BIOL CHEM, V275, P24490, DOI 10.1074/jbc.M001239200; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; Ma P, 2010, EXP EYE RES, V90, P130, DOI 10.1016/j.exer.2009.09.021; McDermott Alison M, 2004, Ocul Surf, V2, P229; McDermott AM, 2003, INVEST OPHTH VIS SCI, V44, P1859, DOI 10.1167/iovs.02-0787; Royet J, 2007, NAT REV MICROBIOL, V5, P264, DOI 10.1038/nrmicro1620; Royet J, 2011, NAT REV IMMUNOL, V11, P837, DOI 10.1038/nri3089; Saha S, 2009, CELL HOST MICROBE, V5, P137, DOI 10.1016/j.chom.2008.12.010; Steiner H, 2004, IMMUNOL REV, V198, P83, DOI 10.1111/j.0105-2896.2004.0120.x; Wang HT, 2005, INFECT IMMUN, V73, P7216, DOI 10.1128/IAI.73.11.7216-7225.2005; Wu F, 2008, EXP EYE RES, V87, P214, DOI 10.1016/j.exer.2008.06.001; Zaidi TS, 2010, INVEST OPHTH VIS SCI, V51, P2085, DOI 10.1167/iovs.09-4139; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	19	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137129	10.1371/journal.pone.0137129	http://dx.doi.org/10.1371/journal.pone.0137129			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332373	Green Published, gold, Green Submitted			2022-12-26	WOS:000360613800100
J	Potter, A; Mills, DS				Potter, Alice; Mills, Daniel Simon			Domestic Cats (Felis silvestris catus) Do Not Show Signs of Secure Attachment to Their Owners	PLOS ONE			English	Article							AINSWORTHS STRANGE SITUATION; SEPARATION ANXIETY SYNDROME; BEHAVIOR; DOGS; RESPONSES; STRESS	The Ainsworth Strange Situation Test (SST) has been widely used to demonstrate that the bond between both children and dogs to their primary carer typically meets the requirements of a secure attachment (i.e. the carer being perceived as a focus of safety and security in otherwise threatening environments), and has been adapted for cats with a similar claim made. However methodological problems in this latter research make the claim that the cat-owner bond is typically a secure attachment, operationally definable by its behaviour in the SST, questionable. We therefore developed an adapted version of the SST with the necessary methodological controls which include a full counterbalance of the procedure. A cross-over design experiment with 20 cat-owner pairs (10 each undertaking one of the two versions of the SST first) and continuous focal sampling was used to record the duration of a range of behavioural states expressed by the cats that might be useful for assessing secure attachment. Since data were not normally distributed, non-parametric analyses were used on those behaviours shown to be reliable across the two versions of the test (which excluded much cat behaviour). Although cats vocalised more when the owner rather the stranger left the cat with the other individual, there was no other evidence consistent with the interpretation of the bond between a cat and its owner meeting the requirements of a secure attachment. These results are consistent with the view that adult cats are typically quite autonomous, even in their social relationships, and not necessarily dependent on others to provide a sense of security and safety. It is concluded that alternative methods need to be developed to characterise the normal psychological features of the cat-owner bond.	[Potter, Alice; Mills, Daniel Simon] Lincoln Univ, Anim Behav Cognit & Welf Grp, Sch Life Sci, Lincoln, Lincs, England	University of Lincoln	Mills, DS (corresponding author), Lincoln Univ, Anim Behav Cognit & Welf Grp, Sch Life Sci, Lincoln, Lincs, England.	dmills@lincoln.ac.uk						Ainsworth M., 1978, PATTERNS ATTACHMENT; Bateson P, 2000, DOMESTIC CAT BIOL IT, P232; Bernstein P.L., 2007, HUMAN CAT RELATIONSH, P47, DOI [10.1007/978-1-4020-3227-1_3, DOI 10.1007/978-1-4020-3227-1_3, 10.1007/978-1-4020-3227-13, DOI 10.1007/978-1-4020-3227-13]; BOWLBY J, 1958, INT J PSYCHOANAL, V39, P350; Bowlby J., 1969, ATTACHMENT LOSS, V1, P177; Bradshaw JWS, 1999, APPL ANIM BEHAV SCI, V63, P251, DOI 10.1016/S0168-1591(99)00007-6; CARLSTEAD K, 1993, APPL ANIM BEHAV SCI, V38, P143, DOI 10.1016/0168-1591(93)90062-T; Cassidy J, 1999, HDB ATTACHMENT THEOR, P3; CROWELL S., 2007, TRANSCENDENTAL HEIDE, P1; Crowell-Davis SL, 2004, J FELINE MED SURG, V6, P19, DOI 10.1016/j.jfms.2003.09.013; CrowellDavis SL, 1997, VET CLIN N AM-SMALL, V27, P549, DOI 10.1016/S0195-5616(97)50054-4; Downey H, 2008, J BUS RES, V61, P434, DOI 10.1016/j.jbusres.2007.07.015; Edwards C, 2007, J VET BEHAV, V2, P119, DOI 10.1016/j.jveb.2007.06.004; European Pet Food Industry Federation, 2010, FACTS FIG 2010; HAZAN C, 1987, J PERS SOC PSYCHOL, V52, P511, DOI 10.1037/0022-3514.52.3.511; Heidenberger E, 1997, APPL ANIM BEHAV SCI, V52, P345, DOI 10.1016/S0168-1591(96)01134-3; Jones B, 2003, DESIGN ANAL CROSS OV, V2nd, P13; Jongman EC, 2007, J VET BEHAV, V2, P193, DOI 10.1016/j.jveb.2007.09.003; Karsh E, 1984, PET CONNECTION ITS I, P207; Kessler MR, 1999, ANIM WELFARE, V8, P259; Ley JM, 2012, THE CAT, P191; Lowe SE, 2002, ANTHROZOOS, V15, P69, DOI 10.2752/089279302786992702; Macdonald David W., 2000, P95; Martin P., 1993, MEASURING BEHAV, DOI [10.1017/CBO9781139168342, DOI 10.1017/CBO9781139168342]; Mendl M, 2000, DOMESTIC CAT BIOL IT, P193; Mertens C., 1991, Anthrozoos, V4, P214, DOI 10.2752/089279391787057062; Mertens C., 1989, Anthrozoos, V2, P83, DOI 10.2752/089279389787058109; Mills DS, 2013, STRESS PHEROMONATHER, P159; Natoli E, 2001, BEHAV PROCESS, V53, P137, DOI 10.1016/S0376-6357(00)00145-5; Palestrini C, 2005, APPL ANIM BEHAV SCI, V94, P75, DOI 10.1016/j.applanim.2005.02.005; Palmer R, 2008, APPL ANIM BEHAV SCI, V109, P306, DOI 10.1016/j.applanim.2007.04.002; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; Parthasarathy V, 2006, J VET BEHAV, V1, P109, DOI 10.1016/j.jveb.2006.09.005; Pet Food Manufacturers Association, 2010, PET POP 2008 2011; PODBERSCEK AL, 1991, APPL ANIM BEHAV SCI, V31, P119, DOI 10.1016/0168-1591(91)90159-U; Prato-Previde E, 2003, BEHAVIOUR, V140, P225, DOI 10.1163/156853903321671514; Ricci E, 2011, J VET BEHAV, V6, P91; Schwartz S, 2003, J AM VET MED ASSOC, V222, P1526, DOI 10.2460/javma.2003.222.1526; Schwartz S, 2002, J AM VET MED ASSOC, V220, P1028, DOI 10.2460/javma.2002.220.1028; Topal J, 2005, ANIM BEHAV, V70, P1367, DOI 10.1016/j.anbehav.2005.03.025; Topal J, 1998, J COMP PSYCHOL, V112, P219, DOI 10.1037/0735-7036.112.3.219; Turner D. C., 2000, The domestic cat: the biology of its behaviour., P193; van IJzendoorn MH, 2009, DEV PSYCHOBIOL, V51, P173, DOI 10.1002/dev.20356; Wedl M, 2011, BEHAV PROCESS, V86, P58, DOI 10.1016/j.beproc.2010.09.001; Weinfield N. S., 1999, HDB ATTACHMENT THEOR, P68; White JM, 2010, J VET BEHAV, V5, P47; ZASLOFF RL, 1994, PSYCHOL REP, V74, P747, DOI 10.2466/pr0.1994.74.3.747	47	22	23	2	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135109	10.1371/journal.pone.0135109	http://dx.doi.org/10.1371/journal.pone.0135109			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332470	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000360613800021
J	Lee, ACH; Lam, JKY; Shiu, SWM; Wong, Y; Betteridge, DJ; Tan, KCB				Lee, Alan C. H.; Lam, Joanne K. Y.; Shiu, Sammy W. M.; Wong, Ying; Betteridge, D. John; Tan, Kathryn C. B.			Serum Level of Soluble Receptor for Advanced Glycation End Products Is Associated with A Disintegrin And Metalloproteinase 10 in Type 1 Diabetes	PLOS ONE			English	Article							A-SECRETASE; RAGE; ADAM10; CLEAVAGE; BIOLOGY; IDENTIFICATION; INSULIN; DISEASE; FORM	Background The receptor for advanced glycation end products (RAGE) is involved in the pathogenesis of diabetic complications, and soluble forms of the receptor (sRAGE) can counteract the detrimental action of the full-length receptor by acting as decoy. Soluble RAGE is produced by alternative splicing [endogenous secretory RAGE (esRAGE)] and/or by proteolytic cleavage of the membrane-bound receptor. We have investigated the role of A Disintegrin And Metalloproteinase 10 (ADAM10) in the ectodomain shedding of RAGE. Methods Constitutive and insulin-induced shedding of RAGE in THP-1 macrophages by ADAM10 was evaluated using an ADAM10-specific metalloproteinase inhibitor. Serum ADAM10 level was measured in type 1 diabetes and control subjects, and the association with serum soluble RAGE was determined. Serum total sRAGE and esRAGE were assayed by ELISA and the difference between total sRAGE and esRAGE gave an estimated measure of soluble RAGE formed by cleavage (cRAGE). Results RAGE shedding (constitutive and insulin-induced) was significantly reduced after inhibition of ADAM10 in macrophages, and insulin stimulated ADAM10 expression and activity. Diabetic subjects have higher serum total sRAGE and esRAGE (p<0.01) than controls, and serum ADAM10 was also increased (p<0.01). Serum ADAM10 correlated with serum cRAGE in type 1 diabetes (r = 0.40, p<0.01) and in controls (r = 0.31. p<0.01) but no correlations were seen with esRAGE. The association remained significant after adjusting for age, gender, BMI, smoking status and HbA1c. Conclusion Our data suggested that ADAM10 contributed to the shedding of RAGE. Serum ADAM10 level was increased in type 1 diabetes and was a significant determinant of circulating cRAGE.	[Lee, Alan C. H.; Lam, Joanne K. Y.; Shiu, Sammy W. M.; Wong, Ying; Tan, Kathryn C. B.] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Betteridge, D. John] Royal Free, Dept Med, London, England; [Betteridge, D. John] UCL, Sch Med, London W1N 8AA, England	University of Hong Kong; University of London; University College London; Royal Free London NHS Foundation Trust; University of London; University College London; UCL Medical School	Tan, KCB (corresponding author), Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China.	kcbtan@hkucc.hku.hk			Hong Kong Research Grants Council Research Fund [HKU777712M]	Hong Kong Research Grants Council Research Fund(Hong Kong Research Grants Council)	Supported by the Hong Kong Research Grants Council Research Fund (HKU777712M awarded to KCBT).	Barlovic DP, 2011, CLIN SCI, V121, P43, DOI 10.1042/CS20100501; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Dreymueller D, 2012, EUR J CELL BIOL, V91, P472, DOI 10.1016/j.ejcb.2011.09.003; Endres K, 2012, CURR ALZHEIMER RES, V9, P157, DOI 10.2174/156720512799361664; Galichet A, 2008, BIOCHEM BIOPH RES CO, V370, P1, DOI 10.1016/j.bbrc.2008.02.163; Hudson BI, 2008, FASEB J, V22, P1572, DOI 10.1096/fj.07-9909com; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Kalea AZ, 2009, CLIN SCI, V116, P621, DOI 10.1042/CS20080494; Lam JKY, 2013, DIABETIC MED, V30, P702, DOI 10.1111/dme.12166; Metz VV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041823; Postina R, 2012, J NEUROCHEM, V120, P46, DOI 10.1111/j.1471-4159.2011.07459.x; Pruessmeyer J, 2009, SEMIN CELL DEV BIOL, V20, P164, DOI 10.1016/j.semcdb.2008.09.005; Quade-Lyssy P, 2013, J LIPID RES, V54, P3052, DOI 10.1194/jlr.M038968; Ramasamy R, 2011, ANN NY ACAD SCI, V1243, P88, DOI 10.1111/j.1749-6632.2011.06320.x; Raucci A, 2008, FASEB J, V22, P3716, DOI 10.1096/fj.08-109033; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Tam HL, 2010, ATHEROSCLEROSIS, V209, P173, DOI 10.1016/j.atherosclerosis.2009.08.031; Tousseyn Thomas, 2006, Birth Defects Research, V78, P24, DOI 10.1002/bdrc.20066; Vazzana N, 2009, INTERN EMERG MED, V4, P389, DOI 10.1007/s11739-009-0300-1; Vingtdeux V, 2012, J NEUROCHEM, V120, P34, DOI 10.1111/j.1471-4159.2011.07477.x	20	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137330	10.1371/journal.pone.0137330	http://dx.doi.org/10.1371/journal.pone.0137330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325204	Green Submitted, Green Published, gold			2022-12-26	WOS:000360437700111
J	Takahara, K; Minami, K; Yoshikawa, Y; Takai, T; Ibuki, N; Hirano, H; Nomi, H; Kawabata, S; Kiyama, S; Miyatake, SI; Kuroiwa, T; Suzuki, M; Kirihata, M; Azuma, H				Takahara, Kiyoshi; Minami, Koichiro; Yoshikawa, Yuki; Takai, Tomoaki; Ibuki, Naokazu; Hirano, Hajime; Nomi, Hayahito; Kawabata, Shinji; Kiyama, Satoshi; Miyatake, Shin-Ichi; Kuroiwa, Toshihiko; Suzuki, Minoru; Kirihata, Mitsunori; Azuma, Haruhito			The Anti-Proliferative Effect of Boron Neutron Capture Therapy in a Prostate Cancer Xenograft Model	PLOS ONE			English	Article							PARA-BORONOPHENYLALANINE; MALIGNANT-MELANOMA; RECURRENT HEAD; BRAIN-TUMOR; RADIATION; DELIVERY; CELLS	Purpose Boron neutron capture therapy (BNCT) is a selective radiation treatment for tumors that preferentially accumulate drugs carrying the stable boron isotope, B-10. BNCT has been evaluated clinically as an alternative to conventional radiation therapy for the treatment of brain tumors, and more recently, recurrent advanced head and neck cancer. Here we investigated the effect of BNCT on prostate cancer (PCa) using an in vivo mouse xenograft model that we have developed. Materials and Methods Mice bearing the xenotransplanted androgen-independent human PCa cell line, PC3, were divided into four groups: Group 1: untreated controls; Group 2: Boronophenylalanine (BPA); Group 3: neutron; Group 4: BPA-mediated BNCT. We compared xenograft growth among these groups, and the body weight and any motility disturbance were recorded. Immunohistochemical (IHC) studies of the proliferation marker, Ki-67, and TUNEL staining were performed 9 weeks after treatment. Results The in vivo studies demonstrated that BPA-mediated BNCT significantly delayed tumor growth in comparison with the other groups, without any severe adverse events. There was a significant difference in the rate of freedom from gait abnormalities between the BPA-mediated BNCT group and the other groups. The IHC studies revealed that BNCT treatment significantly reduced the number of Ki-67-positive cells in comparison with the controls (mean +/- SD 6.9 +/- 1.5 vs 12.7 +/- 4.0, p<0.05), while there was no difference in the number of apoptotic cells, suggesting that BPA-mediated BNCT reduced PCa progression without affecting apoptosis at 9 weeks post-treatment. Conclusions This study has provided the first preclinical proof-of-principle data to indicate that BPA-mediated BNCT reduces the in vivo growth of PCa. Although further studies will be necessary, BNCT might be a novel potential treatment for PCa.	[Takahara, Kiyoshi; Minami, Koichiro; Yoshikawa, Yuki; Takai, Tomoaki; Ibuki, Naokazu; Hirano, Hajime; Nomi, Hayahito; Kiyama, Satoshi; Azuma, Haruhito] Osaka Med Coll, Fac Med, Dept Urol, Osaka, Japan; [Kawabata, Shinji; Miyatake, Shin-Ichi; Kuroiwa, Toshihiko] Osaka Med Coll, Dept Neurosurg, Osaka, Japan; [Suzuki, Minoru] Kyoto Univ, Inst Res Reactor, Radiat Oncol & Particle Radiat Oncol Res Ctr, Osaka 59004, Japan; [Kirihata, Mitsunori] Osaka Prefecture Univ, Res Ctr Boron Neutron Capture Therapy, Res Org 21st Century, Sakai, Osaka 591, Japan	Osaka Medical College; Osaka Medical College; Kyoto University; Osaka Metropolitan University	Takahara, K (corresponding author), Osaka Med Coll, Fac Med, Dept Urol, Osaka, Japan.	uro037@poh.osaka-med.ac.jp	Kawabata, Shinji/ABD-9354-2020	Kawabata, Shinji/0000-0001-5007-5279; Kirihata, Mitsunori/0000-0002-4183-9107	Grants-in-Aid for Scientific Research [26462192] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Barth RF, 2005, CLIN CANCER RES, V11, P3987, DOI 10.1158/1078-0432.CCR-05-0035; CODERRE JA, 1992, RADIAT RES, V129, P290, DOI 10.2307/3578028; CODERRE JA, 1990, CANCER RES, V50, P138; Coderre JA, 2003, TECHNOL CANCER RES T, V2, P355, DOI 10.1177/153303460300200502; Coderre JA, 1999, RADIAT RES, V151, P1, DOI 10.2307/3579742; FARR LE, 1954, AM J ROENTGENOL, V71, P279; Gifford I, 2014, INT J RADIAT BIOL, V90, P480, DOI 10.3109/09553002.2014.901579; Gleave M, 1999, CLIN CANCER RES, V5, P2891; HATANAKA H, 1994, INT J RADIAT ONCOL, V28, P1061, DOI 10.1016/0360-3016(94)90479-0; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Kabalka GW, 1997, J NUCL MED, V38, P1762; Kabalka GW, 2003, J NEURO-ONCOL, V62, P187, DOI 10.1007/BF02699944; Kato I, 2009, APPL RADIAT ISOTOPES, V67, pS37, DOI 10.1016/j.apradiso.2009.03.103; Kawabata S, 2009, J RADIAT RES, V50, P51, DOI 10.1269/jrr.08043; Masunaga S, 2001, INT J RADIAT ONCOL, V51, P828, DOI 10.1016/S0360-3016(01)01695-9; Masunaga SI, 2014, EXP THER MED, V8, P291, DOI 10.3892/etm.2014.1704; MISHIMA Y, 1989, LANCET, V2, P388; Miyata S, 2011, NEUROSURGERY, V68, P1380, DOI 10.1227/NEU.0b013e31820b52aa; Miyatake SI, 2009, J NEURO-ONCOL, V91, P199, DOI 10.1007/s11060-008-9699-x; Moss RL, 2014, APPL RADIAT ISOTOPES, V88, P2, DOI 10.1016/j.apradiso.2013.11.109; Nigg DW, 1997, J NEURO-ONCOL, V33, P93, DOI 10.1023/A:1005777416716; SARIS SC, 1992, CANCER RES, V52, P4672; Schinazi RF, 2004, NUCLEOS NUCLEOT NUCL, V23, P291, DOI 10.1081/NCN-120027836; Sharifi N, 2010, ENDOCR-RELAT CANCER, V17, pR305, DOI 10.1677/ERC-10-0187; SOLOWAY AH, 1967, J MED CHEM, V10, P714, DOI 10.1021/jm00316a042; Suzuki M, 2014, J RADIAT RES, V55, P146, DOI 10.1093/jrr/rrt098; Wittig A, 2000, RADIAT RES, V153, P173, DOI 10.1667/0033-7587(2000)153[0173:MOTOPB]2.0.CO;2; Yasui L, 2012, APPL RADIAT ISOTOPES, V70, P6, DOI 10.1016/j.apradiso.2011.07.001	28	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136981	10.1371/journal.pone.0136981	http://dx.doi.org/10.1371/journal.pone.0136981			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325195	Green Published, gold, Green Submitted			2022-12-26	WOS:000360437700078
J	Wang, XK; Huang, Y; Jastaneiah, S; Majumdar, S; Kang, JU; Yiu, SC; Stark, W; Elisseeff, JH				Wang, Xiaokun; Huang, Yong; Jastaneiah, Sabah; Majumdar, Shoumyo; Kang, Jin U.; Yiu, Samuel C.; Stark, Walter; Elisseeff, Jennifer H.			Protective Effects of Soluble Collagen during Ultraviolet-A Crosslinking on Enzyme-Mediated Corneal Ectatic Models	PLOS ONE			English	Article							PROGRESSIVE KERATOCONUS; BIOMECHANICAL CHANGES; TEAR FILM; RIBOFLAVIN; PROTEOGLYCANS; RABBIT; RIBOFLAVIN/ULTRAVIOLET; TOPOGRAPHY; INHIBITOR; FIBRILS	Collagen crosslinking is a relatively new treatment for structural disorders of corneal ectasia, such as keratoconus. However, there is a lack of animal models of keratoconus, which has been an obstacle for carefully analyzing the mechanisms of crosslinking and evaluating new therapies. In this study, we treated rabbit eyes with collagenase and chondroitinase enzymes to generate ex vivo corneal ectatic models that simulate the structural disorder of keratoconus. The models were then used to evaluate the protective effect of soluble collagen in the UVA crosslinking system. After enzyme treatment, the eyes were exposed to riboflavin/UVA crosslinking with and without soluble type I collagen. Corneal morphology, collagen ultrastructure, and thermal stability were evaluated before and after crosslinking. Enzyme treatments resulted in corneal curvature changes, collagen ultrastructural damage, decreased swelling resistance and thermal stability, which are similar to what is observed in keratoconus eyes. UVA crosslinking restored swelling resistance and thermal stability, but ultrastructural damage were found in the crosslinked ectatic corneas. Adding soluble collagen during crosslinking provided ultrastructural protection and further enhanced the swelling resistance. Therefore, UVA crosslinking on the ectatic model mimicked typical clinical treatment for keratoconus, suggesting that this model replicates aspects of human keratoconus and could be used for investigating experimental therapies and treatments prior to translation.	[Wang, Xiaokun; Yiu, Samuel C.; Stark, Walter; Elisseeff, Jennifer H.] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA; [Huang, Yong; Kang, Jin U.] Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA; [Jastaneiah, Sabah] King Khalid Eye Specialist Hosp, Ophthalmol, Riyadh, Saudi Arabia; [Majumdar, Shoumyo; Elisseeff, Jennifer H.] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA; [Elisseeff, Jennifer H.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; King Khaled Eye Specialist Hospital; Johns Hopkins University; Johns Hopkins University	Elisseeff, JH (corresponding author), Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA.	jhe@jhu.edu	Elisseeff, Jennifer/A-3324-2010; Wang, Xiaokun/D-7461-2018; WANG, XIAOKUN/GQR-1904-2022	Elisseeff, Jennifer/0000-0002-5066-1996; Wang, Xiaokun/0000-0003-1992-4951; 	KKESH-WEI Affiliation Research Grant; Research to Prevent Blindness Jules Stein Professorship	KKESH-WEI Affiliation Research Grant; Research to Prevent Blindness Jules Stein Professorship(Research to Prevent Blindness (RPB))	Funding was provided by KKESH-WEI Affiliation Research Grant, and Research to Prevent Blindness Jules Stein Professorship.	Achur RN, 2004, BBA-PROTEINS PROTEOM, V1701, P109, DOI 10.1016/j.bbapap.2004.06.007; Ahn CS, 1999, CORNEA, V18, P194, DOI 10.1097/00003226-199903000-00009; Akhtar S, 2008, ACTA OPHTHALMOL, V86, P764, DOI 10.1111/j.1755-3768.2007.01142.x; Akhtar S, 2013, MOL VIS, V19, P1526; Almubrad T, 2011, MOL VIS, V17, P2283; Ambekar R, 2011, J MECH BEHAV BIOMED, V4, P223, DOI 10.1016/j.jmbbm.2010.09.014; Angunawela RI, 2009, J CATARACT REFR SURG, V35, P606, DOI 10.1016/j.jcrs.2008.11.050; BIRK DE, 1988, J CELL BIOL, V106, P999, DOI 10.1083/jcb.106.3.999; Chakravarti S, 2006, DEV DYNAM, V235, P2493, DOI 10.1002/dvdy.20868; Collier SA, 2001, CLIN EXP OPHTHALMOL, V29, P340, DOI 10.1046/j.1442-9071.2001.d01-17.x; Dhawan S, 2011, J OPHTHALMOL, V2011, P1; Dong J, 2013, INT J OPHTHALMOL-CHI, V6, P584, DOI 10.3980/j.issn.2222-3959.2013.05.05; Gokhale NS, 2011, CORNEA, V30, P1495, DOI 10.1097/ICO.0b013e31820687f7; Gokhale NS, 2010, CORNEA, V29, P117, DOI 10.1097/ICO.0b013e3181a06c31; Goldich Y, 2012, CORNEA, V31, P609, DOI 10.1097/ICO.0b013e318226bf4a; Grewal DS, 2009, J CATARACT REFR SURG, V35, P425, DOI 10.1016/j.jcrs.2008.11.046; Gwon A, ANIMAL MODELS EYE RE, P192; Hayes S, 2013, PLOS ONE, P8; Hayes S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052860; Henriquez MA, 2011, CORNEA, V30, P281, DOI 10.1097/ICO.0b013e3181eeaea1; Holladay JT, 2009, J REFRACT SURG, V25, pS958, DOI 10.3928/1081597X-20090915-11; Holopainen JM, 2011, AM J OPHTHALMOL, V152, P533, DOI 10.1016/j.ajo.2011.03.023; Hong CW, 2012, INVEST OPHTH VIS SCI, V53, P2321, DOI 10.1167/iovs.11-9327; Hovakimyan M, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/406850; IHALAINEN A, 1986, EUR J CLIN INVEST, V16, P78, DOI 10.1111/j.1365-2362.1986.tb01311.x; Im E, 2007, EXP EYE RES, V84, P383, DOI 10.1016/j.exer.2006.05.017; Johnson RD, 2011, CORNEA, V30, P516, DOI 10.1097/ICO.0b013e3181f0579e; Kenney MC, 2005, INVEST OPHTH VIS SCI, V46, P823, DOI 10.1167/iovs.04-0549; KENNEY MC, 1989, BIOCHEM BIOPH RES CO, V161, P353, DOI 10.1016/0006-291X(89)91604-5; Kling S, 2010, INVEST OPHTH VIS SCI, V51, P3961, DOI 10.1167/iovs.09-4536; Koller T, 2009, J CATARACT REFR SURG, V35, P1358, DOI 10.1016/j.jcrs.2009.03.035; Lim LS, 2011, ARCH OPHTHALMOL-CHIC, V129, P360, DOI 10.1001/archophthalmol.2011.23; Lin YK, 2006, FOOD CHEM, V99, P244, DOI 10.1016/j.foodchem.2005.06.053; Mackiewicz Z, 2006, CORNEA, V25, P603, DOI 10.1097/01.ico.0000208820.32614.00; MAEDA N, 1994, INVEST OPHTH VIS SCI, V35, P2749; MAGUIRE LJ, 1989, AM J OPHTHALMOL, V108, P107, DOI 10.1016/0002-9394(89)90001-9; Mazzotta C, 2007, CLIN EXP OPHTHALMOL, V35, P580, DOI 10.1111/j.1442-9071.2007.01536.x; McCall AS, 2010, INVEST OPHTH VIS SCI, V51, P129, DOI 10.1167/iovs.09-3738; Michelacci YM, 2003, BRAZ J MED BIOL RES, V36, P1037, DOI 10.1590/S0100-879X2003000800009; Netto MV, 2005, CORNEA, V24, P509, DOI 10.1097/01.ico.0000151544.23360.17; Ojeda JL, 2001, J ANAT, V199, P567, DOI 10.1046/j.1469-7580.2001.19950567.x; Patey A, 1984, Cornea, V3, P119; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; Raiskup F, 2013, OCUL SURF, V11, P65, DOI 10.1016/j.jtos.2013.01.002; Raiskup F, 2009, J REFRACT SURG, V25, pS824, DOI 10.3928/1081597X-20090813-12; Redbrake C, 1997, CURR EYE RES, V16, P405, DOI 10.1076/ceyr.16.5.405.7044; Sandali O, 2013, OPHTHALMOLOGY, V120, P2403, DOI 10.1016/j.ophtha.2013.05.027; SAWAGUCHI S, 1990, EXP EYE RES, V50, P549, DOI 10.1016/0014-4835(90)90044-U; SAWAGUCHI S, 1994, INVEST OPHTH VIS SCI, V35, P4008; Smith VA, 2000, EUR J OPHTHALMOL, V10, P215, DOI 10.1177/112067210001000305; Sorkin N, 2014, OPHTHALMOLOGICA, V232, P10, DOI 10.1159/000357979; Tahzib NG, 2011, NED TIJDSCHR GENEES, V155, pA3304; Valdez-Garcia Jorge E, 2015, BMC Res Notes, V8, P28, DOI 10.1186/s13104-015-0995-1; Vinciguerra P, 2012, AM J OPHTHALMOL, V154, P520, DOI 10.1016/j.ajo.2012.03.020; Vinciguerra P, 2009, OPHTHALMOLOGY, V116, P369, DOI 10.1016/j.ophtha.2008.09.048; Wilson SE, 2000, CORNEA, V19, P417, DOI 10.1097/00003226-200007000-00001; Wollensak G, 2004, CORNEA, V23, P503, DOI 10.1097/01.ico.0000105827.85025.7f; Wollensak G, 2004, CORNEA, V23, P43, DOI 10.1097/00003226-200401000-00008; Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1; Wollensak G, 2008, CORNEA, V27, P353, DOI 10.1097/ICO.0b013e31815cf66a; Wollensak G, 2006, CURR OPIN OPHTHALMOL, V17, P356, DOI 10.1097/01.icu.0000233954.86723.25; Zhou LL, 1998, INVEST OPHTH VIS SCI, V39, P1117	62	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136999	10.1371/journal.pone.0136999	http://dx.doi.org/10.1371/journal.pone.0136999			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325407	Green Submitted, gold, Green Published			2022-12-26	WOS:000360437700080
J	Bertalan, Z; Budrikis, Z; La Porta, CAM; Zapperi, S				Bertalan, Zsolt; Budrikis, Zoe; La Porta, Caterina A. M.; Zapperi, Stefano			Navigation Strategies of Motor Proteins on Decorated Tracks	PLOS ONE			English	Article							HAND-OVER-HAND; CYTOPLASMIC DYNEIN; INTRACELLULAR-TRANSPORT; KINETOCHORE DYNEIN; STEPPING BEHAVIOR; MICROTUBULE; CELLS; PROTOFILAMENTS; SPINDLE; FORCE	Motor proteins display widely different stepping patterns as they move on microtubule tracks, from the deterministic linear or helical motion performed by the protein kinesin to the uncoordinated random steps made by dynein. How these different strategies produce an efficient navigation system needed to ensure correct cellular functioning is still unclear. Here, we show by numerical simulations that deterministic and random motor steps yield different outcomes when random obstacles decorate the microtubule tracks: kinesin moves faster on clean tracks but its motion is strongly hindered on decorated tracks, while dynein is slower on clean tracks but more efficient in avoiding obstacles. Further simulations indicate that dynein's advantage on decorated tracks is due to its ability to step backwards. Our results explain how different navigation strategies are employed by the cell to optimize motor driven cargo transport.	[Bertalan, Zsolt; Budrikis, Zoe; Zapperi, Stefano] Inst Sci Interchange Fdn, Turin, Italy; [La Porta, Caterina A. M.] Univ Milan, Dept Biosci, Ctr Complex & Biosyst, Milan, Italy; [Zapperi, Stefano] Univ Milan, Dept Phys, Ctr Complex & Biosyst, Milan, Italy; [Zapperi, Stefano] CNR, Ist Energet & Interfasi, I-20133 Milan, Italy; [Zapperi, Stefano] Aalto Univ, Dept Appl Phys, Espoo, Finland	University of Milan; University of Milan; Consiglio Nazionale delle Ricerche (CNR); Aalto University	La Porta, CAM (corresponding author), Univ Milan, Dept Biosci, Ctr Complex & Biosyst, Milan, Italy.	caterina.laporta@unimi.it; stefano.zapperi@unimi.it	Zapperi, Stefano/C-9473-2009; la porta, caterina/K-7345-2013	Zapperi, Stefano/0000-0001-5692-5465; la porta, caterina/0000-0002-3010-8966	ERC advanced grant SIZEFFECTS; Academy of Finland FiDiPro progam [13282993]	ERC advanced grant SIZEFFECTS; Academy of Finland FiDiPro progam	Zsolt B., Zoe B., and SZ are supported by the ERC advanced grant SIZEFFECTS. SZ acknowledges partial support from the Academy of Finland FiDiPro progam, project 13282993. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bormuth V, 2012, BIOPHYS J, V103, pL04, DOI 10.1016/j.bpj.2012.05.024; Bressloff PC, 2013, REV MOD PHYS, V85, P135, DOI 10.1103/RevModPhys.85.135; Brunnbauer M, 2012, MOL CELL, V46, P147, DOI 10.1016/j.molcel.2012.04.005; Bugiel M, 2015, BIOPHYS J, V108, P2019, DOI 10.1016/j.bpj.2015.03.022; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Can S, 2014, ELIFE, V3, DOI 10.7554/eLife.03205; Chen KJ, 2015, NAT MATER, V14, P589, DOI [10.1038/NMAT4239, 10.1038/nmat4239]; Cho C, 2008, J BIOL CHEM, V283, P25839, DOI 10.1074/jbc.M802951200; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Gross SP, 2000, J CELL BIOL, V148, P945, DOI 10.1083/jcb.148.5.945; Hancock WO, 2014, NAT REV MOL CELL BIO, V15, P615, DOI 10.1038/nrm3853; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Hoeprich GJ, 2014, BIOPHYS J, V106, P1691, DOI 10.1016/j.bpj.2014.02.034; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Kotak S, 2012, J CELL BIOL, V199, P97, DOI 10.1083/jcb.201203166; Kunwar A, 2011, P NATL ACAD SCI USA, V108, P18960, DOI 10.1073/pnas.1107841108; Li Y, 2007, CELL RES, V17, P701, DOI 10.1038/cr.2007.65; Qiu WH, 2012, NAT STRUCT MOL BIOL, V19, P193, DOI 10.1038/nsmb.2205; RAY S, 1993, J CELL BIOL, V121, P1083, DOI 10.1083/jcb.121.5.1083; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; Roberts AJ, 2013, NAT REV MOL CELL BIO, V14, P713, DOI 10.1038/nrm3667; Schneider R, 2015, BIOPHYS J, V108, P2249, DOI 10.1016/j.bpj.2015.03.048; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Sharp DJ, 2000, NATURE, V407, P41, DOI 10.1038/35024000; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103; Torisawa T, 2014, NAT CELL BIOL, V16, P1118, DOI 10.1038/ncb3048; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; von Massowan, 1989, CELL MOT CYT, V14, P562, DOI [10.1002/cm.970140413, DOI 10.1002/CM.970140413]; Vorozhko VV, 2008, CHROMOSOMA, V117, P169, DOI 10.1007/s00412-007-0135-3; Wang B, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.208102; Yang ZY, 2007, CURR BIOL, V17, P973, DOI 10.1016/j.cub.2007.04.056; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Yildiz A, 2008, CELL, V134, P1030, DOI 10.1016/j.cell.2008.07.018	35	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136945	10.1371/journal.pone.0136945	http://dx.doi.org/10.1371/journal.pone.0136945			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26323095	Green Published, gold			2022-12-26	WOS:000360435500052
J	Michel, A; Downey, P; Van Damme, X; De Wolf, C; Schwarting, R; Scheller, D				Michel, Anne; Downey, Patrick; Van Damme, Xavier; De Wolf, Catherine; Schwarting, Rainer; Scheller, Dieter			Behavioural Assessment of the A(2 alpha)/NR2B Combination in the Unilateral 6-OHDA-Lesioned Rat Model: A New Method to Examine the Therapeutic Potential of Non-Dopaminergic Drugs	PLOS ONE			English	Article							LEVODOPA-INDUCED DYSKINESIA; NMDA RECEPTOR ANTAGONIST; ANIMAL-MODELS; PARKINSONS-DISEASE; ROTATIONAL BEHAVIOR; MOTOR COMPLICATIONS; ISTRADEFYLLINE	In Parkinson's disease (PD), dopaminergic therapies are often associated with the development of motor complications. Attention has therefore been focused on the use of non-dopaminergic drugs. This study developed a new behavioural method capable of demonstrating the added value of combining adenosinergic and glutamatergic receptor antagonists in unilateral 6-OHDA lesioned rats. Rats were dosed orally with Tozadenant, a selective A(2A) receptor antagonist, and three different doses of Radiprodil, an NR2B-selective NMDA receptor antagonist. The drugs were given alone or in combination and rats were placed in an open-field for behavioural monitoring. Video recordings were automatically analysed. Five different behaviours were scored: distance traveled, ipsi- and contraversive turns, body position, and space occupancy. The results show that A(2A) or NR2B receptor antagonists given alone or in combination did not produce enhanced turning as observed with an active dose of L-Dopa/benserazide. Instead the treated rats maintained a straight body position, were able to shift from one direction to the other and occupied a significantly larger space in the arena. The highest "Tozadenant/Radiprodil" dose combination significantly increased all five behavioural parameters recorded compared to rats treated with vehicle or the same doses of the drugs alone. Our data suggest that the A(2A)/NR2B antagonist combination may be able to stimulate motor activity to a similar level as that achieved by L-Dopa but in the absence of the side-effects that are associated with dopaminergic hyperstimulation. If these results translate into the clinic, this combination could represent an alternative symptomatic treatment option for PD.	[Michel, Anne; Downey, Patrick; De Wolf, Catherine; Scheller, Dieter] UCB Biopharma SPRL, Neurosci TA Biol, Braine Lalleud, Belgium; [Van Damme, Xavier] UCB Biopharma SPRL, Strategy & Alliance Management, Braine Lalleud, Belgium; [Schwarting, Rainer] Univ Marburg, Behav Neurosci, Marburg, Germany	Philipps University Marburg	Michel, A (corresponding author), UCB Biopharma SPRL, Neurosci TA Biol, Braine Lalleud, Belgium.	anne.michel@ucb.com	Schwarting, RAINER/AAJ-1516-2021	Schwarting, Rainer/0000-0002-4686-3974	UCB Biopharma SPRL	UCB Biopharma SPRL	UCB Biopharma SPRL provided support in the form of salaries for authors (AM, PD, DS, XVD, and CDW), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Addy C, 2009, J CLIN PHARMACOL, V49, P856, DOI 10.1177/0091270009336735; Bibbiani F, 2003, EXP NEUROL, V184, P285, DOI 10.1016/S0014-4886(03)00250-4; Blanchet PJ, 1999, J PHARMACOL EXP THER, V290, P1034; Carta AR, 2006, BEHAV PHARMACOL, V17, P393, DOI 10.1097/00008877-200609000-00005; Cerasa A, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00049; Connolly BS, 2014, JAMA-J AM MED ASSOC, V311, P1670, DOI 10.1001/jama.2014.3654; Fernandez HH, 2010, PARKINSONISM RELAT D, V16, P16, DOI 10.1016/j.parkreldis.2009.06.008; Ferreira Joaquim J., 2000, Current Opinion in Neurology, V13, P431, DOI 10.1097/00019052-200008000-00011; Hauser RA, 2014, LANCET NEUROL, V13, P767, DOI 10.1016/S1474-4422(14)70148-6; Heeringa MJ, 1997, J NEURAL TRANSM, V104, P593, DOI 10.1007/BF01291878; Iravani M M, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS123, DOI 10.1016/S1353-8020(11)70038-4; Jenner P, 2011, J NEURAL TRANSM, V118, P1691, DOI 10.1007/s00702-011-0703-9; Jones N, 2013, BRAIN RES BULL, V98, P163, DOI 10.1016/j.brainresbull.2013.07.001; Konitsiotis S, 2006, BEHAV BRAIN RES, V170, P337, DOI 10.1016/j.bbr.2006.02.030; Lane EL, 2006, EXP NEUROL, V197, P284, DOI 10.1016/j.expneurol.2005.06.006; Loschmann PA, 2004, EXP NEUROL, V187, P86, DOI 10.1016/j.expneurol.2004.01.018; Michel A, 2008, SOC NEUROSCIENCE, pS742; Michel A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114086; Morissette M, 2006, SYNAPSE, V60, P239, DOI 10.1002/syn.20295; Nadjar A, 2009, PROG NEUROBIOL, V87, P1, DOI 10.1016/j.pneurobio.2008.09.013; News CT, RADIPRODIL TRIAL FAI; NUTT JG, 1990, NEUROLOGY, V40, P340; Park A, 2012, EXPERT OPIN PHARMACO, V13, P111, DOI 10.1517/14656566.2012.643869; Paxinos G., RAT BRAIN STEREOTAXI, VSeventh; Prat G, 2000, J NEURAL TRANSM, V107, P409, DOI 10.1007/s007020070083; Rodnitzky RL, 2014, NEUROLOGY, V82, P288, DOI 10.1212/WNL.0000000000000068; Schwarting RKW, 1996, PROG NEUROBIOL, V50, P275, DOI 10.1016/S0301-0082(96)00040-8; Shook BC, 2010, J MED CHEM, V53, P8104, DOI 10.1021/jm100971t; Taylor JL, 2006, NEUROPHARMACOLOGY, V50, P761, DOI 10.1016/j.neuropharm.2005.12.004; Toulouse A, 2008, PROG NEUROBIOL, V85, P376, DOI 10.1016/j.pneurobio.2008.05.003; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3	31	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0135949	10.1371/journal.pone.0135949	http://dx.doi.org/10.1371/journal.pone.0135949			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322641	gold, Green Published, Green Submitted			2022-12-26	WOS:000360435500012
J	Romero-Saavedra, F; Laverde, D; Budin-Verneuil, A; Muller, C; Bernay, B; Benachour, A; Hartke, A; Huebner, J				Romero-Saavedra, Felipe; Laverde, Diana; Budin-Verneuil, Aurelie; Muller, Cecile; Bernay, Benoit; Benachour, Abdellah; Hartke, Axel; Huebner, Johannes			Characterization of Two Metal Binding Lipoproteins as Vaccine Candidates for Enterococcal Infections	PLOS ONE			English	Article							PNEUMOCOCCAL SURFACE ADHESIN; STREPTOCOCCUS-PNEUMONIAE; ANTIMICROBIAL RESISTANCE; ABC TRANSPORTERS; FAECALIS; IDENTIFICATION; PSAA; IMMUNIZATION; DIVERSITY; IMMUNITY	Background Enterococcus faecium and faecalis are Gram-positive opportunistic pathogens that have become leading causes of nosocomial infections over the last decades. Especially multidrug resistant enterococci have become a challenging clinical problem worldwide. Therefore, new treatment options are needed and the identification of alternative targets for vaccine development has emerged as a feasible alternative to fight the infections caused by these pathogens. Results We extrapolate the transcriptomic data from a mice peritonitis infection model in E. faecalis to identify putative up-regulated surface proteins under infection conditions in E. faecium. After the bionformatic analyses two metal binding lipoproteins were identified to have a high homology (>72%) between the two species, the manganese ABC transporter substrate-binding lipoprotein (PsaA(fm),) and the zinc ABC transporter substrate-binding lipoprotein (AdcA(fm)). These candidate lipoproteins were overexpressed in Escherichia coli and purified. The recombinant proteins were used to produce rabbit polyclonal antibodies that were able to induce specific opsonic antibodies that mediated killing of the homologous strain E. faecium E155 as well as clinical strains E. faecium E1162, Enterococcus faecalis 12030, type 2 and type 5. Mice were passively immunized with the antibodies raised against recombinant lipoproteins, showing significant reduction of colony counts in mice livers after the bacterial challenge and demonstrating the efficacy of these metal binding lipoproteins as promising vaccine candidates to treat infections caused by these enterococcal pathogens. Conclusion Overall, our results demonstrate that these two metal binding lipoproteins elicited specific, opsonic and protective antibodies, with an extensive cross-reactivity and serotype-independent coverage among these two important nocosomial pathogens. Pointing these two protein antigens as promising immunogens, that can be used as single components or as carrier proteins together with polysaccharide antigens in vaccine development against enterococcal infections.	[Romero-Saavedra, Felipe; Laverde, Diana; Huebner, Johannes] Univ Med Ctr Freiburg, Dept Med, Div Infect Dis, Freiburg, Germany; [Romero-Saavedra, Felipe; Laverde, Diana; Budin-Verneuil, Aurelie; Muller, Cecile; Benachour, Abdellah; Hartke, Axel] Univ Caen Lower Normandy, Stress Virulence EA4655 U2RM, Caen, France; [Huebner, Johannes] Univ Munich, Div Pediat Infect Dis, Dr von Hauner Childrens Hosp, Munich, Germany; [Bernay, Benoit] Univ Caen Lower Normandy, Proteogen Platform SFR ICORE 4206, Caen, France	University of Freiburg; Universite de Caen Normandie; University of Munich; Universite de Caen Normandie	Huebner, J (corresponding author), Univ Med Ctr Freiburg, Dept Med, Div Infect Dis, Freiburg, Germany.	johannes.huebner@med.uni-muenchen.de		Muller, Cecile/0000-0003-3078-1920; Huebner, Johannes/0000-0003-1232-4646; BUDIN-VERNEUIL, Aurelie/0000-0002-1173-251X				Aarestrup FM, 2002, APPL ENVIRON MICROB, V68, P4127, DOI 10.1128/AEM.68.8.4127-4129.2002; Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Bayle L, 2011, MOL MICROBIOL, V82, P904, DOI 10.1111/j.1365-2958.2011.07862.x; Betts JC, 2002, IUBMB LIFE, V53, P239, DOI 10.1080/15216540212651; Brown JS, 2001, INFECT IMMUN, V69, P6702, DOI 10.1128/IAI.69.11.6702-6706.2001; Burnie J, 2002, FEMS IMMUNOL MED MIC, V33, P179, DOI 10.1111/j.1574-695X.2002.tb00589.x; Chen QY, 2008, J IMMUNOL, V181, P8258, DOI 10.4049/jimmunol.181.12.8258; Fernebro J, 2011, DRUG RESIST UPDATE, V14, P125, DOI 10.1016/j.drup.2011.02.001; Fisher K, 2009, MICROBIOL-SGM, V155, P1749, DOI 10.1099/mic.0.026385-0; Garmory HS, 2004, INFECT IMMUN, V72, P6757, DOI 10.1128/IAI.72.12.6757-6763.2004; Huebner J, 1999, INFECT IMMUN, V67, P1213, DOI 10.1128/IAI.67.3.1213-1219.1999; Huebner J, 2000, INFECT IMMUN, V68, P4631, DOI 10.1128/IAI.68.8.4631-4636.2000; Hufnagel M, 2004, J CLIN MICROBIOL, V42, P2548, DOI 10.1128/JCM.42.6.2548-2557.2004; Hufnagel M, 2003, INT J FOOD MICROBIOL, V88, P263, DOI 10.1016/S0168-1605(03)00189-2; Hutchings MI, 2009, TRENDS MICROBIOL, V17, P13, DOI 10.1016/j.tim.2008.10.001; Koch S, 2004, VACCINE, V22, P822, DOI 10.1016/j.vaccine.2003.11.027; Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10; Kropec A, 2011, MICROBIOL-SGM, V157, P3429, DOI 10.1099/mic.0.053207-0; Laverde D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110953; Leavis HL, 2007, PLOS PATHOG, V3, P75, DOI 10.1371/journal.ppat.0030007; LOWE AM, 1995, INFECT IMMUN, V63, P703, DOI 10.1128/IAI.63.2.703-706.1995; MAEKAWA S, 1992, MICROBIOL IMMUNOL, V36, P671, DOI 10.1111/j.1348-0421.1992.tb02070.x; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Muller C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126143; Murray BE, 2000, NEW ENGL J MED, V342, P710, DOI 10.1056/NEJM200003093421007; Rajam G, 2008, CRIT REV MICROBIOL, V34, P131, DOI [10.1080/10408410802275352, 10.1080/10408410802275352 ]; Rappuoli R, 2001, VACCINE, V19, P2688, DOI 10.1016/S0264-410X(00)00554-5; Reffuveille F, 2012, MICROBIOL-SGM, V158, P816, DOI 10.1099/mic.0.055319-0; Reffuveille F, 2011, MICROBIOL-SGM, V157, P3001, DOI 10.1099/mic.0.053314-0; Rinaudo CD, 2009, J CLIN INVEST, V119, P2515, DOI 10.1172/JCI38330; Rodriguez-Ortega MJ, 2006, NAT BIOTECHNOL, V24, P191, DOI 10.1038/nbt1179; Romero-Saavedra F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111880; Sambrook J., 2001, COLD SPRING HARBOR L, V3, P2344, DOI DOI 10.1016/0307-4412(83)90068-7; Sampson JS, 1997, INFECT IMMUN, V65, P1967, DOI 10.1128/IAI.65.5.1967-1971.1997; Sava IG, 2010, CLIN MICROBIOL INFEC, V16, P533, DOI 10.1111/j.1469-0691.2010.03213.x; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; Singh KV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000716; Singh KV, 1998, FEMS IMMUNOL MED MIC, V21, P323, DOI 10.1016/S0928-8244(98)00087-X; Talkington DF, 1996, MICROB PATHOGENESIS, V21, P17, DOI 10.1006/mpat.1996.0038; Theilacker C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017839; Theilacker C, 2009, MOL MICROBIOL, V71, P1055, DOI [10.1111/j.1365-2958.2008.06587.x, 10.1111/j.1365-2958.2009.06587.x]; vandenBogaard AE, 1997, J ANTIMICROB CHEMOTH, V40, P453, DOI 10.1093/jac/40.3.453; Werner G., 2008, EURO SURVEILL, V13, P19046; Whaley MJ, 2010, VACCINE, V28, P3071, DOI 10.1016/j.vaccine.2010.02.086; Willems RJL, 2012, MBIO, V3, DOI 10.1128/mBio.00151-12; Zarb P, 2012, EUROSURVEILLANCE, V17, P4	46	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136625	10.1371/journal.pone.0136625	http://dx.doi.org/10.1371/journal.pone.0136625			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322633	Green Published, gold, Green Submitted			2022-12-26	WOS:000360435500024
J	Soyka, F; Bulthoff, HH; Barnett-Cowan, M				Soyka, Florian; Buelthoff, Heinrich H.; Barnett-Cowan, Michael			Integration of Semi-Circular Canal and Otolith Cues for Direction Discrimination during Eccentric Rotations	PLOS ONE			English	Article							SELF-MOTION PERCEPTION; QUALITATIVELY DIFFERENT MECHANISMS; GRAVITO-INERTIAL CUES; VERTICAL AXIS; WHOLE-BODY; VESTIBULAR PERCEPTION; BAYESIAN INTEGRATION; SPATIAL ORIENTATION; HUMANS; MODEL	Humans are capable of moving about the world in complex ways. Every time we move, our self-motion must be detected and interpreted by the central nervous system in order to make appropriate sequential movements and informed decisions. The vestibular labyrinth consists of two unique sensory organs the semi-circular canals and the otoliths that are specialized to detect rotation and translation of the head, respectively. While thresholds for pure rotational and translational self-motion are well understood surprisingly little research has investigated the relative role of each organ on thresholds for more complex motion. Eccentric (off-center) rotations during which the participant faces away from the center of rotation stimulate both organs and are thus well suited for investigating integration of rotational and translational sensory information. Ten participants completed a psychophysical direction discrimination task for pure head-centered rotations, translations and eccentric rotations with 5 different radii. Discrimination thresholds for eccentric rotations reduced with increasing radii, indicating that additional tangential accelerations (which increase with radius length) increased sensitivity. Two competing models were used to predict the eccentric thresholds based on the pure rotation and translation thresholds: one assuming that information from the two organs is integrated in an optimal fashion and another assuming that motion discrimination is solved solely by relying on the sensor which is most strongly stimulated. Our findings clearly show that information from the two organs is integrated. However the measured thresholds for 3 of the 5 eccentric rotations are even more sensitive than predictions from the optimal integration model suggesting additional non-vestibular sources of information may be involved.	[Soyka, Florian; Buelthoff, Heinrich H.; Barnett-Cowan, Michael] Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, D-72076 Tubingen, Germany; [Buelthoff, Heinrich H.] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Barnett-Cowan, Michael] Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada	Max Planck Society; Korea University; University of Waterloo	Soyka, F (corresponding author), Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, Spemannstr 38, D-72076 Tubingen, Germany.	florian.soyka@tuebingen.mpg.de; heinrich.buelthoff@tuebingen.mpg.de	Bülthoff, Heinrich H/J-6579-2012; Soyka, Florian/M-4404-2019; Bülthoff, Heinrich/AAC-8818-2019	Bülthoff, Heinrich H/0000-0003-2568-0607; Soyka, Florian/0000-0003-1546-0491	Max Planck Society stipends; WCU (World Class University) program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [R31-10008]	Max Planck Society stipends; WCU (World Class University) program through the National Research Foundation of Korea - Ministry of Education, Science and Technology	This research was supported by Max Planck Society stipends and by the WCU (World Class University) program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (R31-10008).	Angelaki DE, 1999, J NEUROSCI, V19, P316, DOI 10.1523/JNEUROSCI.19-01-00316.1999; Barnett-Cowan M, 2005, ANN NY ACAD SCI, V1039, P314, DOI 10.1196/annals.1325.030; Barnett-Cowan M, 2012, JOVE-J VIS EXP, DOI 10.3791/3436; BENSON AJ, 1989, AVIAT SPACE ENVIR MD, V60, P205; BENSON AJ, 1986, AVIAT SPACE ENVIR MD, V57, P1088; Bertolini G, 2011, J NEUROPHYSIOL, V105, P209, DOI 10.1152/jn.00154.2010; Bertolini G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036763; Bos JE, 2002, BIOL CYBERN, V86, P191, DOI 10.1007/s00422-001-0289-7; Butler JS, 2010, J VISION, V10, DOI 10.1167/10.11.23; Crane BT, 1999, BIOL CYBERN, V81, P109, DOI 10.1007/s004220050548; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Fetsch CR, 2013, NAT REV NEUROSCI, V14, P429, DOI 10.1038/nrn3503; Fetsch CR, 2009, J NEUROSCI, V29, P15601, DOI 10.1523/JNEUROSCI.2574-09.2009; Giordano P. Robuffo, 2010, 2010 IEEE International Conference on Robotics and Automation (ICRA 2010), P3896, DOI 10.1109/ROBOT.2010.5509945; Giordano PR, 2010, IEEE INT CONF ROBOT, P3876, DOI 10.1109/ROBOT.2010.5509647; Grabherr L, 2008, EXP BRAIN RES, V186, P677, DOI 10.1007/s00221-008-1350-8; Heerspink MH, 2005, AIAA MOD SIM TECHN C, P1; Hillis JM, 2002, SCIENCE, V298, P1627, DOI 10.1126/science.1075396; Israel I, 2005, EXP BRAIN RES, V163, P540, DOI 10.1007/s00221-005-2323-9; Kontsevich LL, 1999, VISION RES, V39, P2729, DOI 10.1016/S0042-6989(98)00285-5; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; MacNeilage PR, 2010, J NEUROPHYSIOL, V104, P765, DOI 10.1152/jn.01067.2009; MacNeilage PR, 2008, J NEUROPHYSIOL, V100, P2981, DOI 10.1152/jn.90677.2008; Merfeld DM, 2005, J NEUROPHYSIOL, V94, P186, DOI 10.1152/jn.00904.2004; Merfeld DM, 2005, J NEUROPHYSIOL, V94, P199, DOI 10.1152/jn.00905.2004; MERFELD DM, 1995, ACTA OTO-LARYNGOL, P354; Merfeld DM, 2002, J NEUROPHYSIOL, V87, P819, DOI 10.1152/jn.00485.2001; Merfeld DM, 2001, J NEUROPHYSIOL, V85, P1648, DOI 10.1152/jn.2001.85.4.1648; Mittelstaedt ML, 1996, J VESTIBUL RES-EQUIL, V6, P355, DOI 10.1016/0957-4271(96)00067-5; Nesti A, 2012, DRIV SIM C; Roditi RE, 2012, JARO-J ASSOC RES OTO, V13, P381, DOI 10.1007/s10162-012-0318-3; Seidman SH, 2002, EXP BRAIN RES, V147, P29, DOI 10.1007/s00221-002-1214-6; Soyka F, 2015, SUPPLEMENTARY MAT; Soyka F, 2013, EXP BRAIN RES, V228, P51, DOI 10.1007/s00221-013-3536-y; Soyka F, 2012, EXP BRAIN RES, V220, P89, DOI 10.1007/s00221-012-3120-x; Soyka F, 2011, EXP BRAIN RES, V209, P95, DOI 10.1007/s00221-010-2523-9; Tanner T, 2008, PERCEPTION, V37, P93; Teufel H.J., 2007, AIAA MOD SIM TECHN C, V1, P1; Valko Y, 2012, J NEUROSCI, V32, P13537, DOI 10.1523/JNEUROSCI.2157-12.2012; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; WALSH EG, 1961, J PHYSIOL-LONDON, V155, P506, DOI 10.1113/jphysiol.1961.sp006643; Wood S, 2004, J VESTIBUL RES-EQUIL, V14, P109; Zupan LH, 2000, J NEUROPHYSIOL, V84, P2001, DOI 10.1152/jn.2000.84.4.2001; Zupan LH, 2002, BIOL CYBERN, V86, P209, DOI 10.1007/s00422-001-0290-1	45	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136925	10.1371/journal.pone.0136925	http://dx.doi.org/10.1371/journal.pone.0136925			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322782	Green Published, Green Submitted, gold			2022-12-26	WOS:000360435500049
J	Batchelder, CA; Martinez, ML; Duru, N; Meyers, FJ; Tarantal, AF				Batchelder, Cynthia A.; Martinez, Michele L.; Duru, Nadire; Meyers, Frederick J.; Tarantal, Alice F.			Three Dimensional Culture of Human Renal Cell Carcinoma Organoids	PLOS ONE			English	Article							IN-VITRO; STEM-CELLS; KIDNEY; CANCER; MODEL	Renal cell carcinomas arise from the nephron but are heterogeneous in disease biology, clinical behavior, prognosis, and response to systemic therapy. Development of patient-specific in vitro models that efficiently and faithfully reproduce the in vivo phenotype may provide a means to develop personalized therapies for this diverse carcinoma. Studies to maintain and model tumor phenotypes in vitro were conducted with emerging three-dimensional culture techniques and natural scaffolding materials. Human renal cell carcinomas were individually characterized by histology, immunohistochemistry, and quantitative PCR to establish the characteristics of each tumor. Isolated cells were cultured on renal extracellular matrix and compared to a novel polysaccharide scaffold to assess cell-scaffold interactions, development of organoids, and maintenance of gene expression signatures over time in culture. Renal cell carcinomas cultured on renal extracellular matrix repopulated tubules or vessel lumens in renal pyramids and medullary rays, but cells were not observed in glomeruli or outer cortical regions of the scaffold. In the polysaccharide scaffold, renal cell carcinomas formed aggregates that were loosely attached to the scaffold or free-floating within the matrix. Molecular analysis of cell-scaffold constructs including immunohistochemistry and quantitative PCR demonstrated that individual tumor phenotypes could be sustained for up to 21 days in culture on both scaffolds, and in comparison to outcomes in two-dimensional monolayer cultures. The use of three-dimensional scaffolds to engineer a personalized in vitro renal cell carcinoma model provides opportunities to advance understanding of this disease.	[Batchelder, Cynthia A.; Martinez, Michele L.; Duru, Nadire; Tarantal, Alice F.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Meyers, Frederick J.] Univ Calif Davis, Sch Med, Dept Internal Med, Davis, CA 95616 USA; [Meyers, Frederick J.; Tarantal, Alice F.] Univ Calif Davis, Ctr Comprehens Canc, Davis, CA 95616 USA; [Tarantal, Alice F.] Univ Calif Davis, Sch Med, Dept Pediat, Davis, CA 95616 USA; [Tarantal, Alice F.] Univ Calif Davis, Sch Med, Dept Cell Biol & Human Anat, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Tarantal, AF (corresponding author), Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.	aftarantal@ucdavis.edu			UC Davis Comprehensive Cancer Center Biorepository [P30 CA093373]; California Institute for Regenerative Medicine UC Davis Stem Cell Training Program [TG2-01163]; California National Primate Research Center [P51 OD011107]; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER	UC Davis Comprehensive Cancer Center Biorepository; California Institute for Regenerative Medicine UC Davis Stem Cell Training Program; California National Primate Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the UC Davis Comprehensive Cancer Center Biorepository (P30 CA093373), California Institute for Regenerative Medicine UC Davis Stem Cell Training Program (TG2-01163), and the California National Primate Research Center base operating grant (P51 OD011107). These entities had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addla SK, 2008, AM J PHYSIOL-RENAL, V295, pF680, DOI 10.1152/ajprenal.90286.2008; ANGLARD P, 1992, CANCER RES, V52, P348; Astashkina A, 2014, ADV DRUG DELIVER REV, V69, P1, DOI 10.1016/j.addr.2014.02.008; Astashkina AI, 2012, BIOMATERIALS, V33, P4712, DOI 10.1016/j.biomaterials.2012.03.001; Astashkina AI, 2012, BIOMATERIALS, V33, P4700, DOI 10.1016/j.biomaterials.2012.02.063; Batchelder CA, 2009, DIFFERENTIATION, V78, P45, DOI 10.1016/j.diff.2009.05.001; Bianchi C, 2010, AM J PATHOL, V176, P1660, DOI 10.2353/ajpath.2010.090402; Bielecka ZF, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00194; Brannon AR, 2010, GENES CANC, V1, P154; Cifola I, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-244; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; DesRochers TM, 2014, ADV DRUG DELIVER REV, V69, P67, DOI 10.1016/j.addr.2013.12.002; DesRochers TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059219; EBERT T, 1990, CANCER RES, V50, P5531; Fisher R, 2012, EPMA J, V3, DOI 10.1007/s13167-011-0137-3; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Grainger DW, 2014, ADV DRUG DELIVER REV, V69, pVII, DOI 10.1016/j.addr.2014.04.001; Hoppensack A, 2014, TISSUE ENG PART C-ME, V20, P599, DOI [10.1089/ten.tec.2013.0446, 10.1089/ten.TEC.2013.0446]; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Leibovich BC, 2010, J UROLOGY, V183, P1309, DOI 10.1016/j.juro.2009.12.035; Nakayama KH, 2010, TISSUE ENG PT A, V16, P2207, DOI [10.1089/ten.tea.2009.0602, 10.1089/ten.TEA.2009.0602]; Nakayama KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064134; Nakayama KH, 2011, TISSUE ENG PT A, V17, P2891, DOI [10.1089/ten.TEA.2010.0714, 10.1089/ten.tea.2010.0714]; Pan CC, 2004, HISTOPATHOLOGY, V45, P452, DOI 10.1111/j.1365-2559.2004.01962.x; Pavia-Jimenez A, 2014, NAT PROTOC, V9, P1848, DOI 10.1038/nprot.2014.108; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shimazui T, 2004, ONCOL REP, V11, P357; Shuch B, 2015, EUR UROL, V67, P85, DOI 10.1016/j.eururo.2014.04.029; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sivanand S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003643; Takahashi M, 2001, P NATL ACAD SCI USA, V98, P9754, DOI 10.1073/pnas.171209998; Thoma CR, 2014, ADV DRUG DELIVER REV, V69, P29, DOI 10.1016/j.addr.2014.03.001; Valente MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019337; Zhong Y, 2010, CANCER LETT, V299, P150, DOI 10.1016/j.canlet.2010.08.013	36	29	30	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136758	10.1371/journal.pone.0136758	http://dx.doi.org/10.1371/journal.pone.0136758			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317980	gold, Green Published, Green Submitted			2022-12-26	WOS:000360299100137
J	Deng, LB; Liang, QZ; He, XH; Luo, C; Chen, H; Qin, ZS				Deng, Libao; Liang, Qingzhi; He, Xinhua; Luo, Cong; Chen, Hu; Qin, Zhenshi			Investigation and Analysis of Genetic Diversity of Diospyros Germplasms Using SCoT Molecular Markers in Guangxi	PLOS ONE			English	Article							KAKI THUNB.; MICROSATELLITE MARKERS; ISSR MARKERS; POLYMORPHISM; CULTIVARS; DISTANCE; PCR; DIFFERENTIATION; GENTIANACEAE; MULTIVARIATE	Background Knowledge about genetic diversity and relationships among germplasms could be an invaluable aid in diospyros improvement strategies. Methods This study was designed to analyze the genetic diversity and relationship of local and natural varieties in Guangxi Zhuang Autonomous Region of China using start codon targeted polymorphism (SCoT) markers. The accessions of 95 diospyros germplasms belonging to four species Diospyros kaki Thunb, D. oleifera Cheng, D. kaki var. silverstris Mak, and D. lotus Linn were collected from different eco-climatic zones in Guangxi and were analyzed using SCoT markers. Results Results indicated that the accessions of 95 diospyros germplasms could be distinguished using SCoT markers, and were divided into three groups at similarity coefficient of 0.608; these germplasms that belong to the same species were clustered together; of these, the degree of genetic diversity of the natural D. kaki var. silverstris Mak population was richest among the four species; the geographical distance showed that the 12 natural populations of D. kaki var. silverstris Mak were divided into two groups at similarity coefficient of 0.19. Meanwhile, in order to further verify the stable and useful of SCoT markers in diospyros germplasms, SSR markers were also used in current research to analyze the genetic diversity and relationship in the same diospyros germplasms. Once again, majority of germplasms that belong to the same species were clustered together. Thus SCoT markers were stable and especially useful for analysis of the genetic diversity and relationship in diospyros germplasms. Discussion The molecular characterization and diversity assessment of diospyros were very important for conservation of diospyros germplasm resources, meanwhile for diospyros improvement.	[Deng, Libao; He, Xinhua; Luo, Cong; Chen, Hu] Guangxi Univ, Coll Agr, Nanning 530004, Peoples R China; [Liang, Qingzhi] Chinese Acad Trop Agr Sci, South Subtrop Crops Res Inst, Natl Field Genebank Trop Fruit, Zhanjiang 524091, Peoples R China; [Deng, Libao] Adm Comm Guangxi Baise Natl Agr Sci & Technol Zon, Baise 533612, Peoples R China; [He, Xinhua] Guangxi Crop Genet Improvement & Biotechnol Lab, Nanning 530007, Peoples R China; [Qin, Zhenshi] Guangxi Subtrop Crop Res Inst, Expt Stn, Chongzuo 532415, Peoples R China	Guangxi University; Chinese Academy of Tropical Agricultural Sciences	He, XH (corresponding author), Guangxi Univ, Coll Agr, Nanning 530004, Peoples R China.	honest66222@163.com	He, Xinhua/AAE-6796-2020		public basic scientific research project foundation of Guangxi Zhuang Autonomous Region [Rzz200901]; National Natural Science Foundation of China [31471849]; Fund on Basic Scientific Research Project of Nonprofit Central Research Institutions [SSCRI 1630062014002]	public basic scientific research project foundation of Guangxi Zhuang Autonomous Region; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund on Basic Scientific Research Project of Nonprofit Central Research Institutions	The research was supported by the public basic scientific research project foundation of Guangxi Zhuang Autonomous Region (Rzz200901), National Natural Science Foundation of China (No. 31471849) and Fund on Basic Scientific Research Project of Nonprofit Central Research Institutions. No. SSCRI 1630062014002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai Cheng-xiang, 2011, Xibei Zhiwu Xuebao, V31, P2185; Amirmoradi B, 2012, PLANT SYST EVOL, V298, P1679, DOI 10.1007/s00606-012-0669-6; [Anonymous], 2017, RES AN IS MARS MER K; CAI L H, 1996, HUAZHONG AGR U J, V15, P381; Collard BCY, 2009, PLANT MOL BIOL REP, V27, P86, DOI 10.1007/s11105-008-0060-5; Naval MD, 2010, TREE GENET GENOMES, V6, P677, DOI 10.1007/s11295-010-0283-0; Deng LB, 2013, THESIS GUANGXI U NAN, P15; Deng LiBao, 2012, Acta Horticulturae Sinica, V39, P215; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Du XiaoYun, 2009, Acta Horticulturae Sinica, V36, P481; Fischer M, 1998, AM J BOT, V85, P811, DOI 10.2307/2446416; Ge XJ, 2005, BIODIVERS CONSERV, V14, P849, DOI 10.1007/s10531-004-0655-6; Gong BC, 2011, HIGH QUALITY PRACTIC, P67; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.1093/biomet/53.3-4.325; Guo DL, 2006, GENET RESOUR CROP EV, V53, P1597, DOI 10.1007/s10722-005-8717-5; Guo DaLong, 2004, Journal of Agricultural Biotechnology, V12, P386; He XH, 2010, AGR SCI CHINA, V9, P626, DOI 10.1016/S1671-2927(09)60137-1; [何新华 He Xinhua], 2005, [分子植物育种, Molecular Plant Breeding], V3, P829; Hu DC, 2008, SCI HORTIC-AMSTERDAM, V117, P32, DOI 10.1016/j.scienta.2008.02.001; Kim TC, 1997, ACTA HORTIC, P85, DOI 10.17660/ActaHortic.1997.436.8; Liang QZ, 2014, ELECTROPHORESIS, V35, P2520, DOI 10.1002/elps.201400182; Luo ZR, 1995, J JPN SOC HORTIC SCI, V64, P535, DOI 10.2503/jjshs.64.535; Mulpuri S, 2013, PLANT SCI, V207, P117, DOI 10.1016/j.plantsci.2013.02.013; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Rohlf FJ, 2000, NTSYS PC NUMERICAL T; Sneath P.H.A., 1973, NUMERICAL TAXONOMY; Soriano JM, 2006, MOL ECOL NOTES, V6, P368, DOI 10.1111/j.1471-8286.2006.01236.x; Wang R, 1997, ACTA HORTIC, V436, P43; Wang RZ, 1987, PERSIMMMON, P619; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Wu S, 2012, J CENTRAL S U FOR TE, V32, P153; Xiong FQ, 2011, MOL BIOL REP, V38, P3487, DOI 10.1007/s11033-010-0459-6; Yang Y., 1999, ACTA AGR BOREALI OCC, V8, P64; [杨勇 Yang Yong], 2005, [西北林学院学报, Journal of Northwest Forestry College], V20, P133; Yonemori K, 1997, ACTA HORTIC, V436, P21; Yonemori K, 2008, GENET RESOUR CROP EV, V55, P81, DOI 10.1007/s10722-007-9216-7; Zhang YF, 2009, BIOTECHNOL BIOTEC EQ, V23, P1474, DOI 10.2478/V10133-009-0014-6	38	18	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136510	10.1371/journal.pone.0136510	http://dx.doi.org/10.1371/journal.pone.0136510			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317414	gold, Green Submitted, Green Published			2022-12-26	WOS:000360299100092
J	Luddecke, J; Forchhammer, K				Lueddecke, Jan; Forchhammer, Karl			Energy Sensing versus 2-Oxoglutarate Dependent ATPase Switch in the Control of Synechococcus P-II Interaction with Its Targets NAGK and PipX	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PROTEINS; L-GLUTAMATE KINASE; NITROGEN REGULATION; COMPLEX-FORMATION; ESCHERICHIA-COLI; STRUCTURAL BASIS; PII; MECHANISM; INSIGHTS; BINDING	P-II proteins constitute a superfamily of highly conserved signaling devices, common in all domains of life. Through binding of the metabolites ATP, ADP and 2-oxoglutarate (2-OG), they undergo conformational changes which allow them to regulate a variety of target proteins including enzymes, transport proteins and transcription factors. But, in reverse, these target proteins also modulate the metabolite sensing properties of P-II, as has been recently shown. We used this effect to refine our P-II based Forster resonance energy transfer (FRET) sensor and amplify its sensitivity towards ADP. With this enhanced sensor setup we addressed the question whether the P-II protein from the model organism Synechococcus elongatus autonomously switches into the ADP conformation through ATPase activity as proposed in a recently published model. The present study disproves ATPase activity as a relevant mechanism for the transition of P-II into the ADP state. In the absence of 2-OG, only the ATP/ADP ratio and concentration of ADP directs the competitive interaction of P-II with two targets, one of which preferentially binds P-II in the ATP-state, the other in the ADP-state.	[Lueddecke, Jan; Forchhammer, Karl] Univ Tubingen, Interfac Inst Microbiol & Infect Med, Div Organism Interact, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Forchhammer, K (corresponding author), Univ Tubingen, Interfac Inst Microbiol & Infect Med, Div Organism Interact, Morgenstelle 28, D-72076 Tubingen, Germany.	karl.forchhammer@uni-tuebingen.de			Deutsche Forschungsgemeinschaft [DFG Fo195/9]; Open Access Publishing Fund of Tubingen University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of Tubingen University	This work was supported by Deutsche Forschungsgemeinschaft (DFG Fo195/9) (http://www.dfg.de/en/) to KF, and the Open Access Publishing Fund of Tubingen University (http://www.unituebingen.de/einrichtungen/universitaetsbibliothek/publizieren/open-access-publikationsfonds.html) to KF.	BUENO R, 1985, J BACTERIOL, V164, P816, DOI 10.1128/JB.164.2.816-822.1985; Chellamuthu VR, 2013, PLANTA, V237, P451, DOI 10.1007/s00425-012-1801-0; Chellamuthu VR, 2014, CELL, V159, P1188, DOI 10.1016/j.cell.2014.10.015; Conroy MJ, 2007, P NATL ACAD SCI USA, V104, P1213, DOI 10.1073/pnas.0610348104; Espinosa J, 2006, MOL MICROBIOL, V61, P457, DOI 10.1111/j.1365-2958.2006.05231.x; Fokina O, 2011, BIOCHEM J, V440, P147, DOI 10.1042/BJ20110536; Fokina O, 2010, P NATL ACAD SCI USA, V107, P19760, DOI 10.1073/pnas.1007653107; Fokina O, 2010, J MOL BIOL, V399, P410, DOI 10.1016/j.jmb.2010.04.018; Forchhammer K, 2008, TRENDS MICROBIOL, V16, P65, DOI 10.1016/j.tim.2007.11.004; Heinrich A, 2004, MOL MICROBIOL, V52, P1303, DOI 10.1111/j.1365-2958.2004.04058.x; Helfmann S, 2010, J MOL BIOL, V402, P165, DOI 10.1016/j.jmb.2010.07.020; Huergo LF, 2013, FEMS MICROBIOL REV, V37, P251, DOI 10.1111/j.1574-6976.2012.00351.x; Huergo LF, 2012, MICROBIOL-SGM, V158, P176, DOI 10.1099/mic.0.049783-0; Jiang P, 2007, BIOCHEMISTRY-US, V46, P4117, DOI 10.1021/bi0620508; Jiang P, 2009, BIOCHEMISTRY-US, V48, P11514, DOI 10.1021/bi901158h; Leigh JA, 2007, ANNU REV MICROBIOL, V61, P349, DOI 10.1146/annurev.micro.61.080706.093409; Llacer JL, 2010, P NATL ACAD SCI USA, V107, P15397, DOI 10.1073/pnas.1007015107; Luddecke J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083181; Maheswaran M, 2004, J BIOL CHEM, V279, P55202, DOI 10.1074/jbc.M410971200; Ninfa AJ, 2005, CURR OPIN MICROBIOL, V8, P168, DOI 10.1016/j.mib.2005.02.011; Radchenko MV, 2013, P NATL ACAD SCI USA, V110, P12948, DOI 10.1073/pnas.1304386110; Sant'Anna F, 2009, J MOL EVOL, V68, P322, DOI 10.1007/s00239-009-9209-6; Truan D, 2014, J MOL BIOL, V426, P2783, DOI 10.1016/j.jmb.2014.05.008; Truan D, 2010, J MOL BIOL, V400, P531, DOI 10.1016/j.jmb.2010.05.036; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Zeth K, 2014, J BIOL CHEM, V289, P8960, DOI 10.1074/jbc.M113.536557; Zeth K, 2012, ACTA CRYSTALLOGR D, V68, P901, DOI 10.1107/S0907444912016447	27	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137114	10.1371/journal.pone.0137114	http://dx.doi.org/10.1371/journal.pone.0137114			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317540	gold, Green Published, Green Submitted			2022-12-26	WOS:000360299100205
J	Roura, M; Bisoffi, F; Navaza, B; Pool, R				Roura, Maria; Bisoffi, Federico; Navaza, Barbara; Pool, Robert			"Carrying Ibuprofen in the Bag": Priority Health Concerns of Latin American Migrants in Spain- A Participatory Qualitative Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PROSPECTIVE COHORT; SWEDISH MEN; IMMIGRANTS; STRESS; EUROPE; RISK; DETERMINANTS; SERVICE; MORTALITY	Background An estimated 2.7 million Latin Americans reside in Europe, mostly in Spain. Part of a broader project aimed at developing a research agenda on the health status and determinants of this population, this qualitative study engaged Latin American migrants in the identification of research priorities. Methods We conducted 30 group discussions between November 2012-March 2013 with 84 participants purposively selected for maximum diversity in Madrid and Barcelona (Spain). We facilitated sequences of task-oriented visual activities to explore their views on priority health concerns. We tape-recorded and transcribed discussions and developed a coding frame based on socio-ecological frameworks, which we applied to all the data using NVIVO-10. A final round of eight group discussions allowed us to triangulate and enrich interpretations by including participants' insights. Findings The cumulative toll of daily stresses was the major health concern perceived by a population that conceptualised ill-health as a constellation of symptoms rather than as specific diseases. Work-related factors, legislative frameworks regulating citizenship entitlements and feeling ethnically discriminated were major sources of psycho-social strain. Except for sexually transmitted infections, participants rarely referred to communicable diseases as a concern. The perception that clinicians systematically prescribed painkillers discouraged health seeking and fostered self-medication. Participants felt that the medicalised, chemicalised, sexually liberal and accelerated culture of the host society damaged their own, and the local populations' health. Conclusion Health systems bear a disproportionate responsibility in addressing health problems rooted in other sectors. Occupational and migration policies should be recognised explicitly as health policies. The mismatch between researchers' emphasis on communicable infections and the health concerns of Latin American migrants highlights the need for greater interaction between different forms of knowledge. In this process, the biomedical culture of reliance on pharmacological solutions should not remain unquestioned.	[Roura, Maria; Bisoffi, Federico; Navaza, Barbara] Univ Barcelona, ISGlobal, Barcelona Ctr Int Hlth Res CRESIB, Hosp Clin, Barcelona, Spain; [Pool, Robert] Univ Amsterdam, Ctr Social Sci & Global Hlth, Amsterdam, Netherlands	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; University of Amsterdam	Roura, M (corresponding author), Univ Barcelona, ISGlobal, Barcelona Ctr Int Hlth Res CRESIB, Hosp Clin, Barcelona, Spain.	maria.roura@isglobal.org	Roura, Maria/K-6668-2014	Roura, Maria/0000-0001-9556-1940	European Commission [FP7-GA-261495]; Spanish Ministry of Economy and Competitiveness (MINECO) under the Ramon y Cajal Fellowship program [RYC-2011-08428]	European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Ministry of Economy and Competitiveness (MINECO) under the Ramon y Cajal Fellowship program	This research was undertaken as part of the COHEMI project supported by the European Commission 7th Framework Program, Grant Agreement no FP7-GA-261495, (http://ec.europa.eu/research/health/public-health/public-health-and-health-systems/projects/cohemi_en.html). MR is financed by the Spanish Ministry of Economy and Competitiveness (MINECO) under the Ramon y Cajal Fellowship program (RYC-2011-08428),(http://www.idi.mineco.gob.es/portal/site/MICINN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen EQ, 2010, AM J IND MED, V53, P405, DOI 10.1002/ajim.20710; Aragona M, 2012, ETHNIC HEALTH, V17, P477, DOI 10.1080/13557858.2012.661406; Arango Joaquin., 2013, PROMOTING INTEGRATIO; BARTLEY M, 1994, J EPIDEMIOL COMMUN H, V48, P333, DOI 10.1136/jech.48.4.333; Bazeley P., 2013, QUALITATIVE DATA ANA, V2nd; Bonney R, 2014, SCIENCE, V343, P1436, DOI 10.1126/science.1251554; Bosma H, 1998, AM J PUBLIC HEALTH, V88, P68, DOI 10.2105/AJPH.88.1.68; Boulanger RF, 2013, LANCET INFECT DIS, V13, P540, DOI 10.1016/S1473-3099(13)70042-2; Brigidi S., 2009, MIGRACIONES Y SALUD, P300; Brunner E, 1997, BMJ-BRIT MED J, V314, P1472, DOI 10.1136/bmj.314.7092.1472; Brunner E, 2011, SOCIAL DETERMINANTS; Campanya Tanquem els CIE, 2015, CAMP PEL TANC DELS C; Casino G, 2012, LANCET, V379, P1777, DOI 10.1016/S0140-6736(12)60745-4; Castaneda H., 2010, NAPA B, V34, P6, DOI DOI 10.1111/J.1556-4797.2010.01049.X; Ceberio M., 2012, INTERIOR PROHIBE RED; Conrad P, 2005, J HEALTH SOC BEHAV, V46, P3, DOI 10.1177/002214650504600102; Coyne JC, 2009, AM HEART J, V157, DOI 10.1016/j.ahj.2009.03.004; Cruz Ines, 2010, BMC Public Health, V10, P255, DOI 10.1186/1471-2458-10-255; Davies A.A., 2006, MIGRATION SOCIAL DET; EFE, 2015, PAIS; Espinosa P., 2013, ULISES VIVEN ANDALUC; Factor R, 2011, SOC SCI MED, V73, P1292, DOI 10.1016/j.socscimed.2011.07.027; Ferrie JE, 2001, BMJ-BRIT MED J, V322, P647, DOI 10.1136/bmj.322.7287.647; Frank J., 2013, J EPIDEMIOL COMMUNIT, V67, P469; Ganann R, 2013, J IMMIGR MINOR HEALT, V15, P341, DOI 10.1007/s10903-012-9622-6; Garcia-Ramirez M, 2009, INT J MIGR HEALTH SO, V5, P2, DOI 10.1108/17479894200900001; GILL PS, 2007, HLTH CARE NEEDS ASSE, P227; Glasziou P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4247; Good B., 1985, CULTURE DEPRESSION; Graham GG, 2013, INFLAMMOPHARMACOLOGY, V21, P201, DOI 10.1007/s10787-013-0172-x; Guta A, 2014, SOC SCI MED, V123, P250, DOI 10.1016/j.socscimed.2014.07.028; Guta A, 2013, CRIT PUBLIC HEALTH, V23, P432, DOI 10.1080/09581596.2012.761675; Gutthann SP, 1997, EPIDEMIOLOGY, V8, P18, DOI 10.1097/00001648-199701000-00003; Horowitz CR, 2009, CIRCULATION, V119, P2633, DOI 10.1161/CIRCULATIONAHA.107.729863; Ingleby D, 2010, HLTH SYSTEMS CAN ADD; International Centre for Migration Policy Development, 2012, CLAND DAT IRR MIGR S; Johannes Siegrist, 2002, RES OCCUPATIONAL STR, V2, P261; KARASEK R, 1981, AM J PUBLIC HEALTH, V71, P694, DOI 10.2105/AJPH.71.7.694; Kivimaki M, 2002, BRIT MED J, V325, P857, DOI 10.1136/bmj.325.7369.857; Kleinman A, 2006, PLOS MED, V3, P1673, DOI 10.1371/journal.pmed.0030294; Knutsson A, 1999, OCCUP ENVIRON MED, V56, P46, DOI 10.1136/oem.56.1.46; Kristenson M, 2004, SOC SCI MED, V58, P1511, DOI 10.1016/S0277-9536(03)00353-8; Kristenson M, 1997, BRIT MED J, V314, P629, DOI 10.1136/bmj.314.7081.629; Kunst A. E., 2011, Migration and health in the European Union, P101; Lam JR, 2013, JAMA-J AM MED ASSOC, V310, P2435, DOI 10.1001/jama.2013.280490; Legido-Quigley H, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2363; Lindert J, 2009, SOC SCI MED, V69, P246, DOI 10.1016/j.socscimed.2009.04.032; Lo MCM, 2008, SOCIOL HEALTH ILL, V30, P741, DOI 10.1111/j.1467-9566.2008.01091.x; Marmot M, 2012, LANCET, V380, P1011, DOI 10.1016/S0140-6736(12)61228-8; McDonald JT, 2004, SOC SCI MED, V59, P1613, DOI 10.1016/j.socscimed.2004.02.004; Ministerio de Interior, 2013, LUCH INM IRR BAL 201; Mladovsky P, 2012, HEALTH POLICY, V105, P1, DOI 10.1016/j.healthpol.2012.01.007; MOYNIHAN R, 2013, BMJ-BRIT MED J, V347, DOI DOI 10.1136/BMJ.F7141; Napier AD, 2014, LANCET, V384, P1607, DOI 10.1016/S0140-6736(14)61603-2; Nyberg ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067323; Patino C, 2010, PSYCHOPATHOLOGY, V43, P17, DOI 10.1159/000255959; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; QSR International, NVIVO 10 WIND; Rechel B, 2013, LANCET, V381, P1235, DOI 10.1016/S0140-6736(12)62086-8; Requena-Mendez A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003540; Roberts E, 2015, ANN RHEUMATIC DIS; Ronda E, 2013, J IMMIGR MINOR HEALT, V15, P164, DOI 10.1007/s10903-012-9664-9; Perez ER, 2012, ETHNIC HEALTH, V17, P563, DOI 10.1080/13557858.2012.730606; Roura M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1799-x; Villarroel N, 2012, HEALTH PLACE, V18, P1282, DOI 10.1016/j.healthplace.2012.09.009; Viruell-Fuentes EA, 2007, SOC SCI MED, V65, P1524, DOI 10.1016/j.socscimed.2007.05.010; Whitehead M, 1991, GEOL FORENINGAN STOC; Williams CM, 2014, LANCET, V384, P1586, DOI 10.1016/S0140-6736(14)60805-9; World Health Organization, 2005, HLTH ALL POL FRAM WH	70	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136315	10.1371/journal.pone.0136315	http://dx.doi.org/10.1371/journal.pone.0136315			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317781	Green Submitted, Green Published, gold			2022-12-26	WOS:000360299100071
J	Wang, H; Qu, H; Deng, HC				Wang, Hang; Qu, Hua; Deng, Huacong			Plasma HMGB-1 Levels in Subjects with Obesity and Type 2 Diabetes: A Cross-Sectional Study in China	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; GENE-EXPRESSION; HUMAN ADIPOCYTES; RECEPTOR TLR; BINDING; INSULIN; SECRETION; RAGE; B1; INTERLEUKIN-6	Object To detect the levels of plasma High-Mobility Group Box-1(HMGB1) in Chinese subject with obesity and type 2 diabetes mellitus (T2DM), and to investigate the correlations between plasma HMGB1 concentration and parameters of body fat, insulin resistance (IR) metabolism and inflammation. Methods This study recruited 79 normal glucose tolerance (NGT) subjects and 76 newly diagnosed T2DM patients. NGT and T2DM groups were divided into normal weight (NW) and obese (OB) subgroups respectively. Anthropometric parameters such as height, weight, waist circumference, hip circumference and blood pressure were measured. Plasma concentrations of HMGB1, IL-6, fasting plasma glucose (FPG), 2 hours post challenge plasma glucose (2hPG), serum lipid, glycated hemoglobin (HbA(1C)) and fasting insulin (FINS) were examined. The homeostasis model assessment (HOMA) was performed to assess IR status. Results Plasma HMGB1 levels were higher in T2DM group than that in NGT group. The concentrations of serum HMGB1 were also higher in subjects with OB than those in subjects with NW both in NGT and T2DM groups. Plasma levels of HMGB1 were positively correlated with waist hip ratio (WHR), blood pressure, FPG, FINS, HOMA-IR, TG, IL-6 and negatively correlated with HOMA-beta and high-density lipoprotein-cholesterol (HDL-c) independent of age, gender and BMI. Plasma levels of HMGB1 were significantly correlated with diabetes in fully adjusted models. Conclusion Plasma HMGB1 levels were increased in Chinese subjects with pure T2DM, which might be caused by IR. Serum HMGB1 participated in the pathological process of obesity and T2DM via its proinflammatory effect.	[Wang, Hang; Qu, Hua; Deng, Huacong] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Chongqing, Peoples R China	Chongqing Medical University	Deng, HC (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Chongqing, Peoples R China.	deng_huacong@126.com		Qu, Hua/0000-0002-4895-5979	National Key Clinical Specialties Construction Program of China; National Natural Science Foundation of China [81070639, 81270911, 30771038]	National Key Clinical Specialties Construction Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Key Clinical Specialties Construction Program of China and the National Natural Science Foundation of China (No. 81070639, No. 81270911, No. 30771038).	Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Arrigo T, 2013, EUR J ENDOCRINOL, V168, P631, DOI 10.1530/EJE-13-0037; BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; Ciubotaru M, 2004, MOL CELL BIOL, V24, P8727, DOI 10.1128/MCB.24.19.8727-8744.2004; Czura CJ, 2003, CRIT CARE MED, V31, pS46, DOI 10.1097/00003246-200301001-00007; Dasu MR, 2010, DIABETES CARE, V33, P861, DOI 10.2337/dc09-1799; Devaraj S, 2008, J CLIN ENDOCR METAB, V93, P578, DOI 10.1210/jc.2007-2185; Fasshauer M, 2002, BIOCHEM BIOPH RES CO, V290, P1084, DOI 10.1006/bbrc.2001.6307; Gero D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065994; Gunasekaran MK, 2013, CYTOKINE, V64, P103, DOI 10.1016/j.cyto.2013.07.017; Guzman-Ruiz R, 2014, INT J OBESITY, V38, P1545, DOI 10.1038/ijo.2014.36; Harwood HJ, 2012, NEUROPHARMACOLOGY, V63, P57, DOI 10.1016/j.neuropharm.2011.12.010; *HLTH COMM AUSTR P, 2000, AS PAC PERSP RED OB; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Huttunen HJ, 2002, CANCER RES, V62, P4805; JAVAHERIAN K, 1978, SCIENCE, V199, P1345, DOI 10.1126/science.628842; Jin DQ, 2012, EXP THER MED, V4, P1124, DOI 10.3892/etm.2012.732; Kim JH, 2009, VITAM HORM, V80, P613, DOI 10.1016/S0083-6729(08)00621-3; Kralisch S, 2005, AM J PHYSIOL-ENDOC M, V289, pE586, DOI 10.1152/ajpendo.00090.2005; Lee BW, 2010, INT J MOL MED, V26, P813, DOI 10.3892/ijmm_00000529; Nativel B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076039; Ni XR, 2015, REPROD SCI, V22, P271, DOI 10.1177/1933719114549852; Park JS, 2003, AM J PHYSIOL-CELL PH, V284, pC870, DOI 10.1152/ajpcell.00322.2002; PASQUALINI JR, 1989, BIOCHEM BIOPH RES CO, V161, P1260, DOI 10.1016/0006-291X(89)91378-8; Schierbeck H, 2010, MOL MED, V16, P343, DOI 10.2119/molmed.2010.00031; Simons PJ, 2007, J ENDOCRINOL, V192, P289, DOI 10.1677/JOE-06-0047; Stros M, 2004, BIOCHEMISTRY-US, V43, P7215, DOI 10.1021/bi049928k; Stros M, 2002, J BIOL CHEM, V277, P7157, DOI 10.1074/jbc.M110233200; Tan BK, 2008, DIABETES, V57, P801, DOI 10.2337/db07-0990; Unger RH, 2005, BIOCHIMIE, V87, P57, DOI 10.1016/j.biochi.2004.11.014; van Beijnum JR, 2008, ANGIOGENESIS, V11, P91, DOI 10.1007/s10456-008-9093-5; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; *WHO, 1999, WHONCDNCS992 DEP NON; YAN SD, 1994, J BIOL CHEM, V269, P9889; Yang H, 2005, J LEUKOCYTE BIOL, V78, P1, DOI 10.1189/jlb.1104648; Zhang CC, 1999, MOL ENDOCRINOL, V13, P632, DOI 10.1210/me.13.4.632	36	49	53	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136564	10.1371/journal.pone.0136564	http://dx.doi.org/10.1371/journal.pone.0136564			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317615	Green Published, gold, Green Submitted			2022-12-26	WOS:000360299100102
J	Wong, JK; Chen, L; Huang, Y; Sehba, FA; Friedel, RH; Zou, HY				Wong, Jamie K.; Chen, Lei; Huang, Yong; Sehba, Fatima A.; Friedel, Roland H.; Zou, Hongyan			Attenuation of Cerebral Ischemic Injury in Smad1 Deficient Mice	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; OXIDATIVE STRESS; PROTECTS NEURONS; ARTERY OCCLUSION; STROKE; CELLS; MECHANISMS; EXPRESSION; GENE; NEUROPROTECTION	Stroke results in brain tissue damage from ischemia and oxidative stress. Molecular regulators of the protective versus deleterious cellular responses after cerebral ischemia remain to be identified. Here, we show that deletion of Smad1, a conserved transcription factor that mediates canonical bone morphogenetic protein (BMP) signaling, results in neuroprotection in an ischemia-reperfusion (I/R) stroke model. Uninjured mice with conditional deletion of Smad1 in the CNS (Smad1 cKO) displayed upregulation of the reactive astrocyte marker GFAP and hypertrophic morphological changes in astrocytes compared to littermate controls. Additionally, cultured Smad1(-/-) astrocytes exhibited an enhanced antioxidant capacity. When subjected to I/R injury by transient middle cerebral artery occlusion (tMCAO), Smad1 cKO mice showed enhanced neuronal survival and improved neurological recovery at 7 days post-stroke. This neuroprotective phenotype is associated with attenuated reactive astrocytosis and neuroinflammation, along with reductions in oxidative stress, p53 induction, and apoptosis. Our data suggest that Smad1-mediated signaling pathway is involved in stroke pathophysiology and may present a new potential target for stroke therapy.	[Wong, Jamie K.; Chen, Lei; Huang, Yong; Friedel, Roland H.; Zou, Hongyan] Icahn Sch Med Mt Sinai, Friedman Brain Inst, Fishberg Dept Neurosci, New York, NY 10029 USA; [Sehba, Fatima A.; Friedel, Roland H.; Zou, Hongyan] Icahn Sch Med Mt Sinai, Dept Neurosurg, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Zou, HY (corresponding author), Icahn Sch Med Mt Sinai, Friedman Brain Inst, Fishberg Dept Neurosci, New York, NY 10029 USA.	hongyan.zou@mssm.edu	Huang, Yong/C-8558-2011	Huang, Yong/0000-0001-8095-4215; Wong, Jamie/0000-0002-9059-0053; Friedel, Roland/0000-0002-7513-3604; Zou, Hongyan/0000-0003-4216-5607	American Heart Association [13IRG14560007]; Irma T. Hirschl/Monique Weill-Caulier Foundations; National Institute of Neurological Disorders and Stroke [NS073596]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073596] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Irma T. Hirschl/Monique Weill-Caulier Foundations; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the American Heart Association 13IRG14560007, Irma T. Hirschl/Monique Weill-Caulier Foundations, and National Institute of Neurological Disorders and Stroke NS073596 to HZ.	BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Bell KFS, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/689524; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Chan PH, 1998, J NEUROSCI, V18, P8292, DOI 10.1523/jneurosci.18-20-08292.1998; Chang CF, 2003, STROKE, V34, P558, DOI 10.1161/01.STR.0000051507.64423.00; Chau JFL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1832; Chen C, 2011, J NEUROSCI RES, V89, P1194, DOI 10.1002/jnr.22662; Chen YM, 2001, J NEUROCHEM, V77, P1601, DOI 10.1046/j.1471-4159.2001.00374.x; Chou J, 2006, J NEUROL SCI, V240, P21, DOI 10.1016/j.jns.2005.08.015; Chuang DM, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00015; Deloulme JC, 2004, MOL CELL NEUROSCI, V27, P453, DOI 10.1016/j.mcn.2004.07.008; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; Endo H, 2006, J NEUROSCI, V26, P7974, DOI 10.1523/JNEUROSCI.0897-06.2006; Finelli MJ, 2013, CELL REP, V3, P1592, DOI 10.1016/j.celrep.2013.04.011; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Gupta K, 2012, CELL DEATH DIFFER, V19, P779, DOI 10.1038/cdd.2011.154; Harvey BK, 2005, PHARMACOL THERAPEUT, V105, P113, DOI 10.1016/j.pharmthera.2004.09.003; Haskew-Layton RE, 2010, P NATL ACAD SCI USA, V107, P17385, DOI 10.1073/pnas.1003996107; Huang SX, 2002, GENESIS, V32, P76, DOI 10.1002/gene.10059; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; LI Y, 1994, STROKE, V25, P849, DOI 10.1161/01.STR.25.4.849; Liberman M, 2011, BIOCHEM BIOPH RES CO, V413, P436, DOI 10.1016/j.bbrc.2011.08.114; Lories RJU, 2005, CYTOKINE GROWTH F R, V16, P287, DOI 10.1016/j.cytogfr.2005.02.009; Pachori AS, 2010, J MOL CELL CARDIOL, V48, P1255, DOI 10.1016/j.yjmcc.2010.01.010; Ploughman M, 2009, STROKE, V40, P1490, DOI 10.1161/STROKEAHA.108.531806; Radermacher Kim A, 2012, Exp Transl Stroke Med, V4, P11, DOI 10.1186/2040-7378-4-11; Ridder DA, 2009, NEUROSCIENCE, V158, P995, DOI 10.1016/j.neuroscience.2008.07.007; Rigelsky CM, 2008, AM J MED GENET A, V146A, P2551, DOI 10.1002/ajmg.a.32468; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Rossi DJ, 2007, NAT NEUROSCI, V10, P1377, DOI 10.1038/nn2004; Samanta J, 2010, STROKE, V41, P357, DOI 10.1161/STROKEAHA.109.565523; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; Shin JA, 2012, CELL MOL NEUROBIOL, V32, P587, DOI 10.1007/s10571-012-9806-6; Sloan SA, 2014, NEURON, V81, P221, DOI 10.1016/j.neuron.2013.12.032; Smith J, 2000, P NATL ACAD SCI USA, V97, P10032, DOI 10.1073/pnas.170209797; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sun B, 2013, HYPERTENSION, V61, P352, DOI 10.1161/HYPERTENSIONAHA.111.00562; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; Wong WT, 2010, CIRC RES, V107, P984, DOI 10.1161/CIRCRESAHA.110.222794; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang F., 2012, ANIMAL MODELS ACUTE, V9, P93, DOI [10.1007/978-1-61779-782-8_9, DOI 10.1007/978-1-61779-782-8_9]; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	49	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136967	10.1371/journal.pone.0136967	http://dx.doi.org/10.1371/journal.pone.0136967			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317208	gold, Green Published, Green Submitted			2022-12-26	WOS:000360299100186
J	Bruckert, H; Marchetti, G; Ramialison, M; Besse, F				Bruckert, Helene; Marchetti, Giovanni; Ramialison, Mirana; Besse, Florence			Drosophila Hrp48 Is Required for Mushroom Body Axon Growth, Branching and Guidance	PLOS ONE			English	Article							RNA-BINDING PROTEINS; A2 RESPONSE ELEMENT; MESSENGER-RNA; HNRNPA/B HOMOLOG; LOCALIZATION; TRANSLATION; NEURODEGENERATION; TRAFFICKING; EXPRESSION; MUTATIONS	RNA binding proteins assemble on mRNAs to control every single step of their life cycle, from nuclear splicing to cytoplasmic localization, stabilization or translation. Consistent with an essential role of RNA binding proteins in neuronal maturation and function, mutations in this class of proteins, in particular in members of the hnRNP family, have been associated with neurological diseases. To date, however, the physiological function of hnRNPs during in vivo neuronal development has remained poorly explored. Here, we have investigated the role of Drosophila Hrp48, a fly homologue of mammalian hnRNP A2/B1, during central nervous system development. Using a combination of mutant conditions, we showed that hrp48 is required for the formation, growth and guidance of axonal branches in Mushroom Body neurons. Furthermore, our results revealed that hrp48 inactivation induces an overextension of Mushroom Body dorsal axonal branches, with a significantly higher penetrance in females than in males. Finally, as demonstrated by immunolocalization studies, Hrp48 is confined to Mushroom Body neuron cell bodies, where it accumulates in the cytoplasm from larval stages to adulthood. Altogether, our data provide evidence for a crucial in vivo role of the hnRNP Hrp48 in multiple aspects of axon guidance and branching during nervous system development. They also indicate cryptic sex differences in the development of sexually non-dimorphic neuronal structures.	[Bruckert, Helene; Marchetti, Giovanni; Besse, Florence] Univ Nice Sophia Antipolis, Inst Biol Valrose, F-06189 Nice, France; [Bruckert, Helene; Marchetti, Giovanni; Besse, Florence] Inst Biol Valrose, CNRS, UMR7277, Nice, France; [Bruckert, Helene; Marchetti, Giovanni; Besse, Florence] Inst Biol Valrose, INSERM, UMR1091, Nice, France; [Ramialison, Mirana] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic, Australia	UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Australian Regenerative Medicine Institute; Monash University	Besse, F (corresponding author), Univ Nice Sophia Antipolis, Inst Biol Valrose, F-06189 Nice, France.	besse@unice.fr	Ramialison, Mirana/AEG-6305-2022	Ramialison, Mirana/0000-0001-6315-4777; Besse, Florence/0000-0003-4672-1068	Centre National de la Recherche Scientifique (ATIP); Human Frontier Science Program [CDA-00015/2009]; Association pour la Recherche sur le Cancer [ARC-Fixe 4988]; Agence Nationale de la Recherche [ANR-11-JSV2-001-01]	Centre National de la Recherche Scientifique (ATIP)(Centre National de la Recherche Scientifique (CNRS)); Human Frontier Science Program(Human Frontier Science Program); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the Centre National de la Recherche Scientifique (ATIP), the Human Frontier Science Program (CDA-00015/2009), the Association pour la Recherche sur le Cancer (ARC-Fixe 4988), and the Agence Nationale de la Recherche (ANR-11-JSV2-001-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aso Y, 2014, ELIFE, V3, DOI 10.7554/eLife.04577; Bassell GJ, 2004, CURR OPIN NEUROBIOL, V14, P574, DOI 10.1016/j.conb.2004.08.010; Blanchette M, 2009, MOL CELL, V33, P438, DOI 10.1016/j.molcel.2009.01.022; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Goodrich JS, 2004, DEVELOPMENT, V131, P1949, DOI 10.1242/dev.01078; Goossens T, 2011, DEVELOPMENT, V138, P1595, DOI 10.1242/dev.052787; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Hammond LE, 1997, MOL CELL BIOL, V17, P7260, DOI 10.1128/MCB.17.12.7260; Han SP, 2010, BIOCHEM J, V430, P379, DOI 10.1042/BJ20100396; Hartmann B, 2011, RNA, V17, P453, DOI 10.1261/rna.2460411; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Huynh JR, 2004, DEV CELL, V6, P625, DOI 10.1016/S1534-5807(04)00130-3; Jin P, 2007, NEURON, V55, P556, DOI 10.1016/j.neuron.2007.07.020; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Kolodkin AL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001727; Kosturko LD, 2006, MOL BIOL CELL, V17, P3521, DOI 10.1091/mbc.E05-10-0946; Lee T, 1999, DEVELOPMENT, V126, P4065; Lenzken SC, 2014, WIRES RNA, V5, P565, DOI 10.1002/wrna.1231; Loya CM, 2010, GENE DEV, V24, P625, DOI 10.1101/gad.1907710; Marchetti G, 2014, J NEUROSCI, V34, P13855, DOI 10.1523/JNEUROSCI.3285-13.2014; MATUNIS MJ, 1992, J CELL BIOL, V116, P245, DOI 10.1083/jcb.116.2.245; Muller-McNicoll M, 2013, NAT REV GENET, V14, P275, DOI 10.1038/nrg3434; Munro TP, 1999, J BIOL CHEM, V274, P34389, DOI 10.1074/jbc.274.48.34389; Muslimov IA, 2011, J CELL BIOL, V194, P441, DOI 10.1083/jcb.201010027; Ng JL, 2004, NEURON, V44, P779, DOI 10.1016/j.neuron.2004.11.014; Ng J, 2012, DEVELOPMENT, V139, P165, DOI 10.1242/dev.068668; Sanchez-Soriano N, 2009, J CELL SCI, V122, P2534, DOI 10.1242/jcs.046268; Shan JG, 2003, J NEUROSCI, V23, P8859; Sofola OA, 2007, NEURON, V55, P565, DOI 10.1016/j.neuron.2007.07.021; Suissa Y, 2010, P NATL ACAD SCI USA, V107, P6930, DOI 10.1073/pnas.0910570107; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Wu JS, 2006, NAT PROTOC, V1, P2583, DOI 10.1038/nprot.2006.320; Yano T, 2004, DEV CELL, V6, P637, DOI 10.1016/S1534-5807(04)00132-7	37	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136610	10.1371/journal.pone.0136610	http://dx.doi.org/10.1371/journal.pone.0136610			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313745	Green Published, Green Submitted, gold			2022-12-26	WOS:000360144000075
J	Muller, OA; Grau, J; Thieme, S; Prochaska, H; Adlung, N; Sorgatz, A; Bonas, U				Mueller, Oliver A.; Grau, Jan; Thieme, Sabine; Prochaska, Heike; Adlung, Norman; Sorgatz, Anika; Bonas, Ulla			Genome-Wide Identification and Validation of Reference Genes in Infected Tomato Leaves for Quantitative RT-PCR Analyses	PLOS ONE			English	Article							DEFINING REFERENCE GENES; SYRINGAE PV. TOMATO; REAL-TIME PCR; EXPRESSION ANALYSIS; HOUSEKEEPING GENES; TRIGGERED IMMUNITY; INTERNAL CONTROL; QPCR DATA; NORMALIZATION; PEPPER	The Gram-negative bacterium Xanthomonas campestris pv. vesicatoria (Xcv) causes bacterial spot disease of pepper and tomato by direct translocation of type III effector proteins into the plant cell cytosol. Once in the plant cell the effectors interfere with host cell processes and manipulate the plant transcriptome. Quantitative RT-PCR (qRT-PCR) is usually the method of choice to analyze transcriptional changes of selected plant genes. Reliable results depend, however, on measuring stably expressed reference genes that serve as internal normalization controls. We identified the most stably expressed tomato genes based on microarray analyses of Xcv-infected tomato leaves and evaluated the reliability of 11 genes for qRT-PCR studies in comparison to four traditionally employed reference genes. Three different statistical algorithms, geNorm, NormFinder and BestKeeper, concordantly determined the superiority of the newly identified reference genes. The most suitable reference genes encode proteins with homology to PHD finger family proteins and the U6 snRNA-associated protein LSm7. In addition, we identified pepper orthologs and validated several genes as reliable normalization controls for qRT-PCR analysis of Xcv-infected pepper plants. The newly identified reference genes will be beneficial for future qRT-PCR studies of the Xcv-tomato and Xcv-pepper pathosystems, as well as for the identification of suitable normalization controls for qRT-PCR studies of other plant-pathogen interactions, especially, if related plant species are used in combination with bacterial pathogens.	[Mueller, Oliver A.; Thieme, Sabine; Prochaska, Heike; Adlung, Norman; Sorgatz, Anika; Bonas, Ulla] Univ Halle Wittenberg, Inst Biol, Dept Genet, D-06108 Halle, Saale, Germany; [Grau, Jan] Univ Halle Wittenberg, Inst Informat, Dept Bioinformat, D-06108 Halle, Saale, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Bonas, U (corresponding author), Univ Halle Wittenberg, Inst Biol, Dept Genet, D-06108 Halle, Saale, Germany.	ulla.bonas@genetik.uni-halle.de	Adlung, Norman/P-8812-2018; Grau, Jan/H-5465-2019	Adlung, Norman/0000-0002-4871-7970; Grau, Jan/0000-0003-2081-6405	Deutsche Forschungsgemeinschaft [SFB 648]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (SFB 648) to UB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandra L, 2010, J PLANT PHYSIOL, V167, P1398, DOI 10.1016/j.jplph.2010.05.015; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Ballvora A, 2001, MOL PLANT MICROBE IN, V14, P629, DOI 10.1094/MPMI.2001.14.5.629; Bin WS, 2012, MOL BREEDING, V30, P1393, DOI 10.1007/s11032-012-9726-7; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; BONAS U, 1993, MOL GEN GENET, V238, P261, DOI 10.1007/BF00279555; Buttner D, 2010, FEMS MICROBIOL REV, V34, P107, DOI 10.1111/j.1574-6976.2009.00192.x; Castro-Quezada P, 2013, PLANT MOL BIOL REP, V31, P936, DOI 10.1007/s11105-013-0566-3; Chen L, 2011, PLANTA, V234, P377, DOI 10.1007/s00425-011-1410-3; Cohn JR, 2005, PLANT J, V44, P139, DOI 10.1111/j.1365-313X.2005.02516.x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; DANIELS MJ, 1984, EMBO J, V3, P3323, DOI 10.1002/j.1460-2075.1984.tb02298.x; de Oliveira LA, 2012, PLANT CELL PHYSIOL, V53, P405, DOI 10.1093/pcp/pcr187; Dekkers BJW, 2012, PLANT CELL PHYSIOL, V53, P28, DOI 10.1093/pcp/pcr113; Demidenko NV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019434; Die JV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073354; Die JV, 2010, PLANTA, V232, P145, DOI 10.1007/s00425-010-1158-1; Eulgem T, 2005, TRENDS PLANT SCI, V10, P71, DOI 10.1016/j.tplants.2004.12.006; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Fu XZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041790; Gamm M, 2011, MOL GENET GENOMICS, V285, P273, DOI 10.1007/s00438-011-0607-2; Gao Song, 2012, African Journal of Biotechnology, V11, P12983, DOI 10.5897/AJB12.931; Graeber K, 2011, PLANT CELL, V23, P2045, DOI 10.1105/tpc.111.084103; Grewal RK, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-49; Gu CS, 2011, MOL BIOTECHNOL, V49, P192, DOI 10.1007/s12033-011-9394-6; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Gutierrez L, 2008, PLANT CELL, V20, P1734, DOI 10.1105/tpc.108.059774; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jarosova J, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-146; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Kim JG, 2009, PLANT CELL, V21, P1305, DOI 10.1105/tpc.108.063123; Klie Maik, 2011, BMC Res Notes, V4, P518, DOI 10.1186/1756-0500-4-518; Kong QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087197; Kundu A, 2013, PLANT CELL REP, V32, P1647, DOI 10.1007/s00299-013-1478-2; Lilly ST, 2011, MOL PLANT MICROBE IN, V24, P294, DOI 10.1094/MPMI-10-10-0236; Lin F, 2014, PLANT MOL BIOL, V86, P543, DOI 10.1007/s11103-014-0246-1; Liu DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046451; Lorenz C, 2009, J BACTERIOL, V191, P1414, DOI 10.1128/JB.01446-08; Lovdal T, 2009, ANAL BIOCHEM, V387, P238, DOI 10.1016/j.ab.2009.01.024; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Marois E, 2002, MOL PLANT MICROBE IN, V15, P637, DOI 10.1094/MPMI.2002.15.7.637; Mascia T, 2010, MOL PLANT PATHOL, V11, P805, DOI [10.1111/j.1364-3703.2010.00646.x, 10.1111/j.1365-3059.2009.02239.x]; Miranda Vivian de Jesus, 2013, BMC Res Notes, V6, P196, DOI 10.1186/1756-0500-6-196; Monteiro F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072998; Narsai R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-56; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pinheiro TT, 2011, GENET MOL RES, V10, P3291, DOI 10.4238/2011.November.17.4; Pombo MA, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0492-1; Qi JN, 2010, PLANT MOL BIOL REP, V28, P597, DOI 10.1007/s11105-010-0185-1; R Core Team, 2021, R LANGUAGE ENV STAT; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Saha G. C., 2012, American Journal of Plant Sciences, V3, P235, DOI 10.4236/ajps.2012.32028; Saha GC, 2013, PLANT MOL BIOL REP, V31, P1109, DOI 10.1007/s11105-013-0579-y; Schreiber T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120214; Selim M, 2012, PLANT CELL REP, V31, P205, DOI 10.1007/s00299-011-1156-1; Socquet-Juglard D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054196; Soria-Guerra RE, 2010, THEOR APPL GENET, V120, P1315, DOI 10.1007/s00122-009-1258-0; Stajner N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068228; Stall R. E., 1995, PATHOGENESIS HOST SP, P167; Sturzenbaum SR, 2001, COMP BIOCHEM PHYS B, V130, P281, DOI 10.1016/S1096-4959(01)00440-7; Taylor KW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002768; Teper D, 2014, PLANT J, V77, P297, DOI 10.1111/tpj.12391; Thieme F, 2005, J BACTERIOL, V187, P7254, DOI 10.1128/JB.187.21.7254-7266.2005; Thilmony R, 2006, PLANT J, V46, P34, DOI 10.1111/j.1365-313X.2006.02725.x; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wan HJ, 2011, BIOCHEM BIOPH RES CO, V416, P24, DOI 10.1016/j.bbrc.2011.10.105; Wei LB, 2013, PLANTA, V237, P873, DOI 10.1007/s00425-012-1805-9; Wieczorek P, 2013, J VIROL METHODS, V194, P161, DOI 10.1016/j.jviromet.2013.08.010; Yang HL, 2014, GENE, V538, P113, DOI 10.1016/j.gene.2013.12.057; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044405	76	34	34	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136499	10.1371/journal.pone.0136499	http://dx.doi.org/10.1371/journal.pone.0136499			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313760	Green Published, gold, Green Submitted			2022-12-26	WOS:000360144000063
J	Jeggle, P; Hofschroer, V; Maase, M; Bertog, M; Kusche-Vihrog, K				Jeggle, Pia; Hofschroeer, Verena; Maase, Martina; Bertog, Marko; Kusche-Vihrog, Kristina			Aldosterone synthase knockout mouse as a model for sodium-induced endothelial sodium channel up-regulation in vascular endothelium	FASEB JOURNAL			English	Article						mineralocorticoid receptor; ENaC; atomic force microscopy	NITRIC-OXIDE SYNTHASE; MINERALOCORTICOID RECEPTORS; INDEPENDENT REGULATION; COLLECTING DUCT; BLOOD-PRESSURE; ENAC; DYSFUNCTION; CELLS; MICE; RAT	Recently, a novel feedforward activation of the endothelial epithelial sodium channel (ENaC) [endothelial sodium channel (EnNaC)] by sodium was reported that counteracts ENaC function in kidney. In the absence of aldosterone, a rise in extracellular sodium (> 145 mM) increases EnNaC surface abundance, thereby stiffening the cortex of vascular endothelial cells (ECs) in vitro. The latter reduces the release of NO-the hallmark of endothelial dysfunction. Here, we test whether high extracellular sodium per se increases EnNaC expression and cortical stiffness in an aldosterone synthase (Cyp11b2)-deficient (AS(-/-)) mouse model. Therefore, we employed in situ ECs of ex vivo aorta preparations from wild-type (WT) and AS(-/-). EnNaC surface expression (-16%) and cortical stiffness (-22%) were reduced in AS(-/-), compared with WT, whereas NO secretion was exclusively detectable in AS(-/-). EnNaC inhibition with benzamil decreased stiffness in both, while mineralocorticoid receptor antagonism diminished stiffness only in the WT. In the absence of aldosterone, high sodium (150 mM) increased EnNaC surface expression ex vivo (plus 19%) and cortical stiffness ex vivo (plus 41%) and in vivo (plus 44%). Application of aldosterone adjusted the stiffness of AS(-/-) to the WT level. We conclude that high sodium per se determines EnNaC expression and consequently endothelial cortical nanomechanics, thus likely contributing to endothelial dysfunction.-Jeggle, P., Hofschroer, V., Maase, M., Bertog, M., Kusche-Vihrog, K. Aldosterone synthase knockout mouse as a model for sodium-induced endothelial sodium channel up-regulation in vascular endothelium. FASEB J. 30, 45-53 (2016). www.fasebj.org	[Jeggle, Pia; Hofschroeer, Verena; Maase, Martina; Kusche-Vihrog, Kristina] Univ Munster, Inst Physiol 2, D-48149 Munster, Germany; [Bertog, Marko] Univ Erlangen Nurnberg, Inst Zellulare & Mol Physiol, D-91054 Erlangen, Germany	University of Munster; University of Erlangen Nuremberg	Kusche-Vihrog, K (corresponding author), Univ Munster, Inst Physiol 2, Robert Koch Str 27b, D-48149 Munster, Germany.	kusche@uni-muenster.de			Deutsche Forschungsgemeinschaft [KU 1496/7-1, OB 63/17-1, Koselleck-OB 63/18]; Innovative Medical Research of the University of Munster Medical School [KU 120808]; Else-Kroner-Fresenius Stiftung [2010 A116]; Centre of Excellence (Cells in Motion), University of Munster	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Innovative Medical Research of the University of Munster Medical School; Else-Kroner-Fresenius Stiftung; Centre of Excellence (Cells in Motion), University of Munster	The authors thank Professors Hans Oberleithner (Institute of Physiology II, University of Munster, Munster, Germany) and Christoph Korbmacher (Institute of Physiology, University of Erlangen, Erlangen, Germany) for their support in this study and Marianne Wilhelmi and Sergej Handel (Institute of Physiology II, University of Munster) for their excellent work on the mouse aorta preparations. The authors are grateful to Manfred Fobker (Center of Laboratory Medicine, University of Munster) for the quantification of the plasma aldosterone concentration. This paper is dedicated to the late Professor Hugh de Wardener (Imperial College London, London, United Kingdom), who discussed and commented on our data. This work was supported by grants from the Deutsche Forschungsgemeinschaft (KU 1496/7-1, OB 63/17-1, and Koselleck-OB 63/18), Innovative Medical Research of the University of Munster Medical School (KU 120808), Else-Kroner-Fresenius Stiftung (2010 A116), and by the Centre of Excellence (Cells in Motion), University of Munster. The authors are grateful to COST Action TD1002 as well as COST Action BM1301 for supporting networking activities. The authors declare no conflicts of interest.	Bertog M, 2008, J PHYSIOL-LONDON, V586, P459, DOI 10.1113/jphysiol.2007.140459; Bragulat E, 2001, HYPERTENSION, V37, P444, DOI 10.1161/01.HYP.37.2.444; Cat AND, 2010, FASEB J, V24, P2454, DOI 10.1096/fj.09-147926; Delcayre C, 2000, KIDNEY INT, V57, P1346, DOI 10.1046/j.1523-1755.2000.00973.x; Druppel V, 2013, FASEB J, V27, P3652, DOI 10.1096/fj.13-228312; DuPont JJ, 2014, HYPERTENSION, V63, P632, DOI 10.1161/HYPERTENSIONAHA.113.01273; DuPont JJ, 2013, J HYPERTENS, V31, P530, DOI 10.1097/HJH.0b013e32835c6ca8; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Farquharson CAJ, 2002, CLIN SCI, V103, P425, DOI 10.1042/cs1030425; Fels J, 2010, BBA-MOL BASIS DIS, V1802, P1193, DOI 10.1016/j.bbadis.2010.03.006; Fels J, 2010, PFLUG ARCH EUR J PHY, V460, P915, DOI 10.1007/s00424-010-0871-8; Frindt G, 2012, AM J PHYSIOL-RENAL, V302, pF20, DOI 10.1152/ajprenal.00480.2011; Fuller PJ, 2000, KIDNEY INT, V57, P1256, DOI 10.1046/j.1523-1755.2000.00959.x; Funder JW, 2010, BBA-MOL BASIS DIS, V1802, P1188, DOI 10.1016/j.bbadis.2010.08.005; Funder JW, 2006, HYPERTENSION, V47, P634, DOI 10.1161/01.HYP.0000203732.03784.3b; Heinz WF, 1999, TRENDS BIOTECHNOL, V17, P143, DOI 10.1016/S0167-7799(99)01304-9; Jaffe IZ, 2014, HYPERTENSION, V63, P915, DOI 10.1161/HYPERTENSIONAHA.114.01997; Jeggle P, 2013, HYPERTENSION, V61, P1053, DOI 10.1161/HYPERTENSIONAHA.111.199455; Kasas S, 2008, PFLUG ARCH EUR J PHY, V456, P13, DOI 10.1007/s00424-008-0448-y; Korte S, 2014, FASEB J, V28, P4015, DOI 10.1096/fj.14-250282; Korte S, 2012, PFLUG ARCH EUR J PHY, V463, P269, DOI 10.1007/s00424-011-1038-y; Kusche-Vihrog K, 2008, PFLUG ARCH EUR J PHY, V455, P849, DOI 10.1007/s00424-007-0341-0; Kusche-Vihrog K, 2014, PFLUG ARCH EUR J PHY, V466, P851, DOI 10.1007/s00424-013-1356-3; Kusche-Vihrog K, 2011, HYPERTENSION, V57, P231, DOI 10.1161/HYPERTENSIONAHA.110.163444; Lee G, 2005, ENDOCRINOLOGY, V146, P2650, DOI 10.1210/en.2004-1102; Li J, 2009, J NUTR, V139, P447, DOI 10.3945/jn.108.097451; Meneton P, 2005, PHYSIOL REV, V85, P679, DOI 10.1152/physrev.00056.2003; Mironova E, 2012, P NATL ACAD SCI USA, V109, P10095, DOI 10.1073/pnas.1201978109; Nagata D, 2006, HYPERTENSION, V48, P165, DOI 10.1161/01.HYP.0000226054.53527.bb; NARAYFEJESTOTH A, 1990, AM J PHYSIOL, V259, pF672, DOI 10.1152/ajprenal.1990.259.4.F672; Nesterov V, 2012, AM J PHYSIOL-RENAL, V303, pF1289, DOI 10.1152/ajprenal.00247.2012; Ni ZM, 2001, AM J HYPERTENS, V14, P155, DOI 10.1016/S0895-7061(00)01234-6; Nicco C, 2001, HYPERTENSION, V38, P1143, DOI 10.1161/hy1001.092641; Oberleithner H, 2006, ACTA PHYSIOL, V187, P305, DOI 10.1111/j.1748-1716.2006.01574.x; Oberleithner H, 2007, P NATL ACAD SCI USA, V104, P16281, DOI 10.1073/pnas.0707791104; Oberleithner H, 2006, J CELL SCI, V119, P1926, DOI 10.1242/jcs.02886; Perez FR, 2009, HYPERTENSION, V53, P1000, DOI 10.1161/HYPERTENSIONAHA.108.128520; Pratt JH, 2005, J AM SOC NEPHROL, V16, P3154, DOI 10.1681/ASN.2005050460; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Silvestre JS, 1998, J BIOL CHEM, V273, P4883, DOI 10.1074/jbc.273.9.4883; Stowasser M, 2005, J CLIN ENDOCR METAB, V90, P5070, DOI 10.1210/jc.2005-0681; Struthers AD, 2004, HEART, V90, P1229, DOI 10.1136/hrt.2003.025312; TAKEDA R, 1995, STEROIDS, V60, P120, DOI 10.1016/0039-128X(94)00026-9; Wang S, 2009, MICROCIRCULATION, V16, P276, DOI 10.1080/10739680802653150; Warnock DG, 2014, NAT REV NEPHROL, V10, P146, DOI 10.1038/nrneph.2013.275; Warnock DG, 2013, HYPERTENSION, V61, P952, DOI 10.1161/HYPERTENSIONAHA.113.00768; Widlansky ME, 2003, J AM COLL CARDIOL, V42, P1149, DOI 10.1016/S0735-1097(03)00994-X; YOUNG M, 1995, AM J PHYSIOL-ENDOC M, V269, pE657, DOI 10.1152/ajpendo.1995.269.4.E657; Zatschler B, 2009, J VASC SURG, V50, P397, DOI 10.1016/j.jvs.2009.04.064	49	17	17	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					45	53		10.1096/fj.14-259606	http://dx.doi.org/10.1096/fj.14-259606			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26324851				2022-12-26	WOS:000367621000007
J	Lim, NTY; Harder, MJ; Kennedy, AT; Lin, CS; Weir, C; Cowman, AF; Call, MJ; Schmidt, CQ; Tham, WH				Lim, Nicholas T. Y.; Harder, Markus J.; Kennedy, Alexander T.; Lin, Clara S.; Weir, Christopher; Cowman, Alan F.; Call, Melissa J.; Schmidt, Christoph Q.; Tham, Wai-Hong			Characterization of Inhibitors and Monoclonal Antibodies That Modulate the Interaction between Plasmodium falciparum Adhesin PfRh4 with Its Erythrocyte Receptor Complement Receptor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALARIAL PARASITES; BINDING-PROTEINS; INVASION LIGAND; GLYCOPHORIN-C; MEROZOITES; VACCINE; IDENTIFICATION; SPECIFICITY; IMMUNITY; JUNCTION	Plasmodium falciparum parasites must invade red blood cells to survive within humans. Entry into red blood cells is governed by interactions between parasite adhesins and red blood cell receptors. Previously we identified that P. falciparum reticulocyte binding protein-like homologue 4 (PfRh4) binds to complement receptor 1 (CR1) to mediate entry of malaria parasites into human red blood cells. In this report we characterize a collection of anti-PfRh4 monoclonal antibodies and CR1 protein fragments that modulate the interaction between PfRh4 and CR1. We identify an anti-PfRh4 monoclonal that blocks PfRh4-CR1 interaction in vitro, inhibits PfRh4 binding to red blood cells, and as a result abolishes the PfRh4-CR1 invasion pathway in P. falciparum. Epitope mapping of anti-PfRh4 monoclonal antibodies identified distinct functional regions within PfRh4 involved in modulating its interaction with CR1. Furthermore, we designed a set of protein fragments based on extensive mutagenesis analyses of the PfRh4 binding site on CR1 and determined their interaction affinities using surface plasmon resonance. These CR1 protein fragments bind tightly to PfRh4 and also function as soluble inhibitors to block PfRh4 binding to red blood cells and to inhibit the PfRh4-CR1 invasion pathway. Our findings can aid future efforts in designing specific single epitope antibodies to block P. falciparum invasion via complement receptor 1.	[Lim, Nicholas T. Y.; Kennedy, Alexander T.; Lin, Clara S.; Weir, Christopher; Cowman, Alan F.; Call, Melissa J.; Tham, Wai-Hong] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Harder, Markus J.; Schmidt, Christoph Q.] Univ Ulm, Inst Pharmacol Nat Prod & Clin Pharmacol, D-89081 Ulm, Germany; [Kennedy, Alexander T.; Lin, Clara S.; Weir, Christopher; Cowman, Alan F.; Call, Melissa J.; Tham, Wai-Hong] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Weir, Christopher] Univ Edinburgh, Sch Chem, Edinburgh EH9 3JJ, Midlothian, Scotland	Walter & Eliza Hall Institute; Ulm University; University of Melbourne; University of Edinburgh	Tham, WH (corresponding author), Walter & Eliza Hall Inst Med Res, Div Infect & Immun, 1G Royal Parade, Parkville, Vic 3052, Australia.	tham@wehi.edu.au	Call, Melissa/HHZ-6671-2022; Tham, Wai-Hong/P-6474-2019; Tham, Wai-Hong/L-3173-2018	Call, Melissa/0000-0001-7684-5841; Tham, Wai-Hong/0000-0001-7950-8699; Tham, Wai-Hong/0000-0001-7950-8699	National Health and Medical Research Council Grant [APP1026581]; Australian Research Council Future Fellowship	National Health and Medical Research Council Grant(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Future Fellowship(Australian Research Council)	This work was supported by National Health and Medical Research Council Grant APP1026581 and an Australian Research Council Future Fellowship (to W. H.-T.). The authors declare that they have no conflicts of interest with the contents of this article.	ADAMS JH, 1992, P NATL ACAD SCI USA, V89, P7085, DOI 10.1073/pnas.89.15.7085; AIKAWA M, 1978, J CELL BIOL, V77, P72, DOI 10.1083/jcb.77.1.72; Awandare GA, 2011, MOL BIOCHEM PARASIT, V177, P57, DOI 10.1016/j.molbiopara.2011.01.005; Boyle MJ, 2010, P NATL ACAD SCI USA, V107, P14378, DOI 10.1073/pnas.1009198107; Chen L, 2014, ELIFE, V3, DOI 10.7554/eLife.04187; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; Douglas AD, 2015, CELL HOST MICROBE, V17, P130, DOI 10.1016/j.chom.2014.11.017; Douglas AD, 2014, J IMMUNOL, V192, P245, DOI 10.4049/jimmunol.1302045; DVORAK JA, 1975, SCIENCE, V187, P748, DOI 10.1126/science.803712; Gao XH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3862; Gilson PR, 2009, INT J PARASITOL, V39, P91, DOI 10.1016/j.ijpara.2008.09.007; HAYNES JD, 1988, J EXP MED, V167, P1873, DOI 10.1084/jem.167.6.1873; Hayton K, 2008, CELL HOST MICROBE, V4, P40, DOI 10.1016/j.chom.2008.06.001; Lobo CA, 2003, BLOOD, V101, P4628, DOI 10.1182/blood-2002-10-3076; Lopaticki S, 2011, INFECT IMMUN, V79, P1107, DOI 10.1128/IAI.01021-10; Maier AG, 2003, NAT MED, V9, P87, DOI 10.1038/nm807; Mayer DCG, 2002, J EXP MED, V196, P1523, DOI 10.1084/jem.20020750; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; MILLER LH, 1979, J EXP MED, V149, P172, DOI 10.1084/jem.149.1.172; Park HJ, 2014, J BIOL CHEM, V289, P450, DOI 10.1074/jbc.M113.520346; Rayner JC, 2001, J EXP MED, V194, P1571, DOI 10.1084/jem.194.11.1571; Reiling L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045253; Reiling L, 2010, J IMMUNOL, V185, P6157, DOI 10.4049/jimmunol.1001555; Richards JS, 2013, J IMMUNOL, V191, P795, DOI 10.4049/jimmunol.1300778; Schmidt CQ, 2015, MOL IMMUNOL, V67, P71, DOI 10.1016/j.molimm.2015.03.006; Schmidt CQ, 2011, PROTEIN EXPRES PURIF, V76, P254, DOI 10.1016/j.pep.2010.12.002; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Spadafora C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000968; Tham WH, 2012, TRENDS PARASITOL, V28, P23, DOI 10.1016/j.pt.2011.10.002; Tham WH, 2011, BLOOD, V118, P1923, DOI 10.1182/blood-2011-03-341305; Tham WH, 2010, P NATL ACAD SCI USA, V107, P17327, DOI 10.1073/pnas.1008151107; Tham WH, 2009, INFECT IMMUN, V77, P2427, DOI 10.1128/IAI.00048-09; Triglia T, 2001, INFECT IMMUN, V69, P1084, DOI 10.1128/IAI.69.2.1084-1092.2001; Triglia T, 2009, CELL MICROBIOL, V11, P1671, DOI 10.1111/j.1462-5822.2009.01358.x; Weiss GE, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004670; Wilson DW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-152; Wright KE, 2014, NATURE, V515, P427, DOI 10.1038/nature13715	37	6	7	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25307	25321		10.1074/jbc.M115.657171	http://dx.doi.org/10.1074/jbc.M115.657171			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26324715	hybrid, Green Published			2022-12-26	WOS:000362962800010
J	Adamson, PC; Huchko, MJ; Moss, AM; Kinkel, HF; Medina-Marino, A				Adamson, Paul C.; Huchko, Megan J.; Moss, Alison M.; Kinkel, Hans F.; Medina-Marino, Andrew			Acceptability and Accuracy of Cervical Cancer Screening Using a Self-Collected Tampon for HPV Messenger-RNA Testing among HIV-Infected Women in South Africa	PLOS ONE			English	Article							RISK HUMAN-PAPILLOMAVIRUS; VAGINAL SAMPLES; SPECIMENS; CYTOLOGY	Background HIV increases women's risk for high-risk human papillomavirus (hrHPV) infection and invasive cervical cancer. South Africa has a high HIV prevalence but low cervical cancer screening coverage. Self-collection of cervical specimens and hrHPV testing, including hrHPV messenger-RNA (mRNA) testing, are methods aimed at increasing screening rates. However, data are limited on the acceptability and accuracy of tampon-based self-collection for hrHPV mRNA testing in HIV-infected women. Methods We recruited 325 HIV-infected women seeking care at a government HIV clinic in Pretoria, South Africa. A clinician performed a pelvic examination and obtained an endocervical specimen. Study participants performed self-collection using a tampon. Both clinician-and self-collected specimens were tested for hrHPV mRNA. Acceptability of both collection methods was assessed, the prevalence of hrHPV mRNA in our study population was estimated, test positivity of the two collection methods were compared, and test agreement was assessed by calculating the.-statistic, sensitivity, and specificity. Results Over 90% of women reported no difficulties self-collecting specimens and 82% were willing to perform the tampon-collection at home. Based on clinician-collection specimens, the prevalence of hrHPV mRNA in our study population was 36.7% (95% CI: 31.4%-42.0%). There was no difference in test positivity between clinician-collection, 36.7%, and tampon-collection, 43.5% (p-value = 0.08). Using clinician-collection as the reference test, the sensitivity and specificity for hrHPV mRNA of tampon-collection were 77.4% (95% CI: 69.8-85.0%) and 77.8% (95% CI: 71.9-83.6%), respectively. Conclusions Tampon-based self-collection is acceptable to women and has similar hrHPV mRNA positivity rates as clinician-collection, but has reduced sensitivity and specificity compared to clinician-collection. The hrHPV mRNA prevalence in our study population is high, but similar to other high-risk populations, and highlights the need for improved cervical cancer screening. Further research into the optimal use of tampon-based collection as a cervical cancer screening tool is warranted.	[Adamson, Paul C.] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Adamson, Paul C.; Kinkel, Hans F.; Medina-Marino, Andrew] Fdn Profess Dev, Res Unit, Pretoria, Gauteng, South Africa; [Huchko, Megan J.] Univ Calif San Francisco, Sch Med, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA; [Moss, Alison M.] Drs Martin & Partners, Edenvale, Gauteng, South Africa; [Kinkel, Hans F.] Univ Pretoria, Dept Family Med, ZA-0002 Pretoria, Gauteng, South Africa; [Medina-Marino, Andrew] Univ Pretoria, Sch Hlth Syst & Publ Hlth, ZA-0002 Pretoria, Gauteng, South Africa	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Pretoria; University of Pretoria	Medina-Marino, A (corresponding author), Fdn Profess Dev, Res Unit, Pretoria, Gauteng, South Africa.	andrewmedinamarino@gmail.com	Huchko, Megan/S-6063-2019; Adamson, Paul/AAR-1405-2020	Adamson, Paul/0000-0002-2776-6458; Kinkel, Hans-Friedemann/0000-0002-5455-9219; , Andrew/0000-0002-0095-4141				Adler David H, 2013, J Immunol Tech Infect Dis, V2, DOI 10.4172/2329-9541.1000113; Adler David H, 2014, Infect Dis Obstet Gynecol, V2014, P498048, DOI 10.1155/2014/498048; Belinson JL, 2003, INT J GYNECOL CANCER, V13, P819, DOI 10.1111/j.1525-1438.2003.13611.x; Bhatla N, 2009, CANCER EPIDEMIOL, V33, P446, DOI 10.1016/j.canep.2009.10.013; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Chernesky M, 2014, SEX TRANSM DIS, V41, P365, DOI 10.1097/OLQ.0000000000000125; Cuzick J, 2013, BRIT J CANCER, V108, P908, DOI 10.1038/bjc.2013.22; Day MN, 2014, DISTRICT HLTH BAROME; Denny L, 2008, OBSTET GYNECOL, V111, P1380, DOI 10.1097/AOG.0b013e3181743327; Denny LA, 2012, VACCINE, V30, pF168, DOI 10.1016/j.vaccine.2012.06.045; Firnhaber C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053494; Gen-Probe/Hologic Inc, 2013, APTIMA HPV IN PRESS; Gravitt PE, 2011, INT J CANCER, V129, P517, DOI 10.1002/ijc.25974; Heideman DAM, 2013, J CLIN MICROBIOL, V51, P3653, DOI 10.1128/JCM.01517-13; Holanda F, 2006, INT J GYNECOL OBSTET, V95, P179, DOI 10.1016/j.ijgo.2006.07.012; Johnson DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101255; Jones HE, 2007, J CLIN MICROBIOL, V45, P1679, DOI 10.1128/JCM.02369-06; Kuhn L, 2010, AIDS, V24, P2545, DOI 10.1097/QAD.0b013e32833e163e; Mahomed K, 2014, PAN AFR MED J, V17, DOI 10.11604/pamj.2014.17.189.3454; McDonald AC, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00048; Memon S, 2012, 14 INT AIDS C WASH D; National Department of Health, 2010, CLIN GUID MAN HIV AI; National Department of Health Republic of South Africa, 2000, NAT GUID CERV SCREEN; Qiao YL, 2008, LANCET ONCOL, V9, P929, DOI 10.1016/S1470-2045(08)70210-9; Ratnam S, 2011, J CLIN MICROBIOL, V49, P557, DOI 10.1128/JCM.02147-10; Safaeian M, 2007, SEX TRANSM DIS, V34, P429, DOI 10.1097/01.olq.0000243623.67673.22; Sankaranarayanan R, 2014, ANN GLOB HEALTH, V80, P412, DOI 10.1016/j.aogh.2014.09.014; Soerjomataram FJ, 2013, GLOBOCAN 2012 V1 0 C; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Ting J, 2013, SEX TRANSM DIS, V40, P584, DOI 10.1097/OLQ.0b013e31828e5a91; UNAIDS, 2013, AIDSINFO COUNTR FACT; Untiet S, 2014, INT J CANCER, V135, P1911, DOI 10.1002/ijc.28834; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180; World Health Organization, 2002, CERVICAL CANC SCREEN; Wright TC, 2000, JAMA-J AM MED ASSOC, V283, P81, DOI 10.1001/jama.283.1.81	35	23	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137299	10.1371/journal.pone.0137299	http://dx.doi.org/10.1371/journal.pone.0137299			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332236	gold, Green Published, Green Submitted			2022-12-26	WOS:000360613800118
J	Fournie, G; Goodman, SJ; Cruz, M; Cedeno, V; Velez, A; Patino, L; Millins, C; Gibbons, LM; Fox, MT; Cunningham, AA				Fournie, Guillaume; Goodman, Simon J.; Cruz, Marilyn; Cedeno, Virna; Velez, Alberto; Patino, Leandro; Millins, Caroline; Gibbons, Lynda M.; Fox, Mark T.; Cunningham, Andrew A.			Biogeography of Parasitic Nematode Communities in the Galapagos Giant Tortoise: Implications for Conservation Management	PLOS ONE			English	Article							NORTHERN LESSER ANTILLES; INFECTIOUS-DISEASES; HELMINTH INFECTIONS; ANOLIS LIZARDS; TESTUDO-GRAECA; HOST; WILDLIFE; THREATS; EXTINCT; DIVERSIFICATION	The Galapagos giant tortoise is an icon of the unique, endemic biodiversity of Galapagos, but little is known of its parasitic fauna. We assessed the diversity of parasitic nematode communities and their spatial distributions within four wild tortoise populations comprising three species across three Galapagos islands, and consider their implication for Galapagos tortoise conservation programmes. Coprological examinations revealed nematode eggs to be common, with more than 80% of tortoises infected within each wild population. Faecal samples from tortoises within captive breeding centres on Santa Cruz, Isabela and San Cristobal islands also were examined. Five different nematode egg types were identified: oxyuroid, ascarid, trichurid and two types of strongyle. Sequencing of the 18S small-subunit ribosomal RNA gene from adult nematodes passed with faeces identified novel sequences indicative of rhabditid and ascaridid species. In the wild, the composition of nematode communities varied according to tortoise species, which co-varied with island, but nematode diversity and abundance were reduced or altered in captive-reared animals. Evolutionary and ecological factors are likely responsible for the variation in nematode distributions in the wild. This possible species/island-parasite co-evolution has not been considered previously for Galapagos tortoises. We recommend that conservation efforts, such as the current Galapagos tortoise captive breeding/rearing and release programme, be managed with respect to parasite biogeography and host-parasite co-evolutionary processes in addition to the biogeography of the host.	[Fournie, Guillaume; Goodman, Simon J.; Cruz, Marilyn; Cedeno, Virna; Velez, Alberto; Patino, Leandro; Millins, Caroline; Cunningham, Andrew A.] Galapagos Genet Epidemiol & Pathol Lab, Santa Cruz, Galapagos Islan, Ecuador; [Fournie, Guillaume] Ecole Natl Vet Alfort, Maisons Alfort, France; [Fournie, Guillaume] Royal Vet Coll, Dept Prod & Populat Hlth, Hatfield, Herts, England; [Goodman, Simon J.; Patino, Leandro] Univ Leeds, Sch Biol, Fac Biol Sci, Leeds, W Yorkshire, England; [Cedeno, Virna] Concepto Azul, Guayaquil, Ecuador; [Cedeno, Virna] Univ Guayaquil, Biotechnol Program, Guayaquil, Ecuador; [Patino, Leandro; Millins, Caroline; Cunningham, Andrew A.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Gibbons, Lynda M.; Fox, Mark T.] Univ London Royal Vet Coll, Dept Pathol & Infect Dis, London, England	Ecole Nationale Veterinaire d'Alfort (ENVA); University of London; University of London Royal Veterinary College; University of Leeds; Zoological Society of London; University of London; University of London Royal Veterinary College	Cunningham, AA (corresponding author), Galapagos Genet Epidemiol & Pathol Lab, Galapagos Natl Pk, Santa Cruz, Galapagos Islan, Ecuador.	a.cunningham@ioz.ac.uk	Cunningham, Andrew A/E-7536-2010	Goodman, Simon/0000-0003-4118-8575; Fournie, Guillaume/0000-0002-6998-1201; Millins, Caroline/0000-0002-2006-092X; Fox, Mark/0000-0003-2545-4036; Patino Patino, Leandro Dario/0000-0002-3081-3120; Velez Pinela, Edgar Alberto/0000-0002-7504-5014	Darwin Initiative for the Survival of Species, Department for the Environment, Food and Rural Affairs, UK Government [162-12-17, EIDPO15]; Royal Society Wolfson Research Merit Award	Darwin Initiative for the Survival of Species, Department for the Environment, Food and Rural Affairs, UK Government; Royal Society Wolfson Research Merit Award(Royal Society of London)	This study was funded by the Darwin Initiative for the Survival of Species, Department for the Environment, Food and Rural Affairs, UK Government (162-12-17, EIDPO15); https://www.gov.uk/government/groups/the-darwin-initiative. A.A.C. is supported by a Royal Society Wolfson Research Merit Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albon SD, 2002, P ROY SOC B-BIOL SCI, V269, P1625, DOI 10.1098/rspb.2002.2064; Altizer S, 2003, TRENDS ECOL EVOL, V18, P589, DOI 10.1016/j.tree.2003.08.013; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson RC, 2000, FAMILY ATRACTIDAE NE, P250; Arneberg P, 1998, AM NAT, V151, P497, DOI 10.1086/286136; Behnke JM, 2001, PARASITOLOGY, V122, pS39, DOI 10.1017/S0031182000016796; Bensted-Smith R, 1999, 1999 ANN REPORT C DA, P17; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Bouamer S, 2006, ANN ZOOL, V56, P225; Bursey CR, 2002, J PARASITOL, V88, P320, DOI 10.1645/0022-3395(2002)088[0320:AMNSNA]2.0.CO;2; Butler D, 1996, NATURE, V383, P290, DOI 10.1038/383290a0; Caccone A, 1999, P NATL ACAD SCI USA, V96, P13223, DOI 10.1073/pnas.96.23.13223; Chabaud A. G., 2009, Keys to the nematode parasites of vertebrates: archival volume, P248, DOI 10.1079/9781845935726.0248; Chavarri M, 2012, VET PARASITOL, V187, P491, DOI 10.1016/j.vetpar.2012.02.007; Couch L, 1996, J PARASITOL, V82, P432, DOI 10.2307/3284081; Cunningham AA, 1996, CONSERV BIOL, V10, P349, DOI 10.1046/j.1523-1739.1996.10020349.x; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Daszak P, 2001, ACTA TROP, V78, P103, DOI 10.1016/S0001-706X(00)00179-0; De Ley P, 2002, BIOL NEMATODES, P1; DOBSON AP, 1992, OECOLOGIA, V91, P110, DOI 10.1007/BF00317248; DOBSON AP, 1992, OECOLOGIA, V91, P118, DOI 10.1007/BF00317249; Dybdahl MF, 2003, TRENDS ECOL EVOL, V18, P523, DOI 10.1016/S0169-5347(03)00223-4; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Falk BG, 2013, MOL ECOL, V22, P4576, DOI 10.1111/mec.12410; Floyd RM, 2005, MOL ECOL NOTES, V5, P611, DOI 10.1111/j.1471-8286.2005.01009.x; Garrick RC, 2012, CURR BIOL, V22, pR10, DOI 10.1016/j.cub.2011.12.004; GEIMAN QUENTIN M., 1937, JOUR PARASITOL, V23, P331, DOI 10.2307/3272225; GREGORY RD, 1993, ACTA TROP, V54, P131, DOI 10.1016/0001-706X(93)90059-K; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hudson PJ, 1998, SCIENCE, V282, P2256, DOI 10.1126/science.282.5397.2256; Inglis WG, 1963, B SOC VENEZ CI NAT, P126; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lloyd-Smith JO, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000180; Márquez Cruz, 2004, Ecol. apl., V3, P98; Mathews F, 2006, BIOL CONSERV, V131, P338, DOI 10.1016/j.biocon.2006.04.011; McAllister CT, 2010, J PARASITOL, V96, P1021, DOI 10.1645/GE-2514.1; MCCALLUM H, 1995, TRENDS ECOL EVOL, V10, P190, DOI 10.1016/S0169-5347(00)89050-3; Mes THM, 2003, VET PARASITOL, V115, P311, DOI 10.1016/S0304-4017(03)00219-X; Milinkovitch MC, 2013, EVOL APPL, V6, P377, DOI 10.1111/eva.12014; Ministry of Agriculture Fisheries and Food, 1986, MAN VET PAR TECHN RE, V418; PACALA SW, 1988, PARASITOLOGY, V96, P197, DOI 10.1017/S0031182000081762; Petter A.J, 1966, EQUILIBRE ESPECES PO; Poulakakis N, 2012, MOL ECOL, V21, P160, DOI 10.1111/j.1365-294X.2011.05370.x; Poulin R, 1996, AM NAT, V147, P287, DOI 10.1086/285851; Powell J, 2006, CURR BIOL, V16, pR144, DOI 10.1016/j.cub.2006.02.050; Pritchard Peter C.H., 1996, Chelonian Research Monographs, V1, P1; QUOY J. R. C., 1824, B SCI NATURELLES GEO, V1, P90; Rataj AV, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-33; Reiczigel J, 2003, STAT MED, V22, P611, DOI 10.1002/sim.1320; Rozsa L, 2000, J PARASITOL, V86, P228, DOI 10.1645/0022-3395(2000)086[0228:QPISOH]2.0.CO;2; Russello MA, 2005, BIOL LETT-UK, V1, P287, DOI 10.1098/rsbl.2005.0317; SCHAD GA, 1963, NATURE, V198, P404, DOI 10.1038/198404b0; Shaw DJ, 1998, PARASITOLOGY, V117, P597, DOI 10.1017/S0031182098003448; Sol D, 2003, OECOLOGIA, V135, P542, DOI 10.1007/s00442-003-1223-6; Stanton JM, 1998, AUSTRALAS PLANT PATH, V27, P112, DOI 10.1071/AP98014; STEAR MJ, 1995, INT J PARASITOL, V25, P375, DOI 10.1016/0020-7519(94)00136-C; TOFT CA, 1990, TRENDS ECOL EVOL, V5, P326, DOI 10.1016/0169-5347(90)90179-H; Traversa D, 2005, PARASITOL RES, V98, P14, DOI 10.1007/s00436-005-0019-5; Turtle Taxonomy Working Group, 2012, TURTL WORLD 2012 UPD; WALTON A. C., 1942, PROC HELMINTHOL SOC WASHINGTON, V9, P1; Whiteman NK, 2006, P ROY SOC B-BIOL SCI, V273, P797, DOI 10.1098/rspb.2005.3396; Wilson K, 1997, PARASITOL TODAY, V13, P33, DOI 10.1016/S0169-4758(96)40009-6	62	8	11	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135684	10.1371/journal.pone.0135684	http://dx.doi.org/10.1371/journal.pone.0135684			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332126	Green Accepted, Green Published, gold			2022-12-26	WOS:000360613800037
J	Mascarenhas, R; Pietrzak, M; Smith, RM; Webb, A; Wang, DX; Papp, AC; Pinsonneault, JK; Seweryn, M; Rempala, G; Sadee, W				Mascarenhas, Roshan; Pietrzak, Maciej; Smith, Ryan M.; Webb, Amy; Wang, Danxin; Papp, Audrey C.; Pinsonneault, Julia K.; Seweryn, Michal; Rempala, Grzegorz; Sadee, Wolfgang			Allele-Selective Transcriptome Recruitment to Polysomes Primed for Translation: Protein-Coding and Noncoding RNAs, and RNA Isoforms	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PRIMARY BILIARY-CIRRHOSIS; MESSENGER-RNA; GENETIC ARCHITECTURE; EXPRESSION IMBALANCE; SUSCEPTIBILITY LOCI; QUANTITATIVE TRAIT; RISK LOCI; VARIANTS; IDENTIFICATION	mRNA translation into proteins is highly regulated, but the role of mRNA isoforms, noncoding RNAs (ncRNAs), and genetic variants remains poorly understood. mRNA levels on polysomes have been shown to correlate well with expressed protein levels, pointing to polysomal loading as a critical factor. To study regulation and genetic factors of protein translation we measured levels and allelic ratios of mRNAs and ncRNAs (including microRNAs) in lymphoblast cell lines (LCL) and in polysomal fractions. We first used targeted assays to measure polysomal loading of mRNA alleles, confirming reported genetic effects on translation of OPRM1 and NAT1, and detecting no effect of rs1045642 (3435C>T) in ABCB1 (MDR1) on polysomal loading while supporting previous results showing increased mRNA turnover of the 3435T allele. Use of high-throughput sequencing of complete transcript profiles (RNA-Seq) in three LCLs revealed significant differences in polysomal loading of individual RNA classes and isoforms. Correlated polysomal distribution between protein-coding and non-coding RNAs suggests interactions between them. Allele-selective polysome recruitment revealed strong genetic influence for multiple RNAs, attributable either to differential expression of RNA isoforms or to differential loading onto polysomes, the latter defining a direct genetic effect on translation. Genes identified by different allelic RNA ratios between cytosol and polysomes were enriched with published expression quantitative trait loci (eQTLs) affecting RNA functions, and associations with clinical phenotypes. Polysomal RNA-Seq combined with allelic ratio analysis provides a powerful approach to study polysomal RNA recruitment and regulatory variants affecting protein translation.	[Mascarenhas, Roshan; Pietrzak, Maciej; Smith, Ryan M.; Wang, Danxin; Papp, Audrey C.; Pinsonneault, Julia K.; Rempala, Grzegorz; Sadee, Wolfgang] Ohio State Univ, Coll Med, Wexner Med Ctr, Ctr Pharmacogen, Columbus, OH 43210 USA; [Pietrzak, Maciej; Seweryn, Michal; Rempala, Grzegorz] Ohio State Univ, Coll Publ Hlth, Div Biostat, Columbus, OH 43210 USA; [Webb, Amy] Ohio State Univ, Wexner Med Ctr, Coll Med, Dept Biomed Informat, Columbus, OH 43210 USA; [Seweryn, Michal] Univ Lodz, Dept Math & Comp Sci, PL-90131 Lodz, Poland; [Seweryn, Michal; Rempala, Grzegorz] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Sadee, Wolfgang] Ohio State Univ, Wexner Med Ctr, Coll Med, Dept Med Genet, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Lodz; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Sadee, W (corresponding author), Ohio State Univ, Coll Med, Wexner Med Ctr, Ctr Pharmacogen, Columbus, OH 43210 USA.	Wolfgang.Sadee@osumc.edu	Wang, Danxin/I-5810-2019; Rempala, Grzegorz/C-3576-2013; Pietrzak, Maciej/GNH-5768-2022	Wang, Danxin/0000-0002-7134-3065; Pietrzak, Maciej/0000-0001-5768-7884; Seweryn, Michal/0000-0002-9090-3435	National Institute of General Medical Sciences [U01GM092655]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092655] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences (nigms.nih.gov); (Grant No. U01GM092655 to WS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058257; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; [Anonymous], 2014, R LANG ENV STAT COMP; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Battle A, 2015, SCIENCE, V347, P664, DOI 10.1126/science.1260793; Beilharz Traude H., 2004, Briefings in Functional Genomics & Proteomics, V3, P103, DOI 10.1093/bfgp/3.2.103; Benjamin DJ, 2012, P NATL ACAD SCI USA, V109, P8026, DOI 10.1073/pnas.1120666109; Bond C, 1998, P NATL ACAD SCI USA, V95, P9608, DOI 10.1073/pnas.95.16.9608; Chalasani N, 2010, GASTROENTEROLOGY, V139, P1567, DOI 10.1053/j.gastro.2010.07.057; Chen P, 2014, HUM MOL GENET, V23, P6129, DOI 10.1093/hmg/ddu322; Chu X, 2011, NAT GENET, V43, P897, DOI 10.1038/ng.898; Comuzzie AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051954; Cox B, 2005, METHODS, V35, P303, DOI 10.1016/j.ymeth.2004.08.021; Crosslin DR, 2013, HUM MOL GENET, V22, P2119, DOI 10.1093/hmg/ddt010; Deng XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079629; Ferreira MAR, 2014, J ALLERGY CLIN IMMUN, V133, P1564, DOI 10.1016/j.jaci.2013.10.030; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Fu X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-161; Garge N, 2010, MOL CELL PROTEOMICS, V9, P1383, DOI 10.1074/mcp.M900378-MCP200; Gieger C, 2011, NATURE, V480, P201, DOI 10.1038/nature10659; Hackenberg M, 2011, NUCLEIC ACIDS RES, V39, pW132, DOI 10.1093/nar/gkr247; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hirschfield GM, 2009, NEW ENGL J MED, V360, P2544, DOI 10.1056/NEJMoa0810440; Ingolia Nicholas T, 2013, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0418s103; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Jin Y, 2012, NAT GENET, V44, P676, DOI 10.1038/ng.2272; Johansson A, 2013, P NATL ACAD SCI USA, V110, P4673, DOI 10.1073/pnas.1217238110; Johnson AD, 2008, PHARMACOGENET GENOM, V18, P781, DOI 10.1097/FPC.0b013e3283050107; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Kleijn M, 1998, EUR J BIOCHEM, V253, P531, DOI 10.1046/j.1432-1327.1998.2530531.x; Knight JC, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0092-4; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Q, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3260; Lian Z, 2001, BLOOD, V98, P513, DOI 10.1182/blood.V98.3.513; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Martin JE, 2013, HUM MOL GENET, V22, P4021, DOI 10.1093/hmg/ddt248; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Molotski N, 2012, RNA, V18, P1612, DOI 10.1261/rna.033142.112; Nakamura M, 2012, AM J HUM GENET, V91, P721, DOI 10.1016/j.ajhg.2012.08.010; Nalls MA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002113; Need AC, 2009, HUM MOL GENET, V18, P4650, DOI 10.1093/hmg/ddp413; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Parts L, 2014, GENOME RES, V24, P1363, DOI 10.1101/gr.170506.113; Piccirillo CA, 2014, NAT IMMUNOL, V15, P503, DOI 10.1038/ni.2891; Polychronakos C, 2012, J MED GENET, V49, P554, DOI 10.1136/jmedgenet-2012-101199; Porcu E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003266; Pradet-Balade B, 2001, TRENDS BIOCHEM SCI, V26, P225, DOI 10.1016/S0968-0004(00)01776-X; Rempala GA, 2013, J MATH BIOL, V67, P1339, DOI 10.1007/s00285-012-0589-7; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Sadee W, 2011, CLIN PHARMACOL THER, V89, P355, DOI 10.1038/clpt.2010.314; Sadee W, 2014, HUM GENET, V133, P1199, DOI 10.1007/s00439-014-1476-7; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Smith RM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-571; Smith RM, 2013, BIOL PSYCHIAT, V73, P546, DOI 10.1016/j.biopsych.2012.09.028; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Stanescu HC, 2011, NEW ENGL J MED, V364, P616, DOI 10.1056/NEJMoa1009742; Sterne-Weiler T, 2013, GENOME RES, V23, P1615, DOI 10.1101/gr.148585.112; Tebaldi T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-220; Teumer A, 2013, J CLIN PERIODONTOL, V40, P977, DOI 10.1111/jcpe.12154; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Turner ST, 2012, HYPERTENSION, V59, P1204, DOI 10.1161/HYP.0b013e31825b30f8; van Heesch S, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r6; Volders PJ, 2013, NUCLEIC ACIDS RES, V41, pD246, DOI 10.1093/nar/gks915; Wang DX, 2011, PHARMACOGENET GENOM, V21, P652, DOI 10.1097/FPC.0b013e3283498ee9; Wang DX, 2005, PHARMACOGENET GENOM, V15, P693, DOI 10.1097/01.fpc.0000178311.02878.83; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Ward LD, 2012, NAT BIOTECHNOL, V30, P1095, DOI 10.1038/nbt.2422; Webb A, 2013, PHARMACOGENET GENOM, V23, P269, DOI 10.1097/FPC.0b013e32835ff536; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Wineinger NE, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-4; Wu LF, 2013, NATURE, V499, P79, DOI 10.1038/nature12223; Zhang Y, 2005, J BIOL CHEM, V280, P32618, DOI 10.1074/jbc.M504942200	83	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136798	10.1371/journal.pone.0136798	http://dx.doi.org/10.1371/journal.pone.0136798			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331722	Green Published, Green Submitted, gold			2022-12-26	WOS:000360613800073
J	Wood, S; Ross, S; Sauve, R				Wood, Stephen; Ross, Sue; Sauve, Reg			Cesarean Section and Subsequent Stillbirth, Is Confounding by Indication Responsible for the Apparent Association? An Updated Cohort Analysis of a Large Perinatal Database	PLOS ONE			English	Article							UNEXPLAINED STILLBIRTH; ANTEPARTUM STILLBIRTH; RETROSPECTIVE COHORT; 1ST PREGNANCY; 2ND PREGNANCY; RISK; DELIVERY; AGE; POPULATION; OUTCOMES	Background Several studies and a recent meta-analysis have suggested that previous Cesarean section may increase the risk of stillbirth in a subsequent pregnancy. Given the high rates of Cesarean section in contemporary obstetric practice, this is of considerable public health importance. We sought to evaluate the potential that this association is the result of residual confounding bias. Methods A large perinatal database (Alberta Perinatal Health Project) was searched to identify a matched set of first and second births from the years 1992-2006. Data on pregnancy outcomes, demographics and potential confounding factors were obtained. Results The cohort was comprised of 98538 matched first and second births. Multivariate analysis did not reveal an association between previous Cesarean section and stillbirth, OR = 1.38 (0.98, 1.93). Restricting the analysis to a low risk group further attenuated the association, OR = .99 (0.62, 1.52). Analysis of the risk by indication for Cesarean section found that the risk was not increased for previous dystocia, OR = .91 (0.53, 1.55) nor for breech presentation, OR = 1.06 (0.50, 2.28) but only for other indications including non reassuring fetal status and fetal distress, OR = 1.96 (1.29, 2.98). Conclusions The results of our cohort analysis suggest that previous Cesarean section does not cause an increased risk of stillbirth.	[Wood, Stephen; Ross, Sue] Univ Calgary, Dept Obstet & Gynecol & Community Hlth Sci, Calgary, AB, Canada; [Sauve, Reg] Univ Calgary, Canada Dept Pediat & Community Hlth Sci, Calgary, AB, Canada	University of Calgary; University of Calgary	Wood, S (corresponding author), Univ Calgary, Dept Obstet & Gynecol & Community Hlth Sci, Calgary, AB, Canada.	Stephen.wood@albertahealthservices.ca						Cedergren MI, 2004, OBSTET GYNECOL, V103, P219, DOI 10.1097/01.AOG.0000107291.46159.00; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; Franz MBL, 2009, ARCH GYNECOLOGY OBST, V279; Gray R, 2007, BJOG-INT J OBSTET GY, V114, P264, DOI 10.1111/j.1471-0528.2006.01249.x; Joseph KS, 2013, CAN MED ASSOC J, V185, pE345, DOI 10.1503/cmaj.121372; KEELING JW, 1989, ARCH DIS CHILD, V64, P1345, DOI 10.1136/adc.64.10_Spec_No.1345; Kennare R, 2007, OBSTET GYNECOL, V109, P270, DOI 10.1097/01.AOG.0000250469.23047.73; Mohangoo AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024727; O Bahtiyar M, 2006, AM J OBSTET GYNECOL, V195, P1373, DOI 10.1016/j.ajog.2006.02.051; O'Neill SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054588; Ohana O, 2011, J MATERN-FETAL NEO M, V24, P1079, DOI 10.3109/14767058.2010.545918; Reddy UM, 2010, OBSTET GYNECOL, V116, P1119, DOI 10.1097/AOG.0b013e3181f903f8; Richter R, 2007, EUR J OBSTET GYN R B, V132, P51, DOI 10.1016/j.ejogrb.2006.06.002; Salihu HM, 2006, OBSTET GYNECOL, V107, P383, DOI 10.1097/01.AOG.0000195103.46999.32; Smith GCS, 2003, LANCET, V362, P1779, DOI 10.1016/S0140-6736(03)14896-9; Smith GCS, 2007, AM J EPIDEMIOL, V165, P194, DOI 10.1093/aje/kwj354; Surkan PJ, 2004, NEW ENGL J MED, V350, P777, DOI 10.1056/NEJMoa031587; Taylor LK, 2005, MED J AUSTRALIA, V183, P515, DOI 10.5694/j.1326-5377.2005.tb07152.x; Wilson RE, 2008, ARCH GYNECOL OBSTET, V278, P231, DOI 10.1007/s00404-007-0557-4; Wood SL, 2008, BJOG-INT J OBSTET GY, V115, P726, DOI 10.1111/j.1471-0528.2008.01705.x	20	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136272	10.1371/journal.pone.0136272	http://dx.doi.org/10.1371/journal.pone.0136272			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331274	Green Published, gold, Green Submitted			2022-12-26	WOS:000360613800050
J	Gregoraccl, GB; Soares, ACD; Miranda, MD; Coutinho, R; Thompson, FL				Gregoraccl, Gustavo Bueno; dos Santos Soares, Ana Carolina; Miranda, Milene Dias; Coutinho, Ricardo; Thompson, Fabiano L.			Insights into the Microbial and Viral Dynamics of a Coastal Downwelling-Upwelling Transition	PLOS ONE			English	Article							PHYTOPLANKTON BLOOM; MARINE; METAGENOMES; BACTERIOPLANKTON; PROCHLOROCOCCUS; SYNECHOCOCCUS; ENVIRONMENTS; EXPRESSION; ECOSYSTEM; VIRUSES	Although previous studies have described opposing states in upwelling regions, i.e., the rise of cold nutrient-rich waters and prevalence of surface warm nutrient-poor waters, few have addressed the transition from one state to the other. This study aimed to describe the microbial and viral structure during this transition and was able to obtain the taxonomic and metabolic compositions as well as physical-chemical data. This integrated approach allowed for a better understanding of the dynamics of the downwelling upwelling transition, suggesting that a wealth of metabolic processes and ecological interactions are occurring in the minute fractions of the plankton (femto, pico, nano). These processes and interactions included evidence of microbial predominance during downwelling (with nitrogen recycling and aerobic anoxygenic photosynthesis), different viral predation pressures over primary production in different states (cyanobacteria vs eukaryotes), and a predominance of diatoms and selected bacterial and archaeal groups during upwelling (with the occurrence of a wealth of nitrogen metabolism involving ammonia). Thus, the results provided insights into which microbes, viruses and microbial-mediated processes are probably important in the functioning of upwelling systems.	[Gregoraccl, Gustavo Bueno] UNIFESP Baixada Santista, Dept Ciencias Mar, Santos, SP, Brazil; [Gregoraccl, Gustavo Bueno; dos Santos Soares, Ana Carolina; Miranda, Milene Dias; Thompson, Fabiano L.] Univ Fed Rio de Janeiro UFRJ, Inst Biol, Rio De Janeiro, RJ, Brazil; [Miranda, Milene Dias] Inst Oswaldo Cruz IOC FIOCRUZ, Lab Virus Resp & Sarampo, Rio De Janeiro, RJ, Brazil; [Coutinho, Ricardo] Inst Estudos Mar Almirante Paulo Moreira IEAPM, Arraial Do Cabo, RJ, Brazil; [Thompson, Fabiano L.] Univ Fed Rio de Janeiro, Lab Sistemas Avancados Gestao Prod SAGE COPPE, Ctr Gestao Tecnol CT2, Rio de Janeiro, RJ, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Thompson, FL (corresponding author), Univ Fed Rio de Janeiro UFRJ, Inst Biol, Rio De Janeiro, RJ, Brazil.	fabianothompson1@gmail.com	Miranda, Milene/ABD-8472-2021; coutinho, ricardo/AAW-2458-2020	Miranda, Milene/0000-0003-0037-059X; coutinho, ricardo/0000-0001-5430-2176; Thompson, Fabiano/0000-0002-7562-1683; Gregoracci, Gustavo/0000-0001-6896-1068	Brazilian funding agency CAPES; Brazilian funding agency CNPq; Brazilian funding agency FAPERJ	Brazilian funding agency CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian funding agency CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian funding agency FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	Financial support by Brazilian funding agencies CAPES, CNPq, and FAPERJ.	Allen LZ, 2012, ISME J, V6, P1403, DOI 10.1038/ismej.2011.201; Alves Junior N, 2014, ARCH MICROBIOL; Andrade L, 2003, J MICROBIOL METH, V55, P841, DOI 10.1016/j.mimet.2003.08.002; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; BARLOW RG, 1984, MAR ECOL PROG SER, V16, P121, DOI 10.3354/meps016121; Breitbart M, 2012, ANNU REV MAR SCI, V4, P425, DOI 10.1146/annurev-marine-120709-142805; Carvalho W.F., 2004, BRAZ J OCEANOGR, V52, P35; Cavalcanti GS, 2014, ISME J, V8, P52, DOI 10.1038/ismej.2013.133; Cermeno P, 2005, MAR ECOL PROG SER, V297, P51, DOI 10.3354/meps297051; Clokie MRJ, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-291; Coelho-Souza SA, 2012, BRAZ J OCEANOGR, V60, P353, DOI 10.1590/S1679-87592012000300008; Cuevasa LA, 2004, DEEP-SEA RES PT II, V51, P2427, DOI 10.1016/j.dsr2.2004.07.026; Dugdale RC, 1998, NATURE, V391, P270, DOI 10.1038/34630; Enav H, 2012, ISME J, V6, P619, DOI 10.1038/ismej.2011.146; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; Ghai R, 2010, ISME J, V4, P1154, DOI 10.1038/ismej.2010.44; Gifford SM, 2013, ISME J, V7, P281, DOI 10.1038/ismej.2012.96; GONZALEZRODRIGUEZ E, 1992, J PLANKTON RES, V14, P289, DOI 10.1093/plankt/14.2.289; Grasshoff K, 1999, METHODS SEAWATER ANA; Gregoracci GB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031408; Guenther M, 2008, MAR ECOL PROG SER, V363, P109, DOI 10.3354/meps07458; Hurwitz BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057355; Kim KH, 2011, APPL ENVIRON MICROB, V77, P7663, DOI 10.1128/AEM.00289-11; Lopez-Perez M, 2013, GENOME BIOL EVOL, V5, P1220, DOI 10.1093/gbe/evt089; LORENZZETTI JA, 1996, INT ARCH PHOTOGRA B7, V31; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Moran MA, 2007, APPL ENVIRON MICROB, V73, P4559, DOI 10.1128/AEM.02580-06; Moser Gleyci A. O., 1997, Revista Brasileira de Oceanografia, V45, P11; Ottesen EA, 2013, P NATL ACAD SCI USA, V110, pE488, DOI 10.1073/pnas.1222099110; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Schweizer E, 2004, MICROBIOL MOL BIOL R, V68, P501, DOI 10.1128/MMBR.68.3.501-517.2004; Sowell SM, 2011, ISME J, V5, P856, DOI 10.1038/ismej.2010.168; Sullivan MB, 2010, ENVIRON MICROBIOL, V12, P3035, DOI 10.1111/j.1462-2920.2010.02280.x; Sun J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023973; Teira E, 2009, ENV MICROBIOL REP, V1, P545, DOI 10.1111/j.1758-2229.2009.00079.x; Thompson FL, 2011, ARCH MICROBIOL, V193, P105, DOI 10.1007/s00203-010-0644-y; Thompson LR, 2011, P NATL ACAD SCI USA, V108, pE757, DOI 10.1073/pnas.1102164108; Thurber RV, 2009, NAT PROTOC, V4, P470, DOI 10.1038/nprot.2009.10; Walker CB, 2010, P NATL ACAD SCI USA, V107, P8818, DOI 10.1073/pnas.0913533107; Wyatt T, 2014, DEEP-SEA RES PT II, V101, P32, DOI 10.1016/j.dsr2.2012.12.006; Yilmaz S, 2010, NAT METHODS, V7, P943, DOI 10.1038/nmeth1210-943	42	11	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137090	10.1371/journal.pone.0137090	http://dx.doi.org/10.1371/journal.pone.0137090			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327119	Green Published, Green Submitted, gold			2022-12-26	WOS:000360437700093
J	Ahn, SH; Kim, DH; Lee, AR; Kim, BK; Park, YK; Park, ES; Ahn, SH; Shin, GC; Park, S; Kang, HS; Rhee, JK; Yang, SI; Chong, Y; Kim, KH				Ahn, Sung Hyun; Kim, Doo Hyun; Lee, Ah Ram; Kim, Beom Kyung; Park, Yong Kwang; Park, Eun-Sook; Ahn, Sang Hoon; Shin, Gu-Choul; Park, Soree; Kang, Hong Seok; Rhee, Jin-Kyu; Yang, Sung-Il; Chong, Youhoon; Kim, Kyun-Hwan			Substitution at rt269 in Hepatitis B Virus Polymerase Is a Compensatory Mutation Associated with Multi-Drug Resistance	PLOS ONE			English	Article							DRUG-RESISTANCE; REVERSE-TRANSCRIPTASE; LAMIVUDINE THERAPY; REPLICATION; ENTECAVIR; INHIBITION; MECHANISMS; ADEFOVIR; PROTEIN; 3TC	The emergence of compensatory mutations in the polymerase gene of drug resistant hepatitis B virus (HBV) is associated with treatment failure. We previously identified a multi-drug resistant HBV mutant, which displayed resistance towards lamivudine (LMV), clevudine (CLV), and entecavir (ETV), along with a strong replication capacity. The aim of this study was to identify the previously unknown compensatory mutations, and to determine the clinical relevance of this mutation during antiviral therapy. In vitro mutagenesis, drug susceptibility assay, and molecular modeling studies were performed. The rtL269I substitution conferred 2-to 7-fold higher replication capacity in the wild-type (WT) or YMDD mutation backbone, regardless of drug treatment. The rtL269I substitution alone did not confer resistance to LMV, ETV, adefovir (ADV), or tenofovir (TDF). However, upon combination with YMDD mutation, the replication capacity under LMV or ETV treatment was enhanced by several folds. Molecular modeling studies suggested that the rtL269I substitution affects template binding, which may eventually lead to the enhanced activity of rtI269-HBV polymerase in both WT virus and YMDD mutant. The clinical relevance of the rtL269I substitution was validated by its emergence in association with YMDD mutation in chronic hepatitis B (CHB) patients with sub-optimal response or treatment failure to LMV or CLV. Our study suggests that substitution at rt269 in HBV polymerase is associated with multi-drug resistance, which may serve as a novel compensatory mutation for replication-defective multidrug resistant HBV.	[Ahn, Sung Hyun; Kim, Doo Hyun; Lee, Ah Ram; Park, Yong Kwang; Park, Eun-Sook; Shin, Gu-Choul; Park, Soree; Kang, Hong Seok; Yang, Sung-Il; Kim, Kyun-Hwan] Konkuk Univ, Dept Pharmacol, Ctr Canc Res & Diagnost Med, IBST,Sch Med, Seoul, South Korea; [Kim, Beom Kyung; Ahn, Sang Hoon] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Beom Kyung; Ahn, Sang Hoon] Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea; [Park, Eun-Sook; Shin, Gu-Choul; Kim, Kyun-Hwan] Konkuk Univ, KU Open Innovat Ctr, Seoul, South Korea; [Chong, Youhoon] Konkuk Univ, Dept Biosci & Biotechnol, Bio Mol Informat Ctr, Seoul, South Korea; [Rhee, Jin-Kyu] Ewha Womans Univ, Dept Food Sci, Seoul, South Korea; [Rhee, Jin-Kyu] Ewha Womans Univ, Dept Engn, Seoul, South Korea; [Kim, Kyun-Hwan] Konkuk Univ, Res Inst Med Sci, Seoul, South Korea	Konkuk University; Konkuk University Medical Center; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Konkuk University; Konkuk University; Ewha Womans University; Ewha Womans University; Konkuk University	Kim, KH (corresponding author), Konkuk Univ, Dept Pharmacol, Ctr Canc Res & Diagnost Med, IBST,Sch Med, Seoul, South Korea.	khkim10@kku.ac.kr		Lee, Ah Ram/0000-0001-6075-3352; Rhee, Jin-Kyu/0000-0002-2507-6664; Kim, Beom Kyung/0000-0002-5363-2496; Park, Eun-Sook/0000-0002-6652-9404; Park, Soree/0000-0003-0500-2227; Kim, Kyun-Hwan/0000-0001-5266-072X; Shin, Gu-Choul/0000-0001-8200-9700; Ahn, Sang Hoon/0000-0002-3629-4624	Konkuk University	Konkuk University	This study was supported by Konkuk University.	Ahn SH, 2014, J VIROL, V88, P6805, DOI 10.1128/JVI.00635-14; Block TM, 1998, NAT MED, V4, P610, DOI 10.1038/nm0598-610; Chang TT, 2006, NEW ENGL J MED, V354, P1001, DOI 10.1056/NEJMoa051285; Das K, 2001, J VIROL, V75, P4771, DOI 10.1128/JVI.75.10.4771-4779.2001; Delaney WE, 2003, J VIROL, V77, P11833, DOI 10.1128/JVI.77.21.11833-11841.2003; Deres K, 2003, SCIENCE, V299, P893, DOI 10.1126/science.1077215; Ghany M, 2007, GASTROENTEROLOGY, V132, P1574, DOI 10.1053/j.gastro.2007.02.039; Hoofnagle JH, 2007, HEPATOLOGY, V45, P1056, DOI 10.1002/hep.21627; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Ji D, 2012, J CLIN VIROL, V54, P66, DOI 10.1016/j.jcv.2012.02.003; KASL Clinical Practice Guidelines, 2012, CLIN MOL HEPATOL, V18, P109, DOI DOI 10.3350/CMH.2012.18.2.109; Kim JH, 2014, WORLD J GASTROENTERO, V20, P5708, DOI 10.3748/wjg.v20.i19.5708; Kim KH, 2010, MOLECULES, V15, P5878, DOI 10.3390/molecules15095878; Kim KH, 2010, EXPERT OPIN DRUG DIS, V5, P205, DOI 10.1517/17460441003592072; Kwon SY, 2010, J VIROL, V84, P4494, DOI 10.1128/JVI.02066-09; Langley DR, 2007, J VIROL, V81, P3992, DOI 10.1128/JVI.02395-06; Li J, 2013, ACTA PHARMACOL SIN, V34, P319, DOI 10.1038/aps.2012.146; Lin CL, 2012, J ANTIMICROB CHEMOTH, V67, P39, DOI 10.1093/jac/dkr416; Locarnini S, 2006, J HEPATOL, V44, P422, DOI 10.1016/j.jhep.2005.11.036; Marcellin P, 2003, NEW ENGL J MED, V348, P808, DOI 10.1056/NEJMoa020681; Melegari M, 1998, HEPATOLOGY, V27, P628, DOI 10.1002/hep.510270243; Shin GC, 2013, BBA-MOL BASIS DIS, V1832, P1569, DOI 10.1016/j.bbadis.2013.04.026; Walsh AW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009195; Wu HL, 2005, GASTROENTEROLOGY, V128, P708, DOI 10.1053/j.gastro.2004.12.007; Yano Y, 2015, WORLD J HEPATOL, V7, P583, DOI 10.4254/wjh.v7.i3.583; Yim HJ, 2013, CLIN MOL HEPATOL, V19, P195, DOI 10.3350/cmh.2013.19.3.195; Zoulim F, 2009, GASTROENTEROLOGY, V137, P1593, DOI 10.1053/j.gastro.2009.08.063	27	13	15	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136728	10.1371/journal.pone.0136728	http://dx.doi.org/10.1371/journal.pone.0136728			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322642	Green Published, gold, Green Submitted			2022-12-26	WOS:000360435500030
J	de Chaisemartin, L; Meatchi, T; Malamut, G; Fernani-Oukil, F; Hosking, F; Rault, D; Bellery, F; Cellier, C; Dragon-Durey, MA				de Chaisemartin, Luc; Meatchi, Tchao; Malamut, Georgia; Fernani-Oukil, Fahima; Hosking, Frederique; Rault, Dorothee; Bellery, Fabienne; Cellier, Christophe; Dragon-Durey, Marie-Agnes			Application of Deamidated Gliadin Antibodies in the Follow-Up of Treated Celiac Disease	PLOS ONE			English	Article							GLUTEN-FREE DIET; TRANSGLUTAMINASE ANTIBODIES; TISSUE TRANSGLUTAMINASE; PEPTIDES; CHILDHOOD; DIAGNOSIS; RECOVERY; MULTICENTER; PREDICTORS; ADULTS	Introduction The role of serological tests such as IgA anti-transglutaminase autoantibodies has become increasingly important in celiac disease (CD) diagnosis. However, the efficiency of these tests for patient follow-up is controversial. We investigated the correlation of 12 different serological tests, including recent deamidated gliadin and actin IgA tests, with villous atrophy (VA) in a retrospective cohort of treated celiac patients. Materials and Methods Serum samples were collected from 100 treated CD patients who had intestinal biopsy in the course of their follow-up. Antibodies against transglutaminase, deamidated gliadin peptides, and native gliadin were measured, along with IgA anti-actin. The biopsy slides were all blind-reviewed and scored according to Marsh classification. Results For all deamidated gliadin and transglutaminase tests, we found that a positive result was significantly associated with persistence of intestinal VA, with a diagnostic efficacy up to 80%. Furthermore, antibodies titers directly correlated with the degree of VA, indicating a strong link between disease activity and presence of antibodies in the serum. Interestingly, the tests with the highest association with persistent VA were those for deamidated gliadin IgG. Using a test positivity pattern analysis, we were also able to identify several groups of patients with distinct antibody profiles that showed significant differences in intestinal damage and diet compliance. Conclusions Altogether, these results show that deamidated gliadin antibodies are strongly correlated with VA and should be considered valuable tools in CD follow-up and that multiplex serologic analysis for treated CD represents a promising tool for personalized patient management.	[de Chaisemartin, Luc; Fernani-Oukil, Fahima; Hosking, Frederique; Bellery, Fabienne; Dragon-Durey, Marie-Agnes] Georges Pompidou European Hosp, Dept Immunol, Assistance Publ Hop Paris, Paris, France; [de Chaisemartin, Luc] Univ Paris Sud, INSERM, UMR 996, Chatenay Malabry, France; [Meatchi, Tchao] Georges Pompidou European Hosp, Dept Pathol, Assistance Publ Hop Paris, Paris, France; [Malamut, Georgia; Rault, Dorothee; Cellier, Christophe] Georges Pompidou European Hosp, Dept Gastroenterol, Assistance Publ Hop Paris, Paris, France; [Malamut, Georgia; Cellier, Christophe; Dragon-Durey, Marie-Agnes] Paris Descartes Univ, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Dragon-Durey, MA (corresponding author), Georges Pompidou European Hosp, Dept Immunol, Assistance Publ Hop Paris, Paris, France.	marie-agnes.durey@egp.aphp.fr	, Dragon-Durey/AGM-3653-2022	Malamut, Georgia/0000-0003-4030-3025; christophe, Cellier/0000-0003-0784-2318; Dragon-Durey, Marie-Agnes/0000-0002-5809-8122				Agardh D, 2007, CLIN GASTROENTEROL H, V5, P1276, DOI 10.1016/j.cgh.2007.05.024; Ankelo M, 2007, CLIN EXP IMMUNOL, V150, P285, DOI 10.1111/j.1365-2249.2007.03487.x; Bazzigaluppi E, 2010, ITAL J PEDIATR, V36, DOI 10.1186/1824-7288-36-25; Carroccio A, 2007, DIGEST LIVER DIS, V39, P818, DOI 10.1016/j.dld.2007.06.004; Clemente MG, 2000, GUT, V47, P520, DOI 10.1136/gut.47.4.520; Clemente MG, 2004, AM J GASTROENTEROL, V99, P1551, DOI 10.1111/j.1572-0241.2004.30296.x; Dickey W, 2000, AM J GASTROENTEROL, V95, P712, DOI 10.1111/j.1572-0241.2000.01838.x; Dickson BC, 2006, J CLIN PATHOL, V59, P1008, DOI 10.1136/jcp.2005.035345; Falini ML, 2008, DIGEST DIS SCI, V53, P2697, DOI 10.1007/s10620-007-0191-9; Fasano A, 2012, NEW ENGL J MED, V367, P2419, DOI 10.1056/NEJMcp1113994; Gatselis NK, 2012, CLIN CHIM ACTA, V413, P1683, DOI 10.1016/j.cca.2012.05.015; Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600; Green PHR, 2005, BEST PRACT RES CL GA, V19, P389, DOI 10.1016/j.bpg.2005.02.006; Hopper AD, 2008, CLIN GASTROENTEROL H, V6, P314, DOI 10.1016/j.cgh.2007.12.008; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Kaukinen K, 2007, SCAND J GASTROENTERO, V42, P1428, DOI 10.1080/00365520701452217; Korponay-Szabo IR, 2008, J PEDIATR GASTR NUTR, V46, P253, DOI 10.1097/MPG.0b013e31815ee555; Leffler DA, 2007, ALIMENT PHARM THER, V26, P1227, DOI 10.1111/j.1365-2036.2007.03501.x; Liu E, 2007, J PEDIATR GASTR NUTR, V45, P293, DOI 10.1097/MPG.0b013e31806c7b34; Matysiak-Budnik T, 2007, GUT, V56, P1379, DOI 10.1136/gut.2006.100511; Monzani A, 2011, J PEDIATR GASTR NUTR, V53, P55, DOI 10.1097/MPG.0b013e3182145511; Niveloni S, 2007, CLIN CHEM, V53, P2186, DOI 10.1373/clinchem.2006.081364; Prause C, 2009, J PEDIATR GASTR NUTR, V49, P52, DOI 10.1097/MPG.0b013e318195dae3; Rashtak S, 2008, CLIN GASTROENTEROL H, V6, P426, DOI 10.1016/j.cgh.2007.12.030; Rubio-Tapia A, 2010, AM J GASTROENTEROL, V105, P1412, DOI 10.1038/ajg.2010.10; Sugai E, 2006, CLIN GASTROENTEROL H, V4, P1112, DOI 10.1016/j.cgh.2006.05.004; Tursi A, 2003, J CLIN GASTROENTEROL, V37, P387, DOI 10.1097/00004836-200311000-00007; Vahedi K, 2003, AM J GASTROENTEROL, V98, P1079, DOI [10.1016/S0002-9270(02)06006-9, 10.1111/j.1572-0241.2003.07284.x]; van de Stadt LA, 2011, ARTHRITIS RHEUM-US, V63, P3226, DOI 10.1002/art.30537; Vermeersch P, 2012, CLIN CHIM ACTA, V413, P1761, DOI 10.1016/j.cca.2012.06.024; Vermeersch P, 2010, CLIN CHIM ACTA, V411, P931, DOI 10.1016/j.cca.2010.02.060; Volta U, 2008, DIGEST DIS SCI, V53, P1582, DOI 10.1007/s10620-007-0058-0; Zanini B, 2013, CLIN GASTROENTEROL H, V11, P253, DOI 10.1016/j.cgh.2012.09.027; Ziegler AG, 1999, DIABETES, V48, P460, DOI 10.2337/diabetes.48.3.460	34	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136745	10.1371/journal.pone.0136745	http://dx.doi.org/10.1371/journal.pone.0136745			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322980	Green Published, gold, Green Submitted			2022-12-26	WOS:000360435500033
J	Lensen, JFM; van der Vlag, J; Versteeg, EMM; Wetzels, JFM; van den Heuvel, LPWJ; Berden, JHM; van Kuppevelt, TH; Rops, ALWMM				Lensen, Joost F. M.; van der Vlag, Johan; Versteeg, Elly M. M.; Wetzels, Jack F. M.; van den Heuvel, Lambert P. W. J.; Berden, Jo H. M.; van Kuppevelt, Toin H.; Rops, Angelique L. W. M. M.			Differential Expression of Specific Dermatan Sulfate Domains in Renal Pathology	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; COLLAGEN TYPE-I; CHONDROITIN SULFATE; HEPARAN-SULFATE; SMALL PROTEOGLYCANS; TGF-BETA; DECORIN; BIGLYCAN; KIDNEY; GLYCOSAMINOGLYCANS	Dermatan sulfate (DS), also known as chondroitin sulfate (CS)-B, is a member of the linear polysaccharides called glycosaminoglycans (GAGs). The expression of CS/DS and DS proteoglycans is increased in several fibrotic renal diseases, including interstitial fibrosis, diabetic nephropathy, mesangial sclerosis and nephrosclerosis. Little, however, is known about structural alterations in DS in renal diseases. The aim of this study was to evaluate the renal expression of two different DS domains in renal transplant rejection and glomerular pathologies. DS expression was evaluated in normal renal tissue and in kidney biopsies obtained from patients with acute interstitial or vascular renal allograft rejection, patients with interstitial fibrosis and tubular atrophy (IF/TA), and from patients with focal segmental glomerulosclerosis (FSGS), membranous glomerulopathy (MGP) or systemic lupus erythematosus (SLE), using our unique specific anti-DS antibodies LKN1 and GD3A12. Expression of the 4/2,4-di-O-sulfated DS domain recognized by antibody LKN1 was decreased in the interstitium of transplant kidneys with IF/TA, which was accompanied by an increased expression of type I collagen, decorin and transforming growth factor beta (TGF-beta), while its expression was increased in the interstitium in FSGS, MGP and SLE. Importantly, all patients showed glomerular LKN1 staining in contrast to the controls. Expression of the IdoA-Gal-NAc4SDS domain recognized by GD3A12 was similar in controls and patients. Our data suggest a role for the DS domain recognized by antibody LKN1 in renal diseases with early fibrosis. Further research is required to delineate the exact role of different DS domains in renal fibrosis.	[Lensen, Joost F. M.; Versteeg, Elly M. M.; van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Dept Biochem, Radboud Inst Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [van der Vlag, Johan; Wetzels, Jack F. M.; Berden, Jo H. M.; Rops, Angelique L. W. M. M.] Radboud Univ Nijmegen, Med Ctr, Nephrol Res Lab, Radboud Inst Mol Life Sci,Dept Nephrol, NL-6525 ED Nijmegen, Netherlands; [van den Heuvel, Lambert P. W. J.] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Rops, ALWMM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nephrol Res Lab, Radboud Inst Mol Life Sci,Dept Nephrol, NL-6525 ED Nijmegen, Netherlands.	Angelique.Meulemans-Rops@radboudumc.nl	Berden, J.H.M./H-8009-2014; van Kuppevelt, A.H.M.S.M./L-4463-2015; Van der Vlag, Johan/E-4636-2010; van den Heuvel, L.P.W.J./H-8044-2014; Wetzels, Jack F.M./A-1720-2014; van den Heuvel, Lambertus/AAM-1772-2021	Van der Vlag, Johan/0000-0001-7843-5918; van den Heuvel, L.P.W.J./0000-0003-3917-6727; Wetzels, Jack F.M./0000-0002-0650-6921; van den Heuvel, Lambertus/0000-0003-3917-6727; Versteeg, Elly/0000-0001-7047-5173; Lensen, Joost/0000-0003-2854-3149	Dutch Organization for Scientific Research [902-27-292]; Dutch Kidney Foundation [KJPB 09.010]	Dutch Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Kidney Foundation	This study was supported by the Dutch Organization for Scientific Research (grant 902-27-292) (JFML, ALWMMR) and the Dutch Kidney Foundation (grant KJPB 09.010) (ALWMMR).	Alhasan AA, 2014, J BIOL CHEM, V289, P20295, DOI 10.1074/jbc.M114.554691; Ali S, 2005, TRANSPLANTATION, V79, P672, DOI 10.1097/01.TP.0000155961.57664.DB; Baboolal K, 2002, KIDNEY INT, V61, P686, DOI 10.1046/j.1523-1755.2002.00149.x; Chapman JR, 2005, J AM SOC NEPHROL, V16, P3015, DOI 10.1681/ASN.2005050463; Corsi A, 2002, J BONE MINER RES, V17, P1180, DOI 10.1359/jbmr.2002.17.7.1180; DANIELSEN CC, 1982, CONNECT TISSUE RES, V9, P219, DOI 10.3109/03008208209160265; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Deng SP, 1996, TRANSPLANTATION, V61, P1300, DOI 10.1097/00007890-199605150-00003; El-Zoghby ZM, 2009, AM J TRANSPLANT, V9, P527, DOI 10.1111/j.1600-6143.2008.02519.x; Hadad SJ, 1996, BBA-GEN SUBJECTS, V1290, P18, DOI 10.1016/0304-4165(95)00183-2; Jain S, 2000, TRANSPLANTATION, V69, P1759, DOI 10.1097/00007890-200005150-00001; KLEIN DJ, 1986, J BIOL CHEM, V261, P6636; Koshiishi I, 2002, ARCH BIOCHEM BIOPHYS, V401, P38, DOI 10.1016/S0003-9861(02)00032-2; Kuwaba K, 2002, J DERMATOL SCI, V29, P185, DOI 10.1016/S0923-1811(02)00023-3; Lensen JFM, 2006, MATRIX BIOL, V25, P457, DOI 10.1016/j.matbio.2006.06.003; Malavaki C, 2008, CONNECT TISSUE RES, V49, P133, DOI 10.1080/03008200802148546; Muda AO, 1998, NEPHROL DIAL TRANSPL, V13, P279, DOI 10.1093/oxfordjournals.ndt.a027819; Papaioannou EG, 2004, SURG TODAY, V34, P668, DOI 10.1007/s00595-004-2795-4; Pecly IMD, 2006, NEPHROL DIAL TRANSPL, V21, P1212, DOI 10.1093/ndt/gfk076; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Reine TM, 2013, J HISTOCHEM CYTOCHEM, V61, P606, DOI 10.1369/0022155413494392; Rienstra H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009095; Schaefer L, 2000, KIDNEY INT, V58, P1557, DOI 10.1046/j.1523-1755.2000.00317.x; Schaefer L, 2002, AM J PATHOL, V160, P1181, DOI 10.1016/S0002-9440(10)64937-1; Schaefer L, 2001, FASEB J, V15, P559; Schaefer L, 2011, J AM SOC NEPHROL, V22, P1200, DOI 10.1681/ASN.2010050570; Solez K, 2007, AM J TRANSPLANT, V7, P518, DOI 10.1111/j.1600-6143.2006.01688.x; Sorrell JM, 1999, HISTOCHEM J, V31, P549; STEVENS RR, 1993, TRANSPLANT P, V25, P382; Stokes MB, 2000, KIDNEY INT, V57, P487, DOI 10.1046/j.1523-1755.2000.00868.x; Stokes MB, 2001, KIDNEY INT, V59, P532, DOI 10.1046/j.1523-1755.2001.059002532.x; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; ten Dam GB, 2009, HISTOCHEM CELL BIOL, V132, P117, DOI 10.1007/s00418-009-0592-2; Trowbridge JM, 2002, GLYCOBIOLOGY, V12, p117R, DOI 10.1093/glycob/cwf066; VANDELEST CHA, 1994, ANAL BIOCHEM, V221, P356, DOI 10.1006/abio.1994.1425; Yang CW, 1997, NEPHRON, V77, P290, DOI 10.1159/000190290	36	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0134946	10.1371/journal.pone.0134946	http://dx.doi.org/10.1371/journal.pone.0134946			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322947	gold, Green Published, Green Submitted			2022-12-26	WOS:000360435500004
J	Steiber, N				Steiber, Nadia			Population Aging at Cross-Roads: Diverging Secular Trends in Average Cognitive Functioning and Physical Health in the Older Population of Germany	PLOS ONE			English	Article							COHORT DIFFERENCES; MENTAL-HEALTH; GENERAL-POPULATION; LIFE-COURSE; YOUNG-OLD; DISABILITY; MORTALITY; AGE; SF-12; COMPRESSION	This paper uses individual-level data from the German Socio-Economic Panel to model trends in population health in terms of cognition, physical fitness, and mental health between 2006 and 2012. The focus is on the population aged 50-90. We use a repeated population-based cross-sectional design. As outcome measures, we use SF-12 measures of physical and mental health and the Symbol-Digit Test (SDT) that captures cognitive processing speed. In line with previous research we find a highly significant Flynn effect on cognition; i.e., SDT scores are higher among those who were tested more recently (at the same age). This result holds for men and women, all age groups, and across all levels of education. While we observe a secular improvement in terms of cognitive functioning, at the same time, average physical and mental health has declined. The decline in average physical health is shown to be stronger for men than for women and found to be strongest for low-educated, young-old men aged 50-64: the decline over the 6-year interval in average physical health is estimated to amount to about 0.37 SD, whereas average fluid cognition improved by about 0.29 SD. This pattern of results at the population-level (trends in average population health) stands in interesting contrast to the positive association of physical health and cognitive functioning at the individual-level. The findings underscore the multi-dimensionality of health and the aging process.	[Steiber, Nadia] Int Inst Appl Syst Anal IIASA, Wittgenstein Ctr IIASA, VID OAW, WU, Laxenburg, Austria; [Steiber, Nadia] Univ Vienna, Dept Econ Sociol, Vienna, Austria	International Institute for Applied Systems Analysis (IIASA); University of Vienna	Steiber, N (corresponding author), Int Inst Appl Syst Anal IIASA, Wittgenstein Ctr IIASA, VID OAW, WU, Laxenburg, Austria.	steiber@iiasa.ac.at		Steiber, Nadia/0000-0002-9425-8840	European Research Council [ERC2013-AdG 323947-Re-Ageing]	European Research Council(European Research Council (ERC)European Commission)	The work was supported by funding from the European Research Council, Grant No. ERC2013-AdG 323947-Re-Ageing.	Ambrasat J, 2011, SOEP PAPERS; Andel R, 2015, J GERONTOL B-PSYCHOL, V70, P314, DOI 10.1093/geronb/gbu110; Andersen HH., 2007, SCHMOLLERS JB, V127, P171; Baxendale S, 2010, J CLIN EXP NEUROPSYC, V32, P699, DOI 10.1080/13803390903493515; Bilotta C, 2012, AGING MENT HEALTH, V16, P273, DOI 10.1080/13607863.2011.609534; Bohannon Richard W, 2008, J Geriatr Phys Ther, V31, P3; Booth FW, 2012, COMPR PHYSIOL, V2, P1143, DOI 10.1002/cphy.c110025; Bordone V, 2015, INTELLIGENCE, V52, P90, DOI 10.1016/j.intell.2015.07.005; Bosma H, 2003, EXP AGING RES, V29, P33, DOI 10.1080/03610730303710; Burdine JN, 2000, HEALTH SERV RES, V35, P885; Cambois E, 2013, EUR J PUBLIC HEALTH, V23, P575, DOI 10.1093/eurpub/cks136; Cambois E, 2008, EUR J AGEING, V5, P287, DOI 10.1007/s10433-008-0097-1; Christensen H, 2001, PSYCHOL AGING, V16, P588, DOI 10.1037//0882-7974.16.4.588; Christensen K, 2013, LANCET, V382, P1507, DOI 10.1016/S0140-6736(13)60777-1; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Clouston SAP, 2013, EPIDEMIOL REV, V35, P33, DOI 10.1093/epirev/mxs004; Cooper R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2219; Ribeiro PCC, 2013, OCCUP MED-OXFORD, V63, P556, DOI 10.1093/occmed/kqt115; Crimmins EM, 2011, J GERONTOL B-PSYCHOL, V66, P75, DOI 10.1093/geronb/gbq088; Crimmins EM, 2004, ANNU REV PUBL HEALTH, V25, P79, DOI 10.1146/annurev.publhealth.25.102802.124401; de Rotrou J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078646; Doblhammer G, 2014, ALZHEIMERS DEMENT J, V10, pP279, DOI [10.1016/j.jalz.2014.04.527, DOI 10.1016/J.JALZ.2014.04.527]; Eibich P, 2014, REG SCI URBAN ECON, V49, P305, DOI 10.1016/j.regsciurbeco.2014.06.005; Falk H, 2014, AGE AGEING, V43, P636, DOI 10.1093/ageing/afu018; Ferrer E, 2004, PSYCHOL AGING, V19, P243, DOI 10.1037/0882-7974.19.2.243; Finkel D, 2007, J GERONTOL B-PSYCHOL, V62, pP286, DOI 10.1093/geronb/62.5.P286; Fleishman JA, 2003, MED CARE, V41, P75, DOI 10.1097/01.MLR.0000076052.42628.CF; Fleishman JA, 2010, QUAL LIFE RES, V19, P231, DOI 10.1007/s11136-009-9582-z; Franks P, 2003, SOC SCI MED, V56, P2505, DOI 10.1016/S0277-9536(02)00281-2; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Gerstorf D, 2011, DEV PSYCHOL, V47, P1026, DOI 10.1037/a0023426; Gill SC, 2007, PSYCHIAT RES, V152, P63, DOI 10.1016/j.psychres.2006.11.005; Hays RD, 1995, RAND MONOGR REP; Heikkinen E, 2011, AGING CLIN EXP RES, V23, P126, DOI 10.3275/6932; Heineck G, 2010, LABOUR ECON, V17, P535, DOI 10.1016/j.labeco.2009.06.001; Hiscock M, 2007, J CLIN EXP NEUROPSYC, V29, P514, DOI 10.1080/13803390600813841; Hultsch DF, 1999, PSYCHOL AGING, V14, P245, DOI 10.1037/0882-7974.14.2.245; Jagger C, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-156; Kluge F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108501; Kuh D, 2014, P NUTR SOC, V73, P237, DOI 10.1017/S0029665113003923; Lacson E, 2010, CLIN J AM SOC NEPHRO, V5, P252, DOI 10.2215/CJN.07231009; Lafortune G., 2007, TRENDS SEVERE DISABI, VVol. 26, DOI [10.1787/217072070078, DOI 10.1787/217072070078]; Lang F.R., 2007, SCHMOLLERS JB J APPL, V127, P183; Llewellyn DJ, 2009, AGING NEUROPSYCHOL C, V16, P433, DOI 10.1080/13825580902773867; Manton KG, 2008, ANNU REV PUBL HEALTH, V29, P91, DOI 10.1146/annurev.publhealth.29.020907.090812; Marioni RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050940; Marshall S, 2010, AM J PREV MED, V39, P389, DOI 10.1016/j.amepre.2010.07.001; Martin LG, 2014, DISABIL HEALTH J, V7, pS4, DOI 10.1016/j.dhjo.2013.06.007; Martin LG, 2012, J EPIDEMIOL COMMUN H, V66, P874, DOI 10.1136/jech-2011-200251; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; Mishra GD, 2014, QUAL LIFE RES, V23, P1515, DOI 10.1007/s11136-013-0586-3; Oesch D., 2013, OCCUPATIONAL CHANGE; Parker MG, 2007, GERONTOLOGIST, V47, P150, DOI 10.1093/geront/47.2.150; Peres K, 2013, ANNU REV GERONTOL GE, V33, P293, DOI 10.1891/0198-8794.33.293; Ratey JJ, 2011, REV NEUROSCIENCE, V22, P171, DOI 10.1515/RNS.2011.017; Robertson DA, 2013, AGEING RES REV, V12, P840, DOI 10.1016/j.arr.2013.06.004; Robinson WS, 1950, AM SOCIOL REV, V15, P351, DOI 10.2307/2087176; Ronnlund M, 2008, INTELLIGENCE, V36, P192, DOI 10.1016/j.intell.2007.05.002; ROWE JW, 1987, SCIENCE, V237, P143, DOI 10.1126/science.3299702; Ruesten A, 2011, PLOS ONE, V6, P27455, DOI DOI 10.1371/J0URNAL.P0NE.0027455; Sacuiu S, 2010, NEUROLOGY, V75, P779, DOI 10.1212/WNL.0b013e3181f0737c; Salthouse TA, 2015, INTELLIGENCE, V48, P51, DOI 10.1016/j.intell.2014.10.007; Sanderson WC, 2013, POPUL DEV REV, V39, P673, DOI 10.1111/j.1728-4457.2013.00633.x; Schoeni RF, 2005, AM J PUBLIC HEALTH, V95, P2065, DOI 10.2105/AJPH.2004.048744; Schupp J., 2008, ERFASSUNG KOGNITIVER; Seeman TE, 2010, AM J PUBLIC HEALTH, V100, P100, DOI 10.2105/AJPH.2008.157388; Skirbekk V, 2013, INTELLIGENCE, V41, P169, DOI 10.1016/j.intell.2013.02.001; Smith A, 1982, SYMBOL DIGITS MODALI; Vaupel JW, 2010, NATURE, V464, P536, DOI 10.1038/nature08984; Vilagut G, 2013, VALUE HEALTH, V16, P564, DOI 10.1016/j.jval.2013.01.006; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Weber D, 2014, P NATL ACAD SCI USA, V111, P11673, DOI 10.1073/pnas.1319538111	72	15	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136583	10.1371/journal.pone.0136583	http://dx.doi.org/10.1371/journal.pone.0136583			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ2MT	26323093	gold, Green Accepted, Green Published			2022-12-26	WOS:000360435500022
J	Alaerts, K; Geerlings, F; Herremans, L; Swinnen, SP; Verhoeven, J; Sunaert, S; Wenderoth, N				Alaerts, Kaat; Geerlings, Franca; Herremans, Lynn; Swinnen, Stephan P.; Verhoeven, Judith; Sunaert, Stefan; Wenderoth, Nicole			Functional Organization of the Action Observation Network in Autism: A Graph Theory Approach	PLOS ONE			English	Article							MIRROR NEURON SYSTEM; BIOLOGICAL MOTION PERCEPTION; HUMAN BRAIN; CORTICAL ACTIVATION; SPECTRUM DISORDERS; CONNECTIVITY MRI; SHORT FORMS; IMITATION; DYSFUNCTION; CHILDREN	Background The ability to recognize, understand and interpret other's actions and emotions has been linked to the mirror system or action-observation-network (AON). Although variations in these abilities are prevalent in the neuro-typical population, persons diagnosed with autism spectrum disorders (ASD) have deficits in the social domain and exhibit alterations in this neural network. Method Here, we examined functional network properties of the AON using graph theory measures and region-to-region functional connectivity analyses of resting-state fMRI-data from adolescents and young adults with ASD and typical controls (TC). Results Overall, our graph theory analyses provided convergent evidence that the network integrity of the AON is altered in ASD, and that reductions in network efficiency relate to reductions in overall network density (i.e., decreased overall connection strength). Compared to TC, individuals with ASD showed significant reductions in network efficiency and increased shortest path lengths and centrality. Importantly, when adjusting for overall differences in network density between ASD and TC groups, participants with ASD continued to display reductions in network integrity, suggesting that also network-level organizational properties of the AON are altered in ASD. Conclusion While differences in empirical connectivity contributed to reductions in network integrity, graph theoretical analyses provided indications that also changes in the high-level network organization reduced integrity of the AON.	[Alaerts, Kaat; Geerlings, Franca; Herremans, Lynn; Swinnen, Stephan P.] Katholieke Univ Leuven, Movement Control & Neuroplast Res Grp, Dept Kinesiol, Leuven, Belgium; [Alaerts, Kaat] Katholieke Univ Leuven, Neuromotor Rehabil Res Grp, Dept Rehabil Sci, Leuven, Belgium; [Verhoeven, Judith; Sunaert, Stefan] Katholieke Univ Leuven, Translat MRI, Dept Imaging & Pathol, Leuven, Belgium; [Wenderoth, Nicole] ETH, Dept Hlth Sci & Technol, Neural Control Movement Lab, Zurich, Switzerland	KU Leuven; KU Leuven; KU Leuven; Swiss Federal Institutes of Technology Domain; ETH Zurich	Wenderoth, N (corresponding author), ETH, Dept Hlth Sci & Technol, Neural Control Movement Lab, Zurich, Switzerland.	nicole.wenderoth@hest.ethz.ch	Wenderoth, Nicole/D-7262-2015; Alaerts, Kaat/HGV-0661-2022; Sunaert, Stefan/E-8031-2011	Wenderoth, Nicole/0000-0002-3246-9386; Sunaert, Stefan/0000-0002-1177-4680; Alaerts, Kaat/0000-0001-8665-6374	Flanders Fund for Scientific Research (FWO) [1521313N, G.0401.12]; FWO [1206013N]; Branco Weiss fellowship of the Society in Science - ETH Zurich	Flanders Fund for Scientific Research (FWO)(FWO); FWO(FWO); Branco Weiss fellowship of the Society in Science - ETH Zurich(ETH Zurich)	This work was supported by grants from the Flanders Fund for Scientific Research (FWO projects 1521313N & G.0401.12) (http://www.fwo.be/). KA was supported by an FWO postdoctoral research fellowship (1206013N) and by a Branco Weiss fellowship of the Society in Science - ETH Zurich (http://www.society-in-science.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaerts K, 2014, SOC COGN AFFECT NEUR, V9, P1589, DOI 10.1093/scan/nst156; Alaerts K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020989; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Barttfeld P, 2011, NEUROPSYCHOLOGIA, V49, P254, DOI 10.1016/j.neuropsychologia.2010.11.024; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Bernier R, 2007, BRAIN COGNITION, V64, P228, DOI 10.1016/j.bandc.2007.03.004; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Boersma M, 2013, BRAIN CONNECT, V3, P41, DOI 10.1089/brain.2012.0127; Caeyenberghs K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00726; Caspers S, 2010, NEUROIMAGE, V50, P1148, DOI 10.1016/j.neuroimage.2009.12.112; Chen ZJ, 2008, CEREB CORTEX, V18, P2374, DOI 10.1093/cercor/bhn003; Constantino JN, 2005, BIOL PSYCHIAT, V57, P655, DOI 10.1016/j.biopsych.2004.12.014; Constantino JN, 2004, J CHILD PSYCHOL PSYC, V45, P719, DOI 10.1111/j.1469-7610.2004.00266.x; Constantino JN, 2003, J AUTISM DEV DISORD, V33, P427, DOI 10.1023/A:1025014929212; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; Di Martino A, 2014, Mol Psychiatry, V19, P659, DOI 10.1038/mp.2013.78; Enticott PG, 2012, BIOL PSYCHIAT, V71, P427, DOI 10.1016/j.biopsych.2011.09.001; Fan YT, 2010, J CHILD PSYCHOL PSYC, V51, P981, DOI 10.1111/j.1469-7610.2010.02269.x; Ferrarini L, 2009, HUM BRAIN MAPP, V30, P2220, DOI 10.1002/hbm.20663; Fishman I, 2014, JAMA PSYCHIAT, V71, P751, DOI 10.1001/jamapsychiatry.2014.83; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Freitag CM, 2008, NEUROPSYCHOLOGIA, V46, P1480, DOI 10.1016/j.neuropsychologia.2007.12.025; Girard TA, 2010, ASSESSMENT, V17, P400, DOI 10.1177/1073191110369763; Grezes J, 2001, NEUROIMAGE, V13, P775, DOI 10.1006/nimg.2000.0740; Hamilton AFD, 2013, DEV COGN NEUROS-NETH, V3, P91, DOI 10.1016/j.dcn.2012.09.008; Heitger MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062133; Herrington JD, 2011, BRAIN COGNITION, V77, P372, DOI 10.1016/j.bandc.2011.09.001; Herrington JD, 2007, RES AUTISM SPECT DIS, V1, P14, DOI 10.1016/j.rasd.2006.07.002; Iacoboni M, 2006, NAT REV NEUROSCI, V7, P942, DOI 10.1038/nrn2024; Just MA, 2004, BRAIN, V127, P1811, DOI 10.1093/brain/awh199; Kaiser MD, 2012, DEV COGN NEUROS-NETH, V2, P25, DOI 10.1016/j.dcn.2011.05.005; Kaiser MD, 2010, P NATL ACAD SCI USA, V107, P21223, DOI 10.1073/pnas.1010412107; Kana RK, 2014, SOC COGN AFFECT NEUR, V9, P98, DOI 10.1093/scan/nss106; Kleinhans NM, 2008, BRAIN, V131, P1000, DOI 10.1093/brain/awm334; Koldewyn K, 2011, DEVELOPMENTAL SCI, V14, P1075, DOI 10.1111/j.1467-7687.2011.01058.x; Koshino H, 2008, CEREB CORTEX, V18, P289, DOI 10.1093/cercor/bhm054; Kramer MA, 2008, EPILEPSY RES, V79, P173, DOI 10.1016/j.eplepsyres.2008.02.002; Martineau J, 2008, INT J PSYCHOPHYSIOL, V68, P35, DOI 10.1016/j.ijpsycho.2008.01.002; McKay LS, 2012, NEUROIMAGE, V59, P1524, DOI 10.1016/j.neuroimage.2011.08.033; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Minshew NJ, 2010, CURR OPIN NEUROL, V23, P124, DOI 10.1097/WCO.0b013e32833782d4; Muller RA, 2011, CEREB CORTEX, V21, P2233, DOI 10.1093/cercor/bhq296; Nackaerts E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044473; Oberman LM, 2008, NEUROPSYCHOLOGIA, V46, P1558, DOI 10.1016/j.neuropsychologia.2008.01.010; Oberman LM, 2005, COGNITIVE BRAIN RES, V24, P190, DOI 10.1016/j.cogbrainres.2005.01.014; Pelphrey KA, 2006, CURR DIR PSYCHOL SCI, V15, P136, DOI 10.1111/j.0963-7214.2006.00423.x; Pelphrey KA, 2005, BRAIN, V128, P1038, DOI 10.1093/brain/awh404; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raymaekers R, 2009, BRAIN RES, V1304, P113, DOI 10.1016/j.brainres.2009.09.068; Redcay E, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00573; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rudie JD, 2013, NEUROIMAGE-CLIN, V2, P79, DOI 10.1016/j.nicl.2012.11.006; Rudie JD, 2012, CEREB CORTEX, V22, P1025, DOI 10.1093/cercor/bhr171; Ryan JJ, 1999, PSYCHOL ASSESSMENT, V11, P207, DOI 10.1037/1040-3590.11.2.207; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Saygin AP, 2004, J NEUROSCI, V24, P6181, DOI 10.1523/JNEUROSCI.0504-04.2004; Saygin AP, 2007, BRAIN, V130, P2452, DOI 10.1093/brain/awm162; Schipul SE, 2012, CEREB CORTEX, V22, P937, DOI 10.1093/cercor/bhr162; Shih P, 2010, NEUROPSYCHOLOGIA, V48, P2931, DOI 10.1016/j.neuropsychologia.2010.05.035; Skuse D, 2004, J AM ACAD CHILD PSY, V43, P548, DOI 10.1097/00004583-200405000-00008; Theoret H, 2005, CURR BIOL, V15, pR84, DOI 10.1016/j.cub.2005.01.022; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Vissers ME, 2012, NEUROSCI BIOBEHAV R, V36, P604, DOI 10.1016/j.neubiorev.2011.09.003; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Williams JHG, 2006, NEUROPSYCHOLOGIA, V44, P610, DOI 10.1016/j.neuropsychologia.2005.06.010; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004	72	21	21	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137020	10.1371/journal.pone.0137020	http://dx.doi.org/10.1371/journal.pone.0137020			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ0PO	26317222	Green Published, Green Submitted, gold			2022-12-26	WOS:000360299100194
J	Hamour, S; Gan, PY; Pepper, R; Barros, FF; Wang, HH; O'Sullivan, K; Iwakura, Y; Cook, T; Pusey, C; Holdsworth, S; Salama, A				Hamour, Sally; Gan, Poh-Yi; Pepper, Ruth; Barros, Fernanda Florez; Wang, Hsu-Han; O'Sullivan, Kim; Iwakura, Yoichiro; Cook, Terence; Pusey, Charles; Holdsworth, Stephen; Salama, Alan			Local IL-17 Production Exerts a Protective Role in Murine Experimental Glomerulonephritis	PLOS ONE			English	Article							MAST-CELLS; CRESCENTIC GLOMERULONEPHRITIS; T-CELLS; RENAL INJURY; INTERLEUKIN-17; DISTINCT; INFLAMMATION; ACTIVATION; EXPRESSION; CONTRIBUTE	IL-17 is a pro-inflammatory cytokine implicated in the pathogenesis of glomerulonephritis and IL-17 deficient mice are protected from nephrotoxic nephritis. However, a regulatory role for IL-17 has recently emerged. We describe a novel protective function for IL-17 in the kidney. Bone marrow chimeras were created using wild-type and IL-17 deficient mice and nephrotoxic nephritis was induced. IL-17 deficient hosts transplanted with wild-type bone marrow had worse disease by all indices compared to wild-type to wild-type bone marrow transplants (serum urea p<0.05; glomerular thrombosis p<0.05; tubular damage p<0.01), suggesting that in wild-type mice, IL-17 production by renal cells resistant to radiation is protective. IL-17 deficient mice transplanted with wild-type bone marrow also had a comparatively altered renal phenotype, with significant differences in renal cytokines (IL-10 p<0.01; IL-1 beta p<0.001; IL-23 p<0.01), and macrophage phenotype (expression of mannose receptor p<0.05; inducible nitric oxide synthase p<0.001). Finally we show that renal mast cells are resistant to radiation and produce IL-17, suggesting they are potential local mediators of disease protection. This is a novel role for intrinsic cells in the kidney that are radio-resistant and produce IL-17 to mediate protection in nephrotoxic nephritis. This has clinical significance as IL-17 blockade is being trialled as a therapeutic strategy in some autoimmune diseases.	[Hamour, Sally; Pepper, Ruth; Barros, Fernanda Florez; Wang, Hsu-Han; Salama, Alan] Royal Free Hosp, UCL Ctr Nephrol, London NW3 2QG, England; [Gan, Poh-Yi; O'Sullivan, Kim; Holdsworth, Stephen] Monash Univ, Ctr Inflammatory Dis, Melbourne, Vic 3004, Australia; [Iwakura, Yoichiro] Tokyo Univ Sci, Res Inst Biomed Sci, Tokyo 162, Japan; [Cook, Terence] Univ London Imperial Coll Sci Technol & Med, Dept Med, Ctr Inflammat & Complement Res, London, England; [Pusey, Charles] Univ London Imperial Coll Sci Technol & Med, Dept Med, Renal Sect, London, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Monash University; Tokyo University of Science; Imperial College London; Imperial College London	Salama, A (corresponding author), Royal Free Hosp, UCL Ctr Nephrol, Pond St, London NW3 2QG, England.	a.salama@ucl.ac.uk	Wang, Hsu-Han/Q-7331-2019; Iwakura, Yoichiro/E-5457-2011	Wang, Hsu-Han/0000-0001-6590-7736; Iwakura, Yoichiro/0000-0002-9934-5775; Gan, Poh Yi/0000-0001-8373-7144; O'Sullivan, Kim Maree/0000-0002-3098-7948	Wellcome Trust [083688/z/07/z]; National Health and Medical Research Council of Australia [1011724]; MRC clinical training fellowship [G0802260]; MRC [G0802260] Funding Source: UKRI; Medical Research Council [G0802260] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); MRC clinical training fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	SH was supported by a clinical research training fellowship (grant number 083688/z/07/z) from the Wellcome Trust www.wellcome.ac.uk. PG and KS were supported by a grant (1011724) from the National Health and Medical Research Council of Australia www.nhmrc.gov.au. RP was supported by a MRC clinical training fellowship G0802260 www.mrc.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan CY, 2013, IMMUNITY, V38, P349, DOI 10.1016/j.immuni.2012.10.019; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; FARNSWORTH A, 1988, TRANSPLANTATION, V46, P418, DOI 10.1097/00007890-198809000-00017; Gan PY, 2012, J AM SOC NEPHROL, V23, P1955, DOI 10.1681/ASN.2012060572; Gan PY, 2010, J AM SOC NEPHROL, V21, P925, DOI 10.1681/ASN.2009070763; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Grimbaldeston MA, 2007, NAT IMMUNOL, V8, P1095, DOI 10.1038/ni1503; Hamour S, 2009, CRITICAL ROLE IL 17; Harker JA, 2011, SCIENCE, V334, P825, DOI 10.1126/science.1208421; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hochegger K, 2005, EUR J IMMUNOL, V35, P3074, DOI 10.1002/eji.200526250; HOLDSWORTH SR, 1981, J CLIN INVEST, V68, P686, DOI 10.1172/JCI110304; Hueber AJ, 2010, J IMMUNOL, V184, P3336, DOI 10.4049/jimmunol.0903566; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Ishizuka T, 1999, CLIN EXP ALLERGY, V29, P1424; Ke Y, 2009, J IMMUNOL, V182, P3183, DOI 10.4049/jimmunol.0802487; Kitching AR, 2000, KIDNEY INT, V57, P518, DOI 10.1046/j.1523-1755.2000.t01-1-00872.x; KOJIMA S, 1974, J IMMUNOL, V113, P673; Lee S, 2011, J AM SOC NEPHROL, V22, P317, DOI 10.1681/ASN.2009060615; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Lin AM, 2011, J IMMUNOL, V187, P490, DOI 10.4049/jimmunol.1100123; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Odobasic D, 2011, AM J PATHOL, V179, P1188, DOI 10.1016/j.ajpath.2011.05.039; Ogawa A, 2004, CLIN IMMUNOL, V110, P55, DOI 10.1016/j.clim.2003.09.013; Onishi RM, 2010, IMMUNOLOGY, V129, P311, DOI 10.1111/j.1365-2567.2009.03240.x; Ooi JD, 2009, J AM SOC NEPHROL, V20, P980, DOI 10.1681/ASN.2008080891; Pang MY, 2010, KIDNEY INT, V78, P257, DOI 10.1038/ki.2010.154; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Paust HJ, 2009, J AM SOC NEPHROL, V20, P969, DOI 10.1681/ASN.2008050556; Phoon RKS, 2008, J AM SOC NEPHROL, V19, P477, DOI 10.1681/ASN.2007030392; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Song CW, 2008, J IMMUNOL, V181, P6117, DOI 10.4049/jimmunol.181.9.6117; Summers SA, 2009, J AM SOC NEPHROL, V20, P2518, DOI 10.1681/ASN.2009030337; Tam FWK, 1997, KIDNEY INT, V52, P1224, DOI 10.1038/ki.1997.447; Tao J, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3545; Timoshanko JR, 2006, J AM SOC NEPHROL, V17, P150, DOI 10.1681/ASN.2005080799; Tipping PG, 1998, AM J PATHOL, V152, P1541; Tulone C, 2011, AM J PATHOL, V179, P2683, DOI 10.1016/j.ajpath.2011.08.017; Velden J, 2012, AM J PHYSIOL-RENAL, V302, pF1663, DOI 10.1152/ajprenal.00683.2011; Xu S, 2010, CELL MOL IMMUNOL, V7, P164, DOI 10.1038/cmi.2010.21; Yang M, 2012, AM J PATHOL, V180, P2375, DOI 10.1016/j.ajpath.2012.03.010; Yi TS, 2008, BLOOD, V112, P2101, DOI 10.1182/blood-2007-12-126987; Zhang LJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028432, 10.1371/journal.pone.0020963, 10.1371/journal.pone.0026129, 10.1371/journal.pone.0028953]; Zhang Z, 2006, INFLAMM BOWEL DIS, V12, P382, DOI 10.1097/01.MIB.0000218764.06959.91	48	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136238	10.1371/journal.pone.0136238	http://dx.doi.org/10.1371/journal.pone.0136238			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317864	Green Published, gold, Green Submitted			2022-12-26	WOS:000360299100064
J	Kotta, J; Oganjan, K; Lauringson, V; Parnoja, M; Kaasik, A; Rohtla, L; Kotta, I; Orav-Kotta, H				Kotta, Jonne; Oganjan, Katarina; Lauringson, Velda; Paernoja, Merli; Kaasik, Ants; Rohtla, Liisa; Kotta, Ilmar; Orav-Kotta, Helen			Establishing Functional Relationships between Abiotic Environment, Macrophyte Coverage, Resource Gradients and the Distribution of Mytilus trossulus in a Brackish Non-Tidal Environment	PLOS ONE			English	Article							BENTHIC SUSPENSION FEEDER; WAVE EXPOSURE; BLUE MUSSELS; SPECIES DISTRIBUTION; SPATIAL-PATTERNS; NORTH-SEA; EDULIS-L; COMMUNITY REGULATION; CLIMATE-CHANGE; HYBRID ZONE	Benthic suspension feeding mussels are an important functional guild in coastal and estuarine ecosystems. To date we lack information on how various environmental gradients and biotic interactions separately and interactively shape the distribution patterns of mussels in non-tidal environments. Opposing to tidal environments, mussels inhabit solely subtidal zone in non-tidal waterbodies and, thereby, driving factors for mussel populations are expected to differ from the tidal areas. In the present study, we used the boosted regression tree modelling (BRT), an ensemble method for statistical techniques and machine learning, in order to explain the distribution and biomass of the suspension feeding mussel Mytilus trossulus in the non-tidal Baltic Sea. BRT models suggested that (1) distribution patterns of M. trossulus are largely driven by separate effects of direct environmental gradients and partly by interactive effects of resource gradients with direct environmental gradients. (2) Within its suitable habitat range, however, resource gradients had an important role in shaping the biomass distribution of M. trossulus. (3) Contrary to tidal areas, mussels were not competitively superior over macrophytes with patterns indicating either facilitative interactions between mussels and macrophytes or co-variance due to common stressor. To conclude, direct environmental gradients seem to define the distribution pattern of M. trossulus, and within the favourable distribution range, resource gradients in interaction with direct environmental gradients are expected to set the biomass level of mussels.	[Kotta, Jonne; Oganjan, Katarina; Lauringson, Velda; Paernoja, Merli; Rohtla, Liisa; Kotta, Ilmar; Orav-Kotta, Helen] Univ Tartu, Estonian Marine Inst, Dept Marine Biol, EE-12618 Tallinn, Estonia; [Kaasik, Ants] Univ Tartu, Inst Ecol & Earth Sci, Chair Zool, EE-51014 Tartu, Estonia; [Rohtla, Liisa] Nova SE Univ, Halmos Coll Nat Sci & Oceanog, Dania, FL USA	University of Tartu; Estonian Marine Institute; University of Tartu; Tartu University Institute of Ecology & Earth Sciences; Nova Southeastern University	Kotta, J (corresponding author), Univ Tartu, Estonian Marine Inst, Dept Marine Biol, Maealuse 14, EE-12618 Tallinn, Estonia.	jonne.kotta@sea.ee	Rohtla, Liisa/G-6403-2017; Melzner, Frank/X-4339-2018; Kotta, Jonne/B-5542-2009; Orav-Kotta, Helen/E-2810-2013; Kaasik, Ants/H-2462-2012	Rohtla, Liisa/0000-0001-7301-0232; Melzner, Frank/0000-0002-5884-1318; Kotta, Jonne/0000-0002-4970-6755; Orav-Kotta, Helen/0000-0002-3029-5642; Kaasik, Ants/0000-0002-4904-0877; Ratsep, Merli/0000-0002-2841-7452	Estonian Research Council [IUT02-20]; Estonian Science Foundation [8807]; project "The status of marine biodiversity and its potential futures in the Estonian coastal sea" of Environmental protection and technology program of the European Regional Fund [3.2.0801.11-0029]; BONUS project BIO-C3 from the European Union	Estonian Research Council(Estonian Research Council); Estonian Science Foundation; project "The status of marine biodiversity and its potential futures in the Estonian coastal sea" of Environmental protection and technology program of the European Regional Fund; BONUS project BIO-C3 from the European Union	Funding for this research was provided by Institutional research funding IUT02-20 of the Estonian Research Council. The study has been also supported by the Estonian Science Foundation grant 8807, the project "The status of marine biodiversity and its potential futures in the Estonian coastal sea" No 3.2.0801.11-0029 of Environmental protection and technology program of the European Regional Fund. The project has received funding from the BONUS project BIO-C3, funded jointly from the European Union's Seventh Programme for research, technological development and demonstration and from the Estonian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALATALO RV, 1986, AM NAT, V127, P819, DOI 10.1086/284527; Alenius P., 1998, BOREAL ENVIRON RES, V3, P97; Alimov AF, 1981, LENINGR SCI; Altieri AH, 2006, MAR ECOL PROG SER, V325, P295, DOI 10.3354/meps325295; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; ARDITI R, 1989, J THEOR BIOL, V139, P311, DOI 10.1016/S0022-5193(89)80211-5; AUSTIN MP, 1980, VEGETATIO, V43, P87, DOI 10.1007/BF00121021; AUSTIN MP, 1980, VEGETATIO, V42, P11, DOI 10.1007/BF00048865; AUSTIN MP, 1989, VEGETATIO, V83, P35, DOI 10.1007/BF00031679; Back S, 1996, MAPPING MONITORING P; BAYNE BL, 1977, PHYSL RESPONSES MARI, P379; Begin C, 2004, MAR ECOL PROG SER, V271, P121, DOI 10.3354/meps271121; Bekkby T, 2008, MAR GEOD, V31, P117, DOI 10.1080/01490410802053674; Bendtsen J, 2009, J MARINE SYST, V75, P138, DOI 10.1016/j.jmarsys.2008.08.006; BERGLUND A, 1982, OECOLOGIA, V54, P1, DOI 10.1007/BF00541099; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Blok J.W. De, 1958, ARCH NEERL ZOOL JUBI, V13, P446; Buttger H, 2008, HELGOLAND MAR RES, V62, P23, DOI 10.1007/s10152-007-0099-y; Chapman MG, 1998, J EXP MAR BIOL ECOL, V224, P265, DOI 10.1016/S0022-0981(97)00202-5; Chase J.M., 2009, ECOLOGICAL NICHES LI; Chatfield BS, 2010, J BIOGEOGR, V37, P593, DOI 10.1111/j.1365-2699.2009.02246.x; Christensen TK, 2008, THESIS U AARHUS DENM; Clausen I, 1996, MAR ECOL PROG SER, V141, P37, DOI 10.3354/meps141037; CLOERN JE, 1982, MAR ECOL PROG SER, V9, P191, DOI 10.3354/meps009191; Colwell RK, 2009, P NATL ACAD SCI USA, V106, P19651, DOI 10.1073/pnas.0901650106; Commito JA, 2001, ECOL STU AN, V151, P39; Conlan KE, 1998, MAR ECOL PROG SER, V166, P1, DOI 10.3354/meps166001; Conley DJ, 2011, ENVIRON SCI TECHNOL, V45, P6777, DOI 10.1021/es201212r; Dahlhoff EP, 1996, MAR ECOL PROG SER, V144, P97, DOI 10.3354/meps144097; DAYTON PK, 1971, ECOL MONOGR, V41, P351, DOI 10.2307/1948498; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; ESRI, 2011, ARCGIS DESKT REL 10; Frandsen RP, 2002, MAR BIOL, V141, P253, DOI 10.1007/s00227-002-0831-8; FRECHETTE M, 1989, LIMNOL OCEANOGR, V34, P19, DOI 10.4319/lo.1989.34.1.0019; FRECHETTE M, 1992, MAR ECOL PROG SER, V83, P55, DOI 10.3354/meps083055; Frechette Marcel, 1993, NATO ASI Series Series G Ecological Sciences, V33, P325; Gilek M, 2001, HYDROBIOLOGIA, V452, P59, DOI 10.1023/A:1011919826002; Gleason H.A., 1926, B TORREY BOT CLUB, V53, P7, DOI DOI 10.2307/2479933; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Gutt J, 2001, POLAR BIOL, V24, P553, DOI 10.1007/s003000100262; Harley CDG, 2003, LIMNOL OCEANOGR, V48, P1498, DOI 10.4319/lo.2003.48.4.1498; Hastie T., 2009, UNSUPERVISED LEARNIN; Helsinki Commission (HELCOM), 2008, MAN MAR MON COMBINE; Herkul K, 2006, OCEANOLOGIA, V48, P267; Hoffman JR, 2003, J PHYCOL, V39, P268, DOI 10.1046/j.1529-8817.2003.01111.x; Holmes KW, 2008, CONT SHELF RES, V28, P1800, DOI 10.1016/j.csr.2008.04.016; Holmes KW, 2007, AQUAT CONSERV, V17, P385, DOI 10.1002/aqc.772; Howard JK, 2003, J N AM BENTHOL SOC, V22, P63, DOI 10.2307/1467978; Huston M. A., 1994, BIOL DIVERSITY; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; INCZE LS, 1980, MAR BIOL, V57, P147, DOI 10.1007/BF00390733; Isaeus M., 2004, THESIS STOCKHOLM U S; Jarv L, 2011, ANN ZOOL FENN, V48, P129; JORGENSEN CB, 1990, MAR ECOL PROG SER, V64, P89, DOI 10.3354/meps064089; KAUTSKY H, 1990, MAR ECOL PROG SER, V60, P169, DOI 10.3354/meps060169; KAUTSKY L, 1989, VEGETATIO, V83, P259, DOI 10.1007/BF00031698; KAUTSKY N, 1987, MAR ECOL PROG SER, V38, P201, DOI 10.3354/meps038201; KAUTSKY N, 1982, MAR BIOL, V68, P117, DOI 10.1007/BF00397599; Kendrick GA, 2008, ECOGRAPHY, V31, P191, DOI 10.1111/j.0906-7590.2008.5252.x; Kiirikki M, 1996, EUR J PHYCOL, V31, P225, DOI 10.1080/09670269600651421; Kont A, 2007, BOREAL ENVIRON RES, V12, P653; Kotta J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063946; Kotta J, 2009, MAR ECOL-EVOL PERSP, V30, P56, DOI 10.1111/j.1439-0485.2009.00303.x; Leathwick JR, 2006, MAR ECOL PROG SER, V321, P267, DOI 10.3354/meps321267; Leichter JJ, 1997, J EXP MAR BIOL ECOL, V209, P293, DOI 10.1016/S0022-0981(96)02702-5; Littorin B, 1999, HYDROBIOLOGIA, V393, P211, DOI 10.1023/A:1003565602858; MacArthur R.H., 1969, POPULATION BIOL EVOL, P159; Menge BA, 2000, J EXP MAR BIOL ECOL, V250, P257, DOI 10.1016/S0022-0981(00)00200-8; Menge BA, 1997, P NATL ACAD SCI USA, V94, P14530, DOI 10.1073/pnas.94.26.14530; Menge BA, 2001, MARINE COMMUNITY ECOLOGY, P221; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; Norkko A, 2001, LIMNOL OCEANOGR, V46, P2067, DOI 10.4319/lo.2001.46.8.2067; Orviku K, 2003, J COASTAL RES, V19, P364; Pata MP, 2010, SORT-STAT OPER RES T, V34, P67; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; Remane A, 1971, BIOL BRACKISH WATER; Reynaud S, 2003, GLOBAL CHANGE BIOL, V9, P1660, DOI 10.1046/j.1365-2486.2003.00678.x; RIISGARD H U, 1991, Journal of Shellfish Research, V10, P29; Riisgard HU, 2013, HELGOLAND MAR RES, V67, P591, DOI 10.1007/s10152-013-0347-2; ROUGHGARDEN J, 1972, AM NAT, V106, P683, DOI 10.1086/282807; Saier B, 2002, HELGOLAND MAR RES, V56, P44, DOI 10.1007/s10152-001-0097-4; Sandman AN, 2013, ECOGRAPHY, V36, P354, DOI 10.1111/j.1600-0587.2012.07053.x; Saurel C, 2007, LIMNOL OCEANOGR, V52, P1919, DOI 10.4319/lo.2007.52.5.1919; SEED R, 1969, OECOLOGIA, V3, P317, DOI 10.1007/BF00390381; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Steffani CN, 2003, MAR ECOL PROG SER, V246, P197, DOI 10.3354/meps246197; Stuckas H, 2009, HEREDITY, V103, P146, DOI 10.1038/hdy.2009.37; SUCHANEK TH, 1978, J EXP MAR BIOL ECOL, V31, P105, DOI 10.1016/0022-0981(78)90139-9; Suchanek TH, 1997, BIOL BULL, V193, P187, DOI 10.2307/1542764; Team RC, 2013, R LANGUAGE ENV STAT; TEDENGREN M, 1986, OPHELIA, V25, P147, DOI 10.1080/00785326.1986.10429746; Underwood A.J., 1985, ECOLOGY ROCKY COASTS, P372; Underwood AJ, 2000, J EXP MAR BIOL ECOL, V250, P97, DOI 10.1016/S0022-0981(00)00181-7; UNDERWOOD AJ, 1989, TRENDS ECOL EVOL, V4, P16, DOI 10.1016/0169-5347(89)90008-6; VAINOLA R, 1991, BIOL J LINN SOC, V43, P127, DOI 10.1111/j.1095-8312.1991.tb00589.x; Wallin A, 2011, AQUAT BIOL, V12, P119, DOI 10.3354/ab00329; Westerbom M, 2006, MAR ECOL PROG SER, V306, P191, DOI 10.3354/meps306191; Westerbom M, 2002, MAR BIOL, V140, P991, DOI 10.1007/s00227-001-0765-6; Westerbom M, 2008, MAR BIOL, V153, P1153, DOI 10.1007/s00227-007-0886-7; Wilson KA, 2006, J GREAT LAKES RES, V32, P11, DOI 10.3394/0380-1330(2006)32[11:ROZMBQ]2.0.CO;2; Witman JD, 2001, MARINE COMMUNITY ECOLOGY, P339; Witman JD, 1998, ECOLOGY, V79, P2429, DOI 10.1890/0012-9658(1998)079[2429:LBRSAP]2.0.CO;2; WORCESTER SE, 1995, MAR ECOL PROG SER, V126, P223, DOI 10.3354/meps126223	107	13	13	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136949	10.1371/journal.pone.0136949	http://dx.doi.org/10.1371/journal.pone.0136949			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317668	Green Accepted, gold, Green Published			2022-12-26	WOS:000360299100182
J	Martinez-Ortiz, J; Aires-Da-Silva, AM; Lennert-Cody, CE; Maunder, MN				Martinez-Ortiz, Jimmy; Aires-da-Silva, Alexandre M.; Lennert-Cody, Cleridy E.; Maunder, Mark N.			The Ecuadorian Artisanal Fishery for Large Pelagics: Species Composition and Spatio-Temporal Dynamics	PLOS ONE			English	Article							DOLPHINFISH CORYPHAENA-HIPPURUS; ALOPIAS-PELAGICUS; THRESHER SHARK; STOCK STATUS; PACIFIC; REPRODUCTION; POPULATIONS; INDICATORS; BIOLOGY; CATCH	The artisanal fisheries of Ecuador operate within one of the most dynamic and productive marine ecosystems of the world. This study investigates the catch composition of the Ecuadorian artisanal fishery for large pelagic fishes, including aspects of its spatio-temporal dynamics. The analyses of this study are based on the most extensive dataset available to date for this fishery: a total of 106,963 trip-landing inspection records collected at its five principal ports during 2008. 2012. Ecuadorian artisanal fisheries remove a substantial amount of biomass from the upper trophic-level predatory fish community of the eastern tropical Pacific Ocean. It is estimated that at least 135 thousand metric tons (mt) (about 15.5 million fish) were landed in the five principal ports during the study period. The great novelty of Ecuadorian artisanal fisheries is the "oceanic-artisanal" fleet component, which consists of mother-ship (nodriza) boats with their towed fiber-glass skiffs (fibras) operating with pelagic longlines. This fleet has fully expanded into oceanic waters as far offshore as 100 degrees W, west of the Galapagos Archipelago. It is estimated that nodriza operations produce as much as 80% of the total catches of the artisanal fishery. The remainder is produced by independent fibras operating in inshore waters with pelagic longlines and/or surface gillnets. A multivariate regression tree analysis was used to investigate spatio-environmental effects on the nodriza fleet (n = 6,821 trips). The catch species composition of the nodriza fleet is strongly influenced by the northwesterly circulation of the Humboldt Current along the coast of Peru and its associated cold waters masses. The target species and longline gear-type used by nodrizas change seasonally with the incursion of cool waters (< 25 degrees C) from the south and offshore. During this season, dolphinfish (Coryphaena hippurus) dominates the catches. However, in warmer waters, the fishery changes to tuna-billfish-shark longline gear and the catch composition becomes much more diverse.	[Martinez-Ortiz, Jimmy] Subsecretaria Recursos Pesqueros Viceministerio A, Manta, Manabi, Ecuador; [Aires-da-Silva, Alexandre M.; Lennert-Cody, Cleridy E.; Maunder, Mark N.] Inter Amer Trop Tuna Commiss, La Jolla, CA 92037 USA		Aires-Da-Silva, AM (corresponding author), Inter Amer Trop Tuna Commiss, La Jolla, CA 92037 USA.	alexdasilva@iattc.org						Aires-da-Silva A, 2014, STOCK ASSESSMENT REP, V15, P118; Arrizabalaga H, 2011, AQUAT LIVING RESOUR, V24, P1, DOI 10.1051/alr/2011007; Bentley N, 2015, ICES J MAR SCI, V72, P186, DOI 10.1093/icesjms/fsu023; Bobadilla-Jimenez M, 2007, THESIS CTR INVESTIGA, P83; BRANSTETTER S, 1990, NOAA Technical Report NMFS, P17; Bustamante C, 2013, FISH RES, V143, P174, DOI 10.1016/j.fishres.2013.02.007; Caetano N. BR, 2012, ACTA AGRON, P30; Cardenosa D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110193; Carruthers TR, 2014, FISH RES, V153, P48, DOI 10.1016/j.fishres.2013.12.014; Castro R, 1997, 9243 UEVECEP ALA TRA, P132; Castro R, 1993, B CIENT TEC I NAC PE, V12, P67; Cortes Enric, 2008, Fish and Aquatic Resources Series, V13, P309; Dapp D, 2013, J EXP MAR BIOL ECOL, V448, P228, DOI 10.1016/j.jembe.2013.07.014; De'Ath G, 2002, ECOLOGY, V83, P1105, DOI 10.2307/3071917; Diaz-Jaimes P, 2010, MOL PHYLOGENET EVOL, V57, P1209, DOI 10.1016/j.ympev.2010.10.005; Diaz-Jaimes P, 2006, FISH RES, V80, P333, DOI 10.1016/j.fishres.2006.04.015; Doherty PD, 2014, ECOL EVOL, V4, P2375, DOI 10.1002/ece3.1104; Efron B, 1993, INTRO BOOTSTRAP, DOI [DOI 10.1007/978-1-4899-4541-9, 10.1007/978-1-4899-4541-9]; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Fallows JA, 1990, INTERNAL REPORT, P15; FAO, 2012, AN EST PESC CUADR RE; Gallagher AJ, 2012, J FISH BIOL, V80, P1727, DOI 10.1111/j.1095-8649.2012.03235.x; Geromont HF, 2015, ICES J MAR SCI, V72, P251, DOI 10.1093/icesjms/fst232; Goicochea C, 2012, EDAD CRECIMIENTO COR, V39, P34; Herdson DW, 1985, B CIENT TECN I NAC P, V8, P1; Herrera M, 2013, B ESPEC I NAC PESCA, V1, P328; Hinton Michael G., 2014, Inter-American Tropical Tuna Commission Stock Assessment Report, V15, P142; Hutchings JA, 2012, ECOL APPL, V22, P1061, DOI 10.1890/11-1313.1; IATTC, 2015, 1 INT TROP TUN COMM; Jimenez R, 1987, REV COM PERM PACIFIC, V16, P167; Jimenez R, 1984, REV COM PERM PACIFIC, V15, P269; Jimenez R, 2008, ASPECTOS BIOL NINO O, P330; Kessler WS, 2006, PROG OCEANOGR, V69, P181, DOI 10.1016/j.pocean.2006.03.009; Lasso J, 1999, SCI MAR, V63, P387, DOI 10.3989/scimar.1999.63n3-4387; Legendre L., 1998, NUMERICAL ECOLOGY, P852; Lehodey P, 1997, NATURE, V389, P715, DOI 10.1038/39575; Li B., 1984, BIOMETRICS, V40, P358, DOI [10.2307/2530946, DOI 10.1002/WIDM.8]; Liu KM, 1999, COPEIA, P68; Martinez-Ortiz J, 2012, TIBURONES OCEANO PAC, P49; Martinez-Ortiz J, 1991, PROYECTO EVALUACION, V11, P1; Martinez-Ortiz J, 2012, ESTADO ACTUAL CONOCI, P122; Martinez-Ortiz J, 2010, B TEC SRP MAGAP, P35; Maunder Mark N., 2014, Inter-American Tropical Tuna Commission Stock Assessment Report, V15, P40; Maunder MN, 2015, ICES J MAR SCI, V72, P7, DOI 10.1093/icesjms/fsu015; Ministerio de Comercio Exterior Industrializacion Pesca y Competitividad (MICIP), 2006, PLAN ACC NAC CONS MA, P44; Palko BJ, 1982, FAO FISHERIES SYNOPS, P32; Peralta M, 2003, I NAC PESCA ECUADOR, V3, P51; Peralta M, 2003, I NAC PESCA ECUADOR, V3, P21; Philander S.G, 1989, NINO NINA SO OSCILLA, V46; R Core Team, 2018, R LANG ENV STAT COMP; Rocha-Olivares A, 2006, CIENC MAR, V32, P569, DOI 10.7773/cm.v32i3.1122; Romero-Caicedo AF, 2014, J MAR BIOL ASSOC UK, V94, P1501, DOI 10.1017/S0025315414000927; Rosales- Morales A, 2007, THESIS U MAR PUERTO, P69; SOLANO-SARE A., 2008, BIOL PESQUERIA PERIC; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Tsai WP, 2010, MAR FRESHWATER RES, V61, P1056, DOI 10.1071/MF09303; Wessells C. R., 2001, FAO Fisheries Technical Paper; WOOSTER WS, 1969, DEEP-SEA RES, VS, P407; WYRTKI K, 1981, J PHYS OCEANOGR, V11, P1205, DOI 10.1175/1520-0485(1981)011<1205:AEOEUI>2.0.CO;2; Zuniga-Flores MS, 2012, DETERMINACION INTERP, P73	60	60	61	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135136	10.1371/journal.pone.0135136	http://dx.doi.org/10.1371/journal.pone.0135136			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317751	Green Published, gold, Green Submitted			2022-12-26	WOS:000360299100023
J	van der Maaten, E; van der Maaten-Theunissen, M; Buras, A; Scharnweber, T; Simard, S; Kaiser, K; Lorenz, S; Wilmking, M				van der Maaten, Ernst; van der Maaten-Theunissen, Marieke; Buras, Allan; Scharnweber, Tobias; Simard, Sonia; Kaiser, Knut; Lorenz, Sebastian; Wilmking, Martin			Can We Use Tree Rings of Black Alder to Reconstruct Lake Levels? A Case Study for the Mecklenburg Lake District, Northeastern Germany	PLOS ONE			English	Article							CENTRAL-EUROPE; ALNUS-GLUTINOSA; DROUGHT; VARIABILITY; ANATOMY; SALT; FLOW	In this study, we explore the potential to reconstruct lake-level (and groundwater) fluctuations from tree-ring chronologies of black alder (Alnus glutinosa L.) for three study lakes in the Mecklenburg Lake District, northeastern Germany. As gauging records for lakes in this region are generally short, long-term reconstructions of lake-level fluctuations could provide valuable information on past hydrological conditions, which, in turn, are useful to assess dynamics of climate and landscape evolution. We selected black alder as our study species as alder typically thrives as riparian vegetation along lakeshores. For the study lakes, we tested whether a regional signal in lake-level fluctuations and in the growth of alder exists that could be used for long-term regional hydrological reconstructions, but found that local (i.e. site-specific) signals in lake level and tree-ring chronologies prevailed. Hence, we built lake/ground-water-level reconstruction models for the three study lakes individually. Two sets of models were considered based on (1) local tree-ring series of black alder, and (2) site-specific Standardized Precipitation Evapotranspiration Indices (SPEI). Although the SPEI-based models performed statistically well, we critically reflect on the reliability of these reconstructions, as SPEI cannot account for human influence. Tree-ring based reconstruction models, on the other hand, performed poor. Combined, our results suggest that, for our study area, long-term regional reconstructions of lake-level fluctuations that consider both recent and ancient (e.g., archaeological) wood of black alder seem extremely challenging, if not impossible.	[van der Maaten, Ernst; van der Maaten-Theunissen, Marieke; Buras, Allan; Scharnweber, Tobias; Wilmking, Martin] Ernst Moritz Arndt Univ Greifswald, Inst Bot & Landscape Ecol, Greifswald, Germany; [Simard, Sonia] GFZ German Res Ctr Geosci, Climate Dynam & Landscape Evolut, Potsdam, Germany; [Kaiser, Knut] GFZ German Res Ctr Geosci, Staff Sci Execut Board, Potsdam, Germany; [Lorenz, Sebastian] Ernst Moritz Arndt Univ Greifswald, Inst Geog & Geol, Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; Ernst Moritz Arndt Universitat Greifswald	van der Maaten, E (corresponding author), Ernst Moritz Arndt Univ Greifswald, Inst Bot & Landscape Ecol, Greifswald, Germany.	ernst.vandermaaten@uni-greifswald.de	Wilmking, Martin/AAV-9310-2020; Buras, Allan/B-1412-2012	Wilmking, Martin/0000-0003-4964-2402; van der Maaten, Ernst/0000-0002-5218-6682; Kaiser, Knut/0000-0002-5080-6075; Buras, Allan/0000-0003-2179-0681; Scharnweber, Tobias/0000-0002-4933-5296; Lorenz, Sebastian/0000-0001-9679-5984; van der Maaten-Theunissen, Marieke/0000-0002-2942-9180	Virtual Institute of Integrated Climate and Landscape Evolution Analysis - ICLEA [VH-VI-415]	Virtual Institute of Integrated Climate and Landscape Evolution Analysis - ICLEA	This study is a contribution to the Virtual Institute of Integrated Climate and Landscape Evolution Analysis - ICLEA - (grant no. VH-VI-415) and to the Terrestrial Environmental Observatories project - TERENO - of the Helmholtz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian R, 2009, LIMNOL OCEANOGR, V54, P2283, DOI 10.4319/lo.2009.54.6_part_2.2283; Argyilan EP, 2003, J GREAT LAKES RES, V29, P488, DOI 10.1016/S0380-1330(03)70453-5; Auguie B, 2017, GRIDEXTRA MISCELLANE; Ballesteros JA, 2010, TREE PHYSIOL, V30, P773, DOI 10.1093/treephys/tpq031; Begin Y, 2001, QUATERNARY RES, V55, P133, DOI 10.1006/qres.2000.2203; Buntgen U, 2011, SCIENCE, V331, P578, DOI 10.1126/science.1197175; Cook E. R., 1981, Tree-Ring Bulletin, V41, P45; Crone A., 2014, J WETLAND ARCHAEOLOG, V14, P22, DOI 10.1179/1473297114Z.0000000007; Danis PA, 2006, EARTH PLANET SC LETT, V243, P439, DOI 10.1016/j.epsl.2006.01.023; Dearing J. A., 1986, HDB HOLOCENE PALAEOE, P67; DeRose RJ, 2014, HOLOCENE, V24, P805, DOI 10.1177/0959683614530441; Digerfeldt G., 1988, ROREAS, V17, P165, DOI DOI 10.1111/J.1502-3885.1988.TB00544.X; Elferts Didzis, 2011, Proceedings of the Latvian Academy of Sciences Section B Natural Exact and Applied Sciences, V65, P164, DOI 10.2478/v10046-011-0032-2; Fritts H. C., 1976, TREE RINGS CLIMATE; Grunewald U., 2012, WASSERBEZOGENE ANPAS, P148; Hacke U, 1996, PLANT PHYSIOL, V111, P413, DOI 10.1104/pp.111.2.413; Holzhauser H, 2005, HOLOCENE, V15, P789, DOI 10.1191/0959683605hl853ra; Kaiser K, 2012, SYSTEM ERDE, V2, P62; Kaiser K, 2015, J HYDROL, V529, P584, DOI 10.1016/j.jhydrol.2014.12.057; Kaiser K, 2014, REG ENVIRON CHANGE, V14, P1587, DOI 10.1007/s10113-014-0600-5; Kaiser K, 2014, GEOMORPHOLOGY, V216, P58, DOI 10.1016/j.geomorph.2014.03.025; Kleppe JA, 2011, QUATERNARY SCI REV, V30, P3269, DOI 10.1016/j.quascirev.2011.08.015; Kozlowski T.T., 1997, GROWTH CONTROL WOODY, P352; Laanis J, 2008, ECOL MODEL, V215, P180, DOI 10.1016/j.ecolmodel.2008.02.018; Liang W, 2013, TREE PHYSIOL, V33, P833, DOI 10.1093/treephys/tpt059; Lorenz S, 2010, AKTUELLE PROBLEME, P133; Lorenz S., 2007, THESIS U GREIFSWALD; MCVEAN DN, 1953, J ECOL, V41, P447, DOI 10.2307/2257070; Meko D. M., 2006, Canadian Water Resources Journal, V31, P229; Meko DM, 2001, J AM WATER RESOUR AS, V37, P1029, DOI 10.1111/j.1752-1688.2001.tb05530.x; Nicault A, 2014, J HYDROL, V513, P435, DOI 10.1016/j.jhydrol.2014.03.054; Owen LA, 2006, QUATERN INT, V154, P73, DOI 10.1016/j.quaint.2006.02.008; Perez-Valdivia C, 2011, DENDROCHRONOLOGIA, V29, P41, DOI 10.1016/j.dendro.2010.09.001; Quinn FH, 2006, J GREAT LAKES RES, V32, P29, DOI 10.3394/0380-1330(2006)32[29:AROLMW]2.0.CO;2; Rodriguez-Gonzalez PM, 2014, PLANT ECOL, V215, P233, DOI 10.1007/s11258-013-0292-9; Scheidegger Y, 2000, OECOLOGIA, V125, P350, DOI 10.1007/s004420000466; SMITH LP, 1981, WATER RESOUR BULL, V17, P939; Vicente-Serrano, 2013, SPEI CALCULATION STA; Vicente-Serrano SM, 2013, P NATL ACAD SCI USA, V110, P52, DOI 10.1073/pnas.1207068110; Vicente-Serrano SM, 2010, J CLIMATE, V23, P1696, DOI 10.1175/2009JCLI2909.1; Webster KE, 2000, FRESHWATER BIOL, V43, P499, DOI 10.1046/j.1365-2427.2000.00571.x; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Wiles GC, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037164	43	5	5	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137054	10.1371/journal.pone.0137054	http://dx.doi.org/10.1371/journal.pone.0137054			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317768	Green Published, gold, Green Submitted			2022-12-26	WOS:000360299100199
J	Chan, T; de Lusignan, S; Cooper, A; Elliott, M				Chan, Tom; de Lusignan, Simon; Cooper, Alun; Elliott, Mary			Improving Osteoporosis Management in Primary Care: An Audit of the Impact of a Community Based Fracture Liaison Nurse	PLOS ONE			English	Article							PRACTICE COMPUTER RECORDS; SECONDARY PREVENTION; POSTMENOPAUSAL WOMEN; FRAGILITY FRACTURES; SOCIAL DEPRIVATION; OLDER-PEOPLE; UK; FALLS; LESSONS; QUALITY	Background Osteoporosis and associated fragility fractures are a major health problem; they are more common in women over 50 years old. Fracture liaison nurses have been widely used in secondary care to promote the recognition of fragility fractures and to promote the use of bone-sparing medication to reduce the risk of recurrent facture. Objective Audit the impact of a primary care based fracture liaison nurse on the detection of fragility fractures in people with osteoporosis and their treatment with a bone-sparing medication. Method This audit took place in 12 GP practices using 'before and after' cross-sectional extractions of anonymised routine data. We report, for females 50-74 years and >= 75 years old, socioeconomic deprivation index, the prevalence of osteoporosis, recording of fragility fractures, dual-energy X-ray absorptiometry (DXA), smoking, and body-mass index (BMI) and use of appropriate bone-sparing medication. We used Altman's test of independent proportions to compare before and after data. Results Recording of the diagnosis of osteoporosis increased from 1.5% to 1.7% (p = 0.059); the rate of DXA scans fell (1.8% to 1.4%; p = 0.002); recording of fractures and fragility fractures more than doubled (0.8% to 2.0%; p<0.001 and 0.5% to 1.5%; p<0.001, respectively) with approximate doubling of the recording of smoking, and BMI (p<0.001 level). Fragility fracture recording rose from 8.8% to 15% in females aged 50 to 74, and from 0.8% to 2.3% in people aged >= 75years old (p<0.001). There appeared to be inequity in the service, people who were least deprived were more likely to receive DXA scans and the more deprived to be prescribed bone sparing agents. Conclusion A fracture liaison nurse in primary care has been associated with a period of improved management. Liaison nurses based in different parts of the health system should be tested in a prospective trial.	[Chan, Tom; de Lusignan, Simon] Univ Surrey, Dept Hlth Care Policy & Management, Clin Informat, Guildford GU2 5XH, Surrey, England; [Cooper, Alun; Elliott, Mary] Bridge Med Ctr, Crawley, W Sussex, England	University of Surrey	Chan, T (corresponding author), Univ Surrey, Dept Hlth Care Policy & Management, Clin Informat, Guildford GU2 5XH, Surrey, England.	t.chan@surrey.ac.uk	de Lusignan, Smion/S-7838-2019	de Lusignan, Smion/0000-0002-8553-2641	Crawley Practice Based Commissioning (PBC) group	Crawley Practice Based Commissioning (PBC) group	Crawley Practice Based Commissioning (PBC) group funded the audit.	Altman DG, 1990, PRACTICAL STAT MED R, P234; [Anonymous], 2007, SUMM M REP WHO SCI G; [Anonymous], IR MED J; Chakravarthy J, 2008, INT J CLIN PRACT, V62, P382, DOI 10.1111/j.1742-1241.2007.01662.x; Charalambous CP, 2009, ANN ROY COLL SURG, V91, P596, DOI 10.1308/003588409X432400; Compston J, 2009, MATURITAS, V62, P105, DOI 10.1016/j.maturitas.2008.11.022; Compston JE, 2006, LANCET, V368, P973, DOI 10.1016/S0140-6736(06)69394-X; Cooper A, 2002, BRIT J GEN PRACT, V52, P311; Court-Brown CM, 2011, OSTEOPOROSIS INT, V22, P1211, DOI 10.1007/s00198-010-1315-1; Crandall CJ, 2012, OSTEOPOROSIS INT, V23, P1503, DOI 10.1007/s00198-011-1736-5; De Laet C, 2005, OSTEOPOROSIS INT, V16, P1330, DOI 10.1007/s00198-005-1863-y; de Lusignan S, 2006, FAM PRACT, V23, P253, DOI 10.1093/fampra/cmi106; de Lusignan S, 2005, PUBLIC HEALTH, V119, P771, DOI 10.1016/j.puhe.2004.10.018; de Lusignan S, 2011, Yearb Med Inform, V6, P112; de Lusignan S, 2003, PUBLIC HEALTH, V117, P438, DOI 10.1016/S0033-3506(03)00129-X; de Lusignan Simon, 2006, Inform Prim Care, V14, P59; de Lusignan S, 2007, INT J MED INFORM, V76, P261, DOI 10.1016/j.ijmedinf.2005.11.003; de Lusignan Simon, 2004, Inform Prim Care, V12, P147; de Lusignan Simon, 2005, Inform Prim Care, V13, P65; de Lusignan Simon, 2011, Inform Prim Care, V19, P127; de Lusignan S, 2011, FAM PRACT, V28, P638, DOI 10.1093/fampra/cmr036; de Lusignan S, 2008, J AMBUL CARE MANAG, V31, P201, DOI 10.1097/01.JAC.0000324664.88131.d2; de Lusignan Simon, 2006, Inform Prim Care, V14, P153; Department for Communities and Local Government, 2011, ENGL IND DEPR 2010; Department of Health, 2004, QUAL OUTC FRAM GUID; Department of Health, 2003, INV GEN PRACT NEW GE; Flicker L, 2005, J AM GERIATR SOC, V53, P1881, DOI 10.1111/j.1532-5415.2005.00468.x; Goldhahn J, 2010, BONE, V46, P267, DOI 10.1016/j.bone.2009.10.004; Gormley KJ, 2011, INT J OLDER PEOPLE N, V6, P307, DOI 10.1111/j.1748-3743.2011.00303.x; Gray Sarah, 2012, Menopause Int, V18, P30, DOI 10.1258/mi.2012.012002; Harvey M, 2002, BRIT J GEN PRACT, V52, P496; Iki Masayuki, 2005, Clin Calcium, V15, P156; Ip TP, 2010, OSTEOPOROSIS INT, V21, pS605, DOI 10.1007/s00198-010-1398-8; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P1395, DOI 10.1007/s00198-008-0712-1; Larsson S, 2007, INJURY, V38, P1225, DOI 10.1016/j.injury.2007.09.004; Mercer SW, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4152; Michalakidis G, 2010, STUD HEALTH TECHNOL, V160, P724, DOI 10.3233/978-1-60750-588-4-724; Murray J, 2010, FAM PRACT, V27, P430, DOI 10.1093/fampra/cmq030; National Institute for Health and Care Excellence (NICE) Centre for Clinical Practice, 2013, NICE CLIN GUID; National Institute for Health and Clinical Excellence (NICE), 2008, COST REP TECHN APPR; National Osteoporosis Society (NOS), OST DIR ENH SERV DES; National Research Authority, NAT RES ETH SERV NRE; Neyens JC, 2011, J AM MED DIR ASSOC, V12, P410, DOI 10.1016/j.jamda.2010.07.018; NICE, 2008, AL ET RIS RAL STRONT; NOS (National Osteoporosis Society), 2013, VIT D BON HLTH PRACT; Office for National Statistics, 2003, CENS 2001 S; Oliver D, 2009, ARCH GERONTOL GERIAT, V49, pS7, DOI 10.1016/S0167-4943(09)70005-6; Pearson D, 2004, OSTEOPOROSIS INT, V15, P132, DOI 10.1007/s00198-003-1499-8; Prasad N, 2006, ANN ROY COLL SURG, V88, P470, DOI 10.1308/003588406X116891; Schade CP, 2006, J AM MED INFORM ASSN, V13, P470, DOI 10.1197/jamia.M2041; van Vlymen J, 2005, STUD HEALTH TECHNOL, V116, P1010	51	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0132146	10.1371/journal.pone.0132146	http://dx.doi.org/10.1371/journal.pone.0132146			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP8KZ	26313924	Green Published, Green Submitted, gold			2022-12-26	WOS:000360144000004
J	Pedroza, M; Le, TT; Lewis, K; Karmouty-Quintana, H; To, S; George, AT; Blackburn, MR; Tweardy, DJ; Agarwal, SK				Pedroza, Mesias; Le, Thuy T.; Lewis, Katherine; Karmouty-Quintana, Harry; To, Sarah; George, Anuh T.; Blackburn, Michael R.; Tweardy, David J.; Agarwal, Sandeep K.			STAT-3 contributes to pulmonary fibrosis through epithelial injury and fibroblast-myofibroblast differentiation	FASEB JOURNAL			English	Article						fibrosis; STAT3; epithelial injury; myofibroblast	GROWTH-FACTOR-BETA; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; MESENCHYMAL INTERACTIONS; POTENTIAL ROLE; INTERLEUKIN-6; IL-6; ACTIVATION; EXPRESSION; MICE; INFLAMMATION	Lung fibrosis is the hallmark of the interstitial lung diseases. Alveolar epithelial cell (AEC) injury is a key step that contributes to a profibrotic microenvironment. Fibroblasts and myofibroblasts subsequently accumulate and deposit excessive extracellular matrix. In addition to TGF-beta, the IL-6 family of cytokines, which signal through STAT-3, may also contribute to lung fibrosis. In the current manuscript, the extent to which STAT-3 inhibition decreases lung fibrosis is investigated. Phosphorylated STAT-3 was elevated in lung biopsies from patients with idiopathic pulmonary fibrosis and bleomycin (BLM)-induced fibrotic murine lungs. C-188-9, a small molecule STAT-3 inhibitor, decreased pulmonary fibrosis in the intraperitoneal BLM model as assessed by arterial oxygen saturation (control, 84.4 +/- 1.3%; C-188-9, 94.4 +/- 0.8%), histology (Ashcroft score: untreated, 5.4 +/- 0.25; C-188-9, 3.3 +/- 0.14), and attenuated fibrotic markers such as diminished alpha-smooth muscle actin, reduced collagen deposition. In addition, C-188-9 decreased the expression of epithelial injury markers, including hypoxia-inducible factor-1 alpha (HIF-1 alpha) and plasminogen activator inhibitor-1 (PAI-1). In vitro studies show that inhibition of STAT-3 decreased IL-6- and TGF-beta-induced expression of multiple genes, including HIF-1 alpha and PAI-1, in AECs. Furthermore, C-188-9 decreased fibroblast-to-myofibroblast differentiation. Finally, TGF-beta stimulation of lung fibroblasts resulted in SMAD2/SMAD3-dependent phosphorylation of STAT-3. These findings demonstrate that STAT-3 contributes to the development of lung fibrosis and suggest that STAT-3 may be a therapeutic target in pulmonary fibrosis.	[Pedroza, Mesias; To, Sarah; George, Anuh T.; Agarwal, Sandeep K.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Lewis, Katherine; Tweardy, David J.] Baylor Coll Med, Dept Infect Dis, Houston, TX 77030 USA; [Le, Thuy T.; Karmouty-Quintana, Harry; Blackburn, Michael R.] Univ Texas Hlth Sci Ctr Houston, Houston Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Agarwal, SK (corresponding author), Biol Inflammat Ctr, Dept Pathol & Immunol, Dept Med, Sect Immunol Allergy & Rheumatol, One Baylor Plaza,Suite 672E,MS BCM285, Houston, TX 77030 USA.	skagarwa@bcm.edu	Tweardy, David/L-3929-2019; Karmouty-Quintana, Harry/ABC-9144-2020	Karmouty-Quintana, Harry/0000-0003-4753-9823; Blackburn, Michael/0000-0002-1394-9966	U.S. Department of Defense, Peer Reviewed Medical Research Program Grant [W81XWH-12-1-0516]; U.S. National Institutes of Health [R01AR062056, K08AR054404, 2T32AI053831-11A1]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL114457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI053831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062056, K08AR054404] Funding Source: NIH RePORTER	U.S. Department of Defense, Peer Reviewed Medical Research Program Grant; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the U.S. Department of Defense, Peer Reviewed Medical Research Program Grant W81XWH-12-1-0516 (to M.P. and S.K.A.), and U.S. National Institutes of Health Grants R01AR062056 (to S.K.A., S.T., and A.T.G.), K08AR054404 (to S.K.A.), and 2T32AI053831-11A1 (to M.P.).	ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Ataie-Kachoie P, 2014, J CLIN PATHOL, V67, P932, DOI 10.1136/jclinpath-2014-202493; Baran CP, 2007, AM J RESP CRIT CARE, V176, P78, DOI 10.1164/rccm.200609-1279OC; Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Borok Z, 2014, AM J RESP CELL MOL, V50, P853, DOI 10.1165/rcmb.2014-0089PS; Chapman HA, 2011, ANNU REV PHYSIOL, V73, P413, DOI 10.1146/annurev-physiol-012110-142225; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; COULTAS DB, 1994, AM J RESP CRIT CARE, V150, P967, DOI 10.1164/ajrccm.150.4.7921471; Dai B, 2013, CELL PHYSIOL BIOCHEM, V32, P960, DOI 10.1159/000354499; Dave B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030207; Degryse AL, 2010, AM J PHYSIOL-LUNG C, V299, pL442, DOI 10.1152/ajplung.00026.2010; Deng PY, 2013, BIOL PHARM BULL, V36, P1540, DOI 10.1248/bpb.b13-00235; Dong ZX, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0012-4; Eitzman DT, 1996, J CLIN INVEST, V97, P232, DOI 10.1172/JCI118396; ELIAS JA, 1991, J IMMUNOL, V146, P3437; Fernandez-Perez ER, 2010, CHEST, V137, P242, DOI [10.1378/chest.09-1002, 10.1378/chest.09-1871]; Gao SY, 2014, LIFE SCI, V114, P20, DOI 10.1016/j.lfs.2014.07.037; Garcia-Prieto E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013242; Gourh P, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2821; Hattori N, 2000, J CLIN INVEST, V106, P1341, DOI 10.1172/JCI10531; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Horowitz JC, 2006, SEMIN RESP CRIT CARE, V27, P600, DOI 10.1055/s-2006-957332; Huebner RH, 2008, BIOTECHNIQUES, V44, P507, DOI 10.2144/000112729; Jenkins BJ, 2005, NAT MED, V11, P845, DOI 10.1038/nm1282; Kasembeli MM, 2009, FRONT BIOSCI-LANDMRK, V14, P1010, DOI 10.2741/3292; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; KISHIMOTO T, 1995, BLOOD, V86, P1243, DOI 10.1182/blood.V86.4.1243.bloodjournal8641243; Le TTT, 2014, J IMMUNOL, V193, P3755, DOI 10.4049/jimmunol.1302470; Lee AS, 2014, RESP MED, V108, P955, DOI 10.1016/j.rmed.2014.03.015; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Liu Y, 2013, J BIOL CHEM, V288, P30708, DOI 10.1074/jbc.M113.478685; Lynch J.P., 1998, FISHMANS PULMONARY D, P1069; Ma XQ, 2013, AFR J TRADIT COMPLEM, V10, P442, DOI 10.4314/ajtcam.v10i3.10; Mair M, 2010, GASTROENTEROLOGY, V138, P2499, DOI 10.1053/j.gastro.2010.02.049; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Moodley YP, 2003, AM J PATHOL, V163, P345, DOI 10.1016/S0002-9440(10)63658-9; Mozaffarian A, 2008, J IMMUNOL, V181, P7243, DOI 10.4049/jimmunol.181.10.7243; Namba T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027296; O'Donoghue RJJ, 2012, EMBO MOL MED, V4, P939, DOI 10.1002/emmm.201100604; Ogata H, 2006, ONCOGENE, V25, P2520, DOI 10.1038/sj.onc.1209281; Olson AL, 2007, AM J RESP CRIT CARE, V176, P277, DOI 10.1164/rccm.200701-044OC; PANOS RJ, 1990, AM J MED, V88, P396, DOI 10.1016/0002-9343(90)90495-Y; Pechkovsky DV, 2012, AM J PATHOL, V180, P1398, DOI 10.1016/j.ajpath.2011.12.022; Pedroza M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022667; Pinart M, 2009, RESP PHYSIOL NEUROBI, V166, P41, DOI 10.1016/j.resp.2009.01.002; Redell MS, 2011, BLOOD, V117, P5701, DOI 10.1182/blood-2010-04-280123; Rochester CL, 1996, J IMMUNOL, V156, P4449; Saito F, 2008, AM J RESP CELL MOL, V38, P566, DOI 10.1165/rcmb.2007-0299OC; Schneider DJ, 2012, FASEB J, V26, P503, DOI 10.1096/fj.11-186098; Seluanov Andrei, 2010, J Vis Exp, DOI 10.3791/2033; Sheppard D, 2001, J CLIN INVEST, V107, P1501, DOI 10.1172/JCI13318; Shigekawa M, 2011, BIOCHEM BIOPH RES CO, V406, P614, DOI 10.1016/j.bbrc.2011.02.105; Tanaka KI, 2010, BIOCHEM PHARMACOL, V80, P920, DOI 10.1016/j.bcp.2010.05.025; Tang WL, 1996, J CLIN INVEST, V98, P2845, DOI 10.1172/JCI119113; Tanjore H, 2009, AM J RESP CRIT CARE, V180, P657, DOI 10.1164/rccm.200903-0322OC; Tzouvelekis A, 2007, AM J RESP CRIT CARE, V176, P1108, DOI 10.1164/rccm.200705-683OC; Ueno M, 2011, AM J PHYSIOL-LUNG C, V300, pL740, DOI 10.1152/ajplung.00146.2010; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Xu CP, 2015, J PROTEOMICS, V114, P234, DOI 10.1016/j.jprot.2014.11.002; Xu XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004783; Yamamoto T, 2001, FEBS LETT, V492, P247, DOI 10.1016/S0014-5793(01)02258-X; Zhang LP, 2013, CELL METAB, V18, P368, DOI 10.1016/j.cmet.2013.07.012; Zhong HY, 2005, AM J RESP CELL MOL, V32, P2, DOI 10.1165/rcmb.2004-0103OC; Zhou X, 2015, J CELL MOL MED, V19, P1103, DOI 10.1111/jcmm.12506; Zhou Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009224	67	97	100	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					129	140		10.1096/fj.15-273953	http://dx.doi.org/10.1096/fj.15-273953			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26324850	Green Published			2022-12-26	WOS:000367621000015
J	Yang, X; Chang, HR; Yin, YW				Yang, Xu; Chang, Hae Ryung; Yin, Y. Whitney			Yeast Mitochondrial Transcription Factor Mtf1 Determines the Precision of Promoter-Directed Initiation of RNA Polymerase Rpo41	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; SPECIFICITY FACTOR; STRUCTURAL BASIS; GENE-EXPRESSION; TERMINAL DOMAIN; RIBOSOMAL-RNA; DNA; RECOGNITION; MECHANISM; COMPLEX	Despite their clear T7-bacteriophage origin, mitochondrial RNA polymerases have evolved to require transcription factors. All mitochondrial polymerases contain an extra N-terminal domain that has no counterpart in the self-proficient phage enzyme, which is therefore hypothesized to interact with transcription factors. We studied a series of N-terminal deletion mutants of yeast mitochondrial RNA polymerase, Rpo41, and have found that the N-terminal region does not abolish the effects of Mtf1; rather it contributes directly to enzyme catalysis. Mtf1 can rescue the defective Rpo41 enzymes resulted from N-terminal domain deletions. Although Rpo41 appears to have retained all promoter recognition elements found in T7 RNAP, the elements are not independently functional, and Mtf1 is necessary and sufficient for holoenzyme promoter-directed transcription activity.	[Yang, Xu; Chang, Hae Ryung] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Yin, Y. Whitney] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Sealy Ctr Struct Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Medical Branch Galveston	Yin, YW (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, Sealy Ctr Struct Biol, Galveston, TX 77555 USA.	ywyin@utmb.edu			National Institutes of Health [GM083703]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083703, R01GM110591] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by National Institutes of Health Grant GM083703.	BISWAS TK, 1985, P NATL ACAD SCI USA, V82, P1954, DOI 10.1073/pnas.82.7.1954; Bryan AC, 2002, GENETICS, V160, P75; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Cheetham GMT, 1998, COLD SPRING HARB SYM, V63, P263, DOI 10.1101/sqb.1998.63.263; Cliften PF, 1997, GENE DEV, V11, P2897, DOI 10.1101/gad.11.21.2897; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Fuste JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021; Karlok MA, 2002, J BIOL CHEM, V277, P28143, DOI 10.1074/jbc.M204123200; Kravchenko JE, 2005, NATURE, V436, P735, DOI 10.1038/nature03848; Litonin D, 2010, J BIOL CHEM, V285, P18129, DOI 10.1074/jbc.C110.128918; MANGUS DA, 1994, J BIOL CHEM, V269, P26568; Matsunaga M, 2004, J BIOL CHEM, V279, P44239, DOI 10.1074/jbc.C400384200; Matsunaga M, 2004, PROTEIN EXPRES PURIF, V35, P126, DOI 10.1016/j.pep.2003.12.022; Matsushima Y, 2005, J BIOL CHEM, V280, P16815, DOI 10.1074/jbc.M500569200; McCulloch V, 2002, MOL CELL BIOL, V22, P1116, DOI 10.1128/MCB.22.4.1116-1125.2002; Nayak D, 2009, J BIOL CHEM, V284, P13641, DOI 10.1074/jbc.M900718200; Paratkar S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.228023; Paratkar S, 2010, J BIOL CHEM, V285, P3949, DOI 10.1074/jbc.M109.050732; Savkina M, 2010, J BIOL CHEM, V285, P3957, DOI 10.1074/jbc.M109.051003; SCHINKEL AH, 1986, EMBO J, V5, P1041, DOI 10.1002/j.1460-2075.1986.tb04320.x; SCHINKEL AH, 1988, EMBO J, V7, P3255, DOI 10.1002/j.1460-2075.1988.tb03192.x; Schubot FD, 2001, PROTEIN SCI, V10, P1980, DOI 10.1110/ps.11201; Seidel-Rogol BL, 2003, NAT GENET, V33, P23, DOI 10.1038/ng1064; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Tang GQ, 2009, J BIOL CHEM, V284, P5514, DOI 10.1074/jbc.M807880200; Wang YH, 1999, P NATL ACAD SCI USA, V96, P8046, DOI 10.1073/pnas.96.14.8046; Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105; Westover KD, 2004, SCIENCE, V303, P1014, DOI 10.1126/science.1090839; WILCOXEN SE, 1988, J BIOL CHEM, V263, P12346; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464	31	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136879	10.1371/journal.pone.0136879	http://dx.doi.org/10.1371/journal.pone.0136879			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332125	gold, Green Submitted, Green Published			2022-12-26	WOS:000360613800077
J	Alam, M; Deng, XW; Philipson, C; Bassaganya-Riera, J; Bisset, K; Carbo, A; Eubank, S; Hontecillas, R; Hoops, S; Mei, YG; Abedi, V; Marathe, M				Alam, Maksudul; Deng, Xinwei; Philipson, Casandra; Bassaganya-Riera, Josep; Bisset, Keith; Carbo, Adria; Eubank, Stephen; Hontecillas, Raquel; Hoops, Stefan; Mei, Yongguo; Abedi, Vida; Marathe, Madhav			Sensitivity Analysis of an ENteric Immunity SImulator (ENISI)-Based Model of Immune Responses to Helicobacter pylori Infection	PLOS ONE			English	Article							AGENT-BASED MODEL; IN-SILICO; INFLAMMATION; SYSTEMS	Agent-based models (ABM) are widely used to study immune systems, providing a procedural and interactive view of the underlying system. The interaction of components and the behavior of individual objects is described procedurally as a function of the internal states and the local interactions, which are often stochastic in nature. Such models typically have complex structures and consist of a large number of modeling parameters. Determining the key modeling parameters which govern the outcomes of the system is very challenging. Sensitivity analysis plays a vital role in quantifying the impact of modeling parameters in massively interacting systems, including large complex ABM. The high computational cost of executing simulations impedes running experiments with exhaustive parameter settings. Existing techniques of analyzing such a complex system typically focus on local sensitivity analysis, i.e. one parameter at a time, or a close "neighborhood" of particular parameter settings. However, such methods are not adequate to measure the uncertainty and sensitivity of parameters accurately because they overlook the global impacts of parameters on the system. In this article, we develop novel experimental design and analysis techniques to perform both global and local sensitivity analysis of large-scale ABMs. The proposed method can efficiently identify the most significant parameters and quantify their contributions to outcomes of the system. We demonstrate the proposed methodology for ENteric Immune SImulator (ENISI), a large-scale ABM environment, using a computational model of immune responses to Helicobacter pylori colonization of the gastric mucosa.	[Alam, Maksudul; Bisset, Keith; Eubank, Stephen; Marathe, Madhav] Virginia Tech, Network Dynam & Simulat Sci Lab, Virginia Bioinformat Inst, Blacksburg, VA USA; [Philipson, Casandra; Bassaganya-Riera, Josep; Carbo, Adria; Hontecillas, Raquel; Hoops, Stefan; Mei, Yongguo; Abedi, Vida] Virginia Tech, Nutr Immunol & Mol Med Lab, Virginia Bioinformat Inst, Blacksburg, VA USA; [Alam, Maksudul; Deng, Xinwei; Philipson, Casandra; Bassaganya-Riera, Josep; Bisset, Keith; Carbo, Adria; Eubank, Stephen; Hontecillas, Raquel; Hoops, Stefan; Mei, Yongguo; Abedi, Vida; Marathe, Madhav] Virginia Tech, Ctr Modeling Immun Enter Pathogens, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Bassaganya-Riera, Josep] Virginia Tech, Dept Biomed Sci & Pathobiol, Virginia Maryland Reg Coll Vet Med, Blacksburg, VA USA; [Alam, Maksudul; Marathe, Madhav] Virginia Tech, Dept Comp Sci, Blacksburg, VA USA; [Deng, Xinwei] Virginia Tech, Dept Stat, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Deng, XW (corresponding author), Virginia Tech, Ctr Modeling Immun Enter Pathogens, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA.	xdeng@vt.edu	Eubank, Stephen/AAD-5089-2021; Deng, Xinwei/AAH-8310-2021; Alam, Maksudul/Q-9238-2019; Philipson, Casandra/AAY-5746-2021; Eubank, Stephen/D-7497-2011	Deng, Xinwei/0000-0002-1560-2405; Alam, Maksudul/0000-0002-4941-463X; Eubank, Stephen/0000-0002-7177-309X; Abedi, Vida/0000-0001-7689-933X	Defense Threat Reduction Agency (DTRA)-RD (HPC) Award [HDTRA1-09-1-0017]; DTRA-Validation Award [HDTRA1-11-1-0016]; DTRA-Comprehensive National Incident Management System (CNIMS) Award [HDRTA1-11-D-0016-0001]; National Science Foundation (NSF) PetaApps Grant [OCI-0904844]; NSF Network Science and Engineering (NetSE) Grant [CNS-1011769]; NSF Software Development for Cyberinfrastructure (SDCI) Grant [OCI-1032677]; National Institutes of Health (NIH) MIDAS project [2U01GM070694-7]; National Institute of Allergy and Infectious Diseases (NIAID) NIH project [HHSN272201000056C]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070694] Funding Source: NIH RePORTER; Direct For Computer & Info Scie & Enginr [1032677] Funding Source: National Science Foundation	Defense Threat Reduction Agency (DTRA)-RD (HPC) Award; DTRA-Validation Award; DTRA-Comprehensive National Incident Management System (CNIMS) Award; National Science Foundation (NSF) PetaApps Grant(National Science Foundation (NSF)); NSF Network Science and Engineering (NetSE) Grant(National Science Foundation (NSF)); NSF Software Development for Cyberinfrastructure (SDCI) Grant(National Science Foundation (NSF)); National Institutes of Health (NIH) MIDAS project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID) NIH project; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work has been partially supported by Defense Threat Reduction Agency (DTRA)-R&D (HPC) Award No. HDTRA1-09-1-0017, DTRA-Validation Award No. HDTRA1-11-1-0016, DTRA-Comprehensive National Incident Management System (CNIMS) Award No. HDRTA1-11-D-0016-0001, National Science Foundation (NSF) PetaApps Grant OCI-0904844, NSF Network Science and Engineering (NetSE) Grant CNS-1011769, NSF Software Development for Cyberinfrastructure (SDCI) Grant OCI-1032677, National Institutes of Health (NIH) MIDAS project 2U01GM070694-7, and National Institute of Allergy and Infectious Diseases (NIAID) & NIH project HHSN272201000056C.	An G, 2006, J CRIT CARE, V21, P105, DOI 10.1016/j.jcrc.2005.11.012; An G, 2008, J BURN CARE RES; An G, 2001, SHOCK; An G, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-11; [Anonymous], 2003, USERS GUIDE BRAVE NE; Arwade SR, 2010, ENG STRUCT, V32, P1, DOI 10.1016/j.engstruct.2009.08.011; Baldazzi V, 2006, CELL IMMUNOL, V244, P77, DOI 10.1016/j.cellimm.2006.12.006; BARRETT C, 2008, SC 08; Barrett C, 2001, TRANSIMS TRANSPORTAT; Barrett CL, 2009, FUNDAMENTAL PROBLEMS; Barrett E, 2007, APPL ENVIRON MICROB, V73, P2333, DOI 10.1128/AEM.01855-06; Bassaganya-Riera J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050069; Bauer AL, 2009, INFORM SCIENCES, V179, P1379, DOI 10.1016/j.ins.2008.11.012; Bauer KW, 1999, J MULTICRITERIA DECI, DOI [10.1002/(SICI)1099-1360(199905)8:3%3C162::AID-MCDA241%3E3.3.CO;2-O, DOI 10.1002/(SICI)1099-1360(199905)8:3%3C162::AID-MCDA241%3E3.3.CO;2-O]; Bisset K, 2012, PAR DISTR PROC S IPD; Bonabeau E DdRDF, 1999, SWARM INTELLIGENCE N; Box G.E.P., 2005, STAT EXPT; Broeke GAT, 2014, SENSITIVITY ANAL AGE; Brooks RJ, 2001, EUROPEAN J AGRONOMY; Cacuci D.G, 2005, SENSITIVITY UNCERTAI; Carbo A, 2015, MOJ IMMUNOL; Carbo A, 2014, MBIO, V5, DOI 10.1128/mBio.01243-14; Carbo A, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00031; Carbo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073365; Carbo A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003027; Do H, 2008, P 2008 INT S SOFTW T; Dong X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009249; Duca KA, 2007, PLOS PATHOG, V3, P1388, DOI 10.1371/journal.ppat.0030137; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Fonoberova M, 2013, RELIAB ENG SYST SAFE, V118, P8, DOI 10.1016/j.ress.2013.04.004; Forrest S, 2007, IMMUNOL REV; Frey HC, 2002, IDENTIFICATION REV S; Hamby DM, 1995, HLTH PHYS; Happe K., 2005, P 11 INT C EUR ASS A; Helton JC, 2006, RELIAB ENG SYST SAFE, V91, P1175, DOI 10.1016/j.ress.2005.11.017; Helton JC, 2008, COMPUTATIONAL METHOD; Kaech SM, 2003, SCIENCE, V300, P263, DOI 10.1126/science.1084511; Karaoz U, 2004, P NATL ACAD SCI USA, V101, P2888, DOI 10.1073/pnas.0307326101; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Kelton, 1999, SIMULATION MODELING; Kleijnen J. P., 1992, SIMULATION STAT PERS; Kronsteiner B, 2014, GUT MICROBES, V5, P357, DOI 10.4161/gmic.28899; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; Leber A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134849; Ligmann-Zielinska A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109779; LIM JT, 1989, APPL MATH MODEL, V13, P479, DOI 10.1016/0307-904X(89)90096-6; Lowry SF, 2008, J LEUKOC BIOL; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; Mei Y, 2012, BIOINF BIOM BIBM 201; Mei Y, 2014, BIOINF BIOM BIBM 201; Mei YG, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S12-S2; Mi Q, 2007, WOUND REPAIR REGEN, V15, P671, DOI 10.1111/j.1524-475X.2007.00271.x; Montgomery D.C., 2012, DESIGN ANAL EXPT; Morris MD, 2008, TECHNOMETRICS, V50, P205, DOI 10.1198/004017008000000208; Naresh R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008352; Neugebauer EA, 2001, SHOCK; Noordegraaf AV, 2003, EUROPEAN J OPERATION; Parry HR, 2013, ENVIRON MODELL SOFTW, V45, P104, DOI 10.1016/j.envsoft.2012.08.006; Ramarao N, 2001, INFECT IMMUN, V69, P2604, DOI 10.1128/IAI.69.4.2604-2611.2001; Rodriguez-Fernandez M, 2012, INT J ROBUST NONLIN, V22, P1082, DOI 10.1002/rnc.2797; Sacks J., 1989, STAT SCI, V4, P409, DOI [10.1214/ss/1177012413, DOI 10.1214/SS/1177012413]; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Saltelli A., 2004, SENSITIVITY ANAL PRA, V1, DOI 10.1002/0470870958; Saltelli Andrea, 2010, COMPUTER PHYS COMMUN; Santner T. J, 2003, DESIGN ANAL COMPUTER; Scheffe H, 1959, ANAL VARIANCE; Schouten M, 2014, ENVIRON MODELL SOFTW, V54, P196, DOI 10.1016/j.envsoft.2014.01.003; Schumacher MA, 2012, GASTROENTEROLOGY, V142, P1150, DOI 10.1053/j.gastro.2012.01.029; Seber George A. F., 2012, LINEAR REGRESSION AN; Seely AJ, 2000, CRIT CARE MED; Shapiro M, 2008, J THEOR BIOL, V252, P633, DOI 10.1016/j.jtbi.2008.01.032; Sher AA, 2013, FUTURE GENER COMP SY, V29, P591, DOI 10.1016/j.future.2011.09.006; Sigal M, 2015, GASTROENTEROLOGY, V148, P1392, DOI 10.1053/j.gastro.2015.02.049; Sloane NJ., 1999, ORTHOGONAL ARRAYS TH, DOI [10.1007/978-1-4612-1478-6, DOI 10.1007/978-1-4612-1478-6]; Sumner T, 2012, J R SOC INTERFACE, V9, P2156, DOI 10.1098/rsif.2011.0891; Sumner T, 2012, J R SOC INTERFACE, V9, P701, DOI 10.1098/rsif.2011.0783; Sumner T, 2010, SENSITIVITY ANAL SYS; Vodovotz Y., 2006, SHOCK; Wendelsdorf K, 2011, ENTERIC IMMUNITY SIM; Wendelsdorf K., 2011, P IEEE INT C BIOINF; Wendelsdorf KV, 2012, IEEE T NANOBIOSCI, V11, P273, DOI 10.1109/TNB.2012.2211891; Wu C. J., 2011, EXPT PLANNING ANAL O	82	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136139	10.1371/journal.pone.0136139	http://dx.doi.org/10.1371/journal.pone.0136139			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327290	gold, Green Submitted, Green Published			2022-12-26	WOS:000360437700029
J	Deb, A; Kundu, S				Deb, Arindam; Kundu, Sudip			Deciphering Cis-Regulatory Element Mediated Combinatorial Regulation in Rice under Blast Infected Condition	PLOS ONE			English	Article							DOMAIN TRANSCRIPTION FACTOR; GENE-EXPRESSION; DEFENSE RESPONSES; PROMOTER; NETWORKS; ACID; RESISTANCE; MODULES; MOTIFS; DETERMINANTS	Combinations of cis-regulatory elements (CREs) present at the promoters facilitate the binding of several transcription factors (TFs), thereby altering the consequent gene expressions. Due to the eminent complexity of the regulatory mechanism, the combinatorics of CRE-mediated transcriptional regulation has been elusive. In this work, we have developed a new methodology that quantifies the co-occurrence tendencies of CREs present in a set of promoter sequences; these co-occurrence scores are filtered in three consecutive steps to test their statistical significance; and the significantly co-occurring CRE pairs are presented as networks. These networks of co-occurring CREs are further transformed to derive higher order of regulatory combinatorics. We have further applied this methodology on the differentially up-regulated gene-sets of rice tissues under fungal (Magnaporthe) infected conditions to demonstrate how it helps to understand the CRE-mediated combinatorial gene regulation. Our analysis includes a wide spectrum of biologically important results. The CRE pairs having a strong tendency to co-occur often exhibit very similar joint distribution patterns at the promoters of rice. We couple the network approach with experimental results of plant gene regulation and defense mechanisms and find evidences of auto and cross regulation among TF families, cross-talk among multiple hormone signaling pathways, similarities and dissimilarities in regulatory combinatorics between different tissues, etc. Our analyses have pointed a highly distributed nature of the combinatorial gene regulation facilitating an efficient alteration in response to fungal attack. All together, our proposed methodology could be an important approach in understanding the combinatorial gene regulation. It can be further applied to unravel the tissue and/or condition specific combinatorial gene regulation in other eukaryotic systems with the availability of annotated genomic sequences and suitable experimental data.	[Deb, Arindam; Kundu, Sudip] Univ Calcutta, Dept Biophys Mol Biol & Bioinformat, Kolkata, W Bengal, India; [Kundu, Sudip] Univ Calcutta, Ctr Excellence Syst Biol & Biomed Engn TEQIP Phas, Kolkata, W Bengal, India	University of Calcutta; University of Calcutta	Kundu, S (corresponding author), Univ Calcutta, Dept Biophys Mol Biol & Bioinformat, Kolkata, W Bengal, India.	skbmbg@caluniv.ac.in			UGC (RFSMS), Government of India; Center of Excellence in Systems Biology and Biomedical Engineering (TEQIP Phase II), University of Calcutta	UGC (RFSMS), Government of India; Center of Excellence in Systems Biology and Biomedical Engineering (TEQIP Phase II), University of Calcutta	AD is supported by a research fellowship provided by the UGC (RFSMS), Government of India. This work is supported by Center of Excellence in Systems Biology and Biomedical Engineering (TEQIP Phase II), University of Calcutta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Aftabuddin M, 2007, BIOPHYS J, V93, P225, DOI 10.1529/biophysj.106.098004; Assmann Sarah M, 2005, Sci STKE, V2005, pcm13, DOI 10.1126/stke.3102005cm13; Balaji S, 2006, J MOL BIOL, V360, P204, DOI 10.1016/j.jmb.2006.04.026; Balaji S, 2006, J MOL BIOL, V360, P213, DOI 10.1016/j.jmb.2006.04.029; Banerjee N, 2003, NUCLEIC ACIDS RES, V31, P7024, DOI 10.1093/nar/gkg894; Bate N, 1998, PLANT MOL BIOL, V37, P859, DOI 10.1023/A:1006095023050; Baudry A, 2006, PLANT J, V46, P768, DOI 10.1111/j.1365-313X.2006.02733.x; BENFEY PN, 1990, SCIENCE, V250, P959, DOI 10.1126/science.250.4983.959; Berman BP, 2002, P NATL ACAD SCI USA, V99, P757, DOI 10.1073/pnas.231608898; Boter M, 2004, GENE DEV, V18, P1577, DOI 10.1101/gad.297704; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Brown RL, 2003, PLANT PHYSIOL, V132, P1020, DOI 10.1104/pp.102.017814; Buchel AS, 1999, PLANT MOL BIOL, V40, P387, DOI 10.1023/A:1006144505121; Cao PJ, 2012, RICE, V5, DOI 10.1186/1939-8433-5-17; Chang WC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-561; Choi J, 2011, TRENDS PLANT SCI, V16, P388, DOI 10.1016/j.tplants.2011.03.003; Dozmorov MG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S10-S14; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ficklin SP, 2010, PLANT PHYSIOL, V154, P13, DOI 10.1104/pp.110.159459; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grennan AK, 2008, PLANT PHYSIOL, V146, P1457, DOI 10.1104/pp.104.900254; Hannenhalli S, 2002, NUCLEIC ACIDS RES, V30, P4278, DOI 10.1093/nar/gkf535; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Kato M, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r56; Koornneef A, 2008, PLANT PHYSIOL, V147, P1358, DOI 10.1104/pp.108.121392; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; Lenka SK, 2009, PLANT MOL BIOL, V69, P261, DOI 10.1007/s11103-008-9423-4; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Lin RM, 2007, PLANT SCI, V172, P120, DOI 10.1016/j.plantsci.2006.07.019; Lindlof A, 2009, BIOINFORMATICS, V25, P1345, DOI 10.1093/bioinformatics/btp172; Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121; Liu XQ, 2007, J PLANT PHYSIOL, V164, P969, DOI 10.1016/j.jplph.2006.07.006; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Luo H, 2005, PLANT BIOLOGY, V7, P459, DOI 10.1055/s-2005-865851; Mallik S, 2015, NUCLEIC ACIDS RES, V43, P5352, DOI 10.1093/nar/gkv448; Marcel S, 2010, PLANT CELL, V22, P3177, DOI 10.1105/tpc.110.078048; Mentlak TA, 2012, PLANT CELL, V24, P322, DOI 10.1105/tpc.111.092957; METRAUX JP, 1990, SCIENCE, V250, P1004, DOI 10.1126/science.250.4983.1004; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; Mohanty B, 2012, GENE, V511, P235, DOI 10.1016/j.gene.2012.09.048; Murakami K, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-112; Newman MEJ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.036122; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Nishizawa Y, 1999, THEOR APPL GENET, V99, P383, DOI 10.1007/s001220051248; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Pati A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-218; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; Pre M, 2008, PLANT PHYSIOL, V147, P1347, DOI 10.1104/pp.108.117523; PRESTRIDGE DS, 1991, COMPUT APPL BIOSCI, V7, P203; Puente P, 1996, EMBO J, V15, P3732, DOI 10.1002/j.1460-2075.1996.tb00743.x; Raffaele S, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00098; Redner S, 2008, NATURE, V453, P47, DOI 10.1038/453047a; Remenyi A, 2004, NAT STRUCT MOL BIOL, V11, P812, DOI 10.1038/nsmb820; Ribot C, 2008, J PLANT PHYSIOL, V165, P114, DOI 10.1016/j.jplph.2007.06.013; RIEPING M, 1992, MOL GEN GENET, V231, P226, DOI 10.1007/BF00279795; Risueno A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-221; Ross EJH, 2004, J EXP BOT, V55, P1721, DOI 10.1093/jxb/erh211; Singh KB, 1998, PLANT PHYSIOL, V118, P1111, DOI 10.1104/pp.118.4.1111; Smit A, 1996, REPEATMASKER OPEN 30; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sudarsanam P, 2002, GENOME RES, V12, P1723, DOI 10.1101/gr.301202; Sun LJ, 2013, PLANT MOL BIOL, V81, P41, DOI 10.1007/s11103-012-9981-3; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; Van Verk MC, 2009, ADV BOT RES, V51, P397, DOI 10.1016/S0065-2296(09)51010-5; Vandenbon A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S11; Vardhanabhuti S, 2007, NUCLEIC ACIDS RES, V35, P3203, DOI 10.1093/nar/gkm201; Wei T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059720; Whitmarsh AJ, 2007, BBA-MOL CELL RES, V1773, P1285, DOI 10.1016/j.bbamcr.2006.11.011; Xie Z, 2006, PLANT J, V46, P231, DOI 10.1111/j.1365-313X.2006.02694.x; Yanagisawa S, 2004, PLANT CELL PHYSIOL, V45, P386, DOI 10.1093/pcp/pch055; Yu DQ, 2001, PLANT CELL, V13, P1527, DOI 10.1105/tpc.13.7.1527; Yu XP, 2006, NUCLEIC ACIDS RES, V34, P917, DOI 10.1093/nar/gkj487; Zhou DX, 1999, TRENDS PLANT SCI, V4, P210, DOI 10.1016/S1360-1385(99)01418-1	79	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137295	10.1371/journal.pone.0137295	http://dx.doi.org/10.1371/journal.pone.0137295			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327607	Green Submitted, gold, Green Published			2022-12-26	WOS:000360437700109
J	Fonovic, UP; Kos, J				Fonovic, Ursa Pecar; Kos, Janko			Cathepsin X Cleaves Profilin 1 C-Terminal Tyr139 and Influences Clathrin-Mediated Endocytosis	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; BINDING-SITE; ACTIN; PHOSPHORYLATION; POLY(L-PROLINE); PHAGOCYTOSIS; PROGRESSION; MIGRATION; INVASION; MUTANTS	Cathepsin X, a cysteine carboxypeptidase, is upregulated in several types of cancer. Its molecular target in tumor cells is profilin 1, a known tumor suppressor and regulator of actin cytoskeleton dynamics. Cathepsin X cleaves off the C-terminal Tyr139 of profilin 1, affecting binding of poly-L-proline ligands and, consequently, tumor cell migration and invasion. Profilin 1 with mutations at the C-terminus, transiently expressed in prostate cancer cells PC-3, showed that Tyr139 is important for proper function of profilin 1 as a tumor suppressor. Cleaving off Tyr139 prevents the binding of clathrin, a poly-L-proline ligand involved in endocytosis. More profilin 1-clathrin complexes were present in PC-3 cells when cathepsin X was inhibited by its specific inhibitor AMS36 or silenced by siRNA. As a consequence, the endocytosis of FITC-labeled dextran and transferrin conjugate was significantly increased. These results constitute the first report of the regulation of clathrin-mediated endocytosis in tumor cells through proteolytic processing of profilin 1.	[Fonovic, Ursa Pecar; Kos, Janko] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia; [Kos, Janko] Jozef Stefan Inst, Dept Biotechnol, Ljubljana, Slovenia	University of Ljubljana; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Kos, J (corresponding author), Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia.	janko.kos@ffa.uni-lj.si			Slovenian Research Agency [P4-0127, J4-5529]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by Slovenian Research Agency grants P4-0127 (J.K.) and J4-5529 (J.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BjorkegrenSjogren C, 1997, FEBS LETT, V418, P258, DOI 10.1016/S0014-5793(97)01376-8; CEDERGRENZEPPEZAUER ES, 1994, J MOL BIOL, V240, P459, DOI 10.1006/jmbi.1994.1461; Eisenberg MC, 2011, P NATL ACAD SCI USA, V108, P20078, DOI 10.1073/pnas.1116327108; Fan Y, 2014, NAT CELL BIOL, V16, P445, DOI 10.1038/ncb2954; Fan Y, 2012, NAT CELL BIOL, V14, P1046, DOI 10.1038/ncb2580; Fonovic UP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053918; Fonovic UP, 2009, ACTA CHIM SLOV, V56, P985; Gareus R, 2006, J BIOL CHEM, V281, P2803, DOI 10.1074/jbc.M503528200; Gautier JJ, 2011, J CELL SCI, V124, P3414, DOI 10.1242/jcs.081083; Jevnikar Z, 2008, J CELL SCI, V121, P2652, DOI 10.1242/jcs.023721; Jevnikar Z, 2011, IUBMB LIFE, V63, P686, DOI 10.1002/iub.505; Jockusch BM, 2007, REV PHYSIOL BIOCH P, V159, P131, DOI 10.1007/112_2007_704; Karlsson R, 2007, MOL BIOL INTELL UNIT, P29, DOI 10.1007/978-0-387-46407-7_3; Kasina S, 2005, J BIOCHEM, V138, P687, DOI 10.1093/jb/mvi163; Kawada K, 2009, MOL CELL BIOL, V29, P4508, DOI 10.1128/MCB.00015-09; Kraus S, 2011, EUR J CELL BIOL, V90, P678, DOI 10.1016/j.ejcb.2011.03.008; Lambrechts A, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-12; Lechner AM, 2006, J BIOL CHEM, V281, P39588, DOI 10.1074/jbc.M513439200; Lu PJ, 1996, BIOCHEMISTRY-US, V35, P14027, DOI 10.1021/bi961878z; MALM B, 1983, J MUSCLE RES CELL M, V4, P569, DOI 10.1007/BF00712116; Mondin M, 2010, J BIOL CHEM, V285, P40060, DOI 10.1074/jbc.M110.140442; Mutch LJ, 2014, TRAFFIC, V15, P648, DOI 10.1111/tra.12165; Nagler DK, 2004, PROSTATE, V60, P109, DOI 10.1002/pros.20046; Nagler DK, 2010, INT IMMUNOPHARMACOL, V10, P134, DOI 10.1016/j.intimp.2009.09.018; Obermajer N, 2009, INT J BIOCHEM CELL B, V41, P1685, DOI 10.1016/j.biocel.2009.02.019; Pearson AM, 2003, MICROBES INFECT, V5, P815, DOI 10.1016/S1286-4579(03)00157-6; Puzer L, 2005, BIOL CHEM, V386, P1191, DOI 10.1515/BC.2005.136; RAGHUNATHAN V, 1992, FEBS LETT, V297, P46, DOI 10.1016/0014-5793(92)80324-A; Sadaghiani AM, 2007, CHEM BIOL, V14, P499, DOI 10.1016/j.chembiol.2007.03.010; Seastone DJ, 2001, J CELL SCI, V114, P2673; Sevenich L, 2010, P NATL ACAD SCI USA, V107, P2497, DOI 10.1073/pnas.0907240107; SOHN RH, 1995, J BIOL CHEM, V270, P21114, DOI 10.1074/jbc.270.36.21114; Staudt ND, 2010, HAEMATOL-HEMATOL J, V95, P1452, DOI 10.3324/haematol.2009.018671; Temesvari L, 2000, MOL BIOL CELL, V11, P2019, DOI 10.1091/mbc.11.6.2019; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024967; Weibrecht I, 2010, EXPERT REV PROTEOMIC, V7, P401, DOI 10.1586/EPR.10.10; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Wolven AK, 2000, J CELL BIOL, V150, P895, DOI 10.1083/jcb.150.4.895	39	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137217	10.1371/journal.pone.0137217	http://dx.doi.org/10.1371/journal.pone.0137217			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325675	gold, Green Published, Green Submitted			2022-12-26	WOS:000360437700104
J	Kriticos, DJ; Brunel, S; Ota, N; Fried, G; Lansink, AGJMO; Panetta, FD; Prasad, TVR; Shabbir, A; Yaacoby, T				Kriticos, Darren J.; Brunel, Sarah; Ota, Noboru; Fried, Guillaume; Lansink, Alfons G. J. M. Oude; Panetta, F. Dane; Prasad, T. V. Ramachandra; Shabbir, Asad; Yaacoby, Tuvia			Downscaling Pest Risk Analyses: Identifying Current and Future Potentially Suitable Habitats for Parthenium hysterophorus with Particular Reference to Europe and North Africa	PLOS ONE			English	Article							GEOGRAPHICAL-DISTRIBUTION; WEED; ASTERACEAE; DISTRIBUTIONS; EASTERN; FLY	Pest Risk Assessments (PRAs) routinely employ climatic niche models to identify endangered areas. Typically, these models consider only climatic factors, ignoring the 'Swiss Cheese' nature of species ranges due to the interplay of climatic and habitat factors. As part of a PRA conducted for the European and Mediterranean Plant Protection Organization, we developed a climatic niche model for Parthenium hysterophorus, explicitly including the effects of irrigation where it was known to be practiced. We then downscaled the climatic risk model using two different methods to identify the suitable habitat types: expert opinion (following the EPPO PRA guidelines) and inferred from the global spatial distribution. The PRA revealed a substantial risk to the EPPO region and Central and Western Africa, highlighting the desirability of avoiding an invasion by P. hysterophorus. We also consider the effects of climate change on the modelled risks. The climate change scenario indicated the risk of substantial further spread of P. hysterophorus in temperate northern hemisphere regions (North America, Europe and the northern Middle East), and also high elevation equatorial regions (Western Brazil, Central Africa, and South East Asia) if minimum temperatures increase substantially. Downscaling the climate model using habitat factors resulted in substantial (approximately 22-53%) reductions in the areas estimated to be endangered. Applying expert assessments as to suitable habitat classes resulted in the greatest reduction in the estimated endangered area, whereas inferring suitable habitats factors from distribution data identified more land use classes and a larger endangered area. Despite some scaling issues with using a globally conformal Land Use Systems dataset, the inferential downscaling method shows promise as a routine addition to the PRA toolkit, as either a direct model component, or simply as a means of better informing an expert assessment of the suitable habitat types.	[Kriticos, Darren J.] CSIRO, Canberra, ACT, Australia; [Brunel, Sarah] European & Mediterranean Plant Protect Org, Paris, France; [Ota, Noboru] CSIRO, Wembley, WA, Australia; [Fried, Guillaume] Anses, Lab Sante Vegetaux, Montferrier Lez cede, France; [Lansink, Alfons G. J. M. Oude] Wageningen Univ, NL-6700 AP Wageningen, Netherlands; [Panetta, F. Dane] Univ Melbourne, Parkville, Vic 3052, Australia; [Prasad, T. V. Ramachandra] Univ Agr Sci, Directorate Weed Sci Res Ctr, Bengaluru, India; [Shabbir, Asad] Univ Punjab, Dept Bot, Lahore, Pakistan; [Yaacoby, Tuvia] Bet Dagan Agr Ctr, Minist Agr & Rural Dev, Plant Protect & Inspect Serv, Bet Dagan, Israel	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de la Sante des Vegetaux; Wageningen University & Research; University of Melbourne; University of Agricultural Sciences Bangalore; University of Punjab	Kriticos, DJ (corresponding author), CSIRO, GPO Box 1700, Canberra, ACT, Australia.	darren.kriticos@csiro.au	Shabbir, Asad/AAD-8808-2019; Kriticos, Darren J/A-4170-2008; Fried, Guillaume/B-4777-2015; Ota, Noboru/ABE-4698-2020; Oude Lansink, Alfons GJM/H-8840-2012	Shabbir, Asad/0000-0003-4468-6019; Kriticos, Darren J/0000-0003-2599-8105; Fried, Guillaume/0000-0002-3653-195X; Oude Lansink, Alfons GJM/0000-0002-9273-6044; , Noboru/0000-0002-8759-9030				Adkins S, 2014, PEST MANAG SCI, V70, P1023, DOI 10.1002/ps.3708; Andrewartha H.G., 1984, ECOLOGICAL WEB MORE; Asad Shabbir, 2012, Pakistan Journal of Weed Science Research, V18, P581; Auld BA, 1982, WEEDS-U, V2, P56; Baker RHA, 2003, BCPC INTERNATIONAL CONGRESS CROP SCIENCE & TECHNOLOGY 2003, VOL 1 AND 2, CONGRESS PROCEEDINGS, P1201; BOOTH TH, 1987, AGR FOREST METEOROL, V39, P241, DOI 10.1016/0168-1923(87)90041-4; Bossard M, 2000, CORINE LAND COVER TE; Boulos L, 1984, WEED FLORA EGYPT; Brouwer C., 1985, IRRIGATION WATER MAN; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; CABI, 2014, PARTH HYST; Chippendale J. F., 1994, Plant Protection Quarterly, V9, P73; Clark K, 2011, INT PARTHENIUM NEWS, V3, P1; DAFNI A, 1982, PLANT SYST EVOL, V140, P1, DOI 10.1007/BF02409894; Department of Natural Resources the Arts and Sport, 2010, NT WEED RISK ASS SPE; Dhileepan K., 2009, V5, P227; Dhileepan K, 2012, WEED SCI, V60, P571, DOI 10.1614/WS-D-12-00005.1; EPPO, 2014, PEST RISK AN PARTH H; EPPO, 2013, PQR EPPO DAT QUAR PE; EPPO, 2011, PM 5 3 5 GUID PEST R, P1; FAO, 2006, INT STAND PHYT MEAS; Grime JP, 1979, PLANT STRATEGIES VEG, P7; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HUTCHINSON MF, 1994, GEODERMA, V62, P45, DOI 10.1016/0016-7061(94)90027-2; Kandasamy O.S., 2005, P 2 INT C PARTHENIUM, P134; Khosla S. N., 1981, Pesticides, V15, P18; KILIAN N., 2002, WILLDENOWIA, V32, P239, DOI DOI 10.3372/WI.32.32207; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; Kriticos DJ, 2010, ECOGRAPHY, V33, P115, DOI 10.1111/j.1600-0587.2009.06042.x; McConnachie AJ, 2011, WEED RES, V51, P71, DOI 10.1111/j.1365-3180.2010.00820.x; McFadyen R E, 1995, Aust Fam Physician, V24, P1455; MCFADYEN RC, 1992, CROP PROT, V11, P400, DOI 10.1016/0261-2194(92)90021-V; Mirek Z., 2002, SERIA BIODIVERSITY P, V1; MURPHY ST, 2006, AID TRADE INT ASSIST; Navie S. C., 1996, Plant Protection Quarterly, V11, P76; Navie SC, 1998, WEED RES, V38, P335, DOI 10.1046/j.1365-3180.1998.00104.x; New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2; Portmann FT, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2008GB003435; Ramachandra Prasad T, 2010, INT C BIOD, P206; Ramachandra Prasad T.V., 2010, P 3 INT C PARTHENIUM, P13; Ramankutty N, 1999, GLOBAL BIOGEOCHEM CY, V13, P997, DOI 10.1029/1999GB900046; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Siebert S, 2005, HYDROL EARTH SYST SC, V9, P535, DOI 10.5194/hess-9-535-2005; Sutherst RW, 2009, BIOL INVASIONS, V11, P1231, DOI 10.1007/s10530-008-9335-x; Sutherst R W, 2007, CLIMEX VERSION 3 USE; Sutherst RW, 2014, BIOL INVASIONS, V16, P239, DOI 10.1007/s10530-013-0523-y; SUTHERST RW, 1985, AGR ECOSYST ENVIRON, V13, P281, DOI 10.1016/0167-8809(85)90016-7; Tamado T, 2002, INT J PEST MANAGE, V48, P183, DOI 10.1080/09670870110101739; Towers G. H. N., 1992, Proceedings of the 1st International Weed Control Congress., P134; Verloove F, 2006, CATALOGUE NEOPHYTES; Wabuyele Emily, 2014, Journal of East African Natural History, V103, P49; Watt MS, 2011, WEED SCI, V59, P538, DOI 10.1614/WS-D-11-00032.1; Webber BL, 2011, DIVERS DISTRIB, V17, P978, DOI 10.1111/j.1472-4642.2011.00811.x; WILLIAMS JD, 1980, WEED RES, V20, P47, DOI 10.1111/j.1365-3180.1980.tb00040.x; WILLIAMS JD, 1985, AUST VET J, V62, P367, DOI 10.1111/j.1751-0813.1985.tb14210.x; Woodward F.I., 1987, CLIMATE PLANT DISTRI; Yonow T, 1998, AUST J AGR RES, V49, P935, DOI 10.1071/A97152	57	29	29	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0132807	10.1371/journal.pone.0132807	http://dx.doi.org/10.1371/journal.pone.0132807			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325680	Green Submitted, gold, Green Published			2022-12-26	WOS:000360437700005
J	Markov, OV; Mironova, NL; Sennikov, SV; Vlassov, VV; Zenkova, MA				Markov, Oleg V.; Mironova, Nadezhda L.; Sennikov, Sergey V.; Vlassov, Valentin V.; Zenkova, Marina A.			Prophylactic Dendritic Cell-Based Vaccines Efficiently Inhibit Metastases in Murine Metastatic Melanoma	PLOS ONE			English	Article							CANCER-IMMUNOTHERAPY; GENETIC-MODIFICATION; MESSENGER-RNA; PHASE-II; VACCINATION; RESPONSES; IMMUNITY; IMMUNOGENICITY; IMMUNIZATION; INDUCTION	Recent data on the application of dendritic cells (DCs) as anti-tumor vaccines has shown their great potential in therapy and prophylaxis of cancer. Here we report on a comparison of two treatment schemes with DCs that display the models of prophylactic and therapeutic vaccination using three different experimental tumor models: namely, Krebs-2 adenocarcinoma (primary tumor), melanoma (B16, metastatic tumor without a primary node) and Lewis lung carcinoma (LLC, metastatic tumor with a primary node). Dendritic cells generated from bone marrow-derived DC precursors and loaded with lysate of tumor cells or transfected with the complexes of total tumor RNA with cationic liposomes were used for vaccination. Lipofectamine 2000 and liposomes consisting of helper lipid DOPE (1,2-dioleoyl- sn-glycero-3-phosphoethanolamine) and cationic lipid 2D3 (1,26-Bis(1,2-de-O-tetradecyl-rac-glycerol)-7,11,16,20-tetraazahexacosan tetrahydrocloride) were used for RNA transfection. It was shown that DCs loaded with tumor lysate were ineffective in contrast to tumor-derived RNA. Therapeutic vaccination with DCs loaded by lipoplexes RNA/Lipofectamine 2000 was the most efficient for treatment of non-metastatic Krebs-2, where a 1.9-fold tumor growth retardation was observed. Single prophylactic vaccination with DCs loaded by lipoplexes RNA/2D3 was the most efficient to treat highly aggressive metastatic tumors LLC and B16, where 4.7- and 10-fold suppression of the number of lung metastases was observed, respectively. Antimetastatic effect of single prophylactic DC vaccination in metastatic melanoma model was accompanied by the reductions in the levels of Th2-specific cytokines however the change of the levels of Th1/Th2/Th17 master regulators was not found. Failure of double prophylactic vaccination is explained by Th17-response polarization associated with autoimmune and pro-inflammatory reactions. In the case of therapeutic DC vaccine the polarization of Th1-response was found nevertheless the antimetastatic effect was less effective in comparison with prophylactic DC vaccine.	[Markov, Oleg V.; Mironova, Nadezhda L.; Vlassov, Valentin V.; Zenkova, Marina A.] Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Branch, Novosibirsk, Russia; [Sennikov, Sergey V.] Russian Acad Sci, Fed State Budgetary Inst Res Inst Clin Immunol, Siberian Branch, Novosibirsk, Russia	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Russian Academy of Sciences	Zenkova, MA (corresponding author), Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Branch, Novosibirsk, Russia.	marzen@niboch.nsc.ru	SENNIKOV, SERGEY/GPS-7277-2022; Markov, Oleg V/G-2676-2013; Zenkova, Marina A/G-5088-2013; Zenkova, Marina A./H-4666-2014; Vlassov, Valentin/F-4720-2013	SENNIKOV, SERGEY/0000-0002-7366-7768; Mironova, Nadezhda/0000-0003-4375-0269; Zenkova, Marina/0000-0003-4044-1049; Markov, Oleg/0000-0002-8381-1890; Vlassov, Valentin/0000-0003-2845-2992	Russian Academy of Science under the programs "Molecular and Cellular Biology"; Special Purpose Program "Research and Development in a Priority Direction of Development of a Scientific and Technological Complex of Russia" [14.607.21.0043, RFMEFI60714X0043]; Interdisciplinary grant of SB RAS [86];  [SS-01350.2014.4];  [1619.2013.4]	Russian Academy of Science under the programs "Molecular and Cellular Biology"; Special Purpose Program "Research and Development in a Priority Direction of Development of a Scientific and Technological Complex of Russia"; Interdisciplinary grant of SB RAS; ; 	This research was supported by the Russian Academy of Science under the programs "Molecular and Cellular Biology"; Interdisciplinary grant of SB RAS no. 86, by the grant Scientific schools SS-01350.2014.4, and Special Purpose Program "Research and Development in a Priority Direction of Development of a Scientific and Technological Complex of Russia for 2014-2020" (Agreement No. 14.607.21.0043, project RFMEFI60714X0043). MOV was a recipient of Presidential fellowship 1619.2013.4.	Aarntzen EHJG, 2013, CANCER RES, V73, P19, DOI 10.1158/0008-5472.CAN-12-1127; Ahmed MS, 2014, CLIN EXP VACCINE RES, V3, P113, DOI 10.7774/cevr.2014.3.2.113; Akiyama Y, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-623; Aly HAA, 2012, J IMMUNOL METHODS, V382, P1, DOI 10.1016/j.jim.2012.05.014; Begum-Haque S, 2008, J NEUROIMMUNOL, V204, P58, DOI 10.1016/j.jneuroim.2008.07.018; Benencia F, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/425476; Benteyn D, 2015, EXPERT REV VACCINES, V14, P161, DOI 10.1586/14760584.2014.957684; Blalock LT, 2012, ONCOIMMUNOLOGY, V1, P287, DOI 10.4161/onci.18628; Breckpot K, 2004, J GENE MED, V6, P1175, DOI 10.1002/jgm.615; Drake CG, 2011, CANCER J, V17, P294, DOI 10.1097/PPO.0b013e3182325e78; Finn OJ, 2014, CANCER IMMUNOL RES, V2, P708, DOI 10.1158/2326-6066.CIR-14-0110; Florcken A, 2013, HUM VACC IMMUNOTHER, V9, P1217, DOI 10.4161/hv.24149; Frank SA, 2004, NAT REV GENET, V5, P764, DOI 10.1038/nrg1450; Hong XQ, 2013, INT J COLORECTAL DIS, V28, P25, DOI 10.1007/s00384-012-1530-7; Huck SP, 2008, CANCER IMMUNOL IMMUN, V57, P63, DOI 10.1007/s00262-007-0350-z; Iclozan C, 2013, CANCER IMMUNOL IMMUN, V62, P909, DOI 10.1007/s00262-013-1396-8; Kandalaft LE, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22664; Kim SK, 2013, CANCER LETT, V335, P278, DOI 10.1016/j.canlet.2013.02.038; Koido S, 2000, J IMMUNOL, V165, P5713, DOI 10.4049/jimmunol.165.10.5713; Kong WM, 2011, BRAIN BEHAV IMMUN, V25, P872, DOI 10.1016/j.bbi.2010.09.012; Lesterhuis WJ, 2010, ANTICANCER RES, V30, P5091; Liechtenstein T, 2013, VIRUS RES, V176, P1, DOI 10.1016/j.virusres.2013.05.007; Liu T, 2012, J PROTEOMICS, V75, P4747, DOI 10.1016/j.jprot.2012.01.035; Markov OO, 2012, J CONTROL RELEASE, V160, P200, DOI 10.1016/j.jconrel.2011.11.034; Matheoud D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019104; Matheoud D, 2010, BLOOD, V115, P4412, DOI 10.1182/blood-2009-11-255935; Meany Danni L, 2009, Expert Opin Med Diagn, V3, P597; Mendoza L, 2003, INT J ONCOL, V23, P243; Morse MA, 2013, ANN SURG, V258, P879, DOI 10.1097/SLA.0b013e318292919e; Mossoba ME, 2008, MOL THER, V16, P607, DOI 10.1038/sj.mt.6300390; Oda Y, 2012, J CONTROL RELEASE, V160, P362, DOI 10.1016/j.jconrel.2011.12.003; Palma M, 2012, CANCER IMMUNOL IMMUN, V61, P865, DOI 10.1007/s00262-011-1149-5; Palucka K, 2011, J INTERN MED, V269, P64, DOI 10.1111/j.1365-2796.2010.02317.x; Palucka K, 2013, IMMUNITY, V39, P38, DOI 10.1016/j.immuni.2013.07.004; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Pan K, 2010, INT J BIOL SCI, V6, P639; Pandey VK, 2012, INT IMMUNOPHARMACOL, V14, P641, DOI 10.1016/j.intimp.2012.09.020; Phuphanich S, 2013, CANCER IMMUNOL IMMUN, V62, P125, DOI 10.1007/s00262-012-1319-0; Prasad SJ, 2005, J IMMUNOL, V174, P90, DOI 10.4049/jimmunol.174.1.90; Ribas A, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-89; Ricupito A, 2013, CANCER RES, V73, P3545, DOI 10.1158/0008-5472.CAN-12-2449; Rizzo MM, 2014, METHODS MOL BIOL, V1139, P41, DOI 10.1007/978-1-4939-0345-0_5; Salem ML, 2014, METHODS MOL BIOL, V1139, P479, DOI 10.1007/978-1-4939-0345-0_37; Samadi-Foroushani M, 2011, MED ONCOL, V28, pS660, DOI 10.1007/s12032-010-9720-z; Schaft N, 2006, HDB DENDRITIC CELLS, P1143, DOI [10.1002/9783527619696.ch55, DOI 10.1002/9783527619696.CH55]; Su Z, 2003, CANCER RES, V63, P2127; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Tada F, 2012, INT J ONCOL, V41, P1601, DOI 10.3892/ijo.2012.1626; Topfer K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/918471; Tung N, 2011, JAMA-J AM MED ASSOC, V305, P2211, DOI 10.1001/jama.2011.678; Vik-Mo EO, 2013, CANCER IMMUNOL IMMUN, V62, P1499, DOI 10.1007/s00262-013-1453-3; Xie JP, 2010, LUNG CANCER, V68, P338, DOI 10.1016/j.lungcan.2009.07.007; Yang SX, 1999, INT J CANCER, V83, P532, DOI 10.1002/(SICI)1097-0215(19991112)83:4<532::AID-IJC16>3.0.CO;2-K	53	20	21	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136911	10.1371/journal.pone.0136911	http://dx.doi.org/10.1371/journal.pone.0136911			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325576	gold, Green Submitted, Green Published			2022-12-26	WOS:000360437700070
J	Lai, YJ; Chen, HC; Chou, P				Lai, Yun-Ju; Chen, Hsi-Chung; Chou, Pesus			Gender Difference in the Interaction Effects of Diabetes and Hypertension on Stroke among the Elderly in the Shih-Pai Study, Taiwan	PLOS ONE			English	Article							SEX-DIFFERENCES; FAMILY-HISTORY; CARDIOVASCULAR-DISEASE; RISK-FACTORS; TYPE-2; ATHEROSCLEROSIS; PREVALENCE; MELLITUS; SMOKING; OBESITY	Aims To investigate the interaction effects of diabetes and hypertension on stroke, and also investigate the independent and interaction effects of parental history and environmental factors on diabetes and hypertension in a cross-sectional elderly population. Methods The Shih-Pai Community Medical Service Program was a community-based, fixed cohort study conducted between June 1999 and November 2002. Socio-demographic and clinical data of subjects aged 65 years and older were collected by well-trained interviewers during home visits. Interaction effects were analyzed using Rothman's synergy index (SI). Results In total, 4,124 subjects were included in the study, with 2,284 males and 1,840 females. The synergistic interaction of diabetes and hypertension on stroke was statistically significant in women (SI = 3.16, 95% CI: 1.35-7.39). The synergistic interaction of parental diabetes and being overweight on diabetes was only statistically significant in men, and not in women (SI = 3.30, 95% CI: 1.00-10.83 in men, and SI = 1.15, 95% CI: 0.30-4.39 in women). Conclusions A synergistic interaction was found for diabetes and hypertension in both sexes when parental history and being overweight were combined. Furthermore, combining diabetes and hypertension in elderly women was significant in terms of the risk of stroke. Strategies to control risk factors in individuals at additional high risk are urgently needed.	[Lai, Yun-Ju] Taichung Vet Gen Hosp, Puli Branch, Dept Internal Med, Div Endocrinol & Metab, Nantou, Taiwan; [Lai, Yun-Ju; Chou, Pesus] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Lai, Yun-Ju; Chou, Pesus] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Lai, Yun-Ju] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Chen, Hsi-Chung] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Chen, Hsi-Chung] Natl Taiwan Univ Hosp, Ctr Sleep Disorders, Taipei, Taiwan	Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Chou, P (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan.	pschou@ym.edu.tw	Lai, Yun-Ju/AAX-4990-2020; Chen, Hsi-Chung/E-9949-2017	Chen, Hsi-Chung/0000-0003-3191-0093	Shih-Pai Community Medical Service Program at Taipei Veterans General Hospital [VGH 89-404-1, VGH 90-445-1, VGH 91-382-1]	Shih-Pai Community Medical Service Program at Taipei Veterans General Hospital	This study was supported by a grant from the Shih-Pai Community Medical Service Program (VGH 89-404-1, VGH 90-445-1 and VGH 91-382-1) at Taipei Veterans General Hospital.	Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Cheng S, 2014, CIRCULATION, V130, P820, DOI 10.1161/CIRCULATIONAHA.113.008506; Fagard RH, 2009, DIABETES CARE, V32, pS429, DOI 10.2337/dc09-S354; Gale EAM, 2001, DIABETOLOGIA, V44, P3, DOI 10.1007/s001250051573; Haast RAM, 2012, J CEREBR BLOOD F MET, V32, P2100, DOI 10.1038/jcbfm.2012.141; Hu G, 2005, STROKE, V36, P2538, DOI 10.1161/01.STR.0000190894.30964.75; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Kelly LA, 2007, DIABETES CARE, V30, P2700, DOI 10.2337/dc07-0050; KHOURY MJ, 1995, EPIDEMIOLOGY, V6, P511, DOI 10.1097/00001648-199509000-00009; Lim SJ, 2012, MATURITAS, V73, P331, DOI 10.1016/j.maturitas.2012.09.002; Lundberg M, 1996, EPIDEMIOLOGY, V7, P655; Lyssenko V, 2013, DIABETES CARE, V36, pS120, DOI 10.2337/dcS13-2009; Machann J, 2005, MAGN RESON MATER PHY, V18, P128, DOI 10.1007/s10334-005-0104-x; Meigs JB, 2000, DIABETES, V49, P2201, DOI 10.2337/diabetes.49.12.2201; Meisinger C, 2002, ARCH INTERN MED, V162, P82, DOI 10.1001/archinte.162.1.82; Menke A, 2014, ANN INTERN MED, V161, P328, DOI 10.7326/M14-0286; Natali A, 2010, J CLIN ENDOCR METAB, V95, P4703, DOI 10.1210/jc.2009-2721; Nguyen NT, 2011, OBES SURG, V21, P351, DOI 10.1007/s11695-010-0335-4; Ning F, 2013, CAN J DIABETES, V37, P65, DOI 10.1016/j.jcjd.2012.12.001; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Peters SAE, 2014, LANCET, V383, P1973, DOI 10.1016/S0140-6736(14)60040-4; Reeves MJ, 2008, LANCET NEUROL, V7, P915, DOI 10.1016/S1474-4422(08)70193-5; Rothman KJ, 2002, EPIDEMIOLOGY INTRO; Scott RA, 2013, DIABETOLOGIA, V56, P60, DOI 10.1007/s00125-012-2715-x; Shahid A, 2008, HORM-INT J ENDOCRINO, V7, P313, DOI 10.14310/horm.2002.1212; Simsolo RB, 1999, AM J HYPERTENS, V12, P260, DOI 10.1016/S0895-7061(98)00253-2; Tsao PS, 1998, ARTERIOSCL THROM VAS, V18, P947, DOI 10.1161/01.ATV.18.6.947; Vitale C, 2007, CLIMACTERIC, V10, P16, DOI 10.1080/13697130701602712; Wada J, 1990, JAPANESE J PUBLIC HL, V37, P775; Wikner C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061763	30	6	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136634	10.1371/journal.pone.0136634	http://dx.doi.org/10.1371/journal.pone.0136634			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322779	gold, Green Published, Green Submitted			2022-12-26	WOS:000360435500025
J	Jang, S; Choi, SC; Li, HY; An, G; Schmelzer, E				Jang, Seonghoe; Choi, Sang-Chul; Li, Hsing-Yi; An, Gynheung; Schmelzer, Elmon			Functional Characterization of Phalaenopsis aphrodite Flowering Genes PaFT1 and PaFD	PLOS ONE			English	Article							TISSUE-SPECIFIC EXPRESSION; LOCUS-T PROTEIN; LONG-DISTANCE; DIFFERENTIAL EXPRESSION; TRANSCRIPTION FACTORS; FLORAL TRANSITION; HEADING-DATE; RICE PLANTS; ARABIDOPSIS; TEMPERATURE	We show that the key flowering regulators encoded by Phalaenopsis aphrodite FLOWERING LOCUS T1 (PaFT1) and PaFD share high sequence homologies to these from long-day flowering Arabidopsis and short-day flowering rice. Interestingly, PaFT1 is specifically upregulated during flowering inductive cooling treatment but is not subjected to control by photoperiod in P. aphrodite. Phloem or shoot apex-specific expression of PaFT1 restores the late flowering of Arabidopsis ft mutants. Moreover, PaFT1 can suppress the delayed flowering caused by SHORT VEGATATIVE PHASE (SVP) overexpression as well as an active FRIGIDA (FRI) allele, indicating the functional conservation of flowering regulatory circuit in different plant species. PaFT1 promoter: GUS in Arabidopsis showed similar staining pattern to that of Arabidopsis FT in the leaves and guard cells but different in the shoot apex. A genomic clone or heat shock-inducible expression of PaFT1 is sufficient to the partial complementation of the ft mutants. Remarkably, ectopic PaFT1 expression also triggers precocious heading in rice. To further demonstrate the functional conservation of the flowering regulators, we show that PaFD, a bZIP transcription factor involved in flowering promotion, interacts with PaFT1, and PaFD partially complemented Arabidopsis fd mutants. Transgenic rice expressing PaFD also flowered early with increased expression of rice homologues of APETALA1 (AP1). Consistently, PaFT1 knock-down Phalaenopsis plants generated by virus-induced gene silencing exhibit delayed spiking. These studies suggest functional conservation of FT and FD genes, which may have evolved and integrated into distinct regulatory circuits in monopodial orchids, Arabidopsis and rice that promote flowering under their own inductive conditions.	[Jang, Seonghoe; Li, Hsing-Yi] Acad Sinica, Biotechnol Ctr Southern Taiwan, Tainan 741, Tainan County, Taiwan; [Jang, Seonghoe; Li, Hsing-Yi] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Choi, Sang-Chul; An, Gynheung] Kyung Hee Univ, Crop Biotechnol Ctr, Yongin 446701, South Korea; [Schmelzer, Elmon] Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Kyung Hee University; Max Planck Society	Jang, S (corresponding author), Acad Sinica, Biotechnol Ctr Southern Taiwan, Tainan 741, Tainan County, Taiwan.	florigen@gate.sinica.edu.tw			Development Program of Industrialization for Agricultural Biotechnology (DPIAB, Taiwan ) [099S0030086-AA]	Development Program of Industrialization for Agricultural Biotechnology (DPIAB, Taiwan )	Funded by Development Program of Industrialization for Agricultural Biotechnology (DPIAB, Taiwan 099S0030086-AA to SJ), http://dpiab.sinica.edu.tw/index_en.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Ahn JH, 2006, EMBO J, V25, P605, DOI 10.1038/sj.emboj.7600950; Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; An FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018937; An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; Bilgin DD, 2009, NAT PROTOC, V4, P333, DOI 10.1038/nprot.2008.249; Blanchard MG, 2006, J EXP BOT, V57, P4043, DOI 10.1093/jxb/erl176; Chen WH, 2008, PLANT CELL REP, V27, P1667, DOI 10.1007/s00299-008-0591-0; CHEN WS, 1994, PHYSIOL PLANTARUM, V90, P391, DOI 10.1111/j.1399-3054.1994.tb00404.x; Citovsky V, 2006, J MOL BIOL, V362, P1120, DOI 10.1016/j.jmb.2006.08.017; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cockram J, 2007, J EXP BOT, V58, P1231, DOI 10.1093/jxb/erm042; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; ENDO M, 1989, PLANT CELL PHYSIOL, V30, P43, DOI 10.1093/oxfordjournals.pcp.a077715; Farrona S, 2011, PLANT CELL, V23, P3204, DOI 10.1105/tpc.111.087809; Gao H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003281; Hanano S, 2011, PLANT CELL, V23, P3172, DOI 10.1105/tpc.111.088641; Hanzawa Y, 2005, P NATL ACAD SCI USA, V102, P7748, DOI 10.1073/pnas.0500932102; Hayama R, 2007, PLANT CELL, V19, P2988, DOI 10.1105/tpc.107.052480; Helliwell CA, 2006, PLANT J, V46, P183, DOI 10.1111/j.1365-313X.2006.02686.x; Ho WWH, 2014, PLANT CELL, V26, P552, DOI 10.1105/tpc.113.115220; Hou CJ, 2009, PLANT CELL PHYSIOL, V50, P1544, DOI 10.1093/pcp/pcp099; Hsieh MH, 2013, J EXP BOT, V64, P3869, DOI 10.1093/jxb/ert218; Hsieh MH, 2013, PLANT SCI, V201, P25, DOI 10.1016/j.plantsci.2012.11.003; Hsu CY, 2011, P NATL ACAD SCI USA, V108, P10756, DOI 10.1073/pnas.1104713108; Izawa T, 2007, INT REV CYTOL, V256, P191, DOI 10.1016/S0074-7696(07)56006-7; Jaeger KE, 2013, PLANT CELL, V25, P820, DOI 10.1105/tpc.113.109355; Jang S, 2008, EMBO J, V27, P1277, DOI 10.1038/emboj.2008.68; Jang S, 2009, PLANT J, V60, P614, DOI 10.1111/j.1365-313X.2009.03986.x; Jang SH, 2002, PLANT CELL PHYSIOL, V43, P230, DOI 10.1093/pcp/pcf015; Jeon JS, 2000, MOL BREEDING, V6, P581, DOI 10.1023/A:1011388620872; Kawamoto N, 2015, SCI REP-UK, V5, DOI 10.1038/srep08341; Kim SR, 2009, J PLANT BIOL, V52, P73, DOI 10.1007/s12374-008-9008-4; Kinoshita T, 2011, CURR BIOL, V21, P1232, DOI 10.1016/j.cub.2011.06.025; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Lee H, 2000, GENE DEV, V14, P2366, DOI 10.1101/gad.813600; LEE I, 1995, PLANT PHYSIOL, V108, P157, DOI 10.1104/pp.108.1.157; LEE I, 1994, PLANT J, V6, P903, DOI 10.1046/j.1365-313X.1994.6060903.x; Lee JH, 2007, GENE DEV, V21, P397, DOI 10.1101/gad.1518407; Lee JH, 2013, SCIENCE, V342, P628, DOI 10.1126/science.1241097; Lee N, 1984, J CHINESE SOC HORT S, V30, P223; Lee N, 1987, P S FORC CULT HORT C, P27; Lee N., 1990, J CHINESE SOC HORT S, V36, P223; Li DM, 2014, GENET MOL RES, V13, P5982, DOI 10.4238/2014.August.7.14; Li Yan-Xiao, 2014, Plant Omics, V7, P328; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Lin HY, 2014, PLANT MOL BIOL, V84, P203, DOI 10.1007/s11103-013-0128-y; Lin MK, 2007, PLANT CELL, V19, P1488, DOI 10.1105/tpc.107.051920; Liu C, 2007, DEVELOPMENT, V134, P1901, DOI 10.1242/dev.003103; Liu LX, 2012, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2012-9; Lopez RG, 2005, HORTSCIENCE, V40, P1969, DOI 10.21273/HORTSCI.40.7.1969; Lu HC, 2007, PLANT PHYSIOL, V143, P558, DOI 10.1104/pp.106.092742; Lu SJ, 2012, PLANT MOL BIOL REP, V30, P1461, DOI 10.1007/s11105-012-0468-9; Luan WJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005891; Matsubara K, 2008, PLANT PHYSIOL, V148, P1425, DOI 10.1104/pp.108.125542; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; Nishikawa F, 2007, J EXP BOT, V58, P3915, DOI 10.1093/jxb/erm246; Notaguchi M, 2008, PLANT CELL PHYSIOL, V49, P1645, DOI 10.1093/pcp/pcn154; Noy-Porat T, 2013, J EXP BOT, V64, P3273, DOI 10.1093/jxb/ert165; Pose D, 2013, NATURE, V503, P414, DOI 10.1038/nature12633; SAKANISHI Y, 1980, Bulletin of the University of Osaka Prefecture Series B Agriculture and Life Sciences, V32, P1; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Shirasu K, 1999, CELL, V99, P355, DOI 10.1016/S0092-8674(00)81522-6; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Sinha Pinaki, 2010, Plant Tissue Culture & Biotechnology, V20, P185; Song YH, 2013, TRENDS PLANT SCI, V18, P575, DOI 10.1016/j.tplants.2013.05.003; Su CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080462; Su CL, 2011, PLANT CELL PHYSIOL, V52, P1501, DOI 10.1093/pcp/pcr097; TAKAHASHI T, 1989, MOL GEN GENET, V219, P365, DOI 10.1007/BF00259608; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taoka K, 2011, NATURE, V476, P332, DOI 10.1038/nature10272; Torti S, 2012, PLANT CELL, V24, P444, DOI 10.1105/tpc.111.092791; Tsuji H, 2013, PLANT CELL PHYSIOL, V54, P385, DOI 10.1093/pcp/pct005; Turck F, 2008, ANNU REV PLANT BIOL, V59; Turnbull C, 2011, J EXP BOT, V62, P4399, DOI 10.1093/jxb/err191; Waadt R, 2008, PLANT J, V56, P505, DOI 10.1111/j.1365-313X.2008.03612.x; Wang Y. T., 1995, American Orchid Society Bulletin, V64, P744; Xiang L, 2012, PLANT PHYSIOL BIOCH, V58, P98, DOI 10.1016/j.plaphy.2012.06.011; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; YONEDA K, 1991, J JPN SOC HORTIC SCI, V60, P651, DOI 10.2503/jjshs.60.651; Yoo SK, 2005, PLANT PHYSIOL, V139, P770, DOI 10.1104/pp.105.066928; Zeevaart JAD, 2008, CURR OPIN PLANT BIOL, V11, P541, DOI 10.1016/j.pbi.2008.06.009	85	32	35	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0134987	10.1371/journal.pone.0134987	http://dx.doi.org/10.1371/journal.pone.0134987			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317412	Green Published, Green Submitted, gold			2022-12-26	WOS:000360299100020
J	Rossouw, D; Bagheri, B; Setati, ME; Bauer, FF				Rossouw, Debra; Bagheri, Bahareh; Setati, Mathabatha Evodia; Bauer, Florian Franz			Co-Flocculation of Yeast Species, a New Mechanism to Govern Population Dynamics in Microbial Ecosystems	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; KLUYVEROMYCES-MARXIANUS; GENE-EXPRESSION; ADHESION; FLO1; IDENTIFICATION; PROTEIN; CONSTRUCTION; FERMENTATION; GROWTH	Flocculation has primarily been studied as an important technological property of Saccharomyces cerevisiae yeast strains in fermentation processes such as brewing and winemaking. These studies have led to the identification of a group of closely related genes, referred to as the FLO gene family, which controls the flocculation phenotype. All naturally occurring S. cerevisiae strains assessed thus far possess at least four independent copies of structurally similar FLO genes, namely FLO1, FLO5, FLO9 and FLO10. The genes appear to differ primarily by the degree of flocculation induced by their expression. However, the reason for the existence of a large family of very similar genes, all involved in the same phenotype, has remained unclear. In natural ecosystems, and in wine production, S. cerevisiae growth together and competes with a large number of other Saccharomyces and many more non-Saccharomyces yeast species. Our data show that many strains of such wine-related non-Saccharomyces species, some of which have recently attracted significant biotechnological interest as they contribute positively to fermentation and wine character, were able to flocculate efficiently. The data also show that both flocculent and non-flocculent S. cerevisiae strains formed mixed species flocs (a process hereafter referred to as co-flocculation) with some of these non-Saccharomyces yeasts. This ability of yeast strains to impact flocculation behaviour of other species in mixed inocula has not been described previously. Further investigation into the genetic regulation of co-flocculation revealed that different FLO genes impact differently on such adhesion phenotypes, favouring adhesion with some species while excluding other species from such mixed flocs. The data therefore strongly suggest that FLO genes govern the selective association of S. cerevisiae with specific species of non-Saccharomyces yeasts, and may therefore be drivers of ecosystem organisational patterns. Our data provide, for the first time, insights into the role of the FLO gene family beyond intraspecies cellular association, and suggest a wider evolutionary role for the FLO genes. Such a role would explain the evolutionary persistence of a large multigene family of genes with apparently similar function.	[Rossouw, Debra; Bagheri, Bahareh; Setati, Mathabatha Evodia; Bauer, Florian Franz] Univ Stellenbosch, Dept Oenol & Viticulture, Inst Wine Biotechnol, ZA-7600 Stellenbosch, South Africa	Stellenbosch University	Bauer, FF (corresponding author), Univ Stellenbosch, Dept Oenol & Viticulture, Inst Wine Biotechnol, Private Bag X1, ZA-7600 Stellenbosch, South Africa.	fb2@sun.ac.za	Bauer, Florian/A-1078-2013	Bauer, Florian/0000-0001-5764-4542; Rossouw, Debra/0000-0002-6266-0210; Bagheri, Bahareh/0000-0002-3838-5669; Setati, Mathabatha/0000-0002-5450-009X	National Research Foundation of South Africa [SARChI UID 83471]; RCA grant [91448]	National Research Foundation of South Africa(National Research Foundation - South Africa); RCA grant	This work was funded by National Research Foundation of South Africa (http://www.nrf.ac.za/): SARChI UID 83471 to FFB, and RCA grant number 91448 to DR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagheri B, 2015, S AFR J ENOL VITIC, V36, P243; Barney MC, 1990, J AM SOC BREW CHEM, V38, P71; Bauer FF, 2010, APPL MICROBIOL BIOT, V88, P31, DOI 10.1007/s00253-010-2783-0; Bester MC, 2006, CURR GENET, V49, P375, DOI 10.1007/s00294-006-0068-z; Bester MC, 2012, G3-GENES GENOM GENET, V2, P131, DOI 10.1534/g3.111.001644; Braus GH, 2003, MOL BIOL CELL, V14, P4272, DOI 10.1091/mbc.e03-01-0042; Bruckner S, 2012, FEMS MICROBIOL REV, V36, P25, DOI 10.1111/j.1574-6976.2011.00275.x; Camarasa C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025147; Carstens Elsa, 1998, South African Journal for Enology and Viticulture, V19, P52; Chovanova K, 2011, LETT APPL MICROBIOL, V53, P231, DOI 10.1111/j.1472-765X.2011.03097.x; Ciani M, 2010, FEMS YEAST RES, V10, P123, DOI 10.1111/j.1567-1364.2009.00579.x; de Groot PWJ, 2001, COMP FUNCT GENOM, V2, P124, DOI 10.1002/cfg.85; Domingues L., 2000, BIOTECHNOL BIOPROC E, V5, P288, DOI [DOI 10.1007/BF02942185, 10.1007/BF02942185]; Esteve-Zarzoso B, 1999, INT J SYST BACTERIOL, V49, P329, DOI 10.1099/00207713-49-1-329; Ghosh S, 2015, ANN MICROBIOL, V65, P1833, DOI 10.1007/s13213-014-1021-x; Goossens KVY, 2015, MBIO, V6, DOI 10.1128/mBio.00427-15; Govender P, 2008, APPL ENVIRON MICROB, V74, P6041, DOI 10.1128/AEM.00394-08; Guo B, 2000, P NATL ACAD SCI USA, V97, P12158, DOI 10.1073/pnas.220420397; Hoffman S, 2003, CURRENT PROTOCOLS MO; Jolly NP, 2014, FEMS YEAST RES, V14, P215, DOI 10.1111/1567-1364.12111; Kobayashi O, 1999, CURR GENET, V36, P256, DOI 10.1007/s002940050498; Lambrechts MG, 1996, P NATL ACAD SCI USA, V93, P8419, DOI 10.1073/pnas.93.16.8419; Liu HP, 1996, GENETICS, V144, P967; Lo WS, 1996, J BACTERIOL, V178, P7144, DOI 10.1128/jb.178.24.7144-7151.1996; Lopez CLF, 2014, WORLD J MICROB BIOT, V30, P2223, DOI 10.1007/s11274-014-1643-y; MIKI BLA, 1982, J BACTERIOL, V150, P878, DOI 10.1128/JB.150.2.878-889.1982; Noronha SB, 1998, J IND MICROBIOL BIOT, V20, P192, DOI 10.1038/sj.jim.2900507; Peng X, 2001, APPL MICROBIOL BIOT, V55, P777, DOI 10.1007/s002530000564; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; REGNACQ M, 1993, CURR GENET, V23, P435, DOI 10.1007/BF00312631; Reynolds TB, 2001, SCIENCE, V291, P878, DOI 10.1126/science.291.5505.878; ROSE A H, 1984, P323; Sampermans S, 2005, J APPL MICROBIOL, V98, P525, DOI 10.1111/j.1365-2672.2004.02486.x; Setati ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052609; Smukalla S, 2008, CELL, V135, P726, DOI 10.1016/j.cell.2008.09.037; SOUSA MJ, 1992, BIOTECHNOL LETT, V14, P213, DOI 10.1007/BF01023361; TEUNISSEN AWRH, 1995, YEAST, V11, P1001, DOI 10.1002/yea.320111102; Van Mulders SE, 2009, FEMS YEAST RES, V9, P178, DOI 10.1111/j.1567-1364.2008.00462.x; Veelders M, 2010, P NATL ACAD SCI USA, V107, P22511, DOI 10.1073/pnas.1013210108; Verstrepen KJ, 2006, MOL MICROBIOL, V60, P5, DOI 10.1111/j.1365-2958.2006.05072.x; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Verstrepen KJ, 2004, NAT REV MICROBIOL, V2, P533, DOI 10.1038/nrmicro927; Verstrepen KJ, 2001, J AM SOC BREW CHEM, V59, P69; WATARI J, 1994, J I BREWING, V100, P73, DOI 10.1002/j.2050-0416.1994.tb00809.x; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107	45	26	26	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136249	10.1371/journal.pone.0136249	http://dx.doi.org/10.1371/journal.pone.0136249			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317200	gold, Green Published			2022-12-26	WOS:000360299100066
J	Zou, JX; Zhou, ZG; Wan, LP; Tong, Y; Qin, YW; Wang, C; Zhou, K				Zou, Jixue; Zhou, Zhigang; Wan, Liping; Tong, Yin; Qin, Youwen; Wang, Chun; Zhou, Kun			Targeting the Sonic Hedgehog-Gli1 Pathway as a Potential New Therapeutic Strategy for Myelodysplastic Syndromes	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; P15(INK4B) GENE; PROMOTER HYPERMETHYLATION; DNA METHYLTRANSFERASES; DISEASE PROGRESSION; HEMATOPOIETIC-CELLS; PHASE-III; METHYLATION; CANCER; DECITABINE	The complex mechanistic array underlying the pathogenesis of myelodysplastic syndrome (MDS) is still unclear. Although dysregulations of different signaling pathways involved in MDS have been described, the identification of specific biomarkers and therapy targets remains an important task in order to establish novel therapeutic approaches. Here, we demonstrated that the Shh signaling pathway is active in MDS and correlated it with disease progression. Additionally, the knockdown of Gli1 significantly inhibited cell proliferation in vitro and in vivo. Gli1 silencing also induced apoptosis and G0/G1 phase arrest. Furthermore, Gli1 silencing enhanced the demethylating effect of 5-aza-2'-deoxycytidine on the p15 gene promoter and subsequently promoted its expression by inhibiting DNA methyltransferase 1(DNMT1). Our findings show that the Shh signaling pathway plays a role in the pathogenesis and disease progression of MDS, and proceeds by modulating DNA methylation. This pathway may prove to be a potential therapeutic target for enhancing the therapeutic effects of 5-azacytidine on malignant transformation of MDS.	[Zou, Jixue; Wan, Liping; Tong, Yin; Qin, Youwen; Wang, Chun; Zhou, Kun] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 1, Dept Hematol, Shanghai 200030, Peoples R China; [Zhou, Zhigang] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 1, Dept Intens Care Unit, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, C (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 1, Dept Hematol, Shanghai 200030, Peoples R China.	chunwang_sjtu@163.com; zhkzhw@163.com			National Natural Science Foundation of China [81200347]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Natural Science Foundation of China (grant no. 81200347).	ABE S, 1982, GANN, V73, P961; Aggerholm A, 2006, EUR J HAEMATOL, V76, P23, DOI 10.1111/j.1600-0609.2005.00559.x; Aoki E, 2000, LEUKEMIA, V14, P586, DOI 10.1038/sj.leu.2401719; Bai LY, 2008, LEUKEMIA, V22, P226, DOI 10.1038/sj.leu.2404978; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Eichberger T, 2006, GENOMICS, V87, P616, DOI 10.1016/j.ygeno.2005.12.003; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; Greenberg PL, 2012, BLOOD, V120, P2454, DOI 10.1182/blood-2012-03-420489; He SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027684; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hopfer O, 2009, LEUKEMIA RES, V33, P434, DOI 10.1016/j.leukres.2008.08.014; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1794, DOI 10.1002/cncr.21792; Kobune M, 2009, CANCER SCI, V100, P948, DOI 10.1111/j.1349-7006.2009.01111.x; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Ma D, 2015, GENE THER, V22, P287, DOI 10.1038/gt.2015.1; Mizuno S, 2001, BLOOD, V97, P1172, DOI 10.1182/blood.V97.5.1172; Peukert S, 2010, CHEMMEDCHEM, V5, P500, DOI 10.1002/cmdc.201000011; Plass C, 1999, ONCOGENE, V18, P3159, DOI 10.1038/sj.onc.1202651; Quesnel B, 1998, BLOOD, V91, P2985, DOI 10.1182/blood.V91.8.2985.2985_2985_2990; Quesnel B, 1999, LEUKEMIA LYMPHOMA, V35, P437, DOI 10.1080/10428199909169608; Steube KG, 1997, LEUKEMIA LYMPHOMA, V25, P345, DOI 10.3109/10428199709114174; Tefferi A, 2009, NEW ENGL J MED, V361, P1872, DOI 10.1056/NEJMra0902908; Tien HF, 2001, BRIT J HAEMATOL, V112, P148, DOI 10.1046/j.1365-2141.2001.02496.x; Ting AH, 2006, GENE DEV, V20, P3215, DOI 10.1101/gad.1464906; Uchida T, 1998, LEUKEMIA LYMPHOMA, V32, P9, DOI 10.3109/10428199809059242; Uchida T, 1997, BLOOD, V90, P1403, DOI 10.1182/blood.V90.4.1403.1403_1403_1409; Vardiman JW, 2002, BLOOD, V100, P2292, DOI 10.1182/blood-2002-04-1199; Wong IHN, 2000, BLOOD, V95, P1942, DOI 10.1182/blood.V95.6.1942; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737; Zou JX, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/957502	32	30	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136843	10.1371/journal.pone.0136843	http://dx.doi.org/10.1371/journal.pone.0136843			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317501	gold, Green Published, Green Submitted			2022-12-26	WOS:000360299100149
J	Zwart, SR; Gregory, JF; Zeisel, SH; Gibson, CR; Mader, TH; Kinchen, JM; Ueland, PM; Ploutz-Snyder, R; Heer, MA; Smith, SM				Zwart, Sara R.; Gregory, Jesse F.; Zeisel, Steven H.; Gibson, Charles R.; Mader, Thomas H.; Kinchen, Jason M.; Ueland, Per M.; Ploutz-Snyder, Robert; Heer, Martina A.; Smith, Scott M.			Genotype, B-vitamin status, and androgens affect spaceflight-induced ophthalmic changes	FASEB JOURNAL			English	Article							POLYCYSTIC-OVARY-SYNDROME; IDIOPATHIC INTRACRANIAL HYPERTENSION; SECONDARY PSEUDOTUMOR CEREBRI; DURATION SPACE-FLIGHT; METHYLENETETRAHYDROFOLATE REDUCTASE; BED REST; HOMOCYSTEINE; POLYMORPHISMS; TESTOSTERONE; METABOLISM	Ophthalmic changes have occurred in a subset of astronauts on International Space Station missions. Visual deterioration is considered the greatest human health risk of spaceflight. Affected astronauts exhibit higher concentrations of 1-carbon metabolites (e.g., homocysteine) before flight. We hypothesized that genetic variations in 1-carbon metabolism genes contribute to susceptibility to ophthalmic changes in astronauts. We investigated 5 polymorphisms in the methionine synthase reductase (MTRR), methylenetetrahydrofolate reductase (MTHFR), serine hydroxymethyltransferase (SHMT), and cystathionine beta-synthase (CBS) genes and their association with ophthalmic changes after flight in 49 astronauts. The number of G alleles of MTRR 66 and C alleles of SHMT1 1420 both contributed to the odds of visual disturbances. Preflight dehydroepiandrosterone was positively associated with cotton wool spots, and serum testosterone response during flight was associated with refractive change. Block regression showed that B-vitamin status and genetics were significant predictors of many of the ophthalmic outcomes that we observed. In one example, genetics trended toward improving (P = 0.10) and B-vitamin status significantly improved (P < 0.001) the predictive model for refractive change after flight. We document an association between MTRR 66 and SHMT1 1420 polymorphisms and spaceflight-induced vision changes. This line of research could lead to therapeutic options for both space travelers and terrestrial patients.-Zwart, S. R., Gregory, J. F., Zeisel, S. H., Gibson, C. R., Mader, T. H., Kinchen, J. M., Ueland, P. M., Ploutz-Snyder, R., Heer, M. A., Smith, S. M. Genotype, B-vitamin status, and androgens affect spaceflight-induced ophthalmic changes. FASEB J. 30, 141-148 (2016). www.fasebj.org	[Zwart, Sara R.; Ploutz-Snyder, Robert] Univ Space Res Assoc, Div Space Life Sci, Houston, TX USA; [Gregory, Jesse F.] Univ Florida, Inst Food & Agr Sci, Food Sci & Human Nutr, Gainesville, FL 32611 USA; [Zeisel, Steven H.] Univ N Carolina, Inst Nutr Res, Kannapolis, NC USA; [Gibson, Charles R.] Coastal Eye Associates, Webster, TX USA; [Kinchen, Jason M.] Metabolon Inc, Durham, NC USA; [Ueland, Per M.] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Heer, Martina A.] Univ Bonn, Dept Nutr & Food Sci, Nutrit Physiol, Bonn, Germany; [Smith, Scott M.] NASA, Lyndon B Johnson Space Ctr, Biomed Res & Environm Sci Div, Houston, TX 77058 USA	Universities Space Research Association (USRA); State University System of Florida; University of Florida; University of North Carolina; Metabolon; University of Bergen; University of Bonn; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	Smith, SM (corresponding author), NASA, Lyndon B Johnson Space Ctr, Attn Mail Code SK3,2101 NASA Pkwy, Houston, TX 77058 USA.	scott.m.smith@nasa.gov	Heer, Martina/Q-4959-2019; Kinchen, Jason/ABC-5663-2021; Ueland, Per M/C-7340-2013	Heer, Martina/0000-0001-5534-911X; Ueland, Per Magne/0000-0002-1903-0571; Kinchen, Jason/0000-0001-8430-2265	NASA Human Research Program's Human Health and Countermeasures Element; German Federal Ministry for Economics and Technology/DLR Forschung unter Weltraumbedingungen [50WB0931]; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [DK56350]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	NASA Human Research Program's Human Health and Countermeasures Element; German Federal Ministry for Economics and Technology/DLR Forschung unter Weltraumbedingungen; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank the astronauts for their participation in and support of this study; the staff of the NASA Johnson Space Center Nutritional Biochemistry Laboratory for their assistance in all aspects of the project; the ISS Medical Project, specifically T. Bauer, for help with coordinating the project; the NASA Lifetime Surveillance of Astronaut Health team for their help with eye- and vision-related data; and J. Krauhs for editorial assistance. This project was funded by the NASA Human Research Program's Human Health and Countermeasures Element, by the German Federal Ministry for Economics and Technology/DLR Forschung unter Weltraumbedingungen Grant 50WB0931 (to M.A.H.), and by the U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant DK56350 (to S.H.Z.). S.M.S., S.R.Z., and M.A.H. designed the research; S.M.S. and S.R.Z. oversaw data collection and management of the biological sample collections and analyses; C.R.G. and T.H.M. oversaw data collection and management of the vision and related data; J.M.K. conducted metabolomics analyses; and R.P.S. performed statistical analysis; and all authors were involved in interpreting the data and preparing the manuscript. All authors read and approved the final manuscript. S.M.S. had primary responsibility for the content of the final version. The authors declare no conflicts of interest.	Avisar I., 2012, SCI CAIRO, V2012; Daan NMP, 2014, FERTIL STERIL, V102, DOI 10.1016/j.fertnstert.2014.08.001; Davis SR, 2005, J NUTR, V135, P1040, DOI 10.1093/jn/135.5.1040; Demir M, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/752186; Finsterer J, 2007, GYNECOL ENDOCRINOL, V23, P179, DOI 10.1080/09513590701237290; Garcia-Minguillan CJ, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0435-1; Gaughan DJ, 2001, ATHEROSCLEROSIS, V157, P451, DOI 10.1016/S0021-9150(00)00739-5; Glueck CJ, 2005, J LAB CLIN MED, V145, P72, DOI 10.1016/j.lab.2004.09.011; Grodnitskaya EE, 2012, GYNECOL ENDOCRINOL, V28, P186, DOI 10.3109/09513590.2011.589927; Heimark D, 2014, ENDOCR J, V61, P111, DOI 10.1507/endocrj.EJ13-0423; JONES KJ, 1988, METAB BRAIN DIS, V3, P1, DOI 10.1007/BF01001350; Kapoor KG, 2009, CLIN EXP OPTOM, V92, P519, DOI 10.1111/j.1444-0938.2009.00423.x; Klein A, 2013, CURR EYE RES, V38, P972, DOI 10.3109/02713683.2013.799214; Kluijtmans LAJ, 2003, BLOOD, V101, P2483, DOI 10.1182/blood.V101.7.2483; Kurzrock R, 2007, MED HYPOTHESES, V68, P480, DOI 10.1016/j.mehy.2006.03.057; Lakshmi SVV, 2013, CELL BIOCHEM BIOPHYS, V67, P353, DOI 10.1007/s12013-011-9322-1; Liang S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/560183; Liu DM, 2014, HUM REPROD, V29, P2764, DOI 10.1093/humrep/deu282; Loverro G, 2002, GYNECOL OBSTET INVES, V53, P157, DOI 10.1159/000058367; Mader TH, 2011, OPHTHALMOLOGY, V118, P2058, DOI 10.1016/j.ophtha.2011.06.021; Maleedhu P, 2014, J CLIN DIAGN RES, V8, P31, DOI 10.7860/JCDR/2014/7070.3999; March WA, 2010, HUM REPROD, V25, P544, DOI 10.1093/humrep/dep399; Marshall-Bowman K, 2013, ACTA ASTRONAUT, V87, P77, DOI 10.1016/j.actaastro.2013.01.014; Mowl AD, 2009, CLIN EXP OPTOM, V92, P449, DOI 10.1111/j.1444-0938.2009.00404.x; Nilsson TK, 2014, MOL MED REP, V10, P2706, DOI 10.3892/mmr.2014.2521; Ornek N, 2015, J OBSTET GYNAECOL RE, V41, P1080, DOI 10.1111/jog.12673; Randeva HS, 2012, ENDOCR REV, V33, P812, DOI 10.1210/er.2012-1003; SANBORN TA, 1975, ENDOCRINOLOGY, V97, P1000, DOI 10.1210/endo-97-4-1000; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Shin SH, 2014, PEDIATR INT, V56, P411, DOI 10.1111/ped.12266; Sirek AS, 2014, AVIAT SPACE ENVIR MD, V85, P3, DOI 10.3357/ASEM.3750.2014; Smith SM, 2012, J CLIN ENDOCR METAB, V97, P270, DOI 10.1210/jc.2011-2233; Sprung VS, 2013, J PHYSIOL-LONDON, V591, P1475, DOI 10.1113/jphysiol.2012.246918; Wenner MM, 2013, AM J PHYSIOL-ENDOC M, V305, pE818, DOI 10.1152/ajpendo.00343.2013; Yilmaz M, 2005, HUM REPROD, V20, P2414, DOI 10.1093/humrep/dei070; Zwart SR, 2009, J APPL PHYSIOL, V107, P54, DOI 10.1152/japplphysiol.91136.2008; Zwart SR, 2013, AM J CLIN NUTR, V98, P217, DOI 10.3945/ajcn.112.056465; Zwart SR, 2012, J NUTR, V142, P427, DOI 10.3945/jn.111.154245	38	29	30	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					141	148		10.1096/fj.15-278457	http://dx.doi.org/10.1096/fj.15-278457			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26316272	Green Published, Green Submitted			2022-12-26	WOS:000367621000016
J	Gol'din, P; Steeman, ME				Gol'din, Pavel; Steeman, Mette Elstrup			From Problem Taxa to Problem Solver: A New Miocene Family, Tranatocetidae, Brings Perspective on Baleen Whale Evolution	PLOS ONE			English	Article							CETACEA; MYSTICETI; CETOTHERIIDAE; PLIOCENE; PHYLOGENY; MAMMALIA; DENMARK	Miocene baleen whales were highly diverse and included tens of genera. However, their taxonomy and phylogeny, as well as relationships with living whales, are still a subject of controversy. Here, "Mesocetus" argillarius, a poorly known specimen from Denmark, is redescribed with a focus on the cranial anatomy. It was found to represent not only a new genus, Tranatocetus gen. nov., but also a new family; Tranatocetidae. The whales of this family have the rostral bones either overriding or dividing the frontals; the rostral bones are contacting the parietals and nasals dividing the maxillae on the vertex; the occipital shield is dorsoventrally bent. The tympanic bulla is particularly characteristic of this family featuring a short, narrow anterior portion with a rounded or squared anterior end and a wider and higher posterior portion that is swollen in the posteroventral area. A phylogenetic analysis including 51 taxa supports a monophyletic group comprising most Neogene and modern whales, with Tranatocetidae being possibly closer related to Balaenopteridae (rorquals) than to Cetotheriidae. Tranatocetidae exhibit a charahteristic bulla shape. In fact, all Neogene and modern mysticete families examined have a unique shape of the tympanic bulla that is diagnostic at family-level. Inclusion of problematic taxa like Tranatocetus argillarius in phylogenies brings new understanding of the distribution and diagnostic value of character traits. This underlines the need for re-examination of earlier described specimens in the light of the wealth of new information published in later years.	[Gol'din, Pavel; Steeman, Mette Elstrup] Museum Southern Jutland, Dept Nat Hist & Palaeontol, DK-6510 Gram, Denmark		Gol'din, P (corresponding author), Museum Southern Jutland, Dept Nat Hist & Palaeontol, Lergravsvej 2, DK-6510 Gram, Denmark.	pago@museum-sonderjylland.dk	Gol'din, Pavel/C-2061-2016	Gol'din, Pavel/0000-0001-6118-1384; Elstrup, Mette/0000-0003-2285-4368	Ministry of Culture of Denmark [FORM.2014-0033]	Ministry of Culture of Denmark	The work of PG was supported by the Grant of the Ministry of Culture of Denmark, FORM.2014-0033.	Beneden P. J. Van, 1880, Bulletin de l'Academie de Belgique, V(2), P11; Beyer C., 2005, PALAEONTOS, V7, P19; Bisconti M, 2006, J VERTEBR PALEONTOL, V26, P344, DOI 10.1671/0272-4634(2006)26[344:TANBWF]2.0.CO;2; Bisconti M, 2015, J SYST PALAEONTOL, V13, P377, DOI 10.1080/14772019.2014.890136; Bouetel V, 2006, GEODIVERSITAS, V28, P319; Brandt J.F., 1871, B ACAD IMPERIALE SCI, V16, P563; Brandt J.-F., 1873, MEMOIRES LACADEMIE I, V20, P1, DOI DOI 10.5962/BHL.TITLE.39524; COPE ED, 1896, P AM PHILOS SOC, V35, P139; CZYZEWSKA T, 1976, Acta Palaeontologica Polonica, V21, P259; El Adli JJ, 2014, ZOOL J LINN SOC-LOND, V170, P400, DOI 10.1111/zoj.12108; Fordyce Ewan, 2001, P169; Fordyce RE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2645; FRASER F. C., 1960, BULL BRIT MUS [NAT HIST] ZOOL, V7, P1; Geisler JH, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-112; GoL'Din P, 2014, ACTA PALAEONTOL POL, V59, P795, DOI 10.4202/app.2012.0107; Gol'din P, 2014, J VERTEBR PALEONTOL, V34, P419, DOI 10.1080/02724634.2013.799482; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Kasuya T., 1973, Scientific Rep Whales Res Inst Tokyo, VNo. 25, P1; Kellogg R, 1940, B LAB MINERALOGICO G, V3, P13; Kellogg R., 1934, CARNEGIE I WASHINGTO, V447, P83; Kellogg R, 1931, P CALIFORNIA ACAD SC, V19, P217; Kellogg R, 2012, KELLOGG ILLUSTRATION; Kimura T, 2010, J VERTEBR PALEONTOL, V30, P577, DOI 10.1080/02724631003621912; Marx FG, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140434; Marx FG, 2011, J MAMM EVOL, V18, P77, DOI 10.1007/s10914-010-9148-4; Mchedlidze G.A., 1984, FOSSIL WHALE MIOCENE; Mead James G., 2009, Smithsonian Contributions to Zoology, P1; Piasecki S., 2005, GRAM BOOK PALAEONTOS, V7, P29; Rasmussen L. B., 1966, Danmarks Geologiske Undersogelse Raekke II, V88, P1; ROTH F, 1978, ZOOL SCR, V7, P63, DOI 10.1111/j.1463-6409.1978.tb00589.x; Sanders Albert E., 2002, Smithsonian Contributions to Paleobiology, V93, P313; Schnetler K.I., 2005, Palaeontos, V7, P62; Schulte H.W, 1916, MEM AM MUS NATUR HIS, V1, P391; Steeman ME, 2009, PALAEONTOLOGY, V52, P1169, DOI 10.1111/j.1475-4983.2009.00893.x; Steeman ME, 2007, ZOOL J LINN SOC-LOND, V150, P875, DOI 10.1111/j.1096-3642.2007.00313.x; Steeman ME, 2010, J SYST PALAEONTOL, V8, P63, DOI 10.1080/14772011003594961; Tsai CH, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.0875; Van Beneden P.-J., 1880, OSTEOGRAPHIE CETACES; Van Beneden P. J., 1886, ANN MUSEE ROYAL HIST, V13, P1; Van Beneden P-J., 1859, B ACAD ROYALE SCI LE, V8, P123; Vandelli AA, 1831, HIST MEMORIAS ACAD R, V2, P281	41	21	21	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135500	10.1371/journal.pone.0135500	http://dx.doi.org/10.1371/journal.pone.0135500			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331471	Green Published, gold, Green Submitted			2022-12-26	WOS:000360613800031
J	Gray, CA; Runyon, JB; Jenkins, MJ; Giunta, AD				Gray, Curtis A.; Runyon, Justin B.; Jenkins, Michael J.; Giunta, Andrew D.			Mountain Pine Beetles Use Volatile Cues to Locate Host Limber Pine and Avoid Non-Host Great Basin Bristlecone Pine	PLOS ONE			English	Article							DENDROCTONUS-PONDEROSAE COLEOPTERA; LODGEPOLE PINE; HOPKINS COLEOPTERA; SCOLYTIDAE; MONOTERPENES; ORIENTATION; INTEGRATION; PHEROMONES; RESPONSES; OUTBREAKS	The tree-killing mountain pine beetle (Dendroctonus ponderosae Hopkins) is an important disturbance agent of western North American forests and recent outbreaks have affected tens of millions of hectares of trees. Most western North American pines (Pinus spp.) are hosts and are successfully attacked by mountain pine beetles whereas a handful of pine species are not suitable hosts and are rarely attacked. How pioneering females locate host trees is not well understood, with prevailing theory involving random landings and/or visual cues. Here we show that female mountain pine beetles orient toward volatile organic compounds (VOCs) from host limber pine (Pinus flexilis James) and away from VOCs of non-host Great Basin bristlecone pine (Pinus longaeva Bailey) in a Y-tube olfactometer. When presented with VOCs of both trees, females overwhelmingly choose limber pine over Great Basin bristlecone pine. Analysis of VOCs collected from co-occurring limber and Great Basin bristlecone pine trees revealed only a few quantitative differences. Noticeable differences included the monoterpenes 3-carene and D-limonene which were produced in greater amounts by host limber pine. We found no evidence that 3-carene is important for beetles when selecting trees, it was not attractive alone and its addition to Great Basin bristlecone pine VOCs did not alter female selection. However, addition of D-limonene to Great Basin bristlecone pine VOCs disrupted the ability of beetles to distinguish between tree species. When presented alone, D-limonene did not affect behavior, suggesting that the response is mediated by multiple compounds. A better understanding of host selection by mountain pine beetles could improve strategies for managing this important forest insect. Moreover, elucidating how Great Basin bristlecone pine escapes attack by mountain pine beetles could provide insight into mechanisms underlying the incredible longevity of this tree species.	[Gray, Curtis A.; Jenkins, Michael J.; Giunta, Andrew D.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Runyon, Justin B.] US Forest Serv, USDA, Rocky Mt Res Stn, Forestry Sci Lab, Bozeman, MT USA	Utah System of Higher Education; Utah State University; United States Department of Agriculture (USDA); United States Forest Service	Gray, CA (corresponding author), Utah State Univ, Dept Wildland Resources, 5230 Old Main Hill, Logan, UT 84322 USA.	curtis.gray@aggiemail.usu.edu			USFS EM Project [INT-EM-F-10-02]; Utah Agricultural Experiment Station (UAES) UTA Project [1070]; USDA National Needs Graduate Fellowship Competitive NIFA Grant; PECASE (President's Early Career Award in Science and Engineering)	USFS EM Project; Utah Agricultural Experiment Station (UAES) UTA Project; USDA National Needs Graduate Fellowship Competitive NIFA Grant; PECASE (President's Early Career Award in Science and Engineering)	This project was supported by funding from USFS EM Project INT-EM-F-10-02, Utah Agricultural Experiment Station (UAES) UTA Project 1070, USDA National Needs Graduate Fellowship Competitive NIFA Grant, and PECASE (President's Early Career Award in Science and Engineering) to Justin Runyon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumeister D, 2006, ECOLOGY, V87, P1816, DOI 10.1890/0012-9658(2006)87[1816:FBPFDS]2.0.CO;2; BILLINGS RF, 1976, ENVIRON ENTOMOL, V5, P171, DOI 10.1093/ee/5.1.171; Borden J, 1986, MECH INSECT OLFACTIO; Borden JH, 2008, J ECON ENTOMOL, V101, P1266, DOI 10.1603/0022-0493(2008)101[1266:SBOMFA]2.0.CO;2; Bruce TJA, 2011, PHYTOCHEMISTRY, V72, P1605, DOI 10.1016/j.phytochem.2011.04.011; BURNELL DG, 1977, RES POPUL ECOL, V19, P99, DOI 10.1007/BF02510942; Campbell SA, 2006, ECOL ENTOMOL, V31, P437, DOI 10.1111/j.1365-2311.2006.00809.x; Campbell SA, 2009, OIKOS, V118, P553, DOI 10.1111/j.1600-0706.2009.16761.x; Daisy BH, 2002, MICROBIOL-SGM, V148, P3737, DOI 10.1099/00221287-148-11-3737; Gibson K., 2008, MOUNTAIN PINE BEETLE; Griffin JM, 2011, FOREST ECOL MANAG, V261, P1077, DOI 10.1016/j.foreco.2010.12.031; Hansen EM, 2014, FOREST SCI, V60, P476, DOI 10.5849/forsci.13-039; HUNT DWA, 1989, CAN J FOREST RES, V19, P1275, DOI 10.1139/x89-194; HYNUM BG, 1980, CAN ENTOMOL, V112, P185, DOI 10.4039/Ent112185-2; Jenkins MJ, 2014, FOREST SCI, V60, P489, DOI 10.5849/forsci.13-017; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; LANGOR DW, 1989, CAN ENTOMOL, V121, P149, DOI 10.4039/Ent121149-2; Liu ZD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022005; Logan JA, 2010, ECOL APPL, V20, P895, DOI 10.1890/09-0655.1; LYON R. L., 1958, CANADIAN ENT, V90, P582; Man G, 2010, MAJOR FOREST INSECT; MOECK HA, 1991, CAN ENTOMOL, V123, P299, DOI 10.4039/Ent123299-2; Page WG, 2014, FOREST SCI, V60, P691, DOI 10.5849/forsci.13-050; Page WG, 2012, CAN J FOREST RES, V42, P1631, DOI [10.1139/X2012-094, 10.1139/x2012-094]; Piesik D, 2008, AGR FOREST ENTOMOL, V10, P245, DOI 10.1111/j.1461-9563.2008.00380.x; PITMAN GB, 1968, NATURE, V218, P168, DOI 10.1038/218168a0; Progar RA, 2014, FOREST SCI, V60, P414, DOI 10.5849/forsci.13-010; Pureswaran DS, 2004, CHEMOECOLOGY, V14, P59, DOI 10.1007/s00049-003-0261-1; Pureswaran DS, 2004, BIOCHEM SYST ECOL, V32, P1109, DOI 10.1016/j.bse.2004.04.006; R Development Core Team, 2012, R LANG ENV STAT COMP; Raffa Kenneth F., 1993, P103; RUDINSKY JA, 1966, SCIENCE, V152, P218, DOI 10.1126/science.152.3719.218; Runyon JB, 2006, SCIENCE, V313, P1964, DOI 10.1126/science.1131371; Saab VA, 2014, FOREST SCI, V60, P539, DOI 10.5849/forsci.13-022; Safranyik L, 2004, FOREST ECOL MANAG, V200, P23, DOI 10.1016/j.foreco.2004.06.004; Safranyik L., 2007, BIOL EPIDEMIOLOGY MO, P3; Schoettle AW, 2004, RMRSP32 USDA FOR SER, P124; SHEPHERD RF, 1966, CAN ENTOMOL, V98, P507, DOI 10.4039/Ent98507-5; Sokal R. R., 1981, BIOMETRY; Stritch L, 2011, PINUS LONGAEVA IUCN; Tomback DF, 2010, FOREST PATHOL, V40, P186, DOI 10.1111/j.1439-0329.2010.00655.x; VISSER JH, 1978, ENTOMOL EXP APPL, V24, P738, DOI 10.1007/BF02385130; Vite JP, 1962, CONTRIB BOYCE THOMPS, V21, P3; WOOD DL, 1982, ANNU REV ENTOMOL, V27, P411, DOI 10.1146/annurev.en.27.010182.002211; Youngblood AP, 1985, INT187 USDA FOR SERV	45	27	27	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135752	10.1371/journal.pone.0135752	http://dx.doi.org/10.1371/journal.pone.0135752			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332317	Green Published, Green Submitted, gold			2022-12-26	WOS:000360613800039
J	Jeruschke, S; Jeruschke, K; DiStasio, A; Karaterzi, S; Buscher, AK; Nalbant, P; Klein-Hitpass, L; Hoyer, PF; Weiss, J; Stottmann, RW; Weber, S				Jeruschke, Stefanie; Jeruschke, Kay; DiStasio, Andrew; Karaterzi, Sinem; Buescher, Anja K.; Nalbant, Perihan; Klein-Hitpass, Ludger; Hoyer, Peter F.; Weiss, Juergen; Stottmann, Rolf W.; Weber, Stefanie			Everolimus Stabilizes Podocyte Microtubules via Enhancing TUBB2B and DCDC2 Expression	PLOS ONE			English	Article							MORPHOGENETIC ACTIVITY; ACTIN CYTOSKELETON; DCX SUPERFAMILY; RAT-KIDNEY; DOUBLECORTIN; PROTEIN; GENE; MUTATIONS; CELLS; MOUSE	Background Glomerular podocytes are highly differentiated cells that are key components of the kidney filtration units. The podocyte cytoskeleton builds the basis for the dynamic podocyte cytoarchitecture and plays a central role for proper podocyte function. Recent studies implicate that immunosuppressive agents including the mTOR-inhibitor everolimus have a protective role directly on the stability of the podocyte actin cytoskeleton. In contrast, a potential stabilization of microtubules by everolimus has not been studied so far. Methods To elucidate mechanisms underlying mTOR-inhibitor mediated cytoskeletal rearrangements, we carried out microarray gene expression studies to identify target genes and corresponding pathways in response to everolimus. We analyzed the effect of everolimus in a puromycin aminonucleoside experimental in vitro model of podocyte injury. Results Upon treatment with puromycin aminonucleoside, microarray analysis revealed gene clusters involved in cytoskeletal reorganization, cell adhesion, migration and extracellular matrix composition to be affected. Everolimus was capable of protecting podocytes from injury, both on transcriptional and protein level. Rescued genes included tubulin beta 2B class IIb (TUBB2B) and doublecortin domain containing 2 (DCDC2), both involved in microtubule structure formation in neuronal cells but not identified in podocytes so far. Validating gene expression data, Western-blot analysis in cultured podocytes demonstrated an increase of TUBB2B and DCDC2 protein after everolimus treatment, and immunohistochemistry in healthy control kidneys confirmed a podocyte-specific expression. Interestingly, Tubb2(bbrdp/brdp) mice revealed a delay in glomerular podocyte development as showed by podocyte-specific markers Wilm's tumour 1, Podocin, Nephrin and Synaptopodin. Conclusions Taken together, our study suggests that off-target, non-immune mediated effects of the mTOR-inhibitor everolimus on the podocyte cytoskeleton might involve regulation of microtubules, revealing a potential novel role of TUBB2B and DCDC2 in glomerular podocyte development.	[Jeruschke, Stefanie; Karaterzi, Sinem; Buescher, Anja K.; Hoyer, Peter F.; Weber, Stefanie] Univ Hosp Essen, Pediat Nephrol, Pediat 2, Essen, Germany; [Jeruschke, Kay; Weiss, Juergen] German Diabet Ctr, Inst Clin Biochem & Pathobiochem, Dusseldorf, Germany; [DiStasio, Andrew; Stottmann, Rolf W.] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [DiStasio, Andrew; Stottmann, Rolf W.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Nalbant, Perihan] Univ Duisburg Essen, Ctr Med Biotechnol, Mol Cell Biol, Essen, Germany; [Klein-Hitpass, Ludger] Univ Duisburg Essen, Inst Cell Biol, Essen, Germany	University of Duisburg Essen; Deutsches Diabetes-Zentrum (DDZ); Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University of Duisburg Essen; University of Duisburg Essen	Jeruschke, S (corresponding author), Univ Hosp Essen, Pediat Nephrol, Pediat 2, Essen, Germany.	Stefanie.Jeruschke@uk-essen.de	Stottmann, Rolf/GRO-3453-2022; Stottmann, Rolf/U-6589-2019	Stottmann, Rolf/0000-0003-4512-6806; 	Deutsche Forschungsgemeinschaft [BU 2602/3-1]; Forschungsunterstuttzungskreis Kindernephrologie e. V	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forschungsunterstuttzungskreis Kindernephrologie e. V	AKB and SW received financial support from the Deutsche Forschungsgemeinschaft (BU 2602/3-1) and Stefanie Jeruschke from the Forschungsunterstuttzungskreis Kindernephrologie e. V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS PM, 1981, KIDNEY INT, V20, P549, DOI 10.1038/ki.1981.176; ANDREWS PM, 1977, AM J ANAT, V150, P53, DOI 10.1002/aja.1001500104; Bechstedt S, 2012, DEV CELL, V23, P181, DOI 10.1016/j.devcel.2012.05.006; Breuss M, 2014, ADV EXP MED BIOL, V800, P75, DOI 10.1007/978-94-007-7687-6_5; Buscher AK, 2012, EUR J PEDIATR, V171, P1151, DOI 10.1007/s00431-011-1668-2; Burbridge TJ, 2008, NEUROSCIENCE, V152, P723, DOI 10.1016/j.neuroscience.2008.01.020; Chang YC, 2008, MOL BIOL CELL, V19, P2147, DOI 10.1091/mbc.E07-12-1269; Cong EH, 2014, J AM SOC NEPHROL, V25, P2435, DOI 10.1681/ASN.2013101126; Coquelle FM, 2006, CELL CYCLE, V5, P976, DOI 10.4161/cc.5.9.2715; Cortes P, 2000, KIDNEY INT, V58, P2452, DOI 10.1046/j.1523-1755.2000.00428.x; Dehmelt L, 2006, BRAIN CELL BIOL, V35, P39, DOI 10.1007/s11068-006-9001-0; DRENCKHAHN D, 1988, LAB INVEST, V59, P673; FARQUHAR MG, 1957, J EXP MED, V106, P649, DOI 10.1084/jem.106.5.649; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Friocourt G, 2011, ACTA NEUROPATHOL, V121, P149, DOI 10.1007/s00401-010-0768-9; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Ichimura K, 2003, J HISTOCHEM CYTOCHEM, V51, P1589, DOI 10.1177/002215540305101203; Jaglin XH, 2009, TRENDS GENET, V25, P555, DOI 10.1016/j.tig.2009.10.003; Jaglin XH, 2009, NAT GENET, V41, P746, DOI 10.1038/ng.380; Jeruschke S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055980; Kaverina I, 1998, J CELL BIOL, V142, P181, DOI 10.1083/jcb.142.1.181; KERJASCHKI D, 1978, LAB INVEST, V39, P430; Kim MH, 2003, NAT STRUCT BIOL, V10, P324, DOI 10.1038/nsb918; Kim SY, 2011, CELL ADHES MIGR, V5, P97, DOI 10.4161/cam.5.2.14374; Kobayashi N, 1998, J CELL BIOL, V143, P1961, DOI 10.1083/jcb.143.7.1961; Kobayashi N, 1998, CELL TISSUE RES, V291, P163, DOI 10.1007/s004410050988; Kobayashi N, 2000, BIOCHEM BIOPH RES CO, V268, P306, DOI 10.1006/bbrc.2000.2126; Kobayashi N, 2001, MARC MALPIG SYMP SER, V7, P423; Kobayashi N, 2001, HISTOCHEM CELL BIOL, V115, P255; Liu JS, 2012, MOL CELL, V47, P707, DOI 10.1016/j.molcel.2012.06.025; Massinen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020580; Meng HY, 2005, P NATL ACAD SCI USA, V102, P17053, DOI 10.1073/pnas.0508591102; Moores CA, 2004, MOL CELL, V14, P833, DOI 10.1016/j.molcel.2004.06.009; Moores CA, 2006, EMBO J, V25, P4448, DOI 10.1038/sj.emboj.7601335; MUNDEL P, 1995, ANAT EMBRYOL, V192, P387; Nalbant P, 2009, MOL BIOL CELL, V20, P4070, DOI 10.1091/mbc.E09-01-0041; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Reiner O, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-188; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Scaife RM, 2003, MOL BIOL CELL, V14, P4605, DOI 10.1091/mbc.E02-11-0739; Schueler M, 2015, AM J HUM GENET, V96, P81, DOI 10.1016/j.ajhg.2014.12.002; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Stottmann RW, 2013, HUM MOL GENET, V22, P4053, DOI 10.1093/hmg/ddt255; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tischfield MA, 2010, CELL, V140, P74, DOI 10.1016/j.cell.2009.12.011; TYSON GE, 1977, VIRCHOWS ARCH B, V25, P105; VASMANT D, 1984, ANAT REC, V210, P17, DOI 10.1002/ar.1092100104; VILLASANTE A, 1986, MOL CELL BIOL, V6, P2409, DOI 10.1128/MCB.6.7.2409; WANG D, 1986, J CELL BIOL, V103, P1903, DOI 10.1083/jcb.103.5.1903; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; Weiner JA, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00004; WHITESIDE CI, 1993, AM J PATHOL, V142, P1641; Yuan HP, 2002, AM J PHYSIOL-RENAL, V282, pF585, DOI 10.1152/ajprenal.00290.2001	57	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137043	10.1371/journal.pone.0137043	http://dx.doi.org/10.1371/journal.pone.0137043			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331477	gold, Green Published, Green Submitted			2022-12-26	WOS:000360613800091
J	Sun, CJ; Lu, J; Yi, GQ; Yuan, JW; Duan, ZY; Qu, LJ; Xu, GY; Wang, KH; Yang, N				Sun, Congjiao; Lu, Jian; Yi, Guoqiang; Yuan, Jingwei; Duan, Zhongyi; Qu, Lujiang; Xu, Guiyun; Wang, Kehua; Yang, Ning			Promising Loci and Genes for Yolk and Ovary Weight in Chickens Revealed by a Genome-Wide Association Study	PLOS ONE			English	Article							EGG-YOLK; RECEPTOR; HENS; LIPOPROTEIN; ABSORPTION; PROTEINS; QUALITY; START; ZAR1	Because it serves as the cytoplasm of the oocyte and provides a large amount of reserves, the egg yolk has biological significance for developing embryos. The ovary and its hierarchy of follicles are the main reproductive organs responsible for yolk deposition in chickens. However, the genetic architecture underlying the yolk and ovarian follicle weights remains elusive. Here, we measured the yolk weight (YW) at 11 age points from onset of egg laying to 72 weeks of age and measured the follicle weight (FW) and ovary weight (OW) at 73 weeks as part of a comprehensive genome-wide association study (GWAS) in 1,534 F-2 hens derived from reciprocal crosses between White Leghorn (WL) and Dongxiang chickens (DX). For all ages, YWs exhibited moderate single nucleotide polymorphism (SNP)-based heritability estimates (0.25-0.38), while the estimates for FW (0.16) and OW (0.20) were relatively low. Independent univariate genome-wide screens for each trait identified 12, 3, and 31 novel significant associations with YW, FW, and OW, respectively. A list of candidate genes such as ZAR1, STARD13, ACER1b, ACSBG2, and DHRS12 were identified for having a plausible function in yolk and follicle development. These genes are important to the initiation of embryogenesis, lipid transport, lipoprotein synthesis, lipid droplet promotion, and steroid hormone metabolism, respectively. Our study provides for the first time a genome-wide association (GWA) analysis for follicle and ovary weight. Identification of the promising loci as well as potential candidate genes will greatly advance our understanding of the genetic basis underlying dynamic yolk weight and ovarian follicle development and has practical significance in breeding programs for the alteration of yolk weight at different age points.	[Sun, Congjiao; Yi, Guoqiang; Yuan, Jingwei; Duan, Zhongyi; Qu, Lujiang; Xu, Guiyun; Yang, Ning] China Agr Univ, Natl Engn Lab Anim Breeding, Coll Anim Sci & Technol, Beijing 100094, Peoples R China; [Sun, Congjiao; Yi, Guoqiang; Yuan, Jingwei; Duan, Zhongyi; Qu, Lujiang; Xu, Guiyun; Yang, Ning] China Agr Univ, MOA Key Lab Anim Genet & Breeding, Coll Anim Sci & Technol, Beijing 100094, Peoples R China; [Lu, Jian; Wang, Kehua] Jiangsu Inst Poultry Sci, Yangzhou, Jiangsu, Peoples R China	China Agricultural University; China Agricultural University	Yang, N (corresponding author), China Agr Univ, Natl Engn Lab Anim Breeding, Coll Anim Sci & Technol, Beijing 100094, Peoples R China.	nyang@cau.edu.cn		Yang, Ning/0000-0001-5772-3320	National Natural Science Foundation of China [31472084]; National High Technology Development Plan of China [2013AA102501]; Programs for Changjiang Scholars and Innovative Research in University [IRT1191]; China Agriculture Research Systems [CARS-41]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Development Plan of China(National High Technology Research and Development Program of China); Programs for Changjiang Scholars and Innovative Research in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); China Agriculture Research Systems	The current research was funded in part by the National Natural Science Foundation of China (31472084), the National High Technology Development Plan of China (2013AA102501), Programs for Changjiang Scholars and Innovative Research in University (IRT1191), and China Agriculture Research Systems (CARS-41).	Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Anton M, 2005, P 17 EUR S QUAL POUL, V62, P429; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bakowska JC, 2007, MOL BIOL CELL, V18, P1683, DOI 10.1091/mbc.E06-09-0833; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Brooke RE, 2004, EUR J NEUROSCI, V20, P3313, DOI 10.1111/j.1460-9568.2004.03730.x; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Burley R., 1989, AVIAN EGG CHEM BIOL; D'Andre HC, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-43; DEELEY RG, 1985, CAN J BIOCHEM CELL B, V63, P882, DOI 10.1139/o85-109; EVANS AJ, 1987, J BIOL CHEM, V262, P501; Fujimoto Y, 2006, BIOL PHARM BULL, V29, P2174, DOI 10.1248/bpb.29.2174; Gao XY, 2010, GENET EPIDEMIOL, V34, P100, DOI 10.1002/gepi.20430; GEORGE R, 1987, J BIOL CHEM, V262, P16838; Hartmann C, 2001, WORLD POULTRY SCI J, V57, P13, DOI 10.1079/WPS20010003; Humphrey HHC, 2001, BIOL REPROD, V64, P390, DOI 10.1095/biolreprod64.1.390; Kinsella RJ, 2011, DATABASE-OXFORD, V2011, P56; Kovacs-Nolan J, 2005, J AGR FOOD CHEM, V53, P8421, DOI 10.1021/jf050964f; Kranis A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-59; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Liu W, 2011, PLOS ONE, V6, P1427; MACLACHLAN I, 1994, J BIOL CHEM, V269, P24127; Mann K, 2008, PROTEOMICS, V8, P178, DOI 10.1002/pmic.200700790; Maritzen T, 2010, TRAFFIC, V11, P8, DOI 10.1111/j.1600-0854.2009.00971.x; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Michailidis G, 2010, VET RES COMMUN, V34, P173, DOI 10.1007/s11259-010-9343-z; Mine Y, 2006, WORLD POULTRY SCI J, V62, P87, DOI 10.1079/WPS200586; Nangsuay A, 2011, POULTRY SCI, V90, P2648, DOI 10.3382/ps.2011-01415; Nilsson A, 2006, J LIPID RES, V47, P154, DOI 10.1194/jlr.M500357-JLR200; Nimpf J, 1998, ATHEROSCLEROSIS, V141, P191, DOI 10.1016/S0021-9150(98)00172-5; ODLIND V, 1995, ACTA ONCOL, V34, P53, DOI 10.3109/02841869509094059; Onagbesan O, 2009, ANIM REPROD SCI, V111, P121, DOI 10.1016/j.anireprosci.2008.09.017; Penning TM, 2003, HUM REPROD UPDATE, V9, P193, DOI 10.1093/humupd/dmg022; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sasaki O, 2004, ANIM GENET, V35, P188, DOI 10.1111/j.1365-2052.2004.01133.x; SHEN XY, 1993, CELL TISSUE RES, V272, P459, DOI 10.1007/BF00318552; Soccio RE, 2003, J BIOL CHEM, V278, P22183, DOI 10.1074/jbc.R300003200; Suk YO, 2001, POULTRY SCI, V80, P855, DOI 10.1093/ps/80.7.855; Tuiskula-Haavisto M, 2002, POULTRY SCI, V81, P919, DOI 10.1093/ps/81.7.919; Van Immerseel F., 2011, IMPROVING SAFETY QUA, V2, DOI [10.1533/9780857093929, DOI 10.1533/9780857093929]; Wang YJ, 2007, ENDOCRINOLOGY, V148, P3426, DOI 10.1210/en.2006-1383; Wenger DA, 1997, HUM MUTAT, V10, P268, DOI 10.1002/(SICI)1098-1004(1997)10:4<268::AID-HUMU2>3.0.CO;2-D; Wolc A, 2014, J ANIM BREED GENET, V131, P173, DOI 10.1111/jbg.12086; Wu XM, 2003, NAT GENET, V33, P187, DOI 10.1038/ng1079; Wu XM, 2003, BIOL REPROD, V69, P861, DOI 10.1095/biolreprod.103.016022; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zhao J. H., 2014, GAP GENETIC ANAL PAC; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	48	26	28	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137145	10.1371/journal.pone.0137145	http://dx.doi.org/10.1371/journal.pone.0137145			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332579	Green Published, Green Submitted, gold			2022-12-26	WOS:000360613800102
J	Nakayama, A; Morita, H; Nakao, T; Yamaguchi, T; Sumida, T; Ikeda, Y; Kumagai, H; Motozawa, Y; Takahashi, T; Imaizumi, A; Hashimoto, T; Nagai, R; Komuro, I				Nakayama, Atsuko; Morita, Hiroyuki; Nakao, Tomoko; Yamaguchi, Toshihiro; Sumida, Tomokazu; Ikeda, Yuichi; Kumagai, Hidetoshi; Motozawa, Yoshihiro; Takahashi, Tsukasa; Imaizumi, Atsushi; Hashimoto, Tadashi; Nagai, Ryozo; Komuro, Issei			A Food-Derived Flavonoid Luteolin Protects against Angiotensin II-Induced Cardiac Remodeling	PLOS ONE			English	Article							HUMAN HYPERTROPHIC CARDIOMYOPATHY; MYOCARDIAL FIBROSIS; OXIDATIVE STRESS; HEART-FAILURE; GENE-EXPRESSION; NADPH OXIDASE; MOUSE MODEL; TGF-BETA; RATS; FIBROBLASTS	Oxidative stress has been implicated in cardiac remodeling (cardiac fibrosis and hypertrophy), which impairs cardiac function and metabolism; therefore, it is anticipated antioxidative compounds will have protective properties against cardiac remodeling. Luteolin (3',4',5,7-tetrahydroxyflavone), a widely distributed flavonoid found in many herbal extracts including celery, green pepper, perilla leaves and seeds, and chamomile, is a known to be a potent antioxidant and was previously demonstrated to exert an antifibrotic effect in the lungs and the liver. In this study, we clearly demonstrate that oral pretreatment with the higher-luteolin diet (0.035% (wt/wt)) protected against cardiac fibrosis and hypertrophy as well as a hyperoxidative state in Ang II-infused rats. In cardiac tissue, increased gene expression levels of TGF beta 1, CTGF, Nox2, Nox4, ANP, and BNP induced by Ang II were restored by oral pretreatment of this high-luteolin diet. In cultured rat cardiac fibroblasts, H2O2-induced TGF beta 1 expression and the phosphorylation of JNK were suppressed by luteolin pretreatment. In conclusion, food-derived luteolin has protective actions against Ang II-induced cardiac remodeling, which could be mediated through attenuation of oxidative stress.	[Nakayama, Atsuko; Nakao, Tomoko; Yamaguchi, Toshihiro; Sumida, Tomokazu; Ikeda, Yuichi; Kumagai, Hidetoshi; Motozawa, Yoshihiro; Nagai, Ryozo; Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan; [Morita, Hiroyuki] Univ Tokyo, Grad Sch Med, Dept Translat Res Healthcare & Clin Sci, Tokyo, Japan; [Takahashi, Tsukasa; Imaizumi, Atsushi; Hashimoto, Tadashi] Theravalues Corp, Tokyo, Japan	University of Tokyo; University of Tokyo	Morita, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Translat Res Healthcare & Clin Sci, Tokyo, Japan.	hmrt-tky@umin.net		Sumida, Tomokazu/0000-0002-9806-2642	Theravalues Corporation (Tokyo, Japan)	Theravalues Corporation (Tokyo, Japan)	This research is supported by the Theravalues Corporation (Tokyo, Japan). The funder provided support in the form of salaries for authors TT, AI, TH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ago T, 2011, CIRC J, V75, P1791, DOI 10.1253/circj.CJ-11-0388; Ando C, 2009, FEBS LETT, V583, P3649, DOI 10.1016/j.febslet.2009.10.045; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007; Benavente-Garcia O, 2008, J AGR FOOD CHEM, V56, P6185, DOI 10.1021/jf8006568; Bendall JK, 2002, CIRCULATION, V105, P293, DOI 10.1161/hc0302.103712; Brilla CG, 2000, CIRCULATION, V102, P1388, DOI 10.1161/01.CIR.102.12.1388; Brilla CG, 2000, CARDIOVASC RES, V47, P1, DOI 10.1016/S0008-6363(00)00092-4; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Chen CY, 2010, J AGR FOOD CHEM, V58, P11653, DOI 10.1021/jf1031668; Cheng TH, 2003, J AM COLL CARDIOL, V42, P1845, DOI 10.1016/j.jacc.2003.06.010; Diez J, 2002, CIRCULATION, V105, P2512, DOI 10.1161/01.CIR.0000017264.66561.3D; Diez J, 2001, CURR OPIN CARDIOL, V16, P328, DOI 10.1097/00001573-200111000-00003; Diez Javier, 2007, J Clin Hypertens (Greenwich), V9, P546, DOI 10.1111/j.1524-6175.2007.06626.x; Dolinsky VW, 2009, CIRCULATION, V119, P1643, DOI 10.1161/CIRCULATIONAHA.108.787440; Domitrovic R, 2009, TOXICOL APPL PHARM, V241, P311, DOI 10.1016/j.taap.2009.09.001; Juric D, 2007, AM J PHYSIOL-HEART C, V292, pH2138, DOI 10.1152/ajpheart.00852.2006; Kuwahara F, 2002, CIRCULATION, V106, P130, DOI 10.1161/01.CIR.0000020689.12472.E0; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Li JM, 2002, HYPERTENSION, V40, P477, DOI 10.1161/01.HYP.0000032031.30374.32; Li LP, 2013, PHARMAZIE, V68, P195, DOI 10.1691/ph.2013.2744; Liao PH, 2011, CIRC J, V75, P443, DOI 10.1253/circj.CJ-10-0381; Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158; Lim DS, 2001, CIRCULATION, V103, P789, DOI 10.1161/01.CIR.103.6.789; Lombardi R, 2009, CIRCULATION, V119, P1398, DOI 10.1161/CIRCULATIONAHA.108.790501; Manabe I, 2002, CIRC RES, V91, P1103, DOI 10.1161/01.RES.0000046452.67724.B8; Marian AJ, 2006, J AM COLL CARDIOL, V47, P827, DOI 10.1016/j.jacc.2005.10.041; Morimoto T, 2008, J CLIN INVEST, V118, P868, DOI 10.1172/JCI33160; Okada H, 2005, CIRCULATION, V111, P2430, DOI 10.1161/01.CIR.0000165066.71481.8E; Qin FZ, 2012, CIRCULATION, V125, P1757, DOI 10.1161/CIRCULATIONAHA.111.067801; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; Sano M, 2001, CIRC RES, V89, P661, DOI 10.1161/hh2001.098873; Shimoi K, 1998, FEBS LETT, V438, P220, DOI 10.1016/S0014-5793(98)01304-0; Sia YT, 2002, CIRCULATION, V105, P2549, DOI 10.1161/01.CIR.0000016721.84535.00; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Sumitomo-Ueda Y, 2010, HYPERTENSION, V56, P430, DOI 10.1161/HYPERTENSIONAHA.110.152207; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; Takimoto E, 2007, HYPERTENSION, V49, P241, DOI 10.1161/01.HYP.0000254415.31362.a7; Teekakirikul P, 2010, J CLIN INVEST, V120, P3520, DOI 10.1172/JCI42028; Werner Christian M, 2008, Ther Adv Cardiovasc Dis, V2, P167, DOI 10.1177/1753944708091777; Yu CM, 2001, J AM COLL CARDIOL, V38, P1207, DOI 10.1016/S0735-1097(01)01518-2; Zannad F, 2000, CIRCULATION, V102, P2700, DOI 10.1161/01.CIR.102.22.2700; Zhang P, 2011, AM J PHYSIOL-HEART C, V301, pH147, DOI 10.1152/ajpheart.00026.2011; Zhang W, 2012, CLIN EXP PHARMACOL P, V39, P429, DOI 10.1111/j.1440-1681.2012.05692.x; Zhao WY, 2008, MOL CELL BIOCHEM, V317, P43, DOI 10.1007/s11010-008-9803-8	44	13	15	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137106	10.1371/journal.pone.0137106	http://dx.doi.org/10.1371/journal.pone.0137106			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327560	Green Published, Green Submitted, gold			2022-12-26	WOS:000360437700097
J	van Mol, MMC; Kompanje, EJO; Benoit, DD; Bakker, J; Nijkamp, MD				van Mol, Margo M. C.; Kompanje, Erwin J. O.; Benoit, Dominique D.; Bakker, Jan; Nijkamp, Marjan D.			The Prevalence of Compassion Fatigue and Burnout among Healthcare Professionals in Intensive Care Units: A Systematic Review	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; SECONDARY TRAUMATIC STRESS; JOB-SATISFACTION; NURSES WORKING; EMOTIONAL INTELLIGENCE; MORAL DISTRESS; SELF-CARE; PHYSICIANS; INTERVENTION; OUTCOMES	Background Working in the stressful environment of the Intensive Care Unit (ICU) is an emotionally charged challenge that might affect the emotional stability of medical staff. The quality of care for ICU patients and their relatives might be threatened through long-term absenteeism or a brain and skill drain if the healthcare professionals leave their jobs prematurely in order to preserve their own health. Purpose The purpose of this review is to evaluate the literature related to emotional distress among healthcare professionals in the ICU, with an emphasis on the prevalence of burnout and compassion fatigue and the available preventive strategies. Methods A systematic literature review was conducted, using Embase, Medline OvidSP, Cinahl, Web-of-science, PsychINFO, PubMed publisher, Cochrane and Google Scholar for articles published between 1992 and June, 2014. Studies reporting the prevalence of burnout, compassion fatigue, secondary traumatic stress and vicarious trauma in ICU healthcare professionals were included, as well as related intervention studies. Results Forty of the 1623 identified publications, which included 14,770 respondents, met the selection criteria. Two studies reported the prevalence of compassion fatigue as 7.3% and 40%; five studies described the prevalence of secondary traumatic stress ranging from 0% to 38.5%. The reported prevalence of burnout in the ICU varied from 0% to 70.1%. A wide range of intervention strategies emerged from the recent literature search, such as different intensivist work schedules, educational programs on coping with emotional distress, improving communication skills, and relaxation methods. Conclusions The true prevalence of burnout, compassion fatigue, secondary traumatic stress and vicarious trauma in ICU healthcare professionals remains open for discussion. A thorough exploration of emotional distress in relation to communication skills, ethical rounds, and mindfulness might provide an appropriate starting point for the development of further preventive strategies.	[van Mol, Margo M. C.; Kompanje, Erwin J. O.; Bakker, Jan] Erasmus MC Univ Med Ctr, Dept Intens Care Adults, Rotterdam, Netherlands; [Benoit, Dominique D.] Ghent Univ Hosp, Med Unit, Dept Intens Care, Ghent, Belgium; [Nijkamp, Marjan D.] Open Univ Netherlands, Fac Psychol & Educ Sci, Heerlen, Netherlands	Erasmus University Rotterdam; Erasmus MC; Ghent University; Ghent University Hospital; Open University Netherlands	van Mol, MMC (corresponding author), Erasmus MC Univ Med Ctr, Dept Intens Care Adults, Rotterdam, Netherlands.	m.vanmol@erasmusmc.nl	Bakker, Jan/A-4011-2009	Bakker, Jan/0000-0003-2236-7391; van Mol, M/0000-0002-0213-6054; Seedat, Soraya/0000-0002-5118-786X; Nijkamp, Marjan/0000-0001-7335-9653				Ali NA, 2011, AM J RESP CRIT CARE, V184, P803, DOI 10.1164/rccm.201103-0555OC; Awa WL, 2010, PATIENT EDUC COUNS, V78, P184, DOI 10.1016/j.pec.2009.04.008; Aycock N, 2009, CLIN J ONCOL NURS, V13, P183, DOI 10.1188/09.CJON.183-191; Bakker AB, 2005, J ADV NURS, V51, P276, DOI 10.1111/j.1365-2648.2005.03494.x; Barbosa FT, 2012, SAO PAULO MED J, V130, P282, DOI 10.1590/S1516-31802012000500003; Beck CT, 2011, ARCH PSYCHIAT NURS, V25, P1, DOI 10.1016/j.apnu.2010.05.005; Bellieni CV, 2012, J MATERN-FETAL NEO M, V25, P2130, DOI 10.3109/14767058.2012.666590; Bockerman P, 2008, SOC SCI MED, V67, P520, DOI 10.1016/j.socscimed.2008.04.008; Caine Randy M, 2003, Crit Care Nurse, V23, P59; Cho SH, 2009, J CLIN NURS, V18, P1729, DOI 10.1111/j.1365-2702.2008.02721.x; Coetzee SK, 2010, NURS HEALTH SCI, V12, P235, DOI 10.1111/j.1442-2018.2010.00526.x; Crickmore R, 1987, Intensive Care Nurs, V3, P19, DOI 10.1016/0266-612X(87)90006-X; Curtis JR, 2014, INTENS CARE MED, V40, P606, DOI 10.1007/s00134-013-3201-8; Curtis JR, 2012, CONTEMP CLIN TRIALS, V33, P1245, DOI 10.1016/j.cct.2012.06.010; Czaja AS, 2012, J PEDIATR NURS, V27, P357, DOI 10.1016/j.pedn.2011.04.024; Davies William Richard, 2008, Holist Nurs Pract, V22, P32, DOI 10.1097/01.HNP.0000306326.56955.14; De Villers MJ, 2013, NURS ETHICS, V20, P589, DOI 10.1177/0969733012452882; Donchin Yoel, 2002, Curr Opin Crit Care, V8, P316, DOI 10.1097/00075198-200208000-00008; Eagle S, 2012, J PALLIAT MED, V15, P1178, DOI 10.1089/jpm.2012.0231; Elkonin D, 2011, HEALTH SA GESONDHEID, V16, DOI 10.4102/hsag.v16i1.436; Embriaco N, 2007, CURR OPIN CRIT CARE, V13, P482, DOI 10.1097/MCC.0b013e3282efd28a; Embriaco N, 2007, AM J RESP CRIT CARE, V175, P686, DOI 10.1164/rccm.200608-1184OC; Epp Kirstin, 2012, Dynamics, V23, P25; Fallowfield L, 2003, BRIT J CANCER, V89, P1445, DOI 10.1038/sj.bjc.6601309; Figley C. R., 1995, COPING SECONDARY TRA, DOI [10.4324/9780203777381, DOI 10.4324/9780203777381]; Figley C. R., 2013, TRAUMA AND ITS WAKE; Fink A., 2010, CONDUCTING RES LIT R; Freudenberger H, 1980, BURNOUT COST HIGH AC; Garland A, 2012, AM J RESP CRIT CARE, V185, P738, DOI 10.1164/rccm.201109-1734OC; Goetz K, 2012, INT NURS REV, V59, P88, DOI 10.1111/j.1466-7657.2011.00921.x; Grzeskowiak M, 2011, E J MED, V17, P59; Guntupalli KK, 2014, INDIAN J CRIT CARE M, V18, P139, DOI 10.4103/0972-5229.128703; Guntupalli KK, 1996, INTENS CARE MED, V22, P625, DOI 10.1007/BF01709737; Hays MA, 2006, DIMENS CRIT CARE NUR, V25, P185, DOI 10.1097/00003465-200607000-00016; Jenkins B, 2012, CRIT CARE NURS Q, V35, P388, DOI 10.1097/CNQ.0b013e318268fe09; Jenkins SR, 2002, J TRAUMA STRESS, V15, P423, DOI 10.1023/A:1020193526843; Joinson C, 1992, Nursing, V22, P118; Karanikola MNK, 2012, DIMENS CRIT CARE NUR, V31, P94, DOI 10.1097/DCC.0b013e3182445fd2; Kaschka WP, 2011, DTSCH ARZTEBL INT, V108, P781, DOI 10.3238/arztebl.2011.0781; Kearney MK, 2009, JAMA-J AM MED ASSOC, V301, P1155, DOI 10.1001/jama.2009.352; Kerasiotis Bernadina, 2004, Int J Emerg Ment Health, V6, P121; Klopper HC, 2012, J NURS MANAGE, V20, P685, DOI 10.1111/j.1365-2834.2011.01350.x; Kompanje EJO, 2013, CURR OPIN CRIT CARE, V19, P630, DOI 10.1097/MCC.0000000000000026; Lan HK, 2014, AUST J ADV NURS, V31, P22; Lederer W, 2008, ANAESTH INTENS CARE, V36, P208, DOI 10.1177/0310057X0803600211; Leiter M.P., 2014, BURNOUT WORK PSYCHOL; Liberati, 2009, PLOS MED, V6; Liu K, 2012, J CLIN NURS, V21, P1476, DOI 10.1111/j.1365-2702.2011.03991.x; Liu YE, 2015, J NURS MANAGE, V23, P487, DOI 10.1111/jonm.12161; Loiselle Carmen G, 2012, Intensive Crit Care Nurs, V28, P32, DOI 10.1016/j.iccn.2011.11.006; Iglesias MEL, 2013, DIMENS CRIT CARE NUR, V32, P130, DOI 10.1097/DCC.0b013e31828647fc; Marcial L, 2013, DIMENS CRIT CARE NUR, V32, P18, DOI 10.1097/DCC.0b013e31826bc687; Mason VM, 2014, DIMENS CRIT CARE NUR, V33, P215, DOI 10.1097/DCC.0000000000000056; Meadors P, 2008, J PEDIATR HEALTH CAR, V22, P24, DOI 10.1016/j.pedhc.2007.01.006; Meadors P, 2009, OMEGA-J DEATH DYING, V60, P103, DOI 10.2190/OM.60.2.a; Mealer ML, 2007, AM J RESP CRIT CARE, V175, P693, DOI 10.1164/rccm.200606-735OC; Mehrabi Tayebe, 2012, Iran J Nurs Midwifery Res, V17, P421; Merlani P, 2011, AM J RESP CRIT CARE, V184, P1140, DOI 10.1164/rccm.201101-0068OC; Murphy, 1995, ORG RISK FACTORS JOB, P259, DOI [10.1037/10173-016, DOI 10.1037/10173-016]; Myhren H, 2013, CRIT CARE RES PRACT, V2013, DOI 10.1155/2013/786176; National Center for Post Traumatic Stress Disorder, 2014, HLTH SA GESONDHEID; Nimmo A., 2013, AUSTRALASIAN J DISAS, V1, P37; Nooryan K, 2011, INT J COLLAB RES INT, V3, P704; Nooryan K, 2012, INT J GEN MED, V5, P5, DOI 10.2147/IJGM.S25850; OALVAN ME, 2012, ARCH ARGENT PEDIATR, V110, P466, DOI DOI 10.1590/S0325-00752012000600003; Poncet MC, 2007, AM J RESP CRIT CARE, V175, P698, DOI 10.1164/rccm.200606-806OC; Quenot JP, 2012, INTENS CARE MED, V38, P55, DOI 10.1007/s00134-011-2413-z; Raftopoulos V, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-457; Raggio B, 2007, MINERVA ANESTESIOL, V73, P195; Rochefort CM, 2010, J ADV NURS, V66, P2213, DOI 10.1111/j.1365-2648.2010.05376.x; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Sabo Brenda, 2011, Online J Issues Nurs, V16, P1, DOI 10.3912/OJIN.Vol16No01Man01; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; Saini R., 2011, J MENTAL HLTH HUM BE, V16, P43; Schaufeli W, 2013, PSYCHOL LABOR HLTH; SCHAUFELI WB, 1995, PSYCHOL REP, V76, P1083, DOI 10.2466/pr0.1995.76.3c.1083; Shehabi Yahya, 2008, Crit Care Resusc, V10, P312; Sluiter JK, 2005, INTENS CARE MED, V31, P1409, DOI 10.1007/s00134-005-2769-z; Smart D, 2014, NURS HEALTH SCI, V16, P3, DOI 10.1111/nhs.12068; Stamm B.H., 2002, TREATING COMPASSION, P107, DOI DOI 10.4324/9780203890318; Stamm BH, 2010, CONCISE PROQOL MANUA; Su TP, 2007, J PSYCHIATR RES, V41, P119, DOI 10.1016/j.jpsychires.2005.12.006; Teixeira C, 2014, J MED ETHICS, V40, P97, DOI 10.1136/medethics-2012-100619; Teixeira C, 2013, BMC ANESTHESIOL, V13, DOI 10.1186/1471-2253-13-38; Todaro-Franceschi V., 2019, COMPASSION FATIGUE B, V2nd; Todaro-Franceschi V, 2013, DIMENS CRIT CARE NUR, V32, P184, DOI 10.1097/DCC.0b013e31829980af; Verdon M, 2008, INTENS CARE MED, V34, P152, DOI 10.1007/s00134-007-0907-5; West CP, 2014, JAMA INTERN MED, V174, P527, DOI 10.1001/jamainternmed.2013.14387; West CP, 2014, JAMA INT MED; Whitebird RR, 2013, J PALLIAT MED, V16, P1534, DOI 10.1089/jpm.2013.0202; Yoder EA, 2010, APPL NURS RES, V23, P191, DOI 10.1016/j.apnr.2008.09.003; Young JL, 2011, CRIT CARE NURS Q, V34, P227, DOI 10.1097/CNQ.0b013e31821c67d5; Zhang XC, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004813	93	288	291	10	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136955	10.1371/journal.pone.0136955	http://dx.doi.org/10.1371/journal.pone.0136955			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ2MT	26322644	Green Published, gold			2022-12-26	WOS:000360435500054
J	Chaychi, S; Polosa, A; Lachapelle, P				Chaychi, Samaneh; Polosa, Anna; Lachapelle, Pierre			Differences in Retinal Structure and Function between Aging Male and Female Sprague-Dawley Rats are Strongly Influenced by the Estrus Cycle	PLOS ONE			English	Article							AGE-RELATED-CHANGES; BEAVER DAM EYE; ESTROGEN-RECEPTOR; MACULAR DEGENERATION; POSTNATAL HYPEROXIA; INDUCED RETINOPATHY; ESTRADIOL PROTECTS; PIGMENT EPITHELIUM; MENSTRUAL-CYCLE; FISCHER-344 RAT	Purpose Biological sex and age are considered as two important factors that may influence the function and structure of the retina, an effect that might be governed by sexual hormones such as estrogen. The purpose of this study was to delineate the influence that biological sex and age exert on the retinal function and structure of rodents and also clarify the effect that the estrus cycle might exert on the retinal function of female rats. Method The retinal function of 50 normal male and female albino Sprague-Dawley (SD) rats was investigated with the electroretinogram (ERG) at postnatal day (P) 30, 60, 100, 200, and 300 (n = 5-6 male and female rats/age). Following the ERG recording sessions, retinal histology was performed in both sexes. In parallel, the retinal function of premenopausal and menopausal female rats aged P540 were also compared. Results Sex and age-related changes in retinal structure and function were observed in our animal model. However, irrespective of age, no significant difference was observed in ERG and retinal histology obtained from male and female rats. Notwithstanding the above we did however notice that between P60 and P200 there was a gradual increase in ERG amplitudes of female rats compared to males. Furthermore, the ERG of premenopausal female rats aged 18 months old (P540) was larger compared to age-matched menopausal female rats as well as that of male rats. Conclusion Our results showed that biological sex and age can influence the retinal function and structure of albino SD rats. Furthermore, we showed that cycled female rats have better retinal function compared to the menopausal female rats suggesting a beneficial effect of the estrus cycle on the retinal function.	[Chaychi, Samaneh; Polosa, Anna; Lachapelle, Pierre] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Chaychi, Samaneh; Polosa, Anna; Lachapelle, Pierre] McGill Univ, Dept Ophthalmol, Res Inst, Ctr Hlth, Montreal, PQ H3A 2T5, Canada	McGill University; McGill University	Lachapelle, P (corresponding author), McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada.	pierre.lachapelle@mcgill.ca		Lachapelle, Pierre/0000-0002-7792-1102	research grant from the Canadian Institutes of Health Research (CIHR) [MOP 11755]	research grant from the Canadian Institutes of Health Research (CIHR)	This study was supported by a research grant from the Canadian Institutes of Health Research (CIHR) (Grant #: MOP 11755). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRIS MC, 1980, DOC OPHTHALMOL, V49, P293, DOI 10.1007/BF01886622; BASSI CJ, 1986, PHYSIOL BEHAV, V38, P871, DOI 10.1016/0031-9384(86)90056-9; BIRCH DG, 1992, ARCH OPHTHALMOL-CHIC, V110, P1571, DOI 10.1001/archopht.1992.01080230071024; Brule J, 2007, DOC OPHTHALMOL, V114, P125, DOI 10.1007/s10633-007-9045-1; Chen H, 2010, EYE SCI, V25, P103; Cumming RG, 1997, AM J EPIDEMIOL, V145, P242; CURCIO C A, 1990, Investigative Ophthalmology and Visual Science, V31, P38; DAWSON WW, 1979, INVEST OPHTH VIS SCI, V18, P988; Dembinska O, 2002, INVEST OPHTH VIS SCI, V43, P2481; DILORETO D, 1994, BRAIN RES, V647, P181, DOI 10.1016/0006-8993(94)91316-1; DILORETO D, 1995, CURR EYE RES, V14, P303, DOI 10.3109/02713689509033530; DOREY CK, 1989, INVEST OPHTH VIS SCI, V30, P1691; Dorfman AL, 2006, INVEST OPHTH VIS SCI, V47, P1101, DOI 10.1167/iovs.05-0727; Dorfman A, 2008, INVEST OPHTH VIS SCI, V49, P458, DOI 10.1167/iovs.07-0916; El-Sayyad HIH, 2014, CLIN EXP OPHTHALMOL, V42, P169, DOI 10.1111/ceo.12123; Freund PR, 2011, DOC OPHTHALMOL, V122, P177, DOI 10.1007/s10633-011-9273-2; Giddabasappa A, 2010, INVEST OPHTH VIS SCI, V51, P5278, DOI 10.1167/iovs.10-5316; HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124; HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S; Harwerth RS, 2008, INVEST OPHTH VIS SCI, V49, P4437, DOI 10.1167/iovs.08-1753; Joly S, 2006, INVEST OPHTH VIS SCI, V47, P3202, DOI 10.1167/iovs.05-1515; KARPE G., 1950, ACTA OPHTHALMOL, V28, P301; KARPE G, 1948, J PHYSIOL-LONDON, V107, P272, DOI 10.1113/jphysiol.1948.sp004271; Katalinic V, 2005, COMP BIOCHEM PHYS C, V140, P47, DOI 10.1016/j.cca.2005.01.005; KATZ ML, 1986, EXP EYE RES, V42, P293, DOI 10.1016/0014-4835(86)90022-9; KATZ ML, 1985, MECH AGEING DEV, V30, P99, DOI 10.1016/0047-6374(85)90062-4; KATZ ML, 1984, EXP EYE RES, V38, P137, DOI 10.1016/0014-4835(84)90098-8; KLEIN BEK, 1994, ARCH OPHTHALMOL-CHIC, V112, P85, DOI 10.1001/archopht.1994.01090130095025; KLEIN BEK, 1992, OPHTHALMOLOGY, V99, P546; Kobayashi K, 1998, INVEST OPHTH VIS SCI, V39, P2105; Kolb H, 2009, ORG RETINA VISUAL SY; Kumar DM, 2008, MOL VIS, V14, P1480; LACHAPELLE P, 1990, J NEUROSCI METH, V32, P245, DOI 10.1016/0165-0270(90)90147-8; MARCONDES F. K., 2002, Braz. J. Biol., V62, P609, DOI 10.1590/S1519-69842002000400008; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; Nelson JF, 1980, AGING ITS CHEM, P64; Ooto S, 2011, INVEST OPHTH VIS SCI, V52, P8769, DOI 10.1167/iovs.11-8388; Parikh RS, 2007, OPHTHALMOLOGY, V114, P921, DOI 10.1016/j.ophtha.2007.01.023; Prokai L, 2003, P NATL ACAD SCI USA, V100, P11741, DOI 10.1073/pnas.2032621100; Rahman T., 2012, ADV BIOSCIENCE BIOTE, V03, P997, DOI [10.4236/abb.2012.327123, DOI 10.4236/ABB.2012.327123]; Sandalon S, 2012, INVEST OPHTH VIS SCI, V53, P6532, DOI 10.1167/iovs.12-10103; Seeman MV, 1997, AM J PSYCHIAT, V154, P1641, DOI 10.1176/ajp.154.12.1641; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Snow KK, 2002, AM J OPHTHALMOL, V134, P842, DOI 10.1016/S0002-9394(02)01755-5; Strehlow K, 2003, CIRC RES, V93, P170, DOI 10.1161/01.RES.0000082334.17947.11; Vajaranant TS, 2010, CURR OPIN OPHTHALMOL, V21, P91, DOI 10.1097/ICU.0b013e3283360b7e; Weaver CE, 1997, BRAIN RES, V761, P338, DOI 10.1016/S0006-8993(97)00449-6; WELEBER RG, 1981, INVEST OPHTH VIS SCI, V20, P392; Xia S, 2002, NEUROBIOL DIS, V9, P282, DOI 10.1006/nbdi.2002.0478; Yamashita H, 2011, EXP EYE RES, V93, P75, DOI 10.1016/j.exer.2011.04.006; Yamashita H, 2010, EXP EYE RES, V90, P591, DOI 10.1016/j.exer.2010.02.003; YANNUZZI LA, 1992, ARCH OPHTHALMOL-CHIC, V110, P1701; Zhang QG, 2009, J NEUROSCI, V29, P13823, DOI 10.1523/JNEUROSCI.3574-09.2009; Zinn KM, 1979, RETINAL PIGMENT EPIT	54	38	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136056	10.1371/journal.pone.0136056	http://dx.doi.org/10.1371/journal.pone.0136056			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317201	Green Published, gold, Green Submitted			2022-12-26	WOS:000360299100058
J	Cardoso, LCD; Rodriguez-Laguna, L; Crespo, MD; Vallespin, E; Palomares-Bralo, M; Martin-Arenas, R; Rueda-Arenas, I; de Faria, PAS; Garcia-Miguel, P; Lapunzina, P; Vargas, FR; Seuanez, HN; Martinez-Glez, V				de Almeida Cardoso, Leila Cabral; Rodriguez-Laguna, Lara; Crespo, Maria del Carmen; Vallespin, Elena; Palomares-Bralo, Maria; Martin-Arenas, Ruben; Rueda-Arenas, Inmaculada; Silvestre de Faria, Paulo Antonio; Garcia-Miguel, Purificacion; Lapunzina, Pablo; Vargas, Fernando Regla; Seuanez, Hector N.; Martinez-Glez, Victor		GT CSGP Working Grp	Array CGH Analysis of Paired Blood and Tumor Samples from Patients with Sporadic Wilms Tumor	PLOS ONE			English	Article							FRASIER-SYNDROME; SHORT ARM; WT1 GENE; MUTATIONS; HISTOLOGY; CANCER; REVEALS; PATHWAY; CELLS; GAIN	Wilms tumor (WT), the most common cancer of the kidney in infants and children, has a complex etiology that is still poorly understood. Identification of genomic copy number variants (CNV) in tumor genomes provides a better understanding of cancer development which may be useful for diagnosis and therapeutic targets. In paired blood and tumor DNA samples from 14 patients with sporadic WT, analyzed by aCGH, 22% of chromosome abnormalities were novel. All constitutional alterations identified in blood were segmental (in 28.6% of patients) and were also present in the paired tumor samples. Two segmental gains (2p21 and 20q13.3) and one loss (19q13.31) present in blood had not been previously described in WT. We also describe, for the first time, a small, constitutive partial gain of 3p22.1 comprising 2 exons of CTNNB1, a gene associated to WT. Among somatic alterations, novel structural chromosomal abnormalities were found, like gain of 19p13.3 and 20p12.3, and losses of 2p16.1-p15, 4q32.5-q35.1, 4q35.2-q28.1 and 19p13.3. Candidate genes included in these regions might be constitutively (SIX3, SALL4) or somatically (NEK1, PIAS4, BMP2) operational in the development and progression of WT. To our knowledge this is the first report of CNV in paired blood and tumor samples in sporadic WT.	[de Almeida Cardoso, Leila Cabral; Seuanez, Hector N.] Inst Nacl Canc, Div Genet, Rio De Janeiro, Brazil; [Rodriguez-Laguna, Lara; Crespo, Maria del Carmen; Vallespin, Elena; Palomares-Bralo, Maria; Martin-Arenas, Ruben; Rueda-Arenas, Inmaculada; Martinez-Glez, Victor] Hosp Univ La Paz, Inst Med & Mol Genet INGEMM IdiPAZ, Sect Funct & Struct Genom, Madrid, Spain; [Vallespin, Elena; Palomares-Bralo, Maria; Lapunzina, Pablo; Martinez-Glez, Victor] Ctr Invest Biomed Red Enfermedades Raras, CIBERER, Madrid, Spain; [Silvestre de Faria, Paulo Antonio] Inst Nacl Canc, Div Pathol, Rio De Janeiro, Brazil; [Garcia-Miguel, Purificacion] Hosp Univ La Paz, Serv Pediat Oncohematol IdiPAZ, Madrid, Spain; [Lapunzina, Pablo] Hosp Univ La Paz, Inst Med & Mol Genet INGEMM IdiPAZ, Clin Genet Sect, Madrid, Spain; [Vargas, Fernando Regla; Seuanez, Hector N.] Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil; [Vargas, Fernando Regla] Fundacao Oswaldo Cruz, Birth Defects Epidemiol Lab, Rio De Janeiro, Brazil	National Cancer Institute (Inca); Hospital Universitario La Paz; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; National Cancer Institute (Inca); Hospital Universitario La Paz; Hospital Universitario La Paz; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz	Martinez-Glez, V (corresponding author), Hosp Univ La Paz, Inst Med & Mol Genet INGEMM IdiPAZ, Sect Funct & Struct Genom, Madrid, Spain.	vmartinezglez@salud.madrid.org	del Carmen Crespo, María/P-3925-2015; Vallespin, Elena/E-5277-2018; Martinez-Glez, Victor/E-2344-2011; Vargas, Fernando/V-1934-2019; Lapunzina, Pablo/L-7075-2014; Sabado, Constantino/E-6172-2016	del Carmen Crespo, María/0000-0003-0546-2143; Vallespin, Elena/0000-0002-8080-8629; Martinez-Glez, Victor/0000-0002-4680-881X; Rodriguez-Laguna, Lara/0000-0003-2863-3400; Martin Arenas, Ruben/0000-0003-4022-1783; Lapunzina, Pablo/0000-0002-6324-4825; Palomares-Bralo, Maria/0000-0002-2727-7654; Sabado, Constantino/0000-0003-3956-5466	Ministerio de Economia y Competitividad [SAF2010-18032]	Ministerio de Economia y Competitividad(Spanish Government)	This work was supported by Ministerio de Economia y Competitividad project SAF2010-18032.	Barbaux S, 1997, NAT GENET, V17, P467, DOI 10.1038/ng1297-467; Bhatnagar Sushmita, 2009, J Indian Assoc Pediatr Surg, V14, P6, DOI 10.4103/0971-9261.54811; Borozdin W, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.019901; BRESLOW N, 1993, MED PEDIATR ONCOL, V21, P172, DOI 10.1002/mpo.2950210305; Breslow NE, 2006, PEDIATR BLOOD CANCER, V47, P260, DOI 10.1002/pbc.20891; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; Cardoso LCA, 2013, ONCOL REP, V29, P315, DOI 10.3892/or.2012.2096; Chen Y, 2014, ONCOTARGET, V5, P4283, DOI 10.18632/oncotarget.2005; Christensen KL, 2008, ADV CANCER RES, V101, P93, DOI 10.1016/S0065-230X(08)00405-3; Deisch J, 2011, PATHOL ONCOL RES, V17, P639, DOI 10.1007/s12253-011-9364-0; Dome JS, 1993, GENEREVIEWS; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Fukuzawa R, 2008, J PATHOL, V215, P377, DOI 10.1002/path.2366; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; Getman ME, 1998, CYTOGENET CELL GENET, V82, P284, DOI 10.1159/000015120; Grundy RG, 1998, BRIT J CANCER, V78, P1181, DOI 10.1038/bjc.1998.651; Hawthorn L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018941; Hiepen C, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-43; Hing S, 2001, AM J PATHOL, V158, P393, DOI 10.1016/S0002-9440(10)63982-X; Huff V, 1998, AM J MED GENET, V79, P260, DOI 10.1002/(SICI)1096-8628(19981002)79:4<260::AID-AJMG6>3.0.CO;2-Q; Imoto S, 2004, BIOCHEM BIOPH RES CO, V319, P275, DOI 10.1016/j.bbrc.2004.04.161; Kahlert C, 2015, INT J CANCER, V137, P2104, DOI 10.1002/ijc.29596; Kallioniemi A, 2008, CURR OPIN BIOTECH, V19, P36, DOI 10.1016/j.copbio.2007.11.004; Katoh M, 2014, MED RES REV, V34, P280, DOI 10.1002/med.21288; Kim WJ, 2012, MOL CELL, V45, P587, DOI 10.1016/j.molcel.2011.12.025; Koesters R, 1999, CANCER RES, V59, P3880; Koziell A, 2000, CLIN ENDOCRINOL, V52, P519; Kreidberg JA, 2010, ORGANOGENESIS, V6, P61, DOI 10.4161/org.6.2.11928; Kumar R, 2010, CANCER RES, V70, P6649, DOI 10.1158/0008-5472.CAN-10-0909; Li CM, 2004, AM J PATHOL, V165, P1943, DOI 10.1016/S0002-9440(10)63246-4; Majid S, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-7; MAW MA, 1992, CANCER RES, V52, P3094; Md Zin R, 2011, PATHOLOGY, V43, P302, DOI 10.1097/PAT.0b013e3283463575; Megarbane A, 1997, J MED GENET, V34, P783, DOI 10.1136/jmg.34.9.783; MILLER RW, 1995, CANCER, V75, P395, DOI 10.1002/1097-0142(19950101)75:1+<395::AID-CNCR2820751321>3.0.CO;2-W; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nakadate H, 2001, INT J CANCER, V94, P396, DOI 10.1002/ijc.1475; Natrajan R, 2006, J PATHOL, V210, P49, DOI 10.1002/path.2021; Natrajan R, 2007, J PATHOL, V211, P52, DOI 10.1002/path.2087; Peres EM, 2004, CANCER GENET CYTOGEN, V148, P66, DOI 10.1016/S0165-4608(03)00221-8; Rassekh SR, 2008, CANCER GENET CYTOGEN, V182, P84, DOI 10.1016/j.cancergencyto.2007.12.015; Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509; Rivera MN, 2005, NAT REV CANCER, V5, P699, DOI 10.1038/nrc1696; Royer-Pokora B, 2004, AM J MED GENET A, V127A, P249, DOI 10.1002/ajmg.a.30015; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Satoh Y, 2006, BRIT J CANCER, V95, P541, DOI 10.1038/sj.bjc.6603302; Schell U, 1996, HUM MOL GENET, V5, P223, DOI 10.1093/hmg/5.2.223; Scott RH, 2006, J MED GENET, V43, P705, DOI 10.1136/jmg.2006.041723; Segers H, 2013, GENE CHROMOSOME CANC, V52, P1065, DOI 10.1002/gcc.22101; Senanayake U, 2013, HUM PATHOL, V44, P336, DOI 10.1016/j.humpath.2012.05.021; Shalom O, 2008, FEBS LETT, V582, P1465, DOI 10.1016/j.febslet.2008.03.036; Singh N, 2015, GENE, V565, P295, DOI 10.1016/j.gene.2015.04.051; Surpili MJ, 2003, BIOCHEMISTRY-US, V42, P15369, DOI 10.1021/bi034575v; Toska E, 2014, BIOCHEM J, V461, P15, DOI 10.1042/BJ20131587; Vallespin E, 2013, AM J MED GENET A, V161, P1950, DOI 10.1002/ajmg.a.35960; Wallis DE, 1999, NAT GENET, V22, P196, DOI 10.1038/9718; Walz AL, 2015, CANCER CELL, V27, P286, DOI 10.1016/j.ccell.2015.01.003; Wegert J, 2015, CANCER CELL, V27, P298, DOI 10.1016/j.ccell.2015.01.002; Williams RD, 2011, GENE CHROMOSOME CANC, V50, P982, DOI 10.1002/gcc.20907; Wolf S, 2014, INT J ONCOL, V44, P1727, DOI 10.3892/ijo.2014.2312; Zheng Y, 2014, TUMOR BIOL, V35, P5189, DOI 10.1007/s13277-014-1673-y; Zin R, 2012, CANCER GENET-NY, V205, P80, DOI 10.1016/j.cancergen.2011.12.003	62	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136812	10.1371/journal.pone.0136812	http://dx.doi.org/10.1371/journal.pone.0136812			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317783	Green Published, gold, Green Submitted			2022-12-26	WOS:000360299100143
J	Estruch, G; Collado, MC; Penaranda, DS; Vidal, AT; Cerda, MJ; Martinez, GP; Martinez-Llorens, S				Estruch, G.; Collado, M. C.; Penaranda, D. S.; Tomas Vidal, A.; Jover Cerda, M.; Perez Martinez, G.; Martinez-Llorens, S.			Impact of Fishmeal Replacement in Diets for Gilthead Sea Bream (Sparus aurata) on the Gastrointestinal Microbiota Determined by Pyrosequencing the 16S rRNA Gene	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; FARMED ATLANTIC SALMON; STANDARD SOYBEAN-MEAL; PLANT PROTEIN-SOURCES; INTESTINAL MICROBIOTA; NUTRIENT UTILIZATION; AQUACULTURE SYSTEMS; COMMUNITY STRUCTURE; GUT MICROBIOTA; FRESH-WATER	Recent studies have demonstrated the impact of diet on microbiota composition, but the essential need for the optimization of production rates and costs forces farms and aquaculture production to carry out continuous dietary tests. In order to understand the effect of total fishmeal replacement by vegetable-based feed in the sea bream (Sparus aurata), the microbial composition of the stomach, foregut, midgut and hindgut was analysed using high-throughput 16S rDNA sequencing, also considering parameters of growth, survival and nutrient utilisation indices. A total of 91,539 16S rRNA filtered-sequences were analysed, with an average number of 3661.56 taxonomically assigned, high-quality sequences per sample. The dominant phyla throughout the whole gastrointestinal tract were Actinobacteria, Protebacteria and Firmicutes. A lower diversity in the stomach in comparison to the other intestinal sections was observed. The microbial composition of the Recirculating Aquaculture System was totally different to that of the sea bream gastrointestinal tract. Total fishmeal replacement had an important impact on microbial profiles but not on diversity. Streptococcus (p-value: 0.043) and Photobacterium (p-value: 0.025) were highly represented in fish fed with fishmeal and vegetable-meal diets, respectively. In the stomach samples with the vegetable diet, reads of chloroplasts and mitochondria from vegetable dietary ingredients were rather abundant. Principal Coordinate Analysis showed a clear differentiation between diets in the microbiota present in the gut, supporting the presence of specific bacterial consortia associated with the diet. Although differences in growth and nutritive parameters were not observed, a negative effect of the vegetable diet on the survival rate was determined. Further studies are required to shed more light on the relationship between the immune system and sea bream gastrointestinal tract microbiota and should consider the modulation of the microbiota to improve the survival rate and nutritive efficacy when using plant-based diets.	[Estruch, G.; Penaranda, D. S.; Tomas Vidal, A.; Jover Cerda, M.; Martinez-Llorens, S.] Univ Politecn Valencia, Inst Sci & Anim Technol, Aquaculture & Biodivers Res Group, ICTA, E-46071 Valencia, Valencia, Spain; [Collado, M. C.; Perez Martinez, G.] Spanish Natl Res Council IATA CSIC, Inst Agrochem & Food Technol, Dept Biotechnol, Paterna, Valencia, Spain	Autonomous University of Barcelona; Universitat Politecnica de Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA)	Martinez-Llorens, S (corresponding author), Univ Politecn Valencia, Inst Sci & Anim Technol, Aquaculture & Biodivers Res Group, ICTA, E-46071 Valencia, Valencia, Spain.	silmarll@dca.upv.es	Martinez, Gaspar Perez/H-4167-2012; COLLADO, MARIA CARMEN/H-4924-2012; Peñaranda, David Sanchez/L-3003-2014; TOMAS VIDAL, ANA/L-8254-2014	Martinez, Gaspar Perez/0000-0003-3501-1626; COLLADO, MARIA CARMEN/0000-0002-6204-4864; Peñaranda, David Sanchez/0000-0002-0861-976X; MARTINEZ LLORENS, SILVIA/0000-0002-9824-3267; TOMAS VIDAL, ANA/0000-0002-2985-9324	Vicerrectorat d'Investigacio, Innovacio i Transferencia - Universitat Politecnica de Valencia [SP20120603, 6.000,00]; Contrato Pre-doctoral del Programa para la Formacion de Personal Investigador - FPI from Programa de Ayudas de Investigacion y Desarrollo (PAID) of Universitat Politecnica de Valencia	Vicerrectorat d'Investigacio, Innovacio i Transferencia - Universitat Politecnica de Valencia; Contrato Pre-doctoral del Programa para la Formacion de Personal Investigador - FPI from Programa de Ayudas de Investigacion y Desarrollo (PAID) of Universitat Politecnica de Valencia	Project Name: Aquaculture feed without fishmeal(SP20120603). Grant Numbers: 6.000,00. Funding Institution: Vicerrectorat d'Investigacio, Innovacio i Transferencia - Universitat Politecnica de Valencia. Author who received the funding: ATV. URL of funder: http://www.upv.es/entidades/VIIT/info/indexnormalc.html. The first author was supported by a contract-grant (Contrato Pre-doctoral del Programa para la Formacion de Personal Investigador - FPI) from Programa de Ayudas de Investigacion y Desarrollo (PAID) of Universitat Politecnica de Valencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], STATGR CENT 16; [Anonymous], 2008, FRESHWATER FISHERY; [Anonymous], 2013, BOE; AOAC, 1997, AOAC OFF METH AN; Attramadal KJK, 2012, AQUACULT ENG, V46, P27, DOI 10.1016/j.aquaeng.2011.10.003; Baeza R, 2015, AQUACULT RE IN PRESS; Balcazar JL, 2008, AQUACULTURE, V278, P188, DOI 10.1016/j.aquaculture.2008.03.014; Benedito-Palos L, 2008, BRIT J NUTR, V100, P992, DOI 10.1017/S0007114508966071; Biesbroek G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032942; Blancheton JP, 2013, AQUACULT ENG, V53, P30, DOI 10.1016/j.aquaeng.2012.11.009; Cai CF, 2013, AQUACULTURE, V410, P203, DOI 10.1016/j.aquaculture.2013.07.006; Carda-Dieguez M, 2014, FEMS MICROBIOL ECOL, V87, P451, DOI 10.1111/1574-6941.12236; Cerezuela R, 2013, FISH SHELLFISH IMMUN, V34, P1063, DOI 10.1016/j.fsi.2013.01.015; Davila AM, 2013, PHARMACOL RES, V68, P95, DOI 10.1016/j.phrs.2012.11.005; Silva FCD, 2011, FEMS MICROBIOL ECOL, V78, P285, DOI 10.1111/j.1574-6941.2011.01155.x; Denev S., 2009, International Aquatic Research, V1, P1; Desai AR, 2012, AQUACULTURE, V350, P134, DOI 10.1016/j.aquaculture.2012.04.005; Dimitroglou A, 2009, J ANIM SCI, V87, P3226, DOI 10.2527/jas.2008-1428; Dimitroglou A, 2010, AQUACULTURE, V300, P182, DOI 10.1016/j.aquaculture.2010.01.015; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Estensoro I, 2012, FISH SHELLFISH IMMUN, V33, P401, DOI 10.1016/j.fsi.2012.05.029; Francis G, 2001, AQUACULTURE, V199, P197, DOI 10.1016/S0044-8486(01)00526-9; Glockner FO, 1999, APPL ENVIRON MICROB, V65, P3721; Green TJ, 2013, VET MICROBIOL, V166, P286, DOI 10.1016/j.vetmic.2013.05.009; Hanshew AS, 2013, J MICROBIOL METH, V95, P149, DOI 10.1016/j.mimet.2013.08.007; He Li, 2009, Chinese Journal of Applied and Environmental Biology, V15, P414, DOI 10.3724/SP.J.1145.2009.00414; Hedrera MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069983; Hetland DL, 2010, FISH SHELLFISH IMMUN, V28, P30, DOI 10.1016/j.fsi.2009.09.011; Hovda MB, 2007, AQUACULTURE, V272, P581, DOI 10.1016/j.aquaculture.2007.08.045; Kim DH, 2013, AQUACULTURE, V414, P103, DOI 10.1016/j.aquaculture.2013.06.008; Kissil GW, 2004, ISR J AQUACULT-BAMID, V56, P188; Kormas KA, 2014, MICROBIOLOGYOPEN, V3, P718, DOI 10.1002/mbo3.202; Krogdahl A, 2000, AQUACULT NUTR, V6, P77; Krogdahl A, 2003, AQUACULT NUTR, V9, P361, DOI 10.1046/j.1365-2095.2003.00264.x; Li P, 2007, BRIT J NUTR, V98, P237, DOI 10.1017/S000711450769936X; Mansfield GS, 2010, AQUACULTURE, V307, P95, DOI 10.1016/j.aquaculture.2010.07.014; Martinez-Llorens S, 2009, AQUACULT NUTR, V15, P320, DOI 10.1111/j.1365-2095.2008.00597.x; Michaud L, 2009, J APPL MICROBIOL, V107, P1935, DOI 10.1111/j.1365-2672.2009.04378.x; Morris PC, 2005, AQUACULTURE, V248, P147, DOI 10.1016/j.aquaculture.2005.04.021; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Navarrete P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031335; Navarrete P, 2010, FEMS MICROBIOL ECOL, V71, P148, DOI 10.1111/j.1574-6941.2009.00769.x; Nayak SK, 2010, AQUAC RES, V41, P1553, DOI 10.1111/j.1365-2109.2010.02546.x; Perez T, 2010, MUCOSAL IMMUNOL, V3, P355, DOI 10.1038/mi.2010.12; Perez-Sanchez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065457; Reveco FE, 2014, AQUACULTURE, V420, P262, DOI 10.1016/j.aquaculture.2013.11.007; Ringo E, 2006, AQUACULTURE, V261, P829, DOI 10.1016/j.aquaculture.2006.06.030; Ringo E, 2010, AQUAC RES, V41, P451, DOI 10.1111/j.1365-2109.2009.02339.x; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Rombout JHWM, 2011, FISH SHELLFISH IMMUN, V31, P616, DOI 10.1016/j.fsi.2010.09.001; Sanchez-Lozano NB, 2011, AQUACULT NUTR, V17, pE604, DOI 10.1111/j.1365-2095.2010.00803.x; Santigosa E, 2011, AQUACULTURE, V317, P146, DOI 10.1016/j.aquaculture.2011.04.026; Savas S, 2005, ISR J AQUACULT-BAMID, V57, P3; Schreier HJ, 2010, CURR OPIN BIOTECH, V21, P318, DOI 10.1016/j.copbio.2010.03.011; Sharrer MJ, 2005, AQUACULT ENG, V33, P135, DOI 10.1016/j.aquaeng.2004.12.001; Sitja-Bobadilla A, 2005, AQUACULTURE, V249, P387, DOI 10.1016/j.aquaculture.2005.03.031; Spanggaard B, 2000, AQUACULTURE, V182, P1, DOI 10.1016/S0044-8486(99)00250-1; Sugita H, 2005, AQUACULTURE, V243, P403, DOI 10.1016/j.aquaculture.2004.09.028; Sullam KE, 2012, MOL ECOL, V21, P3363, DOI 10.1111/j.1365-294X.2012.05552.x; Terova G, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-17; Uran PA, 2009, J FISH DIS, V32, P733, DOI 10.1111/j.1365-2761.2009.01049.x; van Kessel MAHJ, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-41; Venou B, 2006, AQUACULTURE, V261, P343, DOI 10.1016/j.aquaculture.2006.07.030; Wong S, 2013, APPL ENVIRON MICROB, V79, P4974, DOI 10.1128/AEM.00924-13; Wu SG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040727, 10.1371/journal.pone.0030440]; Xia Y, 2008, APPL ENVIRON MICROB, V74, P2229, DOI 10.1128/AEM.02502-07	66	111	114	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136389	10.1371/journal.pone.0136389	http://dx.doi.org/10.1371/journal.pone.0136389			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317431	Green Submitted, Green Published, gold			2022-12-26	WOS:000360299100076
J	Lacerda, ALM; Fonseca, LN; Blawid, R; Boiteux, LS; Ribeiro, SG; Brasileiro, ACM				Lacerda, Ana L. M.; Fonseca, Leonardo N.; Blawid, Rosana; Boiteux, Leonardo S.; Ribeiro, Simone G.; Brasileiro, Ana C. M.			Reference Gene Selection for qPCR Analysis in Tomato-Bipartite Begomovirus Interaction and Validation in Additional Tomato-Virus Pathosystems	PLOS ONE			English	Article							EXPRESSION ANALYSIS; CELL-DEATH; RT-PCR; NORMALIZATION; RESISTANCE; IDENTIFICATION; INFECTION; ARABIDOPSIS; INHERITANCE; DIVERSITY	Quantitative Polymerase Chain Reaction (qPCR) is currently the most sensitive technique used for absolute and relative quantification of a target gene transcript, requiring the use of appropriated reference genes for data normalization. To accurately estimate the relative expression of target tomato (Solanum lycopersicum L.) genes responsive to several virus species in reverse transcription qPCR analysis, the identification of reliable reference genes is mandatory. In the present study, ten reference genes were analyzed across a set of eight samples: two tomato contrasting genotypes ('Santa Clara', susceptible, and its near-isogenic line 'LAM 157', resistant); subjected to two treatments (inoculation with Tomato chlorotic mottle virus (ToCMoV) and its mock-inoculated control) and in two distinct times after inoculation (early and late). Reference genes stability was estimated by three statistical programs (geNorm, NormFinder and BestKeeper). To validate the results over broader experimental conditions, a set of ten samples, corresponding to additional three tomato-virus pathosystems that included tospovirus, crinivirus and tymovirus + tobamovirus, was analyzed together with the tomato-ToCMoV pathosystem dataset, using the same algorithms. Taking into account the combined analyses of the ranking order outputs from the three algorithms, TIP41 and EF1 were identified as the most stable genes for tomato-ToCMoV pathosystem, and TIP41 and EXP for the four pathosystems together, and selected to be used as reference in the forthcoming expression qPCR analysis of target genes in experimental conditions involving the aforementioned tomato-virus pathosystems.	[Lacerda, Ana L. M.; Fonseca, Leonardo N.; Blawid, Rosana; Ribeiro, Simone G.; Brasileiro, Ana C. M.] EMBRAPA, Embrapa Recursos Genet & Biotecnol, Brasilia, DF, Brazil; [Boiteux, Leonardo S.] EMBRAPA, Embrapa Hortalicas, Brasilia, DF, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Brasileiro, ACM (corresponding author), EMBRAPA, Embrapa Recursos Genet & Biotecnol, Brasilia, DF, Brazil.	ana.brasileiro@embrapa.br	Blawid, Rosana/F-6289-2014; Blawid, Rosana/AAH-5483-2019; Brasileiro, Ana Cristina Miranda/AAN-2187-2021	Blawid, Rosana/0000-0003-1001-7191; Brasileiro, Ana Cristina Miranda/0000-0003-0530-062X	Brazilian Agricultural Corporation (Embrapa); National Council for Scientific and Technological Development (CNPq); Fundacao de Apoio a Pesquisa do DF (FAPDF); National Research Institute for Plant-Pest Interactions (INCTIPP)	Brazilian Agricultural Corporation (Embrapa); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio a Pesquisa do DF (FAPDF)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Research Institute for Plant-Pest Interactions (INCTIPP)	The authors gratefully acknowledge Brazilian Agricultural Corporation (Embrapa); the National Council for Scientific and Technological Development (CNPq); Fundacao de Apoio a Pesquisa do DF (FAPDF) and the National Research Institute for Plant-Pest Interactions (INCTIPP) for funding this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors [LNF; LSB; SGR and ACMB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alfenas-Zerbini P, 2009, MOL PLANT MICROBE IN, V22, P352, DOI 10.1094/MPMI-22-3-0352; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Bergougnoux V, 2014, BIOTECHNOL ADV, V32, P170, DOI 10.1016/j.biotechadv.2013.11.003; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen X, 2010, ANAL BIOCHEM, V405, P138, DOI 10.1016/j.ab.2010.05.032; Choi HW, 2011, MOL PLANT MICROBE IN, V24, P68, DOI 10.1094/MPMI-02-10-0030; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Czosnek H, 2013, VIRUSES-BASEL, V5, P998, DOI 10.3390/v5030998; Dekkers BJW, 2012, PLANT CELL PHYSIOL, V53, P28, DOI 10.1093/pcp/pcr113; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Eybishtz A, 2009, PLANT MOL BIOL, V71, P157, DOI 10.1007/s11103-009-9515-9; Garcia-Cano E, 2008, PHYTOPATHOLOGY, V98, P618, DOI 10.1094/PHYTO-98-5-0618; Giordano LB, 2005, EUPHYTICA, V143, P27, DOI 10.1007/s10681-005-1685-1; Giordano Leonardo de B., 2005, Hortic. Bras., V23, P815, DOI 10.1590/S0102-05362005000300025; Gongora-Castillo E, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-295; Havelda Z, 2008, PLANT J, V55, P278, DOI 10.1111/j.1365-313X.2008.03501.x; Jacob F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059180; Li Q, 2012, PLANT CELL REP, V31, P1789, DOI 10.1007/s00299-012-1282-4; Lilly ST, 2011, MOL PLANT MICROBE IN, V24, P294, DOI 10.1094/MPMI-10-10-0236; Lovdal T, 2009, ANAL BIOCHEM, V387, P238, DOI 10.1016/j.ab.2009.01.024; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Mascia T, 2010, MOL PLANT PATHOL, V11, P805, DOI [10.1111/j.1364-3703.2010.00646.x, 10.1111/j.1365-3059.2009.02239.x]; Morgante CV, 2013, FUNCT PLANT BIOL, V40, P1298, DOI 10.1071/FP13096; Morgante Carolina V, 2011, BMC Res Notes, V4, P339, DOI 10.1186/1756-0500-4-339; Noutoshi Y, 2006, PLANT MOL BIOL, V62, P29, DOI 10.1007/s11103-006-9001-6; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Ribeiro SG, 2003, ARCH VIROL, V148, P281, DOI 10.1007/s00705-002-0917-0; Ribeiro SG, 2007, PHYTOPATHOLOGY, V97, P702, DOI 10.1094/PHYTO-97-6-0702; Rocha CS, 2013, J VIROL, V87, P5784, DOI 10.1128/JVI.00155-13; Silveira ED, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-84; Taylor S, 2010, METHODS, V50, pS1, DOI 10.1016/j.ymeth.2010.01.005; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Q, 2012, INT J LEGAL MED, V126, P943, DOI 10.1007/s00414-012-0774-7; ZAMIR D, 1994, THEOR APPL GENET, V88, P141, DOI 10.1007/BF00225889; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	40	31	31	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136820	10.1371/journal.pone.0136820	http://dx.doi.org/10.1371/journal.pone.0136820			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317870	gold, Green Published, Green Submitted			2022-12-26	WOS:000360299100144
J	Nobre, L; Wise, D; Ron, D; Volmer, R				Nobre, Luis; Wise, Daniel; Ron, David; Volmer, Romain			Modulation of Innate Immune Signalling by Lipid-Mediated MAVS Transmembrane Domain Oligomerization	PLOS ONE			English	Article							UNFOLDED-PROTEIN RESPONSE; HEPATITIS-C VIRUS; SELF-ASSOCIATION; MITOFUSIN 2; RIG-I; ACTIVATION; MITOCHONDRIA; INFECTION; PATHWAY; PHOSPHOLIPIDS	RIG-I-like receptors detect viral RNA in infected cells and promote oligomerization of the outer mitochondrial membrane protein MAVS to induce innate immunity to viral infection through type I interferon production. Mitochondrial reactive oxygen species (mROS) have been shown to enhance anti-viral MAVS signalling, but the mechanisms have remained obscure. Using a biochemical oligomerization-reporter fused to the transmembrane domain of MAVS, we found that mROS inducers promoted lipid-dependent MAVS transmembrane domain oligomerization in the plane of the outer mitochondrial membrane. These events were mirrored by Sendai virus infection, which similarly induced lipid peroxidation and promoted lipid-dependent MAVS transmembrane domain oligomerization. Our observations point to a role for mROS-induced changes in lipid bilayer properties in modulating antiviral innate signalling by favouring the oligomerization of MAVS transmembrane domain in the outer-mitochondrial membrane.	[Nobre, Luis; Wise, Daniel; Ron, David; Volmer, Romain] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Nobre, Luis; Wise, Daniel; Ron, David; Volmer, Romain] Wellcome Trust MRC Inst Metab Sci, Cambridge, England; [Nobre, Luis; Wise, Daniel; Ron, David; Volmer, Romain] NIHR Cambridge Biomed Res Ctr, Cambridge, England; [Volmer, Romain] Univ Toulouse, UMR1225, INP, ENVT,IHAP, F-31076 Toulouse, France; [Volmer, Romain] INRA, UMR1225, IHAP, F-31076 Toulouse, France	University of Cambridge; University of Cambridge; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; INRAE	Volmer, R (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Cambridge, England.	r.volmer@envt.fr		Volmer, Romain/0000-0003-1591-3251; Ron, David/0000-0002-3014-5636; Nobre, Luis/0000-0003-0467-8989	Wellcome Trust Intermediate Clinical Fellowship [093764]; Wellcome Trust Principal Research Fellowship [084812]; European Union Seventh Framework Programme Grant (Beta Bat) [277713]; Wellcome Trust [100140]	Wellcome Trust Intermediate Clinical Fellowship(Wellcome Trust); Wellcome Trust Principal Research Fellowship(Wellcome Trust); European Union Seventh Framework Programme Grant (Beta Bat); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Wellcome Trust Intermediate Clinical Fellowship (093764 o RV), a Wellcome Trust Principal Research Fellowship (084812 to DR), a Wellcome Trust Strategic Award for core facilities to the Cambridge Institute for Medical Research (100140) and European Union Seventh Framework Programme Grant (Beta Bat, 277713). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anbazhagan V, 2010, BBA-BIOMEMBRANES, V1798, P1899, DOI 10.1016/j.bbamem.2010.06.027; Baril M, 2009, J VIROL, V83, P1299, DOI 10.1128/JVI.01659-08; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Buege J A, 1978, Methods Enzymol, V52, P302; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Castanier C, 2010, EMBO REP, V11, P133, DOI 10.1038/embor.2009.258; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837; Daum G, 1997, PROG LIPID RES, V36, P103, DOI 10.1016/S0163-7827(97)00006-4; Deng L, 2011, J VIROL, V85, P8556, DOI 10.1128/JVI.00146-11; Dey M, 2007, J BIOL CHEM, V282, P6653, DOI 10.1074/jbc.M607897200; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074; Gonzalez-Dosal R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002250; Gottlieb E, 2003, CELL DEATH DIFFER, V10, P709, DOI 10.1038/sj.cdd.4401231; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Ichinohe T, 2013, P NATL ACAD SCI USA, V110, P17963, DOI 10.1073/pnas.1312571110; Koshiba T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001147; Li E, 2012, BBA-BIOMEMBRANES, V1818, P183, DOI 10.1016/j.bbamem.2011.08.031; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Liu SQ, 2013, ELIFE, V2, DOI 10.7554/eLife.00785; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Mall S, 2001, BIOCHEMISTRY-US, V40, P12379, DOI 10.1021/bi011075y; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Mukherjee P, 2013, IMMUNITY, V38, P705, DOI 10.1016/j.immuni.2013.02.013; Naik E, 2011, J EXP MED, V208, P417, DOI 10.1084/jem.20110367; Nakaya T, 2001, BIOCHEM BIOPH RES CO, V283, P1150, DOI 10.1006/bbrc.2001.4913; Odendall C, 2014, NAT IMMUNOL, V15, P717, DOI 10.1038/ni.2915; Onoguchi K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001012; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Pandey S, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016246; Promlek T, 2011, MOL BIOL CELL, V22, P3520, DOI 10.1091/mbc.E11-04-0295; Reczek CR, 2015, CURR OPIN CELL BIOL, V33, P8, DOI 10.1016/j.ceb.2014.09.010; Reis A, 2012, BBA-BIOMEMBRANES, V1818, P2374, DOI 10.1016/j.bbamem.2012.02.002; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Tang ED, 2009, J VIROL, V83, P3420, DOI 10.1128/JVI.02623-08; Tyurina YY, 2015, FREE RADICAL RES, V49, P681, DOI 10.3109/10715762.2015.1005085; Volmer R, 2015, CURR OPIN CELL BIOL, V33, P67, DOI 10.1016/j.ceb.2014.12.002; Volmer R, 2013, P NATL ACAD SCI USA, V110, P4628, DOI 10.1073/pnas.1217611110; Volmer R, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-63; Wallgren M, 2013, FARADAY DISCUSS, V161, P499, DOI 10.1039/c2fd20089a; Wu B, 2014, MOL CELL, V55, P511, DOI 10.1016/j.molcel.2014.06.010; Yasukawa K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000287; Zhao YY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003086	49	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136883	10.1371/journal.pone.0136883	http://dx.doi.org/10.1371/journal.pone.0136883			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317833	Green Published, gold, Green Submitted			2022-12-26	WOS:000360299100160
J	Peralta, L; Mourier, E; Richard, C; Charpigny, G; Larcher, T; Ait-Belkacem, D; Balla, NK; Brasselet, S; Tanter, M; Muller, M; Chavatte-Palmer, P				Peralta, Laura; Mourier, Eve; Richard, Christophe; Charpigny, Gilles; Larcher, Thibaut; Ait-Belkacem, Dora; Balla, Naveen K.; Brasselet, Sophie; Tanter, Mickael; Muller, Marie; Chavatte-Palmer, Pascale			In Vivo Evaluation of Cervical Stiffness Evolution during Induced Ripening Using Shear Wave Elastography, Histology and 2 Photon Excitation Microscopy: Insight from an Animal Model	PLOS ONE			English	Article							2ND-HARMONIC GENERATION; UTERINE CERVIX; LABOR INDUCTION; OVARIAN-CANCER; PRETERM BIRTH; COLLAGEN; PREGNANCY; TERM; LENGTH; PARTURITION	Prematurity affects 11% of the births and is the main cause of infant mortality. On the opposite case, the failure of induction of parturition in the case of delayed spontaneous birth is associated with fetal suffering. Both conditions are associated with precocious and/or delayed cervical ripening. Quantitative and objective information about the temporal evolution of the cervical ripening may provide a complementary method to identify cases at risk of preterm delivery and to assess the likelihood of successful induction of labour. In this study, the cervical stiffness was measured in vivo in pregnant sheep by using Shear Wave Elastography (SWE). This technique assesses the stiffness of tissue through the measurement of shear waves speed (SWS). In the present study, 9 pregnant ewes were used. Cervical ripening was induced at 127 days of pregnancy (term: 145 days) by dexamethasone injection in 5 animals, while 4 animals were used as control. Elastographic images of the cervix were obtained by two independent operators every 4 hours during 24 hours after injection to monitor the cervical maturation induced by the dexamethasone. Based on the measurements of SWS during vaginal ultrasound examination, the stiffness in the second ring of the cervix was quantified over a circular region of interest of 5 mm diameter. SWS was found to decrease significantly in the first 4-8 hours after dexamethasone compared to controls, which was associated with cervical ripening induced by dexamethasone (from 1.779 m/s +/- 0.548 m/s, p < 0.0005, to 1.291 m/s +/- 0.516 m/s, p < 0.000). Consequently a drop in the cervical elasticity was quantified too (from 9.5 kPa +/- 0.9 kPa, p < 0.0005, to 5.0 kPa +/- 0.8 kPa, p < 0.000). Moreover, SWE measurements were highly reproducible between both operators at all times. Cervical ripening induced by dexamethasone was confirmed by the significant increase in maternal plasma Prostaglandin E2 (PGE2), as evidenced by the assay of its metabolite PGEM. Histological analyses and two-photon excitation microscopy, combining both Second Harmonic Generation (SHG) and Two-photon Fluorescence microscopy (2PF) contrasts, were used to investigate, at the microscopic scale, the structure of cervical tissue. Results show that both collagen and 2PF-active fibrillar structures could be closely related to the mechanical properties of cervical tissue that are perceptible in elastography. In conclusion, SWE may be a valuable method to objectively quantify the cervical stiffness and as a complementary diagnostic tool for preterm birth and for labour induction success.	[Peralta, Laura] Univ Granada, Dept Struct Mech, Granada, Spain; [Mourier, Eve; Richard, Christophe; Charpigny, Gilles; Chavatte-Palmer, Pascale] INRA, UMR Biol Dev & Reprod 1198, Jouy En Josas, France; [Mourier, Eve; Richard, Christophe; Chavatte-Palmer, Pascale] PremUp Fdn, F-75006 Paris, France; [Larcher, Thibaut] INRA, UMR APEX 703, F-44307 Nantes, France; [Ait-Belkacem, Dora; Balla, Naveen K.; Brasselet, Sophie] Aix Marseille Univ, CNRS, Cent Marseille, Inst Fresnel,UMR 7249, F-13013 Marseille, France; [Tanter, Mickael; Muller, Marie] Univ Paris 07, CNRS, Inst Langevin, ESPCI ParisTech, Paris, France; [Muller, Marie] N Carolina State Univ, Dept Mech & Aerosp Engn, Raleigh, NC 27695 USA	University of Granada; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Universite Paris Cite; University of North Carolina; North Carolina State University	Peralta, L (corresponding author), Univ Granada, Dept Struct Mech, Granada, Spain.	lperalta@ugr.es	Mickael, Tanter/H-4657-2012; Larcher, Thibaut/X-8500-2019; Chavatte-Palmer, Pascale/K-7349-2012; Brasselet, Sophie/N-1089-2017; Peralta, Laura/I-4732-2019; Larcher, Thibaut/M-9160-2013	Mickael, Tanter/0000-0001-7739-8051; Chavatte-Palmer, Pascale/0000-0002-4581-6092; Brasselet, Sophie/0000-0002-6766-9273; Peralta, Laura/0000-0002-3753-5370; Larcher, Thibaut/0000-0002-0396-3190				Ait-Belkacem D, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.8.080506; Akins ML, 2011, BIOL REPROD, V84, P1053, DOI 10.1095/biolreprod.110.089599; Badir S, 2013, PRENATAL DIAG, V33, P737, DOI 10.1002/pd.4116; BAKKE T, 1974, ACTA OBSTET GYN SCAN, V53, P293, DOI 10.3109/00016347409157742; Bamber J, 2013, ULTRASCHALL MED, V34, P169, DOI 10.1055/s-0033-1335205; Bavu E, 2011, ULTRASOUND MED BIOL, V37, P1361, DOI 10.1016/j.ultrasmedbio.2011.05.016; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Bercoff J, 2004, APPL PHYS LETT, V84, P2202, DOI 10.1063/1.1667613; Berg WA, 2012, RADIOLOGY, V262, P435, DOI 10.1148/radiol.11110640; Bernal M, 2013, ULTRASOUND MED BIOL, V39, P2123, DOI 10.1016/j.ultrasmedbio.2013.05.014; BISHOP EH, 1964, OBSTET GYNECOL, V24, P266; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; CABROL D, 1991, SEMIN PERINATOL, V15, P133; CALDER AA, 1994, AUST NZ J OBSTET GYN, V34, P347, DOI 10.1111/j.1479-828X.1994.tb01087.x; Campagnola P, 2011, ANAL CHEM, V83, P3224, DOI 10.1021/ac1032325; Campagnola PJ, 2002, BIOPHYS J, V82, P493, DOI 10.1016/S0006-3495(02)75414-3; Carlson LC, 2014, ULTRASOUND OBST GYN, V43, P452, DOI 10.1002/uog.12555; Carlson L. C, 2014, ULTRASOUND OBSTET GY; Celik E, 2008, ULTRASOUND OBST GYN, V31, P549, DOI 10.1002/uog.5333; Challis JRG, 2000, ENDOCR REV, V21, P514, DOI 10.1210/er.21.5.514; Chang SK, 2002, J BIOMED OPT, V7, P595, DOI 10.1117/1.1509753; Feltovich H, 2013, ULTRASOUND OBST GYN, V41, P121, DOI 10.1002/uog.12383; FREUND I, 1986, BIOPHYS J, V50, P693, DOI 10.1016/S0006-3495(86)83510-X; Friedl Peter, 2007, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0415s34; GOMEZ R, 1994, AM J OBSTET GYNECOL, V171, P956, DOI 10.1016/0002-9378(94)90014-0; Gusachenko I, 2012, BIOPHYS J, V102, P2220, DOI 10.1016/j.bpj.2012.03.068; HALBERT GW, 1990, THERIOGENOLOGY, V33, P977, DOI 10.1016/0093-691X(90)90060-7; Hernandez-Andrade E, 2013, ULTRASOUND OBST GYN, V41, P152, DOI 10.1002/uog.12344; Hochhaus G, 2001, J CLIN PHARMACOL, V41, P425, DOI 10.1177/00912700122010285; Iams JD, 1996, NEW ENGL J MED, V334, P567, DOI 10.1056/NEJM199602293340904; Ingoldby L, 2001, PRACTICE, P23; Isgro G, 2013, J GASTROENTEROL, V48, P921, DOI 10.1007/s00535-012-0694-9; Johnson MD, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-373; Khalil MR, 2013, DAN MED J, V60; Kolkman DGE, 2013, AM J PERINAT, V30, P625, DOI 10.1055/s-0032-1331024; Kwee A, 2007, EUR J OBSTET GYN R B, V132, P171, DOI 10.1016/j.ejogrb.2006.07.017; LEPPERT PC, 1995, CLIN OBSTET GYNECOL, V38, P267, DOI 10.1097/00003081-199506000-00009; LIGGINS GC, 1968, J ENDOCRINOL, V42, P323, DOI 10.1677/joe.0.0420323; Mahendroo M, 2012, REPRODUCTION, V143, P429, DOI 10.1530/REP-11-0466; Martin JA, 2013, NATL VITAL STAT REPO; Maul H, 2005, ACTA OBSTET GYN SCAN, V84, P534, DOI 10.1111/j.0001-6349.2005.00806.x; Mazza E, 2006, MED IMAGE ANAL, V10, P125, DOI 10.1016/j.media.2005.06.001; Mazza E, 2014, PRENATAL DIAG, V34, P33, DOI 10.1002/pd.4260; Molina FS, 2012, ULTRASOUND OBST GYN, V39, P685, DOI 10.1002/uog.11067; Muglia LJ, 2010, NEW ENGL J MED, V362, P529, DOI 10.1056/NEJMra0904308; Muller M, 2009, ULTRASOUND MED BIOL, V35, P219, DOI 10.1016/j.ultrasmedbio.2008.08.018; Myers K, 2009, EUR J OBSTET GYN R B, V144, pS82, DOI 10.1016/j.ejogrb.2009.02.008; Nadiarnykh O, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-94; Noguchi K, 2012, J STAT SOFTW, V50, P1, DOI 10.18637/jss.v050.i12; Pandis GK, 2001, ULTRASOUND OBST GYN, V18, P623, DOI 10.1046/j.0960-7692.2001.00580.x; Peralta L, 2015, J BIOMECH, V48, P1557, DOI 10.1016/j.jbiomech.2015.02.037; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Purohit GN, 2012, IRAN J APPL ANIM SCI, V2, P1; Raub CB, 2008, BIOPHYS J, V94, P2361, DOI 10.1529/biophysj.107.120006; Reusch LM, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.3.031110; Sanchez-Ramos L, 2003, OBSTET GYNECOL, V101, P1312, DOI 10.1016/S0029-7844(03)00342-9; Schlembach D, 2009, EUR J OBSTET GYN R B, V144, pS70, DOI 10.1016/j.ejogrb.2009.02.036; SILVER M, 1990, EXP PHYSIOL, V75, P285, DOI 10.1113/expphysiol.1990.sp003405; Strupler M, 2007, OPT EXPRESS, V15, P4054, DOI 10.1364/OE.15.004054; Strupler M, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2981830; Swiatkowska-Freund M, 2011, ULTRASOUND OBST GYN, V38, P52, DOI 10.1002/uog.9021; Tang J, 2014, ASIAN J ANDROL, V16, P305, DOI 10.4103/1008-682X.122582; Tanter M, 2008, ULTRASOUND MED BIOL, V34, P1373, DOI 10.1016/j.ultrasmedbio.2008.02.002; Tanter M, 2014, IEEE T ULTRASON FERR, V61, P102, DOI [10.1109/TUFFC.2014.2882, 10.1109/TUFFC.2014.6689779]; Tiaho F, 2007, OPT EXPRESS, V15, P12286, DOI 10.1364/OE.15.012286; Tilbury K, 2014, BIOPHYS J, V106, P354, DOI 10.1016/j.bpj.2013.10.044; ULDBJERG N, 1981, LANCET, V1, P267; Verhoeven CJM, 2013, ULTRASOUND OBST GYN, V42, P500, DOI 10.1002/uog.12467; WHO, 2011, WHO REC IND LAB; Williams RM, 2005, BIOPHYS J, V88, P1377, DOI 10.1529/biophysj.104.047308; Word RA, 2007, SEMIN REPROD MED, V25, P69, DOI 10.1055/s-2006-956777; Zhang YY, 2012, P NATL ACAD SCI USA, V109, P12878, DOI 10.1073/pnas.1121495109	72	18	18	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0133377	10.1371/journal.pone.0133377	http://dx.doi.org/10.1371/journal.pone.0133377			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317774	Green Published, gold			2022-12-26	WOS:000360299100007
J	Maluccio, JA; Palermo, T; Kadiyala, S; Rawat, R				Maluccio, John A.; Palermo, Tia; Kadiyala, Suneetha; Rawat, Rahul			Improving Health-Related Quality of Life among People Living with HIV: Results from an Impact Evaluation of a Food Assistance Program in Uganda	PLOS ONE			English	Article							INSECURITY ACCESS SCALE; ANTIRETROVIRAL THERAPY; MEDICAL OUTCOMES; MATCHING ESTIMATORS; NUTRITIONAL-STATUS; SOCIAL-SERVICES; PUBLIC-HEALTH; INFECTION; ADHERENCE; HIV/AIDS	Introduction Widespread food insecurity in Africa continues to compromise an effective response to the AIDS epidemic. Health-related quality of life (HRQoL) is a comprehensive indicator of physical, mental, and social well-being that is associated with food insecurity and increasingly used to assess the well-being of people living with HIV/AIDS (PLHIV). We examined the impact of a food assistance intervention, previously shown to have reduced household food insecurity and improved nutritional status, on HRQoL of PLHIV. Methods We capitalized on an existing intervention targeting antiretroviral therapy (ART)-naive PLHIV in Uganda, and conducted a prospective impact evaluation including a treatment and a comparison group. Data analyzed included 640 participants from two districts (318 in the intervention district) interviewed in both clinic and household settings at baseline and again approximately one year later. The main outcomes considered were physical and mental health dimensions of HRQoL, and other outcomes included self-and healthcare provider-reported symptoms. We utilized difference-in-difference propensity score matching methodologies to infer causality and examine program impacts. Results Over 12 months, food assistance significantly increased physical health scores (PHS) by 2.85 (P < .01) or approximately 0.35 SD, and reduced substantially the number of self-and healthcare provider-reported HIV-related symptoms by 3.83 and 2.68, respectively (P < .01). There was no significant impact, however, on mental health scores (MHS). Conclusions This study demonstrates the potential importance for HRQoL of including food assistance programming as part of the standard of care for PLHIV in areas of widespread food insecurity.	[Maluccio, John A.] Middlebury Coll, Dept Econ, Middlebury, VT 05753 USA; [Palermo, Tia] SUNY Stony Brook, Program Publ Hlth, Stony Brook, NY 11794 USA; [Kadiyala, Suneetha] London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1, England; [Rawat, Rahul] Int Food Policy Res Inst, Poverty Hlth & Nutr Div, Dakar, Senegal	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of London; London School of Hygiene & Tropical Medicine; CGIAR; International Food Policy Research Institute (IFPRI)	Maluccio, JA (corresponding author), Middlebury Coll, Dept Econ, Middlebury, VT 05753 USA.	maluccio@middlebury.edu	Palermo, Tia/ABI-8328-2020	Kadiyala, Suneetha/0000-0002-9101-1471	International Initiative for Impact Evaluation (3ie), Concern Worldwide; Regional Network on AIDS, Livelihoods, and Food Security (RENEWAL); Irish Aid; Swedish International Development Cooperation Agency (SIDA)	International Initiative for Impact Evaluation (3ie), Concern Worldwide; Regional Network on AIDS, Livelihoods, and Food Security (RENEWAL); Irish Aid(CGIAR); Swedish International Development Cooperation Agency (SIDA)	This study was funded by the International Initiative for Impact Evaluation (3ie), Concern Worldwide, and the Regional Network on AIDS, Livelihoods, and Food Security (RENEWAL), facilitated by IFPRI. RENEWAL is grateful for support from Irish Aid and the Swedish International Development Cooperation Agency (SIDA). The funders had no role in the study design, data collection, analysis, interpretation, or manuscript preparation.	Abadie A, 2004, STATA J, V4, P290, DOI 10.1177/1536867X0400400307; Abadie A, 2011, J BUS ECON STAT, V29, P1, DOI 10.1198/jbes.2009.07333; Adewuya AO, 2008, INT J PSYCHIAT MED, V38, P43, DOI 10.2190/PM.38.1.d; Amarantos E, 2001, J GERONTOL A-BIOL, V56, P54, DOI 10.1093/gerona/56.suppl_2.54; Anema A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061277; Anema Aranka, 2009, Curr HIV/AIDS Rep, V6, P224, DOI 10.1007/s11904-009-0030-z; [Anonymous], 2014, GLOB UPD HLTH SECT R; Arimond M, 2010, J NUTR, V140, p2059S, DOI 10.3945/jn.110.123414; Armon C, 2011, QUAL LIFE RES; Bateganya MH, 2015, JAIDS-J ACQ IMM DEF, V68, pS357, DOI 10.1097/QAI.0000000000000498; Becquey E, 2010, J NUTR, V140, P2233, DOI 10.3945/jn.110.125716; Bukusuba J, 2007, BRIT J NUTR, V98, P211, DOI 10.1017/S0007114507691806; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; Coetzee B, 2011, AIDS CARE, V23, P146, DOI 10.1080/09540121.2010.498874; de Pee S, 2010, FOOD NUTR BULL, V31, pS313, DOI 10.1177/15648265100314S403; Deaton A, 2002, GUIDLINES CONSTRUCTI; Gibson K, 2011, AIDS PATIENT CARE ST, V25, P371, DOI 10.1089/apc.2010.0165; Greeff M, 2010, INT J NURS STUD, V47, P475, DOI 10.1016/j.ijnurstu.2009.09.008; Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10; Hadley C, 2008, AM J PHYS ANTHROPOL, V135, P225, DOI 10.1002/ajpa.20724; Hughes J, 2004, DISABIL REHABIL, V26, P371, DOI 10.1080/09638280410001662932; Imbens GW, 2009, J ECON LIT, V47, P5, DOI 10.1257/jel.47.1.5; Jelsma J, 2005, AIDS CARE, V17, P579, DOI 10.1080/09540120412331319714; Kadiyala S, 2010, SOCIOECONOMIC DIMENS, P74; Kaleeba N, 1997, AIDS CARE, V9, P13, DOI 10.1080/09540129750125307; Kirkpatrick SI, 2008, J NUTR, V138, P604, DOI 10.1093/jn/138.3.604; Knueppel D, 2010, PUBLIC HEALTH NUTR, V13, P360, DOI 10.1017/S1368980009991121; Laraia BA, 2006, J NUTR, V136, P177, DOI 10.1093/jn/136.1.177; Lee JS, 2001, J NUTR, V131, P1503, DOI 10.1093/jn/131.5.1503; Leuven E., 2012, STAT SOFTW COMPONENT; Louwagie GM, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-244; Mahlungulu S, 2007, COCHRANE DATABASE SY, V3; Marcellin F, 2010, AIDS, V24, pS17, DOI 10.1097/01.aids.0000366079.83568.a2; Mast TC, 2004, AIDS CARE, V16, P81, DOI 10.1080/09540120310001633994; Miners A, 2014, LANCET HIV, V1, pE32, DOI 10.1016/S2352-3018(14)70018-9; Musumari PM, 2013, AIDS CARE, P1; O'Leary JF, 1998, J ACQ IMMUN DEF SYND, V17, P433, DOI 10.1097/00042560-199804150-00008; OKeefe EA, 1996, QUAL LIFE RES, V5, P275, DOI 10.1007/BF00434749; Oketch JA, 2011, HEALTH POLICY, V99, P267, DOI 10.1016/j.healthpol.2010.08.018; Palermo T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062353; Pozniak A, 2014, LANCET HIV, V1, pE6, DOI 10.1016/S2352-3018(14)70003-7; Preau M, 2005, J PSYCHOSOM RES, V59, P407, DOI 10.1016/j.jpsychores.2005.06.005; Preau M, 2004, AIDS CARE, V16, P649, DOI 10.1080/09540120410001716441; Rawat R, 2014, JAIDS-J ACQ IMM DEF, V66, pE15, DOI 10.1097/QAI.0000000000000079; Revicki DA, 1998, MED CARE, V36, P126, DOI 10.1097/00005650-199802000-00003; Romero R., 2015, P INT C INT SYST APP, P1; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Rueda S, 2011, AIDS CARE, V23, P435, DOI 10.1080/09540121.2010.507952; Seligman HK, 2010, J NUTR, V140, P304, DOI 10.3945/jn.109.112573; Senkomago V, 2011, AIDS CARE, V23, P1246, DOI 10.1080/09540121.2011.564112; Stangl AL, 2007, AIDS CARE, V19, P626, DOI 10.1080/09540120701203915; Stangl AL, 2011, QUAL LIFE RES; Stuff JE, 2004, J NUTR, V134, P2330, DOI 10.1093/jn/134.9.2330; Tirivayi N, 2011, SOC SCI MED, V73, P685, DOI 10.1016/j.socscimed.2011.06.056; Todd PE, 2007, HDB DEV EC, P3847; Tsai AC, 2012, SOC SCI MED, V74, P2012, DOI 10.1016/j.socscimed.2012.02.033; Tsai AC, 2011, SOC SCI MED, V73, P1717, DOI 10.1016/j.socscimed.2011.09.026; Vella S, 2012, AIDS, V26, P1231, DOI 10.1097/QAD.0b013e32835521a3; Victora CG, 2004, AM J PUBLIC HEALTH, V94, P400, DOI 10.2105/AJPH.94.3.400; Vinck P, 2007, JAMA-J AM MED ASSOC, V298, P543, DOI 10.1001/jama.298.5.543; Weiser SD, 2007, PLOS MED, V4, P1589, DOI 10.1371/journal.pmed.0040260; Weiser SD, 2014, AIDS, V28, P115, DOI 10.1097/01.aids.0000433238.93986.35; Weiser SD, 2012, JAIDS-J ACQ IMM DEF, V61, P179, DOI 10.1097/QAI.0b013e318261f064; Weiser SD, 2012, AIDS, V26, P67, DOI 10.1097/QAD.0b013e32834cad37; Weiser SD, 2011, AM J CLIN NUTR, V94, p1729S, DOI 10.3945/ajcn.111.012070; WHO, 2010, 2010 GUID ANT TREATM; Wu AW, 1997, QUAL LIFE RES, V6, P531, DOI 10.1023/A:1018460132567; Wu AW, 1997, QUAL LIFE RES, V6, P481, DOI 10.1023/A:1018451930750; Wu AW., 1999, MOS HIV HLTH SURVEY	70	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0135879	10.1371/journal.pone.0135879	http://dx.doi.org/10.1371/journal.pone.0135879			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP8KZ	26313908	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000360144000028
J	Jost, M; Born, DA; Cracan, V; Banerjee, R; Drennan, CL				Jost, Marco; Born, David A.; Cracan, Valentin; Banerjee, Ruma; Drennan, Catherine L.			Structural Basis for Substrate Specificity in Adenosylcobalamin-dependent Isobutyryl-CoA Mutase and Related Acyl-CoA Mutases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBON BOND HOMOLYSIS; X-RAY-STRUCTURE; COENZYME B-12; ACTIVE-SITE; STREPTOMYCES-CINNAMONENSIS; METHYLMALONYL-COENZYME; ANAEROBIC DEGRADATION; CRYSTAL-STRUCTURE; PROTEIN; INTERMEDIATE	Background: Acyl-CoA mutases catalyze radical-based carbon skeleton rearrangements. Results: Crystal structures of isobutyryl-CoA mutase in complex with four different substrates reveal active site architecture and determinants of substrate specificity. Conclusion: Identification of specificity-determining residues allows for prediction of new acyl-CoA mutase activities. Significance: Improved understanding of acyl-CoA mutase substrate specificity is critical for biotechnological and engineering applications.	[Jost, Marco; Born, David A.; Drennan, Catherine L.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Drennan, Catherine L.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Drennan, Catherine L.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Born, David A.] Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA; [Cracan, Valentin; Banerjee, Ruma] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; University of Michigan System; University of Michigan	Drennan, CL (corresponding author), MIT, Howard Hughes Med Inst, Dept Chem, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cdrennan@mit.edu	Regan, Clinton/E-6250-2012	Cracan, Valentin/0000-0002-3280-0593	National Institutes of Health [GM069857, DK45776, T32 GM008313]; MIT Poitras pre-doctoral fellowship; National Institutes of Health from NIGMS [P41 GM103403]; DOE Office of Science [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK045776, R01DK045776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069857, T32GM008313, P41GM103403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MIT Poitras pre-doctoral fellowship; National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM069857 (to C. L. D.) and DK45776 (to R. B.), Training Grant T32 GM008313 (to D. A. B.). This work was also supported by an MIT Poitras pre-doctoral fellowship (to M. J.). This work is based in part on research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, supported by the National Institutes of Health and Grant P41 GM103403 from NIGMS. This research used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Banerjee R, 2003, CHEM REV, V103, P2083, DOI 10.1021/cr0204395; Berg IA, 2007, SCIENCE, V318, P1782, DOI 10.1126/science.1149976; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bothe H, 1998, BIOCHEMISTRY-US, V37, P4105, DOI 10.1021/bi971393q; BRENDELBERGER G, 1988, ANGEW CHEM INT EDIT, V27, P1089, DOI 10.1002/anie.198810891; Brown KL, 2005, CHEM REV, V105, P2075, DOI 10.1021/cr030720z; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Bucher D, 2012, J AM CHEM SOC, V134, P1591, DOI 10.1021/ja207809b; Callaghan AV, 2012, ENVIRON MICROBIOL, V14, P101, DOI 10.1111/j.1462-2920.2011.02516.x; Callaghan AV, 2006, APPL ENVIRON MICROB, V72, P4274, DOI 10.1128/AEM.02896-05; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Cracan V, 2013, METAL IONS LIFE SCI, V12, P333, DOI 10.1007/978-94-007-5561-1_10; Cracan V, 2012, BIOCHEMISTRY-US, V51, P6039, DOI 10.1021/bi300827v; Cracan V, 2012, J BIOL CHEM, V287, P3723, DOI 10.1074/jbc.M111.320051; Cracan V, 2010, J BIOL CHEM, V285, P655, DOI 10.1074/jbc.M109.062182; Dayem LC, 2002, BIOCHEMISTRY-US, V41, P5193, DOI 10.1021/bi015593k; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dowling DP, 2012, ANNU REV BIOPHYS, V41, P403, DOI 10.1146/annurev-biophys-050511-102225; DRENNAN CL, 1994, SCIENCE, V266, P1669, DOI 10.1126/science.7992050; Ebenau-Jehle C, 2012, J BACTERIOL, V194, P2894, DOI 10.1128/JB.00250-12; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erb TJ, 2008, J BIOL CHEM, V283, P32283, DOI 10.1074/jbc.M805527200; Erb TJ, 2007, P NATL ACAD SCI USA, V104, P10631, DOI 10.1073/pnas.0702791104; Frey PA, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 7: COFACTORS, P501; Froese DS, 2010, J BIOL CHEM, V285, P38204, DOI 10.1074/jbc.M110.177717; Gruber K, 2001, ANGEW CHEM INT EDIT, V40, P3377, DOI 10.1002/1521-3773(20010917)40:18<3377::AID-ANIE3377>3.0.CO;2-8; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HALPERN J, 1985, SCIENCE, V227, P869, DOI 10.1126/science.2857503; Jarling R, 2012, ANGEW CHEM INT EDIT, V51, P1334, DOI 10.1002/anie.201106055; Jensen KP, 2005, J AM CHEM SOC, V127, P9117, DOI 10.1021/ja050744i; Jost M, 2015, P NATL ACAD SCI USA, V112, P2419, DOI 10.1073/pnas.1419582112; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kitanishi K, 2015, J BIOL CHEM, V290, P20466, DOI 10.1074/jbc.M115.646299; Kniemeyer O, 2003, APPL ENVIRON MICROB, V69, P760, DOI 10.1128/AEM.69.2.760-768.2003; Kurteva-Yaneva N, 2015, J BIOL CHEM, V290, P9727, DOI 10.1074/jbc.M115.645689; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LoBrutto R, 2001, BIOCHEMISTRY-US, V40, P9, DOI 10.1021/bi001865s; Mancia F, 1998, STRUCTURE, V6, P711, DOI 10.1016/S0969-2126(98)00073-2; Mancia F, 1996, STRUCTURE, V4, P339, DOI 10.1016/S0969-2126(96)00037-8; Mancia F, 1999, BIOCHEMISTRY-US, V38, P7999, DOI 10.1021/bi9903852; Mansoorabadi SO, 2005, BIOCHEMISTRY-US, V44, P3153, DOI 10.1021/bi0482102; Masuda J, 2000, STRUCTURE, V8, P775, DOI 10.1016/S0969-2126(00)00164-7; MOORE BS, 1995, J AM CHEM SOC, V117, P11285, DOI 10.1021/ja00150a028; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Ratnatilleke A, 1999, J BIOL CHEM, V274, P31679, DOI 10.1074/jbc.274.44.31679; REYNOLDS KA, 1988, J CHEM SOC PERK T 1, P3195, DOI 10.1039/p19880003195; Rodriguez GM, 2014, NAT CHEM BIOL, V10, P259, DOI 10.1038/nchembio.1476; ROHWERDER T, 2007, VITAMIN B NEW RES, P81; Roman-Melendez GD, 2014, BIOCHEMISTRY-US, V53, P169, DOI 10.1021/bi4012644; Schrodinger L. L. C., 2014, PYMOL MOL GRAPHICS S; Sharma PK, 2007, P NATL ACAD SCI USA, V104, P9661, DOI 10.1073/pnas.0702238104; Smart O.S., 2011, GRADE; So CM, 1999, APPL ENVIRON MICROB, V65, P2969; Thoma NH, 2000, BIOCHEMISTRY-US, V39, P9213, DOI 10.1021/bi0004302; Toraya T, 2014, ARCH BIOCHEM BIOPHYS, V544, P40, DOI 10.1016/j.abb.2013.11.002; Vey JL, 2011, CHEM REV, V111, P2487, DOI 10.1021/cr9002616; Vlasie MD, 2004, BIOCHEMISTRY-US, V43, P8410, DOI 10.1021/bi036299q; Vlasie MD, 2003, J AM CHEM SOC, V125, P5431, DOI 10.1021/ja029420+; Vrijbloed JW, 1999, J BACTERIOL, V181, P5600, DOI 10.1128/JB.181.18.5600-5605.1999; Weichler MT, 2015, APPL ENVIRON MICROB, V81, P4564, DOI 10.1128/AEM.00716-15; Wilkes H, 2002, ARCH MICROBIOL, V177, P235, DOI 10.1007/s00203-001-0381-3; Yabuta Y, 2015, BIOSCI BIOTECH BIOCH, V79, P710, DOI 10.1080/09168451.2014.993353; Yaneva N, 2012, J BIOL CHEM, V287, P15502, DOI 10.1074/jbc.M111.314690	71	13	13	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					26882	26898		10.1074/jbc.M115.676890	http://dx.doi.org/10.1074/jbc.M115.676890			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26318610	hybrid, Green Published			2022-12-26	WOS:000364794000002
J	Quijada, P; Hariharan, N; Cubillo, JD; Bala, KM; Emathinger, JM; Wang, BJY; Ormachea, L; Bers, DM; Sussman, MA; Poizat, C				Quijada, Pearl; Hariharan, Nirmala; Cubillo, Jonathan D.; Bala, Kristin M.; Emathinger, Jacqueline M.; Wang, Bingyan J.; Ormachea, Lucia; Bers, Donald M.; Sussman, Mark A.; Poizat, Coralie			Nuclear Calcium/Calmodulin-dependent Protein Kinase II Signaling Enhances Cardiac Progenitor Cell Survival and Cardiac Lineage Commitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; HISTONE DEACETYLASE-4; CAM KINASE; DELTA-B; DIFFERENTIATION; EXPRESSION; HEART; ACTIVATION; INHIBITORS; DEATH	Ca2+/Calmodulin-dependent protein kinase II (CaMKII) signaling in the heart regulates cardiomyocyte contractility and growth in response to elevated intracellular Ca2+. The delta B isoform of CaMKII is the predominant nuclear splice variant in the adult heart and regulates cardiomyocyte hypertrophic gene expression by signaling to the histone deacetylase HDAC4. However, the role of CaMKII delta in cardiac progenitor cells (CPCs) has not been previously explored. During post-natal growth endogenous CPCs display primarily cytosolic CaMKII delta, which localizes to the nuclear compartment of CPCs after myocardial infarction injury. CPCs undergoing early differentiation in vitro increase levels of CaMKII delta B in the nuclear compartment where the kinase may contribute to the regulation of CPC commitment. CPCs modified with lentiviral-based constructs to overexpress CaMKII delta B (CPCe delta B) have reduced proliferative rate compared with CPCs expressing eGFP alone (CPCe). Additionally, stable expression of CaMKII delta B promotes distinct morphological changes such as increased cell surface area and length of cells compared with CPCe. CPCe delta B are resistant to oxidative stress induced by hydrogen peroxide (H2O2) relative to CPCe, whereas knockdown of CaMKII delta B resulted in an up-regulation of cell death and cellular senescence markers compared with scrambled treated controls. Dexamethasone (Dex) treatment increased mRNA and protein expression of cardiomyogenic markers cardiac troponin T and alpha-smooth muscle actin in CPCe delta B compared with CPCe, suggesting increased differentiation. Therefore, CaMKII delta B may serve as a novel modulatory protein to enhance CPC survival and commitment into the cardiac and smooth muscle lineages.	[Quijada, Pearl; Cubillo, Jonathan D.; Bala, Kristin M.; Emathinger, Jacqueline M.; Wang, Bingyan J.; Ormachea, Lucia; Sussman, Mark A.; Poizat, Coralie] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Hariharan, Nirmala; Bers, Donald M.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Poizat, Coralie] King Faisal Specialist Hosp & Res Ctr, Cardiovasc Res Program, Riyadh 11211, Saudi Arabia	California State University System; San Diego State University; University of California System; University of California Davis; King Faisal Specialist Hospital & Research Center	Poizat, C (corresponding author), Cardiovasc Res Program, POB 3354,MBC 03, Riyadh, Saudi Arabia.	cpoizat99@kfshrc.edu.sa	Wang, Bingyan/AAB-3883-2019; Regan, Clinton/E-6250-2012; Sussman, Mark/H-2284-2014	Wang, Bingyan/0000-0002-3522-2848; Sussman, Mark/0000-0002-0104-4799; Bers, Donald/0000-0002-2237-9483	National Institutes of Health [F31HL117623, R01HL067245, R37HL091102, R01HL105759, R01HL113647, R01HL117163, P01HL085577, R01HL122525]; Rees Stealy Research Foundation; SDSU Heart Institute Fellowship; Achievement Rewards for College Scientists Scholarship; American Heart Association [15BGIA23010047]; Fondation Leducq Transatlantic Network; King Abdulaziz City for Science and Technology [KACST 10-BIO 1350-20, 13-MED456-20]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030077, R01HL113647, F31HL117623, R01HL067245, R37HL091102, R01HL122525, P01HL080101, P01HL085577, R01HL117163, R01HL105759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rees Stealy Research Foundation; SDSU Heart Institute Fellowship; Achievement Rewards for College Scientists Scholarship; American Heart Association(American Heart Association); Fondation Leducq Transatlantic Network(Leducq Foundation); King Abdulaziz City for Science and Technology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant F31HL117623 (to P. Q.), Rees Stealy Research Foundation, and SDSU Heart Institute Fellowship and Achievement Rewards for College Scientists Scholarship. This work was also supported by American Heart Association Grant 15BGIA23010047 (to N. H.), by National Institutes of Health Grants R01HL067245, R37HL091102, R01HL105759, R01HL113647, R01HL117163, P01HL085577, and R01HL122525 as well as an award from the Fondation Leducq Transatlantic Network (to M. A. S.), and by King Abdulaziz City for Science and Technology (Grant No. KACST 10-BIO 1350-20 and 13-MED456-20, to C. P.). Mark A. Sussman is a founder and co-owner of CardioCreate Inc. All other authors declare that they have no conflicts of interest with the contents of this article.	Awad S, 2015, J PATHOL, V235, P606, DOI 10.1002/path.4489; Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Bailey B, 2009, REGEN MED, V4, P823, DOI [10.2217/rme.09.51, 10.2217/RME.09.51]; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Clocchiatti A, 2011, J CELL MOL MED, V15, P1833, DOI 10.1111/j.1582-4934.2011.01321.x; EDMAN CF, 1994, BBA-MOL CELL RES, V1221, P89, DOI 10.1016/0167-4889(94)90221-6; Ellison GM, 2007, J BIOL CHEM, V282, P11397, DOI 10.1074/jbc.M607391200; Ellison GM, 2013, CELL, V154, P827, DOI 10.1016/j.cell.2013.07.039; Ferreira-Martins J, 2012, CIRC RES, V110, P701, DOI 10.1161/CIRCRESAHA.111.259507; Ferreira-Martins J, 2009, CIRC RES, V105, P764, DOI 10.1161/CIRCRESAHA.109.206698; Fischer KM, 2009, CIRCULATION, V120, P2077, DOI 10.1161/CIRCULATIONAHA.109.884403; Fischer TH, 2014, EUR J HEART FAIL, V16, P1292, DOI 10.1002/ejhf.163; Fransioli J, 2008, STEM CELLS, V26, P1315, DOI 10.1634/stemcells.2007-0751; Galvin KE, 2008, STEM CELLS, V26, P1027, DOI 10.1634/stemcells.2007-0879; Gomez AM, 2013, CURR VASC PHARMACOL, V11, P497, DOI 10.2174/1570161111311040013; Hariharan N, 2015, J AM COLL CARDIOL, V65, P133, DOI 10.1016/j.jacc.2014.09.086; Harrison BC, 2010, FEBS LETT, V584, P1103, DOI 10.1016/j.febslet.2010.02.057; Hoch B, 2000, J CELL BIOCHEM, V79, P293, DOI 10.1002/1097-4644(20001101)79:2<293::AID-JCB120>3.3.CO;2-H; Hook SS, 2001, ANNU REV PHARMACOL, V41, P471, DOI 10.1146/annurev.pharmtox.41.1.471; Inagawa K, 2012, CIRC RES, V111, P1147, DOI 10.1161/CIRCRESAHA.112.271148; Khan M, 2013, CIRC RES, V112, P476, DOI 10.1161/CIRCRESAHA.112.280735; Konstandin MH, 2013, CIRC RES, V113, P115, DOI 10.1161/CIRCRESAHA.113.301152; Lee S, 2009, CELL PROLIFERAT, V42, P711, DOI 10.1111/j.1365-2184.2009.00633.x; Leri A, 2011, CIRC RES, V109, P941, DOI 10.1161/CIRCRESAHA.111.243154; Li H, 2010, AM J PHYSIOL-HEART C, V298, pH688, DOI 10.1152/ajpheart.01014.2009; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Ling HY, 2013, CIRC RES, V112, P935, DOI 10.1161/CIRCRESAHA.112.276915; Little GH, 2007, J BIOL CHEM, V282, P7219, DOI 10.1074/jbc.M604281200; Little GH, 2009, J BIOL CHEM, V284, P24857, DOI 10.1074/jbc.M109.003186; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Mohsin S, 2013, CIRC RES, V113, P1169, DOI 10.1161/CIRCRESAHA.113.302302; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; Peng W, 2010, CIRC RES, V106, P102, DOI 10.1161/CIRCRESAHA.109.210914; Porrello ER, 2014, STEM CELL RES, V13, P556, DOI 10.1016/j.scr.2014.06.003; Rota M, 2008, CIRC RES, V103, P107, DOI 10.1161/CIRCRESAHA.108.178525; Savatier P, 1996, ONCOGENE, V12, P309; Scott JA, 2012, AM J PHYSIOL-HEART C, V302, pH1953, DOI 10.1152/ajpheart.00978.2011; Sossalla S, 2010, CIRC RES, V107, P1150, DOI 10.1161/CIRCRESAHA.110.220418; SRINIVASAN M, 1994, J CELL BIOL, V126, P839, DOI 10.1083/jcb.126.4.839; Sun GQ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/835968; Tallini YN, 2009, P NATL ACAD SCI USA, V106, P1808, DOI 10.1073/pnas.0808920106; van Berlo JH, 2014, NATURE, V509, P337, DOI 10.1038/nature13309; Zaruba MM, 2010, CIRCULATION, V121, P1992, DOI 10.1161/CIRCULATIONAHA.109.909093; Zhang LX, 2014, AM J PHYSIOL-CELL PH, V307, pC358, DOI 10.1152/ajpcell.00187.2013; Zhang T, 2007, J BIOL CHEM, V282, P35078, DOI 10.1074/jbc.M707083200; Zhu WZ, 2007, J BIOL CHEM, V282, P10833, DOI 10.1074/jbc.M611507200	46	15	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25411	25426		10.1074/jbc.M115.657775	http://dx.doi.org/10.1074/jbc.M115.657775			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26324717	Green Published, hybrid			2022-12-26	WOS:000362962800018
J	Burzynski, LC; Humphry, M; Bennett, MR; Clarke, MCH				Burzynski, Laura C.; Humphry, Melanie; Bennett, Martin R.; Clarke, Murray C. H.			Interleukin-1 a Activity in Necrotic Endothelial Cells Is Controlled by Caspase-1 Cleavage of Interleukin-1 Receptor-2 IMPLICATIONS FOR ALLOGRAFT REJECTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; ARTERIOSCLEROSIS; TRANSPLANTATION; INFLAMMASOME; ACTIVATION; EXPRESSION; IL-1-ALPHA; PROMOTES; DISEASE; FAMILY	Inflammation is a key instigator of the immune responses that drive atherosclerosis and allograft rejection. IL-1 alpha, a powerful cytokine that activates both innate and adaptive immunity, induces vessel inflammation after release from necrotic vascular smooth muscle cells (VSMCs). Similarly, IL-1 alpha released from endothelial cells (ECs) damaged during transplant drives allograft rejection. However, IL-1 alpha requires cleavage for full cytokine activity, and what controls cleavage in necrotic ECs is currently unknown. We find that ECs have very low levels of IL-1 alpha activity upon necrosis. However, TNF alpha or IL-1 induces significant levels of active IL-1 alpha in EC necrotic lysates without alteration in protein levels. Increased activity requires cleavage of IL-1 alpha by calpain to the more active mature form. Immunofluorescence and proximity ligation assays show that IL-1 alpha associates with interleukin-1 receptor-2, and this association is decreased by TNf alpha or IL-1 and requires caspase activity. Thus, TNFa or IL-1 treatment of ECs leads to caspase proteolytic activity that cleaves interleukin-1 receptor-2, allowing IL-1 alpha dissociation and subsequent processing by calpain. Importantly, ECs could be primed by IL-1 alpha from adjacent damaged VSMCs, and necrotic ECs could activate neighboring normal ECs and VSMCs, causing them to release inflammatory cytokines and up-regulate adhesion molecules, thus amplifying inflammation. These data unravel the molecular mechanisms and interplay between damaged ECs and VSMCs that lead to activation of IL-1 alpha and, thus, initiation of adaptive responses that cause graft rejection.	[Burzynski, Laura C.; Humphry, Melanie; Bennett, Martin R.; Clarke, Murray C. H.] Univ Cambridge, Div Cardiovasc Med, Addenbrookes Hosp, Cambridge CB2 0QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Clarke, MCH (corresponding author), Univ Cambridge, Div Cardiovasc Med, Addenbrookes Hosp, Level 6,Box 110, Cambridge CB2 0QQ, England.	mchc2@cam.ac.uk		Clarke, Murray/0000-0002-8215-8885; Bennett, Martin/0000-0002-2565-1825	British Heart Foundation (BHF) [FS/09/005/26845, FS/13/3/30038, FS/11/77/29327, RG/13/14/30314]; BHF Cambridge Centre for Cardiovascular Research Excellence; National Institute for Health Research Cambridge Biomedical Research Centre; British Heart Foundation [RG/13/14/30314, FS/09/005/26845, FS/13/3/30038] Funding Source: researchfish	British Heart Foundation (BHF)(British Heart Foundation); BHF Cambridge Centre for Cardiovascular Research Excellence; National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation)	This work was supported by British Heart Foundation (BHF) Grants FS/09/005/26845, FS/13/3/30038 and FS/11/77/29327 (to M. C. H. C.) & RG/13/14/30314 (to M. R. B.); the BHF Cambridge Centre for Cardiovascular Research Excellence; and the National Institute for Health Research Cambridge Biomedical Research Centre. The authors declare that they have no conflicts of interest with the contents of this article.	Afonina IS, 2011, MOL CELL, V44, P265, DOI 10.1016/j.molcel.2011.07.037; Antonysamy MA, 1999, J IMMUNOL, V162, P577; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; FANSLOW WC, 1990, SCIENCE, V248, P739, DOI 10.1126/science.2139736; Halloran PF, 1997, TRANSPL P, V29, P79, DOI 10.1016/S0041-1345(96)00015-2; Imaizumi T, 2000, ARTERIOSCL THROM VAS, V20, P410, DOI 10.1161/01.ATV.20.2.410; Kim B, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00391; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Libby P, 2001, IMMUNITY, V14, P387, DOI 10.1016/S1074-7613(01)00119-4; LOETSCHER P, 1994, FASEB J, V8, P1055, DOI 10.1096/fasebj.8.13.7926371; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; McCall M, 2012, AM J TRANSPLANT, V12, P322, DOI 10.1111/j.1600-6143.2011.03796.x; MCCARTHY PL, 1991, BLOOD, V78, P1915; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; POBER JS, 1986, J IMMUNOL, V136, P1680; Rao DA, 2007, J IMMUNOL, V179, P6536, DOI 10.4049/jimmunol.179.10.6536; Rao DA, 2008, J EXP MED, V205, P3145, DOI 10.1084/jem.20081661; Seto T, 2010, J HEART LUNG TRANSPL, V29, P352, DOI 10.1016/j.healun.2009.09.008; Simeoni E, 2007, EUR J CARDIO-THORAC, V31, P222, DOI 10.1016/j.ejcts.2006.10.042; Tellides G, 2000, NATURE, V403, P207, DOI 10.1038/35003221; Tellides G, 2006, CIRCULATION, V114, P1561, DOI 10.1161/CIRCULATIONAHA.106.651521; Yamada J, 1998, ARCH OPHTHALMOL-CHIC, V116, P1351, DOI 10.1001/archopht.116.10.1351; Zheng Y, 2011, ARTERIOSCL THROM VAS, V31, P2781, DOI 10.1161/ATVBAHA.111.224907	24	18	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					25188	25196		10.1074/jbc.M115.667915	http://dx.doi.org/10.1074/jbc.M115.667915			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26324711	hybrid, Green Published			2022-12-26	WOS:000362598300045
J	Wang, YH; Chen, JJ; Ding, W; Yan, B; Gao, QQ; Zhou, JY				Wang, Yuehong; Chen, Junjun; Ding, Wei; Yan, Bing; Gao, Qiqi; Zhou, Jianying			Clinical Features and Gene Mutations of Lung Cancer Patients 30 Years of Age or Younger	PLOS ONE			English	Article							FACTOR RECEPTOR MUTATIONS; THAN 50 YEARS; 1ST-LINE TREATMENT; OPEN-LABEL; ADENOCARCINOMA; CHEMOTHERAPY; ALK; MULTICENTER; PHASE-3; ROS1	Purpose Few studies examining the clinical features and gene mutations in lung cancer patients 30 years of age or younger have been published. A trend towards increasing morbidity has been noted in young patients; thus, an urgent need exists to explore this subgroup of patients. Methods Patients aged <= 30 years with pathologically diagnosed lung cancer were retrospectively evaluated. We reviewed the clinical features, gene mutations and prognosis of each patient. Results Forty-one patients were included in this study. The mean age was 26.4 +/- 3.5 years. Cough, tightness/dyspnea and chest pain were common symptoms, and 58.5% of patients presented with advanced stages of lung cancer. Adenocarcinoma was the predominant histologic type noted in these young patients. Masses and nodules were the dominant imaging features observed upon lung computed tomography (CT). Thoracic lymphadenopathy occurred very frequently in these patients. Five of 6 patients with echinoderm microtubule-associated protein-like 4 (EML4)-anaplastic lymphoma kinase (ALK) gene fusions presented solid masses with no ground-glass opacity (GGO) and thoracic multifocal lymphadenopathy. Six of 22 (27.2%) cases contained EML4-ALK gene fusions. In addition, 5 of 22 (22.7%) patients harbored epidermal growth factor receptor (EGFR) mutations, and 2 of 17 patients exhibited KRAS and ROS1 gene mutations. The median survival times were 44.2 months for patients with early stage disease and 8 months for patients with advanced NSCLC disease. The one-year and 5-year survival rates were 56.6% and 38.6%, respectively. Conclusions Increased gene mutation frequencies are noted in these very young lung cancer patients. This finding indicates that the detection of gene mutations in these patients is important and will help to determine the appropriate targeted therapy.	[Wang, Yuehong; Chen, Junjun; Yan, Bing; Zhou, Jianying] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Resp Med, Hangzhou 310003, Zhejiang, Peoples R China; [Ding, Wei; Gao, Qiqi] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Zhou, JY (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Resp Med, Hangzhou 310003, Zhejiang, Peoples R China.	zjyhz@zju.edu.cn			Fund of Science Technology Department of Zhejiang Province [2012C33064]; Fund of Education Department of Zhejiang Province [Y201120841]	Fund of Science Technology Department of Zhejiang Province; Fund of Education Department of Zhejiang Province	This study was partly supported by the Fund of Science Technology Department of Zhejiang Province (No. 2012C33064) and the Fund of Education Department of Zhejiang Province (No. Y201120841).	Ak G, 2007, LUNG, V185, P279, DOI 10.1007/s00408-007-9021-2; Camidge DR, 2012, LANCET ONCOL, V13, P1011, DOI 10.1016/S1470-2045(12)70344-3; Cha YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103333; Doebele RC, 2012, CANCER-AM CANCER SOC, V118, P4502, DOI 10.1002/cncr.27409; Duan L, 2013, MINERVA CHIR, V68, P175; Fukui T, 2012, LUNG CANCER, V77, P319, DOI 10.1016/j.lungcan.2012.03.013; Hsu CL, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-241; Hsu KH, 2011, J THORAC ONCOL, V6, P1066, DOI 10.1097/JTO.0b013e31821667b0; Jiang W, 2012, CHINESE MED J-PEKING, V125, P72, DOI 10.3760/cma.j.issn.0366-6999.2012.01.014; Kim L, 2012, J KOREAN MED SCI, V27, P1027, DOI 10.3346/jkms.2012.27.9.1027; Korpanty GJ, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00204; Kozielski J, 2012, WSPOLCZESNA ONKOL, V16, P413, DOI 10.5114/wo.2012.31770; Kuo CW, 2000, CHEST, V117, P354, DOI 10.1378/chest.117.2.354; Lara MS, 2014, LUNG CANCER, V85, P264, DOI 10.1016/j.lungcan.2014.04.007; Liam C K, 2000, Respirology, V5, P355; Marugame T, 2005, JPN J CLIN ONCOL, V35, P177, DOI 10.1093/jjco/hyi054; Mauri D, 2006, ANTICANCER RES, V26, P3175; MCDUFFIE HH, 1987, CANCER, V59, P1825, DOI 10.1002/1097-0142(19870515)59:10<1825::AID-CNCR2820591024>3.0.CO;2-2; Mizushima Y, 1999, CANCER, V85, P1730, DOI 10.1002/(SICI)1097-0142(19990415)85:8<1730::AID-CNCR12>3.3.CO;2-7; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Nagashima O, 2013, J THORAC DIS, V5, P27, DOI 10.3978/j.issn.2072-1439.2012.12.02; Nugent WC, 1997, ANN THORAC SURG, V63, P193; Pan YJ, 2014, LUNG CANCER, V84, P121, DOI 10.1016/j.lungcan.2014.02.007; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Park J, 2014, CANCER MED-US, V3, P118, DOI 10.1002/cam4.172; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; She J, 2013, CHEST, V143, P1117, DOI 10.1378/chest.11-2948; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Sholl LM, 2015, ARCH PATHOL LAB MED, V139, P469, DOI 10.5858/arpa.2014-0128-RA; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Strand TE, 2004, CANCER CAUSE CONTROL, V15, P27, DOI 10.1023/B:CACO.0000016575.31651.b0; Subramanian J, 2010, J THORAC ONCOL, V5, P23, DOI 10.1097/JTO.0b013e3181c41e8d; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Tian DL, 2003, LUNG CANCER-J IASLC, V42, P215, DOI 10.1016/S0169-5002(03)00286-1; Togashi Y, 2011, CANCER-AM CANCER SOC, V117, P819, DOI 10.1002/cncr.25618; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; VandenBussche CJ, 2014, HUM PATHOL, V45, P2379, DOI 10.1016/j.humpath.2014.08.005; Whooley B P, 2000, Ann Thorac Cardiovasc Surg, V6, P86; Yang JCH, 2015, LANCET ONCOL, V16, P141, DOI 10.1016/S1470-2045(14)71173-8; Ye T, 2014, J THORAC DIS, V6, P1396, DOI 10.3978/j.issn.2072-1439.2014.08.50; Zhang J, 2010, CANCER-AM CANCER SOC, V116, P3656, DOI 10.1002/cncr.25100; Zhao C, 2014, TRANSL ONCOL, V7, P363, DOI 10.1016/j.tranon.2014.04.013; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Zhou JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092828	46	10	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136659	10.1371/journal.pone.0136659	http://dx.doi.org/10.1371/journal.pone.0136659			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332764	Green Submitted, gold, Green Published			2022-12-26	WOS:000360613800064
J	Hayat, T; Saeed, Y; Alsaedi, A; Asad, S				Hayat, T.; Saeed, Yusra; Alsaedi, A.; Asad, Sadia			Effects of Convective Heat and Mass Transfer in Flow of Powell-Eyring Fluid Past an Exponentially Stretching Sheet	PLOS ONE			English	Article							BOUNDARY-LAYER-FLOW; POROUS-MEDIUM; MIXED CONVECTION; MAXWELL FLUID; SURFACE; PLATE; EQUATIONS; NANOFLUID; SLIP	The aim here is to investigate the effects of convective heat and mass transfer in the flow of Eyring-Powell fluid past an inclined exponential stretching surface. Mathematical formulation and analysis have been performed in the presence of Soret, Dufour and thermal radiation effects. The governing partial differential equations corresponding to the momentum, energy and concentration are reduced to a set of non-linear ordinary differential equations. Resulting nonlinear system is computed for the series solutions. Interval of convergence is determined. Physical interpretation is seen for the embedded parameters of interest. Skin friction coefficient, local Nusselt number and local Sherwood number are numerically computed and examined.	[Hayat, T.; Saeed, Yusra; Asad, Sadia] Quaid I Azam Univ 45320, Dept Math, Islamabad 44000, Pakistan; [Hayat, T.; Alsaedi, A.] King Abdulaziz Univ, Nonlinear Anal & Appl Math NAAM Res Grp, Dept Math, Fac Sci, Jeddah 21589, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Asad, S (corresponding author), Quaid I Azam Univ 45320, Dept Math, Islamabad 44000, Pakistan.	asadsadia@ymail.com	Alsaedi, Ahmed/A-2094-2013; Hayat, Tasawar/A-3853-2013; Hayat, Tasawar/Y-2524-2019	Alsaedi, Ahmed/0000-0003-3452-8922; 				Abbasbandy S, 2013, QUAEST MATH, V36, P93, DOI 10.2989/16073606.2013.780336; Alsaedi A, 2012, COMMUN NONLINEAR SCI, V17, P4210, DOI 10.1016/j.cnsns.2012.03.008; Auranzaib Shafie S., 2013, J FRANKLIN I, V351, P1268; Awais M, 2014, COMPUT FLUIDS, V91, P21, DOI 10.1016/j.compfluid.2013.12.002; Aziz A, 2009, COMMUN NONLINEAR SCI, V14, P1064, DOI 10.1016/j.cnsns.2008.05.003; CRANE LJ, 1970, Z ANGEW MATH PHYS, V21, P645, DOI 10.1007/BF01587695; Das K, 2011, INT J HEAT MASS TRAN, V54, P3505, DOI 10.1016/j.ijheatmasstransfer.2011.03.035; Das K, 2014, J EGYPTIAN MATH 0627; Hamad MAA, 2012, INT J HEAT MASS TRAN, V55, P1355, DOI 10.1016/j.ijheatmasstransfer.2011.08.043; Hayat T, 2014, CHINESE PHYS B, V23, DOI 10.1088/1674-1056/23/8/084701; Hayat T, 2012, NUCL ENG DES, V252, P242, DOI 10.1016/j.nucengdes.2012.07.012; Hayat T, 2010, COMMUN NONLINEAR SCI, V15, P2375, DOI 10.1016/j.cnsns.2009.09.013; Hayat T, 2010, COMMUN NONLINEAR SCI, V15, P1183, DOI 10.1016/j.cnsns.2009.05.062; Hayat T, 2014, APPL MATH MECH, V35, P1; Joneidi AA, 2010, J TAIWAN INST CHEM E, V41, P35, DOI 10.1016/j.jtice.2009.05.008; Kandasamy R, 2011, NUCL ENG DES, V21, P55; KHANI F, 2012, J KING SAUD UNIV SCI, V24, P123, DOI DOI 10.1016/j.jksus.2010.09.002; Liao SJ, 2010, COMMUN NONLINEAR SCI, V15, P2003, DOI 10.1016/j.cnsns.2009.09.002; Makinde OD, 2011, INT J THERM SCI, V50, P1326, DOI 10.1016/j.ijthermalsci.2011.02.019; Pal D, 2013, APPL MATH COMPUT, V219, P7556, DOI 10.1016/j.amc.2012.10.119; Patil PM, 2014, INT J HEAT MASS TRAN, V70, P313, DOI 10.1016/j.ijheatmasstransfer.2013.11.021; Ramesh GK, 2014, AIN SHAMS ENG J, V5, P991, DOI 10.1016/j.asej.2014.04.003; Rashad AM, 2013, COMPUT FLUIDS, V86, P380, DOI 10.1016/j.compfluid.2013.07.030; Rashidi MM, 2014, AIN SHAMS ENG J, V5, P901, DOI 10.1016/j.asej.2014.02.007; Rostami B, 2014, ABSTR APPL ANAL, DOI 10.1155/2014/496254; Shehzad SA, 2012, INT J HEAT MASS TRAN, V55, P3971, DOI 10.1016/j.ijheatmasstransfer.2012.03.027; Sheikholeslami M, 2014, J COMPUT THEOR NANOS, V11, P486, DOI 10.1166/jctn.2014.3384; Turkyilmazoglu M, 2013, APPL MATH MODEL, V37, P7539, DOI 10.1016/j.apm.2013.02.014; Turkyilmazoglu M, 2011, INT J THERM SCI, V50, P2264, DOI 10.1016/j.ijthermalsci.2011.05.014; Turkyilmazoglu M, 2014, J HEAT TRANS-T ASME, V136, DOI 10.1115/1.4027772	30	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0133831	10.1371/journal.pone.0133831	http://dx.doi.org/10.1371/journal.pone.0133831			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327398	gold, Green Submitted, Green Published			2022-12-26	WOS:000360437700008
J	Watanabe, E; Kiyono, K; Hayano, J; Yamamoto, Y; Inamasu, J; Yamamoto, M; Ichikawa, T; Sobue, Y; Harada, M; Ozaki, Y				Watanabe, Eiichi; Kiyono, Ken; Hayano, Junichiro; Yamamoto, Yoshiharu; Inamasu, Joji; Yamamoto, Mayumi; Ichikawa, Tomohide; Sobue, Yoshihiro; Harada, Masehide; Ozaki, Yukio			Multiscale Entropy of the Heart Rate Variability for the Prediction of an Ischemic Stroke in Patients with Permanent Atrial Fibrillation	PLOS ONE			English	Article							RISK STRATIFICATION SCHEMES; PHYSIOLOGICAL TIME-SERIES; VENTRICULAR RESPONSE; APPROXIMATE ENTROPY; CIRCADIAN VARIATION; MORNING INCREASE; THROMBOEMBOLISM; ANTICOAGULATION; MORTALITY	Background Atrial fibrillation (AF) is a significant risk factor for ischemic strokes, and making a robust risk stratification scheme would be important. Few studies have examined whether nonlinear dynamics of the heart rate could predict ischemic strokes in AF. We examined whether a novel complexity measurement of the heart rate variability called multiscale entropy (MSE) was a useful risk stratification measure of ischemic strokes in patients with permanent AF. Methods and Results We examined 173 consecutive patients (age 69 +/- 11 years) with permanent AF who underwent 24-hour Holter electrocardiography from April 2005 to December 2006. We assessed several frequency ranges of the MSE and CHA(2)DS(2)-VASc score (1 point for congestive heart failure, hypertension, diabetes, vascular disease, an age 65 to 74 years, and a female sex and 2 points for an age >= 75 years and a stroke or transient ischemic attack). We found 22 (13%) incident ischemic strokes during a mean follow up of 3.8-years. The average value of the MSE in the very-low frequency subrange (90-300 s, MeanEn(VLF2)) was significantly higher in patients who developed ischemic strokes than in those who did not (0.68 +/- 0.15 vs. 0.60 +/- 0.14, P<0.01). There was no significant difference in the C-statistic between the CHA(2)DS(2)-VASc score and MeanEn(VLF2) (0.56; 95% confidence interval, 0.43-0.69 vs. 0.66; 95% confidence interval, 0.53-0.79). After an adjustment for the age, CHA(2)DS(2)-VASc score, and antithrombotic agent, a Cox hazard regression model revealed that the MeanEn(VLF2) was an independent predictor of an ischemic stroke (hazard ratio per 1-SD increment, 1.80; 95% confidence interval, 1.17-2.07, P<0.01). Conclusion The MeanEn(VLF2) in 24-hour Holter electrocardiography is a useful risk stratification measure of ischemic strokes during the long-term follow-up in patients with permanent AF.	[Watanabe, Eiichi; Yamamoto, Mayumi; Ichikawa, Tomohide; Sobue, Yoshihiro; Harada, Masehide; Ozaki, Yukio] Fujita Hlth Univ, Sch Med, Dept Cardiol, Toyoake, Aichi 47011, Japan; [Kiyono, Ken] Osaka Univ, Grad Sch Engn Sci, Div Bioengn, Toyonaka, Osaka 560, Japan; [Hayano, Junichiro] Nagoya City Univ, Grad Sch Med Sci, Dept Med Educ, Nagoya, Aichi, Japan; [Yamamoto, Yoshiharu] Univ Tokyo, Grad Sch Educ, Educ Physiol Lab, Tokyo, Japan; [Inamasu, Joji] Fujita Hlth Univ, Sch Med, Dept Neurosurg, Toyoake, Aichi 47011, Japan	Fujita Health University; Osaka University; Nagoya City University; University of Tokyo; Fujita Health University	Watanabe, E (corresponding author), Fujita Hlth Univ, Sch Med, Dept Cardiol, Toyoake, Aichi 47011, Japan.	enwatan@fujita-hu.ac.jp	Kiyono, Ken/E-6325-2017; Inamasu, Joji/R-7314-2019	Kiyono, Ken/0000-0001-5433-7002; Watanabe, Eiichi/0000-0002-2375-2323; Harada, Masahide/0000-0002-2345-9557; Hayano, Junichiro/0000-0002-5340-6325; Yamamoto, Yoshiharu/0000-0002-1132-0355	Japan Society for the Promotion of Science KAKENHI; Suzuken Memorial Foundation	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Suzuken Memorial Foundation	This study was supported in part by the Japan Society for the Promotion of Science KAKENHI (to EW, KK) (http://www.e-rad.go.jp/kenkyu/index.html) and the Suzuken Memorial Foundation (to EW) (http://www.suzukenzaidan.or.jp/).	Amer Coll Cardiology Amer Heart, 2006, CIRCULATION, V114, P700, DOI 10.1161/CIRCULATIONAHA.106.177031; ANAN T, 1990, J ELECTROCARDIOL, V23, P243, DOI 10.1016/0022-0736(90)90163-V; Camm AJ, 2012, EUR HEART J, V33; Camm AJ, 1996, CIRCULATION, V93, P1043; CHISHAKI AS, 1991, AM HEART J, V121, P820, DOI 10.1016/0002-8703(91)90194-M; CHORRO FJ, 1990, AM J PHYSIOL, V259, pH1015, DOI 10.1152/ajpheart.1990.259.4.H1015; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Costa M, 2002, COMPUT CARDIOL, V29, P137, DOI 10.1109/CIC.2002.1166726; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; EHRLY A M, 1973, Biorheology, V10, P577; Go AS, 2003, JAMA-J AM MED ASSOC, V290, P2685, DOI 10.1001/jama.290.20.2685; Hayano J, 1997, AM J PHYSIOL-HEART C, V273, pH2811, DOI 10.1152/ajpheart.1997.273.6.H2811; Hayano J, 1998, J AM COLL CARDIOL, V31, P158, DOI 10.1016/S0735-1097(97)00429-4; Ho YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018699; Huikuri HV, 2000, CIRCULATION, V101, P47, DOI 10.1161/01.CIR.101.1.47; Khaykin Y, 2011, EUROPACE, V13, P1797, DOI 10.1093/europace/eur203; Lip GYH, 2010, STROKE, V41, P2731, DOI 10.1161/STROKEAHA.110.590257; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; MARLER JR, 1989, STROKE, V20, P473, DOI 10.1161/01.STR.20.4.473; MARSHALL J, 1977, STROKE, V8, P230, DOI 10.1161/01.STR.8.2.230; MILLARCRAIG MW, 1978, LANCET, V1, P795; Olesen Jonas Bjerring, 2011, BMJ, V342, pd124, DOI 10.1136/bmj.d124; PANZA JA, 1991, NEW ENGL J MED, V325, P986, DOI 10.1056/NEJM199110033251402; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Schurmann J, 1996, PATTERN CLASSIFICATI; Taylor JA, 1998, CIRCULATION, V98, P547, DOI 10.1161/01.CIR.98.6.547; TOFLER GH, 1987, NEW ENGL J MED, V316, P1514, DOI 10.1056/NEJM198706113162405; VANDENBERG MP, 1994, CLIN SCI, V86, P531, DOI 10.1042/cs0860531; Yamada A, 2000, CIRCULATION, V102, P300	30	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137144	10.1371/journal.pone.0137144	http://dx.doi.org/10.1371/journal.pone.0137144			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325058	Green Published, gold, Green Submitted			2022-12-26	WOS:000360437700099
J	Verma, M; Kumar, V; Patel, RK; Garg, R; Jain, M				Verma, Mohit; Kumar, Vinay; Patel, Ravi K.; Garg, Rohini; Jain, Mukesh			CTDB: An Integrated Chickpea Transcriptome Database for Functional and Applied Genomics	PLOS ONE			English	Article							GENE DISCOVERY; GLYCINE-MAX; ATLAS; EXPRESSION; RESOURCE; CROP; SEQUENCE; MARKERS	Chickpea is an important grain legume used as a rich source of protein in human diet. The narrow genetic diversity and limited availability of genomic resources are the major constraints in implementing breeding strategies and biotechnological interventions for genetic enhancement of chickpea. We developed an integrated Chickpea Transcriptome Database (CTDB), which provides the comprehensive web interface for visualization and easy retrieval of transcriptome data in chickpea. The database features many tools for similarity search, functional annotation (putative function, PFAM domain and gene ontology) search and comparative gene expression analysis. The current release of CTDB (v2.0) hosts transcriptome datasets with high quality functional annotation from cultivated (desi and kabuli types) and wild chickpea. A catalog of transcription factor families and their expression profiles in chickpea are available in the database. The gene expression data have been integrated to study the expression profiles of chickpea transcripts in major tissues/organs and various stages of flower development. The utilities, such as similarity search, ortholog identification and comparative gene expression have also been implemented in the database to facilitate comparative genomic studies among different legumes and Arabidopsis. Furthermore, the CTDB represents a resource for the discovery of functional molecular markers (microsatellites and single nucleotide polymorphisms) between different chickpea types. We anticipate that integrated information content of this database will accelerate the functional and applied genomic research for improvement of chickpea. The CTDB web service is freely available at http://nipgr.res.in/ctdb.html.	[Verma, Mohit; Kumar, Vinay; Patel, Ravi K.; Garg, Rohini; Jain, Mukesh] Natl Inst Plant Genome Res, Funct & Appl Genom Lab, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Jain, M (corresponding author), Natl Inst Plant Genome Res, Funct & Appl Genom Lab, New Delhi, India.	mjain@nipgr.ac.in	Jain, Mukesh/AAP-5816-2021; Verma, Mohit/ABB-7093-2020; Patel, Ravi K/W-4441-2019	Jain, Mukesh/0000-0002-7622-1083; Verma, Mohit/0000-0002-0438-5396; Patel, Ravi K/0000-0001-5203-899X	Department of Biotechnology, Government of India, New Delhi, under the Next Generation Challenge Program on Chickpea Genomics [BT/PR12919/AGR/02/676/2009]	Department of Biotechnology, Government of India, New Delhi, under the Next Generation Challenge Program on Chickpea Genomics	The financial support was received from the Department of Biotechnology, Government of India, New Delhi, under the Next Generation Challenge Program on Chickpea Genomics (grant number BT/PR12919/AGR/02/676/2009 from 2009-2014).	Agarwal G, 2015, EUPHYTICA, V205, P381, DOI 10.1007/s10681-015-1394-3; Agarwal G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052443; Choudhary P, 2012, GENET MOL RES, V11, P891, DOI 10.4238/2012.April.10.5; Doddamani D, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-212; Garg R, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2013.04.0011; Garg R, 2011, PLANT SIGNAL BEHAV, V6, P1868, DOI 10.4161/psb.6.11.17879; Garg R, 2011, PLANT PHYSIOL, V156, P1661, DOI 10.1104/pp.111.178616; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Gaur PM, 2012, AGRONOMY-BASEL, V2, P199, DOI 10.3390/agronomy2030199; He J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-441; Hiremath PJ, 2011, PLANT BIOTECHNOL J, V9, P922, DOI 10.1111/j.1467-7652.2011.00625.x; Jain M, 2013, PLANT J, V74, P715, DOI 10.1111/tpj.12173; Jaiswal DK, 2014, SCI REP-UK, V4, DOI 10.1038/srep04177; Jhanwar S, 2012, PLANT BIOTECHNOL J, V10, P690, DOI 10.1111/j.1467-7652.2012.00712.x; Kudapa H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086039; Kujur A, 2013, DNA RES, V20, P355, DOI 10.1093/dnares/dst015; Li J, 2012, NUCLEIC ACIDS RES, V40, pD1221, DOI 10.1093/nar/gkr939; Libault M, 2010, PLANT J, V63, P86, DOI 10.1111/j.1365-313X.2010.04222.x; Lin YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102825; Millan T, 2006, EUPHYTICA, V147, P81, DOI 10.1007/s10681-006-4261-4; Roque E, 2013, PLANT J, V73, P663, DOI 10.1111/tpj.12068; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Singh KB, 1997, THEOR APPL GENET, V95, P418, DOI 10.1007/s001220050578; Singh VK, 2013, PLANT BIOTECHNOL J, V11, P691, DOI 10.1111/pbi.12059; Van Ha C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114107; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Verdier J, 2013, PLANT J, V74, P351, DOI 10.1111/tpj.12119	27	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136880	10.1371/journal.pone.0136880	http://dx.doi.org/10.1371/journal.pone.0136880			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322998	Green Submitted, Green Published, gold			2022-12-26	WOS:000360435500046
J	Younes, M; Robert, C; Cottin, F; Barrey, E				Younes, Mohamed; Robert, Celine; Cottin, Francois; Barrey, Eric			Speed and Cardiac Recovery Variables Predict the Probability of Elimination in Equine Endurance Events	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; EXERCISE; HORSES; PERFORMANCE; PARAMETERS	Nearly 50% of the horses participating in endurance events are eliminated at a veterinary examination (a vet gate). Detecting unfit horses before a health problem occurs and treatment is required is a challenge for veterinarians but is essential for improving equine welfare. We hypothesized that it would be possible to detect unfit horses earlier in the event by measuring heart rate recovery variables. Hence, the objective of the present study was to compute logistic regressions of heart rate, cardiac recovery time and average speed data recorded at the previous vet gate (n-1) and thus predict the probability of elimination during successive phases (n and following) in endurance events. Speed and heart rate data were extracted from an electronic database of endurance events (80-160 km in length) organized in four countries. Overall, 39% of the horses that started an event were eliminated-mostly due to lameness (64%) or metabolic disorders (15%). For each vet gate, logistic regressions of explanatory variables (average speed, cardiac recovery time and heart rate measured at the previous vet gate) and categorical variables (age and/or event distance) were computed to estimate the probability of elimination. The predictive logistic regressions for vet gates 2 to 5 correctly classified between 62% and 86% of the eliminated horses. The robustness of these results was confirmed by high areas under the receiving operating characteristic curves (0.68-0.84). Overall, a horse has a 70% chance of being eliminated at the next gate if its cardiac recovery time is longer than 11 min at vet gate 1 or 2, or longer than 13 min at vet gates 3 or 4. Heart rate recovery and average speed variables measured at the previous vet gate(s) enabled us to predict elimination at the following vet gate. These variables should be checked at each veterinary examination, in order to detect unfit horses as early as possible. Our predictive method may help to improve equine welfare and ethical considerations in endurance events.	[Younes, Mohamed; Barrey, Eric] Univ Evry Val dEssonne, UBIAE, Evry, France; [Robert, Celine; Barrey, Eric] INRA, GABI, UMR1313, Jouy En Josas, France; [Robert, Celine] Univ Paris Est, Ecole Natl Vet Alfort, Creteil, France; [Cottin, Francois] Univ Paris 11, CIAMS, EA4532, Orsay, France; [Cottin, Francois] Univ Evry Val dEssonne, Dept STAPS, Evry, France	UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Ecole Nationale Veterinaire d'Alfort (ENVA); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Barrey, E (corresponding author), Univ Evry Val dEssonne, UBIAE, Evry, France.	eric.barrey@inserm.fr	Robert, Céline/AAD-6158-2020	ROBERT, Celine/0000-0002-3899-1060; Cottin, Francois/0000-0002-7950-2163	Association du Cheval Arabe; Fond Eperon	Association du Cheval Arabe; Fond Eperon	This work was supported by the Association du Cheval Arabe 2011-2014 and Fond Eperon 2011-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amory H, 2010, EQUINE VET J, V42, P216, DOI 10.1111/j.2042-3306.2010.00253.x; Barnes A, 2010, EQUINE VET J, V42, P6, DOI 10.1111/j.2042-3306.2010.00225.x; Barrey E, 2006, Equine Vet J Suppl, P43; Bitschnau C, 2010, EQUINE VET J, V42, P17, DOI 10.1111/j.2042-3306.2010.00260.x; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; Cottin F, 2006, Equine Vet J Suppl, P204; EVANS DL, 1993, EQUINE VET J, V25, P441, DOI 10.1111/j.2042-3306.1993.tb02987.x; Federation Equestre Internationale, 2014, END RUL; Fielding CL, 2011, JAVMA-J AM VET MED A, V239, P493, DOI 10.2460/javma.239.4.493; Flaminio F, 1998, VET CLIN N AM-EQUINE, V14, P147, DOI 10.1016/S0749-0739(17)30217-1; Foreman JH, 1998, VET CLIN N AM-EQUINE, V14, P205, DOI 10.1016/S0749-0739(17)30220-1; Geor, 2013, EQUINE SPORTS MED SU, P1083; Hada T, 2006, Equine Vet J Suppl, P141; HAGBERG JM, 1980, J APPL PHYSIOL, V48, P218, DOI 10.1152/jappl.1980.48.2.218; Javorka M, 2002, BRAZ J MED BIOL RES, V35, P991, DOI 10.1590/S0100-879X2002000800018; LEE E T, 1974, Computer Programs in Biomedicine, V4, P80, DOI 10.1016/0010-468X(74)90011-7; Marlin DJ, 2008, P 4 INT C INT SOC EQ; Munsters CCBM, 2013, VET REC, V172, P15, DOI 10.1136/vr.100952; Nagy A, 2014, EQUINE VET J, V46, P38, DOI 10.1111/evj.12069; Nagy A, 2010, EQUINE VET J, V42, P637, DOI 10.1111/j.2042-3306.2010.00220.x; NCSS User's Guide-III, 2007, NCCS USERS GUIDE 3 R; PRESS SJ, 1978, J AM STAT ASSOC, V73, P699, DOI 10.2307/2286261; Robert C, 2002, EQUINE VET J, V34, P106; Robert C, 2010, EQUINE VET J, V42, P98, DOI 10.1111/j.2042-3306.2010.00198.x; ROSE RJ, 1990, AUST VET J, V67, P345, DOI 10.1111/j.1751-0813.1990.tb07394.x; Schott H C 2nd, 2006, Equine Vet J Suppl, P37; Seshan VE, 2013, STAT MED, V32, P1483, DOI 10.1002/sim.5648; Valette JP, 1996, PFERDEHEILKUNDE, V12, P470; von Borell E, 2007, PHYSIOL BEHAV, V92, P293, DOI 10.1016/j.physbeh.2007.01.007	29	18	18	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0137013	10.1371/journal.pone.0137013	http://dx.doi.org/10.1371/journal.pone.0137013			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322506	Green Published, gold, Green Submitted			2022-12-26	WOS:000360435500059
J	Giannantonio, S; Polonenko, MJ; Papsin, BC; Paludetti, G; Gordon, KA				Giannantonio, Sara; Polonenko, Melissa J.; Papsin, Blake C.; Paludetti, Gaetano; Gordon, Karen A.			Experience Changes How Emotion in Music Is Judged: Evidence from Children Listening with Bilateral Cochlear Implants, Bimodal Devices, and Normal Hearing	PLOS ONE			English	Article							AUDITORY BRAIN-STEM; SHORT-TERM PLASTICITY; AGE-OF-ONSET; SENSITIVE PERIOD; TIME-COURSE; COGNITIVE-DEVELOPMENT; PITCH DISCRIMINATION; SONG RECOGNITION; MELODIC CONTOUR; YOUNG-CHILDREN	Children using unilateral cochlear implants abnormally rely on tempo rather than mode cues to distinguish whether a musical piece is happy or sad. This led us to question how this judgment is affected by the type of experience in early auditory development. We hypothesized that judgments of the emotional content of music would vary by the type and duration of access to sound in early life due to deafness, altered perception of musical cues through new ways of using auditory prostheses bilaterally, and formal music training during childhood. Seventy-five participants completed the Montreal Emotion Identification Test. Thirty-three had normal hearing (aged 6.6 to 40.0 years) and 42 children had hearing loss and used bilateral auditory prostheses (31 bilaterally implanted and 11 unilaterally implanted with contralateral hearing aid use). Reaction time and accuracy were measured. Accurate judgment of emotion in music was achieved across ages and musical experience. Musical training accentuated the reliance on mode cues which developed with age in the normal hearing group. Degrading pitch cues through cochlear implant-mediated hearing induced greater reliance on tempo cues, but mode cues grew in salience when at least partial acoustic information was available through some residual hearing in the contralateral ear. Finally, when pitch cues were experimentally distorted to represent cochlear implant hearing, individuals with normal hearing (including those with musical training) switched to an abnormal dependence on tempo cues. The data indicate that, in a western culture, access to acoustic hearing in early life promotes a preference for mode rather than tempo cues which is enhanced by musical training. The challenge to these preferred strategies during cochlear implant hearing (simulated and real), regardless of musical training, suggests that access to pitch cues for children with hearing loss must be improved by preservation of residual hearing and improvements in cochlear implant technology.	[Giannantonio, Sara; Paludetti, Gaetano] Univ Cattolica Sacro Cuore, Inst Otorhinolaryngol, Dept Head & Neck Surg, I-00168 Rome, Italy; [Polonenko, Melissa J.; Papsin, Blake C.; Gordon, Karen A.] Hosp Sick Children, Dept Otolaryngol, Cochlear Implant Lab, Archies, Toronto, ON M5G 1X8, Canada; [Polonenko, Melissa J.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Papsin, Blake C.; Gordon, Karen A.] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Gordon, KA (corresponding author), Hosp Sick Children, Dept Otolaryngol, Cochlear Implant Lab, Archies, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	karen.gordon@utoronto.ca	Giannantonio, Sara/AAA-7081-2020	Polonenko, Melissa/0000-0003-1914-6117; Giannantonio, Sara/0000-0002-5982-2581				[Anonymous], ANGELSIM; [Anonymous], 1990, COGNITIVE FDN MUSICA; Bailey J, 2012, ANN NY ACAD SCI, V1252, P163, DOI 10.1111/j.1749-6632.2011.06434.x; Bailey JA, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00227; Baker CA, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00019; Barrett KC, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00713; BEISER M, 1985, INT J PEDIATR OTORHI, V9, P69, DOI 10.1016/S0165-5876(85)80005-7; Bigand E, 2005, ANN NY ACAD SCI, V1060, P429, DOI 10.1196/annals.1360.036; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Bosnyak DJ, 2004, CEREB CORTEX, V14, P1088, DOI 10.1093/cercor/bhh068; Casey BJ, 2005, CURR OPIN NEUROBIOL, V15, P239, DOI 10.1016/j.conb.2005.03.012; Casey BJ, 2002, DEV PSYCHOBIOL, V40, P237, DOI 10.1002/dev.10030; COHEN AJ, 1987, CAN J PSYCHOL, V41, P33, DOI 10.1037/h0084148; Cooper WB, 2008, EAR HEARING, V29, P618, DOI 10.1097/AUD.0b013e318174e787; Dalla Bella S, 2001, ANN NY ACAD SCI, V930, P436, DOI 10.1111/j.1749-6632.2001.tb05763.x; David-Pur M, 2014, BIOMED MICRODEVICES, V16, P43, DOI 10.1007/s10544-013-9804-6; der Nederlanden CMV, 2015, COGNITION, V143, P135, DOI 10.1016/j.cognition.2015.06.015; Di Pietro M, 2004, NEUROPSYCHOLOGIA, V42, P868, DOI 10.1016/j.neuropsychologia.2003.12.004; EGGERMONT JJ, 1988, HEARING RES, V33, P35, DOI 10.1016/0378-5955(88)90019-6; Foster NEV, 2010, NEUROIMAGE, V53, P26, DOI 10.1016/j.neuroimage.2010.06.042; Francois C, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00475; Fujioka T, 2006, BRAIN, V129, P2593, DOI 10.1093/brain/awl247; Fujita S, 1999, ANN OTO RHINOL LARYN, V108, P634, DOI 10.1177/000348949910800702; Gabrielsson A, 2003, SER AFFECTIVE SCI, P503; Gagnon L, 2003, COGNITION EMOTION, V17, P25, DOI 10.1080/02699930302279; Galvin JJ, 2007, EAR HEARING, V28, P302, DOI 10.1097/01.aud.0000261689.35445.20; Ganek H, 2012, OTOLARYNG CLIN N AM, V45, P173, DOI 10.1016/j.otc.2011.08.024; Gaser C, 2003, ANN NY ACAD SCI, V999, P514, DOI 10.1196/annals.1284.062; GERARDI GM, 1995, MUSIC PERCEPT, V12, P279; GFELLER K, 1991, J SPEECH HEAR RES, V34, P916, DOI 10.1044/jshr.3404.916; Gfeller K, 2005, EAR HEARING, V26, P237, DOI 10.1097/00003446-200506000-00001; Gfeller K, 2000, J Am Acad Audiol, V11, P390; Gfeller K, 2007, EAR HEARING, V28, P412, DOI 10.1097/AUD.0b013e3180479318; Gfeller K, 2012, J MUSIC THER, V49, P68, DOI 10.1093/jmt/49.1.68; Gordon KA, 2006, AUDIOL NEURO-OTOL, V11, P7, DOI 10.1159/000088851; Gordon KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114841; Gordon KA, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00719; Gordon KA, 2012, J NEUROSCI, V32, P4212, DOI 10.1523/JNEUROSCI.5741-11.2012; Gregory AH, 1996, MOTIV EMOTION, V20, P341, DOI 10.1007/BF02856522; Hargreaves D.J., 1986, PSYCHOL MUSIC, V14, P83, DOI [10.1177/0305735686142001, DOI 10.1177/0305735686142001]; Hauser MD, 2003, NAT NEUROSCI, V6, P663, DOI 10.1038/nn1080; Hevner K, 1935, AM J PSYCHOL, V47, P103, DOI 10.2307/1416710; Hevner K, 1937, AM J PSYCHOL, V49, P621, DOI 10.2307/1416385; Hopyan T, 2011, Cochlear Implants Int, V12, P21, DOI 10.1179/146701010X12677899497399; Hopyan T, 2015, CHILD NEUROPSYCHOL, V6, P1, DOI DOI 10.1080/09297049.2014.99; Hopyan T, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00425; Hsiao Feilin, 2012, Update Univ S C Dep Music, V30, P5; Hughes Kathryn C, 2013, Cochlear Implants Int, V14, P121, DOI 10.1179/1754762812Y.0000000009; Hunter PG, 2010, SPRINGER HANDB AUDIT, V36, P129, DOI 10.1007/978-1-4419-6114-3_5; Huron D, 2001, ANN NY ACAD SCI, V930, P43, DOI 10.1111/j.1749-6632.2001.tb05724.x; Hyde KL, 2009, ANN NY ACAD SCI, V1169, P182, DOI 10.1111/j.1749-6632.2009.04852.x; IBBOTSON NR, 1981, COGNITION, V9, P125, DOI 10.1016/0010-0277(81)90008-1; Jaaskelainen IP, 2007, TRENDS NEUROSCI, V30, P653, DOI 10.1016/j.tins.2007.09.003; JIANG ZD, 1991, HEARING RES, V54, P67, DOI 10.1016/0378-5955(91)90137-X; Juslin PN, 2008, BEHAV BRAIN SCI, V31, P559, DOI 10.1017/S0140525X08005293; Juslin PN, 2001, EMOTION, V1, P381, DOI 10.1037//1528-3542.1.4.381; Khalfa S, 2005, NEUROREPORT, V16, P1981, DOI 10.1097/00001756-200512190-00002; Koelsch S, 2003, J COGNITIVE NEUROSCI, V15, P1149, DOI 10.1162/089892903322598111; Kraus N, 2012, ANN NY ACAD SCI, V1252, P100, DOI 10.1111/j.1749-6632.2012.06463.x; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Kraus N, 2009, ANN NY ACAD SCI, V1169, P543, DOI 10.1111/j.1749-6632.2009.04549.x; Krings T, 2000, NEUROSCI LETT, V278, P189, DOI 10.1016/S0304-3940(99)00930-1; Lappe C, 2008, J NEUROSCI, V28, P9632, DOI 10.1523/JNEUROSCI.2254-08.2008; Lappe C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021493; Limb CJ, 2014, HEARING RES, V308, P13, DOI 10.1016/j.heares.2013.04.009; Looi V, 2008, EAR HEARING, V29, P421, DOI 10.1097/AUD.0b013e31816a0d0b; Looi V, 2011, INT J PEDIATR OTORHI, V75, P472, DOI 10.1016/j.ijporl.2010.12.023; Maess B, 2001, NAT NEUROSCI, V4, P540, DOI 10.1038/87502; Makris I, 2003, AM J PSYCHOL, V116, P581, DOI 10.2307/1423661; McDermott Hugh J, 2004, Trends Amplif, V8, P49, DOI 10.1177/108471380400800203; Meyer M, 2011, EUR J NEUROSCI, V34, P755, DOI 10.1111/j.1460-9568.2011.07795.x; Mick P, 2014, OTOL NEUROTOL, V35, pE40, DOI 10.1097/MAO.0b013e318291c66d; Mikolajczak S, 2013, HNO, V61, P1032, DOI 10.1007/s00106-013-2770-8; Miranda P.C., 2014, INT J OTOLARYNGOL, V2014, DOI DOI 10.1155/2014/468515; Mitani C, 2007, EAR HEARING, V28, p29S, DOI 10.1097/AUD.0b013e318031547a; Mitterschiffthaler MT, 2007, HUM BRAIN MAPP, V28, P1150, DOI 10.1002/hbm.20337; Munte TF, 2002, NAT REV NEUROSCI, V3, P473, DOI 10.1038/nrn843; Pals C, 2013, J SPEECH LANG HEAR R, V56, P1075, DOI 10.1044/1092-4388(2012/12-0074); Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; Parbery-Clark A, 2013, J NEUROSCI, V33, P16741, DOI 10.1523/JNEUROSCI.5700-12.2013; Penhune VB, 1998, J COGNITIVE NEUROSCI, V10, P752, DOI 10.1162/089892998563149; Peretz I, 1998, COGNITION, V68, P111, DOI 10.1016/S0010-0277(98)00043-2; Peretz I, 2002, NEURON, V33, P185, DOI 10.1016/S0896-6273(01)00580-3; PERETZ I, 1990, BRAIN, V113, P1185, DOI 10.1093/brain/113.4.1185; Pinchot Castner M., 1990, MUSIC PERCEPT, V8, P189; Reyes AD, 2011, HEARING RES, V279, P60, DOI 10.1016/j.heares.2011.04.017; Riss D, 2008, OTOL NEUROTOL, V29, P784, DOI 10.1097/MAO.0b013e31817fe00f; Riss D, 2014, EAR HEARING, V35, pE272, DOI 10.1097/AUD.0000000000000063; Schlaug G, 2005, ANN NY ACAD SCI, V1060, P219, DOI 10.1196/annals.1360.015; Schneider P, 2002, NAT NEUROSCI, V5, P688, DOI 10.1038/nn871; Scorpecci A, 2012, INT J PEDIATR OTORHI, V76, P1507, DOI 10.1016/j.ijporl.2012.07.005; Shahin A, 2003, J NEUROSCI, V23, P5545; Sharma A, 2005, HEARING RES, V203, P134, DOI 10.1016/j.heares.2004.12.010; Skoe E, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00622; SPSS, 2013, SPSS SOFTW PACK; Steel MM, 2014, EAR HEARING, V35, pE291, DOI 10.1097/AUD.0000000000000069; Steele CJ, 2013, J NEUROSCI, V33, P1282, DOI 10.1523/JNEUROSCI.3578-12.2013; Stordahl J, 2002, J MUSIC THER, V39, P2, DOI 10.1093/jmt/39.1.2; Strait DL, 2014, HEARING RES, V308, P109, DOI 10.1016/j.heares.2013.08.004; Strait DL, 2012, BRAIN LANG, V123, P191, DOI 10.1016/j.bandl.2012.09.001; Tomblin JB, 2007, INT J AUDIOL, V46, P512, DOI 10.1080/14992020701383043; TRAINOR LJ, 1992, J EXP PSYCHOL HUMAN, V18, P394, DOI 10.1037/0096-1523.18.2.394; Ventura-Campos N, 2013, J NEUROSCI, V33, P9295, DOI 10.1523/JNEUROSCI.4655-12.2013; Virtala P, 2012, PSYCHOPHYSIOLOGY, V49, P1125, DOI 10.1111/j.1469-8986.2012.01386.x; Virtala P, 2011, NEUROSCI LETT, V487, P406, DOI 10.1016/j.neulet.2010.10.066; Vongpaisal T, 2006, J SPEECH LANG HEAR R, V49, P1091, DOI 10.1044/1092-4388(2006/078); Winn MB, 2015, EAR HEARING, P1; Wong PCM, 2007, NAT NEUROSCI, V10, P420, DOI 10.1038/nn1872; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946; Zatorre RJ, 2013, SCIENCE, V342, P585, DOI 10.1126/science.1238414; Zatorre RJ, 2013, P NATL ACAD SCI USA, V110, P10430, DOI 10.1073/pnas.1301228110; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zeng FG, 2015, HEARING RES, V322, P188, DOI 10.1016/j.heares.2014.09.013	113	20	20	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136685	10.1371/journal.pone.0136685	http://dx.doi.org/10.1371/journal.pone.0136685			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ0PO	26317976	Green Submitted, gold, Green Published			2022-12-26	WOS:000360299100121
J	Ilievski, V; Cho, Y; Katwala, P; Rodriguez, H; Tulowiecka, M; Kurian, D; Leoni, L; Christman, JW; Unterman, TG; Watanabe, K				Ilievski, Vladimir; Cho, Yale; Katwala, Priya; Rodriguez, Heriberto; Tulowiecka, Margaret; Kurian, David; Leoni, Lara; Christman, John W.; Unterman, Terry G.; Watanabe, Keiko			TLR4 Expression by Liver Resident Cells Mediates the Development of Glucose Intolerance and Insulin Resistance in Experimental Periodontitis	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; KUPFFER CELLS; DIABETES-MELLITUS; RECEPTOR 4; BONE LOSS; LIPOPOLYSACCHARIDE; INFLAMMATION; PREVALENCE; DISEASE; INJURY	Background Results from epidemiological studies indicate a close association between periodontitis and type 2 diabetes mellitus. However, the mechanism linking periodontitis to glucose intolerance (GI) and insulin resistance (IR) is unknown. We therefore tested the hypothesis that periodontitis induces the development of GI/IR through a liver Toll-like receptor 4 (TLR4) dependent mechanism. Methods TLR4 chimeric mice were developed by bone marrow transplantation using green fluorescent protein expressing TLR4WT mouse (GFPWT) as donor and TLR4 WT or TLR4-/- as recipient mice (GFPWT:WT and GFPWT:KO chimeras respectively). These chimeras were subjected to experimental chronic periodontitis induced by repeated applications of LPS to the gingival sulci for 18 weeks. The levels of GI/IR were monitored and plasma cytokines and LPS were determined at 18 weeks when differences in glucose tolerance were most apparent. Cytokine gene expression was measured in liver tissue by qPCR. Results Alveolar bone loss was significantly greater in GFPWT:WT chimeras treated with LPS compared with chimeras treated with PBS or GFPWT:KO chimeras. However, the degree of gingival inflammation was similar between GFPWT:WT and GFPWT:KO mice with LPS application. Severe GI/IR occurred in GFPWT:WT chimeras but not in the GFPWT:KO chimeras that were subjected to 18 weeks of LPS. Serum LPS was detected only in animals to which LPS was applied and the level was similar in GFPWT:WT and GFPWT:KO mice at the 18 week time point. Surprisingly, there was no significant difference in the plasma levels of IL1 beta, IL6 and TNF alpha at 18 weeks in spite of the severe GI/IR in the GFPWT:WT chimeras with LPS application. Also, no difference in the expression of TNF alpha or IL6 mRNA was detected in the liver of GFPWT:WT vs GFPWT:KO mice. In contrast, liver IL1 beta expression was significantly greater in GFPWT:WT chimeras compared to GFPWT:KO chimeras treated with LPS. Conclusion We observed that GFPWT:WT, but not GFPWT:KO chimeras, treated with LPS developed GI/IR despite similar degrees of gingival inflammation, circulating cytokine levels, and LPS concentrations. We conclude that LPS from periodontitis sites has a pivotal role in triggering the development of GI/IR through a mechanism that involves TLR4 expression by resident macrophages/Kupffer cells in the liver.	[Ilievski, Vladimir; Watanabe, Keiko] Univ Illinois, Coll Dent, Dept Periodont, Chicago, IL 60607 USA; [Cho, Yale] Univ Illinois, Coll Dent, Undergrad Program, Chicago, IL USA; [Katwala, Priya; Rodriguez, Heriberto; Tulowiecka, Margaret; Kurian, David] Univ Illinois, Undergrad Program, Chicago, IL USA; [Leoni, Lara] Univ Chicago, Dept Radiol, Chicago, IL 60637 USA; [Christman, John W.] Ohio State Univ, Dept Internal Med, Sect Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA; [Unterman, Terry G.] Univ Illinois, Coll Med, Dept Med, Chicago, IL USA; [Unterman, Terry G.] Univ Illinois, Coll Med, Dept Physiol & Biophys, Chicago, IL USA; [Unterman, Terry G.] Jesse Brown VA Med Ctr, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago; University System of Ohio; Ohio State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Watanabe, K (corresponding author), Univ Illinois, Coll Dent, Dept Periodont, Chicago, IL 60607 USA.	keiko@uic.edu			National Institute of Health [R01DE021405, R01 HL075557, R01HL103643]; Department of Veterans Affairs Merit Review Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075557, R01HL103643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021405] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Merit Review Program(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Institute of Health, R01DE021405 (KW), the National Institute of Health, R01 HL075557 and R01HL103643 (JWC), and the Department of Veterans Affairs Merit Review Program (TGU).	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Arimatsu K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04828; Arora N, 2014, J CLIN PERIODONTOL, V41, P643, DOI 10.1111/jcpe.12258; Benguigui C, 2010, J CLIN PERIODONTOL, V37, P601, DOI 10.1111/j.1600-051X.2010.01571.x; Bhat UG, 2014, J PERIODONTOL, V85, P1629, DOI 10.1902/jop.2014.140070; BOUWENS L, 1986, HEPATOLOGY, V6, P718, DOI 10.1002/hep.1840060430; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Cheng YJ, 2009, DIABETES CARE, V32, P2027, DOI 10.2337/dc09-0440; Colombo NH, 2012, J PERIODONTOL, V83, P864, DOI 10.1902/jop.2011.110349; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Ekuni D, 2003, J PERIODONTAL RES, V38, P591, DOI 10.1034/j.1600-0765.2003.00694.x; Enomoto N, 2000, J GASTROEN HEPATOL, V15, pD20; Grossi S G, 1998, Ann Periodontol, V3, P51, DOI 10.1902/annals.1998.3.1.51; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; Inokuchi S, 2011, ALCOHOL CLIN EXP RES, V35, P1509, DOI 10.1111/j.1530-0277.2011.01487.x; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Kennedy David W., 1997, Blood, V90, P986; Lalla E, 2011, NAT REV ENDOCRINOL, V7, P738, DOI 10.1038/nrendo.2011.106; Li Y, 2014, J PAIN, V15, P712, DOI 10.1016/j.jpain.2014.04.001; Li ZH, 2006, AM J PHYSIOL-REG I, V290, pR1262, DOI 10.1152/ajpregu.00724.2005; LIU YC, 2013, MEDIAT INFLAMM, V2013, DOI DOI 10.1155/2013/407562; Lott MEJ, 2013, ACTA OPHTHALMOL, V91, pe462, DOI 10.1111/aos.12129; Nishimura F, 2001, J DENT RES, V80, P1690, DOI 10.1177/00220345010800080201; Nishimura F, 2003, J PERIODONTOL, V74, P97, DOI 10.1902/jop.2003.74.1.97; Nwose EU, 2014, N AM J MED SCI, V6, P328, DOI 10.4103/1947-2714.136913; Petersen M, 2008, DIABETES CARE, V31, P1271, DOI 10.2337/dc08-9017; Rogers JE, 2007, J PERIODONTOL, V78, P550, DOI 10.1902/jop.2007.060321; Saberi M, 2009, CELL METAB, V10, P419, DOI 10.1016/j.cmet.2009.09.006; Schwabe RF, 2006, GASTROENTEROLOGY, V130, P1886, DOI 10.1053/j.gastro.2006.01.038; Seki E, 2001, J IMMUNOL, V166, P2651, DOI 10.4049/jimmunol.166.4.2651; Seki E, 2008, HEPATOLOGY, V48, P322, DOI 10.1002/hep.22306; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Soares JB, 2010, HEPATOL INT, V4, P659, DOI 10.1007/s12072-010-9219-x; Su Y, 2013, J PERIODONTOL, V84, P1617, DOI 10.1902/jop.2013.120442; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Thakur V, 2007, J GASTROEN HEPATOL, V22, pS53, DOI 10.1111/j.1440-1746.2006.04650.x; Thurman RG, 1998, AM J PHYSIOL-GASTR L, V275, pG605, DOI 10.1152/ajpgi.1998.275.4.G605; Timonen P, 2011, J CLIN PERIODONTOL, V38, P17, DOI 10.1111/j.1600-051X.2010.01642.x; Uesugi T, 2002, J IMMUNOL, V168, P2963, DOI 10.4049/jimmunol.168.6.2963; Uesugi T, 2001, HEPATOLOGY, V34, P101, DOI 10.1053/jhep.2001.25350; Watanabe K, 2011, J PERIODONTAL RES, V46, P21, DOI 10.1111/j.1600-0765.2010.01304.x; Watanabe K, 2008, J PERIODONTOL, V79, P1208, DOI [10.1902/jop.2008.070605, 10.1902/jop.2008.070605 ]; Yan AW, 2011, HEPATOLOGY, V53, P96, DOI 10.1002/hep.24018; Ziegler D, 2008, DIABETES CARE, V31, P464, DOI 10.2337/dc07-1796	44	14	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136502	10.1371/journal.pone.0136502	http://dx.doi.org/10.1371/journal.pone.0136502			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317345	Green Published, gold, Green Submitted			2022-12-26	WOS:000360299100091
J	Joo, HM; Kang, SJ; Nam, SY; Yang, KH; Kim, CS; Lee, IK; Kim, JY				Joo, Hae Mi; Kang, Su Jin; Nam, Seon Young; Yang, Kwang Hee; Kim, Cha Soon; Lee, In Kyung; Kim, Ji Young			The Inhibitory Effects of Low-Dose Ionizing Radiation in IgE-Mediated Allergic Responses	PLOS ONE			English	Article							MAST-CELL; LATE-PHASE; SKIN REACTION; MICE	Ionizing radiation has different biological effects according to dose and dose rate. In particular, the biological effect of low-dose radiation is unclear. Low-dose whole-body gamma irradiation activates immune responses in several ways. However, the effects and mechanism of low-dose radiation on allergic responses remain poorly understood. Previously, we reported that low-dose ionizing radiation inhibits mediator release in IgE-mediated RBL-2H3 mast cell activation. In this study, to have any physiological relevance, we investigated whether low-dose radiation inhibits allergic responses in activated human mast cells (HMC-1(5C6) and LAD2 cells), mouse models of passive cutaneous anaphylaxis and the late-phase cutaneous response. High-dose radiation induced cell death, but low-dose ionizing radiation of <0.5 Gy did not induce mast cell death. Low-dose ionizing radiation that did not induce cell death significantly suppressed mediator release from human mast cells (HMC-1 (5C6) and LAD2 cells) that were activated by antigen-antibody reaction. To determine the inhibitory mechanism of mediator released by low-dose ionizing radiation, we examined the phosphorylation of intracellular signaling molecules such as Lyn, Syk, phospholipase C gamma, and protein kinase C, as well as the intracellular free Ca2+ concentration ([Ca2+](i)). The phosphorylation of signaling molecules and [Ca2+] i following stimulation of Fc epsilon RI receptors was inhibited by low dose ionizing radiation. In agreement with its in vitro effect, ionizing radiation also significantly inhibited inflammatory cells infiltration, cytokine mRNA expression (TNF-alpha, IL-4, IL-13), and symptoms of passive cutaneous anaphylaxis reaction and the late-phase cutaneous response in anti-dinitrophenyl IgE-sensitized mice. These results indicate that ionizing radiation inhibits both mast cell-mediated immediate- and delayed-type allergic reactions in vivo and in vitro.	[Joo, Hae Mi; Kang, Su Jin; Nam, Seon Young; Yang, Kwang Hee; Kim, Cha Soon; Lee, In Kyung; Kim, Ji Young] Korea Hydro & Nucl Power Co Ltd, Radiat Hlth Inst, Low Dose Radiat Res Team, Seoul, South Korea	Korea Hydro & Nuclear Power	Kim, JY (corresponding author), Korea Hydro & Nucl Power Co Ltd, Radiat Hlth Inst, Low Dose Radiat Res Team, Seoul, South Korea.	elizabeth@khnp.co.kr			Korea Hydro & Nuclear Power Co., Ltd.	Korea Hydro & Nuclear Power Co., Ltd.	Korea Hydro & Nuclear Power Co., Ltd. provided support in the form of salaries for authors HMJ, SJK, SYN, KHY, CSK, IKL, and JYK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abrevaya XC, 2007, GENET MOL BIOL, V30, P1139, DOI 10.1590/S1415-47572007000600018; Akiyama M., 1995, INT J RADIAT BIOL, V107, P417; BERK LB, 1991, YALE J BIOL MED, V64, P155; Bogoljubov WM, 1988, J PHYS MED BALNEOL M, V17, P59; Bradding P, 2006, J ALLERGY CLIN IMMUN, V117, P1277, DOI 10.1016/j.jaci.2006.02.039; CHARLESWORTH EN, 1989, J CLIN INVEST, V83, P1519, DOI 10.1172/JCI114047; DOLOVICH J, 1973, J ALLERGY CLIN IMMUN, V52, P38, DOI 10.1016/0091-6749(73)90119-X; Doss M, 2013, DOSE-RESPONSE, V11, P480, DOI 10.2203/dose-response.13-005.Doss; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; GLEICH GJ, 1982, J ALLERGY CLIN IMMUN, V70, P160, DOI 10.1016/0091-6749(82)90037-9; Guhl S, 2010, EXP DERMATOL, P1; Harrington NP, 1997, CLIN EXP IMMUNOL, V107, P417, DOI 10.1111/j.1365-2249.1997.272-ce1158.x; Joo HM, 2012, J BIOL CHEM, V287, P27789, DOI 10.1074/jbc.M112.378497; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; KALINER MM, 1984, J ALLERGY CLIN IMMUN, V73, P311, DOI 10.1016/0091-6749(84)90401-9; KATAYAMA I, 1990, INT ARCH ALLER A IMM, V93, P148, DOI 10.1159/000235294; Kirshenbaum AS, 2003, LEUKEMIA RES, V27, P677, DOI 10.1016/S0145-2126(02)00343-0; Luckey T. D., 2006, Dose-Response, V4, P169, DOI 10.2203/dose-response.06-102.Luckey; Nagai H, 2000, J ALLERGY CLIN IMMUN, V106, pS91, DOI 10.1067/mai.2000.106778; Nagai H, 1995, J ALLERGY CLIN IMMUN, V52, P38; Ott VL, 2003, NAT IMMUNOL, V4, P974, DOI 10.1038/ni971; RAY MC, 1983, J IMMUNOL, V131, P1096; Sagi-Eisenberg R, 2007, IMMUNOL REV, V217, P292, DOI 10.1111/j.1600-065X.2007.00516.x; SCHLEIMER RP, 1985, J ALLERGY CLIN IMMUN, V76, P369, DOI 10.1016/0091-6749(85)90656-6; Scott S G, 1926, Br Med J, V1, P939; SOLLEY GO, 1976, J CLIN INVEST, V58, P408, DOI 10.1172/JCI108485; TADA H, 1986, J IMMUNOL METHODS, V93, P157, DOI 10.1016/0022-1759(86)90183-3; Weber S, 1996, ARCH DERMATOL RES, V288, P778, DOI 10.1007/BF02505297; Weller K, 2006, FASEB J, V20, P2366, DOI 10.1096/fj.06-5837fje; WERSHIL BK, 1991, J CLIN INVEST, V87, P446, DOI 10.1172/JCI115016; Yang YJ, 2009, J EXP MED, V206, P195, DOI 10.1084/jem.20081140	31	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136394	10.1371/journal.pone.0136394	http://dx.doi.org/10.1371/journal.pone.0136394			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317642	Green Published, Green Submitted, gold			2022-12-26	WOS:000360299100078
J	Wang, TJC; Wu, CC; Chai, YF; Lam, RKK; Hamada, N; Kakinuma, S; Uchihori, Y; Yu, PKN; Hei, TK				Wang, Tony J. C.; Wu, Cheng-Chia; Chai, Yunfei; Lam, Roy K. K.; Hamada, Nobuyuki; Kakinuma, Shizuko; Uchihori, Yukio; Yu, Peter K. N.; Hei, Tom K.			Induction of Non-Targeted Stress Responses in Mammary Tissues by Heavy Ions	PLOS ONE			English	Article							HUMAN SKIN FIBROBLASTS; RAT LUNG IRRADIATION; DOUBLE-STRAND BREAKS; BYSTANDER CELLS; INTERCELLULAR COMMUNICATION; SIGNALING PATHWAY; DNA-DAMAGE; RADIATION; RADIOTHERAPY; CANCER	Purpose Side effects related to radiation exposures are based primarily on the assumption that the detrimental effects of radiation occur in directly irradiated cells. However, several studies have reported over the years of radiation-induced non-targeted/abscopal effects in vivo that challenge this paradigm. There is evidence that Cyclooxygenase-2 (COX2) plays an important role in modulating non-targeted effects, including DNA damages in vitro and mutagenesis in vivo. While most reports on radiation-induced non-targeted response utilize x-rays, there is little information available for heavy ions. Methods and Materials Adult female transgenic gpt delta mice were exposed to an equitoxic dose of either carbon or argon particles using the Heavy Ion Medical Accelerator in Chiba (HIMAC) at the National Institute of Radiological Sciences (NIRS) in Japan. The mice were stratified into 4 groups of 5 animals each: Control; animals irradiated under full shielding (Sham-irradiated); animals receiving whole body irradiation (WBIR); and animals receiving partial body irradiation (PBIR) to the lower abdomen with a 1 x 1 cm(2) field. The doses used in the carbon ion group (4.5 Gy) and in argon particle group (1.5 Gy) have a relative biological effectiveness equivalent to a 5 Gy dose of x-rays. 24 hours after irradiation, breast tissues in and out of the irradiated field were harvested for analysis. Induction of COX2, 8-hydroxydeoxyguanosine (8-OHdG), phosphorylated histone H2AX (gamma-H2AX), and apoptosis-related cysteine protease-3 (Caspase-3) antibodies were examined in the four categories of breast tissues using immunohistochemical techniques. Analysis was performed by measuring the intensity of more than 20 individual microscopic fields and comparing the relative fold difference. Results In the carbon ion group, the relative fold increase in COX2 expression was 1.01 in sham-irradiated group (p > 0.05), 3.07 in PBIR (p < 0.05) and 2.50 in WBIR (p < 0.05), respectively, when compared with controls. The relative fold increase in 8-OHdG expression was 1.29 in sham-irradiated (p > 0.05), 11.31 in PBIR (p < 0.05) and 11.79 in WBIR (p < 0.05), respectively, when compared with controls. A similar increase in gamma-H2AX expression was found in that, compared to controls, the increase was 1.41 fold in sham-irradiated (p > 0.05), 8.41 in PBIR (p < 0.05) and 10.59 in WBIR (p < 0.05). Results for the argon particle therapy group showed a similar magnitude of changes in the various biological end-points examined. There was no statistical significance observed in Caspase-3 expression among the 4 groups. Conclusions Our data show that both carbon and argon ions induced non-targeted, out of field induction of COX2 and DNA damages in breast tissues. These effects may pose new challenges to evaluate the risks associated with radiation exposure and understanding radiation-induced side effects.	[Wang, Tony J. C.; Wu, Cheng-Chia; Chai, Yunfei; Lam, Roy K. K.; Hei, Tom K.] Columbia Univ, Ctr Radiol Res, Dept Radiat Oncol, New York, NY 10032 USA; [Hamada, Nobuyuki; Kakinuma, Shizuko; Uchihori, Yukio] Natl Inst Radiol Sci, Chiba 260, Japan; [Lam, Roy K. K.; Yu, Peter K. N.] City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China; [Hamada, Nobuyuki] Cent Res Inst Elect Power Ind, Nucl Technol Res Lab, Radiat Safety Res Ctr, Tokyo 201, Japan	Columbia University; National Institutes for Quantum Science & Technology; City University of Hong Kong; Central Research Institute of Electric Power Industry - Japan	Wang, TJC (corresponding author), Columbia Univ, Ctr Radiol Res, Dept Radiat Oncol, New York, NY 10032 USA.	tjw2117@cumc.columbia.edu		Wu, Cheng-Chia/0000-0002-5908-0143; YU, Kwan Ngok Peter/0000-0003-1669-5348; Wang, Tony/0000-0001-5809-3025; Hamada, Nobuyuki/0000-0003-2518-6131	National Institutes of Health [CA 49062, ES 12888]; NATIONAL CANCER INSTITUTE [P01CA049062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by funding from the National Institutes of Health grants CA 49062 and ES 12888.	Ando K, 2009, INT J RADIAT BIOL, V85, P715, DOI 10.1080/09553000903072470; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Brenner DJ, 2000, CANCER, V88, P398, DOI 10.1002/(SICI)1097-0142(20000115)88:2<398::AID-CNCR22>3.0.CO;2-V; Buonanno M, 2011, RADIAT RES, V175, P405, DOI 10.1667/RR2461.1; Calveley VL, 2005, INT J RADIAT BIOL, V81, P887, DOI 10.1080/09553000600568002; Chai Y, 2013, BRIT J CANCER, V108, P1106, DOI 10.1038/bjc.2013.53; Chai Y, 2013, BRIT J CANCER, V108, P91, DOI 10.1038/bjc.2012.498; Ermakov AV, 2009, MUTAT RES-FUND MOL M, V669, P155, DOI 10.1016/j.mrfmmm.2009.06.005; Fournier C, 2007, RADIAT RES, V167, P194, DOI 10.1667/RR0760.1; Hamada N, J RAD RES TOKYO, V51, P365; Hamada N, 2008, MUTAT RES-FUND MOL M, V639, P35, DOI 10.1016/j.mrfmmm.2007.11.001; Harada K, 2009, CANCER SCI, V100, P684, DOI 10.1111/j.1349-7006.2009.01093.x; Hasegawa A, 2006, INT J RADIAT ONCOL, V64, P396, DOI 10.1016/j.ijrobp.2005.07.298; Hei TK, 2008, J PHARM PHARMACOL, V60, P943, DOI 10.1211/jpp.60.8.0001; Imai R, 2004, CLIN CANCER RES, V10, P5741, DOI 10.1158/1078-0432.CCR-04-0301; Imai R, 2006, LANCET ONCOL, V7, P1034, DOI 10.1016/S1470-2045(06)70978-0; Ivanov VN, 2014, APOPTOSIS, V19, P399, DOI 10.1007/s10495-013-0925-4; Kamada T, 2002, J CLIN ONCOL, V20, P4466, DOI 10.1200/JCO.2002.10.050; Kanai T, 1999, INT J RADIAT ONCOL, V44, P201, DOI 10.1016/S0360-3016(98)00544-6; Kashino G, 2009, INT J RADIAT ONCOL, V74, P229, DOI 10.1016/j.ijrobp.2008.09.060; Khan MA, 2003, RADIOTHER ONCOL, V66, P95, DOI 10.1016/S0167-8140(02)00325-0; Mancuso M, 2008, P NATL ACAD SCI USA, V105, P12445, DOI 10.1073/pnas.0804186105; Matsumoto Hideki, 2011, Curr Mol Pharmacol, V4, P126; Minohara S, J RAD RES TOKYO, V51, P385; Mizoe J, 2004, INT J RADIAT ONCOL, V60, P358, DOI 10.1016/j.ijrobp.2004.02.067; Mothersill C, 2004, NAT REV CANCER, V4, P158, DOI 10.1038/nrc1277; NAGASAWA H, 1992, CANCER RES, V52, P6394; Nohmi T, 1996, ENVIRON MOL MUTAGEN, V28, P465, DOI 10.1002/(SICI)1098-2280(1996)28:4<465::AID-EM24>3.0.CO;2-C; Ponnaiya B, RAD RES, V176, P280; Prise KM, 2009, NAT REV CANCER, V9, P351, DOI 10.1038/nrc2603; Sedelnikova OA, 2007, CANCER RES, V67, P4295, DOI 10.1158/0008-5472.CAN-06-4442; Shi MG, 2009, CELL, V136, P508, DOI 10.1016/j.cell.2008.12.021; Sokolov MV, 2007, CELL CYCLE, V6, P2210, DOI 10.4161/cc.6.18.4682; Stiff T, 2006, EMBO J, V25, P5775, DOI 10.1038/sj.emboj.7601446; Tamminga J, CURR MOL PHARM, V4, P115; Tsuruoka C, 2005, RADIAT RES, V163, P494, DOI 10.1667/RR3360; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Yang HY, 2007, RADIAT RES, V168, P292, DOI 10.1667/RR0864.1; Zhou HN, 2005, P NATL ACAD SCI USA, V102, P14641, DOI 10.1073/pnas.0505473102	39	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136307	10.1371/journal.pone.0136307	http://dx.doi.org/10.1371/journal.pone.0136307			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317641	Green Submitted, Green Published, gold			2022-12-26	WOS:000360299100070
J	Zhang, Y; Nowicka, A; Solley, TN; Wei, CM; Parikh, A; Court, L; Burks, JK; Andreeff, M; Woodward, WA; Dadbin, A; Kolonin, MG; Lu, KH; Klopp, AH				Zhang, Yan; Nowicka, Aleksandra; Solley, Travis N.; Wei, Caimiao; Parikh, Aaroh; Court, Laurence; Burks, Jared K.; Andreeff, Michael; Woodward, Wendy A.; Dadbin, Ali; Kolonin, Mikhail G.; Lu, Karen H.; Klopp, Ann H.			Stromal Cells Derived from Visceral and Obese Adipose Tissue Promote Growth of Ovarian Cancers	PLOS ONE			English	Article							BREAST-CANCER; M2-POLARIZED MACROPHAGES; TUMOR MICROENVIRONMENT; INSULIN-RESISTANCE; COLORECTAL-CANCER; PROGENITOR CELLS; MOUSE MODELS; STEM-CELLS; ACTIVATION; EXPRESSION	Obesity, and in particular visceral obesity, has been associated with an increased risk of developing cancers as well as higher rates of mortality following diagnosis. The impact of obesity on adipose-derived stromal cells (ASC), which contribute to the formation of tumor stroma, is unknown. Here we hypothesized that visceral source and diet-induced obesity (DIO) changes the ASC phenotype, contributing to the tumor promoting effects of obesity. We found that ASC isolated from subcutaneous (SC-ASC) and visceral (V-ASC) white adipose tissue(WAT) of lean(Le) and obese(Ob) mice exhibited similar mesenchymal cell surface markers expression, and had comparable effects on ovarian cancer cell proliferation and migration. Obese and visceral derived ASC proliferated slower and exhibited impaired differentiation into adipocytes and osteocytes in vitro as compared to ASC derived from subcutaneous WAT of lean mice. Intraperitoneal co-injection of ovarian cancer cells with obese or visceral derived ASC, but not lean SC-ASC, increased growth of intraperitoneal ID8 tumors as compared to controls. Obese and V-ASC increased stromal infiltration of inflammatory cells, including CD3+ T cells and F4/80+ macrophages. Obese and visceral derived ASC, but not lean SC-ASC, increased expression of chemotactic factors IL-6, MIP2, and MCP-1 when cultured with tumor cells. Overall, these results demonstrate that obese and V-ASC have a unique phenotype, with more limited proliferation and differentiation capacity but enhanced expression of chemotactic factors in response to malignant cells which support infiltration of inflammatory cells and support tumor growth and dissemination.	[Zhang, Yan; Nowicka, Aleksandra; Solley, Travis N.; Court, Laurence; Woodward, Wendy A.; Klopp, Ann H.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Lu, Karen H.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Wei, Caimiao] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Parikh, Aaroh] Rice Univ, Dept Phys & Astron, Houston, TX USA; [Burks, Jared K.; Andreeff, Michael] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Dadbin, Ali; Kolonin, Mikhail G.] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Rice University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Klopp, AH (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA.	Aklopp@mdanderson.org	Woodward, Wendy/AAX-6593-2020	Woodward, Wendy/0000-0002-7935-739X; Court, Laurence/0000-0002-3241-6145	Ovarian Cancer Research fund [LT/MDACC/01.2011]; American Cancer Society [RSG-14-159-01]; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA083639] Funding Source: NIH RePORTER; Direct For Biological Sciences [1337525] Funding Source: National Science Foundation; Directorate For Engineering [1343533] Funding Source: National Science Foundation; Division Of Undergraduate Education [0941984] Funding Source: National Science Foundation	Ovarian Cancer Research fund; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); Division Of Undergraduate Education(National Science Foundation (NSF)NSF - Directorate for STEM Education (EDU))	This work was supported by grants from the Ovarian Cancer Research fund (LT/MDACC/01.2011) and the American Cancer Society (RSG-14-159-01) to AHK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Arendt LM, 2013, CANCER RES, V73, P6080, DOI 10.1158/0008-5472.CAN-13-0926; Bardou M, 2013, GUT, V62, P933, DOI 10.1136/gutjnl-2013-304701; Bracci PM, 2012, MOL CARCINOGEN, V51, P53, DOI 10.1002/mc.20778; Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763; Cleveland-Donovan K, 2010, ENDOCRINOLOGY, V151, P3752, DOI 10.1210/en.2010-0043; Coward J, 2011, CLIN CANCER RES, V17, P6083, DOI 10.1158/1078-0432.CCR-11-0945; Daquinag AC, 2015, CELL DEATH DIFFER, V22, P351, DOI 10.1038/cdd.2014.148; Daquinag AC, 2011, CELL STEM CELL, V9, P74, DOI 10.1016/j.stem.2011.05.017; Delort L, 2009, ANTICANCER RES, V29, P5229; Doyle SL, 2012, P NUTR SOC, V71, P181, DOI 10.1017/S002966511100320X; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Jafri SH, 2013, FUTURE ONCOL, V9, P207, DOI [10.2217/fon.12.184, 10.2217/FON.12.184]; JONJIC N, 1992, J EXP MED, V176, P1165, DOI 10.1084/jem.176.4.1165; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Klopp AH, 2012, CLIN CANCER RES, V18, P771, DOI 10.1158/1078-0432.CCR-11-1916; Klopp AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012180; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Lan CY, 2013, TECHNOL CANCER RES T, V12, P259, DOI 10.7785/tcrt.2012.500312; Liu HP, 2010, P NATL ACAD SCI USA, V107, P18115, DOI 10.1073/pnas.1006732107; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Nowicka A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081859; Pelus LM, 2006, EXP HEMATOL, V34, P1010, DOI 10.1016/j.exphem.2006.04.004; Ray A, 2012, J BIOSCIENCES, V37, P289, DOI 10.1007/s12038-012-9191-9; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Rowan BG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089595; Shield K, 2009, GYNECOL ONCOL, V113, P143, DOI 10.1016/j.ygyno.2008.11.032; Spaeth EL, 2013, CANCER RES, V73, P5347, DOI 10.1158/0008-5472.CAN-13-0087; Surmacz E, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1638; Takaishi K, 2010, CANCER SCI, V101, P2128, DOI 10.1111/j.1349-7006.2010.01652.x; Tchkonia T, 2005, AM J PHYSIOL-ENDOC M, V288, pE267, DOI 10.1152/ajpendo.00265.2004; Walter M, 2009, ONCOGENE, V28, P2745, DOI 10.1038/onc.2009.130; Wang E, 2005, CLIN CANCER RES, V11, P113; WILK MB, 1968, BIOMETRIKA, V55, P1; Yoshimura T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058791; Zhang Y, 2012, CANCER RES, V72, P5198, DOI 10.1158/0008-5472.CAN-12-0294; Zhang Y, 2009, CANCER RES, V69, P5259, DOI 10.1158/0008-5472.CAN-08-3444; Zhu GQ, 2014, NEOPLASIA, V16, P168, DOI 10.1593/neo.132034	38	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136361	10.1371/journal.pone.0136361	http://dx.doi.org/10.1371/journal.pone.0136361			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317219	gold, Green Submitted, Green Published			2022-12-26	WOS:000360299100074
J	Nasir, I; Fatih, W; Svensson, A; Radu, D; Linse, S; Lago, CC; Lundqvist, M				Nasir, Irem; Fatih, Warda; Svensson, Anja; Radu, Dennis; Linse, Sara; Lago, Celia Cabaleiro; Lundqvist, Martin			High Throughput Screening Method to Explore Protein Interactions with Nanoparticles	PLOS ONE			English	Article							HUMAN CARBONIC-ANHYDRASE; SILICA NANOPARTICLES; ENZYME-ACTIVITY; ADSORPTION; STABILITY; ORIENTATION; PARTICLES; LYSOZYME; SURFACES; MUTANT	The interactions of biological macromolecules with nanoparticles underlie a wide variety of current and future applications in the fields of biotechnology, medicine and bioremediation. The same interactions are also responsible for mediating potential biohazards of nanomaterials. Some applications require that proteins adsorb to the nanomaterial and that the protein resists or undergoes structural rearrangements. This article presents a screening method for detecting nanoparticle-protein partners and conformational changes on time scales ranging from milliseconds to days. Mobile fluorophores are used as reporters to study the interaction between proteins and nanoparticles in a high-throughput manner in multi-well format. Furthermore, the screening method may reveal changes in colloidal stability of nanomaterials depending on the physicochemical conditions.	[Nasir, Irem; Linse, Sara; Lago, Celia Cabaleiro; Lundqvist, Martin] Lund Univ, Dept Biochem & Struct Biol, Ctr Mol Prot Sci, Lund, Sweden; [Fatih, Warda; Svensson, Anja; Radu, Dennis; Lundqvist, Martin] Upper 2nd Sch, Klippan, Sweden	Lund University	Lundqvist, M (corresponding author), Lund Univ, Dept Biochem & Struct Biol, Ctr Mol Prot Sci, Lund, Sweden.	Martin.Lundqvist@biochemistry.lu.se	Lundqvist, Martin/K-3908-2012	Lundqvist, Martin/0000-0003-1175-9103; NASIR, Irem/0000-0002-3128-2464	Marianne and Marcus Wallenberg Foundation; Magnus Bergvall Foundation; Swedish Research Council; Crafoord Foundation; Swedish Research Council (VR) via OMM	Marianne and Marcus Wallenberg Foundation; Magnus Bergvall Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Crafoord Foundation; Swedish Research Council (VR) via OMM(Swedish Research Council)	This work was supported by the Marianne and Marcus Wallenberg Foundation, https://www.wallenberg.com/mmw/, M.L.; Magnus Bergvall Foundation, www.magnbergvallsstiftelse.nu/, M.L.; the Swedish Research Council, www.vr.se, C.C.L.; the Crafoord Foundation, www.crafoord.se/, C.C.L.; and the Swedish Research Council (VR) via OMM, www.omm.lu.se/, S.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONSSON G, 1995, BIOCHEMISTRY-US, V34, P2153, DOI 10.1021/bi00007a008; Assarsson A, 2014, ADDING CHARGE EFFECT; Assarsson A, 2014, LANGMUIR, V30, P9448, DOI 10.1021/la501413r; Billsten P, 1997, FEBS LETT, V402, P67, DOI 10.1016/S0014-5793(96)01431-7; BRODIN P, 1989, PROTEIN ENG, V2, P353, DOI 10.1093/protein/2.5.353; Caruso F, 2000, LANGMUIR, V16, P9595, DOI 10.1021/la000942h; Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104; Cukalevski R, 2011, LANGMUIR, V27, P14360, DOI 10.1021/la203290a; Engel MFM, 2004, P NATL ACAD SCI USA, V101, P11316, DOI 10.1073/pnas.0401603101; Ferreira SA, 2012, BBA-GEN SUBJECTS, V1820, P1043, DOI 10.1016/j.bbagen.2012.04.015; Fornaguera C, 2015, NANOSCALE, V7, P6045, DOI 10.1039/c5nr00733j; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; He XC, 2015, NANOMEDICINE-UK, V10, P121, DOI 10.2217/nnm.14.167; Huang RX, 2013, NANOSCALE, V5, P6928, DOI 10.1039/c3nr02117c; JOHANSSON C, 1990, EUR J BIOCHEM, V187, P455, DOI 10.1111/j.1432-1033.1990.tb15325.x; Karlsson M, 2005, BIOPHYS J, V88, P3536, DOI 10.1529/biophysj.104.054809; Kasche V, 2001, J BIOCHEM BIOPH METH, V49, P49, DOI 10.1016/S0165-022X(01)00188-9; Kim DT, 2002, LANGMUIR, V18, P5841, DOI 10.1021/la0256331; Klymchenko AS, PROGR MOL BIOL TRANS, V1132013, P35; Li N, 2010, ANAL CHEM, V82, P7460, DOI 10.1021/ac101627p; Lundqvist M, 2005, LANGMUIR, V21, P11903, DOI 10.1021/la050477u; Lundqvist M, 2004, LANGMUIR, V20, P10639, DOI 10.1021/la0484725; Lundqvist M, 2005, BIOCHEMISTRY-US, V44, P10093, DOI 10.1021/bi0500067; Lundqvist M, 2005, LANGMUIR, V21, P5974, DOI 10.1021/la050569j; Lundqvist M, 2006, ANGEW CHEM INT EDIT, V45, P8169, DOI 10.1002/anie.200600965; Lynch I., 2006, DETECTING CRYPTIC EP, V2006, DOI [10.1126/stke.3272006pe14, DOI 10.1126/STKE.3272006PE14]; Lynch I, 2007, ADV COLLOID INTERFAC, V134-35, P167, DOI 10.1016/j.cis.2007.04.021; Norde W, 2012, ADV COLLOID INTERFAC, V179, P5, DOI 10.1016/j.cis.2012.06.011; Rosi NL, 2005, CHEM REV, V105, P1547, DOI 10.1021/cr030067f; Sailor MJ, 2012, ADV MATER, V24, P3779, DOI 10.1002/adma.201200653; Saptarshi SR, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-26; Talbert JN, 2013, FOOD BIOPROD PROCESS, V91, P693, DOI 10.1016/j.fbp.2013.08.006; Tarasevich YI, 2002, COLLOID J+, V64, P482, DOI 10.1023/A:1016828322434; Vinoba M, 2012, CHEM-EUR J, V18, P12028, DOI 10.1002/chem.201201112; Wahlgren M, 1997, LANGMUIR, V13, P8, DOI 10.1021/la960171a; Xia XR, 2010, NAT NANOTECHNOL, V5, P671, DOI [10.1038/nnano.2010.164, 10.1038/NNANO.2010.164]; Yohan D, 2014, J BIOMED NANOTECHNOL, V10, P2371, DOI 10.1166/jbn.2014.2015; Yonzon CR, 2005, TALANTA, V67, P438, DOI 10.1016/j.talanta.2005.06.039; Zheng X, 2014, ENVIRON SCI TECHNOL, V48, P13800, DOI 10.1021/es504251v	39	9	9	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136687	10.1371/journal.pone.0136687	http://dx.doi.org/10.1371/journal.pone.0136687			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313757	Green Published, Green Submitted, gold			2022-12-26	WOS:000360144000087
J	Yesildag, B; Bock, T; Herrmanns, K; Wollscheid, B; Stoffel, M				Yesildag, Burcak; Bock, Thomas; Herrmanns, Karolin; Wollscheid, Bernd; Stoffel, Markus			Kin of IRRE-like Protein 2 Is a Phosphorylated Glycoprotein That Regulates Basal Insulin Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; KIDNEY SLIT DIAPHRAGM; SRC-FAMILY KINASE; MOLECULE N-CAM; E-CADHERIN; ISLET CELLS; NEPHRIN; ADHESION; RELEASE; PODOCYTES	Direct interactions among pancreatic beta-cells via cell surface proteins inhibit basal and enhance stimulated insulin secretion. Here, we functionally and biochemically characterized Kirrel2, an immunoglobulin superfamily protein with beta-cell-specific expression in the pancreas. Our results show that Kirrel2 is a phosphorylated glycoprotein that co-localizes and interacts with the adherens junction proteins E-cadherin and beta-catenin in MIN6 cells. We further demonstrate that the phosphosites Tyr(595-596) are functionally relevant for the regulation of Kirrel2 stability and localization. Analysis of the extracellular and intracellular domains of Kirrel2 revealed that it is cleaved and shed from MIN6 cells and that the remaining membrane spanning cytoplasmic domain is processed by gamma-secretase complex. Kirrel2 knockdown with RNA interference in MIN6 cells and ablation of Kirrel2 from mice with genetic deletion resulted in increased basal insulin secretion from beta-cells, with no immediate influence on stimulated insulin secretion, total insulin content, or whole body glucose metabolism. Our results show that in pancreatic beta-cells Kirrel2 localizes to adherens junctions, is regulated by multiple post-translational events, including glycosylation, extracellular cleavage, and phosphorylation, and engages in the regulation of basal insulin secretion.	[Yesildag, Burcak; Herrmanns, Karolin; Stoffel, Markus] Swiss Fed Inst Technol, Inst Mol Hlth Sci, Dept Biol, CH-8093 Zurich, Switzerland; [Bock, Thomas; Wollscheid, Bernd; Stoffel, Markus] Swiss Fed Inst Technol Zurich, Inst Mol Syst Biol, Dept Hlth Sci & Technol, CH-8093 Zurich, Switzerland; [Stoffel, Markus] Univ Zurich, Fac Med, CH-8091 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Geneva; University of Zurich	Stoffel, M (corresponding author), Swiss Fed Inst Technol, Inst Mol Hlth Sci, Otto Stern Weg 7,HPL H36, CH-8093 Zurich, Switzerland.	stoffel@biol.ethz.ch	Wollscheid, Bernd/E-8909-2010	Wollscheid, Bernd/0000-0002-3923-1610; Bock, Thomas Klaus Christian/0000-0002-9314-5318; Stoffel, Markus/0000-0003-1304-5817				Aaltonen P, 2007, NEPHROL DIAL TRANSPL, V22, P3408, DOI 10.1093/ndt/gfm403; Akerblom B, 2007, MOL CELL ENDOCRINOL, V270, P73, DOI 10.1016/j.mce.2007.02.009; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Barletta GM, 2003, J BIOL CHEM, V278, P19266, DOI 10.1074/jbc.M301279200; Bell GI, 2001, NATURE, V414, P788, DOI 10.1038/414788a; Bock T, 2012, J PROTEOME RES, V11, P4885, DOI 10.1021/pr300360a; Brieher WM, 1996, J CELL BIOL, V135, P487, DOI 10.1083/jcb.135.2.487; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Calabrese A, 2004, EXP CELL RES, V294, P379, DOI 10.1016/j.yexcr.2003.12.007; Charollais A, 2000, J CLIN INVEST, V106, P235, DOI 10.1172/JCI9398; Cheng HY, 2007, AM J PHYSIOL-ENDOC M, V292, pE845, DOI 10.1152/ajpendo.00103.2006; CIRULLI V, 1994, J CELL SCI, V107, P1429; Collino F, 2008, AM J PHYSIOL-RENAL, V294, pF1185, DOI 10.1152/ajprenal.00442.2007; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dahl U, 1996, DEVELOPMENT, V122, P2895; Dhanvantari S, 2002, BIOCHEMISTRY-US, V41, P52, DOI 10.1021/bi015698n; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Esni F, 1999, J CELL BIOL, V144, P325, DOI 10.1083/jcb.144.2.325; Esterhazy D, 2012, BIOL CHEM, V393, P473, DOI 10.1515/hsz-2012-0104; Fornoni A, 2010, DIABETES, V59, P190, DOI 10.2337/db09-0655; Garg P, 2007, MOL CELL BIOL, V27, P8698, DOI 10.1128/MCB.00948-07; Georgakopoulos A, 2006, EMBO J, V25, P1242, DOI 10.1038/sj.emboj.7601031; Gerke P, 2005, J AM SOC NEPHROL, V16, P1693, DOI 10.1681/ASN.2004060439; Gerke P, 2003, J AM SOC NEPHROL, V14, P918, DOI 10.1097/01.ASN.0000057853.05686.89; HALBAN PA, 1982, ENDOCRINOLOGY, V111, P86, DOI 10.1210/endo-111-1-86; Harita Y, 2008, J BIOL CHEM, V283, P9177, DOI 10.1074/jbc.M707247200; Hauge-Evans AC, 1999, DIABETES, V48, P1402, DOI 10.2337/diabetes.48.7.1402; Heikkila E, 2011, BIOCHEM J, V435, P619, DOI 10.1042/BJ20101599; Hodson DJ, 2013, J CLIN INVEST, V123, P4182, DOI 10.1172/JCI68459; Huber TB, 2001, J BIOL CHEM, V276, P41543, DOI 10.1074/jbc.C100452200; Jaques F, 2008, ENDOCRINOLOGY, V149, P2494, DOI 10.1210/en.2007-0974; Jeon J, 2009, J HISTOCHEM CYTOCHEM, V57, P811, DOI 10.1369/jhc.2009.953307; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Kapodistria K, 2015, MOL CELL ENDOCRINOL, V400, P112, DOI 10.1016/j.mce.2014.11.003; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Konstantinova I, 2007, CELL, V129, P359, DOI 10.1016/j.cell.2007.02.044; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Lal M, 2011, PHYSIOLOGY, V26, P34, DOI 10.1152/physiol.00028.2010; Li H, 2004, J AM SOC NEPHROL, V15, P3006, DOI 10.1097/01.ASN.0000146689.88078.80; Liu G, 2003, J CLIN INVEST, V112, P209, DOI 10.1172/JCI200318242; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Meda P, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/621249; Olofsson CS, 2009, ENDOCRINOLOGY, V150, P3067, DOI 10.1210/en.2008-0475; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; PIPELEERS DG, 1992, DIABETES, V41, P777, DOI 10.2337/diabetes.41.7.777; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Qin XS, 2009, J AM SOC NEPHROL, V20, P2534, DOI 10.1681/ASN.2009010011; Rantanen M, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016142.29721.22; Ravier MA, 2005, DIABETES, V54, P1798, DOI 10.2337/diabetes.54.6.1798; Rinta-Valkama J, 2007, MOL CELL BIOCHEM, V294, P117, DOI 10.1007/s11010-006-9251-2; Rinta-Valkama J, 2007, DIABETES-METAB RES, V23, P119, DOI 10.1002/dmrr.655; Ristola M, 2014, CLIN SCI, V126, P315, DOI 10.1042/CS20130258; Rogers GJ, 2007, CELL PHYSIOL BIOCHEM, V20, P987, DOI 10.1159/000110459; ROUILLER DG, 1991, DEV BIOL, V148, P233, DOI 10.1016/0012-1606(91)90332-W; Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962; SALOMON D, 1986, EXP CELL RES, V162, P507, DOI 10.1016/0014-4827(86)90354-X; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sellin L, 2002, FASEB J, V16, P115, DOI 10.1096/fj.02-0242fje; Serre-Beinier V, 2000, DIABETES, V49, P727, DOI 10.2337/diabetes.49.5.727; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Speier S, 2007, DIABETES, V56, P1078, DOI 10.2337/db06-0232; Steed E, 2010, TRENDS CELL BIOL, V20, P142, DOI 10.1016/j.tcb.2009.12.002; Stutzer I, 2012, DIABETOLOGIA, V55, P1877, DOI 10.1007/s00125-012-2531-3; Sun C, 2003, GENOMICS, V82, P130, DOI 10.1016/S0888-7543(03)00110-1; Verma R, 2003, J BIOL CHEM, V278, P20716, DOI 10.1074/jbc.M301689200; VOZZI C, 1995, J CELL BIOL, V131, P1561, DOI 10.1083/jcb.131.6.1561; Wellershaus K, 2008, EXP CELL RES, V314, P997, DOI 10.1016/j.yexcr.2007.12.024; Yoder SM, 2014, J BIOL CHEM, V289, P11476, DOI 10.1074/jbc.M114.559328	71	8	10	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					25891	25906		10.1074/jbc.M115.684704	http://dx.doi.org/10.1074/jbc.M115.684704			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26324709	hybrid, Green Published			2022-12-26	WOS:000363527300013
J	Suh, JH; Chattopadhyay, A; Sieglaff, DH; Samaniego, CS; Cox, MB; Webb, P				Suh, Ji Ho; Chattopadhyay, Arundhati; Sieglaff, Douglas H.; Samaniego, Cheryl Storer; Cox, Marc B.; Webb, Paul			Similarities and Distinctions in Actions of Surface-Directed and Classic Androgen Receptor Antagonists	PLOS ONE			English	Article							RESISTANT PROSTATE-CANCER; NUCLEAR RECEPTOR; DOMAIN; ANTIANDROGEN; EXPRESSION; TRANSCRIPTION; INHIBITION; MECHANISMS	The androgen receptor (AR) surface-directed antagonist MJC13 inhibits AR function and proliferation of prostate cancer (PC) cells. These effects are related to arrest of an AR/chaperone complex in the cytoplasm. Here, we compared MJC13 and classic AR antagonists such as flutamide and bicalutamide. Microarray analysis and confirmatory qRT-PCR reveals that MJC13 and flutamide inhibit dihydrotestosterone (DHT)-dependent genes in LNCaP PC cells. Both compounds are equally effective on a genome wide basis and as effective as second generation AR antagonists (MDV3100, ARN-509) at selected genes. MJC13 inhibits AR binding to the prostate specific antigen (PSA) promoter more strongly than flutamide, consistent with different mechanisms of action. Examination of efficacy of MJC13 in conditions that reflect aspects castrate resistant prostate cancer (CRPC) reveals that it inhibits flutamide activation of an AR mutant (ART877A) that emerges during flutamide withdrawal syndrome, but displays greatly restricted gene-specific activity in 22Rv1 cells that express a constitutively active truncated AR and is inactive against glucocorticoid receptor (GR), which can co-opt androgen-dependent signaling networks in CRPC. Importantly, MJC13 inhibits AR interactions with SRC2 and beta-catenin in the nucleus and, unlike flutamide, strongly inhibits amplification of AR activity obtained with transfected SRC2 and beta-catenin. MJC13 also inhibits DHT and beta-catenin-enhanced cell division in LNCaP cells. Thus, a surface-directed antagonist can block AR activity in some conditions in which a classic antagonist fails and may display utility in particular forms of CRPC.	[Suh, Ji Ho; Chattopadhyay, Arundhati; Sieglaff, Douglas H.; Webb, Paul] Houston Methodist Res Inst, Genom Med Program, Houston, TX 77030 USA; [Samaniego, Cheryl Storer; Cox, Marc B.] Univ Texas El Paso, Border Biomed Res Ctr, Dept Biol Sci, El Paso, TX 79902 USA	The Methodist Hospital System; The Methodist Hospital - Houston; University of Texas System; University of Texas El Paso	Webb, P (corresponding author), Houston Methodist Res Inst, Genom Med Program, 66670 Bertner Ave,R8-114, Houston, TX 77030 USA.	PWebb@tmhs.org		Cox, Marc/0000-0001-7854-2676	Cancer Prevention and Research Institute of Texas (CPRIT) [RP110444-P3, RP110444-C2, RP110444-P2]	Cancer Prevention and Research Institute of Texas (CPRIT)	Cancer Prevention and Research Institute of Texas (CPRIT), http://www.cprit.state.tx.us/. RP110444-P3 (PW); RP110444-C2 (PW); RP110444-P2 (MBC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora VK, 2013, CELL, V155, P1309, DOI 10.1016/j.cell.2013.11.012; Askew EB, 2012, MOL CELL ENDOCRINOL, V348, P403, DOI 10.1016/j.mce.2011.03.026; Bao BY, 2008, PROSTATE, V68, P839, DOI 10.1002/pros.20749; Beildeck ME, 2010, EXP CELL RES, V316, P1763, DOI 10.1016/j.yexcr.2010.02.001; Bergerat JP, 2009, HUM MUTAT, V30, P145, DOI 10.1002/humu.20848; Cai CM, 2011, ENDOCR-RELAT CANCER, V18, pR175, DOI 10.1530/ERC-10-0339; Chen DG, 2000, J BIOL CHEM, V275, P40810, DOI 10.1074/jbc.M005459200; Clegg NJ, 2012, CANCER RES, V72, P1494, DOI 10.1158/0008-5472.CAN-11-3948; De Leon JT, 2011, P NATL ACAD SCI USA, V108, P11878, DOI 10.1073/pnas.1105160108; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Estebanez-Perpina E, 2005, J BIOL CHEM, V280, P8060, DOI 10.1074/jbc.M407046200; Estebanez-Perpina E, 2007, P NATL ACAD SCI USA, V104, P16074, DOI 10.1073/pnas.0708036104; Fletterick RJ, 2005, BJU INT, V96, P2, DOI 10.1111/j.1464-410X.2005.05940.x; Grosdidier S, 2012, MOL ENDOCRINOL, V26, P1078, DOI 10.1210/me.2011-1281; Gupta E, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-55; Haile S, 2011, CELL MOL LIFE SCI, V68, P3971, DOI 10.1007/s00018-011-0766-7; Hu YC, 2004, J BIOL CHEM, V279, P33438, DOI 10.1074/jbc.M401781200; Ishioka J, 2009, INT J UROL, V16, P516, DOI 10.1111/j.1442-2042.2009.02284.x; Jehle K, 2014, J BIOL CHEM, V289, P8839, DOI 10.1074/jbc.M113.534859; Jung SJ, 2013, WORLD J MENS HEALTH, V31, P36, DOI 10.5534/wjmh.2013.31.1.36; Kai L, 2011, ANTICANCER RES, V31, P3323; Lee E, 2013, P NATL ACAD SCI USA, V110, P15710, DOI 10.1073/pnas.1218168110; Lonergan Peter E, 2011, J Carcinog, V10, P20, DOI 10.4103/1477-3163.83937; Lu S, 2007, MOL CANCER THER, V6, P2057, DOI 10.1158/1535-7163.MCT-06-0735; Marhefka CA, 2001, J MED CHEM, V44, P1729, DOI 10.1021/jm0005353; Mulholland DJ, 2002, J BIOL CHEM, V277, P17933, DOI 10.1074/jbc.M200135200; Munuganti RSN, 2014, CHEM BIOL, V21, P1476, DOI 10.1016/j.chembiol.2014.09.012; Pitkanen-Arsiola T, 2006, PROSTATE, V66, P1177, DOI 10.1002/pros.20450; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rathkopf D, 2013, CANCER J, V19, P43, DOI 10.1097/PPO.0b013e318282635a; Ryu BJ, 2013, BIOORG MED CHEM LETT, V23, P3887, DOI 10.1016/j.bmcl.2013.04.065; Sadana P, 2011, ACS CHEM BIOL, V6, P1096, DOI 10.1021/cb200092v; Samaniego CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134015; Shah S, 2010, EXPERT REV ANTICANC, V10, P89, DOI [10.1586/era.09.161, 10.1586/ERA.09.161]; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Smyth G. K., 2004, APPL GENET MOL BIOL, V3, DOI DOI 10.2202/1544-6115.1027; Song LN, 2003, MOL CELL BIOL, V23, P1674, DOI 10.1128/MCB.23.5.1674-1687.2003; Suh JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070097; Truica CI, 2000, CANCER RES, V60, P4709; Urushibara M, 2007, PROSTATE, V67, P799, DOI 10.1002/pros.20542; Wang G, 2006, J CELL BIOCHEM, V98, P36, DOI 10.1002/jcb.20802; Wen SM, 2014, CANCER TREAT REV, V40, P31, DOI 10.1016/j.ctrv.2013.07.008; Williams SB, 2011, EXPERT OPIN PHARMACO, V12, P2069, DOI 10.1517/14656566.2011.590133; Yokoyama NN, 2014, AM J CLIN EXP UROL, V2, P27; Yoon HG, 2006, MOL ENDOCRINOL, V20, P1048, DOI 10.1210/me.2005-0324; Yuan X, 2014, ONCOGENE, V33, P2815, DOI 10.1038/onc.2013.235; Yumoto F, 2012, P NATL ACAD SCI USA, V109, P143, DOI 10.1073/pnas.1117036108; Zaman N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113190	48	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137103	10.1371/journal.pone.0137103	http://dx.doi.org/10.1371/journal.pone.0137103			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332122	Green Published, Green Submitted, gold			2022-12-26	WOS:000360613800097
J	Domitrovic, T; Raymundo, DP; da Silva, TF; Palhano, FL				Domitrovic, Tatiana; Raymundo, Diana P.; da Silva, Tiago Fernandes; Palhano, Fernando L.			Experimental Evidence for a Revision in the Annotation of Putative Pyridoxamine 5 '-Phosphate Oxidases P(N/M)P from Fungi	PLOS ONE			English	Article							FMN-BINDING PROTEIN; X-RAY-STRUCTURE; PYRIDOXINE 5'-PHOSPHATE; MYCOBACTERIUM-TUBERCULOSIS; CRYSTAL-STRUCTURE; PSI-BLAST; DATABASE; PATHWAY	Pyridoxinamine 5'-phosphate oxidases (P(N/M) P oxidases) that bind flavin mononucleotide (FMN) and oxidize pyridoxine 5'-phosphate or pyridoxamine 5'-phosphate to form pyridoxal 5'-phosphate (PLP) are an important class of enzymes that play a central role in cell metabolism. Failure to generate an adequate supply of PLP is very detrimental to most organisms and is often clinically manifested as a neurological disorder in mammals. In this study, we analyzed the function of YLR456Wand YPR172W, two homologous genes of unknown function from S. cerevisiae that have been annotated as putative P(N/M) P oxidases based on sequence homology. Different experimental approaches indicated that neither protein catalyzes PLP formation nor binds FMN. On the other hand, our analysis confirmed the enzymatic activity of Pdx3, the S. cerevisiae protein previously implicated in PLP biosynthesis by genetic and structural characterization. After a careful sequence analysis comparing the putative and confirmed P(N/M) P oxidases, we found that the protein domain (PF01243) that led to the YLR456W and YPR172W annotation is a poor indicator of P(N/M) P oxidase activity. We suggest that a combination of two Pfam domains (PF01243 and PF10590) present in Pdx3 and other confirmed P(N/M) P oxidases would be a stronger predictor of this molecular function. This work exemplifies the importance of experimental validation to rectify genome annotation and proposes a revision in the annotation of at least 400 sequences from a wide variety of fungal species that are homologous to YLR456Wand are currently misrepresented as putative P(N/M) P oxidases.	[Domitrovic, Tatiana] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Virol, Rio De Janeiro, Brazil; [Raymundo, Diana P.; Palhano, Fernando L.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Programa Biol Estrutural, Rio De Janeiro, Brazil; [da Silva, Tiago Fernandes] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Avaliacao & Sintese Subst Bioat LASSBio, Rio De Janeiro, Brazil; [da Silva, Tiago Fernandes] Univ Fed Rio de Janeiro, Inst Quim, Programa Grad Quim PGQu, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Domitrovic, T (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Virol, Rio De Janeiro, Brazil.	domitrovic@micro.ufrj.br; palhano@bioqmed.ufrj.br	Palhano, Fernando/AAB-3144-2021; Domitrovic, Tatiana/AAX-1142-2021	Palhano, Fernando/0000-0001-5336-632X; Domitrovic, Tatiana/0000-0001-9196-9412	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); INCT de Biologia Estrutural e Bioimagem	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); INCT de Biologia Estrutural e Bioimagem	Support for FLP was provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and INCT de Biologia Estrutural e Bioimagem. Support for TD was provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Azevedo EPC, 2011, BIOCHEMISTRY-US, V50, P11070, DOI 10.1021/bi201365r; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Biswal BK, 2006, ACTA CRYSTALLOGR F, V62, P735, DOI 10.1107/S1744309106025012; Biswal BK, 2005, ACTA CRYSTALLOGR D, V61, P1492, DOI 10.1107/S0907444905026673; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Canaan S, 2005, FEBS LETT, V579, P215, DOI 10.1016/j.febslet.2004.11.069; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Chosrowjan H, 2010, J PHYS CHEM B, V114, P6175, DOI 10.1021/jp912137s; Costanzo MC, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar004; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dessimoz C, 2013, TRENDS GENET, V29, P609, DOI 10.1016/j.tig.2013.09.005; di Salvo ML, 2011, BBA-PROTEINS PROTEOM, V1814, P1597, DOI 10.1016/j.bbapap.2010.12.006; di Salvo ML, 2002, J MOL BIOL, V315, P385, DOI 10.1006/jmbi.2001.5254; Domitrovic T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011163; Hess DC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000407; Hong EL, 2008, NUCLEIC ACIDS RES, V36, pD577, DOI 10.1093/nar/gkm909; Kitamura M, 2007, J BIOCHEM, V141, P459, DOI 10.1093/jb/mvm051; KWON O, 1991, J BIOL CHEM, V266, P22136; Kwon OS, 1999, BIOCHIMIE, V81, P1057, DOI 10.1016/S0300-9084(99)00329-6; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liepinsh E, 1997, NAT STRUCT BIOL, V4, P975, DOI 10.1038/nsb1297-975; Liu XH, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-23; LOUBBARDI A, 1995, J BACTERIOL, V177, P1817, DOI 10.1128/jb.177.7.1817-1823.1995; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Mashalidis EH, 2015, PROTEIN SCI, V24, P729, DOI 10.1002/pro.2645; Mashalidis EH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027643; Micallef L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101717; Musayev FN, 2009, J BIOL CHEM, V284, P30949, DOI 10.1074/jbc.M109.038372; Musayev FN, 2003, PROTEIN SCI, V12, P1455, DOI 10.1110/ps.0356203; Parsons JF, 2004, ACTA CRYSTALLOGR D, V60, P2110, DOI 10.1107/S0907444904022474; Pedelacq JD, 2006, PROTEINS, V62, P563, DOI 10.1002/prot.20824; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Safo MK, 2000, STRUCTURE, V8, P751, DOI 10.1016/S0969-2126(00)00162-3; Safo MK, 2005, ACTA CRYSTALLOGR D, V61, P599, DOI 10.1107/S0907444905005512; Safo MK, 2001, J MOL BIOL, V310, P817, DOI 10.1006/jmbi.2001.4734; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Suto K, 2000, ACTA CRYSTALLOGR D, V56, P368, DOI 10.1107/S0907444900000111; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Xu NN, 2013, ACTA CRYSTALLOGR D, V69, P1403, DOI 10.1107/S0907444913008354	44	5	5	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136761	10.1371/journal.pone.0136761	http://dx.doi.org/10.1371/journal.pone.0136761			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327315	gold, Green Submitted, Green Published			2022-12-26	WOS:000360437700062
J	Iliadis, SI; Comasco, E; Sylven, S; Hellgren, C; Poromaa, IS; Skalkidou, A				Iliadis, Stavros I.; Comasco, Erika; Sylven, Sara; Hellgren, Charlotte; Poromaa, Inger Sundstrom; Skalkidou, Alkistis			Prenatal and Postpartum Evening Salivary Cortisol Levels in Association with Peripartum Depressive Symptoms	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; PITUITARY-ADRENAL AXIS; CARDIFF PUERPERAL MOOD; POSTNATAL-DEPRESSION; AWAKENING RESPONSE; PLASMA-CORTISOL; PSYCHOLOGICAL DISTRESS; PERINATAL DEPRESSION; PSYCHOSOCIAL STRESS; MORNING CORTISOL	Background The biology of peripartum depression remains unclear, with altered stress and the Hypothalamus- Pituitary-Adrenal axis response having been implicated in its pathophysiology. Methods The current study was undertaken as a part of the BASIC project (Biology, Affect, Stress, Imaging, Cognition), a population-based longitudinal study of psychological wellbeing during pregnancy and the postpartum period in Uppsala County, Sweden, in order to assess the association between evening salivary cortisol levels and depressive symptoms in the peripartum period. Three hundred and sixty-five pregnant women from the BASIC cohort were recruited at pregnancy week 18 and instructed to complete a Swedish validated version of the Edinburgh Postnatal Depression Scale at the 36th week of pregnancy as well as the sixth week after delivery. At both times, they were also asked to provide evening salivary samples for cortisol analysis. A comprehensive review of the relevant literature is also provided. Results Women with postpartum EPDS score >= 10 had higher salivary evening cortisol at six weeks postpartum compared to healthy controls (median cortisol 1.19 vs 0.89 nmol/L). A logistic regression model showed a positive association between cortisol levels and depressive symptoms postpartum (OR = 4.1; 95% CI 1.7-9.7). This association remained significant even after controlling for history of depression, use of tobacco, partner support, breastfeeding, stressful life events, and sleep problems, as possible confounders (aOR = 4.5; 95% CI 1.5-14.1). Additionally, women with postpartum depressive symptoms had higher postpartum cortisol levels compared to both women with depressive symptoms antenatally and controls (p = 0.019 and p = 0.004, respectively). Conclusions Women with depressive symptoms postpartum had higher postpartum cortisol levels, indicating an altered response of the HPA-axis in postpartum depression.	[Iliadis, Stavros I.; Comasco, Erika; Sylven, Sara; Hellgren, Charlotte; Poromaa, Inger Sundstrom; Skalkidou, Alkistis] Uppsala Univ, Dept Womens & Childrens Hlth, S-75185 Uppsala, Sweden; [Comasco, Erika] Uppsala Univ, Dept Neurosci, S-75124 Uppsala, Sweden	Uppsala University; Uppsala University	Iliadis, SI (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, S-75185 Uppsala, Sweden.	stavros.iliadis@kbh.uu.se	Comasco, Erika/H-9337-2019; Skalkidou, Alkistis/C-1521-2015	Comasco, Erika/0000-0002-2174-2068; Skalkidou, Alkistis/0000-0002-4935-7532; Sundstrom Poromaa, Inger/0000-0002-2491-2042; Sylven, Sara M/0000-0002-3142-5111	Swedish Research Council [521-2013-2339]; Marianne and Marcus Wallenberg Foundation [MMW2011.0115]; Swedish Medical Association [SLS-250581]; Uppsala University Hospital [2012-Skalkidou]; Swedish Council for Working Life and Social Research [FAS: 2011-0627]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Marianne and Marcus Wallenberg Foundation; Swedish Medical Association; Uppsala University Hospital; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	This study was supported by the Swedish Research Council (grant number: 521-2013-2339), the Marianne and Marcus Wallenberg Foundation (grant number: MMW2011.0115), the Swedish Medical Association (grant number: SLS-250581), the Uppsala University Hospital (grant number: 2012-Skalkidou), and the Swedish Council for Working Life and Social Research to E.C. (FAS: 2011-0627). The funding sources had no involvement in study design; in the collection, analysis and interpretation of data; inthe writing of the report; and in the decision to submit the article for publication.	Adam EK, 2010, PSYCHONEUROENDOCRINO, V35, P921, DOI 10.1016/j.psyneuen.2009.12.007; Ahmed N, 2004, CEREBROVASC DIS, V18, P206, DOI 10.1159/000079943; ALLOLIO B, 1990, CLIN ENDOCRINOL, V33, P279, DOI 10.1111/j.1365-2265.1990.tb00492.x; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; AMICO JA, 1994, ENDOCR RES, V20, P79, DOI 10.3109/07435809409035858; Bissette G, 2003, NEUROPSYCHOPHARMACOL, V28, P1328, DOI 10.1038/sj.npp.1300191; Bloch M, 2005, J CLIN ENDOCR METAB, V90, P695, DOI 10.1210/jc.2004-1388; BONNIN F, 1992, J AFFECT DISORDERS, V26, P231, DOI 10.1016/0165-0327(92)90100-K; Brugha TS, 1998, PSYCHOL MED, V28, P63, DOI 10.1017/S0033291797005655; Chrousos George P., 1998, Annals of Internal Medicine, V129, P229; Clements AD, 1998, PSYCHONEUROENDOCRINO, V23, P613; Cox EQ, 2015, PSYCHONEUROENDOCRINO, V55, P164, DOI 10.1016/j.psyneuen.2015.02.009; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Dedovic K, 2015, NEUROPSYCH DIS TREAT, V11, P1181, DOI 10.2147/NDT.S62289; Dennis CL, 2004, J AFFECT DISORDERS, V78, P163, DOI 10.1016/S0165-0327(02)00299-9; Diego MA, 2006, PSYCHOSOM MED, V68, P747, DOI 10.1097/01.psy.0000238212.21598.7b; EHLERT U, 1990, J PSYCHOSOM RES, V34, P319, DOI 10.1016/0022-3999(90)90088-L; Evans LM, 2008, ARCH WOMEN MENT HLTH, V11, P239, DOI 10.1007/s00737-008-0019-4; FEKSI A, 1984, J AFFECT DISORDERS, V6, P351, DOI 10.1016/S0165-0327(84)80013-0; Field T, 2006, INFANT BEHAV DEV, V29, P262, DOI 10.1016/j.infbeh.2005.12.009; Field Tiffany, 2008, Depress Anxiety, V25, pE11, DOI 10.1002/da.20307; Friedman B, 2013, MILBANK Q, V91, P491, DOI 10.1111/1468-0009.12024; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Giesbrecht GF, 2012, PSYCHONEUROENDOCRINO, V37, P270, DOI 10.1016/j.psyneuen.2011.06.011; Glynn LM, 2014, PSYCHOSOM MED, V76, P355, DOI 10.1097/PSY.0000000000000066; Glynn LM, 2013, NEUROPEPTIDES, V47, P363, DOI 10.1016/j.npep.2013.10.007; Gold PW, 1999, P ASSOC AM PHYSICIAN, V111, P22, DOI 10.1046/j.1525-1381.1999.09423.x; Goodyer IM, 2010, BRIT J PSYCHIAT, V197, P365, DOI 10.1192/bjp.bp.110.077750; Groer MW, 2007, PSYCHONEUROENDOCRINO, V32, P133, DOI 10.1016/j.psyneuen.2006.11.007; Groschl M, 2003, CLIN CHEM, V49, P1688, DOI 10.1373/49.10.1688; HANDLEY SL, 1980, BRIT J PSYCHIAT, V136, P498, DOI 10.1192/bjp.136.5.498; HANDLEY SL, 1977, BRIT MED J, V2, P18, DOI 10.1136/bmj.2.6078.18; Handlin L, 2009, BREASTFEED MED, V4, P207, DOI 10.1089/bfm.2009.0001; Hanrahan K, 2006, APPL NURS RES, V19, P95, DOI 10.1016/j.apnr.2006.02.001; HARRIS B, 1994, BRIT MED J, V308, P949, DOI 10.1136/bmj.308.6934.949; Harris B, 1996, BRIT J PSYCHIAT, V168, P739, DOI 10.1192/bjp.168.6.739; HARRIS B, 1989, BRIT J PSYCHIAT, V154, P660, DOI 10.1192/bjp.154.5.660; Harris TO, 2000, BRIT J PSYCHIAT, V177, P505, DOI 10.1192/bjp.177.6.505; Heinrichs M, 2001, J CLIN ENDOCR METAB, V86, P4798, DOI 10.1210/jc.86.10.4798; Hellgren C, 2013, PSYCHONEUROENDOCRINO; Inder WJ, 2012, CLIN ENDOCRINOL, V77, P645, DOI 10.1111/j.1365-2265.2012.04508.x; Johnson DM, 2008, J ANXIETY DISORD, V22, P793, DOI 10.1016/j.janxdis.2007.08.006; Jolley SN, 2007, BIOL RES NURS, V8, P210, DOI 10.1177/1099800406294598; Kalantaridou SN, 2004, J REPROD IMMUNOL, V62, P61, DOI 10.1016/j.jri.2003.09.004; Kammerer M, 2006, ARCH WOMEN MENT HLTH, V9, P187, DOI 10.1007/s00737-006-0131-2; KUEVI V, 1983, CLIN ENDOCRINOL, V19, P39, DOI 10.1111/j.1365-2265.1983.tb00740.x; KUMAR R, 1984, BRIT J PSYCHIAT, V144, P35, DOI 10.1192/bjp.144.1.35; Leproult R, 1997, SLEEP, V20, P865; Llewellyn AM, 1997, J CLIN PSYCHIAT, V58, P26; Lommatzsch M, 2006, PSYCHONEUROENDOCRINO, V31, P388, DOI 10.1016/j.psyneuen.2005.09.003; Magiakou MA, 1996, J CLIN ENDOCR METAB, V81, P1912, DOI 10.1210/jc.81.5.1912; Martin-Santos R, 2012, PSYCHOL MED, V42, P1559, DOI 10.1017/S0033291712000712; McEwen BS, 2002, PSYCHIAT CLIN N AM, V25, P469, DOI 10.1016/S0193-953X(01)00009-0; Meinlschmidt G, 2010, STRESS, V13, P163, DOI 10.3109/10253890903128632; Meliska CJ, 2013, CHRONOBIOL INT, V30, P1160, DOI 10.3109/07420528.2013.808652; Milgrom J, 2008, J AFFECT DISORDERS, V108, P147, DOI 10.1016/j.jad.2007.10.014; MURRAY L, 1990, BRIT J PSYCHIAT, V157, P288, DOI 10.1192/bjp.157.2.288; Nierop A, 2006, PSYCHOSOM MED, V68, P931, DOI 10.1097/01.psy.0000244385.93141.3b; O'Keane V, 2011, J NEUROENDOCRINOL, V23, P1149, DOI 10.1111/j.1365-2826.2011.02139.x; O'Keane V, 2011, J AFFECT DISORDERS, V130, P300, DOI 10.1016/j.jad.2010.10.004; Obel C, 2005, PSYCHONEUROENDOCRINO, V30, P647, DOI 10.1016/j.psyneuen.2004.11.006; Oglodek E, 2014, PHARMACOL REP, V66, P776, DOI 10.1016/j.pharep.2014.04.009; OHARA MW, 1991, J ABNORM PSYCHOL, V100, P63, DOI 10.1037/0021-843X.100.1.63; OKANO T, 1992, PROG NEURO-PSYCHOPH, V16, P921, DOI 10.1016/0278-5846(92)90110-Z; Parry Barbara L, 2003, Curr Womens Health Rep, V3, P230; PEDERSEN CA, 1993, J AFFECT DISORDERS, V29, P201, DOI 10.1016/0165-0327(93)90034-H; Peer M, 2013, CAN J PSYCHIAT, V58, P579, DOI 10.1177/070674371305801007; Petrozzi A, 2013, J PERINAT MED, V41, P343, DOI 10.1515/jpm-2012-0258; Pluess M, 2010, BIOL PSYCHOL, V83, P169, DOI 10.1016/j.biopsycho.2009.12.005; ROSENGREN A, 1993, BRIT MED J, V307, P1102, DOI 10.1136/bmj.307.6912.1102; Rubertsson C, 2011, NORD J PSYCHIAT, V65, P414, DOI 10.3109/08039488.2011.590606; Salacz P, 2012, EUR J OBSTET GYN R B, V165, P225, DOI 10.1016/j.ejogrb.2012.08.017; Saleh ES, 2013, NEUROPSYCH DIS TREAT, V9, P15, DOI 10.2147/NDT.S37156; SBU, 2012, DIAGN TREATM MOOD DI; Shea AK, 2007, PSYCHONEUROENDOCRINO, V32, P1013, DOI 10.1016/j.psyneuen.2007.07.006; Skalkidou A, 2012, WOMENS HEALTH, V8, P659, DOI [10.2217/WHE.12.55, 10.2217/whe.12.55]; SMITH R, 1990, J PSYCHOSOM RES, V34, P53, DOI 10.1016/0022-3999(90)90008-R; Suglia SF, 2010, PSYCHOL TRAUMA-US, V2, P326, DOI 10.1037/a0018953; Susman EJ, 1999, J AM ACAD CHILD PSY, V38, P460, DOI 10.1097/00004583-199904000-00020; TAYLOR A, 1994, PSYCHIAT RES, V54, P241, DOI 10.1016/0165-1781(94)90018-3; Taylor A, 2009, PSYCHONEUROENDOCRINO, V34, P1184, DOI 10.1016/j.psyneuen.2009.03.004; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4; Vesga-Lopez O, 2008, ARCH GEN PSYCHIAT, V65, P805, DOI 10.1001/archpsyc.65.7.805; Voegtline KM, 2013, ARCH WOMEN MENT HLTH, V16, P101, DOI 10.1007/s00737-012-0321-z; Vrshek-Schallhorn S, 2013, PSYCHOL MED, V43, P483, DOI 10.1017/S0033291712001213; Wesstrom J, 2014, J CLIN SLEEP MED, V10, P527, DOI 10.5664/jcsm.3704; Wickberg B, 1996, ACTA PSYCHIAT SCAND, V94, P181, DOI 10.1111/j.1600-0447.1996.tb09845.x; Wisner KL, 2002, NEW ENGL J MED, V347, P194, DOI 10.1056/NEJMcp011542; Yim IS, 2009, ARCH GEN PSYCHIAT, V66, P162, DOI 10.1001/archgenpsychiatry.2008.533	89	46	47	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0135471	10.1371/journal.pone.0135471	http://dx.doi.org/10.1371/journal.pone.0135471			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322643	gold, Green Published, Green Submitted			2022-12-26	WOS:000360435500006
J	Schroder, J; Girirajan, S; Papenfuss, AT; Medvedev, P				Schroeder, Jan; Girirajan, Santhosh; Papenfuss, Anthony T.; Medvedev, Paul			Improving the Power of Structural Variation Detection by Augmenting the Reference	PLOS ONE			English	Article							READ ALIGNMENT	The uses of the Genome Reference Consortium's human reference sequence can be roughly categorized into three related but distinct categories: as a representative species genome, as a coordinate system for identifying variants, and as an alignment reference for variation detection algorithms. However, the use of this reference sequence as simultaneously a representative species genome and as an alignment reference leads to unnecessary artifacts for structural variation detection algorithms and limits their accuracy. We show how decoupling these two references and developing a separate alignment reference can significantly improve the accuracy of structural variation detection, lead to improved genotyping of disease related genes, and decrease the cost of studying polymorphismin a population.	[Schroeder, Jan; Papenfuss, Anthony T.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Schroeder, Jan] Univ Melbourne, Dept Comp & Informat Syst, Melbourne, Vic, Australia; [Papenfuss, Anthony T.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Schroeder, Jan; Papenfuss, Anthony T.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Medvedev, Paul] Penn State Univ, Dept Biochem & Mol Biol, State Coll, PA 16801 USA; [Girirajan, Santhosh; Medvedev, Paul] Penn State Univ, Genom Sci Inst Huck, State Coll, PA USA; [Girirajan, Santhosh; Medvedev, Paul] Penn State Univ, Dept Comp Sci & Engn, State Coll, PA USA	Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne; Peter Maccallum Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Medvedev, P (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, State Coll, PA 16801 USA.	paul.medvedev@psu.edu	Girirajan, Santhosh/AAR-3659-2020; Papenfuss, Anthony T/C-6297-2008	Papenfuss, Anthony T/0000-0002-1102-8506; SCHROEDER, JAN/0000-0001-5270-0605	National Science Foundation [DBI-1356529, IIS-1453527]; NHMRC Program Grant [1054618]; Direct For Computer & Info Scie & Enginr [1453527] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1356529] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); NHMRC Program Grant(National Health and Medical Research Council (NHMRC) of Australia); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	PM was funded in part by National Science Foundation (nsf.gov), grants DBI-1356529 and IIS-1453527. J.S. and A.T.P. were supported by an NHMRC Program Grant (1054618) (www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Hajirasouliha I, 2010, BIOINFORMATICS, V26, P1277, DOI 10.1093/bioinformatics/btq152; Huang L, 2013, BIOINFORMATICS, V29, P361, DOI 10.1093/bioinformatics/btt215; Kim S, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt339; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li RQ, 2010, NAT BIOTECHNOL, V28, P57, DOI 10.1038/nbt.1596; Medvedev P, 2009, NAT METHODS, V6, pS13, DOI [10.1038/NMETH.1374, 10.1038/nmeth.1374]; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Rizk G, 2014, BIOINFORMATICS; Siren J, 2014, IEEE ACM T COMPUT BI, V11, P375, DOI 10.1109/TCBB.2013.2297101; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wolfe D, 2013, VISUALIZING GENOMIC; Zichner T, 2013, GENOME RES, V23, P568, DOI 10.1101/gr.142646.112	16	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136771	10.1371/journal.pone.0136771	http://dx.doi.org/10.1371/journal.pone.0136771			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322511	Green Submitted, Green Published, gold			2022-12-26	WOS:000360435500035
J	Endo-Munoz, L; Cai, N; Cumming, A; Macklin, R; de Long, LM; Topkas, E; Mukhopadhyay, P; Hill, M; Saunders, NA				Endo-Munoz, Liliana; Cai, Na; Cumming, Andrew; Macklin, Rebecca; de Long, Lilia Merida; Topkas, Eleni; Mukhopadhyay, Pamela; Hill, Michelle; Saunders, Nicholas A.			Progression of Osteosarcoma from a Non-Metastatic to a Metastatic Phenotype Is Causally Associated with Activation of an Autocrine and Paracrine uPA Axis	PLOS ONE			English	Article							UROKINASE-PLASMINOGEN-ACTIVATOR; GENE-EXPRESSION; CARCINOMA-CELLS; CANCER INVASION; TUMOR-GROWTH; RECEPTOR; SYSTEM; INHIBITOR; THERAPY; TARGET	Pulmonary metastasis is the major untreatable complication of osteosarcoma (OS) resulting in 10-20% long-term survival. The factors and pathways regulating these processes remain unclear, yet their identification is crucial in order to find new therapeutic targets. In this study we used a multi-omics approach to identify molecules in metastatic and non-metastatic OS cells that may contribute to OS metastasis, followed by validation in vitro and in vivo. We found elevated levels of the urokinase plasminogen activator (uPA) and of the uPA receptor (uPAR) exclusively in metastatic OS cells. uPA was secreted in soluble form and as part of the protein cargo of OS-secreted extracellular vesicles, including exosomes. In addition, in the tumour microenvironment, uPA was expressed and secreted by bone marrow cells (BMC), and OS-and BMC-derived uPA significantly and specifically stimulated migration of metastatic OS cells via uPA-dependent signaling pathways. Silencing of uPAR in metastatic OS cells abrogated the migratory response to uPA in vitro and decreased metastasis in vivo. Finally, a novel small-molecule inhibitor of uPA significantly (P = 0.0004) inhibited metastasis in an orthotopic mouse model of OS. Thus, we show for the first time that malignant conversion of OS cells to a metastatic phenotype is defined by activation of the uPA/uPAR axis in both an autocrine and paracrine fashion. Furthermore, metastasis is driven by changes in OS cells as well as in the microenvironment. Finally, our data show that pharmacological inhibition of the uPA/uPAR axis with a novel small-molecule inhibitor can prevent the emergence of metastatic foci.	[Endo-Munoz, Liliana; Cai, Na; Cumming, Andrew; Macklin, Rebecca; de Long, Lilia Merida; Topkas, Eleni; Mukhopadhyay, Pamela; Hill, Michelle; Saunders, Nicholas A.] Univ Queensland, Translat Res Inst, Diamantina Inst, Brisbane, Qld 4102, Australia	University of Queensland	Endo-Munoz, L (corresponding author), Univ Queensland, Translat Res Inst, Diamantina Inst, Brisbane, Qld 4102, Australia.	l.munoz@uq.edu.au	McTaggart, Jill/G-4696-2010; Cai, Na/L-4951-2019; Hill, Michelle Mei Chih/G-4417-2010; saunders, nicholas/AAJ-6101-2020; Endo-Munoz, Liliana/G-3309-2010	McTaggart, Jill/0000-0002-9000-8529; Cai, Na/0000-0002-7548-4359; Hill, Michelle Mei Chih/0000-0003-1134-0951; saunders, nicholas/0000-0002-2478-3420; Endo-Munoz, Liliana/0000-0001-5706-920X	National Health and Medical Research Council [1049182, 569689]; Wesley Research Institute [2006/10]; Cancer Council Queensland [401542]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Wesley Research Institute; Cancer Council Queensland(Cancer Council Queensland)	LEM was funded by The National Health and Medical Research Council (Grant ID 1049182, https://www.nhmrc.gov.au). LEM and NAS were funded by The Wesley Research Institute (Grant ID 2006/10, http://www.wesleyresearch.org.au). NAS was funded by The National Health and Medical Research Council (Grant ID 569689, https://www.nhmrc.gov.au), and by the Cancer Council Queensland (Grant ID 401542, http://www.cancerqld.org.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nedawi K, 2009, CELL CYCLE, V8, P2014, DOI 10.4161/cc.8.13.8988; Ass K, 2008, CANCER TREAT REV, V34, P122, DOI 10.1016/j.ctrv.2007.10.005; Azmi AS, 2013, CANCER METAST REV, V32, P623, DOI 10.1007/s10555-013-9441-9; Bacci G, 1997, CANCER-AM CANCER SOC, V79, P245; Bard MP, 2004, AM J RESP CELL MOL, V31, P114, DOI 10.1165/rcmb.2003-0238OC; Bauer TW, 2005, CANCER RES, V65, P7775, DOI 10.1158/0008-5472.CAN-05-0946; BERLIN O, 1993, CANCER RES, V53, P4890; Berx G, 2007, CLIN EXP METASTAS, V24, P587, DOI 10.1007/s10585-007-9114-6; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carriero MV, 2011, CURR DRUG TARGETS, V12, P1761; Choong PFM, 1996, INT J CANCER, V69, P268, DOI 10.1002/(SICI)1097-0215(19960822)69:4<268::AID-IJC5>3.0.CO;2-V; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Dass CR, 2005, CLIN EXP METASTAS, V22, P643, DOI 10.1007/s10585-006-9004-3; De Wever O, 2008, HISTOCHEM CELL BIOL, V130, P481, DOI 10.1007/s00418-008-0464-1; Eden G, 2011, CURR PHARM DESIGN, V17, P1874, DOI 10.2174/138161211796718215; Endo-Munoz L, 2010, CANCER RES, V70, P7063, DOI 10.1158/0008-5472.CAN-09-4291; Ertongur S, 2004, INT J CANCER, V110, P815, DOI 10.1002/ijc.20192; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Fisher JL, 2001, CLIN CANCER RES, V7, P1654; Hackel CG, 2000, CANCER-AM CANCER SOC, V89, P995; Haeckel C, 1999, ARCH PATHOL LAB MED, V123, P213; Hakel C, 1994, Zentralbl Pathol, V140, P363; Hayden JB, 2006, ORTHOP CLIN N AM, V37, P1, DOI 10.1016/j.ocl.2005.06.004; Heinemann V, 2013, BRIT J CANCER, V108, P766, DOI 10.1038/bjc.2013.62; Hildenbrand R, 2010, EXPERT OPIN INV DRUG, V19, P641, DOI 10.1517/13543781003767400; Inder KL, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012245; Jones KB, 2012, CANCER RES, V72, P1865, DOI 10.1158/0008-5472.CAN-11-2663; Kansara M, 2007, DNA CELL BIOL, V26, P1, DOI 10.1089/dna.2006.0505; Killeen S, 2008, DRUG NEWS PERSPECT, V21, P107, DOI 10.1358/dnp.2008.21.2.1188197; Lund IK, 2011, CURR DRUG TARGETS, V12, P1744; Luu HH, 2005, CLIN EXP METASTAS, V22, P319, DOI 10.1007/s10585-005-0365-9; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Marina N, 2004, ONCOLOGIST, V9, P422, DOI 10.1634/theoncologist.9-4-422; McMahon B, 2007, PATHOPHYSIOL HAEMO T, V36, P184, DOI 10.1159/000175156; Mekkawy AH, 2009, FUTURE ONCOL, V5, P1487, DOI 10.2217/FON.09.108; Meyers P A, 1987, Hematol Oncol Clin North Am, V1, P655; Ottaviani G, 2009, CANCER TREAT RES, V152, P3, DOI 10.1007/978-1-4419-0284-9_1; Pant S, 2012, BIOCHEM PHARMACOL, V83, P1484, DOI 10.1016/j.bcp.2011.12.037; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Pillay V, 2007, TRENDS BIOTECHNOL, V25, P33, DOI 10.1016/j.tibtech.2006.10.011; Rabbani S A, 2001, Surg Oncol Clin N Am, V10, P393; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Schmitt M, 2011, EXPERT REV MOL DIAGN, V11, P617, DOI [10.1586/ERM.11.47, 10.1586/erm.11.47]; Setyono-Han B, 2005, THROMB HAEMOSTASIS, V93, P779, DOI 10.1160/TH04-11-0712; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615; WANG Y, 1995, CLIN EXP METASTAS, V13, P196, DOI 10.1007/BF00132208; Wang Y, 2001, MED RES REV, V21, P146, DOI 10.1002/1098-1128(200103)21:2<146::AID-MED1004>3.0.CO;2-B; Zhang HG, 2014, AM J PATHOL, V184, P28, DOI 10.1016/j.ajpath.2013.09.027	50	39	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0133592	10.1371/journal.pone.0133592	http://dx.doi.org/10.1371/journal.pone.0133592			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317203	Green Submitted, Green Published, gold			2022-12-26	WOS:000360299100010
J	in't Holt, AFV; Severin, JA; Goessens, WHF; Witt, RT; Vos, MC				in't Holt, Anne F. Voor; Severin, Juliette A.; Goessens, Wil H. F.; Witt, Rene te; Vos, Margreet C.			Instant Typing Is Essential to Detect Transmission of Extended-Spectrum Beta-Lactamase-Producing Klebsiella Species	PLOS ONE			English	Article							ESCHERICHIA-COLI; PROTEUS-MIRABILIS; EPIDEMIOLOGY; PNEUMONIAE; SURVEILLANCE; STRAINS; INFECTIONS; RESISTANCE; PATIENT; LONG	Background Infections with multidrug-resistant (MDR) microorganisms are an increasing threat to hospitalized patients. Although rapid typing of MDR microorganisms is required to apply targeted prevention measures, technical barriers often prevent this. We aimed to assess whether extended-spectrum beta-lactamase (ESBL)-producing Klebsiella species are transmitted between patients and whether routine, rapid typing is needed. Methods For 43 months, the clonality of all ESBL-producing Klebsiella isolates from patients admitted to Erasmus MC University Medical Center in Rotterdam, the Netherlands was assessed with Raman spectroscopy. A cluster was defined as n >= 2 patients who had identical isolates. Primary patients were the first patients in each cluster. Secondary patients were those identified with an isolate clonally related to the isolate of the primary patient. Results Isolates from 132 patients were analyzed. We identified 17 clusters, with 17 primary and 56 secondary patients. Fifty-nine patients had a unique isolate. Patients (n = 15) in four out of the 17 clusters were epidemiologically related. Ten of these 15 patients developed an infection. Conclusions Clonal outbreaks of ESBL-producing Klebsiella species were detected in our hospital. Theoretically, after Raman spectroscopy had detected a cluster of n >= 2, six infections in secondary patients could have been prevented. These findings demonstrate that spread of ESBL-producing Klebsiella species occurs, even in a non-outbreak setting, and underscore the need for routine rapid typing of these MDR bacteria.	[in't Holt, Anne F. Voor; Severin, Juliette A.; Goessens, Wil H. F.; Witt, Rene te; Vos, Margreet C.] Erasmus MC Univ, Med Ctr, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Vos, MC (corresponding author), Erasmus MC Univ, Med Ctr, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.	m.vos@erasmusmc.nl		Voor in 't holt, Anne/0000-0002-3560-1725	Erasmus MC University Medical Center	Erasmus MC University Medical Center	This work was supported by Erasmus MC University Medical Center funding, 2013, no grant number available. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benenson S, 2013, NEONATOLOGY, V103, P155, DOI 10.1159/000343150; Bertrand X, 2012, CLIN THER, V34, P124, DOI 10.1016/j.clinthera.2011.11.023; Chong Y, 2011, EUR J CLIN MICROBIOL, V30, P83, DOI 10.1007/s10096-010-1057-1; Chong Y, 2013, J MED MICROBIOL, V62, P1038, DOI 10.1099/jmm.0.059279-0; Dautzenberg MJ, 2014, EUROSURVEILLANCE, V19; de Smet AMGA, 2009, NEW ENGL J MED, V360, P20, DOI 10.1056/NEJMoa0800394; DiPersio JR, 2005, DIAGN MICR INFEC DIS, V51, P1, DOI 10.1016/j.diagmicrobio.2004.08.001; Dutch Working Group on Preventing Infections (WIP), 2012, BIJZ RES MICR BRMO; Freeman JT, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-5; Harris AD, 2007, CLIN INFECT DIS, V45, P1347, DOI 10.1086/522657; Hawkey PM, 2009, J ANTIMICROB CHEMOTH, V64, P3, DOI 10.1093/jac/dkp256; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; JARVIS WR, 1985, INFECT CONT HOSP EP, V6, P68, DOI 10.1017/S0195941700062639; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Livermore DM, 2012, KOREAN J INTERN MED, V27, P128, DOI 10.3904/kjim.2012.27.2.128; Maquelin K, 2006, J MICROBIOL METH, V64, P126, DOI 10.1016/j.mimet.2005.04.028; Nakamura T, 2012, AM J CLIN PATHOL, V137, P620, DOI 10.1309/AJCP48PDVKWQOXEZ; Paul M, 2010, ANTIMICROB AGENTS CH, V54, P4851, DOI 10.1128/AAC.00627-10; Potz NAC, 2004, J ANTIMICROB CHEMOTH, V53, P545, DOI 10.1093/jac/dkh112; Severin JA, 2012, TROP MED INT HEALTH, V17, P455, DOI 10.1111/j.1365-3156.2011.02949.x; Shorr AF, 2009, CRIT CARE MED, V37, P1463, DOI 10.1097/CCM.0b013e31819ced02; Souverein D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101212; te Witt R, 2013, J CLIN MICROBIOL, V51, P1434, DOI 10.1128/JCM.02101-12; van der Zee A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-27; Willemse-Erix D, 2012, J CLIN MICROBIOL, V50, P1370, DOI 10.1128/JCM.05423-11; Willemse-Erix DFM, 2009, J CLIN MICROBIOL, V47, P652, DOI 10.1128/JCM.01900-08	26	2	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136135	10.1371/journal.pone.0136135	http://dx.doi.org/10.1371/journal.pone.0136135			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317428	Green Published, Green Submitted, gold			2022-12-26	WOS:000360299100060
J	O'Flaherty, BM; Matar, CG; Wakeman, BS; Garcia, A; Wilke, CA; Courtney, CL; Moore, BB; Speck, SH				O'Flaherty, Brigid M.; Matar, Caline G.; Wakeman, Brian S.; Garcia, AnaPatricia; Wilke, Carol A.; Courtney, Cynthia L.; Moore, Bethany B.; Speck, Samuel H.			CD8(+) T Cell Response to Gammaherpesvirus Infection Mediates Inflammation and Fibrosis in Interferon Gamma Receptor-Deficient Mice	PLOS ONE			English	Article							IDIOPATHIC-PULMONARY-FIBROSIS; BARR-VIRUS DNA; EPITHELIAL-MESENCHYMAL TRANSITION; BRONCHOALVEOLAR LAVAGE FLUID; INDUCED LUNG FIBROSIS; MURINE GAMMAHERPESVIRUS; HERPESVIRUS-INFECTION; NEUTROPHIL ELASTASE; INTERSTITIAL PNEUMONIA; COLLAGEN DEPOSITION	Idiopathic pulmonary fibrosis (IPF), one of the most severe interstitial lung diseases, is a progressive fibrotic disorder of unknown etiology. However, there is growing appreciation for the role of viral infection in disease induction and/or progression. A small animal model of multi-organ fibrosis, which involves murine gammaherpesvirus (MHV68) infection of interferon gamma receptor deficient (IFN gamma R-/-) mice, has been utilized to model the association of gammaherpesvirus infections and lung fibrosis. Notably, several MHV68 mutants which fail to induce fibrosis have been identified. Our current study aimed to better define the role of the unique MHV68 gene, M1, in development of pulmonary fibrosis. We have previously shown that the M1 gene encodes a secreted protein which possesses superantigen-like function to drive the expansion and activation of V beta 4(+) CD8(+) T cells. Here we show that M1-dependent fibrosis is correlated with heightened levels of inflammation in the lung. We observe an M1-dependent cellular infiltrate of innate immune cells with most striking differences at 28 days-post infection. Furthermore, in the absence of M1 protein expression we observed reduced CD8(+) T cells and MHV68 epitope specific CD8(+) T cells to the lungs-despite equivalent levels of viral replication between M1 null and wild type MHV68. Notably, backcrossing the IFN gamma R-/- onto the Balb/c background, which has previously been shown to exhibit weak MHV68-driven V beta 4(+) CD8(+) T cell expansion, eliminated MHV68-induced fibrosis-further implicating the activated V beta 4(+) CD8(+) T cell population in the induction of fibrosis. We further addressed the role that CD8(+) T cells play in the induction of fibrosis by depleting CD8(+) T cells, which protected the mice from fibrotic disease. Taken together these findings are consistent with the hypothesized role of V beta 4(+) CD8(+) T cells as mediators of fibrotic disease in IFN gamma R-/- mice.	[O'Flaherty, Brigid M.; Matar, Caline G.; Wakeman, Brian S.; Speck, Samuel H.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [O'Flaherty, Brigid M.; Matar, Caline G.; Wakeman, Brian S.; Speck, Samuel H.] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Garcia, AnaPatricia; Courtney, Cynthia L.] Emory Univ, Div Pathol, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Wilke, Carol A.; Moore, Bethany B.] Univ Michigan, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA	Emory University; Emory University; Emory University; University of Michigan System; University of Michigan	Speck, SH (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	sspeck@emory.edu	Speck, Samuel/L-5893-2019	Moore, Bethany/0000-0003-3051-745X	NIH grant [R01 AI073830]; author discretionary funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073830, R01AI117229] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); author discretionary funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by an NIH grant (R01 AI073830) and author discretionary funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Besnard AG, 2013, J LEUKOCYTE BIOL, V94, P1317, DOI 10.1189/jlb.0313140; Bringardner BD, 2008, ANTIOXID REDOX SIGN, V10, P287, DOI 10.1089/ars.2007.1897; Christensen PJ, 1999, AM J PATHOL, V155, P1773, DOI 10.1016/S0002-9440(10)65493-4; Clambey ET, 2000, J VIROL, V74, P1973, DOI 10.1128/JVI.74.4.1973-1984.2000; Coppola MA, 1999, J IMMUNOL, V163, P1481; CORSINI E, 1994, AM J RESP CELL MOL, V11, P531, DOI 10.1165/ajrcmb.11.5.7946383; Daniil Z, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-81; Dutia BM, 1997, J VIROL, V71, P4278, DOI 10.1128/JVI.71.6.4278-4283.1997; Ebrahimi B, 2001, AM J PATHOL, V158, P2117, DOI 10.1016/S0002-9440(10)64683-4; Egan JJ, 2011, PULM MED, V2011, DOI 10.1155/2011/240805; Evans AG, 2008, J EXP MED, V205, P669, DOI 10.1084/jem.20071135; Feghali-Bostwick CA, 2007, J IMMUNOL, V179, P2592, DOI 10.4049/jimmunol.179.4.2592; Fireman E, 1998, EUR RESPIR J, V11, P706; Flaherty KR, 2001, AM J MED, V110, P278, DOI 10.1016/S0002-9343(00)00711-7; Flano E, 2004, J IMMUNOL, V172, P3078, DOI 10.4049/jimmunol.172.5.3078; Freeman ML, 2012, J IMMUNOL, V188, P3812, DOI 10.4049/jimmunol.1102787; Freeman ML, 2010, J VIROL, V84, P2881, DOI 10.1128/JVI.02229-09; Gilani SR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008959; Gregory AD, 2015, J LEUKOCYTE BIOL, V98, P143, DOI 10.1189/jlb.3HI1014-493R; Herazo-Maya JD, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005964; HUNNINGHAKE GW, 1981, J CLIN INVEST, V68, P259, DOI 10.1172/JCI110242; Kelly BG, 2002, AM J RESP CRIT CARE, V166, P510, DOI 10.1164/rccm.2103058; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; KRADIN RL, 1986, CLIN IMMUNOL IMMUNOP, V40, P224, DOI 10.1016/0090-1229(86)90025-5; Kropski JA, 2015, AM J RESP CRIT CARE, V191, P417, DOI 10.1164/rccm.201406-1162OC; Kropski JA, 2013, DIS MODEL MECH, V6, P9, DOI 10.1242/dmm.010736; Kropski JA, 2012, AM J PHYSIOL-LUNG C, V302, pL441, DOI 10.1152/ajplung.00335.2011; Krug LT, 2013, J VIROL, V87, P3597, DOI 10.1128/JVI.01953-12; Krug LT, 2010, AM J PATHOL, V177, P608, DOI 10.2353/ajpath.2010.091122; Lake-Bullock MHV, 1999, J LEUKOCYTE BIOL, V65, P187, DOI 10.1002/jlb.65.2.187; Lee KS, 2009, CANCER RES, V69, P5481, DOI 10.1158/0008-5472.CAN-09-0291; Liu LZ, 1999, J VIROL, V73, P9849, DOI 10.1128/JVI.73.12.9849-9857.1999; Luzina IG, 2008, J LEUKOCYTE BIOL, V83, P237, DOI 10.1189/jlb.0707504; Luzina IG, 2006, ARTHRITIS RHEUM-US, V54, P2643, DOI 10.1002/art.21950; Malizia AP, 2008, AM J PHYSIOL-LUNG C, V295, pL451, DOI 10.1152/ajplung.00376.2007; Manika K, 2007, SARCOIDOSIS VASC DIF, V24, P134; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Meltzer EB, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-8; Misharin AV, 2013, AM J RESP CELL MOL, V49, P503, DOI 10.1165/rcmb.2013-0086MA; Molyneaux PL, 2013, EUR RESPIR REV, V22, P376, DOI 10.1183/09059180.00000713; Moore BB, 2001, J IMMUNOL, V167, P4368, DOI 10.4049/jimmunol.167.8.4368; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Moore BB, 2013, AM J RESP CELL MOL, V49, P167, DOI 10.1165/rcmb.2013-0094TR; Mora AL, 2005, AM J PHYSIOL-LUNG C, V289, pL711, DOI 10.1152/ajplung.00007.2005; Mora AL, 2007, AM J RESP CRIT CARE, V175, P1139, DOI 10.1164/rccm.200610-1426OC; Mora AL, 2006, AM J RESP CELL MOL, V35, P466, DOI 10.1165/rcmb.2006-0121OC; Nagai S, 1999, SARCOIDOSIS VASC DIF, V16, P209; Naik Payal K, 2010, Expert Rev Respir Med, V4, P759, DOI 10.1586/ers.10.73; Nuovo GJ, 2012, MODERN PATHOL, V25, P416, DOI 10.1038/modpathol.2011.166; Obayashi Y, 1997, CHEST, V112, P1338, DOI 10.1378/chest.112.5.1338; Okazaki T, 2001, J IMMUNOL, V167, P1977, DOI 10.4049/jimmunol.167.4.1977; Paden CR, 2010, J VIROL, V84, P7214, DOI 10.1128/JVI.00133-10; Papiris SA, 2005, CHEST, V128, P2971, DOI 10.1378/chest.128.4.2971; Papiris Spyros A, 2007, J Inflamm (Lond), V4, P14, DOI 10.1186/1476-9255-4-14; Parra ER, 2007, RESPIRATION, V74, P159, DOI 10.1159/000097133; Pohlers D, 2009, BBA-MOL BASIS DIS, V1792, P746, DOI 10.1016/j.bbadis.2009.06.004; Pozharskaya V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007559; Pozharskaya VP, 2011, PROSPECTIVE LONGITUD; Raghu G, 2012, NEW ENGL J MED, V366, P1968, DOI 10.1056/NEJMoa1113354; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Sides MD, 2011, AM J RESP CELL MOL, V44, P852, DOI 10.1165/rcmb.2009-0232OC; Simas JP, 1998, J GEN VIROL, V79, P149, DOI 10.1099/0022-1317-79-1-149; Song JS, 2009, EXP LUNG RES, V35, P817, DOI 10.3109/01902140902912527; Stevenson PG, 1999, P NATL ACAD SCI USA, V96, P9281, DOI 10.1073/pnas.96.16.9281; Stevenson PG, 1999, EUR J IMMUNOL, V29, P1059, DOI 10.1002/(SICI)1521-4141(199904)29:04<1059::AID-IMMU1059>3.0.CO;2-L; Stevenson PG, 1998, P NATL ACAD SCI USA, V95, P15565, DOI 10.1073/pnas.95.26.15565; Stewart JP, 1999, AM J RESP CRIT CARE, V159, P1336, DOI 10.1164/ajrccm.159.4.9807077; Stoolman JS, 2011, AM J PHYSIOL-LUNG C, V300, pL274, DOI 10.1152/ajplung.00028.2010; Takemasa A, 2012, EUR RESPIR J, V40, P1475, DOI 10.1183/09031936.00127011; Tang YW, 2003, J CLIN MICROBIOL, V41, P2633, DOI 10.1128/JCM.41.6.2633-2640.2003; Tripp RA, 1997, J EXP MED, V185, P1641, DOI 10.1084/jem.185.9.1641; Vannella KM, 2010, AM J RESP CRIT CARE, V181, P465, DOI 10.1164/rccm.200905-0798OC; Wangoo A, 1997, THORAX, V52, P888, DOI 10.1136/thx.52.10.888; Wolters PJ, 2014, ANNU REV PATHOL-MECH, V9, P157, DOI 10.1146/annurev-pathol-012513-104706; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Yamanouchi H, 1998, EUR RESPIR J, V11, P120, DOI 10.1183/09031936.98.11010120; Zamo A, 2005, SARCOIDOSIS VASC DIF, V22, P123	78	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135719	10.1371/journal.pone.0135719	http://dx.doi.org/10.1371/journal.pone.0135719			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317335	Green Published, Green Submitted, gold			2022-12-26	WOS:000360299100043
J	Reckien, D; Flacke, J; Olazabal, M; Heidrich, O				Reckien, Diana; Flacke, Johannes; Olazabal, Marta; Heidrich, Oliver			The Influence of Drivers and Barriers on Urban Adaptation and Mitigation Plans-An Empirical Analysis of European Cities	PLOS ONE			English	Article							CLIMATE-CHANGE ADAPTATION; ADAPTIVE CAPACITY; GLOBAL CLIMATE; CHANGE POLICY; VULNERABILITY; AREAS; INFORMATION; GOVERNANCE; FRAMEWORK; KNOWLEDGE	Cities are recognised as key players in global adaptation and mitigation efforts because the majority of people live in cities. However, in Europe, which is highly urbanized and one of the most advanced regions in terms of environmental policies, there is considerable diversity in the regional distribution, ambition and scope of climate change responses. This paper explores potential factors contributing to such diversity in 200 large and medium-sized cities across 11 European countries. We statistically investigate institutional, socioeconomic, environmental and vulnerability characteristics of cities as potential drivers of or barriers to the development of urban climate change plans. Our results show that factors such as membership of climate networks, population size, GDP per capita and adaptive capacity act as drivers of mitigation and adaptation plans. By contrast, factors such as the unemployment rate, warmer summers, proximity to the coast and projected exposure to future climate impacts act as barriers. We see that, overall, it is predominantly large and prosperous cities that engage in climate planning, while vulnerable cities and those at risk of severe climate impacts in the future are less active. Our analysis suggests that climate change planning in European cities is not proactive, i.e. not significantly influenced by anticipated future impacts. Instead, we found that the current adaptive capacity of a city significantly relates to climate planning. Along with the need to further explore these relations, we see a need for more economic and institutional support for smaller and less resourceful cities and those at high risk from climate change impacts in the future.	[Reckien, Diana] Columbia Univ, Ctr Res Environm Decis, New York, NY 10027 USA; [Flacke, Johannes] Univ Twente, Fac Geoinformat Sci & Earth Observat ITC, NL-7500 AE Enschede, Netherlands; [Olazabal, Marta] Basque Ctr Climate Change BC3, Bilbao, Spain; [Olazabal, Marta] Univ Cambridge, Dept Land Econ, Cambridge, England; [Heidrich, Oliver] Newcastle Univ, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Columbia University; University of Twente; Basque Centre for Climate Change (BC3); University of Cambridge; Newcastle University - UK	Reckien, D (corresponding author), Columbia Univ, Ctr Res Environm Decis, New York, NY 10027 USA.	d.reckien@utwente.nl	Reckien, Diana/P-7348-2015; Olazabal, Marta/AFT-6957-2022; Flacke, Johannes/C-9941-2013; Olazabal, Marta/C-3027-2008	Reckien, Diana/0000-0002-1145-9509; Olazabal, Marta/0000-0002-3381-0654; Flacke, Johannes/0000-0001-8906-7719; Olazabal, Marta/0000-0002-3381-0654; Heidrich, Oliver/0000-0002-6581-5572	European Science Foundation [TU0902]; German Research Foundation [RE 2927/2-1]; Engineering & Physical Sciences Research Council Fellowship [EP/H003630/1]; Engineering and Physical Sciences Research Council [EP/K012398/1, EP/H003630/1] Funding Source: researchfish; EPSRC [EP/K012398/1, EP/H003630/1] Funding Source: UKRI	European Science Foundation(European Science Foundation (ESF)European Commission); German Research Foundation(German Research Foundation (DFG)); Engineering & Physical Sciences Research Council Fellowship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Research undertaken for this paper was conducted as part of the European Science Foundation funded COST Action network Integrated assessment technologies to support the sustainable development of urban areas (TU0902). D.R. was funded by the German Research Foundation (RE 2927/2-1). O.H. was funded through an Engineering & Physical Sciences Research Council Fellowship (EP/H003630/1). The authors thank the city representatives and specifically S. Scharf, J.J.-P. Hamann, H. Orru, M. Salvia, K. Oinonen, S. De Gregorio, F. Pietrapertosa, D. Geneletti, A. M. Foley, V. D'Alonzo, E. Feliu, and S. Reiter for their contributions to data gathering. The authors also thank IRPUD, TU Dortmund, and ESPON Climate-Climate Change and Territorial Effects on Regions and Local Economies in Europe for providing data from the (C) ESPON Database (2011).	Adger WN, 2009, CLIMATIC CHANGE, V93, P335, DOI 10.1007/s10584-008-9520-z; Adu-Boateng A, 2015, CURR OPIN ENV SUST, V13, P49, DOI 10.1016/j.cosust.2015.02.001; Amundsen H, 2010, ENVIRON PLANN C, V28, P276, DOI 10.1068/c0941; [Anonymous], 2004, LOCAL ENVIRON, DOI [DOI 10.1080/1354983042000246252, 10.1080/1354983042000246252]; Archie KM, 2014, J ENVIRON MANAGE, V133, P397, DOI 10.1016/j.jenvman.2013.12.015; Baker I, 2012, LANDSCAPE URBAN PLAN, V107, P127, DOI 10.1016/j.landurbplan.2012.05.009; Betsill MM, 2004, INT STUD QUART, V48, P471, DOI 10.1111/j.0020-8833.2004.00310.x; Bettencourt LMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013541; Biesbroek GR, 2013, REG ENVIRON CHANGE, V13, P1119, DOI 10.1007/s10113-013-0421-y; Brody SD, 2008, LANDSCAPE URBAN PLAN, V87, P33, DOI 10.1016/j.landurbplan.2008.04.003; Broto VC, 2013, GLOBAL ENVIRON CHANG, V23, P92, DOI 10.1016/j.gloenvcha.2012.07.005; Bulkeley H, 2009, URB RES S CIT CLIM C, P1; Caragliu A, 2011, J URBAN TECHNOL, V18, P65, DOI 10.1080/10630732.2011.601117; Corfee-Morlot J, 2011, CLIMATIC CHANGE, V104, P169, DOI 10.1007/s10584-010-9980-9; De Gregorio Hurtado S, 2014, IMPLICATIONS GOVERNA; Decker EH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000934; Dodman D, 2011, CURR OPIN ENV SUST, V3, P121, DOI 10.1016/j.cosust.2010.12.013; EEA, 1998, EUR ENV 2 ASS COP; Engle NL, 2011, GLOBAL ENVIRON CHANG, V21, P647, DOI 10.1016/j.gloenvcha.2011.01.019; Eriksen S, 2008, CLIMATE CHANGE E SO; ESPON & IRPUD TU Dortmund University, 2011, ESPON CLIM CLIM CHAN; Eurostat, 2014, URB AUD STAT DAT 201; Eurostat, 2012, URB AUD DAT COLL 201; Eurostat, 2007, URB AUD REF GUID DAT; Ford JD, 2015, MITIG ADAPT STRAT GL, V20, P505, DOI 10.1007/s11027-013-9505-8; Fussel HM, 2007, GLOBAL ENVIRON CHANG, V17, P155, DOI 10.1016/j.gloenvcha.2006.05.002; Fussel HM, 2006, CLIMATIC CHANGE, V75, P301, DOI 10.1007/s10584-006-0329-3; Garb Y, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/4/045015; Garschagen M, 2015, CLIMATIC CHANGE, V133, P37, DOI 10.1007/s10584-013-0812-6; Girvetz EH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008320; Gonzalez-Eguino M, 2011, ECOL ECON, V70, P2292, DOI 10.1016/j.ecolecon.2011.05.023; Granberg M, 2007, LOCAL ENVIRON, V12, P537, DOI 10.1080/13549830701656911; Grothmann T, 2005, GLOBAL ENVIRON CHANG, V15, P199, DOI 10.1016/j.gloenvcha.2005.01.002; Hardoy J, 2011, CURR OPIN ENV SUST, V3, P158, DOI 10.1016/j.cosust.2011.01.004; Harvey J, 2014, PROC INST CIV ENG-U, V167, P165, DOI 10.1680/udap.14.00001; Heidrich O, 2013, CLIMATIC CHANGE, V120, P771, DOI 10.1007/s10584-013-0846-9; Hinkel J, 2011, GLOBAL ENVIRON CHANG, V21, P198, DOI 10.1016/j.gloenvcha.2010.08.002; Hulme M, 2007, LIMITS BARRIERS ADAP; IPCC, 2014, CLIMATE CHANGE 2014, DOI DOI 10.1017/CBO9781107415379; IPCC, 2014, CLIMATE CHANGE MITIG; Johnson CA, 2013, NAT CLIM CHANGE, V3, P537, DOI 10.1038/nclimate1912; Juhola S, 2015, MITIG ADAPT STRAT GL, V20, P99, DOI 10.1007/s11027-013-9481-z; Klein RJT, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P899; Klinenberg E., 2002, HEAT WAVE SOCIAL AUT; Kousky C, 2003, CLIM POLICY, V3, P359, DOI 10.1016/j.clipol.2003.08.002; Kriegler E, 2012, GLOBAL ENVIRON CHANG, V22, P807, DOI 10.1016/j.gloenvcha.2012.05.005; Lamb WF, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/1/014011; Lankao PR, 2011, CURR OPIN ENV SUST, V3, P142, DOI 10.1016/j.cosust.2010.12.016; Lobo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058407; Lorenzoni I, 2007, GLOBAL ENVIRON CHANG, V17, P445, DOI 10.1016/j.gloenvcha.2007.01.004; Malka A, 2009, RISK ANAL, V29, P633, DOI 10.1111/j.1539-6924.2009.01220.x; Marx SM, 2007, GLOBAL ENVIRON CHANG, V17, P47, DOI 10.1016/j.gloenvcha.2006.10.004; McEvoy D, 2006, P I CIVIL ENG-MUNIC, V159, P185, DOI 10.1680/muen.2006.159.4.185; Milfont TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103180; Millard-Ball A, 2012, J URBAN ECON, V71, P289, DOI 10.1016/j.jue.2011.12.004; Minx J, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/035039; Moser SC, 2010, P NATL ACAD SCI USA, V107, P22026, DOI 10.1073/pnas.1007887107; O'Brien K, 2006, AMBIO, V35, P50, DOI 10.1579/0044-7447(2006)35[50:QCCCIV]2.0.CO;2; OECD, 2004, OECD JRC HDB PRACT D; OECD, 1994, ENV IND OECD COR SET; Olazabal M, 2014, ARE ITALIAN SPANISH; Parson EA, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/4/045016; Patt A, 2010, MAKING CLIMATE CHANG, P369; Posey J, 2009, GLOBAL ENVIRON CHANG, V19, P482, DOI 10.1016/j.gloenvcha.2009.06.003; Pradhan NS, 2012, ROLE POLICY I LOCAL; Preston B, 2007, FRAMING VULNERABILIT; Reckien D, 2014, CLIMATIC CHANGE, V122, P331, DOI 10.1007/s10584-013-0989-8; Reckien D., 2014, UNDERSTANDING CITIES, P45; Reckien D, 2007, URBAN STUD, V44, P339, DOI 10.1080/00420980601136588; Reckien D, 2014, GLOBAL ENVIRON CHANG, V26, P1, DOI 10.1016/j.gloenvcha.2014.03.005; Reckien D, 2013, SUSTAIN SCI, V8, P159, DOI 10.1007/s11625-012-0179-z; Reckien D, 2011, ENVIRON MODEL ASSESS, V16, P465, DOI 10.1007/s10666-011-9254-6; Revi A, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P535; Romero-Lankao P, 2012, GLOBAL ENVIRON CHANG, V22, P670, DOI 10.1016/j.gloenvcha.2012.04.002; Rosenzweig C, 2010, NATURE, V467, P909, DOI 10.1038/467909a; Rutland T, 2008, ENVIRON PLANN D, V26, P627, DOI 10.1068/d6907; Schreurs MA, 2007, GLOBAL ENVIRON POLIT, V7, P19, DOI 10.1162/glep.2007.7.4.19; Seto KC, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P923; Slocum R, 2004, ENVIRON PLANN A, V36, P763, DOI 10.1068/a36139; Slovic P, 2000, PERCEPTION RISK; Spence A, 2011, NAT CLIM CHANGE, V1, P46, DOI [10.1038/NCLIMATE1059, 10.1038/nclimate1059]; Stecker R., 2012, Z UMWELTPOLITIK UMWE, V2, P179; Stone B, 2012, LANDSCAPE URBAN PLAN, V107, P263, DOI 10.1016/j.landurbplan.2012.05.014; Tribbia J, 2008, ENVIRON SCI POLICY, V11, P315, DOI 10.1016/j.envsci.2008.01.003; Turner BL, 2003, P NATL ACAD SCI USA, V100, P8074, DOI 10.1073/pnas.1231335100; Wheeler S, 2008, J AM PLANN ASSOC, V74, P481, DOI 10.1080/01944360802377973	86	80	80	4	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135597	10.1371/journal.pone.0135597	http://dx.doi.org/10.1371/journal.pone.0135597			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317420	Green Published, gold, Green Submitted			2022-12-26	WOS:000360299100036
J	Wear, MP; Kryndushkin, D; O'Meally, R; Sonnenberg, JL; Cole, RN; Shewmaker, FP				Wear, Maggie P.; Kryndushkin, Dmitry; O'Meally, Robert; Sonnenberg, Jason L.; Cole, Robert N.; Shewmaker, Frank P.			Proteins with Intrinsically Disordered Domains Are Preferentially Recruited to Polyglutamine Aggregates	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MUTANT HUNTINGTIN PROTEIN; RNA-BINDING PROTEINS; NEURODEGENERATIVE DISEASE; SACCHAROMYCES-CEREVISIAE; EXPRESSION CHANGES; UNSTRUCTURED PROTEINS; STRESS GRANULES; GENOME DATABASE; ENERGY CONTENT	Intracellular protein aggregation is the hallmark of several neurodegenerative diseases. Aggregates formed by polyglutamine (polyQ)-expanded proteins, such as Huntingtin, adopt amyloid-like structures that are resistant to denaturation. We used a novel purification strategy to isolate aggregates formed by human Huntingtin N-terminal fragments with expanded polyQ tracts from both yeast and mammalian (PC-12) cells. Using mass spectrometry we identified the protein species that are trapped within these polyQ aggregates. We found that proteins with very long intrinsically-disordered (ID) domains (>= 100 amino acids) and RNA-binding proteins were disproportionately recruited into aggregates. The removal of the ID domains from selected proteins was sufficient to eliminate their recruitment into polyQ aggregates. We also observed that several neurodegenerative disease-linked proteins were reproducibly trapped within the polyQ aggregates purified from mammalian cells. Many of these proteins have large ID domains and are found in neuronal inclusions in their respective diseases. Our study indicates that neurodegenerative disease-associated proteins are particularly vulnerable to recruitment into polyQ aggregates via their ID domains. Also, the high frequency of ID domains in RNA- binding proteins may explain why RNA-binding proteins are frequently found in pathological inclusions in various neurodegenerative diseases.	[Wear, Maggie P.; Kryndushkin, Dmitry; Shewmaker, Frank P.] Uniformed Serv Univ Hlth Sci, Dept Pharmacol, Bethesda, MD 20814 USA; [O'Meally, Robert; Cole, Robert N.] Johns Hopkins Univ, Johns Hopkins Mass Spectrometry & Prote Facil, Baltimore, MD 21218 USA; [Sonnenberg, Jason L.] Stevenson Univ, Dept Chem, Sch Sci, Stevenson, MD 21153 USA	Uniformed Services University of the Health Sciences - USA; Johns Hopkins University	Shewmaker, FP (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pharmacol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	fshewmaker@usuhs.edu	Sonnenberg, Jason L./B-3485-2008	Sonnenberg, Jason L./0000-0003-0122-5108; Wear, Maggie/0000-0002-8581-7831	Uniformed Services University New Investigator Award [RO75QF]	Uniformed Services University New Investigator Award	This work was supported by the Uniformed Services University New Investigator Award, Grant # RO75QF.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Basso M, 2006, J BIOL CHEM, V281, P33325, DOI 10.1074/jbc.M603489200; Baxa U, 2008, CURR ALZHEIMER RES, V5, P308, DOI 10.2174/156720508784533367; Bergink S, 2006, NEUROBIOL DIS, V23, P708, DOI 10.1016/j.nbd.2006.06.005; Bonini NM, 2002, P NATL ACAD SCI USA, V99, P16407, DOI 10.1073/pnas.152330499; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chen SM, 2002, BIOCHEMISTRY-US, V41, P7391, DOI 10.1021/bi011772q; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Couthouis J, 2011, P NATL ACAD SCI USA, V108, P20881, DOI 10.1073/pnas.1109434108; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Da Cruz S, 2011, CURR OPIN NEUROBIOL, V21, P904, DOI 10.1016/j.conb.2011.05.029; Daigle JG, 2013, HUM MOL GENET, V22, P1193, DOI 10.1093/hmg/dds526; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Davranche A, 2011, HUM MOL GENET, V20, P2795, DOI 10.1093/hmg/ddr178; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Doi H, 2004, FEBS LETT, V571, P171, DOI 10.1016/j.febslet.2004.06.077; Doi H, 2008, J BIOL CHEM, V283, P6489, DOI 10.1074/jbc.M705306200; Dong JJ, 2010, NAT STRUCT MOL BIOL, V17, P1422, DOI 10.1038/nsmb.1954; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11051, DOI 10.1073/pnas.0604548103; Edskes HK, 2000, P NATL ACAD SCI USA, V97, P6625, DOI 10.1073/pnas.120168697; Edskes HK, 2002, P NATL ACAD SCI USA, V99, P16384, DOI 10.1073/pnas.162349599; Fuentealba RA, 2010, J BIOL CHEM, V285, P26304, DOI 10.1074/jbc.M110.125039; Furukawa Y, 2009, J NEUROSCI, V29, P5153, DOI 10.1523/JNEUROSCI.0783-09.2009; Fushimi K, 2011, PROTEIN CELL, V2, P141, DOI 10.1007/s13238-011-1014-5; Futcher B, 1999, MOL CELL BIOL, V19, P7357; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gourfinkel-An I, 1998, NEUROREPORT, V9, P1823, DOI 10.1097/00001756-199806010-00028; Habchi J, 2014, CHEM REV, V114, P6561, DOI 10.1021/cr400514h; Hands SL, 2010, ACTA NEUROPATHOL, V120, P419, DOI 10.1007/s00401-010-0703-0; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Henshall TL, 2009, HUM MOL GENET, V18, P4830, DOI 10.1093/hmg/ddp455; Hoffner G, 2014, BRAIN SCI, V4, P91, DOI 10.3390/brainsci4010091; Holbert S, 2001, P NATL ACAD SCI USA, V98, P1811, DOI 10.1073/pnas.041566798; Ishiura H, 2012, AM J HUM GENET, V91, P320, DOI 10.1016/j.ajhg.2012.07.014; Ivanyi-Nagy R, 2005, CELL MOL LIFE SCI, V62, P1409, DOI 10.1007/s00018-005-5100-9; Jacobsen JC, 2011, HUM MOL GENET, V20, P2846, DOI 10.1093/hmg/ddr195; Jana NR, 2000, HUM MOL GENET, V9, P2009, DOI 10.1093/hmg/9.13.2009; Johnson JO, 2014, NAT NEUROSCI, V17, P664, DOI 10.1038/nn.3688; Ju SL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001052; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Karlin S, 2002, P NATL ACAD SCI USA, V99, P333, DOI 10.1073/pnas.012608599; Kawamoto Y, 2005, ACTA NEUROPATHOL, V110, P203, DOI 10.1007/s00401-005-1039-z; Kiktev DA, 2012, MOL CELL BIOL, V32, P4960, DOI 10.1128/MCB.00875-12; Kim WY, 2005, MOL CELL NEUROSCI, V29, P536, DOI 10.1016/j.mcn.2005.04.005; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Kryndushkin D, 2011, PROTEIN CELL; Kryndushkin D, 2013, PRION, V7, P464, DOI 10.4161/pri.27503; Kryndushkin D, 2013, J BIOL CHEM, V288, P27100, DOI 10.1074/jbc.M113.485359; Kryndushkin D, 2011, PROTEIN CELL, V2, P223, DOI 10.1007/s13238-011-1525-0; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Kuusisto E, 2001, NEUROREPORT, V12, P2085, DOI 10.1097/00001756-200107200-00009; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Laulederkind SJF, 2013, BRIEF BIOINFORM, V14, P520, DOI 10.1093/bib/bbt007; Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; MacPhee CE, 2000, J MOL BIOL, V297, P1203, DOI 10.1006/jmbi.2000.3600; Margittai M, 2008, Q REV BIOPHYS, V41, P265, DOI 10.1017/S0033583508004733; Martindale D, 1998, NAT GENET, V18, P150, DOI 10.1038/ng0298-150; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Mitsui K, 2006, METHOD ENZYMOL, V412, P63, DOI 10.1016/S0076-6879(06)12005-4; Mizuno Y, 2006, J NEUROL SCI, V249, P13, DOI 10.1016/j.jns.2006.05.060; Mori K, 2013, ACTA NEUROPATHOL, V125, P413, DOI 10.1007/s00401-013-1088-7; Nelson DL, 2013, NEURON, V77, P825, DOI 10.1016/j.neuron.2013.02.022; Newman JR, 2006, NATURE, V441; Niikura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101080; Novoselova TV, 2005, J NEUROCHEM, V94, P597, DOI 10.1111/j.1471-4159.2005.03119.x; O'Rourke JG, 2013, CELL REP, V4, P362, DOI 10.1016/j.celrep.2013.06.034; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038; Ramirez A, 2014, HUM MOL GENET, V23, P6644, DOI 10.1093/hmg/ddu372; Ratovitski T, 2012, CELL CYCLE, V11, P2006, DOI 10.4161/cc.20423; Raychaudhuri S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005566; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Rubinsztein David C, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S1462399403006549; Rutherford NJ, 2013, BRAIN RES, V1524, P62, DOI 10.1016/j.brainres.2013.06.006; Sakahira H, 2002, P NATL ACAD SCI USA, V99, P16412, DOI 10.1073/pnas.182426899; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schwartz R, 2001, GENOME RES, V11, P703, DOI 10.1101/gr.GR-1587R; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shelkovnikova TA, 2014, HUM MOL GENET, V23, P2298, DOI 10.1093/hmg/ddt622; Shewmaker F, 2011, J BIOL CHEM, V286, P16533, DOI 10.1074/jbc.R111.227108; Shewmaker F, 2009, BIOCHEMISTRY-US, V48, P5074, DOI 10.1021/bi900345q; Shi BX, 2014, INT J MOL SCI, V15, P22918, DOI 10.3390/ijms151222918; Sieradzan KA, 1999, EXP NEUROL, V156, P92, DOI 10.1006/exnr.1998.7005; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Sun ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000614; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Tompa P, 2004, FASEB J, V18, P1169, DOI 10.1096/fj.04-1584rev; Tompa P, 2009, BIOESSAYS, V31, P328, DOI 10.1002/bies.200800151; Tourette C, 2014, J BIOL CHEM, V289, P6709, DOI 10.1074/jbc.M113.523696; Tycko R, 2011, ANNU REV PHYS CHEM, V62, P279, DOI 10.1146/annurev-physchem-032210-103539; Uversky VN, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00018; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Vendruscolo M, 2014, COLD SPRING HARBOR P, V3; Vucetic S, 2007, J PROTEOME RES, V6, P1899, DOI 10.1021/pr060393m; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Wang GH, 2000, HUM MOL GENET, V9, P1795, DOI 10.1093/hmg/9.12.1795; Wang Y, 2007, PRION, V1, P128, DOI 10.4161/pri.1.2.4440; Wang Y, 2009, FASEB J, V23, P451, DOI 10.1096/fj.08-117614; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Wiederhold E, 2010, MOL CELL PROTEOMICS, V9, P431, DOI 10.1074/mcp.R900002-MCP200; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wyttenbach A, 2001, HUM MOL GENET, V10, P1829, DOI 10.1093/hmg/10.17.1829; Yamanaka T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093891; Yang H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06410; Yao J, 2014, MOL CELL NEUROSCI, V63, P96, DOI 10.1016/j.mcn.2014.10.003; Zainelli GM, 2005, J NEUROPATH EXP NEUR, V64, P58, DOI 10.1093/jnen/64.1.58; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Zhou L., 2014, J BUS RES, V1, P1, DOI DOI 10.1007/S12035-014-8908-1; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	125	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136362	10.1371/journal.pone.0136362	http://dx.doi.org/10.1371/journal.pone.0136362			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317359	Green Submitted, Green Published, gold			2022-12-26	WOS:000360299100075
J	Zhang, L; Li, M; Wu, N; Chen, YH				Zhang, Li; Li, Meng; Wu, Ning; Chen, Yuheng			Time Trends in Epidemiologic Characteristics and Imaging Features of Lung Adenocarcinoma: A Population Study of 21,113 Cases in China	PLOS ONE			English	Article							SUBSOLID PULMONARY NODULES; IASLC/ATS/ERS CLASSIFICATION; AIR-POLLUTION; CANCER; TOBACCO; WOMEN; NITROSAMINES; ASSOCIATION; CARCINOGENS; MORTALITY	Objectives This study aims to describe time trends of epidemiologic characteristics and imaging features over 14 years among histologically confirmed lung adenocarcinoma (ADC) in China and to discuss the possible reasons for these changes. Materials and Methods Data of 21,113 pathologically confirmed lung cancer patients from January 1999 to December 2012 were analyzed retrospectively. Preoperative high-resolution computer tomography (HRCT) images were available and reviewed in 5,439 lung ADC patients since 2005. Time trends of the ADC proportion of lung cancer cases, gender distribution, age at diagnosis, the proportion of early-stage ADC and imaging features were investigated. Results The proportion of ADC increased during the 14 years (P = 0.000). The ratio of female to male ADC cases was higher than both squamous cell carcinoma (SQCC) and total lung cancer cases (P = 0.000). The median age at diagnosis of ADC patients was younger than that of both SQCC and total lung cancer during the 14 years (P = 0.000). The proportion of age group 45-59 years increased in total lung cancer cases (P = 0.000). When stratified by lung cancer histopathologic subtypes, this trend was also observed in ADC (P = 0.001) and SQCC (P = 0.007). The proportion of early-stage cases of ADC increased from 2008 to 2012 (P < 0.001). The proportion of subsolid nodules (SSN) in ADC increased (P = 0.001) from 2005 to 2012. Conclusion The data suggests that the proportion of ADC increased from 1999 to 2012 especially in middle-aged, female patients; early-stage ADC and SSN on HRCT images gradually increased, which may have been caused by a change in smoking habits and increased application of HRCT.	[Zhang, Li; Li, Meng; Wu, Ning] Chinese Acad Med Sci, Peking Union Med Coll, Canc Hosp, Dept Diagnost Radiol, Beijing 100730, Peoples R China; [Wu, Ning] Chinese Acad Med Sci, Peking Union Med Coll, Canc Hosp, PET CT Ctr, Beijing 100730, Peoples R China; [Chen, Yuheng] Chinese Acad Med Sci, Peking Union Med Coll, Canc Hosp, Canc Fdn China, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College	Wu, N (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Canc Hosp, Dept Diagnost Radiol, Beijing 100730, Peoples R China.	cjr.wuning@vip.163.com	meng, li/GVT-2063-2022					Agudo A, 2000, INT J CANCER, V88, P820, DOI 10.1002/1097-0215(20001201)88:5&lt;820::AID-IJC21&gt;3.0.CO;2-J; ALAVANJA MCR, 1992, AM J EPIDEMIOL, V136, P623, DOI 10.1093/oxfordjournals.aje.a116542; Burns DM, 2011, CANCER CAUSE CONTROL, V22, P13, DOI 10.1007/s10552-010-9660-0; Carter D, 2007, LUNG CANCER, V56, P193, DOI 10.1016/j.lungcan.2006.12.001; Charloux A, 1997, INT J EPIDEMIOL, V26, P14, DOI 10.1093/ije/26.1.14; Chen WQ, 2013, CHINESE J CANCER RES, V25, P10, DOI 10.3978/j.issn.1000-9604.2012.12.04; Chen YC, 2004, CANCER-AM CANCER SOC, V101, P1428, DOI 10.1002/cncr.20538; Chiou HL, 2003, CANCER, V97, P1558, DOI 10.1002/cncr.11191; Church TR, 2013, NEW ENGL J MED, V368, P1980, DOI 10.1056/NEJMoa1209120; Clement-Duchene C, 2010, LUNG CANCER, V67, P144, DOI 10.1016/j.lungcan.2009.04.005; DAVIS BR, 1975, BRIT J CANCER, V31, P469, DOI 10.1038/bjc.1975.87; De Stefani E, 2002, LUNG CANCER-J IASLC, V35, P43, DOI 10.1016/S0169-5002(01)00281-1; Felix L, 2011, EUR J RADIOL, V77, P410, DOI 10.1016/j.ejrad.2009.09.008; Godoy MCB, 2009, RADIOLOGY, V253, P606, DOI 10.1148/radiol.2533090179; Gu J, 2013, J SURG ONCOL, V107, P474, DOI 10.1002/jso.23259; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; He J., 2012, CHINESE CANCER REGIS; HECHT SS, 1988, CARCINOGENESIS, V9, P875, DOI 10.1093/carcin/9.6.875; Henschke CI, 2002, AM J ROENTGENOL, V178, P1053, DOI 10.2214/ajr.178.5.1781053; Henschke CI, 2006, JAMA-J AM MED ASSOC, V296, P180; HOFFMANN D, 1994, J TOXICOL ENV HEALTH, V41, P1, DOI 10.1080/15287399409531825; IARC, 2008, CANC INCIDENCE 5 CON, VIX, P1; Jia X, 2001, Zhonghua Bing Li Xue Za Zhi, V30, P332; Jiang XH, 2012, LUNG CANCER, V78, P16, DOI 10.1016/j.lungcan.2012.06.002; Keith C. H., 1960, J COLL SCI IMP U TOK, V15, P340; Matsuguma H, 2013, CHEST, V143, P436, DOI 10.1378/chest.11-3306; Metayer C, 2002, LUNG CANCER, V35, P111, DOI 10.1016/S0169-5002(01)00412-3; National Cancer Institute, THE SEER CANCER STAT, P28; Okazaki I, 2014, ANTICANCER RES, V34, P5229; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; POPE CA, 1995, AM J RESP CRIT CARE, V151, P669, DOI 10.1164/ajrccm/151.3_Pt_1.669; Rachtan J, 2002, LUNG CANCER-J IASLC, V35, P129, DOI 10.1016/S0169-5002(01)00330-0; Ringer G, 2005, CLIN LUNG CANCER, V7, P180, DOI 10.3816/CLC.2005.n.033; She J, 2013, CHEST, V143, P1117, DOI 10.1378/chest.11-2948; Shen L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096911; The New Age Group Classification of Human Being, 2005, MODERN HEALTH, V9, P16; Toyoda Y, 2008, JPN J CLIN ONCOL, V38, P534, DOI 10.1093/jjco/hyn072; Travis WD, 2004, CLASSIFICATION OF TU; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; [王冬梅 Wang Dongmei], 2010, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V10, P1446; Woo T, 2012, PATHOL INT, V62, P785, DOI 10.1111/pin.12016; Yang Gong-huan, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P77; Yoshizawa A, 2013, J THORAC ONCOL, V8, P52, DOI 10.1097/JTO.0b013e3182769aa8; ZHENG TZ, 1994, CANCER, V74, P1556, DOI 10.1002/1097-0142(19940901)74:5<1556::AID-CNCR2820740511>3.0.CO;2-0; Zhou BS, 2000, ONCOL REP, V7, P1253	45	17	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136727	10.1371/journal.pone.0136727	http://dx.doi.org/10.1371/journal.pone.0136727			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317971	gold, Green Published, Green Submitted			2022-12-26	WOS:000360299100129
J	Hassegawa, M; Havreljuk, F; Ouimet, R; Auty, D; Pothier, D; Achim, A				Hassegawa, Mariana; Havreljuk, Filip; Ouimet, Rock; Auty, David; Pothier, David; Achim, Alexis			Large-Scale Variations in Lumber Value Recovery of Yellow Birch and Sugar Maple in Quebec, Canada	PLOS ONE			English	Article							HAUT-SAINT-LAURENT; DIAMETER-LIMIT; WOOD QUALITY; STRUCTURAL DIVERSITY; REGRESSION TREES; HARDWOOD FORESTS; NEW-BRUNSWICK; BASAL AREA; OLD-GROWTH; SOIL	Silvicultural restoration measures have been implemented in the northern hardwoods forests of southern Quebec, Canada, but their financial applicability is often hampered by the depleted state of the resource. To help identify sites most suited for the production of high quality timber, where the potential return on silvicultural investments should be the highest, this study assessed the impact of stand and site characteristics on timber quality in sugar maple (Acer saccharum Marsh.) and yellow birch (Betula alleghaniensis Britt.). For this purpose, lumber value recovery (LVR), an estimate of the summed value of boards contained in a unit volume of round wood, was used as an indicator of timber quality. Predictions of LVR were made for yellow birch and sugar maple trees contained in a network of more than 22000 temporary sample plots across the Province. Next, stand-level variables were selected and models to predict LVR were built using the boosted regression trees method. Finally, the occurrence of spatial clusters was verified by a hotspot analysis. Results showed that in both species LVR was positively correlated with the stand age and structural diversity index, and negatively correlated with the number of merchantable stems. Yellow birch had higher LVR in areas with shallower soils, whereas sugar maple had higher LVR in regions with deeper soils. The hotspot analysis indicated that clusters of high and low LVR exist across the province for both species. Although it remains uncertain to what extent the variability of LVR may result from variations in past management practices or in inherent site quality, we argue that efforts to produce high quality timber should be prioritized in sites where LVR is predicted to be the highest.	[Hassegawa, Mariana; Auty, David; Pothier, David; Achim, Alexis] Univ Laval, Dept Wood & Forest Sci, Quebec City, PQ, Canada; [Havreljuk, Filip; Ouimet, Rock] Minist Forests Wildlife & Pk, Forest Res Div, Quebec City, PQ, Canada	Laval University	Hassegawa, M (corresponding author), Univ Laval, Dept Wood & Forest Sci, Quebec City, PQ, Canada.	mariana.hassegawa.1@ulaval.ca	Ouimet/AAF-1773-2020	Ouimet, Rock/0000-0003-1282-2493; Hassegawa, Mariana/0000-0002-2215-9093; Achim, Alexis/0000-0003-0118-1651; Havreljuk, Filip/0000-0003-1436-8730; Pothier, David/0000-0001-6259-0470	Fonds de recherche du Quebec - Nature et Technologie [2010-FT-134070]	Fonds de recherche du Quebec - Nature et Technologie	Funding for this study was provided by the Fonds de recherche du Quebec - Nature et Technologie (http://www.frqnt.gouv.qc.ca/), grant number 2010-FT-134070. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeare S, 2009, COMP BOOSTED REGRESS; Alqadi KA, 2014, ENVIRON EARTH SCI, V71, P2309, DOI 10.1007/s12665-013-2632-4; Amoroso MM, 2006, CAN J FOREST RES, V36, P1484, DOI 10.1139/X06-042; [Anonymous], 2014, R LANG ENV STAT COMP; Auty D, 2014, CAN J FOREST RES, V44, P638, DOI 10.1139/cjfr-2013-0500; Barrette J, 2012, ANN FOREST SCI, V69, P603, DOI 10.1007/s13595-011-0178-8; Bedard S., 2002, EFFETS REELS COUPES; Berger J. P, 2008, NORME STRATIFICATION; Berger J-P, 2004, QUEBEC GUIDE RECONNA; Boulet B., 2007, DEFAUTS INDICES CARI; Briggs D.G., 1986, DOUGLAS FIR STAND MA, P108; Briggs D, 2010, J FOREST, V108, P174; BRISSON J, 1988, CAN J BOT, V66, P1192, DOI 10.1139/b88-170; Carslaw DC, 2009, ATMOS ENVIRON, V43, P3563, DOI 10.1016/j.atmosenv.2009.04.001; Carty DM, 2011, ANAL BOOSTED REGRESS; Clement C, 2005, FOREST PROD J, V55, P71; Cockwell M, 2014, FOREST PROD J, V64, P250, DOI 10.13073/FPJ-D-14-00026; Cogliastro A, 1997, FOREST ECOL MANAG, V96, P49, DOI 10.1016/S0378-1127(97)00042-X; de Langre E, 2008, ANNU REV FLUID MECH, V40, P141, DOI 10.1146/annurev.fluid.40.111406.102135; Delisle-Boulianne S, 2014, FORESTRY, V87, P607, DOI 10.1093/forestry/cpu034; Deluca T, 2009, NORTH J APPL FOR, V26, P52, DOI 10.1093/njaf/26.2.52; Driscoll CT, 2001, BIOSCIENCE, V51, P180, DOI 10.1641/0006-3568(2001)051[0180:ADITNU]2.0.CO;2; Duarte N, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-012-1355-6; Duchesne L, 2005, FOREST ECOL MANAG, V208, P223, DOI 10.1016/j.foreco.2004.12.003; Duchesne L, 2002, J ENVIRON QUAL, V31, P1676, DOI 10.2134/jeq2002.1676; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; ESRI, 2012, ARCGIS REL 10 1; Fortin M, 2009, CAN J FOREST RES, V39, P1928, DOI 10.1139/X09-108; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Friedman JH, 2003, STAT MED, V22, P1365, DOI 10.1002/sim.1501; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Gagne LV, 2013, FORESTS, V4, P766, DOI 10.3390/f4040766; GAUTHIER S, 1990, CAN J BOT, V68, P391, DOI 10.1139/b90-051; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Giguere M., 1998, GUIDE SCIAGE BILLONS; Goldblum D, 2005, CAN J FOREST RES, V35, P2709, DOI 10.1139/X05-185; Goldstein H, 1995, MULTILEVEL STAT MODE, V2nd; Goodburn JM, 1998, CAN J FOREST RES, V28, P427, DOI 10.1139/cjfr-28-3-427; GRACE J, 1988, AGR ECOSYST ENVIRON, V22-3, P71, DOI 10.1016/0167-8809(88)90008-4; Grondin P, 2007, ATLAS UNITES HOMOGEN, P138; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hanks L.F., 1976, NE333 USDA FOR SERV; Havreljuk F, 2014, CAN J FOREST RES, V44, P750, DOI 10.1139/cjfr-2013-0407; Havreljuk F, 2013, CAN J FOREST RES, V43, P278, DOI 10.1139/cjfr-2012-0479; Hijmans R.J., DISMO SPECIES DISTRI; HMR, 2012, HARDW MARK REP LUMB; Hoad SP, 1998, TREES-STRUCT FUNCT, V13, P1; JAFFE MJ, 1973, PLANTA, V114, P143, DOI 10.1007/BF00387472; Jiang ZH, 2007, ANN FOREST SCI, V64, P807, DOI 10.1051/forest:2007063; Kenefic LS, 2005, NORTH J APPL FOR, V22, P77, DOI 10.1093/njaf/22.2.77; Lei XD, 2009, CAN J FOREST RES, V39, P1835, DOI 10.1139/X09-089; Lenz P, 2014, CAN J FOREST RES, V44, P1383, DOI 10.1139/cjfr-2014-0206; Luyssaert S, 2008, NATURE, V455, P213, DOI 10.1038/nature07276; Macdonald E, 2002, FORESTRY, V75, P107, DOI 10.1093/forestry/75.2.107; Makinen H, 2007, FOREST ECOL MANAG, V241, P175, DOI 10.1016/j.foreco.2007.01.017; McCauley OD, 1969, NE149 USDA FOR SERV; MEILLEUR A, 1994, VEGETATIO, V111, P173, DOI 10.1007/BF00040336; Moisen GG, 2006, ECOL MODEL, V199, P176, DOI 10.1016/j.ecolmodel.2006.05.021; Monger R., 1989, CLASSIFICATION TIGES; Moore JD, 2008, FOREST ECOL MANAG, V255, P3460, DOI 10.1016/j.foreco.2008.02.026; Moore JR, 2009, SILVA FENN, V43, P383, DOI 10.14214/sf.195; NHLA, 2011, RUL MEAS INSP HARDW; Nicoll BC, 1996, TREE PHYSIOL, V16, P891; Nyland RD, 2005, NORTH J APPL FOR, V22, P111, DOI 10.1093/njaf/22.2.111; NYLAND RD, 1992, J FOREST, V90, P33; Ouimet R, 2009, 134 MIN RESS NAT FAU; Ouimet R., 2001, WATER AIR SOIL POLL, V1, P119, DOI DOI 10.1023/A:1011544325004; Ouimet R, 2008, J PLANT NUTR SOIL SC, V171, P858, DOI 10.1002/jpln.200700197; Paquette A, 2011, GLOBAL ECOL BIOGEOGR, V20, P170, DOI 10.1111/j.1466-8238.2010.00592.x; Petro FJ, 1976, GRADE HARDWOOD LOGS; Pokharel B, 2014, CAN J FOREST RES, V44, P465, DOI 10.1139/cjfr-2013-0252; Pothier D, 2013, CAN J FOREST RES, V43, P288, DOI 10.1139/cjfr-2012-0402; Pretzsch H, 2005, ECOL STUD-ANAL SYNTH, V176, P41; Pretzsch H., 2005, FOREST DIVERSITY FUN; Regniere J., 2014, LAUX137E CAN FOR SER; Ridgeway G., 2015, GBM GEN BOOSTED REGR; Robitaille L., 1981, Revue Forestiere Francaise, V33, P105; Rogers R., 1990, SILVICS N AM, V2; Russell-Roy ET, 2014, CAN J FOREST RES, V44, P614, DOI 10.1139/cjfr-2013-0437; Ryan MG, 1997, BIOSCIENCE, V47, P235, DOI 10.2307/1313077; SAKAI A, 1970, ECOLOGY, V51, P657, DOI 10.2307/1934045; Saucier J-P, 2006, C E CANUSA E CANUSA; Schneider R., 2013, MEMOIRE RECHERCHE FO; Sendak PE, 1982, LUMBER VALUE LOSS AS; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Sillett SC, 2010, FOREST ECOL MANAG, V259, P976, DOI 10.1016/j.foreco.2009.12.003; Steele P. H, 1984, FPL39 USDA FOR SERV; Sutton CD, 2005, HANDB STAT, V24, P303, DOI 10.1016/S0169-7161(04)24011-1; Tranquillini W., 1979, PHYSL ECOLOGY ALPINE, VVolume 31; Vaughan CL, 1966, HARDWOOD LOG GRADES; Wang WF, 2011, FOREST SCI, V57, P506	92	3	3	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136674	10.1371/journal.pone.0136674	http://dx.doi.org/10.1371/journal.pone.0136674			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313689	Green Published, gold, Green Submitted			2022-12-26	WOS:000360144000086
J	Hernandez-Corbacho, MJ; Canals, D; Adada, MM; Liu, ML; Senkal, CE; Yi, JK; Mao, CG; Luberto, C; Hannun, YA; Obeid, LM				Hernandez-Corbacho, Maria Jose; Canals, Daniel; Adada, Mohamad M.; Liu, Mengling; Senkal, Can E.; Yi, Jae Kyo; Mao, Cungui; Luberto, Chiara; Hannun, Yusuf A.; Obeid, Lina M.			Tumor Necrosis Factor-alpha (TNF alpha)-induced Ceramide Generation via Ceramide Synthases Regulates Loss of Focal Adhesion Kinase (FAK) and Programmed Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONGEVITY ASSURANCE GENE-1; SMALL-MOLECULE INHIBITOR; ACID BETA-GLUCOSIDASE; HUMAN BREAST-CANCER; INDUCED APOPTOSIS; NEUTRAL SPHINGOMYELINASE; SECONDARY NECROSIS; SPHINGOLIPID METABOLISM; PANCREATIC-CANCER; MASS-SPECTROMETRY	Ceramide synthases (CerS1-CerS6), which catalyze the N-acylation of the (dihydro) sphingosine backbone to produce (dihydro) ceramide in both the de novo and the salvage or recycling pathway of ceramide generation, have been implicated in the control of programmed cell death. However, the regulation of the de novo pathway compared with the salvage pathway is not fully understood. In the current study, we have found that late accumulation of multiple ceramide and dihydroceramide species in MCF-7 cells treated with TNF alpha occurred by up-regulation of both pathways of ceramide synthesis. Nevertheless, fumonisin B1 but not myriocin was able to protect from TNF alpha induced cell death, suggesting that ceramide synthase activity is crucial for the progression of cell death and that the pool of ceramide involved derives from the salvage pathway rather than de novo biosynthesis. Furthermore, compared with control cells, TNF alpha-treated cells exhibited reduced focal adhesion kinase and subsequent plasma membrane permeabilization, which was blocked exclusively by fumonisin B1. In addition, exogenously added C6-ceramide mimicked the effects of TNF alpha that lead to cell death, which were inhibited by fumonisin B1. Knockdown of individual ceramide synthases identified CerS6 and its product C16-ceramide as the ceramide synthase isoform essential for the regulation of cell death. In summary, our data suggest a novel role for CerS6/C16-ceramide as an upstream effector of the loss of focal adhesion protein and plasma membrane permeabilization, via the activation of caspase-7, and identify the salvage pathway as the critical mechanism of ceramide generation that controls cell death.	[Hernandez-Corbacho, Maria Jose; Canals, Daniel; Adada, Mohamad M.; Liu, Mengling; Senkal, Can E.; Yi, Jae Kyo; Mao, Cungui; Luberto, Chiara; Hannun, Yusuf A.; Obeid, Lina M.] SUNY Stony Brook, Hlth Sci Ctr, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA; [Hernandez-Corbacho, Maria Jose; Canals, Daniel; Adada, Mohamad M.; Liu, Mengling; Senkal, Can E.; Yi, Jae Kyo; Mao, Cungui; Hannun, Yusuf A.; Obeid, Lina M.] SUNY Stony Brook, Hlth Sci Ctr, Dept Med, Stony Brook, NY 11794 USA; [Luberto, Chiara] SUNY Stony Brook, Hlth Sci Ctr, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; [Obeid, Lina M.] Northport Vet Affairs Med Ctr, Northport, NY 11768 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Obeid, LM (corresponding author), SUNY Stony Brook, Hlth Sci Ctr, Dept Med, L-4 179, Stony Brook, NY 11794 USA.	lina.obeid@stonybrookmedicine.edu	Canals, Daniel/AAW-1998-2021; Canals, Daniel/AAJ-8176-2021	Canals, Daniel/0000-0002-9293-5123; Liu, Mengling/0000-0003-1309-0087; Adada, Mohamad/0000-0002-2988-2081; Yi, Jae Kyo/0000-0001-7053-601X	National Institutes of Health Grants [GM097741, PO1CA097132]; Veterans Affairs Merit Award; NATIONAL CANCER INSTITUTE [R01CA163825, P01CA097132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097741] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000156] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants GM097741 and PO1CA097132 (to L. M. O.). This work was also supported by a Veterans Affairs Merit Award. The authors declare that they have no conflicts of interest with the contents of this article.	Beierle EA, 2010, CELL CYCLE, V9, P1005, DOI 10.4161/cc.9.5.10936; Beviglia L, 2003, BIOCHEM J, V373, P201, DOI 10.1042/BJ20021846; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; Cance WG, 2000, CLIN CANCER RES, V6, P2417; Chang HY, 2000, MICROBIOL MOL BIOL R, V64, P821, DOI 10.1128/MMBR.64.4.821-846.2000; Ciccimaro E, 2006, RAPID COMMUN MASS SP, V20, P3681, DOI 10.1002/rcm.2783; Cohen-Jonathan E, 1999, CURR OPIN CHEM BIOL, V3, P77, DOI 10.1016/S1367-5931(99)80014-3; Dbaibo GS, 2001, FEBS LETT, V503, P7, DOI 10.1016/S0014-5793(01)02625-4; Dbaibo GS, 1997, J EXP MED, V185, P481, DOI 10.1084/jem.185.3.481; Di Bartolomeo S, 2002, NEUROSCI LETT, V334, P149, DOI 10.1016/S0304-3940(02)01074-1; DINUR T, 1986, P NATL ACAD SCI USA, V83, P1660, DOI 10.1073/pnas.83.6.1660; Dunn KB, 2010, ANTI-CANCER AGENT ME, V10, P722; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Enongene EN, 2002, TOXICOL SCI, V67, P173, DOI 10.1093/toxsci/67.2.173; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Fulda S, 2009, INT J CANCER, V124, P511, DOI 10.1002/ijc.24064; Gervais FG, 1998, J BIOL CHEM, V273, P17102, DOI 10.1074/jbc.273.27.17102; Golubovskaya V, 2015, ARCH TOXICOL, V89, P1095, DOI 10.1007/s00204-014-1290-y; Golubovskaya VM, 2014, FRONT BIOSCI-LANDMRK, V19, P687, DOI 10.2741/4236; Golubovskaya VM, 2013, MOL CANCER THER, V12, P162, DOI 10.1158/1535-7163.MCT-12-0701; Golubovskaya VM, 2009, INT J CANCER, V125, P1735, DOI 10.1002/ijc.24486; Golubovskaya VM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-280; Golubovskaya VM, 2003, MOL CANCER RES, V1, P755; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Guan JL, 1997, MATRIX BIOL, V16, P195, DOI 10.1016/S0945-053X(97)90008-1; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Hao HF, 2009, ONCOL REP, V22, P973, DOI 10.3892/or_00000524; Heffler M, 2013, ANTI-CANCER AGENT ME, V13, P584, DOI 10.2174/1871520611313040008; Herr I, 2001, BLOOD, V98, P2603, DOI 10.1182/blood.V98.9.2603; Hochwald SN, 2009, CELL CYCLE, V8, P2435, DOI 10.4161/cc.8.15.9145; Hoeferlin LA, 2013, J BIOL CHEM, V288, P12880, DOI 10.1074/jbc.M113.461798; JAYADEV S, 1994, J BIOL CHEM, V269, P5757; Jin JF, 2009, J LIPID RES, V50, P2389, DOI 10.1194/jlr.M900119-JLR200; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim WJ, 2008, BLOOD, V111, P4716, DOI 10.1182/blood-2007-10-113068; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Kitatani K, 2009, J BIOL CHEM, V284, P12979, DOI 10.1074/jbc.M809500200; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; Laouar A, 1999, J BIOL CHEM, V274, P23526, DOI 10.1074/jbc.274.33.23526; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Lee H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019783; Levkau B, 1998, J EXP MED, V187, P579, DOI 10.1084/jem.187.4.579; Luberto C, 2002, J BIOL CHEM, V277, P41128, DOI 10.1074/jbc.M206747200; Marushige Y, 1998, ANTICANCER RES, V18, P301; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mullen TD, 2012, ANTI-CANCER AGENT ME, V12, P340, DOI 10.2174/187152012800228661; Mullen TD, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230870; Mullen TD, 2011, J LIPID RES, V52, P68, DOI 10.1194/jlr.M009142; Neumeyer J, 2006, EXP CELL RES, V312, P2142, DOI 10.1016/j.yexcr.2006.03.014; Novgorodov SA, 2005, J BIOL CHEM, V280, P16096, DOI 10.1074/jbc.M411707200; O'Brien S, 2014, ONCOTARGET, V5, P7945, DOI 10.18632/oncotarget.2381; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Ogretmen B, 2002, J BIOL CHEM, V277, P12960, DOI 10.1074/jbc.M110699200; Oktay MH, 2003, HUM PATHOL, V34, P240, DOI 10.1053/hupa.2003.40; Oropesa-Avila M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.58; Oropesa-Avila M, 2014, APOPTOSIS, V19, P1364, DOI 10.1007/s10495-014-1015-y; Ozoren N., 2003, SEMIN CANC BIOL, V13, P135; Panjarian S, 2008, PROSTAG OTH LIPID M, V86, P41, DOI 10.1016/j.prostaglandins.2008.02.004; Perrotti D, 2013, LANCET ONCOL, V14, pE229, DOI 10.1016/S1470-2045(12)70558-2; Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1; Radin NS, 2003, BIOCHEM J, V371, P243, DOI 10.1042/BJ20021878; Rath G, 2009, INT J BIOCHEM CELL B, V41, P1165, DOI 10.1016/j.biocel.2008.10.021; Riboni L, 1998, ANN NY ACAD SCI, V845, P46, DOI 10.1111/j.1749-6632.1998.tb09661.x; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; ROBERTSON AMG, 1978, J PATHOL, V126, P181, DOI 10.1002/path.1711260307; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Segui B, 2001, J CLIN INVEST, V108, P143, DOI 10.1172/JCI200111498; Senkal CE, 2007, MOL CANCER THER, V6, P712, DOI 10.1158/1535-7163.MCT-06-0558; Silva MT, 2010, FEBS LETT, V584, P4491, DOI 10.1016/j.febslet.2010.10.046; Sridevi P, 2010, EXP CELL RES, V316, P78, DOI 10.1016/j.yexcr.2009.09.027; Sridevi P, 2009, BBA-MOL CELL RES, V1793, P1218, DOI 10.1016/j.bbamcr.2009.04.006; Stennicke HR, 2000, BIOCHEM J, V350, P563, DOI 10.1042/0264-6021:3500563; Stiban J, 2010, ADV EXP MED BIOL, V688, P60; Taha TA, 2005, J BIOL CHEM, V280, P17196, DOI 10.1074/jbc.M413744200; Taha TA, 2006, BBA-BIOMEMBRANES, V1758, P2027, DOI 10.1016/j.bbamem.2006.10.018; Takeda S, 2006, J BIOCHEM, V139, P255, DOI 10.1093/jb/mvj026; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Tidhar R, 2013, BBA-MOL CELL RES, V1833, P2511, DOI 10.1016/j.bbamcr.2013.04.010; Vanden Berghe T, 2010, CELL DEATH DIFFER, V17, P922, DOI 10.1038/cdd.2009.184; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; Wang JL, 2014, TUMOR BIOL, V35, P1551, DOI 10.1007/s13277-013-1214-0; White-Gilbertson S, 2009, ONCOGENE, V28, P1132, DOI 10.1038/onc.2008.468; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Xu LH, 2000, J BIOL CHEM, V275, P30597, DOI 10.1074/jbc.M910027199; Xu LH, 1998, CELL GROWTH DIFFER, V9, P999; Xu RJ, 2006, FASEB J, V20, P1813, DOI 10.1096/fj.05-5689com; Zachary I, 1997, INT J BIOCHEM CELL B, V29, P929, DOI 10.1016/S1357-2725(97)00008-3; Zhao YG, 2001, J BIOL CHEM, V276, P27432, DOI 10.1074/jbc.M102465200; Zheng DH, 2010, MOL CARCINOGEN, V49, P200, DOI 10.1002/mc.20590	93	37	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25356	25373		10.1074/jbc.M115.658658	http://dx.doi.org/10.1074/jbc.M115.658658			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26318452	Green Published, hybrid			2022-12-26	WOS:000362962800014
J	Avila, LCM; Bruggemann, TR; Bobinski, F; da Silva, MD; Oliveira, RC; Martins, DF; Mazzardo-Martins, L; Duarte, MMMF; de Souza, LF; Dafre, A; Vieira, RD; Santos, ARS; Bonorino, KC; Kunzler, DDH				Avila, Leonardo C. M.; Bruggemann, Thayse R.; Bobinski, Franciane; da Silva, Morgana Duarte; Oliveira, Regiane Carvalho; Martins, Daniel Fernandes; Mazzardo-Martins, Leidiane; Medeiros Frescura Duarte, Marta Maria; de Souza, Luiz Felipe; Dafre, Alcir; Vieira, Rodolfo de Paula; Soares Santos, Adair Roberto; Bonorino, Kelly Cattelan; Kunzler, Deborah de C. Hizume			Effects of High-Intensity Swimming on Lung Inflammation and Oxidative Stress in a Murine Model of DEP-Induced Injury	PLOS ONE			English	Article							DIESEL EXHAUST PARTICLES; AEROBIC EXERCISE; AIR-POLLUTION; CYTOCHROME-P450 1A1; PARTICULATE MATTER; PERIPHERAL-BLOOD; EPITHELIAL-CELLS; GENE-EXPRESSION; TERM EXPOSURE; MOUSE MODEL	Studies have reported that exposure to diesel exhaust particles (DEPs) induces lung inflammation and increases oxidative stress, and both effects are susceptible to changes via regular aerobic exercise in rehabilitation programs. However, the effects of exercise on lungs exposed to DEP after the cessation of exercise are not clear. Therefore, the aim of this study was to evaluate the effects of high-intensity swimming on lung inflammation and oxidative stress in mice exposed to DEP concomitantly and after exercise cessation. Male Swiss mice were divided into 4 groups: Control (n = 12), Swimming (30 min/day) (n = 8), DEP (3 mg/mL-10 mu L/mouse) (n = 9) and DEP+Swimming (n = 8). The high-intensity swimming was characterized by an increase in blood lactate levels greater than 1 mmoL/L between 10th and 30th minutes of exercise. Twenty-four hours after the final exposure to DEP, the anesthetized mice were euthanized, and we counted the number of total and differential inflammatory cells in the bronchoalveolar fluid (BALF), measured the lung homogenate levels of IL-1 beta, TNF-alpha, IL-6, INF-(sic), IL-10, and IL-1ra using ELISA, and measured the levels of glutathione, non-protein thiols (GSH-t and NPSH) and the antioxidant enzymes catalase and glutathione peroxidase (GPx) in the lung. Swimming sessions decreased the number of total cells (p<0.001), neutrophils and lymphocytes (p<0.001; p<0.05) in the BALF, as well as lung levels of IL-1 beta (p = 0.002), TNF-alpha (p = 0.003), IL-6 (p = 0.0001) and IFN-(sic) (p = 0.0001). However, the levels of IL-10 (p = 0.01) and IL-1ra (p = 0.0002) increased in the swimming groups compared with the control groups, as did the CAT lung levels (p = 0.0001). Simultaneously, swimming resulted in an increase in the GSH-t and NPSH lung levels in the DEP group (p = 0.0001 and p<0.002). We concluded that in this experimental model, the high-intensity swimming sessions decreased the lung inflammation and oxidative stress status during DEP-induced lung inflammation in mice.	[Avila, Leonardo C. M.; Bruggemann, Thayse R.; Bonorino, Kelly Cattelan; Kunzler, Deborah de C. Hizume] Univ Estado Santa Catarina, Dept Phys Therapy, Florianopolis, SC, Brazil; [Bruggemann, Thayse R.; Oliveira, Regiane Carvalho; Kunzler, Deborah de C. Hizume] Univ Sao Paulo, Sch Med, Dept Med LIM 5 & LIM 20, BR-05508 Sao Paulo, Brazil; [Bobinski, Franciane; Mazzardo-Martins, Leidiane; Soares Santos, Adair Roberto] Univ Estado Santa Catarina, Dept Biol Sci, Florianopolis, SC, Brazil; [da Silva, Morgana Duarte] Pampa Fed Univ, Dept Phys Therapy, Uruguaiana, RS, Brazil; [Martins, Daniel Fernandes] Univ Southern Santa Catarina, Postgrad Program Hlth Sci, Lab Expt Neurosci, Palhoca, SC, Brazil; [Medeiros Frescura Duarte, Marta Maria] Brazil Lutheran Univ, Hlth Sci Ctr, Santa Maria, RS, Brazil; [de Souza, Luiz Felipe; Dafre, Alcir] Univ Fed Santa Catarina, Dept Biochem, Florianopolis, SC, Brazil; [Vieira, Rodolfo de Paula] Nove de Julho Univ, Sao Paulo UNINOVE, Postgrad Program Rehabil Sci, Bauru, SP, Brazil	Universidade do Estado de Santa Catarina; Universidade de Sao Paulo; Universidade do Estado de Santa Catarina; Universidade Federal do Pampa; Universidade do Sul de Santa Catarina; Universidade Federal de Santa Catarina (UFSC); Universidade Nove de Julho	Kunzler, DDH (corresponding author), Univ Estado Santa Catarina, Dept Phys Therapy, Florianopolis, SC, Brazil.	dehizume@gmail.com	Bobinski, Franciane/ABB-5476-2021; Hizume-Kunzler, Deborah/AAG-1482-2019; Santos, Adair/C-5565-2013; de Paula Vieira, Rodolfo/E-9315-2011; Martins, Daniel Fernandes/J-7125-2014; de Souza, Luiz/J-2999-2017; da Silva, Morgana D/D-4942-2015; Dafre, Alcir/AAE-7738-2019; Carvalho Oliveira, Regiani/B-8471-2012; Bobinski, Franciane/AAV-8234-2020; Martins, Daniel/D-3493-2018	Bobinski, Franciane/0000-0002-3537-1712; Hizume-Kunzler, Deborah/0000-0002-7954-3192; Santos, Adair/0000-0002-6435-4698; de Paula Vieira, Rodolfo/0000-0001-6379-1143; de Souza, Luiz/0000-0002-0497-8538; da Silva, Morgana D/0000-0002-2487-236X; Dafre, Alcir/0000-0001-8097-4611; Carvalho Oliveira, Regiani/0000-0003-2871-0162; Martins, Daniel Fernandes/0000-0003-0066-6745; Mazzardo Martins, Leidiane/0000-0003-0345-2339; Martins, Daniel/0000-0003-1484-3167	Brazilian Scientific Agency: National Council for Scientific and Technological Development	Brazilian Scientific Agency: National Council for Scientific and Technological Development	This study was supported by the following Brazilian Scientific Agency: National Council for Scientific and Technological Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerboom T P, 1981, Methods Enzymol, V77, P373; Avula CPR, 1999, AGING CLIN EXP RES, V11, P246, DOI 10.1007/BF03339665; Balducci S, 2010, ARCH INTERN MED, V170, P1794, DOI 10.1001/archinternmed.2010.380; Baulig A, 2003, AM J PHYSIOL-LUNG C, V285, pL671, DOI 10.1152/ajplung.00419.2002; Becker S, 1996, TOXICOL APPL PHARM, V141, P637, DOI 10.1006/taap.1996.0330; Biswas SK, 2009, MOL ASPECTS MED, V30, P60, DOI 10.1016/j.mam.2008.07.001; Bonvallot V, 2001, AM J RESP CELL MOL, V25, P515, DOI 10.1165/ajrcmb.25.4.4515; Camiletti-Moiron D, 2013, SCAND J MED SCI SPOR, V23, pe202, DOI 10.1111/sms.12065; Cao D, 2007, AM J PHYSIOL-LUNG C, V292, pL422, DOI 10.1152/ajplung.00204.2006; Chaudhuri N, 2010, AM J PHYSIOL-LUNG C, V299, pL263, DOI 10.1152/ajplung.00297.2009; de Araujo CC, 2012, J APPL PHYSIOL, V112, P1206, DOI 10.1152/japplphysiol.01061.2011; den Hartigh LJ, 2010, TOXICOL IN VITRO, V24, P1993, DOI 10.1016/j.tiv.2010.08.017; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Donaldson K, 2005, PART FIBRE TOXICOL, V2, DOI 10.1186/1743-8977-2-10; Duffin R, 2007, YONSEI MED J, V48, P561, DOI 10.3349/ymj.2007.48.4.561; Dutra MF, 2012, NEUROL SCI, V33, P1137, DOI 10.1007/s10072-011-0925-5; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Emmendoerffer A, 2000, TOXICOL LETT, V112, P185, DOI 10.1016/S0378-4274(99)00285-4; Ferreira JCB, 2007, CLIN EXP PHARMACOL P, V34, P760, DOI 10.1111/j.1440-1681.2007.04635.x; Fisher-Wellman Kelsey, 2009, Dyn Med, V8, P1, DOI 10.1186/1476-5918-8-1; Fridovich I, 1998, J EXP BIOL, V201, P1203; Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041; Hall KE, 2013, METABOLISM, V62, P1485, DOI 10.1016/j.metabol.2013.05.012; Halonen JI, 2008, THORAX, V63, P635, DOI 10.1136/thx.2007.091371; Inoue K, 2006, ARCH TOXICOL, V80, P275, DOI 10.1007/s00204-005-0040-6; JENKINS RR, 1993, MED SCI SPORT EXER, V25, P210; Ji LL, 2008, FREE RADICAL BIO MED, V44, P142, DOI 10.1016/j.freeradbiomed.2007.02.031; Kivela R, 2006, FASEB J, V20, P1570, DOI 10.1096/fj.05-4780fje; Kooter I, 2010, J TOXICOL-US, V2010, DOI 10.1155/2010/206057; Kuphal KE, 2007, J PAIN, V8, P989, DOI 10.1016/j.jpain.2007.08.001; Laks D, 2008, INHAL TOXICOL, V20, P1037, DOI [10.1080/08958370802112922, 10.1080/08958370802112922 ]; LARNER AC, 1993, SCIENCE, V261, P1730, DOI 10.1126/science.8378773; Lu SC, 1999, FASEB J, V13, P1169, DOI 10.1096/fasebj.13.10.1169; Luks V, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-24; Maier KL, 2008, INHAL TOXICOL, V20, P319, DOI [10.1080/08958370701866313, 10.1080/08958370701866313 ]; Menegali BT, 2009, PULM PHARMACOL THER, V22, P567, DOI 10.1016/j.pupt.2009.08.003; Nel AE, 1998, J ALLERGY CLIN IMMUN, V102, P539, DOI 10.1016/S0091-6749(98)70269-6; Park EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025892; Pastva A, 2004, J IMMUNOL, V172, P4520, DOI 10.4049/jimmunol.172.7.4520; Patel H, 2011, TOXICOL LETT, V200, P124, DOI 10.1016/j.toxlet.2010.11.007; Patel MM, 2010, ENVIRON HEALTH PERSP, V118, P1338, DOI 10.1289/ehp.0901499; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; Radak Z, 2008, FREE RADICAL BIO MED, V44, P153, DOI 10.1016/j.freeradbiomed.2007.01.029; Ramos DS, 2010, MED SCI SPORT EXER, V42, P113, DOI 10.1249/MSS.0b013e3181ad1c72; Rao KMK, 2005, ENVIRON HEALTH PERSP, V113, P612, DOI 10.1289/ehp.7696; Reischl E, 2007, COMP BIOCHEM PHYS C, V146, P22, DOI 10.1016/j.cbpc.2006.07.015; Rover L, 2001, QUIM NOVA, V24, P112; Salvi S, 1999, AM J RESP CRIT CARE, V159, P702, DOI 10.1164/ajrccm.159.3.9709083; Salvi SS, 2000, AM J RESP CRIT CARE, V161, P550, DOI 10.1164/ajrccm.161.2.9905052; Saxon A, 2005, NAT IMMUNOL, V6, P223, DOI 10.1038/ni0305-223; SCHWARTZ J, 1994, ENVIRON RES, V64, P26, DOI 10.1006/enrs.1994.1004; Schwarze PE, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/685142; Silva RA, 2010, EUR RESPIR J, V35, P994, DOI 10.1183/09031936.00049509; Souza LC, 2013, NEUROTOX RES, V24, P148, DOI 10.1007/s12640-012-9373-0; Stang J, 2014, CLIN PHYSL FUNCT IMA; Steerenberg PA, 1998, EXP LUNG RES, V24, P85, DOI 10.3109/01902149809046056; Takano H, 2002, AM J RESP CRIT CARE, V165, P1329, DOI 10.1164/rccm.2108122; Toledo AC, 2012, EUR RESPIR J, V39, P254, DOI 10.1183/09031936.00003411; Vieira RD, 2012, MED SCI SPORT EXER, V44, P1227, DOI 10.1249/MSS.0b013e31824b2877; Vieira RP, 2008, AM J PHYSIOL-LUNG C, V295, pL670, DOI 10.1152/ajplung.00465.2007; Vieira RP, 2007, AM J RESP CRIT CARE, V176, P871, DOI 10.1164/rccm.200610-1567OC; Vieira RP, 2011, RESP PHYSIOL NEUROBI, V175, P383, DOI 10.1016/j.resp.2011.01.002; Yang HM, 1997, EXP LUNG RES, V23, P269, DOI 10.3109/01902149709087372; Young DR, 2014, CIRC-HEART FAIL, V7, P21, DOI 10.1161/CIRCHEARTFAILURE.113.000529; YSSEL H, 1992, J IMMUNOL, V149, P2378; Zhao HW, 2006, ENVIRON HEALTH PERSP, V114, P1253, DOI 10.1289/ehp.9063; Zhao HW, 2009, J TOXICOL ENV HEAL A, V72, P560, DOI 10.1080/15287390802706330	68	17	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137273	10.1371/journal.pone.0137273	http://dx.doi.org/10.1371/journal.pone.0137273			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332044	Green Published, Green Submitted, gold			2022-12-26	WOS:000360613800116
J	Bronstad, PM; Albu, A; Bowers, AR; Goldstein, R; Peli, E				Bronstad, P. Matthew; Albu, Amanda; Bowers, Alex R.; Goldstein, Robert; Peli, Eli			Driving with Central Visual Field Loss II: How Scotomas above or below the Preferred Retinal Locus (PRL) Affect Hazard Detection in a Driving Simulator	PLOS ONE			English	Article							DRIVERS; HABITS	We determined whether binocular central scotomas above or below the preferred retinal locus affect detection of hazards (pedestrians) approaching from the side. Seven participants with central field loss (CFL), and seven age-and sex-matched controls with normal vision (NV), each completed two sessions of 5 test drives (each approximately 10 minutes long) in a driving simulator. Participants pressed the horn when detecting pedestrians that appeared at one of four eccentricities (-14 degrees, -4 degrees, left, 4 degrees, or 14 degrees, right, relative to car heading). Pedestrians walked or ran towards the travel lane on a collision course with the participant's vehicle, thus remaining in the same area of the visual field, assuming participant's steady forward gaze down the travel lane. Detection rates were nearly 100% for all participants. CFL participant reaction times were longer (median 2.27s, 95% CI 2.13 to 2.47) than NVs (median 1.17s, 95% CI 1.10 to 2.13; difference p<0.01), and CFL participants would have been unable to stop for 21% of pedestrians, compared with 3% for NV, p<0.001. Although the scotomas were not expected to obscure pedestrian hazards, gaze tracking revealed that scotomas did sometimes interfere with detection; late reactions usually occurred when pedestrians were entirely or partially obscured by the scotoma (time obscured correlated with reaction times, r = 0.57, p<0.001). We previously showed that scotomas lateral to the preferred retinal locus delay reaction times to a greater extent; however, taken together, the results of our studies suggest that any binocular CFL might negatively impact timely hazard detection while driving and should be a consideration when evaluating vision for driving.	[Bronstad, P. Matthew; Albu, Amanda; Bowers, Alex R.; Goldstein, Robert; Peli, Eli] Harvard Univ, Sch Med, Schepens Eye Res Inst, Massachusetts Eye & Ear, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute	Bronstad, PM (corresponding author), Harvard Univ, Sch Med, Schepens Eye Res Inst, Massachusetts Eye & Ear, Boston, MA 02115 USA.	matthew_bronstad@meei.harvard.edu		Bowers, Alex/0000-0002-6038-0178; Peli, Eli/0000-0002-1340-9257	National Institutes of Health [EY12890, EY018680, 2P30EY003790]; NATIONAL EYE INSTITUTE [K99EY018680, R00EY018680, P30EY003790, R01EY012890, R24EY012890] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health grants EY12890 (EP), EY018680 (ARB), and 2P30EY003790. The funding organization had no role in the design or conduct of this research.	Alberti CF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089381; American Association of State Highway and Transportation Officials, 2004, POL GEOM DES HIGHW S; Ball K, 1998, ACCIDENT ANAL PREV, V30, P313, DOI 10.1016/S0001-4575(97)00102-4; Bowers AR, 2005, INVEST OPHTH VIS SCI, V46, P66, DOI 10.1167/iovs.04-0271; Bronstad PM, 2013, JAMA OPHTHALMOL, V131, P303, DOI 10.1001/jamaophthalmol.2013.1443; Bronstad PM, 2009, 5 INT DRIV S HUM FAC; Bronstad PM, 2011, DRIV ASS C DAC N AM; DeCarlo DK, 2003, OPTOMETRY VISION SCI, V80, P207, DOI 10.1097/00006324-200303000-00010; Evans L., 2004, TRAFFIC SAFETY; Fletcher Donald C, 2012, Optom Vis Sci, V89, P1395, DOI 10.1097/OPX.0b013e318264cc77; Legge G., 2013, JAMA OPHTHALMOL, DOI [10.1001/jamaophthalmol.2013.1974:E1-E3, DOI 10.1001/JAMAOPHTHALMOL.2013.1974:E1-E3]; Marottoli RA, 1997, J AM GERIATR SOC, V45, P202, DOI 10.1111/j.1532-5415.1997.tb04508.x; Matthew Bronstad P, 2011, J Clin Exp Ophthalmol, V2011, P1; Owsley C, 1999, J GERONTOL A-BIOL, V54, pM203, DOI 10.1093/gerona/54.4.M203; Peli E, 2005, TRANSPORT RES REC, P128; Peli E., 2002, DRIVING CONFIDENCE P; Peli E, 1979, 12 INT C MED BIOL EN; Petzold A, 2005, OPHTHALMOLOGICA, V219, P191, DOI 10.1159/000085727; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Rauscher FG, 2007, 79 DEP TRANSP; Reinhard J, 2007, VISION RES, V47, P2076, DOI 10.1016/j.visres.2007.04.012; Sengupta S, 2014, OPHTHALMOLOGY, V121, P727, DOI 10.1016/j.ophtha.2013.09.042; SZLYK JP, 1995, ARCH OPHTHALMOL-CHIC, V113, P1033, DOI 10.1001/archopht.1995.01100080085033; U.S. Department of Transportation FHA, SUMM TRAV TRENDS 200; Verezen CA, 2011, OPTOMETRY VISION SCI, V88, P1164, DOI 10.1097/OPX.0b013e31822891e0; Woods RL, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3292015; Yazdan-Ashoori P, 2010, J NEURO-OPHTHALMOL, V30, P177, DOI 10.1097/WNO.0b013e3181dfa982; ZEEVI YY, 1979, J OPT SOC AM, V69, P1274, DOI 10.1364/JOSA.69.001274	28	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136517	10.1371/journal.pone.0136517	http://dx.doi.org/10.1371/journal.pone.0136517			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332315	Green Published, gold, Green Submitted			2022-12-26	WOS:000360613800059
J	Hu, K; Harris, DL; Yamaguchi, T; von Andrian, UH; Hamrah, P				Hu, Kai; Harris, Deshea L.; Yamaguchi, Takefumi; von Andrian, Ulrich H.; Hamrah, Pedram			A Dual Role for Corneal Dendritic Cells in Herpes Simplex Keratitis: Local Suppression of Corneal Damage and Promotion of Systemic Viral Dissemination	PLOS ONE			English	Article							VIRUS TYPE-1 LATENCY; LANGERHANS CELLS; MACROPHAGE-DEPLETION; STROMAL KERATITIS; OCULAR INFECTION; MOUSE MACROPHAGE; HSV-1 INFECTION; IMMUNE EVASION; NERVOUS-SYSTEM; LYMPH-NODES	The cornea is the shield to the foreign world and thus, a primary site for peripheral infections. However, transparency and vision are incompatible with inflammation and scarring that may result from infections. Thus, the cornea is required to perform a delicate balance between fighting infections and preserving vision. To date, little is known about the specific role of antigen-presenting cells in viral keratitis. In this study, utilizing an established murine model of primary acute herpes simplex virus (HSV)-1 keratitis, we demonstrate that primary HSV keratitis results in increased conventional dendritic cells (cDCs) and macrophages within 24 hours after infection. Local depletion of cDCs in CD11c-DTR mice by subconjuntival diphtheria toxin injections, led to increased viral proliferation, and influx of inflammatory cells, resulting in increased scarring and clinical keratitis. In addition, while HSV infection resulted in significant corneal nerve destruction, local depletion of cDCs resulted in a much more severe loss of corneal nerves. Further, local cDC depletion resulted in decreased corneal nerve infection, and subsequently decreased and delayed systemic viral transmission in the trigeminal ganglion and draining lymph node, resulting in decreased mortality of mice. In contrast, sham depletion or depletion of macrophages through local injection of clodronate liposomes had neither a significant impact on the cornea, nor an effect on systemic viral transmission. In conclusion, we demonstrate that corneal cDCs may play a primary role in local corneal defense during viral keratitis and preserve vision, at the cost of inducing systemic viral dissemination, leading to increased mortality.	[Hu, Kai; Harris, Deshea L.; Yamaguchi, Takefumi; Hamrah, Pedram] Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst,Massachusetts Eye & Ear, Boston, MA 02114 USA; [Hu, Kai; Yamaguchi, Takefumi; Hamrah, Pedram] Harvard Univ, Sch Med, Dept Ophthalmol, Cornea Serv,Massachusetts Eye & Ear Infirm, Boston, MA USA; [Hu, Kai; Harris, Deshea L.; Yamaguchi, Takefumi; von Andrian, Ulrich H.; Hamrah, Pedram] Harvard Univ, Sch Med, Childrens Hosp Boston, Immune Dis Inst,Program Cellular & Mol Med, Boston, MA USA; [Harris, Deshea L.; Hamrah, Pedram] Tufts Univ, Sch Med, Dept Ophthalmol, Tufts Med Ctr, Boston, MA 02111 USA; [von Andrian, Ulrich H.] Harvard Univ, Sch Med, Div Immunol, Dept Microbiol & Immunobiol, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Tufts Medical Center; Tufts University; Harvard University; Harvard Medical School	Hamrah, P (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst,Massachusetts Eye & Ear, Boston, MA 02114 USA.	phamrah@tuftsmedicalcenter.org	Yamaguchi, Takefumi/AEV-4169-2022; YAMAGUCHI, Takefumi/AAY-6964-2020	Harris, Deshea/0000-0002-8194-1827; Yamaguchi, Takefumi/0000-0002-2546-2813	NIH [K08-EY020575, R01-EY022695]; Research to Prevent Blindness Career Development Award; Falk Medical Research Trust; MEEI Foundation; NATIONAL EYE INSTITUTE [R01EY022695, K08EY020575] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Career Development Award(Research to Prevent Blindness (RPB)); Falk Medical Research Trust; MEEI Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from the NIH: K08-EY020575 (PH), R01-EY022695 (PH), Research to Prevent Blindness Career Development Award (PH), Falk Medical Research Trust (PH), and MEEI Foundation (PH).	Allen SJ, 2011, J VIROL, V85, P9945, DOI 10.1128/JVI.05208-11; ASBELL PA, 1987, CURR EYE RES, V6, P179, DOI 10.3109/02713688709020087; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Bauer D, 2000, CURR EYE RES, V20, P45; Bauer D, 2012, INVEST OPHTH VIS SCI, V53, P799, DOI 10.1167/iovs.11-7617; Bedoui S, 2009, J IMMUNOL, V182, P4200, DOI 10.4049/jimmunol.0802286; Brissette-Storkus CS, 2002, INVEST OPHTH VIS SCI, V43, P2264; Buela KAG, 2015, J IMMUNOL, V194, P379, DOI 10.4049/jimmunol.1402326; Cheng H, 2000, INVEST OPHTH VIS SCI, V41, P1402; Chentoufi AA, 2012, VIRAL IMMUNOL, V25, P204, DOI 10.1089/vim.2011.0091; Coffin RS, 1998, GENE THER, V5, P718, DOI 10.1038/sj.gt.3300634; Cruzat A, 2011, INVEST OPHTH VIS SCI, V52, P5136, DOI 10.1167/iovs.10-7048; Duan R, 2007, INVEST OPHTH VIS SCI, V48, P277, DOI 10.1167/iovs.06-0053; Edelmann KH, 2001, J VIROL, V75, P612, DOI 10.1128/JVI.75.2.612-621.2001; Eidsmo L, 2009, J IMMUNOL, V182, P3165, DOI 10.4049/jimmunol.0802950; Frank GM, 2012, J IMMUNOL, V188, P1350, DOI 10.4049/jimmunol.1101968; GILLETTE TE, 1982, OPHTHALMOLOGY, V89, P700; Goldwich A, 2011, J LEUKOCYTE BIOL, V89, P973, DOI 10.1189/jlb.0310180; Hamrah P, 2003, J LEUKOCYTE BIOL, V74, P172, DOI 10.1189/jlb.1102544; Hamrah P, 2003, INVEST OPHTH VIS SCI, V44, P581, DOI 10.1167/iovs.02-0838; Hamrah P, 2002, INVEST OPHTH VIS SCI, V43, P639; Hamrah P, 2012, OPHTHALMOLOGY, V119, P1791, DOI 10.1016/j.ophtha.2012.03.005; Hamrah P, 2010, OPHTHALMOLOGY, V117, P1930, DOI 10.1016/j.ophtha.2010.07.010; HENDRICKS RL, 1992, J IMMUNOL, V148, P2522; Herman M, 2012, J EXP MED, V209, P1567, DOI 10.1084/jem.20111316; HOSOI J, 1993, NATURE, V363, P159, DOI 10.1038/363159a0; Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118; Inoue T, 2000, INVEST OPHTH VIS SCI, V41, P4209; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kassim SH, 2006, J VIROL, V80, P3985, DOI 10.1128/JVI.80.8.3985-3993.2006; KAYE SB, 1992, BRIT J OPHTHALMOL, V76, P412, DOI 10.1136/bjo.76.7.412; Kovacs SK, 2009, CURR EYE RES, V34, P896, DOI 10.3109/02713680903184250; Kradin R, 1997, AM J PATHOL, V150, P1735; Kruse M, 2000, J VIROL, V74, P7127, DOI 10.1128/JVI.74.15.7127-7136.2000; Kummer M, 2007, J VIROL, V81, P6326, DOI 10.1128/JVI.02327-06; Labetoulle M, 2000, INVEST OPHTH VIS SCI, V41, P2600; LEENEN PJM, 1994, J IMMUNOL METHODS, V174, P5, DOI 10.1016/0022-1759(94)90005-1; LEWKOWICZMOSS SJ, 1987, EXP EYE RES, V45, P127, DOI 10.1016/S0014-4835(87)80084-2; LIESEGANG TJ, 1989, ARCH OPHTHALMOL-CHIC, V107, P1155, DOI 10.1001/archopht.1989.01070020221029; Liu GQ, 2011, MOL VIS, V17, P2129; Liu Y, 2002, J EXP MED, V195, P259, DOI 10.1084/jem.20010838; Maruyama K, 2012, INVEST OPHTH VIS SCI, V53, P3145, DOI 10.1167/iovs.11-8010; McGillis JP, 1990, ANN N Y ACAD SCI, V594, P85; Mikloska Z, 2001, J VIROL, V75, P5958, DOI 10.1128/JVI.75.13.5958-5964.2001; MILLER JK, 1993, INVEST OPHTH VIS SCI, V34, P2282; Miranda-Saksena M, 2000, J VIROL, V74, P1827, DOI 10.1128/JVI.74.4.1827-1839.2000; Mott K, 2007, INVEST OPHTH VIS SCI, V48, P5605, DOI 10.1167/iovs.07-0894; Mott KR, 2008, J VIROL, V82, P9870, DOI 10.1128/JVI.00566-08; Mott KR, 2007, J VIROL, V81, P12962, DOI 10.1128/JVI.01442-07; Mott KR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-56; Mott KR, 2008, CLIN VACCINE IMMUNOL, V15, P1859, DOI 10.1128/CVI.00318-08; Neumann J, 2003, J IMMUNOL, V171, P3075, DOI 10.4049/jimmunol.171.6.3075; PEPOSE JS, 1989, CURR EYE RES, V8, P851, DOI 10.3109/02713688909000875; Pollara G, 2003, J INFECT DIS, V187, P165, DOI 10.1086/367675; RABIN BS, 1989, CRIT REV IMMUNOL, V9, P279; Raftery MJ, 2006, J IMMUNOL, V177, P6207, DOI 10.4049/jimmunol.177.9.6207; Salio M, 1999, EUR J IMMUNOL, V29, P3245, DOI 10.1002/(SICI)1521-4141(199910)29:10<3245::AID-IMMU3245>3.3.CO;2-O; Schon E, 2001, J REPROD IMMUNOL, V50, P87, DOI 10.1016/S0165-0378(00)00094-2; Shah A, 2010, MOL VIS, V16, P2476; Slegers TPAM, 2003, CURR EYE RES, V26, P73, DOI 10.1076/ceyr.26.2.73.14510; Smith CM, 2003, J IMMUNOL, V170, P4437, DOI 10.4049/jimmunol.170.9.4437; SPRECHER E, 1989, ARCH VIROL, V107, P191, DOI 10.1007/BF01317916; STREILEIN JW, 1979, NATURE, V282, P326, DOI 10.1038/282326a0; Sun Y, 2010, J IMMUNOL, V185, P4272, DOI 10.4049/jimmunol.1000874; WATSON CPN, 1991, PAIN, V44, P105, DOI 10.1016/0304-3959(91)90124-G; Whitley RJ, 2006, ANTIVIR RES, V71, P141, DOI 10.1016/j.antiviral.2006.04.002; Xia LK, 2010, MOL VIS, V16, P2071; Xia LJ, 2002, J CLIN INVEST, V109, P939; YASUMOTO S, 1986, ARCH VIROL, V90, P261, DOI 10.1007/BF01317375; Yoneyama H, 2005, J EXP MED, V202, P425, DOI 10.1084/jem.20041961	70	28	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137123	10.1371/journal.pone.0137123	http://dx.doi.org/10.1371/journal.pone.0137123			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332302	Green Submitted, Green Published, gold			2022-12-26	WOS:000360613800099
J	Liu, J; Gao, L; Zang, DW				Liu, Juan; Gao, Lina; Zang, Dawei			Elevated Levels of IFN-gamma in CSF and Serum of Patients with Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; MOUSE MODEL; ALS; ASTROCYTES; INTERLEUKIN-12; ACTIVATION; EXPRESSION; MICROGLIA; CYTOKINES; BIOMARKER	Objectives To explore whether the levels of IFN-gamma in cerebral spinal fluid (CSF) and serum are elevated in ALS patients and to analyze the correlations between the IFN-gamma levels and disease progression. Methods CSF and serum samples were obtained from 52 ALS patients and 31 non-ALS patients. The levels of IFN-gamma in CSF and serum were assessed, and disease progression parameters, including the disease interval (months from onset, MFO), the revised ALS Functional Rating Scale (ALSFRS-r) score and the disease progression rate (DPR) were analyzed by registered neurologists. All samples were measured using a commercial enzyme-linked immunosorbent assay. Statistical analyses were performed using Prism software. Results Compared to the non-ALS patients, the ALS patients displayed significantly increased levels of IFN-gamma in both CSF and serum, and these values consistently correlated with disease progression. Conclusions These results demonstrated that IFN-gamma in CSF may serve as a biomarker of ALS differentiation and progression. CSF IFN-gamma was a more reliable biomarker of disease diagnosis and progression than serum IFN-gamma.	[Liu, Juan] Tianjin Med Univ, Tianjin Ctr Hosp 1, Dept Lab Med, Microbiol Grp, Tianjin, Peoples R China; [Gao, Lina; Zang, Dawei] Tianjin Med Univ, Tianjin Ctr Hosp 1, Dept Neurol, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University	Zang, DW (corresponding author), Tianjin Med Univ, Tianjin Ctr Hosp 1, Dept Neurol, Tianjin, Peoples R China.	zangdawei@gmail.com			Tianjin Health Bureau [11KG104]	Tianjin Health Bureau	This work was supported by the Tianjin Health Bureau (11KG104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebischer J, 2012, EUR J NEUROL, V19, P752, DOI 10.1111/j.1468-1331.2011.03623.x; Aebischer J, 2011, CELL DEATH DIFFER, V18, P754, DOI 10.1038/cdd.2010.143; Babu GN, 2008, NEUROCHEM RES, V33, P1145, DOI 10.1007/s11064-007-9564-x; Bao Y, 2014, J AUTOIMMUN; Belanger M, 2011, J NEUROCHEM, V116, P564, DOI 10.1111/j.1471-4159.2010.07135.x; Cardona-Rossinyol A, 2013, CELL MOL NEUROBIOL, V33, P421, DOI 10.1007/s10571-013-9908-9; Chelstowska B, 2014, BIOMARKERS, V19, P571, DOI 10.3109/1354750X.2014.949867; Czlonkowska A, 2005, CURR PHARM DESIGN, V11, P1017, DOI 10.2174/1381612053381693; Ford LS, 2004, AMYOTROPH LATERAL SC, V5, P118, DOI 10.1080/14660820410019125; Hashioka S, 2010, J NEUROIMMUNOL, V225, P91, DOI 10.1016/j.jneuroim.2010.04.023; Jang E, 2013, J IMMUNOL, V191, P5204, DOI 10.4049/jimmunol.1301637; Kwon MS, 2014, J NEUROCHEM; Lin HW, 2009, J NEUROCHEM, V111, P808, DOI 10.1111/j.1471-4159.2009.06366.x; Matsumoto T, 2012, NEUROSCI LETT, V520, P115, DOI 10.1016/j.neulet.2012.05.048; Medina TS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-264; Meissner F, 2010, P NATL ACAD SCI USA, V107, P13046, DOI 10.1073/pnas.1002396107; Mitchell RM, 2009, NEUROLOGY, V72, P14, DOI 10.1212/01.wnl.0000333251.36681.a5; Mitchell RM, 2010, MUSCLE NERVE, V42, P95, DOI 10.1002/mus.21625; Otsmane B, 2014, NEUROREPORT, V25, P49, DOI 10.1097/WNR.0000000000000043; Rentzos M, 2010, EUR NEUROL, V63, P285, DOI 10.1159/000287582; Su XWW, 2013, JAMA NEUROL, V70, P1505, DOI 10.1001/jamaneurol.2013.4646; Tateishi T, 2010, J NEUROIMMUNOL, V222, P76, DOI 10.1016/j.jneuroim.2010.03.004; Thornton P, 2006, J NEUROCHEM, V98, P258, DOI 10.1111/j.1471-4159.2006.03872.x; Xu B, 2014, HISTOL HISTOPATHOL, V29, P1437, DOI 10.14670/HH-29.1437	24	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136937	10.1371/journal.pone.0136937	http://dx.doi.org/10.1371/journal.pone.0136937			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332465	Green Published, Green Submitted, gold			2022-12-26	WOS:000360613800081
J	Carlotti, E; Wrench, D; Rosignoli, G; Marzec, J; Sangaralingam, A; Hazanov, L; Michaeli, M; Hallam, S; Chaplin, T; Iqbal, S; Calaminici, M; Young, B; Mehr, R; Campbell, P; Fitzgibbon, J; Gribben, JG				Carlotti, Emanuela; Wrench, David; Rosignoli, Guglielmo; Marzec, Jacek; Sangaralingam, Ajanthah; Hazanov, Lena; Michaeli, Miri; Hallam, Simon; Chaplin, Tracy; Iqbal, Sameena; Calaminici, Maria; Young, Bryan; Mehr, Ramit; Campbell, Peter; Fitzgibbon, Jude; Gribben, John G.			High Throughput Sequencing Analysis of the Immunoglobulin Heavy Chain Gene from Flow-Sorted B Cell Sub-Populations Define the Dynamics of Follicular Lymphoma Clonal Evolution	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; TRANSFORMATION; PROGRESSION; PATTERNS; MUTATION; CANCER; CENTROBLASTS; CENTROCYTES; SELECTION; SUBCLONE	Understanding the dynamics of evolution of Follicular Lymphoma (FL) clones during disease progression is important for monitoring and targeting this tumor effectively. Genetic profiling of serial FL biopsies and examples of FL transmission following bone marrow transplant suggest that this disease may evolve by divergent evolution from a common ancestor cell. However where this ancestor cell resides and how it evolves is still unclear. The analysis of the pattern of somatic hypermutation of the immunoglobulin gene (Ig) is traditionally used for tracking the physiological clonal evolution of B cells within the germinal center and allows to discriminate those cells that have just entered the germinal center and display features of ancestor cells from those B cells that keep re-circulating across different lymphoid organs. Here we investigated the pattern of somatic hypermutation of the heavy chain of the immunoglobulin gene (IgH-VH) in 4 flow-sorted B cells subpopulations belonging to different stages of differentiation, from sequential lymph node biopsies of cases displaying diverse patterns of evolution, using the GS-FLX Titanium sequencing platform. We observed an unexpectedly high level of clonality, with hundreds of distinct tumor subclones in the different subpopulations from the same sample, the majority detected at a frequency <10(-2). By using a lineage trees analysis we observed in all our FL and t-FL cases that the oligoclonal FL population was trapped in a narrow intermediate stage of maturation that maintains the capacity to undergo SHM, but was unable to further differentiate. The presence of such a complex architecture highlights challenges currently encountered in finding a cure for this disease.	[Carlotti, Emanuela; Wrench, David; Hallam, Simon; Chaplin, Tracy; Iqbal, Sameena; Calaminici, Maria; Young, Bryan; Fitzgibbon, Jude; Gribben, John G.] Barts Canc Inst, Ctr Haematooncol, London, England; [Rosignoli, Guglielmo] Barts Canc Inst, Flow Cytometry Core Facil, London, England; [Marzec, Jacek; Sangaralingam, Ajanthah] Barts Canc Inst, Ctr Mol Oncol, London, England; [Hazanov, Lena; Michaeli, Miri; Mehr, Ramit] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Campbell, Peter] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, England	University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London; Bar Ilan University; Wellcome Trust Sanger Institute	Gribben, JG (corresponding author), Barts Canc Inst, Ctr Haematooncol, London, England.	j.gribben@qmul.ac.uk	Strefford, Jonathan/B-2826-2009	Strefford, Jonathan/0000-0002-0972-2881; Fitzgibbon, Jude/0000-0002-9069-1866; Marzec, Jacek/0000-0001-6577-8866; Mehr, Ramit/0000-0002-4303-6834	Cancer Research UK [C1574/A6806]; Cancer Research UK [15968] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK (C1574/A6806) with a program award to JG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts WM, 2001, BLOOD, V98, P238, DOI 10.1182/blood.V98.1.238; Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Barak M, 2008, J IMMUNOL METHODS, V338, P67, DOI 10.1016/j.jim.2008.06.006; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Carlotti E, 2009, BLOOD, V113, P3553, DOI 10.1182/blood-2008-08-174839; Caron G, 2009, J IMMUNOL, V182, P7595, DOI 10.4049/jimmunol.0804272; Choi S, 2007, BLOOD, V110, P632, DOI 10.1182/blood-2007-01-067785; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; Eide MB, 2010, BLOOD, V116, P1489, DOI 10.1182/blood-2010-03-272278; Fitzgibbon J, 2007, LEUKEMIA, V21, P1514, DOI 10.1038/sj.leu.2404696; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Green MR, 2013, BLOOD, V121, P1604, DOI 10.1182/blood-2012-09-457283; Gribben JG, 2007, BLOOD, V109, P4617, DOI 10.1182/blood-2006-10-041863; Guffanti A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-163; Hogerkorp CM, 2006, J IMMUNOL, V177, P4341, DOI 10.4049/jimmunol.177.7.4341; Jiang YW, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0432-0; Keats JJ, 2012, BLOOD, V120, P1067, DOI 10.1182/blood-2012-01-405985; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Lossos IS, 2011, BEST PRACT RES CL HA, V24, P147, DOI 10.1016/j.beha.2011.02.006; Mamessier E, 2014, HAEMATOLOGICA, V99, P481, DOI 10.3324/haematol.2013.094474; Martinez-Climent JA, 2010, HAEMATOL-HEMATOL J, V95, P293, DOI 10.3324/haematol.2009.013318; Montoto S, 2007, J CLIN ONCOL, V25, P2426, DOI 10.1200/JCO.2006.09.3260; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Okosun J, 2014, NAT GENET, V46, P176, DOI 10.1038/ng.2856; Pasqualucci L, 2014, CELL REP, V6, P130, DOI 10.1016/j.celrep.2013.12.027; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Ruminy P, 2008, BLOOD, V112, P1951, DOI 10.1182/blood-2007-11-124560; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; Strothmeyer AM, 2010, BLOOD, V116, P1734, DOI 10.1182/blood-2010-02-270199; Sungalee S, 2014, J CLIN INVEST, V124, P5337, DOI 10.1172/JCI72415; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Weigert O, 2012, CANCER DISCOV, V2, P47, DOI 10.1158/2159-8290.CD-11-0208; Yoshida N, 2011, J IMMUNOL, V186, P2800, DOI 10.4049/jimmunol.1003401	37	23	23	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0134833	10.1371/journal.pone.0134833	http://dx.doi.org/10.1371/journal.pone.0134833			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325507	gold, Green Published, Green Submitted			2022-12-26	WOS:000360437700015
J	Khan, JA; Mustafa, M; Hayat, T; Alsaedi, A				Khan, Junaid Ahmad; Mustafa, M.; Hayat, T.; Alsaedi, A.			Numerical Study of Cattaneo-Christov Heat Flux Model for Viscoelastic Flow Due to an Exponentially Stretching Surface	PLOS ONE			English	Article							STAGNATION-POINT FLOW; MAXWELL FLUID; VELOCITY SLIP; UCM FLUID; MHD FLOW; SHEET	This work deals with the flow and heat transfer in upper-convected Maxwell fluid above an exponentially stretching surface. Cattaneo-Christov heat flux model is employed for the formulation of the energy equation. This model can predict the effects of thermal relaxation time on the boundary layer. Similarity approach is utilized to normalize the governing boundary layer equations. Local similarity solutions are achieved by shooting approach together with fourth-fifth-order Runge-Kutta integration technique and Newton's method. Our computations reveal that fluid temperature has inverse relationship with the thermal relaxation time. Further the fluid velocity is a decreasing function of the fluid relaxation time. A comparison of Fourier's law and the Cattaneo-Christov's law is also presented. Present attempt even in the case of Newtonian fluid is not yet available in the literature.	[Khan, Junaid Ahmad] Natl Univ Sci & Technol NUST, Res Ctr Modeling & Simulat RCMS, Islamabad 44000, Pakistan; [Mustafa, M.] Natl Univ Sci & Technol NUST, Sch Nat Sci SNS, Islamabad 44000, Pakistan; [Hayat, T.] Quaid I Azam Univ 45320, Dept Math, Islamabad 44000, Pakistan; [Hayat, T.; Alsaedi, A.] King Abdulaziz Univ, Nonlinear Anal & Appl Math NAAM Res Grp, Jeddah 21589, Saudi Arabia	National University of Sciences & Technology - Pakistan; National University of Sciences & Technology - Pakistan; Quaid I Azam University; King Abdulaziz University	Mustafa, M (corresponding author), Natl Univ Sci & Technol NUST, Sch Nat Sci SNS, Islamabad 44000, Pakistan.	meraj_mm@hotmail.com	Hayat, Tasawar/A-3853-2013; Hayat, Tasawar/Y-2524-2019; Alsaedi, Ahmed/A-2094-2013; Mustafa Hashmi, Meraj/P-1769-2014; Ahmad, Junaid/AAE-8872-2019	Alsaedi, Ahmed/0000-0003-3452-8922; 				Abbasbandy S, 2014, INT J NUMER METHOD H, V24, P390, DOI 10.1108/HFF-05-2012-0096; Abel MS, 2012, MECCANICA, V47, P385, DOI 10.1007/s11012-011-9448-7; Awais M, 2014, INT J NUMER METHOD H, V24, P483, DOI 10.1108/HFF-04-2012-0084; Cao BY, 2007, J APPL PHYS, V102, DOI 10.1063/1.2775215; Cattaneo C., 1948, ATTI SEMIN MAT FIS, V3, P83, DOI DOI 10.1007/978-3-642-11051-1_5; Christov CI, 2009, MECH RES COMMUN, V36, P481, DOI 10.1016/j.mechrescom.2008.11.003; Ciarletta M, 2010, MECH RES COMMUN, V37, P445, DOI 10.1016/j.mechrescom.2010.06.002; Dong Y, 2011, J APPL PHYS, V110, DOI 10.1063/1.3634113; Fourier J.-B.J., 1822, THEORIE ANAL CHALEUR; Han SH, 2014, APPL MATH LETT, V38, P87, DOI 10.1016/j.aml.2014.07.013; Hayat T, 2014, INT J NUMER METHOD H, V24, P1073, DOI 10.1108/HFF-01-2013-0011; Hayat T, 2012, INT J NUMER METH FL, V68, P233, DOI 10.1002/fld.2503; Hayat T, 2014, INT J NUMER METHOD H, V24, P760, DOI 10.1108/HFF-09-2012-0219; Hsiao KL, 2014, ARAB J SCI ENG, V39, P4325, DOI 10.1007/s13369-014-1065-z; Magyari E, 1999, J PHYS D APPL PHYS, V32, P577, DOI 10.1088/0022-3727/32/5/012; Mustafa M, 2015, AIP ADV, V5, DOI 10.1063/1.4916364; Mustafa M, 2015, AIP ADV, V5, DOI 10.1063/1.4907927; Mustafa M, 2015, AIP ADV, V5, DOI 10.1063/1.4917306; Shateyi S, 2013, BOUND VALUE PROBL, DOI 10.1186/1687-2770-2013-196; Shehzad SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068139; Straughan B, 2010, INT J HEAT MASS TRAN, V53, P95, DOI 10.1016/j.ijheatmasstransfer.2009.10.001; Zhang MK, 2013, INT J HEAT MASS TRAN, V67, P1072, DOI 10.1016/j.ijheatmasstransfer.2013.08.102; Zheng LC, 2011, COMPUT MATH APPL, V61, P2209, DOI 10.1016/j.camwa.2010.09.017; Zheng LC, 2013, J FRANKLIN I, V350, P990, DOI 10.1016/j.jfranklin.2013.01.022; Zheng LC, 2012, MATH COMPUT MODEL, V56, P133, DOI 10.1016/j.mcm.2011.11.080; Zheng LC, 2012, CHEM ENG COMMUN, V199, P1, DOI 10.1080/00986445.2010.524503; Zheng LC, 2011, COMMUN NONLINEAR SCI, V16, P731, DOI 10.1016/j.cnsns.2010.05.022	27	70	71	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137363	10.1371/journal.pone.0137363	http://dx.doi.org/10.1371/journal.pone.0137363			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325426	Green Submitted, Green Published, gold			2022-12-26	WOS:000360437700113
J	Longo, C; Piana, S; Lallas, A; Moscarella, E; Lombardi, M; Raucci, M; Pellacani, G; Argenziano, G				Longo, Caterina; Piana, Simonetta; Lallas, Aimilios; Moscarella, Elvira; Lombardi, Mara; Raucci, Margherita; Pellacani, Giovanni; Argenziano, Giuseppe			Routine Clinical-Pathologic Correlation of Pigmented Skin Tumors Can Influence Patient Management	PLOS ONE			English	Article							TOTAL-BODY PHOTOGRAPHY; HISTOPATHOLOGIC DIAGNOSIS; LENTIGINOUS MELANOMA; DIGITAL DERMATOSCOPY; FOLLOW-UP; HIGH-RISK; LESIONS	Background Several studies have demonstrated the benefit of integrating clinical with pathologic information, to obtain a confident diagnosis for melanocytic tumors. However, all those studies were conducted retrospectively and no data are currently available about the role of a clinical-pathologic correlation approach on a daily basis in clinical practice. Aim of the Study In our study, we evaluated the impact of a routine clinical-pathologic correlation approach for difficult skin tumors seen over 3 years in a tertiary referral center. Results Interestingly, a re-appraisal was requested for 158 out of 2015 (7.7%) excised lesions because clinical-pathologic correlation was missing. Of note, in 0.6% of them (13 out of 2045) the first histologic diagnosis was revised in the light of clinical information that assisted the Pathologist to re-evaluate the histopathologic findings that might be bland or inconspicuous per se. Conclusion In conclusion, our study demonstrated that an integrated approach involving clinicians and pathologists allows improving management of selected patients by shifting from a simply disease-focused management (melanoma versus nevus) to a patient-centered approach.	[Longo, Caterina; Lallas, Aimilios; Moscarella, Elvira; Lombardi, Mara; Raucci, Margherita; Argenziano, Giuseppe] Arcispedale Santa Maria Nuova IRCCS, Dermatol & Skin Canc Unit, Reggio Emilia, Italy; [Piana, Simonetta] Arcispedale Santa Maria Nuova IRCCS, Pathol Unit, Reggio Emilia, Italy; [Pellacani, Giovanni] Univ Modena & Reggio Emilia, Dermatol Unit, Modena, Italy	IRCCS Arcispedale S. Maria Nuova; IRCCS Arcispedale S. Maria Nuova; Universita di Modena e Reggio Emilia	Longo, C (corresponding author), Arcispedale Santa Maria Nuova IRCCS, Dermatol & Skin Canc Unit, Reggio Emilia, Italy.	longo.caterina@gmail.com	Longo, Caterina/A-8046-2012; Lallas, Aimilios/O-4986-2019; PIANA, SIMONETTA/AAC-9158-2019; pellacani, giovanni/E-8573-2011; Argenziano, Giuseppe/E-5926-2010	Longo, Caterina/0000-0002-8218-3896; Lallas, Aimilios/0000-0002-7193-0964; PIANA, SIMONETTA/0000-0003-4875-6977; pellacani, giovanni/0000-0002-7222-2951; Argenziano, Giuseppe/0000-0003-1413-8214	Italian Ministry of Health [RF-2010-2316524]	Italian Ministry of Health(Ministry of Health, Italy)	This study was supported in part by the Italian Ministry of Health (RF-2010-2316524). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There were no other fundings for this study.	Argenziano G, 2012, J AM ACAD DERMATOL, V67, P54, DOI 10.1016/j.jaad.2011.07.019; Aslan C, 2012, J AM ACAD DERMATOL, V66, P393, DOI 10.1016/j.jaad.2010.12.031; Bauer J, 2006, BRIT J DERMATOL, V155, P546, DOI 10.1111/j.1365-2133.2006.07342.x; Cerroni L, 2010, J AM ACAD DERMATOL, V63, P647, DOI 10.1016/j.jaad.2009.09.009; Chang JH, 2001, CANCER-AM CANCER SOC, V91, P1231, DOI 10.1002/1097-0142(20010401)91:7<1231::AID-CNCR1123>3.0.CO;2-K; Ferrara G, 2008, HISTOPATHOLOGY, V52, P523, DOI 10.1111/j.1365-2559.2008.02943.x; Ferrara G, 2002, CANCER, V95, P1094, DOI 10.1002/cncr.10768; Ferrara G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005375; Gaudi S, 2013, J AM ACAD DERMATOL, V68, P119, DOI 10.1016/j.jaad.2012.06.034; King R, 2005, MODERN PATHOL, V18, P1397, DOI 10.1038/modpathol.3800454; Lodha S, 2008, J CUTAN PATHOL, V35, P349, DOI 10.1111/j.1600-0560.2007.00970.x; McGinnis KS, 2002, ARCH DERMATOL, V138, P617, DOI 10.1001/archderm.138.5.617; Newman EA, 2006, CANCER, V107, P2346, DOI 10.1002/cncr.22266; Salerni G, 2013, J EUR ACAD DERMATOL, V27, P805, DOI 10.1111/jdv.12032; Salerni G, 2012, J AM ACAD DERMATOL, V67, P836, DOI 10.1016/j.jaad.2012.01.028; Salerni G, 2012, J AM ACAD DERMATOL, V67, pE17, DOI 10.1016/j.jaad.2011.04.008; Soyer HP, 2005, ARCH DERMATOL, V141, P209, DOI 10.1001/archderm.141.2.209; Zalaudek I, 2006, EXPERT REV DERMATOL, V4, P579; Zalaudek I, 2013, DERMATOL CLIN, V31, P549, DOI 10.1016/j.det.2013.06.011	19	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136031	10.1371/journal.pone.0136031	http://dx.doi.org/10.1371/journal.pone.0136031			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325678	Green Published, Green Submitted, gold			2022-12-26	WOS:000360437700027
J	Winter, B; Brunecker, P; Fiebach, JB; Jungehulsing, GJ; Kronenberg, G; Endres, M				Winter, Benjamin; Brunecker, Peter; Fiebach, Jochen B.; Jungehulsing, Gerhard Jan; Kronenberg, Golo; Endres, Matthias			Striatal Infarction Elicits Secondary Extrafocal MRI Changes in Ipsilateral Substantia Nigra	PLOS ONE			English	Article							MIDDLE CEREBRAL-ARTERY; APPARENT DIFFUSION-COEFFICIENT; TRANSIENT FOREBRAIN ISCHEMIA; POSTISCHEMIC NEURONAL DEATH; OCCLUSION; STROKE; RATS; DEGENERATION; DAMAGE; AGONIST	Focal ischemia may induce pathological alterations in brain areas distant from the primary lesion. In animal models, exofocal neuron death in the ipsilateral midbrain has been described after occlusion of the middle cerebral artery (MCA). Using sequential magnetic resonance imaging (T2- and diffusion-weighted) at 3 Tesla, we investigated acute ischemic stroke patients on days 1, 2, 6, 8, and 10 after stroke onset. Sixteen consecutive patients who had suffered a stroke involving the caudate nucleus and/or putamen of either hemisphere were recruited into the study. Four additional patients with strokes sparing the caudate nucleus and putamen but encompassing at least one-third of the MCA territory served as controls. Ischemic lesions involving striatal structures resulted in hyperintense lesions in ipsilateral midbrain that emerged between days 6 and 10 after stroke and were not present on the initial scans. In contrast, none of the control stroke patients developed secondary midbrain lesions. Hyperintense lesions in the pyramidal tract or the brain stem caused by degeneration of the corticospinal tract could be clearly distinguished from these secondary midbrain gray matter lesions and were detectable from day 2 after ischemia. Co-registration of high-resolution images with a digitized anatomic atlas revealed localization of secondary lesions primarily in the substantia nigra pars compacta. Apparent diffusion coefficient (ADC) values in the secondary lesions showed a delayed sharp decline through day 10. Normalization of ADC values was observed at late measurements. Taken together, our study demonstrates that striatal infarction elicits delayed degenerative changes in ipsilateral substantia nigra pars compacta.	[Winter, Benjamin; Brunecker, Peter; Fiebach, Jochen B.; Jungehulsing, Gerhard Jan; Kronenberg, Golo; Endres, Matthias] Charite, Ctr Stroke Res Berlin CSB, D-10117 Berlin, Germany; [Winter, Benjamin; Kronenberg, Golo; Endres, Matthias] Charite, Dept Neurol, D-10117 Berlin, Germany; [Jungehulsing, Gerhard Jan] Jud Krankenhaus Berlin, Dept Neurol, D-13347 Berlin, Germany; [Kronenberg, Golo] Charite, Dept Psychiat, D-10117 Berlin, Germany; [Kronenberg, Golo] Max Delbruck Ctr, D-13125 Berlin, Germany; [Kronenberg, Golo] Charite Med Fac, Expt & Clin Res Ctr, D-13125 Berlin, Germany; [Endres, Matthias] Charite, Excellence Cluster Neurocure, D-10117 Berlin, Germany; [Endres, Matthias] German Ctr Neurodegenerat Dis DZNE, D-53175 Bonn, Germany; [Endres, Matthias] German Ctr Cardiovasc Res DZHK, D-13347 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); German Centre for Cardiovascular Research	Endres, M (corresponding author), Charite, Ctr Stroke Res Berlin CSB, Charitepl 1, D-10117 Berlin, Germany.	matthias.endres@charite.de		Endres, Matthias/0000-0001-6520-3720; Fiebach, Jochen B./0000-0002-7936-6958; Kronenberg, Golo/0000-0002-5310-9849	Deutsche Forschungsgesellschaft (Excellence cluster NeuroCure) [SFB TR 43, KFO 247, KFO 213]; Bundesministerium fur Bildung und Forschung (Center for Stroke Research Berlin); European Union (European Stroke Network, WakeUp, Counterstroke); Volkswagen Foundation (Lichtenberg Program); Corona Foundation	Deutsche Forschungsgesellschaft (Excellence cluster NeuroCure); Bundesministerium fur Bildung und Forschung (Center for Stroke Research Berlin)(Federal Ministry of Education & Research (BMBF)); European Union (European Stroke Network, WakeUp, Counterstroke); Volkswagen Foundation (Lichtenberg Program); Corona Foundation	ME receives funding from the Deutsche Forschungsgesellschaft (Excellence cluster NeuroCure; SFB TR 43, KFO 247, KFO 213), Bundesministerium fur Bildung und Forschung (Center for Stroke Research Berlin), European Union (European Stroke Network, WakeUp, Counterstroke), Volkswagen Foundation (Lichtenberg Program) and the Corona Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2003, NMR BIOMED, V16, P152, DOI 10.1002/nbm.823; Baron JC, 2014, J CEREBR BLOOD F MET, V34, P2, DOI 10.1038/jcbfm.2013.188; Boutin H, 2007, ACTA NEUROPATHOL, V114, P491, DOI 10.1007/s00401-007-0269-7; Ebinger M, 2012, STROKE, V43, P539, DOI 10.1161/STROKEAHA.111.632026; FORNO LS, 1983, ACTA NEUROPATHOL, V62, P96, DOI 10.1007/BF00684925; Hall ED, 1996, BRAIN RES, V742, P80, DOI 10.1016/S0006-8993(96)00968-7; Hirouchi Y, 2007, EXP TOXICOL PATHOL, V59, P9, DOI 10.1016/j.etp.2007.02.008; HOEHNBERLAGE M, 1995, MAGN RESON MED, V34, P824, DOI 10.1002/mrm.1910340607; Hotter B, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-60; Kinoshita Toshibumi, 2002, Magn Reson Med Sci, V1, P175, DOI 10.2463/mrms.1.175; Kronenberg G, 2014, BRIT J PHARMACOL, V171, P4673, DOI 10.1111/bph.12775; Kronenberg G, 2012, BIOL PSYCHIAT, V72, P273, DOI 10.1016/j.biopsych.2012.02.026; LAPCHAK PA, 1993, NEUROSCIENCE, V53, P639, DOI 10.1016/0306-4522(93)90612-J; MAI JK, 2003, ATLAS HUMAN BRAIN; Nakajima M, 2010, INTERNAL MED, V49, P65, DOI 10.2169/internalmedicine.49.2694; Nakane M, 2001, AM J NEURORADIOL, V22, P660; NAKANE M, 1992, STROKE, V23, P328, DOI 10.1161/01.STR.23.3.328; NAKAYAMA H, 1990, Neurological Research, V12, P231; Ogawa T, 1997, RADIOLOGY, V204, P847, DOI 10.1148/radiology.204.3.9280270; Ohara S, 1989, Rinsho Shinkeigaku, V29, P1352; SAJI M, 1987, SCIENCE, V235, P66, DOI 10.1126/science.3798095; SAJI M, 1993, NEUROSCI LETT, V155, P47, DOI 10.1016/0304-3940(93)90670-G; Soriano MA, 1997, NEUROBIOL DIS, V4, P376, DOI 10.1006/nbdi.1997.0166; Sotak CH, 2004, NEUROCHEM INT, V45, P569, DOI 10.1016/j.neuint.2003.11.010; TAMURA A, 1990, BRAIN RES, V510, P154, DOI 10.1016/0006-8993(90)90744-V; Taskin B, 2006, CEREB CORTEX, V16, P1431, DOI 10.1093/cercor/bhj080; TULLOCH IF, 1978, J ANAT, V127, P425; Venkatesan R, 2000, MAGNET RESON MED, V43, P146, DOI 10.1002/(SICI)1522-2594(200001)43:1<146::AID-MRM18>3.0.CO;2-L; VOLPE BT, 1995, NEUROBIOL DIS, V2, P119, DOI 10.1006/nbdi.1995.0012; Zhang J, 2012, STROKE, V43, P1700, DOI 10.1161/STROKEAHA.111.632448; Zhao FY, 2001, BRAIN RES, V895, P238, DOI 10.1016/S0006-8993(00)03281-9; Zuhayra M, 2011, NEUROPATH APPL NEURO, V37, P738, DOI 10.1111/j.1365-2990.2011.01169.x	32	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136483	10.1371/journal.pone.0136483	http://dx.doi.org/10.1371/journal.pone.0136483			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325192	Green Published, gold, Green Accepted			2022-12-26	WOS:000360437700045
J	Seppala, J; Tossavainen, H; Rodic, N; Permi, P; Pentikainen, U; Ylanne, J				Seppala, Jonne; Tossavainen, Helena; Rodic, Nebojsa; Permi, Perttu; Pentikainen, Ulla; Ylanne, Jari			Flexible Structure of Peptide-Bound Filamin A Mechanosensor Domain Pair 20-21	PLOS ONE			English	Article							BIOLOGICAL MACROMOLECULES; AUTO-INHIBITION; BINDING; SCATTERING; FRAGMENT; MODEL; PHOSPHORYLATION; COMPETITION; RESOLUTION; MIGFILIN	Filamins (FLNs) are large, multidomain actin cross-linking proteins with diverse functions. Besides regulating the actin cytoskeleton, they serve as important links between the extracellular matrix and the cytoskeleton by binding cell surface receptors, functioning as scaffolds for signaling proteins, and binding several other cytoskeletal proteins that regulate cell adhesion dynamics. Structurally, FLNs are formed of an amino terminal actin-binding domain followed by 24 immunoglobulin-like domains (IgFLNs). Recent studies have demonstrated that myosin-mediated contractile forces can reveal hidden protein binding sites in the domain pairs IgFLNa18-19 and 20-21, enabling FLNs to transduce mechanical signals in cells. The atomic structures of these mechanosensor domain pairs in the resting state are known, as well as the structures of individual IgFLN21 with ligand peptides. However, little experimental data is available on how interacting protein binding deforms the domain pair structures. Here, using small-angle x-ray scattering-based modelling, x-ray crystallography, and NMR, we show that the adaptor protein migfilin-derived peptide-bound structure of IgFLNa20-21 is flexible and adopts distinctive conformations depending on the presence or absence of the interacting peptide. The conformational changes reported here may be common for all peptides and may play a role in the mechanosensor function of the site.	[Seppala, Jonne; Pentikainen, Ulla; Ylanne, Jari] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Seppala, Jonne; Pentikainen, Ulla; Ylanne, Jari] Univ Jyvaskyla, Nanosci Ctr, Jyvaskyla, Finland; [Tossavainen, Helena; Rodic, Nebojsa; Permi, Perttu] Univ Helsinki, Inst Biotechnol, Program Struct Biol & Biophys, Helsinki, Finland	University of Jyvaskyla; University of Jyvaskyla; University of Helsinki	Seppala, J (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland.	jonne.s.seppala@jyu.fi		Pentikainen, Ulla/0000-0001-6547-1282; Ylanne, Jari/0000-0003-4627-021X	Academy of Finland [138327, 259447, 121393, 283481]	Academy of Finland(Academy of Finland)	This work was funded by the Academy of Finland (http://www.aka.fi/en-GB/A/), grants 138327 (JY), 259447 (PP), 121393 and 283481 (UP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Chen HS, 2009, BIOPHYS J, V97, P3095, DOI 10.1016/j.bpj.2009.08.059; Chen H, 2013, SCI REP-UK, V3, DOI 10.1038/srep01642; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; Durand D, 2010, J STRUCT BIOL, V169, P45, DOI 10.1016/j.jsb.2009.08.009; Ehrlicher AJ, 2011, NATURE, V478, P260, DOI 10.1038/nature10430; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Furuike S, 2001, FEBS LETT, V498, P72, DOI 10.1016/S0014-5793(01)02497-8; Glogauer M, 1998, J BIOL CHEM, V273, P1689, DOI 10.1074/jbc.273.3.1689; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Heikkinen OK, 2009, J BIOL CHEM, V284, P25450, DOI 10.1074/jbc.M109.019661; Ithychanda SS, 2009, J BIOL CHEM, V284, P35113, DOI 10.1074/jbc.M109.060954; Ithychanda SS, 2009, J BIOL CHEM, V284, P4713, DOI 10.1074/jbc.M807719200; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kolahi KS, 2008, BIOPHYS J, V94, P1075, DOI 10.1529/biophysj.107.118802; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lad Y, 2007, EMBO J, V26, P3993, DOI 10.1038/sj.emboj.7601827; Lad Y, 2008, J BIOL CHEM, V283, P35154, DOI 10.1074/jbc.M802592200; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Marsh JA, 2010, BIOPHYS J, V98, P2383, DOI 10.1016/j.bpj.2010.02.006; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakamura F, 2006, BLOOD, V107, P1925, DOI 10.1182/blood-2005-10-3964; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Nakamura F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5656; Nakamura F, 2011, CELL ADHES MIGR, V5, P160, DOI 10.4161/cam.5.2.14401; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pentikainen U, 2011, J BIOL CHEM, V286, P26921, DOI 10.1074/jbc.M110.195958; Pentikainen U, 2009, J MOL BIOL, V393, P644, DOI 10.1016/j.jmb.2009.08.035; Pernot P, 2013, J SYNCHROTRON RADIAT, V20, P660, DOI 10.1107/S0909049513010431; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pudas R, 2005, STRUCTURE, V13, P111, DOI 10.1016/j.str.2004.10.014; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Razinia Z, 2012, ANNU REV BIOPHYS, V41, P227, DOI 10.1146/annurev-biophys-050511-102252; Rognoni L, 2012, P NATL ACAD SCI USA, V109, P19679, DOI 10.1073/pnas.1211274109; Ruskamo S, 2012, BIOCHEM J, V446, P261, DOI 10.1042/BJ20120361; Seo MD, 2009, PROTEINS, V75, P258, DOI 10.1002/prot.22336; Sethi R, 2014, J BIOL CHEM, V289, P8588, DOI 10.1074/jbc.M113.537456; Smith L, 2010, J BIOL CHEM, V285, P17166, DOI 10.1074/jbc.M109.080911; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Takala H, 2008, BLOOD, V112, P1853, DOI 10.1182/blood-2007-12-127795; Tossavainen H, 2012, J AM CHEM SOC, V134, P6660, DOI 10.1021/ja2114882; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Valentini E, 2015, NUCLEIC ACIDS RES, V43, pD357, DOI 10.1093/nar/gku1047; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Zhou AX, 2010, TRENDS CELL BIOL, V20, P113, DOI 10.1016/j.tcb.2009.12.001; Zhou X, 2007, TRENDS CARDIOVAS MED, V17, P222, DOI 10.1016/j.tcm.2007.08.001	55	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136969	10.1371/journal.pone.0136969	http://dx.doi.org/10.1371/journal.pone.0136969			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322797	Green Submitted, Green Published, gold			2022-12-26	WOS:000360435500055
J	Chen, X; Xie, CS; Sun, LX; Ding, JH; Cai, HB				Chen, Xi; Xie, Chengsong; Sun, Lixin; Ding, Jinhui; Cai, Huaibin			Longitudinal Metabolomics Profiling of Parkinson's Disease-Related alpha-Synuclein A53T Transgenic Mice	PLOS ONE			English	Article							AGE-RELATED-CHANGES; DOPAMINERGIC-NEURONS; ALANINE METABOLISM; REDOX PROTEOMICS; GLUTATHIONE; BRAIN; GUANOSINE; TRANSPORT; URATE; LOCALIZATION	Metabolic homeostasis is critical for all biological processes in the brain. The metabolites are considered the best indicators of cell states and their rapid fluxes are extremely sensitive to cellular changes. While there are a few studies on the metabolomics of Parkinson's disease, it lacks longitudinal studies of the brain metabolic pathways affected by aging and the disease. Using ultra-high performance liquid chromatography and tandem mass spectroscopy (UPLC/MS), we generated the metabolomics profiling data from the brains of young and aged male PD-related alpha-synuclein A53T transgenic mice as well as the age- and gender-matched non-transgenic (nTg) controls. Principal component and unsupervised hierarchical clustering analyses identified distinctive metabolites influenced by aging and the A53T mutation. The following metabolite set enrichment classification revealed the alanine metabolism, redox and acetyl-CoA biosynthesis pathways were substantially disturbed in the aged mouse brains regardless of the genotypes, suggesting that aging plays a more prominent role in the alterations of brain metabolism. Further examination showed that the interaction effect of aging and genotype only disturbed the guanosine levels. The young A53T mice exhibited lower levels of guanosine compared to the age- matched nTg controls. The guanosine levels remained constant between the young and aged nTg mice, whereas the aged A53T mice showed substantially increased guanosine levels compared to the young mutant ones. In light of the neuroprotective function of guanosine, our findings suggest that the increase of guanosine metabolism in aged A53T mice likely represents a protective mechanism against neurodegeneration, while monitoring guanosine levels could be applicable to the early diagnosis of the disease.	[Chen, Xi; Xie, Chengsong; Sun, Lixin; Cai, Huaibin] NIA, Transgen Sect, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Ding, Jinhui] NIA, Bioinformat Core, Neurogenet Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Cai, HB (corresponding author), NIA, Transgen Sect, Neurogenet Lab, NIH, Bethesda, MD 20892 USA.	caih@mail.nih.gov	Cai, Huaibin/H-3359-2013	Cai, Huaibin/0000-0002-8596-6108	National Institutes of Health [AG000928, AG000929]; NATIONAL INSTITUTE ON AGING [ZIAAG000929, ZIAAG000945, ZIAAG000928] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants AG000928 and AG000929, http://grants.nih.gov/grants/oer.htm.	Ascherio A, 2009, ARCH NEUROL-CHICAGO, V66, P1460, DOI 10.1001/archneurol.2009.247; Bak LK, 2006, J NEUROCHEM, V98, P641, DOI 10.1111/j.1471-4159.2006.03913.x; BIFFO S, 1990, NEUROSCIENCE, V35, P637, DOI 10.1016/0306-4522(90)90335-2; Boldyrev AA, 2013, PHYSIOL REV, V93, P1803, DOI 10.1152/physrev.00039.2012; Bonfanti L, 1999, PROG NEUROBIOL, V59, P333, DOI 10.1016/S0301-0082(99)00010-6; Breiman L., 2001, MACH LEARN, V45, P5; Broer S, 2007, J NEUROCHEM, V102, P1758, DOI 10.1111/j.1471-4159.2007.04654.x; Brooks JCW, 2001, CEREB CORTEX, V11, P598, DOI 10.1093/cercor/11.7.598; Calabrese V, 2010, METHODS MOL BIOL, V610, P285, DOI 10.1007/978-1-60327-029-8_17; Cascante M, 1996, J THEOR BIOL, V182, P317, DOI 10.1006/jtbi.1996.0170; Chang R, 2008, NEUROSCI LETT, V431, P101, DOI 10.1016/j.neulet.2007.11.072; CHEN TS, 1989, P SOC EXP BIOL MED, V190, P399; Di Iorio P, 2004, GLIA, V46, P356, DOI 10.1002/glia.20002; Giordano G, 2011, METHODS MOL BIOL, V758, P205, DOI 10.1007/978-1-61779-170-3_14; Kaiser LG, 2005, NEUROBIOL AGING, V26, P665, DOI 10.1016/j.neurobiolaging.2004.07.001; LeWitt Peter, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS49, DOI 10.1016/S1353-8020(11)70017-7; Li DW, 2013, INT J MOL MED, V32, P108, DOI 10.3892/ijmm.2013.1361; Lin X, 2012, J NEUROSCI, V32, P9248, DOI 10.1523/JNEUROSCI.1731-12.2012; Lopez M, 2008, CURR OPIN CLIN NUTR, V11, P483, DOI 10.1097/MCO.0b013e328302f3d8; MARTINEZHERNANDEZ A, 1977, SCIENCE, V195, P1356, DOI 10.1126/science.14400; Nie K, 2013, PARKINSONISM RELAT D, V19, P329, DOI 10.1016/j.parkreldis.2012.11.012; O'Reilly EJ, 2010, AM J EPIDEMIOL, V172, P666, DOI 10.1093/aje/kwq195; Pal NR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-5; Perluigi M, 2010, J NEUROSCI RES, V88, P3498, DOI 10.1002/jnr.22500; Perluigi M, 2014, AGEING RES REV, V13, P75, DOI 10.1016/j.arr.2013.12.005; Pettifer KM, 2007, PURINERG SIGNAL, V3, P399, DOI 10.1007/s11302-007-9073-z; Pettifer KM, 2004, NEUROREPORT, V15, P833, DOI 10.1097/00001756-200404090-00019; Poliquin PO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069146; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rathbone MP, 1999, PROG NEUROBIOL, V59, P663, DOI 10.1016/S0301-0082(99)00017-9; Rebrin I, 2003, FREE RADICAL BIO MED, V35, P626, DOI 10.1016/S0891-5849(03)00388-5; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Schlesinger I, 2008, MOVEMENT DISORD, V23, P1653, DOI 10.1002/mds.22139; Schuff N, 2001, MAGN RESON MED, V45, P899, DOI 10.1002/mrm.1119; Schwarzschild MA, 2008, ARCH NEUROL-CHICAGO, V65, P716, DOI 10.1001/archneur.2008.65.6.nct70003; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; Touw WG, 2013, BRIEF BIOINFORM, V14, P315, DOI 10.1093/bib/bbs034; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Yudkoff M, 1997, GLIA, V21, P92, DOI 10.1002/(SICI)1098-1136(199709)21:1<92::AID-GLIA10>3.0.CO;2-W; Zhang C, 2012, J ALZHEIMERS DIS, V28, P655, DOI 10.3233/JAD-2011-111244; Zhu YG, 2006, BRAIN RES, V1090, P35, DOI 10.1016/j.brainres.2006.03.063; Zwingmann C, 2001, GLIA, V34, P200, DOI 10.1002/glia.1054; Zwingmann C, 2000, GLIA, V32, P286, DOI 10.1002/1098-1136(200012)32:3<286::AID-GLIA80>3.0.CO;2-P	45	29	29	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136612	10.1371/journal.pone.0136612	http://dx.doi.org/10.1371/journal.pone.0136612			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317866	Green Published, Green Submitted, gold			2022-12-26	WOS:000360299100112
J	Nouraie, M; Kansal, V; Belfonte, C; Ghazvini, M; Haidari, T; Shahnazi, A; Brim, H; Soliman, EZ; Ashktorab, H				Nouraie, Mehdi; Kansal, Vandana; Belfonte, Cassius; Ghazvini, Mohammad; Haidari, Tahmineh; Shahnazi, Anahita; Brim, Hassan; Soliman, Elsayed Z.; Ashktorab, Hassan			Atrial Fibrillation and Colonic Neoplasia in African Americans	PLOS ONE			English	Article							COLORECTAL-CANCER; RISK-FACTORS; RACIAL-DIFFERENCES; PREVALENCE; DISPARITIES; STROKE; EPIDEMIOLOGY; SURVIVAL; OUTCOMES; COHORT	Background Colorectal cancer (CRC) and atrial fibrillation/flutter (AF) share several risk factors including increasing age and obesity. However, the association between CRC and AF has not been thoroughly examined, especially in African Americans. In this study we aimed to assess the prevalence of AF and its risk factors in colorectal neoplasia in an African American. Methods We reviewed records of 527 African American patients diagnosed with CRC and 1008 patients diagnosed with benign colonic lesions at Howard University Hospital from January 2000 to December 2012. A control group of 731 hospitalized patients without any cancer or colonic lesion were randomly selected from the same time and age range, excluding patients who had diagnosis of both CRC and/or adenoma. The presence or absence of AF was based upon ICD-9 code documentation. The prevalence of AF in these three groups was compared by multivariate logistic regression. Results The prevalence of AF was highest among CRC patients (10%) followed by adenoma patients (7.2%) then the control group (5.4%, P for trend = 0.002). In the three groups of participants, older age (P<0.008) and heart failure (P<0.001) were significantly associated with higher risk of AF. After adjusting for these risk factors, CRC (OR: 1.4(95% CI): 0.9-2.2, P = 0.2) and adenoma (OR: 1.1(95% CI): 0.7-1.6, P = 0.7) were not significantly associated AF compared to control group. Conclusions AF is highly prevalent among CRC patients; 1 in 10 patients had AF in our study. The predictors of AF in CRC was similar to that in adenoma and other patients after adjustment for potential confounders suggesting that the increased AF risk in CRC is explained by higher prevalence of AF risk factors.	[Nouraie, Mehdi; Kansal, Vandana; Haidari, Tahmineh; Shahnazi, Anahita; Brim, Hassan; Ashktorab, Hassan] Howard Univ, Coll Med, Canc Res Ctr, Washington, DC 20059 USA; [Nouraie, Mehdi; Kansal, Vandana; Haidari, Tahmineh; Shahnazi, Anahita; Ashktorab, Hassan] Howard Univ, Coll Med, Dept Med, Washington, DC USA; [Belfonte, Cassius; Ghazvini, Mohammad] Howard Univ, Coll Med, Dept Med, Div Cardiol, Washington, DC USA; [Brim, Hassan] Howard Univ, Coll Med, Dept Pathol, Washington, DC USA; [Soliman, Elsayed Z.] Wake Forest Sch Med, Epidemiol Cardiol Res Ctr, Dept Epidemiol & Prevent, Winston Salem, NC USA; [Soliman, Elsayed Z.] Wake Forest Sch Med, Dept Internal Med Cardiol, Winston Salem, NC USA	Howard University; Howard University; Howard University; Howard University; Wake Forest University; Wake Forest University	Nouraie, M (corresponding author), Howard Univ, Coll Med, Canc Res Ctr, Washington, DC 20059 USA.	snouraie@howard.edu; hashktorab@howard.edu	Ashktorab, hassan/AAJ-2908-2020; Nouraie, Seyed Mehdi/O-4071-2018; Soliman, Elsayed Z/AAD-7135-2020	Nouraie, Seyed Mehdi/0000-0001-7465-0581; Soliman, Elsayed Z/0000-0001-5632-8150	National Institute on Minority Health and Health Disparities of the National Institutes of Health [G12MD007597]; National Institute on Minority Health and Health Disparities [G12MD007597] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities of the National Institutes of Health; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This project was supported by the National Institute on Minority Health and Health Disparities of the National Institutes of Health under Award Number G12MD007597. Sponsor had no role in study design and report.	Alonso A, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000102; Ashktorab H, 2014, DIGEST DIS SCI, V59, P446, DOI 10.1007/s10620-013-2898-0; Aziz S A, 1998, Clin Oncol (R Coll Radiol), V10, P377, DOI 10.1016/S0936-6555(98)80033-2; Batra GS, 2001, ANN ROY COLL SURG, V83, P174; Borzecki AM, 2008, J NATL MED ASSOC, V100, P237, DOI 10.1016/S0027-9684(15)31212-8; Brandstedt J, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-293; Delaney JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032338; Dimou A, 2009, WORLD J GASTROENTERO, V15, P3734, DOI 10.3748/wjg.15.3734; Erichsen R, 2012, INTERN EMERG MED, V7, P431, DOI 10.1007/s11739-011-0701-9; Farmakis D, 2014, J AM COLL CARDIOL, V63, P945, DOI 10.1016/j.jacc.2013.11.026; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Guzzetti S, 2002, CIRCULATION, V106, pE40, DOI 10.1161/01.CIR.0000028399.42411.13; Guzzetti S, 2002, AM J MED, V112, P587, DOI 10.1016/S0002-9343(02)01029-X; Guzzetti S, 2008, INTERN EMERG MED, V3, P227, DOI 10.1007/s11739-008-0124-4; Guzzetti Stefano, 2003, Recenti Progressi in Medicina, V94, P260; Hernandez MB, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/275624; Imperatori Andrea, 2012, J Cardiothorac Surg, V7, P4, DOI 10.1186/1749-8090-7-4; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; KANNEL WB, 1998, AM J CARDIOL, V0082; Knuiman M, 2014, EUR J EPIDEMIOL, V29, P181, DOI 10.1007/s10654-013-9875-y; Korantzopoulos Panagiotis, 2003, Med Sci Monit, V9, pRA225; Laiyemo AO, 2010, JNCI-J NATL CANCER I, V102, P538, DOI 10.1093/jnci/djq068; MAY D, 1990, DEUT MED WOCHENSCHR, V115, P618, DOI 10.1055/s-2008-1065055; MULLER AD, 1994, DIGEST DIS SCI, V39, P2480, DOI 10.1007/BF02087670; Okin PM, 2014, AM J HYPERTENS, V27, P966, DOI 10.1093/ajh/hpu006; Pathak EB, 2009, NEUROEPIDEMIOLOGY, V32, P302, DOI 10.1159/000208795; Psaty BM, 1997, CIRCULATION, V96, P2455; Ruo B, 2004, J AM COLL CARDIOL, V43, P429, DOI 10.1016/j.jacc.2003.09.035; Soliman EZ, 2009, FUTUR CARDIOL, V5, P547, DOI 10.2217/FCA.09.49; Soliman EZ, 2009, STROKE, V40, P1204, DOI 10.1161/STROKEAHA.108.534735; Stansbury JP, 2005, STROKE, V36, P374, DOI 10.1161/01.STR.0000153065.39325.fd; Sutcliffe P, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17430; Thomas KL, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000200; Thun MJ, 2002, JNCI-J NATL CANCER I, V94, P252, DOI 10.1093/jnci/94.4.252; Upshaw CB, 2002, J NATL MED ASSOC, V94, P204; Vivas Yoel, 2005, Conn Med, V69, P405; Weng M C, 1995, Zhonghua Yi Xue Za Zhi (Taipei), V55, P266; White A, 2008, CANCER, V113, P3400, DOI 10.1002/cncr.23924; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yang TL, 2014, J CHIN MED ASSOC, V77, P117, DOI 10.1016/j.jcma.2013.11.004	40	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135609	10.1371/journal.pone.0135609	http://dx.doi.org/10.1371/journal.pone.0135609			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317627	gold, Green Published, Green Submitted			2022-12-26	WOS:000360299100038
J	Terres, MA; Lawrence, E; Hosack, GR; Haywood, MDE; Babcock, RC				Terres, Maria A.; Lawrence, Emma; Hosack, Geoffrey R.; Haywood, Michael D. E.; Babcock, Russell C.			Assessing Habitat Use by Snapper (Chrysophrys auratus) from Baited Underwater Video Data in a Coastal Marine Park	PLOS ONE			English	Article							REEF FISH ASSEMBLAGES; LONG-TERM PROTECTION; PAGRUS-AURATUS; TEMPORAL VARIATION; RESERVES; AREAS; RECOVERY; PREDICTION; AUSTRALIA; SPARIDAE	Baited Underwater Video (BUV) systems have become increasingly popular for assessing marine biodiversity. These systems provide video footage from which biologists can identify the individual fish species present. Here we explore the relevance of spatial dependence and marine park boundaries while estimating the distribution and habitat associations of the commercially and recreationally important snapper species Chrysophrys auratus in Moreton Bay Marine Park during a period when new Marine National Parks zoned as no-take or "green" areas (i.e., areas with no legal fishing) were introduced. BUV studies typically enforce a minimum distance among BUV sites, and then assume that observations from different sites are independent conditional on the measured covariates. In this study, we additionally incorporated the spatial dependence among BUV sites into the modelling framework. This modelling approach allowed us to test whether or not the incorporation of highly correlated environmental covariates or the geographic placement of BUV sites produced spatial dependence, which if unaccounted for could lead to model bias. We fitted Bayesian logistic models with and without spatial random effects to determine if the Marine National Park boundaries and available environmental covariates had an effect on snapper presence and habitat preference. Adding the spatial dependence component had little effect on the resulting model parameter estimates that emphasized positive association for particular coastal habitat types by snapper. Strong positive relationships between the presence of snapper and rock habitat, particularly rocky substrate composed of indurated freshwater sediments known as coffee rock, and kelp habitat reinforce the consideration of habitat availability in marine reserve design and the design of any associated monitoring programs.	[Terres, Maria A.] N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; [Lawrence, Emma] CSIRO, Digital Prod Flagship, Dutton Pk, Qld, Australia; [Hosack, Geoffrey R.] CSIRO, Digital Prod Flagship, Hobart, Tas, Australia; [Haywood, Michael D. E.; Babcock, Russell C.] CSIRO, Oceans & Atmosphere Flagship, Dutton Pk, Qld, Australia	University of North Carolina; North Carolina State University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Terres, MA (corresponding author), N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA.	mterres.stat@gmail.com	Babcock, Russell C/A-3794-2012; Hosack, Geoffrey R/E-8566-2010; Lawrence, Emma/A-5584-2009	Babcock, Russell C/0000-0002-7756-1290; Hosack, Geoffrey R/0000-0002-6462-6817; 	Australian Government's National Environmental Research Program (NERP); CSIRO Marine and Atmospheric Research; DERM (Queensland Department of Environment and Resource Management)	Australian Government's National Environmental Research Program (NERP)(Australian Government); CSIRO Marine and Atmospheric Research(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); DERM (Queensland Department of Environment and Resource Management)	This work was undertaken for the Marine Biodiversity Hub, a collaborative partnership supported through funding from the Australian Government's National Environmental Research Program (NERP). NERP Marine Biodiversity Hub partners include the Institute for Marine and Antarctic Studies, University of Tasmania; CSIRO, Geoscience Australia, Australian Institute of Marine Science, Museum Victoria, Charles Darwin University and the University of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funding for the fieldwork was jointly (50:50) provided by CSIRO Marine and Atmospheric Research and DERM (Queensland Department of Environment and Resource Management).	Afonso P, 2011, BIOL CONSERV, V144, P2739, DOI 10.1016/j.biocon.2011.07.028; [Anonymous], 2011, STOCK STATUS QUEENSL; Banerjee S., 2004, HIERARCHICAL MODELIN; Brooke B, 2008, AUSTR J EARTH SCI, V107, P18278; Campbell A.B., 2009, STOCK ASSESSMENT SUM; Cappo M, 2004, J EXP MAR BIOL ECOL, V302, P123, DOI 10.1016/j.jembe.2003.10.006; Cappo M., 2007, CUTTINGEDGE TECHNOLO, V1, P101; Cappo M, 2003, AQUATIC PROTECTED AR; Clark JS, 2005, ECOL LETT, V8, P2, DOI 10.1111/j.1461-0248.2004.00702.x; Denny Christopher M., 2003, DOC Science Internal Series, V142, P1; Denny CM, 2004, MAR ECOL PROG SER, V272, P183, DOI 10.3354/meps272183; Dunlop KM, 2014, MARINE ECOLOGY, P1; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; ELLIS DM, 1995, FISH B-NOAA, V93, P67; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Ferrell D., 1997, ASSESSMENT FISHERY S; Fletcher WJ, ECOLOGICAL IN PRESS; Gelman A, 2008, ANN APPL STAT, V2, P1360, DOI 10.1214/08-AOAS191; Harasti D, 2015, J EXP MAR BIOL ECOL, V463, P173, DOI 10.1016/j.jembe.2014.12.003; Harriott VJ, 2002, CORAL REEFS, V21, P83, DOI 10.1007/s00338-001-0201-x; Harvey ES, 2007, MAR ECOL PROG SER, V350, P245, DOI 10.3354/meps07192; Lubchenco J, 2003, ECOL APPL, V13, pS1; Malcolm HA, 2007, MAR ECOL PROG SER, V350, P277, DOI 10.3354/meps07195; Malcolm HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127616; McClanahan TR, 2000, BIOL CONSERV, V94, P191, DOI 10.1016/S0006-3207(99)00176-7; McClanahan TR, 2005, MAR ECOL PROG SER, V294, P241, DOI 10.3354/meps294241; McCook LJ, 2010, P NATL ACAD SCI US; Mclean DL, 2011, J EXP MAR BIOL ECOL, V406, P71, DOI 10.1016/j.jembe.2011.06.009; McLean DL, 2010, MAR ECOL PROG SER, V418, P189, DOI 10.3354/meps08834; McPhee DP, 2007, 2007053 FRDC AUSTR G; Moore CH, 2011, ECOGRAPHY, V34, P425, DOI 10.1111/j.1600-0587.2010.06436.x; Moore CH, 2009, ICES J MAR SCI, V66, P2068, DOI 10.1093/icesjms/fsp205; Mosqueira I, 2000, ANIM CONSERV, V3, P321, DOI 10.1017/S1367943000001049; Parsons DM, 2011, CAN J FISH AQUAT SCI, V68, P632, DOI 10.1139/F11-005; Parsons DM, 2003, MAR ECOL PROG SER, V262, P253, DOI 10.3354/meps262253; Roberts CM, 2003, ECOL APPL, V13, pS199; Ross PM, 2007, MAR FRESHWATER RES, V58, P1144, DOI 10.1071/MF07017; ROSSI RE, 1992, ECOL MONOGR, V62, P277, DOI 10.2307/2937096; Russ GR, 2008, CURR BIOL, V18, pR514, DOI 10.1016/j.cub.2008.04.016; Russ GR, 2004, OECOLOGIA, V138, P622, DOI 10.1007/s00442-003-1456-4; Russ GR, 2002, YET ANOTHER REV MARI, P421; Samoilys MA, 2007, BIOL CONSERV, V136, P584, DOI 10.1016/j.biocon.2007.01.003; Sangil C, 2012, ESTUAR COAST SHELF S, V112, P207, DOI 10.1016/j.ecss.2012.07.025; Smith ANH, 2014, MAR ECOL PROG SER, V499, P203, DOI 10.3354/meps10653; Stevens DL, 2004, J AM STAT ASSOC, V99, P262, DOI 10.1198/016214504000000250; Stevens T, 2005, MAR FRESHWATER RES, V56, P111, DOI 10.1071/MF04233; Sumpton W, 2005, FISH RES, V71, P335, DOI 10.1016/j.fishres.2004.07.003; Sumpton W, 2003, MAR FRESH RES, V54, P1, DOI [10.1071/MF02041, DOI 10.1071/MF02041]; Watson DL, 2010, MAR BIOL, V157, P1237, DOI 10.1007/s00227-010-1404-x; Watson DL, 2006, USE OF UNDERWATER ST; Webley J, 2009, SURVEY MARINE BOAT B; Westera M, 2003, J EXP MAR BIOL ECOL, V294, P145, DOI 10.1016/S0022-0981(03)00268-5; Willis TJ, 2000, MAR FRESHWATER RES, V51, P755, DOI 10.1071/MF00010; Willis TJ, 2003, MAR ECOL PROG SER, V257, P209, DOI 10.3354/meps257209; Willis TJ, 2003, ENVIRON CONSERV, V30, P97, DOI 10.1017/S0376892903000092; Willis TJ, 2001, NEW ZEAL J MAR FRESH, V35, P581, DOI 10.1080/00288330.2001.9517024	57	7	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136799	10.1371/journal.pone.0136799	http://dx.doi.org/10.1371/journal.pone.0136799			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317655	Green Submitted, Green Published, gold			2022-12-26	WOS:000360299100142
J	Wu, S; Wu, QP; Zhang, JM; Chen, MT; Yan, ZA; Hu, HJ				Wu, Shi; Wu, Qingping; Zhang, Jumei; Chen, Moutong; Yan, Ze'an; Hu, Huijuan			Listeria monocytogenes Prevalence and Characteristics in Retail Raw Foods in China	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; ANTIBIOTIC-RESISTANCE; EPIDEMIC CLONES; PROCESSING ENVIRONMENT; CONTAMINATION PATTERNS; GENETIC DIVERSITY; GENUS LISTERIA; MULTIPLEX PCR; VIRULENCE; STRAINS	The prevalence and levels of Listeria monocytogenes in retail raw foods covering most provincial capitals in China were studied with testing of 1036 samples of vegetables, edible mushrooms, raw meat, aquatic products and quick-frozen products from September 2012 to January 2014. The total prevalence of Listeria monocytogenes was 20.0% (207/1036), and the most probable number (MPN) values of 65.7% of the positive samples ranged from 0.3 to 110 MPN/g. Geographical differences were observed in this survey, and the results of both qualitative and quantitative methods indicated that the levels in the samples from North China were higher than those in the samples from South China. A total of 248 isolates were analyzed, of which approximately half belonged to molecular serogroup 1/2a-3a (45.2%), followed by 1/2b-3b-7 (30.6%), 1/2c-3c (16.1%), 4b-4d-4e (5.2%) and 4a-4c (2.8%). Most of the isolates carried hly (100%), inlB (98.8%), inlA (99.6%), inlC (98.0%) and inlJ (99.2%), and 44.8% of the isolates were llsX-positive. Seventeen epidemic clones (ECs) were detected, with 7 strains belonging to ECI (2.8%) and 10 belonging to ECIII (4.03%). Resistance to clindamycin (46.8%) was commonly observed, and 59 strains (23.8%) were susceptible to all 14 tested antibiotics, whereas 84 (33.9%) showed an intermediate level of resistance or were resistant to two or more antibiotics, including 7 multiresistant strains that exhibited resistance to more than 10 antibiotics. The data obtained in the present study provides useful information for assessment of the possible risk posed to Chinese consumers, and this information will have a significant public health impact in China. Furthermore, the presence of virulence markers, epidemic clones, as well as the antibiotic resistance amongst the isolates strongly implies that many of these strains might be capable of causing listeriosis, and more accurate treatment of human listeriosis with effective antibiotics should be considered. This research represents a more full-scale and systematical investigation of the prevalence of L. monocytogenes in retail raw foods in China, and it provides baseline information for Chinese regulatory authorities that will aid in the formulation of a regulatory framework for controlling L. monocytogenes with the aim of improving the microbiological safety of raw foods.	[Wu, Shi; Chen, Moutong; Hu, Huijuan] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China; [Wu, Shi; Wu, Qingping; Zhang, Jumei; Chen, Moutong; Yan, Ze'an; Hu, Huijuan] Guangdong Inst Microbiol, State Key Lab Appl Microbiol Southern China, Guangdong Prov Key Lab Microbial Culture Collect, Guangdong Open Lab Appl Microbiol, Guangzhou, Guangdong, Peoples R China	South China University of Technology; Guangdong Academy of Sciences; Institute of Microbiology, Guangdong Academy of Sciences	Wu, QP (corresponding author), Guangdong Inst Microbiol, State Key Lab Appl Microbiol Southern China, Guangdong Prov Key Lab Microbial Culture Collect, Guangdong Open Lab Appl Microbiol, Guangzhou, Guangdong, Peoples R China.	wuqp203@163.com			National Natural Science Foundation of China [U1031003, 31471664]; Key Projects in the National Science & Technology Pillar Program [2013BAD16B05]; Science and Technology Projects of Guangdong [2013B050800026]; Science and Technology Projects of Guangzhou [201504010036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the National Science & Technology Pillar Program; Science and Technology Projects of Guangdong; Science and Technology Projects of Guangzhou	Our study was supported by the financing support of National Natural Science Foundation of China (No. U1031003, QPW; No. 31471664, QPW), Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (2013BAD16B05, QPW), the Science and Technology Projects of Guangdong (2013B050800026, JMZ) and the Science and Technology Projects of Guangzhou (201504010036, QPW).	Adzitey F, 2013, FOOD CONTROL, V32, P607, DOI 10.1016/j.foodcont.2012.12.016; [Anonymous], 2001, J FOOD SCI, DOI DOI 10.1111/J.1365-2621.2001.TB15526.X; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Bayles DO, 1996, APPL ENVIRON MICROB, V62, P1116, DOI 10.1128/AEM.62.3.1116-1119.1996; Beauchamp CS, 2010, FOOD MICROBIOL, V27, P144, DOI 10.1016/j.fm.2009.09.007; Borucki MK, 2003, VET MICROBIOL, V92, P351, DOI 10.1016/S0378-1135(02)00423-6; BUCHRIESER C, 1993, CAN J MICROBIOL, V39, P395, DOI 10.1139/m93-058; BULA CJ, 1995, CLIN INFECT DIS, V20, P66, DOI 10.1093/clinids/20.1.66; Chao GX, 2007, FOODBORNE PATHOG DIS, V4, P277, DOI 10.1089/fpd.2007.0088; Charpentier E, 1999, ANTIMICROB AGENTS CH, V43, P2103, DOI 10.1128/AAC.43.9.2103; Chen BY, 2010, LETT APPL MICROBIOL, V50, P626, DOI 10.1111/j.1472-765X.2010.02843.x; Chen JS, 2009, FOODBORNE PATHOG DIS, V6, P7, DOI 10.1089/fpd.2008.0139; Chen MT, 2014, FOODBORNE PATHOG DIS, V11, P620, DOI 10.1089/fpd.2013.1727; Chen MT, 2014, FOOD CONTROL, V38, P1, DOI 10.1016/j.foodcont.2013.09.061; Chen Y, 2007, APPL ENVIRON MICROB, V73, P6299, DOI 10.1128/AEM.00961-07; Chen Y, 2007, J CLIN MICROBIOL, V45, P835, DOI 10.1128/JCM.01575-06; Clayton EM, 2011, APPL ENVIRON MICROB, V77, P163, DOI 10.1128/AEM.01673-10; Clinical and Laboratory Standards Institute, 2006, M2A9 CLSI; Conter M, 2009, INT J FOOD MICROBIOL, V128, P497, DOI 10.1016/j.ijfoodmicro.2008.10.018; Cotter PD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000144; den Bakker HC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-688; Dmowska K, 2013, B VET I PULAWY, V57, P179, DOI 10.2478/bvip-2013-0033; Doumith M, 2004, J CLIN MICROBIOL, V42, P3819, DOI 10.1128/JCM.42.8.3819-3822.2004; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2597; Filiousis G, 2009, FOOD CONTROL, V20, P314, DOI 10.1016/j.foodcont.2008.05.018; Godreuil S, 2003, ANTIMICROB AGENTS CH, V47, P704, DOI 10.1128/AAC.47.2.704-708.2003; Gombas DE, 2003, J FOOD PROTECT, V66, P559, DOI 10.4315/0362-028X-66.4.559; Gudbjornsdottir B, 2004, FOOD MICROBIOL, V21, P217, DOI 10.1016/S0740-0020(03)00012-1; Hansen CH, 2006, J FOOD PROTECT, V69, P2113, DOI 10.4315/0362-028X-69.9.2113; Harakeh S, 2009, SCI TOTAL ENVIRON, V407, P4022, DOI 10.1016/j.scitotenv.2009.04.010; HEISICK JE, 1989, APPL ENVIRON MICROB, V55, P1925, DOI 10.1128/AEM.55.8.1925-1927.1989; Helwigh B, 2007, COMMUNITY SUMMARY RE; Hoffman AD, 2003, J FOOD PROTECT, V66, P52, DOI 10.4315/0362-028X-66.1.52; Inoue S, 2000, INT J FOOD MICROBIOL, V59, P73, DOI 10.1016/S0168-1605(00)00284-1; Jensen A, 2008, INT J FOOD MICROBIOL, V123, P254, DOI 10.1016/j.ijfoodmicro.2008.02.016; Jia YM, 2007, FOODBORNE PATHOG DIS, V4, P222, DOI 10.1089/fpd.2006.0081; Kathariou S., 2003, Microbial food safety in animal agriculture: current topics, P243, DOI 10.1002/9780470752616.ch25; Kathariou S, 2002, J FOOD PROTECT, V65, P1811, DOI 10.4315/0362-028X-65.11.1811; Knabel SJ, 2012, J CLIN MICROBIOL, V50, P1748, DOI 10.1128/JCM.06185-11; Korsak D, 2012, INT J FOOD MICROBIOL, V158, P203, DOI 10.1016/j.ijfoodmicro.2012.07.016; Liu D., 2008, HDB LISTERIA MONOCYT; Liu D, 2007, J MICROBIOL METH, V71, P133, DOI 10.1016/j.mimet.2007.08.007; Lomonaco S, 2009, INT J FOOD MICROBIOL, V128, P516, DOI 10.1016/j.ijfoodmicro.2008.10.009; Lomonaco S, 2013, EMERG INFECT DIS, V19, P147, DOI 10.3201/eid1901.121167; Mammina C, 2009, J CLIN MICROBIOL, V47, P2925, DOI 10.1128/JCM.00102-09; Motes ML, 1998, APPL ENVIRON MICROB, V64, P1459; Nesbakken T, 1996, INT J FOOD MICROBIOL, V31, P161, DOI 10.1016/0168-1605(96)00978-6; Norhana MNW, 2010, FOOD CONTROL, V21, P343, DOI 10.1016/j.foodcont.2009.06.020; Pesavento G, 2010, FOOD CONTROL, V21, P708, DOI 10.1016/j.foodcont.2009.10.012; Rahimi E, 2012, ANN MICROBIOL, V62, P37, DOI 10.1007/s13213-011-0222-9; Razavilar V, 1998, INT J FOOD MICROBIOL, V40, P149, DOI 10.1016/S0168-1605(98)00014-2; Ryser ET., 2007, FOOD SCI TECH-BRAZIL; Sant'Ana AS, 2012, INT J FOOD MICROBIOL, V155, P1, DOI 10.1016/j.ijfoodmicro.2011.12.036; Sauders BD, 2006, J FOOD PROTECT, V69, P1680, DOI 10.4315/0362-028X-69.7.1680; Shen JL, 2013, FOOD MICROBIOL, V35, P58, DOI 10.1016/j.fm.2013.02.014; Shen Y, 2006, APPL ENVIRON MICROB, V72, P5073, DOI 10.1128/AEM.00435-06; Soni DK, 2013, INFECT GENET EVOL, V14, P83, DOI 10.1016/j.meegid.2012.09.019; Todd ECD, 2011, FOOD CONTROL, V22, P1484, DOI 10.1016/j.foodcont.2010.07.021; Wang XM, 2013, FOOD CONTROL, V32, P153, DOI 10.1016/j.foodcont.2012.11.032; Wang YM, 2010, CHINESE J FOOD HYGIE, V5, P018; Wieczorek K, 2012, APPL ENVIRON MICROB, V78, P2043, DOI 10.1128/AEM.07156-11; Wong W. C., 2012, International Food Research Journal, V19, P1751; World Health Organization, 2007, P 2 WHO EXP M COP DE; Wu S, 2015, FOOD CONTROL, V47, P340, DOI 10.1016/j.foodcont.2014.07.028; Xu X. K., 2009, CHINESE J HLTH LAB T, V19, P1199; Yan H, 2010, INT J FOOD MICROBIOL, V144, P310, DOI 10.1016/j.ijfoodmicro.2010.10.015; Yu T, 2014, FOOD CONTROL, V37, P228, DOI 10.1016/j.foodcont.2013.09.047; Zarei M, 2012, FOODBORNE PATHOG DIS, V9, P108, DOI 10.1089/fpd.2011.0989	68	69	78	6	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136682	10.1371/journal.pone.0136682	http://dx.doi.org/10.1371/journal.pone.0136682			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317852	Green Submitted, Green Published, gold			2022-12-26	WOS:000360299100120
J	Wang, Y; Wang, BH				Wang, Yang; Wang, Binghong			Evolution of Cooperation on Spatial Network with Limited Resource	PLOS ONE			English	Article							PRISONERS-DILEMMA GAME; RECIPROCITY; PUNISHMENT; EMERGENCE; DIVERSITY; PROMOTES	Considering the external resource offered by environment is limited, here, we will explore the cooperation on spatial networks with limited resource. The individual distributes the limited resource according to the payoffs acquired in games, and one with resource amounts is lower than critical survival resource level will be replaced by the offspring of its neighbors. We find that, for larger temptation to defect, the number of the dead decreases with the resource amount. However the cooperation behavior is interesting, the lower total resource and intermediate temptation to defect can greatly promote the cooperation on square lattice. Our result reveals that the limited resource contributes most to the cooperation.	[Wang, Yang; Wang, Binghong] Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Anhui, Peoples R China; [Wang, Binghong] Wenzhou Univ, Coll Phys & Elect Informat Engn, Wenzhou 325035, Zhejiang, Peoples R China; [Wang, Binghong] Southwest Univ Sci & Technol, Sch Sci, Mianyang 621010, Sichuan, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Wenzhou University; Southwest University of Science & Technology - China	Wang, BH (corresponding author), Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Anhui, Peoples R China.	bhwang@ustc.edu.cn						Axelrod R., 2006, EVOLUTION COOPERATIO; Brandt H, 2003, P ROY SOC B-BIOL SCI, V270, P1099, DOI 10.1098/rspb.2003.2336; Challet D, 1998, PHYSICA A, V256, P514, DOI 10.1016/S0378-4371(98)00260-X; Challet D, 1997, PHYSICA A, V246, P407, DOI 10.1016/S0378-4371(97)00419-6; Gintis H., 2000, GAME THEORY EVOLVING; Guan JY, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.056101; HAMILTON WD, 1964, J THEOR BIOL, V7, P17, DOI 10.1016/0022-5193(64)90039-6; Jiang LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064677; Jiang LL, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.036108; Jiang LL, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.031144; Johnson NF, 1999, PHYS REV LETT, V82, P3360, DOI 10.1103/PhysRevLett.82.3360; Maynard Smith J., 1982, pi; Meloni S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.067101; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/4/043013; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Sekiguchi T, 2009, J THEOR BIOL, V256, P297, DOI 10.1016/j.jtbi.2008.09.025; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2008, EUR PHYS J B, V61, P505, DOI 10.1140/epjb/e2008-00099-7; Szolnoki A, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/30004; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; Taylor P, 2010, J EVOLUTION BIOL, V23, P2569, DOI 10.1111/j.1420-9101.2010.02122.x; Wang WX, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.056113; Wang WX, 2011, CHAOS, V21, DOI 10.1063/1.3621719; Wang XW, 2015, APPL MATH COMPUT, V250, P848, DOI 10.1016/j.amc.2014.11.023; Wang XW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121508; Wang XW, 2013, PHYSICA A, V392, P4668, DOI 10.1016/j.physa.2013.05.020; Wang Z, 2014, J THEOR BIOL, V349, P50, DOI 10.1016/j.jtbi.2014.01.037; Wang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040218; Wang Z, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021115; Wu ZX, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.012109; Wu ZX, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.037103; Yang HX, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.065101; Zhang HF, 2014, PHYSICA A, V414, P86, DOI 10.1016/j.physa.2014.07.013; Zukewich J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054639	40	0	0	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2015	10	8							e0136295	10.1371/journal.pone.0136295	http://dx.doi.org/10.1371/journal.pone.0136295			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP8KZ	26313944	Green Published, Green Submitted, gold			2022-12-26	WOS:000360144000053
J	Xu, C; Liu, K; Ahmed, H; Loppnau, P; Schapira, M; Min, JR				Xu, Chao; Liu, Ke; Ahmed, Hazem; Loppnau, Peter; Schapira, Matthieu; Min, Jinrong			Structural Basis for the Discriminative Recognition of N-6-Methyladenosine RNA by the Human YT521-B Homology Domain Family of Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; YTH DOMAIN; M(6)A RNA; NUCLEAR-RNA; REVEALS; N6-METHYLADENOSINE; BINDING; CRYSTALLOGRAPHY; DEMETHYLASE; METABOLISM	N-6-Methyladenosine (m(6)A) is the most abundant internal modification in RNA and is specifically recognized by YT521-B homology (YTH) domain-containing proteins. Recently we reported that YTHDC1 prefers guanosine and disfavors adenosine at the position preceding the m(6)A nucleotide in RNA and preferentially binds to the GG(m(6)A)C sequence. Now we systematically characterized the binding affinities of the YTH domains of three other human proteins and yeast YTH domain protein Pho92 and determined the crystal structures of theYTH domains of human YTHDF1 and yeast Pho92 in complex with a 5-mer m(6)A RNA, respectively. Our binding and structural data revealed that the YTH domain used a conserved aromatic cage to recognize m(6)A. Nevertheless, none of these YTH domains, except YTHDC1, display sequence selectivity at the position preceding the m(6)A modification. Structural comparison of these different YTH domains revealed that among those, only YTHDC1 harbors a distinctly selective binding pocket for the nucleotide preceding the m(6)A nucleotide.	[Xu, Chao; Liu, Ke; Ahmed, Hazem; Loppnau, Peter; Schapira, Matthieu; Min, Jinrong] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Min, Jinrong] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Toronto; Structural Genomics Consortium; University of Toronto	Xu, C (corresponding author), Univ Toronto, Struct Genom Consortium, 101 Coll St, Toronto, ON M5G 1L7, Canada.	xuchaor@gmail.com; jr.min@utoronto.ca	Min, Jinrong/G-3449-2011; Xu, Chao/G-3885-2010	Min, Jinrong/0000-0001-5210-3130; Xu, Chao/0000-0003-0444-7080; Hussein, Hazem/0000-0002-9298-7038; , KE/0000-0002-7082-262X	AbbVie; Bayer Pharma AG; Baehringer Ingelheim; Canada Foundation for Innovation; Eshelman Institute for Innovation; Genome Canada; Innovative Medicines Initiative (the European Federation of Pharmaceutical Industries and Associations (European Union)) under ULTRA-DD Grant [115766]; Janssen; Merck Co.; Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer; Sao Paulo Research Foundation-Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Takeda; Wellcome Trust	AbbVie(AbbVie); Bayer Pharma AG; Baehringer Ingelheim; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Eshelman Institute for Innovation; Genome Canada(Genome Canada); Innovative Medicines Initiative (the European Federation of Pharmaceutical Industries and Associations (European Union)) under ULTRA-DD Grant; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck Co.(Merck & Company); Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Sao Paulo Research Foundation-Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Takeda; Wellcome Trust(Wellcome TrustEuropean Commission)	The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Baehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada, Innovative Medicines Initiative (the European Federation of Pharmaceutical Industries and Associations (European Union)) under ULTRA-DD Grant 115766, Janssen, Merck & Co., Novartis Pharma AG, Ontario Ministry of Economic Development and Innovation, Pfizer, Sao Paulo Research Foundation-Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Takeda, and the Wellcome Trust.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bertonati C, 2009, PROTEINS, V75, P760, DOI 10.1002/prot.22287; Bokar JA, 1997, RNA, V3, P1233; Bokar JA, 2005, TOP CURR GENET, V12, P141, DOI 10.1007/b106365; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; DUBIN DT, 1975, NUCLEIC ACIDS RES, V2, P1653, DOI 10.1093/nar/2.10.1653; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Gildea RJ, 2011, J APPL CRYSTALLOGR, V44, P1259, DOI 10.1107/S0021889811041161; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kampf G, 2002, J CHEM SOC PERK T 2, P1320, DOI 10.1039/b202023h; Kang HJ, 2014, BIOCHEM J, V457, P391, DOI 10.1042/BJ20130862; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; Li FD, 2014, CELL RES, V24, P1490, DOI 10.1038/cr.2014.153; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Luo SK, 2014, P NATL ACAD SCI USA, V111, P13834, DOI 10.1073/pnas.1412742111; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Pan T, 2013, TRENDS BIOCHEM SCI, V38, P204, DOI 10.1016/j.tibs.2012.12.006; Patel DJ, 2013, ANNU REV BIOCHEM, V82, P81, DOI 10.1146/annurev-biochem-072711-165700; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; PERRY RP, 1975, CELL, V4, P387, DOI 10.1016/0092-8674(75)90159-2; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Schwartz S, 2013, CELL, V155, P1409, DOI 10.1016/j.cell.2013.10.047; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; WEI CM, 1977, BIOCHEMISTRY-US, V16, P1672, DOI 10.1021/bi00627a023; WEI CM, 1975, CELL, V4, P379, DOI 10.1016/0092-8674(75)90158-0; Winn MD, 2003, J SYNCHROTRON RADIAT, V10, P23, DOI 10.1107/S0909049502017235; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Xu C, 2014, NAT CHEM BIOL, V10, P927, DOI [10.1038/nchembio.1654, 10.1038/NCHEMBIO.1654]; Xu C, 2014, J BIOL CHEM, V289, P17299, DOI 10.1074/jbc.M114.550350; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419; Ye YZ, 2004, NUCLEIC ACIDS RES, V32, pW582, DOI 10.1093/nar/gkh430; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zhu TT, 2014, CELL RES, V24, P1493, DOI 10.1038/cr.2014.152	50	147	155	6	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24902	24913		10.1074/jbc.M115.680389	http://dx.doi.org/10.1074/jbc.M115.680389			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26318451	Green Published, hybrid			2022-12-26	WOS:000362598300023
J	Gu, AX; Jie, YM; Sun, L; Zhao, SP; Mingyan, E; You, QS				Gu, Anxin; Jie, Yamin; Sun, Liang; Zhao, Shuping; Mingyan, E.; You, Qingshan			RhNRG-1 beta Protects the Myocardium against Irradiation-Induced Damage via the ErbB2-ERK-SIRT1 Signaling Pathway	PLOS ONE			English	Article							HEART; MICE; NEUREGULIN-1; SURVIVAL; GENE; REGENERATION; DYSFUNCTION; INHIBITION; EXPRESSION; MYOCYTES	Radiation-induced heart disease (RIHD), which is a serious side effect of the radiotherapy applied for various tumors due to the inevitable irradiation of the heart, cannot be treated effectively using current clinical therapies. Here, we demonstrated that rhNRG-1 beta, an epidermal growth factor (EGF)-like protein, protects myocardium tissue against irradiation-induced damage and preserves cardiac function. rhNRG-1 beta effectively ameliorated irradiation- induced myocardial nuclear damage in both cultured adult rat-derived cardiomyocytes and rat myocardium tissue via NRG/ErbB2 signaling. By activating ErbB2, rhNRG-1 beta maintained mitochondrial integrity, ATP production, respiratory chain function and the Krebs cycle status in irradiated cardiomyocytes. Moreover, the protection of irradiated cardiomyocytes and myocardium tissue by rhNRG-1 beta was at least partly mediated by the activation of the ErbB2-ERK-SIRT1 signaling pathway. Long-term observations further showed that rhNRG-1 beta administered in the peri-irradiation period exerts continuous protective effects on cardiac pump function, the myocardial energy metabolism, cardiomyocyte volume and interstitial fibrosis in the rats receiving radiation via NRG/ErbB2 signaling. Our findings indicate that rhNRG-1 beta can protect the myocardium against irradiation-induced damage and preserve cardiac function via the ErbB2-ERK-SIRT1 signaling pathway.	[Gu, Anxin; Zhao, Shuping; Mingyan, E.; You, Qingshan] Harbin Med Univ, Affiliated Tumor Hosp, Dept Radiotherapy, Harbin, Heilongjiang, Peoples R China; [Jie, Yamin] Harbin Med Univ, Affiliated Hosp 4, Dept Radiotherapy, Harbin, Heilongjiang, Peoples R China; [Sun, Liang] Harbin Med Univ, Dept Human Anat, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Mingyan, E (corresponding author), Harbin Med Univ, Affiliated Tumor Hosp, Dept Radiotherapy, Harbin, Heilongjiang, Peoples R China.	emingyan889@163.com; youqingshanradio@163.com			Heilongjiang Province Science and Technology Project Fund [GC07C354]	Heilongjiang Province Science and Technology Project Fund	This work was supported by Heilongjiang Province Science and Technology Project Fund (GC07C354; to ME).	Akman-Anderson L, 2007, INFECT IMMUN, V75, P4012, DOI 10.1128/IAI.00645-07; An T, 2013, PHYSIOL RES, V62, P379, DOI 10.33549/physiolres.932435; Baban B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124059; Barjaktarovic Z, 2013, RADIOTHER ONCOL, V106, P404, DOI 10.1016/j.radonc.2013.01.017; Bassino E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119790; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Cervera AM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-89; Chan JY, 2008, CIRC RES, V102, P571, DOI 10.1161/CIRCRESAHA.107.161687; Chua YL, 2009, ONCOGENE, V28, P4041, DOI 10.1038/onc.2009.259; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; CORN BW, 1990, J CLIN ONCOL, V8, P741, DOI 10.1200/JCO.1990.8.4.741; D'Uva G, 2015, NAT CELL BIOL, V17, P627, DOI 10.1038/ncb3149; Darby SC, 2010, INT J RADIAT ONCOL, V76, P656, DOI 10.1016/j.ijrobp.2009.09.064; Erven K, 2013, INT J RADIAT ONCOL, V85, P1172, DOI 10.1016/j.ijrobp.2012.09.022; Gao RL, 2010, J AM COLL CARDIOL, V55, P1907, DOI 10.1016/j.jacc.2009.12.044; Ghobadi G, 2012, INT J RADIAT ONCOL, V84, pE639, DOI 10.1016/j.ijrobp.2012.07.2362; Hill MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055741; Kim YC, 2009, P NATL ACAD SCI USA, V106, P13707, DOI 10.1073/pnas.0903938106; Lai D, 2010, CIRC RES, V107, P715, DOI 10.1161/CIRCRESAHA.110.218693; Lemmens K, 2006, J BIOL CHEM, V281, P19469, DOI 10.1074/jbc.M600399200; Lenarczyk M, 2013, RADIAT RES, V180, P247, DOI 10.1667/RR3292.1; Li JG, 2014, INT J MOL SCI, V15, P5928, DOI 10.3390/ijms15045928; Liu SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107865; Liu XF, 2006, J AM COLL CARDIOL, V48, P1438, DOI 10.1016/j.jacc.2006.05.057; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Nogueiras R, 2012, PHYSIOL REV, V92, P1479, DOI 10.1152/physrev.00022.2011; Okoshi K, 2004, CIRCULATION, V110, P713, DOI 10.1161/01.CIR.0000138109.32748.80; Ong SB, 2013, ANTIOXID REDOX SIGN, V19, P400, DOI 10.1089/ars.2012.4777; Planavila A, 2012, J MOL CELL CARDIOL, V53, P521, DOI 10.1016/j.yjmcc.2012.07.019; Polidoro L, 2013, J CARDIOVASC TRANSL, V6, P221, DOI 10.1007/s12265-012-9436-x; Polizzotti BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5171; Puente BN, 2014, CELL, V157, P565, DOI 10.1016/j.cell.2014.03.032; Rizk SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114560; Sardaro A, 2012, RADIOTHER ONCOL, V103, P133, DOI 10.1016/j.radonc.2012.02.008; Schwarz K, 2014, INT J CARDIOL, V171, P134, DOI 10.1016/j.ijcard.2013.12.014; Shukla PC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1601; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Sridharan V, 2014, RADIAT RES, V181, P324, DOI 10.1667/RR13452.1; Sridharan V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068762; Srinivasan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077129; Sun L, 2014, STEM CELLS DEV, V23, P2104, DOI 10.1089/scd.2013.0563; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Tian Y, 2012, CIRC RES, V110, P1023, DOI 10.1161/CIRCRESAHA.111.243899; Tony H, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/597032; Tsai MS, 2003, ONCOGENE, V22, P761, DOI 10.1038/sj.onc.1206130; Wadugu B, 2012, AM J PHYSIOL-HEART C, V302, pH2139, DOI 10.1152/ajpheart.00063.2012; Wang JX, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.41; Yamagata K, 2009, BIOCHEM BIOPH RES CO, V390, P1355, DOI 10.1016/j.bbrc.2009.10.156; Yu H, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056514, 10.1371/journal.pone.0080815]; Zhang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066779; Zhao YY, 1998, J BIOL CHEM, V273, P10261, DOI 10.1074/jbc.273.17.10261	51	20	23	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137337	10.1371/journal.pone.0137337	http://dx.doi.org/10.1371/journal.pone.0137337			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332771	Green Submitted, Green Published, gold			2022-12-26	WOS:000360613800124
J	Larsen, PE; Collart, FR; Dai, Y				Larsen, Peter E.; Collart, Frank R.; Dai, Yang			Predicting Ecological Roles in the Rhizosphere Using Metabolome and Transportome Modeling	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; SIGNALING PATHWAY; BACTERIA; KEGG; IDENTIFICATION; PATHOGENS; SYSTEM; HONEY	The ability to obtain complete genome sequences from bacteria in environmental samples, such as soil samples from the rhizosphere, has highlighted the microbial diversity and complexity of environmental communities. However, new algorithms to analyze genome sequence information in the context of community structure are needed to enhance our understanding of the specific ecological roles of these organisms in soil environments. We present a machine learning approach using sequenced Pseudomonad genomes coupled with outputs of metabolic and transportomic computational models for identifying the most predictive molecular mechanisms indicative of a Pseudomonad's ecological role in the rhizosphere: a biofilm, biocontrol agent, promoter of plant growth, or plant pathogen. Computational predictions of ecological niche were highly accurate overall with models trained on transportomic model output being the most accurate (Leave One Out Validation F-scores between 0.82 and 0.89). The strongest predictive molecular mechanism features for rhizosphere ecological niche overlap with many previously reported analyses of Pseudomonad interactions in the rhizosphere, suggesting that this approach successfully informs a system-scale level understanding of how Pseudomonads sense and interact with their environments. The observation that an organism's transportome is highly predictive of its ecological niche is a novel discovery and may have implications in our understanding microbial ecology. The framework developed here can be generalized to the analysis of any bacteria across a wide range of environments and ecological niches making this approach a powerful tool for providing insights into functional predictions from bacterial genomic data.	[Larsen, Peter E.; Collart, Frank R.] Argonne Natl Lab, Biosci Div, Argonne, IL 60439 USA; [Larsen, Peter E.; Dai, Yang] Univ Illinois, Dept Bioengn, Chicago, IL USA	United States Department of Energy (DOE); Argonne National Laboratory; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Larsen, PE (corresponding author), Argonne Natl Lab, Biosci Div, 9700 S Cass Ave, Argonne, IL 60439 USA.	plarsen@anl.gov		Collart, Frank/0000-0001-6942-4483	UChicago Argonne, LLC; U.S. Department of Energy, Office of Biological and Environmental Research (BER), BER's Genomic Science Program; U.S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]	UChicago Argonne, LLC; U.S. Department of Energy, Office of Biological and Environmental Research (BER), BER's Genomic Science Program(United States Department of Energy (DOE)); U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE))	This contribution originates in part from the "Environment Sensing and Response" Scientific Focus Area (SFA) program at Argonne National Laboratory. This research was supported by UChicago Argonne, LLC, Operator of Argonne National Laboratory ("Argonne"), and the U.S. Department of Energy, Office of Biological and Environmental Research (BER), as part of BER's Genomic Science Program. This research has been funded by the U.S. Department of Energy, Office of Biological and Environmental Research, under Contract DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Lateif K, 2012, PLANT SIGNAL BEHAV, V7, P636, DOI 10.4161/psb.20039; Alhede M, 2014, ADV APPL MICROBIOL, V86, P1, DOI 10.1016/B978-0-12-800262-9.00001-9; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; Bannert A, 2011, APPL ENVIRON MICROB, V77, P6109, DOI 10.1128/AEM.01751-10; Baslan T, 2014, CURR OPIN GENET DEV, V26, P59, DOI 10.1016/j.gde.2014.06.004; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Bowden G H, 1997, Adv Dent Res, V11, P81; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; CLARKE PH, 1982, A VAN LEEUW J MICROB, V48, P105, DOI 10.1007/BF00405197; Conde C, 2006, PLANT PHYSIOL, V141, P1563, DOI 10.1104/pp.106.080804; Cornelis P, 2010, APPL MICROBIOL BIOT, V86, P1637, DOI 10.1007/s00253-010-2550-2; Costaglioli P, 2012, MICROBIOLOGYOPEN, V1, P326, DOI 10.1002/mbo3.33; Devoid Scott, 2013, Methods Mol Biol, V985, P17, DOI 10.1007/978-1-62703-299-5_2; Dorel C, 2006, RES MICROBIOL, V157, P306, DOI 10.1016/j.resmic.2005.12.003; Drigo B, 2010, P NATL ACAD SCI USA, V107, P10938, DOI 10.1073/pnas.0912421107; Filiatrault MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055594; Frey-Klett P, 2007, NEW PHYTOL, V176, P22, DOI 10.1111/j.1469-8137.2007.02191.x; Gamper H, 2005, NEW PHYTOL, V167, P531, DOI 10.1111/j.1469-8137.2005.01440.x; Garbeva P, 2009, MICROB ECOL, V58, P36, DOI 10.1007/s00248-009-9502-3; Gross H, 2009, NAT PROD REP, V26, P1408, DOI 10.1039/b817075b; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Haran S, 1996, MICROBIOL-UK, V142, P2321, DOI 10.1099/00221287-142-9-2321; Hu XZ, 2013, P NATL ACAD SCI USA, V110, P678, DOI 10.1073/pnas.1215033110; Hussain SS, 2011, BIOTECHNOL ADV, V29, P300, DOI 10.1016/j.biotechadv.2011.01.003; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Jani AJ, 2010, CELL HOST MICROBE, V8, P2, DOI 10.1016/j.chom.2010.06.012; Jones ML, GUT MICROBES, V5; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kapitein N, 2013, CURR OPIN MICROBIOL, V16, P52, DOI 10.1016/j.mib.2012.11.009; Kilty SJ, 2011, INT FORUM ALLERGY RH, V1, P348, DOI 10.1002/alr.20073; Knief C, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00216; Kosuta S, 2008, P NATL ACAD SCI USA, V105, P9823, DOI 10.1073/pnas.0803499105; Kraepiel AML, 2009, BIOMETALS, V22, P573, DOI 10.1007/s10534-009-9222-7; Kulma A, 2007, PLANT SCI, V172, P433, DOI 10.1016/j.plantsci.2006.10.013; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lalonde S, 1999, PLANT CELL, V11, P707, DOI 10.1105/tpc.11.4.707; Larsen PE, 2015, ISME J, V9, P166, DOI 10.1038/ismej.2014.107; Larsen PE, 2014, IEEE ENG MED BIO, P314, DOI 10.1109/EMBC.2014.6943592; Larsen Peter E, 2011, Microb Inform Exp, V1, P4, DOI 10.1186/2042-5783-1-4; Lennon JT, 2012, ECOLOGY, V93, P1867, DOI 10.1890/11-1745.1; Ma HY, 2013, J CONTROL RELEASE, V172, P1035, DOI 10.1016/j.jconrel.2013.10.005; Majtan J, 2014, PHYTOTHER RES, V28, P69, DOI 10.1002/ptr.4957; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028; MILLER KJ, 1986, SCIENCE, V231, P48, DOI 10.1126/science.3941890; Munoz-Elias EJ, 2008, INFECT IMMUN, V76, P5049, DOI 10.1128/IAI.00425-08; Newton AC, 2010, TRENDS MICROBIOL, V18, P365, DOI 10.1016/j.tim.2010.06.002; Okazaki Y, PLANT J; Olczak T, 2012, ARCH MICROBIOL, V194, P719, DOI 10.1007/s00203-012-0804-3; Peer WA, 2013, CURR OPIN PLANT BIOL, V16, P561, DOI 10.1016/j.pbi.2013.08.003; Philippot L, 2013, NAT REV MICROBIOL, V11, P789, DOI 10.1038/nrmicro3109; Phillips D. A., 1992, Mycorrhiza, V1, P55, DOI 10.1007/BF00206136; Quiles F, 2014, BIOFOULING, V30, P709, DOI 10.1080/08927014.2014.915956; Raffaele S, 2009, PLANT SIGNAL BEHAV, V4, P94, DOI 10.4161/psb.4.2.7580; Rajendhran J, 2011, MICROBIOL RES, V166, P99, DOI 10.1016/j.micres.2010.02.003; Rudrappa T, 2008, FEMS MICROBIOL ECOL, V64, P153, DOI 10.1111/j.1574-6941.2008.00465.x; Ruiz-Duenas FJ, 2009, MICROB BIOTECHNOL, V2, P164, DOI 10.1111/j.1751-7915.2008.00078.x; Ryan RP, 2008, FEMS MICROBIOL LETT, V278, P1, DOI 10.1111/j.1574-6968.2007.00918.x; SANDS DC, 1970, J BACTERIOL, V101, P9, DOI 10.1128/JB.101.1.9-23.1970; Scott NM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00108; Sels J, 2008, PLANT PHYSIOL BIOCH, V46, P941, DOI 10.1016/j.plaphy.2008.06.011; Silby MW, 2011, FEMS MICROBIOL REV, V35, P652, DOI 10.1111/j.1574-6976.2011.00269.x; Sims A, 2012, WATER RES, V46, P4121, DOI 10.1016/j.watres.2012.05.007; Singh S, 2012, CURR OPIN PLANT BIOL, V15, P444, DOI 10.1016/j.pbi.2012.04.002; Steinkellner S, 2007, MOLECULES, V12, P1290, DOI 10.3390/12071290; Suarez J, 2009, J BIOL CHEM, V284, P7017, DOI 10.1074/jbc.M808106200; Suen G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000743; TALAGA P, 1994, J BACTERIOL, V176, P6538, DOI 10.1128/JB.176.21.6538-6544.1994; Thomas Torsten, 2012, Microb Inform Exp, V2, P3, DOI 10.1186/2042-5783-2-3; Tielen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071845; Winter G, 2013, ENVIRON MICROBIOL, V15, P1901, DOI 10.1111/1462-2920.12064; Wu XA, 2011, FEMS MICROBIOL REV, V35, P299, DOI 10.1111/j.1574-6976.2010.00249.x; You J, 2009, WATER RES, V43, P1801, DOI 10.1016/j.watres.2009.01.016	76	8	8	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0132837	10.1371/journal.pone.0132837	http://dx.doi.org/10.1371/journal.pone.0132837			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332409	Green Published, Green Submitted, gold			2022-12-26	WOS:000360613800002
J	Villanueva, VM; Oldfield, LM; Hatfull, GF				Villanueva, Valerie M.; Oldfield, Lauren M.; Hatfull, Graham F.			An Unusual Phage Repressor Encoded by Mycobacteriophage BPs	PLOS ONE			English	Article							GENE-EXPRESSION; SEQUENCE; INTEGRATION; EVOLUTION; IMMUNITY; PHI-C31	Temperate bacteriophages express transcription repressors that maintain lysogeny by down-regulating lytic promoters and confer superinfection immunity. Repressor regulation is critical to the outcome of infection-lysogenic or lytic growth-as well as prophage induction into lytic replication. Mycobacteriophage BPs and its relatives use an unusual integration-dependent immunity system in which the phage attachment site (attP) is located within the repressor gene (33) such that site-specific integration leads to synthesis of a prophage-encoded product (gp33(103)) that is 33 residues shorter at its C-terminus than the virallyencoded protein (gp33(136)). However, the shorter form of the repressor (gp33103) is stable and active in repression of the early lytic promoter PR, whereas the longer virally-encoded form (gp33136) is inactive due to targeted degradation via a C-terminal ssrA-like tag. We show here that both forms of the repressor bind similarly to the 33-34 intergenic regulatory region, and that BPs gp33(103) is a tetramer in solution. The BPs gp33(103) repressor binds to five regulatory regions spanning the BPs genome, and regulates four promoters including the early lytic promoter, P-R. BPs gp33(103) has a complex pattern of DNA recognition in which a full operator binding site contains two half sites separated by a variable spacer, and BPs gp33(103) induces a DNA bend at the full operator site but not a half site. The operator site structure is unusual in that one half site corresponds to a 12 bp palindrome identified previously, but the other half site is a highly variable variant of the palindrome.	[Villanueva, Valerie M.; Oldfield, Lauren M.; Hatfull, Graham F.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hatfull, GF (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	gfh@pitt.edu			NIH [GM093901]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM093901] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH GM093901. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel FM., 1992, CURRENT PROTOCOLS MO, V3; Bibb LA, 2002, MOL MICROBIOL, V45, P1515, DOI 10.1046/j.1365-2958.2002.03130.x; Broussard GW, 2013, MOL CELL, V49, P237, DOI 10.1016/j.molcel.2012.11.012; Broussard GW., 2013, BACTERIOPHAGE, V3, DOI DOI 10.4161/BACT.24186; Brown KL, 1997, EMBO J, V16, P5914, DOI 10.1093/emboj/16.19.5914; Dedrick RM, 2013, MOL MICROBIOL, V88, P577, DOI 10.1111/mmi.12210; DONNELLYWU MK, 1993, MOL MICROBIOL, V7, P407, DOI 10.1111/j.1365-2958.1993.tb01132.x; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; HATFULL GF, 1993, MOL MICROBIOL, V7, P395, DOI 10.1111/j.1365-2958.1993.tb01131.x; Hatfull GF, 2012, ADV VIRUS RES, V82, P179, DOI 10.1016/B978-0-12-394621-8.00015-7; Hatfull GF, 2011, CURR OPIN VIROL, V1, P298, DOI 10.1016/j.coviro.2011.06.009; Lewis D, 2011, P NATL ACAD SCI USA, V108, P14807, DOI 10.1073/pnas.1111221108; Little JW, 2010, CURR BIOL, V20, pR724, DOI 10.1016/j.cub.2010.06.028; Oldfield LM, 2014, J BACTERIOL, V196, P3589, DOI 10.1128/JB.01801-14; Petrova ZO, 2015, MYCOBACTERIOPH UNPUB; Pope WH, 2015, ELIFE, V4, DOI 10.7554/eLife.06416; Pope WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016329; PTASHNE M, 1982, SCI AM, V247, P128, DOI 10.1038/scientificamerican1182-128; Ptashne M, 1987, A GENETIC SWITCH; RIMPHANITCHAYAKIT V, 1990, EMBO J, V9, P719, DOI 10.1002/j.1460-2075.1990.tb08165.x; SINCLAIR RB, 1988, MOL GEN GENET, V213, P269, DOI 10.1007/BF00339591; SMITH MCM, 1991, MOL MICROBIOL, V5, P2833, DOI 10.1111/j.1365-2958.1991.tb01992.x; Smith MCM, 1999, NUCLEIC ACIDS RES, V27, P2145, DOI 10.1093/nar/27.10.2145; Zwieb C, 2009, METHODS MOL BIOL, V543, P547, DOI 10.1007/978-1-60327-015-1_32	24	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137187	10.1371/journal.pone.0137187	http://dx.doi.org/10.1371/journal.pone.0137187			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332854	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000360613800106
J	Sammallahti, S; Lahti, M; Pyhala, R; Lahti, J; Pesonen, AK; Heinonen, K; Hovi, P; Eriksson, JG; Strang-Karlsson, S; Jarvenpaa, AL; Andersson, S; Kajantie, E; Ralkkonen, K				Sammallahti, Sara; Lahti, Marius; Pyhala, Riikka; Lahti, Jari; Pesonen, Anu-Katriina; Heinonen, Kati; Hovi, Petteri; Eriksson, Johan G.; Strang-Karlsson, Sonja; Jarvenpaa, Anna-Liisa; Andersson, Sture; Kajantie, Eero; Ralkkonen, Katri			Infant Growth after Preterm Birth and Mental Health in Young Adulthood	PLOS ONE			English	Article							NEUROCOGNITIVE ABILITIES; BEHAVIORAL SYMPTOMS; HEAD CIRCUMFERENCE; GESTATIONAL-AGE; LINEAR GROWTH; WEIGHT; BORN; DISORDER; ADOLESCENTS; HELSINKI	Objectives Faster growth after preterm birth benefits long-term cognitive functioning. Whether these benefits extend to mental health remains largely unknown. We examined if faster growth in infancy is associated with better self-reported mental health in young adults born preterm at very low birth weight (VLBW) (<1500g). Study Design As young adults, participants of the Helsinki Study of Very Low Birth Weight Adults self-reported symptoms of depression and attention deficit/hyperactivity disorder (ADHD) (n = 157) and other psychiatric problems (n = 104). As main predictors of mental health outcomes in linear regression models, we used infant weight, length, and head circumference at birth, term, and 12 months of corrected age, and growth between these time points. Growth data were collected from records and measures at term and at 12 months of corrected age were interpolated. Additionally, we examined the moderating effects of intrauterine growth restriction. Results Size at birth, term, or 12 months of corrected age, or growth between these time points were not associated with mental health outcomes (p-values >0.05). Intrauterine growth restriction did not systematically moderate any associations. Conclusions Despite the high variability in early growth of VLBW infants, the previously described association between slow growth in infancy and poorer cognitive functioning in later life is not reflected in symptoms of depression, ADHD, and other psychiatric problems. This suggests that the development of cognitive and psychiatric problems may have dissimilar critical periods in VLBW infants.	[Sammallahti, Sara; Lahti, Marius; Pyhala, Riikka; Lahti, Jari; Pesonen, Anu-Katriina; Heinonen, Kati; Ralkkonen, Katri] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Sammallahti, Sara; Hovi, Petteri; Eriksson, Johan G.; Strang-Karlsson, Sonja; Kajantie, Eero] Natl Inst Hlth & Welf, Helsinki, Finland; [Sammallahti, Sara; Hovi, Petteri; Strang-Karlsson, Sonja; Jarvenpaa, Anna-Liisa; Andersson, Sture; Kajantie, Eero] Univ Helsinki, Cent Hosp, Childrens Hosp, Helsinki, Finland; [Sammallahti, Sara; Hovi, Petteri; Strang-Karlsson, Sonja; Jarvenpaa, Anna-Liisa; Andersson, Sture; Kajantie, Eero] Univ Helsinki, Helsinki, Finland; [Lahti, Jari; Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Vasa Cent Hosp, Vaasa, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Kajantie, Eero] Oulu Univ Hosp, Dept Obstet & Gynaecol, Oulu, Finland; [Kajantie, Eero] Univ Oulu, Oulu, Finland	University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Folkhalsan Research Center; University of Helsinki; Vaasa Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Oulu; University of Oulu	Sammallahti, S (corresponding author), Univ Helsinki, Inst Behav Sci, Helsinki, Finland.	sara.sammallahti@helsinki.fi	Lahti, Jari/P-2283-2019; Lahti, Jari/P-7987-2018; Pyhälä, Riikka/AAG-1947-2021; Lahti-Pulkkinen, Marius/Q-2472-2017	Lahti, Jari/0000-0002-4310-5297; Lahti, Jari/0000-0002-4310-5297; Sammallahti, Sara/0000-0001-8928-000X; Eriksson, Johan/0000-0002-2516-2060; Lahti-Pulkkinen, Marius/0000-0002-5244-5525; Raikkonen, Katri/0000-0003-3124-3470; Pesonen, Anu-Katriina/0000-0002-0662-6261; Heinonen, Kati/0000-0002-1262-5599	Academy of Finland, University of Helsinki; Finnish Medical Society Duodecim, Finska Lakaresallskapet; Foundation for Pediatric Research in Finland; Finnish Special Governmental Subsidy for Health Sciences; Jalmari and Rauha Ahokas Foundation; Juho Vainio Foundation; Emil Aaltonen foundation; Novo Nordisk Foundation; Paivikki and Sakari Sohlberg Foundation; Signe and Ane Gyllenberg Foundation; Yrjo Jahnsson Foundation; Orion-Pharma Foundation; Sigrid Juselius Foundation; Finnish National Graduate School of Clinical Investigation; Wilhelm and Else Stockmann Foundation; Research Foundation of the University of Helsinki; Pediatric Graduate School, University of Helsinki; Novo Nordisk Fonden [NNF12OC1016374] Funding Source: researchfish	Academy of Finland, University of Helsinki(Academy of Finland); Finnish Medical Society Duodecim, Finska Lakaresallskapet; Foundation for Pediatric Research in Finland; Finnish Special Governmental Subsidy for Health Sciences; Jalmari and Rauha Ahokas Foundation; Juho Vainio Foundation; Emil Aaltonen foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Paivikki and Sakari Sohlberg Foundation; Signe and Ane Gyllenberg Foundation; Yrjo Jahnsson Foundation; Orion-Pharma Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish National Graduate School of Clinical Investigation; Wilhelm and Else Stockmann Foundation; Research Foundation of the University of Helsinki; Pediatric Graduate School, University of Helsinki; Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was carried out as part of the larger research project, the Helsinki Study of Very Low Birth Weight Adults, which has been funded by the Academy of Finland, University of Helsinki, the Finnish Medical Society Duodecim, Finska Lakaresallskapet, the Foundation for Pediatric Research in Finland, the Finnish Special Governmental Subsidy for Health Sciences, the Jalmari and Rauha Ahokas Foundation, the Juho Vainio Foundation, the Emil Aaltonen foundation, the Novo Nordisk Foundation, the Paivikki and Sakari Sohlberg Foundation, the Signe and Ane Gyllenberg Foundation, the Yrjo Jahnsson Foundation, the Orion-Pharma Foundation, the Sigrid Juselius Foundation, the Finnish National Graduate School of Clinical Investigation, the Wilhelm and Else Stockmann Foundation, Research Foundation of the University of Helsinki, and the Pediatric Graduate School, University of Helsinki. Apart from the aforementioned general funding, the authors received no grants specifically for carrying out the current study, and the authors have no financial relationships relevant to this article to disclose. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; Abel KM, 2010, ARCH GEN PSYCHIAT, V67, P923, DOI 10.1001/archgenpsychiatry.2010.100; Achenbach TM, 2003, MANUAL ASEBA ADULT F; Adair LS, 2013, LANCET, V382, P525, DOI 10.1016/S0140-6736(13)60103-8; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Belfort MB, 2013, J PEDIATR-US, V163, P1564, DOI 10.1016/j.jpeds.2013.06.032; Boyle MH, 2011, PSYCHOL MED, V41, P1763, DOI 10.1017/S0033291710002357; Brandt I, 2003, J PEDIATR-US, V142, P463, DOI 10.1067/mpd.2003.149; Class QA, 2014, BRIT J PSYCHIAT, V205, P355, DOI 10.1192/bjp.bp.113.143693; D'Onofrio BM, 2013, JAMA PSYCHIAT, V70, P1231, DOI 10.1001/jamapsychiatry.2013.2107; De Quiros GB, 2001, ANN NY ACAD SCI, V931, P140; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gustafsson WM, 2009, ACTA PSYCHIAT SCAND, V119, P54, DOI 10.1111/j.1600-0447.2008.01267.x; Hack M, 2004, PEDIATRICS, V114, P932, DOI 10.1542/peds.2003-1017-L; Hallin AL, 2010, ACTA PAEDIATR, V99, P1401, DOI 10.1111/j.1651-2227.2010.01850.x; Heinonen K, 2013, PEDIATRICS, V131, pE243, DOI 10.1542/peds.2012-0839; Heinonen K, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-91; Hovi P, 2007, NEW ENGL J MED, V356, P2053, DOI 10.1056/NEJMoa067187; Hovi P, 2011, PEDIATRICS, V127, pE304, DOI 10.1542/peds.2010-2199; Hovi P, 2010, J PEDIATR-US, V156, P54, DOI 10.1016/j.jpeds.2009.07.022; Howson CP, 2012, BORN TOO SOON THE GL; Huang C, 2013, INT J EPIDEMIOL, V42, P160, DOI 10.1093/ije/dys207; Kajantie E, 2014, SEMIN FETAL NEONAT M, V19, P112, DOI 10.1016/j.siny.2013.11.006; Lafeber HN, 2013, AM J CLIN NUTR, V98, p556S, DOI 10.3945/ajcn.112.045039; Lohaugen GCC, 2010, DEV MED CHILD NEUROL, V52, P1133, DOI 10.1111/j.1469-8749.2010.03743.x; Lund LK, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-146; Lund LK, 2012, EARLY HUM DEV, V88, P623, DOI 10.1016/j.earlhumdev.2012.01.006; Moster D, 2008, NEW ENGL J MED, V359, P262, DOI 10.1056/NEJMoa0706475; Nosarti C, 2007, J INT NEUROPSYCH SOC, V13, P571, DOI 10.1017/S1355617707070725; Nosarti C, 2012, ARCH GEN PSYCHIAT, V69, P610, DOI 10.1001/archgenpsychiatry.2011.1374; Osmond C, 2007, STROKE, V38, P264, DOI 10.1161/01.STR.0000254471.72186.03; Pihkala J, 1989, Duodecim, V105, P1540; Pyhala R, 2011, NEUROLOGY, V77, P2052, DOI 10.1212/WNL.0b013e31823b473e; Pyhala R, 2014, PEDIATRICS, V134, P1075, DOI 10.1542/peds.2014-1097; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raikkonen K, 2008, ARCH GEN PSYCHIAT, V65, P290, DOI 10.1001/archgenpsychiatry.2007.40; Roberts CL, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000101; Sammallahti S, 2014, J PEDIATR-US, V165, P1109, DOI 10.1016/j.jpeds.2014.08.028; Singhal A, 2003, LANCET, V361, P1089, DOI 10.1016/S0140-6736(03)12895-4; SORVA R, 1990, ACTA PAEDIATR SCAND, V79, P490, DOI 10.1111/j.1651-2227.1990.tb11502.x; SORVA R, 1984, ACTA PAEDIATR SCAND, V73, P527, DOI 10.1111/j.1651-2227.1984.tb09965.x; Stathis SL, 1999, DEV MED CHILD NEUROL, V41, P375, DOI 10.1017/S0012162299000833; Stockings E, 2015, J AFFECT DISORDERS, V174, P447, DOI 10.1016/j.jad.2014.11.061; Strang-Karlsson S, 2008, AM J PSYCHIAT, V165, P1345, DOI 10.1176/appi.ajp.2008.08010085; Weisglas-Kuperus N, 2009, ARCH DIS CHILD-FETAL, V94, pF196, DOI 10.1136/adc.2007.135095; Yeung MY, 2006, ACTA PAEDIATR, V95, P909, DOI 10.1080/08035250600724507	46	10	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137092	10.1371/journal.pone.0137092	http://dx.doi.org/10.1371/journal.pone.0137092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327229	Green Published, gold, Green Submitted			2022-12-26	WOS:000360437700094
J	Sengupta, D; Kar, S				Sengupta, Dola; Kar, Sandip			Are Quasi-Steady-State Approximated Models Suitable for Quantifying Intrinsic Noise Accurately?	PLOS ONE			English	Article							POSITIVE FEEDBACK; GENE-EXPRESSION; STOCHASTICITY; QUANTIFICATION; BISTABILITY; BACILLUS	Large gene regulatory networks (GRN) are often modeled with quasi-steady-state approximation (QSSA) to reduce the huge computational time required for intrinsic noise quantification using Gillespie stochastic simulation algorithm (SSA). However, the question still remains whether the stochastic QSSA model measures the intrinsic noise as accurately as the SSA performed for a detailed mechanistic model or not? To address this issue, we have constructed mechanistic and QSSA models for few frequently observed GRNs exhibiting switching behavior and performed stochastic simulations with them. Our results strongly suggest that the performance of a stochastic QSSA model in comparison to SSA performed for a mechanistic model critically relies on the absolute values of the mRNA and protein half-lives involved in the corresponding GRN. The extent of accuracy level achieved by the stochastic QSSA model calculations will depend on the level of bursting frequency generated due to the absolute value of the half-life of either mRNA or protein or for both the species. For the GRNs considered, the stochastic QSSA quantifies the intrinsic noise at the protein level with greater accuracy and for larger combinations of half-life values of mRNA and protein, whereas in case of mRNA the satisfactory accuracy level can only be reached for limited combinations of absolute values of half-lives. Further, we have clearly demonstrated that the abundance levels of mRNA and protein hardly matter for such comparison between QSSA and mechanistic models. Based on our findings, we conclude that QSSA model can be a good choice for evaluating intrinsic noise for other GRNs as well, provided we make a rational choice based on experimental half-life values available in literature.	[Sengupta, Dola; Kar, Sandip] Indian Inst Technol, Dept Chem, Mumbai 400076, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Kar, S (corresponding author), Indian Inst Technol, Dept Chem, Mumbai 400076, Maharashtra, India.	sandipkar@chem.iitb.ac.in			Industrial research and consultancy centre, IIT Bombay [13IRCCSG008]; Department of science and technology, India [EMR/2014/000500]	Industrial research and consultancy centre, IIT Bombay; Department of science and technology, India(Department of Science & Technology (India))	This work was supported by 13IRCCSG008, http://www.ircc.iitb.ac.in, Industrial research and consultancy centre, IIT Bombay, SK; and EMR/2014/000500, http://www.dst.gov.in, Department of science and technology, India, SK.	Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Cantini L, 2014, J THEOR BIOL, V349, P92, DOI 10.1016/j.jtbi.2014.01.035; Cao Y, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2052596; Cao Y, 2005, J CHEM PHYS, V122, DOI [10.1063/1.1824902, 10.1063/1.1924598]; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Gerard C, 2009, P NATL ACAD SCI USA, V106, P21643, DOI 10.1073/pnas.0903827106; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Grigull J, 2004, MOL CELL BIOL, V24, P5534, DOI 10.1128/MCB.24.12.5534-5547.2004; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kar S, 2009, P NATL ACAD SCI USA, V106, P6471, DOI 10.1073/pnas.0810034106; Karmakar R, 2007, PHYS BIOL, V4, P29, DOI 10.1088/1478-3975/4/1/004; Maamar H, 2005, MOL MICROBIOL, V56, P615, DOI 10.1111/j.1365-2958.2005.04592.x; McKane AJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.218102; Meyer R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00451; Niepel M, 2009, CURR OPIN CHEM BIOL, V13, P556, DOI 10.1016/j.cbpa.2009.09.015; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Overton KW, 2014, P NATL ACAD SCI USA, V111, pE4386, DOI 10.1073/pnas.1409797111; Pedraza JM, 2008, SCIENCE, V319, P339, DOI 10.1126/science.1144331; Perumal TM, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-41; Rao CV, 2003, J CHEM PHYS, V118, P4999, DOI 10.1063/1.1545446; Sarkar AX, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000914; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; Smits WK, 2005, MOL MICROBIOL, V56, P604, DOI 10.1111/j.1365-2958.2005.04488.x; Spencer SL, 2013, CELL, V155, P369, DOI 10.1016/j.cell.2013.08.062; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Thomas P, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-39; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Yao G, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.19; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514	39	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136668	10.1371/journal.pone.0136668	http://dx.doi.org/10.1371/journal.pone.0136668			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327626	Green Submitted, Green Published, gold			2022-12-26	WOS:000360437700054
J	Chuang, YF; Chen, MC; Huang, SW; Hsu, YF; Ou, G; Tsai, YJ; Hsu, MJ				Chuang, Yu-Fan; Chen, Mei-Chieh; Huang, Shiu-Wen; Hsu, Ya-Fen; Ou, George; Tsai, Yu-Jou; Hsu, Ming-Jen			Protein Phosphatase 2A in Lipopolysaccharide-Induced Cyclooxygenase-2 Expression in Murine Lymphatic Endothelial Cells	PLOS ONE			English	Article							NF-KAPPA-B; SIGNAL-REGULATING KINASE-1; TRANSCRIPTIONAL REGULATION; NUCLEAR-FACTOR; PROMOTER ELEMENTS; IMMUNE-RESPONSE; GENE-EXPRESSION; SEPTIC SHOCK; 1 ASK1; APOPTOSIS	The lymphatic endothelium plays an important role in the maintenance of tissue fluid homeostasis. It also participates in the pathogenesis of several inflammatory diseases. However, little is known about the underlying mechanisms by which lymphatic endothelial cell responds to inflammatory stimuli. In this study, we explored the mechanisms by which lipopolysaccharide (LPS) induces cyclooxygenase (COX)-2 expression in murine lymphatic endothelial cells (SV-LECs). LPS caused increases in cox-2 mRNA and protein levels, as well as in COX-2 promoter luciferase activity in SV-LECs. These actions were associated with protein phosphatase 2A (PP2A), apoptosis signal-regulating kinase 1 (ASK1), JNK1/2 and p38MAPK activation, and NF-kappa B subunit p65 and C/EBP beta phosphorylation. PP2A-ASK1 signaling blockade reduced LPS-induced JNK1/2, p38MAPK, p65 and C/EBP beta phosphorylation. Transfection with PP2A siRNA reduced LPS's effects on p65 and C/EBP beta binding to the COX-2 promoter region. Transfected with the NF-kappa B or C/EBP beta site deletion of COX-2 reporter construct also abrogated LPS's enhancing effect on COX-2 promoter luciferase activity in SV-LECs. Taken together, the induction of COX-2 in SV-LECs exposed to LPS may involve PP2A-ASK1-JNK and/or p38MAPK-NF-kappa B and/or C/EBP beta cascade.	[Chuang, Yu-Fan; Hsu, Ming-Jen] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan; [Chen, Mei-Chieh] Taipei Med Univ, Dept Microbiol & Immunol, Coll Med, Taipei, Taiwan; [Huang, Shiu-Wen] Natl Taiwan Univ, Coll Med, Grad Inst Pharmacol, Taipei 10764, Taiwan; [Hsu, Ya-Fen] Landseed Hosp, Div Gen Surg, Dept Surg, Taoyuan, Taiwan; [Ou, George] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Tsai, Yu-Jou] Yuans Gen Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Hsu, Ming-Jen] Taipei Med Univ, Sch Med, Dept Pharmacol, Coll Med, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; National Taiwan University; University of British Columbia; Taipei Medical University	Tsai, YJ (corresponding author), Yuans Gen Hosp, Dept Internal Med, Kaohsiung, Taiwan.	yjtsaihome@yahoo.com.tw; aspirin@tmu.edu.tw		Hsu, Ming-Jen/0000-0001-9688-8494	Ministry of Science and Technology of Taiwan [MOST 103-2320-B-038-018]; Yuan's General Hospital, Kaohsiung, Taiwan [103YGH-TMU-01-4]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Yuan's General Hospital, Kaohsiung, Taiwan	This work was supported by grant (MOST 103-2320-B-038-018) from the Ministry of Science and Technology of Taiwan, M.J.H; grant (103YGH-TMU-01-4) from the Yuan's General Hospital, Kaohsiung, Taiwan, Y.J.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Ando T., 2005, Lymphatic Research and Biology, V3, P105, DOI 10.1089/lrb.2005.3.105; Andreasen AS, 2008, CURR MED CHEM, V15, P1697, DOI 10.2174/092986708784872393; Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; Aoki T, 2007, CIRCULATION, V116, P2830, DOI 10.1161/CIRCULATIONAHA.107.728303; Chang YF, 2015, ONCOTARGET, V6, P85, DOI 10.18632/oncotarget.2765; Chen JC, 2004, EXP CELL RES, V301, P305, DOI 10.1016/j.yexcr.2004.05.039; Chen MC, 2003, J BIOL CHEM, V278, P16073, DOI 10.1074/jbc.M208661200; Chen YY, 2014, SCI REP-UK, V4, DOI 10.1038/srep05651; Chuang YF, 2014, BIOCHEM PHARMACOL, V88, P372, DOI 10.1016/j.bcp.2014.02.004; Cromer WE, 2014, ANGIOGENESIS, V17, P395, DOI 10.1007/s10456-013-9393-2; de Martin R, 2000, ARTERIOSCL THROM VAS, V20, pE83; Dean JLE, 1999, J BIOL CHEM, V274, P264, DOI 10.1074/jbc.274.1.264; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Ejima K, 2003, FASEB J, V17, P1325, DOI 10.1096/fj.02-1078fje; Forster R, 2012, TRENDS IMMUNOL, V33, P271, DOI 10.1016/j.it.2012.02.007; Goldman EH, 2004, J BIOL CHEM, V279, P10442, DOI 10.1074/jbc.M311129200; Han EH, 2008, TOXICOL APPL PHARM, V233, P333, DOI 10.1016/j.taap.2008.09.003; Hsieh CY, 2011, J BIOL CHEM, V286, P5942, DOI 10.1074/jbc.M110.123968; Hsu MJ, 2007, J NEUROSCI, V27, P5719, DOI 10.1523/JNEUROSCI.1874-06.2007; Hsu MJ, 2010, J LEUKOCYTE BIOL, V87, P1069, DOI 10.1189/jlb.1009668; Hsu YF, 2011, BBA-GEN SUBJECTS, V1810, P1160, DOI 10.1016/j.bbagen.2011.08.015; Huang YH, 2014, ANGIOGENESIS, V17, P407, DOI 10.1007/s10456-013-9386-1; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; INOUE H, 1995, J BIOL CHEM, V270, P24965, DOI 10.1074/jbc.270.42.24965; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jurisic G, 2010, GENES IMMUN, V11, P219, DOI 10.1038/gene.2010.4; Kim YS, 1998, J BIOL CHEM, V273, P27686, DOI 10.1074/jbc.273.42.27686; KINOSHITA S, 1992, P NATL ACAD SCI USA, V89, P1473, DOI 10.1073/pnas.89.4.1473; LECLAIR KP, 1992, P NATL ACAD SCI USA, V89, P8145, DOI 10.1073/pnas.89.17.8145; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu SF, 2006, AM J PHYSIOL-LUNG C, V290, pL622, DOI 10.1152/ajplung.00477.2005; Maitra U, 2012, J IMMUNOL, V189, P1014, DOI 10.4049/jimmunol.1200857; Makinen T, 2001, NAT MED, V7, P199, DOI 10.1038/84651; Manna PR, 2009, MOL CELL ENDOCRINOL, V302, P1, DOI 10.1016/j.mce.2008.12.009; Marshall JC, 2002, CRIT CARE, V6, P342, DOI 10.1186/cc1522; Mbonye UR, 2008, J BIOL CHEM, V283, P8611, DOI 10.1074/jbc.M710137200; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; Nisato RE, 2004, AM J PATHOL, V165, P11, DOI 10.1016/S0002-9440(10)63271-3; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Nizamutdinova IT, 2007, INT IMMUNOPHARMACOL, V7, P343, DOI 10.1016/j.intimp.2006.11.004; Proulx ST, 2013, J CONTROL RELEASE, V172, P550, DOI 10.1016/j.jconrel.2013.04.027; Reddy ST, 2000, J BIOL CHEM, V275, P3107, DOI 10.1074/jbc.275.5.3107; Saharinen P, 2004, TRENDS IMMUNOL, V25, P387, DOI 10.1016/j.it.2004.05.003; Sakamoto K, 2009, CLIN CANCER RES, V15, P2248, DOI 10.1158/1078-0432.CCR-08-1383; Sayama K, 2001, J BIOL CHEM, V276, P999, DOI 10.1074/jbc.M003425200; Schulte-Merker S, 2011, J CELL BIOL, V193, P607, DOI 10.1083/jcb.201012094; Shi VY, 2012, MICROCIRCULATION, V19, P567, DOI 10.1111/j.1549-8719.2012.00189.x; Silvers AL, 2003, NEOPLASIA, V5, P319, DOI 10.1016/S1476-5586(03)80025-8; Straccia M, 2013, GLIA, V61, P1607, DOI 10.1002/glia.22542; Takeda K, 2000, J BIOL CHEM, V275, P9805, DOI 10.1074/jbc.275.13.9805; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Takeda K, 2008, ANNU REV PHARMACOL, V48, P199, DOI 10.1146/annurev.pharmtox.48.113006.094606; Testi R, 1996, TRENDS BIOCHEM SCI, V21, P468, DOI 10.1016/S0968-0004(96)10056-6; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Wick N, 2007, PHYSIOL GENOMICS, V28, P179, DOI 10.1152/physiolgenomics.00037.2006; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; Yamamoto K, 1995, J BIOL CHEM, V270, P31315, DOI 10.1074/jbc.270.52.31315; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511; Zhang Q, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2326; Zhang R, 2007, J BIOL CHEM, V282, P14788, DOI 10.1074/jbc.M701148200	64	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0137177	10.1371/journal.pone.0137177	http://dx.doi.org/10.1371/journal.pone.0137177			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317424	gold, Green Published, Green Submitted			2022-12-26	WOS:000360299100212
J	Gordoa, A; Sanz, N; Vinas, J				Gordoa, Ana; Sanz, Nuria; Vinas, Jordi			Individual Spawning Duration of Captive Atlantic Bluefin Tuna (Thunnus thynnus) Revealed by Mitochondrial DNA Analysis of Eggs	PLOS ONE			English	Article							POPULATION-STRUCTURE; SEXUAL-MATURITY; L. 1758; WESTERN; SIZE; PREFERENCES; SATELLITE; FECUNDITY; FISHERIES; SOFTWARE	This study presents the first results on Atlantic bluefin tuna (Thunnus thynnus) individual spawning duration and its short-term temporal behavior. The study was based on direct measurements resulting from mtDNA analysis of the offspring of spawners held in transport cages during the 2013 spawning monitoring survey in Balearic waters. The number of females consisted of approximately 259 individuals with an average weight of 186 kg. The survey began on May 22 and ended on July 3. Spawning started on May 30 and was observed every night afterwards. The sampling of eggs for genetic monitoring was conducted for 9 days interspersed from the beginning of spawning to the end of the survey. A total of 946 eggs were analyzed and revealed 129 different haplotypes; 77 of these were not previously detected in the Mediterranean. A total of 69 haplotypes were observed in more than one spawning event and those with higher frequency lasted their maximum possible duration. The haplotypes present at the beginning of spawning were also identified at the end of the sampling, indicating a minimum spawning duration of 34 days, and individual annual fecundity was estimated at around 1290 eggs gr(-1). These results differed from those generally presumed until now and are indicative of a much higher fecundity. Females exhibited a regular spawning schedule but with the capacity to shift the spawning hour during the spawning season. These results were observed for the eastern population of Atlantic bluefin tuna and before extrapolating to the western population, their validity should be proved.	[Gordoa, Ana] CSIC, Dept Marine Ecol, Ctr Estudios Avanzados Blanes, Blanes, Girona, Spain; [Sanz, Nuria; Vinas, Jordi] Univ Girona, Fac Ciencies, Dept Biol, Lab Ictiol Genet, Girona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Universitat de Girona	Gordoa, A (corresponding author), CSIC, Dept Marine Ecol, Ctr Estudios Avanzados Blanes, Blanes, Girona, Spain.	gordoa@ceab.csic.es	Viñas, Jordi/A-5397-2010; Sanz, Nuria/L-3074-2014	Viñas, Jordi/0000-0003-0193-1141; Sanz, Nuria/0000-0001-5274-1917	Balfego Tuna SL Group under a programme of scientific cooperation with the Spanish National Research Council; Spanish Ministry of the Economy and Competitiveness [CTM2011-29525-C04-04]	Balfego Tuna SL Group under a programme of scientific cooperation with the Spanish National Research Council; Spanish Ministry of the Economy and Competitiveness(Spanish Government)	This study was funded by the Balfego Tuna SL Group under a programme of scientific cooperation with the Spanish National Research Council and by the Spanish Ministry of the Economy and Competitiveness (CTM2011-29525-C04-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, ICCAT MADRID; Aranda G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076445; Aranda G, 2013, J SEA RES, V76, P154, DOI 10.1016/j.seares.2012.08.005; Baglin Jr RE, 1982, FISHERY B US NATL MA; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; Boustany AM, 2008, MAR BIOL, V156, P13, DOI 10.1007/s00227-008-1058-0; Bremer JRA, 1997, J FISH BIOL, V50, P540, DOI 10.1006/jfbi.1996.0321; Bremer JRA, 2005, MOL PHYLOGENET EVOL, V36, P169, DOI 10.1016/j.ympev.2004.12.011; Carlsson J, 2004, MOL ECOL, V13, P3345, DOI 10.1111/j.1365-294X.2004.02336.x; Claramunt G, 2007, FISH RES, V85, P248, DOI 10.1016/j.fishres.2007.01.009; Corriero A, 2005, J APPL ICHTHYOL, V21, P483, DOI 10.1111/j.1439-0426.2005.00700.x; Corriero A, 2003, J FISH BIOL, V63, P108, DOI 10.1046/j.1095-8649.2003.00132.x; Diaz Guillermo A., 2011, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V66, P1216; Duclerc J., 1973, Revue Trav Inst Peches Marit, V37, P163; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frade F, 1933, ETAT MATURITE GONADE; Fromentin J-M, 2010, ICCAT COL VOL SCI PA, V65, P1052; Fromentin JM, 2005, FISH FISH, V6, P281, DOI 10.1111/j.1467-2979.2005.00197.x; GARCIA A, 2005, ICCAT COL VOL SCI PA, V58, P1261; Gordoa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090691; Gordoa A, 2009, ICES J MAR SCI, V66, P2205, DOI 10.1093/icesjms/fsp211; Heinisch G, 2014, SCI REPORTS, P4; Heinisch G, 2008, MAR BIOL, V154, P623, DOI 10.1007/s00227-008-0955-6; HUNTER JR, 1992, FISH B-NOAA, V90, P101; Jennings S, 1998, P ROY SOC B-BIOL SCI, V265, P333, DOI 10.1098/rspb.1998.0300; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kell L, 2009, ICCAT COL VOL SCI PA, V64, P633; Knapp JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098233; Lambert Yvan, 2009, Journal of Northwest Atlantic Fishery Science, V41, P93; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Margulies D, 2007, FISH B-NOAA, V105, P249; Masuma S, 2003, B FISHERIES RES AGEN; Masuma S, 2008, REV FISH SCI, V16, P385, DOI 10.1080/10641260701484325; Masuma Shukei, 2009, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V63, P207; MCGOWAN MF, 1989, FISH B-NOAA, V87, P615; Medina A, 2002, J FISH BIOL, V60, P203, DOI [10.1111/j.1095-8649.2002.tb02398.x, 10.1006/jfbi.2001.1835]; Medina A, 2007, MAR ECOL PROG SER, V337, P221, DOI 10.3354/meps337221; Melich B., 2011, COLLECTIVE VOLUME SC, V66, P759; Nakadate M, 2011, AQUACULTURE, V310, P325, DOI 10.1016/j.aquaculture.2010.11.007; Niwa Y, 2003, AQUACULTURE, V218, P387, DOI 10.1016/S0044-8486(03)00015-2; Oray IK, 2005, J APPL ICHTHYOL, V21, P236, DOI 10.1111/j.1439-0426.2005.00658.x; PARRISH RH, 1985, FISH B-NOAA, V83, P483; Reglero P, 2014, AQUACULTURE, V433, P94, DOI 10.1016/j.aquaculture.2014.05.050; Richards WJ, 1976, COL VOL SCI PAP ICCA, V5, P267; Rickman SJ, 2000, CAN J FISH AQUAT SCI, V57, P116, DOI 10.1139/cjfas-57-1-116; Rodriguez-Roda J, 1967, INVESTIGACION PESQUE, V31, P35; RODRIGUEZ-RODA JULIO, 1964, INVEST PESQUERA, V25, P33; RODRIGUEZRODA J, 1967, INVEST PESQ, V31, P33; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; SARA R, 1973, Bollettino di Pesca Piscicoltura e Idrobiologia, V28, P217; Schaefer Kurt M., 2001, Fish Physiology, V19, P225; Secor DH, 2015, CONSERV BIOL, V29, P400, DOI 10.1111/cobi.12392; Stokesbury MJW, 2007, HYDROBIOLOGIA, V582, P91, DOI 10.1007/s10750-006-0552-y; Susca V, 2001, J FISH BIOL, V58, P815, DOI 10.1111/j.1095-8649.2001.tb00533.x; Teo SLH, 2007, MAR BIOL, V152, P1105, DOI 10.1007/s00227-007-0758-1; Trippel EA, 1998, T AM FISH SOC, V127, P339, DOI 10.1577/1548-8659(1998)127&lt;0339:ESAVAS&gt;2.0.CO;2; Trippel Edward A., 1997, Fish and Fisheries Series, V21, P31; Vinas J, 2011, REV FISH BIOL FISHER, V21, P527, DOI 10.1007/s11160-010-9174-6; Vinas J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007606; Vlaming V. de, 1983, Control processes in fish physiology., P176	61	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136733	10.1371/journal.pone.0136733	http://dx.doi.org/10.1371/journal.pone.0136733			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317343	gold, Green Submitted, Green Published			2022-12-26	WOS:000360299100131
J	Iliyasu, G; Ogoina, D; Otu, AA; Dayyab, FM; Ebenso, B; Otokpa, D; Rotifa, S; Olomo, WT; Habib, AG				Iliyasu, Garba; Ogoina, Dimie; Otu, Akan A.; Dayyab, Farouq M.; Ebenso, Bassey; Otokpa, Daniel; Rotifa, Stella; Olomo, Wisdom T.; Habib, Abdulrazaq G.			A Multi-Site Knowledge Attitude and Practice Survey of Ebola Virus Disease in Nigeria	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; EPIDEMIC; CONGO	Background The 2014 Ebola Virus Disease (EVD) outbreak was characterised by fear, misconceptions and irrational behaviours. We conducted a knowledge attitude and practice survey of EVD in Nigeria to inform implementation of effective control measures. Methods Between July 30th and September 30th 2014, we undertook a cross sectional study on knowledge, attitude and practice (KAP) of Ebola Virus Disease (EVD) among adults of the general population and healthcare workers (HCW) in three states of Nigeria, namely Bayelsa, Cross River and Kano states. Demographic information and data on KAP were obtained using a self-administered standardized questionnaire. The percentage KAP scores were categorised as good and poor. Independent predictors of good knowledge of EVD were ascertained using a binary logistic regression model. Results Out of 1035 study participants with median age of 32 years, 648 (62.6%) were males, 846 (81.7%) had tertiary education and 441 (42.6%) were HCW. There were 218, 239 and 578 respondents from Bayelsa, Cross River and Kano states respectively. The overall median percentage KAP scores and interquartile ranges (IQR) were 79.46% (15.07%), 95.0% (33.33%) and 49.95% (37.50%) respectively. Out of the 1035 respondents, 470 (45.4%), 544(52.56%) and 252 (24.35%) had good KAP of EVD defined using 80%, 90% and 70% score cut-offs respectively. Independent predictors of good knowledge of EVD were being a HCW (Odds Ratio-OR-2.89, 95% Confidence interval-CI of 1.41-5.90), reporting 'moderate to high fear of EVD' (OR-2.15, 95% CI-(1.47-3.13) and 'willingness to modify habit' (OR-1.68, 95% CI-1.23-2.30). Conclusion Our results reveal suboptimal EVD-related knowledge, attitude and practice among adults in Nigeria. To effectively control future outbreaks of EVD in Nigeria, there is a need to implement public sensitization programmes that improve understanding of EVD and address EVD-related myths and misconceptions, especially among the general population.	[Iliyasu, Garba; Habib, Abdulrazaq G.] Bayero Univ, Coll Hlth Sci, Infect & Trop Dis Unit, Kano, Kano State, Nigeria; [Ogoina, Dimie] Niger Delta Univ, Niger Delta Univ Teaching Hosp NDUTH, Dept Internal Med, Okolobiri, Bayelsa State, Nigeria; [Otu, Akan A.; Ebenso, Bassey; Otokpa, Daniel] Univ Calabar, Dept Internal Med, Calabar, Cross River Sta, Nigeria; [Dayyab, Farouq M.] Aminu Kano Teaching Hosp, Dept Med, Infect & Trop Dis Unit, Kano, Kano State, Nigeria; [Ebenso, Bassey] Univ Leeds, Nuffield Ctr Int Hlth & Dev, Leeds, W Yorkshire, England; [Rotifa, Stella] Fed Med Ctr, Dept Publ Hlth, Yenagoa, Bayelsa State, Nigeria; [Olomo, Wisdom T.] Niger Delta Univ, Teaching Hosp, Infect Control Unit, Okolobiri, Bayelsa State, Nigeria	Bayero University; University of Calabar; University of Leeds	Habib, AG (corresponding author), Bayero Univ, Coll Hlth Sci, Infect & Trop Dis Unit, Kano, Kano State, Nigeria.	abdulrazaq_habib@yahoo.co.uk	Dayyab, Farouq/R-5746-2019; Ogoina, Dimie/H-4091-2019; Ebenso, Dr. Bassey E./H-5536-2017	Ogoina, Dimie/0000-0002-2098-6300; Ebenso, Dr. Bassey E./0000-0003-4147-0968; Dayyab, Farouq/0000-0001-8920-6483				[Anonymous], 2014, FOCUS 1000 TECHNICAL; [Anonymous], 2014, ALL AFRUCA NIGERIA H; Ansumana R, 2014, LANCET, V384, P303, DOI 10.1016/S0140-6736(14)61119-3; Atinuke B., 2019, STAT ANAL EBOLA VIRU; Beeching NJ, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7348; Birmingham K, 2002, NAT MED, V8, P313, DOI 10.1038/nm0402-313; CDC, EB VIR DIS; Chan M, 2014, NEW ENGL J MED, V371, P1183, DOI 10.1056/NEJMp1409859; Colebunders R, 2000, J INFECTION, V40, P16, DOI 10.1053/jinf.1999.0603; Fasina FO, 2014, EUROSURVEILLANCE, V19, P11, DOI 10.2807/1560-7917.ES2014.19.40.20920; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Gostin LO, 2014, JAMA-J AM MED ASSOC, V312, P1095, DOI 10.1001/jama.2014.11176; Hewlett BS, 2003, EMERG INFECT DIS, V9, P1242; Iftikhar R, 2012, ISRA MED J, V4, P86; Kass N, 2014, ANN INTERN MED, V161, P744, DOI 10.7326/M14-1864; Ndambi R, 1999, J INFECT DIS, V179, pS8, DOI 10.1086/514297; Oyeyemi SO, 2014, BMJ, P349; Pan American Health Organization, 2014, ORGANIZATION; Rahnavardi M, 2008, J HOSP INFECT, V69, P77, DOI 10.1016/j.jhin.2008.02.007; Shuaib F, 2010, W INDIAN MED J, V59, P139; Shuaib F, 2014, MMWR-MORBID MORTAL W, V63, P867; United Nations Children's Fund [UNICEF], 2014, SIT REP EB OUTBR NIG; Washington Post-ABC News Poll, 2014, THE WASHINGTON POST; World Health Organization, EB VIR DIS; World Health Organization, PUBL HLTH EM INT CON; World Health Organization, EB DAT STAT; World Health Organization, 2014, EB EXP THER RUM REM	27	39	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0135955	10.1371/journal.pone.0135955	http://dx.doi.org/10.1371/journal.pone.0135955			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317535	Green Published, gold, Green Submitted			2022-12-26	WOS:000360299100053
J	Murakami, T; Yoshikawa, T; Maekawa, Y; Ueda, T; Isogai, T; Sakata, K; Nagao, K; Yamamoto, T; Takayama, M				Murakami, Tsutomu; Yoshikawa, Tsutomu; Maekawa, Yuichiro; Ueda, Tetsuro; Isogai, Toshiaki; Sakata, Konomi; Nagao, Ken; Yamamoto, Takeshi; Takayama, Morimasa			Gender Differences in Patients with Takotsubo Cardiomyopathy: Multi-Center Registry from Tokyo CCU Network	PLOS ONE			English	Article							TAKO-TSUBO CARDIOMYOPATHY; ACUTE MYOCARDIAL-INFARCTION; PULMONARY-EMBOLISM; NATURAL-HISTORY; HEART-FAILURE; FOLLOW-UP; STRESS; ESTROGEN; SYSTEM; WOMEN	Background The clinical features of gender differences in takotsubo cardiomyopathy (TC) remain to be determined. The aim of this study was to evaluate the differences in clinical characteristics of male and female patients with TC. Methods We obtained the clinical information of 368 patients diagnosed with TC (84 male, 284 female) from the Tokyo CCU Network database collected from 1 January 2010 to 31 December 2012; the Network is comprised of 71 cardiovascular centers in the Tokyo (Japan) metropolitan area. We attempted to characterize clinical differences during hospitalization, comparing male and female patients with TC. Results There were no significant differences in apical ballooning type, median echocardiography ejection fraction, serious ventricular arrhythmias (such as ventricular tachycardia or fibrillation), or cardiovascular death between male and female patients. Male patients were younger than female patients (median age at hospitalization for male patients was 72 years vs. 76 years for female patients; p = 0.040). Prior physical stress was more common in male than female patients (50.0% vs. 31.3%; p = 0.002), while emotional stress was more common in female patients (19.0% vs. 31.0%; p = 0.039). Severe pump failure (defined as Killip Class >= III) (20.2% vs. 10.6%; p = 0.020) and cardiopulmonary supportive therapies (28.6% vs. 12.7%, p < 0.001) were more common in male than female patients. Multivariate analysis revealed that male gender (odds ratio = 4.32, 95% CI = 1.41-13.6, p = 0.011) was an independent predictor of adverse composite cardiac events, including cardiovascular death, severe pump failure, and serious ventricular arrhythmia. Conclusions Cardiac complications in our dataset appeared to be more common in male than female patients with TC during their hospitalization. Further investigation is required to clarify the underlying mechanisms responsible for the observed gender differences.	[Murakami, Tsutomu; Yoshikawa, Tsutomu; Maekawa, Yuichiro; Ueda, Tetsuro; Isogai, Toshiaki; Sakata, Konomi; Nagao, Ken; Yamamoto, Takeshi; Takayama, Morimasa] Tokyo CCU Network Sci Comm, Tokyo, Japan		Yoshikawa, T (corresponding author), Tokyo CCU Network Sci Comm, Tokyo, Japan.	tyoshi@shi.heart.or.jp						Akashi YJ, 2008, CIRCULATION, V118, P2754, DOI 10.1161/CIRCULATIONAHA.108.767012; Bielecka-Dabrowa A, 2010, INT J CARDIOL, V142, P120, DOI 10.1016/j.ijcard.2009.11.040; Brenner R, 2012, CLIN CARDIOL, V35, P340, DOI 10.1002/clc.21986; Brinjikji W, 2012, AM HEART J, V164, P215, DOI 10.1016/j.ahj.2012.04.010; DELRIO G, 1994, J CLIN ENDOCR METAB, V79, P836, DOI 10.1210/jc.79.3.836; Eitel I, 2010, EUR RADIOL, V20, P422, DOI 10.1007/s00330-009-1549-5; Fischer M, 2002, CARDIOVASC RES, V53, P672, DOI 10.1016/S0008-6363(01)00479-5; Heer T, 2002, AM J CARDIOL, V89, P511, DOI 10.1016/S0002-9149(01)02289-5; KILLIP T, 1967, AM J CARDIOL, V20, P457, DOI 10.1016/0002-9149(67)90023-9; Kuo BT, 2010, GENDER MED, V7, P71, DOI 10.1016/j.genm.2010.01.006; Kurisu S, 2012, J CARDIOL, V60, P429, DOI 10.1016/j.jjcc.2012.06.015; Kurisu S, 2010, CLIN CARDIOL, V33, P42, DOI [10.1002/clc.20700, 10.1002/clc.20726]; Maekawa Y, 2012, INTERNAL MED, V51, P257, DOI 10.2169/internalmedicine.51.6559; Maron MS, 2003, NEW ENGL J MED, V348, P295, DOI 10.1056/NEJMoa021332; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Morel O, 2009, J CARD FAIL, V15, P206, DOI 10.1016/j.cardfail.2008.10.031; Murakami T, 2014, J CARDIOL, V63, P269, DOI 10.1016/j.jjcc.2013.09.003; Obayashi T, 2010, CIRC J, V74, P289, DOI 10.1253/circj.CJ-09-0623; Parodi G, 2011, CHEST, V139, P887, DOI 10.1378/chest.10-1041; Prasad A, 2008, AM HEART J, V155, P408, DOI 10.1016/j.ahj.2007.11.008; Roberts BJ, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-25; Schneider B, 2013, HEART FAIL CLIN, V9, P137, DOI 10.1016/j.hfc.2012.12.005; Sharkey SW, 2010, J AM COLL CARDIOL, V55, P333, DOI 10.1016/j.jacc.2009.08.057; Takahashi M, 2011, J CARD FAIL, V17, P742, DOI 10.1016/j.cardfail.2011.05.005; Tanabe Y, 2014, J CARDIOL, V63, P385, DOI 10.1016/j.jjcc.2013.10.003; Thawornkaiwong A, 2003, LIFE SCI, V72, P1813, DOI 10.1016/S0024-3205(02)02473-6; Ueyama T, 2003, J CARDIOVASC PHARM, V42, pS117, DOI 10.1097/00005344-200312001-00024; Ueyama T, 2007, CIRC J, V71, P565, DOI 10.1253/circj.71.565; Ueyama T, 2008, ANN NY ACAD SCI, V1148, P479, DOI 10.1196/annals.1410.079; Vermeulen A, 2002, Aging Male, V5, P98, DOI 10.1080/713604678; Wattanapermpool J, 2000, LIFE SCI, V66, P533, DOI 10.1016/S0024-3205(99)00623-2; Zimmermann S, 2009, CLIN RES CARDIOL, V98, P709, DOI 10.1007/s00392-009-0055-8	32	45	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136655	10.1371/journal.pone.0136655	http://dx.doi.org/10.1371/journal.pone.0136655			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317750	gold, Green Published, Green Submitted			2022-12-26	WOS:000360299100119
J	Zhao, C; Sander, HA				Zhao, Chang; Sander, Heather A.			Quantifying and Mapping the Supply of and Demand for Carbon Storage and Sequestration Service from Urban Trees	PLOS ONE			English	Article							CULTURAL ECOSYSTEM SERVICES; CONCEPTUAL-FRAMEWORK; TROPICAL FORESTS; LIDAR DATA; DECOMPOSITION; BIOMASS; CONSERVATION; VALUATION; CAPACITY; DYNAMICS	Studies that assess the distribution of benefits provided by ecosystem services across urban areas are increasingly common. Nevertheless, current knowledge of both the supply and demand sides of ecosystem services remains limited, leaving a gap in our understanding of balance between ecosystem service supply and demand that restricts our ability to assess and manage these services. The present study seeks to fill this gap by developing and applying an integrated approach to quantifying the supply and demand of a key ecosystem service, carbon storage and sequestration, at the local level. This approach follows three basic steps: (1) quantifying and mapping service supply based upon Light Detection and Ranging (LiDAR) processing and allometric models, (2) quantifying and mapping demand for carbon sequestration using an indicator based on local anthropogenic CO2 emissions, and (3) mapping a supply-to-demand ratio. We illustrate this approach using a portion of the Twin Cities Metropolitan Area of Minnesota, USA. Our results indicate that 1735.69 million kg carbon are stored by urban trees in our study area. Annually, 33.43 million kg carbon are sequestered by trees, whereas 3087.60 million kg carbon are emitted by human sources. Thus, carbon sequestration service provided by urban trees in the study location play a minor role in combating climate change, offsetting approximately 1% of local anthropogenic carbon emissions per year, although avoided emissions via storage in trees are substantial. Our supply-to-demand ratio map provides insight into the balance between carbon sequestration supply in urban trees and demand for such sequestration at the local level, pinpointing critical locations where higher levels of supply and demand exist. Such a ratio map could help planners and policy makers to assess and manage the supply of and demand for carbon sequestration.	[Zhao, Chang; Sander, Heather A.] Univ Iowa, Dept Geog & Sustainabil Sci, Iowa City, IA 52242 USA	University of Iowa	Zhao, C (corresponding author), Univ Iowa, Dept Geog & Sustainabil Sci, Iowa City, IA 52242 USA.	chang-zhao@uiowa.edu	BITOUN, RACHEL Elisabeth/AAC-9538-2021; Bond-Lamberty, Benjamin/C-6058-2008	BITOUN, RACHEL Elisabeth/0000-0002-3614-9910; Bond-Lamberty, Benjamin/0000-0001-9525-4633; Zhao, Chang/0000-0002-5389-0479				ALBAN DH, 1993, CAN J FOREST RES, V23, P1744, DOI 10.1139/x93-220; Alonzo M, 2014, REMOTE SENS ENVIRON, V148, P70, DOI 10.1016/j.rse.2014.03.018; [Anonymous], 2015, EC US; [Anonymous], 2007, TERR CARB CYCL MAN F; [Anonymous], 2015, MINN NAT BIG TREE RE; [Anonymous], 2012, ESRI ARCGIS V 10 1; Bagstad KJ, 2013, ECOSYST SERV, V4, P117, DOI 10.1016/j.ecoser.2012.07.012; Baro F, 2014, AMBIO, V43, P466, DOI 10.1007/s13280-014-0507-x; Bastian O, 2012, ECOL INDIC, V21, P7, DOI 10.1016/j.ecolind.2011.03.014; BERENDSE F, 1987, CAN J BOT, V65, P1116, DOI 10.1139/b87-155; Berland A, 2012, TWIN CITIES URBANIZA; Boddy L, 1989, FEMS MICROBIOL LETT, P62; Boithias L, 2014, SCI TOTAL ENVIRON, V470, P567, DOI 10.1016/j.scitotenv.2013.10.003; Boumans R, 2002, ECOL ECON, V41, P529, DOI 10.1016/S0921-8009(02)00098-8; Boyd J, 2007, ECOL ECON, V63, P616, DOI 10.1016/j.ecolecon.2007.01.002; Brown S, 2002, ENVIRON POLLUT, V116, P363, DOI 10.1016/S0269-7491(01)00212-3; BROWN S, 1982, BIOTROPICA, V14, P161, DOI 10.2307/2388024; Burkhard B., 2014, Landscape Online; Burkhard B, 2012, ECOL INDIC, V21, P17, DOI 10.1016/j.ecolind.2011.06.019; Cairns MA, 1997, OECOLOGIA, V111, P1, DOI 10.1007/s004420050201; Casado-Arzuaga I, 2013, J ENVIRON MANAGE, V129, P33, DOI 10.1016/j.jenvman.2013.05.059; Chambers JQ, 2000, OECOLOGIA, V122, P380, DOI 10.1007/s004420050044; Conte M, 2011, NATURAL CAPITAL: THEORY & PRACTICE OF MAPPING ECOSYSTEM SERVICES, P111; Costanza R, 2008, BIOL CONSERV, V141, P350, DOI 10.1016/j.biocon.2007.12.020; de Groot RS, 2010, ECOL COMPLEX, V7, P260, DOI 10.1016/j.ecocom.2009.10.006; de Groot RS, 2002, ECOL ECON, V41, P393, DOI 10.1016/S0921-8009(02)00089-7; de Groot R, 2012, ECOSYST SERV, V1, P50, DOI 10.1016/j.ecoser.2012.07.005; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Egoh B, 2008, AGR ECOSYST ENVIRON, V127, P135, DOI 10.1016/j.agee.2008.03.013; Estornell J, 2011, FOREST ECOL MANAG, V262, P1697, DOI 10.1016/j.foreco.2011.07.026; Fisher B, 2009, ECOL ECON, V68, P643, DOI 10.1016/j.ecolecon.2008.09.014; Fraver S, 2013, ECOSYSTEMS, V16, P1262, DOI 10.1007/s10021-013-9682-z; Geijzendorffer IR, 2015, ECOL INDIC, V52, P320, DOI 10.1016/j.ecolind.2014.12.016; Gill SJ, 2000, FOREST ECOL MANAG, V126, P405, DOI 10.1016/S0378-1127(99)00113-9; Haase D, 2014, AMBIO, V43, P407, DOI 10.1007/s13280-014-0503-1; HARMON ME, 1986, ADV ECOL RES, V15, P133, DOI 10.1016/S0065-2504(08)60121-X; Hein L, 2006, ECOL ECON, V57, P209, DOI 10.1016/j.ecolecon.2005.04.005; Honey-Roses J, 2013, ECOSYST SERV, V5, pE160, DOI 10.1016/j.ecoser.2013.04.007; Iverson L.R., 1994, EFFECTS LAND USE CHA, P67, DOI DOI 10.1007/978-1-4613-8363-5_3; Jacobs S, 2015, ECOL MODEL, V295, P21, DOI 10.1016/j.ecolmodel.2014.08.024; Jenkins J, 2004, COMPREHENSIVE DATABA, P319; Jenkins JC, 2003, FOREST SCI, V49, P12; LAMBERT RL, 1980, ECOLOGY, V61, P1460, DOI 10.2307/1939054; Liquete C, 2013, ECOL INDIC, V30, P205, DOI 10.1016/j.ecolind.2013.02.013; Liu CF, 2012, URBAN FOR URBAN GREE, V11, P121, DOI 10.1016/j.ufug.2011.03.002; Locatelli B, 2014, ENVIRON CONSERV, V41, P27, DOI 10.1017/S0376892913000234; Locatelli B, 2011, REG ENVIRON CHANGE, V11, P393, DOI 10.1007/s10113-010-0149-x; Maes J, 2012, ECOSYST SERV, V1, P31, DOI 10.1016/j.ecoser.2012.06.004; McPherson E.G., 1994, CHICAGOS URBAN FORES; Mcpherson EG, 1999, URBAN FORESTRY GUIDE, P171; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; Minnesota Geographic Metadata, 2011, MET GEN LAND US 2010; Myeong S, 2006, REMOTE SENS ENVIRON, V101, P277, DOI 10.1016/j.rse.2005.12.001; Nedkov S, 2012, ECOL INDIC, V21, P67, DOI 10.1016/j.ecolind.2011.06.022; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; Nowak DJ, 2013, ENVIRON POLLUT, V178, P229, DOI 10.1016/j.envpol.2013.03.019; Nowak DJ, 2002, ENVIRON POLLUT, V116, P381, DOI 10.1016/S0269-7491(01)00214-7; NOWAK DJ, 1993, J ENVIRON MANAGE, V37, P207, DOI 10.1006/jema.1993.1017; Nowak DJ, 2002, BROOKLYNS URBAN FORE, P290; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; Opitz D, 2008, ASPRS 2008 ANN C POR, P0; Overwatch, 2015, OVERWATCH; Paetzold A, 2010, ECOL COMPLEX, V7, P273, DOI 10.1016/j.ecocom.2009.11.003; Palomo I, 2013, ECOSYST SERV, V4, P104, DOI 10.1016/j.ecoser.2012.09.001; Paracchini ML, 2014, ECOL INDIC, V45, P371, DOI 10.1016/j.ecolind.2014.04.018; Pataki DE, 2006, GLOBAL CHANGE BIOL, V12, P2092, DOI 10.1111/j.1365-2486.2006.01242.x; Pataki DE, 2011, FRONT ECOL ENVIRON, V9, P27, DOI 10.1890/090220; Phillips DL, 2011, ASSESSMENT ECOSYSTEM, P1; Plieninger T, 2013, LAND USE POLICY, V33, P118, DOI 10.1016/j.landusepol.2012.12.013; Popescu SC, 2007, BIOMASS BIOENERG, V31, P646, DOI 10.1016/j.biombioe.2007.06.022; Romaguera M, 2010, REMOTE SENS-BASEL, V2, P1177, DOI 10.3390/rs2041177; Russell MB, 2015, FOREST ECOL MANAG, V350, P107, DOI 10.1016/j.foreco.2015.04.033; SCHEU S, 1994, PLANT SOIL, V163, P13, DOI 10.1007/BF00033936; Schroter M, 2014, ECOL INDIC, V36, P539, DOI 10.1016/j.ecolind.2013.09.018; Schulp CJE, 2014, ECOL INDIC, V36, P131, DOI 10.1016/j.ecolind.2013.07.014; Schulp CJE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109643; Serna-Chavez HM, 2014, ECOL INDIC, V39, P24, DOI 10.1016/j.ecolind.2013.11.024; Simpson JR, 2002, ENERG BUILDINGS, V34, P1067, DOI 10.1016/S0378-7788(02)00028-2; Sturck J, 2014, ECOL INDIC, V38, P198, DOI 10.1016/j.ecolind.2013.11.010; Syrbe RU, 2012, ECOL INDIC, V21, P80, DOI 10.1016/j.ecolind.2012.02.013; Tallis H, 2009, ANN NY ACAD SCI, V1162, P265, DOI 10.1111/j.1749-6632.2009.04152.x; Teck R.M., 1991, INDIVIDUAL TREE DIAM; U.S. Census Bureau, 2010, 2010 CENS URB RUR CL; van Berkel DB, 2014, ECOL INDIC, V37, P163, DOI 10.1016/j.ecolind.2012.06.025; Villa F., 2009, 11 ANN BIOECON C EC; Villamagna AM, 2013, ECOL COMPLEX, V15, P114, DOI 10.1016/j.ecocom.2013.07.004; Willemen L, 2008, LANDSCAPE URBAN PLAN, V88, P34, DOI 10.1016/j.landurbplan.2008.08.004; Wolff S, 2015, ECOL INDIC, V55, P159, DOI 10.1016/j.ecolind.2015.03.016; Xcel Energy Inc, 2013, POW GEN SUPPL	89	23	27	17	140	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2015	10	8							e0136392	10.1371/journal.pone.0136392	http://dx.doi.org/10.1371/journal.pone.0136392			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ0PO	26317530	gold, Green Published			2022-12-26	WOS:000360299100077
J	Lee, SY; Ryan, ME; Hamlet, AF; Palen, WJ; Lawler, JJ; Halabisky, M				Lee, Se-Yeun; Ryan, Maureen E.; Hamlet, Alan F.; Palen, Wendy J.; Lawler, Joshua J.; Halabisky, Meghan			Projecting the Hydrologic Impacts of Climate Change on Montane Wetlands	PLOS ONE			English	Article							NORTHERN PRAIRIE WETLANDS; WATER; MODEL; TRENDS; SIZE; RESTORATION; ECOSYSTEMS; AMPHIBIANS; STREAMFLOW; RESOURCES	Wetlands are globally important ecosystems that provide critical services for natural communities and human society. Montane wetland ecosystems are expected to be among the most sensitive to changing climate, as their persistence depends on factors directly influenced by climate (e.g. precipitation, snowpack, evaporation). Despite their importance and climate sensitivity, wetlands tend to be understudied due to a lack of tools and data relative to what is available for other ecosystem types. Here, we develop and demonstrate a new method for projecting climate-induced hydrologic changes in montane wetlands. Using observed wetland water levels and soil moisture simulated by the physically based Variable Infiltration Capacity (VIC) hydrologic model, we developed site-specific regression models relating soil moisture to observed wetland water levels to simulate the hydrologic behavior of four types of montane wetlands (ephemeral, intermediate, perennial, permanent wetlands) in the U.S. Pacific Northwest. The hybrid models captured observed wetland dynamics in many cases, though were less robust in others. We then used these models to a) hindcast historical wetland behavior in response to observed climate variability (1916-2010 or later) and classify wetland types, and b) project the impacts of climate change on montane wetlands using global climate model scenarios for the 2040s and 2080s (A1B emissions scenario). These future projections show that climate-induced changes to key driving variables (reduced snowpack, higher evapotranspiration, extended summer drought) will result in earlier and faster drawdown in Pacific Northwest montane wetlands, leading to systematic reductions in water levels, shortened wetland hydroperiods, and increased probability of drying. Intermediate hydroperiod wetlands are projected to experience the greatest changes. For the 2080s scenario, widespread conversion of intermediate wetlands to fastdrying ephemeral wetlands will likely reduce wetland habitat availability for many species.	[Lee, Se-Yeun; Hamlet, Alan F.] Univ Washington, Climate Impacts Grp, Seattle, WA 98195 USA; [Ryan, Maureen E.; Lawler, Joshua J.; Halabisky, Meghan] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA; [Ryan, Maureen E.; Palen, Wendy J.] Simon Fraser Univ, Dept Biol, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada; [Hamlet, Alan F.] Univ Notre Dame, Dept Civil & Environm Engn & Earth Sci, Notre Dame, IN 46556 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Simon Fraser University; University of Notre Dame	Ryan, ME (corresponding author), Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA.	mo@csp-inc.org			David H. Smith Conservation Research Fellowship Program; North Pacific Landscape Conservation Cooperative [F11AC00080]; Northwest Climate Science Center [GS276A-A]; Canada Research Chairs Program; Grants-in-Aid for Scientific Research [14F04070] Funding Source: KAKEN	David H. Smith Conservation Research Fellowship Program; North Pacific Landscape Conservation Cooperative; Northwest Climate Science Center; Canada Research Chairs Program(Canada Research Chairs); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The David H. Smith Conservation Research Fellowship Program funded MER's salary and field research (no grant number; smithfellows.org). The North Pacific Landscape Conservation Cooperative funded SL's salary, a workshop to share results, and equipment (USFWS grant #F11AC00080; http://www.northpacificlcc.org/). The Northwest Climate Science Center provided salary support for SL, MER, AFH, JJL, and MH and funding for field research (USGS grant #GS276A-A; http://www.doi.gov/csc/Northwest/index.cfm). The Canada Research Chairs Program provided salary for WJP (http://www.chairs-chaires.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064347; Burkett V, 2000, J AM WATER RESOUR AS, V36, P313, DOI 10.1111/j.1752-1688.2000.tb04270.x; CARPENTER SR, 1992, ANNU REV ECOL SYST, V23, P119, DOI 10.1146/annurev.es.23.110192.001003; Cherkauer KA, 2003, GLOBAL PLANET CHANGE, V38, P151, DOI 10.1016/S0921-8181(03)00025-0; Dahl T., 1990, WETLANDS LOSSES US 1; Daly C, 2006, INT J CLIMATOL, V26, P707, DOI 10.1002/joc.1322; Davidson C, 2004, ECOL APPL, V14, P1892, DOI 10.1890/03-5224; Elsner MM, 2010, CLIMATIC CHANGE, V102, P225, DOI 10.1007/s10584-010-9855-0; Epanchin PN, 2010, ECOLOGY, V91, P2406, DOI 10.1890/09-1974.1; Erwin KL, 2009, WETL ECOL MANAG, V17, P71, DOI 10.1007/s11273-008-9119-1; Gaggiotti O.E., 2004, ECOLOGY GENETICS EVO; Garwood J, COMMUNICATION; Garwood JM, 2007, ECOLOGY CASCADES FRO; GIRDNER SF, 1995, J PLANKTON RES, V17, P1731, DOI 10.1093/plankt/17.9.1731; Halabisky M, 2013, WETL SCI PRAC, V30, P12; Halabisky M, USING LIDAR OBJECT B; Hamlet AF, 2005, J CLIMATE, V18, P4545, DOI 10.1175/JCLI3538.1; Hamlet AF, 2003, ATMOS OCEAN, V51, P392; Hamlet AF, 2007, J CLIMATE, V20, P1468, DOI 10.1175/JCLI4051.1; Hayhoe K, 2004, P NATL ACAD SCI USA, V101, P12422, DOI 10.1073/pnas.0404500101; Hruby T, 2006, STATE DEP ECOLOGY PU; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Johnson AC, 2009, SCI TOTAL ENVIRON, V407, P4787, DOI 10.1016/j.scitotenv.2009.05.018; Johnson WC, 2010, BIOSCIENCE, V60, P128, DOI 10.1525/bio.2010.60.2.7; Johnson WC, 2005, BIOSCIENCE, V55, P863, DOI 10.1641/0006-3568(2005)055[0863:VONPWT]2.0.CO;2; Knapp RA, 2007, BIOL CONSERV, V135, P11, DOI 10.1016/j.biocon.2006.09.013; Liang X, 1994, J GEOPHYS RES-ATMOS, V99, P14415, DOI 10.1029/94JD00483; Littell J. S., 2011, 09JV11015600039 USDA, P1; Metz B, 2007, P 8 SESS WORK GROUP; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING WE, P68; Mitsch W.J., 2007, WETLANDS, V4th ed., DOI DOI 10.1017/CBO9781107415324.004; Mote PW, 2010, CLIMATIC CHANGE, V102, P29, DOI 10.1007/s10584-010-9848-z; Mote PW, 2003, CLIMATIC CHANGE, V61, P45, DOI 10.1023/A:1026302914358; Mote PW, 2005, B AM METEOROL SOC, V86, P39, DOI 10.1175/BAMS-86-1-39; O'Regan SM, 2014, ECOLOGY, V95, P845, DOI 10.1890/13-0916.1; Payne JT, 2004, CLIMATIC CHANGE, V62, P233, DOI 10.1023/B:CLIM.0000013694.18154.d6; Pearl C, COMMUNICATION; Piovia-Scott J, 2011, BIOL CONSERV, V144, P2913, DOI 10.1016/j.biocon.2011.08.008; Poiani KA, 1996, LIMNOL OCEANOGR, V41, P871, DOI 10.4319/lo.1996.41.5.0871; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; R Core Team, 2015, R LANG ENV STAT COMP; Ryan ME, 2014, FRONT ECOL ENVIRON, V12, P232, DOI 10.1890/130145; Safeeq M, 2014, J HYDROMETEOROL, V15, P2501, DOI 10.1175/JHM-D-13-0198.1; Salathe EP, 2013, UNCERTAINTY EXTREME; Salathe EP, 2010, CLIMATIC CHANGE, V102, P51, DOI 10.1007/s10584-010-9849-y; SEMLITSCH RD, 1988, ECOLOGY, V69, P184, DOI 10.2307/1943173; SMITH DC, 1987, ECOLOGY, V68, P344, DOI 10.2307/1939265; Snodgrass JW, 2000, CONSERV BIOL, V14, P414, DOI 10.1046/j.1523-1739.2000.99161.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stewart IT, 2004, CLIMATIC CHANGE, V62, P217, DOI 10.1023/B:CLIM.0000013702.22656.e8; Stewart IT, 2005, J CLIMATE, V18, P1136, DOI 10.1175/JCLI3321.1; Tarr M, 2008, IMPORTANCE HYDROPERI, VAvailable; Taylor BE, 2006, CONSERV BIOL, V20, P792, DOI 10.1111/j.1523-1739.2005.00321.x; Tohver IM, 2014, J AM WATER RESOUR AS, V50, P1461, DOI 10.1111/jawr.12199; Walls SC, 2013, WETLANDS, V33, P345, DOI 10.1007/s13157-013-0391-3; Washington Department of Natural Resources, 2011, STAT WASH NAT HER PL; Watson RT, 2001, CLIMATE CHANGE 2001: IMPACTS, ADAPTATION, AND VULNERABILITY, pIX; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337; Wenger SJ, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008839; Werner BA, 2013, ECOL EVOL, V3, P3471, DOI 10.1002/ece3.731; Zambrano-Bigiarini M, 2014, PACKAGE HYDROGOF GOO; Zedler JB, 2005, ANNU REV ENV RESOUR, V30, P39, DOI 10.1146/annurev.energy.30.050504.144248	62	133	140	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136385	10.1371/journal.pone.0136385	http://dx.doi.org/10.1371/journal.pone.0136385			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331850	Green Published, gold, Green Submitted			2022-12-26	WOS:000360613800054
J	Yamamoto, M; Lopez, MT; Hart, LA				Yamamoto, Mariko; Lopez, Mayllynne T.; Hart, Lynette A.			Registrations of Assistance Dogs in California for Identification Tags: 1999-2012	PLOS ONE			English	Article							GUIDE DOGS; SERVICE; SUITABILITY; EVOLUTION; BEHAVIOR; FUTURE	Dogs are filling a growing number of roles supporting people with various disabilities, leading to a chaotic situation in the U.S. Although the federal laws allow public access with working dogs only for people with disabilities, no governmental enforcement or management system for such dogs exists. Furthermore, there is no substantive way to confirm whether the dog is an adequately trained assistance dog or not, as neither the handlers nor the dogs are required to carry any particular certification or identification. Therefore, unqualified assistance dogs and incidents such as dog bites by assistance dogs sometimes are problems in the U.S. A governmental oversight system could reduce problems, but no information is available about the current uses of assistance dogs in the U.S. We aimed to investigate the current demographics of registered assistance dogs and the evolving patterns in uses of dogs during 1999-2012 in California. We acquired data on assistance dogs registered by animal control facilities throughout California. We used descriptive statistics to describe the uses of these assistance dogs. The number of assistance dogs sharply increased, especially service dogs, in the past decade. Dogs with small body sizes, and new types of service dogs, such as service dogs for psychiatric and medical assistance, strongly contributed to the increase. The Assistance Dog Identification tags sometimes were mistakenly issued to dogs not fitting the definition of assistance dogs under the law, such as emotional support animals and some cats; this reveals errors in the California governmental registering system. Seemingly inappropriate dogs also were registered, such as those registered for the first time at older than 10 years of age. This study reveals a prevalence of misuse and misunderstanding of regulations and legislation on assistance dogs in California.	[Yamamoto, Mariko; Lopez, Mayllynne T.; Hart, Lynette A.] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA	University of California System; University of California Davis	Yamamoto, M (corresponding author), Teikyo Univ Sci, Dept Anim Sci, Yamanashi, Japan.	yamamoto-mariko@ntu.ac.jp	Hart, Lynette/L-4833-2019; Ogura, Yasuhiro/A-2557-2016; Nagao, Miki/ABG-8561-2021	Hart, Lynette/0000-0002-7133-6535; Ogura, Yasuhiro/0000-0001-5768-6160; Nagao, Miki/0000-0002-8886-6145; Matsumura, Yasufumi/0000-0001-8595-8944; Yamamoto, Masaki/0000-0002-7822-3269				Adams B, 2000, BEHAV BRAIN RES, V108, P47, DOI 10.1016/S0166-4328(99)00132-1; American Kennel Club, 2014, DOG BREEDS; American Veterinary Medical Association, 2012, US PET OWN STAT; Assistance Dogs International, 2014, DOG BREEDS BEH; Assistance Dogs International, 2014, GUID DOGS; Assistance Dogs International, 2014, TYP ASS DOGS; Beerda B, 1997, APPL ANIM BEHAV SCI, V52, P307, DOI 10.1016/S0168-1591(96)01131-8; Bergeron R, 2002, CAN J VET RES, V66, P211; Burrows KE, 2008, J APPL ANIM WELF SCI, V11, P42, DOI 10.1080/10888700701555550; Canine Companions for Independence, 2009, WHAT HAPP RET LOSS A; Clutton-Brock Juliet, 1995, P7; Cobb M, 2015, BEHAV PROCESS, V110, P96, DOI 10.1016/j.beproc.2014.10.012; Coppinger R, 1998, J Appl Anim Welf Sci, V1, P133, DOI 10.1207/s15327604jaws0102_4; Davis BW, 2004, ANTHROZOOS, V17, P130, DOI 10.2752/089279304786991765; DogsBite.org, 2012, 2012 DOG BIT FAT STA; Ennik I, 2006, J VET BEHAV, V1, P67, DOI 10.1016/j.jveb.2006.06.004; Fairman S K, 2001, Occup Ther Health Care, V13, P41, DOI 10.1080/J003v13n02_03; Fishman GA, 2003, SURV OPHTHALMOL, V48, P452, DOI 10.1016/S0039-6257(03)00052-3; Guide Dogs for the Blind Association, 2014, REH GUID DOG; Hart BL, 1988, PERFECT PUPPY CHOOSE, P40; Hart LA, 1996, APPL ANIM BEHAV SCI, V47, P7, DOI 10.1016/0168-1591(95)01006-8; Hawks E, 1975, EVENING SUN      DEC; Hoffman CL, 2014, J APPL ANIM WELF SCI, V17, P322, DOI 10.1080/10888705.2014.895904; KNOL BW, 1988, VET QUART, V10, P198, DOI 10.1080/01652176.1988.9694171; Meyers DM, 2014, YAKIMAHERALD; Ministry of Health Labour and Welfare, 2002, ACT ASS DOGS PHYS DI; MOREY DF, 1994, AM SCI, V82, P336; Parenti L, 2013, J REHABIL RES DEV, V50, P745, DOI 10.1682/JRRD.2012.11.0216; Rintala DH, 2002, SCI PSYCHOSOC PROCES, V15, p[65, 70]; Tapp PD, 2003, LEARN MEMORY, V10, P64, DOI 10.1101/lm.54403; VALENTINE DP, 1993, SOC WORK HEALTH CARE, V19, P109, DOI 10.1300/J010v19n01_07; Weiss E, 1997, APPL ANIM BEHAV SCI, V53, P297, DOI 10.1016/S0168-1591(96)01176-8; Whitmarsh L., 2005, VISUAL IMPAIRMENT RE, V7, P27, DOI [DOI 10.1080/13882350590956439, 10.1080/13882350590956439]	33	24	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0132820	10.1371/journal.pone.0132820	http://dx.doi.org/10.1371/journal.pone.0132820			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6SN	26322891	Green Published, gold			2022-12-26	WOS:000360018600004
J	Yamamoto, M; Takakura, S; Iinuma, Y; Hotta, G; Matsumura, Y; Matsushima, A; Nagao, M; Ogawa, K; Fujimoto, Y; Mori, A; Ogura, Y; Kaido, T; Uemoto, S; Ichiyama, S				Yamamoto, Masaki; Takakura, Shunji; Iinuma, Yoshitsugu; Hotta, Go; Matsumura, Yasufumi; Matsushima, Aki; Nagao, Miki; Ogawa, Kohei; Fujimoto, Yasuhiro; Mori, Akira; Ogura, Yasuhiro; Kaido, Toshimi; Uemoto, Shinji; Ichiyama, Satoshi			Changes in Surgical Site Infections after Living Donor Liver Transplantation	PLOS ONE			English	Article							RISK-FACTORS; COMPLICATIONS; PREVENTION; RECIPIENTS; ASSOCIATION; PROPHYLAXIS; SPECTRUM	Surgical site infections (SSIs) are a major threat for liver transplant recipients. We prospectively studied SSIs after living donor liver transplantation (LDLT) at Kyoto University Hospital from April 2001 to March 2002 (1st period) and from January 2011 to June 2012 (2nd period). We investigated the epidemiology of SSIs after LDLT and determined the differences between the two periods. A total of 129 adult recipients (66 during the 1st period and 63 during the 2nd period) and 72 pediatric recipients (39 and 33) were included in this study. The SSI rates for each period were 30.3% (1st period) and 41.3% (2nd period) among the adult recipients and 25.6% and 30.3% among the pediatric recipients. The overall rates of 30-day mortality among adult transplant recipients with SSIs were 10.0% (1st period) and 3.9% (2nd period). No pediatric recipient died from SSIs after LDLT in either period. The incidence of Enterococcus faecium increased from 5.0% to 26.9% in the adults and from 10.0% to 40.0% in the pediatric patients. Extended-spectrum beta-lactamase-producing Enterobacteriaceae were emerging important isolates during the 2nd period. For this period, a univariate analysis showed that ABO incompatibility (P=0.02), total operation duration (P=0.01), graft-to-recipient body weight ratio (GRWR [P=0.04]), and Roux-en-Y biliary reconstruction (P<0.01) in the adults and age (P=0.01) and NHSN risk index (P=0.02) in the children were associated with SSI development. In a multivariate analysis, lower GRWR (P=0.02) and Roux-en-Y biliary reconstruction (P<0.01) in the adults and older age (P=0.01) in the children were independent risk factors for SSIs during the 2nd period. In conclusion, SSIs caused by antibiotic resistant bacteria may become a major concern. Lower GRWR and Roux-en-Y biliary reconstruction among adult LDLT recipients and older age among pediatric LDLT recipients increased the risk of developing SSIs after LDLT.	[Yamamoto, Masaki; Takakura, Shunji; Hotta, Go; Matsumura, Yasufumi; Matsushima, Aki; Nagao, Miki; Ichiyama, Satoshi] Kyoto Univ, Dept Clin Lab Med, Grad Sch Med, Kyoto, Japan; [Iinuma, Yoshitsugu] Kanazawa Med Univ, Dept Infect Dis, Kanazawa, Ishikawa, Japan; [Ogawa, Kohei; Fujimoto, Yasuhiro; Mori, Akira; Kaido, Toshimi; Uemoto, Shinji] Kyoto Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg & Transplantat, Kyoto, Japan; [Ogura, Yasuhiro] Nagoya Univ Hosp, Dept Transplantat Surg, Nagoya, Aichi, Japan	Kyoto University; Kanazawa Medical University; Kyoto University; Nagoya University	Takakura, S (corresponding author), Kyoto Univ, Dept Clin Lab Med, Grad Sch Med, Kyoto, Japan.	stakakr@kuhp.kyoto-u.ac.jp	Hart, Lynette/L-4833-2019; Ogura, Yasuhiro/A-2557-2016; Nagao, Miki/ABG-8561-2021	Hart, Lynette/0000-0002-7133-6535; Ogura, Yasuhiro/0000-0001-5768-6160; Nagao, Miki/0000-0002-8886-6145; Matsumura, Yasufumi/0000-0001-8595-8944; Yamamoto, Masaki/0000-0002-7822-3269	Ministry of Health, Labor and Welfare of Japan [H21-Shinko-Ippan-009, H23-Shinko-Ippan-018]	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a grant from the Ministry of Health, Labor and Welfare of Japan (H21-Shinko-Ippan-009 and H23-Shinko-Ippan-018). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asensio A, 2008, LIVER TRANSPLANT, V14, P799, DOI 10.1002/lt.21435; Bratzler DW, 2006, CLIN INFECT DIS, V43, P322, DOI 10.1086/505220; Bratzler DW, 2004, CLIN INFECT DIS, V38, P1706, DOI 10.1086/421095; COLONNA JO, 1988, ARCH SURG-CHICAGO, V123, P360; de Villa VH, 2003, TRANSPLANTATION, V75, pS2, DOI 10.1097/01.TP.0000046532.44975.57; Prado MEG, 2008, TRANSPLANTATION, V85, P1849, DOI 10.1097/TP.0b013e3181735407; Hashimoto M, 2009, TRANSPL INFECT DIS, V11, P11, DOI 10.1111/j.1399-3062.2008.00341.x; Hellinger WC, 2011, AM J TRANSPLANT, V11, P1877, DOI 10.1111/j.1600-6143.2011.03644.x; Hellinger WC, 2009, TRANSPLANTATION, V87, P1387, DOI 10.1097/TP.0b013e3181a25133; Iinuma Y, 2004, TRANSPLANTATION, V78, P704, DOI 10.1097/01.TP.0000130178.17216.28; Kaido T, 2012, WORLD J SURG, V36, P1666, DOI 10.1007/s00268-012-1529-9; Lee SO, 2011, LIVER TRANSPLANT, V17, P733, DOI 10.1002/lt.22296; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Matsumura Y, 2012, J ANTIMICROB CHEMOTH, V67, P2612, DOI 10.1093/jac/dks278; Matsuo K, 2004, TRANSPLANT P, V36, P2299, DOI 10.1016/j.transproceed.2004.08.043; Mrzljak A, 2010, LIVER TRANSPLANT, V16, P1217, DOI 10.1002/lt.22137; Muiesan P, 2007, J HEPATOL, V46, P340, DOI 10.1016/j.jhep.2006.11.006; Nafady-Hego H, 2011, LIVER TRANSPLANT, V17, P976, DOI 10.1002/lt.22278; OZAKI CF, 1994, SURG CLIN N AM, V74, P1155, DOI 10.1016/S0039-6109(16)46438-8; Park C, 2009, TRANSPLANTATION, V87, P1031, DOI 10.1097/TP.0b013e31819cc3e6; PAYA CV, 1989, EUR J CLIN MICROBIOL, V8, P499, DOI 10.1007/BF01967467; Pungpapong S, 2006, LIVER TRANSPLANT, V12, P1244, DOI 10.1002/lt.20801; Reid GE, 2009, TRANSPLANTATION, V87, P1706, DOI 10.1097/TP.0b013e3181a60338; Shah H, 2014, LIVER TRANSPLANT, V20, P930, DOI 10.1002/lt.23890; SINGH N, 1994, TRANSPLANTATION, V58, P774, DOI 10.1097/00007890-199410150-00004; Vandecasteele E, 2010, TRANSPL INT, V23, P182, DOI 10.1111/j.1432-2277.2009.00974.x	26	24	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2015	10	8							e0136559	10.1371/journal.pone.0136559	http://dx.doi.org/10.1371/journal.pone.0136559			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2MT	26322891	Green Published, gold, Green Submitted			2022-12-26	WOS:000360435500020
J	Lee, S				Lee, Sean			A Sketch of Language History in the Korean Peninsula	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; HOMOGENEITY; BARRIERS; MODEL	Among 7100 languages spoken on Earth, the Koreanic language is the 13th largest, with about 77 million speakers in and around the Korean Peninsula. In comparison to other languages of similar size, however, surprisingly little is known about the evolution of the Koreanic language. This is mainly due to two reasons. The first reason is that the genealogical relationship of the Koreanic to other neighboring languages remains uncertain, and thus inference from the linguistic comparative method provides only provisional evidence. The second reason is that, as the ancestral Koreanic speakers lacked their own writing system until around 500 years ago, there are scant historical materials to peer into the past, except for those preserved in Sinitic characters that we have no straightforward way of interpreting. Here I attempt to overcome these disadvantages and shed some light on the linguistic history of the Korean Peninsula, by analyzing the internal variation of the Koreanic language with methods adopted from evolutionary biology. The preliminary results presented here suggest that the evolutionary history of the Koreanic language is characterized by a weak hierarchical structure, and intensive gene/culture flows within the Korean Peninsula seem to have promoted linguistic homogeneity among the Koreanic variants. Despite the gene/culture flows, however, there are still three detectable linguistic barriers in the Korean Peninsula that appear to have been shaped by geographical features such as mountains, elevated areas, and ocean. I discuss these findings in an inclusive manner to lay the groundwork for future studies.	Univ Tokyo, Sch Sci, Dept Biol Sci, Tokyo, Japan	University of Tokyo	Lee, S (corresponding author), Univ Tokyo, Sch Sci, Dept Biol Sci, Tokyo, Japan.	seanlee@darwin.c.u-tokyo.ac.jp			 [2604070]; Grants-in-Aid for Scientific Research [14F04070] Funding Source: KAKEN	; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) Fellows (2604070). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikhenvald AY, 2006, AREAL DIFFUSION AND; Alekseyenko AV, 2008, SYST BIOL, V57, P772, DOI 10.1080/10635150802434394; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; [Anonymous], 2014, ETHNOLOGUE LANGUAGES; [Anonymous], 2006, LANGUAGE KOREAN CULT; [Anonymous], [No title captured], DOI DOI 10.1075/DIA.23.1.04HAM; Axelsen JB, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3029; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Blust R., 2013, THE AUSTRONESIAN LAN; Bouckaert R., 2014, DENSITREE 2 SEEING T, DOI [10.1101/012401, DOI 10.1101/012401]; Bowern C, 2012, P ROY SOC B-BIOL SCI, V279, P4590, DOI 10.1098/rspb.2012.1842; Brassel K.E., 1979, GEOGR ANAL, V325, P31, DOI [10.1111/j.1538-4632.1979.tb00695.x, DOI 10.1111/J.1538-4632.1979.TB00695.X]; Crowley T, 2010, AN INTRODUCTION TO H; Dixon RMW, 1997, THE RISE AND FALL OF; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dunn Michael., 2015, ROUTLEDGE HDB HIST L, P190; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Gray RD, 2009, SCIENCE, V323, P479, DOI 10.1126/science.1166858; Gray RD, 2003, NATURE, V426, P435, DOI 10.1038/nature02029; Gray RD, 2013, STRUNGMANN FORUM REP, P285; Greenhill S. J., 2015, ROUTLEDGE HDB HIST L, P557; Greenhill SJ, 2009, P ROY SOC B-BIOL SCI, V276, P2299, DOI 10.1098/rspb.2008.1944; Greenhill SJ, 2008, EVOL BIOINFORM, V4, P271; Holden Clare, 2006, PHYLOGENETIC METHODS, P19; Hong SB, 2014, GENES GENOM, V36, P583, DOI 10.1007/s13258-014-0194-9; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Hymes D, 1974, PIDGINIZATION AND CR; Jin HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004210; Kim SH, 2010, INT J LEGAL MED, V124, P653, DOI 10.1007/s00414-010-0501-1; Kim YJ, 2013, GENES GENOM, V35, P355, DOI 10.1007/s13258-013-0082-8; Lee KM, 2011, HISTORY OF THE KOREAN LANGUAGE, P1, DOI 10.1017/CBO9780511974045; Lee S, 2014, J EVOLUTION BIOL, V27, P1905, DOI 10.1111/jeb.12442; Lee SH, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.041009; Lee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062243; Lee S, 2011, P ROY SOC B-BIOL SCI, V278, P3662, DOI 10.1098/rspb.2011.0518; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; MARTIN SE, 1966, LANGUAGE, V42, P185, DOI 10.2307/411687; Mayr E., 1998, THIS IS BIOLOGY; Monmonier MS, 1973, GEOGRAPHICAL ANALYSI; Nam K., 2014, KYOHAKKOE SACEN A MI; Nanmal ohwi chongbo chori yonguso, 2010, URIMAL PANGEN SACEN; Ogura S, 1944, CHOSENGO HOGEN NO KE; Ogura S, 1940, THE OUTLINE OF THE K; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Penny D, 2001, J MOL EVOL, V53, P711, DOI 10.1007/s002390010258; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2013, R A LANGUAGE AND ENV; Reesink G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000241; Ringe D, 2002, T PHILOL SOC, V100, P59, DOI 10.1111/1467-968X.00091; Simpson A., 2007, LANGUAGE AND NATIONA; Sohn H-M, 2001, THE KOREAN LANGUAGE; Starostin S, 2003, LANGUAGES OF THE WOR; Starostin SA, 2003, ETYMOLOGICAL DICTION; Trudgill Peter, 2004, LINGUIST TYPOL, V8, P305, DOI DOI 10.1515/LITY.2004.8.3.305; Voronoi G, 1908, J REINE ANGEW MATH, V134, P198, DOI 10.1515/crll.1908.134.198; Vovin A, 2010, KOREA JAPONICA; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	59	133	140	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128448	10.1371/journal.pone.0128448	http://dx.doi.org/10.1371/journal.pone.0128448			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CJ2MQ	26331850	Green Published, Green Submitted, gold			2022-12-26	WOS:000355319400091
